pathway,pval,padj,ES,NES,nMoreExtreme,size,leadingEdge
PROLINE BIOSYNTHESIS I%HUMANCYC%PROSYN-PWY,0.399685904986258,0.7394926011035,-0.480633922779553,-1.05220812750565,3053,4,PYCR1|PYCRL
MOLYBDENUM COFACTOR BIOSYNTHESIS%HUMANCYC%PWY-6823,0.43698468786808,0.7635056706929721,-0.463519100927406,-1.01474020483074,3338,4,MOCS2|GPHN
GLYCEROL DEGRADATION I%HUMANCYC%PWY-4261,0.33762271159458696,0.699636319850872,-0.66658434043193,-1.10930293732926,2544,2,GK
OXIDATIVE ETHANOL DEGRADATION III%HUMANCYC%PWY66-161,0.264395782643958,0.639661268021129,0.48962501287302,1.1775453481995701,1955,5,ALDH3A2|CYP2E1
TETRAPYRROLE BIOSYNTHESIS II%HUMANCYC%PWY-5189,0.792147806004619,0.92928807928331,0.338516567961009,0.7437353164316949,5830,4,HMBS
ASPARAGINE DEGRADATION I%HUMANCYC%ASPARAGINE-DEG1-PWY,0.0311705685618729,0.250729241129472,-0.98467137185708,-1.3118187008531201,232,1,ASRGL1
TETRAHYDROBIOPTERIN BIOSYNTHESIS I%HUMANCYC%PWY-5663,0.0214995968825585,0.20251241938493103,0.818314396254622,1.60952784998076,159,3,SPR|PTS
UREA CYCLE%HUMANCYC%PWY-4984,0.361193227626982,0.716154857259883,0.558007727505704,1.09753535075955,2687,3,ASL|ARG2
KETOGENESIS%HUMANCYC%REACT_1464.NULL,0.108272506082725,0.452688960675589,0.593183792641857,1.4266036196846599,800,5,HADHB|ACAT1|HMGCL|BDH1
CDP-DIACYLGLYCEROL BIOSYNTHESIS I%HUMANCYC%PWY-5667,0.16986003533088698,0.543060240369657,0.334447844772315,1.28605160585743,1249,17,GPAT2|MBOAT2|AGPAT4|GPD2|MBOAT7|CDS1|LPCAT4
SELENOCYSTEINE BIOSYNTHESIS II (ARCHAEA AND EUKARYOTES)%HUMANCYC%PWY-6281,0.10813733441470699,0.452488212455009,0.593620579372186,1.42765408926634,799,5,SEPSECS|SARS2|PSTK|SEPHS1
CATECHOLAMINE BIOSYNTHESIS%HUMANCYC%PWY66-301,0.844051446945338,0.948285501480553,0.42446289577576896,0.7131524695261641,6299,2,DDC|PNMT
RAPOPORT-LUEBERING GLYCOLYTIC SHUNT%HUMANCYC%PWY-6405,0.451511582253632,0.7698428203132289,-0.45726795500433703,-1.00105513968087,3449,4,PGAM2|PGAM1
L-CARNITINE BIOSYNTHESIS%HUMANCYC%PWY-6100,0.31175378084372496,0.68160868787154,-0.679131891683448,-1.13018406911609,2349,2,TMLHE
ASPARAGINE BIOSYNTHESIS I%HUMANCYC%ASPARAGINE-BIOSYNTHESIS,0.683745819397993,0.885415243771438,-0.6619982355535949,-0.881940604907751,5110,1,ASNS
UDP-D-XYLOSE AND UDP-D-GLUCURONATE BIOSYNTHESIS%HUMANCYC%PWY-4821,0.13906752411575599,0.504314492208813,0.7782740556934109,1.30760090059581,1037,2,UXS1|UGDH
4-HYDROXY-2-NONENAL DETOXIFICATION%HUMANCYC%PWY-7112,0.0757495356858583,0.38528503086409704,-0.8239977087366541,-1.3712639544785201,570,2,GSTP1
GDP-MANNOSE BIOSYNTHESIS%HUMANCYC%PWY-5659,0.7606895615583008,0.91820552689264,0.293519380018279,0.759498647475463,5603,6,GMPPA|PMM1|PMM2
GUANINE AND GUANOSINE SALVAGE I%HUMANCYC%PWY-6620,0.0271955425842399,0.23271567002476898,-0.8924731182795699,-1.48521798599922,204,2,HPRT1|PNP
THREONINE DEGRADATION II%HUMANCYC%THREONINE-DEG2-PWY,0.29021118342409397,0.662840067565582,0.8574658138509041,1.14331496245867,2184,1,GCAT
"SUPERPATHWAY OF D-<I>MYO< I>-INOSITOL (1,4,5)-TRISPHOSPHATE METABOLISM%HUMANCYC%PWY-6358",0.20438252400919799,0.584086105283232,0.309669120144021,1.23461482856049,1510,19,INPP1|INPP5K|INPP5J|IMPA1|INPP5F|INPPL1|ITPKC
S-ADENOSYL-L-METHIONINE BIOSYNTHESIS%HUMANCYC%SAM-PWY,0.47293676312968896,0.7831522581932591,0.60413564929694,1.01502589392997,3529,2,MAT2A|MAT2B
"D-<I>MYO< I>-INOSITOL (1,4,5)-TRISPHOSPHATE DEGRADATION%HUMANCYC%PWY-6363",0.12274270196877099,0.47697345522944606,0.392106656861445,1.3732392615250502,903,13,INPP1|INPP5K|INPP5J|IMPA1|INPP5F|INPPL1
MAP KINASE CASCADE%HUMANCYC%REACT_634.NULL,0.364988710320096,0.7195069672195101,0.8185928539920602,1.09148311572641,2747,1,YWHAB
GUANOSINE NUCLEOTIDES DEGRADATION III%HUMANCYC%PWY-6608,0.63531440700451,0.863600910248377,-0.545014804012396,-0.9069917882966221,4788,2,PNP
ASPARTATE BIOSYNTHESIS%HUMANCYC%ASPARTATESYN-PWY,0.551870522685062,0.822639759332792,-0.579006032584783,-0.9635586282472071,4159,2,GOT1
XANTHINE AND XANTHOSINE SALVAGE%HUMANCYC%SALVPURINE2-PWY,0.0631438127090301,0.36006266503904,-0.9667512130569029,-1.2879447464474099,471,1,PNP
GLYCINE BIOSYNTHESIS I%HUMANCYC%GLYSYN-PWY,0.588617670469621,0.8414799095069009,-0.5632550079202541,-0.9373464044272091,4436,2,SHMT2
GALACTOSE DEGRADATION I (LELOIR PATHWAY)%HUMANCYC%PWY-6317,0.18165161628059198,0.554948538055731,-0.590292447670541,-1.2922735612422,1387,4,GALT|GALK1
BMP SIGNALLING PATHWAY%HUMANCYC%REACT_12034.NULL,0.8720410310362969,0.958573710008769,-0.280358957702064,-0.671966924198654,6630,5,BMP2
GDP-GLUCOSE BIOSYNTHESIS%HUMANCYC%PWY-5661,0.499388670017661,0.794989907195277,0.43422514805098494,0.9540111428918241,3675,4,PGM1|GCK|PGM2
DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE BIOSYNTHESIS%HUMANCYC%MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,0.6111111111111109,0.8515889287679592,0.28564140011827005,0.868037870255338,4476,9,DPAGT1|ALG13|DPM1|ALG8|ALG5
GLUTATHIONE BIOSYNTHESIS%HUMANCYC%GLUTATHIONESYN-PWY,0.154797097554421,0.523022297381039,0.6675306054924449,1.31295392720954,1151,3,GSS|GCLM|GCLC
SUPEROXIDE RADICALS DEGRADATION%HUMANCYC%DETOX1-PWY,0.007198010731579641,0.102315552754816,-0.7983786466662991,-1.74781774867468,54,4,SOD2|SOD3|SOD1|CAT
<I>MYO< I>-INOSITOL BIOSYNTHESIS%HUMANCYC%PWY-2301,0.7254449123760359,0.9040629990111769,0.36109750679986896,0.7933466007295409,5339,4,IMPA1|ISYNA1|IMPAD1
PYRIDOXAL 5'-PHOSPHATE SALVAGE PATHWAY%HUMANCYC%PLPSAL-PWY,0.004510480233483679,0.0743264309917645,-0.957926661152468,-1.59414314814819,33,2,PNPO|PDXK
ARGININE DEGRADATION VI (ARGINASE 2 PATHWAY)%HUMANCYC%ARG-PRO-PWY,0.529458179905313,0.8108997701936519,-0.38831899404368,-0.930726530638425,4025,5,ARG2|PYCR2|OAT|PYCR1|PYCRL
CITRULLINE-NITRIC OXIDE CYCLE%HUMANCYC%PWY-4983,0.664337543671056,0.8804055751124069,0.42585560824322,0.8376077271463349,4943,3,ASL
PHOSPHATIDYLGLYCEROL BIOSYNTHESIS II (NON-PLASTIDIC)%HUMANCYC%PWY4FS-8,0.21308131629045396,0.5955959218692061,0.312432790416031,1.2229952532499198,1566,18,GPAT2|MBOAT2|AGPAT4|GPD2|MBOAT7|CDS1|LPCAT4
L-DOPA DEGRADATION%HUMANCYC%PWY-6334,0.41404682274247495,0.7484205884564641,-0.793559770621967,-1.05721215940633,3094,1,COMT
SALVAGE PATHWAYS OF PYRIMIDINE RIBONUCLEOTIDES%HUMANCYC%PWY0-163,0.254157391645934,0.633328402505013,-0.343203837635885,-1.18137416388475,1940,13,CDA|NME2|NME1|UCK1
SULFATE ACTIVATION FOR SULFONATION%HUMANCYC%PWY-5340,0.266345123258307,0.641603173139009,0.7001957985123609,1.1764193474397902,1987,2,PAPSS1|PAPSS2
TYROSINE DEGRADATION I%HUMANCYC%TYRFUMCAT-PWY,0.84914255091104,0.9492491301138911,0.421064240419079,0.707442289708769,6337,2,GSTZ1|FAH
SPERMINE BIOSYNTHESIS%HUMANCYC%ARGSPECAT-PWY,0.454629875298488,0.770794980018249,-0.6174248690377719,-1.02749371573885,3426,2,AMD1|SMS
PURINE NUCLEOTIDES <I>DE NOVO< I> BIOSYNTHESIS II%HUMANCYC%PWY-841,0.244842562432139,0.62804240987169,0.363059322921489,1.19468810540374,1803,11,PFAS|PAICS|ADSL|ATIC|PPAT
GLUTAMINE DEGRADATION I%HUMANCYC%GLUTAMINDEG-PWY,0.44786347755979605,0.768229288546963,0.5145819775364211,1.01212202514562,3332,3,GLS|GLS2
SEROTONIN DEGRADATION%HUMANCYC%PWY-6313,0.869281932944211,0.956810985742993,0.25944400276852003,0.6713266060525179,6403,6,ALDH3A2|MAOB
EUMELANIN BIOSYNTHESIS%HUMANCYC%PWY-6498,0.748494983277592,0.9131348696838739,-0.6312307013674461,-0.8409508616511691,5594,1,TRPC1
COLANIC ACID BUILDING BLOCKS BIOSYNTHESIS%HUMANCYC%COLANSYN-PWY,0.587141547728166,0.8414799095069009,-0.26043186234307003,-0.89645697362774,4483,13,TSTA3|MPI|GPI|GALT|GMPPB|GALK1
D-MANNOSE DEGRADATION%HUMANCYC%MANNCAT-PWY,0.528561872909699,0.8105400040230321,-0.73869651521835,-0.984121129764213,3950,1,MPI
GLUCONEOGENESIS I%HUMANCYC%GLUCONEO-PWY,0.0645034672249117,0.364712161390154,-0.39364893215889796,-1.49596206978192,492,17,ENO1|VCAN|PGAM1|GAPDH|PGK1|ALDOA
FLAVIN BIOSYNTHESIS IV (MAMMALIAN)%HUMANCYC%11070,0.16410188378880303,0.535290477921284,-0.7556691467855,-1.25755430083322,1236,2,RFK
"FATTY ACID &BETA;-OXIDATION III (UNSATURATED, ODD NUMBER)%HUMANCYC%PWY-5137",0.689868314969094,0.887051934478962,0.41687111668109794,0.819936292483399,5133,3,ECI1|EHHADH
<I>S< I>-METHYL-5-THIO-&ALPHA;-D-RIBOSE 1-PHOSPHATE DEGRADATION%HUMANCYC%PWY-6755,0.569558958251538,0.8323008830498292,-0.412445036480541,-0.9029284013588779,4351,4,ADI1|APIP
GLYCINE DEGRADATION (CREATINE BIOSYNTHESIS)%HUMANCYC%GLYCGREAT-PWY,0.435924648447864,0.7625803425525591,-0.624658238763667,-1.03953119966552,3285,2,GATM
TRIACYLGLYCEROL BIOSYNTHESIS%HUMANCYC%TRIGLSYN-PWY,0.662875710804224,0.879680951980053,0.20908737840719896,0.8473837613380172,4895,20,GPAT2|MBOAT2|AGPAT4|MBOAT7|PPAPDC1A|LPCAT4|DGAT2
TREHALOSE DEGRADATION II (TREHALASE)%HUMANCYC%PWY0-1182,0.8050643086816721,0.932964969466025,0.447256685966363,0.751448980071743,6008,2,GCK|GALM
SPERMINE AND SPERMIDINE DEGRADATION I%HUMANCYC%PWY-6117,0.0652288269331931,0.366933938653309,-0.631111356369177,-1.5126534940856498,495,5,SAT1|SMOX|SAT2|AOC3
NAD SALVAGE PATHWAY III%HUMANCYC%PWY3O-4106,0.6810626881298261,0.8849342663941481,-0.374440727062358,-0.8197290237144642,5203,4,NMNAT3
PYRUVATE FERMENTATION TO LACTATE%HUMANCYC%PWY-5481,0.713227513227513,0.897959620386259,-0.411871041970682,-0.8042797566822791,5391,3,LDHA
NAD BIOSYNTHESIS FROM 2-AMINO-3-CARBOXYMUCONATE SEMIALDEHYDE%HUMANCYC%PWY-5653,0.10494476591267801,0.44586718016414895,-0.5909903994663921,-1.41649121617291,797,5,NMNAT3|QPRT
FATTY ACID BIOSYNTHESIS INITIATION II%HUMANCYC%PWY-5966,0.20005306447333498,0.577896180140049,-0.7333914105851149,-1.22048058531791,1507,2,FASN
PUTRESCINE DEGRADATION III%HUMANCYC%PWY-0,0.326086956521739,0.6940781026265961,-0.386250293867443,-1.11196053628312,2504,8,MAOA|SAT1|ALDH2|SAT2|ALDH3B1
DIPHTHAMIDE BIOSYNTHESIS%HUMANCYC%PWY-6482,0.238809934918316,0.622138010410922,0.882278341420379,1.17639911994735,1797,1,DPH5
CHOLESTEROL BIOSYNTHESIS III (VIA DESMOSTEROL)%HUMANCYC%PWY66-4,0.00418300653594771,0.0711970927459713,-0.5733293434074189,-1.9189869941288,31,12,EBP|DHCR7|DHCR24|NSDHL|TM7SF2
TAURINE BIOSYNTHESIS%HUMANCYC%PWY-5331,0.9827170418006429,0.993436724391485,0.30532825870334,0.5129908971488499,7334,2,CSAD
4-AMINOBUTYRATE DEGRADATION I%HUMANCYC%PWY-6535,0.8278403001071809,0.943061234519578,0.43358147229115,0.7284728554190741,6178,2,ABAT|ALDH5A1
TRNA SPLICING%HUMANCYC%PWY-6689,0.442135718043135,0.7653693162885199,-0.417569681561544,-1.00083484707383,3361,5,TSEN15|TSEN54|TRPT1
TETRAHYDROBIOPTERIN BIOSYNTHESIS II%HUMANCYC%PWY-5664,0.0214995968825585,0.20251241938493103,0.818314396254622,1.60952784998076,159,3,SPR|PTS
NAD SALVAGE PATHWAY II%HUMANCYC%NAD-BIOSYNTHESIS-II,0.810317873892652,0.9351896872820029,-0.23819368467967897,-0.716544906766718,6219,9,NT5C3B|NMNAT3
PUTRESCINE BIOSYNTHESIS III%HUMANCYC%PWY-46,0.8080117899249729,0.934193159096917,0.445717247514685,0.74886252470798,6030,2,AZIN2
ADENOSINE NUCLEOTIDES DEGRADATION II%HUMANCYC%SALVADEHYPOX-PWY,0.787950229207597,0.927797067038212,-0.287060300939233,-0.7383964240722971,6015,6,ADA|PNP
LYSINE DEGRADATION II%HUMANCYC%LYSINE-DEG1-PWY,0.241467347487235,0.6249321365425989,0.618949670178925,1.21740096037539,1796,3,AASS|ALDH7A1
ZYMOSTEROL BIOSYNTHESIS%HUMANCYC%PWY-6074,0.0378748027354024,0.277419110172932,-0.664855796681421,-1.59353247848221,287,5,LBR|CYP51A1|NSDHL|TM7SF2
TRYPTOPHAN DEGRADATION III (EUKARYOTIC)%HUMANCYC%TRYPTOPHAN-DEGRADATION-1,0.7533995815899581,0.9155261442589929,-0.243755894161295,-0.763655396404435,5761,10,TDO2|ACAT2|KMO|KYNU|HAAO|AFMID
ADENINE AND ADENOSINE SALVAGE I%HUMANCYC%P121-PWY,0.982733430734493,0.993436724391485,0.5078848698720779,0.677195943618212,7398,1,APRT
COENZYME A BIOSYNTHESIS%HUMANCYC%COA-PWY,0.849074074074074,0.9492491301138911,-0.356334507037724,-0.695830979635128,6418,3,COASY
INOSITOL PYROPHOSPHATES BIOSYNTHESIS%HUMANCYC%PWY-6369,0.38925998690242297,0.735821783254312,-0.409133528211351,-1.0524016494475,2971,6,PPIP5K1|PPIP5K2|IPMK|IP6K1|IP6K2|IPPK
"D-<I>MYO< I>-INOSITOL (1,3,4)-TRISPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6364",0.721589368049905,0.9019989179378242,0.22087527187578399,0.793907680237266,5320,14,INPP5K|INPP5J|INPPL1|ITPKC
HISTIDINE DEGRADATION III%HUMANCYC%PWY-5030,0.24970553592461703,0.630296201866725,-0.554798721427857,-1.21457037497514,1907,4,FTCD|MTHFD1
SUPERPATHWAY OF GERANYLGERANYLDIPHOSPHATE BIOSYNTHESIS I (VIA MEVALONATE)%HUMANCYC%PWY-5910,0.8781699346405228,0.960725750963158,-0.197282464255599,-0.660322879736412,6717,12,ACAT2|IDI1|FDPS|HMGCR|HMGCS1
L-CYSTEINE DEGRADATION II%HUMANCYC%LCYSDEG-PWY,0.48386239872493,0.787078399497453,0.758215703573004,1.01097833250397,3642,1,CTH
PHOSPHATIDYLETHANOLAMINE BIOSYNTHESIS III%HUMANCYC%PWY-6273,0.49859531772575294,0.794989907195277,-0.754797088663432,-1.00557095956873,3726,1,PTDSS2
THIOSULFATE DISPROPORTIONATION III (RHODANESE)%HUMANCYC%PWY-5350,0.426086956521739,0.7548594444754521,-0.7878804587560649,-1.04964595231775,3184,1,TST
UDP-<I>N< I>-ACETYL-D-GALACTOSAMINE BIOSYNTHESIS I%HUMANCYC%PWY-5512,0.927892976588629,0.979345221662042,-0.535454344949272,-0.713353757642776,6935,1,GALE
L-CYSTEINE DEGRADATION III%HUMANCYC%PWY-5329,0.5525302164962149,0.822813841873357,0.7227062196735771,0.963631227120173,4159,1,MPST
GLUTATHIONE-MEDIATED DETOXIFICATION I%HUMANCYC%PWY-4061,0.399374915069982,0.7392155506460759,0.270458540445576,1.03999366626112,2938,17,GSTM2|GSTM4|GSTM1|GSTK1|MGST3|MGST2|GSTZ1|GSTM3|GGT7
PHOSPHOLIPASES%HUMANCYC%LIPASYN-PWY,0.234603340292276,0.618377513700521,-0.274043886539101,-1.1954294785608301,1797,26,PLCE1|PLCB1|PLCB3|PLA2G2A|PLA2G2D|PLA2G4D|PLA2G4A|PLD4|PLD1|PLA2G4C|PLA2G16|PLD3|PLA2G12A
SUPERPATHWAY OF CHOLESTEROL BIOSYNTHESIS%HUMANCYC%PWY66-5,0.0381799163179916,0.278913804209201,-0.37158382470718,-1.57922077932096,291,24,FDFT1|ACAT2|LBR|IDI1|FDPS|CYP51A1|HMGCR|HMGCS1|EBP|DHCR7|DHCR24|NSDHL|TM7SF2
CHONDROITIN SULFATE DEGRADATION (METAZOA)%HUMANCYC%PWY-6573,0.555555555555556,0.825309970896623,-0.416514136929252,-0.911836512835924,4244,4,ARSB|HYAL1
DOLICHOL AND DOLICHYL PHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6129,0.129761904761905,0.488295138550762,-0.688569999048406,-1.34460269079269,980,3,SRD5A3|DOLK
ACETYL-COA BIOSYNTHESIS III (FROM CITRATE)%HUMANCYC%PWY-5172,0.7582680302829058,0.917143966125732,0.620864578738421,0.8278391407166509,5708,1,ACLY
TRYPTOPHAN DEGRADATION TO 2-AMINO-3-CARBOXYMUCONATE SEMIALDEHYDE%HUMANCYC%PWY-5651,0.057995791688585,0.34736647600529996,-0.6401941319214649,-1.5344231739313798,440,5,TDO2|KMO|KYNU|HAAO|AFMID
ACYL-COA HYDROLYSIS%HUMANCYC%PWY-5148,0.0819672131147541,0.398202308598866,0.7304510863571191,1.4367110879651002,609,3,ACOT9|ACOT7|ACOT8
DOPAMINE DEGRADATION%HUMANCYC%PWY6666-2,0.642200594755339,0.868171925756234,0.35025654097881803,0.842364972504056,4750,5,ALDH3A2|MAOB
STEARATE BIOSYNTHESIS I (ANIMALS)%HUMANCYC%PWY-5972,0.468863991662324,0.780769690730001,-0.32645002337994,-0.9820415762967901,3598,9,ACSL5|ACOT1|ACSL4|ACOT2
SUPERPATHWAY OF INOSITOL PHOSPHATE COMPOUNDS%HUMANCYC%PWY-6371,0.827162199502625,0.943061234519578,0.1364336037462,0.770931459165216,5986,60,PLCD1|PLCD4|INPP5K|FIG4|PIP4K2C|INPP5J|PLCD3|PIKFYVE|PLCB4|PI4K2B|INPPL1|PLCG1|ITPKC
METHYLTHIOPROPIONATE BIOSYNTHESIS%HUMANCYC%PWY-5389,0.32294314381270894,0.6913268291919421,-0.836237318041465,-1.1140689000525499,2413,1,ADI1
"1D-<I>MYO< I>-INOSITOL HEXAKISPHOSPHATE BIOSYNTHESIS V (FROM INS(1,3,4)P3)%HUMANCYC%PWY-6554",0.203703703703704,0.582850213724436,-0.639654082823794,-1.24908230409403,1539,3,IPPK|ITPK1
<I>S< I>-METHYL-5'-THIOADENOSINE DEGRADATION II%HUMANCYC%PWY-6756,0.527825740470182,0.810281988128169,0.734836788707543,0.9798057041146361,3973,1,MTAP
GLYCEROL-3-PHOSPHATE SHUTTLE%HUMANCYC%PWY-6118,0.795150053590568,0.929656485793048,0.45295129833509007,0.761016664112369,5934,2,GPD2
PHOSPHATIDYLCHOLINE BIOSYNTHESIS I%HUMANCYC%PWY3O-450,0.7267845448592009,0.905145599593318,-0.30408639918181396,-0.7821921353465159,5548,6,CHKA|PCYT1A|CHPT1
TRIACYLGLYCEROL DEGRADATION%HUMANCYC%LIPAS-PWY,0.0470203012442698,0.311232297724361,-0.6097303635633841,-1.56839074797323,358,6,ABHD6|LIPE|PNPLA2|MGLL|PNPLA4
GLUTARYL-COA DEGRADATION%HUMANCYC%PWY-5177,0.134901324682347,0.497031952671308,0.569359138298515,1.3693054626116599,997,5,HADHB|ACAT1|GCDH
"<I>TRANS, TRANS< I>-FARNESYL DIPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-5123",0.657010582010582,0.875794784627105,-0.433994698079188,-0.8474816498446,4966,3,IDI1|FDPS
GLUTAMATE REMOVAL FROM FOLATES%HUMANCYC%PWY-2161B,0.348494983277592,0.706503295147533,-0.82261799735333,-1.09592469470421,2604,1,GGH
ACYL CARRIER PROTEIN METABOLISM%HUMANCYC%PWY-6012,0.366981006773808,0.721193319737038,0.817545213939127,1.09008622907689,2762,1,AASDHPPT
GERANYLGERANYLDIPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-5120,0.460751759861867,0.774751791105461,0.7710079400088221,1.02803505369813,3468,1,GGPS1
1D-<I>MYO< I>-INOSITOL HEXAKISPHOSPHATE BIOSYNTHESIS II (MAMMALIAN)%HUMANCYC%PWY-6362,0.881475454298888,0.9622426269432679,0.183625112482844,0.660016786154977,6499,14,INPP5K|INPP5J|INPPL1|ITPKC
CHOLESTEROL BIOSYNTHESIS I%HUMANCYC%PWY66-341,0.00418300653594771,0.0711970927459713,-0.5733293434074189,-1.9189869941288,31,12,EBP|DHCR7|DHCR24|NSDHL|TM7SF2
ALANINE BIOSYNTHESIS II%HUMANCYC%ALANINE-SYN2-PWY,0.8324489254444151,0.9443921657118071,-0.4422592685803571,-0.7359901454921409,6274,2,GPT
FATTY ACID &ALPHA;-OXIDATION II%HUMANCYC%PWY66-387,0.692267638635772,0.8884566307692979,-0.28093110485961703,-0.8087613316496691,5317,8,PHYH|HACL1|ACSL3|ACSL1|SLC27A2|ACSL6|ACSL5|ACSL4
GLUTAMINE BIOSYNTHESIS I%HUMANCYC%GLNSYN-PWY,0.90742474916388,0.9710309567212472,-0.545820467578297,-0.727163922037467,6782,1,GLUL
PHENYLETHYLAMINE DEGRADATION I%HUMANCYC%2PHENDEG-PWY,0.7335427300091609,0.907913422943088,-0.356262622366619,-0.7799333526288879,5604,4,ALDH2|AOC3
MEVALONATE PATHWAY I%HUMANCYC%PWY-922,0.8963127615062758,0.966962129066865,-0.20356110508273498,-0.637730369266962,6854,10,ACAA1|PMVK|MVK|ACAT2|IDI1|HMGCR|HMGCS1
SPHINGOMYELIN METABOLISM%HUMANCYC%PWY3DJ-11281,0.282103271154366,0.654732517474162,0.48115283635585704,1.1571698122595802,2086,5,SMPD2|SMPD4|SMPD3
CYSTEINE BIOSYNTHESIS HOMOCYSTEINE DEGRADATION%HUMANCYC%HOMOCYSDEGR-PWY,0.3942926045016079,0.7376723208557521,0.639261097325614,1.07404118184832,2942,2,CTH|CBS
GDP-L-FUCOSE BIOSYNTHESIS I (FROM GDP-D-MANNOSE)%HUMANCYC%PWY-66,0.982047159699893,0.993436724391485,0.30625722851551695,0.514551686377454,7329,2,GMDS
SUPERPATHWAY OF SERINE AND GLYCINE BIOSYNTHESIS I%HUMANCYC%SER-GLYSYN-PWY,0.6787217254076802,0.884536278926676,-0.3418785348065981,-0.8194176115024151,5160,5,PHGDH|SHMT2
5-AMINOIMIDAZOLE RIBONUCLEOTIDE BIOSYNTHESIS I%HUMANCYC%PWY-6121,0.296963181940339,0.6689039624806751,0.589548905603905,1.15957312597481,2209,3,PFAS|PPAT
GDP-L-FUCOSE BIOSYNTHESIS II (FROM L-FUCOSE)%HUMANCYC%PWY-6,0.47816184351554103,0.7850984235874658,0.601654259718776,1.01085683905348,3568,2,FUK|FPGT
<I>N< I>-ACETYLGLUCOSAMINE DEGRADATION I%HUMANCYC%GLUAMCAT-PWY,0.626444504165547,0.858842084733938,0.44032779956287504,0.866072819641158,4661,3,GNPDA2|AMDHD2
"D-<I>MYO< I>-INOSITOL (1,4,5,6)-TETRAKISPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6366",0.30806878306878305,0.679894338539728,-0.58618391566901,-1.14466861959889,2328,3,ITPK1
FORMALDEHYDE OXIDATION II (GLUTATHIONE-DEPENDENT)%ECOCYC%PWY-1801,0.603697749196142,0.848175106515994,0.547118830989799,0.9192302774345741,4505,2,ADH5|ESD
UDP-<I>N< I>-ACETYL-D-GALACTOSAMINE BIOSYNTHESIS II%HUMANCYC%PWY-5514,0.8546448087431691,0.949296218452153,0.234239092192875,0.679955105431058,6255,8,GNPDA2|PGM3|GCK
L-SERINE DEGRADATION%HUMANCYC%SERDEG-PWY,0.4620589015654021,0.775923491059078,-0.6142817755720981,-1.02226310559353,3482,2,SDS|SDSL
ACETATE CONVERSION TO ACETYL-COA%HUMANCYC%PWY0-1313,0.8551339877951708,0.949296218452153,-0.42878411910670006,-0.7135653419295591,6445,2,ACSS2|ACSS1
THYROID HORMONE BIOSYNTHESIS%HUMANCYC%PWY-6241,0.080133779264214,0.39674006528988004,-0.957487869430966,-1.2756037484776899,598,1,CTSD
ANDROGEN BIOSYNTHESIS%HUMANCYC%PWY66-378,0.0206933619994625,0.19828362800876603,0.821054712766639,1.61491772918127,153,3,HSD17B3|SRD5A1|AKR1C3
FOLATE POLYGLUTAMYLATION%HUMANCYC%PWY-2161,0.140057864281957,0.504567824749508,-0.5644389273840351,-1.35285240407871,1064,5,SHMT2|MTHFD1
CHOLINE BIOSYNTHESIS III%HUMANCYC%PWY-3561,0.108650338718082,0.45309795582492896,-0.47069300194869207,-1.41595976253793,833,9,PCYT1A|CHPT1|PLD4|PLD1|PLD3
INOSINE-5'-PHOSPHATE BIOSYNTHESIS II%HUMANCYC%PWY-6124,0.0212308519215265,0.201150083379966,0.819234586963715,1.6113377565159,157,3,PAICS|ADSL|ATIC
DERMATAN SULFATE BIOSYNTHESIS (LATE STAGES)%HUMANCYC%PWY-6568,0.352324643912927,0.710700173914979,0.5622035954560489,1.10578812787288,2621,3,CHST15|CHST14|DSE
URATE BIOSYNTHESIS INOSINE 5'-PHOSPHATE DEGRADATION%HUMANCYC%PWY-5695,0.39410609037328104,0.7376723208557521,-0.40716208239133594,-1.04733055971831,3008,6,IMPDH2|NT5C3B|PNP
URIDINE-5'-PHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-5686,0.8361634385778721,0.9458813323967309,-0.439218829531674,-0.7309303687123729,6302,2,UMPS
METHYLGLYOXAL DEGRADATION III%HUMANCYC%PWY-5453,0.173365487674169,0.547365883994345,0.7540870722861229,1.26696364556372,1293,2,CYP2E1|AKR1B1
PURINE NUCLEOTIDES DEGRADATION II (AEROBIC)%HUMANCYC%PWY-6353,0.243095362167796,0.626082056933819,-0.398781593060269,-1.1996326426702801,1865,9,IMPDH2|ADA|NT5C3B|PNP
FATTY ACID ACTIVATION%HUMANCYC%PWY-5143,0.51931892599869,0.8049078833377921,-0.365561745077492,-0.9403232855942308,3964,6,ACSL3|ACSL1|SLC27A2|ACSL6|ACSL5|ACSL4
CERAMIDE DEGRADATION%HUMANCYC%PWY-6483,0.795324744321955,0.929656485793048,0.6015659461843851,0.8021070182254579,5987,1,ASAH2
SALVAGE PATHWAYS OF PYRIMIDINE DEOXYRIBONUCLEOTIDES%HUMANCYC%PWY0-181,0.0533961523360817,0.335115832119604,-0.6906601239440421,-1.51199938521878,407,4,TYMP|CDA|TK1
3-PHOSPHOINOSITIDE BIOSYNTHESIS%HUMANCYC%PWY-6352,0.952219321148825,0.985958764731022,-0.137684862735896,-0.578081118725281,7293,23,PIK3C2A|PIK3R6|CDIPT|PIK3CB|PIK3R3|PIK3R4
SPERMIDINE BIOSYNTHESIS I%HUMANCYC%BSUBPOLYAMSYN-PWY,0.454629875298488,0.770794980018249,-0.6174248690377719,-1.02749371573885,3426,2,AMD1|SRM
ADENINE AND ADENOSINE SALVAGE III%HUMANCYC%PWY-6609,0.0194444444444444,0.192337052905818,-0.8213300981581558,-1.60384951644524,146,3,ADA|HPRT1|PNP
PENTOSE PHOSPHATE PATHWAY%HUMANCYC%PENTOSE-P-PWY,0.912431693989071,0.972925642245441,0.21516872019275,0.624597151801022,6678,8,RPE|PGD|RPIA|G6PD
NAD BIOSYNTHESIS II (FROM TRYPTOPHAN)%HUMANCYC%NADSYN-PWY,0.0614539748953975,0.35631208031004796,-0.491659928976414,-1.5403063759771698,469,10,KYNU|HAAO|AFMID|NMNAT3|QPRT
"D-<I>MYO< I>-INOSITOL (1,4,5)-TRISPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6351",0.0960314235405662,0.42752053904712795,0.34127617189621,1.40679192788643,708,21,PLCD1|PLCD4|PIP4K2C|PLCD3|PLCB4|PI4K2B|PLCG1|PIP5K1C|PIP5K1A|PIP5KL1
PROLINE BIOSYNTHESIS II (FROM ARGININE)%HUMANCYC%PWY-4981,0.38424290014396006,0.7313561276300269,-0.488117562792074,-1.06859137985488,2935,4,OAT|PYCR1|PYCRL
GLUTAMATE DEGRADATION II%HUMANCYC%GLUTDEG-PWY,0.551870522685062,0.822639759332792,-0.579006032584783,-0.9635586282472071,4159,2,GOT1
PENTOSE PHOSPHATE PATHWAY (OXIDATIVE BRANCH)%HUMANCYC%OXIDATIVEPENT-PWY,0.984512973780736,0.9943582032224201,0.23777510018835898,0.522402021393932,7246,4,PGD|G6PD
KETOLYSIS%HUMANCYC%REACT_59.NULL,0.0534817429075607,0.335115832119604,0.604774281197754,1.5648889983653997,393,6,BDH2|HADHB|ACAT1|BDH1|OXCT1
SPHINGOSINE AND SPHINGOSINE-1-PHOSPHATE METABOLISM%HUMANCYC%PWY3DJ-11470,0.6831554282738871,0.885415243771438,-0.283529907890147,-0.8162429218449492,5247,8,SPHK1
HEME BIOSYNTHESIS II%HUMANCYC%PWY-5920,0.9392076502732242,0.980854185905783,0.205113661550785,0.595409075656229,6874,8,HMBS|UROD|PPOX|CPOX
HEME BIOSYNTHESIS FROM UROPORPHYRINOGEN-III I%HUMANCYC%HEME-BIOSYNTHESIS-II,0.532808042385546,0.812079525085925,0.42218608079909703,0.927560799423976,3921,4,UROD|PPOX|CPOX
TYROSINE BIOSYNTHESIS IV%HUMANCYC%PWY-6134,0.886571921901979,0.964939379509639,0.556296868107631,0.7417468108961179,6674,1,PAH
FATTY ACID &BETA;-OXIDATION I%HUMANCYC%FAO-PWY,0.853764609948356,0.949296218452153,0.183427104747867,0.690663884007387,6281,16,HADHB|HADHA|ACAA2|ECI1|ECHS1|EHHADH|ACSL3|ACSL1|SLC27A2
CMP-<I>N< I>-ACETYLNEURAMINATE BIOSYNTHESIS I (EUKARYOTES)%HUMANCYC%PWY-6138,0.24931291715744,0.630084224949081,-0.555069865490656,-1.21516396600789,1904,4,NANP|GNE|NANS
ARGININE BIOSYNTHESIS IV%HUMANCYC%ARGININE-SYN4-PWY,0.26545306344246694,0.640784173769173,0.537189511479418,1.18022823435322,1953,4,ASL|GLUD1
NORADRENALINE AND ADRENALINE DEGRADATION%HUMANCYC%PWY-6342,0.9134340015620931,0.9733852712096921,-0.216033504977149,-0.6219302246847049,7016,8,MAOA|COMT|ADH1B|ALDH2
CARDIOLIPIN BIOSYNTHESIS II%HUMANCYC%PWY-5269,0.995846730975348,0.998675570643677,0.274772539288668,0.46165334332357205,7432,2,CRLS1|PGS1
SERINE BIOSYNTHESIS%HUMANCYC%SERSYN-PWY,0.9125661375661379,0.972925642245441,-0.32408734972978903,-0.6328604544211529,6898,3,PSAT1|PSPH|PHGDH
SEROTONIN AND MELATONIN BIOSYNTHESIS%HUMANCYC%PWY-6030,0.398857750033205,0.7388683667002129,0.801720335244817,1.06898588863411,3002,1,DDC
ETHANOL DEGRADATION II%HUMANCYC%PWY66-21,0.719248445525818,0.900474259627538,0.32829407450032,0.7895453665672758,5320,5,ALDH3A2
D-GLUCURONATE DEGRADATION I%HUMANCYC%PWY-5525,0.23653488989121801,0.62149045081524,-0.7143093465674109,-1.18872497934099,1782,2,DCXR|CRYL1
L-CYSTEINE DEGRADATION I%HUMANCYC%CYSTEINE-DEG-PWY,0.165693817988856,0.5375245857985801,-0.7540667218086571,-1.2548876094247299,1248,2,CDO1|GOT1
METHYLGLYOXAL DEGRADATION I%HUMANCYC%PWY-5386,0.719686919607323,0.90068276850426,-0.5078577336641851,-0.8451564813749031,5424,2,HAGH|GLO1
<I>N< I>-ACETYLGLUCOSAMINE DEGRADATION II%HUMANCYC%PWY-6517,0.7402526830593671,0.909493931144346,0.35629797044313793,0.782801814952881,5448,4,GNPDA2|AMDHD2|NAGK
METHYLMALONYL PATHWAY%HUMANCYC%PROPIONMET-PWY,0.803821489333857,0.932964969466025,-0.332687323890536,-0.7283220961419341,6141,4,PCCB
GLUTATHIONE REDOX REACTIONS I%HUMANCYC%PWY-4081,0.19161755075311102,0.565967229895179,-0.4951438600270279,-1.27364339286576,1462,6,GPX4|GPX1|GPX8|GPX3
LACTOSE DEGRADATION III%HUMANCYC%BGALACT-PWY,0.988179041041307,0.996030692679047,0.505679311865902,0.674255129619219,7439,1,GLB1
GLUTAMATE DEGRADATION X%HUMANCYC%PWY-5766,0.291672200823483,0.663837153945439,0.856638729598588,1.14221215720905,2195,1,GLUD1
PRPP BIOSYNTHESIS I%HUMANCYC%PWY0-662,0.28933404085964504,0.662218930390028,-0.688716174725103,-1.1461338487395,2180,2,PRPS1
SORBITOL DEGRADATION I%HUMANCYC%PWY-4101,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
"1,25-DIHYDROXYVITAMIN D<SUB>3< SUB> BIOSYNTHESIS%HUMANCYC%PWY-6076",0.31080354743348604,0.6814986161073721,0.582348859593423,1.14541148513352,2312,3,CYP27B1|CYP2R1
CERAMIDE BIOSYNTHESIS%HUMANCYC%PWY3DJ-12,0.7541005291005292,0.9156579560403149,-0.39544938755331,-0.772212427656354,5700,3,SPTLC1|SPTLC2
L-GLUTAMINE BIOSYNTHESIS II (TRNA-DEPENDENT)%HUMANCYC%PWY-5921,0.37486602357985,0.7254276229586741,0.6488558036945129,1.0901615273707599,2797,2,GATB|QRSL1
ANANDAMIDE DEGRADATION%HUMANCYC%PWY6666-1,0.416800643086817,0.7493091022753771,0.629611248966088,1.05782819066196,3110,2,FAAH2|FAAH
PYRIMIDINE RIBONUCLEOTIDES INTERCONVERSION%HUMANCYC%PWY-5687,0.0705882352941176,0.3767214120425879,-0.45001338742784003,-1.5062369431947902,539,12,CTPS1|NME2|CMPK2|CANT1|NME1
UDP-<I>N< I>-ACETYL-D-GLUCOSAMINE BIOSYNTHESIS II%HUMANCYC%UDPNACETYLGALSYN-PWY,0.3633613887427671,0.7178370462804441,-0.4502897697265421,-1.07925865483783,2762,5,GNPNAT1|GFPT2
"TRYPTOPHAN DEGRADATION X (MAMMALIAN, VIA TRYPTAMINE)%HUMANCYC%PWY-6307",0.12314138956474699,0.47697345522944606,0.5795196675248371,1.3937414771353,910,5,ALDH3A2|MAOB|DDC|AKR1A1
DERMATAN SULFATE DEGRADATION (METAZOA)%HUMANCYC%PWY-6576,0.6461640211640209,0.86958575934482,-0.437978809880717,-0.8552616104240028,4884,3,HYAL1
ALL-<I>TRANS< I>-DECAPRENYL DIPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-5806,0.6444680286548161,0.8688307429995409,-0.5412650036543921,-0.900751520862741,4857,2,PDSS1
THYMINE DEGRADATION%HUMANCYC%PWY-6430,0.0696348581512149,0.37596389138254704,0.585075285422757,1.5139166889839801,512,6,DPYSL5|CRMP1|DPYD|DPYSL4|DPYSL2|DPYSL3
ALANINE BIOSYNTHESIS III%HUMANCYC%PWY0-1021,0.11847522911409199,0.46942161822544604,0.941607851786502,1.25550701652027,891,1,NFS1
LANOSTEROL BIOSYNTHESIS%HUMANCYC%PWY-6132,0.715765705937043,0.899551221015245,0.6415968239964711,0.8554827923071892,5388,1,LSS
URACIL DEGRADATION II (REDUCTIVE)%ARACYC%PWY-3982,0.0696348581512149,0.37596389138254704,0.585075285422757,1.5139166889839801,512,6,DPYSL5|CRMP1|DPYD|DPYSL4|DPYSL2|DPYSL3
PYRIMIDINE RIBONUCLEOTIDES <I>DE NOVO< I> BIOSYNTHESIS%HUMANCYC%PWY0-162,0.0454902988987939,0.30574871755800603,-0.443006517397729,-1.5672922760649397,346,14,CTPS1|UMPS|NME2|CMPK2|CANT1|NME1
GLUCOSE AND GLUCOSE-1-PHOSPHATE DEGRADATION%HUMANCYC%GLUCOSE1PMETAB-PWY,0.499388670017661,0.794989907195277,0.43422514805098494,0.9540111428918241,3675,4,PGM1|GCK|PGM2
OLEATE BIOSYNTHESIS II (ANIMALS)%HUMANCYC%PWY-5996,0.0217419777341192,0.20388952052930198,-0.6498956700974889,-1.6717067363544598,165,6,SCD5|ACOT1|ACOT2|FADS1|FADS2
PHOSPHATIDYLETHANOLAMINE BIOSYNTHESIS II%HUMANCYC%PWY4FS-6,0.9432874918140141,0.9825021479202449,-0.230764988141857,-0.5935897143823571,7201,6,CHKB|EPT1|CEPT1|ETNK1|PCYT2|ETNK2
PHENYLALANINE DEGRADATION I (AEROBIC)%HUMANCYC%PHENYLALANINE-DEG1-PWY,0.156228773264502,0.525661258438322,0.603478436300286,1.32586782527346,1149,4,PCBD1|QDPR|PCBD2|PAH
CALCIUM TRANSPORT I%HUMANCYC%PWY-6166,0.0600706713780919,0.35478972492602706,-0.682071361605912,-1.4931967890867202,458,4,ATP2A2|ATP2C1|ATP2A1|ATP2A3
PURINE RIBONUCLEOSIDES DEGRADATION TO RIBOSE-1-PHOSPHATE%HUMANCYC%PWY0-1296,0.0795967100026532,0.395856190496679,-0.8212848083815829,-1.3667492544623,599,2,ADA|PNP
4-HYDROXYPROLINE DEGRADATION I%HUMANCYC%HYDROXYPRODEG-PWY,0.124147157190635,0.47833715299653395,-0.9367004852227611,-1.2479099613670601,927,1,ALDH4A1
ASPARTATE DEGRADATION II%HUMANCYC%MALATE-ASPARTATE-SHUTTLE-PWY,0.984556995157702,0.9943582032224201,-0.23305575470137302,-0.510207764446998,7522,4,MDH1|GOT2|MDH2|GOT1
GLUTAMATE BIOSYNTHESIS II%HUMANCYC%GLUTAMATE-SYN2-PWY,0.291672200823483,0.663837153945439,0.856638729598588,1.14221215720905,2195,1,GLUD1
"CHOLESTEROL BIOSYNTHESIS II (VIA 24,25-DIHYDROLANOSTEROL)%HUMANCYC%PWY66-3",0.00418300653594771,0.0711970927459713,-0.5733293434074189,-1.9189869941288,31,12,EBP|DHCR7|DHCR24|NSDHL|TM7SF2
GLUTAMATE DEGRADATION III (VIA 4-AMINOBUTYRATE)%HUMANCYC%GLUDEG-I-PWY,0.8278403001071809,0.943061234519578,0.43358147229115,0.7284728554190741,6178,2,ABAT|ALDH5A1
GLYCOGEN DEGRADATION III%HUMANCYC%PWY-5767,0.524993491278313,0.808245162096538,-0.324724737205557,-0.9348370697975591,4032,8,GAA|PGM5|PYGL|PYGM
ETHANOL DEGRADATION IV%HUMANCYC%PWY66-162,0.773857799405245,0.922601613703136,0.31236473737293297,0.751235402122869,5724,5,ALDH3A2
"TETRAHYDROFOLATE SALVAGE FROM 5,10-METHENYLTETRAHYDROFOLATE%HUMANCYC%PWY-6613",0.468263316319853,0.780769690730001,-0.4498922303368379,-0.984908136580245,3577,4,MTHFD1
EPOXYSQUALENE BIOSYNTHESIS%HUMANCYC%PWY-5670,0.5850358185195009,0.839854222268064,-0.564488558036945,-0.939399229080877,4409,2,SQLE|FDFT1
NAD PHOSPHORYLATION AND DEPHOSPHORYLATION%HUMANCYC%NADPHOS-DEPHOS-PWY,0.51079701609737,0.8011667213092171,-0.433255343511033,-0.9484865135843741,3902,4,ACP6|NADK
CREATINE-PHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6158,0.37678043536683703,0.727595707802027,0.55107911683667,1.08390759120341,2803,3,CKMT1B|CKMT1A
ADENINE AND ADENOSINE SALVAGE VI%HUMANCYC%PWY-6619,0.680568468588126,0.884781692722898,0.659131010145567,0.878862263599187,5123,1,ADK
D-<I>MYO< I>-INOSITOL-5-PHOSPHATE METABOLISM%HUMANCYC%PWY-6367,0.14241065362141597,0.508674778494682,0.34678934125714506,1.33350833676806,1047,17,PLCD1|PLCD4|PIP4K2C|PLCD3|PLCB4|PLCG1
PENTOSE PHOSPHATE PATHWAY (NON-OXIDATIVE BRANCH)%HUMANCYC%NONOXIPENT-PWY,0.8127208480565369,0.9356336309698571,-0.32952956902769603,-0.7214091106578149,6209,4,TALDO1
SULFITE OXIDATION IV%HUMANCYC%PWY-5326,0.9856856187290971,0.994876860785749,-0.507057785619762,-0.6755227221998729,7367,1,SUOX
NAD BIOSYNTHESIS III%HUMANCYC%NAD-BIOSYNTHESIS-III,0.612354403873839,0.852045339927398,-0.39746458614107505,-0.8701330640890379,4678,4,NMNAT3
&GAMMA;-GLUTAMYL CYCLE%HUMANCYC%PWY-4041,0.961109600217569,0.990105504429159,0.178190646338332,0.5645200124136589,7067,10,GSS|GCLM|DPP8|GCLC|GGT7
LEUKOTRIENE BIOSYNTHESIS%HUMANCYC%15354,0.459626512361915,0.7738004138686259,-0.41116224433735,-0.985477442698991,3494,5,ALOX5|LTC4S|DPEP1
NADH REPAIR%HUMANCYC%PWY-6938,0.331785619527726,0.6961761803662729,-0.668872346291701,-1.11311054495956,2500,2,APOA1BP|GAPDH
SUCROSE DEGRADATION V (MAMMALIAN)%HUMANCYC%PWY66-373,0.6675723407145769,0.88092952466726,0.379518893921435,0.833819172759005,4913,4,KHK
2-OXOBUTANOATE DEGRADATION I%HUMANCYC%PWY-5130,0.28346994535519104,0.656107501076163,0.39756994800550793,1.1540760057664199,2074,8,BCKDHB|PCCA|DLD|MCEE|DBT|BCKDHA|MUT
3-PHOSPHOINOSITIDE DEGRADATION%HUMANCYC%PWY-6368,0.8295439610986991,0.943504776751861,-0.182263047896901,-0.720104298597692,6311,19,SYNJ2|INPP4B|PTPMT1
DTMP <I>DE NOVO< I> BIOSYNTHESIS%HUMANCYC%PWY66-385,0.36029315534615897,0.7155384949577859,-0.499510179570885,-1.0935321994684801,2752,4,DHFR|SHMT2
ARGININE DEGRADATION I (ARGINASE PATHWAY)%HUMANCYC%ARGASEDEG-PWY,0.573677248677249,0.835204333784353,-0.467967176906441,-0.913821290704863,4336,3,ALDH4A1
MITOCHONDRIAL L-CARNITINE SHUTTLE PATHWAY%HUMANCYC%PWY-6111,0.927573233001881,0.979345221662042,0.314271534134774,0.6181350211620961,6902,3,CPT1A|CPT2|CPT1C
&BETA;-ALANINE DEGRADATION I%HUMANCYC%BETA-ALA-DEGRADATION-I-PWY,0.5456859592711679,0.817297924969912,0.5719878687620621,0.9610134718634179,4072,2,ALDH6A1|ABAT
ALANINE DEGRADATION III%HUMANCYC%ALANINE-DEG3-PWY,0.8324489254444151,0.9443921657118071,-0.4422592685803571,-0.7359901454921409,6274,2,GPT
GLYCOGEN DEGRADATION II%HUMANCYC%PWY-5941,0.45780757097791797,0.7722752961350329,-0.363694150779365,-0.994141742446259,3482,7,PGM5|PYGL|PYGM
HISTAMINE DEGRADATION%HUMANCYC%PWY-6181,0.267312284425577,0.6417330323279019,-0.6992397119863678,-1.1636466975823798,2014,2,HNMT
THIAMIN SALVAGE III%HUMANCYC%PWY-6898,0.591180767698234,0.8417378833576942,0.70213939126599,0.9362081365795591,4450,1,TPK1
"D-<I>MYO< I>-INOSITOL (3,4,5,6)-TETRAKISPHOSPHATE BIOSYNTHESIS%HUMANCYC%PWY-6365",0.129477314937649,0.487857553689733,-0.7790422590979681,-1.2964508973628501,975,2,ITPK1
FATTY ACID &ALPHA;-OXIDATION III%HUMANCYC%PWY66-388,0.27491961414791,0.6494000470551329,0.695947063688999,1.1692809243601898,2051,2,ALDH3A2|HACL1
GLYCOLYSIS I%HUMANCYC%GLYCOLYSIS,0.14771686510532503,0.514965886850433,-0.3466209146794099,-1.31724411929613,1128,17,ENO1|VCAN|PGAM1|GAPDH|PGK1|ALDOA
OXIDIZED GTP AND DGTP DETOXIFICATION%HUMANCYC%PWY-6502,0.338461538461539,0.700045152798993,-0.8278561976179971,-1.1029032352228,2529,1,NUDT1
TRNA CHARGING%HUMANCYC%TRNA-CHARGING-PWY,0.8034140969163001,0.932964969466025,0.15530814430465398,0.7626904845707099,5835,37,PARS2|DARS|SARS2|CARS2|RARS2|DARS2|FARS2|IARS2|LARS2|WARS2|HARS2|QARS|YARS2|FARSB|MARS|EPRS|KARS|MARS2|TARS2|EARS2
ALPHA6BETA4INTEGRIN%IOB%ALPHA6BETA4INTEGRIN,0.40273556231003,0.740287621109606,0.18299379357893303,1.03402437836664,2914,60,IRS2|ITGA6|MET|RTKN|SMAD3|EPHB2|LAMA5|LAMB1|SHC1|YWHAQ|DST|PLEC|LAMA1|PAK1|YWHAB|YWHAE|PRKCA|YWHAH|PIK3R2|EGFR|SRC
ANDROGENRECEPTOR%IOB%ANDROGENRECEPTOR,0.0200280648041842,0.195205495598712,-0.224613007274909,-1.50939304639019,156,128,PIAS2|GSK3B|RNF14|APPL1|AKT1|PA2G4|RAC3|POU2F1|PTEN|NCOA6|CCNH|RBAK|PRMT1|BAG1|BRINP1|HIPK3|PSMC3IP|TMF1|GNB2L1|UXT|NR3C1|RUNX1|HSP90B1|PARP1|NSD1|TRIM68|TOP1|AHR|CASP1|IL6ST|TGIF1|CEBPA|STAT3|PRKD1|PARK7|BRCA1|PXN|SF1|GTF2H1|CALR|HSPB1|FLNA|RAN|RCHY1|NONO|KAT7|NCOA4|GSN|GAPDH|CDK7|KAT2B|PLAGL1|FHL2|SLC25A4|CAV1|CCND3|RELA|KAT5|HSP90AA1|HSPA5|CCND1|PPP1CA
BDNF%IOB%BDNF,0.214128035320088,0.597438672438672,-0.23265244011846803,-1.19591371390426,1648,45,ELK1|GRIN1|IRS1|MAPK9|SYN1|MAPK3|NTRK2|RELB|RPS6KB1|TIAM1|NGFR|GRIA1|SIRPA|BAD
CCR1%IOB%CCR1,0.0394685423993748,0.28367988634143604,-0.365556385274954,-1.5759647989188201,302,25,CCL3L3|CREB3|STAT3|MAPK9|PXN|MAPK3|CCR1|CCL14|RELA|NFKB1
CCR7%IOB%CCR7,0.738328756375049,0.9089185613230608,-0.19189871646688897,-0.7947025153440659,5645,22,MAPK9|MAPK3|RELA|CFL1|RPS6KB1
CCR9%IOB%CCR9,0.23352585980572302,0.617659277783149,-0.331123704849982,-1.20225649756281,1778,15,MAPK14|ITGA4|GSK3B|AKT1|JAK3|MADCAM1|MSN|MAPK3|RPS6KB1
CD40%IOB%CD40,0.0357515657620042,0.268987198588135,-0.364388234470858,-1.58952802278641,273,26,CHUK|BIRC3|FYN|MAPK14|PLCG2|AKT1|JAK3|SYK|STAT6|LYN|FGR|TRAF2|STAT3|MAPK9|MAPK3|NFKBIA|TRAF3|MYC
CXCR4%IOB%CXCR4,0.156041986687148,0.5253529866895421,-0.196428587696424,-1.2267727118678602,1218,93,RPS6KA3|CCR5|RPS6|PTPN11|CBLB|RHOA|FYN|MAP2K2|ITGA4|GSK3B|PLCG2|LCP2|AKT1|RAF1|CXCL12|CDC42|JAK3|SYK|RAC1|ACKR3|LYN|GNA13|SOCS3|ITGB2|VAV1|WAS|ATF1|ELK1|BCAR1|CXCR4|SOCS1|STAT3|PTPN6|ICAM1|SDC4|PXN|MAPK3|PIM1|VCAM1|MAP2K3|NFKBIA|GRK6|RELA|CFL1|RPS6KB1|NFKB1|NCK1|BAD
EGFR1%IOB%EGFR1,0.0005090353779587679,0.0139121625154964,-0.19451756139206897,-1.61689538942047,3,434,EPHB3|TNS1|EIF4EBP1|JUP|SH2B1|CTNND1|SOCS3|TKT|CALCOCO2|DYRK3|RGS16|HGS|DNM1|STX4|TRIP6|SNX5|TFG|CALM3|SPRY1|CASKIN2|SCAMP3|TNK2|VAV1|ATF1|DYRK1A|CDV3|TLN1|PHLPP1|CAV2|CLTA|ELK1|SH3GL2|BCAR1|ERBB2IP|PLSCR1|DDX3X|SLC25A6|SIAH2|DOK2|TGIF1|CYSRT1|PHPT1|LSR|MAGI1|GRB2|PHLDB2|PRKAR1A|CEBPA|SOCS1|STAT3|MAPK9|PTPN6|CLTC|PRKD1|CTNNAL1|KRT18|PKP2|SDC4|S100A10|PXN|ENSA|REPS2|KIRREL|ENO1|PIK3CB|MAPK3|RBBP7|ABL1|HUWE1|EPS15L1|HRAS|PIK3R3|CEBPB|HNRNPR|TNIP1|PGAM1|PTPRE|PLD1|TJP2|DOCK1|WBP2|CEACAM1|MAP2K3|SDPR|EPHA2|GSN|BAIAP2L1|AXL|NOS3|TNS2|MVP|SMU1|VCL|ARAF|DLG3|PDGFRB|EPHA4|LDHA|ERRFI1|NEDD9|KRT7|CD59|CAMK2A|CAV1|MYC|PDLIM1|LDLR|MYH9|RELA|RIN1|CSTB|CFL1|EPHB4|RPS6KB1|MTA2|NFKB1|VIM|PTRF|CRIM1|DAB2|ANXA2|ADRBK1|ACTB|EPS8|ACTA2|ANXA1|TOLLIP|S100A11|NCK1|PPP1R14B|ACTN1|TFRC|ZDHHC5|AHNAK|STIP1|ITGB4|PRKCB|ALDOA|SH3GL3|EIF4G1|GRB10|SIRPA|BAD
EPO%IOB%EPO,0.7984026793765301,0.931282347735928,-0.14631102684980402,-0.776603123767777,6197,50,MAP2K2|FOXO4|GSK3B|PLCG2|AKT1|RAF1|SYK|RPS6KA5|STAT5A|LYN|BCL2L11|HCLS1|VAV1|SGK1|MST1R|STAT3|MAPK9|MAPK3|NFKBIA|NOS3|HIST2H2BE|BAD
FAS%IOB%FAS,0.650539014373717,0.8720434729248241,-0.136911905334341,-0.8964222060283691,5068,113,GLRX|PARP1|PDCD6|CASP10|TOP1|ARHGDIB|PKN1|CASP1|TRAF2|CASP4|MAPK9|PTPN6|LMNB1|MAPK3|CDC27|HSPB1|CAST|STK3|MAX|GSN|SRF|XIAP|FADD|CD59|EIF2S1|TRAF3|RELA|VIM|CSNK1A1|CASP6
FLK2 FLT3%IOB%FLK2 FLT3,0.971040108769544,0.9915747942934481,0.130078171235366,0.544370970310648,7141,22,GAB1|GAB2|SHC1|FOXO3|CBL|ATF2|MAPK1
G-CSF%IOB%G-CSF,0.0182689816014512,0.18550129019106798,-0.32949837303701196,-1.6603815493723602,140,42,PTPN11|POM121|MAPK14|GSK3B|CDKN1B|AKT1|SYK|STAT5A|LYN|RPS6KA1|SOCS3|VAV1|NOTCH1|SYP|GRB2|STAT3|CISH|CSF3R|NOTCH2|MAPK3|SOD1|IL3RA|NOS3|HCK|FTH1|BAD
GDNF%IOB%GDNF,0.22728524229074898,0.609201573718782,0.241375170308448,1.18535023665447,1650,37,RET|MET|GAB1|GAB2|DOK1|MAPK7|CRK|SHC1|PTK2B|CBL|PLCG1|SRC|MAP2K1|MAPK1|DOK5
GM-CSF%IOB%GM-CSF,0.21515735388567803,0.598086191599933,-0.195983140605724,-1.17398532932979,1674,79,SLC2A1|VAV1|FES|ELK1|BCAR1|MAD2L1|CSF2RB|GRB2|PLA2G4A|STAT3|MAPK9|PTPN6|PARK7|CCT5|PXN|MAPK3|BCL3|CSF2RA|MAP2K3|NFKBIA|HCK|TGFBR3|RPS6KB1|GANAB|BAD
HEDGEHOG%IOB%HEDGEHOG,0.43227402969523293,0.7606938907430408,-0.22023027419962302,-1.0149473230052901,3318,31,SMO|MED1|DYRK1A|KIF27|BOC|MED6|SDC2|CCNB1|GAS1|PRKACA|ADRBK1
ID%IOB%ID,0.514896968106051,0.8033168807163741,-0.233558846979038,-0.951520424295472,3922,21,ELK4|ATF3|ID2|ID3|ELK3|ELK1|HES1|PSMD4|IFI16|ID1|ID4
IFN-ALPHA%IOB%IFN-ALPHA,0.9570948565520809,0.9880317864833471,-0.122709019744617,-0.5961138035764499,7405,37,STAT5B|EIF4B|IFNAR2|RPS6|PRKCQ|ARHGAP30|MAPK14|AKT1|RPS6KA5|STAT5A|STAT6|EIF4EBP1|IFNAR1|VAV1|PLA2G4A|IRS1|STAT3|MAP2K3|NFKBIA|RPS6KB1
IFN-GAMMA%IOB%IFN-GAMMA,0.9090909090909091,0.9715076818387142,-0.133266487652134,-0.663430697962568,7029,40,STAT5B|EIF4B|RPS6|PRKCQ|MAPK14|GSK3B|PLCG2|AKT1|IRF8|RAF1|STAT5A|STAT6|IFNGR1|VAV1|PLA2G4A|STAT3|MAPK3|CEBPB|SPI1|MAP3K11|PRKACA
KITRECEPTOR%IOB%KITRECEPTOR,0.364533914604436,0.7188671302410179,-0.171625746027207,-1.05687961536861,2842,88,FYN|MAP2K2|MAPK14|KITLG|GSK3B|SH3KBP1|AKT1|RAF1|JAK3|GRAP|NFATC2|STAT5A|LYN|SOCS4|RPS6KA1|EIF4EBP1|TNFRSF10A|FGR|VAV1|WAS|FES|ELK1|MATK|MAD2L1|CSF2RB|GRB2|SOCS1|STAT3|PTPN6|CLTC|SH2B3|MAPK3|ABL1|HRAS|MITF|HCK|RELA|RPS6KB1|PRKCB|GRB10|BAD
LEPTIN%IOB%LEPTIN,0.731972085810287,0.9074853805288342,-0.15628018205550698,-0.819271501168153,5663,48,ITGB5|ELK1|MAPKAPK2|GRB2|IRS1|STAT3|MAPK3|HSPB1|MAP2K3|CFL2|RPS6KB1|NFKB1
M-CSF%IOB%M-CSF,0.10257731958762899,0.441229839424518,-0.23695098181589,-1.33443499925693,795,62,EIF4EBP1|PSTPIP2|DNM1|LILRA6|LILRB3|ETS2|BCAR1|SKAP2|GAB3|GRB2|STAT3|PTPN6|PXN|MAPK3|CSF1|MITF|PPP2CA|FADD|RPS6KB1|VIM|CSF1R|TFE3|RPS6KB2
NGF%IOB%NGF,0.9590497440609,0.9889996530704799,-0.138861587909166,-0.5657231089924489,7306,21,RPS6KA1|SH2B1|ELK1|MAPK3|IRAK1|BAD
NOTCH%IOB%NOTCH,0.6753695261776489,0.882488012133495,0.144846197259536,0.875034562763867,4888,77,WDR12|CIR1|DLL1|MAGEA1|SMAD3|ADAM17|HDAC1|NCOR1|PSENEN|TCF3|DLL3|ASCL1|SMAD1|HES6
TGF_BETA_RECEPTOR%IOB%TGF_BETA_RECEPTOR,0.206839351792778,0.5866529380099671,-0.15964117164642702,-1.14923386492046,1620,180,GRB2|MEF2C|SMURF2|BRCA1|DDX5|PXN|SNW1|MAPK3|CAMK2B|CDC27|SPARC|SKP1|SNX2|SNX6|MAP2K3|SDC2|GIPC1|KAT2B|PPP2CA|NUP214|TGFBR2|TGFBR3|WWTR1|FKBP1A|CAMK2A|CAV1|MYC|NFYB|YAP1|PJA1|DAB2|DYNC1I1|ENG|CCND1|ACVRL1|NME1|PRKCB
THROMBOPOIETIN%IOB%THROMBOPOIETIN,0.590834919771553,0.8417378833576942,0.28021025287171397,0.8877250219364979,4344,10,GAB1|SHC1|FOXO3|MAP2K1|MAPK1|JAK2
TIE1 TEK%IOB%TIE1 TEK,0.0490878067987925,0.31755592515422,-0.377892023695527,-1.53953482548625,373,21,MAP2K2|MAPK14|AKT1|RAF1|STAT5A|FES|ELK1|DOK2|PXN|MAPK3|NOS3|TEK|NCK1|TIE1
TNFALPHA%IOB%TNFALPHA,0.0287032291132752,0.238792268557792,-0.18856349248910897,-1.3961556326231799,223,211,NSMAF|TRAF2|TNFAIP3|DDX3X|IKBKE|MYLK|MAPKAPK2|MAPK9|PAPOLA|MCM5|PSMB5|POLR2H|MAPK3|HSPB1|FLNA|COPB2|SKP1|NUPR1|USP2|HSPA1A|BCL3|KPNA2|KCNQ1|USP11|NFKBIA|MAP3K11|PSMC1|FADD|RELB|PSMD2|RPS13|PSMD6|PEG3|CAV1|TRAF3|RELA|RPS6KB1|NFKB1|PSMD12|HSP90AA1|MCC|HSPA5|MARK2|ALPL|DPF2|TNFRSF1A|PPP6C|FKBP5|PSMD13|TNFRSF1B|PSMC3|POLR2L
TNFSF1%IOB%TNFSF1,0.000523354703650399,0.0139121625154964,-0.559529634996404,-2.12634924800372,3,17,NFKBIA|RELB|LTA|TRAF3|LTBR|RELA|NFKB1|TNFRSF1A|TNFRSF1B
TNFSF3%IOB%TNFSF3,0.00013109596224436298,0.00518555396908895,-0.664964615576433,-2.35254756966422,0,14,NFKBIA|RELB|LTA|TRAF3|LTBR|RELA|NFKB1|TNFRSF1A|TNFRSF1B
TNFSF8%IOB%TNFSF8,0.110789854120121,0.45638735792888,-0.34964751591932103,-1.3814247161604198,842,19,TNFSF8|NFKB2|TRAF2|BCL3|NFKBIA|RELB|TRAF3|RELA|NFKB1
TRAIL%IOB%TRAIL,0.0850322580645161,0.40376145987147494,-0.253753150334846,-1.3841806921134698,658,55,H2AFX|TNFRSF10A|PARP1|TNFRSF10B|CASP10|IRF5|CASP1|TRAF2|CTSB|TNFSF10|CYCS|MAPK9|MAPK3|TNFRSF10C|NFKBIA|XIAP|FADD|TNFRSF11B|RELA|NFKB1|NGFRAP1
WNT%IOB%WNT,0.8139771283354509,0.93598587081542,-0.12728457467264997,-0.7986806547297521,6405,94,PPARG|PRKACA|WNT3|DAB2|MARK2|CSNK1A1|CCND1|PPP1CA|RPS6KB2|PRKCB
BIOCARTA_IL5_PATHWAY%MSIGDB_C2%BIOCARTA_IL5_PATHWAY,0.089849377865095,0.41413736343552393,-0.5674811097016159,-1.45971428567879,685,6,IL6|HLA-DRB1|IL1B|CCL11|HLA-DRA|CD4
PID_E2F_PATHWAY%MSIGDB_C2%PID_E2F_PATHWAY,0.00168809245552526,0.0345996276682596,-0.317653354012295,-1.83554774438027,12,69,UXT|CES1|TFDP2|SMARCA2|RANBP1|YY1|TRIM28|CDC6|CDKN2A|PLAU|E2F2|ORC1|MCM3|CEBPA|BRCA1|TOPBP1|E2F1|HIC1|DHFR|MYBL2|KAT2B|TK1|SERPINE1|MYC|CCND3|CDKN2C|POLA1|PRMT5|RRM1|TFE3
ST_GAQ_PATHWAY%MSIGDB_C2%ST_GAQ_PATHWAY,0.075678496868476,0.385041962101023,-0.331008887516116,-1.4439212156843102,579,26,NFKB2|TONSL|ITPR2|ITPR3|PIK3CB|PLD1|CFB|GNAQ|NFKBIA|PLD3|NFKB1|ADRBK1
PID_MTOR_4PATHWAY%MSIGDB_C2%PID_MTOR_4PATHWAY,0.8371640046747171,0.946216977301937,-0.132689736359513,-0.766742561350983,6446,69,DEPTOR|SFN|AKT1|RAF1|MLST8|RAC1|RRAGB|PML|FBXW11|RPS6KA1|CLIP1|EIF4EBP1|YY1|RRAGA|ATG13|SGK1|CYCS|IRS1|PXN|MAPK3|HRAS|RPTOR|PLD1|DDIT4|RPS6KB1|MAPKAP1|SSPO|RRAGD
PID_IL8_CXCR2_PATHWAY%MSIGDB_C2%PID_IL8_CXCR2_PATHWAY,0.0523573847356082,0.331837217224037,-0.325705230662787,-1.5010363727303702,401,31,GNA14|AKT1|RAC2|DOCK2|LYN|PLCB1|PIK3R6|DNM1|PLCB3|FGR|RAB7A|ELMO1|ARRB1|GNAI2|PPP2CA|GNA15|HCK|PRKCB
PID_CONE_PATHWAY%MSIGDB_C2%PID_CONE_PATHWAY,0.616193480546793,0.854122579597827,-0.317048478021934,-0.866637876097905,4687,7,GUCA1B|RDH5|GUCA1A|GNGT2
BIOCARTA_TALL1_PATHWAY%MSIGDB_C2%BIOCARTA_TALL1_PATHWAY,0.164986251145738,0.536804971556889,-0.376453337853653,-1.29582539144073,1259,13,MAP3K14|CHUK|TRAF6|MAPK14|TNFSF13B|TRAF2|TNFSF13|TRAF3|RELA|NFKB1
PID_GMCSF_PATHWAY%MSIGDB_C2%PID_GMCSF_PATHWAY,0.146462018730489,0.513872620660976,-0.27054568758047604,-1.2915670029636002,1125,35,CSF2RB|GRB2|STAT3|CISH|OSM|MAPK3|PIM1|HRAS|CCL2|CSF2RA|PRKACA
PID_NEPHRIN_NEPH1_PATHWAY%MSIGDB_C2%PID_NEPHRIN_NEPH1_PATHWAY,0.339767836181036,0.701520400822108,-0.246807687908393,-1.0885424810056301,2604,27,GRB2|MAPK9|KIRREL|PIK3CB|PIK3R3|NCK1|BAD
PID_ERA_GENOMIC_PATHWAY%MSIGDB_C2%PID_ERA_GENOMIC_PATHWAY,0.0438709677419355,0.299062021084573,-0.274367422009886,-1.4966280717693201,339,55,SET|LMO4|PRDM15|COL18A1|ATP5J|MED1|PCNA|C3|SRA1|DSCAM|BRCA1|SOD1|CEBPB|NEDD8|AP1B1|MYC|APBB1|CTSD|CD82|CCND1|NDUFV3
PID_ARF_3PATHWAY%MSIGDB_C2%PID_ARF_3PATHWAY,0.0946247864371139,0.424507034898303,-0.3579389718567821,-1.4141834850446902,719,19,CD4|CLTA|GGA3|ARF1|KDELR1|ARFIP2|GOSR2|AP2M1|CLTB
PID_ECADHERIN_NASCENT_AJ_PATHWAY%MSIGDB_C2%PID_ECADHERIN_NASCENT_AJ_PATHWAY,0.522845275181724,0.807051143864932,-0.19479066220463,-0.953297141280352,4027,38,RAP1B|AKT1|CDC42|RAC1|IQGAP1|KLHL20|CTTN|WASF2|JUP|CTNND1|RAPGEF1|CYFIP2|RAP1A|TIAM1|CCND1|ARF6|NME1
BIOCARTA_CACAM_PATHWAY%MSIGDB_C2%BIOCARTA_CACAM_PATHWAY,0.528581126951799,0.8105400040230321,0.267432443650914,0.936604173891368,3892,13,CAMK1G|CAMK4|CALM2|CAMK2G|CAMK2D
BIOCARTA_MYOSIN_PATHWAY%MSIGDB_C2%BIOCARTA_MYOSIN_PATHWAY,0.7890614802245141,0.9280333261332429,-0.16893143850636702,-0.763826912490356,6044,29,GNA12|GNA13|PLCB1|ARHGEF5|PKN1|MYLK|ARHGEF15|GNAQ|ARHGEF9|PRKCB
SA_G1_AND_S_PHASES%MSIGDB_C2%SA_G1_AND_S_PHASES,0.0668589407446251,0.3690551432905871,-0.421683112105576,-1.49185318634205,509,14,CDKN1B|CDK4|NXT1|CDKN2A|E2F2|E2F1|ARF1|CFL1|CCND1
BIOCARTA_MPR_PATHWAY%MSIGDB_C2%BIOCARTA_MPR_PATHWAY,0.9056680712246841,0.97046527419469,0.14333448589466,0.6635951624799251,6662,30,GNGT1|GNAS|MYT1|PAQR7|ACTR2|SRC|ACTR3|MAPK1|ADCY1|ARPC2|GNB1|CDK1|PRKACB|CAP1|ARPC4|GNAI1|ARPC5
BIOCARTA_IL12_PATHWAY%MSIGDB_C2%BIOCARTA_IL12_PATHWAY,0.358929056808915,0.71522369267386,0.286585016242841,1.07908763368791,2640,16,MAP2K6|ETV5|MAPK8|JAK2|CD247|CD3E|STAT4|TYK2|CD3D|CD3G|CXCR3|JUN|IL12RB1|CCR5|MAPK14
BIOCARTA_AT1R_PATHWAY%MSIGDB_C2%BIOCARTA_AT1R_PATHWAY,0.728822807256854,0.9064076322522902,0.170899552473443,0.8138317668602749,5342,33,AGTR1|CALM2|SHC1|SOS1|PAK1|PTK2B|PRKCA|ATF2|EGFR|SRC|MAP2K1|MAPK1|MAP2K4|MAPK8
BIOCARTA_CHEMICAL_PATHWAY%MSIGDB_C2%BIOCARTA_CHEMICAL_PATHWAY,0.19824767882829897,0.575514816497402,-0.29943583726674894,-1.24004171284335,1515,22,PARP1|TLN1|CYCS|PXN|EIF2S1|CASP6|PRKCB|BAD
BIOCARTA_CXCR4_PATHWAY%MSIGDB_C2%BIOCARTA_CXCR4_PATHWAY,0.0890339425587467,0.41228493992510207,-0.338490622491277,-1.42118046849575,681,23,BCAR1|CXCR4|PXN|MAPK3|HRAS|GNAQ|RELA|NFKB1|PRKCB
BIOCARTA_IL4_PATHWAY%MSIGDB_C2%BIOCARTA_IL4_PATHWAY,0.27968096234309603,0.653204101106396,-0.371029938821373,-1.16238836391403,2138,10,IL2RG|AKT1|JAK3|STAT6|GRB2|IRS1|RPS6KB1
BIOCARTA_TCR_PATHWAY%MSIGDB_C2%BIOCARTA_TCR_PATHWAY,0.49374674309536204,0.7923145426459479,-0.191909568498717,-0.973358689391003,3789,43,CALM3|VAV1|ELK1|GRB2|MAPK3|HRAS|NFATC1|NFKBIA|RELA|NFKB1|PRKCB
BIOCARTA_G2_PATHWAY%MSIGDB_C2%BIOCARTA_G2_PATHWAY,0.7463965189012779,0.9118647019584949,0.183400812344273,0.790021613834699,5488,24,MYT1|CDKN1A|ATM|YWHAQ|CDC34|YWHAH|ATR|CHEK2|EP300|MDM2|CDK1
BIOCARTA_GRANULOCYTES_PATHWAY%MSIGDB_C2%BIOCARTA_GRANULOCYTES_PATHWAY,0.0488603615404768,0.31707541045134696,-0.48445063136279404,-1.5684349834501898,372,11,SELP|C5|ITGAL|TNF|SELPLG|ITGB2|ICAM1|ITGAM|PECAM1
BIOCARTA_NO1_PATHWAY%MSIGDB_C2%BIOCARTA_NO1_PATHWAY,0.089173640167364,0.41228493992510207,-0.333332581539193,-1.41665407423538,681,24,AKT1|PRKG1|PRKAR2A|FLT1|RYR2|KDR|CALM3|FLT4|PRKAR1A|PDE2A|NOS3|CAV1|HSP90AA1
PID_ECADHERIN_KERATINOCYTE_PATHWAY%MSIGDB_C2%PID_ECADHERIN_KERATINOCYTE_PATHWAY,0.522521303936156,0.807051143864932,0.23749862015675,0.9468794243087859,3862,19,PLCG1|EGFR|SRC|FMN1|CTNNA1|PIP5K1A|PIK3CA|VASP|CTNNB1|PIK3R1|AKT2|RHOA|FYN|AKT1|ZYX|AJUBA|RAC1|JUP|CTNND1
ST_TYPE_I_INTERFERON_PATHWAY%MSIGDB_C2%ST_TYPE_I_INTERFERON_PATHWAY,0.31025155531512,0.681045250505892,0.40981247104923396,1.1312763263216798,2293,7,STAT2|JAK1|PTPRU|TYK2|STAT1|IRF9
ST_GA13_PATHWAY%MSIGDB_C2%ST_GA13_PATHWAY,0.420642142207201,0.751774348695433,-0.21640995698114399,-1.02530357836602,3235,34,PRKD1|TBXA2R|PIK3CB|PLD1|CFB|NFKBIA|SRF|PLD3|NFKB1
BIOCARTA_PITX2_PATHWAY%MSIGDB_C2%BIOCARTA_PITX2_PATHWAY,0.814256619144603,0.9360565056688009,0.20652173913043498,0.7232821875619448,5996,13,HDAC1|EP300|AXIN1|DVL1|LDB1|LEF1|CTNNB1
PID_RAC1_PATHWAY%MSIGDB_C2%PID_RAC1_PATHWAY,0.798789127914466,0.931350348412063,-0.146204623354125,-0.7760383455080458,6200,50,STAT3|MAPK9|CYBB|CYFIP2|MAP2K3|NOXA1|NCF2|MAP3K11|CFL1|ARHGDIA
PID_TRAIL_PATHWAY%MSIGDB_C2%PID_TRAIL_PATHWAY,0.271465968586387,0.646576786621306,-0.257680225845494,-1.1508287084622701,2073,28,TNFRSF10A|TNFRSF10B|CASP10|TRAF2|TNFSF10|PIK3CB|MAPK3|TNFRSF10C|PIK3R3|FADD|SMPD1
PID_P53_REGULATION_PATHWAY%MSIGDB_C2%PID_P53_REGULATION_PATHWAY,0.23416655873591502,0.617951264290741,-0.21122332751679201,-1.16720921058818,1807,58,ABL1|HUWE1|RCHY1|PPM1D|NEDD8|PPP2R4|KAT2B|PPP2CA|KAT8|KAT5|PRMT5|CSNK1A1
PID_ALPHA_SYNUCLEIN_PATHWAY%MSIGDB_C2%PID_ALPHA_SYNUCLEIN_PATHWAY,0.697968220890857,0.891764519840571,-0.18075512609114103,-0.8330232163240041,5358,31,SYK|UBE2L3|LYN|GRK5|SNCAIP|FGR|TOR1A|PARK7|MAPK3|PLD1|HCK|FKBP1A|BAD
BIOCARTA_SODD_PATHWAY%MSIGDB_C2%BIOCARTA_SODD_PATHWAY,0.35591004184100394,0.713672237213954,-0.344731062871755,-1.07999741863085,2721,10,FADD|TNFRSF1A|TNFRSF1B
PID_CMYB_PATHWAY%MSIGDB_C2%PID_CMYB_PATHWAY,0.0231869122761819,0.21168602767687303,-0.26929820404368604,-1.57414175447046,179,72,SMARCA2|MCM4|CD4|TRIM28|YEATS4|CD34|CDKN2A|GATA3|MAF|CLTA|ETS2|ADA|HES1|CEBPD|TFEC|CEBPA|ZFHX3|PIM1|CBX4|HRAS|CEBPB|SPI1|CCNB1|ANPEP|H2AFZ|COL1A2|MYC|CSF1R|CCND1|CASP6
PID_AR_PATHWAY%MSIGDB_C2%PID_AR_PATHWAY,0.656077170418006,0.874963280664568,-0.16095763525673001,-0.872758401762699,5100,54,ZNF318|RPS6KA3|UBA3|PRDX1|PIAS1|SVIL|APPL1|AKT1|PA2G4|HNRNPA1|NCOA6|CDK6|TMF1|VAV3|KDM1A|MED1|CDKN2A|TGIF1|BRCA1|NCOA4|GSN|FHL2|SRF|LATS2|FKBP4|CCND3|CCND1
BIOCARTA_RANKL_PATHWAY%MSIGDB_C2%BIOCARTA_RANKL_PATHWAY,0.18562091503268,0.559093571852282,-0.38061716474774604,-1.2739612882051001,1419,12,IFNAR2|TRAF6|FOSL2|FOSL1|IFNAR1|TNFRSF11A|RELA|NFKB1
BIOCARTA_HDAC_PATHWAY%MSIGDB_C2%BIOCARTA_HDAC_PATHWAY,0.7798227675528291,0.924704689181848,0.172559906244249,0.772291383743516,5719,27,CAMK1G|MAPK7|MAP2K6|CALM2
SIG_CD40PATHWAYMAP%MSIGDB_C2%SIG_CD40PATHWAYMAP,0.7398934095931371,0.909493931144346,-0.170284515026046,-0.806771208830007,5691,34,TRAF2|MAPK8IP1|MAPK9|MAPK3|NFKBIA|TRAF3|MAPK13|NFKB1
BIOCARTA_LEPTIN_PATHWAY%MSIGDB_C2%BIOCARTA_LEPTIN_PATHWAY,0.21689871689871698,0.599597524514766,0.404517525840754,1.2292914523818201,1588,9,PRKAG2|LEPR|CPT1A|PRKAA1|PRKAG1
BIOCARTA_AGPCR_PATHWAY%MSIGDB_C2%BIOCARTA_AGPCR_PATHWAY,0.848627450980392,0.9492491301138911,-0.206237217600066,-0.690295277628236,6491,12,PRKAR1A|ARRB1|PRKCB
PID_TCR_CALCIUM_PATHWAY%MSIGDB_C2%PID_TCR_CALCIUM_PATHWAY,0.0584542958022754,0.34885102442576,-0.362030522365872,-1.49926259045681,446,22,PPP3CA|NFATC3|PTGS2|FOSL1|POU2F1|NFATC2|JUNB|RCAN2|AKAP5|IL2RA|CREM|NFATC1|FKBP1A|PRKACA|RCAN1
PID_EPO_PATHWAY%MSIGDB_C2%PID_EPO_PATHWAY,0.9337793555434192,0.9800972968717879,0.13368996913602402,0.623645253031485,6838,31,IRS2|GAB1|VAV2|SHC1|SOS1|CBL|PLCG1|BCL2
PID_TGFBR_PATHWAY%MSIGDB_C2%PID_TGFBR_PATHWAY,0.0567741935483871,0.34436604181231795,-0.266140384396784,-1.4517509673774298,439,55,PPP2CA|TGFBR2|TGFBR3|XIAP|FKBP1A|CAMK2A|CAV1|YAP1|RPS6KB1|DAB2|PPP1CA|OCLN
BIOCARTA_PS1_PATHWAY%MSIGDB_C2%BIOCARTA_PS1_PATHWAY,0.437704026115343,0.7635570545514341,0.296271898267726,1.00697055675192,3217,12,DLL1|ADAM17|BTRC
PID_AURORA_B_PATHWAY%MSIGDB_C2%PID_AURORA_B_PATHWAY,0.0234577501296008,0.213101371309007,-0.32914978799250705,-1.6254232062400702,180,39,EVI5|RHOA|KIF2C|CDCA8|DES|NCAPG|AURKA|RACGAP1|NCAPH|SMC2|NSUN2|NPM1|MYLK|KIF20A|INCENP|NDC80|SGOL1|SMC4|TACC1|VIM|PSMA3|BIRC5
PID_DELTA_NP63_PATHWAY%MSIGDB_C2%PID_DELTA_NP63_PATHWAY,0.104101765316719,0.44419145940290994,-0.278935993197942,-1.36510078001816,801,38,HELLS|BDKRB2|RRAD|FOSL2|IGFBP3|GSK3B|SFN|CCNB2|NRG1|ADRM1|GNB2L1|RUNX1|STXBP4|CDKN2A|ADA|HES1|TOP2A|CEBPD|NOTCH1|PERP|AXL|POU2F2|YAP1|COL5A1|FASN
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY%MSIGDB_C2%PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,0.326072779444372,0.6940781026265961,-0.214622449379895,-1.09407272573791,2499,44,FES|ELK1|ITGA5|DOK2|GRB2|PXN|MAPK3|FN1|NOS3|TEK|RELA|RPS6KB1|NFKB1|NCK1
SA_FAS_SIGNALING%MSIGDB_C2%SA_FAS_SIGNALING,0.325939951311875,0.6940781026265961,0.40331047767874,1.11332774814613,2409,7,CASP8|PDE6D|BCL2|CFLAR|CASP3
PID_ANTHRAX_PATHWAY%MSIGDB_C2%PID_ANTHRAX_PATHWAY,0.9256591465072029,0.978729561725454,0.163015392576863,0.613807018024333,6810,16,MAP2K6|ANTXR1|MAP2K7|NLRP1|MAP2K1|MAPK1|MAP2K4
SA_CASPASE_CASCADE%MSIGDB_C2%SA_CASPASE_CASCADE,0.7663856404677729,0.919992400339549,0.19697590059696302,0.771047722340327,5635,18,CASP9|CASP8|SREBF1|DFFB|APAF1|DFFA|BIRC2|CASP3
PID_INSULIN_PATHWAY%MSIGDB_C2%PID_INSULIN_PATHWAY,0.565235173824131,0.829765064532093,0.17901036723693803,0.9290408537579058,4145,44,EXOC4|NCK2|DOK1|RHOQ|GRB14|CRK|SHC1|FOXO3|SOS1
BIOCARTA_RHO_PATHWAY%MSIGDB_C2%BIOCARTA_RHO_PATHWAY,0.659182874298395,0.8772415412127091,-0.18963281732144502,-0.8574286150770479,5049,29,ARPC1B|RHOA|ARHGAP5|ROCK1|ARHGAP4|ARHGEF5|ARPC1A|TLN1|MYLK|ARHGAP1|GSN|VCL|CFL1
PID_EPHRINB_REV_PATHWAY%MSIGDB_C2%PID_EPHRINB_REV_PATHWAY,0.8378766140602579,0.946216977301937,-0.16411430983606698,-0.7238242840465591,6423,27,HCK|EPHB4|TIAM1|RGS3
PID_UPA_UPAR_PATHWAY%MSIGDB_C2%PID_UPA_UPAR_PATHWAY,0.0005209690023443611,0.0139121625154964,-0.47013731685652704,-2.16666220356202,3,31,RAC1|ITGB1|MMP12|TGFB1|FPR3|ITGB2|LRP1|HGF|PDGFD|ITGB5|PLAU|BCAR1|FPR1|VTN|ITGA5|DOCK1|FN1|PLAUR|PDGFRB|MMP9|SERPINE1|ITGAM
BIOCARTA_ACH_PATHWAY%MSIGDB_C2%BIOCARTA_ACH_PATHWAY,0.39522258414766603,0.7377402989373809,0.316370784839881,1.04105414647949,2911,11,CHRNB1|FOXO3|PTK2B|YWHAH|SRC
BIOCARTA_VIP_PATHWAY%MSIGDB_C2%BIOCARTA_VIP_PATHWAY,0.179916317991632,0.553416445441942,-0.296790358402535,-1.26135065610229,1375,24,PRKAR1A|NFATC1|GNAQ|NFKBIA|MYC|RELA|NFKB1
PID_S1P_META_PATHWAY%MSIGDB_C2%PID_S1P_META_PATHWAY,0.134138338364615,0.495641459539577,-0.327177903772478,-1.33292513576089,1021,21,GNA12|GNA13|SGPP1|S1PR1|GNAI2|GNAQ|GNA15|SPHK1|ABCC1
PID_ECADHERIN_STABILIZATION_PATHWAY%MSIGDB_C2%PID_ECADHERIN_STABILIZATION_PATHWAY,0.42794400219599205,0.756202814008058,0.203937817926029,1.0189247713904301,3117,39,EXOC4|AQP5|MET|MYO6|KIFC3|GIT1|NCKAP1|CAMSAP3|MLLT4|IGF1R
PID_IL12_2PATHWAY%MSIGDB_C2%PID_IL12_2PATHWAY,0.0119307248236049,0.14348927654591198,-0.320415859547403,-1.71093696733695,92,51,IL2RB|PPP3CA|CCR5|CD8B|HLX|MAPK14|HLA-DRB1|IL2RG|IL1B|CCL3|RIPK2|CCL4|GZMA|STAT5A|STAT6|HLA-DRA|B2M|IL18|NFKB2|GZMB|CD4|RAB7A|HLA-A|SOCS1|STAT3|IL2RA|GADD45B|MAP2K3|GADD45G|RELB|RELA|IL1R1|NFKB1
PID_CXCR4_PATHWAY%MSIGDB_C2%PID_CXCR4_PATHWAY,0.062572124631363,0.359087664164358,-0.216521692661657,-1.3772119574443102,487,100,FYN|VPS4A|ITGA4|HLA-DRB1|RAP1B|AKT1|CXCL12|CDC42|PIK3R5|PTEN|MLST8|RAC1|ITGB1|SSH1|ITGA9|STAT5A|LYN|HLA-DRA|GNA13|RGS1|GNB2L1|PLCB1|ITGA10|ITGA11|PIK3R6|CD4|HGS|DNM1|PLCB3|FGR|VAV1|BCAR1|ITGA5|CXCR4|STAT3|UBQLN1|PTPN6|PXN|PIK3CB|PIK3R3|GNAI2|HCK|ITGA8|GRK6|MMP9|CFL1|ADRBK1|MAPKAP1|BAD
PID_GLYPICAN_1PATHWAY%MSIGDB_C2%PID_GLYPICAN_1PATHWAY,0.306239416438713,0.6775726086361429,-0.260176136389475,-1.12165578002449,2350,25,FYN|APP|TGFB2|NRG1|TGFB1|LYN|FLT1|FGR|PLA2G2A|TGFB3|HCK|TGFBR2|SLIT2|PRNP
PID_FANCONI_PATHWAY%MSIGDB_C2%PID_FANCONI_PATHWAY,0.0108513112001033,0.134645873234709,-0.333707642584012,-1.72871058914206,83,46,BLM|FAAP24|ATRIP|FANCD2|FANCG|RAD9A|RFC2|FBXW11|RPA2|UBE2T|BRIP1|PALB2|RFC3|H2AFX|NBN|RAD1|RAD17|HES1|BRCA1|RFC5|TOPBP1|FAAP100|RMI1|FANCM|RFC4|XRCC3|SSPO
PID_FRA_PATHWAY%MSIGDB_C2%PID_FRA_PATHWAY,0.00142302716688228,0.0302137857829966,-0.42154283299988204,-2.0298467094385,10,36,CDKN2A|PLAU|MMP1|TXLNG|DCN|MGP|HMOX1|USF2|NFATC1|CCL2|THBD|PLAUR|NOS3|COL1A2|MMP9|CCND1|ITGB4
BIOCARTA_CTCF_PATHWAY%MSIGDB_C2%BIOCARTA_CTCF_PATHWAY,0.0392310710082385,0.282480768246712,-0.3800792131232171,-1.57400691500264,299,22,TGFB2|CDKN1B|PTEN|TGFB1|CDKN2A|TGFB3|SMAD5|PPP2CA|TGFBR2|TGFBR3|MYC|RPS6KB1
BIOCARTA_AKT_PATHWAY%MSIGDB_C2%BIOCARTA_AKT_PATHWAY,0.026673640167364,0.23124829949084805,-0.426718309876094,-1.65582574311037,203,18,NFKBIA|PPP2CA|RELA|NFKB1|HSP90AA1|BAD
BIOCARTA_SARS_PATHWAY%MSIGDB_C2%BIOCARTA_SARS_PATHWAY,0.27349648529028897,0.647886610340792,-0.406840702418053,-1.17123744065768,2100,8,GPT|ANPEP|LDHA
BIOCARTA_CTL_PATHWAY%MSIGDB_C2%BIOCARTA_CTL_PATHWAY,0.20156862745098003,0.579746099203836,-0.373825959494695,-1.25123048835173,1541,12,ITGAL|FAS|PRF1|B2M|ITGB2|GZMB|HLA-A|ICAM1
PID_TNF_PATHWAY%MSIGDB_C2%PID_TNF_PATHWAY,0.282690559667576,0.655069746883962,-0.220183379387393,-1.13181844492618,2176,45,MAP2K3|FADD|CAV1|RELA|NFKB1|SMPD1|TNFRSF1A|TNFRSF1B|SQSTM1
BIOCARTA_BAD_PATHWAY%MSIGDB_C2%BIOCARTA_BAD_PATHWAY,0.5084856396866839,0.7990325304927759,-0.22744821783063798,-0.954959881594355,3894,23,CSF2RB|PRKAR1A|MAPK3|IGF1|IL3RA|BAD
PID_BETA_CATENIN_NUC_PATHWAY%MSIGDB_C2%PID_BETA_CATENIN_NUC_PATHWAY,0.620803978450062,0.855549195898434,0.154912303337227,0.9021079098800451,4493,67,DKK1|TLE2|CBY1|HBP1|TCF7L1|CAMK4|HDAC1|SALL4|AES|MMP2|TBL1XR1|YWHAQ|BCL9|YWHAB|XPO1|YWHAE
PID_KIT_PATHWAY%MSIGDB_C2%PID_KIT_PATHWAY,0.460614669421488,0.774751791105461,-0.18909073119377803,-0.9962996514182758,3566,49,MATK|GRB2|SOCS1|STAT3|PTPN6|SH2B3|SNAI2|MAPK3|HRAS|MITF|RPS6KB1|GRB10|BAD
BIOCARTA_CYTOKINE_PATHWAY%MSIGDB_C2%BIOCARTA_CYTOKINE_PATHWAY,0.123028391167192,0.47697345522944606,-0.506676016607656,-1.3849762965026,935,7,IL16|IL6|TNF|IL18|IL15|LTA
BIOCARTA_CREB_PATHWAY%MSIGDB_C2%BIOCARTA_CREB_PATHWAY,0.42340814196242205,0.753783909572009,-0.232760885734175,-1.015345490011,3244,26,GRB2|PRKAR1A|MAPK3|CAMK2B|HRAS|CAMK2A|PRKCB
BIOCARTA_MAPK_PATHWAY%MSIGDB_C2%BIOCARTA_MAPK_PATHWAY,0.186544342507645,0.5597458283154859,-0.194800318299885,-1.19818084283723,1463,87,ELK1|TGFB3|TRAF2|MAPKAPK2|GRB2|MEF2C|CEBPA|MAPK9|MAPK3|HRAS|MAP3K13|MAP2K3|MAX|NFKBIA|MAP3K11|ARAF|MYC|RELA|RPS6KB1|MAPK13|NFKB1|RPS6KA4|MEF2BNB-MEF2B|RPS6KB2
BIOCARTA_ACE2_PATHWAY%MSIGDB_C2%BIOCARTA_ACE2_PATHWAY,0.501183587585481,0.795954687014814,-0.396907227296623,-0.9513108869599871,3810,5,AGT|COL4A1|COL4A2
BIOCARTA_PPARA_PATHWAY%MSIGDB_C2%BIOCARTA_PPARA_PATHWAY,0.0302718021383486,0.24599181315662,-0.294522175172145,-1.56329188703165,234,50,SRA1|PRKAR1A|MAPK3|NR1H3|ACOX1|HSPA1A|NFKBIA|CD36|MYC|PPARA|RELA|PDGFA|HSP90AA1|MRPL11|PRKCB
BIOCARTA_EGFR_SMRTE_PATHWAY%MSIGDB_C2%BIOCARTA_EGFR_SMRTE_PATHWAY,0.7924700364773319,0.929506008306088,-0.24398720211827,-0.733973225315421,6082,9,EGFR|MAP2K1|NCOR2|RXRA|ZBTB16|MAP3K1|MAPK14|RARA|THRA
BIOCARTA_FEEDER_PATHWAY%MSIGDB_C2%BIOCARTA_FEEDER_PATHWAY,0.5222134595162989,0.807051143864932,-0.34470518352855295,-0.9422362472670709,3972,7,TPI1|MPI|HK1|PYGL|PYGM
ST_MYOCYTE_AD_PATHWAY%MSIGDB_C2%ST_MYOCYTE_AD_PATHWAY,0.38191615192535205,0.729938071787161,-0.267100277765734,-1.0552882791938298,2905,19,AKT1|RAC1|APC|ITPR2|PLN|ITPR3|CFB|GNAQ|KAT5|KCNJ9
BIOCARTA_P35ALZHEIMERS_PATHWAY%MSIGDB_C2%BIOCARTA_P35ALZHEIMERS_PATHWAY,0.415794979079498,0.7493091022753771,-0.327029308084232,-1.02454013167648,3179,10,APP|GSK3B|MAPT|CSNK1D|CAPN1|PPP2CA|CSNK1A1
BIOCARTA_TEL_PATHWAY%MSIGDB_C2%BIOCARTA_TEL_PATHWAY,0.6446831656241501,0.8688307429995409,0.21865756005517104,0.855918988780258,4740,18,IGF1R|PRKCA|XRCC5|RB1|BCL2|TNKS|EGFR|KRAS|TERF1|POLR2A
PID_LIS1_PATHWAY%MSIGDB_C2%PID_LIS1_PATHWAY,0.9779141104294481,0.992841808657558,0.11798666764014099,0.5280490051154471,7172,27,PAFAH1B2|NDEL1|CDK5R1|VLDLR|YWHAE|DYNLT1|LRP8|CDK5|KATNA1
BIOCARTA_CASPASE_PATHWAY%MSIGDB_C2%BIOCARTA_CASPASE_PATHWAY,0.0776762402088773,0.390053430594062,-0.345550277778422,-1.45082100664289,594,23,GZMB|PARP1|CASP10|ARHGDIB|CASP1|CYCS|CASP4|LMNB1|LMNA|XIAP|CASP6
PID_MAPK_TRK_PATHWAY%MSIGDB_C2%PID_MAPK_TRK_PATHWAY,0.694303219919176,0.889621324957948,-0.177814400128976,-0.8350666194207909,5325,33,ELK1|MAPKAPK2|MEF2C|MAPK3|HRAS|MAP2K3|RAP1A|SRF|EHD4
PID_RHOA_PATHWAY%MSIGDB_C2%PID_RHOA_PATHWAY,0.820638820638821,0.940031154277066,-0.15045606914784398,-0.749004320035894,6345,40,CDKN1B|SCAI|ROCK1|CDC42|PTEN|ITGB1|CIT|TLN1|PKN1|SH3GL2|SLC9A1|MSN|PLD1|MAP2K3|VCL|SRF|CFL1
BIOCARTA_CELLCYCLE_PATHWAY%MSIGDB_C2%BIOCARTA_CELLCYCLE_PATHWAY,0.0545691906005222,0.33896362399005303,-0.36296474054504707,-1.52393704800062,417,23,CDC25A|RBL1|CDKN2D|CDKN1B|CDK4|CCNH|CCND2|CDK6|CDKN2A|CDKN2B|E2F1|CCNB1|CDK7|CCND3|CDKN2C|CCND1
BIOCARTA_LYM_PATHWAY%MSIGDB_C2%BIOCARTA_LYM_PATHWAY,0.0532165271966527,0.334339494273052,-0.499256792198774,-1.5641063567549198,406,10,ITGAL|ITGA4|ITGB1|ITGB2|CD34|ICAM1|VCAM1|PECAM1
PID_IL6_7_PATHWAY%MSIGDB_C2%PID_IL6_7_PATHWAY,0.241010943199583,0.6244696312630601,-0.230454014779865,-1.1688547868968,1849,43,JUNB|HSP90B1|LMO4|SOCS3|VAV1|IL6ST|CEBPD|GRB2|STAT3|CEBPB|PTPRE|MITF|HCK|A2M|MYC|TIMP1
BIOCARTA_TRKA_PATHWAY%MSIGDB_C2%BIOCARTA_TRKA_PATHWAY,0.6681045751633989,0.8811119744196031,-0.24809827842013898,-0.8304081677111509,5110,12,NGF|GRB2|HRAS|PRKCB
BIOCARTA_AHSP_PATHWAY%MSIGDB_C2%BIOCARTA_AHSP_PATHWAY,0.954718520533043,0.9870180073166591,0.18179496227986605,0.57593872895052,7020,10,HMBS|UROD|CPOX|HBA2|UROS|HBB|FECH|HBA1|ALAS1
BIOCARTA_SHH_PATHWAY%MSIGDB_C2%BIOCARTA_SHH_PATHWAY,0.9448519779931881,0.9828335913287599,-0.180015553610856,-0.582810040012062,7212,11,GSK3B|PRKAR2A|SMO|DYRK1A|PRKAR1A
BIOCARTA_TNFR1_PATHWAY%MSIGDB_C2%BIOCARTA_TNFR1_PATHWAY,0.963581777835792,0.990916952887267,-0.126418933898072,-0.57160576393273,7381,29,MADD|PARP1|ARHGDIB|TRAF2|LMNB1|LMNA|FADD|TNFRSF1A
BIOCARTA_VDR_PATHWAY%MSIGDB_C2%BIOCARTA_VDR_PATHWAY,0.10078890097932498,0.43764158078621096,0.416275174420973,1.4148383515263399,740,12,TSC2|HDAC1|NCOR1|CARM1|NCOA3
BIOCARTA_EPHA4_PATHWAY%MSIGDB_C2%BIOCARTA_EPHA4_PATHWAY,0.0893694632621157,0.412959732445284,-0.48533553709932103,-1.46000809236013,685,9,SELP|ITGA1|L1CAM|FYN|RAP1B|ITGB1|LYN|EPHA4
PID_BMP_PATHWAY%MSIGDB_C2%PID_BMP_PATHWAY,0.789391979301423,0.9280333261332429,-0.16026005419829997,-0.7716970096582042,6101,36,SMURF1|PPP1R15A|GSK3B|PPM1A|CHRDL1|SMAD9|FST|GREM1|SMAD6|SMAD5|SMURF2|CHRD|NUP214|BMP2|XIAP|PPP1CA
BIOCARTA_RB_PATHWAY%MSIGDB_C2%BIOCARTA_RB_PATHWAY,0.63245078071962,0.8623429424911601,0.24530978220838398,0.8591260012291708,4657,13,MYT1|ATM|RB1|YWHAH|CDK1|CDK2|TP53|CHEK1|CDC25B|WEE1|MAPK14|CDK4
BIOCARTA_41BB_PATHWAY%MSIGDB_C2%BIOCARTA_41BB_PATHWAY,0.650779101741522,0.8721819781452891,-0.247286937883633,-0.8512095945495649,4969,13,NFKBIA|RELA|NFKB1
BIOCARTA_BCELLSURVIVAL_PATHWAY%MSIGDB_C2%BIOCARTA_BCELLSURVIVAL_PATHWAY,0.16789183512732997,0.5400872099036179,-0.354225713947536,-1.2861361477886102,1278,15,XIAP|BIRC5|DPF2
BIOCARTA_CERAMIDE_PATHWAY%MSIGDB_C2%BIOCARTA_CERAMIDE_PATHWAY,0.0414541650320387,0.291764737397192,-0.376886345202428,-1.5607844181849,316,22,NSMAF|TRAF2|CYCS|MAPK3|FADD|RELA|NFKB1|SMPD1|TNFRSF1A|BAD
PID_TXA2PATHWAY%MSIGDB_C2%PID_TXA2PATHWAY,0.0268120590121873,0.231542581971207,-0.29641200345214397,-1.5827626478446999,208,51,PRKCQ|RHOA|FYN|MAPK14|GNA14|AKT1|ROCK1|PIK3R5|SYK|PRKG1|RAC1|PRKCH|GNA12|LYN|GNA13|PIK3R6|DNM1|FGR|SLC9A3R1|TBXA2R|ICAM1|VCAM1|GNAI2|GNAQ|NOS3|GNA15|HCK|TGM2|PRKACA|ADRBK1|PTGIR|PRKCB
NABA_SECRETED_FACTORS%MSIGDB_C2%NABA_SECRETED_FACTORS,0.00012846865364851,0.00518555396908895,-0.349625934796258,-2.46499076404048,0,163,CXCL14|KITLG|LIF|CTF1|IL1B|TGFB2|NRG1|NRG3|CCL3|FSTL1|GDF15|NRG2|CXCL12|TNF|CHRDL1|CBLN4|CCL4|ARTN|HGFAC|FST|CCL8|CXCL1|WFIKKN1|TGFB1|CXCL2|S100A1|CCL11|MDK|INHBB|TNFSF13B|IL18|TNFSF8|CCL19|ANGPT2|EDA|ANGPTL2|IL17D|SFRP4|ANGPTL4|CCL24|HGF|CFC1|SFRP2|NGF|EGFL7|HCFC1|PDGFD|IL1RN|EBI3|IL34|VEGFC|TGFB3|BRINP3|INS|CCL3L3|CCL18|IL17B|TNFSF10|PDGFC|CBLN1|INHBA|TNFSF12|CRHBP|S100A13|CHRD|S100A10|OSM|FGF10|SCUBE2|CBLN3|IGF1|IL15|TNFSF13|HBEGF|CSF1|CCL2|INSL3|VEGFB|CCBE1|FGF19|S100A3|BMP2|FGF9|ZFP91|FGF7|GDF11|CX3CL1|IL11|LTA|FLT3LG|HCFC2|CCL4L2|CCL14|PTN|MEGF9|S100A8|WNT3|S100A9|PDGFA|S100A6|S100A11|S100A16|S100A4|PDGFB
SA_TRKA_RECEPTOR%MSIGDB_C2%SA_TRKA_RECEPTOR,0.822451916786602,0.9412507273497192,-0.18989733608698,-0.7216562493406701,6285,17,NGF|ELK1|GRB2|HRAS|NGFR
BIOCARTA_WNT_PATHWAY%MSIGDB_C2%BIOCARTA_WNT_PATHWAY,0.5924424686192471,0.8417583856451459,-0.21193925712329398,-0.9007358677862479,4530,24,PPP2CA|MYC|CSNK1A1|CCND1
BIOCARTA_BARRESTIN_SRC_PATHWAY%MSIGDB_C2%BIOCARTA_BARRESTIN_SRC_PATHWAY,0.838934103439223,0.946494154033447,-0.195886576705557,-0.71123240704343,6390,15,PLCB1|DNM1|ARRB1|MAPK3|HRAS|HCK
NABA_CORE_MATRISOME%MSIGDB_C2%NABA_CORE_MATRISOME,0.000127746550843127,0.00518555396908895,-0.42315287995549605,-3.10026808392681,0,198,SMOC1|LAMB2|DPT|LAMC1|COL27A1|FBLN5|NCAN|SVEP1|COL20A1|NTN3|SPON2|COCH|LAMC2|SBSPON|COL18A1|COL23A1|SPOCK2|PCOLCE2|FGL2|COL11A2|NID2|LAMC3|HMCN1|LTBP3|MFAP4|TNFAIP6|PRELP|AEBP1|NTN4|FNDC1|SRPX2|LAMA2|GAS6|HAPLN3|POSTN|VTN|TNXB|PAPLN|SRPX|DCN|SMOC2|PODN|VWA1|MXRA5|VWF|COL14A1|MGP|ACAN|COL5A3|ELN|LGI1|LTBP2|BGN|CTGF|FBN1|LTBP1|MMRN2|SPP1|COL4A1|COMP|CILP|SRGN|NTN1|VCAN|LAMA4|SPARC|MMRN1|WISP1|COL4A2|FBN3|OGN|CRISPLD2|EDIL3|COL5A2|COL12A1|LUM|COL6A3|COL8A1|FN1|ABI3BP|FMOD|MFAP5|VWA5A|COL21A1|NOV|ECM1|TNC|THBS1|ZP3|POMZP3|COL1A2|COL1A1|CTHRC1|THBS2|MFGE8|COL3A1|EMILIN2|IGFBP6|SLIT2|IGFBP5|NID1|COL6A1|TGFBI|CRIM1|EFEMP1|FBLN2|COL16A1|SPARCL1|COL5A1|TINAGL1|IGFBP4|IGFBP7|SNED1|COL6A2|EFEMP2|SSPO|COL13A1|FBLN1|COL26A1|LGI4
PID_NFKAPPAB_CANONICAL_PATHWAY%MSIGDB_C2%PID_NFKAPPAB_CANONICAL_PATHWAY,0.20727082516019396,0.587285451772193,-0.296949003529824,-1.22974308728523,1584,22,RAN|NFKBIA|RELA|NFKB1|TNFRSF1A|SSPO
PID_PDGFRB_PATHWAY%MSIGDB_C2%PID_PDGFRB_PATHWAY,0.189933401639344,0.56366737984224,-0.175456024513065,-1.1759277959521297,1482,127,GRB2|PLA2G4A|S1PR1|STAT3|MAPK9|PIK3CB|MAPK3|ABL1|HRAS|PIK3R3|CYFIP2|RAP1A|PPP2CA|HCK|TAGLN|SRF|PDGFRB|MYC|EPS8|ACTA2|PPP2R2B|NCK1|ARHGDIA|SPHK1|PDGFB|PTPRJ|GRB10
BIOCARTA_CLASSIC_PATHWAY%MSIGDB_C2%BIOCARTA_CLASSIC_PATHWAY,0.000130992926381975,0.00518555396908895,-0.691538874954333,-2.2388943138396002,0,11,C4A|C2|C3|C1QB|C1QA|C1QC|C7|C1S|C1R
BIOCARTA_MCALPAIN_PATHWAY%MSIGDB_C2%BIOCARTA_MCALPAIN_PATHWAY,0.16491596638655498,0.536681729087784,-0.32108615655647604,-1.28819151020215,1255,20,TLN1|MYLK|PRKAR1A|PXN|MAPK3|CAPN1|HRAS
BIOCARTA_PYK2_PATHWAY%MSIGDB_C2%BIOCARTA_PYK2_PATHWAY,0.7853844064113009,0.9274485629622209,0.17018970478280998,0.77104276438298,5781,28,CALM2|SHC1|SOS1|PAK1|PTK2B|PRKCA|PLCG1|SRC|MAP2K1|MAPK1|MAP2K4|MAPK8
PID_FAS_PATHWAY%MSIGDB_C2%PID_FAS_PATHWAY,0.54556718061674,0.817297924969912,0.19097478791828698,0.93784298428336,3962,37,MAP2K6|RFC1|MAPK11|RIPK1|CASP8|BID|MAP2K7|EZR|PIK3R2|SRC|CFLAR|IKBKB|MAPK8|BIRC2|PDPK1|CASP3
PID_THROMBIN_PAR1_PATHWAY%MSIGDB_C2%PID_THROMBIN_PAR1_PATHWAY,0.063343717549325,0.36006266503904,-0.2992891298096,-1.46470815712948,487,38,GNA14|ROCK1|ZYX|SNX1|GNA12|GNA13|PLCB1|DNM1|PLCB3|PKN1|ARRB1|SNX2|GNAI2|GNAQ|F2R|NOS3|GNA15|ARHGDIA|PRKCB
BIOCARTA_EIF4_PATHWAY%MSIGDB_C2%BIOCARTA_EIF4_PATHWAY,0.11344647519582199,0.46139171800540707,-0.3261271167844961,-1.36927128205125,868,23,IRS1|MAPK3|EIF4G2|RPS6KB1|EIF4A2|PRKCB|EIF4G1
BIOCARTA_FREE_PATHWAY%MSIGDB_C2%BIOCARTA_FREE_PATHWAY,0.0833116375943765,0.40190038747464796,-0.5125225835158689,-1.47548078505566,639,8,GPX1|SOD1|RELA|NFKB1
BIOCARTA_CK1_PATHWAY%MSIGDB_C2%BIOCARTA_CK1_PATHWAY,0.7142857142857142,0.898428686580078,-0.232953818124081,-0.8018722168312981,5454,13,CSNK1D|PRKAR2A|PLCB1|PRKAR1A|PPP2CA|PPP1CA
PID_ERB_GENOMIC_PATHWAY%MSIGDB_C2%PID_ERB_GENOMIC_PATHWAY,0.7635294117647059,0.9191113740914171,-0.226840963344023,-0.7592579437949529,5840,12,SMARCA4|SMARCE1|C3|NEDD8
PID_HDAC_CLASSI_PATHWAY%MSIGDB_C2%PID_HDAC_CLASSI_PATHWAY,0.034287187419438,0.264364643644243,-0.269131920467534,-1.52832476876396,265,64,RBBP7|RAN|HDAC5|MAX|NFKBIA|KAT2B|FKBP3|HDAC8|SIRT4|PPARG|RELA|MTA2|NFKB1|PRKACA|PRMT5|TNFRSF1A|SSPO
PID_HES_HEY_PATHWAY%MSIGDB_C2%PID_HES_HEY_PATHWAY,0.372559162032846,0.7234654586828599,-0.21273527782303103,-1.0590442978868,2880,40,KDM1A|YY1|CD4|KDR|PARP1|GAA|HES1|NOTCH1|STAT3|E2F1|GATA6|MAML1|ID1|RCAN1
ST_GA12_PATHWAY%MSIGDB_C2%ST_GA12_PATHWAY,0.23206065529379896,0.6157917821375749,0.295685495555784,1.19834630529056,1713,20,PLD2|MAPK7|EPHB2|MAP2K5|MYEF2|DLG4|NR4A3|SRC|MAPK1|MAPK8
BIOCARTA_RANMS_PATHWAY%MSIGDB_C2%BIOCARTA_RANMS_PATHWAY,0.0432792887029289,0.29791299041195396,-0.5114309563818479,-1.6022464239196799,330,10,AURKA|KIF15|RANBP1|TPX2|KPNB1|RCC1|RAN|KPNA2
BIOCARTA_RNA_PATHWAY%MSIGDB_C2%BIOCARTA_RNA_PATHWAY,0.0237970711297071,0.215592612132976,-0.5436687180308629,-1.70324312283429,181,10,NFKBIA|EIF2S1|RELA|NFKB1
PID_CXCR3_PATHWAY%MSIGDB_C2%PID_CXCR3_PATHWAY,0.8313034464887281,0.9443784929910591,-0.148358426870928,-0.7475957844645491,6415,42,ARRB1|PIK3CB|MAPK3|HRAS|PIK3R3|GNAI2|MAP2K3|MAPKAP1
PID_RB_1PATHWAY%MSIGDB_C2%PID_RB_1PATHWAY,0.0302716688227684,0.24599181315662,-0.280485756975264,-1.54445542290707,233,57,TGFB2|CDKN1B|CDK4|RAF1|CREBBP|SKP2|BGLAP|CCND2|CDK6|SMARCA4|CDKN2A|PPP2R3B|E2F2|CEBPD|MEF2C|CEBPA|MAPK9|ABL1|DNMT1|CBX4|CEBPB|E2F1|UBTF|SPI1|MITF|PPP2CA|PPARG|CCND3|CCND1|SUV39H1
BIOCARTA_DREAM_PATHWAY%MSIGDB_C2%BIOCARTA_DREAM_PATHWAY,0.22562091503268,0.6083599141984499,-0.365943790903757,-1.22484813205779,1725,12,PRKAR2A|KCNIP3|PRKAR1A|MAPK3|CREM
PID_TELOMERASE_PATHWAY%MSIGDB_C2%PID_TELOMERASE_PATHWAY,0.39504580054186605,0.7377402989373809,-0.183837005866118,-1.03960033869108,3061,63,PARP2|MAPK3|RBBP7|ABL1|E2F1|DKC1|MAX|NR2F2|MYC|RPS6KB1|NFKB1|HSP90AA1|CCND1|HNRNPC
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY%MSIGDB_C2%PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,0.497465228129468,0.794989907195277,-0.20498573419087696,-0.971178081229434,3826,34,GRB2|STAT3|PTPN6|PIK3CB|MAPK3|HRAS|PIK3R3|GSN|NCK1
BIOCARTA_G1_PATHWAY%MSIGDB_C2%BIOCARTA_G1_PATHWAY,0.646989528795812,0.8697778704754799,-0.19358007423759602,-0.8645502622015769,4942,28,GSK3B|TGFB2|CDKN1B|CDK4|SKP2|TGFB1|CDK6|CDKN2A|TGFB3|CDKN2B|ABL1|E2F1|DHFR|CCND1
PID_ALK2_PATHWAY%MSIGDB_C2%PID_ALK2_PATHWAY,0.491449511400652,0.790696900371285,0.293215631232002,0.964859472916149,3620,11,ACVR1|BMP7|SMAD1|TLX2|BMPR2
PID_INTEGRIN2_PATHWAY%MSIGDB_C2%PID_INTEGRIN2_PATHWAY,0.00104616189355303,0.0240545523142212,-0.5030794758769039,-2.0833830067140298,7,22,ITGAX|F10|SPON2|ITGB2|GP1BA|PLAU|THY1|C3|ICAM1|VCAM1|FCGR2A|PLAUR|PLAT|TGFBI|ITGAM|ICAM2
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES%MSIGDB_C2%SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,0.7100248550124281,0.896399297418128,0.148446190964724,0.847247940146428,5141,62,IRS2|MET|TSC2|GAB1|RPS6KA2|PARD3|SHC1|FOXO3|SOS1|YWHAQ|CREB5|PAK1|YWHAB|YWHAE|INPPL1|AKT3|YWHAH
PID_NFKAPPAB_ATYPICAL_PATHWAY%MSIGDB_C2%PID_NFKAPPAB_ATYPICAL_PATHWAY,0.0603166295957085,0.355734936871271,-0.39702241842732705,-1.50878214139451,460,17,BCL3|NFKBIA|RELA|NFKB1|SSPO
BIOCARTA_EPONFKB_PATHWAY%MSIGDB_C2%BIOCARTA_EPONFKB_PATHWAY,0.20201359832635998,0.580549715779131,-0.401236717579669,-1.25702225855743,1544,10,SOD2|GRIN1|NFKBIA|RELA|NFKB1
BIOCARTA_NTHI_PATHWAY%MSIGDB_C2%BIOCARTA_NTHI_PATHWAY,0.480648535564854,0.7857006060206241,-0.230013684617441,-0.9775516750824369,3675,24,SMAD4|TGFBR1|MAP3K14|CHUK|MAPK14|IL1B|CREBBP|TNF|DUSP1|NR3C1|TLR2|MAP2K3|NFKBIA|TGFBR2|RELA|NFKB1
BIOCARTA_CARDIACEGF_PATHWAY%MSIGDB_C2%BIOCARTA_CARDIACEGF_PATHWAY,0.0452701818657595,0.305260375357835,-0.4102776252705129,-1.55915516426992,345,17,EDNRA|AGT|ADAM12|HRAS|EDNRB|MYC|RELA|NFKB1|PRKCB
ST_ERK1_ERK2_MAPK_PATHWAY%MSIGDB_C2%ST_ERK1_ERK2_MAPK_PATHWAY,0.203438395415473,0.582256180765724,-0.26469785961613,-1.21987944209299,1561,31,ATF1|CREB3|GRB2|MAPK3|KLF6|RAP1A|ARAF|TRAF3|NFKB1|KAT5|BAD
ST_TUMOR_NECROSIS_FACTOR_PATHWAY%MSIGDB_C2%ST_TUMOR_NECROSIS_FACTOR_PATHWAY,0.7190967236653181,0.900474259627538,-0.18021861025374,-0.814862087605021,5508,29,NFKBIA|FADD|NFKB1|TNFRSF1A|TNFRSF1B
BIOCARTA_PAR1_PATHWAY%MSIGDB_C2%BIOCARTA_PAR1_PATHWAY,0.669569738723515,0.8815356925073421,-0.18037036223364997,-0.854555771874442,5150,34,ARHGEF15|GNAQ|F2R|F2RL3|ARHGEF9|PRKCB
ST_B_CELL_ANTIGEN_RECEPTOR%MSIGDB_C2%ST_B_CELL_ANTIGEN_RECEPTOR,0.7960713362626,0.9299728593747351,-0.157688242329314,-0.766040981419675,6159,37,PLCG2|AKT1|RAF1|ITPKB|SYK|SOS2|LYN|NFKB2|TONSL|VAV1|PPP1R13B|GRB2|NFKBIA|NFKB1|BAD
PID_SMAD2_3PATHWAY%MSIGDB_C2%PID_SMAD2_3PATHWAY,0.9008242836582491,0.9684180373391851,-0.169241520259706,-0.643159105125046,6884,17,KPNB1|MAPK3|KPNA2|NUP214
BIOCARTA_BLYMPHOCYTE_PATHWAY%MSIGDB_C2%BIOCARTA_BLYMPHOCYTE_PATHWAY,0.20205836373111,0.580549715779131,-0.416156052361698,-1.25189926903783,1550,9,ITGAL|HLA-DRB1|CD40|HLA-DRA|ITGB2|FCGR2B|ICAM1
SA_MMP_CYTOKINE_CONNECTION%MSIGDB_C2%SA_MMP_CYTOKINE_CONNECTION,0.0116675406397483,0.141350505146212,-0.508257383194593,-1.79814029737782,88,14,FCGR3A|IL1B|TGFB2|TNF|CD44|TGFB1|TNFSF8|SPN|CSF1|TNFRSF1A|TNFRSF1B
ST_GRANULE_CELL_SURVIVAL_PATHWAY%MSIGDB_C2%ST_GRANULE_CELL_SURVIVAL_PATHWAY,0.9884416644003259,0.996030692679047,0.113418639600101,0.48856477542535603,7268,24,EPHB2|CERK|CREB5|MAP2K7|MAPK1|MAP2K4|MAPK8|CASP3
BIOCARTA_STEM_PATHWAY%MSIGDB_C2%BIOCARTA_STEM_PATHWAY,0.21582544689800198,0.598994355749518,-0.452892839669246,-1.237962380768,1641,7,CD4|CSF1|IL11
PID_TRKR_PATHWAY%MSIGDB_C2%PID_TRKR_PATHWAY,0.0279430789133247,0.23658759196501603,-0.282980885834419,-1.55819449949666,215,57,SH2B1|DNM1|RAPGEF1|NGF|MATK|ELMO1|GRB2|STAT3|MAPK3|RHOG|ABL1|HRAS|NTRK2|FAIM|DOCK1|RAP1A|GIPC1|MAGED1|EHD4|TIAM1|CCND1|NGFR|SQSTM1
PID_AVB3_OPN_PATHWAY%MSIGDB_C2%PID_AVB3_OPN_PATHWAY,0.105626465225319,0.44738616127788,-0.29749799324687,-1.3710412564426397,810,31,MAP3K14|CHUK|ITGB3|RHOA|MAP3K1|CDC42|SYK|RAC1|CD44|VAV3|PLAU|BCAR1|ILK|MAPK3|SPP1|GSN|NFKBIA|MMP9|RELA|NFKB1
SIG_BCR_SIGNALING_PATHWAY%MSIGDB_C2%SIG_BCR_SIGNALING_PATHWAY,0.908713154135827,0.9715076818387142,-0.13158371944529698,-0.6763856615087739,6997,45,GSK3B|PLCG2|AKT1|RAF1|SYK|NFATC2|SOS2|LYN|ITPR2|ITPR3|VAV1|PPP1R13B|GRB2|MAPK3|NFATC1|CD81|BAD
BIOCARTA_IL10_PATHWAY%MSIGDB_C2%BIOCARTA_IL10_PATHWAY,0.11499081123654499,0.4642646694217079,-0.379001846508365,-1.3760942689362,875,15,TNF|IL10RA|STAT5A|STAT6|BLVRA|IL10RB|STAT3|HMOX1|BLVRB
BIOCARTA_INTEGRIN_PATHWAY%MSIGDB_C2%BIOCARTA_INTEGRIN_PATHWAY,0.0727107180020812,0.37960378163431896,-0.301551517211764,-1.43958675818285,558,35,RHOA|FYN|MAP2K2|ROCK1|RAF1|ZYX|ITGB1|TNS1|RAPGEF1|TLN1|BCAR1|GRB2|PXN|MAPK3|CAPN1|HRAS|RAP1A|VCL|CAV1|ACTN1
BIOCARTA_PLATELETAPP_PATHWAY%MSIGDB_C2%BIOCARTA_PLATELETAPP_PATHWAY,0.007203667321545509,0.102315552754816,-0.7132454761912,-1.8346595031850501,54,6,PLAU|COL4A1|COL4A2|SERPINE1|PLAT
PID_HIV_NEF_PATHWAY%MSIGDB_C2%PID_HIV_NEF_PATHWAY,0.6282334589886911,0.8598358835891559,-0.186591429729599,-0.8840298443886221,4832,34,NFKBIA|FADD|RELA|NFKB1|TNFRSF1A|CASP6
PID_S1P_S1P3_PATHWAY%MSIGDB_C2%PID_S1P_S1P3_PATHWAY,0.29199843362485306,0.664073888940016,-0.251078398858176,-1.1352560535121201,2236,29,GNA14|AKT1|RAC1|GNA12|GNA13|FLT1|CXCR4|S1PR1|MAPK3|GNAI2|GNAQ|GNA15|PDGFRB|PDGFB
PID_CERAMIDE_PATHWAY%MSIGDB_C2%PID_CERAMIDE_PATHWAY,0.0660524266805087,0.369007394574627,-0.27389091962782997,-1.4264249034951002,508,47,NSMAF|TRAF2|CYCS|MAPK3|IGF1|NFKBIA|FADD|MYC|RELA|NFKB1|CTSD|PDGFA|SMPD1|TNFRSF1A|BAD
BIOCARTA_NGF_PATHWAY%MSIGDB_C2%BIOCARTA_NGF_PATHWAY,0.23864974486458201,0.622138010410922,-0.31402185408410105,-1.19335972846684,1823,17,NGF|ELK1|GRB2|MAPK3|HRAS|NGFR
BIOCARTA_CD40_PATHWAY%MSIGDB_C2%BIOCARTA_CD40_PATHWAY,0.029627687467226,0.24453163127258604,-0.46572533587370796,-1.6476681335757601,225,14,MAP3K14|CHUK|MAP3K1|TRAF6|CD40|DUSP1|IKBKAP|TNFAIP3|NFKBIA|TRAF3|RELA|NFKB1
SIG_CHEMOTAXIS%MSIGDB_C2%SIG_CHEMOTAXIS,0.177492545053805,0.549327983299583,-0.247824021808034,-1.24112877957577,1368,41,AKT1|ROCK1|CDC42|PIK3R5|PAK2|RACGAP1|PTEN|ARHGAP4|PAK4|ITPR2|ANGPTL2|ITPR3|GDI1|MYLK2|MYLK|PPP1R13B|RPS4X|ARHGAP1|CFL2|CFL1
PID_S1P_S1P4_PATHWAY%MSIGDB_C2%PID_S1P_S1P4_PATHWAY,0.996329313057158,0.9988721305072571,-0.12486895105666801,-0.44176808878805696,7599,14,GNAI3|PLCG1|GNAO1|MAPK1|GNAI1|S1PR4|S1PR5|GNAZ|RHOA|CDC42|GNA12|GNA13|MAPK3|GNAI2
ST_INTEGRIN_SIGNALING_PATHWAY%MSIGDB_C2%ST_INTEGRIN_SIGNALING_PATHWAY,0.0950545921644187,0.42498053239300104,-0.22288979638562,-1.3351625563570502,739,79,ITGA4|PLCG2|AKT1|ROCK1|TERF2IP|RAF1|ZYX|CDC42|PAK2|PTEN|ITGB3BP|ITGA9|SOS2|MRAS|PAK4|ITGA10|ITGA11|ANGPTL2|RASGRF2|TNK2|CDKN2A|WAS|TLN1|MYLK2|BCAR1|ILK|ITGA5|MAPK8IP1|MYLK|GRB2|MAPK9|PIK3CB|ABL1|DOCK1|MAP3K11|ITGA8|CAV1|ACTN1|P4HB
BIOCARTA_MEF2D_PATHWAY%MSIGDB_C2%BIOCARTA_MEF2D_PATHWAY,0.876341894279114,0.960725750963158,0.1744668017581,0.670876831999213,6448,17,HDAC1|CALM2|PPP3CB|PRKCA|CAPNS1|EP300|HDAC2
BIOCARTA_CCR3_PATHWAY%MSIGDB_C2%BIOCARTA_CCR3_PATHWAY,0.480615061111841,0.7857006060206241,-0.247489472590353,-0.9778078174726931,3656,19,MAPK3|HRAS|GNAQ|CFL1|PRKCB
PID_BETA_CATENIN_DEG_PATHWAY%MSIGDB_C2%PID_BETA_CATENIN_DEG_PATHWAY,0.6832395656155961,0.885415243771438,-0.21899184971444802,-0.832222505895066,5221,17,AXIN2|CUL1|DVL3|GSK3B|CSNK1D|APC|SKP1|CSNK1A1|SSPO
BIOCARTA_BIOPEPTIDES_PATHWAY%MSIGDB_C2%BIOCARTA_BIOPEPTIDES_PATHWAY,0.9564919022783421,0.9878679384865371,0.120811188305214,0.603603165303777,6968,39,GNGT1|CALM2|SHC1|SOS1|STAT2|PTK2B|PRKCA|CAMK2G|PLCG1|CAMK2D|MAP2K1|CDK5|MAPK1|MAPK8
ST_ADRENERGIC%MSIGDB_C2%ST_ADRENERGIC,0.631002087682672,0.8613756250889949,-0.20054110761415697,-0.8747969339246621,4835,26,ITPR1|EGFR|SRC|PHKA2|MAPK1|GNA11|PIK3CD|PIK3CA|GNAI1|DAG1|BRAF|PIK3R1|ASAH1|PTX3|MAPK10|MAPK14|AKT1|RAF1|ITPKB|APC|ITPR2|ITPR3|CFB|GNAQ|GNA15|KCNJ9
PID_VEGF_VEGFR_PATHWAY%MSIGDB_C2%PID_VEGF_VEGFR_PATHWAY,0.0675993723849372,0.371075653877479,-0.485841865471822,-1.5220791425098898,516,10,FLT1|KDR|VEGFC|FLT4|VEGFB|NRP2
PID_ATF2_PATHWAY%MSIGDB_C2%PID_ATF2_PATHWAY,0.3781911481719051,0.72828181452034,-0.19740826512417398,-1.05410855422666,2947,51,TGFB2|CDK4|DDIT3|POU2F1|DUSP1|DUSP8|ATF3|JUNB|ACHE|SOCS3|DUSP5|PLAU|INS|HES1|MAPK9|BRCA1|MAPK3|KAT5|PDGFRA|H2AFY|CCND1|JDP2
PID_P38_ALPHA_BETA_PATHWAY%MSIGDB_C2%PID_P38_ALPHA_BETA_PATHWAY,0.806526488257783,0.9337214381011629,0.16136523218661702,0.7527465351952858,5906,31,RALB|DUSP10|MAP2K6|MAPK11|RIPK1|PAK1|DUSP16|SRC|MAP2K4|BLK|CCM2
ST_G_ALPHA_S_PATHWAY%MSIGDB_C2%ST_G_ALPHA_S_PATHWAY,0.6671473518615629,0.880719592999549,-0.23741942864305499,-0.8399552198143779,5088,14,TERF2IP|RAF1|SNX13|RASGRF2|CREB3|RAPGEF3|CFB
BIOCARTA_NKCELLS_PATHWAY%MSIGDB_C2%BIOCARTA_NKCELLS_PATHWAY,0.23456305599162697,0.618369750123741,-0.321156967485634,-1.1935436455098998,1792,16,SYK|RAC1|ITGB1|B2M|IL18|VAV1|HLA-A|PTPN6|MAPK3
NABA_ECM_REGULATORS%MSIGDB_C2%NABA_ECM_REGULATORS,0.00012795905310300702,0.00518555396908895,-0.35561885455885606,-2.3952838600791098,0,130,P4HTM|ADAM9|HYAL2|ADAMTS4|F12|F10|KAZALD1|ADAM8|PLOD2|ADAMTS14|AGT|PCSK5|P4HA3|SERPINB8|CTSF|CTSV|HMSD|CTSS|SERPINB1|HYAL3|PLAU|MMP1|ADAM12|P4HA1|CTSB|PAMR1|ADAM33|HTRA3|LOXL1|SERPINA1|HTRA1|MMP14|TIMP3|ADAMTSL1|ITIH3|SULF1|LOX|CTSZ|CTSH|PCSK6|ADAMTSL2|ITIH5|HYAL1|CTSC|SERPINE2|A2M|F13A1|SERPINH1|C17orf58|TGM2|ADAM19|MMP9|P3H2|SERPINE1|PLAT|CSTB|CTSD|ADAMDEC1|CTSL|TIMP1|ADAMTS8|ADAM11|MMP19|SERPING1|FAM20A|SERPINF1|LOXL2|SERPINF2|CST3
PID_IFNG_PATHWAY%MSIGDB_C2%PID_IFNG_PATHWAY,0.409409020217729,0.7448505271608159,-0.208876544084296,-1.03148412783292,3158,39,IFNGR1|RAPGEF1|CASP1|SOCS1|STAT3|PTGES2|MAPK3|CAMK2B|CEBPB|RAP1A|MAP3K11|CAMK2A
BIOCARTA_D4GDI_PATHWAY%MSIGDB_C2%BIOCARTA_D4GDI_PATHWAY,0.5178735105407879,0.8047565444482679,-0.27500206113173803,-0.9466104233390419,3954,13,GZMB|PARP1|CASP10|ARHGDIB|CASP1|CYCS
PID_IL2_PI3K_PATHWAY%MSIGDB_C2%PID_IL2_PI3K_PATHWAY,0.0471907182896624,0.31186172609540996,-0.32348958244096004,-1.51919839917845,361,33,GRB2|IL2RA|SGMS1|UGCG|E2F1|MYC|RELA|RPS6KB1|NFKB1|HSP90AA1|SMPD1
PID_EPHB_FWD_PATHWAY%MSIGDB_C2%PID_EPHB_FWD_PATHWAY,0.30689476412648997,0.678388172543888,-0.225137756582517,-1.11178602417444,2367,39,KALRN|GRB2|PXN|MAPK3|HRAS|RAP1A|EPHB4|RRAS|NCK1|GRIA1|EFNA5
PID_INSULIN_GLUCOSE_PATHWAY%MSIGDB_C2%PID_INSULIN_GLUCOSE_PATHWAY,0.7748569871969492,0.9232611385688659,0.181351440874462,0.7699175312184391,5688,23,RHOQ|YWHAQ|YWHAB|TBC1D4|YWHAE|YWHAH|YWHAZ|PRKCI|VAMP2|PRKCZ|PPP1CC|GYS1|AKT2|YWHAG|INSR|TRIP10|GSK3B|SFN|AKT1|LNPEP|STX4|STXBP4|INS
PID_CASPASE_PATHWAY%MSIGDB_C2%PID_CASPASE_PATHWAY,0.189488599768131,0.563467720122429,-0.230636222045227,-1.22419214977003,1470,50,MADD|GZMB|PARP1|CASP10|TOP1|ARHGDIB|CASP1|TRAF2|CYCS|CASP4|LMNB1|KRT18|LMNA|GSN|CFL2|XIAP|VIM|TNFRSF1A|CASP6
BIOCARTA_STATHMIN_PATHWAY%MSIGDB_C2%BIOCARTA_STATHMIN_PATHWAY,0.33695083682008403,0.699462084003389,-0.281819813103013,-1.09356568643615,2576,18,PRKAR1A|CAMK2B|CCNB1|CAMK2A|MAPK13
PID_HNF3A_PATHWAY%MSIGDB_C2%PID_HNF3A_PATHWAY,0.0065214555888874395,0.0957322763119865,-0.42521467326050294,-1.87540444673177,49,27,CDKN1B|CREBBP|POU2F1|NFIA|PRDM15|COL18A1|ATP5J|INS|VTN|SERPINA1|DSCAM|BRCA1|NFIC|SOD1|CEBPB|AP1B1|NR2F2|NDUFV3
BIOCARTA_PDGF_PATHWAY%MSIGDB_C2%BIOCARTA_PDGF_PATHWAY,0.20747590518364198,0.5875035269006329,-0.263577847982553,-1.21471778657871,1592,31,ELK1|GRB2|STAT3|MAPK3|HRAS|SRF|PDGFA|PDGFRA|PRKCB
BIOCARTA_TH1TH2_PATHWAY%MSIGDB_C2%BIOCARTA_TH1TH2_PATHWAY,0.0202667364016736,0.195732543984359,-0.550449605560766,-1.7244867582854,154,10,IL4R|IL12RB1|IFNGR2|HLA-DRB1|CD40|HLA-DRA|IL18|IFNGR1|IL2RA|CD86
PID_HIF2PATHWAY%MSIGDB_C2%PID_HIF2PATHWAY,0.5867413388903361,0.8413007197716759,-0.19786620790399898,-0.9118808881077829,4504,31,SLC11A2|ETS1|VHL|CREBBP|TCEB2|FLT1|KDR|BHLHE40|SLC2A1|ELK1|EFNA1|MMP14|FXN|SERPINE1|APEX1|PGK1
PID_ARF6_TRAFFICKING_PATHWAY%MSIGDB_C2%PID_ARF6_TRAFFICKING_PATHWAY,0.510204081632653,0.800685168996958,0.18476765311369,0.964668605169116,3724,45,EXOC4|PLD2|BIN1|ITGA6|AGTR1|ASAP2
PID_NFAT_3PATHWAY%MSIGDB_C2%PID_NFAT_3PATHWAY,0.11192684183410599,0.459194647507502,-0.24694072173933604,-1.3328794209035901,868,53,MAPK9|AKAP5|MAPK3|PIM1|NFATC1|RAN|KPNA2|NUP214|FKBP1A|PRKACA|CSNK1A1|PRKCB|BAD|RCAN1
ST_INTERFERON_GAMMA_PATHWAY%MSIGDB_C2%ST_INTERFERON_GAMMA_PATHWAY,0.7760999739651129,0.9241536998094619,-0.25834238897794104,-0.743731580152947,5961,8,IFNGR1|PLA2G2A|CISH
BIOCARTA_ETC_PATHWAY%MSIGDB_C2%BIOCARTA_ETC_PATHWAY,0.00601307189542484,0.0904473057766855,-0.561001863755376,-1.87772576549176,45,12,SDHC|UQCRC1|SDHB|SLC25A6|SDHD|CYCS|SDHA|SLC25A4|NDUFA1
PID_ARF6_PATHWAY%MSIGDB_C2%PID_ARF6_PATHWAY,0.6073127633546279,0.8492159043277758,0.19318410419714604,0.8943837640542289,4467,30,GULP1|MET|KIF13B|AGTR1|GIT1
BIOCARTA_RAB_PATHWAY%MSIGDB_C2%BIOCARTA_RAB_PATHWAY,0.9740206746463549,0.9920058127185359,0.158012948228065,0.53705527720163,7160,12,RAB1A|RAB11A|RAB6A|RAB2A
SA_REG_CASCADE_OF_CYCLIN_EXPR%MSIGDB_C2%SA_REG_CASCADE_OF_CYCLIN_EXPR,0.296339869281046,0.6687276080240239,-0.34166609124596903,-1.14358839814329,2266,12,CDKN1B|CDK4|CDKN2A|E2F2|E2F1|CCND1
BIOCARTA_NFAT_PATHWAY%MSIGDB_C2%BIOCARTA_NFAT_PATHWAY,0.181166036259293,0.554889181766802,-0.24155454777399202,-1.23136346296045,1388,44,NFATC4|MAPK14|GSK3B|LIF|CTF1|AKT1|RAF1|CREBBP|NFATC2|PRKAR2A|AGT|CAMK1|CALM3|PRKAR1A|MEF2C|MAPK3|CALR|HRAS|IGF1|NFATC1|HBEGF|FKBP1A|RPS6KB1|CSNK1A1
BIOCARTA_IL2RB_PATHWAY%MSIGDB_C2%BIOCARTA_IL2RB_PATHWAY,0.0498059508408797,0.320076193975867,-0.311158460040168,-1.4983150626277302,384,36,NMI|IL2RG|AKT1|RAF1|JAK3|SYK|STAT5A|SOCS3|PPIA|GRB2|IRS1|SOCS1|PTPN6|IL2RA|MAPK3|HRAS|E2F1|MYC|RPS6KB1|BAD
BIOCARTA_GH_PATHWAY%MSIGDB_C2%BIOCARTA_GH_PATHWAY,0.114882506527415,0.46415447440852003,-0.32551675496183,-1.3667086281889298,879,23,INS|GRB2|IRS1|SOCS1|PTPN6|MAPK3|HRAS|SRF|PRKCB
PID_INTEGRIN_A4B1_PATHWAY%MSIGDB_C2%PID_INTEGRIN_A4B1_PATHWAY,0.009515119916579771,0.12396436004013,-0.37894986671617104,-1.7627253969332901,72,32,TLN1|BCAR1|PRKAR1A|PXN|SPP1|VCAM1|DOCK1|FN1|THBS1|THBS2|PRKACA|CD14|CD81|ARF6
PID_SYNDECAN_2_PATHWAY%MSIGDB_C2%PID_SYNDECAN_2_PATHWAY,0.7285578360744871,0.906305590267376,0.175584839202255,0.812904509142783,5359,30,TRAPPC4|EPHB2|MMP2|NF1|LAMA1|ITGA2|BAX|EZR|SRC|MAPK1|MAPK8|SDCBP|CASP3
PID_IL8_CXCR1_PATHWAY%MSIGDB_C2%PID_IL8_CXCR1_PATHWAY,0.0364725804350658,0.271526902825443,-0.36834422238951503,-1.58798355535324,279,25,LYN|PLCB1|PIK3R6|DNM1|PLCB3|FGR|ARRB1|PLD1|GNAI2|GNA15|HCK|ADRBK1|PRKCB
NABA_COLLAGENS%MSIGDB_C2%NABA_COLLAGENS,0.000130344108446298,0.00518555396908895,-0.5998851238764891,-2.7904291199858497,0,32,COL15A1|COL27A1|COL20A1|COL18A1|COL23A1|COL11A2|COL14A1|COL5A3|COL4A1|COL4A2|COL5A2|COL12A1|COL6A3|COL8A1|COL21A1|COL1A2|COL1A1|COL3A1|COL6A1|COL16A1|COL5A1|COL6A2|COL13A1|COL26A1
BIOCARTA_MONOCYTE_PATHWAY%MSIGDB_C2%BIOCARTA_MONOCYTE_PATHWAY,0.0613232217573222,0.35631208031004796,-0.49171591855577707,-1.54048178402041,468,10,SELP|ITGAL|ITGA4|ITGB1|CD44|ITGB2|ICAM1|ITGAM|PECAM1
PID_IL27_PATHWAY%MSIGDB_C2%PID_IL27_PATHWAY,0.35198744769874496,0.7106060713647829,-0.278628580607713,-1.08118251750322,2691,18,IL12RB1|IL6|IL27RA|IL1B|TNF|TGFB1|STAT5A|IL18|GATA3|EBI3|IL6ST|STAT3
PID_EPHA_FWDPATHWAY%MSIGDB_C2%PID_EPHA_FWDPATHWAY,0.21493743482794603,0.5979177134734279,-0.25965215325852,-1.20779946139951,1648,32,RHOA|FYN|EPHA3|EPHA5|ROCK1|PIK3R5|LYN|VAV3|PIK3R6|FGR|EPHA8|EFNA1|NGEF|ARHGEF15|EPHA2|HCK|EFNA3|EPHA4|EFNA5
BIOCARTA_IGF1R_PATHWAY%MSIGDB_C2%BIOCARTA_IGF1R_PATHWAY,0.46397279979076794,0.7777638773705721,-0.238384080993314,-0.987210504954354,3547,22,GRB2|PRKAR1A|IRS1|MAPK3|HRAS|BAD
BIOCARTA_INTRINSIC_PATHWAY%MSIGDB_C2%BIOCARTA_INTRINSIC_PATHWAY,0.0927039748953975,0.421303871141266,-0.464494464353277,-1.45520052150473,708,10,F12|F10|F8|COL4A1|COL4A2|F2R|SERPING1
PID_AURORA_A_PATHWAY%MSIGDB_C2%PID_AURORA_A_PATHWAY,0.12477207606147399,0.47932042487916404,-0.29012295148759903,-1.33705283719452,957,31,OAZ1|GSK3B|AKT1|AURKA|TACC3|AJUBA|AURKAIP1|DLGAP5|TPX2|BRCA1|CKAP5|RAN|NFKBIA|CPEB1|TACC1|PRKACA|BIRC5
PID_A6B1_A6B4_INTEGRIN_PATHWAY%MSIGDB_C2%PID_A6B1_A6B4_INTEGRIN_PATHWAY,0.520867655134541,0.80625191482224,0.18770473771602197,0.9594332405935121,3793,42,ITGA6|MET|ERBB3|LAMA5|LAMB1|SHC1|YWHAQ|LAMA1|MST1|YWHAB|YWHAE|PRKCA|YWHAH|EGFR|RXRB
PID_SMAD2_3NUCLEAR_PATHWAY%MSIGDB_C2%PID_SMAD2_3NUCLEAR_PATHWAY,0.895014813860621,0.966256689108312,-0.12382626896634,-0.7111166438972719,6947,67,LAMC1|NR3C1|RUNX1|RUNX3|SKIL|GATA3|ITGB5|TGIF1|MEF2C|CDKN2B|RBBP7|IRF7|CEBPB|MAX|KAT2B|COL1A2|SERPINE1|MYC|TFE3
BIOCARTA_GSK3_PATHWAY%MSIGDB_C2%BIOCARTA_GSK3_PATHWAY,0.00403803569102514,0.0698267586144378,-0.45108575205303797,-1.94469388352964,30,25,IRAK1|PPP2CA|RELA|NFKB1|TLR4|TOLLIP|CD14|CCND1|LY96
BIOCARTA_AKAP13_PATHWAY%MSIGDB_C2%BIOCARTA_AKAP13_PATHWAY,0.5938264889855861,0.843040556302675,0.279638108898328,0.885912431154687,4366,10,LPAR2|AKAP13|PRKAG1|PRKACB|LPAR1|PRKAR2B|RHOA|GNA12|PRKAR2A|GNA13
BIOCARTA_CFTR_PATHWAY%MSIGDB_C2%BIOCARTA_CFTR_PATHWAY,0.9569822175732221,0.9880317864833471,-0.178259480050061,-0.558463680924985,7318,10,ADRB2|PRKAR2A|SLC9A3R1|PRKAR1A
BIOCARTA_EDG1_PATHWAY%MSIGDB_C2%BIOCARTA_EDG1_PATHWAY,0.181451087664452,0.554948538055731,-0.29143604545832896,-1.25642162817912,1392,25,PDGFA|PDGFRA|SMPD1|SPHK1|PRKCB
PID_BCR_5PATHWAY%MSIGDB_C2%PID_BCR_5PATHWAY,0.824226804123711,0.942095389819365,-0.134892860590732,-0.76918588306045,6395,65,PPP3CA|MAP4K1|MALT1|MAP3K1|TRAF6|MAPK14|DAPP1|ETS1|PLCG2|AKT1|RAF1|SH3BP5|SYK|PTEN|RAC1|LYN|BCL2A1|PIK3AP1|FCGR2B|ELK1|GRB2|PTPN6|MAPK3|HRAS|NFATC1|NFKBIA|RELA|POU2F2|NFKB1
PID_CD40_PATHWAY%MSIGDB_C2%PID_CD40_PATHWAY,0.0623451154297639,0.35881925983255997,-0.33621989376819794,-1.48289399097538,477,27,MAPK10|MAP3K14|BIRC3|CBLB|MAP3K1|TRAF6|MAPK14|CD40|AKT1|JAK3|STAT5A|TRAF2|TNFAIP3|MAPK9|NFKBIA|TRAF3|MYC|RELA|NFKB1
BIOCARTA_FIBRINOLYSIS_PATHWAY%MSIGDB_C2%BIOCARTA_FIBRINOLYSIS_PATHWAY,0.00105207785376118,0.0240655543316835,-0.810004412089124,-1.94142601270935,7,5,PLAU|F2R|F13A1|SERPINE1|PLAT
PID_TAP63_PATHWAY%MSIGDB_C2%PID_TAP63_PATHWAY,0.21925354634347896,0.601686354077891,0.226839649012181,1.18966783042322,1591,46,HBP1|TP53I3|BBC3|SPATA18|CDKN1A|PMAIP1|FLOT2|TRAF4|NQO1|SP1|CABLES1|YWHAQ|DST|AEN
PID_DNA_PK_PATHWAY%MSIGDB_C2%PID_DNA_PK_PATHWAY,0.16034669555796302,0.530251921951962,0.35404303984473495,1.3059188318989199,1183,15,NHEJ1|POLL|XRCC5|PNKP|CSNK2A2|LIG4|DCLRE1C|XRCC4|CSNK2B|CSNK2A1|APLF|PRKDC|XRCC6|POLM
BIOCARTA_TNFR2_PATHWAY%MSIGDB_C2%BIOCARTA_TNFR2_PATHWAY,0.0336035564853557,0.261633782155535,-0.416296589216187,-1.6153855910081798,256,18,TRAF2|TNFAIP3|NFKBIA|LTA|TRAF3|RELA|NFKB1|TNFRSF1B
BIOCARTA_TFF_PATHWAY%MSIGDB_C2%BIOCARTA_TFF_PATHWAY,0.5053608786610879,0.797902257689198,-0.24730586696804396,-0.959638739352014,3864,18,GRB2|CYCS|MAPK3|HRAS|BAD
BIOCARTA_IL22BP_PATHWAY%MSIGDB_C2%BIOCARTA_IL22BP_PATHWAY,0.793243420191175,0.929621926733366,-0.214908949593206,-0.739758280052742,6057,13,JAK3|IL10RA|STAT5A|STAT6|SOCS3|STAT3
BIOCARTA_CSK_PATHWAY%MSIGDB_C2%BIOCARTA_CSK_PATHWAY,0.9213057022890421,0.9771835362885121,0.15235151247516002,0.628015946031316,6801,21,GNGT1|GNAS|ADCY1|ZAP70|GNB1|CD247|CD3E|PRKACB|LCK|PRKAR1B|PTPRC|CD3D|CD3G|PRKAR2B|CSK|HLA-DRB1|CREBBP|PRKAR2A|HLA-DRA|CD4
PID_IL5_PATHWAY%MSIGDB_C2%PID_IL5_PATHWAY,0.23019607843137302,0.6129063110774859,-0.36401638042954704,-1.21839690873408,1760,12,STAT5A|LYN|CSF2RB|GRB2|CISH|PIM1
PID_P38_MK2_PATHWAY%MSIGDB_C2%PID_P38_MK2_PATHWAY,0.157794934308547,0.527852130775783,0.315754613041265,1.3015882074370202,1164,21,ETV1|TSC2|TCF3|MAPK11|YWHAQ|MAPKAPK3|YWHAB|YWHAE|YWHAH
BIOCARTA_TOLL_PATHWAY%MSIGDB_C2%BIOCARTA_TOLL_PATHWAY,0.00651211252930451,0.0957322763119865,-0.39478893372157,-1.81941367002806,49,31,IRAK1|MAP2K3|NFKBIA|PPARA|RELA|NFKB1|TLR4|TOLLIP|CD14|LY96
ST_IL_13_PATHWAY%MSIGDB_C2%ST_IL_13_PATHWAY,0.655354961313968,0.874775007199212,0.32130345694790097,0.83139157954723,4827,6,IL13RA2|JAK1|JAK2|TYK2
PID_CD8_TCR_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_CD8_TCR_DOWNSTREAM_PATHWAY,0.229301842719959,0.61138898362603,-0.22703054712308898,-1.18237591341304,1766,47,IL2RB|IFNAR2|PPP3CA|NFATC3|PRKCQ|CD8B|MAP2K2|FOSL1|IL2RG|RAF1|TNF|NFATC2|PRF1|JUNB|B2M|IFNAR1|GZMB|TNFRSF18|HLA-A|ELK1|MAPK9|IL2RA|MAPK3|TNFRSF4|HRAS|NFATC1|PRKCB
BIOCARTA_IL1R_PATHWAY%MSIGDB_C2%BIOCARTA_IL1R_PATHWAY,0.0266841072596468,0.23124829949084805,-0.354690215476079,-1.61944608374246,203,30,IL6|MAP3K14|CHUK|MAP3K1|TRAF6|MAPK14|IL1B|TGFB2|TNF|TGFB1|IRAK3|IL1RN|TGFB3|IL1RAP|IRAK1|MAP2K3|NFKBIA|RELA|IL1R1|NFKB1|TOLLIP
BIOCARTA_CCR5_PATHWAY%MSIGDB_C2%BIOCARTA_CCR5_PATHWAY,0.753238257228837,0.915498058528019,-0.204848245548191,-0.7784733562487289,5756,17,CALM3|CXCR4|GNAQ|CCL2|PRKCB
BIOCARTA_CDK5_PATHWAY%MSIGDB_C2%BIOCARTA_CDK5_PATHWAY,0.530521351847,0.8115959426370749,-0.28822404008353497,-0.9331408368004109,4049,11,NGF|MAPK3|HRAS|NGFR
BIOCARTA_LAIR_PATHWAY%MSIGDB_C2%BIOCARTA_LAIR_PATHWAY,0.00380178290508652,0.0663449174827586,-0.551524077467468,-1.95121153466587,28,14,SELP|C5|IL6|ITGAL|ITGA4|TNF|ITGB1|SELPLG|ITGB2|C3|ICAM1|VCAM1|C7
PID_RAS_PATHWAY%MSIGDB_C2%PID_RAS_PATHWAY,0.0889526542324247,0.41228493992510207,-0.320910543849358,-1.41537227848553,681,27,SOS2|PLCE1|RASA4|DAB2IP|RASGRF2|GRB2|CAMK2B|HRAS|LGALS3|RIN1|RRAS|LGALS1|PRKCB
PID_HEDGEHOG_2PATHWAY%MSIGDB_C2%PID_HEDGEHOG_2PATHWAY,0.5230245944531661,0.807051143864932,-0.255242461879901,-0.948579820098985,3997,16,TGFB2|AKT1|LRPAP1|PTHLH|SMO|BOC|GAS1|ADRBK1
PID_VEGFR1_PATHWAY%MSIGDB_C2%PID_VEGFR1_PATHWAY,0.0178757828810021,0.18251593112964,-0.389703119225166,-1.6999561730504098,136,26,MAPK3|NOS3|VEGFB|NRP2|CAV1|PRKACA|HSP90AA1|NCK1|PRKCB
BIOCARTA_GABA_PATHWAY%MSIGDB_C2%BIOCARTA_GABA_PATHWAY,0.711949175452825,0.896895656068328,0.330128237029628,0.7939565169322349,5266,5,GABRA3|GABARAP|SRC
PID_ERBB1_INTERNALIZATION_PATHWAY%MSIGDB_C2%PID_ERBB1_INTERNALIZATION_PATHWAY,0.8046498830650709,0.932964969466025,0.15323766590726504,0.7697728657594091,5848,40,CHMP3|ARHGEF7|SPRY2|SHC1|SOS1|CBL|NRAS|EPS15|PIK3R2|EGFR|SRC|STAMBP|AMPH|KRAS
PID_IL3_PATHWAY%MSIGDB_C2%PID_IL3_PATHWAY,0.0332161000390778,0.260336882511674,-0.37248651287232304,-1.60584155004506,254,25,CSF2RB|GRB2|CISH|OSM|PIM1|CEBPB|IL3RA|ID1|PRKACA|SRP9
BIOCARTA_TCRA_PATHWAY%MSIGDB_C2%BIOCARTA_TCRA_PATHWAY,0.39664658108462103,0.7377402989373809,-0.3215822575306189,-1.0411398605241802,3027,11,ZAP70|CD247|CD3E|LCK|PTPRC|CD3D|CD3G|FYN|HLA-DRB1|HLA-DRA|CD4
BIOCARTA_VITCB_PATHWAY%MSIGDB_C2%BIOCARTA_VITCB_PATHWAY,0.00196463654223969,0.038733744971466005,-0.7543539262942719,-1.94040151089544,14,6,SLC2A1|COL4A1|COL4A2|SLC2A3|P4HB
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES%MSIGDB_C2%SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,0.0443227740842133,0.299971173522132,-0.32656294459987106,-1.5336317754766298,339,33,PFN2|AKT1|ROCK1|FSCN1|CDC42|PAK2|ACTG1|PAK4|ANGPTL2|GDI1|FSCN2|MYLK2|MYLK|RPS4X|FLNA|ACTG2|CFL2|CFL1|FLNC
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,0.19676584734799502,0.573300351500729,-0.254850502150891,-1.2271764876379299,1520,36,GDI1|ATF1|MAPKAPK2|SLC9A1|MEF2C|PLA2G4A|HSPB1|CEBPB|MITF|RPS6KA4|KRT19
BIOCARTA_AKAP95_PATHWAY%MSIGDB_C2%BIOCARTA_AKAP95_PATHWAY,0.16112129944982997,0.5313138078301111,-0.406742296919962,-1.31685006982767,1229,11,DDX5|CCNB1|PPP2CA|PPP1CA
PID_ILK_PATHWAY%MSIGDB_C2%PID_ILK_PATHWAY,0.033112582781457005,0.25998057358601,-0.30471775982477195,-1.56635429079989,254,45,AKT1|AURKA|PARVA|ZYX|CDC42|TACC3|RAC1|IQGAP1|TNS1|LIMS3L|PARP1|RUVBL1|ILK|PXN|RHOG|CKAP5|LIMS2|SNAI1|HSP90AA1|PPP1R14B|CCND1|ACTN1|MYL9|PPP1R14A
PID_SYNDECAN_1_PATHWAY%MSIGDB_C2%PID_SYNDECAN_1_PATHWAY,0.000389408099688474,0.0111294649577428,-0.46142932177355794,-2.2582152982649903,2,38,COL11A2|HGF|MMP1|CASK|PPIB|COL14A1|MAPK3|COL4A1|COL5A2|COL12A1|COL6A3|COL8A1|COL1A2|COL1A1|COL3A1|MMP9|COL6A1|PRKACA|COL16A1|COL5A1|COL6A2|COL13A1
BIOCARTA_ARAP_PATHWAY%MSIGDB_C2%BIOCARTA_ARAP_PATHWAY,0.158968991233809,0.5293397224673839,-0.3420454408678111,-1.2998562014986799,1214,17,KDELR2|CYTH1|ARF1|KDELR1|KDELR3|CLTB
BIOCARTA_IL2_PATHWAY%MSIGDB_C2%BIOCARTA_IL2_PATHWAY,0.563197269982937,0.8287081286705841,-0.225282159850415,-0.917801141338509,4290,21,IL2RG|RAF1|JAK3|SYK|STAT5A|ELK1|GRB2|IL2RA|MAPK3|HRAS
SA_PROGRAMMED_CELL_DEATH%MSIGDB_C2%SA_PROGRAMMED_CELL_DEATH,0.36792709466811796,0.721642468110297,0.3138535895763,1.06672730583663,2704,12,CASP9|BID|APAF1|BAX|BCL2|BCL10
PID_LYMPH_ANGIOGENESIS_PATHWAY%MSIGDB_C2%PID_LYMPH_ANGIOGENESIS_PATHWAY,0.4560375146541621,0.7711961414599979,-0.23104425718969798,-0.9960641668163951,3500,25,VEGFC|ITGA5|FLT4|GRB2|MAPK3|FN1|COL1A2|COL1A1
BIOCARTA_GPCR_PATHWAY%MSIGDB_C2%BIOCARTA_GPCR_PATHWAY,0.88228392647634,0.962803380757423,-0.14565133945115,-0.684019806952417,6767,33,CALM3|ELK1|PRKAR1A|MAPK3|HRAS|NFATC1|GNAQ|PRKCB
PID_IL1_PATHWAY%MSIGDB_C2%PID_IL1_PATHWAY,0.207116788321168,0.58723868025798,-0.26187044948073,-1.21811810096705,1588,32,TICAM2|IL1RN|CASP1|IL1RAP|IRAK1|RELA|IL1R1|NFKB1|TOLLIP|SQSTM1
PID_RXR_VDR_PATHWAY%MSIGDB_C2%PID_RXR_VDR_PATHWAY,0.7372062663185379,0.9082631287383801,-0.19022350439781502,-0.798668888104739,5646,23,RARA|TNF|TGFB1|NR4A1|RXRG|MED1|THRA|NR1H3|PPARG|PPARA|RPS6KB1
PID_IL2_1PATHWAY%MSIGDB_C2%PID_IL2_1PATHWAY,0.489309634209171,0.789195252448196,-0.18101514152636103,-0.977041596513663,3798,53,DOK2|MAPKAPK2|GRB2|IRS1|SOCS1|STAT3|MAPK9|IL2RA|CISH|MAPK3|HRAS|MYC|PRKCB
PID_HNF3B_PATHWAY%MSIGDB_C2%PID_HNF3B_PATHWAY,0.656903765690377,0.875783550442628,-0.201395858586388,-0.8559267212437021,5023,24,INS|CEBPD|CEBPA|CEBPB|HMGCS1|TFRC|HADH
PID_TCR_JNK_PATHWAY%MSIGDB_C2%PID_TCR_JNK_PATHWAY,0.40154693235448397,0.740287621109606,-0.29475029400386304,-1.04278343775557,3062,14,DBNL|PRKCB
BIOCARTA_ARENRF2_PATHWAY%MSIGDB_C2%BIOCARTA_ARENRF2_PATHWAY,0.940945397407359,0.981358821491484,-0.170611382641948,-0.5872774643379389,7185,13,PRKCB
PID_IL12_STAT4_PATHWAY%MSIGDB_C2%PID_IL12_STAT4_PATHWAY,0.500976944118797,0.795954687014814,-0.223273035232214,-0.962561340049005,3845,25,PIAS2|HLA-DRB1|CREBBP|PRF1|TGFB1|HLA-DRA|IL18|CD4|STAT3|MAPK9|IL2RA|CD86
PID_S1P_S1P1_PATHWAY%MSIGDB_C2%PID_S1P_S1P1_PATHWAY,0.0570941068381677,0.34436604181231795,-0.37159866631140703,-1.5138956421890402,434,21,S1PR1|MAPK3|GNAI2|PDGFRB|SPHK1|PDGFB|ABCC1
PID_NCADHERIN_PATHWAY%MSIGDB_C2%PID_NCADHERIN_PATHWAY,0.995225102319236,0.99843337141011,0.10006188172038302,0.471686488235599,7294,32,CNR1|DCTN1|KIF5B|CAMK2G|PLCG1|FGFR1|CTNNA1|MAPK8|PIP5K1C|FER|AXIN1
PID_P73PATHWAY%MSIGDB_C2%PID_P73PATHWAY,0.4566939358524871,0.7715177634181241,-0.17235200320469402,-0.9959294517933929,3516,69,ABL1|IL1RAP|RCHY1|JAG2|CCNB1|PLK1|PPAP2A|PEA15|SERPINE1|MYC|RELA|YAP1|KAT5|FASN
BIOCARTA_ALK_PATHWAY%MSIGDB_C2%BIOCARTA_ALK_PATHWAY,0.731576887961393,0.9074802896081321,-0.18273570626894797,-0.8059537397560659,5608,27,SMAD6|TGFB3|SMAD5|MEF2C|CHRD|TGFBR2|BMP2|TGFBR3
BIOCARTA_TOB1_PATHWAY%MSIGDB_C2%BIOCARTA_TOB1_PATHWAY,0.44512995536886296,0.766936869627939,-0.277053353818581,-1.00593581770555,3390,15,TGFB3|TOB1|IL2RA|TGFBR2|TGFBR3
PID_AMB2_NEUTROPHILS_PATHWAY%MSIGDB_C2%PID_AMB2_NEUTROPHILS_PATHWAY,0.015249418454381002,0.166148433567765,-0.347450011253597,-1.68789342618922,117,37,RHOA|FYN|RAP1B|AKT1|ROCK1|TNF|LYN|SELPLG|ITGB2|LRP1|FGR|TLN1|PLAU|THY1|MST1R|ICAM1|CTGF|RAP1A|PLAUR|HCK|MMP9|PLAT|NFKB1|ITGAM
BIOCARTA_GCR_PATHWAY%MSIGDB_C2%BIOCARTA_GCR_PATHWAY,0.16562009419152302,0.5375245857985801,-0.346355596754725,-1.28719150896791,1265,16,NOS3|RELA|NFKB1|HSP90AA1|ANXA1
PID_FOXO_PATHWAY%MSIGDB_C2%PID_FOXO_PATHWAY,0.9381001816766159,0.9806508984207809,-0.122712321265613,-0.639086214529534,7228,47,SGK1|MAPK9|RAN|CCNB1|CAT|PLK1|KAT2B|BCL6|CSNK1A1
PID_ATR_PATHWAY%MSIGDB_C2%PID_ATR_PATHWAY,0.0221617418351477,0.206019523582829,-0.331092732996247,-1.6350179500701898,170,39,FANCD2|TIMELESS|RAD9A|RFC2|RAD51|CLSPN|FBXW11|RPA2|RFC3|NBN|CDC6|RAD1|RAD17|CDC25C|RFC5|TOPBP1|PLK1|PPP2CA|MCM2|PPP2R2B|RFC4|SSPO
PID_MYC_ACTIV_PATHWAY%MSIGDB_C2%PID_MYC_ACTIV_PATHWAY,0.000513544742585698,0.0139121625154964,-0.339781213210352,-2.02843194531993,3,78,TERT|LIN28B|NBN|GPAM|PTMA|ODC1|RUVBL1|SLC2A1|NPM1|TAF12|MYCT1|ENO1|RCC1|PIM1|HUWE1|UBTF|MAX|CCNB1|GAPDH|LDHA|TK1|MMP9|SNAI1|EIF2S1|MYC|TAF10|KAT5|HSP90AA1|BIRC5|NDUFAF2|HSPA4|TFRC|AK6|NME1|EIF4G1
PID_FGF_PATHWAY%MSIGDB_C2%PID_FGF_PATHWAY,0.782950006886104,0.926798202062739,0.15042038032708702,0.7888845195028169,5684,46,IL17RD|FGFR2|MET|GAB1|FGF2|SPRY2|SHC1|SOS1|PTK2B|CBL|PLCG1|FGF1|FGFR1|SRC|MAPK1|NCAM1|PDPK1
BIOCARTA_AKAPCENTROSOME_PATHWAY%MSIGDB_C2%BIOCARTA_AKAPCENTROSOME_PATHWAY,0.684583114840063,0.8857327229801228,-0.23373972742521104,-0.8269369750020219,5221,14,PCNT|PRKAR2A|PKN1|NUP85|PPP2CA|PPP1CA
BIOCARTA_NDKDYNAMIN_PATHWAY%MSIGDB_C2%BIOCARTA_NDKDYNAMIN_PATHWAY,0.81668410041841,0.9374856440721759,-0.187449506389132,-0.7273737991289442,6245,18,SYNJ2|NME1|AP2M1
ST_PAC1_RECEPTOR_PATHWAY%MSIGDB_C2%ST_PAC1_RECEPTOR_PATHWAY,0.473105614448371,0.783353537380471,-0.44802294159819106,-0.9808158727797951,3614,4,DAG1|ASAH1|ITPKB|GNAQ
BIOCARTA_EXTRINSIC_PATHWAY%MSIGDB_C2%BIOCARTA_EXTRINSIC_PATHWAY,0.329796987557302,0.6957352559323989,-0.43033332683812797,-1.10693324244676,2517,6,F10|F3|F2R|TFPI
PID_INTEGRIN_CS_PATHWAY%MSIGDB_C2%PID_INTEGRIN_CS_PATHWAY,0.533342050209205,0.812079525085925,-0.22147655100041502,-0.9412690978887941,4078,24,ITGB1|ITGA9|ITGAX|ITGA10|ITGA11|ITGB2|ITGB5|ITGA5|ITGA8|ITGAM|ITGB4
BIOCARTA_SPRY_PATHWAY%MSIGDB_C2%BIOCARTA_SPRY_PATHWAY,0.187686871432454,0.561103912498404,0.334882771022918,1.26094469865711,1380,16,SPRY2|SHC1|SOS1|SPRY4|CBL|EGFR|SRC|MAP2K1|MAPK1
PID_SHP2_PATHWAY%MSIGDB_C2%PID_SHP2_PATHWAY,0.358178319435536,0.714938712241162,-0.20029385564774,-1.06951685363586,2791,51,LMO4|IFNGR1|KDR|NGF|IL6ST|GRB2|IRS1|IL2RA|HRAS|IGF1|NTRK2|SDC2|NOS3|TEK|PDGFRB|PRKACA|PDGFB
BIOCARTA_IGF1MTOR_PATHWAY%MSIGDB_C2%BIOCARTA_IGF1MTOR_PATHWAY,0.239101890756303,0.622604781889171,-0.298109978408391,-1.19601152354474,1820,20,RPS6|PDK2|GSK3B|AKT1|PTEN|EIF2B5|EIF2S3|EIF4EBP1|IGF1|PPP2CA|EIF2S1|RPS6KB1
BIOCARTA_ERK5_PATHWAY%MSIGDB_C2%BIOCARTA_ERK5_PATHWAY,0.416066989402067,0.7493091022753771,-0.270200692117609,-1.02682861203242,3179,17,RPS6KA1|MEF2D|GRB2|MEF2C|MAPK3|HRAS|MEF2BNB-MEF2B
PID_AP1_PATHWAY%MSIGDB_C2%PID_AP1_PATHWAY,0.0413446676970634,0.291365549672794,-0.26703739733466897,-1.49192065532363,320,60,NFATC3|MAFG|CYR61|FOSL2|FOSL1|ETS1|CDKN1B|NFATC2|PTEN|DUSP1|ATF3|BAG1|TGFB1|GJA1|JUNB|NR3C1|AGT|BCL2L11|TRIP6|CDKN2A|MAF|HLA-A|PLAU|MMP1|NFATC1|CCL2|FABP4|MT2A|COL1A2|MMP9|MYC|TIMP1|CCND1
BIOCARTA_MTOR_PATHWAY%MSIGDB_C2%BIOCARTA_MTOR_PATHWAY,0.142558746736292,0.508674778494682,-0.314648723158314,-1.3210783108215802,1091,23,EIF4G2|PPP2CA|FKBP1A|RPS6KB1|EIF4A2|EIF4G1
PID_ERBB4_PATHWAY%MSIGDB_C2%PID_ERBB4_PATHWAY,0.619916579770594,0.8551097775270831,-0.19070604290470197,-0.8870893347709,4755,32,CBFA2T3|WWOX|GRB2|PIK3CB|MAPK3|PIK3R3|LRIG1|HBEGF|YAP1
BIOCARTA_EGF_PATHWAY%MSIGDB_C2%BIOCARTA_EGF_PATHWAY,0.719032047089601,0.900474259627538,-0.179597768280227,-0.820008248888143,5496,30,ELK1|GRB2|STAT3|MAPK3|HRAS|SRF|PRKCB
PID_FOXM1_PATHWAY%MSIGDB_C2%PID_FOXM1_PATHWAY,0.24566623544631302,0.6280519349499749,-0.243832264747492,-1.17412059109252,1898,36,FOXM1|LAMA4|CCNB1|PLK1|GAS1|MYC|BIRC5|CENPB|CCND1
PID_BARD1_PATHWAY%MSIGDB_C2%PID_BARD1_PATHWAY,0.938291785860237,0.9806508984207809,0.134802297327148,0.616939997532684,6887,29,FANCL|BARD1|ATM|MRE11A|CCNE1|XRCC5|ATR|CSTF1
PID_AVB3_INTEGRIN_PATHWAY%MSIGDB_C2%PID_AVB3_INTEGRIN_PATHWAY,0.000128816179312122,0.00518555396908895,-0.43655689738056197,-2.50708414560937,0,67,BCAR1|VTN|ILK|COL14A1|IRS1|PXN|MAPK3|SPP1|COL4A1|IGF1|EDIL3|COL5A2|COL12A1|CSF1|COL6A3|COL8A1|FN1|TGFBR2|COL1A2|COL1A1|VCL|MFGE8|COL3A1|ADGRA2|COL6A1|RPS6KB1|HSP90AA1|CSF1R|COL16A1|COL5A1|COL6A2|COL13A1
BIOCARTA_CARM1_PATHWAY%MSIGDB_C2%BIOCARTA_CARM1_PATHWAY,0.977647058823529,0.9927322181739301,-0.154096551724138,-0.5157755869274939,7478,12,CARM1|NCOA3|EP300|CREB1|PRKACB|PRKAR1B|RXRA|PRKAR2B|RARA|CREBBP|PRKAR2A|PRKAR1A
PID_PS1_PATHWAY%MSIGDB_C2%PID_PS1_PATHWAY,0.7167981378507691,0.899704384028684,-0.16643455430588097,-0.8285488307943091,5542,40,MYC|CSNK1A1|DTX1|CCND1|SSPO
PID_INTEGRIN4_PATHWAY%MSIGDB_C2%PID_INTEGRIN4_PATHWAY,0.541123778501629,0.815622645995152,0.281723302313496,0.927042654023177,3986,11,ITGA6|LAMA5|LAMB1|LAMA1
BIOCARTA_THELPER_PATHWAY%MSIGDB_C2%BIOCARTA_THELPER_PATHWAY,0.27914592611998995,0.653204101106396,-0.358269888557873,-1.1599180398428601,2130,11,CD247|CD3E|CD2|PTPRC|CD3D|CD3G|ITGAL|ITGB2|CD4|THY1|ICAM1
ST_WNT_CA2_CYCLIC_GMP_PATHWAY%MSIGDB_C2%ST_WNT_CA2_CYCLIC_GMP_PATHWAY,0.6929872247893449,0.888897949789818,0.21756654697228198,0.819210206520472,5098,16,PDE6B|SLC6A13|PDE6D|ITPR1|CAMK2G|CAMK2D
PID_HDAC_CLASSIII_PATHWAY%MSIGDB_C2%PID_HDAC_CLASSIII_PATHWAY,0.9995921142080219,0.999671409271379,0.082037255165681,0.343322017614759,7351,22,CDKN1A|FOXO3|HDAC4|BAX|EP300|SIRT1
PID_INTEGRIN3_PATHWAY%MSIGDB_C2%PID_INTEGRIN3_PATHWAY,0.000130072840790843,0.00518555396908895,-0.5380510597629821,-2.5686197437272202,0,35,PLAU|THY1|VTN|CD47|SDC4|FBN1|SPP1|COL4A1|LAMA4|EDIL3|FN1|PLAUR|TNC|TGFBR2|THBS1|COL1A2|COL1A1|PDGFRB|TGFBI|PECAM1|SPHK1|PDGFB
BIOCARTA_RAS_PATHWAY%MSIGDB_C2%BIOCARTA_RAS_PATHWAY,0.0270694389956846,0.23271567002476898,-0.397797455482423,-1.6473827667518401,206,22,CHUK|RALBP1|RHOA|FOXO4|AKT1|RAF1|CDC42|RAC1|RALGDS|ELK1|MAPK3|HRAS|PLD1|RELA|NFKB1|BAD
PID_CDC42_PATHWAY%MSIGDB_C2%PID_CDC42_PATHWAY,0.8979118329466359,0.9674268340009909,-0.124634413525893,-0.7077639133295229,6965,64,MAPK9|MAPK3|HRAS|PLD1|MAP2K3|MAP3K11|CFL1|RPS6KB1|TIAM1|EPS8|ARHGDIA
BIOCARTA_CALCINEURIN_PATHWAY%MSIGDB_C2%BIOCARTA_CALCINEURIN_PATHWAY,0.702882784878977,0.8934528433311372,0.207921836880651,0.813894787462719,5168,18,CALM2|CDKN1A|SP1|PPP3CB|PRKCA|PLCG1|SP3
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY%MSIGDB_C2%ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY,0.9509075907590758,0.985603993651337,0.12471823233453,0.6083812660722829,6914,36,RPS6KA2|SHC1|SOS1|YWHAQ|A1BG|YWHAB|NR4A3|YWHAE|AKT3|YWHAH
BIOCARTA_VEGF_PATHWAY%MSIGDB_C2%BIOCARTA_VEGF_PATHWAY,0.0302356020942408,0.24599181315662,-0.358283975566094,-1.6001363065813499,230,28,EIF2S3|FLT1|KDR|EIF2B1|FLT4|PXN|HRAS|EIF1AX|NOS3|EIF2S1|EIF2B2|EIF2B3|PRKCB
BIOCARTA_TPO_PATHWAY%MSIGDB_C2%BIOCARTA_TPO_PATHWAY,0.407008793804961,0.7442279600534352,-0.253121695978142,-1.03121961197697,3100,21,GRB2|STAT3|MAPK3|HRAS|PRKCB
BIOCARTA_CDC42RAC_PATHWAY%MSIGDB_C2%BIOCARTA_CDC42RAC_PATHWAY,0.975405546834118,0.992607303743384,-0.142265879366481,-0.528715094117758,7455,16,ACTR2|PAK1|ACTR3|ARPC2|PIK3CA|ARPC4|ARPC5|WASL|PIK3R1|ARPC3|ARPC1B|RHOA|CDC42|RAC1|ARPC1A|PDGFRA
BIOCARTA_MTA3_PATHWAY%MSIGDB_C2%BIOCARTA_MTA3_PATHWAY,0.214285714285714,0.597438672438672,-0.32846561715440104,-1.22070541764179,1637,16,SNAI2|HSPB1|GAPDH|SNAI1|CTSD|ALDOA
BIOCARTA_ARF_PATHWAY%MSIGDB_C2%BIOCARTA_ARF_PATHWAY,0.787306333242729,0.927748696800401,0.197829691349946,0.7448943992631241,5792,16,TWIST1|POLR1A|POLR1B|POLR1D|RB1|POLR1C
BIOCARTA_EIF_PATHWAY%MSIGDB_C2%BIOCARTA_EIF_PATHWAY,0.0125588697017268,0.14869950444299201,-0.47848915294102295,-1.77825096683826,95,16,EIF1AX|EIF4G2|EIF5|EIF2S1|EIF4A2|EIF4G1
PID_PI3KCI_AKT_PATHWAY%MSIGDB_C2%PID_PI3KCI_AKT_PATHWAY,0.5699822137091259,0.8324048186805392,0.192246251962963,0.9223512076279159,4165,34,MAP3K5|CASP9|CDKN1A|FOXO3|YWHAQ|YWHAB|TBC1D4|YWHAE|AKT3|YWHAH|SRC|YWHAZ|PDPK1
PID_P53_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_P53_DOWNSTREAM_PATHWAY,0.37931917071922205,0.728914030571579,-0.155591862342069,-1.03951886279757,2963,125,ATF3|PIDD1|PRMT1|PRDM1|PML|APC|RGCC|BNIP3L|PYCARD|TRIAP1|BCL2A1|SMARCA4|COL18A1|DUSP5|TNFRSF10A|TNFRSF10B|HGF|CASP10|IRF5|CCNK|E2F2|BCL2L2|GPX1|PCNA|CASP1|RNF144B|PPP1R13B|DDX5|PERP|SNAI2|SPP1|VCAN|TNFRSF10C|E2F1|RCHY1|HIC1|EPHA2|CCNB1|CX3CL1|SERPINE1|CAV1|NFYB|DDIT4|BCL6|CTSD|CD82|ZNF385A|CASP6|AK6
BIOCARTA_RAC1_PATHWAY%MSIGDB_C2%BIOCARTA_RAC1_PATHWAY,0.16590103688148097,0.53777394241421,-0.315871211934546,-1.28686159180114,1263,21,VAV1|MYLK|PLD1|NCF2|ARFIP2|CFL1|RPS6KB1|PDGFRA
NABA_ECM_GLYCOPROTEINS%MSIGDB_C2%NABA_ECM_GLYCOPROTEINS,0.000128024580719498,0.00518555396908895,-0.38940428703929103,-2.6805837668386903,0,144,SMOC1|LAMB2|DPT|LAMC1|FBLN5|SVEP1|NTN3|SPON2|COCH|LAMC2|SBSPON|PCOLCE2|FGL2|NID2|LAMC3|HMCN1|LTBP3|MFAP4|TNFAIP6|AEBP1|NTN4|FNDC1|SRPX2|LAMA2|GAS6|POSTN|VTN|TNXB|PAPLN|SRPX|SMOC2|VWA1|MXRA5|VWF|MGP|ELN|LGI1|LTBP2|CTGF|FBN1|LTBP1|MMRN2|SPP1|COMP|CILP|NTN1|LAMA4|SPARC|MMRN1|WISP1|FBN3|CRISPLD2|EDIL3|FN1|ABI3BP|MFAP5|VWA5A|NOV|ECM1|TNC|THBS1|ZP3|POMZP3|CTHRC1|THBS2|MFGE8|EMILIN2|IGFBP6|SLIT2|IGFBP5|NID1|TGFBI|CRIM1|EFEMP1|FBLN2|SPARCL1|TINAGL1|IGFBP4|IGFBP7|SNED1|EFEMP2|SSPO|FBLN1|LGI4
PID_RHOA_REG_PATHWAY%MSIGDB_C2%PID_RHOA_REG_PATHWAY,0.447447447447447,0.768229288546963,0.195892087853369,1.0090658019145,3277,43,ABR|OBSCN|FARP1|ARHGEF28|ARAP3|MYO9B|MCF2L|VAV2|AKAP13|SRGAP1|ARHGEF10
ST_JNK_MAPK_PATHWAY%MSIGDB_C2%ST_JNK_MAPK_PATHWAY,0.0383666758015895,0.279538283304058,0.30937750236040695,1.53301072049842,279,38,MAP3K5|DUSP4|GAB1|DUSP10|MAPK7|MAP2K5|SHC1|MYEF2|MAP2K7|MAP3K4|ATF2|MAP3K10|GCK|NR2C2|DLD|MAP3K2|MAP2K4|MAPK8
SA_G2_AND_M_PHASES%MSIGDB_C2%SA_G2_AND_M_PHASES,0.964617486338798,0.990916952887267,0.19257549755117498,0.559012979067678,7060,8,CDKN1A|NEK1|CDK1|CHEK1|CDC25B|CDC25A|WEE1
PID_ERBB2_ERBB3_PATHWAY%MSIGDB_C2%PID_ERBB2_ERBB3_PATHWAY,0.30888483585200605,0.680809181688249,-0.21867849828449598,-1.10912977478564,2370,43,GRB2|STAT3|MAPK9|PIK3CB|MAPK3|HRAS|PIK3R3|CHRNE|PRKACA|NF2|BAD
BIOCARTA_CELL2CELL_PATHWAY%MSIGDB_C2%BIOCARTA_CELL2CELL_PATHWAY,0.12065359477124199,0.472686039512467,-0.410489045178298,-1.37394526895815,922,12,BCAR1|PXN|VCL|PECAM1|ACTN1
BIOCARTA_KERATINOCYTE_PATHWAY%MSIGDB_C2%BIOCARTA_KERATINOCYTE_PATHWAY,0.10805908266390302,0.452482039948645,-0.26641106810098303,-1.3424771052625701,833,42,ETS2|TRAF2|CEBPA|MAPK3|HRAS|MAP2K3|NFKBIA|PPP2CA|RELA|MAPK13|NFKB1|TNFRSF1A|TNFRSF1B|PRKCB
PID_INTEGRIN5_PATHWAY%MSIGDB_C2%PID_INTEGRIN5_PATHWAY,0.0278649921507064,0.23617479560495197,-0.443211404887042,-1.6471451952668799,212,16,ITGB5|PLAU|VTN|MADCAM1|FBN1|VCAM1|EDIL3|FN1|PLAUR
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES%MSIGDB_C2%SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,0.8206599713055951,0.940031154277066,-0.167366102668232,-0.738166279092335,6291,27,GSK3B|AKT1|RAF1|JAK3|SOS2|STAT6|PPP1R13B|GRB2|IRS1|SOCS1|MAPK3|BAD
PID_NOTCH_PATHWAY%MSIGDB_C2%PID_NOTCH_PATHWAY,0.308657952633622,0.680809181688249,-0.201389999769382,-1.10278164952419,2384,56,JAG1|KDM1A|YY1|DNM1|NUMB|GATA3|ADAM12|NOTCH1|ENO1|NOTCH2|SKP1|NOTCH3|JAG2|MFAP5|MAML1|MYC|MARK2|DTX1|CCND1|SSPO
BIOCARTA_PLCE_PATHWAY%MSIGDB_C2%BIOCARTA_PLCE_PATHWAY,0.36664920094314896,0.721190111986457,-0.330002428838127,-1.0684006181543,2798,11,ADRB2|PRKAR2A|PLCE1|PTGER1|RAP2B|PRKAR1A
PID_HIF1_TFPATHWAY%MSIGDB_C2%PID_HIF1_TFPATHWAY,0.16951566951567001,0.542273324869423,-0.222838498878923,-1.2379815302551598,1308,59,ETS1|FURIN|MCL1|FECH|AKT1|CREBBP|CXCL12|ID2|CP|ADM|TERT|ITGB2|BHLHE40|RORA|SLC2A1|NPM1|PFKFB3|HK1|CXCR4|ENO1|HMOX1|PLIN2|LDHA|SERPINE1|ENG|PGK1|TFRC|ALDOA
PID_RHODOPSIN_PATHWAY%MSIGDB_C2%PID_RHODOPSIN_PATHWAY,0.336183496199783,0.699462084003389,0.333110183215294,1.09613704579687,2476,11,PDE6B|GNGT1|GNB5
PID_MYC_REPRESS_PATHWAY%MSIGDB_C2%PID_MYC_REPRESS_PATHWAY,0.0783577256832017,0.392286062587516,-0.25126914677946,-1.3885003418209199,604,58,CEBPD|CEBPA|BRCA1|CDKN2B|SLC11A1|TJP2|PPP2R4|SPI1|MAX|COL1A2|PDGFRB|MYC|NFYB|LGALS1|CCND1|ITGB4|FTH1|GTF2H2
PID_REG_GR_PATHWAY%MSIGDB_C2%PID_REG_GR_PATHWAY,0.0667525773195876,0.3690551432905871,-0.24731945010147102,-1.41026462624661,517,65,MAPK14|PPP5C|VIPR1|GSK3B|SFN|AKT1|CREBBP|POU2F1|NR1I3|BGLAP|STAT5A|NR4A1|SMARCA4|NR3C1|TSG101|GATA3|MMP1|SGK1|POMC|MAPK9|SUMO2|ICAM1|MAPK3|NFATC1|SPI1|SUV420H1|FKBP4|RELA|NFKB1|PRKACA|HSP90AA1|FKBP5
BIOCARTA_CDMAC_PATHWAY%MSIGDB_C2%BIOCARTA_CDMAC_PATHWAY,0.0159602302459445,0.17130095470064002,-0.46751248010509705,-1.73745740033173,121,16,MAPK3|HRAS|NFKBIA|MYC|RELA|NFKB1|PRKCB
BIOCARTA_P53HYPOXIA_PATHWAY%MSIGDB_C2%BIOCARTA_P53HYPOXIA_PATHWAY,0.4995423041715711,0.7950144243114909,-0.23255775963235603,-0.963082192238126,3819,22,HIC1|HSPA1A|FHL2|HSP90AA1|CSNK1A1
PID_FCER1_PATHWAY%MSIGDB_C2%PID_FCER1_PATHWAY,0.435824375080948,0.7625660301865379,-0.182898909767338,-1.01068993939603,3364,58,PTPN11|CBLB|MAP3K1|FYN|MAP2K2|LCP2|AKT1|RAF1|PAK2|SYK|NFATC2|DUSP1|LYN|HCLS1|LAT2|VAV1|FCGR2B|GRB2|PLA2G4A|S1PR1|FCER1G|PXN|MAPK3|HRAS|PPAP2A|RELA|NFKB1|SPHK1|PRKCB
PID_ERBB1_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_ERBB1_DOWNSTREAM_PATHWAY,0.674109991068011,0.882488012133495,-0.13837146015560997,-0.8853409940989458,5282,102,GRB2|SLC9A1|MEF2C|STAT3|MAPK9|CHN2|PIK3CB|MAPK3|HRAS|PIK3R3|PLD1|CYFIP2|PPP2CA|SRF|RIN1|RPS6KA4|EPS8|MAPKAP1|BAD
BIOCARTA_NOS1_PATHWAY%MSIGDB_C2%BIOCARTA_NOS1_PATHWAY,0.35875964935234894,0.715144264916255,-0.282546738024276,-1.0737466013354,2741,17,CALM3|GRIN1|PRKAR1A|GRIN2C|GRIN2D|PRKCB
BIOCARTA_KREB_PATHWAY%MSIGDB_C2%BIOCARTA_KREB_PATHWAY,0.8634470190054669,0.9531672929044319,-0.23310717634728897,-0.671082934920774,6632,8,MDH1|SUCLA2|CS|OGDH|IDH2|ACO2|FH|SDHA
ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS%MSIGDB_C2%ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS,0.8172766067502908,0.9378212107586109,-0.15114344671534602,-0.7524262409359351,6319,40,RASGRF2|ATF1|ELK1|CREB3|MAPK8IP1|MAPK9|MAPK3|GNAQ|MAP1B
BIOCARTA_MAL_PATHWAY%MSIGDB_C2%BIOCARTA_MAL_PATHWAY,0.283919926730342,0.6567953494316501,-0.301359269477064,-1.14523881480491,2169,17,RHOA|MAP3K1|MAP2K2|ROCK1|RAF1|CDC42|RAC1|MAP4K2|MAPK3|HRAS|SRF
PID_IL23_PATHWAY%MSIGDB_C2%PID_IL23_PATHWAY,0.110617154811715,0.45627165649734003,-0.322345785314598,-1.36996050002042,845,24,IL1B|TNF|CXCL1|STAT5A|IL18|SOCS3|CD4|STAT3|CCL2|NFKBIA|RELA|NFKB1
PID_CDC42_REG_PATHWAY%MSIGDB_C2%PID_CDC42_REG_PATHWAY,0.373449941260932,0.7245436360382259,-0.23467263909299102,-1.06107707925312,2860,29,ITSN1|CDC42|RACGAP1|DOCK11|DOCK10|APC|VAV3|FGD1|DOCK6|NGEF|ARHGAP1|ARHGEF9|ARHGDIA|DNMBP|NME1
BIOCARTA_SKP2E2F_PATHWAY%MSIGDB_C2%BIOCARTA_SKP2E2F_PATHWAY,0.9133106694560671,0.9733164734145379,-0.197985623877718,-0.620263114477442,6984,10,SKP1|E2F1
PID_IGF1_PATHWAY%MSIGDB_C2%PID_IGF1_PATHWAY,0.182864617396992,0.556308895147568,-0.273160694770496,-1.2471982537908,1397,30,BCAR1|GRB2|IRS1|PRKD1|PXN|HRAS|IGF1|RPS6KB1|GRB10|BAD
NABA_MATRISOME_ASSOCIATED%MSIGDB_C2%NABA_MATRISOME_ASSOCIATED,0.00012701638511368,0.00518555396908895,-0.334639745579384,-2.75080440626574,0,397,FSTL1|GDF15|NRG2|CXCL12|TNF|MUC3A|OGFOD2|CHRDL1|CLEC18A|ADAMTS10|CBLN4|CSTA|SERPINB9|C1QL1|COLEC11|CCL4|ARTN|HGFAC|LGALS2|MMP25|FST|CCL8|P4HA2|CXCL1|MMP12|PARM1|WFIKKN1|TGFB1|GREM1|CXCL2|S100A1|CLEC4A|CCL11|MDK|P4HTM|INHBB|ADAM9|SEMA4A|HYAL2|ADAMTS4|FCN3|CD209|TNFSF13B|F12|F10|SDC3|IL18|KAZALD1|ADAM8|TNFSF8|CCL19|ANGPT2|PLOD2|ADAMTS14|AGT|PCSK5|EDA|P4HA3|SERPINB8|ANGPTL2|IL17D|HPX|CTSF|PLXND1|CTSV|C1QL3|SEMA6A|SFRP4|HMSD|CTSS|ANGPTL4|SERPINB1|CCL24|CLEC14A|HGF|CFC1|SFRP2|NGF|EGFL7|EMCN|HYAL3|HCFC1|PDGFD|PLAU|IL1RN|EBI3|IL34|MMP1|VEGFC|TGFB3|BRINP3|ANXA6|ADAM12|INS|CCL3L3|P4HA1|CCL18|CTSB|IL17B|CLEC3B|CLEC4M|TNFSF10|CLEC4E|PDGFC|PAMR1|CBLN1|ANXA11|ADAM33|INHBA|TNFSF12|CRHBP|S100A13|CLEC2B|HTRA3|LOXL1|SERPINA1|CHRD|C1QB|CLEC10A|HTRA1|SDC4|FREM1|S100A10|MUC4|MMP14|OSM|FGF10|TIMP3|SCUBE2|CLEC1A|CBLN3|ADAMTSL1|ITIH3|SULF1|LOX|IGF1|FCN1|SEMA3B|CLEC18B|SEMA3D|IL15|TNFSF13|C1QTNF5|C1QA|SEMA7A|HBEGF|C1QC|CLEC7A|CSF1|CTSZ|CCL2|CTSH|C1QTNF2|SDC2|INSL3|PCSK6|ADAMTSL2|ITIH5|HYAL1|VEGFB|CCBE1|COLEC12|LGALS3|FGF19|MUC20|CTSC|S100A3|SERPINE2|BMP2|A2M|FGF9|LGALS9|ZFP91|F13A1|SERPINH1|FGF7|SEMA5A|C17orf58|TGM2|ELFN2|MUC15|SEMA3E|GDF11|ADAM19|MMP9|P3H2|CX3CL1|IL11|SERPINE1|LTA|FLT3LG|HCFC2|SEMA3A|CCL4L2|CCL14|PLAT|PTN|SEMA6B|CSTB|C1QTNF6|MEGF9|CTSD|S100A8|WNT3|S100A9|ADAMDEC1|PDGFA|ANXA2|CTSL|C1QTNF4|TIMP1|ANXA1|S100A6|LGALS1|CLEC11A|ADAMTS8|S100A11|S100A16|ADAM11|MMP19|S100A4|SERPING1|PDGFB|FAM20A|SERPINF1|LOXL2|SERPINF2|CST3|C1QTNF1
BIOCARTA_SRCRPTP_PATHWAY%MSIGDB_C2%BIOCARTA_SRCRPTP_PATHWAY,0.23251244432800602,0.616398045544439,-0.37555630821857,-1.21588375353833,1774,11,CDC25C|GRB2|CCNB1|PRKCB
ST_JAK_STAT_PATHWAY%MSIGDB_C2%ST_JAK_STAT_PATHWAY,0.571174863387978,0.8335161565658671,0.308597499188418,0.895804552229235,4180,8,PIAS3|JAK1|PTPRU
BIOCARTA_P38MAPK_PATHWAY%MSIGDB_C2%BIOCARTA_P38MAPK_PATHWAY,0.159834475623949,0.529429183067871,-0.254809827624578,-1.2685009169744499,1235,40,TGFB2|DDIT3|CDC42|RPS6KA5|RAC1|TGFB1|HSPB2|MEF2D|HMGN1|ELK1|TGFB3|TRAF2|MAPKAPK2|GRB2|MEF2C|PLA2G4A|HSPB1|HRAS|MAX|MYC|MEF2BNB-MEF2B
PID_WNT_NONCANONICAL_PATHWAY%MSIGDB_C2%PID_WNT_NONCANONICAL_PATHWAY,0.6711383172701221,0.8815356925073421,-0.18520449863223198,-0.8535284750403459,5152,31,FZD2|MAPK9|FLNA|CTHRC1|CAMK2A|PPARG|CSNK1A1
PID_ERBB_NETWORK_PATHWAY%MSIGDB_C2%PID_ERBB_NETWORK_PATHWAY,0.778009379885357,0.924704689181848,-0.247971797593228,-0.7459598638232661,5971,9,NRG1|NRG3|NRG2|HBEGF|HSP90AA1
BIOCARTA_PTC1_PATHWAY%MSIGDB_C2%BIOCARTA_PTC1_PATHWAY,0.16566422594142302,0.5375245857985801,-0.41792269869748205,-1.3092972592041399,1266,10,CDC25C|CCNB1|CDK7|MNAT1
BIOCARTA_PGC1A_PATHWAY%MSIGDB_C2%BIOCARTA_PGC1A_PATHWAY,0.24349418072446696,0.626082056933819,-0.287103272273831,-1.1889693523765401,1861,22,MEF2D|CAMK1|CALM3|MEF2C|CAMK2B|HDAC5|CAMK2A|PPARA|MEF2BNB-MEF2B|ESRRA
BIOCARTA_P27_PATHWAY%MSIGDB_C2%BIOCARTA_P27_PATHWAY,0.605342411941862,0.8484731812466321,-0.256306805833358,-0.882257729182495,4622,13,SKP1|E2F1|NEDD8
BIOCARTA_PTDINS_PATHWAY%MSIGDB_C2%BIOCARTA_PTDINS_PATHWAY,0.542036553524804,0.815689901219835,-0.221879731860033,-0.9315801393661342,4151,23,AP2A1|GSK3B|ARHGEF2|AKT1|RAC1|LYN|JAG1|EEA1|ARF1|RPS6KB1|AP2M1|BAD
BIOCARTA_GLYCOLYSIS_PATHWAY%MSIGDB_C2%BIOCARTA_GLYCOLYSIS_PATHWAY,0.0257745378807602,0.225019807572435,-0.586532737882247,-1.6885456609826601,197,8,GPI|HK1|ENO1|PGAM1|GAPDH|PGK1
BIOCARTA_NUCLEARRS_PATHWAY%MSIGDB_C2%BIOCARTA_NUCLEARRS_PATHWAY,0.133532771280936,0.495171568558794,0.43054951922514795,1.3640099799413001,981,10,ABCB1|ABCB4|PPARD|CYP2E1
SA_PTEN_PATHWAY%MSIGDB_C2%SA_PTEN_PATHWAY,0.8132644740418591,0.9356336309698571,0.19259784207991298,0.725194751589193,5983,16,SHC1|SOS1|PTK2B|AKT3|BPNT1|MAPK1|PIK3CD|RBL2|PIK3CA
PID_PDGFRA_PATHWAY%MSIGDB_C2%PID_PDGFRA_PATHWAY,0.519564075630252,0.804986496071906,-0.236888274181308,-0.9503912187915391,3956,20,RAPGEF1|ELK1|GRB2|SRF|CAV1|PDGFRA
PID_TCPTP_PATHWAY%MSIGDB_C2%PID_TCPTP_PATHWAY,0.416947395698367,0.749491568453345,-0.20354678207577803,-1.0256964800089499,3217,42,KDR|HGF|KPNB1|INS|GRB2|STAT3|PIK3CB|PIK3R3|CSF1|KPNA2|PDGFRB|CSF1R|PDGFB
PID_AR_NONGENOMIC_PATHWAY%MSIGDB_C2%PID_AR_NONGENOMIC_PATHWAY,0.9429578384022971,0.9824677421692641,-0.134322249946086,-0.607340767131453,7223,29,PELP1|PLCG1|GNAO1|SRC|MAP2K1|MAPK1|GNB1|CREB1|PIK3CA|GNRH1|GNAI1|PTK2|FOS|PLCB2|PIK3R1|GNG2|GNAZ|MAP2K2|PLCG2|AKT1|RAF1|CDC42|RAC1|PLCB1|PLCB3|MAPK3|HRAS|GNAI2
PID_INTEGRIN1_PATHWAY%MSIGDB_C2%PID_INTEGRIN1_PATHWAY,0.00012951690195570501,0.00518555396908895,-0.457492809073791,-2.52808166032862,0,58,LAMB2|LAMC1|ITGA10|ITGA11|LAMC2|COL18A1|COL11A2|PLAU|LAMA2|VTN|ITGA5|FBN1|SPP1|COL4A1|LAMA4|VCAM1|COL5A2|COL6A3|FN1|PLAUR|TNC|THBS1|F13A1|COL1A2|COL1A1|THBS2|TGM2|ITGA8|COL3A1|NID1|COL6A1|TGFBI|COL5A1|CD14|COL6A2|CD81
PID_ER_NONGENOMIC_PATHWAY%MSIGDB_C2%PID_ER_NONGENOMIC_PATHWAY,0.472135821669259,0.7831522581932591,-0.20008139737689104,-0.9880515142265358,3642,39,GNA13|PLCB1|GNAL|PLCB3|BCAR1|GRB2|MSN|HRAS|IGF1|GNAI2|HBEGF|GNAQ|NOS3|GNA15|MMP9
BIOCARTA_CBL_PATHWAY%MSIGDB_C2%BIOCARTA_CBL_PATHWAY,0.421699346405229,0.7527812076478722,-0.30510828704485,-1.02122600451643,3225,12,CSF1R|PDGFRA|PRKCB
PID_RAC1_REG_PATHWAY%MSIGDB_C2%PID_RAC1_REG_PATHWAY,0.337799167533819,0.699636319850872,-0.22736997557553398,-1.0854490439092601,2596,35,RASGRF2|VAV1|KALRN|ELMO1|DOCK6|CHN2|NGEF|ARHGAP1|DOCK1|TIAM1|EPS8|ARHGDIA
BIOCARTA_CHREBP2_PATHWAY%MSIGDB_C2%BIOCARTA_CHREBP2_PATHWAY,0.8851246105919001,0.9640874207062379,-0.141253049816574,-0.6912863638494771,6818,38,PPP2R3B|MLX|PRKAR1A|PPP2R4|PPP2CA|PRKACA|PPP2R2B|FASN
PID_LYSOPHOSPHOLIPID_PATHWAY%MSIGDB_C2%PID_LYSOPHOSPHOLIPID_PATHWAY,0.310647073988141,0.681497707288066,-0.19307403363834602,-1.09641333997855,2409,64,BCAR1|ADCY8|PRKD1|PXN|PIK3CB|ADCY4|HRAS|GNAI2|HBEGF|GNAQ|NFKBIA|GNA15|MMP9|RELA|NFKB1|TIAM1|ADCY9
BIOCARTA_RARRXR_PATHWAY%MSIGDB_C2%BIOCARTA_RARRXR_PATHWAY,0.829631635969664,0.9435194014073349,0.19277840442032698,0.711080067627755,6125,15,ERCC3|NCOA3|TBP|POLR2A|GTF2B|NCOA2|NCOR2|HDAC3|GTF2F1
PID_S1P_S1P2_PATHWAY%MSIGDB_C2%PID_S1P_S1P2_PATHWAY,0.40938807531380794,0.7448505271608159,-0.24251848012666102,-1.03069670346165,3130,24,RHOA|MAPK14|GNA14|RAC1|GNA12|GNA13|ELK1|IRS1|MAPK3|GNAI2|CDH5|GNAQ|GNA15
BIOCARTA_RELA_PATHWAY%MSIGDB_C2%BIOCARTA_RELA_PATHWAY,0.0337519623233909,0.26217929082442604,-0.435099317732083,-1.6169975383394097,257,16,NFKBIA|FADD|RELA|NFKB1|TNFRSF1A|TNFRSF1B
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES%MSIGDB_C2%SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,0.543451315245834,0.816444320780226,0.179888309039725,0.943430018807251,3945,46,IRS2|RPS6KA2|PARD3|FLOT2|SHC1|SOS1|YWHAQ|FLOT1|YWHAB|CBL|YWHAE|INPPL1|AKT3|YWHAH
PID_VEGFR1_2_PATHWAY%MSIGDB_C2%PID_VEGFR1_2_PATHWAY,0.0241527074405921,0.21821766935277997,-0.269390637687307,-1.5566634858984099,185,69,VTN|AKAP1|MAPKAPK2|GRB2|PTPN6|PXN|CAMKK2|MAPK3|ARF1|CDH5|MAP2K3|NOS3|VCL|CAV1|PRKACA|HSP90AA1|MYOF|NCK1|PRKCB|PTPRJ|GRB10
BIOCARTA_ACTINY_PATHWAY%MSIGDB_C2%BIOCARTA_ACTINY_PATHWAY,0.9417794716782759,0.981857716743086,-0.149864435069424,-0.592100401840377,7165,19,WASF3|NCK1
BIOCARTA_LONGEVITY_PATHWAY%MSIGDB_C2%BIOCARTA_LONGEVITY_PATHWAY,0.15516339869280998,0.523565820242794,-0.392845617871421,-1.31489106577968,1186,12,SOD2|SOD3|SOD1|HRAS|IGF1|CAT
PID_WNT_CANONICAL_PATHWAY%MSIGDB_C2%PID_WNT_CANONICAL_PATHWAY,0.997552352461246,0.9994836051249741,0.108739478496128,0.42565271674766203,7335,18,CSNK1G1|DVL2|LRP6|AXIN1|DVL1
SA_B_CELL_RECEPTOR_COMPLEXES%MSIGDB_C2%SA_B_CELL_RECEPTOR_COMPLEXES,0.685378590078329,0.8858989071675258,-0.198940183248046,-0.8352665747435128,5249,23,MAPK8IP3|RPS6KA3|MAP3K1|SYK|RAC1|LYN|VAV3|RPS6KA1|VAV1|ELK1|GRB2|MAPK3|HRAS
PID_INTEGRIN_A9B1_PATHWAY%MSIGDB_C2%PID_INTEGRIN_A9B1_PATHWAY,0.000131250820317627,0.00518555396908895,-0.572295266745159,-2.3315350374397,0,21,RAC1|ITGB1|ITGA9|ADAM8|SAT1|VEGFC|ADAM12|BCAR1|PXN|SPP1|VCAM1|CSF2RA|FN1|TNC|F13A1|TGM2
BIOCARTA_SET_PATHWAY%MSIGDB_C2%BIOCARTA_SET_PATHWAY,0.108593135970658,0.45309795582492896,-0.433688208785794,-1.40408890923726,828,11,CREBBP|PRF1|GZMA|SET|HMGB2|GZMB|APEX1|NME1
BIOCARTA_ASBCELL_PATHWAY%MSIGDB_C2%BIOCARTA_ASBCELL_PATHWAY,0.0836401893740137,0.402388938341306,-0.608537392455328,-1.45854801009294,635,5,FAS|HLA-DRB1|CD40|HLA-DRA|CD4
PID_PI3KCI_PATHWAY%MSIGDB_C2%PID_PI3KCI_PATHWAY,0.550917549754459,0.8219590577913142,-0.178998120402384,-0.938366316698131,4262,48,RHOA|FYN|DAPP1|PLCG2|PIK3R5|SYK|PTEN|RAC1|LYN|PLEKHA2|PIK3R6|FGR|CYTH3|SGK1|PIK3CB|CYTH1|HRAS|PIK3R3|ARF1|RAP1A|HCK|HSP90AA1|ARF6
NABA_ECM_AFFILIATED%MSIGDB_C2%NABA_ECM_AFFILIATED,0.000255199693760367,0.00819882332206558,-0.322358598776372,-2.07152715379547,1,104,HPX|PLXND1|C1QL3|SEMA6A|CLEC14A|EMCN|ANXA6|CLEC3B|CLEC4M|CLEC4E|ANXA11|CLEC2B|C1QB|CLEC10A|SDC4|FREM1|MUC4|CLEC1A|FCN1|SEMA3B|CLEC18B|SEMA3D|C1QTNF5|C1QA|SEMA7A|C1QC|CLEC7A|C1QTNF2|SDC2|COLEC12|LGALS3|MUC20|LGALS9|SEMA5A|ELFN2|MUC15|SEMA3E|SEMA3A|SEMA6B|C1QTNF6|ANXA2|C1QTNF4|ANXA1|LGALS1|CLEC11A|C1QTNF1
PID_RETINOIC_ACID_PATHWAY%MSIGDB_C2%PID_RETINOIC_ACID_PATHWAY,0.920418848167539,0.9768322640118741,-0.14299387878133998,-0.638626655561115,7031,28,MAPK3|CDK7|KAT2B|MNAT1|PRKACA
PID_WNT_SIGNALING_PATHWAY%MSIGDB_C2%PID_WNT_SIGNALING_PATHWAY,0.0995682323694884,0.43553869420789704,-0.371225669811169,-1.4107481971848201,760,17,FZD4|RYK|FZD2|FZD8|ATP6AP2|LRP5|CTHRC1|WNT3|IGFBP4
BIOCARTA_NO2IL12_PATHWAY%MSIGDB_C2%BIOCARTA_NO2IL12_PATHWAY,0.28549019607843107,0.6583248923580091,-0.345103448275862,-1.15509355396759,2183,12,JAK2|CD247|CD3E|STAT4|TYK2|CD2|CD3D|CD3G|CXCR3|IL12RB1|CCR5|CD4
BIOCARTA_IL7_PATHWAY%MSIGDB_C2%BIOCARTA_IL7_PATHWAY,0.32794237564555606,0.6950398637731511,0.29452016996854496,1.10896611920358,2412,16,PTK2B|JAK1|BCL2|EP300|IL7R|PIK3CA|LCK|PIK3R1|IL7|STAT5B|FYN|NMI|IL2RG|CREBBP|JAK3|STAT5A
BIOCARTA_IL17_PATHWAY%MSIGDB_C2%BIOCARTA_IL17_PATHWAY,0.613986928104575,0.852182158593687,-0.259806896551724,-0.8695980088942241,4696,12,CD8A|CD247|CD3E|CD2|CXCL8|CD3D|CD3G|CD58|IL6|KITLG|CD4|CD34
BIOCARTA_ATM_PATHWAY%MSIGDB_C2%BIOCARTA_ATM_PATHWAY,0.460507293993955,0.774731947971747,-0.251130042536603,-0.9921913696951009,3503,19,BRCA1|ABL1|NFKBIA|RELA|NFKB1
BIOCARTA_NKT_PATHWAY%MSIGDB_C2%BIOCARTA_NKT_PATHWAY,0.0212654239957994,0.201150083379966,-0.46505470809055105,-1.6885382602775298,161,15,IL4R|IL12RB1|CCR5|IFNGR2|TGFB2|CCL3|CCL4|TGFB1|IFNGR1|CD4|TGFB3|CXCR4|CCR1
PID_THROMBIN_PAR4_PATHWAY%MSIGDB_C2%PID_THROMBIN_PAR4_PATHWAY,0.298823529411765,0.671387424531401,-0.34060725239966305,-1.1400443653839298,2285,12,RHOA|GNA14|ROCK1|GNA13|GNAQ|GNA15|F2RL3
BIOCARTA_MCM_PATHWAY%MSIGDB_C2%BIOCARTA_MCM_PATHWAY,0.13441422594142302,0.4962180106589171,-0.345525424167896,-1.3407671501193899,1027,18,CDT1|MCM4|MCM6|CDC6|ORC1|ORC6|MCM3|MCM5|MCM2
BIOCARTA_MITOCHONDRIA_PATHWAY%MSIGDB_C2%BIOCARTA_MITOCHONDRIA_PATHWAY,0.584179872680482,0.8396554445633291,0.21925361017034803,0.9037964978152908,4312,21,CASP9|CASP8|BID|DFFB|APAF1|BAX|BCL2|DFFA|BIRC2|CASP3
BIOCARTA_PARKIN_PATHWAY%MSIGDB_C2%BIOCARTA_PARKIN_PATHWAY,0.6163137893593921,0.854122579597827,0.264956636282374,0.87187002737508,4540,11,PARK2|UBE2F|SUMO1|UBE2G1
BIOCARTA_ATRBRCA_PATHWAY%MSIGDB_C2%BIOCARTA_ATRBRCA_PATHWAY,0.780942380889881,0.925307658074164,-0.18733309266107198,-0.7631963683629771,5949,21,FANCD2|FANCG|RAD9A|RAD51|TREX1|NBN|RAD1|RAD17|BRCA1
ST_G_ALPHA_I_PATHWAY%MSIGDB_C2%ST_G_ALPHA_I_PATHWAY,0.6846364704346689,0.8857327229801228,-0.18583633170057104,-0.840262728633731,5244,29,AKT1|TERF2IP|RAF1|ITPKB|SOS2|PLCB1|ITPR2|PLCB3|ITPR3|GRB2|STAT3|PIK3CB|CFB|KCNJ9
BIOCARTA_EPO_PATHWAY%MSIGDB_C2%BIOCARTA_EPO_PATHWAY,0.718096234309623,0.900080821429213,-0.207765419325814,-0.806207097013713,5491,18,ELK1|GRB2|PTPN6|MAPK3|HRAS
BIOCARTA_IGF1_PATHWAY%MSIGDB_C2%BIOCARTA_IGF1_PATHWAY,0.14101890756302501,0.506267966215318,-0.331004353376149,-1.32798312587515,1073,20,ELK1|GRB2|IRS1|MAPK3|HRAS|IGF1|SRF
BIOCARTA_EIF2_PATHWAY%MSIGDB_C2%BIOCARTA_EIF2_PATHWAY,0.199895205658894,0.577843341057244,-0.388719262193517,-1.25849952522548,1525,11,EIF2AK4|EIF2AK1|GSK3B|EIF2B5|EIF2S3|EIF5|EIF2S1|PPP1CA
PID_IL2_STAT5_PATHWAY%MSIGDB_C2%PID_IL2_STAT5_PATHWAY,0.716447110995174,0.899551221015245,-0.18482149501629397,-0.8151530871391659,5492,27,STAT5B|IL2RB|CCNA2|PTPN11|IL2RG|FOXP3|JAK3|PRF1|STAT5A|CCND2|CDK6|GRB2|IL2RA|LTA|MYC|CCND3
PID_PLK1_PATHWAY%MSIGDB_C2%PID_PLK1_PATHWAY,0.0308850246561121,0.24938415081905105,-0.30229649409595805,-1.57436123842172,237,47,PRC1|FZR1|KIZ|WEE1|RHOA|CENPE|GOLGA2|TUBG1|AURKA|CENPU|CLSPN|FBXW11|CDC20|ECT2|STAG2|TPX2|NUDC|CDC25C|KIF20A|ERCC6L|INCENP|NDC80|SGOL1|KIF2A|CCNB1|PLK1|PPP2CA|RAB1B|SPC24|SSPO
BIOCARTA_CARM_ER_PATHWAY%MSIGDB_C2%BIOCARTA_CARM_ER_PATHWAY,0.8045887107287191,0.932964969466025,-0.16149233042818303,-0.758413572439754,6171,33,MED1|GTF2A1|SRA1|MEF2C|BRCA1|HDAC5|HDAC8|HIST2H3C|CCND1
BIOCARTA_INFLAM_PATHWAY%MSIGDB_C2%BIOCARTA_INFLAM_PATHWAY,0.0010501443948542901,0.0240545523142212,-0.578518108113771,-2.1005054734835,7,15,HLA-DRB1|TGFB2|TNF|TGFB1|HLA-DRA|CD4|TGFB3|IL15|CSF1|IL11|LTA|PDGFA
BIOCARTA_IL3_PATHWAY%MSIGDB_C2%BIOCARTA_IL3_PATHWAY,0.147614053487153,0.514965886850433,-0.37445547927251005,-1.3247687276508,1125,14,CSF2RB|GRB2|PTPN6|MAPK3|HRAS|IL3RA
BIOCARTA_PROTEASOME_PATHWAY%MSIGDB_C2%BIOCARTA_PROTEASOME_PATHWAY,0.00026178010471204197,0.00819882332206558,-0.509757525977214,-2.2766341240364905,1,28,PSMB2|RPN2|PSMB5|PSMC4|UBA1|PSMC6|PSMB3|PSMD6|PSMD12|PSMA3|PSMA6|PSMB7|PSMA1|PSMC3|RPN1
PID_NETRIN_PATHWAY%MSIGDB_C2%PID_NETRIN_PATHWAY,0.5314129301355579,0.812079525085925,-0.203699651811395,-0.947530481290158,4076,32,BCAR1|MYO10|ELMO1|MAPK3|NTN1|DOCK1|CAMK2A|MAP1B|NCK1
BIOCARTA_LECTIN_PATHWAY%MSIGDB_C2%BIOCARTA_LECTIN_PATHWAY,0.0724237644584648,0.37860162979691797,-0.546872065215492,-1.49485040285492,550,7,C4B|C4A|C2|C3|C7
BIOCARTA_HCMV_PATHWAY%MSIGDB_C2%BIOCARTA_HCMV_PATHWAY,0.604918890633176,0.8484731812466321,-0.238784695858493,-0.887416388995723,4623,16,MAPK3|MAP2K3|RELA|NFKB1
BIOCARTA_ECM_PATHWAY%MSIGDB_C2%BIOCARTA_ECM_PATHWAY,0.36118739374918296,0.716154857259883,-0.25906472291939503,-1.07285442410179,2761,22,RHOA|FYN|ARHGAP5|ROCK1|RAF1|ITGB1|TLN1|MYLK|PXN|MAPK3|HRAS|GSN
BIOCARTA_TGFB_PATHWAY%MSIGDB_C2%BIOCARTA_TGFB_PATHWAY,0.8195606694560671,0.9392252610104441,-0.18672216582285103,-0.7245514472265709,6267,18,SMAD4|TGFBR1|SMAD7|TGFB2|CREBBP|TGFB1|APC|SKIL|TGFB3|MAPK3|TGFBR2
BIOCARTA_AGR_PATHWAY%MSIGDB_C2%BIOCARTA_AGR_PATHWAY,0.8398070907195,0.9470274567210699,-0.15553747564678602,-0.7234990234284291,6442,32,NRG1|NRG3|NRG2|CDC42|PAK2|RAC1|ITGB1|UTRN|PAK4|CTTN|LAMA2|PXN|MAPK3|LAMA4
BIOCARTA_GATA3_PATHWAY%MSIGDB_C2%BIOCARTA_GATA3_PATHWAY,0.0256209150326797,0.22470485454905398,-0.507191353894006,-1.6976169506215801,195,12,MAPK14|NFATC2|PRKAR2A|JUNB|GATA3|MAF|PRKAR1A|NFATC1|MAP2K3
PID_P38_MKK3_6PATHWAY%MSIGDB_C2%PID_P38_MKK3_6PATHWAY,0.9458507306889351,0.983395403194261,-0.13608891640999302,-0.5936447057310821,7248,26,TRAF2|TAOK2|CAMK2B|GADD45B|MAP2K3|GADD45G
ST_WNT_BETA_CATENIN_PATHWAY%MSIGDB_C2%ST_WNT_BETA_CATENIN_PATHWAY,0.6540342298288511,0.874421642059869,0.19001842445521,0.8608765815923899,4814,28,DKK1|SFRP1|CBY1
PID_ENDOTHELIN_PATHWAY%MSIGDB_C2%PID_ENDOTHELIN_PATHWAY,0.126908150064683,0.48326646889427793,-0.23704064452523102,-1.30523101363277,980,57,GNA14|AKT1|RAF1|CDC42|RAC1|PRKCH|GNA12|PLCB1|EDNRA|GNAL|PLCB3|MMP1|BCAR1|ADCY8|SLC9A1|PLA2G4A|MAPK3|ADCY4|HRAS|CYSLTR2|GNAI2|GNAQ|EDNRB|GNA15|COL1A2|COL3A1|PRKCB|ADCY9
PID_IL4_2PATHWAY%MSIGDB_C2%PID_IL4_2PATHWAY,0.107567148760331,0.451309145449614,-0.25458487410008396,-1.3413815670443898,832,49,MAPK14|ETS1|IL2RG|AKT1|JAK3|PARP14|MYBL1|STAT5A|STAT6|CCL11|GTF3A|SOCS3|FES|THY1|IL13RA1|DOK2|GRB2|IRS1|SOCS1|PTPN6|CEBPB|SPI1|COL1A2|COL1A1|LTA|RPS6KB1|BCL6
NABA_BASEMENT_MEMBRANES%MSIGDB_C2%NABA_BASEMENT_MEMBRANES,0.00286757038581856,0.0531801043219946,-0.40838286030266396,-1.89963608053447,21,32,HSPG2|COL15A1|LAMB2|LAMC1|NTN3|LAMC2|COL18A1|NID2|LAMC3|HMCN1|NTN4|LAMA2|PAPLN|COL4A1|NTN1|LAMA4|COL4A2|COL6A3|NID1|COL6A1|COL6A2
PID_SYNDECAN_4_PATHWAY%MSIGDB_C2%PID_SYNDECAN_4_PATHWAY,0.0242146596858639,0.218419923233982,-0.367861534683759,-1.6429107567877599,184,28,ADAM12|ITGA5|CXCR4|SDC4|FN1|GIPC1|TNC|THBS1|MMP9|TFPI|ACTN1
ST_STAT3_PATHWAY%MSIGDB_C2%ST_STAT3_PATHWAY,0.6784063094914331,0.884536278926676,0.26044701768186,0.8251137569572641,4988,10,PIAS3|JAK1|PTPRU|SRC
BIOCARTA_P53_PATHWAY%MSIGDB_C2%BIOCARTA_P53_PATHWAY,0.388148953519978,0.735276444766153,0.27941424196998305,1.0520872903229601,2855,16,CDKN1A|ATM|CCNE1|APAF1|RB1|BAX|BCL2
PID_P75_NTR_PATHWAY%MSIGDB_C2%PID_P75_NTR_PATHWAY,0.236431610158566,0.62149045081524,-0.207829757272496,-1.16547293513822,1833,61,CYCS|MAPK9|IRAK1|E2F1|BEX1|XIAP|MAGED1|ARHGDIA|CASP6|NGFRAP1|MAGEH1|NGFR|SQSTM1|BAD
ST_INTERLEUKIN_4_PATHWAY%MSIGDB_C2%ST_INTERLEUKIN_4_PATHWAY,0.567019746305741,0.831083637363428,-0.221592483845094,-0.917672132129246,4335,22,IL2RG|AKT1|JAK3|IARS|SOS2|STAT6|IL13RA1|PPP1R13B|GRB2|CISH|RPS6KB1
BIOCARTA_ERK_PATHWAY%MSIGDB_C2%BIOCARTA_ERK_PATHWAY,0.46217277486911,0.776036026017168,-0.22303159377520498,-0.996084042415045,3530,28,NGF|ELK1|GRB2|STAT3|MAPK3|HRAS|PPP2CA|MYC|PDGFRA|NGFR
BIOCARTA_DEATH_PATHWAY%MSIGDB_C2%BIOCARTA_DEATH_PATHWAY,0.16608004171555202,0.538143527851939,-0.27000814618455304,-1.2680344768863703,1273,33,TNFRSF10A|TNFRSF10B|CASP10|TRAF2|TNFSF10|TNFSF12|CYCS|LMNA|NFKBIA|XIAP|FADD|RELA|NFKB1|CASP6
BIOCARTA_HER2_PATHWAY%MSIGDB_C2%BIOCARTA_HER2_PATHWAY,0.45516028675774395,0.7711801339028691,0.249413547876573,0.9943828577711791,3364,19,ERBB3|SHC1|SOS1|CARM1|GRIP1|EGFR|MAP2K1|MAPK1|EP300
WNT_SIGNALING%MSIGDB_C2%WNT_SIGNALING,0.48086752313855496,0.7857006060206241,0.16638117472915698,0.9875641078870459,3480,72,DKK1|WNT6|TLE2|KREMEN1|SFRP1|TCF7L1|CSNK1G1|WNT5B|WNT2B|AES|BTRC|DIXDC1|DVL2|WNT4|BCL9|CXXC4
PID_HIF1A_PATHWAY%MSIGDB_C2%PID_HIF1A_PATHWAY,0.802339334998029,0.932946245893631,-0.18778646666273102,-0.741926810851955,6104,19,VHL|TCEB2|GNB2L1|NAA10|CDKN2A|HIF3A|HSP90AA1
PID_NECTIN_PATHWAY%MSIGDB_C2%PID_NECTIN_PATHWAY,0.883183917413746,0.9629606199413431,0.150703368172081,0.6827601102282611,6501,28,FARP2|CRK|PTPRM|VAV2|MLLT4|ITGAV|PVRL1|SRC|CTNNA1|PIP5K1C|PVRL3
BIOCARTA_ERYTH_PATHWAY%MSIGDB_C2%BIOCARTA_ERYTH_PATHWAY,0.0350169226763864,0.26702449097803305,-0.5675437144905949,-1.63387892035018,268,8,IL6|KITLG|TGFB2|CCL3|TGFB1|TGFB3|IGF1|IL11
BIOCARTA_BCR_PATHWAY%MSIGDB_C2%BIOCARTA_BCR_PATHWAY,0.5234628883400491,0.8074766108233571,-0.20128044970771397,-0.9536232446015541,4026,34,BTK|CALM1|PPP3CA|NFATC3|MAP3K1|NFATC4|MAPK14|RAF1|SYK|NFATC2|RAC1|LYN|CALM3|VAV1|ELK1|GRB2|MAPK3|HRAS|NFATC1|PRKCB
BIOCARTA_DNAFRAGMENT_PATHWAY%MSIGDB_C2%BIOCARTA_DNAFRAGMENT_PATHWAY,0.477641213389121,0.7850984235874658,-0.310491634637521,-0.9727297596031921,3652,10,HMGB2|GZMB|TOP2A|ENDOG
BIOCARTA_IL6_PATHWAY%MSIGDB_C2%BIOCARTA_IL6_PATHWAY,0.11141624166339699,0.458084503025701,-0.33178683411036797,-1.37401560823388,851,22,ELK1|IL6ST|GRB2|STAT3|MAPK3|HRAS|CEBPB|SRF
PID_RANBP2_PATHWAY%MSIGDB_C2%PID_RANBP2_PATHWAY,0.0610749185667752,0.35631208031004796,0.46557595883289293,1.5320307868801901,449,11,HDAC1|RANBP2|RANGAP1|HDAC4|SUMO1|XPO1
PID_ATM_PATHWAY%MSIGDB_C2%PID_ATM_PATHWAY,0.9313661770440659,0.9793746057014829,-0.132455222395264,-0.6275442007826121,7164,34,BLM|UBE2N|FANCD2|UIMC1|RAD9A|TERF2|H2AFX|NBN|TRIM28|RAD17|CDC25C|BRCA1|ABL1|SMC1A|KAT5
BIOCARTA_TCAPOPTOSIS_PATHWAY%MSIGDB_C2%BIOCARTA_TCAPOPTOSIS_PATHWAY,0.475814931650894,0.7850084910380921,-0.35819084390513,-0.9790986985220022,3619,7,CD247|CD3E|CD3D|CD3G|CCR5|FAS|CD4
PID_EPHA2_FWD_PATHWAY%MSIGDB_C2%PID_EPHA2_FWD_PATHWAY,0.737153371008017,0.9082631287383801,-0.20061708568029699,-0.7926193895991601,5608,19,RAC1|ACP1|VAV3|BCAR1|EFNA1|GRB2|EPHA2|TIAM1
BIOCARTA_NFKB_PATHWAY%MSIGDB_C2%BIOCARTA_NFKB_PATHWAY,0.0100693082254479,0.12867115240867502,-0.43869050603839704,-1.8167315291367798,76,22,IRAK1|NFKBIA|FADD|RELA|IL1R1|NFKB1|TLR4|TNFRSF1A|TNFRSF1B
PID_RET_PATHWAY%MSIGDB_C2%PID_RET_PATHWAY,0.527554980595084,0.810052447666581,-0.19813666877288397,-0.954083508585847,4077,36,BCAR1|GRB2|IRS1|PXN|MAPK3|HRAS|RAP1A|PRKACA|NCK1|GRB10
BIOCARTA_AMI_PATHWAY%MSIGDB_C2%BIOCARTA_AMI_PATHWAY,0.0453007029419422,0.30534185650040896,-0.552531613561031,-1.59066118287422,347,8,COL4A1|COL4A2|F2R|PLAT|TFPI
BIOCARTA_STRESS_PATHWAY%MSIGDB_C2%BIOCARTA_STRESS_PATHWAY,0.31835352351178803,0.6867397844771489,-0.25726410749552,-1.1091016154272701,2443,25,MAP2K3|NFKBIA|LTA|RELA|NFKB1|TNFRSF1A
PID_HDAC_CLASSII_PATHWAY%MSIGDB_C2%PID_HDAC_CLASSII_PATHWAY,0.30859481582537496,0.680783101756233,0.23624547703410897,1.11364884917074,2261,32,CAMK4|HDAC11|HDAC10|RANBP2|RANGAP1|HDAC4|SUMO1|YWHAB|XPO1|YWHAE|GATA2|RFXANK
PID_ALK1_PATHWAY%MSIGDB_C2%PID_ALK1_PATHWAY,0.0437670965220789,0.299062021084573,-0.361600029849837,-1.5589083963140402,335,25,TGFB3|SMAD5|INHBA|MAPK3|TGFBR2|ID1|FKBP1A|CAV1|ENG|PPP1CA|ACVRL1
BIOCARTA_INSULIN_PATHWAY%MSIGDB_C2%BIOCARTA_INSULIN_PATHWAY,0.10740546218487401,0.451309145449614,-0.346134074744055,-1.38868327821708,817,20,ELK1|INS|GRB2|IRS1|MAPK3|HRAS|SRF
NABA_PROTEOGLYCANS%MSIGDB_C2%NABA_PROTEOGLYCANS,0.00745390349156532,0.10477806266857598,-0.451265387951269,-1.86880738701797,56,22,HAPLN2|HSPG2|NCAN|SPOCK2|PRELP|HAPLN3|DCN|PODN|ACAN|BGN|SRGN|VCAN|OGN|LUM|FMOD
PID_AR_TF_PATHWAY%MSIGDB_C2%PID_AR_TF_PATHWAY,0.748604077392546,0.9131348696838739,-0.15731203768735097,-0.808638083214293,5764,45,GNB2L1|NR3C1|SMARCA2|RXRG|SMARCE1|PKN1|CEBPA|RCHY1|KAT7|KAT2B|DNAJA1|KAT5|HSP90AA1
BIOCARTA_UCALPAIN_PATHWAY%MSIGDB_C2%BIOCARTA_UCALPAIN_PATHWAY,0.40194276713047994,0.740287621109606,-0.28651912805917895,-1.04030450958273,3061,15,ITGA1|ITGB3|SPTAN1|RHOA|RAC1|ITGB1|TLN1|PXN|CAPN1|ACTN1
PID_HEDGEHOG_GLI_PATHWAY%MSIGDB_C2%PID_HEDGEHOG_GLI_PATHWAY,0.45290745290745293,0.769943206592495,0.19503832401432297,1.00466795255605,3317,43,IFT88|STK36|CSNK1G1|IFT172|HDAC1|ARRB2|GNAI3|SUFU|RAB23|CSNK1G2|SIN3A|XPO1|SIN3B|GNAO1|MAP2K1|CSNK1E
PID_REELIN_PATHWAY%MSIGDB_C2%PID_REELIN_PATHWAY,0.930975991649269,0.9793746057014829,-0.141099200681309,-0.615500480693049,7134,26,FYN|GSK3B|ARHGEF2|AKT1|MAPT|ITGB1|LRPAP1|RAPGEF1|MAPK8IP1|RAP1A|MAP3K11|MAP1B
PID_TCR_PATHWAY%MSIGDB_C2%PID_TCR_PATHWAY,0.5373500193523421,0.8137306732814521,-0.167153786073221,-0.945256542862595,4164,63,MAP3K14|CHUK|RASGRP1|ORAI1|MAP4K1|PTPN11|PRKCQ|MALT1|FYN|TRAF6|RASSF5|STK39|HLA-DRB1|GRAP2|LCP2|AKT1|CDC42|PTEN|SLA2|HLA-DRA|CD4|VAV1|WAS|STIM1|GRB2|PTPN6|FLNA|HRAS|RAP1A|CD86|NCK1|DBNL|PRKCB
BIOCARTA_CTLA4_PATHWAY%MSIGDB_C2%BIOCARTA_CTLA4_PATHWAY,0.15686531898136,0.5264612444015649,-0.35834896810506606,-1.3011070152601498,1194,15,CD247|CD3E|CTLA4|PIK3CA|LCK|PIK3R1|CD3D|CD3G|ITK|PTPN11|HLA-DRB1|HLA-DRA|GRB2|ICOSLG|CD86
PID_TOLL_ENDOGENOUS_PATHWAY%MSIGDB_C2%PID_TOLL_ENDOGENOUS_PATHWAY,0.00616878855492847,0.0917891350028485,-0.4602476901662991,-1.8750524036768899,46,21,BGN|VCAN|IRAK1|TICAM1|TLR4|S100A8|S100A9|CD14|LY96
BIOCARTA_FMLP_PATHWAY%MSIGDB_C2%BIOCARTA_FMLP_PATHWAY,0.22567637877211197,0.6083599141984499,-0.250172283636378,-1.1943057362712,1734,35,PPP3CA|NFATC3|MAP3K1|MAP2K2|NFATC4|MAPK14|RAF1|NFATC2|RAC1|PLCB1|CAMK1|CALM3|ELK1|FPR1|MAPK3|HRAS|NFATC1|MAP2K3|NCF2|NFKBIA|GNA15|RELA|NFKB1
BIOCARTA_NEUROTRANSMITTERS_PATHWAY%MSIGDB_C2%BIOCARTA_NEUROTRANSMITTERS_PATHWAY,0.578571428571429,0.8380842665555279,-0.46547921032315,-0.908962922540234,4373,3,DBH|TH|PNMT
BIOCARTA_FAS_PATHWAY%MSIGDB_C2%BIOCARTA_FAS_PATHWAY,0.9285993995561941,0.9793746057014829,-0.138923283291124,-0.6281444323655779,7113,29,PARP1|CASP10|ARHGDIB|LMNB1|LMNA|FADD|CASP6
BIOCARTA_HSP27_PATHWAY%MSIGDB_C2%BIOCARTA_HSP27_PATHWAY,0.972932535364527,0.991858154396548,0.158355544601841,0.538219695640433,7152,12,CASP9|MAPKAPK3|APAF1|BCL2|CASP3
PID_CD8_TCR_PATHWAY%MSIGDB_C2%PID_CD8_TCR_PATHWAY,0.965606080123664,0.990916952887267,-0.11251174876983501,-0.597200207233363,7495,50,PRKCE|SHC1|SOS1|PAG1|CBL|PRKCA|PLCG1|NRAS|BCL10|CD8A|KRAS|IKBKB|PDPK1|ZAP70|RASGRP2|CD247|CD3E|IKBKG|LCK|CARD11|PTPRC|CD3D|CD3G|LAT|MAP3K8|CSK|MAP3K14|CHUK|RASGRP1|ORAI1|PRKCQ|CD8B|MALT1|FYN|TRAF6|RASSF5|GRAP2|LCP2|AKT1|PRF1|B2M|VAV1|HLA-A|STIM1|GRB2|PTPN6|HRAS|RAP1A|CD86|PRKCB
ST_P38_MAPK_PATHWAY%MSIGDB_C2%ST_P38_MAPK_PATHWAY,0.7613078314810029,0.9183912636605319,-0.16293199111537698,-0.7915148303703471,5890,37,ATF1|ELK1|CREB3|MAPKAPK2|HSPB1|MAP2K3|SRF|IL1R1|MAPK13|NFKB1
PID_ARF6_DOWNSTREAM_PATHWAY%MSIGDB_C2%PID_ARF6_DOWNSTREAM_PATHWAY,0.0434497243370964,0.297958958487227,-0.433801226445179,-1.5750619345743302,330,15,KALRN|MAPK3|ARF1|PLD1|PLAUR|TIAM1|ARF6|NME1
PID_AJDISS_2PATHWAY%MSIGDB_C2%PID_AJDISS_2PATHWAY,0.41471615155825703,0.748894797291058,-0.20616540603840103,-1.02633799114463,3206,40,PTPN1|ZBTB33|ROBO1|CREBBP|CDC42|SNX1|RAC1|IQGAP1|GNA12|GNA13|JUP|CTNND1|HGS|RAB7A|PTPN6|ABL1|HRAS|NTRK2|TIAM1|ARF6|NME1
PID_MET_PATHWAY%MSIGDB_C2%PID_MET_PATHWAY,0.639106432147901,0.865463150027443,-0.14975366319386801,-0.894002088817864,4977,78,PTPN11|RHOA|MAP3K1|MAP2K2|DEPTOR|ETS1|PTPN1|RAP1B|SH3KBP1|AKT1|RAF1|CDC42|PAK2|MLST8|RAC1|APC|PAK4|EIF4EBP1|HGS|NUMB|RAPGEF1|HGF|KPNB1|SH3GL2|BCAR1|GRB2|PXN|MAPK3|HRAS|RPTOR|RAP1A|MUC20|SNAI1|NCK1|ARF6|PTPRJ|BAD
PID_PRL_SIGNALING_EVENTS_PATHWAY%MSIGDB_C2%PID_PRL_SIGNALING_EVENTS_PATHWAY,0.6334203655352479,0.8631726958478259,-0.20755297352463897,-0.8714280767380309,4851,23,ROCK1|RAC1|ITGB1|AGT|TUBA1B|PTP4A2|BCAR1|MAPK3|ATF5|PTP4A3
BIOCARTA_PTEN_PATHWAY%MSIGDB_C2%BIOCARTA_PTEN_PATHWAY,0.8301713986654459,0.9435818887072471,-0.18780351588206398,-0.713699221259026,6344,17,CDKN1B|AKT1|PTEN|ITGB1|BCAR1|ILK|GRB2|MAPK3
BIOCARTA_SPPA_PATHWAY%MSIGDB_C2%BIOCARTA_SPPA_PATHWAY,0.138075862974144,0.502897375569561,-0.325492704751339,-1.32605962281477,1051,21,RAF1|SYK|ITGB1|PLCB1|TBXAS1|PLA2G4A|PTGS1|MAPK3|HRAS|F2R|F2RL3|PRKCB
PID_LPA4_PATHWAY%MSIGDB_C2%PID_LPA4_PATHWAY,0.7815941269008921,0.9256278844111601,-0.21227672713644896,-0.75100401859462,5961,14,ADCY8|ADCY4|PRKACA|ADCY9
ST_T_CELL_SIGNAL_TRANSDUCTION%MSIGDB_C2%ST_T_CELL_SIGNAL_TRANSDUCTION,0.9983156258097952,0.999656642395059,-0.0824668748859984,-0.41556040545223,7704,42,GRAP2|LCP2|RAF1|ITPKB|PAK2|SOS2|PAK4|NFKB2|TONSL|VAV1|GRB2|NFKBIA|NFKB1|NCK1
PID_FAK_PATHWAY%MSIGDB_C2%PID_FAK_PATHWAY,0.22529032258064496,0.608155343481347,-0.21656687352079101,-1.18133581586393,1745,55,ITGB5|TLN1|BCAR1|ITGA5|ELMO1|GRB2|MAPK9|PXN|MMP14|DOCK1|RAP1A|VCL|RRAS|NCK1|CCND1|ACTN1
BIOCARTA_BARRESTIN_PATHWAY%MSIGDB_C2%BIOCARTA_BARRESTIN_PATHWAY,0.5033995815899579,0.7974295790858391,-0.303545072990208,-0.9509670887694069,3849,10,PLCB1|DNM1|ARRB1|PPARA|AP2M1
PID_P38_GAMMA_DELTA_PATHWAY%MSIGDB_C2%PID_P38_GAMMA_DELTA_PATHWAY,0.443122384937239,0.7659482117676241,-0.319951878520208,-1.0023674687432,3388,10,PKN1|MAP2K3|MAPK13|CCND1
PID_PI3K_PLC_TRK_PATHWAY%MSIGDB_C2%PID_PI3K_PLC_TRK_PATHWAY,0.238446814328685,0.622072730324094,0.24338508662064,1.17969097845044,1743,35,CAMK4|GAB1|SHC1|FOXO3|SOS1|YWHAQ|TRPV1|YWHAB|YWHAE|PLCG1|NRAS|YWHAH|SRC|KRAS|YWHAZ|AGAP2|PDPK1
BIOCARTA_TCYTOTOXIC_PATHWAY%MSIGDB_C2%BIOCARTA_TCYTOTOXIC_PATHWAY,0.652737752161383,0.8735476294907571,-0.259792563168929,-0.8410924006190379,4982,11,CD8A|CD247|CD3E|CD2|PTPRC|CD3D|CD3G|ITGAL|ITGB2|THY1|ICAM1
PID_PTP1B_PATHWAY%MSIGDB_C2%PID_PTP1B_PATHWAY,0.284201007621754,0.6569867235097528,-0.21836788750298802,-1.13121436635951,2199,46,INS|BCAR1|GRB2|IRS1|STAT3|CAPN1|FCGR2A|CSF1|HCK|PDGFRB|CAV1|CSF1R|PDGFB
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES%MSIGDB_C2%SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,0.9057489245209229,0.97046527419469,-0.139723581998968,-0.6561813845707111,6947,33,PDK1|RPS6KA3|PREX1|DAPP1|PLCG2|AKT1|PIK3R5|SYK|PTEN|LYN|RPS6KA1|ITPR2|ITPR3|VAV1|CDKN2A|CYTH3|PPP1R13B|RPS6KB1
BIOCARTA_PML_PATHWAY%MSIGDB_C2%BIOCARTA_PML_PATHWAY,0.18994486741926997,0.56366737984224,-0.34642380106443604,-1.25780866679061,1446,15,FAS|RARA|CREBBP|TNF|PML|PRAM1|SP100|HRAS|TNFRSF1A|TNFRSF1B
ST_INTERLEUKIN_13_PATHWAY%MSIGDB_C2%ST_INTERLEUKIN_13_PATHWAY,0.655354961313968,0.874775007199212,0.32130345694790097,0.83139157954723,4827,6,IL13RA2|JAK1|JAK2|TYK2
BIOCARTA_RACCYCD_PATHWAY%MSIGDB_C2%BIOCARTA_RACCYCD_PATHWAY,0.227296450939457,0.609201573718782,-0.275576910688458,-1.2021168098588602,1741,26,MAPK3|HRAS|E2F1|NFKBIA|RELA|NFKB1|CCND1
BIOCARTA_ETS_PATHWAY%MSIGDB_C2%BIOCARTA_ETS_PATHWAY,0.12186192468619199,0.474636720302924,-0.351087328319878,-1.36234940675665,931,18,ETV3|ETS2|HRAS|E2F1|HDAC5|CSF1|CSF1R
PID_LKB1_PATHWAY%MSIGDB_C2%PID_LKB1_PATHWAY,0.522517559564798,0.807051143864932,0.18225350735417198,0.955834377390606,3793,46,ETV4|STK11IP|TSC2|YWHAQ|MARK4|STRADB|MAP2|PSEN2|YWHAB|BRSK1|YWHAE|CDC37|YWHAH|AKT1S1|EZR|SIK3|YWHAZ
BIOCARTA_HIVNEF_PATHWAY%MSIGDB_C2%BIOCARTA_HIVNEF_PATHWAY,0.4892626131953429,0.789195252448196,-0.177574877315576,-0.977791119234212,3781,57,ARHGDIB|TRAF2|CYCS|LMNB1|LMNA|GSN|NFKBIA|XIAP|FADD|RELA|NFKB1|TNFRSF1A|CASP6|TNFRSF1B
PID_SYNDECAN_3_PATHWAY%MSIGDB_C2%PID_SYNDECAN_3_PATHWAY,0.538723181580324,0.8142313733497609,-0.25220395426269,-0.9372875492609921,4117,16,PSEN1|CTTN|NCAN|SDC3|CASK|POMC|PTN
PID_MYC_PATHWAY%MSIGDB_C2%PID_MYC_PATHWAY,0.0782857887195519,0.392163020866455,-0.33610023472124606,-1.4489752064668102,600,25,RUVBL1|CDKN2A|TAF12|MAX|PPP2CA|MYC|TAF10|KAT5|AK6
BIOCARTA_HIF_PATHWAY%MSIGDB_C2%BIOCARTA_HIF_PATHWAY,0.0136339800734137,0.15507715933777802,-0.502486553845312,-1.7777239470298702,103,14,NOS3|ASPH|LDHA|HSP90AA1|P4HB
BIOCARTA_COMP_PATHWAY%MSIGDB_C2%BIOCARTA_COMP_PATHWAY,0.00013109596224436298,0.00518555396908895,-0.672448256940197,-2.37902359844855,0,14,C4A|C2|C3|C1QB|C1QA|CFB|C1QC|C7|C1S|CFD|C1R
BIOCARTA_MET_PATHWAY%MSIGDB_C2%BIOCARTA_MET_PATHWAY,0.7571540062434959,0.916855605301775,-0.166458176119147,-0.794660190564093,5820,35,RAPGEF1|HGF|ELK1|GRB2|STAT3|PXN|MAPK3|HRAS|DOCK1|RAP1A
PID_CIRCADIAN_PATHWAY%MSIGDB_C2%PID_CIRCADIAN_PATHWAY,0.0867681806248359,0.406842536616055,-0.39595064795948104,-1.43763261962522,660,15,ARNTL|TIMELESS|NPAS2|PER2|BHLHE40|WDR5|NONO|CRY2|NR1D1
ST_FAS_SIGNALING_PATHWAY%MSIGDB_C2%ST_FAS_SIGNALING_PATHWAY,0.953385739897945,0.986646769115929,0.11087976155432401,0.636185574505161,6912,63,MAP3K5|MET|EPHB2|AGFG1|CAD|RIPK1|NFKBIL1|CASP8|BFAR|NFKBIB|MAP2K7|BAX|EZR|DFFA|EGFR|MAPK1|MAP2K4|CDK2AP1|MAPK8
BIOCARTA_GLEEVEC_PATHWAY%MSIGDB_C2%BIOCARTA_GLEEVEC_PATHWAY,0.346933437949523,0.7041133168973092,-0.261779366628126,-1.08409647002743,2652,22,GRB2|MAPK3|HRAS|MYC|BAD
PID_NFAT_TFPATHWAY%MSIGDB_C2%PID_NFAT_TFPATHWAY,0.0158688865764828,0.17087427216718598,-0.35263309538455606,-1.6834467931266999,121,35,NFATC3|GBP3|PRKCQ|CBLB|PTGS2|FOSL1|TLE4|PTPN1|CDK4|FOXP3|TNF|POU2F1|NFATC2|JUNB|GATA3|MAF|IL2RA|CREM|NFATC1|E2F1|SLC3A2|PPARG
BIOCARTA_BARR_MAPK_PATHWAY%MSIGDB_C2%BIOCARTA_BARR_MAPK_PATHWAY,0.9265505984766049,0.9790847380319629,0.180663687426761,0.614040734125196,6811,12,GNGT1|GNAS|MAP2K1|MAPK1|ADCY1|GNB1
BIOCARTA_TID_PATHWAY%MSIGDB_C2%BIOCARTA_TID_PATHWAY,0.0384615384615385,0.279776552671739,-0.429743202942678,-1.59709214185505,293,16,HSPA1A|NFKBIA|RELA|NFKB1|TNFRSF1A|TNFRSF1B
PID_TCR_RAS_PATHWAY%MSIGDB_C2%PID_TCR_RAS_PATHWAY,0.543523859465129,0.816444320780226,-0.26240261384152497,-0.928342075662614,4145,14,ELK1|MAPK3|HRAS|PRKCB
BIOCARTA_SALMONELLA_PATHWAY%MSIGDB_C2%BIOCARTA_SALMONELLA_PATHWAY,0.8244015233949951,0.942178419436027,0.209931034482759,0.7135147542126422,6060,12,ACTR2|ACTR3|ARPC2|ARPC4|ARPC5|WASL|WASF1|ARPC3|ARPC1B|CDC42|RAC1|ARPC1A
BIOCARTA_FCER1_PATHWAY%MSIGDB_C2%BIOCARTA_FCER1_PATHWAY,0.608667529107374,0.8499587630754359,-0.18677369361253002,-0.899367603266016,4704,36,BTK|CALM1|PPP3CA|NFATC3|MAP3K1|NFATC4|RAF1|PAK2|SYK|NFATC2|LYN|CALM3|VAV1|ELK1|GRB2|PLA2G4A|FCER1G|MAPK3|HRAS|NFATC1|PRKCB
BIOCARTA_DC_PATHWAY%MSIGDB_C2%BIOCARTA_DC_PATHWAY,0.117769671704013,0.46862716515177505,-0.464026870918228,-1.3959064087131101,903,9,CD33|CD7|CD40|ITGAX|TLR2|ANPEP|TLR4
HALLMARK_G2M_CHECKPOINT%MSIGDB_C2%HALLMARK_G2M_CHECKPOINT,0.00012809017548354,0.00518555396908895,-0.3317822610630661,-2.42738240200185,0,197,CENPE|FOXN3|AMD1|KIF2C|PAPD7|MAPK14|CDC7|NASP|CCNT1|STAG1|CASC5|CCNB2|RAD21|UCK2|TRAIP|SAP30|CDKN1B|CDK4|SLC38A1|AURKA|PBK|ARID4A|TACC3|PRIM2|RACGAP1|RPS6KA5|CTCF|KIF11|NEK2|POLE|KIF15|TGFB1|PML|RPA2|NUSAP1|MKI67|LBR|TROAP|CDC20|SMC2|EZH2|SRSF10|H2AFX|MCM6|EXO1|ESPL1|GINS2|CDC6|PURA|ODC1|TOP1|HNRNPU|SLC12A2|SETD8|TPX2|TMPO|KPNB1|H2AFV|HN1|E2F2|PTTG1|CHAF1A|TOP2A|MAD2L1|ORC6|MCM3|SRSF1|UBE2S|CKS2|LMNB1|SNRPD1|MCM5|INCENP|CDC45|KIF4A|NDC80|POLQ|NOTCH2|ABL1|CDC27|RAD23B|HMGN2|E2F1|SMC4|DKC1|BCL3|KPNA2|MYBL2|PLK1|RBM14|H2AFZ|MT2A|CBX1|MCM2|TRA2B|MNAT1|SRSF2|DDX39A|MYC|HMGB3|SMC1A|CDKN2C|NUP98|BIRC5|ATF5|KIF22|CDKN3|PRMT5|G3BP1|CCND1|HIST1H2BK|POLA2|EFNA5|SUV39H1
HALLMARK_XENOBIOTIC_METABOLISM%MSIGDB_C2%HALLMARK_XENOBIOTIC_METABOLISM,0.00038570326562098196,0.0111294649577428,-0.259996048190979,-1.81153189456376,2,154,ABHD6|TGFB2|PTGES3|IRF8|GABARAPL1|ALAS1|ETFDH|PDK4|MAN1A1|ATP2A2|HGFAC|ID2|PYCR1|MAOA|DCXR|SLC6A6|LONP1|POR|MARCH6|ACP1|F10|CES1|CDO1|FMO3|JUP|MPP2|CROT|NDRG2|PTGDS|TMBIM6|COMT|SMOX|ETS2|CBR1|NMT1|ALDH2|BCAR1|HSD11B1|SLC35B1|KYNU|VTN|CA2|GCNT2|SLC46A3|MCCC2|HMOX1|IGF1|HPRT1|ACOX1|ACP2|CFB|CDA|CYFIP2|EPHA2|APOE|CAT|CD36|SPINT2|ATOH8|MT2A|TMEM97|NINJ1|SERPINE1|IL1R1|CYB5A|SERTAD1|SHMT2|TNFRSF1A|SAR1B|IGFBP4|RAP1GAP|CASP6|SSR3|LPIN2|PGRMC1|BLVRB|FBLN1|PTGES|MTHFD1
HALLMARK_BILE_ACID_METABOLISM%MSIGDB_C2%HALLMARK_BILE_ACID_METABOLISM,0.7803946530872059,0.9249005412304508,-0.133865266785512,-0.8111360778647259,6129,82,SOD1|ALDH1A1|ABCA8|ISOC1|CYP46A1|CAT|ABCA6|PEX16|CYP7B1|ABCD1|PRDX5|FADS1|FADS2|DHCR24
HALLMARK_PROTEIN_SECRETION%MSIGDB_C2%HALLMARK_PROTEIN_SECRETION,0.203795694815947,0.583012195310033,-0.187247025783481,-1.1776232605447101,1599,95,DOPEY1|YKT6|TSG101|AP3S1|RAB14|RAB9A|SCAMP3|CAV2|NAPA|CLTA|SH3GL2|GOLGA4|GLA|CLTC|KRT18|CD63|YIPF6|SOD1|SGMS1|COPB2|ARF1|VAMP7|SNX2|COPB1|TMED2|STX7|CTSC|LAMP2|TMED10|GOSR2|TMX1|AP2M1
HALLMARK_ADIPOGENESIS%MSIGDB_C2%HALLMARK_ADIPOGENESIS,0.000128057369701626,0.00518555396908895,-0.292076686086023,-2.1202888101872803,0,189,LTC4S|UQCRC1|DGAT1|SLC19A1|IFNGR1|LIPE|TKT|UQCR10|GPAM|FZD4|PIM3|TST|ANGPTL4|CRAT|ATP1B3|SLC25A10|SDHB|PFKFB3|TOB1|NMT1|ALDH2|RREB1|C3|MYLK|RMDN3|UBQLN1|IDH3G|COL4A1|SOD1|LAMA4|ATP5O|NDUFB7|ACOX1|SDPR|APOE|CAT|FABP4|ITIH5|VEGFB|SNCG|CD36|ADIPOR2|CD151|SQRDL|COX7B|ARAF|PLIN2|UBC|RAB34|NDUFAB1|GPX3|PPARG|DHCR7|RTN3|BCL6|STOM|PTRF|CDKN2C|MGLL|DHRS7B|SPARCL1|UQCRQ|NDUFS3|ESRRA|GPHN|HADH|TALDO1|COX6A1|UCK1|COX8A|ALDOA|COQ3|ETFB|AGPAT3|DNAJC15
HALLMARK_IL2_STAT5_SIGNALING%MSIGDB_C2%HALLMARK_IL2_STAT5_SIGNALING,0.000128024580719498,0.00518555396908895,-0.289469986375777,-2.0772526660781203,0,178,IL10RA|NFKBIZ|CD44|PRKCH|SLC29A2|S100A1|CCND2|DENND5A|CDC42SE2|NFIL3|GPX4|PDCD2L|SWAP70|TWSG1|DCPS|BATF|IFNGR1|CD83|COCH|RGS16|FGL2|CDC6|P2RX4|BHLHE40|ODC1|RORA|WLS|CDKN1C|CKAP4|AHR|TNFRSF18|SLC39A8|P4HA1|PLSCR1|TNFSF10|MAPKAPK2|CA2|SOCS1|IL2RA|CISH|SMPDL3A|PIM1|SPP1|HUWE1|TNFRSF4|KLF6|SHE|PHTF2|LRIG1|GADD45B|CSF1|CTSZ|CD86|IL3RA|PLAGL1|ITIH5|PTRH2|ECM1|UMPS|TNFRSF21|BMP2|PPAP2A|PLIN2|TGM2|ADAM19|SYNGR2|MYO1E|FLT3LG|MYC|CCND3|COL6A1|SLC2A3|DHRS3|EMP1|TIAM1|PRAF2|PNP|RNH1|GLIPR2|IFITM3|CD81|TNFRSF1B|AHNAK|RRAGD|PRNP
HALLMARK_IL6_JAK_STAT3_SIGNALING%MSIGDB_C2%HALLMARK_IL6_JAK_STAT3_SIGNALING,0.00012873326467559198,0.00518555396908895,-0.390136169033875,-2.3151348568061096,0,76,IFNGR1|SOCS3|IFNAR1|TLR2|PLA2G2A|EBI3|IL15RA|IL6ST|IL13RA1|CSF2RB|PDGFC|IL10RB|GRB2|SOCS1|STAT3|IL17RA|IL2RA|HAX1|CSF3R|PIM1|HMOX1|CSF1|CSF2RA|CCR1|IL3RA|CD36|TNFRSF21|A2M|LTBR|IL1R1|TNFRSF12A|OSMR|TNFRSF1A|CD14|ACVRL1|TNFRSF1B
HALLMARK_UNFOLDED_PROTEIN_RESPONSE%MSIGDB_C2%HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.000640614990390775,0.0163600882996276,-0.29278141775459604,-1.9131779698204399,4,112,BAG3|ATP6V0D1|RPS14|HSPA9|IFIT1|STC2|WIPI1|CALR|HERPUD1|CEBPB|CCL2|DKC1|FUS|PDIA5|NOP56|SRPRB|EIF4A3|SSR1|SLC30A5|EIF2S1|NFYB|KDELR3|DDIT4|EIF4A2|HSPA5|GOSR2|SKIV2L2|EXOSC2|BANF1|SERP1|YIF1A|ERN1|EIF4G1
HALLMARK_SPERMATOGENESIS%MSIGDB_C2%HALLMARK_SPERMATOGENESIS,0.12690001394505598,0.48326646889427793,0.202532030691629,1.2651305759512501,909,89,NPHP1|DDX25|IFT88|LPIN1|IL13RA2|CAMK4|SPATA6|CHRM4|JAM3|AGFG1|TUBA3C|MLLT10|OAZ3|MAP7|ADCYAP1|PCSK4|GMCL1|STAM2|SCG3|HSPA2|TEKT2|PACRG|ARL4A|MAST2|SEPT4|SCG5|DCC|HSPA1L|CSNK2A2|CLVS1|NEFH|GRM8|TSN
HALLMARK_PEROXISOME%MSIGDB_C2%HALLMARK_PEROXISOME,0.32142857142857106,0.6895309030347889,-0.17329033691718101,-1.08226536194891,2510,93,SOD1|HRAS|ALDH1A1|CTPS1|ACOX1|ISOC1|STS|CAT|CDK7|MVP|SLC25A4|ABCD1|DHRS3|PRDX5|SLC25A19|ABCB9|FADS1|DHCR24|CNBP
HALLMARK_WNT_BETA_CATENIN_SIGNALING%MSIGDB_C2%HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.135877024430415,0.498838262379094,0.259984407327236,1.2989476669651498,989,39,DKK1|WNT6|DLL1|WNT5B|PPARD|HDAC11|ADAM17
HALLMARK_APICAL_SURFACE%MSIGDB_C2%HALLMARK_APICAL_SURFACE,0.0332470892626132,0.260356918381151,-0.324978931150606,-1.5648644986761902,256,36,GATA3|THY1|SRPX|ATP8B1|BRCA1|GHRL|HSPB1|PLAUR|GAS1|ADIPOR2|CX3CL1|B4GALT1|RTN4RL1|EPHB4|EFNA5
HALLMARK_TGF_BETA_SIGNALING%MSIGDB_C2%HALLMARK_TGF_BETA_SIGNALING,0.4305323925593329,0.759202571928828,-0.190303395125053,-1.01617040488913,3355,51,BMP2|THBS1|WWTR1|XIAP|ID1|FKBP1A|SERPINE1|ENG|PPP1CA
HALLMARK_GLYCOLYSIS%MSIGDB_C2%HALLMARK_GLYCOLYSIS,0.00803879035345158,0.11011613485815701,-0.21629149358506,-1.5570513956932601,62,180,TSTA3|MPI|PGAM2|SDC3|NANP|LHPP|PLOD2|B4GALT4|MERTK|GLRX|GOT1|PPIA|ERO1L|ANGPTL4|PAXIP1|GAL3ST1|SLC25A10|IER3|CACNA1H|P4HA1|IL13RA1|DCN|CXCR4|KIF20A|GNE|HAX1|PKP2|ENO1|STC2|POLR3K|SOD1|VCAN|COPB2|PGAM1|B4GALT7|PSMC4|PRPS1|SDC2|KIF2A|EFNA3|GMPPB|PDK3|EXT2|LDHA|B3GAT3|B4GALT1|SRD5A3|KDELR3|FKBP4|DDIT4|ANG|PYGL|B3GALT6|TGFBI|CYB5A|HSPA5|COL5A1|PGK1|XYLT2|CASP6|TALDO1|NSDHL|ALDOA|GALK1|RRAGD|NDUFV3
HALLMARK_MTORC1_SIGNALING%MSIGDB_C2%HALLMARK_MTORC1_SIGNALING,0.00012750223128904799,0.00518555396908895,-0.341923728416999,-2.51183655444306,0,200,CORO1A|HSP90B1|YKT6|PLOD2|IDI1|SYTL2|MCM4|ITGB2|ETF1|GLRX|FGL2|GOT1|PPIA|ERO1L|BHLHE40|CACYBP|UCHL5|SLC2A1|GPI|GGA2|TUBA4A|CANX|TES|PHGDH|NMT1|P4HA1|SLC9A3R1|WARS|SKAP2|GLA|CXCR4|CYP51A1|SDF2L1|HSPA9|PSMB5|ENO1|GTF2H1|CALR|PIK3R3|PSMG1|IFI30|HMGCR|HPRT1|NUPR1|PSMC4|DHFR|PSMC6|FKBP2|MAP2K3|PLK1|GAPDH|HMGCS1|CTSC|ADIPOR2|SERPINH1|RAB1B|ARPC5L|TMEM97|GMPS|LDHA|SSR1|MCM2|IGFBP5|DDX39A|LDLR|EBP|DDIT4|DHCR7|SLC2A3|CFP|PSMD12|PSMA3|HSPA5|PNP|LGMN|SHMT2|PGK1|HSPA4|TFRC|PSMD13|FADS1|FADS2|DHCR24|STIP1|SERP1|SQSTM1|ALDOA|RPN1|ATP5G1|INSIG1|TM7SF2
HALLMARK_CHOLESTEROL_HOMEOSTASIS%MSIGDB_C2%HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.000129165590286748,0.00518555396908895,-0.392276805294101,-2.27779550042881,0,70,SEMA3B|HMGCR|CXCL16|GPX8|PLAUR|HMGCS1|LGALS3|PDK3|TMEM97|ERRFI1|LDLR|STX5|EBP|PPARG|DHCR7|TNFRSF12A|ATF5|LGMN|S100A11|FADS2|FASN|NSDHL|ALDOC|TM7SF2
HALLMARK_ANGIOGENESIS%MSIGDB_C2%HALLMARK_ANGIOGENESIS,0.00195363375879135,0.0387011108604588,-0.430295856562924,-1.98304992038899,14,31,POSTN|VTN|OLR1|SPP1|VCAN|SLCO2A1|COL5A2|JAG2|LUM|THBD|TNFRSF21|COL3A1|PDGFA|TIMP1|S100A4
HALLMARK_P53_PATHWAY%MSIGDB_C2%HALLMARK_P53_PATHWAY,0.0011541420877148,0.0260318042492992,-0.23951915857599299,-1.7307699590923402,8,185,IKBKAP|ATF3|PIDD1|RALGDS|GM2A|RAD9A|TGFB1|CCND2|DCXR|INHBB|RPL18|TSPYL2|GNB2L1|CGRRF1|TRIAP1|RHBDF2|DRAM1|SAT1|ZFP36L1|KLF4|RGS16|TAX1BP3|CTSF|RAD51C|RAP2B|PLK2|CDKN2A|IER3|CCNK|HEXIM1|TOB1|PCNA|CASP1|ADA|NOTCH1|CEBPA|SOCS1|PERP|S100A10|CDKN2B|HMOX1|IRAK1|HRAS|VAMP8|TRAFD1|IFI30|PTPRE|NUPR1|RCHY1|HBEGF|PPM1D|JAG2|CYFIP2|TM4SF1|EPHA2|F2R|FUCA1|VWA5A|BMP2|SEC61A1|NINJ1|HIST3H2A|SLC3A2|DDIT4|CCND3|CTSD|STOM|HINT1|PDGFA|OSGIN1|HIST1H1C|CD82|RRP8|S100A4|H2AFJ|CD81|SPHK1|ITGB4|AK1
HALLMARK_MYC_TARGETS_V2%MSIGDB_C2%HALLMARK_MYC_TARGETS_V2,0.247506799637353,0.6284111611211011,-0.20858240523837498,-1.15261561032605,1910,58,CDK4|PA2G4|SRM|AIMP2|FARSA|LAS1L|NDUFAF4|SLC29A2|GNL3|PPAN|MCM4|SLC19A1|DCTPP1|NOC4L|NPM1|IPO4|MCM5|PLK1|PRMT3|NOP56|TMEM97|TCOF1|WDR74|MYC|PHB
HALLMARK_KRAS_SIGNALING_DN%MSIGDB_C2%HALLMARK_KRAS_SIGNALING_DN,0.6031827515400411,0.84813292140046,-0.14234392715756,-0.9194697010846942,4699,107,GTF3C5|SGK1|TENM2|CALCB|IFI44L|EFHD1|RSAD2|ITIH3|KLHDC8A|THNSL2|KCNN1|ADRA2C|ITGB1BP2|SEPP1|HTR1B|GPRC5C|MAGIX|SNCB|SPTBN2|RIBC2|SYNPO|DLK2|COPZ2|PTPRJ
HALLMARK_KRAS_SIGNALING_UP%MSIGDB_C2%HALLMARK_KRAS_SIGNALING_UP,0.000128040973111396,0.00518555396908895,-0.27833899800655,-1.9819174614601698,0,171,JUP|LAPTM5|ITGB2|CROT|GLRX|KLF4|RGS16|TOR1AIP2|ERO1L|CTSS|ANGPTL4|PDCD1LG2|CPE|LAT2|NGF|SDCCAG8|PLAU|GYPC|HSD11B1|TNFAIP3|CXCR4|TSPAN7|FLT4|GPNMB|INHBA|MPZL2|CA2|FCER1G|AMMECR1|MALL|SPP1|ADGRL4|G0S2|SEMA3B|MAFB|GNG11|CFB|HBEGF|GPRC5B|CSF2RA|IL33|PLVAP|FBXO4|ALDH1A2|PLAUR|FUCA1|VWA5A|PRRX1|GADD45G|BMP2|FGF9|F13A1|GFPT2|MMP9|PEG3|ADGRA2|SCN1B|C3AR1|PLAT|EMP1|TMEM158|ADAMDEC1|CMKLR1|PECAM1|SPARCL1|ENG|TFPI|RBM4|LY96|PTCD2|DNMBP|TNFRSF1B|CFH
HALLMARK_UV_RESPONSE_UP%MSIGDB_C2%HALLMARK_UV_RESPONSE_UP,0.00012807377049180301,0.00518555396908895,-0.321743385475242,-2.22203443196317,0,146,CXCL2|PPP1R2|PPT1|MAOA|LYN|HYAL2|NR4A1|OLFM1|EIF2S3|CEBPG|JUNB|YKT6|CDO1|DGAT1|BCL2L11|H2AFX|AQP3|HSPA13|PPIF|CTSV|TST|TMBIM6|CDKN1C|HNRNPU|SOD2|TUBA4A|ATP6V1F|NAT1|IL6ST|GGH|MGAT1|CA2|PARP2|ICAM1|CDKN2B|MMP14|POLR2H|APOM|CNP|HMOX1|SLC6A8|NXF1|NFKBIA|BMP2|EIF5|CREG1|CYB5R1|MRPL23|SLC25A4|GPX3|DNAJA1|FKBP4|PDLIM3|CCND3|SIGMAR1|PRKACA|KCNH2|POLE3|MARK2|RFC4|NPTX2|TFRC|PLCL1|STIP1|SQSTM1|PSMC3|ALDOA|FEN1|RPN1|CLTB|NPTXR
HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY%MSIGDB_C2%HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY,0.0153127433168959,0.16672869301190898,-0.323036569864858,-1.68237562830122,117,47,PRDX2|MSRA|SBNO2|GPX4|LSP1|JUNB|GLRX|SOD2|FES|SOD1|NDUFA6|SCAF4|PPP2R4|FTL|CAT|NDUFB4|GPX3|PDLIM1|PRDX4|ATOX1|PRNP|ABCC1
HALLMARK_HYPOXIA%MSIGDB_C2%HALLMARK_HYPOXIA,0.000128106584678452,0.00518555396908895,-0.30558430691945,-2.20050002686045,0,181,ERO1L|BHLHE40|ANGPTL4|RORA|CDKN1C|SLC2A1|GAA|GPI|IER3|TES|PFKFB3|TGFB3|HK1|P4HA1|KLHL24|TNFAIP3|SRPX|DCN|SIAH2|CXCR4|EFNA1|NDST1|PPP1R3C|GCNT2|SELENBP1|SDC4|F3|BGN|CTGF|ENO1|STC2|PIM1|JMJD6|HMOX1|KLF6|LOX|TPST2|SDC2|GAPDH|PLAUR|EFNA3|TIPARP|MT2A|PDK3|PLIN2|TGM2|LDHA|ERRFI1|LXN|CCRN4L|SERPINE1|CAV1|PRKCDBP|KDELR3|DDIT4|MYH9|B3GALT6|SLC2A3|PTRF|TGFBI|ANXA2|PYGM|HSPA5|MT1E|COL5A1|PRDX5|PGK1|S100A4|CASP6|PDGFB|ALDOA|GALK1|ALDOC|RRAGD
HALLMARK_FATTY_ACID_METABOLISM%MSIGDB_C2%HALLMARK_FATTY_ACID_METABOLISM,0.0698356059640627,0.37596389138254704,-0.19625328544380502,-1.33791753863905,547,137,LTC4S|IDI1|NBN|GPD1|ACSL5|BLVRA|ODC1|CRAT|SETD8|FH|ACSL4|CBR1|PDHA1|NCAPH2|SDHD|HCCS|CA2|IDH3G|S100A10|INMT|SDHA|ALAD|G0S2|ALDH1A1|ACOX1|SMS|IL4I1|HMGCS1|CD36|ADIPOR2|H2AFZ|LDHA|HSD17B10|ACOT2|PPARA|MGLL|APEX1|HSP90AA1|LGALS1|UBE2L6|AOC3|HADH|FASN|DHCR24|NSDHL|ALDOA
HALLMARK_ALLOGRAFT_REJECTION%MSIGDB_C2%HALLMARK_ALLOGRAFT_REJECTION,0.00012833675564681698,0.00518555396908895,-0.32733987881661103,-2.31554822128398,0,166,IL2RB|IFNAR2|DEGS1|MAP4K1|CD7|CCR5|LY75|GBP2|CD8B|HLA-DOA|FAS|SIT1|IFNGR2|IL27RA|ST8SIA4|ETS1|LIF|UBE2N|CD40|IL2RG|HLA-DMA|IL1B|TGFB2|LCP2|AKT1|IRF8|CD1D|RIPK2|HLA-DMB|CAPG|TNF|PRF1|CCL4|GZMA|TGFB1|CCND2|HLA-E|CCL11|LYN|INHBB|HLA-DRA|EIF3J|RPL39|TLR1|CD74|B2M|IL18|CCL19|ACHE|TAPBP|IFNGR1|ITGB2|GZMB|DYRK3|CD4|TLR2|FGR|HCLS1|CTSS|CDKN2A|WAS|NPM1|HLA-A|FCGR2B|C2|LY86|THY1|TRAF2|WARS|INHBA|SOCS1|PTPN6|CD47|IL2RA|ICAM1|BRCA1|IGSF6|SRGN|FLNA|IRF7|GALNT1|AARS|NCF4|ICOSLG|IL15|CSF1|CCL2|BCL3|SPI1|F2R|CCR1|CD86|NLRP3|MMP9|IL11|APBB1|STAB1|CCND3|CFP|MRPL3|TIMP1|NCK1|NME1|PRKCB
HALLMARK_PANCREAS_BETA_CELLS%MSIGDB_C2%HALLMARK_PANCREAS_BETA_CELLS,0.0610915722287352,0.35631208031004796,-0.347563886670197,-1.4983966163131002,468,25,LMO2|INS|PCSK1|SST|DPP4|MAFB|SRPRB|CHGA|SRP9|ELP4
HALLMARK_ESTROGEN_RESPONSE_LATE%MSIGDB_C2%HALLMARK_ESTROGEN_RESPONSE_LATE,0.00166453265044814,0.0342526537521637,-0.23851819308416397,-1.6983727581656,12,171,LLGL2|ID2|BAG1|CD44|DNAJC12|TFPI2|DCXR|MDK|NXT1|OLFM1|TSTA3|CDC20|COX6C|RNASEH2A|HR|BATF|LAMC2|KLF4|PPIF|GINS2|CDC6|AFF1|TPSAB1|TST|CPE|DNAJC1|TOB1|IL6ST|TOP2A|SLC9A3R1|CLIC3|GLA|CHPT1|SIAH2|SGK1|KIF20A|LSR|CA2|SERPINA1|PTPN6|SLC26A2|CISH|PERP|SCUBE2|SEMA3B|CKB|HPRT1|MOCS2|GPER1|SLC24A3|PLA2G16|NBL1|ITPK1|IMPA2|CAV1|PRSS23|FKBP4|DHCR7|PDLIM3|MAPK13|S100A9|TIAM1|MYOF|IGFBP4|CCND1|FKBP5|ALDH3B1|KRT19|XRCC3|SNX10|BLVRB|PTGES|ETFB|EMP2
HALLMARK_MYOGENESIS%MSIGDB_C2%HALLMARK_MYOGENESIS,0.000256805341551104,0.00819882332206558,-0.27131113323122097,-1.9105813286109798,1,162,HSPB2|MEF2D|ACHE|EPHB3|MYH11|SH2B1|NAV2|ATP2A1|FDPS|BHLHE40|CRAT|GAA|TNNI2|AEBP1|TNNC2|ITGB5|LAMA2|MYOM1|ADAM12|CACNA1H|CNN3|FABP3|MYLK|PPP1R3C|NOTCH1|MEF2C|SOD3|STC2|CAMK2B|PDE4DIP|SPARC|FXYD1|IGF1|COL4A2|HDAC5|SLC6A8|CKB|GADD45B|HBEGF|LDB3|COL6A3|GSN|APLNR|TAGLN|CD36|WWTR1|COL1A1|COX7A1|COL3A1|SYNGR2|CRYAB|GPX3|EFS|MYH9|ATP6AP1|KCNH2|EIF4A2|CFD|PYGM|IGFBP7|COL6A2|SPHK1|ITGB4|ADCY9|AK1|PTGIS|PRNP|PTP4A3
HALLMARK_MYC_TARGETS_V1%MSIGDB_C2%HALLMARK_MYC_TARGETS_V1,0.00012750223128904799,0.00518555396908895,-0.300741823497489,-2.20930647079743,0,200,SNRPA|CBX3|PSMD7|NOP16|SF3B3|PSMA2|COX5A|PHB2|TUFM|NHP2|SNRPD3|RPLP0|NAP1L1|CSTF2|CDK4|PTGES3|PA2G4|CCT7|HNRNPA1|SRM|UBE2L3|AIMP2|IARS|CYC1|RPS2|GLO1|EXOSC7|TYMS|VDAC1|GNL3|CCT3|RPL18|EIF3J|MRPS18B|PSMD1|ACP1|SRSF3|CDC20|GNB2L1|TXNL4A|HDGF|SET|SF3A1|DEK|MCM4|AP3S1|RANBP1|MCM6|NCBP2|ETF1|TRIM28|PPIA|ODC1|PSMD3|SNRPB2|FAM120A|PSMB2|HNRNPU|IMPDH2|KPNB1|NPM1|CANX|PCNA|MRPL9|MAD2L1|SRSF1|U2AF1|HNRNPA2B1|ILF2|NCBP1|SNRPD1|MCM5|CDC45|CCT5|POLD2|SNRPA1|TOMM70A|RAD23B|EIF1AX|RAN|HNRNPR|EIF3B|CTPS1|HPRT1|EIF4G2|PSMC4|PSMC6|KPNA2|NOP56|PSMB3|H2AFZ|MRPL23|VBP1|LDHA|MCM2|TRA2B|SRSF2|NDUFAB1|EIF2S1|MYC|APEX1|PRDX4|POLE3|ERH|PHB|PGK1|PSMA6|RFC4|G3BP1|RRM1|PSMA1|CNBP|NME1|HNRNPC
HALLMARK_INTERFERON_ALPHA_RESPONSE%MSIGDB_C2%HALLMARK_INTERFERON_ALPHA_RESPONSE,0.00012659830358273202,0.00518555396908895,-0.37300769349188,-2.36087959893348,0,97,CD74|TRIM21|B2M|IFIT3|LPAR6|OASL|OAS1|PARP9|EPSTI1|HLA-C|HERC6|CASP1|PLSCR1|WARS|DDX60|IFIT2|IFI44L|PSME2|CD47|IFIH1|ISG15|CNP|RSAD2|IRF7|IFI44|TRAFD1|IFI30|IL15|TMEM140|BATF2|LGALS3BP|CCRL2|CSF1|IFI27|BST2|CMPK2|IFI35|USP18|DHX58|IFITM1|C1S|PSMA3|UBE2L6|IFITM2|IFITM3|LY6E
HALLMARK_UV_RESPONSE_DN%MSIGDB_C2%HALLMARK_UV_RESPONSE_DN,0.00625718299067807,0.0925225067041246,-0.234417163160328,-1.60708548689728,48,141,RGS4|F3|SNAI2|LTBP1|NOTCH2|DBP|PIK3R3|COL5A2|SDC2|DLC1|SYNJ2|TGFBR2|TGFBR3|FHL2|COL1A2|COL1A1|ARHGEF9|INPP4B|PDGFRB|COL3A1|ID1|MAP1B|IGFBP5|SERPINE1|CAV1|MYC|LDLR|PPARG|SPOP|NFKB1|MGLL|DAB2|ANXA2|EFEMP1|MT1E|TFPI|INSIG1|ABCC1
HALLMARK_OXIDATIVE_PHOSPHORYLATION%MSIGDB_C2%HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.000127632418634333,0.00518555396908895,-0.250109668372074,-1.8351038086430902,0,199,ETFDH|PDK4|DLST|ATP5C1|COX7C|CYC1|COX11|NDUFC2|TIMM17A|VDAC1|ATP6V1D|NDUFV2|NDUFB8|SDHC|POR|GPX4|MRPS15|NDUFS4|COX6C|UQCRC1|MRPS11|NDUFB5|TCIRG1|ISCA1|SURF1|SLC25A20|ATP6V0B|ATP1B1|UQCR10|OXA1L|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|FH|PMPCA|OPA1|SDHB|ATP6V1F|PDHA1|NDUFB6|ATP5B|SLC25A6|SDHD|HCCS|ABCB7|CYCS|HSPA9|IDH3G|MRPS30|TOMM70A|SDHA|NDUFS7|ATP5O|NDUFB1|MRPS22|NDUFB7|NDUFA6|NDUFS6|ATP6V0E1|NDUFB4|FXN|COX7B|LDHA|TIMM9|COX17|SLC25A4|NDUFA2|NDUFAB1|HSD17B10|NDUFA1|ATP6AP1|PDHX|NDUFA4|CYB5A|ATP5H|NDUFV1|UQCRQ|MPC1|NDUFS3|TIMM10|ATP6V1G1|UQCRC2|COX6A1|MRPL11|COX8A|NDUFA8|NDUFS8|ATP5G1|ETFB|SLC25A5
HALLMARK_COAGULATION%MSIGDB_C2%HALLMARK_COAGULATION,0.000127599846880184,0.00518555396908895,-0.400398411499308,-2.54284030802436,0,99,LRP1|CTSV|APOC1|GP1BA|PLAU|PLEK|MMP1|C2|C3|CTSB|OLR1|VWF|S100A13|SERPINA1|HTRA1|F3|FBN1|MMP14|F8|TIMP3|COMP|RAPGEF3|SPARC|DPP4|C1QA|CFB|CTSH|THBD|GSN|FN1|USP11|A2M|THBS1|MMP9|SERPINE1|PRSS23|LAMP2|PLAT|ANG|C1S|CFD|CFI|TIMP1|PECAM1|ANXA1|LGMN|CPQ|SERPING1|C1R|PDGFB|CFH
HALLMARK_ANDROGEN_RESPONSE%MSIGDB_C2%HALLMARK_ANDROGEN_RESPONSE,0.022296258329062,0.206844249860175,-0.247038821327192,-1.53831472120942,173,92,CDK6|ANKH|H1F0|B2M|IDI1|SAT1|MERTK|ELL2|MAF|IQGAP2|ARID5B|SGK1|SLC26A2|CAMKK2|SRP19|HMGCR|MYL12A|NCOA4|SMS|STEAP4|HMGCS1|SRF|PPAP2A|INPP4B|SEPP1|B4GALT1|CCND3|CCND1|ACTN1|FKBP5|FADS1|KRT19|DHCR24|HSD17B14|INSIG1
HALLMARK_HEDGEHOG_SIGNALING%MSIGDB_C2%HALLMARK_HEDGEHOG_SIGNALING,0.508252625835493,0.798966294578331,0.20234730713484197,0.9635874646924971,3725,33,UNC5C|TLE3|SLIT1|CDK5R1|NF1|SCG2|CRMP1|NRCAM|VLDLR|NRP1|NKX6-1
HALLMARK_INTERFERON_GAMMA_RESPONSE%MSIGDB_C2%HALLMARK_INTERFERON_GAMMA_RESPONSE,0.00012779552715655,0.00518555396908895,-0.346382103131068,-2.52962034133577,0,194,ST8SIA4|NMI|ISG20|PTPN1|TRIM25|HLA-DRB1|PSME1|CD40|HLA-DMA|CD69|LCP2|IRF8|OAS3|RIPK2|APOL6|HLA-B|TRIM14|PSMB9|SP110|NUP93|MTHFD2|MX1|PARP14|CD274|IL10RA|GZMA|XAF1|CD38|PML|LAP3|EIF4E3|CD74|TRIM21|B2M|IFIT3|OASL|TAPBP|SOCS3|P2RY14|TOR1B|FGL2|EPSTI1|FCGR1A|PSMB2|TNFAIP6|SOD2|HERC6|IRF5|HLA-A|OAS2|IL15RA|PDE4B|CASP1|ARID5B|FPR1|TNFAIP3|PLSCR1|WARS|CSF2RB|TNFSF10|DDX60|IFIT2|PLA2G4A|CASP4|SOCS1|STAT3|IL18BP|IFI44L|PTPN6|PSME2|VAMP5|ICAM1|IFIH1|IFIT1|ISG15|PIM1|RSAD2|IRF7|VAMP8|IFI44|TRAFD1|IFI30|VCAM1|IL15|BATF2|LGALS3BP|CFB|ISOC1|CCL2|CD86|IFI27|NFKBIA|MVP|BST2|MT2A|LATS2|CMPK2|IFI35|USP18|DHX58|NFKB1|C1S|PSMA3|CMKLR1|PNP|UBE2L6|IFITM2|IFITM3|SERPING1|SAMHD1|C1R|ST3GAL5|CFH|LY6E
HALLMARK_APOPTOSIS%MSIGDB_C2%HALLMARK_APOPTOSIS,0.000257698750161062,0.00819882332206558,-0.267079710130072,-1.8575273659778402,1,152,PPP2R5B|SMAD7|BIRC3|SPTAN1|CLU|IGF2R|WEE1|CYLD|SC5D|BIK|BTG2|FAS|ENO2|APP|ISG20|RARA|MCL1|IL1B|TGFB2|CD69|CDKN1B|ROCK1|DDIT3|CREBBP|TNF|PRF1|ATF3|CD44|CD38|CCND2|PPT1|DNAJC3|PSEN1|GPX4|ANKH|BNIP3L|H1F0|IL18|MADD|FEZ1|HMGB2|TSPO|SAT1|BCL2L11|IFNGR1|ETF1|HGF|SOD2|IER3|BCL2L2|GPX1|CASP1|TOP2A|DCN|TNFSF10|CASP4|KRT18|BRCA1|BGN|TIMP3|HMOX1|HSPB1|SOD1|LMNA|GADD45B|LUM|GSN|F2R|GNA15|LGALS3|BMP2|TGFBR3|XIAP|PEA15|PDGFRB|NEDD9|IGFBP6|BCAP31|GPX3|CAV1|EBP|DNAJA1|PLAT|RELA|TNFRSF12A|EMP1|TIMP1|ANXA1|CD14|CCND1|IFITM3|CASP6|SQSTM1
HALLMARK_TNFA_SIGNALING_VIA_NFKB%MSIGDB_C2%HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.000128057369701626,0.00518555396908895,-0.35623051112666204,-2.58017937063771,0,187,BTG2|MSC|TNFAIP2|ZC3H12A|CLCF1|FUT4|KLF2|CYR61|PTGS2|IFNGR2|ZFP36|PPP1R15A|FOSL2|DUSP2|FOSL1|TRIP10|LIF|MCL1|IL1B|CD69|RIPK2|TNF|CCL4|DUSP1|ATF3|CXCL1|ID2|PPAP2B|CD44|ACKR3|STAT5A|CXCL2|DENND5A|GPR183|NFIL3|NR4A1|JUNB|JAG1|BCL2A1|IL18|DRAM1|NFKB2|SAT1|SOCS3|CD83|CCNL1|DUSP5|SERPINB8|KLF4|TLR2|BHLHE40|TNFAIP6|SOD2|PLK2|GEM|IER3|PFKFB3|PLAU|PLEK|ETS2|IL15RA|PDE4B|IL6ST|HES1|KYNU|TNFAIP3|EFNA1|SGK1|TGIF1|CEBPD|OLR1|IFIT2|INHBA|PTGER4|ICAM1|IFIH1|SDC4|F3|EHD1|SLC2A6|KLF6|G0S2|CEBPB|ICOSLG|TNIP1|PTPRE|GADD45B|CCRL2|HBEGF|CSF1|CCL2|BCL3|MAP2K3|PLAUR|NFKBIA|TIPARP|TNC|BMP2|PHLDA2|RELB|NINJ1|GFPT2|B4GALT1|SERPINE1|MYC|LDLR|RELA|SIK1|NFKB1|BCL6|SLC2A3|CCND1|SPHK1|SQSTM1|LITAF|SPSB1|RCAN1
HALLMARK_APICAL_JUNCTION%MSIGDB_C2%HALLMARK_APICAL_JUNCTION,0.000128106584678452,0.00518555396908895,-0.310772534911651,-2.21563038656873,0,172,PARVA|ADRA1B|FSCN1|RAC2|ZYX|COL9A1|SYK|PTEN|ACTN4|SHROOM2|NLGN3|MAP4K2|ITGB1|CD274|ITGA9|ACTG1|CNN2|MDK|CDH6|ADAM9|CLDN7|MYL12B|NEGR1|CD209|SDC3|LAYN|ITGA10|JUP|CTNND1|LAMC2|AMIGO1|STX4|CLDN5|CLDN11|CD34|CRAT|ATP1A3|THY1|TAOK2|PVRL2|RHOF|SKAP2|CALB2|VWF|MPZL2|IRS1|PCDH1|MADCAM1|ICAM1|RSU1|CDH8|FBN1|MSN|PIK3CB|VCAN|HRAS|PIK3R3|VCAM1|EPB41L2|GNAI2|CDH11|CD86|ACTG2|CD99|VCL|TNFRSF11B|SLIT2|MMP9|CX3CL1|B4GALT1|MYH9|MAPK13|KCNH2|TGFBI|CERCAM|EVL|ACTB|FLNC|NF2|PECAM1|RRAS|COL16A1|NRXN2|ACTN1|MYL9|HADH|ITGB4|ICAM2|TSPAN4|CADM3|SIRPA|INSIG1
HALLMARK_NOTCH_SIGNALING%MSIGDB_C2%HALLMARK_NOTCH_SIGNALING,0.5067364290385871,0.798255683563973,-0.211256140731391,-0.9645541795247758,3873,30,HES1|NOTCH1|ARRB1|NOTCH2|SKP1|NOTCH3|DTX1|CCND1
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION%MSIGDB_C2%HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.000128057369701626,0.00518555396908895,-0.436380802407566,-3.16784384513593,0,189,ITGB5|MMP1|LAMA2|VEGFC|ADAM12|POSTN|THY1|FZD8|FOXC2|PPIB|TNFAIP3|ITGA5|DCN|MYLK|MXRA5|INHBA|MGP|COL5A3|ELN|LOXL1|IL32|RGS4|HTRA1|SDC4|BGN|CTGF|FBN1|SNAI2|MMP14|NOTCH2|TIMP3|SPP1|COL4A1|COMP|FLNA|VCAN|SPARC|LOX|FAP|COL4A2|SLC6A8|VCAM1|IL15|GADD45B|EDIL3|CDH11|COL5A2|COL12A1|LUM|COL6A3|FN1|ABI3BP|FMOD|PLAUR|MFAP5|FUCA1|GAS1|PRRX1|TAGLN|ECM1|TNC|SERPINE2|TGFBR3|THBS1|ANPEP|SERPINH1|GLIPR1|COL1A2|COL1A1|CTHRC1|THBS2|TGM2|PDGFRB|TNFRSF11B|COL3A1|SLIT2|CD59|EMP3|SERPINE1|TNFRSF12A|VIM|TGFBI|DAB2|ACTA2|TIMP1|FBLN2|COL16A1|LGALS1|COL5A1|IGFBP4|COL6A2|MYL9|EFEMP2|NNMT|FBLN1|LOXL2
HALLMARK_INFLAMMATORY_RESPONSE%MSIGDB_C2%HALLMARK_INFLAMMATORY_RESPONSE,0.00012863390789812198,0.00518555396908895,-0.40325468010286,-2.8185077242515497,0,156,TLR1|ADM|RGS1|IL18|KCNA3|TAPBP|IFNAR1|RGS16|MSR1|TLR2|P2RX4|CCL24|SLC7A2|TNFAIP6|GPR132|AHR|GP1BA|EBI3|IL15RA|PDE4B|RNF144B|FPR1|ITGA5|MARCO|TNFSF10|SLC1A2|OLR1|INHBA|PTGER4|CALCRL|ICAM1|F3|MMP14|CSF3R|OSM|RHOG|CYBB|KLF6|IRF7|ICOSLG|IL15|PTPRE|CCRL2|HBEGF|CSF1|CCL2|PDPN|SCARF1|APLNR|PLAUR|NLRP3|NFKBIA|AXL|GNA15|BST2|BEST1|EMP3|CX3CL1|SERPINE1|LTA|SCN1B|MYC|STAB1|LDLR|PTAFR|C3AR1|RELA|IL1R1|IFITM1|NFKB1|PTGIR|CMKLR1|TIMP1|OSMR|CD55|CD82|CD14|TNFRSF1B|SPHK1|C5AR1|LY6E
HALLMARK_HEME_METABOLISM%MSIGDB_C2%HALLMARK_HEME_METABOLISM,0.00437017994858612,0.0731795249024618,-0.22743973927508604,-1.61733143032101,33,170,SYNJ1|FAM46C|SLC22A4|USP15|DCAF11|HTATIP2|ACP5|DCUN1D1|BNIP3L|UBAC1|H1F0|ATP6V0A1|SEC14L1|HDGF|TFDP2|NR3C1|GAPVD1|TNS1|AQP3|ISCA1|BLVRA|ELL2|GDE1|TOP1|SLC2A1|BCAM|SMOX|VEZF1|E2F2|LMO2|GYPC|C3|CTSB|DCAF10|NFE2L1|CA2|TAL1|SELENBP1|ADIPOR1|SLC10A3|MOSPD1|ALAD|CDC27|GLRX5|SLC6A8|FTCD|CAST|NCOA4|MAP2K3|CAT|LRP10|KAT2B|NARF|HEBP1|NUDT4|GMPS|RHCE|LAMP2|CLIC2|CCND3|XK|TFRC|RAP1GAP|LPIN2|ATG4A|TMEM9B|BLVRB|ACKR1|MPP1
HALLMARK_ESTROGEN_RESPONSE_EARLY%MSIGDB_C2%HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0043634496919917895,0.0731407797055425,-0.227253976058076,-1.6211734204659,33,173,KLF4|PPIF|NAV2|AFF1|BHLHE40|SLC7A2|SLC2A1|CBFA2T3|ELOVL2|TOB1|IL6ST|HES1|AKAP1|SLC9A3R1|CLIC3|GLA|CHPT1|SIAH2|CALB2|CELSR1|MAST4|SLC26A2|CISH|KRT18|STC2|TTC39A|RHOD|UGCG|SEMA3B|LRIG1|TMEM164|SLC24A3|PLA2G16|DLC1|TIPARP|FHL2|NBL1|TGM2|ITPK1|CANT1|B4GALT1|PRSS23|MYC|FKBP4|DHCR7|PDLIM3|DHRS3|TIAM1|MYOF|IGFBP4|CCND1|FKBP5|ALDH3B1|KRT19|FASN|BLVRB|PTGES|ADCY9
HALLMARK_MITOTIC_SPINDLE%MSIGDB_C2%HALLMARK_MITOTIC_SPINDLE,0.18934081346423604,0.563467720122429,-0.157466893518238,-1.15678166322323,1484,200,CCNB2|ARHGEF2|CEP72|FGD6|AURKA|ROCK1|FSCN1|TUBGCP5|ITSN1|CDC42|PCGF5|RACGAP1|ACTN4|SHROOM2|CSNK1D|DOCK2|CEP192|PCNT|KIF11|ARHGAP4|NEK2|KIF15|ANLN|MAP1S|DOCK4|APC|NUSAP1|DLGAP5|TBCD|DYNC1H1|CTTN|RABGAP1|UXT|WASF2|MID1|CLIP1|BCL2L11|ECT2|PPP4R2|ESPL1|TUBGCP2|TPX2|TUBA4A|BCAR1|TOP2A|CDK5RAP2|SHROOM1|TAOK2|RHOF|KNTC1|DYNLL2|LMNB1|INCENP|KIF4A|NDC80|PXN|NOTCH2|ABL1|CEP131|CDC27|FLNA|CKAP5|EPB41L2|SMC4|SAC3D1|GSN|PLK1|CDC42EP4|ARFIP2|SUN2|MAP3K11|VCL|NEDD9|MYO1E|MYH9|SMC1A|TIAM1|SEPT9|CDC42EP1|BIRC5|KIF22|SYNPO|NCK1|ARHGDIA|ARF6|NET1|CDC42EP2|RAPGEF5
HALLMARK_PI3K_AKT_MTOR_SIGNALING%MSIGDB_C2%HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0816771380946275,0.397722753303477,-0.20903751931262501,-1.3296079834444399,636,100,GSK3B|SFN|UBE2N|IL2RG|GNA14|CDKN1B|CDK4|AKT1|DDIT3|RAF1|PTEN|RAC1|DUSP3|SLA|PRKAR2A|PAK4|VAV3|PLCB1|RPS6KA1|HSP90B1|ITPR2|SLC2A1|NGF|ATF1|TRAF2|CXCR4|GRB2|MAPK9|CLTC|CALR|HRAS|PIK3R3|E2F1|ARF1|RPTOR|MAP2K3|CFL1|ADRBK1|TIAM1|TNFRSF1A|NCK1|MAPKAP1|ARHGDIA|PPP1CA|AP2M1|SQSTM1|PRKCB|PLA2G12A
HALLMARK_COMPLEMENT%MSIGDB_C2%HALLMARK_COMPLEMENT,0.000128008192524322,0.00518555396908895,-0.36745833238604203,-2.6272793673068904,0,175,CXCL1|NOTCH4|MMP12|CP|GZMA|DOCK4|DOCK10|USP15|TFPI2|LAP3|LYN|ADAM9|PSEN1|USP16|F10|ZFPM2|DGKG|GZMB|DUSP5|SPOCK2|STX4|KLK1|LRP1|CTSV|KCNIP3|APOC1|CTSS|CALM3|CASP10|BRPF3|GATA3|WAS|PRCP|GP1BA|PLEK|C2|CASP1|KYNU|C3|TNFAIP3|CTSB|PLSCR1|CPM|OLR1|CA2|GRB2|S100A13|PLA2G4A|CASP4|SERPINA1|SH2B3|FCER1G|APOBEC3G|F3|EHD1|MMP14|PLA2G7|F8|PIM1|RHOG|GNGT2|IRF7|DPP4|CEBPB|FCN1|COL4A2|C1QA|CFB|GNAI2|C1QC|CTSH|CDA|HSPA1A|KIF2A|FN1|PLAUR|LGALS3|CD36|CTSC|PPP4C|CD59|SERPINE1|LAMP2|PLAT|ANG|CTSD|C1S|ITGAM|S100A9|ATOX1|CTSL|HSPA5|TIMP1|LGMN|CD55|CPQ|SERPING1|C1R|PDGFB|CFH|APOBEC3F
HALLMARK_E2F_TARGETS%MSIGDB_C2%HALLMARK_E2F_TARGETS,0.00012750223128904799,0.00518555396908895,-0.339614300375586,-2.49487105807013,0,200,STAG1|TUBG1|CCNB2|RAD21|NAP1L1|POLE4|CDKN1B|CDK4|AURKA|PNN|PA2G4|POP7|NUP205|TACC3|PRIM2|RACGAP1|TRIP13|TIMELESS|CTCF|MTHFD2|ANP32E|POLE|ING3|RFC2|RPA2|PSIP1|CIT|MKI67|RRM2|DLGAP5|LBR|UBE2T|PSMC3IP|CDC20|RNASEH2A|RFC3|DEK|DONSON|HMGB2|MCM4|EZH2|H2AFX|NBN|RANBP1|MCM6|TCF19|ESPL1|ATAD2|PPP1R8|DCTPP1|RAD51C|CENPM|CDKN2A|TMPO|LUC7L3|HN1|RAD51AP1|RAD1|PTTG1|PCNA|ASF1B|TOP2A|MAD2L1|ORC6|MELK|POLD1|IPO7|MCM3|SRSF1|BRMS1L|KIF18B|UBE2S|CKS2|LMNB1|MCM5|MXD3|POLD2|BRCA1|KIF4A|GINS1|RBBP7|DNMT1|RAN|CTPS1|SMC4|PPM1D|SPC25|KPNA2|PRPS1|MYBL2|UBR7|PLK1|NOP56|H2AFZ|SPC24|SNRPB|MCM2|TRA2B|TK1|SRSF2|DDX39A|EIF2S1|MYC|HMGB3|SMC1A|CDKN2C|PRDX4|BIRC5|KIF22|CDKN3|SSRP1|TFRC|POLA2|NME1|SUV39H1
HALLMARK_DNA_REPAIR%MSIGDB_C2%HALLMARK_DNA_REPAIR,0.000127844541038098,0.00518555396908895,-0.322331115029072,-2.23544058599533,0,149,TYMS|NT5C|POLR2C|RFC2|RAD51|RPA2|GPX4|GMPR2|DCTN4|RFC3|TSG101|NCBP2|SURF1|GTF2A2|POLR2J|BRF2|HCLS1|NUDT9|BCAM|POLD4|IMPDH2|ZNRD1|TAF12|PCNA|PDE4B|ADA|GTF3C5|NFX1|POLD1|DAD1|NPR2|SMAD5|CLP1|RFC5|POLR2H|GTF2H1|HPRT1|CSTF3|TMED2|CDA|SAC3D1|NELFB|USP11|UMPS|STX3|SEC61A1|CMPK2|COX17|BCAP31|CANT1|ERCC8|TAF10|DDB1|POLR2G|ARL6IP1|SUPT4H1|CETN2|POLA1|PNP|ALYREF|SSRP1|RFC4|PDE6G|AK6|EDF1|POLA2|NME1|FEN1|AK1
FANCONI ANEMIA PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FANCONI ANEMIA PATHWAY,0.0353959436765276,0.26787698165153,-0.29954582242954303,-1.5517416117818001,273,46,BLM|FAAP24|ATRIP|FANCD2|FANCG|RAD9A|RFC2|FBXW11|RPA2|UBE2T|BRIP1|PALB2|RFC3|H2AFX|NBN|RAD1|RAD17|HES1|BRCA1|RFC5|TOPBP1|FAAP100|RMI1|FANCM|RFC4|XRCC3
IL8-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL8-MEDIATED SIGNALING EVENTS,0.9645371231239208,0.990916952887267,0.517479047198941,0.689988484513834,7261,1,CXCL8
FOXA2 AND FOXA3 TRANSCRIPTION FACTOR NETWORKS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FOXA2 AND FOXA3 TRANSCRIPTION FACTOR NETWORKS,0.656903765690377,0.875783550442628,-0.201395858586388,-0.8559267212437021,5023,24,INS|CEBPD|CEBPA|CEBPB|HMGCS1|TFRC|HADH
IL5-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL5-MEDIATED SIGNALING EVENTS,0.23019607843137302,0.6129063110774859,-0.36401638042954704,-1.21839690873408,1760,12,STAT5A|LYN|CSF2RB|GRB2|CISH|PIM1
SYNDECAN-4-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SYNDECAN-4-MEDIATED SIGNALING EVENTS,0.0242146596858639,0.218419923233982,-0.367861534683759,-1.6429107567877599,184,28,ADAM12|ITGA5|CXCR4|SDC4|FN1|GIPC1|TNC|THBS1|MMP9|TFPI|ACTN1
BCR SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BCR SIGNALING PATHWAY,0.9182146542827659,0.976131586905157,-0.11960224474190598,-0.683955559031087,7117,66,CSK|BTK|CALM1|CHUK|PPP3CA|MAP4K1|MALT1|MAP3K1|TRAF6|MAPK14|DAPP1|ETS1|PLCG2|AKT1|RAF1|SH3BP5|SYK|PTEN|RAC1|LYN|BCL2A1|CALM3|FCGR2B|ELK1|GRB2|PTPN6|MAPK3|HRAS|NFATC1|NFKBIA|RELA|POU2F2|NFKB1
AURORA B SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AURORA B SIGNALING,0.0201194184839045,0.195205495598712,-0.336331474906824,-1.64599180434255,154,38,EVI5|RHOA|KIF2C|CDCA8|DES|NCAPG|AURKA|RACGAP1|NCAPH|SMC2|NSUN2|NPM1|MYLK|KIF20A|INCENP|NDC80|SGOL1|SMC4|TACC1|VIM|PSMA3|BIRC5
N-CADHERIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%N-CADHERIN SIGNALING EVENTS,0.98632759092152,0.995342833054128,0.10689943173880902,0.5181430669181201,7213,35,CNR1|DCTN1|CALM2|KIF5B|CAMK2G|PLCG1|FGFR1|CTNNA1|MAPK8|PIP5K1C|FER|AXIN1
REGULATION OF TELOMERASE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF TELOMERASE,0.3542525773195879,0.712220724869897,-0.189806526141422,-1.06893193532867,2748,62,PARP2|MAPK3|RBBP7|ABL1|E2F1|DKC1|MAX|NR2F2|MYC|RPS6KB1|NFKB1|HSP90AA1|CCND1|HNRNPC
TRK RECEPTOR SIGNALING MEDIATED BY PI3K AND PLC-GAMMA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TRK RECEPTOR SIGNALING MEDIATED BY PI3K AND PLC-GAMMA,0.238446814328685,0.622072730324094,0.24338508662064,1.17969097845044,1743,35,CAMK4|GAB1|SHC1|FOXO3|SOS1|YWHAQ|TRPV1|YWHAB|YWHAE|PLCG1|NRAS|YWHAH|SRC|KRAS|YWHAZ|AGAP2|PDPK1
MTOR SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%MTOR SIGNALING PATHWAY,0.9422068965517241,0.982117850817794,0.11422777976202,0.6628702325553649,6830,66,PLD2|TSC2|PRR5|BTRC|YWHAQ|PDCD4|SREBF1|CCNE1|YWHAB|ULK2|EIF4A1|YWHAE|PRKCA|NRAS|YWHAH|AKT1S1|MAP2K1|MAPK1|KRAS|IKBKB|YWHAZ
ROLE OF CALCINEURIN-DEPENDENT NFAT SIGNALING IN LYMPHOCYTES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ROLE OF CALCINEURIN-DEPENDENT NFAT SIGNALING IN LYMPHOCYTES,0.0975042027673607,0.430598623028127,-0.253554839612897,-1.3596254782108301,753,52,CALM3|KPNB1|RCAN2|MAPK9|AKAP5|MAPK3|PIM1|NFATC1|RAN|KPNA2|NUP214|FKBP1A|PRKACA|CSNK1A1|PRKCB|BAD|RCAN1
IL6-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL6-MEDIATED SIGNALING EVENTS,0.241010943199583,0.6244696312630601,-0.230454014779865,-1.1688547868968,1849,43,JUNB|HSP90B1|LMO4|SOCS3|VAV1|IL6ST|CEBPD|GRB2|STAT3|CEBPB|PTPRE|MITF|HCK|A2M|MYC|TIMP1
SIGNALING EVENTS MEDIATED BY THE HEDGEHOG FAMILY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY THE HEDGEHOG FAMILY,0.5230245944531661,0.807051143864932,-0.255242461879901,-0.948579820098985,3997,16,TGFB2|AKT1|LRPAP1|PTHLH|SMO|BOC|GAS1|ADRBK1
SYNDECAN-3-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SYNDECAN-3-MEDIATED SIGNALING EVENTS,0.203190376569038,0.581783510781437,-0.32000181104149295,-1.2417260387029199,1553,18,PSEN1|CTTN|NCAN|SDC3|FGFR4|CASK|POMC|FGF19|PTN
ATYPICAL NF-KAPPAB PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ATYPICAL NF-KAPPAB PATHWAY,0.267960146827478,0.6418798906350429,-0.33079399665269704,-1.1703007869226498,2043,14,BCL3|NFKBIA|RELA|NFKB1
ARF1 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ARF1 PATHWAY,0.0946247864371139,0.424507034898303,-0.3579389718567821,-1.4141834850446902,719,19,CD4|CLTA|GGA3|ARF1|KDELR1|ARFIP2|GOSR2|AP2M1|CLTB
EGFR-DEPENDENT ENDOTHELIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EGFR-DEPENDENT ENDOTHELIN SIGNALING EVENTS,0.9782608695652171,0.992937328049893,-0.17979742168271698,-0.517611612498214,7514,8,EDNRA|GRB2|HRAS
ATR SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ATR SIGNALING PATHWAY,0.0694660445826853,0.37596389138254704,-0.29250243007126503,-1.4444494727436101,535,39,FANCD2|TIMELESS|RAD9A|RFC2|RAD51|CLSPN|FBXW11|RPA2|RFC3|NBN|CDC6|RAD1|RAD17|CDC25C|RFC5|TOPBP1|PLK1|PPP2CA|MCM2|PPP2R2B|RFC4
S1P3 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P3 PATHWAY,0.17259346098736497,0.546371269738967,-0.294132857029305,-1.2680479607405901,1324,25,GNA14|AKT1|RAC1|GNA12|GNA13|FLT1|CXCR4|MAPK3|GNAI2|GNAQ|GNA15|PDGFRB|PDGFB
SHP2 SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SHP2 SIGNALING,0.48267422388252007,0.786923392569247,-0.185206312537447,-0.9830550981351779,3746,50,LMO4|IFNGR1|KDR|NGF|IL6ST|GRB2|IRS1|IL2RA|HRAS|NTRK2|SDC2|NOS3|TEK|PDGFRB|PRKACA|PDGFB
IL2 SIGNALING EVENTS MEDIATED BY PI3K%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL2 SIGNALING EVENTS MEDIATED BY PI3K,0.180671175858481,0.554399730107893,-0.261651885564221,-1.24910858746338,1388,35,GRB2|IL2RA|UGCG|E2F1|MYC|RELA|RPS6KB1|NFKB1|HSP90AA1|SMPD1
EPHA FORWARD SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHA FORWARD SIGNALING,0.270773638968481,0.645964021169263,-0.25043127424158396,-1.1541308401491999,2078,31,RHOA|FYN|EPHA3|EPHA5|ROCK1|LYN|VAV3|PIK3R6|FGR|EPHA8|EFNA1|NGEF|ARHGEF15|EPHA2|HCK|EFNA3|EPHA4|EFNA5
P38 MAPK SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P38 MAPK SIGNALING PATHWAY,0.854651954774554,0.949296218452153,0.15557893247284602,0.7120269321745841,6273,29,MAP3K5|MAP2K6|CALM2|MAPK11|ATM
REELIN SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REELIN SIGNALING PATHWAY,0.9721501706484641,0.9915747942934481,0.12675763279559898,0.5522723835781489,7120,25,NCK2|CDK5R1|VLDLR|CBL|MAP2K7|LRP8|CDK5|MAPK8
IL3-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL3-MEDIATED SIGNALING EVENTS,0.0329497907949791,0.259512489684881,-0.37950157787318795,-1.6128710070593402,251,24,CSF2RB|GRB2|CISH|OSM|PIM1|CEBPB|IL3RA|ID1|PRKACA|SRP9
VEGFR1 SPECIFIC SIGNALS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VEGFR1 SPECIFIC SIGNALS,0.0458164730452944,0.307317379547639,-0.338429510395907,-1.5302158692716399,350,29,NOS3|VEGFB|NRP2|CAV1|PRKACA|HSP90AA1|NCK1|PRKCB
ARF6 TRAFFICKING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ARF6 TRAFFICKING EVENTS,0.42451542451542496,0.754564869291744,0.199031905404848,1.02523941336644,3109,43,EXOC4|PLD2|BIN1|ITGA6|AGTR1|ASAP2
CALCIUM SIGNALING IN THE CD4+ TCR PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CALCIUM SIGNALING IN THE CD4+ TCR PATHWAY,0.0494815592597454,0.318857627587799,-0.377330724578848,-1.5372480888433502,376,21,JUN|CABIN1|CALM1|NFATC3|PTGS2|FOSL1|POU2F1|NFATC2|JUNB|CALM3|RCAN2|AKAP5|IL2RA|NFATC1|FKBP1A|PRKACA|RCAN1
INTEGRIN FAMILY CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INTEGRIN FAMILY CELL SURFACE INTERACTIONS,0.533342050209205,0.812079525085925,-0.22147655100041502,-0.9412690978887941,4078,24,ITGB1|ITGA9|ITGAX|ITGA10|ITGA11|ITGB2|ITGB5|ITGA5|ITGA8|ITGAM|ITGB4
RAPID GLUCOCORTICOID SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RAPID GLUCOCORTICOID SIGNALING,0.947677595628415,0.9840421757603729,0.201726343543641,0.585576284079409,6936,8,MAPK11|CRH|MAPK8|GNB1
VEGFR3 SIGNALING IN LYMPHATIC ENDOTHELIUM%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VEGFR3 SIGNALING IN LYMPHATIC ENDOTHELIUM,0.4560375146541621,0.7711961414599979,-0.23104425718969798,-0.9960641668163951,3500,25,VEGFC|ITGA5|FLT4|GRB2|MAPK3|FN1|COL1A2|COL1A1
GLYPICAN 3 NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLYPICAN 3 NETWORK,0.651288117770768,0.872581710088317,-0.30651861914107104,-0.837854976419418,4954,7,MAPK9|FGF7
GMCSF-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GMCSF-MEDIATED SIGNALING EVENTS,0.144157025867672,0.510452107204301,-0.27493476403218203,-1.30258145841217,1108,34,CSF2RB|GRB2|STAT3|CISH|OSM|MAPK3|PIM1|HRAS|CCL2|CSF2RA|PRKACA
PROTEOGLYCAN SYNDECAN-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PROTEOGLYCAN SYNDECAN-MEDIATED SIGNALING EVENTS,0.5004580552283729,0.79532538649238,-0.437544321865791,-0.9578759837604979,3823,4,SDC3|SDC4|SDC2
RAC1 SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RAC1 SIGNALING PATHWAY,0.798789127914466,0.931350348412063,-0.146204623354125,-0.7760383455080458,6200,50,STAT3|MAPK9|CYBB|CYFIP2|MAP2K3|NOXA1|NCF2|MAP3K11|CFL1|ARHGDIA
EPHA2 FORWARD SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHA2 FORWARD SIGNALING,0.737153371008017,0.9082631287383801,-0.20061708568029699,-0.7926193895991601,5608,19,RAC1|ACP1|VAV3|BCAR1|EFNA1|GRB2|EPHA2|TIAM1
NETRIN-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NETRIN-MEDIATED SIGNALING EVENTS,0.5314129301355579,0.812079525085925,-0.203699651811395,-0.947530481290158,4076,32,BCAR1|MYO10|ELMO1|MAPK3|NTN1|DOCK1|CAMK2A|MAP1B|NCK1
ALPHA9 BETA1 INTEGRIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHA9 BETA1 INTEGRIN SIGNALING EVENTS,0.000131250820317627,0.00518555396908895,-0.572295266745159,-2.3315350374397,0,21,RAC1|ITGB1|ITGA9|ADAM8|SAT1|VEGFC|ADAM12|BCAR1|PXN|SPP1|VCAM1|CSF2RA|FN1|TNC|F13A1|TGM2
CANONICAL NF-KAPPAB PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CANONICAL NF-KAPPAB PATHWAY,0.548188832221786,0.818920733395725,-0.22454556610759102,-0.9299016141457599,4191,22,RAN|NFKBIA|RELA|NFKB1|TNFRSF1A
VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL REPRESSION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL REPRESSION,0.0783577256832017,0.392286062587516,-0.25126914677946,-1.3885003418209199,604,58,CEBPD|CEBPA|BRCA1|CDKN2B|SLC11A1|TJP2|PPP2R4|SPI1|MAX|COL1A2|PDGFRB|MYC|NFYB|LGALS1|CCND1|ITGB4|FTH1|GTF2H2
NONGENOTROPIC ANDROGEN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NONGENOTROPIC ANDROGEN SIGNALING,0.9429578384022971,0.9824677421692641,-0.134322249946086,-0.607340767131453,7223,29,PELP1|PLCG1|GNAO1|SRC|MAP2K1|MAPK1|GNB1|CREB1|PIK3CA|GNRH1|GNAI1|PTK2|FOS|PLCB2|PIK3R1|GNG2|GNAZ|MAP2K2|PLCG2|AKT1|RAF1|CDC42|RAC1|PLCB1|PLCB3|MAPK3|HRAS|GNAI2
FAS (CD95) SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FAS (CD95) SIGNALING PATHWAY,0.467642632371049,0.780769690730001,0.206264965513522,0.989609618341894,3417,34,MAP2K6|RFC1|MAPK11|RIPK1|CASP8|BID|MAP2K7|EZR|SRC|CFLAR|IKBKB|MAPK8|BIRC2|PDPK1|CASP3
ALPHA-SYNUCLEIN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHA-SYNUCLEIN SIGNALING,0.866230366492147,0.955293407436668,-0.15679463348267902,-0.700262369580823,6617,28,SYK|UBE2L3|LYN|GRK5|FGR|TOR1A|PARK7|PLD1|HCK|FKBP1A|BAD
DNA-PK PATHWAY IN NONHOMOLOGOUS END JOINING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%DNA-PK PATHWAY IN NONHOMOLOGOUS END JOINING,0.273258977149075,0.647416583771936,0.340532367911612,1.1574032843241102,2008,12,NHEJ1|POLL|XRCC5|PNKP|LIG4|DCLRE1C|XRCC4|APLF|PRKDC|XRCC6|POLM
SIGNALING EVENTS MEDIATED BY VEGFR1 AND VEGFR2%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY VEGFR1 AND VEGFR2,0.0212600466683951,0.201150083379966,-0.276110143306745,-1.59008740691522,163,68,HGS|KDR|CALM3|FES|VTN|AKAP1|MAPKAPK2|GRB2|PTPN6|PXN|CAMKK2|MAPK3|ARF1|CDH5|MAP2K3|NOS3|VCL|CAV1|PRKACA|HSP90AA1|MYOF|NCK1|PRKCB|PTPRJ|GRB10
SIGNALING EVENTS MEDIATED BY HDAC CLASS III%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY HDAC CLASS III,0.6718444067354129,0.8815795277668309,-0.18757813392936104,-0.848138322604568,5146,29,SIRT2|SIRT3|HIST1H4J|HIST4H4|FOXO4|CREBBP|HIST1H4H|ACSS1|MEF2D|TUBA1B|HIST1H4I|KAT2B|FHL2|HIST2H4A|HIST2H4B
ALPHA4 BETA1 INTEGRIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHA4 BETA1 INTEGRIN SIGNALING EVENTS,0.009515119916579771,0.12396436004013,-0.37894986671617104,-1.7627253969332901,72,32,TLN1|BCAR1|PRKAR1A|PXN|SPP1|VCAM1|DOCK1|FN1|THBS1|THBS2|PRKACA|CD14|CD81|ARF6
P75(NTR)-MEDIATED SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P75(NTR)-MEDIATED SIGNALING,0.20517774343122103,0.5851419434522471,-0.21428308091479603,-1.1971857039278602,1592,60,CYCS|MAPK9|IRAK1|E2F1|BEX1|XIAP|MAGED1|ARHGDIA|CASP6|NGFRAP1|MAGEH1|NGFR|SQSTM1|BAD
WNT SIGNALING NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%WNT SIGNALING NETWORK,0.162349555206698,0.5334664650353429,-0.347541076126315,-1.29159720933904,1240,16,FZD4|FZD2|FZD8|ATP6AP2|LRP5|CTHRC1|WNT3|IGFBP4
TRK RECEPTOR SIGNALING MEDIATED BY THE MAPK PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TRK RECEPTOR SIGNALING MEDIATED BY THE MAPK PATHWAY,0.694303219919176,0.889621324957948,-0.177814400128976,-0.8350666194207909,5325,33,ELK1|MAPKAPK2|MEF2C|MAPK3|HRAS|MAP2K3|RAP1A|SRF|EHD4
ARF6 DOWNSTREAM PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ARF6 DOWNSTREAM PATHWAY,0.0434497243370964,0.297958958487227,-0.433801226445179,-1.5750619345743302,330,15,KALRN|MAPK3|ARF1|PLD1|PLAUR|TIAM1|ARF6|NME1
SIGNALING EVENTS REGULATED BY RET TYROSINE KINASE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS REGULATED BY RET TYROSINE KINASE,0.527554980595084,0.810052447666581,-0.19813666877288397,-0.954083508585847,4077,36,BCAR1|GRB2|IRS1|PXN|MAPK3|HRAS|RAP1A|PRKACA|NCK1|GRB10
EFFECTS OF BOTULINUM TOXIN%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EFFECTS OF BOTULINUM TOXIN,0.220081967213115,0.60254214895295,0.42390644823211404,1.2305262584574699,1610,8,RIMS1|SNAP25|STX1A|VAMP2|UNC13B|SYT1
NECTIN ADHESION PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NECTIN ADHESION PATHWAY,0.883183917413746,0.9629606199413431,0.150703368172081,0.6827601102282611,6501,28,FARP2|CRK|PTPRM|VAV2|MLLT4|ITGAV|PVRL1|SRC|CTNNA1|PIP5K1C|PVRL3
STABILIZATION AND EXPANSION OF THE E-CADHERIN ADHERENS JUNCTION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%STABILIZATION AND EXPANSION OF THE E-CADHERIN ADHERENS JUNCTION,0.36530556316799107,0.7197032395461701,0.214781487355484,1.0642736468179899,2665,38,EXOC4|AQP5|MET|MYO6|KIFC3|GIT1|NCKAP1|CAMSAP3|MLLT4|IGF1R
IGF1 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IGF1 PATHWAY,0.29891659052343,0.671417015551137,-0.249685839149966,-1.1289595666545802,2289,29,BCAR1|GRB2|IRS1|PRKD1|PXN|HRAS|RPS6KB1|GRB10|BAD
SIGNALING EVENTS MEDIATED BY HEPATOCYTE GROWTH FACTOR RECEPTOR (C-MET)%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY HEPATOCYTE GROWTH FACTOR RECEPTOR (C-MET),0.617931212160247,0.854944793214197,-0.15220685867505898,-0.905303672890702,4796,77,PTPN11|RHOA|MAP3K1|MAP2K2|DEPTOR|ETS1|PTPN1|RAP1B|SH3KBP1|AKT1|RAF1|CDC42|PAK2|MLST8|RAC1|APC|PAK4|EIF4EBP1|HGS|NUMB|RAPGEF1|HGF|KPNB1|SH3GL2|BCAR1|GRB2|PXN|MAPK3|HRAS|RPTOR|RAP1A|MUC20|SNAI1|NCK1|ARF6|PTPRJ|BAD
ATM PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ATM PATHWAY,0.9313661770440659,0.9793746057014829,-0.132455222395264,-0.6275442007826121,7164,34,BLM|UBE2N|FANCD2|UIMC1|RAD9A|TERF2|H2AFX|NBN|TRIM28|RAD17|CDC25C|BRCA1|ABL1|SMC1A|KAT5
TCR SIGNALING IN NAIVE CD8+ T CELLS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TCR SIGNALING IN NAIVE CD8+ T CELLS,0.965606080123664,0.990916952887267,-0.11251174876983501,-0.597200207233363,7495,50,PRKCE|SHC1|SOS1|PAG1|CBL|PRKCA|PLCG1|NRAS|BCL10|CD8A|KRAS|IKBKB|PDPK1|ZAP70|RASGRP2|CD247|CD3E|IKBKG|LCK|CARD11|PTPRC|CD3D|CD3G|LAT|MAP3K8|CSK|MAP3K14|CHUK|RASGRP1|ORAI1|PRKCQ|CD8B|MALT1|FYN|TRAF6|RASSF5|GRAP2|LCP2|AKT1|PRF1|B2M|VAV1|HLA-A|STIM1|GRB2|PTPN6|HRAS|RAP1A|CD86|PRKCB
LPA RECEPTOR MEDIATED EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%LPA RECEPTOR MEDIATED EVENTS,0.271907216494845,0.646576786621306,-0.20127687172783104,-1.13352939125299,2109,62,BCAR1|ADCY8|PRKD1|PXN|PIK3CB|ADCY4|HRAS|GNAI2|HBEGF|GNAQ|NFKBIA|GNA15|MMP9|RELA|NFKB1|TIAM1|ADCY9
RXR AND RAR HETERODIMERIZATION WITH OTHER NUCLEAR RECEPTOR%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RXR AND RAR HETERODIMERIZATION WITH OTHER NUCLEAR RECEPTOR,0.7372062663185379,0.9082631287383801,-0.19022350439781502,-0.798668888104739,5646,23,RARA|TNF|TGFB1|NR4A1|RXRG|MED1|THRA|NR1H3|PPARG|PPARA|RPS6KB1
NOTCH SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NOTCH SIGNALING PATHWAY,0.47419354838709704,0.7842140358337042,-0.18086156173600398,-0.9865693543907329,3674,55,JAG1|KDM1A|YY1|DNM1|NUMB|GATA3|ADAM12|NOTCH1|ENO1|NOTCH2|SKP1|NOTCH3|JAG2|MFAP5|MAML1|MYC|MARK2|DTX1|CCND1
DIRECT P53 EFFECTORS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%DIRECT P53 EFFECTORS,0.179001280409731,0.551831758165591,-0.176127539119154,-1.18492314835823,1397,129,ATF3|PIDD1|PRMT1|PRDM1|PML|APC|RGCC|BCL2L2-PABPN1|BNIP3L|PYCARD|TRIAP1|BCL2A1|SMARCA4|COL18A1|DUSP5|TNFRSF10A|TNFRSF10B|HGF|CASP10|IRF5|CCNK|E2F2|BCL2L2|GPX1|PCNA|CASP1|RNF144B|PPP1R13B|HSPA1B|DDX5|PERP|SNAI2|SPP1|VCAN|TNFRSF10C|E2F1|RCHY1|HIC1|HSPA1A|EPHA2|CCNB1|CX3CL1|SERPINE1|CAV1|NFYB|DDIT4|BCL6|CTSD|TAF9|CD82|ZNF385A|CASP6|AK6
BETA5 BETA6 BETA7 AND BETA8 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BETA5 BETA6 BETA7 AND BETA8 INTEGRIN CELL SURFACE INTERACTIONS,0.0278649921507064,0.23617479560495197,-0.443211404887042,-1.6471451952668799,212,16,ITGB5|PLAU|VTN|MADCAM1|FBN1|VCAM1|EDIL3|FN1|PLAUR
POSTTRANSLATIONAL REGULATION OF ADHERENS JUNCTION STABILITY AND DISSASSEMBLY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%POSTTRANSLATIONAL REGULATION OF ADHERENS JUNCTION STABILITY AND DISSASSEMBLY,0.41471615155825703,0.748894797291058,-0.20616540603840103,-1.02633799114463,3206,40,PTPN1|ZBTB33|ROBO1|CREBBP|CDC42|SNX1|RAC1|IQGAP1|GNA12|GNA13|JUP|CTNND1|HGS|RAB7A|PTPN6|ABL1|HRAS|NTRK2|TIAM1|ARF6|NME1
VALIDATED NUCLEAR ESTROGEN RECEPTOR ALPHA NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED NUCLEAR ESTROGEN RECEPTOR ALPHA NETWORK,0.0438709677419355,0.299062021084573,-0.274367422009886,-1.4966280717693201,339,55,SET|LMO4|PRDM15|COL18A1|ATP5J|MED1|PCNA|C3|SRA1|DSCAM|BRCA1|SOD1|CEBPB|NEDD8|AP1B1|MYC|APBB1|CTSD|CD82|CCND1|NDUFV3
ERBB1 DOWNSTREAM SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ERBB1 DOWNSTREAM SIGNALING,0.8109007164790172,0.935269673284207,-0.125927475510946,-0.803619018502274,6337,101,GRB2|SLC9A1|MEF2C|STAT3|MAPK9|CHN2|PIK3CB|MAPK3|HRAS|PLD1|CYFIP2|PPP2CA|SRF|RIN1|RPS6KA4|EPS8|MAPKAP1|BAD
INTERNALIZATION OF ERBB1%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INTERNALIZATION OF ERBB1,0.7655561674008811,0.919785404348335,0.161591889630618,0.7935488325925459,5560,37,CHMP3|ARHGEF7|SPRY2|SHC1|SOS1|CBL|NRAS|EPS15|EGFR|SRC|STAMBP|AMPH|KRAS
VISUAL SIGNAL TRANSDUCTION: RODS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VISUAL SIGNAL TRANSDUCTION: RODS,0.33274408485178103,0.6971202277372819,0.347117018987318,1.09969017956,2446,10,PDE6B|GNGT1|GNB5
CDC42 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CDC42 SIGNALING EVENTS,0.8979118329466359,0.9674268340009909,-0.124634413525893,-0.7077639133295229,6965,64,MAPK9|MAPK3|HRAS|PLD1|MAP2K3|MAP3K11|CFL1|RPS6KB1|TIAM1|EPS8|ARHGDIA
REGULATION OF CYTOPLASMIC AND NUCLEAR SMAD2 3 SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF CYTOPLASMIC AND NUCLEAR SMAD2 3 SIGNALING,0.883164673413064,0.9629606199413431,-0.16985526585134397,-0.671082309279691,6719,19,CALM3|KPNB1|MAPK3|KPNA2|NUP214
OSTEOPONTIN-MEDIATED EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%OSTEOPONTIN-MEDIATED EVENTS,0.105626465225319,0.44738616127788,-0.29749799324687,-1.3710412564426397,810,31,MAP3K14|CHUK|ITGB3|RHOA|MAP3K1|CDC42|SYK|RAC1|CD44|VAV3|PLAU|BCAR1|ILK|MAPK3|SPP1|GSN|NFKBIA|MMP9|RELA|NFKB1
INTEGRINS IN ANGIOGENESIS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INTEGRINS IN ANGIOGENESIS,0.000129032258064516,0.00518555396908895,-0.423894760986223,-2.3122745190391805,0,55,COL11A2|KDR|TLN1|BCAR1|VTN|ILK|IRS1|PXN|MAPK3|SPP1|COL4A1|EDIL3|COL5A2|CSF1|COL6A3|FN1|TGFBR2|COL1A2|COL1A1|VCL|MFGE8|COL3A1|ADGRA2|COL6A1|RPS6KB1|HSP90AA1|CSF1R|COL5A1|COL6A2
NOTCH-MEDIATED HES HEY NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NOTCH-MEDIATED HES HEY NETWORK,0.53564022809746,0.8132910857498922,-0.19168114558387198,-0.94656898955013,4132,39,KDM1A|YY1|CD4|KDR|PARP1|GAA|HES1|NOTCH1|STAT3|E2F1|GATA6|MAML1|RCAN1
ENDOTHELINS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ENDOTHELINS,0.126908150064683,0.48326646889427793,-0.23704064452523102,-1.30523101363277,980,57,GNA14|AKT1|RAF1|CDC42|RAC1|PRKCH|GNA12|PLCB1|EDNRA|GNAL|PLCB3|MMP1|BCAR1|ADCY8|SLC9A1|PLA2G4A|MAPK3|ADCY4|HRAS|CYSLTR2|GNAI2|GNAQ|EDNRB|GNA15|COL1A2|COL3A1|PRKCB|ADCY9
CXCR4-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CXCR4-MEDIATED SIGNALING EVENTS,0.10268199233716499,0.441229839424518,-0.218299495039629,-1.31739205769482,803,81,HLA-DRB1|RAP1B|AKT1|CXCL12|CDC42|MLST8|RAC1|SSH1|STAT5A|LYN|HLA-DRA|GNA13|RGS1|GNB2L1|PLCB1|PIK3R6|CD4|HGS|DNM1|PLCB3|FGR|VAV1|BCAR1|CXCR4|STAT3|UBQLN1|PTPN6|PXN|PIK3CB|GNAI2|HCK|GRK6|MMP9|CFL1|ADRBK1|MAPKAP1|BAD
PDGFR-ALPHA SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PDGFR-ALPHA SIGNALING PATHWAY,0.519564075630252,0.804986496071906,-0.236888274181308,-0.9503912187915391,3956,20,RAPGEF1|ELK1|GRB2|SRF|CAV1|PDGFRA
SIGNALING BY AURORA KINASES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING BY AURORA KINASES,0.343187315237839,0.701955655133333,0.56660687795611,1.11444886492898,2553,3,AURKC|AURKB
REGULATION OF P38-ALPHA AND P38-BETA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF P38-ALPHA AND P38-BETA,0.754383580263695,0.9157330845669609,0.17148063371729097,0.793903283522544,5549,30,RALB|DUSP10|MAP2K6|MAPK11|RIPK1|PAK1|DUSP16|SRC|MAP2K4|BLK|CCM2
PAR4-MEDIATED THROMBIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PAR4-MEDIATED THROMBIN SIGNALING EVENTS,0.298823529411765,0.671387424531401,-0.34060725239966305,-1.1400443653839298,2285,12,RHOA|GNA14|ROCK1|GNA13|GNAQ|GNA15|F2RL3
BETA2 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BETA2 INTEGRIN CELL SURFACE INTERACTIONS,0.00104616189355303,0.0240545523142212,-0.5030794758769039,-2.0833830067140298,7,22,ITGAX|F10|SPON2|ITGB2|GP1BA|PLAU|THY1|C3|ICAM1|VCAM1|FCGR2A|PLAUR|PLAT|TGFBI|ITGAM|ICAM2
REGULATION OF NUCLEAR BETA CATENIN SIGNALING AND TARGET GENE TRANSCRIPTION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF NUCLEAR BETA CATENIN SIGNALING AND TARGET GENE TRANSCRIPTION,0.411520928305015,0.746051818625066,0.176832402182585,1.02975622526726,2978,67,DKK1|TLE2|CBY1|HBP1|TCF7L1|CAMK4|HDAC1|SALL4|AES|BTRC|MMP2|TBL1XR1|YWHAQ|BCL9|YWHAB|XPO1|YWHAE
PDGFR-BETA SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PDGFR-BETA SIGNALING PATHWAY,0.204280404972446,0.5838950270536221,-0.17503366716723098,-1.16566336720699,1593,123,GRB2|PLA2G4A|S1PR1|STAT3|MAPK9|PIK3CB|MAPK3|ABL1|HRAS|CYFIP2|RAP1A|PPP2CA|HCK|TAGLN|SRF|PDGFRB|MYC|EPS8|ACTA2|PPP2R2B|NCK1|ARHGDIA|SPHK1|PDGFB|PTPRJ|GRB10
S1P4 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P4 PATHWAY,0.996329313057158,0.9988721305072571,-0.12486895105666801,-0.44176808878805696,7599,14,GNAI3|PLCG1|GNAO1|MAPK1|GNAI1|S1PR4|S1PR5|GNAZ|RHOA|CDC42|GNA12|GNA13|MAPK3|GNAI2
GLYPICAN PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLYPICAN PATHWAY,0.114754098360656,0.463748809895271,0.6970883423403549,1.37109050754695,853,3,GPC1|GPC2|GPC3
JNK SIGNALING IN THE CD4+ TCR PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%JNK SIGNALING IN THE CD4+ TCR PATHWAY,0.40154693235448397,0.740287621109606,-0.29475029400386304,-1.04278343775557,3062,14,DBNL|PRKCB
PLK1 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PLK1 SIGNALING EVENTS,0.10980493476295099,0.45483419590443,-0.25838856044291103,-1.33853404462675,849,46,PRC1|FZR1|KIZ|WEE1|RHOA|CENPE|GOLGA2|TUBG1|AURKA|CENPU|CLSPN|FBXW11|CDC20|ECT2|STAG2|TPX2|NUDC|CDC25C|KIF20A|ERCC6L|INCENP|NDC80|SGOL1|KIF2A|CCNB1|PLK1|PPP2CA|SPC24
REGULATION OF CDC42 ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF CDC42 ACTIVITY,0.373449941260932,0.7245436360382259,-0.23467263909299102,-1.06107707925312,2860,29,ITSN1|CDC42|RACGAP1|DOCK11|DOCK10|APC|VAV3|FGD1|DOCK6|NGEF|ARHGAP1|ARHGEF9|ARHGDIA|DNMBP|NME1
FC-EPSILON RECEPTOR I SIGNALING IN MAST CELLS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FC-EPSILON RECEPTOR I SIGNALING IN MAST CELLS,0.323670247185195,0.69236669641359,-0.199335633916381,-1.09153224803111,2500,56,PTPN11|CBLB|MAP3K1|FYN|MAP2K2|LCP2|AKT1|RAF1|PAK2|SYK|NFATC2|DUSP1|LYN|HCLS1|LAT2|VAV1|FCGR2B|GRB2|PLA2G4A|S1PR1|FCER1G|PXN|MAPK3|HRAS|PPAP2A|RELA|NFKB1|SPHK1|PRKCB
BETA1 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BETA1 INTEGRIN CELL SURFACE INTERACTIONS,0.00012951690195570501,0.00518555396908895,-0.457492809073791,-2.52808166032862,0,58,LAMB2|LAMC1|ITGA10|ITGA11|LAMC2|COL18A1|COL11A2|PLAU|LAMA2|VTN|ITGA5|FBN1|SPP1|COL4A1|LAMA4|VCAM1|COL5A2|COL6A3|FN1|PLAUR|TNC|THBS1|F13A1|COL1A2|COL1A1|THBS2|TGM2|ITGA8|COL3A1|NID1|COL6A1|TGFBI|COL5A1|CD14|COL6A2|CD81
NONCANONICAL WNT SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NONCANONICAL WNT SIGNALING PATHWAY,0.6711383172701221,0.8815356925073421,-0.18520449863223198,-0.8535284750403459,5152,31,FZD2|MAPK9|FLNA|CTHRC1|CAMK2A|PPARG|CSNK1A1
CXCR3-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CXCR3-MEDIATED SIGNALING EVENTS,0.8477642801757559,0.9492491301138911,-0.149056261120883,-0.724107281995891,6559,37,ARRB1|PIK3CB|MAPK3|HRAS|GNAI2|MAP2K3|MAPKAP1
NEUROTROPHIC FACTOR-MEDIATED TRK RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NEUROTROPHIC FACTOR-MEDIATED TRK RECEPTOR SIGNALING,0.0196129032258065,0.192628124925339,-0.29680620699239696,-1.6190278641907798,151,55,DNM1|RAPGEF1|NGF|MATK|ELMO1|GRB2|STAT3|MAPK3|RHOG|ABL1|HRAS|NTRK2|FAIM|DOCK1|RAP1A|GIPC1|MAGED1|EHD4|TIAM1|CCND1|NGFR|SQSTM1
AURORA C SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AURORA C SIGNALING,0.480112872883633,0.7857006060206241,0.497930245964567,0.9793700341773909,3572,3,AURKC|AURKB
CELLULAR ROLES OF ANTHRAX TOXIN%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CELLULAR ROLES OF ANTHRAX TOXIN,0.883673745434871,0.9632410253502859,0.16839591863974304,0.671374976378016,6532,19,MAP2K6|CALM2|ANTXR1|MAP2K7|NLRP1|MAP2K1|MAPK1|MAP2K4
SIGNALING EVENTS MEDIATED BY TCPTP%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY TCPTP,0.374480789200415,0.725184325297951,-0.216313044850315,-1.05862675830337,2884,38,CREBBP|JAK3|ITGB1|STAT5A|STAT6|KDR|HGF|KPNB1|INS|GRB2|STAT3|PIK3CB|CSF1|KPNA2|PDGFRB|CSF1R|PDGFB
INSULIN-MEDIATED GLUCOSE TRANSPORT%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INSULIN-MEDIATED GLUCOSE TRANSPORT,0.738620877623331,0.9089185613230608,0.181381480867981,0.80206341092573,5419,26,RHOQ|CALM2|YWHAQ|YWHAB|TBC1D4|YWHAE|YWHAH|YWHAZ|PRKCI|VAMP2|PRKCZ|PPP1CC|GYS1|AKT2|YWHAG|CALM1|INSR|TRIP10|GSK3B|SFN|AKT1|LNPEP|STX4|STXBP4|CALM3|INS
RAS SIGNALING IN THE CD4+ TCR PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RAS SIGNALING IN THE CD4+ TCR PATHWAY,0.543523859465129,0.816444320780226,-0.26240261384152497,-0.928342075662614,4145,14,ELK1|MAPK3|HRAS|PRKCB
COREGULATION OF ANDROGEN RECEPTOR ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%COREGULATION OF ANDROGEN RECEPTOR ACTIVITY,0.629185986604843,0.8604417113264079,-0.16472315226860998,-0.8891044711408751,4884,53,ZNF318|RPS6KA3|UBA3|PRDX1|PIAS1|SVIL|APPL1|AKT1|PA2G4|HNRNPA1|NCOA6|CDK6|TMF1|VAV3|KDM1A|MED1|CDKN2A|TGIF1|BRCA1|NCOA4|GSN|FHL2|SRF|LATS2|FKBP4|CCND3|CCND1
VISUAL SIGNAL TRANSDUCTION: CONES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VISUAL SIGNAL TRANSDUCTION: CONES,0.616193480546793,0.854122579597827,-0.317048478021934,-0.866637876097905,4687,7,GUCA1B|RDH5|GUCA1A|GNGT2
THROMBOXANE A2 RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%THROMBOXANE A2 RECEPTOR SIGNALING,0.0417097107438017,0.293009782616793,-0.28591874506929,-1.50647651658061,322,49,PRKCQ|RHOA|FYN|MAPK14|GNA14|AKT1|ROCK1|SYK|RAC1|PRKCH|GNA12|LYN|GNA13|PIK3R6|DNM1|FGR|SLC9A3R1|TBXA2R|ICAM1|VCAM1|GNAI2|GNAQ|NOS3|GNA15|HCK|TGM2|PRKACA|ADRBK1|PTGIR|PRKCB
ALK2 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALK2 SIGNALING EVENTS,0.491449511400652,0.790696900371285,0.293215631232002,0.964859472916149,3620,11,ACVR1|BMP7|SMAD1|TLX2|BMPR2
A6B1 AND A6B4 INTEGRIN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%A6B1 AND A6B4 INTEGRIN SIGNALING,0.57807126152153,0.8376444275140479,0.18355443613655603,0.922065886941903,4201,40,ITGA6|MET|ERBB3|LAMA5|LAMB1|SHC1|YWHAQ|LAMA1|YWHAB|YWHAE|PRKCA|YWHAH|EGFR|RXRB|YWHAZ|ERBB2
P38 SIGNALING MEDIATED BY MAPKAP KINASES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P38 SIGNALING MEDIATED BY MAPKAP KINASES,0.157794934308547,0.527852130775783,0.315754613041265,1.3015882074370202,1164,21,ETV1|TSC2|TCF3|MAPK11|YWHAQ|MAPKAPK3|YWHAB|YWHAE|YWHAH
POLO-LIKE KINASE SIGNALING EVENTS IN THE CELL CYCLE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%POLO-LIKE KINASE SIGNALING EVENTS IN THE CELL CYCLE,0.39131003795314795,0.7369216590772479,-0.48447290098763796,-1.06061245329377,2989,4,PLK2|PLK1
IL4-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL4-MEDIATED SIGNALING EVENTS,0.0668131300077539,0.3690551432905871,-0.27314907968192303,-1.4319362417572998,516,48,MAPK14|IGHG1|ETS1|IL2RG|AKT1|JAK3|PARP14|MYBL1|STAT5A|STAT6|CCL11|GTF3A|SOCS3|FES|THY1|IL13RA1|DOK2|GRB2|IRS1|SOCS1|PTPN6|CEBPB|SPI1|COL1A2|COL1A1|LTA|RPS6KB1|BCL6
EPHRINB-EPHB PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHRINB-EPHB PATHWAY,0.565766254920592,0.8298339339066451,0.34570179758942604,0.894523719976017,4167,6,EPHB2|EFNB2
TGF-BETA RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TGF-BETA RECEPTOR SIGNALING,0.0296343810134702,0.24453163127258604,-0.293002003703576,-1.5645541401988,230,51,GRB2|SMURF2|CTGF|PPP2CA|TGFBR2|TGFBR3|XIAP|FKBP1A|CAMK2A|CAV1|YAP1|RPS6KB1|DAB2|PPP1CA|OCLN
SIGNALING MEDIATED BY P38-ALPHA AND P38-BETA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING MEDIATED BY P38-ALPHA AND P38-BETA,0.13296832225264,0.494045143021181,-0.28079467816099396,-1.31869107604992,1019,33,USF1|PTGS2|MAPK14|DDIT3|ELK4|RPS6KA5|EIF4EBP1|GDI1|ATF1|MAPKAPK2|SLC9A1|MEF2C|PLA2G4A|HSPB1|CEBPB|MITF|RPS6KA4|KRT19
VALIDATED TRANSCRIPTIONAL TARGETS OF AP1 FAMILY MEMBERS FRA1 AND FRA2%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TRANSCRIPTIONAL TARGETS OF AP1 FAMILY MEMBERS FRA1 AND FRA2,0.00142302716688228,0.0302137857829966,-0.42154283299988204,-2.0298467094385,10,36,CDKN2A|PLAU|MMP1|TXLNG|DCN|MGP|HMOX1|USF2|NFATC1|CCL2|THBD|PLAUR|NOS3|COL1A2|MMP9|CCND1|ITGB4
SYNDECAN-1-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SYNDECAN-1-MEDIATED SIGNALING EVENTS,0.0005232177894048401,0.0139121625154964,-0.4775835242144021,-2.1805528717808498,3,30,COL11A2|FGFR4|HGF|MMP1|CASK|PPIB|MAPK3|COL4A1|COL5A2|COL6A3|FGF19|COL1A2|COL1A1|COL3A1|MMP9|COL6A1|PRKACA|COL5A1|COL6A2
IFN-GAMMA PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IFN-GAMMA PATHWAY,0.43560507903602,0.762423981601725,-0.20098843153747498,-1.01280464691286,3361,42,IFNGR1|RAPGEF1|CALM3|CASP1|SOCS1|STAT3|PTGES2|MAPK3|CAMK2B|CEBPB|RAP1A|MAP3K11|CAMK2A
SYNDECAN-2-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SYNDECAN-2-MEDIATED SIGNALING EVENTS,0.8364281813216821,0.946051571565932,0.156003644889341,0.72773547050383,6125,31,TRAPPC4|EPHB2|MMP2|NF1|LAMA1|ITGA2|BAX|EZR|SRC|MAPK1|MAPK8|SDCBP|CASP3
TRAIL SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TRAIL SIGNALING PATHWAY,0.29438582779731703,0.667304091726165,-0.263136985544922,-1.13442041560974,2259,25,TNFRSF10A|TNFRSF10B|CASP10|TRAF2|TNFSF10|PIK3CB|MAPK3|TNFRSF10C|FADD|SMPD1
VALIDATED NUCLEAR ESTROGEN RECEPTOR BETA NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED NUCLEAR ESTROGEN RECEPTOR BETA NETWORK,0.7635294117647059,0.9191113740914171,-0.226840963344023,-0.7592579437949529,5840,12,SMARCA4|SMARCE1|C3|NEDD8
SUMOYLATION BY RANBP2 REGULATES TRANSCRIPTIONAL REPRESSION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SUMOYLATION BY RANBP2 REGULATES TRANSCRIPTIONAL REPRESSION,0.0610749185667752,0.35631208031004796,0.46557595883289293,1.5320307868801901,449,11,HDAC1|RANBP2|RANGAP1|HDAC4|SUMO1|XPO1
CASPASE CASCADE IN APOPTOSIS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CASPASE CASCADE IN APOPTOSIS,0.154949599379685,0.5230575449096939,-0.24185106842074397,-1.26786189571887,1198,48,MADD|GZMB|PARP1|CASP10|TOP1|ARHGDIB|CASP1|TRAF2|CYCS|CASP4|LMNB1|KRT18|LMNA|GSN|CFL2|XIAP|VIM|TNFRSF1A|CASP6
IL12-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL12-MEDIATED SIGNALING EVENTS,0.00413543551305247,0.0707509788550227,-0.35736839863629105,-1.8734412807173797,31,48,IL2RB|CCR5|CD8B|HLX|MAPK14|HLA-DRB1|IL2RG|IL1B|CCL3|RIPK2|CCL4|GZMA|STAT5A|STAT6|HLA-DRA|B2M|IL18|NFKB2|GZMB|CD4|RAB7A|HLA-A|SOCS1|STAT3|IL2RA|GADD45B|MAP2K3|GADD45G|RELB|RELA|IL1R1|NFKB1
S1P2 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P2 PATHWAY,0.40938807531380794,0.7448505271608159,-0.24251848012666102,-1.03069670346165,3130,24,RHOA|MAPK14|GNA14|RAC1|GNA12|GNA13|ELK1|IRS1|MAPK3|GNAI2|CDH5|GNAQ|GNA15
SPHINGOSINE 1-PHOSPHATE (S1P) PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SPHINGOSINE 1-PHOSPHATE (S1P) PATHWAY,0.134138338364615,0.495641459539577,-0.327177903772478,-1.33292513576089,1021,21,GNA12|GNA13|SGPP1|S1PR1|GNAI2|GNAQ|GNA15|SPHK1|ABCC1
RHOA SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RHOA SIGNALING PATHWAY,0.820638820638821,0.940031154277066,-0.15045606914784398,-0.749004320035894,6345,40,CDKN1B|SCAI|ROCK1|CDC42|PTEN|ITGB1|CIT|TLN1|PKN1|SH3GL2|SLC9A1|MSN|PLD1|MAP2K3|VCL|SRF|CFL1
VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL ACTIVATION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL ACTIVATION,0.000128452151573539,0.00518555396908895,-0.3579065017513379,-2.1439445302753,0,79,TERT|LIN28B|NBN|GPAM|PTMA|ODC1|RUVBL1|SLC2A1|NPM1|TAF12|MYCT1|ENO1|RCC1|PIM1|HUWE1|UBTF|MAX|CCNB1|GAPDH|NME2|LDHA|TK1|MMP9|SNAI1|EIF2S1|MYC|TAF10|KAT5|TAF9|HSP90AA1|BIRC5|NDUFAF2|HSPA4|TFRC|AK6|NME1|EIF4G1
C-MYB TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%C-MYB TRANSCRIPTION FACTOR NETWORK,0.0231869122761819,0.21168602767687303,-0.26929820404368604,-1.57414175447046,179,72,SMARCA2|MCM4|CD4|TRIM28|YEATS4|CD34|CDKN2A|GATA3|MAF|CLTA|ETS2|ADA|HES1|CEBPD|TFEC|CEBPA|ZFHX3|PIM1|CBX4|HRAS|CEBPB|SPI1|CCNB1|ANPEP|H2AFZ|COL1A2|MYC|CSF1R|CCND1|CASP6
CD40 CD40L SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CD40 CD40L SIGNALING,0.0418077624381349,0.293009782616793,-0.33481459248826695,-1.5430175328259,320,31,MAPK10|MAP3K14|BIRC3|CBLB|MAP3K1|TRAF6|MAPK14|CD40|AKT1|JAK3|STAT5A|PIK3R6|TRAF2|TNFAIP3|MAPK9|PIK3CB|NFKBIA|TRAF3|MYC|RELA|NFKB1
REGULATION OF RAS FAMILY ACTIVATION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF RAS FAMILY ACTIVATION,0.115892740353172,0.46559625491895207,-0.294878245307263,-1.34635633774876,885,30,SOS2|PLCE1|RASA4|DAB2IP|CALM3|RASGRF2|GRB2|CAMK2B|HRAS|LGALS3|RIN1|RRAS|LGALS1|PRKCB
ALPHAE BETA7 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHAE BETA7 INTEGRIN CELL SURFACE INTERACTIONS,0.154742765273312,0.522998966467616,0.766313245980601,1.2875051959556298,1154,2,ITGAE|ITGB7
IL2 SIGNALING EVENTS MEDIATED BY STAT5%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL2 SIGNALING EVENTS MEDIATED BY STAT5,0.716447110995174,0.899551221015245,-0.18482149501629397,-0.8151530871391659,5492,27,STAT5B|IL2RB|CCNA2|PTPN11|IL2RG|FOXP3|JAK3|PRF1|STAT5A|CCND2|CDK6|GRB2|IL2RA|LTA|MYC|CCND3
FOXO FAMILY SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FOXO FAMILY SIGNALING,0.909055677561039,0.9715076818387142,-0.130267523613838,-0.6748267607801701,7036,46,SGK1|MAPK9|RAN|CCNB1|CAT|PLK1|KAT2B|BCL6|CSNK1A1
SIGNALING EVENTS MEDIATED BY HDAC CLASS II%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY HDAC CLASS II,0.30859481582537496,0.680783101756233,0.23624547703410897,1.11364884917074,2261,32,CAMK4|HDAC11|HDAC10|RANBP2|RANGAP1|HDAC4|SUMO1|YWHAB|XPO1|YWHAE|GATA2|RFXANK
CIRCADIAN RHYTHM PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CIRCADIAN RHYTHM PATHWAY,0.0867681806248359,0.406842536616055,-0.39595064795948104,-1.43763261962522,660,15,ARNTL|TIMELESS|NPAS2|PER2|BHLHE40|WDR5|NONO|CRY2|NR1D1
P73 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P73 TRANSCRIPTION FACTOR NETWORK,0.4566939358524871,0.7715177634181241,-0.17235200320469402,-0.9959294517933929,3516,69,ABL1|IL1RAP|RCHY1|JAG2|CCNB1|PLK1|PPAP2A|PEA15|SERPINE1|MYC|RELA|YAP1|KAT5|FASN
CANONICAL WNT SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CANONICAL WNT SIGNALING PATHWAY,0.997552352461246,0.9994836051249741,0.108739478496128,0.42565271674766203,7335,18,CSNK1G1|DVL2|LRP6|AXIN1|DVL1
BMP RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BMP RECEPTOR SIGNALING,0.789391979301423,0.9280333261332429,-0.16026005419829997,-0.7716970096582042,6101,36,SMURF1|PPP1R15A|GSK3B|PPM1A|CHRDL1|SMAD9|FST|GREM1|SMAD6|SMAD5|SMURF2|CHRD|NUP214|BMP2|XIAP|PPP1CA
ALK1 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALK1 PATHWAY,0.33968253968254,0.7015009045057019,-0.5726175131744511,-1.1181768739175901,2567,3,FKBP1A|ACVRL1
VALIDATED TRANSCRIPTIONAL TARGETS OF TAP63 ISOFORMS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TRANSCRIPTIONAL TARGETS OF TAP63 ISOFORMS,0.10218978102189802,0.441073279931729,0.257374588538707,1.3498093022374198,741,46,HBP1|TP53I3|BBC3|SPATA18|CDKN1A|PMAIP1|FLOT2|BTRC|TRAF4|NQO1|SP1|CABLES1|YWHAQ|DST|AEN
GLUCOCORTICOID RECEPTOR REGULATORY NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLUCOCORTICOID RECEPTOR REGULATORY NETWORK,0.0667525773195876,0.3690551432905871,-0.24731945010147102,-1.41026462624661,517,65,MAPK14|PPP5C|VIPR1|GSK3B|SFN|AKT1|CREBBP|POU2F1|NR1I3|BGLAP|STAT5A|NR4A1|SMARCA4|NR3C1|TSG101|GATA3|MMP1|SGK1|POMC|MAPK9|SUMO2|ICAM1|MAPK3|NFATC1|SPI1|SUV420H1|FKBP4|RELA|NFKB1|PRKACA|HSP90AA1|FKBP5
EPHRIN A REVERSE SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHRIN A REVERSE SIGNALING,0.23809523809523803,0.6217283213739421,-0.620436748648947,-1.2115557210638799,1799,3,FYN|EPHA5|EFNA5
REGULATION OF ANDROGEN RECEPTOR ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF ANDROGEN RECEPTOR ACTIVITY,0.748604077392546,0.9131348696838739,-0.15731203768735097,-0.808638083214293,5764,45,GNB2L1|NR3C1|SMARCA2|RXRG|SMARCE1|PKN1|CEBPA|RCHY1|KAT7|KAT2B|DNAJA1|KAT5|HSP90AA1
BETA3 INTEGRIN CELL SURFACE INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BETA3 INTEGRIN CELL SURFACE INTERACTIONS,0.000129988301052905,0.00518555396908895,-0.527116484571604,-2.4973639170127098,0,34,PLAU|THY1|VTN|CD47|SDC4|FBN1|SPP1|COL4A1|LAMA4|EDIL3|FN1|PLAUR|TNC|TGFBR2|THBS1|COL1A2|COL1A1|PDGFRB|TGFBI|SPHK1|PDGFB
EPHRINA-EPHA PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHRINA-EPHA PATHWAY,0.0540220820189274,0.336971638536895,-0.5689618933863411,-1.5552319630781102,410,7,EPHA3|EPHA5|EPHA8|EPHA2|EPHA4|EFNA5
DEGRADATION OF BETA CATENIN%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%DEGRADATION OF BETA CATENIN,0.9930697105585,0.997308795012891,0.11852790521776801,0.45577510881555,7307,17,BTRC|DVL2|LRP6|CSNK1E|AXIN1|DVL1
S1P1 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P1 PATHWAY,0.0286502825601262,0.238792268557792,-0.416736713833659,-1.64648787824972,217,19,S1PR1|MAPK3|GNAI2|PDGFRB|SPHK1|PDGFB|ABCC1
REGULATION OF RHOA ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF RHOA ACTIVITY,0.447447447447447,0.768229288546963,0.195892087853369,1.0090658019145,3277,43,ABR|OBSCN|FARP1|ARHGEF28|ARAP3|MYO9B|MCF2L|VAV2|AKAP13|SRGAP1|ARHGEF10
AP-1 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AP-1 TRANSCRIPTION FACTOR NETWORK,0.0413446676970634,0.291365549672794,-0.26703739733466897,-1.49192065532363,320,60,NFATC3|MAFG|CYR61|FOSL2|FOSL1|ETS1|CDKN1B|NFATC2|PTEN|DUSP1|ATF3|BAG1|TGFB1|GJA1|JUNB|NR3C1|AGT|BCL2L11|TRIP6|CDKN2A|MAF|HLA-A|PLAU|MMP1|NFATC1|CCL2|FABP4|MT2A|COL1A2|MMP9|MYC|TIMP1|CCND1
AURORA A SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AURORA A SIGNALING,0.12477207606147399,0.47932042487916404,-0.29012295148759903,-1.33705283719452,957,31,OAZ1|GSK3B|AKT1|AURKA|TACC3|AJUBA|AURKAIP1|DLGAP5|TPX2|BRCA1|CKAP5|RAN|NFKBIA|CPEB1|TACC1|PRKACA|BIRC5
INSULIN PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INSULIN PATHWAY,0.5387149917627679,0.8142313733497609,0.18553471305531402,0.9483413852800842,3923,42,EXOC4|NCK2|DOK1|RHOQ|GRB14|CRK|SHC1|FOXO3|SOS1
RETINOIC ACID RECEPTORS-MEDIATED SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%RETINOIC ACID RECEPTORS-MEDIATED SIGNALING,0.920418848167539,0.9768322640118741,-0.14299387878133998,-0.638626655561115,7031,28,MAPK3|CDK7|KAT2B|MNAT1|PRKACA
IL1-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL1-MEDIATED SIGNALING EVENTS,0.207116788321168,0.58723868025798,-0.26187044948073,-1.21811810096705,1588,32,TICAM2|IL1RN|CASP1|IL1RAP|IRAK1|RELA|IL1R1|NFKB1|TOLLIP|SQSTM1
GLYPICAN 2 NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLYPICAN 2 NETWORK,0.993033226152197,0.997308795012891,0.284587813620072,0.478144271501697,7411,2,GPC2|MDK
E2F TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%E2F TRANSCRIPTION FACTOR NETWORK,0.00168809245552526,0.0345996276682596,-0.317653354012295,-1.83554774438027,12,69,UXT|CES1|TFDP2|SMARCA2|RANBP1|YY1|TRIM28|CDC6|CDKN2A|PLAU|E2F2|ORC1|MCM3|CEBPA|BRCA1|TOPBP1|E2F1|HIC1|DHFR|MYBL2|KAT2B|TK1|SERPINE1|MYC|CCND3|CDKN2C|POLA1|PRMT5|RRM1|TFE3
LKB1 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%LKB1 SIGNALING EVENTS,0.352723281657292,0.7111578119705879,0.21192738450840898,1.0741697695236998,2570,41,ETV4|STK11IP|TSC2|YWHAQ|MARK4|STRADB|MAP2|PSEN2|YWHAB|BRSK1|YWHAE|CDC37|YWHAH|AKT1S1|EZR
HYPOXIC AND OXYGEN HOMEOSTASIS REGULATION OF HIF-1-ALPHA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HYPOXIC AND OXYGEN HOMEOSTASIS REGULATION OF HIF-1-ALPHA,0.802339334998029,0.932946245893631,-0.18778646666273102,-0.741926810851955,6104,19,VHL|TCEB2|GNB2L1|NAA10|CDKN2A|HIF3A|HSP90AA1
IL23-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL23-MEDIATED SIGNALING EVENTS,0.110617154811715,0.45627165649734003,-0.322345785314598,-1.36996050002042,845,24,IL1B|TNF|CXCL1|STAT5A|IL18|SOCS3|CD4|STAT3|CCL2|NFKBIA|RELA|NFKB1
TCR SIGNALING IN NAIVE CD4+ T CELLS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TCR SIGNALING IN NAIVE CD4+ T CELLS,0.510309278350515,0.800685168996958,-0.170750493831509,-0.961614226550082,3959,62,MAP3K14|CHUK|RASGRP1|ORAI1|MAP4K1|PTPN11|PRKCQ|MALT1|FYN|TRAF6|RASSF5|STK39|HLA-DRB1|GRAP2|LCP2|AKT1|CDC42|PTEN|SLA2|HLA-DRA|CD4|VAV1|WAS|STIM1|GRB2|PTPN6|FLNA|HRAS|RAP1A|CD86|NCK1|DBNL|PRKCB
EPO SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPO SIGNALING PATHWAY,0.9238820171265459,0.9776627603891009,0.137775174486669,0.637857238113463,6796,30,IRS2|GAB1|VAV2|SHC1|SOS1|CBL|PLCG1|BCL2
HIF-1-ALPHA TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HIF-1-ALPHA TRANSCRIPTION FACTOR NETWORK,0.14777878513146,0.514965886850433,-0.22973197459980899,-1.26948703948521,1140,58,ETS1|FURIN|MCL1|FECH|AKT1|CREBBP|CXCL12|ID2|CP|ADM|TERT|ITGB2|BHLHE40|RORA|SLC2A1|NPM1|PFKFB3|HK1|CXCR4|ENO1|HMOX1|PLIN2|LDHA|SERPINE1|ENG|PGK1|TFRC|ALDOA
LPA4-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%LPA4-MEDIATED SIGNALING EVENTS,0.7815941269008921,0.9256278844111601,-0.21227672713644896,-0.75100401859462,5961,14,ADCY8|ADCY4|PRKACA|ADCY9
NEPHRIN NEPH1 SIGNALING IN THE KIDNEY PODOCYTE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%NEPHRIN NEPH1 SIGNALING IN THE KIDNEY PODOCYTE,0.41265690376569003,0.7472130967924342,-0.24205047918906897,-1.02870771267076,3155,24,GRB2|MAPK9|KIRREL|PIK3CB|NCK1|BAD
ARF6 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ARF6 SIGNALING EVENTS,0.6073127633546279,0.8492159043277758,0.19318410419714604,0.8943837640542289,4467,30,GULP1|MET|KIF13B|AGTR1|GIT1
PAR1-MEDIATED THROMBIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PAR1-MEDIATED THROMBIN SIGNALING EVENTS,0.063343717549325,0.36006266503904,-0.2992891298096,-1.46470815712948,487,38,GNA14|ROCK1|ZYX|SNX1|GNA12|GNA13|PLCB1|DNM1|PLCB3|PKN1|ARRB1|SNX2|GNAI2|GNAQ|F2R|NOS3|GNA15|ARHGDIA|PRKCB
E-CADHERIN SIGNALING IN THE NASCENT ADHERENS JUNCTION%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%E-CADHERIN SIGNALING IN THE NASCENT ADHERENS JUNCTION,0.41350156087409007,0.748061280707938,-0.21581726017187197,-1.0302971538775199,3178,35,RAP1B|AKT1|CDC42|RAC1|IQGAP1|KLHL20|CTTN|WASF2|JUP|CTNND1|RAPGEF1|CYFIP2|RAP1A|TIAM1|CCND1|ARF6|NME1
PRESENILIN ACTION IN NOTCH AND WNT SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PRESENILIN ACTION IN NOTCH AND WNT SIGNALING,0.6172788554133989,0.854602501630271,0.17862024797316198,0.897279525571516,4486,40,DKK1|DLL1|PPARD|HDAC1|PSENEN|AES|BTRC
ALK1 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALK1 SIGNALING EVENTS,0.0437670965220789,0.299062021084573,-0.361600029849837,-1.5589083963140402,335,25,TGFB3|SMAD5|INHBA|MAPK3|TGFBR2|ID1|FKBP1A|CAV1|ENG|PPP1CA|ACVRL1
CLASS I PI3K SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CLASS I PI3K SIGNALING EVENTS,0.6409691629955949,0.867245940226311,-0.173994726743364,-0.876780153146056,4946,42,RHOA|FYN|DAPP1|PLCG2|SYK|PTEN|RAC1|LYN|PIK3R6|FGR|CYTH3|SGK1|PIK3CB|CYTH1|HRAS|ARF1|RAP1A|HCK|HSP90AA1|ARF6
E-CADHERIN SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%E-CADHERIN SIGNALING EVENTS,0.7947731493764929,0.929656485793048,-0.464303975826398,-0.7726760635632901,5990,2,JUP
CLASS IB PI3K NON-LIPID KINASE EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CLASS IB PI3K NON-LIPID KINASE EVENTS,0.89879092514604,0.967428248648255,0.296768847548723,0.652013796749061,6615,4,MAP2K1|MAPK1|PDE3B
IL27-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL27-MEDIATED SIGNALING EVENTS,0.35198744769874496,0.7106060713647829,-0.278628580607713,-1.08118251750322,2691,18,IL12RB1|IL6|IL27RA|IL1B|TNF|TGFB1|STAT5A|IL18|GATA3|EBI3|IL6ST|STAT3
PLK2 AND PLK4 EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PLK2 AND PLK4 EVENTS,0.19328734412311,0.567519363754568,-0.7375970608258561,-1.22747945985254,1456,2,PLK2
PDGF RECEPTOR SIGNALING NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PDGF RECEPTOR SIGNALING NETWORK,0.000654878847413229,0.0165075321035167,-0.805030059014947,-2.07075417569906,4,6,PDGFD|PDGFC|PDGFRB|PDGFA|PDGFRA|PDGFB
E-CADHERIN SIGNALING IN KERATINOCYTES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%E-CADHERIN SIGNALING IN KERATINOCYTES,0.522521303936156,0.807051143864932,0.23749862015675,0.9468794243087859,3862,19,PLCG1|EGFR|SRC|FMN1|CTNNA1|PIP5K1A|PIK3CA|VASP|CTNNB1|PIK3R1|AKT2|RHOA|FYN|AKT1|ZYX|AJUBA|RAC1|JUP|CTNND1
SIGNALING EVENTS MEDIATED BY PRL%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY PRL,0.6334203655352479,0.8631726958478259,-0.20755297352463897,-0.8714280767380309,4851,23,ROCK1|RAC1|ITGB1|AGT|TUBA1B|PTP4A2|BCAR1|MAPK3|ATF5|PTP4A3
REGULATION OF NUCLEAR SMAD2 3 SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF NUCLEAR SMAD2 3 SIGNALING,0.7708063261602279,0.9213545359508709,-0.140742855028014,-0.810522347035672,5945,68,LAMC1|NR3C1|RUNX1|RUNX3|SKIL|GATA3|ITGB5|TGIF1|MEF2C|CDKN2B|RBBP7|IRF7|CEBPB|MAX|KAT2B|COL1A2|SERPINE1|MYC|TFE3|IGHA1
IL2-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL2-MEDIATED SIGNALING EVENTS,0.47368421052631604,0.7837630343217421,-0.18416331198674998,-0.9875304747136819,3662,52,DOK2|MAPKAPK2|GRB2|IRS1|SOCS1|STAT3|MAPK9|IL2RA|CISH|MAPK3|HRAS|MYC|PRKCB
AMB2 INTEGRIN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%AMB2 INTEGRIN SIGNALING,0.00430416068866571,0.0728102197803808,-0.4412098430692101,-1.94595095999167,32,27,SELPLG|ITGB2|LRP1|TLN1|PLAU|THY1|MST1R|ICAM1|CTGF|RAP1A|PLAUR|HCK|MMP9|PLAT|NFKB1|ITGAM
SIGNALING EVENTS MEDIATED BY PTP1B%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY PTP1B,0.284201007621754,0.6569867235097528,-0.21836788750298802,-1.13121436635951,2199,46,INS|BCAR1|GRB2|IRS1|STAT3|CAPN1|FCGR2A|CSF1|HCK|PDGFRB|CAV1|CSF1R|PDGFB
REGULATION OF RETINOBLASTOMA PROTEIN%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF RETINOBLASTOMA PROTEIN,0.0302716688227684,0.24599181315662,-0.280485756975264,-1.54445542290707,233,57,TGFB2|CDKN1B|CDK4|RAF1|CREBBP|SKP2|BGLAP|CCND2|CDK6|SMARCA4|CDKN2A|PPP2R3B|E2F2|CEBPD|MEF2C|CEBPA|MAPK9|ABL1|DNMT1|CBX4|CEBPB|E2F1|UBTF|SPI1|MITF|PPP2CA|PPARG|CCND3|CCND1|SUV39H1
CERAMIDE SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CERAMIDE SIGNALING PATHWAY,0.10239708181344499,0.44115166704562797,-0.267479794273019,-1.3566482590153,785,43,NFKBIA|FADD|MYC|RELA|NFKB1|CTSD|PDGFA|SMPD1|TNFRSF1A|BAD
CLASS I PI3K SIGNALING EVENTS MEDIATED BY AKT%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CLASS I PI3K SIGNALING EVENTS MEDIATED BY AKT,0.5699822137091259,0.8324048186805392,0.192246251962963,0.9223512076279159,4165,34,MAP3K5|CASP9|CDKN1A|FOXO3|YWHAQ|YWHAB|TBC1D4|YWHAE|AKT3|YWHAH|SRC|YWHAZ|PDPK1
PLK3 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PLK3 SIGNALING EVENTS,0.497026223303596,0.7946757370274999,0.39470134449484706,0.94925447009089,3676,5,CCNE1|PLK3|CHEK2
VALIDATED TRANSCRIPTIONAL TARGETS OF DELTANP63 ISOFORMS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VALIDATED TRANSCRIPTIONAL TARGETS OF DELTANP63 ISOFORMS,0.104101765316719,0.44419145940290994,-0.278935993197942,-1.36510078001816,801,38,HELLS|BDKRB2|RRAD|FOSL2|IGFBP3|GSK3B|SFN|CCNB2|NRG1|ADRM1|GNB2L1|RUNX1|STXBP4|CDKN2A|ADA|HES1|TOP2A|CEBPD|NOTCH1|PERP|AXL|POU2F2|YAP1|COL5A1|FASN
INTEGRIN-LINKED KINASE SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%INTEGRIN-LINKED KINASE SIGNALING,0.0597967691505993,0.354269451186595,-0.28987920219235996,-1.47025728073351,458,43,AKT1|AURKA|ZYX|CDC42|TACC3|RAC1|IQGAP1|TNS1|PARP1|RUVBL1|ILK|PXN|RHOG|CKAP5|LIMS2|SNAI1|HSP90AA1|PPP1R14B|CCND1|ACTN1|MYL9|PPP1R14A
DOWNSTREAM SIGNALING IN NAIVE CD8+ T CELLS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%DOWNSTREAM SIGNALING IN NAIVE CD8+ T CELLS,0.18479107189203198,0.5581275982958399,-0.23635915616519002,-1.23095934316202,1423,47,IL2RB|IFNAR2|NFATC3|PRKCQ|CD8B|MAP2K2|FOSL1|IL2RG|RAF1|TNF|NFATC2|PRF1|JUNB|B2M|IFNAR1|GZMB|CALM3|TNFRSF18|HLA-A|ELK1|MAPK9|IL2RA|MAPK3|TNFRSF4|HRAS|NFATC1|PRKCB
LISSENCEPHALY GENE (LIS1) IN NEURONAL MIGRATION AND DEVELOPMENT%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%LISSENCEPHALY GENE (LIS1) IN NEURONAL MIGRATION AND DEVELOPMENT,0.9608536088079379,0.990088141828538,0.12520882022502802,0.5796788322261159,7068,30,CALM2|PAFAH1B2|NDEL1|CDK5R1|VLDLR|YWHAE|DYNLT1|LRP8|CDK5|KATNA1
ERBB RECEPTOR SIGNALING NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ERBB RECEPTOR SIGNALING NETWORK,0.778009379885357,0.924704689181848,-0.247971797593228,-0.7459598638232661,5971,9,NRG1|NRG3|NRG2|HBEGF|HSP90AA1
EPHRIN B REVERSE SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHRIN B REVERSE SIGNALING,0.783141962421712,0.926798202062739,-0.17598360081608605,-0.7676726046169781,6001,26,HCK|EPHB4|TIAM1|RGS3
FOXA1 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FOXA1 TRANSCRIPTION FACTOR NETWORK,0.0065214555888874395,0.0957322763119865,-0.42521467326050294,-1.87540444673177,49,27,CDKN1B|CREBBP|POU2F1|NFIA|PRDM15|COL18A1|ATP5J|INS|VTN|SERPINA1|DSCAM|BRCA1|NFIC|SOD1|CEBPB|AP1B1|NR2F2|NDUFV3
P53 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%P53 PATHWAY,0.23416655873591502,0.617951264290741,-0.21122332751679201,-1.16720921058818,1807,58,ABL1|HUWE1|RCHY1|PPM1D|NEDD8|PPP2R4|KAT2B|PPP2CA|KAT8|KAT5|PRMT5|CSNK1A1
PLASMA MEMBRANE ESTROGEN RECEPTOR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%PLASMA MEMBRANE ESTROGEN RECEPTOR SIGNALING,0.621495327102804,0.856074533157243,-0.181948784325187,-0.8904495420546559,4787,38,GNA13|PLCB1|GNAL|PLCB3|BCAR1|GRB2|MSN|HRAS|GNAI2|HBEGF|GNAQ|NOS3|GNA15|MMP9
ENDOGENOUS TLR SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ENDOGENOUS TLR SIGNALING,0.00616878855492847,0.0917891350028485,-0.4602476901662991,-1.8750524036768899,46,21,BGN|VCAN|IRAK1|TICAM1|TLR4|S100A8|S100A9|CD14|LY96
IL8- AND CXCR2-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL8- AND CXCR2-MEDIATED SIGNALING EVENTS,0.0523573847356082,0.331837217224037,-0.325705230662787,-1.5010363727303702,401,31,GNA14|AKT1|RAC2|DOCK2|LYN|PLCB1|PIK3R6|DNM1|PLCB3|FGR|RAB7A|ELMO1|ARRB1|GNAI2|PPP2CA|GNA15|HCK|PRKCB
EGF RECEPTOR (ERBB1) SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EGF RECEPTOR (ERBB1) SIGNALING PATHWAY,0.44797924631348995,0.768229288546963,0.215283195651996,1.0042663925609199,3280,31,NCK2|GAB1|GNAI3|SHC1|SOS1|PAK1|PLCG1|NRAS|EGFR|SRC|MAPK1|KRAS|PIP5K1C
ATF-2 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ATF-2 TRANSCRIPTION FACTOR NETWORK,0.3781911481719051,0.72828181452034,-0.19740826512417398,-1.05410855422666,2947,51,TGFB2|CDK4|DDIT3|POU2F1|DUSP1|DUSP8|ATF3|JUNB|ACHE|SOCS3|DUSP5|PLAU|INS|HES1|MAPK9|BRCA1|MAPK3|KAT5|PDGFRA|H2AFY|CCND1|JDP2
ERBB4 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ERBB4 SIGNALING EVENTS,0.686463908105991,0.8861361847538001,-0.185276130458385,-0.8377297673982391,5258,29,CBFA2T3|WWOX|GRB2|PIK3CB|MAPK3|LRIG1|HBEGF|YAP1
ANGIOPOIETIN RECEPTOR TIE2-MEDIATED SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ANGIOPOIETIN RECEPTOR TIE2-MEDIATED SIGNALING,0.26954142782699303,0.643580678524053,-0.224944427670433,-1.14091035176584,2068,43,FES|ELK1|ITGA5|DOK2|GRB2|PXN|MAPK3|FN1|NOS3|TEK|RELA|RPS6KB1|NFKB1|NCK1
CALCINEURIN-REGULATED NFAT-DEPENDENT TRANSCRIPTION IN LYMPHOCYTES%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%CALCINEURIN-REGULATED NFAT-DEPENDENT TRANSCRIPTION IN LYMPHOCYTES,0.0844760672703752,0.40376145987147494,-0.29184799385905896,-1.4053297639417,652,36,NFATC3|GBP3|PRKCQ|CBLB|PTGS2|FOSL1|PTPN1|CDK4|FOXP3|TNF|POU2F1|NFATC2|JUNB|CALM3|GATA3|MAF|IL2RA|NFATC1|E2F1|SLC3A2|PPARG
FOXM1 TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FOXM1 TRANSCRIPTION FACTOR NETWORK,0.100207684319834,0.43614703285696904,-0.280679302656993,-1.3736324616956601,771,38,HSPA1B|FOXM1|LAMA4|HSPA1A|CCNB1|PLK1|GAS1|MYC|BIRC5|CENPB|CCND1
IL8- AND CXCR1-MEDIATED SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL8- AND CXCR1-MEDIATED SIGNALING EVENTS,0.0364725804350658,0.271526902825443,-0.36834422238951503,-1.58798355535324,279,25,LYN|PLCB1|PIK3R6|DNM1|PLCB3|FGR|ARRB1|PLD1|GNAI2|GNA15|HCK|ADRBK1|PRKCB
EPHB FORWARD SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%EPHB FORWARD SIGNALING,0.465083073727934,0.7786333182377991,-0.20274648963829897,-0.992232619311987,3582,38,RAP1B|ROCK1|ITSN1|CDC42|RAC1|SYNJ1|EPHB3|DNM1|KALRN|GRB2|PXN|MAPK3|HRAS|RAP1A|EPHB4|RRAS|NCK1|EFNA5
SIGNALING EVENTS MEDIATED BY STEM CELL FACTOR RECEPTOR (C-KIT)%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY STEM CELL FACTOR RECEPTOR (C-KIT),0.434349961230292,0.762034923704788,-0.193536853336814,-1.01458307943547,3360,48,MATK|GRB2|SOCS1|STAT3|PTPN6|SH2B3|SNAI2|MAPK3|HRAS|MITF|RPS6KB1|GRB10|BAD
SIGNALING EVENTS MEDIATED BY HDAC CLASS I%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY HDAC CLASS I,0.0781129156999227,0.39141543022887104,-0.24374574881726102,-1.38416381286618,605,64,RBBP7|RAN|HDAC5|MAX|NFKBIA|KAT2B|FKBP3|HDAC8|SIRT4|PPARG|RELA|MTA2|NFKB1|PRKACA|PRMT5|TNFRSF1A
ALTERNATIVE NF-KAPPAB PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALTERNATIVE NF-KAPPAB PATHWAY,0.425409299279633,0.7547028278218628,-0.39664139017163397,-1.0202685052009302,3247,6,RELB|NFKB1
A4B7 INTEGRIN SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%A4B7 INTEGRIN SIGNALING,0.0702941942202551,0.3767214120425879,-0.524355291926202,-1.50954549645793,539,8,RHOA|ITGA4|ITGB1|MADCAM1|PXN|VCAM1
C-MYC PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%C-MYC PATHWAY,0.0348382045929019,0.266492150698867,-0.36553747211108295,-1.5945412072451002,266,26,RUVBL1|CDKN2A|TAF12|MAX|PPP2CA|MYC|TAF10|KAT5|TAF9|AK6
TNF RECEPTOR SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%TNF RECEPTOR SIGNALING PATHWAY,0.268423112038607,0.6425780801490849,-0.224390814015871,-1.14386854790919,2057,44,MAP2K3|FADD|CAV1|RELA|NFKB1|SMPD1|TNFRSF1A|TNFRSF1B|SQSTM1
VEGF AND VEGFR SIGNALING NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%VEGF AND VEGFR SIGNALING NETWORK,0.0675993723849372,0.371075653877479,-0.485841865471822,-1.5220791425098898,516,10,FLT1|KDR|VEGFC|FLT4|VEGFB|NRP2
ERBB2 ERBB3 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ERBB2 ERBB3 SIGNALING EVENTS,0.364282943230312,0.718457761443038,-0.213749641821705,-1.0640940311504599,2816,40,GRB2|STAT3|MAPK9|PIK3CB|MAPK3|HRAS|CHRNE|PRKACA|NF2|BAD
S1P5 PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%S1P5 PATHWAY,0.9996094766987759,0.999671409271379,-0.12482762424844197,-0.35936125928199497,7678,8,GNAI3|GNAO1|GNAI1|S1PR5|GNAZ|RHOA|GNA12|GNAI2
FGF SIGNALING PATHWAY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%FGF SIGNALING PATHWAY,0.8524568909633091,0.949296218452153,-0.14509532063387698,-0.7266526340209742,6574,41,BGLAP|SSH1|PAK4|CTTN|RPS6KA1|CTNND1|FGFR4|PLAU|GRB2|MAPK3|SPP1|SDC2|PLAUR|FGF19|MMP9|CAMK2A
BARD1 SIGNALING EVENTS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%BARD1 SIGNALING EVENTS,0.8950013583265419,0.966256689108312,0.147380109814572,0.6677041213010699,6588,28,FANCL|BARD1|ATM|MRE11A|CCNE1|XRCC5|ATR|CSTF1
SIGNALING EVENTS MEDIATED BY FOCAL ADHESION KINASE%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING EVENTS MEDIATED BY FOCAL ADHESION KINASE,0.32077170418006395,0.6887462975400029,-0.20209914955363398,-1.09583947652248,2493,54,ITGB5|TLN1|BCAR1|ITGA5|ELMO1|GRB2|MAPK9|PXN|DOCK1|RAP1A|VCL|RRAS|NCK1|CCND1|ACTN1
HIF-2-ALPHA TRANSCRIPTION FACTOR NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HIF-2-ALPHA TRANSCRIPTION FACTOR NETWORK,0.5867413388903361,0.8413007197716759,-0.19786620790399898,-0.9118808881077829,4504,31,SLC11A2|ETS1|VHL|CREBBP|TCEB2|FLT1|KDR|BHLHE40|SLC2A1|ELK1|EFNA1|MMP14|FXN|SERPINE1|APEX1|PGK1
GLYPICAN 1 NETWORK%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%GLYPICAN 1 NETWORK,0.3783995815899579,0.7285137724612059,-0.24817742613582,-1.05474706446367,2893,24,FYN|APP|NRG1|TGFB1|LYN|FLT1|FGR|PLA2G2A|TGFB3|HCK|TGFBR2|SLIT2|PRNP
ALPHA6 BETA4 INTEGRIN-LIGAND INTERACTIONS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%ALPHA6 BETA4 INTEGRIN-LIGAND INTERACTIONS,0.541123778501629,0.815622645995152,0.281723302313496,0.927042654023177,3986,11,ITGA6|LAMA5|LAMB1|LAMA1
SIGNALING MEDIATED BY P38-GAMMA AND P38-DELTA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%SIGNALING MEDIATED BY P38-GAMMA AND P38-DELTA,0.443122384937239,0.7659482117676241,-0.319951878520208,-1.0023674687432,3388,10,PKN1|MAP2K3|MAPK13|CCND1
HEDGEHOG SIGNALING EVENTS MEDIATED BY GLI PROTEINS%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HEDGEHOG SIGNALING EVENTS MEDIATED BY GLI PROTEINS,0.22822822822822797,0.610121312048328,0.22989055301368502,1.1841963489763998,1671,43,IFT88|STK36|CSNK1G1|IFT172|HDAC1|ARRB2|BTRC|GNAI3|SUFU|RAB23|CSNK1G2|SIN3A|XPO1|SIN3B|GNAO1|MAP2K1|CSNK1E
UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND UPAR-MEDIATED SIGNALING%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND UPAR-MEDIATED SIGNALING,0.0005209690023443611,0.0139121625154964,-0.47013731685652704,-2.16666220356202,3,31,RAC1|ITGB1|MMP12|TGFB1|FPR3|ITGB2|LRP1|HGF|PDGFD|ITGB5|PLAU|BCAR1|FPR1|VTN|ITGA5|DOCK1|FN1|PLAUR|PDGFRB|MMP9|SERPINE1|ITGAM
REGULATION OF RAC1 ACTIVITY%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%REGULATION OF RAC1 ACTIVITY,0.337799167533819,0.699636319850872,-0.22736997557553398,-1.0854490439092601,2596,35,RASGRF2|VAV1|KALRN|ELMO1|DOCK6|CHN2|NGEF|ARHGAP1|DOCK1|TIAM1|EPS8|ARHGDIA
IL12 SIGNALING MEDIATED BY STAT4%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%IL12 SIGNALING MEDIATED BY STAT4,0.133124100954623,0.494192252511099,-0.321176955313159,-1.33007733953216,1017,22,PIAS2|HLA-DRB1|CREBBP|PRF1|TGFB1|HLA-DRA|IL18|CD4|STAT3|MAPK9|IL2RA|CD86
HIV-1 NEF: NEGATIVE EFFECTOR OF FAS AND TNF-ALPHA%PATHWAY INTERACTION DATABASE NCI-NATURE CURATED DATA%HIV-1 NEF: NEGATIVE EFFECTOR OF FAS AND TNF-ALPHA,0.5342805005213761,0.812434061990131,-0.20329142163261102,-0.945631555423859,4098,32,NFKBIA|FADD|RELA|NFKB1|TNFRSF1A|CASP6
5-ARACHIDONYLGLYCEROL_BIOSYNTHESIS%PANTHER PATHWAY%P05726,0.102423051735429,0.44115166704562797,-0.557340056943031,-1.433628766125,781,6,PLA1A|PLCB1|PLCB3|DAGLA
5HT1 TYPE RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04373,0.5655886157826651,0.8298229800621719,-0.19255206536626604,-0.927192080334602,4371,36,GNGT2|GNG11|GNAI2|GNG10|STX3|HTR1B|PRKACA|GNG3
5HT2 TYPE RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04374,0.49841793919383703,0.794989907195277,0.193700874959328,0.9730354266018472,3622,40,PLCD1|GNG5|PLCD4|KCNK9|GNB5|PRKCE|GNB4|PLCB4|SLC18A1|KCNK3|PRKCA|PLCG1
5HT3 TYPE RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04375,0.24197497279651803,0.625158460820442,0.351658417822662,1.1952185639334298,1778,12,KCNK9|SNAP25|SLC18A1|KCNK3|VAMP3|SNAP23|SLC18A2|VAMP1|VAMP2
5HT4 TYPE RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04376,0.228442991418063,0.6101254638038941,0.260938765674819,1.19421971764263,1676,29,GNG5|ADCY2|KCNK9|SNAP25|GNB5|GNB4|SLC18A1|KCNK3|VAMP3|SNAP23|GNG4|GNG12|ADCY7|GNB1|SLC18A2|VAMP1
5-HYDROXYTRYPTAMINE BIOSYNTHESIS%PANTHER PATHWAY%P04371,0.398857750033205,0.7388683667002129,0.801720335244817,1.06898588863411,3002,1,DDC
5-HYDROXYTRYPTAMINE DEGREDATION%PANTHER PATHWAY%P04372,0.6478078235757421,0.870171576465071,-0.23529881516812398,-0.8543318562253721,4934,15,ALDH2|ALDH1A1|ALDH1A2|IL4I1|ALDH4A1
ACETATE UTILIZATION%PANTHER PATHWAY%P02722,0.8551339877951708,0.949296218452153,-0.42878411910670006,-0.7135653419295591,6445,2,ACSS2|ACSS1
ADENINE AND HYPOXANTHINE SALVAGE PATHWAY%PANTHER PATHWAY%P02723,0.0833771699105734,0.40198233213653706,-0.6090082529656221,-1.45967657288766,633,5,ADA|HPRT1|PNP
ADRENALINE AND NORADRENALINE BIOSYNTHESIS%PANTHER PATHWAY%P00001,0.7374575118966691,0.908309781681485,0.19075459624504199,0.7982989279672199,5423,22,SLC6A2|SNAP25|SLC18A1|SLC6A17|MAOB|DDC|SNAP23
ALANINE BIOSYNTHESIS%PANTHER PATHWAY%P02724,0.266914300875564,0.6417330323279019,-0.699290448987104,-1.16373113206506,2011,2,BCAT2
ALPHA ADRENERGIC RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P00002,0.123341456810181,0.4772565108022,0.335328805060529,1.35901165475319,910,20,SNAP25|PRKCE|PLCB4|VAMP3|STX10|ITPR1|PRKCA|STX6|SNAP23|GNA11|VAMP1|VAMP2|PRKCD
ALZHEIMER DISEASE-AMYLOID SECRETASE PATHWAY%PANTHER PATHWAY%P00003,0.673817381738174,0.882488012133495,0.15536743118395402,0.8661412739561741,4899,57,MAPK7|ADAM17|CHRM4|PSENEN|MAPK12|PCSK2|MAPK11|PRKCE|PCSK4|CACNA1C|MAPK6|CHRM3|PSEN2|APH1B|CACNB2|PRKCA|PCSK7|APBA3|MAPK1|ADAM10|MAPK8
ALZHEIMER DISEASE-PRESENILIN PATHWAY%PANTHER PATHWAY%P00004,0.431256436663234,0.759710440121244,-0.17056649617318,-1.0121708060847,3349,76,MMP1|FZD2|PCSK1|FZD8|NOTCH1|MMP14|NOTCH2|LRP5|NOTCH3|KAT7|PCSK6|ACTG2|MMP9|WNT3|KAT5|BACE2|ACTB|ACTA2|MMP19|ERN1
AMINOBUTYRATE DEGRADATION%PANTHER PATHWAY%P02726,0.853898260061097,0.949296218452153,0.571956329951478,0.7626265902889721,6428,1,ABAT
ANANDAMIDE_DEGRADATION%PANTHER PATHWAY%P05728,0.740470181963076,0.909493931144346,0.629576532862814,0.8394553560126751,5574,1,FAAH
ANDROGEN ESTROGENE PROGESTERONE BIOSYNTHESIS%PANTHER PATHWAY%P02727,0.46803312067327296,0.780769690730001,0.378525646783911,0.979457358997048,3447,6,HSD17B3|HSD17B6
ANGIOGENESIS%PANTHER PATHWAY%P00005,0.06998087954110901,0.37596389138254704,-0.194744062283147,-1.33362068934052,548,140,DOK2|PDGFC|MAPKAPK2|NOTCH1|PLA2G4D|PLA2G4A|STAT3|DOK3|PRKD1|F3|PXN|PIK3CB|NOTCH2|MAPK3|HSPB1|HRAS|PIK3R3|PLD1|ARHGAP1|PLA2G4C|JAG2|F2R|NOS3|TEK|ARAF|PDGFRB|CRYAB|ARHGAP8|PDGFA|PDGFRA|BIRC5|NCK1|SPHK1|PDGFB|PRKCB
ANGIOTENSIN_II-STIMULATED_SIGNALING_THROUGH_G_PROTEINS_AND_BETA-ARRESTIN%PANTHER PATHWAY%P05911,0.0515088449531738,0.327461797032442,-0.314817185412442,-1.5029161702074298,395,35,GRK5|PLCB1|GNG8|AGT|ITPR2|PLCB3|ITPR3|ELK1|ARRB1|MAPK3|GNGT2|GNG11|GNAQ|GNG10|GRK6|ADRBK1|GNG3
APOPTOSIS SIGNALING PATHWAY%PANTHER PATHWAY%P00006,0.0650759219088937,0.36657222541945206,-0.21395747096460999,-1.36896235557304,509,102,MADD|NFKB2|BCL2L11|GZMB|TNFRSF10A|TNFRSF10B|CASP10|TMBIM6|ATF1|BCL2L2|TRAF2|TNFSF10|BAG3|HSPA6|CYCS|MAPK9|PIK3CB|MAPK3|TNFRSF10C|CREM|MAP2K3|NFKBIA|XIAP|FADD|RELB|LTA|EIF2S1|RELA|NFKB1|HSPA5|TNFRSF1A|TNFRSF1B|ENDOG|PRKCB|JDP2
ARGININE BIOSYNTHESIS%PANTHER PATHWAY%P02728,0.0870805597065616,0.407749299171126,0.657955328375416,1.4455558772047299,640,4,ASL|CAD|NAGS
ASCORBATE DEGRADATION%PANTHER PATHWAY%P02729,0.266569265506707,0.641603173139009,0.8692104102337891,1.15897479700331,2006,1,RPE
ASPARAGINE AND ASPARTATE BIOSYNTHESIS%PANTHER PATHWAY%P02730,0.683745819397993,0.885415243771438,-0.6619982355535949,-0.881940604907751,5110,1,ASNS
ATP SYNTHESIS%PANTHER PATHWAY%P02721,0.300875563810029,0.673988937137548,-0.683981251723187,-1.13825417969319,2267,2,ATP5C1|ATP5B
AXON GUIDANCE MEDIATED BY NETRIN%PANTHER PATHWAY%P00009,0.755253883305052,0.916183794263895,-0.174608071868103,-0.7894939249326329,5785,29,NFATC3|PIK3C2B|UNC5D|NFATC4|PLCG2|RAC2|CDC42|PIK3R5|NFATC2|RAC1|PIK3C2A|NTN3|NTN4|PIK3CB|NTN1|PIK3R3|RHOU
AXON GUIDANCE MEDIATED BY SEMAPHORINS%PANTHER PATHWAY%P00007,0.8001087104226121,0.9318153767588689,0.19257210068363198,0.7404971005154001,5887,17,PLXNB1|DPYSL5|PAK1|CRMP1|NRP1|CDK5|DPYSL4|DPYSL2
AXON GUIDANCE MEDIATED BY SLIT ROBO%PANTHER PATHWAY%P00008,0.580020920502092,0.8386526275338391,-0.23354912096587402,-0.906257448592687,4435,18,ROBO1|RAC2|CXCL12|CDC42|RAC1|NTN3|NTN4|CXCR4|ABL1|NTN1|SLIT2
B CELL ACTIVATION%PANTHER PATHWAY%P00010,0.656645161290323,0.8755797517012099,-0.159822461567764,-0.871804606863895,5088,55,MAP2K2|MAPK14|PLCG2|RAF1|RAC2|SYK|RAC1|SOS2|LYN|MAP3K3|VAV3|ITPR2|CALM3|ITPR3|VAV1|GRB2|MAPK9|PTPN6|PIK3CB|MAPK3|HRAS|NFKBIA|ARAF|MAPK13|PRKCB
BETA1 ADRENERGIC RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04377,0.763636363636364,0.9191113740914171,-0.17175330238980901,-0.7841919533970552,5837,30,GNGT2|VAMP8|GNG10|STX3|PRKACA|GNG3
BETA2 ADRENERGIC RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04378,0.9270234986945171,0.979171896286746,-0.148159215004135,-0.6220585404754151,7100,23,ADRB2|PRKAR2A|GNG8|GNAL|GNGT2|GNG10|PRKACA|GNG3
BETA3 ADRENERGIC RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04379,0.705255972696246,0.894639008000397,0.18936282247532102,0.825037948587838,5165,25,GNG5|ADCY2|SNAP25|GNB5|GNB4|VAMP3|SNAP23|GNG4|GNG12|ADCY7|GNB1|VAMP1
BLOOD COAGULATION%PANTHER PATHWAY%P00011,0.000391644908616188,0.0111294649577428,-0.540802447253616,-2.27060315495549,2,23,GP1BA|PLAU|GP1BB|VWF|SERPINA1|F3|F8|THBD|F2R|PLAUR|F2RL3|SERPINE1|PLAT|TFPI|SERPINF2
CADHERIN SIGNALING PATHWAY%PANTHER PATHWAY%P00012,0.366175528507367,0.720655766665538,-0.16080961160301802,-1.05080919620434,2857,112,FYN|PCDHB5|PCDHB10|GSK3B|PTPN1|PCDHA11|CDH23|PCDHGA11|PCDHGA7|PCDHA5|FSTL1|PCDHA4|PCDHA6|PCDHA7|ACTG1|PCDHB12|LYN|CDH6|PCDHGC5|PCDHB8|PCDH18|CTNND1|FZD4|PCDHGA5|CDHR2|PCDHB6|PCDHB11|FAT3|PCDHB13|PCDHGB1|CTNND2|PCDHB7|FZD2|PCDHGB7|FZD8|PCDHB15|PCDH12|CELSR1|PCDHGA12|PCDH1|CDH8|PCDHGA6|PCDHB2|CDH11|CDH5|PCDHB16|PCDH8|CDH7|PCDHGB4|ACTG2|DCHS1|WNT3|ACTB|ACTA2
GASTRIN_CCK2R_240212%PANTHER PATHWAY%P06959,0.14110898661567903,0.5064815620594401,-0.17813196401041298,-1.21985990151396,1106,140,AKT1|ROCK1|RAF1|CDC42|ELK4|NFATC2|PTEN|PRKG1|CSNK1D|RAC1|ITGB1|ARHGAP4|PRKCH|CD38|LYN|RPS6KA1|MEF2D|EIF4EBP1|RYR2|KLF4|DNM1|ODC1|CALM3|CPE|IER3|PLAU|ELK1|BCAR1|AKAP1|GRB2|MEF2C|PLA2G4A|IRS1|STAT3|MAPK9|PRKD1|CETP|PXN|PIK3CB|MAPK3|HSPB1|CREM|MEN1|PDE1A|HBEGF|TPCN2|NFKBIA|MAP3K11|ARAF|SRF|SNAI1|PPARG|RPS6KB1|PRKACA|RGS2|CSNK1A1|AP2M1|PRKCB|BAD
CELL CYCLE%PANTHER PATHWAY%P00013,0.157184058730991,0.526948420373268,-0.36963983136578604,-1.30773166956689,1198,14,PSMD3|PSMD4|CINP|CCND3|PSMD12|PSMD13
CHOLESTEROL BIOSYNTHESIS%PANTHER PATHWAY%P00014,0.32499345035368105,0.692794968343412,-0.34205480740748195,-1.1074208422146699,2480,11,PMVK|SQLE|MVK|FDFT1|FDPS|HMGCR|HMGCS1|PDSS1
CIRCADIAN CLOCK SYSTEM%PANTHER PATHWAY%P00015,0.37910369984366904,0.728914030571579,-0.351082717772175,-1.05614275043343,2909,9,CRY1|PER3|CLOCK|ARNTL|CSNK1D|PER2|CRY2
COENZYME A BIOSYNTHESIS%PANTHER PATHWAY%P02736,0.909868331749695,0.9720875712603501,0.24362305085688102,0.630388963100577,6702,6,PANK1|PANK2|PPCS|PANK4
CORTOCOTROPIN RELEASING FACTOR RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04380,0.838271766087978,0.946300451776032,-0.16027681996819002,-0.7246948799021891,6421,29,POMC|GNGT2|VAMP8|GNAQ|GNG10|STX3|GNG3
CYSTEINE BIOSYNTHESIS%PANTHER PATHWAY%P02737,0.721344136007438,0.901938862696805,0.639225849139832,0.8523214172582709,5430,1,CBS
CYTOSKELETAL REGULATION BY RHO GTPASE%PANTHER PATHWAY%P00016,0.0200927357032458,0.195205495598712,-0.301274883885436,-1.62615177414884,155,53,ROCK1|MYH3|RAC2|CDC42|PAK2|RAC1|SSH1|ACTG1|PAK4|MYH11|ARPC1A|MYLK2|MYLK|TUBB4A|ARHGAP1|ACTG2|CFL2|MYH9|ARHGAP8|CFL1|ACTB|ACTA2|RHOU|TUBB4B|TUBB6|DIAPH2
DE NOVO PURINE BIOSYNTHESIS%PANTHER PATHWAY%P02738,0.23980125523012602,0.623249935321109,-0.27966294324623603,-1.1885596245438002,1833,24,GMPS|NME2|RRM1|NME1|AK1
DE NOVO PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHESIS%PANTHER PATHWAY%P02739,0.30914330626146197,0.680809181688249,-0.347639278346264,-1.12550086733468,2359,11,NME2|RRM1|NME1
DE NOVO PYRIMIDINE RIBONUCLEOTIDES BIOSYTHESIS%PANTHER PATHWAY%P02740,0.363837542306691,0.718261029016069,-0.37389735031920396,-1.07639814073116,2794,8,CTPS1|NME2|NME1
DNA REPLICATION%PANTHER PATHWAY%P00017,0.0119047619047619,0.143385281385281,-0.482402426843709,-1.79279420790899,90,16,RFC2|RPA2|RFC3|TOP1|PCNA|TOP2A|POLD1|POLD2|RFC5|POLA1|RFC4
PNAT%PANTHER PATHWAY%P05912,0.5951175172055579,0.8442752964756541,-0.176296531840245,-0.906224925189472,4582,45,FLNA|VAMP8|EPB41L2|GNG11|GNAI2|STX3|PRKACA|GNG3|PPP1CA
EGF RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P00018,0.324523577688135,0.692794968343412,0.16691014848716199,1.07725955886669,2332,103,MAP3K5|GAB1|PRKD3|GAB2|ERBB3|MAP2K6|MAPK12|SPRY2|MAPK11|PRKCE|SHC1|SOS1|YWHAQ|SHC2|STAT2|NF1|SPRY4|RASAL2|YWHAB|CBL|YWHAE|PRKCA|PLCG1|NRAS|MAP2K7|AKT3|MAP3K4|PPP2CB|YWHAH|PPP2R5C|EGFR|MAP2K1|MAP3K2|MAPK1|YWHAZ|MAP2K4|MAPK8|ERBB2|RASA2
ENDOGENOUS_CANNABINOID_SIGNALING%PANTHER PATHWAY%P05730,0.786081776333604,0.9274485629622209,0.18740963599121602,0.759528783932364,5805,20,CNR1|GNG5|GNB4|GNAI3|GNAO1|CACNA1B|GNG4
UNTITLED%PANTHER PATHWAY%P00019,0.1112828438949,0.457649659236015,-0.23664540235073303,-1.3221225464235502,863,60,FURIN|GNA14|AKT1|RAF1|GUCY1B3|ECE1|PRKG1|PRKCH|PRKAR2A|PLCB1|EDNRA|GNAL|ITPR2|PLCB3|ITPR3|PCSK1|ADCY8|PRKAR1A|PLA2G4A|MAPK3|ADCY4|SEC11C|ECEL1|GNAQ|EDNRB|NOS3|ARAF|PRKACA|PRKCB|ADCY9
ENKEPHALIN RELEASE%PANTHER PATHWAY%P05913,0.672366531784362,0.8820287375433101,-0.18749207323683606,-0.847749197444447,5150,29,GNGT2|CREM|GNAI2|GNG10|PRKACA|GNG3
FAS SIGNALING PATHWAY%PANTHER PATHWAY%P00020,0.797774869109948,0.9308634013872809,-0.169408934170249,-0.7565992472779691,6094,28,MAPK9|LMNB1|PARP2|LMNA|GSN|FADD|CASP6
FGF SIGNALING PATHWAY%PANTHER PATHWAY%P00021,0.287338787962835,0.6604035198820261,0.176204758733555,1.1086570117916599,2071,91,MAP3K5|FGF14|FGFR2|MAP2K6|PPP2R2C|MAPK12|SPRY2|MAPK11|PRKCE|FRS3|SHC1|SOS1|YWHAQ|SPRY4|YWHAB|YWHAE|PRKCA|PLCG1|NRAS|MAP2K7|AKT3|MAP3K4|PPP2CB|FGF1|PPP2R5C|FGFR1|MAP2K1|MAP3K2|MAPK1|YWHAZ|FGF12|MAP2K4|MAPK8|PPP2R2D|RASA2
FLAVIN BIOSYNTHESIS%PANTHER PATHWAY%P02741,0.16410188378880303,0.535290477921284,-0.7556691467855,-1.25755430083322,1236,2,RFK
FORMYLTETRAHYDROFORMATE BIOSYNTHESIS%PANTHER PATHWAY%P02743,0.8259332023575641,0.942939457069048,-0.27568686481609,-0.709140882517908,6305,6,MTHFD2|TYMS|DHFR
FRUCTOSE GALACTOSE METABOLISM%PANTHER PATHWAY%P02744,0.106335436382755,0.448854219496123,-0.519037604640605,-1.41876614613352,808,7,HK1|GALT|ALDOA|ALDOC
GABA-B_RECEPTOR_II_SIGNALING%PANTHER PATHWAY%P05731,0.30203177910914303,0.6750267603004749,-0.244318546154087,-1.12595988576424,2318,31,ADCY8|PRKAR1A|CACNA1G|GNGT2|ADCY4|GNG11|PRKACA|GNG3|ADCY9
GAMMA-AMINOBUTYRIC ACID SYNTHESIS%PANTHER PATHWAY%P04384,0.643644181671594,0.8688307429995409,0.433605382155068,0.852850617897448,4789,3,CSAD|ABAT|ALDH5A1
GENERAL TRANSCRIPTION REGULATION%PANTHER PATHWAY%P00023,0.13760627861347302,0.50219949963275,-0.286762896015475,-1.30930324167971,1051,30,GTF2A2|BRF1|BRF2|GTF2A1|TAF12|TTF1|POLR2H|GTF2H1|TAF7|TAF9B|TAF9|AK6
GENERAL TRANSCRIPTION BY RNA POLYMERASE I%PANTHER PATHWAY%P00022,0.6559533496067261,0.874869342420871,0.234790746199702,0.843925058126973,4836,14,POLR1B|POLR1D|TBP|TAF1B|TAF8|TBPL1|RRN3|TAF1A
GLUTAMINE GLUTAMATE CONVERSION%PANTHER PATHWAY%P02745,0.5333601286173629,0.812079525085925,0.576862785061303,0.9692039606720642,3980,2,GLUD1|GLUL
GLYCOLYSIS%PANTHER PATHWAY%P00024,0.087047718930257,0.407749299171126,-0.406361461165545,-1.43764742585814,663,14,TPI1|PGAM2|GPI|HK1|ENO1|GAPDH|PGK1|ALDOA
UNTITLED%PANTHER PATHWAY%P06664,0.0514550264550265,0.327245273856257,-0.763648395279585,-1.49121177009089,388,3,SKIL|TGIF1|RELA
HEDGEHOG SIGNALING PATHWAY%PANTHER PATHWAY%P00025,0.9146803900325029,0.9740523336757891,0.169801010571823,0.6263259333623901,6753,15,STK36|BTRC|SUFU|UBR5|CSNK1E
HEME BIOSYNTHESIS%PANTHER PATHWAY%P02746,0.16585233441911,0.537721321518182,0.394583434277128,1.29842178883307,1221,11,HMBS|COX10|UROD|QARS|PPOX|CPOX|RSAD1|EPRS|EARS2
HETEROTRIMERIC G-PROTEIN SIGNALING PATHWAY-GI ALPHA AND GS ALPHA MEDIATED PATHWAY%PANTHER PATHWAY%P00026,0.0526046333034686,0.33213318038076395,-0.218190407283707,-1.3985502330804398,410,103,CREB3L2|CALM3|ADORA3|PHKG2|CLTA|PHKA1|CREB3|ADCY8|RGS18|PRKAR1A|CLTC|RGS4|CREB3L1|GNGT2|ADCY4|CREM|GNAI2|CHRM2|RAP1A|GNG10|ADRA2C|HTR1B|GRK6|PYGL|PRKACA|ADRBK1|PYGM|RGS2|KCNJ9|GNG3|RGS3|SSTR2|ADCY9|CLTB
HETEROTRIMERIC G-PROTEIN SIGNALING PATHWAY-GQ ALPHA AND GO ALPHA MEDIATED PATHWAY%PANTHER PATHWAY%P00027,0.34312348359085704,0.701955655133333,-0.173139728557845,-1.06978120527952,2686,89,GRK5|RGS1|PLCB1|GNG8|ITPR2|RGS16|PLCB3|ADORA3|ITPR3|CLTA|RGS18|CLTC|RGS4|GNGT2|CHRM2|GNAQ|CACNA1E|RAP1A|GNA15|GNG10|GRK6|ADRBK1|RGS2|KCNJ9|GNG3|RAP1GAP|RGS3|SSTR2|PRKCB|CLTB
HETEROTRIMERIC G-PROTEIN SIGNALING PATHWAY-ROD OUTER SEGMENT PHOTOTRANSDUCTION%PANTHER PATHWAY%P00028,0.31885044946881,0.6867397844771489,0.261116822872041,1.1085570572577401,2340,23,PDE6B|GNG5|GNGT1|CALM2|GNB5|GNB4
HISTAMINE H1 RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04385,0.8582212462256379,0.949948023858,0.143881459157294,0.7188680567933821,6252,39,PLCD1|GNG5|PLCD4|GNB5|PRKCE|GNB4|PLCB4|ITPR1|PRKCA|PLCG1
HISTAMINE H2 RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04386,0.899829998692298,0.9679192393052181,-0.159057809890641,-0.658699776280271,6880,22,GNGT2|GNG10|PRKACA|GNG3
HUNTINGTON DISEASE%PANTHER PATHWAY%P00029,0.158831003811944,0.529255584331913,-0.19372804075914699,-1.22207354580019,1249,96,MAPK9|DYNLL2|ARL4D|RHOG|CAPN1|ARF1|TUBB4A|RHOJ|CYFIP2|GAPDH|ACTG2|ARFIP2|GRIN2C|ARPC5L|GRIN2D|ACTB|ACTA2|DYNC1I1|TUBB4B|TUBB6|ARF6|SH3GL3|CLTB
HYPOXIA RESPONSE VIA HIF ACTIVATION%PANTHER PATHWAY%P00030,0.243499458288191,0.626082056933819,0.324081227237612,1.1954020559198502,1797,15,ARNT|AKT3|TXN2|EGLN2|MTOR|EGLN3|EGLN1|AKT2|TXN|HIF1A|RORC|AKT1|VHL|CREBBP|PTEN
INFLAMMATION MEDIATED BY CHEMOKINE AND CYTOKINE SIGNALING PATHWAY%PANTHER PATHWAY%P00031,0.00012863390789812198,0.00518555396908895,-0.283443483878712,-1.98109950886904,0,156,AKT1|ROCK1|CCL3|RAF1|MYH3|RAC2|CDC42|PAK2|GRAP|NFATC2|PTEN|CCL4|RAC1|ITGB1|LTB4R2|CCL8|ALOX5AP|ACTG1|CCL11|PAK4|PLCE1|JUNB|PLCB1|GNG8|FPR3|NFKB2|COL20A1|MYH11|IFNAR1|ITPR2|PLCB3|ARPC1A|ITPR3|VAV1|MYLK2|CASK|CCL3L3|FPR1|CCL18|MYLK|CXCR4|VWF|COL14A1|PLA2G4A|STAT3|RGS4|PTGS1|PIK3CB|MAPK3|RHOG|NFATC1|GNAI2|CCRL2|COL12A1|GNAQ|CCL2|COL6A3|CCR1|GNA15|ACTG2|GNG10|ARPC5L|ARAF|RELB|GRK6|CX3CL1|CAMK2A|CCL4L2|MYH9|RELA|COL6A1|PRKACA|ACTB|ACTA2|RRAS|GNG3|COL6A2|PLCL1|C5AR1|PRKCB
INSULIN IGF PATHWAY-MITOGEN ACTIVATED PROTEIN KINASE KINASE MAP KINASE CASCADE%PANTHER PATHWAY%P00032,0.162696335078534,0.5338644749822871,-0.28631705565797305,-1.2787239932456298,1242,28,ELK1|INS|IRS1|MAPK3|IGF1|MAP2K3|INSRR|RPS6KB1|RPS6KA4|RPS6KB2
INSULIN IGF PATHWAY-PROTEIN KINASE B SIGNALING CASCADE%PANTHER PATHWAY%P00033,0.7276174996613841,0.905828042456896,0.194424848993268,0.801448594036183,5371,21,IRS2|TSC2|FOXO3|IGF1R|INPPL1|IGF2|PDPK1|MDM4|MDM2|TSC1|PIK3CA
INTEGRIN SIGNALLING PATHWAY%PANTHER PATHWAY%P00034,0.000128849375080531,0.00518555396908895,-0.28825311068386106,-2.0047874140748,0,152,RAC1|ITGB1|RAP2C|ITGA9|ITGBL1|ACTG1|SOS2|ARL1|COL15A1|ITGAX|MAP3K3|LAMB2|LAMC1|COL27A1|PIK3C2A|ITGA10|COL20A1|ITGA11|ITGB2|LAMC2|COL11A2|RAPGEF1|LAMC3|ARPC1A|RAP2B|NTN4|ITGB5|TLN1|LAMA2|BCAR1|ILK|ITGA5|ELMO1|COL14A1|COL5A3|MAPK9|PXN|PIK3CB|MAPK3|COL4A1|FLNA|LAMA4|HRAS|PIK3R3|COL4A2|ARF1|COL5A2|DOCK1|LIMS2|COL12A1|COL6A3|RND1|MAP2K3|COL8A1|RAP1A|FN1|COL1A2|COL1A1|ARPC5L|VCL|ARAF|ITGA8|COL3A1|CAV1|COL6A1|MAPK13|ITGAM|ACTB|RRAS|COL16A1|COL5A1|ACTN1|COL6A2|ARF6|COL13A1|ITGB4
INTERFERON-GAMMA SIGNALING PATHWAY%PANTHER PATHWAY%P00035,0.908805460750853,0.9715076818387142,0.150141732707495,0.65415494726563,6656,25,PIAS3|SOCS5|MAPK12|MAPK11
INTERLEUKIN SIGNALING PATHWAY%PANTHER PATHWAY%P00036,0.335437330928765,0.6985008974614949,-0.18799005167741395,-1.07960011838245,2603,67,CDKN1B|AKT1|RAF1|JAK3|ELK4|IL10RA|STAT5A|SOS2|STAT6|SLA2|ELK3|RPS6KA1|ELK1|IL15RA|IL6ST|IL13RA1|MAPKAPK2|IL10RB|IRS1|STAT3|IL2RA|PIK3CB|MAPK3|SPI1|IL3RA|NOS3|ARAF|SRF|IL11|MYC
IONOTROPIC GLUTAMATE RECEPTOR PATHWAY%PANTHER PATHWAY%P00037,0.0253230648740373,0.22366681460209697,-0.36119265085935,-1.6331398688096002,193,29,GRIN3A|GRIN1|SLC1A2|STX11|CAMK2B|SLC1A3|VAMP8|GRIN2C|NSF|GRIN2D|CAMK2A|GRIA1
ISOLEUCINE BIOSYNTHESIS%PANTHER PATHWAY%P02748,0.558862433862434,0.8268422944617521,-0.475818570595099,-0.9291530726512629,4224,3,BCAT2
JAK STAT SIGNALING PATHWAY%PANTHER PATHWAY%P00038,0.8628248884221579,0.9529453970190659,-0.189284283281416,-0.6872605498440629,6572,15,PIAS1|MAPK14|PIAS2|JAK3|STAT5A|STAT6|SOCS1|STAT3
LEUCINE BIOSYNTHESIS%PANTHER PATHWAY%P02749,0.266914300875564,0.6417330323279019,-0.699290448987104,-1.16373113206506,2011,2,BCAT2
LIPOATE_BIOSYNTHESIS%PANTHER PATHWAY%P02750,0.0836764510559171,0.402388938341306,0.95892148213498,1.2785924064123702,629,1,LIAS
MANNOSE METABOLISM%PANTHER PATHWAY%P02752,0.343151893579476,0.701955655133333,0.42211464764852896,1.09224646068915,2527,6,GMPPA|PMM1|GMDS|PMM2
METABOTROPIC GLUTAMATE RECEPTOR GROUP III PATHWAY%PANTHER PATHWAY%P00039,0.0765168105114002,0.38654270614299796,-0.263660790205474,-1.39948298974655,593,50,GRIN3A|GRIN1|SLC1A2|PRKAR1A|GNGT2|SLC1A3|VAMP8|STX1B|GNAI2|CACNA1E|GNG10|GRIN2C|GRIN2D|PRKACA|GNG3|GRIA1
METABOTROPIC GLUTAMATE RECEPTOR GROUP II PATHWAY%PANTHER PATHWAY%P00040,0.260532437322306,0.636316525692816,-0.23784764969361802,-1.15545106158997,2015,37,PRKAR1A|GNGT2|VAMP8|STX1B|GNG11|GNAI2|CACNA1E|GNG10|PRKACA|GNG3
METABOTROPIC GLUTAMATE RECEPTOR GROUP I PATHWAY%PANTHER PATHWAY%P00041,0.007322175732217571,0.103466341553972,-0.483107321552279,-1.8746360800492599,55,18,GRIN3A|GRIN1|PRKAR1A|GNAQ|GNA15|GRIN2C|GRIN2D|PRKACA|PRKCB
METHIONINE BIOSYNTHESIS%PANTHER PATHWAY%P02753,0.99521848851109,0.99843337141011,0.502701808557565,0.670285030720578,7492,1,MTR
METHYLCITRATE CYCLE%PANTHER PATHWAY%P02754,0.430883523481029,0.759376613000886,-0.626723738228795,-1.0429685210736899,3247,2,ACO1
METHYLMALONYL PATHWAY%PANTHER PATHWAY%P02755,0.803821489333857,0.932964969466025,-0.332687323890536,-0.7283220961419341,6141,4,PCCB
MRNA SPLICING%PANTHER PATHWAY%P00058,0.28195686480799603,0.654732517474162,-0.486955320637455,-1.1671389839402,2143,5,PRPF3|SNRPA|SNRPB2|ZRSR2
MUSCARINIC ACETYLCHOLINE RECEPTOR 1 AND 3 SIGNALING PATHWAY%PANTHER PATHWAY%P00042,0.32786673553719,0.6950398637731511,-0.207168136043987,-1.09154764182534,2538,49,GNG8|ACHE|ITPR2|BCHE|ITPR3|GRIN3A|PKN1|GRIN1|GNGT2|VAMP8|STX1B|GNG11|GNAQ|GNG10|GRIN2C|GRIN2D|GNG3|PRKCB
MUSCARINIC ACETYLCHOLINE RECEPTOR 2 AND 4 SIGNALING PATHWAY%PANTHER PATHWAY%P00043,0.14903595622720198,0.5157092501209121,-0.251959828235444,-1.27793152842233,1143,43,PRKAR1A|STX11|GNGT2|VAMP8|SLC6A8|STX1B|GNG11|GNAI2|CHRM2|GNG10|PRKACA|KCNJ9|GNG3
N-ACETYLGLUCOSAMINE METABOLISM%PANTHER PATHWAY%P02756,0.7930582842174201,0.929621926733366,-0.285630257626364,-0.734717967437797,6054,6,NPL|GFPT2
NICOTINE_DEGRADATION%PANTHER PATHWAY%P05914,0.15959140355532,0.5293397224673839,-0.7586986490212301,-1.26259587700731,1202,2,FMO3|INMT
NICOTINE PHARMACODYNAMICS PATHWAY%PANTHER PATHWAY%P06587,0.12230999727594699,0.476255306135618,0.318444249192771,1.3519374810974198,897,23,DRD2|ADCY2|KCNK9|DRD4|CHRNB2|CHRNA5|CACNA1C|CHRNB4|KCNK3|DDC
NICOTINIC ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P00044,0.17393109173931098,0.548035161776014,0.22513873025425,1.23528667887722,1256,54,CHRNB1|MYO6|MYO1B|MYO1C|MYO15A|ACTR1B|SNAP25|CHRNB2|MYH15|MYO1D|CHRNA5|MYO18A|SLC18A3|MYO9A|CHRNB4|MYH10|VAMP3|STX16|MYO5A|SNAP23|SLC44A3
NOTCH SIGNALING PATHWAY%PANTHER PATHWAY%P00045,0.357919043738115,0.714938712241162,0.236236879396918,1.07026883190061,2634,28,LNX2|CIR1|ADAM17|NEURL4|DLL3|DLK1
O-ANTIGEN BIOSYNTHESIS%PANTHER PATHWAY%P02757,0.806369255576458,0.9337214381011629,0.372433503607767,0.7325327515515091,6000,3,TGDS|GFPT1
UNTITLED%PANTHER PATHWAY%P05916,0.506112469437653,0.798168488166378,0.21203080440160396,0.9606034499489409,3725,28,GNG5|ADCY2|SNAP25|GNB5|GNB4|GNAI3|VAMP3|SNAP23|GNAO1|GNG4|GNG12|ADCY7|GNB1|VAMP1
OPIOID PROENKEPHALIN PATHWAY%PANTHER PATHWAY%P05915,0.649280086932899,0.871371760105003,0.19070407742714698,0.8639829255605159,4779,28,GNG5|ADCY2|SNAP25|GNB5|GNB4|GNAI3|VAMP3|SNAP23|GNG4|GNG12|ADCY7|GNB1|VAMP1|PENK|VAMP2
OPIOID PROOPIOMELANOCORTIN PATHWAY%PANTHER PATHWAY%P05917,0.646097261953412,0.8695665790500171,0.189629332535616,0.8678629538688621,4742,29,GNG5|ADCY2|SNAP25|GNB5|GNB4|GNAI3|VAMP3|SNAP23|GNAO1|GNG4|GNG12|ADCY7|GNB1|VAMP1
ORNITHINE DEGRADATION%PANTHER PATHWAY%P02758,0.764579414135985,0.9191113740914171,0.38972014627416207,0.766533537718262,5689,3,AZIN2|AZIN1
OXIDATIVE STRESS RESPONSE%PANTHER PATHWAY%P00046,0.350116614076005,0.7077980036270408,0.21223768727895498,1.07574256228143,2551,41,DUSP4|DUSP6|DUSP18|DUSP10|MAP2K6|DUSP19|MAPK12|MAPK11
OXYTOCIN RECEPTOR MEDIATED SIGNALING PATHWAY%PANTHER PATHWAY%P04391,0.818964392852485,0.9389317625496709,-0.148971312999995,-0.759405416076332,6278,44,GNGT2|VAMP8|GNAQ|GNG10|STX3|GNG3|PLCL1|PRKCB
P38 MAPK PATHWAY%PANTHER PATHWAY%P05918,0.758993743482795,0.917242163810958,-0.16961365148955498,-0.788975844583594,5822,32,ATF1|ELK1|MAPKAPK2|MEF2C|HSPB1|SRF|IL1R1|MAPK13|RPS6KA4
P53 PATHWAY BY GLUCOSE DEPRIVATION%PANTHER PATHWAY%P04397,0.729136548823761,0.906471456078912,-0.202188047603463,-0.798826113599763,5547,19,PPP2CA|RPS6KB1|RPS6KB2
P53 PATHWAY FEEDBACK LOOPS 1%PANTHER PATHWAY%P04392,0.244396141828556,0.627316259271964,0.549413046905424,1.2070838622556699,1798,4,RFWD2|MDM4|MDM2|TP53
P53 PATHWAY FEEDBACK LOOPS 2%PANTHER PATHWAY%P04398,0.9066867634968481,0.9709695261809209,0.136015948134566,0.6739788932879169,6616,38,CDKN1A|MAPK12|MAPK11|ATM|CCNE1|NRAS|AKT3|PPP2CB|RB1|PIK3R2|ATR|KRAS|PDPK1
P53 PATHWAY%PANTHER PATHWAY%P00059,0.76768592899715,0.920345060816693,-0.158341963712016,-0.7979040157788199,5924,42,CDKN2A|TRAF2|CDC25C|SUMO2|GADD45B|SUMO3|CCNB1|KAT2B|PPP2CA|GADD45G|MTA2
PARKINSON DISEASE%PANTHER PATHWAY%P00049,0.305551977328352,0.677423587903087,-0.18444065954183606,-1.0970255083581801,2371,77,HSPA6|MAPK9|HSPA9|MAPK3|TOR2A|STX7|PSMB3|HCK|SNCG|PSMA3|ADRBK1|HSPA5|SNCB|UBE2L6|CSNK1A1|PSMA6|PSMB7|PSMA1
PDGF SIGNALING PATHWAY%PANTHER PATHWAY%P00047,0.45928965251955395,0.7735063645065241,-0.15118016463190198,-0.996899182651342,3581,117,ETS1|GSK3B|GRAP2|PLCG2|RAF1|PIK3R5|JAK3|GRAP|ELK4|GABPA|RPS6KA5|IKBKAP|ARHGAP4|STAT5A|SOS2|STAT6|RASA4|VAV3|RPS6KA1|ITPR2|ETV3|ARHGAP15|ITPR3|VAV1|ELK1|RERG|FLI1|MAPKAPK2|GRB2|STAT3|PIK3CB|ARHGAP42|MAPK3|USF2|HRAS|PIK3R3|ARHGAP1|ARAF|SRF|PDGFRB|ERG|MYC|ARHGAP8|RPS6KB1|RPS6KA4|PDGFA|PDGFRA|NCK1|RPS6KB2|PDGFB
PENTOSE PHOSPHATE PATHWAY%PANTHER PATHWAY%P02762,0.220951629863302,0.6033436178707641,-0.45096232468442105,-1.23268540414707,1680,7,TKT|GPI|HK1|TALDO1
PHENYLETHYLAMINE DEGRADATION%PANTHER PATHWAY%P02766,0.24343327142478102,0.626082056933819,-0.711429235257087,-1.18393201355618,1834,2,AOC3
PI3 KINASE PATHWAY%PANTHER PATHWAY%P00048,0.7135268204197981,0.8981683351717429,-0.165481463173499,-0.833880803974582,5506,42,IRS1|PIK3CB|GNGT2|PIK3R3|GNAI2|GNAQ|NOS3|RPS6KB1|RPS6KB2
PLASMINOGEN ACTIVATING CASCADE%PANTHER PATHWAY%P00050,0.00026288117770767596,0.00819882332206558,-0.810093767236625,-2.21435518712545,1,7,PLAU|MMP1|PLAUR|MMP9|SERPINE1|PLAT|SERPINF2
PURINE METABOLISM%PANTHER PATHWAY%P02769,0.530278670953912,0.811490026766563,0.5786185172318471,0.9721538174103349,3957,2,NT5E|AMPD3
PYRIDOXAL-5-PHOSPHATE BIOSYNTHESIS%PANTHER PATHWAY%P02759,0.41761740514725393,0.7501260137357559,-0.63272023203562,-1.05294764567971,3147,2,PNPO
PYRIDOXAL PHOSPHATE SALVAGE PATHWAY%PANTHER PATHWAY%P02770,0.004510480233483679,0.0743264309917645,-0.957926661152468,-1.59414314814819,33,2,PNPO|PDXK
PYRIMIDINE METABOLISM%PANTHER PATHWAY%P02771,0.35956284153005497,0.7155384949577859,0.37103147596030295,1.07703946422015,2631,8,DPYSL5|NT5E|DPYD|DPYSL2|DPYSL3|ALDH6A1|ABAT
PYRUVATE METABOLISM%PANTHER PATHWAY%P02772,0.412066246056782,0.746306769569813,-0.37926089354660797,-1.03669273961153,3134,7,ACLY|CS|PC|ME1|PKM|CLYBL|PDHA1
RAS PATHWAY%PANTHER PATHWAY%P04393,0.912203807697576,0.97288815425551,0.119441897064141,0.701416241820778,6659,69,PLD2|RHOC|RALB|RPS6KA2|MAP2K6|MAPK12|MAPK11|SHC1|SOS1|MAPKAPK3|PAK1|NRAS|MAP2K7|AKT3|MAP3K4|ATF2|MAP2K1|MAPK1|KRAS|RPS6KA6|MAP2K4|MAPK8|PDPK1
S-ADENOSYLMETHIONINE BIOSYNTHESIS%PANTHER PATHWAY%P02773,0.679394426580922,0.884536278926676,0.5062423036779979,0.8505524337686708,5070,2,MAT2A|MTR
SALVAGE PYRIMIDINE DEOXYRIBONUCLEOTIDES%PANTHER PATHWAY%P02774,0.277116402116402,0.652442157557974,-0.600821408886915,-1.17325193399605,2094,3,CDA|TK1
SALVAGE PYRIMIDINE RIBONUCLEOTIDES%PANTHER PATHWAY%P02775,0.72186034392913,0.9019989179378242,-0.262828320984558,-0.7906519226519191,5540,9,NME2|UCK1
SERINE GLYCINE BIOSYNTHESIS%PANTHER PATHWAY%P02776,0.9125661375661379,0.972925642245441,-0.32408734972978903,-0.6328604544211529,6898,3,PSAT1|PSPH|PHGDH
SUCCINATE TO PROPRIONATE CONVERSION%PANTHER PATHWAY%P02777,0.622883597883598,0.857007260823118,-0.44631278752417297,-0.871535756523721,4708,3,PCCB
SYNAPTIC_VESICLE_TRAFFICKING%PANTHER PATHWAY%P05734,0.808811531139516,0.9342433549901921,0.18874096171514998,0.7388126578010079,5947,18,SYT2|RIMS1|SNAP25|SYT5
TCA CYCLE%PANTHER PATHWAY%P00051,0.512506513809276,0.802184867798321,-0.314783998498599,-0.946947317932299,3933,9,PDK2|ACO2|SDHC|FH|PDHA1
T CELL ACTIVATION%PANTHER PATHWAY%P00053,0.992909630011602,0.997305769352475,-0.0909293562556538,-0.509915928865547,7701,61,PRKCQ|MAP3K1|MAP2K2|GRAP2|LCP2|AKT1|RAF1|CDC42|PAK2|RAC1|SOS2|VAV3|CALM3|VAV1|WAS|MAPK9|PIK3CB|MAPK3|HRAS|PIK3R3|CD86|NFKBIA|ARAF|NCK1
TETRAHYDROFOLATE BIOSYNTHESIS%PANTHER PATHWAY%P02742,0.898211467648606,0.967428248648255,-0.269468262445238,-0.6458640058039771,6829,5,TYMS|DHFR
TGF-BETA SIGNALING PATHWAY%PANTHER PATHWAY%P00052,0.670319134365156,0.8815356925073421,0.149415739452629,0.8774360505966841,4893,69,FKBP1B|ACVR1|CITED1|SMAD3|MAPK12|MAPK11|GDF1|BMP7|SMAD1|ACVR2A|LEFTY1|CITED2|ZFYVE16|SKI|NRAS|ATF2|ZFYVE9|BMPR1A|GDF9|BMPR2|MAPK1|BMP1|ACVR2B|MAPK8|EP300|BMPR1B|DCP1B|ACVR1B|SMAD2
THIAMINE METABOLISM%PANTHER PATHWAY%P02780,0.8328469089944279,0.9443921657118071,-0.4421106012131721,-0.735742739219445,6277,2,THTPA
THREONINE BIOSYNTHESIS%PANTHER PATHWAY%P02781,0.0605658121928543,0.355936982159638,0.969783855315395,1.2930759153574098,455,1,THNSL1
THYROTROPIN-RELEASING HORMONE RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P04394,0.607956900124327,0.849421970741672,0.16811240082720702,0.902180854336385,4400,50,PLCD1|GNG5|PLCD4|TRH|SNAP25|GNB5|PRKCE|CACNB4|GNB4|PLCB4|VAMP3|CACNB2|PRKCA|PLCG1|SNAP23
TOLL RECEPTOR SIGNALING PATHWAY%PANTHER PATHWAY%P00054,0.0211941070043939,0.201150083379966,-0.336319022565107,-1.6338196831304699,163,37,TLR2|TICAM2|ELK1|TNFAIP3|IKBKE|MAPK9|MAPK3|IRAK1|MAP2K3|NFKBIA|TICAM1|TLR4|TOLLIP|CD14|LY96
TRANSCRIPTION REGULATION BY BZIP TRANSCRIPTION FACTOR%PANTHER PATHWAY%P00055,0.128554733151539,0.48585005379339,-0.25428235325736803,-1.30709892107507,989,45,GTF2E1|POLR2F|CREBBP|POLR2C|PRKAR2A|PSMC3IP|GTF2A2|BRF1|BRF2|CREB3L2|GTF2A1|TAF12|PRKAR1A|TTF1|POLR2H|GTF2H1|CREB3L1|TAF7|TAF9B|TAF9|AK6|POLR2L
TRIACYLGLYCEROL METABOLISM%PANTHER PATHWAY%P02782,0.477056856187291,0.7850984235874658,-0.764170710189678,-1.01805887418095,3565,1,LIPE
UBIQUITIN PROTEASOME PATHWAY%PANTHER PATHWAY%P00060,0.314848406322882,0.684278800146095,-0.21854731140777697,-1.10128593407546,2429,42,WWP1|UBE2V2|UBE3C|UBE2E1|UBA7|SAE1|UBA3|PSMD7|SMURF1|UBE2N|UBE2L3|UBE2A|UBE2D2|ATG7|PSMD1|UBE2T|UBE2B|UBE2G2|PSMD4|SMURF2|UBE2S|PSMC4|UBA1|PSMD2|UBE2L6|PSMD13
VALINE BIOSYNTHESIS%PANTHER PATHWAY%P02785,0.558862433862434,0.8268422944617521,-0.475818570595099,-0.9291530726512629,4224,3,BCAT2
VASOPRESSIN SYNTHESIS%PANTHER PATHWAY%P04395,0.17267267267267303,0.546371269738967,0.4257491850288,1.2938125064585402,1264,9,NHLRC3|PAM|SEC11A|PREPL|PREP|SPCS3
VEGF SIGNALING PATHWAY%PANTHER PATHWAY%P00056,0.0646289340758969,0.364923210784497,-0.25758411811850196,-1.4233965476433799,498,58,MAPKAPK2|PLA2G4A|PRKD1|PXN|PIK3CB|MAPK3|HSPB1|HRAS|PIK3R3|ARHGAP1|NOS3|ARAF|CRYAB|ARHGAP8|SPHK1|PRKCB
VITAMIN B6 METABOLISM%PANTHER PATHWAY%P02787,0.0424603174603175,0.294833299013666,-0.7752530426714129,-1.51387270526133,320,3,PNPO|PDXK
VITAMIN D METABOLISM AND PATHWAY%PANTHER PATHWAY%P04396,0.173753566091564,0.5479109400550349,0.5910537261115141,1.29857020784966,1278,4,CYP27B1|CYP27A1
WNT SIGNALING PATHWAY%PANTHER PATHWAY%P00057,0.9505555555555559,0.985300779592887,0.0985429460001643,0.743733901539004,6843,218,TLE6|WNT6|TLE2|KREMEN1|SFRP1|GNG5|PCDHGB6|CTNNA2|TCF7L1|PCDHA10|PCDHA3|WNT5B|SMARCAL1|TLE3|FAT1|CDHR1|PCDHA1|HDAC1|WNT2B|PCDHGB2|ARRB2|AES|PRKCE|BTRC|SMAD1|GNB4|PPP3R1|TBL1XR1|PLCB4|PCDHAC1|CELSR3|DVL2|PCDHGC3
XANTHINE AND GUANINE SALVAGE PATHWAY%PANTHER PATHWAY%P02788,0.182671957671958,0.556308895147568,-0.651510433742807,-1.27223475245907,1380,3,HPRT1|PNP
CHONDROITIN SULFATE BIOSYNTHESIS%REACTOME%R-HSA-2022870.1,0.580062794348509,0.8386526275338391,-0.24352022796361397,-0.9050154599311151,4433,16,DCN|CHST7|BGN|VCAN|CSGALNACT1
FGFR1 MUTANT RECEPTOR ACTIVATION%REACTOME%R-HSA-1839124.2,0.082800815771584,0.40048607184380897,0.34242919643555203,1.4330499280238602,608,22,GAB2|FGFR1OP|ZMYM2|LRRFIP1|FGF2|MYO18A
INTERLEUKIN-10 SIGNALING%REACTOME%R-HSA-6783783.3,0.000259976602105811,0.00819882332206558,-0.49037821832063505,-2.32330595602266,1,34,LIF|IL1B|CCL3|TNF|CCL4|CXCL1|IL10RA|CXCL2|IL18|CCL19|IL1RN|CCL3L3|FPR1|IL10RB|STAT3|ICAM1|CSF1|CCL2|CCR1|CD86|PTAFR|IL1R1|TIMP1|TNFRSF1A|TNFRSF1B
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN%REACTOME DATABASE ID RELEASE 66%1237044,0.812923397602918,0.9356336309698571,-0.237440931615826,-0.7142804412974431,6239,9,HBB|HBA1|AQP1|CA2|CYB5R1
ELECTRON TRANSPORT FROM NADPH TO FERREDOXIN%REACTOME%R-HSA-2395516.1,0.228701961838216,0.610365144973336,0.625076516360726,1.22945174379958,1701,3,FDX1L|FDXR|FDX1
EGFR INTERACTS WITH PHOSPHOLIPASE C-GAMMA%REACTOME DATABASE ID RELEASE 66%212718,0.17055198285101802,0.544171946973796,0.75616211745244,1.27044998936306,1272,2,PLCG1|EGFR
CREATINE METABOLISM%REACTOME DATABASE ID RELEASE 66%71288,0.7580178759200841,0.917143966125732,-0.277480884306097,-0.7584816231673179,5766,7,SLC6A8|CKB
PHASE II - CONJUGATION OF COMPOUNDS%REACTOME DATABASE ID RELEASE 66%156580,0.501104362230812,0.795954687014814,0.16895300212546,0.9727461579611001,3629,64,PAPSS1|SULT1C4|GSTM2|GSTM4|SULT4A1|GSTM1|GSTK1|MGST3|AS3MT|GSS|GSTT2|TPST1|GCLM|SLC35D1|SLC35B2|BPNT1|TPMT|UGDH|GSTT2B|AKR1A1|SLC35B3|MGST2|MAT2A|GSTZ1|SLC26A1
PRE-NOTCH EXPRESSION AND PROCESSING%REACTOME DATABASE ID RELEASE 66%1912422,0.00012745347947999,0.00518555396908895,-0.393594565188451,-2.39110155861539,0,83,HIST1H2BE|TFDP2|RUNX1|H2AFX|HIST2H2AC|ATP2A1|HIST1H2AD|HIST1H2BN|H2AFV|ATP2A3|HIST1H2BC|NOTCH1|SEL1L|HIST1H4I|SNW1|NOTCH2|TNRC6C|E2F1|NOTCH3|TMED2|HIST2H3A|KAT2B|H2AFZ|HIST2H2AA4|MAML1|B4GALT1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|CCND1|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
CYTOSOLIC SULFONATION OF SMALL MOLECULES%REACTOME DATABASE ID RELEASE 66%156584,0.6454681342573722,0.86907298954767,0.22301521519647602,0.8575599457946059,4749,17,PAPSS1|SULT1C4|SULT4A1|TPST1|SLC35B2|BPNT1|SLC35B3|SLC26A1|PAPSS2
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS%REACTOME DATABASE ID RELEASE 66%168274,0.877266205817139,0.960725750963158,-0.155292367336836,-0.684915207685186,6725,27,NUP188|NUP85|NUP37|RAN|NUP160|NUP214
SIGNALING BY TGF-BETA FAMILY MEMBERS%REACTOME DATABASE ID RELEASE 66%9006936,0.44892473118279597,0.768229288546963,-0.160684171400866,-1.00353496919873,3506,93,SMAD4|UBB|MTMR4|CDK9|TGFBR1|UBE2M|RNF111|SMAD7|TGIF2|RBL1|RHOA|SMURF1|AMHR2|PPP1R15A|CCNT1|F11R|PPM1A|FURIN|FSTL1|CHRDL1|SMAD9|FST|TGFB1|USP15|INHBB|JUNB|TFDP2|SKIL|PARP1|UCHL5|USP9X|SMAD6|CCNK|TGIF1|SMAD5|INHBA|SMURF2|CDKN2B|SNW1|MEN1|NEDD8|TGFBR2|BMP2|WWTR1|UBC|FKBP1A|SERPINE1|MYC|DRAP1|PPP1CA|ACVRL1
G1 PHASE%REACTOME%R-HSA-69236.4,0.0226742679450635,0.20908271623893998,-0.324302585036483,-1.63419935475023,174,42,CUL1|E2F3|RBL1|CDKN2D|CDKN1B|CDK4|SKP2|CCNH|CCND2|LYN|CDK6|TFDP2|CDKN1C|CDKN2A|PPP2R3B|E2F2|CDKN2B|ABL1|SKP1|E2F1|CDK7|PPP2CA|UBC|MNAT1|CCND3|CDKN2C|CCND1
LOSS OF FUNCTION OF TGFBR2 IN CANCER%REACTOME%R-HSA-3642278.1,0.18583954979714698,0.559093571852282,-0.5880054757869301,-1.28726690172596,1419,4,TGFBR2|FKBP1A
BIOSYNTHESIS OF DHA-DERIVED SULFIDO CONJUGATES%REACTOME%R-HSA-9026395.1,0.618569131832797,0.854944793214197,0.5407026763060689,0.9084503091426429,4616,2,GSTM4
BIOSYNTHESIS OF D-SERIES RESOLVINS%REACTOME DATABASE ID RELEASE 66%9018676,0.998938710533298,0.999656642395059,-0.271408877860491,-0.45166777430263505,7529,2,LTA4H|ALOX5
GLYCOPROTEIN HORMONES%REACTOME DATABASE ID RELEASE 66%209822,0.358465608465608,0.714938712241162,-0.563306496084703,-1.0999948174089,2709,3,INHA|INHBB|INHBA
GSD IV%REACTOME DATABASE ID RELEASE 66%3878781,0.017123745819398,0.17803435145825502,-0.991674018526687,-1.32114790765167,127,1,GYG2
"TRISTETRAPROLIN (TTP, ZFP36) BINDS AND DESTABILIZES MRNA%REACTOME%R-HSA-450513.2",0.8120094191522759,0.935317461845028,-0.198392816100285,-0.737304523782131,6206,16,DCP1A|EXOSC9|DCP2|XRN1|EXOSC7|EXOSC4|MAPKAPK2|EXOSC3|EXOSC2
PHOSPHORYLATION SITE MUTANTS OF CTNNB1 ARE NOT TARGETED TO THE PROTEASOME BY THE DESTRUCTION COMPLEX%REACTOME%R-HSA-4839743.1,0.744946180099764,0.9112137767014771,-0.216311665379097,-0.785392593135168,5674,15,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|CTNNB1|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
SEMA4D INDUCED CELL MIGRATION AND GROWTH-CONE COLLAPSE%REACTOME DATABASE ID RELEASE 66%416572,0.9236430542778291,0.9776627603891009,-0.15681287856295498,-0.619553053850702,7027,19,RND1|MYH9|MYL9
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION%REACTOME DATABASE ID RELEASE 66%6804760,0.3833355877181121,0.730480369014206,0.263898244835319,1.0521316628317399,2833,19,RPS27A|ATM|L3MBTL1|SETD9|JMY|CHEK2|EP300|MDM4|TTC5|MDM2|UBA52
GENE AND PROTEIN EXPRESSION BY JAK-STAT SIGNALING AFTER INTERLEUKIN-12 STIMULATION%REACTOME%R-HSA-8950505.2,0.0382165605095541,0.278935415865459,-0.326984381981901,-1.5491812927307,293,34,LCP1|BOLA2B|RPLP0|RAP1B|CDC42|PAK2|CNN2|PPIA|SOD2|HNRNPA2B1|HSPA9|PSME2|LMNB1|SNRPA1|MSN|SOD1|ARF1|AIP|CFL1|ANXA2|TALDO1
NUCLEOTIDE SALVAGE%REACTOME DATABASE ID RELEASE 66%8956321,0.35792098700616903,0.714938712241162,-0.26388295631339603,-1.07506106406751,2726,21,TYMP|HPRT1|CDA|TK1|PNP|UCK1
GAP-FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG-NER%REACTOME DATABASE ID RELEASE 66%5696397,0.0709912726325388,0.3767214120425879,-0.34090100594957595,-1.46967200391932,544,25,POLE|RFC2|RPA2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|UBC|POLE2|POLE3|RFC4
MITOPHAGY%REACTOME%R-HSA-5205647.2,0.922394678492239,0.9776156396135859,-0.143244815854384,-0.631779619843936,7071,27,UBC|TOMM5|SQSTM1
CHK1 CHK2(CDS1) MEDIATED INACTIVATION OF CYCLIN B:CDK1 COMPLEX%REACTOME%R-HSA-75035.4,0.624711473183978,0.85807802168034,0.246661084958495,0.863858545189307,4600,13,YWHAQ|YWHAB|YWHAE|YWHAH|YWHAZ|CHEK2|CDK1
REMOVAL OF AMINOTERMINAL PROPEPTIDES FROM GAMMA-CARBOXYLATED PROTEINS%REACTOME DATABASE ID RELEASE 66%159782,0.7410071942446039,0.9098143075756671,0.298598155838998,0.7726402784179449,5458,6,PROC|PROS1|FURIN|BGLAP|F10|GAS6
GENE SILENCING BY RNA%REACTOME%R-HSA-211000.2,0.0008955987717502561,0.0214437672455875,-0.29253892563794504,-1.86686696720478,6,101,HIST2H2AC|POLR2J|HIST1H2AD|TSNAX|HIST1H2BN|H2AFV|HIST1H2BC|NUP188|PIWIL1|HIST1H4I|NUP85|POLR2H|TNRC6C|NUP37|RAN|HIST2H3A|NUP160|NUP214|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|POLR2G|HIST2H3C|HIST1H3H|HSP90AA1|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
S37 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED%REACTOME%R-HSA-5358749.1,0.744946180099764,0.9112137767014771,-0.216311665379097,-0.785392593135168,5674,15,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|CTNNB1|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
O-LINKED GLYCOSYLATION OF MUCINS%REACTOME DATABASE ID RELEASE 66%913709,0.0426963207029105,0.29573139571765,0.29615988669834903,1.51379045242154,310,42,GALNT3|GALNT8|GALNTL6|GALNT12|B3GNT9|B3GNT2|B4GALT5|GALNT7|B3GNT7|GALNT14|GALNT6|GALNT2|GALNT9
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE%REACTOME DATABASE ID RELEASE 66%1660517,0.137622149837134,0.50219949963275,0.410418168313346,1.35052778697429,1013,11,FIG4|PIKFYVE|MTMR9|MTMR2
DEADENYLATION-DEPENDENT MRNA DECAY%REACTOME DATABASE ID RELEASE 66%429914,0.5619257150252359,0.828264770520601,-0.17073917384965195,-0.9349422910369509,4341,56,LSM3|NT5C3B|EIF4A3|EXOSC3|TNKS1BP1|EIF4A2|EXOSC2|EIF4G1
CELLULAR SENESCENCE%REACTOME DATABASE ID RELEASE 66%2559583,0.000256739409499358,0.00819882332206558,-0.28018794654621604,-1.96778160917898,1,160,H1F0|PHC2|HIST1H2BE|ANAPC10|RPS6KA1|TFDP2|TERF2|EZH2|ANAPC2|H2AFX|NBN|TINF2|ANAPC5|HIST2H2AC|HIST1H2AD|CDC23|CDKN2A|HIST1H2BN|H2AFV|E2F2|ETS2|HIST1H2BC|MAPKAPK2|STAT3|MAPK9|HIST1H4I|LMNB1|CDKN2B|MAPK3|RBBP7|CDC27|CBX4|CEBPB|TNRC6C|E2F1|CBX6|HIST2H3A|MAP2K3|RING1|H2AFZ|UBC|HIST2H2AA4|ID1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|RELA|NFKB1|CDKN2C|HIST1H3H|KAT5|HIST1H1C|HIST2H4B|ANAPC11|H3F3B|HIST1H2AC|IGFBP7|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
SEROTONIN RECEPTORS%REACTOME DATABASE ID RELEASE 66%390666,0.130836120401338,0.49066507924967295,-0.933557565063961,-1.2437228370559,977,1,HTR1B
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION%REACTOME%R-HSA-69273.6,0.0858408232382441,0.4055062447746421,-0.330038568113398,-1.4228425123556998,658,25,PPP2R3B|PKMYT1|CDC25C|FOXM1|CCNB1|PLK1|CDK7|PPP2CA|MNAT1
FCERI MEDIATED MAPK ACTIVATION%REACTOME DATABASE ID RELEASE 66%2871796,0.6213211249182471,0.855976969451052,-0.193667158429422,-0.8842463298489541,4749,30,GRAP2|PLCG2|LCP2|PAK2|SYK|RAC1|IGKV3-11|LYN|VAV3|VAV1|IGKV2-28|MAPK9|MAPK3|HRAS|IGKV2D-28
TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT%REACTOME DATABASE ID RELEASE 66%159231,0.876584734799483,0.960725750963158,-0.14502039066894298,-0.698313764952381,6775,36,CPSF2|NUP188|NCBP1|NUP85|NUP37|NXF1|NUP160|NUP214
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO%REACTOME DATABASE ID RELEASE 66%428542,0.20966420966421,0.591121718803026,0.4075804647742461,1.23859944130587,1535,9,SLIT1|ROBO2|SLIT3|DCC|SRC|NELL2
FGFR2 MUTANT RECEPTOR ACTIVATION%REACTOME%R-HSA-1839126.2,0.19000915391656897,0.563730132212879,-0.301906901467205,-1.25027503264786,1452,22,NCBP2|POLR2J|NCBP1|POLR2H|FGF10|FGF9|FGF7|POLR2G|POLR2L
INTERLEUKIN-20 FAMILY SIGNALING%REACTOME%R-HSA-8854691.6,0.938647089669638,0.980854185905783,-0.16760103040872198,-0.592947936664968,7159,14,IL10RB|STAT3|IFNLR1
MINERALOCORTICOID BIOSYNTHESIS%REACTOME%R-HSA-193993.2,0.67153672466463,0.8815356925073421,0.6622739303043671,0.883052923547753,5055,1,CYP21A2
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING%REACTOME%R-HSA-163210.2,0.37486924686192497,0.7254276229586741,-0.27382202565542,-1.06253129668265,2866,18,ATP5J|ATP5F1|ATP5B|ATP5O|ATP5H|ATP5G1
VITAMINS B6 ACTIVATION TO PYRIDOXAL PHOSPHATE%REACTOME%R-HSA-964975.1,0.004510480233483679,0.0743264309917645,-0.957926661152468,-1.59414314814819,33,2,PNPO|PDXK
DEFECTIVE EXT2 CAUSES EXOSTOSES 2%REACTOME%R-HSA-3656237.2,0.45308675550720706,0.769943206592495,0.313606736608355,0.993527339852699,3331,10,GPC6|SDC1|AGRN|GPC1|GPC2|GPC3
INTERLEUKIN-37 SIGNALING%REACTOME DATABASE ID RELEASE 66%9008059,0.43908077236877896,0.764869745576875,0.25771423413185196,1.00880347616043,3228,18,SMAD3|PTPN4|PTPN12|PTPN9|PTPN20|PTPN18
ADENOSINE P1 RECEPTORS%REACTOME%R-HSA-417973.1,0.16474066111260402,0.536216605480707,0.66120222732057,1.30050675414322,1225,3,ADORA2B|ADORA2A
MITOCHONDRIAL ABC TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%1369007,0.7799212063578321,0.924704689181848,0.34298234142798806,0.7535468109253959,5740,4,ABCB6|ABCB10|ABCB8
ABACAVIR METABOLISM%REACTOME%R-HSA-2161541.3,0.0952700886858371,0.425159778692037,0.7174975136987309,1.4112329391682,708,3,ADAL|NT5C2|GUK1
AMYLOID FIBER FORMATION%REACTOME%R-HSA-977225.5,0.000129165590286748,0.00518555396908895,-0.41821223750657105,-2.42839224741452,0,70,HIST1H2BE|B2M|SNCAIP|H2AFX|HIST2H2AC|HIST1H2AD|USP9X|GGA2|HIST1H2BN|INS|HIST1H2BC|SIAH2|GGA3|HIST1H4I|HIST2H3A|GSN|H2AFZ|MFGE8|UBC|HIST2H2AA4|HIST1H2BG|HIST1H2BD|TSPAN15|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|TGFBI|HIST2H4B|TSPAN33|UBE2L6|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|CST3
PI AND PC TRANSPORT BETWEEN ER AND GOLGI MEMBRANES%REACTOME%R-HSA-1483196.2,0.536060565812193,0.8132910857498922,0.7305359505955009,0.9740711168165991,4035,1,PITPNB
CITRIC ACID CYCLE (TCA CYCLE)%REACTOME%R-HSA-71403.2,0.24558650451157302,0.6280519349499749,-0.28634627235888,-1.18583441876363,1877,22,MDH2|IDH3A|IDH2|SUCLG2|ACO2|ME3|DLST|SDHC|FH|SDHB|SDHD|IDH3G|SDHA
PLC-GAMMA1 SIGNALLING%REACTOME DATABASE ID RELEASE 66%167021,0.996164021164021,0.9988721305072571,-0.237496383952538,-0.46377024464823996,7530,3,NTRK1|NGF
BETAKLOTHO-MEDIATED LIGAND BINDING%REACTOME DATABASE ID RELEASE 66%1307965,0.131865216237729,0.491539110043253,-0.77628894403088,-1.29186894080303,993,2,FGFR4|FGF19
BUTYROPHILIN (BTN) FAMILY INTERACTIONS%REACTOME DATABASE ID RELEASE 66%8851680,0.323360655737705,0.6919725829786961,0.383368999847954,1.1128531376648798,2366,8,PPL|BTN3A1|BTN3A2|BTN3A3|BTN2A1
INFLUENZA LIFE CYCLE%REACTOME DATABASE ID RELEASE 66%168255,0.36551724137930997,0.719912723446385,-0.15444524893769598,-1.05071774282515,2861,136,KPNB1|CANX|CLTA|RPLP2|NUP188|RPS14|RPS4X|RPL35A|CLTC|RPS29|NUP85|RPL10|RPL36A|RPL24|POLR2H|RPL22L1|CALR|NUP37|RAN|NUP160|RPL35|RPL38|RPS15A|NUP214|RPL36AL|RPS13|POLR2G|RPL26L1|FAU|HSP90AA1|POLR2L
METABOLISM OF COFACTORS%REACTOME%R-HSA-8978934.2,0.0965589428234986,0.42759608527799,-0.372692683256365,-1.41632320651569,737,17,COQ6|DHFR|COQ7|NOS3|PDSS1|HSP90AA1|COQ3
PYRIMIDINE SALVAGE%REACTOME%R-HSA-73614.3,0.21678870292886998,0.599597524514766,-0.39485453957034106,-1.23702772798656,1657,10,TYMP|CDA|TK1|UCK1
MITOTIC METAPHASE AND ANAPHASE%REACTOME DATABASE ID RELEASE 66%2555396,0.00012809017548354,0.00518555396908895,-0.31744908958942303,-2.2674311222651697,0,174,NUF2|NSL1|PSMD1|PSMC2|SPDL1|CDC20|DYNC1H1|ANAPC10|CLIP1|DSN1|ANAPC2|ANAPC5|LEMD3|ESPL1|PSMD3|PSMB2|CENPM|CDC23|STAG2|NUDC|PSMF1|PTTG1|CENPI|MAD2L1|KNTC1|PSMD4|SHFM1|ERCC6L|PSME2|DYNLL2|LMNB1|INCENP|NUP85|PSMB5|NDC80|SGOL1|KIF18A|CDC27|SEC13|NUP37|CKAP5|CENPH|PSMC4|SPC25|PSMC6|NUP160|PSMD10|KIF2A|PLK1|SKA1|PSMB3|PPP2CA|PSMC1|SPC24|PSMD2|UBC|PSMD6|SMC1A|PSMD12|PSMA3|VRK1|DYNC1I1|BIRC5|ANAPC11|CENPK|PSMA6|PSMD13|PSMB7|EMD|CDCA5|PSMA1|BANF1|PSMC5|PSMC3|CENPP|SKA2
HCN CHANNELS%REACTOME DATABASE ID RELEASE 66%1296061,0.15179528403001097,0.519162563817466,0.7692307692307689,1.29240701171259,1132,2,HCN2|HCN3
REACTIONS SPECIFIC TO THE COMPLEX N-GLYCAN SYNTHESIS PATHWAY%REACTOME DATABASE ID RELEASE 66%975578,0.24344062753584,0.626082056933819,0.43597763278581897,1.20350455298153,1799,7,CHST8|CHST10|MAN2A2|MAN2A1|FUT8
RESOLUTION OF D-LOOP STRUCTURES THROUGH HOLLIDAY JUNCTION INTERMEDIATES%REACTOME DATABASE ID RELEASE 66%5693568,0.0598357450136879,0.354269451186595,-0.314439859514968,-1.47669834561124,458,33,RAD51|XRCC2|BRIP1|PALB2|NBN|EXO1|RAD51C|RAD51AP1|SLX1B|SLX1A|BRCA1|EME1|RMI1|RAD51B|RMI2|KAT5|MUS81|XRCC3
NEGATIVE REGULATION OF NOTCH4 SIGNALING%REACTOME DATABASE ID RELEASE 66%9604323,0.000128799587841319,0.00518555396908895,-0.42399412190171293,-2.28853724766959,0,53,PSMD7|PSME3|PSMA2|PSME1|AKT1|PSMB1|TACC3|PSMB9|NOTCH4|PSMB4|PSMD1|PSMC2|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
ORGANIC CATION ANION ZWITTERION TRANSPORT%REACTOME DATABASE ID RELEASE 66%549132,0.0742632612966601,0.38299993877531896,-0.5788428658099389,-1.4889397830886297,566,6,SLC22A5|SLC22A18|SLC22A4|RUNX1|SLC22A3|SLC22A15
NORC NEGATIVELY REGULATES RRNA EXPRESSION%REACTOME DATABASE ID RELEASE 66%427413,0.000127713920817369,0.00518555396908895,-0.37231784009797103,-2.24686074236735,0,81,HIST1H2BN|H2AFV|ZNRD1|TWISTNB|HIST1H2BC|TTF1|HIST1H4I|POLR2H|GTF2H1|DNMT1|HIST2H3A|UBTF|CDK7|H2AFZ|HIST2H2AA4|MNAT1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|SAP30BP|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L|GTF2H2
CELL-CELL COMMUNICATION%REACTOME%R-HSA-1500931.3,0.0108266462870972,0.134645873234709,-0.25702961983763,-1.6164959507541699,84,95,CLDN10|CASK|ILK|PVRL2|SKAP2|PTPN6|CD47|RSU1|CDH8|PXN|KIRREL|PIK3CB|FLNA|CDH11|CDH5|KIRREL3|LIMS2|CDH7|CD151|TYROBP|ANG|FLNC|NCK1|ACTN1|ITGB4|CADM3|SIRPA|FBLIM1
PI3K AKT SIGNALING IN CANCER%REACTOME DATABASE ID RELEASE 66%2219528,0.307622504537205,0.6792715063520871,-0.19106589321727,-1.10032709069391,2372,68,PIK3CB|FGF10|RHOG|PIK3R3|HBEGF|CD86|FGF19|FGF9|FGF7|PDGFRB|PDGFRA|MAPKAP1|RPS6KB2|PDGFB|BAD
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS%REACTOME DATABASE ID RELEASE 66%5669034,0.00761354686269362,0.106403332989932,-0.514674574843596,-1.8686999531381399,57,15,TNFSF13B|TNFRSF14|TNFSF8|EDA|TNFRSF18|TNFRSF4|TNFSF13|TNFRSF11B|LTA|TNFRSF1A|TNFRSF1B
HDL CLEARANCE%REACTOME DATABASE ID RELEASE 66%8964011,0.524770885907823,0.808245162096538,0.7372629025143359,0.9830405995135291,3950,1,HDLBP
RETINOID METABOLISM AND TRANSPORT%REACTOME DATABASE ID RELEASE 66%975634,0.8707447502282509,0.9574934752519241,-0.156896421730605,-0.6919898712188001,6675,27,SDC4|APOM|SDC2|APOE|LRP10|LDLR
FORMATION OF THE EDITOSOME%REACTOME DATABASE ID RELEASE 66%75094,0.031440700451048,0.25182426163873,-0.8853598014888342,-1.47338028935455,236,2,APOBEC3C|APOBEC3B
IRAK1 RECRUITS IKK COMPLEX UPON TLR7 8 OR 9 STIMULATION%REACTOME%R-HSA-975144.1,0.949398535564853,0.984779478109078,-0.18232661189989,-0.571205474085298,7260,10,IRAK1|PELI3
CHAPERONIN-MEDIATED PROTEIN FOLDING%REACTOME%R-HSA-390466.3,0.185996180776575,0.559093571852282,-0.198549645847621,-1.20308116408057,1460,82,PDCL|STAT3|CCT5|GNGT2|TUBB4A|GNG11|GNAI2|FBXO4|USP11|NOP56|PFDN1|GNG10|VBP1|FBXW5|ACTB|GNG3|TUBB4B|TUBB6|SPHK1
SIGNALING BY FGFR2%REACTOME DATABASE ID RELEASE 66%5654738,0.580578778135048,0.8387093286508721,-0.169644869983962,-0.919863076754872,4513,54,NCBP1|HNRNPM|POLR2H|FGF10|MAPK3|HRAS|PPP2CA|FGF9|FGF7|UBC|POLR2G|POLR2L
INOSITOL TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%429593,0.152958344388432,0.52097307188263,-0.7627240143369179,-1.2692947285969198,1152,2,SLC2A13|SLC5A3
ATF4 ACTIVATES GENES%REACTOME%R-HSA-380994.1,0.440376569037657,0.7653693162885199,-0.23708304217508602,-1.0075962454032301,3367,24,DDIT3|ASNS|KHSRP|ATF3|EXOSC7|EXOSC4|HERPUD1|CCL2|EXOSC3|NFYB|EXOSC2
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS%REACTOME DATABASE ID RELEASE 66%1839117,0.0415873878771405,0.29257805039648405,0.422689995224706,1.59156801953695,305,16,GAB2|FGFR1OP|ZMYM2|LRRFIP1|MYO18A
GOLGI-TO-ER RETROGRADE TRANSPORT%REACTOME%R-HSA-8856688.1,0.0362346872985171,0.27097761630552397,-0.22578223279775303,-1.46040678132272,280,108,KIF20A|KIF18B|PLA2G4A|DYNLL2|KIF4A|KIF27|KIF18A|KDELR2|ARFGAP2|GALNT1|COPB2|ARF1|KDELR1|COPB1|TMED2|KIFC1|KIF2A|DCTN5|RAB1B|NSF|KDELR3|TMED10|TMED9|DYNC1I1|KIF22|COPG1|SURF4|COPZ2|DCTN3|AGPAT3
PKB-MEDIATED EVENTS%REACTOME%R-HSA-109703.4,0.72414255091104,0.9034590034658789,0.485084091535704,0.815003905522269,5404,2,PDE3B|AKT2
INHIBITION OF ADENYLATE CYCLASE PATHWAY%REACTOME DATABASE ID RELEASE 66%997269,0.7254157391645941,0.9040629990111769,-0.23069295820465804,-0.794089898558379,5539,13,ADCY8|ADCY4|GNAI2|ADCY9
GLUTATHIONE CONJUGATION%REACTOME DATABASE ID RELEASE 66%156590,0.212505108295872,0.5950741597527031,0.264892260673493,1.21231339440548,1559,29,GSTM2|GSTM4|GSTM1|GSTK1|MGST3|GSS|GSTT2|GCLM|GSTT2B|AKR1A1|MGST2|GSTZ1|GSTM3|GCLC|GGT7
DEFECTIVE GALNT3 CAUSES FAMILIAL HYPERPHOSPHATEMIC TUMORAL CALCINOSIS (HFTC)%REACTOME%R-HSA-5083625.1,0.18664047151277,0.5597458283154859,-0.49796206306819796,-1.28089257027239,1424,6,MUC4|MUC20|MUC15
VLDLR INTERNALISATION AND DEGRADATION%REACTOME%R-HSA-8866427.3,0.150248886560126,0.517264655410678,-0.412210266455948,-1.3345529153881202,1146,11,AP2A2|CLTA|CLTC|NR1H3|MYLIP|AP2M1
NEF MEDIATED CD8 DOWN-REGULATION%REACTOME DATABASE ID RELEASE 66%182218,0.644058885383807,0.8688307429995409,-0.308745255134207,-0.8439413866112401,4899,7,CD8B|ATP6V1H|AP2A1|AP2A2|AP2M1
INTERLEUKIN-2 SIGNALING%REACTOME DATABASE ID RELEASE 66%9020558,0.967833876221498,0.9912626134248801,0.165938573524673,0.5460397998386091,7130,11,SHC1|PTK2B|JAK1|LCK|STAT5B|IL2RB|IL2RG|JAK3|SYK|STAT5A
SPRY REGULATION OF FGF SIGNALING%REACTOME%R-HSA-1295596.1,0.8863398007341371,0.964939379509639,-0.18498945913246104,-0.654465654715047,6760,14,MAPK3|PPP2CA|UBC
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%73817,0.35405331882481,0.7119326145043309,0.317782984557552,1.0800825551029398,2602,12,PFAS|PAICS|ADSL|ATIC|PPAT
RAB REGULATION OF TRAFFICKING%REACTOME%R-HSA-9007101.2,0.492017215049285,0.791072486428528,0.148177656879102,0.9831836368654341,3543,117,TRAPPC4|TSC2|RAB13|ALS2|DENND6B|HPS1|TBC1D2|RAB10|TBC1D14|RAB39A|GABARAP|RIC1|HPS4|RAB1A|RAB3GAP1|RINL|TBC1D17|TBC1D16|TRAPPC1|GGA1|DENND2A|MAP1LC3B|TBC1D7|MON1B|TBC1D20|RAB33B|RAB11B|RAB11A|YWHAE|RAB6A|AKT3|TRAPPC2L|SBF1|CHML|ANKRD27
TRANSFERRIN ENDOCYTOSIS AND RECYCLING%REACTOME%R-HSA-917977.1,0.00574112734864301,0.0874690064589483,-0.44012754893239797,-1.91991674386592,43,26,ATP6V1D|ATP6V0A1|TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|ATP6V1F|ATP6V0D1|HFE|ATP6V0E1|ATP6AP1|ATP6V0E2|TFRC|ATP6V1A|ATP6V1G1
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER%REACTOME DATABASE ID RELEASE 66%5674400,0.6469206680584549,0.8697778704754799,-0.198352075703135,-0.8652479769711091,4957,26,MAPKAP1|RPS6KB2|BAD
LGI-ADAM INTERACTIONS%REACTOME DATABASE ID RELEASE 66%5682910,0.31084967320261403,0.6814986161073721,-0.33783873829882693,-1.13077788946803,2377,12,LGI1|STX1B|ADAM11|LGI4
OPSINS%REACTOME DATABASE ID RELEASE 66%419771,0.215035197237349,0.5979177134734279,0.8939126599029559,1.19191191379204,1618,1,OPN3
DOWNREGULATION OF SMAD2 3:SMAD4 TRANSCRIPTIONAL ACTIVITY%REACTOME%R-HSA-2173795.1,0.5806319803868161,0.8387093286508721,0.213959066409025,0.9083514054099608,4262,23,SMAD3|RPS27A|HDAC1|NCOR1
BETA OXIDATION OF DECANOYL-COA TO OCTANOYL-COA-COA%REACTOME%R-HSA-77346.3,0.15990226686575304,0.529429183067871,0.512360920440755,1.32576399578727,1177,6,HADHB|HADHA|ACADM|ECHS1|MECR
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS%REACTOME%R-HSA-111465.3,0.21177240026160898,0.5937395205509979,-0.26677365452976604,-1.2180362784860301,1618,30,TJP2|GSN|BCAP31|VIM|DBNL|CASP6|OCLN
MET INTERACTS WITH TNS PROTEINS%REACTOME DATABASE ID RELEASE 66%8875513,0.717973101480777,0.900060477413567,0.363206087082695,0.7979792414103649,5284,4,MET|TNS3
FRS-MEDIATED FGFR3 SIGNALING%REACTOME DATABASE ID RELEASE 66%5654706,0.262170247484362,0.6380114459042441,0.369931574566216,1.17196823378602,1927,10,FGF2|FRS3|SOS1|NRAS|FGF1|KRAS
MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS%REACTOME DATABASE ID RELEASE 66%174490,0.628211851074987,0.8598358835891559,-0.245406373695231,-0.8682118634483409,4791,14,TSG101|UBAP1|MVB12B|UBC|VPS37C
SUMOYLATION OF IMMUNE RESPONSE PROTEINS%REACTOME%R-HSA-4755510.2,0.520958868221116,0.806317739870084,-0.290603717915425,-0.9408451718125859,3976,11,NFKB2|IKBKE|SUMO3|NFKBIA|RELA
NEDDYLATION%REACTOME DATABASE ID RELEASE 66%8951664,0.439446366782007,0.7650340344477281,-0.13602424071839,-1.0093811254468101,3428,214,COPS6|FEM1A|DCAF5|RNF7|PSMD4|CCDC22|DCAF10|BTBD6|SHFM1|DCUN1D3|PSME2|CISH|PSMB5|RBBP7|DTL|SKP1|PSMC4|WDR5|NEDD8|HIF3A|PSMC6|COMMD10|FBXO4|PSMD10|PSMB3|DCAF4|PSMC1|PSMD2|UBC|FBXO17|PSMD6|ERCC8|FBXW5|DDB1|CCDC8|PSMD12|PSMA3|BIRC5|GPS1|COMMD9|PSMA6|LRR1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|SPSB1
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION%REACTOME%R-HSA-983231.2,0.189493914157591,0.563467720122429,-0.181090295118469,-1.1833331699326999,1478,112,KIF25|CENPE|KIF2C|RBSN|HBB|KLC1|CAPZA2|KIF3A|HIST1H3D|PHF21A|CDC42|RACGAP1|KIF1C|DOCK11|RAC1|DOCK2|KIF11|KIF15|DOCK4|MAFK|DOCK10|PRKAR2A|KDM1A|ZFPM2|SH2B1|KIF21B|RAD51C|KLC2|GATA3|AKAP1|DOCK5|KIF20A|PRKAR1A|DOCK6|KIF18B|SH2B3|KIF4A|KIF27|EHD1|KIF18A|ABL1|RAD51B|DOCK1|HIST2H3A|KIFC1|KIF2A|GATA6|CABLES2|ITPK1|HIST2H3C|PRKACA|HIST1H3H|KIF22|H3F3B|EHD2
FCERI MEDIATED NF-KB ACTIVATION%REACTOME DATABASE ID RELEASE 66%2871837,0.000642260757867694,0.0163600882996276,-0.32364307668701897,-1.9386985165938202,4,79,PSMD3|PSMB2|PSMF1|IGKV2-28|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|IGKV2D-28|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|PSMD6|RELA|NFKB1|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
FOLDING OF ACTIN BY CCT TRIC%REACTOME DATABASE ID RELEASE 66%390450,0.384283472803347,0.7313561276300269,-0.336066027944313,-1.05285099534069,2938,10,CCT7|CCT3|CCT8|CCT5|ACTB
SYNTHESIS OF VERY LONG-CHAIN FATTY ACYL-COAS%REACTOME%R-HSA-75876.5,0.679262552301255,0.884536278926676,-0.214559990999429,-0.8325725620762441,5194,18,ACSL5|ACSL4|ELOVL2|ACSF3|ELOVL1|HACD2
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2%REACTOME%R-HSA-5654696.1,0.3290296276162,0.695646600584197,0.294257485922413,1.10797702664925,2420,16,GAB1|FGF2|FRS3|SOS1|PLCG1|NRAS|FGF1|KRAS
TRANSCRIPTIONAL REGULATION BY E2F6%REACTOME%R-HSA-8953750.2,0.467827895489406,0.780769690730001,-0.209077821167667,-0.9905655044275871,3598,34,YAF2|RBBP4|RBBP8|CBX3|CDC7|EHMT1|PCGF2|PHC3|RAD51|RRM2|UXT|TFDP2|EZH2|BRCA1|RBBP7|E2F1|MAX|RING1
INTERLEUKIN-15 SIGNALING%REACTOME DATABASE ID RELEASE 66%8983432,0.7486890403775559,0.913171247436494,-0.21956549394141,-0.776790609687134,5710,14,STAT5B|IL2RB|IL2RG|JAK3|STAT5A|SOS2|IL15RA|GRB2|STAT3|IL15
GLUCAGON-TYPE LIGAND RECEPTORS%REACTOME DATABASE ID RELEASE 66%420092,0.120130754562789,0.47223724623656504,0.319117462334214,1.35479557032652,881,23,GNG5|GNGT1|GNAS|GNB5|GNB4|GCGR|ADCYAP1|ADCYAP1R1
ACTIVATION OF E2F1 TARGET GENES AT G1 S%REACTOME%R-HSA-539107.4,0.0286649214659686,0.238792268557792,-0.360965515249323,-1.61211236271921,218,28,LIN54|TYMS|RRM2|TFDP2|CDT1|CDC6|LIN52|PCNA|ORC1|LIN9|CDC45|E2F1|DHFR|TK1|POLA1
"TICAM1,TRAF6-DEPENDENT INDUCTION OF TAK1 COMPLEX%REACTOME%R-HSA-9014325.2",0.0169335783670255,0.17671843887293,-0.47433561346023706,-1.7222357232514598,128,15,UBC|TICAM1|TLR4|CD14|LY96
PHOSPHOLIPASE C-MEDIATED CASCADE; FGFR4%REACTOME DATABASE ID RELEASE 66%5654228,0.713555992141454,0.8981683351717429,-0.307628579901226,-0.791303578371114,5447,6,FGFR4|FGF19|FGF9
SYNDECAN INTERACTIONS%REACTOME DATABASE ID RELEASE 66%3000170,0.245141806722689,0.62804240987169,-0.296447679145466,-1.18934241074062,1866,20,ITGB5|CASK|VTN|SDC4|SDC2|TNC|THBS1|ACTN1|ITGB4
RAF ACTIVATION%REACTOME%R-HSA-5673000.1,0.407426778242678,0.7445496113654559,-0.24285130447984402,-1.0321111975797,3115,24,HRAS|PPP2CA|MAP3K11|ARAF|PHB
HDACS DEACETYLATE HISTONES%REACTOME DATABASE ID RELEASE 66%3214815,0.0005154639175257731,0.0139121625154964,-0.353875138037636,-2.01786632259557,3,65,HIST1H2AK|HIST2H3A|BRMS1|HIST2H2BF|HDAC8|HIST2H2AA4|HIST3H2A|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|MTA2|HIST1H3H|HIST2H4B|HIST1H2AC|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
ACTIVATION OF BMF AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%139910,0.9671957671957672,0.9912626134248801,-0.286408502815542,-0.5592832160621221,7311,3,DYNLL2
CROSSLINKING OF COLLAGEN FIBRILS%REACTOME DATABASE ID RELEASE 66%2243919,0.620005257623554,0.8551097775270831,-0.315854471461049,-0.8633741124096859,4716,7,LOXL1|LOX|LOXL2
PARADOXICAL ACTIVATION OF RAF SIGNALING BY KINASE INACTIVE BRAF%REACTOME DATABASE ID RELEASE 66%6802955,0.234001040582726,0.617951264290741,-0.24836653820587098,-1.18568522845733,1798,35,VWF|ARRB1|MAPK3|HRAS|RAP1A|FN1|MAP3K11|VCL|ARAF|PHB
DNA STRAND ELONGATION%REACTOME DATABASE ID RELEASE 66%69190,0.000782064650677789,0.0191134260247744,-0.457302996656052,-2.12719327040451,5,32,RFC2|RPA2|RFC3|MCM4|MCM6|GINS2|POLD4|PCNA|POLD1|MCM3|MCM5|CDC45|POLD2|RFC5|GINS1|MCM2|POLA1|RFC4|POLA2|FEN1
EFFECTS OF PIP2 HYDROLYSIS%REACTOME DATABASE ID RELEASE 66%114508,0.8903997824313299,0.965159112268525,0.15573934008272303,0.6708664112061969,6547,24,DGKB|DGKK|DGKH|PRKCE|DGKQ|ITPR1
PHASE 4 - RESTING MEMBRANE POTENTIAL%REACTOME DATABASE ID RELEASE 66%5576886,0.853944853944854,0.949296218452153,0.22551887835207998,0.685331071707593,6255,9,KCNK9|KCNK10|KCNK3|KCNK2
FGFR2C LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190375,0.7366299381886591,0.908157084784786,0.40031790098352604,0.7873780706142449,5481,3,FGF2|FGF1
FGFR1B LIGAND BINDING AND ACTIVATION%REACTOME%R-HSA-190370.2,0.66151572158022,0.8791719657403121,0.42693666022817894,0.839734028828221,4922,3,FGF2|FGF1
NEGATIVE REGULATION OF TCF-DEPENDENT SIGNALING BY DVL-INTERACTING PROTEINS%REACTOME DATABASE ID RELEASE 66%5368598,0.32088031517456894,0.6887547458395611,0.506639526921065,1.11310861722681,2361,4,CCDC88C|DVL2|DVL1
ACTIVATION OF THE PHOTOTRANSDUCTION CASCADE%REACTOME%R-HSA-2485179.1,0.25071263743722,0.631479765290861,0.462400108167964,1.1964874575716398,1846,6,PDE6B|GNGT1|GNB1|SLC24A1|CNGB1
IRF3-MEDIATED INDUCTION OF TYPE I IFN%REACTOME%R-HSA-3270619.1,0.977647058823529,0.9927322181739301,-0.15393495836552698,-0.515234718825979,7478,12,IFI16|TMEM173
DEPURINATION%REACTOME%R-HSA-73927.1,0.9287245444801719,0.9793746057014829,0.36619795974634706,0.61525985410633,6931,2,OGG1|MPG
HYALURONAN BIOSYNTHESIS AND EXPORT%REACTOME%R-HSA-2142850.2,0.967616232195646,0.9912626134248801,0.28206683577809605,0.554792179898951,7200,3,HAS3|ABCC5|CEMIP
"SYNTHESIS, SECRETION, AND INACTIVATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)%REACTOME%R-HSA-381771.2",0.643959205020921,0.8688307429995409,-0.270351627220825,-0.846976356261114,4924,10,PCSK1|DPP4|SEC11C
RNA POLYMERASE II PROMOTER ESCAPE%REACTOME DATABASE ID RELEASE 66%73776,0.0299702880764759,0.244735657013286,-0.305821259293732,-1.5842503492941102,231,46,GTF2A2|POLR2J|TAF3|GTF2A1|TAF12|POLR2H|GTF2H1|TAF7|TAF9B|CDK7|MNAT1|TAF10|POLR2G|TAF9|AK6|POLR2L|GTF2H2
DEPOSITION OF NEW CENPA-CONTAINING NUCLEOSOMES AT THE CENTROMERE%REACTOME DATABASE ID RELEASE 66%606279,0.000129416332341141,0.00518555396908895,-0.5043838259029079,-2.76193072227759,0,56,HIST1H4H|HJURP|ITGB3BP|CENPL|CENPU|CENPW|HIST1H2BE|H2AFX|HIST2H2AC|HIST1H2AD|OIP5|RUVBL1|CENPM|HIST1H2BN|NPM1|H2AFV|CENPI|HIST1H2BC|HIST1H4I|STRA13|RBBP7|CENPH|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H4B|CENPK|HIST1H2AC|MIS18A|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|CENPP
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS%REACTOME DATABASE ID RELEASE 66%451306,0.556532323505545,0.8257149029717741,0.3268858711476,0.9023596731732741,4114,7,GRIK3|DLG4|GRIK2
INTRA-GOLGI AND RETROGRADE GOLGI-TO-ER TRAFFIC%REACTOME DATABASE ID RELEASE 66%6811442,0.110087045570917,0.45500616482604295,-0.174672432076024,-1.2488852106053998,859,175,ACTR10|TMF1|DCTN4|RAB6B|DYNC1H1|GOLGA5|YKT6|NAA30|TMED7|NAA38|COG4|RAB9A|KIF21B|BNIP1|KLC2|NAPA|CYTH3|TRIP11|GOLGA4|KIF20A|KIF18B|PLA2G4A|DYNLL2|BET1L|KIF4A|KIF27|KIF18A|KDELR2|ARFGAP2|CYTH1|GALNT1|COPB2|ARF1|KDELR1|COPB1|TMED2|KIFC1|PLIN3|KIF2A|DCTN5|ARFIP2|RAB1B|NSF|COG1|STX5|KDELR3|TMED10|VPS51|RAB9B|TMED9|GOSR2|DYNC1I1|KIF22|COPG1|SURF4|COPZ2|DCTN3|AGPAT3
SYNTHESIS OF DNA%REACTOME DATABASE ID RELEASE 66%69239,0.000128221566867547,0.00518555396908895,-0.360477771104367,-2.37703138009475,0,117,PSMD1|PSMC2|ANAPC10|RFC3|CDT1|MCM4|ANAPC2|MCM6|ANAPC5|GINS2|CDC6|PSMD3|PSMB2|CDC23|POLD4|PSMF1|PCNA|ORC1|ORC6|PSMD4|POLD1|MCM3|SHFM1|PSME2|MCM5|CDC45|POLD2|PSMB5|RFC5|GINS1|CDC27|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|MCM2|PSMD6|PSMD12|PSMA3|POLE2|POLA1|POLE3|ANAPC11|PSMA6|RFC4|PSMD13|PSMB7|PSMA1|POLA2|PSMC5|PSMC3|FEN1
MYD88 DEFICIENCY (TLR2 4)%REACTOME%R-HSA-5602498.1,0.0300937988535696,0.24538818454651198,-0.557191247979801,-1.67616765898655,230,9,TLR1|TLR2|CD36|TLR4|CD14|LY96
CELLULAR RESPONSES TO EXTERNAL STIMULI%REACTOME%R-HSA-8953897.2,0.00012725884448969198,0.00518555396908895,-0.24741742722082,-2.04954721751675,0,423,PSMD1|PSMC2|ACTR10|DCTN4|H1F0|PHC2|DYNC1H1|HIST1H2BE|ANAPC10|MT1G|RPS6KA1|TFDP2|NR3C1|TERF2|EZH2|ANAPC2|H2AFX|NBN|HSPA13|TINF2|ANAPC5|RRAGA|HIST2H2AC|DNAJC7|HIST1H2AD|ERO1L|PSMD3|PSMB2|CDC23|ATG13|SOD2|CDKN2A|HIST1H2BN|H2AFV|PSMF1|BAG5|E2F2|ETS2|GPX1|WDR45B|VCP|HIST1H2BC|NUP188|PSMD4|BAG3|MAPKAPK2|HSPA6|SHFM1|CYCS|WDR45|STAT3|MAPK9|HSPA9|PSME2|DYNLL2|HIST1H4I|LMNB1|ATG101|NUP85|PSMB5|CDKN2B|SOD3|WIPI1|MAPK3|CAMK2B|RBBP7|CYBB|CDC27|SOD1|CBX4|CEBPB|TNRC6C|NUP37|E2F1|NCF4|MT1M|RPTOR|PSMC4|CBX6|HIF3A|HIST2H3A|PIK3R4|PSMC6|NUP160|CCS|MAP2K3|GPX8|PSMD10|CAT|NCF2|PSMB3|DCTN5|RING1|NUP214|CHMP4A|H2AFZ|MT2A|PSMC1|CHMP6|PSMD2|UBC|HIST2H2AA4|ID1|PSMD6|CAMK2A|HIST1H2BG|CRYAB|HIST1H2BD|GPX3|HIST2H4A|HIST1H2AE|DNAJA1|FKBP4|HIST2H3C|RELA|NFKB1|ATG3|CDKN2C|HIST1H3H|PSMD12|PSMA3|KAT5|HSP90AA1|ATOX1|HSPA5|HIST1H1C|DYNC1I1|SNCB|MT1E|HIST2H4B|ANAPC11|GSTP1|H3F3B|HIST1H2AC|PSMA6|AMBRA1|HSPA4|IGFBP7|FKBP5|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|H2AFJ|WTIP|SLC38A9|HIST1H2BK|PSMA1|DCTN3|ATG4A|PSMC5|STIP1|HIST1H2BJ|PSMC3|HIST2H2AA3|RRAGD|P4HB
THE AIM2 INFLAMMASOME%REACTOME DATABASE ID RELEASE 66%844615,0.25304232804232796,0.632257972333528,-0.612319742420119,-1.19570526514575,1912,3,PYCARD|CASP1
RHO GTPASES ACTIVATE FORMINS%REACTOME%R-HSA-5663220.1,0.0283541693517206,0.23858105139263197,-0.225439398752152,-1.47998957902794,219,115,RHOA|CENPE|KIF2C|CDCA8|NUP107|DVL3|NDE1|CASC5|PFN2|ZWINT|SCAI|CDC42|RCC2|ITGB3BP|RAC1|ITGB1|CENPL|CENPU|ACTG1|NUF2|NSL1|SPDL1|CDC20|DYNC1H1|CLIP1|DSN1|FMNL1|CENPM|NUDC|CENPI|MAD2L1|KNTC1|ERCC6L|DYNLL2|INCENP|NUP85|NDC80|SGOL1|KIF18A|RHOD|SEC13|NUP37|CKAP5|CENPH|SPC25|NUP160|KIF2A|PLK1|SKA1|PPP2CA|SRF|SPC24|EVL|ACTB|DYNC1I1|BIRC5|CENPK|CENPP|SKA2
ACTIVATION OF CAMK IV%REACTOME%R-HSA-442745.1,0.0630893877008899,0.36006266503904,0.968736215262462,1.2916790287078899,474,1,CAMK4
HUR (ELAVL1) BINDS AND STABILIZES MRNA%REACTOME%R-HSA-450520.2,0.725592293673523,0.9041786287078409,-0.27180411907110397,-0.782486016981491,5573,8,TNFSF13|NUP214
HYDROLYSIS OF LPC%REACTOME DATABASE ID RELEASE 66%1483115,0.00578338590956887,0.0879510138185217,-0.689109692610291,-1.8836506143421599,43,7,PLA2G4D|PLA2G4A|PLA2G4C|PLBD1
THREONINE CATABOLISM%REACTOME%R-HSA-8849175.2,0.9089797581850291,0.9715076818387142,0.29149449484094103,0.640425819227836,6690,4,GCAT|HRSP12
SYNTHESIS OF (16-20)-HYDROXYEICOSATETRAENOIC ACIDS (HETE)%REACTOME%R-HSA-2142816.1,0.965600644987907,0.990916952887267,0.28442037484009003,0.559421313498011,7185,3,CYP2C8|CYP2U1
SIGNALLING TO ERK5%REACTOME DATABASE ID RELEASE 66%198765,0.0187566988210075,0.188488889062321,0.9123242349048801,1.53282250959031,139,2,MAPK7|MAP2K5
SELENOCYSTEINE SYNTHESIS%REACTOME%R-HSA-2408557.2,0.745090489025799,0.9112137767014771,-0.13560634825819,-0.839345535773895,5804,90,RPL29|RPL11|RPS6|RPL36|RPL17|RPL32|RPL39L|RPL23|RPLP0|RPL10A|RPL8|RPS23|RPL3|RPL7A|RPS2|RPL15|RPL37|RPL27A|RPL18|RPL39|RPL27|SECISBP2|SARS|RPLP2|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|RPL35|RPL38|RPS15A|RPL36AL|RPS13|RPL26L1|FAU|EEFSEC
ABC-FAMILY PROTEINS MEDIATED TRANSPORT%REACTOME%R-HSA-382556.3,0.00012835322808368602,0.00518555396908895,-0.342624558546225,-2.1207000804618,0,90,PSMD3|PSMB2|ABCA10|PSMF1|VCP|ABCG1|PSMD4|SEL1L|SHFM1|ABCB7|PSME2|ABCC9|PSMB5|PSMC4|ABCA8|PSMC6|PSMD10|PSMB3|ABCA6|PSMC1|PSMD2|UBC|PSMD6|EIF2S1|DERL3|ABCD1|PSMD12|PSMA3|PSMA6|ABCB9|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|ABCC1
COPI-INDEPENDENT GOLGI-TO-ER RETROGRADE TRAFFIC%REACTOME DATABASE ID RELEASE 66%6811436,0.806935210533177,0.933810206759044,-0.161049091344999,-0.756331996580198,6189,33,PLA2G4A|DYNLL2|GALNT1|DCTN5|DYNC1I1|DCTN3|AGPAT3
SIGNALING BY NOTCH1 IN CANCER%REACTOME%R-HSA-2644603.2,0.8037113402061858,0.932964969466025,0.140937546244198,0.7829478883872808,5846,56,DLL1|HDAC11|ADAM17|RPS27A|HDAC1|NCOR1|PSENEN|HDAC10|TBL1XR1|HDAC4|PSEN2|APH1B|MAML2|MAML3|TBL1X|MAMLD1|ADAM10|EP300|HDAC6|HDAC2|CDK8|MIB2|HEY2
TICAM1-DEPENDENT ACTIVATION OF IRF3 IRF7%REACTOME DATABASE ID RELEASE 66%9013973,0.21024364684307,0.591474654268711,-0.384379252854063,-1.24444851148781,1604,11,IKBKE|IRF7|UBC|TICAM1|TRAF3
INSULIN RECEPTOR SIGNALLING CASCADE%REACTOME DATABASE ID RELEASE 66%74751,0.153355879292404,0.521561408675329,-0.268632119042224,-1.28243175485073,1178,35,IRS1|PIK3CB|FGF10|MAPK3|HRAS|PIK3R4|FGF19|FGF9|FGF7|FLT3LG|GRB10
NONSENSE MEDIATED DECAY (NMD) ENHANCED BY THE EXON JUNCTION COMPLEX (EJC)%REACTOME%R-HSA-975957.1,0.49152977412730997,0.790696900371285,-0.149587349793017,-0.97941389222461,3829,113,RPLP2|MAGOH|RPS14|RPS4X|RPL35A|NCBP1|RPS29|RPL10|RPL36A|RPL24|RPL22L1|RPL35|PPP2CA|RPL38|RPS15A|RPL36AL|MAGOHB|EIF4A3|RPS13|RBM8A|RPL26L1|FAU|EIF4G1
DEFECTIVE MMADHC CAUSES METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE CBLD%REACTOME%R-HSA-3359473.1,0.27384780278671,0.6484495544388879,0.696388199614006,1.17002208967156,2043,2,MMADHC|MMACHC
CREATION OF C4 AND C2 ACTIVATORS%REACTOME%R-HSA-166786.2,0.000262536098713573,0.00819882332206558,-0.6339177104634339,-2.30165244940736,1,15,COLEC11|IGKV3-11|FCN3|IGHG4|IGKV2-28|C1QB|FCN1|C1QA|C1QC|IGKV2D-28|C1S|IGHG2|C1R
TRANS-GOLGI NETWORK VESICLE BUDDING%REACTOME%R-HSA-199992.2,0.0720743993800052,0.378088098869897,-0.240057777048459,-1.39392010188817,557,70,PIK3C2A|AP3S1|HGS|STX4|SNX5|TXNDC5|NAPA|CLTA|NECAP1|SH3GL2|CLTC|ARRB1|YIPF6|VAMP8|ARF1|VAMP7|SNX2|CTSZ|FTL|AP1B1|AP4S1|DTNBP1|TFRC|FTH1|CLTB
GPCR LIGAND BINDING%REACTOME DATABASE ID RELEASE 66%500792,0.0279764946346449,0.236628563659016,-0.192163152745151,-1.4079008263519401,218,198,FZD2|FZD8|ADGRE2|FPR1|C3|CXCR4|POMC|TAC1|CALCB|SST|OXER1|CRHBP|PTGER4|LTB4R|S1PR1|PROKR1|CALCRL|TBXA2R|NLN|GNGT2|PYY|CYSLTR2|GNG11|CHRM2|CCRL2|P2RY6|CXCL16|GPER1|HCRT|F2R|EDNRB|CCR1|INSL3|APLNR|ADGRE5|GNG10|F2RL3|HEBP1|ADRA2C|HTR1B|CX3CL1|PTAFR|C3AR1|GPR4|WNT3|PTGIR|CMKLR1|ANXA1|XK|CD55|GNG3|SSTR2|C5AR1|ACKR1
PLUS-STRAND DNA SYNTHESIS%REACTOME%R-HSA-164525.1,0.445083612040134,0.76693681188187,-0.77977503308337,-1.03884757909424,3326,1,PPIA
BIOSYNTHESIS OF DPAN-3 SPMS%REACTOME%R-HSA-9025094.1,0.457415760148581,0.7719619284439659,-0.6167080231596359,-1.0263007695653499,3447,2,PTGS2|ALOX5
DNA DAMAGE BYPASS%REACTOME%R-HSA-73893.1,0.009213599792369579,0.121196525942361,-0.33874268555365505,-1.76417313581303,70,47,SPRTN|RAD18|POLE|RFC2|CUL4B|RPA2|RFC3|UBE2B|POLD4|PCNA|VCP|POLD1|POLD2|KIAA0101|RFC5|ISG15|DTL|NPLOC4|RCHY1|UBC|DDB1|POLE2|POLE3|UBE2L6|RFC4
APC C:CDC20 MEDIATED DEGRADATION OF SECURIN%REACTOME DATABASE ID RELEASE 66%174154,0.000128865979381443,0.00518555396908895,-0.39366851971461797,-2.2447760885470696,0,65,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|PTTG1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
STIMULATION OF THE CELL DEATH RESPONSE BY PAK-2P34%REACTOME%R-HSA-211736.1,0.964630225080386,0.990916952887267,0.332285635511442,0.55828277079427,7199,2,CASP3|PAK2
APC C:CDC20 MEDIATED DEGRADATION OF CYCLIN B%REACTOME%R-HSA-174048.2,0.40861618798955607,0.744700417001765,-0.24648184957596,-1.0348741358856601,3129,23,CDC20|ANAPC10|ANAPC2|ANAPC5|CDC23|CDC27|CCNB1|UBC|ANAPC11
REGULATION OF TNFR1 SIGNALING%REACTOME DATABASE ID RELEASE 66%5357905,0.98096976016684,0.993436724391485,-0.11396280875091301,-0.5301100618714489,7525,32,TRAF2|TNFAIP3|USP2|XIAP|UBC|TNFRSF1A
INTEGRATION OF VIRAL DNA INTO HOST GENOMIC DNA%REACTOME%R-HSA-175567.2,0.25978835978836,0.636098664976652,-0.60878595515909,-1.1888046742596599,1963,3,PSIP1|BANF1
ACTIVATION OF DNA FRAGMENTATION FACTOR%REACTOME DATABASE ID RELEASE 66%211227,0.70205836373111,0.8931369333627571,-0.267475870888293,-0.8046328903544999,5388,9,H1F0|HMGB2|KPNB1|HIST1H1C
HH MUTANTS ABROGATE LIGAND SECRETION%REACTOME%R-HSA-5387390.3,0.000128799587841319,0.00518555396908895,-0.450566530883317,-2.43196364104022,0,53,PSMD3|PSMB2|PSMF1|VCP|PSMD4|SEL1L|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|SYVN1|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
VRNP ASSEMBLY%REACTOME%R-HSA-192905.3,0.7561687450252059,0.9166093439295571,-0.488437550336621,-0.8128381907970279,5699,2,HSP90AA1
NEUTROPHIL DEGRANULATION%REACTOME DATABASE ID RELEASE 66%6798695,0.00012683916793505801,0.00518555396908895,-0.333465531004002,-2.74112779077865,0,396,RAC1|DOCK2|IQGAP1|CXCL1|UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|CNN2|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|SERPINB1|HLA-C|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|HLA-A|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|VAMP8|FCN1|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
ACTIVATION AND OLIGOMERIZATION OF BAK PROTEIN%REACTOME DATABASE ID RELEASE 66%111452,0.6717577706323691,0.8815356925073421,0.510334814651837,0.857428380610203,5013,2,BID|BAK1
METABOLISM OF STEROIDS%REACTOME%R-HSA-8957322.1,0.0493954206328788,0.318674546591783,-0.21399392646433898,-1.40300236664121,383,114,POMC|CYP51A1|SEC23A|SUMO2|SMARCD3|MBTPS2|SEC24A|RAN|CYP46A1|HMGCS1|CYP7B1|HSD17B1|SRD5A3|NFYB|EBP|PPARA|DHCR7|OSBP|LGMN|SAR1B|FASN|DHCR24|NSDHL|HSD17B14|OSBPL3|INSIG1|PTGIS|TM7SF2
VEGFR2 MEDIATED CELL PROLIFERATION%REACTOME%R-HSA-5218921.3,0.353479853479854,0.7118407891832621,-0.290727182564739,-1.08045478210795,2701,16,ITPR2|KDR|ITPR3|HRAS|SPHK1|PRKCB
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1%REACTOME DATABASE ID RELEASE 66%937041,0.24454034261802,0.6275891235234821,-0.286676022696656,-1.18720000071066,1869,22,UBC|TICAM1|TLR4|CD14|LY96
MET PROMOTES CELL MOTILITY%REACTOME DATABASE ID RELEASE 66%8875878,0.45398773006134996,0.7705917450640001,0.22275217760108101,0.996926755557702,3329,27,MET|GAB1|LAMA5|CRK|LAMB1|LAMA1|ITGA2|TNS3|DOCK7|SRC
E2F-ENABLED INHIBITION OF PRE-REPLICATION COMPLEX FORMATION%REACTOME%R-HSA-113507.3,0.8335070349140179,0.944683137504178,-0.23155915611249103,-0.696586620886849,6397,9,ORC1|ORC6|CCNB1
ION CHANNEL TRANSPORT%REACTOME%R-HSA-983712.2,0.0277599280298162,0.236123352902818,-0.223006713969205,-1.47918460583627,215,121,ASIC4|RYR2|TCIRG1|ATP6V0B|ATP1B1|ATP2A1|ATP6V0A2|PLN|ATP6V1G2|ATP1A3|ATP11B|SCNN1D|ATP1B3|ATP6V1F|ATP2A3|SGK1|ATP6V0D1|ATP8B1|CLCN4|CAMK2B|NALCN|FXYD1|TPCN2|TSC22D3|ATP6V0E1|ASPH|ATP8B4|TTYH2|UBC|BEST1|CAMK2A|ATP6AP1|CLIC2|ATP1B2|ATP6V0E2|STOM|ATP8A2|ATP2B2|ATP6V1A|ATP6V1G1|FXYD7|WNK2
GLUCAGON-LIKE PEPTIDE-1 (GLP1) REGULATES INSULIN SECRETION%REACTOME DATABASE ID RELEASE 66%381676,0.568434670116429,0.831514598829999,-0.19201824955002497,-0.9246216077913241,4393,36,ADCY8|PRKAR1A|AKAP5|GNGT2|RAPGEF3|GNG11|RAP1A|GNG10|PRKACA|GNG3
TCR SIGNALING%REACTOME DATABASE ID RELEASE 66%202403,0.00166837782340862,0.0342804033914023,-0.278985085572711,-1.82663753928034,12,113,CUL1|PTPN22|PRKCQ|MALT1|PSMD7|PSME3|PSMA2|TRAF6|HLA-DRB1|GRAP2|UBE2N|PSME1|LCP2|PSMB1|RIPK2|PAK2|HLA-DQB2|PTEN|PSMB9|UBE2D2|PSMB4|HLA-DPA1|HLA-DRA|FBXW11|HLA-DRB5|PSMD1|PSMC2|HLA-DPB1|CD4|HLA-DQA2|PSMD3|PSMB2|WAS|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PIK3CB|SKP1|PSMC4|PSMC6|PSMD10|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|PSMD6|RELA|NFKB1|PSMD12|PSMA3|EVL|PSMA6|NCK1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|PTPRJ
ACTIVATION OF BIM AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%111446,0.972354497354497,0.9915747942934481,-0.28035733980368394,-0.547466828360923,7350,3,MAPK8|DYNLL1|BCL2L11
CYTOSOLIC IRON-SULFUR CLUSTER ASSEMBLY%REACTOME%R-HSA-2564830.1,0.7383570943652409,0.9089185613230608,0.224586466511314,0.7865486291131679,5437,13,MMS19|CIAO1|CIAPIN1|RTEL1
CD28 DEPENDENT PI3K AKT SIGNALING%REACTOME DATABASE ID RELEASE 66%389357,0.931066176470588,0.9793746057014829,-0.15264167735092302,-0.612395485919646,7090,20,PIK3R3|CD86|MAPKAP1
PYRUVATE METABOLISM AND CITRIC ACID (TCA) CYCLE%REACTOME%R-HSA-71406.1,0.876074406670943,0.9607117102951591,-0.133401102612344,-0.7123270310819391,6828,51,MDH2|MPC2|ME1|IDH3A|PDK1|IDH2|PDK2|SUCLG2|ACO2|SLC16A1|ME3|PDK4|DLST|GLO1|L2HGDH|VDAC1|SDHC|FH|SDHB|PDHA1|SDHD|IDH3G|SDHA|PDK3|LDHA|PDHX|MPC1
TRIGLYCERIDE METABOLISM%REACTOME%R-HSA-8979227.1,0.00562238493723849,0.0858969713520357,-0.441019708339497,-1.87432132722312,42,24,DGAT1|LIPE|GPAM|FABP3|ABHD5|GK|PLIN3|FABP4|LPIN3|CAV1|PRKACA|MGLL|PPP1CA|PNPLA4|LPIN2
NOSTRIN MEDIATED ENOS TRAFFICKING%REACTOME%R-HSA-203641.1,0.0775907417148869,0.390053430594062,-0.6162464578707081,-1.47702516886853,589,5,NOS3|CAV1
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1%REACTOME DATABASE ID RELEASE 66%113501,0.181746759198638,0.554948538055731,-0.369185547872351,-1.2708082489414099,1387,13,TFDP2|PPP2R3B|E2F1|PPP2CA|POLA1|POLA2
CONDENSATION OF PROPHASE CHROMOSOMES%REACTOME%R-HSA-2299718.1,0.000129769011160135,0.00518555396908895,-0.554571088347494,-2.88820824090172,0,47,HIST1H2BE|SET|SMC2|H2AFX|HIST2H2AC|HIST1H2AD|SETD8|HIST1H2BN|H2AFV|HIST1H2BC|NCAPH2|HIST1H4I|SMC4|HIST2H3A|CCNB1|PLK1|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
MITOCHONDRIAL UNCOUPLING PROTEINS%REACTOME%R-HSA-166187.2,0.846616934956158,0.949216083775675,-0.317211713450615,-0.694442749905143,6468,4,UCP3|SLC25A14|UCP2|SLC25A27
MRNA EDITING: C TO U CONVERSION%REACTOME DATABASE ID RELEASE 66%72200,0.031440700451048,0.25182426163873,-0.8853598014888342,-1.47338028935455,236,2,APOBEC3C|APOBEC3B
JNK (C-JUN KINASES) PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1%REACTOME DATABASE ID RELEASE 66%450321,0.9486343253159399,0.984457616015067,0.15129741033966101,0.581783619092701,6980,17,UBE2V1|NOD1|MAP2K7|MAP2K4|MAPK8|MAP3K7|IKBKG|TAB2
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE%REACTOME DATABASE ID RELEASE 66%1660516,0.248844794781191,0.629562885177406,0.315606169380262,1.1883619002790802,1830,16,FIG4|PIKFYVE|MTMR2|INPP5F|PI4K2B|INPP4A
SIGNALING BY FGFR3%REACTOME DATABASE ID RELEASE 66%5654741,0.0479489269220321,0.31349474092213697,0.336046951853386,1.5224573722022199,352,28,GALNT3|GAB1|RPS27A|FGF2|SPRY2|FRS3|SOS1|CBL|PLCG1|NRAS|PPP2CB|FGF1|MAPK1|KRAS
BBSOME-MEDIATED CARGO-TARGETING TO CILIUM%REACTOME%R-HSA-5620922.1,0.0345343303874915,0.265648036188578,0.382584763500998,1.60109906954537,253,22,BBS5|BBS12|BBS4|BBIP1|MCHR1|TTC8|MKKS|LZTFL1|BBS2|BBS7|BBS9|BBS10|TCP1
MEIOSIS%REACTOME%R-HSA-1500620.1,0.000127713920817369,0.00518555396908895,-0.353683155083586,-2.13440429334469,0,81,DMC1|RAD51|RPA2|MLH3|PSMC3IP|HIST1H2BE|TERF2|H2AFX|NBN|TINF2|HIST2H2AC|HIST1H2AD|RAD51C|STAG2|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|LMNB1|BRCA1|REC8|HIST2H3A|SUN2|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|SMC1A|HIST1H3H|HIST2H4B|H3F3B|SYCE2|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
INTERFERON GAMMA SIGNALING%REACTOME%R-HSA-877300.1,0.00141297366730893,0.0301860198914787,-0.30773172480718797,-1.84338575847089,10,79,GBP1|GBP3|GBP2|PTPN11|HLA-F|PIAS1|IFNGR2|TRIM22|PTPN1|TRIM25|HLA-DRB1|IRF8|OAS3|HLA-DQB2|HLA-B|TRIM14|CD44|HLA-DPA1|PML|HLA-E|HLA-DRA|HLA-DRB5|FCGR1B|TRIM38|SP100|TRIM21|TRIM3|B2M|MID1|OASL|OAS1|IFNGR1|SOCS3|HLA-DPB1|HLA-DQA2|FCGR1A|TRIM68|HLA-C|IRF5|TRIM34|HLA-A|OAS2|SOCS1|PTPN6|ICAM1|CAMK2B|IRF7|IFI30|VCAM1|MT2A|CAMK2A|PTAFR
PREGNENOLONE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%196108,0.58349197715529,0.8391117257440741,0.28190594069758196,0.8930970755890308,4290,10,STARD4|FDX1L|FDXR|STARD3|STAR|STARD3NL
SEMET INCORPORATION INTO PROTEINS%REACTOME DATABASE ID RELEASE 66%2408517,0.397394136807818,0.738055881986572,0.31584464305417603,1.0393228169323498,2927,11,DARS|AIMP1|QARS|MARS|EPRS|KARS|LARS|RARS|EEF1E1|AIMP2|IARS
PERK REGULATES GENE EXPRESSION%REACTOME DATABASE ID RELEASE 66%381042,0.17881831224729397,0.55175028994035,-0.28589498569196,-1.26093656024081,1370,27,HERPUD1|CCL2|EXOSC3|EIF2S1|NFYB|HSPA5|EXOSC2
YAP1- AND WWTR1 (TAZ)-STIMULATED GENE EXPRESSION%REACTOME DATABASE ID RELEASE 66%2032785,0.0409257322175732,0.289711424429654,-0.51488274404104,-1.61306042405803,312,10,CTGF|KAT2B|WWTR1|YAP1|TEAD2
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH MLH1%REACTOME%R-HSA-5545483.1,0.196677384780279,0.573143439969417,0.738902674386545,1.24145189655546,1467,2,MLH1|PMS2
NONSENSE MEDIATED DECAY (NMD) INDEPENDENT OF THE EXON JUNCTION COMPLEX (EJC)%REACTOME DATABASE ID RELEASE 66%975956,0.434587813620072,0.762034923704788,-0.161991286355539,-1.0116984090344099,3394,93,RPS28|RPLP1|RPS18|RPL9|RPL28|GSPT1|RPS3|RPS5|RPS10|RPS15|RPL29|RPL11|RPS6|RPL36|RPL17|RPL32|RPL39L|RPL23|RPLP0|RPL10A|RPL8|RPS23|RPL3|GSPT2|RPL7A|RPS2|RPL15|RPL37|RPL27A|RPL18|RPL39|RPL27|NCBP2|ETF1|RPLP2|RPS14|RPS4X|RPL35A|NCBP1|RPS29|RPL10|RPL36A|RPL24|RPL22L1|RPL35|RPL38|RPS15A|RPL36AL|RPS13|RPL26L1|FAU|EIF4G1
GLYCOLYSIS%REACTOME DATABASE ID RELEASE 66%70171,0.161875161875162,0.532435860141918,-0.224585373572189,-1.2476863102497,1249,59,GPI|PFKFB2|PFKFB3|HK1|HK3|NUP188|NUP85|ENO1|NUP37|PGAM1|NUP160|GAPDH|PPP2CA|NUP214|PRKACA|PGK1|ALDOA|ALDOC
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION%REACTOME%R-HSA-2565942.1,0.24735027454986602,0.6282772847883941,-0.18802292832607,-1.14633272729995,1936,84,HAUS1|NDE1|TUBG1|CCNB2|CEP72|HAUS6|AURKA|AJUBA|CEP78|HAUS4|CEP76|CSNK1D|RAB8A|CEP192|PCNT|NEK2|NEDD1|FBXW11|DYNC1H1|OFD1|CEP70|TUBA4A|SDCCAG8|HAUS8|CDK5RAP2|CEP131|SKP1|CKAP5|TUBB4A|CCNB1|PLK1|UBC|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
BIOLOGICAL OXIDATIONS%REACTOME DATABASE ID RELEASE 66%211859,0.6726434426229512,0.8820330910931731,-0.13280501292653402,-0.890075485156475,5251,127,FMO3|CHAC1|CHAC2|TBXAS1|ABHD14B|COMT|CYP1B1|AHR|ADH1B|GLYATL1|GGT1|NAT1|ALDH2|POMC|CYP51A1|SLC26A2|PTGS1|DPEP1|TRMT112|ALDH1A1|TPST2|ABHD10|N6AMT1|CYP46A1|AIP|CYP7B1|FMO2|GGT5|PODXL2|GSTP1|SULT1A4|AOC3|NNMT|PTGIS
INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION%REACTOME%R-HSA-168273.3,0.600969511417273,0.84675950142966,-0.137800321566727,-0.9260142575295259,4710,128,RPS14|RPS4X|RPL35A|RPS29|NUP85|RPL10|RPL36A|RPL24|POLR2H|RPL22L1|NUP37|NUP160|RPL35|RPL38|RPS15A|NUP214|RPL36AL|RPS13|POLR2G|RPL26L1|FAU|HSP90AA1|POLR2L
MAPK3 (ERK1) ACTIVATION%REACTOME DATABASE ID RELEASE 66%110056,0.907589407589407,0.9710309567212472,0.20781301761927298,0.631524593951991,6648,9,JAK1|MAP2K1|JAK2|CDK1|TYK2
DEGRADATION OF BETA-CATENIN BY THE DESTRUCTION COMPLEX%REACTOME%R-HSA-195253.1,0.0144741898296401,0.16109345280152498,-0.2665782261149,-1.6023511204791698,112,80,PSMD3|PSMB2|PSMF1|FRAT1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PPP2CA|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|CSNK1A1|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
DEFECTIVE MTRR CAUSES METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE CBLE%REACTOME DATABASE ID RELEASE 66%3359467,0.739055452374635,0.9089185613230608,-0.49732561345464604,-0.827629349133577,5570,2,MTR|MTRR
METHIONINE SALVAGE PATHWAY%REACTOME%R-HSA-1237112.1,0.590700720366732,0.8417378833576942,-0.344607370232444,-0.8864229886753309,4509,6,GOT1|ADI1|APIP
SIGNALING BY NOTCH1 T(7;9)(NOTCH1:M1580_K2555) TRANSLOCATION MUTANT%REACTOME%R-HSA-2660825.1,0.5854747092236949,0.8401392131924109,0.319883788195361,0.88303061113051,4328,7,DLL1|ADAM17
SHC-MEDIATED CASCADE:FGFR2%REACTOME%R-HSA-5654699.1,0.33637311099531003,0.699462084003389,-0.365088823693599,-1.09827654535384,2581,9,FGF10|HRAS|FGF9|FGF7
RA BIOSYNTHESIS PATHWAY%REACTOME DATABASE ID RELEASE 66%5365859,0.7142108023072891,0.898428686580078,-0.227040864680436,-0.803237378210586,5447,14,DHRS4|ALDH1A1|ALDH1A2|DHRS3
APOPTOSIS INDUCED DNA FRAGMENTATION%REACTOME%R-HSA-140342.2,0.70205836373111,0.8931369333627571,-0.267475870888293,-0.8046328903544999,5388,9,H1F0|HMGB2|KPNB1|HIST1H1C
TRANSCRIPTION-COUPLED NUCLEOTIDE EXCISION REPAIR (TC-NER)%REACTOME%R-HSA-6781827.1,0.0350494286814739,0.26702449097803305,-0.250688131010113,-1.4965624745669999,272,78,PCNA|COPS6|POLD1|POLD2|RFC5|POLR2H|GTF2H1|CDK7|UBC|MNAT1|ERCC8|DDB1|POLR2G|ISY1|POLE2|POLE3|GPS1|RFC4|XPA|POLR2L|PRPF19|GTF2H2
MITOCHONDRIAL TRANSCRIPTION TERMINATION%REACTOME%R-HSA-163316.2,0.889626776464338,0.965159112268525,0.5548632554036171,0.7398352817967729,6697,1,MTERF1
OAS ANTIVIRAL RESPONSE%REACTOME DATABASE ID RELEASE 66%8983711,0.19332985930172,0.567519363754568,-0.42026303058349296,-1.26425406480409,1483,9,OASL|OAS1|OAS2|PDE12|FLNA
THE CANONICAL RETINOID CYCLE IN RODS (TWILIGHT VISION)%REACTOME%R-HSA-2453902.3,0.514413924394887,0.802865799821292,0.298974442672419,0.94717124359234,3782,10,STRA6|CYP4V2|HSD17B6|NAPEPLD|RBP1
SIGNALING BY TGF-BETA RECEPTOR COMPLEX IN CANCER%REACTOME%R-HSA-3304351.1,0.581887486855941,0.8387093286508721,-0.32624167306320095,-0.8917670647785259,4426,7,TGFBR2|FKBP1A
NEGATIVE REGULATION OF FGFR3 SIGNALING%REACTOME%R-HSA-5654732.1,0.7124014141963559,0.8972606145338691,0.20637130853307797,0.8078253579172952,5238,18,RPS27A|FGF2|SPRY2|CBL|PPP2CB|FGF1|MAPK1
LOSS OF PHOSPHORYLATION OF MECP2 AT T308%REACTOME%R-HSA-9022535.1,0.7240085744908901,0.9034590034658789,0.485184061667503,0.8151718682513559,5403,2,CAMK4
MITOTIC PROMETAPHASE%REACTOME DATABASE ID RELEASE 66%68877,0.004352835744462939,0.0731407797055425,-0.22514437824806302,-1.61564853691314,33,178,CENPE|KIF2C|CDCA8|NUP107|NCAPG|HAUS1|NDE1|STAG1|TUBG1|CASC5|CCNB2|RAD21|CEP72|HAUS6|ZWINT|TUBGCP5|CEP78|RCC2|HAUS4|CEP76|CSNK1D|MZT2A|ITGB3BP|CEP192|CENPL|PCNT|CENPU|NEK2|NEDD1|NCAPH|NUF2|NSL1|SPDL1|CDC20|DYNC1H1|CLIP1|SMC2|DSN1|OFD1|CEP70|TUBGCP2|TUBG2|CENPM|STAG2|TUBA4A|NUDC|SDCCAG8|HAUS8|CENPI|CDK5RAP2|MAD2L1|KNTC1|ERCC6L|DYNLL2|INCENP|NUP85|NDC80|SGOL1|KIF18A|CEP131|SEC13|NUP37|CKAP5|CENPH|TUBB4A|SMC4|SPC25|NUP160|KIF2A|CCNB1|PLK1|SKA1|PPP2CA|SPC24|SSNA1|SMC1A|PRKACA|CETN2|HSP90AA1|CEP63|DYNC1I1|BIRC5|CENPK|TUBB4B|CDCA5|DCTN3|HAUS7|CENPP|SKA2
NUCLEAR PORE COMPLEX (NPC) DISASSEMBLY%REACTOME%R-HSA-3301854.2,0.49674394373534797,0.794531239347218,-0.21049362497463397,-0.970075263058683,3813,31,NUP188|NEK9|NUP85|NUP37|NUP160|CCNB1|NUP214|NEK6
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%2979096,0.9502379333786541,0.9852369031063491,0.141457849615555,0.591994384007306,6988,22,DLL1|RPS27A|PSENEN|PSEN2|APH1B
TERMINATION OF TRANSLESION DNA SYNTHESIS%REACTOME%R-HSA-5656169.1,0.0302162021359729,0.24599181315662,-0.344453865829273,-1.58744082889056,231,31,POLE|RFC2|RPA2|RFC3|POLD4|PCNA|POLD1|POLD2|KIAA0101|RFC5|ISG15|UBC|POLE2|POLE3|UBE2L6|RFC4
TOXICITY OF BOTULINUM TOXIN TYPE D (BONT D)%REACTOME%R-HSA-5250955.1,0.890916463909165,0.965159112268525,0.27183012227718,0.653749885263782,6590,5,SV2C|VAMP1|VAMP2
MOLYBDENUM COFACTOR BIOSYNTHESIS%REACTOME%R-HSA-947581.1,0.148677248677249,0.5154128781388279,-0.6750395621755141,-1.31818117685506,1123,3,MOCS2|GPHN
SIGNALING BY RHO GTPASES%REACTOME%R-HSA-194315.4,0.00012735608762098798,0.00518555396908895,-0.22685646424619102,-1.8461523716911798,0,372,DEPDC7|GNA13|CIT|MYL12B|NUF2|ARHGAP36|ARHGAP25|NSL1|INPP5B|SPDL1|NCKAP1L|VAV3|CDC20|DYNC1H1|CTTN|HIST1H2BE|WASF2|ARHGEF5|CLIP1|KDM1A|DSN1|MYH11|H2AFX|ARHGAP11A|ECT2|FGD1|FMNL1|NCKIPSD|HIST2H2AC|TAX1BP3|HIST1H2AD|ARHGAP15|RASGRF2|ARPC1A|GDI1|CENPM|VAV1|ARHGAP18|KLC2|WAS|NUDC|HIST1H2BN|ARHGDIB|H2AFV|IQGAP2|PKN1|ARHGAP24|KALRN|CENPI|MAD2L1|RHOF|HIST1H2BC|MYLK|CDC25C|KNTC1|ERCC6L|ARHGAP44|DYNLL2|HIST1H4I|INCENP|NUP85|CHN2|NDC80|SGOL1|NGEF|ARHGAP42|KIF18A|MAPK3|RHOG|RHOD|CYBB|ABL1|FLNA|SEC13|NUP37|MEN1|CKAP5|ARHGAP31|CENPH|ARHGEF15|NCF4|ARHGAP1|RHOJ|STARD13|HIST2H3A|SPC25|PIK3R4|CYFIP2|NUP160|KIF2A|NOXA1|PLK1|SKA1|DLC1|NCF2|PPP2CA|A2M|H2AFZ|SRF|ARHGEF9|SPC24|HIST2H2AA4|SYDE1|STARD8|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|MYH9|ARHGAP8|HIST2H3C|RHPN2|CFL1|WASF3|HIST1H3H|EVL|TIAM1|ACTB|NF2|DYNC1I1|BIRC5|HIST2H4B|RHOU|CENPK|H3F3B|HIST1H2AC|RHPN1|NCK1|ARHGDIA|HIST3H2BB|HIST2H2BE|MYL9|H2AFJ|HIST1H2BK|NET1|HIST1H2BJ|HIST2H2AA3|CENPP|DEPDC1B|SKA2|PPP1R14A
"UNBLOCKING OF NMDA RECEPTORS, GLUTAMATE BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%438066",0.0680361114745519,0.37223192670302396,-0.391035261118346,-1.48602948157925,519,17,GRIN1|CAMK2B|GRIN2C|DLG3|GRIN2D|CAMK2A|GRIA1
MITOCHONDRIAL TRANSLATION ELONGATION%REACTOME DATABASE ID RELEASE 66%5389840,0.0005096839959225281,0.0139121625154964,-0.323650096790454,-1.99071207450366,3,87,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|MRPL18|MRPL57|MRPS18B|MRPS15|MRPL47|GADD45GIP1|MRPS11|MRPL13|OXA1L|MRPL10|MRPL50|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|GFM1|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
ORGANIC ANION TRANSPORTERS%REACTOME%R-HSA-428643.2,0.0749901845308206,0.383578507779904,-0.6660148179201221,-1.45804565853785,572,4,SLC25A10|SLC25A18|SLC25A22
METABOLISM OF INGESTED MESEO2H INTO MESEH%REACTOME DATABASE ID RELEASE 66%5263617,0.90876254180602,0.9715076818387142,-0.54510366122629,-0.7262089638612379,6792,1,TXNRD1
TWIK RELATED POTASSIUM CHANNEL (TREK)%REACTOME%R-HSA-1299503.1,0.19841907824222896,0.575811726650469,0.73791011855528,1.2397842746048702,1480,2,KCNK10|KCNK2
PIWI-INTERACTING RNA (PIRNA) BIOGENESIS%REACTOME DATABASE ID RELEASE 66%5601884,0.499455189321711,0.794989907195277,0.22716273386077898,0.9644068467037541,3666,23,TDRD12|HENMT1|TDRD6
MITOCHONDRIAL TRANSLATION INITIATION%REACTOME DATABASE ID RELEASE 66%5368286,0.00152905198776758,0.0322140470829666,-0.30479260774920397,-1.87472313613625,11,87,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|MRPL18|MRPL57|MRPS18B|MRPS15|MRPL47|GADD45GIP1|MRPS11|MRPL13|OXA1L|MRPL10|MRPL50|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
IRS-RELATED EVENTS TRIGGERED BY IGF1R%REACTOME DATABASE ID RELEASE 66%2428928,0.23188216892596497,0.615614074957182,-0.25555067276453897,-1.1887209909558702,1778,32,IRS1|PIK3CB|FGF10|HRAS|IGF1|PIK3R4|FGF19|FGF9|FGF7|FLT3LG
INTERLEUKIN-18 SIGNALING%REACTOME DATABASE ID RELEASE 66%9012546,0.0798941798941799,0.396145962044166,-0.7297893459799271,-1.4250936283494198,603,3,ALOX5|IL18|IL18BP
GLYCINE DEGRADATION%REACTOME%R-HSA-6783984.1,0.069067454985219,0.37596389138254704,0.74534024484394,1.46599630567238,513,3,GCSH|AMT|DLD
APC-CDC20 MEDIATED DEGRADATION OF NEK2A%REACTOME%R-HSA-179409.2,0.555164777908037,0.8249514479080309,-0.21433136094266197,-0.924012529273526,4261,25,CDC20|ANAPC10|ANAPC2|ANAPC5|CDC23|MAD2L1|CDC27|UBC|ANAPC11
INTERLEUKIN-6 SIGNALING%REACTOME%R-HSA-1059683.2,0.9275609117107679,0.979345221662042,-0.188237890323293,-0.609430297496742,7080,11,CBL|JAK1|JAK2|TYK2|STAT1|IL6R|IL6|PTPN11|SOCS3|IL6ST|STAT3
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX%REACTOME DATABASE ID RELEASE 66%445989,0.88302722417611,0.9629606199413431,-0.157049213640937,-0.6770611658440511,6778,25,IRAK1|NFKBIA|RELA|NFKB1
SIGNALING BY NTRK2 (TRKB)%REACTOME%R-HSA-9006115.2,0.11082404133804699,0.45638735792888,0.35173756722992705,1.3768509206062,814,18,GAB1|FRS3|CDK5R1|DOCK3|SOS1|PLCG1|NRAS|SRC|CDK5|KRAS
AMPK INHIBITS CHREBP TRANSCRIPTIONAL ACTIVATION ACTIVITY%REACTOME%R-HSA-163680.3,0.679240340537001,0.884536278926676,-0.317405023987615,-0.8164512261995078,5185,6,ADIPOR1|ADIPOR2
ACTIVATION OF PUMA AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%139915,0.7991614822829319,0.9315769203975249,0.263089961447493,0.7262527768284429,5908,7,BBC3|TP53BP2
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES%REACTOME DATABASE ID RELEASE 66%380320,0.372576710745924,0.7234654586828599,-0.176072473470336,-1.05112059170152,2901,78,HAUS1|NDE1|TUBG1|CEP72|HAUS6|TUBGCP5|CEP78|HAUS4|CEP76|CSNK1D|MZT2A|CEP192|PCNT|NEK2|NEDD1|DYNC1H1|OFD1|CEP70|TUBGCP2|TUBG2|TUBA4A|SDCCAG8|HAUS8|CDK5RAP2|CEP131|CKAP5|TUBB4A|PLK1|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
HEME BIOSYNTHESIS%REACTOME%R-HSA-189451.1,0.41555615991297296,0.7493091022753771,0.323459685797421,1.0247421488947,3055,10,HMBS|COX10|COX15|UROD|PPOX|CPOX
ACTIVATION OF NOXA AND TRANSLOCATION TO MITOCHONDRIA%REACTOME%R-HSA-111448.2,0.9138611257233029,0.9736820566706701,-0.261659332632137,-0.627147491122933,6948,5,TFDP2|E2F1
CONJUGATION OF CARBOXYLIC ACIDS%REACTOME%R-HSA-159424.1,0.38339081984611295,0.730480369014206,-0.646931342256401,-1.07659720561448,2889,2,GLYATL1
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS%REACTOME%R-HSA-176187.2,0.00465717981888745,0.0753198779107374,-0.38711830273609005,-1.8640829625313402,35,36,RAD9A|RFC2|CLSPN|RPA2|MCM10|RFC3|MCM4|MCM6|CDC6|RAD1|RAD17|ORC1|CDC25C|ORC6|MCM3|MCM5|CDC45|RFC5|MCM2|RFC4
FRS-MEDIATED FGFR4 SIGNALING%REACTOME%R-HSA-5654712.3,0.651931447225245,0.873161075414256,0.24971767719651397,0.848741814217356,4792,12,FGF2|FRS3|SOS1|NRAS|FGF1|KRAS
NEUROTRANSMITTER RELEASE CYCLE%REACTOME%R-HSA-112310.5,0.201288024116196,0.5792408283906739,0.245452668081551,1.2162538280033401,1468,38,LIN7B|GLS|RIMS1|SNAP25|LIN7A|DNAJC5|SLC6A13|PPFIA2|SLC18A3|CPLX1|PPFIA3|PPFIA4
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE%REACTOME%R-HSA-6803204.1,0.0175295556461476,0.180006763679715,0.45060409762243897,1.7327070047283102,128,17,TP53INP1|BBC3|AIFM2|PMAIP1|STEAP3|ATM|TP53BP2|BID
ESTROGEN BIOSYNTHESIS%REACTOME%R-HSA-193144.4,0.20727513227513197,0.587285451772193,-0.637711630023428,-1.2452891860875501,1566,3,HSD17B1|HSD17B14
INTERLEUKIN-12 FAMILY SIGNALING%REACTOME%R-HSA-447115.5,0.00908383078120945,0.12034985725408802,-0.339132389912297,-1.76620271752725,69,47,PPIA|SOD2|CANX|EBI3|IL6ST|HNRNPA2B1|STAT3|HSPA9|PSME2|LMNB1|SNRPA1|MSN|SOD1|ARF1|VAMP7|AIP|CFL1|ANXA2|TALDO1|P4HB
TRAIL SIGNALING%REACTOME%R-HSA-75158.3,0.24173392345743303,0.625158460820442,-0.41932319964030695,-1.20717280310474,1856,8,TNFRSF10A|TNFRSF10B|CASP10|TNFSF10|FADD
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA%REACTOME%R-HSA-159230.2,0.7373446697187701,0.908309781681485,-0.17655018315954,-0.806093571873601,5636,30,NUP188|NCBP1|NUP85|NUP37|NXF1|NUP160|NUP214
PKA-MEDIATED PHOSPHORYLATION OF CREB%REACTOME DATABASE ID RELEASE 66%111931,0.40206725107941904,0.740287621109606,-0.272722969655583,-1.03641388260734,3072,17,ADCY8|PRKAR1A|ADCY4|PRKACA|ADCY9
PI3K EVENTS IN ERBB4 SIGNALING%REACTOME DATABASE ID RELEASE 66%1250342,0.271950578338591,0.646576786621306,-0.429579795136235,-1.17423721316739,2068,7,NRG1|NRG3|NRG2|HBEGF
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY%REACTOME%R-HSA-8934593.1,0.823236948842078,0.941678899694271,-0.18971346626359897,-0.720957499111509,6291,17,TNRC6A|CCND2|PML|CDK6|RUNX1|TNRC6C|CCND3|CCND1
HISTAMINE RECEPTORS%REACTOME%R-HSA-390650.1,0.34351554126473705,0.702167474560024,0.662696443341605,1.11341558901519,2563,2,HRH3|HRH1
CDT1 ASSOCIATION WITH THE CDC6:ORC:ORIGIN COMPLEX%REACTOME DATABASE ID RELEASE 66%68827,0.00012936610608020702,0.00518555396908895,-0.401252824339444,-2.20944231604061,0,57,PSMD1|PSMC2|CDT1|CDC6|PSMD3|PSMB2|PSMF1|GMNN|ORC1|ORC6|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
CIRCADIAN CLOCK%REACTOME DATABASE ID RELEASE 66%400253,0.29368556701030896,0.6662639281174979,-0.19513817740536102,-1.1127166452622599,2278,65,NFIL3|NPAS2|PER2|NR3C1|MEF2D|BHLHE40|RORA|MED1|MEF2C|SMARCD3|DBP|KLF15|SKP1|ARNTL2|CRY2|NR1D1|UBC|CCRN4L|SERPINE1|PPARA|SIK1|RBM4|PPP1CA
TOXICITY OF BOTULINUM TOXIN TYPE E (BONT E)%REACTOME%R-HSA-5250992.1,0.9334656084656079,0.9800972968717879,-0.31242511757655894,-0.6100870708064821,7056,3,SV2A
SYNTHESIS OF DOLICHYL-PHOSPHATE%REACTOME DATABASE ID RELEASE 66%446199,0.0107400130975769,0.133934756708563,-0.6939083192406751,-1.78491912634689,81,6,SRD5A3|DOLK|DOLPP1
OREXIN AND NEUROPEPTIDES FF AND QRFP BIND TO THEIR RESPECTIVE RECEPTORS%REACTOME DATABASE ID RELEASE 66%389397,0.12960997612098699,0.4879451726618929,-0.7787151916184171,-1.2959066047748502,976,2,NPFF|HCRT
"PLATELET ACTIVATION, SIGNALING AND AGGREGATION%REACTOME%R-HSA-76002.2",0.000128139415684264,0.00518555396908895,-0.303635679368444,-2.25200530462283,0,213,PIK3R6|ITPR2|STX4|PPIA|STXBP2|HGF|BRPF3|ITPR3|RAB27B|VAV1|TUBA4A|TLN1|GP1BA|PLEK|GP1BB|VEGFC|GAS6|TGFB3|BCAR1|CLEC3B|DAGLB|VWF|PLA2G4A|SERPINA1|PTPN6|TBXA2R|CD63|ARRB1|FCER1G|DGKE|PIK3CB|F8|MAPK3|TIMP3|RHOG|GNGT2|PHACTR2|SOD1|SRGN|RAPGEF3|FLNA|ITIH3|SPARC|PIK3R3|IGF1|MMRN1|LGALS3BP|GNG11|GNAI2|GNAQ|PDPN|F2R|RAP1A|FN1|DAGLA|GNA15|VEGFB|CD36|ECM1|GNG10|TOR4A|A2M|F2RL3|THBS1|F13A1|ADRA2C|CYB5R1|VCL|SEPP1|RARRES2|SERPINE1|LAMP2|CFL1|FERMT3|MGLL|CFD|HSPA5|TIMP1|GNG3|TMSB4X|ACTN1|SERPING1|CHID1|LHFPL2|PDGFB|SERPINF2|PRKCB|ALDOA
NUCLEAR ENVELOPE BREAKDOWN%REACTOME%R-HSA-2980766.1,0.0171406310868718,0.17803435145825502,-0.32362076831017,-1.6635222683643,131,45,NUP188|NEK9|LMNB1|NUP85|NUP37|NUP160|CCNB1|PLK1|NUP214|LPIN3|VRK1|NEK6|EMD|LPIN2|BANF1|PRKCB
TRANSLOCATION OF ZAP-70 TO IMMUNOLOGICAL SYNAPSE%REACTOME DATABASE ID RELEASE 66%202430,0.233124018838305,0.616933025883855,-0.321670989459743,-1.19545395019876,1781,16,ZAP70|CD3E|HLA-DQB1|LCK|HLA-DQA1|CD3D|CD3G|PTPN22|HLA-DRB1|HLA-DQB2|HLA-DPA1|HLA-DRA|HLA-DRB5|HLA-DPB1|CD4|HLA-DQA2
CONSTITUTIVE SIGNALING BY NOTCH1 T(7;9)(NOTCH1:M1580_K2555) TRANSLOCATION MUTANT%REACTOME DATABASE ID RELEASE 66%2660826,0.5854747092236949,0.8401392131924109,0.319883788195361,0.88303061113051,4328,7,DLL1|ADAM17
ACTIVATED NTRK3 SIGNALS THROUGH PI3K%REACTOME DATABASE ID RELEASE 66%9603381,0.93792740662809,0.9806508984207809,-0.24906243106110698,-0.5969551217672391,7131,5,SRC|PIK3CA|NTRK3|PIK3R1|IRS1
CLASSICAL ANTIBODY-MEDIATED COMPLEMENT ACTIVATION%REACTOME%R-HSA-173623.2,0.000261437908496732,0.00819882332206558,-0.649420904211807,-2.1736725727157302,1,12,IGHG4|IGKV2-28|C1QB|C1QA|C1QC|IGKV2D-28|C1S|IGHG2|C1R
MET ACTIVATES PTPN11%REACTOME DATABASE ID RELEASE 66%8865999,0.149164515690803,0.5157600394920371,0.607907496995345,1.33559866024374,1097,4,MET|GAB1
O2 CO2 EXCHANGE IN ERYTHROCYTES%REACTOME%R-HSA-1480926.1,0.812923397602918,0.9356336309698571,-0.237440931615826,-0.7142804412974431,6239,9,HBB|HBA1|AQP1|CA2|CYB5R1
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS%REACTOME DATABASE ID RELEASE 66%6802946,0.234001040582726,0.617951264290741,-0.24836653820587098,-1.18568522845733,1798,35,VWF|ARRB1|MAPK3|HRAS|RAP1A|FN1|MAP3K11|VCL|ARAF|PHB
LOCALIZATION OF THE PINCH-ILK-PARVIN COMPLEX TO FOCAL ADHESIONS%REACTOME%R-HSA-446343.1,0.12936507936507902,0.487857553689733,-0.689092312782618,-1.3456226371357398,977,3,ITGB1|ILK|PXN
REGULATION OF FZD BY UBIQUITINATION%REACTOME%R-HSA-4641263.2,0.759701101206083,0.9177481900265471,-0.21732918604773302,-0.768878879382913,5794,14,LGR4|FZD4|FZD8|LRP5|UBC
AQUAPORIN-MEDIATED TRANSPORT%REACTOME DATABASE ID RELEASE 66%445717,0.320340378808674,0.688266348397827,0.220250428717077,1.10042668893609,2333,39,AQP5|GNG5|ADCY2|GNGT1|GNAS|GNB5|ADCY3|GNB4|RAB11FIP2|AQP11|ADCY6|RAB11A
SIGNALLING TO ERKS%REACTOME DATABASE ID RELEASE 66%187687,0.144103612815269,0.510372098339109,0.293369909347425,1.31297621892504,1056,27,RALB|CRK|MAPK12|MAPK11|SHC1|SOS1|SHC2|MAPKAPK3|YWHAB|NRAS|RIT1
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION%REACTOME DATABASE ID RELEASE 66%8940973,0.22071129707113002,0.603022518406817,-0.314319579575961,-1.21967686733815,1687,18,MAF|HES1|MAPK3|ABL1|WWTR1|COL1A1|YAP1
MAP KINASE ACTIVATION%REACTOME DATABASE ID RELEASE 66%450294,0.554819110742889,0.824585775196355,0.16468333556734502,0.9399204919244641,4017,62,DUSP4|DUSP6|UBE2V1|MAPK7|RPS6KA2|RPS27A|MAP2K6|MAPK11|BTRC|VRK3|MAPKAPK3|TNIP2|NOD1|MAP2K7|PPP2CB|ATF2|MAP2K1|MAPK1|IKBKB|MAP2K4|MAPK8
METAL ION SLC TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%425410,0.582319863998954,0.8387371079915351,-0.21911647666551298,-0.907418342162067,4452,22,SLC39A7|CP|SLC39A1|SLC41A2|SLC39A3|SLC39A8|SLC41A1|SLC11A1|SLC30A5|HEPH
"GLUTAMATE BINDING, ACTIVATION OF AMPA RECEPTORS AND SYNAPTIC PLASTICITY%REACTOME DATABASE ID RELEASE 66%399721",0.292950391644909,0.665416463589539,-0.269690953551028,-1.1323194506713201,2243,23,TSPAN7|AKAP5|CAMK2B|NSF|CAMK2A|GRIA1|PRKCB
P2Y RECEPTORS%REACTOME DATABASE ID RELEASE 66%417957,0.231194108364019,0.614674205910502,-0.5122869098321079,-1.2278539695276598,1757,5,P2RY13|LPAR6|P2RY14|P2RY6
RECEPTOR MEDIATED MITOPHAGY%REACTOME DATABASE ID RELEASE 66%8934903,0.148102648102648,0.515403737647103,0.43822255707720503,1.3317179336946299,1084,9,MAP1LC3B|ATG5|MAP1LC3A|CSNK2A2
ARACHIDONIC ACID METABOLISM%REACTOME DATABASE ID RELEASE 66%2142753,0.0040411941076782705,0.0698267586144378,-0.3964302198703089,-1.86174822344658,30,33,ALOX5AP|GPX4|ALOX5|LTC4S|TBXAS1|PTGDS|CYP1B1|GGT1|GPX1|CBR1|MAPKAPK2|PTGR2|PLA2G4A|PTGES2|PTGS1|DPEP1|GGT5|PTGES|PTGIS|ABCC1
ACTIVATION OF THE AP-1 FAMILY OF TRANSCRIPTION FACTORS%REACTOME DATABASE ID RELEASE 66%450341,0.8829208593962471,0.9629606199413431,0.207069470347811,0.656010078942567,6492,10,MAPK11|ATF2|MAPK1|MAPK8
"DEFECTIVE POMT1 CAUSES MDDGA1, MDDGB1 AND MDDGC1%REACTOME DATABASE ID RELEASE 66%5083633",0.894275468189667,0.9658968257150641,0.5520511689457429,0.7360857439480559,6732,1,DAG1
FCGAMMA RECEPTOR (FCGR) DEPENDENT PHAGOCYTOSIS%REACTOME%R-HSA-2029480.1,0.10381815860043402,0.443813248472326,-0.21094714100986398,-1.30338246824967,812,89,NCKAP1L|VAV3|WASF2|IGHG4|ITPR2|NCKIPSD|FGR|FCGR1A|ARPC1A|ITPR3|VAV1|WAS|IGKV2-28|MYO10|ELMO1|PIK3CB|PLD4|MAPK3|ABL1|FCGR2A|PLD1|DOCK1|CYFIP2|IGKV2D-28|HCK|PLD3|MYH9|CFL1|WASF3|HSP90AA1|ACTB|NF2|NCK1|IGHG2
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1-AMPK%REACTOME%R-HSA-380972.1,0.7492529204020649,0.9136571397377651,0.176261119921888,0.7985492502689799,5515,28,CAB39L|PRKAG2|TSC2
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS%REACTOME%R-HSA-3108214.2,0.384784293464221,0.731872365230385,-0.17919128800749498,-1.04049259102512,2978,70,POM121|HERC2|PIAS1|NUP107|BLM|STAG1|RAD21|PCGF2|NUP205|CBX2|NUP93|NUP210|PML|PHC3|SP100|PHC2|PARP1|NDNL2|STAG2|CDKN2A|NUP188|SUMO2|RNF168|BRCA1|NUP85|CBX4|NUP37|SUMO3|NUP160|RING1|NUP214|SMC1A|CETN2|NSMCE1|EID3
FANCONI ANEMIA PATHWAY%REACTOME DATABASE ID RELEASE 66%6783310,0.66420041536864,0.8804055751124069,-0.17639555894355902,-0.863272295356708,5116,38,SLX1B|SLX1A|STRA13|EME1|FAAP100|UBC|FANCM|MUS81
BIOSYNTHESIS OF E-SERIES 18(R)-RESOLVINS%REACTOME%R-HSA-9023661.1,0.998938710533298,0.999656642395059,-0.271408877860491,-0.45166777430263505,7529,2,LTA4H|ALOX5
TRANSPORT AND SYNTHESIS OF PAPS%REACTOME%R-HSA-174362.2,0.224921949233066,0.6078034241178771,0.47423392304585704,1.22710814910375,1656,6,PAPSS1|SLC35B2|SLC35B3|SLC26A1|PAPSS2
INTERLEUKIN-23 SIGNALING%REACTOME%R-HSA-9020933.1,0.312508185985593,0.68160868787154,-0.43844160672609,-1.1277899225765502,2385,6,STAT3|P4HB
INTERLEUKIN-35 SIGNALLING%REACTOME DATABASE ID RELEASE 66%8984722,0.327144351464435,0.694149597002244,-0.353626226913317,-1.10786480639439,2501,10,CANX|EBI3|IL6ST|STAT3
SIGNALING BY WNT%REACTOME DATABASE ID RELEASE 66%195721,0.000382995021064726,0.0111294649577428,-0.22527228350382,-1.73298722268731,2,262,SOX13|PRICKLE1|LGR4|PSMD1|PSMC2|HIST1H2BE|PLCB1|GNG8|SMARCA4|PORCN|TERT|AP2A2|RUNX3|H2AFX|ITPR2|SOX17|HIST2H2AC|FZD4|HIST1H2AD|PLCB3|PSMD3|WLS|PSMB2|RUVBL1|ITPR3|SFRP2|HIST1H2BN|H2AFV|PSMF1|FRAT1|CLTA|FZD2|FZD8|HIST1H2BC|PSMD4|SHFM1|SMURF2|CLTC|PSME2|HIST1H4I|PSMB5|VPS29|GNGT2|TNRC6C|SKP1|NFATC1|MEN1|LRP5|PSMC4|GNG11|HIST2H3A|PSMC6|PSMD10|PSMB3|PPP2CA|GNG10|H2AFZ|PSMC1|XIAP|PSMD2|UBC|HIST2H2AA4|PSMD6|CAMK2A|HIST1H2BG|HIST1H2BD|CAV1|HIST2H4A|MYC|HIST1H2AE|CHD8|HIST2H3C|DACT1|WNT3|HIST1H3H|PSMD12|PSMA3|KAT5|HIST2H4B|H3F3B|GNG3|CSNK1A1|HIST1H2AC|PSMA6|PDE6G|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|H2AFJ|HIST1H2BK|PSMA1|PSMC5|AP2M1|HIST1H2BJ|PSMC3|PRKCB|HIST2H2AA3|CLTB
TELOMERE MAINTENANCE%REACTOME DATABASE ID RELEASE 66%157579,0.000128899200824955,0.00518555396908895,-0.4697569782670011,-2.66761825924613,0,64,HIST1H2BE|RFC3|TERF2|TERT|H2AFX|TINF2|HIST2H2AC|HIST1H2AD|RUVBL1|POLD4|HIST1H2BN|H2AFV|PCNA|HIST1H2BC|POLD1|HIST1H4I|POLD2|RFC5|DKC1|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|POLE2|POLA1|POLE3|HIST2H4B|HIST1H2AC|RFC4|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|POLA2|HIST1H2BJ|HIST2H2AA3|FEN1
GAB1 SIGNALOSOME%REACTOME%R-HSA-180292.3,0.38260988260988305,0.730480369014206,0.347081044072044,1.05474728165298,2802,9,GAB1|PAG1|EGFR|SRC
WAX BIOSYNTHESIS%REACTOME%R-HSA-8848584.2,0.6263397642015011,0.858842084733938,0.537778378403918,0.9035371110956449,4674,2,FAR2
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT%REACTOME%R-HSA-201681.1,0.000128106584678452,0.00518555396908895,-0.280138820919815,-2.0172681286320002,0,181,SOX17|HIST2H2AC|FZD4|HIST1H2AD|PSMD3|PSMB2|RUVBL1|SFRP2|HIST1H2BN|H2AFV|PSMF1|FRAT1|FZD2|FZD8|HIST1H2BC|PSMD4|SHFM1|SMURF2|PSME2|HIST1H4I|PSMB5|MEN1|LRP5|PSMC4|HIST2H3A|PSMC6|PSMD10|PSMB3|PPP2CA|H2AFZ|PSMC1|XIAP|PSMD2|UBC|HIST2H2AA4|PSMD6|HIST1H2BG|HIST1H2BD|CAV1|HIST2H4A|MYC|HIST1H2AE|CHD8|HIST2H3C|DACT1|WNT3|HIST1H3H|PSMD12|PSMA3|KAT5|HIST2H4B|H3F3B|CSNK1A1|HIST1H2AC|PSMA6|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|H2AFJ|HIST1H2BK|PSMA1|PSMC5|HIST1H2BJ|PSMC3|HIST2H2AA3
PI-3K CASCADE:FGFR4%REACTOME%R-HSA-5654720.2,0.8330160456894209,0.944514496279782,0.221762747605387,0.702559374488052,6125,10,GAB1|FGF2|FGF1
ACETYLATION%REACTOME%R-HSA-156582.1,0.358394648829431,0.714938712241162,-0.8186479929422141,-1.09063569557433,2678,1,NAT1
INTERLEUKIN-1 SIGNALING%REACTOME DATABASE ID RELEASE 66%9020702,0.00139771283354511,0.0301860198914787,-0.29761114363166496,-1.86743966157655,10,94,PSMD4|SHFM1|PSME2|PSMB5|IRAK1|SKP1|PSMC4|PSMC6|PSMD10|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|PSMD6|RELA|IL1R1|NFKB1|PSMD12|PSMA3|TOLLIP|PSMA6|PSMD13|PELI3|PSMB7|PSMA1|PSMC5|SQSTM1|PSMC3
INWARDLY RECTIFYING K+ CHANNELS%REACTOME DATABASE ID RELEASE 66%1296065,0.404995423041716,0.742103253042029,-0.249786388413815,-1.0344304267684898,3096,22,ABCC9|GNGT2|KCNJ12|GNG10|KCNJ9|GNG3
CROSS-PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS (ENDOSOMES)%REACTOME%R-HSA-1236978.1,0.000129769011160135,0.00518555396908895,-0.48199540143843606,-2.51023380006952,0,47,FCGR1A|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|MRC2|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|MRC1|PSMD2|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
VLDL CLEARANCE%REACTOME%R-HSA-8964046.1,0.262661955241461,0.6382897491935179,-0.5472852118522029,-1.1981217319083401,2006,4,APOC1|LSR|APOBR
INTERLEUKIN-21 SIGNALING%REACTOME DATABASE ID RELEASE 66%9020958,0.48176133402814003,0.786054133284731,-0.32335902976852504,-0.9727431109235941,3697,9,IL2RG|JAK3|STAT5A|STAT3|IL21R
DEFECTIVE CSF2RB CAUSES PULMONARY SURFACTANT METABOLISM DYSFUNCTION 5 (SMDP5)%REACTOME DATABASE ID RELEASE 66%5688849,0.0668612364022287,0.3690551432905871,-0.833691756272402,-1.38739639977276,503,2,CSF2RB|CSF2RA
HOMOLOGY DIRECTED REPAIR%REACTOME%R-HSA-5693538.1,0.00012830382345393898,0.00518555396908895,-0.308969294843413,-2.0531884855513898,0,122,POLE|UIMC1|RAD9A|RFC2|RAD51|CLSPN|RPA2|XRCC2|BRIP1|HIST1H2BE|PALB2|RFC3|H2AFX|NBN|PPP4R2|EXO1|PARP1|RAD51C|POLD4|HIST1H2BN|RAD51AP1|RAD1|RAD17|BRCC3|PCNA|HIST1H2BC|POLD1|SLX1B|RHNO1|SUMO2|SLX1A|RNF168|HIST1H4I|PARP2|POLD2|BRCA1|RFC5|TOPBP1|POLQ|EME1|ABL1|RMI1|RAD51B|RMI2|UBC|PPP4C|HIST1H2BG|HIST1H2BD|HIST2H4A|KAT5|POLE2|POLE3|HIST2H4B|RFC4|MUS81|HIST3H2BB|HIST2H2BE|HIST1H2BK|XRCC3|HIST1H2BJ|FEN1
REGULATION OF SIGNALING BY NODAL%REACTOME DATABASE ID RELEASE 66%1433617,0.312111381454447,0.68160868787154,0.46721519125844396,1.12364985572589,2308,5,ACVR2A|LEFTY1|ACVR2B|ACVR1B
ORC1 REMOVAL FROM CHROMATIN%REACTOME%R-HSA-68949.3,0.00012985326580963502,0.00518555396908895,-0.39538323485983795,-2.2847068848662597,0,69,PSMD1|PSMC2|CDT1|MCM4|MCM6|CDC6|PSMD3|PSMB2|PSMF1|ORC1|ORC6|PSMD4|MCM3|SHFM1|PSME2|MCM5|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|MCM2|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
EPHA-MEDIATED GROWTH CONE COLLAPSE%REACTOME DATABASE ID RELEASE 66%3928663,0.126227576273406,0.481893704625144,-0.397946620698786,-1.3698094390120301,963,13,RHOA|FYN|ROCK1|LYN|MYL12B|MYH11|NGEF|MYH9|MYL9
BIOSYNTHESIS OF PROTECTIN AND RESOLVIN CONJUGATES IN TISSUE REGENERATION (PCTR AND RCTR)%REACTOME DATABASE ID RELEASE 66%9026766,0.504080267558528,0.797772889025646,-0.7517093074547858,-1.00145729357882,3767,1,LTC4S
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%2644602,0.8037113402061858,0.932964969466025,0.140937546244198,0.7829478883872808,5846,56,DLL1|HDAC11|ADAM17|RPS27A|HDAC1|NCOR1|PSENEN|HDAC10|TBL1XR1|HDAC4|PSEN2|APH1B|MAML2|MAML3|TBL1X|MAMLD1|ADAM10|EP300|HDAC6|HDAC2|CDK8|MIB2|HEY2
DISEASES OF GLYCOSYLATION%REACTOME DATABASE ID RELEASE 66%3781865,0.00840879689521345,0.11368006969928998,-0.315970814309411,-1.7398489067791298,64,57,HSPG2|ADAMTS4|NCAN|SDC3|ADAMTS14|SPON2|SBSPON|PRELP|DCN|NOTCH1|SDC4|BGN|MUC4|NOTCH2|VCAN|ADAMTSL1|OGN|NOTCH3|LUM|SDC2|FMOD|ADAMTSL2|MUC20|THBS1|SEMA5A|THBS2|MUC15|CFP|ADAMTS8
METALLOTHIONEINS BIND METALS%REACTOME%R-HSA-5661231.2,0.11827111984282901,0.4691344446484289,-0.5444977199657061,-1.40059481587217,902,6,MT1X|MT1G|MT1M|MT2A|MT1E
ACTIVATION OF NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME DATABASE ID RELEASE 66%629602,0.266458531288177,0.641603173139009,0.453835422502164,1.17432583001975,1962,6,CHRNB2|CHRNA5|CHRNB4|CHRNA3|CHRNA7
SIGNALING BY EGFRVIII IN CANCER%REACTOME DATABASE ID RELEASE 66%5637812,0.0339443312966735,0.26293361581113606,0.46499796895618,1.62851983338215,249,13,GAB1|SHC1|SOS1|CBL|PLCG1|NRAS|CDC37|EGFR|KRAS
BETA OXIDATION OF OCTANOYL-COA TO HEXANOYL-COA%REACTOME%R-HSA-77348.2,0.267639902676399,0.6417330323279019,0.48825361086430696,1.17424713423294,1979,5,HADHB|HADHA|ACADM|ECHS1
RHO GTPASE EFFECTORS%REACTOME DATABASE ID RELEASE 66%195258,0.000128238009746089,0.00518555396908895,-0.268146278895791,-2.04780943013349,0,252,CIT|MYL12B|NUF2|NSL1|SPDL1|NCKAP1L|CDC20|DYNC1H1|CTTN|HIST1H2BE|WASF2|CLIP1|KDM1A|DSN1|MYH11|H2AFX|FMNL1|NCKIPSD|HIST2H2AC|TAX1BP3|HIST1H2AD|ARPC1A|CENPM|KLC2|WAS|NUDC|HIST1H2BN|H2AFV|IQGAP2|PKN1|CENPI|MAD2L1|HIST1H2BC|MYLK|CDC25C|KNTC1|ERCC6L|DYNLL2|HIST1H4I|INCENP|NUP85|NDC80|SGOL1|KIF18A|MAPK3|RHOG|RHOD|CYBB|ABL1|FLNA|SEC13|NUP37|MEN1|CKAP5|CENPH|NCF4|HIST2H3A|SPC25|PIK3R4|CYFIP2|NUP160|KIF2A|NOXA1|PLK1|SKA1|NCF2|PPP2CA|H2AFZ|SRF|SPC24|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|MYH9|HIST2H3C|RHPN2|CFL1|WASF3|HIST1H3H|EVL|ACTB|NF2|DYNC1I1|BIRC5|HIST2H4B|CENPK|H3F3B|HIST1H2AC|RHPN1|NCK1|HIST3H2BB|HIST2H2BE|MYL9|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|CENPP|SKA2|PPP1R14A
PERVASIVE DEVELOPMENTAL DISORDERS%REACTOME DATABASE ID RELEASE 66%9005895,0.0252923579004623,0.223514802128899,0.5288311581002921,1.6753728552545601,185,10,CAMK4|HDAC1|NCOR1|GPS2|TBL1XR1|SIN3A|TBL1X
SIGNALING BY FGFR3 FUSIONS IN CANCER%REACTOME%R-HSA-8853334.2,0.32704918032786895,0.694125525491457,0.38223414750545504,1.10955885985254,2393,8,GAB1|SOS1|NRAS|KRAS|PIK3CA
DEFECTIVE B3GAT3 CAUSES JDSSDHD%REACTOME%R-HSA-3560801.1,0.7029042386185239,0.8934528433311372,-0.219422876422587,-0.8154603709334021,5372,16,HSPG2|NCAN|SDC3|DCN|SDC4|BGN|VCAN|SDC2
C-TYPE LECTIN RECEPTORS (CLRS)%REACTOME%R-HSA-5621481.1,0.00012851818532322299,0.00518555396908895,-0.31599142299558697,-2.09594428863658,0,121,PSMA4|PSMA7|MAP3K14|CHUK|UBE2M|PPP3CA|CUL1|UBA3|ICAM3|NFATC3|MALT1|PSMD7|PSME3|PSMA2|FYN|TRAF6|UBE2N|PSME1|AHCYL1|PLCG2|IL1B|PSMB1|RAF1|CREBBP|PAK2|MUC3A|SYK|NFATC2|PSMB9|RPS6KA5|UBE2D2|PSMB4|CLEC4A|LYN|FBXW11|PSMD1|PSMC2|CD209|PYCARD|NFKB2|ITPR2|PSMD3|PSMB2|ITPR3|PSMF1|PSMD4|CLEC4E|SHFM1|PSME2|CLEC10A|FCER1G|PSMB5|MUC4|HRAS|SKP1|NFATC1|PSMC4|CLEC7A|PSMC6|PSMD10|NFKBIA|PSMB3|MUC20|PSMC1|RELB|PSMD2|UBC|MUC15|PSMD6|RELA|NFKB1|PRKACA|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|ICAM2
OTHER INTERLEUKIN SIGNALING%REACTOME DATABASE ID RELEASE 66%449836,0.0122063262895393,0.14574547201229998,-0.434308666453576,-1.7693766343014898,92,21,CD4|STX4|STXBP2|IL34|IL10RB|IL32|CSF3R|CSF1|STX3|IFNLR1|FLT3LG|CSF1R
SODIUM PROTON EXCHANGERS%REACTOME%R-HSA-425986.1,0.214931237721022,0.5979177134734279,-0.482715617154054,-1.24167460420053,1640,6,SLC9A5|SLC9A1|SLC9A7|SLC9A9
PURINE SALVAGE%REACTOME%R-HSA-74217.4,0.6243199129488579,0.857753590658582,0.255685918410757,0.8690267052700479,4589,12,ADAL|DGUOK|AMPD2|GMPR|DCK|ADK
GSD 0 (MUSCLE)%REACTOME DATABASE ID RELEASE 66%3828062,0.636906341204564,0.8643617075054308,-0.5443136522854639,-0.905824959700415,4800,2,GYG1
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION%REACTOME DATABASE ID RELEASE 66%112314,0.127855046573944,0.48497650625540295,-0.195896716447461,-1.2534043760561102,1001,102,CAMK2B|GNGT2|ADCY4|HRAS|KCNJ12|GNG11|GNAI2|CHRNE|GNG10|GRIN2C|DLG3|ARHGEF9|NSF|GRIN2D|CAMK2A|PRKACA|RRAS|KCNJ9|GNG3|GABRQ|GRIA1|PRKCB|ADCY9
TNFR2 NON-CANONICAL NF-KB PATHWAY%REACTOME%R-HSA-5668541.2,0.00012745347947999,0.00518555396908895,-0.42003592370180504,-2.55173379072693,0,83,PSMD1|PSMC2|TNFSF13B|TNFRSF14|TNFSF8|NFKB2|EDA|PSMD3|PSMB2|TNFRSF11A|TNFRSF18|PSMF1|TRAF2|PSMD4|SHFM1|TNFSF12|PSME2|PSMB5|TNFRSF4|SKP1|TNFSF13|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|RELB|PSMD2|UBC|TNFRSF11B|PSMD6|LTA|TRAF3|LTBR|TNFRSF12A|PSMD12|PSMA3|TNFRSF1A|PSMA6|PSMD13|PSMB7|TNFRSF1B|PSMA1|PSMC5|PSMC3
RRNA PROCESSING IN THE NUCLEUS AND CYTOSOL%REACTOME%R-HSA-8868773.2,0.9992341077355121,0.999656642395059,-0.0709212795145121,-0.515884657347122,7827,190,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|RIOK1|TRMT112|UTP14A|DKC1|RPL35|NOP56|RPL38|RPS15A|RPL36AL|EXOSC3|RPS13|RPL26L1|FAU|BOP1|DIMT1|SKIV2L2|EXOSC2|NAT10
"ANTIGEN PRESENTATION: FOLDING, ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC%REACTOME%R-HSA-983170.3",0.00417754569190601,0.0711970927459713,-0.4621010631342679,-1.94016897887464,31,23,PDIA3|HLA-F|ERAP2|ERAP1|HLA-B|HLA-E|B2M|TAPBP|HLA-C|CANX|HLA-A|SEC23A|CALR|SEC13|SEC24A|HSPA5|SAR1B
UNWINDING OF DNA%REACTOME%R-HSA-176974.2,0.0147712418300654,0.16327644723639997,-0.531030063444472,-1.77740734354352,112,12,MCM4|MCM6|GINS2|MCM3|MCM5|CDC45|GINS1|MCM2
RESOLUTION OF D-LOOP STRUCTURES%REACTOME%R-HSA-5693537.1,0.0842324190822826,0.40376145987147494,-0.297758195206948,-1.41071393984008,647,34,RAD51|XRCC2|BRIP1|PALB2|NBN|EXO1|RAD51C|RAD51AP1|SLX1B|SLX1A|BRCA1|EME1|RMI1|RAD51B|RMI2|KAT5|MUS81|XRCC3
METABOLISM OF FAT-SOLUBLE VITAMINS%REACTOME%R-HSA-6806667.3,0.663178548070634,0.879828561611614,-0.187484800674804,-0.8560188947036891,5069,30,SDC4|APOM|SDC2|APOE|LRP10|LDLR|VKORC1
SCAVENGING BY CLASS H RECEPTORS%REACTOME DATABASE ID RELEASE 66%3000497,0.0334306182011144,0.261061407921079,-0.8818307140887791,-1.4675073235773601,251,2,SPARC|STAB1
U12 DEPENDENT SPLICING%REACTOME%R-HSA-72165.1,0.0218543902754429,0.20448054087661602,-0.298514898452528,-1.600712738046,168,52,SF3B3|PRPF8|SNRPD3|POLR2F|SNRNP48|PDCD7|SF3B4|SNRPE|POLR2C|YBX1|TXNL4A|NCBP2|POLR2J|DDX23|SNRNP35|DDX42|ZRSR2|SNRPF|SRSF1|NCBP1|SNRPD1|POLR2H|EFTUD2|SNRNP25|SNRPB|SRSF2|POLR2G|SF3B2|POLR2L
PRPP BIOSYNTHESIS%REACTOME%R-HSA-73843.2,0.28933404085964504,0.662218930390028,-0.688716174725103,-1.1461338487395,2180,2,PRPS1
ERYTHROPOIETIN ACTIVATES STAT5%REACTOME DATABASE ID RELEASE 66%9027283,0.759060675987512,0.917242163810958,0.29392579786604806,0.7605502775438779,5591,6,IRS2|JAK2|EPOR|STAT5B|STAT5A|LYN
REGULATION OF GAP JUNCTION ACTIVITY%REACTOME%R-HSA-191650.1,0.5904749270363491,0.841700481190927,-0.562834298318169,-0.936646276372815,4450,2,TJP1|GJA1
LATE PHASE OF HIV LIFE CYCLE%REACTOME%R-HSA-162599.2,0.0386528893991581,0.279777317018993,-0.212342763938786,-1.42693735874432,302,128,RANBP1|NCBP2|GTF2A2|POLR2J|PPIA|TAF3|UBAP1|CCNK|GTF2A1|TAF12|NMT1|SUPT16H|NUP188|NCBP1|NUP85|POLR2H|RCC1|GTF2H1|TAF7|MVB12B|NUP37|RAN|TAF9B|NUP160|NELFB|CDK7|NUP214|CHMP4A|CHMP6|UBC|MNAT1|TAF10|POLR2G|SUPT4H1|TAF9|SSRP1|VPS37C|AK6|POLR2L|GTF2H2
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU-RICH ELEMENTS%REACTOME DATABASE ID RELEASE 66%450531,0.00063653723742839,0.0163600882996276,-0.323633089996255,-1.9610051329253,4,82,PSMD4|MAPKAPK2|SHFM1|PSME2|PSMB5|HSPB1|TNFSF13|PSMC4|PSMC6|PSMD10|PSMB3|NUP214|PSMC1|PSMD2|UBC|EXOSC3|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|EXOSC2|PSMA1|PSMC5|PSMC3|EIF4G1
INTERLEUKIN-38 SIGNALING%REACTOME%R-HSA-9007892.2,0.5587727453845129,0.8268422944617521,0.7196735774150859,0.9595876078715558,4206,1,MAPK8
POST-TRANSLATIONAL MODIFICATION: SYNTHESIS OF GPI-ANCHORED PROTEINS%REACTOME%R-HSA-163125.2,0.5301391035548689,0.811490026766563,-0.170527732555966,-0.952727404644756,4115,60,THY1|CPM|NRN1|PIGP|ART4|LYPD1|BST1|RECK|PLAUR|PIGH|RTN4RL1|LY6H|ALPL|FOLR2|LY6E
SLC TRANSPORTER DISORDERS%REACTOME%R-HSA-5619102.4,0.46765838756807,0.780769690730001,0.767644464049405,1.02355031234966,3520,1,GCK
RUNX3 REGULATES P14-ARF%REACTOME DATABASE ID RELEASE 66%8951936,0.872459614382491,0.9587056110602221,-0.219741939869647,-0.661037541899476,6696,9,TGFB1|RUNX1|RUNX3|CCND1
P75NTR SIGNALS VIA NF-KB%REACTOME DATABASE ID RELEASE 66%193639,0.0175300889586604,0.180006763679715,-0.46367292289896705,-1.7231881190490401,133,16,IRAK1|NFKBIA|UBC|RELA|NFKB1|NGFR|SQSTM1
FCERI MEDIATED CA+2 MOBILIZATION%REACTOME%R-HSA-2871809.1,0.33142037302726,0.695999593926509,-0.248610948180911,-1.09649573978611,2540,27,GRAP2|AHCYL1|PLCG2|LCP2|SYK|NFATC2|IGKV3-11|LYN|VAV3|ITPR2|ITPR3|VAV1|IGKV2-28|NFATC1|IGKV2D-28
INTERLEUKIN RECEPTOR SHC SIGNALING%REACTOME DATABASE ID RELEASE 66%912526,0.34847092794330004,0.706503295147533,-0.265881832048431,-1.08320449820463,2654,21,CSF2RB|PTPN6|IL2RA|PIK3CB|PIK3R3|CSF2RA|IL3RA
ABACAVIR TRANSPORT AND METABOLISM%REACTOME DATABASE ID RELEASE 66%2161522,0.101919437685861,0.441073279931729,0.599355686457598,1.4414469889187198,753,5,ABCB1|ADAL|NT5C2
VITAMIN C (ASCORBATE) METABOLISM%REACTOME DATABASE ID RELEASE 66%196836,0.0939800210304942,0.42374851931717106,-0.529778103526535,-1.4481248208725,714,7,SLC2A1|SLC2A3|CYB5A
"CELL CYCLE, MITOTIC%REACTOME%R-HSA-69278.3",0.000126374320738026,0.00518555396908895,-0.284954332095443,-2.39991446799255,0,478,NUP205|NCAPG2|PRIM2|AJUBA|CEP78|RCC2|HAUS4|PSMB9|SKP2|CEP76|CSNK1D|CCNH|MZT2A|NCAPD3|NUP93|ITGB3BP|RAB8A|FBXL7|LIN54|CEP192|NUP210|CENPL|PCNT|CENPU|NEK2|NEDD1|POLE|TYMS|PSMB4|NCAPH|CCND2|RFC2|LYN|FBXW11|RPA2|NUF2|CDK6|RRM2|NSL1|PSMD1|MCM10|PSMC2|SPDL1|CDC20|DYNC1H1|HIST1H2BE|ANAPC10|TFDP2|ESCO2|SET|CLIP1|RFC3|CDT1|SMC2|DSN1|MCM4|LCMT1|ANAPC2|H2AFX|MCM6|ANAPC5|LEMD3|ESPL1|GINS2|CDC6|HIST2H2AC|OFD1|HIST1H2AD|CEP70|TUBGCP2|PSMD3|PSMB2|TUBG2|CDKN1C|CENPM|LIN52|CDC23|SETD8|STAG2|TPX2|POLD4|CDKN2A|TUBA4A|DYRK1A|NUDC|HIST1H2BN|H2AFV|PPP2R3B|SDCCAG8|PSMF1|E2F2|PTTG1|HAUS8|PCNA|GMNN|ORC1|PKMYT1|TOP2A|CENPI|CDK5RAP2|MAD2L1|HIST1H2BC|NCAPH2|NUP188|CDC25C|LIN9|ORC6|KNTC1|PSMD4|KIF20A|POLD1|NEK9|MCM3|SHFM1|ERCC6L|FOXM1|PSME2|DYNLL2|HIST1H4I|LMNB1|MCM5|INCENP|CDC45|POLD2|NUP85|PSMB5|NDC80|RFC5|CDKN2B|SGOL1|ENSA|KIF18A|GINS1|ABL1|CEP131|CDC27|SEC13|SKP1|NUP37|E2F1|CKAP5|CENPH|TUBB4A|PSMC4|SMC4|HIST2H3A|SPC25|DHFR|PSMC6|NUP160|MAX|MYBL2|PSMD10|KIF2A|CCNB1|PLK1|SKA1|CDK7|PSMB3|PPP2CA|NUP214|H2AFZ|PSMC1|RAB1B|SPC24|PSMD2|UBC|MCM2|HIST2H2AA4|MNAT1|TK1|PSMD6|HIST1H2BG|LPIN3|HIST1H2BD|HIST2H4A|MYC|HIST1H2AE|HIST2H3C|CCND3|SSNA1|SMC1A|PRKACA|CETN2|CDKN2C|HIST1H3H|PSMD12|PSMA3|POLE2|POLA1|HSP90AA1|POLE3|CEP63|VRK1|DYNC1I1|BIRC5|NEK6|HIST2H4B|ANAPC11|CENPK|H3F3B|HIST1H2AC|PSMA6|TUBB4B|RFC4|CCND1|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|EMD|H2AFJ|CDCA5|HIST1H2BK|LPIN2|PSMA1|DCTN3|BANF1|POLA2|HAUS7|PSMC5|HIST1H2BJ|PSMC3|PRKCB|HIST2H2AA3|FEN1|CENPP|SKA2
TANDEM OF PORE DOMAIN IN A WEAK INWARDLY RECTIFYING K+ CHANNELS (TWIK)%REACTOME%R-HSA-1299308.1,0.0843725126028124,0.40376145987147494,-0.817149159084643,-1.35986687269215,635,2,KCNK6|KCNK7
SIGNALING BY PTK6%REACTOME%R-HSA-8848021.2,0.46669263731982896,0.7806653415096191,-0.192787863374047,-0.990996052162278,3593,45,PTPN1|CDKN1B|NRG1|CDK4|AKT1|NRG3|NRG2|RAC1|STAP2|NR3C1|KHDRBS3|SOCS3|BCAR1|ELMO1|GPNMB|STAT3|PXN|HRAS|HBEGF|DOCK1|UBC|CCND1
CLATHRIN DERIVED VESICLE BUDDING%REACTOME DATABASE ID RELEASE 66%421837,0.0720743993800052,0.378088098869897,-0.240057777048459,-1.39392010188817,557,70,PIK3C2A|AP3S1|HGS|STX4|SNX5|TXNDC5|NAPA|CLTA|NECAP1|SH3GL2|CLTC|ARRB1|YIPF6|VAMP8|ARF1|VAMP7|SNX2|CTSZ|FTL|AP1B1|AP4S1|DTNBP1|TFRC|FTH1|CLTB
SIGNALING BY BMP%REACTOME DATABASE ID RELEASE 66%201451,0.97976501305483,0.993436724391485,-0.121131857468496,-0.508581976894423,7504,23,SMAD6|SMAD5|SMURF2|BMP2|ACVRL1
PENTOSE PHOSPHATE PATHWAY%REACTOME%R-HSA-71336.6,0.176510522742702,0.548380753278361,0.367722959262639,1.2878424688466001,1299,13,DERA|RPE|PGD|RPIA|RBKS|SHPK|G6PD|PGM2
DEGRADATION OF THE EXTRACELLULAR MATRIX%REACTOME%R-HSA-1474228.4,0.0131341746072624,0.151789996978976,-0.277635506698615,-1.63439575285124,101,74,MMP25|MMP12|CD44|ADAM9|PSEN1|HSPG2|COL15A1|ADAMTS4|LAMC1|ADAM8|LAMC2|COL18A1|COL23A1|CTSV|TPSAB1|CTSS|MMP1|CTSB|DCN|COL14A1|HTRA1|MMP14|SPP1|CAPN1|CAST|COL12A1|A2M|MMP9|NID1|CTSD|CTSL|TIMP1|COL16A1|ADAMTS8|MMP19|COL13A1|COL26A1
SYNTHESIS OF PA%REACTOME%R-HSA-1483166.6,0.239372138652714,0.6231125413749761,-0.260328426983905,-1.18860863133776,1829,30,GPD1|AGPAT1|GPAM|PLA2G2A|PLA2G2D|PLA2R1|PLA2G4D|PLA2G4A|PLD1|AGPAT2|AGPAT3|PLA2G12A
"ROS, RNS PRODUCTION IN PHAGOCYTES%REACTOME%R-HSA-1222556.7",0.000521920668058455,0.0139121625154964,-0.5066511940683279,-2.2101050323956297,3,26,ATP6V1D|ATP6V0A1|TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|ATP6V1F|ATP6V0D1|SLC11A1|CYBB|NCF4|NCF2|NOS3|ATP6V0E1|ATP6V0E2|ATP6V1A|ATP6V1G1
PHOSPHOLIPASE C-MEDIATED CASCADE: FGFR1%REACTOME%R-HSA-5654219.2,0.699648553663152,0.892809346371973,0.33424772800535196,0.8038638691055849,5175,5,FGF2|PLCG1|FGF1
SMAC-MEDIATED APOPTOTIC RESPONSE%REACTOME DATABASE ID RELEASE 66%111469,0.9255204109218709,0.9786453534208341,0.257304996991988,0.618817042247385,6846,5,CASP9|CASP3|CASP7
SIGNALING BY MST1%REACTOME%R-HSA-8852405.1,0.170634920634921,0.544171946973796,-0.660673931148105,-1.29012874041275,1289,3,MST1R|SPINT2
OPIOID SIGNALLING%REACTOME%R-HSA-111885.1,0.0816694576838851,0.397722753303477,-0.234317236043572,-1.3696658184488402,633,72,PLCB1|GNG8|GNAL|ITPR2|PLCB3|ITPR3|PDE4B|ADCY8|PDE4D|POMC|PRKAR1A|PLA2G4A|GNGT2|ADCY4|PDE1C|PDE1A|GNG11|GNAI2|PDE1B|PPP2CA|GNG10|PDE4A|PRKACA|ADRBK1|GNG3|PPP1CA|ADCY9
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS%REACTOME DATABASE ID RELEASE 66%9022699,0.477470141150923,0.7850984235874658,0.296273843105391,0.9749228678444,3517,11,MET|PTPN4|HDAC1|SIN3A
RHO GTPASES ACTIVATE PAKS%REACTOME%R-HSA-5627123.2,0.0596661847811802,0.354042166306387,-0.381194173474834,-1.50606261711862,453,19,CDC42|PAK2|RAC1|MYL12B|CTTN|MYH11|MYLK|FLNA|MYH9|NF2|MYL9
SIGNAL AMPLIFICATION%REACTOME%R-HSA-392518.1,0.165644971957741,0.5375245857985801,-0.289290045958049,-1.2759104346631598,1269,27,PLA2G4A|TBXA2R|GNGT2|GNG11|GNAI2|GNAQ|GNA15|GNG10|GNG3
DEATH RECEPTOR SIGNALLING%REACTOME DATABASE ID RELEASE 66%73887,0.804230769230769,0.932964969466025,-0.12150537012982801,-0.819452394019118,6272,131,VAV3|GNB2L1|ARHGEF5|BCL2L11|ECT2|FGD1|TNFRSF10A|TNFRSF10B|RASGRF2|CASP10|VAV1|NGF|KALRN|NSMAF|TRAF2|TNFAIP3|TNFSF10|NGEF|IRAK1|ARHGEF15|USP2|NFKBIA|XIAP|ARHGEF9|FADD|UBC|RELA|MAGED1|NFKB1|TIAM1|TNFRSF1A|ARHGDIA|NGFRAP1|NET1|NGFR|SQSTM1|BAD
LIGAND-RECEPTOR INTERACTIONS%REACTOME DATABASE ID RELEASE 66%5632681,0.0506478209658422,0.323146514170008,-0.6939230135464699,-1.5191425326249701,386,4,BOC|GAS1
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES%REACTOME DATABASE ID RELEASE 66%1650814,0.000128287363694676,0.00518555396908895,-0.514538748804261,-2.7475024728801603,0,51,COL15A1|COL27A1|PLOD2|ADAMTS14|COL20A1|COL18A1|COL23A1|P4HA3|PCOLCE2|COL11A2|P4HA1|PPIB|COL14A1|COL5A3|COL4A1|COL4A2|COL5A2|COL12A1|COL6A3|COL8A1|COL21A1|SERPINH1|COL1A2|COL1A1|COL3A1|P3H2|COL6A1|COL16A1|COL5A1|COL6A2|COL13A1|COL26A1|P4HB
DIGESTION%REACTOME%R-HSA-8935690.5,0.43953238376780396,0.7650340344477281,0.51902911470417,1.02086901915787,3270,3,AMY2B|CHIT1|PIR
OLIGOMERIZATION OF CONNEXINS INTO CONNEXONS%REACTOME%R-HSA-190704.1,0.547290969899666,0.818317601346006,-0.729102337891487,-0.971339381866999,4090,1,GJA1
BIOSYNTHESIS OF ELECTROPHILIC Ω-3 PUFA OXO-DERIVATIVES%REACTOME DATABASE ID RELEASE 66%9027604,0.457415760148581,0.7719619284439659,-0.6167080231596359,-1.0263007695653499,3447,2,PTGS2|ALOX5
ION TRANSPORT BY P-TYPE ATPASES%REACTOME DATABASE ID RELEASE 66%936837,0.0855143819642395,0.40462962277421993,-0.27584893917076503,-1.3900356617591798,659,42,ATP8B3|FXYD2|ATP1A1|ATP2A2|ATP2C1|PDZD11|ATP10A|ATP11C|ATP1B1|ATP2A1|PLN|ATP1A3|ATP11B|ATP1B3|ATP2A3|ATP8B1|CAMK2B|FXYD1|ATP8B4|CAMK2A|ATP1B2|ATP8A2|ATP2B2|FXYD7
"SYNTHESIS, SECRETION, AND INACTIVATION OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)%REACTOME DATABASE ID RELEASE 66%400511",0.6011455350169229,0.846830230102787,-0.305623762564302,-0.8798480371862081,4617,8,PCSK1|DPP4|SEC11C
SYNTHESIS OF PIPS IN THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%8847453,0.7007200108680891,0.8931369333627571,0.36887149403786296,0.810426381767176,5157,4,PIP4K2C|PIP4K2A|PIP4K2B
SIGNAL TRANSDUCTION BY L1%REACTOME%R-HSA-445144.1,0.18995396696452801,0.56366737984224,0.309939788550634,1.25611572449322,1402,20,VAV2|PAK1|ITGAV|ITGA2B|NRP1|EGFR|CSNK2A2|MAP2K1|MAPK1|NCAM1
DEFECTIVE TPR MAY CONFER SUSCEPTIBILITY TOWARDS THYROID PAPILLARY CARCINOMA (TPC)%REACTOME%R-HSA-5619107.2,0.46765838756807,0.780769690730001,0.767644464049405,1.02355031234966,3520,1,GCK
PD-1 SIGNALING%REACTOME%R-HSA-389948.1,0.0499408595084768,0.3202045177909881,-0.390127556824158,-1.54135758132063,379,19,PTPN11|HLA-DRB1|HLA-DQB2|CD274|HLA-DPA1|HLA-DRA|HLA-DRB5|HLA-DPB1|CD4|HLA-DQA2|PDCD1LG2|PTPN6
ACTIVATION OF TRKA RECEPTORS%REACTOME DATABASE ID RELEASE 66%187015,0.382109406814171,0.730138904609379,0.407866348892769,1.0553781502111401,2814,6,ADORA2A|ADCYAP1|ADCYAP1R1
ACTIVATION OF BID AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%75108,0.61078657791061,0.8515562847300799,0.397041696502128,0.8723175162835759,4495,4,CASP8|BID
GOLGI ASSOCIATED VESICLE BIOGENESIS%REACTOME%R-HSA-432722.3,0.18104228630544397,0.5547162448666899,-0.22978437161197,-1.2321621887212801,1399,52,PIK3C2A|AP3S1|SNX5|TXNDC5|NAPA|NECAP1|SH3GL2|ARRB1|YIPF6|VAMP8|ARF1|VAMP7|SNX2|FTL|AP1B1|DTNBP1|TFRC|FTH1
MRNA DECAY BY 5' TO 3' EXORIBONUCLEASE%REACTOME%R-HSA-430039.1,0.333420845366238,0.6971906052358929,-0.302946694625317,-1.09995034089594,2539,15,DCP1B|LSM7|LSM4|LSM2|DDX6|LSM1|EDC4|LSM6|EDC3|DCP1A|DCP2|XRN1|LSM5|PATL1|LSM3
MHC CLASS II ANTIGEN PRESENTATION%REACTOME DATABASE ID RELEASE 66%2132295,0.00038279954064055096,0.0111294649577428,-0.31611899888993106,-2.00760070325858,2,99,CTSO|CENPE|AP2A1|KIF2C|KLC1|CAPZA2|AP1S3|KIF3A|HLA-DRB1|HLA-DMA|HLA-DMB|RACGAP1|HLA-DQB2|AP1S2|KIF11|KIF15|HLA-DPA1|HLA-DRA|HLA-DRB5|ACTR10|DCTN4|DYNC1H1|CD74|AP2A2|HLA-DPB1|DNM1|HLA-DQA2|CTSF|CTSV|RAB7A|CTSS|KLC2|CANX|CLTA|SH3GL2|CTSB|KIF20A|SEC23A|CLTC|DYNLL2|KIF4A|LAG3|KIF18A|RILP|SEC13|SEC24A|ARF1|IFI30|CTSH|KIF2A|AP1B1|DCTN5|CTSC|CTSD|CTSL|DYNC1I1|SPTBN2|LGMN|KIF22|SAR1B|DCTN3|AP2M1|DNM3
SIGNALING BY WNT IN CANCER%REACTOME DATABASE ID RELEASE 66%4791275,0.8960632066475959,0.966818865417345,0.14659280248957401,0.670900756140256,6577,29,DKK1|KREMEN1|CTBP2|PPP2CB|LRP6|PPP2R5C|TNKS|TNKS2|AXIN1|FZD6
TOLL LIKE RECEPTOR 9 (TLR9) CASCADE%REACTOME DATABASE ID RELEASE 66%168138,0.44093985442472206,0.7653693162885199,-0.162982028613714,-1.00701966245159,3452,89,TICAM2|ATF1|EEA1|ELK1|MAPKAPK2|MEF2C|MAPK9|MAPK3|IRF7|IRAK1|SKP1|PIK3R4|MAP2K3|NFKBIA|PPP2CA|UBC|TICAM1|RELA|NFKB1|TLR4|CD14|LY96|PELI3
FORMATION OF HIV ELONGATION COMPLEX IN THE ABSENCE OF HIV TAT%REACTOME%R-HSA-167152.3,0.103169427416199,0.441899546263084,-0.266260702182515,-1.3573070898938502,790,44,NCBP2|POLR2J|CCNK|SUPT16H|NCBP1|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|POLR2L|GTF2H2
MITOCHONDRIAL TRANSCRIPTION INITIATION%REACTOME%R-HSA-163282.2,0.8918301531846279,0.965443067117994,0.334675195764862,0.6582666157979921,6636,3,TFB2M|POLRMT
RUNX2 REGULATES CHONDROCYTE MATURATION%REACTOME%R-HSA-8941284.1,0.0537245444801715,0.33574799288155494,0.856796250344637,1.4395283260208003,400,2,CBFB|HDAC4
DISEASES ASSOCIATED WITH SURFACTANT METABOLISM%REACTOME%R-HSA-5687613.1,0.0738123282292894,0.38224076541753,-0.666960789720399,-1.46011658855229,563,4,CCDC59|CSF2RB|TTF1|CSF2RA
REPRESSION OF WNT TARGET GENES%REACTOME DATABASE ID RELEASE 66%4641265,0.0142818280739935,0.160136326833721,0.519006170058801,1.76400102432098,104,12,TLE2|TCF7L1|TLE3|HDAC1|AES
INHIBITION OF SIGNALING BY OVEREXPRESSED EGFR%REACTOME DATABASE ID RELEASE 66%5638303,0.48824545092309707,0.7882673024233101,0.756120423467137,1.0081845592049201,3675,1,EGFR
SMAD2 3 MH2 DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3315487,0.9607710058368399,0.990064627444708,0.21695347750275798,0.5613798745356489,7077,6,SMAD3|SMAD2
MYOCLONIC EPILEPSY OF LAFORA%REACTOME%R-HSA-3785653.2,0.17652423137050502,0.548380753278361,-0.42831209084193,-1.28846760824962,1354,9,EPM2A|GYG1|PPP1R3C|UBC|GYG2
E2F MEDIATED REGULATION OF DNA REPLICATION%REACTOME DATABASE ID RELEASE 66%113510,0.20204001569242802,0.580549715779131,-0.298412013123778,-1.23580179067676,1544,22,PPP2R3B|ORC1|ORC6|E2F1|CCNB1|PPP2CA|POLA1|POLA2
CYCLIN A:CDK2-ASSOCIATED EVENTS AT S PHASE ENTRY%REACTOME%R-HSA-69656.3,0.000127697612054655,0.00518555396908895,-0.35413421425573605,-2.15907518977681,0,84,CDC25B|TFDP1|UBB|PSMA4|PSMA7|RBBP4|FZR1|CCNA2|CUL1|CDC25A|WEE1|PSMD7|PSME3|PSMA2|PSME1|CDKN1B|CDK4|AKT1|PSMB1|PSMB9|SKP2|CCNH|LIN54|PSMB4|PSMD1|PSMC2|TFDP2|PSMD3|PSMB2|LIN52|PSMF1|LIN9|PSMD4|SHFM1|PSME2|PSMB5|SKP1|E2F1|PSMC4|PSMC6|MAX|PSMD10|CDK7|PSMB3|PSMC1|PSMD2|UBC|MNAT1|PSMD6|MYC|PSMD12|PSMA3|PSMA6|CCND1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
INFECTIOUS DISEASE%REACTOME DATABASE ID RELEASE 66%5663205,0.000128799587841319,0.00518555396908895,-0.21952453662131696,-1.76842015042447,0,350,CTNND1|RANBP1|NCBP2|CD4|GTF2A2|HGS|POLR2J|PACS1|PPIA|TAF3|PSMD3|PSMB2|UBAP1|KPNB1|NPM1|CANX|CCNK|PSMF1|HLA-A|GTF2A1|TAF12|CLTA|NMT1|SH3GL2|RPLP2|SUPT16H|NUP188|SLC25A6|CXCR4|PSMD4|ELMO1|SHFM1|RPS14|RPS4X|RPL35A|NCBP1|CLTC|PSME2|RPS29|NUP85|PSMB5|RPL10|RPL36A|RPL24|POLR2H|ISG15|RCC1|GTF2H1|RPL22L1|TAF7|KPNA4|CALR|MVB12B|SKP1|NUP37|ARF1|RAN|STX1B|PSMC4|HBEGF|TAF9B|PSMC6|NUP160|KPNA2|NELFB|PSMD10|RPL35|CDK7|SV2A|PSMB3|AP1B1|RPL38|HCK|RPS15A|NUP214|RPL36AL|CHMP4A|PSMC1|CHMP6|PSMD2|UBC|PABPN1|MNAT1|RPS13|SLC25A4|PSMD6|TAF10|POLR2G|SUPT4H1|RPL26L1|PSMD12|PSMA3|FAU|TAF9|HSP90AA1|PSMA6|SSRP1|VPS37C|PSMD13|PSMB7|PSMA1|AK6|BANF1|PSMC5|AP2M1|PSMC3|FEN1|SH3GL3|POLR2L|GTF2H2|SLC25A5
SIGNALING BY OVEREXPRESSED WILD-TYPE EGFR IN CANCER%REACTOME%R-HSA-5638302.1,0.48824545092309707,0.7882673024233101,0.756120423467137,1.0081845592049201,3675,1,EGFR
MAP3K8 (TPL2)-DEPENDENT MAPK1 3 ACTIVATION%REACTOME DATABASE ID RELEASE 66%5684264,0.9232077446363158,0.9776156396135859,-0.168384030663606,-0.6257802574776179,7056,16,SKP1|UBC|NFKB1
POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME%R-HSA-622327.1,0.266458531288177,0.641603173139009,0.453835422502164,1.17432583001975,1962,6,CHRNB2|CHRNA5|CHRNB4|CHRNA3|CHRNA7
HISTIDINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%70921,0.131481481481482,0.490819490032838,-0.6877136869968019,-1.34293053038731,993,3,C9orf41|FTCD|HNMT
REGULATION OF PYRUVATE DEHYDROGENASE (PDH) COMPLEX%REACTOME DATABASE ID RELEASE 66%204174,0.5953412784398701,0.8442752964756541,0.241211093966166,0.889728294648862,4395,15,PPARD|PDPR|DLAT|PDP1
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX%REACTOME DATABASE ID RELEASE 66%937042,0.9718520533043241,0.9915747942934481,0.170752637107755,0.5409558963982439,7146,10,RPS27A|UBA52|MAP3K7|TAB2|TAB1|IRAK2|TAB3|UBB|TRAF6
SIGNALING BY TGF-BETA RECEPTOR COMPLEX%REACTOME%R-HSA-170834.1,0.600978876867594,0.84675950142966,-0.156368497791127,-0.911371601483505,4665,71,SMAD4|UBB|MTMR4|CDK9|TGFBR1|UBE2M|RNF111|SMAD7|TGIF2|RBL1|RHOA|SMURF1|PPP1R15A|CCNT1|F11R|PPM1A|FURIN|TGFB1|USP15|JUNB|TFDP2|SKIL|PARP1|UCHL5|USP9X|CCNK|TGIF1|SMURF2|CDKN2B|SNW1|MEN1|NEDD8|TGFBR2|WWTR1|UBC|FKBP1A|SERPINE1|MYC|PPP1CA
REGULATION OF ACTIVATED PAK-2P34 BY PROTEASOME MEDIATED DEGRADATION%REACTOME%R-HSA-211733.1,0.000258464719565779,0.00819882332206558,-0.43593215028912,-2.2852979979763504,1,48,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
MMR%REACTOME DATABASE ID RELEASE 66%5358508,0.590968758204253,0.8417378833576942,-0.246050615584218,-0.8933699006825151,4501,15,RPA2|EXO1|POLD4|PCNA|POLD1|POLD2
PROGRAMMED CELL DEATH%REACTOME DATABASE ID RELEASE 66%5357801,0.000385010266940452,0.0111294649577428,-0.259916404041099,-1.81054128177441,2,153,PSMD1|PSMC2|H1F0|TFDP2|RIPK3|HMGB2|BCL2L11|GZMB|TNFRSF10A|TNFRSF10B|PSMD3|PSMB2|TICAM2|OPA1|KPNB1|PSMF1|NMT1|TRAF2|PPP1R13B|TNFSF10|PSMD4|SHFM1|CYCS|MLKL|STAT3|PSME2|DYNLL2|LMNB1|PSMB5|E2F1|PSMC4|TJP2|PSMC6|GSN|PSMD10|PSMB3|PSMC1|XIAP|FADD|PSMD2|UBC|TICAM1|BCAP31|PSMD6|MAGED1|TLR4|VIM|PSMD12|PSMA3|HIST1H1C|PSMA6|CD14|LY96|PSMD13|PSMB7|DBNL|CASP6|PSMA1|PSMC5|OCLN|PSMC3|BAD
DAP12 INTERACTIONS%REACTOME%R-HSA-2172127.1,0.34303615715964003,0.701955655133333,-0.24024127424697897,-1.08625577561694,2627,29,SIRPB1|FYN|GRAP2|PLCG2|LCP2|SYK|HLA-B|RAC1|HLA-E|VAV3|B2M|HLA-C|SIGLEC14|PIK3CB|HRAS|TREM2|TYROBP
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12%REACTOME%R-HSA-392170.2,0.501690788583796,0.796500289838735,0.24084356846414998,0.9602153448525071,3708,19,GNG5|GNGT1|GNB5|GNB4|GNAI3
REVERSIBLE HYDRATION OF CARBON DIOXIDE%REACTOME%R-HSA-1475029.1,0.217249051171313,0.5996151428055749,-0.571185218236232,-1.25044384188193,1659,4,CA5B|CA14|CA2
FORMATION OF A POOL OF FREE 40S SUBUNITS%REACTOME DATABASE ID RELEASE 66%72689,0.73625111649866,0.908157084784786,-0.133720811922256,-0.8492308181353649,5769,99,RPL29|RPL11|RPS6|RPL36|RPL17|EIF3F|RPL32|RPL39L|RPL23|RPLP0|RPL10A|RPL8|RPS23|RPL3|RPL7A|RPS2|RPL15|RPL37|RPL27A|RPL18|EIF3J|RPL39|RPL27|EIF3C|EIF3M|RPLP2|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|EIF1AX|EIF3B|RPL35|RPL38|RPS15A|RPL36AL|RPS13|RPL26L1|FAU
GLYCOGEN SYNTHESIS%REACTOME%R-HSA-3322077.2,0.8957731688107121,0.966568898141399,-0.17911558556889298,-0.6503396567833499,6823,15,EPM2A|GYG1|PPP1R3C|UBC|GYG2
RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASES%REACTOME DATABASE ID RELEASE 66%388844,0.0656360184431787,0.3682242891048379,0.419207594808616,1.5067876376832199,483,14,SLITRK1|SLITRK6|PTPRS|PTPRD|PPFIA2|PPFIA3|PPFIA4
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST%REACTOME DATABASE ID RELEASE 66%6804116,0.862489829129373,0.9527544063641651,0.18865351482691797,0.678090729907849,6359,14,ARID3A|CDKN1A|CCNE1
DCC MEDIATED ATTRACTIVE SIGNALING%REACTOME DATABASE ID RELEASE 66%418885,0.829383265680241,0.943504776751861,-0.20491078983916503,-0.705342675317146,6333,13,NTN1|DOCK1|NCK1
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES%REACTOME%R-HSA-2022090.3,0.000259302476338649,0.00819882332206558,-0.466393227239914,-2.3357463602744,1,41,LAMC2|COL18A1|COL11A2|CTSV|CTSS|CTSB|COL5A3|LOXL1|COL4A1|LOX|COL4A2|COL5A2|COL6A3|COL8A1|CD151|COL1A2|COL1A1|COL3A1|MMP9|COL6A1|CTSL|COL5A1|COL6A2|LOXL2|ITGB4
OXIDATIVE STRESS INDUCED SENESCENCE%REACTOME%R-HSA-2559580.3,0.00025319660716546403,0.00819882332206558,-0.324615443201599,-2.0545902691148896,1,97,PHC2|HIST1H2BE|TFDP2|EZH2|H2AFX|HIST2H2AC|HIST1H2AD|CDKN2A|HIST1H2BN|H2AFV|E2F2|HIST1H2BC|MAPKAPK2|MAPK9|HIST1H4I|CDKN2B|MAPK3|RBBP7|CBX4|TNRC6C|E2F1|CBX6|HIST2H3A|MAP2K3|RING1|H2AFZ|UBC|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|CDKN2C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
ADRENALINE SIGNALLING THROUGH ALPHA-2 ADRENERGIC RECEPTOR%REACTOME DATABASE ID RELEASE 66%392023,0.0462987529848766,0.30805382986873603,-0.860103284184545,-1.43134940573944,348,2,ADRA2C
"FORMATION OF THE ACTIVE COFACTOR, UDP-GLUCURONATE%REACTOME DATABASE ID RELEASE 66%173599",0.4414135984950279,0.7653693162885199,0.51823982674392,1.0193165828821602,3284,3,SLC35D1|UGDH
CAM-PDE 1 ACTIVATION%REACTOME DATABASE ID RELEASE 66%111957,0.0037037037037037,0.0650445779820117,-0.8911437079519141,-1.74017780218578,27,3,PDE1C|PDE1A|PDE1B
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER%REACTOME%R-HSA-76066.2,0.945089343941568,0.9828952916990891,-0.136185580284253,-0.6006449422063199,7245,27,GTF3C1|BRF1|POLR3B|GTF3C5|POLR2H|POLR3K|BDP1|POLR2L
INTERLEUKIN-12 SIGNALING%REACTOME%R-HSA-9020591.1,0.0173283331178068,0.17886971906195498,-0.33695426217021196,-1.6774344793761498,133,40,HNRNPA2B1|HSPA9|PSME2|LMNB1|SNRPA1|MSN|SOD1|ARF1|VAMP7|AIP|CFL1|ANXA2|TALDO1|P4HB
CDC6 ASSOCIATION WITH THE ORC:ORIGIN COMPLEX%REACTOME DATABASE ID RELEASE 66%68689,0.487948650772858,0.7882673024233101,-0.298646164414335,-0.966883025052518,3724,11,CDC6|E2F2|ORC1|ORC6|E2F1
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE%REACTOME%R-HSA-392154.1,0.791383528132645,0.92865461697759,0.196876414404375,0.7413049954033871,5822,16,KCNMB4|PDE10A|PDE3A|KCNMA1|ITPR1|GUCY1A3
GAMMA-CARBOXYLATION OF PROTEIN PRECURSORS%REACTOME%R-HSA-159740.3,0.43817021854214705,0.764010646165493,0.38771531685691296,1.0032361704361998,3227,6,PROC|GGCX
CYCLIN D ASSOCIATED EVENTS IN G1%REACTOME DATABASE ID RELEASE 66%69231,0.0226742679450635,0.20908271623893998,-0.324302585036483,-1.63419935475023,174,42,CUL1|E2F3|RBL1|CDKN2D|CDKN1B|CDK4|SKP2|CCNH|CCND2|LYN|CDK6|TFDP2|CDKN1C|CDKN2A|PPP2R3B|E2F2|CDKN2B|ABL1|SKP1|E2F1|CDK7|PPP2CA|UBC|MNAT1|CCND3|CDKN2C|CCND1
BIOSYNTHESIS OF EPA-DERIVED SPMS%REACTOME DATABASE ID RELEASE 66%9018679,0.978439153439153,0.992937328049893,-0.271423844711592,-0.5300219766310901,7396,3,LTA4H|PTGS2|ALOX5
COLLAGEN CHAIN TRIMERIZATION%REACTOME DATABASE ID RELEASE 66%8948216,0.000130344108446298,0.00518555396908895,-0.5998851238764891,-2.7904291199858497,0,32,COL15A1|COL27A1|COL20A1|COL18A1|COL23A1|COL11A2|COL14A1|COL5A3|COL4A1|COL4A2|COL5A2|COL12A1|COL6A3|COL8A1|COL21A1|COL1A2|COL1A1|COL3A1|COL6A1|COL16A1|COL5A1|COL6A2|COL13A1|COL26A1
TRANSPORT OF NUCLEOSIDES AND FREE PURINE AND PYRIMIDINE BASES ACROSS THE PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%83936,0.442481350608559,0.7656673901363249,-0.461097532362483,-1.00943888504335,3380,4,SLC29A1|SLC29A2|SLC29A4
S45 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED%REACTOME%R-HSA-5358751.1,0.744946180099764,0.9112137767014771,-0.216311665379097,-0.785392593135168,5674,15,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|CTNNB1|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
INVADOPODIA FORMATION%REACTOME%R-HSA-8941237.1,0.629891375474414,0.8609087289949471,-0.392076878883976,-0.8583382466700842,4812,4,ADAM12|ADAM19
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE%REACTOME%R-HSA-210500.3,0.277552125643109,0.6531032612639279,0.28342993456729,1.1486772939573502,2049,20,GLS|RIMS1|SNAP25|PPFIA2|CPLX1|PPFIA3|PPFIA4
PTK6 DOWN-REGULATION%REACTOME DATABASE ID RELEASE 66%8849472,0.7317725752508358,0.9074802896081321,-0.6383987648875171,-0.8505004434134549,5469,1,PTPN1
TANDEM PORE DOMAIN POTASSIUM CHANNELS%REACTOME DATABASE ID RELEASE 66%1296346,0.38088774263608,0.729499056535481,0.40844974661260797,1.05688772610058,2805,6,KCNK9|KCNK10|KCNK3|KCNK2
ER TO GOLGI ANTEROGRADE TRANSPORT%REACTOME%R-HSA-199977.3,0.00012756729174639598,0.00518555396908895,-0.31379663578374895,-2.10870450371079,0,128,ACTR10|DCTN4|DYNC1H1|MCFD2|SPTBN5|YKT6|TMED7|COG4|TFG|TMEM115|SPTBN4|TRAPPC5|NAPA|SCFD1|INS|SEC23A|SERPINA1|DYNLL2|BET1L|F8|SEC13|KDELR2|SEC24A|ARFGAP2|COPB2|PPP6R3|CNIH2|ARF1|KDELR1|CNIH1|COPB1|TMED2|CTSZ|DCTN5|CTSC|RAB1B|NSF|CD59|COG1|STX5|KDELR3|CNIH3|TMED10|LMAN2|TRAPPC2|SEC22A|TMED9|GOSR2|DYNC1I1|SPTBN2|CD55|COPG1|PPP6C|SAR1B|COPZ2|DCTN3|GRIA1
DEFECTIVE CSF2RA CAUSES PULMONARY SURFACTANT METABOLISM DYSFUNCTION 4 (SMDP4)%REACTOME%R-HSA-5688890.1,0.0668612364022287,0.3690551432905871,-0.833691756272402,-1.38739639977276,503,2,CSF2RB|CSF2RA
PROCESSING OF CAPPED INTRON-CONTAINING PRE-MRNA%REACTOME%R-HSA-72203.3,0.000127746550843127,0.00518555396908895,-0.247145471359387,-1.86535668729152,0,235,HNRNPA1|NUP205|SNRNP48|PDCD7|DNAJC8|NUP93|SUGP1|SF3A2|NUP210|PRCC|PPWD1|SF3B4|CPSF1|SNRPE|POLR2C|LSM5|NXT1|YBX1|DHX9|PTBP1|SRSF3|TXNL4A|HNRNPH1|SF3A1|FYTTD1|NXF2B|SRSF10|ELAVL2|HNRNPUL1|HNRNPL|NCBP2|PRPF4|POLR2J|SLU7|DDX23|RBM17|SNRNP35|CHTOP|SNRPB2|SRSF9|HNRNPU|RBMX|BCAS2|HNRNPH2|DDX42|MAGOH|CPSF2|CD2BP2|NUP188|SRSF5|ZRSR2|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|NUP85|SNRPA1|HNRNPM|DDX5|CLP1|SF1|SNW1|POLR2H|EFTUD2|GLE1|NUP37|HNRNPR|NXF1|RBM22|CSTF3|LSM3|FUS|NUP160|WBP11|THOC7|SNRNP25|NUP214|HNRNPK|MAGOHB|EIF4A3|SNRPB|TRA2B|PABPN1|SRSF2|RBM8A|DDX39A|POLR2G|SF3B2|ISY1|THOC3|CPSF7|SKIV2L2|CWC27|PQBP1|HNRNPA0|GPKOW|SART1|HNRNPC|POLR2L|PRPF19
SIGNALING BY FGFR2 IN DISEASE%REACTOME%R-HSA-5655253.1,0.43474863245636897,0.762034923704788,-0.219865634289221,-1.01326685331388,3337,31,NCBP1|POLR2H|FGF10|HRAS|FGF9|FGF7|POLR2G|POLR2L
CA ACTIVATED K+ CHANNELS%REACTOME DATABASE ID RELEASE 66%1296052,0.801190154179064,0.9325377000668108,0.26266637484616195,0.7250834773851981,5923,7,KCNMB4|KCNMA1|KCNN4|KCNN3|KCNMB3
FGFR3C LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190372,0.28229860073359603,0.654732517474162,0.5280737215037921,1.1602004555568,2077,4,GALNT3|FGF2|FGF1
KETONE BODY CATABOLISM%REACTOME DATABASE ID RELEASE 66%77108,0.15224402042461702,0.519849132875151,0.6690746663725601,1.31599091274955,1132,3,ACAT1|BDH1|OXCT1
ATTENUATION PHASE%REACTOME%R-HSA-3371568.1,0.5509803921568629,0.82197876538238,-0.274105017400483,-0.917455158130963,4214,12,PTGES3|HSF1|CREBBP|DNAJB1|FKBP4|HSP90AA1
TRNA MODIFICATION IN THE MITOCHONDRION%REACTOME%R-HSA-6787450.4,0.8765946368133299,0.960725750963158,-0.22897015830989004,-0.6591730390099699,6733,8,GTPBP3|TRMT61B|KIAA0391|TRIT1|TRMU|MTO1|TRMT10C|HSD17B10
APC C:CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C:CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1%REACTOME DATABASE ID RELEASE 66%174178,0.000129165590286748,0.00518555396908895,-0.37377902571089,-2.1703862462136,0,70,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|PTTG1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|PSMC4|PSMC6|PSMD10|PLK1|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
TOLL-LIKE RECEPTOR CASCADES%REACTOME DATABASE ID RELEASE 66%168898,0.0172369765066394,0.17877145941578798,-0.22240819679904603,-1.5093651567678503,134,134,RPS6KA1|IRAK3|RIPK3|HSP90B1|NFKB2|ITGB2|DNM1|TLR2|CTSV|CTSS|TICAM2|ATF1|EEA1|LY86|ELK1|CTSB|IKBKE|MAPKAPK2|UNC93B1|MEF2C|SOCS1|MAPK9|MAPK3|IRF7|IRAK1|SKP1|PIK3R4|MAP2K3|NFKBIA|PPP2CA|CD36|FADD|UBC|TLR5|TICAM1|TRAF3|RELA|NFKB1|TLR4|S100A8|ITGAM|S100A9|CTSL|LGMN|CD14|LY96|PELI3|DNM3
DECTIN-1 MEDIATED NONCANONICAL NF-KB SIGNALING%REACTOME DATABASE ID RELEASE 66%5607761,0.00012951690195570501,0.00518555396908895,-0.40836063605351897,-2.25657980700746,0,58,UBB|PSMA4|PSMA7|MAP3K14|CHUK|UBE2M|CUL1|UBA3|PSMD7|PSME3|PSMA2|PSME1|PSMB1|PSMB9|PSMB4|FBXW11|PSMD1|PSMC2|NFKB2|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|RELB|PSMD2|UBC|PSMD6|RELA|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
ANTAGONISM OF ACTIVIN BY FOLLISTATIN%REACTOME DATABASE ID RELEASE 66%2473224,0.173930113859442,0.548035161776014,-0.593759676117148,-1.29986404909279,1328,4,FST|INHBB|INHBA
SIGNALING BY FGFR1%REACTOME%R-HSA-5654736.4,0.17692097347552602,0.548551967663807,0.257108276020455,1.24620747276532,1293,35,SPRED2|GAB1|RPS27A|FGF2|SPRY2|FRS3|SOS1|CBL|PLCG1|NRAS|PPP2CB|FGF1|MAPK1|KRAS|FLRT3
SCAVENGING BY CLASS F RECEPTORS%REACTOME DATABASE ID RELEASE 66%3000484,0.0727248816412415,0.37960378163431896,-0.622139228065432,-1.49114901458123,552,5,CALR|SCARF1|HSP90AA1
PLATELET CALCIUM HOMEOSTASIS%REACTOME%R-HSA-418360.1,0.305871583627566,0.677423587903087,-0.270934256677391,-1.1220092517479099,2338,22,ITPR2|ATP2A1|P2RX4|ITPR3|P2RX5|P2RX3|STIM1|ATP2A3|ATP2B2
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM%REACTOME DATABASE ID RELEASE 66%72202,0.0808965606080124,0.397722753303477,-0.22977361872515303,-1.3666591819581002,627,77,FYTTD1|NXF2B|NCBP2|SLU7|CHTOP|SRSF9|MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|NCBP1|NUP85|GLE1|NUP37|NXF1|NUP160|THOC7|NUP214|MAGOHB|EIF4A3|SRSF2|RBM8A|DDX39A|THOC3
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM%REACTOME%R-HSA-3560782.2,0.145614495798319,0.512646109386394,-0.328676748135891,-1.31864481823287,1108,20,HSPG2|NCAN|SDC3|PRELP|DCN|SDC4|BGN|VCAN|OGN|LUM|SDC2|FMOD
SWITCHING OF ORIGINS TO A POST-REPLICATIVE STATE%REACTOME%R-HSA-69052.3,0.000256443133735094,0.00819882332206558,-0.35088221774873907,-2.16074960731816,1,88,PSMD1|PSMC2|ANAPC10|CDT1|MCM4|ANAPC2|MCM6|ANAPC5|CDC6|PSMD3|PSMB2|CDC23|PSMF1|ORC1|ORC6|PSMD4|MCM3|SHFM1|PSME2|MCM5|PSMB5|CDC27|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|MCM2|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
CATION-COUPLED CHLORIDE COTRANSPORTERS%REACTOME DATABASE ID RELEASE 66%426117,0.261422005947553,0.6372263165872061,0.49095906144552404,1.18075372736633,1933,5,SLC12A5|SLC12A4|SLC12A6|SLC12A7
BILE ACID AND BILE SALT METABOLISM%REACTOME DATABASE ID RELEASE 66%194068,0.5041884816753929,0.797772889025646,-0.215464211463151,-0.962287266647537,3851,28,CYP46A1|CYP7B1|OSBP|OSBPL3|PTGIS
APOPTOTIC EXECUTION PHASE%REACTOME%R-HSA-75153.4,0.365576102418208,0.719912723446385,-0.213630991809838,-1.06350336457275,2826,40,TJP2|GSN|BCAP31|VIM|HIST1H1C|DBNL|CASP6|OCLN
CD22 MEDIATED BCR REGULATION%REACTOME%R-HSA-5690714.2,0.0638353309015112,0.36192294250596596,-0.509014842591169,-1.5312412393210801,489,9,IGKV3-11|LYN|IGKV2-28|PTPN6|IGKV2D-28
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION%REACTOME%R-HSA-6804758.2,0.976077205382629,0.9926773910205121,0.11718854028328199,0.54254737054153,7180,30,MAP2K6|HDAC1|PIP4K2C
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR (BCR)%REACTOME DATABASE ID RELEASE 66%1168372,0.000256772371292849,0.00819882332206558,-0.36229535038945293,-2.16283724290515,1,78,PSMD4|SHFM1|PSME2|PSMB5|HRAS|SKP1|NFATC1|PSMC4|PSMC6|PSMD10|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|FKBP1A|PSMD6|RELA|NFKB1|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|PRKCB
G-PROTEIN ACTIVATION%REACTOME%R-HSA-202040.1,0.625474042108016,0.858842084733938,-0.21125477995732003,-0.874861010545148,4782,22,POMC|GNGT2|GNG11|GNAI2|GNG10|GNG3
PROTEIN FOLDING%REACTOME%R-HSA-391251.1,0.111680984741634,0.458831254851449,-0.209658538154412,-1.29108738224074,870,88,PDCL|STAT3|CCT5|GNGT2|TUBB4A|GNG11|GNAI2|FBXO4|USP11|NOP56|PFDN1|GNG10|TBCA|ARL2|VBP1|FBXW5|ACTB|GNG3|TUBB4B|TUBB6|SPHK1
RHO GTPASES ACTIVATE CIT%REACTOME DATABASE ID RELEASE 66%5625900,0.669848326359833,0.8815356925073421,-0.21633003907145398,-0.8394410068942142,5122,18,RHOB|PRC1|RHOA|CDKN1B|RAC1|CIT|MYL12B|MYH11|MYH9|MYL9
CONSTITUTIVE SIGNALING BY EGFRVIII%REACTOME DATABASE ID RELEASE 66%5637810,0.0339443312966735,0.26293361581113606,0.46499796895618,1.62851983338215,249,13,GAB1|SHC1|SOS1|CBL|PLCG1|NRAS|CDC37|EGFR|KRAS
G0 AND EARLY G1%REACTOME DATABASE ID RELEASE 66%1538133,0.084648493543759,0.40376145987147494,-0.322918391260157,-1.4242278664963899,648,27,TFDP2|CDC6|LIN52|DYRK1A|PCNA|TOP2A|LIN9|E2F1|MAX|MYBL2|MYC
G2 PHASE%REACTOME%R-HSA-68911.3,0.417937927406628,0.75036705317022,-0.42659386719611697,-1.02246409806678,3177,5,CCNA1|CDK2|CCNA2|E2F3|E2F1
RAP1 SIGNALLING%REACTOME%R-HSA-392517.2,0.48112218143681196,0.7857362908355991,-0.275694107967265,-0.975365438214938,3669,14,RAPGEF3|RAP1A|PRKACA|RAP1GAP
GRB7 EVENTS IN ERBB2 SIGNALING%REACTOME%R-HSA-1306955.3,0.892367643106692,0.965443067117994,0.33423403551340003,0.657398905643703,6640,3,ERBB2|NRG1|NRG2
COMPLEMENT CASCADE%REACTOME DATABASE ID RELEASE 66%166658,0.00012960082944530802,0.00518555396908895,-0.5536796040338671,-2.7342070693934204,0,39,C4A|C2|IGKV2-28|VTN|C3|C1QB|FCN1|C1QA|CFB|C1QC|C7|IGKV2D-28|CD59|C3AR1|C1S|CFD|CFI|CD55|IGHG2|SERPING1|CD81|C1R|CFH|C5AR1
HDL REMODELING%REACTOME%R-HSA-8964058.1,0.336927932667017,0.699462084003389,-0.46221802040875004,-1.10784839560335,2561,5,APOC2|ABCG1|CETP|APOE
MISCELLANEOUS SUBSTRATES%REACTOME DATABASE ID RELEASE 66%211958,0.366693461950697,0.721190111986457,0.652605459057072,1.09646143251745,2736,2,CYP2D6|CYP2U1
PI-3K CASCADE:FGFR1%REACTOME%R-HSA-5654689.2,0.702429702429703,0.8933296192549759,0.264609782768126,0.804124724874152,5145,9,GAB1|FGF2|FGF1
PROPIONYL-COA CATABOLISM%REACTOME%R-HSA-71032.2,0.8694108364018941,0.956852095187406,-0.281679699953652,-0.6751324913548921,6610,5,PCCB
SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE (SASP)%REACTOME DATABASE ID RELEASE 66%2559582,0.000127697612054655,0.00518555396908895,-0.40945068042030996,-2.4963270137302302,0,84,HIST1H2BE|ANAPC10|RPS6KA1|ANAPC2|H2AFX|ANAPC5|HIST2H2AC|HIST1H2AD|CDC23|CDKN2A|HIST1H2BN|H2AFV|HIST1H2BC|STAT3|HIST1H4I|CDKN2B|MAPK3|CDC27|CEBPB|HIST2H3A|H2AFZ|UBC|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|RELA|NFKB1|CDKN2C|HIST1H3H|HIST2H4B|ANAPC11|H3F3B|HIST1H2AC|IGFBP7|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
APOPTOSIS%REACTOME%R-HSA-109581.2,0.00102577253494038,0.023972547589817,-0.25667758413506697,-1.78287363598535,7,150,TNFRSF10A|TNFRSF10B|PSMD3|PSMB2|TICAM2|OPA1|KPNB1|PSMF1|NMT1|TRAF2|PPP1R13B|TNFSF10|PSMD4|SHFM1|CYCS|STAT3|PSME2|DYNLL2|LMNB1|PSMB5|E2F1|PSMC4|TJP2|PSMC6|GSN|PSMD10|PSMB3|PSMC1|XIAP|FADD|PSMD2|UBC|TICAM1|BCAP31|PSMD6|MAGED1|TLR4|VIM|PSMD12|PSMA3|HIST1H1C|PSMA6|CD14|LY96|PSMD13|PSMB7|DBNL|CASP6|PSMA1|PSMC5|OCLN|PSMC3|BAD
ACYL CHAIN REMODELLING OF PE%REACTOME DATABASE ID RELEASE 66%1482839,0.0201491560905404,0.195205495598712,-0.45178360277579205,-1.71688801439246,153,17,PLA2G2A|PLA2G2D|PLA2R1|PLA2G4D|PLA2G4A|PLA2G4C|PLA2G16|PLBD1|PLA2G12A
MYD88 CASCADE INITIATED ON PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%975871,0.799861014593468,0.931670998922663,0.131453180260684,0.800551285561769,5754,80,DUSP4|DUSP6|UBE2V1|MAPK7|RPS6KA2|RPS27A|MAP2K6|MAPK11|BTRC|VRK3|MAPKAPK3|TNIP2|PELI2|NFKBIB|NOD1|MAP2K7|MYD88|PPP2CB|ATF2|IRAK4|MAP2K1|MAPK1|PELI1|IKBKB|MAP2K4|MAPK8
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING%REACTOME%R-HSA-389958.2,0.109951741228642,0.45483419590443,-0.30967557730098805,-1.3658205871900901,842,27,PFDN2|CCT3|TUBA1B|TUBA4A|CCT8|CCT5|TUBB4A|PFDN1|VBP1|ACTB|TUBB4B|TUBB6
GLYCEROPHOSPHOLIPID CATABOLISM%REACTOME DATABASE ID RELEASE 66%6814848,0.399214145383104,0.739115199741709,-0.405416105156163,-1.04283943592743,3047,6,GDPD5|GDE1|GDPD1|PNPLA7
GLYCOSPHINGOLIPID METABOLISM%REACTOME DATABASE ID RELEASE 66%1660662,0.618893771000258,0.854944793214197,-0.18409803336017397,-0.894338322689537,4788,37,SUMF1|ARSE|ARSB|GLTP|GLA|ARSF|UGCG|ARSG|STS|HEXB|SMPD1
TAT-MEDIATED HIV ELONGATION ARREST AND RECOVERY%REACTOME%R-HSA-167243.3,0.43479398299542205,0.762034923704788,-0.22241380540997402,-1.01549789203511,3323,30,SUPT16H|POLR2H|NELFB|POLR2G|SUPT4H1|SSRP1|POLR2L
ERBB2 ACTIVATES PTK6 SIGNALING%REACTOME DATABASE ID RELEASE 66%8847993,0.694006309148265,0.889500280068691,-0.29449567492385803,-0.8049907945572109,5279,7,NRG1|NRG3|NRG2|HBEGF
VPR-MEDIATED NUCLEAR IMPORT OF PICS%REACTOME DATABASE ID RELEASE 66%180910,0.854849236392116,0.949296218452153,-0.156579693134294,-0.707978246221751,6548,29,NUP188|NUP85|NUP37|NUP160|NUP214|BANF1
SIGNALING BY NOTCH3%REACTOME DATABASE ID RELEASE 66%9012852,0.8694404591104731,0.956852095187406,-0.140037646446805,-0.7138646026855491,6665,44,PSEN1|DLGAP5|YBX1|JAG1|PLXND1|HES1|NOTCH1|SNW1|NOTCH3|JAG2|NEURL1B|KAT2B|UBC|MAML1
PTK6 PROMOTES HIF1A STABILIZATION%REACTOME%R-HSA-8857538.1,0.406360424028269,0.7436993018380099,-0.477908243197418,-1.0462410451309498,3104,4,GPNMB|HBEGF
PROTEIN LOCALIZATION%REACTOME%R-HSA-9609507.1,0.5879623662843149,0.8414799095069009,-0.14152919966705302,-0.9291265936425079,4561,115,CHCHD4|USP9X|CRAT|CMC4|PMPCA|TOMM20|CHCHD3|ATP5B|SLC25A6|HSPA9|IDH3G|COA6|DHRS4|TOMM70A|TIMM21|ACOX1|CAT|TIMM10B|FXN|UBC|TIMM9|COX17|SLC25A4|TIMM17B|ACOT2|TOMM5|TIMM10|DNAJC19|CHCHD7|ATP5G1
TRANSLESION SYNTHESIS BY POLH%REACTOME DATABASE ID RELEASE 66%110320,0.063214614272572,0.36006266503904,-0.378346410941909,-1.49481137302385,480,19,SPRTN|RFC2|RPA2|RFC3|PCNA|VCP|RFC5|NPLOC4|RCHY1|UBC|RFC4
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR%REACTOME%R-HSA-392851.2,0.47076420995376705,0.7820569847571801,0.251589710428378,0.984829477119568,3461,18,GNG5|GNGT1|GNAS|GNB5|GNB4
BETA DEFENSINS%REACTOME DATABASE ID RELEASE 66%1461957,0.19779782435659302,0.574790273586514,-0.7349324510614829,-1.22304512310149,1490,2,TLR1|TLR2
DAP12 SIGNALING%REACTOME DATABASE ID RELEASE 66%2424491,0.7063957274977211,0.894843171056815,-0.19082294388991503,-0.8226644493444459,5422,25,FYN|GRAP2|PLCG2|LCP2|SYK|RAC1|HLA-E|VAV3|B2M|PIK3CB|HRAS|TREM2|TYROBP
ALPHA-DEFENSINS%REACTOME DATABASE ID RELEASE 66%1462054,0.490755627009646,0.7904081687771529,0.595345323103065,1.00025701095931,3662,2,PRSS3
METHYLATION%REACTOME DATABASE ID RELEASE 66%156581,0.401699346405229,0.740287621109606,-0.31119130893963004,-1.04158644836133,3072,12,COMT|TRMT112|N6AMT1|NNMT
RRNA PROCESSING%REACTOME DATABASE ID RELEASE 66%72312,0.997765050984775,0.999635137169127,0.0789817195573568,0.586691848856391,7142,200,WDR12|WDR75|IMP4|EBNA1BP2|RPS27A|MPHOSPH6|UTP14C|TFB1M|RPS27L|RPL26|EXOSC10|ELAC2|DCAF13|RPS26|HEATR1|TSR1|PDCD11|WDR18|MTERF4|ISG20L2|RPP38|RPL4|RPL37A|UTP20|XRN2|C1D|UTP3|PELP1|BMS1|RNMTL1|NOP58|PNO1|RPS4Y1|EXOSC8|WDR46|RPL31|RPL23A|NSUN4|GAR1|RPP40|RPL21|CIRH1A|RPS24|UTP6|DDX21|WBSCR22|NIP7|MPHOSPH10|RPL34|CSNK1E|RPS21|RPL22|DIEXF|DIS3|RPL14|RPS19|RPS12|RPS20
RNF MUTANTS SHOW ENHANCED WNT SIGNALING AND PROLIFERATION%REACTOME%R-HSA-5340588.1,0.324296005239031,0.692794968343412,-0.432457276079647,-1.1123966120583701,2475,6,FZD4|FZD8|LRP5
TRNA PROCESSING%REACTOME DATABASE ID RELEASE 66%72306,0.7308655719454491,0.9074042084855379,0.132792387213949,0.853848665558141,5251,101,PUS7|TRMT6|NUP88|NUP35|QTRT1|TYW5|ALKBH8|METTL1|TRMT44|ELAC2|NSUN6|RANBP2|ADAT2|RPP38|TSEN34|TPRKB|C2orf49|NDC1|TRMT1|DDX1|CPSF4|CTU1|RPP40|KIAA1456|GTPBP3|DUS2|NUP43|TRMT61B|POP5|THG1L|NUP54|QTRTD1|TRMT13|TRNT1|XPOT|NUPL2
COMPLEX I BIOGENESIS%REACTOME%R-HSA-6799198.1,0.000129032258064516,0.00518555396908895,-0.40872757551961697,-2.2295400771263303,0,55,NDUFAF5|TIMMDC1|NDUFC2|NDUFAF4|NDUFV2|NDUFB8|NDUFS4|NDUFB5|NDUFA11|NDUFA9|NDUFA7|NDUFA3|NDUFB6|NDUFAF3|NDUFB9|NDUFB10|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|NDUFB4|NDUFA12|NDUFA2|NDUFAB1|NDUFA1|NDUFB11|NDUFV1|NDUFAF2|NDUFS3|NDUFA8|NDUFS8|NDUFV3
CONJUGATION OF BENZOATE WITH GLYCINE%REACTOME DATABASE ID RELEASE 66%177135,0.38339081984611295,0.730480369014206,-0.646931342256401,-1.07659720561448,2889,2,GLYATL1
BINDING OF TCF LEF:CTNNB1 TO TARGET GENE PROMOTERS%REACTOME%R-HSA-4411364.2,0.9125683060109291,0.972925642245441,0.215081280682466,0.624343330199866,6679,8,TCF7L1|TCF7|LEF1|TCF7L2|CTNNB1
DEGRADATION OF DVL%REACTOME DATABASE ID RELEASE 66%4641258,0.000258064516129032,0.00819882332206558,-0.406020095708215,-2.21477123081138,1,55,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|DACT1|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL%REACTOME%R-HSA-1855167.2,0.30784262636790005,0.67948577039568,-0.37500836263362497,-1.1281169465152299,2362,9,NUDT11|IPPK|NUDT4|ITPK1
DOWNSTREAM SIGNAL TRANSDUCTION%REACTOME DATABASE ID RELEASE 66%186763,0.29723382045929,0.6692652587893061,-0.258102240792898,-1.1258891085768201,2277,26,BCAR1|STAT3|PIK3CB|HRAS|PDGFRB|PDGFRA|NCK1|PDGFB
HOST INTERACTIONS OF HIV FACTORS%REACTOME DATABASE ID RELEASE 66%162909,0.000128667009778693,0.00518555396908895,-0.327536813734516,-2.1680225498029397,0,120,POM121|CD8B|PSMD7|ATP6V1H|PSME3|AP2A1|NUP107|PSMA2|FYN|KPNA1|CCNT1|AP1S3|PSME1|PSMB1|PAK2|NUP205|AP1S2|PSMB9|NUP93|RAC1|DOCK2|NUP210|TCEB2|PSMB4|PSIP1|PSMD1|PSMC2|B2M|AP2A2|RANBP1|CD4|PACS1|PPIA|PSMD3|PSMB2|KPNB1|NPM1|PSMF1|HLA-A|NUP188|SLC25A6|PSMD4|ELMO1|SHFM1|PSME2|NUP85|PSMB5|RCC1|SKP1|NUP37|ARF1|RAN|PSMC4|PSMC6|NUP160|PSMD10|PSMB3|AP1B1|HCK|NUP214|PSMC1|PSMD2|UBC|SLC25A4|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|BANF1|PSMC5|AP2M1|PSMC3|SLC25A5
DARPP-32 EVENTS%REACTOME DATABASE ID RELEASE 66%180024,0.14293214332589602,0.509272638902788,-0.323853215665399,-1.31938033247377,1088,21,PDE4B|PDE4D|PRKAR1A|PPP2CA|PDE4A|PRKACA|PPP1CA
TNFR1-MEDIATED CERAMIDE PRODUCTION%REACTOME%R-HSA-5626978.1,0.7711853307138179,0.9213545359508709,-0.291333983180125,-0.7493894860664879,5887,6,TNF|GNB2L1|NSMAF|TNFRSF1A
AMINO ACID SYNTHESIS AND INTERCONVERSION (TRANSAMINATION)%REACTOME%R-HSA-70614.5,0.954074679749251,0.9870180073166591,0.13399788813689598,0.5925346000132671,7000,26,NAALAD2|GLS|SERINC2|GLUD1|GLS2|SRR|RIMKLA|PSAT1|NAT8L|SERINC1|RIMKLB|PYCR2|GOT2|GLUL|PSPH|OAT|ASNS|SERINC3|PYCR1|FOLH1|CCBL1|PYCRL|GOT1|GPT|PHGDH
CTLA4 INHIBITORY SIGNALING%REACTOME DATABASE ID RELEASE 66%389513,0.652911026416086,0.8736252329705749,-0.21531074069985698,-0.850672649784304,4967,19,AKT3|PPP2CB|PPP2R5C|YES1|CTLA4|PPP2R1B|LCK|PPP2R1A|PPP2R5A|AKT2|PPP2R5E|PPP2R5D|PPP2R5B|PTPN11|FYN|AKT1|LYN|CD86|PPP2CA
TRANSCRIPTIONAL REGULATION BY RUNX2%REACTOME DATABASE ID RELEASE 66%8878166,0.000127942681678608,0.00518555396908895,-0.329538235222043,-2.10298183199178,0,101,PSMD3|PSMB2|MAF|SMAD6|PSMF1|HES1|ITGA5|PSMD4|SHFM1|PSME2|PSMB5|MAPK3|ABL1|SKP1|PSMC4|PPM1D|PSMC6|PSMD10|CCNB1|RBM14|PSMB3|LGALS3|BMP2|WWTR1|PSMC1|COL1A1|PSMD2|UBC|PSMD6|YAP1|PSMD12|PSMA3|PSMA6|ESRRA|CCND1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
MECP2 REGULATES TRANSCRIPTION OF NEURONAL LIGANDS%REACTOME%R-HSA-9022702.1,0.214062712094475,0.597438672438672,0.48104056913847604,1.2447207459308,1576,6,DLL1|HDAC1|SIN3A|CRH|CREB1
GLYCOSAMINOGLYCAN METABOLISM%REACTOME%R-HSA-1630316.2,0.34493346980552697,0.7024647311177249,-0.16744031486916502,-1.06853743352596,2695,101,PRELP|HYAL3|NAGLU|ARSB|HS3ST5|DCN|CHST7|NDST1|SLC9A1|SLC26A2|SDC4|BGN|VCAN|OGN|B4GALT7|LUM|SDC2|FMOD|HS3ST4|HYAL1|EXT2|B3GAT3|LYVE1|B4GALT1|B3GALT6|B4GAT1|HEXB|CSGALNACT1|XYLT2
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY%REACTOME DATABASE ID RELEASE 66%5357769,0.159649581589958,0.529342225823707,-0.303416871049282,-1.28951314803644,1220,24,TNFRSF10A|TNFRSF10B|TICAM2|TRAF2|TNFSF10|FADD|TICAM1|MAGED1|TLR4|CD14|LY96
TRANSCRIPTION FROM MITOCHONDRIAL PROMOTERS%REACTOME%R-HSA-75944.2,0.805461214508898,0.93314048083119,0.33469365245684696,0.735336208260107,5928,4,TFB2M|POLRMT|MTERF1
LOSS OF FUNCTION OF SMAD4 IN CANCER%REACTOME%R-HSA-3304347.1,0.49247514109110496,0.7912515533650171,0.49262757639359006,0.968940308887458,3664,3,SMAD3|SMAD2|SMAD4
CREB3 FACTORS ACTIVATE GENES%REACTOME DATABASE ID RELEASE 66%8874211,0.17705047318612,0.5486682494146969,-0.47448441871491903,-1.29698199922662,1346,7,CREB3L2|CREB3|MBTPS2|CREB3L1
DSCAM INTERACTIONS%REACTOME DATABASE ID RELEASE 66%376172,0.840358988305684,0.947151866837735,0.21985189932507102,0.696505677972038,6179,10,MAPK12|MAPK11|PAK1|DCC|MAPK8
ACYL CHAIN REMODELING OF CL%REACTOME%R-HSA-1482798.2,0.15080765576218302,0.5178365305986949,0.519066513174031,1.34311511110758,1110,6,HADHB|HADHA|PLA2G6
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL%REACTOME%R-HSA-198323.3,0.5048820179007321,0.797902257689198,0.26678137333372,0.958911241784448,3722,14,TSC2|CASP9|CDKN1A|AKT3|AKT1S1|MKRN1|MDM2
LYSINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%71064,0.0262442208322002,0.22827234306831198,0.527843849297355,1.67224499422962,192,10,AASS|AADAT|GCDH|PIPOX|DLD|ALDH7A1
TGF-BETA RECEPTOR SIGNALING ACTIVATES SMADS%REACTOME%R-HSA-2173789.1,0.7100807501953629,0.896399297418128,-0.179015523762631,-0.825006131784507,5451,31,SMAD4|UBB|MTMR4|TGFBR1|UBE2M|SMAD7|SMURF1|PPP1R15A|FURIN|TGFB1|USP15|UCHL5|SMURF2|NEDD8|TGFBR2|UBC|FKBP1A|PPP1CA
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION%REACTOME DATABASE ID RELEASE 66%450302,0.7829752515637751,0.926798202062739,0.193956435391462,0.759228247154115,5757,18,UBE2V1|MAP2K6|MAPK11|MAPKAPK3|NOD1
CONJUGATION OF SALICYLATE WITH GLYCINE%REACTOME%R-HSA-177128.1,0.38339081984611295,0.730480369014206,-0.646931342256401,-1.07659720561448,2889,2,GLYATL1
DEGRADATION OF GLI1 BY THE PROTEASOME%REACTOME DATABASE ID RELEASE 66%5610780,0.000129416332341141,0.00518555396908895,-0.41027580093281896,-2.24660919127396,0,56,NUMB|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PRKACA|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
DAG AND IP3 SIGNALING%REACTOME DATABASE ID RELEASE 66%1489509,0.313669064748201,0.68331834948726,-0.244194411233381,-1.11494387408712,2397,30,ITPR2|ITPR3|ADCY8|PRKAR1A|ADCY4|PDE1C|PDE1A|PDE1B|PRKACA|ADRBK1|ADCY9
CS DS DEGRADATION%REACTOME DATABASE ID RELEASE 66%2024101,0.0293308890925756,0.24279324540366198,-0.48201879094083705,-1.6592021524205902,223,13,NCAN|HYAL3|ARSB|DCN|BGN|VCAN|HYAL1|HEXB
REGULATION OF KIT SIGNALING%REACTOME DATABASE ID RELEASE 66%1433559,0.8721436343852009,0.958587680888923,0.19786292033983602,0.6724975815125049,6411,12,KIT|SOS1|CBL|PRKCA
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION%REACTOME DATABASE ID RELEASE 66%5250913,0.0005123607019341621,0.0139121625154964,-0.33567951519871103,-2.01770585369835,3,80,HIST1H2BN|H2AFV|ZNRD1|TWISTNB|HIST1H2BC|TTF1|HIST1H4I|POLR2H|RBBP7|HIST2H3A|KAT2B|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|MTA2|HIST1H3H|ACTB|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
TRANSCRIPTIONAL REGULATION BY RUNX1%REACTOME DATABASE ID RELEASE 66%8878171,0.000128172263522174,0.00518555396908895,-0.34741468579610496,-2.53912002547783,0,196,FOXP3|PSMB1|TNRC6A|CREBBP|HIST1H4H|PCGF5|NFATC2|RBBP5|PSMB9|CCNH|CBX2|PRMT1|PSMB4|CCND2|PML|PHC3|ACTL6B|CDK6|PSMD1|PSMC2|SETD1B|PHC2|SOCS4|HIST1H2BE|SMARCA4|RUNX1|SMARCA2|H2AFX|SOCS3|GPAM|HIST2H2AC|CLDN5|HIST1H2AD|CTSV|PSMD3|PSMB2|GATA3|SMARCE1|TNFRSF18|HIST1H2BN|H2AFV|GP1BA|PSMF1|LMO2|HIST1H2BC|PSMD4|SHFM1|TAL1|SMARCD3|PSME2|HIST1H4I|IL2RA|SETD1A|PSMB5|ABL1|CBX4|TNRC6C|PSMC4|WDR5|CBX6|SMARCD2|HIST2H3A|PSMC6|SPI1|PSMD10|CDK7|KAT2B|PSMB3|LGALS3|RING1|THBS1|H2AFZ|PSMC1|PSMD2|UBC|HIST2H2AA4|MNAT1|PSMD6|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|CCND3|YAP1|HIST1H3H|PSMD12|PSMA3|CTSL|HIST2H4B|H3F3B|HIST1H2AC|PSMA6|CCND1|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|MYL9|H2AFJ|HIST1H2BK|PSMA1|PSMC5|HIST1H2BJ|OCLN|PSMC3|PRKCB|HIST2H2AA3
UCH PROTEINASES%REACTOME%R-HSA-5689603.2,0.000128008192524322,0.00518555396908895,-0.36790675334804496,-2.2977203614415496,0,93,YY1|HIST2H2AC|HIST1H2AD|UCHL5|PSMD3|PSMB2|RUVBL1|HIST1H2AI|HCFC1|OGT|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|TFPT|FOXK2|PSMC4|HIST1H2AK|NEDD8|INO80E|PSMC6|PSMD10|PSMB3|TGFBR2|PSMC1|PSMD2|UBC|HIST2H2AA4|HIST3H2A|PSMD6|HIST1H2AE|PSMD12|PSMA3|ACTB|HIST1H2AC|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|HIST2H2AA3
METABOLISM OF FOLATE AND PTERINES%REACTOME%R-HSA-196757.5,0.32291940141769504,0.6913268291919421,-0.30597460615172806,-1.11094419682758,2459,15,DHFR|SHMT2|FOLR2|MTHFD1
ARMS-MEDIATED ACTIVATION%REACTOME%R-HSA-170984.3,0.9755206924533409,0.992663483116422,0.193568394292487,0.534340356764992,7212,7,CRK|YWHAB|KIDINS220
RAB GEFS EXCHANGE GTP FOR GDP ON RABS%REACTOME%R-HSA-8876198.3,0.946162657502864,0.983395403194261,-0.10897089304003499,-0.668794038893766,7433,86,RAB39B|RAB21|TRAPPC6B|RAB8A|CCZ1|DENND5A|RAB5C|RAB35|RAB6B|ALS2CL|GAPVD1|RAB14|RAB9A|RAB7A|GDI1|RAB27B|TRAPPC5|CHM|RIN3|CCZ1B|RAB7B|RAB1B|TRAPPC13|MON1A|RIN1|RAB9B|TRAPPC2|DENND1A|RAB3IL1
ROLE OF SECOND MESSENGERS IN NETRIN-1 SIGNALING%REACTOME%R-HSA-418890.1,0.43633414436334106,0.7626864968659259,0.416505164301452,1.00169253169153,3227,5,PITPNA|PLCG1|DCC
S PHASE%REACTOME DATABASE ID RELEASE 66%69242,0.000128865979381443,0.00518555396908895,-0.329608197953541,-2.30699073858579,0,158,DNA2|GSK3B|STAG1|PSME1|RAD21|POLE4|CDKN1B|CDK4|AKT1|PSMB1|PRIM2|PSMB9|SKP2|CCNH|LIN54|POLE|PSMB4|RFC2|RPA2|PSMD1|PSMC2|ANAPC10|TFDP2|ESCO2|RFC3|CDT1|MCM4|ANAPC2|MCM6|ANAPC5|GINS2|CDC6|PSMD3|PSMB2|LIN52|CDC23|STAG2|POLD4|PSMF1|PCNA|ORC1|LIN9|ORC6|PSMD4|POLD1|MCM3|SHFM1|PSME2|MCM5|CDC45|POLD2|PSMB5|RFC5|GINS1|CDC27|SKP1|E2F1|PSMC4|PSMC6|MAX|PSMD10|CDK7|PSMB3|PSMC1|PSMD2|UBC|MCM2|MNAT1|PSMD6|MYC|SMC1A|PSMD12|PSMA3|POLE2|POLA1|POLE3|ANAPC11|PSMA6|RFC4|CCND1|PSMD13|PSMB7|CDCA5|PSMA1|POLA2|PSMC5|PSMC3|FEN1
TRAF6-MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX%REACTOME DATABASE ID RELEASE 66%937072,0.0169335783670255,0.17671843887293,-0.47433561346023706,-1.7222357232514598,128,15,UBC|TICAM1|TLR4|CD14|LY96
POST NMDA RECEPTOR ACTIVATION EVENTS%REACTOME%R-HSA-438064.2,0.36903678668919804,0.72201432219986,-0.225425524157933,-1.06801738606834,2838,34,GRIN1|ADCY8|CAMK2B|HRAS|GRIN2C|DLG3|GRIN2D|CAMK2A|PRKACA|RRAS
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY%REACTOME DATABASE ID RELEASE 66%442380,0.797578755532413,0.9308634013872809,-0.252772787886945,-0.727697478135792,6126,8,SLC39A7|SLC39A1|SLC39A3|SLC39A8
SIGNALING BY HIPPO%REACTOME DATABASE ID RELEASE 66%2028269,0.215008542515442,0.5979177134734279,-0.309922510278764,-1.2244749248908,1635,19,TJP2|SAV1|STK3|WWTR1|LATS2|YAP1
G ALPHA (Z) SIGNALLING EVENTS%REACTOME DATABASE ID RELEASE 66%418597,0.40115242145699004,0.740287621109606,0.20509084040751396,1.03951823537567,2923,41,GNG5|RGS17|ADCY2|GNGT1|GNAS|GNB5|PRKCE|ADCY3|GNB4|GNAI3
BETA-CATENIN INDEPENDENT WNT SIGNALING%REACTOME DATABASE ID RELEASE 66%3858494,0.0121794871794872,0.145529933029933,-0.23005027194330302,-1.55149723742466,94,131,ITPR2|FZD4|PLCB3|PSMD3|PSMB2|ITPR3|PSMF1|CLTA|FZD2|FZD8|PSMD4|SHFM1|SMURF2|CLTC|PSME2|PSMB5|GNGT2|TNRC6C|NFATC1|PSMC4|GNG11|PSMC6|PSMD10|PSMB3|GNG10|PSMC1|PSMD2|UBC|PSMD6|CAMK2A|PSMD12|PSMA3|GNG3|PSMA6|PDE6G|PSMD13|PSMB7|PSMA1|PSMC5|AP2M1|PSMC3|PRKCB|CLTB
REV-MEDIATED NUCLEAR EXPORT OF HIV RNA%REACTOME%R-HSA-165054.2,0.8295618051013741,0.943504776751861,-0.15991130091116,-0.7301236930349,6341,30,NUP188|NUP85|RCC1|NUP37|RAN|NUP160|NUP214
SIGNALLING TO STAT3%REACTOME DATABASE ID RELEASE 66%198745,0.263492063492064,0.638950455433329,-0.607367376199404,-1.18603454908875,1991,3,NTRK1|NGF|STAT3
BETA OXIDATION OF PALMITOYL-COA TO MYRISTOYL-COA%REACTOME DATABASE ID RELEASE 66%77305,0.0123622682074711,0.14707724409765,0.847027682805779,1.6660034962361399,91,3,HADHB|HADHA|ACADVL
RELEASE OF HH-NP FROM THE SECRETING CELL%REACTOME DATABASE ID RELEASE 66%5362798,0.871620703708735,0.958238879057379,0.30937175236233505,0.6797029153525279,6415,4,ADAM17
ENDOSOMAL VACUOLAR PATHWAY%REACTOME%R-HSA-1236977.1,0.0053608786610878706,0.0829378624098312,-0.611167776132807,-1.9147088605106002,40,10,HLA-B|HLA-E|B2M|LNPEP|CTSV|CTSS|HLA-C|HLA-A|CTSL
FGFR1 LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190242,0.628221988427144,0.8598358835891559,-0.357686420188493,-0.857306096340647,4776,5,FGF10|FGF9
MISSPLICED LRP5 MUTANTS HAVE ENHANCED BETA-CATENIN-DEPENDENT SIGNALING%REACTOME%R-HSA-5339717.2,0.069201827465735,0.37596389138254704,0.7448468962879391,1.4650259472816798,514,3,DKK1|KREMEN1
REGULATION OF SIGNALING BY CBL%REACTOME DATABASE ID RELEASE 66%912631,0.772471542587989,0.9216519933009191,-0.20078177428456304,-0.763019772430063,5903,17,SYK|LYN|RAPGEF1|VAV1|PIK3CB|PIK3R3|HCK
ABC TRANSPORTERS IN LIPID HOMEOSTASIS%REACTOME%R-HSA-1369062.2,0.160927065601676,0.5311416159351421,-0.378689887701127,-1.30352402973174,1228,13,ABCA2|ABCA5|ABCA9|ABCA10|ABCG1|ABCA6|ABCD1
SYNTHESIS OF PI%REACTOME%R-HSA-1483226.3,0.8847982611058279,0.963895803326774,0.303413056035739,0.6666114057561879,6512,4,CDS1|PITPNM2
ASSEMBLY OF VIRAL COMPONENTS AT THE BUDDING SITE%REACTOME DATABASE ID RELEASE 66%168316,0.0945874237198196,0.424507034898303,-0.806672180865729,-1.34243150554109,712,2,CANX|CALR
NADE MODULATES DEATH SIGNALLING%REACTOME%R-HSA-205025.1,0.18847413228552698,0.562501370477675,-0.496955560084692,-1.2783035734608998,1438,6,NGFRAP1|NGFR
HDR THROUGH SINGLE STRAND ANNEALING (SSA)%REACTOME DATABASE ID RELEASE 66%5685938,0.0540750323415265,0.337048028079797,-0.308664489777003,-1.4863058978743002,417,36,RAD9A|RFC2|RAD51|RPA2|BRIP1|RFC3|NBN|EXO1|RAD1|RAD17|RHNO1|BRCA1|RFC5|TOPBP1|ABL1|RMI1|RMI2|KAT5|RFC4
MRNA DECAY BY 3' TO 5' EXORIBONUCLEASE%REACTOME DATABASE ID RELEASE 66%429958,0.6265044479330191,0.858842084733938,-0.23439339469108303,-0.871096613513605,4788,16,NT5C3B|EXOSC3|EXOSC2
CALCITONIN-LIKE LIGAND RECEPTORS%REACTOME DATABASE ID RELEASE 66%419812,0.94794952681388,0.984208682089217,-0.21070671663467602,-0.57595741358899,7211,7,ADM|CALCB|CALCRL
VEGFR2 MEDIATED VASCULAR PERMEABILITY%REACTOME%R-HSA-5218920.2,0.348773486430063,0.7068948364665609,-0.24724180103368498,-1.07851388703016,2672,26,AKT1|PAK2|MLST8|RAC1|VAV3|JUP|CTNND1|VAV1|CDH5|NOS3|CAV1|HSP90AA1|MAPKAP1
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM%REACTOME DATABASE ID RELEASE 66%1793185,0.11724856696195901,0.46811801288741794,-0.26193641816199603,-1.32853244723772,899,43,HYAL3|ARSB|DCN|CHST7|SDC4|BGN|VCAN|B4GALT7|SDC2|HYAL1|B3GAT3|B3GALT6|HEXB|CSGALNACT1|XYLT2
TELOMERE C-STRAND SYNTHESIS INITIATION%REACTOME%R-HSA-174430.2,0.0072897682895079405,0.103163519143488,-0.640048159050439,-1.8426090684839698,55,8,POLE2|POLA1|POLE3|POLA2
SYNTHESIS OF 5-EICOSATETRAENOIC ACIDS%REACTOME DATABASE ID RELEASE 66%2142688,0.271905697445972,0.646576786621306,-0.45387325386976296,-1.1674842761014,2075,6,ALOX5AP|GPX4|ALOX5|LTC4S|GPX1
PLATELET DEGRANULATION%REACTOME DATABASE ID RELEASE 66%114608,0.000127599846880184,0.00518555396908895,-0.43257566168475003,-2.7677453566530095,0,102,PPIA|STXBP2|HGF|BRPF3|RAB27B|TUBA4A|TLN1|PLEK|VEGFC|GAS6|TGFB3|CLEC3B|VWF|SERPINA1|CD63|F8|TIMP3|PHACTR2|SOD1|SRGN|FLNA|ITIH3|SPARC|IGF1|MMRN1|LGALS3BP|FN1|VEGFB|CD36|ECM1|TOR4A|A2M|THBS1|F13A1|CYB5R1|VCL|SEPP1|RARRES2|SERPINE1|LAMP2|CFL1|FERMT3|CFD|HSPA5|TIMP1|TMSB4X|ACTN1|SERPING1|CHID1|LHFPL2|PDGFB|SERPINF2|ALDOA
TRAFFICKING OF GLUR2-CONTAINING AMPA RECEPTORS%REACTOME%R-HSA-416993.1,0.236009414225941,0.6213269448976729,-0.38689203222795704,-1.2120822319121298,1804,10,TSPAN7|NSF|GRIA1|PRKCB
CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS%REACTOME%R-HSA-442742.1,0.320328810020877,0.688266348397827,-0.252910531331501,-1.1032419238041298,2454,26,RASGRF2|GRIN1|CAMK2B|HRAS|GRIN2C|DLG3|GRIN2D|CAMK2A|RRAS
INTERLEUKIN-6 FAMILY SIGNALING%REACTOME%R-HSA-6783589.6,0.332589578684867,0.6969525512590259,-0.269153881119695,-1.09653484968082,2533,21,LIFR|IL6|PTPN11|CLCF1|IL11RA|CNTFR|LIF|CTF1|SOCS3|IL6ST|STAT3|OSM|IL11|OSMR
RIPK1-MEDIATED REGULATED NECROSIS%REACTOME DATABASE ID RELEASE 66%5213460,0.192579968536969,0.566989663811688,-0.355391073006265,-1.25732164613975,1468,14,RIPK3|TNFRSF10A|TNFRSF10B|TRAF2|TNFSF10|MLKL|XIAP|FADD
NEUROPHILIN INTERACTIONS WITH VEGF AND VEGFR%REACTOME DATABASE ID RELEASE 66%194306,0.334772935479649,0.697851482247329,-0.5113951841534999,-1.11955095891215,2557,4,FLT1|KDR|NRP2
CERAMIDE SIGNALLING%REACTOME%R-HSA-193681.2,0.724603174603175,0.9036259920634921,-0.407225001188752,-0.795207216569365,5477,3,NGF|NGFR
LOSS OF FUNCTION OF TGFBR1 IN CANCER%REACTOME DATABASE ID RELEASE 66%3656534,0.545776031434185,0.817297924969912,-0.35841666919175996,-0.92194422563196,4166,6,TGFBR2|FKBP1A
INTERLEUKIN-9 SIGNALING%REACTOME DATABASE ID RELEASE 66%8985947,0.530625657202944,0.8115959426370749,-0.34220132450331303,-0.9353920602795759,4036,7,STAT5B|IL2RG|JAK3|STAT5A|STAT3
PROLACTIN RECEPTOR SIGNALING%REACTOME DATABASE ID RELEASE 66%1170546,0.956782087997917,0.9880317864833471,-0.195678795776992,-0.5633318657515201,7349,8,STAT5B|CUL1|PTPN11|STAT5A|SKP1
BIOSYNTHESIS OF E-SERIES 18(S)-RESOLVINS%REACTOME DATABASE ID RELEASE 66%9018896,0.998938710533298,0.999656642395059,-0.271408877860491,-0.45166777430263505,7529,2,LTA4H|ALOX5
SIGNALING BY BRAF AND RAF FUSIONS%REACTOME%R-HSA-6802952.1,0.932475884244373,0.980055411497814,-0.120493769501116,-0.6533517314939571,7249,54,VWF|FXR1|ARRB1|MAPK3|HRAS|FAM114A2|LMNA|RAP1A|FN1|VCL|ARAF
INACTIVATION OF CDC42 AND RAC1%REACTOME%R-HSA-428543.2,0.917500676223965,0.975772456906312,0.22574531133622502,0.623163872585292,6783,7,SRGAP1|ARHGAP39|SRGAP3
"SUMO IS TRANSFERRED FROM E1 TO E2 (UBE2I, UBC9)%REACTOME%R-HSA-3065678.1",0.7431650893796009,0.910591672478216,-0.28144738842920597,-0.769323885304108,5653,7,SUMO2|SUMO3
SIGNALING BY RECEPTOR TYROSINE KINASES%REACTOME DATABASE ID RELEASE 66%9006934,0.0005103342689461599,0.0139121625154964,-0.19527972087250103,-1.5925498141683798,3,378,PTBP1|LAMB2|FLT1|NCKAP1L|VAV3|LAMC1|ATP6V0A1|WASF2|RPS6KA1|SH3GL1|HNRNPH1|AP2A2|JUP|CTNND1|PCSK5|TCIRG1|LAMC2|NCBP2|ITPR2|ATP6V0B|HGS|FGFR4|DNM1|KDR|POLR2J|RAPGEF1|ATP6V0A2|LAMC3|HGF|ATP6V1G2|SPRY1|ITPR3|VAV1|NGF|FES|ATF1|PDGFD|LAMA2|CLTA|ELK1|VEGFC|WWOX|ATP6V1F|ADAM12|INS|SH3GL2|BCAR1|MATK|ERBB2IP|MST1R|FLT4|ELMO1|MAPKAPK2|ATP6V0D1|MEF2C|IRS1|SOCS1|GGA3|STAT3|NCBP1|PTPN6|CLTC|SH2B3|HNRNPM|PXN|POLR2H|PIK3CB|FGF10|MAPK3|SPP1|COL4A1|CYBB|CILP|EPS15L1|HSPB1|LAMA4|HRAS|PIK3R3|IGF1|NTRK2|COL4A2|NCF4|LRIG1|HBEGF|CDH5|DOCK1|PIK3R4|CYFIP2|COL6A3|NELFB|RAP1A|PCSK6|NCF2|AXL|NOS3|PPP2CA|VEGFB|NRP2|FGF19|MUC20|ATP6V0E1|FGF9|THBS1|SPINT2|FGF7|THBS2|UBC|PDGFRB|MMP9|CAV1|FLT3LG|POLR2G|PLAT|ATP6AP1|YAP1|WASF3|COL6A1|MAPK13|PRKACA|ATP6V0E2|HSP90AA1|TIAM1|PDGFRA|NCK1|MAPKAP1|COL6A2|ATP6V1A|ARF6|SPHK1|ATP6V1G1|PDGFB|AP2M1|PRKCB|PTPRJ|SH3GL3|POLR2L|GRB10|DNM3
PAUSING AND RECOVERY OF HIV ELONGATION%REACTOME DATABASE ID RELEASE 66%167290,0.47223670490093894,0.7831522581932591,-0.212963611077591,-0.9906227679194841,3622,32,POLR2J|CCNK|SUPT16H|POLR2H|NELFB|POLR2G|SUPT4H1|SSRP1|POLR2L
GLUCURONIDATION%REACTOME DATABASE ID RELEASE 66%156588,0.942399130552914,0.9821945878594591,0.275249222711617,0.604734264511927,6936,4,SLC35D1|UGDH
SUMOYLATION OF DNA REPLICATION PROTEINS%REACTOME DATABASE ID RELEASE 66%4615885,0.518086347724621,0.8047799431921201,-0.190688113158243,-0.9549861366829949,3995,41,TOP1|PCNA|TOP2A|NUP188|SUMO2|INCENP|NUP85|NUP37|SUMO3|NUP160|NUP214|BIRC5
CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE%REACTOME DATABASE ID RELEASE 66%442720,0.8084910620399579,0.934193159096917,-0.261629596549187,-0.71515283496189,6150,7,ADCY8|PRKACA
PPARA ACTIVATES GENE EXPRESSION%REACTOME%R-HSA-1989781.3,0.5999487113732529,0.8464076674715391,-0.14517135974574,-0.9233796857144498,4678,100,G0S2|NR1H3|MED6|HMGCS1|CD36|TNFRSF21|FHL2|GLIPR1|NR1D1|PLIN2|NFYB|PPARG|PPARA|ESRRA|FADS1|MED27|MED19
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE%REACTOME%R-HSA-1614558.6,0.963598271572607,0.990916952887267,-0.159715291909224,-0.549771007045231,7358,13,ADO|CDO1|TST|SLC25A10|SQRDL
DEPYRIMIDINATION%REACTOME DATABASE ID RELEASE 66%73928,0.0668109277792805,0.3690551432905871,0.551873582917912,1.52343221249202,493,7,NTHL1|NEIL1|OGG1|SMUG1|NEIL2|TDG
MITOCHONDRIAL TRANSLATION TERMINATION%REACTOME DATABASE ID RELEASE 66%5419276,0.0005096839959225281,0.0139121625154964,-0.329542119124245,-2.02695281757601,3,87,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|MRPL18|MRPL57|GFM2|MRPS18B|MRPS15|MRPL47|GADD45GIP1|MRPS11|MRPL13|OXA1L|MRPL10|MRPL50|MRRF|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
DEFECTIVE B3GALT6 CAUSES EDSP2 AND SEMDJL1%REACTOME%R-HSA-4420332.1,0.7029042386185239,0.8934528433311372,-0.219422876422587,-0.8154603709334021,5372,16,HSPG2|NCAN|SDC3|DCN|SDC4|BGN|VCAN|SDC2
SIGNALING BY FGFR2 FUSIONS%REACTOME%R-HSA-8853333.1,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
PI-3K CASCADE:FGFR2%REACTOME%R-HSA-5654695.2,0.587735355648536,0.8414799095069009,-0.283408468424495,-0.8878817353063508,4494,10,FGF10|FGF9|FGF7
PHASE I - FUNCTIONALIZATION OF COMPOUNDS%REACTOME%R-HSA-211945.5,0.658473479948254,0.8769585284618442,-0.158322299991042,-0.8717795064718679,5089,57,MAOA|POR|CES1|FMO3|TBXAS1|CYP1B1|AHR|ADH1B|ALDH2|POMC|CYP51A1|PTGS1|ALDH1A1|CYP46A1|AIP|CYP7B1|FMO2|AOC3|PTGIS
TOLL LIKE RECEPTOR 4 (TLR4) CASCADE%REACTOME%R-HSA-166016.2,0.342479805103218,0.701955655133333,-0.161382065942229,-1.0641716790302,2670,117,RPS6KA1|IRAK3|RIPK3|NFKB2|ITGB2|DNM1|TLR2|TICAM2|ATF1|LY86|ELK1|IKBKE|MAPKAPK2|MEF2C|SOCS1|MAPK9|MAPK3|IRF7|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|CD36|FADD|UBC|TICAM1|TRAF3|RELA|NFKB1|TLR4|ITGAM|CD14|LY96|PELI3|DNM3
STAT6-MEDIATED INDUCTION OF CHEMOKINES%REACTOME DATABASE ID RELEASE 66%3249367,0.4321428571428571,0.760603358397838,-0.532004263147569,-1.038869490001,3266,3,STAT6|TMEM173
"GAMMA CARBOXYLATION, HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION%REACTOME DATABASE ID RELEASE 66%163841",0.894183506280721,0.9658968257150641,0.144482589369581,0.6739913367349001,6548,31,PROC|DPH2|GGCX|ARSA|DPH5
INTERACTIONS OF TAT WITH HOST CELLULAR PROTEINS%REACTOME%R-HSA-176034.2,0.5811886442027061,0.8387093286508721,-0.566087675765095,-0.9420604166986701,4380,2,CDK9|CCNT1
PROCESSING OF CAPPED INTRONLESS PRE-MRNA%REACTOME DATABASE ID RELEASE 66%75067,0.093848167539267,0.42349305248441493,-0.313367381445383,-1.399533773613,716,28,CPSF1|SNRPE|LSM11|NCBP2|LSM10|CPSF2|SNRPF|PAPOLA|NCBP1|CLP1|CSTF3|SNRPB|PABPN1|CPSF7
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE%REACTOME DATABASE ID RELEASE 66%181429,0.165398206034248,0.5375245857985801,0.34234656233236,1.28904834834556,1216,16,RIMS1|SNAP25|PPFIA2|CPLX1|PPFIA3|PPFIA4
ELASTIC FIBRE FORMATION%REACTOME%R-HSA-1566948.1,0.000388098318240621,0.0111294649577428,-0.46252309145256104,-2.22717812219231,2,36,LTBP3|MFAP4|ITGB5|TGFB3|VTN|ITGA5|ELN|LOXL1|LTBP2|FBN1|LTBP1|LOX|FBN3|MFAP5|BMP2|ITGA8|EFEMP1|FBLN2|EFEMP2|FBLN1|LOXL2
"AXIN MUTANTS DESTABILIZE THE DESTRUCTION COMPLEX, ACTIVATING WNT SIGNALING%REACTOME%R-HSA-4839735.1",0.7642894598846359,0.9191113740914171,-0.21629972962533803,-0.7652368131017159,5829,14,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
THE IPAF INFLAMMASOME%REACTOME DATABASE ID RELEASE 66%844623,0.882064208012736,0.9626270411136021,-0.412750124243591,-0.6868822104487879,6648,2,CASP1
SEMAPHORIN INTERACTIONS%REACTOME DATABASE ID RELEASE 66%373755,0.38124113017675104,0.729499056535481,-0.18570839462319896,-1.05018306318944,2954,63,TREM2|SEMA7A|RND1|SEMA5A|SEMA3E|TYROBP|SEMA3A|MYH9|CFL1|HSP90AA1|RRAS|MYL9
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER%REACTOME DATABASE ID RELEASE 66%76071,0.877225130890052,0.960725750963158,-0.15417539877177402,-0.688564574417769,6701,28,ZNF143|BRF2|POLR3B|POLR2H|POLR3K|BDP1|POLR2L
DEFECTIVE MTR CAUSES METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE CBLG%REACTOME DATABASE ID RELEASE 66%3359469,0.739055452374635,0.9089185613230608,-0.49732561345464604,-0.827629349133577,5570,2,MTR|MTRR
REGULATION OF GENE EXPRESSION BY HYPOXIA-INDUCIBLE FACTOR%REACTOME DATABASE ID RELEASE 66%1234158,0.599235599235599,0.8461750306054542,0.289273558531715,0.879075664679856,4389,9,EPAS1|CITED2|ARNT|EP300
TRYPTOPHAN CATABOLISM%REACTOME DATABASE ID RELEASE 66%71240,0.597516339869281,0.8449219534562551,-0.262888806291266,-0.8799134493566141,4570,12,KMO|CCBL1|KYNU|HAAO|AFMID|SLC3A2
SYNTHESIS AND PROCESSING OF ENV AND VPU%REACTOME DATABASE ID RELEASE 66%171286,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING%REACTOME DATABASE ID RELEASE 66%975110,0.8784149310251559,0.960725750963158,0.24079131763612,0.664697969117736,6494,7,UBE2V1|MYD88|IRAK4
THE NLRP3 INFLAMMASOME%REACTOME%R-HSA-844456.2,0.38398007341373896,0.7312516375535559,-0.299015436233718,-1.05787288725721,2928,14,PYCARD|NFKB2|CASP1|NLRP3|RELA|NFKB1
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%190872,0.547290969899666,0.818317601346006,-0.729102337891487,-0.971339381866999,4090,1,GJA1
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS%REACTOME DATABASE ID RELEASE 66%8866910,0.4143900459832299,0.748680069094768,0.371317842075226,1.02501293629517,3063,7,KIT|TFAP2B|EGFR|ERBB2
GROWTH HORMONE RECEPTOR SIGNALING%REACTOME DATABASE ID RELEASE 66%982772,0.317152950412142,0.6861326333203311,-0.29241566465535807,-1.11125093248801,2423,17,STAT5A|LYN|SOCS3|IRS1|SOCS1|STAT3|PTPN6|CISH|MAPK3
RHO GTPASES ACTIVATE WASPS AND WAVES%REACTOME DATABASE ID RELEASE 66%5663213,0.558402705515088,0.8268422944617521,-0.19458526829268802,-0.9289370458544021,4292,35,CDC42|RAC1|WIPF3|ACTG1|NCKAP1L|WASF2|NCKIPSD|ARPC1A|WAS|MAPK3|ABL1|CYFIP2|WASF3|ACTB|NCK1
"PTK6 REGULATES RHO GTPASES, RAS GTPASE AND MAP KINASES%REACTOME DATABASE ID RELEASE 66%8849471",0.43341626293047,0.761732646757032,-0.29392140800467603,-1.0117344841514802,3309,13,BCAR1|ELMO1|PXN|HRAS|DOCK1
CYTOCHROME P450 - ARRANGED BY SUBSTRATE TYPE%REACTOME DATABASE ID RELEASE 66%211897,0.801548492257539,0.9325377000668108,0.16739873619525303,0.758398308963055,5900,28,CYP27B1|CYP2E1|FDX1L|CYP4V2|CYP2C8|CYP27A1|ARNT|FDXR|CYP2D6|ARNT2
CYTOSOLIC SENSORS OF PATHOGEN-ASSOCIATED DNA%REACTOME DATABASE ID RELEASE 66%1834949,0.30578832022689195,0.677423587903087,-0.19671427455112397,-1.10313925182563,2371,61,DHX9|TRIM21|RIPK3|TREX1|TRIM56|NFKB2|POLR3B|DHX36|MB21D1|TRIM32|POLR2H|POLR3K|IRF7|IFI16|TMEM173|NFKBIA|UBC|TICAM1|RELA|NFKB1|POLR2L
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION%REACTOME DATABASE ID RELEASE 66%2730905,0.7072722499343659,0.8950890823141551,-0.22405571045022302,-0.813509965488193,5387,15,FYN|SYK|IGKV3-11|LYN|LAT2|IGKV2-28|PIK3CB|IGKV2D-28
B CELL ACTIVATION%REACTOME DATABASE ID RELEASE 66%983705,0.000255885363357216,0.00819882332206558,-0.3115904856555611,-2.02782141211984,1,110,PSMA4|PSMA7|CHUK|RASGRP1|ORAI1|PPP3CA|CUL1|NFATC3|MALT1|PSMD7|PSME3|PSMA2|FYN|DAPP1|TRPC1|PSME1|AHCYL1|PLCG2|SH3KBP1|PSMB1|SYK|NFATC2|PSMB9|IGKV3-11|PSMB4|LYN|FBXW11|PSMD1|PSMC2|ITPR2|PIK3AP1|PPIA|PSMD3|PSMB2|ITPR3|VAV1|PSMF1|STIM1|IGKV2-28|PSMD4|SHFM1|PTPN6|PSME2|PSMB5|HRAS|SKP1|NFATC1|PSMC4|PSMC6|PSMD10|IGKV2D-28|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|FKBP1A|PSMD6|RELA|NFKB1|PSMD12|PSMA3|PSMA6|NCK1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|PRKCB
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE-3-KINASE (PI3K)%REACTOME DATABASE ID RELEASE 66%9027276,0.43622518357356505,0.7626864968659259,0.318177346673813,1.00800734149089,3207,10,IRS2|GAB1|PIK3CD|JAK2|EPOR|PIK3CA
ABASIC SUGAR-PHOSPHATE REMOVAL VIA THE SINGLE-NUCLEOTIDE REPLACEMENT PATHWAY%REACTOME%R-HSA-73930.1,0.564871318652162,0.8295590091625621,-0.573326898037117,-0.954107640197995,4257,2,APEX1
RAF-INDEPENDENT MAPK1 3 ACTIVATION%REACTOME%R-HSA-112409.2,0.625968728755948,0.858842084733938,0.20916841354051502,0.8753598790327289,4603,22,DUSP4|DUSP6|DUSP10|DUSP16|JAK1|MAP2K1|MAPK1
CLEC7A (DECTIN-1) SIGNALING%REACTOME%R-HSA-5607764.1,0.00025412960609911097,0.00819882332206558,-0.309006995259332,-1.9389459400285602,1,94,PSMA4|PSMA7|MAP3K14|CHUK|UBE2M|PPP3CA|CUL1|UBA3|NFATC3|MALT1|PSMD7|PSME3|PSMA2|TRAF6|UBE2N|PSME1|AHCYL1|PLCG2|IL1B|PSMB1|SYK|NFATC2|PSMB9|UBE2D2|PSMB4|FBXW11|PSMD1|PSMC2|PYCARD|NFKB2|ITPR2|PSMD3|PSMB2|ITPR3|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|NFATC1|PSMC4|CLEC7A|PSMC6|PSMD10|NFKBIA|PSMB3|PSMC1|RELB|PSMD2|UBC|PSMD6|RELA|NFKB1|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
ZINC TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%435354,0.9697525206232809,0.991546057544123,-0.155428023714877,-0.535013398525073,7405,13,SLC39A7|SLC39A1|SLC39A3|SLC39A8|SLC30A5
"WNT5A-DEPENDENT INTERNALIZATION OF FZD2, FZD5 AND ROR2%REACTOME%R-HSA-5140745.1",0.12811108200157198,0.48509801008225,-0.423446234952108,-1.3709299679120202,977,11,AP2A2|CLTA|FZD2|CLTC|AP2M1|CLTB
REGULATION OF CORTICAL DENDRITE BRANCHING%REACTOME%R-HSA-8985801.1,0.0186116016845537,0.18771421163087398,0.7598841682382159,1.66949787929193,136,4,NCK2|SLIT1|ROBO2
GLUTATHIONE SYNTHESIS AND RECYCLING%REACTOME DATABASE ID RELEASE 66%174403,0.606366256222164,0.848933263107216,-0.271042893216087,-0.8775159494369771,4628,11,OPLAH|CHAC1|CHAC2|GGT1|GGT5
NON-CODING RNA METABOLISM%REACTOME DATABASE ID RELEASE 66%194441,0.191244834710744,0.5657618283915489,-0.23217985566088897,-1.22333182489116,1480,49,DDX20|NUP107|SNRPD3|SMN2|GEMIN5|GEMIN7|NUP205|NUP93|NUP210|SNRPE|GEMIN8|NCBP2|PHAX|GEMIN2|NUP188|SNRPF|NCBP1|SNRPD1|NUP85|NUP37|NUP160|NUP214|SNRPB|PRMT5|SMN1
DNA DAMAGE RECOGNITION IN GG-NER%REACTOME DATABASE ID RELEASE 66%5696394,0.40394600207684295,0.7412049911665691,-0.21155067918377302,-1.03531994511087,3111,38,YY1|PARP1|RUVBL1|COPS6|PARP2|TFPT|RAD23B|INO80E|UBC|DDB1|CETN2|ACTB|GPS1
CYTOSOLIC TRNA AMINOACYLATION%REACTOME DATABASE ID RELEASE 66%379716,0.44874476987447703,0.768229288546963,-0.235720660093034,-1.00180615996275,3431,24,NARS|HARS|RARS|PPA1|EEF1E1|TARS|AIMP2|FARSA|IARS|GARS|VARS|SARS|YARS|WARS|AARS|CARS
MITOCHONDRIAL BIOGENESIS%REACTOME%R-HSA-1592230.2,0.9406218144750258,0.9812919575525741,-0.11045398628601501,-0.6793821054192201,7381,87,ATP5J|MED1|ATP5F1|SOD2|HCFC1|CHCHD3|APOO|ATP5B|CYCS|MEF2C|HSPA9|SMARCD3|ATP5O|CHCHD6|NR1D1|SIRT4|PPARA|ATP5H|ESRRA|ATP5G1
SPHINGOLIPID METABOLISM%REACTOME DATABASE ID RELEASE 66%428157,0.30473982483256107,0.6770795415897549,-0.18882022360775602,-1.1005118806713998,2365,71,CERS6|SPTSSB|SUMF1|CERS4|PPAP2C|ARSE|ARSB|GLTP|GLA|ARSF|PRKD1|ORMDL3|UGCG|ARSG|STS|PPAP2A|OSBP|SPTSSA|HEXB|SMPD1|ALDH3B1|SPHK1
EGFR TRANSACTIVATION BY GASTRIN%REACTOME%R-HSA-2179392.1,0.35204219637544,0.7106060713647829,0.39322320277639,1.08548209653648,2602,7,SOS1|PRKCA|NRAS|EGFR|KRAS
PROCESSIVE SYNTHESIS ON THE C-STRAND OF THE TELOMERE%REACTOME DATABASE ID RELEASE 66%174414,0.12090647105056301,0.472999327000989,-0.42710837992003703,-1.3827863592764198,922,11,RPA2|POLD4|PCNA|POLD1|POLD2|FEN1
REVERSE TRANSCRIPTION OF HIV RNA%REACTOME%R-HSA-162589.1,0.445083612040134,0.76693681188187,-0.77977503308337,-1.03884757909424,3326,1,PPIA
PRE-MRNA SPLICING%REACTOME DATABASE ID RELEASE 66%72163,0.000127909951394218,0.00518555396908895,-0.265807716873742,-1.90972644096874,0,179,SUGP1|SF3A2|PRCC|PPWD1|SF3B4|CPSF1|SNRPE|POLR2C|LSM5|YBX1|DHX9|PTBP1|SRSF3|TXNL4A|HNRNPH1|SF3A1|SRSF10|ELAVL2|HNRNPUL1|HNRNPL|NCBP2|PRPF4|POLR2J|SLU7|DDX23|RBM17|SNRPB2|SRSF9|HNRNPU|RBMX|BCAS2|HNRNPH2|DDX42|MAGOH|CPSF2|CD2BP2|SRSF5|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|SNRPA1|HNRNPM|DDX5|CLP1|SF1|SNW1|POLR2H|EFTUD2|HNRNPR|RBM22|CSTF3|LSM3|FUS|WBP11|HNRNPK|MAGOHB|EIF4A3|SNRPB|TRA2B|PABPN1|SRSF2|RBM8A|POLR2G|SF3B2|ISY1|CPSF7|SKIV2L2|CWC27|PQBP1|HNRNPA0|GPKOW|SART1|HNRNPC|POLR2L|PRPF19
SUMO E3 LIGASES SUMOYLATE TARGET PROTEINS%REACTOME%R-HSA-3108232.3,0.114451612903226,0.463748809895271,-0.179971375264135,-1.2500603280587401,886,151,RORA|TOP1|NDNL2|STAG2|CDKN2A|NPM1|PCNA|TOP2A|IKBKE|NUP188|SUMO2|RNF168|HIST1H4I|PARK7|INCENP|BRCA1|NUP85|ZBED1|DDX5|DNMT1|CBX4|NUP37|HIC1|SUMO3|NUP160|MITF|NFKBIA|RING1|NUP214|HNRNPK|HIST2H4A|PPARG|PPARA|RELA|SMC1A|CETN2|NSMCE1|BIRC5|HIST2H4B|EID3|HNRNPC
CENTROSOME MATURATION%REACTOME DATABASE ID RELEASE 66%380287,0.41558608293747606,0.7493091022753771,-0.17104541472946302,-1.0211099667919101,3236,78,HAUS1|NDE1|TUBG1|CEP72|HAUS6|TUBGCP5|CEP78|HAUS4|CEP76|CSNK1D|MZT2A|CEP192|PCNT|NEK2|NEDD1|DYNC1H1|OFD1|CEP70|TUBGCP2|TUBG2|TUBA4A|SDCCAG8|HAUS8|CDK5RAP2|CEP131|CKAP5|TUBB4A|PLK1|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
INTRACELLULAR OXYGEN TRANSPORT%REACTOME DATABASE ID RELEASE 66%8981607,0.668408360128617,0.881120023250023,0.512755477230461,0.861495406286687,4988,2,NGB
REGULATED NECROSIS%REACTOME DATABASE ID RELEASE 66%5218859,0.192579968536969,0.566989663811688,-0.355391073006265,-1.25732164613975,1468,14,RIPK3|TNFRSF10A|TNFRSF10B|TRAF2|TNFSF10|MLKL|XIAP|FADD
RNA POLYMERASE I TRANSCRIPTION INITIATION%REACTOME DATABASE ID RELEASE 66%73762,0.29055281598754196,0.663153967140254,-0.21582287036951103,-1.1240062922026999,2238,47,ZNRD1|TWISTNB|TTF1|POLR2H|GTF2H1|RBBP7|UBTF|CDK7|KAT2B|MNAT1|MTA2|POLR2L|GTF2H2
BETA OXIDATION OF LAUROYL-COA TO DECANOYL-COA-COA%REACTOME%R-HSA-77310.2,0.496535796766744,0.79427502465508,0.434783286214225,0.955237396206247,3654,4,HADHB|HADHA|ECHS1
PEROXISOMAL PROTEIN IMPORT%REACTOME DATABASE ID RELEASE 66%9033241,0.279818406933553,0.653204101106396,0.208257219924922,1.13075041744854,2033,52,IDH1|PEX7|RPS27A|MPV17|NUDT7|GSTK1|PEX2|PEX13|PIPOX|GNPAT|ACOX2|PEX1|HMGCL|ACOX3|EHHADH|PEX10|ACOT8|PHYH|ZFAND6|ECH1|HACL1|PAOX|UBA52|PECR|SLC27A2|UBE2D3|PEX12|EPHX2
DEFECTIVE PRO-SFTPB CAUSES PULMONARY SURFACTANT METABOLISM DYSFUNCTION 1 (SMDP1) AND RESPIRATORY DISTRESS SYNDROME (RDS)%REACTOME DATABASE ID RELEASE 66%5688031,0.336826744494561,0.699462084003389,-0.6668872346291701,-1.10980700170989,2538,2,CCDC59|TTF1
RNA POLYMERASE II TRANSCRIPTION INITIATION AND PROMOTER CLEARANCE%REACTOME DATABASE ID RELEASE 66%76042,0.0299702880764759,0.244735657013286,-0.305821259293732,-1.5842503492941102,231,46,GTF2A2|POLR2J|TAF3|GTF2A1|TAF12|POLR2H|GTF2H1|TAF7|TAF9B|CDK7|MNAT1|TAF10|POLR2G|TAF9|AK6|POLR2L|GTF2H2
PTK6 REGULATES CELL CYCLE%REACTOME DATABASE ID RELEASE 66%8849470,0.582719621251973,0.838862400059828,-0.371737926443915,-0.890984875560707,4430,5,CDKN1B|CDK4|CCND1
SMOOTH MUSCLE CONTRACTION%REACTOME%R-HSA-445355.2,0.0039241334205363,0.0680498152643996,-0.412465368801353,-1.8832361227900498,29,30,ITGB5|TLN1|ANXA6|MYLK|LMOD1|PXN|DYSF|MYL12A|ACTG2|VCL|ANXA2|ACTA2|ANXA1|MYL9
MICROTUBULE-DEPENDENT TRAFFICKING OF CONNEXONS FROM GOLGI TO THE PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%190840,0.547290969899666,0.818317601346006,-0.729102337891487,-0.971339381866999,4090,1,GJA1
TOLL LIKE RECEPTOR 10 (TLR10) CASCADE%REACTOME DATABASE ID RELEASE 66%168142,0.799861014593468,0.931670998922663,0.131453180260684,0.800551285561769,5754,80,DUSP4|DUSP6|UBE2V1|MAPK7|RPS6KA2|RPS27A|MAP2K6|MAPK11|BTRC|VRK3|MAPKAPK3|TNIP2|PELI2|NFKBIB|NOD1|MAP2K7|MYD88|PPP2CB|ATF2|IRAK4|MAP2K1|MAPK1|PELI1|IKBKB|MAP2K4|MAPK8
GALACTOSE CATABOLISM%REACTOME%R-HSA-70370.2,0.7764243614931241,0.924197789886266,-0.289842348326337,-0.74555259939684,5927,6,GALK1
OXYGEN-DEPENDENT ASPARAGINE HYDROXYLATION OF HYPOXIA-INDUCIBLE FACTOR ALPHA%REACTOME DATABASE ID RELEASE 66%1234162,0.269013705993013,0.643036619584462,0.6040674105674649,1.1881293119418301,2001,3,EPAS1|HIF1AN
RUNX2 REGULATES GENES INVOLVED IN CELL MIGRATION%REACTOME DATABASE ID RELEASE 66%8941332,0.9706800597258041,0.9915747942934481,0.20982377974202598,0.5429313625299079,7150,6,CBFB|AKT3
INLA-MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELLS%REACTOME DATABASE ID RELEASE 66%8876493,0.995901639344262,0.998675570643677,0.156764687804569,0.455060463333133,7289,8,RPS27A|SRC|UBA52|CTNNB1
MINUS-STRAND DNA SYNTHESIS%REACTOME DATABASE ID RELEASE 66%164516,0.445083612040134,0.76693681188187,-0.77977503308337,-1.03884757909424,3326,1,PPIA
WNT LIGAND BIOGENESIS AND TRAFFICKING%REACTOME%R-HSA-3238698.1,0.279837067209776,0.653204101106396,0.329340017025075,1.15341740278073,2060,13,WNT6|WNT5B|WNT2B|WNT4|VPS35
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON%REACTOME%R-HSA-936964.2,0.0132129774986918,0.152381699412141,-0.47499793752746394,-1.76527625853726,100,16,TICAM2|IKBKE|IRF7|UBC|TICAM1|TRAF3|TLR4|CD14|LY96
SIGNALING BY NTRKS%REACTOME DATABASE ID RELEASE 66%166520,0.0480689080300083,0.31390740768334696,0.224024709407918,1.41248500263406,345,92,DUSP4|DUSP6|DNAL4|IRS2|GAB1|RALB|MAPK7|RPS6KA2|CRK|MAP2K5|PTPRO|MAPK12|MAPK11|PTPRS|ADORA2A|FRS3|VRK3|CDK5R1|DOCK3|SHC1|SOS1|ADCYAP1|ADCYAP1R1|SHC2|MAPKAPK3|YWHAB|PLCG1|NRAS|AP2S1|AP2B1|RIT1|PPP2CB|BAX|PIK3R2|SRC|CDK5|MAPK1|KRAS
PINK PARKIN MEDIATED MITOPHAGY%REACTOME%R-HSA-5205685.1,0.84699882306787,0.9492491301138911,-0.171619733451978,-0.7107219702561041,6476,22,TOMM70A|UBC|TOMM5|SQSTM1
BUTYRATE RESPONSE FACTOR 1 (BRF1) BINDS AND DESTABILIZES MRNA%REACTOME DATABASE ID RELEASE 66%450385,0.30105979327489196,0.674038850802402,-0.296783962381467,-1.12785153056898,2300,17,DCP1A|EXOSC9|DCP2|XRN1|AKT1|EXOSC7|EXOSC4|ZFP36L1|MAPKAPK2|EXOSC3|EXOSC2
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER%REACTOME DATABASE ID RELEASE 66%2219530,0.0734646281420057,0.381513862232598,-0.283428508690313,-1.42823001539573,566,42,PIK3AP1|FGFR4|HGF|VAV1|IRS1|PIK3CB|FGF10|RHOG|PIK3R3|HBEGF|CD86|FGF19|FGF9|FGF7|PDGFRB|PDGFRA|PDGFB
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS (PARS)%REACTOME%R-HSA-456926.1,0.0854712041884817,0.40462962277421993,-0.31772043373180703,-1.4189749919844,652,28,ARRB1|MAPK3|GNGT2|GNG11|GNAQ|F2R|GNA15|GNG10|F2RL3|GNG3
RNA POLYMERASE I TRANSCRIPTION%REACTOME%R-HSA-73864.2,0.00012727504136438798,0.00518555396908895,-0.38845905610933706,-2.3841146367844903,0,86,HIST1H2BN|H2AFV|ZNRD1|TWISTNB|HIST1H2BC|TTF1|HIST1H4I|POLR2H|GTF2H1|MAPK3|RBBP7|HIST2H3A|UBTF|CDK7|KAT2B|H2AFZ|HIST2H2AA4|MNAT1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|MTA2|PTRF|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L|GTF2H2
VPU MEDIATED DEGRADATION OF CD4%REACTOME DATABASE ID RELEASE 66%180534,0.000128816179312122,0.00518555396908895,-0.429415242369663,-2.2792897145074202,0,50,CD4|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
ROBO RECEPTORS BIND AKAP5%REACTOME%R-HSA-9010642.1,0.857722477684609,0.9496417938851991,0.24685701346422698,0.68144215963843,6341,7,ROBO2|PPP3CB|PRKCA
CHOLESTEROL BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%191273,0.0097911227154047,0.12648267027286803,-0.431642460165184,-1.8122860516646102,74,23,FDFT1|ACAT2|LBR|IDI1|FDPS|CYP51A1|HMGCS1|EBP|DHCR7|DHCR24|NSDHL|TM7SF2
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4%REACTOME DATABASE ID RELEASE 66%5654716,0.29641206849687396,0.6687276080240239,0.302261432884186,1.13811454151439,2180,16,GAB1|FGF2|FRS3|SOS1|PLCG1|NRAS|FGF1|KRAS
ACTIVATED NTRK3 SIGNALS THROUGH PLCG1%REACTOME DATABASE ID RELEASE 66%9034793,0.521704180064309,0.8069433946058672,0.5821339950372211,0.978060274025075,3893,2,PLCG1|NTRK3
RELEASE OF APOPTOTIC FACTORS FROM THE MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%111457,0.9858657243816259,0.994998004843933,-0.23034234517890195,-0.50426754379781,7532,4,DIABLO|BAK1|CYCS
ERKS ARE INACTIVATED%REACTOME%R-HSA-202670.2,0.241140529531568,0.6244696312630601,0.34227640698245504,1.19872333748244,1775,13,DUSP4|DUSP6|MAPK7|VRK3|PPP2CB|MAPK1
KSRP (KHSRP) BINDS AND DESTABILIZES MRNA%REACTOME%R-HSA-450604.2,0.920057569017402,0.9768322640118741,-0.16387950986685001,-0.622782156249569,7031,17,EXOSC9|DCP2|MAPK14|AKT1|KHSRP|EXOSC7|EXOSC4|EXOSC3|EXOSC2
PHOSPHATE BOND HYDROLYSIS BY NUDT PROTEINS%REACTOME DATABASE ID RELEASE 66%2393930,0.9806308074859309,0.993436724391485,-0.23995408635392398,-0.52530965444483,7492,4,NUDT5|NUDT16
TRANSCRIPTIONAL REGULATION BY TP53%REACTOME%R-HSA-3700989.5,0.41829143150333503,0.75036705317022,-0.125898882542371,-1.01428977213699,3260,349,SURF1|EXO1|RRAGA|TNFRSF10A|POLR2J|TNFRSF10B|TMEM55B|TAF3|SCO2|CASP10|BRPF3|GPI|SETD8|PLK2|TPX2|CDKN2A|NPM1|CCNK|RAD1|CHM|TAF12|RAD17|PCNA|CASP1|PRELID1|SUPT16H|PPP1R13B|SGK1|CDC25C|NUAK1|PHF20|CYCS|RHNO1|BRCA1|PERP|RFC5|TOPBP1|POLR2H|GTF2H1|TAF7|RBBP7|RMI1|TNFRSF10C|MT-CO3|TNRC6C|E2F1|RPTOR|USP2|TAF9B|NELFB|CCNB1|COX16|CDK7|PLAGL1|PPP2CA|RMI2|COX7B|UBC|MNAT1|TNKS1BP1|TAF10|DDIT4|POLR2G|MTA2|SUPT4H1|BCL6|NDUFA4|KAT5|TAF9|BIRC5|ZNF385A|PRMT5|SSRP1|RFC4|MAPKAP1|TACO1|SLC38A9|CASP6|AK6|COX6A1|COX8A|POLR2L|RRAGD|GTF2H2
PYRIMIDINE BIOSYNTHESIS%REACTOME%R-HSA-500753.2,0.733001881214727,0.90781066069377,0.402224623980665,0.7911283697415009,5454,3,CAD|DHODH
MITOTIC ANAPHASE%REACTOME%R-HSA-68882.2,0.00012833675564681698,0.00518555396908895,-0.319045492466915,-2.27599129959617,0,173,NUF2|NSL1|PSMD1|PSMC2|SPDL1|CDC20|DYNC1H1|ANAPC10|CLIP1|DSN1|ANAPC2|ANAPC5|LEMD3|ESPL1|PSMD3|PSMB2|CENPM|CDC23|STAG2|NUDC|PSMF1|PTTG1|CENPI|MAD2L1|KNTC1|PSMD4|SHFM1|ERCC6L|PSME2|DYNLL2|LMNB1|INCENP|NUP85|PSMB5|NDC80|SGOL1|KIF18A|CDC27|SEC13|NUP37|CKAP5|CENPH|PSMC4|SPC25|PSMC6|NUP160|PSMD10|KIF2A|PLK1|SKA1|PSMB3|PPP2CA|PSMC1|SPC24|PSMD2|UBC|PSMD6|SMC1A|PSMD12|PSMA3|VRK1|DYNC1I1|BIRC5|ANAPC11|CENPK|PSMA6|PSMD13|PSMB7|EMD|CDCA5|PSMA1|BANF1|PSMC5|PSMC3|CENPP|SKA2
EUKARYOTIC TRANSLATION TERMINATION%REACTOME%R-HSA-72764.4,0.4473109998716471,0.768229288546963,-0.162125873918596,-1.0060594957537,3484,91,RPS28|RPLP1|RPS18|RPL9|RPL28|GSPT1|RPS3|RPS5|RPS10|RPS15|RPL29|RPL11|RPS6|RPL36|RPL17|RPL32|RPL39L|RPL23|RPLP0|RPL10A|RPL8|RPS23|RPL3|GSPT2|RPL7A|RPS2|RPL15|RPL37|RPL27A|RPL18|RPL39|RPL27|ETF1|RPLP2|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|TRMT112|N6AMT1|RPL35|RPL38|RPS15A|RPL36AL|RPS13|RPL26L1|FAU
SOS-MEDIATED SIGNALLING%REACTOME DATABASE ID RELEASE 66%112412,0.423238767476585,0.753783909572009,0.392100835075007,1.01458395658549,3117,6,IRS2|SOS1|NRAS|KRAS
REGULATION OF PTEN LOCALIZATION%REACTOME%R-HSA-8948747.2,0.7137832204273058,0.898267902818609,-0.26453010478482997,-0.7957713048729169,5478,9,XIAP|UBC
AMPLIFICATION OF SIGNAL FROM UNATTACHED KINETOCHORES VIA A MAD2 INHIBITORY SIGNAL%REACTOME DATABASE ID RELEASE 66%141444,0.0201514568091388,0.195205495598712,-0.249317789759503,-1.54712214519081,156,91,NUF2|NSL1|SPDL1|CDC20|DYNC1H1|CLIP1|DSN1|CENPM|NUDC|CENPI|MAD2L1|KNTC1|ERCC6L|DYNLL2|INCENP|NUP85|NDC80|SGOL1|KIF18A|SEC13|NUP37|CKAP5|CENPH|SPC25|NUP160|KIF2A|PLK1|SKA1|PPP2CA|SPC24|DYNC1I1|BIRC5|CENPK|CENPP|SKA2
FORMATION OF FIBRIN CLOT (CLOTTING CASCADE)%REACTOME DATABASE ID RELEASE 66%140877,0.0013125082031762699,0.0285255227727063,-0.517350093701137,-2.1076880068344797,9,21,F12|F10|PRCP|GP1BA|GP1BB|VWF|F3|F8|THBD|F2R|SERPINE2|A2M|F13A1|TFPI|SERPING1
RET SIGNALING%REACTOME DATABASE ID RELEASE 66%8853659,0.16371077762619402,0.5351003413847161,0.269499535100608,1.2704067433786699,1199,32,RET|IRS2|GAB1|GAB2|DOK1|MAPK7|GFRA1|SHC1|SOS1
NUCLEOBASE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%8956320,0.26056338028168996,0.636316525692816,0.319163188581289,1.17726143860927,1923,15,PFAS|PAICS|CAD|ADSL|ATIC|PPAT|DHODH
INTRACELLULAR SIGNALING BY SECOND MESSENGERS%REACTOME%R-HSA-9006925.2,0.00153668843641952,0.0322140470829666,-0.210981803740835,-1.6102086514523999,11,250,SHFM1|PRKAR1A|IRS1|PSME2|PSMB5|SNAI2|PIK3CB|FGF10|MAPK3|RHOG|RBBP7|ADCY4|CBX4|IRAK1|PIK3R3|TNRC6C|HDAC5|PDE1C|RPTOR|PDE1A|PSMC4|CBX6|HBEGF|PSMC6|IL33|PSMD10|CD86|PDE1B|PSMB3|PPP2CA|FGF19|RING1|FGF9|FGF7|PSMC1|XIAP|PSMD2|UBC|PDGFRB|PSMD6|SNAI1|PPARG|MTA2|PRKACA|PSMD12|PSMA3|ADRBK1|PDGFRA|PSMA6|MAPKAP1|PSMD13|PSMB7|SLC38A9|PSMA1|RPS6KB2|PDGFB|PSMC5|PSMC3|ADCY9|BAD|RRAGD
HIV INFECTION%REACTOME DATABASE ID RELEASE 66%162906,0.00012868356710848,0.00518555396908895,-0.27868524505368,-2.0714286484518896,0,217,TSG101|AP2A2|RANBP1|NCBP2|CD4|GTF2A2|POLR2J|PACS1|PPIA|TAF3|PSMD3|PSMB2|UBAP1|KPNB1|NPM1|CCNK|PSMF1|HLA-A|GTF2A1|TAF12|NMT1|SUPT16H|NUP188|SLC25A6|CXCR4|PSMD4|ELMO1|SHFM1|NCBP1|PSME2|NUP85|PSMB5|POLR2H|RCC1|GTF2H1|TAF7|MVB12B|SKP1|NUP37|ARF1|RAN|PSMC4|TAF9B|PSMC6|NUP160|NELFB|PSMD10|CDK7|PSMB3|AP1B1|HCK|NUP214|CHMP4A|PSMC1|CHMP6|PSMD2|UBC|MNAT1|SLC25A4|PSMD6|TAF10|POLR2G|SUPT4H1|PSMD12|PSMA3|TAF9|PSMA6|SSRP1|VPS37C|PSMD13|PSMB7|PSMA1|AK6|BANF1|PSMC5|AP2M1|PSMC3|FEN1|POLR2L|GTF2H2|SLC25A5
M PHASE%REACTOME%R-HSA-68886.2,0.000128287363694676,0.00518555396908895,-0.276925232576596,-2.2221171436837004,0,339,LEMD3|ESPL1|HIST2H2AC|OFD1|HIST1H2AD|CEP70|TUBGCP2|PSMD3|PSMB2|TUBG2|CENPM|CDC23|SETD8|STAG2|TUBA4A|NUDC|HIST1H2BN|H2AFV|SDCCAG8|PSMF1|PTTG1|HAUS8|CENPI|CDK5RAP2|MAD2L1|HIST1H2BC|NCAPH2|NUP188|KNTC1|PSMD4|KIF20A|NEK9|SHFM1|ERCC6L|PSME2|DYNLL2|HIST1H4I|LMNB1|INCENP|NUP85|PSMB5|NDC80|SGOL1|ENSA|KIF18A|CEP131|CDC27|SEC13|NUP37|CKAP5|CENPH|TUBB4A|PSMC4|SMC4|HIST2H3A|SPC25|PSMC6|NUP160|PSMD10|KIF2A|CCNB1|PLK1|SKA1|PSMB3|PPP2CA|NUP214|H2AFZ|PSMC1|RAB1B|SPC24|PSMD2|UBC|HIST2H2AA4|PSMD6|HIST1H2BG|LPIN3|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|SSNA1|SMC1A|PRKACA|CETN2|HIST1H3H|PSMD12|PSMA3|HSP90AA1|CEP63|VRK1|DYNC1I1|BIRC5|NEK6|HIST2H4B|ANAPC11|CENPK|H3F3B|HIST1H2AC|PSMA6|TUBB4B|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|EMD|H2AFJ|CDCA5|HIST1H2BK|LPIN2|PSMA1|DCTN3|BANF1|HAUS7|PSMC5|HIST1H2BJ|PSMC3|PRKCB|HIST2H2AA3|CENPP|SKA2
DNA REPAIR%REACTOME DATABASE ID RELEASE 66%73894,0.00704315533358945,0.10102825149798,-0.18964397450689896,-1.48413695464024,54,291,RAD51AP1|RAD1|RAD17|BRCC3|PCNA|COPS6|VCP|HIST1H2BC|POLD1|SLX1B|RHNO1|SUMO2|SLX1A|RNF168|HIST1H4I|PARP2|POLD2|BRCA1|STRA13|KIAA0101|RFC5|TOPBP1|POLQ|EME1|POLR2H|ISG15|TFPT|GTF2H1|ABL1|FAAP100|RMI1|RAD23B|DTL|NPLOC4|RAD51B|RCHY1|INO80E|SUMO3|KPNA2|CDK7|RMI2|UBC|PPP4C|MNAT1|HIST1H2BG|FANCM|HIST1H2BD|ERCC8|HIST2H4A|APBB1|DDB1|POLR2G|CETN2|KAT5|ISY1|POLE2|APEX1|ACTB|POLE3|HIST2H4B|GPS1|UBE2L6|RFC4|MUS81|HIST3H2BB|HIST2H2BE|HIST1H2BK|XRCC3|HIST1H2BJ|XPA|FEN1|ALKBH3|POLR2L|PRPF19|GTF2H2
MET RECEPTOR RECYCLING%REACTOME%R-HSA-8875656.1,0.27177177177177203,0.646576786621306,0.383339648707188,1.1649338370083602,1990,9,MET|GAB1|CRK|RAB4B
LOSS OF MECP2 BINDING ABILITY TO THE NCOR SMRT COMPLEX%REACTOME%R-HSA-9022537.1,0.0625763540111307,0.359087664164358,0.5935138712701999,1.53575202584432,460,6,NCOR1|GPS2|TBL1XR1|TBL1X|NCOR2|HDAC3
TRAF6 MEDIATED IRF7 ACTIVATION%REACTOME%R-HSA-933541.4,0.9184825413494359,0.9761906972716509,-0.17156562450234197,-0.622926971990156,6996,15,TRAF2|IKBKE|IFIH1|IRF7
SIGNALING BY RETINOIC ACID%REACTOME%R-HSA-5362517.2,0.43658503215214095,0.7629296947843841,0.211151267931546,1.0130529203053,3190,34,CRABP1|RARG|PPARD|CRABP2|ALDH8A1|DLAT|ALDH1A3|CPT1B|RDH14|RARB|RXRB|CPT1A|DLD
HIV ELONGATION ARREST AND RECOVERY%REACTOME%R-HSA-167287.3,0.47223670490093894,0.7831522581932591,-0.212963611077591,-0.9906227679194841,3622,32,POLR2J|CCNK|SUPT16H|POLR2H|NELFB|POLR2G|SUPT4H1|SSRP1|POLR2L
NEF-MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS%REACTOME%R-HSA-164938.1,0.255224076751216,0.633888112639005,-0.297993519216324,-1.17734459407983,1941,19,CD8B|ATP6V1H|AP2A1|AP1S3|AP1S2|B2M|AP2A2|CD4|PACS1|HLA-A|ARF1|AP1B1|AP2M1
BETA-OXIDATION OF VERY LONG CHAIN FATTY ACIDS%REACTOME DATABASE ID RELEASE 66%390247,0.821741977734119,0.9407485755049599,-0.27700483753566496,-0.712531063396193,6273,6,ABCD1
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS%REACTOME%R-HSA-1971475.1,0.20509138381201003,0.5851419434522471,-0.29328247880665104,-1.2313703923740802,1570,23,DCN|SDC4|BGN|VCAN|B4GALT7|SDC2|B3GAT3|B3GALT6|XYLT2
DEFECTS IN VITAMIN AND COFACTOR METABOLISM%REACTOME%R-HSA-3296482.1,0.9968536969061351,0.9992386811371659,-0.12285369203848699,-0.4346383970805421,7603,14,MCCC2|PCCB
VPR-MEDIATED INDUCTION OF APOPTOSIS BY MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION%REACTOME DATABASE ID RELEASE 66%180897,0.0144179894179894,0.16079417073357402,-0.8353369361420541,-1.6312013210093002,108,3,SLC25A6|SLC25A4|SLC25A5
NS1 MEDIATED EFFECTS ON HOST PATHWAYS%REACTOME DATABASE ID RELEASE 66%168276,0.590660770031218,0.8417378833576942,-0.190221285463121,-0.908103683938437,4540,35,KPNB1|NUP188|NUP85|ISG15|KPNA4|NUP37|NUP160|KPNA2|NUP214|PABPN1
TGFBR2 MSI FRAMESHIFT MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3642279,0.253250198991775,0.632257972333528,-0.7057071960297769,-1.1744096252590701,1908,2,TGFB1|TGFBR2
SIGNALING BY FGFR4%REACTOME%R-HSA-5654743.2,0.241656450074922,0.625158460820442,0.257419176987092,1.17811186874557,1773,29,GAB1|RPS27A|FGF2|SPRY2|FRS3|SOS1|CBL|PLCG1|NRAS|PPP2CB|FGF1|MAPK1|KRAS
NCAM SIGNALING FOR NEURITE OUT-GROWTH%REACTOME%R-HSA-375165.2,0.19477989871445303,0.569626484656312,-0.236704696982015,-1.21674371058475,1499,45,CACNA1G|MAPK3|COL4A1|HRAS|COL4A2|COL6A3|COL6A1|CACNA1I|SPTBN2|COL6A2|PRNP
IKBKB DEFICIENCY CAUSES SCID%REACTOME DATABASE ID RELEASE 66%5602636,0.8445873526259381,0.948285501480553,0.424317617866005,0.71290838388017,6303,2,IKBKG|CHUK
TOLL LIKE RECEPTOR 2 (TLR2) CASCADE%REACTOME DATABASE ID RELEASE 66%181438,0.708124759337697,0.89516234575314,-0.138913877247169,-0.85981773141223,5516,90,MAPKAPK2|MEF2C|SOCS1|MAPK9|MAPK3|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|CD36|UBC|RELA|NFKB1|TLR4|CD14|LY96|PELI3
ACTIVATION OF NA-PERMEABLE KAINATE RECEPTORS%REACTOME%R-HSA-451307.2,0.5697967857617211,0.8324048186805392,0.7130017644464051,0.9506916455246021,4289,1,GRIK2
GLYCOGEN METABOLISM%REACTOME DATABASE ID RELEASE 66%8982491,0.44848248013547,0.768229288546963,-0.23217900149771803,-1.00095620852938,3442,25,EPM2A|GYG1|GAA|PHKG2|PHKA1|PPP1R3C|UBC|PYGL|PYGM|GYG2
ALPHA-LINOLENIC ACID (ALA) METABOLISM%REACTOME DATABASE ID RELEASE 66%2046106,0.0461095100864553,0.30746333312705,-0.487579483704307,-1.57856481124435,351,11,ELOVL2|ELOVL1|ABCD1|FADS1|FADS2
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION%REACTOME%R-HSA-948021.2,0.000769428058476533,0.0191058847417112,-0.25287433890068,-1.7652104066888898,5,155,SERPINA1|DYNLL2|BET1L|F8|SEC13|KDELR2|SEC24A|ARFGAP2|COPB2|PPP6R3|CNIH2|ARF1|KDELR1|CNIH1|COPB1|TMED2|CTSZ|FUCA1|DCTN5|CTSC|RAB1B|NSF|CD59|B4GALT1|COG1|STX5|KDELR3|CNIH3|TMED10|LMAN2|TRAPPC2|SEC22A|TMED9|GOSR2|DYNC1I1|SPTBN2|CD55|COPG1|PPP6C|SAR1B|COPZ2|DCTN3|GRIA1
CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION%REACTOME%R-HSA-109688.2,0.00193348801237432,0.0383938788644259,-0.326124658128055,-1.85197055724912,14,64,CPSF1|SNRPE|LSM11|SRSF3|FYTTD1|NCBP2|SLU7|CHTOP|SRSF9|LSM10|MAGOH|CPSF2|SRSF5|SNRPF|SRSF1|U2AF1|PAPOLA|NCBP1|CLP1|CSTF3|THOC7|MAGOHB|EIF4A3|SNRPB|PABPN1|SRSF2|RBM8A|DDX39A|THOC3|CPSF7
BREAKDOWN OF THE NUCLEAR LAMINA%REACTOME%R-HSA-352238.2,0.0477580260015919,0.312864188533372,-0.856299972429005,-1.4250200867829401,359,2,LMNB1|CASP6
SYNTHESIS OF PG%REACTOME%R-HSA-1483148.2,0.18614944024993502,0.559093571852282,-0.44468492010297606,-1.2801856466791999,1429,8,PLD4|PLD1|PLD3|PTPMT1
PEPTIDE CHAIN ELONGATION%REACTOME DATABASE ID RELEASE 66%156902,0.7702599388379209,0.9213545359508709,-0.13344065904254698,-0.8207688915282909,6044,87,RPS28|RPLP1|RPS18|RPL9|RPL28|RPS3|RPS5|EEF2|RPS10|RPS15|RPL29|RPL11|RPS6|RPL36|RPL17|RPL32|RPL39L|RPL23|RPLP0|RPL10A|RPL8|RPS23|RPL3|RPL7A|RPS2|RPL15|RPL37|RPL27A|RPL18|RPL39|RPL27|RPLP2|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|RPL35|RPL38|RPS15A|RPL36AL|RPS13|RPL26L1|FAU
CASP8 ACTIVITY IS INHIBITED%REACTOME%R-HSA-5218900.1,0.45661803022407504,0.7715177634181241,-0.329655564159647,-0.991684627590198,3504,9,TNFRSF10A|TNFRSF10B|TRAF2|TNFSF10|FADD
ACTIVATION OF THE PRE-REPLICATIVE COMPLEX%REACTOME%R-HSA-68962.3,0.00391032325338895,0.0679526373550623,-0.39800501475992894,-1.8513624340435701,29,32,POLE4|PRIM2|POLE|RPA2|MCM10|CDT1|MCM4|MCM6|CDC6|GMNN|ORC1|ORC6|MCM3|MCM5|CDC45|MCM2|POLE2|POLA1|POLE3|POLA2
PROTEIN METHYLATION%REACTOME%R-HSA-8876725.2,0.8204675183473771,0.940031154277066,0.191242864383571,0.720092811176487,6036,16,METTL21A|N6AMT2
GP1B-IX-V ACTIVATION SIGNALLING%REACTOME%R-HSA-430116.1,0.0985804416403785,0.433390687254715,-0.525779766975386,-1.43719554621321,749,7,GP1BA|GP1BB|VWF|FLNA
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES%REACTOME DATABASE ID RELEASE 66%380270,0.41558608293747606,0.7493091022753771,-0.17104541472946302,-1.0211099667919101,3236,78,HAUS1|NDE1|TUBG1|CEP72|HAUS6|TUBGCP5|CEP78|HAUS4|CEP76|CSNK1D|MZT2A|CEP192|PCNT|NEK2|NEDD1|DYNC1H1|OFD1|CEP70|TUBGCP2|TUBG2|TUBA4A|SDCCAG8|HAUS8|CDK5RAP2|CEP131|CKAP5|TUBB4A|PLK1|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
INTRA-GOLGI TRAFFIC%REACTOME DATABASE ID RELEASE 66%6811438,0.841150557139155,0.9476390732504458,-0.147032357159227,-0.7409135612347489,6491,42,COG2|VTI1A|NAPG|SNAP29|MAN1A1|MAN1C1|CYTH4|GOLGA5|YKT6|COG4|NAPA|CYTH3|TRIP11|BET1L|CYTH1|ARF1|NSF|COG1|STX5|GOSR2
INTESTINAL HEXOSE ABSORPTION%REACTOME%R-HSA-8981373.1,0.8445484949832779,0.948285501480553,-0.580999117776798,-0.7740303309939169,6312,1,SLC2A5
PASSIVE TRANSPORT BY AQUAPORINS%REACTOME%R-HSA-432047.1,0.48512430376307597,0.7872939093021379,0.43890264704457593,0.964287807384381,3570,4,AQP5|AQP11
REGULATION OF INSULIN SECRETION%REACTOME DATABASE ID RELEASE 66%422356,0.132148377125193,0.491948396065839,-0.22058652316241398,-1.28565725014988,1025,71,PLCB1|GNG8|ITPR2|PLCB3|ITPR3|SLC2A1|INS|ADCY8|SLC25A6|PRKAR1A|AKAP5|GNGT2|RAPGEF3|GNG11|GNAI2|GNAQ|CACNA1E|RAP1A|GNA15|GNG10|ADRA2C|ARL2|SLC25A4|PRKACA|GNG3|SLC25A5
PKMTS METHYLATE HISTONE LYSINES%REACTOME%R-HSA-3214841.3,0.0551768488745981,0.34147376465329604,-0.26923626622432395,-1.4598761533226001,428,54,HIST4H4|SMYD3|AEBP2|HIST1H3D|EHMT1|ATF7IP|HIST1H4H|RBBP5|SETD3|SETD1B|NFKB2|EZH2|NSD1|SETD8|HIST1H4I|SETD1A|RBBP7|WDR5|HIST2H3A|SUV420H1|HIST2H4A|HIST2H3C|RELA|NFKB1|HIST1H3H|HIST2H4B|SUV39H1
CILIUM ASSEMBLY%REACTOME%R-HSA-5617833.3,0.00013896609227348502,0.00526859796630401,0.29549382288490994,2.1506361461122703,0,181,EXOC4|DYNLRB2|DYNC2H1|NPHP1|CC2D2A|DYNC1I2|TTC30B|WDR19|TTC21B|DYNC2LI1|BBS5|BBS12|IFT88|TTC30A|WDR35|CEP162|NPHP3-ACAD11|BBS4|CLASP1|BBIP1|TMEM67|SFI1|IFT46|IFT172|AHI1|FGFR1OP|ARL3|IFT20|MCHR1|NINL|CEP89|IFT140|KIF3B|SEPT2|CLUAP1|TTC8|RPGRIP1L|IFT81|PKD1|TTBK2|CEP164|TNPO1|WDR60|PCM1|CEP290|MARK4|PDE6D|TCTN2|RAB11FIP3|CEP57|MKKS|B9D1|NPHP4|NPHP3|PKD2|IFT52|RAB11A|CEP250|DCTN2|YWHAE|TRAF3IP1|KIF3C|LZTFL1|IFT27|BBS2|EXOC1|BBS7|B9D2|HAUS2|TCTE3
SYNTHESIS OF IPS IN THE ER LUMEN%REACTOME DATABASE ID RELEASE 66%1855231,0.807012883517067,0.933810206759044,0.59660344067049,0.795490186727723,6075,1,MINPP1
RUNX3 REGULATES NOTCH SIGNALING%REACTOME DATABASE ID RELEASE 66%8941856,0.183009963293131,0.556308895147568,-0.35897415825116097,-1.2699980777683302,1395,14,JAG1|RUNX3|HES1|NOTCH1|SNW1|KAT2B|MAML1
G ALPHA (12 13) SIGNALLING EVENTS%REACTOME%R-HSA-416482.4,0.17629179331307002,0.548366806412612,0.206097783509404,1.21723865664934,1275,71,ARHGEF33|GNG5|RHOC|ABR|PLXNB1|OBSCN|TIAM2|GNGT1|FGD4|ARHGEF7|MCF2L|VAV2|GNB5|GNB4|SOS1|AKAP13|ARHGEF4|PLEKHG5
REGULATION OF GENE EXPRESSION IN ENDOCRINE-COMMITTED (NEUROG3+) PROGENITOR CELLS%REACTOME DATABASE ID RELEASE 66%210746,0.0787621198034268,0.39324071934415206,0.9613475959417729,1.28182730181126,592,1,INSM1
POLO-LIKE KINASE MEDIATED EVENTS%REACTOME%R-HSA-156711.2,0.0121664050235479,0.145478580212979,-0.479996287556032,-1.78385206264121,92,16,CENPF|RBBP4|CDC25A|WEE1|CCNB2|LIN54|LIN52|PKMYT1|CDC25C|LIN9|FOXM1|MYBL2|CCNB1|PLK1
METAL SEQUESTRATION BY ANTIMICROBIAL PROTEINS%REACTOME%R-HSA-6799990.1,0.004510480233483679,0.0743264309917645,-0.9585332230493521,-1.59515256414114,33,2,S100A8|S100A9
UBIQUINOL BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%2142789,0.111950013017443,0.459194647507502,-0.48876626934431605,-1.4070896814999598,859,8,COQ6|COQ7|PDSS1|COQ3
CONSTITUTIVE SIGNALING BY NOTCH1 HD+PEST DOMAIN MUTANTS%REACTOME DATABASE ID RELEASE 66%2894862,0.8037113402061858,0.932964969466025,0.140937546244198,0.7829478883872808,5846,56,DLL1|HDAC11|ADAM17|RPS27A|HDAC1|NCOR1|PSENEN|HDAC10|TBL1XR1|HDAC4|PSEN2|APH1B|MAML2|MAML3|TBL1X|MAMLD1|ADAM10|EP300|HDAC6|HDAC2|CDK8|MIB2|HEY2
SUMOYLATION%REACTOME%R-HSA-2990846.2,0.0874148348116725,0.408874392525297,-0.183654424926318,-1.28447236934208,679,157,RORA|TOP1|NDNL2|STAG2|CDKN2A|NPM1|PCNA|TOP2A|IKBKE|NUP188|SENP2|SENP5|SUMO2|RNF168|HIST1H4I|PARK7|INCENP|BRCA1|NUP85|ZBED1|DDX5|DNMT1|CBX4|NUP37|HIC1|SUMO3|NUP160|MITF|NFKBIA|RING1|NUP214|HNRNPK|HIST2H4A|PPARG|PPARA|RELA|SMC1A|CETN2|NSMCE1|BIRC5|HIST2H4B|EID3|HNRNPC
RUNX3 REGULATES WNT SIGNALING%REACTOME DATABASE ID RELEASE 66%8951430,0.47865139286644104,0.7850984235874658,-0.338122740056834,-0.9734080448160041,3676,8,MYC|CCND1
SUMOYLATION OF TRANSCRIPTION COFACTORS%REACTOME DATABASE ID RELEASE 66%3899300,0.999611046285492,0.999671409271379,-0.078118188098665,-0.3912241063244,7709,41,PIAS1|ZNF350|TOPORS|PCGF2|CREBBP|CBX2|PHC3|PHC2|TRIM28|NPM1|SUMO2|PARK7|DDX5|CBX4|SUMO3|RING1
CALCINEURIN ACTIVATES NFAT%REACTOME%R-HSA-2025928.1,0.5922936735225199,0.8417378833576942,-0.307594484055648,-0.8855214685367471,4549,8,PPP3CA|NFATC3|NFATC2|PPIA|NFATC1|FKBP1A
COPI-MEDIATED ANTEROGRADE TRANSPORT%REACTOME DATABASE ID RELEASE 66%6807878,0.00140899193031894,0.0301860198914787,-0.31049204717759804,-1.8663087640190699,10,80,ACTR10|DCTN4|DYNC1H1|SPTBN5|YKT6|TMED7|COG4|TMEM115|SPTBN4|NAPA|INS|DYNLL2|BET1L|KDELR2|ARFGAP2|COPB2|ARF1|KDELR1|COPB1|TMED2|DCTN5|RAB1B|NSF|CD59|COG1|STX5|KDELR3|TMED10|TMED9|GOSR2|DYNC1I1|SPTBN2|CD55|COPG1|COPZ2|DCTN3
PHOSPHORYLATION OF EMI1%REACTOME DATABASE ID RELEASE 66%176417,0.34983628028814695,0.7075366679683229,-0.42308680229288,-1.08829322920336,2670,6,CDC20|CCNB1|PLK1
ACYL CHAIN REMODELLING OF PG%REACTOME%R-HSA-1482925.1,0.0209588682211161,0.199767280220222,-0.532121394452282,-1.72277164373483,159,11,PLA2G2A|PLA2G2D|PLA2R1|PLA2G4D|PLA2G4A|PLA2G12A
NICOTINATE METABOLISM%REACTOME%R-HSA-196807.3,0.38007043172036,0.729249457747391,-0.23965306252678897,-1.05698708769694,2913,27,NMNAT3|QPRT|NNMT|PTGIS
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE%REACTOME%R-HSA-110313.1,0.0210280373831776,0.200061313056718,-0.33490306103072603,-1.6390012081341,161,38,SPRTN|POLE|RFC2|RPA2|RFC3|POLD4|PCNA|VCP|POLD1|POLD2|KIAA0101|RFC5|ISG15|NPLOC4|RCHY1|UBC|POLE2|POLE3|UBE2L6|RFC4
PI3K CASCADE%REACTOME DATABASE ID RELEASE 66%109704,0.22860492379835895,0.610365144973336,-0.27852618783517896,-1.20076542302807,1754,25,IRS1|PIK3CB|FGF10|PIK3R4|FGF19|FGF9|FGF7|FLT3LG
HYPUSINYLATION%REACTOME DATABASE ID RELEASE 66%204626,0.0972693927455509,0.43014109833353004,0.6490890797590899,1.42607635140207,715,4,DOHH|EIF5A2|DHPS|EIF5A
SIGNALING BY ERBB2%REACTOME DATABASE ID RELEASE 66%1227986,0.143053267435475,0.509375437970093,0.251835563434895,1.28723128495872,1041,42,GAB1|RPS27A|PTPN12|PRKCE|SHC1|SOS1|STUB1|PRKCA|PTPN18|PLCG1|NRAS|AKT3|CUL5|CDC37|EGFR|SRC|RNF41|KRAS|ERBB2|MEMO1|USP8|YES1|UBA52|PIK3CA|PRKCD|DIAPH1
TBC RABGAPS%REACTOME DATABASE ID RELEASE 66%8854214,0.3615888615888621,0.716154857259883,0.207835075772409,1.07058569694366,2648,43,TSC2|TBC1D2|TBC1D14|GABARAP|TBC1D17|TBC1D16|GGA1|MAP1LC3B|TBC1D7|TBC1D20|RAB33B|RAB11B|RAB11A|RAB6A
CLASS A 1 (RHODOPSIN-LIKE RECEPTORS)%REACTOME DATABASE ID RELEASE 66%373076,0.00293667007150153,0.0541257446671854,-0.25017977425809396,-1.690866442088,22,132,FPR1|C3|CXCR4|POMC|TAC1|SST|OXER1|PTGER4|LTB4R|S1PR1|PROKR1|TBXA2R|NLN|PYY|CYSLTR2|CHRM2|CCRL2|P2RY6|CXCL16|GPER1|HCRT|F2R|EDNRB|CCR1|INSL3|APLNR|F2RL3|HEBP1|ADRA2C|HTR1B|CX3CL1|PTAFR|C3AR1|GPR4|PTGIR|CMKLR1|ANXA1|XK|SSTR2|C5AR1|ACKR1
DUAL INCISION IN TC-NER%REACTOME DATABASE ID RELEASE 66%6782135,0.0130154639175258,0.151262524868873,-0.29112102782771004,-1.6600299221655601,100,65,POLE|POLR2C|RFC2|CUL4B|RPA2|RFC3|HMGN1|POLR2J|POLD4|PCNA|POLD1|POLD2|RFC5|POLR2H|GTF2H1|CDK7|UBC|MNAT1|ERCC8|DDB1|POLR2G|ISY1|POLE2|POLE3|RFC4|XPA|POLR2L|PRPF19|GTF2H2
ACTIVATION OF THE TFAP2 (AP-2) FAMILY OF TRANSCRIPTION FACTORS%REACTOME DATABASE ID RELEASE 66%8866907,0.6603876603876601,0.87816605457524,0.274805409955769,0.8351082955547849,4837,9,CITED1|TFAP2B|CITED2|EP300|TFAP2E
ACTIVATION OF C3 AND C5%REACTOME DATABASE ID RELEASE 66%174577,0.0248853962017027,0.22169287062743304,-0.6422302300799761,-1.65198915966638,189,6,C4B|C4A|C2|C3|CFB
SCF(SKP2)-MEDIATED DEGRADATION OF P27 P21%REACTOME DATABASE ID RELEASE 66%187577,0.00012950012950013,0.00518555396908895,-0.392868777640545,-2.18258646050733,0,59,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|CCND1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
RNA POL II CTD PHOSPHORYLATION AND INTERACTION WITH CE DURING HIV INFECTION%REACTOME DATABASE ID RELEASE 66%167160,0.11647319681753,0.46625878958064004,-0.30693660062273903,-1.35374036191823,892,27,POLR2H|GTF2H1|CDK7|MNAT1|POLR2G|POLR2L|GTF2H2
ACTIVATION OF CASPASES THROUGH APOPTOSOME-MEDIATED CLEAVAGE%REACTOME%R-HSA-111459.2,0.5716409840497428,0.833854868733934,0.37152474758873605,0.8935148874381429,4228,5,CASP9|APAF1|CASP3|CASP7
COHESIN LOADING ONTO CHROMATIN%REACTOME DATABASE ID RELEASE 66%2470946,0.9676366603209141,0.9912626134248801,0.17457366801448498,0.553061180593714,7115,10,PDS5B|PDS5A|MAU2
XBP1(S) ACTIVATES CHAPERONE GENES%REACTOME DATABASE ID RELEASE 66%381038,0.0860450160771704,0.4057980029059221,-0.255050848813497,-1.38295875696509,668,54,SEC62|TSPYL2|HDGF|MYDGF|SEC61G|TLN1|ATP6V0D1|TPP1|WIPI1|LMNA|PDIA5|SRPRB|SYVN1|SEC61A1|SEC61B|SSR1|KDELR3|GOSR2|DNAJB11|SERP1|YIF1A
NEGATIVE REGULATION OF MET ACTIVITY%REACTOME DATABASE ID RELEASE 66%6807004,0.532169117647059,0.812079525085925,-0.234904854249224,-0.942433776013322,4052,20,SH3GL1|HGS|HGF|SH3GL2|LRIG1|UBC|PTPRJ|SH3GL3
AURKA ACTIVATION BY TPX2%REACTOME%R-HSA-8854518.3,0.23430638078016003,0.6181066955939499,-0.200570531896724,-1.16463336324576,1813,70,HAUS1|NDE1|TUBG1|CEP72|HAUS6|AURKA|CEP78|HAUS4|CEP76|CSNK1D|CEP192|PCNT|NEK2|NEDD1|DYNC1H1|OFD1|CEP70|TPX2|TUBA4A|SDCCAG8|HAUS8|CDK5RAP2|CEP131|CKAP5|TUBB4A|PLK1|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
MITOCHONDRIAL FATTY ACID BETA-OXIDATION OF UNSATURATED FATTY ACIDS%REACTOME DATABASE ID RELEASE 66%77288,0.0274398486077318,0.23409664586741,0.694780536401098,1.6709432058179798,202,5,HADHB|HADHA|ACADM|ECI1
G2 M DNA REPLICATION CHECKPOINT%REACTOME%R-HSA-69478.2,0.36349289847448707,0.717981693238167,-0.45022730876401396,-1.0791089478293001,2763,5,WEE1|CCNB2|PKMYT1|CCNB1
RESOLUTION OF AP SITES VIA THE MULTIPLE-NUCLEOTIDE PATCH REPLACEMENT PATHWAY%REACTOME DATABASE ID RELEASE 66%110373,0.00729451608701316,0.103163519143488,-0.431171374189035,-1.8588402101423502,55,25,POLE|RFC2|RPA2|RFC3|PARP1|POLD4|PCNA|POLD1|PARP2|POLD2|RFC5|POLE2|APEX1|POLE3|RFC4|FEN1
ERK1 ERK2 PATHWAY%REACTOME%R-HSA-5684996.3,0.00484508478898381,0.0776010146908712,-0.214960846629263,-1.5791431464473,37,200,CSF2RB|PSMD4|VWF|SHFM1|IRS1|PSME2|IL2RA|ARRB1|PSMB5|FGF10|MAPK3|CAMK2B|HRAS|PSMC4|HBEGF|PSMC6|CSF2RA|PSMD10|RAP1A|FN1|IL3RA|PSMB3|PPP2CA|FGF19|FGF9|TEK|MAP3K11|GRIN2C|FGF7|PSMC1|VCL|ARAF|DLG3|PEA15|PSMD2|UBC|PDGFRB|GRIN2D|PSMD6|CAMK2A|FLT3LG|PSMD12|PSMA3|PDGFRA|SPTBN2|PHB|PSMA6|PSMD13|PSMB7|PSMA1|PDGFB|PSMC5|PSMC3
THE CITRIC ACID (TCA) CYCLE AND RESPIRATORY ELECTRON TRANSPORT%REACTOME%R-HSA-1428517.1,0.000256476019492177,0.00819882332206558,-0.266599396551559,-1.8950112689972702,1,169,COX4I1|UQCR11|MT-CO2|SLC16A1|ME3|ETFDH|PDK4|NDUFAF5|DLST|ATP5C1|COX7C|CYC1|GLO1|TIMMDC1|COX11|NDUFC2|NDUFAF4|L2HGDH|VDAC1|NDUFV2|NDUFB8|SDHC|NDUFS4|COX6C|SLC25A27|UQCRC1|NDUFB5|SURF1|UQCR10|NDUFA11|NDUFA9|ATP5J|SCO2|NDUFA7|ATP5F1|FH|SDHB|PDHA1|NDUFA3|NDUFB6|ATP5B|SDHD|NDUFAF3|CYCS|IDH3G|NDUFB9|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|COX16|NDUFS6|NDUFB4|PDK3|COX7B|NDUFA12|LDHA|NDUFA2|NDUFAB1|NDUFA1|PDHX|NDUFB11|NDUFA4|ATP5H|NDUFV1|UQCRQ|NDUFAF2|MPC1|NDUFS3|TACO1|UQCRC2|COX6A1|COX8A|NDUFA8|NDUFS8|ATP5G1|ETFB|NDUFV3
RECYCLING OF EIF2:GDP%REACTOME%R-HSA-72731.2,0.0758916948711273,0.38531099082072706,-0.5198727346386579,-1.49664084140779,582,8,EIF2B5|EIF2S3|EIF2B1|EIF2S1|EIF2B2|EIF2B3
FGFR2B LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190377,0.667477696674777,0.88092952466726,0.3419547882386789,0.8223993047705149,4937,5,FGF2|FGFBP3|FGF1
TRANSLESION SYNTHESIS BY POLI%REACTOME DATABASE ID RELEASE 66%5656121,0.799816825853722,0.931670998922663,-0.195520808916387,-0.7430268193231792,6112,17,RFC2|RPA2|RFC3|PCNA|RFC5|UBC|RFC4
ACTIVATION OF AMPA RECEPTORS%REACTOME%R-HSA-399710.1,0.16679894179894197,0.53917243184018,-0.663512756041978,-1.29567224593327,1260,3,GRIA1
DNA REPLICATION%REACTOME DATABASE ID RELEASE 66%69306,0.000127665007021575,0.00518555396908895,-0.36648366014137296,-2.44636117805906,0,124,PSMD1|MCM10|PSMC2|ANAPC10|RFC3|CDT1|MCM4|ANAPC2|MCM6|ANAPC5|GINS2|CDC6|PSMD3|PSMB2|CDC23|POLD4|PSMF1|E2F2|PCNA|GMNN|ORC1|ORC6|PSMD4|POLD1|MCM3|SHFM1|PSME2|MCM5|CDC45|POLD2|PSMB5|RFC5|GINS1|CDC27|SKP1|E2F1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|MCM2|PSMD6|PSMD12|PSMA3|POLE2|POLA1|POLE3|ANAPC11|PSMA6|RFC4|PSMD13|PSMB7|PSMA1|POLA2|PSMC5|PSMC3|FEN1
PRE-NOTCH TRANSCRIPTION AND TRANSLATION%REACTOME DATABASE ID RELEASE 66%1912408,0.000128816179312122,0.00518555396908895,-0.443660068956568,-2.5478766492866605,0,67,HIST1H2BE|TFDP2|RUNX1|H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|NOTCH1|HIST1H4I|SNW1|NOTCH2|TNRC6C|E2F1|NOTCH3|HIST2H3A|KAT2B|H2AFZ|HIST2H2AA4|MAML1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|CCND1|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO-FACTORS%REACTOME%R-HSA-6804759.1,0.842677495415248,0.9481593344082329,-0.215092976577288,-0.696375084101417,6432,11,PPP1R13B|PHF20|ZNF385A
SIGNALING BY FGFR%REACTOME DATABASE ID RELEASE 66%190236,0.773137406548079,0.9220082515908941,-0.142074293558249,-0.8068001055857951,5997,64,NCBP1|HNRNPM|POLR2H|FGF10|MAPK3|HRAS|PPP2CA|FGF19|FGF9|FGF7|UBC|POLR2G|POLR2L
HEDGEHOG 'OFF' STATE%REACTOME%R-HSA-5610787.1,0.0337941628264209,0.262384027458207,-0.237444775812825,-1.4829347141310099,263,93,OFD1|NUMB|PSMD3|PSMB2|SMO|PSMF1|ADCY8|PSMD4|SHFM1|PRKAR1A|PSME2|PSMB5|ADCY4|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PRKACA|PSMD12|PSMA3|CSNK1A1|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|ADCY9
CALMODULIN INDUCED EVENTS%REACTOME%R-HSA-111933.1,0.0746600418410042,0.383186929742657,-0.341400286634825,-1.45094159344722,570,24,ADCY8|PRKAR1A|ADCY4|PDE1C|PDE1A|PDE1B|PRKACA|ADRBK1|ADCY9
DEGRADATION OF GLI2 BY THE PROTEASOME%REACTOME DATABASE ID RELEASE 66%5610783,0.000129416332341141,0.00518555396908895,-0.41876999047536,-2.2931221083295297,0,56,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PRKACA|PSMD12|PSMA3|CSNK1A1|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
IL-6-TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS%REACTOME DATABASE ID RELEASE 66%6788467,0.388175144205559,0.735276444766153,-0.297988751860916,-1.0542406280821,2960,14,CLCF1|IL11RA|CNTFR|LIF|CTF1|IL6ST|OSM|IL11|OSMR
SYNTHESIS OF 15-EICOSATETRAENOIC ACID DERIVATIVES%REACTOME%R-HSA-2142770.1,0.24537037037037,0.62804240987169,-0.616742031542958,-1.2043408749780802,1854,3,PTGS2|GPX4|GPX1
REGULATION OF PAK-2P34 ACTIVITY BY PS-GAP RHG10%REACTOME DATABASE ID RELEASE 66%211728,0.706993569131833,0.894949003158309,0.49237269771523706,0.8272497049739191,5276,2,ARHGAP10|PAK2
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY%REACTOME%R-HSA-8939902.1,0.000644496004124775,0.0163600882996276,-0.35535672205540003,-2.01797125781501,4,64,PSMD1|PSMC2|NR3C1|HIVEP3|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|BMP2|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|ESRRA|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
G2 M TRANSITION%REACTOME%R-HSA-69275.5,0.00102145045965271,0.0239606813913718,-0.243177013464563,-1.74338068227012,7,177,TUBG1|PSME1|CCNB2|CEP72|HAUS6|AURKA|PSMB1|TUBGCP5|AJUBA|CEP78|HAUS4|PSMB9|CEP76|CSNK1D|CCNH|MZT2A|RAB8A|FBXL7|LIN54|CEP192|PCNT|NEK2|NEDD1|PSMB4|FBXW11|PSMD1|PSMC2|DYNC1H1|LCMT1|OFD1|CEP70|TUBGCP2|PSMD3|PSMB2|TUBG2|LIN52|TPX2|TUBA4A|PPP2R3B|SDCCAG8|PSMF1|HAUS8|PKMYT1|CDK5RAP2|CDC25C|LIN9|PSMD4|SHFM1|FOXM1|PSME2|PSMB5|CEP131|SKP1|CKAP5|TUBB4A|PSMC4|PSMC6|MYBL2|PSMD10|CCNB1|PLK1|CDK7|PSMB3|PPP2CA|PSMC1|PSMD2|UBC|MNAT1|PSMD6|SSNA1|PRKACA|CETN2|PSMD12|PSMA3|HSP90AA1|CEP63|PSMA6|TUBB4B|PSMD13|PSMB7|PSMA1|DCTN3|HAUS7|PSMC5|PSMC3
APEX1-INDEPENDENT RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY%REACTOME DATABASE ID RELEASE 66%5649702,0.135650527454693,0.498614450236932,0.49569139824682795,1.36834279972548,1002,7,NEIL1|POLB|PNKP|OGG1|NEIL2|LIG3
VOLTAGE GATED POTASSIUM CHANNELS%REACTOME%R-HSA-1296072.1,0.15732934457438097,0.527132257259573,0.30046582809907896,1.2942936041713,1156,24,KCNQ3|KCNS3|KCNQ5|KCNAB3|KCNH8|KCNQ2|KCNG1|KCNC3|KCNC4|KCNB1|KCNH1
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION%REACTOME%R-HSA-164940.1,0.6581552892131322,0.8766757616551658,-0.278182149570051,-0.8368399972312242,5051,9,AP1S3|AP1S2|B2M|PACS1|HLA-A|AP1B1
OXIDATIVE DEMETHYLATION OF DNA%REACTOME DATABASE ID RELEASE 66%5221030,0.452248335823937,0.769943206592495,0.45148424973299295,0.9919301243115841,3328,4,TET2|TET3|TDG
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION%REACTOME%R-HSA-9013695.1,0.0714942830858194,0.3767214120425879,-0.372563429273045,-1.4719633519547901,543,19,HES1|FLT4|NOTCH1|SNW1|NOTCH2|KAT2B|MAML1|ACTA2
MISSPLICED GSK3BETA MUTANTS STABILIZE BETA-CATENIN%REACTOME DATABASE ID RELEASE 66%5339716,0.744946180099764,0.9112137767014771,-0.216311665379097,-0.785392593135168,5674,15,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|CTNNB1|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
CRISTAE FORMATION%REACTOME%R-HSA-8949613.2,0.41338890336024997,0.748061280707938,-0.22361347980961602,-1.03053907345613,3173,31,ATP5J|ATP5F1|CHCHD3|APOO|ATP5B|HSPA9|ATP5O|CHCHD6|ATP5H|ATP5G1
SEMA4D MEDIATED INHIBITION OF CELL ATTACHMENT AND MIGRATION%REACTOME DATABASE ID RELEASE 66%416550,0.477868852459016,0.7850984235874658,0.33431355769625,0.9704537711545129,3497,8,MET|PLXNB1
CHYLOMICRON REMODELING%REACTOME DATABASE ID RELEASE 66%8963901,0.692841251145138,0.8888422672681031,-0.370603599223583,-0.8113287487715559,5293,4,APOC2|APOE
SIGNALING BY NODAL%REACTOME%R-HSA-1181150.1,0.38954514596062495,0.7358910495632479,0.299686231718567,1.04956366420439,2868,13,SMAD3|GDF1|ACVR2A|FOXO3|LEFTY1|ACVR2B|ACVR1B|SMAD2
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION%REACTOME DATABASE ID RELEASE 66%381340,0.138774459320288,0.504314492208813,-0.21335048812989102,-1.2660583431915,1077,76,MED10|CDK4|MED30|CREBBP|TNF|MED26|NCOA6|TGFB1|MED22|MED7|SREBF2|MED13|MED8|KLF4|ANGPTL4|MED1|CEBPD|CEBPA|SMARCD3|CEBPB|MED6|FABP4|ADIRF|CD36|NR2F2|PPARG|PPARA|CCND3|RELA|NFKB1|MED27|MED19|EBF1|ZNF467
ACTIVATED NTRK2 SIGNALS THROUGH PLCG1%REACTOME%R-HSA-9026527.1,0.837622711594588,0.946216977301937,-0.43847732025488795,-0.729696378699552,6313,2,NTRK2
SUMOYLATION OF UBIQUITINYLATION PROTEINS%REACTOME DATABASE ID RELEASE 66%3232142,0.9948165325330791,0.9982558473047859,0.0988141766252212,0.470557791344971,7292,33,NUP88|NUP35|RANBP2|SUMO1|TRIM27|NDC1|NUP43|NUP54|NUPL2|TPR|MDM2|AAAS
"DEFECTIVE CYP11A1 CAUSES ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL (AICSR)%REACTOME%R-HSA-5579026.1",0.228701961838216,0.610365144973336,0.625076516360726,1.22945174379958,1701,3,FDX1L|FDXR|FDX1
THE RETINOID CYCLE IN CONES (DAYLIGHT VISION)%REACTOME%R-HSA-2187335.3,0.0794648829431438,0.395675864829045,-0.9577084252315842,-1.2758975817626799,593,1,DHRS3
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1%REACTOME%R-HSA-418592.2,0.28141754936576396,0.654633920184298,-0.27672947130664194,-1.14600874339442,2151,22,PLA2G4A|GNGT2|GNG11|GNAQ|GNA15|GNG10|GNG3
DEGRADATION OF AXIN%REACTOME DATABASE ID RELEASE 66%4641257,0.000257599175682638,0.00819882332206558,-0.406324752730787,-2.1931656200887097,1,53,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|SMURF2|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
"DEFECTIVE CHST14 CAUSES EDS, MUSCULOCONTRACTURAL TYPE%REACTOME DATABASE ID RELEASE 66%3595174",0.271381794368042,0.646576786621306,-0.45412786351121,-1.1681392006875,2071,6,CSPG4|NCAN|DCN|BGN|VCAN
TCF7L2 MUTANTS DON'T BIND CTBP%REACTOME DATABASE ID RELEASE 66%5339700,0.625235151840903,0.8586548925812421,0.44071909120988206,0.866842444135369,4652,3,CTBP2|TCF7L2|CTBP1
MITOCHONDRIAL FATTY ACID BETA-OXIDATION%REACTOME DATABASE ID RELEASE 66%77289,0.24635111171736498,0.6280519349499749,0.24625739630744398,1.17268938998797,1805,33,HADHB|HADHA|PCCA|ACADVL|ACOT13|ACADM|ACOT9|MCAT|ACOT7|ACAA2|ACAD11|ECI1|ACADS|ECHS1|MECR|THEM4|MCEE
REGULATION OF IFNA SIGNALING%REACTOME DATABASE ID RELEASE 66%912694,0.330151673640167,0.6957352559323989,-0.35217477996853097,-1.1033176125889,2524,10,SOCS3|IFNAR1|SOCS1|PTPN6|USP18
RNA POLYMERASE III TRANSCRIPTION INITIATION%REACTOME%R-HSA-76046.2,0.8891332470892629,0.965159112268525,-0.142409842850405,-0.685743246645662,6872,36,GTF3C4|SNAPC1|POLR2F|POU2F1|GTF3A|GTF3C1|BRF1|ZNF143|BRF2|POLR3B|GTF3C5|POLR2H|POLR3K|BDP1|POLR2L
DIMERIZATION OF PROCASPASE-8%REACTOME DATABASE ID RELEASE 66%69416,0.45661803022407504,0.7715177634181241,-0.329655564159647,-0.991684627590198,3504,9,TNFRSF10A|TNFRSF10B|TRAF2|TNFSF10|FADD
NTF3 ACTIVATES NTRK2 (TRKB) SIGNALING%REACTOME%R-HSA-9025046.1,0.226220735785953,0.608682632875901,-0.8838773709748571,-1.17753688961113,1690,1,NTRK2
TOXICITY OF BOTULINUM TOXIN TYPE F (BONT F)%REACTOME%R-HSA-5250981.1,0.890916463909165,0.965159112268525,0.27183012227718,0.653749885263782,6590,5,SV2C|VAMP1|VAMP2
PLC BETA MEDIATED EVENTS%REACTOME%R-HSA-112043.1,0.20762052877138398,0.587660840366244,-0.244114558310487,-1.20549817297146,1601,39,ITPR2|PLCB3|ITPR3|ADCY8|PRKAR1A|PLA2G4A|ADCY4|PDE1C|PDE1A|GNAI2|PDE1B|PRKACA|ADRBK1|ADCY9
TOLL LIKE RECEPTOR TLR6:TLR2 CASCADE%REACTOME DATABASE ID RELEASE 66%168188,0.708124759337697,0.89516234575314,-0.138913877247169,-0.85981773141223,5516,90,MAPKAPK2|MEF2C|SOCS1|MAPK9|MAPK3|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|CD36|UBC|RELA|NFKB1|TLR4|CD14|LY96|PELI3
MET ACTIVATES STAT3%REACTOME DATABASE ID RELEASE 66%8875791,0.765116904058049,0.9195283779466871,0.389588249512863,0.766274112353628,5693,3,MET
FORMATION OF THE BETA-CATENIN:TCF TRANSACTIVATING COMPLEX%REACTOME%R-HSA-201722.4,0.000128865979381443,0.00518555396908895,-0.39214088197970504,-2.2360651947682597,0,65,HIST1H2BE|SMARCA4|TERT|RUNX3|H2AFX|HIST2H2AC|HIST1H2AD|RUVBL1|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|MEN1|HIST2H3A|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|MYC|HIST1H2AE|HIST2H3C|HIST1H3H|KAT5|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
DEFENSINS%REACTOME DATABASE ID RELEASE 66%1461973,0.671508964795184,0.8815356925073421,-0.377410721145707,-0.8262309616032231,5130,4,TLR1|CD4|TLR2
BIOSYNTHESIS OF DPA-DERIVED SPMS%REACTOME DATABASE ID RELEASE 66%9018683,0.457415760148581,0.7719619284439659,-0.6167080231596359,-1.0263007695653499,3447,2,PTGS2|ALOX5
REGULATION OF MECP2 EXPRESSION AND ACTIVITY%REACTOME DATABASE ID RELEASE 66%9022692,0.0482205922303722,0.314649813998106,0.335787225141982,1.5212806829201,354,28,CAMK4|HDAC1|NCOR1|GPS2|HTT|TBL1XR1|AGO2|SIN3A|TNRC6B|CAMK2G|AGO3|MOV10|CAMK2D|TBL1X|HDAC2|AGO1|CREB1|AURKB|NCOR2|HDAC3|HIPK2
PLATELET AGGREGATION (PLUG FORMATION)%REACTOME DATABASE ID RELEASE 66%76009,0.40237380983435495,0.740287621109606,-0.235256843697362,-1.03759761489655,3084,27,TLN1|GP1BA|GP1BB|BCAR1|VWF|RAPGEF3|RAP1A|FN1|ADRA2C
DEFECTS IN BIOTIN (BTN) METABOLISM%REACTOME%R-HSA-3323169.1,0.51879502292076,0.8047799431921201,-0.36573590889096297,-0.940771281839791,3960,6,MCCC2|PCCB
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF KERATINOCYTES%REACTOME%R-HSA-8939242.1,0.164432176656151,0.535643394219061,-0.48206457731977903,-1.31770202474066,1250,7,SOCS4|RUNX1|SOCS3|CTSV|CTSL
MICRORNA (MIRNA) BIOGENESIS%REACTOME DATABASE ID RELEASE 66%203927,0.8840219665271971,0.963303578606192,-0.158906044026063,-0.675346207234412,6760,24,POLR2H|RAN|POLR2G|POLR2L
NRAGE SIGNALS DEATH THROUGH JNK%REACTOME DATABASE ID RELEASE 66%193648,0.7400027674000279,0.909493931144346,0.15066315999692,0.8266556106608829,5347,54,ARHGEF33|ABR|OBSCN|TIAM2|FGD4|ARHGEF7|MCF2L|VAV2|SOS1|AKAP13|ARHGEF4|PLEKHG5|ARHGEF10|ARHGEF19
SEMA3A PAK DEPENDENT AXON REPULSION%REACTOME DATABASE ID RELEASE 66%399954,0.44113029827315503,0.7653693162885199,-0.271432155915972,-1.00874699190529,3371,16,SEMA3A|CFL1|HSP90AA1
RHO GTPASES ACTIVATE ROCKS%REACTOME DATABASE ID RELEASE 66%5627117,0.5723064853556489,0.8342809238628159,-0.23500711310028896,-0.911915000316018,4376,18,MYH9|CFL1|MYL9
TOXICITY OF BOTULINUM TOXIN TYPE B (BONT B)%REACTOME%R-HSA-5250958.1,0.288632088148347,0.661755006838166,0.5948313103577441,1.1699629927608401,2147,3,SYT2|VAMP2|SYT1
TFAP2A ACTS AS A TRANSCRIPTIONAL REPRESSOR DURING RETINOIC ACID INDUCED CELL DIFFERENTIATION%REACTOME%R-HSA-8869496.2,0.576495223138333,0.836604755247265,-0.409960655332062,-0.897489571695891,4404,4,NPM1|MYBL2
NGF PROCESSING%REACTOME%R-HSA-167060.1,0.0964533438031671,0.427566585262796,-0.6474935201014721,-1.4174986659659699,736,4,FURIN|PCSK5|NGF|PCSK6
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY%REACTOME DATABASE ID RELEASE 66%383280,0.59303235908142,0.8422269872864581,-0.20665088221825198,-0.90144888650546,4544,26,RARA|ESRRG|RORC|NR2F1|NR4A1|RXRG|RORA|NR1D2|MED1|THRA|NR1D1|PPARG|PPARA|ESRRA
L1CAM INTERACTIONS%REACTOME%R-HSA-373760.2,0.18180557481625303,0.555001313277782,0.19121050490407102,1.1994192351221,1310,90,KCNQ3|CHL1|SCN5A|SHTN1|ANK2|RPS6KA2|EPHB2|NFASC|LAMB1|VAV2|LYPLA2|SPTBN1|KCNQ2|LAMA1|PAK1|SCN3A|ITGAV|NRCAM|SCN9A|ITGA2|SCN2A|DLG4|ITGA2B|AP2S1|AP2B1|NRP1|EZR|EGFR|CSNK2A2|RANBP9|MAP2K1|MAPK1|RPS6KA6|NCAM1
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES%REACTOME DATABASE ID RELEASE 66%6791312,0.8613119834710741,0.952024812004569,-0.137263005647836,-0.72322468592825,6669,49,CCNA2|PCBP4|CNOT4|RBL1|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PRMT1|RGCC|TFDP2|PLK2|NPM1|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A
ERBB2 REGULATES CELL MOTILITY%REACTOME%R-HSA-6785631.3,0.751830543933054,0.915314007578303,-0.244000661995918,-0.764422222078206,5749,10,EGFR|ERBB2|MEMO1|DIAPH1|NRG4|RHOA|NRG1|NRG3|NRG2|HBEGF
INTERACTION BETWEEN PHLDA1 AND AURKA%REACTOME%R-HSA-8854521.2,0.627885380737596,0.859799056589659,-0.548662806727323,-0.9130626481737549,4732,2,PHLDA1|AURKA
RNA POLYMERASE III TRANSCRIPTION TERMINATION%REACTOME DATABASE ID RELEASE 66%73980,0.658616187989556,0.877078054784098,-0.20351947083005104,-0.854493086908816,5044,23,POLR2H|NFIC|POLR3K|NFIX|POLR2L
CHYLOMICRON ASSEMBLY%REACTOME DATABASE ID RELEASE 66%8963888,0.0147886402303363,0.16327644723639997,-0.76440070422095,-1.67343292999572,112,4,APOE|SAR1B|P4HB
RRNA PROCESSING IN THE MITOCHONDRION%REACTOME%R-HSA-8868766.2,0.31438672831112296,0.6839036657770279,0.35271819816911,1.1174350938201598,2311,10,TFB1M|ELAC2|MTERF4|RNMTL1|NSUN4
INSULIN RECEPTOR RECYCLING%REACTOME DATABASE ID RELEASE 66%77387,0.00156924284032954,0.0323893370023386,-0.4883395204396889,-2.0223410160343502,11,22,ATP6V1D|ATP6V0A1|TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|ATP6V1F|INS|ATP6V0D1|ATP6V0E1|ATP6AP1|ATP6V0E2|ATP6V1A|ATP6V1G1
BETA-OXIDATION OF PRISTANOYL-COA%REACTOME%R-HSA-389887.3,0.91850683491062,0.9761906972716509,-0.225096525096525,-0.615291313315105,6987,7,ACOX2|ACOX3|ACOT8|HSD17B4|AMACR|CROT|CRAT
FIBRONECTIN MATRIX FORMATION%REACTOME%R-HSA-1566977.1,0.0545740086376129,0.33896362399005303,-0.689130314895494,-1.50865031342397,416,4,ITGB1|ITGA5|CEACAM1|FN1
TRIF(TICAM1)-MEDIATED TLR4 SIGNALING%REACTOME DATABASE ID RELEASE 66%937061,0.645929339477727,0.869411231395532,-0.143308812603228,-0.895019114750908,5045,93,TICAM2|ATF1|ELK1|IKBKE|MAPKAPK2|MEF2C|MAPK9|MAPK3|IRF7|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|FADD|UBC|TICAM1|TRAF3|RELA|NFKB1|TLR4|CD14|LY96
VIRUS ASSEMBLY AND RELEASE%REACTOME DATABASE ID RELEASE 66%168268,0.0945874237198196,0.424507034898303,-0.806672180865729,-1.34243150554109,712,2,CANX|CALR
AMINE LIGAND-BINDING RECEPTORS%REACTOME%R-HSA-375280.2,0.370807875084861,0.7231271705612199,0.30393059000255396,1.06442829180903,2730,13,DRD2|CHRM4|DRD4|HRH3|CHRM3
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%2122948,0.485253959584926,0.7872939093021379,0.209501366417296,0.977294957236625,3553,31,DLL1|ADAM17|RPS27A|PSENEN|DLK1|ARRB2|DNER|PSEN2|APH1B
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1%REACTOME DATABASE ID RELEASE 66%5654687,0.218248572205602,0.600900183590521,0.31121561939119496,1.2182307265055101,1604,18,GAB1|FGF2|FRS3|SOS1|PLCG1|NRAS|FGF1|KRAS|FLRT3
AUTODEGRADATION OF CDH1 BY CDH1:APC C%REACTOME%R-HSA-174084.3,0.000129015610888918,0.00518555396908895,-0.3916369393968321,-2.2147113032149504,0,63,PSMD1|PSMC2|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
NUCLEOBASE CATABOLISM%REACTOME%R-HSA-8956319.1,0.368428221193135,0.7217539780398442,0.251118986792791,1.06611179608669,2704,23,NT5M|ADPRM|ENTPD7|ITPA|NT5C2|NT5E|DPYD|ENTPD6|ENTPD3|ENTPD4
GRB2 EVENTS IN ERBB2 SIGNALING%REACTOME%R-HSA-1963640.3,0.915580890336591,0.9746069626471451,0.18909500662935,0.6222386837320749,6745,11,SOS1|NRAS|EGFR|KRAS|ERBB2
P53-INDEPENDENT G1 S DNA DAMAGE CHECKPOINT%REACTOME DATABASE ID RELEASE 66%69613,0.000256574727389352,0.00819882332206558,-0.407376332236664,-2.17528316927375,1,51,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
INTERCONVERSION OF POLYAMINES%REACTOME%R-HSA-351200.1,0.976518970549217,0.9927322181739301,-0.32293566690168796,-0.537416591020273,7360,2,SAT1
"ACTIVATION, TRANSLOCATION AND OLIGOMERIZATION OF BAX%REACTOME DATABASE ID RELEASE 66%114294",0.140809217577706,0.505734429040207,0.776895505927764,1.30528475899775,1050,2,BID|BAX
ABNORMAL CONVERSION OF 2-OXOGLUTARATE TO 2-HYDROXYGLUTARATE%REACTOME DATABASE ID RELEASE 66%2978092,0.0604329924292735,0.355787695563881,0.969838994265549,1.2931494357073898,454,1,IDH1
ZINC EFFLUX AND COMPARTMENTALIZATION BY THE SLC30 FAMILY%REACTOME%R-HSA-435368.1,0.8897948448185171,0.965159112268525,-0.273200636513684,-0.654809794243514,6765,5,SLC30A5
SCF-BETA-TRCP MEDIATED DEGRADATION OF EMI1%REACTOME DATABASE ID RELEASE 66%174113,0.000257599175682638,0.00819882332206558,-0.40774624913924107,-2.20083824409488,1,53,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
HIV TRANSCRIPTION INITIATION%REACTOME DATABASE ID RELEASE 66%167161,0.0299702880764759,0.244735657013286,-0.305821259293732,-1.5842503492941102,231,46,GTF2A2|POLR2J|TAF3|GTF2A1|TAF12|POLR2H|GTF2H1|TAF7|TAF9B|CDK7|MNAT1|TAF10|POLR2G|TAF9|AK6|POLR2L|GTF2H2
TRAF6 MEDIATED NF-KB ACTIVATION%REACTOME%R-HSA-933542.1,0.6810513927030211,0.8849342663941481,-0.20171128898702695,-0.8353389312999571,5207,22,NFKBIB|RNF135|IKBKB|MAVS|NKIRAS1|HMGB1|AGER|IKBKG|NKIRAS2|DDX58|CHUK|S100B|MAP3K1|TRAF6|APP|TRIM25|NFKB2|TRAF2|IFIH1|NFKBIA|RELA|NFKB1
NEGATIVE REGULATION OF MAPK PATHWAY%REACTOME%R-HSA-5675221.1,0.806851011143211,0.933810206759044,0.152874945293091,0.767950777926174,5864,40,DUSP4|DUSP6|DUSP10|RPS27A|DUSP16|YWHAB|NRAS|PPP2CB|PPP2R5C|MAP2K1|MAPK1|KRAS
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH MSH2%REACTOME%R-HSA-5632928.1,0.399892502015587,0.73962695174002,0.539649277600088,1.06142644623483,2975,3,MSH2|MSH6|MSH3
SIGNALING BY NTRK3 (TRKC)%REACTOME DATABASE ID RELEASE 66%9034015,0.15988608624898298,0.529429183067871,0.364277711194689,1.30934925490147,1178,14,PTPRO|PTPRS|SOS1|PLCG1|NRAS|BAX|SRC|KRAS
"INACTIVATION, RECOVERY AND REGULATION OF THE PHOTOTRANSDUCTION CASCADE%REACTOME DATABASE ID RELEASE 66%2514859",0.11278706345970901,0.460292399693505,0.35923067037345,1.3813489538900399,829,17,PDE6B|PPEF1|NMT2|METAP1|GNGT1|PRKCA|CAMKMT|FNTA
"GABA SYNTHESIS, RELEASE, REUPTAKE AND DEGRADATION%REACTOME DATABASE ID RELEASE 66%888590",0.0850284784377543,0.40376145987147494,0.403585248250992,1.4506351276711398,626,14,RIMS1|SNAP25|DNAJC5|SLC6A13|CPLX1
VIRAL MRNA TRANSLATION%REACTOME%R-HSA-192823.3,0.789500509683996,0.9280333261332429,-0.131522022138471,-0.808967709667358,6195,87,RPS28|RPLP1|RPS18|RPL9|RPL28|RPS3|RPS5|RPS10|RPS15|RPL29|RPL11|RPS6|RPL36|RPL17|RPL32|RPL39L|RPL23|RPLP0|RPL10A|RPL8|RPS23|RPL3|RPL7A|RPS2|RPL15|RPL37|RPL27A|DNAJC3|RPL18|RPL39|RPL27|RPLP2|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|RPL35|RPL38|RPS15A|RPL36AL|RPS13|RPL26L1|FAU
EPH-EPHRIN MEDIATED REPULSION OF CELLS%REACTOME%R-HSA-3928665.3,0.312233561555355,0.68160868787154,-0.213833342578413,-1.10772399686316,2416,46,LYN|PSEN1|VAV3|EPHB3|AP2A2|DNM1|EPHA8|CLTA|EFNA1|CLTC|EPHA2|EFNA3|EPHA4|MMP9|EPHB4|TIAM1|AP2M1|EFNA5|CLTB
ESTABLISHMENT OF SISTER CHROMATID COHESION%REACTOME DATABASE ID RELEASE 66%2468052,0.482184962012051,0.7865660622599749,-0.29961304355636303,-0.9700133482948651,3680,11,STAG1|RAD21|ESCO2|STAG2|SMC1A|CDCA5
REGULATION OF TP53 ACTIVITY%REACTOME%R-HSA-5633007.2,0.679480586268964,0.884536278926676,-0.127855191281822,-0.890835681942516,5284,154,TMEM55B|TAF3|BRPF3|SETD8|TPX2|CDKN2A|RAD1|TAF12|RAD17|SUPT16H|PPP1R13B|SGK1|NUAK1|PHF20|RHNO1|BRCA1|RFC5|TOPBP1|TAF7|RBBP7|RMI1|USP2|TAF9B|PPP2CA|RMI2|UBC|TAF10|MTA2|KAT5|TAF9|ZNF385A|PRMT5|SSRP1|RFC4|MAPKAP1|AK6
"TRANSPORT OF VITAMINS, NUCLEOSIDES, AND RELATED MOLECULES%REACTOME%R-HSA-425397.2",0.300104384133612,0.6734519006497671,-0.25741923281409196,-1.1229097030433899,2299,26,SLC35A3|PDZD11|SLC29A2|SLC29A4|APOD|SLC16A2|SLC33A1|SLCO2B1|SLCO2A1|SLC35A2|LCN12|LCN1|SLC27A4|SLCO4A1
ER QUALITY CONTROL COMPARTMENT (ERQC)%REACTOME DATABASE ID RELEASE 66%901032,0.6957876202085871,0.890650553958115,0.199910410944923,0.8240609089558899,5136,21,UGGT2|RNF103|RPS27A|TRIM13|DERL2|RNF185|UGGT1|MAN1B1|UBA52|EDEM2
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA%REACTOME%R-HSA-3134975.2,0.450839014158364,0.7691712077342808,-0.282933492162889,-1.00097732085702,3438,14,TRIM21|TREX1|TRIM56|TRIM32|TMEM173|UBC
NA+ CL- DEPENDENT NEUROTRANSMITTER TRANSPORTERS%REACTOME%R-HSA-442660.1,0.301938301938302,0.674908924065355,0.372808853272348,1.1329317209370602,2211,9,SLC6A2|SLC6A13|SLC18A1
"GAMMA-CARBOXYLATION, TRANSPORT, AND AMINO-TERMINAL CLEAVAGE OF PROTEINS%REACTOME%R-HSA-159854.3",0.5166351095482821,0.804108323152586,0.338015349596546,0.9330822996989259,3819,7,PROC|GGCX
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES%REACTOME%R-HSA-425393.2,0.746841969579789,0.911925817165146,-0.145209233933331,-0.824602553602787,5793,64,SLC6A6|SLC38A5|SLC9A5|SLC7A7|SLC16A10|SLC36A1|SLC43A2|SLC8B1|SLC12A2|SLC25A10|SLC25A18|SLC1A2|SLC9A1|SLC26A2|SLC9A7|SLC15A3|SLC1A3|SLC25A22|SLC9A9|SLC24A3|SLC7A3|SLC3A2|SLC7A8
INTERFERON SIGNALING%REACTOME DATABASE ID RELEASE 66%913531,0.000643335048893464,0.0163600882996276,-0.256513780639381,-1.81637235618857,4,167,GBP1|GBP3|GBP2|PTPN11|POM121|HLA-F|PIAS1|NUP107|KPNA1|IFNGR2|TRIM22|ISG20|PTPN1|TRIM25|HLA-DRB1|HERC5|UBE2N|IRF8|OAS3|NUP205|HLA-DQB2|HLA-B|TRIM14|NUP93|NUP210|MX1|USP41|CD44|HLA-DPA1|XAF1|PML|HLA-E|HLA-DRA|HLA-DRB5|FCGR1B|TRIM38|SP100|EIF4E3|TRIM21|TRIM3|B2M|MID1|IFIT3|OASL|OAS1|IFNGR1|SOCS3|IFNAR1|HLA-DPB1|HLA-DQA2|FCGR1A|TRIM68|HLA-C|IRF5|KPNB1|TRIM34|HLA-A|OAS2|PDE12|NUP188|IFIT2|SOCS1|PTPN6|ICAM1|IFIT1|NUP85|ISG15|MAPK3|KPNA4|CAMK2B|IFI6|RSAD2|FLNA|IRF7|NUP37|IFI30|VCAM1|EIF4G2|NUP160|KPNA2|NUP214|BST2|MT2A|EIF4A3|UBC|IFI35|CAMK2A|USP18|PTAFR|IFITM1|EIF4A2|UBE2L6|IFITM2|IFITM3|SAMHD1|EIF4G1
DOWNREGULATION OF ERBB2 SIGNALING%REACTOME%R-HSA-8863795.2,0.80717976611368,0.933811101775582,0.172810043899885,0.7444005728412769,5935,24,RPS27A|PTPN12|STUB1|PTPN18|AKT3|CUL5|CDC37|EGFR|RNF41|ERBB2|USP8
NTRK3 AS A DEPENDENCE RECEPTOR%REACTOME%R-HSA-9603505.1,0.758597883597884,0.9172140592138721,-0.393409343723541,-0.768228739103798,5734,3,NELFB
RHO GTPASES ACTIVATE RHOTEKIN AND RHOPHILINS%REACTOME%R-HSA-5666185.1,0.289617486338798,0.6622817015650171,0.395732486434856,1.14874217628347,2119,8,RHOC|RTKN|LIN7B
COPI-DEPENDENT GOLGI-TO-ER RETROGRADE TRAFFIC%REACTOME%R-HSA-6811434.1,0.0217195733196247,0.20379481798657503,-0.264089659730289,-1.5617535003303102,168,75,KIF21B|BNIP1|KLC2|NAPA|KIF20A|KIF18B|KIF4A|KIF27|KIF18A|KDELR2|ARFGAP2|COPB2|ARF1|KDELR1|COPB1|TMED2|KIFC1|KIF2A|RAB1B|NSF|KDELR3|TMED10|TMED9|KIF22|COPG1|SURF4|COPZ2
PEPTIDE HORMONE BIOSYNTHESIS%REACTOME%R-HSA-209952.1,0.0800894266175697,0.39674006528988004,-0.6119656992432261,-1.46676500728238,608,5,INHBB|PCSK1|POMC|INHBA
IRAK1 RECRUITS IKK COMPLEX%REACTOME DATABASE ID RELEASE 66%937039,0.949398535564853,0.984779478109078,-0.18232661189989,-0.571205474085298,7260,10,IRAK1|PELI3
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 27-HYDROXYCHOLESTEROL%REACTOME DATABASE ID RELEASE 66%193807,0.34126569037656895,0.701955655133333,-0.348369946616342,-1.0913975663811302,2609,10,CYP7B1|PTGIS
FCGR ACTIVATION%REACTOME%R-HSA-2029481.1,0.0010467094073008,0.0240545523142212,-0.548376573592995,-2.08396489113542,7,17,FCGR3A|FYN|IGHG1|SYK|IGKV3-11|LYN|IGHG4|FGR|FCGR1A|IGKV2-28|FCGR2A|IGKV2D-28|HCK|IGHG2
AMER1 MUTANTS DESTABILIZE THE DESTRUCTION COMPLEX%REACTOME DATABASE ID RELEASE 66%4839748,0.7642894598846359,0.9191113740914171,-0.21629972962533803,-0.7652368131017159,5829,14,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
INHIBITION OF TSC COMPLEX FORMATION BY PKB%REACTOME DATABASE ID RELEASE 66%165181,0.295485084654663,0.6684308347279571,0.5907733623879661,1.1619814879736499,2198,3,TSC2|TSC1|AKT2
CELLULAR HEXOSE TRANSPORT%REACTOME%R-HSA-189200.4,0.0732250458475242,0.38086682923393506,-0.460973082191128,-1.49242515486781,558,11,SLC2A8|SLC2A9|SLC50A1|SLC2A1|SLC2A10|SLC2A6|SLC45A3|SLC2A3
MRNA 3'-END PROCESSING%REACTOME DATABASE ID RELEASE 66%72187,0.0047741935483871,0.0769118865319443,-0.33946207211593205,-1.85170842335421,36,55,SRSF3|FYTTD1|NCBP2|SLU7|CHTOP|SRSF9|MAGOH|CPSF2|SRSF5|SRSF1|U2AF1|PAPOLA|NCBP1|CLP1|CSTF3|THOC7|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|THOC3|CPSF7
SIGNALING BY NUCLEAR RECEPTORS%REACTOME DATABASE ID RELEASE 66%9006931,0.000385901723694366,0.0111294649577428,-0.27309906371313103,-1.90879823233542,2,156,HIST1H2BE|KANK1|RUNX1|KDM1A|H2AFX|YY1|RXRG|GTF2A2|GPAM|HIST2H2AC|POLR2J|HIST1H2AD|MED1|STAG2|GATA3|HIST1H2BN|H2AFV|GTF2A1|PDHA1|HIST1H2BC|HIST1H4I|DHRS4|DDX5|POLR2H|MAPK3|USF2|TNRC6C|ALDH1A1|HIST2H3A|KPNA2|ALDH1A2|KAT2B|H2AFZ|PDK3|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|MYC|HIST1H2AE|FKBP4|POLR2G|HIST2H3C|PDHX|SMC1A|CTSD|DHRS3|HIST1H3H|CXXC5|KAT5|HSP90AA1|HIST2H4B|H3F3B|HIST1H2AC|CCND1|FKBP5|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE%REACTOME DATABASE ID RELEASE 66%212676,0.16023296762833497,0.5300563172412229,0.314631049263719,1.2969567078396798,1182,21,LIN7B|RIMS1|SNAP25|LIN7A|PPFIA2|CPLX1|PPFIA3|PPFIA4
TGFBR2 KINASE DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3645790,0.18583954979714698,0.559093571852282,-0.5880054757869301,-1.28726690172596,1419,4,TGFBR2|FKBP1A
PROTEIN REPAIR%REACTOME DATABASE ID RELEASE 66%5676934,0.143811394891945,0.510100773357357,-0.524295405658816,-1.3486290212520802,1097,6,PCMT1|TXN|MSRB2|MSRB1|MSRA|MSRB3
SIGNALING BY TYPE 1 INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF1R)%REACTOME DATABASE ID RELEASE 66%2404192,0.143266849172207,0.509384864704371,-0.27770275978820896,-1.30417055453303,1098,33,IRS1|PIK3CB|FGF10|CILP|HRAS|IGF1|PIK3R4|FGF19|FGF9|FGF7|FLT3LG
FORMATION OF XYLULOSE-5-PHOSPHATE%REACTOME%R-HSA-5661270.2,0.6751709626512359,0.882488012133495,-0.34305650942725396,-0.8222409918898811,5133,5,CRYL1
SIGNALING BY SCF-KIT%REACTOME%R-HSA-1433557.2,0.638163001293661,0.86542887851493,-0.182552637101002,-0.8790420349025241,4932,36,VAV1|FES|SOCS1|STAT3|PTPN6|SH2B3|HRAS|PIK3R3|MMP9|GRB10
TRUNCATIONS OF AMER1 DESTABILIZE THE DESTRUCTION COMPLEX%REACTOME DATABASE ID RELEASE 66%5467348,0.7642894598846359,0.9191113740914171,-0.21629972962533803,-0.7652368131017159,5829,14,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
INTEGRIN ALPHAIIB BETA3 SIGNALING%REACTOME%R-HSA-354192.1,0.901697127937337,0.9684180373391851,-0.156091504782133,-0.655362905659802,6906,23,PTPN1|RAP1B|AKT1|SYK|APBB1IP|TLN1|BCAR1|VWF|RAPGEF3|RAP1A|FN1
GPVI-MEDIATED ACTIVATION CASCADE%REACTOME%R-HSA-114604.5,0.0130531262237306,0.151381528985436,-0.383336978740654,-1.7332658947542199,99,29,PTPN11|RHOA|FYN|PLCG2|LCP2|RAC2|CDC42|PIK3R5|SYK|RAC1|LYN|VAV3|PIK3R6|VAV1|PTPN6|FCER1G|PIK3CB|RHOG|PIK3R3|PDPN
INTESTINAL ABSORPTION%REACTOME DATABASE ID RELEASE 66%8963676,0.8445484949832779,0.948285501480553,-0.580999117776798,-0.7740303309939169,6312,1,SLC2A5
INTERCONVERSION OF NUCLEOTIDE DI- AND TRIPHOSPHATES%REACTOME%R-HSA-499943.6,0.18599191339507,0.559093571852282,-0.28368514501969,-1.2511900832635101,1425,27,CTPS1|NME2|TAF9|RRM1|AK6|NME1|AK1
FORMATION OF THE CORNIFIED ENVELOPE%REACTOME DATABASE ID RELEASE 66%6809371,0.732400108725197,0.9075412450030892,0.20928322376425698,0.7880207474314951,5388,16,KAZN|SPINK5|PKP4|PPL|CAPNS1|EVPL
ERYTHROPOIETIN ACTIVATES PHOSPHOLIPASE C GAMMA (PLCG)%REACTOME DATABASE ID RELEASE 66%9027277,0.509705443192616,0.8001926101728042,0.36365145191862797,0.940969505548444,3754,6,IRS2|PLCG1|JAK2|EPOR
TRAFFICKING OF MYRISTOYLATED PROTEINS TO THE CILIUM%REACTOME%R-HSA-5624138.1,0.0969180859691809,0.42893116561614203,0.604022275815309,1.45267010956341,716,5,NPHP3-ACAD11|ARL3|NPHP3
MUSCLE CONTRACTION%REACTOME DATABASE ID RELEASE 66%397014,0.0126744334912303,0.148760661267374,-0.223146539363683,-1.5360976007543599,98,144,KCND2|RYR2|MYH11|ITPR2|ATP1B1|ATP2A1|KCNIP3|PLN|ITPR3|ATP1A3|TNNI2|ATP1B3|TNNC2|ITGB5|TLN1|ANXA6|KCNK6|STIM1|ATP2A3|KCNIP4|MYLK|KCNK7|LMOD1|NPR2|CACNA2D4|ABCC9|PXN|CAMK2B|FXYD1|DYSF|KCNJ12|MYL12A|NPR1|KCNQ1|KAT2B|ACTG2|ASPH|WWTR1|VCL|CAMK2A|SCN1B|CLIC2|ATP1B2|PRKACA|KCNH2|VIM|KCNE4|ANXA2|ACTA2|ANXA1|ATP2B2|MYL9|FXYD7
MECP2 REGULATES TRANSCRIPTION FACTORS%REACTOME DATABASE ID RELEASE 66%9022707,0.5916764821358461,0.8417378833576942,-0.405402286327353,-0.887510349074258,4520,4,MEF2C|PPARG
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF MYELOID CELLS%REACTOME DATABASE ID RELEASE 66%8939246,0.3495528669121519,0.70736446849153,-0.456496291001188,-1.09413450201989,2657,5,CREBBP|RUNX1|LGALS3|PRKCB
SIGNALING BY NOTCH1%REACTOME%R-HSA-1980143.2,0.609641873278237,0.8506427722100329,0.154859010543946,0.911455552124044,4425,70,TLE2|DLL1|HDAC11|ADAM17|RPS27A|HDAC1|NCOR1|PSENEN|HDAC10|DLK1|ARRB2|TBL1XR1|HDAC4|DNER|PSEN2|APH1B|MAML2
UBIQUITIN-DEPENDENT DEGRADATION OF CYCLIN D1%REACTOME DATABASE ID RELEASE 66%69229,0.000128816179312122,0.00518555396908895,-0.4384041292172439,-2.32700175477759,0,50,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|CCND1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
B-WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION%REACTOME%R-HSA-5250924.2,0.000128865979381443,0.00518555396908895,-0.38163075049162204,-2.1761343375357898,0,65,HIST1H2BE|DEK|H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|ZNRD1|TWISTNB|HIST1H2BC|HIST1H4I|POLR2H|HIST2H3A|KAT2B|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|ACTB|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
HEMOSTASIS%REACTOME%R-HSA-109582.1,0.000126151129052605,0.00518555396908895,-0.25940693030760603,-2.18401327981243,0,474,F12|VAV3|CD74|F10|SDC3|GNG8|SLC7A7|APOOL|ANGPT2|CD84|ITGA10|KDM1A|ZFPM2|SERPINA3|SH2B1|ITGB2|DGKG|CXADR|PIK3R6|ITPR2|MERTK|MRVI1|ATP1B1|SERPINB8|TNFRSF10A|ATP2A1|STX4|P2RX4|TNFRSF10B|PPIA|FGR|KIF21B|RAD51C|STXBP2|HGF|BRPF3|ITPR3|RAB27B|VAV1|KLC2|SPN|GATA3|ATP1B3|TUBA4A|TLN1|PRCP|GP1BA|P2RX5|PLAU|PLEK|GP1BB|MMP1|P2RX3|GYPC|VEGFC|GAS6|TGFB3|ESAM|STIM1|ATP2A3|BCAR1|IGKV2-28|AKAP1|DOCK5|ITGA5|CLEC3B|DOK2|KIF20A|TSPAN7|DAGLB|OLR1|VWF|JCHAIN|PRKAR1A|DOCK6|KIF18B|PLA2G4A|SERPINA1|PTPN6|CD47|TBXA2R|SH2B3|CD63|ARRB1|SDC4|FCER1G|KIF4A|F3|PDE2A|S100A10|DGKE|KIF27|EHD1|PIK3CB|F8|KIF18A|MAPK3|TIMP3|RHOG|GNGT2|ABL1|PHACTR2|SOD1|SRGN|RAPGEF3|FLNA|ITIH3|SPARC|HRAS|PIK3R3|IGF1|MMRN1|PDE1A|LGALS3BP|RAD51B|GNG11|GNAI2|DOCK1|GNAQ|CEACAM1|HIST2H3A|THBD|PDPN|KIFC1|SDC2|F2R|KIF2A|RAP1A|IGKV2D-28|FN1|PLAUR|PDE1B|GATA6|DAGLA|NOS3|PPP2CA|GNA15|VEGFB|CD99|CD36|ECM1|GNG10|SERPINE2|TOR4A|A2M|F2RL3|CABLES2|THBS1|TEK|F13A1|ADRA2C|CYB5R1|VCL|SEPP1|RARRES2|ITPK1|CD99L2|SLC3A2|SERPINE1|CAV1|LAMP2|PLAT|HIST2H3C|CFL1|ATP1B2|PRKACA|FERMT3|HIST1H3H|MGLL|ITGAM|CFD|ANXA2|PTGIR|HSPA5|TIMP1|KIF22|TFPI|H3F3B|GNG3|TMSB4X|ATP2B2|ACTN1|SLC7A8|SERPING1|EHD2|IGHA1|CHID1|LHFPL2|PDGFB|SERPINF2|PRKCB|ALDOA|SIRPA
ERYTHROCYTES TAKE UP OXYGEN AND RELEASE CARBON DIOXIDE%REACTOME%R-HSA-1247673.1,0.17727511835875898,0.548981775981255,-0.540980805689284,-1.29662776259801,1347,5,HBB|HBA1|AQP1|CA2
O-GLYCOSYLATION OF TSR DOMAIN-CONTAINING PROTEINS%REACTOME%R-HSA-5173214.1,0.172774869109948,0.546371269738967,-0.28324093041505705,-1.26498567386642,1319,28,ADAMTS4|ADAMTS14|SPON2|SBSPON|B3GLCT|ADAMTSL1|ADAMTSL2|THBS1|SEMA5A|THBS2|CFP|ADAMTS8
"SYNTHESIS, SECRETION, AND DEACYLATION OF GHRELIN%REACTOME%R-HSA-422085.2",0.07974335472044,0.395958593986611,-0.42775316382295603,-1.4724093405870602,608,13,SPCS2|ACHE|KLF4|BCHE|INS|PCSK1|PLA2G7|IGF1|SEC11C
CARBOXYTERMINAL POST-TRANSLATIONAL MODIFICATIONS OF TUBULIN%REACTOME DATABASE ID RELEASE 66%8955332,0.26786199402336297,0.6418798906350429,0.254610969832229,1.15351246582279,1971,28,TTLL4|TTLL1|TTLL7|LRRC49|AGBL5|TTLL3|TUBA1C|TTL|TUBB3|AGTPBP1
CD209 (DC-SIGN) SIGNALING%REACTOME%R-HSA-5621575.1,0.0769432773109244,0.388019980373392,-0.36286622365488796,-1.45581233916923,585,20,RAF1|CREBBP|PAK2|RPS6KA5|LYN|CD209|HRAS|RELB|RELA|NFKB1|PRKACA|ICAM2
OTHER SEMAPHORIN INTERACTIONS%REACTOME%R-HSA-416700.1,0.126692075174136,0.48305559706617496,-0.342201251421658,-1.35200521980537,963,19,ITGB1|SEMA4A|PLXND1|SEMA6A|TREM2|SEMA7A|SEMA5A|SEMA3E|TYROBP
STEROLS ARE 12-HYDROXYLATED BY CYP8B1%REACTOME%R-HSA-211994.1,0.0054849498327759205,0.0843419258872813,-0.997684164093516,-1.32915486466774,40,1,PTGIS
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND%REACTOME DATABASE ID RELEASE 66%69183,0.0322919401417695,0.256001350257465,-0.44617279958270095,-1.6199811112198002,245,15,DNA2|PRIM2|RPA2|POLD4|PCNA|POLD1|POLD2|POLA1|POLA2|FEN1
CELL-CELL JUNCTION ORGANIZATION%REACTOME DATABASE ID RELEASE 66%421270,0.7635487232933821,0.9191113740914171,-0.15781349593652,-0.800424589428489,5860,43,CDH6|CLDN7|JUP|CTNND1|CLDN5|CLDN11|CLDN10|PVRL2|CDH8|CDH11|CDH5|CDH7|ANG|CADM3
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN BCR SIGNALING%REACTOME DATABASE ID RELEASE 66%8939245,0.5512300621789671,0.8222031036427879,0.378209852680895,0.9095925268489771,4077,5,CBFB|BLK|ELF1|ELF2
DOPAMINE RECEPTORS%REACTOME%R-HSA-390651.1,0.020096463022508,0.195205495598712,0.907251171767301,1.5242991085094801,149,2,DRD2|DRD4
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS%REACTOME DATABASE ID RELEASE 66%141405,0.358849789915966,0.7151517895064159,-0.26705157807630303,-1.07140581628742,2732,20,CDC20|ANAPC10|ANAPC2|ANAPC5|CDC23|MAD2L1|CDC27|ANAPC11
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES%REACTOME%R-HSA-5633008.2,0.703122850460861,0.8935935481914151,0.167426223203288,0.841047551040512,5110,40,TP53I3|TP53INP1|BBC3|AIFM2|PMAIP1|STEAP3|ATM|TP53BP2|BID
SIGNALING BY ERBB4%REACTOME DATABASE ID RELEASE 66%1236394,0.449275362318841,0.768229288546963,0.207231414508073,1.00445361521984,3285,35,ADAM17|RPS27A|NCOR1|PSENEN|SHC1|SOS1|NEDD4|PSEN2|APH1B|NRAS|EGFR|SRC|KRAS
ENOS ACTIVATION AND REGULATION%REACTOME DATABASE ID RELEASE 66%203765,0.29627687467226005,0.6687276080240239,-0.321566085073048,-1.1376537851856299,2259,14,NOS3|CAV1|HSP90AA1|CYGB
MAPK6 MAPK4 SIGNALING%REACTOME%R-HSA-5687128.3,0.00127697612054655,0.0282297792550925,-0.30666688185676394,-1.86967773654598,9,84,PSMD3|PSMB2|PSMF1|KALRN|SEPT7|PSMD4|SHFM1|PSME2|PSMB5|HSPB1|TNRC6C|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|MYC|CCND3|PRKACA|PSMD12|PSMA3|CDC42EP5|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|CDC42EP2|PSMC3
FRUCTOSE CATABOLISM%REACTOME%R-HSA-70350.5,0.3969569351990221,0.7377402989373809,0.472480599218057,1.0380599983152201,2921,4,KHK
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS%REACTOME DATABASE ID RELEASE 66%391160,0.0353680901231333,0.26787698165153,-0.503772174087483,-1.6309895175590199,269,11,SKAP2|PTPN6|CD47|TYROBP|SIRPA
G ALPHA (Q) SIGNALLING EVENTS%REACTOME%R-HSA-416476.6,0.0999615532487505,0.43605057892447596,-0.193324011984137,-1.28747070445647,779,123,PLCB1|GNG8|RPS6KA1|EDNRA|LPAR6|AGT|DGKG|ITPR2|NPFF|PLCB3|PTGER1|ITPR3|GPR132|KALRN|RGS18|DAGLB|TAC1|LTB4R|PROKR1|TBXA2R|DGKE|MAPK3|GNGT2|HRAS|PIK3R3|CYSLTR2|GNG11|HBEGF|P2RY6|GNAQ|HCRT|F2R|EDNRB|DAGLA|GNA15|GNG10|F2RL3|PTAFR|GPR4|MGLL|ADRBK1|ANXA1|RGS2|GNG3|RGS3
PHOSPHORYLATION OF THE APC C%REACTOME DATABASE ID RELEASE 66%176412,0.265737941910895,0.641154728436237,-0.295314229619648,-1.16675897083904,2021,19,ANAPC10|ANAPC2|ANAPC5|CDC23|CDC27|CCNB1|PLK1|ANAPC11
POST-TRANSCRIPTIONAL SILENCING BY SMALL RNAS%REACTOME DATABASE ID RELEASE 66%426496,0.6606708141736539,0.8784720476539449,0.298961072108045,0.825274014970003,4884,7,AGO2|TNRC6B|AGO3|AGO1
HIGHLY CALCIUM PERMEABLE NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME DATABASE ID RELEASE 66%629597,0.0226871349001494,0.20908271623893998,0.7489659736392209,1.6455101407778099,166,4,CHRNB2|CHRNA5|CHRNB4|CHRNA3
ER-PHAGOSOME PATHWAY%REACTOME DATABASE ID RELEASE 66%1236974,0.000128452151573539,0.00518555396908895,-0.40193371358572205,-2.40767793420542,0,79,PSMD1|PSMC2|TLR1|B2M|TAPBP|SEC61G|STX4|TLR2|PSMD3|HLA-C|PSMB2|PSMF1|HLA-A|PSMD4|SHFM1|PSME2|PSMB5|CALR|VAMP8|PSMC4|PSMC6|PSMD10|PSMB3|CD36|PSMC1|PSMD2|SEC61A1|SEC61B|UBC|PSMD6|TLR4|PSMD12|PSMA3|PSMA6|CD14|LY96|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
DOWNREGULATION OF ERBB2:ERBB3 SIGNALING%REACTOME%R-HSA-1358803.1,0.8858813928182809,0.964636912970251,0.19381812512123997,0.65875010928503,6512,12,RPS27A|AKT3|RNF41|ERBB2|USP8|UBA52
REGULATION OF TP53 EXPRESSION AND DEGRADATION%REACTOME DATABASE ID RELEASE 66%6806003,0.9895321788575859,0.996330399687529,-0.103248041461123,-0.501573420073784,7656,37,SGK1|PHF20|USP2|PPP2CA|UBC|MAPKAP1
MET ACTIVATES PTK2 SIGNALING%REACTOME%R-HSA-8874081.1,0.655561599129725,0.874869342420871,0.216383509028929,0.8470173827515199,4820,18,MET|LAMA5|LAMB1|LAMA1|ITGA2
TELOMERE C-STRAND (LAGGING STRAND) SYNTHESIS%REACTOME DATABASE ID RELEASE 66%174417,0.0022228033472803397,0.0430044932643804,-0.476347381049655,-2.02446294028417,16,24,DNA2|POLE4|PRIM2|POLE|RFC2|RPA2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|POLE2|POLA1|POLE3|RFC4|POLA2|FEN1
HEDGEHOG LIGAND BIOGENESIS%REACTOME DATABASE ID RELEASE 66%5358346,0.00012950012950013,0.00518555396908895,-0.42007186568251603,-2.33371349076149,0,59,PSMD3|PSMB2|PSMF1|VCP|PSMD4|SEL1L|SHFM1|PSME2|PSMB5|SCUBE2|PSMC4|PSMC6|PSMD10|PSMB3|SYVN1|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|P4HB
ACTIVATION OF BH3-ONLY PROTEINS%REACTOME DATABASE ID RELEASE 66%114452,0.247622928552024,0.6284111611211011,0.259357356483826,1.1750159233283402,1822,28,BBC3|PMAIP1|PPP3R1|TP53BP2|BID|YWHAQ|YWHAB|YWHAE|AKT3|BCL2|YWHAH|YWHAZ|MAPK8
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION%REACTOME DATABASE ID RELEASE 66%5250941,0.000127697612054655,0.00518555396908895,-0.38634663624659293,-2.35546694839083,0,84,HIST1H2BN|H2AFV|ZNRD1|TWISTNB|HIST1H2BC|TTF1|HIST1H4I|POLR2H|GTF2H1|DNMT1|HIST2H3A|UBTF|CDK7|H2AFZ|HIST2H2AA4|MNAT1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|SAP30BP|HIST2H4B|RRP8|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L|GTF2H2|SUV39H1
METABOLISM OF VITAMINS AND COFACTORS%REACTOME%R-HSA-196854.3,0.00409678658302394,0.0703076503642067,-0.24032275252317398,-1.65433532874951,31,144,COQ6|SDC4|MCCC2|APOM|BST1|SLC25A16|DHFR|MOCS2|SDC2|RFK|APOE|LRP10|COQ7|NOS3|PDSS1|LDLR|PCCB|SLC2A3|PNPO|CYB5A|NMNAT3|HSP90AA1|MMAB|SHMT2|SLC25A19|FOLR2|GPHN|FASN|VKORC1|QPRT|PDXK|NNMT|COQ3|MTHFD1|PTGIS|ABCC1
REPRODUCTION%REACTOME DATABASE ID RELEASE 66%1474165,0.00025539522410930897,0.00819882332206558,-0.32311392148983503,-1.99642914571455,1,89,DMC1|RAD51|RPA2|MLH3|PSMC3IP|HIST1H2BE|TERF2|H2AFX|NBN|TINF2|HIST2H2AC|HIST1H2AD|RAD51C|STAG2|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|LMNB1|BRCA1|REC8|HIST2H3A|ZP3|SUN2|H2AFZ|HIST2H2AA4|B4GALT1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|SMC1A|HIST1H3H|HIST2H4B|H3F3B|SYCE2|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
PLCG1 EVENTS IN ERBB2 SIGNALING%REACTOME%R-HSA-1251932.3,0.102929320075249,0.44146292546620297,0.709054814161244,1.3946271454820502,765,3,PLCG1|EGFR|ERBB2
NCAM1 INTERACTIONS%REACTOME%R-HSA-419037.1,0.169109947643979,0.541811331682474,-0.28424634814079697,-1.2694759818789199,1291,28,CACNA1G|COL4A1|COL4A2|COL6A3|COL6A1|CACNA1I|COL6A2|PRNP
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS%REACTOME DATABASE ID RELEASE 66%176033,0.19473409801877,0.569626484656312,-0.265115604234392,-1.23321328163258,1493,32,NUP188|SLC25A6|NUP85|NUP37|NUP160|NUP214|SLC25A4|BANF1|SLC25A5
EXTRACELLULAR MATRIX ORGANIZATION%REACTOME%R-HSA-1474244.2,0.000127779197546639,0.00518555396908895,-0.36544117210618704,-2.72865379862557,0,221,ADAM9|PSEN1|HSPG2|COL15A1|ITGAX|ADAMTS4|LAMB2|LAMC1|COL27A1|FBLN5|NCAN|SDC3|ADAM8|PLOD2|ADAMTS14|ITGA10|COL20A1|ITGA11|ITGB2|LAMC2|COL18A1|COL23A1|P4HA3|PCOLCE2|COL11A2|KDR|NID2|CTSV|LAMC3|TPSAB1|CTSS|LTBP3|MFAP4|NTN4|ITGB5|MMP1|LAMA2|TGFB3|ADAM12|CASK|DDR2|P4HA1|VTN|PPIB|TNXB|CTSB|ITGA5|DCN|COL14A1|COL5A3|ELN|LOXL1|LTBP2|CD47|ICAM1|HTRA1|SDC4|BGN|FBN1|MMP14|LTBP1|SPP1|COL4A1|CAPN1|COMP|DDR1|VCAN|LAMA4|SPARC|LOX|COL4A2|FBN3|VCAM1|CAST|COL5A2|COL12A1|CEACAM1|LUM|COL6A3|SDC2|COL8A1|FN1|FMOD|MFAP5|COL21A1|TNC|CD151|BMP2|A2M|THBS1|SERPINH1|COL1A2|COL1A1|ITGA8|COL3A1|ADAM19|MMP9|P3H2|SERPINE1|NID1|COL6A1|CTSD|ITGAM|PDGFA|EFEMP1|CTSL|TIMP1|FBLN2|COL16A1|ADAMTS8|COL5A1|ACTN1|MMP19|COL6A2|EFEMP2|PDGFB|COL13A1|FBLN1|LOXL2|ITGB4|ICAM2|COL26A1|P4HB
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA%REACTOME DATABASE ID RELEASE 66%111447,0.08071505958829901,0.397722753303477,0.395580539087258,1.4591335441965698,595,15,PPP3R1|BID|YWHAQ|YWHAB|YWHAE|AKT3|BCL2|YWHAH|YWHAZ
GSD 0%REACTOME DATABASE ID RELEASE 66%3858516,0.017123745819398,0.17803435145825502,-0.991674018526687,-1.32114790765167,127,1,GYG2
REGULATION BY C-FLIP%REACTOME DATABASE ID RELEASE 66%3371378,0.45661803022407504,0.7715177634181241,-0.329655564159647,-0.991684627590198,3504,9,TNFRSF10A|TNFRSF10B|TRAF2|TNFSF10|FADD
AMINE-DERIVED HORMONES%REACTOME DATABASE ID RELEASE 66%209776,0.39785530066512803,0.7384982777757441,0.40229441288401097,1.04096043829649,2930,6,DDC|DUOX1|DBH|TH|DIO2|PNMT
SLC-MEDIATED TRANSMEMBRANE TRANSPORT%REACTOME DATABASE ID RELEASE 66%425407,0.19019354838709698,0.5637722131445689,-0.16873570334858,-1.17201865226388,1473,151,SLC39A7|SLC2A9|SLC35A3|SLC8A3|CP|PDZD11|SLC22A4|SLC29A2|SLC29A4|SLC6A6|SLC38A5|SLC9A5|SLC50A1|APOD|SLC16A2|SLC39A1|SLC7A7|RUNX1|SLC16A10|SLC41A2|SLC2A13|SLC36A1|SLC43A2|SLC39A3|SLC13A3|SLC22A3|SLC6A1|SLC2A1|SLC8B1|SLC12A2|SLC25A10|SLC25A18|SLC39A8|SLC41A1|SLC1A2|SLC33A1|SLC9A1|RHBG|SLCO2B1|SLC26A2|SLC9A7|SLC11A1|SLC15A3|SLC2A10|SLC2A6|SLC1A3|SLC25A22|SLCO2A1|SLC9A9|SLC22A15|SLC44A1|SLC35A2|LCN12|LCN1|SLC24A3|SLC45A3|SLC7A3|SLC27A4|SLC5A3|SLC3A2|SLC30A5|SLCO4A1|HEPH|SLC2A3|SLC7A8
GENERATION OF SECOND MESSENGER MOLECULES%REACTOME DATABASE ID RELEASE 66%202433,0.227992151733159,0.609818988326981,-0.262923326904474,-1.2004564363538301,1742,30,HLA-DRB1|GRAP2|LCP2|PAK2|HLA-DQB2|HLA-DPA1|HLA-DRA|HLA-DRB5|HLA-DPB1|CD4|HLA-DQA2|WAS|EVL|NCK1
"ADRENALINE,NORADRENALINE INHIBITS INSULIN SECRETION%REACTOME%R-HSA-400042.1",0.5340149965916839,0.812403303192621,0.21043320121550102,0.9417932107720609,3916,27,GNG5|GNGT1|GNB5|GNB4|CACNA1C|CACNA2D2|ADCY6|CACNB2
BRANCHED-CHAIN AMINO ACID CATABOLISM%REACTOME DATABASE ID RELEASE 66%70895,0.780421481985044,0.9249005412304508,0.18247109709280201,0.76363287732823,5739,22,BCKDHB|HIBCH|ACADSB|ACAT1|SHMT1|ACAD8|DLD|IVD|DBT|BCKDHA|ALDH9A1|BCAT1|AUH
HDR THROUGH HOMOLOGOUS RECOMBINATION (HRR)%REACTOME DATABASE ID RELEASE 66%5685942,0.0011609907120743,0.0260530720632284,-0.333799205886493,-1.9088590097861,8,66,EME2|POLE|RAD9A|RFC2|RAD51|RPA2|XRCC2|BRIP1|PALB2|RFC3|NBN|EXO1|RAD51C|POLD4|RAD51AP1|RAD1|RAD17|PCNA|POLD1|SLX1B|RHNO1|SLX1A|POLD2|BRCA1|RFC5|TOPBP1|EME1|RMI1|RAD51B|RMI2|UBC|KAT5|POLE2|POLE3|RFC4|MUS81|XRCC3
G ALPHA (I) SIGNALLING EVENTS%REACTOME%R-HSA-418594.5,0.12483962022068301,0.47935751228257,-0.161723086726146,-1.21157465133718,972,226,NMT1|PDE4B|FPR1|C3|METAP2|ADCY8|FNTB|RGS18|CXCR4|PDE4D|POMC|SST|OXER1|PRKAR1A|PLA2G4A|S1PR1|RGS4|SDC4|APOM|GNGT2|ADCY4|PYY|PDE1C|PDE1A|GNG11|GNAI2|CHRM2|CXCL16|GPER1|SDC2|CCR1|APOE|APLNR|PDE1B|LRP10|PPP2CA|GNG10|HEBP1|ADRA2C|HSD17B1|HTR1B|CX3CL1|LDLR|C3AR1|CCL4L2|PDE4A|PRKACA|DHRS3|ADRBK1|ANXA1|GNG3|PDE6G|PPP1CA|SSTR2|C5AR1|ADCY9
PCNA-DEPENDENT LONG PATCH BASE EXCISION REPAIR%REACTOME DATABASE ID RELEASE 66%5651801,0.00498753117206983,0.0794877127863817,-0.46528350256060896,-1.89556833963086,37,21,POLE|RFC2|RPA2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|POLE2|APEX1|POLE3|RFC4|FEN1
SYNTHESIS OF GDP-MANNOSE%REACTOME DATABASE ID RELEASE 66%446205,0.5915112192484461,0.8417378833576942,0.36534163077306797,0.8786445269536128,4375,5,GMPPA|PMM1|PMM2
INTRAFLAGELLAR TRANSPORT%REACTOME%R-HSA-5620924.3,0.00013719303059404599,0.00526859796630401,0.517588944405859,2.62343820460068,0,41,DYNLRB2|DYNC2H1|TTC30B|WDR19|TTC21B|DYNC2LI1|IFT88|TTC30A|WDR35|IFT46|IFT172|IFT20|IFT140|KIF3B|CLUAP1|IFT81|TNPO1|WDR60|IFT52|TRAF3IP1|KIF3C|IFT27
TRANSPORT OF THE SLBP INDEPENDENT MATURE MRNA%REACTOME DATABASE ID RELEASE 66%159227,0.686463908105991,0.8861361847538001,-0.1852446906467,-0.8375876116544608,5258,29,NUP188|NCBP1|NUP85|NUP37|NXF1|NUP160|NUP214
METABOLISM OF NITRIC OXIDE%REACTOME%R-HSA-202131.2,0.29627687467226005,0.6687276080240239,-0.321566085073048,-1.1376537851856299,2259,14,NOS3|CAV1|HSP90AA1|CYGB
INITIAL TRIGGERING OF COMPLEMENT%REACTOME DATABASE ID RELEASE 66%166663,0.000130770236694128,0.00518555396908895,-0.629368679284964,-2.60637945743026,0,22,IGHG1|GZMM|COLEC11|IGKV3-11|C4B|FCN3|IGHG4|C4A|C2|IGKV2-28|C3|C1QB|FCN1|C1QA|CFB|C1QC|IGKV2D-28|C1S|CFD|IGHG2|C1R
AGMATINE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%351143,0.211847522911409,0.5937395205509979,0.895511689457433,1.19404400394131,1594,1,AZIN2
LIGAND-INDEPENDENT CASPASE ACTIVATION VIA DCC%REACTOME%R-HSA-418889.3,0.129589339135165,0.4879451726618929,0.433164550067018,1.37229457441161,952,10,CASP9|UNC5B|DCC|DAPK3|DAPK1|DAPK2|CASP3
PEPTIDE HORMONE METABOLISM%REACTOME DATABASE ID RELEASE 66%2980736,0.0868167202572347,0.40695491202379397,-0.25482023330737696,-1.38170829363527,674,54,EXOC8|EXOC7|SPCS2|INHBB|EXOC6|ACHE|AGT|KLF4|ERO1L|BCHE|CPE|ERO1LB|INS|PCSK1|POMC|INHBA|EXOC5|ATP6AP2|PLA2G7|IGF1|DPP4|SEC11C|CTSZ|ANPEP|SLC30A5|CTSD
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN WNT SIGNALING%REACTOME%R-HSA-8939256.1,0.973101480777068,0.991969323104089,0.251750951304252,0.55310756149405,7162,4,CBFB|AXIN1
GDP-FUCOSE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%6787639,0.9541584806810741,0.9870180073166591,-0.22534356029050898,-0.579644341491356,7284,6,FUOM
PKA ACTIVATION%REACTOME%R-HSA-163615.2,0.34129692832764497,0.701955655133333,-0.301105535466081,-1.0932653904384,2599,15,ADCY8|PRKAR1A|ADCY4|PRKACA|ADCY9
P38MAPK EVENTS%REACTOME%R-HSA-171007.3,0.498367791077258,0.794989907195277,0.282007473819219,0.9584885525097241,3663,12,RALB|MAPK12|MAPK11|MAPKAPK3|NRAS|KRAS
BETA OXIDATION OF BUTANOYL-COA TO ACETYL-COA%REACTOME%R-HSA-77352.3,0.5564716660123019,0.8257149029717741,-0.41615456405073503,-0.9110493326406128,4251,4,HADH
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%198693,0.936846234309624,0.9806508984207809,-0.188640656576837,-0.590986551819969,7164,10,RPS6KB2
SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1%REACTOME%R-HSA-1839122.1,0.42752343431599,0.755868004239042,0.46068809268797495,1.01215135925362,3146,4,FGF2|FGF1|FGFR1
INTERLEUKIN-4 AND INTERLEUKIN-13 SIGNALING%REACTOME DATABASE ID RELEASE 66%6785807,0.00012742099898063202,0.00518555396908895,-0.39343520503428997,-2.41994740914191,0,87,LIF|IL2RG|MCL1|IL1B|RORC|AKT1|FSCN1|TNF|JAK3|POU2F1|ITGB1|TGFB1|NDN|STAT6|MAOA|CCL11|ITGAX|ALOX5|JUNB|IL18|HSP90B1|BATF|SOCS3|ITGB2|IGHG4|RORA|HGF|GATA3|MMP1|IL13RA1|POMC|CEBPD|S1PR1|SOCS1|STAT3|ICAM1|OSM|PIM1|HMOX1|VCAM1|CCL2|FN1|CD36|F13A1|COL1A2|MMP9|MYC|BCL6|VIM|ITGAM|HSP90AA1|TIMP1|BIRC5|ANXA1|RHOU|CCND1|TNFRSF1B
EICOSANOID LIGAND-BINDING RECEPTORS%REACTOME DATABASE ID RELEASE 66%391903,0.0221378045585538,0.206019523582829,-0.52863467982406,-1.71148321753374,168,11,PTGER2|PTGFR|LTB4R2|PTGER1|OXER1|PTGER4|LTB4R|TBXA2R|CYSLTR2|PTGIR
AMINE OXIDASE REACTIONS%REACTOME DATABASE ID RELEASE 66%140179,0.8356624563289441,0.945788393670804,0.360390225186793,0.708845044097809,6218,3,MAOB|PAOX
EGFR DOWNREGULATION%REACTOME DATABASE ID RELEASE 66%182971,0.42290928902206504,0.7535830358827651,0.241311054144382,1.02447275944817,3104,23,PTPRK|RPS27A|ARHGEF7|PTPN12|SPRY2|PTPN3|STAM2|CBL|EPS15|EGFR
SIGNALING BY PLASMA MEMBRANE FGFR1 FUSIONS%REACTOME%R-HSA-8853336.1,0.42313894114485395,0.753783909572009,0.527407080622036,1.0373474894532901,3148,3,FGFR1|ERLIN2|BAG4
S33 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED%REACTOME%R-HSA-5358747.1,0.744946180099764,0.9112137767014771,-0.216311665379097,-0.785392593135168,5674,15,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|CTNNB1|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS%REACTOME%R-HSA-2173782.1,0.00012936610608020702,0.00518555396908895,-0.633105700328499,-3.0485811213849403,0,36,MSR1|APOL1|HPX|LRP1|HP|SSC5D|IGKV2-28|MARCO|JCHAIN|COL4A1|CALR|SPARC|COL4A2|SCARF1|APOE|FTL|IGKV2D-28|CD163|COLEC12|CD36|COL1A2|COL1A1|COL3A1|STAB1|HSP90AA1|IGHA1|FTH1
SEPARATION OF SISTER CHROMATIDS%REACTOME%R-HSA-2467813.1,0.000128982329420869,0.00518555396908895,-0.305931367230568,-2.1606638629438897,0,165,NUF2|NSL1|PSMD1|PSMC2|SPDL1|CDC20|DYNC1H1|ANAPC10|CLIP1|DSN1|ANAPC2|ANAPC5|ESPL1|PSMD3|PSMB2|CENPM|CDC23|STAG2|NUDC|PSMF1|PTTG1|CENPI|MAD2L1|KNTC1|PSMD4|SHFM1|ERCC6L|PSME2|DYNLL2|INCENP|NUP85|PSMB5|NDC80|SGOL1|KIF18A|CDC27|SEC13|NUP37|CKAP5|CENPH|PSMC4|SPC25|PSMC6|NUP160|PSMD10|KIF2A|PLK1|SKA1|PSMB3|PPP2CA|PSMC1|SPC24|PSMD2|UBC|PSMD6|SMC1A|PSMD12|PSMA3|DYNC1I1|BIRC5|ANAPC11|CENPK|PSMA6|PSMD13|PSMB7|CDCA5|PSMA1|PSMC5|PSMC3|CENPP|SKA2
REELIN SIGNALLING PATHWAY%REACTOME%R-HSA-8866376.2,0.7642983290313821,0.9191113740914171,0.34892185518116103,0.766596175590986,5625,4,VLDLR|RELN|FYN|SH3KBP1
NUCLEOTIDE EXCISION REPAIR%REACTOME%R-HSA-5696398.2,0.0282753326509724,0.23806191359062198,-0.22883073860899103,-1.48922349322135,220,110,YY1|HMGN1|POLR2J|PARP1|RUVBL1|POLD4|PCNA|COPS6|POLD1|SUMO2|PARP2|POLD2|RFC5|POLR2H|TFPT|GTF2H1|RAD23B|INO80E|SUMO3|CDK7|UBC|MNAT1|ERCC8|DDB1|POLR2G|CETN2|ISY1|POLE2|ACTB|POLE3|GPS1|RFC4|XPA|POLR2L|PRPF19|GTF2H2
MITOCHONDRIAL FATTY ACID BETA-OXIDATION OF SATURATED FATTY ACIDS%REACTOME DATABASE ID RELEASE 66%77286,0.0397215397215397,0.284404850552711,0.529807427645613,1.6100359084801399,290,9,HADHB|HADHA|ACADVL|ACADM|ACADS|ECHS1|MECR
COLLAGEN FORMATION%REACTOME%R-HSA-1474290.1,0.000129634430904848,0.00518555396908895,-0.487502618925536,-2.80747301025629,0,68,COL27A1|PLOD2|ADAMTS14|COL20A1|LAMC2|COL18A1|COL23A1|P4HA3|PCOLCE2|COL11A2|CTSV|CTSS|P4HA1|PPIB|CTSB|COL14A1|COL5A3|LOXL1|COL4A1|LOX|COL4A2|COL5A2|COL12A1|COL6A3|COL8A1|COL21A1|CD151|SERPINH1|COL1A2|COL1A1|COL3A1|MMP9|P3H2|COL6A1|CTSL|COL16A1|COL5A1|COL6A2|COL13A1|LOXL2|ITGB4|COL26A1|P4HB
G1 S TRANSITION%REACTOME DATABASE ID RELEASE 66%69206,0.000128040973111396,0.00518555396908895,-0.35312913668602297,-2.37572664962945,0,129,POLE4|CDKN1B|CDK4|AKT1|PSMB1|PRIM2|PSMB9|SKP2|CCNH|LIN54|POLE|TYMS|PSMB4|RPA2|RRM2|PSMD1|MCM10|PSMC2|TFDP2|CDT1|MCM4|MCM6|CDC6|PSMD3|PSMB2|LIN52|PPP2R3B|PSMF1|PCNA|GMNN|ORC1|LIN9|ORC6|PSMD4|MCM3|SHFM1|PSME2|MCM5|CDC45|PSMB5|SKP1|E2F1|PSMC4|DHFR|PSMC6|MAX|PSMD10|CCNB1|CDK7|PSMB3|PPP2CA|PSMC1|PSMD2|UBC|MCM2|MNAT1|TK1|PSMD6|MYC|PSMD12|PSMA3|POLE2|POLA1|POLE3|PSMA6|CCND1|PSMD13|PSMB7|PSMA1|POLA2|PSMC5|PSMC3
SUMOYLATION OF RNA BINDING PROTEINS%REACTOME DATABASE ID RELEASE 66%4570464,0.55464799688837,0.8244794431799929,-0.186350534691968,-0.9332630872833181,4277,41,NUP188|SUMO2|NUP85|CBX4|NUP37|NUP160|RING1|NUP214|HNRNPK|HNRNPC
INLB-MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL%REACTOME DATABASE ID RELEASE 66%8875360,0.91809058855438,0.976125232231811,0.17203300199913302,0.618350439963208,6769,14,MET|RPS27A|STAM2|CBL|EPS15
PRE-NOTCH PROCESSING IN THE ENDOPLASMIC RETICULUM%REACTOME%R-HSA-1912399.2,0.0593320235756385,0.35281782493219005,-0.591528321659037,-1.5215701928180598,452,6,POFUT1|POGLUT1|NOTCH4|NOTCH1|NOTCH2|NOTCH3
LIGAND-DEPENDENT CASPASE ACTIVATION%REACTOME DATABASE ID RELEASE 66%140534,0.0100943890928159,0.128792895043239,-0.5142207055703649,-1.8192376599045301,76,14,TNFRSF10A|TNFRSF10B|TICAM2|TRAF2|TNFSF10|FADD|TICAM1|TLR4|CD14|LY96
FICOLINS BIND TO REPETITIVE CARBOHYDRATE STRUCTURES ON THE TARGET CELL SURFACE%REACTOME DATABASE ID RELEASE 66%2855086,0.20509418944017,0.5851419434522471,-0.730245381858285,-1.21524509042865,1545,2,FCN3|FCN1
PAOS OXIDISE POLYAMINES TO AMINES%REACTOME DATABASE ID RELEASE 66%141334,0.620135476158852,0.8551097775270831,0.687031318923688,0.916063560686454,4668,1,PAOX
PP2A-MEDIATED DEPHOSPHORYLATION OF KEY METABOLIC FACTORS%REACTOME%R-HSA-163767.3,0.8741451867438191,0.9596763962654549,-0.278889012802162,-0.668443746764894,6646,5,PPP2CA
SDK INTERACTIONS%REACTOME%R-HSA-373756.2,0.6862272240085749,0.8861293611544642,0.503060380479735,0.8452063919608571,5121,2,SDK2|SDK1
PLASMALOGEN BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%75896,0.519694533762058,0.8050637202008951,0.58334711883099,0.980098478631361,3878,2,GNPAT|AGPS
ACTIVATED NTRK2 SIGNALS THROUGH FYN%REACTOME DATABASE ID RELEASE 66%9032500,0.9728297785626949,0.9918144522763359,0.251949836233977,0.5535445201546939,7160,4,DOCK3|SRC
FRUCTOSE METABOLISM%REACTOME DATABASE ID RELEASE 66%5652084,0.19600923035156798,0.571699341995829,0.490413347567359,1.26897336100303,1443,6,KHK|SORD
BH3-ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI-APOPTOTIC BCL-2 MEMBERS%REACTOME DATABASE ID RELEASE 66%111453,0.676767676767677,0.8835592822191172,0.271116193642715,0.823897107435804,4957,9,BBC3|PMAIP1|BID|BCL2|BMF
PLASMA LIPOPROTEIN REMODELING%REACTOME%R-HSA-8963899.1,0.0641900761354686,0.36331232087474197,-0.413697962855385,-1.5020702431942201,488,15,PCSK5|ANGPTL4|ABCG1|CETP|MBTPS2|APOE|PCSK6|LMF1
INTEGRATION OF PROVIRUS%REACTOME DATABASE ID RELEASE 66%162592,0.850312662845232,0.949296218452153,-0.227194229110846,-0.6834558520520521,6526,9,BANF1
SUMOYLATION OF DNA METHYLATION PROTEINS%REACTOME DATABASE ID RELEASE 66%4655427,0.695589393541612,0.890511436799833,-0.22638126584898896,-0.821953680171427,5298,15,PCGF2|CBX2|DNMT3B|PHC3|PHC2|DNMT1|CBX4|RING1
EICOSANOIDS%REACTOME%R-HSA-211979.1,0.140222870788007,0.504613420930072,-0.7702784670526609,-1.28186654596374,1056,2,TBXAS1|PTGIS
PLASMA LIPOPROTEIN CLEARANCE%REACTOME%R-HSA-8964043.1,0.0100522193211488,0.128551972337873,-0.431333760454974,-1.81098995076955,76,23,AP2A2|APOC1|CLTA|LSR|APOBR|CLTC|NR1H3|APOE|LDLR|MYLIP|NPC2|AP2M1
MUSCARINIC ACETYLCHOLINE RECEPTORS%REACTOME%R-HSA-390648.1,0.634696372775438,0.8634223229282929,0.38957248236971503,0.85590733473847,4671,4,CHRM4|CHRM3|CHRM1
BIOSYNTHESIS OF DPAN-3-DERIVED PROTECTINS AND RESOLVINS%REACTOME%R-HSA-9026286.1,0.5463545150501671,0.817655622966367,-0.729708866343185,-0.9721474234007309,4083,1,ALOX5
STRIATED MUSCLE CONTRACTION%REACTOME%R-HSA-390522.1,0.7920899363402409,0.92928601839974,0.18287477930425397,0.753837462222468,5847,21,TMOD3|DMD|NEB|TPM1|TPM2|TMOD1|TMOD2
TAT-MEDIATED ELONGATION OF THE HIV-1 TRANSCRIPT%REACTOME%R-HSA-167246.2,0.0820160663384296,0.398202308598866,-0.278479315614888,-1.4032904419739398,632,42,SUPT16H|NCBP1|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|POLR2L|GTF2H2
P75 NTR RECEPTOR-MEDIATED SIGNALLING%REACTOME DATABASE ID RELEASE 66%193704,0.486961372193557,0.7880171277015351,0.157630745581538,0.9846515401251971,3491,89,SMPD2|ARHGEF33|ABR|OBSCN|TIAM2|ADAM17|RPS27A|HDAC1|FGD4|RTN4|ARHGEF7|PSENEN|MCF2L|VAV2|SOS1|AKAP13|ARHGEF4|PLEKHG5|PSEN2|ARHGEF10|LINGO1|APH1B|YWHAE|ARHGEF19
SEMA3A-PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION%REACTOME%R-HSA-399955.1,0.44218668065023603,0.7653693162885199,-0.284837467593096,-1.00771330750369,3372,14,FES|TLN1|RND1|SEMA3A|RRAS
TYSND1 CLEAVES PEROXISOMAL PROTEINS%REACTOME DATABASE ID RELEASE 66%9033500,0.7460567823343851,0.911706491458069,-0.28091560948703803,-0.767870291280037,5675,7,PHYH|AGPS|ACAA1|HSD17B4|TYSND1|SCP2|ACOX1
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE%REACTOME%R-HSA-264642.2,0.0192568483862219,0.19188487733105897,0.476941906262885,1.71430617467243,141,14,RIMS1|SNAP25|PPFIA2|SLC18A3|CPLX1|PPFIA3|PPFIA4
RESOLUTION OF SISTER CHROMATID COHESION%REACTOME DATABASE ID RELEASE 66%2500257,0.0143350825547165,0.160299326258379,-0.247242406842025,-1.58476685579799,111,103,CENPE|KIF2C|CDCA8|NUP107|NDE1|STAG1|CASC5|CCNB2|RAD21|ZWINT|RCC2|ITGB3BP|CENPL|CENPU|NUF2|NSL1|SPDL1|CDC20|DYNC1H1|CLIP1|DSN1|CENPM|STAG2|NUDC|CENPI|MAD2L1|KNTC1|ERCC6L|DYNLL2|INCENP|NUP85|NDC80|SGOL1|KIF18A|SEC13|NUP37|CKAP5|CENPH|SPC25|NUP160|KIF2A|CCNB1|PLK1|SKA1|PPP2CA|SPC24|SMC1A|DYNC1I1|BIRC5|CENPK|CDCA5|CENPP|SKA2
NUCLEOTIDE METABOLISM%REACTOME DATABASE ID RELEASE 66%15869,0.408468418110676,0.744594988699055,0.16799687937871502,1.03138410502485,2922,83,NUDT13|ADAL|DGUOK|AK9|PFAS|NT5M|PAICS|AMPD2|NME3|CAD|UCKL1|ADSL|DCTD|ADPRM|ENTPD7|AK5|ITPA|NT5C2|NT5E|ATIC|DPYD|PPAT|ENTPD6|ENTPD3|AK7|DHODH|AK4|ENTPD4|TK2
APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS%REACTOME DATABASE ID RELEASE 66%351906,0.17766964755391895,0.5496706581618629,-0.5407943797427079,-1.2961809351774198,1350,5,TJP2|OCLN
CLEARANCE OF SERATONIN%REACTOME%R-HSA-380615.3,0.24223932077474103,0.625158460820442,-0.7121036669423771,-1.18505437573024,1825,2,MAOA|ALDH2
FORMATION OF THE EARLY ELONGATION COMPLEX%REACTOME DATABASE ID RELEASE 66%113418,0.0525355233998175,0.331996459809677,-0.319283934528066,-1.4994474893390501,402,33,NCBP1|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|POLR2L|GTF2H2
TOLL LIKE RECEPTOR 3 (TLR3) CASCADE%REACTOME%R-HSA-168164.3,0.62109174782163,0.855874557802797,-0.14579491299102698,-0.9078672725469971,4846,92,TICAM2|ATF1|ELK1|IKBKE|MAPKAPK2|MEF2C|MAPK9|MAPK3|IRF7|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|FADD|UBC|TICAM1|TRAF3|RELA|NFKB1|TLR4|CD14|LY96
POTASSIUM CHANNELS%REACTOME%R-HSA-1296071.1,0.133609385783299,0.495264631574533,0.226065535056214,1.2835532861288201,967,61,KCNQ3|KCNS3|KCNQ5|GNG5|KCNAB3|KCNMB4|KCNH8|GNGT1|KCNK9|HCN2|KCNJ8|KCNK10|KCNQ2|KCNK3|GABBR1|KCNMA1|KCNG1|KCNC3|KCNC4|HCN3|KCNB1|KCNN4|KCNK2|GNG4|KCNH1
NF-KB ACTIVATION THROUGH FADD RIP-1 PATHWAY MEDIATED BY CASPASE-8 AND -10%REACTOME DATABASE ID RELEASE 66%933543,0.9488574537540799,0.984504384435631,0.17119708213846502,0.581865584023405,6975,12,RIPK1|CASP8|RNF135|IKBKB|MAVS
PROCESSING AND ACTIVATION OF SUMO%REACTOME DATABASE ID RELEASE 66%3215018,0.21927301255230103,0.601686354077891,-0.39395160583382793,-1.23419895445944,1676,10,SENP2|SENP5|SUMO2|SUMO3
COENZYME A BIOSYNTHESIS%REACTOME%R-HSA-196783.3,0.938167143972924,0.9806508984207809,-0.205603598309917,-0.5919039831640749,7206,8,COASY|SLC25A16
SPERM MOTILITY AND TAXES%REACTOME DATABASE ID RELEASE 66%1300642,0.117844665412524,0.46862716515177505,0.693779640454395,1.36458268138977,876,3,CATSPERG|CATSPER2|HVCN1
SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE%REACTOME%R-HSA-1799339.1,0.0292988741044012,0.24279324540366198,-0.22789554275422402,-1.483137267017,228,110,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|SRP19|SEC11C|RPL35|RPL38|RPS15A|SRPRB|RPL36AL|SEC61A1|SEC61B|SSR1|RPS13|RPL26L1|FAU|SRP9|SSR3|SRP68|RPN1|SSR4
ABC TRANSPORTER DISORDERS%REACTOME DATABASE ID RELEASE 66%5619084,0.000128799587841319,0.00518555396908895,-0.40373071891101897,-2.2556173957055297,0,60,PSMD3|PSMB2|PSMF1|VCP|PSMD4|SEL1L|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|DERL3|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
TRIGLYCERIDE CATABOLISM%REACTOME DATABASE ID RELEASE 66%163560,0.00183150183150183,0.0366658253519131,-0.5462767363854221,-2.03017587476713,13,16,FABP3|ABHD5|PLIN3|FABP4|CAV1|PRKACA|MGLL|PPP1CA|PNPLA4
SUMO IS CONJUGATED TO E1 (UBA2:SAE1)%REACTOME DATABASE ID RELEASE 66%3065676,0.48250920568122,0.7867318061717721,-0.40296766005627604,-0.9658365878478621,3668,5,SUMO2|SUMO3
PKA-MEDIATED PHOSPHORYLATION OF KEY METABOLIC FACTORS%REACTOME DATABASE ID RELEASE 66%163358,0.278057840275935,0.653204101106396,-0.6935234187337179,-1.15413387150595,2095,2,PRKACA
INOSITOL PHOSPHATE METABOLISM%REACTOME DATABASE ID RELEASE 66%1483249,0.250686436024163,0.631479765290861,0.227507060731457,1.1628786741958401,1825,42,PLCD1|PLCD4|INPP1|INPP5J|PLCD3|MTMR9|IMPA1|PLCB4|INPP4A|INPPL1|PLCG1|ITPKC|ISYNA1
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION%REACTOME%R-HSA-389661.5,0.195314628166712,0.570175490405239,0.29256517967631107,1.24206932004908,1433,23,LIPT1|LIAS|GCSH|BCKDHB|DLAT|AMT|HOGA1|DHTKD1
CLOSTRIDIUM NEUROTOXICITY%REACTOME%R-HSA-168799.1,0.319825945063911,0.687907957122243,0.350627765708136,1.1108124624808202,2351,10,SYT2|SV2C|SNAP25
BETA OXIDATION OF MYRISTOYL-COA TO LAUROYL-COA%REACTOME DATABASE ID RELEASE 66%77285,0.0215702036441586,0.20285300542357199,0.903611800385994,1.51818449469062,160,2,HADHB|HADHA
UBIQUITIN-DEPENDENT DEGRADATION OF CYCLIN D%REACTOME%R-HSA-75815.2,0.000128816179312122,0.00518555396908895,-0.4384041292172439,-2.32700175477759,0,50,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|CCND1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
RUNX1 INTERACTS WITH CO-FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN%REACTOME DATABASE ID RELEASE 66%8939243,0.567529107373868,0.83116084992853,-0.19213925342976504,-0.9252042753351429,4386,36,PCGF5|CBX2|PHC3|ACTL6B|PHC2|SMARCA4|RUNX1|SMARCA2|SMARCE1|SMARCD3|CBX4|CBX6|SMARCD2|RING1
COSTIMULATION BY THE CD28 FAMILY%REACTOME%R-HSA-388841.2,0.32012432012432,0.6881592504645461,-0.19617719261538397,-1.08986437414081,2471,59,HLA-DQA1|CD3D|CD3G|AKT2|RICTOR|PPP2R5E|PPP2R5D|MAP3K8|CSK|MAP3K14|TRIB3|PPP2R5B|PTPN11|FYN|HLA-DRB1|GRAP2|AKT1|CDC42|PAK2|HLA-DQB2|MLST8|RAC1|CD274|HLA-DPA1|LYN|HLA-DRA|HLA-DRB5|TNFRSF14|HLA-DPB1|CD4|HLA-DQA2|PDCD1LG2|VAV1|PTPN6|PIK3R3|ICOSLG|CD86|PPP2CA|MAPKAP1
"ACTIVATION OF THE MRNA UPON BINDING OF THE CAP-BINDING COMPLEX AND EIFS, AND SUBSEQUENT BINDING TO 43S%REACTOME DATABASE ID RELEASE 66%72662",0.5977725977725981,0.84497371045681,-0.16466341169186302,-0.9147892460633029,4615,59,RPS14|RPS4X|RPS29|EIF1AX|EIF3B|RPS15A|RPS13|EIF2S1|EIF4A2|FAU|EIF4G1
REGULATION OF CYTOSKELETAL REMODELING AND CELL SPREADING BY IPP COMPLEX COMPONENTS%REACTOME DATABASE ID RELEASE 66%446388,0.0626971608832808,0.35953174563296797,-0.5568089190293181,-1.5220123496273499,476,7,RSU1|PXN|ACTN1
ASSEMBLY OF THE ORC COMPLEX AT THE ORIGIN OF REPLICATION%REACTOME DATABASE ID RELEASE 66%68616,0.8596443599837109,0.951070228184264,0.26299433479348,0.680513298838795,6332,6,ORC2|ORC4
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING%REACTOME%R-HSA-879415.1,0.631647891013885,0.8616028929314681,-0.26503365331567896,-0.8580607119502769,4821,11,MAPK1|HMGB1|AGER|DDOST|CAPZA1|PRKCSH|S100B|APP|CAPZA2|MAPK3|LGALS3
TOLL LIKE RECEPTOR 7 8 (TLR7 8) CASCADE%REACTOME%R-HSA-168181.1,0.5971443141254461,0.844862323067435,-0.15026663233939402,-0.9192590988370921,4683,85,MAPKAPK2|MEF2C|MAPK9|MAPK3|IRF7|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|UBC|TICAM1|RELA|NFKB1|TLR4|CD14|LY96|PELI3
LYSOSOME VESICLE BIOGENESIS%REACTOME%R-HSA-432720.1,0.0993110620044196,0.434988230059559,-0.291138121669388,-1.37934946298425,763,34,HGS|TXNDC5|CLTA|SH3GL2|CLTC|ARRB1|VAMP8|ARF1|VAMP7|CTSZ|AP1B1|AP4S1|CLTB
IKBKG DEFICIENCY CAUSES ANHIDROTIC ECTODERMAL DYSPLASIA WITH IMMUNODEFICIENCY (EDA-ID) (VIA TLR)%REACTOME DATABASE ID RELEASE 66%5603027,0.669040580489116,0.8815356925073421,0.42434101687438003,0.8346287046573649,4978,3,IKBKB|IKBKG|CHUK
REMOVAL OF THE FLAP INTERMEDIATE FROM THE C-STRAND%REACTOME DATABASE ID RELEASE 66%174437,0.11427824267782401,0.463696586909637,-0.4497655859308471,-1.4090568681216002,873,10,RPA2|POLD4|PCNA|POLD1|POLD2|FEN1
BIOSYNTHESIS OF MARESIN-LIKE SPMS%REACTOME DATABASE ID RELEASE 66%9027307,0.0653050255307713,0.366933938653309,0.7483180765413041,1.47185334921383,485,3,CYP2E1|CYP2C8|CYP2D6
DEFECTIVE MMACHC CAUSES METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE CBLC%REACTOME%R-HSA-3359474.1,0.602470447602603,0.8479232669964059,0.69634980149978,0.9284884998322008,4535,1,MMACHC
CHREBP ACTIVATES METABOLIC GENE EXPRESSION%REACTOME DATABASE ID RELEASE 66%163765,0.547871643745907,0.8186230305367759,-0.35787813093719495,-0.9205589601664961,4182,6,AGPAT1|MLX|FASN
ION HOMEOSTASIS%REACTOME%R-HSA-5578775.1,0.0269671704012507,0.232363844440745,-0.316305436297097,-1.60429022549467,206,43,RYR2|ITPR2|ATP1B1|ATP2A1|PLN|ITPR3|ATP1A3|ATP1B3|STIM1|ATP2A3|ABCC9|CAMK2B|FXYD1|ASPH|CAMK2A|CLIC2|ATP1B2|PRKACA|ATP2B2|FXYD7
METABOLISM OF STEROID HORMONES%REACTOME DATABASE ID RELEASE 66%196071,0.278477583638088,0.653204101106396,0.27765429670042197,1.14453294869918,2055,21,HSD17B3|STARD4|SRD5A1|HSD17B11|FDX1L|HSD11B2
FGFR3 MUTANT RECEPTOR ACTIVATION%REACTOME DATABASE ID RELEASE 66%2033514,0.7366299381886591,0.908157084784786,0.40031790098352604,0.7873780706142449,5481,3,FGF2|FGF1
LIPOPROTEIN METABOLISM%REACTOME DATABASE ID RELEASE 66%174824,0.000391287335333246,0.0111294649577428,-0.42877378775728797,-2.18574388677409,2,44,AP2A2|PCSK5|APOC1|ANGPTL4|CLTA|ABCG1|LSR|APOBR|CLTC|CETP|MBTPS2|NR1H3|APOE|PCSK6|A2M|LDLR|LMF1|PRKACA|MYLIP|NPC2|SAR1B|AP2M1|P4HB
ALPHA-OXIDATION OF PHYTANATE%REACTOME DATABASE ID RELEASE 66%389599,0.0750202757502028,0.383578507779904,0.6264615045223909,1.5066363259259399,554,5,SLC25A17|PHYH|HACL1|PECR|SLC27A2
FGFR4 MUTANT RECEPTOR ACTIVATION%REACTOME DATABASE ID RELEASE 66%1839128,0.45043478260869607,0.7687932540972091,-0.776246140273489,-1.0341462465343398,3366,1,FGFR4
SODIUM CALCIUM EXCHANGERS%REACTOME DATABASE ID RELEASE 66%425561,0.9902623748985658,0.9968231941827841,0.174706703888491,0.482273166682128,7321,7,SRI|SLC8A2|SLC8A1|SLC24A1
SYNTHESIS OF ACTIVE UBIQUITIN: ROLES OF E1 AND E2 ENZYMES%REACTOME DATABASE ID RELEASE 66%8866652,0.6468279921517329,0.8697778704754799,-0.189729298809974,-0.8662668337681751,4944,30,UBE2L3|UBE2A|UCHL3|UBE2D2|UBE2T|UBE2Z|UBE2B|USP9X|UBE2G2|UBE2S|UBE2R2|UBA1|UBC
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING%REACTOME%R-HSA-112308.3,0.337269272529859,0.699636319850872,0.33278259057827503,1.09505906486605,2484,11,CACNB4|CACNA2D2|CACNG4|CACNB2|CACNA2D3|CACNA1B|CACNB3|CACNG2
EPH-EPHRIN SIGNALING%REACTOME%R-HSA-2682334.1,0.25739041794087697,0.636027662086593,-0.184561016653587,-1.1352007862146398,2019,87,EPHA5|ROCK1|ITSN1|CDC42|PAK2|RAC1|ACTG1|LYN|PSEN1|MYL12B|VAV3|EPHB3|AP2A2|MYH11|DNM1|ARPC1A|EPHA8|CLTA|KALRN|GRIN1|EFNA1|CLTC|NGEF|HRAS|MYL12A|SDC2|EPHA2|EFNA3|EPHA4|MMP9|MYH9|CFL1|EPHB4|TIAM1|ACTB|MYL9|AP2M1|EFNA5|CLTB
RIP-MEDIATED NFKB ACTIVATION VIA ZBP1%REACTOME DATABASE ID RELEASE 66%1810476,0.393511250654108,0.73762759729289,-0.281736052465348,-1.04704026122709,3007,16,NFKBIA|TICAM1|RELA|NFKB1
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST%REACTOME%R-HSA-6804114.2,0.66265690376569,0.8796297678152929,-0.217651270590768,-0.84456787656832,5067,18,RBL1|SFN|AURKA|PRMT1|TFDP2|PCNA|CDC25C|CCNB1|ZNF385A
ASSEMBLY OF THE PRE-REPLICATIVE COMPLEX%REACTOME%R-HSA-68867.4,0.000128998968008256,0.00518555396908895,-0.42986264577093103,-2.45820592104511,0,66,PSMD1|PSMC2|CDT1|MCM4|MCM6|CDC6|PSMD3|PSMB2|PSMF1|E2F2|GMNN|ORC1|ORC6|PSMD4|MCM3|SHFM1|PSME2|MCM5|PSMB5|E2F1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|MCM2|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
SIGNALING BY LEPTIN%REACTOME%R-HSA-2586552.2,0.7535797969278829,0.915550465961143,-0.264482095608939,-0.7614069362275458,5788,8,STAT5B|PTPN11|STAT5A|SOCS3|IRS1|STAT3
DISEASES OF CARBOHYDRATE METABOLISM%REACTOME DATABASE ID RELEASE 66%5663084,0.17652423137050502,0.548380753278361,-0.42831209084193,-1.28846760824962,1354,9,EPM2A|GYG1|PPP1R3C|UBC|GYG2
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER%REACTOME DATABASE ID RELEASE 66%76061,0.873821989528796,0.9595052445364269,-0.15495197989939802,-0.6920328725892231,6675,28,GTF3A|GTF3C1|BRF1|POLR3B|GTF3C5|POLR2H|POLR3K|BDP1|POLR2L
SMAD2 SMAD3:SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION%REACTOME%R-HSA-2173796.1,0.44738213076322,0.768229288546963,-0.21780200708800196,-1.00375647645416,3434,31,CCNK|TGIF1|CDKN2B|SNW1|MEN1|WWTR1|UBC|SERPINE1|MYC
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL%REACTOME%R-HSA-1855204.3,0.26145479265805605,0.6372263165872061,0.279228915054451,1.16855975128941,1922,22,PLCD1|PLCD4|INPP5J|PLCD3|PLCB4|INPPL1|PLCG1|ITPKC
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24-HYDROXYCHOLESTEROL%REACTOME DATABASE ID RELEASE 66%193775,0.6180700836820079,0.854944793214197,-0.276520345606703,-0.8663021456968271,4726,10,CYP46A1|PTGIS
RAF MAP KINASE CASCADE%REACTOME%R-HSA-5673001.4,0.00332438307121851,0.0594547603050214,-0.220237324112495,-1.60912201286096,25,195,CSF2RB|PSMD4|VWF|SHFM1|IRS1|PSME2|IL2RA|ARRB1|PSMB5|FGF10|MAPK3|CAMK2B|HRAS|PSMC4|HBEGF|PSMC6|CSF2RA|PSMD10|RAP1A|FN1|IL3RA|PSMB3|PPP2CA|FGF19|FGF9|TEK|MAP3K11|GRIN2C|FGF7|PSMC1|VCL|ARAF|DLG3|PEA15|PSMD2|UBC|PDGFRB|GRIN2D|PSMD6|CAMK2A|FLT3LG|PSMD12|PSMA3|PDGFRA|SPTBN2|PHB|PSMA6|PSMD13|PSMB7|PSMA1|PDGFB|PSMC5|PSMC3
ANTIGEN PROCESSING: UBIQUITINATION & PROTEASOME DEGRADATION%REACTOME%R-HSA-983168.2,0.9346580053496372,0.980482119883153,-0.0991086420050543,-0.7732527629731241,7337,284,PSMB1|KLHL11|DZIP3|VHL|UBE2J1|UBE2L3|KLHL3|UBE2A|PSMB9|KBTBD8|SKP2|FBXL7|FBXO10|KLHL22|TCEB2|ASB8|UBE2D2|FBXL14|PSMB4|NPEPPS|ATG7|FBXW11|KLHL20|PSMD1|HECTD1|PSMC2|UBE2O|UBAC1|CDC20|ANAPC10|TRIM21|UBA5|UBE2Z|DTX3L|UBE2B|FBXO6|ANAPC2|RLIM|SOCS3|TRIM9|LNPEP|ANAPC5|PSMD3|PSMB2|CDC23|HERC6|RNF114|FBXW2|PSMF1|RNF144B|UBE2G2|RNF7|TRIM69|SIAH2|PSMD4|BTBD6|RBBP6|SHFM1|SMURF2|UBE2S|SOCS1|PSME2|RNF138|PSMB5|TRIM32|UBE2R2|HUWE1|CDC27|SKP1|ANAPC13|HECTD2|RCHY1|PSMC4|UBA1|PSMC6|FBXO4|PSMD10|PSMB3|PSMC1|PSMD2|UBC|FBXO17|PSMD6|FBXW5|PJA1|MYLIP|PSMD12|PSMA3|ANAPC11|UBE2L6|PSMA6|LRR1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|RNF130|SPSB1
SMAC-MEDIATED DISSOCIATION OF IAP:CASPASE COMPLEXES%REACTOME DATABASE ID RELEASE 66%111464,0.9255204109218709,0.9786453534208341,0.257304996991988,0.618817042247385,6846,5,CASP9|CASP3|CASP7
CARGO CONCENTRATION IN THE ER%REACTOME DATABASE ID RELEASE 66%5694530,0.00013089005235602098,0.00518555396908895,-0.612624220246679,-2.73604828560625,0,28,SEC23A|SERPINA1|F8|SEC24A|CNIH2|CNIH1|TMED2|CTSZ|CTSC|CD59|STX5|CNIH3|TMED10|LMAN2|GOSR2|SAR1B|GRIA1
DISPLACEMENT OF DNA GLYCOSYLASE BY APEX1%REACTOME DATABASE ID RELEASE 66%110357,0.9407627806329459,0.9812919575525741,0.215504689523151,0.594894910944657,6955,7,NTHL1|OGG1|SMUG1|TDG
RUNX1 AND FOXP3 CONTROL THE DEVELOPMENT OF REGULATORY T LYMPHOCYTES (TREGS)%REACTOME%R-HSA-8877330.1,0.42021556256572,0.751774348695433,-0.3760676013115539,-1.0279640176898501,3196,7,FOXP3|NFATC2|RUNX1|TNFRSF18|IL2RA
ACTIVATION OF RAS IN B CELLS%REACTOME%R-HSA-1169092.1,0.9766153014328199,0.9927322181739301,0.22053799941779603,0.530392623922206,7224,5,NRAS|KRAS|RASGRP3
CELLULAR RESPONSES TO STRESS%REACTOME DATABASE ID RELEASE 66%2262752,0.000128567755206994,0.00518555396908895,-0.263244624810263,-2.1255230553468003,0,355,PSMD1|PSMC2|ACTR10|DCTN4|H1F0|PHC2|DYNC1H1|HIST1H2BE|ANAPC10|RPS6KA1|TFDP2|NR3C1|TERF2|EZH2|ANAPC2|H2AFX|NBN|HSPA13|TINF2|ANAPC5|HIST2H2AC|DNAJC7|HIST1H2AD|ERO1L|PSMD3|PSMB2|CDC23|SOD2|CDKN2A|HIST1H2BN|H2AFV|PSMF1|BAG5|E2F2|ETS2|GPX1|VCP|HIST1H2BC|NUP188|PSMD4|BAG3|MAPKAPK2|HSPA6|SHFM1|CYCS|STAT3|MAPK9|HSPA9|PSME2|DYNLL2|HIST1H4I|LMNB1|NUP85|PSMB5|CDKN2B|SOD3|MAPK3|CAMK2B|RBBP7|CYBB|CDC27|SOD1|CBX4|CEBPB|TNRC6C|NUP37|E2F1|NCF4|RPTOR|PSMC4|CBX6|HIF3A|HIST2H3A|PSMC6|NUP160|CCS|MAP2K3|GPX8|PSMD10|CAT|NCF2|PSMB3|DCTN5|RING1|NUP214|H2AFZ|PSMC1|PSMD2|UBC|HIST2H2AA4|ID1|PSMD6|CAMK2A|HIST1H2BG|CRYAB|HIST1H2BD|GPX3|HIST2H4A|HIST1H2AE|DNAJA1|FKBP4|HIST2H3C|RELA|NFKB1|CDKN2C|HIST1H3H|PSMD12|PSMA3|KAT5|HSP90AA1|ATOX1|HSPA5|HIST1H1C|DYNC1I1|HIST2H4B|ANAPC11|GSTP1|H3F3B|HIST1H2AC|PSMA6|HSPA4|IGFBP7|FKBP5|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|H2AFJ|WTIP|HIST1H2BK|PSMA1|DCTN3|PSMC5|STIP1|HIST1H2BJ|PSMC3|HIST2H2AA3|P4HB
MITOTIC G2-G2 M PHASES%REACTOME%R-HSA-453274.2,0.000767459708365311,0.0191058847417112,-0.24400028071433,-1.75304838085377,5,179,TUBG1|PSME1|CCNB2|CEP72|HAUS6|AURKA|PSMB1|TUBGCP5|AJUBA|CEP78|HAUS4|PSMB9|CEP76|CSNK1D|CCNH|MZT2A|RAB8A|FBXL7|LIN54|CEP192|PCNT|NEK2|NEDD1|PSMB4|FBXW11|PSMD1|PSMC2|DYNC1H1|LCMT1|OFD1|CEP70|TUBGCP2|PSMD3|PSMB2|TUBG2|LIN52|TPX2|TUBA4A|PPP2R3B|SDCCAG8|PSMF1|HAUS8|PKMYT1|CDK5RAP2|CDC25C|LIN9|PSMD4|SHFM1|FOXM1|PSME2|PSMB5|CEP131|SKP1|E2F1|CKAP5|TUBB4A|PSMC4|PSMC6|MYBL2|PSMD10|CCNB1|PLK1|CDK7|PSMB3|PPP2CA|PSMC1|PSMD2|UBC|MNAT1|PSMD6|SSNA1|PRKACA|CETN2|PSMD12|PSMA3|HSP90AA1|CEP63|PSMA6|TUBB4B|PSMD13|PSMB7|PSMA1|DCTN3|HAUS7|PSMC5|PSMC3
REGULATION OF APOPTOSIS%REACTOME DATABASE ID RELEASE 66%169911,0.000128287363694676,0.00518555396908895,-0.423259781210579,-2.26009663654928,0,51,PSMD3|PSMB2|OPA1|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
SYNTHESIS OF EPOXY (EET) AND DIHYDROXYEICOSATRIENOIC ACIDS (DHET)%REACTOME%R-HSA-2142670.1,0.967616232195646,0.9912626134248801,0.28202593442803003,0.5547117317700461,7200,3,CYP2C8|EPHX2
NFG AND PRONGF BINDS TO P75NTR%REACTOME%R-HSA-205017.1,0.10228177235340899,0.441073279931729,-0.7998345740281221,-1.33105263434777,770,2,NGF|NGFR
REGULATION OF TLR BY ENDOGENOUS LIGAND%REACTOME DATABASE ID RELEASE 66%5686938,0.00104602510460251,0.0240545523142212,-0.659582575459431,-2.06638610671147,7,10,S100A1|TLR1|TLR2|CD36|TLR4|S100A8|S100A9|CD14|LY96
MET RECEPTOR ACTIVATION%REACTOME DATABASE ID RELEASE 66%6806942,0.862835349815886,0.9529453970190659,-0.284367686101826,-0.681575081237099,6560,5,HGFAC|HGF|SPINT2
RHO GTPASES ACTIVATE PKNS%REACTOME%R-HSA-5625740.1,0.000128865979381443,0.00518555396908895,-0.39999624010481893,-2.28085800700281,0,65,KDM1A|MYH11|H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|PKN1|HIST1H2BC|CDC25C|HIST1H4I|HIST2H3A|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|MYH9|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|MYL9|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|PPP1R14A
INTERLEUKIN-2 FAMILY SIGNALING%REACTOME%R-HSA-451927.5,0.0307891332470893,0.24897404087160396,-0.328500520325665,-1.58182193606901,237,36,IL15RA|CSF2RB|GRB2|STAT3|PTPN6|IL2RA|PIK3CB|PIK3R3|IL15|IL21R|CSF2RA|IL3RA|LGALS9|HAVCR2
DIGESTION AND ABSORPTION%REACTOME DATABASE ID RELEASE 66%8963743,0.4921885613367751,0.791072486428528,0.436438691552078,0.958874392233314,3622,4,AMY2B|CHIT1|SLC2A5|PIR
EARLY PHASE OF HIV LIFE CYCLE%REACTOME%R-HSA-162594.2,0.20241216570529602,0.5810727835229039,-0.351603508112365,-1.24392179541481,1543,14,PSIP1|CD4|PPIA|CXCR4|BANF1|FEN1
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL%REACTOME DATABASE ID RELEASE 66%6790901,0.9320254213871241,0.9798929027166171,0.118616617220481,0.6702548293390971,6745,60,WDR75|IMP4|UTP14C|DCAF13|HEATR1|PDCD11|UTP20|UTP3|BMS1|NOP58|PNO1|WDR46|GAR1|CIRH1A|UTP6|WBSCR22|MPHOSPH10
REGULATION OF ORNITHINE DECARBOXYLASE (ODC)%REACTOME DATABASE ID RELEASE 66%350562,0.000258264462809917,0.00819882332206558,-0.423933709721408,-2.2336631973095495,1,49,ODC1|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
"DEFECTIVE EXT1 CAUSES EXOSTOSES 1, TRPS2 AND CHDS%REACTOME%R-HSA-3656253.3",0.45308675550720706,0.769943206592495,0.313606736608355,0.993527339852699,3331,10,GPC6|SDC1|AGRN|GPC1|GPC2|GPC3
"PI5P, PP2A AND IER3 REGULATE PI3K AKT SIGNALING%REACTOME%R-HSA-6811558.2",0.0927476491047275,0.421303871141266,-0.23515815246665,-1.35047980984249,719,67,PIK3AP1|FGFR4|HGF|VAV1|IER3|INS|IRS1|PIK3CB|FGF10|MAPK3|RHOG|IRAK1|PIK3R3|HBEGF|IL33|CD86|PPP2CA|FGF19|FGF9|FGF7|PDGFRB|PDGFRA|PDGFB
REACTIONS SPECIFIC TO THE HYBRID N-GLYCAN SYNTHESIS PATHWAY%REACTOME DATABASE ID RELEASE 66%975574,0.8778595317725749,0.960725750963158,-0.563575209528011,-0.750817501479437,6561,1,MGAT3
CA-DEPENDENT EVENTS%REACTOME%R-HSA-111996.1,0.0558455114822547,0.343175330485202,-0.34681274083673,-1.5128605099444499,427,26,ADCY8|PRKAR1A|PLA2G4A|ADCY4|PDE1C|PDE1A|PDE1B|PRKACA|ADRBK1|ADCY9
POLYMERASE SWITCHING ON THE C-STRAND OF THE TELOMERE%REACTOME%R-HSA-174411.2,0.0124541164132145,0.14774543117424402,-0.504916555118035,-1.78632093618466,94,14,PRIM2|RFC2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|POLA1|RFC4|POLA2
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION%REACTOME DATABASE ID RELEASE 66%8936459,0.00025970653161927005,0.00819882332206558,-0.37474424984301596,-2.16544530013746,1,69,SETD1B|HIST1H2BE|RUNX1|H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|GP1BA|HIST1H2BC|HIST1H4I|SETD1A|TNRC6C|WDR5|HIST2H3A|KAT2B|THBS1|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|MYL9|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
SIGNALING BY ERYTHROPOIETIN%REACTOME DATABASE ID RELEASE 66%9006335,0.7926580557443921,0.929557432458778,0.18038518766081102,0.754903445397502,5829,22,IRS2|GAB1|SHC1|SOS1|PLCG1|NRAS|KRAS|PIK3CD|JAK2|EPOR
ARACHIDONATE PRODUCTION FROM DAG%REACTOME%R-HSA-426048.2,0.0560231457127827,0.343943018657969,-0.6420989947204361,-1.5389887665792399,425,5,DAGLB|DAGLA|MGLL
MYD88 DEFICIENCY (TLR5)%REACTOME%R-HSA-5602680.1,0.6805518705226851,0.884781692722898,-0.525281886093413,-0.874153057348606,5129,2,TLR5
VEGF BINDS TO VEGFR LEADING TO RECEPTOR DIMERIZATION%REACTOME DATABASE ID RELEASE 66%195399,0.0554543087737568,0.34165878259009896,-0.540571125627076,-1.5562286121075202,425,8,FLT1|KDR|VEGFC|FLT4|VEGFB
"SYNTHESIS AND PROCESSING OF GAG, GAGPOL POLYPROTEINS%REACTOME DATABASE ID RELEASE 66%174495",0.628211851074987,0.8598358835891559,-0.245406373695231,-0.8682118634483409,4791,14,TSG101|UBAP1|MVB12B|UBC|VPS37C
DISEASES ASSOCIATED WITH THE TLR SIGNALING CASCADE%REACTOME DATABASE ID RELEASE 66%5602358,0.000262605042016807,0.00819882332206558,-0.573985511139009,-2.3028188768962403,1,20,NFKBIA|CD36|TLR5|TICAM1|TRAF3|RELA|NFKB1|TLR4|CD14|LY96
"DEFECTIVE B4GALT7 CAUSES EDS, PROGEROID TYPE%REACTOME%R-HSA-3560783.1",0.7029042386185239,0.8934528433311372,-0.219422876422587,-0.8154603709334021,5372,16,HSPG2|NCAN|SDC3|DCN|SDC4|BGN|VCAN|SDC2
MEIOTIC RECOMBINATION%REACTOME DATABASE ID RELEASE 66%912446,0.00012936610608020702,0.00518555396908895,-0.43004719987645396,-2.36799450039013,0,57,DMC1|RAD51|RPA2|MLH3|PSMC3IP|HIST1H2BE|H2AFX|NBN|HIST2H2AC|HIST1H2AD|RAD51C|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|BRCA1|HIST2H3A|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
NEGATIVE REGULATION OF ACTIVITY OF TFAP2 (AP-2) FAMILY TRANSCRIPTION FACTORS%REACTOME%R-HSA-8866904.2,0.522991614822829,0.807051143864932,0.33631647547687205,0.928392603292013,3866,7,SUMO1|TFAP2B|KCTD1|TFAP2E|UBE2I
TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION%REACTOME DATABASE ID RELEASE 66%975138,0.719320648703869,0.9004965804811229,-0.13930446976304098,-0.8493074444176608,5632,84,MAPKAPK2|MEF2C|MAPK9|MAPK3|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|UBC|TICAM1|RELA|NFKB1|TLR4|CD14|LY96|PELI3
MITOTIC PROPHASE%REACTOME%R-HSA-68875.4,0.00012833675564681698,0.00518555396908895,-0.35495936837321795,-2.29285780470333,0,107,SET|SMC2|H2AFX|LEMD3|HIST2H2AC|HIST1H2AD|SETD8|HIST1H2BN|H2AFV|HIST1H2BC|NCAPH2|NUP188|NEK9|HIST1H4I|LMNB1|NUP85|ENSA|NUP37|SMC4|HIST2H3A|NUP160|CCNB1|PLK1|PPP2CA|NUP214|H2AFZ|RAB1B|HIST2H2AA4|HIST1H2BG|LPIN3|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|VRK1|NEK6|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|EMD|H2AFJ|HIST1H2BK|LPIN2|BANF1|HIST1H2BJ|PRKCB|HIST2H2AA3
GPCR DOWNSTREAM SIGNALLING%REACTOME DATABASE ID RELEASE 66%388396,0.266472007109306,0.641603173139009,-0.131346312384219,-1.08566670351864,2098,413,NMT1|PDE4B|KALRN|FPR1|C3|METAP2|ADCY8|FNTB|RGS18|CXCR4|PDE4D|POMC|DAGLB|TAC1|CALCB|SST|OXER1|PRKAR1A|PTGER4|LTB4R|PLA2G4A|S1PR1|PROKR1|CALCRL|TBXA2R|RGS4|ARRB1|SDC4|PDE2A|DGKE|NGEF|MAPK3|APOM|GNGT2|ADCY4|PYY|HRAS|PIK3R3|ARHGEF15|PDE1C|PDE1A|CYSLTR2|GNG11|GNAI2|CHRM2|HBEGF|P2RY6|GNAQ|CXCL16|GPER1|SDC2|HCRT|F2R|EDNRB|CCR1|APOE|INSL3|APLNR|PDE1B|LRP10|DAGLA|PPP2CA|GNA15|GNG10|F2RL3|HEBP1|ADRA2C|ARHGEF9|HSD17B1|HTR1B|GRK6|CX3CL1|LDLR|PTAFR|C3AR1|GPR4|CCL4L2|PDE4A|PRKACA|DHRS3|MGLL|ADRBK1|TIAM1|PTGIR|ANXA1|RGS2|GNG3|PDE6G|PPP1CA|RGS3|SSTR2|NET1|C5AR1|PRKCB|ADCY9
INSULIN EFFECTS INCREASED SYNTHESIS OF XYLULOSE-5-PHOSPHATE%REACTOME DATABASE ID RELEASE 66%163754,0.14645794640488197,0.513872620660976,-0.7666390956713539,-1.275810050006,1103,2,TKT|TALDO1
REGULATION OF PTEN MRNA TRANSLATION%REACTOME DATABASE ID RELEASE 66%8943723,0.562244062244062,0.828541380171721,0.29821086967953103,0.9062353289699291,4118,9,AGO2|TNRC6B|AGO3|MOV10|AGO1
CARDIAC CONDUCTION%REACTOME%R-HSA-5576891.2,0.12313765439959301,0.47697345522944606,-0.19937866422008999,-1.2629561542682302,966,98,KCND2|RYR2|ITPR2|ATP1B1|ATP2A1|KCNIP3|PLN|ITPR3|ATP1A3|ATP1B3|KCNK6|STIM1|ATP2A3|KCNIP4|KCNK7|NPR2|CACNA2D4|ABCC9|CAMK2B|FXYD1|KCNJ12|NPR1|KCNQ1|KAT2B|ASPH|WWTR1|CAMK2A|SCN1B|CLIC2|ATP1B2|PRKACA|KCNH2|KCNE4|ATP2B2|FXYD7
INFLUENZA VIRUS INDUCED APOPTOSIS%REACTOME DATABASE ID RELEASE 66%168277,0.253250198991775,0.632257972333528,-0.7057071960297769,-1.1744096252590701,1908,2,TGFB1|SLC25A6
HH MUTANTS THAT DON'T UNDERGO AUTOCATALYTIC PROCESSING ARE DEGRADED BY ERAD%REACTOME%R-HSA-5362768.1,0.000128799587841319,0.00518555396908895,-0.450566530883317,-2.43196364104022,0,53,PSMD3|PSMB2|PSMF1|VCP|PSMD4|SEL1L|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|SYVN1|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY%REACTOME DATABASE ID RELEASE 66%168333,0.877266205817139,0.960725750963158,-0.155292367336836,-0.684915207685186,6725,27,NUP188|NUP85|NUP37|RAN|NUP160|NUP214
TRANSCRIPTIONAL ACTIVATION OF P53 RESPONSIVE GENES%REACTOME%R-HSA-69560.2,0.6522706452035071,0.8734034730930859,-0.384336594509237,-0.8413931461636421,4983,4,ZNF385A
LIPID PARTICLE ORGANIZATION%REACTOME DATABASE ID RELEASE 66%8964572,0.764026626817009,0.9191113740914171,0.34896866433198603,0.766699017288838,5623,4,HSD17B13|HILPDA
FORMATION OF ANNULAR GAP JUNCTIONS%REACTOME%R-HSA-196025.2,0.0134184471078687,0.15397542988128501,-0.596316298118719,-1.79386538653854,102,9,GJA1|DNM1|CLTA|CLTC|DAB2|AP2M1|CLTB
"DEFECTIVE POMT2 CAUSES MDDGA2, MDDGB2 AND MDDGC2%REACTOME%R-HSA-5083629.1",0.894275468189667,0.9658968257150641,0.5520511689457429,0.7360857439480559,6732,1,DAG1
INTERLEUKIN-17 SIGNALING%REACTOME%R-HSA-448424.5,0.6148965517241379,0.853015730700574,0.15589322093994698,0.904657131860204,4457,66,DUSP4|DUSP6|UBE2V1|MAPK7|RPS6KA2|RPS27A|MAP2K6|IL17RC|MAPK11|BTRC|VRK3|MAPKAPK3|TNIP2|NOD1|MAP2K7|PPP2CB|ATF2|MAP2K1|MAPK1|IKBKB|MAP2K4|MAPK8
ACTIVATION OF PKB%REACTOME%R-HSA-165158.3,0.538377937780193,0.8142313733497609,0.42050405338333396,0.9238653135579692,3962,4,THEM4|PDPK1|AKT2|TRIB3
MGMT-MEDIATED DNA DAMAGE REVERSAL%REACTOME%R-HSA-5657655.1,0.0685349980077035,0.373973015487835,0.9663101014556679,1.288444133309,515,1,MGMT
SYNTHESIS OF DOLICHYL-PHOSPHATE-GLUCOSE%REACTOME DATABASE ID RELEASE 66%480985,0.8784833869239008,0.960725750963158,0.40374965536255897,0.678351551237246,6556,2,ALG5|NUDT14
FRS-MEDIATED FGFR2 SIGNALING%REACTOME%R-HSA-5654700.3,0.537254901960784,0.8137043915765061,-0.27684343120625804,-0.9266208855409591,4109,12,FGF10|HRAS|FGF9|FGF7
SUMOYLATION OF TRANSCRIPTION FACTORS%REACTOME%R-HSA-3232118.6,0.829539508110937,0.943504776751861,-0.19404823438489802,-0.721158375873848,6340,16,CDKN2A|SUMO2|HIC1|SUMO3|MITF
GLUCONEOGENESIS%REACTOME DATABASE ID RELEASE 66%70263,0.0775042334245148,0.38994345969071,-0.336628285177806,-1.45125170597581,594,25,PGAM2|GOT1|GPI|SLC25A10|G6PC3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
LEADING STRAND SYNTHESIS%REACTOME DATABASE ID RELEASE 66%69109,0.0124541164132145,0.14774543117424402,-0.504916555118035,-1.78632093618466,94,14,PRIM2|RFC2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|POLA1|RFC4|POLA2
ERYTHROPOIETIN ACTIVATES RAS%REACTOME DATABASE ID RELEASE 66%9027284,0.553046789989119,0.8231366946320219,0.270630997004025,0.9198221205617321,4065,12,IRS2|SHC1|SOS1|NRAS|KRAS|JAK2|EPOR
THE PROTON BUFFERING MODEL%REACTOME%R-HSA-167827.2,0.846616934956158,0.949216083775675,-0.317211713450615,-0.694442749905143,6468,4,UCP3|SLC25A14|UCP2|SLC25A27
PHASE 1 - INACTIVATION OF FAST NA+ CHANNELS%REACTOME%R-HSA-5576894.2,0.25029469548133604,0.6309150060330451,-0.463695761199596,-1.1927504110007299,1910,6,KCND1|KCNIP1|KCND2|KCNIP3|KCNIP4
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE%REACTOME DATABASE ID RELEASE 66%4641262,0.833442024259815,0.944674106068496,-0.16520887836615,-0.72865186601317,6389,27,FRAT1|FZD2|LRP5|PPP2CA|CAV1|CSNK1A1
APC TRUNCATION MUTANTS ARE NOT K63 POLYUBIQUITINATED%REACTOME DATABASE ID RELEASE 66%5467333,0.5824749163879599,0.8388145295913921,-0.7131671812968678,-0.9501099270262241,4353,1,APC
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL (GPI)%REACTOME DATABASE ID RELEASE 66%162710,0.974453050686235,0.9920717971974051,0.138707793571684,0.533372791770408,7170,17,PIGF|PIGL|PIGO|PIGG|PIGN|PIGB|PIGZ|PIGV|PIGM
STABILIZATION OF P53%REACTOME%R-HSA-69541.4,0.000258064516129032,0.00819882332206558,-0.4055850071666379,-2.2123978961047404,1,55,PSMD3|PSMB2|CDKN2A|PSMF1|PSMD4|SHFM1|PHF20|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
GRB2 EVENTS IN EGFR SIGNALING%REACTOME%R-HSA-179812.2,0.26007028926736997,0.636098664976652,0.49150306999557397,1.18206206480957,1923,5,SOS1|NRAS|EGFR|KRAS
TIE2 SIGNALING%REACTOME DATABASE ID RELEASE 66%210993,0.80037971250339,0.931890163905641,0.204323105593834,0.734413053137524,5901,14,GRB14|SHC1|SOS1|NRAS|PIK3R2|KRAS
UB-SPECIFIC PROCESSING PROTEASES%REACTOME%R-HSA-5689880.2,0.000128024580719498,0.00518555396908895,-0.31745061462610996,-2.27804320522608,0,178,HGS|HIST2H2AC|HIST1H2AD|USP25|USP9X|PSMD3|PSMB2|RUVBL1|USP30|HIST1H2AI|GATA3|TOMM20|HIST1H2BN|PSMF1|TRAF2|HIST1H2BC|SIAH2|PSMD4|SHFM1|SMURF2|PSME2|IFIH1|ARRB1|PSMB5|TOMM70A|PSMC4|HIST1H2AK|USP2|TAF9B|PSMC6|IL33|USP44|PSMD10|USP47|USP11|NFKBIA|PSMB3|HIST2H2BF|PTRH2|PSMC1|PSMD2|UBC|USP20|HIST2H2AA4|HIST3H2A|PSMD6|HIST1H2BG|HIST1H2BD|USP18|MYC|HIST1H2AE|TAF10|PSMD12|PSMA3|HIST1H2AC|PSMA6|OTUB1|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|HIST1H2BK|PSMA1|PSMC5|HIST1H2BJ|PSMC3|HIST2H2AA3
NOSIP MEDIATED ENOS TRAFFICKING%REACTOME%R-HSA-203754.1,0.42425046431414204,0.754268592539614,-0.629556106975462,-1.0476820355979701,3197,2,NOSIP|NOS3
MACROAUTOPHAGY%REACTOME DATABASE ID RELEASE 66%1632852,0.36117556071152396,0.716154857259883,-0.186858873559015,-1.06111918730215,2801,64,WDR45|DYNLL2|ATG101|WIPI1|RPTOR|PIK3R4|CHMP4A|CHMP6|ATG3|AMBRA1|SLC38A9|ATG4A|RRAGD
COX REACTIONS%REACTOME%R-HSA-140180.1,0.267826086956522,0.6418798906350429,-0.8622629025143359,-1.14874122768178,2001,1,PTGS1
REGULATION OF LIPID METABOLISM BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPARALPHA)%REACTOME%R-HSA-400206.2,0.627686796315251,0.859598200097318,-0.142120566161106,-0.9069568767575901,4905,101,G0S2|NR1H3|MED6|HMGCS1|CD36|TNFRSF21|FHL2|GLIPR1|NR1D1|PLIN2|NFYB|PPARG|PPARA|ESRRA|FADS1|MED27|MED19
MRNA EDITING: A TO I CONVERSION%REACTOME DATABASE ID RELEASE 66%75064,0.113425311753781,0.46139171800540707,-0.791216907632366,-1.31671145939676,854,2,ADARB1
EXTRINSIC PATHWAY OF FIBRIN CLOT FORMATION%REACTOME DATABASE ID RELEASE 66%140834,0.0675925925925926,0.371075653877479,-0.743355023712364,-1.45158395875398,510,3,F10|F3|TFPI
EPIGENETIC REGULATION OF GENE EXPRESSION%REACTOME%R-HSA-212165.1,0.00012851818532322299,0.00518555396908895,-0.307095027716519,-2.03693525384112,0,121,TTF1|HIST1H4I|UHRF1|POLR2H|GTF2H1|RBBP7|DNMT1|HIST2H3A|UBTF|PHF19|CDK7|KAT2B|H2AFZ|HIST2H2AA4|MNAT1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|MTA2|HIST1H3H|SAP30BP|ACTB|HIST2H4B|RRP8|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L|GTF2H2|SUV39H1
HDL ASSEMBLY%REACTOME DATABASE ID RELEASE 66%8963896,0.288006312467123,0.6611689133307479,-0.4843544685664579,-1.16090523781427,2189,5,A2M|PRKACA
NEGATIVE REGULATION OF FGFR1 SIGNALING%REACTOME%R-HSA-5654726.2,0.577599789915966,0.83729927068764,-0.226896758222728,-0.9103054481375551,4398,20,FGF10|MAPK3|PPP2CA|FGF9|UBC
TNF SIGNALING%REACTOME%R-HSA-75893.5,0.920236133992312,0.9768322640118741,0.12746403073909698,0.65151913350285,6702,42,SMPD2|TRADD|ADAM17|RPS27A|RIPK1|CASP8|RBCK1|USP4
MET ACTIVATES PI3K AKT SIGNALING%REACTOME%R-HSA-8851907.1,0.10813733441470699,0.452488212455009,0.593213834938303,1.42667587123533,799,5,MET|GAB1
PLATELET ADHESION TO EXPOSED COLLAGEN%REACTOME%R-HSA-75892.3,0.106825313807531,0.44970701744055097,-0.453968905260294,-1.4222253188775802,816,10,FYN|ITGB1|LYN|ITGA10|GP1BA|GP1BB|VWF|FCER1G
TRP CHANNELS%REACTOME DATABASE ID RELEASE 66%3295583,0.225225225225225,0.608078734097645,0.40083958860969604,1.21811454035276,1649,9,TRPM4|TRPM7|TRPV1|TRPV2
ENDOGENOUS STEROLS%REACTOME%R-HSA-211976.3,0.21626569037656895,0.5991362048583871,-0.315673604776818,-1.2249309886929398,1653,18,CYP1B1|AHR|POMC|CYP51A1|CYP46A1|CYP7B1|PTGIS
REGULATION OF GENE EXPRESSION IN LATE STAGE (BRANCHING MORPHOGENESIS) PANCREATIC BUD PRECURSOR CELLS%REACTOME%R-HSA-210744.2,0.206143790849673,0.5859847786236589,-0.372382638339704,-1.2463995573055,1576,12,HES1|NOTCH1|SNW1|KAT2B|MAML1
CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION%REACTOME DATABASE ID RELEASE 66%69202,0.000127307447485678,0.00518555396908895,-0.35589877367655104,-2.15651410055014,0,82,PSMA4|PSMA7|RBBP4|CCNA2|CUL1|CDC25A|WEE1|PSMD7|PSME3|PSMA2|PSME1|CDKN1B|CDK4|AKT1|PSMB1|PSMB9|SKP2|CCNH|LIN54|PSMB4|PSMD1|PSMC2|TFDP2|PSMD3|PSMB2|LIN52|PSMF1|LIN9|PSMD4|SHFM1|PSME2|PSMB5|SKP1|E2F1|PSMC4|PSMC6|MAX|PSMD10|CDK7|PSMB3|PSMC1|PSMD2|UBC|MNAT1|PSMD6|MYC|PSMD12|PSMA3|PSMA6|CCND1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
ROLE OF ABL IN ROBO-SLIT SIGNALING%REACTOME DATABASE ID RELEASE 66%428890,0.415573770491803,0.7493091022753771,0.353624776590802,1.02651086118386,3041,8,CLASP1|CLASP2|CAP2
CROSS-PRESENTATION OF PARTICULATE EXOGENOUS ANTIGENS (PHAGOSOMES)%REACTOME DATABASE ID RELEASE 66%1236973,0.0450403540744598,0.304206078232924,-0.552798433250741,-1.59142931941669,345,8,ITGB5|CYBB|NCF4|NCF2|CD36
RESPIRATORY ELECTRON TRANSPORT%REACTOME DATABASE ID RELEASE 66%611105,0.000128221566867547,0.00518555396908895,-0.36668437662517295,-2.3323395540110097,0,100,ETFDH|NDUFAF5|COX7C|CYC1|TIMMDC1|COX11|NDUFC2|NDUFAF4|NDUFV2|NDUFB8|SDHC|NDUFS4|COX6C|UQCRC1|NDUFB5|SURF1|UQCR10|NDUFA11|NDUFA9|SCO2|NDUFA7|SDHB|NDUFA3|NDUFB6|SDHD|NDUFAF3|CYCS|NDUFB9|NDUFB10|SDHA|MT-CO3|NDUFS7|NDUFB1|NDUFB7|NDUFA6|COX16|NDUFS6|NDUFB4|COX7B|NDUFA12|NDUFA2|NDUFAB1|NDUFA1|NDUFB11|NDUFA4|NDUFV1|UQCRQ|NDUFAF2|NDUFS3|TACO1|UQCRC2|COX6A1|COX8A|NDUFA8|NDUFS8|ETFB|NDUFV3
SIGNALING BY INSULIN RECEPTOR%REACTOME%R-HSA-74752.1,0.0074838709677419405,0.10494528966704,-0.323623879827301,-1.76531375225368,57,55,TCIRG1|ATP6V0B|FGFR4|ATP6V0A2|ATP6V1G2|ATP6V1F|INS|ATP6V0D1|IRS1|PIK3CB|FGF10|MAPK3|HRAS|PIK3R4|FGF19|ATP6V0E1|FGF9|FGF7|FLT3LG|ATP6AP1|ATP6V0E2|ATP6V1A|ATP6V1G1|GRB10
RHO GTPASE CYCLE%REACTOME DATABASE ID RELEASE 66%194840,0.65595390524968,0.874869342420871,-0.133540908864388,-0.898415517286939,5122,129,RAC2|ITSN1|TAGAP|CDC42|RAC3|RACGAP1|RAC1|ARHGAP4|SOS2|DEPDC7|GNA13|ARHGAP36|ARHGAP25|INPP5B|VAV3|ARHGEF5|ARHGAP11A|ECT2|FGD1|ARHGAP15|RASGRF2|GDI1|VAV1|ARHGAP18|ARHGDIB|ARHGAP24|KALRN|RHOF|ARHGAP44|CHN2|NGEF|ARHGAP42|RHOG|RHOD|ARHGAP31|ARHGEF15|ARHGAP1|RHOJ|STARD13|DLC1|A2M|ARHGEF9|SYDE1|STARD8|ARHGAP8|TIAM1|RHOU|ARHGDIA|NET1|DEPDC1B
ATF6 (ATF6-ALPHA) ACTIVATES CHAPERONE GENES%REACTOME%R-HSA-381183.2,0.452709744658676,0.769943206592495,-0.33076566827237897,-0.995024092484192,3474,9,CALR|NFYB|HSPA5
CLASS I MHC MEDIATED ANTIGEN PROCESSING & PRESENTATION%REACTOME DATABASE ID RELEASE 66%983169,0.0790285273708558,0.39433306471489704,-0.154542065501194,-1.24168006039961,614,342,PSMD1|HECTD1|PSMC2|TLR1|UBE2O|UBAC1|CDC20|ANAPC10|TRIM21|B2M|UBA5|UBE2Z|DTX3L|UBE2B|TAPBP|FBXO6|ANAPC2|RLIM|SOCS3|SEC61G|TRIM9|LNPEP|ANAPC5|STX4|TLR2|CTSV|FCGR1A|PSMD3|CTSS|HLA-C|PSMB2|CDC23|HERC6|RNF114|FBXW2|CANX|ITGB5|PSMF1|HLA-A|RNF144B|UBE2G2|RNF7|TRIM69|SIAH2|PSMD4|BTBD6|RBBP6|SEC23A|SHFM1|SMURF2|UBE2S|SOCS1|PSME2|RNF138|PSMB5|TRIM32|UBE2R2|CYBB|CALR|HUWE1|CDC27|MRC2|SEC13|SEC24A|VAMP8|SKP1|ANAPC13|NCF4|HECTD2|RCHY1|PSMC4|UBA1|PSMC6|FBXO4|PSMD10|NCF2|PSMB3|CD36|PSMC1|MRC1|PSMD2|SEC61A1|SEC61B|UBC|FBXO17|PSMD6|FBXW5|TLR4|PJA1|MYLIP|PSMD12|PSMA3|CTSL|HSPA5|ANAPC11|UBE2L6|PSMA6|SAR1B|LRR1|CD14|LY96|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|RNF130|SPSB1
RUNX2 REGULATES BONE DEVELOPMENT%REACTOME%R-HSA-8941326.1,0.17532637075718,0.548366806412612,-0.301548443000417,-1.26607571679047,1342,23,MAF|SMAD6|HES1|MAPK3|ABL1|RBM14|WWTR1|COL1A1|YAP1
SLBP INDEPENDENT PROCESSING OF HISTONE PRE-MRNAS%REACTOME DATABASE ID RELEASE 66%111367,0.0974110878661088,0.430598623028127,-0.460346893206425,-1.44220672252742,744,10,SNRPE|LSM11|NCBP2|LSM10|SNRPF|NCBP1|SNRPB
MULTIFUNCTIONAL ANION EXCHANGERS%REACTOME%R-HSA-427601.2,0.900013585110719,0.968053840554563,0.29595899537878195,0.650234517042009,6624,4,SLC26A6|SLC26A1|SLC26A11
ASTROCYTIC GLUTAMATE-GLUTAMINE UPTAKE AND METABOLISM%REACTOME%R-HSA-210455.2,0.264755921999738,0.6400909232463741,-0.5459107704185739,-1.19511279230025,2022,4,GLUL|SLC38A1|SLC1A2|SLC1A3
PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS%REACTOME%R-HSA-202427.5,0.23261926665790497,0.616483865437921,-0.30451454929120697,-1.20310857554723,1769,19,PTPRC|HLA-DQA1|CD3D|CD3G|CSK|PTPN22|HLA-DRB1|HLA-DQB2|HLA-DPA1|HLA-DRA|HLA-DRB5|HLA-DPB1|CD4|HLA-DQA2|PTPRJ
GABA RECEPTOR ACTIVATION%REACTOME%R-HSA-977443.2,0.171927554980595,0.545786420273949,-0.260765716023284,-1.25565989780305,1328,36,GNGT2|ADCY4|KCNJ12|GNAI2|GNG10|ARHGEF9|KCNJ9|GNG3|GABRQ|ADCY9
PI3K EVENTS IN ERBB2 SIGNALING%REACTOME DATABASE ID RELEASE 66%1963642,0.9721240141419629,0.9915747942934481,0.170623274477318,0.540546066840741,7148,10,GAB1|EGFR|ERBB2|PIK3CA|NRG4|PIK3R1|NRG1|NRG3|NRG2
NONCANONICAL ACTIVATION OF NOTCH3%REACTOME DATABASE ID RELEASE 66%9017802,0.6874316939890711,0.88650960007421,0.279875504646063,0.812429626872385,5031,8,PSENEN|PSEN2|APH1B
"XAV939 INHIBITS TANKYRASE, STABILIZING AXIN%REACTOME DATABASE ID RELEASE 66%5545619",0.219319399785638,0.601686354077891,0.724510614833196,1.21727137827181,1636,2,TNKS|TNKS2
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR%REACTOME%R-HSA-1679131.1,0.004689942678478371,0.0757018915187918,-0.6436061707126071,-1.9361248985586297,35,9,HSP90B1|CTSV|CTSS|CTSB|UNC93B1|CTSL|LGMN
P53-DEPENDENT G1 DNA DAMAGE RESPONSE%REACTOME%R-HSA-69563.3,0.000386697602474865,0.0111294649577428,-0.36180371786470705,-2.05458194064432,2,64,PSMD3|PSMB2|CDKN2A|PSMF1|PSMD4|SHFM1|PHF20|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ZNF385A|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION%REACTOME%R-HSA-6804756.1,0.47758906908440796,0.7850984235874658,-0.15950297080979,-0.9855235524500309,3739,89,RFC3|NBN|EXO1|TAF3|TPX2|RAD1|TAF12|RAD17|SUPT16H|NUAK1|RHNO1|BRCA1|RFC5|TOPBP1|TAF7|RMI1|TAF9B|RMI2|UBC|TAF10|KAT5|TAF9|SSRP1|RFC4|AK6
SIGNALING BY FGFR2 IIIA TM%REACTOME%R-HSA-8851708.1,0.7470101195952159,0.9120638890162471,-0.19903459526203196,-0.7863671175899319,5683,19,NCBP2|POLR2J|NCBP1|POLR2H|POLR2G|POLR2L
VEGFA-VEGFR2 PATHWAY%REACTOME DATABASE ID RELEASE 66%4420097,0.0965216275189321,0.42759608527799,-0.211288582247271,-1.31113485698733,751,91,NCKAP1L|VAV3|WASF2|JUP|CTNND1|ITPR2|KDR|ITPR3|VAV1|BCAR1|ELMO1|MAPKAPK2|PXN|PIK3CB|CYBB|HSPB1|HRAS|NCF4|CDH5|DOCK1|CYFIP2|NCF2|AXL|NOS3|CAV1|WASF3|MAPK13|PRKACA|HSP90AA1|NCK1|MAPKAP1|SPHK1|PRKCB
COMPETING ENDOGENOUS RNAS (CERNAS) REGULATE PTEN TRANSLATION%REACTOME DATABASE ID RELEASE 66%8948700,0.40628415300546505,0.743641894111792,0.35679785658097496,1.0357217572775,2973,8,AGO2|TNRC6B|AGO3|MOV10|AGO1
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS%REACTOME DATABASE ID RELEASE 66%4551638,0.48362883395884604,0.787078399497453,-0.17935431884408304,-0.982117542135459,3736,56,NUP188|SUMO2|HIST1H4I|NUP85|ZBED1|CBX4|NUP37|SUMO3|NUP160|RING1|NUP214|HIST2H4A|HIST2H4B
AXONAL GROWTH STIMULATION%REACTOME%R-HSA-209563.2,0.0687082842559874,0.3746716811206479,-0.6724630238999139,-1.4721621293448401,524,4,NGF|ARHGDIA|NGFR
SYNTHESIS OF BILE ACIDS AND BILE SALTS%REACTOME%R-HSA-192105.2,0.340481171548117,0.701955655133333,-0.25555509195015197,-1.08610193618356,2603,24,CYP46A1|CYP7B1|OSBP|OSBPL3|PTGIS
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE%REACTOME%R-HSA-1660499.6,0.696957236842105,0.891229155998927,0.160762922409241,0.848702286308356,5084,47,MTMR6|PLEKHA1|INPP5K|PIP4K2C|INPP5J|PLEKHA3|MTMR9|MTMR2|PI4K2B|INPP4A|INPPL1|PLEKHA6|PIK3R2
NONSENSE-MEDIATED DECAY (NMD)%REACTOME DATABASE ID RELEASE 66%927802,0.49152977412730997,0.790696900371285,-0.149587349793017,-0.97941389222461,3829,113,RPLP2|MAGOH|RPS14|RPS4X|RPL35A|NCBP1|RPS29|RPL10|RPL36A|RPL24|RPL22L1|RPL35|PPP2CA|RPL38|RPS15A|RPL36AL|MAGOHB|EIF4A3|RPS13|RBM8A|RPL26L1|FAU|EIF4G1
N-GLYCAN ANTENNAE ELONGATION%REACTOME%R-HSA-975577.1,0.367507458638459,0.721642468110297,0.29785174773489503,1.07058969567137,2709,14,MGAT5|ST8SIA2|B4GALT5|ST3GAL4|MGAT4A
PI3K AKT SIGNALING%REACTOME%R-HSA-1257604.8,0.005111167901865579,0.0803856140767292,-0.209662455573082,-1.5654948032577398,39,221,IRS1|PSME2|PSMB5|SNAI2|PIK3CB|FGF10|MAPK3|RHOG|RBBP7|CBX4|IRAK1|PIK3R3|TNRC6C|HDAC5|RPTOR|PSMC4|CBX6|HBEGF|PSMC6|IL33|PSMD10|CD86|PSMB3|PPP2CA|FGF19|RING1|FGF9|FGF7|PSMC1|XIAP|PSMD2|UBC|PDGFRB|PSMD6|SNAI1|PPARG|MTA2|PSMD12|PSMA3|PDGFRA|PSMA6|MAPKAP1|PSMD13|PSMB7|SLC38A9|PSMA1|RPS6KB2|PDGFB|PSMC5|PSMC3|BAD|RRAGD
PI5P REGULATES TP53 ACETYLATION%REACTOME DATABASE ID RELEASE 66%6811555,0.345481845481845,0.703195314591758,0.35812060864702905,1.0882955002174,2530,9,MAP2K6|PIP4K2C|EP300|ING2|PIP4K2A|PIP4K2B|PIN1|TP53
PTK6 REGULATES PROTEINS INVOLVED IN RNA PROCESSING%REACTOME%R-HSA-8849468.1,0.558730158730159,0.8268422944617521,-0.475901621263924,-0.9293152495583721,4223,3,SFPQ|KHDRBS1|KHDRBS3
P75NTR NEGATIVELY REGULATES CELL CYCLE VIA SC1%REACTOME%R-HSA-193670.1,0.771709233791749,0.9215496572020819,-0.29112076876579496,-0.7488410411558292,5891,6,NGFR
CONVERSION FROM APC C:CDC20 TO APC C:CDH1 IN LATE ANAPHASE%REACTOME%R-HSA-176407.3,0.679064266000789,0.884536278926676,-0.21105756600027104,-0.833868753332451,5166,19,CDC20|ANAPC10|ANAPC2|ANAPC5|CDC23|CDC27|ANAPC11
LEUKOTRIENE RECEPTORS%REACTOME%R-HSA-391906.1,0.126190476190476,0.481863148764233,-0.6909672438513289,-1.3492839023136003,953,3,LTB4R2|LTB4R|CYSLTR2
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE%REACTOME%R-HSA-5620912.2,0.18570829254649698,0.559093571852282,0.18782446666967,1.19101250701138,1327,95,NPHP1|CC2D2A|DYNC1I2|CEP162|CLASP1|TMEM67|SFI1|AHI1|FGFR1OP|NINL|CEP89|SEPT2|RPGRIP1L|TTBK2|CEP164|PCM1|CEP290|MARK4|TCTN2|CEP57|B9D1|NPHP4|RAB11A|CEP250|DCTN2|YWHAE
ELECTRIC TRANSMISSION ACROSS GAP JUNCTIONS%REACTOME%R-HSA-112303.1,0.360277136258661,0.7155384949577859,0.488243939218399,1.0726927276194,2651,4,GJD2|PANX1
PORPHYRIN METABOLISM%REACTOME DATABASE ID RELEASE 66%189445,0.9251442055584691,0.9785037131586608,-0.17280741585335596,-0.611367367019004,7056,14,ALAD|HMOX1|BLVRB
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%2122947,0.844789356984479,0.9483360183395692,-0.144803215782243,-0.7381578648656221,6476,44,HES1|NOTCH1|SNW1|SKP1|HDAC5|KAT2B|HDAC8|UBC|MAML1|MYC
PHOSPHO-PLA2 PATHWAY%REACTOME%R-HSA-111995.1,0.8597771292119929,0.951153576277876,-0.426439501769284,-0.7096635237475981,6480,2,PLA2G4A
TP53 REGULATES METABOLIC GENES%REACTOME%R-HSA-5628897.4,0.7561163058793391,0.9166093439295571,-0.137417809936461,-0.8259923735503242,5902,80,MT-CO3|TNRC6C|RPTOR|COX16|COX7B|DDIT4|NDUFA4|TACO1|SLC38A9|COX6A1|COX8A|RRAGD
HOST INTERACTIONS WITH INFLUENZA FACTORS%REACTOME%R-HSA-168253.4,0.48785215818040795,0.788226301622024,-0.20080562882632996,-0.975502920880239,3774,37,KPNB1|NUP188|SLC25A6|NUP85|ISG15|KPNA4|NUP37|NUP160|KPNA2|NUP214|PABPN1
SIGNALING BY FGFR1 IN DISEASE%REACTOME DATABASE ID RELEASE 66%5655302,0.0281977932161831,0.23801409452253197,0.35049765792082305,1.60409747089181,206,29,GAB1|GAB2|FGFR1OP|ZMYM2|LRRFIP1|FGF2|MYO18A|SOS1|PLCG1|NRAS|FGF1|FGFR1|KRAS
TRUNCATED APC MUTANTS DESTABILIZE THE DESTRUCTION COMPLEX%REACTOME%R-HSA-4839744.1,0.7642894598846359,0.9191113740914171,-0.21629972962533803,-0.7652368131017159,5829,14,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
DNA METHYLATION%REACTOME DATABASE ID RELEASE 66%5334118,0.00012960082944530802,0.00518555396908895,-0.568381003684861,-2.80680622342198,0,39,H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|UHRF1|DNMT1|HIST2H3A|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
PTK6 REGULATES RTKS AND THEIR EFFECTORS AKT1 AND DOK1%REACTOME DATABASE ID RELEASE 66%8849469,0.489890710382514,0.7898753213846479,0.33071867517813697,0.9600184561149441,3585,8,DOK1|RPS27A|CBL
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY%REACTOME%R-HSA-8941858.1,0.000258064516129032,0.00819882332206558,-0.403535957661585,-2.2012206762028903,1,55,PSMD3|PSMB2|CDKN2A|PSMF1|PSMD4|SHFM1|SMURF2|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
XENOBIOTICS%REACTOME%R-HSA-211981.1,0.14701109007303198,0.514131830678897,0.488437772316516,1.34831936004356,1086,7,CYP2E1|CYP2C8|ARNT|CYP2D6|ARNT2
REGULATION OF TP53 EXPRESSION%REACTOME DATABASE ID RELEASE 66%6804754,0.721146192624038,0.901895642353625,-0.507030603804797,-0.843780005020872,5435,2,TP53|PRDM1
LACTOSE SYNTHESIS%REACTOME DATABASE ID RELEASE 66%5653890,0.11077208808702599,0.45638735792888,-0.793327819134271,-1.32022435369606,834,2,SLC2A1|B4GALT1
HEME DEGRADATION%REACTOME%R-HSA-189483.1,0.0668760633424944,0.3690551432905871,-0.6749009417624189,-1.4774992411622598,510,4,BLVRA|HMOX1|BLVRB
DECTIN-2 FAMILY%REACTOME%R-HSA-5621480.2,0.0108809648662821,0.134645873234709,-0.51144960361173,-1.8094339064034097,82,14,FYN|PLCG2|MUC3A|SYK|CLEC4A|LYN|CLEC4E|CLEC10A|FCER1G|MUC4|MUC20|MUC15
TYPE I HEMIDESMOSOME ASSEMBLY%REACTOME%R-HSA-446107.1,0.7433060109289621,0.9106935298684872,0.265100071219981,0.769539128540244,5440,8,ITGA6|DST|PLEC
MISMATCH REPAIR (MMR) DIRECTED BY MSH2:MSH6 (MUTSALPHA)%REACTOME%R-HSA-5358565.1,0.5656790770844261,0.8298339339066451,-0.25783320999965,-0.9121761930709541,4314,14,RPA2|EXO1|POLD4|PCNA|POLD1|POLD2
REGULATION OF PTEN STABILITY AND ACTIVITY%REACTOME DATABASE ID RELEASE 66%8948751,0.0023195876288659802,0.0447202453104185,-0.319358634946425,-1.82104636641624,17,65,PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|XIAP|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
AXIN MISSENSE MUTANTS DESTABILIZE THE DESTRUCTION COMPLEX%REACTOME DATABASE ID RELEASE 66%5467340,0.7642894598846359,0.9191113740914171,-0.21629972962533803,-0.7652368131017159,5829,14,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
ACYL CHAIN REMODELING OF DAG AND TAG%REACTOME%R-HSA-1482883.3,0.267111634602801,0.6417330323279019,-0.5441636872810061,-1.1912880621061201,2040,4,DGAT1|PNPLA2|MGLL
BDNF ACTIVATES NTRK2 (TRKB) SIGNALING%REACTOME%R-HSA-9024909.1,0.226220735785953,0.608682632875901,-0.8838773709748571,-1.17753688961113,1690,1,NTRK2
IRF3 MEDIATED ACTIVATION OF TYPE 1 IFN%REACTOME%R-HSA-1606341.1,0.538377937780193,0.8142313733497609,0.420559201455909,0.923986476222042,3962,4,IRF3|TBK1|DTX4|ZBP1
LAMININ INTERACTIONS%REACTOME DATABASE ID RELEASE 66%3000157,0.34530026109660605,0.7029523815637231,-0.258997969506724,-1.0874240855889599,2644,23,ITGB1|HSPG2|LAMB2|LAMC1|LAMC2|COL18A1|NID2|LAMC3|LAMA2|LAMA4|NID1|ITGB4
PROLONGED ERK ACTIVATION EVENTS%REACTOME%R-HSA-169893.1,0.9191945606694559,0.976687251055112,-0.195617838514762,-0.612845152027054,7029,10,RAPGEF1|NGF|RAP1A
LYSOSOMAL OLIGOSACCHARIDE CATABOLISM%REACTOME DATABASE ID RELEASE 66%8853383,0.188697187882081,0.5628627753089239,0.580899828830043,1.27626166309176,1388,4,MANBA|MAN2B2|MAN2C1
LOSS OF PROTEINS REQUIRED FOR INTERPHASE MICROTUBULE ORGANIZATION FROM THE CENTROSOME%REACTOME%R-HSA-380284.1,0.31083344068014895,0.6814986161073721,-0.191430352456851,-1.09935727625123,2412,67,HAUS1|NDE1|TUBG1|CEP72|HAUS6|CEP78|HAUS4|CEP76|CSNK1D|CEP192|PCNT|NEK2|NEDD1|DYNC1H1|OFD1|CEP70|TUBA4A|SDCCAG8|HAUS8|CDK5RAP2|CEP131|CKAP5|TUBB4A|PLK1|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
MET ACTIVATES RAS SIGNALING%REACTOME%R-HSA-8851805.1,0.5603330603330601,0.8272130337115179,0.29861710900891697,0.907469852824485,4104,9,MET|SOS1|NRAS|RANBP9|KRAS
HS-GAG DEGRADATION%REACTOME%R-HSA-2024096.1,0.22871906445471898,0.610365144973336,0.308016733015897,1.20570892030372,1681,18,GPC6|SDC1|GLB1L|AGRN|HPSE|IDUA|GPC1|GPC2|GPC3
RIBOSOMAL SCANNING AND START CODON RECOGNITION%REACTOME DATABASE ID RELEASE 66%72702,0.324828390104909,0.692794968343412,-0.196424912347662,-1.08543393183189,2507,58,RPS14|RPS4X|RPS29|EIF1AX|EIF3B|RPS15A|EIF5|RPS13|EIF2S1|EIF4A2|FAU|EIF4G1
BIOSYNTHESIS OF MARESINS%REACTOME%R-HSA-9018682.1,0.35698837523654997,0.714610778064251,0.44701602454723904,1.07507097561778,2640,5,CYP2E1|CYP2C8|CYP2D6|EPHX2
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA-HYDROXYCHOLESTEROL%REACTOME DATABASE ID RELEASE 66%193368,0.81305599162742,0.9356336309698571,-0.198130774276389,-0.7363306749000171,6214,16,CYP7B1|PTGIS
DIGESTION OF DIETARY CARBOHYDRATE%REACTOME DATABASE ID RELEASE 66%189085,0.201366559485531,0.57936615560109,0.7357147300602329,1.2360957384751001,1502,2,AMY2B|CHIT1
SIGNALING BY NOTCH2%REACTOME DATABASE ID RELEASE 66%1980145,0.953069577080491,0.986609905365046,0.12668282561028,0.597176228394911,6985,32,DLL1|RPS27A|PSENEN|PSEN2|APH1B|MAML2|FCER2|MAML3|MAMLD1|ADAM10|EP300|MIB2|UBA52|NCSTN|CREB1
TRAF3-DEPENDENT IRF ACTIVATION PATHWAY%REACTOME%R-HSA-918233.1,0.6298284666753959,0.860897694974173,-0.25170445838848604,-0.8664155567812609,4809,13,IKBKE|IFIH1|IRF7|TRAF3
ORGANELLE BIOGENESIS AND MAINTENANCE%REACTOME%R-HSA-1852241.4,0.000418235048097031,0.0118197792347012,0.22861707938627102,1.7903470774460801,2,268,EXOC4|DYNLRB2|DYNC2H1|NPHP1|CC2D2A|DYNC1I2|TTC30B|WDR19|TTC21B|DYNC2LI1|MTX2|BBS5|BBS12|IFT88|PRKAG2|TTC30A|WDR35|CEP162|NPHP3-ACAD11|CAMK4|BBS4|CLASP1|BBIP1|HELZ2|IMMT|TMEM67|SFI1|IFT46|IFT172|AHI1|FGFR1OP|NCOR1|ARL3|IFT20|MCHR1|NINL|CEP89|IFT140|KIF3B|MAPK12|SEPT2|MAPK11|TFB1M|CLUAP1|TTC8|ATP5E|RPGRIP1L|IFT81|PKD1|TTBK2|CEP164|TNPO1|WDR60|PCM1|TBL1XR1|CEP290|C10orf2|MARK4|PDE6D|TCTN2|GLUD1|RAB11FIP3|CEP57|MKKS|B9D1|CARM1|NPHP4|NPHP3|CRTC1|PKD2|SIRT5|IFT52|RAB11A|CEP250|DCTN2|YWHAE|TRAF3IP1|KIF3C|LZTFL1|IFT27|BBS2
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS%REACTOME DATABASE ID RELEASE 66%372708,0.37019607843137303,0.7226447402424641,-0.32011933217900396,-1.07146937808862,2831,12,TLN1|BCAR1|VWF|RAP1A|FN1
PHASE 3 - RAPID REPOLARISATION%REACTOME DATABASE ID RELEASE 66%5576890,0.0278800631246712,0.23617479560495197,-0.685594738833656,-1.6432397654667101,211,5,KCNQ1|KCNH2|KCNE4
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION%REACTOME%R-HSA-427359.2,0.000130276185513288,0.00518555396908895,-0.528783324970088,-2.68197072293529,0,43,H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|HIST2H3A|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|RRP8|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|SUV39H1
RAB GERANYLGERANYLATION%REACTOME%R-HSA-8873719.2,0.5723956894169661,0.834311301921702,0.164577871987481,0.929963407208973,4142,60,RAB22A|RAB36|RAB13|RAB3B|RAB40C|RAB3D|RAB10|RAB39A|RAB1A|RAB23|RAB15|RAB4B|RAB33B|RAB11B|RAB11A|RAB25|RAB6A
THE PHOTOTRANSDUCTION CASCADE%REACTOME%R-HSA-2514856.1,0.12292629861300002,0.47697345522944606,0.347207702593344,1.35911909757626,903,18,PDE6B|PPEF1|NMT2|METAP1|GNGT1|PRKCA|CAMKMT|FNTA
FGFR3 LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190239,0.28229860073359603,0.654732517474162,0.5280737215037921,1.1602004555568,2077,4,GALNT3|FGF2|FGF1
MRNA SPLICING%REACTOME%R-HSA-72172.3,0.000128057369701626,0.00518555396908895,-0.262245136411524,-1.8994428323364498,0,187,SF3A3|CSTF2|PUF60|SRRT|POLR2F|HNRNPA1|SNRNP48|PDCD7|DNAJC8|SUGP1|SF3A2|PRCC|PPWD1|SF3B4|CPSF1|SNRPE|POLR2C|LSM5|YBX1|DHX9|PTBP1|SRSF3|TXNL4A|HNRNPH1|SF3A1|SRSF10|ELAVL2|HNRNPUL1|HNRNPL|NCBP2|PRPF4|POLR2J|SLU7|DDX23|RBM17|SNRNP35|SNRPB2|SRSF9|HNRNPU|RBMX|BCAS2|HNRNPH2|DDX42|MAGOH|CPSF2|CD2BP2|SRSF5|ZRSR2|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|SNRPA1|HNRNPM|DDX5|CLP1|SF1|SNW1|POLR2H|EFTUD2|HNRNPR|RBM22|CSTF3|LSM3|FUS|WBP11|SNRNP25|HNRNPK|MAGOHB|EIF4A3|SNRPB|TRA2B|PABPN1|SRSF2|RBM8A|POLR2G|SF3B2|ISY1|CPSF7|SKIV2L2|CWC27|PQBP1|HNRNPA0|GPKOW|SART1|HNRNPC|POLR2L|PRPF19
DEFECTIVE ST3GAL3 CAUSES MCT12 AND EIEE15%REACTOME DATABASE ID RELEASE 66%3656243,0.00745975657636435,0.10477806266857598,-0.796669056416478,-1.74407509824925,56,4,PRELP|OGN|LUM|FMOD
TRANSCRIPTION OF THE HIV GENOME%REACTOME DATABASE ID RELEASE 66%167172,0.0195747990666321,0.192628124925339,-0.277632278777599,-1.59885321470061,150,68,NCBP2|GTF2A2|POLR2J|TAF3|CCNK|GTF2A1|TAF12|SUPT16H|NCBP1|POLR2H|GTF2H1|TAF7|TAF9B|NELFB|CDK7|MNAT1|TAF10|POLR2G|SUPT4H1|TAF9|SSRP1|AK6|POLR2L|GTF2H2
PHASE 0 - RAPID DEPOLARISATION%REACTOME DATABASE ID RELEASE 66%5576892,0.0139135179375256,0.15750963604385598,0.35959444226787,1.71240577326539,101,33,FGF14|SCN5A|RANGRF|CACNG7|CACNB4|CACNA1C|CACNA2D2|CACNG4|SCN3A|SCN9A|SCN2A|CACNB2|CACNA2D3|CAMK2G|CAMK2D
NTF3 ACTIVATES NTRK3 SIGNALING%REACTOME%R-HSA-9034013.1,0.834506574578297,0.9453631152329971,0.582101896779885,0.7761543346843409,6282,1,NTRK3
TRANSPORT OF NUCLEOTIDE SUGARS%REACTOME DATABASE ID RELEASE 66%727802,0.39817089817089796,0.7388683667002129,0.342332994613481,1.04031839726097,2916,9,SLC35D2|SLC35A1|SLC35D1|SLC35B2|SLC35B3
SIGNALING BY FGFR3 IN DISEASE%REACTOME%R-HSA-5655332.3,0.12146354733405901,0.47376597884378,0.40481734069769504,1.37589540327185,892,12,GAB1|FGF2|SOS1|PLCG1|NRAS|FGF1|KRAS
DISORDERS OF TRANSMEMBRANE TRANSPORTERS%REACTOME DATABASE ID RELEASE 66%5619115,0.00012891581797086499,0.00518555396908895,-0.393875334082284,-2.20878399568904,0,61,PSMD3|PSMB2|PSMF1|VCP|PSMD4|SEL1L|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|DERL3|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
CONDENSATION OF PROMETAPHASE CHROMOSOMES%REACTOME DATABASE ID RELEASE 66%2514853,0.32984018862981396,0.6957352559323989,-0.340650321437297,-1.10287374332204,2517,11,NCAPG|CCNB2|NCAPH|SMC2|SMC4|CCNB1
SIGNALING BY NOTCH%REACTOME DATABASE ID RELEASE 66%157118,0.000128008192524322,0.00518555396908895,-0.28373548271588106,-2.08644509774539,0,202,HIST2H2AC|ATP2A1|NUMB|HIST1H2AD|PLXND1|PSMD3|PSMB2|HIST1H2BN|H2AFV|PSMF1|ATP2A3|HES1|HIST1H2BC|PSMD4|FLT4|NOTCH1|SEL1L|SHFM1|PSME2|HIST1H4I|ARRB1|PSMB5|SNW1|NOTCH2|TNRC6C|SKP1|E2F1|HDAC5|NOTCH3|PSMC4|TMED2|JAG2|HIST2H3A|NEURL1B|PSMC6|PSMD10|KAT2B|PSMB3|H2AFZ|PSMC1|HDAC8|PSMD2|UBC|HIST2H2AA4|MAML1|PSMD6|B4GALT1|HIST1H2BG|HIST1H2BD|HIST2H4A|MYC|HIST1H2AE|HIST2H3C|HIST1H3H|PSMD12|PSMA3|ACTA2|HIST2H4B|H3F3B|HIST1H2AC|PSMA6|DTX1|CCND1|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|H2AFJ|HIST1H2BK|PSMA1|PSMC5|HIST1H2BJ|PSMC3|HIST2H2AA3
MAP2K AND MAPK ACTIVATION%REACTOME DATABASE ID RELEASE 66%5674135,0.7877211238293441,0.927797067038212,-0.16139321143985902,-0.770480388219255,6055,35,VWF|ARRB1|MAPK3|HRAS|RAP1A|FN1|VCL|ARAF
CA2+ PATHWAY%REACTOME%R-HSA-4086398.3,0.736114948880906,0.908157084784786,0.15130654176295902,0.825239115673555,5327,53,PDE6B|GNG5|TCF7L1|GNGT1|GNB5|GNB4|PPP3R1|AGO2|PPP3CB|ITPR1|PRKCA|TNRC6B|AGO3|MOV10
REGULATION OF BETA-CELL DEVELOPMENT%REACTOME%R-HSA-186712.1,0.369733560834755,0.722411220031192,-0.26110505557091396,-1.06374387644082,2816,21,INS|HES1|NOTCH1|SNW1|FGF10|KAT2B|MAML1
TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRON-CONTAINING TRANSCRIPT%REACTOME%R-HSA-159236.3,0.024760176302826,0.22093387917624,-0.27194249120041897,-1.5660863649712,190,68,FYTTD1|NXF2B|NCBP2|SLU7|CHTOP|SRSF9|MAGOH|NUP188|SRSF5|SRSF1|U2AF1|NCBP1|NUP85|GLE1|NUP37|NXF1|NUP160|THOC7|NUP214|MAGOHB|EIF4A3|SRSF2|RBM8A|DDX39A|THOC3
PHOSPHATE BOND HYDROLYSIS BY NTPDASE PROTEINS%REACTOME%R-HSA-8850843.3,0.0362427039500475,0.27097761630552397,0.633023040958,1.6379843245732701,266,6,ENTPD7|ENTPD6|ENTPD3|ENTPD4|ENTPD5|ENTPD1
HDR THROUGH HOMOLOGOUS RECOMBINATION (HRR) OR SINGLE STRAND ANNEALING (SSA)%REACTOME DATABASE ID RELEASE 66%5693567,0.00025783163594172997,0.00819882332206558,-0.297469555419182,-1.9572563115115202,1,116,POLE|UIMC1|RAD9A|RFC2|RAD51|CLSPN|RPA2|XRCC2|BRIP1|HIST1H2BE|PALB2|RFC3|H2AFX|NBN|PPP4R2|EXO1|RAD51C|POLD4|HIST1H2BN|RAD51AP1|RAD1|RAD17|BRCC3|PCNA|HIST1H2BC|POLD1|SLX1B|RHNO1|SUMO2|SLX1A|RNF168|HIST1H4I|POLD2|BRCA1|RFC5|TOPBP1|EME1|ABL1|RMI1|RAD51B|RMI2|UBC|PPP4C|HIST1H2BG|HIST1H2BD|HIST2H4A|KAT5|POLE2|POLE3|HIST2H4B|RFC4|MUS81|HIST3H2BB|HIST2H2BE|HIST1H2BK|XRCC3|HIST1H2BJ
RNA POLYMERASE II HIV PROMOTER ESCAPE%REACTOME DATABASE ID RELEASE 66%167162,0.0299702880764759,0.244735657013286,-0.305821259293732,-1.5842503492941102,231,46,GTF2A2|POLR2J|TAF3|GTF2A1|TAF12|POLR2H|GTF2H1|TAF7|TAF9B|CDK7|MNAT1|TAF10|POLR2G|TAF9|AK6|POLR2L|GTF2H2
BIOSYNTHESIS OF DPAN-3-DERIVED MARESINS%REACTOME DATABASE ID RELEASE 66%9026290,0.5463545150501671,0.817655622966367,-0.729708866343185,-0.9721474234007309,4083,1,ALOX5
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS%REACTOME DATABASE ID RELEASE 66%5617472,0.00012835322808368602,0.00518555396908895,-0.381083770095471,-2.36478568358973,0,91,PIAS2|HIST1H3D|RARA|KDM6A|PCGF2|CNOT6|POLR2F|CREBBP|HIST1H4H|HOXC4|AJUBA|NCOA6|RBBP5|CTCF|POLR2C|HIST1H2BE|EZH2|H2AFX|YY1|HIST2H2AC|POLR2J|HIST1H2AD|PAXIP1|HIST1H2BN|H2AFV|HOXA4|HIST1H2BC|HIST1H4I|HOXB3|POLR2H|HOXB2|RBBP7|MAFB|WDR5|HIST2H3A|PKNOX1|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|POLR2G|HIST2H3C|PAGR1|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
LRR FLII-INTERACTING PROTEIN 1 (LRRFIP1) ACTIVATES TYPE I IFN PRODUCTION%REACTOME%R-HSA-3134973.1,0.372397945390646,0.7234654586828599,0.441254518932369,1.06121458765344,2754,5,LRRFIP1|IRF3|EP300|CTNNB1
BICARBONATE TRANSPORTERS%REACTOME%R-HSA-425381.2,0.0131668250305416,0.151955253889059,0.6901439523468089,1.78578804008829,96,6,SLC4A2|SLC4A3|AHCYL2|SLC4A5|SLC4A7|SLC4A8
TRAFFICKING OF AMPA RECEPTORS%REACTOME DATABASE ID RELEASE 66%399719,0.292950391644909,0.665416463589539,-0.269690953551028,-1.1323194506713201,2243,23,TSPAN7|AKAP5|CAMK2B|NSF|CAMK2A|GRIA1|PRKCB
TRNA AMINOACYLATION%REACTOME DATABASE ID RELEASE 66%379724,0.714305326743548,0.898428686580078,0.16313514747845198,0.833848335979383,5202,42,PARS2|DARS|SARS2|CARS2|RARS2|DARS2|FARS2|IARS2|LARS2|AIMP1|WARS2|HARS2|QARS|YARS2|FARSB|VARS2|MARS|EPRS|KARS|MARS2|TARS2|EARS2
TELOMERE EXTENSION BY TELOMERASE%REACTOME DATABASE ID RELEASE 66%171319,0.468107400130976,0.780769690730001,-0.381734389054144,-0.9819236825877621,3573,6,RUVBL2|NHP2|TERT|RUVBL1|DKC1
UPTAKE AND FUNCTION OF DIPHTHERIA TOXIN%REACTOME%R-HSA-5336415.1,0.22973149967256098,0.6122599559184541,-0.47435585118228896,-1.22017103411634,1753,6,HBEGF|HSP90AA1
HS-GAG BIOSYNTHESIS%REACTOME%R-HSA-2022928.1,0.0546075085324232,0.33896362399005303,0.344328235061477,1.5002092648519498,399,25,HS6ST3|HS6ST1|GPC6|SLC35D2|NDST3|SDC1|AGRN|HS6ST2|NDST2|GLCE
TERMINATION OF O-GLYCAN BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%977068,0.41636077608809596,0.7493091022753771,-0.291370852665083,-1.03082746848722,3175,14,ST3GAL1|ST6GALNAC4|MUC4|MUC20|MUC15
NUCLEOTIDE-LIKE (PURINERGIC) RECEPTORS%REACTOME DATABASE ID RELEASE 66%418038,0.7184426229508198,0.900213987946472,0.272126680827558,0.789936146953418,5258,8,ADORA2B|ADORA2A
GLUCOCORTICOID BIOSYNTHESIS%REACTOME%R-HSA-194002.2,0.701740609867818,0.8931369333627571,-0.367765910923741,-0.80511645589977,5361,4,HSD11B1|POMC
THYROXINE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%209968,0.817926045016077,0.93826094282131,0.439371381306865,0.73820065013089,6104,2,DUOX1|DIO2
RUNX3 REGULATES YAP1-MEDIATED TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%8951671,0.152304087477219,0.519849132875151,-0.4633773692506721,-1.3339985915719998,1169,8,RUNX3|CTGF|WWTR1|YAP1|TEAD2
RUNX3 REGULATES RUNX1-MEDIATED TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%8951911,0.751607717041801,0.9152481913183279,0.472613142988181,0.794051101773085,5609,2,CBFB
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%2197563,0.7436468430704741,0.9108818367874129,-0.239248260843925,-0.774579116517272,5676,11,GZMB|HES1|NOTCH2|MAML1
LAGGING STRAND SYNTHESIS%REACTOME%R-HSA-69186.2,0.0115546218487395,0.140084987142734,-0.44098442572885704,-1.76922106965819,87,20,RFC2|RPA2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|POLA1|RFC4|POLA2|FEN1
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES%REACTOME%R-HSA-5579029.2,0.746501833989947,0.9118647019584949,0.35437571831888,0.7785785451717091,5494,4,FDX1L|FDXR
ABORTIVE ELONGATION OF HIV-1 TRANSCRIPT IN THE ABSENCE OF TAT%REACTOME DATABASE ID RELEASE 66%167242,0.251697127937337,0.632068187660447,-0.280394409160542,-1.17725878147374,1927,23,NCBP2|POLR2J|NCBP1|POLR2H|NELFB|POLR2G|SUPT4H1|POLR2L
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES%REACTOME%R-HSA-6803207.1,0.792233263598326,0.9293225016611341,-0.23324278238971397,-0.7307191896103621,6058,10,PIDD1|CASP10|CASP1|CASP6
HSP90 CHAPERONE CYCLE FOR SHRS%REACTOME DATABASE ID RELEASE 66%3371497,0.0950208550573514,0.42498053239300104,-0.299670365502843,-1.39394840947599,728,32,DCTN5|DNAJA1|FKBP4|HSP90AA1|DYNC1I1|FKBP5|DCTN3|STIP1
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE%REACTOME DATABASE ID RELEASE 66%181430,0.12283315276272999,0.47697345522944606,0.37011307290008294,1.36519455952068,906,15,RIMS1|SNAP25|PPFIA2|CPLX1|PPFIA3|PPFIA4
TRANSPORT OF FATTY ACIDS%REACTOME%R-HSA-804914.1,0.175960021041557,0.548366806412612,-0.542085911076237,-1.2992764893370201,1337,5,LCN12|LCN1|SLC27A4
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME%REACTOME DATABASE ID RELEASE 66%9005891,0.0252923579004623,0.223514802128899,0.5288311581002921,1.6753728552545601,185,10,CAMK4|HDAC1|NCOR1|GPS2|TBL1XR1|SIN3A|TBL1X
ANTIMICROBIAL PEPTIDES%REACTOME%R-HSA-6803157.2,0.0409525055606437,0.289711424429654,-0.41545780184958503,-1.5788411002498899,312,17,PDZD11|TLR1|CD4|TLR2|PLA2G2A|SLC11A1|RNASE6|CHGA|S100A8|S100A9|ATOX1
SULFIDE OXIDATION TO SULFATE%REACTOME%R-HSA-1614517.2,0.410085134250164,0.7452892204937491,-0.401366064479562,-1.0324216402825301,3130,6,TST|SLC25A10|SQRDL
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS%REACTOME DATABASE ID RELEASE 66%177243,0.692127215849844,0.888433240372712,-0.18015654461661898,-0.838017227374603,5309,32,KPNB1|NPM1|NUP188|NUP85|RCC1|NUP37|RAN|NUP160|NUP214
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH MSH6%REACTOME%R-HSA-5632968.1,0.566741931199362,0.8308398918711859,0.7146007940008821,0.9528237356738721,4266,1,MSH2
FORMATION OF INCISION COMPLEX IN GG-NER%REACTOME DATABASE ID RELEASE 66%5696395,0.150078165711308,0.517154494869948,-0.251682619334746,-1.2765255344722501,1151,43,SUMO2|PARP2|GTF2H1|RAD23B|SUMO3|CDK7|UBC|MNAT1|DDB1|CETN2|XPA|GTF2H2
TRANSCRIPTIONAL REGULATION BY RUNX3%REACTOME%R-HSA-8878159.2,0.000127372309259967,0.00518555396908895,-0.33447625018316196,-2.10356885866336,0,95,PSMD1|PSMC2|JAG1|RUNX1|BCL2L11|RUNX3|PSMD3|PSMB2|CDKN2A|PSMF1|HES1|PSMD4|NOTCH1|SHFM1|SMURF2|PSME2|PSMB5|ZFHX3|CTGF|SNW1|SPP1|PSMC4|PSMC6|PSMD10|KAT2B|PSMB3|WWTR1|PSMC1|PSMD2|UBC|MAML1|PSMD6|MYC|YAP1|PSMD12|PSMA3|TEAD2|PSMA6|CCND1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
CELL JUNCTION ORGANIZATION%REACTOME DATABASE ID RELEASE 66%446728,0.0595975232198143,0.35396661720226896,-0.250342039717638,-1.4316021416951499,461,66,JUP|CTNND1|LAMC2|CLDN5|CLDN11|CLDN10|ILK|PVRL2|RSU1|CDH8|PXN|FLNA|CDH11|CDH5|LIMS2|CDH7|CD151|ANG|FLNC|ACTN1|ITGB4|CADM3|FBLIM1
ION INFLUX EFFLUX AT HOST-PATHOGEN INTERFACE%REACTOME%R-HSA-6803544.1,0.45282031147755497,0.769943206592495,-0.45670131009578296,-0.9998146355259759,3459,4,PDZD11|SLC11A1|ATOX1
PROTON-COUPLED NEUTRAL AMINO ACID TRANSPORTERS%REACTOME%R-HSA-428559.1,0.472909698996656,0.7831522581932591,-0.76582487869431,-1.0202626238184,3534,1,SLC36A1
PHOSPHOLIPASE C-MEDIATED CASCADE; FGFR2%REACTOME%R-HSA-5654221.2,0.36777996070726904,0.721642468110297,-0.416501021452625,-1.0713528267643702,2807,6,FGF10|FGF9|FGF7
ACTIVATION OF MATRIX METALLOPROTEINASES%REACTOME DATABASE ID RELEASE 66%1592389,0.7740833223813909,0.922671217932792,-0.19386782950960302,-0.765953708118823,5889,19,COL18A1|CTSV|TPSAB1|MMP1|MMP14|MMP9|TIMP1
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS%REACTOME DATABASE ID RELEASE 66%5678895,0.00012951690195570501,0.00518555396908895,-0.416990677889072,-2.30426897295632,0,58,PSMD3|PSMB2|PSMF1|VCP|PSMD4|SEL1L|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|DERL3|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
CHEMOKINE RECEPTORS BIND CHEMOKINES%REACTOME DATABASE ID RELEASE 66%380108,0.5612869610524941,0.827957010954873,-0.21345369720037,-0.920228797901694,4308,25,CXCL12|CXCL1|ACKR3|CXCL2|CCL19|CXCR4|CCRL2|CXCL16|CCR1|CX3CL1
CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKK%REACTOME DATABASE ID RELEASE 66%442717,0.437651169040581,0.7635570545514341,0.52001081171329,1.02279990132694,3256,3,CAMK4|CREB1
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH PMS2%REACTOME DATABASE ID RELEASE 66%5632987,0.196677384780279,0.573143439969417,0.738902674386545,1.24145189655546,1467,2,MLH1|PMS2
CLEAVAGE OF THE DAMAGED PYRIMIDINE%REACTOME DATABASE ID RELEASE 66%110329,0.0668109277792805,0.3690551432905871,0.551873582917912,1.52343221249202,493,7,NTHL1|NEIL1|OGG1|SMUG1|NEIL2|TDG
NEGATIVE REGULATION OF FGFR2 SIGNALING%REACTOME%R-HSA-5654727.1,0.30357142857142894,0.676550454659054,-0.280774769393888,-1.12646299700733,2311,20,FGF10|MAPK3|PPP2CA|FGF9|FGF7|UBC
RNA POLYMERASE I PROMOTER ESCAPE%REACTOME DATABASE ID RELEASE 66%73772,0.34990189666448696,0.7075366679683229,-0.236837121562457,-1.08135192983643,2674,30,ZNRD1|TWISTNB|POLR2H|GTF2H1|UBTF|CDK7|MNAT1|POLR2L|GTF2H2
RECYCLING PATHWAY OF L1%REACTOME DATABASE ID RELEASE 66%437239,0.12095511482254699,0.472999327000989,-0.30965625089301196,-1.3507771153483399,926,26,RPS6KA1|AP2A2|DNM1|NUMB|CLTA|SH3GL2|CLTC|KIF4A|MSN|RPS6KA4|AP2M1|DNM3
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53-DEPENDENT APOPTOSIS REMAIN UNCERTAIN%REACTOME DATABASE ID RELEASE 66%6803205,0.219020172910663,0.601686354077891,-0.38064456656387796,-1.23235726368974,1671,11,CHM|PPP1R13B|PERP|BCL6|BIRC5
NEUROTRANSMITTER CLEARANCE%REACTOME DATABASE ID RELEASE 66%112311,0.0489849377865095,0.317359880131657,-0.6058963208084339,-1.5585285571696499,373,6,MAOA|ACHE|BCHE|COMT|ALDH2
DUAL INCISION IN GG-NER%REACTOME DATABASE ID RELEASE 66%5696400,0.0622325943212758,0.358473315814565,-0.29246895018800606,-1.46471527885954,479,41,POLE|RFC2|CUL4B|RPA2|RFC3|PARP1|POLD4|PCNA|POLD1|PARP2|POLD2|RFC5|GTF2H1|UBC|DDB1|POLE2|POLE3|RFC4|XPA|GTF2H2
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS%REACTOME DATABASE ID RELEASE 66%432040,0.682734556733006,0.885415243771438,-0.174924510756428,-0.849773844357833,5282,37,ADCY8|PRKAR1A|GNGT2|ADCY4|GNG11|GNG10|PRKACA|GNG3|ADCY9
RNA POLYMERASE III ABORTIVE AND RETRACTIVE INITIATION%REACTOME DATABASE ID RELEASE 66%749476,0.772073123298327,0.9215496572020819,-0.157458450101734,-0.7885684873600991,5954,41,GTF3C4|SNAPC1|POLR2F|POU2F1|NFIA|GTF3A|GTF3C1|BRF1|ZNF143|BRF2|POLR3B|GTF3C5|POLR2H|NFIC|POLR3K|BDP1|NFIX|POLR2L
N-GLYCAN TRIMMING AND ELONGATION IN THE CIS-GOLGI%REACTOME%R-HSA-964739.1,0.683587585481326,0.885415243771438,-0.340455116786147,-0.816005950120555,5197,5,MAN1A1|MAN1C1|MGAT1
REGULATION OF GENE EXPRESSION IN BETA CELLS%REACTOME%R-HSA-210745.1,0.641601298350014,0.8679594103883821,0.30450989837237297,0.840591400933477,4743,7,AKT3|GCK|NKX6-1
TNFR1-INDUCED NFKAPPAB SIGNALING PATHWAY%REACTOME%R-HSA-5357956.1,0.9630741127348641,0.990916952887267,-0.129711663086605,-0.565825962130174,7380,26,TRAF2|TNFAIP3|USP2|XIAP|TNFRSF1A
IRS-MEDIATED SIGNALLING%REACTOME%R-HSA-112399.3,0.25753818039420395,0.636098664976652,-0.258118182557036,-1.1670865777463502,1972,29,IRS1|PIK3CB|FGF10|HRAS|PIK3R4|FGF19|FGF9|FGF7|FLT3LG
ANTIGEN PROCESSING-CROSS PRESENTATION%REACTOME%R-HSA-1236975.1,0.000127064803049555,0.00518555396908895,-0.428761500628004,-2.6903771876928597,0,94,HLA-E|FCGR1B|PSMD1|PSMC2|TLR1|B2M|TAPBP|SEC61G|LNPEP|STX4|TLR2|CTSV|FCGR1A|PSMD3|CTSS|HLA-C|PSMB2|ITGB5|PSMF1|HLA-A|PSMD4|SHFM1|PSME2|PSMB5|CYBB|CALR|MRC2|VAMP8|NCF4|PSMC4|PSMC6|PSMD10|NCF2|PSMB3|CD36|PSMC1|MRC1|PSMD2|SEC61A1|SEC61B|UBC|PSMD6|TLR4|PSMD12|PSMA3|CTSL|PSMA6|CD14|LY96|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
OVARIAN TUMOR DOMAIN PROTEASES%REACTOME DATABASE ID RELEASE 66%5689896,0.6859482646561811,0.886114603039861,-0.17811162100351396,-0.843854344370055,5276,34,VCP|TNFAIP3|IFIH1|TNIP1|OTUD5|UBC|TRAF3|OTUB1
KETONE BODY METABOLISM%REACTOME%R-HSA-74182.3,0.0965647822558831,0.42759608527799,0.524073141196969,1.4466898393288299,713,7,BDH2|HMGCLL1|ACAT1|HMGCL|BDH1|OXCT1
HEPARAN SULFATE HEPARIN (HS-GAG) METABOLISM%REACTOME DATABASE ID RELEASE 66%1638091,0.256713951246385,0.635017139147331,0.220310679764095,1.15542644134466,1863,46,HS6ST3|HS6ST1|GPC6|SLC35D2|NDST3|SDC1|GLB1L|XYLT1|AGRN|HS6ST2|CSPG5|NDST2|GLCE|HPSE
NEF MEDIATED DOWNREGULATION OF CD28 CELL SURFACE EXPRESSION%REACTOME%R-HSA-164939.1,0.0184615384615385,0.186740972764028,-0.991012351124835,-1.32026640779669,137,1,AP2M1
MITOCHONDRIAL IRON-SULFUR CLUSTER BIOGENESIS%REACTOME DATABASE ID RELEASE 66%1362409,0.699502226879749,0.8926914062846201,-0.249976434530388,-0.8093121560244051,5339,11,GLRX5|FXN|ISCA2
NIK-->NONCANONICAL NF-KB SIGNALING%REACTOME%R-HSA-5676590.1,0.00012936610608020702,0.00518555396908895,-0.40429788578987397,-2.22620951919887,0,57,UBB|PSMA4|PSMA7|MAP3K14|CHUK|UBE2M|CUL1|UBA3|PSMD7|PSME3|PSMA2|PSME1|PSMB1|PSMB9|PSMB4|FBXW11|PSMD1|PSMC2|NFKB2|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|RELB|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
CATECHOLAMINE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%209905,0.594348593941041,0.8433730669400721,0.402250041361055,0.883760471749748,4374,4,DDC|DBH|TH|PNMT
UREA CYCLE%REACTOME%R-HSA-70635.1,0.0454730555178499,0.30574871755800603,0.617862760649262,1.59875620822497,334,6,SLC25A15|ASL|NMRAL1|NAGS
GLUCAGON SIGNALING IN METABOLIC REGULATION%REACTOME%R-HSA-163359.2,0.48044473512099395,0.7857006060206241,-0.215341523423996,-0.983207237075991,3672,30,ADCY8|PRKAR1A|ADCY4|GNG11|GNG10|PRKACA|GNG3|ADCY9
PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC%REACTOME DATABASE ID RELEASE 66%389957,0.0996483001172333,0.435773831064563,-0.322946145646328,-1.3922660853053102,764,25,TUBA4A|CCT8|CCT5|TUBB4A|PFDN1|VBP1|ACTB|TUBB4B|TUBB6
APC C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS%REACTOME%R-HSA-176409.2,0.00025809781907342903,0.00819882332206558,-0.372581222370023,-2.18398407276597,1,73,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|PTTG1|MAD2L1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|PSMC4|PSMC6|PSMD10|CCNB1|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE%REACTOME%R-HSA-110330.1,0.9287245444801719,0.9793746057014829,0.36619795974634706,0.61525985410633,6931,2,OGG1|MPG
HDMS DEMETHYLATE HISTONES%REACTOME DATABASE ID RELEASE 66%3214842,0.0796828285454309,0.395958593986611,-0.29998850204886895,-1.42128065136193,612,34,KDM1A|PHF2|KDM3B|KDM8|KDM2A|ARID5B|HIST1H4I|JMJD6|HIST2H3A|KDM5C|HIST2H4A|HIST2H3C|HIST1H3H|HIST2H4B
VEGF LIGAND-RECEPTOR INTERACTIONS%REACTOME%R-HSA-194313.1,0.0554543087737568,0.34165878259009896,-0.540571125627076,-1.5562286121075202,425,8,FLT1|KDR|VEGFC|FLT4|VEGFB
SIGNAL ATTENUATION%REACTOME%R-HSA-74749.3,0.496873371547681,0.794550673730064,-0.319152294980949,-0.9600882229898101,3813,9,INS|IRS1|MAPK3|GRB10
RUNX3 REGULATES IMMUNE RESPONSE AND CELL MIGRATION%REACTOME%R-HSA-8949275.1,0.813650710152551,0.935884804197555,-0.301901257070755,-0.7235997051363309,6186,5,ITGAL|ITGA4|RUNX3|SPP1
G2 M CHECKPOINTS%REACTOME%R-HSA-69481.3,0.000128221566867547,0.00518555396908895,-0.31556136055058503,-2.19187831363278,0,150,UIMC1|PSMB4|RAD9A|RFC2|CLSPN|RPA2|PSMD1|MCM10|PSMC2|BRIP1|HIST1H2BE|RFC3|MCM4|H2AFX|NBN|MCM6|EXO1|CDC6|PSMD3|PSMB2|HIST1H2BN|PSMF1|RAD1|RAD17|BRCC3|ORC1|PKMYT1|HIST1H2BC|CDC25C|ORC6|PSMD4|MCM3|SHFM1|RHNO1|RNF168|PSME2|HIST1H4I|MCM5|CDC45|BRCA1|PSMB5|RFC5|TOPBP1|RMI1|PSMC4|PSMC6|PSMD10|CCNB1|PSMB3|RMI2|PSMC1|PSMD2|UBC|MCM2|PSMD6|HIST1H2BG|HIST1H2BD|HIST2H4A|PSMD12|PSMA3|KAT5|HIST2H4B|PSMA6|RFC4|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|HIST1H2BK|PSMA1|PSMC5|HIST1H2BJ|PSMC3
RNA POLYMERASE III TRANSCRIPTION%REACTOME%R-HSA-74158.2,0.772073123298327,0.9215496572020819,-0.157458450101734,-0.7885684873600991,5954,41,GTF3C4|SNAPC1|POLR2F|POU2F1|NFIA|GTF3A|GTF3C1|BRF1|ZNF143|BRF2|POLR3B|GTF3C5|POLR2H|NFIC|POLR3K|BDP1|NFIX|POLR2L
"SYNTHESIS OF IP2, IP, AND INS IN THE CYTOSOL%REACTOME%R-HSA-1855183.5",0.197012898845893,0.57371735849953,0.3584875968754579,1.25549830431239,1450,13,INPP1|INPP5J|MTMR9|IMPA1|INPP4A|ISYNA1
ACTIVATION OF RAC1%REACTOME%R-HSA-428540.3,0.733795993191044,0.907913422943088,-0.228524091304889,-0.7866242380985742,5603,13,ROBO1|PAK2|RAC1|SOS2|PAK4|SLIT2|NCK1
FORMATION OF SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI (SAHF)%REACTOME DATABASE ID RELEASE 66%2559584,0.624836258842023,0.858178245370935,-0.26678848289323004,-0.863742067120942,4769,11,UBN1|HIRA|ASF1A|TP53|EP400|HMGA1|CABIN1|H1F0|LMNB1|HIST1H1C
MTOR SIGNALLING%REACTOME%R-HSA-165159.4,0.7013996889580091,0.8931369333627571,-0.169203858424366,-0.835570576380212,5411,39,RPS6KB1|SLC38A9|EIF4G1|RRAGD
"BIOSYNTHESIS OF A2E, IMPLICATED IN RETINAL DEGRADATION%REACTOME DATABASE ID RELEASE 66%2466712",0.5377872227387439,0.81379229560463,0.729874283193648,0.9731888726169009,4048,1,NAPEPLD
AUF1 (HNRNP D0) BINDS AND DESTABILIZES MRNA%REACTOME DATABASE ID RELEASE 66%450408,0.000128287363694676,0.00518555396908895,-0.453562553767623,-2.42190552408026,0,51,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|HSPB1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|EIF4G1
NEGATIVE REGULATION OF TCF-DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS%REACTOME%R-HSA-3772470.2,0.0676223965377333,0.371075653877479,0.55063617000014,1.5200163673466203,499,7,DKK1|KREMEN1|SFRP1|WNT4|LRP6
DOWNREGULATION OF TGF-BETA RECEPTOR SIGNALING%REACTOME%R-HSA-2173788.1,0.9570144587729581,0.9880317864833471,-0.132927096842396,-0.5730673403188461,7346,25,TGFBR2|UBC|PPP1CA
CHL1 INTERACTIONS%REACTOME%R-HSA-447041.1,0.5178961748633879,0.8047565444482679,0.3226420871338211,0.9365735339894999,3790,8,CHL1|ITGA2|NRP1
PROCESSING OF DNA DOUBLE-STRAND BREAK ENDS%REACTOME DATABASE ID RELEASE 66%5693607,0.00776575429662635,0.10744248697278999,-0.27898691032348605,-1.69047844634693,60,82,UIMC1|RAD9A|RFC2|CLSPN|RPA2|BRIP1|HIST1H2BE|RFC3|H2AFX|NBN|PPP4R2|EXO1|HIST1H2BN|RAD1|RAD17|BRCC3|HIST1H2BC|RHNO1|SUMO2|RNF168|HIST1H4I|BRCA1|RFC5|TOPBP1|RMI1|RMI2|UBC|PPP4C|HIST1H2BG|HIST1H2BD|HIST2H4A|KAT5|HIST2H4B|RFC4|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ
ECM PROTEOGLYCANS%REACTOME%R-HSA-3000178.3,0.0556279312141741,0.34247366871298807,-0.292465720395382,-1.48337601153925,426,43,ITGB1|ITGA9|TGFB1|HSPG2|ITGAX|LAMB2|LAMC1|NCAN|ITGB5|LAMA2|TGFB3|VTN|TNXB|DCN|BGN|COMP|VCAN|LAMA4|SPARC|LUM|FMOD|TNC|ITGA8|SERPINE1
INTERLEUKIN-27 SIGNALING%REACTOME%R-HSA-9020956.1,0.484963389121339,0.7872939093021379,-0.308570962739795,-0.9667125452729781,3708,10,CANX|EBI3|IL6ST|STAT3
TGFBR1 LBD MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3656535,0.18583954979714698,0.559093571852282,-0.5880054757869301,-1.28726690172596,1419,4,TGFBR2|FKBP1A
ACTIVATED NTRK2 SIGNALS THROUGH CDK5%REACTOME%R-HSA-9032845.1,0.5783798001052081,0.8380181863116659,-0.373237509653636,-0.894579090367595,4397,5,NTRK2|TIAM1
RAS ACTIVATION UPON CA2+ INFLUX THROUGH NMDA RECEPTOR%REACTOME%R-HSA-442982.2,0.0701203558346415,0.376178559435536,-0.39888280847816204,-1.48240296665383,535,16,RASGRF2|GRIN1|CAMK2B|HRAS|GRIN2C|DLG3|GRIN2D|CAMK2A
TRANSPORT OF CONNEXINS ALONG THE SECRETORY PATHWAY%REACTOME DATABASE ID RELEASE 66%190827,0.547290969899666,0.818317601346006,-0.729102337891487,-0.971339381866999,4090,1,GJA1
SLBP DEPENDENT PROCESSING OF REPLICATION-DEPENDENT HISTONE PRE-MRNAS%REACTOME DATABASE ID RELEASE 66%77588,0.106497249148546,0.449288135667161,-0.436646876475206,-1.41366775506398,812,11,SLBP|SNRPD3|SNRPE|LSM11|NCBP2|LSM10|SNRPF|NCBP1|SNRPB
SIGNALING BY NON-RECEPTOR TYROSINE KINASES%REACTOME DATABASE ID RELEASE 66%9006927,0.46669263731982896,0.7806653415096191,-0.192787863374047,-0.990996052162278,3593,45,PTPN1|CDKN1B|NRG1|CDK4|AKT1|NRG3|NRG2|RAC1|STAP2|NR3C1|KHDRBS3|SOCS3|BCAR1|ELMO1|GPNMB|STAT3|PXN|HRAS|HBEGF|DOCK1|UBC|CCND1
METABOLISM OF VITAMIN K%REACTOME DATABASE ID RELEASE 66%6806664,0.260582010582011,0.636316525692816,-0.6085449100550571,-1.1883339742641101,1969,3,VKORC1
THE NLRP1 INFLAMMASOME%REACTOME DATABASE ID RELEASE 66%844455,0.154259607632357,0.5225398777782271,0.6677782197896851,1.3134409553118,1147,3,BCL2|NLRP1|BCL2L1
INTEGRATION OF ENERGY METABOLISM%REACTOME%R-HSA-163685.1,0.0375996961640714,0.276381965456363,-0.2312355895628,-1.46356065966252,296,97,TKT|ITPR2|AGPAT1|PLCB3|ITPR3|SLC2A1|MLX|INS|ADCY8|SLC25A6|PRKAR1A|ADIPOR1|AKAP5|GNGT2|ADCY4|RAPGEF3|GNG11|GNAI2|GNAQ|CACNA1E|RAP1A|PPP2CA|GNA15|ADIPOR2|GNG10|ADRA2C|ARL2|SLC25A4|PRKACA|GNG3|TALDO1|FASN|ADCY9|SLC25A5
"INCRETIN SYNTHESIS, SECRETION, AND INACTIVATION%REACTOME%R-HSA-400508.1",0.708802724652869,0.8957937975409159,-0.247606153848441,-0.8016382447907572,5410,11,PCSK1|DPP4|SEC11C
REGULATION OF MITOTIC CELL CYCLE%REACTOME DATABASE ID RELEASE 66%453276,0.000383092836163964,0.0111294649577428,-0.333178983545778,-2.0313159479396297,2,84,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|PTTG1|MAD2L1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|SKP1|PSMC4|PSMC6|PSMD10|CCNB1|PLK1|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
WNT MEDIATED ACTIVATION OF DVL%REACTOME DATABASE ID RELEASE 66%201688,0.183391939410333,0.556308895147568,0.46657434381645,1.2879659525178502,1355,7,DVL2|CSNK2A2|CSNK1E|DVL1|CSNK2B|CSNK2A1
NEPHRIN FAMILY INTERACTIONS%REACTOME%R-HSA-373753.3,0.317781574451308,0.6867397844771489,-0.28216810044726504,-1.11481984090466,2417,19,MAGI2|SPTAN1|FYN|CD2AP|ACTN4|IQGAP1|CASK|KIRREL|PIK3CB|KIRREL3|NCK1|ACTN1
UNCOATING OF THE HIV VIRION%REACTOME DATABASE ID RELEASE 66%162585,0.445083612040134,0.76693681188187,-0.77977503308337,-1.03884757909424,3326,1,PPIA
SIGNALING BY HEDGEHOG%REACTOME%R-HSA-5358351.2,0.0103806228373702,0.131171792348333,-0.23734355150147798,-1.5806255328224998,80,123,OFD1|NUMB|PSMD3|PSMB2|SMO|PSMF1|VCP|ADCY8|PSMD4|SEL1L|SHFM1|PRKAR1A|SMURF2|PSME2|ARRB1|PSMB5|BOC|SCUBE2|ADCY4|SKP1|PSMC4|PSMC6|PSMD10|GAS1|PSMB3|SYVN1|PSMC1|PSMD2|UBC|PSMD6|SPOP|PRKACA|PSMD12|PSMA3|ADRBK1|CSNK1A1|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|ADCY9|P4HB
"METABOLISM OF INGESTED SEMET, SEC, MESEC INTO H2SE%REACTOME%R-HSA-2408508.2",0.266955835962145,0.6417330323279019,-0.43184949816511603,-1.1804413451808797,2030,7,HNMT|NNMT
TRANSCRIPTIONAL ACTIVATION OF CELL CYCLE INHIBITOR P21%REACTOME%R-HSA-69895.3,0.6522706452035071,0.8734034730930859,-0.384336594509237,-0.8413931461636421,4983,4,ZNF385A
KANDUTSCH-RUSSELL PATHWAY%REACTOME%R-HSA-6807062.1,0.00510404397330192,0.0803498785568947,-0.8275102116132141,-1.8115928339346599,38,4,EBP|DHCR7|DHCR24
ADENYLATE CYCLASE INHIBITORY PATHWAY%REACTOME%R-HSA-170670.1,0.7254157391645941,0.9040629990111769,-0.23069295820465804,-0.794089898558379,5539,13,ADCY8|ADCY4|GNAI2|ADCY9
FRS-MEDIATED FGFR1 SIGNALING%REACTOME DATABASE ID RELEASE 66%5654693,0.453583061889251,0.7702341823050379,0.30200117463519704,0.9937693053888291,3341,11,FGF2|FRS3|SOS1|NRAS|FGF1|KRAS
HSF1-DEPENDENT TRANSACTIVATION%REACTOME DATABASE ID RELEASE 66%3371571,0.24571727474826702,0.6280519349499749,-0.286263143001125,-1.1854901584635902,1878,22,CAMK2B|RPTOR|CAMK2A|CRYAB|FKBP4|HSP90AA1
NEURONAL SYSTEM%REACTOME DATABASE ID RELEASE 66%112316,0.0198545861297539,0.194448137726112,0.181621744001418,1.40964729232328,141,255,HTR3A|KCNQ3|EPB41L5|KCNS3|KCNQ5|GNG5|LRFN2|SLITRK1|CAMK4|GRIK3|MYO6|SYT2|HOMER2|KCNAB3|KCNMB4|KCNH8|PICK1|RPS6KA2|ADCY2|GNGT1|LIN7B|GLS|GJD2|GABRA3|KCNK9|RIMS1|SNAP25|HCN2|HOMER3|DLG2|FLOT2|SLITRK6|CHRNB2|KCNJ8|PTPRS|GNB5|KCNK10|LIN7A|DNAJC5|CHRNA5|PTPRD|ADCY3|GABRB3|CACNB4|GNB4|GNAI3|SLC6A13|PPFIA2|PANX1|SLC18A3|BEGAIN|KCNQ2|CPLX1|CHRNB4|CACNA2D2|LRRC7|CACNG4|PPFIA3|KCNK3|EPB41L3|LRFN3|PPFIA4|SIPA1L1|FLOT1|ADCY6|GRIP1|GABBR1|DLG4|KCNMA1|NLGN2|CACNB2|CACNA2D3|PRKCA|KCNG1|CAMK2G
ACTIVATED POINT MUTANTS OF FGFR2%REACTOME%R-HSA-2033519.1,0.494433529796988,0.7929977188111991,-0.37370149064578206,-0.961260903930236,3774,6,FGF10|FGF9|FGF7
NON-INTEGRIN MEMBRANE-ECM INTERACTIONS%REACTOME DATABASE ID RELEASE 66%3000171,0.0622325943212758,0.358473315814565,-0.29240713345977803,-1.4644056941796397,479,41,ITGB1|TGFB1|HSPG2|LAMB2|LAMC1|SDC3|LAMC2|LAMC3|NTN4|ITGB5|LAMA2|CASK|DDR2|VTN|SDC4|DDR1|LAMA4|SDC2|TNC|THBS1|PDGFA|ACTN1|PDGFB|ITGB4
INFLAMMASOMES%REACTOME DATABASE ID RELEASE 66%622312,0.788802733604942,0.928016475452072,-0.19081767536209,-0.7539028336362879,6001,19,PYCARD|NFKB2|CASP1|NLRP3|RELA|NFKB1
INTERFERON ALPHA BETA SIGNALING%REACTOME%R-HSA-909733.2,0.000386448537936365,0.0111294649577428,-0.4038989758043379,-2.14385212823537,2,50,GBP2|PTPN11|HLA-F|ISG20|PTPN1|IRF8|OAS3|HLA-B|MX1|XAF1|HLA-E|IFIT3|OASL|OAS1|SOCS3|IFNAR1|HLA-C|IRF5|HLA-A|OAS2|IFIT2|SOCS1|PTPN6|IFIT1|ISG15|IFI6|RSAD2|IRF7|BST2|IFI35|USP18|IFITM1|IFITM2|IFITM3|SAMHD1
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON-LYMPHOID CELL%REACTOME DATABASE ID RELEASE 66%198933,0.00012809017548354,0.00518555396908895,-0.4173707129439,-2.50873613830933,0,80,HLA-B|PVR|ITGB1|IGKV3-11|MICA|CD300C|NCR3|LILRB1|HLA-E|SIGLEC8|B2M|ITGB2|CXADR|SIGLEC10|FCGR1A|HLA-C|LILRA6|HLA-A|LILRB3|FCGR2B|LAIR1|IGKV2-28|C3|PVRL2|OSCAR|LILRB2|LILRB5|CLEC2B|PILRA|HCST|ICAM1|SIGLEC1|SIGLEC9|TREM2|VCAM1|SIGLEC7|CD300A|IGKV2D-28|CD99|COLEC12|CD200|CD300LF|TYROBP|IFITM1|LILRB4|CD81|ICAM2
PROTEIN-PROTEIN INTERACTIONS AT SYNAPSES%REACTOME%R-HSA-6794362.3,0.145462080397845,0.512552662440151,0.21103974442414197,1.2526373688021202,1052,72,EPB41L5|LRFN2|SLITRK1|SYT2|HOMER2|LIN7B|HOMER3|DLG2|FLOT2|SLITRK6|PTPRS|LIN7A|PTPRD|PPFIA2|BEGAIN|PPFIA3|EPB41L3|LRFN3|PPFIA4|SIPA1L1|FLOT1|DLG4|NLGN2
TOLL LIKE RECEPTOR 5 (TLR5) CASCADE%REACTOME%R-HSA-168176.1,0.799861014593468,0.931670998922663,0.131453180260684,0.800551285561769,5754,80,DUSP4|DUSP6|UBE2V1|MAPK7|RPS6KA2|RPS27A|MAP2K6|MAPK11|BTRC|VRK3|MAPKAPK3|TNIP2|PELI2|NFKBIB|NOD1|MAP2K7|MYD88|PPP2CB|ATF2|IRAK4|MAP2K1|MAPK1|PELI1|IKBKB|MAP2K4|MAPK8
G PROTEIN GATED POTASSIUM CHANNELS%REACTOME%R-HSA-1296059.1,0.294779536831087,0.667556940989968,-0.298600107255404,-1.1347533245856398,2252,17,GNGT2|KCNJ12|GNG10|KCNJ9|GNG3
DEFECTS IN COBALAMIN (B12) METABOLISM%REACTOME DATABASE ID RELEASE 66%3296469,0.511748633879781,0.801554805389805,0.324397374372552,0.9416688257629621,3745,8,MMADHC|MMACHC|MMAA|MUT|CD320|MTR
VISUAL PHOTOTRANSDUCTION%REACTOME%R-HSA-2187338.1,0.235505742355057,0.620163873293386,0.213364013728808,1.17068139992318,1701,54,PDE6B|STRA6|GPC6|RETSAT|PPEF1|NMT2|SDC1|METAP1|GNGT1|AGRN|CYP4V2|HSD17B6
SIGNALING BY FGFR4 IN DISEASE%REACTOME DATABASE ID RELEASE 66%5655291,0.330160456894207,0.6957352559323989,0.34759860328603104,1.10121587117106,2427,10,GAB1|SOS1|PLCG1|NRAS|KRAS
MTORC1-MEDIATED SIGNALLING%REACTOME%R-HSA-166208.2,0.0890339425587467,0.41228493992510207,-0.338522232963453,-1.42131318763971,681,23,LAMTOR3|EIF4B|LAMTOR2|LAMTOR5|RPS6|LAMTOR1|MLST8|RRAGB|EIF4EBP1|RRAGA|RPTOR|RPS6KB1|SLC38A9|EIF4G1|RRAGD
ENOS ACTIVATION%REACTOME%R-HSA-203615.3,0.247907949790795,0.62852193925262,-0.382602999098552,-1.19864525100999,1895,10,NOS3|CAV1|HSP90AA1|CYGB
REGULATION OF NECROPTOTIC CELL DEATH%REACTOME%R-HSA-5675482.2,0.377777777777778,0.7281989978224692,-0.317706889302151,-1.06339470589891,2889,12,TNFRSF10A|TNFRSF10B|TRAF2|TNFSF10|XIAP|FADD
NOD1 2 SIGNALING PATHWAY%REACTOME DATABASE ID RELEASE 66%168638,0.63558515699334,0.8636797415465791,0.189264382102504,0.876236640533783,4675,30,UBE2V1|MAP2K6|CASP9|MAPK12|MAPK11|CASP8
CREB PHOSPHORYLATION%REACTOME DATABASE ID RELEASE 66%199920,0.694663512092534,0.889726625344871,-0.294155946367182,-0.804062161697516,5284,7,RPS6KA5|RPS6KA1|ATF1|MAPKAPK2
APC C-MEDIATED DEGRADATION OF CELL CYCLE PROTEINS%REACTOME DATABASE ID RELEASE 66%174143,0.000383092836163964,0.0111294649577428,-0.333178983545778,-2.0313159479396297,2,84,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|PTTG1|MAD2L1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|SKP1|PSMC4|PSMC6|PSMD10|CCNB1|PLK1|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
CLEARANCE OF NUCLEAR ENVELOPE MEMBRANES FROM CHROMATIN%REACTOME%R-HSA-2993913.1,0.0128879537085744,0.149991146428462,-0.720339786277271,-1.72651701422376,97,5,VRK1|EMD|BANF1
POTASSIUM TRANSPORT CHANNELS%REACTOME%R-HSA-1296067.1,0.759464882943144,0.917529758274103,-0.624393471548302,-0.831842029816373,5676,1,KCNJ10
ANDROGEN BIOSYNTHESIS%REACTOME%R-HSA-193048.2,0.311300351446337,0.68160868787154,0.46743687874406004,1.12418301285752,2302,5,HSD17B3|SRD5A1
NEUROFASCIN INTERACTIONS%REACTOME DATABASE ID RELEASE 66%447043,0.152420881796051,0.5200334205653889,0.485218599429657,1.33943291969704,1126,7,NFASC|NRCAM|SDCBP|CNTNAP1|ANK1|DCX
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN%REACTOME DATABASE ID RELEASE 66%170822,0.9838204592901879,0.9939453283228069,-0.11784902792045401,-0.514078981199052,7539,26,NUP188|NUP85|NUP37|NUP160|NUP214
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PYRIMIDINE%REACTOME DATABASE ID RELEASE 66%110328,0.0668109277792805,0.3690551432905871,0.551873582917912,1.52343221249202,493,7,NTHL1|NEIL1|OGG1|SMUG1|NEIL2|TDG
RECRUITMENT AND ATM-MEDIATED PHOSPHORYLATION OF REPAIR AND SIGNALING PROTEINS AT DNA DOUBLE STRAND BREAKS%REACTOME%R-HSA-5693565.2,0.144641937145801,0.511403740621608,-0.22715223739374202,-1.2690848482393502,1122,60,HIST1H2BN|BRCC3|HIST1H2BC|RNF168|HIST1H4I|BRCA1|ABL1|UBC|HIST1H2BG|HIST1H2BD|HIST2H4A|APBB1|KAT5|HIST2H4B|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ
FASL  CD95L SIGNALING%REACTOME%R-HSA-75157.2,0.7247742442088729,0.903635192226391,-0.35925971695568004,-0.786494619189675,5537,4,CASP10|FADD
TNFR1-INDUCED PROAPOPTOTIC SIGNALING%REACTOME DATABASE ID RELEASE 66%5357786,0.5295273012963211,0.8108997701936519,-0.272716052063378,-0.938741536818513,4043,13,TRAF2|TNFAIP3|USP2|FADD|TNFRSF1A
ALKBH2 MEDIATED REVERSAL OF ALKYLATION DAMAGE%REACTOME DATABASE ID RELEASE 66%112122,0.993093372293797,0.997308795012891,0.503749448610499,0.6716819173701,7476,1,ALKBH2
ACTIVATION OF HOX GENES DURING DIFFERENTIATION%REACTOME DATABASE ID RELEASE 66%5619507,0.00012835322808368602,0.00518555396908895,-0.381083770095471,-2.36478568358973,0,91,PIAS2|HIST1H3D|RARA|KDM6A|PCGF2|CNOT6|POLR2F|CREBBP|HIST1H4H|HOXC4|AJUBA|NCOA6|RBBP5|CTCF|POLR2C|HIST1H2BE|EZH2|H2AFX|YY1|HIST2H2AC|POLR2J|HIST1H2AD|PAXIP1|HIST1H2BN|H2AFV|HOXA4|HIST1H2BC|HIST1H4I|HOXB3|POLR2H|HOXB2|RBBP7|MAFB|WDR5|HIST2H3A|PKNOX1|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|POLR2G|HIST2H3C|PAGR1|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
ATP SENSITIVE POTASSIUM CHANNELS%REACTOME DATABASE ID RELEASE 66%1296025,0.977448716207037,0.9927322181739301,0.24635182726397,0.5412454560416049,7194,4,KCNJ8|ABCC8
FORMATION OF TC-NER PRE-INCISION COMPLEX%REACTOME DATABASE ID RELEASE 66%6781823,0.026661514683153,0.23124829949084805,-0.292689495887652,-1.57981155572671,206,53,CDK7|UBC|MNAT1|ERCC8|DDB1|POLR2G|ISY1|GPS1|XPA|POLR2L|PRPF19|GTF2H2
INSULIN-LIKE GROWTH FACTOR-2 MRNA BINDING PROTEINS (IGF2BPS IMPS VICKZS) BIND RNA%REACTOME DATABASE ID RELEASE 66%428359,0.20585864015049699,0.585932546425919,0.6378641037758821,1.2546034192105902,1531,3,IGF2BP2|IGF2BP3|IGF2BP1
NECTIN NECL TRANS HETERODIMERIZATION%REACTOME DATABASE ID RELEASE 66%420597,0.7349202055720859,0.9080812895978001,0.279064493132041,0.7703500427621409,5433,7,PVRL4|CADM1|PVRL1|PVRL3
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS%REACTOME%R-HSA-159234.2,0.900232618247609,0.968163672368249,-0.138924665012155,-0.674888534219697,6965,37,CPSF2|NUP188|NCBP1|NUP85|NUP37|NXF1|NUP160|NUP214
RNA POLYMERASE I PROMOTER CLEARANCE%REACTOME DATABASE ID RELEASE 66%73854,0.000127697612054655,0.00518555396908895,-0.385568236657012,-2.3507212243858,0,84,HIST1H2BN|H2AFV|ZNRD1|TWISTNB|HIST1H2BC|TTF1|HIST1H4I|POLR2H|GTF2H1|MAPK3|RBBP7|HIST2H3A|UBTF|CDK7|KAT2B|H2AFZ|HIST2H2AA4|MNAT1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|MTA2|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L|GTF2H2
TLR3-MEDIATED TICAM1-DEPENDENT PROGRAMMED CELL DEATH%REACTOME DATABASE ID RELEASE 66%9013957,0.5516833245660179,0.8225828340810141,-0.3816950613365921,-0.9148502279022349,4194,5,FADD|TICAM1
"PROGRESSIVE TRIMMING OF ALPHA-1,2-LINKED MANNOSE RESIDUES FROM MAN9 8 7GLCNAC2 TO PRODUCE MAN5GLCNAC2%REACTOME%R-HSA-964827.2",0.812037037037037,0.935317461845028,-0.372352366301721,-0.727109799067973,6138,3,MAN1A1|MAN1C1
THE ROLE OF NEF IN HIV-1 REPLICATION AND DISEASE PATHOGENESIS%REACTOME DATABASE ID RELEASE 66%164952,0.0351699882766706,0.267547057426989,-0.369607221240056,-1.5934285203701397,269,25,CD8B|ATP6V1H|AP2A1|FYN|AP1S3|PAK2|AP1S2|RAC1|DOCK2|B2M|AP2A2|CD4|PACS1|HLA-A|ELMO1|ARF1|AP1B1|HCK|AP2M1
MAJOR PATHWAY OF RRNA PROCESSING IN THE NUCLEOLUS AND CYTOSOL%REACTOME DATABASE ID RELEASE 66%6791226,0.9906489881367759,0.9970911567116291,0.0874108894128998,0.63500837488856,7097,180,WDR12|WDR75|IMP4|EBNA1BP2|RPS27A|MPHOSPH6|UTP14C|RPS27L|RPL26|EXOSC10|DCAF13|RPS26|HEATR1|TSR1|PDCD11|WDR18|ISG20L2|RPP38|RPL4|RPL37A|UTP20|XRN2|C1D|UTP3|PELP1|BMS1|NOP58|PNO1|RPS4Y1|EXOSC8|WDR46|RPL31|RPL23A|RPP40|RPL21|CIRH1A|RPS24|UTP6|DDX21|WBSCR22|NIP7|MPHOSPH10|RPL34|CSNK1E|RPS21|RPL22|DIEXF|DIS3|RPL14|RPS19|RPS12|RPS20|LTV1|FTSJ3|RPS11|SENP3|NOP14|EMG1|PES1|RPS25
EUKARYOTIC TRANSLATION INITIATION%REACTOME DATABASE ID RELEASE 66%72613,0.28811386075137796,0.661232490008811,-0.166582574887219,-1.0984644258945402,2246,117,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|EIF1AX|EIF3B|RPL35|RPL38|RPS15A|RPL36AL|EIF5|RPS13|EIF2S1|EIF2B2|EIF4A2|RPL26L1|FAU|EIF2B3|EIF4G1
RESPONSE TO METAL IONS%REACTOME DATABASE ID RELEASE 66%5660526,0.131318394997394,0.490819490032838,-0.4542533154644821,-1.3665051616111898,1007,9,MT1M|MT2A|SNCB|MT1E
TNF RECEPTOR SUPERFAMILY (TNFSF) MEMBERS MEDIATING NON-CANONICAL NF-KB PATHWAY%REACTOME DATABASE ID RELEASE 66%5676594,0.0119156736938588,0.14341240700871802,-0.5238510491577659,-1.8031968973944699,90,13,TNFSF13B|TNFRSF11A|TRAF2|TNFSF12|LTA|TRAF3|LTBR|TNFRSF12A
TRNA PROCESSING IN THE NUCLEUS%REACTOME%R-HSA-6784531.5,0.997374965460072,0.9994836051249741,0.0846811995007928,0.461858670325633,7218,53,NUP88|NUP35|ELAC2|RANBP2|RPP38|TSEN34|C2orf49|NDC1|DDX1|CPSF4|RPP40|NUP43|POP5|NUP54|TRNT1|XPOT|NUPL2|TPR|AAAS
HYDROLYSIS OF LPE%REACTOME DATABASE ID RELEASE 66%1483152,0.159458742371982,0.5293397224673839,-0.7588390122128549,-1.26282946380393,1201,2,PLA2G4C
SIGNALLING TO P38 VIA RIT AND RIN%REACTOME%R-HSA-187706.2,0.984744871120463,0.9943582032224201,-0.21365541583939998,-0.512091262561179,7487,5,RIT1|RIT2|BRAF|NTRK1|NGF
RNA POLYMERASE II PRE-TRANSCRIPTION EVENTS%REACTOME DATABASE ID RELEASE 66%674695,0.0318561335902376,0.253761148815741,-0.25213346412768806,-1.5103390373486,247,79,NCBP2|GTF2A2|POLR2J|TAF3|MLLT3|CCNK|GTF2A1|TAF12|SUPT16H|NCBP1|CTR9|POLR2H|GTF2H1|TAF7|TAF9B|NELFB|CDK7|MNAT1|TAF10|POLR2G|SUPT4H1|TAF9|SSRP1|AK6|POLR2L|GTF2H2
HORMONE LIGAND-BINDING RECEPTORS%REACTOME%R-HSA-375281.1,0.8222132904608791,0.9412230803430301,0.43711055969120505,0.7344021779100859,6136,2,GNRH1|GNRH2
ATF6 (ATF6-ALPHA) ACTIVATES CHAPERONES%REACTOME DATABASE ID RELEASE 66%381033,0.31477600209588696,0.684263851274465,-0.34561852235256,-1.11895856108435,2402,11,MBTPS2|CALR|NFYB|HSPA5
MITOTIC SPINDLE CHECKPOINT%REACTOME%R-HSA-69618.2,0.0138603696098563,0.157188774525237,-0.244992539888922,-1.58252776860865,107,107,NUF2|NSL1|SPDL1|CDC20|DYNC1H1|ANAPC10|CLIP1|DSN1|ANAPC2|ANAPC5|CENPM|CDC23|NUDC|CENPI|MAD2L1|KNTC1|ERCC6L|DYNLL2|INCENP|NUP85|NDC80|SGOL1|KIF18A|CDC27|SEC13|NUP37|CKAP5|CENPH|SPC25|NUP160|KIF2A|PLK1|SKA1|PPP2CA|SPC24|DYNC1I1|BIRC5|ANAPC11|CENPK|CENPP|SKA2
PROTON-COUPLED MONOCARBOXYLATE TRANSPORT%REACTOME%R-HSA-433692.2,0.600515813764083,0.8464076674715391,0.336771275715625,0.8714154697338019,4423,6,SLC16A8|SLC16A3|EMB|BSG
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN INTERLEUKIN SIGNALING%REACTOME%R-HSA-8939247.1,0.9025947561472629,0.9686656000326079,0.294799050154873,0.6476860679857529,6643,4,CBFB|ELF1
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP (SREBF)%REACTOME%R-HSA-1655829.2,0.0609222050489438,0.35631208031004796,-0.26830979606413397,-1.44822045988115,472,53,SREBF2|IDI1|GPAM|FDPS|MED1|KPNB1|CYP51A1|SEC23A|SMARCD3|MBTPS2|SEC24A|RAN|HMGCS1|NFYB|PPARA|DHCR7|SAR1B|FASN|INSIG1|TM7SF2
FGFRL1 MODULATION OF FGFR1 SIGNALING%REACTOME DATABASE ID RELEASE 66%5658623,0.28602324952689895,0.6588082107670339,0.4792487111879529,1.15259040215,2115,5,SPRED2|FGF2
NEURODEGENERATIVE DISEASES%REACTOME DATABASE ID RELEASE 66%8863678,0.7616859243697479,0.9184699428006701,-0.193196066608409,-0.7750989188648741,5800,20,PRDX1|CDC25A|GOLGA2|APP|PRDX2|BCL2L11|SOD2|CDC25C|LMNB1|CAPN1|CAST
NUCLEAR IMPORT OF REV PROTEIN%REACTOME%R-HSA-180746.1,0.414175695078971,0.7484998347457041,-0.227481217923566,-1.02856092313187,3172,29,KPNB1|NPM1|NUP188|NUP85|RCC1|NUP37|RAN|NUP160|NUP214
CAP-DEPENDENT TRANSLATION INITIATION%REACTOME DATABASE ID RELEASE 66%72737,0.28811386075137796,0.661232490008811,-0.166582574887219,-1.0984644258945402,2246,117,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|EIF1AX|EIF3B|RPL35|RPL38|RPS15A|RPL36AL|EIF5|RPS13|EIF2S1|EIF2B2|EIF4A2|RPL26L1|FAU|EIF2B3|EIF4G1
SULFUR AMINO ACID METABOLISM%REACTOME DATABASE ID RELEASE 66%1614635,0.8406005221932109,0.9473416296727991,-0.170229764047861,-0.714723539579578,6438,23,CDO1|GOT1|TST|SLC25A10|ADI1|SQRDL|APIP
ONCOGENE INDUCED SENESCENCE%REACTOME%R-HSA-2559585.4,0.45417807326293796,0.7707713235598309,-0.21293992957134,-1.00002602150254,3483,33,CDKN2A|E2F2|ETS2|CDKN2B|MAPK3|TNRC6C|E2F1|UBC|ID1|CDKN2C
N-GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE%REACTOME%R-HSA-532668.2,0.267559833506764,0.6417330323279019,-0.24111641756339497,-1.15107363781225,2056,35,CANX|VCP|SEL1L|UBXN1|CALR|RAD23B|SYVN1|PSMC1|UBC|GANAB|ENGASE
MEIOTIC SYNAPSIS%REACTOME%R-HSA-1221632.1,0.000128799587841319,0.00518555396908895,-0.449358299506614,-2.4254421296169304,0,53,HIST1H2BE|TERF2|H2AFX|TINF2|HIST2H2AC|HIST1H2AD|STAG2|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|LMNB1|BRCA1|REC8|SUN2|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|SMC1A|HIST2H4B|SYCE2|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
AFLATOXIN ACTIVATION AND DETOXIFICATION%REACTOME DATABASE ID RELEASE 66%5423646,0.823229016629567,0.941678899694271,-0.206816263558422,-0.711901685371922,6286,13,CYP3A5|AKR7A3|AKR7L|GGT1|DPEP1|GGT5
RRNA MODIFICATION IN THE MITOCHONDRION%REACTOME%R-HSA-6793080.3,0.14252748744400698,0.508674778494682,0.524367581203396,1.35683193620522,1049,6,TFB1M|MTERF4|RNMTL1|NSUN4
EPHRIN SIGNALING%REACTOME%R-HSA-3928664.2,0.06604158173664901,0.369007394574627,0.39026038927025497,1.50066746779378,485,17,NCK2|GIT1|EPHB2|ARHGEF7|EFNB2|EFNB3|PAK1
ASYMMETRIC LOCALIZATION OF PCP PROTEINS%REACTOME DATABASE ID RELEASE 66%4608870,0.00012891581797086499,0.00518555396908895,-0.39960785999316795,-2.24093099853789,0,61,FZD4|PSMD3|PSMB2|PSMF1|FZD2|FZD8|PSMD4|SHFM1|SMURF2|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
TOXICITY OF BOTULINUM TOXIN TYPE G (BONT G)%REACTOME DATABASE ID RELEASE 66%5250989,0.373018005912389,0.7241297850093872,0.552939230175361,1.0875662146328,2775,3,VAMP1|VAMP2|SYT1
ACTIVATION OF G PROTEIN GATED POTASSIUM CHANNELS%REACTOME%R-HSA-1296041.1,0.294779536831087,0.667556940989968,-0.298600107255404,-1.1347533245856398,2252,17,GNGT2|KCNJ12|GNG10|KCNJ9|GNG3
FERTILIZATION%REACTOME%R-HSA-1187000.1,0.416120218579235,0.7493091022753771,0.3535066025130779,1.0261678225103101,3045,8,IZUMO4|CATSPERG|CATSPER2|HVCN1|CD9|OVGP1
TRANSPORT OF ORGANIC ANIONS%REACTOME DATABASE ID RELEASE 66%879518,0.11770120988953199,0.46862716515177505,-0.5809537305583149,-1.39243523597295,894,5,SLC16A2|SLCO2B1|SLCO2A1|SLCO4A1
CGMP EFFECTS%REACTOME DATABASE ID RELEASE 66%418457,0.511473183978276,0.801504475859147,0.271650412113439,0.951376378839321,3766,13,KCNMB4|PDE10A|PDE3A|KCNMA1|ITPR1
PHOSPHORYLATION OF PROTEINS INVOLVED IN G1 S TRANSITION BY ACTIVE CYCLIN E:CDK2 COMPLEXES%REACTOME DATABASE ID RELEASE 66%69200,0.22388262464339104,0.607146964504641,0.5603842099754129,1.23118797475636,1647,4,CCNE1|RB1|CCNE2|CDK2
RESOLUTION OF AP SITES VIA THE SINGLE-NUCLEOTIDE REPLACEMENT PATHWAY%REACTOME DATABASE ID RELEASE 66%110381,0.68682109671509,0.8861361847538001,-0.372534265979446,-0.815555381882001,5247,4,APEX1
FORMATION OF EDITOSOMES BY ADAR PROTEINS%REACTOME DATABASE ID RELEASE 66%77042,0.113425311753781,0.46139171800540707,-0.791216907632366,-1.31671145939676,854,2,ADARB1
FREE FATTY ACIDS REGULATE INSULIN SECRETION%REACTOME DATABASE ID RELEASE 66%400451,0.124079915878023,0.47832576509682107,-0.506037024245063,-1.38322963937491,943,7,GNA14|PLCB1|PLCB3|GNAQ|GNA15
"BMAL1:CLOCK,NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION%REACTOME%R-HSA-1368108.4",0.187052233945552,0.560277092850838,-0.28988964406255896,-1.24975487507919,1435,25,ARNTL|CREBBP|NCOA6|NPAS2|BHLHE40|MED1|SMARCD3|DBP|KLF15|ARNTL2|CCRN4L|SERPINE1|PPARA
DEFECTIVE GALNT12 CAUSES COLORECTAL CANCER 1 (CRCS1)%REACTOME%R-HSA-5083636.1,0.18664047151277,0.5597458283154859,-0.49796206306819796,-1.28089257027239,1424,6,MUC4|MUC20|MUC15
NUCLEAR ENVELOPE REASSEMBLY%REACTOME DATABASE ID RELEASE 66%2995410,0.00797594142259414,0.10934566713541498,-0.590152845402819,-1.8488718258319599,60,10,LEMD3|LMNB1|PPP2CA|VRK1|EMD|BANF1
APOPTOTIC FACTOR-MEDIATED RESPONSE%REACTOME DATABASE ID RELEASE 66%111471,0.877103049421661,0.960725750963158,-0.24033772992803898,-0.65695246705022,6672,7,CYCS|XIAP
CLASS C 3 (METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS)%REACTOME%R-HSA-420499.1,0.398580398580399,0.7388683667002129,0.34223300970873805,1.04001455235706,2919,9,TAS2R5|GABBR1|GRM4|GRM8|TAS2R14|GRM2|TAS2R19|TAS2R4|TAS2R20
LECTIN PATHWAY OF COMPLEMENT ACTIVATION%REACTOME%R-HSA-166662.3,0.14246031746031698,0.508674778494682,-0.6797728024704971,-1.32742399551634,1076,3,COLEC11|FCN3|FCN1
ADENYLATE CYCLASE ACTIVATING PATHWAY%REACTOME DATABASE ID RELEASE 66%170660,0.7872646443514649,0.927748696800401,-0.234671354583429,-0.73519471980682,6020,10,GNAL|ADCY8|ADCY4|ADCY9
CLASS B 2 (SECRETIN FAMILY RECEPTORS)%REACTOME DATABASE ID RELEASE 66%373080,0.31600660066006603,0.685583406115178,0.196929881237276,1.09784333122519,2297,57,WNT6|CRHR1|GNG5|GNGT1|GNAS|PTH1R|WNT2B|RAMP1|GNB5|GNB4|GCGR|ADCYAP1|ADCYAP1R1|WNT4|RAMP3|UCN
SEMA4D IN SEMAPHORIN SIGNALING%REACTOME%R-HSA-400685.2,0.7925633342413508,0.929512171827138,0.17798300307356,0.755617014480175,5818,23,RHOC|MET|PLXNB1|LIMK1|MYH10
OXYGEN-DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA-INDUCIBLE FACTOR ALPHA%REACTOME%R-HSA-1234176.2,0.000644496004124775,0.0163600882996276,-0.35610299915062504,-2.02220915634081,4,64,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|HIF3A|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|WTIP|PSMA1|PSMC5|PSMC3
DEFECTIVE CHST6 CAUSES MCDC1%REACTOME DATABASE ID RELEASE 66%3656225,0.00745975657636435,0.10477806266857598,-0.796669056416478,-1.74407509824925,56,4,PRELP|OGN|LUM|FMOD
REGULATION BY TREX1%REACTOME%R-HSA-3248023.1,0.50247491638796,0.7970718494574169,-0.752922364358183,-1.00307337664629,3755,1,TREX1
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME DATABASE ID RELEASE 66%629594,0.0635306839686402,0.360813325515998,0.63888607062702,1.5365173361587598,469,5,CHRNB2|CHRNA5|CHRNB4|CHRNA3|CHRNA7
GAP JUNCTION DEGRADATION%REACTOME%R-HSA-190873.2,0.0662918410041841,0.3690551432905871,-0.487122022010094,-1.5260897058320901,506,10,GJA1|DNM1|CLTA|CLTC|DAB2|AP2M1|CLTB
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN%REACTOME%R-HSA-6804115.1,0.705079406746292,0.894639008000397,-0.20200854978552396,-0.822984286356261,5371,21,CNOT4|BTG2|CNOT10|CNOT6L|CNOT6|RGCC|PLK2|NPM1|CDC25C|PLAGL1|TNKS1BP1
REGULATION OF HSF1-MEDIATED HEAT SHOCK RESPONSE%REACTOME DATABASE ID RELEASE 66%3371453,0.8515030318668559,0.949296218452153,-0.132485763219564,-0.749208483166389,6599,63,GSK3B|HSPA14|HSPH1|HSF1|NUP205|NUP93|DNAJB1|NUP210|BAG1|RPA2|HSPA13|DNAJC7|BAG5|NUP188|BAG3|MAPKAPK2|HSPA6|HSPA9|NUP85|MAPK3|NUP37|NUP160|NUP214|HSPA5|HSPA4
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%205043,0.604395604395604,0.848175106515994,-0.23892582504074103,-0.887940879683211,4619,16,UBC|NGFR|SQSTM1
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%9013508,0.266176663604148,0.641603173139009,-0.285715900200355,-1.1640086346675802,2027,21,KAT2A|PBX1|HEYL|CREBBP|DLGAP5|PLXND1|HES1|NOTCH1|SNW1|NOTCH3|KAT2B|MAML1
COMMON PATHWAY OF FIBRIN CLOT FORMATION%REACTOME DATABASE ID RELEASE 66%140875,0.07335251046025099,0.381170670138757,-0.479991688141577,-1.50375130061898,560,10,F8|THBD|F2R|SERPINE2|F13A1
SHC-RELATED EVENTS TRIGGERED BY IGF1R%REACTOME DATABASE ID RELEASE 66%2428933,0.33283743575872304,0.6971202277372819,0.40086735618711894,1.10658357684573,2460,7,SOS1|IGF1R|NRAS|IGF2|KRAS
TRNA PROCESSING IN THE MITOCHONDRION%REACTOME DATABASE ID RELEASE 66%6785470,0.9306943713834821,0.9793746057014829,-0.252814553018801,-0.6059482421290601,7076,5,HSD17B10
P53-INDEPENDENT DNA DAMAGE RESPONSE%REACTOME DATABASE ID RELEASE 66%69610,0.000256574727389352,0.00819882332206558,-0.407376332236664,-2.17528316927375,1,51,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
HATS ACETYLATE HISTONES%REACTOME%R-HSA-3214847.1,0.00012863390789812198,0.00518555396908895,-0.37183412963331697,-2.43784565521513,0,114,HIST1H2BE|KAT6A|KANSL1|KANSL2|JADE3|HIST2H2AC|HIST1H2AD|YEATS4|TAF6L|BRPF3|RUVBL1|HIST1H2AI|HCFC1|OGT|HIST1H2BN|TAF12|MORF4L2|HIST1H2BC|MSL2|PHF20|HIST1H4I|RBBP7|WDR5|HIST1H2AK|KAT7|HIST2H3A|MBIP|KAT2B|HIST2H2BF|HIST2H2AA4|HIST3H2A|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|TAF10|HIST2H3C|HIST1H3H|KAT8|KAT5|TAF9|ACTB|HIST2H4B|HIST1H2AC|CCDC101|HIST3H2BB|ELP4|HIST2H2BE|HIST1H2BK|AK6|HIST1H2BJ|HIST2H2AA3
LOSS OF MECP2 BINDING ABILITY TO 5MC-DNA%REACTOME DATABASE ID RELEASE 66%9022538,0.08011789924973199,0.39674006528988004,0.8274607113316791,1.39024083281427,597,2,HDAC1|SIN3A
PACKAGING OF TELOMERE ENDS%REACTOME DATABASE ID RELEASE 66%171306,0.000129988301052905,0.00518555396908895,-0.5410699107559621,-2.56347223290011,0,34,HIST1H2BE|TERF2|H2AFX|TINF2|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H4B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
ACYL CHAIN REMODELLING OF PS%REACTOME DATABASE ID RELEASE 66%1482801,0.00406397482957525,0.0699620448571681,-0.548656180400584,-1.94106533422648,30,14,PLA2G2A|PLA2G2D|PLA2R1|PLA2G4D|PLA2G4A|PLA2G16|OSBPL5|PLA2G12A
PI METABOLISM%REACTOME DATABASE ID RELEASE 66%1483255,0.9223327805417358,0.9776156396135859,0.11598633157678999,0.693496550514985,6673,74,MTMR6|PLEKHA1|INPP5K|FIG4|PIP4K2C|INPP5J|PNPLA6|PLEKHA3|PIKFYVE|MTMR9|MTMR2|INPP5F|PI4K2B|INPP4A|INPPL1|PLEKHA6|SBF1|PIK3R2
RMTS METHYLATE HISTONE ARGININES%REACTOME DATABASE ID RELEASE 66%3214858,0.000129416332341141,0.00518555396908895,-0.43137285177654205,-2.3621335001084502,0,56,SMARCA4|SMARCA2|H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2AI|SMARCE1|H2AFV|SMARCD3|HIST1H4I|RBBP7|WDR5|SMARCD2|HIST1H2AK|HIST2H3A|PRMT3|H2AFZ|HIST2H2AA4|HIST3H2A|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|PRMT5|HIST1H2AC|CCND1|H2AFJ|HIST2H2AA3
G-PROTEIN MEDIATED EVENTS%REACTOME%R-HSA-112040.1,0.16022242338031797,0.5300563172412229,-0.254666829661164,-1.26778904079052,1238,40,PLCB1|GNAL|ITPR2|PLCB3|ITPR3|ADCY8|PRKAR1A|PLA2G4A|ADCY4|PDE1C|PDE1A|GNAI2|PDE1B|PRKACA|ADRBK1|ADCY9
OLFACTORY SIGNALING PATHWAY%REACTOME DATABASE ID RELEASE 66%381753,0.5967698154180239,0.844613508628182,0.269488548293452,0.8867828006673449,4396,11,GNGT1|REEP4|REEP6|GNB1|REEP2|RTP5|REEP1
G1 S DNA DAMAGE CHECKPOINTS%REACTOME%R-HSA-69615.2,0.000515995872033024,0.0139121625154964,-0.352649475492933,-2.0166558719134,3,66,PSMD3|PSMB2|CDKN2A|PSMF1|PSMD4|SHFM1|PHF20|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ZNF385A|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
METABOLISM OF POLYAMINES%REACTOME%R-HSA-351202.2,0.00321916044295648,0.0581345224635642,-0.300581160958791,-1.7694731437626898,24,74,GOT1|ODC1|PSMD3|PSMB2|PSMF1|ADI1|PSMD4|SHFM1|PSME2|PSMB5|SLC6A8|CKB|PSMC4|PSMC6|PSMD10|SMS|PSMB3|PSMC1|PSMD2|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|APIP|PSMC5|PSMC3
NRCAM INTERACTIONS%REACTOME%R-HSA-447038.1,0.40536277602523707,0.74261205019402,-0.381646523015117,-1.04321375137807,3083,7,NRP2|DLG3
GAP JUNCTION ASSEMBLY%REACTOME DATABASE ID RELEASE 66%190861,0.32874918140144105,0.695505262287846,-0.430796378210509,-1.1081243353161299,2509,6,GJC1|GJA5|GJA1|GJC2|GJA4
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES%REACTOME%R-HSA-8963889.1,0.12798008907518998,0.485006465714925,-0.4235412912098571,-1.3712377176607,976,11,FURIN|APOC2|PCSK5|ANGPTL4|MBTPS2|PCSK6|LMF1
CHROMATIN MODIFYING ENZYMES%REACTOME DATABASE ID RELEASE 66%3247509,0.000127844541038098,0.00518555396908895,-0.249663433930095,-1.8852176367282,0,236,SETD1B|HIST1H2BE|KAT6A|KANSL1|SMARCA4|SMARCA2|REST|KANSL2|JADE3|NFKB2|KDM1A|EZH2|H2AFX|PHF2|HIST2H2AC|HIST1H2AD|KDM3B|KDM8|NSD1|YEATS4|TAF6L|BRPF3|RUVBL1|KDM2A|HIST1H2AI|SETD8|HCFC1|SMARCE1|OGT|HIST1H2BN|H2AFV|TAF12|MORF4L2|ARID5B|HIST1H2BC|MSL2|PHF20|SMARCD3|HIST1H4I|SETD1A|RBBP7|JMJD6|WDR5|SMARCD2|HIST1H2AK|KAT7|HIST2H3A|KDM5C|MBIP|PRMT3|BRMS1|KAT2B|HIST2H2BF|H2AFZ|SUV420H1|HDAC8|HIST2H2AA4|HIST3H2A|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|TAF10|HIST2H3C|RELA|MTA2|NFKB1|HIST1H3H|KAT8|KAT5|TAF9|ACTB|HIST2H4B|PRMT5|HIST1H2AC|CCND1|CCDC101|HIST3H2BB|ELP4|HIST2H2BE|H2AFJ|HIST1H2BK|AK6|HIST1H2BJ|HIST2H2AA3|SUV39H1
CLEC7A (DECTIN-1) INDUCES NFAT ACTIVATION%REACTOME DATABASE ID RELEASE 66%5607763,0.768959205020921,0.9208716027443391,-0.23991607332901002,-0.7516257389888059,5880,10,PPP3CA|NFATC3|AHCYL1|NFATC2|ITPR2|ITPR3|NFATC1
MITOCHONDRIAL TRANSLATION%REACTOME DATABASE ID RELEASE 66%5368287,0.00140809011776754,0.0301860198914787,-0.298404679941651,-1.86365295774483,10,93,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|MRPL18|MRPL57|GFM2|MRPS18B|MRPS15|MRPL47|GADD45GIP1|MRPS11|MRPL13|OXA1L|MRPL10|MRPL50|MRRF|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|GFM1|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
P75NTR RECRUITS SIGNALLING COMPLEXES%REACTOME%R-HSA-209543.1,0.288333115097551,0.661438410876056,-0.332221912618987,-1.14357224834076,2201,13,IRAK1|UBC|NGFR|SQSTM1
GLYCOGEN BREAKDOWN (GLYCOGENOLYSIS)%REACTOME DATABASE ID RELEASE 66%70221,0.449986873195064,0.768588477853328,-0.27598672212158804,-1.00206305091346,3427,15,GYG1|GAA|PHKG2|PHKA1|PYGL|PYGM|GYG2
PLASMA LIPOPROTEIN ASSEMBLY%REACTOME%R-HSA-8963898.1,0.0145135983263598,0.16142357413220002,-0.566374034267737,-1.7743759146423301,110,10,APOE|A2M|PRKACA|SAR1B|P4HB
EXPRESSION AND PROCESSING OF NEUROTROPHINS%REACTOME DATABASE ID RELEASE 66%9036866,0.0964533438031671,0.427566585262796,-0.6474935201014721,-1.4174986659659699,736,4,FURIN|PCSK5|NGF|PCSK6
INTERCONVERSION OF 2-OXOGLUTARATE AND 2-HYDROXYGLUTARATE%REACTOME%R-HSA-880009.1,0.188927707605482,0.5632471197622879,0.6470290264083721,1.2726297404966698,1405,3,ADHFE1|D2HGDH
GLUCOSE METABOLISM%REACTOME DATABASE ID RELEASE 66%70326,0.271777003484321,0.646576786621306,-0.192176372985147,-1.12649299686033,2105,73,GPI|SLC25A10|PFKFB2|PFKFB3|G6PC3|HK1|HK3|NUP188|NUP85|ENO1|NUP37|PGAM1|NUP160|GAPDH|PPP2CA|NUP214|PRKACA|PGK1|ALDOA|ALDOC
MRNA EDITING%REACTOME DATABASE ID RELEASE 66%75072,0.00510404397330192,0.0803498785568947,-0.827500980843759,-1.81157262585074,38,4,APOBEC3C|APOBEC3B|ADARB1
DISEASES OF SIGNAL TRANSDUCTION%REACTOME DATABASE ID RELEASE 66%5663202,0.033067421513124,0.25998057358601,-0.16844703941697697,-1.3362479689624298,256,318,PSMD4|VWF|NOTCH1|SEL1L|SHFM1|IRS1|STAT3|FXR1|NCBP1|PSME2|ARRB1|PSMB5|SNW1|POLR2H|PIK3CB|FGF10|MAPK3|RHOG|HRAS|PIK3R3|SKP1|FAM114A2|LMNA|LRP5|HDAC5|PSMC4|HBEGF|JAG2|NEURL1B|PSMC6|PSMD10|RAP1A|FN1|CD86|KAT2B|PSMB3|PPP2CA|FGF19|TGFBR2|SYVN1|FGF9|MAP3K11|FGF7|PSMC1|HDAC8|VCL|ARAF|PSMD2|UBC|PDGFRB|MAML1|FKBP1A|PSMD6|MYC|POLR2G|PSMD12|PSMA3|HSP90AA1|PDGFRA|PHB|CSNK1A1|PSMA6|MAPKAP1|PSMD13|PSMB7|PSMA1|RPS6KB2|PDGFB|PSMC5|PSMC3|POLR2L|BAD
"SODIUM-COUPLED SULPHATE, DI- AND TRI-CARBOXYLATE TRANSPORTERS%REACTOME%R-HSA-433137.1",0.9901830724330061,0.9968039549305829,-0.298219580552335,-0.496285070935575,7463,2,SLC13A3
MYD88:MAL(TIRAP) CASCADE INITIATED ON PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%166058,0.708124759337697,0.89516234575314,-0.138913877247169,-0.85981773141223,5516,90,MAPKAPK2|MEF2C|SOCS1|MAPK9|MAPK3|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|CD36|UBC|RELA|NFKB1|TLR4|CD14|LY96|PELI3
CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII%REACTOME DATABASE ID RELEASE 66%442729,0.177080598582305,0.5486682494146969,-0.35097149254076004,-1.27432059736592,1348,15,GRIN1|CAMK2B|GRIN2C|DLG3|GRIN2D|CAMK2A
INHIBITION OF PKR%REACTOME%R-HSA-169131.4,0.605525302164962,0.8484731812466321,0.694861049845611,0.92650345038288,4558,1,EIF2AK2
AKT-MEDIATED INACTIVATION OF FOXO1A%REACTOME DATABASE ID RELEASE 66%211163,0.779649504143459,0.924704689181848,0.343186455633376,0.7539952585273759,5738,4,AKT3|FOXO1|AKT2
SYNTHESIS OF DOLICHYL-PHOSPHATE MANNOSE%REACTOME%R-HSA-162699.1,0.965873015873016,0.9910057007541669,-0.287893014017878,-0.5621820901924661,7301,3,DPM3|DPM2
DEFECTIVE ACTH CAUSES OBESITY AND PRO-OPIOMELANOCORTININ DEFICIENCY (POMCD)%REACTOME DATABASE ID RELEASE 66%5579031,0.31933110367893,0.687256973102892,-0.837781208645787,-1.1161257330475098,2386,1,POMC
NF-KB IS ACTIVATED AND SIGNALS SURVIVAL%REACTOME%R-HSA-209560.1,0.00536860023569465,0.0829378624098312,-0.5515452517162359,-1.8985257131132502,40,13,IRAK1|NFKBIA|UBC|RELA|NFKB1|NGFR|SQSTM1
SHC-MEDIATED CASCADE:FGFR3%REACTOME DATABASE ID RELEASE 66%5654704,0.32823911279415696,0.6950398637731511,0.40244757772515505,1.1109457359858501,2426,7,FGF2|SOS1|NRAS|FGF1|KRAS
ENZYMATIC DEGRADATION OF DOPAMINE BY MONOAMINE OXIDASE%REACTOME DATABASE ID RELEASE 66%379398,0.24223932077474103,0.625158460820442,-0.7121036669423771,-1.18505437573024,1825,2,MAOA|COMT
TRANSCRIPTIONAL REGULATION BY SMALL RNAS%REACTOME DATABASE ID RELEASE 66%5578749,0.00025763235862424303,0.00819882332206558,-0.378713251607043,-2.25252988358544,1,77,HIST2H2AC|POLR2J|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|NUP188|HIST1H4I|NUP85|POLR2H|NUP37|RAN|HIST2H3A|NUP160|NUP214|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|POLR2G|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
CHOLINE CATABOLISM%REACTOME%R-HSA-6798163.1,0.6667989417989421,0.880719592999549,-0.43024927170118504,-0.840167781402775,5040,3,SLC44A1
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR (ANDROGEN RECEPTOR) REGULATED GENES KLK2 AND KLK3%REACTOME DATABASE ID RELEASE 66%5625886,0.00012960082944530802,0.00518555396908895,-0.577177057607564,-2.85024331708229,0,39,HIST1H2BE|KDM1A|H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|PKN1|HIST1H2BC|HIST1H4I|HIST2H3A|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
INSULIN PROCESSING%REACTOME%R-HSA-264876.2,0.809692832764505,0.9347733010395931,0.171536226299075,0.747368962948004,5930,25,EXOC4|PCSK2|KIF5B|KIF5A|MYO5A|EXOC1|SLC30A6|MYRIP|STX1A|SLC30A7|KIF5C
LOSS OF FUNCTION OF SMAD2 3 IN CANCER%REACTOME%R-HSA-3304349.1,0.9607710058368399,0.990064627444708,0.21695347750275798,0.5613798745356489,7077,6,SMAD3|SMAD2
FGFR4 LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190322,0.503682272488164,0.797546192421419,-0.395948636398609,-0.9490133274934259,3829,5,FGFR4|FGF19|FGF9
SHC-MEDIATED CASCADE:FGFR1%REACTOME DATABASE ID RELEASE 66%5654688,0.555464480874317,0.825309970896623,0.313219458779057,0.909221292327268,4065,8,FGF2|SOS1|NRAS|FGF1|KRAS
STIMULI-SENSING CHANNELS%REACTOME DATABASE ID RELEASE 66%2672351,0.6732522796352579,0.882195523984236,0.153772165393208,0.868904702291009,4872,60,TRPM4|FKBP1B|RPS27A|BEST4|UNC80|ASIC1|TRPM7|SRI|CLCN3|SGK2|SLC9B2|RYR1
REMOVAL OF THE FLAP INTERMEDIATE%REACTOME DATABASE ID RELEASE 66%69166,0.031069743051914,0.250509257391795,-0.46378149634875604,-1.64079111359135,236,14,DNA2|PRIM2|RPA2|POLD4|PCNA|POLD1|POLD2|POLA1|POLA2|FEN1
RNA POLYMERASE I TRANSCRIPTION TERMINATION%REACTOME%R-HSA-73863.4,0.11018494399583198,0.4552826490805829,-0.295412762718364,-1.36143131906937,845,31,ZNRD1|TWISTNB|TTF1|POLR2H|GTF2H1|UBTF|CDK7|MNAT1|PTRF|POLR2L|GTF2H2
MAPK FAMILY SIGNALING CASCADES%REACTOME%R-HSA-5683057.2,0.00626438251086679,0.0925463325267305,-0.20350999742562198,-1.5367113652082398,48,236,KALRN|GRIN1|SEPT7|CSF2RB|PSMD4|VWF|SHFM1|IRS1|PSME2|IL2RA|ARRB1|PSMB5|FGF10|MAPK3|CAMK2B|HSPB1|HRAS|TNRC6C|PSMC4|HBEGF|PSMC6|CSF2RA|PSMD10|RAP1A|FN1|IL3RA|PSMB3|PPP2CA|FGF19|FGF9|TEK|MAP3K11|GRIN2C|FGF7|PSMC1|VCL|ARAF|DLG3|PEA15|PSMD2|UBC|PDGFRB|GRIN2D|PSMD6|CAMK2A|FLT3LG|MYC|CCND3|PRKACA|PSMD12|PSMA3|PDGFRA|SPTBN2|CDC42EP5|PHB|PSMA6|PSMD13|PSMB7|PSMA1|PDGFB|PSMC5|CDC42EP2|PSMC3
RNA POLYMERASE I PROMOTER OPENING%REACTOME DATABASE ID RELEASE 66%73728,0.000129802699896158,0.00518555396908895,-0.589262512625898,-2.8838254482641803,0,38,H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|MAPK3|HIST2H3A|UBTF|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
DDX58 IFIH1-MEDIATED INDUCTION OF INTERFERON-ALPHA BETA%REACTOME DATABASE ID RELEASE 66%168928,0.143998968673456,0.510372098339109,-0.226200497288302,-1.26849283261522,1116,61,TRAF2|TNFAIP3|IKBKE|IFIH1|ISG15|IRF7|NFKBIA|OTUD5|FADD|UBC|TRAF3|RELA|DHX58|NFKB1|UBE2L6|NLRX1
ACTIVATED NTRK2 SIGNALS THROUGH PI3K%REACTOME DATABASE ID RELEASE 66%9028335,0.633337861703573,0.8631726958478259,0.390061940552205,0.856982695210269,4661,4,GAB1|PIK3CA|PIK3R1
SIGNALING BY NTRK1 (TRKA)%REACTOME DATABASE ID RELEASE 66%187037,0.0866915939620551,0.406842536616055,0.222716149057436,1.33506865764492,625,75,DUSP4|DUSP6|DNAL4|IRS2|RALB|MAPK7|RPS6KA2|CRK|MAP2K5|MAPK12|MAPK11|ADORA2A|VRK3|SHC1|SOS1|ADCYAP1|ADCYAP1R1|SHC2|MAPKAPK3|YWHAB|PLCG1|NRAS|AP2S1|AP2B1|RIT1|PPP2CB
RHESUS GLYCOPROTEINS MEDIATE AMMONIUM TRANSPORT.%REACTOME DATABASE ID RELEASE 66%444411,0.296989966555184,0.6689039624806751,-0.848202470224967,-1.13000935576345,2219,1,RHBG
TERMINAL PATHWAY OF COMPLEMENT%REACTOME DATABASE ID RELEASE 66%166665,0.35952380952381,0.7155384949577859,-0.5628101908018089,-1.09902565897946,2717,3,C5|CLU|C7
INTERLEUKIN-1 PROCESSING%REACTOME%R-HSA-448706.1,0.0218729535036018,0.204538669098334,-0.649715956097292,-1.6712444635335002,166,6,IL1B|IL18|NFKB2|CASP1|RELA|NFKB1
FMO OXIDISES NUCLEOPHILES%REACTOME%R-HSA-217271.1,0.15959140355532,0.5293397224673839,-0.7586986490212301,-1.26259587700731,1202,2,FMO3|FMO2
GABA A RECEPTOR ACTIVATION%REACTOME DATABASE ID RELEASE 66%977441,0.44673855865334006,0.768189935609799,-0.4157406106549,-0.9964509131294531,3396,5,ARHGEF9|GABRQ
ENTRY OF INFLUENZA VIRION INTO HOST CELL VIA ENDOCYTOSIS%REACTOME DATABASE ID RELEASE 66%168275,0.0874237198195808,0.408874392525297,-0.814281775572098,-1.35509508799817,658,2,CLTA|CLTC
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE%REACTOME DATABASE ID RELEASE 66%2559586,0.00012936610608020702,0.00518555396908895,-0.40694804522831896,-2.2408022498972597,0,57,H1F0|HIST1H2BE|TERF2|H2AFX|NBN|TINF2|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|LMNB1|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|KAT5|HIST1H1C|HIST2H4B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
L13A-MEDIATED TRANSLATIONAL SILENCING OF CERULOPLASMIN EXPRESSION%REACTOME DATABASE ID RELEASE 66%156827,0.476074093130949,0.7850084910380921,-0.15221333335234602,-0.9876143661969781,3700,109,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|EIF1AX|EIF3B|RPL35|RPL38|RPS15A|RPL36AL|RPS13|EIF2S1|EIF4A2|RPL26L1|FAU|EIF4G1
"TETRAHYDROBIOPTERIN (BH4) SYNTHESIS, RECYCLING, SALVAGE AND REGULATION%REACTOME%R-HSA-1474151.3",0.30343660505076797,0.6765231039641589,-0.39460592594641,-1.1360152315805199,2330,8,DHFR|NOS3|HSP90AA1
NETRIN-1 SIGNALING%REACTOME DATABASE ID RELEASE 66%373752,0.27677100494233897,0.6520063460668679,0.22238739996207302,1.13671006075285,2015,42,UNC5C|PITPNA|ABLIM2|ABLIM1|SLIT1|UNC5B|MAPK12|MAPK11|SLIT3|PAK1|PLCG1|DCC|EZR|SRC|AGAP2|TRIO|MAPK8|RGMA
INTERLEUKIN-33 SIGNALING%REACTOME%R-HSA-9014843.2,0.185284280936455,0.559025865656518,-0.905546978385532,-1.20640600986174,1384,1,IL33
BIOSYNTHESIS OF ASPIRIN-TRIGGERED D-SERIES RESOLVINS%REACTOME DATABASE ID RELEASE 66%9020265,0.998938710533298,0.999656642395059,-0.271408877860491,-0.45166777430263505,7529,2,LTA4H|ALOX5
KERATAN SULFATE BIOSYNTHESIS%REACTOME%R-HSA-2022854.1,0.6660128154831961,0.880719592999549,-0.204530938508311,-0.847015833617018,5092,22,B4GALT4|ST3GAL1|PRELP|OGN|LUM|FMOD|B4GALT1|B4GAT1
VITAMIN D (CALCIFEROL) METABOLISM%REACTOME DATABASE ID RELEASE 66%196791,0.645448592010478,0.86907298954767,-0.32766619804875297,-0.842845730102475,4927,6,SUMO2|LGMN
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC%REACTOME%R-HSA-389960.2,0.22728466386554602,0.609201573718782,-0.301010831651817,-1.20764969119607,1730,20,TUBA1B|TUBA4A|CCT8|CCT5|TUBB4A|TUBB4B|TUBB6
PLATELET HOMEOSTASIS%REACTOME DATABASE ID RELEASE 66%418346,0.346728490468831,0.7038391566282349,-0.183750243017037,-1.07096221820277,2691,71,ITPR2|MRVI1|ATP2A1|P2RX4|FGR|ITPR3|P2RX5|P2RX3|STIM1|ATP2A3|PLA2G4A|PTPN6|PDE2A|GNGT2|PDE1A|GNG11|PDE1B|NOS3|PPP2CA|GNG10|PTGIR|GNG3|ATP2B2
PEROXISOMAL LIPID METABOLISM%REACTOME DATABASE ID RELEASE 66%390918,0.522881126455456,0.807051143864932,0.232686464212244,0.9430255080850279,3861,20,SLC25A17|ACBD5|NUDT7|ACOX2|ACOX3|EHHADH|ACOT8|PHYH|HACL1|PECR|SLC27A2|NUDT19
FORMATION OF APOPTOSOME%REACTOME%R-HSA-111458.2,0.595673206127385,0.8445090144443349,0.45141528586138396,0.8878805967808591,4432,3,CASP9|APAF1
TGF-BETA RECEPTOR SIGNALING IN EMT (EPITHELIAL TO MESENCHYMAL TRANSITION)%REACTOME DATABASE ID RELEASE 66%2173791,0.648002174503941,0.870291461516485,0.22623959086358997,0.851867093235068,4767,16,CGN|RPS27A|PARD3
RESOLUTION OF D-LOOP STRUCTURES THROUGH SYNTHESIS-DEPENDENT STRAND ANNEALING (SDSA)%REACTOME%R-HSA-5693554.1,0.188935281837161,0.5632471197622879,-0.28657643678784994,-1.2500987514211201,1447,26,RAD51|XRCC2|BRIP1|PALB2|NBN|EXO1|RAD51C|RAD51AP1|BRCA1|RMI1|RAD51B|RMI2|KAT5|XRCC3
SUMOYLATION OF INTRACELLULAR RECEPTORS%REACTOME%R-HSA-4090294.2,0.7477430328405079,0.912622327870267,-0.206056362162503,-0.783064494400617,5714,17,NR3C1|RORA|SUMO2|SUMO3|PPARG|PPARA
SIGNALING BY VEGF%REACTOME DATABASE ID RELEASE 66%194138,0.038210026926529,0.278935415865459,-0.228545335480715,-1.4536897664753001,297,100,FLT1|NCKAP1L|VAV3|WASF2|JUP|CTNND1|ITPR2|KDR|ITPR3|VAV1|VEGFC|BCAR1|FLT4|ELMO1|MAPKAPK2|PXN|PIK3CB|CYBB|HSPB1|HRAS|NCF4|CDH5|DOCK1|CYFIP2|NCF2|AXL|NOS3|VEGFB|NRP2|CAV1|WASF3|MAPK13|PRKACA|HSP90AA1|NCK1|MAPKAP1|SPHK1|PRKCB
RAS SIGNALING DOWNSTREAM OF NF1 LOSS-OF-FUNCTION VARIANTS%REACTOME DATABASE ID RELEASE 66%6802953,0.49368292351582704,0.7923145426459479,0.435858358384127,0.9575993755483081,3633,4,NF1|NRAS|KRAS
INTERACTION BETWEEN L1 AND ANKYRINS%REACTOME%R-HSA-445095.1,0.021484906173511002,0.20251241938493103,0.384647496515444,1.6569165210903,157,24,KCNQ3|SCN5A|ANK2|NFASC|SPTBN1|KCNQ2|SCN3A|NRCAM|SCN9A|SCN2A
FC EPSILON RECEPTOR (FCERI) SIGNALING%REACTOME%R-HSA-2454202.1,0.0037112874328129,0.0651087194648458,-0.25146228748981403,-1.68003510719088,28,125,PSMA4|PSMA7|MAPK10|CHUK|RASGRP1|PPP3CA|CUL1|NFATC3|PRKCQ|MALT1|PSMD7|MAP3K1|PSME3|PSMA2|FYN|TRAF6|GRAP2|UBE2N|PSME1|AHCYL1|PLCG2|LCP2|PSMB1|PAK2|SYK|NFATC2|PSMB9|RAC1|IGKV3-11|UBE2D2|PSMB4|LYN|FBXW11|PSMD1|PSMC2|VAV3|ITPR2|PSMD3|PSMB2|ITPR3|LAT2|VAV1|PSMF1|IGKV2-28|PSMD4|SHFM1|MAPK9|PSME2|FCER1G|PSMB5|PIK3CB|MAPK3|HRAS|SKP1|NFATC1|PSMC4|PSMC6|PSMD10|IGKV2D-28|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|PSMD6|RELA|NFKB1|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
PTEN REGULATION%REACTOME%R-HSA-6807070.2,0.0035750766087844703,0.0633906249658241,-0.24503740495816398,-1.6561111957541998,27,132,PSMD4|SHFM1|PSME2|PSMB5|SNAI2|MAPK3|RBBP7|CBX4|TNRC6C|HDAC5|RPTOR|PSMC4|CBX6|PSMC6|PSMD10|PSMB3|RING1|PSMC1|XIAP|PSMD2|UBC|PSMD6|SNAI1|PPARG|MTA2|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|SLC38A9|PSMA1|PSMC5|PSMC3|RRAGD
C6 DEAMINATION OF ADENOSINE%REACTOME%R-HSA-75102.2,0.113425311753781,0.46139171800540707,-0.791216907632366,-1.31671145939676,854,2,ADARB1
NTRK2 ACTIVATES RAC1%REACTOME DATABASE ID RELEASE 66%9032759,0.9111111111111109,0.972245398885683,-0.325044981946453,-0.6347304674294111,6887,3,RAC1|NTRK2
ACTIVATION OF SMO%REACTOME%R-HSA-5635838.1,0.38030938647089707,0.729416463582188,-0.300111567503038,-1.0617508393967199,2900,14,ARRB1|BOC|GAS1|ADRBK1|CSNK1A1
RESOLUTION OF ABASIC SITES (AP SITES)%REACTOME%R-HSA-73933.1,0.234152652005175,0.617951264290741,-0.246698650671605,-1.18792304147374,1809,36,POLE|RFC2|RPA2|RFC3|PARP1|POLD4|PCNA|POLD1|PARP2|POLD2|RFC5|POLE2|APEX1|POLE3|RFC4|FEN1
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR%REACTOME DATABASE ID RELEASE 66%428930,0.267948214986269,0.6418798906350429,-0.280468813444762,-1.16149433213419,2048,22,TBXA2R|GNGT2|GNG11|GNAQ|GNA15|GNG10|GNG3
G BETA:GAMMA SIGNALLING THROUGH PLC BETA%REACTOME DATABASE ID RELEASE 66%418217,0.666841897752661,0.880719592999549,-0.213112126853714,-0.8419861315907771,5073,19,PLCB1|GNG8|PLCB3|GNGT2|GNG11|GNG10|GNG3
SCAVENGING OF HEME FROM PLASMA%REACTOME%R-HSA-2168880.1,0.00091767173571054,0.0216489481696613,-0.593141348907272,-2.09844735517174,6,14,HBB|HBA1|IGKV3-11|APOL1|HPX|LRP1|HP|IGKV2-28|JCHAIN|IGKV2D-28|CD163|IGHA1
SIGNALLING TO RAS%REACTOME%R-HSA-167044.4,0.174887892376682,0.54811765844537,0.332200339246991,1.2774092775088,1286,17,RALB|MAPK12|MAPK11|SHC1|SOS1|SHC2|MAPKAPK3|NRAS
TRANSLATION%REACTOME%R-HSA-72766.3,0.000255460467492656,0.00819882332206558,-0.22281402831007,-1.74252030271266,1,289,MRPS10|RPS23|MRPL53|AIMP2|MRPS17|FARSA|MRPL37|RPL3|AURKAIP1|SRP14|GSPT2|IARS|RPL7A|RPS2|EIF2B5|GARS|RPL15|SPCS2|MRPL18|RPL37|MRPL57|GFM2|RPL27A|RPL18|EIF3J|RPL39|MRPS18B|RPL27|EIF2S3|MRPS15|MRPL47|EEF1D|VARS|GADD45GIP1|MRPS11|MRPL13|EIF4EBP1|SEC61G|ETF1|SARS|OXA1L|EIF3C|TRAM1|MRPL10|MRPL50|MRRF|EIF2B1|EIF3M|MRPL51|RPN2|YARS|RPLP2|MRPS34|MRPL9|WARS|RPS14|RPS4X|RPL35A|RPS29|MRPS30|RPL10|RPL36A|RPL24|MRPS23|MRPL41|RPL22L1|MRPS6|MRPS18C|SRP19|TRMT112|EIF1AX|AARS|MRPL38|EIF3B|MRPS22|MRPL52|SEC11C|N6AMT1|EEF1G|GFM1|RPL35|MRPL21|RPL38|RPS15A|SRPRB|RPL36AL|MRPS18A|EIF5|MRPS24|MRPL27|MRPL23|MRPS7|SEC61A1|SEC61B|SSR1|MRPL36|ICT1|RPS13|EIF2S1|EIF2B2|CARS|MRPL22|MRPL49|MRPS2|MRPL39|EIF4A2|RPL26L1|MRPL3|FAU|MRPL12|MRPS36|MRPL17|SRP9|EIF2B3|SSR3|MRPS27|SRP68|MRPL11|RPN1|EIF4G1|SSR4|MRPL16
DISEASES OF METABOLISM%REACTOME DATABASE ID RELEASE 66%5668914,0.31973409801877,0.687856118120141,-0.237629810058207,-1.10536020209705,2452,32,CSF2RB|POMC|PPP1R3C|TTF1|MCCC2|CSF2RA|UBC|PCCB|GYG2
TRANSLESION SYNTHESIS BY POLK%REACTOME%R-HSA-5655862.1,0.7769200575690172,0.9244556023423259,-0.199973675685995,-0.7599488004208891,5937,17,RFC2|RPA2|RFC3|PCNA|RFC5|UBC|RFC4
RETROGRADE TRANSPORT AT THE TRANS-GOLGI-NETWORK%REACTOME%R-HSA-6811440.1,0.836518595041322,0.946089220274489,-0.141657517225525,-0.7463789163094251,6477,49,ARL1|TMF1|RAB6B|NAA30|NAA38|COG4|RAB9A|NAPA|GOLGA4|PLIN3|ARFIP2|NSF|COG1|VPS51|RAB9B
PYRUVATE METABOLISM%REACTOME%R-HSA-70268.6,0.8214425459762621,0.9406008438023141,-0.16720704868897698,-0.7374647733383629,6297,27,PDK3|LDHA|PDHX|MPC1
SYNTHESIS OF KETONE BODIES%REACTOME%R-HSA-77111.5,0.15080765576218302,0.5178365305986949,0.518904360178483,1.34269553070102,1110,6,BDH2|HMGCLL1|ACAT1|HMGCL|BDH1
PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS%REACTOME DATABASE ID RELEASE 66%622323,0.20532576371992398,0.58515351714347,0.521172108284229,1.25341593175636,1518,5,CHRNB2|CHRNA5|CHRNB4|CHRNA3
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS%REACTOME DATABASE ID RELEASE 66%500657,0.45924722447874394,0.7735063645065241,0.244858586763727,0.992356362341833,3391,20,GNG5|GRIK3|GNGT1|GNB5|GNB4
GAP JUNCTION TRAFFICKING%REACTOME%R-HSA-190828.1,0.0631399317406143,0.36006266503904,-0.414509733241031,-1.50501764987751,480,15,GJA5|GJA1|GJC2|DNM1|CLTA|CLTC|GJA4|DAB2|AP2M1|CLTB
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS%REACTOME DATABASE ID RELEASE 66%452723,0.636720282463711,0.8642856997441619,-0.209579322498678,-0.867922505268774,4868,22,KLF4|POLR2J|STAT3|POLR2H|HIF3A|POLR2G|POLR2L
NEGATIVE FEEDBACK REGULATION OF MAPK PATHWAY%REACTOME%R-HSA-5674499.1,0.878454485920105,0.960725750963158,-0.258231757762947,-0.6642416450139089,6706,6,MAP2K1|MAPK1|BRAF|MAP2K2|RAF1|MAPK3
FATTY ACID METABOLISM%REACTOME DATABASE ID RELEASE 66%8978868,0.31203585147247104,0.68160868787154,-0.16094863406913298,-1.08280489898933,2436,129,CROT|ACSL5|TBXAS1|SLC25A20|ACOT1|PTGDS|ACSF2|CRAT|CYP1B1|ACSL4|GGT1|GPX1|ELOVL2|CBR1|ACSF3|MAPKAPK2|ELOVL1|PTGR2|PLA2G4A|PTGES2|PTGS1|ACAD10|DPEP1|HACD2|GGT5|NDUFAB1|ACOT2|PCCB|ABCD1|PCTP|FADS1|FADS2|HADH|FASN|PTGES|PTGIS|ABCC1
SNRNP ASSEMBLY%REACTOME DATABASE ID RELEASE 66%191859,0.191244834710744,0.5657618283915489,-0.23217985566088897,-1.22333182489116,1480,49,DDX20|NUP107|SNRPD3|SMN2|GEMIN5|GEMIN7|NUP205|NUP93|NUP210|SNRPE|GEMIN8|NCBP2|PHAX|GEMIN2|NUP188|SNRPF|NCBP1|SNRPD1|NUP85|NUP37|NUP160|NUP214|SNRPB|PRMT5|SMN1
SCAVENGING BY CLASS A RECEPTORS%REACTOME DATABASE ID RELEASE 66%3000480,0.00013109596224436298,0.00518555396908895,-0.7040342934128359,-2.49077037654533,0,14,HSP90B1|MSR1|MARCO|COL4A1|CALR|COL4A2|APOE|FTL|COLEC12|COL1A2|COL1A1|COL3A1|FTH1
TIGHT JUNCTION INTERACTIONS%REACTOME DATABASE ID RELEASE 66%420029,0.830388692579505,0.943602795238726,0.188399385168258,0.7093861688749491,6109,16,PARD3|CLDN12|CLDN3|CLDN15|PARD6A|PRKCI|PARD6B|CLDN4|INADL
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3%REACTOME%R-HSA-9028731.1,0.71379781420765,0.898267902818609,0.273316208178977,0.793389136751468,5224,8,FRS3|SOS1|NRAS|KRAS
FATTY ACIDS%REACTOME%R-HSA-211935.1,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
AMPLIFICATION OF SIGNAL FROM THE KINETOCHORES%REACTOME%R-HSA-141424.2,0.0201514568091388,0.195205495598712,-0.249317789759503,-1.54712214519081,156,91,NUF2|NSL1|SPDL1|CDC20|DYNC1H1|CLIP1|DSN1|CENPM|NUDC|CENPI|MAD2L1|KNTC1|ERCC6L|DYNLL2|INCENP|NUP85|NDC80|SGOL1|KIF18A|SEC13|NUP37|CKAP5|CENPH|SPC25|NUP160|KIF2A|PLK1|SKA1|PPP2CA|SPC24|DYNC1I1|BIRC5|CENPK|CENPP|SKA2
DEFECTIVE CHST3 CAUSES SEDCJD%REACTOME DATABASE ID RELEASE 66%3595172,0.271381794368042,0.646576786621306,-0.45412786351121,-1.1681392006875,2071,6,CSPG4|NCAN|DCN|BGN|VCAN
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS%REACTOME DATABASE ID RELEASE 66%8939236,0.000127942681678608,0.00518555396908895,-0.469315894773195,-2.9949872114474902,0,101,HIST2H2AC|HIST1H2AD|PSMD3|PSMB2|GATA3|HIST1H2BN|H2AFV|PSMF1|LMO2|HIST1H2BC|PSMD4|SHFM1|TAL1|PSME2|HIST1H4I|PSMB5|ABL1|PSMC4|HIST2H3A|PSMC6|SPI1|PSMD10|CDK7|PSMB3|H2AFZ|PSMC1|PSMD2|UBC|HIST2H2AA4|MNAT1|PSMD6|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|YAP1|HIST1H3H|PSMD12|PSMA3|HIST2H4B|H3F3B|HIST1H2AC|PSMA6|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|H2AFJ|HIST1H2BK|PSMA1|PSMC5|HIST1H2BJ|PSMC3|HIST2H2AA3
"DEFECTIVE POMGNT1 CAUSES MDDGA3, MDDGB3 AND MDDGC3%REACTOME DATABASE ID RELEASE 66%5083628",0.894275468189667,0.9658968257150641,0.5520511689457429,0.7360857439480559,6732,1,DAG1
PHOSPHOLIPASE C-MEDIATED CASCADE; FGFR3%REACTOME DATABASE ID RELEASE 66%5654227,0.38051895122945295,0.729499056535481,0.48060479798895395,1.05590920900532,2800,4,FGF2|PLCG1|FGF1
PROCESSING OF INTRONLESS PRE-MRNAS%REACTOME DATABASE ID RELEASE 66%77595,0.16848468918386098,0.541253459162226,-0.325163406492107,-1.28469028397948,1281,19,CPSF2|PAPOLA|NCBP1|CLP1|CSTF3|PABPN1|CPSF7
DEFECTIVE MMAA CAUSES METHYLMALONIC ACIDURIA TYPE CBLA%REACTOME DATABASE ID RELEASE 66%3359475,0.507100750267953,0.798677653370192,0.5878136200716851,0.987602777409047,3784,2,MMAA|MUT
TOXICITY OF BOTULINUM TOXIN TYPE A (BONT A)%REACTOME DATABASE ID RELEASE 66%5250968,0.337590001358511,0.699636319850872,0.49846834914120397,1.09515619165328,2484,4,SV2C|SNAP25
PROTEIN UBIQUITINATION%REACTOME DATABASE ID RELEASE 66%8852135,0.12971789256730598,0.48824045881981,-0.220003911402781,-1.28599945296983,1006,72,UBE2L3|UBE2A|UCHL3|HLTF|RAD18|UBE2D2|UBE2T|HIST1H2BE|UBE2Z|UBE2B|RRAGA|USP9X|HIST1H2BN|HLA-A|PCNA|VCP|UBE2G2|HIST1H2BC|UBE2S|UBE2R2|CTR9|RNF20|RNF152|UBA1|RNF40|UBC|HIST1H2BG|HIST1H2BD|HIST1H2BK|HIST1H2BJ
CASPASE-MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS%REACTOME DATABASE ID RELEASE 66%264870,0.227712418300654,0.609818988326981,-0.365107818368377,-1.22205005370843,1741,12,GSN|VIM|DBNL|CASP6
ACTIVATED NTRK2 SIGNALS THROUGH RAS%REACTOME DATABASE ID RELEASE 66%9026519,0.705944239873751,0.894639008000397,-0.334157417926846,-0.8009115676663621,5367,5,HRAS|NTRK2
LOSS OF NLP FROM MITOTIC CENTROSOMES%REACTOME%R-HSA-380259.1,0.31083344068014895,0.6814986161073721,-0.191430352456851,-1.09935727625123,2412,67,HAUS1|NDE1|TUBG1|CEP72|HAUS6|CEP78|HAUS4|CEP76|CSNK1D|CEP192|PCNT|NEK2|NEDD1|DYNC1H1|OFD1|CEP70|TUBA4A|SDCCAG8|HAUS8|CDK5RAP2|CEP131|CKAP5|TUBB4A|PLK1|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
CYTOCHROME C-MEDIATED APOPTOTIC RESPONSE%REACTOME%R-HSA-111461.2,0.5716409840497428,0.833854868733934,0.37152474758873605,0.8935148874381429,4228,5,CASP9|APAF1|CASP3|CASP7
VLDL ASSEMBLY%REACTOME%R-HSA-8866423.3,0.120456354470682,0.472686039512467,-0.785718224427902,-1.30756077123898,907,2,APOC1|P4HB
TRANSLOCATION OF SLC2A4 (GLUT4) TO THE PLASMA MEMBRANE%REACTOME DATABASE ID RELEASE 66%1445148,0.0174834801762115,0.180006763679715,0.3062834387225711,1.62603739347182,126,48,EXOC4|PRKAG2|TBC1D1|MYO1C|RAB13|RHOQ|RAB10|STXBP3|KIF3B|YWHAQ|RALGAPB|YWHAB|RAB11A|TBC1D4|YWHAE|MYO5A|EXOC1|SNAP23|YWHAH
DEFECTIVE CHSY1 CAUSES TPBS%REACTOME DATABASE ID RELEASE 66%3595177,0.271381794368042,0.646576786621306,-0.45412786351121,-1.1681392006875,2071,6,CSPG4|NCAN|DCN|BGN|VCAN
NADPH REGENERATION%REACTOME DATABASE ID RELEASE 66%389542,0.0604329924292735,0.355787695563881,0.969838994265549,1.2931494357073898,454,1,IDH1
CARBOHYDRATE METABOLISM%REACTOME%R-HSA-71387.8,0.0649583600256246,0.366283759068563,-0.172325298061198,-1.29364195087123,506,228,SLC2A1|GAA|GPI|PRELP|HYAL3|SLC25A10|PHKG2|PFKFB2|PFKFB3|G6PC3|NAGLU|HK1|GALT|ARSB|PHKA1|HK3|HS3ST5|DCN|NUP188|CHST7|NDST1|PPP1R3C|SLC9A1|SLC26A2|NUP85|SDC4|BGN|ENO1|VCAN|NUP37|OGN|ALDH1A1|PGAM1|B4GALT7|LUM|NUP160|PRPS1|SDC2|FMOD|GAPDH|HS3ST4|PPP2CA|HYAL1|NUP214|EXT2|UBC|B3GAT3|LYVE1|B4GALT1|PYGL|B3GALT6|PRKACA|PYGM|B4GAT1|HEXB|CSGALNACT1|PGK1|XYLT2|TALDO1|CRYL1|GYG2|ALDOA|GALK1|ALDOC
BIOSYNTHESIS OF PROTECTINS%REACTOME DATABASE ID RELEASE 66%9018681,0.540310798246779,0.81505408470595,0.728606087340097,0.97149790456748,4067,1,LTA4H
RNA POLYMERASE II TRANSCRIPTION INITIATION%REACTOME DATABASE ID RELEASE 66%75953,0.0299702880764759,0.244735657013286,-0.305821259293732,-1.5842503492941102,231,46,GTF2A2|POLR2J|TAF3|GTF2A1|TAF12|POLR2H|GTF2H1|TAF7|TAF9B|CDK7|MNAT1|TAF10|POLR2G|TAF9|AK6|POLR2L|GTF2H2
MRNA CAPPING%REACTOME%R-HSA-72086.3,0.107949353870252,0.452480194746961,-0.30276573035386795,-1.3689613672198,826,29,NCBP1|POLR2H|GTF2H1|CDK7|MNAT1|POLR2G|POLR2L|GTF2H2
NR1D1 (REV-ERBA) REPRESSES GENE EXPRESSION%REACTOME%R-HSA-1368071.3,0.820612738511153,0.940031154277066,0.36685586868176295,0.721562201856286,6106,3,NCOR1|HDAC3
RNA POL II CTD PHOSPHORYLATION AND INTERACTION WITH CE%REACTOME DATABASE ID RELEASE 66%77075,0.11647319681753,0.46625878958064004,-0.30693660062273903,-1.35374036191823,892,27,POLR2H|GTF2H1|CDK7|MNAT1|POLR2G|POLR2L|GTF2H2
CDK-MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6%REACTOME DATABASE ID RELEASE 66%69017,0.000258331180573495,0.00819882332206558,-0.356226298627334,-2.0684645362588103,1,70,PSMD1|PSMC2|ANAPC10|ANAPC2|ANAPC5|CDC6|PSMD3|PSMB2|CDC23|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
REGULATION OF HYPOXIA-INDUCIBLE FACTOR (HIF) BY OXYGEN%REACTOME DATABASE ID RELEASE 66%1234174,0.00141679546625451,0.0301860198914787,-0.318225403517721,-1.8547316098418,10,71,PSMB1|VHL|CREBBP|HIGD1A|AJUBA|PSMB9|TCEB2|UBE2D2|PSMB4|PSMD1|PSMC2|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|HIF3A|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|WTIP|PSMA1|PSMC5|PSMC3
FGFR2 ALTERNATIVE SPLICING%REACTOME%R-HSA-6803529.2,0.28739539748953996,0.6604035198820261,-0.267104268963755,-1.1351856128971798,2197,24,POLR2F|HNRNPA1|POLR2C|PTBP1|HNRNPH1|NCBP2|POLR2J|NCBP1|HNRNPM|POLR2H|POLR2G|POLR2L
HYALURONAN METABOLISM%REACTOME%R-HSA-2142845.1,0.04732564237021499,0.312255783864335,-0.440246077204098,-1.5575262423293001,360,14,CD44|CEMIP|HYAL2|HYAL3|SLC9A1|HYAL1|LYVE1|HEXB
RSK ACTIVATION%REACTOME DATABASE ID RELEASE 66%444257,0.337450794081716,0.699636319850872,0.42458729335015793,1.09864457677251,2485,6,RPS6KA2|MAPK1|RPS6KA6|PDPK1
SIGNALING BY LIGAND-RESPONSIVE EGFR VARIANTS IN CANCER%REACTOME%R-HSA-5637815.1,0.0816687049870907,0.397722753303477,0.37860098380467794,1.4558335800689097,600,17,GAB1|RPS27A|SHC1|SOS1|CBL|PLCG1|NRAS|CDC37|EGFR|KRAS
METABOLISM OF SEROTONIN%REACTOME%R-HSA-380612.3,0.24223932077474103,0.625158460820442,-0.7121036669423771,-1.18505437573024,1825,2,MAOA|ALDH2
WNT5A-DEPENDENT INTERNALIZATION OF FZD4%REACTOME DATABASE ID RELEASE 66%5099900,0.16786696346733,0.5400872099036179,-0.37487603846569395,-1.29039602107448,1281,13,AP2A2|FZD4|CLTA|CLTC|AP2M1|PRKCB|CLTB
DEFECTIVE CD320 CAUSES METHYLMALONIC ACIDURIA%REACTOME%R-HSA-3359485.1,0.828203767577607,0.943061234519578,-0.44543700027571,-0.741278399190713,6242,2,CD320|TCN2
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS%REACTOME%R-HSA-2029485.1,0.272727272727273,0.6469898816267529,-0.249965926705255,-1.15198625199946,2093,31,IGHG4|ITPR2|FCGR1A|ITPR3|IGKV2-28|PIK3CB|PLD4|FCGR2A|PLD1|IGKV2D-28|PLD3|IGHG2
SYNTHESIS OF 12-EICOSATETRAENOIC ACID DERIVATIVES%REACTOME%R-HSA-2142712.2,0.220615547890687,0.603022518406817,-0.7236283429831821,-1.2042332795964,1662,2,GPX4|GPX1
ALTERNATIVE COMPLEMENT ACTIVATION%REACTOME DATABASE ID RELEASE 66%173736,0.0725035990053658,0.37889936987310296,-0.6686734776099029,-1.46386602035851,553,4,C3|CFB|CFD
MITOCHONDRIAL CALCIUM ION TRANSPORT%REACTOME DATABASE ID RELEASE 66%8949215,0.377284595300261,0.727975088287035,-0.252079288864614,-1.05837544097967,2889,23,PHB2|AFG3L2|SLC8A3|VDAC1|MICU3|CCDC109B|SLC8B1|PMPCA|AKAP1|STOML2|PARL|PHB
TRANSLESION SYNTHESIS BY REV1%REACTOME%R-HSA-110312.1,0.733908948194662,0.907913422943088,-0.21410347716253894,-0.7956914235726559,5609,16,RFC2|RPA2|RFC3|PCNA|RFC5|UBC|RFC4
RHO GTPASES ACTIVATE IQGAPS%REACTOME DATABASE ID RELEASE 66%5626467,0.0676133402813966,0.371075653877479,-0.504730788844316,-1.51835375703224,518,9,IQGAP3|CDC42|RAC1|IQGAP1|CLIP1|IQGAP2|MEN1
TRANSLATION INITIATION COMPLEX FORMATION%REACTOME DATABASE ID RELEASE 66%72649,0.541639683978759,0.815622645995152,-0.171398238842808,-0.9471378252007421,4181,58,RPS14|RPS4X|RPS29|EIF1AX|EIF3B|RPS15A|RPS13|EIF2S1|EIF4A2|FAU|EIF4G1
ASPARAGINE N-LINKED GLYCOSYLATION%REACTOME%R-HSA-446203.4,0.000127713920817369,0.00518555396908895,-0.235638076754194,-1.81753890904621,0,267,CANX|TRAPPC5|NAPA|RPN2|SCFD1|INS|VCP|ST6GALNAC4|MGAT1|DAD1|SEC23A|SEL1L|GNE|SERPINA1|DYNLL2|BET1L|UBXN1|NEU4|F8|CALR|RAD23B|SEC13|KDELR2|SEC24A|ARFGAP2|COPB2|RFT1|PPP6R3|CNIH2|ARF1|NPL|KDELR1|CNIH1|COPB1|GNPNAT1|TMED2|CTSZ|FUCA1|DCTN5|CTSC|SYVN1|GMPPB|PSMC1|RAB1B|UBC|NSF|CD59|GFPT2|B4GALT1|SRD5A3|COG1|STX5|KDELR3|CNIH3|TMED10|LMAN2|TRAPPC2|GANAB|DOLK|SEC22A|TMED9|FUOM|ALG6|GOSR2|NANS|MAGT1|DYNC1I1|SPTBN2|DOLPP1|CD55|COPG1|PPP6C|SAR1B|COPZ2|ST3GAL5|DCTN3|GRIA1|ENGASE|RPN1|RENBP
PRESYNAPTIC PHASE OF HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE%REACTOME DATABASE ID RELEASE 66%5693616,0.0329698857736241,0.259512489684881,-0.32055340921916997,-1.5687746279915902,253,38,RAD9A|RFC2|RAD51|RPA2|XRCC2|BRIP1|RFC3|NBN|EXO1|RAD51C|RAD1|RAD17|RHNO1|BRCA1|RFC5|TOPBP1|RMI1|RAD51B|RMI2|KAT5|RFC4
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE%REACTOME%R-HSA-5620920.2,0.00507127192982456,0.0803498785568947,0.340586367422256,1.79802919967391,36,47,EXOC4|BBS5|BBS12|NPHP3-ACAD11|BBS4|BBIP1|ARL3|MCHR1|TTC8|PKD1|PDE6D|RAB11FIP3|MKKS|NPHP3|PKD2|RAB11A|LZTFL1|BBS2|EXOC1|BBS7
HSF1 ACTIVATION%REACTOME DATABASE ID RELEASE 66%3371511,0.8614379084967321,0.9521004539918829,-0.202310028656394,-0.677150608524777,6589,12,HDAC6|RPA3|EEF1A1|RPA1|HSBP1|HSP90AB1|PTGES3|HSF1|RPA2|VCP|HSP90AA1
NETRIN MEDIATED REPULSION SIGNALS%REACTOME DATABASE ID RELEASE 66%418886,0.353415300546448,0.7118407891832621,0.373356580711209,1.08378883654413,2586,8,UNC5C|UNC5B|DCC|SRC
ANTIGEN ACTIVATES B CELL RECEPTOR (BCR) LEADING TO GENERATION OF SECOND MESSENGERS%REACTOME DATABASE ID RELEASE 66%983695,0.0946298227320125,0.424507034898303,-0.299731739347267,-1.39423389640652,725,32,FYN|DAPP1|TRPC1|AHCYL1|PLCG2|SH3KBP1|SYK|IGKV3-11|LYN|ITPR2|PIK3AP1|ITPR3|VAV1|STIM1|IGKV2-28|PTPN6|IGKV2D-28|NCK1
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS%REACTOME%R-HSA-390471.1,0.650452781371281,0.8720434729248241,-0.180678606498377,-0.8700180531043861,5027,36,FBXO6|DCAF7|FBXW2|CCT8|STAT3|CCT5|FBXO4|USP11|NOP56|FBXW5|SPHK1
SYNAPTIC ADHESION-LIKE MOLECULES%REACTOME%R-HSA-8849932.4,0.27654288702928903,0.651912680514098,-0.297738418787096,-1.15533579677845,2114,18,GRIN2C|DLG3|GRIN2D|RTN3|GRIA1
MISMATCH REPAIR (MMR) DIRECTED BY MSH2:MSH3 (MUTSBETA)%REACTOME DATABASE ID RELEASE 66%5358606,0.485972732039853,0.7872939093021379,-0.274570189712545,-0.971389179784479,3706,14,RPA2|EXO1|POLD4|PCNA|POLD1|POLD2
INTERACTION WITH THE ZONA PELLUCIDA%REACTOME DATABASE ID RELEASE 66%1300644,0.0888888888888889,0.41228493992510207,-0.721401125432342,-1.40871355960574,671,3,ZP3|B4GALT1
SYNTHESIS OF PROSTAGLANDINS (PG) AND THROMBOXANES (TX)%REACTOME%R-HSA-2162123.1,0.008104575163398691,0.110912204494754,-0.552347818673553,-1.8487598663108,61,12,TBXAS1|PTGDS|CBR1|PTGR2|PTGES2|PTGS1|PTGES|PTGIS
CONSTITUTIVE SIGNALING BY LIGAND-RESPONSIVE EGFR CANCER VARIANTS%REACTOME%R-HSA-1236382.1,0.0816687049870907,0.397722753303477,0.37860098380467794,1.4558335800689097,600,17,GAB1|RPS27A|SHC1|SOS1|CBL|PLCG1|NRAS|CDC37|EGFR|KRAS
INTEGRIN SIGNALING%REACTOME DATABASE ID RELEASE 66%9006921,0.901697127937337,0.9684180373391851,-0.156091504782133,-0.655362905659802,6906,23,PTPN1|RAP1B|AKT1|SYK|APBB1IP|TLN1|BCAR1|VWF|RAPGEF3|RAP1A|FN1
HIV LIFE CYCLE%REACTOME%R-HSA-162587.2,0.0172391776273784,0.17877145941578798,-0.21823686141802698,-1.4961587622790602,134,141,RANBP1|NCBP2|CD4|GTF2A2|POLR2J|PPIA|TAF3|UBAP1|CCNK|GTF2A1|TAF12|NMT1|SUPT16H|NUP188|CXCR4|NCBP1|NUP85|POLR2H|RCC1|GTF2H1|TAF7|MVB12B|NUP37|RAN|TAF9B|NUP160|NELFB|CDK7|NUP214|CHMP4A|CHMP6|UBC|MNAT1|TAF10|POLR2G|SUPT4H1|TAF9|SSRP1|VPS37C|AK6|BANF1|FEN1|POLR2L|GTF2H2
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX%REACTOME%R-HSA-1362277.2,0.0659745038769878,0.369007394574627,-0.375826378471903,-1.48485495983315,501,19,TFDP2|CDC6|LIN52|PCNA|TOP2A|LIN9|E2F1|MAX|MYC
SIGNALING BY GPCR%REACTOME%R-HSA-372790.3,0.076417004048583,0.38654270614299796,-0.146801304063962,-1.2265353632876201,603,445,NMT1|PDE4B|FZD2|KALRN|FZD8|ADGRE2|FPR1|C3|METAP2|ADCY8|FNTB|RGS18|CXCR4|PDE4D|POMC|DAGLB|TAC1|CALCB|SST|OXER1|CRHBP|PRKAR1A|PTGER4|LTB4R|PLA2G4A|S1PR1|PROKR1|CALCRL|TBXA2R|RGS4|ARRB1|SDC4|PDE2A|DGKE|NGEF|NLN|MAPK3|APOM|GNGT2|ADCY4|PYY|HRAS|PIK3R3|ARHGEF15|PDE1C|PDE1A|CYSLTR2|GNG11|GNAI2|CHRM2|CCRL2|HBEGF|P2RY6|GNAQ|CXCL16|GPER1|SDC2|HCRT|F2R|EDNRB|CCR1|APOE|INSL3|APLNR|PDE1B|LRP10|DAGLA|PPP2CA|GNA15|ADGRE5|GNG10|F2RL3|HEBP1|ADRA2C|ARHGEF9|HSD17B1|HTR1B|GRK6|CX3CL1|LDLR|PTAFR|C3AR1|GPR4|CCL4L2|PDE4A|PRKACA|DHRS3|WNT3|MGLL|ADRBK1|TIAM1|PTGIR|CMKLR1|ANXA1|RGS2|XK|CD55|GNG3|PDE6G|PPP1CA|RGS3|SSTR2|NET1|C5AR1|PRKCB|ADCY9|ACKR1
TICAM1 DEFICIENCY - HSE%REACTOME%R-HSA-5602566.2,0.11665551839464901,0.46669484702093395,-0.93956771063079,-1.25172979407197,871,1,TICAM1
GABA B RECEPTOR ACTIVATION%REACTOME%R-HSA-977444.1,0.291693917593198,0.663837153945439,-0.248693367367756,-1.1354852270053601,2229,30,GNGT2|ADCY4|KCNJ12|GNAI2|GNG10|KCNJ9|GNG3|ADCY9
KERATAN SULFATE KERATIN METABOLISM%REACTOME DATABASE ID RELEASE 66%1638074,0.588887439676536,0.8414799095069009,-0.20487523006001998,-0.903599855888239,4514,27,OGN|LUM|FMOD|B4GALT1|B4GAT1|HEXB
MISCELLANEOUS TRANSPORT AND BINDING EVENTS%REACTOME DATABASE ID RELEASE 66%5223345,0.279588800216421,0.653204101106396,0.287849992129062,1.14762449842683,2066,19,ADD3|LRRC8C|LRRC8B|TUSC3|NIPA1|CTNS|ADD1
PLATELET SENSITIZATION BY LDL%REACTOME DATABASE ID RELEASE 66%432142,0.744946180099764,0.9112137767014771,-0.216311665379097,-0.785392593135168,5674,15,PPP2CB|PPP2R5C|LRP8|PPP2R1B|PPP2R1A|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|PTPN11|MAPK14|FGR|PLA2G4A|PTPN6|PPP2CA
POLB-DEPENDENT LONG PATCH BASE EXCISION REPAIR%REACTOME DATABASE ID RELEASE 66%110362,0.24342619109606894,0.626082056933819,-0.41829911915702395,-1.2042246187241201,1869,8,PARP1|PARP2|APEX1|FEN1
INHIBITION OF HOST MRNA PROCESSING AND RNA SILENCING%REACTOME DATABASE ID RELEASE 66%168315,0.682674449456089,0.885415243771438,-0.5238815363704099,-0.871822651476771,5145,2,PABPN1
SUMO IS PROTEOLYTICALLY PROCESSED%REACTOME%R-HSA-3065679.1,0.0763588736083825,0.38654270614299796,-0.577400193733313,-1.4852288418717399,582,6,SENP2|SENP5|SUMO2|SUMO3
MYOGENESIS%REACTOME DATABASE ID RELEASE 66%525793,0.21955870335058603,0.601964339800201,0.28469034603627896,1.2086371485391498,1611,23,CTNNA2|MAP2K6|TCF3|MAPK12|MAPK11|CDH4|TCF12|BNIP2
IRAK4 DEFICIENCY (TLR2 4)%REACTOME%R-HSA-5603041.1,0.0639382845188285,0.362134722953597,-0.48865392433475,-1.53088895584003,488,10,CD36|TLR4|CD14|LY96
MYD88 DEPENDENT CASCADE INITIATED ON ENDOSOME%REACTOME%R-HSA-975155.1,0.5971443141254461,0.844862323067435,-0.15026663233939402,-0.9192590988370921,4683,85,MAPKAPK2|MEF2C|MAPK9|MAPK3|IRF7|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|UBC|TICAM1|RELA|NFKB1|TLR4|CD14|LY96|PELI3
VITAMIN B1 (THIAMIN) METABOLISM%REACTOME DATABASE ID RELEASE 66%196819,0.19931946080355997,0.577166177580918,-0.581250474041004,-1.27247879085507,1522,4,THTPA|SLC25A19
NEGATIVE REGULATORS OF RIG-I MDA5 SIGNALING%REACTOME DATABASE ID RELEASE 66%936440,0.18928431755964,0.563467720122429,-0.26344725726816504,-1.23722269041784,1451,33,TNFAIP3|IKBKE|IFIH1|ISG15|OTUD5|UBC|TRAF3|UBE2L6|NLRX1
"CELL DEATH SIGNALLING VIA NRAGE, NRIF AND NADE%REACTOME%R-HSA-204998.1",0.602928985907709,0.8480120088902141,0.15492463232764903,0.9150037818227971,4363,71,ARHGEF33|ABR|OBSCN|TIAM2|RPS27A|FGD4|ARHGEF7|PSENEN|MCF2L|VAV2|SOS1|AKAP13|ARHGEF4|PLEKHG5|PSEN2|ARHGEF10|APH1B|YWHAE|ARHGEF19
DNA DOUBLE-STRAND BREAK REPAIR%REACTOME%R-HSA-5693532.2,0.00153413449245717,0.0322140470829666,-0.252537860532253,-1.75140827742711,11,149,POLE|TDP1|UIMC1|RAD9A|RFC2|RAD51|CLSPN|RPA2|KDM4B|XRCC2|BRIP1|HIST1H2BE|PALB2|RFC3|H2AFX|NBN|PPP4R2|EXO1|PARP1|RAD51C|PAXIP1|POLD4|HIST1H2BN|RAD51AP1|RAD1|RAD17|BRCC3|PCNA|HIST1H2BC|POLD1|SLX1B|RHNO1|SUMO2|SLX1A|RNF168|HIST1H4I|PARP2|POLD2|BRCA1|RFC5|TOPBP1|POLQ|EME1|ABL1|RMI1|RAD51B|KPNA2|RMI2|UBC|PPP4C|HIST1H2BG|HIST1H2BD|HIST2H4A|APBB1|KAT5|POLE2|POLE3|HIST2H4B|RFC4|MUS81|HIST3H2BB|HIST2H2BE|HIST1H2BK|XRCC3|HIST1H2BJ|FEN1
PECAM1 INTERACTIONS%REACTOME DATABASE ID RELEASE 66%210990,0.9802562761506279,0.993436724391485,-0.16467148452584499,-0.515894264730601,7496,10,ITGAV|PLCG1|YES1|LCK|INPP5D|ITGB3|PTPN11|FYN|LYN|PTPN6
INTEGRIN CELL SURFACE INTERACTIONS%REACTOME%R-HSA-216083.2,0.0011591962905718699,0.0260481000924841,-0.37071683250114396,-2.00096943729239,8,53,ITGB1|CD44|ITGA9|HSPG2|ITGAX|ITGA10|ITGA11|ITGB2|COL18A1|COL23A1|KDR|ITGB5|VTN|ITGA5|CD47|ICAM1|FBN1|SPP1|COL4A1|COMP|COL4A2|VCAM1|LUM|FN1|TNC|THBS1|ITGA8|ITGAM|COL16A1|COL13A1|ICAM2
RNA POLYMERASE I CHAIN ELONGATION%REACTOME DATABASE ID RELEASE 66%73777,0.000128865979381443,0.00518555396908895,-0.428521251424225,-2.4435132870891003,0,65,HIST1H2BN|H2AFV|ZNRD1|TWISTNB|HIST1H2BC|HIST1H4I|POLR2H|GTF2H1|HIST2H3A|UBTF|CDK7|H2AFZ|HIST2H2AA4|MNAT1|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L|GTF2H2
SIGNALING BY FGFR3 POINT MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%8853338,0.12146354733405901,0.47376597884378,0.40481734069769504,1.37589540327185,892,12,GAB1|FGF2|SOS1|PLCG1|NRAS|FGF1|KRAS
SIGNALING BY EGFR%REACTOME DATABASE ID RELEASE 66%177929,0.0910961723144464,0.41755984215321007,0.272325303134946,1.38030112900455,663,41,GAB1|PTPRK|ADAM17|RPS27A|ARHGEF7|PTPN12|SPRY2|PTPN3|SHC1|SOS1|STAM2|PAG1|CBL|PLCG1|NRAS|EPS15|EGFR|SRC|KRAS|ADAM10
CONSTITUTIVE SIGNALING BY NOTCH1 HD DOMAIN MUTANTS%REACTOME DATABASE ID RELEASE 66%2691232,0.61646803900325,0.854122579597827,0.236066594067968,0.8707523551678761,4551,15,DLL1|ADAM17|RPS27A
DNA REPLICATION PRE-INITIATION%REACTOME DATABASE ID RELEASE 66%69002,0.000127307447485678,0.00518555396908895,-0.409041504680756,-2.4785243383726,0,82,POLE|PSMB4|RPA2|PSMD1|MCM10|PSMC2|CDT1|MCM4|MCM6|CDC6|PSMD3|PSMB2|PSMF1|E2F2|GMNN|ORC1|ORC6|PSMD4|MCM3|SHFM1|PSME2|MCM5|CDC45|PSMB5|E2F1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|MCM2|PSMD6|PSMD12|PSMA3|POLE2|POLA1|POLE3|PSMA6|PSMD13|PSMB7|PSMA1|POLA2|PSMC5|PSMC3
SCAVENGING BY CLASS B RECEPTORS%REACTOME%R-HSA-3000471.2,0.10228177235340899,0.441073279931729,-0.8001654259718779,-1.3316032248893799,770,2,SSC5D|CD36
BASIGIN INTERACTIONS%REACTOME%R-HSA-210991.1,0.231332548711913,0.614943553646548,-0.290755803217912,-1.20409543337424,1768,22,SLC7A7|ATP1B1|PPIA|SPN|ATP1B3|MMP1|SLC3A2|CAV1|ATP1B2|SLC7A8
SIGNALING BY NOTCH1 HD+PEST DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%2894858,0.8037113402061858,0.932964969466025,0.140937546244198,0.7829478883872808,5846,56,DLL1|HDAC11|ADAM17|RPS27A|HDAC1|NCOR1|PSENEN|HDAC10|TBL1XR1|HDAC4|PSEN2|APH1B|MAML2|MAML3|TBL1X|MAMLD1|ADAM10|EP300|HDAC6|HDAC2|CDK8|MIB2|HEY2
BIOSYNTHESIS OF DHA-DERIVED SPMS%REACTOME DATABASE ID RELEASE 66%9018677,0.29047229047229,0.663080262067683,0.376164542734748,1.14312935171808,2127,9,GSTM4|CYP2E1|CYP2C8|CYP2D6|LTA4H
SHC1 EVENTS IN ERBB2 SIGNALING%REACTOME DATABASE ID RELEASE 66%1250196,0.18700733895080202,0.560277092850838,0.335009840773421,1.26142315841115,1375,16,PTPN12|PRKCE|SHC1|SOS1|PRKCA|NRAS|EGFR|KRAS|ERBB2
PHOSPHOLIPID METABOLISM%REACTOME%R-HSA-1483257.1,0.285495403472932,0.6583248923580091,-0.152592347181941,-1.09396256886763,2235,177,PIK3C2A|ACHE|PTDSS2|DGAT1|RAB14|GPD1|PIK3R6|AGPAT1|GPAM|TMEM55B|GDE1|BCHE|PLA2G2A|PLA2G2D|PCYT1A|PNPLA2|GDPD1|MTMR12|PLA2R1|CPNE6|CHPT1|TMEM86B|PLA2G4D|ETNK2|PLA2G4A|CDIPT|PIK3CB|PLD4|PNPLA7|PIK3R3|MTMR1|ARF1|PLD1|PLA2G4C|SLC44A1|PIK3R4|PLA2G16|SYNJ2|INPP4B|TNFAIP8L1|PLD3|PLEKHA4|LPIN3|MGLL|PCTP|PLBD1|AGPAT2|LPIN2|PTPMT1|AGPAT3|OSBPL5|PLA2G12A
ORGANIC CATION TRANSPORT%REACTOME%R-HSA-549127.1,0.0742632612966601,0.38299993877531896,-0.5788428658099389,-1.4889397830886297,566,6,SLC22A5|SLC22A18|SLC22A4|RUNX1|SLC22A3|SLC22A15
CHROMOSOME MAINTENANCE%REACTOME DATABASE ID RELEASE 66%73886,0.00012835322808368602,0.00518555396908895,-0.448178846094993,-2.78113895710564,0,91,DNA2|CASC5|POLE4|TERF2IP|HIST1H4H|HJURP|PRIM2|ITGB3BP|CENPL|CENPU|POLE|RFC2|RPA2|CENPW|HIST1H2BE|RFC3|TERF2|TERT|H2AFX|TINF2|HIST2H2AC|HIST1H2AD|OIP5|RUVBL1|CENPM|POLD4|HIST1H2BN|NPM1|H2AFV|PCNA|CENPI|HIST1H2BC|POLD1|HIST1H4I|POLD2|STRA13|RFC5|RBBP7|CENPH|DKC1|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|POLE2|POLA1|POLE3|HIST2H4B|CENPK|HIST1H2AC|RFC4|MIS18A|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|POLA2|HIST1H2BJ|HIST2H2AA3|FEN1|CENPP
RORA ACTIVATES GENE EXPRESSION%REACTOME%R-HSA-1368082.3,0.5140059831384279,0.8026073059358391,0.24321530807248998,0.952048493035223,3779,18,HELZ2|TBL1XR1|CARM1|SREBF1|TGS1|CPT1A|TBL1X|EP300
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR (GG-NER)%REACTOME%R-HSA-5696399.1,0.0919422806793513,0.4198114448113421,-0.21930764755187002,-1.3370684946459999,719,84,RUVBL1|POLD4|PCNA|COPS6|POLD1|SUMO2|PARP2|POLD2|RFC5|TFPT|GTF2H1|RAD23B|INO80E|SUMO3|CDK7|UBC|MNAT1|DDB1|CETN2|POLE2|ACTB|POLE3|GPS1|RFC4|XPA|GTF2H2
TOLL LIKE RECEPTOR TLR1:TLR2 CASCADE%REACTOME DATABASE ID RELEASE 66%168179,0.708124759337697,0.89516234575314,-0.138913877247169,-0.85981773141223,5516,90,MAPKAPK2|MEF2C|SOCS1|MAPK9|MAPK3|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|CD36|UBC|RELA|NFKB1|TLR4|CD14|LY96|PELI3
BASE EXCISION REPAIR%REACTOME DATABASE ID RELEASE 66%73884,0.234152652005175,0.617951264290741,-0.246698650671605,-1.18792304147374,1809,36,POLE|RFC2|RPA2|RFC3|PARP1|POLD4|PCNA|POLD1|PARP2|POLD2|RFC5|POLE2|APEX1|POLE3|RFC4|FEN1
RUNX1 REGULATES EXPRESSION OF COMPONENTS OF TIGHT JUNCTIONS%REACTOME DATABASE ID RELEASE 66%8935964,0.425828511309837,0.7547028278218628,-0.4240733525741521,-1.01642290547639,3237,5,RUNX1|CLDN5|OCLN
SMAC BINDS TO IAPS%REACTOME%R-HSA-111463.2,0.9255204109218709,0.9786453534208341,0.257304996991988,0.618817042247385,6846,5,CASP9|CASP3|CASP7
POLYMERASE SWITCHING%REACTOME%R-HSA-69091.2,0.0124541164132145,0.14774543117424402,-0.504916555118035,-1.78632093618466,94,14,PRIM2|RFC2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|POLA1|RFC4|POLA2
ADRENOCEPTORS%REACTOME%R-HSA-390696.2,0.12302054704881599,0.47697345522944606,-0.626594614661575,-1.37174659330189,939,4,ADRA1B|ADRB2|ADRA2C
SEROTONIN AND MELATONIN BIOSYNTHESIS%REACTOME%R-HSA-209931.1,0.398857750033205,0.7388683667002129,0.801720335244817,1.06898588863411,3002,1,DDC
DISEASES ASSOCIATED WITH VISUAL TRANSDUCTION%REACTOME DATABASE ID RELEASE 66%2474795,0.114754098360656,0.463748809895271,0.6972537774346529,1.37141589885481,853,3,STRA6|NAPEPLD|RBP1
TRKA ACTIVATION BY NGF%REACTOME DATABASE ID RELEASE 66%187042,0.47917219421597207,0.7851559026823699,-0.60733388475324,-1.01070070421967,3611,2,NTRK1|NGF
"RESPIRATORY ELECTRON TRANSPORT, ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING, AND HEAT PRODUCTION BY UNCOUPLING PROTEINS.%REACTOME%R-HSA-163200.1",0.00012830382345393898,0.00518555396908895,-0.338984553708872,-2.2526483830944,0,122,ETFDH|NDUFAF5|ATP5C1|COX7C|CYC1|TIMMDC1|COX11|NDUFC2|NDUFAF4|NDUFV2|NDUFB8|SDHC|NDUFS4|COX6C|SLC25A27|UQCRC1|NDUFB5|SURF1|UQCR10|NDUFA11|NDUFA9|ATP5J|SCO2|NDUFA7|ATP5F1|SDHB|NDUFA3|NDUFB6|ATP5B|SDHD|NDUFAF3|CYCS|NDUFB9|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|COX16|NDUFS6|NDUFB4|COX7B|NDUFA12|NDUFA2|NDUFAB1|NDUFA1|NDUFB11|NDUFA4|ATP5H|NDUFV1|UQCRQ|NDUFAF2|NDUFS3|TACO1|UQCRC2|COX6A1|COX8A|NDUFA8|NDUFS8|ATP5G1|ETFB|NDUFV3
SIGNALING BY HIGH-KINASE ACTIVITY BRAF MUTANTS%REACTOME DATABASE ID RELEASE 66%6802948,0.5195363375879141,0.804986496071906,-0.207595547566407,-0.9567192614007249,3988,31,TLN1|VWF|ARRB1|MAPK3|HRAS|RAP1A|FN1|VCL|ARAF
PYROPHOSPHATE HYDROLYSIS%REACTOME DATABASE ID RELEASE 66%71737,0.838551339877952,0.946300451776032,-0.437386269644334,-0.72788069601148,6320,2,PPA2|PPA1
REGULATION OF EXPRESSION OF SLITS AND ROBOS%REACTOME DATABASE ID RELEASE 66%9010553,0.00115532734274711,0.0260318042492992,-0.247410470984133,-1.7401737906613002,8,161,MAGOH|PSMD4|SHFM1|RPS14|RPS4X|RPL35A|NCBP1|PSME2|RPS29|PSMB5|RPL10|RPL36A|RPL24|RPL22L1|PSMC4|PSMC6|MSI1|PSMD10|RPL35|PSMB3|RPL38|RPS15A|RPL36AL|PSMC1|MAGOHB|EIF4A3|PSMD2|UBC|SLIT2|RPS13|PSMD6|RBM8A|RPL26L1|PSMD12|PSMA3|FAU|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|EIF4G1
NTF4 ACTIVATES NTRK2 (TRKB) SIGNALING%REACTOME%R-HSA-9026357.1,0.226220735785953,0.608682632875901,-0.8838773709748571,-1.17753688961113,1690,1,NTRK2
TRIGLYCERIDE BIOSYNTHESIS%REACTOME%R-HSA-75109.6,0.41516393442622995,0.7492948908056658,0.35377457133877,1.02694568913121,3038,8,GPAT2|LPIN1
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT%REACTOME DATABASE ID RELEASE 66%8852276,0.00012951690195570501,0.00518555396908895,-0.40988891778583897,-2.26502501301433,0,58,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|CCNB1|PLK1|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|HSP90AA1|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
HYALURONAN UPTAKE AND DEGRADATION%REACTOME DATABASE ID RELEASE 66%2160916,0.0226617762640817,0.20908271623893998,-0.52824213842936,-1.7102123436488799,172,11,CD44|HYAL2|HYAL3|SLC9A1|HYAL1|LYVE1|HEXB
PHASE 2 - PLATEAU PHASE%REACTOME%R-HSA-5576893.2,0.19934729398966503,0.577166177580918,0.316828890876518,1.2402034662189398,1465,18,CACNG7|CACNB4|CACNA1C|CACNA2D2|CACNG4|CACNB2|CACNA2D3|CACNA2D1|CACNB3|AKAP9|CACNG2|KCNE3
NEUREXINS AND NEUROLIGINS%REACTOME%R-HSA-6794361.4,0.838459550271388,0.946300451776032,-0.141901061575934,-0.7438914787889008,6487,48,EPB41L1|LRRTM2|DLGAP1|LRRTM4|APBA2|SYT7|CASK|GRIN1|LRRTM1|LIN7C|EPB41L2|APBA1|GRIN2C|DLG3|GRIN2D|NRXN2|DBNL
METABOLISM OF INGESTED H2SEO4 AND H2SEO3 INTO H2SE%REACTOME%R-HSA-2408550.2,0.29736629938188697,0.66938742477415,0.5893065287311989,1.15909639926855,2212,3,PAPSS1|PAPSS2|TXNRD1
REGULATION OF IFNG SIGNALING%REACTOME%R-HSA-877312.2,0.41577154833639,0.7493091022753771,-0.31645303009439196,-1.0245337107367,3173,11,PTPN11|PIAS1|IFNGR2|PTPN1|IFNGR1|SOCS3|SOCS1|PTPN6
ATTACHMENT OF GPI ANCHOR TO UPAR%REACTOME%R-HSA-162791.2,0.694752502028672,0.889726625344871,0.289783643734495,0.7999399702813961,5136,7,PGAP1|PIGU|PIGT|PIGS
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 (RBL1) AND P130 (RBL2) IN COMPLEX WITH HDAC1%REACTOME%R-HSA-1362300.2,0.509157509157509,0.7995597865690791,-0.258030711793175,-0.9589420364075258,3891,16,TFDP1|RBBP4|CCNA2|RBL1|LIN54|TFDP2|LIN52|LIN9|E2F1|MYBL2
ACTIVATION OF APC C AND APC C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS%REACTOME DATABASE ID RELEASE 66%176814,0.000257532835436518,0.00819882332206558,-0.3792762655349521,-2.2327386180490296,1,74,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|PTTG1|MAD2L1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|PSMC4|PSMC6|PSMD10|CCNB1|PLK1|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
NUCLEAR SIGNALING BY ERBB4%REACTOME%R-HSA-1251985.4,0.90712158137016,0.9709695261809209,0.157652118286383,0.6389283083183089,6699,20,ADAM17|NCOR1|PSENEN|PSEN2|APH1B
CAMK IV-MEDIATED PHOSPHORYLATION OF CREB%REACTOME%R-HSA-111932.2,0.260048231511254,0.636098664976652,0.703382273039568,1.18177303606788,1940,2,CAMK4|CREB1
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE%REACTOME%R-HSA-352230.3,0.38145678043677295,0.729565277839634,-0.25482351449525,-1.0552904764901399,2916,22,SLC6A6|SLC38A5|SLC7A7|SLC16A10|SLC36A1|SLC43A2|SLC7A3|SLC3A2|SLC7A8
NICOTINAMIDE SALVAGING%REACTOME DATABASE ID RELEASE 66%197264,0.560177917320775,0.827091649887284,-0.247233777938404,-0.918816449551221,4281,16,RNLS|PARP16|NAMPT|PTGS2|PARP8|APOA1BP|PARP14|PARP10|PARP9|NNMT|PTGIS
JOSEPHIN DOMAIN DUBS%REACTOME DATABASE ID RELEASE 66%5689877,0.8169109663409341,0.9376160866014419,0.21791186881602698,0.717063855035903,6018,11,PARK2|RPS27A|JOSD1|ATXN3|UBA52|JOSD2
GRB2:SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS%REACTOME%R-HSA-354194.1,0.578726748755567,0.8381193804335091,-0.277076914081012,-0.8970514166295649,4417,11,TLN1|VWF|RAP1A|FN1
RHO GTPASES ACTIVATE NADPH OXIDASES%REACTOME%R-HSA-5668599.4,0.0134675732217573,0.154243762189158,-0.570601703801974,-1.78762065141124,102,10,CYBB|NCF4|PIK3R4|NOXA1|NCF2
CYSTEINE FORMATION FROM HOMOCYSTEINE%REACTOME DATABASE ID RELEASE 66%1614603,0.3942926045016079,0.7376723208557521,0.639261097325614,1.07404118184832,2942,2,CTH|CBS
EPHB-MEDIATED FORWARD SIGNALING%REACTOME DATABASE ID RELEASE 66%3928662,0.370959332638165,0.7231271705612199,-0.228977221426224,-1.0651117706541702,2845,32,ARPC1B|RHOA|FYN|ROCK1|ITSN1|CDC42|RAC1|ACTG1|LYN|ARPC1A|KALRN|GRIN1|HRAS|SDC2|CFL1|TIAM1|ACTB
PHYSIOLOGICAL FACTORS%REACTOME DATABASE ID RELEASE 66%5578768,0.0110019646365422,0.13557402637094002,-0.6898814953313841,-1.77456105048179,83,6,NPR2|NPR1|KAT2B|WWTR1
MAPK1 (ERK2) ACTIVATION%REACTOME DATABASE ID RELEASE 66%112411,0.334289617486339,0.6974768376198021,0.379723095592697,1.1022697154484298,2446,8,JAK1|MAPK1|JAK2|TYK2|IL6R|IL6|PTPN11|MAP2K2
BIOSYNTHESIS OF DPAN-3-DERIVED 13-SERIES RESOLVINS%REACTOME%R-HSA-9026403.1,0.5463545150501671,0.817655622966367,-0.729708866343185,-0.9721474234007309,4083,1,ALOX5
FORMATION OF RNA POL II ELONGATION COMPLEX%REACTOME%R-HSA-112382.2,0.19353169469598996,0.567519363754568,-0.221149220486152,-1.21772711931904,1495,57,NCBP2|POLR2J|MLLT3|CCNK|SUPT16H|NCBP1|CTR9|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|POLR2L|GTF2H2
PTK6 ACTIVATES STAT3%REACTOME DATABASE ID RELEASE 66%8849474,0.0853174603174603,0.404044169378742,-0.72427484283666,-1.4143252013557,644,3,STAP2|SOCS3|STAT3
PROLINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%70688,0.248607057574954,0.629153649220478,-0.708309822228432,-1.17874081144485,1873,2,ALDH4A1
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3:SMAD4 HETEROTRIMER%REACTOME DATABASE ID RELEASE 66%2173793,0.458311620635748,0.7730011965931991,-0.19683379586992003,-0.998334200189098,3517,43,JUNB|TFDP2|SKIL|PARP1|USP9X|CCNK|TGIF1|SMURF2|CDKN2B|SNW1|MEN1|WWTR1|UBC|SERPINE1|MYC
PRE-NOTCH PROCESSING IN GOLGI%REACTOME DATABASE ID RELEASE 66%1912420,0.0719142259414226,0.377545917506675,-0.378410787552818,-1.4683745904471899,549,18,LFNG|RFNG|FURIN|MFNG|ATP2A2|NOTCH4|ATP2A1|ATP2A3|NOTCH1|SEL1L|NOTCH2|NOTCH3|TMED2|B4GALT1
DISSOLUTION OF FIBRIN CLOT%REACTOME DATABASE ID RELEASE 66%75205,0.00013075313807531399,0.00518555396908895,-0.721433831708504,-2.2601580184493,0,10,SERPINB8|PLAU|S100A10|PLAUR|SERPINE2|SERPINE1|PLAT|ANXA2|SERPINF2
TRANSFER OF LPS FROM LBP CARRIER TO CD14%REACTOME DATABASE ID RELEASE 66%166020,0.0422742474916388,0.294833299013666,-0.978220114689016,-1.30322407726707,315,1,CD14
BIOGENIC AMINES ARE OXIDATIVELY DEAMINATED TO ALDEHYDES BY MAOA AND MAOB%REACTOME DATABASE ID RELEASE 66%141333,0.920953912111468,0.976910172414188,0.37338011499967105,0.627326802257516,6873,2,MAOB|MAOA
PHENYLALANINE AND TYROSINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%71182,0.6316063525123671,0.8616028929314681,-0.29673460949619396,-0.8542574096329041,4851,8,IL4I1|ASRGL1
TRAF3 DEFICIENCY - HSE%REACTOME DATABASE ID RELEASE 66%5602571,0.00822499336694083,0.112202730765986,-0.939619520264682,-1.56367713817897,61,2,TICAM1|TRAF3
NONHOMOLOGOUS END-JOINING (NHEJ)%REACTOME DATABASE ID RELEASE 66%5693571,0.317942122186495,0.6867397844771489,-0.202495460641218,-1.09798838875549,2471,54,H2AFX|NBN|PAXIP1|HIST1H2BN|BRCC3|HIST1H2BC|RNF168|HIST1H4I|BRCA1|HIST1H2BG|HIST1H2BD|HIST2H4A|KAT5|HIST2H4B|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ
REGULATION OF GENE EXPRESSION IN EARLY PANCREATIC PRECURSOR CELLS%REACTOME DATABASE ID RELEASE 66%210747,0.837357389227912,0.946216977301937,-0.43861111655109397,-0.729919037132075,6311,2,FGF10
SHC-MEDIATED CASCADE:FGFR4%REACTOME%R-HSA-5654719.2,0.70205836373111,0.8931369333627571,-0.26747901164357396,-0.804642338515157,5388,9,HRAS|FGF19|FGF9
ALPHA-LINOLENIC (OMEGA3) AND LINOLEIC (OMEGA6) ACID METABOLISM%REACTOME DATABASE ID RELEASE 66%2046104,0.0461095100864553,0.30746333312705,-0.487579483704307,-1.57856481124435,351,11,ELOVL2|ELOVL1|ABCD1|FADS1|FADS2
RHO GTPASES REGULATE CFTR TRAFFICKING%REACTOME DATABASE ID RELEASE 66%5627083,0.10275991425509101,0.441339974060831,0.806807669024625,1.35554105511619,766,2,RHOQ|GOPC
IKBA VARIANT LEADS TO EDA-ID%REACTOME DATABASE ID RELEASE 66%5603029,0.121713985278654,0.474283602399951,-0.507538236413384,-1.38733313589142,925,7,NFKBIA|RELA|NFKB1
SUMOYLATION OF SUMOYLATION PROTEINS%REACTOME DATABASE ID RELEASE 66%4085377,0.9542184434270771,0.9870180073166591,-0.128950382219435,-0.588762199718587,7294,30,NUP188|SUMO2|NUP85|NUP37|NUP160|NUP214
ONCOGENIC MAPK SIGNALING%REACTOME%R-HSA-6802957.2,0.8983700862895491,0.967428248648255,0.121922782694673,0.715985111858239,6558,69,SPRED3|PAPSS1|SPRED2|ZC3HAV1|CNKSR1|ARRB2|KIAA1549|KDM7A|NF1|RASAL2|YWHAB|ITGA2B|AP3B1|NRAS|CLCN6|TRAK1|SRC|FAM131B|MAP2K1|MAPK1|KRAS|AGTRAP|MPRIP|RASA2
CLEAVAGE OF THE DAMAGED PURINE%REACTOME%R-HSA-110331.1,0.9287245444801719,0.9793746057014829,0.36619795974634706,0.61525985410633,6931,2,OGG1|MPG
BETA OXIDATION OF HEXANOYL-COA TO BUTANOYL-COA%REACTOME DATABASE ID RELEASE 66%77350,0.28156258448229304,0.654669602959902,0.48136794282427897,1.15768714208261,2082,5,HADHB|HADHA|ACADS|ECHS1
UPTAKE AND FUNCTION OF ANTHRAX TOXINS%REACTOME DATABASE ID RELEASE 66%5210891,0.30392289941631606,0.676707700393746,0.43765786822499997,1.13246545748761,2238,6,MAP2K7|PDCD6IP|MAP2K1|MAP2K4
AXONAL GROWTH INHIBITION (RHOA ACTIVATION)%REACTOME%R-HSA-193634.2,0.24342451341399302,0.626082056933819,-0.505098122171456,-1.21062381725202,1850,5,ARHGDIA|NGFR
CD28 CO-STIMULATION%REACTOME DATABASE ID RELEASE 66%389356,0.954314058216943,0.9870180073166591,-0.13076232054342402,-0.5912444744084351,7310,29,MAP3K14|TRIB3|FYN|GRAP2|AKT1|CDC42|PAK2|MLST8|RAC1|LYN|VAV1|PIK3R3|CD86|MAPKAP1
CONSTITUTIVE SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS%REACTOME%R-HSA-2644606.1,0.8037113402061858,0.932964969466025,0.140937546244198,0.7829478883872808,5846,56,DLL1|HDAC11|ADAM17|RPS27A|HDAC1|NCOR1|PSENEN|HDAC10|TBL1XR1|HDAC4|PSEN2|APH1B|MAML2|MAML3|TBL1X|MAMLD1|ADAM10|EP300|HDAC6|HDAC2|CDK8|MIB2|HEY2
CYP2E1 REACTIONS%REACTOME DATABASE ID RELEASE 66%211999,0.0653050255307713,0.366933938653309,0.7483180765413041,1.47185334921383,485,3,CYP2E1|CYP2C8|CYP2D6
ACTIVATION OF GABAB RECEPTORS%REACTOME DATABASE ID RELEASE 66%991365,0.291693917593198,0.663837153945439,-0.248693367367756,-1.1354852270053601,2229,30,GNGT2|ADCY4|KCNJ12|GNAI2|GNG10|KCNJ9|GNG3|ADCY9
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS%REACTOME DATABASE ID RELEASE 66%8866654,0.12440191387559801,0.47848721859351595,-0.24462208734791502,-1.3117257907564,961,52,UBE2L3|UBE2A|HLTF|RAD18|UBE2D2|HIST1H2BE|UBE2B|RRAGA|HIST1H2BN|HLA-A|PCNA|VCP|HIST1H2BC|CTR9|RNF20|RNF152|RNF40|UBC|HIST1H2BG|HIST1H2BD|HIST1H2BK|HIST1H2BJ
CD28 DEPENDENT VAV1 PATHWAY%REACTOME%R-HSA-389359.1,0.33559145388223,0.6986461430224531,-0.36548132653844295,-1.09945728998502,2575,9,FYN|CDC42|PAK2|RAC1|VAV1|CD86
GASTRIN-CREB SIGNALLING PATHWAY VIA PKC AND MAPK%REACTOME%R-HSA-881907.1,0.257526444263629,0.636098664976652,0.32844824923855603,1.18056487453977,1898,14,MAPK7|RPS6KA2|SOS1|PRKCA|NRAS|EGFR|MAPK1|KRAS
METALLOPROTEASE DUBS%REACTOME DATABASE ID RELEASE 66%5689901,0.0164813603662525,0.17512293405535098,-0.37105535209896706,-1.69416609364821,125,30,HIST2H2AC|HIST1H2AD|HIST1H2AI|BRCC3|BRCA1|HIST1H2AK|NLRP3|KAT2B|UBC|HIST2H2AA4|HIST3H2A|MYSM1|HIST1H2AE|HIST1H2AC|HIST2H2AA3
ESR-MEDIATED SIGNALING%REACTOME DATABASE ID RELEASE 66%8939211,0.00012830382345393898,0.00518555396908895,-0.33569009630618796,-2.23075578043705,0,122,HIST1H2BE|KANK1|RUNX1|KDM1A|H2AFX|YY1|GTF2A2|GPAM|HIST2H2AC|POLR2J|HIST1H2AD|MED1|STAG2|GATA3|HIST1H2BN|H2AFV|GTF2A1|HIST1H2BC|HIST1H4I|DDX5|POLR2H|MAPK3|USF2|TNRC6C|HIST2H3A|KPNA2|KAT2B|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|MYC|HIST1H2AE|FKBP4|POLR2G|HIST2H3C|SMC1A|CTSD|HIST1H3H|CXXC5|KAT5|HSP90AA1|HIST2H4B|H3F3B|HIST1H2AC|CCND1|FKBP5|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
ARL13B-MEDIATED CILIARY TRAFFICKING OF INPP5E%REACTOME%R-HSA-5624958.1,0.856624563289438,0.949296218452153,0.35154957538325804,0.691456529199572,6374,3,PDE6D|ARL13B|INPP5E
PHOSPHORYLATION OF PROTEINS INVOLVED IN THE G2 M TRANSITION BY CYCLIN A:CDC2 COMPLEXES%REACTOME%R-HSA-170145.2,0.7096210696049449,0.8963492131589879,0.410113598764751,0.806645052181524,5280,3,CDK1|CCNA1|CCNA2
KERATINIZATION%REACTOME DATABASE ID RELEASE 66%6805567,0.319135078806826,0.6869601115014491,-0.257050143969239,-1.10817918868477,2449,25,KRT9|KRT18|PKP2|PERP|CAPN1|PCSK6|KRT7|KRT19
O-LINKED GLYCOSYLATION%REACTOME DATABASE ID RELEASE 66%5173105,0.0826963168867269,0.400097488741187,0.220204329817591,1.34104674357935,594,80,GALNT3|GALNT8|GALNTL6|GALNT12|ADAMTS7|POMGNT1|B3GNT9|B3GNT2|B4GALT5|GALNT7|B3GALNT2|B3GNT7|THSD7A|GALNT14|SPON1|GALNT6|THSD7B|GALNT2|GALNT9|LARGE
"TRANSPORT OF BILE SALTS AND ORGANIC ACIDS, METAL IONS AND AMINE COMPOUNDS%REACTOME%R-HSA-425366.3",0.7650695517774341,0.9195283779466871,-0.14852832725338197,-0.8016917964070679,5939,53,SLC16A1|SLC22A18|SLC39A7|CP|SLC22A4|SLC6A6|SLC39A1|RUNX1|SLC41A2|SLC2A13|SLC39A3|SLC13A3|SLC22A3|SLC6A1|SLC39A8|SLC41A1|RHBG|SLC11A1|SLC22A15|SLC44A1|SLC5A3|SLC30A5|HEPH
SMAD2 3 PHOSPHORYLATION MOTIF MUTANTS IN CANCER%REACTOME%R-HSA-3304356.1,0.9468775344687751,0.983704839617175,0.24458162628680497,0.588217408663731,7004,5,SMAD3|SMAD2
UNFOLDED PROTEIN RESPONSE (UPR)%REACTOME%R-HSA-381119.2,0.00911307919394173,0.12051332749931,-0.264746038867732,-1.6428609445756701,70,91,ATP6V0D1|TPP1|MBTPS2|CREB3L1|WIPI1|CALR|HERPUD1|LMNA|CCL2|PDIA5|SRPRB|SYVN1|SEC61A1|SEC61B|SSR1|EXOSC3|EIF2S1|NFYB|KDELR3|HSPA5|GOSR2|DNAJB11|EXOSC2|SERP1|YIF1A|ERN1
MET ACTIVATES RAP1 AND RAC1%REACTOME%R-HSA-8875555.1,0.33791134076692997,0.699781132229726,0.34526436439569,1.09382084458336,2484,10,MET|GAB1|CRK
DEFECTIVE C1GALT1C1 CAUSES TN POLYAGGLUTINATION SYNDROME (TNPS)%REACTOME%R-HSA-5083632.1,0.18664047151277,0.5597458283154859,-0.49796206306819796,-1.28089257027239,1424,6,MUC4|MUC20|MUC15
PYRIMIDINE CATABOLISM%REACTOME DATABASE ID RELEASE 66%73621,0.51879902623749,0.8047799431921201,0.33734835668307805,0.931241083664432,3835,7,NT5M|NT5E|DPYD|UPP1
DEFECTIVE B3GALTL CAUSES PETERS-PLUS SYNDROME (PPS)%REACTOME%R-HSA-5083635.1,0.24830375782880998,0.629058977115332,-0.27033334950422,-1.17924343840206,1902,26,ADAMTS4|ADAMTS14|SPON2|SBSPON|ADAMTSL1|ADAMTSL2|THBS1|SEMA5A|THBS2|CFP|ADAMTS8
"HISTIDINE, LYSINE, PHENYLALANINE, TYROSINE, PROLINE AND TRYPTOPHAN CATABOLISM%REACTOME%R-HSA-6788656.2",0.44544387954634296,0.7671494493272959,-0.21434334902112398,-1.00661687541938,3416,33,HAAO|FTCD|IL4I1|ALDH4A1|AFMID|SLC3A2|HNMT|ASRGL1
NEF MEDIATED CD4 DOWN-REGULATION%REACTOME DATABASE ID RELEASE 66%167590,0.42886920270974505,0.7570379447218231,-0.33724299591306606,-1.01450947949869,3291,9,ATP6V1H|AP2A1|AP2A2|CD4|ARF1|AP2M1
PKA ACTIVATION IN GLUCAGON SIGNALLING%REACTOME%R-HSA-164378.2,0.499345892203035,0.794989907195277,-0.260182244148508,-0.9669379637290519,3816,16,ADCY8|PRKAR1A|ADCY4|PRKACA|ADCY9
GLYCOGEN STORAGE DISEASES%REACTOME%R-HSA-3229121.2,0.17652423137050502,0.548380753278361,-0.42831209084193,-1.28846760824962,1354,9,EPM2A|GYG1|PPP1R3C|UBC|GYG2
REGULATED PROTEOLYSIS OF P75NTR%REACTOME%R-HSA-193692.1,0.326565365470265,0.6941148928066879,-0.341498230485033,-1.10561889448329,2492,11,RELA|NFKB1|NGFR
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS%REACTOME%R-HSA-2151201.2,0.9368972168641501,0.9806508984207809,0.12069868928871699,0.644944047330228,6799,49,CAMK4|HELZ2|NCOR1|TFB1M|TBL1XR1|C10orf2|GLUD1|CARM1|CRTC1|SIRT5
ACTIVATED NTRK3 SIGNALS THROUGH RAS%REACTOME%R-HSA-9034864.1,0.56609894566099,0.8302483739896959,0.37312528375154896,0.897364167731415,4187,5,SOS1|NRAS|KRAS|NTRK3
GSD XV%REACTOME DATABASE ID RELEASE 66%3814836,0.636906341204564,0.8643617075054308,-0.5443136522854639,-0.905824959700415,4800,2,GYG1
FORMATION OF THE HIV-1 EARLY ELONGATION COMPLEX%REACTOME%R-HSA-167158.2,0.0525355233998175,0.331996459809677,-0.319283934528066,-1.4994474893390501,402,33,NCBP1|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|POLR2L|GTF2H2
IGF1R SIGNALING CASCADE%REACTOME%R-HSA-2428924.1,0.23188216892596497,0.615614074957182,-0.25555067276453897,-1.1887209909558702,1778,32,IRS1|PIK3CB|FGF10|HRAS|IGF1|PIK3R4|FGF19|FGF9|FGF7|FLT3LG
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS%REACTOME DATABASE ID RELEASE 66%181431,0.266458531288177,0.641603173139009,0.453835422502164,1.17432583001975,1962,6,CHRNB2|CHRNA5|CHRNB4|CHRNA3|CHRNA7
DEFECTIVE LFNG CAUSES SCDO3%REACTOME%R-HSA-5083630.2,0.0505169480434498,0.322642181468404,-0.694314233717532,-1.51999899535914,385,4,NOTCH4|NOTCH1|NOTCH2|NOTCH3
PEPTIDE LIGAND-BINDING RECEPTORS%REACTOME%R-HSA-375276.5,0.0024265644955300102,0.0464045434301069,-0.297988761499903,-1.79830020958602,18,81,FPR1|C3|CXCR4|POMC|TAC1|SST|PROKR1|NLN|PYY|CCRL2|CXCL16|GPER1|HCRT|F2R|EDNRB|CCR1|INSL3|APLNR|F2RL3|HEBP1|CX3CL1|C3AR1|ANXA1|XK|SSTR2|C5AR1|ACKR1
CAM PATHWAY%REACTOME%R-HSA-111997.1,0.0746600418410042,0.383186929742657,-0.341400286634825,-1.45094159344722,570,24,ADCY8|PRKAR1A|ADCY4|PDE1C|PDE1A|PDE1B|PRKACA|ADRBK1|ADCY9
SELENOAMINO ACID METABOLISM%REACTOME%R-HSA-2408522.2,0.824087123638693,0.9420007492117891,-0.12243314284855099,-0.8000384500838069,6431,112,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|INMT|RPL35|RPL38|RPS15A|RPL36AL|RPS13|RPL26L1|FAU|HNMT|EEFSEC|NNMT
VITAMIN B5 (PANTOTHENATE) METABOLISM%REACTOME DATABASE ID RELEASE 66%199220,0.955790615676702,0.987574768294351,0.156264062482943,0.561671020466488,7047,14,SLC5A6|PANK1|AASDHPPT
DISEASES OF IMMUNE SYSTEM%REACTOME%R-HSA-5260271.1,0.000262605042016807,0.00819882332206558,-0.573985511139009,-2.3028188768962403,1,20,NFKBIA|CD36|TLR5|TICAM1|TRAF3|RELA|NFKB1|TLR4|CD14|LY96
CARGO RECOGNITION FOR CLATHRIN-MEDIATED ENDOCYTOSIS%REACTOME DATABASE ID RELEASE 66%8856825,0.149150810879837,0.5157600394920371,-0.200357855753797,-1.23795428236396,1167,89,AP2A2|TOR1B|CD4|UBQLN2|HGS|FZD4|TOR1A|SGIP1|CLTA|NECAP1|COPS6|SH3GL2|UBQLN1|CLTC|ARRB1|REPS2|EPS15L1|VAMP8|VAMP7|CHRM2|NEDD8|UBC|LDLR|STON2|DAB2|ADRBK1|GPS1|TFRC|AP2M1|SH3GL3|CLTB
PI3K AKT ACTIVATION%REACTOME DATABASE ID RELEASE 66%198203,0.852006253256905,0.949296218452153,-0.226425492917399,-0.6811433054167271,6539,9,NGF|IRS1|PIK3CB
SIGNALING BY FGFR2 AMPLIFICATION MUTANTS%REACTOME DATABASE ID RELEASE 66%2023837,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
FORMYL PEPTIDE RECEPTORS BIND FORMYL PEPTIDES AND MANY OTHER LIGANDS%REACTOME%R-HSA-444473.1,0.0652288269331931,0.366933938653309,-0.631153323903033,-1.51275408225615,495,5,FPR3|FPR1|HEBP1|ANXA1
SMALL INTERFERING RNA (SIRNA) BIOGENESIS%REACTOME DATABASE ID RELEASE 66%426486,0.326781326781327,0.6941148928066879,0.36351503223195597,1.10468865596435,2393,9,PRKRA|AGO2|AGO3|TSN|AGO1|TARBP2
MTF1 ACTIVATES GENE EXPRESSION%REACTOME%R-HSA-5660489.1,0.7460317460317459,0.911706491458069,-0.39930202367809703,-0.7797356495614509,5639,3,SNCB
NEUROTRANSMITTER UPTAKE AND METABOLISM IN GLIAL CELLS%REACTOME DATABASE ID RELEASE 66%112313,0.264755921999738,0.6400909232463741,-0.5459107704185739,-1.19511279230025,2022,4,GLUL|SLC38A1|SLC1A2|SLC1A3
LINOLEIC ACID (LA) METABOLISM%REACTOME%R-HSA-2046105.1,0.00591482649842271,0.0892939303923232,-0.68810374505999,-1.880900901573,44,7,ELOVL2|ELOVL1|ABCD1|FADS1|FADS2
PROCESSING OF SMDT1%REACTOME DATABASE ID RELEASE 66%8949664,0.54160125588697,0.815622645995152,-0.251585818517915,-0.9349903174867141,4139,16,STOML2|PARL|PHB
PAUSING AND RECOVERY OF TAT-MEDIATED HIV ELONGATION%REACTOME%R-HSA-167238.2,0.43479398299542205,0.762034923704788,-0.22241380540997402,-1.01549789203511,3323,30,SUPT16H|POLR2H|NELFB|POLR2G|SUPT4H1|SSRP1|POLR2L
FGFR3B LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190371,0.706553462456885,0.894843171056815,-0.513788286361679,-0.8550258694302121,5325,2,FGF9
FATTY ACIDS BOUND TO GPR40 (FFAR1) REGULATE INSULIN SECRETION%REACTOME%R-HSA-434316.1,0.124079915878023,0.47832576509682107,-0.506037024245063,-1.38322963937491,943,7,GNA14|PLCB1|PLCB3|GNAQ|GNA15
CLASSICAL KIR CHANNELS%REACTOME%R-HSA-1296053.1,0.3910851684797029,0.7369216590772479,-0.643782740556934,-1.07135742888729,2947,2,KCNJ14|KCNJ12
METHYLATION OF MESEH FOR EXCRETION%REACTOME DATABASE ID RELEASE 66%2408552,0.243745819397993,0.626320329556411,-0.8748897220996908,-1.16556318324765,1821,1,INMT
CELLULAR RESPONSE TO HEAT STRESS%REACTOME DATABASE ID RELEASE 66%3371556,0.422890644914606,0.7535830358827651,-0.16751807373572,-1.01767850126169,3317,83,GSK3B|HSPA14|HSPH1|PTGES3|HSF1|CREBBP|NUP205|MLST8|NUP93|DNAJB1|NUP210|BAG1|RPA2|HSPA13|DNAJC7|BAG5|VCP|NUP188|BAG3|MAPKAPK2|HSPA6|HSPA9|NUP85|MAPK3|CAMK2B|NUP37|RPTOR|NUP160|NUP214|CAMK2A|CRYAB|FKBP4|HSP90AA1|HSPA5|HSPA4
MITOCHONDRIAL PROTEIN IMPORT%REACTOME DATABASE ID RELEASE 66%1268020,0.0535414785189008,0.33531875720878496,-0.25666113863355605,-1.4514216296940903,414,63,CMC4|PMPCA|TOMM20|CHCHD3|ATP5B|SLC25A6|HSPA9|IDH3G|COA6|TOMM70A|TIMM21|TIMM10B|FXN|TIMM9|COX17|SLC25A4|TIMM17B|TOMM5|TIMM10|DNAJC19|CHCHD7|ATP5G1
INTRINSIC PATHWAY FOR APOPTOSIS%REACTOME%R-HSA-109606.2,0.33772652388797403,0.699636319850872,0.212624518890587,1.086808109753,2459,42,BBC3|CASP9|PMAIP1|PPP3R1|CASP8|TP53BP2|BID|YWHAQ|YWHAB|YWHAE|AKT3|APAF1|BAX|BCL2|YWHAH
ANTIVIRAL MECHANISM BY IFN-STIMULATED GENES%REACTOME%R-HSA-1169410.2,0.24922760041194603,0.630084224949081,-0.19281565785094298,-1.14420114272963,1935,76,KPNB1|OAS2|PDE12|NUP188|IFIT1|NUP85|ISG15|MAPK3|KPNA4|FLNA|NUP37|EIF4G2|NUP160|KPNA2|NUP214|EIF4A3|UBC|USP18|EIF4A2|UBE2L6|EIF4G1
FBXL7 DOWN-REGULATES AURKA DURING MITOTIC ENTRY AND IN EARLY MITOSIS%REACTOME%R-HSA-8854050.2,0.000128799587841319,0.00518555396908895,-0.41446635443265706,-2.2371104716513903,0,53,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
NUCLEOSOME ASSEMBLY%REACTOME%R-HSA-774815.1,0.000129416332341141,0.00518555396908895,-0.5043838259029079,-2.76193072227759,0,56,HIST1H4H|HJURP|ITGB3BP|CENPL|CENPU|CENPW|HIST1H2BE|H2AFX|HIST2H2AC|HIST1H2AD|OIP5|RUVBL1|CENPM|HIST1H2BN|NPM1|H2AFV|CENPI|HIST1H2BC|HIST1H4I|STRA13|RBBP7|CENPH|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H4B|CENPK|HIST1H2AC|MIS18A|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|CENPP
ACTIVATION OF PPARGC1A (PGC-1ALPHA) BY PHOSPHORYLATION%REACTOME DATABASE ID RELEASE 66%2151209,0.107425607425607,0.451309145449614,0.465449475735052,1.41445802835734,786,9,PRKAG2|MAPK12|MAPK11
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3%REACTOME%R-HSA-5654708.1,0.0865202061296447,0.40660077574150005,0.40265377176032396,1.4472870555505202,637,14,GAB1|FGF2|FRS3|SOS1|PLCG1|NRAS|FGF1|KRAS
SIGNALING BY RAS MUTANTS%REACTOME%R-HSA-6802949.1,0.8079418634829999,0.93418454242421,-0.14692061112930802,-0.7651630760024319,6225,47,VWF|ARRB1|MAPK3|HRAS|RAP1A|FN1|MAP3K11|VCL|ARAF|PHB
RECYCLING OF BILE ACIDS AND SALTS%REACTOME%R-HSA-159418.2,0.133060109289618,0.49418561861470095,0.46991008880798707,1.36406677889384,973,8,FABP6|SLCO1A2|SLC27A5|STARD5|NCOA2|NCOA1|RXRA|ABCC3
SIGNALING BY ACTIVIN%REACTOME DATABASE ID RELEASE 66%1502540,0.969733984799131,0.991546057544123,0.165226399115675,0.543696308729342,7144,11,SMAD3|ACVR2A|ACVR2B|ACVR1B|SMAD2
GAP JUNCTION TRAFFICKING AND REGULATION%REACTOME DATABASE ID RELEASE 66%157858,0.0746991104133961,0.383186929742657,-0.394750672809629,-1.46704635051633,570,16,GJA5|GJA1|GJC2|DNM1|CLTA|CLTC|GJA4|DAB2|AP2M1|CLTB
SLIT2:ROBO1 INCREASES RHOA ACTIVITY%REACTOME DATABASE ID RELEASE 66%8985586,0.919905771495877,0.9768322640118741,-0.286185780897319,-0.626520497960822,7028,4,RHOA|ROBO1|SLIT2
VXPX CARGO-TARGETING TO CILIUM%REACTOME DATABASE ID RELEASE 66%5620916,0.44492793037802597,0.76693681188187,0.256769810790784,1.0051066002286602,3271,18,EXOC4|PKD1|RAB11FIP3|PKD2|RAB11A|EXOC1
SYNTHESIS OF LEUKOTRIENES (LT) AND EOXINS (EX)%REACTOME%R-HSA-2142691.1,0.0335341891537857,0.261345744270986,-0.5072490071728211,-1.64224595173338,255,11,ALOX5AP|ALOX5|LTC4S|GGT1|MAPKAPK2|DPEP1|GGT5|ABCC1
CELL-EXTRACELLULAR MATRIX INTERACTIONS%REACTOME DATABASE ID RELEASE 66%446353,0.0010501443948542901,0.0240545523142212,-0.5823242958349011,-2.1143251241205503,7,15,ILK|RSU1|PXN|FLNA|LIMS2|FLNC|ACTN1|FBLIM1
VASOPRESSIN-LIKE RECEPTORS%REACTOME DATABASE ID RELEASE 66%388479,0.78801965732501,0.927797067038212,0.6056462284958101,0.807547524123596,5932,1,OXTR
INTERLEUKIN-1 FAMILY SIGNALING%REACTOME DATABASE ID RELEASE 66%446652,0.003996390357096821,0.0692303563848121,-0.258881679669178,-1.70336020018312,30,116,PSMF1|IL1RN|CASP1|PSMD4|SHFM1|STAT3|IL18BP|PTPN6|PSME2|PSMB5|IRAK1|SKP1|PSMC4|PSMC6|IL33|PSMD10|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|PSMD6|RELA|IL1R1|NFKB1|PSMD12|PSMA3|TOLLIP|PSMA6|PSMD13|PELI3|PSMB7|PSMA1|PSMC5|SQSTM1|PSMC3
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF CELL CYCLE FACTORS%REACTOME DATABASE ID RELEASE 66%8866911,0.6596345068529971,0.8776458000975379,0.42759944242237,0.841037643190749,4908,3,CDKN1A|KDM5B
VIRAL MESSENGER RNA SYNTHESIS%REACTOME%R-HSA-168325.3,0.755832037325039,0.9164836996734491,-0.1614596468377,-0.797327740789243,5831,39,NUP188|NUP85|POLR2H|NUP37|NUP160|NUP214|POLR2G|POLR2L
SIGNALING BY NOTCH4%REACTOME DATABASE ID RELEASE 66%9013694,0.00025618035096708103,0.00819882332206558,-0.343865170643357,-2.06690827493411,1,80,PSMD3|PSMB2|PSMF1|HES1|PSMD4|FLT4|NOTCH1|SHFM1|PSME2|PSMB5|SNW1|NOTCH2|SKP1|PSMC4|PSMC6|PSMD10|KAT2B|PSMB3|PSMC1|PSMD2|UBC|MAML1|PSMD6|PSMD12|PSMA3|ACTA2|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
EUKARYOTIC TRANSLATION ELONGATION%REACTOME DATABASE ID RELEASE 66%156842,0.689513541265563,0.887051934478962,-0.140501560688547,-0.8718715025702941,5371,91,RPS28|RPLP1|RPS18|RPL9|RPL28|RPS3|RPS5|EEF2|RPS10|RPS15|RPL29|RPL11|RPS6|RPL36|RPL17|RPL32|RPL39L|RPL23|RPLP0|RPL10A|RPL8|RPS23|RPL3|RPL7A|RPS2|RPL15|RPL37|RPL27A|RPL18|RPL39|RPL27|EEF1D|RPLP2|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|EEF1G|RPL35|RPL38|RPS15A|RPL36AL|RPS13|RPL26L1|FAU
THE FATTY ACID CYCLING MODEL%REACTOME%R-HSA-167826.2,0.846616934956158,0.949216083775675,-0.317211713450615,-0.694442749905143,6468,4,UCP3|SLC25A14|UCP2|SLC25A27
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL%REACTOME DATABASE ID RELEASE 66%202733,0.0005119672340970179,0.0139121625154964,-0.295143331497206,-1.89180074502926,3,103,ITGB1|IGKV3-11|CD44|TGFB1|LYN|ITGAX|SELPLG|CD74|SDC3|SLC7A7|ANGPT2|CD84|ITGB2|CXADR|MERTK|ATP1B1|TNFRSF10A|TNFRSF10B|PPIA|SPN|ATP1B3|MMP1|GYPC|GAS6|ESAM|IGKV2-28|ITGA5|DOK2|TSPAN7|OLR1|JCHAIN|PTPN6|CD47|SDC4|FCER1G|PIK3CB|HRAS|CEACAM1|THBD|SDC2|IGKV2D-28|FN1|CD99|TEK|CD99L2|SLC3A2|CAV1|ATP1B2|ITGAM|SLC7A8|IGHA1|SIRPA
SENSING OF DNA DOUBLE STRAND BREAKS%REACTOME%R-HSA-5693548.1,0.642174197773412,0.868171925756234,-0.32920256695513,-0.846797684806114,4902,6,NBN|KPNA2|KAT5
SIGNALING BY MET%REACTOME%R-HSA-6806834.2,0.483163462778996,0.787078399497453,-0.173165881170445,-0.9792550083503822,3744,63,LAMB2|LAMC1|SH3GL1|LAMC2|HGS|RAPGEF1|LAMC3|HGF|LAMA2|SH3GL2|GGA3|STAT3|LAMA4|HRAS|LRIG1|RAP1A|MUC20|SPINT2|UBC|ARF6|PTPRJ|SH3GL3
CHYLOMICRON CLEARANCE%REACTOME DATABASE ID RELEASE 66%8964026,0.0374338624338624,0.27552986478542,-0.7819194125629929,-1.5268904360750901,282,3,APOE|LDLR
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS%REACTOME DATABASE ID RELEASE 66%8876384,0.922855648535565,0.9776156396135859,-0.159359331203344,-0.618373472392053,7057,18,SH3GL1|CTNND1|HGS|SH3GL2|UBC|SH3GL3
"INTERLEUKIN-3, INTERLEUKIN-5 AND GM-CSF SIGNALING%REACTOME%R-HSA-512988.5",0.642543292840527,0.8682408185975831,-0.180578909860123,-0.8772426104164169,4971,37,RAPGEF1|VAV1|CSF2RB|PTPN6|IL2RA|PIK3CB|PIK3R3|CSF2RA|IL3RA|HCK|PRKACA
SERINE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%977347,0.9983606557377049,0.999656642395059,0.142644944778785,0.414073319522608,7307,8,SERINC2|SRR|PSAT1|SERINC1
IRS ACTIVATION%REACTOME DATABASE ID RELEASE 66%74713,0.305234087322462,0.677423587903087,-0.475326489579266,-1.13926689487893,2320,5,INS|IRS1|GRB10
SIALIC ACID METABOLISM%REACTOME%R-HSA-4085001.1,0.8092931937172779,0.9345725250088441,-0.167558860520103,-0.7483366114378659,6182,28,NEU1|NANP|ST3GAL1|ST6GALNAC4|GNE|NEU4|NPL|NANS|ST3GAL5
SURFACTANT METABOLISM%REACTOME DATABASE ID RELEASE 66%5683826,0.0617558550307471,0.357351053516493,-0.396083996555114,-1.5052159091210402,471,17,LMCD1|CKAP4|CSF2RB|ADGRF5|TTF1|CTSH|CSF2RA|GATA6|ADRA2C|ZDHHC2
ERK MAPK TARGETS%REACTOME DATABASE ID RELEASE 66%198753,0.22474507138001398,0.6078034241178771,0.289658474841766,1.21220696378797,1652,22,DUSP4|DUSP6|MAPK7|RPS6KA2|MAPK11|VRK3
"POU5F1 (OCT4), SOX2, NANOG ACTIVATE GENES RELATED TO PROLIFERATION%REACTOME DATABASE ID RELEASE 66%2892247",0.281483494090477,0.654633920184298,0.528325173961409,1.1607529073149498,2071,4,SALL4|FGF2|EPHA1
BETA-CATENIN PHOSPHORYLATION CASCADE%REACTOME%R-HSA-196299.1,0.9788041345021591,0.9929540748232929,-0.13747575866682302,-0.5224414539934389,7480,17,PPP2CA|CSNK1A1
MOLECULES ASSOCIATED WITH ELASTIC FIBRES%REACTOME DATABASE ID RELEASE 66%2129379,0.00847789226555367,0.114334180626901,-0.41451947387327204,-1.8282333923189598,64,27,LTBP3|MFAP4|ITGB5|TGFB3|VTN|LTBP2|LTBP1|MFAP5|BMP2|ITGA8|EFEMP1|FBLN2|EFEMP2|FBLN1
"TICAM1, RIP1-MEDIATED IKK COMPLEX RECRUITMENT%REACTOME%R-HSA-168927.2",0.925074789230351,0.9785037131586608,0.15782052204838598,0.617776863541072,6802,18,UBE2V1|RPS27A|RIPK1
SYNTHESIS OF DIPHTHAMIDE-EEF2%REACTOME%R-HSA-5358493.1,0.39058696240194796,0.7364714265545841,0.38015750790669,1.0494145965524302,2887,7,DPH2|DPH5|DPH1|DPH6|DPH3
G-PROTEIN BETA:GAMMA SIGNALLING%REACTOME%R-HSA-397795.3,0.90553235908142,0.970460195350249,-0.148809713552276,-0.649135145918325,6939,26,PLCB1|GNG8|PIK3R6|PLCB3|GNGT2|GNG11|GNG10|GNG3
ZBP1(DAI) MEDIATED INDUCTION OF TYPE I IFNS%REACTOME DATABASE ID RELEASE 66%1606322,0.508345380470496,0.798966294578331,-0.24241567257504804,-0.957761706956023,3867,19,NFKBIA|TICAM1|RELA|NFKB1
AXON GUIDANCE%REACTOME%R-HSA-422475.4,0.0334346504559271,0.261061407921079,-0.153508678793266,-1.29520300954682,263,485,CACNA1H|SH3GL2|RPLP2|KALRN|GRIN1|MYO10|ITGA5|MAGOH|SIAH2|DOK2|CXCR4|EFNA1|PSMD4|SHFM1|RPS14|RPS4X|RPL35A|NCBP1|CLTC|PSME2|RPS29|AKAP5|DSCAM|PSMB5|KIF4A|RPL10|RPL36A|NGEF|RPL24|MSN|PIK3CB|CACNA1G|RPL22L1|MAPK3|COL4A1|ABL1|NTN1|HRAS|PIK3R3|COL4A2|TREM2|MYL12A|PSMC4|SEMA7A|DOCK1|PSMC6|COL6A3|RND1|SDC2|EPHA2|MSI1|PSMD10|RPL35|PSMB3|NRP2|RPL38|RPS15A|EFNA3|RPL36AL|PSMC1|SEMA5A|DLG3|MAGOHB|EIF4A3|PSMD2|UBC|SEMA3E|EPHA4|SLIT2|RPS13|MMP9|PSMD6|TYROBP|RBM8A|SCN1B|SEMA3A|MYH9|CFL1|EPHB4|COL6A1|MAPK13|PRKACA|RPL26L1|RPS6KA4|PSMD12|PSMA3|FAU|HSP90AA1|EVL|TIAM1|ACTB|RRAS|CACNA1I|SPTBN2|PSMA6|NCK1|PSMD13|RAP1GAP|PSMB7|COL6A2|MYL9|PSMA1|PSMC5|AP2M1|EFNA5|PSMC3|CLTB|EIF4G1|GRB10|DNM3|PRNP
PCP CE PATHWAY%REACTOME%R-HSA-4086400.2,0.00101988781234064,0.0239579603690403,-0.31066221908781105,-1.9004822768396201,7,85,RHOA|PSMD7|PSME3|AP2A1|PSMA2|SMURF1|DVL3|PSME1|PSMB1|RAC2|RAC3|PSMB9|RAC1|PSMB4|PRICKLE1|PSMD1|PSMC2|AP2A2|FZD4|PSMD3|PSMB2|PSMF1|CLTA|FZD2|FZD8|PSMD4|SHFM1|SMURF2|CLTC|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|AP2M1|PSMC3|PRKCB|CLTB
DISEASES ASSOCIATED WITH O-GLYCOSYLATION OF PROTEINS%REACTOME DATABASE ID RELEASE 66%3906995,0.0346342724218144,0.266191770413233,-0.323205335849078,-1.5701140999266299,267,37,MUC3A|ADAMTS10|NOTCH4|ADAMTS4|ADAMTS14|SPON2|SBSPON|NOTCH1|MUC4|NOTCH2|ADAMTSL1|NOTCH3|ADAMTSL2|MUC20|THBS1|SEMA5A|THBS2|MUC15|CFP|ADAMTS8
SIGNALING BY EGFR IN CANCER%REACTOME%R-HSA-1643713.1,0.0816687049870907,0.397722753303477,0.37860098380467794,1.4558335800689097,600,17,GAB1|RPS27A|SHC1|SOS1|CBL|PLCG1|NRAS|CDC37|EGFR|KRAS
SIGNALING BY INTERLEUKINS%REACTOME DATABASE ID RELEASE 66%449147,0.000127746550843127,0.00518555396908895,-0.283282879074664,-2.3025000127455297,0,370,S100B|PSMD7|PSME3|PTGS2|BRWD1|PSMA2|FYN|TRAF6|MAPK14|IL11RA|IL27RA|APP|LCP1|IGHG1|BOLA2B|HIST1H3D|CNTFR|LIF|RPLP0|UBE2N|PSME1|CTF1|RAP1B|IL2RG|MCL1|IL1B|RORC|AKT1|CCL3|PSMB1|RIPK2|FSCN1|CDC42|PAK2|TNF|JAK3|SYK|POU2F1|PSMB9|CCL4|RPS6KA5|ITGB1|DUSP7|PTPN5|CXCL1|DUSP3|IL10RA|PSMB4|TGFB1|STAT5A|CNN2|CXCL2|SOS2|NDN|STAT6|MAOA|CCL11|LYN|FBXW11|ITGAX|ALOX5|PSMD1|PSMC2|MAP3K3|JUNB|RPS6KA1|SMARCA4|IL18|IRAK3|CCL19|HSP90B1|BATF|NFKB2|SOCS3|IL17RE|ITGB2|IGHG4|CD4|STX4|RAPGEF1|PPIA|PSMD3|STXBP2|RORA|HGF|PSMB2|VAV1|SOD2|GATA3|ATF1|CANX|PSMF1|IL1RN|EBI3|IL34|MMP1|ELK1|IL15RA|CASP1|CCL3L3|IL6ST|FPR1|IL13RA1|CSF2RB|POMC|PSMD4|CEBPD|MAPKAPK2|IL10RB|SHFM1|GRB2|MEF2C|S1PR1|HNRNPA2B1|IRS1|SOCS1|STAT3|MAPK9|IL18BP|HSPA9|IL17RA|IL32|PTPN6|PSME2|LMNB1|IL2RA|CISH|ICAM1|SNRPA1|PSMB5|MSN|CSF3R|PIK3CB|OSM|MAPK3|PIM1|HMOX1|SOD1|IRAK1|PIK3R3|SKP1|ARF1|VAMP7|VCAM1|IL15|IL21R|PSMC4|CSF1|CCL2|HIST2H3A|PSMC6|CSF2RA|IL33|MAP2K3|AIP|PSMD10|CCR1|FN1|CD86|IL3RA|NFKBIA|PSMB3|PPP2CA|HCK|CD36|LGALS9|F13A1|STX3|PSMC1|COL1A2|PSMD2|UBC|IFNLR1|MMP9|PSMD6|IL11|FLT3LG|MYC|PTAFR|HAVCR2|HIST2H3C|RELA|IL1R1|CFL1|NFKB1|PRKACA|BCL6|VIM|HIST1H3H|PSMD12|PSMA3|ITGAM|ANXA2|HSP90AA1|CSF1R|TIMP1|BIRC5|ANXA1|RHOU|OSMR|TNFRSF1A|TOLLIP|PSMA6|CCND1|PSMD13|PELI3|PSMB7|TALDO1|TNFRSF1B|PSMA1|PSMC5|SQSTM1|PSMC3|P4HB
DEFECTIVE TCN2 CAUSES HEREDITARY MEGALOBLASTIC ANEMIA%REACTOME%R-HSA-3359454.1,0.6559197324414721,0.874869342420871,-0.675727834142038,-0.9002317268985909,4902,1,TCN2
FORMATION OF HIV-1 ELONGATION COMPLEX CONTAINING HIV-1 TAT%REACTOME%R-HSA-167200.3,0.0820160663384296,0.398202308598866,-0.278479315614888,-1.4032904419739398,632,42,SUPT16H|NCBP1|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|POLR2L|GTF2H2
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF OTHER TRANSCRIPTION FACTORS%REACTOME%R-HSA-8866906.2,0.35396466994288794,0.7118407891832621,0.8236104984561099,1.09817346757412,2664,1,CITED2
FRUCTOSE BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%5652227,0.18019828510182198,0.553886683619651,0.749570737196545,1.25937561948561,1344,2,SORD|AKR1B1
TRANSMISSION ACROSS ELECTRICAL SYNAPSES%REACTOME DATABASE ID RELEASE 66%112307,0.360277136258661,0.7155384949577859,0.488243939218399,1.0726927276194,2651,4,GJD2|PANX1
HIGHLY SODIUM PERMEABLE ACETYLCHOLINE NICOTINIC RECEPTORS%REACTOME DATABASE ID RELEASE 66%629587,0.427659285423176,0.7559515106076821,0.46041100833197707,1.0115425931231201,3147,4,CHRNB2|CHRNB4|CHRNA3
AMINO ACID AND DERIVATIVE METABOLISM%REACTOME%R-HSA-71291.4,0.240880583642647,0.6244696312630601,-0.140621242688768,-1.10694235810928,1881,302,RPLP2|PDHA1|KYNU|BCKDK|ADI1|PSMD4|SHFM1|RPS14|RPS4X|RPL35A|PSME2|RPS29|PSMB5|RPL10|RPL36A|RPL24|MCCC2|HAAO|RPL22L1|INMT|SDSL|SLC6A8|CKB|PSMC4|FTCD|SERINC5|SLC44A1|PSMC6|PSMD10|SMS|RPL35|PSMB3|IL4I1|RPL38|RPS15A|RPL36AL|SQRDL|PSMC1|PSMD2|ALDH4A1|AFMID|RPS13|PSMD6|SLC3A2|NDUFAB1|HSD17B10|PDHX|RPL26L1|TMLHE|PSMD12|PSMA3|FAU|BCAT2|HNMT|PSMA6|EEFSEC|PSMD13|PSMB7|ASRGL1|PSMA1|APIP|PSMC5|NNMT|PSMC3
2-LTR CIRCLE FORMATION%REACTOME%R-HSA-164843.2,0.6716614090431129,0.8815356925073421,-0.300935340881408,-0.82259333427937,5109,7,BANF1
GSD II%REACTOME DATABASE ID RELEASE 66%5357609,0.514648829431438,0.8030810575910721,-0.745533745037495,-0.993229961599009,3846,1,GYG1
DETOXIFICATION OF REACTIVE OXYGEN SPECIES%REACTOME DATABASE ID RELEASE 66%3299685,0.000783187573423835,0.0191134260247744,-0.47120768233170396,-2.13057505648125,5,29,ERO1L|SOD2|GPX1|CYCS|SOD3|CYBB|SOD1|NCF4|CCS|GPX8|CAT|NCF2|GPX3|ATOX1|GSTP1|P4HB
"FORMATION OF THE TERNARY COMPLEX, AND SUBSEQUENTLY, THE 43S COMPLEX%REACTOME%R-HSA-72695.2",0.8428479794740219,0.9481593344082329,-0.13916385455109803,-0.743098620664097,6569,51,RPS14|RPS4X|RPS29|EIF1AX|EIF3B|RPS15A|RPS13|EIF2S1|FAU
INFLUENZA INFECTION%REACTOME%R-HSA-168254.2,0.16982581967213098,0.543055686346817,-0.172734592320872,-1.19294515149445,1325,146,KPNB1|CANX|CLTA|RPLP2|NUP188|SLC25A6|RPS14|RPS4X|RPL35A|CLTC|RPS29|NUP85|RPL10|RPL36A|RPL24|POLR2H|ISG15|RPL22L1|KPNA4|CALR|NUP37|RAN|NUP160|KPNA2|RPL35|RPL38|RPS15A|NUP214|RPL36AL|PABPN1|RPS13|POLR2G|RPL26L1|FAU|HSP90AA1|POLR2L
DEFECTIVE ABCC8 CAN CAUSE HYPOGLYCEMIAS AND HYPERGLYCEMIAS%REACTOME DATABASE ID RELEASE 66%5683177,0.847266881028939,0.9492491301138911,0.42277364212848106,0.710314305290353,6323,2,ABCC8|KCNJ11
POST-TRANSLATIONAL PROTEIN PHOSPHORYLATION%REACTOME DATABASE ID RELEASE 66%8957275,0.0005152647172484861,0.0139121625154964,-0.34062141414899,-2.02596532100189,3,77,CKAP4|C4A|GAS6|PNPLA2|C3|VWA1|NUCB1|SERPINA1|EVA1A|FBN1|LTBP1|STC2|SPP1|VCAN|MEN1|CSF1|SDC2|APOE|FN1|TNC|MFGE8|IGFBP5|PRSS23|TIMP1|SPARCL1|LGALS1|IGFBP4|IGFBP7|TMEM132A|FAM20A|CST3|P4HB
TP53 REGULATES TRANSCRIPTION OF DEATH RECEPTORS AND LIGANDS%REACTOME%R-HSA-6803211.1,0.602641213389121,0.8480120088902141,-0.28037591235112896,-0.8783811329997149,4608,10,TNFRSF10A|TNFRSF10B|PPP1R13B|TNFRSF10C
ABACAVIR TRANSMEMBRANE TRANSPORT%REACTOME%R-HSA-2161517.1,0.44399785637727796,0.766503259003379,0.617761577248064,1.03791921220263,3313,2,ABCB1
SYNTHESIS OF PC%REACTOME%R-HSA-1483191.4,0.613651165819982,0.852182158593687,-0.205708444269647,-0.8868379272474691,4710,25,ABHD3|ACHE|BCHE|PCYT1A|CHPT1|SLC44A1|LPIN3|PCTP|LPIN2
DEX H-BOX HELICASES ACTIVATE TYPE I IFN AND INFLAMMATORY CYTOKINES PRODUCTION%REACTOME%R-HSA-3134963.2,0.0247108307045216,0.22073142788434805,-0.61060481041518,-1.66906101973707,187,7,DHX9|NFKB2|DHX36|IRF7|RELA|NFKB1
INITIATION OF NUCLEAR ENVELOPE REFORMATION%REACTOME%R-HSA-2995383.2,0.00797594142259414,0.10934566713541498,-0.590152845402819,-1.8488718258319599,60,10,LEMD3|LMNB1|PPP2CA|VRK1|EMD|BANF1
DEPOLYMERISATION OF THE NUCLEAR LAMINA%REACTOME DATABASE ID RELEASE 66%4419969,0.102658111824015,0.441229839424518,-0.413037217688118,-1.42175420024663,783,13,LMNB1|CCNB1|LPIN3|EMD|LPIN2|PRKCB
MITOTIC G1-G1 S PHASES%REACTOME%R-HSA-453279.3,0.00012807377049180301,0.00518555396908895,-0.37275773935104206,-2.57435138999152,0,146,POLE4|CDKN1B|CDK4|AKT1|PSMB1|PRIM2|PSMB9|SKP2|CCNH|LIN54|POLE|TYMS|PSMB4|CCND2|LYN|RPA2|CDK6|RRM2|PSMD1|MCM10|PSMC2|TFDP2|CDT1|MCM4|MCM6|CDC6|PSMD3|PSMB2|CDKN1C|LIN52|CDKN2A|DYRK1A|PPP2R3B|PSMF1|E2F2|PCNA|GMNN|ORC1|TOP2A|LIN9|ORC6|PSMD4|MCM3|SHFM1|PSME2|MCM5|CDC45|PSMB5|CDKN2B|ABL1|SKP1|E2F1|PSMC4|DHFR|PSMC6|MAX|MYBL2|PSMD10|CCNB1|CDK7|PSMB3|PPP2CA|PSMC1|PSMD2|UBC|MCM2|MNAT1|TK1|PSMD6|MYC|CCND3|CDKN2C|PSMD12|PSMA3|POLE2|POLA1|POLE3|PSMA6|CCND1|PSMD13|PSMB7|PSMA1|POLA2|PSMC5|PSMC3
SYNTHESIS OF SUBSTRATES IN N-GLYCAN BIOSYTHESIS%REACTOME DATABASE ID RELEASE 66%446219,0.296075637870742,0.6687276080240239,-0.20025905497138102,-1.10662120616246,2285,58,TSTA3|MPI|NEU1|NANP|DPM2|ST3GAL1|ST6GALNAC4|GNE|NEU4|NPL|GNPNAT1|GMPPB|GFPT2|SRD5A3|DOLK|FUOM|NANS|DOLPP1|ST3GAL5|RENBP
RNA POLYMERASE II TRANSCRIPTION ELONGATION%REACTOME%R-HSA-75955.2,0.19353169469598996,0.567519363754568,-0.221149220486152,-1.21772711931904,1495,57,NCBP2|POLR2J|MLLT3|CCNK|SUPT16H|NCBP1|CTR9|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|POLR2L|GTF2H2
CLEARANCE OF DOPAMINE%REACTOME DATABASE ID RELEASE 66%379401,0.559391534391534,0.8268422944617521,-0.475520152233054,-0.9285703372240101,4228,3,MAOA|COMT
SODIUM-COUPLED PHOSPHATE COTRANSPORTERS%REACTOME%R-HSA-427652.1,0.17859056806002102,0.55175028994035,0.75070306038048,1.26127806863478,1332,2,SLC20A1|SLC20A2
ACYL CHAIN REMODELLING OF PI%REACTOME DATABASE ID RELEASE 66%1482922,0.00013075313807531399,0.00518555396908895,-0.7106177913346291,-2.22627277588867,0,10,PLA2G2A|PLA2G2D|PLA2R1|PLA2G4D|PLA2G4A|PLA2G4C|PLA2G16|PLBD1|PLA2G12A
CLATHRIN-MEDIATED ENDOCYTOSIS%REACTOME%R-HSA-8856828.3,0.29021516393442603,0.662840067565582,-0.163665219104488,-1.09690437196262,2265,127,CTTN|SH3GL1|PIK3C2A|GAPVD1|AP2A2|SNX18|TOR1B|CD4|UBQLN2|HGS|DNM1|FZD4|TOR1A|ARPC1A|SGIP1|CLTA|NECAP1|COPS6|SH3GL2|UBQLN1|CLTC|ARRB1|REPS2|EPS15L1|VAMP8|VAMP7|CHRM2|NEDD8|SYNJ2|UBC|LDLR|STON2|DAB2|ADRBK1|GPS1|TFRC|ARF6|AP2M1|SH3GL3|CLTB|DNM3
C-SRC MEDIATED REGULATION OF CX43 FUNCTION AND CLOSURE OF GAP JUNCTIONS%REACTOME%R-HSA-191647.1,0.5904749270363491,0.841700481190927,-0.562834298318169,-0.936646276372815,4450,2,TJP1|GJA1
ACTIVATION OF NF-KAPPAB IN B CELLS%REACTOME%R-HSA-1169091.1,0.000128865979381443,0.00518555396908895,-0.396439962947212,-2.26057940831417,0,65,PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|PSMD6|RELA|NFKB1|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|PRKCB
REDUCTION OF CYTOSOLIC CA++ LEVELS%REACTOME DATABASE ID RELEASE 66%418359,0.857610689022793,0.9495815083844671,-0.21113199908038002,-0.683551206346664,6546,11,ATP2A2|SLC8A3|ATP2A1|ATP2A3|ATP2B2
CRMPS IN SEMA3A SIGNALING%REACTOME%R-HSA-399956.1,0.466702908399021,0.7806653415096191,0.261262835513685,0.9837412249988831,3433,16,CDK5R1|DPYSL5|CRMP1|NRP1|CDK5|PLXNA4|DPYSL4|DPYSL2|PLXNA2|PLXNA1|DPYSL3
TOXICITY OF TETANUS TOXIN (TENT)%REACTOME%R-HSA-5250982.1,0.753619338557577,0.915550465961143,0.623842082046758,0.831809239615292,5673,1,VAMP2
ADHERENS JUNCTIONS INTERACTIONS%REACTOME%R-HSA-418990.2,0.43154878207633207,0.76006374348252,-0.23494611300069898,-1.0128856139481899,3312,25,JUP|CTNND1|PVRL2|CDH8|CDH11|CDH5|CDH7|ANG|CADM3
BUDDING AND MATURATION OF HIV VIRION%REACTOME DATABASE ID RELEASE 66%162588,0.6358419199165251,0.8636797415465791,-0.19727000391773,-0.8700570930849599,4874,27,TSG101|PPIA|UBAP1|MVB12B|CHMP4A|CHMP6|UBC|VPS37C
REUPTAKE OF GABA%REACTOME DATABASE ID RELEASE 66%888593,0.948938457403924,0.984504384435631,0.29957679867133397,0.589232210598382,7061,3,SLC6A13
MYD88-INDEPENDENT TLR4 CASCADE%REACTOME DATABASE ID RELEASE 66%166166,0.645929339477727,0.869411231395532,-0.143308812603228,-0.895019114750908,5045,93,TICAM2|ATF1|ELK1|IKBKE|MAPKAPK2|MEF2C|MAPK9|MAPK3|IRF7|IRAK1|SKP1|MAP2K3|NFKBIA|PPP2CA|FADD|UBC|TICAM1|TRAF3|RELA|NFKB1|TLR4|CD14|LY96
MITOCHONDRIAL TRNA AMINOACYLATION%REACTOME DATABASE ID RELEASE 66%379726,0.0024380333197887,0.046570092051927,0.492535651232648,2.03030634837612,17,21,PARS2|SARS2|CARS2|RARS2|DARS2|FARS2|IARS2|LARS2|WARS2|HARS2|QARS|YARS2|VARS2|KARS|MARS2|TARS2|EARS2|NARS2|PPA2
NGF-INDEPENDANT TRKA ACTIVATION%REACTOME%R-HSA-187024.2,0.21465260881319298,0.5979177134734279,0.5146612239037079,1.23775729215795,1587,5,ADORA2A|ADCYAP1|ADCYAP1R1
RUNX2 REGULATES GENES INVOLVED IN DIFFERENTIATION OF MYELOID CELLS%REACTOME DATABASE ID RELEASE 66%8941333,0.7708994708994709,0.9213545359508709,-0.38855185339935205,-0.7587432916265191,5827,3,RUNX1|LGALS3
G2 M DNA DAMAGE CHECKPOINT%REACTOME%R-HSA-69473.4,0.0357096981374438,0.268987198588135,-0.249815968543363,-1.49645669109996,277,79,UIMC1|RAD9A|RFC2|RPA2|BRIP1|HIST1H2BE|RFC3|H2AFX|NBN|EXO1|HIST1H2BN|RAD1|RAD17|BRCC3|HIST1H2BC|CDC25C|RHNO1|RNF168|HIST1H4I|BRCA1|RFC5|TOPBP1|RMI1|CCNB1|RMI2|HIST1H2BG|HIST1H2BD|HIST2H4A|KAT5|HIST2H4B|RFC4|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES%REACTOME%R-HSA-1834941.3,0.6744552375951689,0.882488012133495,-0.23048319888555102,-0.8368471341088579,5137,15,DDX41|STAT6|TRIM21|TREX1|MB21D1|IFI16|TMEM173
G ALPHA (S) SIGNALLING EVENTS%REACTOME DATABASE ID RELEASE 66%418555,0.142239576070283,0.508373262859943,0.199136428706538,1.2439197093025,1019,89,ADORA2B|CRHR1|GNG5|PDE10A|ADCY2|GNGT1|GNAS|PTH1R|RAMP1|GNB5|ARRB2|ADORA2A|ADCY3|PDE8A|PDE3A|GNB4|GNAI3|ADRBK2|GCGR|ADCYAP1|REEP4|ADCYAP1R1|PDE7B|GPR27|RAMP3|ADCY6
RNA POLYMERASE II TRANSCRIBES SNRNA GENES%REACTOME DATABASE ID RELEASE 66%6807505,0.6626397635265389,0.8796297678152929,-0.14856765840224,-0.878588206681553,5155,75,CCNT1|INTS12|SNAPC1|GTF2E1|INTS2|SRRT|POLR2F|POU2F1|INTS1|POLR2C|NABP2|SSU72|INTS7|NCBP2|GTF2A2|POLR2J|ELL2|ZNF143|PHAX|CCNK|GTF2A1|NCBP1|POLR2H|CDK7|POLR2G|POU2F2|INTS5|SUPT4H1|TAF9|AK6|POLR2L
ARYL HYDROCARBON RECEPTOR SIGNALLING%REACTOME%R-HSA-8937144.1,0.9339882121807471,0.9800972968717879,-0.236307628175019,-0.6078468776578649,7130,6,AHR|AIP
PROTON OLIGOPEPTIDE COTRANSPORTERS%REACTOME DATABASE ID RELEASE 66%427975,0.821560846560847,0.9406712652028609,-0.367912528684366,-0.718439921473496,6210,3,SLC15A3
POST-CHAPERONIN TUBULIN FOLDING PATHWAY%REACTOME DATABASE ID RELEASE 66%389977,0.10257752191547802,0.441229839424518,-0.36917994298316703,-1.40297393567967,783,17,TBCD|TUBA1B|TUBA4A|TUBB4A|TBCA|ARL2|TUBB4B|TUBB6
DERMATAN SULFATE BIOSYNTHESIS%REACTOME%R-HSA-2022923.1,0.282178217821782,0.654732517474162,-0.384630111651944,-1.15706152270135,2165,9,CSPG4|DSEL|NCAN|DCN|BGN|VCAN
RECOGNITION OF DNA DAMAGE BY PCNA-CONTAINING REPLICATION COMPLEX%REACTOME DATABASE ID RELEASE 66%110314,0.0078482668410726,0.108222437264782,-0.392074439535708,-1.79013513183433,59,30,RAD18|POLE|RFC2|CUL4B|RPA2|RFC3|UBE2B|POLD4|PCNA|POLD1|POLD2|RFC5|DTL|UBC|DDB1|POLE2|POLE3|RFC4
ELEVATION OF CYTOSOLIC CA2+ LEVELS%REACTOME DATABASE ID RELEASE 66%139853,0.157977469216662,0.527990543848753,-0.40840091119113797,-1.32221992276737,1205,11,ITPR2|P2RX4|ITPR3|P2RX5|P2RX3|STIM1
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER%REACTOME%R-HSA-2691230.1,0.61646803900325,0.854122579597827,0.236066594067968,0.8707523551678761,4551,15,DLL1|ADAM17|RPS27A
ETHANOL OXIDATION%REACTOME%R-HSA-71384.2,0.280757097791798,0.653918409964198,-0.42589450650858296,-1.16416364104681,2135,7,ACSS1|ADH1B|ALDH2|ALDH1A1
KINESINS%REACTOME DATABASE ID RELEASE 66%983189,0.857956015523933,0.9498368589539309,-0.1486199046674,-0.7156464321770841,6631,36,KIF25|CENPE|KIF2C|KLC1|KIF3A|RACGAP1|KIF1C|KIF11|KIF15|KIF21B|KLC2|KIF20A|KIF18B|KIF4A|KIF27|KIF18A|KIFC1|KIF2A|KIF22
CALNEXIN CALRETICULIN CYCLE%REACTOME%R-HSA-901042.2,0.952848187517035,0.9865040531051271,0.13436211680451599,0.594145208142114,6991,26,UGGT2|RNF103|RPS27A|TRIM13
SYNTHESIS OF PIPS AT THE ER MEMBRANE%REACTOME%R-HSA-1483248.6,0.0399402255128379,0.285353785469417,0.7158324079189491,1.57271428581004,293,4,MTMR2|PI4K2B|SBF1|SACM1L
MASTL FACILITATES MITOTIC PROGRESSION%REACTOME DATABASE ID RELEASE 66%2465910,0.42494769874477,0.7546470443593142,-0.32451986525652005,-1.01667837488105,3249,10,ENSA|CCNB1|PPP2CA
ACETYLCHOLINE REGULATES INSULIN SECRETION%REACTOME DATABASE ID RELEASE 66%399997,0.6702405857740589,0.8815356925073421,-0.263422257937916,-0.8252675468607099,5125,10,PLCB1|PLCB3|GNAQ|GNA15
RNA POLYMERASE III CHAIN ELONGATION%REACTOME DATABASE ID RELEASE 66%73780,0.837996861924686,0.946274787285881,-0.18317810336293303,-0.7107991668099479,6408,18,POLR3B|POLR2H|POLR3K|POLR2L
TRANSCRIPTIONAL REGULATION BY THE AP-2 (TFAP2) FAMILY OF TRANSCRIPTION FACTORS%REACTOME%R-HSA-8864260.3,0.5789187720728061,0.8381391541478929,0.201571665546423,0.9132184254184871,4261,28,CITED1|CDKN1A|KIT|SUMO1|TFAP2B|HSPD1|CITED2|KCTD1|KDM5B|EGFR|EP300|ERBB2
SYNTHESIS OF CL%REACTOME DATABASE ID RELEASE 66%1483076,0.491300305485456,0.790696900371285,0.7548522276135858,1.0064935911555,3698,1,CRLS1
COPII-MEDIATED VESICLE TRANSPORT%REACTOME%R-HSA-204005.4,0.000128865979381443,0.00518555396908895,-0.38295182635536895,-2.15666681860398,0,62,TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|F8|SEC13|SEC24A|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|LMAN2|TRAPPC2|SEC22A|GOSR2|PPP6C|SAR1B|GRIA1
NOTCH-HLH TRANSCRIPTION PATHWAY%REACTOME%R-HSA-350054.2,0.0669110907424381,0.36912544096786104,-0.4380643233323979,-1.50790235117825,510,13,NOTCH1|SNW1|NOTCH2|NOTCH3|KAT2B|MAML1
CHROMATIN ORGANIZATION%REACTOME%R-HSA-4839726.2,0.000127844541038098,0.00518555396908895,-0.249663433930095,-1.8852176367282,0,236,SETD1B|HIST1H2BE|KAT6A|KANSL1|SMARCA4|SMARCA2|REST|KANSL2|JADE3|NFKB2|KDM1A|EZH2|H2AFX|PHF2|HIST2H2AC|HIST1H2AD|KDM3B|KDM8|NSD1|YEATS4|TAF6L|BRPF3|RUVBL1|KDM2A|HIST1H2AI|SETD8|HCFC1|SMARCE1|OGT|HIST1H2BN|H2AFV|TAF12|MORF4L2|ARID5B|HIST1H2BC|MSL2|PHF20|SMARCD3|HIST1H4I|SETD1A|RBBP7|JMJD6|WDR5|SMARCD2|HIST1H2AK|KAT7|HIST2H3A|KDM5C|MBIP|PRMT3|BRMS1|KAT2B|HIST2H2BF|H2AFZ|SUV420H1|HDAC8|HIST2H2AA4|HIST3H2A|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|TAF10|HIST2H3C|RELA|MTA2|NFKB1|HIST1H3H|KAT8|KAT5|TAF9|ACTB|HIST2H4B|PRMT5|HIST1H2AC|CCND1|CCDC101|HIST3H2BB|ELP4|HIST2H2BE|H2AFJ|HIST1H2BK|AK6|HIST1H2BJ|HIST2H2AA3|SUV39H1
NEGATIVE REGULATION OF THE PI3K AKT NETWORK%REACTOME DATABASE ID RELEASE 66%199418,0.146149884110224,0.513872620660976,-0.214486939123889,-1.2626502514561,1134,74,PIK3AP1|FGFR4|HGF|VAV1|IER3|PHLPP1|INS|IRS1|PIK3CB|FGF10|MAPK3|RHOG|IRAK1|PIK3R3|HBEGF|IL33|CD86|PPP2CA|FGF19|FGF9|FGF7|PDGFRB|PDGFRA|PDGFB
GAP-FILLING DNA REPAIR SYNTHESIS AND LIGATION IN TC-NER%REACTOME DATABASE ID RELEASE 66%6782210,0.0155968032998195,0.16882265323419102,-0.28791252184881205,-1.63497454190654,120,64,POLE|POLR2C|RFC2|CUL4B|RPA2|RFC3|HMGN1|POLR2J|POLD4|PCNA|POLD1|POLD2|RFC5|POLR2H|GTF2H1|CDK7|UBC|MNAT1|ERCC8|DDB1|POLR2G|ISY1|POLE2|POLE3|RFC4|POLR2L|PRPF19|GTF2H2
TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS%REACTOME DATABASE ID RELEASE 66%168271,0.971566453632451,0.9915747942934481,-0.12487509554517301,-0.5507601787956121,7448,27,KPNB1|NUP188|NUP85|NUP37|NUP160|NUP214
SPHINGOLIPID DE NOVO BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%1660661,0.48589626933576,0.7872939093021379,-0.206486976257645,-0.9782906415040308,3737,34,PPAP2B|SPTLC2|SGPP1|CERS6|SPTSSB|CERS4|PPAP2C|PRKD1|ORMDL3|PPAP2A|OSBP|SPTSSA|ALDH3B1|SPHK1
NUCLEAR EVENTS (KINASE AND TRANSCRIPTION FACTOR ACTIVATION)%REACTOME%R-HSA-198725.1,0.375153583617747,0.725723455004499,0.243307891322987,1.06007209286559,2747,25,DUSP4|DUSP6|MAPK7|RPS6KA2|MAPK11|VRK3
CLEC7A INFLAMMASOME PATHWAY%REACTOME DATABASE ID RELEASE 66%5660668,0.357039947609692,0.714610778064251,-0.42070233967223497,-1.08215974900196,2725,6,MALT1|IL1B|PYCARD|RELA|NFKB1
IRE1ALPHA ACTIVATES CHAPERONES%REACTOME DATABASE ID RELEASE 66%381070,0.0257538501358872,0.225019807572435,-0.287033090709783,-1.57175046230416,198,56,ATP6V0D1|TPP1|WIPI1|LMNA|PDIA5|SRPRB|SYVN1|SEC61A1|SEC61B|SSR1|KDELR3|HSPA5|GOSR2|DNAJB11|SERP1|YIF1A|ERN1
ALKBH3 MEDIATED REVERSAL OF ALKYLATION DAMAGE%REACTOME%R-HSA-112126.1,0.59298521135977,0.8422269872864581,-0.40485917139526395,-0.8863213569564972,4530,4,ALKBH3
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%9013700,0.565553745928339,0.8298229800621719,0.27621545552611304,0.9089184560537571,4166,11,PSENEN|PSEN2|APH1B|ADAM10|YWHAZ
KERATAN SULFATE DEGRADATION%REACTOME%R-HSA-2022857.1,0.0534132360604482,0.335115832119604,-0.5202925377160701,-1.5651673067257699,409,9,PRELP|OGN|LUM|FMOD|HEXB
COLLAGEN DEGRADATION%REACTOME DATABASE ID RELEASE 66%1442490,0.00536649214659686,0.0829378624098312,-0.42261154155920605,-1.8874304109212101,40,28,CTSK|MMP11|COL9A3|PHYKPL|FURIN|COL9A1|MMP12|ADAM9|COL15A1|COL18A1|COL23A1|MMP1|CTSB|COL14A1|MMP14|COL12A1|MMP9|CTSD|CTSL|COL16A1|MMP19|COL13A1|COL26A1
DEFECTIVE MISMATCH REPAIR ASSOCIATED WITH MSH3%REACTOME%R-HSA-5632927.1,0.622320471596999,0.856495765504366,0.5396195202646821,0.9066304671411759,4644,2,MSH2|MSH3
DISEASES OF MISMATCH REPAIR (MMR)%REACTOME DATABASE ID RELEASE 66%5423599,0.139767504731008,0.504314492208813,0.565659169761639,1.36040705949799,1033,5,MLH1|PMS2|MSH2|MSH6|MSH3
APC TRUNCATION MUTANTS HAVE IMPAIRED AXIN BINDING%REACTOME DATABASE ID RELEASE 66%5467337,0.7642894598846359,0.9191113740914171,-0.21629972962533803,-0.7652368131017159,5829,14,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
ANCHORING FIBRIL FORMATION%REACTOME%R-HSA-2214320.2,0.887164650184114,0.965013712426871,-0.273880432384734,-0.656439135229431,6745,5,BMP1|LAMA3|COL7A1|LAMB3|LAMC2
CELLULAR RESPONSE TO HYPOXIA%REACTOME%R-HSA-2262749.1,0.00141679546625451,0.0301860198914787,-0.318225403517721,-1.8547316098418,10,71,PSMB1|VHL|CREBBP|HIGD1A|AJUBA|PSMB9|TCEB2|UBE2D2|PSMB4|PSMD1|PSMC2|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|HIF3A|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|WTIP|PSMA1|PSMC5|PSMC3
TACHYKININ RECEPTORS BIND TACHYKININS%REACTOME%R-HSA-380095.2,0.9013000795967099,0.9684180373391851,-0.39982661837304495,-0.665375430056228,6793,2,TAC1
CELL DIVISION%REACTOME%R-HSA-68884.2,0.421997902464604,0.7527812076478722,-0.28985267792606,-1.02545638826889,3218,14,STAG2|NUDC|KIF20A|PLK1|SMC1A
SYNTHESIS OF WYBUTOSINE AT G37 OF TRNA(PHE)%REACTOME DATABASE ID RELEASE 66%6782861,0.8705035971223021,0.9574934752519241,0.259134899631919,0.670526783518947,6412,6,TYW5|TRMT12|TYW1|TYW3
IRAK4 DEFICIENCY (TLR5)%REACTOME%R-HSA-5603037.1,0.847089947089947,0.9492491301138911,-0.35675283031692206,-0.6966478589758021,6403,3,TLR5
"BASE-EXCISION REPAIR, AP SITE FORMATION%REACTOME%R-HSA-73929.1",0.14959016393442598,0.51590227091171,0.45866889635649505,1.33143556380942,1094,8,NTHL1|NEIL1|OGG1|SMUG1|NEIL2|TDG
FGFR2 LIGAND BINDING AND ACTIVATION%REACTOME%R-HSA-190241.1,0.39332023575638503,0.7375199755844078,-0.4074517474435271,-1.0480756562642801,3002,6,FGF10|FGF9|FGF7
"NUCLEOTIDE-BINDING DOMAIN, LEUCINE RICH REPEAT CONTAINING RECEPTOR (NLR) SIGNALING PATHWAYS%REACTOME%R-HSA-168643.1",0.9090033039647579,0.9715076818387142,0.128792431997441,0.6837500300292371,6602,48,UBE2V1|MAP2K6|CASP9|SUGT1|MAPK12|MAPK11|CASP8|PANX1
MITOTIC METAPHASE ANAPHASE TRANSITION%REACTOME DATABASE ID RELEASE 66%68881,0.344919076678164,0.7024647311177249,-0.663332395778388,-1.10389118140071,2599,2,PLK1
REGULATION OF THYROID HORMONE ACTIVITY%REACTOME DATABASE ID RELEASE 66%350864,0.8840133779264209,0.963303578606192,-0.560652845169828,-0.7469242104532741,6607,1,DIO2
DEFECTIVE B4GALT1 CAUSES B4GALT1-CDG (CDG-2D)%REACTOME DATABASE ID RELEASE 66%3656244,0.00745975657636435,0.10477806266857598,-0.796669056416478,-1.74407509824925,56,4,PRELP|OGN|LUM|FMOD
ASSEMBLY OF THE HIV VIRION%REACTOME DATABASE ID RELEASE 66%175474,0.517399267399267,0.804492467129778,-0.25627232431863395,-0.952407187691604,3954,16,TSG101|PPIA|UBAP1|MVB12B|UBC|VPS37C
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION%REACTOME%R-HSA-140837.4,0.0300209753539591,0.244914961988629,-0.46503354482773207,-1.64522067801827,228,14,F12|F10|PRCP|GP1BA|GP1BB|VWF|F8|SERPINE2|A2M|SERPING1
RUNX3 REGULATES BCL2L11 (BIM) TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%8952158,0.525817788591511,0.808999293651432,0.385326023375771,0.926706876562394,3889,5,SMAD3|FOXO3
RETROGRADE NEUROTROPHIN SIGNALLING%REACTOME%R-HSA-177504.1,0.0676455165180912,0.371075653877479,-0.421162043795896,-1.4900097228601599,515,14,AP2A2|DNM1|NGF|CLTA|SH3GL2|CLTC|AP2M1|DNM3
VITAMIN B2 (RIBOFLAVIN) METABOLISM%REACTOME%R-HSA-196843.1,0.717576233477294,0.900060477413567,-0.362163251193901,-0.7928510625848461,5482,4,ACP5|RFK
SMAD4 MH2 DOMAIN MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3311021,0.49247514109110496,0.7912515533650171,0.49262757639359006,0.968940308887458,3664,3,SMAD3|SMAD2|SMAD4
HDR THROUGH MMEJ (ALT-NHEJ)%REACTOME DATABASE ID RELEASE 66%5685939,0.191553347280335,0.565967229895179,-0.40589257394174705,-1.27160844876226,1464,10,NBN|PARP1|PARP2|POLQ|FEN1
SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR3%REACTOME DATABASE ID RELEASE 66%1839130,0.7366299381886591,0.908157084784786,0.40031790098352604,0.7873780706142449,5481,3,FGF2|FGF1
FRS2-MEDIATED ACTIVATION%REACTOME DATABASE ID RELEASE 66%170968,0.33083596214511,0.6957352559323989,-0.406765681795044,-1.11187585173011,2516,7,RAPGEF1|NGF|RAP1A
BIOSYNTHESIS OF MARESIN CONJUGATES IN TISSUE REGENERATION (MCTR)%REACTOME%R-HSA-9026762.1,0.618569131832797,0.854944793214197,0.5407026763060689,0.9084503091426429,4616,2,GSTM4
TRANSCRIPTIONAL REGULATION BY MECP2%REACTOME DATABASE ID RELEASE 66%8986944,0.206445393196529,0.586182872727595,0.22984848873633398,1.20544778706798,1498,46,MET|DLL1|CAMK4|RBFOX1|PTPN4|HDAC1|NCOR1|GPS2|HTT|TBL1XR1|AGO2|SIN3A|TNRC6B|CAMK2G|AGO3|MOV10|CAMK2D
ACTIVATION OF CA-PERMEABLE KAINATE RECEPTOR%REACTOME DATABASE ID RELEASE 66%451308,0.556532323505545,0.8257149029717741,0.3268858711476,0.9023596731732741,4114,7,GRIK3|DLG4|GRIK2
BINDING AND ENTRY OF HIV VIRION%REACTOME%R-HSA-173107.1,0.14409108755398498,0.510372098339109,-0.6122513936367989,-1.3403462842067702,1100,4,CD4|PPIA|CXCR4
PTK6 EXPRESSION%REACTOME DATABASE ID RELEASE 66%8849473,0.447085993750849,0.768229288546963,0.453665351135243,0.9967220969802859,3290,4,EPAS1|PELP1
ACTIVATION OF RRNA EXPRESSION BY ERCC6 (CSB) AND EHMT2 (G9A)%REACTOME DATABASE ID RELEASE 66%427389,0.000128287363694676,0.00518555396908895,-0.465697277467715,-2.48670177791187,0,51,H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|TTF1|HIST1H4I|RBBP7|HIST2H3A|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|MTA2|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
GLYCEROPHOSPHOLIPID BIOSYNTHESIS%REACTOME DATABASE ID RELEASE 66%1483206,0.0963378843945387,0.427566585262796,-0.20258621517580602,-1.30185094275231,754,104,PLA1A|ABHD3|PGS1|ACP6|ACHE|PTDSS2|DGAT1|GPD1|AGPAT1|GPAM|BCHE|PLA2G2A|PLA2G2D|PCYT1A|PNPLA2|PLA2R1|CPNE6|CHPT1|TMEM86B|PLA2G4D|ETNK2|PLA2G4A|CDIPT|PLD4|PLD1|PLA2G4C|SLC44A1|PLA2G16|PLD3|LPIN3|MGLL|PCTP|PLBD1|AGPAT2|LPIN2|PTPMT1|AGPAT3|OSBPL5|PLA2G12A
"COBALAMIN (CBL, VITAMIN B12) TRANSPORT AND METABOLISM%REACTOME DATABASE ID RELEASE 66%196741",0.46759198638208704,0.780769690730001,-0.285839791378037,-0.9839159925201,3570,13,MMAB|ABCC1
DOWNREGULATION OF ERBB4 SIGNALING%REACTOME DATABASE ID RELEASE 66%1253288,0.7268055179875571,0.905145599593318,0.281191940954412,0.776222805371761,5373,7,RPS27A|NEDD4|UBA52|ITCH|WWP1|UBB
TRANSMISSION ACROSS CHEMICAL SYNAPSES%REACTOME DATABASE ID RELEASE 66%112315,0.318883457679444,0.6867397844771489,-0.154063861083072,-1.07681374554635,2478,156,ALDH2|CASK|GRIN1|ADCY8|SLC1A2|TSPAN7|AKAP5|SYN1|LIN7C|CAMK2B|GNGT2|ADCY4|SLC1A3|PPFIA1|HRAS|KCNJ12|GNG11|GNAI2|CACNA1E|APBA1|CHRNE|CACFD1|GNG10|GRIN2C|DLG3|ARHGEF9|NSF|GRIN2D|CAMK2A|PRKACA|ARL6IP5|RRAS|KCNJ9|GNG3|GABRQ|GRIA1|PRKCB|ADCY9
REGULATION OF PTEN GENE TRANSCRIPTION%REACTOME%R-HSA-8943724.1,0.19767141009055603,0.5747254604125179,-0.22033583482308203,-1.21324832541595,1527,57,SNAI2|MAPK3|RBBP7|CBX4|HDAC5|RPTOR|CBX6|RING1|SNAI1|PPARG|MTA2|SLC38A9|RRAGD
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS%REACTOME DATABASE ID RELEASE 66%442755,0.22421814422331401,0.607638142117869,-0.24525288279610802,-1.1914252848400901,1734,37,GRIN1|ADCY8|CAMK2B|HRAS|GRIN2C|DLG3|GRIN2D|CAMK2A|PRKACA|RRAS|GRIA1
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE%REACTOME DATABASE ID RELEASE 66%1660514,0.802685109845403,0.932964969466025,0.203991017343139,0.7332194047471701,5918,14,FIG4|PIKFYVE|PI4K2B
N-GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS-GOLGI%REACTOME DATABASE ID RELEASE 66%975576,0.0970768184908226,0.429404164269902,0.33465569593272304,1.40051819751714,713,22,CHST8|MGAT5|ST8SIA2|CHST10|B4GALT5
CELL CYCLE CHECKPOINTS%REACTOME%R-HSA-69620.1,0.00012807377049180301,0.00518555396908895,-0.27351516105934803,-2.11412981849488,0,270,NSL1|PSMD1|MCM10|PSMC2|SPDL1|BRIP1|CDC20|DYNC1H1|HIST1H2BE|ANAPC10|CLIP1|RFC3|DSN1|MCM4|ANAPC2|H2AFX|NBN|MCM6|ANAPC5|EXO1|CDC6|PSMD3|PSMB2|CENPM|CDC23|CDKN2A|NUDC|HIST1H2BN|PSMF1|RAD1|RAD17|BRCC3|ORC1|PKMYT1|CENPI|MAD2L1|HIST1H2BC|CDC25C|ORC6|KNTC1|PSMD4|MCM3|SHFM1|ERCC6L|PHF20|RHNO1|RNF168|PSME2|DYNLL2|HIST1H4I|MCM5|INCENP|CDC45|BRCA1|NUP85|PSMB5|NDC80|RFC5|SGOL1|TOPBP1|KIF18A|RMI1|CDC27|SEC13|NUP37|CKAP5|CENPH|PSMC4|SPC25|PSMC6|NUP160|PSMD10|KIF2A|CCNB1|PLK1|SKA1|PSMB3|PPP2CA|RMI2|PSMC1|SPC24|PSMD2|UBC|MCM2|PSMD6|HIST1H2BG|HIST1H2BD|HIST2H4A|PSMD12|PSMA3|KAT5|DYNC1I1|BIRC5|HIST2H4B|ANAPC11|CENPK|ZNF385A|PSMA6|RFC4|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|HIST1H2BK|PSMA1|PSMC5|HIST1H2BJ|PSMC3|CENPP|SKA2
WNT LIGAND SECRETION IS ABROGATED BY THE PORCN INHIBITOR LGK974%REACTOME%R-HSA-5340573.1,0.510903010033445,0.8011667213092171,-0.747959858844288,-0.9964621277339358,3818,1,PORCN
"ACTIVATION OF NIMA KINASES NEK9, NEK6, NEK7%REACTOME DATABASE ID RELEASE 66%2980767",0.0695320715036803,0.37596389138254704,-0.5495718453347371,-1.5022301314159,528,7,NEK9|CCNB1|PLK1|NEK6
THE ACTIVATION OF ARYLSULFATASES%REACTOME%R-HSA-1663150.1,0.0631537656903766,0.36006266503904,-0.489698021545796,-1.5341599761053202,482,10,SUMF1|ARSE|ARSB|ARSF|ARSG|STS
INTERLEUKIN-7 SIGNALING%REACTOME%R-HSA-1266695.7,0.0902196652719665,0.414848344511905,-0.33251228974669605,-1.41316785724293,689,24,BRWD1|HIST1H3D|IL2RG|JAK3|STAT5A|SMARCA4|HGF|IRS1|SOCS1|STAT3|CISH|PIK3R3|HIST2H3A|HIST2H3C|HIST1H3H
ISG15 ANTIVIRAL MECHANISM%REACTOME DATABASE ID RELEASE 66%1169408,0.20521130412237498,0.5851419434522471,-0.207506428373042,-1.19500629226564,1582,68,IFIT1|NUP85|ISG15|MAPK3|KPNA4|NUP37|EIF4G2|NUP160|KPNA2|NUP214|EIF4A3|UBC|USP18|EIF4A2|UBE2L6|EIF4G1
REGULATION OF IGF ACTIVITY BY IGFBP%REACTOME%R-HSA-381426.2,0.00025497195308516097,0.00819882332206558,-0.337991869505943,-2.0676719544399,1,85,APOL1|KLK1|CKAP4|C4A|MMP1|GAS6|PNPLA2|C3|VWA1|NUCB1|SERPINA1|EVA1A|FBN1|LTBP1|STC2|SPP1|VCAN|IGF1|MEN1|CSF1|SDC2|APOE|FN1|TNC|MFGE8|IGFBP6|IGFBP5|PRSS23|TIMP1|SPARCL1|LGALS1|IGFBP4|IGFBP7|TMEM132A|FAM20A|CST3|P4HB
FGFR1C LIGAND BINDING AND ACTIVATION%REACTOME DATABASE ID RELEASE 66%190373,0.8043744056514059,0.932964969466025,0.334992363611237,0.735992489387705,5920,4,FGF2|FGF1|ANOS1
ACYL CHAIN REMODELLING OF PC%REACTOME DATABASE ID RELEASE 66%1482788,0.0143251412800631,0.16029639509400304,-0.44632339995763703,-1.76338211493114,108,19,PLA2G2A|PLA2G2D|PLA2R1|TMEM86B|PLA2G4D|PLA2G4A|PLA2G4C|PLA2G16|PLBD1|PLA2G12A
SHC1 EVENTS IN EGFR SIGNALING%REACTOME%R-HSA-180336.2,0.125831410343423,0.48149121688942603,0.5361392992135929,1.38729194844241,926,6,SHC1|SOS1|NRAS|EGFR|KRAS
REGULATION OF TP53 DEGRADATION%REACTOME%R-HSA-6804757.1,0.979301423027167,0.993397701013899,-0.111947202320944,-0.53905710754209,7569,36,CDKN2A|SGK1|PHF20|USP2|PPP2CA|UBC|MAPKAP1
SYNTHESIS OF PS%REACTOME DATABASE ID RELEASE 66%1483101,0.8770230830459009,0.960725750963158,-0.416524183741064,-0.693162848970073,6610,2,PTDSS2
LOSS OF FUNCTION OF FBXW7 IN CANCER AND NOTCH1 SIGNALING%REACTOME%R-HSA-2644607.1,0.25690354665619697,0.63510667803751,-0.550935583471407,-1.2061131584475402,1962,4,NOTCH1|SKP1
RETINOID CYCLE DISEASE EVENTS%REACTOME%R-HSA-2453864.2,0.114754098360656,0.463748809895271,0.6972537774346529,1.37141589885481,853,3,STRA6|NAPEPLD|RBP1
LYSOSPHINGOLIPID AND LPA RECEPTORS%REACTOME DATABASE ID RELEASE 66%419408,0.666530054644809,0.880719592999549,0.285143970962308,0.827723062891055,4878,8,LPAR2|S1PR2|LPAR1|S1PR4|S1PR3
DEACTIVATION OF THE BETA-CATENIN TRANSACTIVATING COMPLEX%REACTOME DATABASE ID RELEASE 66%3769402,0.26651137297889804,0.641603173139009,0.23146034128304702,1.14691980460744,1944,38,TLE2|CBY1|TCF7L1|TLE3|RPS27A|HDAC1|SOX6|BTRC|BCL9|XPO1|SOX7
RELAXIN RECEPTORS%REACTOME%R-HSA-444821.1,0.171772575250836,0.545489092757257,-0.9116674018526691,-1.2145598835203002,1283,1,INSL3
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE%REACTOME%R-HSA-5693579.1,0.007779074290159471,0.10753693599276401,-0.35538653840930395,-1.77981318144881,59,41,RAD9A|RFC2|RAD51|RPA2|XRCC2|BRIP1|PALB2|RFC3|NBN|EXO1|RAD51C|RAD51AP1|RAD1|RAD17|RHNO1|BRCA1|RFC5|TOPBP1|RMI1|RAD51B|RMI2|KAT5|RFC4|XRCC3
SIGNALING BY FGFR IN DISEASE%REACTOME DATABASE ID RELEASE 66%1226099,0.703912923670433,0.8941859268931529,0.15832066792244,0.845974160512025,5108,49,FGFR2|GAB1|GAB2|FGFR1OP|ZMYM2|LRRFIP1|FGF2|MYO18A|SOS1|PLCG1|NRAS|FGF1|FGFR1|GTF2F2|POLR2B|KRAS
SIGNALING BY PDGF%REACTOME DATABASE ID RELEASE 66%186797,0.0053413236060448205,0.0829378624098312,-0.35499472771660606,-1.80052097252911,40,43,PDGFD|BCAR1|STAT3|PIK3CB|SPP1|COL4A1|HRAS|COL4A2|COL6A3|THBS1|THBS2|PDGFRB|PLAT|COL6A1|PDGFRA|NCK1|COL6A2|PDGFB
IMPORT OF PALMITOYL-COA INTO THE MITOCHONDRIAL MATRIX%REACTOME DATABASE ID RELEASE 66%200425,0.30374592833876196,0.676707700393746,0.34336719603789195,1.1298889162006498,2237,11,PRKAG2|PPARD|CPT1B|CPT1A
REGULATION OF RAS BY GAPS%REACTOME%R-HSA-5658442.1,0.00541237113402062,0.0834583597304613,-0.307245586351216,-1.75197535747287,41,65,PSMD4|SHFM1|PSME2|PSMB5|HRAS|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
TGFBR1 KD MUTANTS IN CANCER%REACTOME DATABASE ID RELEASE 66%3656532,0.545776031434185,0.817297924969912,-0.35841666919175996,-0.92194422563196,4166,6,TGFBR2|FKBP1A
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT (ESCRT)%REACTOME%R-HSA-917729.1,0.338260300850229,0.6998037279675999,-0.238865781312471,-1.09061439309044,2585,30,MVB12B|VPS25|CHMP4A|SNF8|CHMP6|UBC|VPS37C
CARNITINE SYNTHESIS%REACTOME%R-HSA-71262.2,0.657671957671958,0.8762433862433859,-0.4337434588817429,-0.846991043368303,4971,3,TMLHE
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%9013507,0.967180962343096,0.9912626134248801,-0.13020376788103,-0.5533623427920781,7396,24,NOTCH3|JAG2|NEURL1B|UBC
COOPERATION OF PDCL (PHLP1) AND TRIC CCT IN G-PROTEIN BETA FOLDING%REACTOME%R-HSA-6814122.2,0.7792711294908249,0.924704689181848,-0.15999305122647198,-0.7772376188067299,6029,37,CCT8|PDCL|CCT5|GNGT2|GNG11|GNAI2|GNG10|GNG3
METABOLISM OF WATER-SOLUBLE VITAMINS AND COFACTORS%REACTOME%R-HSA-196849.1,0.00840443142747994,0.11368006969928998,-0.260281122606767,-1.6487403349898402,65,98,PCCB|SLC2A3|PNPO|CYB5A|NMNAT3|MMAB|SHMT2|SLC25A19|FOLR2|GPHN|FASN|QPRT|PDXK|NNMT|MTHFD1|PTGIS|ABCC1
DEUBIQUITINATION%REACTOME DATABASE ID RELEASE 66%5688426,0.000127991808524254,0.00518555396908895,-0.26622222077041,-2.03209159794533,0,251,HGS|HIST2H2AC|HIST1H2AD|USP25|UCHL5|USP9X|PSMD3|PSMB2|RUVBL1|USP30|HIST1H2AI|GATA3|HCFC1|TOMM20|OGT|HIST1H2BN|PSMF1|BRCC3|VCP|TRAF2|TNFAIP3|HIST1H2BC|SIAH2|PSMD4|SHFM1|SMURF2|PSME2|IFIH1|BRCA1|ARRB1|PSMB5|TFPT|TOMM70A|RAD23B|TNIP1|FOXK2|PSMC4|HIST1H2AK|USP2|NEDD8|INO80E|TAF9B|PSMC6|IL33|USP44|PSMD10|USP47|USP11|NLRP3|NFKBIA|KAT2B|PSMB3|HIST2H2BF|PTRH2|TGFBR2|OTUD5|PSMC1|PSMD2|UBC|USP20|HIST2H2AA4|HIST3H2A|PSMD6|HIST1H2BG|HIST1H2BD|MYSM1|USP18|TRAF3|MYC|HIST1H2AE|TAF10|PSMD12|PSMA3|ACTB|HIST1H2AC|PSMA6|OTUB1|PSMD13|HIST3H2BB|PSMB7|HIST2H2BE|HIST1H2BK|PSMA1|PSMC5|HIST1H2BJ|PSMC3|HIST2H2AA3
BLOCH PATHWAY%REACTOME DATABASE ID RELEASE 66%6807047,0.00510404397330192,0.0803498785568947,-0.8275102116132141,-1.8115928339346599,38,4,EBP|DHCR7|DHCR24
SPERM:OOCYTE MEMBRANE BINDING%REACTOME DATABASE ID RELEASE 66%1300652,0.309753483386924,0.680809181688249,0.679735318444996,1.1420430991671,2311,2,IZUMO4|CD9
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL%REACTOME%R-HSA-6782315.5,0.25915763479215304,0.636098664976652,0.22786717791050198,1.15496180234522,1888,41,PUS7|TRMT6|QTRT1|TYW5|ALKBH8|METTL1|TRMT44|NSUN6|ADAT2|TPRKB|TRMT1|CTU1|KIAA1456|DUS2
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS%REACTOME DATABASE ID RELEASE 66%2022377,0.11855132881709199,0.469583486376433,-0.46376975507414897,-1.39513294131925,909,9,AGT|ATP6AP2|CTSZ|ANPEP|CTSD
TWIK-RELEATED ACID-SENSITIVE K+ CHANNEL (TASK)%REACTOME DATABASE ID RELEASE 66%1299316,0.0707395498392283,0.3767214120425879,0.835732009925558,1.4041376824025802,527,2,KCNK9|KCNK3
T41 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED%REACTOME%R-HSA-5358752.1,0.744946180099764,0.9112137767014771,-0.216311665379097,-0.785392593135168,5674,15,PPP2CB|PPP2R5C|AXIN1|PPP2R1B|PPP2R1A|CTNNB1|PPP2R5A|PPP2R5E|PPP2R5D|PPP2R5B|GSK3B|AMER1|APC|PPP2CA|CSNK1A1
ACTIVATION OF GENE EXPRESSION BY SREBF (SREBP)%REACTOME DATABASE ID RELEASE 66%2426168,0.463856200698306,0.77767994935864,-0.19956940134713103,-0.9935015888863579,3586,40,SREBF2|IDI1|GPAM|FDPS|MED1|CYP51A1|SMARCD3|HMGCS1|NFYB|PPARA|DHCR7|FASN|TM7SF2
G1 S-SPECIFIC TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%69205,0.0286649214659686,0.238792268557792,-0.360965515249323,-1.61211236271921,218,28,LIN54|TYMS|RRM2|TFDP2|CDT1|CDC6|LIN52|PCNA|ORC1|LIN9|CDC45|E2F1|DHFR|TK1|POLA1
MAPK TARGETS  NUCLEAR EVENTS MEDIATED BY MAP KINASES%REACTOME%R-HSA-450282.1,0.6073184052430369,0.8492159043277758,0.192426165182367,0.897641500335264,4447,31,DUSP4|DUSP6|MAPK7|RPS6KA2|MAPK11|VRK3
PI-3K CASCADE:FGFR3%REACTOME DATABASE ID RELEASE 66%5654710,0.5086065573770491,0.7990325304927759,0.325103004933651,0.9437171478345479,3722,8,GAB1|FGF2|FGF1
PRC2 METHYLATES HISTONES AND DNA%REACTOME%R-HSA-212300.1,0.00012923235978289,0.00518555396908895,-0.51465606370046,-2.6979943352216695,0,48,EZH2|H2AFX|HIST2H2AC|HIST1H2AD|HIST1H2BN|H2AFV|HIST1H2BC|HIST1H4I|RBBP7|DNMT1|HIST2H3A|PHF19|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|HIST1H2AE|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|HIST1H2AC|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3
AUTOINTEGRATION RESULTS IN VIRAL DNA CIRCLES%REACTOME%R-HSA-177539.2,0.25978835978836,0.636098664976652,-0.60878595515909,-1.1888046742596599,1963,3,PSIP1|BANF1
SHC1 EVENTS IN ERBB4 SIGNALING%REACTOME%R-HSA-1250347.2,0.954174598857765,0.9870180073166591,0.18207848738572896,0.576836955650803,7016,10,SHC1|SOS1|NRAS|KRAS
SYNTHESIS OF LIPOXINS (LX)%REACTOME%R-HSA-2142700.4,0.47899489595602707,0.7850984235874658,-0.44538089492687705,-0.975031880329306,3659,4,ALOX5AP|ALOX5|LTC4S
RUNX3 REGULATES CDKN1A TRANSCRIPTION%REACTOME DATABASE ID RELEASE 66%8941855,0.472274817419529,0.7831522581932591,0.3532371953185429,0.9751017962362741,3491,7,SMAD3|CDKN1A
GTP HYDROLYSIS AND JOINING OF THE 60S RIBOSOMAL SUBUNIT%REACTOME DATABASE ID RELEASE 66%72706,0.3794779938587511,0.728914030571579,-0.160366250591886,-1.04365868568618,2965,110,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL22L1|EIF1AX|EIF3B|RPL35|RPL38|RPS15A|RPL36AL|EIF5|RPS13|EIF2S1|EIF4A2|RPL26L1|FAU|EIF4G1
PROSTANOID LIGAND RECEPTORS%REACTOME DATABASE ID RELEASE 66%391908,0.162592008412198,0.533733647435958,-0.48291143383797297,-1.32001686926812,1236,7,PTGER2|PTGFR|PTGER1|PTGER4|TBXA2R|PTGIR
DEFECTIVE HLCS CAUSES MULTIPLE CARBOXYLASE DEFICIENCY%REACTOME%R-HSA-3371599.2,0.51879502292076,0.8047799431921201,-0.36573590889096297,-0.940771281839791,3960,6,MCCC2|PCCB
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION%REACTOME%R-HSA-975163.1,0.0169335783670255,0.17671843887293,-0.47433561346023706,-1.7222357232514598,128,15,UBC|TICAM1|TLR4|CD14|LY96
AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1%REACTOME%R-HSA-349425.2,0.00025763235862424303,0.00819882332206558,-0.41627160516815603,-2.20952470821819,1,50,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
DEADENYLATION OF MRNA%REACTOME DATABASE ID RELEASE 66%429947,0.5102253484434021,0.800685168996958,-0.22185663490889804,-0.956455039788255,3916,25,EIF4A3|TNKS1BP1|EIF4A2|EIF4G1
SYNTHESIS OF IPS IN THE NUCLEUS%REACTOME DATABASE ID RELEASE 66%1855191,0.44038738385028103,0.7653693162885199,-0.46180995974190703,-1.01099853750099,3364,4,IPMK|IP6K1|IP6K2|IPPK
NEGATIVE REGULATION OF FGFR4 SIGNALING%REACTOME%R-HSA-5654733.1,0.610819327731092,0.8515562847300799,-0.22071680847852598,-0.885511608131077,4651,20,MAPK3|PPP2CA|FGF19|FGF9|UBC
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2+%REACTOME DATABASE ID RELEASE 66%76005,0.000128369704749679,0.00518555396908895,-0.425848859991585,-2.74468363831096,0,106,STX4|PPIA|STXBP2|HGF|BRPF3|RAB27B|TUBA4A|TLN1|PLEK|VEGFC|GAS6|TGFB3|CLEC3B|VWF|SERPINA1|CD63|F8|TIMP3|PHACTR2|SOD1|SRGN|FLNA|ITIH3|SPARC|IGF1|MMRN1|LGALS3BP|FN1|VEGFB|CD36|ECM1|TOR4A|A2M|THBS1|F13A1|CYB5R1|VCL|SEPP1|RARRES2|SERPINE1|LAMP2|CFL1|FERMT3|CFD|HSPA5|TIMP1|TMSB4X|ACTN1|SERPING1|CHID1|LHFPL2|PDGFB|SERPINF2|PRKCB|ALDOA
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES%REACTOME%R-HSA-6796648.3,0.53345365476344,0.812141765487046,-0.169569387728392,-0.9509154734097099,4137,61,BRCA1|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|POLR2L|GTF2H2
INHIBITION OF VOLTAGE GATED CA2+ CHANNELS VIA GBETA GAMMA SUBUNITS%REACTOME DATABASE ID RELEASE 66%997272,0.294779536831087,0.667556940989968,-0.298600107255404,-1.1347533245856398,2252,17,GNGT2|KCNJ12|GNG10|KCNJ9|GNG3
REGULATION OF COMPLEMENT CASCADE%REACTOME DATABASE ID RELEASE 66%977606,0.000129988301052905,0.00518555396908895,-0.5836807589867621,-2.76535321738761,0,34,C4A|C2|IGKV2-28|VTN|C3|C1QB|C1QA|CFB|C1QC|C7|IGKV2D-28|CD59|C3AR1|C1S|CFI|CD55|IGHG2|SERPING1|CD81|C1R|CFH|C5AR1
LDL REMODELING%REACTOME DATABASE ID RELEASE 66%8964041,0.26301003344481605,0.638901217604674,-0.865019850022056,-1.15241414374419,1965,1,CETP
SIGNALING BY ROBO RECEPTORS%REACTOME%R-HSA-376176.4,0.0104658583280153,0.13160598312092803,-0.20347483670169,-1.5005252145235801,81,205,MAGOH|CXCR4|PSMD4|SHFM1|RPS14|RPS4X|RPL35A|NCBP1|PSME2|RPS29|AKAP5|PSMB5|RPL10|RPL36A|RPL24|RPL22L1|ABL1|NTN1|PSMC4|PSMC6|MSI1|PSMD10|RPL35|PSMB3|RPL38|RPS15A|RPL36AL|PSMC1|MAGOHB|EIF4A3|PSMD2|UBC|SLIT2|RPS13|PSMD6|RBM8A|PRKACA|RPL26L1|PSMD12|PSMA3|FAU|EVL|PSMA6|NCK1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|EIF4G1
FBXW7 MUTANTS AND NOTCH1 IN CANCER%REACTOME%R-HSA-2644605.1,0.25690354665619697,0.63510667803751,-0.550935583471407,-1.2061131584475402,1962,4,NOTCH1|SKP1
ENZYMATIC DEGRADATION OF DOPAMINE BY COMT%REACTOME DATABASE ID RELEASE 66%379397,0.559391534391534,0.8268422944617521,-0.475520152233054,-0.9285703372240101,4228,3,MAOA|COMT
UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A%REACTOME DATABASE ID RELEASE 66%69601,0.000256574727389352,0.00819882332206558,-0.407376332236664,-2.17528316927375,1,51,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
DISINHIBITION OF SNARE FORMATION%REACTOME%R-HSA-114516.4,0.766391833529643,0.919992400339549,-0.34630043541987104,-0.7581240429312309,5855,4,PRKCB
RNA POLYMERASE II TRANSCRIPTION TERMINATION%REACTOME%R-HSA-73856.3,0.00193348801237432,0.0383938788644259,-0.326124658128055,-1.85197055724912,14,64,CPSF1|SNRPE|LSM11|SRSF3|FYTTD1|NCBP2|SLU7|CHTOP|SRSF9|LSM10|MAGOH|CPSF2|SRSF5|SNRPF|SRSF1|U2AF1|PAPOLA|NCBP1|CLP1|CSTF3|THOC7|MAGOHB|EIF4A3|SNRPB|PABPN1|SRSF2|RBM8A|DDX39A|THOC3|CPSF7
LDL CLEARANCE%REACTOME%R-HSA-8964038.1,0.0837490154896298,0.40248620009395203,-0.398040703376466,-1.44522127204887,637,15,AP2A2|CLTA|LSR|CLTC|LDLR|NPC2|AP2M1
CDO IN MYOGENESIS%REACTOME DATABASE ID RELEASE 66%375170,0.21955870335058603,0.601964339800201,0.28469034603627896,1.2086371485391498,1611,23,CTNNA2|MAP2K6|TCF3|MAPK12|MAPK11|CDH4|TCF12|BNIP2
REVERSAL OF ALKYLATION DAMAGE BY DNA DIOXYGENASES%REACTOME%R-HSA-73943.2,0.6653522607781279,0.8804055751124069,-0.302423986486312,-0.826662480655172,5061,7,ALKBH3
PURINE CATABOLISM%REACTOME%R-HSA-74259.3,0.7781699346405229,0.924704689181848,-0.22353135122297196,-0.748180362141513,5952,12,NUDT5|NT5C|DNPH1|GPX1|NUDT16|PNP
HIV TRANSCRIPTION ELONGATION%REACTOME DATABASE ID RELEASE 66%167169,0.0820160663384296,0.398202308598866,-0.278479315614888,-1.4032904419739398,632,42,SUPT16H|NCBP1|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|POLR2L|GTF2H2
VIF-MEDIATED DEGRADATION OF APOBEC3G%REACTOME DATABASE ID RELEASE 66%180585,0.000256574727389352,0.00819882332206558,-0.4096123194877829,-2.18722275694534,1,51,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
GLI3 IS PROCESSED TO GLI3R BY THE PROTEASOME%REACTOME DATABASE ID RELEASE 66%5610785,0.000129416332341141,0.00518555396908895,-0.41876999047536,-2.2931221083295297,0,56,PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|SKP1|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PRKACA|PSMD12|PSMA3|CSNK1A1|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
DOWNSTREAM TCR SIGNALING%REACTOME DATABASE ID RELEASE 66%202424,0.000384418247052793,0.0111294649577428,-0.31276271138375605,-1.9475784436721,2,92,PRKCQ|MALT1|PSMD7|PSME3|PSMA2|TRAF6|HLA-DRB1|UBE2N|PSME1|PSMB1|RIPK2|HLA-DQB2|PTEN|PSMB9|UBE2D2|PSMB4|HLA-DPA1|HLA-DRA|FBXW11|HLA-DRB5|PSMD1|PSMC2|HLA-DPB1|CD4|HLA-DQA2|PSMD3|PSMB2|PSMF1|PSMD4|SHFM1|PSME2|PSMB5|PIK3CB|SKP1|PSMC4|PSMC6|PSMD10|NFKBIA|PSMB3|PSMC1|PSMD2|UBC|PSMD6|RELA|NFKB1|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS (SPMS)%REACTOME DATABASE ID RELEASE 66%9018678,0.267643865363735,0.6417330323279019,0.35497648799809,1.1680906153207902,1971,11,GSTM4|CYP2E1|CYP2C8|PTGR1|CYP2D6|LTA4H
FATTY ACYL-COA BIOSYNTHESIS%REACTOME%R-HSA-75105.6,0.9681503720140969,0.9912626134248801,-0.123095204286782,-0.5565774533388521,7416,29,PPT1|SCD5|ACSL5|ACSL4|ELOVL2|ACSF3|ELOVL1|HACD2|FASN
DNA REPLICATION INITIATION%REACTOME%R-HSA-68952.2,0.0072897682895079405,0.103163519143488,-0.640048159050439,-1.8426090684839698,55,8,POLE2|POLA1|POLE3|POLA2
BIOTIN TRANSPORT AND METABOLISM%REACTOME DATABASE ID RELEASE 66%196780,0.646444082519001,0.8697778704754799,0.257482358420079,0.847275063701615,4762,11,ACACB|SLC5A6|PCCA|BTD
HEDGEHOG 'ON' STATE%REACTOME DATABASE ID RELEASE 66%5632684,0.00038555455596967,0.0111294649577428,-0.341804223747367,-2.0213360243271596,2,75,NUMB|PSMD3|PSMB2|SMO|PSMF1|PSMD4|SHFM1|SMURF2|PSME2|ARRB1|PSMB5|BOC|PSMC4|PSMC6|PSMD10|GAS1|PSMB3|PSMC1|PSMD2|UBC|PSMD6|SPOP|PSMD12|PSMA3|ADRBK1|CSNK1A1|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
PDE3B SIGNALLING%REACTOME DATABASE ID RELEASE 66%165160,0.72414255091104,0.9034590034658789,0.485084091535704,0.815003905522269,5404,2,PDE3B|AKT2
DNA DOUBLE STRAND BREAK RESPONSE%REACTOME%R-HSA-5693606.1,0.0986206007477117,0.433390687254715,-0.239626870668637,-1.34378558663275,764,61,HIST1H2BN|BRCC3|HIST1H2BC|RNF168|HIST1H4I|BRCA1|ABL1|KPNA2|UBC|HIST1H2BG|HIST1H2BD|HIST2H4A|APBB1|KAT5|HIST2H4B|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ
TOXICITY OF BOTULINUM TOXIN TYPE C (BONT C)%REACTOME DATABASE ID RELEASE 66%5250971,0.8966675624832041,0.967092901483838,0.33210447802209303,0.6532103173626179,6672,3,SNAP25|STX1A
TRIF-MEDIATED PROGRAMMED CELL DEATH%REACTOME DATABASE ID RELEASE 66%2562578,0.028921313183949998,0.2403240680579,-0.55889070237479,-1.68128003378628,221,9,FADD|TICAM1|TLR4|CD14|LY96
TRANSPORT OF GAMMA-CARBOXYLATED PROTEIN PRECURSORS FROM THE ENDOPLASMIC RETICULUM TO THE GOLGI APPARATUS%REACTOME DATABASE ID RELEASE 66%159763,0.664368748310354,0.8804055751124069,0.342913234637796,0.824704362864169,4914,5,PROC
DNA DAMAGE REVERSAL%REACTOME%R-HSA-73942.1,0.742896174863388,0.910329526593605,0.265311395615876,0.770152566291157,5437,8,MGMT|ASCC1|FTO|ASCC3|ALKBH5
RNA POLYMERASE II TRANSCRIPTION PRE-INITIATION AND PROMOTER OPENING%REACTOME DATABASE ID RELEASE 66%73779,0.0299702880764759,0.244735657013286,-0.305821259293732,-1.5842503492941102,231,46,GTF2A2|POLR2J|TAF3|GTF2A1|TAF12|POLR2H|GTF2H1|TAF7|TAF9B|CDK7|MNAT1|TAF10|POLR2G|TAF9|AK6|POLR2L|GTF2H2
APC:CDC20 MEDIATED DEGRADATION OF CELL CYCLE PROTEINS PRIOR TO SATISFATION OF THE CELL CYCLE CHECKPOINT%REACTOME DATABASE ID RELEASE 66%179419,0.000257599175682638,0.00819882332206558,-0.359698851309394,-2.09645371542491,1,71,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|MAD2L1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
REGULATION OF ACTIN DYNAMICS FOR PHAGOCYTIC CUP FORMATION%REACTOME%R-HSA-2029482.2,0.0721649484536082,0.378321151505122,-0.24442734934750798,-1.39377329332806,559,65,CDC42|SYK|RAC1|WIPF3|IGKV3-11|ACTG1|NCKAP1L|VAV3|WASF2|IGHG4|NCKIPSD|FCGR1A|ARPC1A|VAV1|WAS|IGKV2-28|MYO10|ELMO1|MAPK3|ABL1|FCGR2A|DOCK1|CYFIP2|IGKV2D-28|MYH9|CFL1|WASF3|HSP90AA1|ACTB|NF2|NCK1|IGHG2
CDC20:PHOSPHO-APC C MEDIATED DEGRADATION OF CYCLIN A%REACTOME DATABASE ID RELEASE 66%174184,0.000129165590286748,0.00518555396908895,-0.367719669538056,-2.13520197317041,0,70,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|MAD2L1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
IRON UPTAKE AND TRANSPORT%REACTOME DATABASE ID RELEASE 66%917937,0.000901713255184851,0.021472448318834,-0.383555280893664,-2.0358699934860502,6,50,TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|ATP6V1F|ATP6V0D1|ACO1|HMOX1|SKP1|NEDD8|CYBRD1|HFE|FTL|ATP6V0E1|UBC|SLC22A17|ATP6AP1|HEPH|ATP6V0E2|TFRC|ATP6V1A|ATP6V1G1|FTH1
P53-DEPENDENT G1 S DNA DAMAGE CHECKPOINT%REACTOME%R-HSA-69580.2,0.000386697602474865,0.0111294649577428,-0.36180371786470705,-2.05458194064432,2,64,PSMD3|PSMB2|CDKN2A|PSMF1|PSMD4|SHFM1|PHF20|PSME2|PSMB5|PSMC4|PSMC6|PSMD10|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ZNF385A|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
AMINO ACID CONJUGATION%REACTOME DATABASE ID RELEASE 66%156587,0.38339081984611295,0.730480369014206,-0.646931342256401,-1.07659720561448,2889,2,GLYATL1
RUNX1 REGULATES ESTROGEN RECEPTOR MEDIATED TRANSCRIPTION%REACTOME%R-HSA-8931987.1,0.9735063530683971,0.9920058127185359,0.224409883079638,0.539704481925578,7201,5,CBFB|AXIN1|KCTD6
G BETA:GAMMA SIGNALLING THROUGH PI3KGAMMA%REACTOME%R-HSA-392451.3,0.9418414600926178,0.98186053258176,0.14209773909896803,0.6032681072246489,6914,23,GNG5|GNGT1|GNB5|GNB4|AKT3|GNG4|PDPK1|GNG12|GNB1
RHO GTPASES ACTIVATE KTN1%REACTOME DATABASE ID RELEASE 66%5625970,0.74163179916318,0.909955740610127,-0.24686691176238199,-0.7734018084350179,5671,10,RHOA|KLC1|CDC42|RAC1|KLC2|RHOG
REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE%REACTOME DATABASE ID RELEASE 66%176408,0.000256772371292849,0.00819882332206558,-0.36089914480690005,-2.15450214992244,1,78,PSMD1|PSMC2|CDC20|ANAPC10|ANAPC2|ANAPC5|PSMD3|PSMB2|CDC23|PSMF1|MAD2L1|PSMD4|SHFM1|PSME2|PSMB5|CDC27|SKP1|PSMC4|PSMC6|PSMD10|CCNB1|PLK1|PSMB3|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|ANAPC11|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING%REACTOME DATABASE ID RELEASE 66%451326,0.739029708367403,0.9089185613230608,0.18135526394093698,0.801947480468947,5422,26,GNG5|GRIK3|GNGT1|GNB5|GNB4
INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX%REACTOME DATABASE ID RELEASE 66%141430,0.358849789915966,0.7151517895064159,-0.26705157807630303,-1.07140581628742,2732,20,CDC20|ANAPC10|ANAPC2|ANAPC5|CDC23|MAD2L1|CDC27|ANAPC11
SYNTHESIS OF PE%REACTOME DATABASE ID RELEASE 66%1483213,0.738276133088813,0.9089185613230608,-0.24070427733113398,-0.7792930482312129,5635,11,ETNK2|LPIN3|LPIN2
DEGRADATION OF GABA%REACTOME%R-HSA-916853.1,0.8278403001071809,0.943061234519578,0.43358147229115,0.7284728554190741,6178,2,ABAT|ALDH5A1
P75NTR REGULATES AXONOGENESIS%REACTOME DATABASE ID RELEASE 66%193697,0.328356254092993,0.6950398637731511,-0.430926822160604,-1.10845987229556,2506,6,ARHGDIA|NGFR
APOBEC3G MEDIATED RESISTANCE TO HIV-1 INFECTION%REACTOME DATABASE ID RELEASE 66%180689,0.10849365266326401,0.45309795582492896,-0.6378200132601101,-1.39632133736399,828,4,PSIP1|PPIA|BANF1
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION%REACTOME%R-HSA-162658.1,0.5985064494229461,0.84557799939374,0.251627981704179,0.8812536531268,4407,13,RAB1A|USO1|GORASP2|BLZF1|MAPK1|RAB2A|GORASP1
SYNTHESIS OF UDP-N-ACETYL-GLUCOSAMINE%REACTOME DATABASE ID RELEASE 66%446210,0.15048164540484302,0.517264655410678,-0.464531002766923,-1.33731974100223,1155,8,GNPNAT1|GFPT2|RENBP
UPTAKE AND ACTIONS OF BACTERIAL TOXINS%REACTOME%R-HSA-5339562.2,0.8352141400407891,0.945788393670804,0.17192326411669798,0.7194906971503829,6142,22,SYT2|SV2C|SNAP25|MAP2K7|PDCD6IP|MAP2K1|MAP2K4|STX1A|CD9|VAMP1
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER'S DISEASE MODELS%REACTOME DATABASE ID RELEASE 66%8862803,0.7616859243697479,0.9184699428006701,-0.193196066608409,-0.7750989188648741,5800,20,PRDX1|CDC25A|GOLGA2|APP|PRDX2|BCL2L11|SOD2|CDC25C|LMNB1|CAPN1|CAST
"BIOSYNTHESIS OF THE N-GLYCAN PRECURSOR (DOLICHOL LIPID-LINKED OLIGOSACCHARIDE, LLO) AND TRANSFER TO A NASCENT PROTEIN%REACTOME DATABASE ID RELEASE 66%446193",0.443670150987224,0.7664039155808309,-0.17109998477249302,-1.0029481336086,3437,73,GNE|NEU4|RFT1|NPL|GNPNAT1|GMPPB|GFPT2|SRD5A3|DOLK|FUOM|ALG6|NANS|DOLPP1|ST3GAL5|RENBP
NEF AND SIGNAL TRANSDUCTION%REACTOME%R-HSA-164944.2,0.0755783385909569,0.385018945189654,-0.5446057460324679,-1.48865552043319,574,7,FYN|PAK2|RAC1|DOCK2|ELMO1|HCK
VITAMINS%REACTOME%R-HSA-211916.1,0.199811878527278,0.5778211722863521,0.641043319368502,1.26085656110915,1486,3,CYP27B1|CYP26B1|CYP2R1
EXTENSION OF TELOMERES%REACTOME%R-HSA-180786.1,0.0013080444735121,0.0284733155294161,-0.445924055596954,-2.0360019362635704,9,30,NHP2|DNA2|POLE4|PRIM2|POLE|RFC2|RPA2|RFC3|TERT|RUVBL1|POLD4|PCNA|POLD1|POLD2|RFC5|DKC1|POLE2|POLA1|POLE3|RFC4|POLA2|FEN1
ESTROGEN-DEPENDENT GENE EXPRESSION%REACTOME%R-HSA-9018519.1,0.000128221566867547,0.00518555396908895,-0.334686352418121,-2.20695983486036,0,117,HIST1H2BE|KANK1|RUNX1|KDM1A|H2AFX|YY1|GTF2A2|GPAM|HIST2H2AC|POLR2J|HIST1H2AD|MED1|STAG2|GATA3|HIST1H2BN|H2AFV|GTF2A1|HIST1H2BC|HIST1H4I|DDX5|POLR2H|USF2|TNRC6C|HIST2H3A|KPNA2|KAT2B|H2AFZ|HIST2H2AA4|HIST1H2BG|HIST1H2BD|HIST2H4A|MYC|HIST1H2AE|FKBP4|POLR2G|HIST2H3C|SMC1A|CTSD|HIST1H3H|CXXC5|KAT5|HSP90AA1|HIST2H4B|H3F3B|HIST1H2AC|CCND1|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|HIST1H2BJ|HIST2H2AA3|POLR2L
MICRORNAS IN CARDIOMYOCYTE HYPERTROPHY%WIKIPATHWAYS_20181110%WP1544%HOMO SAPIENS,0.508308643565632,0.798966294578331,-0.16257146499947303,-0.9669508040071109,3945,77,MAP2K2|NFATC4|MAPK14|GSK3B|LIF|CTF1|NRG1|AKT1|ROCK1|RAF1|TNF|PRKG1|RAC1|EIF2B5|TGFB1|MAPK4|AGT|CALM3|PLA2G2A|FZD2|IL6ST|IKBKE|MYLK|STAT3|CISH|PIK3CB|MAPK3|PIK3R3|IGF1|LRP5|HDAC5|MAP2K3|CDK7|NFKB1|PRKCB|RCAN1
MELATONIN METABOLISM AND EFFECTS%WIKIPATHWAYS_20181110%WP3298%HOMO SAPIENS,0.18953139276856798,0.563467720122429,-0.274728309699779,-1.2421896032322501,1451,29,PER3|SULT1A1|CLOCK|TRAF6|GSK3B|ARNTL|ECE1|CSNK1D|MAOA|PER2|ACHE|CALM3|CYP1B1|IRAK1|CRY2|APOE|CAMK2A|NFKB1
EXRNA MECHANISM OF ACTION AND BIOGENESIS%WIKIPATHWAYS_20181110%WP2805%HOMO SAPIENS,0.411565087552599,0.746051818625066,0.396282609894656,1.02540454471624,3031,6,AGO2|XPO5|DGCR8|ERI1|DROSHA
ESC PLURIPOTENCY PATHWAYS%WIKIPATHWAYS_20181110%WP3931%HOMO SAPIENS,0.6267488127326399,0.8590240079173431,-0.145850752820934,-0.902754036532495,4882,90,SMAD6|ELK1|FZD2|IL6ST|FZD8|SMAD5|GRB2|STAT3|FGF10|HRAS|LRP5|MAP2K3|FGF19|FGF9|FGF7|ARAF|SEPP1|PDGFRB|ERAS|WNT3|PDGFA|PDGFRA|PDGFB
SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20181110%WP1422%HOMO SAPIENS,0.41781090623774,0.75036705317022,-0.247304773091422,-1.02415341202273,3194,22,B4GALT6|GBA|SPTLC1|SPTLC2|CERS6|GAL3ST1|CERS4|PPP2CA|PPAP2A|PPP1CA|SPHK1
CATALYTIC CYCLE OF MAMMALIAN FLAVIN-CONTAINING MONOOXYGENASES (FMOS)%WIKIPATHWAYS_20181110%WP688%HOMO SAPIENS,0.7522486772486771,0.915314007578303,-0.39637957486748904,-0.7740288477259409,5686,3,FMO3|FMO2
PPAR ALPHA PATHWAY%WIKIPATHWAYS_20181110%WP2878%HOMO SAPIENS,0.38775510204081604,0.734887192861895,-0.283014159775115,-1.05179020288271,2963,16,NR1H3|MYC|PPARA|CCND1
NANOPARTICLE TRIGGERED REGULATED NECROSIS%WIKIPATHWAYS_20181110%WP2513%HOMO SAPIENS,0.175530521351847,0.548366806412612,-0.3997865380707721,-1.29433042631967,1339,11,RIPK3|PARP1|PLA2G4A|FTL|FADD|TICAM1|TNFRSF1A
COPPER HOMEOSTASIS%WIKIPATHWAYS_20181110%WP3286%HOMO SAPIENS,0.0766934855956398,0.386878103852997,-0.269122450044834,-1.40159069659994,590,47,SOD3|SOD1|MT1L|CCS|STEAP4|MT2A|XIAP|COX17|STEAP1|ATOX1|MT1E|CCND1|PRNP
"NAD METABOLISM, SIRTUINS AND AGING%WIKIPATHWAYS_20181110%WP3630%HOMO SAPIENS",0.49267782426778206,0.7914674020466339,-0.306331705894863,-0.959697245891392,3767,10,HIF1A|NAMPT|SIRT3|TFAM|PARP1|PPARG|NFKB1
T-CELL ANTIGEN RECEPTOR (TCR) PATHWAY DURING STAPHYLOCOCCUS AUREUS INFECTION%WIKIPATHWAYS_20181110%WP3863%HOMO SAPIENS,0.701442555383823,0.8931369333627571,-0.15688595003709999,-0.84680263652137,5445,53,CALM1|MAP3K14|CHUK|PDK1|PRKCQ|MALT1|FYN|MAP2K2|GSK3B|GRAP2|CDK4|LCP2|AKT1|RAF1|TNF|NFATC2|CD4|CALM3|GRB2|MAPK9|PTPN6|AHSA1|MAPK3|NFKBIA|NFKB1|RRAS|NCK1
ESTROGEN RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2881%HOMO SAPIENS,0.11390262952356199,0.46290587669685995,-0.487887412345596,-1.40455957520585,874,8,GPAM|CYP1B1|STAT3|ACOX1|PPARA
IL1 AND MEGAKARYOCYTES IN OBESITY%WIKIPATHWAYS_20181110%WP2865%HOMO SAPIENS,0.000131302521008403,0.00518555396908895,-0.6053866533174921,-2.42879965787662,0,20,TLR1|IL18|TLR2|SELENBP1|ICAM1|PLA2G7|IRAK1|HBEGF|CCL2|F2R|NLRP3|MMP9|IL1R1|NFKB1|S100A9|TIMP1
PHOTODYNAMIC THERAPY-INDUCED HIF-1 SURVIVAL SIGNALING%WIKIPATHWAYS_20181110%WP3614%HOMO SAPIENS,0.228753910323253,0.610365144973336,-0.256434097862214,-1.19283033626176,1754,32,BAK1|PTGS2|IGFBP3|MCL1|SLC16A1|BNIP3L|BCL2A1|ANGPT2|SLC2A1|TGFB3|HK1|PDHA1|LDHA|SERPINE1|SLC2A3|BIRC5|PGK1
ATR SIGNALING%WIKIPATHWAYS_20181110%WP3875%HOMO SAPIENS,0.5792762301483989,0.8384367809375659,-0.311543232407877,-0.8968893623742551,4449,8,ATRIP|RAD9A|RAD1|TOPBP1
TRANSLATION FACTORS%WIKIPATHWAYS_20181110%WP107%HOMO SAPIENS,0.254778704297627,0.6334469481869079,-0.21586831290821698,-1.15268038589922,1985,51,GSPT2|EIF2B5|EIF4EBP3|EIF3J|EIF2S3|EEF1D|EIF4EBP1|ETF1|EIF3C|EIF2B1|EIF1AX|EIF3B|EEF1G|EIF5|EIF2S1|EIF2B2|EIF4A2|EIF2B3|EIF4G1
G1 TO S CELL CYCLE CONTROL%WIKIPATHWAYS_20181110%WP45%HOMO SAPIENS,0.006321764933556961,0.0933108280433483,-0.30798579753834604,-1.7416631538597,48,63,CDKN1B|CDK4|PRIM2|CCNH|POLE|CCND2|RPA2|CDK6|TFDP2|MCM4|MCM6|CDKN1C|CDKN2A|E2F2|PCNA|ORC1|CREB3|ORC6|MCM3|MCM5|CDC45|CDKN2B|CREB3L1|E2F1|CCNB1|CDK7|MCM2|MNAT1|MYC|CCND3|CDKN2C|POLE2|CCND1|POLA2
SELENIUM METABOLISM AND SELENOPROTEINS%WIKIPATHWAYS_20181110%WP28%HOMO SAPIENS,0.31772315653298805,0.6867397844771489,-0.22938637062143102,-1.10455956819952,2455,36,GPX4|SECISBP2|TXNRD3|SARS|GPX1|SEPN1|SELENBP1|SEPHS2|CREM|SEPP1|GPX3|RELA|NFKB1|C11orf31|EEFSEC
CELL DIFFERENTIATION - INDEX EXPANDED%WIKIPATHWAYS_20181110%WP2023%HOMO SAPIENS,0.15948670944088,0.5293397224673839,-0.37948986419032105,-1.30627770394052,1217,13,ID2|MEF2D|EZH2|KLF4|MEF2C|STAT3|HDAC5|SRF
BENZO(A)PYRENE METABOLISM%WIKIPATHWAYS_20181110%WP696%HOMO SAPIENS,0.527623184471291,0.810052447666581,0.35764882339937104,0.925437351448808,3886,6,AKR1A1|AKR1C2|AKR1C1|AKR1C3|EPHX1
APOPTOSIS MODULATION BY HSP70%WIKIPATHWAYS_20181110%WP384%HOMO SAPIENS,0.24830020920502105,0.629058977115332,-0.305776413272498,-1.1865262047920502,1898,18,CYCS|HSPA1A|FADD|NFKB1|TNFRSF1A|CASP6
BMP SIGNALING PATHWAY IN EYELID DEVELOPMENT%WIKIPATHWAYS_20181110%WP3927%HOMO SAPIENS,0.39195433541723296,0.7372124643776031,0.278361365615161,1.04812286165468,2883,16,FOXC1|SFRP1|FGFR2|SMAD1
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) MEDIATED LDL RECEPTOR DEGRADATION%WIKIPATHWAYS_20181110%WP2846%HOMO SAPIENS,0.10046822742474901,0.436743648703065,-0.9474525805028671,-1.26223433401049,750,1,LDLR
TNF RELATED WEAK INDUCER OF APOPTOSIS (TWEAK) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2036%HOMO SAPIENS,0.0864773758589395,0.406514851433408,-0.277615469064231,-1.3903274823694798,666,41,TRAF2|TNFSF12|MAPK9|MAPK3|CCL2|NFKBIA|FADD|RELB|MMP9|TRAF3|RELA|TNFRSF12A|NFKB1
NAD+ METABOLISM%WIKIPATHWAYS_20181110%WP3644%HOMO SAPIENS,0.7450774481491209,0.9112137767014771,-0.216267048512603,-0.7852305965252661,5675,15,NMNAT1|NAMPT|SIRT2|SIRT3|SIRT6|CD38|NADK|PARP1|SIRT4|NMNAT3
MESODERMAL COMMITMENT PATHWAY%WIKIPATHWAYS_20181110%WP2857%HOMO SAPIENS,0.342167337310948,0.701955655133333,0.16002378323389002,1.06626203434227,2465,119,DKK1|FOXC1|EPB41L5|ACVR1|WDFY2|TCF7L1|DLL1|RARG|TBX3|HES7|SMAD3|DDAH1|C2orf44|CCDC88A|TOX3|BMP7|SMAD1|HTT|ACVR2A|NFE2L2|TRERF1|SESN1|C1QBP|CRTC1|BCORL1|LEFTY1|CEP250|ARL4A|KLF5|TRIM5|CTBP2|BMPR1A|ATP8B2|RARB|FGFR1|UBR5|TOX|BMPR2|LATS1|CCDC6|ACVR2B
NICOTINE ACTIVITY ON CHROMAFFIN CELLS%WIKIPATHWAYS_20181110%WP1603%HOMO SAPIENS,0.39423991305529105,0.7376723208557521,0.473764926007635,1.04088171896837,2901,4,CACNA1C|CHRNB4|CHRNA3
EUKARYOTIC TRANSCRIPTION INITIATION%WIKIPATHWAYS_20181110%WP405%HOMO SAPIENS,0.17452707955428898,0.54811765844537,-0.24672191889221298,-1.24326113716003,1346,42,GTF2A2|POLR2J|GTF2H2C|POLR3B|TAF12|ILK|POLR2H|GTF2H1|TAF7|POLR3K|CDK7|MNAT1|POLR2G|AK6|GTF2H2
ADIPOGENESIS%WIKIPATHWAYS_20181110%WP236%HOMO SAPIENS,0.0007676560900716481,0.0191058847417112,-0.29383806449790506,-1.9122891946815401,5,110,TGFB1|STAT5A|NDN|STAT6|MBNL1|ID3|NR2F1|CISD1|GTF3A|NR3C1|MEF2D|AGT|SOCS3|LIPE|RXRG|SFRP4|RORA|AHR|GATA3|CELF1|INS|IL6ST|FOXC2|CEBPD|MEF2C|IRS1|CEBPA|SOCS1|STAT3|OSM|KLF6|IGF1|CEBPB|KLF15|E2F1|NR1H3|LMNA|BSCL2|GADD45B|BMP2|WWTR1|PLIN2|LPIN3|SERPINE1|PPARG|PPARA|CFD|MEF2BNB-MEF2B|AGPAT2|LPIN2|EBF1|PTGIS
TGIF DISRUPTION OF SHH SIGNALING%WIKIPATHWAYS_20181110%WP3674%HOMO SAPIENS,0.9205026455026459,0.9768322640118741,-0.31967574721517605,-0.624245712826174,6958,3,SMAD2|TGIF2|TGIF1
OXIDATIVE DAMAGE%WIKIPATHWAYS_20181110%WP3941%HOMO SAPIENS,0.00155179102547524,0.0323260517898055,-0.39829616429991105,-1.9828083333827702,11,40,CDKN1C|TNK2|C2|PCNA|TRAF2|CYCS|C1QB|C1QA|C1QC|TRAF3|C3AR1|MAPK13|NFKB1|C1S|C1R|TNFRSF1B|C5AR1|BAD
MICRORNA NETWORK ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA%WIKIPATHWAYS_20181110%WP4399%HOMO SAPIENS,0.7577774758864291,0.917143966125732,0.35107263001158096,0.77132151948984,5577,4,BCL2|ZAP70|TP53
OSTEOBLAST SIGNALING%WIKIPATHWAYS_20181110%WP322%HOMO SAPIENS,0.0175872850442939,0.180237022041183,-0.5863416142988129,-1.76385909608053,134,9,COL1A1|PDGFRB|TNFRSF11B|PDGFRA|PDGFB
LNCRNA-MEDIATED MECHANISMS OF THERAPEUTIC RESISTANCE%WIKIPATHWAYS_20181110%WP3672%HOMO SAPIENS,0.00122950819672131,0.0272582131805912,0.7264878064940951,2.10886700607737,8,8,WNT6|ABCB1|MEG3|CDKN1A
DRUG INDUCTION OF BILE ACID PATHWAY%WIKIPATHWAYS_20181110%WP2289%HOMO SAPIENS,0.10232495268991601,0.441073279931729,0.598578439996861,1.43957771563778,756,5,ABCC4|ABCB1
APOPTOSIS-RELATED NETWORK DUE TO ALTERED NOTCH3 IN OVARIAN CANCER%WIKIPATHWAYS_20181110%WP2864%HOMO SAPIENS,0.00566718186501803,0.0865015657756347,-0.33511731782295695,-1.80881862403448,43,53,ABL1|HSPB1|BCL3|F2R|APOE|TNFRSF21|THBS1|YBX3|RPS6KB1|NFKB1|VIM|HSPA5|BIRC5|NGFRAP1|NET1|SQSTM1|ERN1
NRF2 PATHWAY%WIKIPATHWAYS_20181110%WP2884%HOMO SAPIENS,0.115591397849462,0.46497671600314505,-0.20468274448979396,-1.2783231222858897,902,93,CES1|SLC39A1|SLC2A13|TXNRD3|SLC39A9|SLC39A3|HGF|SLC6A1|SLC2A1|GGT1|SLC39A8|CBR1|SERPINA1|SLC39A11|SOD3|SLC2A10|SLC2A6|HMOX1|SLC6A8|HBEGF|HSPA1A|EPHA2|FTL|TGFBR2|SLC5A3|GPX3|SLC2A3|HSP90AA1|GSTP1|PDGFB|BLVRB|SQSTM1|FTH1
BONE MORPHOGENIC PROTEIN (BMP) SIGNALLING AND REGULATION%WIKIPATHWAYS_20181110%WP1425%HOMO SAPIENS,0.8327440848517809,0.9443921657118071,0.221797476035261,0.702669396501365,6123,10,SMAD1|TOB2|BMPR1A|BMPR2|BMPR1B
ENDODERM DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2853%HOMO SAPIENS,0.920794811646198,0.9768961564057891,0.110173563010941,0.720044627124711,6672,108,DKK1|EPB41L5|DUSP4|SFRP1|WDFY2|TCF7L1|RARG|SMAD3|DDAH1|TOX3|BMP7|TRERF1|SESN1|C1QBP|CRTC1|BCORL1|LRPPRC|CEP250|TRIM5|KDM4A|SOX7|MAD2L2|CTBP2
NOTCH SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP268%HOMO SAPIENS,0.961104628549203,0.990105504429159,-0.11782051815117402,-0.590057553077817,7412,41,KAT2A|LFNG|RFNG|DLL4|DVL3|CREBBP|MFNG|NOTCH4|PSEN1|JAG1|DTX3L|NUMB|HES1|NOTCH1|NOTCH2|NOTCH3|JAG2|KAT2B|MAML1|DTX1
PYRIMIDINE METABOLISM AND RELATED DISEASES%WIKIPATHWAYS_20181110%WP4225%HOMO SAPIENS,0.599345121152587,0.84625395439332,-0.34213127322230896,-0.880053800139134,4575,6,TYMS|NT5C|TYMP
BDNF-TRKB SIGNALING%WIKIPATHWAYS_20181110%WP3676%HOMO SAPIENS,0.27434954365890196,0.648886431381759,0.250555260854441,1.1466982765004399,2013,29,TSC2|GAB1|GAB2|SHC1|SOS1|DLG4|PLCG1|NRAS|HOMER1|MAP2K1|MAPK1|KRAS|ADCY1|MTOR|TSC1|RHEB|MKNK1|CREB1
NEURAL CREST DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2064%HOMO SAPIENS,0.508289582757668,0.798966294578331,0.164350533523318,0.970674304395895,3678,71,TCF7L1|FGFR2|DLL1|HDAC11|HDAC1|DLX5|FGF2|DLL3|TWIST1|HDAC10|ASCL1|BMP7|SMAD1|DVL2|HDAC4|TFAP2B
IL-3 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP286%HOMO SAPIENS,0.37683417737956104,0.7276146451653158,-0.20496996452813201,-1.05361625002876,2901,45,CD69|AKT1|RAF1|SYK|TGFB1|STAT5A|LYN|RAPGEF1|VAV1|CSF2RB|GRB2|STAT3|PTPN6|MAPK3|HRAS|CD86|IL3RA|HCK|PRKACA|BAD
ONE CARBON METABOLISM AND RELATED PATHWAYS%WIKIPATHWAYS_20181110%WP3940%HOMO SAPIENS,0.471227208069313,0.782669119730809,-0.198438162308652,-0.9878700252570991,3643,40,CDO1|DNM1|SOD2|GPX1|PCYT1A|CHPT1|ETNK2|SOD3|SOD1|PLD1|GPX3|BCAT2|SHMT2
RALA DOWNSTREAM REGULATED GENES%WIKIPATHWAYS_20181110%WP2290%HOMO SAPIENS,0.33437908496732,0.6974768376198021,-0.330824644386185,-1.10730106040157,2557,12,RAC2|CDC42|RAC3|EXOC8|RAC1|HRAS|YBX3
NANOMATERIAL INDUCED APOPTOSIS%WIKIPATHWAYS_20181110%WP2507%HOMO SAPIENS,0.684431218720411,0.8856747470877271,0.20733885727671103,0.826635951339165,5059,19,HTRA2|CASP9|CASP8|BID|APAF1|BAX|BCL2|CFLAR|CASP3
GLUCOCORTICOID AND MINERALCORTICOID METABOLISM%WIKIPATHWAYS_20181110%WP237%HOMO SAPIENS,0.9568664337543671,0.9880317864833471,0.29202719165895197,0.574383024517268,7120,3,HSD11B2|CYP21A2
THYROXINE (THYROID HORMONE) PRODUCTION%WIKIPATHWAYS_20181110%WP1981%HOMO SAPIENS,0.0292068595927117,0.242210716932848,0.8892748828232699,1.4940966220708898,217,2,TRH|TG
RETT SYNDROME CAUSING GENES%WIKIPATHWAYS_20181110%WP4312%HOMO SAPIENS,0.47523665797777503,0.784986345464663,0.19465530879357604,0.9866249643403899,3463,41,HDAC1|NCOR1|GABRA3|CRK|GPS2|HTT|TBL1XR1|HAP1|SCN2A|KDM5B|RHOBTB2|TAF1B|GNAO1|TBL1X
TGF-BETA SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP366%HOMO SAPIENS,0.239667306461932,0.623187683081912,-0.16808640236589997,-1.13215213851708,1872,130,ITGB3|PDK1|DCP1A|RNF111|EID2|SMAD7|MAP4K1|CUL1|RBL1|RHOA|PIAS1|MAP2K2|SMURF1|TRAF6|MAPK14|APP|PIAS2|ETS1|CCNB2|PPM1A|AKT1|ROCK1|FOXP3|RAF1|CREBBP|CDC42|PAK2|RAC1|ITGB1|ATF3|MMP12|TGFB1|PML|PRKAR2A|MAPK4|JUNB|TERT|SKIL|HGS|UCHL5|MMP1|BCAR1|TGIF1|GRB2|MEF2C|SMURF2|MAPK9|CDKN2B|SNW1|KLF6|SKP1|MAP2K3|FN1|TNC|NUP214|TGFBR2|TGFBR3|THBS1|COL1A2|NEDD9|CAV1|MYC|SIK1|YAP1|PJA1|DAB2|CCND1|ITGB4
TRANS-SULFURATION PATHWAY%WIKIPATHWAYS_20181110%WP2333%HOMO SAPIENS,0.7865107424530869,0.927659709144581,0.23476195627243301,0.7437417462280109,5783,10,CSAD|GCLM|CTH|MPST|CBS|MAT2B
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN (NOD) PATHWAY%WIKIPATHWAYS_20181110%WP1433%HOMO SAPIENS,0.268248175182482,0.642437892870149,-0.247511468679595,-1.15132578262803,2057,32,COPS6|CASP1|ERBB2IP|NAIP|NLRP3|NFKBIA|CARD6|XIAP|RELA|HSP90AA1
PURINE METABOLISM%WIKIPATHWAYS_20181110%WP4224%HOMO SAPIENS,0.402638020125102,0.740287621109606,0.32699939993133603,1.03595620253826,2960,10,DGUOK|ADSL|ATIC|PPAT
TLR4 SIGNALING AND TOLERANCE%WIKIPATHWAYS_20181110%WP3851%HOMO SAPIENS,0.154297639233077,0.5225398777782271,-0.292891588519284,-1.29179499688356,1182,27,TRAM1|IKBKE|IRF7|IRAK1|NFKBIA|TICAM1|TRAF3|NFKB1|TLR4
CYTOSINE METHYLATION%WIKIPATHWAYS_20181110%WP3585%HOMO SAPIENS,0.746792246792247,0.911925817165146,0.253616226804705,0.770716322236895,5470,9,IDH1|TET2|TET3
ULTRACONSERVED REGION 339 MODULATION OF TUMOR SUPPRESSOR MICRORNAS IN CANCER%WIKIPATHWAYS_20181110%WP4284%HOMO SAPIENS,0.7057877813504821,0.894639008000397,0.493024538185829,0.8283448811270441,5267,2,CCNE2|TP53
OVARIAN INFERTILITY GENES%WIKIPATHWAYS_20181110%WP34%HOMO SAPIENS,0.8552303451896569,0.949296218452153,-0.171494239465061,-0.698668766397319,6515,21,CEBPB|ZP3|GJA4|SMPD1
ANGIOGENESIS%WIKIPATHWAYS_20181110%WP1539%HOMO SAPIENS,0.40992167101827703,0.7452753094449099,-0.2461850871537,-1.03362815466705,3139,23,TIMP3|NOS3|TEK|MMP9|PDGFRA|PDGFB
APOE AND MIR-146 IN INFLAMMATION AND ATHEROSCLEROSIS%WIKIPATHWAYS_20181110%WP3926%HOMO SAPIENS,0.00833116375943765,0.113028938028938,-0.632792915545859,-1.82172223788136,63,8,NFKB2|TLR2|IRAK1|SPI1|APOE|RELA|TLR4
MIRNA REGULATION OF DNA DAMAGE RESPONSE%WIKIPATHWAYS_20181110%WP1530%HOMO SAPIENS,0.607337308789214,0.8492159043277758,-0.15746339483531,-0.9068140640511879,4684,68,SFN|CCNB2|ATRIP|CDKN1B|CDK4|FANCD2|PIDD1|RAD9A|CCND2|PML|RAD51|RPA2|CDK6|H2AFX|NBN|TNFRSF10B|RAD1|RAD17|CDC25C|CYCS|BRCA1|ABL1|E2F1|GADD45B|CCNB1|GADD45G|TLK2|MYC|CCND3|SMC1A|CCND1
RAS SIGNALING%WIKIPATHWAYS_20181110%WP4223%HOMO SAPIENS,0.0333161821456136,0.260751083418481,-0.20315176529695897,-1.41990867790738,258,156,ELK1|ETS2|PLA2G2D|GRIN1|FLT4|GRB2|PLA2G4D|PLA2G4A|MAPK9|PIK3CB|MAPK3|GNGT2|ABL1|HRAS|PIK3R3|NTRK2|RRAS2|PLD1|PLA2G4C|GNG11|EPHA2|RAP1A|PLA2G16|GNG10|TEK|PDGFRB|RELA|RIN1|NFKB1|PRKACA|CSF1R|TIAM1|PDGFRA|RRAS|GNG3|ARF6|NGFR|PRKCB|RAPGEF5|BAD|PLA2G12A
PARKINSONS DISEASE PATHWAY%WIKIPATHWAYS_20181110%WP2371%HOMO SAPIENS,0.878521581804084,0.960725750963158,-0.143437694394215,-0.696812587693441,6797,37,UBE2G2|CYCS|PARK7|UBA1|MIR497HG|MAPK13|UBE2L6|CASP6
LEPTIN INSULIN OVERLAP%WIKIPATHWAYS_20181110%WP3935%HOMO SAPIENS,0.5672522286313579,0.831087370400857,-0.257542219475103,-0.9111467111477319,4326,14,AKT1|DGKZ|SOCS3|INS|IRS1|SOCS1|STAT3|PIK3R3
ECTODERM DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2858%HOMO SAPIENS,0.0763994999305459,0.38654270614299796,0.19674259698791102,1.31995099273322,549,123,ABCC4|PRKAG2|CTNNA2|TCF7L1|FGFR2|EDA2R|PPARD|JAKMIP1|DMD|AHI1|KIFC3|HESX1|ASTN1|TCF3|HIST1H2BH|ROR2|MZF1|HDAC10|PAN2|GREB1|SPRY2|GRAMD1B|TOX3|KCNK10|AES|ARHGAP10|CCDC88C|CAP2|ANKS1B
MIRNA BIOGENESIS%WIKIPATHWAYS_20181110%WP2338%HOMO SAPIENS,0.9648984937786509,0.990916952887267,-0.21747283657823605,-0.559398719839779,7366,6,XPO5|DGCR8|TARBP2|DROSHA|DICER1|RAN
NUCLEAR RECEPTORS IN LIPID METABOLISM AND TOXICITY%WIKIPATHWAYS_20181110%WP299%HOMO SAPIENS,0.0417232943734711,0.293009782616793,0.42247584789134396,1.59076168380368,306,16,ABCB1|ABCB4|CYP27B1|RARG|PPARD|CYP2E1
HEMATOPOIETIC STEM CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2849%HOMO SAPIENS,0.18254894334240898,0.556226209760009,-0.246668939050504,-1.23534400357745,1407,41,NCKAP1L|RUNX1|CD34|VAV1|IRF5|CBFA2T3|LMO2|ZNF835|TNXB|FLI1|CXCR4|NOTCH1|PIM1|CSF1|SPI1|KCNH2
ARACHIDONATE EPOXYGENASE / EPOXIDE HYDROLASE%WIKIPATHWAYS_20181110%WP678%HOMO SAPIENS,0.15084166228300902,0.517845930569841,-0.556538943276942,-1.33391764962972,1146,5,GSTP1|COX8A
DEVELOPMENT OF PULMONARY DENDRITIC CELLS AND MACROPHAGE SUBSETS%WIKIPATHWAYS_20181110%WP3892%HOMO SAPIENS,0.0897602918186556,0.4139571687019651,-0.48499163805751294,-1.45897355986536,688,9,IRF8|ID2|STAT3|CSF1|SPI1|FLT3LG
SECRETION OF HYDROCHLORIC ACID IN PARIETAL CELLS%WIKIPATHWAYS_20181110%WP2597%HOMO SAPIENS,0.6440430336034,0.8688307429995409,0.6761689457432729,0.901580051741411,4848,1,CHRM1
NOTCH SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP61%HOMO SAPIENS,0.707459207459207,0.89516234575314,-0.152267160067163,-0.8459217450121841,5462,59,HES1|NOTCH1|STAT3|SNW1|NOTCH2|SKP1|NOTCH3|JAG2|RING1|MAML1|MYC|NFKB1|DTX1|CCND1
PI3K/AKT/MTOR - VITD3 SIGNALLING%WIKIPATHWAYS_20181110%WP4141%HOMO SAPIENS,0.0463168912730603,0.30805382986873603,-0.409058446153058,-1.5545219859046702,353,17,PDHA1|HK3|CD86|LDHA|MYC|RELA|SLC2A3
HISTONE MODIFICATIONS%WIKIPATHWAYS_20181110%WP2369%HOMO SAPIENS,0.496126033057851,0.794012168719884,-0.18446197780580603,-0.971911224984976,3841,49,HIST4H4|SMYD3|AEBP2|HIST1H3D|EHMT1|HIST1H4H|SETD3|SETD1B|SETMAR|SET|EZH2|NSD1|SETD8|SETD1A|HIST2H3A|SUV420H1|HIST2H3C|HIST1H3H|SETBP1|H3F3B|SUV39H1
CORI CYCLE%WIKIPATHWAYS_20181110%WP1946%HOMO SAPIENS,0.000785648814979704,0.0191134260247744,-0.608558666124447,-2.09477694165624,5,13,GPT|SLC2A1|GPI|HK1|INS|PGAM1|GAPDH|LDHA|PGK1|TALDO1
HYPERTROPHY MODEL%WIKIPATHWAYS_20181110%WP516%HOMO SAPIENS,0.943423470727225,0.98255739075553,-0.161938415180939,-0.587972135502995,7186,15,ATF3|IL18|EIF4EBP1|HBEGF|IL1R1
HORMONAL CONTROL OF PUBERTAL GROWTH SPURT%WIKIPATHWAYS_20181110%WP4194%HOMO SAPIENS,0.641682143804723,0.867997874993875,-0.542485409045236,-0.9027824705905999,4836,2,SST
FELBAMATE METABOLISM%WIKIPATHWAYS_20181110%WP2816%HOMO SAPIENS,0.17160313454642098,0.54516008272075,0.916023378914866,1.22139357413195,1291,1,CYP2E1
METABOLISM OF SPINGOLIPIDS IN ER AND GOLGI APPARATUS%WIKIPATHWAYS_20181110%WP4142%HOMO SAPIENS,0.000390828556539865,0.0111294649577428,-0.718442034261111,-2.16124949386972,2,9,GALNT16|GALNT1|B4GALT1|B3GALT1|SPHK1
MITOCHONDRIAL LC-FATTY ACID BETA-OXIDATION%WIKIPATHWAYS_20181110%WP368%HOMO SAPIENS,0.631965207936939,0.861822777391605,0.229750191642263,0.8650856694772779,4649,16,HADHA|ACADVL|ACADM|ECI1|ACADS|CPT1A|EHHADH|PECR|ACSL3|ACSL1
INTERLEUKIN-1 INDUCED ACTIVATION OF NF-KAPPA-B%WIKIPATHWAYS_20181110%WP3656%HOMO SAPIENS,0.266336891434522,0.641603173139009,-0.4092317848650511,-1.17812103236563,2045,8,TRAF6|UBE2N|TIFA|AJUBA|IRAK1|SQSTM1
SYNTHESIS AND DEGRADATION OF KETONE BODIES%WIKIPATHWAYS_20181110%WP311%HOMO SAPIENS,0.0759407689172667,0.38531099082072706,0.669111564550819,1.47006660319985,558,4,ACAT1|HMGCL|BDH1|OXCT1
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PATHWAY%WIKIPATHWAYS_20181110%WP2533%HOMO SAPIENS,0.44380252100840295,0.7664039155808309,-0.250055549216847,-1.00321807403559,3379,20,PGS1|GPD1|PLA2G2A|CHPT1|CDIPT|GK|LPIN2|PTPMT1
VALPROIC ACID PATHWAY%WIKIPATHWAYS_20181110%WP3871%HOMO SAPIENS,0.0912568306010929,0.41778255328704206,0.501248650204624,1.4550371400706201,667,8,HADHB|HDAC1|HADHA|ACADSB|EHHADH|IVD
OXYTOCIN SIGNALING%WIKIPATHWAYS_20181110%WP2889%HOMO SAPIENS,0.634152968346692,0.863354277348854,0.38966972437234,0.856120979559544,4667,4,PLCD1|OXTR
LEPTIN AND ADIPONECTIN%WIKIPATHWAYS_20181110%WP3934%HOMO SAPIENS,0.92593074720125,0.9788732664014979,-0.211433625329409,-0.608687814980043,7112,8,ADIPOR1|ADIPOR2
DOPAMINE METABOLISM%WIKIPATHWAYS_20181110%WP2436%HOMO SAPIENS,0.688236835210899,0.8869263269728191,-0.25212399322858,-0.8162649928527559,5253,11,COMT|SOD1|PPP2CA|PRKACA
HOMOLOGOUS RECOMBINATION%WIKIPATHWAYS_20181110%WP186%HOMO SAPIENS,0.9198913781398509,0.9768322640118741,0.176036055929635,0.6165149691197801,6774,13,BRCA2|ATM|MRE11A|RAD52|POLD3
TRANSCRIPTIONAL CASCADE REGULATING ADIPOGENESIS%WIKIPATHWAYS_20181110%WP4211%HOMO SAPIENS,0.23019510278905303,0.6129063110774859,-0.35116724159199497,-1.20878574458015,1757,13,CEBPG|GATA3|CEBPD|CEBPA|CEBPB|KLF15|PPARG
NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20181110%WP4336%HOMO SAPIENS,0.6650117225210319,0.8804055751124069,0.152744994345172,0.876392234417479,4821,63,DKK1|WNT6|KREMEN1|SFRP1|TCF7L1|WNT5B|WNT2B|DANCR|ROR2
ERBB SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP673%HOMO SAPIENS,0.46366467687516205,0.777437553278279,-0.190800377154685,-0.993689056722006,3572,47,ABL1|HRAS|HBEGF|ARAF|CAMK2A|MYC|RPS6KB1|NCK1|CCND1|BAD
DOPAMINERGIC NEUROGENESIS%WIKIPATHWAYS_20181110%WP2855%HOMO SAPIENS,0.5319640914037,0.812079525085925,0.27486450367992105,0.9342109863278248,3910,12,RET|ASCL1|DDC|NR4A2|NKX6-1
VITAMIN B6-DEPENDENT AND RESPONSIVE DISORDERS%WIKIPATHWAYS_20181110%WP4228%HOMO SAPIENS,0.557940497215052,0.8267682185551151,0.41419260672531893,0.909998796460697,4106,4,AASS|ALDH7A1|PIGV
"GPCRS, CLASS C METABOTROPIC GLUTAMATE, PHEROMONE%WIKIPATHWAYS_20181110%WP501%HOMO SAPIENS",0.631572029442692,0.8616028929314681,-0.312609612263839,-0.854504434496544,4804,7,GPRC5B|GPRC5C
ERK PATHWAY IN HUNTINGTON'S DISEASE%WIKIPATHWAYS_20181110%WP3853%HOMO SAPIENS,0.8560387739062092,0.949296218452153,-0.211574533818824,-0.684983936371631,6534,11,MAP2K7|EGFR|MAPK1|CASP3|CREB1|CASP7|RAF1|RPS6KA5|ELK1|HRAS|NTRK2
PDGFR-BETA PATHWAY%WIKIPATHWAYS_20181110%WP3972%HOMO SAPIENS,0.381412348257408,0.729564552955755,-0.23314484823323398,-1.05416914201149,2921,29,ELK1|GRB2|STAT3|MAPK3|HRAS|SRF|PDGFRB|PRKCB
MODEL FOR REGULATION OF MSMP EXPRESSION IN CANCER CELLS AND ITS PROANGIOGENIC ROLE IN OVARIAN TUMORS%WIKIPATHWAYS_20181110%WP4397%HOMO SAPIENS,0.6305016722408029,0.8611032652135849,-0.6892920158800179,-0.9183024739256871,4712,1,CTCF
PATHWAYS IN CLEAR CELL RENAL CELL CARCINOMA%WIKIPATHWAYS_20181110%WP4018%HOMO SAPIENS,0.0257466529351184,0.225019807572435,-0.259757276510633,-1.54144417485827,199,76,SLC2A1|GPI|PHGDH|TGFB3|HK1|HK3|STAT3|ENO1|SDSL|RPTOR|KDM5C|GAPDH|PDGFRB|LDHA|PDGFRA|SHMT2|PGK1|FASN|PDGFB|SQSTM1|ALDOA|RAPGEF5|ALDOC|GRB10
IL-2 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP49%HOMO SAPIENS,0.300661221314664,0.673988937137548,-0.22253121357696,-1.11445973440874,2318,41,STAT5B|IL2RB|RPS6|PTPN11|FYN|MAP2K2|NMI|IL2RG|AKT1|RAF1|MAPT|JAK3|SYK|STAT5A|CCND2|SOCS3|GRB2|STAT3|IL2RA|CISH|MAPK3|HRAS|MYC|RPS6KB1|RPS6KB2
REGULATION OF ACTIN CYTOSKELETON%WIKIPATHWAYS_20181110%WP51%HOMO SAPIENS,0.045594262295082,0.306090947669213,-0.21042285759147397,-1.4102797999225403,355,127,ROCK1|RAF1|RAC2|CDC42|PIK3R5|PAK2|RAC3|RAC1|IQGAP1|SSH1|ACTG1|SOS2|APC|MRAS|GNA12|PAK4|GNA13|MAPK4|WASF2|PIK3C2A|FGD1|FGFR4|VAV1|WAS|BCAR1|MYLK|SLC9A1|PXN|MSN|PIK3CB|FGF10|MAPK3|PIK3R3|RRAS2|CHRM2|DOCK1|PIK3R4|CYFIP2|GSN|F2R|FN1|FGF19|FGF9|FGF7|CFL2|VCL|PDGFRB|CFL1|PDGFA|ACTB|PDGFRA|RRAS|TMSB4X|CD14|ACTN1|PDGFB
COMPOSITION OF LIPID PARTICLES%WIKIPATHWAYS_20181110%WP3601%HOMO SAPIENS,0.21462388216727998,0.5979177134734279,-0.5203185131169931,-1.24710419003056,1631,5,CETP|APOE|LDLR
FLUOROPYRIMIDINE ACTIVITY%WIKIPATHWAYS_20181110%WP1601%HOMO SAPIENS,0.08673535933220301,0.406842536616055,-0.321858430811924,-1.4195529230784398,664,27,TYMP|CDA|DHFR|UMPS|TK1|RRM1|XRCC3|UCK1
TRIACYLGLYCERIDE SYNTHESIS%WIKIPATHWAYS_20181110%WP325%HOMO SAPIENS,0.0160826359832636,0.17227977653223098,-0.44751711504818603,-1.7365328424609598,122,18,DGAT1|LIPE|GPD1|AGPAT1|GPAM|PPAP2C|PNPLA2|GK|PPAP2A|AGPAT2|AGPAT3
NLR PROTEINS%WIKIPATHWAYS_20181110%WP288%HOMO SAPIENS,0.992901992901993,0.997305769352475,0.15381853269448598,0.46744033417648395,7273,9,EPHB2|IKBKB|MAPK8|MAP3K7|IKBKG
MTHFR DEFICIENCY%WIKIPATHWAYS_20181110%WP4288%HOMO SAPIENS,0.24701404383777398,0.6280519349499749,-0.290562217062624,-1.18375256445959,1881,21,COMT|PCYT1A|GRIN1|CHPT1|CYCS|DNMT1|SGMS1|GRIN2D|HNMT
SIGNALING PATHWAYS IN GLIOBLASTOMA%WIKIPATHWAYS_20181110%WP2261%HOMO SAPIENS,0.28543716225578497,0.6583248923580091,0.18364585720610702,1.11456857965359,2059,79,FGFR2|MET|TSC2|GAB1|ERBB3|MAP2K6|CDKN1A|MAP2K5|SPRY2|BRCA2|ATM|FOXO3|IGF1R|NF1|CCNE1|CBL|PRKCA|PLCG1|NRAS|MAP2K7|AKT3|RB1|PIK3R2|FGFR1|EGFR|SRC|MAP2K1|MAPK1|KRAS|MAP2K4|EP300|ERBB2|PDPK1
BENZENE METABOLISM%WIKIPATHWAYS_20181110%WP3891%HOMO SAPIENS,0.143417139767505,0.509575467000568,0.562879340037677,1.35372158495282,1060,5,CYP2E1|GSTM1|NQO1
EXERCISE-INDUCED CIRCADIAN REGULATION%WIKIPATHWAYS_20181110%WP410%HOMO SAPIENS,0.202439657409811,0.5810727835229039,-0.23232064068944897,-1.20992673990677,1559,47,PER2|IDI1|PURA|CLDN5|QKI|NR1D2|HIST1H2BN|TOB1|PPP1R3C|HERPUD1|G0S2|CEBPB|EIF4G2|CRY2|SUMO3|NCOA4|DNAJA1|GSTP1
MET IN TYPE 1 PAPILLARY RENAL CELL CARCINOMA%WIKIPATHWAYS_20181110%WP4205%HOMO SAPIENS,0.86869340232859,0.956481047534325,-0.131080687451519,-0.7217773934622209,6714,57,GRB2|STAT3|PIK3CB|MAPK3|HRAS|PIK3R3|RAP1A|INSL3|ARAF|TFE3|BAD
COCAINE METABOLISM%WIKIPATHWAYS_20181110%WP2826%HOMO SAPIENS,0.31031746031746005,0.681045250505892,-0.585219187887357,-1.14278475075057,2345,3,CES1|BCHE
MIR-509-3P ALTERATION OF YAP1/ECM AXIS%WIKIPATHWAYS_20181110%WP3967%HOMO SAPIENS,0.011121287452571,0.136936536432735,-0.47479857789228797,-1.80435054000489,84,17,BCAR1|SNAI2|SPARC|FN1|COL1A1|THBS2|COL3A1|YAP1|TEAD2|COL5A1
ATM SIGNALING NETWORK IN DEVELOPMENT AND DISEASE %WIKIPATHWAYS_20181110%WP3878%HOMO SAPIENS,0.667144906743185,0.880719592999549,-0.16917450063315,-0.862394439947154,5114,44,RNF168|HSPB1|RNF20|PPM1D|PPP2R4|RNF40|SMC1A|NFKB1|KAT5|CEP63
NUCLEOTIDE GPCRS%WIKIPATHWAYS_20181110%WP80%HOMO SAPIENS,0.6223700285054979,0.856495765504366,0.33067551886337204,0.855642340598898,4584,6,ADORA2B|ADORA2A
CHEMOKINE SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP3929%HOMO SAPIENS,0.181736909323116,0.554948538055731,-0.173677630931215,-1.1815589641406299,1422,136,AKT1|ROCK1|CCL3|RAF1|RAC2|CXCL12|CDC42|PIK3R5|JAK3|CCL4|RAC1|DOCK2|GRK4|SOS2|CCL11|LYN|GRK5|VAV3|PLCB1|GNG8|CCL19|PLCB3|FGR|CCL24|VAV1|WAS|BCAR1|ADCY8|CXCR4|ELMO1|GRB2|STAT3|ARRB1|PXN|PIK3CB|MAPK3|GNGT2|ADCY4|HRAS|PIK3R3|GNG11|GNAI2|CXCL16|CCR1|RAP1A|NFKBIA|HCK|GNG10|GRK6|CX3CL1|RELA|NFKB1|ADRBK1|TIAM1|GNG3|PRKCB|ADCY9
IL-1 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP195%HOMO SAPIENS,0.262508038585209,0.638240557311977,-0.211098150946807,-1.14463463967729,2040,54,MAPKAPK2|MAPK9|MAPK3|IL1RAP|IRAK1|CCL2|MAP2K3|NFKBIA|RELA|IL1R1|NFKB1|TOLLIP|SQSTM1
T-CELL RECEPTOR AND CO-STIMULATORY SIGNALING%WIKIPATHWAYS_20181110%WP2583%HOMO SAPIENS,0.45480631276901,0.77085243169122,-0.225455952820887,-0.9943708979285442,3486,27,CALM1|RASGRP1|PDK1|PPP3CA|CD8B|FYN|GSK3B|AKT1|NFATC2|PTEN|CALM3|DYRK1A|PTPN6|NFKBIA|NFKB1|CSNK1A1
SEROTONIN RECEPTOR 2 AND STAT3 SIGNALING%WIKIPATHWAYS_20181110%WP733%HOMO SAPIENS,0.206349206349206,0.586178082333662,-0.6384917438523471,-1.2468125506763899,1559,3,STAT3|GNAQ
BLOOD CLOTTING CASCADE%WIKIPATHWAYS_20181110%WP272%HOMO SAPIENS,0.00169934640522876,0.0346995370450957,-0.5955876131925311,-1.993487507177,12,12,F12|F10|KLK1|PLAU|VWF|F3|F8|SERPINE1|PLAT|SERPINF2
SEROTONIN RECEPTOR 2 AND ELK-SRF/GATA4 SIGNALING%WIKIPATHWAYS_20181110%WP732%HOMO SAPIENS,0.289446048831714,0.6622817015650171,-0.314226788153688,-1.14090653200809,2204,15,ELK1|MAPKAPK2|MAPK3|HRAS|GNAQ|SRF
PHYSIOLOGICAL AND PATHOLOGICAL HYPERTROPHY  OF THE HEART%WIKIPATHWAYS_20181110%WP1528%HOMO SAPIENS,0.9822847466458249,0.993436724391485,-0.11821998666467698,-0.5096629275728529,7540,25,LIFR|CALM1|PPP3CA|RHOA|NFATC4|MAPK14|CTF1|RAC1|AGT|CALM3|IL6ST|STAT3|MAP2K3|PRKCB
PPAR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP3942%HOMO SAPIENS,0.18033845756362196,0.553994656967381,-0.23848931941970497,-1.2354497148633201,1395,46,RXRG|ACSL5|ANGPTL4|ACSL4|MMP1|FABP3|ILK|OLR1|NR1H3|ACOX1|FABP4|CD36|SLC27A4|PPARG|PPARA|FADS2
CANONICAL AND NON-CANONICAL TGF-B SIGNALING%WIKIPATHWAYS_20181110%WP3874%HOMO SAPIENS,0.419806384092098,0.7514346091901549,-0.276210686195342,-1.02650586070541,3208,16,MAPK9|LOXL1|LOX|TGFBR2|LOXL2
ENERGY METABOLISM%WIKIPATHWAYS_20181110%WP1541%HOMO SAPIENS,0.579959100204499,0.8386526275338391,0.17713375195281503,0.9193014610476039,4253,44,PRKAG2|CAMK4|PPARD|HDAC1|TFB1M|PPP3R1|MYBBP1A|FOXO3|PPP3CB|CAMK2G|ATF2|EP300|TFB2M|SIRT1|UCP3|PRKAA1|PRKAG1|MEF2B
ARYLAMINE METABOLISM%WIKIPATHWAYS_20181110%WP694%HOMO SAPIENS,0.8057525083612042,0.9334126532575471,-0.6015659461843851,-0.8014302848195541,6022,1,SULT1A1
DISORDERS OF FOLATE METABOLISM AND TRANSPORT%WIKIPATHWAYS_20181110%WP4259%HOMO SAPIENS,0.090254126277181,0.414848344511905,-0.44802370468103603,-1.45050084847647,688,11,FTCD|DHFR|SHMT2|MTHFD1
IL-4 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP395%HOMO SAPIENS,0.0526790314270994,0.332476158332391,-0.271876969679605,-1.4674745232424298,408,53,GATA3|FES|ELK1|DOK2|GRB2|IRS1|CEBPA|SOCS1|STAT3|PTPN6|MAPK3|FLNA|CEBPB|NFKBIA|RELA|RPS6KB1|NFKB1|BIRC5|BAD
ALZHEIMERS DISEASE%WIKIPATHWAYS_20181110%WP2059%HOMO SAPIENS,0.15816589386914,0.528194339395059,-0.214132295576627,-1.24803970048809,1227,71,ITPR2|ATP2A1|PLCB3|LRP1|CALM3|ITPR3|ATP2A3|GRIN1|CYCS|MAPK3|CAPN1|GNAQ|APOE|GAPDH|GRIN2C|FADD|GRIN2D|HSD17B10|APBB1|TNFRSF1A|VMP1|ERN1|BAD
TGF-B SIGNALING IN THYROID CELLS FOR EPITHELIAL-MESENCHYMAL TRANSITION%WIKIPATHWAYS_20181110%WP3859%HOMO SAPIENS,0.0309792596482016,0.250023157423912,-0.44773967366261697,-1.6256701770156001,235,15,SNAI2|MAPK3|FN1|TNC|ID1|SNAI1|VIM
TCA CYCLE AND DEFICIENCY OF PYRUVATE DEHYDROGENASE COMPLEX (PDHC)%WIKIPATHWAYS_20181110%WP2453%HOMO SAPIENS,0.9474927802572851,0.9840421757603729,-0.16020759073917298,-0.581687792519468,7217,15,FH|PDHA1|SDHA|ACO1
LET-7 INHIBITION OF ES CELL REPROGRAMMING%WIKIPATHWAYS_20181110%WP3299%HOMO SAPIENS,0.157804232804233,0.527852130775783,-0.668934841141577,-1.3062602039109699,1192,3,KLF4|MYC
ACRYLAMIDE BIOTRANSFORMATION AND EXPOSURE BIOMARKERS%WIKIPATHWAYS_20181110%WP4233%HOMO SAPIENS,0.17160313454642098,0.54516008272075,0.916023378914866,1.22139357413195,1291,1,CYP2E1
TRYPTOPHAN CATABOLISM LEADING TO NAD+ PRODUCTION%WIKIPATHWAYS_20181110%WP4210%HOMO SAPIENS,0.21226043580992396,0.594796121395626,-0.33776458856855696,-1.2263684698658301,1616,15,KYNU|HAAO|AFMID|NMNAT3|QPRT
MIRNA REGULATION OF P53 PATHWAY IN PROSTATE CANCER%WIKIPATHWAYS_20181110%WP3982%HOMO SAPIENS,0.0484024473147519,0.31517882292381394,0.367796820152665,1.5392122287866297,355,22,BBC3|CASP9|PMAIP1|ATM|CASP8|BID|DDB2|APAF1|BAX|EI24|CHEK2|CASP3|SHISA5|MDM2|ZMAT3
PATHWAYS AFFECTED IN ADENOID CYSTIC CARCINOMA%WIKIPATHWAYS_20181110%WP3651%HOMO SAPIENS,0.4699896960329729,0.7812405255447221,-0.177127151194793,-0.9895979294426508,3648,60,KDM6A|AKT1|RAF1|CREBBP|PTEN|MYBL1|SRCAP|KAT6A|KANSL1|SMARCA2|BCOR|FGFR4|NSD1|SMARCE1|ARID5B|ERBB2IP|NOTCH1|MAGI1|CEBPA|BRCA1|UHRF1|HRAS|MAX|MYC|INSRR|SMC1A
NON-SMALL CELL LUNG CANCER%WIKIPATHWAYS_20181110%WP4255%HOMO SAPIENS,0.643013804670365,0.8685931173854742,-0.156400927071844,-0.8844490041025821,4983,63,GRB2|STAT3|PIK3CB|MAPK3|HRAS|PIK3R3|E2F1|GADD45B|GADD45G|ARAF|CCND1|PRKCB|BAD
EXTRACELLULAR VESICLE-MEDIATED SIGNALING IN RECIPIENT CELLS%WIKIPATHWAYS_20181110%WP2870%HOMO SAPIENS,0.751204897746516,0.914892212941612,-0.18358913253960102,-0.7914784750068921,5766,25,TGFB2|AKT1|RAF1|PIK3R5|TGFB1|APC|HGF|TGFB3|HRAS|TGFBR2|TGFBR3|MFGE8
ETHANOL METABOLISM RESULTING IN PRODUCTION OF ROS BY CYP2E1%WIKIPATHWAYS_20181110%WP4269%HOMO SAPIENS,0.149986401958118,0.516945848663557,0.42077526459301395,1.3330444805750201,1102,10,CYP2E1|SP1|NFE2L2|MAFF|MAP2K1|MAPK8
TYROBP CAUSAL NETWORK%WIKIPATHWAYS_20181110%WP3945%HOMO SAPIENS,0.00012950012950013,0.00518555396908895,-0.455847261965613,-2.53246406599354,0,59,IL10RA|STAT5A|APBB1IP|ITGAX|PYCARD|NCKAP1L|RGS1|SAMSN1|RPS6KA1|IL18|SLC7A7|CD84|RUNX3|ITGB2|TCIRG1|CD4|CREB3L2|HCLS1|MAF|PLEK|GPX1|C3|IL13RA1|FKBP15|SH2B3|IGSF6|SPP1|C1QC|CXCL16|RNASE6|NCF2|ADAP2|RBM47|TYROBP|ITGAM|NPC2|TNFRSF1B|LHFPL2
ENDOCHONDRAL OSSIFICATION%WIKIPATHWAYS_20181110%WP474%HOMO SAPIENS,0.0439916947832858,0.299062021084573,-0.29014412749542895,-1.5110716690597599,338,47,TGFB1|PTHLH|ADAMTS4|SOX5|RUNX3|CTSV|CALM3|CDKN1C|PLAU|DDR2|THRA|MGP|ACAN|MEF2C|TIMP3|SPP1|IGF1|HMGCS1|SERPINH1|MMP9|PLAT|PRKACA|ALPL
GLIAL CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2276%HOMO SAPIENS,0.0385068762278978,0.279776552671739,-0.6220167405074721,-1.59999461925266,293,6,GAP43|TPPP|PLP1|MSN|CNP
ESTROGEN SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP712%HOMO SAPIENS,0.916960899699228,0.97526102754601,-0.15404915621228502,-0.637957638188044,7011,22,ELK1|MAPK9|GPER1|NFKB1|PRKACA
FARNESOID X RECEPTOR  PATHWAY%WIKIPATHWAYS_20181110%WP2879%HOMO SAPIENS,0.40928961748633896,0.7448505271608159,0.355636751080793,1.0323512711413,2995,8,ABCB4|IRS2
ACE INHIBITOR PATHWAY%WIKIPATHWAYS_20181110%WP554%HOMO SAPIENS,0.394038010934652,0.7376723208557521,-0.363842100935586,-1.04745048509286,3026,8,ACE|BDKRB2|BDKRB1|TGFB1|AGT|ATP6AP2|NOS3
GENE REGULATORY NETWORK MODELLING SOMITOGENESIS %WIKIPATHWAYS_20181110%WP2854%HOMO SAPIENS,0.5315573770491799,0.812079525085925,0.319461151810319,0.927339835237457,3890,8,DLL1|HES7
FOLATE-ALCOHOL AND CANCER PATHWAY HYPOTHESES%WIKIPATHWAYS_20181110%WP1589%HOMO SAPIENS,0.809426229508197,0.934660980817546,0.24692383927326397,0.71677670705898,5924,8,CYP2E1|MTHFR|ADH5|CBS|CREB1
BIOGENIC AMINE SYNTHESIS%WIKIPATHWAYS_20181110%WP550%HOMO SAPIENS,0.779224160374902,0.924704689181848,-0.25763705317998803,-0.7417010171097501,5985,8,PAH|DBH|TH|PNMT|MAOA|ACHE|COMT
SREBF AND MIR33 IN CHOLESTEROL AND LIPID HOMEOSTASIS%WIKIPATHWAYS_20181110%WP2011%HOMO SAPIENS,0.0395081109366824,0.28367988634143604,-0.42873844998838295,-1.59335809082917,301,16,NR1H3|HMGCR|HMGCS1|LDLR|PPARA|FASN
SULINDAC METABOLIC PATHWAY%WIKIPATHWAYS_20181110%WP2542%HOMO SAPIENS,0.0698861405575187,0.37596389138254704,-0.6719241162521371,-1.4709823478519197,533,4,MSRB2|MSRA|CYP1B1|MSRB3
FACTORS AND PATHWAYS AFFECTING INSULIN-LIKE GROWTH FACTOR (IGF1)-AKT SIGNALING%WIKIPATHWAYS_20181110%WP3850%HOMO SAPIENS,0.12286422329463902,0.47697345522944606,-0.30416706394553805,-1.34152535212099,941,27,ILK|IRS1|IGF1|PLD1|IGFBP5|EIF2B2|RPS6KB1|NFKB1|TNFRSF1A
SEROTONIN AND ANXIETY-RELATED EVENTS%WIKIPATHWAYS_20181110%WP3944%HOMO SAPIENS,0.46860496860496903,0.780769690730001,0.322888657885745,0.9812288512964029,3432,9,CRHR1|PLCD4
ONCOSTATIN M SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2374%HOMO SAPIENS,0.0220616694620049,0.20560681370864603,-0.28069112682847,-1.5873114835811202,170,63,MMP1|IL6ST|GRB2|IRS1|STAT3|MAPK9|PXN|OSM|MAPK3|TIMP3|HRAS|CEBPB|CCL2|NFKBIA|SERPINE1|LDLR|RELA|NFKB1|OSMR|PRKCB
SMALL LIGAND GPCRS%WIKIPATHWAYS_20181110%WP247%HOMO SAPIENS,0.208311484006293,0.5883094281426011,-0.348493409432922,-1.23291872108822,1588,14,PTGER1|PTGER4|S1PR1|TBXA2R|PTAFR|PTGIR
CELL CYCLE%WIKIPATHWAYS_20181110%WP179%HOMO SAPIENS,0.0203686992393967,0.196348095520168,-0.230946668792235,-1.5195565962345001,157,116,FZR1|CCNA2|CUL1|CDC25A|E2F3|WEE1|RBL1|TTK|MAD1L1|CDKN2D|CDC7|GSK3B|STAG1|SFN|CCNB2|RAD21|TGFB2|CDKN1B|CDK4|SKP2|CCNH|TGFB1|CCND2|CDK6|CDC20|ANAPC10|TFDP2|MCM4|ANAPC2|MCM6|ANAPC5|ESPL1|CDC6|CDKN1C|CDC23|STAG2|CDKN2A|E2F2|PTTG1|TGFB3|PCNA|ORC1|PKMYT1|CDC25C|ORC6|MCM3|MCM5|CDC45|CDKN2B|ABL1|CDC27|SKP1|E2F1|ANAPC13|GADD45B|CCNB1|PLK1|CDK7|GADD45G|MCM2|MYC|CCND3|SMC1A|CDKN2C|ANAPC11|CCND1
FABP4 IN OVARIAN CANCER%WIKIPATHWAYS_20181110%WP4400%HOMO SAPIENS,0.17056856187291,0.544171946973796,-0.9124944861049851,-1.21566175833903,1274,1,FABP4
MICROGLIA PATHOGEN PHAGOCYTOSIS PATHWAY%WIKIPATHWAYS_20181110%WP3937%HOMO SAPIENS,0.000129802699896158,0.00518555396908895,-0.489476618294651,-2.39547756377396,0,38,PLCG2|RAC2|SYK|RAC3|RAC1|LYN|NCKAP1L|VAV3|PIK3C2A|ITGB2|PIK3R6|FCGR1A|VAV1|PTPN6|C1QB|FCER1G|PIK3CB|CYBB|PIK3R3|TREM2|NCF4|C1QA|SIGLEC7|C1QC|NCF2|HCK|TYROBP|ITGAM
SLEEP REGULATION%WIKIPATHWAYS_20181110%WP3591%HOMO SAPIENS,0.6966689326988439,0.89107464564121,0.19777959001931,0.8276981933551442,5123,22,DRD2|CHRNB2|ADORA2A|DLAT|BTBD9
NO/CGMP/PKG MEDIATED NEUROPROTECTION%WIKIPATHWAYS_20181110%WP4008%HOMO SAPIENS,0.0126088652021318,0.14869950444299201,-0.360978799750151,-1.71023949295618,96,34,GRIN1|CYCS|PDE2A|CAMK2B|NPR1|NFKBIA|NOS3|GRIN2C|XIAP|GRIN2D|CAMK2A|RELA|NFKB1|BAD
MICRORNA FOR TARGETING CANCER GROWTH AND VASCULARIZATION IN GLIOBLASTOMA%WIKIPATHWAYS_20181110%WP3593%HOMO SAPIENS,0.15733438485804402,0.527132257259573,-0.48614611385127,-1.3288587228359698,1196,7,VEGFC|HES1|VEGFB
CORTICOTROPIN-RELEASING HORMONE SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2355%HOMO SAPIENS,0.29665684641988,0.6687903666702459,-0.183460976803075,-1.1027491105665301,2315,80,NR4A1|GJA1|JUNB|IL18|JUP|TRIM28|PARP1|ELK1|CACNA1H|POMC|CRHBP|MAPK9|ARRB1|MAPK3|RAPGEF3|GNAI2|GNAQ|NFKBIA|NOS3|GRK6|CAMK2A|RELA|NFKB1|TLR4|HSP90AA1|PRKCB|ERN1
PI3K-AKT SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP4172%HOMO SAPIENS,0.000127599846880184,0.00518555396908895,-0.266404083843508,-2.05810185114223,0,269,HSP90B1|ANGPT2|ITGA10|LPAR6|EIF4EBP1|BCL2L11|ITGA11|IFNAR1|LAMC2|PIK3R6|PIK3AP1|FGFR4|KDR|TLR2|LAMC3|CREB3L2|HGF|NGF|PDGFD|ITGB5|PPP2R3B|PHLPP1|LAMA2|G6PC3|VEGFC|PKN1|INS|VTN|CREB3|TNXB|ITGA5|EFNA1|SGK1|PDGFC|FLT4|VWF|GRB2|IRS1|IL2RA|BRCA1|CSF3R|PIK3CB|OSM|CREB3L1|FGF10|MAPK3|SPP1|GNGT2|COL4A1|COMP|LAMA4|HRAS|PIK3R3|IGF1|NTRK2|COL4A2|RPTOR|GNG11|CHRM2|CSF1|COL6A3|EPHA2|F2R|FN1|IL3RA|NOS3|PPP2CA|VEGFB|FGF19|EFNA3|TNC|GNG10|FGF9|THBS1|TEK|FGF7|COL1A2|COL1A1|THBS2|PDGFRB|ITGA8|FLT3LG|MYC|DDIT4|CCND3|RELA|COL6A1|RPS6KB1|NFKB1|TLR4|PDGFA|HSP90AA1|CSF1R|PDGFRA|OSMR|PPP2R2B|GNG3|CCND1|COL6A2|RPS6KB2|PDGFB|NGFR|EFNA5|ITGB4|BAD
RANKL/RANK (RECEPTOR ACTIVATOR OF NFKB (LIGAND)) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2018%HOMO SAPIENS,0.0598918083462133,0.354269451186595,-0.268920496028217,-1.451516754671,464,53,MAPK9|ICAM1|MAPK3|NFATC1|VCAM1|SPI1|MITF|NFKBIA|FHL2|RELB|TNFRSF11B|TRAF3|RELA|NFKB1|SQSTM1
STATIN PATHWAY%WIKIPATHWAYS_20181110%WP430%HOMO SAPIENS,0.11950836820083698,0.471120705968593,-0.3521935900909871,-1.36664211385833,913,18,ACSS1|FDFT1|PLTP|DGAT1|LRP1|APOC1|CETP|HMGCR|APOE|LDLR
MITOCHONDRIAL GENE EXPRESSION%WIKIPATHWAYS_20181110%WP391%HOMO SAPIENS,0.6835735654065821,0.885415243771438,0.21148658972955497,0.827848751153323,5026,18,CAMK4|TFB1M|SP1|MYEF2
TUMOR SUPPRESSOR ACTIVITY OF SMARCB1%WIKIPATHWAYS_20181110%WP4204%HOMO SAPIENS,0.0361256544502618,0.27047868194758395,-0.353020078991318,-1.5766271557462401,275,28,ACTL6B|CDK6|SMARCA4|EZH2|SMO|CDKN2A|SMARCE1|SMARCD3|SMARCD2|DPF1|DPF2|H3F3B|DPF3
RETINOBLASTOMA GENE IN CANCER%WIKIPATHWAYS_20181110%WP2446%HOMO SAPIENS,0.000382262996941896,0.0111294649577428,-0.33158882484040003,-2.0395417270881997,2,87,CCNA2|PRIM1|CDC25A|E2F3|WEE1|TTK|CDC7|PRMT2|CCNB2|SAP30|CDKN1B|CDK4|RAF1|SKP2|HLTF|FANCG|POLE|TYMS|ANLN|RPA2|CDK6|RRM2|TFDP2|SMARCA2|RFC3|HMGB2|CDT1|SMC2|MCM4|MCM6|E2F2|PCNA|ORC1|TOP2A|MCM3|CDC45|KIF4A|RFC5|RBBP7|ABL1|DNMT1|E2F1|DHFR|CCNB1|H2AFZ|MYC|CCND3|SMC1A|MAPK13|POLE2|POLA1|RFC4|CCND1|RRM1|SUV39H1
AMINO ACID CONJUGATION OF BENZOIC ACID%WIKIPATHWAYS_20181110%WP521%HOMO SAPIENS,0.623677248677249,0.857551285930326,-0.44599549562871293,-0.870916165869188,4714,3,GLYATL1
NAD BIOSYNTHESIS II (FROM TRYPTOPHAN)%WIKIPATHWAYS_20181110%WP2485%HOMO SAPIENS,0.0683415777141369,0.37331514441341707,-0.5264000097591571,-1.5154319529194,524,8,TDO2|KMO|KYNU|HAAO|AFMID|QPRT
PRADER-WILLI AND ANGELMAN SYNDROME%WIKIPATHWAYS_20181110%WP3998%HOMO SAPIENS,0.283299250170416,0.6560202082186041,0.25428257964059303,1.1380409827908702,2077,27,BBS4|CYFIP1|MKRN3|DLX5|NIPA1|GABRB3|PCM1|SNRPN
G13 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP524%HOMO SAPIENS,0.48481308411215,0.7872939093021379,-0.19986979514209402,-0.978154199902495,3734,38,ROCK1|CDC42|RAC1|IQGAP1|GNA13|CIT|CALM3|TNK2|WAS|ARHGDIB|IQGAP2|PKN1|PIK3CB|CFL2|RHPN2|CFL1|RPS6KB1
GLYCOGEN METABOLISM%WIKIPATHWAYS_20181110%WP500%HOMO SAPIENS,0.21651090342679102,0.5995270850310329,-0.24443223904387898,-1.19624088793588,1667,38,CALM3|PHKG2|PPP2R3B|HK1|PHKA1|HK3|PPP2R4|PPP2CA|PYGL|PYGM|PPP2R2B|GYG2
TYPE II INTERFERON SIGNALING (IFNG)%WIKIPATHWAYS_20181110%WP619%HOMO SAPIENS,0.0759312320916906,0.38531099082072706,-0.31147791050143603,-1.4354687273928601,582,31,GBP1|PTPN11|IFNGR2|IL1B|IRF8|HLA-B|PSMB9|OAS1|IFNGR1|SOCS3|IFIT2|SOCS1|ICAM1|ISG15|CYBB|IFI6|SPI1|HIST2H4A
NAD+ BIOSYNTHETIC PATHWAYS%WIKIPATHWAYS_20181110%WP3645%HOMO SAPIENS,0.797479984249902,0.9308634013872809,-0.18401282877970895,-0.7496695894032809,6075,21,PARP2|BST1|SIRT4|QPRT
MATRIX METALLOPROTEINASES%WIKIPATHWAYS_20181110%WP129%HOMO SAPIENS,0.7196691176470591,0.90068276850426,-0.20133121542892898,-0.8077369801167651,5480,20,MMP14|TIMP3|MMP9|TIMP1|MMP19
FOLLICLE STIMULATING HORMONE (FSH) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2035%HOMO SAPIENS,0.336528361344538,0.699462084003389,-0.272362313619172,-1.09271238556659,2562,20,SGK1|MAPK3|GRK6|RPS6KB1|PRKACA|RPS6KB2
FATTY ACID BIOSYNTHESIS%WIKIPATHWAYS_20181110%WP357%HOMO SAPIENS,0.39178762913560905,0.7371240382543249,-0.25242025237042104,-1.04533794272235,2995,22,HADH|ECHDC3|FASN
ALPHA 6 BETA 4 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP244%HOMO SAPIENS,0.61151275405811,0.851817875343288,0.187106769956333,0.8910113044839292,4482,33,IRS2|ITGA6|GAB1|LAMA5|LAMB1|SHC1|SOS1|LAMA1|PRKCA|PIK3R2|SRC|MAPK1
SEROTONIN TRANSPORTER ACTIVITY%WIKIPATHWAYS_20181110%WP1455%HOMO SAPIENS,0.9125227805259051,0.972925642245441,-0.216228142754702,-0.622490559604693,7009,8,PPP2CB|STX1A|SCAMP2|TGFB1I1|ITGB3|IL1B|MAOA|IL1R1
INTEGRIN-MEDIATED CELL ADHESION%WIKIPATHWAYS_20181110%WP185%HOMO SAPIENS,0.344885123860865,0.7024647311177249,-0.17192728278658498,-1.0668813758464302,2686,91,RAP1B|SORBS1|AKT1|ROCK1|RAF1|RAC2|ZYX|CDC42|PAK2|RAC3|RAC1|ITGB1|ITGA9|PAK4|ITGAX|MAPK4|VAV3|ITGA10|TNS1|ITGA11|ITGB2|RAPGEF1|ITGB5|TLN1|CAV2|MYLK2|BCAR1|ILK|ITGA5|GRB2|PXN|CAPN1|HRAS|DOCK1|MAP2K3|RAP1A|VCL|ARAF|SEPP1|ITGA8|CAV1|ITGAM|ITGB4
DUAL HIJACK MODEL OF VIF IN HIV INFECTION%WIKIPATHWAYS_20181110%WP3300%HOMO SAPIENS,0.998770491803279,0.999656642395059,0.138507363892107,0.40206264606203007,7310,8,CBFB|CUL5|TCEB1|RBX1
DNA IR-DAMAGE AND CELLULAR RESPONSE VIA ATR%WIKIPATHWAYS_20181110%WP4016%HOMO SAPIENS,0.0895311496467566,0.413430792765036,-0.224509153456,-1.34486288791464,696,79,TDP1|UIMC1|RAD9A|PML|RAD51|CLSPN|RPA2|BRIP1|PALB2|H2AFX|NBN|EXO1|TRIM28|PARP1|RAD1|RAD17|BRCC3|PCNA|CDC25C|SHFM1|FOXM1|CDC45|BRCA1|TOPBP1|RMI1|E2F1|PPM1D|PLK1|MCM2|SMC1A|BCL6|XPA|FEN1
SEROTONIN RECEPTOR 4/6/7 AND NR3C SIGNALING%WIKIPATHWAYS_20181110%WP734%HOMO SAPIENS,0.185897435897436,0.559093571852282,-0.33835194828506104,-1.25744685218325,1420,16,ELK4|RPS6KA5|NR3C1|ATF1|ELK1|MAPKAPK2|MAPK3|RAP1A|SRF
MIR-222 IN EXERCISE-INDUCED CARDIAC GROWTH%WIKIPATHWAYS_20181110%WP3938%HOMO SAPIENS,0.7524792827061539,0.915314007578303,0.353039924322517,0.7756437488733872,5538,4,HMBOX1|HIPK2|HIPK1|CDKN1B
HEDGEHOG SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP4249%HOMO SAPIENS,0.398331595411887,0.7388683667002129,-0.22423996870633603,-1.04307593843869,3055,32,SMURF2|ARRB1|BOC|GAS1|SPOP|PRKACA|ADRBK1|CSNK1A1|CCND1
NOTCH1 REGULATION OF HUMAN ENDOTHELIAL CELL CALCIFICATION%WIKIPATHWAYS_20181110%WP3413%HOMO SAPIENS,0.334249084249084,0.6974768376198021,-0.29512722328160995,-1.0968070371398801,2554,16,DLL4|CALU|GJA5|JAG1|SAT1|NOTCH1|MGP|JAG2|PLAT|ALPL
TCA CYCLE (AKA KREBS OR CITRIC ACID CYCLE)%WIKIPATHWAYS_20181110%WP78%HOMO SAPIENS,0.138990585774059,0.504314492208813,-0.343726464240456,-1.3337865165498,1062,18,MDH2|IDH3A|IDH2|SUCLG2|ACO2|DLST|SDHC|FH|SDHB|SDHD|IDH3G|SDHA
PEPTIDE GPCRS%WIKIPATHWAYS_20181110%WP24%HOMO SAPIENS,0.0738569753810082,0.38235241303059603,-0.33874124964699104,-1.46036099187242,566,25,EDNRA|FPR3|FPR1|CXCR4|EDNRB|CCR1|C3AR1|SSTR2|C5AR1|ACKR1
EDA SIGNALLING IN HAIR FOLLICLE DEVELOPMENT%WIKIPATHWAYS_20181110%WP3930%HOMO SAPIENS,0.618953732912724,0.854944793214197,-0.31624943370260805,-0.8644537240838979,4708,7,RELB|WNT3
INTEGRATED BREAST CANCER PATHWAY%WIKIPATHWAYS_20181110%WP1984%HOMO SAPIENS,0.5650012745347951,0.829593590528481,-0.137962169059074,-0.9477094774744621,4432,142,BRCA1|NUP85|APOBEC3G|GRN|ABL1|E2F1|HMGCR|MAP3K13|MAX|RAP1A|NOXA1|PLK1|CDK7|TGFBR2|ARAF|FADD|MYC|NFKB1|FAU|RRAS|ANXA1|TFPI|PHB|CCND1|XRCC3|BAD
PREGNANE X RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2876%HOMO SAPIENS,0.5267735797771129,0.809755446473093,0.24917432418652602,0.9382239706293091,3875,16,ABCC4|ABCB1
THE HUMAN IMMUNE RESPONSE TO TUBERCULOSIS%WIKIPATHWAYS_20181110%WP4197%HOMO SAPIENS,0.243624950961161,0.626307484145885,-0.287011803094945,-1.18859055470725,1862,22,IFIT3|OAS1|IFNGR1|IFNAR1|SOCS1|IFIT1|IFI35|IFITM1
INTERFERON TYPE I SIGNALING PATHWAYS%WIKIPATHWAYS_20181110%WP585%HOMO SAPIENS,0.6908038585209,0.887747551871237,-0.157184423010624,-0.8522989641959721,5370,54,EIF4B|IFNAR2|RPS6|PTPN11|PIAS1|MAP3K1|FYN|MAPK14|MLST8|RPS6KA5|RAC1|PRMT1|STAT5A|GNB2L1|EIF4EBP1|SOCS3|IFNAR1|RAPGEF1|VAV1|IRS1|SOCS1|STAT3|PTPN6|RPTOR|MAP2K3|RAP1A|RPS6KB1|RPS6KA4|MAPKAP1
BLADDER CANCER%WIKIPATHWAYS_20181110%WP2828%HOMO SAPIENS,0.189391979301423,0.563467720122429,-0.25652929090639104,-1.2352603253038301,1463,36,TYMP|HRAS|E2F1|HBEGF|THBS1|ARAF|MMP9|MYC|CCND1
ACETYLCHOLINE SYNTHESIS%WIKIPATHWAYS_20181110%WP528%HOMO SAPIENS,0.24053129931614897,0.624461333747413,-0.50654978907128,-1.21410318580735,1828,5,CHKA|ACHE|PCYT1A|PDHA1
PREIMPLANTATION EMBRYO%WIKIPATHWAYS_20181110%WP3527%HOMO SAPIENS,0.9683453237410071,0.9912626134248801,-0.12337844624191399,-0.5633218309011171,7402,30,PBX1|ZFP36L2|ZFP36|ATP1A1|DDIT3|SOX11|KHSRP|MYBL1|SMARCA4|AQP3|KLF4|GATA3|ESRRA|HNRNPAB
REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP1449%HOMO SAPIENS,0.0008959426596697811,0.0214437672455875,-0.277272082659036,-1.8093660571283998,6,111,CD40|IL1B|AKT1|CCL3|PIK3R5|TIFA|TNF|SYK|CD180|MLST8|CCL4|RAC1|TLR1|IRAK3|RNF216|NFKB2|TMED7|IFNAR1|TLR2|TICAM2|IRF5|SMAD6|TNFAIP3|IKBKE|SOCS1|MAPK9|PTPN6|CTNNAL1|CISH|PIK3CB|MAPK3|SPP1|IRF7|IRAK1|PIK3R3|TRAFD1|MAP2K3|PLK1|CD86|NFKBIA|OTUD5|FADD|TLR5|TICAM1|TRAF3|FBXW5|RELA|MAPK13|NFKB1|TLR4|TOLLIP|CD14|LY96|PELI3|SQSTM1
OVERVIEW OF NANOPARTICLE EFFECTS%WIKIPATHWAYS_20181110%WP3287%HOMO SAPIENS,0.259060578306948,0.636098664976652,-0.307557629827404,-1.1687940977523201,1979,17,PTGS1|COL4A1|HMOX1|FN1|CCND3
TGF-BETA RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP560%HOMO SAPIENS,0.0059423847048185,0.0896282632937151,-0.352353859879488,-1.82530386173401,45,46,TGIF1|SMAD5|INHBA|STAT3|MAPK9|LTBP1|MAPK3|SPP1|HRAS|TGFBR2|TGFBR3|THBS1|FKBP1A|SERPINE1|NFKB1|ENG|TFE3
KIT RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP304%HOMO SAPIENS,0.35459249676584703,0.7124978659342509,-0.193979617849398,-1.06812151872426,2740,57,VAV1|TBX2|MATK|GRB2|SOCS1|STAT3|PTPN6|SNAI2|MAPK3|HRAS|MITF|SNAI1|RPS6KB1|PRKCB|GRB10|BAD
DNA DAMAGE RESPONSE%WIKIPATHWAYS_20181110%WP707%HOMO SAPIENS,0.51430412371134,0.8027700841454759,-0.168582424182146,-0.9612904659679541,3990,65,SFN|CCNB2|ATRIP|CDKN1B|CDK4|FANCD2|PIDD1|RAD9A|CCND2|PML|RAD51|RPA2|CDK6|H2AFX|NBN|TNFRSF10B|RAD1|RAD17|CDC25C|CYCS|BRCA1|ABL1|E2F1|GADD45B|CCNB1|GADD45G|TLK2|MYC|CCND3|SMC1A|CCND1
SIGNAL TRANSDUCTION OF S1P RECEPTOR%WIKIPATHWAYS_20181110%WP26%HOMO SAPIENS,0.9138566552901021,0.9736820566706701,0.14876106289134802,0.648139484579236,6693,25,SMPD2|MAPK7|MAPK12|GNAI3|MAPK6
MYOMETRIAL RELAXATION AND CONTRACTION PATHWAYS%WIKIPATHWAYS_20181110%WP289%HOMO SAPIENS,0.16717752234993602,0.5394830373416389,-0.175754942041394,-1.1956912709344398,1308,136,ATF3|GRK4|DGKZ|ACKR3|PRKCH|ACTG1|CNN2|PRKAR2A|GJA1|GRK5|ADM|RGS1|GNG8|RYR2|ITPR2|RGS16|PLCB3|CALM3|ITPR3|ATF1|ETS2|PDE4B|MYLK2|ATP2A3|CREB3|ADCY8|RGS18|PDE4D|PRKAR1A|PRKD1|RGS4|ARRB1|CAMK2B|ADCY4|GNG11|GNAQ|NOS3|GRK6|IGFBP6|CAMK2A|IGFBP5|NFKB1|PRKACA|ACTB|ACTA2|ATF5|RGS2|GNG3|IGFBP4|RGS3|PRKCB|ADCY9|CNN1
FTO OBESITY VARIANT MECHANISM%WIKIPATHWAYS_20181110%WP3407%HOMO SAPIENS,0.8350867964229352,0.945788393670804,-0.29443057716799703,-0.7056939109463571,6349,5,TBX1|ARID5B
BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2380%HOMO SAPIENS,0.11278195488721801,0.460292399693505,-0.18508972659089004,-1.26181220797328,884,137,GRB2|MEF2C|IRS1|STAT3|MAPK9|SYN1|MAPK3|RHOG|SPP1|HRAS|NTRK2|RAP1A|NCF2|NFKBIA|PPP2CA|BMP2|NSF|CAMK2A|EIF2S1|RELA|CFL1|RPS6KB1|NFKB1|TIAM1|ALPL|NCK1|NGFR|GRIA1|SQSTM1|SIRPA|BAD
CALORIC RESTRICTION AND AGING%WIKIPATHWAYS_20181110%WP4191%HOMO SAPIENS,0.604009372559229,0.848175106515994,-0.30487064923603097,-0.877679929320189,4639,8,SIRT1|MTOR|PPARGC1A|TP53|NAMPT|PRKAB2|AKT1|IGF1
PDGF PATHWAY%WIKIPATHWAYS_20181110%WP2526%HOMO SAPIENS,0.0524883359253499,0.331996459809677,-0.302187308209916,-1.4922758006054,404,39,VAV1|ELK1|GRB2|PLA2G4A|STAT3|MAPK3|HRAS|NFKBIA|ARFIP2|SRF|PDGFRB|PDGFA|TIAM1|PDGFB
NUCLEOTIDE METABOLISM%WIKIPATHWAYS_20181110%WP404%HOMO SAPIENS,0.10014456564594601,0.43605057892447596,-0.355166169463845,-1.4032284014698502,761,19,SRM|MTHFD2|RRM2|SAT1|POLD1|HPRT1|DHFR|PRPS1|POLA1|RRM1
HUMAN THYROID STIMULATING HORMONE (TSH) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2032%HOMO SAPIENS,0.243710488969165,0.626320329556411,-0.20470864145170398,-1.15762967300048,1888,63,PDE4D|STAT3|TTF1|MAPK3|HRAS|E2F1|PLD1|GNAI2|GNAQ|MAP2K3|RAP1A|MYC|CCND3|RPS6KB1|APEX1|RAP1GAP
FOCAL ADHESION-PI3K-AKT-MTOR-SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP3932%HOMO SAPIENS,0.0001271132579128,0.00518555396908895,-0.25679132592589005,-1.97067027816908,0,257,HSP90B1|ANGPT2|PIK3C2A|ITGA10|LPAR6|EIF4EBP1|RAB14|LIPE|ITGA11|ITGB2|IFNAR1|LAMC2|COL11A2|FGFR4|KDR|LAMC3|CREB3L2|HGF|SLC2A1|NGF|PDGFD|ITGB5|PFKFB2|PHLPP1|PFKFB3|LAMA2|VEGFC|INS|STRADA|VTN|CREB3|TNXB|ITGA5|EFNA1|PDGFC|FLT4|VWF|COL5A3|GRB2|IRS1|IL2RA|CSF3R|PIK3CB|PELO|OSM|CREB3L1|FGF10|MAPK3|SPP1|GNGT2|COL4A1|COMP|LAMA4|HRAS|IGF1|COL4A2|RPTOR|GNG11|CHRM2|COL5A2|CSF1|HIF3A|PIK3R4|EPHA2|F2R|FN1|IL3RA|NOS3|PPP2CA|VEGFB|FGF19|EFNA3|TNC|GNG10|FGF9|THBS1|TEK|FGF7|COL1A2|COL1A1|THBS2|PDGFRB|ITGA8|COL3A1|DDIT4|RPS6KB1|SLC2A3|PDGFA|HSP90AA1|CSF1R|PDGFRA|COL5A1|OSMR|PPP2R2B|GNG3|COL6A2|RPS6KB2|PDGFB|NGFR|EFNA5|ITGB4|BAD
VITAMIN A AND CAROTENOID METABOLISM%WIKIPATHWAYS_20181110%WP716%HOMO SAPIENS,0.568274734260016,0.831514598829999,0.20753731327612102,0.917723709080116,4169,26,CRABP1|RETSAT|RARG|CRABP2|CYP2E1
HIF1A AND PPARG REGULATION OF GLYCOLYSIS%WIKIPATHWAYS_20181110%WP2456%HOMO SAPIENS,0.0207676130389064,0.19869002861775198,-0.618224886585813,-1.68989015813705,157,7,TPI1|GPD1|SLC2A1|GAPDH|LDHA|PPARG
VIRAL ACUTE MYOCARDITIS%WIKIPATHWAYS_20181110%WP4298%HOMO SAPIENS,0.0150375939849624,0.16514429309347597,-0.28352003706204304,-1.63276015557186,115,68,NFKB2|ITGB2|CD4|PARP1|LAMA2|CASP1|CXCR4|CAAP1|CYCS|SOCS1|STAT3|MAPK3|ABL1|EIF4G2|AIF1|TLR5|TICAM1|MMP9|CAV1|TLR4|ACTB|CD55|CCND1|CASP6|ENDOG|EIF4G1
CARDIAC PROGENITOR DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2406%HOMO SAPIENS,0.17869236780411601,0.55175028994035,-0.271479054692836,-1.25113107547942,1371,31,LIN28B|SOX17|KDR|INS|THY1|MESP1|CXCR4|NOTCH1|INHBA|MEF2C|IGF1|ANPEP|PDGFRA|SIRPA
POLYOL PATHWAY%WIKIPATHWAYS_20181110%WP690%HOMO SAPIENS,0.013705993012631,0.15568240760094798,0.839946354780669,1.6520753596624398,101,3,KHK|SORD
VITAMINS A AND D - ACTION MECHANISMS%WIKIPATHWAYS_20181110%WP4342%HOMO SAPIENS,0.7292385248076411,0.906471456078912,-0.502619244554728,-0.836438797799374,5496,2,RXRA|RARA
MIR34A AND TGIF2 IN OSTEOCLASTOGENESIS%WIKIPATHWAYS_20181110%WP2866%HOMO SAPIENS,0.833979933110368,0.944960431871976,-0.586623290692545,-0.78152307976125,6233,1,TGIF2
PATHOGENIC ESCHERICHIA COLI INFECTION%WIKIPATHWAYS_20181110%WP2272%HOMO SAPIENS,0.0230033600413544,0.211174415545936,-0.307211124637379,-1.61050055065734,177,48,TUBA1B|HCLS1|ARPC1A|WAS|TUBA4A|KRT18|ABL1|TUBB4A|ARPC5L|TLR5|TLR4|ACTB|TUBB4B|NCK1|CD14|LY96|TUBB6|OCLN
LNCRNA INVOLVEMENT IN CANONICAL WNT SIGNALING AND COLORECTAL CANCER%WIKIPATHWAYS_20181110%WP4258%HOMO SAPIENS,0.435398686074971,0.7622670566428509,-0.17246831408955401,-1.00813733792094,3379,72,CCND2|APC|CDK6|PORCN|EZH2|SOX17|SFRP4|RYK|RUVBL1|HNRNPU|SFRP2|PLAU|FRAT1|FZD2|FZD8|SENP2|NKD2|LRP5|HNRNPK|H19|MYC|CHD8|CCND3|WNT3|CSNK1A1|CCND1|SERPINF1
MIRS IN MUSCLE CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP2012%HOMO SAPIENS,0.140208877284595,0.504613420930072,-0.31549865847350606,-1.3246468335196298,1073,23,ID2|PRKCH|PRKAR2A|MEF2D|EZH2|PRKAR1A|MEF2C|PRKD1|SRF|PRKACA|PRKCB
FATTY ACID BETA OXIDATION%WIKIPATHWAYS_20181110%WP143%HOMO SAPIENS,0.166372162566263,0.5386230242605929,0.275245401055434,1.27430265992978,1223,30,HADHB|HADHA|GPD2|ACADVL|ACADM|ACAT1|CPT1B|GCDH|CHKB|ECI1|ACADS|CPT1A|ECHS1|DLD
H19 ACTION RB-E2F1 SIGNALING AND CDK-BETA-CATENIN ACTIVITY%WIKIPATHWAYS_20181110%WP3969%HOMO SAPIENS,0.390665967488201,0.7364714265545841,-0.297455207497689,-1.05235302614718,2979,14,E2F1|H19|H2AFY|CCND1
HYPOXIA-MEDIATED EMT AND STEMNESS%WIKIPATHWAYS_20181110%WP2943%HOMO SAPIENS,0.890273311897106,0.965159112268525,0.39619520264681607,0.6656590952799251,6644,2,ZEB1|DICER1
METASTATIC BRAIN TUMOR%WIKIPATHWAYS_20181110%WP2249%HOMO SAPIENS,0.12841745531020002,0.48544201720890606,-0.5029049272791629,-1.37466819199249,976,7,E2F3|MIRLET7BHG|CDC42|CDK6|MYC
CYTOPLASMIC RIBOSOMAL PROTEINS%WIKIPATHWAYS_20181110%WP477%HOMO SAPIENS,0.870158002038736,0.9573965249923859,-0.12243973995499599,-0.75310426644275,6828,87,RPS28|RPLP1|RPS18|RPL9|RPL28|RPS3|RPS5|RPS10|RPS15|RPS6KA3|RPL29|RPL11|RPS6|RPL36|RPL17|RPL32|RPL23|RPLP0|RPL10A|RPL8|RPS23|RPL3|RPL7A|RPS2|RPL15|RPL37|RPL27A|RPL18|RPL39|RPL27|RPS6KA1|RPLP2|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|RPL35|RPL38|RPS15A|RPS13|RPS6KB1|FAU|RPS6KB2
LIPID METABOLISM PATHWAY%WIKIPATHWAYS_20181110%WP3965%HOMO SAPIENS,0.603881724632018,0.848175106515994,-0.20700773821469698,-0.8924393655024899,4635,25,PDHA1|PNPLA2|PRKAR1A|ABHD5|PRKACA|FASN
SPLICING FACTOR NOVA REGULATED SYNAPTIC PROTEINS%WIKIPATHWAYS_20181110%WP4148%HOMO SAPIENS,0.647195657792711,0.869851601649336,-0.180053901756364,-0.8746921493476891,5007,37,EPB41L1|MAPK4|NEO1|STXBP2|CAV2|CASK|GRIN1|MAPK9|SNW1|EPB41L2|GPHN|RAP1GAP|EFNA5|CADM3
TRYPTOPHAN METABOLISM%WIKIPATHWAYS_20181110%WP465%HOMO SAPIENS,0.0256577233654598,0.22470485454905398,-0.3512018145449439,-1.61853924399102,196,31,CYP1B1|ALDH2|KYNU|WARS|HAAO|INMT|ALDH1A1|CAT|ALDH1A2|CYP7B1|AFMID|HSD17B10|HADH|DHCR24
EXTRACELLULAR VESICLES IN THE CROSSTALK OF CARDIAC CELLS%WIKIPATHWAYS_20181110%WP4300%HOMO SAPIENS,0.00013075313807531399,0.00518555396908895,-0.6114355594123871,-2.37259736949675,0,18,KDR|ETS2|STAT3|CD63|SPP1|HSPB1|SOD1|IGF1|MMP9|TLR4|BIRC5|CD81
GABA RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP4159%HOMO SAPIENS,0.40834750752322396,0.7445496113654559,-0.27171589303907,-1.0325867455403,3120,17,GPHN|GABRQ|AP2M1
GLOBO SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20181110%WP1424%HOMO SAPIENS,0.6711145996860279,0.8815356925073421,-0.22523287768344,-0.837052585293835,5129,16,ST3GAL1|ST6GALNAC4|FUT9|A4GALT|GBGT1
PHOSPHODIESTERASES IN NEURONAL FUNCTION%WIKIPATHWAYS_20181110%WP4222%HOMO SAPIENS,0.0663814339426942,0.3690551432905871,-0.289994135482185,-1.45232114638964,511,41,PDE4B|GRIN1|PDE12|ADCY8|PDE4D|PDE2A|ADCY4|PDE1C|PDE1A|PDE1B|GRIN2C|GRIN2D|PDE4A|PDE6G|GRIA1|ADCY9
SOMATROPH AXIS (GH) AND ITS RELATIONSHIP TO DIETARY RESTRICTION AND AGING%WIKIPATHWAYS_20181110%WP4186%HOMO SAPIENS,0.645310166960771,0.8690722676292859,0.32392035739893,0.838162963273276,4753,6,IGF1R|SIRT1|MTOR|FOXO1|AKT1|PTEN
HFE EFFECT ON HEPCIDIN PRODUCTION%WIKIPATHWAYS_20181110%WP3924%HOMO SAPIENS,0.0342887056667975,0.264364643644243,-0.716052046487529,-1.5675876115319398,261,4,HAMP|HFE|ID1
DICLOFENAC METABOLIC PATHWAY%WIKIPATHWAYS_20181110%WP2491%HOMO SAPIENS,0.28157789879134004,0.654669602959902,0.8616012351124829,1.1488289887067802,2119,1,CYP2C8
GPR40 PATHWAY%WIKIPATHWAYS_20181110%WP3958%HOMO SAPIENS,0.758705114254625,0.9172140592138721,0.226058889912978,0.768330197920728,5577,12,PLCD1|PLCD3|PKD1|PLCG1
LUNG FIBROSIS%WIKIPATHWAYS_20181110%WP3624%HOMO SAPIENS,0.0134349567239375,0.15397669086860097,-0.328210292910581,-1.70023258810173,103,46,IL1B|CCL3|TNF|CCL4|TGFB1|GREM1|CXCL2|CCL11|TERT|SKIL|HGF|PLAU|ELN|SERPINA1|CTGF|MECP2|SPP1|HMOX1|IGF1|CEBPB|CYSLTR2|CCL2|MT2A|FGF7|MMP9|PDGFA|TIMP1|PDGFB
TARGET OF RAPAMYCIN (TOR) SIGNALING%WIKIPATHWAYS_20181110%WP1471%HOMO SAPIENS,0.435200831925127,0.7621997649653159,-0.21427890167674102,-1.0152070991661701,3347,34,AKT1|CDC42|MLST8|RAC1|RRAGB|IDI1|EIF4EBP1|RRAGA|PRR5L|HMGCR|RPTOR|FKBP1A|DDIT4|RPS6KB1|MAPKAP1|RRAGD
REGULATION OF APOPTOSIS BY PARATHYROID HORMONE-RELATED PROTEIN%WIKIPATHWAYS_20181110%WP3872%HOMO SAPIENS,0.636114016736402,0.8637819146582121,-0.222593874835827,-0.8637470192429151,4864,18,BAK1|GSK3B|MCL1|AKT1|PTHLH|BCL2A1|BCL2L2|MYC|BCL2L12|ITGB4
BUTYRATE-INDUCED HISTONE ACETYLATION%WIKIPATHWAYS_20181110%WP2366%HOMO SAPIENS,0.9259750596975319,0.9788732664014979,-0.379156327543424,-0.630976760687712,6979,2,ACLY|AKT1
MRNA PROCESSING%WIKIPATHWAYS_20181110%WP411%HOMO SAPIENS,0.000127975428717686,0.00518555396908895,-0.30252299148637896,-2.02117483103748,0,125,DICER1|SRP54|SNRPA|SF3B3|DDX20|PRMT2|RNMT|PRPF8|SNRPD3|SRSF4|SF3A3|CSTF2|HNRNPA1|DNAJC8|SUGP1|SF3A2|PRMT1|SF3B4|CPSF1|SNRPE|CLK4|CELF2|YBX1|DHX9|PTBP1|SRSF3|TXNL4A|HNRNPH1|SF3A1|SRSF10|HNRNPL|NCBP2|PRPF4|RBM17|DHX8|SNRPB2|SRSF9|HNRNPU|RBMX|CELF1|HNRNPH2|CPSF2|CD2BP2|SRSF5|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|SNRPA1|HNRNPM|CLP1|CELF4|EFTUD2|SREK1|HNRNPR|NXF1|NONO|CSTF3|FUS|HNRNPK|SNRPB|TRA2B|PABPN1|SRSF2|SPOP|TMED10|SF3B2|SMC1A|HNRNPC|HNRNPAB
TFS REGULATE MIRNAS RELATED TO CARDIAC HYPERTROPHY%WIKIPATHWAYS_20181110%WP1559%HOMO SAPIENS,0.7737907465825451,0.922601613703136,-0.27220794027842304,-0.7440682658112528,5886,7,AKT1|TGFB1|STAT3|NFKB1
CELL DIFFERENTIATION - INDEX%WIKIPATHWAYS_20181110%WP2029%HOMO SAPIENS,0.34989539748953996,0.7075366679683229,-0.346204197425732,-1.08461255688482,2675,10,MEF2D|MEF2C|STAT3|HDAC5|SRF
HYPOTHETICAL CRANIOFACIAL DEVELOPMENT PATHWAY%WIKIPATHWAYS_20181110%WP3655%HOMO SAPIENS,0.980107315796362,0.993436724391485,-0.240445596426405,-0.526385672737556,7488,4,ARHGAP29|IRF6|RHOA|TGFB3
P38 MAPK SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP400%HOMO SAPIENS,0.553904314952418,0.823817634479299,-0.19842308508755602,-0.9318508217496649,4248,33,MAP3K1|MAPK14|TGFB2|DDIT3|CDC42|RPS6KA5|RAC1|MEF2D|HMGN1|ELK1|TRAF2|MAPKAPK2|GRB2|PLA2G4A|HSPB1|HRAS|MAX|MYC
ARIPIPRAZOLE METABOLIC PATHWAY%WIKIPATHWAYS_20181110%WP2640%HOMO SAPIENS,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
HAIR FOLLICLE DEVELOPMENT: CYTODIFFERENTIATION (PART 3 OF 3)%WIKIPATHWAYS_20181110%WP2840%HOMO SAPIENS,0.175626776944947,0.548366806412612,-0.236822526089799,-1.24150064267977,1358,48,NR3C1|HR|RUNX3|CD34|GATA3|NOTCH1|PERP|CTGF|NOTCH2|IGF1|NFATC1|LRIG1|GAS1|CD200|IGFBP5|NFKB1|S100A4|KRT19
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA PATHWAY%WIKIPATHWAYS_20181110%WP4206%HOMO SAPIENS,0.948613484032067,0.984457616015067,-0.147102252460874,-0.581187276042912,7217,19,ACACA|HIF1A|PDK1|RPS6|KEAP1|PRKAB1|SLC11A2|SLC2A1|PDHA1|LDHA
INSULIN SIGNALLING IN HUMAN ADIPOCYTES (NORMAL CONDITION)%WIKIPATHWAYS_20181110%WP3634%HOMO SAPIENS,0.650893796004206,0.8721945267113571,-0.30668982858919397,-0.8383229698108859,4951,7,IRS1|RPS6KB1
ANDROGEN RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP138%HOMO SAPIENS,0.690670405302065,0.8876449311041049,-0.142494309179214,-0.8656582049325501,5418,83,TGIF1|STAT3|PARK7|BRCA1|CALR|FLNA|RAN|KAT7|NCOA4|KAT2B|FHL2|PPAP2A|CAV1|FKBP4|RELA|KAT5|CCND1
TYPE 2 PAPILLARY RENAL CELL CARCINOMA%WIKIPATHWAYS_20181110%WP4241%HOMO SAPIENS,0.8760427528675699,0.9607117102951591,-0.148608567935223,-0.691268476147811,6720,32,TGFB2|VHL|CREBBP|TCEB2|PRCC|TGFB1|SLC2A1|FH|TGFB3|COL21A1|TFE3|PDGFB
INHIBITION OF EXOSOME BIOGENESIS AND SECRETION BY MANUMYCIN A IN CRPC CELLS%WIKIPATHWAYS_20181110%WP4301%HOMO SAPIENS,0.0847280334728034,0.40376145987147494,-0.370177714067606,-1.4364272033625,647,18,MRAS|RAB5C|HNRNPH1|HGS|MAPK3|HRAS|RRAS2|ARAF|RRAS
EV RELEASE FROM CARDIAC CELLS AND THEIR FUNCTIONAL EFFECTS%WIKIPATHWAYS_20181110%WP3297%HOMO SAPIENS,0.144923724355602,0.5122531353179961,-0.561328038826384,-1.3453961978181899,1101,5,MYB|KLF2|CXCL12|TNF|RGS16
IL-5 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP127%HOMO SAPIENS,0.44908245024554205,0.768229288546963,-0.20625653408257502,-1.00198312479677,3474,37,RPS6|PTPN11|MAP2K2|GSK3B|AKT1|RAF1|MAPT|SYK|STAT5A|LYN|RPS6KA1|ELK1|CSF2RB|GRB2|STAT3|MAPK3|MYC|RPS6KB1|RPS6KB2
FAS LIGAND (FASL) PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS (HSP) REGULATION%WIKIPATHWAYS_20181110%WP314%HOMO SAPIENS,0.533566614826335,0.812141765487046,-0.19189287954230902,-0.9476145842980159,4116,39,PARP1|CASP10|ARHGDIB|NFX1|MAPKAPK2|CYCS|LMNB1|HSPB1|LMNA|FADD|ACTB|CASP6
WNT/BETA-CATENIN SIGNALING PATHWAY IN LEUKEMIA%WIKIPATHWAYS_20181110%WP3658%HOMO SAPIENS,0.697493870879869,0.8915023536035749,0.19462428458179298,0.8262666564866,5120,23,DKK1|PPARD|SALL4|TCF3
PHOTODYNAMIC THERAPY-INDUCED UNFOLDED PROTEIN RESPONSE%WIKIPATHWAYS_20181110%WP3613%HOMO SAPIENS,0.320046893317702,0.68808212387829,-0.256836449795101,-1.10725792315709,2456,25,XBP1|NARS|UBE2E1|TRIB3|EDEM1|PPP1R15A|DDIT3|ASNS|ATF3|DNAJC3|HSP90B1|BCL2L11|WARS|CALR|HSPA5|DNAJB11|ERN1
NCRNAS INVOLVED IN STAT3 SIGNALING IN HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20181110%WP4337%HOMO SAPIENS,0.14521408930208202,0.5122531353179961,-0.38746538058987,-1.3337309780151,1108,13,IL6ST|STAT3|IL11|RELA|NFKB1
IRINOTECAN PATHWAY%WIKIPATHWAYS_20181110%WP229%HOMO SAPIENS,0.268631303208906,0.642691584293687,-0.45550497304452003,-1.17168149738135,2050,6,CES1|BCHE|ABCC1
INITIATION OF TRANSCRIPTION AND TRANSLATION ELONGATION AT THE HIV-1 LTR%WIKIPATHWAYS_20181110%WP3414%HOMO SAPIENS,0.21750455847877104,0.599749083078075,-0.26148387004974,-1.20506753615304,1669,31,NFATC1|HDAC5|NELFB|NFKBIA|HDAC8|RELA|NFKB1|SUPT4H1
WNT SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP428%HOMO SAPIENS,0.33076626877165993,0.6957352559323989,-0.174190728717634,-1.07816641625048,2576,90,SOX17|PLCB3|SFRP4|RYK|SFRP2|PLAU|FRAT1|FZD2|FZD8|SENP2|MAPK9|DAAM2|CAMK2B|VANGL1|NKD2|NFATC1|LRP5|CAMK2A|MYC|CHD8|CCND3|WNT3|PRICKLE2|CSNK1A1|CCND1|SERPINF1|PRKCB
GLUCURONIDATION%WIKIPATHWAYS_20181110%WP698%HOMO SAPIENS,0.653097105761428,0.8737330292038951,0.301244020557035,0.8315760328855211,4828,7,PGM1|PGM3|UGDH|PGM2
FIBRIN COMPLEMENT RECEPTOR 3 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP4136%HOMO SAPIENS,0.008763897972531071,0.11733137778745902,-0.390267339463993,-1.78188426669518,66,30,IRAK1|CCL2|TICAM1|TYROBP|PLAT|NFKB1|TLR4|ITGAM|CD14|LY96
PHYTOCHEMICAL ACTIVITY ON NRF2 TRANSCRIPTIONAL ACTIVATION%WIKIPATHWAYS_20181110%WP3%HOMO SAPIENS,0.640461642905635,0.8669133852194699,0.243868786928125,0.8540793353287159,4716,13,EPHB2|NQO1|NFE2L2|PRKCA|GCLM|MAPK8|GCLC|PIK3CA
PYRIMIDINE METABOLISM%WIKIPATHWAYS_20181110%WP4022%HOMO SAPIENS,0.0640450877417702,0.36261562327913,-0.232958785803385,-1.4002710457553602,499,80,POLR2J|DCTPP1|POLD4|ZNRD1|POLR3B|TWISTNB|POLD1|POLD2|POLR2H|POLR3K|TYMP|CTPS1|CDA|UMPS|NME2|CMPK2|TK1|POLR2G|POLE2|POLA1|POLE3|RRM1|POLA2|NME1|UCK1|POLR2L
DEREGULATION OF RAB AND RAB EFFECTOR GENES IN BLADDER CANCER%WIKIPATHWAYS_20181110%WP2291%HOMO SAPIENS,0.7508486082824171,0.914525542528874,0.221494352612226,0.775719401572573,5529,13,GCC2|RPH3A|SYTL3|SYTL4|MYRIP
SULFATION BIOTRANSFORMATION REACTION%WIKIPATHWAYS_20181110%WP692%HOMO SAPIENS,0.26040250203970605,0.636316525692816,0.37107010905697896,1.1755751880121101,1914,10,PAPSS1|SULT1C4|SULT4A1
CARDIAC HYPERTROPHIC RESPONSE%WIKIPATHWAYS_20181110%WP2795%HOMO SAPIENS,0.8582636655948549,0.949948023858,-0.134392592631995,-0.72871513157585,6672,54,CALM1|CDK9|TGFBR1|MAP3K14|CHUK|PPP3CA|MAP4K1|MAP3K1|MAP2K2|MAPK14|GSK3B|NRG1|AKT1|RAF1|TNF|NFATC2|PRKG1|RAC1|TGFB1|GUCA1A|CALM3|PLA2G2A|IKBKE|PRKD1|MAPK3|IGF1|HDAC5|MAP2K3|CDK7|NFKB1|TNFRSF1A
SPINAL CORD INJURY%WIKIPATHWAYS_20181110%WP2431%HOMO SAPIENS,0.000768836494105587,0.0191058847417112,-0.30749177209715506,-1.91475621979806,5,92,IL1B|CDKN1B|CDK4|GAP43|CDC42|TNF|RAC1|CXCL1|MMP12|TGFB1|CXCL2|AQP1|NR4A1|GJA1|TNFSF13B|NCAN|SEMA6A|LILRA6|PLA2G2A|LILRB3|GRIN1|LILRB2|ACAN|LTB4R|C1QB|CD47|ICAM1|MAPK3|COL4A1|NTN1|VCAN|E2F1|FCGR2A|TNFSF13|CCL2|LGALS3|AIF1|EPHA4|SLIT2|FKBP1A|MMP9|MYC|IL1R1|TLR4|VIM|APEX1|ANXA1|CCND1|NGFR
ROLE OF OSX AND MIRNAS IN TOOTH DEVELOPMENT%WIKIPATHWAYS_20181110%WP3971%HOMO SAPIENS,0.39213131839499704,0.737280445732591,-0.347257397939402,-1.04463525204357,3009,9,KLF4|NOTCH1|NOTCH2|NOTCH3|ALPL
HEPATITIS C AND HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20181110%WP3646%HOMO SAPIENS,0.40692417000387604,0.744155386421619,-0.19880557637479898,-1.0298754394667,3149,46,MMP1|E2F2|GRB2|STAT3|BRCA1|MAPK3|COL4A2|MYC|NFKB1|MYOF|BIRC5|CCND1
ETHANOL EFFECTS ON HISTONE MODIFICATIONS%WIKIPATHWAYS_20181110%WP3996%HOMO SAPIENS,0.7030104712041889,0.893519294981778,-0.18492624637069396,-0.825901299074336,5370,28,ALDH1A1|HDAC5|DHFR|ALDH1A2|KAT2B|HDAC8
REGULATION OF MICROTUBULE CYTOSKELETON%WIKIPATHWAYS_20181110%WP2038%HOMO SAPIENS,0.563574778530485,0.828821766028182,-0.182722803341226,-0.9267637344682729,4325,43,AKT1|ROCK1|MAPT|CDC42|PTEN|RAC1|APC|TPPP|CLIP1|MAPKAPK2|PHLDB2|STAT3|ABL1|GNAQ|CFL2|MAP1B|PRKACA|TIAM1|MARK2
ZINC HOMEOSTASIS%WIKIPATHWAYS_20181110%WP3529%HOMO SAPIENS,0.24246771879483497,0.6254685188413179,-0.268455212986611,-1.18401864244928,1858,27,SLC39A13|MT1G|SLC39A1|SLC39A9|SLC39A3|SLC39A8|SLC39A11|MT1M|MT1L|MT2A|SLC30A5|MT1E
GLUTATHIONE METABOLISM%WIKIPATHWAYS_20181110%WP100%HOMO SAPIENS,0.672193530850775,0.881897889916793,0.22136117852118897,0.8334982528130179,4945,16,IDH1|GSTM2|GSTM1|GSS|GSTT2|GCLM|G6PD
VITAMIN B12 DISORDERS%WIKIPATHWAYS_20181110%WP4271%HOMO SAPIENS,0.920401250651381,0.9768322640118741,-0.20291832479534,-0.6104279897985899,7064,9,MMAB
CANNABINOID RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP3869%HOMO SAPIENS,0.423368146214099,0.753783909572009,-0.243095192915873,-1.0206549818559498,3242,23,AHR|DAGLB|PRKAR1A|MAPK9|MAPK3|DAGLA|MAPK13|PRKACA
OXIDATIVE PHOSPHORYLATION%WIKIPATHWAYS_20181110%WP623%HOMO SAPIENS,0.00012950012950013,0.00518555396908895,-0.445587088227714,-2.4754635672079597,0,59,NDUFV2|NDUFB8|NDUFS4|NDUFA4L2|NDUFB5|GZMB|NDUFA11|NDUFA9|ATP5J|NDUFA7|ATP5F1|NDUFB6|ATP5B|NDUFB9|ATP6AP2|NDUFB10|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|NDUFS6|NDUFB4|NDUFA2|NDUFAB1|ATP6AP1|NDUFA4|ATP5H|NDUFV1|NDUFS3|NDUFA8|NDUFS8|ATP5G1|NDUFV3
MAPK CASCADE%WIKIPATHWAYS_20181110%WP422%HOMO SAPIENS,0.96123221511552,0.990138923096717,-0.127884898980001,-0.578234154670708,7363,29,MAPK3|HRAS|MAP2K3|ARAF|RRAS
NON-HOMOLOGOUS END JOINING%WIKIPATHWAYS_20181110%WP438%HOMO SAPIENS,0.18163375710035198,0.554948538055731,0.467509090178177,1.2905462947593402,1342,7,NHEJ1|MRE11A|XRCC5|XRCC4|RAD50|PRKDC|XRCC6
ARYL HYDROCARBON RECEPTOR%WIKIPATHWAYS_20181110%WP2586%HOMO SAPIENS,0.313374805598756,0.6829583044507169,-0.223849464874953,-1.10542412052367,2417,39,KLF6|HRAS|E2F1|AIP|PLAGL1|CD36|MYC|RELA|NFKB1|HSP90AA1
TRANS-SULFURATION AND ONE CARBON METABOLISM%WIKIPATHWAYS_20181110%WP2525%HOMO SAPIENS,0.721678891605542,0.9019989179378242,0.180168885092962,0.8162533415000529,5312,28,AMT|MTHFR|SHMT1|GSS|AHCYL2|GCLM|MTHFD1L|DNMT3A|DHFRL1|CTH|MTHFD2L|MAT2A|PSAT1|GCLC
FOLATE METABOLISM%WIKIPATHWAYS_20181110%WP176%HOMO SAPIENS,0.000391287335333246,0.0111294649577428,-0.43164463182559004,-2.20037847977239,2,44,NFKB2|SLC19A1|SOD2|GPX1|INS|ICAM1|SOD3|SOD1|CSF1|CCL2|DHFR|RFK|CAT|GPX3|SERPINE1|LDLR|PLAT|RELA|NFKB1|SHMT2|FOLR2|MTHFD1
COMPLEMENT AND COAGULATION CASCADES%WIKIPATHWAYS_20181110%WP558%HOMO SAPIENS,0.00012956724540036298,0.00518555396908895,-0.5907350540850379,-2.97678430193676,0,42,PLAU|C2|C3|VWF|SERPINA1|CLTC|C1QB|F3|F8|C1QA|CFB|C1QC|C7|THBD|F2R|PLAUR|SERPINE1|C3AR1|PLAT|C1S|CFD|CFI|CD55|TFPI|SERPING1|C1R|CFH|C5AR1|SERPINF2
"GPCRS, CLASS B SECRETIN-LIKE%WIKIPATHWAYS_20181110%WP334%HOMO SAPIENS",0.43530210454853996,0.7622670566428509,0.28836148437941606,1.00990203795847,3205,13,CRHR1|PTH1R|GCGR|ADCYAP1R1|ADGRL2
TYPE III INTERFERON SIGNALING%WIKIPATHWAYS_20181110%WP2113%HOMO SAPIENS,0.679679284963197,0.8846407291948679,-0.298555033109528,-0.8160868691332459,5170,7,IL10RB|IFNLR1
STEROID BIOSYNTHESIS%WIKIPATHWAYS_20181110%WP496%HOMO SAPIENS,0.6243716886292621,0.857753590658582,0.392699714481266,0.862777996868979,4595,4,HSD17B3
WNT SIGNALING IN KIDNEY DISEASE%WIKIPATHWAYS_20181110%WP4150%HOMO SAPIENS,0.8017747440273041,0.9325377000668108,0.17310757565020599,0.754215200389043,5872,25,WNT6|WNT5B|WNT2B|DVL2|WNT4|LRP6|MAPK8|DVL1|FZD6
PROSTAGLANDIN SYNTHESIS AND REGULATION%WIKIPATHWAYS_20181110%WP98%HOMO SAPIENS,0.00103385887826312,0.0240545523142212,-0.424886781161186,-2.0640770803522,7,37,EDNRA|TBXAS1|PTGER1|PTGDS|ANXA6|CBR1|HSD11B1|PTGER4|PLA2G4A|TBXA2R|PTGS1|S100A10|EDNRB|MITF|PPARG|ANXA2|PTGIR|ANXA1|S100A6|PTGES|PTGIS
ATM SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2516%HOMO SAPIENS,0.72248147131485,0.9019989179378242,0.164681568578238,0.822790649239275,5263,39,TLK1|CDKN1A|MDC1|RIPK1|ATM|MRE11A|BID|AP3B2|CCNE1|TP53BP1|ATF2
MEVALONATE PATHWAY%WIKIPATHWAYS_20181110%WP3963%HOMO SAPIENS,0.14721345951629902,0.514454970046301,-0.49161248717479206,-1.3438008105463701,1119,7,PMVK|MVK|ACAT2|FDPS|HMGCR|HMGCS1
EGF/EGFR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP437%HOMO SAPIENS,0.363332905379381,0.7178370462804441,-0.14961727071456601,-1.04968174956349,2829,159,AKT1|AURKA|ROCK1|RAF1|MT-CO2|CDC42|ELK4|PTEN|RPS6KA5|RAC1|IQGAP1|PTPN5|RALGDS|SYNJ1|STAT5A|SOS2|IQSEC1|PLCE1|GJA1|MAP3K3|MAPK4|VAV3|RPS6KA1|MEF2D|EIF4EBP1|HGS|DNM1|TNK2|VAV1|ATF1|CAV2|ELK1|PCNA|SH3GL2|BCAR1|PLSCR1|DOK2|GRB2|MEF2C|STAT3|MAPK9|REPS2|ABL1|EPS15L1|HRAS|E2F1|PLD1|NEDD8|MYBL2|RAP1A|NOS3|ERRFI1|CAMK2A|CAV1|RIN1|CFL1|RPS6KB1|EPS8|NCK1|ARF6|AP2M1|PRKCB|SH3GL3|GRB10
ESTROGEN METABOLISM%WIKIPATHWAYS_20181110%WP697%HOMO SAPIENS,0.520177037229888,0.805333449898493,-0.326375671691115,-0.9395898791159609,3995,8,COMT|CYP1B1|ARSE|STS
THE EFFECT OF PROGERIN ON THE INVOLVED GENES IN HUTCHINSON-GILFORD PROGERIA SYNDROME%WIKIPATHWAYS_20181110%WP4320%HOMO SAPIENS,0.0356350345907845,0.268984415614395,-0.34743024888475393,-1.5709128902101699,272,29,RBBP7|E2F1|HIST2H3A|CBX1|HIST2H3C|MTA2|HIST1H3H|H3F3B|SUV39H1
NEUROTRANSMITTER DISORDERS%WIKIPATHWAYS_20181110%WP4220%HOMO SAPIENS,0.9165874201874742,0.9751624921048409,0.28798323498593703,0.632711431790126,6746,4,DDC|DBH|TH
METHYLATION PATHWAYS%WIKIPATHWAYS_20181110%WP704%HOMO SAPIENS,0.167794845092424,0.5400872099036179,-0.454505677538418,-1.3084582328182999,1288,8,COMT|INMT|HNMT|NNMT
VITAMIN B12 METABOLISM%WIKIPATHWAYS_20181110%WP1533%HOMO SAPIENS,0.00234619395203337,0.0450757749879636,-0.415013927272861,-1.9304811900958503,17,32,ABCA1|IL6|INSR|SCARB1|MTRR|HBB|IL1B|HBA1|TNF|TCN2|NFKB2|SOD2|INS|ICAM1|SOD3|SOD1|CCL2|APOE|SERPINE1|LDLR|PLAT|RELA|NFKB1|MMAB|SHMT2
CALCIUM REGULATION IN THE CARDIAC CELL%WIKIPATHWAYS_20181110%WP536%HOMO SAPIENS,0.214148404459823,0.597438672438672,-0.173918236703461,-1.15823498813384,1670,123,SLC8A3|GRK4|ADRB2|GJA5|PRKCH|PRKAR2A|GJA1|GRK5|RGS1|GNG8|CAMK1|RYR2|GJC2|ITPR2|ATP1B1|RGS16|PLCB3|PLN|CALM3|ITPR3|ATP1B3|ANXA6|ATP2A3|ADCY8|RGS18|PRKAR1A|PRKD1|RGS4|ARRB1|CAMK2B|CALR|ADCY4|GNG11|GNAI2|CHRM2|GNAQ|CACNA1E|GJA4|GRK6|FKBP1A|CAMK2A|ATP1B2|PRKACA|RGS2|GNG3|ATP2B2|RGS3|PRKCB|ADCY9
AMINO ACID METABOLISM%WIKIPATHWAYS_20181110%WP3925%HOMO SAPIENS,0.978630278063852,0.992937328049893,-0.10048575327581899,-0.5962996730022929,7601,76,OAT|ACO2|TDO2|ASNS|MCCC1|ACSS1|SRM|PDK4|DLST|IARS|P4HA2|PYCR1|MAOA|VARS|GOT1|ODC1|FH|PDHA1|WARS|SDHA|ALDH1A1|FTCD|SMS|LDHA|PDHX|HNMT|AOC3|HADH
OSTEOPONTIN SIGNALING%WIKIPATHWAYS_20181110%WP1434%HOMO SAPIENS,0.112216839072934,0.459194647507502,-0.40680373828484007,-1.4002973553323501,856,13,PLAU|MAPK3|SPP1|MMP9|RELA|NFKB1
PARKIN-UBIQUITIN PROTEASOMAL SYSTEM PATHWAY%WIKIPATHWAYS_20181110%WP2359%HOMO SAPIENS,0.00025779840164991,0.00819882332206558,-0.37359884509065294,-2.12156316330576,1,64,PSMD1|PSMC2|SEPT5|SNCAIP|TUBA1B|PSMD3|TUBA4A|CASP1|CASK|UBE2G2|SIAH2|PSMD4|HSPA6|HSPA1B|HSPA9|TUBB4A|PSMC4|UBA1|HSPA1A|PSMC6|PSMD10|PSMC1|PSMD2|PSMD6|PSMD12|HSPA5|UBE2L6|TUBB4B|HSPA4|PSMD13|TUBB6|PSMC5|PSMC3
DEVELOPMENT AND HETEROGENEITY OF THE ILC FAMILY%WIKIPATHWAYS_20181110%WP3893%HOMO SAPIENS,0.0158834339721712,0.170919785583578,-0.477053975620777,-1.73210565561319,120,15,IL6|ZBTB16|BCL11B|IL1B|TNF|ID2|NFIL3|IL18|RORA|AHR|GATA3|IL15|IL33
SEROTONIN AND ANXIETY%WIKIPATHWAYS_20181110%WP3947%HOMO SAPIENS,0.254257270107414,0.6334469481869079,-0.36745939412031897,-1.18966955851506,1940,11,PLEK|FMR1|POMC|CAMK2B|PRKCB
NANOPARTICLE-MEDIATED ACTIVATION OF RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP2643%HOMO SAPIENS,0.6469283944176341,0.8697778704754799,-0.195691692099602,-0.863095966886396,4959,27,TLN1|GRB2|MAPK9|PXN|HRAS|FN1|COL1A1|MAPK13
AMP-ACTIVATED PROTEIN KINASE (AMPK) SIGNALING%WIKIPATHWAYS_20181110%WP1403%HOMO SAPIENS,0.428589909443726,0.756703357174578,-0.18466258764092003,-1.0168186005795001,3312,57,ADIPOR1|CAMKK2|PIK3CB|PIK3R3|HMGCR|RPTOR|CCNB1|ADIPOR2|RPS6KB1|MEF2BNB-MEF2B|RPS6KB2|FASN
PTF1A RELATED REGULATORY PATHWAY%WIKIPATHWAYS_20181110%WP4147%HOMO SAPIENS,0.10270762822181698,0.441229839424518,-0.49637946888313705,-1.4290070174254599,788,8,HES1|NOTCH1|FGF10|KAT2B
MECP2 AND ASSOCIATED RETT SYNDROME%WIKIPATHWAYS_20181110%WP3584%HOMO SAPIENS,0.394355355997434,0.7376723208557521,-0.195161727250656,-1.04211262898826,3073,51,GRIN1|SGK1|CEBPD|SST|MEF2C|MECP2|CNP|E2F1|GPRIN1|CAMK2A|BCL6|FKBP5|GRIA1|MPP1
INTERLEUKIN-11 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2332%HOMO SAPIENS,0.16791915003886998,0.5400872099036179,-0.24831053388827398,-1.2512663573503502,1295,42,RPS6|PTPN11|PIAS1|FYN|MAP2K2|IL11RA|AKT1|RAF1|BGLAP|TGFB1|RPS6KA1|SOCS3|FES|ATF1|IL6ST|GRB2|STAT3|ICAM1|MAPK3|HRAS|PPP2R4|IL11|RELA|RPS6KB1|BIRC5
GASTRIC ACID PRODUCTION%WIKIPATHWAYS_20181110%WP2596%HOMO SAPIENS,0.764510559171205,0.9191113740914171,0.6177767975297751,0.82372200111806,5755,1,VIP
MONOAMINE TRANSPORT%WIKIPATHWAYS_20181110%WP727%HOMO SAPIENS,0.893048128342246,0.965443067117994,-0.15140978774049899,-0.667791134839984,6846,27,ACHE|AGT|SLC6A1|PVRL2|CDC25C|SYN1|TNFRSF11B|IL1R1
LEPTIN SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2034%HOMO SAPIENS,0.29191346896729303,0.664000960265434,-0.1885570366073,-1.11000506911289,2266,74,RPS6|PTPN11|RHOA|FYN|MAP2K2|MAPK14|GSK3B|PTPN1|PLCG2|IL1B|AKT1|ROCK1|RAF1|CDC42|PTEN|RAC1|RPS6KA1|EIF4EBP1|SH2B1|SOCS3|IL1RN|ELK1|GRB2|IRS1|STAT3|CISH|MAPK3|KPNA4|HRAS|NOS3|CFL2|RELA|RPS6KB1|NFKB1|CCND1|BAD
TAMOXIFEN METABOLISM%WIKIPATHWAYS_20181110%WP691%HOMO SAPIENS,0.837841493102516,0.946216977301937,0.252814552070241,0.6978877850506489,6194,7,CYP2E1|CYP2C8|CYP2D6
IL-7 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP205%HOMO SAPIENS,0.152533541748079,0.520203456525933,-0.30056014250461605,-1.2957568890200701,1170,25,FYN|MAP2K2|GSK3B|IL2RG|CDKN1B|AKT1|JAK3|STAT5A|STAT3|IL2RA|MAPK3|MYC|CCND1|BAD
GUT-LIVER INDOLE METABOLISM %WIKIPATHWAYS_20181110%WP3627%HOMO SAPIENS,0.17160313454642098,0.54516008272075,0.916023378914866,1.22139357413195,1291,1,CYP2E1
ASSOCIATION BETWEEN PHYSICO-CHEMICAL FEATURES AND TOXICITY ASSOCIATED PATHWAYS%WIKIPATHWAYS_20181110%WP3680%HOMO SAPIENS,0.653806451612903,0.8743526548195151,-0.160187214602391,-0.8737942732276569,5066,55,ELK1|GPX1|FZD2|FZD8|MYLK|GRB2|SOD1|FN1|PPP2CA|MYC|TMSB4X|NCK1|GRIA1
PHOTODYNAMIC THERAPY-INDUCED AP-1 SURVIVAL SIGNALING.%WIKIPATHWAYS_20181110%WP3611%HOMO SAPIENS,0.603344298245614,0.8481440389818871,0.171400695065513,0.904861392147598,4401,47,MAP3K5|TRAF5|MAP2K6|CDKN1A|MAPK12|MAPK11|MMP2|NFE2L2|BID|CCNE1|MAP2K7|ATF2|RB1|BAX|BCL2|EGFR|CFLAR|MAP2K4|MAPK8
SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR%WIKIPATHWAYS_20181110%WP313%HOMO SAPIENS,0.748602625763681,0.9131348696838739,-0.168813138939432,-0.7998001471109809,5758,34,RAPGEF1|HGF|ELK1|GRB2|STAT3|PXN|MAPK3|HRAS|DOCK1|RAP1A
MEVALONATE ARM OF CHOLESTEROL BIOSYNTHESIS PATHWAY WITH INHIBITORS%WIKIPATHWAYS_20181110%WP4189%HOMO SAPIENS,0.267577606792253,0.6417330323279019,-0.6990378685039711,-1.16331079775047,2016,2,HMGCR
TP53 NETWORK%WIKIPATHWAYS_20181110%WP1742%HOMO SAPIENS,0.049469964664311,0.318857627587799,0.41592915757081894,1.5661112235002101,363,16,BBC3|CDKN1A|BOK|PMAIP1|ATM|BID|SUMO1|BAX|BCL2
MIRNAS INVOLVED IN DNA DAMAGE RESPONSE%WIKIPATHWAYS_20181110%WP1545%HOMO SAPIENS,0.26634287214492003,0.641603173139009,-0.321109541949317,-1.1658966953540502,2028,15,ABL1|E2F1|MYC|CCND3|CCND1
THIAMINE METABOLIC PATHWAYS%WIKIPATHWAYS_20181110%WP4297%HOMO SAPIENS,0.11611559489716199,0.466085789276584,-0.486007993928508,-1.39914899262729,891,8,TKT|PDHA1|BCKDK|SLC25A19
"PHASE I BIOTRANSFORMATIONS, NON P450%WIKIPATHWAYS_20181110%WP136%HOMO SAPIENS",0.628683427953501,0.8598964527864159,0.35432101768577395,0.852140015676499,4650,5,PON2|CES2|ESD
IL17 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2112%HOMO SAPIENS,0.262162514673275,0.6380114459042441,-0.263367136749783,-1.1615777404768999,2009,27,IL17RE|IL17D|IL17B|CEBPD|STAT3|IL17RA|MAPK3|CEBPB|TRAF3|RELA|NFKB1
METHIONINE DE NOVO AND SALVAGE PATHWAY%WIKIPATHWAYS_20181110%WP3580%HOMO SAPIENS,0.266082635983264,0.641603173139009,-0.300406271823014,-1.16568805875894,2034,18,SRM|MSRB2|MSRA|ODC1|ADI1|SMS|IL4I1|MSRB3|APIP
PEROXISOMAL BETA-OXIDATION OF TETRACOSANOYL-COA%WIKIPATHWAYS_20181110%WP1941%HOMO SAPIENS,0.291061379400602,0.663400427230026,-0.532620084928032,-1.16601670350902,2223,4,ACAA1|HSD17B4|SCP2|ACOX1
COMPLEMENT ACTIVATION%WIKIPATHWAYS_20181110%WP545%HOMO SAPIENS,0.000130821559392988,0.00518555396908895,-0.692780053173511,-2.5746389271104304,0,16,C4A|C2|C3|C1QB|C1QA|CFB|C1QC|C7|CFP|C1S|CFD|CD55|C1R
ALLOGRAFT REJECTION%WIKIPATHWAYS_20181110%WP2328%HOMO SAPIENS,0.00219072164948454,0.0425827948792411,-0.321420371535791,-1.83280279794408,16,65,HLA-DRB1|CD40|HLA-DMA|IL1B|FOXP3|HLA-DMB|CXCL12|TNF|PRF1|HLA-B|GABPA|HLA-DPA1|MICA|TGFB1|HLA-E|HLA-DRA|HLA-DRB5|C4B|CCL19|GZMB|HLA-DPB1|HLA-DQA2|TUBA1B|HLA-C|C4A|HLA-A|C2|C3|C1QB|IL2RA|C1QA|C1QC|C7|CD86|VIM|PDGFRA|COL5A1|CD55
IL-9 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP22%HOMO SAPIENS,0.722368075610396,0.9019989179378242,-0.220859483633333,-0.8019049840205219,5502,15,CDK9|STAT5B|MAP2K2|IL2RG|JAK3|STAT5A|GRB2|STAT3|MAPK3
APOPTOSIS%WIKIPATHWAYS_20181110%WP254%HOMO SAPIENS,0.0552068656334059,0.341531902037667,-0.237479137747421,-1.42744202332562,430,80,BCL2L11|GZMB|TNFRSF10B|CASP10|IRF5|CDKN2A|BCL2L2|CASP1|TRAF2|TNFSF10|CYCS|CASP4|IRF7|IGF1|NFKBIA|TNFRSF21|XIAP|FADD|LTA|TRAF3|MYC|RELA|NFKB1|BIRC5|TNFRSF1A|CASP6|TNFRSF1B|BAD
GENOTOXICITY PATHWAY%WIKIPATHWAYS_20181110%WP4286%HOMO SAPIENS,0.693542125016177,0.8892653400737779,-0.155308750965727,-0.8504475930863281,5358,56,HIST1H2BC|CEBPD|SMAD5|SEL1L|BRMS1L|PTGER4|PPM1D|PCDH8|HIST1H2BG|SERTAD1|ACTA2|NLRX1
NONALCOHOLIC FATTY LIVER DISEASE%WIKIPATHWAYS_20181110%WP4396%HOMO SAPIENS,0.000127697612054655,0.00518555396908895,-0.352127972289265,-2.41407133405843,0,141,IL1B|COX4I1|UQCR11|AKT1|DDIT3|MT-CO2|CDC42|TNF|COX7C|CYC1|RAC1|NDUFC2|TGFB1|NDUFV2|NDUFB8|SDHC|NDUFS4|COX6C|NDUFA4L2|UQCRC1|BCL2L11|SOCS3|NDUFB5|UQCR10|NDUFA11|NDUFA9|NDUFA7|SDHB|MLX|INS|NDUFB6|TRAF2|SDHD|CYCS|IRS1|CEBPA|MAPK9|ADIPOR1|MLXIP|NDUFB9|PIK3CB|NDUFB10|SDHA|MT-CO3|PIK3R3|NR1H3|NDUFS7|NDUFB1|NDUFB7|NDUFA6|VCAM1|CCL2|NDUFS6|ADIPOR2|MAP3K11|NDUFB4|COX7B|NDUFA12|COX7A1|NDUFA2|NDUFAB1|COX4I2|NDUFA1|EIF2S1|PPARA|RELA|NDUFB11|NFKB1|NDUFA4|COX6B2|NDUFV1|UQCRQ|TNFRSF1A|NDUFS3|UQCRC2|COX6A1|COX8A|VMP1|NDUFA8|ERN1|NDUFS8|NDUFV3
UREA CYCLE AND METABOLISM OF AMINO GROUPS%WIKIPATHWAYS_20181110%WP497%HOMO SAPIENS,0.574175824175824,0.835204333784353,-0.24460096213232,-0.909031886570222,4388,16,ASS1|OAT|SRM|PYCR1|GATM|PYCRL|ODC1|CKB|SMS
INTERACTOME OF POLYCOMB REPRESSIVE COMPLEX 2 (PRC2) %WIKIPATHWAYS_20181110%WP2916%HOMO SAPIENS,0.669152276295133,0.8815356925073421,-0.225594613983776,-0.83839693745283,5114,16,TRIM35|STK38|EED|THRAP3|EZH1|BCLAF1|SUZ12|MTF2|RBBP4|JARID2|ELL|AEBP2|MORC3|SETX|EZH2|RBBP7
NICOTINE METABOLISM%WIKIPATHWAYS_20181110%WP1600%HOMO SAPIENS,0.48936454849498295,0.789206961498239,-0.758656815174239,-1.0107130420561201,3657,1,FMO3
ONE CARBON METABOLISM%WIKIPATHWAYS_20181110%WP241%HOMO SAPIENS,0.5684512179236679,0.831514598829999,-0.21239901553246301,-0.915681917448665,4363,25,TCN2|MTHFD2|TYMS|DNMT3B|FOLH1|GLRX|DNMT1|FTCD|DHFR|SHMT2|MTHFD1
EICOSANOID SYNTHESIS%WIKIPATHWAYS_20181110%WP167%HOMO SAPIENS,0.0018305439330543898,0.0366658253519131,-0.517312675965936,-2.00736557648636,13,18,ALOX5AP|ALOX5|LTC4S|TBXAS1|PTGDS|PLA2G2A|GGT1|PLA2G4A|PTGES2|PTGS1|DPEP1|PTGES|PTGIS
TOLL-LIKE RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP3858%HOMO SAPIENS,0.00534968684759916,0.0829378624098312,-0.44559996239699395,-1.94378841076231,40,26,TLR1|NFKB2|TLR2|TICAM2|IKBKE|IRF7|IRAK1|RELB|TLR5|TICAM1|TRAF3|RELA|NFKB1|TLR4|TOLLIP
OXIDATION BY CYTOCHROME P450%WIKIPATHWAYS_20181110%WP43%HOMO SAPIENS,0.7110966057441249,0.8966571213032921,-0.19480085841856196,-0.8178872820555011,5446,23,CYP46A1|CYP4X1|CYP7B1|CYB5R1|CYB5A
CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2875%HOMO SAPIENS,0.718880753138075,0.900474259627538,-0.20755281186258498,-0.8053821009855521,5497,18,SULT1A1|CYP3A5|ALAS1|NR1I3|NCOA6|DNAJC7|PPP2R4|SMC1A|HSP90AA1
AGE/RAGE PATHWAY%WIKIPATHWAYS_20181110%WP2324%HOMO SAPIENS,0.0999870984389111,0.43605057892447596,-0.236438700392629,-1.33706351368051,774,63,CYCS|PLA2G4A|IRS1|STAT3|MAPK9|MMP14|MSN|MAPK3|SOD1|NFKBIA|NOS3|LGALS3|MMP9|RELA|NFKB1|ALPL|PRKCB
"GPCRS, CLASS A RHODOPSIN-LIKE%WIKIPATHWAYS_20181110%WP455%HOMO SAPIENS",0.0370464672183323,0.274263095039249,-0.245005504386576,-1.48457332253196,290,82,GPR173|RABGAP1|GPR85|EDNRA|FPR3|LPAR6|P2RY14|PTGER1|ADORA3|FPR1|GPR171|CXCR4|PTGER4|LTB4R|TBXA2R|CYSLTR2|CHRM2|CCRL2|P2RY6|GPER1|F2R|EDNRB|CCR1|APLNR|F2RL3|ADRA2C|HTR1B|PTAFR|C3AR1|GPR34|GPR4|PTGIR|GPR12|CMKLR1|SSTR2
APOPTOSIS MODULATION AND SIGNALING%WIKIPATHWAYS_20181110%WP1772%HOMO SAPIENS,0.0112130479102956,0.137656995138922,-0.26265552550363,-1.6155457119906598,87,87,BCL2A1|MADD|BCL2L11|TNFRSF10A|TNFRSF10B|CASP10|CDKN2A|HN1|BCL2L2|CASP1|TNFSF10|BAG3|CYCS|CASP4|PRKD1|MAPK3|TNFRSF10C|IRAK1|NAIP|HSPA1A|NFKBIA|PTRH2|XIAP|PEA15|FADD|TNFRSF11B|TRAF3|IL1R1|NFKB1|BIRC5|TNFRSF1A|TOLLIP|CASP6|TNFRSF1B|ENDOG|BAD
MACROPHAGE MARKERS%WIKIPATHWAYS_20181110%WP4146%HOMO SAPIENS,0.0104220948410631,0.13155511635887598,-0.605427438597395,-1.82127392725452,79,9,CD74|CD83|F3|CD86|CD163|CD68|CD14
SELENIUM MICRONUTRIENT NETWORK%WIKIPATHWAYS_20181110%WP15%HOMO SAPIENS,0.00012936610608020702,0.00518555396908895,-0.424476090254796,-2.33731796779337,0,57,TXN|DIO2|ABCA1|IL6|SEPW1|INSR|SCARB1|PRDX1|PTGS2|HBB|IL1B|HBA1|TNF|MSRB1|PRDX2|KMO|ALOX5AP|GPX4|ALOX5|NFKB2|TXNRD3|SOD2|GGT1|GPX1|INS|KYNU|SEPN1|ICAM1|PTGS1|SOD3|SEPHS2|SOD1|CCL2|RFK|CAT|SEPP1|GPX3|SERPINE1|LDLR|PLAT|RELA|NFKB1|PNPO|PRDX4|C11orf31|PRDX5
TRANSCRIPTION FACTOR REGULATION IN ADIPOGENESIS%WIKIPATHWAYS_20181110%WP3599%HOMO SAPIENS,0.696674990143251,0.89107464564121,-0.20817142102161804,-0.8224658637753759,5300,19,CEBPD|IRS1|CEBPA|CEBPB|PPARG
TCA CYCLE NUTRIENT UTILIZATION AND INVASIVENESS OF OVARIAN CANCER%WIKIPATHWAYS_20181110%WP2868%HOMO SAPIENS,0.77682798527091,0.924412464185639,-0.31286052577888596,-0.7498669810087679,5906,5,STAT3|MAPK3
THYMIC STROMAL LYMPHOPOIETIN (TSLP) SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2203%HOMO SAPIENS,0.0889786347055758,0.41228493992510207,-0.273343846505212,-1.3863905289807799,682,43,BTK|IL6|STAT5B|RPS6|PTPN11|FYN|MAP2K2|MAPK14|AKT1|STAT5A|STAT6|CCL11|LYN|NFKB2|EIF4EBP1|FES|STAT3|MAPK9|IL2RA|CISH|MAPK3|NFKBIA|HCK|RELB|MYC|RELA|NFKB1
PENTOSE PHOSPHATE PATHWAY%WIKIPATHWAYS_20181110%WP134%HOMO SAPIENS,0.705301595888558,0.894639008000397,0.28715129215139196,0.7926734343926871,5214,7,RPE|PGD|RPIA|G6PD
HEROIN METABOLISM%WIKIPATHWAYS_20181110%WP2645%HOMO SAPIENS,0.31031746031746005,0.681045250505892,-0.585219187887357,-1.14278475075057,2345,3,CES1|BCHE
TNF ALPHA SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP231%HOMO SAPIENS,0.239433022602477,0.623173076743616,-0.18617400028207298,-1.15031626809399,1874,89,NSMAF|TRAF2|TNFAIP3|GRB2|MAPK9|MAPK3|HRAS|SKP1|CCL2|MAP2K3|RFK|PLK1|NFKBIA|PPP2CA|FADD|PSMD2|PYGL|NFKB1|HSP90AA1|TNFRSF1A|TNFRSF1B|BAD
STEROL REGULATORY ELEMENT-BINDING PROTEINS (SREBP) SIGNALLING%WIKIPATHWAYS_20181110%WP1982%HOMO SAPIENS,0.205207527713328,0.5851419434522471,-0.210494958081626,-1.19534188875559,1591,64,SREBF2|IDI1|YY1|GPAM|FDPS|KPNB1|INS|CYP51A1|SEC23A|MBTPS2|SEC13|SEC24A|HMGCR|HMGCS1|LDLR|PPARG|PRKACA|SAR1B|FASN|INSIG1
MIRNA TARGETS IN ECM AND MEMBRANE RECEPTORS%WIKIPATHWAYS_20181110%WP2911%HOMO SAPIENS,0.000131250820317627,0.00518555396908895,-0.716487535797759,-2.91897537979321,0,21,LAMB2|LAMC1|ITGA11|ITGB5|TNXB|COL5A3|COL4A1|LAMA4|COL4A2|COL5A2|COL6A3|SDC2|FN1|THBS1|COL1A2|THBS2|COL3A1|COL6A1|COL5A1|COL6A2
INFLAMMATORY RESPONSE PATHWAY%WIKIPATHWAYS_20181110%WP453%HOMO SAPIENS,0.0164770498234602,0.17512293405535098,-0.417036043648755,-1.72705476606973,125,22,LAMB2|LAMC1|LAMC2|VTN|IL2RA|FN1|CD86|THBS1|COL1A2|COL1A1|COL3A1|TNFRSF1A|TNFRSF1B
BMP2-WNT4-FOXO1 PATHWAY IN HUMAN PRIMARY ENDOMETRIAL STROMAL CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP3876%HOMO SAPIENS,0.37391186071817206,0.724682900261831,0.312290902723662,1.06141603717014,2748,12,DKK1|SFRP1|SMAD1|WNT4
DNA REPLICATION%WIKIPATHWAYS_20181110%WP466%HOMO SAPIENS,0.000518604952677298,0.0139121625154964,-0.44062885918642,-2.20671569389476,3,41,POLE|RFC2|RPA2|MCM10|RFC3|CDT1|MCM4|MCM6|CDC6|POLD4|PCNA|GMNN|ORC1|ORC6|POLD1|MCM3|MCM5|CDC45|POLD2|RFC5|UBC|MCM2|POLE2|POLA1|RFC4|POLA2
EPO RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP581%HOMO SAPIENS,0.742154811715481,0.909955740610127,-0.18745333204157102,-0.796671376495688,5675,24,GRB2|IRS1|SOCS1|STAT3|CISH|MAPK3
MIRNA REGULATION OF PROSTATE CANCER SIGNALING PATHWAYS%WIKIPATHWAYS_20181110%WP3981%HOMO SAPIENS,0.185479666319082,0.559093571852282,-0.26823250489470396,-1.24771187481395,1422,32,PLCL2|GRB2|CREB3L1|NFKBIA|PDGFRB|NFKB1|PDGFA|CCND1|BAD
MAPK SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP382%HOMO SAPIENS,0.031129900076864,0.250729241129472,-0.187697382361023,-1.38857900908008,242,210,ELK1|TGFB3|CACNA1H|TRAF2|TAOK2|MAPK8IP1|MAPKAPK2|HSPA6|GRB2|PLA2G4D|HSPA1B|MEF2C|CACNA2D4|PLA2G4A|MAPK9|ARRB1|CACNA1G|FGF10|MAPK3|HSPB1|FLNA|HRAS|NTRK2|NFATC1|RRAS2|MAP3K13|PLA2G4C|HSPA1A|STK3|MAP2K3|CACNA1E|MAX|RAP1A|FGF19|TGFBR2|FGF9|MAP3K11|FGF7|SRF|RELB|PDGFRB|MYC|RELA|IL1R1|MAPK13|NFKB1|PRKACA|RPS6KA4|PDGFA|FLNC|RRAS|CACNA1I|TNFRSF1A|CD14|PDGFB
CANONICAL  AND NON-CANONICAL NOTCH SIGNALING%WIKIPATHWAYS_20181110%WP3845%HOMO SAPIENS,0.505741127348643,0.79793773931292,-0.21995919122065302,-0.9595021607170581,3875,26,HES1|NOTCH1|NOTCH2|NOTCH3|JAG2|MAML1|RRAS|DLK2
DDX1 AS A REGULATORY COMPONENT OF THE DROSHA MICROPROCESSOR%WIKIPATHWAYS_20181110%WP2942%HOMO SAPIENS,0.3628617798214771,0.7173634875997951,0.390113084126326,1.07689669748345,2682,7,ATM|MRE11A|DDX1|DGCR8|RAD50|DROSHA
MIRNAS INVOLVEMENT IN THE IMMUNE RESPONSE IN SEPSIS%WIKIPATHWAYS_20181110%WP4329%HOMO SAPIENS,0.0282625683771816,0.23806191359062198,-0.346284273483043,-1.59587639641166,216,31,TRAF6|MAPK14|CCL3|TNF|CCL4|NFKB2|GZMB|IRF5|ICAM1|IRF7|IRAK1|VCAM1|NFKBIA|RELB|TRAF3|RELA|NFKB1|TLR4
HEDGEHOG SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP47%HOMO SAPIENS,0.21076964917051896,0.592523537584956,0.390754875096574,1.2379378574192,1549,10,STK36|KIF7|SUFU|SIN3A|PTCH2
SENESCENCE AND AUTOPHAGY IN CANCER%WIKIPATHWAYS_20181110%WP615%HOMO SAPIENS,0.00609911054637865,0.0914854365410948,-0.268000580631281,-1.69059893738236,47,96,ATG13|IRF5|CDKN2A|PLAU|PCNA|INS|IL6ST|VTN|INHBA|MMP14|IRF7|SPARC|HRAS|IGF1|CEBPB|E2F1|IFI16|MAP2K3|GSN|FN1|BMP2|CREG1|THBS1|COL1A1|COL3A1|IGFBP5|SERPINE1|LAMP2|PLAT|ATG3|AMBRA1|IGFBP7|SQSTM1
NUCLEAR RECEPTORS%WIKIPATHWAYS_20181110%WP170%HOMO SAPIENS,0.1456589958159,0.512646109386394,-0.309025353051687,-1.31334903843244,1113,24,RARA|RORC|NR1I3|NR2F1|NR4A1|NR3C1|RXRG|RORA|NR1D2|THRA|NR1H3|NR2F2|PPARG|PPARA|ESRRA
ENDOMETRIAL CANCER%WIKIPATHWAYS_20181110%WP4155%HOMO SAPIENS,0.683928571428571,0.885415243771438,0.153080915230135,0.862069298312628,4978,59,CTNNA2|TCF7L1|FGFR2|CASP9|CDKN1A|FGF2|FOXO3|SOS1|DDB2|NRAS|AKT3|BAX|FGF1|PIK3R2|FGFR1|EGFR|MAP2K1|MAPK1|KRAS|CTNNA1|ERBB2|PDPK1|AXIN1
PROTEASOME DEGRADATION%WIKIPATHWAYS_20181110%WP183%HOMO SAPIENS,0.00012950012950013,0.00518555396908895,-0.46577506564681703,-2.58761807957361,0,59,HLA-F|PSMD7|PSME3|PSMA2|PSME1|PSMB1|HLA-B|PSMB9|UCHL3|UBE2D2|PSMB4|HLA-E|PSMD1|PSMC2|UBE2B|H2AFX|PSMD3|HLA-C|PSMB2|HLA-A|RPN2|PSMD4|PSME2|PSMB5|PSMC4|UBA1|PSMC6|PSMD10|PSMB3|H2AFZ|PSMC1|PSMD2|UBC|PSMD6|PSMD12|PSMA3|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3|RPN1
PHOTODYNAMIC THERAPY-INDUCED NF-KB SURVIVAL SIGNALING%WIKIPATHWAYS_20181110%WP3617%HOMO SAPIENS,0.0155332202062394,0.16857513750690098,-0.377523157229077,-1.70697858332053,118,29,IL6|CHUK|BIRC3|PTGS2|TRAF6|IL1B|TNF|CXCL2|BCL2A1|NFKB2|MMP1|BCL2L2|ICAM1|VCAM1|RELB|MMP9|RELA|NFKB1|BIRC5|TNFRSF1A|CCND1
MISMATCH REPAIR%WIKIPATHWAYS_20181110%WP531%HOMO SAPIENS,0.93342886920271,0.9800972968717879,-0.197787666184102,-0.5949937128521421,7164,9,EXO1|PCNA|POLD1
B CELL RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP23%HOMO SAPIENS,0.455837173579109,0.7711961414599979,-0.16004505094919502,-0.9995434141053359,3560,93,MAP4K1|NFATC3|E2F3|PTPN11|MALT1|FYN|MAP2K2|MAPK14|DAPP1|ETS1|GSK3B|PLCG2|AKT1|RAF1|RAC2|CDC42|SYK|NFATC2|RAC1|LYN|MAPK4|RPS6KA1|MEF2D|PIK3AP1|RAPGEF1|HCLS1|LAT2|VAV1|ELK1|GRB2|MEF2C|MAPK9|ILF2|PTPN6|HRAS|MAX|NFKBIA|CAMK2A|MYC|RELA|NFKB1|BCL6|NCK1|CD81|PRKCB
HUMAN COMPLEMENT SYSTEM%WIKIPATHWAYS_20181110%WP2806%HOMO SAPIENS,0.000129634430904848,0.00518555396908895,-0.462218227961865,-2.66186303308791,0,68,ITGAX|SELPLG|ADM|F12|LAMC1|F10|ITGB2|TLR2|C4A|WAS|C2|FPR1|C3|DCN|CLEC4M|ICAM1|VSIG4|CD93|SPP1|CALR|FCN1|CFB|GNAI2|C7|FKBP2|PLAUR|GNA15|THBS1|F13A1|CD59|C3AR1|PRKACA|CFP|C1S|CFD|CFI|CD55|CSNK1A1|SERPING1|C1R|CFH|C5AR1|ICAM2|PRNP
STRUCTURAL PATHWAY OF INTERLEUKIN 1 (IL-1)%WIKIPATHWAYS_20181110%WP2637%HOMO SAPIENS,0.114370638407857,0.463748809895271,-0.25331248071234197,-1.32794634360049,884,48,MAPKAPK2|MAPK9|MAPK3|IL1RAP|IRF7|IRAK1|MAP2K3|NFKBIA|MYC|RELA|IL1R1|NFKB1|TOLLIP
G PROTEIN SIGNALING PATHWAYS%WIKIPATHWAYS_20181110%WP35%HOMO SAPIENS,0.11799259353850099,0.46871560124517003,-0.20695338361228302,-1.2787061756508202,923,89,PDE4B|AKAP1|ADCY8|PDE4D|PRKAR1A|SLC9A1|PRKD1|AKAP5|GNGT2|ADCY4|HRAS|PDE1C|PDE1A|GNG11|GNAI2|GNAQ|PDE1B|GNA15|GNG10|PDE4A|PRKACA|RRAS|GNG3|PRKCB|ADCY9
ALANINE AND ASPARTATE METABOLISM%WIKIPATHWAYS_20181110%WP106%HOMO SAPIENS,0.334562841530055,0.697556995918323,0.379669058583428,1.1021128554640902,2448,8,ASL|DARS
TOLL-LIKE RECEPTOR SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP75%HOMO SAPIENS,0.0219540377455386,0.205074417774411,-0.260571139432742,-1.55556223447402,170,78,PIK3CB|MAPK3|SPP1|IRF7|IRAK1|PIK3R3|MAP2K3|CD86|NFKBIA|FADD|TLR5|TICAM1|TRAF3|RELA|MAPK13|NFKB1|TLR4|TOLLIP|CD14|LY96
FOCAL ADHESION%WIKIPATHWAYS_20181110%WP306%HOMO SAPIENS,0.000127877237851662,0.00518555396908895,-0.315008638746987,-2.25501214554836,0,176,AKT1|ROCK1|PARVA|RAF1|RAC2|ZYX|CDC42|PAK2|RAC3|THBS4|PTEN|ACTN4|RAC1|ITGB1|ITGA9|ACTG1|CCND2|PAK4|MYL12B|LAMB2|FLT1|VAV3|LAMC1|ITGA10|ITGA11|LAMC2|KDR|RAPGEF1|LAMC3|FGR|HGF|TNK2|VAV1|PDGFD|ITGB5|TLN1|CAV2|LAMA2|ELK1|VEGFC|MYLK2|BCAR1|VTN|ILK|TNXB|ITGA5|MYLK|PDGFC|VWF|COL5A3|GRB2|MAPK9|PXN|PIK3CB|MAPK3|SPP1|COL4A1|COMP|FLNA|LAMA4|HRAS|PIK3R3|IGF1|COL4A2|MYL12A|COL5A2|DOCK1|RAP1A|FN1|VEGFB|HCK|TNC|THBS1|COL1A2|COL1A1|VCL|XIAP|THBS2|PDGFRB|ITGA8|CAV1|CCND3|PDGFA|ACTB|FLNC|PDGFRA|CCND1|ACTN1|COL6A2|MYL9|PPP1CA|PDGFB|ITGB4|PRKCB|BAD
INTEGRATED CANCER PATHWAY%WIKIPATHWAYS_20181110%WP1971%HOMO SAPIENS,0.5462849352419911,0.817655622966367,0.18146804143844,0.9417958677476841,4006,44,MAP3K5|SMAD3|BBC3|BARD1|CASP9|CDKN1A|ATM|MRE11A|CASP8|JAK1|RB1|BAX|BCL2|ATR|CHEK2|MSH2|CASP3|SMAD2|MDM2|CDK1|MSH6
ID SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP53%HOMO SAPIENS,0.93819562655493,0.9806508984207809,-0.172076368791974,-0.5923202307592329,7164,13,ELK4|ID2|ID3|ELK3|ELK1|ID1
OXIDATIVE STRESS%WIKIPATHWAYS_20181110%WP408%HOMO SAPIENS,0.20185281837160798,0.58036189671045,-0.282671307978255,-1.23306386640499,1546,26,SOD2|GPX1|SOD3|HMOX1|SOD1|CAT|NFIX|GPX3|NFKB1
COMMON PATHWAYS UNDERLYING DRUG ADDICTION%WIKIPATHWAYS_20181110%WP2636%HOMO SAPIENS,0.0395421436004162,0.28367988634143604,-0.322950914592362,-1.5417460488640702,303,35,GRIN1|ADCY8|MAPK3|RAP1A|PPP1R1A|ACTG2|ARAF|CAMK2A|PRKACA|ACTB|PPP1CA|GRIA1|PRKCB
INSULIN SIGNALING%WIKIPATHWAYS_20181110%WP481%HOMO SAPIENS,0.823406913785923,0.941748323139748,0.11664112770814501,0.8158623753455649,5930,150,MAP3K5|IRS2|TSC2|GAB1|MYO1C|MAPK7|RPS6KA2|MAP2K6|RHOQ|GRB14|CRK|MAP4K4|SNAP25|MAP2K5|STXBP3|MAPK12|FLOT2|MINK1|MAPK11|SHC1|PFKL|FOXO3|SOS1|SGK2|SHC2|IGF1R|MAPK6|FLOT1|KIF5B|INPP4A|CBL|TBC1D4|PRKCA|INPPL1|MAP2K7|MAP3K4|SNAP23|MAP3K10|PIK3R2|PFKM|MAP2K1|MAP3K2|MAPK1|IKBKB|RPS6KA6|MAP2K4|MAPK8
GLUCOSE HOMEOSTASIS%WIKIPATHWAYS_20181110%WP661%HOMO SAPIENS,0.358260869565217,0.714938712241162,-0.8188685487428321,-1.09092952885932,2677,1,INS
HYPOTHESIZED PATHWAYS IN PATHOGENESIS OF CARDIOVASCULAR DISEASE%WIKIPATHWAYS_20181110%WP3668%HOMO SAPIENS,0.0126631853785901,0.14873405181193602,-0.42108364250124897,-1.7679539950659697,96,23,POSTN|LTBP2|CTGF|FBN1|LTBP1|MAPK3|FLNA|FBN3|TGFBR2|TGFBR3|SERPINE1|ENG
GLYCOLYSIS AND GLUCONEOGENESIS%WIKIPATHWAYS_20181110%WP534%HOMO SAPIENS,0.0143080124869927,0.160215272500577,-0.35713038999145097,-1.7049165765441299,109,35,GOT1|SLC2A1|GPI|HK1|PDHA1|HK3|ENO1|PGAM1|GAPDH|LDHA|SLC2A3|MPC1|PGK1|ALDOA|ALDOC
NRF2-ARE REGULATION%WIKIPATHWAYS_20181110%WP4357%HOMO SAPIENS,0.9060002708925908,0.9705220236903108,0.156997652107822,0.6471680353633821,6688,21,EPHB2|NQO1|NFE2L2|PRKCA|GCLM|SRC|MAPK8|GCLC|YES1
MITOCHONDRIAL COMPLEX I ASSEMBLY MODEL OXPHOS SYSTEM%WIKIPATHWAYS_20181110%WP4324%HOMO SAPIENS,0.0055483870967741895,0.0851592573769022,-0.33599621761186493,-1.83280277083374,42,55,COA1|TIMMDC1|NDUFC2|NDUFAF4|NDUFV2|NDUFB8|NDUFS4|NDUFB5|NDUFA7|NDUFB6|TMEM70|NDUFAF3|NDUFB9|NDUFB10|NDUFB1|NDUFB7|NDUFA6|NDUFS6|NDUFB4|NDUFA12|NDUFA2|NDUFAB1|NDUFA1|NDUFB11|NDUFV1|NDUFAF2|NDUFS3|NDUFA8|NDUFV3
CELL-TYPE DEPENDENT SELECTIVITY OF CCK2R SIGNALING%WIKIPATHWAYS_20181110%WP3679%HOMO SAPIENS,0.824921548117155,0.9422643049903799,-0.223775261149017,-0.701058681457693,6308,10,CD38|PLCB1|RYR2|GNAQ|DAGLA
NUCLEAR RECEPTORS META-PATHWAY%WIKIPATHWAYS_20181110%WP2882%HOMO SAPIENS,0.000128155837498398,0.00518555396908895,-0.24473882217690301,-1.81610826470911,0,214,JUNB|SEC14L1|CES1|SLC39A1|NR3C1|NFKB2|SLC2A13|TXNRD3|SLC39A9|GPAM|DNAJC7|SLC39A3|BHLHE40|ANGPTL4|HGF|SPRY1|SLC6A1|CDKN1C|SLC2A1|CYP1B1|PLK2|AHR|SRPX2|GGT1|SLC39A8|CBR1|PDE4B|HES1|TNFAIP3|IL17B|ETNK2|STAT3|SLCO2B1|SERPINA1|SLC26A2|SLC39A11|SNAI2|SOD3|SLC2A10|SLC2A6|HMOX1|SRGN|NR1H3|SLC6A8|LRRC8A|ACOX1|GADD45B|HBEGF|CCL2|HSPA1A|THBD|PPP2R4|AIP|SDPR|EPHA2|FTL|TSC22D3|KAT2B|FGF19|TGFBR2|TGFBR3|MFGE8|SLC5A3|NAV3|B3GNT5|GPX3|IL11|MYC|PPARA|SMC1A|STOM|SLC2A3|HSP90AA1|MYOF|RGS2|GSTP1|CCND1|FKBP5|FASN|PDGFB|BLVRB|PSMC5|SQSTM1|FTH1|DNAJC15
MFAP5-MEDIATED OVARIAN CANCER CELL MOTILITY AND INVASIVENESS%WIKIPATHWAYS_20181110%WP3301%HOMO SAPIENS,0.900576368876081,0.96834471139831,-0.197000047935176,-0.637798254186822,6874,11,ITPR3|MAPK3|MFAP5
DIFFERENTIATION OF WHITE AND BROWN ADIPOCYTE   %WIKIPATHWAYS_20181110%WP2895%HOMO SAPIENS,0.12133891213389099,0.47375385823484295,-0.35139610492408396,-1.3635475748180699,927,18,SMAD5|MPZL2|CEBPA|CEBPB|HSPB7|BMP2|PPARG
ANGIOPOIETIN LIKE PROTEIN 8 REGULATORY PATHWAY%WIKIPATHWAYS_20181110%WP3915%HOMO SAPIENS,0.9208633093525179,0.976902009236247,0.11054129299719301,0.729830819850272,6655,114,MAP3K5|PRKAG2|IRS2|TSC2|MAPK7|RPS6KA2|MAP2K6|RHOQ|CRK|MAP4K4|MAP2K5|MAPK12|FLOT2|MINK1|MAPK11|SHC1|FOXO3|SOS1
FATTY ACID OMEGA OXIDATION%WIKIPATHWAYS_20181110%WP206%HOMO SAPIENS,0.460021041557075,0.774149829207065,-0.410895617931881,-0.984838390082082,3497,5,ADH1B|ALDH2|ALDH1A1
METABOLIC REPROGRAMMING IN COLON CANCER%WIKIPATHWAYS_20181110%WP4290%HOMO SAPIENS,0.12342797873719699,0.477479737413389,-0.26355296502750797,-1.31990098236539,951,41,SLC2A1|GPI|FH|SDHB|PDHA1|HK3|ENO1|PGAM1|GAPDH|LDHA|SHMT2|PGK1|TALDO1|FASN
ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY%WIKIPATHWAYS_20181110%WP2118%HOMO SAPIENS,0.5755494505494511,0.835965133358135,0.16458582207546302,0.926858739611657,4189,59,CTNNA2|TCF7L1|ITGA6|DMD|CACNG7|ITGB8|CACNB4|CACNA1C|SGCB|CACNA2D2|CACNG4|ITGAV|ITGA2|ITGA2B|CACNB2|CACNA2D3
REGULATION OF SISTER CHROMATID SEPARATION AT THE METAPHASE-ANAPHASE TRANSITION%WIKIPATHWAYS_20181110%WP4240%HOMO SAPIENS,0.0131268049356787,0.151789996978976,-0.489066491728286,-1.7757211543854,99,15,MAD1L1|CENPE|STAG1|RAD21|CDC20|ANAPC2|ESPL1|PTTG1|MAD2L1|SMC1A|ANAPC11
METABOLISM OF DICHLOROETHYLENE BY CYP450%WIKIPATHWAYS_20181110%WP3666%HOMO SAPIENS,0.17160313454642098,0.54516008272075,0.916023378914866,1.22139357413195,1291,1,CYP2E1
SYNAPTIC VESICLE PATHWAY%WIKIPATHWAYS_20181110%WP2267%HOMO SAPIENS,0.136789994788953,0.501079208958161,-0.255505967311496,-1.29591742308337,1049,43,AP2A2|DNM1|SLC22A3|NAPA|CLTA|CPLX2|SYP|CLTC|PARK7|SYN1|SLC1A3|STX1B|STX3|NSF|SLC25A4|AP2M1|DNM3
"GPCRS, OTHER%WIKIPATHWAYS_20181110%WP117%HOMO SAPIENS",0.0579335316177421,0.347244740181479,-0.29624355696206,-1.47476738694633,447,40,LTB4R2|ADRB2|GPR183|GPR135|EDNRA|OR2A20P|ADORA3|SMO|GPR132|ADGRE2|CELSR1|S1PR1|ADGRF5|CHRM2|F2R|ADGRG1|ALG6|ADGRV1|SSTR2|ACKR1
BREAST CANCER PATHWAY%WIKIPATHWAYS_20181110%WP4262%HOMO SAPIENS,0.193097254298178,0.567519363754568,-0.176681034277719,-1.17409552097457,1504,122,E2F2|FRAT1|FZD2|FZD8|HES1|FLT4|NOTCH1|GRB2|BRCA1|NOTCH2|FGF10|MAPK3|HRAS|PIK3R3|IGF1|SKP1|E2F1|LRP5|NOTCH3|GADD45B|JAG2|FGF19|GADD45G|FGF9|FGF7|ARAF|MYC|RPS6KB1|WNT3|CSNK1A1|CCND1|RPS6KB2
EFFECTS OF NITRIC OXIDE%WIKIPATHWAYS_20181110%WP1995%HOMO SAPIENS,0.33015873015873,0.6957352559323989,-0.576561576708948,-1.12587863038167,2495,3,HBA1|NOS3
CODEINE AND MORPHINE METABOLISM%WIKIPATHWAYS_20181110%WP1604%HOMO SAPIENS,0.0872164108137481,0.4082507008158521,0.657832389812121,1.44528577594551,641,4,ABCB1|CYP2C8|CYP2D6
VEGFA-VEGFR2 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP3888%HOMO SAPIENS,0.00012830382345393898,0.00518555396908895,-0.24697558283125698,-1.8502575093949198,0,226,MAPKAPK2|GRB2|MEF2C|PLA2G4A|STAT3|MAPK9|PTPN6|CLTC|PRKD1|ICAM1|F3|CTGF|PXN|MMP14|CAMKK2|MMRN2|MAPK3|HERPUD1|HSPB1|TNFRSF10C|HRAS|NFATC1|ARHGEF15|HDAC5|RHOJ|HBEGF|CDH5|CCL2|HSPA1A|RND1|MAP2K3|TPCN2|RAP1A|GIPC1|PLAUR|NCF2|NFKBIA|NOS3|NRP2|FHL2|VCL|SRF|FADD|INPP4B|ERG|CAV1|MYH9|RELA|CFL1|RPS6KB1|NFKB1|HSP90AA1|ANXA1|NCK1|IGFBP7|MAPKAP1|CCND1|ARF6|OCLN|PRKCB|PTPRJ|ERN1|GRB10|RCAN1
FERROPTOSIS%WIKIPATHWAYS_20181110%WP4313%HOMO SAPIENS,0.0855109961190168,0.40462962277421993,-0.29126410543146597,-1.40251817776197,660,36,CP|ATG7|GPX4|SAT1|ACSL5|ACSL4|SLC39A8|CYBB|HMOX1|NCOA4|FTL|SLC3A2|SAT2|TFRC|FTH1|PRNP
CYTOKINES AND INFLAMMATORY RESPONSE%WIKIPATHWAYS_20181110%WP530%HOMO SAPIENS,0.00170424750917672,0.0347159200485555,-0.578808662280823,-2.04774040580936,12,14,HLA-DRB1|IL1B|TNF|CXCL1|TGFB1|CXCL2|HLA-DRA|CD4|IL15|CSF1|IL11|PDGFA
SRF AND MIRS IN SMOOTH MUSCLE DIFFERENTIATION AND PROLIFERATION%WIKIPATHWAYS_20181110%WP1991%HOMO SAPIENS,0.0905419489317353,0.41591576627717103,-0.48420691110739394,-1.45661290911987,694,9,CCND2|MEF2D|KLF4|ELK1|MEF2C|SRF
EPITHELIAL TO MESENCHYMAL TRANSITION IN COLORECTAL CANCER%WIKIPATHWAYS_20181110%WP4239%HOMO SAPIENS,0.12764592687620302,0.484643747394476,-0.188300487487735,-1.2452783579932099,994,119,TGFB3|CLDN10|FZD2|FZD8|FOXC2|VTN|ITGA5|NOTCH1|GRB2|FOXM1|PKP2|SNAI2|PIK3CB|NOTCH2|MAPK3|COL4A1|SPARC|HRAS|PIK3R3|COL4A2|LRP5|NOTCH3|JAG2|MAP2K3|FN1|NRP2|TGFBR2|LATS2|ID1|MMP9|SNAI1|MAPK13|WNT3|OCLN
"NON-GENOMIC ACTIONS OF 1,25 DIHYDROXYVITAMIN D3%WIKIPATHWAYS_20181110%WP4341%HOMO SAPIENS",0.17003996390357098,0.543216018944259,-0.220069047311872,-1.23410873336752,1318,61,PLCB1|NFKB2|RXRG|TLR2|PLCB3|MED1|OAS2|MAPK9|IFI44L|ISG15|MAPK3|CAMK2B|RSAD2|HRAS|CCL2|RELB|CAMK2A|CAV1|MAPK13|NFKB1|TLR4|TNFRSF1A|PRKCB
HEME BIOSYNTHESIS%WIKIPATHWAYS_20181110%WP561%HOMO SAPIENS,0.9392076502732242,0.980854185905783,0.205113661550785,0.595409075656229,6874,8,HMBS|UROD|PPOX|CPOX
RAC1/PAK1/P38/MMP2 PATHWAY%WIKIPATHWAYS_20181110%WP3303%HOMO SAPIENS,0.0136527563111798,0.15518414363037,-0.29836324042215,-1.66693611313634,105,60,DOK2|GRB2|STAT3|MAPK9|PXN|MAPK3|HRAS|TNIP1|FN1|NFKBIA|TEK|MYC|RELA|YAP1|MAPK13|NFKB1|BIRC5|NCK1|TIE1|BAD
OSTEOCLAST SIGNALING%WIKIPATHWAYS_20181110%WP12%HOMO SAPIENS,0.0144035616079612,0.16079417073357402,-0.515885114644401,-1.7757766060302702,109,13,ITGB3|CTSK|GPR68|AIMP2|ACP5|IFNAR1|TNFRSF11A|SLC9A1|SPP1|TNFRSF11B|ATP6V1G1|PDGFB
AFLATOXIN B1 METABOLISM%WIKIPATHWAYS_20181110%WP699%HOMO SAPIENS,0.6374133949191689,0.864837230317578,0.388930350106859,0.8544965428100791,4691,4,GSTM1|AKR7A2|EPHX1
EIF5A REGULATION IN RESPONSE TO INHIBITION OF THE NUCLEAR EXPORT SYSTEM%WIKIPATHWAYS_20181110%WP3302%HOMO SAPIENS,0.158402390979487,0.528252516514554,0.6015973388642621,1.32173497409502,1165,4,XPO1|XPO4|EIF5A
RIG-I-LIKE RECEPTOR SIGNALING%WIKIPATHWAYS_20181110%WP3865%HOMO SAPIENS,0.0261093247588424,0.227337816683065,-0.290819798761062,-1.5769082489489499,202,54,TRAF2|DDX3X|IKBKE|MAPK9|IFIH1|SNW1|ISG15|IRF7|TMEM173|NFKBIA|OTUD5|FADD|TRAF3|RELA|DHX58|MAPK13|NFKB1|NLRX1
CIRCADIAN RYTHM RELATED GENES%WIKIPATHWAYS_20181110%WP3594%HOMO SAPIENS,0.0020568196426275897,0.0403589930113217,-0.241656620971436,-1.69013761923197,15,157,BHLHE40|PTGDS|RORA|TOP1|NR1D2|HNRNPU|AHR|TNFRSF11A|DYRK1A|OGT|PHLPP1|NAGLU|ADA|TOP2A|MAPK9|CIPC|ZFHX3|DDX5|DBP|GHRL|MAGEL2|CREM|SKP1|NR1H3|ARNTL2|NONO|USP2|GNAQ|CRY2|RBM4B|HEBP1|NR1D1|RELB|UBC|CCRN4L|SERPINE1|PRKCDBP|PPARG|PPARA|SIK1|MAGED1|ID4|ATF5|RBM4|PRMT5|PPP1CA|CIART|NGFR|CST3|SUV39H1
PRION DISEASE PATHWAY%WIKIPATHWAYS_20181110%WP3995%HOMO SAPIENS,0.0676258992805755,0.371075653877479,-0.31981124509191605,-1.46019553346216,516,30,HSP90B1|BATF|ELK1|MEF2C|STAT3|MAPK3|SPI1|POU2F2|NFKB1|HSPA5|EBF1|PRNP
DIFFERENTIATION PATHWAY%WIKIPATHWAYS_20181110%WP2848%HOMO SAPIENS,0.0694426315102467,0.37596389138254704,-0.321735285643957,-1.4547325947465102,531,29,HGF|TGFB3|INS|NOTCH1|INHBA|FGF10|IGF1|CSF1|IL11|FLT3LG|PDGFA|CSF1R|PDGFB
SCFA AND SKELETAL MUSCLE SUBSTRATE METABOLISM%WIKIPATHWAYS_20181110%WP4030%HOMO SAPIENS,0.661709539121115,0.8792178816900501,0.516752587160604,0.8682110670570808,4938,2,PPARD
VITAMIN D METABOLISM%WIKIPATHWAYS_20181110%WP1531%HOMO SAPIENS,0.368806841319397,0.721792732107131,0.412024067575427,1.06613649167352,2716,6,CYP27B1|CYP27A1|RXRB
MIR-517 RELATIONSHIP WITH ARCN1 AND USP1%WIKIPATHWAYS_20181110%WP3596%HOMO SAPIENS,0.877169910573383,0.960725750963158,-0.277479844790867,-0.665066239935827,6669,5,ID1
WHITE FAT CELL DIFFERENTIATION%WIKIPATHWAYS_20181110%WP4149%HOMO SAPIENS,0.197514715500327,0.574572493132077,-0.270103621810233,-1.2332402571582501,1509,30,NR3C1|KLF4|RORA|GATA3|INS|CEBPD|CEBPA|CEBPB|KLF15|NR1H3|NR2F2|PPARG|EBF1
NICOTINE ACTIVITY ON DOPAMINERGIC NEURONS%WIKIPATHWAYS_20181110%WP1602%HOMO SAPIENS,0.0330207908683245,0.259789699558348,0.42155104808799,1.62098937343584,242,17,DRD2|ADCY2|KCNK9|DRD4|CHRNB2|CHRNA5|KCNK3|DDC|CHRNA3|CDK5|GNB1|SLC18A2
GASTRIC CANCER NETWORK 2%WIKIPATHWAYS_20181110%WP2363%HOMO SAPIENS,0.0298254753842146,0.244735657013286,-0.34477093852009105,-1.5889020815721597,228,31,LBR|UBE2T|MTDH|RFC3|ATAD2|CACYBP|RAD17|RNF144B|TOP2A|OTUD5|MYC|S100A6|RFC4
IL-6 SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP364%HOMO SAPIENS,0.670899196683079,0.8815356925073421,-0.17050740508788,-0.8592071239376751,5177,42,MAP2K2|GSK3B|AKT1|CREBBP|RAC1|PRDM1|JUNB|AGT|SOCS3|VAV1|IL6ST|GRB2|STAT3|MAPK3|HCK|RPS6KB1|TIMP1|BAD
IMATINIB AND CHRONIC MYELOID LEUKEMIA%WIKIPATHWAYS_20181110%WP3640%HOMO SAPIENS,0.344329083979498,0.7021837162645569,-0.275822873338609,-1.08975044055585,2619,19,PIM1|ABL1|PDGFRB|MYC|CSF1R|PDGFRA
AMPLIFICATION AND EXPANSION OF ONCOGENIC PATHWAYS AS METASTATIC TRAITS%WIKIPATHWAYS_20181110%WP3678%HOMO SAPIENS,0.644788658440536,0.8688307429995409,-0.235877524933637,-0.8564330575758029,4911,15,CYTIP|VHL|JAG1|POSTN|CXCR4|NOTCH1|VCAM1|TNC
GASTRIC CANCER NETWORK 1%WIKIPATHWAYS_20181110%WP2361%HOMO SAPIENS,0.0453893308986566,0.305507129637833,-0.34879474498010904,-1.53835522823462,347,27,HIST4H4|NUP107|AURKA|CEP192|KIF15|C21orf33|APC|RNF216|MCM4|ECT2|RUVBL1|TPX2|TOP2A|SMOC2|LIN9|NOTCH1|MYBL2
DNA IR-DOUBLE STRAND BREAKS (DSBS) AND CELLULAR RESPONSE VIA ATM%WIKIPATHWAYS_20181110%WP3959%HOMO SAPIENS,0.65967845659164,0.8776458000975379,-0.160653214715902,-0.8711077463945749,5128,54,RAD9A|RAD51|NABP2|TERF2|H2AFX|NBN|EXO1|TRIM28|PARP1|CDKN2A|RAD17|PCNA|CDC25C|BRCA1|ABL1|E2F1|STK3|SMC1A|YAP1|KAT5
ENDOTHELIN PATHWAYS%WIKIPATHWAYS_20181110%WP2197%HOMO SAPIENS,0.6667539267015711,0.880719592999549,-0.190245085301593,-0.849655828616841,5093,28,RAF1|MT-CO2|ECE1|ATP2A2|PLCB1|EDNRA|CALM3|MYLK|CALCRL|EDNRB|NOS3|GNA15|PTGIR|CNN1
INSULIN SIGNALLING IN HUMAN ADIPOCYTES (DIABETIC CONDITION)%WIKIPATHWAYS_20181110%WP3635%HOMO SAPIENS,0.650893796004206,0.8721945267113571,-0.30668982858919397,-0.8383229698108859,4951,7,IRS1|RPS6KB1
STRIATED MUSCLE CONTRACTION%WIKIPATHWAYS_20181110%WP383%HOMO SAPIENS,0.680700836820084,0.884781692722898,-0.19728101831292602,-0.838438766086991,5205,24,DES|MYH3|ACTN4|ACTG1|TNNT2|TNNI2|TNNC2|MYOM1|VIM|ACTA2|MYL9
MIR-124 PREDICTED INTERACTIONS WITH CELL CYCLE AND DIFFERENTIATION %WIKIPATHWAYS_20181110%WP3595%HOMO SAPIENS,0.52338469856718,0.807431205679653,0.38614807199533,0.928683898778386,3871,5,STRADB|CTDSP1|PRKAA1|STK11
SIMPLIFIED DEPICTION OF MYD88 DISTINCT INPUT-OUTPUT PATHWAY%WIKIPATHWAYS_20181110%WP3877%HOMO SAPIENS,0.14183006535947698,0.5078130330642999,-0.398924624614528,-1.335238070536,1084,12,TRAF6|UBE2N|TIFA|TLR1|TLR2|IRAK1|TLR5|NFKB1|TLR4
GANGLIO SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20181110%WP1423%HOMO SAPIENS,0.274692166623002,0.649047934290704,-0.36032246235486,-1.16656335794318,2096,11,B4GALNT1|ST8SIA3|ST6GALNAC6|ST3GAL1|SLC33A1|B3GALT1|ST3GAL5
DISORDERS OF THE KREBS CYCLE%WIKIPATHWAYS_20181110%WP4236%HOMO SAPIENS,0.647870662460568,0.8701854047858449,-0.307767098036422,-0.841267637804738,4928,7,SUCLG2|DLST|FH|PDHX
TYPE II DIABETES MELLITUS%WIKIPATHWAYS_20181110%WP1584%HOMO SAPIENS,0.557101601470202,0.8260320520479609,-0.25289703123275603,-0.9182281261067541,4243,15,PHKA2|MAPK1|IKBKB|MAPK8|MTOR|PRKCD|PRKCZ|INSR|KCNJ11|PIK3R5|TNF|SOCS4|SURF1|IRS1|GK
T-CELL ANTIGEN RECEPTOR (TCR)  SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP69%HOMO SAPIENS,0.472158365261814,0.7831522581932591,-0.16383356248556,-0.9887014807942809,3696,81,IL6|MAP3K14|CHUK|MAP4K1|CCR5|PTPN11|PRKCQ|MALT1|CBLB|FAS|FYN|MAP2K2|TRAF6|MAPK14|GRAP2|IL1B|LCP2|AKT1|RAF1|RIPK2|CDC42|NFATC2|TGFB1|VAV3|CD83|CD4|VAV1|GATA3|WAS|IL15RA|GRB2|MAPK9|SH2B3|MAPK3|HRAS|NFATC1|NFKBIA|RELA|NFKB1|VIM|NCK1|DBNL
DNA DAMAGE RESPONSE (ONLY ATM DEPENDENT)%WIKIPATHWAYS_20181110%WP710%HOMO SAPIENS,0.7401524777636591,0.909493931144346,-0.133671387916762,-0.8432246894323571,5824,96,PIK3C2B|BIK|RHOA|BAK1|MAP3K1|SCP2|DVL3|FOSL1|GSK3B|CDKN1B|AKT1|RAC2|CDC42|PIK3R5|RAC3|PTEN|RAC1|TGFB1|SOS2|CCND2|APC|PIK3C2A|NFKB2|BCL2L11|SOD2|CDKN2A|PLAU|FRAT1|GRB2|MLKL|IRS1|MAPK9|PIK3CB|ABL1|HRAS|PIK3R3|PIK3R4|CAT|MYC|LDLR|CCND3|NFKB1|BCL6|WNT3|CCND1|BAD
ROBO4 AND VEGF SIGNALING PATHWAYS CROSSTALK%WIKIPATHWAYS_20181110%WP3943%HOMO SAPIENS,0.167648984937787,0.5400573506233579,-0.509016422127732,-1.30932735966425,1279,6,RAC1|KDR|ROBO4|SLIT2
VITAMIN D RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2877%HOMO SAPIENS,0.0020621214073978603,0.0403673671724775,-0.267497979542636,-1.7561004168990701,15,115,PTGER4|CEBPA|CDKN2B|TIMP3|SPP1|G0S2|LRRC25|SEMA3B|LRP5|STS|CEACAM1|THBD|STEAP4|ADGRE5|CD200|LGALS9|TNFRSF11B|ID1|NINJ1|IGFBP5|MYC|EPHB4|ABCD1|BCL6|S100A8|ID4|CDKN2C|ITGAM|S100A9|S100A6|CD14|CCND1|S100A4|COL13A1|EFNA5
LAMIN A-PROCESSING PATHWAY%WIKIPATHWAYS_20181110%WP4299%HOMO SAPIENS,0.5309523809523811,0.811770899275515,-0.489593332426,-0.9560516913079781,4013,3,LMNA
PHOTODYNAMIC THERAPY-INDUCED NFE2L2 (NRF2) SURVIVAL SIGNALING%WIKIPATHWAYS_20181110%WP3612%HOMO SAPIENS,0.33861359328459195,0.7001468935792379,0.269254681548875,1.09122820586716,2500,20,ABCC4|MAPK12|MAPK11|NQO1|NFE2L2|GCLM|NQO2
PI3K-AKT-MTOR SIGNALING PATHWAY AND THERAPEUTIC OPPORTUNITIES%WIKIPATHWAYS_20181110%WP3844%HOMO SAPIENS,0.21694295783840198,0.599597524514766,-0.267519916150366,-1.20959670615196,1661,29,PIK3CB|HRAS|PIK3R3|RPTOR|NOS3|GRB10|BAD
PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS FSGS%WIKIPATHWAYS_20181110%WP2572%HOMO SAPIENS,0.0230540085481155,0.21132547286123998,-0.28783385092204905,-1.5905550104951,177,58,CDKN1B|AKT1|PARVA|ACTN4|ITGB1|UTRN|TGFB1|PLCE1|MKI67|LAMB2|JAG1|LIMS3L|DNM1|CDKN1C|TLN1|PCNA|VTN|ILK|NOTCH1|CAMK2B|LRP5|KIRREL3|PLAUR|CD151|VCL|MYO1E|MYH9|TLR4|VIM|CTSL|SYNPO|NCK1|ITGB4
SUDDEN INFANT DEATH SYNDROME (SIDS) SUSCEPTIBILITY PATHWAYS%WIKIPATHWAYS_20181110%WP706%HOMO SAPIENS,0.182576340774955,0.556226209760009,-0.178048401539802,-1.1831820637633998,1422,122,SCN4B|MAOA|PRKAR2A|C4B|YBX1|GJA1|TPPP|NR3C1|HSP90B1|REST|NFKB2|FMO3|RYR2|RUNX3|PLP1|BHLHE40|RORA|ATP1A3|CDCA7L|NGF|C4A|GATA3|IL1RN|HES1|GRIN1|TAC1|SST|PRKAR1A|MEF2C|FOXM1|MECP2|SLC1A3|CREM|NTRK2|CEBPB|CHRM2|KCNQ1|GAPDH|DEAF1|PKNOX1|SLC25A4|POU2F2|NFKB1|PRKACA|KCNH2|SSTR2|MAZ|ALDOA
"OLIGODENDROCYTE SPECIFICATION AND DIFFERENTIATION(INCLUDING REMYELINATION), LEADING TO MYELIN COMPONENTS FOR CNS%WIKIPATHWAYS_20181110%WP4304%HOMO SAPIENS",0.21587343096234302,0.598994355749518,-0.315780574321487,-1.2253460703093,1650,18,LIF|IL1B|TNF|CXCL1|CXCL2|SOX5|SOX10|PLP1|CNP|IGF1|BMP2|PDGFB
INFLUENZA A VIRUS INFECTION%WIKIPATHWAYS_20181110%WP1438%HOMO SAPIENS,0.450126178775402,0.768588477853328,0.776246140273489,1.03501948694574,3388,1,BCL2
EVOLOCUMAB MECHANISM%WIKIPATHWAYS_20181110%WP3408%HOMO SAPIENS,0.10046822742474901,0.436743648703065,-0.9474525805028671,-1.26223433401049,750,1,LDLR
LIVER X RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2874%HOMO SAPIENS,0.272619673855865,0.646919962562973,-0.4904834846918871,-1.17559531994301,2072,5,NR1H3|FASN
PANCREATIC ADENOCARCINOMA PATHWAY%WIKIPATHWAYS_20181110%WP4263%HOMO SAPIENS,0.26580826109128,0.641230970419911,-0.18483235017512697,-1.13071556214936,2084,85,STAT3|MAPK9|PIK3CB|MAPK3|PIK3R3|E2F1|GADD45B|PLD1|GADD45G|TGFBR2|ARAF|RELA|RPS6KB1|NFKB1|TIAM1|CCND1|RPS6KB2|BAD
CHOLESTEROL BIOSYNTHESIS%WIKIPATHWAYS_20181110%WP197%HOMO SAPIENS,0.0212654239957994,0.201150083379966,-0.46479633501191103,-1.6876001495109498,161,15,PMVK|SQLE|MVK|SC5D|FDFT1|IDI1|FDPS|CYP51A1|HMGCR|HMGCS1|DHCR7|NSDHL
GENES TARGETED BY MIRNAS IN ADIPOCYTES%WIKIPATHWAYS_20181110%WP1992%HOMO SAPIENS,0.0984571129707113,0.43319560252602296,-0.45949962375633097,-1.43955233794321,752,10,IGF1|KCNQ1|SRF|ERG|TMSB4X
AMYOTROPHIC LATERAL SCLEROSIS (ALS)%WIKIPATHWAYS_20181110%WP2447%HOMO SAPIENS,0.350840879689521,0.709089066211638,-0.22297987926072896,-1.07371051944444,2711,36,GPX1|CASP1|SLC1A2|SOD1|CCS|CAT|TNFRSF1A|GRIA1|CST3|BAD
ARYL HYDROCARBON RECEPTOR PATHWAY%WIKIPATHWAYS_20181110%WP2873%HOMO SAPIENS,0.615183246073299,0.853341966514775,-0.198481973649273,-0.8864426932192941,4699,28,IL1B|CDKN1B|PTGES3|TNF|TGFB1|JUNB|CYP1B1|AHR|HES1|IL17B|AIP|HSP90AA1|MYOF
KENNEDY PATHWAY FROM SPHINGOLIPIDS%WIKIPATHWAYS_20181110%WP3933%HOMO SAPIENS,0.8956396490768629,0.966487797508433,-0.186783025093492,-0.642943393691867,6839,13,PTDSS2|PCYT1A|CHPT1|ETNK2
PROLACTIN SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP2037%HOMO SAPIENS,0.207882534775889,0.5879000441296949,-0.20360176294515397,-1.1866639852743999,1613,71,EIF4EBP1|SOCS3|PPIA|VAV1|ELK1|PPIB|GRB2|IRS1|SOCS1|STAT3|MAPK9|PTPN6|CISH|PXN|PIK3CB|MAPK3|FLNA|HRAS|NFKBIA|MYC|RELA|RPS6KB1|NFKB1|CTSD|SIRPA
"4-HYDROXYTAMOXIFEN, DEXAMETHASONE, AND RETINOIC ACIDS REGULATION OF P27 EXPRESSION%WIKIPATHWAYS_20181110%WP3879%HOMO SAPIENS",0.9609736197987491,0.990105504429159,0.143670857068356,0.562389037306153,7066,18,MAP3K5|MAP2K6|MAP2K1|MAPK1|MKNK2|PRKAA1|MTOR|TSC1|MKNK1
NANOPARTICLE TRIGGERED AUTOPHAGIC CELL DEATH%WIKIPATHWAYS_20181110%WP2509%HOMO SAPIENS,0.40992167101827703,0.7452753094449099,-0.246164969719194,-1.03354368997853,3139,23,ATG3|AMBRA1|ATG4A|VMP1
HEMATOPOIETIC STEM CELL GENE REGULATION BY GABP ALPHA/BETA COMPLEX%WIKIPATHWAYS_20181110%WP3657%HOMO SAPIENS,0.740570377184913,0.909493931144346,-0.20003657622117496,-0.790325850882923,5634,19,MCL1|CREBBP|PTEN|GABPA|DNMT3B|SMARCA4|TERF2|GZMB|ZFX|DNMT1
WNT SIGNALING PATHWAY%WIKIPATHWAYS_20181110%WP363%HOMO SAPIENS,0.8280583903888391,0.943061234519578,-0.145545368322579,-0.7539708035199749,6409,46,TEK|MYC|PPARG|CSNK1A1|CCND1|PRKCB
SIMPLIFIED INTERACTION MAP BETWEEN LOXL4 AND OXIDATIVE STRESS PATHWAY%WIKIPATHWAYS_20181110%WP3670%HOMO SAPIENS,0.0927524856096285,0.421303871141266,-0.38191098091347603,-1.41932908380735,708,16,DDR1|FN1|BMP2|FGF7|IGFBP7|SUV39H1
CHROMOSOMAL AND MICROSATELLITE INSTABILITY IN COLORECTAL CANCER %WIKIPATHWAYS_20181110%WP4216%HOMO SAPIENS,0.780239598093521,0.924883543341693,-0.13799423937306,-0.806624369608822,6056,72,CYCS|MAPK9|MAPK3|NTN1|GADD45B|GADD45G|TGFBR2|ARAF|MYC|BIRC5|CSNK1A1|CCND1|BAD
HEART DEVELOPMENT%WIKIPATHWAYS_20181110%WP1591%HOMO SAPIENS,0.15917090340242498,0.5293397224673839,-0.272137079275035,-1.27803254767002,1220,33,TBX1|BHLHE40|TBX2|VEGFC|FOXC2|NOTCH1|MEF2C|FGF10|NFATC1|GATA6|VEGFB|BMP2|SRF
REGULATION OF WNT/B-CATENIN SIGNALING BY SMALL MOLECULE COMPOUNDS%WIKIPATHWAYS_20181110%WP3664%HOMO SAPIENS,0.9140194276713051,0.973695853702848,-0.173519355714205,-0.6300206533229901,6962,15,APC|LRP1|SFRP4|FZD8|CSNK1A1
EBV LMP1 SIGNALING%WIKIPATHWAYS_20181110%WP262%HOMO SAPIENS,0.330358314739467,0.6957352559323989,-0.26984594551778196,-1.09935432502173,2516,21,IRAK1|NFKBIA|RELA|NFKB1|HSP90AA1
ELECTRON TRANSPORT CHAIN (OXPHOS SYSTEM IN MITOCHONDRIA)%WIKIPATHWAYS_20181110%WP111%HOMO SAPIENS,0.000128221566867547,0.00518555396908895,-0.386352845829103,-2.4574431897682203,0,100,ATP5C1|COX7C|COX11|NDUFC2|NDUFV2|NDUFB8|SDHC|NDUFS4|COX6C|SLC25A27|UQCRC1|NDUFB5|SURF1|UQCR10|NDUFA9|ATP5J|NDUFA7|ATP5F1|SDHB|ATPIF1|NDUFB6|ATP5B|SLC25A6|SDHD|NDUFB9|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|NDUFS6|NDUFB4|COX7B|NDUFA12|COX7A1|COX17|SLC25A4|NDUFA2|NDUFAB1|NDUFA1|NDUFA4|ATP5H|NDUFV1|UQCRQ|NDUFS3|UQCRC2|COX6A1|COX8A|NDUFA8|NDUFS8|ATP5G1|SLC25A5|NDUFV3
MONOAMINE GPCRS%WIKIPATHWAYS_20181110%WP58%HOMO SAPIENS,0.6104461371055501,0.8511912500298899,0.258916826469635,0.880007933344277,4487,12,DRD2|CHRM4|DRD4|CHRM3
IRON METABOLISM IN PLACENTA%WIKIPATHWAYS_20181110%WP2007%HOMO SAPIENS,0.140686402934242,0.505564604777695,-0.416474573376628,-1.3483588384720702,1073,11,HAMP|ACO1|TFRC|FTH1
"DEGRADATION PATHWAY OF SPHINGOLIPIDS, INCLUDING DISEASES%WIKIPATHWAYS_20181110%WP4153%HOMO SAPIENS",0.3571986461858889,0.7146993813561079,-0.3759629620233,-1.08234474772333,2743,8,GM2A|NEU1|GLA|NEU4
WNT SIGNALING PATHWAY AND PLURIPOTENCY%WIKIPATHWAYS_20181110%WP399%HOMO SAPIENS,0.6527475342641221,0.8735476294907571,-0.14723856610000596,-0.8850230748643408,5095,80,FBXW2|PPP2R3B|PLAU|FRAT1|FZD2|FZD8|MAPK9|PRKD1|NKD2|LRP5|PPP2R4|PPP2CA|MYC|LDLR|CCND3|WNT3|PPP2R2B|CCND1|PRKCB
MAPK  AND NFKB SIGNALLING PATHWAYS INHIBITED BY YERSINIA YOPJ%WIKIPATHWAYS_20181110%WP3849%HOMO SAPIENS,0.43359477124183,0.7617458538169591,-0.302324352429731,-1.01190791469537,3316,12,NFKBIA|NFKB1|RRAS
METAPATHWAY BIOTRANSFORMATION PHASE I AND II%WIKIPATHWAYS_20181110%WP702%HOMO SAPIENS,0.39348160581899605,0.73762759729289,0.162415040932347,1.03732768711758,2812,98,HS6ST3|CHST8|HS6ST1|CYP27B1|SULT1C4|NDST3|GSTM2|KCNAB3|GSTM4|CHST10|SULT4A1|CYP2E1|FMO5|GSTM1|HS6ST2|CYP4V2|GSTK1|MGST3|CYP2C8|CYP27A1|GSS|NDST2|GSTT2
REGULATION OF GLYCOGEN METABOLIC PROCESS%GOBP%GO:0070873,0.35957504767093396,0.7155384949577859,0.252849487118166,1.0734585396904899,2639,23,KHK|IRS2|INPP5K|PPP1R3B|PASK|GCGR
MONOUBIQUITINATED PROTEIN DEUBIQUITINATION%GOBP%GO:0035520,0.32920792079207895,0.695646600584197,-0.36787328990282797,-1.1066529012718,2526,9,USP15|USP16|USP47|MYSM1
HISTONE H3-R2 METHYLATION%GOBP%GO:0034970,0.27424973204716,0.6487430099175849,0.696222773642129,1.1697441526798,2046,2,CARM1|PRMT6
"POSITIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, SLEEP%GOBP%GO:0045938",0.24521739130434803,0.62804240987169,-0.8741729157476841,-1.16460822507142,1832,1,GHRL
GLYCOPHAGY%GOBP%GO:0061723,0.129957127545552,0.488696636984988,0.785426731620419,1.3196183196725502,969,2,FAM47E-STBD1|RB1CC1
REGULATION OF DNA-TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS%GOBP%GO:0043620,0.9450889404485691,0.9828952916990891,-0.11496698087197198,-0.652865271987842,7331,64,BAG3|NOTCH1|MBTPS2|CREB3L1|HMOX1|CEBPB|HIF3A|UBC|RELA|HSPA5|NCK1
NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT%GOBP%GO:0010977,0.28826628967999,0.661399005734318,-0.188093848619115,-1.11233520756364,2242,75,SEMA3B|SEMA3D|STX1B|SEMA7A|APOE|SEMA5A|SEMA3E|EPHA4|SLIT2|FKBP4|SEMA3A|SEMA6B|RTN4RL1|MYLIP|ARHGDIA|NGFR
DETECTION OF CELL DENSITY BY CONTACT STIMULUS%GOBP%GO:0060246,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
MULTI-ORGANISM LOCALIZATION%GOBP%GO:1902579,0.0698068893528184,0.37596389138254704,-0.334911863657844,-1.46094671037009,534,26,RAB7A|KPNB1|CAV2|RAB29|CLEC4M|IFIT1|RAN|THOC7|UBC|CAV1|THOC3
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071880,0.273143305439331,0.647246599153167,-0.37408322172541997,-1.1719539006755,2088,10,PDE4D|CHGA|ADRA2C|ADCY9
LEFT/RIGHT AXIS SPECIFICATION%GOBP%GO:0070986,0.0198871271163666,0.194536746706525,0.823701334509761,1.6201233218280802,147,3,AHI1|SETDB2|CITED2
HISTONE H3-K36 DIMETHYLATION%GOBP%GO:0097676,0.408201058201058,0.7445496113654559,-0.541907040161151,-1.05820710366001,3085,3,SETD2|SETMAR
CELLULAR RESPONSE TO CGMP%GOBP%GO:0071321,0.32631435946203,0.6940781026265961,0.504288844680965,1.1079440682353001,2401,4,HCN2|PDE3A
REGULATION OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM%GOBP%GO:1905550,0.258306538049303,0.636098664976652,0.70432864626413,1.18336306527634,1927,2,RTN4|DDRGK1
NOR-SPERMIDINE METABOLIC PROCESS%GOBP%GO:0046204,0.07130434782608701,0.3767214120425879,-0.9628914865460959,-1.2828026639600199,532,1,SAT2
ACTIN POLYMERIZATION-DEPENDENT CELL MOTILITY%GOBP%GO:0070358,0.903994760969221,0.96959927854485,-0.248444329081119,-0.639065741846948,6901,6,EPS8
REGULATION OF T CELL CYTOKINE PRODUCTION%GOBP%GO:0002724,0.19161519253515602,0.565967229895179,-0.31747239462987703,-1.25430381361995,1457,19,IL6|SMAD7|MALT1|TRAF6|IL1B|FOXP3|B2M|IL18|TRAF2|RSAD2|HFE|NLRP3|IL1R1|TNFRSF1B
COENZYME METABOLIC PROCESS%GOBP%GO:0006732,0.0133247918001281,0.153244359029112,-0.19579284251143303,-1.46981225393363,103,228,SLC19A1|PARP9|NADK|TKT|GPD1|CROT|ACSL5|ACOT1|NDUFA9|ACSF2|DCAKD|SLC2A1|GPI|FAR1|COASY|ACSL4|PFKFB2|HLCS|NUDT17|ELOVL2|HK1|PDHA1|GGH|VCP|ACSF3|KYNU|HK3|PDXP|ELOVL1|THTPA|COQ6|MCCC2|HAAO|ENO1|BST1|SLC25A16|PGAM1|FTCD|DHFR|MOCS2|MBIP|RFK|GAPDH|COQ7|HMGCS1|FMO2|HACD2|PDSS1|LDHA|ACOT2|PDHX|PCCB|ABCD1|SLC2A3|PNPO|CYB5A|NMNAT3|PNP|SHMT2|PGK1|FOLR2|GPHN|TALDO1|FASN|QPRT|PDXK|NNMT|ALDOA|COQ3|ALDOC|MTHFD1|PTGIS
CELLULAR RESPONSE TO STARVATION%GOBP%GO:0009267,0.816608513607816,0.9374638564993091,0.12484354577918302,0.8037436134878929,5850,102,MAP3K5|SFRP1|RALB|PICK1|MIOS|WRN|WDR59|CDKN1A|PMAIP1|STK24|GABARAP|KIAA1324|CLEC16A|MYBBP1A|SESN1|MAP1LC3B|NPRL3|SH3GLB1|SREBF1|ATG5|GAS2L1|MAP1LC3A|ATG14|SESN2|BMPR2|MAPK1|EIF2AK3|MAPK8|ATF4|C12orf66|DEPDC5|SIRT1|EIF2AK2|CARTPT|STK26|PRKAA1|MTMR3
NEGATIVE REGULATION OF PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0071901,0.0274675908099089,0.23411774132933702,-0.243257721068088,-1.50566168061899,213,90,DUSP1|DUSP8|ZNF675|DUSP7|DUSP3|HIPK3|APC|PRKAR2A|HEXIM2|LYN|HYAL2|PYCARD|IRAK3|DAB2IP|DUSP5|SPRY1|CDKN2A|HEXIM1|MAPK8IP1|HEG1|IPO7|PRKAR1A|CEBPA|RGS4|ABL1|MEN1|LRP5|CD300A|MBIP|APOE|PLK1|PPP2CA|LATS2|NR2F2|CAV1|DNAJA1|RASIP1|SMPD1|H2AFY|RGS2|GPS1|GSTP1|RGS3|PTPRJ
AUTOPHAGY OF MITOCHONDRION%GOBP%GO:0000422,0.143210197710718,0.509384864704371,-0.271820739518564,-1.29765401556775,1100,35,ATG7|FUNDC1|ATG2B|FIS1|USP30|ATG13|WDR45B|ATG2A|WDR45|WIPI1|ATG3|MARK2|AMBRA1|FUNDC2|SQSTM1
COAGULATION%GOBP%GO:0050817,0.000127323656735421,0.00518555396908895,-0.280127336651214,-2.0432989566023503,0,192,KDM1A|ZFPM2|SH2B1|DGKG|PIK3R6|ITPR2|P2RX4|RAD51C|ITPR3|RAP2B|VAV1|GATA3|WAS|TLN1|PRCP|GP1BA|P2RX5|PLEK|GP1BB|P2RX3|GAS6|AKAP1|ILK|PLSCR1|VWF|PRKAR1A|DOCK6|PTPN6|SH2B3|ARRB1|FCER1G|F3|DGKE|EHD1|PIK3CB|F8|MAPK3|HSPB1|FLNA|MYL12A|RAD51B|DOCK1|GNAQ|HIST2H3A|THBD|PDPN|F2R|PLAUR|GATA6|GNA15|CD36|SERPINE2|A2M|F2RL3|F13A1|COL1A2|COL1A1|VCL|ITPK1|COL3A1|CD59|PLAT|MYH9|HIST2H3C|FIBP|PRKACA|FERMT3|HIST1H3H|ACTB|PDGFRA|TFPI|H3F3B|ACTN1|SERPING1|MYL9|EHD2|VKORC1|FBLN1|PRKCB
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY%GOBP%GO:0010466,0.00012835322808368602,0.00518555396908895,-0.40524819701135395,-2.50831372875168,0,90,FNIP1|RPS6KA1|TRIAP1|IGBP1|AGT|SERPINA3|SERPINB8|SPOCK2|KLF4|SERPINB1|HGF|NGF|GAS6|GPX1|VTN|DDX3X|SIAH2|CAAP1|SERPINA1|PARK7|UBXN1|TIMP3|DPEP1|CARD16|IFI6|RECK|IFI16|NAIP|CAST|USP47|GAPDH|PLAUR|ECM1|SERPINE2|THBS1|SERPINH1|XIAP|MMP9|SERPINE1|CSTB|BCL2L12|ARL6IP1|TIMP1|SERPING1|NGFRAP1|DHCR24|NGFR|SERPINF1|SERPINF2|CST3
SEGMENTATION%GOBP%GO:0035282,0.153364205938436,0.521561408675329,0.30646184752637895,1.30106685627872,1125,23,DLL1|TBX3|HES7|BMI1|HES6|DVL2|ACD|HES4|LRP6
FOREBRAIN CELL MIGRATION%GOBP%GO:0021885,0.0269173542540241,0.232176199896298,0.41374776646494105,1.6495643076191397,198,19,EFHC1|DRD2|SLIT1|RTN4|LAMB1|SLIT3|MBOAT7|PEX13
PULMONARY VALVE MORPHOGENESIS%GOBP%GO:0003184,0.25850340136054395,0.636098664976652,-0.314238335908669,-1.167831331625,1975,16,BMP4|TBX20|HEYL|TGFB2|ROBO1|GJA5|JAG1|SMAD6|NOTCH1|NOTCH2|NOS3|SLIT2
ACTIN FILAMENT BUNDLE ORGANIZATION%GOBP%GO:0061572,0.300489438433797,0.673988937137548,-0.205922545280994,-1.1114810103894,2332,53,FSCN2|ITGB5|SHROOM1|RHOF|PDXP|ARRB1|AIF1L|RHOD|RND1|BAIAP2L1|CORO1B|PLS3|AIF1|NEDD9|FAM107A|EPS8
POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070564,0.54916934619507,0.8197939014184742,0.570650738310865,0.958766920061506,4098,2,CYP27B1
POSITIVE REGULATION OF CELL GROWTH%GOBP%GO:0030307,0.00177237625015825,0.0358830355487417,-0.290298654570106,-1.8373888344137401,13,97,SYT4|SFRP2|NGF|INS|GOLGA4|DDX3X|CPNE6|LGI1|NCBP1|DSCAM|TRIM32|MMP14|CPNE5|NTN1|IGF1|MAP3K13|EIF4G2|RPTOR|SEMA7A|N6AMT1|CXCL16|TAF9B|PSMD10|USP47|HYAL1|FXN|SEMA5A|PLAA|S100A8|S100A9|TAF9|H3F3B|EXOSC2|SPHK1|AK6|FAM122A|EIF4G1
POSITIVE REGULATION OF ADIPONECTIN SECRETION%GOBP%GO:0070165,0.388763448001063,0.7356350957002221,0.8071239523599469,1.07619088293165,2926,1,C1QTNF3
DNA EXCISION%GOBP%GO:0044349,0.469119404967459,0.780769690730001,0.766541685046317,1.02207990535017,3531,1,PNKP
POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY%GOBP%GO:2000786,0.00969150969150969,0.12539147812585302,0.606942916938279,1.8444435462349702,70,9,RALB|PIP4K2C|KIAA1324|RAB3GAP1|SH3GLB1
SPERMATID NUCLEUS DIFFERENTIATION%GOBP%GO:0007289,0.14385245901639301,0.51013716783094,0.462713058632314,1.3431750593858898,1052,8,PSME4|TSSK6|CHD5|RNF8|PYGO1
CYSTEINE BIOSYNTHETIC PROCESS%GOBP%GO:0019344,0.661099421357181,0.878689206829556,-0.346992194321218,-0.831674077582912,5026,5,GGT1|GGT5
REGULATION OF T CELL MIGRATION%GOBP%GO:2000404,0.797818677573279,0.9308634013872809,0.16982106163588598,0.7600336922641461,5851,27,TMEM102|XCL1|ADAM17|LRCH1
CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:0071402,0.06381302521008402,0.36192038030965795,-0.37237534780525605,-1.4939627631281298,485,20,ADTRP|AKT1|SYK|ITGB1|SREBF2|ITGB2|FCER1G|CD36|TICAM1|LDLR|PPARG|TLR4|CD81
TRNA EXON LIGATION%GOBP%GO:0000968,0.973568867047417,0.9920058127185359,0.512130569033966,0.682857010566275,7329,1,RTCB
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0019885,0.3579694897422411,0.714938712241162,-0.4532318552834771,-1.0863102725162,2721,5,TAP1|TAP2|ERAP2|ERAP1|B2M
CONNECTIVE TISSUE REPLACEMENT%GOBP%GO:0097709,0.366798941798942,0.721190111986457,-0.559611778978714,-1.0927799713231001,2772,3,HIF1A|TGFB1|F2R
MESONEPHRIC TUBULE DEVELOPMENT%GOBP%GO:0072164,0.017584201271473,0.180237022041183,0.431976354453479,1.72223957153922,129,19,FOXC1|FGFR2|CITED1|PAX8|FGF2|ROBO2|BMP7|PKD1|PKD2|FGF1|FOXJ1
DNA TOPOLOGICAL CHANGE%GOBP%GO:0006265,0.256668410041841,0.634999333537934,-0.38036673430709494,-1.1916393253413602,1962,10,RPA2|HMGB2|TOP1|TOP2A|TOP1MT
POSITIVE REGULATION OF TROPHECTODERMAL CELL PROLIFERATION%GOBP%GO:1904075,0.227157190635452,0.609201573718782,-0.8834913983237759,-1.1770226813623899,1697,1,IGF1
NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION%GOBP%GO:0010757,0.000131509731720147,0.00518555396908895,-0.9015552614162808,-2.16085592903655,0,5,CTSZ|SERPINE2|THBS1|SERPINE1|SERPINF2
ESTABLISHMENT OF MITOCHONDRION LOCALIZATION%GOBP%GO:0051654,0.6405761652398421,0.8669975378013259,0.22389111262670602,0.860928032371692,4713,17,TRAK2|HAP1|LRPPRC|TRAK1|SPAST|MYO19|NEFL|RHOT2
NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION%GOBP%GO:1903392,0.0391156462585034,0.281882798544675,-0.428967713262441,-1.5942101219279998,298,16,PTEN|RCC2|APOD|CORO1C|PHLDB2|BCAS3|DLC1|THBS1|FAM107A|ACVRL1
INTRACELLULAR STEROL TRANSPORT%GOBP%GO:0032366,0.42517006802721097,0.7547028278218628,-0.274630405395287,-1.02063292535608,3249,16,CES1|SYT7|ABCG1|LDLR|OSBP|NPC2
ASPARAGINE METABOLIC PROCESS%GOBP%GO:0006528,0.565608465608466,0.8298229800621719,-0.471974778164272,-0.9216471202390429,4275,3,ASRGL1
CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086001,0.32683126449324795,0.6941148928066879,0.229566943160454,1.09320866123402,2395,33,TRPM4|SCN5A|ANK2|DMD|HCN2|KCNIP2|KCNJ8|CACNA1C|YWHAE|CACNB2|NEDD4L|SLC8A1|SNTA1|FGF12
INTERLEUKIN-1 BETA PRODUCTION%GOBP%GO:0032611,0.21293375394321803,0.595473809364003,-0.454412513796945,-1.24211634222716,1619,7,CD36|TLR4
PLATELET DEGRANULATION%GOBP%GO:0002576,0.000127942681678608,0.00518555396908895,-0.429473879890173,-2.74073133308945,0,101,STXBP2|HGF|BRPF3|RAB27B|TUBA4A|TLN1|PLEK|VEGFC|GAS6|TGFB3|CLEC3B|VWF|SERPINA1|CD63|F8|TIMP3|PHACTR2|SOD1|SRGN|FLNA|ITIH3|SPARC|IGF1|MMRN1|LGALS3BP|FN1|VEGFB|CD36|ECM1|TOR4A|A2M|THBS1|F13A1|CYB5R1|VCL|SEPP1|RARRES2|SERPINE1|LAMP2|FERMT3|PDGFA|CFD|TIMP1|TMSB4X|ACTN1|SERPING1|CHID1|LHFPL2|PDGFB|SERPINF2|ALDOA
DNA GEOMETRIC CHANGE%GOBP%GO:0032392,0.48006050605060496,0.7857006060206241,0.20101111120426998,0.9805414335975319,3490,36,ZRANB3|SMARCAL1|WRN|MRE11A|ERCC3|PIF1|MCM9|DDX1|RTEL1|POT1
NUCLEOTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:1901679,0.39021164021164,0.736024484458425,-0.5490338075792071,-1.07212387415569,2949,3,SLC25A42
MULTI-MULTICELLULAR ORGANISM PROCESS%GOBP%GO:0044706,0.6052703815536651,0.8484731812466321,0.180070192952957,0.899676097619968,4409,39,TLE6|CRHR1|CYP27B1|TEAD3|PPARD|PRLHR|ADCYAP1|MAFF|STOX2|TRO|BCL2|APOL2|TAC3|CRH
NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS%GOBP%GO:1904406,0.0554543087737568,0.34165878259009896,-0.540717253278739,-1.5566492931645701,425,8,CD34|GLA|CAV1|SIRPA|PTGIS
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS%GOBP%GO:0060560,0.681080379171536,0.8849342663941481,-0.165972888543029,-0.853157841129194,5244,45,USP9X|COBL|SH3GL2|MESP1|NOTCH1|S1PR1|FGF10|NRP2|SLIT2|TMEM108|MAP1B|SEMA3A|HSP90AA1
MECHANORECEPTOR DIFFERENTIATION%GOBP%GO:0042490,0.21691945606694601,0.599597524514766,-0.39471267376863,-1.23658328094903,1658,10,MYO7A|DFNB31|PDZD7|SOD1|JAG2|ADGRV1
RESPONSE TO VIRUS%GOBP%GO:0009615,0.000128369704749679,0.00518555396908895,-0.35212630049727095,-2.47669775935706,0,161,OAS3|FOXP3|CXCL12|TNF|PRF1|CCL4|SKP2|CCL8|MX1|SERINC3|MICA|LILRB1|EXOSC4|ATG7|CCL11|PIM2|CDK6|HYAL2|FCN3|BNIP3L|PYCARD|AGBL4|IRAK3|CCL19|IFIT3|TRIM56|OASL|OAS1|IFNGR1|IFNAR1|SLFN13|FGR|ODC1|GATA3|HYAL3|AZU1|OAS2|SLFN11|FMR1|PLSCR1|DDX3X|PDE12|CXCR4|DDX60|MST1R|IFIT2|MB21D1|IFI44L|ABCC9|CCT5|IFIH1|IFIT1|APOBEC3G|ENO1|ISG15|IFI6|RSAD2|HSPB1|FLNA|IRF7|APOBEC3C|ARF1|IFI44|APOBEC3B|IFI16|CHRM2|SERINC5|TMEM173|EEF1G|BCL3|RNASE6|HYAL1|RPS15A|BST2|LGALS9|FADD|IFNLR1|RRP1B|DDIT4|RELA|CFL1|DHX58|IFITM1|BTBD17|RNASE1|ACTA2|NPC2|IFITM2|IFITM3|PQBP1|SAMHD1|BANF1|LYST|APOBEC3F
ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:0046165,0.0199456029011786,0.19499358302622102,-0.290143012995972,-1.6033153209831001,153,58,LBR|IPPK|CES1|PGP|MOXD1|FDPS|GOT1|CACNA1H|CYP51A1|PARK7|HMGCR|DHFR|APOE|HMGCS1|SRD5A3|EBP|DHCR7|C14orf1|SPHK1|DHCR24|CNBP|NSDHL|TM7SF2
RESPONSE TO FORSKOLIN%GOBP%GO:1904321,0.566803278688525,0.8308398918711859,0.310096610184182,0.900156209186385,4148,8,ADCY2|ADCY3|ADCY6|ADCY1
TRANSEPITHELIAL AMMONIUM TRANSPORT%GOBP%GO:0070634,0.104537012470151,0.44493381226372997,-0.7981251723187209,-1.3282079165494398,787,2,SLC12A2|RHBG
REGULATION OF ANGIOGENESIS%GOBP%GO:0045765,0.000127860887354558,0.00518555396908895,-0.34518475053015,-2.52202655848773,0,195,HOXA5|AQP1|S100A1|PML|RGCC|KIAA1462|PAK4|HTATIP2|HSPG2|CHI3L1|SP100|MTDH|MAP3K3|FLT1|TMEM2|RUNX1|MYDGF|PIK3C2A|JUP|DAB2IP|PIK3R6|SARS|KLF4|HGS|KDR|PLXND1|EMC10|SEMA6A|PDCD6|CD34|ANGPTL4|SYNJ2BP|SFRP2|CYP1B1|SRPX2|E2F2|VEGFC|ADAM12|STIM1|FOXC2|TNFAIP3|ITGA5|WARS|DCN|SMOC2|NOTCH1|GPNMB|TNFSF12|FAM129B|PRKD1|TBXA2R|BRCA1|F3|MMRN2|CREB3L1|MECP2|GHRL|JMJD8|HMOX1|HSPB1|RAPGEF3|SPARC|SULF1|COL4A2|HDAC5|MEOX2|RHOJ|CDH5|STARD13|CTSH|CEACAM1|EPHA2|NPR1|APLNR|GATA6|SASH1|NOS3|HYAL1|VEGFB|ECSCR|EFNA3|ECM1|THBS1|TEK|SEMA5A|THBS2|SEMA3E|SERPINE1|ADGRA2|STAB1|PPARG|RRAS|ANXA1|RNH1|HSPB6|PGK1|SPHK1|NGFR|SERPINF1|PRKCB|CARD10|EMP2|ADGRB1|PTGIS
RECOMBINATIONAL REPAIR%GOBP%GO:0000725,0.143243591395079,0.509384864704371,-0.21200255417137,-1.2609595429814902,1111,77,NIPBL|XRCC1|CDC7|MMS22L|BLM|ZFYVE26|RAD54B|UBE2N|INO80|DMC1|RAD51|RPA2|XRCC2|NABP2|PALB2|TONSL|NBN|YY1|GINS2|PARP1|RAD51C|AP5S1|RAD51AP1|SLX1B|RHNO1|AUNIP|SLX1A|RNF138|CDC45|BRCA1|POLQ|NUCKS1|RMI1|RAD51B|NSMCE1|MUS81|SAMHD1|XRCC3|FEN1
REGULATION OF INTRACELLULAR TRANSPORT OF VIRAL MATERIAL%GOBP%GO:1901252,0.0711063942690369,0.3767214120425879,-0.828839261097326,-1.3793210718291202,535,2,FMR1|BST2
REGULATION OF TRANSLATIONAL INITIATION%GOBP%GO:0006446,0.0166237113402062,0.17569702079137303,-0.285331017539396,-1.62701413350898,128,65,ALKBH1|DNAJC3|EIF4EBP3|PAIP2B|EIF4EBP1|IMPACT|NCBP2|NPM1|FMR1|DDX3X|NCBP1|HSPB1|GLE1|EIF3B|EIF4G2|PAIP2|EIF5|MIF4GD|EIF2S1|EIF2B2|POLR2G|RPS6KB1|EIF4A2|RBM4|NCK1|PPP1CA|RPS6KB2|EIF4G1
POSITIVE REGULATION OF NON-CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:2000052,0.25329170625763503,0.632257972333528,0.46093520958397904,1.1926969463857902,1865,6,DKK1|SFRP1
PEPTIDYL-LYSINE BUTYRYLATION%GOBP%GO:0140067,0.5684685881259129,0.831514598829999,0.7133325981473309,0.9511327676244509,4279,1,EP300
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0002053,0.0299635226680563,0.244735657013286,-0.557212995757896,-1.6762330816263202,229,9,TBX1|CHRD|LRP5|TGFBR2|MYC|PDGFA
CELLULAR RESPONSE TO INTERLEUKIN-9%GOBP%GO:0071355,0.530625657202944,0.8115959426370749,-0.34220132450331303,-0.9353920602795759,4036,7,STAT5B|IL2RG|JAK3|STAT5A|STAT3
REGULATION OF PEPTIDYL-TYROSINE PHOSPHORYLATION%GOBP%GO:0050730,0.00012768130745658798,0.00518555396908895,-0.308749731416877,-2.0867176869298403,0,132,PTPN1|CSPG4|LIF|CD40|ARHGEF2|CTF1|RIPK2|PAK2|TNF|SH3BP5|ZFYVE28|THBS4|PARP14|RAP2C|CD44|TGFB1|GREM1|LYN|STAP2|HYAL2|SOCS4|CD74|TNFRSF14|SAMSN1|IL18|TSG101|AGT|SOCS3|PARP9|ITGB2|HCLS1|HGF|RAP2B|TNK2|SFRP2|TNFRSF18|GAS6|THY1|IL6ST|HES1|VTN|ITGA5|EFNA1|SOCS1|STAT3|PTPN6|HAX1|OSM|FGF10|BST1|ABL1|IGF1|NTRK2|TREM2|SNX6|GPRC5B|VPS25|CD300A|PPP2CA|MVP|FGF7|DLG3|CHMP6|EPHA4|ERRFI1|NEDD9|IL11|CAV1|PDGFA|CSF1R|NF2|TNFRSF1A|CD81|PDGFB|EFNA5|PTPRJ|PRNP
ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086044,0.602943143812709,0.8480120088902141,-0.7022496691662989,-0.93556517941905,4506,1,GJA5
TOLL-LIKE RECEPTOR TLR1:TLR2 SIGNALING PATHWAY%GOBP%GO:0038123,0.0747354497354497,0.383186929742657,-0.734972978934598,-1.43521594972352,564,3,TLR1|TLR2|CD14
REGULATION OF APOPTOTIC PROCESS INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1902256,0.7014046822742479,0.8931369333627571,-0.652183502426114,-0.8688650237255441,5242,1,TGFB2
MORPHOGENESIS OF A BRANCHING EPITHELIUM%GOBP%GO:0061138,0.0743058271411811,0.38299993877531896,-0.305750455082638,-1.43589044940698,569,33,FGF10|COL4A1|LRP5|CTSH|EPHA2|TGFBR2|BMP2|SEMA3E|SLIT2|MYC|RASIP1|ENG
REGULATION OF TOLL-LIKE RECEPTOR 9 SIGNALING PATHWAY%GOBP%GO:0034163,0.666228300894266,0.880719592999549,-0.345384574557106,-0.8278209197704219,5065,5,RSAD2|RAB7B
PRENYLATION%GOBP%GO:0097354,0.8930073606729759,0.965443067117994,-0.234517091383707,-0.64104201115696,6793,7,PGGT1B|CHM|FNTB
POSITIVE REGULATION OF PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:1900373,0.014437590234938999,0.16079417073357402,-0.42826728968959293,-1.7447640218650702,109,21,GUCA1A|PID1|PFKFB2|PFKFB3|INS|VCP|ENO1|IGF1|NOS3|TMSB4X
NEGATIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1905064,0.0859151262692007,0.40571440152387606,-0.510934786400968,-1.4709097393906498,659,8,DNMT1|NFATC1|FGF9|PDGFB
LONG-CHAIN FATTY-ACYL-COA METABOLIC PROCESS%GOBP%GO:0035336,0.37389932974109596,0.724682900261831,-0.268777646159439,-1.06191540523269,2844,19,DGAT1|ACSL5|FAR1|ACSL4|ELOVL2|ACSF3|ELOVL1|HACD2
NEGATIVE REGULATION OF MESONEPHROS DEVELOPMENT%GOBP%GO:0061218,0.561820111435394,0.8282270665374359,-0.574469258340226,-0.9560087104195151,4234,2,BMP4|GATA3
RESPONSE TO RAFFINOSE%GOBP%GO:1901545,0.48762541806020093,0.788226301622024,-0.759483899426555,-1.01181491687484,3644,1,ZFP36L1
REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS%GOBP%GO:0000960,0.7903439153439151,0.928247620398227,-0.379903264416437,-0.7418547893187529,5974,3,SLIRP
CELLULAR RESPONSE TO ETHANOL%GOBP%GO:0071361,0.618275999468721,0.854944793214197,0.6875275694750771,0.9167252438362271,4654,1,ADCY7
NEGATIVE REGULATION OF HISTONE METHYLATION%GOBP%GO:0031061,0.578464762902803,0.8380679676697859,-0.2772367778579,-0.897568984208231,4415,11,DNMT3B|BCOR|BRCA1|DNMT1|H2AFY
NEGATIVE REGULATION OF TYPE IIA HYPERSENSITIVITY%GOBP%GO:0001797,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905453,0.0497658862876254,0.31994287376139896,-0.973202470224967,-1.29653937003347,371,1,DPF2
HISTIDINE CATABOLIC PROCESS%GOBP%GO:0006548,0.131481481481482,0.490819490032838,-0.6877136869968019,-1.34293053038731,993,3,C9orf41|FTCD|HNMT
SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:0071173,0.845842050209205,0.948909006295342,-0.18112837669182102,-0.702845465012262,6468,18,ZNF207|TRIP13|KLHL22|APC|CDC20|MAD2L1|PLK1|IK
NEGATIVE REGULATION OF ELECTRON TRANSFER ACTIVITY%GOBP%GO:1904733,0.7359197324414721,0.908157084784786,-0.6367445963828849,-0.848296693776004,5500,1,METTL20
CEREBELLAR GRANULAR LAYER MORPHOGENESIS%GOBP%GO:0021683,0.89321409784324,0.965443067117994,-0.27219532439954697,-0.652400252937136,6791,5,CBLN1
NEGATIVE REGULATION OF PROTEIN FOLDING%GOBP%GO:1903333,0.6947089947089949,0.889726625344871,-0.41917633705521296,-0.8185451464629409,5251,3,PDCD5|BAG5
MANGANESE ION TRANSPORT%GOBP%GO:0006828,0.837194084543908,0.946216977301937,-0.320820255351773,-0.702342602447563,6396,4,SLC11A2|TRPC1|SLC11A1
PRENYLCYSTEINE CATABOLIC PROCESS%GOBP%GO:0030328,0.9725348338692389,0.9915747942934481,0.320147066686413,0.5378884078941589,7258,2,PCYOX1|PCYOX1L
NEGATIVE REGULATION OF COMPLEMENT ACTIVATION%GOBP%GO:0045916,0.000925925925925926,0.0217816182659933,-0.923789566560053,-1.8039268899886298,6,3,A2M|CD55|SERPING1
CELL WALL MANNOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0000032,0.528561872909699,0.8105400040230321,-0.73869651521835,-0.984121129764213,3950,1,MPI
OOCYTE DIFFERENTIATION%GOBP%GO:0009994,0.7445637935551479,0.9112137767014771,-0.238993372132112,-0.7737539005992571,5683,11,ZP3|ANG
NEGATIVE REGULATION OF VIRAL LIFE CYCLE%GOBP%GO:1903901,0.031213573371325,0.250729241129472,-0.28042320774919105,-1.54960417864602,240,58,FCN3|PARP10|TRIM21|OASL|OAS1|TRIM28|CCNK|PLSCR1|IFIT1|APOBEC3G|TRIM32|ISG15|RSAD2|APOBEC3C|FCN1|IFI16|TNIP1|GSN|BST2|IFITM1|BTBD17|IFITM2|IFITM3|MID2|BANF1|APOBEC3F
REGULATION OF LYMPHOCYTE CHEMOTAXIS%GOBP%GO:1901623,0.625764370158989,0.858842084733938,0.22652803809741698,0.871067796430996,4604,17,XCL1|ADAM17|CXCL13|PTK2B|OXSR1|ADAM10|KLRK1|CCL21
"BLOOD COAGULATION, FIBRIN CLOT FORMATION%GOBP%GO:0072378",0.00039380414807036,0.0111483598225525,-0.6287773284494189,-2.28298855556411,2,15,F12|F10|PRCP|GP1BA|GP1BB|VWF|F3|F8|A2M|F13A1|TFPI|SERPING1|FBLN1
RESPONSE TO CAPSAZEPINE%GOBP%GO:1901594,0.334440164696507,0.6974768376198021,0.832487869430966,1.11001024392007,2517,1,TRPV1
CEREBELLAR CORTEX STRUCTURAL ORGANIZATION%GOBP%GO:0021698,0.012593783494104999,0.14869950444299201,0.9299161109752799,1.5623791327676397,93,2,DLL1|KIF14
"COMPLEMENT ACTIVATION, ALTERNATIVE PATHWAY%GOBP%GO:0006957",0.00510404397330192,0.0803498785568947,-0.8281034577841501,-1.81289157381356,38,4,C3|CFB|CFP|CFD
TRACHEA SUBMUCOSA DEVELOPMENT%GOBP%GO:0061152,0.7412671005445608,0.9098143075756671,0.6290802823114251,0.838793672862902,5580,1,LEF1
REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY%GOBP%GO:2000810,0.49914954860656796,0.794989907195277,-0.25367355271920106,-0.964021446453628,3814,17,ROCK1|TNF|PRKCH|RUNX1|CLDN5|SNAI2|EPHA2|SNAI1|PRKACA|OCLN
LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002443,0.000126518218623482,0.00518555396908895,-0.329165601645175,-2.7741089843002897,0,481,IGHV1OR15-1|UNC13D|IGKV3-11|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|MICA|CNN2|IGHV5-51|SLA2|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|CEBPG|PYCARD|IGHV1-24|NCKAP1L|ATP6V0A1|DYNC1H1|CD74|GSDMD|JAG1|B2M|NEU1|GYG1|CORO1A|ADAM8|FRMPD3|IGHV3-49|BATF|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|IGHG4|GZMB|EXO1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|IGLL5|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|MYO1G|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|FCGR2B|ARMC8|LAIR1|GGH|VCP|IGKV2-28|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|IGHV4-4|HK3|GLA|LILRB2|OLR1|HSPA6|IGHV4-61|S100A13|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|RNF168|C1QB|ORMDL3|CD47|IGHV1-3|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|IGHV3-43|ALAD|ERP44|VAMP8|FCN1|IGHV3-73|VAMP7|PGAM1|CRISPLD2|FCGR2A|C1QA|PLD1|COPB1|C1QC|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|HFE|GSN|FTL|RAP1A|IGKV2D-28|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|CHGA|BST2|CREG1|ZP3|ATP8B4|ANPEP|GLIPR1|IGHV3-15|VCL|PSMD2|NME2|EXOSC3|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|MILR1|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|C1S|PSMD12|TMEM179B|ITGAM|IGHV1-18|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|IGHG2|PSMD13|ALDH3B1|PSMB7|DBNL|IGHA1|C1R|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|LYST|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA|EMP2
POSITIVE REGULATION OF RNA BINDING%GOBP%GO:1905216,0.19799531372038504,0.5750614504600671,-0.438353440931743,-1.26195820430183,1520,8,EIF3C|FMR1|NCBP1|EIF4G1
ELECTRON TRANSPORT CHAIN%GOBP%GO:0022900,0.00012748597654258,0.00518555396908895,-0.359231893236942,-2.19760822019808,0,85,NDUFV2|NDUFB8|SDHC|NDUFS4|UQCRC1|NDUFB5|UQCR10|NDUFA9|NDUFA7|SLC25A18|SDHB|NDUFA3|NDUFB6|SDHD|CYCS|NDUFB9|COA6|NDUFB10|SDHA|SLC25A22|MT-CO3|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|COQ7|LYRM5|NDUFB4|NDUFA12|SDHAF2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|NDUFA4|NDUFV1|UQCRQ|NDUFS3|COX6A1|UQCC3|NDUFA8|NDUFS8|NDUFV3
REGULATION OF CAMP-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:2000479,0.718171926006529,0.900080821429213,0.23542026035093502,0.8001476752345981,5279,12,HTT|PKIG|ATP2B4|PKIA|SIRT1
ESTABLISHMENT OF SERTOLI CELL BARRIER%GOBP%GO:0097368,0.124319298711648,0.478357784842846,0.9392368769298629,1.25234564147135,935,1,RAB13
POSITIVE REGULATION OF CHEMOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070101,0.598412698412698,0.84557799939374,-0.45730297199646397,-0.8929968013473009,4523,3,TREM2
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ARSENIC-CONTAINING SUBSTANCE%GOBP%GO:0061394,0.9812433011789921,0.993436724391485,0.307361455748553,0.516406930701503,7323,2,ATF4|ATF3
ARP2/3 COMPLEX-MEDIATED ACTIN NUCLEATION%GOBP%GO:0034314,0.8778139408733392,0.960725750963158,0.18466755537749105,0.663763712704249,6472,14,ACTR2|TRIM27|WASH1|JMY|ACTR3|ARPC2
PHOSPHOLIPID HOMEOSTASIS%GOBP%GO:0055091,0.0106522882693319,0.13314154417238197,-0.7302730827415341,-1.75032523040117,80,5,FABP3|ABCG1|CETP|RCN3
CELLULAR RESPONSE TO PURINE-CONTAINING COMPOUND%GOBP%GO:0071415,0.813085380752002,0.9356336309698571,0.277849351895093,0.718951528696725,5989,6,GSTM2|RYR1|SLC8A1
NEURAL RETINA DEVELOPMENT%GOBP%GO:0003407,0.486343253159397,0.7876325655752758,0.25243514240571696,0.9706883310512379,3578,17,AHI1|SDHAF4|PTPRM|MEGF11|TFAP2B
POLYUBIQUITINATED PROTEIN TRANSPORT%GOBP%GO:0070844,0.619471377340948,0.854944793214197,0.687141596823996,0.916210601386403,4663,1,HDAC6
FERROUS IRON TRANSPORT%GOBP%GO:0015684,0.832775919732442,0.9443921657118071,-0.58706440229378,-0.7821107463312359,6224,1,SLC40A1
REGULATION OF EPITHELIAL CELL MIGRATION%GOBP%GO:0010632,0.00012853470437018,0.00518555396908895,-0.31773082937798103,-2.2593943273626502,0,170,PPAP2B|TGFB1|STAT5A|IQSEC1|RGCC|KIAA1462|ADAM9|SP100|MAP3K3|MAPRE2|CORO1C|ANGPT2|PIK3C2A|AGT|JUP|DAB2IP|PPM1F|KLF4|KDR|P2RX4|EMC10|PDCD6|SYNJ2BP|GPI|GATA3|PRCP|SRPX2|BCAR1|RREB1|ARSB|FOXC2|DOCK5|ATP5B|DCN|SMOC2|FLT4|NOTCH1|MEF2C|ADIPOR1|PRKD1|TBXA2R|BCAS3|MMRN2|MECP2|FGF10|ABL1|CALR|HMOX1|HSPB1|SPARC|HDAC5|MEOX2|RHOJ|DOCK1|STARD13|CTSH|CEACAM1|MAP2K3|EPHA2|APOE|INSL3|SASH1|NOS3|HYAL1|NRP2|THBS1|TEK|ATOH8|FGF7|SEMA5A|SLIT2|FOXP1|MMP9|NR2F2|PPARG|EVL|MCC|ANXA1|LGMN|TMSB4X|GLIPR2|ACVRL1|ARF6|PDGFB|CARD10|EMP2|ADGRB1
MIDDLE EAR MORPHOGENESIS%GOBP%GO:0042474,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
POSITIVE REGULATION OF METANEPHRIC CAP MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0090096,0.102207357859532,0.441073279931729,-0.946570357300397,-1.26105900087051,763,1,MYC
PROTEIN LOCALIZATION BY THE CVT PATHWAY%GOBP%GO:0032258,0.918542336548767,0.9761906972716509,0.375516956162117,0.6309169713091559,6855,2,TRAPPC8|BECN1
HEART PROCESS%GOBP%GO:0003015,0.390096463022508,0.7358910495632479,-0.19239744155162805,-1.0432340368569801,3032,54,RYR2|ATP1B1|GAA|TNNI2|KCNN2|GPX1|MYLK2|PDE4D|PKP2|CACNA1G|SOD1|KCNQ1|CHGA|CAV1|SCN1B|KCNH2|KCNE4|ADRBK1
REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME%GOBP%GO:1905666,0.8926130389064141,0.965443067117994,-0.234859349145063,-0.641977557484861,6790,7,EZR|ROCK2|SORL1|RDX|MGAT3|DTX3L|MSN
RRNA ACETYLATION INVOLVED IN MATURATION OF SSU-RRNA%GOBP%GO:1904812,0.0145819397993311,0.161640900278931,-0.992666519629466,-1.3224701574341398,108,1,NAT10
REGULATION OF METANEPHRIC URETERIC BUD DEVELOPMENT%GOBP%GO:2001074,0.47812709030100303,0.7850984235874658,-0.7638950154389059,-1.01769158257471,3573,1,BASP1
NEGATIVE REGULATION OF RECEPTOR RECYCLING%GOBP%GO:0001920,0.43912926632625604,0.764873767314801,0.5192456159700011,1.02129485159893,3267,3,OPTN|TRAT1|AP1AR
TRNA N2-GUANINE METHYLATION%GOBP%GO:0002940,0.18689710610932503,0.5601505529923929,0.745188861317894,1.25201350224258,1394,2,TRMT1|TRMT1L
REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0034391,0.20750523012552302,0.5875035269006329,-0.398460294356271,-1.2483240870340502,1586,10,SOD2|CDKN2A|DNMT1|IGF1|PPARG
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0060973,0.0074656188605108096,0.10477806266857598,-0.709781035393524,-1.82574802818121,56,6,MESP1|NOTCH1|SNAI2|PDGFRB|DCHS1
DORSAL ROOT GANGLION DEVELOPMENT%GOBP%GO:1990791,0.425952981803692,0.7547028278218628,0.7878804587560649,1.05053228079043,3206,1,POU4F2
MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904948,0.786822724881641,0.9276917050905171,-0.31006580471599104,-0.7431685679028729,5982,5,WNT3
POSITIVE REGULATION OF NLRP3 INFLAMMASOME COMPLEX ASSEMBLY%GOBP%GO:1900227,0.340662216987305,0.701955655133333,-0.509135171626216,-1.11460331906243,2602,4,CD36|TLR4
PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0019363,0.00697584291435215,0.10045820391703099,-0.34712278593970797,-1.7982052527772001,53,46,PGAM2|PARP10|PARP9|GPI|PFKFB2|HK1|KYNU|HK3|HAAO|ENO1|PGAM1|GAPDH|LDHA|NMNAT3|PNP|PGK1|QPRT|NNMT|ALDOA|ALDOC|PTGIS
PROLINE BIOSYNTHETIC PROCESS%GOBP%GO:0006561,0.399685904986258,0.7394926011035,-0.480633922779553,-1.05220812750565,3053,4,PYCR1|PYCRL
MALONATE CATABOLIC PROCESS%GOBP%GO:0090410,0.344615384615385,0.702388156466409,-0.8247684164093522,-1.0987895692329,2575,1,ACSF3
POSITIVE REGULATION OF CAMP-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:2000481,0.886971878820812,0.965013712426871,0.30226658578282695,0.6640925617850789,6528,4,ATP2B4|SIRT1|RAPGEF2
REGULATION OF NITRIC-OXIDE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0051769,0.14369769874476998,0.509982599740886,-0.43197772921948707,-1.3533298350796399,1098,10,KDR|TLR2|CCL2|TLR4|GSTP1
LYSINE BIOSYNTHETIC PROCESS VIA AMINOADIPIC ACID%GOBP%GO:0019878,0.0901661307609861,0.414794277220364,0.81759029500965,1.37365725897223,672,2,AASS|AASDHPPT
FLAVONOID METABOLIC PROCESS%GOBP%GO:0009812,0.503316529583444,0.7974194055707851,-0.597684036393714,-0.9946418134226459,3793,2,SULT1A3|SULT1A1
NEGATIVE REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS%GOBP%GO:1900126,0.24695767195767201,0.6280519349499749,-0.615583985882872,-1.2020795053094,1866,3,AP2A1|TGFB1|CLTC
POSITIVE REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STARVATION%GOBP%GO:0071264,0.5390023879013,0.8142313733497609,-0.583733112765371,-0.97142524558466,4062,2,EIF2AK4|IMPACT
REGULATION OF PROTEINASE ACTIVATED RECEPTOR ACTIVITY%GOBP%GO:1900276,0.603076923076923,0.8480561198163299,-0.7021945302161451,-0.9354917210978021,4507,1,BICD1
NEGATIVE REGULATION OF PROTEIN PHOSPHORYLATION%GOBP%GO:0001933,0.018007662835249,0.18341015019345605,-0.18325800477396997,-1.4135175378226998,140,267,ZFYVE28|PTEN|PPM1E|DUSP1|SNX25|DUSP8|ZNF675|DUSP7|PARP14|DUSP3|PPAP2B|TGFB1|GREM1|HIPK3|APC|PRKAR2A|HEXIM2|LYN|DNAJC3|HYAL2|PYCARD|SOCS4|GNB2L1|SAMSN1|CORO1C|IRAK3|IGBP1|TSG101|IMPACT|SOCS3|DAB2IP|PRDM15|PPM1F|PID1|DUSP5|SEMA6A|SPRY1|CDKN1C|SYNJ2BP|SFRP2|CDKN2A|NPM1|SMAD6|HEXIM1|PRR5L|THY1|SLC9A3R1|WARS|MAPK8IP1|HEG1|PDE4D|IPO7|PRKAR1A|CEBPA|SOCS1|FOXM1|PTPN6|PARK7|RGS4|TIMP3|TAF7|ABL1|HSPB1|C14orf166|MEN1|LRP5|LDLRAD4|TNIP1|SNX6|GNAQ|CEACAM1|VPS25|GPER1|CD300A|MBIP|PSMD10|APOE|PLK1|PPP2CA|MVP|WWTR1|CHMP6|LATS2|C3orf33|ERRFI1|ADARB1|SLIT2|NR2F2|CAV1|MYC|DNAJA1|RASIP1|DDIT4|DACT1|TLR4|NF2|SMPD1|H2AFY|RGS2|GPS1|ENG|GSTP1|PHB|NCK1|RGS3|FBLN1|PTPRJ|EIF4G1|SIRPA|WNK2|PRNP
MITOCHONDRIAL RIBOSOME ASSEMBLY%GOBP%GO:0061668,0.9336225026288121,0.9800972968717879,-0.217722712697709,-0.595135325953411,7102,7,DDX28|DHX30|MPV17L2|MRPS2
REGULATION OF THYMIDYLATE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0050758,0.0062350756168745,0.092360543194149,-0.946677695064792,-1.5754230697333702,46,2,APBB1|FOLR2
POSITIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE%GOBP%GO:0045870,0.187184929689573,0.560573168280111,-0.7411634175658759,-1.23341444777126,1410,2,TOP2A
OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA-TYPE EYE DEVELOPMENT%GOBP%GO:0002072,0.9291264737406221,0.9793746057014829,0.36577692779961696,0.6145524660741889,6934,2,PHACTR4|SOX11
B CELL HOMEOSTASIS%GOBP%GO:0001782,0.005337151783389739,0.0829378624098312,-0.654400816415332,-1.88392836023325,40,8,DOCK11|DOCK10|LYN|NCKAP1L|TNFAIP3|MEF2C
POSITIVE REGULATION OF ANTIGEN RECEPTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0050857,0.17593078133193502,0.548366806412612,-0.36181356208647797,-1.2800434733211201,1341,14,RAB29|PVRL2|NFAM1|RELA|PRKCB
IMPORT INTO CELL%GOBP%GO:0098657,0.000127307447485678,0.00518555396908895,-0.22183796772333103,-1.8178714256552402,0,389,RAC1|ITGB1|DOCK2|WIPF3|GRK4|IGHV1OR15-1|IGKV3-11|ADRB2|ACKR3|SYNJ1|ACTG1|SLC29A2|LILRB1|IGHV5-51|PPT1|LYN|FCGR1B|HSPG2|C4B|ARHGAP25|SLC9A5|FCN3|FCHO1|MESDC2|PYCARD|ADM|IGHV1-24|NCKAP1L|VAV3|CTTN|WASF2|CORO1C|CORO1A|HSP90B1|IGHV3-49|PIK3C2A|AP2A2|SNX18|SLC19A1|RAB14|ITGB2|IGHG4|MERTK|ATP1B1|NCKIPSD|MSR1|DNM1|APOL1|HPX|SLC12A8|LRP1|FGR|SNX5|FCGR1A|RAB7A|IGLL5|SLC7A2|ARPC1A|HP|ATP1A3|VAV1|SGIP1|SLC12A2|MYO1G|ATP1B3|WAS|TXNDC5|CANX|SYT7|CAV2|FCGR2B|EEA1|CLTA|GAS6|SLC39A8|RIN3|IGKV2-28|C3|MYO10|IGHV4-4|MARCO|SLC1A2|ELMO1|ANXA11|MAPKAPK2|IGHV4-61|SYP|GRB2|JCHAIN|SLC9A1|CLTC|CALCRL|ABCC9|IGHV1-3|ARRB1|FCER1G|CD93|EHD1|SLC9A7|PIK3CB|SLC11A1|PLD4|MAPK3|ABL1|CALR|IGHV3-43|SLC1A3|SPARC|FCN1|NR1H3|IGHV3-73|VAMP7|SLC9A9|KCNJ12|FCGR2A|RHOJ|P2RY6|CLEC7A|DOCK1|CEACAM1|NEURL1B|CXCL16|CYFIP2|HFE|SCARF1|GSN|APOE|IGKV2D-28|RAB7B|CD163|AXL|SLC7A3|HCK|COLEC12|CD36|THBS1|MRC1|IGHV3-15|AIF1|TGM2|RAB34|TMEM108|SLC3A2|MYO1E|CAV1|STAB1|LDLR|MYH9|ATP1B2|KCNH2|STON2|ITGAM|IGHV1-18|ADRBK1|HSP90AA1|RAB20|ACTB|ANXA1|RHOU|KCNJ9|DENND1A|NCK1|CD14|FOLR2|IGHG2|TFRC|IGHA1|CD81|AP2M1|CLTB|DNM3|ADGRB1|GTF2H2
POSITIVE REGULATION OF GLUTAMATE SECRETION%GOBP%GO:0014049,0.22473103997874902,0.6078034241178771,0.8889501543890609,1.1852950822943,1691,1,RAB3GAP1
LUNG GROWTH%GOBP%GO:0060437,0.0407269832846909,0.288980107188417,-0.870581748001103,-1.44878724516254,306,2,FGF10|FGF7
ANTIBACTERIAL HUMORAL RESPONSE%GOBP%GO:0019731,0.000785648814979704,0.0191134260247744,-0.602542850682835,-2.07406933830783,5,13,HLA-E|RPL39|HIST1H2BE|HIST1H2BC|JCHAIN|RNASE6|HIST1H2BG|HIST2H2BE|IGHA1|HIST1H2BK|HIST1H2BJ
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING%GOBP%GO:0021914,0.28575250836120397,0.658457633141178,-0.8541574768416409,-1.1379428544582701,2135,1,CHRD
EMBRYONIC HINDGUT MORPHOGENESIS%GOBP%GO:0048619,0.0848160535117057,0.40376145987147494,-0.955337450374945,-1.272738873949,633,1,DACT1
POSITIVE REGULATION OF TELOMERIC RNA TRANSCRIPTION FROM RNA POL II PROMOTER%GOBP%GO:1901582,0.803478260869565,0.932964969466025,-0.6027238641376271,-0.8029729095657689,6005,1,ATRX
RESPONSE TO IRON(II) ION%GOBP%GO:0010040,0.783862433862434,0.927080511528825,-0.383178107203088,-0.7482497272755909,5925,3,ACO1
NEGATIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0045079,0.754046166091802,0.9156579560403149,-0.489771160738903,-0.8150575317667629,5683,2,SIGIRR|IL6
EXOSOMAL SECRETION%GOBP%GO:1990182,0.13840365493147,0.503641687094073,0.6783111710786129,1.3341580275270901,1029,3,RAB11A|COPS5|RAB27A
GENERATION OF CATALYTIC SPLICEOSOME FOR FIRST TRANSESTERIFICATION STEP%GOBP%GO:0000349,0.131467232687716,0.490819490032838,-0.776945556630803,-1.2929616491695501,990,2,PRPF19
ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0003228,0.47505969753250205,0.784986345464663,-0.608811733538369,-1.01316008092392,3580,2,ENG
REGULATION OF CYCLASE ACTIVITY%GOBP%GO:0031279,0.499086161879896,0.794989907195277,-0.229185631844304,-0.962254555945271,3822,23,STIM1|AKAP5|MAPK3|GNAI2|EDNRB|NOS3|ADGRV1
CHROMOSOME PASSENGER COMPLEX LOCALIZATION TO SPINDLE MIDZONE%GOBP%GO:0035853,0.985016722408027,0.9944441562911079,-0.507609175121306,-0.676257305412357,7362,1,KLHL21
METANEPHRIC TUBULE MORPHOGENESIS%GOBP%GO:0072173,0.0330921757770632,0.25998057358601,0.8828784119106701,1.48334972505593,246,2,PAX8|PKD1
REGULATION OF PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE%GOBP%GO:2000167,0.0716773847802787,0.3767214120425879,0.8351805900193,1.40321122576336,534,2,NPHP3-ACAD11|NPHP3
DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0050651,0.23045698572738,0.613305180882394,-0.350870799129734,-1.2077653321383501,1759,13,DCN|BGN|VCAN|B3GAT3|CSGALNACT1
NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION%GOBP%GO:1904761,0.139335476956056,0.504314492208813,0.7778329197684041,1.30685973528443,1039,2,PDCD4|RB1
POSTSYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:0001941,0.582222222222222,0.8387093286508721,-0.26689530955885804,-0.8933235909285592,4453,12,APOE|NRXN2|GPHN
LATE ENDOSOME TO GOLGI TRANSPORT%GOBP%GO:0034499,0.35595270088685793,0.713672237213954,0.560601623034802,1.10263723716547,2648,3,SGSM2|GCC2
PATHWAY-RESTRICTED SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0060389,0.29533611255862396,0.6682992987170799,-0.37959556761025,-1.14191638190629,2266,9,TGFBR1|SMAD7|TGFB2|TGFB1|USP15|TGFBR2|BMP2|TGFBR3
NEGATIVE REGULATION OF NECROPTOTIC PROCESS%GOBP%GO:0060546,0.334250163719712,0.6974768376198021,-0.42894622836978896,-1.1033652515211398,2551,6,SLC25A4|YBX3
NEGATIVE REGULATION OF OOGENESIS%GOBP%GO:1905880,0.227157190635452,0.609201573718782,-0.8834913983237759,-1.1770226813623899,1697,1,IGF1
REGULATION OF AXONOGENESIS%GOBP%GO:0050770,0.21500139159476803,0.5979177134734279,0.18048869017121102,1.1605336004896798,1544,101,ISLR2|SHTN1|SLITRK1|SEMA4G|SEMA4F|KIF13B|PLXNB1|RTN4|SEMA6C|CHN1|PTPRO|ROBO2|PTPRS|ZSWIM4|EFNB3|SEMA4C|RUFY3|MAP6|TRIM46|LIMK1|PAK1|NRCAM|SIPA1L1|MAP2|BRSK1|LINGO1|ZSWIM8|PLXNB2|POU4F2|NRP1|ZFYVE27|DCC|MEGF8
NEGATIVE REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 2 PRODUCTION%GOBP%GO:2000342,0.7367363344051451,0.908157084784786,0.479455507846848,0.805547158189132,5498,2,MAP2K5
ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION%GOBP%GO:0090500,0.014021164021164,0.15839324512585098,-0.8358883864563801,-1.6322781637086698,105,3,EFNA1|ENG|ACVRL1
CELLULAR RESPONSE TO HIGH DENSITY LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:0071403,0.12458493823881,0.47882366260685294,0.9390714600794001,1.25212508042143,937,1,ADAM17
OXIDATIVE SINGLE-STRANDED RNA DEMETHYLATION%GOBP%GO:0035553,0.322354497354497,0.690622617165308,-0.579897905450552,-1.1323936348249801,2436,3,ALKBH3
SPHINGOSINE-1-PHOSPHATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0003376,0.97218489653319,0.9915747942934481,0.276263647654679,0.543377993681442,7234,3,EZR|S1PR2
POSITIVE REGULATION OF ERAD PATHWAY%GOBP%GO:1904294,0.46824669372790395,0.780769690730001,-0.285744492603699,-0.983587955658309,3575,13,UBQLN2|UBQLN1|HERPUD1|BCAP31|CAV1
REGULATION OF FASL BIOSYNTHETIC PROCESS%GOBP%GO:0045219,0.667558528428094,0.88092952466726,-0.669827966475518,-0.892371686525017,4989,1,JAK3
NEGATIVE REGULATION OF CELLULAR RESPONSE TO HEAT%GOBP%GO:1900035,0.42715719063545204,0.755533439554473,-0.78743934715483,-1.04905828574776,3192,1,CD34
NEGATIVE REGULATION OF HAIR CYCLE%GOBP%GO:0042636,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
AMINE CATABOLIC PROCESS%GOBP%GO:0009310,0.11785527005768198,0.46862716515177505,-0.38839483637202005,-1.3740841346649098,898,14,KMO|CCBL1|SMOX|KYNU|HAAO|SLC44A1|AFMID|HNMT
NEGATIVE REGULATION OF ANDROGEN BIOSYNTHETIC PROCESS%GOBP%GO:2000180,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
REGULATION OF CARDIAC MYOFIBRIL ASSEMBLY%GOBP%GO:1905304,0.8778595317725749,0.960725750963158,-0.5636303484781651,-0.7508909598006851,6561,1,SMAD4
SPLICEOSOME CONFORMATIONAL CHANGE TO RELEASE U4 (OR U4ATAC) AND U1 (OR U11)%GOBP%GO:0000388,0.30575109576305,0.677423587903087,0.848423026025585,1.1312576250628001,2301,1,SNRNP200
REGULATION OF OPIOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:2000474,0.301538461538462,0.6746525886974419,-0.8459969122187909,-1.1270710229135101,2253,1,SYP
NEGATIVE REGULATION OF LEUKOCYTE ACTIVATION%GOBP%GO:0002695,0.000255427841634738,0.00819882332206558,-0.35169987621236,-2.12243561777504,1,81,CD274|DUSP3|MNDA|MICA|LILRB1|SLA2|LYN|NDFIP1|TNFAIP8L2|TNFRSF14|SAMSN1|RUNX1|TWSG1|CD84|RUNX3|PDCD1LG2|SPN|FCGR2B|PLA2G2D|TNFAIP3|RC3H2|LILRB2|GPNMB|INHBA|PRKAR1A|SOCS1|SDC4|CEBPB|NR1H3|C10orf54|CEACAM1|GPER1|CD300A|HFE|LST1|CD86|LGALS3|TNFRSF21|CD200|LGALS9|CD300LF|CX3CL1|LDLR|HAVCR2|MILR1|ANXA1|PRNP
GLYCEROL-3-PHOSPHATE CATABOLIC PROCESS%GOBP%GO:0046168,0.214769557710187,0.5979177134734279,0.894078076753419,1.19213247484196,1616,1,GPD2
NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:0006289,0.263919109177013,0.639468085893271,-0.17483501857227698,-1.1206521818209199,2061,103,POLD2|RFC5|POLR2H|GTF2H1|RAD23B|CDK7|UBC|MNAT1|ERCC8|DDB1|POLR2G|CETN2|ISY1|POLA1|GPS1|RFC4|XPA|POLR2L|PRPF19|GTF2H2
POSITIVE REGULATION OF CHROMATIN SILENCING%GOBP%GO:0031937,0.985680812288467,0.994876860785749,-0.17265155276077,-0.49703965601089,7571,8,SIN3A|MIER1|SIRT1|SETDB1|ZNF304|SIRT6|TRIM28|DNMT1
NEGATIVE REGULATION OF SNARE COMPLEX ASSEMBLY%GOBP%GO:0035544,0.576545502785885,0.836604755247265,-0.568616099202261,-0.946268117623421,4345,2,PRRT2
NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION%GOBP%GO:0045650,0.316843345111896,0.6861326333203311,-0.519544940390216,-1.13739247891946,2420,4,INHBA|C1QC
REGULATION OF MAP KINASE ACTIVITY%GOBP%GO:0043405,0.10556127703398599,0.44738616127788,-0.16618368778017498,-1.23448561639697,819,216,ARHGEF5|IRAK3|ADAM8|MADD|CCL19|TSG101|EZH2|DAB2IP|PIK3R6|DUSP5|HGS|RAPGEF1|SPRY1|NGF|TNFRSF11A|PDGFD|PKN1|MDFIC|TRAF2|FPR1|TAOK2|MAPK8IP1|CXCR4|MST1R|PDGFC|MAPKAPK2|MLKL|RGS4|PIK3CB|FGF10|MAPK3|GHRL|SOD1|IRAK1|HRAS|IGF1|MAP3K13|GADD45B|CD300A|MAP2K3|MBIP|F2R|APOE|SASH1|PPP2CA|MUC20|GADD45G|BMP2|SNF8|THBS1|MAP3K11|PEA15|UBC|PDGFRB|CAV1|DNAJA1|TLR4|PDGFA|SMPD1|RGS2|GPS1|GSTP1|GNG3|DBNL|CD81|RGS3|PDGFB|C5AR1|PTPRJ|ERN1
POSITIVE REGULATION OF MITOTIC CYTOKINETIC PROCESS%GOBP%GO:1903438,0.739683815648446,0.9093988038963969,0.47824648469809794,0.8035158431959342,5520,2,NUP62|KIF20B
POSITIVE REGULATION OF CELL MOTILITY%GOBP%GO:2000147,0.00012863390789812198,0.00518555396908895,-0.269351121534517,-2.1714354065652,0,351,FLT1|MAPRE2|PYCARD|NCKAP1L|CD74|GNB2L1|TNFRSF14|F10|ADAM8|CCL19|PIK3C2A|AGT|DAB2IP|LAMC2|PPM1F|SPOCK2|KDR|STX4|NUMB|P2RX4|FGR|EMC10|SEMA6A|TRIP6|PDCD6|CCL24|HGF|MOSPD2|GPI|SOD2|SPN|GATA3|TNFRSF18|PDGFD|PLAU|SRPX2|VEGFC|GAS6|INS|THY1|DDR2|BCAR1|RREB1|FOXC2|VTN|CREB3|DOCK5|ATP5B|MYLK|SMOC2|PDGFC|ZNF268|FLT4|PHPT1|NOTCH1|GPNMB|SMURF2|STAT3|GCNT2|PRKD1|MADCAM1|ICAM1|F3|BCAS3|TRIM32|SNAI2|MMP14|PLA2G7|FGF10|RHOD|ABL1|CALR|HMOX1|HSPB1|NTN1|SPARC|HRAS|PIK3R3|IGF1|SEMA3B|SEMA3D|NSMF|SEMA7A|RHOJ|HBEGF|C10orf54|DOCK1|CSF1|CTSH|CXCL16|PDPN|GPER1|MAP2K3|PLVAP|F2R|CCR1|FN1|INSL3|SASH1|NOS3|HYAL1|VEGFB|NRP2|LGALS3|CD151|BMP2|FGF9|LGALS9|THBS1|ZP3|TEK|ATOH8|SUN2|FGF7|COL1A1|SEMA5A|FADD|AIF1|PDGFRB|SEMA3E|RARRES2|NEDD9|SYDE1|FAM89B|FOXP1|MMP9|IGFBP5|SNAI1|SERPINE1|CAV1|FAM107A|SEMA3A|SEMA6B|PLAA|PTRF|FERMT3|DAB2|PDGFA|CSF1R|TIAM1|PDGFRA|HSPA5|CMKLR1|ANXA1|LGMN|TMSB4X|GLIPR2|ARF6|SPHK1|PDGFB
"CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043367",0.126046025104603,0.48175523567590006,-0.349175918590825,-1.3549324261356002,963,18,RORC|FOXP3|GPR183|BATF|RORA|SPN|PLA2G2D|PTGER4|STAT3|RSAD2|FOXP1
REGULATION OF INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE%GOBP%GO:0060730,0.8490969899665551,0.9492491301138911,-0.578683281870313,-0.770945081501486,6346,1,SLC22A5
SMOOTH MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048745,0.47592642683256703,0.7850084910380921,0.35160072810863396,0.9705843724286701,3518,7,STRA6|NF1|PKD2|PROX1
NEGATIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1902010,0.454376411209988,0.770794980018249,0.7737648875165419,1.03171107119687,3420,1,SESN2
TRNA WOBBLE BASE CYTOSINE METHYLATION%GOBP%GO:0002127,0.484659317306415,0.7872939093021379,0.75766431407146,1.01024312900422,3648,1,NSUN3
ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL/BASAL POLARITY%GOBP%GO:0045197,0.750783912747103,0.914514002574638,0.177134375970495,0.7927644103675279,5506,27,PARD3|DLG2|CAMSAP3|WDR1|MYO9A|LRRC7|MTCL1
ABSCISSION%GOBP%GO:0009838,0.56353068396864,0.828821766028182,0.374420913302449,0.9004801493715279,4168,5,ZFYVE19|IST1|AURKB|SPG20
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:1902110,0.444284216046146,0.766596259839573,-0.284482572742803,-1.00645774142095,3388,14,STPG1|BAD
DNA CLAMP UNLOADING%GOBP%GO:0090618,0.259780278670954,0.636098664976652,0.7035903607729879,1.1821226503273201,1938,2,RFC1|ATAD5
SEPTUM PRIMUM DEVELOPMENT%GOBP%GO:0003284,0.37395861327600105,0.724682900261831,0.552336277288902,1.08638027745826,2782,3,ACVR1|SOX4
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION%GOBP%GO:0045638,0.0263602129593559,0.229040654155243,-0.31151327374223603,-1.6012855740599499,202,45,CCL3|HIST1H4H|ZNF675|PRMT1|HOXA5|LILRB1|CDK6|ZFP36L1|LILRB3|TCTA|INHBA|HSPA9|HIST1H4I|FBN1|CTR9|MAFB|C1QC|CEACAM1|HIST2H4A|MYC|TLR4|LILRB4|HIST2H4B
DUTP CATABOLIC PROCESS%GOBP%GO:0046081,0.536857484393678,0.813365364472024,0.7302051168945741,0.9736299947167499,4041,1,DUT
GANGLIOSIDE GM1 TRANSPORT TO MEMBRANE%GOBP%GO:1905572,0.7578595317725749,0.917143966125732,-0.625220555800618,-0.8329439046350979,5664,1,PSAP
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL%GOBP%GO:1903321,0.0436415436415436,0.299062021084573,-0.267155305012592,-1.48418399414445,336,59,PARP10|TRIM21|PER2|DTX3L|TRIM44|OGT|BAG5|MAD2L1|TNFAIP3|SENP2|PARK7|UBXN1|ARRB1|ISG15|ABL1|USP44|PRMT3|HDAC8|CAV1|DNAJA1|PLAA|NXN|OTUB1|ADGRB1
SIGNAL RELEASE%GOBP%GO:0023061,0.156333100069979,0.5257250974517679,0.19854414352007502,1.2275705918072,1116,86,CRHR1|SYT2|RAB11FIP5|TBX3|LIN7B|RIMS1|SNAP25|PTPRN|RAB1A|LIN7A|DNAJC5|UNC13A|RIMS2|GAL|ADCYAP1|RAB11FIP2|SLC18A3|CPLX1|PPFIA3|HRH3|SYT5|BRSK1|RAB11B|CAMK2G|CYB5R4|GRM4|SNAP23|PTPRN2|NAAA|OTOF
NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION%GOBP%GO:0010626,0.613096046732781,0.852045339927398,0.3962389014503939,0.870553741365771,4512,4,SKI|CERS2|RNF10|DICER1
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001237,0.0539285253515675,0.336641654107542,-0.256340471210356,-1.4496082518042799,417,63,GPX1|TRAF2|TNFAIP3|SIAH2|TNFSF10|PARK7|ICAM1|BRCA1|SNAI2|SCRT2|IFI6|HMOX1|TNFRSF4|IGF1|NOS3|LGALS3|THBS1|PEA15|FADD|SERPINE1|RELA|GSTP1|PELI3
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE%GOBP%GO:1902230,0.0442154688926568,0.29950475077556604,-0.350188208006294,-1.54450108095326,338,27,CD44|ACKR3|CD74|TRIAP1|KDM1A|SFRP2|TRIM32|SNAI2|TAF9B|SNAI1|TAF9|ZNF385A|AK6
RESPONSE TO COCAINE%GOBP%GO:0042220,0.0706947823736145,0.3767214120425879,0.6314302625253609,1.51858616042968,522,5,DRD2|DRD4|CHRNB2
PROTEIN EXPORT FROM NUCLEUS%GOBP%GO:0006611,0.510934902161402,0.8011667213092171,-0.142766548626203,-0.9739000158624409,3994,138,MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|XPO6|NCBP1|NUP85|CALR|GLE1|NUP37|NMD3|RAN|NXF1|NUP160|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
L-LYSINE CATABOLIC PROCESS%GOBP%GO:0019477,0.39181830256342104,0.7371240382543249,0.805359505955007,1.07383823173245,2949,1,PIPOX
POSITIVE REGULATION OF MEMBRANE POTENTIAL%GOBP%GO:0045838,0.126628452318916,0.482978765281799,-0.45783824074886503,-1.37728949435754,971,9,GLRX|VCP|STOML2|BAD
NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:1903799,0.7570245690240259,0.916855605301775,0.29441288401081,0.7618106415720659,5576,6,NCOR1|ZC3H10|NCOR2|BCDIN3D
ENDOCARDIUM FORMATION%GOBP%GO:0060214,0.618121693121693,0.854944793214197,-0.44867875669044205,-0.876155894653025,4672,3,SOX18|SOX17
RENAL SODIUM ION ABSORPTION%GOBP%GO:0070294,0.264285714285714,0.6396077326151851,-0.6071467960736739,-1.185603812009,1997,3,MAGED2|KLHL3|SGK1
REGULATION OF PYRUVATE KINASE ACTIVITY%GOBP%GO:1903302,0.23959866220735798,0.623187683081912,-0.877205558006176,-1.1686484327400801,1790,1,JMJD8
POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA%GOBP%GO:0090200,0.467588365723229,0.780769690730001,-0.22355787901744198,-0.985999465155749,3584,27,PYCARD|APOPT1|BCL2L11|PPIF|PDCD5|TNFSF10|GPER1|CIDEB|PLAUR|MMP9|BAD
"REGULATION OF DNA-TEMPLATED TRANSCRIPTION, ELONGATION%GOBP%GO:0032784",0.9116122343183001,0.9723824689260179,-0.134752278207941,-0.66544013723591,7033,39,HMGN1|HNRNPU|CCNK|SUPT16H|RNF168|CTR9|EAPP|NELFB|SUPT4H1
REGULATION OF SYNAPTIC PLASTICITY%GOBP%GO:0048167,0.0108542970246456,0.134645873234709,-0.26190080624398604,-1.61821069318452,84,89,MCTP1|SHISA7|PLK2|SYT7|INS|CPLX2|GRIN1|FMR1|ADCY8|LILRB2|JPH4|CALB2|NPAS4|CBLN1|SYP|MEF2C|DBN1|CAMK2B|ABL1|ARF1|NSMF|APOE|GIPC1|GRIN2C|EPHA4|GRIN2D|CX3CL1|CAMK2A|FAM107A|PRRT2|LGMN|SQSTM1|ADGRB1
FUNGIFORM PAPILLA MORPHOGENESIS%GOBP%GO:0061197,0.305466237942122,0.677423587903087,0.6811690102012679,1.14445188642908,2279,2,HDAC1|HDAC2
PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER%GOBP%GO:1905508,0.48607147710286697,0.7872939093021379,0.252480520801441,0.9708628245024699,3576,17,BBS4|KIAA0753|PIBF1|PCM1|DCTN2
"MRNA CIS SPLICING, VIA SPLICEOSOME%GOBP%GO:0045292",0.0208686578844398,0.199356153540639,-0.37942864047056196,-1.6734656734668703,159,27,PSIP1|SRSF3|DCPS|SRSF10|NCBP2|DDX23|SRSF9|SRSF5|SRSF1|RBM22|WBP11|RBM4B|SRSF2|RBM4|SART1
GUANOSINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901070,0.0391310037953147,0.281882798544675,-0.7087904730946429,-1.55169050943335,298,4,IMPDH2|HPRT1|GMPS
NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION IN THYMUS%GOBP%GO:0033088,0.8419078242229371,0.94808068996515,0.42558588365040007,0.7150392341503771,6283,2,KIAA0922|BMP4
POSITIVE REGULATION OF MICROTUBULE NUCLEATION%GOBP%GO:0090063,0.6717577706323691,0.8815356925073421,0.51041932213964,0.857570364100915,5013,2,DCTN1
PANTOTHENATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015887,0.0633550272280515,0.36006266503904,0.9685707984119979,1.2914584676579701,476,1,SLC5A6
PYRIMIDINE NUCLEOTIDE IMPORT INTO MITOCHONDRION%GOBP%GO:1990519,0.8538317256162921,0.949296218452153,0.41852770885028995,0.703180589168355,6372,2,SLC25A36|SLC25A33
PROTECTION FROM NON-HOMOLOGOUS END JOINING AT TELOMERE%GOBP%GO:0031848,0.8552880714092509,0.949296218452153,0.24776613348041895,0.6839517610409219,6323,7,ACD|DCLRE1A|DCLRE1C|TFIP11|DCLRE1B|TERF2IP|TERF2
NEGATIVE REGULATION OF ACTIN FILAMENT SEVERING%GOBP%GO:1903919,0.094448160535117,0.424465668011418,-0.950319805910896,-1.2660541667154,705,1,MYH9
MRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:1990481,0.6363882130305489,0.8640125591079622,0.352055152614296,0.8466906231732221,4707,5,PUS7|PUS1|TRUB1|PUS3
CARDIAC JELLY DEVELOPMENT%GOBP%GO:1905072,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
ESCRT COMPLEX DISASSEMBLY%GOBP%GO:1904896,0.295349469676367,0.6682992987170799,0.358746621062503,1.13653354503826,2171,10,CHMP1A|IST1|VTA1|CHMP2A|CHMP7|VPS4B|CHMP2B|CHMP1B|VPS4A|CHMP5
RESPONSE TO ORGANIC CYCLIC COMPOUND%GOBP%GO:0014070,0.00510399387520735,0.0803498785568947,-0.19766507525323,-1.52705938818795,39,269,NDUFS4|JUNB|STRN3|IL18|IRAK3|NR3C1|HSP90B1|REST|ZFP36L1|IMPACT|RYR2|BCL2L11|JUP|MED13|AQP3|FGFR4|GOT1|P2RX4|RAPGEF1|RORA|SMO|MED1|HNRNPU|ATP1A3|CYP1B1|AHR|LARP1|NPM1|IL1RN|P2RX3|HLCS|HID1|GGT1|TGFB3|PDE4B|KYNU|PDE12|ADCY8|PDXP|CRHBP|SLC9A1|MEF2C|STAT3|MB21D1|IFIH1|BRCA1|IFIT1|DDX5|PDE2A|MSN|MAPK3|PIM1|SPP1|ABL1|CALR|RAPGEF3|NR1H3|RAN|P2RY6|TMEM173|WBP2|CCL2|DHFR|NCOA4|GPER1|RAP1A|KCNQ1|RBM14|CDK7|COLEC12|TIPARP|TGFBR2|THBS1|H2AFZ|FHL2|PPAP2A|SLIT2|TICAM1|SLC3A2|IGFBP5|CAV1|FAM107A|YAP1|PRKACA|KAT5|ACTB|ANXA1|ALPL|SHMT2|TFPI|PHB|PQBP1|CASP6|SSTR2|PDGFB|INSIG1
RESPONSE TO LIPOTEICHOIC ACID%GOBP%GO:0070391,0.10625986322987899,0.44869189060429,-0.5898671791715779,-1.4137990714564,807,5,TLR2|RELA|CD14
REGULATION OF GAMMA-DELTA T CELL DIFFERENTIATION%GOBP%GO:0045586,0.528829431438127,0.8106205307336929,-0.738586237318042,-0.983974213121716,3952,1,NCKAP1L
NEGATIVE REGULATION OF PROTECTION FROM NON-HOMOLOGOUS END JOINING AT TELOMERE%GOBP%GO:1905765,0.82636655948553,0.943041978946366,0.435015164047422,0.7308816426810479,6167,2,ERCC1|ERCC4
METHYLATION%GOBP%GO:0032259,0.7842323651452281,0.927080511528825,0.117763935748595,0.8448485177348871,5669,167,TDRD12|FDXACB1|NDUFAF7|METTL21A|HENMT1|N6AMT2|PRDM5|TRMT6|PICK1|ALKBH8|ZC3H13|METTL1|SETDB2|PRMT9|METTL21B|TFB1M|TET2|TRMT44|CHD5|SETD6|MTERF4|CARM1|AS3MT|WDR61|TET3|TRMT1|PRMT7|RNMTL1|DPY30|CAMKMT|RAB6A|EEF2KMT|FAM103A1|DNMT3A|METTL14|NSUN4|TPMT|GTPBP3|GATAD2A|TGS1|DYDC2|NSUN3|WBSCR22|ARMT1|PIWIL4|TRMT1L|TRMT61B|CMTR1
VESICLE ORGANIZATION%GOBP%GO:0016050,0.00422210849539406,0.0715684122745354,-0.20691365492827102,-1.55986682784494,32,234,VPS18|RFX2|SERPINA1|S100A10|STX11|F8|RILP|CALR|SRGN|SEC13|SEC24A|ARFGAP2|NKD2|PPP6R3|CNIH2|VAMP7|CNIH1|STX1B|TMED2|CTSZ|VPS25|STX7|F2R|RAB7B|CTSC|F2RL3|CHMP4A|SNF8|STX3|RAB1B|CHMP6|NSF|RAB34|DTNBP1|CD59|CAV1|STX5|CNIH3|TMED10|PRRT2|TRAPPC2|ANXA2|RAB20|TMED9|GOSR2|PPP6C|SAR1B|VPS37C|SNX10|AP2M1|GRIA1|LYST|SQSTM1|DNM3|RNF26
MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0007517,0.363659563608524,0.7180834664267031,-0.165091665581089,-1.05630466830834,2849,102,DISP1|MEF2D|ACHE|TBX1|ZFPM2|RYR2|BASP1|ITGA11|AEBP1|CAV2|LAMA2|MYOM1|CACNA1H|MYLK2|MYLK|NOTCH1|SEPN1|MEF2C|S1PR1|FHL3|VAMP5|PKP2|POPDC2|IGF1|HBEGF|COL6A3|TAGLN|BMP2|TGFBR3|ITGB1BP2|IGSF22|FKBP1A|CAV1|ENG|EMD
ONCOSTATIN-M-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038165,0.0354665619683288,0.268079293819029,-0.713303854240841,-1.56157124422855,270,4,IL6ST|OSM|OSMR
REGULATION OF TOLERANCE INDUCTION TO TUMOR CELL%GOBP%GO:0002843,0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
BRASSINOSTEROID BIOSYNTHETIC PROCESS%GOBP%GO:0016132,0.09418060200668901,0.42418410384356203,-0.9507057785619759,-1.2665683749641399,703,1,DHCR7
NEGATIVE REGULATION OF GAP JUNCTION ASSEMBLY%GOBP%GO:1903597,0.893110367892977,0.965443067117994,-0.555083811204235,-0.7395049200071899,6675,1,ACE
TRANS-GOLGI NETWORK MEMBRANE ORGANIZATION%GOBP%GO:0098629,0.211847522911409,0.5937395205509979,0.895511689457433,1.19404400394131,1594,1,AZIN2
ISOTYPE SWITCHING%GOBP%GO:0045190,0.628399581589958,0.8598358835891559,-0.274256566077412,-0.859210019946344,4805,10,BATF|EXO1|RNF168|EXOSC3
REGULATION OF PROTEIN KINASE C ACTIVITY%GOBP%GO:1900019,0.745502645502646,0.91143284454225,-0.39955214921788396,-0.7802240813465992,5635,3,CEMIP|C8orf4
POSITIVE REGULATION OF AXONOGENESIS%GOBP%GO:0050772,0.58577351645504,0.8404223517293531,-0.180998662311657,-0.9120738187365699,4520,42,AMIGO1|PLXND1|NGF|GOLGA4|DSCAM|NTN1|NTRK2|MAP3K13|SEMA7A|SEMA5A|SLIT2|ARHGDIA|NGFR
NEGATIVE REGULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY%GOBP%GO:0001814,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
MENAQUINONE BIOSYNTHETIC PROCESS%GOBP%GO:0009234,0.608048877672998,0.849421970741672,0.6932068813409791,0.924297839883635,4577,1,UBIAD1
ANTEROGRADE AXONAL TRANSPORT%GOBP%GO:0008089,0.557138942175939,0.8260320520479609,0.18782527757148298,0.9307016893628042,4065,38,DLG2|KIF3B|TRAK2|BLOC1S3|HAP1|AP3B2|KIF5B|AP3B1|KIF5A|TRAK1|SPAST|KIF1A|AP3M1|BLOC1S5|KIF5C|AP3M2|KIF1B|NEFL
NEGATIVE REGULATION OF JAK-STAT CASCADE%GOBP%GO:0046426,0.0753478603307955,0.38436410265336796,-0.403851801031036,-1.4663204256608,573,15,VHL|PARP14|SOCS3|HGS|SOCS1|ADIPOR1|BCL3|PPP2CA|CAV1|NF2
SENSORY ORGAN DEVELOPMENT%GOBP%GO:0007423,0.00556018904642758,0.085261380368414,0.240011579657702,1.62180603588417,39,127,PDE6B|NPHP1|FOXC1|WNT6|STRA6|IFT88|SH3PXD2B|LRP5L|FGFR2|DLL1|BBS4|WNT5B|RARG|PAX8|AHI1|EPHB2|HDAC1|GNGT1|SDHAF4|WNT2B|MFAP2|IFT140|MPV17|TWIST1|PTPRM|NES|ASCL1|RAB3GAP1|BLOC1S3|CEP290|ALDH1A3|CACNA1C|ZNF513|MEGF11|TFAP2B|NF1
REGULATION OF MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905000,0.23371237458194,0.6177989841103759,-0.879907366563741,-1.1722478904812499,1746,1,FLNA
L-XYLITOL CATABOLIC PROCESS%GOBP%GO:0051160,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ISCHEMIC CONDITIONS%GOBP%GO:0001980,0.7727453845132158,0.9218062603848851,0.6127040141155711,0.816958128920375,5817,1,TNNI3
POSITIVE REGULATION OF INSULIN SECRETION%GOBP%GO:0032024,0.240256200599618,0.6242678039913271,0.267473731497749,1.18276073384948,1762,26,TRPM4|IRS2|TRH|CAPN10|GLUD1|NLGN2|PPP3CB|NNAT|GCK|TM7SF3|MYRIP
POSITIVE REGULATION OF NEURON MIGRATION%GOBP%GO:2001224,0.391241830065359,0.7369216590772479,-0.314100018370816,-1.0513221711746301,2992,12,DAB2IP|SEMA6A|NSMF|SEMA3A|PLAA
CELLULAR RESPONSE TO ACID CHEMICAL%GOBP%GO:0071229,0.5539558289069051,0.823820266031543,0.15278859556765698,0.948024689726361,3962,87,RET|WNT6|ABCB4|SFRP1|BRINP2|WNT5B|RARG|HTRA2|IPO5|PTK7|ATM|SESN1|GATSL3|SH3BP4|PTK2B|PKD2|SHMT1|ADCY6
CERAMIDE CATABOLIC PROCESS%GOBP%GO:0046514,0.742704533611256,0.9101620379706981,-0.257335245215217,-0.774127406184163,5700,9,GALC|GBA|NEU1|GLA|NEU4
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902930,0.0891332470892626,0.41228493992510207,-0.24915986308014101,-1.3719637883033202,688,57,REST|SREBF2|IDI1|GPAM|FDPS|KPNB1|PLEK|ABCG1|CYP51A1|MBTPS2|SOD1|RAN|HMGCR|P2RY6|GPER1|APOE|HMGCS1|BMP2|NFYB|DHCR7|NFKB1|FASN|TM7SF2
ATRIOVENTRICULAR CANAL MORPHOGENESIS%GOBP%GO:1905222,0.0528428093645485,0.333002194020657,-0.97198941332157,-1.2949232869660001,394,1,ENG
REPLICATION FORK PROCESSING%GOBP%GO:0031297,0.20538262878890898,0.58515351714347,0.263695197761839,1.22082872458583,1510,30,ZRANB3|ETAA1|SMARCAL1|WRN|BRCA2|MRE11A|PRIMPOL|BOD1L1|FBXO18|RTEL1|APITD1
POSITIVE REGULATION OF BLEB ASSEMBLY%GOBP%GO:1904172,0.824754576810825,0.942178419436027,-0.44731182795698904,-0.7443984122598492,6216,2,P2RX7|ANLN
NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS%GOBP%GO:0010713,0.134126984126984,0.495641459539577,-0.68555341227151,-1.33871206136819,1013,3,CST3
NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM%GOBP%GO:0070862,0.38835330901511206,0.7352989049211659,-0.34836683277892,-1.04797270359991,2980,9,DERL3|INSIG1
REGULATION OF NECROTIC CELL DEATH%GOBP%GO:0010939,0.685744289839853,0.885989326262897,-0.22846041555133,-0.8295027357130059,5223,15,SLC25A4|YBX3|FTH1
POSITIVE REGULATION OF HISTONE METHYLATION%GOBP%GO:0031062,0.41570981210856,0.7493091022753771,-0.234218087158623,-1.0217020687363498,3185,26,BRD4|DNMT3B|CHTOP|PAXIP1|OGT|BRCA1|SNW1|CTR9|DNMT1|PHF19
MYOBLAST MIGRATION INVOLVED IN SKELETAL MUSCLE REGENERATION%GOBP%GO:0014839,0.17590872910586403,0.548366806412612,-0.74835817407617,-1.24538767313246,1325,2,ANXA1
TRANSCRIPTIONAL ACTIVATION BY PROMOTER-ENHANCER LOOPING%GOBP%GO:0071733,0.7843321687718359,0.927080511528825,0.381603617514062,0.7505692834605551,5836,3,ZFPM1|RUVBL2|NIPBL
SYMPATHETIC NEURON PROJECTION EXTENSION%GOBP%GO:0097490,0.19931946080355997,0.577166177580918,-0.5813850519321241,-1.27277340999056,1522,4,NRP2|SEMA3A
DENSE CORE GRANULE PRIMING%GOBP%GO:0061789,0.34378349410503806,0.702174649119653,0.6624069595248101,1.1129292188262099,2565,2,UNC13A|UNC13B
NEGATIVE REGULATION OF MYD88-INDEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034128,0.0145383104125737,0.161481528331746,-0.672451898159418,-1.72972743126418,110,6,TICAM1|TLR4|CD14|LY96
SUPPRESSION BY VIRUS OF HOST APOPTOTIC PROCESS%GOBP%GO:0019050,0.187566988210075,0.5609377558550861,0.7445369496671329,1.2509182064975801,1399,2,CASP8|BCL2L1
CELLULAR RESPONSE TO SALT%GOBP%GO:1902075,0.102815979043877,0.441351847834537,-0.557112128398875,-1.43304247250865,784,6,DAXX|ZC3H12A|HSF1|HNRNPA1|MAPK13|ZNF16
SPHINGOLIPID CATABOLIC PROCESS%GOBP%GO:0030149,0.5814470757555931,0.8387093286508721,-0.23823360763644502,-0.9053458847630541,4443,17,GLA|NEU4|SMPDL3A|SMPD1|SPHK1
PROGESTERONE SECRETION%GOBP%GO:0042701,0.304749163879599,0.6770795415897549,-0.8443427437141601,-1.12486727327606,2277,1,INHBA
REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION%GOBP%GO:0010998,0.857583065380493,0.9495815083844671,0.416322029225255,0.699474762611473,6400,2,EIF2AK3|EIF2AK4
PEPTIDE STABILIZATION%GOBP%GO:0050822,0.48842809364548495,0.788277714516235,-0.7590427878253199,-1.01122725030486,3650,1,TAPBP
CELL FATE SPECIFICATION%GOBP%GO:0001708,0.24253528773072697,0.625545382356109,0.36385590067821794,1.19730933535408,1786,11,DLL1|POU3F2|ASCL1|NRP1
NEGATIVE REGULATION OF CELLULAR EXTRAVASATION%GOBP%GO:0002692,0.386336866902238,0.733589579210772,-0.48712602974216795,-1.0664207067409899,2951,4,CXCL12|PLCB1|PTGER4
REGULATION OF BLOOD MICROPARTICLE FORMATION%GOBP%GO:2000332,0.6709030100334449,0.8815356925073421,-0.668228936921041,-0.8902413952088148,5014,1,TNF
CELLULAR RESPONSE TO AMINO ACID STIMULUS%GOBP%GO:0071230,0.581465067778936,0.8387093286508721,-0.196400466615732,-0.91357754911786,4460,32,NSMF|RPTOR|CPEB1|SLC38A9|RRAGD
ORGANIC ACID TRANSPORT%GOBP%GO:0015849,0.143039591315453,0.509375437970093,-0.180612997894939,-1.2236203864319,1119,133,FABP3|SLC9A3R1|SLC1A2|SLC16A13|SLCO2B1|ATP8B1|SLC51A|SLC1A3|SLC25A22|SLCO2A1|SLC38A6|SLC6A8|CEACAM1|PDPN|LCN12|LCN1|APOE|GIPC1|FABP4|SLC7A3|CD36|SLC27A4|SLC3A2|PPARG|PPARA|RPS6KB1|ABCD1|ARL6IP5|PRAF2|ANXA1|MPC1|FOLR2|SLC7A8|SLC38A9
CLEAVAGE INVOLVED IN RRNA PROCESSING%GOBP%GO:0000469,0.850732600732601,0.949296218452153,-0.188170601413376,-0.699314815889076,6502,16,EXOSC3|EXOSC2
GOLGI TO PLASMA MEMBRANE CFTR PROTEIN TRANSPORT%GOBP%GO:0043000,0.343327142478111,0.701955655133333,-0.6642955610697551,-1.1054940424672601,2587,2,SEC16A|KRT18
GLYCOLIPID CATABOLIC PROCESS%GOBP%GO:0019377,0.164019786513929,0.535290477921284,-0.45692780703628205,-1.31543120464034,1259,8,GALC|GBA|NEU1|GLA|NEU4|FUCA1
POSITIVE REGULATION OF I-KAPPAB KINASE/NF-KAPPAB SIGNALING%GOBP%GO:0043123,0.0553071912121599,0.34165878259009896,-0.197153282375651,-1.3598266853111398,432,145,TRIM22|TRIM25|UBE2N|CD40|PPM1A|IL1B|TMED4|AKT1|TERF2IP|RIPK2|TIFA|TNF|APOL3|ATP2C1|UBD|MUL1|ALPK1|BRD4|PIM2|TRIM38|GJA1|NDFIP1|MTDH|MAP3K3|EEF1D|CD74|CCL19|ECT2|CD4|TNFRSF10B|TFG|CASP10|WLS|PLK2|TICAM2|IL1RN|CASP1|DHX36|IKBKE|TNFSF10|CCDC22|S100A13|ZDHHC13|PRKD1|TRIM32|CARD16|JMJD8|HMOX1|FLNA|IRAK1|GPRC5B|F2R|ECM1|BST2|LGALS9|FADD|TICAM1|FKBP1A|CANT1|CX3CL1|LTBR|RELA|CXXC5|NEK6|LGALS1|TNFRSF1A|S100A4|MID2|TMEM9B|PRKCB|LITAF
POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0010560,0.771494439924058,0.9214423351783,0.21103121825257398,0.7585244989976341,5688,14,RAMP1|ARFGEF1|CHP1|CCR7|CCL21|PXYLP1|ALG10B|TCF7L2|CTNNB1|SOAT1
RESPONSE TO GLUCAGON%GOBP%GO:0033762,0.5363493723849371,0.8132910857498922,-0.241150144486564,-0.9357522467493449,4101,18,ADCY8|PRKAR1A|ADCY4|PRKACA|ADCY9
'DE NOVO' L-METHIONINE BIOSYNTHETIC PROCESS%GOBP%GO:0071266,0.48386239872493,0.787078399497453,0.758215703573004,1.01097833250397,3642,1,CTH
PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0006163,0.000127877237851662,0.00518555396908895,-0.24515942978495397,-1.93481577252196,0,306,NDUFB5|NADK|CROT|SURF1|ACSL5|DNPH1|ATP1B1|ABHD14B|UQCR10|ACOT1|PARP1|NDUFA9|ATP5J|NDUFA7|ACSF2|DCAKD|GPI|ATP5F1|FAR1|COASY|OPA1|IMPDH2|ACSL4|PFKFB2|GPX1|ELOVL2|HK1|ADA|PDHA1|NDUFA3|NDUFB6|ACSF3|NUDT1|ATP5B|HK3|ADCY8|PDE4D|SDHD|NPR2|ELOVL1|CYCS|SLC26A2|NDUFB9|COA6|NUDT16|PDE2A|ENO1|NDUFB10|SDHA|ADCY4|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|HPRT1|TPST2|MOCS2|PRPS1|MBIP|EPHA2|NPR1|GAPDH|NDUFS6|COQ7|HMGCS1|NUDT18|NDUFB4|HACD2|NUDT4|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|ACOT2|STOML2|PDHX|ABCD1|NDUFA4|HINT1|ATP5H|NDUFV1|PNP|UQCRQ|SULT1A4|PGK1|NDUFS3|GPHN|SAMHD1|UQCRC2|FASN|COX6A1|UQCC3|NDUFA8|ADCY9|ALDOA|NDUFS8|ALDOC|ATP5G1|MTHFD1|BAD|NDUFV3
GLYCOLIPID TRANSLOCATION%GOBP%GO:0034203,0.22354515050167198,0.606760475740296,-0.8848147331274809,-1.17878568107235,1670,1,RFT1
LYMPH VESSEL DEVELOPMENT%GOBP%GO:0001945,0.00840115515883434,0.11368006969928998,-0.507553095055255,-1.84284301440984,63,15,TBX1|SOX18|TMEM204|FOXC2|FLT4|PDPN|CCBE1|NR2F2|ACVRL1
REGULATION OF PYRROLINE-5-CARBOXYLATE REDUCTASE ACTIVITY%GOBP%GO:1903167,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
ANAPHASE-PROMOTING COMPLEX-DEPENDENT CATABOLIC PROCESS%GOBP%GO:0031145,0.24657179818887498,0.6280519349499749,-0.24371800741962302,-1.17357041008397,1905,36,CDC20|ANAPC10|ANAPC2|ANAPC5|CDC23|PTTG1|MAD2L1|UBE2S|CDC27|CCNB1|PLK1|UBC|ANAPC11
AGING%GOBP%GO:0007568,0.126133126133126,0.48175523567590006,-0.23426791068798497,-1.30147774294948,973,59,PML|PSEN1|APOD|KAT6A|TERF2|TERT|SOD2|CDKN2A|OPA1|NPM1|TBX2|PLA2R1|CISD2|CDKN2B|CALR|SOD1|TPRA1|ROMO1|HRAS|COQ7|SRF|CX3CL1|SERPINE1|LOXL2|PRNP
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS%GOBP%GO:0031400,0.00292769857433809,0.0540530837119432,-0.182664676761488,-1.4908102455366399,22,379,PYCARD|NCKAP1L|SOCS4|GNB2L1|PARP10|TRIM21|SAMSN1|CORO1C|PER2|IRAK3|IGBP1|SET|DTX3L|TSG101|IMPACT|SOCS3|DAB2IP|TINF2|PRDM15|PPM1F|BCOR|PID1|DUSP5|PPP1R8|SEMA6A|SPRY1|TRIM44|CDKN1C|SYNJ2BP|SFRP2|CDKN2A|BOD1|OGT|NPM1|SMAD6|BAG5|HEXIM1|PRR5L|THY1|MAD2L1|TNFAIP3|SLC9A3R1|WARS|MAPK8IP1|HEG1|PDE4D|IPO7|SENP2|PRKAR1A|CEBPA|SOCS1|FOXM1|PTPN6|PARK7|RGS4|UBXN1|BRCA1|ARRB1|ENSA|ISG15|TIMP3|TAF7|ABL1|DNMT1|HSPB1|FXYD1|KLF15|C14orf166|MEN1|LRP5|LDLRAD4|TNIP1|BEX4|SNX6|GNAQ|CEACAM1|CRY2|VPS25|PPP2R4|GPER1|CD300A|SPI1|MBIP|USP44|PSMD10|APOE|PLK1|TMEM59|PRMT3|PPP2CA|MVP|LGALS3|WWTR1|HDAC8|CHMP6|LATS2|C3orf33|ERRFI1|ADARB1|SLIT2|FKBP1A|NR2F2|CAV1|MYC|DNAJA1|RASIP1|DDIT4|PLAA|DACT1|TLR4|NXN|NF2|SMPD1|STYXL1|H2AFY|RGS2|GPS1|ENG|GSTP1|PHB|OTUB1|NCK1|RGS3|FBLN1|PTPRJ|EIF4G1|SIRPA|ADGRB1|WNK2|PRNP
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051151,0.292756276150628,0.665340563926245,-0.36634916944433704,-1.14772412448549,2238,10,DNMT1|NFATC1|FGF9|PDGFB
POSITIVE REGULATION OF GLUTAMATE-CYSTEINE LIGASE ACTIVITY%GOBP%GO:0035229,0.41864789480674697,0.75036705317022,0.7919607410674899,1.05597278668857,3151,1,GCLM
RESPONSE TO GLYCOPROTEIN%GOBP%GO:1904587,0.64243988588507,0.868171925756234,0.387415209838416,0.851167715114063,4728,4,MAN1B1|EDEM2|EDEM3|EDEM1
REGULATION OF TYPE 2 IMMUNE RESPONSE%GOBP%GO:0002828,0.29931883678281396,0.6722293539408979,-0.350658225058258,-1.1352748697401398,2284,11,NDFIP1|IL18|RSAD2|CD86|NLRP3|ANXA1
POSITIVE REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY%GOBP%GO:0010536,0.698148148148148,0.8919255944983009,-0.41766846807102703,-0.815600660504648,5277,3,CCL5|IL6R|AGT
HISTONE H3-K36 DEMETHYLATION%GOBP%GO:0070544,0.7160895600104141,0.899551221015245,-0.274368906715534,-0.789869681640995,5500,8,KDM4B|KDM8|KDM2A|C14orf169
PROTEIN K27-LINKED DEUBIQUITINATION%GOBP%GO:1990167,0.7804126473740619,0.9249005412304508,0.45867107802591706,0.7706266325036071,5824,2,OTUD3|YOD1
FRUCTOSELYSINE METABOLIC PROCESS%GOBP%GO:0030393,0.881259131358746,0.9622426269432679,0.5588883987648879,0.7452022673449351,6634,1,FN3K
CELLULAR RESPONSE TO AMINO ACID STARVATION%GOBP%GO:0034198,0.663332419841052,0.879862677092874,0.17405721519007702,0.862478928915929,4840,38,MAP3K5|MIOS|WDR59|CDKN1A|SESN1|NPRL3|SH3GLB1|SESN2|MAPK1|EIF2AK3|MAPK8|ATF4|C12orf66|DEPDC5|EIF2AK2
REGULATION OF ALDOSTERONE SECRETION%GOBP%GO:2000858,0.60952380952381,0.8505496974657741,-0.45250447465892096,-0.883626552221231,4607,3,C1QTNF1
PEPTIDE HORMONE SECRETION%GOBP%GO:0030072,0.012100611828687999,0.14490110809464998,0.423839508613443,1.77374821900292,88,22,CRHR1|RAB11FIP5|PTPRN|RAB1A|RIMS2|GAL|ADCYAP1|RAB11FIP2|RAB11B|CAMK2G|CYB5R4|PTPRN2|EXOC3L1
CRANIAL NERVE MORPHOGENESIS%GOBP%GO:0021602,0.765608465608466,0.919785404348335,-0.39108441011111206,-0.7636887330107259,5787,3,TBX1|MAFB
NEGATIVE REGULATION OF HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:1902203,0.861003344481605,0.951993398605548,-0.5721217468019411,-0.762203541272932,6435,1,ADAMTS12
REGULATION OF DNA STRAND ELONGATION%GOBP%GO:0060382,0.8814009020960469,0.9622426269432679,-0.413380684271769,-0.687931563169806,6643,2,NUCKS1
VEGF-ACTIVATED NEUROPILIN SIGNALING PATHWAY%GOBP%GO:0038190,0.31229903536977505,0.68160868787154,0.678208652446664,1.1394781031740802,2330,2,NRP1|VEGFA
TRNA WOBBLE URIDINE MODIFICATION%GOBP%GO:0002098,0.0278230184581976,0.23617479560495197,0.507590367447574,1.67028398975521,204,11,ALKBH8|ELP3|CTU1|KIAA1456|GTPBP3|MOCS3
NEGATIVE REGULATION OF OXIDATIVE STRESS-INDUCED NEURON DEATH%GOBP%GO:1903204,0.857084357084357,0.949296218452153,0.224287568536759,0.6815892347425279,6278,9,PARK2|NR4A3|FBXO7|ATF4
PROTEIN HETEROTRIMERIZATION%GOBP%GO:0070208,0.021031746031746002,0.200061313056718,-0.816921010981006,-1.5952396866668201,158,3,COL6A1|COL6A2
PROTEIN REPAIR%GOBP%GO:0030091,0.0489849377865095,0.317359880131657,-0.605503372764214,-1.5575177889451701,373,6,MSRB2|MSRB1|MSRA|PARK7|MSRB3
METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION%GOBP%GO:0072162,0.25817256162915303,0.636098664976652,0.7043939808375721,1.18347283579541,1926,2,WNT4|STAT1
NEGATIVE REGULATION OF MAST CELL PROLIFERATION%GOBP%GO:0070667,0.575919732441472,0.8359897176758009,-0.7165857962064399,-0.954664342943622,4304,1,LYN
KETONE BIOSYNTHETIC PROCESS%GOBP%GO:0042181,0.7909055066368771,0.928357780000476,-0.19019226478089102,-0.751431894775634,6017,19,ADM|NDUFA9|CACNA1H|COQ6|COQ7|PDSS1|COQ3
CELLULAR RESPONSE TO STEM CELL FACTOR STIMULUS%GOBP%GO:0036216,0.267282958199357,0.6417330323279019,0.6997518610421839,1.17567347517081,1994,2,KIT|FER
L-ASCORBIC ACID METABOLIC PROCESS%GOBP%GO:0019852,0.23397602918186602,0.617951264290741,-0.40243450094633504,-1.21062148372275,1795,9,SLC2A3|CYB5A
ACTIVATION OF PROTEIN KINASE A ACTIVITY%GOBP%GO:0034199,0.118033648790747,0.468766248830589,-0.5102116007138721,-1.3946406579898198,897,7,PRKAR2A|ADCY8|PRKAR1A|PRKACA
PROTEIN MATURATION BY PROTEIN FOLDING%GOBP%GO:0022417,0.49220694171578294,0.791072486428528,-0.37466644909060404,-0.9637430369967149,3757,6,CHCHD4|CALR|AIP|FKBP1A
INHIBITION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:0097340,0.152304087477219,0.519849132875151,-0.463465351216103,-1.3342518793364802,1169,8,CARD16|CAST|XIAP|BCL2L12
REGULATION OF ARACHIDONIC ACID SECRETION%GOBP%GO:0090237,0.32939771822764696,0.695646600584197,-0.670361180038599,-1.11558820239682,2482,2,SYK|PLA2R1
POSITIVE REGULATION OF MICROTUBULE MOTOR ACTIVITY%GOBP%GO:2000576,0.416655345741068,0.7493091022753771,0.46421900872068206,1.01990893215086,3066,4,DNAL4|MTCL1
GLOMERULAR VISCERAL EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0072015,0.309757694826457,0.680809181688249,-0.43960078067205,-1.1307716302309099,2364,6,MAGI2|NUP93|IQGAP1|JAG1|MYO1E
MITOCHONDRIAL TRANSMEMBRANE TRANSPORT%GOBP%GO:1990542,0.474457215836526,0.784493405697755,-0.163637164290648,-0.987516258528533,3714,81,SLC25A20|CCDC109B|CHCHD4|TST|ATP5J|SLC8B1|ATP5F1|TOMM20|SLC25A18|ATP5B|MRS2|TIMM21|SLC25A22|ROMO1|ATP5O|TIMM9|TIMM17B|STOML2|ATP5H|MPC1|TIMM10|DNAJC19|DNAJC15
COPII VESICLE COATING%GOBP%GO:0048208,0.00012951690195570501,0.00518555396908895,-0.392691078686275,-2.1699906414076797,0,58,TFG|PDCD6|TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|F8|SEC13|SEC24A|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|TRAPPC2|GOSR2|PPP6C|SAR1B|GRIA1
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:0072655,0.0278673719520062,0.23617479560495197,-0.27498537325706895,-1.55504538287213,215,63,PITRM1|FIS1|TSPO|BCL2L11|CHCHD4|PMPCA|TOMM20|HK1|SLC25A6|TOMM70A|TIMM21|ROMO1|AIP|IMMP1L|TIMM10B|TIMM9|TIMM17B|HSP90AA1|TOMM5|HSPA4|TIMM10|UQCRC2|DNAJC19|BAD|DNAJC15
NEGATIVE REGULATION OF RESPONSE TO FOOD%GOBP%GO:0032096,0.194923306637709,0.5697855203224189,0.490992983420841,1.27047320284217,1435,6,BBS4|NENF|MKKS|BBS2|CARTPT
POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS%GOBP%GO:2001022,0.644338528919232,0.8688307429995409,-0.14976862991054699,-0.890801452195294,5001,77,NPAS2|DHX9|CEBPG|SETMAR|DTX3L|H2AFX|PARP9|TRIM28|ANKRD32|PARP1|WAS|BRCC3|PCNA|FMR1|PLA2R1|FOXM1|RNF168|BRCA1|NUDT16|DDX5|FGF10|HIC1|NACC2|MYC|NSMCE1|ZNF385A|EID3
REGULATION OF ORGAN GROWTH%GOBP%GO:0046620,0.31223134036733097,0.68160868787154,-0.258608027288183,-1.1148954419643602,2396,25,TBX2|NOTCH1|MEF2C|PIM1|SOD1|WWC3|IGF1|TGFBR3|LATS2
PROTEIN LOCALIZATION TO GOLGI MEMBRANE%GOBP%GO:1903292,0.406082529474812,0.7435193776265749,0.6334711883098979,1.0643133871365,3030,2,ARL5A|ARL5B
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:1904282,0.17953177257525102,0.5528496998175401,-0.908193647992942,-1.20993200928166,1341,1,HFE
PIRNA METABOLIC PROCESS%GOBP%GO:0034587,0.0140059831384281,0.15832975205154098,0.551149529478407,1.7460789643928798,102,10,GPAT2|TDRD12|HENMT1
NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION%GOBP%GO:1902037,0.16443086731305598,0.535643394219061,0.9198279664755179,1.22646647828021,1237,1,N4BP2L2
CHORIONIC TROPHOBLAST CELL DIFFERENTIATION%GOBP%GO:0060718,0.662377288405413,0.879470077229378,-0.5336641852770889,-0.888102543620663,4992,2,E2F7|E2F8
REGULATION OF HISTONE H3-K9 TRIMETHYLATION%GOBP%GO:1900112,0.41376047580427106,0.74818194067571,0.42451533229758004,1.02095693978782,3060,5,PIH1D1|SMARCB1|ZNF274|ZNF304
TYROSINE CATABOLIC PROCESS%GOBP%GO:0006572,0.848695652173913,0.9492491301138911,-0.578958976621085,-0.771312373107728,6343,1,FAH
NEGATIVE REGULATION OF TYPE II HYPERSENSITIVITY%GOBP%GO:0002893,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
NEGATIVE REGULATION OF GTP CYCLOHYDROLASE I ACTIVITY%GOBP%GO:0043105,0.891220613627308,0.9651611606244209,0.5540913101014561,0.7388059968971249,6709,1,GCHFR
NEGATIVE REGULATION OF MITOTIC CELL CYCLE DNA REPLICATION%GOBP%GO:1903464,0.49469355266649,0.793143688290573,-0.601115891333168,-1.00035296883676,3728,2,BCL6
POSITIVE REGULATION OF B CELL TOLERANCE INDUCTION%GOBP%GO:0002663,0.70270628814009,0.8934528433311372,-0.515512799203831,-0.8578957345698921,5296,2,TGFBR2
ESTABLISHMENT OF ENDOTHELIAL BLOOD-BRAIN BARRIER%GOBP%GO:0014045,0.0528428093645485,0.333002194020657,-0.97198941332157,-1.2949232869660001,394,1,ENG
RNA LOCALIZATION%GOBP%GO:0006403,0.23160867890614997,0.6150986887877521,-0.16207090893872,-1.13705372672313,1803,159,FYTTD1|NXF2B|ZFP36L1|NCBP2|SLU7|CHTOP|TST|PHAX|SRSF9|HNRNPU|TOMM20|NPM1|FMR1|MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|C14orf166|NUP37|NMD3|CKAP5|RAN|NXF1|DKC1|NUP160|THOC7|ZC3H3|NUP214|TGFBR2|MAGOHB|EIF4A3|EXOSC3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3|ZNF385A|EXOSC2
CELLULAR CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0044262,0.263251783893986,0.638950455433329,-0.18369276001747198,-1.12986029972499,2065,87,INPP5B|IPPK|GYG1|PER2|PGP|AOAH|GOT1|GAL3ST3|SLC2A1|GAA|PHKG2|HK1|NDST1|PPP1R3C|PGM5|GK|ABHD10|SYNJ2|NR1D1|EXT2|SLC5A3|ITPK1|IMPA2|IDNK|B4GALT1|B3GNT5|PYGL|PYGM|B4GAT1|CSGALNACT1|GYG2|COQ3
DAMP PHOSPHORYLATION%GOBP%GO:0061565,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
REGULATION OF POTASSIUM ION IMPORT%GOBP%GO:1903286,0.010515247108306999,0.13202654083447501,-0.657924137090596,-1.7984062890290702,79,7,ATP1B1|ATP1B3|ATP1B2|WNK2
RIBOSOMAL PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0006610,0.8466324046524208,0.949216083775675,0.250460089308848,0.691388353795297,6259,7,IPO5|TNPO1|RANBP6|TNPO2
MODULATION BY VIRUS OF HOST MORPHOLOGY OR PHYSIOLOGY%GOBP%GO:0019048,0.547809025506867,0.8186230305367759,-0.20476969717392002,-0.934938348136636,4187,30,TGFB1|ATG7|HYAL2|CD209|CD4|RRAGA|KPNB1|CCNK|SLC25A6|CLEC4M|KPNA4|KPNA2|PABPN1
CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021814,0.78429291589281,0.927080511528825,-0.47043833978827,-0.782884626154397,5911,2,DAB2IP
ACTIVE INDUCTION OF HOST IMMUNE RESPONSE BY VIRUS%GOBP%GO:0046732,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
RESPONSE TO MONOSACCHARIDE%GOBP%GO:0034284,0.44756239493081607,0.768229288546963,-0.20172305151896897,-1.00422294623465,3460,40,GPER1|THBS1|PDK3|TRA2B|EIF2B2|PRKACA|EIF2B3|ERN1
MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS%GOBP%GO:0051457,0.511499540018399,0.801504475859147,-0.24194697247479896,-0.955909916585803,3891,19,PML|SP100|TAF3|HNRNPU|PARK7|SKP1|BCL3|SUN2|ARL2
POSITIVE REGULATION BY HOST OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:0044791,0.9626926196269259,0.9908714970603191,0.234131498085208,0.5630849102652641,7121,5,ZNF502|SMC3|PC|VAPA
REGULATION OF INTERLEUKIN-8 SECRETION%GOBP%GO:2000482,0.00968206201753238,0.12539147812585302,-0.479986788204307,-1.8240670061318702,73,17,HYAL2|TLR1|PYCARD|TLR2|SSC5D|FCN1|F2R|LGALS9|ANXA1|TMSB4X|CD14
RENAL SYSTEM DEVELOPMENT%GOBP%GO:0072001,0.0268900464592426,0.232061521319185,0.23548869539891198,1.4975142490662199,190,97,RET|FOXC1|STRA6|IFT88|NPHP3-ACAD11|ITGA6|FGFR2|DLL1|CITED1|PAX8|AGTR1|AHI1|ARL3|FGF2|IFT140|SULF2|MPV17|PTPRO|ROBO2|WFS1|BMP7|PKD1|CEP290|WNT4|TFAP2B|NF1|NPHP3|PKD2
ACTIN FILAMENT NETWORK FORMATION%GOBP%GO:0051639,0.6400785854616899,0.866465706541691,-0.329699909907388,-0.848076984856604,4886,6,COBL|PLS3|ACTN1
CELL MIGRATION IN HINDBRAIN%GOBP%GO:0021535,0.200297538544766,0.578098211195516,0.45784984754907304,1.2638822147509299,1480,7,CTNNA2|TTBK2|SEMA4C
POSITIVE REGULATION OF HISTONE ACETYLATION%GOBP%GO:0035066,0.32628953930962107,0.6940781026265961,-0.270695574396666,-1.10281571919191,2485,21,SMAD4|TADA2A|RUVBL2|LIF|IL1B|FOXP3|RPS6KA5|PAXIP1|BRCA1|ARRB1|MAPK3|WBP2|KAT7|RPS6KA4
POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION%GOBP%GO:0032481,0.123518804739825,0.47770553946915606,-0.243219729972173,-1.31279511355699,958,53,IRF5|POLR3B|DHX36|DDX3X|MB21D1|IFIH1|IRF7|IRAK1|IFI16|TMEM173|RELA|DHX58|NFKB1|TLR4|CD14|PQBP1
POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002732,0.545238095238095,0.817297924969912,-0.481412743052818,-0.940077073624007,4121,3,TICAM1
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT%GOBP%GO:0061213,0.23470857891290098,0.618458039041616,-0.47216269386093396,-1.2145296426797099,1791,6,AGT|BASP1|SMO|GATA3
EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0001837,0.0373027259684362,0.275053626341617,-0.303173692185105,-1.5454770399803999,285,44,TRIM28|PDCD6|HGF|SPRY1|EFNA1|NOTCH1|DDX5|SNAI2|BMP2|TGFBR3|TCOF1|SNAI1|ENG|S100A4|ACVRL1|LOXL2|HNRNPAB
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIARY MEMBRANE%GOBP%GO:1903569,0.41705405764377707,0.7496019371216189,0.792567269519188,1.05678151053829,3139,1,EFCAB7
GLIAL CELL PROLIFERATION%GOBP%GO:0014009,0.18398211467648604,0.556414865076203,-0.53715449968276,-1.2874568372267599,1398,5,CX3CL1|NF2
PURINE NUCLEOBASE CATABOLIC PROCESS%GOBP%GO:0006145,0.3944746978350379,0.7376723208557521,0.8039810322011469,1.07200022298308,2969,1,DPYD
REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING%GOBP%GO:1905595,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
REGULATION OF PROTEIN EXPORT FROM NUCLEUS%GOBP%GO:0046825,0.595287958115183,0.8442752964756541,-0.201359105105857,-0.8992922840926071,4547,28,GAS6|BAG3|PARK7|ANP32B|RAPGEF3|RBM22|ZC3H3|EMD
POSITIVE REGULATION OF GLUCONEOGENESIS BY POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0035948,0.30628237481737297,0.677577131892935,0.8480921923246579,1.13081650296295,2305,1,SUPT20H
MONOSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046364,0.188343717549325,0.562213465453203,-0.250692393871357,-1.2268778170035501,1450,38,PGAM2|PER2|TKT|GOT1|GPI|SLC25A10|G6PC3|ENO1|PGAM1|GAPDH|PGK1|TALDO1|ALDOA|ALDOC
CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0003300,0.554368406816338,0.824211795070057,0.327601307065009,0.9043346148198579,4098,7,HDAC4|INPP5F|CAMTA2|PDLIM5|TCAP|SORBS2
CELLULAR RESPONSE TO LIPID%GOBP%GO:0071396,0.0161207778915046,0.17257673087343697,-0.19266014646640398,-1.45241343122024,125,234,RARA|SETX|OSBPL7|RNF14|EPHA3|CHMP5|ADTRP|ATP1A1|IL1B|RORC|MED30|CCL3|TNF|CD180|UBE2L3|PDK4|NCOA6|CXCL1|CD274|BRINP1|TGFB1|CXCL2|AQP1|LILRB1|SBNO2|LYN|ADAM9|MTDH|PYCARD|IL18|NR3C1|REST|HMGB2|TBX1|ZFP36L1|BCL2L11|MED13|DAB2IP|PID1|FZD4|RORA|PDCD1LG2|SMO|MED1|HNRNPU|ATP1A3|TICAM2|AHR|IL1RN|BRINP3|PDE4B|CASP1|TNFAIP3|ADCY8|LILRB2|TESC|CRHBP|PTGER4|MEF2C|BRCA1|DDX5|MSN|SNW1|CTR9|PIM1|SPP1|CARD16|CALR|IRAK1|NR1H3|RAN|WBP2|CCL2|NCOA4|GPER1|CD86|RBM14|NLRP3|CDK7|AXL|HCK|H2AFZ|FHL2|NR1D1|PDK3|PPAP2A|PABPN1|TICAM1|SERPINE1|FAM107A|PLAA|YAP1|NFKB1|TLR4|VIM|WNT3|KAT5|ANXA1|TFPI|GSTP1|PHB|CD14|TNFRSF1B|SSTR2|SIRPA|INSIG1
TRANSFORMING GROWTH FACTOR BETA ACTIVATION%GOBP%GO:0036363,0.46895728309896506,0.780769690730001,-0.611359250068928,-1.01739955580929,3534,2,NRROS|LTBP3
REGULATION OF PLASMA MEMBRANE ORGANIZATION%GOBP%GO:1903729,0.7727272727272729,0.9218062603848851,0.24742999265057697,0.751916927198827,5660,9,TMEFF2|SH3GLB1
INTERCELLULAR BRIDGE ORGANIZATION%GOBP%GO:0043063,0.435781644308673,0.7625660301865379,0.7834693427437142,1.04465065279244,3280,1,TEX14
ENDOTHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:0072577,0.983862433862434,0.9939453283228069,-0.264861585971104,-0.517207548508559,7437,3,BMPR2|HIPK1|DAB2IP
HINDGUT MORPHOGENESIS%GOBP%GO:0007442,0.0848160535117057,0.40376145987147494,-0.955337450374945,-1.272738873949,633,1,DACT1
NEGATIVE REGULATION OF PEPTIDYL-THREONINE PHOSPHORYLATION%GOBP%GO:0010801,0.152415852334419,0.5200334205653889,0.40148145259801393,1.3211205047688102,1122,11,SPRED2|INPP5K|PARD3|SPRY2|DGKQ
LIPOPROTEIN CATABOLIC PROCESS%GOBP%GO:0042159,0.8996725605762941,0.9678510292896422,-0.24975866573845104,-0.64244656979364,6868,6,PPT1|LYPLAL1|APOE
SA NODE CELL ACTION POTENTIAL%GOBP%GO:0086015,0.0862395241957286,0.40608835945563304,0.614710145249412,1.47837437426272,637,5,SCN5A|ANK2
NEGATIVE REGULATION OF EXIT FROM MITOSIS%GOBP%GO:0001100,0.580735785953177,0.8387093286508721,-0.7139942655491841,-0.95121180184495,4340,1,RGCC
PYRIDOXAL PHOSPHATE CATABOLIC PROCESS%GOBP%GO:0032361,0.30421404682274295,0.676707700393746,-0.8445081605646229,-1.12508764823981,2273,1,PDXP
TOLL-LIKE RECEPTOR 5 SIGNALING PATHWAY%GOBP%GO:0034146,0.125083612040134,0.47962715883228896,-0.9363145125716809,-1.2473957531183202,934,1,TLR5
LYSINE CATABOLIC PROCESS%GOBP%GO:0006554,0.024344062753583997,0.21922894141495605,0.615774836335647,1.69982990734178,179,7,AASS|AADAT|GCDH|PIPOX|ALDH7A1
EUKARYOTIC TRANSLATION INITIATION FACTOR 2 COMPLEX ASSEMBLY%GOBP%GO:1905143,0.6793730907158989,0.884536278926676,0.659847816497574,0.87981802814886,5114,1,CDC123
ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING%GOBP%GO:0086026,0.341113841113841,0.701955655133333,0.35925551463536204,1.09174437484358,2498,9,SCN5A|ANK2|CACNA1C|CACNB2
MEDIUM-CHAIN FATTY-ACYL-COA METABOLIC PROCESS%GOBP%GO:0036112,0.82542872454448,0.9426884426716179,0.43534601599117706,0.73143751666458,6160,2,ACOT7|HSD17B4
LATERAL MESODERM MORPHOGENESIS%GOBP%GO:0048369,0.804816053511706,0.932964969466025,-0.601951918835465,-0.801944493068292,6015,1,TBX20
RENAL SYSTEM VASCULATURE MORPHOGENESIS%GOBP%GO:0061438,0.209920167517341,0.591291692741505,-0.575180424459166,-1.25919018345209,1603,4,PDGFRB|PDGFRA
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING%GOBP%GO:2000677,0.8623566214807091,0.9527544063641651,-0.15132304957565101,-0.703895174683311,6615,32,DDIT3|SOX11|ZNF675|TGFB1|PSEN1|H1F0|ZNF593|PER2|NSD1|GATA3|FAM129B|PARK7|IGF1|TMSB4X
CLATHRIN COAT ASSEMBLY%GOBP%GO:0048268,0.435380384967919,0.7622670566428509,-0.293692045253322,-1.01094497308286,3324,13,FCHO1|PIK3C2A|SGIP1|CLTA|CLTC|CLTB
DIADENOSINE POLYPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0015960,0.9298222340143271,0.9793746057014829,-0.375572098152743,-0.625012029820246,7008,2,KARS|GARS
QUINONE METABOLIC PROCESS%GOBP%GO:1901661,0.5229095853161121,0.807051143864932,0.225838955493773,0.9451253055644359,3845,22,COQ10B|COQ2|CBR4|COQ10A|ADCK4|FDXR|PDSS2|COQ9|AKR1C2|UBIAD1|AKR7A2|AKR1C1|AKR1C3|ADCK3
EMBRYONIC SKELETAL JOINT MORPHOGENESIS%GOBP%GO:0060272,0.84951520786293,0.9492491301138911,0.574327304808116,0.7657879653378901,6395,1,CTNNB1
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1902307,0.0678655815174587,0.3717128095954961,-0.41082148749372704,-1.4916262274291798,516,15,GLRX|ATP1B1|ATP1B3|TESC|SLC9A1|FXYD1|ATP1B2|WNK2
REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032483,0.47768616673210296,0.7850984235874658,-0.44589006525237895,-0.97614656060755,3649,4,MADD|DENND1A
TRNA PROCESSING%GOBP%GO:0008033,0.23823406913785897,0.621833336192322,0.18419207081043804,1.14832927490148,1715,88,SSB|PUS10|PUS7|QTRT1|TYW5|ALKBH8|METTL1|TRMT44|ELAC2|NSUN6|ADAT2|TSEN34|TPRKB|FARS2|TRMT1|DDX1|ELP3|CTU1|KIAA1456|GTPBP3|NSUN3|TRMT1L|MOCS3|TRMT61B|POP5|PUS1|THG1L|MTFMT|SEPHS1|ANKRD16|THUMPD3|QTRTD1|TRUB1|TRMT13|TRNT1|THUMPD2
REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0033047,0.0215095311695003,0.20251241938493103,-0.28580374029202005,-1.59676699880364,166,60,ATRX|MAD1L1|CENPE|NIPBL|BECN1|ZNF207|TACC3|TRIP13|DUSP1|KLHL22|APC|DLGAP5|CDC20|CDT1|LCMT1|ANAPC5|ESPL1|CDC6|ANKRD32|NAA10|CDC23|HNRNPU|PTTG1|CDK5RAP2|MAD2L1|NDC80|CDC27|USP44|CCNB1|PLK1|IK|NEK6|H2AFY|ANAPC11|XRCC3
REGULATION OF IMMATURE T CELL PROLIFERATION IN THYMUS%GOBP%GO:0033084,0.8419078242229371,0.94808068996515,0.42558588365040007,0.7150392341503771,6283,2,KIAA0922|BMP4
PLATELET DENSE GRANULE ORGANIZATION%GOBP%GO:0060155,0.32848722986247497,0.6950398637731511,-0.43085004112861,-1.1082623707975299,2507,6,F2R|F2RL3
POSITIVE REGULATION OF JUN KINASE ACTIVITY%GOBP%GO:0043507,0.9240902569453501,0.9776627603891009,-0.128701102387179,-0.656074731702347,7084,44,ARHGEF5|CCL19|DAB2IP|TNFRSF11A|PKN1|MDFIC|TRAF2|MLKL|MAP3K13|SASH1|MAP3K11|DBNL|ERN1
POSITIVE REGULATION OF RELAXATION OF MUSCLE%GOBP%GO:1901079,0.151438127090301,0.518496345408823,-0.922088663431848,-1.22844350623624,1131,1,CHGA
TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0006383,0.671979294374063,0.881686665673337,0.185985794723793,0.851187835913114,4932,29,SNAPC2|GTF3C2|GTF3C3|ZC3H8|POLR3H|CRCP|TBP|ZNF345|GTF3C6|TBPL1|IVNS1ABP|POLR3GL
IMMUNOGLOBULIN V(D)J RECOMBINATION%GOBP%GO:0033152,0.388605213652244,0.735423487977924,0.545283311438078,1.0725079259344201,2891,3,TCF3|LIG4|PRKDC
POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH%GOBP%GO:0040018,0.0719023613690634,0.377545917506675,-0.8274055693410529,-1.3769351794821298,541,2,PPIB|GHRL
REGULATION OF CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS%GOBP%GO:2001112,0.8378885316184351,0.946216977301937,0.427901847256686,0.718930352035103,6253,2,CNKSR3|ADAMTS12
REGULATION OF TIMING OF CATAGEN%GOBP%GO:0051794,0.7694168234345609,0.921135900129782,0.38791792931131697,0.762988789627939,5725,3,GAL|CDH3|TGFB2
HEAT ACCLIMATION%GOBP%GO:0010286,0.031540374296557996,0.252151273228238,-0.721778649266608,-1.58012434209041,240,4,HSBP1L1|HSPA6|RBBP7
POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS%GOBP%GO:0045725,0.7788398585832129,0.924704689181848,-0.21837887747251603,-0.751702444708354,5947,13,INS|PPP1R3E|IRS1|IGF1
OLIGOSACCHARIDE TRANSPORT%GOBP%GO:0015772,0.0167153091005572,0.17569702079137303,-0.9174524400330849,-1.5267875718909498,125,2,SLC45A3|SLC45A4
REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING%GOBP%GO:0014722,0.0275777747588643,0.234935971081045,0.7405741470761541,1.6270729404306699,202,4,GSTM2|DMD|DMPK
ASPARAGINE BIOSYNTHETIC PROCESS%GOBP%GO:0006529,0.683745819397993,0.885415243771438,-0.6619982355535949,-0.881940604907751,5110,1,ASNS
MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098914,0.0895462987529849,0.413430792765036,-0.8118555279845602,-1.35105742402635,674,2,KCNN2|KCNQ1
MRNA 3'-END PROCESSING BY STEM-LOOP BINDING AND CLEAVAGE%GOBP%GO:0006398,0.326709921600433,0.6941148928066879,0.460855057258836,1.1083537699290902,2416,5,CPSF3|ZNF473
HISTONE H4 DEACETYLATION%GOBP%GO:0070933,0.508599508599509,0.7990325304927759,0.31259268656806105,0.9499403440593148,3725,9,HDAC1|SMARCAD1|HDAC4
REGULATION OF PROTEIN HETERODIMERIZATION ACTIVITY%GOBP%GO:0043497,0.623685594111462,0.857551285930326,-0.314754922079305,-0.860368543208393,4744,7,BAK1|NRG1|HSF1|DAB2IP|CD36
POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:2000503,0.645156908028801,0.86905852565918,0.386553688950834,0.849274917033904,4748,4,XCL1|CCL5|CCL3|CCL4
CLEAVAGE FURROW FORMATION%GOBP%GO:0036089,0.516770354341358,0.8041941212410479,0.337983765143189,0.9329951116632099,3820,7,SNX33|SPIRE2|AURKB|SNX9|SPIRE1
CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS%GOBP%GO:0042219,0.582698871094776,0.838862400059828,-0.24740330338640198,-0.898281290823205,4438,15,PCYOX1L|CHAC1|CHAC2|GGT1|GGT5|ALDH4A1
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY%GOBP%GO:0002706,0.140097862477466,0.5046021532164661,-0.215915707642987,-1.27106118285025,1087,74,MALT1|HLA-F|CLCF1|TRAF6|MICB|IL1B|FOXP3|CD1D|HLA-B|PVR|SERPINB9|MICA|TGFB1|NCR3|LILRB1|HLA-E|NDFIP1|B2M|IL18|RIPK3|PIK3R6|HLA-C|PAXIP1|WAS|HLA-A|FCGR2B|TRAF2|PVRL2|RSAD2|TNFSF13|CEACAM1|STX7|HFE|NLRP3|LGALS9|ZP3|FADD|IL1R1|TFRC|TNFRSF1B
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND%GOBP%GO:0071407,0.0044837304637458395,0.0743264309917645,-0.213498095974352,-1.5794518326224198,34,210,IL18|NR3C1|HSP90B1|REST|ZFP36L1|IMPACT|RYR2|BCL2L11|JUP|MED13|P2RX4|RAPGEF1|RORA|SMO|MED1|HNRNPU|ATP1A3|CYP1B1|AHR|LARP1|NPM1|P2RX3|PDE4B|PDE12|ADCY8|PDXP|CRHBP|SLC9A1|MEF2C|MB21D1|IFIH1|BRCA1|IFIT1|DDX5|PDE2A|MSN|MAPK3|PIM1|SPP1|ABL1|CALR|RAPGEF3|RAN|P2RY6|TMEM173|WBP2|CCL2|NCOA4|GPER1|RAP1A|KCNQ1|RBM14|CDK7|COLEC12|TIPARP|H2AFZ|FHL2|PPAP2A|IGFBP5|CAV1|FAM107A|YAP1|PRKACA|KAT5|ACTB|ANXA1|SHMT2|TFPI|PHB|PQBP1|CASP6|SSTR2|PDGFB|INSIG1
REGULATION OF ELECTRON TRANSFER ACTIVITY%GOBP%GO:1904732,0.20806878306878301,0.588125467895907,-0.6368148229844489,-1.2435379492352399,1572,3,METTL20|CHCHD10|COX17
CYTIDINE METABOLIC PROCESS%GOBP%GO:0046087,0.12419840335034699,0.47833715299653395,-0.6254795869379499,-1.3693055645322099,948,4,APOBEC3G|APOBEC3C|CDA
POSITIVE REGULATION OF NUCLEASE ACTIVITY%GOBP%GO:0032075,0.44400785854616903,0.766503259003379,-0.390215652749435,-1.0037397775466501,3389,6,PRKCD|DDX11|RPS3|AKT1|HMGB2|PCNA
MICROTUBULE NUCLEATION%GOBP%GO:0007020,0.6095173351461589,0.8505496974657741,0.21204578259112802,0.887401531887687,4482,22,CLASP1|CLASP2|NDEL1|TUBGCP3|MZT1|TUBGCP6|CENPJ|RANBP9
PRONEPHRIC NEPHRON MORPHOGENESIS%GOBP%GO:0039007,0.11555319431531401,0.46493596964429496,0.943537715041906,1.2580802287693897,869,1,AHI1
"REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000561",0.0980546792849632,0.43165431781985,-0.526223726311662,-1.4384090892608299,745,7,CD274|TWSG1|C10orf54|TGFBR2|LGALS9|CD55
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY%GOBP%GO:0010715,0.15823282642894598,0.528194339395059,-0.369066065327818,-1.3057017692285,1206,14,FGFR4|LRP1|DDR2|DDR1|DPP4|FAP|PDPN|CST3
AMINO ACID ACTIVATION%GOBP%GO:0043038,0.84588899600606,0.948909006295342,0.14079859204940398,0.738422741612798,6141,46,PARS2|DARS|SARS2|CARS2|RARS2|DARS2|FARS2|IARS2|GATB|LARS2|AIMP1|WARS2|HARS2|QARS|YARS2|FARSB|VARS2|QRSL1|MARS|EPRS|KARS|MARS2|TARS2|EARS2
"MRNA SPLICING, VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION%GOBP%GO:0070054",0.0101672240802676,0.129323654372743,-0.9944309660344071,-1.32482082371408,75,1,ERN1
POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS%GOBP%GO:2000271,0.368806841319397,0.721792732107131,0.412073090084094,1.06626334029601,2716,6,SFRP1|BTG1
CELL MIGRATION INVOLVED IN GASTRULATION%GOBP%GO:0042074,0.27277599142550896,0.6470127748493061,0.697049903501516,1.1711338376386298,2035,2,MEGF8|GPC3
POSITIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION%GOBP%GO:0060355,0.306635257165293,0.6779955265573311,-0.524663943434185,-1.1485990466466,2342,4,COLEC12|CAV1
NEGATIVE REGULATION OF CORE PROMOTER BINDING%GOBP%GO:1904797,0.572040133779264,0.8340866926851909,-0.7182951036612258,-0.9569415509023209,4275,1,PSEN1
PLASMACYTOID DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002470,0.584347826086957,0.8396554445633291,-0.712505513895016,-0.949228427171244,4367,1,CLEC4A
REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS%GOBP%GO:0048259,0.13324742268041198,0.49444556733370093,-0.22803110247889702,-1.2842009842500601,1033,62,RAB21|RAC1|APOC2|BICD1|SYNJ1|LRPAP1|GREM1|PPT1|PSEN1|B2M|CCL19|UBQLN2|SFRP4|APOC1|TNK2|SGIP1|VTN|FMR1|CD63|ARRB1|PIK3CB|NECAB2|ARF1|HFE|HNRNPK|SERPINE1|DAB2|ANXA2|ARF6
POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1900827,0.8358528428093649,0.945788393670804,-0.585796206440229,-0.780421204942524,6247,1,ANK3
EMBRYONIC CAMERA-TYPE EYE FORMATION%GOBP%GO:0060900,0.0861043525277102,0.4057980029059221,0.614963364305084,1.47898336463952,636,5,STRA6|TWIST1|PHACTR4|PROX1
REGULATION OF SISTER CHROMATID SEGREGATION%GOBP%GO:0033045,0.0029708085765952,0.05456914496596799,-0.30724769598228496,-1.78406525693221,22,70,ATRX|MAD1L1|CENPE|NIPBL|BECN1|RAD21|ZNF207|TACC3|TRIP13|DUSP1|CTCF|KLHL22|APC|DLGAP5|CDC20|CDT1|LCMT1|ANAPC5|ESPL1|CDC6|ANKRD32|NAA10|CDC23|HNRNPU|PTTG1|CDK5RAP2|MAD2L1|NDC80|CDC27|USP44|CCNB1|PLK1|RMI2|HDAC8|IK|NEK6|H2AFY|ANAPC11|CDCA5|XRCC3|FEN1
ALDEHYDE BIOSYNTHETIC PROCESS%GOBP%GO:0046184,0.17459070072036703,0.54811765844537,-0.504708309152954,-1.29824573254735,1332,6,TPI1|TKT|CACNA1H|PNPO|PDXK
ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:0042773,0.000128816179312122,0.00518555396908895,-0.41134751806836406,-2.4044694471269596,0,72,COX7C|CYC1|NDUFC2|NDUFV2|NDUFB8|SDHC|NDUFS4|UQCRC1|NDUFB5|UQCR10|NDUFA9|NDUFA7|NDUFA3|NDUFB6|SDHD|CYCS|NDUFB9|COA6|NDUFB10|SDHA|MT-CO3|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|COQ7|NDUFB4|NDUFA12|SDHAF2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|NDUFA4|NDUFV1|UQCRQ|NDUFS3|COX6A1|UQCC3|NDUFA8|NDUFS8|NDUFV3
PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009211,0.682894909043319,0.885415243771438,-0.37384015419410793,-0.81841424416358,5217,4,DCTPP1|CMPK2
CELLULAR RESPONSE TO AMYLOID-BETA%GOBP%GO:1904646,0.0036615666274356,0.0646052543079676,-0.470383162777383,-1.94797906685938,27,22,NTRK1|APP|CACNB1|GSK3B|ADRB2|PSEN1|LRP1|ATP1A3|FCGR2B|GRIN1|CASP4|IGF1|CD36|EPHA4|TLR4|LGMN|NGFR|PRNP
REGULATION OF RECEPTOR RECYCLING%GOBP%GO:0001919,0.4662951889100301,0.780268225072144,0.261508610866982,0.9846666507168241,3430,16,BVES|TBC1D16|INPP5F|VAMP3|RAMP3
BRANCHED-CHAIN AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009083,0.728121195725687,0.906017151800216,0.200004757415539,0.797395746702244,5382,19,BCKDHB|HIBCH|HMGCLL1|ACADSB|ACAT1|ACAD8|HMGCL|IVD|BCKDHA|BCAT1|AUH
METANEPHRIC RENAL VESICLE FORMATION%GOBP%GO:0072093,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
NEGATIVE REGULATION OF NEUTROPHIL CHEMOTAXIS%GOBP%GO:0090024,0.121070234113712,0.472999327000989,-0.937858403176003,-1.2494525861132701,904,1,SLIT2
REGULATION OF INTERLEUKIN-5 PRODUCTION%GOBP%GO:0032674,0.0542849631966351,0.33797491560130605,-0.568327044432698,-1.55349663177402,412,7,GATA3|PDE4D|TNFRSF21|LGALS9
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND%GOBP%GO:2001239,0.0592452319761937,0.352681627159505,0.37865734820890395,1.5096628841283302,437,19,RET|EYA4|HTRA2|MAPK7|MAP2K5|UNC5B|EYA1
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE%GOBP%GO:0001990,0.5362299816224729,0.8132910857498922,-0.25687644009654603,-0.9326767146338659,4084,15,AGT|PCSK5|ATP6AP2|CTSZ|NOS3|SERPINF2
RESPONSE TO PEPTIDE HORMONE%GOBP%GO:0043434,0.0921457905544148,0.42062470710354605,-0.178739934432385,-1.2750862972956298,717,173,ZFP36L1|AP3S1|TCIRG1|ATP6V0B|GOT1|PARP1|ATP6V0A2|ATP6V1G2|OGT|EIF2B1|CAV2|ATP6V1F|INS|BCAR1|FOXC2|SYAP1|ADCY8|ATP6V0D1|CA2|GRB2|CRHBP|PRKAR1A|IRS1|STAT3|PXN|ADCY4|PIK3R3|HDAC5|CEACAM1|GPER1|KAT2B|CPEB1|ATP6V0E1|TGFBR3|RARRES2|CAMK2A|IGFBP5|LPIN3|CAV1|EIF2B2|PPARG|ATP6AP1|RELA|RPS6KB1|NFKB1|PRKACA|ATP6V0E2|ANXA1|ATP6V1A|EIF2B3|LPIN2|ATP6V1G1|ADCY9
REGULATION OF SEQUESTERING OF TRIGLYCERIDE%GOBP%GO:0010889,0.0286607608129234,0.238792268557792,-0.559374925930808,-1.68273669676737,219,9,OSBPL11|PNPLA2|ABHD5|FITM2|PPARG|PPARA
POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS%GOBP%GO:2001171,0.0387698777763175,0.28020075641001296,-0.401748586550697,-1.5872711856237098,294,19,PID1|PFKFB2|PFKFB3|INS|VCP|ENO1|IGF1|TMSB4X
NITRIC OXIDE TRANSPORT%GOBP%GO:0030185,0.706349206349206,0.894843171056815,-0.41447005624793204,-0.809354972848288,5339,3,EDN1|HBB|AQP1
REGULATION OF IMMUNE EFFECTOR PROCESS%GOBP%GO:0002697,0.000128122998078155,0.00518555396908895,-0.325249044594646,-2.4416369117144905,0,228,UNC13D|IGKV3-11|NFKBIZ|MICA|TGFB1|NCR3|MUL1|LILRB1|DNASE1L3|HLA-E|LYN|C4B|DHX9|NDFIP1|SEC14L1|CD74|TNFRSF14|B2M|IL18|IRAK3|RIPK3|CCL19|SLAMF8|RNF216|DTX3L|CD84|PARP9|ITGB2|IGHG4|PIK3R6|SNX4|STX4|FGR|STXBP2|HLA-C|TRIM44|PAXIP1|GPI|C4A|WAS|FES|HLA-A|FCGR2B|C2|TGFB3|INS|IGKV2-28|TRAF2|ADGRE2|VTN|C3|PVRL2|TNFAIP3|MZB1|RC3H2|DDX60|MB21D1|C1QB|CD47|IFIT1|APOBEC3G|RSAD2|TNFRSF4|VAMP8|VAMP7|NPLOC4|TNFSF13|SNX6|C1QA|SEMA7A|CFB|GPRC5B|C1QC|TMEM173|C7|CEACAM1|STX7|CD300A|HFE|IGKV2D-28|CD86|NLRP3|LGALS3|A2M|BST2|LGALS9|ZP3|FADD|SUSD4|CD59|TICAM1|IFNLR1|TRAF3|C3AR1|HAVCR2|IL1R1|DHX58|CFP|C1S|ITGAM|CFI|ANXA1|CD55|PHB|IGHG2|TFRC|SERPING1|PQBP1|CD81|C1R|TNFRSF1B|CFH|C5AR1|PTPRJ|APOBEC3F|RNF26
SEPTIN RING ORGANIZATION%GOBP%GO:0031106,0.890425820450231,0.965159112268525,0.181194196849427,0.651279173406438,6565,14,RTKN|SEPT2|SEPT10|SEPT4|SEPT12
COMMA-SHAPED BODY MORPHOGENESIS%GOBP%GO:0072049,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
REGULATION OF MYELOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002733,0.545238095238095,0.817297924969912,-0.481412743052818,-0.940077073624007,4121,3,TICAM1
BOX C/D SNORNA 3'-END PROCESSING%GOBP%GO:0000494,0.8268771557442289,0.943041978946366,-0.44637441411635,-0.7428384057252809,6232,2,FBL|FBLL1
CELL MATURATION%GOBP%GO:0048469,0.553152683689422,0.823143282826895,-0.18406491331268202,-0.933570869792764,4245,43,RND1|SCARF1|AXL|LHX6|CX3CL1|PPARG|ANG|PRKACA
MEMBRANE ASSEMBLY%GOBP%GO:0071709,0.472163865546219,0.7831522581932591,-0.244807273064865,-0.982162090636352,3595,20,CAV1|ANXA2|NRXN2|EMP2
MITOCHONDRIAL TRNA MODIFICATION%GOBP%GO:0070900,0.86535690897184,0.954584411475564,-0.262699244388065,-0.6757332240925351,6606,6,TRMT61B|PUS1|TRIT1|MTO1|TRMT5|HSD17B10
PLASMA MEMBRANE LONG-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0015911,0.583078762119803,0.839100397937614,0.706605646228496,0.94216328492752,4389,1,SLC27A5
DIADENOSINE TETRAPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0015966,0.9298222340143271,0.9793746057014829,-0.375572098152743,-0.625012029820246,7008,2,KARS|GARS
POSITIVE REGULATION OF VITAMIN D 24-HYDROXYLASE ACTIVITY%GOBP%GO:0010980,0.0358613361668216,0.268987198588135,0.9820247022496691,1.30939743305183,269,1,CYP27B1
CELLULAR RESPONSE TO TESTOSTERONE STIMULUS%GOBP%GO:0071394,0.156878306878307,0.5264612444015649,-0.6700211256186429,-1.3083814421770101,1185,3,MSN|SPP1
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS%GOBP%GO:2000242,0.0170223909912269,0.17730051396585503,-0.5088881150142,-1.75169157643162,129,13,HYAL3|ARHGDIB|RAD1|CALR|SULF1|IGF1|ZP3|TIMP1
MACROPHAGE CYTOKINE PRODUCTION%GOBP%GO:0010934,0.604595563819896,0.848175106515994,0.6952470224966919,0.9270180928327041,4551,1,SIRT1
S-SHAPED BODY MORPHOGENESIS%GOBP%GO:0072050,0.0723472668810289,0.378321151505122,0.8341328921974079,1.4014509581488401,539,2,PAX8|PKD2
SMAD PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0007183,0.7238301325398969,0.9033421872639971,0.2819304944605481,0.7782615625015141,5351,7,SMAD3|SMAD1
POSITIVE REGULATION OF NATURAL KILLER CELL DEGRANULATION%GOBP%GO:0043323,0.32462486602358004,0.692794968343412,0.6720705817480009,1.12916535188194,2422,2,LAMP1|AP1G1
NEURAL TUBE DEVELOPMENT%GOBP%GO:0021915,0.6503294892915981,0.8720434729248241,0.17164196556819403,0.877330051711718,4736,42,BBS4|TSC2|BMP7|PKD1|SEMA4C|DVL2|MTHFR|PKD2|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10|PROX1
REGULATION OF THYROID-STIMULATING HORMONE SECRETION%GOBP%GO:2000612,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
RESPONSE TO ANTICOAGULANT%GOBP%GO:0061476,0.47018068197255797,0.781244333716016,0.44404635115888996,0.975588744381742,3460,4,SFRP1|EGR1|GPIHBP1
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0051056,0.0742022299115725,0.38294270164086996,-0.174087405187581,-1.28670122990185,578,209,LYN|PLCE1|DEPDC7|GNA13|ARHGAP36|ARHGAP25|INPP5B|MAPRE2|VAV3|KANK1|ARHGEF5|MADD|LPAR6|ARHGAP11A|ECT2|DAB2IP|FGD1|RAPGEF1|ARHGAP15|RASGRF2|SPRY1|GDI1|VAV1|ARHGAP18|NGF|OGT|ARHGDIB|ARHGAP24|KALRN|CCDC125|RHOF|HEG1|NOTCH1|GRB2|ARHGAP44|FOXM1|ARRB1|CHN2|NGEF|NOTCH2|FGF10|RHOG|RHOD|ABL1|IGF1|ARHGAP31|ARHGAP1|RHOJ|STARD13|KANK2|F2R|APOE|DLC1|A2M|F2RL3|ARHGEF9|COL3A1|SYDE1|SLIT2|STARD8|RASIP1|GPR4|ARHGAP8|ADGRG1|TIAM1|EPS8|RHOU|DENND1A|MAPKAP1|ARHGDIA|ARF6|NET1|SQSTM1|DEPDC1B
KIDNEY VASCULATURE DEVELOPMENT%GOBP%GO:0061440,0.00980648535564853,0.126483803718766,-0.584340161162144,-1.8306614448963099,74,10,TEK|PDGFRB|PDGFRA|ACTA2|PDGFB
"NEGATIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, ELONGATION%GOBP%GO:0032785",0.008461338193178859,0.11427831033307999,-0.630784845941621,-1.81594128654107,64,8,HNRNPU|RNF168|EAPP|NELFB|SUPT4H1
NEGATIVE REGULATION OF STRESS-ACTIVATED PROTEIN KINASE SIGNALING CASCADE%GOBP%GO:0070303,0.6261706555671179,0.858842084733938,-0.18547787873248398,-0.8854589777162991,4813,35,MYC|DNAJA1|DACT1|GSTP1|SIRPA
POSITIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0043280,0.0191246309844693,0.191027149417247,-0.25063371724430805,-1.5513159552301499,148,90,FIS1|PYCARD|APOPT1|GNB2L1|REST|PPM1F|TNFRSF10A|TNFRSF10B|PDCD6|CASP10|NGF|PDCD5|CASP1|VCP|TRAF2|DDX3X|TNFSF10|CYCS|CASP4|F3|IFI27L1|ANP32B|GPER1|GSN|F2R|DLC1|NLRP3|LGALS9|FADD|BCAP31|MYC|PPARG|S100A8|S100A9|ARL6IP5|NGFRAP1|NGFR|BAD
RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0034976,0.10751725901303999,0.451309145449614,-0.167787011966866,-1.2373255802078702,840,206,TSPYL2|HDGF|UBA5|HSP90B1|MYDGF|FBXO6|BCL2L11|CHAC1|HSPA13|DAB2IP|UBQLN2|ATP2A1|TNFRSF10B|ERO1L|RNF121|HM13|CREB3L2|RASGRF2|TOR1A|TLN1|PDIA4|VCP|TRAF2|UBE2G2|CREB3|SEL1L|ATP6V0D1|CASP4|UBQLN1|TPP1|RCN3|FAF2|MBTPS2|CREB3L1|WIPI1|CALR|HERPUD1|ERP44|SEC13|CEBPB|LMNA|NPLOC4|CCL2|PSMC6|PDIA5|FICD|TMCO1|SRPRB|SYVN1|THBS1|KIAA0368|SEC61B|SSR1|SGTB|EIF2S1|KDELR3|DERL3|HSPA5|GOSR2|DNAJB11|TMX1|NCK1|SERP1|YIF1A|ERN1|P4HB
REGULATION OF MATING TYPE SWITCHING%GOBP%GO:0031494,0.559702483729579,0.8268422944617521,0.7189567710630791,0.958631843321884,4213,1,RTFDC1
POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS%GOBP%GO:2000302,0.8898924159914989,0.965159112268525,0.554808116453463,0.739761761446798,6699,1,UNC13B
ACTIVIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0032924,0.24172095548317,0.625158460820442,0.36407603818540507,1.1980337229259899,1780,11,ACVR1|SMAD3|ACVR2A|CITED2|ACVR2B|ACVR1B|SMAD2
POSTSYNAPTIC SPECIALIZATION ASSEMBLY%GOBP%GO:0098698,0.885265225933202,0.9640874207062379,-0.25562331108899305,-0.6575320174892061,6758,6,NRXN2
LEARNING OR MEMORY%GOBP%GO:0007611,0.945894334818587,0.983395403194261,-0.109685109004049,-0.664620115838277,7429,82,NLGN4Y|INSR|ATAD1|FGF13|EIF4EBP2|EIF2AK4|CLN3|KAT2A|PJA2|S100B|BHLHB9|FYN|APP|CPEB3|MAP1A|CIC|ARC|MAPT|PTEN|NLGN3|SLC8A3|NRXN3|GATM|SYNJ1|PSEN1|PLCB1|TLR2|CLDN5|SHISA7|PLK2|NGF|GRIN1|ADCY8|LILRB2|SGK1|NPAS4|CRHBP|MEF2C|NTRK2|APOE|LDLR|NRXN2|LGMN|FEN1|PRNP
NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION%GOBP%GO:1902904,0.28083989501312295,0.653963653165402,0.18565425814949,1.1215613228285402,2032,77,MET|CLASP1|ADD3|PARK2|TMEFF2|INPP5K|PICK1|KATNB1|INPP5J|CLASP2|SPEF1|ARFGEF1|TTBK2|CAMSAP3|STMN2|TRIOBP|TWF1|TMSB10|MAP2|ADD1
CELLULAR ZINC ION HOMEOSTASIS%GOBP%GO:0006882,0.12670693277310902,0.48305559706617496,-0.336174742686726,-1.34872662875848,964,20,MT1M|MT2A|SLC30A5|S100A8|S100A9|MT1E
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TESTOSTERONE STIMULUS%GOBP%GO:2000655,0.604595563819896,0.848175106515994,0.6952470224966919,0.9270180928327041,4551,1,SIRT1
PROTEIN LOCALIZATION TO KINETOCHORE%GOBP%GO:0034501,0.927712418300653,0.979345221662042,-0.18041379310344802,-0.6038618579494829,7096,12,MTBP|MIS12|ZW10|CDK1|BUB3|AURKB|CHAMP1|CASC5|RCC2|SPDL1|GSG2|IK
HEXOSE PHOSPHATE TRANSPORT%GOBP%GO:0015712,0.9689599570008058,0.9912626134248801,0.280591505190743,0.551890378734089,7210,3,SLC37A3|SLC37A1
ALDONIC ACID METABOLIC PROCESS%GOBP%GO:0019520,0.11933110367892999,0.47098246139817795,-0.9386854874283191,-1.250554460932,891,1,IDNK
POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0002833,0.7956328451882849,0.929819740961342,-0.192076214186045,-0.7453271460996971,6084,18,CD180|PVR|CD274|LY86|PVRL2|DDX60|SASH1|DHX58
SENSORY PERCEPTION OF SMELL%GOBP%GO:0007608,0.0377358490566038,0.276891181314318,0.62921205008145,1.6281231616882101,277,6,DRD2|BBS4|ADCY3|MKKS
PROTEIN LOCALIZATION TO VACUOLAR MEMBRANE%GOBP%GO:1903778,0.329127374153274,0.695646600584197,0.834913983237759,1.11324513931896,2477,1,SH3GLB1
FRUCTOSE IMPORT%GOBP%GO:0032445,0.8445484949832779,0.948285501480553,-0.580999117776798,-0.7740303309939169,6312,1,SLC2A5
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050907,0.976047904191617,0.9926773910205121,-0.18237820367429397,-0.5250413226445809,7497,8,RTP5|TAS2R14|RTP4|TAS2R19|TAS2R4|TAS2R20|PKD2L1
REGULATION OF SEQUESTERING OF CALCIUM ION%GOBP%GO:0051282,0.216383095499451,0.599351136405153,0.20123481200850799,1.1772350848138,1576,68,FKBP1B|DRD2|ANK2|XCL1|GSTM2|DMD|NOL3|FGF2|UBASH3B|HTT|SRI|LIME1|CACNA1C|HAP1|RYR1|PTK2B|PKD2|ITPR1|PLCG1|CXCL9|CAMK2D|JPH3
VENOUS BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0048845,0.102161100196464,0.441073279931729,-0.557618962437111,-1.4343461861890399,779,6,NOTCH1|CCBE1|ENG
REGULATION OF CELL KILLING%GOBP%GO:0031341,0.103296132883467,0.44215230206335104,-0.258258467725809,-1.3450110372521697,795,47,TGFB2|CD1D|PRF1|HLA-B|PVR|SERPINB9|MICA|NCR3|LILRB1|DNASE1L3|HLA-E|RIPK3|PIK3R6|HLA-C|HLA-A|FCGR2B|PVRL2|ICAM1|CEACAM1|STX7|HFE|GAPDH|LGALS9|FADD|IL11
BARBED-END ACTIN FILAMENT CAPPING%GOBP%GO:0051016,0.301060647266794,0.674038850802402,0.35684090354353293,1.130496103121,2213,10,ADD3|TRIOBP|TWF1|ADD1
NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION%GOBP%GO:1902915,0.5371976866456359,0.8137043915765061,-0.340076569694838,-0.929584137762697,4086,7,PARP10|TRIM44|PLAA|OTUB1
MONOCYTE ACTIVATION%GOBP%GO:0042117,0.0109346524342619,0.135040103627003,-0.619974705654172,-1.7848204056455002,83,8,ADAM9|HYAL2|MT1G|AZU1|DYSF|CSF1|FOXP1
POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION%GOBP%GO:0098884,0.0708022510142652,0.3767214120425879,-0.670644266659826,-1.4681804895577197,540,4,SYNJ1|DNM1|DNM3
REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010728,0.701086245255857,0.8931369333627571,-0.36786355152419703,-0.805330211584721,5356,4,FYN|DUOXA1|MPV17L
NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:1902187,0.534276387377584,0.812434061990131,0.274154318951502,0.9317972065682399,3927,12,CHMP3|TRIM11|TRIM13|TRIM5|TRIM35
RESPONSE TO GLUCOCORTICOID%GOBP%GO:0051384,0.0314457202505219,0.25182426163873,-0.3709492928949679,-1.6181485578028798,240,26,TNF|UBE2L3|PDCD7|AQP1|ADAM9|NR3C1|REST|ZFP36L1|BCL2L11|GOT1|HNRNPU|IL1RN|SLIT2|FAM107A|ANXA1|SSTR2
PEPTIDYL-ASPARAGINE HYDROXYLATION%GOBP%GO:0042265,0.467392748040909,0.780769690730001,0.767754741949713,1.0236973530496098,3518,1,HIF1AN
LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002269,0.0612298071912454,0.35631208031004796,-0.51293212251581,-1.5430253761765802,469,9,MAPT|TNF|ITGB2|AZU1|AIF1|CX3CL1|ITGAM
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION%GOBP%GO:0043415,0.902228707880074,0.968486494114721,-0.39862145023435297,-0.66336983755257,6800,2,CAPN3|SOX15
NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS%GOBP%GO:0090206,0.289058390320884,0.6622070134491391,-0.483834108699966,-1.15965803450809,2197,5,SOD1|APOE
GLYCOSYL COMPOUND METABOLIC PROCESS%GOBP%GO:1901657,0.1383222845487,0.5034627152551681,-0.20564275827194398,-1.2580236457584,1084,85,TYMP|APOBEC3C|RAN|CTPS1|HPRT1|ABHD10|CDA|MOCS2|MBIP|FUCA1|NUDT18|UMPS|MACROD2|GMPS|TK1|ENPP4|PNP|ERH|GPHN|UCK1
NEGATIVE REGULATION OF CD40 SIGNALING PATHWAY%GOBP%GO:2000349,0.337123745819398,0.699462084003389,-0.8283524481693871,-1.1035643601140401,2519,1,TNFAIP3
ENDOCANNABINOID SIGNALING PATHWAY%GOBP%GO:0071926,0.0615547890687185,0.35631208031004796,-0.8394265232974909,-1.39693996916071,463,2,DAGLB|DAGLA
HEXADECANAL METABOLIC PROCESS%GOBP%GO:0046458,0.0298844468056847,0.244735657013286,0.9854433171592409,1.31395569475027,224,1,ALDH3A2
DNA DAMAGE INDUCED PROTEIN PHOSPHORYLATION%GOBP%GO:0006975,0.349863387978142,0.7075366679683229,0.374524980122702,1.0871804956288298,2560,8,MAP2K6|MAPK12|ATM
CELL-CELL SIGNALING BY WNT%GOBP%GO:0198738,0.6159188776218921,0.854004733112538,0.13744180894119698,0.92210052592795,4433,123,WNT6|SFRP1|LRP5L|TCF7L1|MET|WNT5B|RARG|RPS27A|WNT2B|ROR2|USP34|ARRB2|BTRC|PKD1|DIXDC1|FRAT2|PPP3R1|CELSR3|DVL2|WNT4|PKD2|AGO2|STRN|VPS35|ARHGEF19|PPP3CB|TNRC6B|AGO3|AP2S1|AP2B1|MOV10|NR4A2|LRP6|CELSR2
POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION%GOBP%GO:0032819,0.23879013000795998,0.622138010410922,-0.7134822167080229,-1.18734850298696,1799,2,HLA-E|IL18
KERATINOCYTE PROLIFERATION%GOBP%GO:0043616,0.806215964935582,0.9337214381011629,0.597209969122188,0.796298910577446,6069,1,CDH13
CYTOSINE METABOLIC PROCESS%GOBP%GO:0019858,0.19250836120401302,0.566989663811688,-0.9020732245258051,-1.20177813562309,1438,1,CDA
PHOSPHATIDYLINOSITOL-3-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0036092,0.6216110019646371,0.856075054950132,-0.33671612155976,-0.866124571296437,4745,6,PIK3CD|PIK3CA|PIK3C3|PIK3C2B|PIK3C2A|PIK3CB
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL%GOBP%GO:2000463,0.301168795868443,0.674189838926369,0.30081466671533696,1.13266698706053,2215,16,RIMS1|RIMS2|CUX2|PTK2B|DLG4|NLGN2|SHANK2|NRXN1|CHRNA7|RELN|SHANK1
'DE NOVO' ACTIN FILAMENT NUCLEATION%GOBP%GO:0070060,0.49249568335768396,0.7912515533650171,0.754190560211734,1.0056113469558001,3707,1,JMY
CORONARY ARTERY MORPHOGENESIS%GOBP%GO:0060982,0.289229158487109,0.662218930390028,-0.533648571411656,-1.16826827541397,2209,4,TGFBR1|TBX1|NOTCH1
PH REDUCTION%GOBP%GO:0045851,0.0389644351464435,0.28119598004076196,-0.37063529659845895,-1.5751895615997902,297,24,PPT1|CLN6|ATP6V0A1|SLAMF8|GPR89B|TCIRG1|ATP6V0A2|RAB7A|DMXL1|ATP6V0D1|SLC11A1|ATP6V0E1|ATP6AP1|ATP6V0E2|RAB20
LIMB DEVELOPMENT%GOBP%GO:0060173,0.0619067271976888,0.357540960865252,0.263416711722452,1.4302436038014201,449,52,DKK1|KREMEN1|INTU|ITGA6|FGFR2|RARG|TBX3|HDAC1|KIAA1715|IQCE|TWIST1|CACNA1C|TFAP2B|ACD|SKI|CHD7|LRP6|MEGF8
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS%GOBP%GO:1902218,0.388962589546299,0.735662494422088,-0.644665012406948,-1.07282567033159,2931,2,ARHGEF2|YBX3
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002862,0.928379467884977,0.9793746057014829,0.313619306180557,0.616852165744111,6908,3,ADCYAP1|VIMP
REGULATION OF STEM CELL PROLIFERATION%GOBP%GO:0072091,0.262526096033403,0.638240557311977,-0.266922564545214,-1.16436497153852,2011,26,HMGB2|KDM1A|TERT|ZFP36L1|LTBP3|HNRNPU|SMARCD3|CX3CL1|YAP1|FBLN1
EVASION OR TOLERANCE OF IMMUNE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051805,0.605525302164962,0.8484731812466321,0.694861049845611,0.92650345038288,4558,1,EIF2AK2
GOLGI TRANSPORT VESICLE COATING%GOBP%GO:0048200,0.00654878847413229,0.0957322763119865,-0.717002051608922,-1.8443224271286598,49,6,ARFGAP2|TMED2|TMED10|TMED9
B CELL ACTIVATION%GOBP%GO:0042113,0.8145763584857071,0.936234233665195,-0.133011874805145,-0.783019599493448,6325,74,ITGA4|CD40|PLCG2|MFNG|JAK3|CD180|DOCK11|ITGB1|DOCK10|GPR183|CEBPG|FNIP1|SLAMF8|BATF|EXO1|LAT2|FCGR2B|AKAP17A|MEF2C|NFAM1|RNF168|NOTCH2|KLF6|HDAC5|VCAM1|CTPS1|LRRC8A|EXOSC3|IL11|PRKCB|PTPRJ
NEGATIVE REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE%GOBP%GO:1904506,0.42192958882021003,0.7527812076478722,0.5278460333374451,1.03821085764467,3139,3,RTEL1|ERCC1|ERCC4
REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0042058,0.693348801237432,0.8891520167182042,-0.15054567256569798,-0.8549066933892009,5378,64,SOCS4|RHBDF2|TSG101|AGT|DAB2IP|HGS|RAB7A|SPRY1|SH3GL2|GRB2|IFI6|MVB12B|EPS15L1|SNX6|CEACAM1|VPS25|GPER1|PLAUR|CHMP6|ERRFI1|MMP9|PTPRJ
"NEGATIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, SLEEP%GOBP%GO:0042321",0.8052533828601751,0.932964969466025,-0.458262207577985,-0.762621595046547,6069,2,GHRL
REGULATION OF CYTOPLASMIC TRANSLATIONAL ELONGATION%GOBP%GO:1900247,0.28583128583128603,0.658457633141178,0.377890505806484,1.14837439430753,2093,9,DPH2|CPEB2|DPH5
NEGATIVE REGULATION OF CELL ADHESION%GOBP%GO:0007162,0.000128238009746089,0.00518555396908895,-0.29180619421336307,-2.0741833385605,0,169,AKT1|FOXP3|SIPA1|CXCL12|JAK3|PTEN|RCC2|PRKG1|ACTN4|DUSP1|MMP12|CD274|DUSP3|TGFB1|LILRB1|RGCC|TBCD|NDFIP1|TNFAIP8L2|APOD|TNFRSF14|KANK1|JAG1|CORO1C|RUNX1|TWSG1|RUNX3|PPM1F|KLF4|FZD4|PLXND1|SEMA6A|PDCD1LG2|CYP1B1|CDKN2A|SPN|ARHGDIB|IL1RN|FCGR2B|PLA2G2D|CASK|RC3H2|LILRB2|NOTCH1|GPNMB|PHLDB2|PRKAR1A|SOCS1|GCNT2|DSCAM|SDC4|BCAS3|SNAI2|CEBPB|C10orf54|CEACAM1|RND1|CD300A|HFE|DLC1|CD86|LGALS3|SERPINE2|TNFRSF21|BMP2|LGALS9|THBS1|SPINT2|SEMA5A|SEMA3E|CX3CL1|SERPINE1|FAM107A|PPARA|HAVCR2|KIAA2022|TGFBI|ADAMDEC1|NF2|ANXA1|ARHGDIA|FXYD5|ACVRL1|FBLN1|EFNA5|C1QTNF1|PRNP
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION%GOBP%GO:0032446,0.7622778788302779,0.918917160526149,0.10632326677061399,0.8928685347887879,5447,427,TRPM4|FBXO2|PIAS3|WSB1|ASB1|DET1|TRIM17|FBXO44|LMO7|SPSB2|FBXL8|DCUN1D2|TNFAIP1|KLHL2|RMND5A|PARK2|KLHL13|NHLRC3|CUL4A|RNF212|FANCL|UBE2V1|RNF103|FBXW9|RPS27A|BARD1|RNF167|MARCH5|UBA6|MARCH8|FBXL2|BMI1|UBE4B|HIST1H2BH|TRIM36|BLMH|RNF112|FBXO30|CBFB|COMMD3-BMI1|TPP2|ZNRF1|UFM1|MARCH1|ARRB2|FBXO41|TRIM13|ATG10|TRIP12|BTRC|PEX2|ANAPC4|ANAPC1|NFE2L2|PPIL2|MARCH2|RANBP2|PEX5|UBE2F|UBE3D|CDC16|SH3RF3|EYA1|FBXO31|PEX13|SUMO1|NEDD4|TRIM27|RBCK1|CUL7|KLHL25|FBXO11|UBE2G1|FBXO18|WDR61|UFC1|ANKIB1|BFAR|RUSC1|SH3RF1|PDZRN3|FBXL5|RNF19A|RFFL|FBXO7|CBL|UVSSA|DDB2|TRIM5|TSSC1|PELI2|STUB1|CDC34|UBE2Q2|SPSB4|RNF135|FBXL3|MARCH7|BCL2|NEDD4L|PCGF3|UBE2K|UBR5|BCL10|TNKS|CUL9|TSPAN17|PCGF1|FBXL16|CDK5RAP3|DCUN1D4|MOCS3|RNF185|UBE2E3|FBXO9|PELI1|RNF41|ZNF598|UNKL|PEX10|BIRC6|FBXW8|RC3H1
POSITIVE REGULATION OF FERTILIZATION%GOBP%GO:1905516,0.0220820189274448,0.205680717355126,-0.6159046534976489,-1.6835479044598702,167,7,PLCB1|HYAL3|CACNA1H|ZP3|POMZP3|LHFPL2
ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE INVOLVED IN MEIOTIC CHROMOSOME SEGREGATION%GOBP%GO:0051316,0.840350644175853,0.947151866837735,0.579124393471548,0.7721842357857,6326,1,CENPC
REGULATION OF TRANSCRIPTION INVOLVED IN PRIMARY GERM LAYER CELL FATE COMMITMENT%GOBP%GO:0060796,0.453244147157191,0.769943206592495,-0.7742059991177771,-1.03142828864815,3387,1,SOX17
RESPONSE TO ANGIOTENSIN%GOBP%GO:1990776,0.173759329579678,0.5479109400550349,-0.372626141944125,-1.28265144094301,1326,13,CAMK2A|CAV1|RELA|NFKB1
NEGATIVE REGULATION OF MITOTIC CELL CYCLE%GOBP%GO:0045930,0.259718670076726,0.636098664976652,-0.14993399351618,-1.1042794349416598,2030,204,CUL1|PCBP4|GTSE1|WEE1|CNOT4|RBL1|ZFP36L2|ATRX|MAD1L1|MCPH1|BTG2|CNOT10|CNOT6L|KIF25|FOXN3|C17orf104|PRMT2|VPS4A|BLM|SFN|STK33|PINX1|ZNF207|CDKN1B|ZWINT|CNOT6|AURKA|PTEN|FHL1|TRIP13|DUSP1|AURKAIP1|FBXL7|EME2|KLHL22|PRCC|PIDD1|PRMT1|YTHDC2|RAD9A|BRINP1|TGFB1|PML|APC|RGCC|CLSPN|RPA2|NABP2|CDC20|TRIAP1|TFDP2|SETMAR|DONSON|GADD45GIP1|CDT1|ZFP36L1|NBN|KLF4|CDC6|NAA10|PLK2|PTTG1|SLFN11|BRINP3|RAD17|PCNA|ORC1|TOP2A|MAD2L1|TAOK2|SLC9A3R1|CDC25C|KNTC1|GPNMB|DCUN1D3|CDKN2B|TOPBP1|EME1|HRAS|SKP1|FAP|E2F1|CCL2|KANK2|NACC2|CCNB1|PLK1|USP47|GAS1|PLAGL1|TNKS1BP1|FAM107A|IK|DACT1|BCL6|CDK2AP2|ZNF385A|CCND1|MUS81
REGULATION OF CALCIUM-MEDIATED SIGNALING%GOBP%GO:0050848,0.0951828954147347,0.42504444493541294,-0.242191081128904,-1.35310589482165,738,60,P2RX5|PLEK|P2RX3|RCAN2|JPH4|PDE4D|SEPN1|SLC9A1|BST1|IGF1|TREM2|P2RY6|RCAN3|FHL2|FKBP1A|CLIC2|PRKACA|CMKLR1|PRNP|RCAN1
POSITIVE REGULATION OF LACTATION%GOBP%GO:1903489,0.920133779264214,0.9768322640118741,-0.539534627260697,-0.7187896734151541,6877,1,XBP1
EMBRYONIC HEART TUBE LEFT/RIGHT PATTERN FORMATION%GOBP%GO:0060971,0.153001071811361,0.52097307188263,0.767907361455749,1.2901835157784598,1141,2,CITED2|MEGF8
REGULATION OF LYMPHOCYTE ACTIVATION%GOBP%GO:0051249,0.000127665007021575,0.00518555396908895,-0.285004979929459,-2.1908096609334202,0,261,IGHV1OR15-1|CD274|DUSP3|NFKBIZ|PRDM1|MNDA|HLA-DPA1|MICA|TGFB1|CD38|LILRB1|IGHV5-51|SLA2|HLA-E|LYN|GPR183|NDFIP1|CD209|TNFSF13B|PYCARD|TNFAIP8L2|IGHV1-24|NCKAP1L|VAV3|CD74|TNFRSF14|SAMSN1|IL18|ADAM8|RUNX1|RIPK3|CCL19|SLAMF8|TWSG1|IGHV3-49|ZFP36L1|RUNX3|CCDC88B|IGHG4|HLA-DPB1|CD4|IGLL5|PDCD1LG2|PAXIP1|VAV1|SPN|AHR|GATA3|TNFRSF18|EBI3|FCGR2B|GAS6|PLA2G2D|THY1|IL6ST|PRELID1|TNFAIP3|MAPK8IP1|MZB1|IGHV4-4|RC3H2|LILRB2|GPNMB|INHBA|IGHV4-61|GRB2|PRKAR1A|MEF2C|SOCS1|PTPN6|CD47|IL2RA|IGHV1-3|SDC4|MMP14|FGF10|BST1|ABL1|IGHV3-43|SOD1|TNFRSF4|IGF1|DPP4|CEBPB|IGHV3-73|NKAP|ICOSLG|VCAM1|TNFSF13|C10orf54|CCL2|CEACAM1|CD300A|HFE|GSN|LST1|CD86|NLRP3|AXL|LGALS3|TGFBR2|TNFRSF21|LGALS9|ZP3|IGHV3-15|FADD|AIF1|CAV1|HAVCR2|BCL6|IGHV1-18|LILRB4|PNP|ANXA1|CD55|NCK1|IGHG2|TFRC|IGHA1|CD81|TNFRSF1B|SART1|SIRPA|PRNP
PROTEIN HOMOTETRAMERIZATION%GOBP%GO:0051289,0.23360020661157002,0.617659277783149,-0.22263507183159198,-1.17304133872108,1808,49,KCNJ12|HPRT1|CDA|CAT|TK1|HSD17B10|GPX3|SHMT2|SAMHD1|APIP|ALDOA
ARTERY DEVELOPMENT%GOBP%GO:0060840,0.752242298193163,0.915314007578303,-0.16833390791056,-0.797529654128027,5786,34,JAG1|TBX1|LRP1|TBX2|HES1|MYLK|NDST1|NOTCH1|PDGFRB|ENG|ACVRL1
EPICARDIUM MORPHOGENESIS%GOBP%GO:1905223,0.867692307692308,0.9558022175108679,-0.569309660344067,-0.7584571668892659,6485,1,TGFBR1
POSITIVE REGULATION OF COLLAGEN CATABOLIC PROCESS%GOBP%GO:0120158,0.19598662207357898,0.571699341995829,-0.8999779444199381,-1.1989867194156498,1464,1,C10orf54
"TRANS-SYNAPTIC SIGNALING BY TRANS-SYNAPTIC COMPLEX, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099557",0.12830389161907302,0.485234242773114,0.9375275694750771,1.2500665106221298,965,1,EPHB2
NEGATIVE REGULATION OF CELL GROWTH%GOBP%GO:0030308,0.0659312467932273,0.369007394574627,-0.20480710697164498,-1.3520211713249901,513,118,TGFB1|MUL1|PPT1|PML|SEMA4A|HYAL2|GJA1|TSPYL2|GNB2L1|SMARCA4|SMARCA2|CCDC85B|SOX17|CDHR2|SEMA6A|SFRP2|CDKN2A|DDX3X|RERG|INHBA|DCUN1D3|ENO1|RBBP7|SEMA3B|SEMA3D|SEMA7A|CDA|NPR1|PPP2CA|HYAL1|NOV|BST2|WFDC1|SEMA5A|DACT3|SEMA3E|SLIT2|APBB1|SEMA3A|SEMA6B|BCL6|CDKN2C|OSGIN1|PHB|NDUFS3|ACVRL1|PTPRJ
REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS%GOBP%GO:0060556,0.35271774721676497,0.7111578119705879,-0.422301495533081,-1.08627320866642,2692,6,SNAI2|SNAI1|NFKB1
PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE%GOBP%GO:0032978,0.660905680600214,0.878572722461081,0.517439158531832,0.8693645956075609,4932,2,C2orf47|COX18
REGULATION OF NEUROTRANSMITTER LEVELS%GOBP%GO:0001505,0.377377892030848,0.7280702784159921,-0.145839696182659,-1.03707085303768,2935,170,SEPT5|PER2|SNCAIP|SNAP47|ACHE|MOXD1|KLF4|STX4|P2RX4|CD34|TOR1A|SYT4|MCTP1|CYP1B1|SYT7|NAPA|CASK|CPLX2|FMR1|GLA|SLC1A2|DAGLB|MEF2C|VPS18|CD47|SYN1|LIN7C|STX11|SLC1A3|SDSL|GPM6B|STX1B|SLC44A1|GPER1|APBA1|DAGLA|NOS3|CD36|STX3|DTNBP1|CAMK2A|CAV1|PRRT2|ARL6IP1|TLR4|ARL6IP5|HSP90AA1|NRXN2|SHMT2|HNMT|SNPH|SIRPA|PTGIS
REGULATION OF PROTEIN GLUTATHIONYLATION%GOBP%GO:0010732,0.7886707349429559,0.92796987860677,-0.46780954560292604,-0.7785098922541891,5944,2,FXYD1
MUSCLE ATROPHY%GOBP%GO:0014889,0.802643633032326,0.932964969466025,-0.33314257600426195,-0.729318738183672,6132,4,GATM|GSN
NEGATIVE REGULATION OF NEUTROPHIL MIGRATION%GOBP%GO:1902623,0.173388166622446,0.547365883994345,-0.749931072511718,-1.24800522765458,1306,2,SLAMF8|SLIT2
RECEPTOR LOCALIZATION TO SYNAPSE%GOBP%GO:0097120,0.7343898144385749,0.9079405785880958,0.19333798666229002,0.7969683833450941,5421,21,CACNG7|DLG2|LRRC7|CACNG4|DLG4|RAB11A|KIF5A
NEUTROPHIL CLEARANCE%GOBP%GO:0097350,0.31586627752719604,0.685583406115178,-0.676689483960972,-1.12611951209553,2380,2,ANXA1
SOMATIC STEM CELL DIVISION%GOBP%GO:0048103,0.323721436343852,0.692386763178424,0.326081838679268,1.1082887461194,2379,12,FGFR2|TEAD3|RAB10
POSITIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR PRODUCTION%GOBP%GO:0090362,0.7763210702341141,0.9241536998094619,-0.616674018526687,-0.8215578648416031,5802,1,PTGS2
POSITIVE REGULATION OF INTRACELLULAR STEROL TRANSPORT%GOBP%GO:0032382,0.390079365079365,0.7358910495632479,-0.549077459092162,-1.07220911449707,2948,3,ANXA2
ZINC ION HOMEOSTASIS%GOBP%GO:0055069,0.221917091669936,0.604468578148982,-0.293387821184979,-1.21499530460511,1696,22,MT1M|MT2A|SLC30A5|S100A8|S100A9|MT1E
CHEMOREPULSION INVOLVED IN EMBRYONIC OLFACTORY BULB INTERNEURON PRECURSOR MIGRATION%GOBP%GO:0021834,0.41883902176834203,0.75036705317022,0.529339709365713,1.0411487421269,3116,3,SLIT1|SLIT3
NUCLEOSOME POSITIONING%GOBP%GO:0016584,0.135778128286015,0.498614450236932,-0.499099999454,-1.36426759146075,1032,7,CTCF|H1F0|H1FX|HIST1H1C
NEUROTROPHIN SIGNALING PATHWAY%GOBP%GO:0038179,0.134937238493724,0.497031952671308,-0.345430016256648,-1.3403969319405902,1031,18,RAPGEF1|NGF|BCAR1|GRB2|NTRK2|RAP1A|DDIT4|NGFR
RESPONSE TO TNF AGONIST%GOBP%GO:0061481,0.8941806020066891,0.9658968257150641,-0.55414644905161,-0.7382561285459681,6683,1,RPS3
GDP-MANNOSE BIOSYNTHETIC PROCESS%GOBP%GO:0009298,0.9744599918489342,0.9920717971974051,0.249938156260895,0.549124773581134,7172,4,PMM1|PMM2
T CELL LINEAGE COMMITMENT%GOBP%GO:0002360,0.7900286383754229,0.928247620398227,-0.25503411532876996,-0.7342075233444201,6068,8,FOXP3|BATF|SPN|STAT3
MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002279,0.5109095688748689,0.8011667213092171,-0.347665648631424,-0.950328546605711,3886,7,S100A13|CHGA|MILR1
REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002739,0.23719711853307102,0.6217158626397761,-0.470965589006785,-1.2114503665114198,1810,6,TNF|LILRB1|TNFRSF14|TNFRSF1B
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098911,0.193946796959826,0.568081639653546,0.3827694667187221,1.2595465813158,1428,11,TRPM4|BIN1|RNF207|CACNA1C
NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION%GOBP%GO:2000402,0.8245292887029291,0.942178419436027,-0.22387571011667198,-0.701373374960704,6305,10,ADTRP|AKT1|APOD|CCL2|CD200
REGULATION OF TRANSFERRIN RECEPTOR BINDING%GOBP%GO:1904435,0.181745821172725,0.554948538055731,-0.744527157430383,-1.23901224880824,1369,2,B2M|HFE
POSITIVE REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 5 PRODUCTION%GOBP%GO:0071651,0.874496103198065,0.9599980090854541,0.342727946087427,0.6741054253954201,6507,3,ADCYAP1|MAVS
MYD88-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002755,0.046972860125260994,0.31104259757474895,-0.354867627517924,-1.54799739661897,359,26,IRAK1|TNIP1|CD36|UBC|TLR5|TLR4|CD14|LY96
REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072124,0.133087848500789,0.49418561861470095,-0.5705278605493579,-1.3674464150006003,1011,5,PDGFA|PDGFB
REGULATION OF DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000508,0.33254468980021,0.6969466727133999,-0.406284397309617,-1.1105602820517702,2529,7,SLAMF8|GAS6|CALR|LGALS9
NICOTINAMIDE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0046496,0.0876136800307416,0.40905715364188894,-0.22434627106440302,-1.34850285431949,683,80,PARP9|NADK|TKT|GPD1|GPI|PFKFB2|NUDT17|HK1|VCP|KYNU|HK3|HAAO|ENO1|BST1|PGAM1|GAPDH|FMO2|LDHA|PDHX|NMNAT3|PNP|PGK1|TALDO1|QPRT|NNMT|ALDOA|ALDOC|PTGIS
POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY%GOBP%GO:1904874,0.0679968495668154,0.37214006136022204,-0.4106761558119021,-1.4910985516505602,517,15,SHQ1|NOP10|RUVBL2|CCT2|NHP2|CCT7|CCT3|RUVBL1|CCT8|CCT5|DKC1
VASOCONSTRICTION%GOBP%GO:0042310,0.441114616193481,0.7653693162885199,-0.36907685674267104,-1.0088551291586099,3355,7,ADRA1B|EDNRA|PIK3C2A|EDNRB
CYANATE METABOLIC PROCESS%GOBP%GO:0009439,0.959140355531971,0.9889996530704799,-0.34448779631066195,-0.573282780801425,7229,2,TST
REGULATION OF ZINC ION TRANSMEMBRANE IMPORT%GOBP%GO:0071581,0.710718554920972,0.8964108318214721,0.643857520952801,0.858497126656157,5350,1,SLC30A1
TERPENE CATABOLIC PROCESS%GOBP%GO:0046247,0.791074511887369,0.928357780000476,0.603936921041023,0.8052683932743759,5955,1,BCO2
"VESICLE TARGETING, TO, FROM OR WITHIN GOLGI%GOBP%GO:0048199",0.000128865979381443,0.00518555396908895,-0.400474481683195,-2.28358503546946,0,65,TFG|PDCD6|TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|F8|WIPI1|SEC13|SEC24A|ARFGAP2|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|TRAPPC2|TMED9|GOSR2|PPP6C|SAR1B|GRIA1
REGULATION OF TRANSLATIONAL FIDELITY%GOBP%GO:0006450,0.37203853163238704,0.7234654586828599,-0.371581594848526,-1.06973140484523,2857,8,AARS|AARSD1|DTD2
PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE%GOBP%GO:0034497,0.21915116583704503,0.601686354077891,-0.38062727900868,-1.23230129429968,1672,11,ATG13|WDR45B|WDR45|WIPI1
NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010664,0.8886020921070509,0.965159112268525,0.301425273757078,0.6622441634350171,6540,4,BMP7|HAND2|PPP1R10
NEGATIVE REGULATION OF LIPOPROTEIN OXIDATION%GOBP%GO:0034443,0.532709030100334,0.812079525085925,-0.736821790913101,-0.9816235468417691,3981,1,APOD
CELLULAR LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0097384,0.416764898493779,0.7493091022753771,-0.39965145238292704,-1.02801119607731,3181,6,DHRS7B|C14orf1
NEGATIVE REGULATION OF INTERFERON-GAMMA PRODUCTION%GOBP%GO:0032689,0.0298117154811716,0.244735657013286,-0.42126813444923794,-1.63467703547962,227,18,ZC3H12A|RARA|FOXP3|CD274|LILRB1|PDCD1LG2|GAS6|INHBA|C10orf54|AXL|LGALS9|HAVCR2|TLR4|PRNP
CHOLESTEROL BIOSYNTHETIC PROCESS VIA LATHOSTEROL%GOBP%GO:0033490,0.00510404397330192,0.0803498785568947,-0.8275102116132141,-1.8115928339346599,38,4,EBP|DHCR7|DHCR24
POSITIVE REGULATION OF T-HELPER 1 CELL CYTOKINE PRODUCTION%GOBP%GO:2000556,0.8273786153644809,0.943061234519578,-0.32469646912121697,-0.7108284446631329,6321,4,IL1B|IL18|IL1R1
LENS FIBER CELL DEVELOPMENT%GOBP%GO:0070307,0.739048642837947,0.9089185613230608,0.39919703354563796,0.78517345663498,5499,3,WNT5B|PROX1
HSP90 DEACETYLATION%GOBP%GO:0070846,0.619471377340948,0.854944793214197,0.687141596823996,0.916210601386403,4663,1,HDAC6
SH2 DOMAIN-MEDIATED COMPLEX ASSEMBLY%GOBP%GO:0071538,0.157125780316111,0.526948420373268,0.9240736656374058,1.23212754522827,1182,1,CRK
PROTEIN BIOTINYLATION%GOBP%GO:0009305,0.369230769230769,0.7221103884306529,-0.81318923687693,-1.08336332177074,2759,1,HLCS
ADENINE METABOLIC PROCESS%GOBP%GO:0046083,0.42552910052910103,0.7547028278218628,-0.535337407641712,-1.04537827641606,3216,3,GART|HPRT1
PEPTIDYL-LYSINE DESUCCINYLATION%GOBP%GO:0036049,0.342143710984194,0.701955655133333,0.829234671371857,1.1056725432715602,2575,1,SIRT5
REGULATION OF MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION%GOBP%GO:0071640,0.00655518394648829,0.0957322763119865,-0.9969673577415091,-1.32819990649151,48,1,SIRPA
DUCTUS ARTERIOSUS CLOSURE%GOBP%GO:0097070,0.062433011789925004,0.358856014313751,0.845106148331955,1.4198874452693302,465,2,STRA6|TFAP2B
RETINAL BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0061304,0.42285041224970604,0.7535830358827651,-0.469354024610022,-1.02751407249018,3230,4,CYP1B1|COL4A1|LRP5
IRON ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098711,0.700185725656673,0.8931369333627571,-0.516364649556851,-0.8593133497784309,5277,2,HFE
CEREBELLAR PURKINJE CELL DIFFERENTIATION%GOBP%GO:0021702,0.8926842036382671,0.965443067117994,-0.29911075498369,-0.6548159680409,6820,4,CEND1
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:2000137,0.958333333333333,0.988711428754361,-0.29323318110640195,-0.5726100830565689,7244,3,NOTCH1
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA GERMLINE RECOMBINATION WITHIN A SINGLE LOCUS%GOBP%GO:0002562,0.945309433468533,0.9830007238272249,-0.15493835442238002,-0.588803582164292,7224,17,HMGB2|BATF|EXO1|RNF168|EXOSC3
CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1990034,0.500132275132275,0.7951717058944731,-0.50270350604483,-0.981652537625708,3780,3,SLC35G1
RESPONSE TO CAMPTOTHECIN%GOBP%GO:1901563,0.603869927438861,0.848175106515994,0.447705879413488,0.8805846320366091,4493,3,SPIDR|BLM|RAD51
CELLULAR RESPONSE TO MECHANICAL STIMULUS%GOBP%GO:0071260,0.0364745586708204,0.271526902825443,-0.318273183654455,-1.55761530193502,280,38,TNFRSF10A|TNFRSF10B|CASP1|PIEZO1|SLC9A1|PTGER4|PDE2A|MAPK3|FADD|TLR5|LTBR|NFKB1|TLR4|TNFRSF1A|BAD
CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009190,0.7346938775510201,0.9079405785880958,-0.21381598684462197,-0.7946229982329179,5615,16,ADCY8|NPR2|ADCY4|NPR1|ADCY9
PROTEIN DEPALMITOYLATION%GOBP%GO:0002084,0.9722863741339491,0.9915747942934481,0.252539901325137,0.554840918289454,7156,4,LYPLA2|LYPLA1
POSITIVE REGULATION OF PIGMENT CELL DIFFERENTIATION%GOBP%GO:0050942,0.27250739048642797,0.646838884025475,0.602128598213301,1.1843158968361,2027,3,BLOC1S5|ZEB2|BLOC1S6
POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0060732,0.576933193056286,0.8370939732087921,-0.37382118588387603,-0.8959780509158041,4386,5,P2RY6|GPER1
OXIDATION-REDUCTION PROCESS%GOBP%GO:0055114,0.00127844541038098,0.0282297792550925,-0.19411063529696498,-1.5572374741597101,9,338,NDOR1|GPD1|CROT|SURF1|PID1|UQCR10|OXA1L|BLVRA|ECHDC2|CHCHD4|NDUFA9|SUMF1|SCO2|NDUFA7|CRAT|GAA|GPI|CYP1B1|FH|SLC25A10|ADH1B|SLC25A18|SDHB|PHKG2|WWOX|HK1|CBR1|ALDH2|PDHA1|NDUFA3|NDUFB6|HK3|SDHD|CYP51A1|PPP1R3C|HCCS|CYCS|LOXL1|ADIPOR1|NDUFB9|COA6|DHRS4|PLA2G7|ENO1|MICAL2|ACAD10|NDUFB10|CYBB|SDHA|ACO1|HMOX1|SLC25A22|MT-CO3|LOX|NDUFS7|NCF4|PGM5|ALDH1A1|NDUFB1|NDUFB7|NDUFA6|PGAM1|ACOX1|DHFR|PDIA5|GAPDH|STEAP4|NDUFS6|COQ7|LYRM5|ADIPOR2|FMO2|SQRDL|NDUFB4|NR1D1|NDUFA12|SDHAF2|GFPT2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|MYC|PYGL|ABCD1|NDUFA4|NDUFV1|PYGM|UQCRQ|NDUFAF2|PGK1|NDUFS3|ALDH3B1|HADH|UQCRC2|DHCR24|COX6A1|GYG2|PTGES|LOXL2|UQCC3|NDUFA8|ALDOA|NDUFS8|ALKBH3|ALDOC|ETFB|NDUFV3
REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS%GOBP%GO:1900376,0.399673957342752,0.7394926011035,0.470743947499035,1.03424450052863,2941,4,SP1|ZEB2|RAPGEF2|CDH3
REGULATION OF NATURAL KILLER CELL DIFFERENTIATION%GOBP%GO:0032823,0.19660704892161998,0.573143439969417,-0.53000713984482,-1.27032597953701,1494,5,PRDM1|GAS6|AXL
NEGATIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000509,0.507826086956522,0.7987565605553191,-0.7498897220996908,-0.9990331689776291,3795,1,SLAMF8
INTERLEUKIN-3-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038156,0.32939771822764696,0.695646600584197,-0.670361180038599,-1.11558820239682,2482,2,SYK|FCER1G
LYSOSOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1905146,0.5718892770760551,0.834013589085641,0.46050233699104703,0.905753754010323,4255,3,CCDC115|TMEM199
MANNOSE TRIMMING INVOLVED IN GLYCOPROTEIN ERAD PATHWAY%GOBP%GO:1904382,0.64243988588507,0.868171925756234,0.387415209838416,0.851167715114063,4728,4,MAN1B1|EDEM2|EDEM3|EDEM1
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING%GOBP%GO:0106015,0.4493645484949829,0.768229288546963,-0.776962946625496,-1.0351012047105699,3358,1,SIGLEC10
NEGATIVE REGULATION OF PRE-MIRNA PROCESSING%GOBP%GO:2000632,0.848983928808607,0.9492491301138911,0.5746029995588879,0.766155567087764,6391,1,BCDIN3D
"MITOCHONDRIAL ELECTRON TRANSPORT, UBIQUINOL TO CYTOCHROME C%GOBP%GO:0006122",0.205789887346083,0.585932546425919,-0.386164096939374,-1.25022704024219,1570,11,CYC1|UQCRC1|UQCR10|CYCS|UQCRQ|UQCC3
REGULATION OF CELL FATE COMMITMENT%GOBP%GO:0010453,0.0135135135135135,0.154334841212238,0.5887658140741839,1.78920500710504,98,9,DKK1|FGFR2|LOXL3|FGF2
RESPONSE TO PEPTIDE%GOBP%GO:1901652,0.0111409911640415,0.137077232293976,-0.20189820128532301,-1.49974864207904,86,215,ZFP36L1|AP3S1|TCIRG1|ATP6V0B|GOT1|PARP1|ATP6V0A2|LRP1|ATP6V1G2|ATP1A3|IRF5|OGT|EIF2B1|CAV2|FCGR2B|ATP6V1F|INS|BCAR1|GRIN1|ERBB2IP|FOXC2|SYAP1|ADCY8|ATP6V0D1|CA2|GRB2|CRHBP|PRKAR1A|CASP4|IRS1|STAT3|PXN|ADCY4|PIK3R3|IGF1|HDAC5|KAT7|CEACAM1|GPER1|KAT2B|CPEB1|CD36|ATP6V0E1|TGFBR3|EPHA4|RARRES2|CAMK2A|IGFBP5|LPIN3|CAV1|EIF2B2|PPARG|ATP6AP1|RELA|RPS6KB1|NFKB1|PRKACA|TLR4|ATP6V0E2|VIM|ANXA1|LGMN|ATP6V1A|EIF2B3|LPIN2|ATP6V1G1|NGFR|ADCY9|PRNP
REGULATION OF INTERLEUKIN-10 PRODUCTION%GOBP%GO:0032653,0.49843342036553495,0.794989907195277,-0.229364315992245,-0.963004775904733,3817,23,FOXP3|JAK3|CD274|LILRB1|PYCARD|CD34|PDCD1LG2|FCGR2B|CD47|C10orf54|TNFRSF21|LGALS9|TLR4
REGULATION OF ACONITATE HYDRATASE ACTIVITY%GOBP%GO:1904232,0.141939799331104,0.5078130330642999,-0.927878253198059,-1.2361566299673201,1060,1,FXN
RNA ACETYLATION%GOBP%GO:1990884,0.0145819397993311,0.161640900278931,-0.992666519629466,-1.3224701574341398,108,1,NAT10
METABOLISM BY HOST OF SYMBIONT PROTEIN%GOBP%GO:0052417,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
POSITIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010666,0.657070841071902,0.875794784627105,-0.535864479932586,-0.8917641857809809,4952,2,CAMK2A
NEGATIVE REGULATION OF AMINE TRANSPORT%GOBP%GO:0051953,0.505763688760807,0.79793773931292,-0.294648512633418,-0.953940412330134,3860,11,CHGA|ADRA2C|ARL6IP5
POSITIVE REGULATION OF IMMUNOGLOBULIN BIOSYNTHETIC PROCESS%GOBP%GO:0002642,0.333779264214047,0.6974768376198021,-0.830613145125717,-1.10657615128522,2494,1,MZB1
POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION%GOBP%GO:0032816,0.27922416037490194,0.653204101106396,-0.404375602840546,-1.16414076399046,2144,8,HLA-E|IL18|GAS6|AXL
MRNA 3'-END PROCESSING%GOBP%GO:0031124,0.0591037857326809,0.35209273220105297,-0.240522972323292,-1.41592020812772,458,74,MAGOH|CPSF2|SRSF5|SRSF1|U2AF1|PAPOLA|NCBP1|CLP1|CSTF3|THOC7|ZC3H3|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|TUT1|THOC3|CPSF7
RANDOM INACTIVATION OF X CHROMOSOME%GOBP%GO:0060816,0.336694083311223,0.699462084003389,-0.666997518610422,-1.10999053189043,2537,2,CDYL|RLIM
REGULATION OF TRANSLATIONAL INITIATION BY IRON%GOBP%GO:0006447,0.804816053511706,0.932964969466025,-0.60200705778562,-0.8020179513895409,6015,1,EIF2AK1
MYOSIN FILAMENT ORGANIZATION%GOBP%GO:0031033,0.423837590045842,0.7540202308249201,-0.397254315084084,-1.0218451131892,3235,6,MYH11|MYOM1|IGSF22
POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION%GOBP%GO:0043923,0.889455782312925,0.965159112268525,-0.178843668207358,-0.664652320638569,6798,16,SMARCB1|EP300|TFAP4|TAF11|LEF1|GTF2B|JUN|CTDP1|CHD1|CCNT1|SMARCA4|ZNF639|SNW1|NUCKS1|RRP1B
MITOTIC SPINDLE CHECKPOINT%GOBP%GO:0071174,0.845842050209205,0.948909006295342,-0.18112837669182102,-0.702845465012262,6468,18,ZNF207|TRIP13|KLHL22|APC|CDC20|MAD2L1|PLK1|IK
INORGANIC CATION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098659,0.537574501166105,0.813781655741487,-0.187280666714322,-0.943729587191879,4148,42,ATP1B1|SLC12A8|ATP1A3|SLC12A2|ATP1B3|SLC39A8|SLC9A1|ABCC9|SLC9A7|SLC9A9|KCNJ12|HFE|ATP1B2|KCNH2|KCNJ9
RESPONSE TO ACTIVITY%GOBP%GO:0014823,0.294324394688883,0.667256167069486,-0.39875337856473103,-1.1479551671893702,2260,8,CAPN3|PPARGC1A|IREB2|PEBP1|FNDC5|AGT|RYR2|METRNL
CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002753,0.9342122438323979,0.980138674064513,-0.137059414852694,-0.619716913561488,7156,29,TNFAIP3|IFIH1|IRF7|IRAK1|UBC|RELA
MITOCHONDRION TRANSPORT ALONG MICROTUBULE%GOBP%GO:0047497,0.721966413867822,0.9019989179378242,0.21521908087191702,0.793854472659229,5330,15,TRAK2|HAP1|LRPPRC|TRAK1|SPAST|NEFL|RHOT2
REGULATION OF INTERLEUKIN-2 SECRETION%GOBP%GO:1900040,0.41146255744795895,0.7460292767566941,0.42532999132034793,1.0229161900659,3043,5,SPTBN1|TRIM27|EZR
PRIMITIVE HEMOPOIESIS%GOBP%GO:0060215,0.0927116827438371,0.421303871141266,0.816170849808329,1.37127240776202,691,2,THOC5|VEGFA
FIBRONECTIN FIBRIL ORGANIZATION%GOBP%GO:1905590,0.0848718289281445,0.40376145987147494,0.958204675782973,1.2776366418627,638,1,LOXL3
POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902993,0.569934640522876,0.8324048186805392,-0.26968275862069,-0.9026534439318259,4359,12,PICALM|CASP3|GSAP|ROCK2|CHRNA7|GSK3A|CLU|APP|LYN|EFNA1|EFNA3|EPHA4
CELLULAR RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0031669,0.788432073544433,0.927903725560957,-0.12263945995921001,-0.8288717500676009,6174,132,P2RX3|GAS6|WDR45B|POSTN|PDXP|WDR45|PRKD1|CDKN2B|WIPI1|MAPK3|PIM1|USF2|RNF152|IFI16|RPTOR|PIK3R4|WDR24|NIM1K|EIF2S1|FAM107A|LAMP2|SIK1|HSPA5|RRP8|FADS1|EIF4G1|RRAGD
REGULATION OF TISSUE REMODELING%GOBP%GO:0034103,0.14204398447606698,0.508075686157268,-0.2693656496198,-1.29707098475725,1097,36,ROCK1|SYK|THBS4|BGLAP|TGFB1|GREM1|IL18|ADAM8|SYT7|TNFAIP3|FLT4|GPNMB|S1PR1|SPP1|IL15|CEACAM1|ATP6AP1|CSF1R|CST3
SNRNA METABOLIC PROCESS%GOBP%GO:0016073,0.5322436470438,0.812079525085925,-0.15426390999201198,-0.9531528837256479,4167,89,NHP2|CCNT1|INTS12|MEPCE|SNAPC1|GTF2E1|INTS2|SRRT|POLR2F|POU2F1|INTS1|EXOSC7|POLR2C|EXOSC4|NABP2|INTS7|NCBP2|GTF2A2|POLR2J|ELL2|ZNF143|PHAX|CCNK|GTF2A1|NCBP1|POLR2H|DKC1|CDK7|EXOSC3|POLR2G|POU2F2|INTS5|TAF9|TUT1|EXOSC2|AK6|POLR2L
REGULATION OF 1-PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE ACTIVITY%GOBP%GO:0090215,0.601739130434783,0.847181989214523,-0.7026907807675339,-0.936152845989037,4497,1,DGKZ
APICAL PROTEIN LOCALIZATION%GOBP%GO:0045176,0.37089386205994,0.7231271705612199,-0.494623062923951,-1.08283327953742,2833,4,MAL|GOPC|VANGL2|SHROOM2
PROTEIN LOCALIZATION TO NUCLEOLUS%GOBP%GO:1902570,0.937966607845799,0.9806508984207809,0.229814196341643,0.5946577404233679,6909,6,WRN|RPF2
EPICARDIUM-DERIVED CARDIAC FIBROBLAST CELL DEVELOPMENT%GOBP%GO:0060939,0.562830687830688,0.828541380171721,-0.473456703255675,-0.924540944350183,4254,3,SPRY1|TGFBR3
TRNA-CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS%GOBP%GO:0071431,0.47167504415161,0.7830987875884521,0.443577424406341,0.974558492335908,3471,4,SSB|XPOT|NOL6
L-AMINO ACID TRANSPORT%GOBP%GO:0015807,0.277154046997389,0.652442157557974,-0.27325127418251605,-1.1472677470401,2122,23,SLC36A1|SLC7A2|SLC25A18|SLC1A2|SLC1A3|SLC25A22|SLC7A3|SLC3A2|ARL6IP5|PRAF2
APOPTOTIC PROCESS%GOBP%GO:0006915,0.000255199693760367,0.00819882332206558,-0.198882515969689,-1.62904216228529,1,390,BCL2A1|FASTK|MADD|RIPK3|TNFSF8|HMGB2|TBX1|TSPO|RYR2|BCL2L11|CHAC1|DAB2IP|ITGB2|GZMB|PPM1F|PPIF|TNFRSF10A|ESPL1|ATP2A1|TLR2|PARP1|P2RX4|TNFRSF10B|ERO1L|SEMA6A|PDCD6|CASP10|BNIP1|CYP1B1|SOD2|TICAM2|NGF|AHR|KPNB1|OGT|IER3|LY86|YARS|BCL2L2|ANXA6|CASP1|TOP2A|TRAF2|TAOK2|PLSCR1|DDX3X|IKBKE|PPP1R13B|CXCR4|ZNF622|MELK|CSRNP1|BAG3|ELMO1|SST|IFIT2|INHBA|TNFSF12|CYCS|CASP4|FXR1|PTPN6|IL2RA|MRPS30|BRCA1|DDX5|IFI27L1|SNW1|NOTCH2|TFPT|ABL1|IFI6|SRGN|TNFRSF10C|G0S2|CEBPB|RNF152|FAP|E2F1|IFI16|HIC1|CYFIP2|STK3|BCL3|GPER1|EPHA2|CIDEB|GSN|RFK|DLC1|GAPDH|NLRP3|PDE1B|NFKBIA|PLAGL1|PPP2CA|TMEM109|TGFBR2|TNFRSF21|PHLDA2|FADD|MCM2|SLIT2|TICAM1|CAMK2A|LTA|CAV1|MYC|DPF1|DDIT4|TLR4|ATG3|HINT1|ARL6IP5|CTSL|SIVA1|RRP8|ZNF385A|DPF2|TNFRSF1A|CRIP1|CD14|LY96|STPG1|CASP6|ENDOG|DHCR24|MAGEH1|NGFR|EFNA5|FEN1|BAD|PTGIS
RESPONSE TO PROSTAGLANDIN D%GOBP%GO:0071798,0.8185971513034129,0.938835694095279,0.36792764971876,0.723670268677575,6091,3,AKR1C2|AKR1C3|PTGFR
REGULATION OF LIPOPOLYSACCHARIDE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0031664,0.0988448411656603,0.43379768462003404,-0.387316782364652,-1.4062844531894498,752,15,LY86|TNFAIP3|CARD16|SASH1|CD36|CX3CL1|CD55
SYNAPSIS%GOBP%GO:0007129,0.0439918533604888,0.299062021084573,0.45472881439506,1.59255511312242,323,13,SYCE1|RNF212|C14orf39|CCNB1IP1|SYCP2|CCNE1|P3H4|MSH5|STAG3|BAG6
NEGATIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL%GOBP%GO:0051280,0.161482282932107,0.531565908892591,0.4797334255247179,1.3242912443631298,1193,7,FKBP1B|GSTM2|SRI|PKD2
POSITIVE REGULATION OF TRANSLATION%GOBP%GO:0045727,0.21477199743095698,0.5979177134734279,-0.196034484595978,-1.17429289196564,1671,79,FMR1|DHX36|DDX3X|RPS4X|WIBG|FXR1|COA3|UQCC2|BCL3|THBS1|EIF4A3|YBX3|POLR2G|RPS6KB1|VIM|NCK1|RPS6KB2|MRPS27
RECOGNITION OF APOPTOTIC CELL%GOBP%GO:0043654,0.32936507936507897,0.695646600584197,-0.57709275394287,-1.12691588489321,2489,3,SCARB1|FCN3|FCN1
NEGATIVE REGULATION OF OXIDATIVE STRESS-INDUCED CELL DEATH%GOBP%GO:1903202,0.219369736484651,0.601686354077891,0.26652097415642606,1.20747062192666,1614,28,MET|PARK2|NOL3|HTRA2|MAPK7|NME5|PDE8A|NFE2L2|NR4A3|FBXO7
FOURTH VENTRICLE DEVELOPMENT%GOBP%GO:0021592,0.9268227424749158,0.9790847380319629,-0.536281429201588,-0.7144556324615021,6927,1,KDM2B
POSITIVE REGULATION OF UBIQUITIN-PROTEIN TRANSFERASE ACTIVITY%GOBP%GO:0051443,0.785451573355129,0.9274485629622209,0.16852700422690897,0.771285442707368,5765,29,MAGEA2|DCUN1D2|CDC14B|BMI1|RAB1A
CITRATE METABOLIC PROCESS%GOBP%GO:0006101,0.808838912133891,0.9342433549901921,-0.17498531228039402,-0.7436826440088772,6185,24,FH|PDHA1|SDHD|SDHA|ACO1|SDHAF2
REGULATION OF PLASMA CELL DIFFERENTIATION%GOBP%GO:1900098,0.920133779264214,0.9768322640118741,-0.539534627260697,-0.7187896734151541,6877,1,XBP1
TRNA MODIFICATION%GOBP%GO:0006400,0.0475006904170119,0.312255783864335,0.254398689628103,1.4519656204218798,343,62,SSB|PUS10|PUS7|QTRT1|TYW5|ALKBH8|METTL1|TRMT44|NSUN6|ADAT2|TPRKB|TRMT1|ELP3|CTU1|KIAA1456|GTPBP3|NSUN3|TRMT1L|MOCS3|TRMT61B|PUS1|THG1L|MTFMT|SEPHS1|ANKRD16|THUMPD3|QTRTD1|TRUB1|TRMT13|THUMPD2
NEGATIVE REGULATION OF FAT CELL PROLIFERATION%GOBP%GO:0070345,0.763150973172015,0.9191113740914171,-0.31693969364982394,-0.759643968018533,5802,5,TFDP1|E2F3|PER2|E2F1
POSITIVE REGULATION OF FATTY ACID OXIDATION%GOBP%GO:0046321,0.591714434601355,0.8417378833576942,-0.294485150565408,-0.885883414750649,4541,9,IRS1|PPARA|ABCD1
PEPTIDYL-CYSTEINE OXIDATION%GOBP%GO:0018171,0.8728836334318729,0.95899070275078,0.34392876489896096,0.676467294291764,6495,3,PRDX3|TMX3
"REGULATION OF ATP-DEPENDENT MICROTUBULE MOTOR ACTIVITY, PLUS-END-DIRECTED%GOBP%GO:2000580",0.46304756785810297,0.776796066784647,0.5059660215418401,0.9951754564539799,3445,3,DNAL4|DYNLL1
ACTOMYOSIN STRUCTURE ORGANIZATION%GOBP%GO:0031032,0.583402375034521,0.8391117257440741,0.161827198888604,0.9236192591200779,4224,62,NEBL|EPB41L5|TMOD3|RTKN|TNFAIP1|OBSCN|NEB|MYO18A|EPB41L4B|WDR1|MYH10|EPB41L3|TPM1|CDC42BPA|OBSL1|SRC|PROX1|PDCD6IP|CFLAR|TMOD1|TMOD2|FHDC1
CELLULAR RESPONSE TO TRICHOSTATIN A%GOBP%GO:0035984,0.296588628762542,0.6687276080240239,-0.848698720776356,-1.13067048065468,2216,1,MEF2C
REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:2000752,0.779784831982999,0.924704689181848,0.6098919276576971,0.813208591071659,5870,1,PRKCD
PRONEPHRIC DUCT DEVELOPMENT%GOBP%GO:0039022,0.11555319431531401,0.46493596964429496,0.943537715041906,1.2580802287693897,869,1,AHI1
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO NON-ANTIGENIC STIMULUS%GOBP%GO:0002878,0.27825740470182003,0.653204101106396,0.8633105425672699,1.151108119556,2094,1,ADCYAP1
SNRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0031120,0.36957671957672,0.722232671030729,-0.558508878350061,-1.09062628592436,2793,3,NOP10|NHP2|DKC1
MO-MOLYBDOPTERIN COFACTOR METABOLIC PROCESS%GOBP%GO:0019720,0.267111634602801,0.6417330323279019,-0.544103242275852,-1.19115573535456,2040,4,MOCS2|GPHN
ANDROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030521,0.486416558861578,0.787674257485734,-0.203535723455078,-0.9800814678032741,3759,36,BRCA1|DDX5|RAN|NCOA4|CDK7|FHL2|PPAP2A|KAT5
ORGANELLE FUSION%GOBP%GO:0048284,0.349382080329557,0.70736446849153,-0.1797589104964,-1.0667201673259101,2713,76,SNAP47|TAPBP|STX4|RAB7A|BNIP1|USP30|OPA1|SYT7|CHCHD3|CAV2|EEA1|STX11|CALR|NKD2|VAMP7|STX1B|STX7|RAB7B|STX3|RAB34|STX5|STOML2|PRRT2|RAB20|GOSR2
POSITIVE REGULATION OF CAMP-MEDIATED SIGNALING%GOBP%GO:0043950,0.16639522258414802,0.5386230242605929,0.39409805068012393,1.2968245787539199,1225,11,ADCYAP1|PRKCA|CXCL9|GPR61|RAPGEF2|PEBP1|MRAP2|GSK3A|CXCL10|CXCL11
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS%GOBP%GO:0034248,0.18828184835333198,0.5621301046654991,-0.14717661371019503,-1.1470288766841699,1474,283,NSMAF|FMR1|DHX36|DDX3X|EFNA1|RPS4X|ZNF540|GGA3|STAT3|WIBG|FXR1|NCBP1|ORMDL3|COA3|RPL10|MALSU1|CALR|HSPB1|UQCC2|AARS|GLE1|TNRC6C|EIF3B|PGAM1|EIF4G2|DHFR|BCL3|APOE|GAPDH|UNK|CPEB1|PAIP2|RBM4B|EIF5|THBS1|MIF4GD|PDK3|EIF4A3|TCOF1|EPHA4|IGFBP5|EIF2S1|EIF2B2|YBX3|POLR2G|TMED10|RPS6KB1|EIF4A2|VIM|SHMT2|ZNF385A|RBM4|TNFRSF1A|CAPRIN1|NCK1|EEFSEC|PPP1CA|RPS6KB2|MRPS27|EIF4G1|PRNP
MESODERMAL CELL FATE DETERMINATION%GOBP%GO:0007500,0.455384615384615,0.7711801339028691,-0.773323775915307,-1.03025295550818,3403,1,KLF4
TRIVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0072506,0.6749083005026489,0.882488012133495,0.37706343986958296,0.8284244356350949,4967,4,XPR1|TFAP2B
REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048742,0.4479968161316,0.768229288546963,-0.619998280753453,-1.0317762843532101,3376,2,FAM129B
TRIMMING OF TERMINAL MANNOSE ON C BRANCH%GOBP%GO:0036510,0.44198821007502703,0.7653693162885199,0.6189137027846711,1.03985493186108,3298,2,MAN1B1|EDEM2
GLUCONEOGENESIS%GOBP%GO:0006094,0.117331589274035,0.46833657507045096,-0.294523802717919,-1.34473802227746,896,30,PGAM2|PER2|GOT1|GPI|SLC25A10|G6PC3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
NEGATIVE REGULATION OF APPETITE%GOBP%GO:0032099,0.194923306637709,0.5697855203224189,0.490992983420841,1.27047320284217,1435,6,BBS4|NENF|MKKS|BBS2|CARTPT
NEGATIVE REGULATION OF SPINDLE CHECKPOINT%GOBP%GO:0090233,0.49377926421404705,0.7923145426459479,-0.7567269519188349,-1.00814200081242,3690,1,CDT1
PURINE RIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009150,0.00012756729174639598,0.00518555396908895,-0.23902077624613002,-1.86694936251157,0,286,NDUFB5|NADK|CROT|SURF1|ACSL5|ATP1B1|ABHD14B|UQCR10|ACOT1|PARP1|NDUFA9|ATP5J|NDUFA7|ACSF2|DCAKD|GPI|ATP5F1|FAR1|COASY|OPA1|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|PDHA1|NDUFA3|NDUFB6|ACSF3|ATP5B|HK3|ADCY8|PDE4D|SDHD|NPR2|ELOVL1|CYCS|SLC26A2|NDUFB9|COA6|NUDT16|PDE2A|ENO1|NDUFB10|SDHA|ADCY4|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|HPRT1|TPST2|MOCS2|MBIP|EPHA2|NPR1|GAPDH|NDUFS6|COQ7|HMGCS1|NUDT18|NDUFB4|HACD2|NUDT4|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|ACOT2|STOML2|PDHX|ABCD1|NDUFA4|HINT1|ATP5H|NDUFV1|UQCRQ|SULT1A4|PGK1|NDUFS3|GPHN|UQCRC2|FASN|COX6A1|UQCC3|NDUFA8|ADCY9|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
SUSCEPTIBILITY TO NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0042271,0.913954699297058,0.973689532007628,-0.215883817756286,-0.6214992961261321,7020,8,MICB|PVR|MICA|PVRL2|HFE
REGULATION OF GONADOTROPIN SECRETION%GOBP%GO:0032276,0.358465608465608,0.714938712241162,-0.563306496084703,-1.0999948174089,2709,3,INHA|INHBB|INHBA
REGULATION OF ACTIVATION-INDUCED CELL DEATH OF T CELLS%GOBP%GO:0070235,0.0632275132275132,0.36006266503904,-0.7492003970442259,-1.46299849136733,477,3,RIPK3|TNFRSF4|FADD
NEGATIVE REGULATION OF MAPK CASCADE%GOBP%GO:0043409,0.0547085201793722,0.339336255689357,-0.212284112486572,-1.38716893465079,426,112,FOXM1|RGS4|TIMP3|MEN1|TNIP1|GPER1|CD300A|MBIP|PSMD10|APOE|PPP2CA|C3orf33|CAV1|MYC|DNAJA1|DACT1|TLR4|SMPD1|RGS2|GPS1|GSTP1|PHB|RGS3|FBLN1|PTPRJ|SIRPA|WNK2
NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0051055,0.00912527701733803,0.12051332749931,-0.375265887345516,-1.76235454328931,69,33,ORMDL3|BRCA1|SNAI2|SOD1|CEACAM1|GPER1|APOE|FGF19|BMP2|SNAI1|SIK1|NFKB1|PDGFA|PDGFB
NEGATIVE REGULATION OF RNA INTERFERENCE%GOBP%GO:1900369,0.491371237458194,0.790696900371285,-0.75766431407146,-1.00939079227365,3672,1,TERT
PEPTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0043043,0.00933503836317136,0.122308204376963,-0.179823939415424,-1.4349321870583098,72,327,MRPS10|RPS23|MRPL53|AIMP2|MRPS17|FARSA|MRPL37|RPL3|AURKAIP1|GSPT2|IARS|RPL7A|RPS2|EIF2B5|GARS|OPLAH|RPL15|MRPL18|RPL37|MRPL57|GFM2|RPL27A|YAE1D1|RPL18|EIF3J|RPL39|DENR|MRPS18B|RPL27|EIF2S3|MRPS15|MRPL47|SECISBP2|EEF1D|GNB2L1|VARS|GADD45GIP1|MRPS11|MRPL13|CHAC1|PCSK5|CHAC2|ETF1|SARS|OXA1L|GATC|EIF3C|NDUFA7|MRPL10|LARP1|MRPL50|MRRF|EIF2B1|EIF3M|MRPL51|YARS|GGT1|RPLP2|MRPS34|PCSK1|MRPL9|WARS|DDX3X|RPS14|RPS4X|RPL35A|RPS29|MRPS30|RPL10|RPL36A|RPL24|MRPS23|MRPL41|MRPS6|MRPS18C|EIF1AX|AARS|MRPL38|EIF3B|MRPS22|MRPL52|TNIP1|EEF1G|GFM1|RPL35|MRPL21|FTSJ1|RPL38|RPS15A|MRPS18A|EIF5|MRPS24|MRPL27|MRPL23|MRPS7|GGT5|MCTS1|MRPL36|ICT1|RPS13|EIF2S1|EIF2B2|CARS|MRPL22|MRPL49|MRPS2|MRPL39|EIF4A2|RPL26L1|MRPL3|MRPL12|MRPS36|ORAOV1|MRPL17|RBM4|IGHMBP2|EEFSEC|EIF2B3|RPS6KB2|MRPS27|RRBP1|MRPL11|EIF2D|TARSL2|EIF4G1|MRPL16
ESTABLISHMENT OF T CELL POLARITY%GOBP%GO:0001768,0.8981481481481479,0.967428248648255,-0.331366493878901,-0.647074778052869,6789,3,CCR7|CCL21|CCL19
POSITIVE REGULATION OF TYROSINE 3-MONOOXYGENASE ACTIVITY%GOBP%GO:1903178,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
CELLULAR RESPONSE TO ATP%GOBP%GO:0071318,0.40899581589958206,0.7448505271608159,-0.32927981122765304,-1.03159066424314,3127,10,SSH1|HSP90B1|P2RX4|P2RX3|PDXP
UV PROTECTION%GOBP%GO:0009650,0.0955805439330544,0.42595828544352005,-0.461429184650745,-1.4455974003396699,730,10,MFAP4|GPX1|CAT|XPA|FEN1
NORADRENERGIC NEURON DEVELOPMENT%GOBP%GO:0003358,0.0322493953238377,0.25578651147417397,0.795453071128188,1.56456232127092,239,3,INSM1|ASCL1
DENDRITIC CELL DIFFERENTIATION%GOBP%GO:0097028,0.0175209205020921,0.180006763679715,-0.44448308133471104,-1.72475966326531,133,18,UBD|LILRB1|LYN|CCL19|BATF|GAS6|TREM2|BATF2|AXL|TGFBR2|LGALS9|LTBR
POSITIVE REGULATION OF MITOTIC CYTOKINESIS%GOBP%GO:1903490,0.739683815648446,0.9093988038963969,0.47824648469809794,0.8035158431959342,5520,2,NUP62|KIF20B
ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT ORGANIZATION%GOBP%GO:0097111,0.6037410453701251,0.848175106515994,-0.557706093189964,-0.928112122977825,4550,2,STX17|GBF1
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1902305,0.7993746743095359,0.931670998922663,-0.152481813543531,-0.773382480862004,6135,43,GLRX|ATP1B1|ATP1B3|SLC9A3R1|TESC|SLC9A1|FXYD1|SCN1B|ATP1B2|FXYD5|FXYD7|WNK2
NEGATIVE REGULATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0045744,0.6727533585496279,0.8820330910931731,-0.191560947165091,-0.844877363659243,5157,27,PLEK|ADA|ARRB1|GPRASP1|ADRBK1|RGS2|GTF2H2
POSITIVE REGULATION OF PROTEIN IMPORT%GOBP%GO:1904591,0.120255641059084,0.472400580631237,-0.305250867968082,-1.3463054573503799,921,27,TGFB1|PSEN1|HYAL2|ARHGEF5|JUP|ECT2|TRIM28|HCLS1|PDCD5|BAG3|FLNA|IGF1|RBM22|TMEM173
REGULATION OF NLRP3 INFLAMMASOME COMPLEX ASSEMBLY%GOBP%GO:1900225,0.494742376445846,0.793143688290573,-0.35205140169600396,-0.962316807027875,3763,7,CD36|TLR4
SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:0014909,0.0267190569744597,0.23130909699635502,-0.639111562676546,-1.6439671069791002,203,6,DDR1|NOV|PDGFRB|PLAT
SUBSTRATE LOCALIZATION TO AUTOPHAGOSOME%GOBP%GO:0061753,0.766822742474917,0.9202428578352959,-0.62097485663873,-0.827287613898975,5731,1,SMURF1
MOLTING CYCLE%GOBP%GO:0042303,0.862457569585879,0.9527544063641651,0.194315451070113,0.6805332219205861,6351,13,FGFR2|HDAC1|ATP7A
INTRACELLULAR SIGNAL TRANSDUCTION INVOLVED IN G1 DNA DAMAGE CHECKPOINT%GOBP%GO:1902400,0.9923644363918729,0.997305769352475,-0.0952026996766654,-0.5213158066875929,7667,56,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A
POLYPRENOL BIOSYNTHETIC PROCESS%GOBP%GO:0016094,0.5343915343915341,0.8124537043108601,-0.48794257387146994,-0.952828178234016,4039,3,SRD5A3
POSITIVE REGULATION OF LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER%GOBP%GO:1903002,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
POLYKETIDE METABOLIC PROCESS%GOBP%GO:0030638,0.10899959277860699,0.45309795582492896,0.5478899892204321,1.4176975494849802,802,6,CBR4|AKR1C2|AKR7A2|AKR1C1|AKR1C3|AKR1B1
RRNA (GUANINE-N7)-METHYLATION%GOBP%GO:0070476,0.7987529848766249,0.931350348412063,-0.46114773953409394,-0.767423581652764,6020,2,TRMT112
POSITIVE REGULATION OF POSITIVE CHEMOTAXIS%GOBP%GO:0050927,0.281331934976403,0.654557203588677,-0.32581046734269203,-1.15266978898385,2145,14,KDR|AZU1|VEGFC|F3|VEGFB
ATP GENERATION FROM POLY-ADP-D-RIBOSE%GOBP%GO:1990966,0.9767046198141609,0.9927322181739301,-0.243477934323477,-0.5330240942667539,7462,4,NMNAT1|NUDT5|PARP1
NMDA SELECTIVE GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0098989,0.8117725752508359,0.935317461845028,-0.597651080723423,-0.796214744010921,6067,1,SULT1A3
REGULATION OF ALDOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0032347,0.974092582851131,0.9920058127185359,-0.223194797726614,-0.5349553406632229,7406,5,CLCN2|REST|BMP2
NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042036,0.733895080184833,0.907913422943088,0.20906919780425698,0.787214868709179,5399,16,ASB1|TRIB2|MAP2K5|ZFPM1|FOXJ1
POSITIVE REGULATION OF ASPARTIC-TYPE PEPTIDASE ACTIVITY%GOBP%GO:1905247,0.209299279633268,0.5902938300419871,-0.48536085562662495,-1.24847887014247,1597,6,LYN|EFNA1|EFNA3|EPHA4
PROTEOGLYCAN CATABOLIC PROCESS%GOBP%GO:0030167,0.6496399945659561,0.871642870453439,0.38520928693542206,0.8463212085511359,4781,4,HPSE|GPC1|ADAMTS12|SGSH
IMMUNOGLOBULIN BIOSYNTHETIC PROCESS%GOBP%GO:0002378,0.277733118971061,0.653204101106396,0.6949219187906949,1.16755854856922,2072,2,GALNT2|PTPRC
IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098739,0.175167439464194,0.548366806412612,-0.229521038266876,-1.23885548894309,1359,53,SLC19A1|ATP1B1|SLC12A8|SLC7A2|ATP1A3|SLC12A2|ATP1B3|SLC39A8|SLC1A2|SLC9A1|ABCC9|SLC9A7|SLC1A3|SLC9A9|KCNJ12|HFE|SLC7A3|SLC3A2|ATP1B2|KCNH2|KCNJ9
CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT%GOBP%GO:0021680,0.348224043715847,0.706126899470814,0.37488116608864597,1.0882144411746302,2548,8,DLL1|ATP7A|ADCK4|AGTPBP1
DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN%GOBP%GO:0050965,0.7473797366299381,0.912246154063119,0.395999069761836,0.7788834392567959,5561,3,MMP24|EPHB1
REGULATION OF MIRNA MEDIATED INHIBITION OF TRANSLATION%GOBP%GO:1905616,0.4206686123640221,0.751774348695433,-0.631297959782432,-1.0505807572119699,3170,2,EIF4G1
REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN%GOBP%GO:0002923,0.951843990448395,0.9858647066977451,-0.3528723751113921,-0.5872360607207989,7174,2,FCGR2B
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2001187",0.616397448079272,0.854122579597827,0.332729713586995,0.8609576901821031,4540,6,XCL1|CBFB
NEGATIVE REGULATION OF PROTEIN IMPORT%GOBP%GO:1904590,0.804347826086957,0.932964969466025,-0.250812525129732,-0.7220541560170141,6178,8,APOD|GAS6|MDFIC|PDE2A
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS%GOBP%GO:0042177,0.0785260482846252,0.3930099382416671,-0.213522749190485,-1.3398048393667399,617,94,USP25|UCHL5|OGT|PSMF1|BAG5|INS|UBE2G2|MAD2L1|EFNA1|PARK7|UBXN1|TIMP3|RILP|ALAD|FLNA|HFE|GIPC1|TLK2|EPHA4|DERL3|TAF9|ANXA2|TIMP1|PHB|AK6|CST3|ADGRB1
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM%GOBP%GO:0070972,0.488455160096951,0.788277714516235,-0.146056196732845,-0.9814935047859108,3828,128,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|SRP19|KDELR2|KDELR1|RPL35|RPL38|RPS15A|CHMP4A|SEC61A1|SEC61B|SGTB|RPS13|BCAP31|KDELR3|HSPA5|SRP9|SRP68|INSIG1
FUSED ANTRUM STAGE%GOBP%GO:0048165,0.5849382388099351,0.839854222268064,0.7058337009263341,0.941134000027873,4403,1,BMPR1B
RESPONSE TO LEUCINE%GOBP%GO:0043201,0.562892259414226,0.828541380171721,-0.28893010292581606,-0.905180295402364,4304,10,RPTOR|RRAGD
REGULATION OF DNA CATABOLIC PROCESS%GOBP%GO:1903624,0.485622144584789,0.7872939093021379,0.495752866139059,0.97508738500834,3613,3,BAX|DFFA
POSITIVE REGULATION OF NEUTROPHIL DEGRANULATION%GOBP%GO:0043315,0.14778455823826,0.514965886850433,-0.7655913978494621,-1.2740665132909,1113,2,ITGB2|ITGAM
REGULATION OF TRANSCRIPTION BY GLUCOSE%GOBP%GO:0046015,0.127910052910053,0.485006465714925,-0.6897655259911059,-1.34693725190673,966,3,USF2|RRP8
PROTEIN-TETRAPYRROLE LINKAGE%GOBP%GO:0017006,0.30943143812709006,0.680809181688249,-0.84246801940891,-1.12236969035362,2312,1,HCCS
INDUCTION BY ORGANISM OF DEFENSE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052251,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
NEGATIVE REGULATION OF MAST CELL DEGRANULATION%GOBP%GO:0043305,0.0583333333333333,0.34882197449105895,-0.75526635050182,-1.47484376106042,440,3,CD84|CD300A|LGALS9
"REGULATION OF PROTON-TRANSPORTING ATP SYNTHASE ACTIVITY, ROTATIONAL MECHANISM%GOBP%GO:1905271",0.0461538461538462,0.30746333312705,-0.975518306131451,-1.2996246195258998,344,1,TMSB4X
REGULATION OF DOPAMINE SECRETION%GOBP%GO:0014059,0.6826923076923079,0.885415243771438,0.22296236536307998,0.822416257243935,5040,15,SYT2|PARK2|CHRNB2|SYT5
POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT%GOBP%GO:2000003,0.983264709788816,0.993583919629788,0.507719453021615,0.676975382568288,7402,1,CCAR2
REGULATION OF DEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032070,0.7590219665271971,0.917242163810958,-0.24212500689579103,-0.75854603949836,5804,10,DFFA|SIRT1|HMGB1|PRKCD|DDX11|RPS3|AKT1|GZMA|NPM1|PCNA
REGULATION OF DENSE CORE GRANULE TRANSPORT%GOBP%GO:1904809,0.0852090032154341,0.40376145987147494,0.8227736421284809,1.3823659513809,635,2,TRIM46|MAP2
REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:2000794,0.573155821219943,0.835051777533516,0.40914681669426295,0.8989129808741851,4218,4,FGFR2|NFIB|SRSF6
PHARYNGEAL ARCH ARTERY MORPHOGENESIS%GOBP%GO:0061626,0.9650184113624409,0.990916952887267,-0.23119347010809602,-0.5541266320744611,7337,5,BMPR1A|BMPR2|BMP4|TGFB2|HES1
REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY%GOBP%GO:0010603,0.9882337030024341,0.996030692679047,0.17793712079426396,0.49119064584105393,7306,7,PAN3|CNOT1|CNOT2|ATXN2|CNOT6L|CNOT6
MYELOID DENDRITIC CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002277,0.28840541257628,0.6614432956205201,-0.689164598842018,-1.14688009817845,2173,2,DOCK2|PYCARD
POSITIVE REGULATION OF AGGREPHAGY%GOBP%GO:1905337,0.9307981725342651,0.9793746057014829,0.31228019797882395,0.614218297936467,6926,3,HTT
CELLULAR RESPONSE TO PROGESTERONE STIMULUS%GOBP%GO:0071393,0.49980077035462894,0.7951717058944731,0.750992501102779,1.00134716665726,3762,1,SRC
FERRIC IRON TRANSPORT%GOBP%GO:0015682,0.00130344108446298,0.0284733155294161,-0.43567211815582396,-2.02657495057043,9,32,ATP6V1D|ATP6V0A1|TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|ATP6V1F|ATP6V0D1|CLTC|ARHGAP1|HFE|STEAP4|ATP6V0E1|ATP6AP1|ATP6V0E2|TFRC|ATP6V1A|ATP6V1G1
GALACTOSE METABOLIC PROCESS%GOBP%GO:0006012,0.37424679067330396,0.72498550711669,-0.32764648905033006,-1.06077313633703,2856,11,GALT|PGM5|SLC35A2|GALK1
CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM%GOBP%GO:1990036,0.6448160535117061,0.8688307429995409,-0.6819585355094839,-0.908532517199655,4819,1,ATP2A2
"ENERGY COUPLED PROTON TRANSPORT, DOWN ELECTROCHEMICAL GRADIENT%GOBP%GO:0015985",0.40215251345320896,0.740287621109606,-0.25428079905830203,-1.03594180627147,3063,21,ATP5J|ATP5F1|ATP5B|ATP5O|STOML2|ATP5H|ATP5G1
NEGATIVE REGULATION OF CHROMATIN ORGANIZATION%GOBP%GO:1905268,0.34902975420439897,0.706981624190196,-0.22342819161321398,-1.07586926888164,2697,36,DNMT3B|H1F0|SET|BCOR|PHF2|ATAD2|BRCA1|TAF7|DNMT1|SPI1|H1FX|HIST1H1C|H2AFY|OTUB1
REGULATION OF AMPA GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:1904717,0.40374581939799303,0.7412049911665691,-0.7985774150860171,-1.06389686663993,3017,1,SHISA7
2'-DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009265,0.31707650273224,0.6861326333203311,0.386140406937556,1.12089804759926,2320,8,DCTD|CDADC1|AK5|DUT|DTYMK
RESPONSE TO GLYCOSIDE%GOBP%GO:1903416,0.380737596179358,0.729499056535481,-0.6484146677695071,-1.0790656964698702,2869,2,ATP1A1|ATP1A3
REGULATION OF COLLAGEN CATABOLIC PROCESS%GOBP%GO:0010710,0.0291846616934956,0.242147886926844,-0.727031049989558,-1.59162294522196,222,4,FAP|C10orf54|CST3
POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION%GOBP%GO:1903003,0.970031545741325,0.9915747942934481,-0.19585673510054,-0.535365651290901,7379,7,ZC3H12A|SART3|VCP|TNIP1
REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:2000322,0.186908517350158,0.5601505529923929,-0.46889998732596794,-1.2817172050590901,1421,7,CRY1|LMO3|CLOCK|ARNTL|CRY2|PHB
DORSAL AORTA MORPHOGENESIS%GOBP%GO:0035912,0.0987118822292324,0.433510337204539,-0.5256007326443429,-1.4367061638532201,750,7,ENG|ACVRL1
POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW%GOBP%GO:0071864,0.502149959688256,0.796769413401376,0.487925839495702,0.9596925472507709,3736,3,FGFR2|LEF1
ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0051315,0.33743777835996897,0.699636319850872,-0.33835103190853305,-1.09542966976629,2575,11,MAD1L1|CENPE|KIF2C|NUF2|CDT1|BOD1|NDC80
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN NEGATIVE REGULATION OF APOPTOTIC PROCESS%GOBP%GO:0044336,0.84951520786293,0.9492491301138911,0.574327304808116,0.7657879653378901,6395,1,CTNNB1
MODULATION BY HOST OF SYMBIONT CATALYTIC ACTIVITY%GOBP%GO:0052422,0.381966773847803,0.7299505817786128,0.644766699308682,1.08329130403692,2850,2,SUGT1|PTX3
CERAMIDE TRANSLOCATION%GOBP%GO:0099040,0.00026795284030010696,0.008341291331221941,0.986214502343535,1.6569676992458502,1,2,ABCB1|ABCB4
ARGININE CATABOLIC PROCESS TO ORNITHINE%GOBP%GO:0019547,0.774737680966928,0.923210645518754,0.611766651962947,0.8157082829708029,5832,1,ARG2
POSITIVE REGULATION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY%GOBP%GO:0051343,0.523210702341137,0.807237976660292,-0.741012351124835,-0.9872063792566441,3910,1,GNB2L1
ANGIOGENESIS INVOLVED IN WOUND HEALING%GOBP%GO:0060055,0.141692954784437,0.50780718982581,-0.495406220978803,-1.3541708127204999,1077,7,CD34|PRCP|ADIPOR2|SRF
NEGATIVE REGULATION OF CITRULLINE BIOSYNTHETIC PROCESS%GOBP%GO:1903249,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS%GOBP%GO:0050654,0.0714659685863874,0.3767214120425879,-0.32549874862144795,-1.4537138162348402,545,28,ARSB|DCN|CHST7|BGN|VCAN|HYAL1|B3GAT3|HEXB|CSGALNACT1|XYLT2
POSITIVE REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS%GOBP%GO:0032058,0.19329930637351103,0.567519363754568,-0.583797496277505,-1.2780547549540802,1476,4,EIF2AK4|PPP1R15A|DNAJC3|IMPACT
BIOMINERAL TISSUE DEVELOPMENT%GOBP%GO:0031214,0.152219321148825,0.519849132875151,-0.31040874724506606,-1.30327642635444,1165,23,LGR4|TBX1|SBDS|ANXA6|STIM1|DDR2|CLEC3B|IGF1|BMP2|COL1A1|ANXA2|FAM20A
MARGINAL ZONE B CELL DIFFERENTIATION%GOBP%GO:0002315,0.931160400324588,0.9793746057014829,0.21962436452166698,0.606267163199521,6884,7,DLL1|PTK2B
NEGATIVE REGULATION OF CELL DIVISION%GOBP%GO:0051782,0.603687238493724,0.848175106515994,-0.28002479252476,-0.8772811204190392,4616,10,ORC6|SUSD2|MYC
DETECTION OF MECHANICAL STIMULUS%GOBP%GO:0050982,0.36687432286023797,0.721190111986457,0.291059202675613,1.07359741950656,2708,15,PIEZO2|KIT|COL11A1|PKD1|MKKS|PKD2
PROTEIN LOCALIZATION TO ACTIN CYTOSKELETON%GOBP%GO:1903119,0.47293676312968896,0.7831522581932591,0.604324346991733,1.01534293042097,3529,2,RTKN
NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:1904063,0.0682317408017573,0.37295204814599103,0.28029317869893106,1.43268942503851,496,42,FKBP1B|CRHR1|BIN1|GSTM2|C19orf26|EPHB2|DRD4|GNB5|PRKCE|SRI|SUMO1|NEDD4|PKD2|YWHAE|CAMK2D|SESTD1|NEDD4L
PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009155,0.0031562335612835397,0.0571886039479394,-0.779224118054647,-1.8676515213294198,23,5,NUDT1|NUDT16|NUDT18|SAMHD1
REGULATION OF TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:0022898,0.47832258064516103,0.7850984235874658,-0.142457681290351,-0.989494554603163,3706,151,GLRX|ATP1B1|PPIF|CTSS|PLN|SHISA7|ATP1B3|STAC3|INS|PDE4B|STIM1|SLC9A3R1|FMR1|JPH4|PDE4D|TESC|SEPN1|CRHBP|SLC9A1|MEF2C|UBQLN1|CAPN1|FXYD1|CNIH2|P2RY6|COX17|FKBP1A|MMP9|CAV1|SCN1B|CNIH3|CLIC2|ATP1B2|PRKACA|KCNE4|ACTB|TMSB4X|FXYD5|AHNAK|FXYD7|WNK2|PRNP
REGULATION OF HAIR FOLLICLE DEVELOPMENT%GOBP%GO:0051797,0.26264538815255606,0.6382897491935179,0.427588369955734,1.18034621812005,1941,7,SPINK5|GAL|HPSE
GLYCEROL-3-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0046167,0.33762271159458696,0.699636319850872,-0.66658434043193,-1.10930293732926,2544,2,GK
RESPONSE TO PROSTAGLANDIN E%GOBP%GO:0034695,0.9689964645091109,0.9912626134248801,0.17357605099201903,0.5499006624325239,7125,10,SFRP1|ADCY6|GNB1|CCR7|CCL21
NEGATIVE REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS%GOBP%GO:0110091,0.112240802675585,0.459194647507502,-0.9416629907366559,-1.2545212102794099,838,1,CX3CL1
DOPAMINE UPTAKE%GOBP%GO:0090494,0.260048231511254,0.636098664976652,0.703391232423491,1.18178808898966,1940,2,SLC6A2|SNCA
CLATHRIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:0072583,0.5642002891312919,0.8292998125768459,-0.232056765180698,-0.916834630241787,4292,19,FCHO1|AP2A2|SGIP1|CANX|CLTA|CLTC|AP2M1|CLTB
ACTIVATION OF MAPK ACTIVITY%GOBP%GO:0000187,0.143512033617726,0.509803257988665,-0.19521181673527102,-1.2365614259484499,1126,98,PKN1|MDFIC|FPR1|TAOK2|CXCR4|MAPKAPK2|MLKL|PIK3CB|FGF10|MAPK3|GHRL|SOD1|IRAK1|IGF1|MAP3K13|MAP2K3|MUC20|BMP2|THBS1|MAP3K11|PEA15|UBC|TLR4|GNG3|DBNL|CD81|C5AR1|ERN1
CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002367,0.628061490359562,0.8598358835891559,-0.285514933455062,-0.858898806020768,4820,9,TLR2|SLC11A1|CHGA|CD55
ACTIN-MEDIATED CELL CONTRACTION%GOBP%GO:0070252,0.8773572803078901,0.960725750963158,-0.13323107837654902,-0.711419146089057,6838,51,TNNI2|TNNC2|KCNN2|PKP2|CACNA1G|PDPN|KCNQ1|SCN1B|KCNH2|VIM|KCNE4|EMP2
VITAMIN D METABOLIC PROCESS%GOBP%GO:0042359,0.592174976226056,0.8417378833576942,0.40282134211248294,0.8850156438309871,4358,4,CYP27B1|PIAS4|CYP2R1
EMBRYONIC RETINA MORPHOGENESIS IN CAMERA-TYPE EYE%GOBP%GO:0060059,0.183547695605573,0.556308895147568,0.747780534877309,1.2563678484469099,1369,2,LRP6|PROX1
PROTEIN KINASE C SIGNALING%GOBP%GO:0070528,0.0549421661409043,0.34040299792724105,-0.5677422801716789,-1.5518982047437098,417,7,AZU1|PLEK|PLVAP|ADGRG1|PDGFB
POSITIVE REGULATION OF NUCLEAR RECEPTOR TRANSCRIPTION COACTIVATOR ACTIVITY%GOBP%GO:2000327,0.94895498392283,0.984504384435631,0.35038070590560993,0.5886848254055821,7082,2,RQCD1|CNOT6
EMBRYONIC EPITHELIAL TUBE FORMATION%GOBP%GO:0001838,0.381584348064031,0.7296501420979891,0.21993032367583,1.05517271502115,2788,34,BBS4|TSC2|PAX8|BMP7|SEMA4C|DVL2|MTHFR|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10
RIBOSOMAL LARGE SUBUNIT ASSEMBLY%GOBP%GO:0000027,0.981937172774869,0.993436724391485,-0.11590921641172901,-0.517663524177313,7501,28,MDN1|FASTKD2|WDR18|RPF1|RPL23A|RPF2|GLTSCR2|MRTO4|NLE1|TRAF7|NOP2|RSL24D1|RPL6|RPL12|RPL5|RRS1|RPL11|DDX28|RPLP0|MRPL20|BRIX1|RPL3|DHX30|PPAN|RPL10|RPL24|BOP1|MRPL11
INORGANIC ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098661,0.17558711086837803,0.548366806412612,0.269145612049652,1.25552713052269,1285,31,SLC12A5|SLC12A4|GABRA3|SLC12A9|SLC25A30|GABRB3|XPR1|CLCN3|SLC37A3|SLC20A1|CLCN6|SLC20A2|SLC12A6|GLRB|GABRG2|SLC12A7
CYTOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042089,0.9711995652764571,0.9915747942934481,0.254394731361955,0.558916058873174,7148,4,NOD1|BCL10
NUCLEAR RETENTION OF PRE-MRNA WITH ABERRANT 3'-ENDS AT THE SITE OF TRANSCRIPTION%GOBP%GO:0071049,0.00955160520031839,0.12416337026881699,-0.9360352908740001,-1.55771240731151,71,2,EXOSC3|EXOSC2
CELLULAR RESPONSE TO DRUG%GOBP%GO:0035690,0.0021853708702918103,0.042528703857699995,-0.241065361364743,-1.6860023710439098,16,157,PLCB1|NR3C1|SLAMF8|HSP90B1|REST|DCPS|IMPACT|RYR2|JUP|ECT2|NDOR1|PPM1F|PPIF|KDR|P2RX4|NDNL2|CYP1B1|AHR|LARP1|P2RX3|GAS6|PDE4B|TNFAIP3|FMR1|ADCY8|PDXP|CRHBP|MEF2C|PARK7|BRCA1|PDE2A|MAPK3|DPEP1|ABL1|RBM22|CHRM2|GNAQ|KCNQ1|GNA15|ADIRF|FXN|MT2A|HTR1B|SLIT2|MYC|RELA|SIGMAR1|MAPK13|NFKB1|KCNH2|VIM|ADRBK1|ACTB|LY6H|ANXA1|TFRC|NET1|PDGFB|SIRPA|BAD
POSITIVE REGULATION OF MITOCHONDRIAL DNA REPLICATION%GOBP%GO:0090297,0.0976588628762542,0.430598623028127,-0.948886193206881,-1.26414425036294,729,1,STOML2
"CHOLESTEROL BIOSYNTHETIC PROCESS VIA 24,25-DIHYDROLANOSTEROL%GOBP%GO:0033488",0.311036789297659,0.68160868787154,-0.841365240405823,-1.1209005239286498,2324,1,CYP51A1
REGULATION OF STEROID HORMONE SECRETION%GOBP%GO:2000831,0.440848517813435,0.7653693162885199,0.316935291538933,1.00407242686676,3241,10,CRHR1|AGTR1|GAL|UCN|GDF9|CRH
PULMONARY VALVE FORMATION%GOBP%GO:0003193,0.492968957283099,0.791704703410144,-0.601985111662531,-1.00179949046361,3715,2,TBX20|GJA5
TRAIL-ACTIVATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0036462,0.13111520252498698,0.490819490032838,-0.5718857520435799,-1.3707010218026998,996,5,TNFRSF10A|TNFRSF10B|TNFRSF10C|FADD
REGULATION OF WNT-MEDIATED MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1905424,0.97414255091104,0.9920058127185359,0.31794871794871804,0.534194898174537,7270,2,CSNK1E|CSNK1D
CHOLESTEROL ESTERIFICATION%GOBP%GO:0034435,0.20123258306538103,0.5792408283906739,0.73575305664721,1.23616013208977,1501,2,LCAT|SOAT1
NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS%GOBP%GO:0045922,0.542752389681812,0.816099720857136,-0.269740043755962,-0.928497539111188,4144,13,APOC1|INS|BRCA1|CEACAM1|SIRT4
CELL PROJECTION ASSEMBLY%GOBP%GO:0030031,0.000138427464008859,0.00526859796630401,0.290286900759442,2.37524341770846,0,353,DYNLRB2|DYNC2H1|NPHP1|ABCC4|CC2D2A|DYNC1I2|TTC30B|LRRC6|WDR19|TTC21B|DYNC2LI1|BBS5|RABL2B|INTU|IFT88|STK36|DNALI1|SHTN1|WDR35|DNAI1|ZMYND10|CBY1|CEP162|NPHP3-ACAD11|FAM161A|TBC1D32|RSPH9|LRGUK|BBS4|SPATA6|ABLIM2|CLASP1|BBIP1|CYFIP1|DCTN1|TMEM67|SFI1|IFT46|CFAP44|IFT172|INPP5K|AHI1|CFAP20|DYX1C1|FGFR1OP|ABLIM1|CFAP43|FGD4|ARL3|CCDC65|RHOQ|PIBF1|IFT20|TMEM17|ARHGEF7|MAP4K4|VSTM5|CCDC88A|NINL|LRRC49|CEP89|IFT140|RFX3|RSPH1|PTPRO|SPAG16|CCDC176|KIT|TMEM107|KIF3B|DZIP1|C9orf117|ARMC9|MINK1|SEPT2|CLUAP1|TTC8|TTLL3|IQCG|CCDC113|RAB1A|RPGRIP1L|IFT81|TTBK2|CEP164|NCKAP1|CFAP46|TNPO1|WDR11|WDR60|LRRC16A|PCM1|EHD3|RILPL1|RAB23|TMEM231|CEP290|MARK4|WDPCP|RSPH4A|WDR90|ACTR2|TCTN2|POC1B|SEPT10|CEP57|MKKS|B9D1|TEKT2|ARHGEF4|GAS8|NPHP4|FGD5|NPHP3|IFT52|DNAH1|RPGR|RAB11A|CEP250|DCTN2|YWHAE|TRAF3IP1|SEPT4|CCDC40
NEGATIVE REGULATION OF HYDROGEN PEROXIDE CATABOLIC PROCESS%GOBP%GO:2000296,0.40923076923076895,0.7448505271608159,-0.795544772827525,-1.0598566589712701,3058,1,HP
CYTOLYSIS IN OTHER ORGANISM%GOBP%GO:0051715,0.23036789297658897,0.6131990870645471,-0.881616674018527,-1.17452509843995,1721,1,ROMO1
POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003084,0.893110367892977,0.965443067117994,-0.555083811204235,-0.7395049200071899,6675,1,ACE
VENOUS BLOOD VESSEL DEVELOPMENT%GOBP%GO:0060841,0.0995310057321522,0.435490881355396,-0.477150445014081,-1.4353853318827399,763,9,NOTCH1|CCBE1|ENG|ACVRL1
RESPONSE TO DIAMIDE%GOBP%GO:0072737,0.606261607853542,0.8488585126532391,-0.556989247311828,-0.9269191768043309,4569,2,DAXX|HSF1
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS%GOBP%GO:1901137,0.0951296647691334,0.424991199957275,-0.14330710941225303,-1.2016517277463798,751,459,DCAKD|GAL3ST1|GPI|PRELP|ATP5F1|COASY|IMPDH2|ACSL4|OGT|PFKFB2|RPN2|ELOVL2|HK1|C1GALT1C1|ADA|PDHA1|VCP|ST6GALNAC4|ACSF3|UBE2G2|B3GLCT|KRTCAP2|GALNT10|ATP5B|HK3|HS3ST5|DCN|ADCY8|CHST7|PIGP|MGAT1|DAD1|NDST1|NPR2|ELOVL1|GALNT18|GCNT2|FUT9|SLC26A2|SDC4|GALNT16|BGN|MUC4|ENO1|ADCY4|TYMP|VCAN|GALNT1|UGCG|IGF1|ATP5O|OGN|CTPS1|TNIP1|PGAM1|HPRT1|GK|B4GALT7|GNPNAT1|CDA|LUM|PRPS1|SDC2|NPR1|RFK|FMOD|GAPDH|B3GALT2|HYAL1|MUC20|UMPS|SYVN1|GMPPB|HACD2|EXT2|GMPS|PIGH|MUC15|LDHA|CMPK2|B3GAT3|TK1|GFPT2|CANT1|B4GALT1|B3GNT5|NDUFAB1|SRD5A3|STOML2|PDHX|B3GALT6|DERL3|DOLK|ATP5H|B4GAT1|ALG6|NANS|MAGT1|CSGALNACT1|DOLPP1|A4GALT|B3GALT1|PGK1|XYLT2|RRM1|ST3GAL5|FASN|UCK1|CRYL1|SERP1|GBGT1|ADCY9|ALDOA|RPN1|RENBP|ALDOC|ATP5G1
PYRIMIDINE NUCLEOTIDE TRANSPORT%GOBP%GO:0006864,0.8538317256162921,0.949296218452153,0.41852770885028995,0.703180589168355,6372,2,SLC25A36|SLC25A33
INTESTINAL CHOLESTEROL ABSORPTION%GOBP%GO:0030299,0.0599397984556995,0.354269451186595,-0.6823391960206321,-1.4937831346079902,457,4,CD36|LDLR
NEGATIVE REGULATION OF HISTONE H3-K27 ACETYLATION%GOBP%GO:1901675,0.3473236817638469,0.704732601530392,0.8274150860167621,1.10324637172239,2614,1,SIN3A
POSITIVE REGULATION OF PROTEIN SUMOYLATION%GOBP%GO:0033235,0.277231777231777,0.652442157557974,0.380757517928928,1.1570869797231298,2030,9,PIAS3|RASD2|HDAC4|RWDD3|PIAS4|UBE2I
RIBOSOMAL SMALL SUBUNIT BIOGENESIS%GOBP%GO:0042274,0.852585258525853,0.949296218452153,0.13433042510079,0.7488643188681899,6199,57,RPS27L|BTRC|MRPS9|DCAF13|HEATR1|TSR1|ERAL1|UTP20|UTP3|BMS1|WDR46|CIRH1A|NOL10|RPS24|UTP6|RPS21|DIEXF|RPS19|LTV1|NOM1|NOP14|EMG1|DHX37|RPS7
TISSUE REMODELING%GOBP%GO:0048771,0.248566214807091,0.629153649220478,-0.25156665793946,-1.1701889244986898,1906,32,ZNF675|TGFB1|LGR4|ACP5|AGT|TGFB3|MEF2C|TPP1|NOTCH2|LRP5|EPHA2|F2R|NOS3|CAV1|ANXA1|ACVRL1
MECHANOSENSORY BEHAVIOR%GOBP%GO:0007638,0.408353609083536,0.7445496113654559,0.42645391094793894,1.02561921032513,3020,5,STRA6|HTT|NRXN1
NEGATIVE REGULATION OF BILE ACID METABOLIC PROCESS%GOBP%GO:1904252,0.686654284956222,0.8861361847538001,-0.522353001230436,-0.8692789245727081,5175,2,FGF19
NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY PROTEIN PHOSPHORYLATION%GOBP%GO:0100002,0.692709030100335,0.888747617562104,-0.656870313189237,-0.875108981031654,5177,1,AKT1
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT%GOBP%GO:0070169,0.5210633946830271,0.806328805769539,0.21248203774711397,0.95096277300991,3821,27,WNT6|NELL1|ACVR1|BMP7|ACVR2A|WNT4|BMPR1A|ATRAID|BMPR2|SLC8A1|ACVR2B|BMPR1B
NEGATIVE REGULATION OF INTERFERON-GAMMA-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060336,0.32246186217780104,0.6906261309079051,-0.46894652138498605,-1.12397532852722,2451,5,NR1H3|PPARG
METHIONINE BIOSYNTHETIC PROCESS%GOBP%GO:0009086,0.4036349372384939,0.7412049911665691,-0.33055228006546994,-1.03557714300337,3086,10,APIP|MTHFD1
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0019886,0.000256706456167373,0.00819882332206558,-0.323007928025622,-1.9992814930145202,1,90,CENPE|AP2A1|KIF2C|KLC1|CAPZA2|AP1S3|KIF3A|HLA-DRB1|HLA-DMA|HLA-DMB|RACGAP1|HLA-DQB2|AP1S2|KIF11|KIF15|HLA-DPA1|HLA-DRA|HLA-DRB5|ACTR10|DCTN4|DYNC1H1|CD74|AP2A2|HLA-DPB1|HLA-DQA2|CTSF|CTSV|RAB7A|CTSS|KLC2|CANX|FCGR2B|CLTA|SH3GL2|SEC23A|CLTC|DYNLL2|FCER1G|KIF4A|LAG3|KIF18A|RILP|SEC13|SEC24A|ARF1|IFI30|KIF2A|AP1B1|DCTN5|CTSD|CTSL|DYNC1I1|SPTBN2|LGMN|KIF22|SAR1B|DCTN3|AP2M1
MESENCHYMAL CELL DEVELOPMENT%GOBP%GO:0014031,0.12234250684752801,0.476255306135618,-0.25906435110964304,-1.3206225237806002,937,44,HEYL|NRG1|SOX11|KBTBD8|SEMA4A|PEF1|JAG1|CORO1C|SOX10|TBX1|SEMA6A|PDCD6|ANXA6|NOTCH1|SNAI2|SEMA3B|SEMA3D|SEMA7A|FN1|SEMA5A|TCOF1|SEMA3E|SEMA3A|SEMA6B
RRNA BASE METHYLATION%GOBP%GO:0070475,0.587295081967213,0.8414799095069009,0.304530098290577,0.883997598998542,4298,8,FDXACB1|WBSCR22|EMG1|METTL15|NOP2|METTL16
REGULATION OF AMYLOID-BETA CLEARANCE%GOBP%GO:1900221,0.0697734964852903,0.37596389138254704,-0.525147290683359,-1.51182555003129,535,8,CLU|ROCK1|LRPAP1|LRP1|APOE|SRF|LDLR
STRIATED MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0014706,0.39284802043422706,0.737280445732591,-0.171487413230143,-1.03489087843748,3075,81,ZFPM2|RYR2|MYH11|CXADR|C3orf58|CAV2|TBX2|MYOM1|MYLK2|MESP1|NOTCH1|SEPN1|MEF2C|S1PR1|VAMP5|PKP2|POPDC2|BMP2|TGFBR3|PDGFRB|IGSF22|MAML1|FKBP1A|CAV1|SIK1|PDGFRA|ENG
POSITIVE REGULATION OF PROTEIN UBIQUITINATION%GOBP%GO:0031398,0.341454032568278,0.701955655133333,-0.174049739553612,-1.07180668432618,2662,88,AMER1|UBE2N|TOPORS|MTA1|RIPK2|UBE2L3|PTEN|SPRTN|RPS2|ADRB2|PRICKLE1|PEF1|NDFIP1|DCUN1D1|CDC20|KDM1A|PDCD6|PAXIP1|NDNL2|MAGEC2|SENP2|UBE2S|DCUN1D3|UBQLN1|BRCA1|STRA13|CTR9|ARRDC3|RNF20|RCHY1|FBXO4|PSMD10|PLK1|RNF40|XIAP|FKBP1A|FANCM|CAV1|FAM107A|SPHK1
NEGATIVE REGULATION OF CYTOKINE PRODUCTION%GOBP%GO:0001818,0.000128849375080531,0.00518555396908895,-0.294934507615373,-2.0512562290858605,0,152,RARA|TRIM25|HERC5|GBA|FURIN|MC1R|TGFB2|OTUD7B|FOXP3|TNF|JAK3|RPS6KA5|RAC1|CD274|TGFB1|MUL1|LILRB1|CLEC4A|RGCC|INHBB|LGR4|NDFIP1|PYCARD|APOD|NCKAP1L|IRAK3|RNF216|TWSG1|CD84|YY1|SARS|KLF4|CD34|PDCD1LG2|SSC5D|FCGR2B|GAS6|TGFB3|TNFAIP3|IKBKE|POMC|GPNMB|INHBA|PTGER4|PTPN6|IFIH1|ARRB1|ISG15|SLC11A1|CARD16|GHRL|SRGN|TNFRSF4|NPLOC4|C10orf54|CEACAM1|BCL3|HFE|FN1|NLRP3|GATA6|AXL|TNFRSF21|BST2|OTUD5|CD200|LGALS9|THBS1|RELB|NAV3|CX3CL1|HAVCR2|DHX58|ABCD1|TLR4|RPS6KA4|KAT5|CMKLR1|ANXA1|UBE2L6|GSTP1|TMSB4X|CHID1|NLRX1|SIRPA|PRNP
POSITIVE REGULATION OF RIBONUCLEOPROTEIN COMPLEX LOCALIZATION%GOBP%GO:2000199,0.847892976588629,0.9492491301138911,-0.5794000882223199,-0.771900039677715,6337,1,RIOK2
POSITIVE REGULATION OF DNA DEMETHYLATION%GOBP%GO:1901537,0.8356624563289441,0.945788393670804,0.36052310729667003,0.7091064075268181,6218,3,OTUD4|USP7
POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002888,0.0418196119559518,0.293009782616793,-0.44933457881185906,-1.5896800319722102,318,14,SYK|HLA-E|ITGB2|SNX4|STX4|FGR|VAMP8|VAMP7|TICAM1|ITGAM
"NEGATIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-DEPENDENT DECAY%GOBP%GO:1900152",0.36227424749163895,0.716544107573036,-0.8170489633877371,-1.0885054042581301,2707,1,TOB1
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0055026,0.18569110089261603,0.559093571852282,0.46556770321477203,1.2851871481567299,1372,7,DKK1|SOX6
NON-CANONICAL WNT SIGNALING PATHWAY VIA MAPK CASCADE%GOBP%GO:0038030,0.7397205052405269,0.9093988038963969,0.399014636371795,0.7848147029183119,5504,3,WNT4|FZD7
"ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I, TAP-DEPENDENT%GOBP%GO:0002479",0.17271540469973903,0.546371269738967,-0.30239846801359105,-1.2696446160928,1322,23,HLA-B|HLA-E|FCGR1B|B2M|TAPBP|FCGR1A|HLA-C|ITGB5|HLA-A|CALR|VAMP8|CD36
PURINE NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0034033,0.715988598082405,0.899551221015245,-0.165215330645612,-0.8325397304666311,5525,42,ACSL5|DCAKD|COASY|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|SLC26A2|HACD2|PDHX|FASN
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048643,0.6364754098360661,0.864060108393727,0.29269562776579805,0.849644201459027,4658,8,DLL1|RBM24|FLOT1|GPC1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM%GOBP%GO:1903565,0.40895205206534707,0.7448505271608159,0.79736435818262,1.0631777809861,3078,1,LZTFL1
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION%GOBP%GO:0010770,0.26015114640707104,0.636108539147718,-0.18854648167537902,-1.13331711512226,2030,80,RREB1|GOLGA4|DHX36|DOCK5|DSCAM|S100A10|DBN1|CAMK2B|ABL1|CALR|NTN1|FLNA|NTRK2|MAP3K13|SEMA7A|DOCK1|SEMA5A|NEDD9|SLIT2|CAPRIN1|ARHGDIA|NGFR
IMP BIOSYNTHETIC PROCESS%GOBP%GO:0006188,0.318865896264445,0.6867397844771489,0.5784953974620141,1.13783217985949,2372,3,PFAS|AMPD2
REGULATION OF COLD-INDUCED THERMOGENESIS%GOBP%GO:0120161,0.004356181934657271,0.0731407797055425,-0.259909321490107,-1.6983755042905,33,112,ADRB2|GATM|STAT6|APC|NOVA2|LGR4|GJA1|DYNC1H1|PER2|IL18|ACHE|PGAM5|KDM1A|LNPEP|NRD1|EBF2|FH|OGT|NOVA1|FOXC2|THRA|CXCR4|PLCL2|PDGFC|NOTCH1|ADIPOR1|ARRDC3|GHRL|LAMA4|G0S2|CEBPB|NR1H3|BSCL2|ALDH1A1|IL15|HCRT|FABP4|CD36|GADD45G|ADIPOR2|NR1D1|ID1|CAV1|TLR4|PCTP|CMKLR1|TFE3|HADH|PLCL1|GRB10
PEPTIDYL-THREONINE DEPHOSPHORYLATION%GOBP%GO:0035970,0.34628975265017703,0.703504080836324,0.29032401290357696,1.09316619617487,2547,16,DUSP4|DUSP18|DUSP10|PDP1|PPM1B|PPM1G|PPP2CB
CELLULAR RESPONSE TO STEROL DEPLETION%GOBP%GO:0071501,0.330451866404715,0.6957352559323989,-0.430240729153186,-1.10669505625656,2522,6,INSIG1
LATE ENDOSOME TO VACUOLE TRANSPORT%GOBP%GO:0045324,0.8061973362326721,0.9337214381011629,0.194176166673472,0.731137667144179,5931,16,CHMP3|TMEM50B|VPS36|LEPROTL1|CHMP1A
REGULATION OF EIF2 ALPHA PHOSPHORYLATION BY DSRNA%GOBP%GO:0060735,0.3884949832775921,0.7352989049211659,-0.8054697838553159,-1.0730791567959699,2903,1,NPM1
POSITIVE REGULATION OF VASCULAR WOUND HEALING%GOBP%GO:0035470,0.162169312169312,0.53309662716112,-0.666055473504043,-1.30063752868759,1225,3,FOXC2|SMOC2
PROSTAGLANDIN CATABOLIC PROCESS%GOBP%GO:1905344,0.9378403506441758,0.9806508984207809,0.531815174239083,0.709103775507291,7060,1,ABHD16A
REGULATION OF VIRAL LIFE CYCLE%GOBP%GO:1903900,0.000771803447388732,0.0191058847417112,-0.292672131515275,-1.89896111795203,5,109,TRIM38|FCN3|CD74|PARP10|TRIM21|TSG101|OASL|OAS1|CD4|TRIM28|PPIA|LARP1|CCNK|CAV2|TOP2A|PPIB|PVRL2|FMR1|PLSCR1|DDX3X|HS3ST5|PDE12|IFIT1|APOBEC3G|TRIM32|ISG15|NUCKS1|RSAD2|APOBEC3C|FCN1|IFI16|TNIP1|GSN|BST2|SNF8|LGALS9|ADARB1|DDB1|IFITM1|BTBD17|ANXA2|LGALS1|IFITM2|IFITM3|MID2|BANF1|APOBEC3F|P4HB
REGULATION OF GRANZYME A PRODUCTION%GOBP%GO:2000511,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0006636,0.0341310317771675,0.26378188727568896,-0.38709746880411106,-1.6030713378691501,260,22,DECR2|DEGS1|SCD|PTGS2|PTGES3|SCD5|CD74|TBXAS1|PTGDS|CBR1|PTGES2|PTGS1|FADS1|PTGES|PTGIS
BLOOD COAGULATION%GOBP%GO:0007596,0.000127323656735421,0.00518555396908895,-0.280127336651214,-2.0432989566023503,0,192,KDM1A|ZFPM2|SH2B1|DGKG|PIK3R6|ITPR2|P2RX4|RAD51C|ITPR3|RAP2B|VAV1|GATA3|WAS|TLN1|PRCP|GP1BA|P2RX5|PLEK|GP1BB|P2RX3|GAS6|AKAP1|ILK|PLSCR1|VWF|PRKAR1A|DOCK6|PTPN6|SH2B3|ARRB1|FCER1G|F3|DGKE|EHD1|PIK3CB|F8|MAPK3|HSPB1|FLNA|MYL12A|RAD51B|DOCK1|GNAQ|HIST2H3A|THBD|PDPN|F2R|PLAUR|GATA6|GNA15|CD36|SERPINE2|A2M|F2RL3|F13A1|COL1A2|COL1A1|VCL|ITPK1|COL3A1|CD59|PLAT|MYH9|HIST2H3C|FIBP|PRKACA|FERMT3|HIST1H3H|ACTB|PDGFRA|TFPI|H3F3B|ACTN1|SERPING1|MYL9|EHD2|VKORC1|FBLN1|PRKCB
MODULATION OF PROGRAMMED CELL DEATH IN OTHER ORGANISM%GOBP%GO:0044531,0.9070802251014259,0.9709695261809209,-0.29216290141823,-0.6396056642237711,6930,4,GAPDH
HORMONE SECRETION%GOBP%GO:0046879,0.0100844916871082,0.12876581868172599,0.40028409867982107,1.7700441521929602,73,26,CRHR1|RAB11FIP5|TBX3|PTPRN|RAB1A|RIMS2|GAL|ADCYAP1|RAB11FIP2|RAB11B|CAMK2G|CYB5R4|SNAP23|PTPRN2
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS%GOBP%GO:2001053,0.542872454448017,0.816132055021207,0.573256898341187,0.9631456054073891,4051,2,PAX8
REGULATION OF LIPID TRANSPORT%GOBP%GO:0032368,0.0851228978007762,0.40376145987147494,-0.25063994873693696,-1.3801136720751501,657,57,TRIAP1|SREBF2|TSPO|AGT|P2RX4|LRP1|APOC1|TNFRSF11A|PRELID1|PLA2R1|POMC|CETP|SPP1|GHRL|NR1H3|APOE|NFKBIA|THBS1|HNRNPK|PPARG|PPARA|NFKB1|ANXA2|C1QTNF1
REGULATION OF MITOCHONDRIAL TRANSCRIPTION%GOBP%GO:1903108,0.655250836120401,0.874775007199212,-0.675948389942656,-0.900525560183585,4897,1,CHCHD10
RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009158,0.502760252365931,0.7970718494574169,-0.34922847830453,-0.9546004718237511,3824,7,HPRT1|NUDT4
ENERGY RESERVE METABOLIC PROCESS%GOBP%GO:0006112,0.17882782926510896,0.55175028994035,-0.27771367661060603,-1.2556880000393202,1369,29,GYG1|PER2|PID1|GAA|PHKG2|PPP1R3C|PGM5|NR1D1|GFPT2|MYC|PYGL|PYGM|GYG2
NATURAL KILLER CELL MEDIATED IMMUNITY%GOBP%GO:0002228,0.163788592360021,0.535221562366675,-0.347110362424328,-1.28999651044695,1251,16,MICA|CEBPG|CORO1A|GZMB|VAMP7|HFE|TUBB4B|LYST
CYANATE CATABOLIC PROCESS%GOBP%GO:0009440,0.959140355531971,0.9889996530704799,-0.34448779631066195,-0.573282780801425,7229,2,TST
NEGATIVE REGULATION OF INTERLEUKIN-1 BETA PRODUCTION%GOBP%GO:0032691,0.00521104742053153,0.0814152418220968,-0.636558710541834,-1.9149244133409,39,9,TNFAIP3|CARD16|GHRL|NLRP3|CX3CL1|GSTP1
MICROTUBULE ANCHORING%GOBP%GO:0034453,0.000676956404007582,0.0170122534245365,0.5442027514540011,2.2055304245075,4,20,BBS4|CLASP1|DCTN1|CCDC68|CLASP2|NINL|GCC2|PCM1|CAMSAP3|SAXO2
REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS%GOBP%GO:0043471,0.5630914826498421,0.8286316188106659,-0.332075578493549,-0.907713785113083,4283,7,PHKG2|INS|PGAM1
T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002286,0.10447175732217599,0.444812304941063,-0.324929147579909,-1.3809397168178899,798,24,F2RL1|IL6|ITGAL|EIF2AK4|LCP1|RORC|LILRB1|GPR183|BATF|RORA|SPN|PTGER4|STAT3|ICAM1|FCER1G|SLC11A1|FOXP1
AMYLOID-BETA CLEARANCE%GOBP%GO:0097242,0.0347712418300654,0.26620723045800804,-0.48921843262755105,-1.63745990030936,265,12,ITGB2|MSR1|LRP1|C3|MARCO|LDLR|ITGAM
CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS%GOBP%GO:0034637,0.17554980595084102,0.548366806412612,-0.25980823554498395,-1.25104936134962,1356,36,GYG1|PER2|PGP|GOT1|SLC2A1|NDST1|PPP1R3C|PGM5|NR1D1|EXT2|B4GALT1|B3GNT5|B4GAT1|CSGALNACT1|GYG2
EPIBOLY INVOLVED IN WOUND HEALING%GOBP%GO:0090505,0.166754201680672,0.53917243184018,-0.320453068603307,-1.2856515734598501,1269,20,RHOA|CYR61|LCP1|PDCD10|MMP12|CD44|TOR1A|ITGA5|DDR1|FLNA|CEACAM1|PDPN|CD151|COL5A1|ACVRL1
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH%GOBP%GO:0048639,0.30256542477762,0.675222663526765,-0.19710888790198497,-1.1053521744903603,2346,61,SYT4|NGF|TBX2|GOLGA4|PPIB|CPNE6|NOTCH1|MEF2C|DSCAM|CPNE5|PIM1|GHRL|NTN1|IGF1|MAP3K13|SEMA7A|TGFBR3|ZP3|SEMA5A|PLAA
HEART TRABECULA MORPHOGENESIS%GOBP%GO:0061384,0.0424750917671736,0.294833299013666,-0.44830279721636207,-1.5860297395686,323,14,NOTCH1|S1PR1|TGFBR3|TEK|FKBP1A|ENG
POSITIVE REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002741,0.802910052910053,0.932964969466025,-0.375592809087901,-0.7334375625425351,6069,3,KARS|F2RL1|TNFRSF14
NEGATIVE REGULATION OF CREATINE TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1905408,0.7501003344481608,0.914180498652832,-0.630183061314513,-0.83955515354745,5606,1,STK39
REGULATION OF 3'-UTR-MEDIATED MRNA STABILIZATION%GOBP%GO:1905868,0.177314384380396,0.548981775981255,0.913101014556683,1.21749699558328,1334,1,RBM24
REGULATION OF T CELL MEDIATED IMMUNITY%GOBP%GO:0002709,0.0130429111777749,0.151381528985436,-0.33472991476768704,-1.7063399998183502,99,44,MALT1|HLA-F|TRAF6|IL1B|FOXP3|CD1D|HLA-B|PVR|LILRB1|HLA-E|B2M|IL18|RIPK3|HLA-C|WAS|HLA-A|FCGR2B|TRAF2|PVRL2|RSAD2|CEACAM1|STX7|HFE|NLRP3|ZP3|FADD|IL1R1|TNFRSF1B
DEFENSE RESPONSE TO VIRUS%GOBP%GO:0051607,0.00012727504136438798,0.00518555396908895,-0.4030490217609,-2.47365856712417,0,86,MX1|SERINC3|MICA|LILRB1|EXOSC4|ATG7|FCN3|BNIP3L|PYCARD|AGBL4|IFIT3|TRIM56|OASL|OAS1|SLFN13|AZU1|OAS2|SLFN11|PLSCR1|PDE12|IFIT2|MB21D1|IFI44L|ABCC9|IFIH1|IFIT1|APOBEC3G|ISG15|IFI6|RSAD2|FLNA|IRF7|APOBEC3C|APOBEC3B|IFI16|SERINC5|TMEM173|RNASE6|BST2|FADD|IFNLR1|DDIT4|RELA|IFITM1|RNASE1|IFITM2|IFITM3|PQBP1|SAMHD1|LYST|APOBEC3F
B CELL CHEMOTAXIS%GOBP%GO:0035754,0.7352709100473441,0.908157084784786,-0.325766755127086,-0.780800750021167,5590,5,GAS6|CYP7B1
AGMATINE BIOSYNTHETIC PROCESS%GOBP%GO:0097055,0.211847522911409,0.5937395205509979,0.895511689457433,1.19404400394131,1594,1,AZIN2
REGULATION OF EXCRETION%GOBP%GO:0044062,0.8718754089778828,0.958455270367256,-0.307696530702224,-0.673612025838355,6661,4,STC1|AGT|NPR1
ENDOSOME ORGANIZATION%GOBP%GO:0007032,0.8333762886597941,0.9446656856458421,-0.134945241289249,-0.759970064607975,6466,62,VPS25|CHMP4A|SNF8|CHMP6|VPS37C|SNX10|SQSTM1|RNF26
PHENYLPROPANOID METABOLIC PROCESS%GOBP%GO:0009698,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION%GOBP%GO:0046856,0.40065235118238596,0.740287621109606,0.27610061290035104,1.0396103778920602,2947,16,MTMR6|INPP5K|INPP5J|MTMR2|INPP5F
D-GLUCURONATE METABOLIC PROCESS%GOBP%GO:0042839,0.525036525434985,0.808245162096538,0.737097485663873,0.982820038463605,3952,1,AKR1A1
REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS%GOBP%GO:1902547,0.45660130718954295,0.7715177634181241,-0.296059654057557,-0.990939382669961,3492,12,ROBO1|KIAA1462|DAB2IP|SEMA6A|DCN|SMOC2|CD63|CCBE1
NEGATIVE REGULATION OF RNA-DIRECTED 5'-3' RNA POLYMERASE ACTIVITY%GOBP%GO:1900260,0.0786622073578595,0.393097409792852,-0.9581495368328191,-1.2764852483326699,587,1,EIF4A2
REGULATION OF ENDOCANNABINOID SIGNALING PATHWAY%GOBP%GO:2000124,0.0758528428093646,0.38531099082072706,-0.9600242611380679,-1.2789828312551101,566,1,MGLL
RESPONSE TO TETRAHYDROFOLATE%GOBP%GO:1904481,0.588617670469621,0.8414799095069009,-0.5632550079202541,-0.9373464044272091,4436,2,SHMT2
POSITIVE REGULATION OF PERIPHERAL TOLERANCE INDUCTION%GOBP%GO:0002660,0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
TRYPTOPHAN CATABOLIC PROCESS TO ACETYL-COA%GOBP%GO:0019442,0.728026755852843,0.906017151800216,-0.640052933392148,-0.852704193050906,5441,1,TDO2
REGULATION OF CELLULAR PH%GOBP%GO:0030641,0.25991189427312805,0.636098664976652,-0.228410063427752,-1.15098551628906,2005,42,PPT1|CLN6|SLC9A5|ATP6V0A1|SLAMF8|GPR89B|TCIRG1|ATP6V0A2|RAB7A|ATP5B|DMXL1|ATP6V0D1|CA2|SLC9A1|SLC9A7|SLC11A1|SLC9A9|ATP6V0E1|ATP6V0E2|RAB20
HISTONE PHOSPHORYLATION%GOBP%GO:0016572,0.41418105703819996,0.7484998347457041,-0.277455924275831,-1.03113364757782,3165,16,RPS6KA4|VRK1|PRKCB
PROTEIN POLYUFMYLATION%GOBP%GO:1990564,0.372397945390646,0.7234654586828599,0.441296514776407,1.06131558741752,2754,5,UFM1|UFC1|DDRGK1
REGULATION OF HEART INDUCTION%GOBP%GO:0090381,0.245211248471675,0.62804240987169,0.548659177929897,1.20542758001094,1804,4,DKK1|ROBO2
REGULATION OF TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE%GOBP%GO:0002652,0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
REGULATION OF ERAD PATHWAY%GOBP%GO:1904292,0.222077244258873,0.604705893155408,-0.27698740905186303,-1.2082696613031,1701,26,UBQLN2|USP25|UBE2G2|UBQLN1|UBXN1|HERPUD1|BCAP31|CAV1|DERL3
AUDITORY RECEPTOR CELL STEREOCILIUM ORGANIZATION%GOBP%GO:0060088,0.10849365266326401,0.45309795582492896,-0.637869285190249,-1.39642920391875,828,4,DFNB31|PDZD7|SOD1
NEUTROPHIL APOPTOTIC PROCESS%GOBP%GO:0001781,0.8707692307692311,0.9574934752519241,-0.5673246581385091,-0.755812667324325,6508,1,IL6
RESPONSE TO MITOTIC CELL CYCLE CHECKPOINT SIGNALING%GOBP%GO:0072414,0.441492894142648,0.7653693162885199,0.7806572562858399,1.04090111494372,3323,1,APAF1
CELLULAR KETONE METABOLIC PROCESS%GOBP%GO:0042180,0.73701214784182,0.9082631287383801,-0.166574409113768,-0.809209500670502,5702,37,NMT1|CACNA1H|KYNU|COQ6|PARK7|DHRS4|COQ7|PDSS1|AFMID|COQ3
ADIPOSE TISSUE DEVELOPMENT%GOBP%GO:0060612,0.0632308947511558,0.36006266503904,0.479387944350966,1.51873341197792,464,10,SH3PXD2B|LRP5L|DYRK1B|ZNF516
REGULATION OF ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0046637,0.133367996880281,0.49478212283475104,-0.278252293753936,-1.3182991968309499,1025,34,MYB|IL12RB1|ZNF683|SMAD7|MALT1|ZC3H12A|RARA|FOXP3|JAK3|NFKBIZ|PRDM1|NCKAP1L|IL18|RUNX1|CCL19|RUNX3|RC3H2|SOCS1|NKAP|CD86|NLRP3|TGFBR2|LGALS9|PNP|ANXA1
REGULATION OF PLASMA MEMBRANE STEROL DISTRIBUTION%GOBP%GO:0097036,0.970248372957896,0.9915747942934481,0.513895015438906,0.6852096617654699,7304,1,ARV1
NEGATIVE REGULATION OF STEROL TRANSPORT%GOBP%GO:0032372,0.0460672686821097,0.30746333312705,-0.700215077483042,-1.5329171758598101,351,4,APOC2|SREBF2|APOC1|NFKB1
CELL COMPETITION IN A MULTICELLULAR ORGANISM%GOBP%GO:0035212,0.47934652676318196,0.7852861637872259,0.760972651080723,1.0146543500027099,3608,1,VPRBP
REGULATION OF CHROMATIN DISASSEMBLY%GOBP%GO:0010848,0.6004013377926422,0.8464076674715391,-0.703573003970004,-0.937328179129011,4487,1,MAP1S
POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION%GOBP%GO:0033601,0.682612201021231,0.885415243771438,0.418914418452165,0.823955225941615,5079,3,RTN4|ZNF703
REGULATION OF CHAPERONE-MEDIATED PROTEIN FOLDING%GOBP%GO:1903644,0.604502028530297,0.848175106515994,-0.401136916912716,-0.8781725638032151,4618,4,PDCD5|SGTB
NEGATIVE REGULATION OF T CELL MIGRATION%GOBP%GO:2000405,0.889935872268028,0.965159112268525,-0.30030371968546504,-0.6574276171475121,6799,4,APOD|CD200
INTERLEUKIN-12 PRODUCTION%GOBP%GO:0032615,0.9714778455823829,0.9915747942934481,-0.331348221670802,-0.5514164274247328,7322,2,CCR7|CCL19
REGULATION OF DIACYLGLYCEROL KINASE ACTIVITY%GOBP%GO:1905687,0.687892976588629,0.8866901918807819,-0.660123511248346,-0.879443021985307,5141,1,MAPT
POSITIVE REGULATION BY ORGANISM OF APOPTOTIC PROCESS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052501,0.16909698996655498,0.541811331682474,-0.913542126157918,-1.21705746644275,1263,1,GAPDH
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE%GOBP%GO:0072594,0.597582926202109,0.8449219534562551,-0.117141925230262,-0.9453498623544109,4647,353,RPS14|RPS4X|STAT3|RPL35A|RPS29|NUP85|DHRS4|RPL10|RPL36A|RPL24|KPNA4|TOMM70A|TIMM21|SRP19|ROMO1|RAN|RBM22|ACOX1|NEURL1B|PIK3R4|NCOA4|VPS25|BCL3|KPNA2|AIP|CAT|RPL35|RPL38|RPS15A|NUP214|PEX16|CHMP4A|SNF8|IMMP1L|TIMM10B|SEC61A1|SEC61B|UBC|TIMM9|SGTB|RPS13|TIMM17B|ACOT2|LAMP2|BCL6|HSP90AA1|NUP98|GOSR2|H2AFY|TOMM5|SRP9|HSPA4|CCDC101|TIMM10|UQCRC2|IPO11|DNAJC19|SRP68|BAD|DNAJC15
REGULATION OF CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION%GOBP%GO:2000690,0.558528428093645,0.8268422944617521,-0.724139832377592,-0.964728132954647,4174,1,PRICKLE1
REGULATION OF EXIT FROM MITOSIS%GOBP%GO:0007096,0.9444808170747679,0.982694945797028,-0.168953288215087,-0.5815699817798521,7212,13,ANLN|RGCC|CDC23|KNTC1|CDCA5
PROTEIN LOCALIZATION TO PHOTORECEPTOR CONNECTING CILIUM%GOBP%GO:1903621,0.40815513348386206,0.7445496113654559,0.7981363034847819,1.06420706588575,3072,1,SPATA7
PITUITARY GLAND DEVELOPMENT%GOBP%GO:0021983,0.10921870775885402,0.45349438410841897,0.592222737112283,1.4242922866472199,807,5,DRD2|HESX1|ADCYAP1
HOMOLOGOUS CHROMOSOME SEGREGATION%GOBP%GO:0045143,0.130334329980973,0.489670335484323,0.358148779944407,1.3485489385493201,958,16,SYCE1|RNF212|C14orf39|CCNB1IP1|SYCP2|CCNE1|P3H4|MSH5|STAG3|BAG6
POSITIVE REGULATION OF FEMALE GONAD DEVELOPMENT%GOBP%GO:2000196,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
PARAXIAL MESODERM DEVELOPMENT%GOBP%GO:0048339,0.41814040728831703,0.75036705317022,0.629114971050455,1.05699437968666,3120,2,SMAD2|LEF1
POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS%GOBP%GO:1904407,0.7782136785667579,0.924704689181848,-0.18503827119997304,-0.766291626462802,5950,22,INSR|CLU|ASS1|KLF2|PTGS2|HBB|IL1B|AKT1|TNF|KLF4|P2RX4|CD36|TLR4|HSP90AA1
STRESS RESPONSE TO ACID CHEMICAL%GOBP%GO:0097532,0.758158662775272,0.917143966125732,-0.4868486352357321,-0.810193981982521,5714,2,VEGFA|KLF2
REGULATION OF OOGENESIS%GOBP%GO:1905879,0.9774898573485149,0.9927322181739301,-0.242855668996217,-0.531661825388557,7468,4,IGF1
TRNA SELENO-MODIFICATION%GOBP%GO:0070329,0.5749767565413729,0.8354258054828342,0.710465372739303,0.947309709425759,4328,1,SEPHS1
PROTEIN MATURATION BY [2FE-2S] CLUSTER TRANSFER%GOBP%GO:0106034,0.598394648829431,0.84557799939374,-0.7047860608734009,-0.9389442621964741,4472,1,CISD3
PROTEIN LOCALIZATION TO CHROMATIN%GOBP%GO:0071168,0.66230537746958,0.879470077229378,-0.223299948637762,-0.8485943338250971,5061,17,PLK1|H2AFY|CCDC101
POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS%GOBP%GO:0061003,0.309145388223033,0.680809181688249,-0.374615214498191,-1.12693426069201,2372,9,DHX36|DBN1|CAMK2B|CAPRIN1
"CD8-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0036037",0.0997354497354497,0.43592472501155494,-0.712584096172935,-1.391496136129,753,3,CLEC4A|HLA-E|TNFSF8
POSITIVE REGULATION OF INTERLEUKIN-12 PRODUCTION%GOBP%GO:0032735,0.606750392464678,0.849040409768275,-0.238253390763771,-0.885441853538505,4637,16,PLCB1|CCL19|TLR2|IRF5|LGALS9|TLR4
"PROTEIN IMPORT INTO PEROXISOME MATRIX, DOCKING%GOBP%GO:0016560",0.329167232712947,0.695646600584197,0.5028936835242329,1.1048788397573401,2422,4,PEX5|PEX13|PEX5L
GLUTAMINYL-TRNAGLN BIOSYNTHESIS VIA TRANSAMIDATION%GOBP%GO:0070681,0.974334856221446,0.9920717971974051,0.273925093442295,0.5387783335132371,7250,3,GATB|QRSL1
GLUCOSAMINE CATABOLIC PROCESS%GOBP%GO:0006043,0.528804930332262,0.8106205307336929,0.5794522324847089,0.9735545666804771,3946,2,GNPDA2
POSITIVE REGULATION OF MACROPHAGE MIGRATION%GOBP%GO:1905523,0.019526165061182,0.192628124925339,-0.5983524557890949,-1.72257297454355,149,8,P2RX4|CSF1|THBS1|RARRES2|CMKLR1
CELLULAR RESPONSE TO HEPARIN%GOBP%GO:0071504,0.485622144584789,0.7872939093021379,0.49569192251072497,0.974967516083228,3613,3,SFRP1|EGR1
MITOTIC RECOMBINATION%GOBP%GO:0006312,0.9824100813861909,0.993436724391485,-0.140333489608366,-0.509528152880988,7483,15,XRCC3
REGULATION OF NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0051960,0.35167494586676895,0.710514673478047,-0.126183058606613,-1.04517606741544,2760,422,FZD4|AMIGO1|TLR2|NUMB|P2RX4|RAPGEF1|PLXND1|SEMA6A|BHLHE40|GDI1|MED1|SYT4|NGF|COBL|FES|BAG5|SRPX2|BRINP3|THY1|CLSTN2|HES1|ARSB|CDK5RAP2|RAB29|GOLGA4|FMR1|DHX36|CPNE6|CXCR4|EFNA1|NOTCH1|MEF2C|ARHGAP44|SMARCD3|CHRD|PRKD1|DSCAM|DAAM2|ZFHX3|TRIM32|DBN1|NGEF|SNW1|CPNE5|CAMK2B|GHRL|ABL1|CALR|NTN1|IL1RAP|TYMP|NTRK2|SEMA3B|ARHGEF15|SEMA3D|NSMF|MAP3K13|STX1B|SEMA7A|GPRC5B|CSF1|GPER1|SDC2|SCARF1|EDNRB|APOE|RAP1A|SLC45A3|SERPINE2|TNFRSF21|BMP2|ADRA2C|SEMA5A|NBL1|SEMA3E|EPHA4|COL3A1|SLIT2|ID1|ZSWIM6|CX3CL1|CAMK2A|SCN1B|LDLR|FKBP4|SEMA3A|SEMA6B|PLAA|CFL1|RTN4RL1|YAP1|KIAA2022|ID4|WNT3|ADGRG1|MYLIP|S100A9|TIAM1|STYXL1|MARK2|CAPRIN1|DTX1|ADGRL1|ARHGDIA|ARF6|TNFRSF1B|NGFR|SERPINF1|EIF4G1|LGI4
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT%GOBP%GO:0032388,0.5525131765008361,0.822813841873357,-0.13607034965555498,-0.9516710772931141,4297,157,SPAG5|ZC3H12A|EDEM1|SCP2|FYN|PDZK1|OAZ1|GSK3B|ABLIM3|USP36|IL1B|PDCD10|RAC2|SEC16A|SYK|UBE2L3|CPSF6|RAB21|PCNT|TGFB1|NPEPPS|CEMIP|PSEN1|HYAL2|DHX9|FIS1|DYNC1H1|SREBF2|CAMK1|JUP|ECT2|ITGB2|NCBP2|TRIM28|SNX4|MICALL2|FGR|HCLS1|ATG13|PDCD5|GAS6|PRR5L|RAB29|BAG3|BCAS3|EHD1|MSN|ANP32B|HUWE1|CEP131|RAPGEF3|FLNA|HRAS|IGF1|VAMP8|VAMP7|RBM22|TMEM173|RBM27|B3GAT3|BCAP31|ITGAM|DAB2|ANXA2|RHOU|SAR1B|EMD|EHD2|PRNP
LIVER DEVELOPMENT%GOBP%GO:0001889,0.6373791036643511,0.864837230317578,0.191172262695571,0.8749243715742729,4678,29,NPHP3-ACAD11|MET|SULF2|WNT4|NF1|NPHP3|PKD2|CITED2|CCDC40|RARB|PROX1
D-GLUCONATE METABOLIC PROCESS%GOBP%GO:0019521,0.11933110367892999,0.47098246139817795,-0.9386854874283191,-1.250554460932,891,1,IDNK
LYSOSOMAL MEMBRANE ORGANIZATION%GOBP%GO:0097212,0.534732368176385,0.8126734651160049,0.731087340097045,0.9748063203163481,4025,1,LAPTM4B
MICROTUBULE CYTOSKELETON ORGANIZATION%GOBP%GO:0000226,0.00873301912947047,0.11710731158150699,0.177439469656741,1.44319729804151,62,340,LRRC6|EFHC1|AURKC|DNALI1|DNAI1|ZMYND10|WDR73|CNTROB|RSPH9|LRGUK|BBS4|EML4|CLASP1|LLGL1|ULK4|DCTN1|CFAP44|KATNAL1|KATNB1|DYX1C1|STARD9|CFAP43|FSD1|CDC14B|NCOR1|CCDC65|CCDC68|PARD3|PIBF1|NAV1|CLASP2|TACC2|CCDC88A|NINL|LRRC49|MAP9|TRIM36|RSPH1|SPAG16|KATNAL2|STMN3|KIF3B|C9orf117|NDEL1|TTLL3|IQCG|GCC2|BRCA2|HTT|TTBK2|SPIRE2|TUBA1C|MAP7|CFAP46|CDK5R1|CCDC88C|PCM1|DCLK2|GPSM2|MARK4|CAMSAP3|RSPH4A|SAXO2|TUBE1|TUBGCP3|DST|STMN2|CDC14A|TPPP3|GAS8|CUL7|PKD2|MTCL1|DNAH1|MAP2|BRSK1|ARHGEF10|TUBB3|CEP68|RNF19A|RAB11A|CEP250|DCTN2|PSRC1|CCDC40|PLK3|BBS2|MZT1|STMN4|DYNLT1|TUBGCP6|GOLGA8B|MAP4|DOCK7|HAUS2|EZR|OBSL1|SPAST|CHP1|TNKS|CUL9|TAOK1|ZW10|CENPJ
REGULATION OF DOPAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051584,0.085698837523655,0.405270830448101,0.615332529130557,1.4798712039278101,633,5,DRD2|RAB3B|DRD4|SNCA
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT%GOBP%GO:1903650,0.804394426580922,0.932964969466025,0.4475875379101189,0.7520048540552751,6003,2,SNX12|SNX3
POSITIVE REGULATION OF ANDROGEN RECEPTOR ACTIVITY%GOBP%GO:2000825,0.782539682539683,0.9264826767614871,-0.383864563802801,-0.7495902030331201,5915,3,BUD31|TAF1|PARK7
REGULATION OF MAST CELL PROLIFERATION%GOBP%GO:0070666,0.575919732441472,0.8359897176758009,-0.7165857962064399,-0.954664342943622,4304,1,LYN
DNA DUPLEX UNWINDING%GOBP%GO:0032508,0.326552901023891,0.6941148928066879,0.25228814166834695,1.0991982910595701,2391,25,WRN|MRE11A|ERCC3|PIF1|MCM9|DDX1|RTEL1|POT1
MYELINATION%GOBP%GO:0042552,0.8921662779530799,0.965443067117994,0.135978666844695,0.6892180241997479,6502,41,NFASC|PARD3|TENM4|MARVELD1|EIF2B4|NF1|EPB41L3|SCN2A|ZSCAN26|ARHGEF10|SKI
GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0006688,0.225696715949235,0.6083599141984499,-0.318049017714049,-1.20866393367875,1724,17,UGCG|B3GALT2|A4GALT|B3GALT1|ST3GAL5
RESPONSE TO GONADOTROPIN%GOBP%GO:0034698,0.251276010993325,0.631873138618812,-0.5538272967548671,-1.21244372330172,1919,4,NOTCH1|NSMF|TGFBR3
CELL ADHESION%GOBP%GO:0007155,0.00012653422750854098,0.00518555396908895,-0.235021195876763,-1.97676809700675,0,472,PCDHA11|CDH23|SORBS1|PCDHGA11|PCDHGA7|IL1B|PCDHA5|TGFB2|ROCK1|PNN|LRRC4C|SPECC1L|CD1D|ROBO1|RAC2|ZYX|CXCL12|TNF|SYK|THBS4|PVR|RCC2|CSTA|CCL4|ATP2A2|NLGN3|MTSS1|PCDHA4|PCDHA6|ITGB3BP|BGLAP|RAC1|ITGB1|ATP2C1|ROPN1B|ECM2|PCDHA7|NRXN3|PPAP2B|CD44|ITGA9|ITGBL1|ACTG1|FGFRL1|PCDHB12|CLEC4A|APC|CCL11|CDH6|ADAM9|PSEN1|CLDN7|PARD3B|ITGAX|SELPLG|CD209|TSTA3|LAMC1|CTTN|FBLN5|PEAK1|CORO1A|FEZ1|PCDHGC5|ACHE|EPHB3|CD84|ITGA10|PCDHB8|PCDH18|JUP|CTNND1|ITGA11|ITGB2|CXADR|SERPINB8|AMIGO1|NID2|CLDN5|MICALL2|PCDHGA5|CDHR2|TRIP6|HMCN1|CLDN11|CD34|TOR1A|PCDHB6|RAP2B|SYNJ2BP|PCDHB11|BCAM|CYP1B1|SPN|FES|SMAD6|ITGB5|TLN1|GP1BA|PCDHB13|PLEK|SRPX2|PCDHGB1|GAS6|CTNND2|PCDHB7|POSTN|CLDN10|THY1|CASK|DDR2|PCDHGB7|ERBB2IP|PCDHB15|ADGRE2|VTN|ILK|TAOK2|PVRL2|TNXB|ITGA5|LILRB2|CLEC4M|EFNA1|TENM2|PCDH12|VWF|CBLN1|GPNMB|COL14A1|MPZL2|MAGI1|COL5A3|PCDHGA12|S1PR1|GNE|PCDH1|IL32|MADCAM1|ICAM1|DSCAM|PKP2|CD63|PCDHGB5|SIGLEC1|CD93|CTGF|CDH8|FBN1|PXN|MSN|PIK3CB|PCDHGA6|SPP1|PCDHB2|RHOD|HSPB1|PPFIA1|DDR1|FLNA|PPFIBP1|MMRN1|WISP1|VCAM1|TNIP1|MYL12A|CDH11|CDH5|KIRREL3|PCDHB16|CCL2|CEACAM1|ROBO4|CYFIP2|PCDH8|CCR1|FN1|CDH7|PCDHGB4|DLC1|APBA1|MPZ|NOV|NRP2|HCK|CD151|TGFBR2|CD200|THBS1|TEK|TIMM10B|SEMA5A|VCL|DLG3|NINJ2|NME2|DCHS1|ITGA8|COL3A1|LYVE1|CX3CL1|STAB1|MYH9|FIBP|EPHB4|S100A8|FERMT3|TGFBI|ADGRG1|CERCAM|ITGAM|S100A9|TIAM1|ACTB|PDGFRA|COL16A1|NRXN2|PODXL2|COL5A1|THEMIS2|TINAGL1|ADGRV1|IGFBP7|ADGRL1|FOLR2|ACTN1|AOC3|MYL9|ARF6|COL13A1|VMP1|LOXL2|ITGB4|ICAM2|CADM3|SIRPA|FBLIM1|EMP2|ADGRB1
REGULATION OF ASTROCYTE DIFFERENTIATION%GOBP%GO:0048710,0.0682352941176471,0.37295204814599103,-0.4526750440714,-1.51514575719596,521,12,HES1|NOTCH1|SERPINE2|BMP2|EPHA4|LDLR
AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM%GOBP%GO:0032291,0.895320530159589,0.966332331854337,0.233866519580805,0.6455822499584829,6619,7,TENM4|CNTNAP1|MYRF|CLU|PTEN|SOX10|PLP1
SREBP SIGNALING PATHWAY%GOBP%GO:0032933,0.330451866404715,0.6957352559323989,-0.430240729153186,-1.10669505625656,2522,6,INSIG1
REGULATION OF STORE-OPERATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901339,0.0585218306154656,0.34912825533959807,-0.639532318552835,-1.5328369335723897,444,5,CRACR2A|STIM2|TMEM110|STIM1|UBQLN1
PROTEIN MATURATION BY [4FE-4S] CLUSTER TRANSFER%GOBP%GO:0106035,0.24051472539135102,0.624461333747413,-0.712930796801765,-1.18643085208427,1812,2,YAE1D1|ORAOV1
REGULATION OF CELL-CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033632,0.15690376569037698,0.5264612444015649,-0.42385515480201297,-1.3278828697541698,1199,10,ADA|PIEZO1|DPP4|FERMT3
DETECTION OF TRIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0042495,0.19779782435659302,0.574790273586514,-0.7349324510614829,-1.22304512310149,1490,2,TLR1|TLR2
HYDROXYLYSINE BIOSYNTHETIC PROCESS%GOBP%GO:0046947,0.9461640211640211,0.983395403194261,-0.303904268225433,-0.5934480116241241,7152,3,PLOD3|PLOD1|PLOD2
NATURAL KILLER CELL DIFFERENTIATION%GOBP%GO:0001779,0.698553054662379,0.892206463710019,0.49638819961400604,0.833996266626289,5213,2,PIK3CD|PTPRC
DENDRITIC SPINE MAINTENANCE%GOBP%GO:0097062,0.47332699877833595,0.7835158707411,0.376736577501319,0.974828037075328,3486,6,PICK1|MTMR2|IGF1R
REELIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038026,0.314700349368449,0.684226399618077,0.58040145582883,1.14158117173733,2341,3,VLDLR|LRP8|RELN
PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE%GOBP%GO:0051204,0.811767768810206,0.935317461845028,-0.24867250749223802,-0.71589334475648,6235,8,BAD
MANNOPROTEIN METABOLIC PROCESS%GOBP%GO:0006056,0.528561872909699,0.8105400040230321,-0.73869651521835,-0.984121129764213,3950,1,MPI
REGULATION OF LIPID TRANSPORT BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072368,0.638933547695606,0.865463150027443,0.530082110517012,0.8906063873402719,4768,2,NCOR1
"NEGATIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, INITIATION%GOBP%GO:2000143",0.829996073812328,0.9435818887072471,-0.323664037941874,-0.7085682369946601,6341,4,ZNF451|HEY2|HMGB1|THRA
NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002323,0.41031746031746,0.7452892204937491,-0.540995914606493,-1.05642790637558,3101,3,CORO1A|VAMP7
CELL-MATRIX ADHESION%GOBP%GO:0007160,0.00448315614192391,0.0743264309917645,-0.288137395751724,-1.73193919722357,34,80,RAC1|ITGB1|ECM2|CD44|ITGBL1|ADAM9|CTTN|FBLN5|PEAK1|ITGA10|ITGA11|ITGB2|TRIP6|CD34|BCAM|ITGB5|THY1|VTN|ILK|TAOK2|MADCAM1|CD63|SIGLEC1|RHOD|PPFIA1|DDR1|VCAM1|DLC1|TIMM10B|VCL|ITGA8|COL3A1|LYVE1|TIAM1|ACTN1|COL13A1|ITGB4|EMP2
REGULATION OF DENSE CORE GRANULE EXOCYTOSIS%GOBP%GO:1905413,0.744587594634082,0.9112137767014771,0.6273709748566391,0.8365145420136809,5605,1,BAIAP3
INDUCTION OF HOST IMMUNE RESPONSE BY VIRUS%GOBP%GO:0046730,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
POSITIVE REGULATION OF ATF6-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903893,0.648160446274406,0.8702993441108309,0.674018526687252,0.8987127580923929,4879,1,ATF6
PLATELET AGGREGATION%GOBP%GO:0070527,0.000261062524474612,0.00819882332206558,-0.488088067701421,-2.2069000600010296,1,29,RAP2B|TLN1|GP1BA|PLEK|GAS6|ILK|PIK3CB|HSPB1|FLNA|MYL12A|VCL|MYH9|FIBP|FERMT3|ACTB|PDGFRA|ACTN1|MYL9
BINDING OF SPERM TO ZONA PELLUCIDA%GOBP%GO:0007339,0.0439989586045301,0.299062021084573,-0.5538025049629429,-1.5943199013458003,337,8,ZP3|POMZP3|B4GALT1|ALDOA
DNA DEPHOSPHORYLATION%GOBP%GO:0098502,0.7257936507936509,0.904327817490601,-0.406633908209077,-0.7940529617919609,5486,3,APEX1
NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0019184,0.863574537540805,0.9531672929044319,0.19992878892006402,0.6795190670012479,6348,12,BDH2|GSS|GCLM|MGST2|GCLC
POSITIVE REGULATION OF LYMPHOTOXIN A PRODUCTION%GOBP%GO:0032761,0.16936454849498303,0.541894568706611,-0.9133215703573,-1.21676363315775,1265,1,CD86
PRE-MIRNA EXPORT FROM NUCLEUS%GOBP%GO:0035281,0.815733616343858,0.9368364474725541,-0.45267514802243397,-0.753323834508112,6148,2,RAN
MITOCHONDRIAL TYROSYL-TRNA AMINOACYLATION%GOBP%GO:0070184,0.590118209589587,0.8414799095069009,0.702580502867225,0.9367962993793578,4442,1,YARS2
NEGATIVE REGULATION OF CELL-CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033633,0.926417850976225,0.9790847380319629,0.53743934715483,0.7166028512047241,6974,1,WNK1
ASYMMETRIC NEUROBLAST DIVISION%GOBP%GO:0055059,0.38509569702728397,0.7322123809952751,0.406533073219101,1.0519282210419,2836,6,TEAD3|RAB10|DOCK7
RESPONSE TO DNA DAMAGE CHECKPOINT SIGNALING%GOBP%GO:0072423,0.19751146037983,0.574572493132077,-0.491821993815623,-1.2650986581054298,1507,6,EME1|SMC1A|MUS81
SEMAPHORIN-PLEXIN SIGNALING PATHWAY INVOLVED IN AXON GUIDANCE%GOBP%GO:1902287,0.246655746655747,0.6280519349499749,0.393080892179611,1.19453657748624,1806,9,PLXNB1|PLXNB2|PLXNA4|PLXNB3|PLXNC1|PLXNA2|PLXNA1
CATECHOLAMINE TRANSPORT%GOBP%GO:0051937,0.138432278223068,0.503641687094073,0.617879005128771,1.35750648827587,1018,4,SLC6A2|SNCA|SLC18A2|VIP
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0032881,0.5069371727748689,0.7984959595134692,-0.214942140741476,-0.9599556404143621,3872,28,PHKG2|INS|PPP1R3E|IRS1|CLTC|IGF1|NFKB1|PDGFB|PPP1R3F
ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0055009,0.47505969753250205,0.784986345464663,-0.608811733538369,-1.01316008092392,3580,2,ENG
REGULATION OF MEMBRANE INVAGINATION%GOBP%GO:1905153,0.248461034708579,0.629072495919397,-0.4647998367074361,-1.1955903906295,1896,6,NCKAP1L|CD300A|ITGAM
REGULATION OF ACYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0050812,0.932650273224044,0.9800972968717879,0.207636272414651,0.6027317736732171,6826,8,PDPR|PDP1|GSTZ1
NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING%GOBP%GO:0010944,0.712568306010929,0.89739524968595,0.273631021127852,0.7943029836667711,5215,8,DACH1|MAD2L2|MUC1|BHLHE41|CREB1
NEGATIVE REGULATION OF CARDIAC CHAMBER FORMATION%GOBP%GO:1901211,0.37404682274247497,0.724682900261831,-0.8110939567710631,-1.0805719055633,2795,1,TBX2
MODULATION BY HOST OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:0044789,0.9626926196269259,0.9908714970603191,0.234131498085208,0.5630849102652641,7121,5,ZNF502|SMC3|PC|VAPA
POSITIVE REGULATION OF INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE ACTIVITY%GOBP%GO:0010925,0.37618729096990006,0.7266197487465021,-0.810101455668284,-1.07924965578083,2811,1,PLEK
NEGATIVE REGULATION OF MITOCHONDRIAL FISSION%GOBP%GO:0090258,0.6444680286548161,0.8688307429995409,-0.5412186379928321,-0.900674360987478,4857,2,PINK1|MAPT
REGULATION OF ZINC ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071580,0.710718554920972,0.8964108318214721,0.643857520952801,0.858497126656157,5350,1,SLC30A1
REGULATION OF MEMBRANE REPOLARIZATION%GOBP%GO:0060306,0.284945530909568,0.658064835782089,-0.28052677920329905,-1.1428681183621499,2170,21,FLNA|KCNQ1|CAV1|SCN1B|KCNH2|KCNE4
REGULATION OF BLOOD VESSEL BRANCHING%GOBP%GO:1905553,0.7953177257525079,0.929656485793048,-0.606473312748125,-0.807968075410657,5944,1,SIRT6
POSITIVE REGULATION OF VIRAL ENTRY INTO HOST CELL%GOBP%GO:0046598,0.0563880126182965,0.34436604181231795,-0.5653511282933029,-1.54536209771607,428,7,TRIM38|CD74|CD4|LGALS9|LGALS1|P4HB
BONE MORPHOGENESIS%GOBP%GO:0060349,0.245441613862667,0.6280519349499749,-0.233934861355272,-1.16458061648494,1897,40,COL20A1|COCH|SFRP4|ANXA6|VWA1|COL14A1|MEF2C|FREM1|COMP|LRP5|COL12A1|COL6A3|COL21A1|COL6A1|ANXA2|COL6A2|COL13A1
OLFACTORY BULB INTERNEURON DIFFERENTIATION%GOBP%GO:0021889,0.206271965396053,0.5861479099046041,0.520651376067808,1.25216357376201,1525,5,SLIT1|ROBO2|SLIT3
POSITIVE REGULATION OF SECRETION BY CELL%GOBP%GO:1903532,0.0256278831368529,0.22470485454905398,-0.197114037782958,-1.42318133694817,199,184,HLA-E|RGCC|INHBB|ADAM9|HYAL2|DHX9|TLR1|PYCARD|TNFRSF14|GSDMD|ADAM8|CCL19|ACHE|TSG101|ITGB2|RAB9A|SNX4|HGS|STX4|TLR2|PPIA|FGR|RAB7A|CD34|WLS|RAB27B|SYT4|GPI|GATA3|HYAL3|MYOM1|TGFB3|INS|CACNA1H|CASP1|DHX36|ADCY8|INHBA|PTGER4|IFIH1|SDC4|CACNA1G|OSM|SPP1|GHRL|TNFRSF4|IGF1|VAMP8|FCN1|VAMP7|STX1B|IL33|GPER1|HFE|F2R|GAPDH|NLRP3|SNF8|LGALS9|ZP3|DTNBP1|ATP6AP1|HAVCR2|ANG|TLR4|ITGAM|ADRBK1|CSF1R|C1QTNF4|CACNA1I|CD14|BAD|C1QTNF1
RESPONSE TO NERVE GROWTH FACTOR%GOBP%GO:1990089,0.167301879353397,0.5396740210307,-0.32551960120927803,-1.28609757607699,1272,19,MAGI2|NTRK1|AKT1|MAPT|RAB35|RAPGEF1|NGF|SH3GL2|EHD1|NTRK2|RAP1A|TMEM108
MITOCHONDRIAL RESPIRATORY CHAIN SUPERCOMPLEX ASSEMBLY%GOBP%GO:0097250,0.7836296099761211,0.927080511528825,-0.47085149775029206,-0.783572187072128,5906,2,COX7A1
VOCAL LEARNING%GOBP%GO:0042297,0.408353609083536,0.7445496113654559,0.42645391094793894,1.02561921032513,3020,5,STRA6|HTT|NRXN1
ACTION POTENTIAL PROPAGATION%GOBP%GO:0098870,0.4345980366144871,0.762034923704788,-0.6251986164020601,-1.04043047446869,3275,2,SCN1B
RAC PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0016601,0.254612063325919,0.6334469481869079,-0.309135529169979,-1.1747905005711399,1945,17,ELMO1|RHOG|AIF1|TIAM1|EPS8|DBNL
POSITIVE REGULATION OF COMPLEMENT ACTIVATION%GOBP%GO:0045917,0.0464214046822743,0.308253762206553,-0.975077194530216,-1.29903695295591,346,1,PHB
DNA DOUBLE-STRAND BREAK PROCESSING%GOBP%GO:0000729,0.741728782529096,0.909955740610127,-0.19126257283230602,-0.792068079033959,5671,22,SETMAR|NBN|EXO1|SLX1B|SLX1A|RNF138|BRCA1|KAT5
DNA-TEMPLATED TRANSCRIPTIONAL OPEN COMPLEX FORMATION%GOBP%GO:0001112,0.7546891747052521,0.9158903477696649,0.47097227858632507,0.7912942377173879,5632,2,ERCC3|GTF2E1
NEGATIVE REGULATION OF CATECHOLAMINE METABOLIC PROCESS%GOBP%GO:0045914,0.14778455823826,0.514965886850433,-0.7655913978494621,-1.2740665132909,1113,2,ITGB2|ITGAM
EPINEPHRINE TRANSPORT%GOBP%GO:0048241,0.764510559171205,0.9191113740914171,0.6177767975297751,0.82372200111806,5755,1,VIP
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0045954,0.997112102914151,0.9992843289779879,-0.118351377099104,-0.429714665633402,7595,15,PVR|MICA|NCR3|HLA-E|PVRL2|HFE
CELLULAR RESPONSE TO COLD%GOBP%GO:0070417,0.782745923198317,0.926660607197607,-0.311243084025869,-0.7459902817630809,5951,5,EIF2AK4|DNAJC3|NFKBIA
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS%GOBP%GO:0090026,0.00326797385620915,0.0586994740050756,-0.5785844392540129,-1.93657629197038,24,12,MOSPD2|CREB3|PLA2G7|CCR1|AIF1|SERPINE1|LGMN
GLOMERULAR EPITHELIUM DEVELOPMENT%GOBP%GO:0072010,0.646535947712418,0.8697778704754799,-0.252739916617553,-0.8459441653619109,4945,12,NUP93|IQGAP1|JAG1|BASP1|CD34|KLF15|MYO1E
PANCREATIC A CELL DIFFERENTIATION%GOBP%GO:0003310,0.0787621198034268,0.39324071934415206,0.9613475959417729,1.28182730181126,592,1,INSM1
REGULATION OF NON-CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:2000050,0.438244853737811,0.764056534661743,0.27366969014812803,1.0094546760222,3235,15,DKK1|SFRP1|NPHP3-ACAD11
DIVALENT INORGANIC CATION TRANSPORT%GOBP%GO:0072511,0.318773353949233,0.6867397844771489,-0.154817904748569,-1.07675156107427,2473,152,ITPR2|CCDC109B|ATP2A1|P2RX4|ERO1L|SLC39A3|ITPR3|SLC8B1|PMPCA|GRIN3A|GAS6|ANXA6|SLC39A8|CACNA1H|STIM1|ATP2A3|GRIN1|SLC41A1|JPH4|CACNA2D4|SLC39A11|CALCRL|SLC11A1|CACNA1G|MRS2|NALCN|SLC35G1|SLC24A3|CACNA1E|F2R|CCR1|TMCO1|GRIN2C|GRIN2D|FKBP1A|CAMK2A|SLC3A2|SLC30A5|CAV1|STOML2|MAGT1|CACNA1I|PHB|ATP2B2|NIPAL3
POSITIVE REGULATION OF CENTRAL TOLERANCE INDUCTION%GOBP%GO:0002648,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
NON-MOTILE CILIUM ASSEMBLY%GOBP%GO:1905515,0.00421481985044188,0.0715180651057048,0.46584938806262105,1.9495575698047798,30,22,IFT88|TBC1D32|BBS4|DCTN1|PIBF1|TMEM17|CEP89|TMEM107|TTC8|PCM1
REGULATION OF ENDORIBONUCLEASE ACTIVITY%GOBP%GO:0060699,0.118253968253968,0.4691344446484289,-0.697911503231874,-1.3628442808685,893,3,TMBIM6|NPM1
LENS MORPHOGENESIS IN CAMERA-TYPE EYE%GOBP%GO:0002089,0.9414538310412571,0.9817036201910501,-0.23179107145884498,-0.59622907708624,7187,6,SOX11|SHROOM2|EPHA2
MULTI-ORGANISM MEMBRANE FUSION%GOBP%GO:0044800,0.0152471083070452,0.166148433567765,-0.6387085015856769,-1.7458812062854,115,7,HYAL2|CD4|PPIA|GAS6|PVRL2|CXCR4
GAMMA-AMINOBUTYRIC ACID SIGNALING PATHWAY%GOBP%GO:0007214,0.49043029727161697,0.7903790206418191,0.370772050945191,0.9593944740447421,3612,6,GABRA3|GABRB3|GABBR1|GABRG2
REGULATION OF GOLGI TO PLASMA MEMBRANE CFTR PROTEIN TRANSPORT%GOBP%GO:0042999,0.9954841280382521,0.9984987368688449,0.5025363917071021,0.6700644696706529,7494,1,GOPC
EPITHELIAL CELL PROLIFERATION INVOLVED IN RENAL TUBULE MORPHOGENESIS%GOBP%GO:2001013,0.30459007694348605,0.6770795415897549,-0.682326992004411,-1.13550122698513,2295,2,MTSS1|MEF2C
NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS%GOBP%GO:0045347,0.632354894408288,0.8622831952487159,0.6811314512571679,0.908196883239146,4760,1,HDAC2
SPHINGOLIPID METABOLIC PROCESS%GOBP%GO:0006665,0.263493683807579,0.638950455433329,-0.17471192245514802,-1.1227263452299598,2064,104,CERS6|SPTSSB|SUMF1|CERS4|PPAP2C|ELOVL2|NSMAF|GLTP|GLA|ELOVL1|PRKD1|ORMDL3|NEU4|SMPDL3A|UGCG|STS|B3GALT2|PPP2CA|HACD2|PPAP2A|SPTSSA|HEXB|SMPD1|A4GALT|B3GALT1|ALDH3B1|SPHK1|ST3GAL5|TEX2
MICROGLIAL CELL ACTIVATION%GOBP%GO:0001774,0.0612298071912454,0.35631208031004796,-0.51293212251581,-1.5430253761765802,469,9,MAPT|TNF|ITGB2|AZU1|AIF1|CX3CL1|ITGAM
ATTACHMENT OF GPI ANCHOR TO PROTEIN%GOBP%GO:0016255,0.395547712773178,0.7377402989373809,0.40279421477748795,1.04225370507185,2913,6,PGAP1|PIGU|PIGT|PIGS
TRANSCRIPTION-DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY%GOBP%GO:0000972,0.8132285527177471,0.9356336309698571,-0.279280696293435,-0.718385185205905,6208,6,NUP98
"MAPK PHOSPHATASE EXPORT FROM NUCLEUS, LEPTOMYCIN B SENSITIVE%GOBP%GO:0045209",0.339088856421836,0.700817490478225,0.8308337009263341,1.10780463342083,2552,1,DUSP16
PHOSPHOLIPID TRANSPORT%GOBP%GO:0015914,0.176789868182993,0.548551967663807,-0.236455029969839,-1.23957410859264,1367,48,PRELID2|APOC2|TNFAIP8L3|ATP10A|PLTP|ATP11C|TRIAP1|APOC1|ATP11B|PRELID1|ABCG1|ATP8B1|CETP|APOE|ATP8B4|LDLR|PCTP|ATP8A2|NPC2|OSBPL5|ABCC1
MEMBRANE PROTEIN PROTEOLYSIS%GOBP%GO:0033619,0.353102189781022,0.7116618431256551,-0.231966857863945,-1.07901838083993,2708,32,MYH9|RELA|NFKB1|PARL|BACE2|NGFR
CYCLOOXYGENASE PATHWAY%GOBP%GO:0019371,0.007191422594142259,0.102315552754816,-0.597007950523581,-1.8703479753068302,54,10,TBXAS1|PTGDS|CBR1|PTGES2|PTGS1|PTGES|PTGIS
CELLULAR RESPONSE TO SALT STRESS%GOBP%GO:0071472,0.85678590215676,0.949296218452153,-0.286454886388705,-0.6865777020502739,6514,5,SLC12A6|CAPN3|AKR1B1|AQP1|ZFP36L1
PROTEIN UBIQUITINATION%GOBP%GO:0016567,0.9332773814519509,0.9800972968717879,0.0963303305326291,0.7983919385220299,6671,388,FBXO2|WSB1|ASB1|DET1|TRIM17|FBXO44|LMO7|SPSB2|FBXL8|TNFAIP1|KLHL2|RMND5A|PARK2|KLHL13|NHLRC3|CUL4A|FANCL|UBE2V1|RNF103|FBXW9|RPS27A|BARD1|RNF167|MARCH5|UBA6|MARCH8|FBXL2|BMI1|UBE4B|HIST1H2BH|TRIM36|BLMH|RNF112|FBXO30|CBFB|COMMD3-BMI1|TPP2|ZNRF1|MARCH1|ARRB2|FBXO41|TRIM13|TRIP12|BTRC|PEX2|ANAPC4|ANAPC1|NFE2L2|PPIL2|MARCH2|PEX5|UBE3D|CDC16|SH3RF3|FBXO31|PEX13|NEDD4|TRIM27|RBCK1|CUL7|KLHL25|FBXO11|UBE2G1|FBXO18|WDR61|ANKIB1|BFAR|RUSC1|SH3RF1|PDZRN3|FBXL5|RNF19A|RFFL|FBXO7|CBL|UVSSA|DDB2|TRIM5|TSSC1|PELI2|STUB1|CDC34|UBE2Q2|SPSB4|RNF135|FBXL3|MARCH7|BCL2|NEDD4L|PCGF3|UBE2K|UBR5|BCL10|TNKS|CUL9|TSPAN17|PCGF1|FBXL16|RNF185|UBE2E3|FBXO9|PELI1|RNF41|ZNF598|UNKL|PEX10|BIRC6|FBXW8|RC3H1|TNKS2|DCAF15|UBOX5|BIRC2|KLHL42|ZNRF3|FBXL12|KCTD10|UHRF2|RNF146|RNF19B|RNF126|WWP2|SIRT1|SHPRH|ANAPC16|VCPIP1|HACE1|GAN|LONRF1|RNF2|VIMP|MKRN1
TRAM-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035668,0.839496248660236,0.946999344326828,0.426785490596831,0.717054728707903,6265,2,PRKCE
NEURON PROJECTION ORGANIZATION%GOBP%GO:0106027,0.46783016410523603,0.780769690730001,-0.214819575310278,-0.9900117215159581,3591,31,FYN|APP|GSK3B|MAP1A|ARC|CDC42|PTEN|DOCK10|PSEN1|EPHB3|ATP1A3|CTNND2|INS|ARF1|ABCD1|LGMN|PRNP
POSITIVE REGULATION OF GLIAL CELL PROLIFERATION%GOBP%GO:0060252,0.49986849026828006,0.7951717058944731,-0.397572801643489,-0.9529061416661501,3800,5,IL6|IL1B|TNF|PRKCH
TELOMERE-TELOMERASE COMPLEX ASSEMBLY%GOBP%GO:1905324,0.31810333377606603,0.6867397844771489,0.8410895456550509,1.12147941851615,2394,1,ACD
POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM%GOBP%GO:1905332,0.7007328990228011,0.8931369333627571,0.246202009571874,0.8101557894042041,5162,11,PAX8|AHI1
MAMMALIAN OOGENESIS STAGE%GOBP%GO:0022605,0.410101822079314,0.7452892204937491,0.6322029225255029,1.0621825368663,3060,2,BMPR1B|ZNF830
MINERALOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0006705,0.8400106128946669,0.947127979312948,-0.436633553784025,-0.72662805645161,6331,2,CACNA1H
MITOCHONDRIAL FUSION%GOBP%GO:0008053,0.874830116879587,0.9601737401844279,0.177943082460639,0.67001472128912,6436,16,MFF|MIEF2|MFN1|GDAP1|BAX
"BASE-EXCISION REPAIR, AP SITE FORMATION VIA DEAMINATED BASE REMOVAL%GOBP%GO:0097510",0.956036658254748,0.987705745312345,0.522331274812528,0.6964582753116191,7197,1,UNG
VASCULAR PROCESS IN CIRCULATORY SYSTEM%GOBP%GO:0003018,0.0172591447707367,0.17886204374062303,-0.291855230798593,-1.63057628459044,133,60,ADRB2|DOCK4|TGFB1|ADM|C2CD4A|PER2|EDNRA|PIK3C2A|C2CD4B|AGT|SOD2|AZU1|INS|DOCK5|TBXA2R|PDE2A|HMOX1|SOD1|CEACAM1|GPER1|NPR1|F2R|EDNRB|SMTNL1|NOS3|CHGA|TEK|SLIT2|CAV1|SERPINF2|PTPRJ
PROTEIN K48-LINKED DEUBIQUITINATION%GOBP%GO:0071108,0.876683666797437,0.960725750963158,-0.16460579912783,-0.6816754432522629,6703,22,OTUD5|USP20|OTUB1
CELLULAR LIPID CATABOLIC PROCESS%GOBP%GO:0044242,0.6001029336078231,0.8464076674715391,-0.139515702987341,-0.9234784532444459,4663,120,PNPLA2|FABP3|GLA|DAGLB|PLA2G4D|PLA2G4A|NEU4|SMPDL3A|ACAD10|ACOX1|PLA2G4C|APOE|FABP4|FUCA1|DAGLA|SLC27A4|SRD5A3|LPIN3|ABCD1|MGLL|SMPD1|PNPLA4|HADH|LPIN2|SPHK1|ETFB
COPII-COATED VESICLE BUDDING%GOBP%GO:0090114,0.000644496004124775,0.0163600882996276,-0.35226677173065796,-2.00042429568822,4,64,TFG|PDCD6|TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|F8|SEC13|SEC24A|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|TRAPPC2|GOSR2|PPP6C|SAR1B|GRIA1
NUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0009164,0.289817232375979,0.6622817015650171,-0.27051881641944797,-1.13579530040249,2219,23,ADA|APOBEC3G|TYMP|APOBEC3C|HPRT1|CDA|NUDT18|ENPP4|PNP
POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1905065,0.39439768542872206,0.7376723208557521,-0.437183008902993,-1.04784425014394,2998,5,SOD2|GPER1|ENG
PHYTOSPHINGOSINE METABOLIC PROCESS%GOBP%GO:0006671,0.738743525036525,0.9089185613230608,0.6300727834142039,0.8401170391624481,5561,1,ACER3
REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE%GOBP%GO:1902816,0.683681672025724,0.885415243771438,0.504595559402384,0.8477856907658801,5102,2,TTBK2|MAP1A
GASTRIC ACID SECRETION%GOBP%GO:0001696,0.24521739130434803,0.62804240987169,-0.8741729157476841,-1.16460822507142,1832,1,GHRL
"DNA REPLICATION, SYNTHESIS OF RNA PRIMER%GOBP%GO:0006269",0.43902116402116403,0.7648463599152641,-0.529458565957193,-1.03389838859249,3318,3,POLA1
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY%GOBP%GO:0002717,0.997112102914151,0.9992843289779879,-0.118351377099104,-0.429714665633402,7595,15,PVR|MICA|NCR3|HLA-E|PVRL2|HFE
POSITIVE REGULATION OF NEURON DEATH%GOBP%GO:1901216,0.657179818887452,0.8757990649871321,-0.179534117943475,-0.864507020428001,5079,36,EIF2S1|DDIT4|TLR4|ITGAM|PRNP
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 SIGNALING PATHWAY%GOBP%GO:0036323,0.536321070234114,0.8132910857498922,-0.734836788707543,-0.9789790472768279,4008,1,FLT1
DICARBOXYLIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0043650,0.541265295495965,0.815622645995152,-0.32020639493554903,-0.9218293947913789,4157,8,GOT1|KYNU|HAAO|MTHFD1
POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR DIFFUSION TRAPPING%GOBP%GO:0098970,0.36134111578661604,0.716154857259883,0.41465152790657794,1.07293519971004,2661,6,CACNG7|CACNG4|DLG4
SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION%GOBP%GO:0000393,0.0764071541294056,0.38654270614299796,-0.618435164739336,-1.48227108158892,580,5,ISY1|PRPF19
PROTEIN LOCALIZATION TO CILIARY MEMBRANE%GOBP%GO:1903441,0.5834460373275631,0.8391117257440741,0.320353534641469,0.88432733358626,4313,7,BBIP1|ARL3|TULP3
REPLACEMENT OSSIFICATION%GOBP%GO:0036075,0.5327292399242629,0.812079525085925,0.333797178261632,0.9214381509512339,3938,7,FOXC1|DLX5|INPPL1
REGULATION OF MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0051900,0.141239260609216,0.506729504971671,-0.47016114029140993,-1.3535281189387,1084,8,GNB2L1|KDR|DCN|IFI6|ABCD1
MAST CELL CHEMOTAXIS%GOBP%GO:0002551,0.9082010582010579,0.971434329578746,-0.32661603808816303,-0.6377983418916279,6865,3,CHGA
POSITIVE REGULATION OF HYDROGEN SULFIDE BIOSYNTHETIC PROCESS%GOBP%GO:1904828,0.252224731039979,0.632257972333528,0.8759373621526251,1.16794427970024,1898,1,SP1
PROTEIN DEPOLYMERIZATION%GOBP%GO:0051261,0.707087847539486,0.894949003158309,-0.182248962307673,-0.8240423654404331,5416,29,KIF18B|MICAL2|KIF18A|CKAP5|KIF2A|CFL2|CFL1
FOREBRAIN NEURON DEVELOPMENT%GOBP%GO:0021884,0.0172695131901006,0.17886204374062303,0.5427447483666811,1.7194520497089498,126,10,DRD2|FGFR2|SLIT1|ROBO2|SLIT3|ATP7A
POSITIVE REGULATION OF IP-10 PRODUCTION%GOBP%GO:0071660,0.5820162040111571,0.8387093286508721,0.707432730480812,0.9432660901771429,4381,1,MAVS
ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE%GOBP%GO:0002251,0.00705882352941177,0.10112558518216999,-0.558655081562402,-1.8698708657589,53,12,RPL39|HIST1H2BE|HIST1H2BC|IFNLR1|HIST1H2BG|HIST2H2BE|HIST1H2BK|HIST1H2BJ
REGULATION OF GRANZYME B PRODUCTION%GOBP%GO:0071661,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
REGULATION OF MICROVILLUS ORGANIZATION%GOBP%GO:0032530,0.111593059936909,0.458583787993832,-0.51433366554425,-1.4059081383827998,848,7,CDHR2|ATP8B1|PLD1|RAP1GAP
REGULATION OF METALLOENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902962,0.553054662379421,0.8231366946320219,0.568374926363169,0.9549432621474008,4127,2,PICALM|SORL1
REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS%GOBP%GO:2000668,0.07335251046025099,0.381170670138757,-0.479980996625504,-1.5037178054948,560,10,CXCL12|LILRB1|LYN|CCL19|GAS6|AXL|LGALS9
NEGATIVE REGULATION OF T-HELPER 2 CELL DIFFERENTIATION%GOBP%GO:0045629,0.78309896524277,0.926798202062739,-0.47136240775703897,-0.7844224230240071,5902,2,ANXA1
NEGATIVE REGULATION OF INTEGRIN ACTIVATION%GOBP%GO:0033624,0.108516847970284,0.45309795582492896,-0.7951788218594059,-1.32330471822828,817,2,PTGER4
MRNA 5'-SPLICE SITE RECOGNITION%GOBP%GO:0000395,0.10410094637224,0.44419145940290994,-0.520628792057364,-1.42311558597924,791,7,SFSWAP|PRPF39|SNRPC|SRSF12|PSIP1|SRSF10|SRSF1
REGULATION OF RNA BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:1905255,0.254715719063545,0.6334469481869079,-0.8692655491839442,-1.15807043448032,1903,1,NUCKS1
NUCLEAR EXPORT%GOBP%GO:0051168,0.558692042406438,0.8268422944617521,-0.137534915596787,-0.9486205156563209,4373,145,MAGOH|CPSF2|NUP188|SRSF5|RITA1|SRSF1|U2AF1|HNRNPA2B1|XPO6|NCBP1|NUP85|CALR|GLE1|NUP37|NMD3|RAN|NXF1|NUP160|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
GERM-LINE STEM CELL DIVISION%GOBP%GO:0042078,0.6683490503386911,0.8811119744196031,0.6641486546096159,0.885552615446897,5031,1,ING2
POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS%GOBP%GO:0033034,0.0800261951538965,0.39656308137153795,-0.574902793023958,-1.4788048544822299,610,6,CDKN2A|MEF2C|PIK3CB|ANXA1
POSITIVE REGULATION OF CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1905312,0.696374020454244,0.891033775225429,0.65113586237318,0.8682018128528359,5242,1,SEMA3C
BIOTIN TRANSPORT%GOBP%GO:0015878,0.0633550272280515,0.36006266503904,0.9685707984119979,1.2914584676579701,476,1,SLC5A6
INTRA-GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:0006891,0.357068062827225,0.714610778064251,-0.240197434641209,-1.07274860760888,2727,28,COG2|COPA|VTI1A|NAPG|TRAPPC10|VTI1B|GOLGA3|RAB6B|GOLGA5|NAPA|COPB2|COPB1|COG1|GOSR2|COPG1|COPZ2
SMOOTH MUSCLE ADAPTATION%GOBP%GO:0014805,0.25022902761418697,0.6308569567945129,-0.554301748587001,-1.21348239754051,1911,4,HMOX1|NOS3
THORAX AND ANTERIOR ABDOMEN DETERMINATION%GOBP%GO:0007356,0.47812709030100303,0.7850984235874658,-0.7638950154389059,-1.01769158257471,3573,1,BASP1
PLACENTA BLOOD VESSEL DEVELOPMENT%GOBP%GO:0060674,0.044115650875526,0.29942594022524,0.619511223546212,1.6030217028596698,324,6,ITGB8|PKD1|PKD2|HEY2|HEY1|RBPJ
NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION%GOBP%GO:0048712,0.10046822742474901,0.436743648703065,-0.9474525805028671,-1.26223433401049,750,1,LDLR
"POSITIVE REGULATION OF SYNAPTIC TRANSMISSION, GLUTAMATERGIC%GOBP%GO:0051968",0.0134255492270138,0.15397542988128501,0.49434889337276205,1.77687334499874,98,14,CACNG7|RAB3GAP1|ADCYAP1|TSHZ3|CACNG4|PTK2B|NLGN2|SHANK2|NRXN1|CACNG2|RELN|SHANK1
"REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, WAKEFULNESS%GOBP%GO:0010840",0.519856554655333,0.8050637202008951,0.7395787384208199,0.986128454212472,3913,1,CRH
GLUTAMATE HOMEOSTASIS%GOBP%GO:0090461,0.17665028556249202,0.548551967663807,0.913597265108072,1.21815867873305,1329,1,KCTD7
REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0061178,0.303982126429229,0.676707700393746,-0.285416347536432,-1.12765336211923,2312,19,PIM3|STX4|STXBP4|CDK16|ADCY8|LRP5|NR1D1|EFNA5
DOLICHOL METABOLIC PROCESS%GOBP%GO:0019348,0.47768616673210296,0.7850984235874658,-0.446023757727112,-0.9764392413814891,3649,4,DPM2|SRD5A3
RESPONSE TO CARBON MONOXIDE%GOBP%GO:0034465,0.386903971310931,0.733589579210772,0.808061314512572,1.07744072888122,2912,1,KCNMA1
REGULATION OF HEART LOOPING%GOBP%GO:1901207,0.707529474812433,0.89516234575314,0.491826653729733,0.8263322805756809,5280,2,RNF207
RESPONSE TO HYDROPEROXIDE%GOBP%GO:0033194,0.95201359832636,0.9858647066977451,-0.18057730375979003,-0.565725120037827,7280,10,STX4|PRKD1|GPX3
GENE SILENCING%GOBP%GO:0016458,0.324843210034558,0.692794968343412,-0.16508146546929903,-1.07725522676753,2537,111,HNRNPA2B1|STAT3|PIWIL1|NCBP1|HIST1H4I|CLP1|TNRC6C|RAN|HDAC5|PPM1D|HIST2H3A|SIRT4|HIST2H4A|HIST2H3C|HIST1H3H|POLE3|HIST2H4B|RRP8|RBM4|H3F3B|WTIP|SUV39H1
TUBULIN COMPLEX ASSEMBLY%GOBP%GO:0007021,0.236059968437664,0.6213269448976729,-0.509105281526819,-1.22022821359044,1794,5,ARL2|VBP1
PROTEIN TRANS-AUTOPHOSPHORYLATION%GOBP%GO:0036290,0.0101672240802676,0.129323654372743,-0.9944309660344071,-1.32482082371408,75,1,ERN1
POSITIVE REGULATION OF PLATELET AGGREGATION%GOBP%GO:1901731,0.16264261077208803,0.5337939510496529,-0.756623693743417,-1.25914281961473,1225,2,PDPN
ICOSANOID TRANSPORT%GOBP%GO:0071715,0.0776685776685777,0.390053430594062,0.48740801955367996,1.48118801778582,568,9,ABCC4|DRD2|SLCO3A1|DRD4
EXOCYTIC PROCESS%GOBP%GO:0140029,0.337643863959653,0.699636319850872,-0.217941089211168,-1.08496000365455,2610,40,SYK|EXOC8|RAB8A|VTI1B|SYNJ1|SEPT5|YKT6|SNAP47|SYTL2|STX4|PLEK|CPLX2|VPS18|STX11|STX1B|RAB3C|STX3|PRRT2|SNPH
POSITIVE REGULATION OF PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000758,0.44233786610878706,0.7655509876295971,-0.23682267257211603,-1.00648968193094,3382,24,BRCA1|ARRB1|MAPK3|WBP2|KAT7|RPS6KA4
FUMARATE METABOLIC PROCESS%GOBP%GO:0006106,0.39933110367893004,0.7392155506460759,-0.800176444640494,-1.06602715795613,2984,1,FH
BASAL DENDRITE DEVELOPMENT%GOBP%GO:0150018,0.366931216931217,0.721190111986457,-0.559477320966464,-1.09251740890342,2773,3,TAOK2|SEMA3A
JNK CASCADE%GOBP%GO:0007254,0.8735063864853729,0.9593566726297671,0.12972924651666098,0.7272583411047691,6359,58,ADORA2B|MAP3K5|TNFRSF19|UBE2V1|RPS27A|MINK1|RIPK1|GPS2
REGULATION OF CARDIAC CHAMBER MORPHOGENESIS%GOBP%GO:1901219,0.37404682274247497,0.724682900261831,-0.8110939567710631,-1.0805719055633,2795,1,TBX2
CYSTEINE CATABOLIC PROCESS%GOBP%GO:0009093,0.9815909701693091,0.993436724391485,0.265542511996752,0.522290785019545,7304,3,CSAD|CBS
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0051058,0.452729511561089,0.769943206592495,0.20855123840534304,1.00057860494739,3308,34,ARHGAP12|MET|TNFAIP1|EPHB2|ARAP3|STMN3|SPRY2
UREA METABOLIC PROCESS%GOBP%GO:0019627,0.04235102484050499,0.294833299013666,0.622996982319417,1.61204130856172,311,6,SLC25A15|ASL|CAD|NAGS
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030949,0.137673565627456,0.50219949963275,-0.41777026162656106,-1.35255369889184,1050,11,HIF1A|ITGB3|IL1B|FLT1|VTN|ITGA5|PRKCB|GRB10
ISOQUINOLINE ALKALOID METABOLIC PROCESS%GOBP%GO:0033076,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
SYNAPTONEMAL COMPLEX ASSEMBLY%GOBP%GO:0007130,0.505139302136868,0.797902257689198,0.34166238412979605,0.9431498406358321,3734,7,SYCE1|SYCP2|P3H4|STAG3|BAG6
REGULATION OF SUMO TRANSFERASE ACTIVITY%GOBP%GO:1903182,0.8192323017665029,0.9389789016232991,0.589655932951037,0.786226622630894,6167,1,UBE2I
REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1903789,0.11870174060986802,0.469617660353565,-0.630287321458115,-1.37983070039393,906,4,STK39|PER2|ARL6IP1|ARL6IP5
ADAPTIVE IMMUNE RESPONSE%GOBP%GO:0002250,0.00012659830358273202,0.00518555396908895,-0.37843599337464207,-2.3952369665527202,0,97,IGHV1OR15-1|IGKV3-11|MICA|IGHV5-51|SLA2|HLA-E|GPR183|IGHV1-24|CD74|JAG1|IL18|IGHV3-49|BATF|IGHG4|EXO1|IGLL5|CTSS|RORA|SPN|MYO1G|TNFRSF11A|EBI3|FCGR2B|IGKV2-28|IGHV4-4|IGHV4-61|JCHAIN|MEF2C|STAT3|IL18BP|RNF168|C1QB|IGHV1-3|FCER1G|SLC11A1|IGHV3-43|IGHV3-73|C1QA|C1QC|CTSH|HFE|IGKV2D-28|TNFRSF21|ZP3|IGHV3-15|EXOSC3|TLR4|C1S|IGHV1-18|CTSL|CD55|IGHG2|IGHA1|C1R|EMP2
NEGATIVE REGULATION OF MRNA 3'-END PROCESSING%GOBP%GO:0031441,0.39994788952579496,0.739629257825225,-0.34502577067259604,-1.03792197098415,3069,9,CTR9|RNF20|RNF40
POSITIVE REGULATION OF NEURONAL ACTION POTENTIAL%GOBP%GO:1904457,0.7178595317725749,0.900060477413567,-0.6446846052051171,-0.8588746920357678,5365,1,GBA
RESPONSE TO GLUCOSE%GOBP%GO:0009749,0.395508826583593,0.7377402989373809,-0.21305168102849498,-1.04266578372261,3046,38,GPER1|THBS1|PDK3|TRA2B|EIF2B2|PRKACA|EIF2B3|ERN1
REGULATION OF ANGIOTENSIN METABOLIC PROCESS%GOBP%GO:0060177,0.893110367892977,0.965443067117994,-0.555083811204235,-0.7395049200071899,6675,1,ACE
POSITIVE REGULATION OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR SECRETION%GOBP%GO:1900168,0.47749196141479106,0.7850984235874658,0.602023097862262,1.0114765347571602,3563,2,DRD2
UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0043162,0.626438284518828,0.858842084733938,-0.224507988136628,-0.871174490727832,4790,18,TSG101|UBAP1|MVB12B|VPS25|SNF8|PLAA
PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006164,0.0412397540983607,0.291121725329476,-0.21235302923904104,-1.4232160470399198,321,127,ATP5J|DCAKD|GPI|ATP5F1|COASY|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|ADA|PDHA1|ACSF3|ATP5B|HK3|ADCY8|NPR2|ELOVL1|SLC26A2|ENO1|ADCY4|ATP5O|PGAM1|HPRT1|PRPS1|NPR1|GAPDH|HACD2|GMPS|LDHA|STOML2|PDHX|ATP5H|PGK1|FASN|ADCY9|ALDOA|ALDOC|ATP5G1|MTHFD1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS%GOBP%GO:1900181,0.8113488624052009,0.935317461845028,0.19692334562919003,0.7263690471375409,5990,15,POLR1A|SUFU|RAB23|SIN3A|CHP1|MFHAS1|CABP1|FLCN
NEGATIVE REGULATION OF EPITHELIUM REGENERATION%GOBP%GO:1905042,0.11581883384247599,0.46559625491895207,0.9433722981914421,1.25785966771947,871,1,DUSP10
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR%GOBP%GO:1902166,0.17278447823807,0.546371269738967,-0.362831291862246,-1.28364405244138,1317,14,CD44|CD74|TRIAP1|KDM1A|TAF9B|TAF9|ZNF385A|AK6
NEGATIVE REGULATION OF THE FORCE OF HEART CONTRACTION%GOBP%GO:0098736,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL%GOBP%GO:0086011,0.37983786610878706,0.729249457747391,-0.33727190615784997,-1.05662885436782,2904,10,ATP1B1|KCNN2|KCNQ1|KCNH2|KCNE4
POSITIVE REGULATION OF REPRODUCTIVE PROCESS%GOBP%GO:2000243,0.250748990491077,0.631479765290861,-0.27305275503662696,-1.17716868729255,1924,25,YTHDC2|INHBB|PLCB1|HYAL3|CACNA1H|CDC25C|INHBA|SMURF2|ZP3|POMZP3|SYDE1|LHFPL2
MESENCHYMAL-EPITHELIAL CELL SIGNALING%GOBP%GO:0060638,0.42180602006689005,0.7527812076478722,-0.78970004411116,-1.05207007691894,3152,1,HGF
NEGATIVE REGULATION OF CELL MOTILITY%GOBP%GO:2000146,0.000128024580719498,0.00518555396908895,-0.27932109128641697,-2.00442363241536,0,178,PLCB1|KANK1|JAG1|CORO1C|SLAMF8|ANGPT2|JUP|FRMD5|DAB2IP|KLF4|LRP1|ADORA3|SYNJ2BP|MCTP1|SFRP2|CYP1B1|GATA3|WAS|ARHGDIB|THY1|CCDC125|DCN|PODN|NOTCH1|PHLDB2|PTGER4|MEF2C|CHRD|ADIPOR1|TBXA2R|MMRN2|MECP2|DPEP1|CALR|HMOX1|RNF20|SULF1|RECK|HDAC5|LDLRAD4|MEOX2|STARD13|CCL2|CD300A|CORO1B|APOE|MITF|DLC1|NOV|BST2|CD200|THBS1|SPINT2|VCL|NBL1|AIF1|COL3A1|ADARB1|SLIT2|NAV3|CX3CL1|NR2F2|IGFBP5|SERPINE1|PPARG|IFITM1|KIAA2022|ADGRG1|EVL|MCC|NF2|TIMP1|ENG|ACVRL1|FBLN1|PTPRJ|CARD10|ADGRB1
SPONTANEOUS NEUROTRANSMITTER SECRETION%GOBP%GO:0061669,0.254748306548014,0.6334469481869079,0.874834583149537,1.16647387270074,1917,1,RIMS2
RETINAL CONE CELL DEVELOPMENT%GOBP%GO:0046549,0.38312549747943797,0.730480369014206,-0.6471464019851121,-1.0769550993936898,2887,2,TOPORS|THY1
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I ASSEMBLY%GOBP%GO:0032981,0.00025779840164991,0.00819882332206558,-0.373034000171323,-2.11835556727173,1,64,COA1|NDUFAF5|TIMMDC1|NDUFC2|NDUFAF4|NDUFV2|NDUFB8|NDUFS4|C17orf89|NDUFB5|OXA1L|NDUFA11|NDUFA9|NDUFA7|NDUFA3|NDUFB6|NDUFAF3|NDUFB9|NDUFB10|TIMM21|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|NDUFB4|NDUFA12|NDUFA2|NDUFAB1|NDUFA1|NDUFB11|NDUFV1|NDUFAF2|NDUFS3|NDUFA8|NDUFS8|NDUFV3
INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002437,0.8590215675960021,0.950698755744279,-0.28568240551518104,-0.684726212799356,6531,5,PNMA1|TNF|HMGB2
ENDODERMAL CELL FATE SPECIFICATION%GOBP%GO:0001714,0.453244147157191,0.769943206592495,-0.7742059991177771,-1.03142828864815,3387,1,SOX17
REGULATION OF NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0030811,0.255380200860832,0.634085683126873,-0.264800335340476,-1.16789884644773,1957,27,OGT|CBFA2T3|PFKFB2|PFKFB3|INS|JMJD8|IGF1|PGAM1|PPARA
FLAVIN ADENINE DINUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0072389,0.3458193979933111,0.7033175795366851,-0.82399647110719,-1.09776115273542,2584,1,VCP
VITAMIN D3 METABOLIC PROCESS%GOBP%GO:0070640,0.0358613361668216,0.268987198588135,0.9820247022496691,1.30939743305183,269,1,CYP27B1
CELLULAR RESPONSE TO LEUCINE%GOBP%GO:0071233,0.562892259414226,0.828541380171721,-0.28893010292581606,-0.905180295402364,4304,10,RPTOR|RRAGD
MEIOTIC CHROMOSOME SEPARATION%GOBP%GO:0051307,0.0297237135000655,0.244735657013286,-0.48132427374244197,-1.65681148954162,226,13,ESPL1|TOP2A|STRA13|EME1|RMI1|FANCM|MUS81
CEREBELLAR CORTEX DEVELOPMENT%GOBP%GO:0021695,0.48443223443223404,0.7872939093021379,-0.26301452984520896,-0.977463834059788,3702,16,CBLN1|CLP1|AARS|CEND1|TRNP1
REGULATION OF APOPTOTIC DNA FRAGMENTATION%GOBP%GO:1902510,0.485622144584789,0.7872939093021379,0.495752866139059,0.97508738500834,3613,3,BAX|DFFA
POSITIVE REGULATION OF INTERLEUKIN-1 SECRETION%GOBP%GO:0050716,0.36163810022242604,0.716154857259883,-0.28198249834175604,-1.07160235275663,2763,17,CCL3|RIPK2|PYCARD|GSDMD|CCL19|CASP1|NLRP3|LGALS9|TLR4
POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY%GOBP%GO:0120034,0.828014919187733,0.943061234519578,0.13120529057059402,0.778775819700367,5993,72,EPS8L1|RLTPR|ZMYND10|BBS4|RHOQ|CCDC88A|AGRN|NDEL1|HTT|NCKAP1|MARK4|HAP1|CDC42EP3|WASH1|C15orf62|TAPT1|KCTD17|NRP1
TYPE B PANCREATIC CELL APOPTOTIC PROCESS%GOBP%GO:0097050,0.6544748124330121,0.874775007199212,0.521599373559309,0.876354294000828,4884,2,CAPN10
NEGATIVE REGULATION OF GLUCOSE IMPORT%GOBP%GO:0046325,0.0766701735928459,0.386878103852997,-0.61773365210844,-1.4805896896735902,582,5,PID1|PEA15|GRB10
REGULATION OF NK T CELL PROLIFERATION%GOBP%GO:0051140,0.988712711636657,0.996050320421843,0.254053159810301,0.499692585101557,7357,3,ZBTB7B|RASAL3
REGULATION OF DETERMINATION OF DORSAL IDENTITY%GOBP%GO:2000015,0.28751339764201506,0.6604035198820261,0.6898560883688021,1.1590472993846002,2145,2,ACVR1|DDIT3
KUPFFER'S VESICLE DEVELOPMENT%GOBP%GO:0070121,0.11555319431531401,0.46493596964429496,0.943537715041906,1.2580802287693897,869,1,AHI1
POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY%GOBP%GO:0045880,0.0822905331882481,0.39895009371504003,0.42853543808051103,1.4565086030599999,604,12,STK36|SFRP1|EVC|KIF7|ULK3|GAS8
RIBOSOME LOCALIZATION%GOBP%GO:0033750,0.8147178211339531,0.936266868072958,-0.2087683187362,-0.7186210378400941,6221,13,BCCIP|PA2G4|ZNF593|NPM1|NMD3|RAN
PURINE RIBONUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0034035,0.41859200869801594,0.75036705317022,0.272067900355464,1.02442587768875,3079,16,PAPSS1|SULT1C4|SULT4A1|TPST1|SLC35B2|BPNT1|SLC35B3|SLC26A1|PAPSS2
MONOUNSATURATED FATTY ACID METABOLIC PROCESS%GOBP%GO:1903964,0.539814814814815,0.8150125944159129,-0.48472208347088397,-0.946539376711609,4080,3,SCD|SCD5
CELL CHEMOTAXIS TO VASCULAR ENDOTHELIAL GROWTH FACTOR%GOBP%GO:0090667,0.0883251427812459,0.41066453213355103,0.9567159241288051,1.2756515924133798,664,1,GAB1
NEGATIVE REGULATION OF TELOMERIC LOOP DISASSEMBLY%GOBP%GO:1904534,0.976253648182542,0.9926773910205121,-0.323533956058063,-0.53841223985011,7358,2,TERF2
INTERLEUKIN-2 PRODUCTION%GOBP%GO:0032623,0.0215940321947389,0.202961842892776,-0.746098273865329,-1.63336508405193,164,4,IL18|SLC11A1|STOML2|PNP
DNA REPLICATION PROOFREADING%GOBP%GO:0045004,0.269036879808968,0.643036619584462,-0.697987317342156,-1.16156251262145,2027,2,POLE|POLD1
REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0000820,0.518005912389143,0.8047799431921201,0.48089880746544006,0.9458712044915809,3854,3,ATCAY|ATP2B4
CENTROSOME CYCLE%GOBP%GO:0007098,0.9783591288864542,0.992937328049893,0.10044899033631499,0.589881398639829,7142,69,CNTROB|BBS4|DCTN1|KIF3B|NDEL1|BRCA2|PCM1|TUBE1|PKD2|BRSK1|ARHGEF10|CEP68|CEP250
POSITIVE REGULATION OF IMMUNE RESPONSE%GOBP%GO:0050778,0.00012688745083111298,0.00518555396908895,-0.2759936312386789,-2.30685912076821,0,448,RAF1|CD1D|RIPK2|HLA-DMB|SPPL3|CREBBP|CDC42|TIFA|PAK2|MUC3A|BTNL9|SYK|IGHV2-26|HLA-DQB2|NFATC2|HLA-B|PVR|COLEC11|RPS6KA5|RAC1|WIPF3|EIF2B5|IGHV1OR15-1|CD274|IGKV3-11|NFKBIZ|PRKCH|MNDA|HLA-DPA1|MICA|TGFB1|ACTG1|NCR3|CD38|LILRB1|S100A1|ALPK1|IGHV5-51|SLA2|CLEC4A|HLA-E|RGCC|LYN|HLA-DRA|HLA-DRB5|PRAM1|C4B|DHX9|FCN3|CD209|TLR1|PYCARD|IGHV1-24|NCKAP1L|VAV3|CD74|TNFRSF14|B2M|WASF2|IL18|IRAK3|ADAM8|CCL19|HSP90B1|IGHV3-49|FPR3|HMGB2|COL20A1|PARP9|ITGB2|IGHG4|HLA-DPB1|CD4|NCKIPSD|SNX4|PIK3AP1|STX4|TLR2|HLA-DQA2|FGR|FCGR1A|IGLL5|HMSD|CTSS|ARPC1A|HLA-C|PAXIP1|LAT2|VAV1|TICAM2|MYO1G|C4A|GATA3|WAS|EIF2B1|HLA-A|HEXIM1|POLR3B|FCGR2B|C2|MATR3|THY1|PDE4B|IL6ST|BCAR1|IGKV2-28|TRAF2|FPR1|RAB29|C3|MYO10|PVRL2|TNFAIP3|PLSCR1|IKBKE|IGHV4-4|RC3H2|PDE4D|DDX60|CLEC4E|ELMO1|MAPKAPK2|UNC93B1|IGHV4-61|GRB2|MEF2C|MB21D1|NFAM1|C1QB|PARK7|CLEC10A|IFIH1|IGHV1-3|FCER1G|MUC4|PIK3CB|SLC11A1|MAPK3|ABL1|IGHV3-43|RSAD2|IRF7|IRAK1|HRAS|VAMP8|FCN1|NR1H3|IGHV3-73|VAMP7|IFI16|ICOSLG|TNIP1|FCGR2A|TNFSF13|C1QA|SEMA7A|CFB|NONO|GPRC5B|C1QC|TMEM173|DOCK1|C7|PIK3R4|CYFIP2|STX7|HFE|IGKV2D-28|CD86|RBM14|NLRP3|HCK|COLEC12|CD36|MUC20|TNFRSF21|LGALS9|ZP3|IGHV3-15|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|CAV1|EIF2B2|TRAF3|C3AR1|STOML2|RELA|IL1R1|HMGB3|DHX58|NFKB1|PRKACA|TLR4|S100A8|CFP|C1S|ITGAM|IGHV1-18|S100A9|CFD|HSP90AA1|ACTB|CMKLR1|ANXA1|PHB|NCK1|CD14|IGHG2|TFRC|LY96|PQBP1|IGHA1|EIF2B3|C1R|CFH|C5AR1|PRKCB|PTPRJ|ICAM2
DEOXYRIBOSE PHOSPHATE METABOLIC PROCESS%GOBP%GO:0019692,0.453105802047782,0.769943206592495,0.229397464311982,0.9994655280968601,3318,25,AK9|NT5M|NTHL1|DCTD|CDADC1|AK5|NEIL1|OGG1|DUT|DTYMK|SMUG1|NEIL2
CHITIN METABOLIC PROCESS%GOBP%GO:0006030,0.49825315775329204,0.794989907195277,0.49012489987513197,0.9640178395109109,3707,3,CTBS|OVGP1|CHIT1
PHOSPHATIDYLINOSITOL 5-PHOSPHATE METABOLIC PROCESS%GOBP%GO:1904562,0.312031082529475,0.68160868787154,0.67874276261373,1.14037547721651,2328,2,PIKFYVE|MTMR3
NEGATIVE REGULATION OF IRON ION TRANSPORT%GOBP%GO:0034757,0.30327759197324394,0.6762596203943579,-0.8448941332157042,-1.12560185648854,2266,1,HAMP
MAST CELL CYTOKINE PRODUCTION%GOBP%GO:0032762,0.8514194746617141,0.949296218452153,-0.43084457110039504,-0.716994263538115,6417,2,CHGA
SPERMINE METABOLIC PROCESS%GOBP%GO:0008215,0.188058916359811,0.5615657616002211,-0.5347092373861261,-1.28159601010073,1429,5,SMOX|SMS|SAT2
REGULATION OF INTRACELLULAR TRANSPORT%GOBP%GO:0032386,0.195913154533844,0.571699341995829,-0.148142257664726,-1.14266047783297,1533,267,NPEPPS|ABCA2|LYN|CEMIP|PSEN1|HYAL2|DHX9|SP100|FIS1|APOD|DYNC1H1|SEPT5|SREBF2|CD84|CAMK1|JUP|ECT2|ITGB2|NCBP2|TRIM28|SNX4|MICALL2|FGR|HCLS1|PLN|STXBP2|GDI1|ATG13|FES|ATPIF1|PDCD5|NAPA|GAS6|SCFD1|PRR5L|MYLK2|MDFIC|ADGRE2|UBE2G2|RAB29|FMR1|BAG3|SEC23A|VPS18|PARK7|HAX1|SYN1|PDE2A|BCAS3|EHD1|MSN|ANP32B|MAPK3|HUWE1|CEP131|RAPGEF3|FLNA|HRAS|IGF1|VAMP8|VAMP7|RBM22|SNX6|STX1B|ARHGAP1|TMEM173|CD300A|GAS1|ZC3H3|RBM27|NUP214|LGALS9|B3GAT3|BCAP31|CRYAB|DERL3|ITGAM|DAB2|ANXA2|PARL|RHOU|RBM4|SAR1B|EMD|EHD2|INSIG1|PRNP
ESCRT COMPLEX ASSEMBLY%GOBP%GO:1904895,0.134715719063545,0.496974190065009,-0.9317379797088661,-1.2412987124547,1006,1,CHMP6
GAMMA-AMINOBUTYRIC ACID RECEPTOR CLUSTERING%GOBP%GO:0097112,0.29981427434332697,0.673068211657834,-0.6843935179805489,-1.1389402566717701,2259,2,GPHN
NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE%GOBP%GO:0045824,0.0005232177894048401,0.0139121625154964,-0.47504273833760097,-2.16895214089435,3,30,SERPINB9|PARP14|MICA|MUL1|LILRB1|HLA-E|IRAK3|SLAMF8|INS|TNFAIP3|NR1H3|TRAFD1|IFI16|CEACAM1|A2M|LGALS9|PPARG|DHX58|FAM3A|SERPING1|SAMHD1
ACTIVATION OF INNATE IMMUNE RESPONSE%GOBP%GO:0002218,0.000639467962655071,0.0163600882996276,-0.27311901616224604,-1.86311581201821,4,138,TNFAIP3|IKBKE|CLEC4E|MAPKAPK2|UNC93B1|MB21D1|CLEC10A|IFIH1|FCER1G|MUC4|IRF7|IRAK1|HRAS|FCN1|IFI16|TNIP1|NONO|TMEM173|PIK3R4|RBM14|HCK|COLEC12|CD36|MUC20|LGALS9|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|TRAF3|RELA|NFKB1|PRKACA|TLR4|S100A8|ITGAM|S100A9|CD14|LY96|PQBP1|ICAM2
ACYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0006639,0.0162211263950169,0.17331488659862898,-0.32109799562932695,-1.6722795266466102,124,47,PNPLA2|FABP3|DAGLB|SEL1L|APOBR|DGKE|CETP|GK|APOE|PLA2G16|FABP4|DAGLA|LPIN3|CAV1|ANG|LMF1|MGLL|PNPLA4|LPIN2
CARDIAC CHAMBER FORMATION%GOBP%GO:0003207,0.36356466876971605,0.717981693238167,-0.39482831923659006,-1.0792456035156601,2765,7,TBX20|SOX11|MESP1|NOTCH1|MEF2C
POSTTRANSCRIPTIONAL GENE SILENCING BY RNA%GOBP%GO:0035194,0.9148634724368879,0.9740523336757891,-0.12471495600605499,-0.6731574977529808,7102,53,CNOT6|SRRT|TNRC6A|AJUBA|NOTCH4|C9orf114|DHX9|HELZ|TERT|LIN28B|PPP1R8|CELF1|HNRNPA2B1|STAT3|NCBP1|CLP1|TNRC6C|RAN|RBM4|WTIP
REGULATION OF WNT-FRIZZLED-LRP5/6 COMPLEX ASSEMBLY%GOBP%GO:1904711,0.004648691725328729,0.0752560935123842,0.9979047198941329,1.33057129384458,34,1,DKK1
URACIL METABOLIC PROCESS%GOBP%GO:0019860,0.3944746978350379,0.7376723208557521,0.8039810322011469,1.07200022298308,2969,1,DPYD
NEGATIVE REGUATION OF STEROL BIOSYNTHETIC PROCESS%GOBP%GO:0106119,0.289058390320884,0.6622070134491391,-0.483834108699966,-1.15965803450809,2197,5,SOD1|APOE
NEGATIVE REGULATION OF HISTONE PHOSPHORYLATION%GOBP%GO:0033128,0.7216768373573891,0.9019989179378242,-0.506896320904916,-0.843556536802019,5439,2,H2AFY
REGULATION OF ROOT MORPHOGENESIS%GOBP%GO:2000067,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
REGULATION OF MESODERM FORMATION%GOBP%GO:1905902,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
NEGATIVE REGULATION OF INTERLEUKIN-8 SECRETION%GOBP%GO:2000483,0.39332023575638503,0.7375199755844078,-0.40762563292839704,-1.0485229365737,3002,6,ANXA1|TMSB4X
POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0030813,0.40172842739295506,0.740287621109606,-0.302201703735149,-1.0402368677865,3067,13,PFKFB2|PFKFB3|INS|IGF1
NEGATIVE REGULATION OF OOCYTE DEVELOPMENT%GOBP%GO:0060283,0.227157190635452,0.609201573718782,-0.8834913983237759,-1.1770226813623899,1697,1,IGF1
ITP METABOLIC PROCESS%GOBP%GO:0046041,0.9775250836120399,0.9927322181739301,-0.511138067931187,-0.680958637972251,7306,1,AK3
POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION%GOBP%GO:0090336,0.429054933611039,0.75728218645768,-0.35195503315893106,-1.01322928068311,3295,8,HNRNPU|INS|METRNL
POSITIVE REGULATION OF CHEMOKINE SECRETION%GOBP%GO:0090197,0.252497371188223,0.632257972333528,-0.43777328041036606,-1.1966337397809699,1920,7,TNF|PYCARD|IL33|CSF1R
N-TERMINAL PEPTIDYL-ASPARTIC ACID ACETYLATION%GOBP%GO:0017190,0.7278523044228979,0.9059042547382851,0.635310983678871,0.847101472410058,5479,1,NAT6
RESPONSE TO MECHANICAL STIMULUS%GOBP%GO:0009612,0.06775731031817599,0.37156583317195796,-0.24553583852450897,-1.41007738427066,525,67,CNN2|AQP1|CHI3L1|JUNB|DFNB31|RYR2|JUP|TNFRSF10A|TNFRSF10B|PDZD7|CASP1|PIEZO1|SLC9A1|PTGER4|MAPK9|PKD2L1|PDE2A|TMC2|MAPK3|COL1A1|FADD|TLR5|LTBR|NFKB1|TLR4|NRXN2|TNFRSF1A|ADGRV1|BAD
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS%GOBP%GO:0002690,0.0797204607221431,0.395958593986611,-0.25436248440639203,-1.39285108720378,615,56,GPSM3|CCL3|RAC2|CXCL12|THBS4|CCL4|RAC1|NCKAP1L|CD74|CCL19|MOSPD2|VEGFC|GAS6|CREB3|PLA2G7|CALR|CSF1|CCR1|VEGFB|LGALS9|THBS1|AIF1|RARRES2|SERPINE1|CMKLR1|LGMN
POSITIVE REGULATION OF GAMMA-DELTA T CELL DIFFERENTIATION%GOBP%GO:0045588,0.528829431438127,0.8106205307336929,-0.738586237318042,-0.983974213121716,3952,1,NCKAP1L
POSITIVE REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS%GOBP%GO:1901860,0.0976588628762542,0.430598623028127,-0.948886193206881,-1.26414425036294,729,1,STOML2
PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009218,0.65984165984166,0.8777219059146769,0.274902878970771,0.835404494901807,4833,9,CAD|AK5|DHODH|ENTPD4
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS%GOBP%GO:0021955,0.11773940345368901,0.46862716515177505,-0.36824672046246903,-1.36854740106954,899,16,SPTBN4|C12orf57|EPHA4|SLIT2|SCN1B|HSP90AA1
POSITIVE REGULATION OF MYELOID DENDRITIC CELL ACTIVATION%GOBP%GO:0030887,0.47293676312968896,0.7831522581932591,0.6040805073063139,1.01493324826605,3529,2,KLRK1|CD2
NEGATIVE ADAPTATION OF SIGNALING PATHWAY%GOBP%GO:0022401,0.12612966601178802,0.48175523567590006,-0.538588816153816,-1.38539552349141,962,6,ADRB2|ADM|ARRB1|ADRBK1|GTF2H2
REGULATION OF ADIPOSE TISSUE DEVELOPMENT%GOBP%GO:1904177,0.19290857220486302,0.567400875461191,0.577731732310927,1.26930122011751,1419,4,TRPM4|KLF7|SIRT1
CANNABINOID SIGNALING PATHWAY%GOBP%GO:0038171,0.703571428571429,0.89388925420571,-0.415625558970819,-0.811611376805126,5318,3,DAGLB|DAGLA
N-TERMINAL PROTEIN AMINO ACID MODIFICATION%GOBP%GO:0031365,0.716840731070496,0.899704384028684,-0.193767786937144,-0.813549847236346,5490,23,PPM1A|CREBBP|NAA25|NAA20|NAA40|NAA30|NAA10|NMT1|METAP2|NAA50|KAT2B|NTMT1
POSITIVE REGULATION OF FOCAL ADHESION DISASSEMBLY%GOBP%GO:0120183,0.610969899665552,0.8515630793099821,-0.698279664755183,-0.9302761802891691,4566,1,DUSP3
NEGATIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT%GOBP%GO:2000642,0.804394426580922,0.932964969466025,0.4475875379101189,0.7520048540552751,6003,2,SNX12|SNX3
REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 2 PRODUCTION%GOBP%GO:2000341,0.822527832351015,0.9412507273497192,-0.276796679270937,-0.711995624264368,6279,6,TNF|CD74|KLF4
EMBRYO DEVELOPMENT%GOBP%GO:0009790,0.297600816743236,0.669824290035979,-0.138387026597618,-1.07559089110396,2331,277,LMO4|TBX1|SOX18|DFNB31|RYR2|PCSK5|BASP1|ITGB2|KLF4|SOX17|KDR|BHLHE40|FOXN4|PDCD6|SMO|SFRP2|COBL|GATA3|SMAD6|ITGB5|TBX2|PDZD7|CELF1|TGFB3|HOXA4|HES1|MESP1|VTN|ITGA5|NDST1|SMAD5|NOTCH1|INHBA|CELSR1|MEF2C|TAL1|CHRD|BRCA1|ATP6AP2|RPL10|HOXB3|FBN1|MMP14|CTR9|MICAL2|CELF4|SOD1|SULF1|COL4A2|LRP5|MEOX2|COL5A2|COL12A1|MEOX1|COL8A1|FN1|ALDH1A2|DLC1|DEAF1|LUZP1|TGFBR2|BMP2|ZP3|ATOH8|COL1A1|SRF|EIF4A3|TCOF1|RARRES2|ITGA8|MMP9|DNAAF1|SNAI1|WDR74|FLT3LG|DACT1|COL6A1|PDGFA|EFEMP1|PDGFRA|ENG|PDGFB|ITGB4|MTHFD1
ESTROGEN BIOSYNTHETIC PROCESS%GOBP%GO:0006703,0.234000785237534,0.617951264290741,-0.562165783332446,-1.23069841347691,1787,4,HSD17B1|HSD17B14
HISTONE H2B CONSERVED C-TERMINAL LYSINE DEUBIQUITINATION%GOBP%GO:0035616,0.84452296819788,0.948285501480553,-0.318094082611813,-0.6963744404472989,6452,4,C17orf96|USP49|USP7|USP15
MUCOSAL IMMUNE RESPONSE%GOBP%GO:0002385,0.00523012552301255,0.0816362948035918,-0.6125827723005219,-1.9191418587898201,39,10,RPL39|HIST1H2BE|HIST1H2BC|IFNLR1|HIST1H2BG|HIST2H2BE|HIST1H2BK|HIST1H2BJ
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:1900544,0.00768529373453172,0.106864945035751,-0.42865572119093703,-1.84799487757261,58,25,GUCA1A|PID1|PFKFB2|PFKFB3|INS|VCP|PARK7|ENO1|IGF1|CCNB1|NOS3|TMSB4X
RIBOSOMAL SMALL SUBUNIT ASSEMBLY%GOBP%GO:0000028,0.8550078657577349,0.949296218452153,-0.19383978571745802,-0.685776815956644,6521,14,MRPS11|ABT1|RPS14|MRPS7
REGULATION OF ADIPONECTIN SECRETION%GOBP%GO:0070163,0.404568802379021,0.741731864961693,0.42819295531970897,1.02980160206667,2992,5,RAB11FIP5|RAB11FIP3|C1QTNF3
"RETROGRADE VESICLE-MEDIATED TRANSPORT, GOLGI TO ER%GOBP%GO:0006890",0.0397997175503916,0.28475403983757397,-0.24758491048492104,-1.4780368133416497,309,78,TMED7|TAPBP|COG4|TMEM115|BNIP1|KLC2|NAPA|SCFD1|ERGIC2|KIF4A|KIF18A|KDELR2|ARFGAP2|COPB2|KDELR1|COPB1|TMED2|KIF2A|RAB1B|NSF|KDELR3|TMED10|LMAN2|TMED9|KIF22|COPG1|SURF4|COPZ2|SCYL1
HINDBRAIN MORPHOGENESIS%GOBP%GO:0021575,0.530200433369448,0.811490026766563,0.25416138972117003,0.93749659737425,3914,15,DLL1|ATP7A|ADCK4|AGTPBP1|LRP6|PROX1|ZNF365
RESPONSE TO CORTICOSTEROID%GOBP%GO:0031960,0.0210732984293194,0.200341501313409,-0.37156644459272203,-1.6594572988109602,160,28,TNF|UBE2L3|PDCD7|AQP1|ADAM9|NR3C1|REST|ZFP36L1|BCL2L11|GOT1|HNRNPU|IL1RN|GPER1|SLIT2|FAM107A|ANXA1|SSTR2
REGULATION OF LYSOSOME ORGANIZATION%GOBP%GO:1905671,0.20913719185423396,0.590037654905956,0.7311276537082991,1.22838885794245,1560,2,SCARB2|LAPTM4B
REGULATION OF COENZYME METABOLIC PROCESS%GOBP%GO:0051196,0.5983904465212879,0.84557799939374,-0.18514719430093102,-0.906102423214412,4609,38,OGT|CBFA2T3|PFKFB2|PFKFB3|INS|JMJD8|IGF1|PGAM1|PDK3|PPARA
MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER%GOBP%GO:0051418,0.861748633879781,0.9523801880640441,0.232219677215316,0.674093097039886,6307,8,TUBGCP3|MZT1|TUBGCP6
ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009068,0.391310251188052,0.7369216590772479,0.29900735166125103,1.0471860847059,2881,13,AASS|AADAT|GCDH|PIPOX|HRSP12|ALDH7A1
NEGATIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0032108,0.5685792349726779,0.831529557610607,0.30933174826496995,0.897935948844487,4161,8,BBS4|NENF|MKKS|BBS2|CARTPT
POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION%GOBP%GO:0045636,0.638730243060167,0.865463150027443,0.6783193647992939,0.9044473453904301,4808,1,ZEB2
DETECTION OF HYPOXIA%GOBP%GO:0070483,0.36387959866220704,0.718261029016069,-0.8163872959858841,-1.0876239044031502,2719,1,TGFB3
CALCIUM ION IMPORT%GOBP%GO:0070509,0.420313565098841,0.751774348695433,0.22870920905949696,1.02358743339507,3082,27,MCUR1|MICU2|FAM155A|SLC25A23|CACNA1C|TRPV1|CACNB2|ATP2B4|MICU1|C2orf47|CACNA1B|SLC8A1
REGULATION OF VACUOLAR TRANSPORT%GOBP%GO:1903335,0.5750267952840301,0.8354258054828342,0.5594154948993659,0.939890260489191,4291,2,VPS35|SNAPIN
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL%GOBP%GO:0010523,0.24426229508196698,0.627241747929009,0.4138485017895229,1.20132979953267,1787,8,FKBP1B|GSTM2|SRI|PKD2
REGULATION OF GLUCAN BIOSYNTHETIC PROCESS%GOBP%GO:0010962,0.8321724273886191,0.9443921657118071,-0.181421041347492,-0.7167776092732651,6331,19,INS|PPP1R3E|IRS1|IGF1|PPP1R3F
ER OVERLOAD RESPONSE%GOBP%GO:0006983,0.597511495807411,0.8449219534562551,0.316344061979975,0.8732592919247429,4417,7,WFS1|ATG10|EIF2AK3|VIMP
NEGATIVE REGULATION OF LEUKOCYTE MIGRATION%GOBP%GO:0002686,0.0244887325778299,0.219638825480684,-0.38500139572471703,-1.65979496361526,187,25,ADTRP|AKT1|CXCL12|DUSP1|GREM1|APOD|PLCB1|SLAMF8|PTGER4|HMOX1|CCL2|CD300A|NOV|CD200|NBL1|SLIT2
REGULATION OF THYMOCYTE MIGRATION%GOBP%GO:2000410,0.543006430868167,0.8161852878569359,0.573202041451165,0.963053438749293,4052,2,XCL1
PYRIDOXINE METABOLIC PROCESS%GOBP%GO:0008614,0.644574312657723,0.8688307429995409,0.675948389942656,0.9012859703415121,4852,1,PSAT1
RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0009607,0.000127242651736862,0.00518555396908895,-0.34442552412327604,-2.8140764982068998,0,381,MICA|TGFB1|CXCL2|LILRB1|IGHV5-51|HLA-E|SBNO2|EXOSC4|ATG7|CCL11|LYN|ADAM9|PIM2|CDK6|RPL39|HYAL2|C4B|FCN3|MTDH|BNIP3L|TLR1|PYCARD|AGBL4|JUNB|IGHV1-24|HIST1H2BE|TNFRSF14|GSDMD|IL18|IRAK3|CCL19|SLAMF8|IGHV3-49|IFIT3|HMGB2|BATF|TRIM56|OASL|OAS1|IFNGR1|DAB2IP|IFNAR1|IGHG4|CALCOCO2|SLFN13|TLR2|FGR|ODC1|IGLL5|MPEG1|PDCD1LG2|SMO|PLA2G2A|TICAM2|IRF5|SSC5D|SPN|GATA3|HYAL3|TNFRSF11A|AZU1|IL1RN|FCGR2B|GGT1|OAS2|SLFN11|PDE4B|CASP1|ERBB2IP|RAB29|TNFAIP3|FMR1|PLSCR1|HIST1H2BC|DDX3X|IGHV4-4|PDE12|LILRB2|SLC25A6|CXCR4|DDX60|MST1R|MAPKAPK2|IFIT2|HAMP|IGHV4-61|JCHAIN|MEF2C|MB21D1|IFI44L|ABCC9|CCT5|IFIH1|IGHV1-3|IFIT1|FCER1G|APOBEC3G|EME1|CTR9|ENO1|ISG15|SLC11A1|CARD16|IFI6|IGHV3-43|RSAD2|HSPB1|FLNA|IRF7|IRAK1|ROMO1|CEBPB|APOBEC3C|HMGN2|NR1H3|IGHV3-73|ARF1|IFI44|APOBEC3B|IFI16|BATF2|CHRM2|SERINC5|CLEC7A|TMEM173|EEF1G|CCL2|BCL3|F2R|BAIAP2L1|CD86|GAPDH|NLRP3|RNASE6|AXL|NOS3|HYAL1|TMCO1|HCK|RPS15A|CD36|CHGA|BST2|OTUD5|LGALS9|NR1D1|IGHV3-15|FADD|RARRES2|PABPN1|FOXP1|TICAM1|IFNLR1|RRP1B|CCRN4L|HIST1H2BG|SERPINE1|CAV1|STAB1|DDIT4|RELA|PLAA|CFL1|DHX58|SMC1A|IFITM1|BTBD17|NFKB1|TLR4|VIM|S100A8|CFP|RNASE1|IGHV1-18|S100A9|ACTA2|GSTP1|NPC2|IFITM2|CD14|FAM3A|IFITM3|IGHG2|MUS81|LY96|PQBP1|HIST2H2BE|IGHA1|SAMHD1|HIST1H2BK|TNFRSF1B|HNRNPA0|BANF1|LYST|HIST1H2BJ|APOBEC3F|SIRPA|ADGRB1
LAYER FORMATION IN CEREBRAL CORTEX%GOBP%GO:0021819,0.7387776469048549,0.9089185613230608,-0.3546952104629221,-0.77650196032374,5644,4,DAB2IP|ADGRG1
CELLULAR RESPONSE TO GONADOTROPIN-RELEASING HORMONE%GOBP%GO:0097211,0.9297619047619051,0.9793746057014829,-0.314198423517769,-0.613549887867124,7028,3,CRHBP
NEGATIVE REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010916,0.11468253968254,0.463748809895271,-0.700176464100585,-1.36726717539312,866,3,APOC2|LRPAP1|APOC1
TROPHECTODERMAL CELL PROLIFERATION%GOBP%GO:0001834,0.7997077965201221,0.931670998922663,0.599966916629907,0.799974928076188,6020,1,ZPR1
NOSE MORPHOGENESIS%GOBP%GO:0043585,0.11508574490889599,0.46440911828368103,0.7982354562999721,1.3411386309355902,858,2,STRA6|SKI
LIPOSACCHARIDE METABOLIC PROCESS%GOBP%GO:1903509,0.63018771548972,0.8611005574443281,-0.147286681717368,-0.897973162375321,4934,84,ST6GALNAC4|GLTP|GLA|PIGP|NEU4|UGCG|STS|B3GALT2|FUCA1|PIGH|B3GNT5|NDUFAB1|HEXB|SMPD1|A4GALT|B3GALT1|ST3GAL5|GBGT1
CELLULAR RESPONSE TO THYROID HORMONE STIMULUS%GOBP%GO:0097067,0.012636789994788998,0.14869950444299201,-0.597427429486493,-1.79720794166715,96,9,CTSS|MED1|LMO2|CTSB|CTSH|CTSL
REGULATION OF METALLOENDOPEPTIDASE ACTIVITY%GOBP%GO:1904683,0.0504256712508186,0.322183465117595,-0.6044528105623311,-1.55481545995507,384,6,STAT3|TIMP3|RECK
REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY%GOBP%GO:0001672,0.44038010934652394,0.7653693162885199,-0.348352155288935,-1.00285709955576,3382,8,MAP1S|PARP10|TAL1|SPTY2D1|TLK2
REGULATION OF ECTODERM DEVELOPMENT%GOBP%GO:2000383,0.937441891353433,0.9806508984207809,0.5320357300397001,0.7093978569071909,7057,1,FZD7
LEUKOCYTE CHEMOTAXIS%GOBP%GO:0030595,0.00025809781907342903,0.00819882332206558,-0.37348726480757505,-2.1892950818401204,1,73,IL1B|TGFB2|CCL3|SYK|CCL4|CCL8|CXCL1|CXCL2|CCL11|GPR183|FLT1|NCKAP1L|ADAM8|CCL19|SLAMF8|ITGB2|CXADR|SBDS|CCL24|SLC12A2|TNFRSF11A|AZU1|IL1RN|GAS6|PDE4B|CCL3L3|ADGRE2|CCL18|CXCR4|FCER1G|CCL2|CXCL16|EDNRB|CCR1|LGALS3|CHGA|CYP7B1|CX3CL1|CCL4L2|CCL14|S100A8|S100A9|ANXA1|FOLR2|PDGFB|LYST
REGULATION OF SEMAPHORIN-PLEXIN SIGNALING PATHWAY%GOBP%GO:2001260,0.622990353697749,0.8570098885895309,0.539343810311552,0.9061672388215649,4649,2,NCAM1|HAND2
REGULATION OF ESTROGEN RECEPTOR BINDING%GOBP%GO:0071898,0.835744908896034,0.945788393670804,0.42889440308795207,0.7205979739857,6237,2,LEF1|RUVBL2
FOREBRAIN MORPHOGENESIS%GOBP%GO:0048853,0.539328895530499,0.8145759998979101,0.420020045586436,0.922801927815433,3969,4,SLIT1|NF1
L-ASPARTATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0140009,0.47744759883258203,0.7850984235874658,-0.6076708961626159,-1.0112615450970501,3598,2,SLC1A3
VASCULAR SMOOTH MUSCLE CELL DEVELOPMENT%GOBP%GO:0097084,0.0924688932547479,0.420939346122012,-0.5649264912658399,-1.45314311888327,705,6,HES1|NOTCH1|ENG
HORMONE CATABOLIC PROCESS%GOBP%GO:0042447,0.40780527604024996,0.7445496113654559,0.32573080783137204,1.03193721701497,2998,10,HSD17B11|HSD17B6|COLQ|YWHAH
THYROID HORMONE MEDIATED SIGNALING PATHWAY%GOBP%GO:0002154,0.41377926421404704,0.74818194067571,-0.7936149095721221,-1.05728561772757,3092,1,MED1
NEURON DEVELOPMENT%GOBP%GO:0048666,0.008277216610549941,0.11272942786786,0.16964951962054997,1.4192344517806201,58,415,TNR|RET|CNTN4|SLC12A5|IFT88|HS6ST1|SHTN1|DRD2|ROBO3|ETV1|FRY|ADGRB3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|TRAPPC4|BBS4|SEMA4F|PLXNB1|INSM1|LLGL1|FARP1|FARP2|GAB1|CYFIP1|GAB2|DOK1|CDHR1|PICK1|AHI1|MAPK7|RAB13|ALS2|SLIT1|EPHB2|GNGT1|ARL3|EFNA4|RTN4|POU3F2|PARD3|TENM4|SKOR1|LAMB1|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|NYAP2|STK24|STMN3|ROBO2|KCNIP2|AGRN|PTPRM|SLITRK6|CHRNB2|MINK1|ASCL1|LYPLA2|EFNB2|BMP7|NTNG1|EFNB3|SLIT3|CDK5R1|NREP|BLOC1S3|SHC1|SOS1|CEP290|NYAP1|MAP6|ADCYAP1|ATP7A|FRYL|DRAXIN|MICALL1|SPTBN1|PPP1R9A|STMN2|NEDD4|PAK1|EFNA2|EPB41L3|NRCAM|STRADB|STRN|ALK|MAP2|DLG4|BRSK1|VLDLR|TUBB3|ULK2|RAB11A|CLN5|PPP3CB|ATCAY|SKI|PRKCA|PLCG1|TDP2|TENM3|KIF5A|PLXNB2|POU4F2|STMN4|RB1|MAP4|DOCK7|C8orf37|CELSR2|NRP1|ZFYVE27|DCC|CPNE1|LRP12|MEGF8
ELASTIN METABOLIC PROCESS%GOBP%GO:0051541,0.907417360924483,0.9710309567212472,0.32549547331152895,0.640211185010807,6752,3,ATP7A|HIF1A|MMP12
POSITIVE REGULATION OF ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:0046641,0.115847280334728,0.46559625491895207,-0.44807908427786297,-1.40377327859948,885,10,BLM|SYK|HLA-E|IL18|EBI3|TGFBR2|LGALS9|CD55
REGULATION OF DEFENSE RESPONSE TO FUNGUS%GOBP%GO:1900150,0.0387959866220736,0.28020075641001296,-0.980094838994266,-1.30572166018951,289,1,FAM3A
LUTEINIZING HORMONE SECRETION%GOBP%GO:0032275,0.0943020321423828,0.424384770192935,0.953683281870313,1.27160797316476,709,1,TBX3
RESPONSE TO INTERLEUKIN-4%GOBP%GO:0070670,0.46983346983346996,0.7810597690409531,0.322624118584331,0.980424940757864,3441,9,CITED1|XCL1|SHPK|TCF7|LEF1
SINUS VENOSUS MORPHOGENESIS%GOBP%GO:0003236,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
CALCIUM ION TRANSPORT FROM CYTOSOL TO ENDOPLASMIC RETICULUM%GOBP%GO:1903515,0.6448160535117061,0.8688307429995409,-0.6819585355094839,-0.908532517199655,4819,1,ATP2A2
APELIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060183,0.76,0.9179084014002329,-0.624172915747684,-0.8315481965313791,5680,1,APLN
S-ADENOSYLMETHIONINE CYCLE%GOBP%GO:0033353,0.8105685618729099,0.935197572326686,-0.598147331274813,-0.7968758689021559,6058,1,MTRR
ERYTHROSE 4-PHOSPHATE/PHOSPHOENOLPYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS%GOBP%GO:1902222,0.6316063525123671,0.8616028929314681,-0.29673460949619396,-0.8542574096329041,4851,8,IL4I1|ASRGL1
TRNA-GUANINE TRANSGLYCOSYLATION%GOBP%GO:0101030,0.18247782854071498,0.55613090144696,0.6508768059997789,1.2801978688851101,1357,3,QTRT1|QTRTD1|C9orf64
ADENOSINE 5'-(HEXAHYDROGEN PENTAPHOSPHATE) CATABOLIC PROCESS%GOBP%GO:1901911,0.7360293155346159,0.908157084784786,-0.35559109356837504,-0.7784632357147929,5623,4,NUDT11|NUDT4
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE-EPINEPHRINE%GOBP%GO:0001993,0.649784059678053,0.871765538911879,-0.38487796357138204,-0.8425783162071441,4964,4,ADRA1B|ADRB2|PDE4D
REGULATION OF CHOLESTEROL EFFLUX%GOBP%GO:0010874,0.19847729062746103,0.575811726650469,-0.34315233160987707,-1.2459304915023,1511,15,PLTP|SREBF2|LRP1|CETP|NR1H3|APOE|NFKBIA
NEGATIVE REGULATION OF ADENOSINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060169,0.352240802675585,0.7106176066646809,-0.821239523599471,-1.094088236673,2632,1,ADA
ADENINE SALVAGE%GOBP%GO:0006168,0.130405943221014,0.489803809246725,-0.7778217398347409,-1.2944197581331298,982,2,HPRT1
RESPONSE TO CADMIUM ION%GOBP%GO:0046686,0.0428198433420366,0.29576373695179803,-0.373955843410923,-1.57008408925466,327,23,MAPK9|HAAO|MAPK3|MT1M|MT2A|MMP9|MT1E|PRNP
REGULATION OF HAIR CYCLE%GOBP%GO:0042634,0.6855277475516871,0.885899038297278,0.24248275862069,0.824151733183853,5039,12,SPINK5|GAL|HPSE|PER1|NUMA1|CDH3|CLOCK|NIPBL|TGFB2|ARNTL|FST|TERT
NEGATIVE REGULATION OF VASOCONSTRICTION%GOBP%GO:0045906,0.40531344064913,0.742603815752875,-0.47814675090757197,-1.04676318836555,3096,4,DOCK4|ADM|DOCK5
POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS%GOBP%GO:0046985,0.690873015873016,0.887767536923729,-0.420833557128856,-0.8217812772460631,5222,3,PRMT1|KLF4
ENDOSOME TO MELANOSOME TRANSPORT%GOBP%GO:0035646,0.5319672131147539,0.812079525085925,0.319318195569565,0.926924858280179,3893,8,BLOC1S3|AP1M1|BLOC1S5|AP1G1|BLOC1S6|AP3D1
REGULATION OF SEROTONIN SECRETION%GOBP%GO:0014062,0.7785714285714291,0.924704689181848,-0.385495793799916,-0.752775581783943,5885,3,LILRB1|HTR1B
PROTEIN LOCALIZATION TO VACUOLE%GOBP%GO:0072665,0.31262911444704605,0.681692003207048,0.21121968354369397,1.10774841946001,2269,46,NAGPA|CACNG7|GCC2|VPS36|SCARB2|VPS13C|SNX16|SH3BP4|NEDD4|VPS13A|CACNG4|SH3GLB1|AP4M1|ZFYVE16
FOLATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0098838,0.8880677237301802,0.965159112268525,0.33610897070979,0.6610866819180911,6608,3,SLC25A32|SLC46A1
NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0045019,0.0554543087737568,0.34165878259009896,-0.540717253278739,-1.5566492931645701,425,8,CD34|GLA|CAV1|SIRPA|PTGIS
ESTABLISHMENT OF SPINDLE LOCALIZATION%GOBP%GO:0051293,0.448304045770331,0.768229288546963,0.218643651055687,1.00065070267661,3290,29,CLASP1|LLGL1|DCTN1|NDEL1|HTT|SPIRE2|GPSM2|DYNLT1|MAP4|ZW10
NEUROBLAST PROLIFERATION%GOBP%GO:0007405,0.52762730227519,0.810052447666581,0.254623546604953,0.9392013036102199,3895,15,FGFR2|TEAD3|RAB10|PLXNB2|DOCK7
GOLGI ORGANIZATION%GOBP%GO:0007030,0.686113049546406,0.886120113353976,0.136905389584106,0.881397847550121,4915,102,DYNC2H1|CLASP1|LMAN2L|ARHGEF7|CLASP2|STK25|DNAJC28|ARFGEF1|GCC2|RAB1A|MYO18A|HTT|UBXN2A|GOLPH3L|TBC1D20|CUL7|PI4K2B|GORASP2|STX16|PLK3|STX6|BLZF1|GOLGA8B|ATP8B2|OBSL1|COG3|ARHGAP21|RAB30|ZW10|TRAPPC11|RAB2A|FBXW8|YWHAZ|COG7|FHDC1|GORASP1
"PROTEIN ALPHA-1,2-DEMANNOSYLATION%GOBP%GO:0036508",0.854995938261576,0.949296218452153,0.17166165979465697,0.695705805211412,6314,20,UGGT2|RNF103|TRIM13|DERL2|RNF185|UGGT1|MAN1A2|MAN1B1
CELLULAR RESPONSE TO RADIATION%GOBP%GO:0071478,0.0154360689477746,0.167850779937029,-0.238302329667245,-1.56237486747071,119,114,RAD9A|AQP1|CUL4B|RAD51|HYAL2|EEF1D|TRIAP1|INTS7|KDM1A|IMPACT|ECT2|YY1|PARP1|MFAP4|NDNL2|HYAL3|NPM1|RAD51AP1|RAD1|PCNA|FMR1|DHX36|POLD1|GRB2|RHNO1|NUCKS1|CARD16|HRAS|IFI16|CRY2|USP47|HYAL1|ADIRF|TMEM109|TLK2|HIST3H2A|CRYAB|TNKS1BP1|EIF2S1|MYC|DDB1|YAP1|MAPK13|POLA1|POLE3|CRIP1|NET1|XPA
AXON ENSHEATHMENT%GOBP%GO:0008366,0.8432174505794141,0.9481593344082329,0.142157840824957,0.7377809668061879,6184,44,PPARD|NFASC|PARD3|TENM4|MARVELD1|EIF2B4|NF1|EPB41L3|SCN2A|ZSCAN26|ARHGEF10|SKI
NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT%GOBP%GO:0061000,0.7215938979484481,0.9019989179378242,-0.32951519634048,-0.789785048341254,5486,5,PTEN|EFNA1|NGEF
GLUTATHIONE METABOLIC PROCESS%GOBP%GO:0006749,0.771200440528634,0.9213545359508709,0.16071154831577403,0.7892256340441899,5601,37,GSTM2|GSTM4|GSTM1|ETHE1|GSTK1|CTNS|GSS|GSTT2|GCLM|GSTT2B|G6PD|MGST2|GSTZ1|MMACHC|GSTM3|GCLC|GGT7
REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0045540,0.0607784818311134,0.35631208031004796,-0.29436466003453104,-1.4654138133511103,469,40,SREBF2|IDI1|GPAM|FDPS|KPNB1|ABCG1|CYP51A1|MBTPS2|SOD1|RAN|HMGCR|APOE|HMGCS1|NFYB|DHCR7|FASN|TM7SF2
FORMATE TRANSPORT%GOBP%GO:0015724,0.480674724398991,0.7857006060206241,0.760200705778562,1.01362506510306,3618,1,SLC26A6
PURINE RIBONUCLEOSIDE SALVAGE%GOBP%GO:0006166,0.211103678929766,0.5929592989748729,-0.8924239082487869,-1.18892292940463,1577,1,HPRT1
VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0035886,0.00650872168706066,0.0957322763119865,-0.648284640202205,-1.8663207449383798,49,8,HES1|MESP1|NOTCH1|GATA6|ENG
RESPONSE TO LIPOPOLYSACCHARIDE%GOBP%GO:0032496,0.00025783163594172997,0.00819882332206558,-0.31307867196188693,-2.0599593993192,1,116,CXCL1|CD274|TGFB1|CXCL2|LILRB1|SBNO2|LYN|ADAM9|MTDH|PYCARD|JUNB|IL18|IRAK3|HMGB2|DAB2IP|IFNAR1|PDCD1LG2|TICAM2|TNFRSF11A|IL1RN|GGT1|PDE4B|CASP1|ERBB2IP|TNFAIP3|LILRB2|MAPKAPK2|MEF2C|CTR9|SLC11A1|CARD16|IRAK1|NR1H3|CCL2|F2R|CD86|NLRP3|AXL|NOS3|HCK|OTUD5|LGALS9|NR1D1|PABPN1|FOXP1|TICAM1|CCRN4L|SERPINE1|PLAA|NFKB1|TLR4|VIM|GSTP1|CD14|LY96|TNFRSF1B|HNRNPA0|SIRPA
POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY%GOBP%GO:0010606,0.658421194917545,0.8769585284618442,0.345411427310832,0.8307125019169069,4870,5,PAN3|CNOT1|CNOT2|CNOT6L|CNOT6
REGULATION OF STEM CELL DIFFERENTIATION%GOBP%GO:2000736,0.26565538700894603,0.6411423585332491,-0.22868847986219001,-1.14529597189031,2048,41,PRICKLE1|SOX5|JAG1|RUNX1|REST|LTBP3|HNRNPU|GATA3|LMO2|HES1|DHX36|NOTCH1|TAL1|SETD1A|ABL1|YAP1|PDGFRA|ENG
NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0032105,0.5685792349726779,0.831529557610607,0.30933174826496995,0.897935948844487,4161,8,BBS4|NENF|MKKS|BBS2|CARTPT
FATTY ACID CATABOLIC PROCESS%GOBP%GO:0009062,0.0199724517906336,0.19502581020323298,0.26501515371442896,1.55980289685162,144,70,ALDH3A2|LPIN1|BDH2|PPARD|HADHB|SLC25A17|ACBD5|HADHA|NUDT7|PEX2|HIBCH|PEX13|ACADVL|ACADM|ACAT1|GCDH|ECHDC1|MCAT|ACOT7|ACOX2|ACAA2|ACAD11|ECI1|ACADS|ECHS1|MECR|ACOX3|EHHADH|ACOT8|ABCD3|PHYH|IVD|MCEE|HACL1
VIRAL LIFE CYCLE%GOBP%GO:0019058,0.0419866871479775,0.293516895676511,-0.231793095324447,-1.4476377775667,327,93,ZNF639|DEK|TSG101|PCSK5|CD4|PPIA|RAB7A|UBAP1|KPNB1|CAV2|EEA1|GAS6|VCP|RAB29|PVRL2|CLEC4M|CXCR4|ICAM1|MVB12B|VAMP8|RAN|CCL2|APOE|AXL|CHMP4A|RAB1B|CHMP6|UBC|CAV1|ADRBK1|VPS37C|CD81
MULTI-ORGANISM CELLULAR LOCALIZATION%GOBP%GO:1902581,0.543253968253968,0.8163350846796089,-0.4830759134506679,-0.9433248238822042,4106,3,RAB7A|IFIT1
POTASSIUM ION EXPORT%GOBP%GO:0071435,0.174815983175605,0.54811765844537,-0.47593477254965605,-1.3009464767562702,1329,7,KCNQ1|KCNH2|KCNE4
CELLULAR RESPONSE TO ANISOMYCIN%GOBP%GO:0072740,0.0814715719063545,0.397722753303477,-0.9568813409792679,-1.27479570694395,608,1,MAPK13
FEAR RESPONSE%GOBP%GO:0042596,0.16111941312321698,0.5313138078301111,0.5990319500180501,1.31609870554604,1185,4,DRD4|ADCYAP1|MAPK8IP2|GNG7
NEGATIVE REGULATION OF I-KAPPAB PHOSPHORYLATION%GOBP%GO:1903720,0.00655518394648829,0.0957322763119865,-0.9969673577415091,-1.32819990649151,48,1,SIRPA
REGULATION OF PROTEIN LOCALIZATION TO SPINDLE POLE BODY%GOBP%GO:1902363,0.982876254180602,0.993436724391485,-0.508601676224085,-0.677579555194827,7346,1,NUMA1
PRE-B CELL DIFFERENTIATION%GOBP%GO:0002329,0.896656938179889,0.967092901483838,-0.403705128468413,-0.671829891075317,6758,2,LRRC8A
ACETYLCHOLINE CATABOLIC PROCESS%GOBP%GO:0006581,0.8116291532690251,0.935317461845028,0.44297769518470503,0.7442597230756921,6057,2,COLQ
ADULT LOCOMOTORY BEHAVIOR%GOBP%GO:0008344,0.0756210756210756,0.385018945189654,0.48889094569653,1.48569449356368,553,9,DRD2|PARK2|DRD4|BTBD9
CELLULAR RESPONSE TO AMMONIUM ION%GOBP%GO:0071242,0.4196022357987779,0.751409237355489,-0.216584958020584,-1.02613269544759,3227,34,ADCY8|CRHBP|MAPK3|ABL1|CHRM2|GNAQ|GNA15|ADRBK1|LY6H|CASP6
REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0043502,0.317171454569089,0.6861326333203311,-0.23390585423917398,-1.1081953561548998,2439,34,AGT|LMCD1|PARP1|P2RX4|IL6ST|NOTCH1|SLC9A1|CAMK2B|IGF1|LMNA|NOS3|RGS2
CONVERGENT EXTENSION%GOBP%GO:0060026,0.10948905109489099,0.454106730574125,0.5919665587497089,1.42367617915428,809,5,NPHP3-ACAD11|MKKS|NPHP3|LRP6
POSITIVE REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0046628,0.64369769874477,0.8688307429995409,-0.270609107095604,-0.847783007097258,4922,10,PTPN11|SORBS1|FAM132A|INS|IRS1|GKAP1
AMYLIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0097647,0.45713897568265205,0.7719619284439659,0.449172259026377,0.986850582266923,3364,4,RAMP1|RAMP3|RAMP2
MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021815,0.850312126444415,0.949296218452153,0.573886193206881,0.765199802538091,6401,1,SRGAP2C
OMEGA-HYDROXYLASE P450 PATHWAY%GOBP%GO:0097267,0.965600644987907,0.990916952887267,0.28442037484009003,0.559421313498011,7185,3,CYP2C8|CYP2U1
MAGNESIUM ION TRANSPORT%GOBP%GO:0015693,0.251042209484106,0.631552488419609,-0.396096298389308,-1.19155461901389,1926,9,SLC41A1|MRS2|MAGT1|NIPAL3
D-ASPARTATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0070779,0.145767195767196,0.512646109386394,-0.6769361697067571,-1.3218847706703798,1101,3,SLC1A2|SLC1A3
"RNA SPLICING, VIA TRANSESTERIFICATION REACTIONS WITH BULGED ADENOSINE AS NUCLEOPHILE%GOBP%GO:0000377",0.000383484596702033,0.0111294649577428,-0.21551683980792102,-1.66693194470858,2,271,SNRPD3|SRSF4|RBMX2|SETX|SMN2|SF3A3|CSTF2|SART3|PUF60|GEMIN5|DDX41|SRSF12|PNN|HNRNPH3|SRRT|GEMIN7|POLR2F|HNRNPA1|SNRNP48|PDCD7|RBM41|DNAJC8|AAR2|SUGP1|SF3A2|SCNM1|PRCC|PPWD1|SF3B4|CPSF1|SNRPE|POLR2C|LSM5|PSIP1|CELF2|YBX1|WDR83|GEMIN8|DHX9|PTBP1|SRSF3|TXNL4A|SRPK3|HNRNPH1|SF3A1|DCPS|SRSF10|ELAVL2|HNRNPUL1|HNRNPL|NCBP2|PRPF4|POLR2J|SLU7|DDX23|RBM17|SNRNP35|DHX8|SNRPB2|SRSF9|HNRNPU|RBMX|LUC7L3|GEMIN2|CELF1|BCAS2|HNRNPH2|DDX42|MAGOH|CPSF2|CD2BP2|SRSF5|ZRSR2|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|SNRPA1|HNRNPM|DDX5|CLP1|SF1|SNW1|POLR2H|CELF4|EFTUD2|HNRNPR|RBM22|CSTF3|LSM3|FUS|WBP11|SNRNP25|RBM4B|SMU1|ZMAT2|HNRNPK|MAGOHB|EIF4A3|SNRPB|TRA2B|PABPN1|SRSF2|RBM8A|DDX39A|POLR2G|IK|SF3B2|ISY1|CPSF7|RBM4|PRMT5|SKIV2L2|CWC27|PQBP1|HNRNPA0|GPKOW|SART1|HNRNPC|POLR2L|SMN1|PRPF19
EXTRACELLULAR POLYSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0045226,0.409084871828928,0.7448505271608159,0.7969783855315401,1.0626631385362801,3079,1,HAS3
NITRIC OXIDE METABOLIC PROCESS%GOBP%GO:0046209,0.312312312312312,0.68160868787154,0.3697023073520879,1.1234912144021,2287,9,SPR|DDAH2|NQO1
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0042536,0.246617139824887,0.6280519349499749,-0.7100082712985942,-1.18156730230003,1858,2,LILRB1|GHRL
REGULATION OF PROTEIN PROCESSING%GOBP%GO:0070613,0.000128766417718259,0.00518555396908895,-0.527705899027986,-3.1065200931311296,0,74,C2|IGKV2-28|VTN|C3|CLEC3B|C1QB|ENO1|CARD16|NKD2|C1QA|CFB|CAST|C1QC|CTSZ|C7|GSN|IGKV2D-28|TMEM59|GAS1|CCBE1|SERPINE2|A2M|THBS1|XIAP|SUSD4|CD59|SERPINE1|C3AR1|MYH9|BCL2L12|CFP|C1S|ANXA2|CFI|CD55|PHB|IGHG2|SERPING1|CD81|C1R|CFH|C5AR1|SERPINF2|PRNP
REGULATION OF GLIOGENESIS%GOBP%GO:0014013,0.148358749030757,0.5154128781388279,-0.26477803709710396,-1.28627743197651,1147,37,IL6|SIRT2|RNF10|DICER1|CLCF1|APP|IL1B|SOX11|TNF|PRKCH|SYNJ1|TGFB1|GPR183|P2RX4|HES1|CXCR4|NOTCH1|DAAM2|CSF1|SLC45A3|SERPINE2|TNFRSF21|BMP2|EPHA4|LDLR
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001238,0.0537606278613473,0.335846758963324,-0.32948541559194205,-1.50436590198697,410,30,PAK2|PTEN|ATF3|PML|HYAL2|PYCARD|AGT|WWOX|TRAF2|TNFSF10|INHBA|TNFSF12|TIMP3|G0S2|GPER1|THBS1|FADD|CAV1|LTBR|TNFRSF12A
CELLULAR RESPONSE TO GAMMA RADIATION%GOBP%GO:0071480,0.12796022504252302,0.485006465714925,-0.355737400679369,-1.3518889923073198,977,17,HRAS|TMEM109|TLK2|CRYAB|YAP1|POLE3
DEPURINATION%GOBP%GO:0045007,0.574307981725343,0.835204333784353,0.45943703681355497,0.9036584342748871,4273,3,MUTYH|OGG1
REGULATION OF HORMONE METABOLIC PROCESS%GOBP%GO:0032350,0.306186267845003,0.6775726086361429,0.26739738718844397,1.1190453689491,2251,22,CYP27B1|PAX8|TRERF1|WNT4|ARNT|DGKQ|STUB1|DKK3
GLUCOCORTICOID METABOLIC PROCESS%GOBP%GO:0008211,0.9241188847974751,0.9776627603891009,-0.25655220888994196,-0.6149066900418001,7026,5,CACNA1H|HSD11B1
MITOCHONDRION MORPHOGENESIS%GOBP%GO:0070584,0.496041496041496,0.794012168719884,0.315795297967128,0.959672784724256,3633,9,MFF|DNM1L|PNPT1
RESPIRATORY BURST AFTER PHAGOCYTOSIS%GOBP%GO:0045728,0.223268771557442,0.606473710658924,-0.722194651226909,-1.2018473872494098,1682,2,C17orf62|HCK
EXOCYST LOCALIZATION%GOBP%GO:0051601,0.6315931836624289,0.8616028929314681,0.30750137892995,0.8488493027166379,4669,7,EXOC1|EXOC3L1|EXOC3L4|TNFAIP2|EXOC3|EXOC8|EXOC3L2
CELLULAR RESPONSE TO LEUKEMIA INHIBITORY FACTOR%GOBP%GO:1990830,0.852645502645503,0.949296218452153,-0.35451623509748,-0.6922803553749589,6445,3,SBNO2|HNRNPU
MITOTIC DNA REPLICATION CHECKPOINT%GOBP%GO:0033314,0.139004689942678,0.504314492208813,-0.45008844499453604,-1.35397621179207,1066,9,CLSPN|CDC6|RAD17|ORC1|TOPBP1
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION%GOBP%GO:0010769,0.33666154633896594,0.699462084003389,-0.14826731966968,-1.06009208522942,2629,175,THY1|RREB1|GOLGA4|FMR1|DHX36|DOCK5|EFNA1|ARHGAP44|DSCAM|S100A10|DBN1|NGEF|CAMK2B|ABL1|CALR|NTN1|FLNA|NTRK2|SEMA3B|SEMA3D|NSMF|MAP3K13|SEMA7A|DOCK1|PDPN|SDC2|APOE|SEMA5A|SEMA3E|EPHA4|NEDD9|SLIT2|ZSWIM6|SEMA3A|SEMA6B|CFL1|MARK2|CAPRIN1|ARHGDIA|NGFR|FBLN1|EFNA5
CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0055008,0.215356537609177,0.5984093321049639,-0.257439237354511,-1.2090073328592401,1651,33,SMAD4|TGFBR1|SMAD7|TBX20|DLL4|TGFB2|NRG1|TGFB1|TNNT2|ZFPM2|RYR2|MYOM1|MYLK2|NOTCH1|S1PR1|PKP2|BMP2|TGFBR3|IGSF22|FKBP1A|ENG
REGULATION OF EPITHELIAL CELL PROLIFERATION%GOBP%GO:0050678,0.000257964658841739,0.00819882332206558,-0.275429005302192,-1.9452385806340602,1,165,TGFB1|STAT5A|RGCC|KIAA1462|CCL11|CDK6|NR4A1|FLT1|LAMC1|MYDGF|HMGB2|TBX1|ZFP36L1|RUNX3|DAB2IP|TINF2|KDR|STXBP4|EMC10|PDCD6|CCL24|CDKN1C|MED1|SYNJ2BP|SFRP2|EGFL7|GATA3|ATPIF1|CAV2|VEGFC|GPX1|CASK|RREB1|FLT4|TNFSF12|MEF2C|PRKD1|F3|SNAI2|CDKN2B|FGF10|GHRL|HMOX1|SPARC|HRAS|SULF1|IGF1|CCL2|CEACAM1|APOE|APLNR|DEAF1|HYAL1|VEGFB|NRP2|ECM1|BMP2|TGFBR3|THBS1|TEK|ATOH8|NR1D1|FGF7|SEMA5A|NME2|NR2F2|CAV1|MYC|PPARG|ANG|MAGED1|MCC|ACVRL1|PDGFB|NME1|C5AR1|NGFR|BAD
NEGATIVE REGULATION OF INTESTINAL ABSORPTION%GOBP%GO:1904479,0.30327759197324394,0.6762596203943579,-0.8448941332157042,-1.12560185648854,2266,1,HAMP
NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION%GOBP%GO:0033689,0.0328491923442378,0.259301942046198,0.639930542609489,1.65585789108671,241,6,NELL1|SFRP1|PLXNB1|ATRAID|EIF2AK2
PROTEIN MATURATION BY IRON-SULFUR CLUSTER TRANSFER%GOBP%GO:0097428,0.818956476140535,0.9389317625496709,-0.20343658113388896,-0.7197288747649442,6246,14,ORAOV1|MAGEF1
COLLATERAL SPROUTING IN ABSENCE OF INJURY%GOBP%GO:0048669,0.43194481294773207,0.760487817191567,-0.626137303556658,-1.0419926000013,3255,2,APP|COBL
REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0042984,0.705836373110995,0.894639008000397,-0.266514101769992,-0.8017396534320741,5417,9,NECAB2|BACE2
CELLULAR RESPONSE TO LEAD ION%GOBP%GO:0071284,0.472174259529818,0.7831522581932591,0.764887516541685,1.01987429485092,3554,1,ANXA5
LYMPHATIC ENDOTHELIAL CELL MIGRATION%GOBP%GO:1904977,0.9771550006640991,0.9927322181739301,0.510531539479488,0.680724920417004,7356,1,LGALS8
REGULATION OF METANEPHRIC MESENCHYMAL CELL MIGRATION BY PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:1900238,0.000529100529100529,0.0139529201631112,-0.93448770265799,-1.8248176383564498,3,3,PDGFRB|PDGFA|PDGFB
TONGUE DEVELOPMENT%GOBP%GO:0043586,0.763504434291857,0.9191113740914171,0.389896351853526,0.7668801132992429,5681,3,HDAC1|HDAC2
OXYGEN METABOLIC PROCESS%GOBP%GO:0072592,0.666086956521739,0.880719592999549,-0.6706550507278339,-0.8934735613437429,4978,1,ME3
POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010661,0.28430096329081,0.6570343640886271,-0.402634480043817,-1.15912831514699,2183,8,SOD2|CDKN2A|CAMK2A|PPARG
"POSITIVE REGULATION OF PROTON-TRANSPORTING ATP SYNTHASE ACTIVITY, ROTATIONAL MECHANISM%GOBP%GO:1905273",0.0461538461538462,0.30746333312705,-0.975518306131451,-1.2996246195258998,344,1,TMSB4X
BASOPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002276,0.75242396068535,0.915314007578303,0.624448610498456,0.832617963465015,5664,1,KARS
NEGATIVE REGULATION BY HOST OF SYMBIONT MOLECULAR FUNCTION%GOBP%GO:0052405,0.7622039000130871,0.918894867010027,-0.3477666640014289,-0.761333923793103,5823,4,RAB9A|ANXA2
SYNCYTIUM FORMATION%GOBP%GO:0006949,0.441377497371188,0.7653693162885199,-0.36899511707776705,-1.00863169742972,3357,7,ADAM12|TCTA|CACNA1H|PGK1
DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS%GOBP%GO:0046386,0.8592175847180429,0.95085214971704,-0.181420225261261,-0.689441158124585,6566,17,DCTPP1|NUDT1|NUDT16|NUDT18|SAMHD1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION%GOBP%GO:0044340,0.8095798979191209,0.934773247538071,-0.330745078285739,-0.724070114510757,6185,4,WNT3
MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN PROGRAMMED CELL DEATH%GOBP%GO:1902686,0.558084772370487,0.8267682185551151,-0.247703120658749,-0.9205607088329659,4265,16,STPG1|BAD
REGULATION OF NECROPTOTIC PROCESS%GOBP%GO:0060544,0.7451033732317741,0.9112137767014771,0.22951979681521104,0.7800931473283,5477,12,RIPK1|CASP8|SPATA2|CFLAR|PELI1|BIRC2
RESPONSE TO ZINC ION%GOBP%GO:0010043,0.264423708765935,0.639661268021129,-0.2956739505859389,-1.16818019481785,2011,19,HAAO|MT1M|MT2A|SLC30A5|MT1E|CRIP1
GLOMERULAR VISCERAL EPITHELIAL CELL MIGRATION%GOBP%GO:0090521,0.0270910047343503,0.23271567002476898,-0.686300463269358,-1.6449312522744701,205,5,NUP93|ANLN|KANK1|NUP188|KANK2
NEGATIVE REGULATION OF COLLAGEN BINDING%GOBP%GO:0033342,0.469119404967459,0.780769690730001,0.766596823996471,1.02215342570014,3531,1,GTPBP4
NEGATIVE REGULATION OF CHROMATIN SILENCING%GOBP%GO:0031936,0.156642259414226,0.5259991179339351,-0.42394294882089795,-1.32815791695467,1197,10,TET1|H1F0|PHF2|ATAD2|H1FX|HIST1H1C
NEGATIVE REGULATION OF T CELL PROLIFERATION%GOBP%GO:0042130,0.009031413612565441,0.119944947211922,-0.40523495812923105,-1.8098246458665201,68,28,CD274|LILRB1|NDFIP1|TNFRSF14|TWSG1|PDCD1LG2|SPN|PLA2G2D|LILRB2|GPNMB|PRKAR1A|SDC4|CEBPB|C10orf54|CD86|TNFRSF21|LGALS9|PRNP
PROTEIN HEXAMERIZATION%GOBP%GO:0034214,0.435001359804188,0.762034923704788,0.318410378221694,1.00874560118637,3198,10,LRRC8C|PANX1|C10orf2|SPAST|MAT2A|YME1L1
REGULATION OF DNA HELICASE ACTIVITY%GOBP%GO:1905774,0.0962962962962963,0.427566585262796,-0.7157307281439491,-1.3976407108578,727,3,MNAT1|GTF2H2
POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY%GOBP%GO:0045799,0.896825396825397,0.967166974453851,-0.332028234256094,-0.6483669892921159,6779,3,TPR|SIRT6|TAL1
ACTIVATED T CELL PROLIFERATION%GOBP%GO:0050798,0.0545284030010718,0.33896362399005303,0.8555279845602429,1.4373974757506,406,2,CADM1|BTN3A1
POSITIVE REGULATION OF LIPOPOLYSACCHARIDE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0031666,0.511713126554116,0.801554805389805,-0.43302723649205394,-0.9479871396368951,3909,4,CD180|LY86|SASH1
REGULATION OF VIRAL ENTRY INTO HOST CELL%GOBP%GO:0046596,0.00130770236694128,0.0284733155294161,-0.49233804677461207,-2.03889995397066,9,22,TRIM38|FCN3|CD74|CD4|PVRL2|HS3ST5|FCN1|GSN|LGALS9|IFITM1|LGALS1|IFITM2|IFITM3|MID2|P4HB
NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009123,0.000255754475703325,0.00819882332206558,-0.26585960835031897,-1.90317525330545,1,176,TPI1|ATP5C1|NUDT11|COX7C|CYC1|TYMS|NDUFC2|TGFB1|NDUFV2|NDUFB8|SDHC|GMPR2|NDUFS4|PGAM2|LHPP|UQCRC1|NDUFB5|NADK|SURF1|DNPH1|ATP1B1|UQCR10|PARP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|NDUFA3|NDUFB6|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|HPRT1|RFK|GAPDH|NDUFS6|COQ7|UMPS|NDUFB4|NUDT4|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
CELLULAR TRIGLYCERIDE HOMEOSTASIS%GOBP%GO:0035356,0.819680994863477,0.9392981563751751,0.29777445167109495,0.716145848678102,6063,5,C1QTNF3|DGAT2|SIRT1
LACRIMAL GLAND DEVELOPMENT%GOBP%GO:0032808,0.202633700618113,0.581093803625381,0.639564931742098,1.25794874710923,1507,3,FGFR2|IGSF3
DNA-TEMPLATED VIRAL TRANSCRIPTION%GOBP%GO:0039695,0.545819397993311,0.817297924969912,-0.7299845610939569,-0.972514715006973,4079,1,DHX9
NEGATIVE REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010730,0.39373839214645795,0.7376723208557521,-0.6423354433030469,-1.0689488948166,2967,2,MPV17L
REGULATION OF DEATH-INDUCING SIGNALING COMPLEX ASSEMBLY%GOBP%GO:1903072,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
REGULATION OF COLLAGEN METABOLIC PROCESS%GOBP%GO:0010712,0.0195640756302521,0.192628124925339,-0.42476820221693895,-1.7041618915247398,148,20,ITGB1|TGFB1|RGCC|MFAP4|TGFB3|CREB3L1|FAP|C10orf54|F2R|VIM|SERPINF2|CST3
RESPONSE TO FOLLICLE-STIMULATING HORMONE%GOBP%GO:0032354,0.0592995489519767,0.352751375787962,-0.842404190791288,-1.40189528403522,446,2,NOTCH1|TGFBR3
PEPTIDYL-PROLINE HYDROXYLATION TO 4-HYDROXY-L-PROLINE%GOBP%GO:0018401,0.0984118719083572,0.433111615911322,-0.501075909662177,-1.4425274131124,755,8,P4HA2|P4HTM|P4HA3|P4HA1|P4HB
PEPTIDYL-L-CYSTEINE S-PALMITOYLATION%GOBP%GO:0018230,0.426441741859553,0.755007255274521,-0.24583065683404698,-1.01804871304811,3260,22,ZDHHC11|ZDHHC15|ZDHHC9|ZDHHC4|ZDHHC12|ZDHHC19|ZDHHC24|ZDHHC2
VIRION ASSEMBLY%GOBP%GO:0019068,0.47402429568363896,0.7841690501265359,-0.202885815941978,-0.9856083577604342,3667,37,MVB12B|APOE|CHMP4A|RAB1B|CHMP6|UBC|VPS37C
BMP SIGNALING PATHWAY%GOBP%GO:0030509,0.840667094291212,0.947352187571908,-0.139513428330188,-0.744965253303013,6552,51,USP9X|CFC1|SMAD6|SMAD5|SLC33A1|SMURF2|CHRD|DDX5|MAPK3|HFE|BMP2|TGFBR3|ENG|ACVRL1
PROTEIN DESUMOYLATION%GOBP%GO:0016926,0.951104100946372,0.9857459800846659,-0.20854911891767103,-0.570059716446251,7235,7,SENP2|SENP5
MITOTIC DNA REPLICATION MAINTENANCE OF FIDELITY%GOBP%GO:1990505,0.226988975959623,0.609201573718782,0.887957653286281,1.18397171599476,1708,1,BRCA2
POSITIVE REGULATION OF CELL KILLING%GOBP%GO:0031343,0.7202396457410791,0.9011702004471139,-0.17705913179917201,-0.815989956359592,5529,31,CD1D|PRF1|HLA-B|PVR|MICA|NCR3|HLA-E|HLA-C|HLA-A|PVRL2|STX7|HFE|GAPDH|FADD
CARDIAC PACEMAKER CELL DEVELOPMENT%GOBP%GO:0060926,0.12321070234113699,0.47697345522944606,-0.937141596823997,-1.24849762793704,920,1,MAML1
POSITIVE REGULATION OF AMPA RECEPTOR ACTIVITY%GOBP%GO:2000969,0.3596387907341971,0.7155384949577859,-0.499692133936629,-1.09393053561039,2747,4,ARC|NLGN3|ADRB2
PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002221,0.00935058281029845,0.122415021281702,-0.27701023298343497,-1.66505593376515,72,80,TLR1|IRAK3|HSP90B1|ITGB2|PIK3AP1|TLR2|CTSS|TICAM2|TNFAIP3|IKBKE|MAPKAPK2|UNC93B1|IFIH1|IRF7|IRAK1|FCN1|TNIP1|PIK3R4|COLEC12|CD36|LGALS9|FADD|UBC|CD300LF|TLR5|TICAM1|TRAF3|RELA|TLR4|S100A8|ITGAM|S100A9|CD14|LY96
MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0007064,0.321854131203352,0.689907619319016,-0.32238432017853996,-1.1097093474360802,2457,13,GSG2|BOD1|NAA50|SGOL1|SMC1A|CDCA5
MULTI-ORGANISM MEMBRANE ORGANIZATION%GOBP%GO:0044803,0.0152471083070452,0.166148433567765,-0.6387085015856769,-1.7458812062854,115,7,HYAL2|CD4|PPIA|GAS6|PVRL2|CXCR4
NEURAL FOLD FORMATION%GOBP%GO:0001842,0.8315202971610509,0.9443784929910591,-0.44318163289486995,-0.737525107208633,6267,2,LUZP1
CARBAMOYL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0070409,0.206667552131757,0.586366512053115,0.898213498014998,1.19764650109008,1555,1,CAD
CHEMOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042033,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
NEGATIVE REGULATION OF MYOSIN-LIGHT-CHAIN-PHOSPHATASE ACTIVITY%GOBP%GO:0035509,0.842582851130984,0.9481593344082329,-0.29170505908056704,-0.6991613641675072,6406,5,ROCK1|TNF|NCKAP1L
TOXIN METABOLIC PROCESS%GOBP%GO:0009404,0.5264121338912129,0.8096880606828628,-0.29790741112290603,-0.9333050300820391,4025,10,N6AMT1|FMO2|SQRDL
NEGATIVE REGULATION OF UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:2000059,0.33839563862928396,0.699996274211787,-0.22227378918135302,-1.08779838525082,2606,38,UCHL5|OGT|BAG5|PARK7|UBXN1|HFE|GIPC1|TLK2|TAF9|AK6
CONTACT INHIBITION%GOBP%GO:0060242,0.0280288146692862,0.23695007643596103,-0.6375313922031429,-1.63990248284553,213,6,CDHR2|SMO|FAP|YAP1|PTPRJ
ARGININE METABOLIC PROCESS%GOBP%GO:0006525,0.15379385368506898,0.5225398777782271,0.418015719763646,1.3243020560238898,1130,10,ASL|DDAH1|DDAH2|CAD|NAGS
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS%GOBP%GO:2000107,0.16647127784290697,0.53863486872938,-0.29625298990479304,-1.27718815064121,1277,25,CXCL12|JAK3|LILRB1|CCL19|MERTK|HCLS1|GAS6|TNFRSF4|IRF7|AXL|FADD|FOXP1|BCL6
CARBOHYDRATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0034219,0.37571951857666097,0.726563632315284,-0.285978194373505,-1.06280570314626,2871,16,SLC2A10|SLC2A6|SLC45A3|SLC2A3|SLC45A1
ACTIVATION OF JNKK ACTIVITY%GOBP%GO:0007256,0.5630952380952379,0.8286316188106659,-0.47340769068231603,-0.924445235216598,4256,3,MAP3K13
INNER MITOCHONDRIAL MEMBRANE ORGANIZATION%GOBP%GO:0007007,0.0696227148969273,0.37596389138254704,-0.287505938585647,-1.43985999450043,536,41,ATP5J|ATP5F1|OPA1|CHCHD3|APOO|ATP5B|ROMO1|ATP5O|CHCHD6|TIMM9|ATP5H|TIMM10|UQCC3|ATP5G1
"NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION, CHOLINERGIC%GOBP%GO:0032223",0.499933110367893,0.7951717058944731,-0.7540802823114251,-1.0046160013924998,3736,1,ACHE
POSITIVE REGULATION OF AXON GUIDANCE%GOBP%GO:1902669,0.46404715127701396,0.7777638773705721,-0.382826956367969,-0.984734060041374,3542,6,DSCAM|SEMA5A
"WNT SIGNALING PATHWAY, PLANAR CELL POLARITY PATHWAY%GOBP%GO:0060071",0.7789133247089259,0.924704689181848,-0.161705086649945,-0.7786552453044571,6020,36,RHOA|AP2A1|SMURF1|DVL3|CDC42|RAC1|PRICKLE1|AP2A2|FZD4|FZD2|CELSR1|SMURF2|CLTC|VANGL1|TIAM1|PRICKLE2|AP2M1
AMP CATABOLIC PROCESS%GOBP%GO:0006196,0.9562541806020071,0.9877474384126891,-0.521559329510366,-0.6948422606881911,7147,1,AMPD3
EXIT FROM HOST CELL%GOBP%GO:0035891,0.670988867059594,0.8815356925073421,-0.320129401710009,-0.82345905961101,5122,6,VPS4A|PPIA|RAB7A
NUCLEOSOME ORGANIZATION%GOBP%GO:0034728,0.00012863390789812198,0.00518555396908895,-0.388455311005269,-2.5204365302627703,0,109,ITGB3BP|CTCF|ANP32E|CENPL|CENPU|SRCAP|CENPW|H1F0|HIST1H2BE|SMARCA4|SET|HMGB2|H2AFX|OIP5|RUVBL1|CENPM|SMARCE1|HIST1H2BN|NPM1|ASF1B|CHAF1A|CENPI|IPO4|HIST1H2BC|SUPT16H|PIWIL1|SMARCD3|HIST1H4I|STRA13|ANP32B|RBBP7|CENPH|NAP1L4|SMARCD2|HIST2H3A|HIST2H2BF|SPTY2D1|H1FX|HIST3H2A|HIST1H2BG|HIST1H2BD|CHAF1B|HIST2H4A|HIST2H3C|HIST1H3H|POLE3|HIST1H1C|H2AFY|HIST2H4B|CENPK|H3F3B|MIS18A|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ|CENPP
REGULATION OF CRISTAE FORMATION%GOBP%GO:1903850,0.6444680286548161,0.8688307429995409,-0.5412186379928321,-0.900674360987478,4857,2,PINK1|CHCHD10
NEGATIVE REGULATION OF INTERLEUKIN-2 BIOSYNTHETIC PROCESS%GOBP%GO:0045085,0.7277792517909258,0.9059042547382851,-0.50366694237662,-0.83818233451448,5485,2,PTPRC|FOXP3
PEPTIDYL-GLUTAMINE MODIFICATION%GOBP%GO:0018199,0.0442122186495177,0.29950475077556604,0.8688723462917008,1.4598177264197298,329,2,QPCT|QPCTL
ARGINYL-TRNA AMINOACYLATION%GOBP%GO:0006420,0.5210342979635579,0.806328805769539,0.5824354020642571,0.978566676746732,3888,2,RARS2|RARS
NEGATIVE REGULATION OF SUPEROXIDE ANION GENERATION%GOBP%GO:0032929,0.8830769230769231,0.9629606199413431,-0.561259373621526,-0.7477322519870059,6600,1,AATF
POSITIVE REGULATION OF SODIUM-DEPENDENT PHOSPHATE TRANSPORT%GOBP%GO:2000120,0.224481605351171,0.6078034241178771,-0.8843736215262459,-1.17819801450237,1677,1,CEBPB
ADENYLATE CYCLASE-INHIBITING G PROTEIN-COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007196,0.20994105037513397,0.591291692741505,0.7303556658395369,1.2270918186475401,1566,2,GRM4|GRM8
NUCLEAR POLYADENYLATION-DEPENDENT MRNA CATABOLIC PROCESS%GOBP%GO:0071042,0.6193451976633609,0.854944793214197,0.39443212358558094,0.866584173450374,4558,4,PNPT1|EXOSC8
EXCRETION%GOBP%GO:0007588,0.044284940411700995,0.299837652558536,0.426948385560635,1.5748365995190599,326,15,ADORA2B|NPHP1|AQP5|CHRNB2|CHRNB4|KCNMA1|NEDD4L|CHRNA3
FATTY ACID BETA-OXIDATION USING ACYL-COA OXIDASE%GOBP%GO:0033540,0.668982695332984,0.8815356925073421,-0.23701021231098102,-0.8385074722727249,5102,14,ACAA1|HSD17B4|DECR2|AMACR|SCP2|ECI2|CROT|CRAT|ACOX1|ABCD1
REGULATION OF CHOLESTEROL TRANSPORTER ACTIVITY%GOBP%GO:0060694,0.0963210702341137,0.427566585262796,-0.949437582708425,-1.26487883357543,719,1,PPARG
CORECEPTOR-MEDIATED VIRION ATTACHMENT TO HOST CELL%GOBP%GO:0046814,0.337123745819398,0.699462084003389,-0.828297309219233,-1.10349090179279,2519,1,PVRL2
REGULATION OF LYMPHANGIOGENESIS%GOBP%GO:1901490,0.22387459807074,0.607146964504641,0.7219381060732489,1.21294923140505,1670,2,FOXC1|VASH1
MEDIUM-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0001579,0.8361634385778721,0.9458813323967309,-0.43923676021534397,-0.7309602082373309,6302,2,SLC27A4
CELLULAR RESPONSE TO HEAT%GOBP%GO:0034605,0.0950343575781149,0.42498053239300104,-0.2739679278931,-1.37206021235607,732,41,HSPA13|SLU7|PDCD6|HSBP1L1|C8orf4|VCP|DHX36|BAG3|HSPA6|HSPA9|RBBP7|HMOX1|THBS1|PRKACA|HSP90AA1|HSPA5
EMBRYONIC HEMOPOIESIS%GOBP%GO:0035162,0.6703713389121341,0.8815356925073421,-0.26339152598613397,-0.82517126766754,5126,10,KDR|TAL1|TGFBR2|FLT3LG
VESTIBULAR REFLEX%GOBP%GO:0060005,0.26247491638796,0.638240557311977,-0.865736656374063,-1.15336910192042,1961,1,TMC2
POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010986,0.0583903208837454,0.34885102442576,-0.6395941917300121,-1.5329852317715902,443,5,LDLR|ANXA2
RAP PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032486,0.0513859832635983,0.32705736695943605,-0.501171883485278,-1.5701060877586699,392,10,RAP1B|RAP2C|RAPGEF1|RAP2B|PLK2|RAPGEF3|RAP1A
POLYADENYLATION-DEPENDENT NCRNA CATABOLIC PROCESS%GOBP%GO:0043634,0.42047844374342797,0.751774348695433,-0.37596591947505803,-1.02768607492422,3198,7,EXOSC3|EXOSC2
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN%GOBP%GO:0002237,0.000128221566867547,0.00518555396908895,-0.33782727795742695,-2.25976542401104,0,126,CXCL1|CD274|TGFB1|CXCL2|LILRB1|SBNO2|LYN|ADAM9|C4B|MTDH|TLR1|PYCARD|JUNB|IL18|IRAK3|HMGB2|DAB2IP|IFNAR1|TLR2|PDCD1LG2|TICAM2|IRF5|SSC5D|TNFRSF11A|IL1RN|FCGR2B|GGT1|PDE4B|CASP1|ERBB2IP|TNFAIP3|LILRB2|MAPKAPK2|MEF2C|CTR9|SLC11A1|CARD16|IRAK1|NR1H3|CCL2|F2R|CD86|NLRP3|AXL|NOS3|HCK|CD36|OTUD5|LGALS9|NR1D1|PABPN1|FOXP1|TICAM1|CCRN4L|SERPINE1|RELA|PLAA|NFKB1|TLR4|VIM|GSTP1|CD14|LY96|TNFRSF1B|HNRNPA0|SIRPA
NEGATIVE REGULATION OF PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000757,0.49607843137254903,0.794012168719884,-0.287008070311075,-0.960642884356212,3794,12,BRCA1|TAF7|KLF15|SPI1
DNA REPLICATION INITIATION%GOBP%GO:0006270,0.188894723024416,0.5632471197622879,-0.34694307230118604,-1.25969405647802,1438,15,MCM10|PURA|ORC1|ORC6|CDC45|MCM2|POLA1|POLA2
TRICARBOXYLIC ACID TRANSPORT%GOBP%GO:0006842,0.796022574576727,0.9299728593747351,0.376708875729812,0.740941903988467,5923,3,SLC13A4|SLC25A1
VESICLE-MEDIATED TRANSPORT TO THE PLASMA MEMBRANE%GOBP%GO:0098876,0.255785123966942,0.6348055504295711,0.19438721285633198,1.14410717075803,1856,70,EXOC4|CCDC93|KIF13A|LLGL1|ARL3|RAB10|FAM21C|SYS1-DBNDD2|GCC2|EXOC6B|GGA1|MICALL1|GOLPH3L|SPTBN1|LRRC7|WASH1|RAB11B|VPS35|RAB11A|BBS2|BLZF1|EXOC1|GOLGA7
DOUBLE-STRAND BREAK REPAIR VIA BREAK-INDUCED REPLICATION%GOBP%GO:0000727,0.381641241451867,0.7296501420979891,-0.44251290807865096,-1.06061900142962,2901,5,GINS2|CDC45|MUS81
SULFUR COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0044272,0.873343562561027,0.959352672679547,0.115194708560554,0.7738046617676121,6260,124,PAPSS1|SLC35D2|LIAS|GSTM2|PPT2|GSTM4|B3GNT2|B4GALT5|B3GNT7|GSTM1|CHPF|GSTK1|CHST15|CSPG5|MGST3|MTHFR|CSGALNACT2|ACAT1|GSS|GLCE|ST3GAL4|ST3GAL6|MRI1|ENOPH1|HACD1|GCLM|SLC35B2|CTH|GSTT2B|CHSY1|DLD|ELOVL6|AKR1A1|SLC35B3|SLC25A1|MTAP|MPST|MGST2|MAT2A|GSTZ1|SLC26A1|TPK1|CHST1|ST3GAL3|GSTM3
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN MAMMARY GLAND SPECIFICATION%GOBP%GO:0060595,0.613879957127546,0.852182158593687,0.5426020733436789,0.911641541406907,4581,2,FGFR2
PROTEIN LOCALIZATION TO NUCLEAR BODY%GOBP%GO:1903405,0.360340018594767,0.7155384949577859,0.8211843846493159,1.0949385721752298,2712,1,WRAP53
NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS%GOBP%GO:0050687,0.321260460251046,0.689291724169437,-0.28565027315665303,-1.10842929603053,2456,18,IFIT1|NPLOC4|DHX58|RNF26
POSITIVE REGULATION OF TELOMERASE ACTIVITY%GOBP%GO:0051973,0.5827308689128361,0.838862400059828,0.19095256226761104,0.9093251497009941,4271,33,HMBOX1|PARN|ACD|WRAP53|POT1|MAP2K7|MAP3K4|XRCC5|PNKP|HNRNPD|TNKS|MAPK1|NEK7|TCP1
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING%GOBP%GO:1905597,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
POSITIVE REGULATION OF GLUTAMATE NEUROTRANSMITTER SECRETION IN RESPONSE TO MEMBRANE DEPOLARIZATION%GOBP%GO:0061646,0.22473103997874902,0.6078034241178771,0.8889501543890609,1.1852950822943,1691,1,RAB3GAP1
PIGMENTATION%GOBP%GO:0043473,0.0341334813375885,0.26378188727568896,0.281695893002116,1.5193054288631298,245,51,BBS5|KIF13A|BBS4|CITED1|HPS1|KIT|HPS4|VPS33B|BLOC1S3|ATP7A|AP1M1|MKKS|NF1|RAB11B|RAB11A|MREG|AP3B1|BBS2|MYO5A|BBS7
GENETIC IMPRINTING AT MATING-TYPE LOCUS%GOBP%GO:0071515,0.559702483729579,0.8268422944617521,0.7189567710630791,0.958631843321884,4213,1,RTFDC1
PROTEIN TRANSPORT INTO PLASMA MEMBRANE RAFT%GOBP%GO:0044861,0.45752508361204,0.772025274257641,-0.772276135862373,-1.02885724740446,3419,1,ATP1B1
CELLULAR RESPONSE TO INTERLEUKIN-1%GOBP%GO:0071347,0.00930173292558614,0.121992788205563,-0.267009540214921,-1.6423264537370401,72,87,CCL11|FBXW11|HYAL2|MAP3K3|PYCARD|PLCB1|IRAK3|CCL19|DAB2IP|CCL24|RBMX|HYAL3|IL1RN|CCL3L3|CCL18|CD47|MAPK3|IL1RAP|IRAK1|SKP1|CCL2|NFKBIA|HYAL1|UBC|CX3CL1|CCL4L2|CCL14|RELA|IL1R1|MAPK13|NFKB1|RPS6KA4|TOLLIP|PELI3|SQSTM1|SIRPA|PTGIS
REGULATION OF GLIAL CELL MIGRATION%GOBP%GO:1903975,0.37782745923198297,0.7281989978224692,-0.443959804850813,-1.06408693689918,2872,5,GPR183|P2RX4|CSF1
FC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038093,0.7756541816316059,0.9238786609609481,-0.126100935614099,-0.8324473559296709,6046,118,PRKCQ|MALT1|ARPC1B|MAP3K1|FCGR3A|FYN|TRAF6|IGHG1|GRAP2|PLCG2|LCP2|CDC42|PAK2|SYK|NFATC2|RAC1|WIPF3|IGKV3-11|ACTG1|LYN|NCKAP1L|VAV3|WASF2|IGHG4|NCKIPSD|FGR|FCGR1A|ARPC1A|LAT2|VAV1|MYO1G|WAS|FCGR2B|IGKV2-28|MYO10|ELMO1|GRB2|MAPK9|FCER1G|PIK3CB|MAPK3|ABL1|NFATC1|FCGR2A|DOCK1|CYFIP2|IGKV2D-28|HCK|RELA|NFKB1|HSP90AA1|ACTB|NCK1|IGHG2
NEGATIVE REGULATION OF CORTICOTROPIN SECRETION%GOBP%GO:0051460,0.29886287625418106,0.671387424531401,-0.8471548301720341,-1.12861364765973,2233,1,CRHBP
PROTEIN PRENYLATION%GOBP%GO:0018342,0.8930073606729759,0.965443067117994,-0.234517091383707,-0.64104201115696,6793,7,PGGT1B|CHM|FNTB
REGULATION OF TUMOR NECROSIS FACTOR (LIGAND) SUPERFAMILY MEMBER 11 PRODUCTION%GOBP%GO:2000307,0.511571906354515,0.801504475859147,-0.7476290251433609,-0.996021377806446,3823,1,ADAM8
LIPID CATABOLIC PROCESS%GOBP%GO:0016042,0.289803220035778,0.6622817015650171,-0.16141763233085502,-1.0969989199919399,2267,135,PNPLA2|FABP3|GLA|DAGLB|PLA2G4D|PLA2G4A|NEU4|SMPDL3A|SPP1|ACAD10|ACOX1|PLA2G4C|STS|CYP46A1|SCARF1|APOE|PLA2G16|FABP4|FUCA1|DAGLA|SLC27A4|SRD5A3|LPIN3|ABCD1|MGLL|SMPD1|PNPLA4|HADH|LPIN2|SPHK1|HSD17B14|ETFB
HETEROCHROMATIN ASSEMBLY%GOBP%GO:0031507,0.43217665615142,0.760603358397838,-0.372041395717524,-1.01695856424464,3287,7,BAHD1|HMGA1|HELLS|SMCHD1|CDKN2A|POLE3
METANEPHRIC EPITHELIUM DEVELOPMENT%GOBP%GO:0072207,0.0165278151034668,0.17512293405535098,0.834178890481968,1.6407314379924598,122,3,PAX8|PKD1|PKD2
REGULATION OF OLIGODENDROCYTE DIFFERENTIATION%GOBP%GO:0048713,0.0613600833767587,0.35631208031004796,-0.511854685828341,-1.53978418289386,470,9,HES1|CXCR4|NOTCH1|DAAM2|SLC45A3|TNFRSF21
BEHAVIOR%GOBP%GO:0007610,0.100639421740339,0.43722178998996797,0.18232241813460898,1.2688999149348898,723,146,CALB1|DKK1|NPHP1|CHRNB1|STRA6|DRD2|RASD2|CAMK4|BBS4|GRID1|TRH|DCTN1|PARK2|EPHB2|MCHR1|DRD4|PTCHD1|CHRNB2|CHRNA5|HTT|ADCY3|BTBD9|ADCYAP1|ATP7A|PEX13|TAS2R5|CUX2|MKKS|NF1|NPHP4|CFAP69|NETO1|TRPV1|STRN|ATXN1L|DLG4|BRSK1|VLDLR
AORTIC VALVE DEVELOPMENT%GOBP%GO:0003176,0.0421671018276762,0.29452946999921803,-0.374701914934149,-1.57321653135632,322,23,GATA3|SMAD6|EFNA1|NOTCH1|ELN|SNAI2|NOS3|SLIT2|SNAI1|TNFRSF1A|TNFRSF1B
VIRAL RELEASE FROM HOST CELL%GOBP%GO:0019076,0.670988867059594,0.8815356925073421,-0.320129401710009,-0.82345905961101,5122,6,VPS4A|PPIA|RAB7A
BASEMENT MEMBRANE DISASSEMBLY%GOBP%GO:0034769,0.42568561872909705,0.7547028278218628,-0.7879907366563741,-1.04979286896024,3181,1,CTSS
REGULATION OF LIPID TRANSPORTER ACTIVITY%GOBP%GO:0110112,0.306049349960202,0.677423587903087,-0.681671316261879,-1.13441007769912,2306,2,PPARG
CLOSURE OF OPTIC FISSURE%GOBP%GO:0061386,0.9291264737406221,0.9793746057014829,0.36577692779961696,0.6145524660741889,6934,2,PHACTR4|SOX11
LYMPHOCYTE MIGRATION INTO LYMPH NODE%GOBP%GO:0097022,0.6268756698821011,0.8590556862985079,0.537468982630273,0.9030172862482159,4678,2,CCR7|WNK1
CELL DEATH%GOBP%GO:0008219,0.000251572327044025,0.00819882332206558,-0.203313931373739,-1.70792241408538,1,464,BCL2A1|FASTK|SNCAIP|MADD|RIPK3|TNFSF8|PGAM5|HMGB2|TBX1|TSPO|RYR2|BCL2L11|CHAC1|JUP|DAB2IP|ITGB2|NDOR1|GZMB|PPM1F|RRAGA|PPIF|TNFRSF10A|ESPL1|ATP2A1|TLR2|PARP1|P2RX4|TNFRSF10B|ERO1L|SEMA6A|PDCD6|CASP10|TOP1|BNIP1|CYP1B1|SOD2|TICAM2|NGF|AHR|KPNB1|OGT|IER3|BAG5|LY86|YARS|BCL2L2|ANXA6|CASP1|TOP2A|TRAF2|TAOK2|PLSCR1|DDX3X|IKBKE|SUSD6|PPP1R13B|CXCR4|KRT9|ZNF622|MELK|CSRNP1|BAG3|ELMO1|SST|IFIT2|INHBA|TNFSF12|CYCS|MLKL|CASP4|FXR1|PTPN6|IL2RA|KRT18|MRPS30|PKP2|BRCA1|DDX5|PERP|IFI27L1|SNW1|NOTCH2|TFPT|ABL1|CAPN1|IFI6|HMOX1|SRGN|TMEM123|TNFRSF10C|G0S2|CEBPB|RNF152|FAP|E2F1|IFI16|EIF4G2|HIC1|CYFIP2|STK3|BCL3|GPER1|EPHA2|CIDEB|GSN|RFK|PCSK6|DLC1|GAPDH|NLRP3|PDE1B|NFKBIA|PLAGL1|PPP2CA|TMEM109|TGFBR2|TNFRSF21|PHLDA2|FADD|ITPK1|MCM2|SLIT2|KRT7|TICAM1|EMP3|CAMK2A|LTA|CAV1|MYC|DPF1|DDIT4|SIGMAR1|TLR4|EMP1|ATG3|HINT1|ARL6IP5|CTSL|SIVA1|RRP8|ZNF385A|DPF2|TNFRSF1A|CRIP1|CD14|LY96|STPG1|KRT19|CASP6|APIP|ENDOG|DHCR24|MAGEH1|NGFR|EFNA5|FEN1|RNF130|BAD|EMP2|PTGIS
NEGATIVE REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL%GOBP%GO:0046725,0.991366715367247,0.997150662115148,0.504631671812969,0.672858242969697,7463,1,STAT1
ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071875,0.273143305439331,0.647246599153167,-0.37408322172541997,-1.1719539006755,2088,10,PDE4D|CHGA|ADRA2C|ADCY9
REGULATION OF EXECUTION PHASE OF APOPTOSIS%GOBP%GO:1900117,0.8433577405857741,0.948190600260761,-0.18184887463063698,-0.7056412649752299,6449,18,FAP|DLC1|PTGIS
MESENCHYMAL TO EPITHELIAL TRANSITION%GOBP%GO:0060231,0.325804706518799,0.69388525522863,0.4035324988854,1.1139406317277198,2408,7,CITED1|PAX8
RESPONSE TO FRUCTOSE%GOBP%GO:0009750,0.326586061676403,0.6941148928066879,0.5042201576851221,1.10779315998022,2403,4,KHK|SLC26A6|XBP1|SLC2A5
HORMONE METABOLIC PROCESS%GOBP%GO:0042445,0.48979591836734704,0.789825725811259,-0.167728332749674,-0.973931765721397,3791,70,ACHE|TSPO|PCSK5|CPE|MED1|CYP1B1|NGF|CACNA1H|PCSK1|HSD11B1|CRHBP|ATP6AP2|SPP1|CTSZ|ALDH1A2|PCSK6|HSD17B1|SRD5A3|DHCR7|DHRS3|BACE2|CPQ|HSD17B14
ACTIVATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0097296,0.362138263665595,0.716531873902738,0.655141990625862,1.1007231330578702,2702,2,CASP8|JAK2
REGULATION OF TOLERANCE INDUCTION TO SELF ANTIGEN%GOBP%GO:0002649,0.14876254180602,0.5154128781388279,-0.9232465813850899,-1.22998613098246,1111,1,TGFBR2
NEGATIVE REGULATION OF PLANT ORGAN MORPHOGENESIS%GOBP%GO:1905422,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
RELAXATION OF SKELETAL MUSCLE%GOBP%GO:0090076,0.44949832775919707,0.768229288546963,-0.7766872518747242,-1.03473391310433,3359,1,ATP2A1
PEPTIDE AMIDATION%GOBP%GO:0001519,0.0961615088325143,0.427566585262796,0.9524702249669158,1.26999052546531,723,1,PAM
PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX%GOBP%GO:0002503,0.19166666666666698,0.5660113528292919,-0.646244623359435,-1.2619519593945,1448,3,HLA-DMA|HLA-DMB|HLA-DRA
ATRIOVENTRICULAR VALVE DEVELOPMENT%GOBP%GO:0003171,0.608752792745433,0.849975128628035,-0.22323670104998303,-0.881987379700755,4631,19,HEYL|TGFB2|GJA5|OLFM1|SMAD6|EFNA1|NOTCH1|TGFBR2|BMP2|DCHS1
PSEUDOPODIUM ORGANIZATION%GOBP%GO:0031268,0.5415326902465171,0.815622645995152,0.573917838433968,0.96425607010069,4041,2,RAB25|SRGAP2C
GOLGI APPARATUS MANNOSE TRIMMING%GOBP%GO:1904381,0.812037037037037,0.935317461845028,-0.372352366301721,-0.727109799067973,6138,3,MAN1A1|MAN1C1
NEGATIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0032792,0.19329930637351103,0.567519363754568,-0.583797496277505,-1.2780547549540802,1476,4,EIF2AK4|DDIT3|FOXP3|SIK1
VACUOLAR PROTEIN PROCESSING%GOBP%GO:0006624,0.234412310957814,0.618169153148464,-0.7156876664172851,-1.19101872398109,1766,2,LGMN
SITE-SPECIFIC DNA REPLICATION TERMINATION AT RTS1 BARRIER%GOBP%GO:0071171,0.559702483729579,0.8268422944617521,0.7189567710630791,0.958631843321884,4213,1,RTFDC1
"SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE, TRANSLOCATION%GOBP%GO:0006616",0.222728456131216,0.6055424221927729,-0.427033590430952,-1.2293699390413102,1710,8,SRP19|SEC61A1|SEC61B|SRP9
REGULATION OF NK T CELL DIFFERENTIATION%GOBP%GO:0051136,0.343915343915344,0.702174649119653,-0.570034189919488,-1.11313229834124,2599,3,ZNF683|PRDM1|TGFBR2
NEGATIVE REGULATION OF RESPONSE TO DRUG%GOBP%GO:2001024,0.937567713976165,0.9806508984207809,0.16167864576814,0.5963658777676359,6922,15,MET|PDE8A|NFE2L2|NR4A3|TRAP1|SNCA
NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION UNCOUPLER ACTIVITY%GOBP%GO:2000276,0.45297658862876294,0.769943206592495,-0.7745919717688579,-1.03194249689689,3385,1,PPIF
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:1905007,0.461730668069437,0.775450927278973,-0.41005403864334206,-0.982821285115566,3510,5,TGFBR2|ENG
ALANYL-TRNA AMINOACYLATION%GOBP%GO:0006419,0.39612629344653794,0.7377402989373809,-0.641562299665334,-1.06766226016848,2985,2,AARS
NEGATIVE REGULATION OF CHLORIDE TRANSPORT%GOBP%GO:2001226,0.537277792517909,0.8137043915765061,-0.584459120723962,-0.972633438925158,4049,2,GABRE
GOLGI VESICLE BUDDING%GOBP%GO:0048194,0.000515198351365276,0.0139121625154964,-0.337075996492638,-1.96459961619313,3,71,TFG|PDCD6|TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|F8|SEC13|SEC24A|ARFGAP2|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|TRAPPC2|TMED9|GOSR2|PPP6C|SAR1B|GRIA1
NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION%GOBP%GO:1902564,0.0876890421862563,0.40905715364188894,-0.813895781637717,-1.35445273236629,660,2,FCGR2B|CD300A
NEGATIVE REGULATION OF RELAXATION OF CARDIAC MUSCLE%GOBP%GO:1901898,0.0821172724860706,0.39834333615753204,-0.819409980700303,-1.36362924139317,618,2,PDE4B|PDE4D
NEGATIVE REGULATION OF DENSE CORE GRANULE BIOGENESIS%GOBP%GO:2000706,0.506488294314381,0.798168488166378,-0.7508270842523159,-1.00028196043885,3785,1,REST
TARGETING OF MRNA FOR DESTRUCTION INVOLVED IN RNA INTERFERENCE%GOBP%GO:0030423,0.5170789163722029,0.8044475278572141,-0.431083434989795,-0.943731751820932,3950,4,DICER1|DHX9|CLP1
SPECIFICATION OF SYMMETRY%GOBP%GO:0009799,0.0993942731277533,0.435237587855294,0.254576271775137,1.35152765400408,721,48,LRRC6|BBS5|DNAI1|NPHP3-ACAD11|DLL1|BBS4|AHI1|DYX1C1|RFX3|SETDB2|KIF3B|MKKS|NPHP3|PKD2|LEFTY1|CITED2|CCDC40
"DNA-TEMPLATED TRANSCRIPTION, INITIATION%GOBP%GO:0006352",0.0105765510125113,0.13269565251378698,-0.21829220401202998,-1.54002046568612,81,164,MED10|GTF3C4|ESRRG|RORC|CDK4|GTF2E1|MED30|POLR2F|CREBBP|TFAM|MED26|PTEN|NR1I3|NCOA6|CCNH|POLR1E|NOTCH4|POLR2C|NR2F1|NR4A1|MED7|GTF3C1|NR3C1|MED13|RXRG|GTF2A2|MED8|BRF1|TRIM28|POLR2J|TAF3|RORA|NR1D2|MED1|ZNRD1|E2F2|GTF2A1|TWISTNB|TAF12|THRA|NOTCH1|CTGF|SNW1|POLR2H|NOTCH2|GTF2H1|MECP2|MAPK3|TAF7|NR1H3|NOTCH3|PPM1D|MED6|TAF9B|UBTF|BDP1|CDK7|KAT2B|NR1D1|WWTR1|MAML1|MNAT1|TAF10|PPARG|PPARA|POLR2G|YAP1|PTRF|TAF9|TEAD2|ESRRA|CCND1|MED27|AK6|MAZ|POLR2L|GTF2H2
RELAXATION OF SMOOTH MUSCLE%GOBP%GO:0044557,0.786282833642876,0.927466524783453,-0.46933464561854704,-0.78104790256201,5926,2,SOD1
POSITIVE REGULATION OF PROTEIN PROCESSING%GOBP%GO:0010954,0.0239905610907184,0.21710802307288896,-0.477385969459865,-1.68892175002583,182,14,F12|ADAM8|CLEC3B|ENO1|NKD2|GSN|CCBE1|MYH9|PHB
POSITIVE REGULATION OF G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0010971,0.0653173873045078,0.366933938653309,-0.376139554860187,-1.4860922905264802,496,19,FBXO5|CDC25B|CDC25A|CDC7|CDK4|RCC2|BRD4|RAD51C|CDC25C|MECP2|DTL|RAD51B|CCNB1|CCND1
NEGATIVE REGULATION OF ANGIOGENESIS%GOBP%GO:0016525,0.000129165590286748,0.00518555396908895,-0.39532865391681205,-2.29551637244312,0,70,DAB2IP|SARS|KLF4|HGS|SEMA6A|SYNJ2BP|E2F2|DCN|NOTCH1|FAM129B|TBXA2R|MMRN2|CREB3L1|MECP2|GHRL|SPARC|SULF1|COL4A2|HDAC5|MEOX2|STARD13|NPR1|ECSCR|EFNA3|THBS1|TEK|THBS2|SEMA3E|SERPINE1|STAB1|PPARG|PGK1|NGFR|SERPINF1|CARD10|ADGRB1
MAINTENANCE OF LOCATION IN CELL%GOBP%GO:0051651,0.0196632823544532,0.19280261638371698,-0.26631463988567394,-1.5749114200663001,152,75,C9orf114|PML|TMSB15A|SP100|GPAA1|JUP|CD4|TBCCD1|ATP2A1|TAF3|SPTBN4|HNRNPU|GAA|TLN1|HK1|PARK7|SRGN|KDELR2|SKP1|KDELR1|BCL3|GSN|FTL|SUN2|ARL2|SYNE3|CAV1|KDELR3|HSPA5|TMSB4X|FTH1|INSIG1
REGULATION OF INTERLEUKIN-2 PRODUCTION%GOBP%GO:0032663,0.130673642903859,0.4906112446453879,-0.28937332801195503,-1.32122196311357,998,30,RUNX1|CD4|CD34|PDE4B|TRAF2|TNFAIP3|PDE4D|CD86|NAV3|HAVCR2|KAT5|ANXA1|PRNP
SODIUM-INDEPENDENT ORGANIC ANION TRANSPORT%GOBP%GO:0043252,0.6591745531019979,0.8772415412127091,-0.30426963583601596,-0.83170748084703,5014,7,SLCO2B1|SLCO2A1|SLCO4A1
PHOTORECEPTOR CELL MORPHOGENESIS%GOBP%GO:0008594,0.14509646302250798,0.5122531353179961,0.774358974358974,1.3010230584573401,1082,2,CDHR1|C8orf37
POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0042998,0.49206349206349204,0.791072486428528,-0.506313196768377,-0.988701348736442,3719,3,GNB2L1|CNST
REGULATION OF NADP METABOLIC PROCESS%GOBP%GO:1902031,0.6729485669415,0.8821197733986209,-0.37690773195675703,-0.8251298131249821,5141,4,PGAM1
NEUROMUSCULAR SYNAPTIC TRANSMISSION%GOBP%GO:0007274,0.0498302783435166,0.32010831638750104,0.4462011790090101,1.56268955609814,366,13,CHRNB1|FCHSD1|RIMBP2|CHRNB2|CHRNA5|CHRNB4
CELLULAR PHOSPHATE ION HOMEOSTASIS%GOBP%GO:0030643,0.254748306548014,0.6334469481869079,0.8748897220996908,1.16654739305072,1917,1,XPR1
INTERMEDIATE MESODERM DEVELOPMENT%GOBP%GO:0048389,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
VITAMIN METABOLIC PROCESS%GOBP%GO:0006766,0.0135204738604172,0.154334841212238,-0.277171268624598,-1.63166285767689,104,74,HLCS|CBR1|KYNU|PDXP|THTPA|MCCC2|DHFR|RFK|ALDH1A2|PCCB|SLC2A3|PNPO|CYB5A|MMAB|LGMN|SHMT2|SLC25A19|FOLR2|VKORC1|PDXK|MTHFD1|ABCC1
REGULATION OF INTERLEUKIN-8 PRODUCTION%GOBP%GO:0032677,0.0261725835708733,0.227768868374794,-0.319321324952966,-1.6090981918550602,201,42,HYAL2|TLR1|PYCARD|KLF4|IL17D|TLR2|SSC5D|PARK7|ARRB1|FCN1|BCL3|F2R|LGALS9|FADD|TLR5|SERPINE1|TLR4|ANXA1|TMSB4X|CD14
REGULATION OF G2/MI TRANSITION OF MEIOTIC CELL CYCLE%GOBP%GO:0110030,0.38121693121693107,0.729499056535481,-0.5531598103010921,-1.08018091174044,2881,3,CDC25B|CDC25A|CDC25C
DEFENSE RESPONSE TO OTHER ORGANISM%GOBP%GO:0098542,0.00012853470437018,0.00518555396908895,-0.41457941558325,-2.9480877938218395,0,170,MX1|IGHV1OR15-1|SERINC3|MICA|LILRB1|IGHV5-51|HLA-E|EXOSC4|ATG7|RPL39|FCN3|BNIP3L|PYCARD|AGBL4|IGHV1-24|HIST1H2BE|TNFRSF14|GSDMD|SLAMF8|IGHV3-49|IFIT3|HMGB2|BATF|TRIM56|OASL|OAS1|IGHG4|CALCOCO2|SLFN13|TLR2|FGR|IGLL5|MPEG1|PLA2G2A|SPN|AZU1|OAS2|SLFN11|PLSCR1|HIST1H2BC|IGHV4-4|PDE12|IFIT2|HAMP|IGHV4-61|JCHAIN|MB21D1|IFI44L|ABCC9|IFIH1|IGHV1-3|IFIT1|FCER1G|APOBEC3G|ISG15|SLC11A1|IFI6|IGHV3-43|RSAD2|FLNA|IRF7|ROMO1|CEBPB|APOBEC3C|IGHV3-73|APOBEC3B|IFI16|BATF2|SERINC5|CLEC7A|TMEM173|GAPDH|RNASE6|CHGA|BST2|IGHV3-15|FADD|RARRES2|IFNLR1|HIST1H2BG|SERPINE1|STAB1|DDIT4|RELA|IFITM1|TLR4|S100A8|CFP|RNASE1|IGHV1-18|S100A9|IFITM2|FAM3A|IFITM3|IGHG2|PQBP1|HIST2H2BE|IGHA1|SAMHD1|HIST1H2BK|LYST|HIST1H2BJ|APOBEC3F|ADGRB1
CAMP BIOSYNTHETIC PROCESS%GOBP%GO:0006171,0.761129207383279,0.9183912636605319,0.23211270747660398,0.763793334113947,5607,11,ADCY2|ADORA2A|ADCY3|ADCY6|ADCY1|ADCY7
CYTOSKELETON-DEPENDENT INTRACELLULAR TRANSPORT%GOBP%GO:0030705,0.00013945056477478702,0.00527269589779738,0.288718026240788,1.9949893985397802,0,141,DYNLRB2|DYNC2H1|TTC30B|WDR19|TTC21B|DYNC2LI1|RABL2B|IFT88|TTC30A|WDR35|TTC21A|KIF13A|LCA5|DCTN1|IFT46|IFT172|IFT20|CCDC88A|IFT140|DLG2|KIF3B|TRAK2|NDEL1|CLUAP1|RAB1A|IFT81|HTT|TUBA1C|TNPO1|WDR60|CCDC88C|BLOC1S3|PCM1|MAP6|CAMSAP3|HAP1|DST|AP3B2|LRPPRC|IFT52|KIF5B|RPGR|TRAF3IP1|KIF3C|IFT27|AP3B1|RAB6A|KIF5A|MYO5A|SPG11|COPG2|TRAK1|SPAST|ARHGAP21|KIF1A|AP3M1
ESTABLISHMENT OF CHROMATIN SILENCING%GOBP%GO:0006343,0.604595563819896,0.848175106515994,0.6952470224966919,0.9270180928327041,4551,1,SIRT1
PYRIDINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0072526,0.104911591355599,0.44584061186555796,-0.555129616213495,-1.4279429171066103,800,6,NUDT17|PDXP|PNP|QPRT
GLYCEROL ETHER METABOLIC PROCESS%GOBP%GO:0006662,0.106612861234054,0.449288135667161,-0.493370963540499,-1.42034595161574,818,8,FAR1|TMEM86B|PLA2G16|DHRS7B|TMEM86A
POSITIVE REGULATION OF AMINE TRANSPORT%GOBP%GO:0051954,0.036316648531012,0.271407949603831,0.47318320668892294,1.60825768448221,266,12,DRD2|TRH|RAB3B|DRD4|CHRNB2|RAB3GAP1|KCNB1|STX1A|CARTPT
POSITIVE REGULATION OF HEXOKINASE ACTIVITY%GOBP%GO:1903301,0.31984126984127004,0.687907957122243,-0.581389896117201,-1.1353071144534699,2417,3,BAD
REGULATION OF CALCIUM-TRANSPORTING ATPASE ACTIVITY%GOBP%GO:1901894,0.15806878306878303,0.527990543848753,-0.6687437961839641,-1.3058871415289,1194,3,THADA|RYR2|PLN
THIAMINE METABOLIC PROCESS%GOBP%GO:0006772,0.302608695652174,0.675222663526765,-0.845280105866784,-1.12611606473728,2261,1,THTPA
CORONARY VEIN MORPHOGENESIS%GOBP%GO:0003169,0.15096842663836602,0.5180663310314899,-0.763931866723452,-1.27130478811823,1137,2,NOTCH1
POSITIVE REGULATION OF TRANSLATIONAL ELONGATION%GOBP%GO:0045901,0.392146457946405,0.737280445732591,-0.643092026468672,-1.07020797019094,2955,2,USP16
CELLULAR RESPONSE TO PEPTIDOGLYCAN%GOBP%GO:0071224,0.0923076923076923,0.420939346122012,-0.9515880017644459,-1.26774370810411,689,1,RELA
EVASION OR TOLERANCE BY VIRUS OF HOST IMMUNE RESPONSE%GOBP%GO:0030683,0.605525302164962,0.8484731812466321,0.694861049845611,0.92650345038288,4558,1,EIF2AK2
CELL-CELL ADHESION VIA PLASMA-MEMBRANE ADHESION MOLECULES%GOBP%GO:0098742,0.7459480319012091,0.911706491458069,-0.12949563132737502,-0.8490085687187959,5798,114,ITGB2|CXADR|AMIGO1|CLDN5|HMCN1|CLDN11|PCDHB6|PCDHB11|PCDHB13|CLDN10|PVRL2|TENM2|CBLN1|MPZL2|ICAM1|DSCAM|CDH8|PCDHB2|VCAM1|CDH11|CDH5|KIRREL3|PCDHB16|CEACAM1|ROBO4|CDH7|PCDHGB4|MPZ|TGFBR2|DCHS1|ITGAM|ADGRL1|CADM3
GLYCOSAMINOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0006024,0.29048048434883394,0.663080262067683,-0.18657787957622698,-1.10973737406352,2254,77,HS3ST5|DCN|CHST7|NDST1|GCNT2|SDC4|BGN|VCAN|OGN|B4GALT7|LUM|SDC2|FMOD|HYAL1|EXT2|B3GAT3|B4GALT1|B3GALT6|B4GAT1|CSGALNACT1|XYLT2
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0046578,0.0243964421855146,0.21958123860560197,-0.243182030264909,-1.52590982567993,191,94,MAPRE2|KANK1|MADD|LPAR6|DAB2IP|RAPGEF1|SPRY1|VAV1|NGF|OGT|ARHGDIB|CCDC125|HEG1|NOTCH1|GRB2|ARHGAP44|FOXM1|ARRB1|NOTCH2|FGF10|ABL1|IGF1|KANK2|F2R|APOE|DLC1|F2RL3|COL3A1|RASIP1|GPR4|ADGRG1|EPS8|DENND1A|MAPKAP1|ARHGDIA|ARF6|SQSTM1
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:1903750,0.8904761904761909,0.965159112268525,-0.335811946052103,-0.6557556194519101,6731,3,PARK7
INFERIOR ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:1905317,0.14876254180602,0.5154128781388279,-0.9232465813850899,-1.22998613098246,1111,1,TGFBR2
NEURON PROJECTION RETRACTION%GOBP%GO:0106028,0.7317725752508358,0.9074802896081321,-0.638343625937362,-0.850426985092207,5469,1,GSK3B
NEGATIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES%GOBP%GO:0048297,0.987514942223403,0.996030692679047,0.5058998676665201,0.674549211019118,7434,1,THOC1
POSITIVE REGULATION OF HISTONE H3-K36 METHYLATION%GOBP%GO:0000416,0.6359788359788361,0.8636797415465791,-0.44148633688275896,-0.8621109216799259,4807,3,BRD4|PAXIP1
REGULATION OF T CELL TOLERANCE INDUCTION%GOBP%GO:0002664,0.0798324826593378,0.395958593986611,-0.66166337690638,-1.4485194445441698,609,4,LILRB2|IL2RA|TGFBR2
CELL CYCLE DNA REPLICATION MAINTENANCE OF FIDELITY%GOBP%GO:1902298,0.226988975959623,0.609201573718782,0.887957653286281,1.18397171599476,1708,1,BRCA2
BRAIN-DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0031547,0.332050941894402,0.6961761803662729,-0.6687185627308221,-1.1128546245224198,2502,2,NTRK2
CYTIDINE DEAMINATION%GOBP%GO:0009972,0.12419840335034699,0.47833715299653395,-0.6254795869379499,-1.3693055645322099,948,4,APOBEC3G|APOBEC3C|CDA
TRNA WOBBLE POSITION URIDINE THIOLATION%GOBP%GO:0002143,0.31422361092242895,0.6836386259178071,0.5105693559917179,1.1217426190571698,2312,4,CTU1|MOCS3|TRMU|CTU2
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:0048661,0.0005192107995846309,0.0139121625154964,-0.457118027767774,-2.23711601042225,3,38,DNMT1|HMOX1|IGF1|P2RY6|FGF9|THBS1|AIF1|HTR1B|PDGFRB|FOXP1|MMP9|CX3CL1|IGFBP5|PDGFB|SERPINF2|ERN1
CYTOSOLIC CALCIUM ION TRANSPORT%GOBP%GO:0060401,0.255993386607881,0.634929462604421,0.21575911011854604,1.15289200361874,1857,49,DRD2|XCL1|NOL3|MCUR1|FGF2|MICU2|FAM155A|SLC25A23|CACNA1C|RYR1|PKD2|TRPV1|ATP2B4|ITPR1|JPH3|MICU1|C2orf47|SLC8A1|JPH1|CACNA2D1|CCR7|CACNB3|FAM155B|SMDT1|CCL21|IBTK
REGULATION OF HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0010908,0.32625638269282503,0.6940781026265961,0.574390647402669,1.1297586208851398,2427,3,PXYLP1|TCF7L2|CTNNB1
CELLULAR RESPONSE TO GLYCINE%GOBP%GO:1905430,0.768294314381271,0.920474726214876,-0.620368328187031,-0.8264795723652429,5742,1,FYN
PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009128,0.502760252365931,0.7970718494574169,-0.34922847830453,-0.9546004718237511,3824,7,HPRT1|NUDT4
TRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0031119,0.0862395241957286,0.40608835945563304,0.614622789615197,1.47816428446338,637,5,PUS10|PUS7|PUS1|PUSL1|PUS3
POSITIVE REGULATION OF BEHAVIORAL FEAR RESPONSE%GOBP%GO:2000987,0.296588628762542,0.6687276080240239,-0.848698720776356,-1.13067048065468,2216,1,MEF2C
REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0002889,0.781380753138075,0.925507556338125,-0.19509185148055702,-0.7570289403479591,5975,18,TGFB1|HLA-E|NDFIP1|PAXIP1|FCGR2B|PVRL2|TNFSF13|TFRC
HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0050665,0.980238188718754,0.993436724391485,-0.240388516056833,-0.5262607118766229,7489,4,SOD1
ERAD PATHWAY%GOBP%GO:0036503,0.8535645472061659,0.949296218452153,-0.126896185463106,-0.7601381405623159,6644,79,HSP90B1|FBXO6|HSPA13|UBQLN2|RNF121|HM13|TOR1A|VCP|UBE2G2|SEL1L|UBQLN1|RCN3|FAF2|HERPUD1|SEC13|NPLOC4|PSMC6|SYVN1|KIAA0368|SEC61B|SGTB|DERL3|HSPA5
NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT%GOBP%GO:2000791,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
DUMP BIOSYNTHETIC PROCESS%GOBP%GO:0006226,0.131096318434995,0.490819490032838,0.622852824984222,1.36843418232154,964,4,DCTD|CDADC1|DUT|HDDC2
REGULATION OF GRANULOCYTE CHEMOTAXIS%GOBP%GO:0071622,0.11751662971175199,0.468397810988284,-0.306576869106378,-1.35215377018508,900,27,RAC2|THBS4|RAC1|NCKAP1L|CD74|CCL19|MOSPD2|BST1|CSF1|THBS1|RARRES2|SLIT2|CMKLR1|MPP1
POLYAMINE METABOLIC PROCESS%GOBP%GO:0006595,0.448235294117647,0.768229288546963,-0.29825621934083,-0.998291492341003,3428,12,SAT1|ODC1|SMOX|SMS|SAT2
PENTOSE METABOLIC PROCESS%GOBP%GO:0019321,0.8810146443514649,0.9622426269432679,-0.208434683252307,-0.652998653473167,6737,10,NUDT5|DCXR|TKT|DHDH|TALDO1
PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION%GOBP%GO:0003402,0.840936454849498,0.947591251871983,-0.583149536832819,-0.776895205522603,6285,1,MAGI2
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT%GOBP%GO:0070167,0.28762026940346397,0.660471578149057,-0.21027165908495002,-1.12279571685337,2241,51,GAS6|TGFB3|DDR2|TXLNG|NOTCH1|MEF2C|S1PR1|ISG15|SRGN|CEBPB|GPM6B|CCR1|NOS3|ECM1|BMP2|TMEM119|ADGRV1
SMOOTH MUSCLE CELL-MATRIX ADHESION%GOBP%GO:0061302,0.0730963120191032,0.380316689710452,-0.8263027295285359,-1.37509987767676,550,2,VTN|DDR1
POST-EMBRYONIC ANIMAL MORPHOGENESIS%GOBP%GO:0009886,0.433201058201058,0.7614924524950341,-0.5315953888411971,-1.03807106210942,3274,3,FBN1|EFEMP1
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA%GOBP%GO:0090199,0.07655502392344501,0.38654270614299796,-0.28535679832687605,-1.4205706417094999,591,40,PYCARD|APOPT1|TRIAP1|BCL2L11|PPIF|HGF|OPA1|PDCD5|GPX1|PRELID1|TNFSF10|IGF1|GPER1|CIDEB|PSMD10|PLAUR|FXN|MMP9|BAD
PROTEIN RETENTION IN GOLGI APPARATUS%GOBP%GO:0045053,0.31711273317112704,0.6861326333203311,0.46466794916878107,1.1175237531074298,2345,5,VPS13C|VPS13A|SORL1|GOLPH3|VPS13D
LUNG VASCULATURE DEVELOPMENT%GOBP%GO:0060426,0.577036441586281,0.837152999580265,0.558635496507689,0.938579762481505,4306,2,STRA6
POSITIVE REGULATION OF T-HELPER 17 TYPE IMMUNE RESPONSE%GOBP%GO:2000318,0.7327656123276558,0.9077895949849131,0.32421607867985697,0.779737810004374,5420,5,NFKBID|IL12RB1|PRKCQ|MALT1|NFKBIZ
RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0051123,0.501307531380753,0.796064246542972,-0.304164690574279,-0.952908269775146,3833,10,GTF2A2|TAF12|TAF7|MED6
POSITIVE REGULATION OF INTEGRIN ACTIVATION%GOBP%GO:0033625,0.286705959397511,0.659921805918303,-0.44772322233951795,-1.15166473827257,2188,6,PLEK|PIEZO1|RASIP1
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN UNFOLDED PROTEIN RESPONSE%GOBP%GO:0006990,0.94457671957672,0.9827324445853779,-0.30524202062564504,-0.596060303009786,7140,3,CREB3
RESPONSE TO IRON(III) ION%GOBP%GO:0010041,0.853765440297516,0.949296218452153,0.572011468901632,0.762700110638946,6427,1,IREB2
RESPONSE TO DSDNA%GOBP%GO:1990784,0.965201221941825,0.990916952887267,0.516817379797089,0.689106240314136,7266,1,RIOK3
REGULATION OF PROGESTERONE SECRETION%GOBP%GO:2000870,0.490370567140391,0.7903790206418191,0.755348478164976,1.00715527430528,3691,1,GDF9
PROTEIN DEGLYCOSYLATION%GOBP%GO:0006517,0.9673069064160199,0.9912626134248801,0.122945588164471,0.562676247829549,7100,29,UGGT2|RNF103|MAN2B2|TRIM13
LIPOXYGENASE PATHWAY%GOBP%GO:0019372,0.775644397685429,0.9238786609609481,-0.31334761712057696,-0.75103444600922,5897,5,PTGS2|GPX4|ALOX5|GPX1
C21-STEROID HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0006700,0.935667752442997,0.9806508984207809,0.181121041597705,0.595999442443477,6893,11,FDX1L|FDXR|STARD3|STAR|STARD3NL|AKR1B1|FDX1|BZRAP1|ADM|TSPO|CACNA1H
COENZYME TRANSPORT%GOBP%GO:0051182,0.263551147941856,0.638950455433329,0.538655411725425,1.1834488796229299,1939,4,SLC5A6|SLC25A26
POSITIVE REGULATION OF TELOMERASE CATALYTIC CORE COMPLEX ASSEMBLY%GOBP%GO:1904884,0.172159699892819,0.5459855974578649,0.7550041356492969,1.2685044304207,1284,2,ATM|ATR
NATURAL KILLER CELL ACTIVATION%GOBP%GO:0030101,0.9674369747899159,0.9912626134248801,-0.13654672196794101,-0.547822833196786,7367,20,VAMP7|IL21R|HFE
REGULATION OF BILE ACID METABOLIC PROCESS%GOBP%GO:1904251,0.776490497266337,0.9242100851823921,-0.258184747153117,-0.743277751402899,5964,8,FGF19|NR1D1
SHORT-CHAIN FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0051790,0.5541257628018039,0.8239989905504781,-0.577904350835616,-0.9617252536444351,4176,2,THNSL2
RESPONSE TO TRICHOSTATIN A%GOBP%GO:0035983,0.296588628762542,0.6687276080240239,-0.848698720776356,-1.13067048065468,2216,1,MEF2C
L-METHIONINE BIOSYNTHETIC PROCESS%GOBP%GO:0071265,0.691190443871318,0.8879225792175841,0.31122823409646505,0.805321348245289,5091,6,MRI1|ENOPH1|CTH|MTAP
NEGATIVE REGULATION OF CELLULAR SENESCENCE%GOBP%GO:2000773,0.7096905537459279,0.896368613528548,0.24422027300608298,0.803634659236985,5228,11,TWIST1|ZKSCAN3|SLC30A10|AKT3|SIRT1
MAMMARY GLAND LOBULE DEVELOPMENT%GOBP%GO:0061377,0.516052003183868,0.804056180000979,-0.5926360311950379,-0.9862411255353241,3889,2,ID2
POSITIVE REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:1902425,0.43632263199787696,0.7626864968659259,-0.624538185828508,-1.03933141238351,3288,2,BECN1|HNRNPU
ARTERIAL ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060844,0.0613627307743392,0.35631208031004796,0.9693427437141601,1.2924877525576102,461,1,DLL1
REGULATION OF PLATELET AGGREGATION%GOBP%GO:0090330,0.10888888888888901,0.45309795582492896,-0.41854717637157896,-1.4009165885577801,832,12,CEACAM1|PDPN|SERPINE2|C1QTNF1
POSITIVE REGULATION OF 1-PHOSPHATIDYLINOSITOL-3-KINASE ACTIVITY%GOBP%GO:0061903,0.542701553991234,0.816099720857136,0.7271173356859291,0.9695128551181601,4085,1,AGAP2
BRAIN MORPHOGENESIS%GOBP%GO:0048854,0.0608282416836388,0.35631208031004796,0.435394857563479,1.52484356541682,447,13,CTNNA2|BBS4|SLIT1|MKKS|NF1|BBS2|SHANK2|FZD6|PAFAH1B1|FZD3|SHANK1
FEMALE GONAD DEVELOPMENT%GOBP%GO:0008585,0.48247907949790797,0.7867318061717721,-0.22967198922442,-0.9760994792951692,3689,24,HYAL3|INHBA|SOD1|CEBPB|SLIT2|EIF2B2|ANG|PDGFRA
MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING%GOBP%GO:0098787,0.15830823621841,0.528194339395059,-0.380271938107936,-1.30896975402621,1208,13,CSTF2|CPSF6|CPSF1|NCBP2|NCBP1|TUT1|CPSF7|ERN1
REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0045066,0.35553197134518394,0.7132037834765931,-0.659001929969672,-1.09668459380146,2679,2,FOXP3|PLA2G2D
AMINO SUGAR CATABOLIC PROCESS%GOBP%GO:0046348,0.717854217854218,0.900060477413567,0.26142675911303404,0.794451809556575,5258,9,GNPDA2|CTBS
PLACENTA DEVELOPMENT%GOBP%GO:0001890,0.0136221223266585,0.15504877515587,0.37583327768812,1.72004918318935,99,29,CYP27B1|FGFR2|CITED1|PPARD|ITGB8|BMP7|PKD1|ZNF568|CASP8|STOX2|CUL7|PKD2
REGULATION OF TRANSCRIPTION INVOLVED IN G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0000117,0.963879598662207,0.990916952887267,-0.51808557565064,-0.690214386449544,7204,1,BACH1
LIPID HYDROXYLATION%GOBP%GO:0002933,0.6990889603429801,0.892576692023752,0.49591539086576,0.833201886882427,5217,2,CYP2C8|CYP3A5
SCHWANN CELL DIFFERENTIATION%GOBP%GO:0014037,0.11925482730486801,0.47098246139817795,0.44102864861691204,1.39720857019217,876,10,ERBB3|PARD3|NF1|ARHGEF10|SKI|GPC1|CNTNAP1
REGULATION OF POTASSIUM ION TRANSPORT%GOBP%GO:0043266,0.674772036474164,0.882488012133495,0.158403851187237,0.8639484621744341,4883,53,BIN1|DRD2|ANK2|RNF207|KCNIP2|GAL|ADCYAP1|SUMO1|NEDD4|NETO1|PTK2B|KIF5B|YWHAE|KCNG1
POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE%GOBP%GO:1902952,0.0830459007694349,0.401085786714089,-0.8189137027846709,-1.3628033555807502,625,2,INS|APOE
REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST%GOBP%GO:0050691,0.00417536534446764,0.0711970927459713,-0.453118157647145,-1.9765841514048301,31,26,MUL1|LILRB1|DHX9|RNF216|DTX3L|PARP9|TRIM44|TNFAIP3|MB21D1|IFIT1|APOBEC3G|TMEM173|IFNLR1|PQBP1|APOBEC3F
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN%GOBP%GO:0003100,0.525,0.808245162096538,-0.49230683955434495,-0.9613504829940809,3968,3,ECE1|NOS3
NEGATIVE REGULATION OF T-HELPER 1 CELL DIFFERENTIATION%GOBP%GO:0045626,0.667558528428094,0.88092952466726,-0.669827966475518,-0.892371686525017,4989,1,JAK3
PROTOPORPHYRINOGEN IX METABOLIC PROCESS%GOBP%GO:0046501,0.86629938188659,0.9553059038103481,0.347027682805779,0.682562500118103,6446,3,CPOX|IREB2
D-AMINO ACID TRANSPORT%GOBP%GO:0042940,0.145767195767196,0.512646109386394,-0.6769361697067571,-1.3218847706703798,1101,3,SLC1A2|SLC1A3
POSITIVE REGULATION OF APOPTOTIC DNA FRAGMENTATION%GOBP%GO:1902512,0.9084941050375129,0.971496795604459,0.38340226082161605,0.64416530125001,6780,2,BAX|ST20
HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT%GOBP%GO:0048534,0.000382165605095541,0.0111294649577428,-0.22753853188167003,-1.7428968752246499,2,255,FST|DOCK11|ITGB1|GLO1|NOTCH4|ACIN1|TGFB1|DOCK10|UBD|LILRB1|SBNO2|LYN|GPR183|PIR|CEBPG|NCKAP1L|CD74|FNIP1|KAT6A|MT1G|JAG1|RUNX1|RIPK3|TNFSF8|CCL19|SLAMF8|EPHB3|TBX1|BATF|ZFP36L1|RUNX3|DYRK3|CD4|KLF4|SBDS|KDR|TLR2|PARP1|HCLS1|CD34|RORA|MED1|SFRP2|SPN|TNFRSF11A|CBFA2T3|ATPIF1|PLEK|FCGR2B|GAS6|PLA2G2D|TCTA|HES1|OSCAR|MELK|INHBA|RPS14|PTGER4|MEF2C|CEBPA|STAT3|HSPA9|TAL1|NFAM1|FCER1G|CDKN2B|NOTCH2|FGF10|PLD4|RSAD2|SOD1|KLF6|GLRX5|TREM2|LRP5|IFI16|HDAC5|VCAM1|LRRC8A|BATF2|KIRREL3|CSF1|JAG2|PDPN|MEOX1|EPHA2|PDE1B|MFAP5|AXL|TGFBR2|TGFBR3|LGALS9|TEK|FADD|RELB|FOXP1|MMP9|TYROBP|IL11|FLT3LG|LTBR|PPARG|MYH9|KAT8|ANXA2|CSF1R|RRAS|ANXA1|ZNF385A|ACTN1|PDGFB|SNX10|PTPRJ
REGULATION OF MYELINATION%GOBP%GO:0031641,0.22286313581541697,0.6057502695288229,-0.343637105248864,-1.2157378270404198,1699,14,TYMP|TNFRSF21|TNFRSF1B|LGI4
BONE TRABECULA MORPHOGENESIS%GOBP%GO:0061430,0.268756698821008,0.642726308906095,0.698728661550897,1.1739543679148101,2005,2,PLXNB1|SEMA4D
VIRAL GENE EXPRESSION%GOBP%GO:0019080,0.6004731239321861,0.8464076674715391,-0.22484107363230801,-0.8883261060987591,4568,19,EIF2AK4|PCBP2|EIF3F|USF1|FURIN|DENR|DHX9|PTBP1|USF2|EIF3B|MCTS1|EIF2D
REGULATION OF CHORIONIC TROPHOBLAST CELL PROLIFERATION%GOBP%GO:1901382,0.172532872891486,0.546371269738967,0.9153617115130129,1.2205113299322499,1298,1,BOK
PEPTIDYL-LYSINE TRIMETHYLATION%GOBP%GO:0018023,0.642265737941911,0.868171925756234,-0.217336047848383,-0.858674449383637,4886,19,OGT|METTL12|CTR9|HIST1H1C|SUV39H1
PROTEIN LOCALIZATION TO EXTRACELLULAR REGION%GOBP%GO:0071692,0.0336343410548358,0.261633782155535,-0.717766895361977,-1.57134177418593,256,4,FBN1|LTBP1|NBL1
INTERLEUKIN-7-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038111,0.11869747899159698,0.469617660353565,-0.33988497553416697,-1.36361201187871,903,20,BRWD1|HIST1H3D|IL2RG|JAK3|STAT5A|SMARCA4|IRS1|SOCS1|STAT3|CISH|HIST2H3A|HIST2H3C|HIST1H3H
POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY%GOBP%GO:1903307,0.0525629320464328,0.331996459809677,-0.343697893212168,-1.51587562188276,402,27,ITGB2|SNX4|STX4|FGR|SYT4|HYAL3|CACNA1H|CACNA1G|VAMP8|VAMP7|ZP3|ITGAM|CACNA1I
MRNA TRANSPORT%GOBP%GO:0051028,0.14567080189282502,0.512646109386394,-0.19071015630789898,-1.2277723604296202,1138,105,FYTTD1|NXF2B|ZFP36L1|NCBP2|SLU7|CHTOP|SRSF9|FMR1|MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|NUP37|NXF1|NUP160|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS%GOBP%GO:0015980,0.000513347022587269,0.0139121625154964,-0.258715346976591,-1.80217488641326,3,153,GYG1|PER2|UQCRC1|NDUFB5|SURF1|PID1|UQCR10|OXA1L|NDUFA9|NDUFA7|GAA|FH|SLC25A18|SDHB|PHKG2|PDHA1|NDUFA3|NDUFB6|SDHD|PPP1R3C|CYCS|NDUFB9|COA6|NDUFB10|SDHA|ACO1|SLC25A22|MT-CO3|NDUFS7|PGM5|NDUFB1|NDUFB7|NDUFA6|NDUFS6|COQ7|LYRM5|NDUFB4|NR1D1|NDUFA12|SDHAF2|GFPT2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|MYC|PYGL|NDUFA4|NDUFV1|PYGM|UQCRQ|NDUFAF2|NDUFS3|UQCRC2|COX6A1|GYG2|UQCC3|NDUFA8|NDUFS8|NDUFV3
REGULATION OF NMDA RECEPTOR ACTIVITY%GOBP%GO:2000310,0.38846572361262205,0.7352989049211659,0.30856610319282896,1.04875616804559,2855,12,EPHB2|ANXA3|PTK2B|DLG4|DAPK1|CRH
REGULATION OF BUNDLE OF HIS CELL ACTION POTENTIAL%GOBP%GO:0098905,0.5422025723472671,0.815809610803359,0.5737252234328759,0.963932452029327,4046,2,RANGRF
REGULATION OF RENAL ALBUMIN ABSORPTION%GOBP%GO:2000532,0.36428093645485,0.718457761443038,-0.8158359064843409,-1.08688932119066,2722,1,GAS6
ODONTOGENESIS%GOBP%GO:0042476,0.0138091331692644,0.15674643894187,0.348475354553314,1.6890650026541103,100,35,FOXC1|WNT6|AQP5|TUFT1|SCN5A|ITGA6|FGFR2|ROGDI|HDAC1|LAMB1|SSUH2
ENDOSOMAL LUMEN ACIDIFICATION%GOBP%GO:0048388,0.259529818036924,0.636098664976652,0.8723533303925891,1.16316545695188,1953,1,CLCN3
RESPONSE TO UNFOLDED PROTEIN%GOBP%GO:0006986,0.0070440573770491795,0.10102825149798,-0.240054739372589,-1.6088763059671998,54,127,TSPYL2|HDGF|HSPB2|HSP90B1|MYDGF|HSPA13|DAB2IP|TOR1B|RNF121|TMBIM6|TLN1|VCP|CREB3|DNAJC4|BAG3|ATP6V0D1|HSPA6|HSPA9|TPP1|MBTPS2|CREB3L1|WIPI1|CALR|HERPUD1|HSPB1|ERP44|LMNA|CCL2|HSPB7|PDIA5|SRPRB|SYVN1|SERPINH1|SSR1|EIF2S1|KDELR3|DNAJA1|DERL3|HSP90AA1|HSPA5|GOSR2|DNAJB11|DNAJB5|HSPA4|SERP1|YIF1A|ERN1
POSITIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901995,0.38121693121693107,0.729499056535481,-0.5531598103010921,-1.08018091174044,2881,3,CDC25B|CDC25A|CDC25C
ESTABLISHMENT OF GLIAL BLOOD-BRAIN BARRIER%GOBP%GO:0060857,0.390091645636871,0.7358910495632479,0.8062968681076309,1.07508807768202,2936,1,MXRA8
LIPOPROTEIN LOCALIZATION%GOBP%GO:0044872,0.238089039312679,0.6217283213739421,-0.42125602519226396,-1.21273713734971,1828,8,CD36|PPARG|PRKCB
FLAVIN-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0042727,0.16410188378880303,0.535290477921284,-0.7556691467855,-1.25755430083322,1236,2,RFK
VALINE CATABOLIC PROCESS%GOBP%GO:0006574,0.730573419078242,0.9071775056875441,0.48221670802315997,0.810186330998322,5452,2,ALDH6A1|HIBADH
PROSTATE GLAND DEVELOPMENT%GOBP%GO:0030850,0.26410155738777696,0.6395074119587459,-0.546287834724219,-1.1959382648858998,2017,4,ANXA1|CRIP1
POSITIVE REGULATION OF CELL AGING%GOBP%GO:0090343,0.241213225722468,0.6244696312630601,-0.41979604297566103,-1.20853405288786,1852,8,YPEL3|CDKN2A|MB21D1|LMNA
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS%GOBP%GO:0043618,0.95324439839399,0.986646769115929,-0.114098153952819,-0.630500512280073,7359,58,BAG3|NOTCH1|MBTPS2|CREB3L1|HMOX1|CEBPB|HIF3A|UBC|HSPA5|NCK1
VACUOLAR PROTON-TRANSPORTING V-TYPE ATPASE COMPLEX ASSEMBLY%GOBP%GO:0070072,0.48898912178296605,0.788908801349022,-0.603755643954099,-1.0047459393261802,3685,2,VMA21
NEGATIVE REGULATION OF INTERLEUKIN-6 PRODUCTION%GOBP%GO:0032715,0.0267857142857143,0.231542581971207,-0.410848248793637,-1.64831530500535,203,20,NCKAP1L|IRAK3|GAS6|TNFAIP3|PTPN6|ARRB1|GHRL|CD200|CX3CL1|TLR4|SIRPA
SYNAPTIC VESICLE RECYCLING%GOBP%GO:0036465,0.7093039095491078,0.896085288431061,0.18069159278727498,0.8269582419490992,5206,29,PLD2|SYT2|KIAA1109|SYT5|NLGN2|NLGN4X|CDK5|AMPH|PIP5K1C|SNCA|DNAJC6|FCHO2
AMINERGIC NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE%GOBP%GO:0015842,0.34297963558413697,0.701955655133333,0.6630824372759859,1.11406410866264,2559,2,SLC18A1|SLC18A2
POSITIVE REGULATION OF CGMP-MEDIATED SIGNALING%GOBP%GO:0010753,0.29123745819397995,0.663619089866607,-0.85151080723423,-1.13441685503835,2176,1,MB21D1
POSITIVE REGULATION OF SARCOMERE ORGANIZATION%GOBP%GO:0060298,0.5142015005359061,0.8027202916321279,0.58560794044665,0.983896950852164,3837,2,PROX1|EDN1
CYTOPLASMIC SEQUESTERING OF CFTR PROTEIN%GOBP%GO:0043004,0.9954841280382521,0.9984987368688449,0.5025363917071021,0.6700644696706529,7494,1,GOPC
NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS%GOBP%GO:0033085,0.19964855366315198,0.577735400526903,0.52560195357911,1.26406968428755,1476,5,ZC3H8|FOXJ1|KIAA0922|PTPN2
REGULATION OF SPROUTING ANGIOGENESIS%GOBP%GO:1903670,0.0112592209136793,0.13791712836645198,-0.310289839757889,-1.69910095690276,86,56,S100A1|KIAA1462|MAP3K3|TMEM2|PIK3C2A|KLF4|KDR|SEMA6A|SYNJ2BP|SRPX2|E2F2|FOXC2|ITGA5|NOTCH1|TBXA2R|MMRN2|CREB3L1|JMJD8|HMOX1|HDAC5|MEOX2|RHOJ|STARD13|CEACAM1|APLNR|THBS1|ANXA1|NGFR|CARD10
REGULATION OF RAP PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032487,0.765720350225524,0.919853091548303,-0.481996140060656,-0.8021186540388728,5771,2,KIF14|RDX
D-XYLOSE METABOLIC PROCESS%GOBP%GO:0042732,0.19183946488294298,0.5663196752097011,-0.9025143361270401,-1.20236580219308,1433,1,DHDH
HISTONE H3-K4 METHYLATION%GOBP%GO:0051568,0.738381201044386,0.9089185613230608,-0.18981605713618901,-0.796958187566264,5655,23,SETD1B|SETMAR|PAXIP1|OGT|CTR9|WDR5|PAGR1|HIST1H1C
RESPONSE TO INTRA-S DNA DAMAGE CHECKPOINT SIGNALING%GOBP%GO:0072429,0.35335689045936397,0.7118407891832621,-0.502902923725932,-1.1009596256348302,2699,4,EME1|MUS81
REGULATION OF INTRACELLULAR CALCIUM ACTIVATED CHLORIDE CHANNEL ACTIVITY%GOBP%GO:1902938,0.0196338551339878,0.192628124925339,-0.9087351927104591,-1.51228067835344,147,2,PRNP
NEGATIVE REGULATION OF LYMPHOCYTE PROLIFERATION%GOBP%GO:0050672,0.0029754204398447603,0.05456914496596799,-0.40197854865587607,-1.93563920526725,22,36,FOXP3|SOX11|CD274|MNDA|LILRB1|LYN|NDFIP1|TNFRSF14|TWSG1|PDCD1LG2|SPN|FCGR2B|PLA2G2D|LILRB2|GPNMB|PRKAR1A|SDC4|CEBPB|C10orf54|CD300A|LST1|CD86|TNFRSF21|LGALS9|PRNP
POSITIVE REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0010650,0.8358528428093649,0.945788393670804,-0.585796206440229,-0.780421204942524,6247,1,ANK3
NEGATIVE REGULATION OF HISTONE H3-K9 TRIMETHYLATION%GOBP%GO:1900113,0.20779742765273299,0.5877597266194561,0.7317342156051829,1.2294079602456,1550,2,PIH1D1|SMARCB1
REGULATION OF NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:2000501,0.938373829238496,0.9806530564787491,0.229680087469025,0.594310725833187,6912,6,XCL1|KLRK1|CCL5
EMBRYONIC HINDLIMB MORPHOGENESIS%GOBP%GO:0035116,0.0840032154340836,0.40347368062756894,0.8234265852584369,1.38346298014412,626,2,RARG|AFF3
PYRIDINE NUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0070638,0.475590342265853,0.784986345464663,-0.608460444895451,-1.0125754804468199,3584,2,PNP
MYOFIBRIL ASSEMBLY%GOBP%GO:0030239,0.5723244717109749,0.8342809238628159,0.20428353801002397,0.9142704100828192,4197,27,NEBL|TMOD3|OBSCN|NEB|WDR1|TPM1|OBSL1|PROX1|CFLAR|TMOD1|TMOD2|MYOM2
MICROTUBULE ORGANIZING CENTER ORGANIZATION%GOBP%GO:0031023,0.888533703961084,0.965159112268525,0.119977108078223,0.730661882196635,6392,80,CNTROB|BBS4|CLASP1|DCTN1|CLASP2|KIF3B|NDEL1|GCC2|BRCA2|PCM1|TUBE1|PKD2|BRSK1|ARHGEF10|CEP68|CEP250
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION%GOBP%GO:0050679,0.10565457109885901,0.447390782911839,-0.20261590455231898,-1.28876253962179,823,100,MYDGF|HMGB2|TBX1|KDR|STXBP4|EMC10|PDCD6|CCL24|EGFL7|VEGFC|RREB1|FLT4|TNFSF12|PRKD1|F3|FGF10|HMOX1|HRAS|IGF1|APLNR|HYAL1|VEGFB|NRP2|ECM1|BMP2|TEK|FGF7|SEMA5A|NME2|MYC|ANG|PDGFB|NME1|C5AR1|BAD
NEGATIVE REGULATION OF COLLATERAL SPROUTING%GOBP%GO:0048671,0.339962375705456,0.701745885104582,0.567945221605333,1.11708122895206,2529,3,PTPRS|DCC
REGULATION OF HISTONE H3-K79 METHYLATION%GOBP%GO:2001160,0.9088617670469621,0.9715076818387142,-0.39228746864615904,-0.652829079310004,6850,2,CTR9
POSITIVE REGULATION OF ATPASE ACTIVITY%GOBP%GO:0032781,0.010595160235448,0.132828500120556,-0.38641429717528003,-1.76429202994127,80,30,DNAJB1|TNNT2|DHX9|SETMAR|RYR2|ATP1B1|TOR1AIP2|CHTOP|HNRNPU|ATP1B3|PLSCR1|DYNLL2|UHRF1|AHSA1|FGF10|ATP1B2|DNAJB11|TMSB4X
POSITIVE REGULATION OF ORGANELLE ASSEMBLY%GOBP%GO:1902117,0.0219673943078198,0.205074417774411,0.29178712162245396,1.5914324880273798,158,53,ZMYND10|BBS4|SDC1|RALB|PIP4K2C|CCDC88A|KIAA1324|PAN3|RAB3GAP1|HTT|GPSM2|MARK4|HAP1|SH3GLB1|TAPT1|KCTD17|STX18|CENPJ|PROX1|PDCD6IP
EYE PIGMENT BIOSYNTHETIC PROCESS%GOBP%GO:0006726,0.843272678974632,0.9481593344082329,0.5772496691662989,0.7696845438865558,6348,1,AP3D1
CARDIAC MUSCLE TISSUE GROWTH INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0003245,0.293779264214047,0.666362999188702,-0.849966916629908,-1.1323600220433898,2195,1,S1PR1
NEGATIVE REGULATION OF ORGANELLE ASSEMBLY%GOBP%GO:1902116,0.7637434554973821,0.9191113740914171,-0.17491023933702696,-0.7811686914375559,5834,28,SCFD1|CDK5RAP2|BRCA1|RBM14|KAT2B|CHMP4A|STYXL1
RESPONSE TO VITAMIN K%GOBP%GO:0032571,0.0860971079862032,0.4057980029059221,-0.8158808933002479,-1.3577562756159698,648,2,GAS6|POSTN
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT%GOBP%GO:0040019,0.47866268007610796,0.7850984235874658,0.25871590930293203,0.9741512031129851,3521,16,CLASP1|TENM4|CLASP2|WNT4|RBM19|PHLDB1
TRNA TRANSPORT%GOBP%GO:0051031,0.647201946472019,0.869851601649336,0.34873649648742994,0.838709274218978,4787,5,SSB|XPOT
"WOUND HEALING, SPREADING OF EPIDERMAL CELLS%GOBP%GO:0035313",0.278274592319832,0.653204101106396,-0.48818243749904605,-1.1700801489019799,2115,5,ITGA5|COL5A1|ACVRL1
REGULATION OF CENTROMERIC SISTER CHROMATID COHESION%GOBP%GO:0070602,0.5066090825808139,0.7981861395854799,-0.43534578621991404,-0.9530629296551509,3870,4,AXIN2|CTCF|NAA10
NEGATIVE REGULATION OF CALCINEURIN-NFAT SIGNALING CASCADE%GOBP%GO:0070885,0.208181344450235,0.588242833209407,-0.41298885023922705,-1.24237154980964,1597,9,FHL2|PRNP|RCAN1
MULTINUCLEAR OSTEOCLAST DIFFERENTIATION%GOBP%GO:0072674,0.6491157556270101,0.871221819348319,0.524935937138807,0.881960151615547,4844,2,SH3PXD2A
ENDOTHELIAL TO HEMATOPOIETIC TRANSITION%GOBP%GO:0098508,0.766383656142213,0.919992400339549,-0.48122415219189396,-0.8008339427751109,5776,2,METTL3|YTHDF2
PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0046122,0.117412671005446,0.468392769062825,0.942159241288046,1.25624222002002,883,1,DGUOK
POSITIVE REGULATION OF INTERFERON-BETA PRODUCTION%GOBP%GO:0032728,0.46357702349869495,0.7773692877847191,-0.23555169982813198,-0.988983011265965,3550,23,DHX9|TLR2|IRF5|POLR3B|DDX3X|IFIH1|IRF7|TLR4
POSITIVE REGULATION OF TIGHT JUNCTION DISASSEMBLY%GOBP%GO:1905075,0.574953568585832,0.8354258054828342,-0.569341053212021,-0.9474745570245241,4333,2,TGFBR1|TGFB3
RESPONSE TO NITROGEN COMPOUND%GOBP%GO:1901698,0.00113866396761134,0.0259743994044233,-0.18062143979506898,-1.5222233319290701,8,481,ZFP36L1|FBXO6|IMPACT|RYR2|JUP|AP3S1|HSPA13|ITGB2|TCIRG1|ATP6V0B|RRAGA|UBQLN2|GOT1|PARP1|P2RX4|RAPGEF1|ATP6V0A2|LRP1|RNF121|HM13|TOR1A|ATP6V1G2|TMBIM6|NDNL2|ATP1A3|IRF5|AHR|OGT|LARP1|NPM1|EIF2B1|CAV2|P2RX3|HLCS|FCGR2B|ATP6V1F|INS|PDE4B|BCAR1|GRIN1|VCP|ERBB2IP|FOXC2|KYNU|UBE2G2|FMR1|SYAP1|PDE12|ADCY8|SEL1L|ATP6V0D1|PDXP|CA2|GRB2|CRHBP|PRKAR1A|SLC9A1|MEF2C|CASP4|IRS1|STAT3|UBQLN1|MB21D1|IFIH1|BRCA1|IFIT1|FCER1G|PDE2A|PXN|RCN3|FAF2|MAPK3|DPEP1|ABL1|ADCY4|HERPUD1|RAPGEF3|SEC13|PIK3R3|IGF1|NPLOC4|HDAC5|NSMF|RPTOR|CHRM2|P2RY6|TMEM173|GNAQ|KAT7|CEACAM1|DHFR|PSMC6|GPER1|RAP1A|KCNQ1|KAT2B|GNA15|CPEB1|COLEC12|CD36|SYVN1|ATP6V0E1|TGFBR3|KIAA0368|HTR1B|SEC61B|EPHA4|RARRES2|SLIT2|SGTB|TICAM1|CAMK2A|SLC3A2|IGFBP5|LPIN3|CAV1|EIF2B2|LDLR|PPARG|ATP6AP1|RELA|DERL3|RPS6KB1|MAPK13|NFKB1|PRKACA|TLR4|ATP6V0E2|VIM|ADRBK1|ACTB|HSPA5|LY6H|ANXA1|LGMN|SHMT2|PQBP1|ATP6V1A|CD81|SLC38A9|CASP6|EIF2B3|LPIN2|ATP6V1G1|NGFR|ADCY9|RRAGD|PRNP
PROTEIN LOCALIZATION TO PERICENTRIOLAR MATERIAL%GOBP%GO:1905793,0.705519828510182,0.894639008000397,0.493189964157706,0.8286228181188101,5265,2,GOLGB1|NUDCD3
SENSORY PERCEPTION OF TASTE%GOBP%GO:0050909,0.9986398258977149,0.999656642395059,0.12425435621544,0.42231638906248203,7341,12,ASIC1|TAS2R5|ASIC2
GLYCINE TRANSPORT%GOBP%GO:0015816,0.9289360031409499,0.9793746057014829,-0.280180561334441,-0.613373817021254,7097,4,SLC38A5|SLC36A1
POSITIVE REGULATION OF CYCLIN-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:1904031,0.302590266875981,0.675222663526765,-0.30267136694044394,-1.12484399612386,2312,16,CKS2|PSMD10|CCND3|CCND1|PDGFB
REGULATION OF GRANULOCYTE DIFFERENTIATION%GOBP%GO:0030852,0.0308754559666493,0.24938415081905105,-0.5558620754544971,-1.67216918268563,236,9,RUNX1|HCLS1|TESC|HAX1|C1QC|CEACAM1
POSITIVE REGULATION OF CARDIAC MUSCLE MYOBLAST PROLIFERATION%GOBP%GO:0110024,0.8844396667562479,0.9635685363561758,0.33780452495543206,0.6644216370307039,6581,3,ATF2|MEIS2
ACTIN FILAMENT REORGANIZATION%GOBP%GO:0090527,0.0152471083070452,0.166148433567765,-0.638099873250446,-1.74421754787244,115,7,BCAR1|GSN|NEDD9|EFS
DIPHOSPHOINOSITOL POLYPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0071544,0.940231106388631,0.9812919575525741,0.529995588883988,0.706677603958121,7078,1,NUDT3
LYSINE METABOLIC PROCESS%GOBP%GO:0006553,0.00969945355191257,0.125396292172696,0.6307422013970121,1.83093426479633,70,8,AASS|AADAT|GCDH|AASDHPPT|PIPOX|ALDH7A1
DYNAMIN FAMILY PROTEIN POLYMERIZATION INVOLVED IN MEMBRANE FISSION%GOBP%GO:0003373,0.409455237060182,0.7448505271608159,0.4668483199986961,1.02568564100481,3013,4,MX2|DNM1L
POSITIVE REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1903818,0.206461246097462,0.586182872727595,0.48495875872203,1.25485929177086,1520,6,RNF207|KCNIP2|NOS1AP|ALG10B|LRRC55
REGULATION OF ARF PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032012,0.154662725073905,0.522941892598803,0.66757321494703,1.3130377349784599,1150,3,ARFGAP1|MAP4K4
ENZYME ACTIVE SITE FORMATION VIA CYSTEINE MODIFICATION TO L-CYSTEINE PERSULFIDE%GOBP%GO:0018192,0.516536060565812,0.804056180000979,0.741288045875607,0.988407585061692,3888,1,MOCS3
DOLICHOL BIOSYNTHETIC PROCESS%GOBP%GO:0019408,0.0741576014858052,0.38287566727393396,-0.825386277156813,-1.37357475437845,558,2,SRD5A3
AMYLOID-BETA FORMATION%GOBP%GO:0034205,0.943227899432279,0.9825021479202449,0.246970466075565,0.5939625546568679,6977,5,PSENEN|NCSTN|APH1A
CALCIUM ION REGULATED EXOCYTOSIS%GOBP%GO:0017156,0.9968855437321571,0.9992386811371659,-0.088728632736789,-0.462099041329322,7681,47,SEPT5|SNAP47|STX4|SYT4|SYT7|CPLX2|STX11|VAMP7|STX1B|STX3|PRRT2|SNPH
PYRAMIDAL NEURON DEVELOPMENT%GOBP%GO:0021860,0.0495712754555198,0.319063308518797,0.861262751585332,1.4470326247984902,369,2,FGFR2|ATP7A
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION%GOBP%GO:0086070,0.19312956451176602,0.567519363754568,0.461669184087415,1.27442539074803,1427,7,SCN5A|ANK2
TRIMMING OF SECOND MANNOSE ON A BRANCH%GOBP%GO:0036512,0.44198821007502703,0.7653693162885199,0.6189137027846711,1.03985493186108,3298,2,MAN1B1|EDEM2
PHENOL-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0046189,0.560482777325739,0.8273596711618421,0.254571252361588,0.9150235365919308,4132,14,CITED1|INSM1
CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0072111,0.0796948974224093,0.395958593986611,-0.612560471884197,-1.4681905638097301,605,5,BMP2|PDGFRB
POSITIVE REGULATION OF CELLULAR SENESCENCE%GOBP%GO:2000774,0.529179810725552,0.810782389252093,-0.342526929988774,-0.936282088353915,4025,7,YPEL3|CDKN2A|MB21D1
POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION%GOBP%GO:0090277,0.0679518731200438,0.37201684983175004,0.29780222420368296,1.4434516187228301,496,35,TRPM4|DRD2|IRS2|TRH|CAPN10|ADCYAP1|GLUD1|UCN|NLGN2|PPP3CB|NNAT|GCK|TM7SF3|AIMP1|MYRIP|CRH|BLK|RASL10B
DICHOTOMOUS SUBDIVISION OF TERMINAL UNITS INVOLVED IN LUNG BRANCHING%GOBP%GO:0060448,0.193311036789298,0.567519363754568,-0.901742390824879,-1.2013373856956,1444,1,CTSH
POSITIVE REGULATION OF CALCINEURIN-NFAT SIGNALING CASCADE%GOBP%GO:0070886,0.21626932145664104,0.5991362048583871,-0.38166208260154605,-1.2356515266060901,1650,11,SPPL3|TMEM110|TNF|PTBP1|LMCD1|SLC9A1|IGF1
REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:2000586,0.44214652608813204,0.7653693162885199,0.41467768319410103,0.997297450108061,3270,5,PTPN12|HIP1|PTPN2|HIP1R
ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL%GOBP%GO:0075509,0.41653439153439203,0.7493091022753771,-0.538602953526926,-1.05175505988068,3148,3,CAV2|CAV1
OXYGEN TRANSPORT%GOBP%GO:0015671,0.38899803536345795,0.735662494422088,-0.40926176493216904,-1.05273150883863,2969,6,MYC|CYGB
N-TERMINAL PROTEIN AMINO ACID ACETYLATION%GOBP%GO:0006474,0.270450970110121,0.6452872087586379,-0.329623703990718,-1.1661604626208102,2062,14,CREBBP|NAA25|NAA20|NAA40|NAA30|NAA10|NAA50|KAT2B
PROPIONATE CATABOLIC PROCESS%GOBP%GO:0019543,0.982999070261655,0.993436724391485,0.507829730921923,0.6771224232682379,7400,1,PCK2
PROTEIN KINASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007205,0.22667935817242302,0.609201573718782,0.383320896067946,1.21438650935598,1666,10,PRKD3|PICK1|PARD3|DGKH
REGULATION OF TORC2 SIGNALING%GOBP%GO:1903939,0.37459807073955,0.725326628027322,0.649131513647643,1.09062475569037,2795,2,PIH1D1|TELO2
PATTERN SPECIFICATION INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:0061227,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
CELLULAR RESPONSE TO MONOAMINE STIMULUS%GOBP%GO:0071868,0.68999474789916,0.887051934478962,-0.20670994191888,-0.8293163277733689,5254,20,PDE4B|SLC9A1|MAPK3|ABL1|KCNQ1|PRKACA
DETECTION OF OXYGEN%GOBP%GO:0003032,0.9613955956487129,0.990215340477538,-0.341348702938094,-0.568058827450698,7246,2,TGFB3
REGULATION OF TRANSPORTER ACTIVITY%GOBP%GO:0032409,0.525032092426187,0.808245162096538,-0.13744209005527,-0.9652664237405769,4089,160,GLRX|ATP1B1|PPIF|CTSS|PLN|SHISA7|ATP1B3|STAC3|INS|PDE4B|STIM1|SLC9A3R1|FMR1|SGK1|JPH4|PDE4D|TESC|SEPN1|CRHBP|SLC9A1|MEF2C|UBQLN1|CAPN1|FXYD1|CNIH2|P2RY6|COX17|FKBP1A|MMP9|CAV1|SCN1B|PPARG|CNIH3|CLIC2|ATP1B2|PRKACA|KCNE4|ACTB|TMSB4X|FXYD5|AHNAK|FXYD7|WNK2|PRNP
ATP BIOSYNTHETIC PROCESS%GOBP%GO:0006754,0.10891597177678,0.45309795582492896,-0.250395571792144,-1.33704692658408,848,51,ATP5J|GPI|ATP5F1|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|PGAM1|GAPDH|LDHA|STOML2|ATP5H|PGK1|ALDOA|ALDOC|ATP5G1
NUCLEAR PROTEIN QUALITY CONTROL BY THE UBIQUITIN-PROTEASOME SYSTEM%GOBP%GO:0071630,0.793066380005375,0.929621926733366,0.377513704223293,0.7425249066591341,5901,3,ANKZF1|CUL3
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:0048662,0.00913361169102297,0.12051637208341301,-0.420722343202214,-1.83526769272174,69,26,SOD2|TGFB3|TNFAIP3|MEF2C|HMOX1|OGN|GPER1|AIF1|IGFBP5|PPARG|ANG|PTGIR|CNN1
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION%GOBP%GO:0045662,0.541530054644809,0.815622645995152,0.316696201466801,0.919313668107375,3963,8,DLL1|TBX3
CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE-GATED CALCIUM CHANNEL%GOBP%GO:0061577,0.161381349099704,0.531565908892591,0.664166758575052,1.3063376372830802,1200,3,CACNA1C|CACNA2D1|CACNB3
EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:0009913,0.33600413543551305,0.6992597390318461,-0.20682154786478896,-1.08422576531761,2599,48,JAG1|DFNB31|JUP|MED1|PDZD7|KRT9|KRT18|PKP2|PERP|CAPN1|SOD1|JAG2|EPHA2|PCSK6|KRT7|ANXA1|KRT19
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA%GOBP%GO:0071559,0.833914863921842,0.944951355553174,0.12268336042690599,0.78983632520954,5974,102,ACVR1|SFRP1|FNDC4|CGN|CITED1|XCL1|SMAD3|STK16|MAPK7|PTPRK|RPS27A|PARD3|SOX6|ARRB2|SMAD1|PDE3A|ACVR2A
REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS%GOBP%GO:2001270,0.811710365439478,0.935317461845028,0.332322285336128,0.7301262137049599,5974,4,RFFL|RNF34|RPS3|PAK2
SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT%GOBP%GO:0072395,0.9443585780525501,0.982694945797028,-0.11298100025682199,-0.6584937285693551,7331,71,FZR1|PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|SOX11|PIDD1|PRMT1|UIMC1|PML|RGCC|TRIAP1|TFDP2|PLK2|BRCC3|PCNA|CDC25C|BRCA1|DTL|E2F1|CCNB1|PLK1|PLAGL1|TNKS1BP1|ZNF385A|PRPF19
POSITIVE REGULATION OF EOSINOPHIL DEGRANULATION%GOBP%GO:0043311,0.6066595914035551,0.848985084775586,-0.55682382133995,-0.926643881533525,4572,2,F2RL1|STX4
NEGATIVE REGULATION OF PROTEIN DEUBIQUITINATION%GOBP%GO:0090086,0.0675925925925926,0.371075653877479,-0.7426381383037389,-1.4501840632448,510,3,TRIM21|PARK7|UBXN1
NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION%GOBP%GO:0002725,0.839559842412716,0.9470065760929699,0.322731413542638,0.709054659922078,6179,4,XCL1
HISTONE MODIFICATION%GOBP%GO:0016570,0.0208733512613651,0.199356153540639,-0.18455961700599696,-1.4085550826783502,162,250,NAA40|SETD1B|USP16|KAT6A|KANSL1|PER2|SETMAR|REST|DTX3L|KANSL2|HR|JADE3|UBE2B|KDM1A|EZH2|BCOR|KDM3B|GSG2|KDM8|NSD1|YEATS4|TAF6L|BRPF3|RUVBL1|PAXIP1|KDM2A|HCFC1|OGT|HLCS|TAF12|BRCC3|PKN1|MORF4L2|MSL2|USP51|BRMS1L|PHF20|RNF168|NAA50|C14orf169|UHRF1|CTR9|JMJD6|HUWE1|RNF20|SKP1|HDAC5|MIER3|WDR5|KAT7|TAF9B|KDM5C|SPI1|MBIP|RBM14|PRMT3|BRMS1|KAT2B|RING1|RNF40|HDAC8|MYSM1|APBB1|TAF10|DDB1|PAGR1|MTA2|RPS6KA4|KAT8|KAT5|TAF9|POLE3|VRK1|HIST1H1C|PRMT5|PHB|CCDC101|AK6|PRKCB|NTMT1|SUV39H1
POSITIVE REGULATION OF DOPAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051586,0.00255307712980382,0.0482115283314493,0.9073012021616851,1.78455439606597,18,3,DRD2|RAB3B|DRD4
MODULATION BY SYMBIONT OF HOST DEFENSE RESPONSE%GOBP%GO:0052031,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS%GOBP%GO:2001054,0.542872454448017,0.816132055021207,0.573256898341187,0.9631456054073891,4051,2,PAX8
REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050856,0.0037918410041841,0.0663111709295596,-0.457385842292938,-1.94387693513149,28,24,THY1|RAB29|PVRL2|PHPT1|CEACAM1|CD300A|LGALS3|RELA|LILRB4|PTPRJ|PRNP
ALPHA-BETA T CELL LINEAGE COMMITMENT%GOBP%GO:0002363,0.7900286383754229,0.928247620398227,-0.25503411532876996,-0.7342075233444201,6068,8,FOXP3|BATF|SPN|STAT3
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL%GOBP%GO:0051279,0.18145875937286998,0.554948538055731,0.23852410428788398,1.23790951836967,1330,44,FKBP1B|ANK2|XCL1|GSTM2|DMD|UBASH3B|HTT|SRI|LIME1|CACNA1C|HAP1|PTK2B|PKD2|PLCG1|CXCL9|CAMK2D|JPH3
RNA TRANSPORT%GOBP%GO:0050658,0.172804893589907,0.546371269738967,-0.17445998021044698,-1.18934603711903,1355,137,FYTTD1|NXF2B|ZFP36L1|NCBP2|SLU7|CHTOP|TST|PHAX|SRSF9|TOMM20|NPM1|FMR1|MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|C14orf166|NUP37|NMD3|CKAP5|RAN|NXF1|NUP160|THOC7|ZC3H3|NUP214|TGFBR2|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS%GOBP%GO:0071624,0.757406904050014,0.9169833860642059,0.20451409966337397,0.77006341348482,5572,16,XCL1|C1QBP|CAMK1D|DAPK2|CCR7|CCL21|FAM65B|TIRAP|CXCL8|RAC2|THBS4|RAC1|NCKAP1L|CD74|CCL19|MOSPD2
"POSITIVE REGULATION OF PHAGOCYTOSIS, ENGULFMENT%GOBP%GO:0060100",0.492240925828511,0.791072486428528,-0.39990072799470594,-0.958485736920782,3742,5,ABCA7|ANO6|F2RL1|NCKAP1L|ITGAM
SYNAPTONEMAL COMPLEX ORGANIZATION%GOBP%GO:0070193,0.505139302136868,0.797902257689198,0.34166238412979605,0.9431498406358321,3734,7,SYCE1|SYCP2|P3H4|STAG3|BAG6
AUTOPHAGOSOME MATURATION%GOBP%GO:0097352,0.8386481330062691,0.946300451776032,0.16452097691895498,0.7275067734864008,6153,26,CHMP3|GABARAP|VPS33B|SNX14|MAP1LC3B|MAP1LC3A|ATG14|VPS33A|LIX1L|VPS16|VIPAS39
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:1904752,0.18509300497773104,0.5585505203054311,-0.395021621938748,-1.27890375398022,1412,11,DOCK5|MEF2C|FGF9|IGFBP5|PDGFB
PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009126,0.00038600102933607797,0.0111294649577428,-0.26971692113425894,-1.9098637052692802,2,167,NDUFB5|NADK|SURF1|ATP1B1|UQCR10|PARP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|NDUFA3|NDUFB6|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|HPRT1|GAPDH|NDUFS6|COQ7|NDUFB4|NUDT4|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
PROTEIN TRIMERIZATION%GOBP%GO:0070206,0.6118000261062521,0.852045339927398,-0.197287871269087,-0.8920410961727678,4686,29,HSF1|CLYBL|ALOX5AP|TRIM21|DISP1|TRIM34|P2RX3|TRAF2|SLC1A2|MLKL|SIGMAR1|COL6A1|COL6A2
TYPE I INTERFERON PRODUCTION%GOBP%GO:0032606,0.10993325480958,0.45483419590443,-0.6367791095737171,-1.39404258160651,839,4,TRIM56|IRF7|TMEM173
POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION%GOBP%GO:2001200,0.0231457127827459,0.21165950231047198,-0.6929419426572829,-1.6608496110564097,175,5,LGALS3|LGALS9|LGALS1
LIPID A BIOSYNTHETIC PROCESS%GOBP%GO:0009245,0.10969899665551801,0.454522162524904,-0.9426003528892809,-1.25577000174063,819,1,NDUFAB1
ACTIN FILAMENT BRANCHING%GOBP%GO:0090135,0.175919732441472,0.548366806412612,-0.909682399647111,-1.21191538395536,1314,1,CORO1B
PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE%GOBP%GO:0030422,0.0721311475409836,0.378265970369294,0.5213942861901509,1.5135163969370902,527,8,HENMT1|PRKRA|MRPL44|AGO2
REGULATION OF CELL MORPHOGENESIS%GOBP%GO:0022604,0.0394063459570113,0.283496305557803,-0.167245732619839,-1.3204796310183702,307,307,FGD1|ITGB2|COCH|TBCCD1|FMNL1|KDR|FZD4|AMIGO1|PLXND1|FGR|SEMA6A|ARHGAP15|CCL24|GDI1|SYT4|ARHGAP18|NGF|FES|THY1|RREB1|SEPT7|GOLGA4|MYO10|TAOK2|SLC9A3R1|RHOF|FMR1|DHX36|DOCK5|CPNE6|EFNA1|SEC23A|ARHGAP44|DSCAM|S100A10|DBN1|NGEF|MSN|CPNE5|RHOG|RHOD|CAMK2B|ABL1|CALR|NTN1|FLNA|SPARC|NTRK2|SEMA3B|SEMA3D|NSMF|MAP3K13|SEMA7A|RHOJ|DOCK1|CCL2|PDPN|RND1|SDC2|CORO1B|APOE|DLC1|HCK|CDC42EP4|SEMA5A|FITM2|SEMA3E|EPHA4|NEDD9|SLIT2|SYNE3|ZSWIM6|SEMA3A|MYH9|SEMA6B|PLAA|CFL1|WASF3|CSF1R|EPS8|CDC42EP1|ANXA1|MARK2|RHOU|CDC42EP5|CAPRIN1|ARHGDIA|WTIP|NGFR|FBLN1|EFNA5|CDC42EP2|ALDOA
REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION%GOBP%GO:0090270,0.8154761904761909,0.9367483658511608,-0.370740046321826,-0.723961346788058,6164,3,ROCK2|PTGS2|RGCC
REGULATION OF ACTIN CYTOSKELETON REORGANIZATION%GOBP%GO:2000249,0.000521716447110995,0.0139121625154964,-0.49980939632896704,-2.2044036185444904,3,27,HCLS1|FES|ARHGDIB|PHPT1|HAX1|BCAS3|ABL1|RAPGEF3|HRAS|BAIAP2L1|HCK|TEK|SEMA3E|CSF1R|PDGFRA|ARHGDIA
SODIUM-DEPENDENT ORGANIC CATION TRANSPORT%GOBP%GO:0070715,0.8490969899665551,0.9492491301138911,-0.578683281870313,-0.770945081501486,6346,1,SLC22A5
SOMITE ROSTRAL/CAUDAL AXIS SPECIFICATION%GOBP%GO:0032525,0.681739130434783,0.885373411161421,-0.663101014556683,-0.883409771332718,5095,1,RIPPLY2
REGULATION OF DEFENSE RESPONSE TO VIRUS%GOBP%GO:0050688,0.0293778062860808,0.243019905046845,-0.293528937519449,-1.5673678290910802,228,51,MUL1|LILRB1|DHX9|SEC14L1|RNF216|DTX3L|PARP9|TRIM44|TNFAIP3|DDX60|MB21D1|IFIT1|APOBEC3G|NPLOC4|TMEM173|IFNLR1|TRAF3|DHX58|PQBP1|APOBEC3F|RNF26
BASAL DENDRITE ARBORIZATION%GOBP%GO:0150020,0.366931216931217,0.721190111986457,-0.559477320966464,-1.09251740890342,2773,3,TAOK2|SEMA3A
FACE DEVELOPMENT%GOBP%GO:0060324,0.7226525343117269,0.9021444761598459,0.20852204496977697,0.801829388294078,5317,17,STRA6|CRISPLD1|RAB3GAP1|SKI|CHD7|LRP6
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0002474,0.0012956724540036301,0.0284583972291168,-0.39838048011107197,-2.0074866916936998,9,42,CLEC4A|HLA-E|FCGR1B|B2M|TAPBP|LNPEP|FCGR1A|HLA-C|CANX|ITGB5|HLA-A|SEC23A|FCER1G|CALR|SEC13|SEC24A|VAMP8|IFI30|HFE|CD36|BCAP31|SAR1B|ABCB9
REGULATION OF CELL MATURATION%GOBP%GO:1903429,0.40149921094160995,0.740287621109606,-0.43430151706027703,-1.0409378640362101,3052,5,MAP3K13|EDNRB
FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS%GOBP%GO:1901570,0.110090556274256,0.45500616482604295,-0.24128449321710502,-1.32859917035076,850,57,ALOX5AP|PPT1|ALOX5|SCD5|CD74|LTC4S|ACSL5|TBXAS1|PTGDS|AACS|FAR1|ACSL4|GGT1|ELOVL2|CBR1|ACSF3|ELOVL1|PTGES2|PTGS1|HACD2|GGT5|FADS1|FASN|PTGES|PTGIS
REGULATION OF CLATHRIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:2000369,0.9416001047531751,0.9817325191902121,-0.17036018894622304,-0.586412806925294,7190,13,UBQLN2|TNK2|PIK3CB|DAB2
REGULATION OF HELICASE ACTIVITY%GOBP%GO:0051095,0.363529411764706,0.717981693238167,-0.322038897288522,-1.07789434224213,2780,12,RPA2|CHTOP|IFIT1|MNAT1|GTF2H2
POSITIVE REGULATION OF INTERLEUKIN-6 PRODUCTION%GOBP%GO:0032755,0.0323881373569199,0.256518384872286,-0.329313331463419,-1.57211980112472,248,35,HYAL2|DHX9|TLR1|PYCARD|IL17D|TLR2|IL1RN|LILRB2|STAT3|IFIH1|F2R|RAB7B|LGALS9|MAPK13|TLR4|C1QTNF4
CHROMATIN REPROGRAMMING IN THE ZYGOTE%GOBP%GO:0044725,0.36193385575773707,0.7162129985904979,0.820191883546537,1.09361520587568,2724,1,TET3
CELLULAR RESPONSE TO CORTICOTROPIN-RELEASING HORMONE STIMULUS%GOBP%GO:0071376,0.174976226056242,0.54811765844537,0.5903351359086,1.29699143457079,1287,4,CRHR1|NR4A3|NR4A2
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0002589,0.317192889360573,0.6861326333203311,-0.676040805073063,-1.1250400066945,2390,2,TAPBPL|HFE
PHOSPHOLIPID TRANSLOCATION%GOBP%GO:0045332,0.5939615488762521,0.843040556302675,0.220649401103996,0.894242019144506,4386,20,ABCB1|ABCB4|ATP11A
LATERAL INHIBITION%GOBP%GO:0046331,0.0613627307743392,0.35631208031004796,0.9693427437141601,1.2924877525576102,461,1,DLL1
INSULIN SECRETION%GOBP%GO:0030073,0.00257976917854718,0.0485494970067272,0.5705902600941679,1.99832605158238,18,13,RAB11FIP5|PTPRN|RIMS2|GAL|ADCYAP1|RAB11FIP2|RAB11B|CAMK2G|CYB5R4|PTPRN2
HEME BIOSYNTHETIC PROCESS%GOBP%GO:0006783,0.960315303071487,0.989779794259826,0.148934653243154,0.560788364476469,7065,16,HMBS|COX10|COX15|UROD
NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM%GOBP%GO:1900425,0.6897106109324761,0.887051934478962,0.500531192438712,0.8409570294952521,5147,2,MAPKBP1|SIRT2
REGULATION OF MICROTUBULE-BASED MOVEMENT%GOBP%GO:0060632,0.0101916021198532,0.12936633073190199,0.47331960142259,1.82005488451487,74,17,BBS4|CFAP20|CCDC65|HAP1|TRIM46|MKKS|MAP2|CCDC40|BBS2|C21orf59|NEFH|LAMP1|HDAC6
CELLULAR RESPONSE TO ENVIRONMENTAL STIMULUS%GOBP%GO:0104004,0.00153629496863398,0.0322140470829666,-0.237371953529388,-1.70339429484409,11,178,REST|INTS7|KDM1A|ZFP36L1|IMPACT|ECT2|YY1|TNFRSF10A|PARP1|TNFRSF10B|MFAP4|NDNL2|HYAL3|NPM1|RAD51AP1|RAD1|PCNA|CASP1|PIEZO1|FMR1|DHX36|DDX3X|MYLK|POLD1|GRB2|SLC9A1|PTGER4|RHNO1|PKD2L1|PDE2A|NUCKS1|MAPK3|CARD16|HRAS|IFI16|NSMF|CRY2|MBIP|USP47|HYAL1|ADIRF|TMEM109|FADD|TLK2|TLR5|HIST3H2A|CRYAB|TNKS1BP1|EIF2S1|YBX3|MYC|LTBR|DDB1|INSRR|YAP1|MAPK13|NFKB1|TLR4|POLA1|POLE3|TNFRSF1A|CRIP1|NET1|XPA|BAD
URATE BIOSYNTHETIC PROCESS%GOBP%GO:0034418,0.0217564340673919,0.20390962342392602,-0.905541770057899,-1.5069663123929,163,2,PRPS1|PNP
RNA FOLDING%GOBP%GO:0034337,0.360340018594767,0.7155384949577859,0.8211843846493159,1.0949385721752298,2712,1,WRAP53
RESPONSE TO PEPTIDOGLYCAN%GOBP%GO:0032494,0.13767831435676,0.50219949963275,-0.6158232257904219,-1.34816577143812,1051,4,IRAK3|IRF5|RELA
POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0090154,0.85580967402734,0.949296218452153,-0.24798316858792,-0.6778509326835359,6510,7,TNF|GNB2L1|NSMAF|TNFRSF1A
POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION%GOBP%GO:0051251,0.000128106584678452,0.00518555396908895,-0.287985410813722,-2.0737710997641496,0,181,HSPH1|IL1B|AKT1|FOXP3|CD1D|HLA-DMB|CDC42|PAK2|JAK3|SYK|IGHV2-26|NFATC2|RAC1|IGHV1OR15-1|CD274|NFKBIZ|HLA-DPA1|TGFB1|CD38|LILRB1|IGHV5-51|HLA-E|LYN|GPR183|CD209|TNFSF13B|PYCARD|IGHV1-24|NCKAP1L|VAV3|CD74|TNFRSF14|IL18|ADAM8|RUNX1|CCL19|IGHV3-49|RUNX3|CCDC88B|IGHG4|HLA-DPB1|IGLL5|PDCD1LG2|PAXIP1|VAV1|GATA3|EBI3|GAS6|THY1|IL6ST|IGHV4-4|LILRB2|IGHV4-61|GRB2|MEF2C|SOCS1|PTPN6|CD47|IGHV1-3|MMP14|FGF10|BST1|IGHV3-43|TNFRSF4|IGF1|DPP4|IGHV3-73|NKAP|ICOSLG|VCAM1|TNFSF13|C10orf54|CCL2|CD86|NLRP3|AXL|TGFBR2|LGALS9|ZP3|IGHV3-15|FADD|AIF1|CAV1|BCL6|IGHV1-18|LILRB4|PNP|ANXA1|CD55|NCK1|IGHG2|TFRC|IGHA1|CD81|SART1|SIRPA
CELLULAR RESPONSE TO TUMOR CELL%GOBP%GO:0071228,0.933279742765273,0.9800972968717879,0.362062310449407,0.6083114293121761,6965,2,TXNIP|IGFBPL1
CAP-INDEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:0002190,0.0488294314381271,0.31702674791770696,-0.9736435818262019,-1.29712703660345,364,1,RBM4
CALCIUM-MEDIATED SIGNALING%GOBP%GO:0019722,0.25181969097177903,0.632068187660447,-0.18738106462036397,-1.1424194313053102,1971,84,RYR2|ATP1B1|KDR|P2RX4|LAT2|MCTP1|AZU1|CXCR4|SLC9A1|CAMKK2|NFATC1|VCAM1|CCRL2|TPCN2|EDNRB|CCR1|NUDT4|BCAP31|CLIC2|PRKACA|CETN2|ADGRL1|SPHK1|PTPRJ|PRNP
REGULATION OF T-HELPER 2 CELL ACTIVATION%GOBP%GO:2000569,0.805217391304348,0.932964969466025,-0.601841640935157,-0.8017975764257959,6018,1,PRKCQ
PLASMA MEMBRANE ORGANIZATION%GOBP%GO:0007009,0.0164913647578237,0.17512293405535098,-0.32434617995417603,-1.6672511341903,126,45,SGIP1|SYT7|CAV2|PLSCR1|CXCR4|SOD1|SDPR|PLSCR4|CHMP4A|CAV1|ABCD1|MYOF|COL5A1|A4GALT|EHD2|AHNAK2|SERP1|EMP2
CILIUM OR FLAGELLUM-DEPENDENT CELL MOTILITY%GOBP%GO:0001539,0.0008143322475570031,0.0196591200463433,0.6663652740822211,2.19275092674672,5,11,RSPH9|CFAP44|CCDC65|RFX3|SPEF1|TEKT2|GAS8|DNAH1
RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009161,0.00025706940874036,0.00819882332206558,-0.27551994471223806,-1.95923134489901,1,170,NDUFB5|NADK|SURF1|ATP1B1|UQCR10|PARP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|NDUFA3|NDUFB6|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|HPRT1|RFK|GAPDH|NDUFS6|COQ7|UMPS|NDUFB4|NUDT4|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
REGULATION OF OLIGODENDROCYTE PROGENITOR PROLIFERATION%GOBP%GO:0070445,0.592979635584137,0.8422269872864581,0.551664168371216,0.926867031107621,4425,2,ADCYAP1|SIRT2
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, EXONUCLEOLYTIC%GOBP%GO:0000291",0.7345213319458901,0.9079405785880958,-0.170019198588779,-0.8116602734695741,5646,35,PATL1|LSM3|NT5C3B|EXOSC3|POLR2G|EXOSC2
GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0009084,0.0609357997823722,0.35631208031004796,0.44562508907856396,1.5145930028320398,447,12,ASL|GLS|CAD|GLUD1|NAGS|GLS2
CAROTENE CATABOLIC PROCESS%GOBP%GO:0016121,0.791074511887369,0.928357780000476,0.603936921041023,0.8052683932743759,5955,1,BCO2
POSITIVE REGULATION OF PROTEIN LINEAR POLYUBIQUITINATION%GOBP%GO:1902530,0.742229367631297,0.909955740610127,0.476966727091495,0.801365685180648,5539,2,PARK2
REGULATION OF VASCULOGENESIS%GOBP%GO:2001212,0.131799163179916,0.49149424485984994,-0.438742610392574,-1.37452332470432,1007,10,KDR|CD34|CEACAM1|RAP1A|EMP2
TELOMERIC LOOP DISASSEMBLY%GOBP%GO:0090657,0.815168980875033,0.9365903629992659,-0.22225923875445197,-0.7195762434592271,6222,11,SLX1B|SLX1A|XRCC3
RESPONSE TO TUMOR NECROSIS FACTOR%GOBP%GO:0034612,0.00320759558634847,0.0579923477134466,-0.254365331724008,-1.6903296830316898,24,122,CD40|ARHGEF2|GBA|AKT1|CCL3|TNF|ACTN4|CCL4|CCL8|YTHDC2|UBD|CCL11|ADAM9|COMMD7|HYAL2|DHX9|CHI3L1|TNFSF13B|PYCARD|TNFRSF14|IGBP1|TNFSF8|CCL19|ZFP36L1|DAB2IP|EDA|PID1|CCL24|GATA3|HYAL3|TNFRSF11A|TNFRSF18|GGT1|CCL3L3|ERBB2IP|TRAF2|CCL18|ILK|TNFSF12|CRHBP|BRCA1|TRIM32|TNFRSF4|TNFSF13|CCL2|CXCL16|GPER1|PLVAP|NFKBIA|HYAL1|TNFRSF21|TNFRSF11B|CX3CL1|LTA|YBX3|TRAF3|LTBR|CCL4L2|CCL14|RELA|TNFRSF12A|TNFRSF1A|TMSB4X|TNFRSF1B
RESPONSE TO DIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0071724,0.0406084656084656,0.288441534418227,-0.7777655233263481,-1.51877894319482,306,3,TLR2|CD36|CD14
T CELL RECEPTOR V(D)J RECOMBINATION%GOBP%GO:0033153,0.6647629167220079,0.8804055751124069,0.665747684164094,0.887684705596167,5004,1,LIG4
NEURAL PLATE ANTERIOR/POSTERIOR REGIONALIZATION%GOBP%GO:0021999,0.4542435914464071,0.7707713235598309,0.7739854433171591,1.0320051525967702,3419,1,CELSR2
RESPONSE TO MINERALOCORTICOID%GOBP%GO:0051385,0.235473600424516,0.620163873293386,-0.7151546713698921,-1.1901317349899099,1774,2,GPER1
CRANIOFACIAL SUTURE MORPHOGENESIS%GOBP%GO:0097094,0.314631164243989,0.684165797143474,0.510419997968923,1.12141447312029,2315,4,TWIST1|RAB23|MEGF8
REGULATION OF ANOIKIS%GOBP%GO:2000209,0.176501511368117,0.548380753278361,-0.32221096793499604,-1.27302547467856,1342,19,ITGA5|NOTCH1|SNAI2|BRMS1|PTRH2|CAV1|SIK1
COCAINE METABOLIC PROCESS%GOBP%GO:0050783,0.43505016722408,0.762034923704788,-0.783579620644023,-1.0439162032603702,3251,1,BCHE
ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE INVOLVED IN HOMOLOGOUS CHROMOSOME SEGREGATION%GOBP%GO:0051455,0.840350644175853,0.947151866837735,0.579124393471548,0.7721842357857,6326,1,CENPC
POSITIVE REGULATION OF HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0010909,0.32625638269282503,0.6940781026265961,0.574390647402669,1.1297586208851398,2427,3,PXYLP1|TCF7L2|CTNNB1
NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION%GOBP%GO:1903979,0.00833333333333333,0.113028938028938,-0.86276837087364,-1.6847679605715302,62,3,CX3CL1|LDLR
POSITIVE REGULATION OF ENDOSOME ORGANIZATION%GOBP%GO:1904980,0.599464882943144,0.84625395439332,-0.704289810322011,-0.938283137305239,4480,1,SYNJ1
POSITIVE REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0010902,0.606153846153846,0.8488511623671441,-0.700099250110278,-0.9327003048903639,4530,1,APOC2
EYE PIGMENTATION%GOBP%GO:0048069,0.742328042328042,0.909955740610127,-0.400558039563394,-0.7821883302495201,5611,3,ATP6AP2
REGULATION OF AMINE TRANSPORT%GOBP%GO:0051952,0.38601321585903103,0.7332167375750358,0.213879978294888,1.05032627243112,2803,37,DRD2|SYT2|TRH|PARK2|RAB3B|DRD4|CHRNB2|RAB3GAP1|HRH3|SYT5|UCN|KCNB1|CHRNA3|CRH|STX1A|SNCA|CARTPT
LYSOSOMAL MICROAUTOPHAGY%GOBP%GO:0016237,0.26944444444444393,0.6434418809581031,-0.604966774117342,-1.18134678165258,2036,3,ATG7|ATG13
POSITIVE REGULATION OF MYELOID DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000529,0.708194979412937,0.89516234575314,0.645235994706661,0.860335135405528,5331,1,CCL21
N-ACETYLMANNOSAMINE METABOLIC PROCESS%GOBP%GO:0006051,0.11621119660387401,0.466224231336423,-0.788672416629654,-1.31247701947355,875,2,RENBP
REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0045073,0.20104780615586101,0.5791533688897579,-0.489879212398654,-1.26010130094266,1534,6,SIGIRR|EGR1|IL6|TNF|AZU1|HMOX1
CORTICOTROPIN HORMONE SECRETING CELL DIFFERENTIATION%GOBP%GO:0060128,0.148494983277592,0.5154128781388279,-0.9235774150860171,-1.23042688090995,1109,1,BMP2
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903362,0.0160153747597694,0.17167030511103,-0.206032470663828,-1.48699931472625,124,183,OGT|CBFA2T3|ATPIF1|PSMF1|BAG5|GPX1|VCP|RNF144B|UBE2G2|FMR1|EFNA1|CCDC22|CEBPA|UBQLN1|SUMO2|PSME2|PARK7|UBXN1|MSN|ALAD|HERPUD1|RAD23B|UQCC2|NKD2|RCHY1|HFE|PSMD10|APOE|PLK1|GIPC1|ECSCR|CTSC|ARAF|TLK2|EPHA4|BCAP31|CAV1|LDLR|DERL3|DACT1|PRKACA|DAB2|TAF9|ANXA2|HSP90AA1|CSNK1A1|MAGEF1|CD81|AK6|FAM122A
NEGATIVE REGULATION OF SEQUESTERING OF CALCIUM ION%GOBP%GO:0051283,0.7496932515337421,0.9139249126720871,0.17730173011314102,0.7935134033706659,5498,27,DRD2|XCL1|NOL3|FGF2|RYR1|PKD2|ITPR1|ANXA5
CEREBELLAR MOLECULAR LAYER FORMATION%GOBP%GO:0021688,0.0613627307743392,0.35631208031004796,0.9693427437141601,1.2924877525576102,461,1,DLL1
NEGATIVE REGULATION OF TELOMERASE ACTIVITY%GOBP%GO:0051974,0.26747348381832997,0.6417330323279019,0.36798433890754295,1.16579925959577,1966,10,PARP3|CERS1|PIF1|POT1|SRC|TERF1
NEGATIVE REGULATION OF LYASE ACTIVITY%GOBP%GO:0051350,0.0837044799580823,0.402388938341306,-0.45329571053418205,-1.4675692510704899,638,11,PHPT1|AKAP5|GNAI2|EDNRB|ADGRV1
NUCLEAR MIGRATION ALONG MICROTUBULE%GOBP%GO:0030473,0.796652941957763,0.930355360818174,0.601179973533304,0.801592375775634,5997,1,TMEM201
NEGATIVE REGULATION OF OXIDATIVE STRESS-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903377,0.620725933719095,0.855512831917605,-0.3600082410317829,-0.8628710578578169,4719,5,PARK7|NONO
STEROL ESTERIFICATION%GOBP%GO:0034434,0.20123258306538103,0.5792408283906739,0.73575305664721,1.23616013208977,1501,2,LCAT|SOAT1
POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT%GOBP%GO:0045684,0.46695675822681504,0.7806653415096191,0.25231280071420603,0.987659961032803,3433,18,FOXC1|CYP27B1|TRIM16|GAL|NCOA3
NUCLEOSIDE PHOSPHATE METABOLIC PROCESS%GOBP%GO:0006753,0.000127404764938209,0.00518555396908895,-0.21307158969348602,-1.7540788061233898,0,402,NDUFB5|PARP9|NADK|TKT|GPD1|CROT|SURF1|ACSL5|DNPH1|ATP1B1|ABHD14B|UQCR10|ACOT1|PARP1|DCTPP1|NDUFA9|ATP5J|NDUFA7|ACSF2|DCAKD|GPI|ATP5F1|FAR1|COASY|OPA1|IMPDH2|ACSL4|PFKFB2|NUDT17|GPX1|ELOVL2|HK1|ADA|PDHA1|NDUFA3|VCP|NDUFB6|ACSF3|KYNU|NUDT1|ATP5B|HK3|ADCY8|PDE4D|SDHD|NPR2|ELOVL1|CYCS|SLC26A2|NDUFB9|PARK7|COA6|NUDT16|PDE2A|SMPDL3A|HAAO|ENO1|BST1|NDUFB10|SDHA|ADCY4|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|CTPS1|PGAM1|HPRT1|TPST2|MOCS2|PRPS1|MBIP|EPHA2|NPR1|RFK|GAPDH|NDUFS6|COQ7|HMGCS1|NUDT18|UMPS|FMO2|NDUFB4|HACD2|NUDT4|NDUFA12|SDHAF2|GMPS|NME2|LDHA|CMPK2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|ACOT2|STOML2|PDHX|ABCD1|NDUFA4|HINT1|ATP5H|NMNAT3|NDUFV1|PNP|UQCRQ|SULT1A4|PGK1|NDUFS3|GPHN|RRM1|SAMHD1|TALDO1|UQCRC2|FASN|QPRT|COX6A1|NNMT|UQCC3|NDUFA8|ADCY9|ALDOA|NDUFS8|ALDOC|AK1|ATP5G1|MTHFD1|BAD|PTGIS|NDUFV3
NEGATIVE REGULATION OF ENDOTHELIAL CELL-MATRIX ADHESION VIA FIBRONECTIN%GOBP%GO:1904905,0.6185953177257529,0.854944793214197,-0.694585355094839,-0.925354472765529,4623,1,MMP12
GLOBAL GENOME NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:0070911,0.247520876826722,0.6284111611211011,-0.270526798963358,-1.1800873002702599,1896,26,GTF2H1|RAD23B|UBC|DDB1|CETN2|XPA|GTF2H2
"DNA CATABOLIC PROCESS, ENDONUCLEOLYTIC%GOBP%GO:0000737",0.116419477621735,0.46625878958064004,-0.33574614576511597,-1.36783221533314,886,21,DICER1|KPNA1|DNASE2|EXOG|DNASE1L3|H1F0|SETMAR|HMGB2|DNASE1L2|KPNB1|MUS81|ENDOG|DNASE1L1|FEN1
REGULATION OF CELL CYCLE ARREST%GOBP%GO:0071156,0.633264992311635,0.8631726958478259,-0.14475412949065303,-0.901386296918893,4941,92,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|RPL23|SDE2|FOXO4|SFN|CDKN1B|CDK4|CNOT6|AURKA|PIDD1|ID2|PRMT1|PML|RGCC|TRIAP1|TFDP2|SETMAR|DAB2IP|PLK2|CCNK|PCNA|CDC25C|ZNF268|FOXM1|BRCA1|FGF10|CALR|FAP|E2F1|GPER1|CCNB1|GATA6|PLAGL1|TNKS1BP1|PRKACA|RRP8|ZNF385A|CCND1
NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009143,0.0807081489195522,0.397722753303477,-0.5158506707930229,-1.48506188252603,619,8,DCTPP1|NUDT1|NUDT16|SMPDL3A|SAMHD1
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE/THREONINE KINASE SIGNALING PATHWAY%GOBP%GO:0090100,0.40760309278350504,0.7445496113654559,-0.182957003469153,-1.0303575318295501,3162,62,INHA|SMAD4|TGFBR1|BMP4|RNF111|RBPMS|BMP8B|TTK|CYR61|TGFB2|SOX11|GDF15|CREBBP|NUP93|TGFB1|INHBB|RNF165|UBE2O|TWSG1|CDKN1C|TGFB3|NOTCH1|INHBA|CDKN2B|SNW1|SULF1|MEN1|HFE|GIPC1|BMP2|THBS1|GDF11|DAB2|ENG|ACVRL1
REGULATION OF MITOTIC SPINDLE CHECKPOINT%GOBP%GO:1903504,0.0207131620346093,0.19828362800876603,-0.484695816116004,-1.71478291854923,157,14,CDT1|LCMT1|CDK5RAP2|MAD2L1|NDC80|USP44|CCNB1|XRCC3
REGULATION OF PROTEIN LOCALIZATION TO PHAGOCYTIC VESICLE%GOBP%GO:1905169,0.665427015539912,0.8804055751124069,0.6653617115130129,0.8871700631463431,5009,1,SYT11
NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION%GOBP%GO:0043922,0.582812075061191,0.838862400059828,0.28205397954037803,0.8935660726497091,4285,10,INPP5K|HDAC1|TFAP4|CCL5|TARDBP|JUN|CCL3|CCL4|ZNF639|REST
VENTRAL MIDLINE DETERMINATION%GOBP%GO:0007371,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
AMINO ACID TRANSPORT%GOBP%GO:0006865,0.213085311096857,0.5955959218692061,-0.22440571351783997,-1.1982678743855901,1660,51,SLC6A6|SLC38A5|SLC16A10|SLC36A1|SLC43A2|SLC7A2|SLC25A18|SLC1A2|SLC1A3|SLC25A22|SLC38A6|SLC6A8|PDPN|GIPC1|SLC7A3|SLC3A2|ARL6IP5|PRAF2|SLC7A8|SLC38A9
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:0061951,0.16751269035532998,0.539933371929665,0.24646124531203198,1.249207221084,1220,41,KIF13A|RAB10|SYS1-DBNDD2|GCC2|RILPL1|GGA1|GOLPH3L|SPTBN1|MLLT4|LRRC7|GORASP2|VPS35|RAB11A|BBS2|BLZF1|GOLGA7
POSITIVE REGULATION OF GAMMA-DELTA T CELL ACTIVATION%GOBP%GO:0046645,0.246617139824887,0.6280519349499749,-0.7100082712985942,-1.18156730230003,1858,2,LILRB1|NCKAP1L
PRIMARY ALCOHOL METABOLIC PROCESS%GOBP%GO:0034308,0.612426422498365,0.852045339927398,-0.19493601629655,-0.8900396864573051,4681,30,GDE1|CYP1B1|ADH1B|CACNA1H|ALDH2|GDPD1|PARK7|IGF1|ALDH1A1|DHRS3
POSITIVE REGULATION OF CILIUM ASSEMBLY%GOBP%GO:0045724,0.07982050584715801,0.395958593986611,0.37164064952714204,1.45476007713911,586,18,ZMYND10|BBS4|CCDC88A|HTT|MARK4|HAP1|TAPT1|KCTD17
NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0090051,0.00642370214997378,0.0946467360371137,-0.529601630656322,-1.87365312364885,48,14,NOTCH1|TBXA2R|MMRN2|HDAC5|MEOX2|STARD13|THBS1|CARD10
MODULATION BY HOST OF VIRAL RNA-BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:1990969,0.254715719063545,0.6334469481869079,-0.8692655491839442,-1.15807043448032,1903,1,NUCKS1
TYPE B PANCREATIC CELL MATURATION%GOBP%GO:0072560,0.479877805817506,0.785690196949452,0.7607520952801059,1.0143602686028101,3612,1,NKX6-1
REGULATION OF GROWTH HORMONE SECRETION%GOBP%GO:0060123,0.246162206221981,0.6280519349499749,0.548030392311471,1.20404611122876,1811,4,DRD2|ADCYAP1|CHD7
MACROPINOCYTOSIS%GOBP%GO:0044351,0.648093048417636,0.8702993441108309,0.302482285236705,0.8349942292967829,4791,7,SNX33|LRRC16A|MAPKAPK3
ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:0003203,0.0248463449718844,0.221583370532783,-0.39972744038801594,-1.6553753364119699,189,22,TBX2|NOTCH1|SNAI2|NOS3|TGFBR2|BMP2|DCHS1|SNAI1|ENG|ACVRL1
NUCLEAR PORE ORGANIZATION%GOBP%GO:0006999,0.7092487116897209,0.8960839116793909,0.223270917096424,0.8025185180356189,5229,14,NUP35|RTN4|NDC1|TMEM170A|NUP54|TPR|NUP133|AHCTF1|SEH1L
POSITIVE REGULATION OF CARDIAC MUSCLE FIBER DEVELOPMENT%GOBP%GO:0055020,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
SPERMINE TRANSPORT%GOBP%GO:0000296,0.250836120401338,0.63148176332757,-0.871746801940891,-1.1613760589364899,1874,1,TAF7
REGULATION OF FERROPTOSIS%GOBP%GO:0110075,0.559732441471572,0.8268422944617521,-0.723588442876048,-0.963993549742163,4183,1,GPX4
LIPID STORAGE%GOBP%GO:0019915,0.23522489539749,0.6197199320200171,-0.387060994051348,-1.2126115672484599,1798,10,BSCL2|APOE|CD36|CAV1
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC DNA DAMAGE CHECKPOINT%GOBP%GO:1902402,0.9923644363918729,0.997305769352475,-0.0952026996766654,-0.5213158066875929,7667,56,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A
NEGATIVE REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:1902227,0.685217160313455,0.8857920062408181,0.656815174239083,0.875774408900244,5158,1,PTPN2
POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES%GOBP%GO:0048295,0.7890301003344481,0.9280333261332429,-0.6095610939567709,-0.8120817414005649,5897,1,CLCF1
GROWTH FACTOR DEPENDENT REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION%GOBP%GO:0014843,0.17080621596493603,0.544378398009534,0.9165747684164091,1.2221287776316998,1285,1,FGF2
PEPTIDYL-TRYPTOPHAN MODIFICATION%GOBP%GO:0018211,0.163287374966207,0.534744357685457,0.5500323963358029,1.32282475902076,1207,5,DPY19L3|DPY19L1|DPY19L2|DPY19L4
NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT/RIGHT ASYMMETRY%GOBP%GO:0038107,0.35396466994288794,0.7118407891832621,0.8236104984561099,1.09817346757412,2664,1,CITED2
REGULATION OF STEM CELL DIVISION%GOBP%GO:2000035,0.3035244608101,0.676536823078878,-0.4761341961860999,-1.1412028134909,2307,5,PRDM15|SFRP2|CDK2AP2
REGULATION OF SPHINGOMYELIN CATABOLIC PROCESS%GOBP%GO:2000754,0.779784831982999,0.924704689181848,0.6098919276576971,0.813208591071659,5870,1,PRKCD
REGULATION OF NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072182,0.642200594755339,0.868171925756234,0.350130156073505,0.842061017531533,4750,5,PAX8|CTNNB1|STAT1
SYNAPTIC SIGNALING BY NITRIC OXIDE%GOBP%GO:0099163,0.680802675585284,0.884781692722898,-0.663707543008381,-0.88421781286645,5088,1,GUCY1B3
POSITIVE REGULATION OF MULTI-ORGANISM PROCESS%GOBP%GO:0043902,0.0025789813023855603,0.0485494970067272,-0.268949918448134,-1.73962441539712,19,108,TRIM38|DHX9|CD74|PLCB1|SMARCA4|ZNF639|TSG101|CD4|PPIA|RAB7A|HYAL3|LARP1|CAV2|LY86|CACNA1H|MDFIC|TOP2A|PPIB|FMR1|DDX3X|PDE12|DDX60|INHBA|SMURF2|IFIT1|SNW1|NUCKS1|APOE|GAPDH|SASH1|LGALS9|ZP3|POMZP3|ADARB1|SYDE1|RRP1B|DDB1|OSBP|CFL1|DHX58|ANXA2|LGALS1|LHFPL2|P4HB
NAD METABOLIC PROCESS%GOBP%GO:0019674,0.0227772744920409,0.20967867277886898,-0.29054913284893896,-1.59100378548036,175,56,PGAM2|PARP10|PARP9|NADK|GPD1|GPI|NUDT17|HK1|VCP|KYNU|HK3|HAAO|ENO1|BST1|PGAM1|GAPDH|NMNAT3|PNP|PGK1|QPRT|NNMT|ALDOA|ALDOC|PTGIS
EOSINOPHIL ACTIVATION%GOBP%GO:0043307,0.287135191728831,0.6603864229308399,-0.534671385277368,-1.17050742877253,2193,4,VAMP8|VAMP7
NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT%GOBP%GO:0051589,0.604270369400052,0.848175106515994,-0.271274499706809,-0.878265787911583,4612,11,FMR1|GPM6B|HTR1B|ARL6IP5
VITAMIN B6 CATABOLIC PROCESS%GOBP%GO:0042820,0.30421404682274295,0.676707700393746,-0.8445081605646229,-1.12508764823981,2273,1,PDXP
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:2000698,0.39576634512325803,0.7377402989373809,0.6382355902109941,1.07231819748718,2953,2,PAX8|LIF
DEOXYRIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009189,0.853968253968254,0.949296218452153,-0.35385834673033795,-0.6909956661350539,6455,3,CMPK2
FASCICULATION OF SENSORY NEURON AXON%GOBP%GO:0097155,0.762433862433863,0.918971411627889,-0.391956714282318,-0.7653921219725079,5763,3,EPHA4
NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY%GOBP%GO:0051005,0.5646825396825401,0.8295590091625621,-0.47279644392581605,-0.9232516252210079,4268,3,APOC1|ANGPTL4
LIPID HYDROPEROXIDE TRANSPORT%GOBP%GO:1901373,0.778327759197325,0.924704689181848,-0.615846934274371,-0.820455990022878,5817,1,SCP2
REGULATION OF CD24 BIOSYNTHETIC PROCESS%GOBP%GO:2000559,0.5187959866220739,0.8047799431921201,-0.7429422143802379,-0.989777420500336,3877,1,PLCB1
SPHINGOID BIOSYNTHETIC PROCESS%GOBP%GO:0046520,0.652471083070452,0.8734599956939421,-0.306130932024352,-0.836795250974527,4963,7,SPHK1
SULFUR AMINO ACID METABOLIC PROCESS%GOBP%GO:0000096,0.752800208387601,0.915314007578303,-0.171835264071939,-0.7919153799428921,5779,31,ADO|MSRA|PCYOX1L|CDO1|TST|GGT1|ADI1|DPEP1|SMS|GGT5|APIP|MTHFD1
"PROTEIN IMPORT INTO PEROXISOME MATRIX, SUBSTRATE RELEASE%GOBP%GO:0044721",0.766822742474917,0.9202428578352959,-0.6209197176885749,-0.8272141555777259,5731,1,PEX14
POSITIVE REGULATION OF CENTRAL B CELL TOLERANCE INDUCTION%GOBP%GO:0002897,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
EMBRYONIC HEART TUBE DEVELOPMENT%GOBP%GO:0035050,0.281903190319032,0.654732517474162,0.232299491366805,1.1331675892150601,2049,36,BBS5|ACVR1|NPHP3-ACAD11|DLL1|BBS4|AHI1|SETDB2|MKKS|NPHP3|PKD2|CITED2|CCDC40|BBS7|MEGF8
POSITIVE REGULATION OF ARF PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032014,0.671623794212219,0.8815356925073421,0.510536381920022,0.8577670396461571,5012,2,MAP4K4
"REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2000514",0.22421814422331401,0.607638142117869,-0.24521891847000302,-1.19126028797463,1734,37,MYB|IL12RB1|SMAD7|PRKCQ|MALT1|ZC3H12A|RARA|FOXP3|JAK3|CD274|NFKBIZ|NCKAP1L|IL18|RUNX1|CCL19|TWSG1|RUNX3|RC3H2|SOCS1|C10orf54|CD86|NLRP3|TGFBR2|LGALS9|ANXA1|CD55
CELLULAR RESPONSE TO NOREPINEPHRINE STIMULUS%GOBP%GO:0071874,0.699397993311037,0.892627170717022,-0.6531760035288929,-0.8701872735080141,5227,1,APLP1
INTRACELLULAR PH REDUCTION%GOBP%GO:0051452,0.0698433420365535,0.37596389138254704,-0.35026108619064006,-1.47059971973395,534,23,PPT1|CLN6|ATP6V0A1|SLAMF8|GPR89B|TCIRG1|ATP6V0A2|RAB7A|DMXL1|ATP6V0D1|SLC11A1|ATP6V0E1|ATP6V0E2|RAB20
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0060501,0.522440204246171,0.807051143864932,0.479524982013699,0.9431690519500759,3887,3,FGFR2|SRSF6
NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY%GOBP%GO:0006469,0.0645533880903491,0.36474536341326197,-0.19131175399850198,-1.3326508943552,502,153,DUSP2|DUSP26|DEPTOR|PTPN1|SFN|GBA|IL1B|CDKN1B|AKT1|PAK2|SH3BP5|ZFYVE28|PPM1E|DUSP1|DUSP8|ZNF675|DUSP7|DUSP3|HIPK3|APC|PRKAR2A|HEXIM2|LYN|HYAL2|PYCARD|SOCS4|CORO1C|IRAK3|TSG101|DAB2IP|PPM1F|DUSP5|SPRY1|CDKN1C|CDKN2A|NPM1|HEXIM1|THY1|WARS|MAPK8IP1|HEG1|IPO7|PRKAR1A|CEBPA|PARK7|RGS4|TAF7|ABL1|HSPB1|C14orf166|MEN1|LRP5|SNX6|GNAQ|CEACAM1|VPS25|CD300A|MBIP|APOE|PLK1|PPP2CA|MVP|WWTR1|CHMP6|LATS2|ERRFI1|ADARB1|NR2F2|CAV1|DNAJA1|RASIP1|SMPD1|H2AFY|RGS2|GPS1|GSTP1|RGS3|PTPRJ
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0034144,0.0639161755075311,0.36213335018139703,-0.587122882309618,-1.51023821604721,487,6,LYN|DAB2IP|TNFAIP3|RAB7B|NR1D1
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN%GOBP%GO:0019884,0.00012827090815803,0.00518555396908895,-0.312846623598365,-2.06523721142689,0,118,PDIA3|HLA-DOA|HLA-F|CENPE|AP2A1|KIF2C|KLC1|CAPZA2|AP1S3|KIF3A|HLA-DRB1|HLA-DMA|CD1D|HLA-DMB|RACGAP1|HLA-DQB2|HLA-B|AP1S2|KIF11|KIF15|HLA-DPA1|CLEC4A|HLA-E|HLA-DRA|HLA-DRB5|FCGR1B|ACTR10|DCTN4|DYNC1H1|CD74|B2M|AP2A2|TAPBP|LNPEP|HLA-DPB1|HLA-DQA2|CTSF|CTSV|FCGR1A|RAB7A|CTSS|HLA-C|KLC2|CANX|ITGB5|HLA-A|FCGR2B|CLTA|SH3GL2|SEC23A|CLTC|DYNLL2|FCER1G|KIF4A|LAG3|KIF18A|RILP|CALR|SEC13|SEC24A|VAMP8|ARF1|IFI30|KIF2A|AP1B1|DCTN5|CD36|CTSD|CTSL|DYNC1I1|SPTBN2|LGMN|KIF22|SAR1B|DCTN3|AP2M1
MAINTENANCE OF SISTER CHROMATID COHESION%GOBP%GO:0034086,0.6433908436353759,0.868818962935866,0.387163654888508,0.8506150381759829,4735,4,MAU2|RB1|DSCC1|NIPBL
POSITIVE REGULATION OF LIGASE ACTIVITY%GOBP%GO:0051351,0.5329818869964861,0.812079525085925,0.383014596291057,0.92114790767856,3942,5,NHEJ1|GCLM|XRCC4|MID1IP1|XRCC1
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM%GOBP%GO:0010880,0.0878763222131815,0.40948783685213797,0.401931916216202,1.4446924388891202,647,14,FKBP1B|ANK2|GSTM2|DMD|SRI|CACNA1C
REGULATION OF PHOSPHOLIPID TRANSLOCATION%GOBP%GO:0061091,0.0284234294062957,0.23858105139263197,0.9861601235112479,1.3149114592999398,213,1,ABCB4
SIGNAL COMPLEX ASSEMBLY%GOBP%GO:0007172,0.7681728880157169,0.920474726214876,-0.29261570049379104,-0.752686408274071,5864,6,PXN|NCK1
FOLIC ACID CATABOLIC PROCESS%GOBP%GO:0046657,0.48780814576634496,0.788226301622024,0.597009740918925,1.00305344779164,3640,2,PM20D2|MTHFS
NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS%GOBP%GO:2001021,0.264121542656798,0.6395074119587459,-0.196607124939286,-1.13608674409724,2033,69,CD74|TRIAP1|TERF2|KDM1A|PARPBP|KLHL15|SFRP2|DYRK1A|AUNIP|TRIM32|SNAI2|POLQ|TAF9B|PSMD10|CXorf57|RMI2|SNAI1|TAF9|ZNF385A|OTUB1|MAGEF1|AK6
SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT%GOBP%GO:0072425,0.465451577801959,0.779171492972631,0.289478847243108,0.9838822975808691,3421,12,CDC14B|FAM175A|ATM|BRE
VESICLE DOCKING%GOBP%GO:0048278,0.705593592559101,0.894639008000397,-0.16141194068933898,-0.836164640770504,5461,46,YKT6|SYTL2|STX4|CAV2|PLEK|CPLX2|VPS18|STX11|STX1B|STX7|RAB3C|STX3|NSF|STX5|SNPH
CRISTAE FORMATION%GOBP%GO:0042407,0.18600392413342104,0.559093571852282,-0.27243128320557697,-1.24386790338725,1421,30,ATP5J|ATP5F1|CHCHD3|APOO|ATP5B|ATP5O|CHCHD6|ATP5H|UQCC3|ATP5G1
REGULATION OF SECRETION BY CELL%GOBP%GO:1903530,0.00012756729174639598,0.00518555396908895,-0.21967217836874303,-1.78364366462024,0,366,SEPT5|TNFRSF14|GSDMD|DISP1|PER2|SNCAIP|ADAM8|CCL19|REST|RHBDF2|ACHE|TSG101|CD84|AGT|STXBP5L|ITGB2|ITPR2|RAB9A|SNX4|HGS|PIM3|STX4|TLR2|STXBP4|PPIA|FGR|RAB7A|CD34|STXBP2|WLS|GIPR|ITPR3|SLC2A1|RAB27B|SYT4|SLC8B1|GPI|MCTP1|CDK16|SSC5D|GATA3|FES|HYAL3|SYT7|NAPA|DNAJC1|FCGR2B|MYOM1|GAS6|TGFB3|INS|CACNA1H|CASP1|CPLX2|ADGRE2|TNFAIP3|FMR1|DHX36|ADCY8|SLC25A6|POMC|NOTCH1|INHBA|CRHBP|PTGER4|MEF2C|IRS1|VPS18|IFIH1|SDC4|SYN1|ENSA|CACNA1G|OSM|SPP1|CARD16|GHRL|RSAD2|SRGN|RAPGEF3|TNFRSF4|UQCC2|IGF1|VAMP8|DPP4|FCN1|NR1H3|VAMP7|LRP5|SNX6|STX1B|CEACAM1|IL33|GPER1|CD300A|RAB3C|HFE|CACNA1E|F2R|RAP1A|FN1|GAPDH|NLRP3|NOV|CHGA|TNFRSF21|SNF8|CD200|LGALS9|ZP3|ADRA2C|NR1D1|CHMP6|HTR1B|ARL2|NSF|DTNBP1|FOXP1|SLC25A4|DOC2A|CX3CL1|CAMK2A|IL11|SIRT4|ATP6AP1|HAVCR2|ANG|TLR4|SERGEF|ITGAM|RAB11FIP1|ADRBK1|CSF1R|C1QTNF4|ANXA1|CACNA1I|TNFRSF1A|TMSB4X|CD14|TNFRSF1B|EFNA5|BAD|C1QTNF1|SLC25A5
DENDRITIC CELL DENDRITE ASSEMBLY%GOBP%GO:0097026,0.708194979412937,0.89516234575314,0.645235994706661,0.860335135405528,5331,1,CCL21
RENAL WATER HOMEOSTASIS%GOBP%GO:0003091,0.7388994824298559,0.9089185613230608,0.18722612328901503,0.794858171113528,5424,23,ADCY2|WFS1|ADCY3|RAB11FIP2|TFAP2B|ADCY6|RAB11A
TACHYKININ RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007217,0.0744708994708995,0.383186929742657,-0.735083268997463,-1.4354313182634,562,3,GRK5|TAC1|ADRBK1
INTERFERON-GAMMA SECRETION%GOBP%GO:0072643,0.18572587185725897,0.559093571852282,0.534732422113013,1.28602840875282,1373,5,BTN3A1|TRIM27|BTN3A2
PYRIMIDINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0072528,0.265052356020942,0.640406488040947,-0.259309473996318,-1.1581051129245301,2024,28,TYMP|CTPS1|CDA|PRPS1|UMPS|CMPK2|TK1|UCK1
MANNOSE METABOLIC PROCESS%GOBP%GO:0006013,0.287226822315732,0.6603864229308399,0.44461464955113106,1.15046653805562,2115,6,MAN2B2|PMM1|PMM2|MAN2A2|MAN2A1
THYROID-STIMULATING HORMONE-SECRETING CELL DIFFERENTIATION%GOBP%GO:0060129,0.148494983277592,0.5154128781388279,-0.9235774150860171,-1.23042688090995,1109,1,BMP2
INTERLEUKIN-12-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035722,0.0301969932607569,0.24598741042370603,-0.32276304776931397,-1.5938839005813301,232,39,HNRNPA2B1|HSPA9|PSME2|LMNB1|SNRPA1|MSN|SOD1|ARF1|AIP|CFL1|ANXA2|TALDO1|P4HB
INOSITOL PHOSPHATE-MEDIATED SIGNALING%GOBP%GO:0048016,0.9643341470029829,0.990916952887267,0.151950176547341,0.5461653137983901,7110,14,PPP3R1|PPP3CB|HRH1|EDN1|PPP3CC|NFAT5|INPP5A|ADGRB2|PPP3CA|NFATC3|NFATC4|NFATC2|PLCE1
RECIPROCAL MEIOTIC RECOMBINATION%GOBP%GO:0007131,0.37024579560155196,0.7226447402424641,-0.21981540137594802,-1.05847267285172,2861,36,BLM|RAD54B|RAD21|TRIP13|EME2|DMC1|RAD51|RPA2|MLH3|BRIP1|RAD51C|TOP2A|STRA13|EME1|RMI1|REC8|RAD51B|FANCM|MUS81
REGULATION OF ECTODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042665,0.937441891353433,0.9806508984207809,0.5320357300397001,0.7093978569071909,7057,1,FZD7
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE%GOBP%GO:0002921,0.0334034718569174,0.261061407921079,-0.672239740370529,-1.61123038251886,253,5,FCGR2B|A2M|CD55|SERPING1
MEIOTIC CELL CYCLE PROCESS%GOBP%GO:1903046,0.862431151530678,0.9527544063641651,-0.125302319775178,-0.7531684617177091,6732,80,GOLGA2|C17orf104|BLM|FIGNL1|TUBG1|RAD54B|RAD21|TRIP13|NCAPD3|EME2|MYBL1|DMC1|RAD51|PIM2|RPA2|NUF2|MLH3|BRIP1|EXO1|ESPL1|RAD51C|TUBG2|RAD1|PTTG1|TOP2A|NCAPH2|STRA13|SGOL1|EME1|RMI1|REC8|RAD51B|FANCM|SYCE2|MUS81
POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060161,0.443518518518519,0.766392965899957,-0.527635952168444,-1.0303392858026301,3352,3,CAV2|PRMT5
TOLL-LIKE RECEPTOR 2 SIGNALING PATHWAY%GOBP%GO:0034134,0.326670173592846,0.6941148928066879,-0.467170212039391,-1.11971785397686,2483,5,RIPK2|PIK3AP1|IRAK1|LGALS9
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY%GOBP%GO:0043552,0.0179155224270956,0.18267953582463603,-0.412166159391889,-1.70688730825854,136,22,TGFB1|TNFAIP8L3|FLT1|CCL19|FGR|EPHA8|IRS1|PRKD1|PIK3R4|TEK|PDGFRB|PDGFRA|AMBRA1|PDGFB
FATTY ACID ALPHA-OXIDATION%GOBP%GO:0001561,0.0196104949959427,0.192628124925339,0.6265306122448979,1.72952093803736,144,7,ALDH3A2|SLC25A17|PEX13|PHYH|HACL1|PECR|SLC27A2
REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0032960,0.37861536448108896,0.7285942545132281,-0.491468004923687,-1.07592619804922,2892,4,P2RY6|GPER1
INDOLE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042430,0.691422594142259,0.8879225792175841,-0.258753755516391,-0.8106417382024541,5287,10,TDO2|KMO|CCBL1|KYNU|HAAO|AFMID
POSITIVE REGULATION OF CHOLESTEROL ESTERIFICATION%GOBP%GO:0010873,0.411057042443904,0.7455388982492049,0.42566122577184995,1.0237128070223,3040,5,STARD4|AGTR1
REGULATION OF BROWN FAT CELL DIFFERENTIATION%GOBP%GO:0090335,0.742677824267782,0.9101620379706981,-0.246645323187542,-0.772707600356317,5679,10,HNRNPU|INS|METRNL
NEGATIVE REGULATION OF PLANT EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:1903889,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
MALATE METABOLIC PROCESS%GOBP%GO:0006108,0.565728969434677,0.8298339339066451,0.324697688890584,0.8963192547870259,4182,7,MDH1B|MDH1
AXON MIDLINE CHOICE POINT RECOGNITION%GOBP%GO:0016199,0.19508218991984802,0.5697855203224189,0.576585306038822,1.2667824727741002,1435,4,ROBO3|ROBO2
NEGATIVE REGULATION OF CELLULAR RESPONSE TO THAPSIGARGIN%GOBP%GO:1905892,0.829163879598662,0.9433761342424741,-0.58893912659903,-0.7846083292536808,6197,1,CLU
PROPYLENE METABOLIC PROCESS%GOBP%GO:0018964,0.346086956521739,0.703504080836324,-0.823775915306573,-1.09746731945042,2586,1,GRIN1
TRIGLYCERIDE-RICH LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0071830,0.0460672686821097,0.30746333312705,-0.700215077483042,-1.5329171758598101,351,4,APOC2|APOC1|APOE|LDLR
T CELL SELECTION%GOBP%GO:0045058,0.34170591313448495,0.701955655133333,-0.29334883654133803,-1.09019786340864,2611,16,FOXP3|CD1D|CD74|BATF|CD4|SPN|STAT3|JAG2
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION%GOBP%GO:2000737,0.123275188752929,0.47711156834243,-0.481234828934174,-1.3854077186628797,946,8,PRICKLE1|JAG1|REST|HNRNPU|HES1|NOTCH1
MACROMOLECULE DEPALMITOYLATION%GOBP%GO:0098734,0.9722863741339491,0.9915747942934481,0.252539901325137,0.554840918289454,7156,4,LYPLA2|LYPLA1
CARNITINE METABOLIC PROCESS%GOBP%GO:0009437,0.92042042042042,0.9768322640118741,0.20392001136187402,0.619694106987692,6742,9,ACADM|SHMT1|CPT1B|CPT1A
CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033627,0.0653173873045078,0.366933938653309,-0.37616542836268796,-1.4861945143210802,496,19,ITGB1|ITGBL1|ADAM9|ITGA11|ITGB2|ITGB5|VTN|ITGA5|FBN1|NOV|COL16A1|ITGB4
PROTEIN LOCALIZATION TO MICROTUBULE PLUS-END%GOBP%GO:1904825,0.8781746031746029,0.960725750963158,-0.34245064519686796,-0.668719316310254,6638,3,MAPRE3|MAPRE1|MAPRE2
MIDBRAIN-HINDBRAIN BOUNDARY MORPHOGENESIS%GOBP%GO:0021555,0.9268227424749158,0.9790847380319629,-0.536281429201588,-0.7144556324615021,6927,1,KDM2B
REGULATION OF NEURAL CREST FORMATION%GOBP%GO:0090299,0.830256342143711,0.9435818887072471,0.58392148213498,0.7785805062335109,6250,1,FUZ
CAP-DEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:0002191,0.0074290262669143,0.10470817362244099,-0.942259973149649,-1.56807127401972,55,2,EIF4G1
PROTEIN C-LINKED GLYCOSYLATION VIA 2'-ALPHA-MANNOSYL-L-TRYPTOPHAN%GOBP%GO:0018406,0.163287374966207,0.534744357685457,0.5500323963358029,1.32282475902076,1207,5,DPY19L3|DPY19L1|DPY19L2|DPY19L4
POSITIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001269,0.694957432874918,0.889839960247528,-0.313121434275513,-0.8054326795204291,5305,6,GSN|LGALS9
NEGATIVE REGULATION OF MEMBRANE PERMEABILITY%GOBP%GO:1905709,0.35304232804232794,0.7116618431256551,-0.565080680246775,-1.1034593494123,2668,3,HEG1|RASIP1
PERIPHERAL NERVOUS SYSTEM NEURON AXONOGENESIS%GOBP%GO:0048936,0.914916387959866,0.9740523336757891,-0.542346713718571,-0.72253604779882,6838,1,ISL1
ACTIVATION OF STORE-OPERATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:0032237,0.105876194215417,0.447796222692122,-0.639497049578117,-1.39999272042768,808,4,CRACR2A|STIM2|TMEM110|STIM1
D-XYLOSE CATABOLIC PROCESS%GOBP%GO:0042843,0.19183946488294298,0.5663196752097011,-0.9025143361270401,-1.20236580219308,1433,1,DHDH
REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0042304,0.12591336116910198,0.481582257349077,-0.307552651978693,-1.34160083272805,964,26,ADIPOR1|BRCA1|NR1H3|CEACAM1|SLC45A3|ADIPOR2|ABCD1|ANXA1
REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033146,0.805193110647182,0.932964969466025,-0.171384789045144,-0.7476117478441271,6170,26,STRN3|RUNX1|UBA5|GPAM|BRCA1|WBP2|KANK2|PAGR1|YAP1
RETINOL TRANSPORT%GOBP%GO:0034633,0.0193916854827998,0.19226875441368102,0.990681517423908,1.32094012799787,145,1,STRA6
REGULATION OF VITAMIN D 24-HYDROXYLASE ACTIVITY%GOBP%GO:0010979,0.0358613361668216,0.268987198588135,0.9820247022496691,1.30939743305183,269,1,CYP27B1
POSITIVE REGULATION OF KINASE ACTIVITY%GOBP%GO:0033674,0.00692396461084755,0.100321765459533,-0.17891173558066503,-1.4469565091121497,53,358,MUL1|TNFAIP8L3|CCND2|RGCC|PRKAR2A|PAK4|CLSPN|ADAM9|CEMIP|PLCE1|CHI3L1|MAP3K3|FLT1|CD74|IL18|ARHGEF5|ADAM8|MADD|RIPK3|CCL19|LMO4|AGT|EZH2|CAMK1|NBN|ECT2|DAB2IP|PIK3R6|CD4|DUSP5|TNFRSF10A|TNFRSF10B|RAPGEF1|FGR|ATG13|C8orf4|TPX2|NGF|TNFRSF11A|PDGFD|JTB|AZU1|EPHA8|GAS6|PKN1|INS|STRADA|MDFIC|DDR2|TRAF2|FPR1|TAOK2|SYAP1|DDX3X|ADCY8|CXCR4|EFNA1|ZNF622|MST1R|PDGFC|MAPKAPK2|PRKAR1A|MLKL|IRS1|PRKD1|CKS2|PARK7|PIK3CB|SLC11A1|FGF10|MAPK3|GHRL|ABL1|SOD1|IRAK1|HRAS|IGF1|NTRK2|MAP3K13|RPTOR|GADD45B|GPRC5B|CSF1|PIK3R4|STK3|MAP2K3|F2R|PSMD10|RAP1A|SASH1|PPP2CA|MUC20|GADD45G|TGFBR2|BMP2|THBS1|TEK|MAP3K11|ZFP91|ADRA2C|DLG3|PEA15|UBC|PDGFRB|EPHA4|NEDD9|ANG|CCND3|PRKACA|TLR4|ZNF16|PDGFA|HSP90AA1|CSF1R|PDGFRA|MARK2|GNG3|AMBRA1|MAPKAP1|CCND1|DBNL|CD81|PDGFB|C5AR1|ERN1|CARD10|BAD|EMP2|PRNP
POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY%GOBP%GO:1903348,0.38981456597688796,0.7358910495632479,0.54466406919,1.07128994950784,2900,3,NPHP1|NPHP4
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR%GOBP%GO:1902255,0.457546529004211,0.772025274257641,0.44898171073083704,0.98643193954662,3367,4,RPL26|RPS7|MSX1|UBB
NEURON PROJECTION ARBORIZATION%GOBP%GO:0140058,0.8049770792403409,0.932964969466025,-0.28204211135587104,-0.72548828863334,6145,6,TAOK2|SEMA3A
MENAQUINONE METABOLIC PROCESS%GOBP%GO:0009233,0.608048877672998,0.849421970741672,0.6932068813409791,0.924297839883635,4577,1,UBIAD1
"RNA SPLICING, VIA TRANSESTERIFICATION REACTIONS%GOBP%GO:0000375",0.0005123607019341621,0.0139121625154964,-0.21411278802615802,-1.65879995896852,3,274,SNRPD3|SRSF4|RBMX2|SETX|SMN2|SF3A3|CSTF2|SART3|PUF60|GEMIN5|DDX41|SRSF12|PNN|HNRNPH3|SRRT|GEMIN7|POLR2F|HNRNPA1|SNRNP48|PDCD7|RBM41|DNAJC8|KHSRP|AAR2|SUGP1|SF3A2|SCNM1|PRCC|PPWD1|SF3B4|CPSF1|SNRPE|POLR2C|LSM5|PSIP1|CELF2|YBX1|WDR83|GEMIN8|DHX9|PTBP1|SRSF3|TXNL4A|SRPK3|HNRNPH1|SF3A1|DCPS|SRSF10|ELAVL2|HNRNPUL1|HNRNPL|NCBP2|PRPF4|POLR2J|SLU7|DDX23|RBM17|SNRNP35|DHX8|SNRPB2|SRSF9|HNRNPU|RBMX|LUC7L3|GEMIN2|CELF1|BCAS2|HNRNPH2|DDX42|MAGOH|CPSF2|CD2BP2|SRSF5|ZRSR2|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|SNRPA1|HNRNPM|DDX5|CLP1|SF1|SNW1|POLR2H|CELF4|EFTUD2|HNRNPR|RBM22|CSTF3|LSM3|FUS|WBP11|SNRNP25|RBM4B|SMU1|ZMAT2|HNRNPK|MAGOHB|EIF4A3|SNRPB|TRA2B|PABPN1|SRSF2|RBM8A|DDX39A|POLR2G|IK|SF3B2|ISY1|CPSF7|RBM4|PRMT5|SKIV2L2|CWC27|PQBP1|HNRNPA0|GPKOW|SART1|HNRNPC|POLR2L|SMN1|PRPF19
CYSTEINE BIOSYNTHETIC PROCESS FROM SERINE%GOBP%GO:0006535,0.721344136007438,0.901938862696805,0.639225849139832,0.8523214172582709,5430,1,CBS
NEURON FATE SPECIFICATION%GOBP%GO:0048665,0.0058123817247904795,0.0881615800553922,0.7664128704834772,1.8432185585096899,42,5,DLL1|POU3F2|ASCL1
MITOCHONDRIAL TRANSLATIONAL TERMINATION%GOBP%GO:0070126,0.000512886267470189,0.0139121625154964,-0.316366034705743,-1.9481972886660799,3,88,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|MRPL18|MRPL57|GFM2|MRPS18B|MRPS15|MRPL47|GADD45GIP1|MRPS11|MRPL13|OXA1L|MRPL10|MRPL50|MRRF|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
REGULATION OF STEROID BIOSYNTHETIC PROCESS%GOBP%GO:0050810,0.0424133041124146,0.294833299013666,-0.266556004991966,-1.4947994627611398,328,61,REST|SREBF2|IDI1|GPAM|FGFR4|FDPS|KPNB1|ABCG1|CYP51A1|SNAI2|MBTPS2|SOD1|RAN|HMGCR|APOE|HMGCS1|FGF19|BMP2|NR1D1|SNAI1|NFYB|DHCR7|NFKB1|FASN|TM7SF2
SIDEROPHORE TRANSPORT%GOBP%GO:0015891,0.12066889632107,0.472686039512467,-0.9379135421261581,-1.24952604443452,901,1,SLC22A17
T CELL AGGREGATION%GOBP%GO:0070489,0.753250198991775,0.915498058528019,-0.49046830101660793,-0.8162176846699759,5677,2,MSN
RIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0042455,0.172517684045062,0.546371269738967,-0.4016018728503571,-1.30020767033722,1316,11,IMPDH2|ADA|CTPS1|HPRT1|UMPS|GMPS
DIAPHRAGM CONTRACTION%GOBP%GO:0002086,0.41070234113712395,0.7453853667476059,-0.7951588001764449,-1.05934245072253,3069,1,GAA
ANOIKIS%GOBP%GO:0043276,0.07002457002457001,0.37603012457098106,0.496145546974181,1.5077405577546399,512,9,TSC2|DAPK2|BMF|MTOR|MAP3K7|IKBKG|PIK3CA|STK11
L-ALANINE METABOLIC PROCESS%GOBP%GO:0042851,0.758666489573649,0.9172140592138721,0.6206991618879579,0.827618579666726,5711,1,GPT2
TETRATERPENOID METABOLIC PROCESS%GOBP%GO:0016108,0.791074511887369,0.928357780000476,0.603936921041023,0.8052683932743759,5955,1,BCO2
CIRCADIAN BEHAVIOR%GOBP%GO:0048512,0.28934340802501296,0.662218930390028,-0.38159360730658504,-1.14792697437792,2220,9,MTA1|PTEN|ID2|USP2|CIART
ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION%GOBP%GO:0051905,0.0029899429192715397,0.0547143035205039,0.5310674215351,1.9996449735789998,21,16,BBS5|BBS4|BLOC1S3|MKKS|RAB11B|RAB11A|MREG|BBS2|MYO5A|BBS7
RESPONSE TO CORTICOSTERONE%GOBP%GO:0051412,0.904635409748971,0.9698755111576809,0.547529775033083,0.730057075250119,6810,1,PEBP1
REGULATION OF ASPARTIC-TYPE PEPTIDASE ACTIVITY%GOBP%GO:1905245,0.5639156469669361,0.8289882771095609,-0.314713363820057,-0.9060157270169309,4331,8,EFNA1|EFNA3|EPHA4
PHAGOSOME MATURATION%GOBP%GO:0090382,0.0390205578106586,0.28145446772749,-0.4664613144129439,-1.6056503012761,297,13,CORO1A|SLAMF8|RAB14|RAB7A|SYT7|RAB7B|RAB34|RAB20
PROSTATE GLANDULAR ACINUS DEVELOPMENT%GOBP%GO:0060525,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
ADHERENS JUNCTION ASSEMBLY%GOBP%GO:0034333,0.366419174156572,0.7209537772611361,-0.246781798168526,-1.0639109111306,2812,25,TBCD|CTTN|PEAK1|TRIP6|THY1|TAOK2|RHOD|DLC1|VCL|ACTN1
POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072126,0.0562483417352083,0.34424567164700104,-0.845359028176015,-1.40681260595743,423,2,PDGFB
NEGATIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS%GOBP%GO:0046986,0.804816053511706,0.932964969466025,-0.60200705778562,-0.8020179513895409,6015,1,EIF2AK1
CEREBELLAR CORTEX FORMATION%GOBP%GO:0021697,0.5530985530985529,0.8231366946320219,0.300257893946714,0.9124560469208659,4051,9,DLL1|ATP7A|AGTPBP1|PROX1
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:1903020,0.8791791247621641,0.960892397008799,0.17667683226032502,0.66524686932593,6468,16,RAMP1|ARFGEF1|RAB1A|CHP1|CCR7|CCL21|PXYLP1|ALG10B|TCF7L2|CTNNB1|SOAT1
AXON DEVELOPMENT%GOBP%GO:0061564,0.0841857893281725,0.40376145987147494,0.166524212863194,1.25576040891337,608,216,TNR|RET|CNTN4|SHTN1|DRD2|ROBO3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|SEMA4F|PLXNB1|LLGL1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|SLIT1|EPHB2|EFNA4|RTN4|PARD3|RAB10|GFRA1|CHN1|PTPRO|ROBO2|PTPRM|SLITRK6|CHRNB2|LYPLA2|EFNB2|NTNG1|EFNB3|SLIT3|CDK5R1|NREP|SHC1|SOS1
WAX METABOLIC PROCESS%GOBP%GO:0010166,0.6263397642015011,0.858842084733938,0.537778378403918,0.9035371110956449,4674,2,FAR2
PROTEIN TARGETING%GOBP%GO:0006605,0.6041933009460501,0.848175106515994,-0.11949724208966499,-0.9395731688972672,4725,299,RPS14|RPS4X|RPL35A|LTBP2|RPS29|DHRS4|RPL10|RPL36A|RPL24|TOMM70A|TIMM21|SRP19|ROMO1|ACOX1|PIK3R4|NCOA4|AIP|CAT|GIPC1|RPL35|RPL38|RPS15A|PEX16|AP4S1|CHMP4A|IMMP1L|TIMM10B|SEC61A1|ZDHHC19|SEC61B|UBC|SSR1|TIMM9|SGTB|RPS13|TIMM17B|ACOT2|LAMP2|ARL6IP1|ATG3|HSP90AA1|ZDHHC24|GOSR2|TOMM5|SRP9|HSPA4|ZDHHC2|TIMM10|UQCRC2|DNAJC19|SRP68|DNAJC15
MOTOR NEURON MIGRATION%GOBP%GO:0097475,0.31229903536977505,0.68160868787154,0.678208652446664,1.1394781031740802,2330,2,NRP1|VEGFA
REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY%GOBP%GO:0010533,0.320900405706059,0.6887547458395611,-0.5178828803301021,-1.1337538820148998,2451,4,AGT|CD300A
RESPONSE TO ESTROGEN%GOBP%GO:0043627,0.49550019564366793,0.793890905419504,-0.21934207403368106,-0.9674057055555141,3798,27,SRA1|CRHBP|BRCA1|BCAS3|GHRL|WBP2|CAV1|KRT19
GERM CELL MIGRATION%GOBP%GO:0008354,0.220390001308729,0.6027391478106829,-0.5694038493354661,-1.24654405298515,1683,4,TGFBR1|PPAP2B|CXADR|PPAP2A
DESENSITIZATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002029,0.12612966601178802,0.48175523567590006,-0.538588816153816,-1.38539552349141,962,6,ADRB2|ADM|ARRB1|ADRBK1|GTF2H2
"CELLULAR RESPONSE TO 2,3,7,8-TETRACHLORODIBENZODIOXINE%GOBP%GO:1904613",0.10108782170337,0.43836486389879703,-0.8012131237937691,-1.33334676160449,761,2,AHR|PDE2A
MITOTIC SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:0007094,0.845842050209205,0.948909006295342,-0.18112837669182102,-0.702845465012262,6468,18,ZNF207|TRIP13|KLHL22|APC|CDC20|MAD2L1|PLK1|IK
PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009151,0.161803364879075,0.532305428240436,-0.483298347331001,-1.32107448004715,1230,7,NUDT1|NUDT16|NUDT18|SAMHD1
NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903363,0.290376676986584,0.663080262067683,-0.195507865199147,-1.11802827384898,2250,66,DAB2IP|USP25|UCHL5|OGT|PSMF1|BAG5|UBE2G2|EFNA1|PARK7|UBXN1|ALAD|HFE|GIPC1|TLK2|EPHA4|DERL3|TAF9|ANXA2|AK6
DATP CATABOLIC PROCESS%GOBP%GO:0046061,0.0716370390023879,0.3767214120425879,-0.8279018472566859,-1.37776106529455,539,2,NUDT1|SAMHD1
REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME%GOBP%GO:0150031,0.740603001726657,0.909493931144346,0.6293008381120421,0.8390877542628009,5575,1,ROCK2
REGULATION OF MEDIATOR COMPLEX ASSEMBLY%GOBP%GO:2001176,0.8132368703108249,0.9356336309698571,0.44172315665115297,0.7421519363592991,6069,2,MED25
TRANSLOCATION OF MOLECULES INTO HOST%GOBP%GO:0044417,0.0851735015772871,0.40376145987147494,-0.53692474202122,-1.4676598384979298,647,7,THOC7|THOC3
NEGATIVE REGULATION OF ECTODERM DEVELOPMENT%GOBP%GO:2000384,0.937441891353433,0.9806508984207809,0.5320357300397001,0.7093978569071909,7057,1,FZD7
FORAMEN OVALE CLOSURE%GOBP%GO:0035922,0.804816053511706,0.932964969466025,-0.601951918835465,-0.801944493068292,6015,1,TBX20
POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY%GOBP%GO:0045860,0.0576258163657319,0.34590110360017606,-0.159717773590705,-1.2776468829438001,449,333,IL18|ARHGEF5|ADAM8|MADD|RIPK3|CCL19|AGT|EZH2|CAMK1|ECT2|DAB2IP|PIK3R6|CD4|DUSP5|TNFRSF10A|TNFRSF10B|RAPGEF1|ATG13|C8orf4|TPX2|NGF|TNFRSF11A|PDGFD|JTB|AZU1|GAS6|PKN1|INS|STRADA|MDFIC|DDR2|TRAF2|FPR1|TAOK2|SYAP1|DDX3X|ADCY8|CXCR4|EFNA1|MST1R|PDGFC|MAPKAPK2|PRKAR1A|MLKL|CKS2|PARK7|PIK3CB|SLC11A1|FGF10|MAPK3|GHRL|ABL1|SOD1|IRAK1|HRAS|IGF1|NTRK2|MAP3K13|RPTOR|GADD45B|GPRC5B|CSF1|STK3|MAP2K3|F2R|PSMD10|RAP1A|SASH1|PPP2CA|MUC20|GADD45G|TGFBR2|BMP2|THBS1|MAP3K11|ZFP91|ADRA2C|DLG3|PEA15|UBC|PDGFRB|EPHA4|NEDD9|ANG|CCND3|PRKACA|TLR4|PDGFA|HSP90AA1|CSF1R|MARK2|GNG3|MAPKAP1|CCND1|DBNL|CD81|PDGFB|C5AR1|ERN1|CARD10|EMP2|PRNP
SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION%GOBP%GO:0051124,0.544346195069668,0.8171943796142529,0.572594430658947,0.962032574166561,4062,2,SHANK2|SHANK1
POSITIVE REGULATION OF INTERLEUKIN-6 BIOSYNTHETIC PROCESS%GOBP%GO:0045410,0.19225232299437198,0.566629421802777,-0.5846594494158069,-1.2799417505544,1468,4,TNF|TLR1|STAT3
CORTICOSTEROID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0031958,0.6905042567125079,0.887500271277908,-0.31444375120100704,-0.808834034866607,5271,6,CALR|RBM14
NEGATIVE REGULATION OF NOREPINEPHRINE UPTAKE%GOBP%GO:0051622,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
VESICLE TETHERING%GOBP%GO:0099022,0.877833582190851,0.960725750963158,0.25619105399591896,0.6629094099105,6466,6,WDR11|STARD3|FAM91A1|STARD3NL
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:1903725,0.0125721616420783,0.14869950444299201,-0.3181064110619,-1.6986051158687099,97,51,APOC2|DGKZ|TGFB1|TNFAIP8L3|FLT1|CCL19|DAB2IP|FGR|APOC1|EPHA8|FABP3|IRS1|PRKD1|PIK3R3|MTMR1|PIK3R4|ZP3|TEK|PDGFRB|LDLR|STOML2|PDGFA|PDGFRA|AMBRA1|CD81|PDGFB
PRONEPHRIC NEPHRON DEVELOPMENT%GOBP%GO:0039019,0.792068595927117,0.92928601839974,0.454292774370952,0.7632705170575981,5911,2,AHI1
RNA LOCALIZATION TO CAJAL BODY%GOBP%GO:0090670,0.988953182535508,0.9961107928457941,-0.207652878548485,-0.49770432606439596,7519,5,DKC1
REGULATION OF TRAIL-ACTIVATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903121,0.0656982070409632,0.368448359907007,-0.676280813985551,-1.4805200699038201,501,4,PTEN|ATF3|PARK7|TIMP3
REGULATION OF NITROSATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1905258,0.0474927036349164,0.312255783864335,-0.856906534325889,-1.42602950277589,357,2,PARK7|DNAJA1
OLIGOSACCHARIDE METABOLIC PROCESS%GOBP%GO:0009311,0.7342790888009821,0.9079405785880958,0.170296138624416,0.810958281518777,5382,33,ST6GALNAC5|ST8SIA2|MANBA|MAN2B2|MPDU1|ST3GAL4|ST3GAL6|NAGA|MAN2C1|GAL3ST4|IDUA|ATHL1
NEGATIVE REGULATION OF MULTI-ORGANISM PROCESS%GOBP%GO:0043901,0.0115104233277913,0.139771630097924,-0.250007815671793,-1.6095245891238201,89,105,IFIT1|APOBEC3G|TRIM32|ISG15|CARD16|CALR|RSAD2|IGF1|APOBEC3C|FCN1|NPLOC4|IFI16|TNIP1|GSN|BST2|ZP3|DHX58|IFITM1|BTBD17|ANXA2|TIMP1|IFITM2|FAM3A|IFITM3|MID2|BANF1|APOBEC3F|RNF26
NEGATIVE REGULATION OF COLLAGEN FIBRIL ORGANIZATION%GOBP%GO:1904027,0.940895205206535,0.981358821491484,0.529719894133216,0.706310002208247,7083,1,CHADL
NEGATIVE REGULATION OF VESICLE FUSION%GOBP%GO:0031339,0.576545502785885,0.836604755247265,-0.568616099202261,-0.946268117623421,4345,2,PRRT2
PURINE NUCLEOTIDE TRANSPORT%GOBP%GO:0015865,0.574171488690163,0.835204333784353,-0.37444689695714206,-0.897477760961761,4365,5,SLC25A4|SLC25A42
MITOCHONDRIAL GLYCYL-TRNA AMINOACYLATION%GOBP%GO:0070150,0.61819397993311,0.854944793214197,-0.694805910895457,-0.9256483060505221,4620,1,GARS
POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT%GOBP%GO:0060999,0.621997637485234,0.8562679031083101,-0.21585662629160396,-0.879401449752876,4738,21,NEURL1|BHLHB9|CPEB3|LLPH|PSEN1|CAMK1|FMR1|DHX36|DBN1|CAMK2B|APOE|CAPRIN1
HISTIDYL-TRNA AMINOACYLATION%GOBP%GO:0006427,0.801580921757771,0.9325377000668108,0.448966087675765,0.7543209956533259,5982,2,HARS2|HARS
MYELOID CELL APOPTOTIC PROCESS%GOBP%GO:0033028,0.5920634920634921,0.8417378833576942,-0.46041963150938,-0.899082847461919,4475,3,CTSL
NEGATIVE REGULATION OF RRNA PROCESSING%GOBP%GO:2000233,0.564738657468825,0.8295590091625621,-0.573528717477905,-0.9544435000208199,4256,2,NUDT16
INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE%GOBP%GO:0060729,0.0805351170568562,0.397722753303477,-0.957432730480812,-1.27553029015644,601,1,TLR4
ADENOSINE 5'-(HEXAHYDROGEN PENTAPHOSPHATE) METABOLIC PROCESS%GOBP%GO:1901910,0.7360293155346159,0.908157084784786,-0.35559109356837504,-0.7784632357147929,5623,4,NUDT11|NUDT4
REGULATION OF TIGHT JUNCTION DISASSEMBLY%GOBP%GO:1905073,0.574953568585832,0.8354258054828342,-0.569341053212021,-0.9474745570245241,4333,2,TGFBR1|TGFB3
CARDIOBLAST MIGRATION TO THE MIDLINE INVOLVED IN HEART FIELD FORMATION%GOBP%GO:0060975,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS%GOBP%GO:0090205,0.9893992932862191,0.9962702115525078,-0.226493134064964,-0.49584081603971203,7559,4,FGF1|PRKAA1|LDLRAP1|ABCG1
POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION%GOBP%GO:1903599,0.970672097759674,0.9915747942934481,0.154906425457739,0.5425145979509329,7148,13,PARK2|HTT|FBXO7|HDAC6|OPTN|MFN2
REGULATION OF INTERLEUKIN-1 BETA PRODUCTION%GOBP%GO:0032651,0.00117324990222917,0.0261694927157725,-0.43719391968148297,-2.05318606521705,8,33,PYCARD|GSDMD|CCL19|AZU1|CASP1|TNFAIP3|CARD16|GHRL|HSPB1|IFI16|F2R|NLRP3|LGALS9|FOXP1|CX3CL1|TLR4|GSTP1|SIRPA
NEGATIVE REGULATION OF PROTEIN HOMODIMERIZATION ACTIVITY%GOBP%GO:0090074,0.4064814814814821,0.7437564705352799,-0.542406529171722,-1.05918247910268,3072,3,ISL1|ITGA4|HSPA5
NEGATIVE REGULATION OF WOUND HEALING%GOBP%GO:0061045,0.00259201658890617,0.0487246160373156,-0.38798059228865706,-1.91594429430745,19,39,CD34|GP1BA|PLAU|CASK|VTN|PHLDB2|CEACAM1|THBD|APOE|PLAUR|NOS3|SERPINE2|SERPINE1|PLAT|PDGFA|ANXA2|PDGFRA|TFPI|PDGFB|SERPINF2|C1QTNF1
PANTOTHENATE METABOLIC PROCESS%GOBP%GO:0015939,0.319940876108573,0.6880109854925379,0.5774236241314661,1.1357241281958799,2380,3,AASDHPPT|PANK2|VNN2
REGULATION OF PROTEIN PROCESSING IN PHAGOCYTIC VESICLE%GOBP%GO:1903921,0.0196338551339878,0.192628124925339,-0.909181141439206,-1.5130228083506398,147,2,GSN|MYH9
REPLICATION FORK ARREST%GOBP%GO:0043111,0.90149921094161,0.9684180373391851,-0.268144716523274,-0.642691718784835,6854,5,TIPIN|MSH6|MSH3|TIMELESS|SLFN11
LYMPH VESSEL MORPHOGENESIS%GOBP%GO:0036303,0.0461095100864553,0.30746333312705,-0.487587995883575,-1.57859236988271,351,11,SOX18|FOXC2|FLT4|PDPN|CCBE1|ACVRL1
CANALICULAR BILE ACID TRANSPORT%GOBP%GO:0015722,0.938996655518395,0.980854185905783,-0.5302712836347601,-0.7064486754454309,7018,1,ABCC3
WATER-SOLUBLE VITAMIN CATABOLIC PROCESS%GOBP%GO:0042365,0.91005291005291,0.9720943283119721,-0.325644504237572,-0.6359011825156651,6879,3,PDXP
PIGMENT GRANULE TRANSPORT%GOBP%GO:0051904,0.0014897074756229699,0.031468170285448994,0.5725490791761529,2.11189753937947,10,15,BBS5|BBS4|BLOC1S3|MKKS|RAB11B|RAB11A|MREG|BBS2|MYO5A|BBS7|BLOC1S5|ARL6
CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072203,0.0866277527195543,0.406842536616055,-0.814840357541076,-1.35602465771853,652,2,PDGFRB
RNA 3' URIDYLATION%GOBP%GO:0071076,0.734592711682744,0.9079405785880958,0.480507306313758,0.807314315416739,5482,2,ZCCHC11|ZCCHC6
RESPONSE TO TESTOSTERONE%GOBP%GO:0033574,0.5147290899526571,0.803130625466925,-0.39237244010788597,-0.9404418673856271,3913,5,MSN|SPP1
NEGATIVE REGULATION OF SYNAPSE ASSEMBLY%GOBP%GO:0051964,0.21284600913732898,0.595429519818125,0.634158915623021,1.2473157513548798,1583,3,SLIT1|ROBO2
REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS%GOBP%GO:0045343,0.79047619047619,0.928247620398227,-0.379728686445351,-0.741513882787828,5975,3,NLRC5|CIITA|HSPH1
ENTRY OF ORGANISM INTO CELL OF OTHER ORGANISM BY PROMOTION OF PHAGOCYTOSIS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052370,0.32846327533537,0.6950398637731511,0.835410233789149,1.11390682246874,2472,1,ITGAV
CENTRAL NERVOUS SYSTEM MYELIN FORMATION%GOBP%GO:0032289,0.15725860007969197,0.5270916162557739,0.9239633877370981,1.23198050452832,1183,1,TENM4
REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS%GOBP%GO:0002023,0.678528428093645,0.884536278926676,-0.6649757388619321,-0.885907354255162,5071,1,GDF15
POSITIVE REGULATION OF CYTOKINE SECRETION%GOBP%GO:0050715,0.034020618556701,0.263401338904874,-0.26756962063446305,-1.5257351206473602,263,65,RGCC|HYAL2|DHX9|TLR1|PYCARD|TNFRSF14|GSDMD|CCL19|TLR2|FGR|CD34|GATA3|INS|CASP1|DHX36|PTGER4|IFIH1|OSM|FCN1|IL33|F2R|GAPDH|NLRP3|LGALS9|HAVCR2|TLR4|CSF1R|C1QTNF4|CD14
MYELOID DENDRITIC CELL ACTIVATION%GOBP%GO:0001773,0.17173172648677,0.5454639666949349,-0.40189726892818506,-1.30116403103209,1310,11,DHRS2|DOCK2|UBD|PYCARD|BATF|BATF2|TGFBR2|LTBR
NEGATIVE REGULATION OF AMINO ACID TRANSPORT%GOBP%GO:0051956,0.688357560114115,0.8870128815009231,0.37293337593507,0.8193505092812992,5066,4,TRH|HRH3
REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900449,0.43462390822578495,0.762034923704788,-0.21609173813458898,-1.01482780426066,3333,33,CRHBP|MEF2C|FRRS1L|CAPN1|NECAB2|CNIH2|CX3CL1|CNIH3|PRNP
POSITIVE REGULATION OF COHESIN LOADING%GOBP%GO:1905309,0.772307692307692,0.9215496572020819,-0.6184384649316279,-0.82390853112155,5772,1,NIPBL
POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION%GOBP%GO:0042104,0.400419012701323,0.7401048291681479,-0.302567597990887,-1.04149634676966,3057,13,PYCARD|IL18|IGF1|ICOSLG|FADD
PEPTIDYL-HISTIDINE HYDROXYLATION%GOBP%GO:0036138,0.467392748040909,0.780769690730001,0.767754741949713,1.0236973530496098,3518,1,HIF1AN
POSITIVE REGULATION OF TISSUE REMODELING%GOBP%GO:0034105,0.43354720439963296,0.7617458538169591,-0.293908939324857,-1.0116915645376,3310,13,ROCK1|SYK|IL18|ADAM8|SPP1|IL15|ATP6AP1
ALDOSTERONE METABOLIC PROCESS%GOBP%GO:0032341,0.357859531772575,0.714938712241162,-0.818978826643141,-1.09107644550182,2674,1,CACNA1H
RESPONSE TO HOST DEFENSES%GOBP%GO:0052200,0.9028664583616359,0.968731546286171,0.294620848442425,0.647294551234315,6645,4,SMAD3|EIF2AK2
NUCLEOTIDE-SUGAR BIOSYNTHETIC PROCESS%GOBP%GO:0009226,0.55969661305087,0.8268422944617521,-0.222750483224047,-0.9224677088593249,4279,22,GNPNAT1|GMPPB|GFPT2|NANS|RENBP
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052192,0.670988867059594,0.8815356925073421,-0.320129401710009,-0.82345905961101,5122,6,VPS4A|PPIA|RAB7A
EMBRYONIC ORGAN MORPHOGENESIS%GOBP%GO:0048562,0.0846004976499862,0.40376145987147494,0.22257307830369602,1.33932304035463,611,76,RBPMS2|STRA6|BBS5|ACVR1|NPHP3-ACAD11|FGFR2|DLL1|BBS4|RARG|PAX8|AHI1|EPHB2|MFAP2|TWIST1|SETDB2|WDR60|CEP290|ALDH1A3|MKKS|NPHP3|PKD2|CCDC40|PHACTR4|CHD7|MTHFD1L|LRP6|BBS7|MEGF8
POSITIVE REGULATION OF PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN SERINE 2 RESIDUES%GOBP%GO:2001165,0.379531772575251,0.728914030571579,-0.8088883987648879,-1.0776335727133701,2836,1,CCNK
TELOMERE MAINTENANCE VIA RECOMBINATION%GOBP%GO:0000722,0.921417364016736,0.977239382995912,-0.19480414964948603,-0.61029597103145,7046,10,XRCC3
METABOLISM BY HOST OF SYMBIONT MACROMOLECULE%GOBP%GO:0052416,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
POSITIVE REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:1901628,0.20045104802334804,0.5782976272452409,-0.733223049352082,-1.2202004053031599,1510,2,MESDC2|APOE
POSITIVE REGULATION OF PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0071902,0.169968051118211,0.543216018944259,-0.161261736927686,-1.17769066682136,1329,194,ARHGEF5|ADAM8|MADD|CCL19|EZH2|CAMK1|DAB2IP|PIK3R6|DUSP5|RAPGEF1|C8orf4|NGF|TNFRSF11A|PDGFD|PKN1|MDFIC|TRAF2|FPR1|TAOK2|SYAP1|DDX3X|CXCR4|MST1R|PDGFC|MAPKAPK2|MLKL|CKS2|PIK3CB|FGF10|MAPK3|GHRL|SOD1|IRAK1|HRAS|IGF1|MAP3K13|RPTOR|GADD45B|MAP2K3|F2R|PSMD10|SASH1|PPP2CA|MUC20|GADD45G|BMP2|THBS1|MAP3K11|PEA15|UBC|PDGFRB|CCND3|TLR4|PDGFA|CSF1R|GNG3|CCND1|DBNL|CD81|PDGFB|C5AR1|ERN1
REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STARVATION%GOBP%GO:0071262,0.5390023879013,0.8142313733497609,-0.583733112765371,-0.97142524558466,4062,2,EIF2AK4|IMPACT
CELLULAR MONOVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0030320,0.0385852090032154,0.279776552671739,0.8749379652605459,1.4700087494511598,287,2,SLC12A5|XPR1
PEROXISOME LOCALIZATION%GOBP%GO:0060151,0.167872454448017,0.5400872099036179,0.757871519161842,1.2733220049446499,1252,2,PEX13|PEX1
OUTER EAR MORPHOGENESIS%GOBP%GO:0042473,0.706993569131833,0.894949003158309,0.492388475337533,0.827276213416509,5276,2,TWIST1
REGULATION OF HISTONE H3-K4 METHYLATION%GOBP%GO:0051569,0.18328100470957603,0.556308895147568,-0.339695466966304,-1.26243988782303,1400,16,DNMT3B|BCOR|PAXIP1|BRCA1|SNW1|CTR9|DNMT1|H2AFY
MICROGLIA DIFFERENTIATION%GOBP%GO:0014004,0.25515873015873,0.633820868480386,-0.6113929634939891,-1.1938955007941698,1928,3,NRROS|APP|TLR2
"MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0000398",0.000383484596702033,0.0111294649577428,-0.21551683980792102,-1.66693194470858,2,271,SNRPD3|SRSF4|RBMX2|SETX|SMN2|SF3A3|CSTF2|SART3|PUF60|GEMIN5|DDX41|SRSF12|PNN|HNRNPH3|SRRT|GEMIN7|POLR2F|HNRNPA1|SNRNP48|PDCD7|RBM41|DNAJC8|AAR2|SUGP1|SF3A2|SCNM1|PRCC|PPWD1|SF3B4|CPSF1|SNRPE|POLR2C|LSM5|PSIP1|CELF2|YBX1|WDR83|GEMIN8|DHX9|PTBP1|SRSF3|TXNL4A|SRPK3|HNRNPH1|SF3A1|DCPS|SRSF10|ELAVL2|HNRNPUL1|HNRNPL|NCBP2|PRPF4|POLR2J|SLU7|DDX23|RBM17|SNRNP35|DHX8|SNRPB2|SRSF9|HNRNPU|RBMX|LUC7L3|GEMIN2|CELF1|BCAS2|HNRNPH2|DDX42|MAGOH|CPSF2|CD2BP2|SRSF5|ZRSR2|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|SNRPA1|HNRNPM|DDX5|CLP1|SF1|SNW1|POLR2H|CELF4|EFTUD2|HNRNPR|RBM22|CSTF3|LSM3|FUS|WBP11|SNRNP25|RBM4B|SMU1|ZMAT2|HNRNPK|MAGOHB|EIF4A3|SNRPB|TRA2B|PABPN1|SRSF2|RBM8A|DDX39A|POLR2G|IK|SF3B2|ISY1|CPSF7|RBM4|PRMT5|SKIV2L2|CWC27|PQBP1|HNRNPA0|GPKOW|SART1|HNRNPC|POLR2L|SMN1|PRPF19
POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT%GOBP%GO:2001140,0.7700065487884741,0.921326382088427,-0.29203643306106203,-0.751196376390495,5878,6,TRIAP1|PRELID1|APOE
FRUCTOSE CATABOLIC PROCESS%GOBP%GO:0006001,0.3969569351990221,0.7377402989373809,0.472480599218057,1.0380599983152201,2921,4,KHK
MEDIUM-CHAIN FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0051792,0.87875101378751,0.960725750963158,0.276693139201412,0.665445413079534,6500,5,ACOT7|OXSM|ABHD1
TELOMERE ASSEMBLY%GOBP%GO:0032202,0.217090069284065,0.599597524514766,0.5646387051706,1.2405352818891,1597,4,ACD|WRAP53|POT1
REGULATION OF JAK-STAT CASCADE%GOBP%GO:0046425,0.00192926045016077,0.0383938788644259,-0.35893880201760403,-1.94626899606121,14,54,LIF|CD40|CTF1|VHL|TNF|JAK3|PARP14|LYN|STAP2|IL18|AGT|SOCS3|PARP9|HGS|HCLS1|CYP1B1|TNFRSF18|IL6ST|HES1|NOTCH1|SOCS1|STAT3|ADIPOR1|OSM|IGF1|BCL3|CD300A|F2R|PPP2CA|CAV1|CSF1R|NF2|TNFRSF1A
RESPONSE TO CYTOCHALASIN B%GOBP%GO:1901328,0.0667558528428094,0.3690551432905871,-0.9648213498015,-1.28537370520372,498,1,ACTB
REGULATION OF STRESS GRANULE ASSEMBLY%GOBP%GO:0062028,0.0619397993311037,0.357540960865252,-0.9671923246581391,-1.2885324130173998,462,1,STYXL1
REGULATION OF B CELL MEDIATED IMMUNITY%GOBP%GO:0002712,0.830332500985675,0.943602795238726,-0.181997659770207,-0.719055774867654,6317,19,TGFB1|HLA-E|NDFIP1|PAXIP1|FCGR2B|PVRL2|TNFSF13|TFRC
POSITIVE REGULATION OF CELL-CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033634,0.7587891950590471,0.917242163810958,0.29397920024176194,0.7606884593297769,5589,6,CXCL13|PODXL|CD3E|CCL5|SKAP1
'DE NOVO' COTRANSLATIONAL PROTEIN FOLDING%GOBP%GO:0051083,0.8230299814274341,0.941637272706027,-0.448580093741384,-0.74650900933603,6203,2,DNAJC2|HSPA14
POSITIVE REGULATION OF METHYLATION-DEPENDENT CHROMATIN SILENCING%GOBP%GO:0090309,0.425467870697553,0.7547028278218628,-0.468407197511308,-1.02544127004867,3250,4,TRIM28|DNMT1
URETER DEVELOPMENT%GOBP%GO:0072189,0.15439398011287303,0.5225398777782271,0.667709440063838,1.3133056737076,1148,3,NPHP3-ACAD11|NPHP3
POSITIVE REGULATION OF PROTEIN TYROSINE PHOSPHATASE ACTIVITY%GOBP%GO:1903615,0.992508361204013,0.997305769352475,-0.50363917071019,-0.670968306282475,7418,1,PTPRC
POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0099170,0.33672240802675607,0.699462084003389,-0.8287935597706221,-1.10415202668403,2516,1,FMR1
REGULATION OF G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:2000045,0.0135810377962844,0.154714834039479,-0.241767758825666,-1.5798295996565601,105,112,PCBP4|GTSE1|WEE1|CNOT4|RBL1|BTG2|CNOT10|CNOT6L|PSME3|PRMT2|SFN|PSME1|INO80|CDKN1B|CNOT6|AURKA|PTEN|FHL1|PIDD1|ID2|PRMT1|TMEM14B|LSM11|CCND2|PML|RGCC|RPA2|PLCB1|TRIAP1|TFDP2|KLF4|CDC6|PLK2|SLFN11|PCNA|LSM10|DDX3X|CDC25C|GPNMB|DCUN1D3|PTPN6|PSME2|CDC45|FGF10|E2F1|RPTOR|CCL2|KANK2|NACC2|CCNB1|PLAGL1|HYAL1|AIF1|TNKS1BP1|FAM107A|CCND3|DACT1|CDK2AP2|ANXA1|ZNF385A|CCND1|EIF4G1
LEUCINE BIOSYNTHETIC PROCESS%GOBP%GO:0009098,0.266914300875564,0.6417330323279019,-0.699290448987104,-1.16373113206506,2011,2,BCAT2
ADP BIOSYNTHETIC PROCESS%GOBP%GO:0006172,0.30083676451055896,0.673988937137548,0.8507940008822229,1.13441900011172,2264,1,AK5
"ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS, MEVALONATE PATHWAY%GOBP%GO:0019287",0.606084656084656,0.8488511623671441,-0.45411933384802,-0.8867799629331629,4581,3,MVD|PMVK|MVK
GENE SILENCING BY MIRNA%GOBP%GO:0035195,0.987534086482275,0.996030692679047,-0.10083613285770401,-0.5183324708745529,7604,45,HNRNPA2B1|STAT3|NCBP1|TNRC6C|RAN|RBM4|WTIP
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1901964,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS%GOBP%GO:2000270,0.47816184351554103,0.7850984235874658,0.601740643737115,1.01100197535778,3568,2,SFRP1
N-ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006045,0.200267558528428,0.578098211195516,-0.897441552712836,-1.19560763663823,1496,1,GNPNAT1
GOLGI TO SECRETORY GRANULE TRANSPORT%GOBP%GO:0055107,0.943020321423828,0.982471033159286,0.528837670930745,0.7051336766086501,7099,1,CCDC64
MONONUCLEAR CELL PROLIFERATION%GOBP%GO:0032943,0.825195822454308,0.942487449356262,-0.17323850822128198,-0.7273559972308259,6320,23,MEF2C|MSN|SLC11A1|TNFRSF4|CTPS1
PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS%GOBP%GO:0006208,0.52505359056806,0.808245162096538,0.580920871243452,0.97602206941879,3918,2,DPYD|ALDH6A1
L-GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098712,0.145767195767196,0.512646109386394,-0.6769361697067571,-1.3218847706703798,1101,3,SLC1A2|SLC1A3
NEGATIVE REGULATION OF BETA-CATENIN-TCF COMPLEX ASSEMBLY%GOBP%GO:1904864,0.0848160535117057,0.40376145987147494,-0.955337450374945,-1.272738873949,633,1,DACT1
INTERFERON-GAMMA BIOSYNTHETIC PROCESS%GOBP%GO:0042095,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
POSITIVE REGULATION OF ENDOCYTIC RECYCLING%GOBP%GO:2001137,0.03664441826986,0.27230608441566395,-0.711621103920405,-1.5578873520191001,279,4,EHD1|EHD2
LENS DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0002088,0.8448041349292711,0.9483360183395692,0.20484368577582396,0.6962238454569821,6210,12,WNT5B|WNT2B|SKI|PROX1
PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0061004,0.27103429796355805,0.6462219082477939,0.69759890738121,1.17205623504127,2022,2,PAX8|BMP4
SENSORY PERCEPTION OF PAIN%GOBP%GO:0019233,0.193008705114255,0.5674728273201639,0.3709010033493979,1.26062036941852,1418,12,CHRNB2|MMP24|ADCYAP1|SCN9A
MYELOID CELL DEVELOPMENT%GOBP%GO:0061515,0.352192176424258,0.7106060713647829,-0.29830823955671604,-1.08310886242974,2682,15,NCKAP1L|TLR2|MED1|FOXP1|ANXA2|ZNF385A
REGULATION OF MEMBRANE DEPOLARIZATION%GOBP%GO:0003254,0.585316111488783,0.840057207935327,0.216022604373193,0.904044342220085,4304,22,TRPM4|SCN5A|RANGRF|PTPN3|CAMK2D|BCL2|NEDD4L|SRC
SHORT-CHAIN FATTY ACID METABOLIC PROCESS%GOBP%GO:0046459,0.935559921414538,0.9806508984207809,-0.235232474766974,-0.6050812934609829,7142,6,ACADS|MCEE|OXSM|PCK2|ALDH5A1|THNSL2
SENSORY PERCEPTION OF LIGHT STIMULUS%GOBP%GO:0050953,0.7300012881617929,0.9066030246154821,-0.155129124087042,-0.823408631237539,5666,50,DFNB31|COL18A1|RGS16|CYP1B1|OPA1|FSCN2|CACNA2D4|OPA3|GPR179|COL1A1|BEST1|DHRS3|EFEMP1|ADGRV1|DNAJC19
POSITIVE REGULATION OF ENDOCYTOSIS%GOBP%GO:0045807,0.000256706456167373,0.00819882332206558,-0.32018056734228195,-1.9817813346659898,1,90,RAB21|DOCK2|BICD1|SYNJ1|GREM1|PPT1|C4B|PYCARD|NCKAP1L|B2M|CCL19|MERTK|LRP1|SFRP4|TOR1A|SGIP1|C4A|AZU1|FCGR2B|C2|GAS6|VTN|C3|FMR1|CD47|CD63|ARRB1|FCER1G|SLC11A1|CALR|CCL2|HFE|APOE|AXL|CD151|HNRNPK|CD300LF|SERPINE1|LDLR|TUB|LMAN2|ITGAM|DAB2|ANXA2|PTPRJ|SIRPA
PYRIDOXINE BIOSYNTHETIC PROCESS%GOBP%GO:0008615,0.644574312657723,0.8688307429995409,0.675948389942656,0.9012859703415121,4852,1,PSAT1
NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0030809,0.21595688748685601,0.598994355749518,-0.452678199116796,-1.23737567038963,1642,7,PID1|PARP1|CBFA2T3|PPARA
REGULATION OF GROWTH RATE%GOBP%GO:0040009,0.6643109540636041,0.8804055751124069,-0.380016234818706,-0.831934975683633,5075,4,NOTCH1|NOTCH2
CELLULAR ION HOMEOSTASIS%GOBP%GO:0006873,0.00012871669455528402,0.00518555396908895,-0.23381825569776302,-1.8567969416517698,0,320,PPT1|PML|CCL11|CEMIP|PSEN1|PLCE1|CLN6|SLC39A13|SLC9A5|NDFIP1|FIS1|ATP6V0A1|MT1G|OCM|EDNRA|CCL19|SLAMF8|HSP90B1|FPR3|LPAR6|RYR2|GPR89B|TCIRG1|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|ATP6V0A2|ERO1L|PTGER1|RAB7A|PLN|ITPR3|SLC8B1|ATP1A3|ATP1B3|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ATP5B|ADCY8|CXCR4|JPH4|CALB2|CCDC22|TAC1|CALCB|DMXL1|RMDN3|ATP6V0D1|ABCB7|HAMP|CA2|SLC9A1|PTGER4|TBXA2R|SLC9A7|SLC11A1|GHRL|ABL1|CALR|ACO1|HERPUD1|HMOX1|SOD1|SKP1|SLC35G1|ARF1|SLC9A9|MT1M|CCRL2|P2RY6|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|FTL|APLNR|GNA15|TMCO1|MTL5|CD36|F2RL3|ATP6V0E1|GRIN2C|FXN|MT2A|TGM2|GRIN2D|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|ATP1B2|PRKACA|ATP6V0E2|S100A8|S100A9|RAB20|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|TFRC|ATP6V1A|ATP6V1G1|C5AR1|FTH1|C1QTNF1|PRNP
METHYLGLYOXAL BIOSYNTHETIC PROCESS%GOBP%GO:0019242,0.6409364548494979,0.867245940226311,-0.68366784296427,-0.910809725158354,4790,1,TPI1
REGULATION OF T CELL DIFFERENTIATION%GOBP%GO:0045580,0.112522686025408,0.45989343614678896,-0.227553185009299,-1.31045331965497,867,68,NCKAP1L|IL18|ADAM8|RUNX1|CCL19|RUNX3|GATA3|TNFRSF18|PRELID1|RC3H2|LILRB2|SOCS1|IL2RA|ABL1|SOD1|NKAP|C10orf54|CD86|NLRP3|TGFBR2|LGALS9|BCL6|LILRB4|PNP|ANXA1|SART1
MICROTUBULE-BASED PROTEIN TRANSPORT%GOBP%GO:0099118,0.7449007342942621,0.9112137767014771,0.244870369566256,0.775765882822009,5477,10,DLG2|CAMSAP3|KIF5B|KIF5A
PROTEIN LOCALIZATION TO ENDOSOME%GOBP%GO:0036010,0.377279833246483,0.727975088287035,-0.351621036294781,-1.0577621443149698,2895,9,TOLLIP|ARF6
INTERLEUKIN-21-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038114,0.547712933753943,0.8186230305367759,-0.336445373856774,-0.9196584258702171,4166,7,IL2RG|JAK3|STAT3|IL21R
NEGATIVE REGULATION OF MACROPHAGE MIGRATION%GOBP%GO:1905522,0.760126249342451,0.91797162753179,-0.317682622499254,-0.7614246267067439,5779,5,SLAMF8|CD200
REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010866,0.296975252062328,0.6689039624806751,-0.32999091572746003,-1.13589272440096,2267,13,C3|NR1H3|FITM2|LDLR|SIK1
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE-GATED CALCIUM CHANNEL%GOBP%GO:1904878,0.13545016077170402,0.49837594146638403,0.781417149159085,1.31288170343936,1010,2,BIN1|SESTD1
RESPONSE TO STAUROSPORINE%GOBP%GO:0072733,0.34100529100529103,0.701955655133333,-0.5716527685650811,-1.11629297220901,2577,3,CASP6
PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0042270,0.312549747943752,0.68160868787154,-0.67874276261373,-1.12953649611766,2355,2,SERPINB9|HLA-E
NEGATIVE REGULATION OF PROTEIN K48-LINKED DEUBIQUITINATION%GOBP%GO:1903094,0.0474927036349164,0.312255783864335,-0.856906534325889,-1.42602950277589,357,2,PARK7|UBXN1
REGULATION OF JNK CASCADE%GOBP%GO:0046328,0.387718626324524,0.734887192861895,-0.15518583039851,-1.0359004565860401,3036,124,TNFRSF11A|PHLPP1|IL1RN|FCGR2B|PKN1|MDFIC|TRAF2|TAOK2|MAPK8IP1|ZNF622|FLT4|MLKL|CTGF|HRAS|MEN1|MAP3K13|GADD45B|SASH1|FGF19|GADD45G|TGFBR3|MAP3K11|LTBR|DNAJA1|SEMA3A|DACT1|GSTP1|DBNL|SERPINF2|ERN1|SIRPA
TOLL SIGNALING PATHWAY%GOBP%GO:0008063,0.7242222524113571,0.9034590034658789,0.36150044958625605,0.794231883191616,5330,4,PELI2|PALM3|PELI1
RECEPTOR-MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL%GOBP%GO:0019065,0.41653439153439203,0.7493091022753771,-0.538602953526926,-1.05175505988068,3148,3,CAV2|CAV1
REGULATION OF CAP-DEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:1903674,0.0425418060200669,0.29503134401102504,-0.97788928098809,-1.3027833273395801,317,1,NCK1
D-SERINE BIOSYNTHETIC PROCESS%GOBP%GO:0070179,0.517332979147297,0.8044682962948779,0.740902073224526,0.9878929426118679,3894,1,SRR
DORSAL/VENTRAL PATTERN FORMATION%GOBP%GO:0009953,0.609346285114203,0.8505496974657741,-0.24261704457084102,-0.880903160910604,4641,15,FOXN4|SMAD6|CHRD|MDFI|NBL1
RESPONSE TO HEAT%GOBP%GO:0009408,0.0395860284605433,0.28367988634143604,-0.274682822928413,-1.51250238167574,305,57,HSPA13|SLU7|PDCD6|HSBP1L1|C8orf4|EIF2B1|VCP|DHX36|BAG3|HSPA6|HSPA9|RBBP7|HMOX1|SOD1|IGF1|NOS3|THBS1|EIF2B2|PRKACA|HSP90AA1|HSPA5|EIF2B3
REGULATION OF LEUKOCYTE ACTIVATION%GOBP%GO:0002694,0.000127991808524254,0.00518555396908895,-0.30607741590937604,-2.40938033296005,0,302,IGHV1OR15-1|CD274|UNC13D|DUSP3|NFKBIZ|PRDM1|MNDA|HLA-DPA1|MICA|TGFB1|CD38|LILRB1|IGHV5-51|SLA2|HLA-E|LYN|GPR183|NDFIP1|CD209|TNFSF13B|PYCARD|TNFAIP8L2|IGHV1-24|NCKAP1L|VAV3|CD74|TNFRSF14|SAMSN1|IL18|ADAM8|RUNX1|RIPK3|CCL19|SLAMF8|TWSG1|IGHV3-49|CD84|ZFP36L1|RUNX3|CCDC88B|ITGB2|IGHG4|HLA-DPB1|CD4|SNX4|STX4|FGR|IGLL5|STXBP2|PDCD1LG2|PAXIP1|VAV1|SPN|AHR|GATA3|FES|TNFRSF18|EBI3|FCGR2B|GAS6|PLA2G2D|THY1|IL6ST|ADGRE2|PRELID1|PVRL2|TNFAIP3|PLSCR1|MAPK8IP1|MZB1|IGHV4-4|RC3H2|LILRB2|GPNMB|INHBA|IGHV4-61|GRB2|PRKAR1A|MEF2C|CEBPA|SOCS1|PTPN6|CD47|IL2RA|IGHV1-3|SDC4|MMP14|FGF10|BST1|ABL1|IGHV3-43|SOD1|TNFRSF4|IGF1|VAMP8|DPP4|CEBPB|NR1H3|IGHV3-73|VAMP7|NKAP|ICOSLG|VCAM1|TNFSF13|SNX6|C10orf54|CCL2|CEACAM1|IL33|GPER1|CD300A|HFE|GSN|LST1|CD86|NLRP3|AXL|LGALS3|TGFBR2|TNFRSF21|CD200|LGALS9|THBS1|ZP3|IGHV3-15|FADD|AIF1|CD300LF|CX3CL1|CAV1|LDLR|HAVCR2|MILR1|BCL6|TLR4|ITGAM|IGHV1-18|LILRB4|PNP|ANXA1|CD55|NCK1|IGHG2|TFRC|IGHA1|CD81|TNFRSF1B|SART1|SIRPA|PRNP
REGULATION OF EXOCYST ASSEMBLY%GOBP%GO:0001928,0.0931066542701554,0.422068646506606,0.954620644022938,1.27285781911433,700,1,RALB
LUNG EPITHELIUM DEVELOPMENT%GOBP%GO:0060428,0.6348064853556489,0.8634223229282929,-0.273005648653399,-0.855291058952229,4854,10,THRA|RCN3|FGF10|ERRFI1
NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009165,0.0113110539845758,0.138143337049086,-0.215024386384666,-1.52904544955,87,170,ATP5J|DCAKD|GPI|ATP5F1|COASY|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|ADA|PDHA1|ACSF3|KYNU|ATP5B|HK3|ADCY8|NPR2|ELOVL1|SLC26A2|HAAO|ENO1|ADCY4|ATP5O|CTPS1|PGAM1|HPRT1|PRPS1|NPR1|RFK|GAPDH|UMPS|HACD2|GMPS|LDHA|CMPK2|STOML2|PDHX|ATP5H|NMNAT3|PNP|PGK1|RRM1|FASN|QPRT|NNMT|ADCY9|ALDOA|ALDOC|ATP5G1|MTHFD1|PTGIS
MONOUNSATURATED FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:1903966,0.491907667816397,0.7910456783193008,-0.602591673559416,-1.00280890645656,3707,2,SCD|SCD5
REGULATION OF MITOCHONDRIAL TRANSLATION%GOBP%GO:0070129,0.559347382732835,0.8268422944617521,0.219915945759345,0.9203377910593641,4113,22,RMND1|RPUSD4|MTG2|FASTKD2|MTG1|C1QBP|UQCC1|TSFM|NSUN3
REGULATION OF IRE1-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903894,0.68037725962798,0.884781692722898,-0.25401546961425303,-0.822388749416584,5193,11,BCL2L11|DAB2IP|FICD|HSPA5
PEPTIDYL-ARGININE ADP-RIBOSYLATION%GOBP%GO:0018120,0.304347826086957,0.676914363124642,-0.844397882664314,-1.1249407315973101,2274,1,ART4
ARGININOSUCCINATE METABOLIC PROCESS%GOBP%GO:0000053,0.823411371237458,0.941748323139748,-0.5920269078076751,-0.788721995243588,6154,1,ASS1
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION%GOBP%GO:1903373,0.19426708327672898,0.568821988356772,0.576914524021928,1.2675057787036001,1429,4,KIAA1715|RAB3GAP1
CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION%GOBP%GO:0021930,0.116343857787211,0.46625878958064004,-0.788640749931072,-1.31242432102322,876,2,RORA|ATF5
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0031110,0.38998899889989,0.7358910495632479,0.186996602130087,1.0424673559973,2835,57,MET|CLASP1|DCTN1|RANGRF|KATNB1|INPP5J|CLASP2|SPEF1|STMN3|TTBK2|CDK5R1|CAMSAP3|STMN2|PAK1|MAP2|PSRC1|ANKRD53|STMN4
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, EXONUCLEOLYTIC, 3'-5'%GOBP%GO:0034427",0.47316310578426296,0.7833704083668069,-0.325230700568913,-0.9783735548245941,3631,9,EXOSC3|EXOSC2
REMOVAL OF NONHOMOLOGOUS ENDS%GOBP%GO:0000735,0.9224332580688008,0.9776156396135859,0.539589766210851,0.7194701448537428,6944,1,MSH3
RIG-I SIGNALING PATHWAY%GOBP%GO:0039529,0.9313712374581941,0.9793746057014829,-0.533689898544332,-0.711003091362829,6961,1,DDX58
MITOTIC SPINDLE ELONGATION%GOBP%GO:0000022,0.26904176904176896,0.643036619584462,0.384771100300126,1.16928388637653,1970,9,AURKC|CDC14B|CDC14A
ETHANOLAMINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042439,0.232772225144661,0.616523546447917,-0.510882519682573,-1.22448791432153,1769,5,MOXD1|GDE1|GDPD1
"NEGATIVE REGULATION OF MITOTIC CELL CYCLE, EMBRYONIC%GOBP%GO:0045976",0.540594855305466,0.8151499042806,0.574358974358974,0.964997235412066,4034,2,FZD3|CTNNB1
REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY DIRECTED AGAINST TUMOR CELL TARGET%GOBP%GO:0002858,0.39131003795314795,0.7369216590772479,-0.4845041725981551,-1.0606809133861301,2989,4,PVR|PVRL2|CEACAM1
REGULATION OF CHROMATIN SILENCING%GOBP%GO:0031935,0.0902314633189486,0.414848344511905,-0.34178595318746,-1.4154245620199901,689,22,NAA40|H1F0|TRIM28|PHF2|ATAD2|CDC45|DNMT1|H1FX|HIST1H1C|H2AFY
UDP-GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015786,0.121530083676451,0.47378995192224704,0.940339655932951,1.25381604847085,914,1,SLC35C2
SCF COMPLEX ASSEMBLY%GOBP%GO:0010265,0.6518664047151279,0.8731445752577829,-0.32546467376316807,-0.8371828165798969,4976,6,CAND1|CAND2|RBX1|CUL1|FBXL7|SKP1
NEGATIVE REGULATION OF TELOMERE SINGLE STRAND BREAK REPAIR%GOBP%GO:1903824,0.5031438127090301,0.797298314254545,-0.752315835906484,-1.00226533511256,3760,1,TERF2
NEGATIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:1902109,0.45915792269889794,0.7735063645065241,0.7721658579620642,1.0295789810476,3456,1,ACAA2
TRACHEA MORPHOGENESIS%GOBP%GO:0060439,0.442024173196972,0.7653693162885199,0.780381561535068,1.04053351319385,3327,1,LRP6
REGULATION OF CYTOKINE SECRETION%GOBP%GO:0050707,0.00025412960609911097,0.00819882332206558,-0.31023992581374604,-1.9466822881678998,1,94,LILRB1|RGCC|HYAL2|LGR4|DHX9|TLR1|PYCARD|TNFRSF14|GSDMD|CCL19|TLR2|FGR|CD34|SSC5D|GATA3|FCGR2B|GAS6|INS|CASP1|TNFAIP3|DHX36|PTGER4|IFIH1|OSM|CARD16|SRGN|TNFRSF4|FCN1|IL33|F2R|FN1|GAPDH|NLRP3|TNFRSF21|CD200|LGALS9|FOXP1|CX3CL1|HAVCR2|TLR4|CSF1R|C1QTNF4|ANXA1|TMSB4X|CD14|TNFRSF1B
POSITIVE REGULATION OF GASTRULATION%GOBP%GO:2000543,0.644316044074174,0.8688307429995409,0.433339562303805,0.85232778161882,4794,3,TENM4|SCX
REGULATION OF FIBROBLAST PROLIFERATION%GOBP%GO:0048145,0.000390828556539865,0.0111294649577428,-0.429293639711475,-2.17736248266459,2,43,AQP1|CDK6|DHX9|NDUFS4|CD74|PARP10|FBRS|AGT|DAB2IP|GAS6|DDR2|PDGFC|TRIM32|IGF1|E2F1|B4GALT7|CD300A|FN1|MYC|PDGFA|ANXA2|PDGFRA|S100A6|GSTP1|EMD|SPHK1|PDGFB|FTH1
INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030518,0.15045278137128099,0.517264655410678,-0.230928437309022,-1.27157500313581,1162,57,BRCA1|DDX5|CALR|RAN|WBP2|NCOA4|GPER1|RBM14|CDK7|FHL2|PPAP2A|YAP1|KAT5|PHB
SMOOTH MUSCLE CELL CHEMOTAXIS%GOBP%GO:0071670,0.12949832775919698,0.487857553689733,-0.934384649316277,-1.2448247118746298,967,1,PDGFRB
PROTEIN N-LINKED GLYCOSYLATION VIA ASPARAGINE%GOBP%GO:0018279,0.137423472710694,0.50219949963275,-0.30587593785399,-1.31867402762393,1054,25,RPN2|VCP|UBE2G2|MGAT1|DAD1|SYVN1|DERL3|MAGT1|RPN1
"PENTOSE-PHOSPHATE SHUNT, NON-OXIDATIVE BRANCH%GOBP%GO:0009052",0.7754798594214649,0.9238039096445749,0.311837180462317,0.749966630778119,5736,5,RPE|RPIA|SHPK
NEGATIVE REGULATION OF DNA DUPLEX UNWINDING%GOBP%GO:1905463,0.0744229238524808,0.38312652841807104,-0.82531017369727,-1.3734481060519201,560,2,TOP2A|MNAT1
ELASTIN BIOSYNTHETIC PROCESS%GOBP%GO:0051542,0.282640456899987,0.655069746883962,0.861215262461403,1.14831434625696,2127,1,ATP7A
NEGATIVE REGULATION OF GTP BINDING%GOBP%GO:1904425,0.867959866220736,0.955991177472839,-0.569144243493604,-0.7582367919255211,6487,1,ARHGAP28
AMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0043604,0.00596977010034294,0.0899593836503908,-0.173640781084811,-1.42736131026078,46,397,SPTLC1|MRPL53|AIMP2|MRPS17|FARSA|MRPL37|RPL3|AURKAIP1|GSPT2|IARS|RPL7A|ST6GALNAC6|RPS2|EIF2B5|GARS|OPLAH|RPL15|MRPL18|RPL37|MRPL57|GFM2|SPTLC2|RPL27A|PPT1|YAE1D1|RPL18|EIF3J|RPL39|DENR|MRPS18B|RPL27|EIF2S3|ST20-MTHFS|MRPS15|MRPL47|SCD5|SECISBP2|EEF1D|GNB2L1|VARS|GADD45GIP1|MRPS11|MRPL13|CHAC1|PCSK5|CHAC2|ETF1|ACSL5|SARS|OXA1L|CERS6|GATC|EIF3C|NDUFA7|CERS4|ACSL4|MRPL10|LARP1|MRPL50|MRRF|EIF2B1|EIF3M|MRPL51|YARS|GGT1|ELOVL2|RPLP2|MRPS34|PDHA1|PCSK1|ACSF3|MRPL9|WARS|DDX3X|ELOVL1|RPS14|RPS4X|RPL35A|RPS29|MRPS30|RPL10|RPL36A|RPL24|MRPS23|MRPL41|MRPS6|MRPS18C|UGCG|EIF1AX|AARS|MRPL38|EIF3B|MRPS22|MRPL52|TNIP1|EEF1G|DHFR|GFM1|RPL35|B3GALT2|MRPL21|FTSJ1|RPL38|RPS15A|MRPS18A|EIF5|MRPS24|HACD2|MRPL27|MRPL23|MRPS7|GGT5|MCTS1|MRPL36|ICT1|RPS13|EIF2S1|EIF2B2|CARS|MRPL22|MRPL49|MRPS2|PDHX|MRPL39|EIF4A2|RPL26L1|MRPL3|MRPL12|MRPS36|SPTSSA|SMPD1|ORAOV1|MRPL17|RBM4|B3GALT1|IGHMBP2|EEFSEC|EIF2B3|RPS6KB2|ST3GAL5|FASN|MRPS27|RRBP1|MRPL11|EIF2D|TARSL2|EIF4G1|MTHFD1|MRPL16
CARDIOBLAST MIGRATION%GOBP%GO:0003260,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0090394,0.956255943485939,0.9877474384126891,0.26632702327289,0.585131812369638,7038,4,MTMR2|NLGN4X
REGULATION OF C-C CHEMOKINE RECEPTOR CCR7 SIGNALING PATHWAY%GOBP%GO:1903080,0.21712374581939803,0.599597524514766,-0.8887295985884429,-1.1840012218809899,1622,1,TREM2
NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001015,0.7859056806002142,0.9274485629622209,0.456741108354012,0.767384034266335,5865,2,EPHB1|AKIRIN1
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS%GOBP%GO:0048701,0.202122085407388,0.5806320652960539,-0.387835803477954,-1.255639280102,1542,11,NDST1|TGFBR2|EIF4A3|PDGFRA|MTHFD1
B-1 B CELL DIFFERENTIATION%GOBP%GO:0001923,0.507826086956522,0.7987565605553191,-0.7498897220996908,-0.9990331689776291,3795,1,SLAMF8
REGULATION OF MRNA METABOLIC PROCESS%GOBP%GO:1903311,0.143368717227267,0.509575016463429,-0.159245116140933,-1.1948721356346201,1120,227,SRSF9|HNRNPU|RBMX|LARP1|NPM1|CELF1|TOB1|PRR5L|FMR1|DHX36|MAGOH|PDE12|SRSF5|MAPKAPK2|SRSF1|FXR1|PAPOLA|NCBP1|HNRNPM|DDX5|SNW1|CTR9|SLC11A1|JMJD6|CELF4|HSPB1|RBM15|RNF20|TNRC6C|E2F1|TNFSF13|CPEB1|NUP214|RBM4B|SMU1|RNF40|UBC|EXOSC3|TRA2B|PABPN1|CCRN4L|SRSF2|RBM8A|RBFOX3|YBX3|POLR2G|CSDC2|VIM|APEX1|NUP98|CPSF7|RBM4|PTCD2|EXOSC2|HNRNPA0|HNRNPC|EIF4G1
REGULATION OF MISMATCH REPAIR%GOBP%GO:0032423,0.8539657020364421,0.949296218452153,0.41841742486903793,0.7029952978405111,6373,2,HMGB1|AXIN2
ETHER LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0008611,0.8987375065754871,0.967428248648255,-0.269267951194601,-0.6453838979591031,6833,5,FAR1|DHRS7B
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046474,0.35454797559622897,0.7124978659342509,0.14799505419911702,1.05145015874038,2556,160,GPAT2|PLD2|LPIN1|MTMR6|SLC44A5|PLEKHA1|INPP5K|PGAP2|LCAT|AGPAT4|FIG4|PIP4K2C|INPP5J|PIGF|PGAP1|SLC27A1|FGF2|PLEKHA3|PIKFYVE|MTMR9|LPCAT2|PIGU|PLA2G6|IMPA1|MTMR2|PIGL|CDS1|INPP5F|PGAP3|PI4K2B|LPCAT4|DGKQ|INPP4A|CPNE3|PIGO|PIGG|INPPL1|PIGT|PISD|CECR5|GNPAT|SLC44A3|SBF1|CPNE1|CHKB|PITPNM2|CRLS1|EPT1
TESTOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0061370,0.77991765174658,0.924704689181848,0.609726510807234,0.8129880300217339,5871,1,AKR1C3
POSITIVE REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:2000741,0.8619047619047621,0.952425753113016,-0.350414067753433,-0.6842698622420761,6515,3,SOX5|LTBP3
CHROMATIN SILENCING AT CENTROMERE%GOBP%GO:0030702,0.8384186786946141,0.946300451776032,-0.437772263578715,-0.728523051643361,6319,2,HIRA|ZNFX1
REGULATION OF PROTEIN LOCALIZATION TO CILIARY MEMBRANE%GOBP%GO:1903567,0.119640943193998,0.4714189055997621,0.7926109732561349,1.33168877321554,892,2,LZTFL1|EFCAB7
REGULATION OF RESTING MEMBRANE POTENTIAL%GOBP%GO:0060075,0.10758821968691999,0.451309145449614,-0.7958092087124351,-1.32435378275815,810,2,ATP1A3|NALCN
POSITIVE REGULATION OF CALCIUM ION IMPORT%GOBP%GO:0090280,0.0626139026295236,0.35917867732855496,-0.533229391845073,-1.53509278810143,480,8,CCL2|LGALS3|PDGFRB|PDGFB
KERATAN SULFATE METABOLIC PROCESS%GOBP%GO:0042339,0.580148689187427,0.8386526275338391,-0.20624309097682503,-0.909632790796664,4447,27,OGN|LUM|FMOD|B4GALT1|B4GAT1|HEXB
DEVELOPMENT INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0044111,0.30960286890689304,0.680809181688249,0.846217468019409,1.1283168110638,2330,1,NEDD4
SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS%GOBP%GO:0016445,0.7671286610878659,0.9202818175694271,-0.198010707245973,-0.7683551862693141,5866,18,BATF|EXO1|RNF168|POLQ|EXOSC3|SAMHD1
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:1903588,0.12681586179819399,0.48326646889427793,-0.6235041085314069,-1.3649808293511,968,4,DLL4|PDCD10|THBS1|NGFR
PEPTIDE ANTIGEN STABILIZATION%GOBP%GO:0050823,0.48842809364548495,0.788277714516235,-0.7590427878253199,-1.01122725030486,3650,1,TAPBP
NEGATIVE REGULATION OF GLYCOGEN CATABOLIC PROCESS%GOBP%GO:0045818,0.358260869565217,0.714938712241162,-0.8188685487428321,-1.09092952885932,2677,1,INS
NEGATIVE REGULATION OF METANEPHROS DEVELOPMENT%GOBP%GO:0072217,0.20908357968288102,0.589986908012982,0.636017838960107,1.25097203419154,1555,3,PAX8|STAT1|BMP4
PROTEIN-COFACTOR LINKAGE%GOBP%GO:0018065,0.65451705285082,0.874775007199212,-0.290262428341071,-0.8356249059366301,5027,8,GLRX5|SDHAF2|NDUFAB1
PROTEIN ADP-RIBOSYLATION%GOBP%GO:0006471,0.9083356033778259,0.971496795604459,0.151797954808029,0.6444498375433879,6668,23,PARP4|PARP3|ZC3HAV1|SIRT5|TNKS|TNKS2|C4orf27|SIRT1|PARP6|PARP15
POSITIVE REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:1904692,0.21915260990835397,0.601686354077891,0.891927657697397,1.1892651811929398,1649,1,PTPRN
REGULATION OF ESTABLISHMENT OF T CELL POLARITY%GOBP%GO:1903903,0.9036775291192249,0.9693517997267149,-0.293764498958883,-0.643111896034298,6904,4,GSN
VESICLE FUSION WITH ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT (ERGIC) MEMBRANE%GOBP%GO:1990668,0.17459070072036703,0.54811765844537,-0.5048287803157461,-1.2985556168313102,1332,6,TAPBP|STX4|CALR
POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1900740,0.170632222977566,0.544171946973796,0.304739517804002,1.27532041251407,1254,22,BBC3|PMAIP1|CASP8|TP53BP2|BID|YWHAQ|YWHAB|YWHAE|BCL2|YWHAH|YWHAZ|MAPK8
RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE%GOBP%GO:0002679,0.5339947089947089,0.812403303192621,-0.48823158969197494,-0.9533925528807041,4036,3,C17orf62|HCK
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS%GOBP%GO:0045923,0.145005230125523,0.5122531353179961,-0.34131206936555103,-1.32441776649766,1108,18,IRS1|NR1H3|SLC45A3|PPARA|ABCD1|ANXA1
NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0090315,0.577231354435539,0.837152999580265,0.40736959436395703,0.8950083477268,4248,4,INPP5K|ITGB1BP1|DMTN
POSITIVE REGULATION OF ALDOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0032349,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
NEGATIVE REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0046627,0.0906119246861925,0.41591576627717103,-0.33227433022238106,-1.41215653597314,692,24,SLA2|KANK1|SOCS3|PID1|IRS1|SOCS1|CISH|PTPRE|RPS6KB1|NCK1|PRKCB|GRB10
LIPOPOLYSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0009104,0.45137123745819396,0.769762028992395,-0.7756947507719449,-1.03341166332186,3373,1,AOAH
MYELOID LEUKOCYTE MIGRATION%GOBP%GO:0097529,0.000257599175682638,0.00819882332206558,-0.3740167907890011,-2.08960760247615,1,60,IL1B|TGFB2|CCL3|SYK|CCL4|CCL8|CXCL1|CXCL2|CCL11|FLT1|NCKAP1L|CCL19|ITGB2|CXADR|CCL24|TNFRSF11A|AZU1|IL1RN|PDE4B|CCL3L3|ADGRE2|CCL18|CD47|FCER1G|CCL2|EDNRB|LGALS3|CHGA|CX3CL1|CCL4L2|CCL14|S100A8|S100A9|ANXA1|FOLR2|PDGFB|SIRPA
ACTIN FILAMENT DEPOLYMERIZATION%GOBP%GO:0030042,0.518890046899427,0.8048457494334929,-0.313057968641835,-0.9417549976386059,3982,9,DSTN|MICAL2|CFL2|CFL1
NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902260,0.7335427300091609,0.907913422943088,-0.35620375539939897,-0.7798044805322359,5604,4,KCNE4
CELLULAR RESPONSE TO TETRAHYDROFOLATE%GOBP%GO:1904482,0.588617670469621,0.8414799095069009,-0.5632550079202541,-0.9373464044272091,4436,2,SHMT2
AMINOGLYCAN METABOLIC PROCESS%GOBP%GO:0006022,0.320880245649949,0.6887547458395611,-0.166131235786441,-1.08117703414755,2507,110,CD44|TGFB1|CEMIP|HSPG2|CLN6|HYAL2|TMEM2|NCAN|SDC3|B4GALT4|ST3GAL1|GAL3ST3|PRELP|HYAL3|NAGLU|ARSB|HS3ST5|DCN|CHST7|NDST1|SLC9A1|GCNT2|SDC4|BGN|VCAN|OGN|B4GALT7|LUM|SDC2|FMOD|FUCA1|HYAL1|EXT2|B3GAT3|LYVE1|B4GALT1|B3GNT5|B3GALT6|B4GAT1|HEXB|CSGALNACT1|XYLT2
REGULATION OF MUSCLE CONTRACTION%GOBP%GO:0006937,0.0181210641305745,0.18433841711697999,-0.268448861984723,-1.58753262165775,140,75,RYR2|JUP|ATP1B1|ATP2A1|P2RX4|PLN|TNNC2|ANXA6|C12orf57|PDE4B|MYLK2|DOCK5|PDE4D|SLC9A1|PKP2|ENO1|SOD1|FLNA|CHRM2|GPER1|F2R|KCNQ1|KCNB2|CHGA|SRF|CAV1|CLIC2|PRKACA|ADRBK1|RGS2|MYL9|SPHK1|CNN1
NEGATIVE REGULATION OF INTERFERON-GAMMA BIOSYNTHETIC PROCESS%GOBP%GO:0045077,0.358465608465608,0.714938712241162,-0.563306496084703,-1.0999948174089,2709,3,INHA|LILRB1|INHBA
DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING%GOBP%GO:0110025,0.586495091536217,0.841166122017085,-0.564063009738125,-0.9386910486613509,4420,2,SAMHD1
RESPONSE TO OXYGEN LEVELS%GOBP%GO:0070482,0.0378419841472769,0.277419110172932,-0.20308327285079103,-1.40842931166132,295,149,AQP1|NPEPPS|PML|RGCC|ATG7|LONP1|FUNDC1|BNIP3L|ADAM8|HSP90B1|REST|PLOD2|TERT|KCND2|ZFP36L1|RYR2|AQP3|ITPR2|ATP6V0A2|ANGPTL4|RORA|CBFA2T3|VEGFC|TGFB3|ADA|CXCR4|NOTCH1|ATP6V0D1|UBQLN1|CARD16|HMOX1|DPP4|LMNA|HIF3A|GATA6|VEGFB|CPEB1|BMP2|THBS1|PDK3|SRF|UBC|CAV1|MYC|DDIT4|ATP6AP1|ANG|PGK1|ATP6V1A|WTIP|ATP6V1G1|LOXL2|BAD|PTGIS|P4HB|SUV39H1
SYNAPTIC VESICLE EXOCYTOSIS%GOBP%GO:0016079,0.9924492037342121,0.997305769352475,0.0960234337380997,0.490813792583336,7228,42,SYT2|RIMS1|SNAP25|DNAJC5|UNC13A|RIMS2|CPLX1|SYT5
REGULATION OF T CELL CHEMOTAXIS%GOBP%GO:0010819,0.151194353963084,0.518359045388749,0.40245419405482397,1.32432142146401,1113,11,XCL1|ADAM17|CXCL13|OXSR1|ADAM10|CCL21|CCL5|WNK1
NEGATIVE REGULATION OF CORTISOL BIOSYNTHETIC PROCESS%GOBP%GO:2000065,0.61005291005291,0.850714570847612,-0.45228383087048707,-0.8831956908243579,4611,3,REST|BMP2
POSITIVE REGULATION OF ACTIN FILAMENT BINDING%GOBP%GO:1904531,0.24334448160535102,0.626082056933819,-0.8750551389501541,-1.1657835582114,1818,1,ABL1
CHROMATIN SILENCING BY SMALL RNA%GOBP%GO:0031048,0.449603174603175,0.7682499148373071,-0.5248704091761329,-1.02493888126264,3398,3,FAM172A|ZNFX1|NRDE2
RESPONSE TO DIURETIC%GOBP%GO:0036270,0.30715935334872996,0.6786107324984411,0.51426644226592,1.1298652750517701,2260,4,GSTM2|RYR1|SLC8A1
'DE NOVO' IMP BIOSYNTHETIC PROCESS%GOBP%GO:0006189,0.14145304821357402,0.50708003098953,0.930800617556242,1.2410970279252,1064,1,PFAS
MITOCHONDRIAL MRNA 3'-END PROCESSING%GOBP%GO:0090616,0.25023243458626604,0.6308569567945129,0.876599029554477,1.16882652389994,1883,1,PNPT1
OOGENESIS%GOBP%GO:0048477,0.765015113681167,0.9195283779466871,-0.19573729348696303,-0.7733397858877622,5820,19,ZP3|POMZP3|ANG
POSITIVE REGULATION OF T-HELPER 2 CELL ACTIVATION%GOBP%GO:2000570,0.805217391304348,0.932964969466025,-0.601841640935157,-0.8017975764257959,6018,1,PRKCQ
CYCLIC-NUCLEOTIDE-MEDIATED SIGNALING%GOBP%GO:0019935,0.161409781637083,0.531565908892591,-0.19860008528049,-1.22709351787506,1263,89,ADGRE2|ADCY8|PDE4D|CALCB|PRKAR1A|PTGER4|CALCRL|TBXA2R|PDE2A|ADCY4|RAPGEF3|ADGRL4|GNAQ|GPER1|APOE|ADGRE5|CD36|CHGA|ADRA2C|NUDT4|ADGRG1|PTGIR|ADGRL1|ADCY9|ADGRB1
MULTI-CILIATED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:1903251,0.0786428195686481,0.393097409792852,-0.6140904741722171,-1.4718576873428,597,5,CEP63
REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:1903798,0.927359131025119,0.979345221662042,0.17319167415136497,0.6065533511152521,6829,13,NCOR1|EGFR|MAP2K1|MYCN|ZC3H10|NCOR2|BCDIN3D
NEGATIVE REGULATION OF SEROTONIN UPTAKE%GOBP%GO:0051612,0.7206155478906869,0.9015043124805608,-0.507437204049731,-0.8444566528487091,5431,2,GPM6B
ACTIN FILAMENT SEVERING%GOBP%GO:0051014,0.13770230830459002,0.50219949963275,-0.7721532947339399,-1.2849865590328702,1037,2,FMNL1|GSN
ACTIVATION OF MEIOSIS%GOBP%GO:0090427,0.5187959866220739,0.8047799431921201,-0.7429422143802379,-0.989777420500336,3877,1,PLCB1
CELLULAR PIGMENT ACCUMULATION%GOBP%GO:0043482,0.817908817908818,0.93826094282131,0.234897493555809,0.713831818322121,5991,9,BLOC1S3|AP1M1|BLOC1S5|AP1G1|BLOC1S6|AP3D1
CHEMOKINE METABOLIC PROCESS%GOBP%GO:0050755,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
AGE-DEPENDENT RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:0001315,0.40414715719063593,0.7412049911665691,-0.7982465813850899,-1.06345611671244,3020,1,SOD2
REGULATION OF ACTIVATED T CELL AUTONOMOUS CELL DEATH%GOBP%GO:0070239,0.14648829431438098,0.513872620660976,-0.92550727834142,-1.23299792215364,1094,1,LGALS9
REGULATION OF TWITCH SKELETAL MUSCLE CONTRACTION%GOBP%GO:0014724,0.44949832775919707,0.768229288546963,-0.7766872518747242,-1.03473391310433,3359,1,ATP2A1
OXALATE METABOLIC PROCESS%GOBP%GO:0033609,0.318368973303228,0.6867397844771489,0.8408138509042791,1.12111181676627,2396,1,HOGA1
3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE BIOSYNTHETIC PROCESS%GOBP%GO:0050428,0.224921949233066,0.6078034241178771,0.47423392304585704,1.22710814910375,1656,6,PAPSS1|SLC35B2|SLC35B3|SLC26A1|PAPSS2
MAINTENANCE OF ER LOCATION%GOBP%GO:0051685,0.761605351170569,0.9184699428006701,-0.623290692545214,-0.8303728633914059,5692,1,POLR2M
CELLULAR RESPONSE TO INTERLEUKIN-15%GOBP%GO:0071350,0.13801230849810098,0.50277647185153,-0.390955079134211,-1.3457431971337102,1053,13,STAT5B|IL2RB|IL2RG|JAK3|STAT5A|PLCB1|CD4|IL15RA|GRB2|STAT3|IL15
ACTIN CORTICAL PATCH LOCALIZATION%GOBP%GO:0051666,0.9684348395546821,0.9912626134248801,-0.21438420384976,-0.5514539244273959,7393,6,WIPF1|WIPF2|WASL|TIGD5|WIPF3|WAS
PROLINE CATABOLIC PROCESS TO GLUTAMATE%GOBP%GO:0010133,0.8493823880993492,0.9492491301138911,0.574382443758271,0.7658614856878639,6394,1,PRODH
POSITIVE REGULATION OF KERATINOCYTE APOPTOTIC PROCESS%GOBP%GO:1902174,0.30886243386243395,0.680809181688249,-0.586094783082269,-1.14449456624755,2334,3,SFRP4|GSN
MELANOSOME LOCALIZATION%GOBP%GO:0032400,0.0013598041881969,0.0294375387721946,0.530743898293724,2.07755808038028,9,18,BBS5|BBS4|VPS33B|BLOC1S3|MKKS|RAB11B|RAB11A|MREG|BBS2|MYO5A|BBS7|VPS33A|BLOC1S5|ARL6
TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION%GOBP%GO:0032905,0.7860869565217391,0.9274485629622209,-0.611325540361712,-0.814432407680513,5875,1,NRROS
BOX C/D SNORNA METABOLIC PROCESS%GOBP%GO:0033967,0.8268771557442289,0.943041978946366,-0.44637441411635,-0.7428384057252809,6232,2,FBL|FBLL1
MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL%GOBP%GO:0086045,0.0596107055961071,0.35396661720226896,0.64201178888058,1.5440346706341002,440,5,TRPM4|SCN5A|CACNA1C|CACNB2
NEGATIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY%GOBP%GO:0051387,0.49056856187291,0.7903790206418191,-0.757995147772386,-1.0098315422011401,3666,1,AGT
NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY%GOBP%GO:2001258,0.0459551325628824,0.30746333312705,0.370915164178226,1.55226235046989,337,22,FKBP1B|CRHR1|GSTM2|C19orf26|EPHB2|DRD4|GNB5|SRI|SUMO1|PKD2
VERY LONG-CHAIN FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0042761,0.5691766545075561,0.832269842301315,-0.300582362437395,-0.9042253204910359,4368,9,ELOVL2|ELOVL1|HACD2
G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CGMP NUCLEOTIDE SECOND MESSENGER%GOBP%GO:0007199,0.49056856187291,0.7903790206418191,-0.757995147772386,-1.0098315422011401,3666,1,AGT
MESONEPHRIC DUCT DEVELOPMENT%GOBP%GO:0072177,0.190599103382693,0.56467115404665,0.579738961397771,1.27371118790445,1402,4,PKD1|PKD2|GPC3|WNT11
GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0042921,0.6905042567125079,0.887500271277908,-0.31444375120100704,-0.808834034866607,5271,6,CALR|RBM14
NEGATIVE REGULATION OF AXON EXTENSION%GOBP%GO:0030517,0.41818893528183704,0.75036705317022,-0.233668523080688,-1.01930476986784,3204,26,SEMA3B|SEMA3D|SEMA7A|SEMA5A|SEMA3E|SEMA3A|SEMA6B
REGULATION OF SUPEROXIDE METABOLIC PROCESS%GOBP%GO:0090322,0.0192207112970711,0.19171563493967,-0.441080327330247,-1.7115557122098701,146,18,MAPT|TNF|SYK|TGFB1|FBLN5|ITGB2|PARK7|BST1|SOD1|DHFR|ITGAM|GSTP1
POLYPRENOL METABOLIC PROCESS%GOBP%GO:0016093,0.9414538310412571,0.9817036201910501,-0.231683266799351,-0.5959517744609449,7187,6,DPM2|SRD5A3
PROTEIN MANNOSYLATION%GOBP%GO:0035268,0.75942500678058,0.917529758274103,0.213453285235369,0.767230306412651,5599,14,LARGE|DPY19L3|DPY19L1|DPY19L2|DPM1|DPY19L4
NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL ELONGATION%GOBP%GO:1900248,0.429796355841372,0.7582675454446529,0.624455685868171,1.04916617899576,3207,2,CPEB2|CPEB3
NEGATIVE REGULATION OF DETERMINATION OF DORSAL IDENTITY%GOBP%GO:2000016,0.6920401337792641,0.888433240372712,-0.657807675341862,-0.8763577724928759,5172,1,DDIT3
PROTEIN POLYGLUTAMYLATION%GOBP%GO:0018095,0.0650273224043716,0.36649820053831705,0.527898348587791,1.53239655221739,475,8,TTLL4|CFAP20|TTLL1|TTLL7
REGULATION OF NEURONAL SIGNAL TRANSDUCTION%GOBP%GO:1902847,0.829163879598662,0.9433761342424741,-0.58893912659903,-0.7846083292536808,6197,1,CLU
STEM CELL DEVELOPMENT%GOBP%GO:0048864,0.0697523661350966,0.37596389138254704,-0.287356742643101,-1.43911280552037,537,41,SEMA4A|PEF1|JAG1|CORO1C|SOX10|TBX1|SEMA6A|PDCD6|ANXA6|SNAI2|SEMA3B|SEMA3D|SEMA7A|FN1|SEMA5A|TCOF1|SEMA3E|SEMA3A|SEMA6B
POSITIVE REGULATION OF MALE GERM CELL PROLIFERATION%GOBP%GO:2000256,0.6793730907158989,0.884536278926676,0.659958094397883,0.8799650688488101,5114,1,CIB1
MYELOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002372,0.0630893877008899,0.36006266503904,0.968736215262462,1.2916790287078899,474,1,CAMK4
N-TERMINAL PEPTIDYL-SERINE METHYLATION%GOBP%GO:0035570,0.00989966555183947,0.126895016411775,-0.994816938685487,-1.32533503196282,73,1,NTMT1
NOTCH SIGNALING PATHWAY INVOLVED IN ARTERIAL ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060853,0.0613627307743392,0.35631208031004796,0.9693427437141601,1.2924877525576102,461,1,DLL1
CYSTEINE BIOSYNTHETIC PROCESS VIA CYSTATHIONINE%GOBP%GO:0019343,0.48386239872493,0.787078399497453,0.758215703573004,1.01097833250397,3642,1,CTH
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE%GOBP%GO:1904352,0.0375661375661376,0.276257905964833,-0.7814050954009041,-1.52588610501068,283,3,LRP1|LDLR|CD81
BEHAVIORAL RESPONSE TO ETHANOL%GOBP%GO:0048149,0.22252082773448,0.605117804287475,0.628892806864682,1.23695793686895,1655,3,DRD2|DRD4
CEREBRAL CORTEX DEVELOPMENT%GOBP%GO:0021987,0.497804007685973,0.794989907195277,0.19493031572262698,0.9739210186939609,3626,39,EFHC1|BBS4|FAT4|RTN4|TACC2|LAMB1|MBOAT7|PEX13|MKKS|NF1
HEPARIN BIOSYNTHETIC PROCESS%GOBP%GO:0030210,0.5827805784027591,0.838862400059828,-0.565414866283744,-0.940940754131377,4392,2,CSGALNACT1
N-ACETYLNEURAMINATE BIOSYNTHETIC PROCESS%GOBP%GO:0046380,0.513311036789298,0.802184867798321,-0.746140273489193,-0.994038003132741,3836,1,NANP
CELLULAR RESPONSE TO MANGANESE ION%GOBP%GO:0071287,0.33015318462778803,0.6957352559323989,0.5720745560824971,1.1252031425751101,2456,3,PARK2|ATP13A2|IREB2
PEPTIDYL-DIPHTHAMIDE BIOSYNTHETIC PROCESS FROM PEPTIDYL-HISTIDINE%GOBP%GO:0017183,0.289805891136148,0.6622817015650171,0.443910205931313,1.14864374878548,2134,6,DPH2|DPH5|DPH1|DPH6|DPH3
DEPHOSPHORYLATION%GOBP%GO:0016311,0.0346796657381616,0.266191770413233,0.20021795211535504,1.3991957056611601,248,149,DUSP4|DUSP6|DUSP18|PTPRR|MTMR6|PPEF1|DUSP11|INPP1|EYA4|PTPN4|INPP5K|DUSP10|PTPRK|CDC14B|PPP2R2C|INPP5J|PTPRO|PTPN12|PTPRM|UBASH3B|CTDNEP1|PTPRS|PPAPDC1B|BTRC|PTPRD|PTPN3|IMPA1|PTPN9|PDP1|MTMR2|EYA1|PPM1B|INPP5F|DUSP16|PPAPDC1A|DUSP23|PTPRH|PPP3CB|PPM1G|PTPN18|PTPRU|SHOC2|PPP2CB|POLB|PTPRN2|SBF1|PNKP|PTPN21|CTDSP1|PPM1M|RPAP2|DUSP28
NEGATIVE REGULATION OF MELANIN BIOSYNTHETIC PROCESS%GOBP%GO:0048022,0.890556514809404,0.965159112268525,0.554367004852228,0.739173598646999,6704,1,RAPGEF2
CARDIAC CHAMBER MORPHOGENESIS%GOBP%GO:0003206,0.0909208651729051,0.41687166337997794,-0.24706451177340302,-1.36526574569971,701,58,HEYL|TGFB2|NRG1|ROBO1|SOX11|TGFB1|TNNT2|JAG1|TBX1|ZFPM2|RYR2|CPE|SFRP2|GATA3|SMAD6|TBX2|HES1|MESP1|NOTCH1|MEF2C|PKP2|NOTCH2|GATA6|NRP2|TGFBR2|TGFBR3|TEK|SLIT2|FKBP1A|ENG
SYNAPTIC VESICLE MATURATION%GOBP%GO:0016188,0.49398907103825107,0.7924976271882671,0.329415016315682,0.9562341625072079,3615,8,UNC13A|CLCN3|DLG4|PICALM
PROTEIN DEGLYCOSYLATION INVOLVED IN GLYCOPROTEIN CATABOLIC PROCESS%GOBP%GO:0035977,0.64243988588507,0.868171925756234,0.387415209838416,0.851167715114063,4728,4,MAN1B1|EDEM2|EDEM3|EDEM1
NUCLEAR FRAGMENTATION INVOLVED IN APOPTOTIC NUCLEAR CHANGE%GOBP%GO:0030264,0.1838127090301,0.556308895147568,-0.906263784737538,-1.20736096803796,1373,1,GPER1
FAD METABOLIC PROCESS%GOBP%GO:0046443,0.9308009031743921,0.9793746057014829,0.535123511248346,0.7135149965057808,7007,1,FLAD1
POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:1903955,0.984761656681427,0.9943582032224201,-0.11100658861800401,-0.511581981011701,7560,31,UBE2J2|PINK1|FBXW7|TOMM7|SAE1|ABLIM3|USP36|RAC2|UBE2L3|NPEPPS|SREBF2|MICALL2|ATG13|PDCD5|HUWE1|RHOU
SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION%GOBP%GO:0014834,0.227157190635452,0.609201573718782,-0.8834913983237759,-1.1770226813623899,1697,1,IGF1
RESPONSE TO THYROID HORMONE%GOBP%GO:0097066,0.0364801255230126,0.271526902825443,-0.519961111058052,-1.62897028499004,278,10,CTSS|MED1|LMO2|CTSB|CTSH|CTSL
INTERSTRAND CROSS-LINK REPAIR%GOBP%GO:0036297,0.226497933884298,0.6091952781136228,-0.224148159227487,-1.181013640883,1753,49,SLX1B|SLX1A|RNF168|STRA13|EME1|NUCKS1|FAAP100|UBC|FANCM|MUS81|XRCC3|XPA
FERTILIZATION%GOBP%GO:0009566,0.7541792271855301,0.9156695413521451,0.16199143862162899,0.80269124335558,5503,38,TDRD12|UBXN8|IGSF8|ADCY3|SPESP1|PCSK4|TUBGCP3|C1orf111|CATSPERG|CATSPER2|PRND
REGULATION OF HETEROCHROMATIN ASSEMBLY%GOBP%GO:0031445,0.895498392282958,0.9663983366739259,0.393548387096774,0.661212103411667,6683,2,TPR|SIRT6
RRNA-CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS%GOBP%GO:0071428,0.9299028616434759,0.9793746057014829,-0.16755174000356798,-0.608353208020876,7083,15,BCCIP|PA2G4|ZNF593|NPM1|NMD3|RAN
LYSINE BIOSYNTHETIC PROCESS%GOBP%GO:0009085,0.0901661307609861,0.414794277220364,0.81759029500965,1.37365725897223,672,2,AASS|AASDHPPT
POSITIVE REGULATION OF CHOLESTEROL TRANSPORT%GOBP%GO:0032376,0.432922026778682,0.761429660735106,-0.27967408512469,-1.01545126826069,3297,15,NR1H3|APOE|NFKBIA|ANXA2
TELOMERE MAINTENANCE VIA SEMI-CONSERVATIVE REPLICATION%GOBP%GO:0032201,0.0439387995292272,0.299062021084573,-0.374377189991993,-1.5503933535971102,335,22,RFC2|RPA2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|POLA1|RFC4|POLA2|FEN1
INTERLEUKIN-13 BIOSYNTHETIC PROCESS%GOBP%GO:0042231,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
NOREPINEPHRINE TRANSPORT%GOBP%GO:0015874,0.0540576437773941,0.337048028079797,0.973147331274813,1.29756065670588,406,1,SLC6A2
NEGATIVE REGULATION OF SEROTONIN SECRETION%GOBP%GO:0014063,0.7785714285714291,0.924704689181848,-0.385495793799916,-0.752775581783943,5885,3,LILRB1|HTR1B
RNA 3'-END PROCESSING%GOBP%GO:0031123,0.170485088954307,0.544171946973796,-0.18399897333606602,-1.20070327206417,1331,111,MAGOH|CPSF2|SRSF5|ATP5J2-PTCD1|SRSF1|U2AF1|PAPOLA|NCBP1|CLP1|CSTF3|DKC1|THOC7|ZC3H3|MAGOHB|EIF4A3|EXOSC3|PABPN1|SRSF2|HSD17B10|RBM8A|DDX39A|TUT1|THOC3|CPSF7|EXOSC2
NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION%GOBP%GO:0055118,0.33808116097823204,0.6998037279675999,0.56914486232627,1.11944078068322,2515,3,BIN1|KCNE3
INSULIN PROCESSING%GOBP%GO:0030070,0.794078242229368,0.929656485793048,0.45338911423946393,0.761752251360417,5926,2,PCSK2
SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS%GOBP%GO:0016447,0.893202614379085,0.965443067117994,-0.192334123297317,-0.643760319227959,6832,12,BATF|EXO1|RNF168|EXOSC3
PROSTATE GLAND MORPHOGENESIS%GOBP%GO:0060512,0.7740780047758029,0.922671217932792,-0.47590085974029206,-0.7919751328771791,5834,2,CRIP1
MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0060537,0.59122964482626,0.8417378833576942,-0.150058739607327,-0.9240689504344509,4610,88,SRPK3|ZFPM2|RYR2|MYH11|CXADR|C3orf58|CAV2|TBX2|MYOM1|MYLK2|MESP1|MYLK|NOTCH1|SEPN1|MEF2C|S1PR1|VAMP5|PKP2|POPDC2|BMP2|TGFBR3|PDGFRB|IGSF22|MAML1|FKBP1A|CAV1|SIK1|PDGFRA|ENG
POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0033008,0.275834970530452,0.650819624868901,-0.45196761536455393,-1.16258246051347,2105,6,SYK|SNX4|FGR|VAMP8|VAMP7
POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION%GOBP%GO:1901165,0.7574960547080479,0.917024280849414,-0.318567346831651,-0.763545142110558,5759,5,SMURF2|SYDE1
HEMOGLOBIN BIOSYNTHETIC PROCESS%GOBP%GO:0042541,0.588617670469621,0.8414799095069009,-0.563275434243176,-0.937380397094965,4436,2,INHA|INHBA
MAINTENANCE OF CENTROSOME LOCATION%GOBP%GO:0051661,0.988452655889146,0.996030692679047,0.228699056967959,0.502461567911462,7275,4,GPSM2|AKAP9
"PROTEIN IMPORT INTO NUCLEUS, TRANSLOCATION%GOBP%GO:0000060",0.12598116169544699,0.481730320673818,-0.363027926459126,-1.3491523417978,962,16,PHB2|AKT1|TNF|TGFB1|KPNB1|RAN|RBM22|BCL3|SEC61B|BCL6
CHEMOREPULSION OF AXON%GOBP%GO:0061643,0.217257525083612,0.5996151428055749,-0.888619320688134,-1.18385430523849,1623,1,SEMA3B
DNA METHYLATION INVOLVED IN EMBRYO DEVELOPMENT%GOBP%GO:0043045,0.0877545551982851,0.40905715364188894,0.8202371105596908,1.37810425084048,654,2,PICK1|TET3
POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION%GOBP%GO:1905908,0.183483837194085,0.556308895147568,-0.5890365631721171,-1.28952416754813,1401,4,CLU|APP|PSEN1|APOE
DISSEMINATION OR TRANSMISSION OF SYMBIONT FROM HOST%GOBP%GO:0044007,0.30960286890689304,0.680809181688249,0.846217468019409,1.1283168110638,2330,1,NEDD4
INOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0006021,0.43365652809138,0.7617458538169591,0.784572121746802,1.04612105979194,3264,1,ISYNA1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS%GOBP%GO:0090288,0.0455124936257012,0.305773795916932,-0.23693609326537898,-1.4494612422349098,356,85,AGT|SKIL|DAB2IP|HGS|LEMD3|SEMA6A|PDCD6|SPRY1|GATA3|SMAD6|CASK|DCN|NOTCH1|SMURF2|FAM129B|HTRA3|CHRD|FBN1|LTBP1|MMRN2|CREB3L1|SULF1|LDLRAD4|SNX6|ADAMTSL2|TGFBR2|THBS1|NBL1|UBC|SLIT2|FAM89B|CAV1
MUSCLE SYSTEM PROCESS%GOBP%GO:0003012,0.0010245901639344302,0.023972547589817,-0.25907329486502395,-1.78922025309679,7,146,PGAM2|SNTB1|EDNRA|PIK3C2A|RYR2|MYH11|ATP1B1|ATP2A1|P2RX4|PLN|GAA|TNNI2|TNNC2|ITGB5|TLN1|KCNN2|STAC3|MYOM1|CACNA1H|MYLK2|MYLK|LMOD1|LTB4R|PKP2|PXN|CACNA1G|HMOX1|SOD1|FXYD1|DYSF|SULF1|IGF1|KCNJ12|SLC6A8|MYL12A|TPCN2|GSN|EDNRB|KCNQ1|NOS3|CHRNE|ACTG2|CHGA|ASPH|VCL|IGSF22|PABPN1|CRYAB|SCN1B|KCNH2|VIM|KCNE4|ADRBK1|MYOF|ACTA2|RGS2|EMD|MYL9|ALDOA
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT%GOBP%GO:0061036,0.13594651284740403,0.498982756929491,-0.3806685409486,-1.3467496313017198,1036,14,BMP2|ANXA2|ACVRL1|LOXL2
POSITIVE REGULATION OF LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902608,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030948,0.340151120375195,0.701786807591082,-0.363895108899303,-1.09468555906411,2610,9,DAB2IP|HGS|PDCD6|FAM129B|MMRN2
UTP BIOSYNTHETIC PROCESS%GOBP%GO:0006228,0.206667552131757,0.586366512053115,0.898213498014998,1.19764650109008,1555,1,CAD
PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0071947,0.842714360862704,0.9481593344082329,-0.291608529972388,-0.69893000231465,6407,5,OTUD7B|USP9X|TNFAIP3
NEGATIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0060633,0.829996073812328,0.9435818887072471,-0.323664037941874,-0.7085682369946601,6341,4,ZNF451|HEY2|HMGB1|THRA
N-TERMINAL PROTEIN LIPIDATION%GOBP%GO:0006498,0.505230267626681,0.797902257689198,0.43165093837891294,0.948355494612768,3718,4,NMT2|PPM1B
REGULATION OF CONNECTIVE TISSUE REPLACEMENT%GOBP%GO:1905203,0.9355266648978509,0.9806508984207809,-0.370719602977668,-0.616936701876598,7051,2,ROCK2|ROCK1
MODULATION OF CATALYTIC ACTIVITY IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052203,0.10655737704917999,0.449288135667161,0.705667993960478,1.3879656698182299,792,3,SUGT1|CASP8
AXONEME ASSEMBLY%GOBP%GO:0035082,0.000136407038603192,0.00526859796630401,0.6030215437537829,2.87161716520126,0,33,LRRC6|DNALI1|DNAI1|ZMYND10|RSPH9|LRGUK|CFAP44|DYX1C1|CFAP43|CCDC65|LRRC49|RSPH1|SPAG16|C9orf117|TTLL3|IQCG|CFAP46|RSPH4A|GAS8|DNAH1|CCDC40|BBS2
REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING%GOBP%GO:0060147,0.0256443465872296,0.22470485454905398,-0.286278824202448,-1.58196201306831,197,58,ZC3H12A|HIST4H4|PUM1|MAP2K2|HIST1H3D|POLR2F|TNRC6A|HIST1H4H|AJUBA|TGFB1|POLR2C|DHX9|DND1|TERT|POLR2J|FMR1|STAT3|FXR1|HIST1H4I|DDX5|POLR2H|HIST2H3A|HIST2H4A|PPARG|POLR2G|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|WTIP|POLR2L|EIF4G1
POSITIVE REGULATION OF INTERMEDIATE FILAMENT DEPOLYMERIZATION%GOBP%GO:0030844,0.20069066277061998,0.578325746675525,0.9013564181737981,1.2018371610386398,1510,1,NES
NORADRENERGIC NEURON DIFFERENTIATION%GOBP%GO:0003357,0.30227211252366804,0.675222663526765,0.41332261862117103,1.1409659944761399,2234,7,INSM1|ASCL1|SOX4|HAND2|PHOX2B|PHOX2A|SOX11
AMINO ACID HOMEOSTASIS%GOBP%GO:0080144,0.44426580921757797,0.766596259839573,0.617458642791481,1.0374102432021202,3315,2,KCTD7|PQLC2
MYELINATION IN PERIPHERAL NERVOUS SYSTEM%GOBP%GO:0022011,0.28989071038251396,0.6622817015650171,0.39554818475882103,1.14820718076079,2121,8,PARD3|NF1|ARHGEF10|SKI
SYNAPSE PRUNING%GOBP%GO:0098883,0.452248677248677,0.769943206592495,-0.523953682393874,-1.02314874620034,3418,3,CX3CL1|ITGAM
DETECTION OF TEMPERATURE STIMULUS%GOBP%GO:0016048,0.7473797366299381,0.912246154063119,0.395999069761836,0.7788834392567959,5561,3,MMP24|EPHB1
RENAL SYSTEM PATTERN SPECIFICATION%GOBP%GO:0072048,0.27103429796355805,0.6462219082477939,0.69759890738121,1.17205623504127,2022,2,PAX8|BMP4
POSITIVE REGULATION OF BONE MINERALIZATION%GOBP%GO:0030501,0.6004895295077509,0.8464076674715391,0.207508765994333,0.893869596869365,4415,24,NELL1|ACVR1|BMP7|ACVR2A|WNT4|BMPR1A|ATRAID|BMPR2|SLC8A1|ACVR2B|BMPR1B
REGULATION OF LIPOPHAGY%GOBP%GO:1904502,0.765475723072896,0.9197593738525891,-0.346491241680433,-0.7585417577212771,5848,4,SPTLC1|ADRB2|SPTLC2
TERMINATION OF RNA POLYMERASE I TRANSCRIPTION%GOBP%GO:0006363,0.0821451929365598,0.39836209084110297,-0.31172300744784004,-1.4232662238687301,627,30,ZNRD1|TWISTNB|TTF1|POLR2H|GTF2H1|UBTF|CDK7|MNAT1|PTRF|POLR2L|GTF2H2
INTERACTION WITH HOST%GOBP%GO:0051701,0.0475331701661729,0.312255783864335,-0.243167794399613,-1.4463257392932,368,77,TGFB1|ATG7|HYAL2|CD209|ZNF639|CTNND1|CD4|RRAGA|PPIA|RAB7A|KPNB1|CCNK|CAV2|GAS6|PVRL2|SLC25A6|CLEC4M|CXCR4|GRB2|IFIT1|KPNA4|VAMP8|TNIP1|KPNA2|THOC7|GAPDH|AXL|PABPN1|CAV1|ADRBK1|THOC3|CD81
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0010513,0.634385778721146,0.863354277348854,-0.545571803065689,-0.907918723792146,4781,2,ZP3
COBALAMIN BIOSYNTHETIC PROCESS%GOBP%GO:0009236,0.602470447602603,0.8479232669964059,0.69634980149978,0.9284884998322008,4535,1,MMACHC
ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:0009887,0.0014153371075656198,0.0301860198914787,-0.20100861301196898,-1.59455073719823,10,318,TBX1|COL20A1|ZFPM2|SOX18|DFNB31|RYR2|AQP3|FGD1|COCH|COL18A1|EDA|BCOR|SOX17|CLDN5|SEMA6A|SFRP4|FOXN4|SPRY1|SMO|CPE|NRL|SFRP2|GATA3|SMAD6|TBX2|PDZD7|WWOX|MYOM1|TGFB3|HOXA4|ANXA6|C12orf57|THY1|MYLK2|STIM1|HES1|MESP1|SLC9A3R1|DCN|THRA|MYLK|EFNA1|VWA1|NDST1|NOTCH1|HCCS|COL14A1|INHBA|MGP|ELN|MEF2C|S1PR1|STAT3|DSCAM|PKP2|FREM1|HOXB3|FBN1|SNAI2|MSN|NOTCH2|MICAL2|FGF10|COMP|SOD1|HRAS|CEBPB|LRP5|COL5A2|COL12A1|CCL2|CTSH|COL6A3|EPHA2|DLC1|GATA6|NOS3|COL21A1|NRP2|ACTG2|TGFBR2|BMP2|TGFBR3|TEK|COL1A2|COL1A1|SRF|EIF4A3|IGSF22|ERRFI1|DCHS1|SLIT2|FKBP1A|DNAAF1|SNAI1|SERPINE1|CAV1|MYC|EPHB4|COL6A1|PDGFA|ANXA2|EFEMP1|CSF1R|EVL|PDGFRA|ACTA2|LY6H|COL5A1|ENG|CRIP1|COL6A2|ACVRL1|FAM20A|COL13A1|ITGB4|MTHFD1
POSITIVE REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905026,0.28336012861736304,0.6560202082186041,0.6921422663358149,1.16288837354956,2114,2,RNF207|NOS1AP
POSITIVE REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION%GOBP%GO:0003331,0.580735785953177,0.8387093286508721,-0.7139942655491841,-0.95121180184495,4340,1,RGCC
NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION%GOBP%GO:0045656,0.218492968957283,0.6013731193122099,-0.724786324786325,-1.20616034649204,1646,2,CDK6|MYC
MAINTENANCE OF APICAL/BASAL CELL POLARITY%GOBP%GO:0035090,0.242139209889815,0.625158460820442,0.6187823977059671,1.21707195516053,1801,3,WDR1|PDCD6IP|ANK1
NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION%GOBP%GO:0010745,0.0184700026198585,0.186740972764028,-0.538194410657807,-1.74243336044064,140,11,ABCA5|ABCG1|CETP|NR1H3|NFKBIA|PPARG|PPARA
ISOPRENOID METABOLIC PROCESS%GOBP%GO:0006720,0.820698576972833,0.940031154277066,-0.138751929155305,-0.7640180083783209,6343,57,SDC4|APOM|ALDH1A1|HMGCR|SDC2|APOE|ALDH1A2|HMGCS1|PDSS1|RARRES2|SRD5A3|DHRS3
POSITIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0043243,0.0739733478379114,0.38239128347091206,0.338082057597901,1.4563301510937399,543,24,RLTPR|KATNB1|FAM21C|NES|LRRC16A|SMCR8|WDR1|IGF1R|STMN2
"NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION, GABAERGIC%GOBP%GO:0032229",0.938996655518395,0.980854185905783,-0.5303264225849139,-0.706522133766679,7018,1,STXBP1
POSITIVE REGULATION OF FAST-TWITCH SKELETAL MUSCLE FIBER CONTRACTION%GOBP%GO:0031448,0.44949832775919707,0.768229288546963,-0.7766872518747242,-1.03473391310433,3359,1,ATP2A1
PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:0072659,0.267505241090147,0.6417330323279019,0.162347668327768,1.11329898953826,1913,137,ANK2|KIF13A|TMEM150A|EFR3B|INPP5K|RAB13|RAB3B|CLASP2|RAMP1|RAB3D|RAB10|ZDHHC23|FLOT2|SYS1-DBNDD2|GCC2|MAP7|PPIL2|EHD3|RILPL1|GGA1|GOLPH3L|SPTBN1|MLLT4|RAB15|ZDHHC22|LRRC7|EPB41L3|RAMP3|TTC7A|FLOT1|GORASP2|TSPAN5|VPS35|RAB11A|CACNB2|BBS2|MYO5A|BLZF1|LRP6|GOLGA7|ZFYVE27|EZR|KCNB1
GLYCOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0009247,0.662356136040347,0.879470077229378,-0.16196722618192003,-0.868509422609628,5121,52,B3GALT2|PIGH|B3GNT5|NDUFAB1|A4GALT|B3GALT1|ST3GAL5|GBGT1
METANEPHRIC CORTEX DEVELOPMENT%GOBP%GO:0072214,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
GLYCOGEN METABOLIC PROCESS%GOBP%GO:0005977,0.37140992167101794,0.7231271705612199,-0.253394243233924,-1.0638963840795699,2844,23,GYG1|PER2|GAA|PHKG2|PPP1R3C|PGM5|NR1D1|PYGL|PYGM|GYG2
POSITIVE REGULATION OF INTERLEUKIN-13 SECRETION%GOBP%GO:2000667,0.0794973544973545,0.39571857163531293,-0.730051414776417,-1.4256053822878998,600,3,GATA3|LGALS9
POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902932,0.933631921824104,0.9800972968717879,0.18197968431701803,0.5988249042311,6878,11,PTH1R|WNT4|FGF1|SNCA|PRKAA1|HRH1
CELL MIGRATION INVOLVED IN CORONARY ANGIOGENESIS%GOBP%GO:0060981,0.12949832775919698,0.487857553689733,-0.934384649316277,-1.2448247118746298,967,1,PDGFRB
DOPAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051583,0.260048231511254,0.636098664976652,0.703391232423491,1.18178808898966,1940,2,SLC6A2|SNCA
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT%GOBP%GO:0033157,0.852161605764282,0.949296218452153,-0.11360371028926701,-0.8044271088108559,6622,167,CEMIP|PSEN1|HYAL2|SP100|FIS1|APOD|SREBF2|CAMK1|JUP|ECT2|ITGB2|TRIM28|MICALL2|HCLS1|GDI1|ATG13|ATPIF1|PDCD5|GAS6|PRR5L|MDFIC|UBE2G2|RAB29|BAG3|PARK7|HAX1|PDE2A|BCAS3|ANP32B|HUWE1|CEP131|RAPGEF3|FLNA|HRAS|IGF1|RBM22|TMEM173|ZC3H3|B3GAT3|BCAP31|DERL3|ITGAM|PARL|RHOU|SAR1B|EMD|INSIG1|PRNP
FREE UBIQUITIN CHAIN POLYMERIZATION%GOBP%GO:0010994,0.705474799619617,0.894639008000397,0.367401318757993,0.8071963440660059,5192,4,PARK2|UBE2K|UBE2C
REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS%GOBP%GO:0010310,0.327144351464435,0.694149597002244,-0.353705266604296,-1.1081124274283503,2501,10,FYN|RAC2|RAC1|DUOXA1|HP|NOXA1|MPV17L
POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY%GOBP%GO:1901890,0.14371649012684698,0.509982599740886,-0.317228250895649,-1.3137247271191101,1098,22,AGT|PPM1F|KDR|THY1|S100A10|ABL1|EPHA2|TEK|CAV1|COL16A1|PTPRJ
NITRIC OXIDE STORAGE%GOBP%GO:0035732,0.0488294314381271,0.31702674791770696,-0.973698720776356,-1.2972004949247,364,1,GSTP1
UBIQUINONE-6 BIOSYNTHETIC PROCESS%GOBP%GO:1901006,0.43304347826087,0.761481529356367,-0.7848478164975742,-1.04560574464909,3236,1,NDUFA9
REGULATION OF PLASMINOGEN ACTIVATION%GOBP%GO:0010755,0.000130992926381975,0.00518555396908895,-0.670354068408992,-2.17030736286408,0,11,CLEC3B|ENO1|CTSZ|SERPINE2|THBS1|SERPINE1|ANXA2|SERPINF2
INTERACTION WITH SYMBIONT%GOBP%GO:0051702,0.223989737010904,0.607317294472428,-0.22188282201850998,-1.18479629299482,1745,51,SMARCA4|ZNF639|REST|RAB9A|CCNK|AZU1|CAV2|PPIB|FMR1|SNW1|NUCKS1|APOE|FN1|GAPDH|RRP1B|DDB1|CFL1|ANXA2|PSMC3
REGULATION OF UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:2000058,0.14091375770020498,0.5060001607270379,-0.18857260175485802,-1.23466741076168,1097,113,OGT|CBFA2T3|BAG5|VCP|RNF144B|CCDC22|CEBPA|UBQLN1|SUMO2|PARK7|UBXN1|HERPUD1|RAD23B|NKD2|RCHY1|HFE|PSMD10|PLK1|GIPC1|ARAF|TLK2|BCAP31|CAV1|DAB2|TAF9|CSNK1A1|MAGEF1|AK6|FAM122A
MITOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:0044772,0.0133043367020596,0.153115441364009,-0.198901399964488,-1.4827342033304398,103,219,CEP72|HAUS6|POLE4|CDKN1B|CDK4|AURKA|TACC3|PRIM2|AJUBA|CEP78|HAUS4|SKP2|CEP76|CSNK1D|FBXL7|CEP192|PCNT|ID2|NEK2|NEDD1|POLE|TYMS|BRD4|CUL4B|PIM2|FBXW11|RPA2|CDK6|RRM2|MCM10|DYNC1H1|PLCB1|TFDP2|CDT1|MCM4|EIF4EBP1|LCMT1|MCM6|CDC6|OFD1|CEP70|KDM8|CDC23|PLK2|CDKN2A|TUBA4A|SDCCAG8|HAUS8|PCNA|GMNN|ORC1|PKMYT1|CDK5RAP2|CDC25C|ORC6|MELK|MCM3|INHBA|UBE2S|FOXM1|MCM5|CDC45|CDKN2B|ENSA|RCC1|CEP131|CDC27|SKP1|E2F1|CKAP5|TUBB4A|DHFR|MAX|CCNB1|PLK1|LATS2|MCM2|CAMK2A|MYC|SSNA1|RPS6KB1|PRKACA|CETN2|CDKN2C|POLE2|POLA1|HSP90AA1|EPS8|POLE3|CEP63|CDKN3|PPP6C|TUBB4B|CCND1|DCTN3|POLA2|HAUS7
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING%GOBP%GO:0009792,0.7107279693486591,0.8964108318214721,-0.128160422854831,-0.871897524512825,5564,136,BHLHE40|PDCD6|COBL|GATA3|CELF1|TGFB3|HOXA4|HES1|MESP1|NDST1|CELSR1|CHRD|BRCA1|ATP6AP2|HOXB3|CELF4|SULF1|ALDH1A2|DLC1|DEAF1|LUZP1|TGFBR2|BMP2|ZP3|COL1A1|SRF|EIF4A3|TCOF1|RARRES2|WDR74|DACT1|PDGFRA|PDGFB|MTHFD1
N-ACETYLGLUCOSAMINE METABOLIC PROCESS%GOBP%GO:0006044,0.8582858692704101,0.949948023858,0.18992377635661103,0.6826565211608461,6328,14,EXTL2|GNPDA2|LARGE
CONTRACTILE RING CONTRACTION%GOBP%GO:0036213,0.757190635451505,0.916855605301775,-0.625661667401853,-0.8335315712050849,5659,1,VPS4A
SELF PROTEOLYSIS%GOBP%GO:0097264,0.0349815886375592,0.26702449097803305,-0.670063526195018,-1.6060144124000502,265,5,CAPN1|LGMN|ADGRV1
INTERLEUKIN-27-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070106,0.484963389121339,0.7872939093021379,-0.308570962739795,-0.9667125452729781,3708,10,CANX|EBI3|IL6ST|STAT3
COFACTOR METABOLIC PROCESS%GOBP%GO:0051186,0.0271277963486758,0.23271567002476898,-0.166006293142166,-1.3403890152008,210,355,TSPO|DGAT1|CHAC1|SLC19A1|PARP9|NADK|TKT|GPD1|CROT|ISCA1|CHAC2|ACSL5|ACOT1|BLVRA|GOT1|HPX|NDUFA9|ACSF2|DCAKD|SLC2A1|GPI|FAR1|COASY|ACSL4|PFKFB2|ATPIF1|HLCS|GGT1|NUDT17|GPX1|ELOVL2|HK1|PDHA1|GGH|VCP|ACSF3|KYNU|HK3|NFE2L1|PDXP|ELOVL1|THTPA|HSPA9|COQ6|PARK7|MCCC2|HAAO|ENO1|BST1|DPEP1|ALAD|HMOX1|SOD1|SLC25A16|PGAM1|FTCD|DHFR|MOCS2|MBIP|RFK|CAT|GAPDH|COQ7|NOS3|HMGCS1|FMO2|HACD2|FXN|GGT5|PDSS1|LDHA|GPX3|ACOT2|PDHX|PCCB|ABCD1|SLC2A3|PNPO|CYB5A|NMNAT3|HSP90AA1|MRPS36|PRDX4|PNP|MMAB|SHMT2|PRDX5|GSTP1|PGK1|FOLR2|GPHN|ISCA2|TALDO1|FASN|QPRT|PDXK|BLVRB|NNMT|PTGES|ALDOA|COQ3|ALDOC|MTHFD1|PTGIS|ABCC1
UREA TRANSPORT%GOBP%GO:0015840,0.343737548147164,0.702174649119653,0.8287384208204681,1.10501086012178,2587,1,AQP11
"GERMLINE CELL CYCLE SWITCHING, MITOTIC TO MEIOTIC CELL CYCLE%GOBP%GO:0051729",0.44481294773149394,0.76693681188187,-0.621395092362834,-1.0341008022382001,3352,2,C17orf104|YTHDC2
"REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT, NADH TO UBIQUINONE%GOBP%GO:1902956",0.863492063492064,0.9531672929044319,-0.349752321065277,-0.6829776386791159,6527,3,PARK7
PIGMENT METABOLIC PROCESS%GOBP%GO:0042440,0.29133247089262604,0.663744263372236,-0.233931805589101,-1.12644710960648,2251,36,TSPO|BLVRA|HPX|ATPIF1|ADA|NFE2L1|ALAD|HMOX1|HPRT1|PRPS1|FXN|GMPS|BLVRB|MTHFD1
FEMALE GENITALIA DEVELOPMENT%GOBP%GO:0030540,0.004689174705251879,0.0757018915187918,0.953735869864902,1.60239940319577,34,2,STRA6|TBX3
ARACHIDONIC ACID METABOLIC PROCESS%GOBP%GO:0019369,0.0183977035490605,0.18646534178457302,-0.389180681740743,-1.69767720533661,140,26,TBXAS1|PTGDS|CYP1B1|CBR1|DAGLB|PLA2G4A|PTGES2|PTGS1|PLA2G4C|DAGLA|MGLL|PTGES|PTGIS
CELLULAR RESPONSE TO CAMPTOTHECIN%GOBP%GO:0072757,0.603869927438861,0.848175106515994,0.447705879413488,0.8805846320366091,4493,3,SPIDR|BLM|RAD51
CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS%GOBP%GO:0060029,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN ORBITOFRONTAL CORTEX DEVELOPMENT%GOBP%GO:0035607,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
CELLULAR HEAT ACCLIMATION%GOBP%GO:0070370,0.031540374296557996,0.252151273228238,-0.721778649266608,-1.58012434209041,240,4,HSBP1L1|HSPA6|RBBP7
UMBILICAL CORD MORPHOGENESIS%GOBP%GO:0036304,0.638665594855306,0.865463150027443,0.530245381858285,0.890880704274427,4766,2,HEY2|HEY1
IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0002381,0.7345098039215692,0.9079405785880958,-0.2336508483621,-0.78205126657089,5618,12,BATF|EXO1|RNF168|EXOSC3
TUMOR NECROSIS FACTOR PRODUCTION%GOBP%GO:0032640,0.8527777777777779,0.949296218452153,-0.354387043980055,-0.692028077865983,6446,3,APP|TLR2
COMPLEMENT-MEDIATED SYNAPSE PRUNING%GOBP%GO:0150062,0.0739799331103679,0.38239128347091206,-0.961402734891928,-1.2808192892863202,552,1,ITGAM
PYRIMIDINE RIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046132,0.37076298913754707,0.7231271705612199,-0.494761715378196,-1.08313681874333,2832,4,CTPS1|UMPS
URETERIC BUD FORMATION%GOBP%GO:0060676,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
EPITHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:1904019,0.716614090431125,0.8996926655772769,-0.288392111386367,-0.7883069758120089,5451,7,RYR2|DAB2IP|GSN
SEQUESTERING OF NEUROTRANSMITTER%GOBP%GO:0042137,0.670075707265241,0.8815356925073421,0.663045875606529,0.8840822084474,5044,1,SLC18A2
REGULATION OF AMPA RECEPTOR ACTIVITY%GOBP%GO:2000311,0.9870554393305441,0.9959559575186221,-0.124585132530856,-0.48343664867183395,7548,18,ARC|NLGN3|ADRB2|SHISA7|MEF2C|CNIH2|CNIH3
MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0060644,0.721053346002443,0.901895642353625,0.303733936352104,0.785929412352448,5311,6,LATS1|IRF6|AKT2|ZNF703|AKT1|ID2
POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION%GOBP%GO:0051561,0.659984379067951,0.8778412418074321,-0.28918489726034197,-0.832522844766937,5069,8,FIS1|ATP2A1|TGM2|BCAP31
REGULATION OF ANION TRANSPORT%GOBP%GO:0044070,0.29595015576323996,0.6687276080240239,-0.22944259609004003,-1.1228822186086203,2279,38,TRIAP1|PER2|GABRE|P2RX4|SFRP4|TNFRSF11A|PRELID1|PLA2R1|CA2|CEBPB|CRY2|APOE|THBS1|ARL6IP1|ARL6IP5|PRNP
ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION%GOBP%GO:0071786,0.51822633297062,0.8047799431921201,0.27792646836618395,0.94461800873835,3809,12,RTN4|KIAA1715|RAB10|TMEM170A|ZFYVE27|REEP2|ATL2|REEP1
SEPTUM DIGESTION AFTER CYTOKINESIS%GOBP%GO:0000920,0.329306366227772,0.695646600584197,0.42788594120567003,1.10718002197754,2425,6,CHMP3|CHMP1A|CHMP2A|CEP55|CHMP2B|CHMP1B
REGULATION OF ISOMERASE ACTIVITY%GOBP%GO:0010911,0.00236593059936909,0.0452973140533542,-0.730226144511859,-1.99604060205309,17,7,DHX9|SETMAR|ITGB2|HNRNPU|PLSCR1|UHRF1|ITGAM
POSITIVE REGULATION OF RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:2000202,0.847892976588629,0.9492491301138911,-0.5794000882223199,-0.771900039677715,6337,1,RIOK2
NEURON RECOGNITION%GOBP%GO:0008038,0.35843414435231796,0.714938712241162,0.23114731721202203,1.07014191710179,2636,30,CNTN4|ROBO3|IGSF9|EPHB2|RTN4|ROBO2|CDK5R1|NRCAM
POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION%GOBP%GO:0030836,0.35694859940168605,0.714610778064251,0.34048884330774104,1.0786916709749301,2624,10,RLTPR|FAM21C|LRRC16A|WDR1
PROTEIN LOCALIZATION TO NUCLEAR INNER MEMBRANE%GOBP%GO:0036228,0.8352090032154341,0.945788393670804,0.429170113041081,0.721061202305311,6233,2,NUP54|NUP155
RIBONUCLEOPROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0032988,0.105933315830927,0.44788400395097705,-0.383034749948731,-1.3907370875994598,806,15,GFM2|DENR|DYRK3|DHX8|MRRF|VCP|PELO|MCTS1|EIF2D
TRNA WOBBLE CYTOSINE MODIFICATION%GOBP%GO:0002101,0.9934351554126469,0.9974705716496209,0.28282326992004403,0.47517961025619104,7414,2,NSUN3|ALKBH1
REGULATION OF SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1902803,0.447650006772315,0.768229288546963,0.242687736836141,1.0003955074892799,3304,21,PARK2|RIMS1|RAB3GAP1|RIMS2|MAP2|PREPL
CHROMATIN-MEDIATED MAINTENANCE OF TRANSCRIPTION%GOBP%GO:0048096,0.8609037328094301,0.951993398605548,-0.264243560752303,-0.6797056217987271,6572,6,ARID1B|KMT2B|ARID1A|CHEK1|SMARCD1|ELOF1
SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT%GOBP%GO:0099514,0.5562026002166851,0.8257149029717741,0.24887298898683802,0.917989867026946,4106,15,BLOC1S3|AP3B2|AP3B1|AP3M1|BLOC1S5|AP3M2|AP3S2|BLOC1S6|AP3D1|SNAPIN|BLOC1S4|BLOC1S2
INDOLALKYLAMINE METABOLIC PROCESS%GOBP%GO:0006586,0.691422594142259,0.8879225792175841,-0.258753755516391,-0.8106417382024541,5287,10,TDO2|KMO|CCBL1|KYNU|HAAO|AFMID
MORPHOGENESIS OF AN EPITHELIUM%GOBP%GO:0002009,0.318462329647724,0.6867397844771489,-0.15455339102648097,-1.07685635687738,2476,154,FOXN4|TOR1A|SMO|SFRP2|COBL|GATA3|TBX2|HES1|MESP1|SLC9A3R1|ITGA5|NOTCH1|CELSR1|MEF2C|LIN7C|MSN|MICAL2|FGF10|COL4A1|DDR1|FLNA|LRP5|STARD13|CTSH|CEACAM1|PDPN|EPHA2|DLC1|DEAF1|LUZP1|CD151|TGFBR2|BMP2|VCL|SRF|SEMA3E|SLIT2|DNAAF1|MYC|RASIP1|CSF1R|COL5A1|ENG|ACVRL1|MTHFD1
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0016480,0.5578042328042329,0.8266484026372171,-0.476223503519976,-0.9299438040237191,4216,3,PRDX5
CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0061323,0.14876254180602,0.5154128781388279,-0.9232465813850899,-1.22998613098246,1111,1,TGFBR2
VERY LONG-CHAIN FATTY-ACYL-COA METABOLIC PROCESS%GOBP%GO:0036111,0.264128416025471,0.6395074119587459,-0.700428062068308,-1.16562430215019,1990,2,ABCD1
POSITIVE REGULATION OF CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:1904716,0.390091645636871,0.7358910495632479,0.8063520070577859,1.075161598032,2936,1,PLK3
NEGATIVE REGULATION OF HORMONE SECRETION%GOBP%GO:0046888,0.18535439237697401,0.559093571852282,-0.27607421673250704,-1.24827514907497,1419,29,INHBA|CRHBP|IRS1|OSM|NOV|CHGA|ADRA2C|IL11|SIRT4|RAB11FIP1
PEPTIDYL-ASPARTIC ACID AUTOPHOSPHORYLATION%GOBP%GO:1990938,0.676716695444282,0.8835592822191172,0.6609505955006619,0.881288435148356,5094,1,ATP13A2
CARGO LOADING INTO VESICLE%GOBP%GO:0035459,0.5010460251046029,0.795954687014814,-0.24799046437195105,-0.962295231887767,3831,18,SEC23A|SEC13|SEC24A|TMED2|TMED10
L-ALANINE TRANSPORT%GOBP%GO:0015808,0.7936038699274391,0.929656485793048,0.37724260971029105,0.741991695743317,5905,3,SLC1A4|SLC36A4
RIBOFLAVIN TRANSPORT%GOBP%GO:0032218,0.36140257670341297,0.716154857259883,0.8206881340979271,1.09427688902546,2720,1,SLC52A2
NEPHRIC DUCT FORMATION%GOBP%GO:0072179,0.561820111435394,0.8282270665374359,-0.574469258340226,-0.9560087104195151,4234,2,BMP4|GATA3
COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0006613,0.538246505717916,0.8142313733497609,-0.15128508354793302,-0.9543352513844721,4235,96,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|SRP19|RPL35|RPL38|RPS15A|SEC61A1|SEC61B|SSR1|RPS13|ARL6IP1|SRP9|SRP68
BOX H/ACA SNORNA METABOLIC PROCESS%GOBP%GO:0033979,0.837755372777925,0.946216977301937,-0.438387948194218,-0.72954764929893,6314,2,DKC1
METANEPHRIC NEPHRON TUBULE MORPHOGENESIS%GOBP%GO:0072282,0.0330921757770632,0.25998057358601,0.8828784119106701,1.48334972505593,246,2,PAX8|PKD1
SUCCINYL-COA METABOLIC PROCESS%GOBP%GO:0006104,0.7385586533403471,0.9089185613230608,-0.32445400397088,-0.7776543359957191,5615,5,SUCLA2|SUCLG1|OGDH|SUCLG2|DLST
PYRIMIDINE DIMER REPAIR BY NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:0000720,0.604595563819896,0.848175106515994,0.6952470224966919,0.9270180928327041,4551,1,SIRT1
REGULATION OF PHOSPHOLIPASE C ACTIVITY%GOBP%GO:1900274,0.0169557845311073,0.17671843887293,-0.387704769785171,-1.70996744702828,129,27,ABL1|HRAS|NTRK2|P2RY6|GNAQ|GNA15|PDGFRB|ANG|PDGFRA|C5AR1
ACID SECRETION%GOBP%GO:0046717,0.35395703018765295,0.7118407891832621,0.250126666827644,1.07745145980777,2602,24,ABCC4|ABCB4|DRD2|GLS|DRD4
CELLULAR RESPONSE TO FOLLICLE-STIMULATING HORMONE STIMULUS%GOBP%GO:0071372,0.309698996655518,0.680809181688249,-0.8423577415086021,-1.1222227737111201,2314,1,NOTCH1
RESPONSE TO SODIUM DODECYL SULFATE%GOBP%GO:0072706,0.0774581939799331,0.38990430106433793,-0.958976621085134,-1.27758712315139,578,1,ZNF16
NEGATIVE REGULATION OF HISTONE H3-K9 ACETYLATION%GOBP%GO:2000616,0.643378934785496,0.868818962935866,0.676389501543891,0.90187413314131,4843,1,ZNF451
VACUOLAR ACIDIFICATION%GOBP%GO:0007035,0.11656200941915199,0.466501555821793,-0.36894754327753404,-1.37115193001405,890,16,PPT1|CLN6|ATP6V0A1|TCIRG1|ATP6V0A2|DMXL1|ATP6V0D1|SLC11A1|ATP6V0E1|ATP6V0E2
TETRAHYDROFOLATE METABOLIC PROCESS%GOBP%GO:0046653,0.512287581699346,0.802184867798321,-0.28330274392715504,-0.9482408100135901,3918,12,DHFR|SHMT2|MTHFD1
PLASMA MEMBRANE TO ENDOSOME TRANSPORT%GOBP%GO:0048227,0.6849726775956291,0.8857920062408181,0.280850881197526,0.815260974363006,5013,8,RAB11A|SORT1|COMMD1|SGSM3|RAB5B|USP6NL
ENDOCRINE HORMONE SECRETION%GOBP%GO:0060986,0.377669640443363,0.7281989978224692,0.43927803920502,1.05646116524331,2793,5,CRHR1|TBX3
REGULATION OF PROSTAGLANDIN SECRETION%GOBP%GO:0032306,0.186111111111111,0.559093571852282,-0.649608470276828,-1.26852069986068,1406,3,IL1B|P2RX4|TNFRSF11A
POSITIVE REGULATION OF INTERLEUKIN-2 PRODUCTION%GOBP%GO:0032743,0.22095761381475698,0.6033436178707641,-0.32601014663099,-1.2115799384006,1688,16,MALT1|TRAF6|IL1B|RUNX1|CD4|PDE4B|TRAF2|PDE4D|CD86|ANXA1
STRESS RESPONSE TO COPPER ION%GOBP%GO:1990169,0.168575891694871,0.541253459162226,-0.45374885772958795,-1.30627945451351,1294,8,PARK7|MT1M|MT2A|MT1E
ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009240,0.458447847140427,0.773047151415595,-0.45414437765400106,-0.994216975916003,3502,4,MVD|PMVK|MVK|IDI1
REPRODUCTIVE BEHAVIOR%GOBP%GO:0019098,0.906075882196869,0.970540242226399,-0.3943755169561621,-0.6563039256018791,6829,2,OXTR|APP
REGULATION OF CHOLESTEROL ESTERIFICATION%GOBP%GO:0010872,0.5716797403299971,0.833854868733934,0.32316705828056397,0.8920939900725942,4226,7,STARD4|AGTR1
CELLULAR RESPONSE TO JASMONIC ACID STIMULUS%GOBP%GO:0071395,0.25799516259070104,0.636098664976652,0.609793757582442,1.19939236076688,1919,3,AKR1C2|AKR1C1|AKR1C3
ADHESION OF SYMBIONT TO HOST CELL%GOBP%GO:0044650,0.00696635120925342,0.10045820391703099,-0.681248755231142,-1.8621630925697499,52,7,CD209|GAS6|PVRL2|CLEC4M|ICAM1|CD81
MITOTIC METAPHASE PLATE CONGRESSION%GOBP%GO:0007080,0.337488637839242,0.699636319850872,-0.211297027068173,-1.0861395317812,2598,45,MAD1L1|CENPE|KIF2C|CDCA8|BECN1|VPS4A|CHMP5|PINX1|NUF2|SPDL1|CDT1|CDC23|BOD1|KPNB1|NDC80|KIF18A|KIFC1|CCNB1|CHMP4A|CHMP6|KIF22|CDCA5
RIBONUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0033875,0.852233676975945,0.949296218452153,-0.12428043111973598,-0.762754247168462,6695,86,DGAT1|CROT|ACSL5|ABHD14B|ACOT1|ACSF2|DCAKD|FAR1|COASY|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|SLC26A2|TPST2|HMGCS1|HACD2|ACOT2|PDHX|ABCD1|SULT1A4|FASN
PURINE RIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0046128,0.21366184330595803,0.596905159748644,-0.257832341684045,-1.2108534617627802,1638,33,OPA1|IMPDH2|ADA|RAN|HPRT1|MOCS2|MBIP|NUDT18|GMPS|ENPP4|PNP|GPHN
REGULATION OF POST-TRANSLATIONAL PROTEIN MODIFICATION%GOBP%GO:1901873,0.9138888888888891,0.9736820566706701,-0.32348075438403,-0.631675927451844,6908,3,CRTAP|P3H1|PPIB
O-GLYCAN PROCESSING%GOBP%GO:0016266,0.0357632228007673,0.268987198588135,0.31092207590479,1.54066430805431,260,38,GALNT3|GALNT8|GALNT12|POMGNT1|B3GNT2|B4GALT5|GALNT7|B3GNT7|GALNT14|GALNT6|GALNT2|GALNT9
POSITIVE REGULATION OF VIRAL LIFE CYCLE%GOBP%GO:1903902,0.0525570011593456,0.331996459809677,-0.276169566991259,-1.4658782255364498,407,50,TRIM38|CD74|TSG101|CD4|PPIA|LARP1|CAV2|TOP2A|PPIB|FMR1|DDX3X|PDE12|IFIT1|NUCKS1|LGALS9|ADARB1|DDB1|ANXA2|LGALS1|P4HB
REGULATION OF INTRALUMENAL VESICLE FORMATION%GOBP%GO:1905365,0.60034833869239,0.8464076674715391,0.5484914713504789,0.921536490469288,4480,2,PARK2
POSITIVE REGULATION OF T-HELPER 1 TYPE IMMUNE RESPONSE%GOBP%GO:0002827,0.44861401673640205,0.768229288546963,-0.31865535004309903,-0.998305614273825,3430,10,IL18|CCL19|SLC11A1|IL1R1|ANXA1
NEGATIVE REGULATION OF ANION TRANSPORT%GOBP%GO:1903792,0.35164090046108,0.710514673478047,0.30170189664896396,1.08442855942002,2592,14,TCAF2|IRS2|TRH
REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:1902513,0.0271695052716951,0.23271567002476898,0.6962276637988088,1.67442353891091,200,5,HAP1|TRIM46|MAP2|NEFH|LAMP1
PLASMINOGEN ACTIVATION%GOBP%GO:0031639,0.11948697814422198,0.471120705968593,-0.6298032565685561,-1.37877098116294,912,4,PLAU|PLAT|PGK1
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT%GOBP%GO:1902742,0.7373737373737371,0.908309781681485,0.25636885320975894,0.7790813000071428,5401,9,ROBO2|SLIT3|LEF1|PPP2R1B|ZPR1|SCRIB|SIX3
NEGATIVE REGULATION OF VIRAL GENOME REPLICATION%GOBP%GO:0045071,0.0254116426811876,0.22409063601871598,-0.324193692457944,-1.62359612652145,195,41,PARP10|OASL|OAS1|CCNK|PLSCR1|IFIT1|APOBEC3G|ISG15|RSAD2|APOBEC3C|IFI16|TNIP1|BST2|IFITM1|BTBD17|IFITM2|IFITM3|BANF1|APOBEC3F
REGULATION OF GLUCOSE IMPORT%GOBP%GO:0046324,0.599754701553557,0.8464076674715391,0.20315114148420396,0.8983281903562859,4400,26,PRKAG2|IRS2|RHOQ|CAPN10|CLTCL1
POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY%GOBP%GO:1903598,0.160652693022022,0.530945769135442,-0.7580369451337191,-1.26149469592408,1210,2,AGT|CAV1
SUCROSE BIOSYNTHETIC PROCESS%GOBP%GO:0005986,0.925886571921902,0.9788732664014979,0.537715041905602,0.716970452954598,6970,1,FBP1
CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:0035766,0.327002257935981,0.6941148928066879,0.8358513453903841,1.1144949852685402,2461,1,CXCL13
RIBOSOME ASSEMBLY%GOBP%GO:0042255,0.8533762057877808,0.949296218452153,-0.135122559964548,-0.732673223538881,6634,54,PPAN|MRPS11|SBDS|ABT1|NPM1|DDX3X|RPS14|RPL10|RPL24|MRPS7|MRPL22|MRPS2|BOP1|MRPL11
REGULATION OF STRESS-ACTIVATED MAPK CASCADE%GOBP%GO:0032872,0.450443501735442,0.7687932540972091,-0.14355822358329098,-1.00404099524719,3503,157,TNFRSF11A|PHLPP1|IL1RN|FCGR2B|PKN1|MDFIC|TRAF2|TAOK2|MAPK8IP1|ZNF622|FLT4|MLKL|FOXM1|CTGF|MAPK3|HRAS|MEN1|MAP3K13|GADD45B|SASH1|FGF19|GADD45G|BMP2|TGFBR3|LGALS9|MAP3K11|MYC|LTBR|DNAJA1|SEMA3A|DACT1|ARL6IP5|GSTP1|DBNL|SERPINF2|ERN1|SIRPA
DNA REPAIR%GOBP%GO:0006281,0.0298926928972918,0.244735657013286,-0.162972387027305,-1.32462619849552,233,370,SETMAR|RNASEH2A|DTX3L|RFC3|TREX1|UBE2B|HMGB2|TONSL|FBXO6|H2AFX|NBN|PARP9|YY1|HMGN1|EXO1|TRIM28|GINS2|POLR2J|PARP1|RBM17|ENDOV|INIP|GTF2H2C|RAD51C|PAXIP1|NDNL2|AP5S1|KDM2A|POLD4|TMEM189-UBE2V1|NPM1|RAD51AP1|BRCC3|PCNA|COPS6|VCP|NUDT1|POLD1|SLX1B|RHNO1|AUNIP|SLX1A|RNF168|HIST1H4I|PARK7|RNF138|CDC45|PARP2|POLD2|BRCA1|STRA13|KIAA0101|WDHD1|RFC5|TOPBP1|POLQ|EME1|POLR2H|ISG15|GTF2H1|NUCKS1|C9orf142|ABL1|FAAP100|RMI1|HUWE1|RAD23B|DTL|MEN1|REC8|NPLOC4|RAD51B|RCHY1|CRY2|USP47|RBM14|CDK7|RMI2|UBC|MNAT1|HIST3H2A|FANCM|TNKS1BP1|ERCC8|HIST2H4A|DDB1|POLR2G|SMC1A|CETN2|NSMCE1|KAT5|ISY1|POLE2|APEX1|POLA1|HIST2H4B|GPS1|UBE2L6|RFC4|EID3|IGHMBP2|MUS81|SAMHD1|CDCA5|XRCC6BP1|XRCC3|XPA|FEN1|ALKBH3|POLR2L|PRPF19|GTF2H2
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS%GOBP%GO:0060561,0.524113571525608,0.808028752377173,0.42563282413279707,0.935133441316774,3857,4,LEF1|PPP2R1B|SCRIB|BMP4
4-HYDROXYPROLINE CATABOLIC PROCESS%GOBP%GO:0019470,0.67072372726083,0.8815356925073421,-0.37773071882765397,-0.8269315034205401,5124,4,ALDH4A1
"PROTEIN LOCALIZATION TO CHROMOSOME, TELOMERIC REGION%GOBP%GO:0070198",0.521833468944942,0.807051143864932,0.26306682000147397,0.9455597588679759,3847,14,BRCA2|ACD|POT1|XRCC5|TNKS|ATR|TNKS2
SPLEEN DEVELOPMENT%GOBP%GO:0048536,0.396864017301974,0.7377402989373809,0.431648373863613,1.0381118638496198,2935,5,ADAM17|PCID2|CITED2
VIRAL LATENCY%GOBP%GO:0019042,0.10820015719151199,0.45250070789106706,-0.434245288624242,-1.40589248518625,825,11,PSIP1|PPIA|HCFC1|NUCKS1|IRF7|BANF1
REGULATION OF LIPID METABOLIC PROCESS%GOBP%GO:0019216,0.000381339773738401,0.0111294649577428,-0.22107291370086105,-1.6965597212744499,2,257,CCL19|REST|SREBF2|IDI1|AGT|SERPINA3|DAB2IP|GPAM|FGFR4|FDPS|FGR|APOC1|ANGPTL4|RORA|NR1D2|MED1|KPNB1|EPHA8|INS|PNPLA2|NSMAF|FABP3|C3|ABCG1|CYP51A1|IRS1|SMARCD3|ADIPOR1|PRKD1|ORMDL3|BRCA1|SNAI2|MBTPS2|OPA3|SOD1|G0S2|ABHD5|PIK3R3|MTMR1|NR1H3|CREBL2|RAN|BSCL2|HMGCR|ACOX1|CEACAM1|PIK3R4|GPER1|APOE|SLC45A3|HMGCS1|FGF19|CD36|ADIPOR2|TNFRSF21|BMP2|ZP3|TEK|FHL2|GLIPR1|NR1D1|PDK3|PPAP2A|PLIN2|FITM2|PDGFRB|RARRES2|SNAI1|CAV1|SIRT4|NFYB|LDLR|STOML2|PPARG|PPARA|DHCR7|SIK1|ABCD1|NFKB1|PDGFA|PDGFRA|ANXA1|H2AFY|NPC2|TNFRSF1A|AMBRA1|FADS1|CD81|FASN|EDF1|PDGFB|TM7SF2
PROSTAGLANDIN METABOLIC PROCESS%GOBP%GO:0006693,0.0119000915391657,0.143385281385281,-0.429823710688668,-1.78001182252692,90,22,CD74|TBXAS1|PTGDS|CBR1|PTGR2|PTGES2|PTGS1|ACOX1|PLAA|PTGES|PTGIS
COLLAGEN-ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038063,0.0779852709100473,0.390894089449544,-0.615423444316189,-1.47505256242379,592,5,DDR2|DDR1|COL4A2|COL1A1
"COMPLEMENT ACTIVATION, LECTIN PATHWAY%GOBP%GO:0001867",0.47190569744597294,0.7831522581932591,-0.3805114594826429,-0.978777978289626,3602,6,COLEC11|FCN3|COL20A1|FCN1
MEMBRANE DEPOLARIZATION DURING BUNDLE OF HIS CELL ACTION POTENTIAL%GOBP%GO:0086048,0.0166621875839828,0.17569702079137303,0.8313558080191421,1.63517876793373,123,3,TRPM4|SCN5A|CACNA2D1
ESTABLISHMENT OF SYNAPTIC VESICLE LOCALIZATION%GOBP%GO:0097480,0.988656870327404,0.996050320421843,-0.0955604518484384,-0.542661031142393,7669,64,SEPT5|SNAP47|AP3S1|DNM1|STX4|TOR1A|SYT4|SYT7|CPLX2|STX11|STX1B|STX3|DTNBP1|PRRT2|SNPH|DNM3
PEPTIDYL-TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY%GOBP%GO:1990264,0.6710561676968559,0.8815356925073421,0.42340336755817803,0.8327844591022959,4993,3,DUSP10|PTPN1|DUSP3
REGULATION OF BLOOD COAGULATION%GOBP%GO:0030193,0.00012923235978289,0.00518555396908895,-0.5240467056185829,-2.74722313186116,0,48,GP1BA|PLAU|PLEK|VTN|FCER1G|F3|FAP|CEACAM1|THBD|PDPN|F2R|APOE|PLAUR|NOS3|SERPINE2|THBS1|SERPINE1|CAV1|PLAT|ENPP4|TLR4|PDGFA|ANXA2|PDGFRA|TFPI|PDGFB|SERPINF2|C1QTNF1
POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0002891,0.882938326568024,0.9629606199413431,-0.19072501754515397,-0.656512496149172,6742,13,TGFB1|HLA-E|PAXIP1|PVRL2|TNFSF13|TFRC
POSITIVE REGULATION OF WNT SIGNALING PATHWAY BY BMP SIGNALING PATHWAY%GOBP%GO:0060804,0.148494983277592,0.5154128781388279,-0.9235774150860171,-1.23042688090995,1109,1,BMP2
NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048642,0.5626226933647429,0.828541380171721,-0.41432746925495,-0.9070494402012059,4298,4,EPHB1|USP19|AKIRIN1|TGFB1
TUBE CLOSURE%GOBP%GO:0060606,0.3906547133931,0.7364714265545841,0.23019893975257397,1.04291400641047,2875,28,BBS4|TSC2|SEMA4C|DVL2|MTHFR|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10
POSITIVE REGULATION OF MAST CELL PROLIFERATION%GOBP%GO:0070668,0.575919732441472,0.8359897176758009,-0.7165857962064399,-0.954664342943622,4304,1,LYN
REGULATION OF RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING%GOBP%GO:1902145,0.752822419976092,0.915314007578303,0.6240626378473749,0.8321033210151909,5667,1,TIGAR
NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1903573,0.291926272066459,0.664000960265434,-0.230125133096999,-1.12622252542922,2248,38,USP25|TMBIM6|OPA1|UBE2G2|CREB3|PARK7|UBXN1|CREB3L1|HERPUD1|SYVN1|DERL3|HSPA5|NCK1
GPI ANCHOR BIOSYNTHETIC PROCESS%GOBP%GO:0006506,0.193018201575659,0.5674728273201639,0.273873041029491,1.24077908775291,1420,28,PGAP2|PIGF|PGAP1|PIGU|PIGL|PGAP3|PIGO|PIGG|PIGT|DPM1|PIGQ|PIGN|PIGS|PIGB|PIGZ
FAS SIGNALING PATHWAY%GOBP%GO:0036337,0.7909030100334449,0.928357780000476,-0.6084031760035289,-0.81053911665435,5911,1,FAS
MEIOTIC CHROMOSOME CONDENSATION%GOBP%GO:0010032,0.36626984126984097,0.7207455847516451,-0.559832359104445,-1.09321070840285,2768,3,NCAPD2|NCAPD3|NCAPH2
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-DEPENDENT DECAY%GOBP%GO:0000288",0.9913704276146321,0.997150662115148,-0.0945034284450343,-0.510088713161626,7696,53,PAN2|PAN3|CNOT11|SAMD4A|PARN|WDR61|SAMD4B|EXOSC8|RQCD1|RC3H1|SKIV2L|DIS3|DCP1B|ZCCHC11|LSM7|POLR2D|CNOT7|PATL2|LSM4|EXOSC1|CNOT1|CNOT3|CNOT2|EXOSC5|EXOSC6|LSM2|DDX6|LSM1|EDC4|HBS1L|ZCCHC6|CNOT8|LSM6|EDC3|DCP1A|EXOSC9|CNOT4|CNOT10|CNOT6L|DCP2|CNOT6|TTC37|EXOSC7|LSM5|EXOSC4|DCPS|PDE12|PATL1|LSM3|NT5C3B|EXOSC3|TNKS1BP1|EXOSC2
NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION%GOBP%GO:0031953,0.0230021030494217,0.211174415545936,-0.613924999580562,-1.6781366087589198,174,7,MVP|ERRFI1|CAV1|ENG
OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION%GOBP%GO:0007008,0.13611257233035198,0.499189931577426,-0.568519733540937,-1.36263331774731,1034,5,TOMM20|HSP90AA1|HSPA4
MITOCHONDRION ORGANIZATION%GOBP%GO:0007005,0.00050935948045333,0.0139121625154964,-0.20367753569796695,-1.65458716742963,3,367,TSPO|TERT|BCL2L11|C17orf89|NDUFB5|CXADR|GZMB|SURF1|PID1|UQCR10|PPIF|OXA1L|ATP2A1|NDUFA11|PARP1|CHCHD4|NDUFA9|ATP5J|SCO2|NDUFA7|USP30|ATG13|ATP5F1|SOD2|PMPCA|PET117|HCFC1|OPA1|TOMM20|CHCHD3|CAV2|APOO|WDR45B|NMT1|NDUFA3|NDUFB6|RAB29|ATP5B|PPP1R13B|SLC25A6|TMEM70|IFIT2|ATG2A|NDUFAF3|CYCS|WDR45|NDUFB9|PARK7|COA3|HAX1|WIPI1|NDUFB10|TOMM70A|TIMM21|IFI6|TYMP|ROMO1|UQCC2|E2F1|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|ATPAF1|CHCHD6|AIP|COX16|NDUFS6|NOS3|IMMP1L|TIMM10B|NDUFB4|FXN|NDUFA12|SDHAF2|COX7A1|TIMM9|COX17|SLC25A4|TIMM17B|CAMK2A|NDUFA2|NDUFAB1|SLIRP|HSD17B10|NDUFA1|SIRT4|STOML2|MPV17L|NDUFB11|ATG3|ATP5H|NDUFV1|HSP90AA1|MARK2|NDUFAF2|PHB|TOMM5|AMBRA1|FUNDC2|HSPA4|NDUFS3|ESRRA|STPG1|TIMM10|UQCRC2|DNAJC19|SQSTM1|UQCC3|NDUFA8|NDUFS8|EIF4G1|ATP5G1|BAD|SLC25A5|NDUFV3|DNAJC15
NEGATIVE REGULATION OF BONE TRABECULA FORMATION%GOBP%GO:1900155,0.595317725752508,0.8442752964756541,-0.706495368328187,-0.941221470155173,4449,1,GREM1
PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009153,0.30083676451055896,0.673988937137548,0.8507940008822229,1.13441900011172,2264,1,AK5
VITAMIN TRANSMEMBRANE TRANSPORT%GOBP%GO:0035461,0.161475409836066,0.531565908892591,0.451368524091371,1.31024386029508,1181,8,STRA6|SLC5A6|SLC25A32|SLC46A1
CELLULAR RESPONSE TO ETHER%GOBP%GO:0071362,0.47413106924913795,0.784206173348341,-0.609208712434519,-1.01382071728881,3573,2,ZC3H12A|LARP1
ENDODERMAL CELL FATE COMMITMENT%GOBP%GO:0001711,0.562933857236411,0.828541380171721,-0.35359329325464706,-0.909537203371246,4297,6,RTF1|CDC73|LEO1|PAF1|SOX17|CTR9
POSITIVE REGULATION OF FIBROBLAST MIGRATION%GOBP%GO:0010763,0.695805619655219,0.890650553958115,0.310154098522233,0.8025419593143629,5125,6,ARHGEF7|PRKCE
NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION%GOBP%GO:0045617,0.944481338823217,0.982694945797028,0.528120864578738,0.7041779120589771,7110,1,SRSF6
ACTIVATION OF MAPKKK ACTIVITY%GOBP%GO:0000185,0.277208201892744,0.652442157557974,-0.427478190168455,-1.1684925697077,2108,7,MAP4K1|TNF|DAB2IP|GADD45B|GADD45G
POSITIVE REGULATION OF UROTHELIAL CELL PROLIFERATION%GOBP%GO:0050677,0.253244147157191,0.632257972333528,-0.870533745037495,-1.15975997586903,1892,1,FGF10
SUBSTRATE-INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION%GOBP%GO:0021826,0.287226822315732,0.6603864229308399,0.444630455371721,1.15050743654538,2115,6,DRD2|SLIT1|SLIT3
REGULATION OF FEVER GENERATION%GOBP%GO:0031620,0.45318253550762805,0.769943206592495,-0.413555506716443,-0.991213635945181,3445,5,PTGS2|IL1B|TNF|TNFRSF11A
NEGATIVE REGULATION OF DNA REPAIR%GOBP%GO:0045738,0.8043336379062791,0.932964969466025,-0.16606517036033802,-0.7508670231547301,6161,29,TERF2|PARPBP|KLHL15|AUNIP|POLQ|CXorf57|RMI2|OTUB1|MAGEF1
REGULATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0008277,0.0573540657659954,0.344894946677796,-0.23297955341186102,-1.41535941438087,449,83,CAV2|PLEK|NMT1|FZD2|ADA|C3|METAP2|SYP|PDCL|RGS4|ARRB1|NECAB2|GPER1|APLNR|CHGA|GPRASP1|USP20|GRK6|DTNBP1|MGLL|ADRBK1|RGS2|PRMT5|PHB|PDE6G|RGS3|GTF2H2
REGULATION OF TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION%GOBP%GO:0032909,0.9063390796796529,0.9707593777373379,0.24528289500051997,0.634683907380014,6676,6,SMAD3
CLOACAL SEPTATION%GOBP%GO:0060197,0.852171603134547,0.949296218452153,0.5728385531539479,0.7638029158885691,6415,1,WNT11
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME%GOBP%GO:1905668,0.8926130389064141,0.965443067117994,-0.234859349145063,-0.641977557484861,6790,7,EZR|ROCK2|SORL1|RDX|MGAT3|DTX3L|MSN
CELLULAR AMIDE CATABOLIC PROCESS%GOBP%GO:0043605,0.24668896321070197,0.6280519349499749,-0.873456109395677,-1.1636532668951898,1843,1,DPEP1
REGULATION OF INNATE IMMUNE RESPONSE%GOBP%GO:0045088,0.0001271132579128,0.00518555396908895,-0.23739454882055303,-1.82181535872841,0,257,MICA|NCR3|MUL1|LILRB1|S100A1|ALPK1|CLEC4A|HLA-E|LYN|LGR4|DHX9|CD209|TLR1|PYCARD|SEC14L1|IRAK3|ADAM8|SLAMF8|HSP90B1|HMGB2|IFNGR1|SOCS3|PARP9|DAB2IP|ITGB2|PIK3R6|PIK3AP1|TLR2|FGR|CTSS|TICAM2|HEXIM1|POLR3B|FCGR2B|MATR3|INS|ERBB2IP|PVRL2|TNFAIP3|PLSCR1|IKBKE|DDX60|CLEC4E|MAPKAPK2|UNC93B1|SOCS1|MB21D1|PTPN6|CLEC10A|IFIH1|FCER1G|MUC4|RSAD2|IRF7|IRAK1|HRAS|FCN1|NR1H3|TRAFD1|NPLOC4|IFI16|TNIP1|NONO|TMEM173|CEACAM1|PIK3R4|CD300A|HFE|RBM14|RAB7B|HCK|COLEC12|CD36|MUC20|A2M|LGALS9|NR1D1|XIAP|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|CAV1|USP18|TRAF3|PPARG|RELA|HMGB3|DHX58|NFKB1|PRKACA|TLR4|S100A8|ITGAM|S100A9|CD14|FAM3A|LY96|SERPING1|PQBP1|SAMHD1|ICAM2
PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035590,0.6842592592592591,0.885659835294458,-0.423072681151428,-0.8261537189584971,5172,3,ANO6|P2RX7|P2RX4
GONADOTROPIN SECRETION%GOBP%GO:0032274,0.665460878885316,0.8804055751124069,0.514644366268995,0.8646689837557601,4966,2,TBX3
REGULATION OF UROTHELIAL CELL PROLIFERATION%GOBP%GO:0050675,0.253244147157191,0.632257972333528,-0.870533745037495,-1.15975997586903,1892,1,FGF10
BRAIN DEVELOPMENT%GOBP%GO:0007420,0.14860335195530702,0.5154128781388279,0.153382619726487,1.18227452108427,1063,245,FOXC1|CNTN4|EFHC1|SCN5A|DRD2|CTNNA2|FGFR2|DLL1|BBS4|SYNGR3|ROGDI|AHI1|FAT4|SLIT1|EPHB2|RTN4|HESX1|PAFAH1B2|WNT2B|ABCB6|TACC2|LAMB1|ROBO2|PTCHD1|NES|CHRNB2|ASCL1|KLHL17|RAB3GAP1|BMP7|TTBK2|CHD5|CTNS|SLIT3|GNB4|CDK5R1|SEMA4C|PCM1|CEP290|YWHAQ|ADCYAP1|ATP7A|HAP1|MBOAT7|ADGRL2|GLUD1|DRAXIN|PEX13|SLC6A17|MKKS|KDM7A|NF1|CA10|ADCK4|MAOB|ATXN1L|SPATA5|CLN5|YWHAE|UTP3|SKI|BBS2|C21orf91|PLXNB2|NNAT|AGTPBP1|METTL14|NR4A2|LRP6|YWHAH|DOCK7|FOXJ1|NLGN4X|SHANK2|PROX1|CDK5RAP3|G6PD|ZDHHC16|SRR|SUDS3|LRP8
IRON ION TRANSPORT%GOBP%GO:0006826,0.00156331422615946,0.0323893370023386,-0.38790491553497203,-1.96744030611466,11,43,TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|ATP6V1F|ATP6V0D1|CLTC|SLC11A1|ARHGAP1|HFE|STEAP4|ATP6V0E1|ATP6AP1|HEPH|ATP6V0E2|TFRC|ATP6V1A|ATP6V1G1|FTH1
POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS%GOBP%GO:0070230,0.218733715476811,0.6013948176405761,-0.409076026374893,-1.23060081787426,1678,9,CD274|FNIP1|ADAM8|PRELID1|LGALS9
ADENYLATE CYCLASE-INHIBITING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071881,0.972107849648028,0.9915747942934481,0.51306793118659,0.684106856515847,7318,1,ADRA2A
REGULATION OF KINETOCHORE ASSEMBLY%GOBP%GO:0090234,0.260145122278957,0.636108539147718,0.608525421859491,1.1968976940733,1935,3,RNF4|SENP6|TRAPPC12
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME%GOBP%GO:1904780,0.26120986999204004,0.637033618828779,-0.7017693815464449,-1.1678564722549198,1968,2,NSFL1C
REGULATION OF CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS%GOBP%GO:1903242,0.7505291005291009,0.914270866779142,-0.397203257456609,-0.775637291060998,5673,3,LMNA
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER BY GALACTOSE%GOBP%GO:0000435,0.988311860804888,0.996030692679047,0.505513895015439,0.6740345685692951,7440,1,NCOA1
PROTEIN GLYCOSYLATION%GOBP%GO:0006486,0.686853359084012,0.8861361847538001,0.125098882565241,0.894144691760111,4978,164,GALNT3|GALNT8|GALNTL6|MGAT5|GALNT12|UGGT2|POMGNT1|SERP2|ST8SIA2|B3GNT9|B3GNT2|B4GALT5|GALNT7|B3GALNT2|ALG12|TUSC3|PMM1|DPAGT1|B3GNT7|MGAT5B|MOGS|TET2|GALNT14|GALNT6|GALNT2|GALNT9|SDF2|LARGE|FUT2|MPDU1|TET3|DPY19L3|ST3GAL4|ST3GAL6|ALG11|DPY19L1|GALNT15|PGM3|DHDDS|EOGT|DPY19L2|TRAK1|OST4|COG3|PMM2|MUC1|GFPT1|ALG13
NEGATIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0002890,0.679492213061118,0.884536278926676,-0.37501090891704003,-0.8209772709837858,5191,4,NDFIP1|FCGR2B
L-LYSINE TRANSPORT%GOBP%GO:1902022,0.61322884845265,0.852045339927398,0.690174239082488,0.920254220635019,4616,1,SLC25A29
DNA-DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY%GOBP%GO:0045005,0.53336084743431,0.812079525085925,0.188888627842511,0.948861622909894,3876,40,ZRANB3|ETAA1|SMARCAL1|WRN|BRCA2|MRE11A|PRIMPOL|BOD1L1|FBXO18|MCM9|RTEL1|APITD1
MAMMARY GLAND BUD FORMATION%GOBP%GO:0060615,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT%GOBP%GO:0072239,0.00863761287789556,0.11593697760655802,-0.7875696244416259,-1.72415453953327,65,4,CD34|PDGFRB|PDGFRA|PDGFB
COENZYME BIOSYNTHETIC PROCESS%GOBP%GO:0009108,0.0046159764072317,0.0752560935123842,-0.24767932072242999,-1.6567553946357803,35,126,NDUFA9|DCAKD|GPI|COASY|ACSL4|PFKFB2|ELOVL2|HK1|PDHA1|ACSF3|KYNU|HK3|ELOVL1|COQ6|HAAO|ENO1|SLC25A16|PGAM1|DHFR|MOCS2|RFK|GAPDH|COQ7|HACD2|PDSS1|LDHA|PDHX|PNPO|NMNAT3|PNP|PGK1|GPHN|FASN|QPRT|PDXK|NNMT|ALDOA|COQ3|ALDOC|MTHFD1|PTGIS
NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS%GOBP%GO:0033033,0.8727513227513229,0.9589089534986172,-0.345249953392933,-0.674185655735424,6597,3,IRF7
PEPTIDYL-LYSINE DEMALONYLATION%GOBP%GO:0036047,0.342143710984194,0.701955655133333,0.829234671371857,1.1056725432715602,2575,1,SIRT5
REGULATION OF T-HELPER 17 TYPE IMMUNE RESPONSE%GOBP%GO:2000316,0.577633007600434,0.83729927068764,0.27371051302048394,0.9006756570750301,4255,11,LOXL3|NFKBID
T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL%GOBP%GO:0002291,0.563279384452109,0.8287553203546,-0.574083264405845,-0.955366354787634,4245,2,ITGAL|ICAM1
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL-MATRIX ADHESION%GOBP%GO:2000098,0.194746617139825,0.569626484656312,-0.7368624207333891,-1.22625690126089,1467,2,APOD|SERPINE1
NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS%GOBP%GO:0070874,0.411836568481064,0.746217222167933,0.39610021032661996,1.02493257511337,3033,6,INPP5K|PASK|VIMP
TETRAPYRROLE METABOLIC PROCESS%GOBP%GO:0033013,0.682863789092789,0.885415243771438,-0.17490976476292996,-0.8497022091162671,5283,37,ABCD4|TSPO|BLVRA|HPX|ATPIF1|NFE2L1|ALAD|HMOX1|FXN|MMAB|BLVRB|ABCC1
L-SERINE BIOSYNTHETIC PROCESS%GOBP%GO:0006564,0.7329404060248851,0.9078024129966441,-0.30268233813997397,-0.7785805121123679,5595,6,SERINC3|PHGDH|SERINC5
REGULATION OF IRON ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034759,0.30327759197324394,0.6762596203943579,-0.8448941332157042,-1.12560185648854,2266,1,HAMP
POSITIVE REGULATION OF MITOTIC SPINDLE ORGANIZATION%GOBP%GO:0110028,0.982876254180602,0.993436724391485,-0.508601676224085,-0.677579555194827,7346,1,NUMA1
PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE%GOBP%GO:0044743,0.3870716510903429,0.7337790308730731,-0.214452292275156,-1.04952031505576,2981,38,TIMM21|ROMO1|PEX16|TIMM9|TIMM17B|TIMM10|DNAJC19|DNAJC15
REGULATION OF B CELL ACTIVATION%GOBP%GO:0050864,0.000638488060273273,0.0163600882996276,-0.321513075263208,-1.96019157722034,4,84,SYK|IGHV2-26|NFATC2|IGHV1OR15-1|MNDA|TGFB1|CD38|IGHV5-51|SLA2|LYN|GPR183|NDFIP1|TNFSF13B|IGHV1-24|NCKAP1L|VAV3|CD74|SAMSN1|SLAMF8|IGHV3-49|ZFP36L1|IGHG4|IGLL5|PAXIP1|AHR|FCGR2B|TNFAIP3|MZB1|IGHV4-4|INHBA|IGHV4-61|MEF2C|IGHV1-3|MMP14|BST1|IGHV3-43|TNFRSF4|IGHV3-73|TNFSF13|CD300A|TNFRSF21|IGHV3-15|IGHV1-18|IGHG2|TFRC|IGHA1|CD81
NEGATIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0043154,0.00334405144694534,0.0597420021713719,-0.347167449936219,-1.8824413533852402,25,54,FNIP1|RPS6KA1|TRIAP1|IGBP1|KLF4|HGF|NGF|GAS6|GPX1|DDX3X|SIAH2|CAAP1|PARK7|DPEP1|CARD16|IFI6|NAIP|USP47|PLAUR|THBS1|XIAP|MMP9|BCL2L12|ARL6IP1|NGFRAP1|DHCR24|NGFR
POSTERIOR COMPARTMENT SPECIFICATION%GOBP%GO:0007388,0.781245849382388,0.925413955483995,0.6092302602558449,0.8123263468719609,5881,1,PBX3
POLYAMINE ACETYLATION%GOBP%GO:0032917,0.16250994958875,0.5335700386874099,-0.756878963330576,-1.2595676290284399,1224,2,SAT1|SAT2
CELLULAR RESPONSE TO LEPTIN STIMULUS%GOBP%GO:0044320,0.037431693989071,0.27552986478542,0.561155412926396,1.62893599180019,273,8,BBS4|MKKS|LEPR|NR4A3|BBS2|GCK|SIRT1
MEIOSIS II%GOBP%GO:0007135,0.7319131832797429,0.9074802896081321,0.481555004135649,0.8090745830312571,5462,2,BUB1|BUB1B
TRNA CATABOLIC PROCESS%GOBP%GO:0016078,0.16048895899053603,0.530616420411713,-0.48395919618232897,-1.32288088091212,1220,7,EXOSC7|POP1|SLFN13|EXOSC3|EXOSC2
REGULATION OF LYSOSOMAL MEMBRANE PERMEABILITY%GOBP%GO:0097213,0.534732368176385,0.8126734651160049,0.731087340097045,0.9748063203163481,4025,1,LAPTM4B
HISTONE H4-K20 TRIMETHYLATION%GOBP%GO:0034773,0.786027360871298,0.9274485629622209,0.606638729598588,0.8088708904231429,5917,1,BEND3
MITOCHONDRIAL MEMBRANE FISSION%GOBP%GO:0090149,0.7454448017148979,0.91143284454225,0.47572509681748204,0.799279586006933,5563,2,DNM1L
MEMBRANE FISSION%GOBP%GO:0090148,0.41229508196721293,0.7466395683388759,0.354685357544758,1.02958954214874,3017,8,MX2|DNM1L|SH3GLB1|SPAST
POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION%GOBP%GO:0070131,0.578819068255688,0.8381193804335091,0.24415967462767998,0.9006043932580391,4273,15,RMND1|RPUSD4|FASTKD2|C1QBP|UQCC1
REGULATION OF EIF2 ALPHA PHOSPHORYLATION BY AMINO ACID STARVATION%GOBP%GO:0060733,0.5390023879013,0.8142313733497609,-0.583733112765371,-0.97142524558466,4062,2,EIF2AK4|IMPACT
TELOMERASE RNA STABILIZATION%GOBP%GO:0090669,0.37704488941238107,0.727766947967183,-0.492196122434039,-1.07752019948329,2880,4,DHX36|DKC1
CHOLESTEROL ESTER HYDROLYSIS INVOLVED IN CHOLESTEROL TRANSPORT%GOBP%GO:0090122,0.515183946488294,0.803478510349408,-0.745037494486105,-0.9925688367077741,3850,1,CES1
IMMUNOGLOBULIN TRANSCYTOSIS IN EPITHELIAL CELLS%GOBP%GO:0002414,0.638929765886288,0.865463150027443,-0.684384649316277,-0.911764683334583,4775,1,FCGRT
NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION%GOBP%GO:0044828,0.807785888077859,0.9340694101701871,0.302404615089268,0.727281365147086,5975,5,PARK2|VAPA|EIF2AK4|ZC3H12A
POSITIVE REGULATION OF NEUROTROPHIN PRODUCTION%GOBP%GO:0032901,0.284898392880861,0.6580477384239799,0.860222761358624,1.1469909799574098,2144,1,HAP1
REGULATION OF GLYCOLYTIC PROCESS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072361,0.807110639426904,0.933810206759044,-0.457219094794323,-0.7608856885682571,6083,2,PPARA
PURINE NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0034032,0.852233676975945,0.949296218452153,-0.12428043111973598,-0.762754247168462,6695,86,DGAT1|CROT|ACSL5|ABHD14B|ACOT1|ACSF2|DCAKD|FAR1|COASY|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|SLC26A2|TPST2|HMGCS1|HACD2|ACOT2|PDHX|ABCD1|SULT1A4|FASN
PEROXISOME MEMBRANE BIOGENESIS%GOBP%GO:0016557,0.14943143812709,0.51590227091171,-0.92286060873401,-1.2294719227337199,1116,1,PEX16
CREATINE BIOSYNTHETIC PROCESS%GOBP%GO:0006601,0.435924648447864,0.7625803425525591,-0.624658238763667,-1.03953119966552,3285,2,GATM
MAINTENANCE OF TRANSCRIPTIONAL FIDELITY DURING DNA-TEMPLATED TRANSCRIPTION ELONGATION%GOBP%GO:0001192,0.8908361204013381,0.965159112268525,-0.55690339655933,-0.741929044608386,6658,1,POLR2I
SNRNA (ADENINE-N6)-METHYLATION%GOBP%GO:0120049,0.92070660114225,0.9768961564057891,0.540251433612704,0.720352389053441,6931,1,METTL16
MALATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0071423,0.937248051599033,0.9806508984207809,0.308320575209864,0.6064301872161519,6974,3,SLC25A30|SLC25A14
REGULATION OF MYELOID CELL DIFFERENTIATION%GOBP%GO:0045637,0.00114957210371695,0.0260082836197492,-0.258087565946097,-1.7801091368684399,8,145,TNRC6A|CREBBP|HIST1H4H|TNF|RBBP5|BGLAP|ZNF675|PRMT1|ACIN1|TGFB1|HOXA5|LILRB1|LYN|CDK6|NDFIP1|NCKAP1L|CD74|RUNX1|HMGB2|ZFP36L1|CD4|HCLS1|MED1|FES|GP1BA|LILRB3|IL34|TCTA|TESC|INHBA|MEF2C|STAT3|HSPA9|TAL1|HIST1H4I|HAX1|SETD1A|FBN1|CTR9|NOTCH2|RBM15|IRF7|CEBPB|TNRC6C|MAFB|WDR5|C1QC|CSF1|CEACAM1|HIST2H3A|SPI1|CCR1|RAB7B|KAT2B|LGALS3|THBS1|FADD|FOXP1|HIST2H4A|MYC|ATP6AP1|HIST2H3C|TLR4|ZNF16|HIST1H3H|LILRB4|HIST2H4B|H3F3B|MYL9|PRKCB
ERYTHROSE 4-PHOSPHATE/PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:1902221,0.6316063525123671,0.8616028929314681,-0.29673460949619396,-0.8542574096329041,4851,8,IL4I1|ASRGL1
MORPHOGENESIS OF EMBRYONIC EPITHELIUM%GOBP%GO:0016331,0.23038009297238196,0.6131990870645471,0.245083605722826,1.18792372471027,1684,35,FGFR2|BBS4|TSC2|PAX8|BMP7|SEMA4C|DVL2|MTHFR|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10
RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES%GOBP%GO:0000712,0.0274509803921569,0.23409664586741,-0.504512494443431,-1.68865055721461,209,12,TOP2A|STRA13|EME1|RMI1|FANCM|MUS81
MRNA CLEAVAGE INVOLVED IN GENE SILENCING BY SIRNA%GOBP%GO:0090625,0.22075804917810102,0.603022518406817,0.562358217763578,1.23552495393529,1624,4,AGO2|AGO3|AGO1|AGO4
REGULATION OF MONOCYTE AGGREGATION%GOBP%GO:1900623,0.9287245444801719,0.9793746057014829,0.36598053792709706,0.614894557377523,6931,2,NR4A3|CD44
POSITIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING%GOBP%GO:2001034,0.577395577395577,0.8371780911616321,0.294640579068505,0.895385545090898,4229,9,RIF1|WRAP53|MAD2L2|FAM35A|C20orf196
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:1905460,0.0372777925179093,0.27499221464993107,-0.8766473669699479,-1.4588814050921002,280,2,DNMT1|IGF1
G PROTEIN-COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007213,0.55166802278275,0.8225828340810141,0.256381386754064,0.9215298312271071,4067,14,CHRM4|AGRN|CDK5R1|HRH3|CHRM3|RGS10|GNA11|CHRM1|GNB1
INSULIN-LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048009,0.978569478569479,0.992937328049893,0.171910706109777,0.522420780544541,7168,9,TSC2|IGF1R|EIF2AK3
REGULATION OF INTERLEUKIN-1-MEDIATED SIGNALING PATHWAY%GOBP%GO:2000659,0.718572587185726,0.9003087166275391,0.328370465993063,0.7897290876692541,5315,5,OTUD4|VRK2
REGULATION OF HOMOPHILIC CELL ADHESION%GOBP%GO:1903385,0.321978913219789,0.69008577479396,0.462682509790576,1.1127487827883702,2381,5,PTPRR|TENM3|PTPRG
POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002863,0.267504253369978,0.6417330323279019,-0.543873087427406,-1.1906518782803,2043,4,HLA-E|PARK7|ZP3
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC G2 DNA DAMAGE CHECKPOINT%GOBP%GO:0072434,0.23973967326338197,0.623187683081912,0.881947507719453,1.1759579978475,1804,1,ATM
CHOLESTEROL HOMEOSTASIS%GOBP%GO:0042632,0.0161542470036477,0.17282331048282298,-0.33038763301732105,-1.67571463987157,123,43,FABP3|ABCG1|EHD1|CETP|MALL|APOM|NR1H3|LRP5|APOE|CYP7B1|NR1D1|TMEM97|CAV1|LDLR|NPC2|INSIG1
HISTONE H3-K36 TRIMETHYLATION%GOBP%GO:0097198,0.887090301003345,0.965013712426871,-0.5586127040141159,-0.7442062525670851,6630,1,SETD2
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE RELAXATION%GOBP%GO:0086030,0.151438127090301,0.518496345408823,-0.922088663431848,-1.22844350623624,1131,1,CHGA
POSITIVE REGULATION OF LYS63-SPECIFIC DEUBIQUITINASE ACTIVITY%GOBP%GO:1903007,0.3458193979933111,0.7033175795366851,-0.82399647110719,-1.09776115273542,2584,1,VCP
IRON CHELATE TRANSPORT%GOBP%GO:0015688,0.12066889632107,0.472686039512467,-0.9379135421261581,-1.24952604443452,901,1,SLC22A17
NEGATIVE REGULATION OF FC-GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:1905450,0.280401337792642,0.6535857220526321,-0.856693868548743,-1.14132193723569,2095,1,CD47
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CAJAL BODY%GOBP%GO:1904871,0.274622199062011,0.649047934290704,-0.38757950694736804,-1.16593402568068,2107,9,CCT7|CCT3|CCT8|CCT5|DKC1
REGULATION OF MELANOSOME ORGANIZATION%GOBP%GO:1903056,0.638730243060167,0.865463150027443,0.6783193647992939,0.9044473453904301,4808,1,ZEB2
POSITIVE REGULATION OF DNA METHYLATION%GOBP%GO:1905643,0.0409923056513664,0.289869160500546,-0.8699200441135929,-1.44768606407931,308,2,MECP2|MYC
POSITIVE REGULATION OF RYANODINE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0060316,0.259473259876377,0.636098664976652,0.609060248572849,1.19794963510477,1930,3,GSTM2|GSTO1|AKAP6
CROSS-RECEPTOR INHIBITION WITHIN G PROTEIN-COUPLED RECEPTOR HETERODIMER%GOBP%GO:0038041,0.342940629565679,0.701955655133333,0.829124393471548,1.10552550257161,2581,1,RAMP3
AUTOPHAGOSOME ORGANIZATION%GOBP%GO:1905037,0.650437918598661,0.8720434729248241,-0.162643451761645,-0.877879145532967,5049,53,RAB7A|ATG13|WDR45B|ATG2A|WDR45|TMEM41B|UBQLN1|ATG101|WIPI1|NSFL1C|ATG3|AMBRA1|ATG4A|VMP1
HEMATOPOIETIC STEM CELL MIGRATION TO BONE MARROW%GOBP%GO:0097241,0.746749801008225,0.911925817165146,-0.49374541430929797,-0.82167132523883,5628,2,GAS6
PHOSPHATIDYLINOSITOL-MEDIATED SIGNALING%GOBP%GO:0048015,0.665108427476951,0.8804055751124069,-0.16774417956318802,-0.8622628873571421,5121,45,PIK3C2A|ZFP36L1|PIK3R6|NGF|GATA3|OGT|IRS1|PIK3CB|IGF1|ZP3|PDGFRB|PTAFR|RPS6KB1|CSF1R|PDGFRA
REGULATION OF MYELOID DENDRITIC CELL ACTIVATION%GOBP%GO:0030885,0.5417989417989421,0.815622645995152,-0.483912294240125,-0.944958063584173,4095,3,HAVCR2
EPOXIDE METABOLIC PROCESS%GOBP%GO:0097176,0.4744105037513401,0.784493405697755,0.603143093465674,1.0133582719793799,3540,2,EPHX2|EPHX1
POSITIVE REGULATION OF INTERFERON-GAMMA PRODUCTION%GOBP%GO:0032729,0.0232831916285154,0.21209732484039803,-0.35846087592024,-1.63666218112259,177,30,HLA-DPA1|CEBPG|PYCARD|IL18|HLA-DPB1|EBI3|PDE4B|PDE4D|SLC11A1|LGALS9|ZP3|FADD|IL1R1|TLR4|CD14
REGULATION OF GLUCOKINASE ACTIVITY%GOBP%GO:0033131,0.551498494961392,0.8225294105777758,-0.418042532556409,-0.9151824903558579,4213,4,BAD
LEAD ION TRANSPORT%GOBP%GO:0015692,0.74943143812709,0.913740267011908,-0.630513895015439,-0.8399959034749399,5601,1,SLC11A2
REGULATION OF BODY FLUID LEVELS%GOBP%GO:0050878,0.000127226463104326,0.00518555396908895,-0.277839796269365,-2.14380137964535,0,266,RAD51C|CD34|ITPR3|RAP2B|GPI|VAV1|GATA3|WAS|TLN1|PRCP|GP1BA|P2RX5|PLAU|PLEK|GP1BB|P2RX3|OAS2|GAS6|VTN|AKAP1|ILK|PLSCR1|FLI1|ADCY8|VWF|PRKAR1A|DOCK6|PTPN6|SH2B3|ARRB1|FCER1G|F3|DGKE|EHD1|PIK3CB|F8|FGF10|MAPK3|ADCY4|HSPB1|FLNA|VAMP8|FAP|NR1H3|MYL12A|RAD51B|DOCK1|GNAQ|CEACAM1|HIST2H3A|THBD|PDPN|NPR1|F2R|APOE|PLAUR|GATA6|NOS3|GNA15|CD36|SERPINE2|A2M|F2RL3|THBS1|F13A1|COL1A2|COL1A1|VCL|ITPK1|COL3A1|CD59|SERPINE1|CAV1|PLAT|MYH9|HIST2H3C|FIBP|ENPP4|PRKACA|TLR4|FERMT3|HIST1H3H|PDGFA|ANXA2|ACTB|PDGFRA|TFPI|H3F3B|ACTN1|SERPING1|MYL9|EHD2|VKORC1|PDGFB|FBLN1|SERPINF2|PRKCB|ADCY9|EMP2|C1QTNF1
NEGATIVE REGULATION OF ACTION POTENTIAL%GOBP%GO:0045759,0.0358646922972422,0.268987198588135,0.723571694041998,1.5897178270203,263,4,BIN1|CHRNB2|SUMO1|KCNE3
TRANSPOSITION%GOBP%GO:0032196,0.41881028938906795,0.75036705317022,0.628618693134822,1.05616056871136,3125,2,THAP9|PGBD5
POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION%GOBP%GO:0035307,0.36809176225234597,0.721642468110297,-0.229346700596397,-1.0668304421041601,2823,32,HSP90AB1|AKAP6|CDCA2|ITGA1|MAGI2|PPP1R15B|PPP1R15A|DUSP26|GBA|SPPL3|PPP1R7|TGFB1|PTBP1|LILRB2|NSMF|PPP2R4|CD300A|DLC1|PDGFRB|SMPD1
SUPEROXIDE METABOLIC PROCESS%GOBP%GO:0006801,0.0857405462184874,0.405352322559055,-0.35725466414268203,-1.4332988698868998,652,20,SOD3|CYBB|SOD1|NCF4|CCS|NOXA1|NCF2|NOS3
MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN RENAL SYSTEM DEVELOPMENT%GOBP%GO:2001012,0.25817256162915303,0.636098664976652,0.7043939808375721,1.18347283579541,1926,2,WNT4|STAT1
DTDP BIOSYNTHETIC PROCESS%GOBP%GO:0006233,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CONTACT INHIBITION%GOBP%GO:0060243,0.44147157190635494,0.7653693162885199,-0.7807675341861491,-1.0401698288767098,3299,1,CDHR2
MUSCLE ORGAN MORPHOGENESIS%GOBP%GO:0048644,0.139312483845955,0.504314492208813,-0.267696674491347,-1.3004560151154199,1077,37,SMAD4|TGFBR1|BMP4|SMAD7|TBX20|DLL4|TGFB2|NRG1|TGFB1|TNNT2|TBX1|ZFPM2|RYR2|MYOM1|MYLK2|MYLK|NOTCH1|S1PR1|PKP2|BMP2|TGFBR3|IGSF22|FKBP1A|ENG
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION%GOBP%GO:0010822,0.869085833914864,0.9566976576317809,0.118792910713971,0.7647895829782858,6226,102,MFF|MIEF2|PARK2|BBC3|HTRA2|HRK|MARCH5|BOK|PMAIP1|HPS4|DNM1L|HTT|CASP8|TP53BP2|BID|YWHAQ|SH3GLB1|YWHAB|VPS35|FBXO7|YWHAE|ZNF205|VPS11|BAX|BCL2|YWHAH
COPI COATING OF GOLGI VESICLE%GOBP%GO:0048205,0.00654878847413229,0.0957322763119865,-0.717002051608922,-1.8443224271286598,49,6,ARFGAP2|TMED2|TMED10|TMED9
OTIC VESICLE FORMATION%GOBP%GO:0030916,0.0655737704918033,0.367999733349629,0.7478217712584101,1.47087717529026,487,3,FGFR2|CEP290|PROX1
CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0035787,0.849765886287625,0.949296218452153,-0.578242170269078,-0.7703574149315,6351,1,VANGL2
POSITIVE REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032079,0.634733673602932,0.8634223229282929,-0.390172613467159,-0.854169411609681,4849,4,PRKCD|DDX11|RPS3|AKT1
ACTIVATION OF JANUS KINASE ACTIVITY%GOBP%GO:0042976,0.174415479709755,0.54811765844537,0.655178118451528,1.2886580428894299,1297,3,PIBF1|PTK2B|JAK2
NEGATIVE REGULATION OF PROTEIN GLYCOSYLATION IN GOLGI%GOBP%GO:0090285,0.42637304324754605,0.755007255274521,-0.628471463164717,-1.0458770148493002,3213,2,TMEM59
NEUROMUSCULAR PROCESS CONTROLLING BALANCE%GOBP%GO:0050885,0.4146690984887961,0.748894797291058,-0.340499279728785,-1.0243051782649202,3182,9,CLN3|PCDH15|CDH23|MYO7A|TPP1|AARS
NEGATIVE REGULATION OF GLYCOGEN (STARCH) SYNTHASE ACTIVITY%GOBP%GO:2000466,0.28500403117441603,0.6581081651254179,0.5962472343999909,1.1727479482619099,2120,3,INPP5K|GSK3A
REGULATION OF NIK/NF-KAPPAB SIGNALING%GOBP%GO:1901222,0.005154639175257729,0.0808389956263668,-0.307822497221177,-1.7552650178375102,39,65,TNFRSF10A|TLR2|TNFRSF10B|TRIP6|TRIM44|C8orf4|TRAF2|ILK|ADIPOR1|IRAK1|BCL3|NLRP3|NFKBIA|SASH1|NOV|LGALS9|ZFP91|RELA|TLR4|C1QTNF4|TMSB4X|CD14|SPHK1|CARD10|PTP4A3
BLASTODERM SEGMENTATION%GOBP%GO:0007350,0.5923222492565561,0.8417378833576942,0.36517068898500005,0.878233412933578,4381,5,TBX3|FZD5|HOXD8|PLD6|BASP1
FORMATE METABOLIC PROCESS%GOBP%GO:0015942,0.522240085744909,0.807051143864932,0.581919775021278,0.977700356739225,3897,2,MTHFD1L|MTHFS
CHOLESTEROL EFFLUX%GOBP%GO:0033344,0.208442579968537,0.588579295287117,-0.3483903193435539,-1.23255400342729,1589,14,APOC2|ABCA5|APOC1|ABCG1|APOM|APOE|NPC2
REGULATION OF STORE-OPERATED CALCIUM ENTRY%GOBP%GO:2001256,0.6890722207195021,0.887051934478962,0.291131740376722,0.803661354877234,5094,7,HOMER2|HOMER3|HOMER1|SARAF
SARCOSINE METABOLIC PROCESS%GOBP%GO:1901052,0.720084903157336,0.9010446604600408,-0.507692307692308,-0.8448811861040959,5427,2,SARDH|GNMT
REGULATION OF RETINOIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:1900052,0.77991765174658,0.924704689181848,0.609726510807234,0.8129880300217339,5871,1,AKR1C3
MATERNAL BEHAVIOR%GOBP%GO:0042711,0.78801965732501,0.927797067038212,0.6056462284958101,0.807547524123596,5932,1,OXTR
REGULATION OF WATER LOSS VIA SKIN%GOBP%GO:0033561,0.38010273046769394,0.729249457747391,0.438004420043638,1.05339811846377,2811,5,MET|STMN1|TMEM79|CLDN4
NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051045,0.577327722251447,0.837152999580265,-0.373471618201116,-0.8951402038838829,4389,5,TIMP3|TIMP1
TERPENOID TRANSPORT%GOBP%GO:0046865,0.0193916854827998,0.19226875441368102,0.990681517423908,1.32094012799787,145,1,STRA6
POSTSYNAPSE ORGANIZATION%GOBP%GO:0099173,0.380321910695742,0.729416463582188,-0.215584351721876,-1.05506056540505,2929,38,ARF1|APOE|TMEM108|ACTB|NRXN2|LGMN|GPHN|PRNP
TERMINATION OF RNA POLYMERASE III TRANSCRIPTION%GOBP%GO:0006386,0.238795986622074,0.622138010410922,-0.877812086457874,-1.16945647427381,1784,1,POLR3K
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035025,0.0380677343134681,0.278462786203774,-0.439486182299914,-1.59570308775848,289,15,GPR35|ROBO1|RAC1|LPAR6|ARRB1|F2R|F2RL3|COL3A1|GPR4|ADGRG1
NEGATIVE REGULATION OF INTERFERON-BETA PRODUCTION%GOBP%GO:0032688,0.634152719665272,0.863354277348854,-0.273112874456061,-0.855626983394664,4849,10,LILRB1|PYCARD|YY1|RELB|SIRPA
MAINTENANCE OF SYNAPSE STRUCTURE%GOBP%GO:0099558,0.5044342918570279,0.797795146880088,0.48670878582817895,0.957298746308533,3753,3,DCTN1|RAB3A|CHCHD10
POSITIVE REGULATION OF B CELL ACTIVATION%GOBP%GO:0050871,0.00375550375550376,0.0657451349840356,-0.331385170728828,-1.84101366158299,28,59,SYK|IGHV2-26|NFATC2|IGHV1OR15-1|TGFB1|CD38|IGHV5-51|GPR183|TNFSF13B|IGHV1-24|NCKAP1L|VAV3|CD74|IGHV3-49|IGHG4|IGLL5|PAXIP1|IGHV4-4|IGHV4-61|MEF2C|IGHV1-3|MMP14|BST1|IGHV3-43|TNFRSF4|IGHV3-73|TNFSF13|IGHV3-15|IGHV1-18|IGHG2|TFRC|IGHA1|CD81
N-ACETYLNEURAMINATE METABOLIC PROCESS%GOBP%GO:0006054,0.23326359832635998,0.617203778859697,-0.387805305728296,-1.2149433985695601,1783,10,GNPDA1|NANP|ST3GAL1|GNE|NPL|RENBP
PROTEIN N-LINKED GLYCOSYLATION VIA ARGININE%GOBP%GO:0042543,0.33819397993310996,0.6998037279675999,-0.827911336568152,-1.10297669354405,2527,1,KRTCAP2
PLASMA LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0034381,0.00965175427155341,0.12526857562006,-0.40825366845003797,-1.8005981292576398,73,27,AP2A2|MSR1|APOC1|CLTA|APOBR|CLTC|EHD1|APOM|HMOX1|APOE|CD36|LDLR|NPC2|AP2M1
REGULATION OF GLYCOGEN CATABOLIC PROCESS%GOBP%GO:0005981,0.651851851851852,0.8731445752577829,-0.43615222875866294,-0.8516947604377142,4927,3,PHKG2|INS
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS%GOBP%GO:0002698,0.0046391752577319605,0.0752560935123842,-0.318073007103193,-1.7912892774050302,35,62,TGFB2|FOXP3|TNF|JAK3|SERPINB9|MICA|TGFB1|MUL1|LILRB1|HLA-E|NDFIP1|SEC14L1|IRAK3|SLAMF8|CD84|FCGR2B|TGFB3|INS|RC3H2|CD47|IFIT1|NPLOC4|CEACAM1|CD300A|HFE|LGALS3|A2M|BST2|LGALS9|HAVCR2|DHX58|ANXA1|CD55|SERPING1|RNF26
ESCRT III COMPLEX ASSEMBLY%GOBP%GO:1904902,0.134715719063545,0.496974190065009,-0.9317379797088661,-1.2412987124547,1006,1,CHMP6
HISTAMINE SECRETION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002441,0.4486651613760129,0.768229288546963,0.7769078076753421,1.03590173114544,3377,1,SNAP23
NEGATIVE REGULATION OF CENTRIOLE-CENTRIOLE COHESION%GOBP%GO:1903126,0.613913043478261,0.852182158593687,-0.696515218350243,-0.9279255140092209,4588,1,NEK2
SCHWANN CELL PROLIFERATION%GOBP%GO:0014010,0.0654180602006689,0.36737487113709005,-0.9653727393030441,-1.2861082884162,488,1,NF2
NEGATIVE REGULATION OF ACTIN BINDING%GOBP%GO:1904617,0.323947403373622,0.692691148776056,0.83756065284517,1.11677411611776,2438,1,CRMP1
RHYTHMIC BEHAVIOR%GOBP%GO:0007622,0.28934340802501296,0.662218930390028,-0.38159360730658504,-1.14792697437792,2220,9,MTA1|PTEN|ID2|USP2|CIART
POSITIVE REGULATION OF HETEROCHROMATIN ASSEMBLY%GOBP%GO:0031453,0.895498392282958,0.9663983366739259,0.393548387096774,0.661212103411667,6683,2,TPR|SIRT6
ENTRAINMENT OF CIRCADIAN CLOCK BY PHOTOPERIOD%GOBP%GO:0043153,0.0324615586805099,0.256976994889065,-0.411935059799538,-1.6275169911157301,246,19,MTA1|ID2|PML|PER2|BHLHE40|USP2|CRY2|RBM4B|SIK1|RBM4|PPP1CA
AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086053,0.920988981456598,0.976910172414188,0.318133109084731,0.6257302833928361,6853,3,GJC3|GJC1|GJA5
ATP HYDROLYSIS COUPLED CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:0099132,0.24801587301587302,0.62852193925262,-0.6148671004742471,-1.20067960980021,1874,3,ATP6V1H|ATP1A1|ATP1A3
LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032802,0.247133923918708,0.6280519349499749,-0.39719594228864497,-1.19486261702562,1896,9,AP2A2|CLTA|CLTC|MYLIP|AP2M1
REGULATION OF MITOTIC SPINDLE ASSEMBLY%GOBP%GO:1901673,0.9450836820083679,0.9828952916990891,-0.15151486083367302,-0.587934009921039,7227,18,CHMP1B|CEP97|STAG1|CHMP5|CCSAP|HNRNPU|STAG2|PLK1|SMC1A
MITOCHONDRIAL TRANSCRIPTION%GOBP%GO:0006390,0.746599564744287,0.911868716700273,0.22926370763072898,0.779222750000087,5488,12,FOXO3|C10orf2|MTERF4|TFB2M|MTERF2|POLRMT|MTERF3|MTERF1|TEFM
PROPRIOCEPTION%GOBP%GO:0019230,0.6176119006508171,0.854920652514057,0.687968681076312,0.9173134066360259,4649,1,TMEM150C
SPHINGOMYELIN BIOSYNTHETIC PROCESS%GOBP%GO:0006686,0.954974100146102,0.9870204197558861,0.523213498014998,0.697634600911217,7189,1,SAMD8
AUTOPHAGY%GOBP%GO:0006914,0.360251636923867,0.7155384949577859,-0.149943320049092,-1.05196923973274,2805,159,SEC23A|ATG2A|WDR45|TMEM41B|UBQLN1|DYNLL2|ATG101|WIPI1|VAMP8|VAMP7|PIK3R4|VPS25|NSFL1C|CHMP4A|SNF8|CHMP6|LAMP2|PLAA|VPS51|S100A8|ATG3|S100A9|HSP90AA1|MARK2|AMBRA1|FUNDC2|VPS37C|ATG4A|SQSTM1|VMP1|ITGB4
NEGATIVE REGULATION OF BRANCH ELONGATION INVOLVED IN URETERIC BUD BRANCHING%GOBP%GO:0072096,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:1903726,0.41629783910440005,0.7493091022753771,-0.35607675952917606,-1.0250951540244,3197,8,DAB2IP|APOC1|PDGFA|PDGFB
POSITIVE REGULATION OF MITOPHAGY%GOBP%GO:1901526,0.392750879091155,0.737280445732591,0.37937120794263707,1.04724403660718,2903,7,PARK2|HDAC6|OPTN|MFN2|PINK1|TOMM7|VPS13D
CILIARY BASAL BODY ORGANIZATION%GOBP%GO:0032053,0.696736534889891,0.8910845435409291,-0.5182244279018471,-0.862408318345422,5251,2,RTTN|CCP110
RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0009991,0.144576770393136,0.511354191031423,-0.166138862773788,-1.2033446125498202,1128,187,RRAGA|P2RX4|DCTPP1|GIPR|TMBIM6|SGIP1|OGT|LARP1|P2RX3|HLCS|GAS6|WDR45B|POSTN|GRIN1|KYNU|NUDT1|POMC|SST|PDXP|WDR45|PRKD1|BCAS3|CDKN2B|ENSA|WIPI1|MAPK3|PIM1|SPP1|GHRL|USF2|RNF152|IFI16|RPTOR|GNAI2|PIK3R4|WDR24|APOE|SLC27A4|CCRN4L|NIM1K|EIF2S1|LDLR|FAM107A|LAMP2|PPARG|PPARA|SIK1|HSPA5|ALPL|RRP8|FADS1|EIF4G1|RRAGD
NEUROPEPTIDE CATABOLIC PROCESS%GOBP%GO:0010813,0.331122313611037,0.6957352559323989,-0.66942376619796,-1.11402819586225,2495,2,ECE1|CTSH
RENAL PROTEIN ABSORPTION%GOBP%GO:0097017,0.17632107023411397,0.548366806412612,-0.9091310101455671,-1.21118080074288,1317,1,GSN
NEUTROPHIL MEDIATED CYTOTOXICITY%GOBP%GO:0070942,0.378060200668896,0.7281989978224692,-0.8093295103661229,-1.07822123928336,2825,1,AZU1
TERPENOID CATABOLIC PROCESS%GOBP%GO:0016115,0.45940514469453403,0.7735063645065241,0.609760132340778,1.02447575165002,3428,2,CYP26B1|AKR1C3
URINARY BLADDER SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014832,0.386903971310931,0.733589579210772,0.808061314512572,1.07744072888122,2912,1,KCNMA1
REGULATION OF T-HELPER CELL DIFFERENTIATION%GOBP%GO:0045622,0.370010504201681,0.7226447402424641,-0.264524977453845,-1.06126914298319,2817,20,MYB|IL12RB1|SMAD7|MALT1|ZC3H12A|RARA|FOXP3|JAK3|NFKBIZ|IL18|CCL19|RC3H2|CD86|NLRP3|ANXA1
SENSORY PERCEPTION OF CHEMICAL STIMULUS%GOBP%GO:0007606,0.298660895441634,0.671387424531401,0.282787234575377,1.12743987186065,2207,19,DRD2|BBS4|ASIC1|ADCY3|TAS2R5|MKKS
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY%GOBP%GO:0002715,0.474865467909175,0.7849333280810301,-0.24077253064005602,-0.980909023471428,3617,21,PVR|SERPINB9|MICA|NCR3|LILRB1|HLA-E|PIK3R6|PVRL2|CEACAM1|HFE|LGALS9
NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0090032,0.61005291005291,0.850714570847612,-0.45228383087048707,-0.8831956908243579,4611,3,REST|BMP2
POSITIVE REGULATION OF HORMONE METABOLIC PROCESS%GOBP%GO:0032352,0.460824460824461,0.774751791105461,0.325170639351803,0.98816358250462,3375,9,PAX8|WNT4|ARNT
POSITIVE REGULATION OF VASCULAR PERMEABILITY%GOBP%GO:0043117,0.6758592582529549,0.8829301235250601,0.37680255045739597,0.8278512504858572,4974,4,PDE3A|FGFBP3
METANEPHRIC COMMA-SHAPED BODY MORPHOGENESIS%GOBP%GO:0072278,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
CELLULAR RESPONSE TO IONOMYCIN%GOBP%GO:1904637,0.789565217391304,0.9280333261332429,-0.60917512130569,-0.8115675331518271,5901,1,ZC3H12A
METANEPHROS MORPHOGENESIS%GOBP%GO:0003338,0.153929686439528,0.5225398777782271,0.5166728895952479,1.3369214694116298,1133,6,PAX8|PKD1|PKD2|FOXJ1
POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001016,0.9633087848500791,0.990916952887267,-0.232324217953469,-0.5568368188932701,7324,5,ARNTL|TBX1|MEF2C
CHROMATIN MAINTENANCE%GOBP%GO:0070827,0.19067454985219,0.564793636219303,0.6461894783280029,1.27097844849578,1418,3,MTHFR|SUPT6H|SUPV3L1
ESTABLISHMENT OR MAINTENANCE OF ACTIN CYTOSKELETON POLARITY%GOBP%GO:0030950,0.418039215686275,0.75036705317022,-0.306202114978837,-1.02488714902834,3197,12,RHOF|RHOD|RND1|MAPKAP1
PROTEIN GLYCOSYLATION IN ENDOPLASMIC RETICULUM%GOBP%GO:0033577,0.828628762541806,0.9433505833817859,-0.589214821349802,-0.784975620859922,6193,1,ALG2
'DE NOVO' PROTEIN FOLDING%GOBP%GO:0006458,0.66020942408377,0.8780700507750809,-0.191407389072207,-0.854846807252424,5043,28,HSPA13|DNAJC7|CHCHD4|ERO1L|HSPA6|HSPA9|FKBP1A|HSPA5|DNAJB5
REGULATION OF LYMPHOCYTE MIGRATION%GOBP%GO:2000401,0.71630378434422,0.899551221015245,-0.167016177216665,-0.8247672645368721,5526,39,RHOA|APP|STK39|ADTRP|AKT1|CCL3|CXCL12|CCL4|PYCARD|APOD|TNFRSF14|ADAM8|RIPK3|SLC8B1|SPN|MSN|CCL2|CD200|FADD|AIF1
PHASIC SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014821,0.678168727075126,0.884536278926676,0.37569904939366705,0.8254268116533391,4991,4,DRD2|PTGER3|EDN1
TELOMERASE RNA LOCALIZATION TO CAJAL BODY%GOBP%GO:0090671,0.360340018594767,0.7155384949577859,0.8211843846493159,1.0949385721752298,2712,1,WRAP53
RIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0042454,0.0413775042555977,0.291472925553788,-0.46300255374114097,-1.5937445763143,315,13,ADA|APOBEC3G|APOBEC3C|HPRT1|CDA|NUDT18|ENPP4|PNP
POSITIVE REGULATION OF FRACTALKINE PRODUCTION%GOBP%GO:0032724,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|AZU1
ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER%GOBP%GO:0090557,0.902588912133891,0.9686656000326079,-0.20158584288679,-0.631542130658671,6902,10,F11R|RAP2C|RAP2B|TJP2|RAB1B
POSITIVE REGULATION OF METANEPHRIC DCT CELL DIFFERENTIATION%GOBP%GO:2000594,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051883,0.0912708941363757,0.41778255328704206,-0.809374138406396,-1.3469279949642599,687,2,AZU1|GAPDH
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS%GOBP%GO:0036003,0.8779471147583691,0.960725750963158,-0.15828243508168802,-0.6823777562749201,6739,25,NOTCH1|MBTPS2|CREB3L1|CEBPB|HSPA5
"MATURATION OF SSU-RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000462",0.160255538942504,0.5300563172412229,0.27705906300940997,1.2826993642645401,1178,30,BTRC|MRPS9|DCAF13|HEATR1|TSR1|UTP20|UTP3|BMS1|WDR46|CIRH1A|NOL10|UTP6|RPS21|DIEXF|RPS19|NOP14|DHX37
TRNA 3'-END PROCESSING%GOBP%GO:0042780,0.6640519340005411,0.8804055751124069,0.298105138461657,0.8229112331137509,4909,7,SSB|ELAC2
REGULATION OF CYCLIN-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:1904029,0.0130953909359353,0.15155329789659303,-0.271129166063134,-1.6185917301141,101,78,CDKN1C|CDKN2A|CCNK|HEXIM1|PKMYT1|CDC25C|IPO7|CEBPA|CKS2|CDKN2B|GTF2H1|MEN1|CCNI2|CCNI|PSMD10|CCNB1|PLK1|CDK7|LATS2|MNAT1|NR2F2|CCND3|CDKN2C|SERTAD1|ACTB|CDKN3|CCND1|PDGFB
ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE%GOBP%GO:0030968,0.0651365559687139,0.36678901849638595,-0.22487190007355604,-1.38477199813176,507,88,TSPYL2|HDGF|HSP90B1|MYDGF|HSPA13|RNF121|TLN1|VCP|CREB3|ATP6V0D1|TPP1|MBTPS2|CREB3L1|WIPI1|CALR|HERPUD1|LMNA|CCL2|PDIA5|SRPRB|SYVN1|SSR1|EIF2S1|KDELR3|DERL3|HSPA5|GOSR2|DNAJB11|SERP1|YIF1A|ERN1
POSITIVE REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051944,0.00255307712980382,0.0482115283314493,0.9073012021616851,1.78455439606597,18,3,DRD2|RAB3B|DRD4
GASTRULATION WITH MOUTH FORMING SECOND%GOBP%GO:0001702,0.314087759815243,0.683550177109913,0.510645271790426,1.1219094093000102,2311,4,LRP5L|LRP6|MEGF8
POSITIVE REGULATION OF ACTION POTENTIAL%GOBP%GO:0045760,0.0267408714537804,0.231376996941513,0.6528606409723929,1.6893152805706297,196,6,TRPM4|SCN5A|RNF207
TRANSITION METAL ION TRANSPORT%GOBP%GO:0000041,0.020095323972691002,0.195205495598712,-0.276653783595207,-1.58878331515573,155,67,SLC39A13|ATP6V0A1|SLC39A1|TCIRG1|ATP6V0B|ATP6V0A2|SLC39A3|ATP6V1G2|ATP6V1F|SLC39A8|ATP6V0D1|CLTC|SLC39A11|SLC11A1|ARHGAP1|HFE|STEAP4|ATP6V0E1|SLC30A5|ATP6AP1|HEPH|ATP6V0E2|ATOX1|TFRC|ATP6V1A|ATP6V1G1|FTH1
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:2000607,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0060947,0.007198010731579641,0.102315552754816,-0.799080070351617,-1.74935331174573,54,4,MESP1|NOTCH1|GATA6
STRESS FIBER ASSEMBLY%GOBP%GO:0043149,0.583475186591594,0.8391117257440741,-0.26117089965670703,-0.8990008833768042,4455,13,RHOA|SORBS1|PDCD10|ZYX|PHACTR1|ITGB1|ITGB5|ARRB1
MITOTIC CELL CYCLE CHECKPOINT%GOBP%GO:0007093,0.6575989782886329,0.8762166448980659,-0.132714589957119,-0.899117337850417,5148,133,PCBP4|GTSE1|WEE1|CNOT4|MAD1L1|BTG2|CNOT10|CNOT6L|FOXN3|VPS4A|BLM|SFN|STK33|ZNF207|CDKN1B|ZWINT|CNOT6|AURKA|TRIP13|EME2|KLHL22|PRCC|PIDD1|PRMT1|RAD9A|TGFB1|PML|APC|RGCC|CLSPN|RPA2|NABP2|CDC20|TRIAP1|TFDP2|SETMAR|DONSON|NBN|CDC6|PLK2|RAD17|PCNA|ORC1|TOP2A|MAD2L1|TAOK2|CDC25C|KNTC1|CDKN2B|TOPBP1|EME1|HRAS|E2F1|CCNB1|PLK1|PLAGL1|TNKS1BP1|IK|ZNF385A|CCND1|MUS81
MICROTUBULE BUNDLE FORMATION%GOBP%GO:0001578,0.000137570504883753,0.00526859796630401,0.47189652755378003,2.56220262479408,0,52,LRRC6|DNALI1|DNAI1|ZMYND10|RSPH9|LRGUK|CLASP1|CFAP44|DYX1C1|CFAP43|CCDC65|NAV1|LRRC49|RSPH1|SPAG16|C9orf117|TTLL3|IQCG|CFAP46|MARK4|RSPH4A|TPPP3|GAS8|MTCL1|DNAH1|PSRC1|CCDC40|BBS2
SNORNA PROCESSING%GOBP%GO:0043144,0.118240146654445,0.4691344446484289,-0.40239939174155104,-1.3851367404310801,902,13,DKC1|EXOSC3|EXOSC2|RNF113A
REGULATION OF EPIDERMAL CELL DIVISION%GOBP%GO:0010482,0.7289632107023409,0.9064076322522902,-0.6396118217909129,-0.8521165264809191,5448,1,SFN
CELLULAR HYPOTONIC SALINITY RESPONSE%GOBP%GO:0071477,0.5676716695444279,0.83116084992853,0.713608292898103,0.951500369374325,4273,1,SLC12A6
"TRANS-SYNAPTIC SIGNALING BY NEUROPEPTIDE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099551",0.226220735785953,0.608682632875901,-0.8838773709748571,-1.17753688961113,1690,1,NTRK2
LATERAL MESODERM FORMATION%GOBP%GO:0048370,0.804816053511706,0.932964969466025,-0.601951918835465,-0.801944493068292,6015,1,TBX20
B-1 B CELL HOMEOSTASIS%GOBP%GO:0001922,0.337123745819398,0.699462084003389,-0.8283524481693871,-1.1035643601140401,2519,1,TNFAIP3
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1901379,0.459901375551518,0.774149829207065,-0.19131861939211103,-0.996388064175452,3543,47,ATP1B1|AMIGO1|KCNIP3|ATP1B3|KCNN2|KCNIP4|CD63|FLNA|KCNQ1|CAV1|ATP1B2|KCNH2|KCNE4|WNK2
"ANTIGEN PROCESSING AND PRESENTATION, ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB%GOBP%GO:0048006",0.814021164021164,0.93598587081542,-0.37134664166758596,-0.7251458737573672,6153,3,CD1E|CD1C|CD1D
TRNA METHYLATION%GOBP%GO:0030488,0.796858638743456,0.9304414572767159,-0.169638804263382,-0.7576258728233579,6087,28,TRMT61A|THADA|TRMT5|METTL2B|NSUN2|LCMT2|C9orf156|TRDMT1|TRMT112|METTL2A|FTSJ1|HSD17B10
REGULATION OF DENDRITIC SPINE MORPHOGENESIS%GOBP%GO:0061001,0.0552783613445378,0.34165878259009896,-0.3796081579678471,-1.5229806589672898,420,20,DHX36|EFNA1|ARHGAP44|DBN1|NGEF|CAMK2B|EPHA4|CFL1|CAPRIN1
POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS%GOBP%GO:0034250,0.21306494492973801,0.5955959218692061,-0.18423307761113,-1.16606740817884,1682,97,NSMAF|FMR1|DHX36|DDX3X|EFNA1|RPS4X|WIBG|FXR1|COA3|UQCC2|BCL3|THBS1|EIF4A3|EPHA4|YBX3|POLR2G|RPS6KB1|VIM|TNFRSF1A|NCK1|RPS6KB2|MRPS27
REGULATION OF TRANSLATION%GOBP%GO:0006417,0.24633431085044,0.6280519349499749,-0.146683554783972,-1.10891636200433,1931,237,RPS4X|ZNF540|STAT3|WIBG|FXR1|NCBP1|COA3|RPL10|MALSU1|CALR|HSPB1|UQCC2|AARS|GLE1|TNRC6C|EIF3B|EIF4G2|DHFR|BCL3|GAPDH|UNK|CPEB1|PAIP2|RBM4B|EIF5|THBS1|MIF4GD|EIF4A3|TCOF1|IGFBP5|EIF2S1|EIF2B2|YBX3|POLR2G|RPS6KB1|EIF4A2|VIM|SHMT2|ZNF385A|RBM4|CAPRIN1|NCK1|EEFSEC|PPP1CA|RPS6KB2|MRPS27|EIF4G1
STILBENE CATABOLIC PROCESS%GOBP%GO:0046272,0.771151547350246,0.9213545359508709,0.613641376268196,0.818207974869947,5805,1,EPHX2
POSITIVE REGULATION OF RECEPTOR RECYCLING%GOBP%GO:0001921,0.5481370682621699,0.8189172744690849,0.290558126783947,0.920507785955981,4030,10,BVES|INPP5F|VAMP3|RAMP3
HORMONE TRANSPORT%GOBP%GO:0009914,0.0154055896387185,0.16762941524758,0.3796042685919529,1.69891785552355,112,27,CRHR1|RAB11FIP5|TBX3|PTPRN|RAB1A|RIMS2|GAL|ADCYAP1|RAB11FIP2|RAB11B|CAMK2G|CYB5R4|SNAP23|PTPRN2
PHOSPHOLIPASE C-INHIBITING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030845,0.37618729096990006,0.7266197487465021,-0.810101455668284,-1.07924965578083,2811,1,PLEK
CELLULAR SODIUM ION HOMEOSTASIS%GOBP%GO:0006883,0.14696693569383,0.514131830678897,-0.466211106916892,-1.3421565257018702,1128,8,ATP1B1|ATP1A3|ATP1B3|SLC9A1|ATP1B2
TRABECULAR MESHWORK DEVELOPMENT%GOBP%GO:0002930,0.40441471571906396,0.7415314556048951,-0.798026025584473,-1.06316228342744,3022,1,CYP1B1
PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007200,0.0939815416612505,0.42374851931717106,-0.293223839662769,-1.38923114380849,722,34,ANO1|GNA14|GPR35|ADRA1B|PLCE1|FPR3|LPAR6|AGT|FPR1|LTB4R|CHRM2|P2RY6|F2R|GNA15|F2RL3|C3AR1|GPR4|CMKLR1|C5AR1
REGULATION OF GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0032645,0.0889852786540484,0.41228493992510207,-0.533866519580805,-1.45930032383654,676,7,DDX58|ISL1|RASGRP1|IL1B|IL18|CD84|IL17D
SNRNA MODIFICATION%GOBP%GO:0040031,0.293266701735928,0.6657871238651031,-0.48134719525482106,-1.1536973775268502,2229,5,NOP10|NHP2|MEPCE|DKC1
POSITIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071879,0.968123256740603,0.9912626134248801,0.51532862814292,0.6871211908648149,7288,1,GSK3A
PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0046125,0.844973544973545,0.9483976196751529,-0.35777455627134597,-0.6986430308094139,6387,3,TK1
GALACTOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:0006683,0.746354515050167,0.9118647019584949,-0.6322232024702249,-0.842273111433639,5578,1,GALC
CELLULAR DETOXIFICATION OF ALDEHYDE%GOBP%GO:0110095,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
WATER HOMEOSTASIS%GOBP%GO:0030104,0.625800299686691,0.858842084733938,0.19285799144639498,0.8826393253398621,4593,29,MET|ADCY2|WFS1|ADCY3|RAB11FIP2|TFAP2B|ADCY6|RAB11A|NEDD4L|ADCY1|STMN1|TMEM79|ADCY7
RESPONSE TO MUSCLE ACTIVITY%GOBP%GO:0014850,0.240471512770138,0.624461333747413,-0.469121725307431,-1.2067074523654198,1835,6,AGT|RYR2|METRNL
REGULATION OF RYANODINE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0060314,0.417855686913983,0.75036705317022,0.266036790731472,1.02299072122976,3074,17,FKBP1B|GSTM2|DMD|SRI|PKD2|CAMK2D|JPH3
REGULATION OF MYELOID CELL APOPTOTIC PROCESS%GOBP%GO:0033032,0.22659518828451897,0.6091952781136228,-0.39109828163471505,-1.2252598622178301,1732,10,CDKN2A|MEF2C|PIK3CB|IRF7|ANXA1
RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014874,0.31870669745958397,0.6867397844771489,0.508240076693006,1.1166250932394,2345,4,SCN5A|HDAC4
CELLULAR RESPONSE TO MONOSACCHARIDE STIMULUS%GOBP%GO:0071326,0.39709728033472796,0.737835527838374,-0.244495227856691,-1.0390978255858399,3036,24,GNB2L1|ZNF236|GAS6|ADCY8|GPER1|PDK3|TRA2B|PRKACA|ERN1
SIDEROPHORE METABOLIC PROCESS%GOBP%GO:0009237,0.0353300571124983,0.267780812741458,0.9823555359505959,1.30983855515167,265,1,BDH2
GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT%GOBP%GO:0032836,0.559027306072545,0.8268422944617521,0.41384802423197997,0.909241734047877,4114,4,SULF2|MPV17
CELLULAR RESPONSE TO NITROGEN COMPOUND%GOBP%GO:1901699,0.000384664700602641,0.0111294649577428,-0.20837105483807,-1.66284077807754,2,328,ZFP36L1|IMPACT|RYR2|JUP|AP3S1|TCIRG1|ATP6V0B|RRAGA|GOT1|PARP1|P2RX4|RAPGEF1|ATP6V0A2|LRP1|ATP6V1G2|NDNL2|ATP1A3|AHR|LARP1|NPM1|CAV2|P2RX3|FCGR2B|ATP6V1F|INS|PDE4B|BCAR1|GRIN1|FOXC2|FMR1|SYAP1|PDE12|ADCY8|ATP6V0D1|PDXP|CA2|GRB2|CRHBP|PRKAR1A|SLC9A1|MEF2C|CASP4|IRS1|STAT3|MB21D1|IFIH1|BRCA1|IFIT1|PDE2A|PXN|MAPK3|DPEP1|ABL1|ADCY4|RAPGEF3|PIK3R3|IGF1|HDAC5|NSMF|RPTOR|CHRM2|P2RY6|TMEM173|GNAQ|CEACAM1|GPER1|RAP1A|KCNQ1|KAT2B|GNA15|CPEB1|COLEC12|CD36|ATP6V0E1|HTR1B|EPHA4|RARRES2|SLIT2|CAMK2A|IGFBP5|LPIN3|CAV1|PPARG|ATP6AP1|RELA|RPS6KB1|MAPK13|NFKB1|PRKACA|TLR4|ATP6V0E2|VIM|ADRBK1|ACTB|LY6H|LGMN|SHMT2|PQBP1|ATP6V1A|SLC38A9|CASP6|LPIN2|ATP6V1G1|NGFR|ADCY9|RRAGD|PRNP
NEGATIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002731,0.33032634651101095,0.6957352559323989,-0.669864902122967,-1.1147623165843998,2489,2,JAK3|BST2
CELLULAR RESPONSE TO DIAMIDE%GOBP%GO:0072738,0.606261607853542,0.8488585126532391,-0.556989247311828,-0.9269191768043309,4569,2,DAXX|HSF1
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES%GOBP%GO:0007156,0.40818568877901396,0.7445496113654559,0.18438089812449301,1.03363389291099,2971,58,CDHR3|CNTN4|PVRL4|ROBO3|IGSF9|ANXA3|CADM1|ROBO2|PTPRM|PKD1|CDH4|AMIGO2|PVRL1|TENM3|TRO|PLXNB2|CELSR2|CDH24|VSTM2L
REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE%GOBP%GO:0042749,0.9571278274592321,0.9880317864833471,-0.237262574652493,-0.568673117575639,7277,5,PTGDS|GHRL
NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS%GOBP%GO:2001027,0.41626984126984096,0.7493091022753771,-0.538737686602188,-1.05201815942871,3146,3,NOTCH1|THBS1
ABDUCENS NERVE DEVELOPMENT%GOBP%GO:0021560,0.214180602006689,0.597438672438672,-0.890769739744155,-1.1867191797671799,1600,1,MAFB
"MATERNAL DETERMINATION OF ANTERIOR/POSTERIOR AXIS, EMBRYO%GOBP%GO:0008358",0.77123745819398,0.9213545359508709,-0.6190449933833261,-0.824716572655282,5764,1,PLD6
REGULATION OF GLUCOSE MEDIATED SIGNALING PATHWAY%GOBP%GO:1902659,0.9621777254286089,0.9906325367238141,-0.25731848980586397,-0.563323963413609,7351,4,SMARCA4|UBTF
COMPLEMENT ACTIVATION%GOBP%GO:0006956,0.000129182276191707,0.00518555396908895,-0.572630401395474,-2.9664056564356804,0,46,IGHV2-26|COLEC11|IGHV1OR15-1|IGKV3-11|IGHV5-51|RGCC|C4B|FCN3|IGHV1-24|IGHV3-49|COL20A1|IGHG4|IGLL5|C4A|C2|IGKV2-28|C3|IGHV4-4|IGHV4-61|C1QB|IGHV1-3|IGHV3-43|FCN1|IGHV3-73|C1QA|CFB|C1QC|C7|IGKV2D-28|IGHV3-15|CFP|C1S|IGHV1-18|CFD|IGHG2|IGHA1|C1R|CFH
ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0099624,0.0895462987529849,0.413430792765036,-0.8118555279845602,-1.35105742402635,674,2,KCNN2|KCNQ1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME%GOBP%GO:1902966,0.8926130389064141,0.965443067117994,-0.234859349145063,-0.641977557484861,6790,7,EZR|ROCK2|SORL1|RDX|MGAT3|DTX3L|MSN
ALDEHYDE CATABOLIC PROCESS%GOBP%GO:0046185,0.5161628059154559,0.804056180000979,-0.431498201710081,-0.9446397628734592,3943,4,PDXP|ALDH3B1
ADENYLATE CYCLASE-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007189,0.23727940229292802,0.6217158626397761,-0.20215436910441897,-1.16094377797802,1841,67,ADGRE2|ADCY8|PDE4D|CALCB|PTGER4|CALCRL|TBXA2R|ADCY4|ADGRL4|GNAQ|GPER1|ADGRE5|CHGA|ADRA2C|ADGRG1|PTGIR|ADGRL1|ADCY9|ADGRB1
REGULATION OF DNA DEMETHYLATION%GOBP%GO:1901535,0.8356624563289441,0.945788393670804,0.36052310729667003,0.7091064075268181,6218,3,OTUD4|USP7
REGULATION OF CELLULAR RESPONSE TO VERY-LOW-DENSITY LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:1905890,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0097623,0.174815983175605,0.54811765844537,-0.47593477254965605,-1.3009464767562702,1329,7,KCNQ1|KCNH2|KCNE4
NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS%GOBP%GO:2000672,0.7997077965201221,0.931670998922663,0.599966916629907,0.799974928076188,6020,1,ZPR1
ECTODERMAL PLACODE FORMATION%GOBP%GO:0060788,0.133834990593926,0.495404845602596,0.681206573287747,1.33985294199252,995,3,HDAC1|PROX1|HDAC2
WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002246,0.202591283863369,0.5810727835229039,-0.579075162784474,-1.26771657979277,1547,4,TGFB1|HMOX1|F2R
INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR%GOBP%GO:0072332,0.5535714285714289,0.823501729860726,-0.20026749252822199,-0.93156542927102,4246,32,PPP1R13B|DDX5|SNW1|IFI16|BCL3|TMEM109|DDIT4|HINT1|RRP8
SYNTHESIS OF RNA PRIMER INVOLVED IN MITOTIC DNA REPLICATION%GOBP%GO:1902981,0.0698327759197324,0.37596389138254704,-0.9637185707984119,-1.28390453877875,521,1,POLA1
REGULATION OF INTERLEUKIN-13 PRODUCTION%GOBP%GO:0032656,0.11382754994742401,0.46282790441426097,-0.513173457420467,-1.4027367612151798,865,7,RARA|HLA-E|GATA3|TNFRSF21|LGALS9
POSITIVE REGULATION OF NITRIC-OXIDE SYNTHASE ACTIVITY%GOBP%GO:0051000,0.164132144729942,0.535290477921284,-0.36630600017789794,-1.2959370623426498,1251,14,AKT1|TNF|S100A1|TERF2|TERT|INS|DHFR|APOE
DEADENYLATION-INDEPENDENT DECAPPING OF NUCLEAR-TRANSCRIBED MRNA%GOBP%GO:0031087,0.42403352257366905,0.754206762683119,0.420803000220604,1.0120288024311,3136,5,DCP1B|EDC4|EDC3|PNRC2|DCP1A
NEGATIVE REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:1901257,0.0937792642140468,0.42337598780415003,-0.9508160564622851,-1.26671529160663,700,1,HAVCR2
DEOXYRIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009262,0.5117831358125601,0.801554805389805,0.209009297058952,0.9565578463319621,3756,29,DERA|AK9|NT5M|NTHL1|DCTD|CDADC1|AK5|NEIL1|OGG1|DUT|DTYMK|SMUG1|NEIL2
ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING%GOBP%GO:0000478,0.9222677595628421,0.9776156396135859,0.21141719514026802,0.613707130888172,6750,8,UTP20|RPS21|NOP14|RPSA|KRI1
SERTOLI CELL DEVELOPMENT%GOBP%GO:0060009,0.124319298711648,0.478357784842846,0.9392368769298629,1.25234564147135,935,1,RAB13
DOUBLE-STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING%GOBP%GO:0097680,0.422089390028529,0.7527812076478722,0.46258203275795506,1.0163124262458,3106,4,ZBTB7A|LIG4|UVRAG|XRCC6
CHAPERONE COFACTOR-DEPENDENT PROTEIN REFOLDING%GOBP%GO:0051085,0.25170693277310896,0.632068187660447,-0.29442215359557,-1.18121604103021,1916,20,HSPA14|PTGES3|DNAJB1|BAG1|HSPA13|DNAJC7|ERO1L|HSPA6|HSPA9|HSPA5|DNAJB5
REGULATION OF MYD88-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034124,0.00680539196440257,0.0989500406694213,-0.804583929161362,-1.76140240919347,51,4,IRF7|CD300A|CD300LF
REGULATION OF I-KAPPAB PHOSPHORYLATION%GOBP%GO:1903719,0.12354403873838499,0.47770553946915606,-0.626344134861962,-1.3711982406608603,943,4,CX3CL1|SIRPA
RECEPTOR LOCALIZATION TO NON-MOTILE CILIUM%GOBP%GO:0097500,0.7849476973237329,0.9274485629622209,0.340792789076392,0.748736271161076,5777,4,BBIP1|TULP3
"POSITIVE REGULATION OF MITOTIC CELL CYCLE, EMBRYONIC%GOBP%GO:0045977",0.34675585284280896,0.7038391566282349,-0.823610498456109,-1.09724694448668,2591,1,HES1
REPRODUCTION%GOBP%GO:0000003,0.0647824261928082,0.365484450623565,0.15052662030559802,1.247182364643,462,389,TDRD12|TLE6|NPHP1|LRRC6|SPAG6|CRHR1|TSGA10|STRA6|DDX25|SYCE1|CYP27B1|TDRD6|UBXN8|FGFR2|LRGUK|BBS4|SPATA6|TEAD3|SRD5A1|CITED1|PPARD|CDKL2|TBX3|CFAP44|RNF212|PICK1|CFAP43|PSME4|RAB13|IFT20|WNT2B|TSSK6|ZNF296|IGSF8|ITGB8|PRLHR|KIT|ROBO2|C14orf39|DZIP1|C9orf117|AZIN2|RAD51D|IQCG|PTPRN|BMP7|BRCA2|IFT81|NME5|ADCY3|PKD1|CHD5|ATM|SPIRE2|PDE3A|SLIT3|MRE11A|TOB2|ZNF568|WDR33|TDRP|EIF2B4|CASP8|CCNB1IP1|SPESP1|ADCYAP1|PCSK4|MAFF|CEP57|TUBGCP3|STOX2|HSPA2|WNT4|MKKS|SYCP2|TRIM27|PARN|CUL7|C1orf111|LEPR|PKD2|HERC4|NDRG3|DNAH1|CITED2|CCNE1|XRN2|ELL3|CATSPERG|MAST2|MCM9|SPATA2|RHOXF1|PRMT7|CATSPER2|IFT27|BBS2|PRND|TRO|APITD1|CHD7|RQCD1|TEX14|DPY19L2|METTL14|LRP6|TUBGCP6|BCL2
REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION%GOBP%GO:0033135,0.22788547952240304,0.609818988326981,-0.19460820667244397,-1.16177554228528,1774,78,LIF|PFN2|GPD1L|PDCD10|AKT1|TERF2IP|RAF1|RIPK2|TNF|SH2D3C|CD44|TGFB1|GNB2L1|FNIP1|CAMK1|PPM1F|NSD1|HCLS1|SPTBN4|SFRP2|GAS6|PDE4D|PRKD1|PARK7|HAX1|OSM|RAPGEF3|CREBL2|RPTOR|ARAF|IL11|TNKS1BP1|CAV1|DDIT4|HSP90AA1|NCK1|EIF4G1
HISTONE H2A MONOUBIQUITINATION%GOBP%GO:0035518,0.797594142259414,0.9308634013872809,-0.19177149371598395,-0.744144717347279,6099,18,PCGF2|PCGF5|CUL4B|BCOR|RNF168|SKP1|RING1|DDB1
LYMPHOTOXIN A BIOSYNTHETIC PROCESS%GOBP%GO:0042109,0.48386239872493,0.787078399497453,0.758325981473313,1.01112537320392,3642,1,BCL10
REGULATION OF RESPONSE TO CYTOKINE STIMULUS%GOBP%GO:0060759,0.008211444701052091,0.112202730765986,-0.24121061873582003,-1.60291288890731,63,122,DHX9|PYCARD|CD74|GNB2L1|IRAK3|RUNX1|MADD|IFNGR1|SOCS3|PARP9|AGPAT1|KLF4|TLR2|TRIM44|TICAM2|IL1RN|GAS6|CASP1|TRAF2|TNFAIP3|CASP4|SOCS1|PTPN6|IFIH1|CARD16|IRAK1|NR1H3|TREM2|CSF1|AXL|FADD|CD300LF|SLIT2|USP18|PPARG|TLR4|TAF9|C1QTNF4|GSTP1|TNFRSF1A|AGPAT2|PELI3|SAMHD1|SPHK1|RNF113A|AK6|HIST1H2BJ
POSITIVE REGULATION OF DENDRITIC CELL DENDRITE ASSEMBLY%GOBP%GO:2000549,0.5079598662207361,0.798783771845792,-0.749834583149537,-0.998959710656381,3796,1,CCL19
POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:2001280,0.0408730158730159,0.289643994810875,-0.777135509639746,-1.5175486861412,308,3,ABCD1|ANXA1
ACTIN FILAMENT-BASED PROCESS%GOBP%GO:0030029,0.37800204394481396,0.7281989978224692,-0.12679628996874,-1.0305898479384001,2958,370,ARHGEF2|SORBS1|ATP1A1|GJC1|FGD2|GPD1L|FGD6|CCDC53|PDCD10|ROCK1|SPECC1L|MYH3|FSCN1|RAC2|ZYX|CDC42|TNF|MSRB2|RAC3|RACGAP1|PHACTR1|PRKG1|ACTN4|SHROOM2|MSRB1|MTSS1|RAC1|ITGB1|DOCK2|WIPF3|LLGL2|ATP2C1|CXCL1|SSH1|ANLN|CDC42BPB|SCN4B|AQP1|IQSEC1|MRAS|TNNT2|EPB41L1|ARHGAP25|GJA1|MYO7A|NCKAP1L|CTTN|KANK1|WASF2|CORO1A|SPTBN5|HSP90B1|RYR2|MYH11|FRMD5|FGD1|CXADR|PSTPIP2|IQSEC2|FMNL1|TTC17|DSTN|MICALL2|ARPC1A|TNNI2|COBL|WAS|FSCN2|TNNC2|FRMD6|ITGB5|IQGAP2|PLEK|KCNN2|MYOM1|BCAR1|SHROOM1|TAOK2|TNXB|RHOF|LMOD1|ELMO1|PDXP|S1PR1|FHL3|FRMD3|PKP2|ARRB1|DBN1|CACNA1G|MICAL2|FGF10|AIF1L|RHOG|RHOD|GHRL|ABL1|FLNA|EPB41L2|RHOJ|PDPN|RND1|IQSEC3|GSN|BAIAP2L1|CORO1B|KCNQ1|DLC1|PLS3|SMTNL1|ARFIP2|SUN2|FGF7|CFL2|ARPC5L|SRF|AIF1|PDGFRB|IGSF22|NEDD9|DTNBP1|MYO1E|SCN1B|FAM107A|EFS|MYH9|ANG|INSRR|CFL1|WASF3|GAS7|KCNH2|VIM|KCNE4|PDGFA|EVL|ACTB|NF2|PDGFRA|EPS8|ANXA1|RHOU|MAPKAP1|ACTN1|KRT19|ARF6|SPECC1|CDC42EP2|ALDOA|EMP2
REGULATION OF ENDOTHELIAL CELL MIGRATION%GOBP%GO:0010594,0.000128221566867547,0.00518555396908895,-0.351577019314161,-2.35173902156926,0,126,PPAP2B|TGFB1|STAT5A|RGCC|KIAA1462|SP100|MAP3K3|ANGPT2|PIK3C2A|AGT|JUP|DAB2IP|KLF4|KDR|P2RX4|EMC10|PDCD6|SYNJ2BP|GPI|GATA3|PRCP|SRPX2|BCAR1|FOXC2|ATP5B|DCN|SMOC2|FLT4|NOTCH1|MEF2C|PRKD1|TBXA2R|BCAS3|MMRN2|MECP2|ABL1|CALR|HMOX1|HSPB1|SPARC|HDAC5|MEOX2|RHOJ|STARD13|CEACAM1|MAP2K3|EPHA2|APOE|SASH1|NOS3|NRP2|THBS1|TEK|ATOH8|SEMA5A|SLIT2|FOXP1|NR2F2|PPARG|ANXA1|LGMN|TMSB4X|ACVRL1|PDGFB|CARD10|EMP2|ADGRB1
TRANSPORT ALONG MICROTUBULE%GOBP%GO:0010970,0.00013848497438028002,0.00526859796630401,0.31336537119816305,2.09556637073584,0,121,DYNLRB2|DYNC2H1|TTC30B|WDR19|TTC21B|DYNC2LI1|RABL2B|IFT88|TTC30A|WDR35|TTC21A|KIF13A|LCA5|DCTN1|IFT46|IFT172|IFT20|IFT140|DLG2|KIF3B|TRAK2|NDEL1|CLUAP1|RAB1A|IFT81|HTT|TNPO1|WDR60|BLOC1S3|PCM1|CAMSAP3|HAP1|DST|AP3B2|LRPPRC|IFT52|KIF5B|RPGR|TRAF3IP1|KIF3C|IFT27|AP3B1|RAB6A|KIF5A|SPG11|COPG2|TRAK1|SPAST|ARHGAP21|KIF1A|AP3M1
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0035850,0.060407949790795,0.355787695563881,-0.387892757849861,-1.50516816163894,461,18,MTSS1|NUP93|IQGAP1|JAG1|BASP1|CD34|SMO|MEF2C|KLF15|MYO1E|ACTA2|PDGFB
NEGATIVE REGULATION OF NIK/NF-KAPPAB SIGNALING%GOBP%GO:1901223,0.258335521134156,0.636098664976652,-0.32333417911474605,-1.17397399229076,1967,15,ADIPOR1|NLRP3|NOV|RELA|TMSB4X
VIRAL GENOME REPLICATION%GOBP%GO:0019079,0.11429318687066801,0.463696586909637,-0.330579163372842,-1.36901432948388,873,22,HTATSF1|PCBP2|ATG16L2|CDC42|NFIA|CD209|DEK|EEA1|GAS6|VCP|RAB29|CLEC4M|CCL2|ADRBK1
REGULATION OF SYNAPTIC ACTIVITY%GOBP%GO:0060025,0.0535951180684532,0.33531875720878496,-0.8487455197132621,-1.41244826941612,403,2,MEF2C|STX1B
REGULATION OF ARP2/3 COMPLEX-MEDIATED ACTIN NUCLEATION%GOBP%GO:0034315,0.0969945355191257,0.429154823064985,0.49622612353870205,1.4404576238306699,709,8,CYFIP1|PICK1|ABI2|NCKAP1
MIRNA MEDIATED INHIBITION OF TRANSLATION%GOBP%GO:0035278,0.521574267782427,0.8068178076540979,-0.298944742606215,-0.9365548542055351,3988,10,STAT3|TNRC6C|RBM4
PIGMENT GRANULE MATURATION%GOBP%GO:0048757,0.5319672131147539,0.812079525085925,0.319318195569565,0.926924858280179,3893,8,BLOC1S3|AP1M1|BLOC1S5|AP1G1|BLOC1S6|AP3D1
MALE GENITALIA DEVELOPMENT%GOBP%GO:0030539,0.0943020321423828,0.424384770192935,0.953683281870313,1.27160797316476,709,1,TBX3
PYRIMIDINE NUCLEOSIDE TRANSPORT%GOBP%GO:0015864,0.517909259750597,0.8047565444482679,-0.5917838433967471,-0.984822948763893,3903,2,SLC29A1|SLC29A2
AMMONIUM ION METABOLIC PROCESS%GOBP%GO:0097164,0.502444044250064,0.7970718494574169,-0.148326495151896,-0.972468832045962,3905,114,SNCAIP|ACHE|SAT1|MOXD1|CROT|BCHE|ODC1|COMT|CRAT|PLA2G2A|SMOX|PLA2G2D|PCYT1A|CHPT1|TMEM86B|PLA2G4D|PLA2G4A|SMPDL3A|CETP|PLA2G7|PLA2G4C|SLC44A1|PLA2G16|SMS|LPIN3|TMLHE|PCTP|SAT2|SMPD1|PLBD1|HNMT|LPIN2|SPHK1|PLA2G12A
DATP METABOLIC PROCESS%GOBP%GO:0046060,0.0716370390023879,0.3767214120425879,-0.8279018472566859,-1.37776106529455,539,2,NUDT1|SAMHD1
POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0045723,0.0254968619246862,0.22470485454905398,-0.540905831080708,-1.69458735868795,194,10,NR1H2|ELOVL5|LPGAT1|MID1IP1|PTGS2|APOC2|NR1H3|SLC45A3|ABCD1|ANXA1
RESPONSE TO MUSCLE STRETCH%GOBP%GO:0035994,0.93227899432279,0.9800350656963129,0.253839854371511,0.6104833941160369,6896,5,DMD|SLC8A1
POSITIVE REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:1905448,0.246564585787201,0.6280519349499749,-0.556419749568956,-1.21811914443176,1883,4,PARK7|CCNB1
BLOOD VESSEL ENDOTHELIAL CELL FATE SPECIFICATION%GOBP%GO:0097101,0.0826390755173341,0.399980174480082,0.7295291445629029,1.4348977372521698,614,3,DLL1|NRP1|RBPJ
POSITIVE REGULATION OF HH TARGET TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0007228,0.452304394426581,0.769943206592495,0.6133020599283872,1.03042664731399,3375,2,STK36
NEURON PROJECTION GUIDANCE%GOBP%GO:0097485,0.11458915595304599,0.463748809895271,0.180640360401323,1.25110739807937,819,143,TNR|RET|CNTN4|ROBO3|IRS2|UNC5C|IGSF9|SEMA4F|PLXNB1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|SLIT1|EPHB2|EFNA4|GFRA1|CHN1|PTPRO|ROBO2|PTPRM|LYPLA2|EFNB2|EFNB3|SLIT3|CDK5R1|SHC1|SOS1|DRAXIN|SPTBN1
RESPONSE TO BRONCHODILATOR%GOBP%GO:0097366,0.564467969598263,0.8295590091625621,0.27643510396389503,0.9096412342870129,4158,11,DRD2|DRD4
RESPONSE TO SORBITOL%GOBP%GO:0072708,0.0567460317460318,0.34436604181231795,-0.756810411381935,-1.47785892061867,428,3,CDT1|KAT7|MAPK13
POSITIVE REGULATION OF EPHRIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:1901189,0.95789613494488,0.988578419070365,0.521338773709749,0.6951349090120721,7211,1,RBPJ
D-RIBOSE CATABOLIC PROCESS%GOBP%GO:0019303,0.674247491638796,0.882488012133495,-0.666409351565946,-0.887817270607619,5039,1,NUDT5
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN%GOBP%GO:0002584,0.469833791388562,0.7810597690409531,-0.4492502696512129,-0.983502750445519,3589,4,HLA-DOA|TAPBPL|HFE
"ENERGY COUPLED PROTON TRANSMEMBRANE TRANSPORT, AGAINST ELECTROCHEMICAL GRADIENT%GOBP%GO:0015988",0.18454485920104802,0.5576076287590861,-0.4990393190347,-1.28366356281603,1408,6,ATP6V1H|ATP1A1|ATP1A3|NDUFS7
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:1905564,0.0791259500542888,0.394700258689481,0.449814815682945,1.48016694794255,582,11,ADAM17|FGF2|SP1|PLCG1|AKT3|FGFR1|PDPK1|HMGB1
INTERLEUKIN-13 PRODUCTION%GOBP%GO:0032616,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
MITOTIC SPINDLE MIDZONE ASSEMBLY%GOBP%GO:0051256,0.218032786885246,0.6006056193623679,0.42478054820405997,1.23306361775569,1595,8,AURKC|CDC14B|CDC14A
POSITIVE REGULATION OF VIRAL PROCESS%GOBP%GO:0048524,0.0192282875209704,0.19171563493967,-0.27129610162956197,-1.59027436002672,148,73,TRIM38|DHX9|CD74|SMARCA4|ZNF639|TSG101|CD4|PPIA|RAB7A|LARP1|CAV2|MDFIC|TOP2A|PPIB|FMR1|DDX3X|PDE12|IFIT1|SNW1|NUCKS1|APOE|LGALS9|ADARB1|RRP1B|DDB1|CFL1|ANXA2|LGALS1|P4HB
REGULATION OF ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034765,0.18362378267555102,0.556308895147568,-0.158082150171265,-1.16111967129479,1432,201,GLRX|ATP1B1|PPIF|AMIGO1|KCNIP3|CTSS|PLN|SHISA7|ATP1B3|KCNN2|STAC3|THY1|PDE4B|STIM1|SLC9A3R1|FMR1|KCNIP4|JPH4|PDE4D|TESC|HAMP|SEPN1|CRHBP|SLC9A1|MEF2C|UBQLN1|CD63|CAPN1|FLNA|FXYD1|CNIH2|P2RY6|GPER1|F2R|KCNQ1|APLNR|F2RL3|THBS1|COX17|FKBP1A|MMP9|CX3CL1|SLC30A5|CAV1|SCN1B|CNIH3|CLIC2|ARL6IP1|ATP1B2|PRKACA|KCNH2|KCNE4|ARL6IP5|TMSB4X|FXYD5|AHNAK|FXYD7|WNK2|PRNP
REGULATION OF MRNA EXPORT FROM NUCLEUS%GOBP%GO:0010793,0.9588706393375871,0.9889996530704799,0.21796024720549803,0.563984950314639,7063,6,IWS1|SUPT6H|TPR
TOR SIGNALING%GOBP%GO:0031929,0.7566684100418409,0.9167299629693821,-0.185237249714807,-0.7872530890826941,5786,24,FNIP1|EIF4EBP1|GATA3|LARP1|PRR5L|SYAP1|RPTOR|RPS6KB1|MAPKAP1
REGULATION OF HISTONE UBIQUITINATION%GOBP%GO:0033182,0.13192991631799197,0.491539110043253,-0.43865831877465294,-1.37425925006884,1008,10,WDR70|KDM1A|CTR9|RNF20|RNF40|OTUB1
PRONEPHRIC NEPHRON TUBULE MORPHOGENESIS%GOBP%GO:0039008,0.11555319431531401,0.46493596964429496,0.943537715041906,1.2580802287693897,869,1,AHI1
PRE-MIRNA PROCESSING%GOBP%GO:0031054,0.28214528173795,0.654732517474162,0.32836268004190805,1.14999456490348,2077,13,PRKRA|MRPL44|AGO2|AGO3|ZCCHC11|AGO1|TARBP2|DROSHA|ADAR|AGO4|ZCCHC6
CELLULAR MAGNESIUM ION HOMEOSTASIS%GOBP%GO:0010961,0.342608695652174,0.701955655133333,-0.8259263343625942,-1.1003321939791102,2560,1,SLC41A1
ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY%GOBP%GO:0030952,0.19636316064887502,0.5726307982930121,-0.334472172926225,-1.2430281046723402,1500,16,RHOF|RHOD|CKAP5|LMNA|RND1|MAPKAP1
EXTRACELLULAR MATRIX ORGANIZATION%GOBP%GO:0030198,0.00012782819890067802,0.00518555396908895,-0.357776927479154,-2.59529622014929,0,188,COL15A1|ITGAX|ADAMTS4|LAMB2|DPT|LAMC1|COL27A1|FBLN5|NCAN|ADAM8|PLOD2|ITGA10|MYH11|ITGA11|ITGB2|LAMC2|COL18A1|COL23A1|SPOCK2|ST7|COL11A2|KDR|NID2|CTSV|LAMC3|TPSAB1|CTSS|MFAP4|CYP1B1|ITGB5|MMP1|LAMA2|GAS6|ADAM12|POSTN|DDR2|VTN|TNXB|ITGA5|DCN|VWF|COL14A1|COL5A3|ELN|MADCAM1|CD47|ICAM1|HTRA1|BGN|FBN1|MMP14|CREB3L1|SPP1|COL4A1|COMP|DDR1|VCAN|LAMA4|SPARC|SULF1|RECK|COL4A2|GPM6B|VCAM1|COL5A2|COL12A1|LUM|COL6A3|COL8A1|GSN|FN1|MFAP5|TNC|A2M|THBS1|SERPINH1|COL1A2|COL1A1|ITGA8|COL3A1|ADAM19|MMP9|SERPINE1|MYO1E|NID1|COL6A1|TGFBI|ITGAM|PDGFA|ANXA2|CTSL|TIMP1|COL16A1|CSGALNACT1|COL5A1|MMP19|COL6A2|PDGFB|COL13A1|LOXL2|ITGB4|SERPINF2|ICAM2
DOUBLE-STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION%GOBP%GO:1990918,0.538595317725753,0.8142313733497609,-0.7338442876047641,-0.977656797494358,4025,1,BRIP1
INDOLE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0042436,0.21882322311897895,0.6013948176405761,-0.428890796315461,-1.23471657484746,1680,8,TDO2|KMO|CCBL1|KYNU|HAAO|AFMID
PHOSPHATIDYLETHANOLAMINE ACYL-CHAIN REMODELING%GOBP%GO:0036152,0.0395081109366824,0.28367988634143604,-0.428774196967303,-1.59349094044433,301,16,PLA2G2A|PLA2G2D|PLA2G4D|PLA2G4A|PLA2G4C|PLA2G16|PLBD1|PLA2G12A
RESPONSE TO AMINO ACID%GOBP%GO:0043200,0.675291073738681,0.882488012133495,-0.176931345983803,-0.8519739450577959,5219,36,RRAGC|UBR2|XBP1|LAMTOR3|CPEB4|LAMTOR2|LAMTOR5|LAMTOR1|NEURL1|FYN|CPEB3|RRAGB|KLHL22|RRAGA|TMBIM6|GRIN1|NSMF|RPTOR|CPEB1|SLC38A9|RRAGD
GLUTAMINE CATABOLIC PROCESS%GOBP%GO:0006543,0.15581457663451198,0.524929617605427,0.7654259718775849,1.28601446090197,1162,2,GLS|GLS2
POSITIVE REGULATION OF KERATINOCYTE MIGRATION%GOBP%GO:0051549,0.13951359832635998,0.504314492208813,-0.43461678801644,-1.3615976617865801,1066,10,IQSEC1|ADAM9|MAPRE2|FGF10|FGF7|MMP9|ARF6
REGULATION OF RAL PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032485,0.9602675585284279,0.989779794259826,-0.519629466254963,-0.692271219444498,7177,1,RALGPS1
PROTEIN IMPORT INTO MITOCHONDRIAL INTERMEMBRANE SPACE%GOBP%GO:0045041,0.955921757770632,0.987648651222125,0.341793530919922,0.574257262694584,7134,2,HSPD1
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION%GOBP%GO:0002639,0.6655724789915971,0.8804055751124069,-0.210781176580893,-0.84565004325924,5068,20,TGFB1|HLA-E|STX4|PAXIP1|GPI|MZB1|TNFRSF4|TNFSF13|TFRC
RESPONSE TO EPINEPHRINE%GOBP%GO:0071871,0.120671700078105,0.472686039512467,-0.48354211033173206,-1.3920500588783202,926,8,RYR2|PDE4B|SLC9A1|KCNQ1|PRKACA
STRESS-ACTIVATED MAPK CASCADE%GOBP%GO:0051403,0.438619090557774,0.764387115513764,-0.169442671191914,-1.0078197126578399,3404,77,PKN1|MDFIC|TAOK2|PTGER4|MLKL|MAPK9|MAPK3|IRAK1|SKP1|MAP3K13|MAP2K3|LGALS9|MAP3K11|UBC|MAPK13|NFKB1|GPS1|DBNL|ERN1
RENAL CORTEX DEVELOPMENT%GOBP%GO:0072055,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009204,0.0537000654878847,0.33572170046993605,-0.5993412221901829,-1.54166707767102,409,6,DCTPP1|NUDT1|NUDT16|SAMHD1
CALCIUM IMPORT INTO THE MITOCHONDRION%GOBP%GO:0036444,0.159432159432159,0.5293397224673839,0.431851276468193,1.31235619954701,1167,9,MCUR1|MICU2|SLC25A23|MICU1|C2orf47
MITOCHONDRIAL ALANYL-TRNA AMINOACYLATION%GOBP%GO:0070143,0.9324414715719059,0.980055411497814,-0.533193647992942,-0.7103419664715931,6969,1,AARS2
GLUTAMINE TRANSPORT%GOBP%GO:0006868,0.865353697749196,0.954584411475564,0.412627515853322,0.6932675031286961,6458,2,SLC1A4|SLC1A5
MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION%GOBP%GO:0097345,0.847058823529412,0.9492491301138911,-0.20673258412916698,-0.691953315783098,6479,12,BAD
MEMBRANE DISRUPTION IN OTHER ORGANISM%GOBP%GO:0051673,0.518260869565217,0.8047799431921201,-0.7434384649316279,-0.990438545391571,3873,1,GSDMD
REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX%GOBP%GO:1904776,0.684610347085789,0.8857327229801228,-0.316195661872087,-0.8133404210530191,5226,6,SAPCD2|EPB41L2
HISTONE H3-K27 DEMETHYLATION%GOBP%GO:0071557,0.704380542864821,0.894436909245845,0.412098819896327,0.810549747875827,5241,3,KDM7A|KDM6B|PHF8
PLATELET FORMATION%GOBP%GO:0030220,0.734366857738405,0.9079405785880958,-0.25955276998609805,-0.780798263483931,5636,9,MEF2C|MYH9|ACTN1
NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION%GOBP%GO:0030835,0.608689748811948,0.8499587630754359,0.249706163247405,0.87452304421674,4482,13,ADD3|TRIOBP|TWF1|ADD1
DEOXYNUCLEOTIDE TRANSPORT%GOBP%GO:0030302,0.0409364548494983,0.289711424429654,-0.9789920599911779,-1.30425249376454,305,1,SLC25A19
HOMOGENTISATE CATABOLIC PROCESS%GOBP%GO:1902000,0.848695652173913,0.9492491301138911,-0.578958976621085,-0.771312373107728,6343,1,FAH
"REGULATION OF TRANSLATION, NCRNA-MEDIATED%GOBP%GO:0045974",0.521574267782427,0.8068178076540979,-0.298944742606215,-0.9365548542055351,3988,10,STAT3|TNRC6C|RBM4
SPERMIDINE BIOSYNTHETIC PROCESS%GOBP%GO:0008295,0.454629875298488,0.770794980018249,-0.6174248690377719,-1.02749371573885,3426,2,AMD1|SRM
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:1903747,0.774375948145084,0.92295358598278,0.140693024133176,0.807242648543944,5614,63,PARK2|BBC3|HTRA2|PMAIP1|HPS4|CASP8|TP53BP2|BID|YWHAQ|SH3GLB1|SREBF1|YWHAB|YWHAE|VPS11|BCL2|YWHAH|HSPA1L|CSNK2A2|UBL4B|YWHAZ|MAPK8
POSITIVE REGULATION OF GLOMERULAR METANEPHRIC MESANGIAL CELL PROLIFERATION%GOBP%GO:0072303,0.981939799331104,0.993436724391485,-0.50904278782532,-0.6781672217648139,7339,1,EGR1
POSITIVE REGULATION OF CALCIDIOL 1-MONOOXYGENASE ACTIVITY%GOBP%GO:0060559,0.377819050145927,0.7281989978224692,-0.64957264957265,-1.0809927633655099,2847,2,IL1B|TNF
CELLULAR DETOXIFICATION OF NITROGEN COMPOUND%GOBP%GO:0070458,0.11999462510077902,0.47202636254014396,0.691876745196764,1.3608399109744298,892,3,GSTM2|GSTM1|GSTM3
POSITIVE REGULATION OF B CELL DIFFERENTIATION%GOBP%GO:0045579,0.307439537329127,0.6790485699796851,-0.415803855314916,-1.13658129599508,2338,7,XBP1|BTK|SYK|NCKAP1L|MMP14
PULMONARY VEIN MORPHOGENESIS%GOBP%GO:0060577,0.804816053511706,0.932964969466025,-0.601951918835465,-0.801944493068292,6015,1,TBX20
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035023,0.0516815997922348,0.328140151305953,-0.289260103974125,-1.4868966130416497,397,45,ARHGEF2|GPR35|SCAI|PDCD10|RAF1|ROBO1|RAC1|KANK1|LPAR6|ARHGDIB|CCDC125|HEG1|ARRB1|ABL1|KANK2|F2R|APOE|DLC1|F2RL3|COL3A1|RASIP1|GPR4|ADGRG1|EPS8|ARHGDIA
MEIOSIS I CELL CYCLE PROCESS%GOBP%GO:0061982,0.954855305466238,0.9870180073166591,-0.11462608599314099,-0.621535470822003,7423,54,C17orf104|BLM|RAD54B|RAD21|TRIP13|EME2|MYBL1|DMC1|RAD51|RPA2|MLH3|BRIP1|RAD51C|PTTG1|TOP2A|STRA13|EME1|RMI1|REC8|RAD51B|FANCM|SYCE2|MUS81
REGULATION OF FILOPODIUM ASSEMBLY%GOBP%GO:0051489,0.9236968672819449,0.9776627603891009,-0.134747823910104,-0.63840605099377,7105,34,FAM206A|GAP43|FSCN1|CDC42|DOCK11|GPM6A|TGFB3|MYO10|FMR1|TENM2|BCAS3|ARF6
INHIBITORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0060080,0.9744599918489342,0.9920717971974051,0.250167768137323,0.5496292406522729,7172,4,DRD4|C15orf59
NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1901799,0.0252735799895779,0.223514802128899,-0.31856466251099397,-1.6157489426592202,193,43,USP25|UCHL5|OGT|PSMF1|BAG5|UBE2G2|PARK7|UBXN1|ALAD|HFE|GIPC1|TLK2|DERL3|TAF9|AK6
ACYLGLYCEROL ACYL-CHAIN REMODELING%GOBP%GO:0036155,0.267111634602801,0.6417330323279019,-0.5441636872810061,-1.1912880621061201,2040,4,DGAT1|PNPLA2|MGLL
VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0055015,0.406611126041387,0.743829322696499,0.5360648505569651,1.05437630123122,3025,3,PROX1|HEY2|MEF2A
REGULATION OF POSITIVE THYMIC T CELL SELECTION%GOBP%GO:1902232,0.685217160313455,0.8857920062408181,0.656815174239083,0.875774408900244,5158,1,PTPN2
REGULATION OF WOUND HEALING%GOBP%GO:0061041,0.00012809017548354,0.00518555396908895,-0.41769220879547997,-2.51066858885308,0,80,GP1BA|PLAU|PLEK|CASK|RREB1|FOXC2|VTN|TNFAIP3|MYLK|SMOC2|PHLDB2|FCER1G|F3|HRAS|FAP|HBEGF|CEACAM1|THBD|PDPN|F2R|APOE|INSL3|PLAUR|NOS3|SERPINE2|THBS1|SERPINE1|CAV1|PLAT|ENPP4|TNFRSF12A|TLR4|PDGFA|ANXA2|PDGFRA|ANXA1|TFPI|PDGFB|SERPINF2|C1QTNF1
RESPONSE TO GLYCINE%GOBP%GO:1905429,0.44693552666489794,0.768229288546963,-0.620402536531569,-1.03244903061336,3368,2,FYN|GRIN1
CELL MIGRATION INVOLVED IN HEART FORMATION%GOBP%GO:0060974,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
LINOLEIC ACID METABOLIC PROCESS%GOBP%GO:0043651,0.0241893305439331,0.218419923233982,-0.542711400723497,-1.70024397267894,184,10,ELOVL2|ELOVL1|ABCD1|GSTP1|FADS1|FADS2
REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING%GOBP%GO:0006349,0.0879781420765027,0.409521734239444,0.505327298445322,1.4668767423699498,643,8,KDM1B|PRMT7|DNMT3A|PCGF3|IGF2
ELASTIC FIBER ASSEMBLY%GOBP%GO:0048251,0.21251972645975797,0.5950741597527031,-0.521581074961005,-1.25013030985168,1615,5,FBLN5|MYH11|MFAP4|TNXB
POSITIVE REGULATION OF TRAIL PRODUCTION%GOBP%GO:0032759,0.5820735785953179,0.8387093286508721,-0.71344287604764,-0.9504772186324659,4350,1,HLA-E
NEGATIVE REGULATION OF CHEMOTAXIS%GOBP%GO:0050922,0.0254116426811876,0.22409063601871598,-0.324295792073978,-1.62410745214242,195,41,SEMA3B|SEMA3D|SEMA7A|CCL2|CORO1B|NOV|THBS1|SEMA5A|NBL1|AIF1|SEMA3E|SLIT2|SEMA3A|SEMA6B
SENSORY PERCEPTION OF TEMPERATURE STIMULUS%GOBP%GO:0050951,0.34329574786034495,0.701955655133333,0.49610865953527794,1.0899718530954599,2526,4,MMP24|TRPV1|EPHB1
VITAMIN D RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070561,0.250033444816054,0.630643295704944,-0.8719673577415091,-1.16166989222149,1868,1,PIM1
PURINE RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009181,0.0459007694348634,0.30746333312705,-0.860545905707196,-1.4320859987336299,345,2,NUDT16|NUDT18
POSITIVE REGULATION OF PEPTIDYL-THREONINE PHOSPHORYLATION%GOBP%GO:0010800,0.563938284518828,0.8289882771095609,-0.236546596569193,-0.917888768724609,4312,18,APP|RIPK2|TGFB1|CEMIP|CHI3L1|AZU1|RPTOR|PLK1|TNKS1BP1|SPHK1
MODULATION BY HOST OF VIRAL EXO-ALPHA-SIALIDASE ACTIVITY%GOBP%GO:0044866,0.878929765886288,0.960725750963158,-0.563134097926776,-0.7502298349094499,6569,1,PTX3
"POSITIVE REGULATION OF SYNAPTIC TRANSMISSION, GABAERGIC%GOBP%GO:0032230",0.10342979635584101,0.442538815478223,0.806120760959471,1.3543869608764398,771,2,HAP1|NLGN2
"REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, REM SLEEP%GOBP%GO:0042320",0.7952163396936309,0.929656485793048,0.37696385901080104,0.7414434260121658,5917,3,CHRNB2|CRH
REGULATION OF CHEMOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070099,0.157465825446898,0.527359258893039,-0.485761850503473,-1.32780835611074,1197,7,TREM2|SLIT2|RNF113A
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1901028,0.1159140969163,0.46559625491895207,0.27220688907466895,1.33675928626509,841,37,TMEM102|BBC3|BOK|PMAIP1|CASP8|TP53BP2|BID|YWHAQ|TMEM14A|YWHAB|YWHAE|ZNF205|BAX|BCL2|YWHAH|ACAA2
REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION%GOBP%GO:1902460,0.424214046822743,0.754268592539614,-0.7886524040582271,-1.05067436881522,3170,1,LTBP3
POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0035774,0.691256830601093,0.8879225792175841,0.27912199740735,0.810242327181521,5059,8,TRPM4|PPP3CB
REGULATION OF PEPTIDYL-TYROSINE AUTOPHOSPHORYLATION%GOBP%GO:1900084,0.31317890328491,0.682621192063885,-0.521031683014209,-1.14064726930843,2392,4,ACE|GREM1|CAV1
PLUS-END-DIRECTED VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072383,0.21357123546904602,0.5967526962380401,0.515443279420591,1.23963813119135,1579,5,KIF13A|KIF3B|KIFAP3|FYCO1
CELLULAR RESPONSE TO VITAMIN%GOBP%GO:0071295,0.410155738777647,0.7452892204937491,-0.47578145091244706,-1.04158505223968,3133,4,GAS6|POSTN|PIM1
DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS%GOBP%GO:0046545,0.270027354435326,0.644555061516783,-0.26836305250537196,-1.1569507225561397,2072,25,INHBA|SOD1|CEBPB|SLIT2|EIF2B2|ANG|PDGFRA|LHFPL2
REGULATION OF GRANULOSA CELL APOPTOTIC PROCESS%GOBP%GO:1904708,0.172532872891486,0.546371269738967,0.9153617115130129,1.2205113299322499,1298,1,BOK
PEPTIDYL-THREONINE PHOSPHORYLATION%GOBP%GO:0018107,0.7548076923076921,0.915912235661466,0.145160068340554,0.8174633530850559,5494,59,ACVR1|CSNK1G1|CDK10|CAD|TTBK2|VRK3|CDK5R1|VRK2|CSNK1G2|PRKCA|CAMK2D|OXSR1|MAP3K10|VPRBP|TNKS|MAP2K1|CDK5|CSNK1E|MAPK1|MAPK8|PDPK1
CELLULAR RESPONSE TO TRIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0071727,0.0747354497354497,0.383186929742657,-0.734972978934598,-1.43521594972352,564,3,TLR1|TLR2|CD14
POSITIVE REGULATION OF RRNA PROCESSING%GOBP%GO:2000234,0.569437206878583,0.832269842301315,-0.300404577309032,-0.903690499308019,4370,9,RIOK1|TRMT112|DIMT1
CHROMATIN REMODELING AT CENTROMERE%GOBP%GO:0031055,0.000777604976671851,0.0191067003244251,-0.44269530201359103,-2.18613908754129,5,39,MIS18BP1|RBBP4|HIST1H4J|CENPQ|HELLS|HIST4H4|NASP|CASC5|HIST1H4H|HJURP|ITGB3BP|CENPL|CENPU|CENPW|OIP5|RUVBL1|CENPM|NPM1|CENPI|HIST1H4I|STRA13|RBBP7|CENPH|HIST2H4A|POLE3|HIST2H4B|CENPK|MIS18A|CENPP
ISOCITRATE METABOLIC PROCESS%GOBP%GO:0006102,0.612552642304035,0.852045339927398,0.396394616346021,0.8708958536229939,4508,4,IDH1|IDH3B
MITOCHONDRIAL DNA REPLICATION%GOBP%GO:0006264,0.38920765027322396,0.735806837462884,0.361851177671135,1.05039066434365,2848,8,PRIMPOL|C10orf2|MGME1|POLG|TEFM|POLG2|SSBP1|DNA2
POSITIVE REGULATION OF TYPE II HYPERSENSITIVITY%GOBP%GO:0002894,0.5820735785953179,0.8387093286508721,-0.71344287604764,-0.9504772186324659,4350,1,HLA-E
REGULATION OF TUMOR NECROSIS FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0010803,0.6933558266286011,0.8891520167182042,-0.162159006293274,-0.8445246933233559,5342,47,GSTP1|TNFRSF1A|PELI3|SPHK1|HIST1H2BJ
REGULATION OF FOREBRAIN NEURON DIFFERENTIATION%GOBP%GO:2000977,0.926505704430884,0.9790847380319629,-0.378566135270128,-0.6299945863661071,6983,2,HES1
NEGATIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0010642,0.15598849372384901,0.52527967559184,-0.42421619541221606,-1.32901396285554,1192,10,APOD|HGS|LRP1|SLC9A3R1|PTGIR|PTPRJ
CELLULAR RESPONSE TO INTERFERON-ALPHA%GOBP%GO:0035457,0.0193844138834316,0.19226875441368102,-0.6568180286945521,-1.6895129074533302,147,6,IFNAR1|GATA3|GAS6|PDE12|AXL
PROMOTER CLEARANCE DURING DNA-TEMPLATED TRANSCRIPTION%GOBP%GO:0001109,0.275468189666622,0.65032483094354,0.864578738420821,1.15279908760543,2073,1,ERCC3
RESPONSE TO CHEMOKINE%GOBP%GO:1990868,0.154377279833246,0.5225398777782271,-0.250440745997121,-1.2702267958853402,1184,43,ZC3H12A|RHOA|STK39|GPR35|CCL3|CXCL12|CCL4|DUSP1|CCL8|CXCL1|ACKR3|CXCL2|CCL11|CCL19|CCL24|SLC12A2|CCL3L3|CCL18|CXCR4|RBM15|CCL2|CCR1|CX3CL1|CCL4L2|CCL14
CORPUS CALLOSUM MORPHOGENESIS%GOBP%GO:0021540,0.837037037037037,0.946216977301937,-0.361806551229734,-0.7065164950582249,6327,3,SZT2|PAFAH1B1|C12orf57
"CARNITINE METABOLIC PROCESS, COA-LINKED%GOBP%GO:0019254",0.9520364415862809,0.9858647066977451,0.34693808068262705,0.5829007705356349,7105,2,ACADM
REGULATION OF MATRIX METALLOPEPTIDASE SECRETION%GOBP%GO:1904464,0.146755852842809,0.514049001465687,-0.9252315835906478,-1.2326306305474,1096,1,CD200
NEURONAL DENSE CORE VESICLE EXOCYTOSIS%GOBP%GO:0099011,0.34378349410503806,0.702174649119653,0.6624069595248101,1.1129292188262099,2565,2,UNC13A|UNC13B
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA%GOBP%GO:0061418,0.863488182559087,0.9531672929044319,0.15533314220456199,0.7037352554230251,6356,28,EPAS1|RPS27A|NFE2L2|CITED2|ARNT|HIF1AN|EP300|EGLN2|LIMD1|TCEB1|UBA52|EGLN3
CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:0055007,0.45007179219422994,0.768588477853328,-0.22224870978803601,-1.0049020318735,3447,29,MYH11|CXADR|MYOM1|MESP1|MEF2C|BMP2|PDGFRB|IGSF22|MAML1|SIK1|PDGFRA
ARGININE BIOSYNTHETIC PROCESS%GOBP%GO:0006526,0.0870805597065616,0.407749299171126,0.657955328375416,1.4455558772047299,640,4,ASL|CAD|NAGS
ORGANELLE MEMBRANE FUSION%GOBP%GO:0090174,0.236862442040185,0.6217158626397761,-0.208476071094165,-1.16474231590978,1838,60,SNAP47|TAPBP|STX4|RAB7A|BNIP1|SYT7|CAV2|EEA1|STX11|CALR|NKD2|VAMP7|STX1B|STX7|RAB7B|STX3|RAB34|STX5|PRRT2|RAB20|GOSR2
REMOVAL OF SUPEROXIDE RADICALS%GOBP%GO:0019430,0.0667718191377497,0.3690551432905871,-0.55263380604467,-1.51059986447032,507,7,PRDX2|SOD2|SOD3|SOD1|CCS|NOS3
POSITIVE REGULATION OF VACUOLE ORGANIZATION%GOBP%GO:0044090,0.0527604025020397,0.332862866985249,0.489432039001259,1.5505537827615903,387,10,RALB|PIP4K2C|KIAA1324|RAB3GAP1|SH3GLB1
REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION%GOBP%GO:1902036,0.384092454112848,0.7313123859005379,0.250651579545807,1.04896495908108,2824,22,FOXC1|PUS7|TCF3|N4BP2L2|CBFB|TCF12|GATA2
NEGATIVE REGULATION OF RELAXATION OF MUSCLE%GOBP%GO:1901078,0.0821172724860706,0.39834333615753204,-0.819409980700303,-1.36362924139317,618,2,PDE4B|PDE4D
ADP METABOLIC PROCESS%GOBP%GO:0046031,0.0506544502617801,0.323146514170008,-0.33769672550520197,-1.50819134526106,386,28,GPI|PFKFB2|HK1|HK3|ENO1|PGAM1|GAPDH|LDHA|PGK1|ALDOA|ALDOC|BAD
D-GLUCONATE CATABOLIC PROCESS%GOBP%GO:0046177,0.11933110367892999,0.47098246139817795,-0.9386854874283191,-1.250554460932,891,1,IDNK
MICTURITION%GOBP%GO:0060073,0.0226871349001494,0.20908271623893998,0.7489659736392209,1.6455101407778099,166,4,CHRNB2|CHRNB4|KCNMA1|CHRNA3
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086054,0.602943143812709,0.8480120088902141,-0.7022496691662989,-0.93556517941905,4506,1,GJA5
TRNA TRANSCRIPTION%GOBP%GO:0009304,0.672707600757371,0.8820330910931731,0.29580720440724,0.8165678478366899,4973,7,GTF3C2|GTF3C3|GTF3C6
POSITIVE REGULATION OF DNA DUPLEX UNWINDING%GOBP%GO:1905464,0.3179888564606,0.6867397844771489,-0.675773773359633,-1.12459562322177,2396,2,GTF2H2
POSITIVE REGULATION OF TYPE I INTERFERON-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060340,0.9200420831141509,0.9768322640118741,-0.25861766288001703,-0.619857189131111,6995,5,FADD
POSITIVE REGULATION OF HEPATOCYTE DIFFERENTIATION%GOBP%GO:0070368,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
POSITIVE REGULATION OF POLARIZED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030862,0.11555319431531401,0.46493596964429496,0.943537715041906,1.2580802287693897,869,1,AHI1
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE%GOBP%GO:1902229,0.0950768429278458,0.42498053239300104,-0.302282032101687,-1.39308884933828,729,31,CD44|ACKR3|CD74|TRIAP1|KDM1A|SFRP2|TRIM32|SNAI2|TAF9B|NACC2|SNAI1|TAF9|ZNF385A|AK6
NEGATIVE REGULATION OF TRAIL-ACTIVATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903122,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
REGULATION OF GOLGI INHERITANCE%GOBP%GO:0090170,0.961261614971862,0.990138923096717,-0.258203275795511,-0.5652609448984489,7344,4,MAP2K1|MAPK1|MAP2K2|MAPK3
RETINOID METABOLIC PROCESS%GOBP%GO:0001523,0.6754675467546759,0.882488012133495,0.17531339630791,0.8551867999471959,4911,36,STRA6|GPC6|RETSAT|SDC1|ALDH8A1|AGRN|CYP4V2|ALDH1A3
PROTEIN O-LINKED GLYCOSYLATION VIA THREONINE%GOBP%GO:0018243,0.177576413308088,0.549484861882519,0.47047069460986396,1.2987217242989,1312,7,GALNT3|GALNTL6|GALNT2
REGULATION OF AGGREPHAGY%GOBP%GO:1905335,0.9307981725342651,0.9793746057014829,0.31228019797882395,0.614218297936467,6926,3,HTT
REGULATION OF NEURON DIFFERENTIATION%GOBP%GO:0045664,0.0673143650242887,0.370856021013721,0.15653051286243,1.2588060343107,484,312,RET|DKK1|ISLR2|CNTN4|BIN1|PTCHD2|BRINP2|SHTN1|ADGRB3|SLITRK1|DLL1|CPNE9|SEMA4G|SYT2|SEMA4F|KIF13B|PLXNB1|ULK4|RTN4IP1|SS18L1|PCP4|RTN4|INPP5J|SEMA6C|PTK7|TCF3|CCDC88A|RIMS1|CHN1|PTPRO|STK24|ROBO2|CHRNB2|NDEL1|ASCL1|PTPRS|ZSWIM4|EFNB2|BMP7|PTPRD|UNC13A|EFNB3|SCARB2|RIMS2|CDK5R1|NREP|SEMA4C|PTPN9|SARM1|RUFY3|MAP6|ADCYAP1|CAPRIN2|DVL2|TRIM46|CUX2|LIMK1|STMN2|NEDD4|CUL7|LRRC7|PAK1|TWF1|CRMP1|PTK2B|NRCAM|INPP5F|FOXO6|SIPA1L1|MAP2|ADCY6|GRIP1|DLG4|BRSK1|VLDLR|LINGO1|FBXO7|TCF12|ZSWIM8|CBFA2T2|TENM3|C21orf91|PLXNB2|CAMK1D|POU4F2|MOV10|YWHAH|NEDD4L|CERS2|NRP1|ZFYVE27|DCC|CPNE1|MEGF8|OBSL1|FGFR1|SHANK2|SEMA6D|CHRNA3|PROX1|CDK5RAP3
ENTERIC SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0035645,0.175652173913043,0.548366806412612,-0.909902955447728,-1.21220921724036,1312,1,EDNRB
REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL%GOBP%GO:0046719,0.7323869610935859,0.9075412450030892,-0.284314289913354,-0.7771604326633801,5571,7,IFIT1|DDB1
DESENSITIZATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY BY ARRESTIN%GOBP%GO:0002032,0.717845659163987,0.900060477413567,0.4877282837823971,0.819446489902192,5357,2,ARRB2|ADRB2
REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1905897,0.23869638026536102,0.622138010410922,-0.20190614939372503,-1.15951828749776,1852,67,BCL2L11|DAB2IP|UBQLN2|USP25|TMBIM6|OPA1|FCGR2B|UBE2G2|CREB3|UBQLN1|PARK7|UBXN1|CREB3L1|HERPUD1|FICD|SYVN1|BCAP31|CAV1|DERL3|HSPA5|NCK1|ERN1
POSITIVE REGULATION OF CORTICOTROPIN SECRETION%GOBP%GO:0051461,0.861193227626982,0.952004809592153,0.34929473082676393,0.687021516046113,6408,3,UCN|CRH
CELLULAR OXIDANT DETOXIFICATION%GOBP%GO:0098869,0.280334728033473,0.6535224424215009,-0.370815654366734,-1.1617170386904299,2143,10,SOD2|SOD3|SOD1|CCS|NOS3
POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION%GOBP%GO:0045989,0.49934912783129404,0.794989907195277,-0.332222533772225,-0.956422176718087,3835,8,KCNQ1|CHGA|RGS2
SOMITE SPECIFICATION%GOBP%GO:0001757,0.39826086956521706,0.7388683667002129,-0.80050727834142,-1.06646790788362,2976,1,COBL
PROTEIN LOCALIZATION TO EARLY ENDOSOME%GOBP%GO:1902946,0.20411179790378897,0.5836145519828481,0.6383875410720841,1.25563295860256,1518,3,LRRC7|NRP1|SCRIB
REGULATION OF ACETYL-COA BIOSYNTHETIC PROCESS FROM PYRUVATE%GOBP%GO:0010510,0.932650273224044,0.9800972968717879,0.207636272414651,0.6027317736732171,6826,8,PDPR|PDP1|GSTZ1
"O-GLYCAN PROCESSING, CORE 1%GOBP%GO:0016267",0.14314141682143802,0.509384864704371,-0.7688297010894671,-1.2794555677258899,1078,2,C1GALT1C1
DERMATAN SULFATE CATABOLIC PROCESS%GOBP%GO:0030209,0.47894806747244,0.7850984235874658,0.761138067931187,1.01487491105263,3605,1,IDUA
HYDROGEN SULFIDE BIOSYNTHETIC PROCESS%GOBP%GO:0070814,0.20317119054017702,0.581783510781437,0.639296349398919,1.257420477335,1511,3,CTH|MPST|CBS
NEGATIVE REGULATION OF HISTONE H3-K27 METHYLATION%GOBP%GO:0061086,0.5000654364611961,0.7951717058944731,-0.43764552836165205,-0.958097545935895,3820,4,H2AFY
REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL%GOBP%GO:0098903,0.7444675865659991,0.9112137767014771,-0.266659533246962,-0.767675474432282,5718,8,FLNA|CAV1
RESPONSE TO MANGANESE ION%GOBP%GO:0010042,0.285482562854826,0.6583248923580091,0.47960145845918395,1.15343875731448,2111,5,PARK2|D2HGDH|ATP13A2|IREB2
MITOTIC DNA REPLICATION PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:1902977,0.277190635451505,0.652442157557974,-0.858237759153066,-1.14337877023065,2071,1,CDC45
POSITIVE REGULATION OF AMINO ACID TRANSPORT%GOBP%GO:0051957,0.39774254232733103,0.7384545116012259,0.540901152063769,1.06388873557398,2959,3,TRH|RAB3GAP1
CELLULAR RESPONSE TO INTERLEUKIN-21%GOBP%GO:0098757,0.547712933753943,0.8186230305367759,-0.336445373856774,-0.9196584258702171,4166,7,IL2RG|JAK3|STAT3|IL21R
REGULATION OF MACROPHAGE CYTOKINE PRODUCTION%GOBP%GO:0010935,0.0455966649296509,0.306090947669213,-0.5307993869605829,-1.59677448104043,349,9,TGFB2|TGFB1|LILRB1|CD74|IRAK3|TGFB3|SEMA7A|GPRC5B
CHAPERONE-MEDIATED PROTEIN FOLDING%GOBP%GO:0061077,0.0937378451964216,0.42337598780415003,-0.274387874133042,-1.37416334731637,722,41,CHORDC1|HSPA13|DNAJC7|ERO1L|TOR1A|PDIA4|PPIB|HSPA6|HSPA9|HSPB1|FKBP1A|FKBP4|HSPA5|HSPB6|DNAJB5|FKBP5
POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM%GOBP%GO:1900426,0.811093247588424,0.935316201530063,0.44323132065067605,0.7446858466054329,6053,2,CYBA|F2RL1
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS%GOBP%GO:1903427,0.0138670852956567,0.157188774525237,-0.473772665585014,-1.76072267356483,105,16,CD34|INS|GLA|PARK7|CAV1|MPV17L|ABCD1|SIRPA|PTGIS
RNA PHOSPHODIESTER BOND HYDROLYSIS%GOBP%GO:0090501,0.27257503542444894,0.646906729960491,-0.21464180476683603,-1.13929551081749,2115,50,PDE12|NCBP1|NUDT16|RNASE4|CSTF3|RNASE6|EXOSC3|RNASE1|TUT1|CPSF7|EXOSC2|ERN1
NEGATIVE REGULATION OF CHAPERONE-MEDIATED PROTEIN FOLDING%GOBP%GO:1903645,0.37618729096990006,0.7266197487465021,-0.81004631671813,-1.07917619745958,2811,1,PDCD5
RNA STABILIZATION%GOBP%GO:0043489,0.0794228519433251,0.3955855191077921,-0.300360308524086,-1.4230421900398,610,34,FAM46C|YBX1|DHX9|PAPD4|HNRNPU|LARP1|DHX36|MAPKAPK2|SLC11A1|E2F1|DKC1|CCRN4L|YBX3|HNRNPA0|HNRNPC
SLIT DIAPHRAGM ASSEMBLY%GOBP%GO:0036060,0.18023641917917396,0.553886683619651,0.9118879576532859,1.21587954788383,1356,1,PTPRO
PRESYNAPSE ORGANIZATION%GOBP%GO:0099172,0.536612021857923,0.8132910857498922,0.317888465993712,0.9227746034470241,3927,8,PTPRD|NLGN2|NLGN4X|DVL1|FZD1|NLGN4Y|PTEN|NLGN3
POSITIVE REGULATION OF STRESS-ACTIVATED PROTEIN KINASE SIGNALING CASCADE%GOBP%GO:0070304,0.565603293028042,0.8298229800621719,-0.145135361339105,-0.941689960694101,4396,109,PYCARD|PLCB1|ARHGEF5|CCL19|MID1|DAB2IP|EMC10|TNFRSF11A|IL1RN|FCGR2B|PKN1|MDFIC|TRAF2|TAOK2|MAPK8IP1|ZNF622|FLT4|MLKL|CTGF|HRAS|MAP3K13|GADD45B|SASH1|FGF19|GADD45G|BMP2|MAP3K11|LTBR|SEMA3A|ARL6IP5|DBNL|SERPINF2|ERN1
POSITIVE REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL%GOBP%GO:2001190,0.34465375431148904,0.702388156466409,-0.663523573200993,-1.1042093312035,2597,2,HLA-DMB|LGALS9
MITOTIC G1/S TRANSITION CHECKPOINT%GOBP%GO:0044819,0.992393966739719,0.997305769352475,-0.091693083972122,-0.514198780344758,7697,61,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|RPA2|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A|CCND1
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION%GOBP%GO:1902107,0.00038714672861014303,0.0111294649577428,-0.34981909155633695,-2.05055778025696,2,73,NCKAP1L|CD74|IL18|ADAM8|RUNX1|CCL19|ZFP36L1|RUNX3|CD4|HCLS1|GATA3|IL34|GAS6|LILRB2|TESC|SOCS1|HAX1|MMP14|NKAP|C10orf54|CSF1|CCR1|CD86|NLRP3|AXL|LGALS3|TGFBR2|LGALS9|FADD|ATP6AP1|BCL6|LILRB4|PNP|ANXA1|LGALS1|SART1
DCDP PHOSPHORYLATION%GOBP%GO:0061570,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0090050,0.12482009682062,0.47935751228257,-0.357074512348725,-1.35697034316848,953,17,KIAA1462|MAP3K3|PIK3C2A|KDR|SRPX2|FOXC2|HMOX1|RHOJ|ANXA1
POSITIVE REGULATION OF INTERFERON-GAMMA BIOSYNTHETIC PROCESS%GOBP%GO:0045078,0.975265017667845,0.9925252846799709,-0.24619941320686198,-0.538981980433781,7451,4,CEBPG|EBI3
PROTEIN K11-LINKED UBIQUITINATION%GOBP%GO:0070979,0.274637775747292,0.649047934290704,-0.254597626057675,-1.1511683104011399,2103,29,UBE2L3|UBE2A|UBE2D2|UBE2T|ANAPC10|UBE2B|ANAPC2|ANAPC5|CDC23|UBE2S|CDC27|ANAPC13|ANAPC11|RNF26
POSITIVE REGULATION OF SINGLE-STRANDED TELOMERIC DNA BINDING%GOBP%GO:0060381,0.31810333377606603,0.6867397844771489,0.8410895456550509,1.12147941851615,2394,1,ACD
GLYCOLIPID METABOLIC PROCESS%GOBP%GO:0006664,0.5898547030333929,0.8414799095069009,-0.151598302412507,-0.920965300952355,4627,83,ST6GALNAC4|GLTP|GLA|PIGP|NEU4|UGCG|STS|B3GALT2|FUCA1|PIGH|B3GNT5|NDUFAB1|HEXB|SMPD1|A4GALT|B3GALT1|ST3GAL5|GBGT1
TELOMERE LOCALIZATION%GOBP%GO:0034397,0.0663545150501672,0.3690551432905871,-0.964986766651963,-1.28559408016746,495,1,NUP98
NITRITE TRANSPORT%GOBP%GO:0015707,0.256588628762542,0.634929462604421,-0.868052492280547,-1.1564543514128502,1917,1,SLC11A1
REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS%GOBP%GO:2000674,0.965086265453063,0.990916952887267,0.260009535796026,0.571252023336091,7103,4,WFS1|TCF7L2
NEGATIVE REGULATION OF GROWTH OF SYMBIONT IN HOST%GOBP%GO:0044130,0.9232301766502858,0.9776156396135859,0.539258932509925,0.719029022753894,6950,1,TIRAP
THREONYL-TRNA AMINOACYLATION%GOBP%GO:0006435,0.274206349206349,0.6487430099175849,-0.6023752064987329,-1.1762861069235502,2072,3,TARSL2
CELL PROJECTION MORPHOGENESIS%GOBP%GO:0048858,0.10411723656664301,0.44419145940290994,0.155710800291634,1.22063617403755,745,269,TNR|RET|CNTN4|SHTN1|DRD2|ROBO3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|SEMA4F|PLXNB1|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|ALS2|SLIT1|EPHB2|EFNA4|PARD3|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|NYAP2|STK24|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|BMP7|NTNG1|EFNB3|SLIT3|CDK5R1|SHC1|SOS1|NYAP1|MAP6|ATP7A|DRAXIN|SPTBN1|PAK1|EFNA2|EPB41L3|NRCAM|STRADB|MAP2|DLG4|BRSK1|VLDLR|TUBB3|ULK2|PPP3CB|PRKCA|PLCG1|KIF5A|PLXNB2|POU4F2|DOCK7|CELSR2|NRP1|DCC|CPNE1|EZR|ANKRD27|SRC|SHANK2|VSTM2L|GPC1|RANBP9
RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN-ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0001999,0.479732441471572,0.785690196949452,-0.7630679311865899,-1.01658970775599,3585,1,PCSK5
NEPHRON TUBULE DEVELOPMENT%GOBP%GO:0072080,0.183981506663041,0.556414865076203,0.32211340744607897,1.26088931891605,1352,18,CITED1|PAX8|AHI1|FGF2|PKD1|TFAP2B|PKD2
ANASTRAL SPINDLE ASSEMBLY%GOBP%GO:0055048,0.982876254180602,0.993436724391485,-0.508601676224085,-0.677579555194827,7346,1,NUMA1
RESPONSE TO DIETARY EXCESS%GOBP%GO:0002021,0.50515873015873,0.797902257689198,-0.500359789656595,-0.977075853531962,3818,3,GDF15|SGIP1
POSITIVE REGULATION OF L-GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0002038,0.0877591973244147,0.40905715364188894,-0.9539038376709309,-1.27082895759654,655,1,ARL6IP1
DETECTION OF HORMONE STIMULUS%GOBP%GO:0009720,0.33525083612040096,0.6982881520550831,-0.829620644022938,-1.10525390150275,2505,1,ABCG1
PYRUVATE OXIDATION%GOBP%GO:0009444,0.36817638464603497,0.721642468110297,0.816993824437583,1.08935102557714,2771,1,NR4A3
MULTICELLULAR ORGANISMAL MOVEMENT%GOBP%GO:0050879,0.0739141810570382,0.38239128347091206,-0.395718150854462,-1.47064187354552,564,16,JSRP1|TNNT3|VTI1A|XRCC1|MAP1A|RCSD1|MYH3|TNNT2|GAA|TNNI2|TNNC2|STAC3
ANGIOTENSIN-ACTIVATED SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0086098,0.600424515786681,0.8464076674715391,-0.559170513394604,-0.930549152376743,4525,2,CAV1
EPITHELIAL CELL FATE COMMITMENT%GOBP%GO:0072148,0.485109289617486,0.7872939093021379,0.33214043822911304,0.9641455855200909,3550,8,ACVR1|DLL1|NRP1|PROX1
POSITIVE REGULATION OF HEART CONTRACTION%GOBP%GO:0045823,0.673076923076923,0.8821483794774391,-0.224807149264769,-0.8354704136448861,5144,16,APLN|TGFB2|ATP2A2|ADM|RYR2|PDE4D|KCNQ1|CHGA|RGS2
DOUBLE-STRAND BREAK REPAIR%GOBP%GO:0006302,0.152987945627084,0.52097307188263,-0.17277820779438,-1.20609268529807,1192,155,NIPBL|PAPD7|XRCC1|CDC7|MMS22L|BLM|C7orf49|ZFYVE26|DNA2|SETX|RAD54B|UBE2N|RAD21|INO80|MTA1|HIST1H4H|TRIP13|EME2|TDP1|UIMC1|DMC1|APTX|RAD51|RPA2|XRCC2|NABP2|BRIP1|PALB2|SETMAR|DTX3L|TONSL|H2AFX|NBN|PARP9|YY1|EXO1|GINS2|PARP1|RAD51C|PAXIP1|AP5S1|KDM2A|RAD51AP1|BRCC3|VCP|SLX1B|AUNIP|SLX1A|RNF168|HIST1H4I|RNF138|CDC45|PARP2|BRCA1|POLQ|EME1|NUCKS1|C9orf142|RMI1|REC8|RAD51B|TNKS1BP1|HIST2H4A|NSMCE1|KAT5|POLA1|HIST2H4B|MUS81|SAMHD1|CDCA5|XRCC6BP1|XRCC3|FEN1|PRPF19
DEDIFFERENTIATION%GOBP%GO:0043696,0.8894694533762059,0.965159112268525,0.396498592596279,0.666168829567286,6638,2,NCOA3
DCTP METABOLIC PROCESS%GOBP%GO:0046065,0.43959866220735794,0.7650340344477281,-0.7818703131892372,-1.04163899530167,3285,1,DCTPP1
MAINTENANCE OF ANIMAL ORGAN IDENTITY%GOBP%GO:0048496,0.68753287743293,0.886571049066943,-0.33947061409736895,-0.813646285035958,5227,5,PKP2|ADGRV1
RNA (GUANINE-N7)-METHYLATION%GOBP%GO:0036265,0.7437516796560072,0.91090604694447,0.39774509626182303,0.782317667337587,5534,3,METTL1|WBSCR22
DENDRITE SELF-AVOIDANCE%GOBP%GO:0070593,0.11221436343852001,0.459194647507502,0.41006699496466,1.3937379570572999,824,12,CNTN4|ROBO3|IGSF9
GLYCOPROTEIN TRANSPORT%GOBP%GO:0034436,0.9582117272486071,0.988711428754361,-0.346639414095063,-0.576863416864221,7222,2,ABCG1
CELL-CELL JUNCTION MAINTENANCE%GOBP%GO:0045217,0.8164073164073159,0.937396775102383,0.23521454076372303,0.71479529554571,5980,9,KIFC3|CAMSAP3|NLGN2|PARD6A|PLEKHA7
SEMI-LUNAR VALVE DEVELOPMENT%GOBP%GO:1905314,0.0747590518364157,0.383189309025961,-0.31200856410491495,-1.43791428332859,573,31,HEYL|TGFB2|ROCK1|ROBO1|GJA5|TGFB1|JAG1|GATA3|SMAD6|EFNA1|NOTCH1|ELN|SNAI2|NOTCH2|NOS3|SLIT2|SNAI1|TNFRSF1A|TNFRSF1B
LUNG LOBE DEVELOPMENT%GOBP%GO:0060462,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
MAINTENANCE OF PROTEASE LOCATION IN T CELL SECRETORY GRANULE%GOBP%GO:0033379,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
PROTEIN TRANSPORT WITHIN PLASMA MEMBRANE%GOBP%GO:0099632,0.516409004610795,0.804056180000979,0.264299331613896,0.9499898629116429,3807,14,CACNG7|LRRC7|CACNG4|VPS35|RAB11A
LIMBIC SYSTEM DEVELOPMENT%GOBP%GO:0021761,0.6505485574969531,0.8720434729248241,0.207717576214731,0.856243223414636,4802,21,FGFR2|BBS4|RAB3GAP1|MKKS|BBS2|PROX1|LRP8|MFSD2A|LEF1|PAFAH1B1
PROTEIN-HEME LINKAGE%GOBP%GO:0017003,0.30943143812709006,0.680809181688249,-0.84246801940891,-1.12236969035362,2312,1,HCCS
NEUROTRANSMITTER UPTAKE%GOBP%GO:0001504,0.788822409573022,0.928016475452072,0.234283385773717,0.7422256025390591,5800,10,SLC6A2|SNAP25
METHOTREXATE TRANSPORT%GOBP%GO:0051958,0.573781378669146,0.835204333784353,0.7110719011910009,0.9481184332754821,4319,1,SLC46A1
REGULATION OF ACTIN FILAMENT-BASED MOVEMENT%GOBP%GO:1903115,0.191274710293115,0.5657618283915489,0.278584218112255,1.24680289864373,1402,27,TRPM4|BIN1|SCN5A|ANK2|RANGRF|RNF207|SRI|CACNA1C
POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0010613,0.8083464154892729,0.934193159096917,-0.199088279256525,-0.739889134159154,6178,16,AGT|PARP1|IL6ST|SLC9A1|IGF1
NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION%GOBP%GO:0002091,0.98527865404837,0.99458733327411,-0.181456551557886,-0.496003391744074,7495,7,LRPAP1|UBQLN2|NECAB2
POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901992,0.0009052114315272211,0.0215081872561296,-0.387810444407446,-2.07953814542693,6,52,LSM11|CCND2|BRD4|DLGAP5|PLCB1|CDT1|ANAPC5|ESPL1|CDC6|RAD51C|LSM10|DDX3X|CDC25C|CDC45|MECP2|FGF10|DTL|RPTOR|RAD51B|CCNB1|HYAL1|AIF1|CCND3|ANXA1|ANAPC11|CCND1|CDCA5|EIF4G1
NEGATIVE REGULATION OF OXIDATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902176,0.216741405082212,0.599597524514766,0.317420577637557,1.2205766907569098,1594,17,PARK2|NOL3|HTRA2|MAPK7|NME5|NFE2L2
NEPHRIC DUCT DEVELOPMENT%GOBP%GO:0072176,0.313497430348932,0.683135650527455,0.4088452916214939,1.12860645347202,2317,7,AHI1|PKD1|PKD2|GPC3
NEGATIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032804,0.3829928362960999,0.730480369014206,-0.647422111938241,-1.07741392484503,2886,2,FURIN|ANXA2
CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION%GOBP%GO:0060581,0.9161515721580219,0.9747758552206228,0.321016054675281,0.631400697159484,6817,3,ASCL1
POSITIVE REGULATION OF BLOOD MICROPARTICLE FORMATION%GOBP%GO:2000334,0.6709030100334449,0.8815356925073421,-0.668228936921041,-0.8902413952088148,5014,1,TNF
POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY%GOBP%GO:0090091,0.18298620503110602,0.556308895147568,0.466671287929488,1.28823356413976,1352,7,RLTPR|CLASP1|CLASP2
RESPONSE TO ELECTRICAL STIMULUS%GOBP%GO:0051602,0.147089947089947,0.514131830678897,-0.6762435204588071,-1.32053220224036,1111,3,PTEN|REST|NSMF
POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0045591,0.0504168837936425,0.322183465117595,-0.5246115458908761,-1.57815994048977,386,9,LILRB2|SOCS1|C10orf54|LGALS9|BCL6|LILRB4
POSITIVE REGULATION OF NON-MOTILE CILIUM ASSEMBLY%GOBP%GO:1902857,0.46159915833771703,0.775450927278973,-0.410153233769647,-0.983059036905146,3509,5,SEPT7|SEPT9
RESPONSE TO L-ARGININE%GOBP%GO:1903576,0.407148615963451,0.74431926580977,0.5358313095857921,1.05391695370057,3029,3,GATSL3|GATS|GATSL2
RESPONSE TO VASOPRESSIN%GOBP%GO:1904116,0.358613361668216,0.714938712241162,0.821956329951478,1.09596785707488,2699,1,ADCY6
PROTEIN-LIPID COMPLEX REMODELING%GOBP%GO:0034368,0.0345234969808349,0.265648036188578,-0.44333028237662897,-1.6096603920131103,262,15,APOC2|PLTP|AGT|ABCA5|APOC1|PLA2G2A|ABCG1|CETP|PLA2G7|APOM|APOE
POSITIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033148,0.0729879011046817,0.38011088999831294,-0.6218705550652621,-1.4905050566673503,554,5,WBP2|PAGR1|YAP1
DGDP CATABOLIC PROCESS%GOBP%GO:0046067,0.154247491638796,0.5225398777782271,-0.9210961623290691,-1.22712125645377,1152,1,NUDT18
TENDON DEVELOPMENT%GOBP%GO:0035989,0.675378084372513,0.882488012133495,-0.5279294182519989,-0.878558974232716,5090,2,SCX|BMP4
FOLIC ACID TRANSPORT%GOBP%GO:0015884,0.329563387690689,0.6957352559323989,-0.4657107117130139,-1.1162197101928302,2505,5,SLC19A1|PDPN|FOLR2
POSITIVE REGULATION OF DNA LIGASE ACTIVITY%GOBP%GO:1904877,0.7606688963210699,0.91820552689264,-0.6239523599470671,-0.831254363246386,5685,1,XRCC1
GAMMA-AMINOBUTYRIC ACID CATABOLIC PROCESS%GOBP%GO:0009450,0.8278403001071809,0.943061234519578,0.43358147229115,0.7284728554190741,6178,2,ABAT|ALDH5A1
REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0034243,0.5521119393226099,0.822813841873357,-0.22378330517049,-0.9267448932712521,4221,22,HNRNPU|SUPT16H|RNF168|CTR9|EAPP|NELFB
INTRACELLULAR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030522,0.0793671047594743,0.395545778489815,-0.207955977322732,-1.3363578804887501,621,104,STAT3|IFIH1|BRCA1|DDX5|SNW1|PIM1|CALR|IRF7|IRAK1|RAN|WBP2|CRY2|NCOA4|GPER1|RBM14|CDK7|FHL2|PDK3|PPAP2A|UBC|PPARG|RELA|YAP1|KAT5|PHB
REGULATION OF HEMATOPOIETIC STEM CELL MIGRATION%GOBP%GO:2000471,0.992508361204013,0.997305769352475,-0.50363917071019,-0.670968306282475,7418,1,PTPRC
POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS%GOBP%GO:1900119,0.41446161907257,0.748680069094768,-0.31692603514802004,-1.0260650900464399,3163,11,FAP|DLC1|PTGIS
POSITIVE REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE-SPECIFIC DNA BINDING%GOBP%GO:1905636,0.588125913135875,0.8414799095069009,0.704289810322011,0.939075430228577,4427,1,DDRGK1
ESTABLISHMENT OF GOLGI LOCALIZATION%GOBP%GO:0051683,0.9425930747201251,0.982273087744777,-0.20295227134455698,-0.584271183911694,7240,8,PDCD10|CDC42|SLC9A3R1|COPG1
GROWTH PLATE CARTILAGE AXIS SPECIFICATION%GOBP%GO:0003421,0.736722408026756,0.908157084784786,-0.6364689016321129,-0.8479294021697621,5506,1,STC1
REGULATION OF CELL JUNCTION ASSEMBLY%GOBP%GO:1901888,0.009299922500645829,0.121992788205563,-0.28777737342149606,-1.6710088321772099,71,70,EPHA3|RAP1B|ROCK1|TNF|PTEN|RCC2|RAC1|DUSP3|PRKCH|APOD|PEAK1|CORO1C|RUNX1|AGT|PPM1F|KDR|CLDN5|RAPGEF1|THY1|PHLDB2|SLC9A1|BCAS3|S100A10|SNAI2|ABL1|GPM6B|EPHA2|RAP1A|DLC1|THBS1|TEK|SNAI1|CAV1|FAM107A|PRKACA|COL16A1|ACVRL1|OCLN|EFNA5|PTPRJ
NEGATIVE REGULATION OF RECEPTOR BINDING%GOBP%GO:1900121,0.62226588081205,0.856494784917583,-0.3363300424687,-0.865131471869889,4750,6,PTPRF|LEF1|ADAM15|RUVBL2|B2M|HFE
CEREBELLUM MORPHOGENESIS%GOBP%GO:0021587,0.32438296718199106,0.692794968343412,0.309433901755201,1.11222025463943,2391,14,DLL1|ATP7A|ADCK4|AGTPBP1|LRP6|PROX1|ZNF365
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT%GOBP%GO:1903651,0.224700761697497,0.6078034241178771,0.35798575651956394,1.21672395748453,1651,12,PARK2|MTMR2|TRIM46|MAP2|VPS11|EZR
EXONUCLEOLYTIC TRIMMING INVOLVED IN RRNA PROCESSING%GOBP%GO:0000459,0.34568874868559396,0.7033175795366851,-0.4014792535811,-1.0974256359521901,2629,7,EXOSC3|EXOSC2
DTTP METABOLIC PROCESS%GOBP%GO:0046075,0.44378306878306895,0.7664039155808309,-0.527478055006127,-1.0300309526635,3354,3,DCTPP1|CMPK2
DGTP CATABOLIC PROCESS%GOBP%GO:0006203,0.0708994708994709,0.3767214120425879,-0.7386277177805509,-1.44235272839991,535,3,NUDT1|SAMHD1
PROSTATE GLAND EPITHELIUM MORPHOGENESIS%GOBP%GO:0060740,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
NEGATIVE REGULATION OF ENDODERMAL CELL DIFFERENTIATION%GOBP%GO:1903225,0.0173280423280423,0.17886971906195498,-0.825576265578471,-1.6121412052304,130,3,MESP1|COL5A2|COL5A1
ENDOSOMAL TRANSPORT%GOBP%GO:0016197,0.619539427773901,0.854944793214197,0.127730789663523,0.927917811067326,4438,180,CHMP3|FAM21A|DCTN1|CCDC132|SGSM2|RAB13|RPS27A|RAB10|TBC1D14|FAM21C|CLTCL1|HEATR5B|TMEM50B|SNX33|PIKFYVE|RIC1|GCC2|TBC1D17|VPS36|CLEC16A|EHD3|GGA1|ARL4C|DENND2A|FAM109B|STAM2|MICALL1|RAB11FIP3|DCLK1|TRIM27|LRRC7|VAMP3|WASH1|STX10|STX16|RAB11B|VPS35|RAB11A|CLN5|ZFYVE16|TMEM87A|DPY30|RAB6A|STX6|TMEM87B|ZFYVE9|SORT1|LEPROTL1|EPS15|ANKRD27|VPS52|TBC1D5|KIAA1033|UBXN6|CHMP1A|PLEKHJ1|LAPTM4B|PICALM|GOSR1
POSITIVE REGULATION OF NK T CELL DIFFERENTIATION%GOBP%GO:0051138,0.14876254180602,0.5154128781388279,-0.9232465813850899,-1.22998613098246,1111,1,TGFBR2
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE%GOBP%GO:2000010,0.7794157794157791,0.924704689181848,0.24554197748982,0.7461794232569119,5709,9,RANGRF|SNX33|TM9SF4
POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS%GOBP%GO:0062013,0.0182918974623213,0.18562016781464602,-0.27305920964034,-1.5961261415164598,141,72,PHKG2|PFKFB2|PFKFB3|INS|VCP|ABCG1|PPP1R3E|IRS1|PARK7|ENO1|IGF1|NR1H3|P2RY6|GPER1|CCNB1|NOS3|SLC45A3|NR1D1|PPARA|ABCD1|NFKB1|ANXA1|TMSB4X|PDGFB
REGULATION OF DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING%GOBP%GO:0110026,0.5534599548412801,0.8234525480304059,0.722265108072342,0.963043064320374,4166,1,ZNF365
NEURAL FOLD BENDING%GOBP%GO:0021503,0.151304347826087,0.518496345408823,-0.922198941332157,-1.2285904228787399,1130,1,LUZP1
REGULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0071655,0.204497354497355,0.584214223487405,-0.639339048650194,-1.24846712219807,1545,3,CD34|HAVCR2
POSITIVE REGULATION OF MUSCLE HYPERTROPHY%GOBP%GO:0014742,0.8083464154892729,0.934193159096917,-0.199088279256525,-0.739889134159154,6178,16,AGT|PARP1|IL6ST|SLC9A1|IGF1
POSITIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0090031,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
REGULATION OF ESTABLISHMENT OF PROTEIN-CONTAINING COMPLEX LOCALIZATION TO TELOMERE%GOBP%GO:1904913,0.6392615221144909,0.865463150027443,0.6779885310983679,0.904006223290581,4812,1,TERF1
PROTEIN LOCALIZATION TO T-TUBULE%GOBP%GO:0036371,0.0612299110107584,0.35631208031004796,0.9695632995147769,1.29278183395751,460,1,ANK2
REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0006359,0.12166951043444,0.47422187863138704,-0.33327665221263697,-1.35777148081916,926,21,ZNF143|BRF2|DHX36|CEBPA|BRCA1|RPTOR|CHD8|PRDX5
VITAMIN TRANSPORT%GOBP%GO:0051180,0.7191483590995391,0.900474259627538,0.22140138077687602,0.7957987108341791,5302,14,STRA6|SLC5A6
REGULATION OF SKELETAL MUSCLE FIBER DIFFERENTIATION%GOBP%GO:1902809,0.7106109324758839,0.8964108318214721,0.490919231161419,0.824807693498843,5303,2,RBM24
NEURONAL SIGNAL TRANSDUCTION%GOBP%GO:0023041,0.7555293809710771,0.916183794263895,-0.34974907626978397,-0.765673838647152,5772,4,P2RY11|RTN4R|TMEM57|OLFM1
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0060445,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
REGULATION OF PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0090313,0.331970564186427,0.6961761803662729,0.24729429065583103,1.09352785806309,2435,26,TCAF2|MFF|MIEF2|MYO1C|INPP5K
INTERLEUKIN-2 SECRETION%GOBP%GO:0070970,0.0631438127090301,0.36006266503904,-0.9667512130569029,-1.2879447464474099,471,1,PNP
NERVOUS SYSTEM PROCESS%GOBP%GO:0050877,0.0965315503552027,0.42759608527799,0.154599106550103,1.22594591079675,692,287,CALB1|DKK1|HTR3A|CHRNB1|STRA6|SCN5A|DRD2|CTNNA2|GPR155|PITPNA|CAMK4|BBS4|HOMER2|JAKMIP1|CYFIP1|DCTN1|KCNMB4|EYA4|KIFC3|ABLIM1|EPHB2|EYS|PIEZO2|GABRA3|CACNG7|DOPEY2|TUSC3|KIT|DRD4|PTCHD1|WFS1|CHRNB2|ASIC1|TTC8|COL11A1|ARRB2|ADORA2A|RAB3GAP1|CHRNA5|MMP24|HTT|ADCY3|CTNS|GABRB3|ADCYAP1|WDR1|EYA1|TAS2R5|CUX2|TSHZ3|MYO9A|CHRNB4|DFNB59|MKKS|CDC14A|NF1|DFNA5|CACNG4|SCN3A|NETO1|SCN9A|HRH3|TRPV1|TIMM13|SCN2A|ATXN1L|DLG4|BRSK1|ST3GAL4|VLDLR|RPGR
POSITIVE REGULATION OF INTRACELLULAR MRNA LOCALIZATION%GOBP%GO:1904582,0.15826479172194197,0.528194339395059,-0.7595257788806179,-1.26397235336134,1192,2,ZFP36L1|DHX36
TRANSLESION SYNTHESIS%GOBP%GO:0019985,0.0418610679108346,0.293009782616793,-0.30995776080776194,-1.5306482208112901,322,39,POLD4|PCNA|VCP|POLD1|POLD2|KIAA0101|RFC5|ISG15|DTL|NPLOC4|RCHY1|UBC|POLE2|UBE2L6|RFC4
UNIDIMENSIONAL CELL GROWTH%GOBP%GO:0009826,0.418382255279586,0.75036705317022,0.7920710189677991,1.0561198273885202,3149,1,BIN3
PREGANGLIONIC PARASYMPATHETIC FIBER DEVELOPMENT%GOBP%GO:0021783,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
"POSITIVE REGULATION OF MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0048026",0.20635337358886802,0.586178082333662,-0.340128299557153,-1.23495072131076,1571,15,RBMX|NCBP1|SNW1|CELF4|TRA2B|NUP98
REGULATION OF ENDOCYTOSIS%GOBP%GO:0030100,0.000773893976525216,0.0191067003244251,-0.251157583266852,-1.77381979161365,5,165,APOC2|BICD1|SYNJ1|LRPAP1|GREM1|LILRB1|PPT1|PSEN1|RAB5C|C4B|PYCARD|NCKAP1L|GNB2L1|B2M|CCL19|MERTK|UBQLN2|TLR2|LRP1|FGR|SFRP4|APOC1|TOR1A|MCTP1|TNK2|SGIP1|C4A|SYT7|AZU1|FCGR2B|C2|GAS6|VTN|C3|FMR1|PRKD1|CD47|CD63|ARRB1|FCER1G|PIK3CB|SLC11A1|ABL1|CALR|NECAB2|DYSF|NR1H3|ARF1|STX1B|CCL2|CD300A|HFE|APOE|AXL|HCK|LGALS3|CD151|HNRNPK|CD300LF|SERPINE1|CAV1|LDLR|TUB|LMAN2|STON2|ITGAM|DAB2|ANXA2|RAB20|ARF6|PTPRJ|SIRPA
LONG-CHAIN FATTY ACID IMPORT%GOBP%GO:0044539,0.20010422094841102,0.577942761520067,-0.41714364048200103,-1.25487017583806,1535,9,FABP3|CD36|SLC27A4|RPS6KB1
AMINE METABOLIC PROCESS%GOBP%GO:0009308,0.0512720664589824,0.326583343318156,-0.307054821495203,-1.5027131189698701,394,38,KMO|MAOA|CCBL1|SAT1|MOXD1|GDE1|ODC1|SMOX|KYNU|GDPD1|HAAO|INMT|VCAM1|SLC44A1|SMS|AFMID|SAT2|HNMT|AOC3
NEGATIVE REGULATION OF NITRIC-OXIDE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0051771,0.400132275132275,0.739739965222774,-0.5446950217860971,-1.06365132516249,3024,3,GSTP1
ADENOSINE CATABOLIC PROCESS%GOBP%GO:0006154,0.169174952969632,0.541811331682474,0.6584605639557579,1.2951142258422,1258,3,ADAL|CECR1
REGULATION OF MITOTIC SISTER CHROMATID SEPARATION%GOBP%GO:0010965,0.0291838842975207,0.242147886926844,-0.29825281844677504,-1.57146348304362,225,49,TACC3|TRIP13|DUSP1|KLHL22|APC|DLGAP5|CDC20|CDT1|LCMT1|ANAPC5|ESPL1|CDC6|CDC23|PTTG1|CDK5RAP2|MAD2L1|NDC80|CDC27|USP44|CCNB1|PLK1|IK|NEK6|ANAPC11|XRCC3
REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY%GOBP%GO:0043666,0.461707632600259,0.775450927278973,-0.206697617135543,-0.995306870729029,3568,36,PPP6R3|CRY2|PPP2R4|CD300A|LGALS3|PDGFRB|FKBP1A|STYXL1
AGGRESOME ASSEMBLY%GOBP%GO:0070842,0.815761016490944,0.9368364474725541,0.299504258996475,0.7203060253760419,6034,5,PARK2|HDAC6|TRIM37
CORNEA DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0061303,0.0759204514915345,0.38531099082072706,0.7366235347116551,1.4488515654816498,564,3,WNT6|WNT2B
POSITIVE REGULATION OF VACUOLAR TRANSPORT%GOBP%GO:1903337,0.879399654668615,0.960922253956646,0.559384649316277,0.7458639504947092,6620,1,SNAPIN
NEGATIVE REGULATION OF GLUTAMATE METABOLIC PROCESS%GOBP%GO:2000212,0.392880860672068,0.737280445732591,0.8045875606528449,1.0728089468328001,2957,1,ATCAY
IMMUNE RESPONSE-ACTIVATING SIGNAL TRANSDUCTION%GOBP%GO:0002757,0.000127975428717686,0.00518555396908895,-0.25974776192732996,-2.0370666270649798,0,294,RAF1|RIPK2|SPPL3|CREBBP|CDC42|TIFA|PAK2|MUC3A|BTNL9|SYK|IGHV2-26|HLA-DQB2|NFATC2|RPS6KA5|RAC1|WIPF3|EIF2B5|IGHV1OR15-1|IGKV3-11|NFKBIZ|MNDA|HLA-DPA1|ACTG1|NCR3|CD38|S100A1|ALPK1|IGHV5-51|SLA2|CLEC4A|LYN|HLA-DRA|HLA-DRB5|PRAM1|CD209|TLR1|IGHV1-24|NCKAP1L|VAV3|WASF2|IRAK3|HSP90B1|IGHV3-49|FPR3|ITGB2|IGHG4|HLA-DPB1|CD4|NCKIPSD|PIK3AP1|TLR2|HLA-DQA2|FGR|FCGR1A|IGLL5|CTSS|ARPC1A|LAT2|VAV1|TICAM2|MYO1G|GATA3|WAS|EIF2B1|FCGR2B|THY1|PDE4B|BCAR1|IGKV2-28|FPR1|MYO10|TNFAIP3|IKBKE|IGHV4-4|RC3H2|PDE4D|CLEC4E|ELMO1|MAPKAPK2|UNC93B1|IGHV4-61|GRB2|MEF2C|CLEC10A|IFIH1|IGHV1-3|FCER1G|MUC4|PIK3CB|MAPK3|ABL1|IGHV3-43|IRF7|IRAK1|HRAS|FCN1|IGHV3-73|ICOSLG|TNIP1|FCGR2A|DOCK1|PIK3R4|CYFIP2|IGKV2D-28|HCK|COLEC12|CD36|MUC20|TNFRSF21|LGALS9|IGHV3-15|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|EIF2B2|TRAF3|C3AR1|STOML2|RELA|NFKB1|PRKACA|TLR4|S100A8|ITGAM|IGHV1-18|S100A9|HSP90AA1|ACTB|CMKLR1|NCK1|CD14|IGHG2|LY96|IGHA1|EIF2B3|C5AR1|PRKCB|PTPRJ|ICAM2
CARNITINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902603,0.8490969899665551,0.9492491301138911,-0.578683281870313,-0.770945081501486,6346,1,SLC22A5
RENAL SYSTEM VASCULATURE DEVELOPMENT%GOBP%GO:0061437,0.00980648535564853,0.126483803718766,-0.584340161162144,-1.8306614448963099,74,10,TEK|PDGFRB|PDGFRA|ACTA2|PDGFB
REGULATION OF BRANCH ELONGATION INVOLVED IN URETERIC BUD BRANCHING%GOBP%GO:0072095,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS%GOBP%GO:1900242,0.35778721146192605,0.714938712241162,-0.657788806175903,-1.09466576181555,2696,2,ROCK1|TOR1A
NEGATIVE REGULATION OF BILE ACID BIOSYNTHETIC PROCESS%GOBP%GO:0070858,0.686654284956222,0.8861361847538001,-0.522353001230436,-0.8692789245727081,5175,2,FGF19
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION%GOBP%GO:1903556,0.0141268803139307,0.158957792983414,-0.3777618796051189,-1.7247867852586898,107,30,PTPN22|DICER1|ZC3H12A|RARA|MC1R|CD274|LILRB1|CLEC4A|IRAK3|CD34|GAS6|TNFAIP3|POMC|PTPN6|GHRL|C10orf54|LGALS9|CX3CL1|HAVCR2|TLR4|GSTP1|SIRPA
MACROPHAGE ACTIVATION%GOBP%GO:0042116,0.00026150627615062797,0.00819882332206558,-0.562948637840286,-2.18445008102776,1,18,MAPT|TNF|SYK|SBNO2|TLR1|ITGB2|AZU1|CD93|SLC11A1|DYSF|AIF1|FOXP1|CX3CL1|TLR4|ITGAM
REGULATION OF CHROMATIN SILENCING AT TELOMERE%GOBP%GO:0031938,0.481427434332714,0.7857362908355991,-0.606506754893852,-1.00932422786564,3628,2,SIRT6|CDC45
CELLULAR RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0071216,0.00025598361704850896,0.00819882332206558,-0.32641470601693895,-2.09224304983898,1,103,IGFBPL1|GSK3B|CHMP5|IL1B|CCL3|TNF|SYK|CD180|CXCL1|CD274|TGFB1|CXCL2|LILRB1|SBNO2|LYN|ADAM9|MTDH|TLR1|PYCARD|IL18|HMGB2|DAB2IP|TLR2|PDCD1LG2|TICAM2|IL1RN|FCGR2B|PDE4B|CASP1|TNFAIP3|LILRB2|MEF2C|EME1|CTR9|CARD16|IRAK1|NR1H3|CCL2|CD86|NLRP3|AXL|TMCO1|HCK|CD36|NR1D1|PABPN1|TICAM1|SERPINE1|RELA|PLAA|SMC1A|NFKB1|TLR4|VIM|GSTP1|CD14|MUS81|TNFRSF1B|SIRPA
RESPIRATORY BURST%GOBP%GO:0045730,0.004322766570605189,0.0730503440569312,-0.583469531938685,-1.8890140014795802,32,11,SLC11A1|CYBB|PGAM1|NCF2|HCK|CD55
NEGATIVE REGULATION OF FASL BIOSYNTHETIC PROCESS%GOBP%GO:0045221,0.667558528428094,0.88092952466726,-0.669827966475518,-0.892371686525017,4989,1,JAK3
POSITIVE REGULATION OF PHOSPHOLIPID SCRAMBLASE ACTIVITY%GOBP%GO:1900163,0.779784831982999,0.924704689181848,0.6098919276576971,0.813208591071659,5870,1,PRKCD
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009129,0.7901452422967289,0.928247620398227,0.285396842967298,0.738481105451812,5820,6,DCTD|CDADC1|DUT
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002579,0.381046267087277,0.729499056535481,-0.388481113381462,-1.06189579936027,2898,7,PYCARD|CCL19|SLC11A1|TREM2
NEURONAL-GLIAL INTERACTION INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021812,0.163899588258733,0.535290477921284,0.9201588001764449,1.22690760038006,1233,1,LAMB1
"DNA-TEMPLATED TRANSCRIPTION, TERMINATION%GOBP%GO:0006353",0.0024471921689850603,0.0466374562837302,-0.307686884413956,-1.7933093466076002,18,71,ZNRD1|TWISTNB|LSM10|CPSF2|SNRPF|PAPOLA|NCBP1|TTF1|CLP1|POLR2H|GTF2H1|POLR3K|CSTF3|UBTF|CDK7|SNRPB|PABPN1|MNAT1|PTRF|CPSF7|PRMT5|MAZ|POLR2L|SMN1|GTF2H2
ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB%GOBP%GO:0048003,0.814021164021164,0.93598587081542,-0.37134664166758596,-0.7251458737573672,6153,3,CD1E|CD1C|CD1D
POSITIVE REGULATION OF PERK-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903899,0.397240085744909,0.73793528435462,0.637809373746526,1.07160209879583,2964,2,BOK|TMEM33
GLOMERULUS DEVELOPMENT%GOBP%GO:0032835,0.0386070170862136,0.279777317018993,-0.35677892559934793,-1.5735693654185803,295,27,MTSS1|NUP93|IQGAP1|PLCE1|JAG1|ANGPT2|BASP1|CD34|MEF2C|SULF1|KLF15|TEK|PDGFRB|MYO1E|PDGFRA|ACTA2|PDGFB
NEGATIVE REGULATION OF ZINC ION TRANSMEMBRANE IMPORT%GOBP%GO:0071584,0.710718554920972,0.8964108318214721,0.643857520952801,0.858497126656157,5350,1,SLC30A1
REGULATION OF UBIQUITIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:2000395,0.965351170568562,0.990916952887267,-0.516927657697397,-0.6886717617033289,7215,1,VPS28
LEADING STRAND ELONGATION%GOBP%GO:0006272,0.11785714285714301,0.46862716515177505,-0.698025807874711,-1.36306748886557,890,3,POLE|PCNA|POLA1
RESPONSE TO STEM CELL FACTOR%GOBP%GO:0036215,0.267282958199357,0.6417330323279019,0.6997518610421839,1.17567347517081,1994,2,KIT|FER
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION%GOBP%GO:0010595,0.0017823042647994898,0.0360399767147062,-0.30279300268508597,-1.83472781626313,13,82,PPAP2B|TGFB1|STAT5A|KIAA1462|MAP3K3|PIK3C2A|AGT|KDR|P2RX4|EMC10|PDCD6|GPI|GATA3|SRPX2|BCAR1|FOXC2|ATP5B|SMOC2|FLT4|PRKD1|BCAS3|ABL1|CALR|HMOX1|HSPB1|SPARC|RHOJ|MAP2K3|SASH1|NOS3|NRP2|THBS1|TEK|ATOH8|SEMA5A|FOXP1|ANXA1|LGMN|TMSB4X|PDGFB
SPHINGOLIPID TRANSLOCATION%GOBP%GO:0099039,0.29521633969363104,0.668293026992989,0.591343283681439,1.16310245590278,2196,3,ABCB1|ABCB4
REGULATION OF HETEROTYPIC CELL-CELL ADHESION%GOBP%GO:0034114,0.441092539747248,0.7653693162885199,0.260966691058869,1.00349467744377,3245,17,MAPK7|MAP2K5|FLOT2|BMP7|FLOT1
POST-CHAPERONIN TUBULIN FOLDING PATHWAY%GOBP%GO:0007023,0.31095406360424,0.68160868787154,-0.5226382837919821,-1.14416445425088,2375,4,TBCC|TBCE|RP2|TBCD
PURINE NUCLEOTIDE INTERCONVERSION%GOBP%GO:0015950,0.99880604934996,0.999656642395059,-0.272015439757375,-0.452677190295591,7528,2,GMPR|GMPR2
NEGATIVE REGULATION OF OSSIFICATION%GOBP%GO:0030279,0.45900968489974103,0.7735063645065241,0.209279341086674,0.9965981388417571,3364,33,TRPM4|DKK1|SFRP1|CITED1|FAM101B|TWIST1
HINDBRAIN DEVELOPMENT%GOBP%GO:0030902,0.0913316926442439,0.417945333484754,0.285474364395291,1.38369830679444,667,35,FOXC1|SCN5A|CTNNA2|DLL1|AHI1|BMP7|TTBK2|SEMA4C|CEP290|ATP7A|ADCK4|AGTPBP1|LRP6|NLGN4X|PROX1
POSITIVE REGULATION OF GAMMA-DELTA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:2001193,0.589565217391304,0.8414799095069009,-0.7099691221879141,-0.9458493443938201,4406,1,LILRB1
HISTONE H2A-K119 MONOUBIQUITINATION%GOBP%GO:0036353,0.17308217308217302,0.5470255474072271,0.42532781623958704,1.29253200557096,1267,9,BMI1|COMMD3-BMI1|PCGF3|PCGF1|RNF2
REGULATION OF INTERLEUKIN-13 SECRETION%GOBP%GO:2000665,0.0193691925140688,0.19226875441368102,-0.754444829826477,-1.65163743979455,147,4,GATA3|TNFRSF21|LGALS9
PRONUCLEAR FUSION%GOBP%GO:0007344,0.702085270288219,0.8931369333627571,0.648599470666079,0.8648198767539929,5285,1,CDK1
CANONICAL GLYCOLYSIS%GOBP%GO:0061621,0.108800836929515,0.45309795582492896,-0.333166647892361,-1.37972977612122,831,22,GPI|HK1|HK3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0086103,0.434446627373936,0.762034923704788,-0.393363141073312,-1.01183596540528,3316,6,PDE4D|CHGA|CAV1
ORGANOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0046434,0.0255885363357216,0.22470485454905398,-0.23512214789034602,-1.5004559485460502,199,101,DCTPP1|GDE1|GPI|PFKFB2|NUDT17|GPX1|HK1|VCP|NUDT1|HK3|PDE4D|PDXP|PLA2G4D|PLA2G4A|NUDT16|PDE2A|SMPDL3A|ENO1|PGAM1|HPRT1|PLA2G4C|GAPDH|SYNJ2|NUDT18|NUDT4|LDHA|IMPA2|ABCD1|HINT1|SMPD1|PNP|PGK1|SAMHD1|ALDOA|ALDOC
HISTONE DEACETYLATION%GOBP%GO:0016575,0.734696678561625,0.9079405785880958,0.162974236931589,0.814260389744292,5352,39,PRDM5|HDAC11|HDAC1|MTA3|HDAC10|TBL1XR1|SMARCAD1|HDAC4|SIN3A|SIN3B|TBL1X|SUDS3|MIER1|SIRT1|HDAC6|HDAC2
CATION TRANSPORT%GOBP%GO:0006812,0.116935996946176,0.46732071559498706,-0.14569826454267998,-1.1898650570004,918,380,SLC36A1|TCIRG1|ITPR2|ATP6V0B|ATP1B1|CCDC109B|ATP2A1|P2RX4|SLC12A8|ATP6V0A2|ERO1L|SLC39A3|NDUFA9|ATP5J|SLC7A2|ATP6V1G2|SLC22A3|ITPR3|SLC8B1|ATP1A3|ATP5F1|SLC12A2|SCNN1D|PMPCA|ATP1B3|P2RX5|KCNN2|P2RX3|GRIN3A|GAS6|ATP6V1F|ANXA6|KCNK6|SLC39A8|CACNA1H|STIM1|ATP2A3|GRIN1|PIEZO1|SLC41A1|ATP5B|TMEM63C|SGK1|KCNK7|JPH4|ATP6V0D1|SLC9A1|RHBG|CACNA2D4|PKD2L1|CLTC|SLC39A11|CALCRL|ABCC9|SLC9A7|SLC11A1|CACNA1G|MRS2|TAF7|NALCN|SLC1A3|SLC35G1|NDUFS7|SLC9A9|ATP5O|KCNJ12|ARHGAP1|SLC44A1|KCNN1|SLC24A3|HFE|CACNA1E|F2R|CCR1|KCNQ1|STEAP4|SLC7A3|TMCO1|KCNB2|ATP6V0E1|GRIN2C|GRIN2D|FKBP1A|CAMK2A|SLC3A2|RHCE|SLC30A5|CAV1|SCN1B|STOML2|ATP6AP1|ATP1B2|HEPH|KCNH2|ATP6V0E2|KCNE4|ATP5H|SLC25A42|ATOX1|MAGT1|CACNA1I|KCNJ9|PHB|ATP2B2|SLC25A19|TFRC|ATP6V1A|ATP6V1G1|NIPAL3|FTH1|ATP5G1
RESPONSE TO CAFFEINE%GOBP%GO:0031000,0.30715935334872996,0.6786107324984411,0.51426644226592,1.1298652750517701,2260,4,GSTM2|RYR1|SLC8A1
ATRIOVENTRICULAR CANAL DEVELOPMENT%GOBP%GO:0036302,0.234000785237534,0.617951264290741,-0.562130758829693,-1.2306217375189399,1787,4,PTPN11|FOXN4|TBX2
REGULATION OF ALDOSTERONE METABOLIC PROCESS%GOBP%GO:0032344,0.974092582851131,0.9920058127185359,-0.223194797726614,-0.5349553406632229,7406,5,CLCN2|REST|BMP2
POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY%GOBP%GO:0099527,0.446537543114885,0.768043844625006,-0.620567962503446,-1.03272432588416,3365,2,KPNA1|KPNA2
REGULATION OF ISOTYPE SWITCHING%GOBP%GO:0045191,0.9166327223353701,0.9751624921048409,0.177257082054443,0.6207912571771039,6750,13,RIF1|TP53BP1|MAD2L2|SUPT6H|FAM35A|C20orf196
TRIMMING OF FIRST MANNOSE ON A BRANCH%GOBP%GO:0036511,0.44198821007502703,0.7653693162885199,0.6189137027846711,1.03985493186108,3298,2,MAN1B1|EDEM2
PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009173,0.149030100334448,0.5157092501209121,-0.9231914424349359,-1.22991267266121,1113,1,UMPS
BRADYKININ CATABOLIC PROCESS%GOBP%GO:0010815,0.561608477109088,0.8282270665374359,0.4129478512378211,0.907264015643468,4133,4,XPNPEP1
REGULATION OF CHRONIC INFLAMMATORY RESPONSE%GOBP%GO:0002676,0.833576836233232,0.944697596992989,0.5823775915306569,0.7765219364342159,6275,1,CCL5
RRNA TRANSPORT%GOBP%GO:0051029,0.7690897184020958,0.920961303431461,-0.29221234688366904,-0.7516488741309799,5871,6,MRPL18|TST|NPM1
NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009124,0.263590798097931,0.638953045564964,-0.191714479149356,-1.13374661916446,2050,75,ATP5J|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|PGAM1|HPRT1|RFK|GAPDH|UMPS|GMPS|LDHA|STOML2|ATP5H|PGK1|ALDOA|ALDOC|ATP5G1
REGULATION OF INTERLEUKIN-23 PRODUCTION%GOBP%GO:0032667,0.422065174715351,0.7527812076478722,-0.470018285890165,-1.02896827928797,3224,4,RAC1|IL17RA|TLR4
REGULATION OF TUMOR NECROSIS FACTOR SECRETION%GOBP%GO:1904467,0.0239717055279015,0.21705599521464,-0.523706122024069,-1.69552674649,182,11,IFIH1|LGALS9|CX3CL1|HAVCR2|C1QTNF4
UTERUS MORPHOGENESIS%GOBP%GO:0061038,0.22052518756698802,0.602958169274706,0.7238468583961422,1.21615618175649,1645,2,STRA6|NIPBL
GLOMERULUS VASCULATURE DEVELOPMENT%GOBP%GO:0072012,0.0022146951537259,0.0428977385273153,-0.670482660543951,-2.0169759585954,16,9,ANGPT2|CD34|TEK|PDGFRB|PDGFRA|ACTA2|PDGFB
MAMMARY GLAND DUCT MORPHOGENESIS%GOBP%GO:0060603,0.47542060988433205,0.784986345464663,-0.35831827233702,-0.9794470184579849,3616,7,LRP5|EPHA2|CSF1R
REGULATION OF INTRACELLULAR STEROL TRANSPORT%GOBP%GO:0032380,0.31879502292076,0.6867397844771489,-0.43490949971612497,-1.1187043918463602,2433,6,SCP2|ABCA2|ANXA2
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS%GOBP%GO:0002699,0.0025624599615631,0.0483335984321714,-0.267771348534986,-1.74974986081815,19,112,MALT1|HLA-F|CLCF1|SASH3|PUM1|TRAF6|MICB|RARA|IL1B|CD1D|HLA-DMB|SYK|HLA-B|PVR|UNC13D|NFKBIZ|MICA|TGFB1|NCR3|LILRB1|HLA-E|LYN|CD74|TNFRSF14|B2M|IL18|CCL19|CD84|ITGB2|SNX4|STX4|FGR|STXBP2|HLA-C|PAXIP1|GPI|FES|HLA-A|TRAF2|ADGRE2|PVRL2|MZB1|DDX60|RSAD2|TNFRSF4|VAMP8|VAMP7|TNFSF13|SNX6|SEMA7A|GPRC5B|STX7|CD300A|HFE|CD86|NLRP3|LGALS9|ZP3|FADD|TICAM1|IL1R1|DHX58|ITGAM|ANXA1|PHB|TFRC|PTPRJ
DRUG TRANSMEMBRANE TRANSPORT%GOBP%GO:0006855,0.157977059436913,0.527990543848753,-0.275293962748412,-1.2805589931042098,1211,32,SLC7A2|SLC22A3|SLC25A10|SLC25A18|SLC1A2|ATP8B1|SLC1A3|SLC25A22|SLC6A8|SLC7A3|ARL6IP5|PRAF2|ABCC1
REGULATION OF MINERALOCORTICOID SECRETION%GOBP%GO:2000855,0.60952380952381,0.8505496974657741,-0.45250447465892096,-0.883626552221231,4607,3,C1QTNF1
POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035022,0.30010718113612,0.6734519006497671,0.6838709677419351,1.14899152396126,2239,2,ALS2|AUTS2
RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009156,0.150477912684061,0.517264655410678,-0.21705582026067302,-1.2603568808024999,1164,70,ATP5J|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|PGAM1|HPRT1|RFK|GAPDH|UMPS|GMPS|LDHA|STOML2|ATP5H|PGK1|ALDOA|ALDOC|ATP5G1
HIPPOCAMPUS DEVELOPMENT%GOBP%GO:0021766,0.9893935273320641,0.9962702115525078,0.125073095908471,0.48958946467061604,7275,18,BBS4|MKKS|BBS2|PROX1|LRP8|MFSD2A|LEF1|PAFAH1B1
THIRD VENTRICLE DEVELOPMENT%GOBP%GO:0021678,0.635977712921199,0.8636797415465791,-0.5447177972081361,-0.906497521479374,4793,2,C12orf57
POSITIVE REGULATION OF CHEMOTAXIS%GOBP%GO:0050921,0.00203925567167984,0.0401182609751702,-0.301294901837055,-1.8303776858313998,15,83,NCKAP1L|CD74|CCL19|PPM1F|KDR|STX4|P2RX4|MOSPD2|AZU1|VEGFC|GAS6|CREB3|SMOC2|PRKD1|DSCAM|F3|PLA2G7|CALR|HSPB1|CSF1|CCR1|VEGFB|LGALS9|THBS1|STX3|SEMA5A|AIF1|PDGFRB|RARRES2|SLIT2|SERPINE1|CMKLR1|LGMN|TMSB4X|PDGFB
TRNA TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0042797,0.5416044522872271,0.815622645995152,0.35369540810415795,0.9152076570094301,3989,6,GTF3C2|GTF3C3|GTF3C6
REGULATION OF VESICLE SIZE%GOBP%GO:0097494,0.377666077978536,0.7281989978224692,0.48168842257975397,1.05828997838033,2779,4,RAB22A|RAB3B|PICALM
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-INDEPENDENT DECAY%GOBP%GO:0031086",0.7326784544859201,0.907749523807984,-0.30279631570238796,-0.778873693106869,5593,6,DCP1B|EDC4|EDC3|PNRC2|DCP1A|ZFP36L1
GRANULOCYTE CHEMOTAXIS%GOBP%GO:0071621,0.00104343289422199,0.0240545523142212,-0.395239628075025,-2.0147980719494503,7,44,IL1B|TGFB2|CCL3|SYK|CCL4|CCL8|CXCL1|CXCL2|CCL11|NCKAP1L|CCL19|ITGB2|CXADR|CCL24|IL1RN|PDE4B|CCL3L3|ADGRE2|CCL18|FCER1G|CCL2|LGALS3|CX3CL1|CCL4L2|CCL14|S100A8|S100A9|ANXA1
SYNAPTIC MEMBRANE ADHESION%GOBP%GO:0099560,0.0196823673136962,0.192875553303031,0.672504719250419,1.74014548770085,144,6,SLITRK1|PTPRS|PTPRD|NTNG1
NEGATIVE REGULATION OF METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072308,0.991366715367247,0.997150662115148,0.504631671812969,0.672858242969697,7463,1,STAT1
POSITIVE REGULATION OF INTRACELLULAR CHOLESTEROL TRANSPORT%GOBP%GO:0032385,0.390079365079365,0.7358910495632479,-0.549077459092162,-1.07220911449707,2948,3,ANXA2
RESPONSE TO AMYLOID-BETA%GOBP%GO:1904645,0.0159185803757829,0.17118675948268897,-0.394347007027274,-1.72021365970292,121,26,NTRK1|FYN|APP|CACNB1|GSK3B|ADRB2|PSEN1|LRP1|ATP1A3|FCGR2B|GRIN1|CASP4|IGF1|CD36|EPHA4|TLR4|LGMN|NGFR|PRNP
MONOACYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0046462,0.694801714898178,0.889726625344871,0.497766749379653,0.8363124082243399,5185,2,ABHD16A|ABHD12
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION%GOBP%GO:0010575,0.24536732816401602,0.62804240987169,-0.30099117754440097,-1.1891880624772,1866,19,RORA|CYP1B1|IL6ST|C3|FLT4|BRCA1|SULF1|CCBE1
EMBRYONIC FORELIMB MORPHOGENESIS%GOBP%GO:0035115,0.217905175927184,0.6003539541723659,0.564243434962335,1.2396668564079099,1603,4,TBX3|CACNA1C|ZNF358
G1 TO G0 TRANSITION%GOBP%GO:0070314,0.163049303322615,0.534744357685457,0.761230506949255,1.27896553812397,1216,2,CYP27B1|ZNF503
RADIAL GLIAL CELL DIFFERENTIATION%GOBP%GO:0060019,0.174197773411919,0.54811765844537,-0.5051415953679571,-1.2993602614136202,1329,6,HES1|STAT3|FGF10
L-LYSINE CATABOLIC PROCESS TO ACETYL-COA VIA L-PIPECOLATE%GOBP%GO:0033514,0.39181830256342104,0.7371240382543249,0.805359505955007,1.07383823173245,2949,1,PIPOX
PEPTIDYL-PROLINE MODIFICATION%GOBP%GO:0018208,0.074166121648136,0.38287566727393396,-0.31603862632791496,-1.4429704947770199,566,30,P4HA3|PPIF|PPIA|P4HA1|PPIB|PPIC|FKBP1A|P3H2|FKBP4|CWC27|FKBP5|NTMT1|P4HB
RESPONSE TO MAGNESIUM ION%GOBP%GO:0032026,0.7841519318925999,0.927080511528825,-0.28805438051526,-0.7409534645330641,5986,6,SLC41A1|THBS1
RESPONSE TO TUMOR CELL%GOBP%GO:0002347,0.520497707924034,0.8057545841213242,-0.36502323448836604,-0.93893809129173,3973,6,IGFBPL1|RBMS3|PRF1|MICA
SERYL-TRNA AMINOACYLATION%GOBP%GO:0006434,0.717845659163987,0.900060477413567,0.487783234594383,0.8195388143613159,5357,2,SARS2
ADENYLATE CYCLASE-INHIBITING G PROTEIN-COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007197,0.31576101649094396,0.685583406115178,0.465797425288442,1.12024013669823,2335,5,CHRM4|HRH3|CHRM3|CHRM1
LUNG-ASSOCIATED MESENCHYME DEVELOPMENT%GOBP%GO:0060484,0.151929260450161,0.519318984997959,0.7688725986994979,1.29180523897478,1133,2,FGFR2|WNT11
MOLYBDOPTERIN COFACTOR METABOLIC PROCESS%GOBP%GO:0043545,0.214931237721022,0.5979177134734279,-0.4827031430633689,-1.2416425174789398,1640,6,MOCS2|MBIP|GPHN
REGULATION OF POTASSIUM ION EXPORT%GOBP%GO:1902302,0.682798527091005,0.885415243771438,-0.340732165792594,-0.8166699837231921,5191,5,KCNH2
NEGATIVE REGULATION OF PRI-MIRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:1902894,0.00784518828451883,0.108222437264782,-0.5904294545120511,-1.84973840606251,59,10,SRF|PPARA|RELA|LILRB4|PDGFB
MITOCHONDRIAL CALCIUM ION HOMEOSTASIS%GOBP%GO:0051560,0.7224339597844659,0.9019989179378242,-0.20402408233840802,-0.806080115550597,5496,19,AFG3L2|SLC8A3|FIS1|CCDC109B|ATP2A1|SLC8B1|ANXA6|TGM2|BCAP31
MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0050804,0.247304928131417,0.6282584621543791,-0.15694941291773998,-1.11963812908138,1926,173,NPTX1|CDC20|SEPT5|SNCAIP|ACHE|ANAPC2|MPP2|IQSEC2|STX4|PXK|TOR1A|MCTP1|SHISA7|PLK2|NGF|SYT7|NAPA|INS|CLSTN2|CPLX2|GRIN1|FMR1|ADCY8|LILRB2|JPH4|CALB2|NPAS4|CBLN1|SYP|MEF2C|LGI1|VPS18|SYN1|DBN1|CAMK2B|ABL1|NTRK2|ARF1|NSMF|STX1B|GPER1|APOE|GIPC1|GRIN2C|EPHA4|GRIN2D|DTNBP1|TMEM108|CX3CL1|CAMK2A|FAM107A|PRRT2|LGMN|NPTX2|PSMC5|SQSTM1|NPTXR|ADGRB1
CAP1 MRNA METHYLATION%GOBP%GO:0097309,0.252411575562701,0.632257972333528,0.7069754618141719,1.1878100571446002,1883,2,CMTR1|CMTR2
REGULATION OF NOTCH SIGNALING PATHWAY INVOLVED IN SOMITOGENESIS%GOBP%GO:1902366,0.82247491638796,0.9412507273497192,-0.5923577415086021,-0.789162745171078,6147,1,LFNG
REGULATION OF GLUCOCORTICOID SECRETION%GOBP%GO:2000849,0.354282611646532,0.712220724869897,0.416917577366289,1.07879873587469,2609,6,CRHR1|GAL|UCN|CRH
LYMPHOTOXIN A PRODUCTION%GOBP%GO:0032641,0.48386239872493,0.787078399497453,0.758325981473313,1.01112537320392,3642,1,BCL10
RESPONSE TO LIPID HYDROPEROXIDE%GOBP%GO:0006982,0.0492172990183073,0.318097230821966,-0.8548951469383269,-1.42268223251796,370,2,GPX3
REGULATION OF LYASE ACTIVITY%GOBP%GO:0051339,0.15141213389121302,0.518496345408823,-0.306692133360792,-1.30343292052422,1157,24,STIM1|PHPT1|PARK7|AKAP5|GNAI2|EDNRB|NOS3|FXN|ADGRV1
NEGATIVE REGULATION OF CD4 BIOSYNTHETIC PROCESS%GOBP%GO:0045225,0.5363262053393539,0.8132910857498922,0.730370533745037,0.973850555766675,4037,1,ACOT8
SPINAL CORD MOTOR NEURON DIFFERENTIATION%GOBP%GO:0021522,0.6069827469093871,0.8492159043277758,0.39811393591794,0.8746732719442591,4467,4,SOX4|ZC4H2|ISL1|TBX20
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SPINDLE POLE BODY%GOBP%GO:1902365,0.982876254180602,0.993436724391485,-0.508601676224085,-0.677579555194827,7346,1,NUMA1
REGULATION OF METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072307,0.30395055092717,0.676707700393746,0.585816936009131,1.15223278218328,2261,3,PAX8|STAT1
MEMBRANE LIPID METABOLIC PROCESS%GOBP%GO:0006643,0.425213948141525,0.7547028278218628,-0.147303356685303,-1.01599645130392,3328,145,PPAP2B|SPTLC2|GM2A|PPT1|CLN6|SGPP1|FUT7|NEU1|GPAA1|DPM2|B4GALT4|PYURF|CERS6|SPTSSB|SUMF1|CERS4|CYP1B1|PPAP2C|ELOVL2|ST6GALNAC4|NSMAF|GLTP|GLA|PIGP|ELOVL1|PRKD1|ORMDL3|NEU4|SMPDL3A|UGCG|STS|B3GALT2|FUCA1|PPP2CA|HACD2|PPAP2A|PIGH|B3GNT5|NDUFAB1|SPTSSA|HEXB|SMPD1|A4GALT|B3GALT1|ALDH3B1|SPHK1|ST3GAL5|GBGT1|TEX2
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION%GOBP%GO:0010744,0.0220068116321719,0.20532665207909803,-0.529293134168135,-1.71361499889884,167,11,PRKCH|IL18|AGT|MSR1|PLA2G2A|MAPK9|CSF1|CD36|NFKB1
MRNA SPLICE SITE SELECTION%GOBP%GO:0006376,0.10416394726537001,0.44419145940290994,-0.304173424283053,-1.37532628376326,797,29,SETX|SF3A3|SRSF12|SF3A2|PSIP1|CELF2|SF3A1|SRSF10|SLU7|SRSF9|LUC7L3|CELF1|SRSF5|SRSF1|SF1|CELF4|ISY1
REGULATION OF METALLOPEPTIDASE ACTIVITY%GOBP%GO:1905048,0.0975418410041841,0.430598623028127,-0.46025402897256606,-1.44191579100528,745,10,STAT3|TIMP3|RECK|TIMP1
ACTIVATION OF BLOOD COAGULATION VIA CLOTTING CASCADE%GOBP%GO:0002543,0.5,0.7951717058944731,-0.5993495130790589,-0.997413432956806,3768,2,F3
REGULATION OF IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:2000520,0.5525338286017509,0.822813841873357,-0.5785720498983461,-0.9628364116579251,4164,2,LGALS3
CELL CYCLE CHECKPOINT%GOBP%GO:0000075,0.322568193515183,0.690723022084942,-0.151375515679131,-1.07188900884006,2506,167,PCBP4|GTSE1|WEE1|CNOT4|MAD1L1|BTG2|CNOT10|CNOT6L|CLOCK|FOXN3|VPS4A|BLM|DNA2|SFN|ATRIP|STK33|ZNF207|CDKN1B|ZWINT|CNOT6|AURKA|SOX11|TRIP13|TIMELESS|EME2|KLHL22|PRCC|PIDD1|PRMT1|UIMC1|RAD9A|TGFB1|PML|APC|RGCC|CLSPN|RPA2|NABP2|BRIP1|CDC20|TRIAP1|TFDP2|SETMAR|INTS7|DONSON|CDT1|FBXO6|H2AFX|NBN|CDC6|PLK2|RAD1|RAD17|BRCC3|PCNA|ORC1|TOP2A|MAD2L1|TAOK2|CDC25C|KNTC1|RHNO1|CDC45|BRCA1|CDKN2B|TOPBP1|EME1|HRAS|DTL|E2F1|CCNB1|PLK1|PLAGL1|TNKS1BP1|IK|CEP63|ZNF385A|CCND1|MUS81|PRPF19
INTRALUMENAL VESICLE FORMATION%GOBP%GO:0070676,0.5153886972671801,0.803478510349408,-0.5929020994157951,-0.986683905602172,3884,2,RILP
DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007212,0.0883272183720614,0.41066453213355103,0.373529534644956,1.4363323471029,649,17,DRD2|GNAS|DRD4|GNB5|ARRB2|GNAI3|ADCY6|GNAO1|GNA11|GNB1
ABDUCENS NERVE FORMATION%GOBP%GO:0021599,0.214180602006689,0.597438672438672,-0.890769739744155,-1.1867191797671799,1600,1,MAFB
REGULATION OF EXOSOMAL SECRETION%GOBP%GO:1903541,0.5844544095665171,0.8396554445633291,0.23374586918151397,0.898822507372042,4300,17,CHMP3|SDC1|PARK2|PDCD6IP|SMPD3|SDCBP|STAM|ATP13A2|CHMP2A
HORMONE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0009755,0.0355187778485041,0.26835149632713395,-0.24567376273898603,-1.4886225316508899,278,82,THRA|SST|CRHBP|ADIPOR1|BRCA1|DDX5|GHRL|CALR|RAN|WBP2|NCOA4|GPER1|RBM14|CDK7|ADIPOR2|FHL2|NR1D1|PPAP2A|LATS2|PPARG|PPARA|YAP1|KAT5|PHB
REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1901979,0.293977182276466,0.666651528916959,-0.6866504410248371,-1.1426961375266,2215,2,CAV1
T-HELPER 17 CELL LINEAGE COMMITMENT%GOBP%GO:0072540,0.6163861125723299,0.854122579597827,-0.361350099272005,-0.8660872360095111,4686,5,SLAMF6|LY9|IL6|BATF|STAT3
POSITIVE REGULATION OF B CELL CHEMOTAXIS%GOBP%GO:2000538,0.0716773847802787,0.3767214120425879,0.8351254480286742,1.40311858009944,534,2,XCL1|PTK2B
DISRUPTION OF CELLS OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051818,0.0912708941363757,0.41778255328704206,-0.809374138406396,-1.3469279949642599,687,2,AZU1|GAPDH
CHROMOSOME CONDENSATION%GOBP%GO:0030261,0.039556135770235,0.28367988634143604,-0.378031211233,-1.587194853234,302,23,NIPBL|PAPD7|NCAPG|AIFM1|NCAPD3|ACIN1|NCAPH|NUSAP1|H1F0|SMC2|TOP2A|NCAPH2|SMC4|GPER1|H1FX|HIST1H1C|CDCA5
GLOMERULAR EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0072310,0.584384858044164,0.8396554445633291,-0.325549305172366,-0.889874508024635,4445,7,NUP93|IQGAP1|JAG1|MYO1E
REGULATION OF SNARE COMPLEX ASSEMBLY%GOBP%GO:0035542,0.42580057276750805,0.7547028278218628,-0.353075480727581,-1.01645489241492,3270,8,VPS18|SEPT8|PRRT2
L-FUCOSE CATABOLIC PROCESS%GOBP%GO:0042355,0.950315457413249,0.9852369031063491,-0.20904744147246,-0.5714218589273911,7229,7,FUT4|FUT7|FUT9
NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009125,0.457302785732882,0.7719619284439659,-0.343605578211305,-0.9891923684822841,3512,8,NUDT11|DNPH1|HPRT1|NUDT4
NEGATIVE REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014745,0.21934301792959002,0.601686354077891,-0.5699524562085411,-1.24774506810975,1675,4,LMNA|NOS3
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002761,0.0018111254851229,0.036458923837937994,-0.35001011354343803,-1.9272815267484498,13,57,RARA|LIF|CCL3|TNF|BGLAP|ZNF675|ACIN1|TGFB1|LILRB1|CDK6|NDFIP1|CD74|RUNX1|ZFP36L1|CD4|HCLS1|LILRB3|IL34|TCTA|TESC|INHBA|HAX1|FBN1|NOTCH2|IRF7|CEBPB|MAFB|C1QC|CSF1|CEACAM1|CCR1|FADD|FOXP1|MYC|ATP6AP1|TLR4|LILRB4
"DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS, POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS%GOBP%GO:0050652",0.31876743259396995,0.6867397844771489,0.840262461402735,1.12037661326652,2399,1,CSGALNACT2
REGULATION OF ICOSANOID SECRETION%GOBP%GO:0032303,0.0501052077853761,0.321002841831185,-0.649680123538496,-1.55715928574359,380,5,IL1B|SYK|P2RX4|TNFRSF11A|PLA2R1
NEGATIVE REGULATION OF ELASTIN CATABOLIC PROCESS%GOBP%GO:0060311,0.00882943143812709,0.117827730899938,-0.995644022937803,-1.32643690678155,65,1,CST3
REGULATION OF CELLULAR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:2000282,0.90541257628018,0.9704288384943391,-0.39613415752607894,-0.659230584737992,6824,2,PARK7
REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:0061469,0.335496080021627,0.6985354012117391,0.457370963748744,1.0999745450168898,2481,5,SFRP1|PTPRN|NR4A3
POSITIVE REGULATION OF TYPE IIA HYPERSENSITIVITY%GOBP%GO:0001798,0.5820735785953179,0.8387093286508721,-0.71344287604764,-0.9504772186324659,4350,1,HLA-E
MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE%GOBP%GO:0048790,0.870367892976589,0.9574934752519241,-0.567600352889281,-0.7561799589305671,6505,1,RAB3A
POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1990573,0.296194586112201,0.6687276080240239,-0.27351863992267,-1.1327118552017,2264,22,ATP1B1|SLC12A8|ATP1A3|SLC12A2|ATP1B3|ABCC9|KCNJ12|ATP1B2|KCNH2|KCNJ9
REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY%GOBP%GO:1901668,0.665079365079365,0.8804055751124069,-0.4308550132673329,-0.841350641156893,5027,3,TNF|PARK7
ENZYME-DIRECTED RRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0000455,0.383258158662775,0.730480369014206,-0.6470240671255529,-1.07675151462457,2888,2,DKC1
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE%GOBP%GO:0090178,0.144092998107597,0.510372098339109,0.562279703380792,1.3522794622316399,1065,5,NPHP3-ACAD11|DVL2|NPHP3|DVL1
HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0015012,0.164446860559935,0.535643394219061,0.342755586438656,1.29058845976091,1209,16,HS6ST3|HS6ST1|NDST3|XYLT1|HS6ST2|NDST2|GLCE
CLARA CELL DIFFERENTIATION%GOBP%GO:0060486,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
LYSOSOMAL LUMEN PH ELEVATION%GOBP%GO:0035752,0.8382608695652171,0.946300451776032,-0.584528010586678,-0.7787316635538121,6265,1,CLN3
RESPONSE TO METHOTREXATE%GOBP%GO:0031427,0.19090301003344504,0.5652402799587389,-0.902900308778121,-1.20288001044181,1426,1,DHFR
NEUROTRANSMITTER RECEPTOR TRANSPORT TO POSTSYNAPTIC MEMBRANE%GOBP%GO:0098969,0.39261303890641397,0.737280445732591,-0.385300027911154,-1.0532004440856702,2986,7,ARHGAP44|STX1B|STX3
PSYCHOMOTOR BEHAVIOR%GOBP%GO:0036343,0.36173913043478295,0.716154857259883,-0.8173246581385091,-1.08887269586437,2703,1,C12orf57
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND%GOBP%GO:2001241,0.131232169542182,0.490819490032838,0.6227672712506811,1.36824621712542,965,4,RET|HTRA2
REGULATION OF PENILE ERECTION%GOBP%GO:0060405,0.764510559171205,0.9191113740914171,0.6177767975297751,0.82372200111806,5755,1,VIP
TRANSSULFURATION%GOBP%GO:0019346,0.3942926045016079,0.7376723208557521,0.639261097325614,1.07404118184832,2942,2,CTH|CBS
MALE GONAD DEVELOPMENT%GOBP%GO:0008584,0.768048946295037,0.920474726214876,0.184839583060618,0.773544878644227,5648,22,LRRC6|RAB13|WNT2B|KIT|WNT4
PROTEIN HOMOOLIGOMERIZATION%GOBP%GO:0051260,0.0729674275455245,0.38011088999831294,-0.18409389995391498,-1.3085551560836202,568,169,FGFRL1|APC|DCXR|RAD51|LONP1|FIS1|PYCARD|USP16|TMCC1|GSDMD|DISP1|SPTBN5|RIPK3|ECT2|MPP2|TOR1B|HM13|TOR1A|ITPR3|SOD2|RBMX|ATPIF1|P2RX3|ANXA6|TRAF2|IKBKE|ADCY8|SLC1A2|VWF|MLKL|PKD2L1|FCER1G|EHD1|POLQ|ALAD|HMOX1|KCNJ12|HPRT1|TOR2A|CDA|NACC2|CAT|COLEC12|MUC20|CHMP4A|TK1|B4GALT1|CRYAB|HSD17B10|GPX3|CAV1|TAF10|SIGMAR1|EHD4|STOM|SHMT2|IGHMBP2|SAMHD1|APIP|ALDOA|PRNP
APOPTOTIC NUCLEAR CHANGES%GOBP%GO:0030262,0.11462710084033599,0.463748809895271,-0.341944556275742,-1.37187501036587,872,20,BLCAP|DICER1|KPNA1|DNASE2|EXOG|ACIN1|DNASE1L3|H1F0|HMGB2|KPNB1|TOP2A|GPER1|ENDOG|FEN1
NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903051,0.0712258064516129,0.3767214120425879,-0.259762533966455,-1.4169608675847802,551,55,USP25|UCHL5|OGT|PSMF1|BAG5|UBE2G2|EFNA1|PARK7|UBXN1|ALAD|HFE|GIPC1|TLK2|EPHA4|DERL3|TAF9|AK6
PHOSPHATIDYLSERINE BIOSYNTHETIC PROCESS%GOBP%GO:0006659,0.9189896610391309,0.976540762044854,-0.286475067993604,-0.627153807886457,7021,4,PTDSS2|PLSCR1
CELLULAR PROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0043624,0.000384664700602641,0.0111294649577428,-0.28211769872693104,-1.8871176565115202,2,126,MRPS10|MRPL53|MRPS17|MRPL37|KIF24|AURKAIP1|GSPT2|MRPL18|MRPL57|GFM2|SYNJ1|MRPS18B|MRPS15|MRPL47|CCSAP|GADD45GIP1|MRPS11|MRPL13|ETF1|OXA1L|DSTN|MRPL10|MRPL50|MRRF|MRPL51|NAPA|MRPS34|MRPL9|KIF18B|MRPS30|MRPS23|MICAL2|MRPL41|KIF18A|MRPS6|MRPS18C|CKAP5|MRPL38|MRPS22|MRPL52|KIF2A|MRPL21|MRPS18A|MRPS24|CFL2|MRPL27|MRPL23|MRPS7|NSF|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|CFL1|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
NEGATIVE REGULATION OF MYELOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905454,0.0497658862876254,0.31994287376139896,-0.973202470224967,-1.29653937003347,371,1,DPF2
POSITIVE REGULATION OF DOPAMINE SECRETION%GOBP%GO:0033603,0.20480807544162602,0.5845960940001321,0.8992059991177771,1.19896986738962,1541,1,CHRNB2
10-FORMYLTETRAHYDROFOLATE BIOSYNTHETIC PROCESS%GOBP%GO:0009257,0.351950119395065,0.7106060713647829,-0.660872683989396,-1.09979782764634,2652,2,MTHFD1
SUPERIOR ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:1905316,0.14876254180602,0.5154128781388279,-0.9232465813850899,-1.22998613098246,1111,1,TGFBR2
DITERPENOID METABOLIC PROCESS%GOBP%GO:0016101,0.4623184434091529,0.776123237840749,0.20075172457673396,0.9947541226710258,3373,38,STRA6|ALDH3A2|GPC6|RETSAT|SDC1|ALDH8A1|AGRN|CYP4V2|ALDH1A3
PEPTIDYL-ASPARTIC ACID HYDROXYLATION%GOBP%GO:0042264,0.467392748040909,0.780769690730001,0.767754741949713,1.0236973530496098,3518,1,HIF1AN
REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:2000351,0.12685595207085198,0.48326646889427793,-0.289196374738255,-1.33278264048917,973,31,KDR|GATA3|GAS6|TNFAIP3|ICAM1|CCL2|GPER1|ECSCR|THBS1|TEK|SEMA5A|IL11|SERPINE1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061316,0.84951520786293,0.9492491301138911,0.574327304808116,0.7657879653378901,6395,1,CTNNB1
NEGATIVE REGULATION OF BARBED-END ACTIN FILAMENT CAPPING%GOBP%GO:2000813,0.007256113947863479,0.102883992372061,0.870629756258961,1.71242598949064,53,3,RLTPR|FAM21C|LRRC16A
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:1903078,0.144597045866805,0.511354191031423,-0.254486401089327,-1.2823872878043898,1115,42,STX4|LRP1|CNST|STAC3|AKAP5|RHOG|NKD2|TREM2|GPER1|EPHA2|LGALS3|STX3|ARF6|SQSTM1|PRNP
REGULATION OF MAST CELL CHEMOTAXIS%GOBP%GO:0060753,0.338637559179379,0.7001468935792379,-0.46097703518140204,-1.10487399081517,2574,5,VEGFC|VEGFB
COMPOUND EYE DEVELOPMENT%GOBP%GO:0048749,0.6678260869565219,0.8810898721211949,-0.669441993824438,-0.8918574782762791,4991,1,CHRDL1
POSITIVE REGULATION OF HETEROTYPIC CELL-CELL ADHESION%GOBP%GO:0034116,0.6912454403335071,0.8879225792175841,-0.270323799093368,-0.813200155489712,5305,9,IL1B|TNF|CD44|THY1|GCNT2
NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION%GOBP%GO:0032331,0.560103345118303,0.827091649887284,0.28775426111896196,0.91162495000174,4118,10,ADAMTS7|FAM101B
VISUAL PERCEPTION%GOBP%GO:0007601,0.687775759148715,0.8866901918807819,-0.162874535995626,-0.848251174610186,5299,47,COL18A1|RGS16|CYP1B1|OPA1|FSCN2|CACNA2D4|OPA3|GPR179|COL1A1|BEST1|DHRS3|EFEMP1|ADGRV1|DNAJC19
ZYMOGEN INHIBITION%GOBP%GO:0097341,0.152304087477219,0.519849132875151,-0.463465351216103,-1.3342518793364802,1169,8,CARD16|CAST|XIAP|BCL2L12
REGULATION OF TYPE I INTERFERON PRODUCTION%GOBP%GO:0032479,0.0008969759097898509,0.0214437672455875,-0.306448673833476,-1.90826083010156,6,92,LILRB1|STAT6|DHX9|PYCARD|TRIM21|RNF216|TREX1|TRIM56|NFKB2|YY1|TLR2|IRF5|POLR3B|TNFAIP3|DHX36|DDX3X|IKBKE|MB21D1|IFIH1|TRIM32|ISG15|IRF7|IRAK1|NPLOC4|IFI16|TMEM173|OTUD5|RELB|TRAF3|HAVCR2|RELA|DHX58|NFKB1|TLR4|UBE2L6|CD14|PQBP1|NLRX1|SIRPA|RNF26
DENSE CORE GRANULE TRANSPORT%GOBP%GO:1901950,0.257845401440022,0.636098664976652,0.5414402592426399,1.1895673082183302,1897,4,KIF5B|KIF5A|KIF1A
RESPONSE TO STARVATION%GOBP%GO:0042594,0.731137974155898,0.9074802896081321,0.130862588247245,0.8603427488859101,5261,112,MAP3K5|SFRP1|RALB|PICK1|MIOS|WRN|WDR59|CDKN1A|PMAIP1|STK24|GABARAP|KIAA1324|CLEC16A|GCGR|MYBBP1A|SESN1|ADCYAP1|MAP1LC3B|NPRL3|SH3GLB1|SREBF1|ULK2|ATG5|GAS2L1|MAP1LC3A|ATG14|SESN2|TBC1D5|BMPR2|MAPK1|EIF2AK3|MAPK8|ATF4|C12orf66|DEPDC5|SIRT1|EIF2AK2|CARTPT|STK26|PRKAA1|MTMR3
POSITIVE REGULATION OF EOSINOPHIL MIGRATION%GOBP%GO:2000418,0.9981427434332719,0.999656642395059,-0.276365418756141,-0.45991625096347993,7523,2,ADAM8
POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE-NOREPINEPHRINE%GOBP%GO:0001996,0.946272220748209,0.983446140433705,-0.359238273140509,-0.5978299330248829,7132,2,PDE4D
PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE%GOBP%GO:1903361,0.30173113335136603,0.674719052043204,0.4137021861245179,1.14201378038095,2230,7,LIN7B|RAB10|LIN7A|AP4M1
NEGATIVE REGULATION OF CENTRIOLE ELONGATION%GOBP%GO:1903723,0.715101607119139,0.8990888031809949,0.64170710189678,0.855629833007139,5383,1,CHMP2A
CELL CHEMOTAXIS%GOBP%GO:0060326,0.00012863390789812198,0.00518555396908895,-0.328294075264418,-2.13008898713204,0,109,IL1B|TGFB2|CCL3|CXCL12|SYK|CCL4|CCL8|CXCL1|ACKR3|DOCK4|CXCL2|CCL11|GPR183|NR4A1|FLT1|NCKAP1L|ADAM8|CCL19|SLAMF8|HMGB2|ITGB2|CXADR|SBDS|CCL24|HGF|SLC12A2|TNFRSF11A|AZU1|IL1RN|GAS6|PDE4B|CCL3L3|BCAR1|ADGRE2|CCL18|CXCR4|FCER1G|RHOG|CCRL2|HBEGF|CCL2|CXCL16|EPHA2|CORO1B|EDNRB|CCR1|NOV|LGALS3|CHGA|CYP7B1|SEMA5A|PDGFRB|CX3CL1|CCL4L2|CCL14|S100A8|S100A9|PDGFRA|ANXA1|FOLR2|PDGFB|LYST|ABCC1
POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION%GOBP%GO:0001956,0.119449901768173,0.471120705968593,-0.54336333820859,-1.3976768804061899,911,6,STX1B|GPER1|DTNBP1
POSITIVE REGULATION OF TOR SIGNALING%GOBP%GO:0032008,0.785611510791367,0.9274485629622209,-0.168206925533709,-0.7679998909704749,6005,30,SEC13|RPTOR|WDR24|SLC38A9|RRAGD
AMYLOID-BETA CLEARANCE BY TRANSCYTOSIS%GOBP%GO:0150093,0.536060565812193,0.8132910857498922,0.730480811645346,0.973997596466624,4035,1,PICALM
EARLY ENDOSOME TO GOLGI TRANSPORT%GOBP%GO:0034498,0.25647058823529395,0.634929462604421,-0.354438236396777,-1.1863379638394398,1961,12,SNX2|STX5|TMED9|SURF4
SULFIDE OXIDATION%GOBP%GO:0019418,0.7160704892162021,0.899551221015245,-0.330931334867352,-0.793179262166063,5444,5,SLC25A10|SQRDL
BLOOD VESSEL ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060846,0.0826390755173341,0.399980174480082,0.7295291445629029,1.4348977372521698,614,3,DLL1|NRP1|RBPJ
HOMOLOGOUS RECOMBINATION%GOBP%GO:0035825,0.37024579560155196,0.7226447402424641,-0.21981540137594802,-1.05847267285172,2861,36,BLM|RAD54B|RAD21|TRIP13|EME2|DMC1|RAD51|RPA2|MLH3|BRIP1|RAD51C|TOP2A|STRA13|EME1|RMI1|REC8|RAD51B|FANCM|MUS81
RECEPTOR CLUSTERING%GOBP%GO:0043113,0.37343423799582504,0.7245436360382259,-0.242103088564787,-1.05609788481699,2861,26,ITGB2|SYNJ2BP|THY1|MADCAM1|FLNA|APOE|DLG3|NRXN2|GPHN
LAGGING STRAND ELONGATION%GOBP%GO:0006273,0.30929445456912297,0.680809181688249,-0.392308898686845,-1.12940241159318,2375,8,WRNIP1|RNASEH2A|POLA1|FEN1
PYRIDINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0019362,0.0876136800307416,0.40905715364188894,-0.22434627106440302,-1.34850285431949,683,80,PARP9|NADK|TKT|GPD1|GPI|PFKFB2|NUDT17|HK1|VCP|KYNU|HK3|HAAO|ENO1|BST1|PGAM1|GAPDH|FMO2|LDHA|PDHX|NMNAT3|PNP|PGK1|TALDO1|QPRT|NNMT|ALDOA|ALDOC|PTGIS
RESPONSE TO PROGESTERONE%GOBP%GO:0032570,0.0334031962274037,0.261061407921079,-0.507786791872869,-1.64398705863368,254,11,TGFB3|NR1H3|WBP2|THBS1|CAV1|YAP1
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION%GOBP%GO:0010574,0.22837642735267102,0.610121312048328,-0.296296564379787,-1.20711433671896,1739,21,SARS|RORA|CYP1B1|IL6ST|C3|FLT4|BRCA1|SULF1|CCBE1
FLAGELLATED SPERM MOTILITY%GOBP%GO:0030317,0.000135961930659415,0.00526859796630401,0.638898118514255,2.67375829012802,0,22,LRRC6|DNAI1|CFAP44|CFAP43|SORD|C9orf117|IQCG|ADCY3|SLC9B2|TEKT2|GAS8|DNAH1|CCDC40|ATP2B4|CATSPER2|BBS2
POSITIVE REGULATION OF INTRACELLULAR LIPID TRANSPORT%GOBP%GO:0032379,0.390079365079365,0.7358910495632479,-0.549077459092162,-1.07220911449707,2948,3,ANXA2
DYNAMIN FAMILY PROTEIN POLYMERIZATION INVOLVED IN MITOCHONDRIAL FISSION%GOBP%GO:0003374,0.409455237060182,0.7448505271608159,0.4668483199986961,1.02568564100481,3013,4,MX2|DNM1L
REGULATION OF NEURON MATURATION%GOBP%GO:0014041,0.0267975590342266,0.231542581971207,-0.8932451061483321,-1.48650269726298,201,2,MAP3K13|EDNRB
HISTONE H2A-K15 UBIQUITINATION%GOBP%GO:0036352,0.283612040133779,0.656174769021447,-0.8551499779444199,-1.13926510424074,2119,1,RNF168
POSITIVE REGULATION OF DNA-DEPENDENT DNA REPLICATION%GOBP%GO:2000105,0.24348619072433603,0.626082056933819,-0.39866504854368895,-1.19928204823752,1868,9,WIZ|DBF4B|E2F7|E2F8|ATRX|CDC7|INO80|CDT1|STOML2
POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0098779,0.32686303787159005,0.6941148928066879,0.42887871601125105,1.10974888513758,2407,6,PARK2|HDAC6|OPTN|MFN2|PINK1|TOMM7
REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE%GOBP%GO:1902473,0.5084479371316311,0.7990325304927759,-0.36895309158082595,-0.949046742382435,3881,6,MAPT|IQSEC2|HRAS|RAP1A
POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION%GOBP%GO:2000848,0.536559705418201,0.8132910857498922,-0.38618411618035,-0.9256096357722159,4079,5,GHRL|C1QTNF1
ACTIVATION OF PLASMA PROTEINS INVOLVED IN ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002541,0.267826086956522,0.6418798906350429,-0.8623180414644911,-1.14881468600302,2001,1,F3
NEGATIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS%GOBP%GO:0031645,0.498948475289169,0.794989907195277,-0.35020223855844396,-0.9572622020536071,3795,7,CBLN1|NOV|TNFRSF21
MALATE-ASPARTATE SHUTTLE%GOBP%GO:0043490,0.8415976090205141,0.9480782261743229,0.322021855571619,0.707495730841351,6194,4,SLC25A13|SLC25A12
ACTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0030036,0.488064681724846,0.7882673024233101,-0.12407410146935999,-0.987217224669143,3802,323,FGD6|CCDC53|PDCD10|ROCK1|SPECC1L|MYH3|FSCN1|RAC2|ZYX|CDC42|TNF|MSRB2|RAC3|RACGAP1|PHACTR1|PRKG1|SHROOM2|MSRB1|MTSS1|RAC1|ITGB1|DOCK2|WIPF3|LLGL2|ATP2C1|CXCL1|SSH1|ANLN|CDC42BPB|AQP1|IQSEC1|MRAS|TNNT2|EPB41L1|ARHGAP25|NCKAP1L|CTTN|KANK1|WASF2|CORO1A|SPTBN5|HSP90B1|MYH11|FRMD5|FGD1|CXADR|PSTPIP2|IQSEC2|FMNL1|TTC17|DSTN|MICALL2|ARPC1A|COBL|WAS|FSCN2|FRMD6|ITGB5|IQGAP2|PLEK|MYOM1|BCAR1|SHROOM1|TAOK2|TNXB|RHOF|LMOD1|ELMO1|PDXP|S1PR1|FHL3|FRMD3|ARRB1|DBN1|MICAL2|FGF10|AIF1L|RHOG|RHOD|GHRL|ABL1|FLNA|EPB41L2|RHOJ|RND1|IQSEC3|GSN|BAIAP2L1|CORO1B|DLC1|PLS3|SMTNL1|ARFIP2|FGF7|CFL2|ARPC5L|SRF|AIF1|PDGFRB|IGSF22|NEDD9|DTNBP1|FAM107A|EFS|MYH9|ANG|INSRR|CFL1|WASF3|GAS7|PDGFA|EVL|ACTB|NF2|PDGFRA|EPS8|ANXA1|RHOU|MAPKAP1|ACTN1|KRT19|ARF6|SPECC1|CDC42EP2|ALDOA|EMP2
ERK1 AND ERK2 CASCADE%GOBP%GO:0070371,0.0391156462585034,0.281882798544675,-0.429282047021178,-1.5953783078878,298,16,ZFP36L1|KDR|MED1|PTGER4|FGF10|IGF1|CTSH|LGALS9|MYC
DEVELOPMENT OF PRIMARY MALE SEXUAL CHARACTERISTICS%GOBP%GO:0046546,0.7377284595300259,0.9085009680455649,-0.19001047227756304,-0.797774455383867,5650,23,GATA3|INHBA|MEA1|NCOA4|GATA6|FGF9|LHFPL2
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION%GOBP%GO:0048146,0.000130259215839521,0.00518555396908895,-0.5426204440463971,-2.3393127666135998,0,25,AQP1|CDK6|DHX9|NDUFS4|CD74|FBRS|AGT|GAS6|DDR2|PDGFC|IGF1|E2F1|FN1|MYC|PDGFA|ANXA2|PDGFRA|S100A6|SPHK1|PDGFB
"REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000564",0.9147347740667979,0.9740523336757891,-0.24419685839393898,-0.628140103029933,6983,6,HLA-E|MAPK8IP1|C10orf54
REGULATION OF HYDROGEN PEROXIDE-MEDIATED PROGRAMMED CELL DEATH%GOBP%GO:1901298,0.9109542554635541,0.972245398885683,0.243233986213473,0.6293822354683821,6710,6,MET|TRAP1|HDAC6
REGULATION OF ER-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:1903069,0.0951016154247004,0.42498053239300104,-0.480845472538933,-1.44650087911841,729,9,UBQLN2|UBQLN1|HERPUD1|BCAP31|CAV1
POSITIVE REGULATION OF FAT CELL PROLIFERATION%GOBP%GO:0070346,0.183072433006102,0.556308895147568,-0.7433977644142741,-1.23713275822592,1379,2,PID1
RESPONSE TO HYPOXIA%GOBP%GO:0001666,0.06235624840276,0.35881925983255997,-0.199669516971793,-1.35695983958192,487,135,SLC8A3|TCEB2|MMP12|AQP1|NPEPPS|PML|RGCC|LONP1|FUNDC1|BNIP3L|ADAM8|HSP90B1|REST|PLOD2|TERT|KCND2|ZFP36L1|RYR2|AQP3|ITPR2|ANGPTL4|RORA|CBFA2T3|VEGFC|TGFB3|ADA|CXCR4|NOTCH1|UBQLN1|CARD16|HMOX1|DPP4|LMNA|HIF3A|GATA6|VEGFB|CPEB1|BMP2|THBS1|PDK3|SRF|UBC|CAV1|MYC|DDIT4|ANG|PGK1|WTIP|LOXL2|BAD|PTGIS|P4HB|SUV39H1
PROTEIN IMPORT%GOBP%GO:0017038,0.24741478360781302,0.6283447678774721,-0.16929329780102,-1.13007098675626,1937,124,IPO4|NUP188|IPO7|STAT3|NUP85|KPNA4|TIMM21|ROMO1|RAN|RBM22|BCL3|KPNA2|APOE|NUP214|PEX16|SEC61B|TIMM9|TIMM17B|LAMP2|BCL6|HSP90AA1|NUP98|HSPA4|TIMM10|IPO11|DNAJC19|DNAJC15
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX II ASSEMBLY%GOBP%GO:0034553,0.859965973040178,0.9511718746756421,-0.312619252273954,-0.6843888923925651,6570,4,SDHAF2
RESOLUTION OF RECOMBINATION INTERMEDIATES%GOBP%GO:0071139,0.222222222222222,0.6049017459273871,-0.6288930437585589,-1.2280687221737598,1679,3,XRCC3
CELLULAR DIVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0072501,0.254748306548014,0.6334469481869079,0.8748897220996908,1.16654739305072,1917,1,XPR1
POSITIVE REGULATION OF MAST CELL CYTOKINE PRODUCTION%GOBP%GO:0032765,0.16693461950696697,0.53917243184018,0.758367797077475,1.27415581591995,1245,2,NR4A3|BCL10
MITOTIC DNA REPLICATION%GOBP%GO:1902969,0.127564439768543,0.484643747394476,-0.573959424353278,-1.37567121863595,969,5,CDC45|GINS1|POLA1
REGULATION OF KILLING OF CELLS OF OTHER ORGANISM%GOBP%GO:0051709,0.9341136244082059,0.9800972968717879,-0.25122033492280604,-0.6021272055577751,7102,5,GAPDH
SERINE TRANSPORT%GOBP%GO:0032329,0.43777394076238496,0.7635570545514341,0.782697397441553,1.04362136789279,3295,1,SLC1A4
DNA METHYLATION ON CYTOSINE%GOBP%GO:0032776,0.241070234113712,0.6244696312630601,-0.876599029554477,-1.16784039120635,1801,1,DNMT1
CELLULAR RESPONSE TO PHORBOL 13-ACETATE 12-MYRISTATE%GOBP%GO:1904628,0.8420005306447329,0.94808068996515,-0.435787151916184,-0.725219508393687,6346,2,ADAM15|MAP4K1
NEGATIVE REGULATION OF STEROID METABOLIC PROCESS%GOBP%GO:0045939,0.0525072197427146,0.331996459809677,-0.42524726824458203,-1.5440038989341203,399,15,SNAI2|SOD1|APOE|FGF19|BMP2|SNAI1|NFKB1
POSITIVE REGULATION OF JNK CASCADE%GOBP%GO:0046330,0.35309973045822096,0.7116618431256551,-0.17109016968784696,-1.06168673564712,2750,91,TNFRSF11A|IL1RN|FCGR2B|PKN1|MDFIC|TRAF2|TAOK2|MAPK8IP1|ZNF622|FLT4|MLKL|CTGF|HRAS|MAP3K13|GADD45B|SASH1|FGF19|GADD45G|MAP3K11|LTBR|SEMA3A|DBNL|SERPINF2|ERN1
REGULATION OF GLYCOLYTIC PROCESS%GOBP%GO:0006110,0.255380200860832,0.634085683126873,-0.264800335340476,-1.16789884644773,1957,27,OGT|CBFA2T3|PFKFB2|PFKFB3|INS|JMJD8|IGF1|PGAM1|PPARA
REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905024,0.165466648553186,0.5375245857985801,0.596350051003119,1.31020645919448,1217,4,RNF207|NOS1AP|KCNE3|DLG1
POSITIVE REGULATION OF NK T CELL ACTIVATION%GOBP%GO:0051135,0.5454783405313439,0.817297924969912,-0.42006286880273497,-0.919605428725221,4167,4,RASAL3|IL6R|HSPH1|IL18
NEGATIVE REGULATION OF PROTEIN GLYCOSYLATION%GOBP%GO:0060051,0.42637304324754605,0.755007255274521,-0.628471463164717,-1.0458770148493002,3213,2,TMEM59
FLAVIN ADENINE DINUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0072387,0.38392146457946397,0.7312390310408861,-0.6466692335456229,-1.0761610148054102,2893,2,VCP
NEGATIVE REGULATION BY HOST OF VIRAL GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:0044871,0.878929765886288,0.960725750963158,-0.563134097926776,-0.7502298349094499,6569,1,PTX3
CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS%GOBP%GO:0071378,0.344118417605449,0.702174649119653,-0.33661212247150396,-1.0897998569071,2626,11,PTPN1|JAK3|STAT5A|LYN|STAT3|PXN
REGULATION OF PODOSOME ASSEMBLY%GOBP%GO:0071801,0.384535277271544,0.7314827391332459,-0.366937100758179,-1.0563605564045602,2953,8,LCP1|FSCN1|CAPG|TNF|GSN|HCK
REGULATION OF LONG-TERM NEURONAL SYNAPTIC PLASTICITY%GOBP%GO:0048169,0.7817514277943979,0.925666442349475,0.236047183703451,0.7478134336045469,5748,10,DRD2|NETO1|DLG4
ECTODERMAL CELL DIFFERENTIATION%GOBP%GO:0010668,0.183284063423811,0.556308895147568,0.650589954207047,1.2796336652595401,1363,3,ITGA6|EDA2R
PROTEIN LOCALIZATION TO MEMBRANE RAFT%GOBP%GO:1903044,0.39753987564206505,0.7381609911994891,0.430993431353583,1.03653673086878,2940,5,RFTN1|FLOT2|FLOT1
NEGATIVE REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS%GOBP%GO:0000961,0.10889632107023402,0.45309795582492896,-0.943537715041906,-1.25701879320185,813,1,SLIRP
PYRIDOXAL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0042823,0.004510480233483679,0.0743264309917645,-0.957926661152468,-1.59414314814819,33,2,PNPO|PDXK
REGULATION OF BONE DEVELOPMENT%GOBP%GO:1903010,0.243723849372385,0.626320329556411,-0.384151663988269,-1.20349701594607,1863,10,GREM1|LILRB1|FBN1|NOTCH2|ATP6AP1|TMEM119
POSITIVE REGULATION OF CORE PROMOTER BINDING%GOBP%GO:1904798,0.159097016930933,0.5293397224673839,0.665429526815904,1.30882135339638,1183,3,FOXC1|GTF2B|CTNNB1
MULTI-ORGANISM CATABOLIC PROCESS%GOBP%GO:0044035,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
CILIARY TRANSITION ZONE ASSEMBLY%GOBP%GO:1905349,0.527197213290461,0.810052447666581,0.580062521587941,0.974579931171522,3934,2,CBY1
NEUTRAL LIPID METABOLIC PROCESS%GOBP%GO:0006638,0.0162211263950169,0.17331488659862898,-0.32109799562932695,-1.6722795266466102,124,47,PNPLA2|FABP3|DAGLB|SEL1L|APOBR|DGKE|CETP|GK|APOE|PLA2G16|FABP4|DAGLA|LPIN3|CAV1|ANG|LMF1|MGLL|PNPLA4|LPIN2
EMBRYONIC FOREGUT MORPHOGENESIS%GOBP%GO:0048617,0.453244147157191,0.769943206592495,-0.7742059991177771,-1.03142828864815,3387,1,SOX17
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0061005,0.113314075630252,0.46139171800540707,-0.342753449602364,-1.37512027489919,862,20,MTSS1|NUP93|IQGAP1|JAG1|BASP1|CD34|SMO|MEF2C|KLF15|MYO1E|ACTA2|PDGFB
SNRNA PROCESSING%GOBP%GO:0016180,0.5907255438322261,0.8417378833576942,-0.20906003209431498,-0.9012870919862759,4534,25,EXOSC3|INTS5|TUT1|EXOSC2
REGULATION OF CELLULAR RESPONSE TO X-RAY%GOBP%GO:2000683,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
BUD ELONGATION INVOLVED IN LUNG BRANCHING%GOBP%GO:0060449,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
POSITIVE REGULATION OF CHOLINE O-ACETYLTRANSFERASE ACTIVITY%GOBP%GO:1902771,0.982733430734493,0.993436724391485,0.507940008822232,0.677269463968187,7398,1,SORL1
REGULATION OF COLLAGEN FIBRIL ORGANIZATION%GOBP%GO:1904026,0.991362387122104,0.997150662115148,-0.22224673247670002,-0.48654455530558505,7574,4,RB1|COLGALT1|CHADL|AEBP1
VESICLE FUSION WITH GOLGI APPARATUS%GOBP%GO:0048280,0.37992409370501296,0.729249457747391,-0.49094897632600704,-1.07478993595243,2902,4,VTI1A|VTI1B|GOSR2
NEGATIVE REGULATION OF GLOMERULAR FILTRATION%GOBP%GO:0003105,0.8656216505894959,0.9547492610997429,0.41258163255035707,0.6931904132554809,6460,2,PTPRO
SNORNA GUIDED RRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0000454,0.321141479099678,0.689182847657092,0.6744713078092739,1.13319888163516,2396,2,GAR1|NAF1
REGULATION OF SECRETION OF LYSOSOMAL ENZYMES%GOBP%GO:0090182,0.220066889632107,0.60254214895295,-0.886689457432731,-1.1812832639948,1644,1,NR1H3
CELLULAR RESPONSE TO GLUCAGON STIMULUS%GOBP%GO:0071377,0.469387755102041,0.780769690730001,-0.266056250416564,-0.9887680454794571,3587,16,ADCY8|PRKAR1A|ADCY4|PRKACA|ADCY9
REGULATION OF STAT CASCADE%GOBP%GO:1904892,0.0068590656140805,0.09955564034600099,-0.32468025963747305,-1.7779007532696298,52,56,LIF|CD40|CTF1|VHL|TNF|JAK3|PARP14|LYN|STAP2|IL18|AGT|SOCS3|PARP9|HGS|HCLS1|CYP1B1|TNFRSF18|IL6ST|HES1|NOTCH1|SOCS1|STAT3|ADIPOR1|OSM|IGF1|BCL3|CD300A|F2R|PPP2CA|CAV1|CSF1R|NF2|TNFRSF1A
PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION%GOBP%GO:0048934,0.623964135307703,0.857688646775448,0.392966774635636,0.863364739401592,4592,4,ETV1|ISL1|RUNX1|RUNX3
REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA%GOBP%GO:2000359,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
RESPONSE TO LEUKEMIA INHIBITORY FACTOR%GOBP%GO:1990823,0.852645502645503,0.949296218452153,-0.35451623509748,-0.6922803553749589,6445,3,SBNO2|HNRNPU
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL%GOBP%GO:0010522,0.220645161290323,0.603022518406817,-0.21744593475879898,-1.1861309468454801,1709,55,P2RX4|TMBIM6|P2RX5|P2RX3|THY1|GRIN1|JPH4|PDE4D|SEPN1|P2RY6|GPER1|F2R|APLNR|F2RL3|FKBP1A|CX3CL1|CAV1|CLIC2|PRKACA|PRNP
POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS%GOBP%GO:0046833,0.529179810725552,0.810782389252093,-0.342636769026135,-0.93658232846434,4025,7,CPSF6|DHX9|NCBP2|RBM27
BENZENE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042537,0.0703210010881393,0.3767214120425879,0.437092300652966,1.48559171461737,516,12,GSTM2|AADAT|CCBL2|CYP2E1|GSTM1
NEUTROPHIL ACTIVATION%GOBP%GO:0042119,0.00012690355329949199,0.00518555396908895,-0.32463177916865604,-2.6782913271339397,0,406,UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|CNN2|DNASE1L3|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
MACROPHAGE DIFFERENTIATION%GOBP%GO:0030225,0.16758169934640502,0.5400460530398901,-0.387648349828454,-1.29749532301135,1281,12,BMP4|NRROS|APP|CDC42|TLR2|PARP1|CSF1|MMP9|CSF1R
REGULATION OF MITOTIC CENTROSOME SEPARATION%GOBP%GO:0046602,0.954438948190575,0.9870180073166591,-0.19697646345442002,-0.5670676693726949,7331,8,KIF25|KIF11|NEK2|NSFL1C
PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE%GOBP%GO:1904491,0.41050792797634994,0.7453853667476059,0.533059724202845,1.0484655723209102,3054,3,TMEM107|SPATA7
"POSITIVE REGULATION OF RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:1904154",0.549603174603175,0.8203675686888849,-0.479008699220771,-0.935382585322423,4154,3,BCAP31
REGULATION OF GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:0106104,0.40374581939799303,0.7412049911665691,-0.7985774150860171,-1.06389686663993,3017,1,SHISA7
POSITIVE REGULATION OF PRI-MIRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:1902895,0.0569628560178501,0.34436604181231795,-0.371832671948815,-1.5148489828407499,433,21,TGFB1|GNL3|SMARCA4|TERT|STAT3|SPI1|ATOH8|SRF|RELA|PDGFB|NGFR
RUFFLE ORGANIZATION%GOBP%GO:0031529,0.26220070652885,0.6380114459042441,-0.306867379163398,-1.1661709766725001,2003,17,AIF1L|CORO1B|ARFIP2|AIF1|CSF1R|ARF6
NEGATIVE REGULATION OF MACROAUTOPHAGY%GOBP%GO:0016242,0.0478125423269674,0.313097474684423,0.37664928074319703,1.5526052254093603,352,21,TSC2|PHF23|NRBP2|UBQLN4|LZTS1|CLEC16A|SMCR8
DETECTION OF CHEMICAL STIMULUS%GOBP%GO:0009593,0.3414665970772439,0.701955655133333,-0.248624135156715,-1.08454388091457,2616,26,C4B|TLR1|RYR2|TLR2|SSC5D|TGFB3|STIM1|ABCG1|PKD2L1|TLR4|LY96
POSITIVE REGULATION OF GLYCOGEN CATABOLIC PROCESS%GOBP%GO:0045819,0.384882943143813,0.7319759326371941,-0.80690339655933,-1.07498907314843,2876,1,PHKG2
SIRNA LOADING ONTO RISC INVOLVED IN RNA INTERFERENCE%GOBP%GO:0035087,0.997513414474545,0.9994836051249741,-0.20574921826446999,-0.45042804809493897,7621,4,CLP1
DADP BIOSYNTHETIC PROCESS%GOBP%GO:0006173,0.30083676451055896,0.673988937137548,0.8507940008822229,1.13441900011172,2264,1,AK5
REGULATION OF RESPONSE TO DNA DAMAGE CHECKPOINT SIGNALING%GOBP%GO:1902153,0.752822419976092,0.915314007578303,0.6240626378473749,0.8321033210151909,5667,1,TIGAR
NEGATIVE REGULATION OF INTERLEUKIN-18 PRODUCTION%GOBP%GO:0032701,0.49819397993310993,0.794989907195277,-0.755183061314513,-1.00608516781747,3723,1,CD84
"ADENOSINE 3',5'-BISPHOSPHATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0071106",0.0699665551839465,0.37596389138254704,-0.9634980149977941,-1.28361070549376,522,1,SLC25A42
TRNA WOBBLE BASE MODIFICATION%GOBP%GO:0002097,0.0150528885272579,0.165202708349847,0.489865314900542,1.76075770039165,110,14,ALKBH8|ADAT2|ELP3|CTU1|KIAA1456|GTPBP3|NSUN3|MOCS3
MULTI-ORGANISM TOXIN TRANSPORT%GOBP%GO:1990967,0.423321836030777,0.753783909572009,-0.6300523848910949,-1.04850792141038,3190,2,RAB40B|RAB29
POSITIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:2000304,0.85580967402734,0.949296218452153,-0.24798316858792,-0.6778509326835359,6510,7,TNF|GNB2L1|NSMAF|TNFRSF1A
"ENDONUCLEOLYTIC CLEAVAGE IN 5'-ETS OF TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000480",0.9367105616769681,0.9806508984207809,0.308539336757099,0.6068604653640021,6970,3,UTP20|NOP14
REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES%GOBP%GO:0048293,0.473467763332449,0.7836397789874759,-0.6095947063689,-1.0144630729206898,3568,2,CLCF1|NDFIP1
REGULATION OF PEPTIDYL-CYSTEINE S-NITROSYLATION%GOBP%GO:2000169,0.114084887807516,0.463473523153693,0.5871975356011729,1.41220670583007,843,5,DMD|ATP2B4|SNTA1|NOS1AP
REGULATION OF CELL PROLIFERATION IN BONE MARROW%GOBP%GO:0071863,0.502149959688256,0.796769413401376,0.487925839495702,0.9596925472507709,3736,3,FGFR2|LEF1
MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM%GOBP%GO:0035437,0.021482839926643994,0.20251241938493103,-0.530469855606748,-1.71742469786632,163,11,KDELR2|KDELR1|KDELR3|HSPA5|INSIG1
NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902963,0.553054662379421,0.8231366946320219,0.568374926363169,0.9549432621474008,4127,2,PICALM|SORL1
NUCLEAR MRNA SURVEILLANCE OF SPLICEOSOMAL PRE-MRNA SPLICING%GOBP%GO:0071030,0.15179528403001097,0.519162563817466,0.769183539624649,1.29232765987625,1132,2,EXOSC10|PRPF18
PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002532,0.8367724867724871,0.9461941948757601,-0.361972581896738,-0.7068407108705831,6325,3,SYK|CD36
REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0042534,0.000781046602447279,0.0191134260247744,-0.7102432566605991,-2.04469092996685,5,8,LILRB1|TLR1|SPN|AZU1|GHRL|HSPB1|THBS1|TLR4
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT%GOBP%GO:1901343,0.000127713920817369,0.00518555396908895,-0.37464248563032704,-2.26088949475051,0,81,DAB2IP|SARS|KLF4|HGS|SEMA6A|SYNJ2BP|E2F2|DCN|NOTCH1|FAM129B|TBXA2R|MMRN2|CREB3L1|MECP2|GHRL|DNMT1|SPARC|SULF1|NFATC1|COL4A2|HDAC5|MEOX2|STARD13|NPR1|ECSCR|EFNA3|FGF9|THBS1|TEK|THBS2|SEMA3E|SERPINE1|STAB1|PPARG|PGK1|PDGFB|NGFR|SERPINF1|CARD10|ADGRB1
TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION%GOBP%GO:0070127,0.5021639166892079,0.796769413401376,0.342932051248288,0.9466547226365709,3712,7,DARS2|WARS2|YARS2|TARS2|EARS2
REGULATION OF MEMBRANE POTENTIAL%GOBP%GO:0042391,0.25414057063326395,0.633328402505013,0.146267795750462,1.10481337334365,1825,219,TRPM4|HTR3A|CHRNB1|BVES|POPDC3|BIN1|SCN5A|DRD2|HEBP2|ANK2|GRIK3|KCNMB4|KCNH8|DMD|RANGRF|RNF207|PIEZO2|GABRA3|RIMS1|PMAIP1|HCN2|DRD4|PRDX3|KCNIP2|CHRNB2|KCNJ8|ARRB2|RAB3GAP1|CHRNA5|GABRB3|CACNB4|SRI|RIMS2|PTPN3|EHD3|ADCYAP1|MTMR2|CACNA1C|SNX16|CUX2|CHRNB4|SUMO1|NEDD4|CACNG4|SCN3A|PTK2B|SCN9A|SCN2A|DLG4|KIF5B|SLC26A10|YWHAE|KCNMA1|NLGN2|CACNB2|CAMK2D|BAX|BCL2|YWHAH|NEDD4L|HCN3|KCNB1|SLC26A6|KCNN4|NLGN4X|SRC|SHANK2|CHRNA3
POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS INVOLVED IN IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:2000526,0.659184486651614,0.8772415412127091,0.668670048522276,0.891581284144833,4962,1,CCR7
"REGULATION OF GLYCOGEN SYNTHASE ACTIVITY, TRANSFERRING GLUCOSE-1-PHOSPHATE%GOBP%GO:1904226",0.968123256740603,0.9912626134248801,0.51532862814292,0.6871211908648149,7288,1,GSK3A
STEROID BIOSYNTHETIC PROCESS%GOBP%GO:0006694,0.0851474945253124,0.40376145987147494,-0.22823865997446102,-1.3575294764583998,660,77,HMGCR|CYP46A1|APOE|HMGCS1|CYP7B1|HSD17B1|SRD5A3|EBP|DHCR7|OSBP|C14orf1|DHCR24|CNBP|NSDHL|HSD17B14|OSBPL3|TM7SF2
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 7 SIGNALING PATHWAY%GOBP%GO:0034157,0.24066889632107,0.6244696312630601,-0.876874724305249,-1.1682076828125902,1798,1,RSAD2
PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL SIGNALING%GOBP%GO:0086029,0.149707920119549,0.516200888007464,0.6074916285949771,1.33468497965728,1101,4,TRPM4|SCN5A
PURINERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035587,0.293809710770842,0.666362999188702,-0.531109670380053,-1.1627100903301202,2244,4,P2RX4|GNAI2
NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:1903019,0.145402148283993,0.512552662440151,-0.41443153841044394,-1.3417444028496799,1109,11,TMEM59|BACE2|CST3
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY%GOBP%GO:1901186,0.136123527021536,0.499189931577426,0.323070987270842,1.33174740709745,1004,21,AFAP1L2|DOK1|ADAM17|RTN4|HAP1|SHKBP1|CBL|RQCD1
BEHAVIORAL DEFENSE RESPONSE%GOBP%GO:0002209,0.16111941312321698,0.5313138078301111,0.5990319500180501,1.31609870554604,1185,4,DRD4|ADCYAP1|MAPK8IP2|GNG7
POSITIVE REGULATION OF ANION TRANSPORT%GOBP%GO:1903793,0.45355834641548903,0.7702341823050379,-0.26918688906514804,-1.0004027109038398,3466,16,TRIAP1|P2RX4|TNFRSF11A|PRELID1|PLA2R1|CEBPB|APOE|ARL6IP1
POSITIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS%GOBP%GO:2000111,0.4,0.739629257825225,-0.544852482151832,-1.0639588053486,3023,3,CDKN2A|MEF2C
CELLULAR HORMONE METABOLIC PROCESS%GOBP%GO:0034754,0.76723070573669,0.9202818175694271,0.158447101486725,0.7959419027990121,5576,40,RETSAT|HSD17B3|SRD5A1|ALDH8A1|HSD17B11|FDX1L|HSD17B6|ALDH1A3
CARDIOBLAST DIFFERENTIATION%GOBP%GO:0010002,0.007940640458214009,0.10904224430222399,-0.636388029091962,-1.8320720666069201,60,8,TGFB2|NRG1|GREM1|REST|TBX2|NOTCH1|SRF
PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009195,0.481471642980476,0.7857362908355991,0.7596493162770179,1.0128898616033102,3624,1,ENTPD4
POSITIVE REGULATION OF GERM CELL PROLIFERATION%GOBP%GO:1905938,0.6793730907158989,0.884536278926676,0.659958094397883,0.8799650688488101,5114,1,CIB1
ARGININE TRANSPORT%GOBP%GO:0015809,0.686051080550098,0.886120113353976,-0.315629242787227,-0.8118834385813279,5237,6,PQLC2|CLN3|SLC7A2|SLC7A3
PEPTIDYL-LYSINE DEACETYLATION%GOBP%GO:0034983,0.9547844374342801,0.9870180073166591,-0.20622951574826698,-0.5637191846239129,7263,7,SIRT4
REGULATION OF THROMBIN-ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070494,0.11273851115291599,0.460292399693505,0.699294143597662,1.3754290583183997,838,3,MET|SNCA|STMN1
REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0010675,0.45221535291087106,0.769943206592495,-0.17130732429712303,-0.9984404320304381,3510,71,OGT|CBFA2T3|PHKG2|PLEK|INS|PPP1R3E|IRS1|ADIPOR1|IGF1|PGAM1|P2RY6|GPER1|SLC45A3|NR1D1|PDK3|PPARA|SIK1|PPP1R3F|BAD
CHEMOREPULSION INVOLVED IN POSTNATAL OLFACTORY BULB INTERNEURON MIGRATION%GOBP%GO:0021836,0.346245688511542,0.703504080836324,-0.662641301350979,-1.1027410897591998,2609,2,ROBO1|SLIT2
BRONCHUS DEVELOPMENT%GOBP%GO:0060433,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
REGULATION OF TORC1 SIGNALING%GOBP%GO:1903432,0.806850618458611,0.933810206759044,0.16262936696209002,0.75292460512628,5935,30,PIH1D1|ATM|CLEC16A|SESN1|SMCR8|GATSL3|DGKQ|SESN2|C12orf66|DEPDC5|TELO2|SZT2|GATS|STK11|SESN3
SISTER CHROMATID SEGREGATION%GOBP%GO:0000819,0.0395771561170556,0.28367988634143604,-0.218262385396901,-1.4360979925547501,306,116,MAD1L1|SPAG5|KIF25|CENPE|KIF2C|CDCA8|NIPBL|PAPD7|PHB2|BECN1|VPS4A|NCAPG|TUBG1|CHMP5|RAD21|INO80|PINX1|ZNF207|ZWINT|RACGAP1|NCAPD3|KNSTRN|KLHL22|NCAPH|NUSAP1|NUF2|DLGAP5|NSL1|SPDL1|ESCO2|CDT1|SMC2|DSN1|ESPL1|GSG2|RAD51C|TUBG2|CDC23|STAG2|BOD1|KPNB1|TOP2A|NCAPH2|KIF18B|KIF4A|NAA50|NDC80|SGOL1|KIF18A|REC8|RAN|SMC4|KIFC1|CCNB1|PLK1|CHMP4A|HDAC8|CHMP6|SMC1A|KIF22|CDCA5
REGULATION OF PHOSPHATE TRANSPORT%GOBP%GO:0010966,0.0371693121693122,0.274804008408919,-0.782838866218154,-1.52868589602904,280,3,SFRP4|CEBPB|CRY2
REGULATION OF ACTIN BINDING%GOBP%GO:1904616,0.899708145396657,0.9678510292896422,-0.40116175957510797,-0.667597318521592,6781,2,ABL1
CELL PROLIFERATION IN BONE MARROW%GOBP%GO:0071838,0.893110367892977,0.965443067117994,-0.555083811204235,-0.7395049200071899,6675,1,ACE
MITOPHAGY BY INDUCED VACUOLE FORMATION%GOBP%GO:0035695,0.14278124584938198,0.509126938596407,0.930138950154389,1.2402147837255,1074,1,SPATA18
FIBRINOLYSIS%GOBP%GO:0042730,0.00026288117770767596,0.00819882332206558,-0.808549365692223,-2.21013363437543,1,7,GP1BA|PLAU|PLAUR|SERPINE1|PLAT|ANXA2|SERPINF2
HETEROPHILIC CELL-CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES%GOBP%GO:0007157,0.580235602094241,0.8386526275338391,-0.20382494595629397,-0.9103050051187191,4432,28,CXADR|AMIGO1|HMCN1|TENM2|CBLN1|ICAM1|VCAM1|DCHS1|ADGRL1|CADM3
FERRIC IRON IMPORT ACROSS CELL OUTER MEMBRANE%GOBP%GO:0098706,0.875696471212523,0.9605516796761558,-0.417280810828985,-0.6944219974381421,6600,2,STEAP4
RETROGRADE AXONAL PROTEIN TRANSPORT%GOBP%GO:0099642,0.611066452304394,0.8515889287679592,0.5435799957325901,0.9132845772849479,4560,2,DLG2|MAP1A
REGULATION OF ATF6-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903891,0.7433581991885879,0.9106935298684872,-0.353340286184621,-0.773535747848478,5679,4,HSPA5
DIVALENT METAL ION EXPORT%GOBP%GO:0070839,0.530512072167684,0.8115959426370749,-0.587096774193548,-0.977022916091052,3998,2,SLC40A1|SLC11A1
POSITIVE REGULATION OF HISTONE PHOSPHORYLATION%GOBP%GO:0033129,0.0907662082514735,0.416406989132751,-0.5662125641167061,-1.4564512447058502,692,6,CDK9|IL1B|RPS6KA5|FMR1|MAPK3|RPS6KA4
DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0071344,0.838551339877952,0.946300451776032,-0.437386269644334,-0.72788069601148,6320,2,PPA2|PPA1
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS%GOBP%GO:0071872,0.120671700078105,0.472686039512467,-0.48354211033173206,-1.3920500588783202,926,8,RYR2|PDE4B|SLC9A1|KCNQ1|PRKACA
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0045980,0.0351061042703694,0.26730675532027,-0.5039818098341989,-1.63166822456784,267,11,PID1|PPIF|PARP1|CBFA2T3|PDE12|CDA|PPARA
NEGATIVE REGULATION OF LYMPHANGIOGENESIS%GOBP%GO:1901491,0.22387459807074,0.607146964504641,0.7219381060732489,1.21294923140505,1670,2,FOXC1|VASH1
ESTABLISHMENT OF ENDOTHELIAL BARRIER%GOBP%GO:0061028,0.0699491989058226,0.37596389138254704,-0.34159689975182006,-1.47267209960989,536,25,SOX18|RAPGEF1|RAP2B|PDE4D|ICAM1|PDE2A|MSN|RAPGEF3|TJP2|RAP1A|RAB1B|ENG
NEGATIVE REGULATION OF MRNA METABOLIC PROCESS%GOBP%GO:1903312,0.11883870967741901,0.46993502172104606,-0.24236394115710602,-1.3220544744824099,920,55,C17orf104|MAPK14|CCNT1|SRSF4|SRSF12|PAIP1|FAM46C|ZC3H14|YBX1|DHX9|PTBP1|SRSF10|SRSF9|HNRNPU|RBMX|LARP1|TOB1|FMR1|MAPKAPK2|CTR9|SLC11A1|RNF20|E2F1|RNF40|CCRN4L|YBX3|HNRNPA0|HNRNPC
GLUCOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0006704,0.7269990838895429,0.905250513405619,-0.358124868847993,-0.7840101994560731,5554,4,CACNA1H|HSD11B1
REGULATION OF HISTONE H3-K36 TRIMETHYLATION%GOBP%GO:2001253,0.7719699005643641,0.9215496572020819,0.386498757301993,0.7601974457589151,5744,3,IWS1|WHSC1L1
REGULATION OF MITOCHONDRIAL FUSION%GOBP%GO:0010635,0.906816337571004,0.9709695261809209,0.229398786541644,0.633249192824843,6704,7,PARK2|OMA1|BNIP3|PLD6|VAT1|MUL1|PID1
ANTHRANILATE METABOLIC PROCESS%GOBP%GO:0043420,0.34287625418060197,0.701955655133333,-0.8256506396118221,-1.0999649023728701,2562,1,KYNU
BRANCHED-CHAIN AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0009082,0.266914300875564,0.6417330323279019,-0.699290448987104,-1.16373113206506,2011,2,BCAT2
PEPTIDYL-LYSINE CROTONYLATION%GOBP%GO:0140066,0.5684685881259129,0.831514598829999,0.7133325981473309,0.9511327676244509,4279,1,EP300
MRNA DESTABILIZATION%GOBP%GO:0061157,0.8375998916429642,0.946216977301937,0.174459361888174,0.71914784054464,6183,21,RBM24|MEX3D|MOV10|METTL14|RC3H1|FTO|GIGYF2|UPF1|METTL16|METTL3|YTHDF3|ZC3H12D|YTHDF2|ZFP36L2|ZC3H12A|PUM1|RBM23|CPEB3|KHSRP
CELLULAR RESPONSE TO COBALT ION%GOBP%GO:0071279,0.5841371918542341,0.8396554445633291,0.556106975461814,0.9343315206538678,4359,2,TIGAR|BNIP3
GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:1904659,0.49517978113600797,0.7934854722199741,-0.31969889990329997,-0.961732544390066,3800,9,SLC2A1|SLC2A10|SLC2A3|SLC45A1
LATENT VIRUS REPLICATION%GOBP%GO:0019045,0.10002653223666802,0.43605057892447596,-0.8022056796250351,-1.33499853322932,753,2,HCFC1|NUCKS1
POSITIVE REGULATION OF MYOSIN LIGHT CHAIN KINASE ACTIVITY%GOBP%GO:0035505,0.707826086956522,0.89516234575314,-0.649536832818703,-0.8653390243056229,5290,1,IL1B
PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0006220,0.137148294141634,0.50191360557578,0.284646332206948,1.3178261176379,1008,30,NT5M|CAD|NTHL1|DCTD|CDADC1|CDS1|AK5|NEIL1|DHODH|ENTPD4|OGG1|DUT|DTYMK|SMUG1|NEIL2|DCK
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT%GOBP%GO:0046823,0.7156224572823431,0.899551221015245,0.222006570859995,0.797973988541417,5276,14,BARD1|SUFU|RAB23|RANGAP1|CHP1|CABP1|TPR
REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS%GOBP%GO:0060687,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
SPINDLE LOCALIZATION%GOBP%GO:0051653,0.45725159711839103,0.7719619284439659,0.214731313787447,0.994140804098127,3363,30,CLASP1|LLGL1|DCTN1|NDEL1|HTT|SPIRE2|GPSM2|DYNLT1|MAP4|ZW10
POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION%GOBP%GO:1902745,0.7534153929392672,0.9155261442589929,0.195681736208189,0.7801603630634292,5569,19,RLTPR|ARHGEF7|NCKAP1|LRRC16A
SIGNAL TRANSDUCTION INVOLVED IN DNA DAMAGE CHECKPOINT%GOBP%GO:0072422,0.966933608886593,0.9912626134248801,-0.106694347509643,-0.619531671000653,7485,70,FZR1|PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|UIMC1|PML|RGCC|TRIAP1|TFDP2|PLK2|BRCC3|PCNA|CDC25C|BRCA1|DTL|E2F1|CCNB1|PLK1|PLAGL1|TNKS1BP1|ZNF385A|PRPF19
OLIGODENDROCYTE APOPTOTIC PROCESS%GOBP%GO:0097252,0.164499867338817,0.535643394219061,-0.755487542383432,-1.25725208206745,1239,2,TNFRSF21
THIAMINE PYROPHOSPHATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0030974,0.0409364548494983,0.289711424429654,-0.9789920599911779,-1.30425249376454,305,1,SLC25A19
TRANS-GOLGI NETWORK TO RECYCLING ENDOSOME TRANSPORT%GOBP%GO:0044795,0.124319298711648,0.478357784842846,0.9392368769298629,1.25234564147135,935,1,RAB13
SYMPATHETIC NEURON PROJECTION GUIDANCE%GOBP%GO:0097491,0.19931946080355997,0.577166177580918,-0.5813850519321241,-1.27277340999056,1522,4,NRP2|SEMA3A
RESPONSE TO TRIGLYCERIDE%GOBP%GO:0034014,0.7870899189799442,0.9276917050905171,0.60603220114689,0.80806216657342,5925,1,GPLD1
REGULATION OF LONG-TERM SYNAPTIC POTENTIATION%GOBP%GO:1900271,0.0174632352941176,0.179978459887059,-0.427727894976343,-1.7160361221871798,132,20,SHISA7|INS|ADCY8|LILRB2|CALB2|ABL1|APOE|EPHA4|FAM107A|LGMN|SQSTM1
REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:2000739,0.214755391899001,0.5979177134734279,-0.5202408657736289,-1.24691808416499,1632,5,SOX5|REST|LTBP3|PDGFRA
POSITIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS%GOBP%GO:0050747,0.7424263007743509,0.909955740610127,0.35537417967241997,0.780772207287548,5464,4,RAB3GAP1|SVIP|RAB3GAP2|GBA
MITOTIC CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE%GOBP%GO:0007079,0.24761904761904802,0.6284111611211011,-0.615253115694276,-1.2014333996897801,1871,3,CENPE|DLGAP5|KPNB1
FACTOR XII ACTIVATION%GOBP%GO:0002542,0.9991961414791,0.999656642395059,0.26269644334160497,0.4413639429246429,7457,2,KLKB1|F12
PROTEIN SIDE CHAIN DEGLUTAMYLATION%GOBP%GO:0035610,0.9825315775329209,0.993436724391485,0.263648395279585,0.5185652809573571,7311,3,AGTPBP1|AGBL2
LENS FIBER CELL MORPHOGENESIS%GOBP%GO:0070309,0.7295038471743169,0.906544799850309,-0.502480875071414,-0.836208528852195,5498,2,EPHA2
MITOTIC G2 DNA DAMAGE CHECKPOINT%GOBP%GO:0007095,0.6826923076923079,0.885415243771438,0.222932986522726,0.82230789081229,5040,15,ATM|MRE11A|BRSK1|TAOK1|CDK5RAP3|GLTSCR2
CHRONOLOGICAL CELL AGING%GOBP%GO:0001300,0.10755852842809402,0.451309145449614,-0.944199382443758,-1.25790029305683,803,1,SERPINE1
NEUROMUSCULAR JUNCTION DEVELOPMENT%GOBP%GO:0007528,0.49102529235790104,0.7905764988080101,0.24749186068134402,0.96878874470323,3610,18,DCTN1|UNC13A|CACNB4|NEDD4|PDZRN3|CACNB2|SHANK2|DVL1|CACNB3
NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048387,0.852183061546555,0.949296218452153,-0.288407497161533,-0.6912577374803119,6479,5,EZH2|CALR
PURINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009205,0.000128386185646424,0.00518555396908895,-0.30224129382913595,-2.12045821035028,0,159,NDUFB5|NADK|SURF1|ATP1B1|UQCR10|PARP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|OPA1|IMPDH2|PFKFB2|HK1|NDUFA3|NDUFB6|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|MOCS2|MBIP|GAPDH|NDUFS6|COQ7|NDUFB4|NDUFA12|SDHAF2|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|GPHN|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
BLUE LIGHT SIGNALING PATHWAY%GOBP%GO:0009785,0.3309896524277,0.6957352559323989,-0.6694854178050871,-1.11413079399534,2494,2,CRY2
REGULATION OF MOTILE CILIUM ASSEMBLY%GOBP%GO:1905503,0.0483463939434188,0.315098240888217,0.9758491398323779,1.3011631538546398,363,1,ZMYND10
REGULATION OF SERINE C-PALMITOYLTRANSFERASE ACTIVITY%GOBP%GO:1904220,0.595914035553197,0.8445090144443349,-0.5610456329517141,-0.933669651173936,4491,2,SERINC5
REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS%GOBP%GO:0043558,0.36800312418641,0.721642468110297,-0.372629171110872,-1.07274723028529,2826,8,EIF2AK4|PPP1R15A|DNAJC3|IMPACT|EIF2S1|PPP1CA
NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS%GOBP%GO:0050995,0.15182080167670903,0.519162563817466,-0.41083120837192794,-1.33008814064502,1158,11,METTL20|IL1B|AKT1|TNF|APOC1|INS|BSCL2
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF CELL-CELL ADHESION%GOBP%GO:0044329,0.603745819397993,0.848175106515994,-0.7015328628142921,-0.934610221242822,4512,1,PPAP2B
UDP PHOSPHORYLATION%GOBP%GO:0061569,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION%GOBP%GO:1901988,0.0744108606557377,0.38312652841807104,-0.191503155394663,-1.32256520048733,580,146,CUL1|PCBP4|GTSE1|WEE1|CNOT4|RBL1|ZFP36L2|MAD1L1|BTG2|CNOT10|CNOT6L|FOXN3|PRMT2|VPS4A|BLM|SFN|PINX1|ZNF207|CDKN1B|CNOT6|AURKA|PTEN|FHL1|TRIP13|FBXL7|KLHL22|PIDD1|PRMT1|UIMC1|PML|APC|RGCC|CLSPN|RPA2|CDC20|TRIAP1|TFDP2|DONSON|ZFP36L1|NBN|KLF4|CDC6|PLK2|SLFN11|RAD17|BRCC3|PCNA|ORC1|MAD2L1|TAOK2|CDC25C|GPNMB|DCUN1D3|BRCA1|TOPBP1|DTL|SKP1|E2F1|CCL2|KANK2|NACC2|CCNB1|PLK1|USP47|PLAGL1|SUSD2|TNKS1BP1|FAM107A|IK|DACT1|CDK2AP2|H2AFY|ATF5|ZNF385A|CCND1
CORNIFIED ENVELOPE ASSEMBLY%GOBP%GO:1903575,0.8383946488294319,0.946300451776032,-0.58441773268637,-0.7785847469113149,6266,1,STX2
MITOCHONDRION DISTRIBUTION%GOBP%GO:0048311,0.0621430514005983,0.35846432401438794,0.480081891466932,1.52093188334873,456,10,TRAK2|DNM1L|HAP1|ATCAY|TRAK1|CLUH|MTM1|MEF2A|MSTO1
NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC MEMBRANE TO ENDOSOME%GOBP%GO:0098968,0.442524115755627,0.7656673901363249,0.618330312167321,1.03887476029932,3302,2,LRRC7|SCRIB
DNA REPLICATION PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0071163,0.0567460317460318,0.34436604181231795,-0.756810411381935,-1.47785892061867,428,3,CDT1|GMNN|CDC45
REGULATION OF MYOBLAST FUSION%GOBP%GO:1901739,0.214917990106743,0.5979177134734279,-0.43102760113635397,-1.24086813685867,1650,8,EHD1|EHD2|ADGRB1
GLYCEROPHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:0006650,0.854153293105662,0.949296218452153,-0.109324815757453,-0.817501691472114,6652,224,PLA1A|ABHD3|PGS1|INPP5B|ACP6|PLCB1|GPAA1|PGP|DPM2|PIK3C2A|ACHE|PTDSS2|SOCS3|RAB14|GPD1|PYURF|AGPAT1|GPAM|TMEM55B|GDE1|PLA2G2A|FAR1|PLEK|PLA2G2D|PCYT1A|MTMR12|PLSCR1|CPNE6|CHPT1|PIGP|TMEM86B|PLA2G4D|ETNK2|PLA2G4A|SOCS1|CDIPT|CISH|CETP|PLA2G7|PIK3CB|ABHD5|PIK3R3|MTMR1|ARF1|TTC7B|PLD1|PLA2G4C|SERINC5|SLC44A1|PLA2G16|SYNJ2|FAM126A|INPP4B|PIGH|PDGFRB|PLEKHA4|LPIN3|PCTP|CSF1R|PLBD1|AGPAT2|LPIN2|PTPMT1|AGPAT3|OSBPL5|PLA2G12A
RESCUE OF STALLED RIBOSOME%GOBP%GO:0072344,0.939274964009946,0.980854185905783,-0.27409270431877397,-0.600046225423199,7176,4,NEMF|GNB2L1
"NUCLEOTIDE-EXCISION REPAIR, DNA DAMAGE REMOVAL%GOBP%GO:0000718",0.469119404967459,0.780769690730001,0.766541685046317,1.02207990535017,3531,1,PNKP
POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN-1 PRODUCTION%GOBP%GO:0071639,0.9160052910052909,0.9747669359607141,-0.322064125315569,-0.628909609924301,6924,3,LGALS9
REGULATION OF BEHAVIOR%GOBP%GO:0050795,0.230727322255516,0.613827338774876,0.281843335920368,1.19655032425351,1693,23,STRA6|AHI1|CFAP20|CNTNAP4|CHRNB2|LEPR|NR4A3|UCN|MBD5
NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION%GOBP%GO:0034242,0.789201379676307,0.9280333261332429,-0.46702391250579295,-0.7772024731483801,5948,2,RAPGEF3
DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS%GOBP%GO:0015959,0.631827111984283,0.8617160466758159,-0.33257557217464695,-0.855473962871453,4823,6,NUDT11|GARS|NUDT4
CELLULAR TRIVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0072502,0.254748306548014,0.6334469481869079,0.8748897220996908,1.16654739305072,1917,1,XPR1
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:2000651,0.449411764705882,0.768229288546963,-0.29789223189298497,-0.9970731922723359,3437,12,GLRX|ATP1B1|TESC|SLC9A1|WNK2
REGULATION OF PROTEIN POLYUBIQUITINATION%GOBP%GO:1902914,0.476402726796015,0.785008843326641,-0.27673352117968103,-0.9790427301632101,3633,14,SASH1|XIAP|PLAA|OTUB1
POSITIVE REGULATION OF SEMAPHORIN-PLEXIN SIGNALING PATHWAY INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:2000764,0.923097356886705,0.9776156396135859,0.53931407146008,0.719102543103869,6949,1,HAND2
REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032803,0.109391534391534,0.453815932128808,-0.7027300929366271,-1.37225376529535,826,3,APOE|ANXA2
IMMUNE RESPONSE-ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002429,0.00012750223128904799,0.00518555396908895,-0.24435517013632602,-1.8391993431108502,0,230,RAF1|RIPK2|SPPL3|CREBBP|CDC42|PAK2|MUC3A|BTNL9|SYK|IGHV2-26|HLA-DQB2|NFATC2|RPS6KA5|RAC1|WIPF3|EIF2B5|IGHV1OR15-1|IGKV3-11|NFKBIZ|MNDA|HLA-DPA1|ACTG1|NCR3|CD38|IGHV5-51|SLA2|CLEC4A|LYN|HLA-DRA|HLA-DRB5|PRAM1|CD209|IGHV1-24|NCKAP1L|VAV3|WASF2|IGHV3-49|FPR3|IGHG4|HLA-DPB1|CD4|NCKIPSD|HLA-DQA2|FGR|FCGR1A|IGLL5|ARPC1A|LAT2|VAV1|MYO1G|GATA3|WAS|EIF2B1|FCGR2B|THY1|PDE4B|BCAR1|IGKV2-28|FPR1|MYO10|IGHV4-4|RC3H2|PDE4D|CLEC4E|ELMO1|IGHV4-61|GRB2|MEF2C|CLEC10A|IGHV1-3|FCER1G|MUC4|PIK3CB|MAPK3|ABL1|IGHV3-43|HRAS|FCN1|IGHV3-73|ICOSLG|FCGR2A|DOCK1|CYFIP2|IGKV2D-28|HCK|MUC20|TNFRSF21|IGHV3-15|RELB|MUC15|EIF2B2|C3AR1|STOML2|RELA|NFKB1|PRKACA|IGHV1-18|HSP90AA1|ACTB|CMKLR1|NCK1|IGHG2|IGHA1|EIF2B3|C5AR1|PRKCB|PTPRJ|ICAM2
REGULATION OF VASOCONSTRICTION%GOBP%GO:0019229,0.5770797739518989,0.837152999580265,-0.22928608800411898,-0.9058879431985121,4390,19,ADRA1B|ECE1|DOCK4|ADM|PER2|AGT|DOCK5|TBXA2R|F2R|SMTNL1|CAV1
POSITIVE REGULATION OF MITOCHONDRIAL FISSION%GOBP%GO:0090141,0.10509899647409801,0.446168961873938,0.392520596954647,1.4108646655061599,774,14,MFF|MIEF2|PARK2|MARCH5|DNM1L|VPS35
POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010867,0.533306033306033,0.812079525085925,0.30575614305826193,0.9291647188673889,3906,9,SLC27A1|CTDNEP1|SREBF1|CNEP1R1
REGULATION OF NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL%GOBP%GO:0070949,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
POSITIVE REGULATION OF NF-KAPPAB TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0051092,0.0846758602912747,0.40376145987147494,-0.200813070912967,-1.3183199295635601,656,115,PRKCQ|MALT1|NTRK1|CLOCK|TRAF6|APP|TRIM22|TRIM25|UBE2N|CD40|ARHGEF2|IL1B|TERF2IP|RIPK2|TNF|TRIM14|RPS6KA5|PIDD1|PRKCH|TRIM38|DHX9|MTDH|TRIM52|PYCARD|IL18|IRAK3|ADAM8|RIPK3|NFKB2|AGT|EDA|TLR2|TNFRSF11A|NPM1|INS|TRAF2|STAT3|PRKD1|TRIM32|CARD16|IRAK1|MAP3K13|NLRP3|RAB7B|CD36|LGALS9|UBC|CX3CL1|CAMK2A|RELA|NFKB1|TLR4|S100A8|RPS6KA4|S100A9|PSMA6|MID2|SPHK1|PRKCB
"REGULATION OF CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0032829",0.35553197134518394,0.7132037834765931,-0.659001929969672,-1.09668459380146,2679,2,FOXP3|LGALS9
PROTEIN TRANSPORT ALONG MICROTUBULE%GOBP%GO:0098840,0.7449007342942621,0.9112137767014771,0.244870369566256,0.775765882822009,5477,10,DLG2|CAMSAP3|KIF5B|KIF5A
CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS%GOBP%GO:0071364,0.87221843003413,0.958587680888923,0.157923872858295,0.6880610797456551,6388,25,FOXC1|INPP5K|PTPN12|PDE8A|PLCG1|EGFR|ERBB2|PDPK1
NEGATIVE REGULATION OF RIBONUCLEASE ACTIVITY%GOBP%GO:0060701,0.45210931281507,0.769943206592495,-0.6185589284603421,-1.02938097196774,3407,2,TMBIM6
NEGATIVE REGULATION OF NODAL SIGNALING PATHWAY%GOBP%GO:1900108,0.649488643910214,0.871510406076572,0.6730811645346271,0.8974629121428209,4889,1,DACT2
POSITIVE REGULATION OF NATURAL KILLER CELL CYTOKINE PRODUCTION%GOBP%GO:0002729,0.5820735785953179,0.8387093286508721,-0.71344287604764,-0.9504772186324659,4350,1,HLA-E
HEMOPOIESIS%GOBP%GO:0030097,0.000637999234400919,0.0163600882996276,-0.228573808027349,-1.7316083604012702,4,239,FST|DOCK11|ITGB1|GLO1|NOTCH4|ACIN1|TGFB1|DOCK10|UBD|LILRB1|SBNO2|LYN|GPR183|PIR|CEBPG|NCKAP1L|CD74|FNIP1|KAT6A|MT1G|JAG1|RUNX1|RIPK3|TNFSF8|CCL19|SLAMF8|BATF|ZFP36L1|RUNX3|DYRK3|CD4|KLF4|KDR|TLR2|PARP1|HCLS1|CD34|RORA|MED1|SFRP2|SPN|TNFRSF11A|CBFA2T3|ATPIF1|PLEK|FCGR2B|GAS6|PLA2G2D|TCTA|OSCAR|MELK|INHBA|RPS14|PTGER4|MEF2C|CEBPA|STAT3|HSPA9|TAL1|NFAM1|FCER1G|CDKN2B|NOTCH2|PLD4|RSAD2|KLF6|GLRX5|TREM2|IFI16|HDAC5|VCAM1|LRRC8A|BATF2|KIRREL3|CSF1|JAG2|MEOX1|EPHA2|PDE1B|MFAP5|AXL|TGFBR2|TGFBR3|LGALS9|TEK|FADD|RELB|FOXP1|MMP9|TYROBP|IL11|FLT3LG|LTBR|PPARG|MYH9|KAT8|ANXA2|CSF1R|RRAS|ANXA1|ZNF385A|ACTN1|PDGFB|SNX10|PTPRJ
POSITIVE REGULATION OF SYNAPTIC VESICLE PRIMING%GOBP%GO:0010808,0.8898924159914989,0.965159112268525,0.554808116453463,0.739761761446798,6699,1,UNC13B
RNA IMPORT INTO NUCLEUS%GOBP%GO:0006404,0.669408331122314,0.8815356925073421,-0.530557598742513,-0.882932686846591,5045,2,RAN
NEUTROPHIL EXTRAVASATION%GOBP%GO:0072672,0.7367363344051451,0.908157084784786,0.479404466501241,0.805461402138297,5498,2,PIK3CD|AMICA1
LONG-CHAIN FATTY ACID CATABOLIC PROCESS%GOBP%GO:0042758,0.38659861274702295,0.733589579210772,-0.48681121794712895,-1.06573151791416,2953,4,ABCD1
PURINE RIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046129,0.35265509989484795,0.7111578119705879,-0.399316824672856,-1.09151473296365,2682,7,IMPDH2|ADA|HPRT1|GMPS
PROTEIN POLYUBIQUITINATION%GOBP%GO:0000209,0.8864269788182829,0.964939379509639,0.10564026229142401,0.799673754473579,6360,221,FBXO2|WSB1|FBXO44|LMO7|FBXL8|RMND5A|PARK2|NHLRC3|UBE2V1|FBXW9|RPS27A|BARD1|RNF167|MARCH5|MARCH8|UBE4B|TRIM36|BLMH|FBXO30|CBFB|TPP2|ZNRF1|MARCH1|FBXO41|TRIP12|BTRC|ANAPC4|ANAPC1|PPIL2|UBE3D|CDC16|FBXO31|NEDD4|TRIM27|RBCK1|FBXO11|UBE2G1|ANKIB1|BFAR|RUSC1|FBXL5|RNF19A|RFFL|FBXO7|DDB2|TRIM5|PELI2|STUB1|CDC34|UBE2Q2|FBXL3|BCL2|NEDD4L|UBE2K|UBR5|TNKS|FBXL16|UBE2E3|FBXO9|PELI1|RNF41|UNKL|FBXW8|RC3H1|TNKS2|UBOX5|BIRC2|KLHL42|FBXL12|RNF146|RNF19B|RNF126|WWP2|SHPRH|HACE1|LONRF1|MKRN1|UBE4A|RNF4|MIB2|UBE2D4|HECW2|FBXL4|UBE2W|RNF8|UBE2H|UBE2C|NHLRC1|UBA52|FBXW4|LRSAM1
MODIFICATION-DEPENDENT MACROMOLECULE CATABOLIC PROCESS%GOBP%GO:0043632,0.6860730593607309,0.886120113353976,-0.111475829805335,-0.9154817023533259,5408,394,VCP|RNF144B|UBE2G2|MAD2L1|TNFAIP3|RNF7|SIAH2|PSMD4|RBBP6|SEL1L|SMURF2|UBE2S|UBQLN1|RNF168|UBXN1|ARRB1|PSMB5|UHRF1|TRIM32|UBE2R2|FAF2|HUWE1|MVB12B|CDC27|RAD23B|RNF20|SEC13|DTL|SKP1|NPLOC4|RCHY1|NEDD8|VPS25|PSMC6|USP44|FBXO4|CCNB1|PLK1|NSFL1C|PSMB3|SYVN1|SNF8|RNF40|KIAA0368|PSMD2|SEC61B|UBC|EXOSC3|SGTB|PSMD6|ERCC8|FBXW5|DDB1|SPOP|PLAA|DERL3|MYLIP|PSMD12|PSMA3|KAT5|HSPA5|ANAPC11|UBE2L6|TOLLIP|PSMA6|PSMD13|PSMB7|EXOSC2|PSMA1|PSMC5|SQSTM1|RMND5B|RNF130|SPSB1
CIRCADIAN REGULATION OF GENE EXPRESSION%GOBP%GO:0032922,0.00581921634553214,0.08817204199300802,-0.33669431721950605,-1.8054404828530601,44,52,RORC|MTA1|ARNTL|CSNK1D|ID2|PML|NPAS2|LGR4|PER2|BHLHE40|RORA|TOP1|HNRNPU|AHR|OGT|ZFHX3|USP2|CRY2|RBM4B|NR1D1|RELB|CCRN4L|PRKCDBP|PPARA|MAGED1|PRMT5|PPP1CA|CIART|NGFR
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901016,0.42790824685964,0.756202814008058,0.218373754721809,1.01868342403724,3133,31,ANK2|RNF207|KCNIP2|GAL|SUMO1|NEDD4|NETO1|YWHAE|KCNG1|NEDD4L|WWP2|NOS1AP|AKAP9|KCNAB1|KCNE3|VAMP2
CHROMATIN ORGANIZATION INVOLVED IN NEGATIVE REGULATION OF TRANSCRIPTION%GOBP%GO:0097549,0.36706349206349204,0.721193319737038,-0.5593911988529829,-1.09234923424335,2774,3,CTBP1|SMCHD1|POLE3
RIBOSOME-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:1990116,0.7927832316264258,0.9295725785163721,-0.46567411083540095,-0.7749561873193329,5975,2,LTN1|NEMF
REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:2000224,0.45940514469453403,0.7735063645065241,0.609760132340778,1.02447575165002,3428,2,WNT4|AKR1C3
PROTEIN NUCLEOTIDYLATION%GOBP%GO:0018175,0.160936454849498,0.5311416159351421,-0.9178429642699599,-1.22278721550012,1202,1,FICD
NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA%GOBP%GO:0090201,0.0474567383324594,0.312255783864335,-0.440090891720461,-1.55697721878154,361,14,TRIAP1|PPIF|HGF|OPA1|GPX1|PRELID1|IGF1|PSMD10|FXN
POSITIVE REGULATION OF GLYCOGEN (STARCH) SYNTHASE ACTIVITY%GOBP%GO:2000467,0.536683687180865,0.8133252693450141,0.47413698025807893,0.932571488322811,3993,3,IGF2|GSK3A|EPM2AIP1
RESPONSE TO INTERLEUKIN-6%GOBP%GO:0070741,0.0613577023498695,0.35631208031004796,-0.35657669720976204,-1.49711632737564,469,23,SBNO2|CHI3L1|SELPLG|SOCS3|PID1|IL6ST|STAT3|CTR9|RELA|NFKB1|PHB|PTGIS
POSITIVE REGULATION OF CHROMATIN ORGANIZATION%GOBP%GO:1905269,0.11915496586371198,0.47098246139817795,-0.227156574624547,-1.30452788680985,924,67,CTBP1|MYB|SMAD4|TADA2A|CDK9|RUVBL2|AKAP8L|JARID2|SIRT6|NIPBL|LIF|UBE2N|SART3|IL1B|C6orf89|FOXP3|TET1|RPS6KA5|BRD4|DNMT3B|KDM1A|TRIM28|CHTOP|PAXIP1|OGT|FMR1|TAL1|PRKD1|BRCA1|ARRB1|SNW1|CTR9|MAPK3|DNMT1|RNF20|WBP2|KAT7|PHF19|RNF40|RPS6KA4
TYROSINE BIOSYNTHETIC PROCESS%GOBP%GO:0006571,0.886571921901979,0.964939379509639,0.556296868107631,0.7417468108961179,6674,1,PAH
POSITIVE REGULATION OF HIGH VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901843,0.31666893085178605,0.6861326333203311,0.509305605728929,1.11896610590969,2330,4,CACNB2|CACNA2D1|CACNB3|GBAS
"NUCLEOTIDE-EXCISION REPAIR, DNA INCISION, 5'-TO LESION%GOBP%GO:0006296",0.23158438873093803,0.6150986887877521,-0.24392672556863698,-1.18498288451243,1791,37,RFC2|CUL4B|RPA2|RFC3|PARP1|POLD4|PCNA|POLD1|POLD2|RFC5|GTF2H1|UBC|DDB1|RFC4|XPA|GTF2H2
EOSINOPHIL MIGRATION%GOBP%GO:0072677,0.0244956772334294,0.219638825480684,-0.522835261959395,-1.6927072901766003,186,11,CCL3|CCL4|CCL8|CCL11|CCL24|CCL2|LGALS3|CX3CL1|CCL4L2
THIOSULFATE TRANSPORT%GOBP%GO:0015709,0.937248051599033,0.9806508984207809,0.308320575209864,0.6064301872161519,6974,3,SLC25A30|SLC25A14
REGULATION OF ACTIN NUCLEATION%GOBP%GO:0051125,0.736605928746261,0.908157084784786,0.201751288740281,0.7897406291377459,5416,18,CYFIP1|PICK1|ABI2|NCKAP1|WIPF1|WIPF2
PROTEIN K11-LINKED DEUBIQUITINATION%GOBP%GO:0035871,0.9322563835330899,0.9800350656963129,-0.19842233009708699,-0.5969029372506371,7155,9,OTUD7A|USP37|VCPIP1|OTUD3|OTUB2|YOD1|OTUD7B|USP30|TNFAIP3
NEGATIVE REGULATION OF COLLAGEN BIOSYNTHETIC PROCESS%GOBP%GO:0032966,0.7020429822234011,0.8931369333627571,-0.515743038323684,-0.8582788892833291,5291,2,CIITA|IL6
POSITIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS%GOBP%GO:0060557,0.377819050145927,0.7281989978224692,-0.64957264957265,-1.0809927633655099,2847,2,IL1B|TNF
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:0090150,0.5411522633744861,0.815622645995152,-0.12889038506245698,-0.96264624341864,4207,223,RPS14|RPS4X|ARHGAP44|GGA3|RPL35A|RPS29|VAMP5|KRT18|RPL10|RPL36A|RPL24|SRP19|ROMO1|STX1B|RPL35|RPL38|RPS15A|PEX16|UBL4A|CHMP4A|STX3|SEC61A1|ZDHHC19|SEC61B|NSF|SSR1|RAB34|TIMM9|SYNE3|SGTB|RPS13|ARL6IP1|ATG3|HSP90AA1|ZDHHC24|SRP9|HSPA4|ZDHHC2|TIMM10|SRP68|BAD
RESPONSE TO COBALT ION%GOBP%GO:0032025,0.36509002956194603,0.719535401591739,0.5561376419984561,1.0938571132514,2716,3,D2HGDH|TIGAR|BNIP3
MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0072330,0.10931692938613399,0.453620062030508,-0.190996223035478,-1.27196843938967,852,123,ABHD3|GPX4|ALOX5|SCD5|PGAM2|CD74|NCAN|PER2|LTC4S|TBXAS1|PTGDS|GPI|PFKFB2|ELOVL2|HK1|CBR1|ACSF3|HK3|DCN|ELOVL1|PARK7|PTGES2|PTGS1|BGN|ENO1|VCAN|THNSL2|PGAM1|CYP46A1|GAPDH|CYP7B1|HACD2|LDHA|NDUFAB1|OSBP|ABCD1|PGK1|FADS1|OSBPL3|PTGES|ALDOA|ALDOC|PTGIS
GLUTAMINE METABOLIC PROCESS%GOBP%GO:0006541,0.261807261807262,0.637592109988467,0.387057552706664,1.17623220436051,1917,9,GLS|CAD|GLUD1|NIT2|GLS2
REGULATION OF INTERLEUKIN-17 SECRETION%GOBP%GO:1905076,0.253913043478261,0.633195891137401,-0.8695963828848701,-1.1585111844078102,1897,1,OSM
"REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, NON-REM SLEEP%GOBP%GO:0045188",0.24521739130434803,0.62804240987169,-0.8741729157476841,-1.16460822507142,1832,1,GHRL
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0042509,0.0173350582147477,0.17886971906195498,-0.34591866723578996,-1.6656951879006698,133,36,LIF|CD40|CTF1|TNF|PARP14|LYN|STAP2|IL18|SOCS3|PARP9|HCLS1|TNFRSF18|IL6ST|HES1|SOCS1|STAT3|OSM|IGF1|PPP2CA|CSF1R|NF2|TNFRSF1A
REGULATION OF INTERLEUKIN-15 PRODUCTION%GOBP%GO:0032658,0.9232301766502858,0.9776156396135859,0.539258932509925,0.719029022753894,6950,1,TIRAP
CHLORIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902476,0.21879230977525,0.6013948176405761,0.299870676060638,1.2153078934318302,1615,20,SLC12A5|SLC12A4|GABRA3|SLC12A9|GABRB3|CLCN3|CLCN6|SLC12A6|GLRB|GABRG2|SLC12A7
WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904953,0.5692972124067529,0.832269842301315,-0.412523532859729,-0.903100246341611,4349,4,WNT3
RECEPTOR INTERNALIZATION%GOBP%GO:0031623,0.00599973914177645,0.0903287999335997,-0.3526484820832921,-1.79768280128643,45,44,SYK|SNX1|ITGB1|GRK4|ACKR3|SYNJ1|LILRB1|ADM|ITGB2|DNM1|LRP1|GRB2|CLTC|CALCRL|ARRB1|FCER1G|CEACAM1|CD36|CAV1|ADRBK1|TFRC|CD81|AP2M1|DNM3|GTF2H2
REGULATION OF CYTOPLASMIC TRANSPORT%GOBP%GO:1903649,0.121495327102804,0.47376597884378,0.329608225344659,1.3586948898408797,896,21,CHMP3|PARK2|MTMR2|TRIM46|MAP2|VPS11|EZR|SRC|MAP2K1|MAPK1
LATE NUCLEOPHAGY%GOBP%GO:0044805,0.7111111111111109,0.8966571213032921,-0.412650270210654,-0.805801391940359,5375,3,ATG9B|ATG9A|ATG7
ROOF OF MOUTH DEVELOPMENT%GOBP%GO:0060021,0.6166492693110649,0.854159296508911,-0.203016477624251,-0.885594949956995,4725,26,EPHB3|TBX1|BCOR|COL11A2|CLDN5|TGFB3|INHBA|LRRC32|TGFBR2|TGFBR3
INTESTINAL ABSORPTION%GOBP%GO:0050892,0.058553838092743,0.34919341471152904,-0.474723718999847,-1.5369435813478003,446,11,TJP2|KCNQ1|CD36|LDLR
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA SEMI-CONSERVATIVE REPLICATION%GOBP%GO:0032214,0.976253648182542,0.9926773910205121,-0.323533956058063,-0.53841223985011,7358,2,TERF2
ORGANIC ANION TRANSPORT%GOBP%GO:0015711,0.0575345976422348,0.34572948895248495,-0.17776753894853398,-1.3162205871578798,448,211,SLC35B1|FABP3|PRELID1|SLC9A3R1|ABCG1|SLC37A2|SLC1A2|SLC16A13|CA2|SLCO2B1|ATP8B1|CETP|SLC51A|SLC1A3|SLC25A22|SLCO2A1|SLC38A6|SLC6A8|SLC35A2|CEACAM1|PDPN|LCN12|LCN1|APOE|GIPC1|FABP4|SLC7A3|CD36|ATP8B4|CYB5R1|SLC27A4|SLC25A4|SLC3A2|SLCO4A1|LDLR|PPARG|PPARA|RPS6KB1|ABCD1|PCTP|ARL6IP5|SLC25A42|PRAF2|ANXA1|ATP8A2|NPC2|MPC1|SLC25A19|FOLR2|SLC7A8|SLC38A9|OSBPL5|ABCC1
POSITIVE REGULATION OF STEM CELL PROLIFERATION%GOBP%GO:2000648,0.684417113698809,0.8856747470877271,-0.218629873014808,-0.8308469060430941,5230,17,KDM1A|TERT|LTBP3|HNRNPU|SMARCD3|CX3CL1
NEGATIVE REGULATION OF HEART GROWTH%GOBP%GO:0061117,0.968123256740603,0.9912626134248801,0.51532862814292,0.6871211908648149,7288,1,GSK3A
PRONEPHRIC DUCT MORPHOGENESIS%GOBP%GO:0039023,0.11555319431531401,0.46493596964429496,0.943537715041906,1.2580802287693897,869,1,AHI1
GERMLINE STEM CELL ASYMMETRIC DIVISION%GOBP%GO:0098728,0.6683490503386911,0.8811119744196031,0.6641486546096159,0.885552615446897,5031,1,ING2
REGULATION OF ACROSOMAL VESICLE EXOCYTOSIS%GOBP%GO:2000367,0.10015919342000501,0.43605057892447596,-0.802040253653157,-1.33472323795852,754,2,HYAL3|ZP3
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902237,0.62124898621249,0.855976969451052,0.356370137649801,0.8570681374392819,4595,5,BOK|PMAIP1
ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX%GOBP%GO:0098971,0.689868314969094,0.887051934478962,0.416871301914832,0.819936656816294,5133,3,KIF5A|KIF5C|KIF17
NEGATIVE REGULATION OF MITOTIC RECOMBINATION%GOBP%GO:0045950,0.41973998408065794,0.7514346091901549,-0.6318169285911222,-1.05144440429898,3163,2,BLM|TERF2
NEGATIVE REGULATION OF JUN KINASE ACTIVITY%GOBP%GO:0043508,0.829759414225942,0.9435818887072471,-0.222467621477668,-0.696962017067222,6345,10,DNAJA1|GSTP1
NEGATIVE REGULATION OF HEPATOCYTE GROWTH FACTOR PRODUCTION%GOBP%GO:0032686,0.573913043478261,0.835204333784353,-0.717247463608293,-0.955545842798603,4289,1,INHBB
TELOMERE ORGANIZATION%GOBP%GO:0032200,0.309656925031766,0.680809181688249,-0.17285556780170902,-1.0904059929939,2436,96,RFC2|RAD51|RPA2|SP100|RFC3|TERF2|TERT|NBN|TINF2|EXO1|PARP1|POLD4|PCNA|POLD1|SLX1B|SLX1A|HIST1H4I|POLD2|RFC5|DKC1|TNKS1BP1|HIST2H4A|HIST1H3H|APEX1|POLA1|HSP90AA1|ORAOV1|HIST2H4B|H3F3B|RFC4|POLA2|XRCC3|FEN1
POSITIVE REGULATION OF ICOSANOID SECRETION%GOBP%GO:0032305,0.0931815207433582,0.422068646506606,-0.6496442949318921,-1.4222071616624798,711,4,IL1B|P2RX4|TNFRSF11A|PLA2R1
POSITIVE REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE%GOBP%GO:1905492,0.209765886287625,0.591207086931478,-0.8931958535509481,-1.1899513459021,1567,1,MAP3K13
TELENCEPHALON REGIONALIZATION%GOBP%GO:0021978,0.125364818254179,0.480371761940642,-0.7817596137962108,-1.3009730101184098,944,2,BMP2
NEGATIVE REGULATION OF EPINEPHRINE SECRETION%GOBP%GO:0032811,0.800026174584479,0.931797839320173,-0.334363798627166,-0.731992249786603,6112,4,ADRA2C
PERICENTRIC HETEROCHROMATIN ASSEMBLY%GOBP%GO:0031508,0.8843783494105041,0.9635685363561758,0.400385993934381,0.6727001657380011,6600,2,CENPV|HELLS
CELLULAR POLYSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0044247,0.19015233949945604,0.563750965709003,0.372427370387752,1.26580819410053,1397,12,PYGB|MANBA|FAM47E-STBD1|AGL|PGM2L1|PGM1|PGM2
POSITIVE REGULATION OF CENTRIOLE ELONGATION%GOBP%GO:1903724,0.258388805868768,0.636098664976652,0.541112888104561,1.18884805988601,1901,4,CENPJ|CEP120|CEP295|VPS4B
POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION%GOBP%GO:2000251,0.0103701758991861,0.131171792348333,-0.499061894270401,-1.81201284077329,78,15,HCLS1|FES|HAX1|BCAS3|ABL1|HRAS|BAIAP2L1|HCK|TEK
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:1905005,0.470425867507886,0.781573313783919,-0.36015782199493396,-0.984475345414346,3578,7,TGFB2|TGFB1|TGFB3|TGFBR2|ENG
REGULATION OF INTERLEUKIN-1 ALPHA PRODUCTION%GOBP%GO:0032650,0.250331652958344,0.6309150060330451,-0.7071948244309839,-1.1768852768083402,1886,2,CX3CL1
EMBRYONIC PATTERN SPECIFICATION%GOBP%GO:0009880,0.646803900325027,0.8697778704754799,0.22989601585166897,0.8479916357369709,4775,15,FGFR2|TBX3|SMAD1
"REGULATION OF SYNAPTIC TRANSMISSION, GLUTAMATERGIC%GOBP%GO:0051966",0.0012233247247519401,0.0271574809203979,0.44563896155059596,2.0631731244,8,30,DRD2|GRIK3|TPRG1L|CACNG7|RAB3GAP1|UNC13A|ADCYAP1|TSHZ3|CACNG4|PTK2B|NLGN2|GRM4|HOMER1|SHANK2|CDK5|GRM8
LAMELLIPODIUM ASSEMBLY%GOBP%GO:0030032,0.0299645873059112,0.244735657013286,0.379471959504147,1.61102725635525,219,23,ABLIM2|CYFIP1|ABLIM1|ARHGEF7|CCDC88A|PTPRO|KIT|LRRC16A|ARHGEF4
VIRAL RNA GENOME REPLICATION%GOBP%GO:0039694,0.894089958158996,0.9658968257150641,-0.20422574060793303,-0.639812585605589,6837,10,ATG16L1|SMARCB1|ROCK2|RAB5A|PCBP1|PCBP2|ATG16L2|CDC42|EEA1|RAB29
POSITIVE REGULATION OF ORGANELLE ORGANIZATION%GOBP%GO:0010638,0.44948219247284704,0.768229288546963,-0.11970028095474301,-1.00356282935332,3558,457,MUL1|NPEPPS|BRD4|PML|DNMT3B|GNL3|PFDN2|RGCC|CCL11|NUSAP1|CCT3|DLGAP5|NABP2|FIS1|PYCARD|APOPT1|NCKAP1L|DYNC1H1|CTTN|PLCB1|ARHGEF5|TFDP2|CLIP1|SREBF2|KDM1A|CDT1|BCL2L11|NBN|GZMB|PPM1F|CALCOCO2|ANAPC5|TRIM28|PPIF|ESPL1|KDR|ANKRD32|MICALL2|CHTOP|HCLS1|CCL24|ARPC1A|PAXIP1|HNRNPU|ATG13|WAS|FES|OGT|ATPIF1|IQGAP2|PDCD5|PLEK|TGFB3|NMT1|INS|SEPT7|CDK5RAP2|FMR1|DHX36|CCT8|DCN|PPP1R13B|TNFSF10|LMOD1|PDXP|SLX1B|HNRNPA2B1|TAL1|SLX1A|PRKD1|CD47|PARK7|HAX1|CCT5|BRCA1|ARRB1|SDC4|BCAS3|S100A10|CTGF|PXN|CAMKK2|SNW1|CTR9|MECP2|MAPK3|ABL1|HUWE1|DNMT1|RAPGEF3|RNF20|HRAS|IGF1|E2F1|ARHGEF15|LRP5|WBP2|KAT7|GPER1|CIDEB|PHF19|FBXO4|GSN|BAIAP2L1|NSFL1C|PLAUR|HCK|CDC42EP4|TEK|CFL2|RNF40|SEMA5A|ARPC5L|ARL2|PDGFRB|NAV3|MMP9|CX3CL1|STOML2|RPS6KA4|ANXA2|EVL|NF2|TMED9|SEPT9|CDC42EP1|ANXA1|H2AFY|RHOU|CDC42EP5|ANAPC11|SYNPO|SURF4|NCK1|CDCA5|ARF6|PDGFB|CDC42EP2|SERPINF2|FEN1|BAD|GTF2H2
RESPONSE TO HYDROXYUREA%GOBP%GO:0072710,0.410700338453528,0.7453853667476059,-0.35809327849336603,-1.0309004298894302,3154,8,ATRX|BLM|TIMELESS|NDNL2|FMR1|KAT7
CAMP-MEDIATED SIGNALING%GOBP%GO:0019933,0.37482337829158596,0.7254276229586741,-0.174568757074234,-1.0457081110705602,2917,79,ADGRE2|ADCY8|PDE4D|CALCB|PTGER4|CALCRL|TBXA2R|PDE2A|ADCY4|RAPGEF3|ADGRL4|GNAQ|GPER1|ADGRE5|CHGA|ADRA2C|ADGRG1|PTGIR|ADGRL1|ADCY9|ADGRB1
REGULATION OF LIPID CATABOLIC PROCESS%GOBP%GO:0050994,0.156514934133299,0.525982918868011,-0.29185831734343,-1.2872377661957801,1199,27,METTL20|IL1B|AKT1|TNF|APOC2|APOC1|INS|PNPLA2|IRS1|ABHD5|BSCL2|RARRES2|LDLR|PPARA|ABCD1
REGULATION OF MITOTIC SPINDLE ELONGATION%GOBP%GO:0032888,0.982876254180602,0.993436724391485,-0.508601676224085,-0.677579555194827,7346,1,NUMA1
NEGATIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:2000117,0.0020722704312912802,0.0405181471223317,-0.343927236886307,-1.9005241674072502,15,58,FNIP1|RPS6KA1|TRIAP1|IGBP1|KLF4|HGF|NGF|GAS6|GPX1|DDX3X|SIAH2|CAAP1|PARK7|DPEP1|CARD16|IFI6|IFI16|NAIP|CAST|USP47|PLAUR|THBS1|XIAP|MMP9|BCL2L12|ARL6IP1|NGFRAP1|DHCR24|NGFR
NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS%GOBP%GO:0051198,0.476115691663395,0.7850084910380921,-0.446616287349374,-0.9777364125855659,3637,4,CBFA2T3|PPARA
REGULATION OF GONAD DEVELOPMENT%GOBP%GO:1905939,0.7615571776155721,0.9184699428006701,0.31606250998471197,0.7601285240492779,5633,5,WNT4|CITED2|GDF9
FOLIC ACID-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0009397,0.48780814576634496,0.788226301622024,0.597009740918925,1.00305344779164,3640,2,PM20D2|MTHFS
REGULATION OF INTERFERON-BETA SECRETION%GOBP%GO:0035547,0.42464492372435597,0.754564869291744,-0.4244969448545,-1.01743817534354,3228,5,LILRB1|DHX9|IFIH1
REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002886,0.0020928711576193603,0.0408245456317246,-0.43165066629213295,-1.9708324350964799,15,30,UNC13D|DNASE1L3|HLA-E|LYN|CD84|ITGB2|SNX4|STX4|FGR|STXBP2|FES|FCGR2B|ADGRE2|VAMP8|VAMP7|SNX6|CD300A|LGALS9|TICAM1|ITGAM
REGULATION OF CYTOPLASMIC TRANSLATION%GOBP%GO:2000765,0.157441253263708,0.527359258893039,-0.30799727839149704,-1.29315167781679,1205,23,FMR1|DHX36|AARS|UNK|CPEB1|YBX3|ZNF385A|NCK1
NEGATIVE REGULATION OF PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE%GOBP%GO:1903704,0.491371237458194,0.790696900371285,-0.75766431407146,-1.00939079227365,3672,1,TERT
PROTEIN SECRETION%GOBP%GO:0009306,0.5037988672468571,0.7975731804297109,0.16408413709178102,0.9739299216347199,3646,72,RAB11FIP5|RAB3B|RAB3D|RAB10|STEAP3|PTPRN|RAB1A|RIMS2|GAL|ADCYAP1|RAB11FIP2|BTN3A1|RAB15|TRIM27|SCG2|BTN3A2|RAB11B|CAMK2G|CYB5R4|ZBTB7B|TVP23B|COPG2|PTPRN2|OLFM2
NEGATIVE REGULATION OF SATELLITE CELL DIFFERENTIATION%GOBP%GO:1902725,0.7859056806002142,0.9274485629622209,0.456741108354012,0.767384034266335,5865,2,EPHB1|AKIRIN1
"POSITIVE REGULATION OF WNT SIGNALING PATHWAY, CALCIUM MODULATING PATHWAY%GOBP%GO:0045813",0.004648691725328729,0.0752560935123842,0.9979047198941329,1.33057129384458,34,1,DKK1
GALACTOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0019375,0.0287037037037037,0.238792268557792,-0.7999561498643699,-1.5621116126323997,216,3,B3GALT2|B3GALT1
NEGATIVE REGULATION OF TESTICULAR BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0061369,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
MITOTIC DNA INTEGRITY CHECKPOINT%GOBP%GO:0044774,0.9229987293519699,0.9776156396135859,-0.11191529643161399,-0.705983101896437,7263,96,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|FOXN3|BLM|SFN|STK33|CDKN1B|CNOT6|AURKA|EME2|PIDD1|PRMT1|RAD9A|PML|RGCC|CLSPN|RPA2|TRIAP1|TFDP2|SETMAR|DONSON|NBN|CDC6|PLK2|RAD17|PCNA|ORC1|TOP2A|TAOK2|CDC25C|TOPBP1|EME1|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A|CCND1|MUS81
"NUCLEOTIDE-EXCISION REPAIR, DNA INCISION, 3'-TO LESION%GOBP%GO:0006295",0.41400161246976597,0.7484205549734521,0.531956188366367,1.04629504755635,3080,3,ERCC5|ERCC1|ERCC4
REGULATION OF AUTOPHAGOSOME SIZE%GOBP%GO:0016243,0.676716695444282,0.8835592822191172,0.6609505955006619,0.881288435148356,5094,1,ATP13A2
NEUROMUSCULAR PROCESS%GOBP%GO:0050905,0.236489232019504,0.62149045081524,0.289861092366036,1.19485120418221,1745,21,STRA6|DRD2|CTNNA2|DCTN1
RESPONSE TO CISPLATIN%GOBP%GO:0072718,0.3617724867724871,0.716154857259883,-0.561925023547016,-1.09729715167557,2734,3,TIMELESS|ADIRF
CYTOPLASMIC TRANSLATIONAL TERMINATION%GOBP%GO:0002184,0.406746031746032,0.743993928843167,-0.542296239108856,-1.05896711056281,3074,3,GSPT1|GSPT2|ETF1
REGULATION OF LIPOPROTEIN LIPID OXIDATION%GOBP%GO:0060587,0.532709030100334,0.812079525085925,-0.736821790913101,-0.9816235468417691,3981,1,APOD
REGULATION OF NEUTROPHIL DIFFERENTIATION%GOBP%GO:0045658,0.962809364548495,0.9908714970603191,-0.518802382002647,-0.691169344625773,7196,1,EVI2B
MONOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002280,0.22836120401337803,0.610121312048328,-0.8826091751213059,-1.1758473482224199,1706,1,DYSF
ESTABLISHMENT OF NATURAL KILLER CELL POLARITY%GOBP%GO:0001770,0.7278523044228979,0.9059042547382851,0.635476400529334,0.8473220334599821,5479,1,SNX27
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002588,0.1950119395065,0.5697855203224189,-0.7363661428177559,-1.22543101544847,1469,2,PYCARD|TREM2
WALKING BEHAVIOR%GOBP%GO:0090659,0.47749196141479106,0.7850984235874658,0.601974140915169,1.0113942807649499,3563,2,DRD2
HISTONE H2B CONSERVED C-TERMINAL LYSINE UBIQUITINATION%GOBP%GO:0071894,0.920175322087927,0.9768322640118741,0.540471989413322,0.72064647045334,6927,1,WAC
MITOCHONDRIAL PROTEIN CATABOLIC PROCESS%GOBP%GO:0035694,0.756285482562855,0.9166093439295571,0.317055929181289,0.7625176915202739,5594,5,SPATA18|YME1L1|LACE1|BNIP3
REGULATION OF PROSTATIC BUD FORMATION%GOBP%GO:0060685,0.22795986622073602,0.609818988326981,-0.882940008822232,-1.17628809814991,1703,1,SULF1
PULMONARY VALVE DEVELOPMENT%GOBP%GO:0003177,0.0797594142259414,0.395958593986611,-0.3728431760354,-1.4467701871094099,609,18,HEYL|TGFB2|ROBO1|GJA5|JAG1|SMAD6|NOTCH1|NOTCH2|NOS3|SLIT2|TNFRSF1A|TNFRSF1B
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN NEPHRON MORPHOGENESIS%GOBP%GO:0072039,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN METANEPHRIC NEPHRON MORPHOGENESIS%GOBP%GO:0072304,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
SHORT-TERM MEMORY%GOBP%GO:0007614,0.26504551012090805,0.640406488040947,0.5375375912542321,1.1809929804423798,1950,4,CALB1|CUX2
GLUCOSYLCERAMIDE METABOLIC PROCESS%GOBP%GO:0006678,0.312037037037037,0.68160868787154,-0.584592478217713,-1.1415609456046698,2358,3,CLN3|GBA|UGCG
DICARBOXYLIC ACID TRANSPORT%GOBP%GO:0006835,0.18481805138907,0.5581275982958399,-0.28404538077461405,-1.25277889893507,1416,27,SLC25A10|SLC25A18|SLC1A2|SLC1A3|SLC25A22|PDPN|GIPC1|ARL6IP5|PRAF2|FOLR2
RENAL SYSTEM PROCESS%GOBP%GO:0003014,0.0498904215547248,0.32012215085927803,-0.261625259500791,-1.46714870429692,386,61,AQP1|PRKAR2A|HYAL2|ADM|AGT|AQP3|PCSK5|CD34|GAS6|SLC9A3R1|ADCY8|SGK1|JCHAIN|PRKAR1A|ADCY4|SULF1|NPR1|GSN|F2R|KCNQ1|MYO1E|PRKACA|LGMN|IGHA1|PDGFB|SERPINF2|ADCY9|EMP2
NEGATIVE REGULATION OF BLOOD COAGULATION%GOBP%GO:0030195,0.00013089005235602098,0.00518555396908895,-0.5614128384574689,-2.50733252687983,0,28,CD34|GP1BA|PLAU|VTN|CEACAM1|THBD|APOE|PLAUR|NOS3|SERPINE2|SERPINE1|PLAT|PDGFA|ANXA2|PDGFRA|TFPI|PDGFB|SERPINF2|C1QTNF1
METANEPHRIC LOOP OF HENLE DEVELOPMENT%GOBP%GO:0072236,0.0723472668810289,0.378321151505122,0.8341328921974079,1.4014509581488401,539,2,PKD1|PKD2
REGULATION OF PROTEIN DEACETYLATION%GOBP%GO:0090311,0.9828057835091829,0.993436724391485,-0.117697560586399,-0.507410675546717,7544,25,ZBTB7B|CAMK2D|FNTA|AKAP8|EP300|PRKAA1|ING2|ZNHIT1|SPRED1|KDM5A|VEGFA|PRKAA2|CCAR2|PRKD2|CTBP1|AKAP8L|NIPBL|C6orf89|FOXP3|MAPT|DYRK1A|PRKD1|BEX4|BRMS1
REGULATION OF PROGESTERONE BIOSYNTHETIC PROCESS%GOBP%GO:2000182,0.464898177920686,0.7786333182377991,0.607662196379089,1.02095094835891,3469,2,DGKQ|EGR1
REGULATION OF VIRAL-INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0039531,0.9570905285190999,0.9880317864833471,-0.153258876678374,-0.569569328697939,7315,16,DDX60|NPLOC4|DHX58
RENAL FILTRATION%GOBP%GO:0097205,0.122980719124544,0.47697345522944606,-0.46026845629328705,-1.38460017756496,943,9,CD34|JCHAIN|SULF1|MYO1E|IGHA1
SEMAPHORIN-PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE%GOBP%GO:1902285,0.7808553971486759,0.9252823577689769,0.214247104216193,0.7503380267315569,5750,13,PLXNB1|PLXNB2|NRP1|PLXNA4|PLXNB3|PLXNC1|PLXNA2|SEMA3F|PLXNA1
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN PROGRAMMED NECROTIC CELL DEATH%GOBP%GO:1902445,0.836682743837085,0.9461941948757601,0.42839012610177296,0.7197507235390841,6244,2,ALKBH7
RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM%GOBP%GO:1903514,0.534198432008651,0.812434061990131,0.382761342165526,0.920538832958947,3951,5,NOL3|RYR1
REGULATION OF PROTEIN LOCALIZATION TO CAJAL BODY%GOBP%GO:1904869,0.274622199062011,0.649047934290704,-0.38757950694736804,-1.16593402568068,2107,9,CCT7|CCT3|CCT8|CCT5|DKC1
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS%GOBP%GO:0002823,0.6661433804290949,0.880719592999549,-0.22632073256196397,-0.8410954752478158,5091,16,SMAD7|ZC3H12A|FOXP3|JAK3|LILRB1|NDFIP1|FCGR2B|RC3H2|CEACAM1|HFE
CHROMATIN DISASSEMBLY%GOBP%GO:0031498,0.0699895342752486,0.37596389138254704,-0.39914267375903,-1.48336872665928,534,16,SMARCA4|SET|SMARCE1|SUPT16H|SMARCD3|SMARCD2|HIST3H2A
PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086055,0.602943143812709,0.8480120088902141,-0.7022496691662989,-0.93556517941905,4506,1,GJA5
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009157,0.344282238442822,0.702174649119653,0.45341616615021296,1.09046327947125,2546,5,DCTD|CDADC1|DUT|HDDC2
PROTEASOMAL UBIQUITIN-INDEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0010499,0.0715316970731067,0.3767214120425879,-0.36004866115840994,-1.46684083803177,544,21,PSMA4|PSMA7|KEAP1|PSMA2|PSMB1|PSMB9|PSMB4|ENC1|PSMB2|PSMB5|PSMB3|PSMA3|PSMA6|PSMB7|PSMA1
SPHINGOMYELIN METABOLIC PROCESS%GOBP%GO:0006684,0.485258317554774,0.7872939093021379,0.349054455982161,0.9635554565694789,3587,7,SMPD2|SMPD4
NEGATIVE REGULATION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0043569,0.006216931216931221,0.0922568081394246,-0.8767508547479871,-1.7120722077321597,46,3,CILP|BMP2|IGFBP5
NEGATIVE REGULATION OF CELL-CELL ADHESION%GOBP%GO:0022408,0.00140109540185964,0.0301860198914787,-0.297691883824735,-1.8722267304408702,10,95,AKT1|FOXP3|CXCL12|JAK3|PRKG1|CD274|DUSP3|TGFB1|LILRB1|RGCC|NDFIP1|TNFAIP8L2|TNFRSF14|JAG1|RUNX1|TWSG1|RUNX3|PPM1F|KLF4|PDCD1LG2|SPN|IL1RN|FCGR2B|PLA2G2D|RC3H2|LILRB2|GPNMB|PRKAR1A|SOCS1|SDC4|SNAI2|CEBPB|C10orf54|CEACAM1|CD300A|HFE|CD86|LGALS3|SERPINE2|TNFRSF21|BMP2|LGALS9|SPINT2|PPARA|HAVCR2|KIAA2022|NF2|ANXA1|FXYD5|C1QTNF1|PRNP
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION%GOBP%GO:1901389,0.929765886287625,0.9793746057014829,-0.5343515659461839,-0.711884591217809,6949,1,HSP90AB1
THALAMUS DEVELOPMENT%GOBP%GO:0021794,0.0571933161255264,0.34436604181231795,0.6941020146691601,1.52497168639411,420,4,PTCHD1|CHRNB2|LRP6
MULTI-LAYER FOLLICLE STAGE%GOBP%GO:0048162,0.733962013547616,0.907913422943088,0.632168063520071,0.8429108124614921,5525,1,ZNF830
RESPONSE TO AMPHETAMINE%GOBP%GO:0001975,0.020096463022508,0.195205495598712,0.907251171767301,1.5242991085094801,149,2,DRD2|DRD4
AXONOGENESIS INVOLVED IN INNERVATION%GOBP%GO:0060385,0.697814422196048,0.8916368062640799,-0.36876001378729,-0.807292754872912,5331,4,NTRK1|NPTX1|SEMA3A
REGULATION OF PHOSPHOLIPASE ACTIVITY%GOBP%GO:0010517,0.03474653182937899,0.26620723045800804,-0.31454703584276195,-1.5752846550812,267,41,APOC2|BICD1|ARL1|GNA13|FLT1|EDNRA|LRP1|PLA2R1|ABL1|HRAS|NTRK2|P2RY6|GNAQ|GNA15|PDGFRB|ANG|PLAA|PDGFRA|ANXA1|RGS2|C5AR1
LIPOPROTEIN METABOLIC PROCESS%GOBP%GO:0042157,0.9367616400277969,0.9806508984207809,0.111875352445325,0.6813221030116681,6739,80,NMT2|PGAP2|PIGF|PGAP1|ZDHHC23|LYPLA2|ATG10|PIGU|ZDHHC8|PIGL|ZDHHC6|ZDHHC22|PPM1B|PGAP3|PIGO|PIGG|ATG5|ZDHHC17|PIGT|GOLGA7|ZDHHC16|DPM1|ZDHHC14|PIGQ|LYPLA1
NEGATIVE REGULATION OF ESTABLISHMENT OF T CELL POLARITY%GOBP%GO:1903904,0.844468056846859,0.948285501480553,0.5761468901632111,0.7682141368870591,6357,1,FAM65B
SISTER CHROMATID COHESION%GOBP%GO:0007062,0.0632977337848398,0.36006266503904,-0.318247083668158,-1.46666495692803,485,31,GSG2|RAD51C|STAG2|BOD1|NAA50|SGOL1|REC8|PLK1|HDAC8|SMC1A|KIF22|CDCA5
POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY%GOBP%GO:0060369,0.0376757760679225,0.276572928839036,-0.875504220780963,-1.45697902703081,283,2,PTPRJ
REGULATION OF KERATINOCYTE PROLIFERATION%GOBP%GO:0010837,0.0428683796539067,0.29593298684799796,-0.447675833328625,-1.58381163301705,326,14,ZFP36L1|STXBP4|MED1|CASK|PRKD1|SNAI2|FGF10|FGF7
PROTEIN KINASE D SIGNALING%GOBP%GO:0089700,0.561408223595808,0.828062129584091,0.46458293903882397,0.9137798166955771,4177,3,PRKD3|PRKD2
OVULATION CYCLE PROCESS%GOBP%GO:0022602,0.583943514644352,0.839558852248902,-0.284083075047608,-0.889995189793116,4465,10,TGFB3|INHBA|SLIT2|PDGFRA
POSITIVE REGULATION OF GROWTH OF SYMBIONT IN HOST%GOBP%GO:0044128,0.0896321070234114,0.41359635676085704,-0.9528561976179971,-1.26943324949282,669,1,OSBP
PHOSPHATIDYLCHOLINE CATABOLIC PROCESS%GOBP%GO:0034638,0.399892502015587,0.73962695174002,0.539759567662954,1.0616433737734001,2975,3,PNPLA8|PLA2G15|ENPP2
PURINE RIBONUCLEOTIDE INTERCONVERSION%GOBP%GO:0015951,0.99880604934996,0.999656642395059,-0.272015439757375,-0.452677190295591,7528,2,GMPR|GMPR2
NEGATIVE REGULATION OF POSITIVE CHEMOTAXIS%GOBP%GO:0050928,0.507290969899666,0.7987565605553191,-0.750441111601235,-0.999767752190112,3791,1,ANGPT2
RESPONSE TO BACTERIAL LIPOPEPTIDE%GOBP%GO:0070339,0.0282745923198317,0.23806191359062198,-0.683956551071046,-1.63931334199474,214,5,TLR1|TLR2|CD36|CD14
REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:1901722,0.10622233793283001,0.44869189060429,-0.493784836471081,-1.42153743385705,815,8,MYC|PDGFA|PDGFB
POSITIVE REGULATION OF SODIUM ION TRANSPORT%GOBP%GO:0010765,0.148825065274151,0.515518072789212,-0.31157572791286303,-1.3081760898073898,1139,23,AHCYL1|GPD1L|ACTN4|SCN4B|GLRX|ATP1B1|ATP1B3|TESC|SLC9A1|PKP2|FXYD1|SCN1B|ATP1B2|WNK2
REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY%GOBP%GO:1904375,0.00381922342457034,0.0665791148782204,-0.28925546329623997,-1.75269917009159,29,82,IQSEC2|PID1|STX4|NUMB|LRP1|CNST|STAC3|INS|SAPCD2|CLTC|AKAP5|MMP14|RHOG|PPFIA1|HRAS|VAMP8|NKD2|TREM2|EPB41L2|STX7|GPER1|EPHA2|RAP1A|TMEM59|LGALS3|STX3|DAB2|ACTB|ARF6|AP2M1|SQSTM1|PRNP
SKELETAL MUSCLE MYOSIN THICK FILAMENT ASSEMBLY%GOBP%GO:0030241,0.423837590045842,0.7540202308249201,-0.397254315084084,-1.0218451131892,3235,6,MYH11|MYOM1|IGSF22
REGULATION OF PROTEIN ACTIVATION CASCADE%GOBP%GO:2000257,0.00012960082944530802,0.00518555396908895,-0.589195264850409,-2.9095922021873504,0,39,C4A|C2|IGKV2-28|VTN|C3|C1QB|C1QA|CFB|C1QC|C7|IGKV2D-28|A2M|SUSD4|CD59|C3AR1|CFP|C1S|CFI|CD55|PHB|IGHG2|SERPING1|CD81|C1R|CFH|C5AR1
GLYCEROL BIOSYNTHETIC PROCESS FROM PYRUVATE%GOBP%GO:0046327,0.982999070261655,0.993436724391485,0.507829730921923,0.6771224232682379,7400,1,PCK2
PROTEIN AUTOPHOSPHORYLATION%GOBP%GO:0046777,0.14427733877134802,0.510659757938086,-0.17733501393208898,-1.2181750586970301,1131,142,SIK2|SLA|LYN|PIM2|MAP3K3|FLT1|GRK5|PEAK1|RIPK3|EPHB3|FGFR4|KDR|PIM3|FGR|TNK2|FES|DYRK1A|EPHA8|MYLK2|DDR2|TAOK2|MELK|FLT4|PRKD1|CAMKK2|MAPK3|PIM1|CAMK2B|ABL1|DDR1|IRAK1|NTRK2|MAP3K13|HCK|TEK|MAP3K11|PDGFRB|EPHA4|CAMK2A|INSRR|SIK1|EPHB4|CSF1R|PDGFRA|VRK1|NEK6|MARK2|ERN1|WNK2
DETECTION OF EXTERNAL STIMULUS%GOBP%GO:0009581,0.0177329150184149,0.181548349676725,0.349983574327449,1.66663836472739,129,33,PDE6B|PLEKHB1|GNGT1|EYS|PIEZO2|KIT|COL11A1|OPN3|MMP24|PKD1|CDS1|MKKS|PKD2|UNC119
POSITIVE REGULATION OF BONE REMODELING%GOBP%GO:0046852,0.556625878677428,0.8257149029717741,-0.31680111750387396,-0.912026077669715,4275,8,SYK|ADAM8|SPP1|ATP6AP1
ETHANOL OXIDATION%GOBP%GO:0006069,0.280757097791798,0.653918409964198,-0.42589450650858296,-1.16416364104681,2135,7,ACSS1|ADH1B|ALDH2|ALDH1A1
REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045714,0.794055760126249,0.929656485793048,-0.307903274388042,-0.7379853953555471,6037,5,SCAP|ITGB3|CNPY2|HNRNPK
SYMBIONT PROCESS%GOBP%GO:0044403,0.0126485243388271,0.14869950444299201,-0.187205782480465,-1.4428957053819098,98,265,CDC42|PAK2|NUP205|VPS37B|AP1S2|SERPINB9|CCL4|NUP93|RAC1|DOCK2|NUP210|YTHDC2|BICD1|TGFB1|NFIA|AQP1|ATG7|PSIP1|HYAL2|DENR|DHX9|PTBP1|CD209|B2M|SMARCA4|ZNF639|REST|DEK|TSG101|AP2A2|CTNND1|PCSK5|RANBP1|CALCOCO2|CD4|RAB9A|RRAGA|PACS1|PPIA|RAB7A|UBAP1|HCFC1|KPNB1|CCNK|AZU1|CAV2|EEA1|GAS6|VCP|RAB29|PPIB|PVRL2|FMR1|NUP188|SLC25A6|CLEC4M|CXCR4|ELMO1|GRB2|ICAM1|IFIT1|NUP85|SNW1|RCC1|NUCKS1|KPNA4|MVB12B|USF2|IRF7|VAMP8|NUP37|ARF1|RAN|EIF3B|TNIP1|CCL2|NUP160|KPNA2|APOE|FN1|THOC7|GAPDH|AXL|AP1B1|HCK|NUP214|CHMP4A|RAB1B|CHMP6|MCTS1|UBC|PABPN1|RRP1B|CAV1|HCFC2|DDB1|CFL1|ANXA2|ADRBK1|NUP98|THOC3|VPS37C|CD81|BANF1|AP2M1|EIF2D|PSMC3
AMINO ACID IMPORT%GOBP%GO:0043090,0.11216779572694098,0.459194647507502,-0.46778611138724396,-1.40721512420239,860,9,SLC7A2|SLC1A2|SLC1A3|SLC7A3|SLC3A2
MITOCHONDRIAL OUTER MEMBRANE TRANSLOCASE COMPLEX ASSEMBLY%GOBP%GO:0070096,0.394247491638796,0.7376723208557521,-0.802657697397441,-1.0693327824123,2946,1,TOMM20
PUTRESCINE ACETYLATION%GOBP%GO:0032920,0.07130434782608701,0.3767214120425879,-0.9628914865460959,-1.2828026639600199,532,1,SAT2
REGULATION OF AV NODE CELL ACTION POTENTIAL%GOBP%GO:0098904,0.11071428571428599,0.45638735792888,-0.7023271203264589,-1.3714668619206798,836,3,GJA5|RYR2|CXADR
REGULATION OF RNA POLYMERASE II TRANSCRIPTIONAL PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0045898,0.0223587866108787,0.2071441845173,-0.545705867293173,-1.7096252455427399,170,10,THRA|PSMC4|PSMC6|PSMC5|PSMC3
REGULATION OF HEMOSTASIS%GOBP%GO:1900046,0.00012923235978289,0.00518555396908895,-0.5240467056185829,-2.74722313186116,0,48,GP1BA|PLAU|PLEK|VTN|FCER1G|F3|FAP|CEACAM1|THBD|PDPN|F2R|APOE|PLAUR|NOS3|SERPINE2|THBS1|SERPINE1|CAV1|PLAT|ENPP4|TLR4|PDGFA|ANXA2|PDGFRA|TFPI|PDGFB|SERPINF2|C1QTNF1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PRESYNAPSE%GOBP%GO:1905386,0.612963208925488,0.852045339927398,0.6903396559329511,0.920474781684944,4614,1,DVL1
REGULATION OF PROTEIN IMPORT INTO MITOCHONDRIAL OUTER MEMBRANE%GOBP%GO:1903636,0.37618729096990006,0.7266197487465021,-0.81004631671813,-1.07917619745958,2811,1,PDCD5
POSITIVE REGULATION OF HEART RATE%GOBP%GO:0010460,0.793202293202293,0.929621926733366,0.241718749661475,0.734560986502842,5810,9,TRPM4|TPM1
BRANCH ELONGATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0060667,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
POSITIVE REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LATERAL MESODERM LEFT/RIGHT ASYMMETRY%GOBP%GO:1900224,0.6336830920440961,0.8631726958478259,0.680359505955007,0.9071675983394991,4770,1,SMAD2
NEGATIVE REGULATION OF CELL CYCLE G1/S PHASE TRANSITION%GOBP%GO:1902807,0.23362222788682102,0.617659277783149,-0.190604943896458,-1.1579320924119099,1832,83,PCBP4|GTSE1|WEE1|CNOT4|RBL1|BTG2|CNOT10|CNOT6L|PRMT2|SFN|CDKN1B|CNOT6|AURKA|PTEN|FHL1|PIDD1|PRMT1|PML|RGCC|RPA2|TRIAP1|TFDP2|KLF4|PLK2|SLFN11|PCNA|CDC25C|GPNMB|DCUN1D3|E2F1|CCL2|KANK2|NACC2|CCNB1|PLAGL1|SUSD2|TNKS1BP1|FAM107A|DACT1|CDK2AP2|ZNF385A|CCND1
NUCLEAR MEMBRANE ORGANIZATION%GOBP%GO:0071763,0.21567857610260396,0.598994355749518,-0.572233475096915,-1.25273869527502,1647,4,TOR1A|GPER1
MONOAMINE TRANSPORT%GOBP%GO:0015844,0.11955639707871199,0.47119788006200797,0.5052617503703271,1.39476149987914,883,7,SLC6A2|PICK1|SLC18A1|SNCA|SLC18A2|VIP
REGULATION OF GLUCOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046317,0.629831318900252,0.860897694974173,0.6827856197618,0.9104024937383921,4741,1,PRKAA1
PEPTIDYL-SERINE AUTOPHOSPHORYLATION%GOBP%GO:0036289,0.8086225026288121,0.9342433549901921,-0.261519339255807,-0.714851451567292,6151,7,ERN1
STRIATED MUSCLE ATROPHY%GOBP%GO:0014891,0.6973544973544971,0.8913930094695759,-0.417811936878503,-0.8158808187236289,5271,3,GSN
POSITIVE REGULATION OF PROTEIN OXIDATION%GOBP%GO:1904808,0.662239341213973,0.879470077229378,0.6671812968681079,0.889596234695513,4985,1,TRABD2A
CELLULAR TRANSITION METAL ION HOMEOSTASIS%GOBP%GO:0046916,0.000128816179312122,0.00518555396908895,-0.39319728765146206,-2.2983750316295897,0,72,CCDC22|ATP6V0D1|ABCB7|HAMP|SLC11A1|ACO1|HMOX1|SOD1|SKP1|ARF1|MT1M|NEDD8|CYBRD1|HFE|FTL|FXN|MT2A|SLC22A17|SLC30A5|MYC|ATP6AP1|S100A8|S100A9|ATOX1|MT1E|TFRC|ATP6V1A|ATP6V1G1|FTH1|PRNP
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:2000546,0.16626473740621697,0.5385312568324571,0.758974358974359,1.27517491822309,1240,2,FGF2|FGFR1
POSITIVE REGULATION OF CRISTAE FORMATION%GOBP%GO:1903852,0.6444680286548161,0.8688307429995409,-0.5412186379928321,-0.900674360987478,4857,2,PINK1|CHCHD10
CELLULAR RESPONSE TO LIPID HYDROPEROXIDE%GOBP%GO:0071449,0.977686279718422,0.9927322181739301,0.5103109836788711,0.680430839017105,7360,1,MGST1
FAT CELL DIFFERENTIATION%GOBP%GO:0045444,0.6554632753698421,0.8748490734526071,-0.16689784152879902,-0.8692045644293359,5050,47,INHBB|NR4A1|OSBPL11|PER2|PID1|KLF4|MED1|SMAD6|SENP2|CEBPA|TRIM32|BSCL2|STEAP4|IL11|PPARG|ATF5|METRNL
REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033143,0.674653542287269,0.882488012133495,-0.156599235217405,-0.865359294665447,5208,58,PARK7|BRCA1|DDX5|CALR|WBP2|CRY2|KANK2|FOXP1|PAGR1|YAP1|DAB2|PHB
PRI-MIRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:0061614,0.0169558359621451,0.17671843887293,-0.631605074462217,-1.7264643050162398,128,7,FOSL1|ETS1|KLF4|DDX5|SPI1|PPARG|RELA
RESOLUTION OF MITOTIC RECOMBINATION INTERMEDIATES%GOBP%GO:0071140,0.0510745555850358,0.32545044826617103,-0.8521582096675161,-1.41812753123016,384,2,XRCC3
PRONEPHRIC NEPHRON TUBULE DEVELOPMENT%GOBP%GO:0039020,0.11555319431531401,0.46493596964429496,0.943537715041906,1.2580802287693897,869,1,AHI1
NEGATIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071878,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS I PROTEIN COMPLEX%GOBP%GO:0002502,0.24294314381270896,0.626082056933819,-0.8755513895015441,-1.1664446831026298,1815,1,CALR
NEGATIVE REGULATION OF CHEMOKINE SECRETION%GOBP%GO:0090198,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
7-METHYLGUANOSINE MRNA CAPPING%GOBP%GO:0006370,0.20724713242961398,0.587285451772193,-0.261849652023378,-1.21802135939386,1589,32,NCBP1|POLR2H|GTF2H1|CDK7|MNAT1|POLR2G|POLR2L|GTF2H2
NEURAL PRECURSOR CELL PROLIFERATION%GOBP%GO:0061351,0.9705641864268191,0.9915747942934481,0.12645585691510902,0.559183966541168,7121,26,FGFR2|TEAD3|RAB10|PCM1|PLXNB2|DOCK7
STEROL TRANSPORT%GOBP%GO:0015918,0.0542775911088137,0.33797491560130605,-0.30636836292351,-1.4883209930118897,419,37,CES1|ABCA5|MSR1|APOC1|SYT7|ABCG1|CETP|APOM|APOE|CD36|CAV1|LDLR|OSBP|NPC2|OSBPL5
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042035,0.165694282380397,0.5375245857985801,-0.25072201769468,-1.25564224793032,1277,41,LILRB1|INHBB|CEBPG|TLR1|CD4|KLF4|SPN|GATA3|AZU1|EBI3|INHBA|STAT3|GHRL|HMOX1|HSPB1|BCL3|CD86|THBS1|TLR4
POSITIVE REGULATION OF RHO GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:2001108,0.127090301003344,0.48362648780247897,-0.935266872518747,-1.2460000450146003,949,1,EPHA4
POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0061081,0.359692548202189,0.7155384949577859,-0.357128497643721,-1.07432993612735,2760,9,LILRB1|CD74|SEMA7A|GPRC5B|TICAM1
AMELOGENESIS%GOBP%GO:0097186,0.253176162409954,0.632257972333528,-0.46250236053687604,-1.18968066301066,1932,6,TBX1|STIM1|FAM20A|ITGB4
TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER%GOBP%GO:0006361,0.0992445949466007,0.43481209971181295,-0.300492398940779,-1.38484119404917,761,31,ZNRD1|TWISTNB|POLR2H|GTF2H1|MAPK3|UBTF|CDK7|MNAT1|PTRF|POLR2L|GTF2H2
PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0006606,0.7845737831573529,0.927233741730459,-0.13665378564626401,-0.8044589452088741,6092,74,IPO4|NUP188|IPO7|STAT3|NUP85|KPNA4|RAN|RBM22|BCL3|KPNA2|NUP214|SEC61B|BCL6|NUP98|IPO11
"RNA PHOSPHODIESTER BOND HYDROLYSIS, ENDONUCLEOLYTIC%GOBP%GO:0090502",0.9686737184703009,0.9912626134248801,0.14932178760276302,0.536717908699441,7142,14,ELAC2|RNASEH1|UTP20|RPS21|NOP14
PROTEASOME-MEDIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0043161,0.7550890585241729,0.9161194064629179,-0.113295558289187,-0.874184250885986,5934,266,VCP|UBE2G2|MAD2L1|RNF7|SIAH2|PSMD4|SEL1L|SMURF2|UBE2S|UBQLN1|UBXN1|ARRB1|PSMB5|UBE2R2|FAF2|CDC27|RAD23B|SEC13|SKP1|NPLOC4|PSMC6|USP44|FBXO4|CCNB1|PLK1|NSFL1C|PSMB3|SYVN1|KIAA0368|PSMD2|SEC61B|UBC|SGTB|PSMD6|ERCC8|FBXW5|DDB1|SPOP|PLAA|DERL3|PSMD12|PSMA3|KAT5|HSPA5|ANAPC11|PSMA6|PSMB7|PSMA1|PSMC5|RMND5B|SPSB1
NEGATIVE REGULATION OF STAT CASCADE%GOBP%GO:1904893,0.0753478603307955,0.38436410265336796,-0.403851801031036,-1.4663204256608,573,15,VHL|PARP14|SOCS3|HGS|SOCS1|ADIPOR1|BCL3|PPP2CA|CAV1|NF2
SELECTIVE AUTOPHAGY%GOBP%GO:0061912,0.5654847572942561,0.8298229800621719,-0.24085163664692602,-0.915295034315648,4321,17,CALCOCO2|RAB7A|ATG13|UBQLN1|AMBRA1|SQSTM1
GLUCOCORTICOID SECRETION%GOBP%GO:0035933,0.24521739130434803,0.62804240987169,-0.8741729157476841,-1.16460822507142,1832,1,GHRL
REGULATION OF MESENCHYMAL STEM CELL MIGRATION%GOBP%GO:1905320,0.9115719063545149,0.9723824689260179,-0.543614909572122,-0.724225589187533,6813,1,FBXO5
SREBP-SCAP COMPLEX RETENTION IN ENDOPLASMIC RETICULUM%GOBP%GO:0036316,0.00615384615384615,0.0917316347019317,-0.9973533303925891,-1.32871411474025,45,1,INSIG1
CELLULAR RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0034599,0.032134169760594,0.25523932153726503,-0.20752984906556698,-1.4285953263876399,250,144,IMPACT|ECT2|PPIF|PARP1|ERO1L|BRF2|CYP1B1|SOD2|GPX1|PRR5L|TNFAIP3|PLA2R1|ZNF622|CYCS|MAPK9|PRKD1|PARK7|PXN|CAMKK2|SOD3|MAPK3|DPEP1|CYBB|ABL1|HMOX1|SOD1|ROMO1|CCS|GPX8|CAT|NOS3|MSRB3|FXN|MMP9|GPX3|EIF2S1|RELA|SIGMAR1|MAPK13|ARL6IP5|PDGFRA|ANXA1|PRDX5|ALDH3B1|NET1|SIRPA
ENDOCARDIAL CUSHION FUSION%GOBP%GO:0003274,0.603332437516797,0.8481440389818871,0.44811877857178894,0.88139675595568,4489,3,ACVR1
PLATELET ACTIVATION%GOBP%GO:0030168,0.00331168004075914,0.0593557718127837,-0.27995655123171004,-1.76068669338204,25,95,DGKZ|PRKCH|ACTG1|GNA12|LYN|GNA13|VAV3|DGKG|PIK3R6|ITPR2|ITPR3|RAP2B|VAV1|TLN1|GP1BA|PLEK|GP1BB|GAS6|ILK|PLSCR1|VWF|PTPN6|ARRB1|FCER1G|DGKE|PIK3CB|MAPK3|HSPB1|FLNA|MYL12A|GNAQ|PDPN|F2R|GNA15|F2RL3|COL1A2|COL1A1|VCL|COL3A1|MYH9|FIBP|FERMT3|ACTB|PDGFRA|ACTN1|MYL9|PRKCB
REGULATION OF ACTIN FILAMENT ORGANIZATION%GOBP%GO:0110053,0.35970302099334395,0.7155384949577859,-0.14650411413345701,-1.04748539457266,2809,175,LMOD1|PDXP|PHLDB2|SLC9A1|PTGER4|CD47|HAX1|S100A10|CTGF|PXN|ABL1|RAPGEF3|PPFIA1|ARF1|ARHGEF15|KANK3|GSN|BAIAP2L1|CORO1B|DLC1|HCK|CDC42EP4|CFL2|SEMA5A|ARPC5L|SLIT2|CX3CL1|EVL|NF2|EPS8|CDC42EP1|CDC42EP5|SYNPO|TMSB4X|NCK1|ARF6|CDC42EP2|SERPINF2
C-TERMINAL PROTEIN-TYROSINYLATION%GOBP%GO:0018166,0.329924292734759,0.6957352559323989,0.8346382884869871,1.11287753756909,2483,1,TTL
STRAND DISPLACEMENT%GOBP%GO:0000732,0.8964362272240091,0.967032331882283,0.392515206102067,0.6594762259411601,6690,2,RTEL1|BLM
NOSE DEVELOPMENT%GOBP%GO:0043584,0.18311388624949101,0.556308895147568,0.4978344195579679,1.2881758209541798,1348,6,STRA6|SKI|CHD7|PROX1
NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0042059,0.349018588327051,0.706981624190196,-0.228434151563901,-1.08227161211386,2684,34,EPN1|SH3KBP1|CDC42|ZFYVE28|DUSP3|SOCS4|TSG101|DAB2IP|HGS|RAB7A|SPRY1|SH3GL2|GRB2|EPS15L1|SNX6|VPS25|CHMP6|ERRFI1|PTPRJ
REGULATION OF EXOCYTOSIS%GOBP%GO:0017157,0.0366215344938749,0.27230608441566395,-0.225499688204209,-1.4585792237008202,283,108,REST|TSG101|CD84|STXBP5L|ITGB2|RAB9A|SNX4|HGS|STX4|FGR|RAB7A|STXBP2|RAB27B|SYT4|FES|HYAL3|NAPA|FCGR2B|CACNA1H|CPLX2|ADGRE2|FMR1|VPS18|SDC4|SYN1|CACNA1G|VAMP8|VAMP7|SNX6|STX1B|CEACAM1|CD300A|RAB3C|SNF8|LGALS9|ZP3|CHMP6|NSF|DOC2A|ATP6AP1|ITGAM|ANXA1|CACNA1I
CELLULAR RESPONSE TO STAUROSPORINE%GOBP%GO:0072734,0.34100529100529103,0.701955655133333,-0.5716527685650811,-1.11629297220901,2577,3,CASP6
GLUTAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006542,0.90742474916388,0.9710309567212472,-0.545820467578297,-0.727163922037467,6782,1,GLUL
PROSTATE EPITHELIAL CORD ARBORIZATION INVOLVED IN PROSTATE GLANDULAR ACINUS MORPHOGENESIS%GOBP%GO:0060527,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE%GOBP%GO:0010890,0.55359246171967,0.823501729860726,-0.417367001160104,-0.9137036109179141,4229,4,OSBPL11|FITM2
NEUTROPHIL MIGRATION%GOBP%GO:1990266,0.0022026431718061698,0.0427643300917725,-0.380297773109221,-1.91636577722045,16,42,IL1B|TGFB2|CCL3|SYK|CCL4|CCL8|CXCL1|CXCL2|CCL11|NCKAP1L|CCL19|ITGB2|CXADR|CCL24|IL1RN|PDE4B|CCL3L3|CCL18|FCER1G|CCL2|LGALS3|CX3CL1|CCL4L2|CCL14|S100A8|S100A9
MINERALOCORTICOID METABOLIC PROCESS%GOBP%GO:0008212,0.8400106128946669,0.947127979312948,-0.436633553784025,-0.72662805645161,6331,2,CACNA1H
POSITIVE REGULATION OF JAK-STAT CASCADE%GOBP%GO:0046427,0.006763787721123829,0.09869170788505001,-0.377009349505493,-1.79981739862413,51,35,LIF|CD40|CTF1|TNF|PARP14|LYN|STAP2|IL18|AGT|SOCS3|PARP9|HCLS1|CYP1B1|TNFRSF18|IL6ST|HES1|NOTCH1|STAT3|OSM|IGF1|F2R|CSF1R|TNFRSF1A
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0045981,0.00768529373453172,0.106864945035751,-0.42865572119093703,-1.84799487757261,58,25,GUCA1A|PID1|PFKFB2|PFKFB3|INS|VCP|PARK7|ENO1|IGF1|CCNB1|NOS3|TMSB4X
PEPTIDYL-TYROSINE MODIFICATION%GOBP%GO:0018212,0.0392838742916023,0.28273804525998497,-0.268587638353043,-1.5005817515563202,304,60,FGFR4|KDR|FGR|TNK2|FES|DYRK1A|DDR2|FLT4|ABI3|PTPN6|MAPK3|ABL1|DDR1|IL15|TPST2|HCK|TEK|PDGFRB|EPHA4|EFEMP1|CSF1R|PDGFRA|PDGFB
CARDIAC VENTRICLE FORMATION%GOBP%GO:0003211,0.586664913203577,0.8413007197716759,-0.3703001328884529,-0.8875387587645279,4460,5,SOX11|MESP1|MEF2C
SUPEROXIDE ANION GENERATION%GOBP%GO:0042554,0.37092337917485296,0.7231271705612199,-0.415350002263474,-1.06839209534129,2831,6,CYBB|NCF2
POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000510,0.362409954158481,0.716726922715381,-0.41836649905677104,-1.07615133769598,2766,6,GAS6|CALR|LGALS9
POSITIVE REGULATION OF HYALURANON CABLE ASSEMBLY%GOBP%GO:1900106,0.6715936576189201,0.8815356925073421,0.423272306262721,0.832526677000383,4997,3,BMP7|HAS3
UBIQUITIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:0070086,0.54789068718493,0.8186230305367759,-0.580120586307381,-0.96541342387215,4129,2,NEURL1B
TONGUE MORPHOGENESIS%GOBP%GO:0043587,0.763504434291857,0.9191113740914171,0.389896351853526,0.7668801132992429,5681,3,HDAC1|HDAC2
CELLULAR LACTAM METABOLIC PROCESS%GOBP%GO:0072338,0.24668896321070197,0.6280519349499749,-0.873456109395677,-1.1636532668951898,1843,1,DPEP1
REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS%GOBP%GO:1904749,0.7093647675180091,0.896093815016457,-0.30846098037623,-0.793444736629947,5415,6,PINX1|NVL|TERT|NMD3
DNA CATABOLIC PROCESS%GOBP%GO:0006308,0.22977725674091398,0.612283370697713,-0.27828223831432397,-1.1997137224613001,1763,25,DICER1|KPNA1|ISG20|DNASE2|EXOG|DNASE1L3|H1F0|SETMAR|HMGB2|DNASE1L2|KPNB1|MUS81|ENDOG|DNASE1L1|FEN1
REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS%GOBP%GO:0097006,0.00271282780002584,0.0505936274732296,-0.36970878826816106,-1.9152078514868,20,46,DGAT1|AP2A2|AGT|ABCA5|MSR1|APOC1|PLA2G2A|CLTA|ABCG1|APOBR|CLTC|EHD1|CETP|PLA2G7|APOM|HMOX1|APOE|CD36|LDLR|PRKACA|NPC2|AP2M1|P4HB
RECEPTOR-MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT%GOBP%GO:0090118,0.5920634920634921,0.8417378833576942,-0.460378700351933,-0.899002919285386,4475,3,LDLR
SQUAMOUS BASAL EPITHELIAL STEM CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND ACINUS DEVELOPMENT%GOBP%GO:0060529,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
TRANSLATIONAL ATTENUATION%GOBP%GO:0009386,0.529286757869571,0.810871230071967,0.733899426554918,0.9785558581650642,3984,1,TRAP1
PROSTATE GLAND MORPHOGENETIC GROWTH%GOBP%GO:0060737,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
WOUND HEALING%GOBP%GO:0042060,0.000127665007021575,0.00518555396908895,-0.26000587391065305,-1.99864360476747,0,261,RAD51C|CD34|TOR1A|ITPR3|RAP2B|VAV1|GATA3|WAS|TLN1|SYT7|PRCP|GP1BA|P2RX5|PLEK|GP1BB|P2RX3|GAS6|INS|AKAP1|ILK|PLSCR1|ITGA5|VWF|PRKAR1A|DOCK6|PTPN6|SH2B3|ARRB1|FCER1G|F3|DGKE|EHD1|PIK3CB|SLC11A1|F8|FGF10|MAPK3|HMOX1|HSPB1|DDR1|FLNA|IGF1|MYL12A|RAD51B|DOCK1|GNAQ|CEACAM1|HIST2H3A|THBD|PDPN|F2R|CORO1B|PLAUR|GATA6|GNA15|NOV|CD36|ADIPOR2|SERPINE2|CD151|A2M|F2RL3|F13A1|COL1A2|COL1A1|VCL|SRF|ITPK1|COL3A1|CD59|PLAT|MYH9|HIST2H3C|FIBP|PRKACA|FERMT3|HIST1H3H|PDGFA|ACTB|PDGFRA|MYOF|ANXA1|COL5A1|TFPI|H3F3B|ACTN1|CPQ|SERPING1|MYL9|EHD2|ACVRL1|VKORC1|AHNAK2|FBLN1|PRKCB
REGULATION OF PROTEIN COMPLEX STABILITY%GOBP%GO:0061635,0.464852902889872,0.7786333182377991,-0.34138407798081205,-0.9827969802408449,3570,8,SNF8|SQSTM1
IGG IMMUNOGLOBULIN TRANSCYTOSIS IN EPITHELIAL CELLS MEDIATED BY FCRN IMMUNOGLOBULIN RECEPTOR%GOBP%GO:0002416,0.638929765886288,0.865463150027443,-0.684384649316277,-0.911764683334583,4775,1,FCGRT
POSITIVE REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904958,0.97414255091104,0.9920058127185359,0.31794871794871804,0.534194898174537,7270,2,CSNK1E|CSNK1D
POSITIVE REGULATION OF SINGLE STRAND BREAK REPAIR%GOBP%GO:1903518,0.43738392146457894,0.7635570545514341,-0.62398676592225,-1.03841376148082,3296,2,XRCC1|PARP1
NEGATIVE REGULATION OF MRNA POLYADENYLATION%GOBP%GO:1900364,0.0807081489195522,0.397722753303477,-0.515858569143362,-1.4850846207712,619,8,SUPT5H|NELFE|CDK9|CCNT1|ZC3H14|CTR9|RNF20|RNF40
NEGATIVE REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION%GOBP%GO:0033137,0.120260905014268,0.472400580631237,0.35614580252305605,1.3694867179245,884,17,DKK1|NCK2|DMD|INPP5K|INPP5J
RHYTHMIC PROCESS%GOBP%GO:0048511,0.0005063932143309281,0.0139121625154964,-0.30537291596113897,-1.9327984380439498,3,97,BHLHE40|NDUFA9|RORA|TOP1|HNRNPU|AHR|TNFRSF11A|IMPDH2|DYRK1A|OGT|TGFB3|INHBA|PROKR1|ZFHX3|ARNTL2|NONO|USP2|CRY2|RBM4B|HEBP1|NR1D1|RELB|SLIT2|ID1|CCRN4L|SERPINE1|PRKCDBP|PPARA|MAGED1|ID4|PDGFRA|ANXA1|RBM4|PRMT5|PPP1CA|CIART|NGFR
POSITIVE REGULATION OF SISTER CHROMATID COHESION%GOBP%GO:0045876,0.27826993225638397,0.653204101106396,-0.38596785830158703,-1.16108579206699,2135,9,H2AFY|FEN1
GLYCEROLIPID CATABOLIC PROCESS%GOBP%GO:0046503,0.0171465968586387,0.17803435145825502,-0.37999474654246895,-1.6970990379686002,130,28,PNPLA2|FABP3|DAGLB|PLA2G4D|PLA2G4A|PLA2G4C|APOE|FABP4|DAGLA|MGLL|PNPLA4
POSITIVE REGULATION OF NIK/NF-KAPPAB SIGNALING%GOBP%GO:1901224,0.00688222308791066,0.099804287704806,-0.350172222957796,-1.80000589484608,52,45,MALT1|RHOA|TRAF6|APP|IL1B|TERF2IP|TNF|ACTN4|CHI3L1|CCL19|TNFRSF10A|TLR2|TNFRSF10B|TRIP6|TRIM44|C8orf4|TRAF2|ILK|IRAK1|SASH1|LGALS9|ZFP91|RELA|TLR4|C1QTNF4|CD14|SPHK1|CARD10|PTP4A3
NEGATIVE REGULATION OF HYDROGEN PEROXIDE-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903384,0.5228177235340941,0.807051143864932,-0.589649259982075,-0.9812706606163271,3940,2,PARK7
NEGATIVE REGULATION OF POTASSIUM ION EXPORT%GOBP%GO:1902303,0.31865216237728805,0.6867397844771489,-0.675302519088455,-1.1238113807553,2401,2,KCNH2
POLY(A)+ MRNA EXPORT FROM NUCLEUS%GOBP%GO:0016973,0.343790849673203,0.702174649119653,-0.327949842844471,-1.0976788304691898,2629,12,HHEX|NXF2|NUP93|NXF2B|NXF1|ZC3H3|PABPN1
REGULATION OF PROTEIN POLYMERIZATION%GOBP%GO:0032271,0.377864728898826,0.7281989978224692,0.150751555418573,1.04285179377749,2703,142,NCK2|BIN1|RLTPR|MET|CLASP1|ADD3|CYFIP1|DCTN1|RANGRF|PICK1|FCHSD1|INPP5J|ABI2|FAM21C|ARFGEF1|RHOBTB1|PRKCE|NCKAP1|CDK5R1|LRRC16A|CAMSAP3|ACTR2|STMN2|TRIM27|TPPP3|TRIOBP|PAK1|TWF1|PTK2B|CDC42EP3|WASH1|TMSB10|MAP2|ADD1|C15orf62|PSRC1
DIVALENT METAL ION TRANSPORT%GOBP%GO:0070838,0.318773353949233,0.6867397844771489,-0.154817904748569,-1.07675156107427,2473,152,ITPR2|CCDC109B|ATP2A1|P2RX4|ERO1L|SLC39A3|ITPR3|SLC8B1|PMPCA|GRIN3A|GAS6|ANXA6|SLC39A8|CACNA1H|STIM1|ATP2A3|GRIN1|SLC41A1|JPH4|CACNA2D4|SLC39A11|CALCRL|SLC11A1|CACNA1G|MRS2|NALCN|SLC35G1|SLC24A3|CACNA1E|F2R|CCR1|TMCO1|GRIN2C|GRIN2D|FKBP1A|CAMK2A|SLC3A2|SLC30A5|CAV1|STOML2|MAGT1|CACNA1I|PHB|ATP2B2|NIPAL3
"NEGATIVE REGULATION OF TRANSPOSITION, RNA-MEDIATED%GOBP%GO:0010526",0.41668906208008605,0.7493091022753771,0.530567194049935,1.04356305964805,3100,3,MOV10|ZCCHC11|ZCCHC6
RESPONSE TO DSRNA%GOBP%GO:0043331,0.0126000787504922,0.14869950444299201,-0.433571433798299,-1.76637314315557,95,21,MUL1|DHX9|IRAK3|NPM1|PDE12|MB21D1|IFIH1|IFIT1|TMEM173|COLEC12|TICAM1|SLC3A2|CAV1|PQBP1
REGULATION OF CELL AGING%GOBP%GO:0090342,0.6858112517948051,0.886006719788889,-0.185452828426642,-0.8385287108319209,5253,29,NEK4|VASH1|ARNTL|CDK6|MAP3K3|TERF2|YPEL3|TERT|CDKN2A|NUAK1|MB21D1|FOXM1|LMNA|NEK6
NEGATIVE REGULATION OF MACROPHAGE ACTIVATION%GOBP%GO:0043031,0.00512618296529969,0.0805452714310513,-0.694462306756908,-1.89828174641551,38,7,FCGR2B|NR1H3|CD200|CX3CL1|LDLR
EPITHELIAL CELL MORPHOGENESIS%GOBP%GO:0003382,0.37005187005186996,0.7226447402424641,0.351054753163147,1.06682301708568,2710,9,MET|RILPL1|RAB25|CLDN3|DACT2|SIPA1L3
PYRIMIDINE DIMER REPAIR%GOBP%GO:0006290,0.9074853960059771,0.9710309567212472,0.292375725136468,0.6423619197166259,6679,4,DDB2|SIRT1|MSH6
POSITIVE REGULATION OF HOMOTYPIC CELL-CELL ADHESION%GOBP%GO:0034112,0.552414605418139,0.822813841873357,-0.41769150168201596,-0.9144140103931759,4220,4,CCL5|DMTN|ANK3|PDPN
NEGATIVE REGULATION OF CELL DIFFERENTIATION%GOBP%GO:0045596,0.00345268542199489,0.0614177478771829,-0.18973608468054,-1.51402764192349,26,327,GDI1|MED1|HNRNPU|SFRP2|GATA3|SMAD6|LILRB3|BAG5|FCGR2B|TCTA|THY1|HES1|MESP1|RAB29|ABCG1|RC3H2|EFNA1|NOTCH1|INHBA|SRA1|SOCS1|HSPA9|CHRD|ADIPOR1|HIST1H4I|PKP2|DAAM2|C14orf169|FBN1|SNAI2|CETP|NGEF|CTR9|ANP32B|CALR|DNMT1|IGF1|NFATC1|MEN1|E2F1|NR1H3|SEMA3B|LRP5|HDAC5|SEMA3D|MAFB|LDLRAD4|STX1B|SEMA7A|C1QC|COL5A2|CEACAM1|GPER1|EDNRB|APOE|NFKBIA|PPP2CA|NOV|BMP2|FGF9|SEMA5A|SDHAF2|SEMA3E|EPHA4|COL3A1|SLIT2|ID1|CCRN4L|CX3CL1|CAV1|HIST2H4A|MYC|LDLR|FKBP4|SEMA3A|PPARG|PPARA|SEMA6B|RTN4RL1|TLR4|KIAA2022|ID4|ADGRG1|MYLIP|LILRB4|EFEMP1|ANXA1|HIST2H4B|COL5A1|DPF2|ADGRV1|DTX1|ARHGDIA|PDGFB|NGFR|FBLN1|EFNA5
NEGATIVE REGULATION BY SYMBIONT OF HOST APOPTOTIC PROCESS%GOBP%GO:0033668,0.683955925826391,0.885415243771438,0.41850115188845294,0.8231423793794559,5089,3,CASP8|BCL2L1
REGULATION OF CELL-SUBSTRATE JUNCTION ASSEMBLY%GOBP%GO:0090109,0.0398390864261614,0.28475403983757397,-0.293310771493954,-1.5275635624972501,306,47,PTEN|RCC2|RAC1|DUSP3|APOD|PEAK1|CORO1C|PPM1F|KDR|THY1|PHLDB2|SLC9A1|BCAS3|S100A10|ABL1|GPM6B|DLC1|THBS1|TEK|FAM107A|COL16A1|ACVRL1|EFNA5|PTPRJ
SKELETAL MUSCLE ATROPHY%GOBP%GO:0014732,0.5456859592711679,0.817297924969912,0.5720430107526879,0.9611061175273399,4072,2,CFLAR|IREB2
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002263,0.00012683916793505801,0.00518555396908895,-0.31804364380547995,-2.66335502667217,0,455,DOCK11|RAC1|DOCK2|IQGAP1|CXCL1|UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|DOCK10|CNN2|LILRB1|DNASE1L3|SBNO2|ATP6V1D|ATG7|GPR183|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|CORO1A|ADAM8|FRMPD3|BATF|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|EXO1|FGL2|METTL7A|TLR2|PPIA|LRP1|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|RORA|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|C8orf4|CKAP4|TICAM2|SPN|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|FCGR2B|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|S100A13|PTGER4|STAT3|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|RNF168|ORMDL3|CD47|ICAM1|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|NOTCH2|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|DYSF|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|CHGA|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|EXOSC3|COTL1|FOXP1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|MILR1|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
REGULATION OF ACTIN POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0008064,0.7224442439087281,0.9019989179378242,-0.130823635241934,-0.860778459870731,5603,116,KANK3|GSN|BAIAP2L1|CORO1B|HCK|CDC42EP4|CFL2|SEMA5A|ARPC5L|SLIT2|EPS8|CDC42EP1|CDC42EP5|TMSB4X|NCK1|ARF6|CDC42EP2
CYTOPLASMIC TRANSLATION%GOBP%GO:0002181,0.0156510583707505,0.169299266935336,-0.312165858328109,-1.66688411649928,121,51,RPS28|RPLP1|RPL9|GSPT1|EIF4H|TICRR|EIF4B|RPL29|RPL11|RPL36|RPL17|RPL32|HSPA14|RPLP0|RPL10A|RPL8|RPS23|GSPT2|RPL15|RPL18|RPL39|DENR|EIF2S3|ETF1|EIF3M|RPL35A|RPS29|RPL36A|RPL24|FTSJ1|RPL38|MCTS1|RPL26L1|RBM4|EIF2D|EIF4G1
NEGATIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I%GOBP%GO:1901837,0.590476190476191,0.841700481190927,-0.461242771257688,-0.900690230766453,4463,3,H2AFY
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL CONTRACTION%GOBP%GO:0106135,0.207529474812433,0.5875035269006329,0.732005271597182,1.2298633693096102,1548,2,BIN1|KCNE3
REGULATION OF BONE RESORPTION%GOBP%GO:0045124,0.6801156525167559,0.8847768831854209,-0.210850502541907,-0.833050664925773,5174,19,TNFAIP3|S1PR1|SPP1|ATP6AP1|CSF1R
POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION%GOBP%GO:0034093,0.701735928458706,0.8931369333627571,-0.335516596156322,-0.804169258527336,5335,5,ANKRD32|H2AFY
TRACHEA GLAND DEVELOPMENT%GOBP%GO:0061153,0.7412671005445608,0.9098143075756671,0.6290802823114251,0.838793672862902,5580,1,LEF1
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR 9 SIGNALING PATHWAY%GOBP%GO:0034164,0.854338020695145,0.949296218452153,-0.429142751636762,-0.714162163809236,6439,2,RAB7B
RESPONSE TO INSECTICIDE%GOBP%GO:0017085,0.150578642819569,0.517264655410678,-0.5570814030443421,-1.33521782218133,1144,5,DAXX|ZC3H12A|HSF1|HNRNPA1|MAPK13
CEREBELLAR CORTEX MATURATION%GOBP%GO:0021699,0.0964548494983278,0.427566585262796,-0.9493824437582711,-1.26480537525418,720,1,CEND1
REGULATION OF ESTABLISHMENT OF CELL POLARITY%GOBP%GO:2000114,0.560538116591928,0.8273596711618421,0.238435752112017,0.916856504505922,4124,17,SHTN1|FLOT2|ARFGEF1|RUFY3|PTK2B
NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:0110111,0.19008372579801197,0.563750965709003,-0.336511799097253,-1.25060814528209,1452,16,FBXW7|BMP4|ASPN|TGFB2|TNF|GREM1|BCOR|GATA3|TBX2|NOTCH1|SULF1|CEACAM1
POSITIVE REGULATION OF SYNAPSE ASSEMBLY%GOBP%GO:0051965,0.44259409694015706,0.7656673901363249,0.247848146810291,1.00447237171696,3268,20,EPHB2|VSTM5|AGRN|PTPRD|CUX2|SYNDIG1|NLGN2|CLSTN1|DLG5|NRXN1
SYMPATHETIC GANGLION DEVELOPMENT%GOBP%GO:0061549,0.7341063053673791,0.9079405785880958,-0.259640732634428,-0.781062876660938,5634,9,NRP2|SEMA3A
"ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS IB VIA ER PATHWAY, TAP-DEPENDENT%GOBP%GO:0002489",0.954113712374582,0.9870180073166591,-0.522220996912219,-0.695723760543171,7131,1,TAP2
MAINTENANCE OF PROTEASE LOCATION IN MAST CELL SECRETORY GRANULE%GOBP%GO:0033373,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
SPERMIDINE CATABOLIC PROCESS%GOBP%GO:0046203,0.620135476158852,0.8551097775270831,0.687031318923688,0.916063560686454,4668,1,PAOX
CELLULAR RESPONSE TO INSULIN-LIKE GROWTH FACTOR STIMULUS%GOBP%GO:1990314,0.54430883523481,0.8171943796142529,-0.5815274331403361,-0.9677546419739109,4102,2,SLC25A33|SYAP1
NEGATIVE REGULATION OF ENDORIBONUCLEASE ACTIVITY%GOBP%GO:0060702,0.45210931281507,0.769943206592495,-0.6185589284603421,-1.02938097196774,3407,2,TMBIM6
RETROGRADE TRANS-SYNAPTIC SIGNALING BY ENDOCANNABINOID%GOBP%GO:0098921,0.0615547890687185,0.35631208031004796,-0.8394265232974909,-1.39693996916071,463,2,DAGLB|DAGLA
GANGLIOSIDE CATABOLIC PROCESS%GOBP%GO:0006689,0.200529100529101,0.578325746675525,-0.641649974953162,-1.2529797755659,1515,3,NEU1|NEU4
REGULATION OF METAPHASE/ANAPHASE TRANSITION OF CELL CYCLE%GOBP%GO:1902099,0.041293338527463995,0.291251694784212,-0.29641874965630605,-1.5236945187070399,317,45,TRIP13|DUSP1|KLHL22|APC|DLGAP5|CDC20|CDT1|LCMT1|ANAPC5|ESPL1|CDC6|CDC23|CDK5RAP2|MAD2L1|NDC80|USP44|CCNB1|PLK1|IK|NEK6|ANAPC11|XRCC3
POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE-NOREPINEPHRINE%GOBP%GO:0003321,0.9435185185185191,0.98255739075553,-0.3056773910163,-0.596910471038564,7132,3,ADRA1B|PDE4D
NEGATIVE REGULATION OF THYMIDYLATE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0050760,0.10207357859531802,0.441073279931729,-0.9466254962505509,-1.2611324591917599,762,1,APBB1
CELL FATE DETERMINATION%GOBP%GO:0001709,0.0690875721027792,0.37596389138254704,-0.419740743335234,-1.4849813696723797,526,14,MCL1|NOTCH4|JAG1|KLF4|SOX17|GATA3|TBX2|MESP1|MEF2C|NOTCH2
POSITIVE REGULATION OF CDP-DIACYLGLYCEROL-SERINE O-PHOSPHATIDYLTRANSFERASE ACTIVITY%GOBP%GO:1904219,0.595914035553197,0.8445090144443349,-0.5610456329517141,-0.933669651173936,4491,2,SERINC5
CELL CYCLE SWITCHING%GOBP%GO:0060184,0.44481294773149394,0.76693681188187,-0.621395092362834,-1.0341008022382001,3352,2,C17orf104|YTHDC2
POSITIVE REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903766,0.356913183279743,0.714610778064251,0.6571847576592961,1.1041552454263701,2663,2,KCNIP2|ANO6
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1990440,0.121469665271967,0.47376597884378,-0.44478616067902,-1.3934569788240099,928,10,MBTPS2|CREB3L1|CEBPB|HSPA5
BUD OUTGROWTH INVOLVED IN LUNG BRANCHING%GOBP%GO:0060447,0.253244147157191,0.632257972333528,-0.870533745037495,-1.15975997586903,1892,1,FGF10
REGULATION OF REGULATED SECRETORY PATHWAY%GOBP%GO:1903305,0.00322248002062387,0.0581345224635642,-0.31600419500807003,-1.79449928282443,24,64,SEPT5|REST|CD84|ITGB2|SNX4|STX4|FGR|STXBP2|SYT4|FES|HYAL3|NAPA|FCGR2B|CACNA1H|ADGRE2|FMR1|VPS18|SYN1|CACNA1G|VAMP8|VAMP7|SNX6|STX1B|CEACAM1|CD300A|LGALS9|ZP3|DOC2A|ITGAM|CACNA1I
"REGULATION OF SYNAPTIC TRANSMISSION, CHOLINERGIC%GOBP%GO:0032222",0.9986733881666221,0.999656642395059,-0.272945426784404,-0.454224837424674,7527,2,ACHE
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION%GOBP%GO:1904950,0.0251540041067762,0.22334422304908896,-0.233994673706642,-1.5114871212616297,195,107,LILRB1|RGCC|INHBB|LGR4|NDFIP1|SP100|APOD|REST|RHBDF2|PPM1F|PIM3|CD34|GDI1|SSC5D|FCGR2B|GAS6|INS|MDFIC|UBE2G2|TNFAIP3|PTGER4|IRS1|PARK7|PDE2A|CARD16|RSAD2|SRGN|TNFRSF4|NR1H3|F2R|FN1|NLRP3|NOV|CHGA|TNFRSF21|CD200|CX3CL1|SIRT4|DNAJA1|DERL3|SERGEF|RAB11FIP1|ANXA1|TMSB4X|INSIG1
VIRAL MRNA EXPORT FROM HOST CELL NUCLEUS%GOBP%GO:0046784,0.0851735015772871,0.40376145987147494,-0.53692474202122,-1.4676598384979298,647,7,THOC7|THOC3
POSITIVE REGULATION OF CELL SIZE%GOBP%GO:0045793,0.4867724867724871,0.78790014907289,-0.509312243251392,-0.994557726412564,3679,3,TMEM123
REGULATION OF PEPTIDYL-SERINE DEPHOSPHORYLATION%GOBP%GO:1902308,0.39627767966308897,0.7377402989373809,0.4728078758121789,1.0387790389304399,2916,4,PPP1R16B|YWHAE
PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048008,0.0017009027868638,0.0346995370450957,-0.535730383329818,-2.03590627998358,12,17,PDGFD|BCAR1|PDGFC|ABL1|PDGFRB|PLAT|PDGFA|PDGFRA|PDGFB|PTPRJ
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0040036,0.649952439190107,0.8719208056239259,0.22209917362462397,0.854037493032757,4782,17,FGFR2|SULF2|SPRY2|FGFBP3|SPRY4
POSITIVE REGULATION OF RECEPTOR INTERNALIZATION%GOBP%GO:0002092,0.773664225657716,0.922570077845438,0.21035593894718901,0.756097294619807,5704,14,PICK1|AHI1|ARRB2
MAINTENANCE OF CHROMATIN SILENCING%GOBP%GO:0006344,0.305466237942122,0.677423587903087,0.6811690102012679,1.14445188642908,2279,2,SIRT1|HDAC2
REGULATION OF CELLULAR AMINE METABOLIC PROCESS%GOBP%GO:0033238,0.46341133504666604,0.777170138704591,0.24764045027876702,0.987313723510335,3425,19,PARK2|DRD4|CHRNB2|NQO1|OAZ3|ATCAY|ATP2B4
POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION%GOBP%GO:0033690,0.254940452820311,0.633563751374126,-0.551698685876503,-1.2077837491293602,1947,4,BMP2|TMEM119
REGULATION OF RAS GTPASE BINDING%GOBP%GO:1904475,0.25921995224197397,0.636098664976652,-0.702565262889671,-1.16918094608105,1953,2,EPHA4
POSITIVE REGULATION OF MYOBLAST PROLIFERATION%GOBP%GO:2000288,0.9598220128255459,0.9895799382246301,-0.259475101472817,-0.568045237165405,7333,4,GATA6
MITOCHONDRIAL MRNA SURVEILLANCE%GOBP%GO:0035946,0.7069996015407092,0.894949003158309,0.6461182179091309,0.861511461005126,5322,1,SUPV3L1
CELLULAR COMPONENT MORPHOGENESIS%GOBP%GO:0032989,0.217049915872126,0.599597524514766,0.13267675848925697,1.1073398420737501,1547,408,TNR|NEBL|RET|CNTN4|BVES|SHTN1|DRD2|ROBO3|FRY|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|TMOD3|MET|MFF|SEMA4F|PLXNB1|OBSCN|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|CDHR1|MAPK7|ALS2|SLIT1|EPHB2|CASP9|LAMA5|EFNA4|PARD3|TENM4|LAMB1|NBEAL2|NEB|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|NYAP2|STK24|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|RHOBTB1|BMP7|DNM1L|NTNG1|EFNB3|SLIT3|PNPT1|NCKAP1|CDK5R1|CAP2|RILPL1|SHC1|SOS1|NYAP1|MAP6|WDR1|ATP7A|FRYL|DRAXIN|SPTBN1|PAK1|EFNA2|EPB41L3|ITGAV|NRCAM|STRADB|VAMP3|MAP2|ZFPM1|DLG4|BRSK1|VLDLR|TUBB3|ULK2|TPM1|PPP3CB|ANTXR1|PRKCA|RAB25|PLCG1|KIF5A|BIN3|SCARA3|PLXNB2|RADIL|POU4F2|RHOBTB2|RB1|DOCK7|C8orf37|CELSR2|NRP1|DCC|CPNE1|CLDN3|EZR|OBSL1
NEUROTRANSMITTER RECEPTOR DIFFUSION TRAPPING%GOBP%GO:0099628,0.36134111578661604,0.716154857259883,0.41465152790657794,1.07293519971004,2661,6,CACNG7|CACNG4|DLG4
RESPONSE TO INTERFERON-BETA%GOBP%GO:0035456,0.0439330543933054,0.299062021084573,-0.404180475373099,-1.56837056319354,335,18,UBE2G2|PLSCR1|IKBKE|IFIT1|BST2|IFITM1|IFITM2|IFITM3
NEGATIVE REGULATION OF TYPE I INTERFERON-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060339,0.7943680419122459,0.929656485793048,-0.285279308294672,-0.7338152312158119,6064,6,SAMHD1
POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1901534,0.224561880179323,0.6078034241178771,0.560019535159803,1.23038676865583,1652,4,FOXC1|ZBTB1|NUDT21
TOLERANCE INDUCTION TO LIPOPOLYSACCHARIDE%GOBP%GO:0072573,0.337123745819398,0.699462084003389,-0.8283524481693871,-1.1035643601140401,2519,1,TNFAIP3
POSITIVE REGULATION OF DIPEPTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:2001150,0.8973202440965771,0.967166974453851,-0.402923115333027,-0.6705284961647321,6763,2,CA2
POSITIVE REGULATION OF PINOCYTOSIS%GOBP%GO:0048549,0.558465608465609,0.8268422944617521,-0.47597844974642106,-0.9294652761125891,4221,3,PPT1|AXL
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:1903018,0.5832247981245121,0.8391117257440741,-0.198399660536408,-0.9143393435730041,4477,31,NECAB2|IGF1|TMEM59|RAB1B|BACE2|CST3
REGULATION OF T-HELPER 2 CELL CYTOKINE PRODUCTION%GOBP%GO:2000551,0.45896896370331397,0.7735063645065241,-0.41132505915072903,-0.9858676787387359,3489,5,RSAD2|NLRP3
REGULATION OF CENTRIOLE-CENTRIOLE COHESION%GOBP%GO:0030997,0.943966675624832,0.982694945797028,0.30351825300540397,0.596984586151285,7024,3,CEP250|CTNNB1
PURINE NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0006195,0.0203628769090197,0.196348095520168,-0.368455804465281,-1.66598036459187,155,29,GPX1|NUDT1|PDE4D|NUDT16|PDE2A|HPRT1|NUDT18|NUDT4|ABCD1|HINT1|PNP|SAMHD1
NEGATIVE REGULATION OF CALCIUM-INDEPENDENT CELL-CELL ADHESION%GOBP%GO:0051042,0.148494983277592,0.5154128781388279,-0.9235774150860171,-1.23042688090995,1109,1,BMP2
REGULATION OF SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION%GOBP%GO:0014717,0.902228707880074,0.968486494114721,-0.39862145023435297,-0.66336983755257,6800,2,CAPN3|SOX15
MIRNA TRANSPORT%GOBP%GO:1990428,0.0529318121517644,0.333436189062522,-0.8501240694789081,-1.41474239667284,398,2,HNRNPA2B1|TGFBR2
SESQUITERPENOID CATABOLIC PROCESS%GOBP%GO:0016107,0.77991765174658,0.924704689181848,0.609726510807234,0.8129880300217339,5871,1,AKR1C3
RESPONSE TO ISOQUINOLINE ALKALOID%GOBP%GO:0014072,0.6271163665681271,0.859069247760118,0.44026249036289,0.8659443641517809,4666,3,DRD2|SRR
L-SERINE METABOLIC PROCESS%GOBP%GO:0006563,0.466072832067068,0.780053781896182,-0.30308328311377697,-0.9812484355678242,3557,11,PHGDH|SDSL|SERINC5|SHMT2
"PHOTOTRANSDUCTION, VISIBLE LIGHT%GOBP%GO:0007603",0.223564544590742,0.606760475740296,0.47458771338840605,1.22802360240921,1646,6,PDE6B|GNGT1|GNA11|GNB1
COGNITION%GOBP%GO:0050890,0.29183474753095,0.6639751688226488,0.16760412867098498,1.09924924523201,2097,111,CALB1|DKK1|STRA6|DRD2|GPR155|CAMK4|BBS4|JAKMIP1|CYFIP1|EPHB2|DOPEY2|TUSC3|PTCHD1|CHRNB2|TTC8|HTT|ADCY3|CTNS|CUX2|NF1|NETO1|HRH3|ATXN1L|DLG4|BRSK1|ST3GAL4|VLDLR|PPP3CB|CHD7|SLC1A4|DGCR2|SLC8A2|EGFR|NLGN4X|SHANK2|CRH|MAPK1|PICALM|RP9
MYOTUBE DIFFERENTIATION%GOBP%GO:0014902,0.249344520188778,0.630084224949081,-0.3358594013770769,-1.18822144810456,1901,14,CAV2|ADAM12|CACNA1H|SEPN1|MEF2C|IGF1|PGK1
DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009264,0.756323089475116,0.9166093439295571,0.19847233759619395,0.7769054152681741,5561,18,DERA|NT5M|NTHL1|NEIL1|OGG1|DUT|SMUG1|NEIL2
PROTEIN SULFHYDRATION%GOBP%GO:0044524,0.48386239872493,0.787078399497453,0.758215703573004,1.01097833250397,3642,1,CTH
REGULATION OF SMAD PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0010990,0.453998167779087,0.7705917450640001,-0.456304369176745,-0.998945648878641,3468,4,PPM1A|SMAD6|LDLRAD4
TNFSF11-MEDIATED SIGNALING PATHWAY%GOBP%GO:0071847,0.3941137123745821,0.7376723208557521,-0.8027128363475959,-1.06940624073355,2945,1,TNFRSF11A
REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:1903972,0.120664834445753,0.472686039512467,-0.6281810649294971,-1.37521966456606,921,4,TLR2|CSF1|TLR4
DNA REPAIR COMPLEX ASSEMBLY%GOBP%GO:0090735,0.533201058201058,0.812079525085925,-0.488572505770788,-0.9540582755778009,4030,3,DMC1|RAD51
POSITIVE REGULATION OF NOREPINEPHRINE UPTAKE%GOBP%GO:0051623,0.0667558528428094,0.3690551432905871,-0.9648213498015,-1.28537370520372,498,1,ACTB
CELL-SUBSTRATE JUNCTION ASSEMBLY%GOBP%GO:0007044,0.264640667797052,0.6400265792424089,-0.262814586528363,-1.15914072405329,2028,27,LAMC1|CTTN|PEAK1|LAMC2|TRIP6|THY1|TAOK2|RHOD|DLC1|CD151|ACTN1|ITGB4
CEREBELLAR PURKINJE CELL LAYER FORMATION%GOBP%GO:0021694,0.8926842036382671,0.965443067117994,-0.29911075498369,-0.6548159680409,6820,4,CEND1
NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS%GOBP%GO:0034351,0.970246145523397,0.9915747942934481,0.19754057531657,0.545305455862404,7173,7,DLL1|PRKCA|PRKCI|PRKCD
REGULATION OF EOSINOPHIL MIGRATION%GOBP%GO:2000416,0.260044496793613,0.636098664976652,-0.548894475563214,-1.2016447465683,1986,4,ADAM8|PTGER4|CD300A
AROMATIC COMPOUND CATABOLIC PROCESS%GOBP%GO:0019439,0.12181447502548401,0.47456351938297897,-0.145808325166851,-1.18602819217823,955,371,NUDT17|GPX1|HK1|RPLP2|ADA|VCP|KYNU|NUDT1|HK3|MAGOH|PDE12|PDE4D|PDXP|RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|PATL1|NUDT16|APOBEC3G|RPL10|DDX5|PDE2A|RPL36A|SMPDL3A|RPL24|HAAO|ENO1|PELO|HMOX1|TYMP|APOBEC3C|PGAM1|HPRT1|FTCD|CDA|LSM3|NT5C3B|RPL35|GAPDH|RNASE6|IL4I1|PPP2CA|RPL38|RPS15A|NUDT18|NUDT4|MAGOHB|EIF4A3|LDHA|EXOSC3|AFMID|RPS13|RBM8A|TNKS1BP1|POLR2G|ENPP4|ABCD1|HINT1|TUT1|PNP|RNH1|HNMT|PGK1|SKIV2L2|MUS81|SAMHD1|ASRGL1|EXOSC2|ENDOG|BLVRB|DNASE1L1|ERN1|ALDOA|FEN1|ALDOC|EIF4G1|RNASEH2C
NEURAL NUCLEUS DEVELOPMENT%GOBP%GO:0048857,0.141355140186916,0.506974113776998,-0.264844134016216,-1.29613582594272,1088,38,BASP1|PLP1|NDRG2|ATP5J|ATP5F1|RAD1|ZNF430|CNP|ZNF148|CKB|FGF9|ACTB|HSPA5|NDUFS3|MAPKAP1
DIADENOSINE PENTAPHOSPHATE METABOLIC PROCESS%GOBP%GO:1901906,0.7360293155346159,0.908157084784786,-0.35559109356837504,-0.7784632357147929,5623,4,NUDT11|NUDT4
"POSITIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, INITIATION%GOBP%GO:2000144",0.0346957550269418,0.266191770413233,-0.40700888663871504,-1.60805414052874,263,19,FOSL1|SETX|SUB1|PSMC2|PAXIP1|DHX36|PSMC4|PSMC6|MITF|SRF|PSMC5|PSMC3
PHAGOLYSOSOME ASSEMBLY INVOLVED IN APOPTOTIC CELL CLEARANCE%GOBP%GO:0090387,0.477725752508361,0.7850984235874658,-0.764005293339215,-1.01783849921721,3570,1,RAB14
POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0042108,0.0222309402380018,0.206487157196606,-0.402630047580111,-1.66739578802876,169,22,CEBPG|TLR1|CD4|SPN|AZU1|EBI3|STAT3|HMOX1|HSPB1|CD86|THBS1|TLR4
EPITHELIAL STRUCTURE MAINTENANCE%GOBP%GO:0010669,0.196635120925342,0.573143439969417,-0.46383405594370397,-1.26786970753765,1495,7,SERPINA3|CXADR|MUC4|TLR4
COLUMNAR/CUBOIDAL EPITHELIAL CELL MATURATION%GOBP%GO:0002069,0.479877805817506,0.785690196949452,0.7607520952801059,1.0143602686028101,3612,1,NKX6-1
REGULATION OF CYTOCHROME-C OXIDASE ACTIVITY%GOBP%GO:1904959,0.317192889360573,0.6861326333203311,-0.675985663082437,-1.12494824160423,2390,2,CHCHD10|COX17
SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002208,0.628399581589958,0.8598358835891559,-0.274256566077412,-0.859210019946344,4805,10,BATF|EXO1|RNF168|EXOSC3
RECRUITMENT OF MRNA CAPPING ENZYME TO RNA POLYMERASE II HOLOENZYME COMPLEX%GOBP%GO:0036031,0.422101208659849,0.7527812076478722,0.7900308778120871,1.05339957443945,3177,1,FAM103A1
GLYCEROL TRANSPORT%GOBP%GO:0015793,0.9113076098606641,0.972245398885683,0.38081356921937803,0.6398159651187479,6801,2,AQP11|AQP1
PEPTIDYL-ARGININE HYDROXYLATION%GOBP%GO:0030961,0.647090301003345,0.8698427333536031,-0.6807454786060869,-0.906916434132192,4836,1,NDUFAF5
NEGATIVE REGULATION OF LIGASE ACTIVITY%GOBP%GO:0051352,0.971505016722408,0.9915747942934481,-0.513950154389061,-0.684705012355918,7261,1,TFIP11
REGULATION OF COFACTOR METABOLIC PROCESS%GOBP%GO:0051193,0.580191115702479,0.8386526275338391,-0.17432865801467,-0.9185198032485379,4492,49,HP|OGT|CBFA2T3|PFKFB2|PFKFB3|INS|JMJD8|IGF1|PGAM1|NOXA1|PDK3|PPARA|MPV17L
MEIOTIC SISTER CHROMATID COHESION%GOBP%GO:0051177,0.7319131832797429,0.9074802896081321,0.481555004135649,0.8090745830312571,5462,2,BUB1|BUB1B
REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002861,0.504468980021031,0.797795146880088,-0.348969886605482,-0.953893622946137,3837,7,HLA-E|FCGR2B|PARK7|ZP3
REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION%GOBP%GO:1901388,0.8429600523903079,0.9481593344082329,-0.270667060856788,-0.6962285944691421,6435,6,LTBP1|LRRC32
MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION%GOBP%GO:0097029,0.570082449941107,0.8324048186805392,-0.4122350207264411,-0.902468632971973,4355,4,CCL19|LGALS9
TRANS-SYNAPTIC SIGNALING BY NITRIC OXIDE%GOBP%GO:0099548,0.680802675585284,0.884781692722898,-0.663707543008381,-0.88421781286645,5088,1,GUCY1B3
SMALL-SUBUNIT PROCESSOME ASSEMBLY%GOBP%GO:0034462,0.4202006688963211,0.751774348695433,-0.790416850463167,-1.05302503509517,3140,1,ABT1
POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS%GOBP%GO:0045080,0.19264494176154998,0.56708014228813,-0.584123761108432,-1.27876901687058,1471,4,TNF|AZU1|HMOX1
ARF PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032011,0.16004781511488902,0.5296866239243959,0.9218129686810759,1.2291132108793001,1204,1,MYO9B
MUSCLE STRUCTURE DEVELOPMENT%GOBP%GO:0061061,0.18340248962655603,0.556308895147568,0.163083150438666,1.16997242865404,1325,167,NEBL|CHRNB1|STRA6|BVES|ACVR1|POPDC3|BIN1|EVC|ADGRB3|CBY1|FGFR2|TMOD3|ANK2|DLL1|EPAS1|OBSCN|SDC1|CHODL|ALPK3|DMD|SPEG|NEB|MKL1|IGSF8|MAPK12|SOX6|GLMN|SRI|SEMA4C|DDX17|MYEF2|WDR1|LARGE|RYR1|AKAP13
DIACYLGLYCEROL CATABOLIC PROCESS%GOBP%GO:0046340,0.0615547890687185,0.35631208031004796,-0.8394265232974909,-1.39693996916071,463,2,DAGLB|DAGLA
REGULATION OF CELLULAR RESPONSE TO TESTOSTERONE STIMULUS%GOBP%GO:2000654,0.604595563819896,0.848175106515994,0.6952470224966919,0.9270180928327041,4551,1,SIRT1
PURINE NUCLEOTIDE SALVAGE%GOBP%GO:0032261,0.0568783068783069,0.34436604181231795,-0.756647944837354,-1.47754166463408,429,3,ADA|HPRT1
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043537,0.0015651493413329901,0.0323893370023386,-0.47194263388813207,-2.08149758193756,11,27,RHOA|DLL4|VASH1|PDCD10|TGFB1|RGCC|ANGPT2|JUP|KLF4|NOTCH1|MEF2C|TBXA2R|MMRN2|MECP2|HDAC5|MEOX2|STARD13|APOE|THBS1|PPARG|ACVRL1|CARD10
PROTEIN DELIPIDATION%GOBP%GO:0051697,0.603343061820111,0.8481440389818871,-0.557955470583709,-0.928527126839459,4547,2,ATG4A
PUTRESCINE TRANSPORT%GOBP%GO:0015847,0.211847522911409,0.5937395205509979,0.895511689457433,1.19404400394131,1594,1,AZIN2
CELLULAR RESPONSE TO NITROGEN LEVELS%GOBP%GO:0043562,0.477835191732391,0.7850984235874658,0.307687234791657,0.974773957968105,3513,10,GABARAP|MAP1LC3B|ATG5|MAP1LC3A
NEGATIVE REGULATION OF MONONUCLEAR CELL PROLIFERATION%GOBP%GO:0032945,0.0029754204398447603,0.05456914496596799,-0.40197854865587607,-1.93563920526725,22,36,FOXP3|SOX11|CD274|MNDA|LILRB1|LYN|NDFIP1|TNFRSF14|TWSG1|PDCD1LG2|SPN|FCGR2B|PLA2G2D|LILRB2|GPNMB|PRKAR1A|SDC4|CEBPB|C10orf54|CD300A|LST1|CD86|TNFRSF21|LGALS9|PRNP
PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009144,0.00012846865364851,0.00518555396908895,-0.312507061852057,-2.20328912845567,0,163,NDUFB5|NADK|SURF1|ATP1B1|UQCR10|PARP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|OPA1|IMPDH2|PFKFB2|HK1|NDUFA3|NDUFB6|NUDT1|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|NUDT16|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|MOCS2|MBIP|GAPDH|NDUFS6|COQ7|NDUFB4|NDUFA12|SDHAF2|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|GPHN|SAMHD1|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0000086,0.49916204718318896,0.794989907195277,-0.14798926221349898,-0.973722897777342,3871,116,HAUS1|NDE1|TUBG1|CCNB2|CEP72|HAUS6|AURKA|AJUBA|CEP78|HAUS4|SKP2|CEP76|CSNK1D|FBXL7|CEP192|PCNT|NEK2|NEDD1|FBXW11|DYNC1H1|PLCB1|LCMT1|OFD1|CEP70|KDM8|TUBA4A|SDCCAG8|HAUS8|PKMYT1|CDK5RAP2|CDC25C|MELK|FOXM1|CDKN2B|ENSA|CEP131|SKP1|CKAP5|TUBB4A|CCNB1|PLK1|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
POSITIVE REGULATION OF LONG-TERM SYNAPTIC DEPRESSION%GOBP%GO:1900454,0.131658159926711,0.49118963427489604,-0.6205076457560711,-1.35842094596263,1005,4,ADCY8|LILRB2|CBLN1
REGULATION OF PHOSPHOLIPID TRANSPORT%GOBP%GO:2001138,0.7700065487884741,0.921326382088427,-0.29203643306106203,-0.751196376390495,5878,6,TRIAP1|PRELID1|APOE
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION%GOBP%GO:0010633,0.00245700245700246,0.0467168974631661,-0.35791829830381794,-1.9192488624341797,18,52,TGFB1|RGCC|SP100|CORO1C|ANGPT2|JUP|DAB2IP|KLF4|SYNJ2BP|DCN|NOTCH1|MEF2C|ADIPOR1|TBXA2R|MMRN2|MECP2|HDAC5|MEOX2|STARD13|APOE|THBS1|SLIT2|NR2F2|PPARG|EVL|MCC|ACVRL1|CARD10|ADGRB1
NUCLEOBASE BIOSYNTHETIC PROCESS%GOBP%GO:0046112,0.214623260698346,0.5979177134734279,-0.336791134104363,-1.22283401450211,1634,15,CTPS1|HPRT1|PRPS1|GMPS|MTHFD1
NEGATIVE REGULATION OF STEM CELL PROLIFERATION%GOBP%GO:2000647,0.481825417882728,0.7860812477150871,-0.6061281994243081,-1.00869425102875,3631,2,FBLN1
POSITIVE REGULATION OF PATHWAY-RESTRICTED SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0010862,0.493655984303466,0.7923145426459479,-0.21343400024978101,-0.9744978597113441,3773,30,INHA|SMAD4|TGFBR1|BMP4|RBPMS|BMP8B|TTK|TGFB2|GDF15|TGFB1|INHBB|TWSG1|TGFB3|INHBA|HFE|BMP2|GDF11|DAB2|ENG|ACVRL1
POSITIVE REGULATION OF TOLERANCE INDUCTION TO SELF ANTIGEN%GOBP%GO:0002651,0.14876254180602,0.5154128781388279,-0.9232465813850899,-1.22998613098246,1111,1,TGFBR2
NUCLEOLAR CHROMATIN ORGANIZATION%GOBP%GO:1990700,0.9104794793465271,0.9720943283119721,0.5452690780767531,0.7270427409011508,6854,1,DDX11
2-OXOGLUTARATE METABOLIC PROCESS%GOBP%GO:0006103,0.20285132382892102,0.581516491938853,0.356266388201102,1.24771916844134,1493,13,IDH1|AADAT|ADHFE1|D2HGDH
CYTIDINE CATABOLIC PROCESS%GOBP%GO:0006216,0.12419840335034699,0.47833715299653395,-0.6254795869379499,-1.3693055645322099,948,4,APOBEC3G|APOBEC3C|CDA
CARDIOLIPIN BIOSYNTHETIC PROCESS%GOBP%GO:0032049,0.65661347038139,0.8755797517012099,0.300156359038358,0.828573572457756,4854,7,SLC27A1|PLA2G6|CRLS1|TAMM41|TAZ
REGULATION OF CELLULAR RESPONSE TO TUNICAMYCIN%GOBP%GO:1905894,0.829163879598662,0.9433761342424741,-0.58893912659903,-0.7846083292536808,6197,1,CLU
REGULATION OF 1-PHOSPHATIDYLINOSITOL 4-KINASE ACTIVITY%GOBP%GO:0043126,0.031438127090301,0.25182426163873,-0.984340538156153,-1.3113779509256298,234,1,CD81
"ANTIGEN PROCESSING AND PRESENTATION, EXOGENOUS LIPID ANTIGEN VIA MHC CLASS IB%GOBP%GO:0048007",0.814021164021164,0.93598587081542,-0.37134664166758596,-0.7251458737573672,6153,3,CD1E|CD1C|CD1D
REGULATION OF ANTEROGRADE SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1903742,0.356621065214504,0.714406853878965,0.8227282752536391,1.0969971419745201,2684,1,MAP2
AMMONIUM TRANSPORT%GOBP%GO:0015696,0.83876029815614,0.946362535615467,-0.173367403856841,-0.717959528131991,6413,22,SYK|SLC22A4|AQP1|SEC14L1|SLC22A3|SLC12A2|RHBG|TAF7|SLC44A1|RHCE
DIGESTION%GOBP%GO:0007586,0.269727403156385,0.643931890395399,-0.261569122006649,-1.1536476170437,2067,27,SST|MUC4|GHRL|TJP2|KCNQ1|CD36|LDLR|TLR4
SEPTUM TRANSVERSUM DEVELOPMENT%GOBP%GO:0003343,0.867692307692308,0.9558022175108679,-0.569309660344067,-0.7584571668892659,6485,1,TGFBR1
INNATE VOCALIZATION BEHAVIOR%GOBP%GO:0098582,0.627174923628636,0.859069247760118,0.683833259814733,0.911799380387913,4721,1,AUTS2
ACYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0071616,0.43506069703694,0.762034923704788,-0.22478054815152101,-1.01634979019015,3332,29,PPT1|SCD5|ACSL5|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|HACD2|PDHX|FASN
REGULATION OF CARBOHYDRATE METABOLIC PROCESS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:1900402,0.327327722251447,0.6944497064061241,-0.46678813477127395,-1.11880208767223,2488,5,MLXIP|NR1D1|PPARA
NEGATIVE REGULATION OF GLOMERULUS DEVELOPMENT%GOBP%GO:0090194,0.519292604501608,0.8049078833377921,0.583620904831139,0.9805584744615521,3875,2,BMP7|BMP4
NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION%GOBP%GO:0010616,0.7505291005291009,0.914270866779142,-0.397203257456609,-0.775637291060998,5673,3,LMNA
CHAPERONE-MEDIATED AUTOPHAGY TRANSLOCATION COMPLEX DISASSEMBLY%GOBP%GO:1904764,0.981003344481605,0.993436724391485,-0.509539038376709,-0.6788283466560489,7332,1,HSPA8
RIBONUCLEOPROTEIN COMPLEX BIOGENESIS%GOBP%GO:0022613,0.566226439287088,0.830361822459352,-0.11822462788635699,-0.9562499044898941,4415,359,SETX|RRP1|BCCIP|RPLP0|RPL10A|SMN2|SF3A3|ZNF658|SART3|MRPL20|BRIX1|GEMIN5|UTP18|PTGES3|SRSF12|SRFBP1|PA2G4|GEMIN7|MAPT|TEX10|KRR1|NVL|RPS23|CPSF6|RPL3|HEATR3|AAR2|LAS1L|RPL7A|SF3A2|RPS2|DHX30|EXOSC7|BICD1|SNRPE|YAE1D1|EXOSC4|RRP36|PWP2|MPV17L2|PSIP1|CELF2|LSM14A|DENR|RPL27|EIF2S3|GEMIN8|DHX9|GTF3A|UTP15|ZNF593|DYNC1H1|TXNL4A|SRPK3|PPAN|SF3A1|MRPS11|FTSJ2|SRSF10|SBDS|SLU7|TBL3|DDX23|ABT1|RUVBL1|SRSF9|LUC7L3|NOC4L|NPM1|GEMIN2|THUMPD1|CELF1|NOL11|ATXN2L|SURF6|DDX3X|CD2BP2|SRSF5|ZNF622|ZRSR2|SNRPF|SRSF1|RPS14|RPL35A|NCBP1|SNRPD1|PATL1|RPL10|MALSU1|CLP1|RPL24|SF1|CELF4|RIOK1|TRMT112|NMD3|RAN|RBM22|UTP14A|DKC1|LSM3|RPL35|NOP56|MRPS7|MCTS1|EXOSC3|SNRPB|RRP1B|WDR74|EIF2S1|MRPL22|MRPS2|RPL26L1|TAF9|BOP1|ISY1|HSP90AA1|ORAOV1|CPSF7|DIMT1|PRMT5|TSR2|G3BP1|SKIV2L2|EXOSC2|NGDN|AK6|MRPL11|EIF2D|SART1|NAT10|SMN1|PRPF19
TRIGEMINAL SENSORY NUCLEUS DEVELOPMENT%GOBP%GO:0021730,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0050650,0.29554073492872995,0.6684308347279571,-0.27373207768859,-1.1335957565251102,2259,22,DCN|CHST7|BGN|VCAN|B3GAT3|CSGALNACT1|XYLT2
REGULATION OF HISTONE DEUBIQUITINATION%GOBP%GO:1903584,0.7079598662207359,0.89516234575314,-0.6493162770180861,-0.8650451910206289,5291,1,SART3
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0090049,0.0036467830164105203,0.0645239033491183,-0.4119841554109771,-1.89865910658564,27,31,KIAA1462|MAP3K3|PIK3C2A|KLF4|KDR|SRPX2|FOXC2|NOTCH1|TBXA2R|MMRN2|HMOX1|HDAC5|MEOX2|RHOJ|STARD13|THBS1|ANXA1|CARD10
CELLULAR RESPONSE TO MISFOLDED PROTEIN%GOBP%GO:0071218,0.12552414446097698,0.48053753037869495,0.340352292363089,1.35694507379553,927,19,UGGT2|ANKZF1|SDF2|STUB1|DNAJB12|RNF185|UGGT1|ATXN3|RNF126|BAG6|UBE2W
NEGATIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0045541,0.289058390320884,0.6622070134491391,-0.483834108699966,-1.15965803450809,2197,5,SOD1|APOE
PROTEIN HETEROTETRAMERIZATION%GOBP%GO:0051290,0.058171383852876,0.348166349110039,-0.338920924250316,-1.4948068549837699,445,27,KRT10|HSD17B8|INSR|HIST1H4J|HIST4H4|HIST1H3D|HIST1H4H|CPSF6|FARSA|CD74|GRIN1|HIST1H4I|S100A10|RCC1|HIST2H4A|HIST1H3H|ANXA2|HIST2H4B|CPSF7
ERGOSTEROL METABOLIC PROCESS%GOBP%GO:0008204,0.0489632107023411,0.317359880131657,-0.973533303925893,-1.29698011996096,365,1,C14orf1
ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086014,0.341113841113841,0.701955655133333,0.35925551463536204,1.09174437484358,2498,9,SCN5A|ANK2|CACNA1C|CACNB2
TUBULIN DEACETYLATION%GOBP%GO:0090042,0.8326634512325831,0.9443921657118071,0.43043837882547603,0.7231920525755179,6214,2,HDAC6|SIRT2
MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034088,0.6433908436353759,0.868818962935866,0.387163654888508,0.8506150381759829,4735,4,MAU2|RB1|DSCC1|NIPBL
MITOTIC SPINDLE MICROTUBULE DEPOLYMERIZATION%GOBP%GO:1990755,0.5129096989966561,0.802184867798321,-0.7466916629907371,-0.994772586345224,3833,1,CCSAP
NEGATIVE REGULATION OF T CELL DIFFERENTIATION%GOBP%GO:0045581,0.8518014955812371,0.949296218452153,0.16872748491129502,0.7061165129162291,6264,22,SOCS5|LOXL3|CBFB|ZC3H8|ZBTB7B|FOXJ1|RC3H1|KIAA0922|PTPN2|HMGB1|CTLA4
GLAND DEVELOPMENT%GOBP%GO:0048732,0.5395342351136521,0.8147375278305091,0.15302717889939801,0.9558950370273059,3868,89,STRA6|LRP5L|DRD2|NPHP3-ACAD11|FGFR2|MET|RARG|INSM1|PAX8|TBX3|HESX1|IGSF3|SULF2|TG|ADCYAP1|WNT4|NF1|NPHP3|PKD2|CITED2|CCDC40|DKK3|ZBTB7B|LRP6|EZR|RARB
ARGININE BIOSYNTHETIC PROCESS VIA ORNITHINE%GOBP%GO:0042450,0.0580422366848187,0.34751897387465003,0.971272606969563,1.29506096480673,436,1,ASL
CAMP METABOLIC PROCESS%GOBP%GO:0046058,0.530676455165181,0.8115959426370749,-0.264922230887262,-0.9372561123174742,4047,14,ADCY8|PDE4D|ADCY4|EPHA2|ADCY9
N-ACYLETHANOLAMINE METABOLIC PROCESS%GOBP%GO:0070291,0.5043650793650789,0.797795146880088,-0.5006599515197729,-0.977661993575037,3812,3,GDE1|GDPD1
NEGATIVE REGULATION OF TELOMERIC D-LOOP DISASSEMBLY%GOBP%GO:1905839,0.976253648182542,0.9926773910205121,-0.323533956058063,-0.53841223985011,7358,2,TERF2
POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048743,0.290969899665552,0.663296678175849,-0.851621085134539,-1.13456377168084,2174,1,FAM129B
POSITIVE REGULATION OF NEURAL CREST CELL DIFFERENTIATION%GOBP%GO:1905294,0.696374020454244,0.891033775225429,0.65113586237318,0.8682018128528359,5242,1,SEMA3C
KARYOGAMY%GOBP%GO:0000741,0.702085270288219,0.8931369333627571,0.648599470666079,0.8648198767539929,5285,1,CDK1
PURINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009179,0.015565729234793999,0.168596495655607,-0.372436477091507,-1.7004720399718898,118,30,GPI|PFKFB2|HK1|HK3|NUDT16|ENO1|PGAM1|GAPDH|NUDT18|LDHA|PGK1|ALDOA|ALDOC|BAD
PROTEIN LOCALIZATION TO CELL SURFACE%GOBP%GO:0034394,0.0834755217220108,0.402201069234289,-0.353220118402286,-1.4390213056755001,635,21,MESDC2|FBLN5|GGA2|GGA3|FGF10|FLNA|FCN1|FGF7|VCL|ARF6|EMP2
POSITIVE REGULATION OF GLOMERULUS DEVELOPMENT%GOBP%GO:0090193,0.451491534533728,0.7698428203132289,0.512070421511456,1.0071820908276201,3359,3,RET|EGR1
RHYTHMIC SYNAPTIC TRANSMISSION%GOBP%GO:0060024,0.317060228177235,0.6861326333203311,-0.6762062310449412,-1.1253153019653,2389,2,PTEN|NLGN3
REGULATION OF NEUROTRANSMITTER SECRETION%GOBP%GO:0046928,0.51391779396462,0.8025452697640809,-0.201094338958859,-0.9600109135163459,3950,35,SEPT5|SNCAIP|MCTP1|NAPA|CPLX2|FMR1|MEF2C|VPS18|SYN1|STX1B|GPER1|DTNBP1|CAMK2A
CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION%GOBP%GO:0021799,0.594945355191257,0.844147534897396,0.302496433433299,0.878094225699505,4354,8,RTN4|LAMB1|MBOAT7
REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905930,0.0298941798941799,0.244735657013286,-0.798334620050733,-1.55894517588141,225,3,SOD2|DNMT1|FGF9
REGULATION OF NUCLEAR RECEPTOR TRANSCRIPTION COACTIVATOR ACTIVITY%GOBP%GO:2000325,0.908068783068783,0.971418326749055,-0.326942316606147,-0.6384354811423001,6864,3,CNOT6|NR1H3
XENOBIOTIC TRANSPORT%GOBP%GO:0042908,0.34933862433862395,0.70736446849153,-0.56713864656145,-1.10747803603544,2640,3,ABCC1
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT%GOBP%GO:1901863,0.786211604095563,0.9274485629622209,0.176214088377515,0.767750016010708,5758,25,FGFR2|DLL1|FGF2|RBM24|EFNB2|FLOT1|BMPR1A|GPC1|MKL2
POSITIVE REGULATION OF MRNA 3'-UTR BINDING%GOBP%GO:1903839,0.8734448160535121,0.959352672679547,-0.566056462284958,-0.7541231259356129,6528,1,CDK9
POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:1901798,0.46097361979874896,0.7748867354331179,0.25361783199648,0.9927684103138101,3389,18,SPRED2|PMAIP1|RPL26|CHD5|ATM
SYNAPTIC VESICLE UNCOATING%GOBP%GO:0016191,0.95489417989418,0.9870180073166591,-0.297011139296349,-0.579987477881969,7218,3,DNAJC6|GAK|SYNJ1
MALATE TRANSPORT%GOBP%GO:0015743,0.937248051599033,0.9806508984207809,0.308320575209864,0.6064301872161519,6974,3,SLC25A30|SLC25A14
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN CONTACT INHIBITION%GOBP%GO:0060244,0.878217033695941,0.960725750963158,-0.41575220872998103,-0.6918781591035439,6619,2,FAP
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043378",0.524276927103782,0.808136316886519,-0.42794639161082,-0.9368641081044692,4005,4,NCKAP1L|RUNX1|RUNX3
MODULATION BY VIRUS OF HOST APOPTOTIC PROCESS%GOBP%GO:0039526,0.187566988210075,0.5609377558550861,0.7445369496671329,1.2509182064975801,1399,2,CASP8|BCL2L1
REGULATION OF NON-MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:1903995,0.9816166531495001,0.993436724391485,0.21498462277400895,0.517036784939799,7261,5,DOCK3|SRC
REGULATION OF MACROPHAGE MIGRATION%GOBP%GO:1905521,0.09530060383302699,0.42518138471949396,-0.38938469658594704,-1.41379271452061,725,15,CSF1|CD200|THBS1|RARRES2|CMKLR1
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS%GOBP%GO:0031330,0.23378447395301302,0.6178909468777299,-0.157738840611376,-1.13085872569791,1830,177,USP25|UCHL5|APOC1|HGF|HNRNPU|HP|OGT|CBFA2T3|LARP1|PSMF1|BAG5|TOB1|SCFD1|INS|UBE2G2|FMR1|DHX36|EFNA1|MAPKAPK2|PARK7|UBXN1|SLC11A1|TIMP3|ALAD|E2F1|EIF4G2|DKC1|HFE|GIPC1|CHMP4A|TLK2|EPHA4|CCRN4L|SLIRP|YBX3|RASIP1|PPARA|DERL3|TAF9|ANXA2|TIMP1|AK6|HNRNPA0|HNRNPC|CST3|EIF4G1
MONOTERPENOID METABOLIC PROCESS%GOBP%GO:0016098,0.18260986066452303,0.556226209760009,0.7482768127929421,1.25720165942221,1362,2,CYP2E1|CYP2D6
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CONTROLLING TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:2000080,0.0298844468056847,0.244735657013286,0.9855535950595501,1.31410273545021,224,1,SFRP1
NK T CELL DIFFERENTIATION%GOBP%GO:0001865,0.637995712754555,0.865272868637146,0.530654092278448,0.8915673905510401,4761,2,ZBTB7B|ITK
HUMORAL IMMUNE RESPONSE%GOBP%GO:0006959,0.000127942681678608,0.00518555396908895,-0.495110180548874,-3.22216200973917,0,110,CXCL1|IGHV1OR15-1|IGKV3-11|CXCL2|IGHV5-51|HLA-E|RGCC|GPR183|RPL39|C4B|FCN3|IGHV1-24|HIST1H2BE|IGHV3-49|COL20A1|CD83|IGHG4|EXO1|IGLL5|GPI|PLA2G2A|C4A|AZU1|EBI3|C2|LY86|IGKV2-28|C3|HIST1H2BC|IGHV4-4|IGHV4-61|JCHAIN|MEF2C|C1QB|IGHV1-3|SLC11A1|BST1|IGHV3-43|ROMO1|HMGN2|FCN1|IGHV3-73|TREM2|C1QA|CFB|C1QC|CCL2|C7|IGKV2D-28|GAPDH|RNASE6|CHGA|TNFRSF21|BST2|ZP3|IGHV3-15|RARRES2|HIST1H2BG|POU2F2|S100A8|CFP|C1S|IGHV1-18|S100A9|CFD|FAM3A|IGHG2|TFE3|HIST2H2BE|IGHA1|HIST1H2BK|C1R|CFH|HIST1H2BJ
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS%GOBP%GO:0071380,0.6732727025926429,0.882195523984236,0.316413922975958,0.8187396230111921,4959,6,SFRP1|ADCY6|GNB1
DGDP PHOSPHORYLATION%GOBP%GO:0006186,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
RECEPTOR INTERNALIZATION INVOLVED IN CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:2000286,0.39722222222222203,0.73793528435462,-0.5462042269985,-1.0665984204358199,3002,3,CAV1
PEPTIDE METABOLIC PROCESS%GOBP%GO:0006518,0.00420221571373997,0.07145061030312899,-0.174694359409464,-1.4417131743439697,32,409,ECE1|MRPS10|RPS23|MRPL53|AIMP2|MRPS17|FARSA|MRPL37|RPL3|AURKAIP1|GSPT2|IARS|RPL7A|C9orf41|RPS2|EIF2B5|GARS|OPLAH|RPL15|SPCS2|MRPL18|RPL37|MRPL57|GFM2|RPL27A|NPEPPS|YAE1D1|PSEN1|RPL18|EIF3J|RPL39|DENR|MRPS18B|RPL27|EIF2S3|MRPS15|MRPL47|SECISBP2|EEF1D|GNB2L1|VARS|GADD45GIP1|MRPS11|MRPL13|TAPBP|CHAC1|PCSK5|CHAC2|LNPEP|ETF1|SARS|OXA1L|GATC|EIF3C|HM13|NDUFA7|CPE|AEBP1|NGF|DYRK1A|MRPL10|LARP1|MRPL50|MRRF|EIF2B1|EIF3M|MRPL51|CPZ|YARS|GGT1|GPX1|RPLP2|MRPS34|PCSK1|MRPL9|WARS|DDX3X|CPM|RPS14|RPS4X|RPL35A|TPP1|RPS29|PARK7|MRPS30|ATP6AP2|RPL10|RPL36A|RPL24|NLN|MRPS23|MRPL41|DPEP1|MRPS6|MRPS18C|SOD1|EIF1AX|AARS|MRPL38|EIF3B|MRPS22|MRPL52|TNIP1|SEC11C|EEF1G|CTSZ|CTSH|GFM1|PCSK6|RPL35|MRPL21|FTSJ1|RPL38|RPS15A|MRPS18A|EIF5|MRPS24|ANPEP|MRPL27|MRPL23|MRPS7|GGT5|MCTS1|MRPL36|ICT1|RPS13|EIF2S1|EIF2B2|CARS|MRPL22|MRPL49|LAMP2|MRPS2|MRPL39|EIF4A2|RPL26L1|CPXM2|MRPL3|MRPL12|BACE2|HSP90AA1|MRPS36|ORAOV1|MRPL17|RBM4|GSTP1|IGHMBP2|EEFSEC|CPQ|EIF2B3|RPS6KB2|MRPS27|RRBP1|MRPL11|EIF2D|PTGES|TARSL2|EIF4G1|MRPL16
REGULATION OF DIPEPTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:2001148,0.8973202440965771,0.967166974453851,-0.402923115333027,-0.6705284961647321,6763,2,CA2
TRNA 5'-END PROCESSING%GOBP%GO:0099116,0.85437908496732,0.949296218452153,-0.20480803801733102,-0.6855116797484471,6535,12,RPP14|RPP30|TRMT10C|POP4|RPP25|POP7|POP1|HSD17B10
VASODILATION%GOBP%GO:0042311,0.0473759979060332,0.312255783864335,-0.697898858434898,-1.52784648818665,361,4,ADRB2|SOD2|SOD1|NOS3
LACTOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0001572,0.7521070234113709,0.915314007578303,-0.6288045875606529,-0.8377186955162409,5621,1,B4GALT6
CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051934,0.260048231511254,0.636098664976652,0.703391232423491,1.18178808898966,1940,2,SLC6A2|SNCA
REGULATION OF HISTONE H4-K16 ACETYLATION%GOBP%GO:2000618,0.379967558799676,0.729249457747391,0.438222793388077,1.05392330510488,2810,5,PIH1D1|SMARCB1|SIRT1|AUTS2
NEGATIVE REGULATION OF SISTER CHROMATID COHESION%GOBP%GO:0045875,0.84797475013151,0.9492491301138911,-0.289914264591714,-0.6948691714927671,6447,5,ESPL1|NAA10
RESPONSE TO GONADOTROPIN-RELEASING HORMONE%GOBP%GO:0097210,0.9297619047619051,0.9793746057014829,-0.314198423517769,-0.613549887867124,7028,3,CRHBP
NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS%GOBP%GO:0090027,0.0128356254092993,0.149991146428462,-0.6814295957200379,-1.7528204878570801,97,6,DUSP1|GREM1|SLAMF8|NOV|NBL1|SLIT2
PORPHYRIN-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0006778,0.68331589958159,0.885415243771438,-0.19686660570359196,-0.836677524180436,5225,24,TSPO|BLVRA|HPX|ATPIF1|NFE2L1|ALAD|HMOX1|FXN|BLVRB
HOMOCYSTEINE CATABOLIC PROCESS%GOBP%GO:0043418,0.655737704918033,0.874869342420871,0.42908720055671,0.8439638878739871,4879,3,BLMH|CBS|MTRR
POSITIVE REGULATION OF STRAND INVASION%GOBP%GO:0098530,0.120733165094966,0.472686039512467,0.941001323334804,1.25469829267055,908,1,WRN
NEGATIVE REGULATION OF HYDROGEN PEROXIDE-MEDIATED PROGRAMMED CELL DEATH%GOBP%GO:1901299,0.863071100297378,0.95308264526335,0.283104526273958,0.6808647622228371,6384,5,MET|TRAP1
NUCLEUS ORGANIZATION%GOBP%GO:0006997,0.6607624181748171,0.8785233146590509,-0.143095402541467,-0.885699591911949,5147,90,SEC13|LMNA|GPER1|CCNB1|PLK1|NSFL1C|CHMP4A|SUN2|CHMP6|NUP98|VRK1|NEK6|EMD|BANF1|PRKCB
REGULATION OF MESENCHYMAL CELL PROLIFERATION INVOLVED IN URETER DEVELOPMENT%GOBP%GO:0072199,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
POSITIVE REGULATION OF FRACTALKINE BIOSYNTHETIC PROCESS%GOBP%GO:0050754,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|AZU1
POSITIVE REGULATION BY ORGANISM OF PHAGOCYTOSIS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052522,0.32846327533537,0.6950398637731511,0.835410233789149,1.11390682246874,2472,1,ITGAV
REGULATION OF MITOTIC NUCLEAR DIVISION%GOBP%GO:0007088,0.0503643103668669,0.32216428890910903,-0.19852827303691503,-1.3750075471949499,393,148,TRIP13|DUSP1|AURKAIP1|KLHL22|KIF11|NEK2|ANLN|CCND2|APC|RGCC|NUSAP1|MKI67|DLGAP5|CDC20|CCSAP|CDT1|LCMT1|ANAPC5|ESPL1|CDC6|ANKRD32|NAA10|CDC23|HNRNPU|STAG2|CAV2|PTTG1|INS|PKMYT1|CDK5RAP2|MAD2L1|CDC25C|KNTC1|PDXP|NDC80|RCC1|CDC27|IGF1|LRP5|CCNI2|CCNI|USP44|CCNB1|PLK1|NSFL1C|PDGFRB|CCND3|IK|SMC1A|CCDC8|NEK6|H2AFY|ANAPC11|PRMT5|CCND1|CDCA5|PDGFB|XRCC3
HOMOLOGOUS CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE INVOLVED IN HOMOLOGOUS CHROMOSOME SEGREGATION%GOBP%GO:0051758,0.9439464882943142,0.982694945797028,-0.526852668725188,-0.701894259528033,7055,1,FMN2
MYOBLAST MIGRATION%GOBP%GO:0051451,0.37874802735402396,0.7286721377338231,-0.44357358067871006,-1.063161231257,2879,5,ROCK1|THBS4|ANXA1
CELL WALL GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0031506,0.528561872909699,0.8105400040230321,-0.73869651521835,-0.984121129764213,3950,1,MPI
REGULATION OF LIPID KINASE ACTIVITY%GOBP%GO:0043550,0.0475077881619938,0.312255783864335,-0.309246200334519,-1.51343763296524,365,38,DGKZ|TGFB1|TNFAIP8L3|FLT1|CCL19|DAB2IP|FGR|EPHA8|IRS1|PRKD1|PIK3R3|PIK3R4|TEK|PDGFRB|PDGFRA|AMBRA1|CD81|PDGFB
REGULATION OF PEPTIDYL-LYSINE CROTONYLATION%GOBP%GO:0120093,0.672775919732441,0.8820330910931731,-0.6669607410674899,-0.8885518538201029,5028,1,CDYL
OLFACTORY PLACODE DEVELOPMENT%GOBP%GO:0071698,0.506308938770089,0.798168488166378,0.7477393030436701,0.997009466008748,3811,1,PROX1
REGULATION OF BONE REMODELING%GOBP%GO:0046850,0.8674163179916321,0.9558022175108679,-0.16261192032582,-0.691096077032381,6633,24,SYK|BGLAP|GREM1|ADAM8|SYT7|TNFAIP3|S1PR1|SPP1|ATP6AP1|CSF1R
REGULATION OF CHEMOTAXIS%GOBP%GO:0050920,0.000639467962655071,0.0163600882996276,-0.27230249122272304,-1.85754578417061,4,138,CCL3|ROBO1|RAC2|CXCL12|THBS4|CCL4|DUSP1|RAC1|DUSP3|TGFB1|GREM1|LYN|GPR183|SEMA4A|NCKAP1L|CD74|CCL19|SLAMF8|ANGPT2|PPM1F|KDR|STX4|P2RX4|SEMA6A|SLC8B1|MOSPD2|AZU1|VEGFC|GAS6|CREB3|SMOC2|CXCR4|NOTCH1|PRKD1|DSCAM|F3|PLA2G7|BST1|CALR|HSPB1|SEMA3B|SEMA3D|SEMA7A|CSF1|CCL2|CORO1B|CCR1|VEGFB|NOV|LGALS9|THBS1|STX3|SEMA5A|NBL1|AIF1|PDGFRB|SEMA3E|RARRES2|SLIT2|ZSWIM6|SERPINE1|ADGRA2|SEMA3A|SEMA6B|PDGFRA|CMKLR1|LGMN|TMSB4X|PDGFB|MPP1
NEGATIVE REGULATION OF DNA RECOMBINATION%GOBP%GO:0045910,0.49627985902623706,0.794012168719884,-0.214820859778913,-0.9713168579764799,3801,29,NDFIP1|H1F0|TERF2|PARPBP|KLHL15|POLQ|CXorf57|RMI2|H1FX|HIST1H1C|MAGEF1
REGULATION OF T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0001914,0.0576191101194382,0.34590110360017606,-0.3711637644716939,-1.51212384896261,438,21,CD1D|HLA-B|PVR|LILRB1|HLA-E|RIPK3|HLA-C|HLA-A|FCGR2B|PVRL2|CEACAM1|STX7|FADD
CELL CYCLE G2/M PHASE TRANSITION%GOBP%GO:0044839,0.594150846587994,0.843236967207453,-0.140550179736966,-0.9278331277059608,4631,118,HAUS1|NDE1|TUBG1|CCNB2|CEP72|HAUS6|AURKA|AJUBA|CEP78|HAUS4|SKP2|CEP76|CSNK1D|FBXL7|CEP192|PCNT|NEK2|NEDD1|FBXW11|DYNC1H1|PLCB1|LCMT1|OFD1|CEP70|KDM8|TUBA4A|SDCCAG8|HAUS8|PKMYT1|CDK5RAP2|CDC25C|MELK|FOXM1|CDKN2B|ENSA|CEP131|SKP1|CKAP5|TUBB4A|CCNB1|PLK1|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|DCTN3|HAUS7
AMINO ACID IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0089718,0.0376204113512106,0.276411549417657,-0.56414009936674,-1.6240803887800699,288,8,SLC7A2|SLC1A2|SLC1A3|SLC7A3|SLC3A2
PURINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009152,0.0673508659397049,0.370933718266529,-0.203546828248986,-1.34610623391579,524,119,ATP5J|DCAKD|GPI|ATP5F1|COASY|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|PDHA1|ACSF3|ATP5B|HK3|ADCY8|NPR2|ELOVL1|SLC26A2|ENO1|ADCY4|ATP5O|PGAM1|HPRT1|NPR1|GAPDH|HACD2|GMPS|LDHA|STOML2|PDHX|ATP5H|PGK1|FASN|ADCY9|ALDOA|ALDOC|ATP5G1
REGULATION OF ARGININE CATABOLIC PROCESS%GOBP%GO:1900081,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
PARAMESONEPHRIC DUCT DEVELOPMENT%GOBP%GO:0061205,0.0605573419078242,0.355936982159638,0.848304383788255,1.42526089377681,451,2,STRA6|WNT4
ICOSANOID METABOLIC PROCESS%GOBP%GO:0006690,0.0034726688102893898,0.061706940093565005,-0.34529811978320696,-1.8723053098598301,26,54,GPX4|ALOX5|CD74|LTC4S|TBXAS1|PTGDS|CYP1B1|GGT1|GPX1|CBR1|DAGLB|MAPKAPK2|PTGR2|PLA2G4A|PTGES2|PTGS1|DPEP1|ACOX1|PLA2G4C|DAGLA|GGT5|PLAA|MGLL|FADS1|PTGES|PTGIS|ABCC1
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS%GOBP%GO:0060444,0.6726868210967151,0.8820330910931731,-0.37704900480419606,-0.825439088919357,5139,4,LRP5|EPHA2
POSITIVE REGULATION OF LYMPHOCYTE MIGRATION%GOBP%GO:2000403,0.895017064846416,0.966256689108312,0.15347193847018,0.668664374696557,6555,25,TMEM102|XCL1|ADAM17|CXCL13|PTK2B
TRNA C5-CYTOSINE METHYLATION%GOBP%GO:0002946,0.484659317306415,0.7872939093021379,0.75766431407146,1.01024312900422,3648,1,NSUN3
BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0048514,0.000128040973111396,0.00518555396908895,-0.30149490194638,-2.1467994603281997,0,171,FLT1|APOD|ADM|JAG1|IL18|ADAM8|EPHB3|TBX1|SAT1|SOX18|COL23A1|SOX17|FGFR4|KDR|PLXND1|LRP1|CD34|RORA|APOLD1|MED1|SFRP2|CYP1B1|EGFL7|PRCP|ATPIF1|TBX2|VEGFC|THY1|HES1|ITGA5|ATP5B|MYLK|FLT4|NOTCH1|CALCRL|HOXB3|COL4A1|JMJD6|HMOX1|LOX|PIK3R3|LRP5|CCL2|CEACAM1|ROBO4|APLNR|VEGFB|NOV|CCBE1|NRP2|ADIPOR2|TGFBR2|TGFBR3|THBS1|TEK|SEMA5A|SRF|PDGFRB|SEMA3E|SLIT2|ID1|SERPINE1|CAV1|ADGRA2|RASIP1|MYH9|ANG|EPHB4|TGFBI|ADGRG1|PDGFA|ANXA2|PDGFRA|ENG|ACVRL1|LOXL2|SERPINF2
POSITIVE REGULATION OF MISMATCH REPAIR%GOBP%GO:0032425,0.705272944614159,0.894639008000397,0.646890163211292,0.8625407459047729,5309,1,HMGB1
QUINONE BIOSYNTHETIC PROCESS%GOBP%GO:1901663,0.655200433369448,0.874775007199212,0.22847723316879998,0.84275833126432,4837,15,COQ10B|COQ2|COQ10A|ADCK4|FDXR|PDSS2|COQ9|UBIAD1
CYTOSKELETAL ANCHORING AT PLASMA MEMBRANE%GOBP%GO:0007016,0.903074517978114,0.9688920116763109,-0.209255260800228,-0.629491044408603,6931,9,JUP|SPTBN4|TLN1
REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 5 PRODUCTION%GOBP%GO:0071649,0.564965807469753,0.829593590528481,-0.377693933982359,-0.9052602891195128,4295,5,MUL1|DDX3X|SIRPA
NEGATIVE REGULATION OF MACROPINOCYTOSIS%GOBP%GO:1905302,0.20307692307692302,0.5817604087661171,-0.8961733568592858,-1.19391809524952,1517,1,STX1B
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002763,0.0453713389121339,0.305507129637833,-0.364953484612649,-1.55104202084164,346,24,TRAF6|LIF|TNF|ACIN1|TGFB1|CD74|RUNX1|ZFP36L1|CD4|HCLS1|IL34|TESC|HAX1|CSF1|CCR1|FADD|ATP6AP1
POSITIVE REGULATION OF HYDROGEN PEROXIDE-INDUCED CELL DEATH%GOBP%GO:1905206,0.293542336548767,0.666121490214324,0.6871794871794871,1.15455026379658,2190,2,RIPK1|HDAC6
BEHAVIORAL RESPONSE TO PAIN%GOBP%GO:0048266,0.14920634920634898,0.5157600394920371,-0.674809749641557,-1.31773241122199,1127,3,THBS4|P2RX4|THBS1
[2FE-2S] CLUSTER ASSEMBLY%GOBP%GO:0044571,0.7100937372639591,0.896399297418128,0.36601775767936895,0.8041566014536708,5226,4,HSCB|GLRX3|BOLA2|BOLA2B
NEGATIVE REGULATION OF IRON ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034760,0.30327759197324394,0.6762596203943579,-0.8448941332157042,-1.12560185648854,2266,1,HAMP
POSITIVE REGULATION OF HEAT GENERATION%GOBP%GO:0031652,0.9660772757039949,0.9910924712218209,-0.21673067238999102,-0.557489673618892,7375,6,PTGS2|IL1B|TNF|TNFRSF11A
LEUCINE CATABOLIC PROCESS%GOBP%GO:0006552,0.831305758313058,0.9443784929910591,0.29362477507296003,0.7061659002559542,6149,5,HMGCLL1|HMGCL|IVD
INNER EAR MORPHOGENESIS%GOBP%GO:0042472,0.335010881392818,0.698139575531202,0.32253046722719897,1.09621832530246,2462,12,FGFR2|PAX8|EPHB2|CEP290|CHD7|PROX1
CATECHOLAMINE CATABOLIC PROCESS%GOBP%GO:0042424,0.851472134595163,0.949296218452153,-0.249489316959049,-0.681967922090289,6477,7,MAOA|MOXD1|COMT
ALDITOL CATABOLIC PROCESS%GOBP%GO:0019405,0.6034668099973131,0.848175106515994,0.447988039558201,0.8811396077441709,4490,3,SORD|TKFC
REGULATION OF T-HELPER 1 TYPE IMMUNE RESPONSE%GOBP%GO:0002825,0.41485459785171597,0.7490461307518279,-0.31681042350536204,-1.0256907911331998,3166,11,IL1B|JAK3|IL18|CCL19|SLC11A1|IL1R1|ANXA1
POSITIVE REGULATION OF TRANSFERRIN RECEPTOR BINDING%GOBP%GO:1904437,0.181745821172725,0.554948538055731,-0.744527157430383,-1.23901224880824,1369,2,B2M|HFE
POSITIVE REGULATION OF TELOMERE MAINTENANCE%GOBP%GO:0032206,0.595814977973568,0.8445090144443349,0.171874256908787,0.9124684307923521,4327,48,HMBOX1|ATM|MRE11A|PARN|ACD|RTEL1|POT1|MAP2K7|MAP3K4|XRCC5|PNKP|HNRNPD|TNKS|ATR|ERCC1|MAPK1|TNKS2|NEK7|TCP1
REGULATION OF RNA BINDING%GOBP%GO:1905214,0.0915841584158416,0.41875351947121797,-0.48373464790729903,-1.4551922258169698,702,9,EIF3C|FMR1|NCBP1|NUCKS1|EIF4G1
LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002523,0.0072330352446081,0.10264464154751901,-0.7477939554379,-1.79231941896413,54,5,ADAM8|SLAMF8|CX3CL1|S100A8|S100A9
POSITIVE REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:1904849,0.16626473740621697,0.5385312568324571,0.758974358974359,1.27517491822309,1240,2,FGF2|FGFR1
CYTOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0019221,0.000127518490181076,0.00518555396908895,-0.32300169244662796,-2.68343358374269,0,432,PTGS2|CDIP1|BRWD1|JAGN1|FYN|TRAF6|IL11RA|IFNGR2|IL27RA|LCP1|STK39|IGHG1|BOLA2B|TRIM22|HIST1H3D|ISG20|TRIM25|HLA-DRB1|CNTFR|LIF|RPLP0|UBE2N|CD40|CTF1|RAP1B|IL2RG|MCL1|IL1B|GPR35|RORC|AKT1|IRF8|CCL3|OAS3|RIPK2|FSCN1|CXCL12|CDC42|PAK2|TNF|JAK3|SYK|HLA-DQB2|POU2F1|HLA-B|ACTN4|CCL4|RPS6KA5|ITGB1|ZNF675|CCL8|CXCL1|MX1|IL10RA|CD44|ACKR3|HLA-DPA1|XAF1|TGFB1|STAT5A|CNN2|CXCL2|NDN|STAT6|PML|MAOA|HLA-E|CCL11|HLA-DRA|FBXW11|HLA-DRB5|COMMD7|FCGR1B|ITGAX|TRIM38|ALOX5|SP100|MAP3K3|TNFSF13B|PYCARD|JUNB|TRIM21|TNFRSF14|PLCB1|B2M|SMARCA4|IL18|IRAK3|TNFSF8|CCL19|HSP90B1|MID1|IFIT3|BATF|OASL|OAS1|IFNGR1|SOCS3|IL17RE|ITGB2|IFNAR1|IGHG4|HLA-DPB1|EDA|CD4|STX4|HLA-DQA2|RAPGEF1|PPIA|FCGR1A|TRIM68|RORA|CCL24|HGF|HLA-C|VAV1|SOD2|IRF5|GATA3|TNFRSF11A|TNFRSF18|TRIM34|CANX|HLA-A|IL1RN|EBI3|IL34|MMP1|OAS2|IL15RA|CASP1|CCL3L3|IL6ST|TRAF2|FPR1|CCL18|ILK|IL13RA1|CSF2RB|CXCR4|POMC|CEBPD|IFIT2|IL10RB|GRB2|TNFSF12|S1PR1|HNRNPA2B1|IRS1|CEBPA|SOCS1|STAT3|IL18BP|HSPA9|IL17RA|ADIPOR1|IL32|PTPN6|PSME2|LMNB1|IL2RA|CISH|ICAM1|IFIT1|SNRPA1|FCER1G|F3|MSN|CSF3R|CTR9|ISG15|PIK3CB|OSM|MAPK3|PIM1|CAMK2B|IFI6|RSAD2|HMOX1|SOD1|TNFRSF4|IL1RAP|KLF6|RBM15|IRF7|IRAK1|SKP1|ARF1|IFI30|VCAM1|IL15|TNFSF13|IL21R|CSF1|CCL2|CEACAM1|HIST2H3A|CSF2RA|IL33|PLVAP|AIP|CCR1|FN1|CD86|IL3RA|NFKBIA|HCK|CD36|ADIPOR2|BST2|F13A1|MT2A|STX3|COL1A2|UBC|CD300LF|TNFRSF11B|IFI35|IFNLR1|MMP9|CX3CL1|CAMK2A|IL11|LTA|FLT3LG|TRAF3|MYC|LTBR|PTAFR|CCL4L2|CCL14|HIST2H3C|RELA|IL1R1|CFL1|IFITM1|TNFRSF12A|NFKB1|PRKACA|BCL6|VIM|HIST1H3H|RPS6KA4|ITGAM|ANXA2|HSP90AA1|CSF1R|TIMP1|BIRC5|ANXA1|RHOU|OSMR|TNFRSF1A|TMSB4X|IFITM2|TOLLIP|CCND1|IFITM3|PELI3|SAMHD1|TALDO1|TNFRSF1B|PDGFB|SQSTM1|P4HB
POSITIVE REGULATION OF TUBULIN DEACETYLATION%GOBP%GO:0090044,0.460751759861867,0.774751791105461,0.771063078958977,1.0281085740481,3468,1,FNTA
HISTONE H3-Y41 PHOSPHORYLATION%GOBP%GO:0035409,0.688537654402975,0.887051934478962,0.655105866784296,0.8734952780510241,5183,1,JAK2
REGULATION OF CHYLOMICRON REMNANT CLEARANCE%GOBP%GO:0090320,0.9360535117056858,0.9806508984207809,-0.531539479488311,-0.7081382168341429,6996,1,GPIHBP1
VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0055010,0.34268929503916495,0.701955655133333,-0.259671748576167,-1.09025300193094,2624,23,ISL1|SMAD4|TGFBR1|SMAD7|DLL4|TGFB2|NRG1|TGFB1|TNNT2|ZFPM2|RYR2|NOTCH1|PKP2|TGFBR3|FKBP1A|ENG
EMBRYONIC PLACENTA DEVELOPMENT%GOBP%GO:0001892,0.0424028268551237,0.294833299013666,0.42124910596510606,1.58614259359553,311,16,FGFR2|BMP7|PKD1|ZNF568|CASP8|PKD2|IGF2|HEY2|LEF1
ICOSANOID SECRETION%GOBP%GO:0032309,0.117933459561807,0.468705549268799,0.506142397223622,1.39719250187971,871,7,ABCC4|DRD2|DRD4
BRASSINOSTEROID METABOLIC PROCESS%GOBP%GO:0016131,0.09418060200668901,0.42418410384356203,-0.9507057785619759,-1.2665683749641399,703,1,DHCR7
NEGATIVE REGULATION OF MUSCLE CONTRACTION%GOBP%GO:0045932,0.543903074517978,0.8169398528108319,-0.306635588732149,-0.922434906848645,4174,9,ADRB2|DOCK4|DOCK5|SOD1|ADRBK1
REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS%GOBP%GO:0045346,0.8031299316149398,0.932964969466025,-0.30482020736818893,-0.7305958720122959,6106,5,SIRT1|HDAC2|CIITA|XBP1|AZU1
REGULATION OF HYALURANON CABLE ASSEMBLY%GOBP%GO:1900104,0.6715936576189201,0.8815356925073421,0.423272306262721,0.832526677000383,4997,3,BMP7|HAS3
UBIQUITIN-DEPENDENT SMAD PROTEIN CATABOLIC PROCESS%GOBP%GO:0030579,0.93792740662809,0.9806508984207809,-0.24901168761347,-0.5968334994059921,7131,5,RNF111|SMURF1|SMURF2
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002857,0.7608465608465609,0.9182611787042629,-0.392578637336635,-0.7666065800718391,5751,3,PVR|PVRL2
GDP-L-FUCOSE BIOSYNTHETIC PROCESS%GOBP%GO:0042350,0.48723461435098103,0.788226301622024,0.495142498923555,0.973886864723514,3625,3,FUK|GMDS
POSITIVE REGULATION OF PROTEIN KINASE D SIGNALING%GOBP%GO:1903572,0.971709390357285,0.9915747942934481,0.513178209086899,0.684253897215797,7315,1,VEGFA
NEURONAL ACTION POTENTIAL PROPAGATION%GOBP%GO:0019227,0.4345980366144871,0.762034923704788,-0.6251986164020601,-1.04043047446869,3275,2,SCN1B
REGULATION OF LOCOMOTOR RHYTHM%GOBP%GO:1904059,0.270234113712375,0.6448627027652211,-0.861380679311866,-1.1475658945418,2019,1,ZFHX3
PROTEIN INSERTION INTO ER MEMBRANE%GOBP%GO:0045048,0.623706614276359,0.857551285930326,-0.335483685886778,-0.862954414744483,4761,6,GET4|TRAM2|UBL4A
IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE%GOBP%GO:0016064,0.000129182276191707,0.00518555396908895,-0.49987848136862895,-2.58952781942551,0,46,IGHV1OR15-1|IGKV3-11|IGHV5-51|IGHV1-24|CD74|IGHV3-49|BATF|IGHG4|EXO1|IGLL5|FCGR2B|IGKV2-28|IGHV4-4|IGHV4-61|RNF168|C1QB|IGHV1-3|FCER1G|IGHV3-43|IGHV3-73|C1QA|C1QC|IGKV2D-28|ZP3|IGHV3-15|EXOSC3|C1S|IGHV1-18|IGHG2|IGHA1|C1R
PHOSPHATIDYLGLYCEROL ACYL-CHAIN REMODELING%GOBP%GO:0036148,0.129552004191774,0.4879451726618929,-0.42250260568184794,-1.36787491738041,988,11,PLA2G2A|PLA2G2D|PLA2G4D|PLA2G4A|PLA2G12A
TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS%GOBP%GO:0070525,0.9816310578426259,0.993436724391485,-0.169351279788173,-0.509450102129402,7534,9,TPRKB|TRMT61B|PUS1|TRIT1|MTO1|TP53RK|OSGEP|TRMT5|HSD17B10
REGULATION OF MOTOR NEURON APOPTOTIC PROCESS%GOBP%GO:2000671,0.48097534833869204,0.7857006060206241,0.6,1.00807746913582,3589,2,KCNB1|ZPR1
TIE SIGNALING PATHWAY%GOBP%GO:0048014,0.17259219952242003,0.546371269738967,-0.7504824924179759,-1.24892287855727,1300,2,ANGPT2|TEK
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002856,0.192107023411371,0.5665036350989531,-0.902459197176886,-1.20229234387183,1435,1,CEACAM1
CEREBELLAR GRANULAR LAYER FORMATION%GOBP%GO:0021684,0.9240937050124329,0.9776627603891009,-0.282978810628916,-0.619499769666057,7060,4,CBLN1
CENTROSOME-TEMPLATED MICROTUBULE NUCLEATION%GOBP%GO:0090222,0.496285486866543,0.794012168719884,-0.6006617038875101,-0.999597128297157,3740,2,NIN|CEP192
"POSITIVE REGULATION OF GENE EXPRESSION, EPIGENETIC%GOBP%GO:0045815",0.553243732230551,0.8232048022884231,-0.17873180788248103,-0.9369702199244301,4280,48,SLC50A1|H1F0|DEK|PHF2|ATAD2|ZNRD1|TWISTNB|ELOF1|POLR2H|WBP2|KAT2B|H1FX|ACTB|HIST1H1C|H2AFY|POLR2L
REGULATION OF MACROAUTOPHAGY%GOBP%GO:0016241,0.335144927536232,0.698243193474341,0.156356523500387,1.0692205102264,2404,135,EXOC4|IFT88|ATP6V1E2|TSC2|PHF23|PARK2|RALB|NRBP2|PIP4K2C|PAFAH1B2|IFT20|TBC1D14|UBQLN4|KIAA1324|PIKFYVE|TRIM13|RAB3GAP1|HTT|LZTS1|CLEC16A|GNAI3|CDK5R1|VPS13C|SESN1|SMCR8|NPRL3|NEDD4|UCHL1|SH3GLB1
MAINTENANCE OF LOCATION%GOBP%GO:0051235,0.00192950861847183,0.0383938788644259,-0.270115832066332,-1.77095283925955,14,114,C9orf114|PML|TMSB15A|GET4|SP100|GPAA1|HSP90B1|DGAT1|TONSL|JUP|CD4|TBCCD1|ATP2A1|TAF3|SPTBN4|HNRNPU|GAA|TLN1|HK1|CCDC22|PARK7|DBN1|FBN1|LTBP1|CALR|SRGN|FLNA|KDELR2|SKP1|BSCL2|KDELR1|BCL3|MDFI|GSN|PSMD10|APOE|FTL|NFKBIA|CD36|SUN2|NBL1|ARL2|SYNE3|CAV1|KDELR3|S100A8|S100A9|HSPA5|TMSB4X|FTH1|INSIG1
G2 DNA DAMAGE CHECKPOINT%GOBP%GO:0031572,0.84927773235214,0.9492491301138911,0.16211874323903602,0.71688416896285,6231,26,CDC14B|FAM175A|ATM|MRE11A|BRE|BRSK1|TAOK1|CDK5RAP3|GLTSCR2
RESPONSE TO ORGANONITROGEN COMPOUND%GOBP%GO:0010243,0.0026778882938026,0.0499983179635455,-0.17754857453228798,-1.47503811523931,20,432,ZFP36L1|FBXO6|IMPACT|RYR2|JUP|AP3S1|HSPA13|ITGB2|TCIRG1|ATP6V0B|RRAGA|UBQLN2|GOT1|PARP1|P2RX4|RAPGEF1|ATP6V0A2|LRP1|RNF121|HM13|TOR1A|ATP6V1G2|TMBIM6|ATP1A3|IRF5|AHR|OGT|LARP1|EIF2B1|CAV2|P2RX3|HLCS|FCGR2B|ATP6V1F|INS|PDE4B|BCAR1|GRIN1|VCP|ERBB2IP|FOXC2|KYNU|UBE2G2|SYAP1|ADCY8|SEL1L|ATP6V0D1|PDXP|CA2|GRB2|CRHBP|PRKAR1A|SLC9A1|MEF2C|CASP4|IRS1|STAT3|UBQLN1|BRCA1|FCER1G|PDE2A|PXN|RCN3|FAF2|MAPK3|ABL1|ADCY4|HERPUD1|RAPGEF3|SEC13|PIK3R3|IGF1|NPLOC4|HDAC5|NSMF|RPTOR|P2RY6|KAT7|CEACAM1|DHFR|PSMC6|GPER1|RAP1A|KCNQ1|KAT2B|CPEB1|CD36|SYVN1|ATP6V0E1|TGFBR3|KIAA0368|HTR1B|SEC61B|EPHA4|RARRES2|SLIT2|SGTB|TICAM1|CAMK2A|IGFBP5|LPIN3|CAV1|EIF2B2|LDLR|PPARG|ATP6AP1|RELA|DERL3|RPS6KB1|MAPK13|NFKB1|PRKACA|TLR4|ATP6V0E2|VIM|ACTB|HSPA5|ANXA1|LGMN|SHMT2|ATP6V1A|CD81|SLC38A9|CASP6|EIF2B3|LPIN2|ATP6V1G1|NGFR|ADCY9|RRAGD|PRNP
MACROAUTOPHAGY%GOBP%GO:0016236,0.7479487179487181,0.912806095648395,-0.126163616730126,-0.8508683826660991,5833,131,SEC23A|ATG2A|WDR45|TMEM41B|UBQLN1|DYNLL2|ATG101|WIPI1|VAMP8|VAMP7|PIK3R4|VPS25|NSFL1C|CHMP4A|SNF8|CHMP6|LAMP2|PLAA|ATG3|AMBRA1|VPS37C|ATG4A|SQSTM1|VMP1
NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0010829,0.105831814631606,0.447796222692122,-0.494169420199786,-1.42264459658548,812,8,PEA15|PRKCB|GRB10
NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033147,0.713876594636813,0.8982987830544991,-0.274866515506828,-0.791302227705587,5483,8,STRN3|BRCA1|KANK2
XYLULOSE CATABOLIC PROCESS%GOBP%GO:0005998,0.981405233098685,0.993436724391485,0.50904278782532,0.678739870967684,7388,1,XYLB
NEUTROPHIL HOMEOSTASIS%GOBP%GO:0001780,0.32757492474807004,0.6947961486619849,-0.514875271733807,-1.1271695980944498,2502,4,PDE4B|ANXA1
SPERMINE ACETYLATION%GOBP%GO:0032919,0.07130434782608701,0.3767214120425879,-0.9628914865460959,-1.2828026639600199,532,1,SAT2
ENGULFMENT OF TARGET BY AUTOPHAGOSOME%GOBP%GO:0061736,0.766822742474917,0.9202428578352959,-0.62097485663873,-0.827287613898975,5731,1,SMURF1
REGULATION OF INSULIN SECRETION%GOBP%GO:0050796,0.0875652284586993,0.40905715364188894,-0.21753119323245398,-1.33506812001498,687,86,ITPR2|PIM3|STX4|STXBP4|GIPR|ITPR3|SLC2A1|SLC8B1|CDK16|SYT7|ADCY8|SLC25A6|IRS1|ENSA|GHRL|RAPGEF3|UQCC2|DPP4|LRP5|GPER1|CACNA1E|RAP1A|NOV|CHGA|ADRA2C|NR1D1|ARL2|SLC25A4|SIRT4|EFNA5|BAD|SLC25A5
REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905664,0.39219576719576704,0.737280445732591,-0.547986319274092,-1.07007839498062,2964,3,PRNP
SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION%GOBP%GO:0000768,0.441377497371188,0.7653693162885199,-0.36899511707776705,-1.00863169742972,3357,7,ADAM12|TCTA|CACNA1H|PGK1
POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0010750,0.9553883364686909,0.9872823062684392,0.29431155484064503,0.578876097323068,7109,3,EGFR|NOS1AP
POSITIVE REGULATION OF CELL-CELL ADHESION%GOBP%GO:0022409,0.000513347022587269,0.0139121625154964,-0.257587784795357,-1.79432044611956,3,153,PTPN11|PRKCQ|MALT1|SIRPB1|RHOA|FYN|TRAF6|BLM|ETS1|RARA|GRAP2|HSPH1|IL1B|AKT1|FOXP3|CD1D|HLA-DMB|CDC42|PAK2|TNF|JAK3|SYK|RAC1|CD274|PPAP2B|NFKBIZ|CD44|HLA-DPA1|LILRB1|HLA-E|LYN|CD209|PYCARD|NCKAP1L|TNFRSF14|IL18|ADAM8|RUNX1|CCL19|RUNX3|CCDC88B|HLA-DPB1|PDCD1LG2|VAV1|GATA3|EBI3|THY1|IL6ST|PIEZO1|LILRB2|GRB2|SOCS1|GCNT2|PTPN6|CD47|IRAK1|IGF1|DPP4|NKAP|ICOSLG|VCAM1|C10orf54|CCL2|PDPN|CD86|NLRP3|TGFBR2|LGALS9|ZP3|FADD|AIF1|ADAM19|CX3CL1|CAV1|RELA|BCL6|LILRB4|PNP|ANXA1|CD55|NCK1|TFRC|SART1|SERPINF2|SIRPA
NEGATIVE REGULATION OF INTERLEUKIN-8 BIOSYNTHETIC PROCESS%GOBP%GO:0045415,0.717989417989418,0.900060477413567,-0.40961916801066495,-0.799882417573474,5427,3,KLF4|BCL3
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION%GOBP%GO:0098909,0.9862902131125291,0.995342833054128,0.193719236683202,0.50125991081648,7265,6,RANGRF|CAMK2D|AKAP9
TYPE 2 IMMUNE RESPONSE%GOBP%GO:0042092,0.0630807485931161,0.36006266503904,-0.678641409118944,-1.4856879061038601,481,4,IL18|BATF|BCL6
HELPER T CELL EXTRAVASATION%GOBP%GO:0035684,0.19357859531772603,0.567519363754568,-0.901411557123952,-1.2008966357681101,1446,1,CCL2
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1990441,0.12815070310427198,0.48509801008225,-0.780093738439631,-1.29820072713156,965,2,NCK1
ASSEMBLY OF ACTOMYOSIN APPARATUS INVOLVED IN CYTOKINESIS%GOBP%GO:0000912,0.789294932753702,0.9280333261332429,0.33929247024664605,0.745440006797087,5809,4,RTKN|PDCD6IP
REGULATION OF PHOSPHATIDYLCHOLINE CATABOLIC PROCESS%GOBP%GO:0010899,0.27314814814814803,0.647246599153167,-0.60308975414764,-1.17768143738051,2064,3,APOC1|LDLR
MITOTIC CYTOKINESIS CHECKPOINT%GOBP%GO:0044878,0.6007793603869929,0.846622446168226,0.44942985823439097,0.883975494934439,4470,3,ZFYVE19|AURKB
IRIS MORPHOGENESIS%GOBP%GO:0061072,0.154867844335237,0.523022297381039,0.9251213056903399,1.23352443187779,1165,1,WNT2B
NEURON PROJECTION EXTENSION%GOBP%GO:1990138,0.512382690302398,0.802184867798321,-0.206454434415031,-0.9603446440197528,3930,32,NRP2|SLIT2|TMEM108|MAP1B|SEMA3A|HSP90AA1
CELLULAR RESPONSE TO LIGHT STIMULUS%GOBP%GO:0071482,0.197090628218332,0.573842808355097,-0.20109738859641801,-1.19334635162172,1530,76,AQP1|CUL4B|HYAL2|TRIAP1|KDM1A|IMPACT|YY1|PARP1|MFAP4|NDNL2|HYAL3|NPM1|PCNA|FMR1|DHX36|POLD1|RHNO1|CARD16|CRY2|USP47|HYAL1|HIST3H2A|EIF2S1|MYC|DDB1|MAPK13|POLA1|CRIP1|XPA
REGULATION OF MITOCHONDRION ORGANIZATION%GOBP%GO:0010821,0.7182178978363851,0.900080821429213,-0.12628175492920402,-0.8692991669014959,5609,144,FIS1|PYCARD|APOPT1|TRIAP1|TFDP2|SREBF2|BCL2L11|GZMB|PID1|PPIF|KDR|MICALL2|HGF|ATG13|OPA1|ATPIF1|PDCD5|GPX1|NMT1|PRELID1|DCN|PPP1R13B|TNFSF10|PARK7|HAX1|PDE2A|CAMKK2|HUWE1|IGF1|E2F1|GPER1|CIDEB|PSMD10|PLAUR|FXN|MMP9|STOML2|MPV17L|PARL|RHOU|SQSTM1|BAD|SLC25A5
POSITIVE REGULATION OF PROTEIN KINASE C ACTIVITY%GOBP%GO:1900020,0.745502645502646,0.91143284454225,-0.39955214921788396,-0.7802240813465992,5635,3,CEMIP|C8orf4
SUPPRESSION BY VIRUS OF HOST CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0039650,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
RECYCLING ENDOSOME TO GOLGI TRANSPORT%GOBP%GO:0071955,0.0285369774919614,0.238789399313666,0.891425420457679,1.4977098029638503,212,2,TBC1D14|GCC2
REGULATION OF CARDIOLIPIN METABOLIC PROCESS%GOBP%GO:1900208,0.0976588628762542,0.430598623028127,-0.948886193206881,-1.26414425036294,729,1,STOML2
EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0060664,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
REGULATION OF DOUBLE-STRANDED TELOMERIC DNA BINDING%GOBP%GO:1905767,0.8753177257525079,0.9605179470041941,-0.5650088222320251,-0.752727417831895,6542,1,ERCC4
INTERFERON-GAMMA PRODUCTION%GOBP%GO:0032609,0.5785772247768461,0.8380842665555279,0.32142667411009496,0.887289706284656,4277,7,BTN3A1|TRIM27|BTN3A2
NEGATIVE REGULATION OF INTERLEUKIN-23 PRODUCTION%GOBP%GO:0032707,0.28946670204298197,0.6622817015650171,-0.6886131789357599,-1.1459624472757601,2181,2,RAC1|TLR4
MIDGUT DEVELOPMENT%GOBP%GO:0007494,0.33520900321543395,0.6982881520550831,0.6664244858213221,1.11967918172816,2501,2,RET
"TRANSPOSITION, DNA-MEDIATED%GOBP%GO:0006313",0.41881028938906795,0.75036705317022,0.628618693134822,1.05616056871136,3125,2,THAP9|PGBD5
POSITIVE REGULATION OF TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE%GOBP%GO:0002654,0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043534,0.0291376821105132,0.242000578451459,-0.3994185222331239,-1.6272339355265,221,21,ADTRP|AKT1|ROBO1|GREM1|NR4A1|SOX18|KDR|PIK3R3|SRF|SLIT2|ID1|MYH9|EPHB4|EMP2
EPIBOLY INVOLVED IN GASTRULATION WITH MOUTH FORMING SECOND%GOBP%GO:0055113,0.467127108513747,0.780769690730001,0.7678650198500219,1.02384439374956,3516,1,MEGF8
OTIC VESICLE MORPHOGENESIS%GOBP%GO:0071600,0.0655737704918033,0.367999733349629,0.7478217712584101,1.47087717529026,487,3,FGFR2|CEP290|PROX1
ACTIVATION OF PROTEIN KINASE ACTIVITY%GOBP%GO:0032147,0.0566351316798773,0.34436604181231795,-0.17909919648875103,-1.32074595412646,442,206,GAS6|PKN1|INS|STRADA|MDFIC|TRAF2|FPR1|TAOK2|ADCY8|CXCR4|MAPKAPK2|PRKAR1A|MLKL|PARK7|PIK3CB|SLC11A1|FGF10|MAPK3|GHRL|ABL1|SOD1|IRAK1|IGF1|MAP3K13|GADD45B|STK3|MAP2K3|F2R|MUC20|GADD45G|TGFBR2|BMP2|THBS1|MAP3K11|ZFP91|ADRA2C|PEA15|UBC|ANG|PRKACA|TLR4|MARK2|GNG3|MAPKAP1|DBNL|CD81|PDGFB|C5AR1|ERN1|CARD10|EMP2|PRNP
NEGATIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0033048,0.703394255874674,0.8937327199279169,-0.196235752313064,-0.8239118010280551,5387,23,ATRX|MAD1L1|ZNF207|TRIP13|KLHL22|APC|CDC20|NAA10|PTTG1|MAD2L1|PLK1|IK
REGULATION OF PROTEIN SECRETION%GOBP%GO:0050708,0.000128600823045268,0.00518555396908895,-0.24230089815492303,-1.80967765184946,0,223,LILRB1|HLA-E|RGCC|INHBB|ADAM9|HYAL2|LGR4|DHX9|TLR1|PYCARD|TNFRSF14|GSDMD|DISP1|PER2|ADAM8|CCL19|REST|RHBDF2|ACHE|ITPR2|PIM3|STX4|TLR2|STXBP4|PPIA|FGR|CD34|WLS|GIPR|ITPR3|SLC2A1|SLC8B1|GPI|CDK16|SSC5D|GATA3|SYT7|DNAJC1|FCGR2B|MYOM1|GAS6|TGFB3|INS|CASP1|TNFAIP3|DHX36|ADCY8|SLC25A6|PTGER4|IRS1|IFIH1|ENSA|OSM|CARD16|GHRL|RSAD2|SRGN|RAPGEF3|TNFRSF4|UQCC2|IGF1|DPP4|FCN1|NR1H3|LRP5|IL33|GPER1|CACNA1E|F2R|RAP1A|FN1|GAPDH|NLRP3|NOV|CHGA|TNFRSF21|CD200|LGALS9|ADRA2C|NR1D1|ARL2|FOXP1|SLC25A4|CX3CL1|SIRT4|HAVCR2|ANG|TLR4|SERGEF|RAB11FIP1|CSF1R|C1QTNF4|ANXA1|TMSB4X|CD14|TNFRSF1B|EFNA5|BAD|SLC25A5
BLOOD CIRCULATION%GOBP%GO:0008015,0.000128982329420869,0.00518555396908895,-0.284205715802112,-2.0072247750683303,0,165,ADM|C2CD4A|PER2|EDNRA|PIK3C2A|C2CD4B|AGT|RYR2|PCSK5|ATP1B1|KLK1|P2RX4|PLCB3|CD34|PLN|GAA|TNNI2|SOD2|PRCP|AZU1|KCNN2|GAS6|GPX1|INS|MYLK2|DOCK5|SGK1|PDE4D|POMC|OLR1|NPR2|ELN|TBXA2R|PKP2|ATP6AP2|PTGS1|PDE2A|CACNA1G|HOXB2|HMOX1|SOD1|LRP5|MEOX2|CTSZ|CEACAM1|GPER1|NPR1|F2R|EDNRB|KCNQ1|SMTNL1|NOS3|CHGA|TEK|COL1A2|SLIT2|CAV1|SCN1B|C3AR1|PPARG|KCNH2|KCNE4|ADRBK1|MYOF|SERPING1|ACVRL1|PDGFB|SERPINF2|PTPRJ|RENBP|EMP2|RCAN1
POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS%GOBP%GO:2000646,0.289229158487109,0.662218930390028,-0.533674988165111,-1.1683261072093798,2209,4,PTPN1|DTX3L|APOE
REGULATION OF INFLAMMATORY RESPONSE%GOBP%GO:0050727,0.000128008192524322,0.00518555396908895,-0.429408614281719,-3.1576505328904503,0,202,BRD4|DNASE1L3|HLA-E|SBNO2|HYAL2|C4B|DHX9|NDFIP1|PYCARD|TNFAIP8L2|APOD|F12|C2CD4A|IL18|ADAM8|SLAMF8|C2CD4B|AGT|ITGB2|IGHG4|KLF4|IL17D|SNX4|PIK3AP1|SIGLEC10|TLR2|RORA|TNFAIP6|NR1D2|PLA2G2A|C4A|GATA3|TNFRSF11A|FCGR2B|C2|GGT1|INS|CCL3L3|FEM1A|IL6ST|IGKV2-28|VTN|CCL18|C3|TNFAIP3|PTGER4|CEBPA|C1QB|CD47|PARK7|PDE2A|PLA2G7|OSM|BST1|GHRL|VAMP8|NR1H3|VAMP7|TNIP1|IL15|SNX6|C1QA|SEMA7A|CFB|GPRC5B|C1QC|CDH5|C7|IL33|GPER1|APOE|IGKV2D-28|NLRP3|NFKBIA|NOV|HCK|A2M|CD200|ZP3|TEK|XIAP|SUSD4|FOXP1|CD59|TICAM1|MMP9|CX3CL1|SERPINE1|USP18|LDLR|C3AR1|PPARA|CCL14|RELA|MAPK13|ABCD1|BCL6|TLR4|S100A8|CFP|MGLL|C1S|ITGAM|S100A9|CFI|ANXA1|OSMR|CD55|GSTP1|TNFRSF1A|PHB|TMSB4X|METRNL|PSMA6|IGHG2|SERPING1|CD81|CHID1|C1R|TNFRSF1B|CFH|C5AR1|SIRPA|PTGIS
MELANOCYTE DIFFERENTIATION%GOBP%GO:0030318,0.815573770491803,0.9367954787844879,0.24517070232001503,0.711687657188088,5969,8,CITED1|KIT|MREG
COPPER ION IMPORT%GOBP%GO:0015677,0.14631164243988598,0.513872620660976,0.6102880139463169,1.3408287573656201,1076,4,ATP7B|STEAP3|ATP7A
INOSITOL PHOSPHATE METABOLIC PROCESS%GOBP%GO:0043647,0.183456183456183,0.556308895147568,0.23902140509956,1.23123056400346,1343,43,PLCD1|PLCD4|INPP1|INPP5K|INPP5J|FGF2|PLCD3|IMPA1|PLCB4|INPP4A|INPPL1|PLCG1|ITPKC|ISYNA1
REPLICATION-BORN DOUBLE-STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE%GOBP%GO:1990414,0.494444444444445,0.7929977188111991,-0.5050181978603729,-0.9861725440852339,3737,3,RECQL5|NIPBL|XRCC1
PERISTALSIS%GOBP%GO:0030432,0.0383849116748572,0.27954816281763895,0.980480811645346,1.30733886325253,288,1,DRD2
REGULATION OF IMMUNE COMPLEX CLEARANCE BY MONOCYTES AND MACROPHAGES%GOBP%GO:0090264,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:0033262,0.652588912133891,0.873547120421062,-0.26821867931814397,-0.8402941089179828,4990,10,TIPIN|CHEK2|TERF1|WIZ|DBF4B|ATRX|CDC7|INO80|TERF2|BCL6
NEGATIVE REGULATION OF HYDROGEN PEROXIDE-INDUCED NEURON DEATH%GOBP%GO:1903208,0.812197356366968,0.935317461845028,-0.329852382445294,-0.7221158167090641,6205,4,GNB2L1|PARK7
PLASMA MEMBRANE REPAIR%GOBP%GO:0001778,0.0714566156262269,0.3767214120425879,-0.670052712660285,-1.46688545419572,545,4,SYT7|MYOF|AHNAK2
OXIDATIVE PHOSPHORYLATION%GOBP%GO:0006119,0.000128139415684264,0.00518555396908895,-0.38882019293183295,-2.42118960686883,0,92,CHCHD10|ATP5C1|COX7C|CYC1|NDUFC2|NDUFV2|NDUFB8|SDHC|NDUFS4|UQCRC1|NDUFB5|SURF1|UQCR10|NDUFA9|ATP5J|NDUFA7|ATP5F1|NDUFA3|NDUFB6|ATP5B|SDHD|CYCS|NDUFB9|COA6|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|NDUFS6|COQ7|NDUFB4|NDUFA12|SDHAF2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|NDUFS3|UQCRC2|COX6A1|UQCC3|NDUFA8|NDUFS8|NDUFV3
HYALURONAN METABOLIC PROCESS%GOBP%GO:0030212,0.0759675732217573,0.38532893725130896,-0.37533307836838997,-1.4564319341808998,580,18,CD44|TGFB1|CEMIP|HYAL2|TMEM2|HYAL3|SLC9A1|HYAL1|LYVE1|HEXB
T CELL HOMEOSTASIS%GOBP%GO:0043029,0.41089108910891103,0.745437377934693,-0.341638310971974,-1.02773166304789,3153,9,AKT1|FOXP3|JAK3|NCKAP1L|RIPK3|FADD
RESPONSE TO WOUNDING%GOBP%GO:0009611,0.00012781186094069498,0.00518555396908895,-0.26904847234052104,-2.10961184894898,0,293,RAD51C|CD34|TOR1A|ADORA3|ITPR3|RAP2B|VAV1|GATA3|WAS|TLN1|SYT7|PRCP|GP1BA|P2RX5|PLEK|GP1BB|P2RX3|GAS6|INS|AKAP1|ILK|PLSCR1|ITGA5|VWF|INHBA|PRKAR1A|DOCK6|PTPN6|SH2B3|ARRB1|FCER1G|F3|DGKE|EHD1|CTGF|PIK3CB|SLC11A1|F8|FGF10|MAPK3|HMOX1|HSPB1|SOD1|DDR1|FLNA|IGF1|MYL12A|RAD51B|DOCK1|GNAQ|CEACAM1|HIST2H3A|DHFR|THBD|PDPN|F2R|CORO1B|CCR1|FN1|PLAUR|GATA6|GNA15|NOV|CD36|TNC|ADIPOR2|SERPINE2|CD151|A2M|F2RL3|F13A1|FGF7|COL1A2|COL1A1|VCL|SRF|ITPK1|COL3A1|CD59|LYVE1|PLAT|MYH9|HIST2H3C|FIBP|RTN4RL1|PRKACA|FERMT3|HIST1H3H|PDGFA|ACTB|PDGFRA|MYOF|ANXA1|COL5A1|TFPI|H3F3B|ACTN1|CPQ|SERPING1|MYL9|EHD2|ACVRL1|VKORC1|PDGFB|AHNAK2|FBLN1|ITGB4|PRKCB
REGULATION OF MYOSIN-LIGHT-CHAIN-PHOSPHATASE ACTIVITY%GOBP%GO:0035507,0.589905362776025,0.8414799095069009,-0.32419520761646003,-0.8861731427406841,4487,7,ROCK1|TNF|NCKAP1L|NUAK1
NEGATIVE REGULATION OF COLLAGEN CATABOLIC PROCESS%GOBP%GO:0010711,0.00882943143812709,0.117827730899938,-0.995644022937803,-1.32643690678155,65,1,CST3
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:1901796,0.851273518494816,0.949296218452153,-0.11982157423704902,-0.781907385904446,6650,111,SETD8|TPX2|DYRK1A|HEXIM1|TAF12|SUPT16H|PLA2R1|PPP1R13B|NUAK1|PHF20|DDX5|SNAI2|TAF7|HIC1|TAF9B|PSMD10|SNAI1|TAF10|TAF9|BOP1|ZNF385A|PRMT5|SSRP1|AK6
IMMUNE SYSTEM DEVELOPMENT%GOBP%GO:0002520,0.00012761613067891798,0.00518555396908895,-0.22744919633052102,-1.7678122709678603,0,277,FST|DOCK11|ITGB1|GLO1|NOTCH4|ACIN1|TGFB1|DOCK10|UBD|LILRB1|HLA-E|SBNO2|LYN|GPR183|PIR|CEBPG|NCKAP1L|CD74|FNIP1|KAT6A|MT1G|JAG1|RUNX1|RIPK3|TNFSF8|CCL19|SLAMF8|HMGB2|EPHB3|TBX1|BATF|ZFP36L1|RUNX3|DYRK3|CD4|EXO1|KLF4|SBDS|KDR|TLR2|PARP1|HCLS1|CD34|RORA|MED1|SFRP2|SPN|TNFRSF11A|CBFA2T3|ATPIF1|PLEK|FCGR2B|GAS6|PLA2G2D|TCTA|HES1|TNFAIP3|OSCAR|MELK|INHBA|RPS14|PTGER4|MEF2C|CEBPA|STAT3|HSPA9|TAL1|NFAM1|RNF168|FCER1G|CDKN2B|POLQ|NOTCH2|FGF10|PLD4|RSAD2|SOD1|KLF6|GLRX5|TREM2|LRP5|IFI16|HDAC5|VCAM1|LRRC8A|BATF2|KIRREL3|CSF1|JAG2|PDPN|MEOX1|EPHA2|PDE1B|MFAP5|AXL|TGFBR2|TGFBR3|LGALS9|TEK|FADD|RELB|EXOSC3|FOXP1|MMP9|TYROBP|IL11|FLT3LG|LTBR|PPARG|MYH9|HAVCR2|KAT8|ANXA2|CSF1R|RRAS|ANXA1|ZNF385A|ACTN1|SAMHD1|PDGFB|SNX10|PTPRJ
VITAMIN D BIOSYNTHETIC PROCESS%GOBP%GO:0042368,0.0358613361668216,0.268987198588135,0.9820247022496691,1.30939743305183,269,1,CYP27B1
MHC CLASS II BIOSYNTHETIC PROCESS%GOBP%GO:0045342,0.256588628762542,0.634929462604421,-0.868052492280547,-1.1564543514128502,1917,1,SLC11A1
NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS%GOBP%GO:0062014,0.0144255538382277,0.16079417073357402,-0.310516782170752,-1.6760355517122,111,53,PGP|REST|PID1|PPIF|PARP1|APOC1|CBFA2T3|PLEK|INS|PDE12|CLTC|BRCA1|SNAI2|SOD1|CDA|CEACAM1|APOE|FGF19|BMP2|SNAI1|SIRT4|PPARA|SIK1|NFKB1
POSITIVE REGULATION OF INTERLEUKIN-5 PRODUCTION%GOBP%GO:0032754,0.202591283863369,0.5810727835229039,-0.579034125850189,-1.2676267413653601,1547,4,RARA|GATA3|PDE4D
CRANIAL SKELETAL SYSTEM DEVELOPMENT%GOBP%GO:1904888,0.22331240188382998,0.606473710658924,-0.32528245748586604,-1.20887556377075,1706,16,NDST1|FREM1|TGFBR2|EIF4A3|PDGFRA|MTHFD1
PYROPTOSIS%GOBP%GO:0070269,0.616982124079916,0.8544774173680791,-0.31666558708935805,-0.865591260808485,4693,7,DHX9|GSDMD|APIP
COVALENT CHROMATIN MODIFICATION%GOBP%GO:0016569,0.0342492012779553,0.264364643644243,-0.17742780242473602,-1.35911666254879,267,256,NAA40|SETD1B|USP16|KAT6A|KANSL1|PER2|SETMAR|REST|DTX3L|KANSL2|HR|JADE3|UBE2B|KDM1A|EZH2|BCOR|KDM3B|GSG2|KDM8|NSD1|YEATS4|TAF6L|BRPF3|RUVBL1|PAXIP1|KDM2A|HCFC1|OGT|HLCS|TAF12|BRCC3|PKN1|MORF4L2|MSL2|USP51|BRMS1L|PHF20|RNF168|NAA50|C14orf169|UHRF1|CTR9|JMJD6|HUWE1|RNF20|SKP1|HDAC5|MIER3|WDR5|KAT7|TAF9B|KDM5C|SPI1|MBIP|RBM14|PRMT3|BRMS1|KAT2B|RING1|RNF40|HDAC8|MYSM1|APBB1|TAF10|DDB1|PAGR1|MTA2|RPS6KA4|KAT8|KAT5|TAF9|POLE3|VRK1|HIST1H1C|PRMT5|PHB|CCDC101|AK6|PRKCB|NTMT1|SUV39H1
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ATRIAL NATRIURETIC PEPTIDE%GOBP%GO:0003050,0.589985389826006,0.8414799095069009,0.7028561976179971,0.9371639011292321,4441,1,RASL10B
PEROXISOMAL TRANSPORT%GOBP%GO:0043574,0.46887508626639096,0.780769690730001,0.17490376597156498,0.993067357716797,3396,61,IDH1|PEX7|RPS27A|MPV17|NUDT7|GSTK1|PEX2|PEX5|PEX13|PIPOX|GNPAT|ACOX2|PEX1|HMGCL|ACOX3|EHHADH|PEX10|ACOT8|PHYH|ZFAND6|ECH1|HACL1|PAOX|PEX19|UBA52|PECR|PEX5L|SLC27A2|UBE2D3|PEX12
PROTEIN N-LINKED GLYCOSYLATION%GOBP%GO:0006487,0.0758611792026835,0.38531099082072706,-0.24513835495016395,-1.38626015818578,587,63,RPN2|VCP|UBE2G2|KRTCAP2|MGAT1|DAD1|B4GALT7|B3GALT2|SYVN1|GFPT2|B4GALT1|SRD5A3|DERL3|DOLK|ALG6|MAGT1|DOLPP1|B3GALT1|RPN1
SYNAPSE ORGANIZATION%GOBP%GO:0050808,0.6770002572678161,0.8836483435332951,-0.13487831567716,-0.8842989108626379,5262,114,SPOCK2|PLXND1|NRD1|PCDHB6|PCDHB11|PCDHB13|CTNND2|RAB29|NPAS4|ARHGAP44|DSCAM|PCDHB2|ARF1|CAST|KIRREL3|PCDHB16|F2R|APOE|SEMA3E|TMEM108|CX3CL1|ITGAM|ACTB|NRXN2|LGMN|SYNPO|GPHN|DBNL|DNM3|PRNP
DIVALENT INORGANIC CATION HOMEOSTASIS%GOBP%GO:0072507,0.00767067246228586,0.106864945035751,-0.20092638320492104,-1.51720240060459,59,236,MT1G|OCM|EDNRA|CCL19|HSP90B1|FPR3|LPAR6|RYR2|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|ERO1L|PTGER1|PLN|ITPR3|SLC8B1|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ADCY8|CXCR4|JPH4|CALB2|TAC1|CALCB|RMDN3|SEPN1|PTGER4|TBXA2R|SLC11A1|GHRL|ABL1|CALR|HERPUD1|SLC35G1|MT1M|CCRL2|P2RY6|GPER1|SLC24A3|TPCN2|F2R|CCR1|APLNR|GNA15|TMCO1|CD36|F2RL3|GRIN2C|MT2A|TGM2|GRIN2D|BCAP31|CX3CL1|SLC30A5|CAV1|C3AR1|STOML2|CHRNA10|GPR4|CCL14|PRKACA|S100A8|S100A9|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|FAM20A|C5AR1|C1QTNF1
OXALIC ACID SECRETION%GOBP%GO:0046724,0.480674724398991,0.7857006060206241,0.760200705778562,1.01362506510306,3618,1,SLC26A6
REGULATION OF ACTIN FILAMENT SEVERING%GOBP%GO:1903918,0.094448160535117,0.424465668011418,-0.950319805910896,-1.2660541667154,705,1,MYH9
PH ELEVATION%GOBP%GO:0045852,0.427707605482397,0.7559515106076821,0.52486604984283,1.03234958177195,3182,3,BCL2|SLC26A6|CLN3
RESPONSE TO INTERLEUKIN-13%GOBP%GO:0035962,0.6683470416556121,0.8811119744196031,-0.531030535599466,-0.88371972940485,5037,2,CD300LF
V(D)J RECOMBINATION%GOBP%GO:0033151,0.466939890710383,0.7806653415096191,0.337382263448316,0.9793616870948,3417,8,TCF3|VPRBP|LIG4|HMGB1|LIG3|LIG1
REGULATION OF REMOVAL OF SUPEROXIDE RADICALS%GOBP%GO:2000121,0.5813617245005259,0.8387093286508721,-0.32642803808569604,-0.8922764852566869,4422,7,TNF|FBLN5|PARK7|DHFR
SNRNA IMPORT INTO NUCLEUS%GOBP%GO:0061015,0.217658862876254,0.6000568371428749,-0.888178209086899,-1.1832666386685,1626,1,RAN
TELENCEPHALON DEVELOPMENT%GOBP%GO:0021537,0.523645388115263,0.807607680441131,0.161353930077357,0.9617137347369421,3797,73,EFHC1|SCN5A|DRD2|BBS4|FAT4|SLIT1|EPHB2|RTN4|TACC2|LAMB1|ROBO2|SLIT3|MBOAT7|PEX13|MKKS|NF1
NCRNA EXPORT FROM NUCLEUS%GOBP%GO:0097064,0.51029181865555,0.800685168996958,-0.315418594566664,-0.9488563382366669,3916,9,NCBP2|PHAX|NPM1|RAN
NEGATIVE REGULATION OF I-KAPPAB KINASE/NF-KAPPAB SIGNALING%GOBP%GO:0043124,0.55238718116416,0.822813841873357,-0.20409544298176102,-0.9318598354985759,4222,30,ZC3H12A|C9orf89|TLE1|PPM1A|OTUD7B|TRIM59|PYCARD|DAB2IP|RORA|TNFAIP3|CCDC22|TNIP1|GSTP1|NLRX1|SIRPA
ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS%GOBP%GO:1901361,0.0253923695291566,0.22409063601871598,-0.163188542354713,-1.33568573497563,198,386,NUDT17|GPX1|HK1|RPLP2|ADA|VCP|KYNU|NUDT1|HK3|MAGOH|PDE12|PDE4D|PDXP|RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|PATL1|NUDT16|APOBEC3G|RPL10|DDX5|PDE2A|RPL36A|SMPDL3A|RPL24|HAAO|ENO1|PELO|SPP1|HMOX1|TYMP|APOBEC3C|PGAM1|HPRT1|FTCD|STS|CDA|LSM3|CYP46A1|SCARF1|APOE|NT5C3B|RPL35|GAPDH|RNASE6|IL4I1|PPP2CA|RPL38|RPS15A|NUDT18|NUDT4|MAGOHB|EIF4A3|LDHA|EXOSC3|ALDH4A1|AFMID|RPS13|RBM8A|TNKS1BP1|POLR2G|ENPP4|ABCD1|HINT1|TUT1|PNP|RNH1|HNMT|PGK1|SKIV2L2|MUS81|SAMHD1|ASRGL1|EXOSC2|ENDOG|QPRT|HSD17B14|BLVRB|DNASE1L1|ERN1|ALDOA|FEN1|ALDOC|EIF4G1|RNASEH2C
REGULATION OF CD40 SIGNALING PATHWAY%GOBP%GO:2000348,0.0638888888888889,0.36210263137881205,-0.7487081982969291,-1.46203735196112,482,3,TNFAIP3|TREM2
NEGATIVE REGULATION OF OLIGODENDROCYTE APOPTOTIC PROCESS%GOBP%GO:1900142,0.36428093645485,0.718457761443038,-0.8158359064843409,-1.08688932119066,2722,1,GAS6
FATTY-ACYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0046949,0.5593994778067889,0.8268422944617521,-0.219050836070903,-0.9197027898155551,4284,23,PPT1|SCD5|ACSL5|ACSL4|ELOVL2|ACSF3|ELOVL1|HACD2|FASN
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE%GOBP%GO:1900102,0.48679393305439295,0.78790014907289,-0.308115506300983,-0.9652856597056679,3722,10,HSPA5|NCK1
OOCYTE CONSTRUCTION%GOBP%GO:0007308,0.77123745819398,0.9213545359508709,-0.6190449933833261,-0.824716572655282,5764,1,PLD6
INTERMEDIATE FILAMENT CYTOSKELETON ORGANIZATION%GOBP%GO:0045104,0.166951043444022,0.53917243184018,-0.315440643232669,-1.2851074518094598,1271,21,TOR1A|KLHL24|ERBB2IP|KRT9|KRT18|PKP2|SOD1|SYNM|CSNK1A1
PROTEIN LOCALIZATION TO CILIUM%GOBP%GO:0061512,0.0305623471882641,0.247447840028175,0.3540258898301621,1.60391077184219,224,28,TTC21B|WDR35|TTC21A|BBS4|BBIP1|ARL3|IFT20|IFT140|TMEM107
HISTIDINE METABOLIC PROCESS%GOBP%GO:0006547,0.131481481481482,0.490819490032838,-0.6877136869968019,-1.34293053038731,993,3,C9orf41|FTCD|HNMT
INTERMEDIATE FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0045110,0.848187410024866,0.9492491301138911,-0.31682533520558304,-0.6935968871592041,6480,4,NEFM|PKP2
L-XYLITOL METABOLIC PROCESS%GOBP%GO:0051164,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
POSITIVE REGULATION OF PROTEIN GLYCOSYLATION IN GOLGI%GOBP%GO:0090284,0.20228449993359,0.5809978500520611,0.9005293339214822,1.20073435578902,1522,1,ARFGEF1
ANDROGEN METABOLIC PROCESS%GOBP%GO:0008209,0.144398907103825,0.510871672836242,0.462205751852222,1.3417024365546002,1056,8,HSD17B3|SRD5A1|HSD17B11|HSD17B6
DEVELOPMENTAL PIGMENTATION%GOBP%GO:0048066,0.7830380089273641,0.926798202062739,0.190351676754793,0.7589100348575991,5788,19,CITED1|KIT|BLOC1S3|AP1M1|MREG|BLOC1S5|HPS6|ZEB2|AP1G1|LEF1|BLOC1S6|AP3D1
ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060839,0.34406275358398697,0.702174649119653,0.39665724295697996,1.09496167227997,2543,7,ACVR1|DLL1|NRP1|PROX1
PROTEIN K63-LINKED DEUBIQUITINATION%GOBP%GO:0070536,0.901617954070981,0.9684180373391851,-0.15007191414062301,-0.6546410953858439,6909,26,USP13|OTUD7B|USP27X|UIMC1|USP16|USP25|BRCC3|TNFAIP3|OTUD5|USP20|SHMT2
EVASION OR TOLERANCE OF DEFENSE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051807,0.605525302164962,0.8484731812466321,0.694861049845611,0.92650345038288,4558,1,EIF2AK2
TREHALOSE METABOLIC PROCESS%GOBP%GO:0005991,0.62433011789925,0.857753590658582,0.538737248414668,0.9051481365184221,4659,2,ATHL1|BRAF
MEGAKARYOCYTE DIFFERENTIATION%GOBP%GO:0030219,0.0998948475289169,0.43605057892447596,-0.5242366664792519,-1.43297754982061,759,7,MED1|TAL1|CDKN2B|IL11|ZNF385A
INTERSPECIES INTERACTION BETWEEN ORGANISMS%GOBP%GO:0044419,0.00370086778968862,0.0650445779820117,-0.197308655610748,-1.5335497692855302,28,277,CDC42|PAK2|NUP205|VPS37B|AP1S2|SERPINB9|CCL4|NUP93|RAC1|DOCK2|NUP210|YTHDC2|BICD1|TGFB1|NFIA|AQP1|ATG7|PSIP1|HYAL2|DENR|DHX9|PTBP1|CD209|GSDMD|B2M|SMARCA4|ZNF639|REST|DEK|TSG101|AP2A2|CTNND1|PCSK5|RANBP1|CALCOCO2|CD4|RAB9A|RRAGA|PACS1|APOL1|PPIA|RAB7A|UBAP1|HCFC1|KPNB1|CCNK|AZU1|CAV2|EEA1|GAS6|VCP|RAB29|PPIB|PVRL2|FMR1|NUP188|SLC25A6|CLEC4M|CXCR4|ELMO1|GRB2|ICAM1|IFIT1|NUP85|SNW1|RCC1|NUCKS1|KPNA4|MVB12B|USF2|IRF7|ROMO1|VAMP8|NUP37|HMGN2|ARF1|RAN|EIF3B|TNIP1|CCL2|NUP160|KPNA2|APOE|FN1|THOC7|GAPDH|AXL|AP1B1|HCK|NUP214|CHMP4A|RAB1B|CHMP6|MCTS1|UBC|PABPN1|RRP1B|CAV1|HCFC2|DDB1|CFL1|S100A9|ANXA2|ADRBK1|NUP98|THOC3|VPS37C|CD81|HIST1H2BK|BANF1|AP2M1|EIF2D|HIST1H2BJ|PSMC3
NEGATIVE REGULATION OF INTEGRIN BIOSYNTHETIC PROCESS%GOBP%GO:0045720,0.0935051135608979,0.42298229600710996,0.954234671371857,1.2723431766645101,703,1,TMEFF2
NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION%GOBP%GO:0032815,0.6260718113611999,0.858842084733938,0.5378157538477,0.9035999066669379,4672,2,PIBF1
REGULATION OF TYPE II HYPERSENSITIVITY%GOBP%GO:0002892,0.23879013000795998,0.622138010410922,-0.7134822167080229,-1.18734850298696,1799,2,HLA-E|FCGR2B
10-FORMYLTETRAHYDROFOLATE METABOLIC PROCESS%GOBP%GO:0009256,0.351950119395065,0.7106060713647829,-0.660872683989396,-1.09979782764634,2652,2,MTHFD1
CALCINEURIN-MEDIATED SIGNALING%GOBP%GO:0097720,0.8834162955200421,0.9630871746499521,-0.20347083701294003,-0.658747781967483,6743,11,ADGRB2|PPP3CA|NFATC3|SULT1A3|NFATC4|NFATC2|NFATC1
REGULATION OF ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098910,0.0937966607845799,0.42337598780415003,0.5609202432902951,1.45141409774733,690,6,TRPM4|ANK2|RNF207
RENIN SECRETION INTO BLOOD STREAM%GOBP%GO:0002001,0.479732441471572,0.785690196949452,-0.7630679311865899,-1.01658970775599,3585,1,PCSK5
METANEPHRIC DISTAL TUBULE DEVELOPMENT%GOBP%GO:0072235,0.0165278151034668,0.17512293405535098,0.834178890481968,1.6407314379924598,122,3,PAX8|PKD1|PKD2
REGULATION OF CD4 BIOSYNTHETIC PROCESS%GOBP%GO:0045223,0.5363262053393539,0.8132910857498922,0.730370533745037,0.973850555766675,4037,1,ACOT8
LEFT VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0003220,0.587954364552932,0.8414799095069009,-0.563661428177557,-0.9380227527268459,4431,2,SMAD4|RYR2
CELLULAR COPPER ION HOMEOSTASIS%GOBP%GO:0006878,0.0946652719665272,0.4245197858211911,-0.46231340454137293,-1.4483675458305503,723,10,CCDC22|ARF1|MT2A|ATOX1|PRNP
RENAL SYSTEM SEGMENTATION%GOBP%GO:0061150,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS%GOBP%GO:0060761,0.27242181442233104,0.6468211711323629,-0.23554592199306898,-1.1442693924899499,2107,37,CARD16|NR1H3|SLIT2|PPARG|GSTP1|PELI3|SAMHD1|RNF113A|HIST1H2BJ
PROTEIN-CARBOHYDRATE COMPLEX SUBUNIT ORGANIZATION%GOBP%GO:0071823,0.39917750066330604,0.739115199741709,-0.6401985111662529,-1.06539269801983,3008,2,HLA-DRB1|HLA-DRA
RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009201,0.0772615504076615,0.38915101469017105,-0.255345743715623,-1.39823526876287,596,56,ATP5J|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|CTPS1|PGAM1|GAPDH|LDHA|STOML2|ATP5H|PGK1|ALDOA|ALDOC|ATP5G1
CELLULAR RESPONSE TO SUPEROXIDE%GOBP%GO:0071451,0.0667718191377497,0.3690551432905871,-0.55263380604467,-1.51059986447032,507,7,PRDX2|SOD2|SOD3|SOD1|CCS|NOS3
TRIMMING OF TERMINAL MANNOSE ON B BRANCH%GOBP%GO:0036509,0.44198821007502703,0.7653693162885199,0.6189137027846711,1.03985493186108,3298,2,MAN1B1|EDEM2
REGULATION OF NEURAL CREST CELL DIFFERENTIATION%GOBP%GO:1905292,0.574206349206349,0.835204333784353,-0.46781100083876,-0.9135163184273442,4340,3,ENG
EXPLORATION BEHAVIOR%GOBP%GO:0035640,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
NEGATIVE REGULATION OF BEHAVIOR%GOBP%GO:0048521,0.6999083889543251,0.8930679216759608,-0.36812362872048204,-0.80589957493329,5347,4,INS|GHRL
REGULATION OF ER TO GOLGI VESICLE-MEDIATED TRANSPORT BY GTP HYDROLYSIS%GOBP%GO:0090113,0.225013150973172,0.6078034241178771,-0.514883508274757,-1.2340775205181,1710,5,SEC23B|PREB|SEC23A|SAR1B
RESPONSE TO PROSTAGLANDIN%GOBP%GO:0034694,0.974066530889342,0.9920058127185359,0.15283920518440197,0.535274761564859,7173,13,SFRP1|ADCY6|AKR1C2|GNB1|CCR7|CCL21|AKR1C3
PROTEIN-CONTAINING COMPLEX DISASSEMBLY%GOBP%GO:0032984,0.000640532923392262,0.0163600882996276,-0.232001268664411,-1.7163376904623702,4,210,MRPL53|CHCHD10|MRPS17|MRPL37|KIF24|AURKAIP1|GSPT2|VTI1B|MRPL18|MRPL57|GFM2|SYNJ1|APC|DENR|MRPS18B|MRPS15|MRPL47|SMARCA4|CCSAP|SET|GADD45GIP1|TSG101|MRPS11|MRPL13|DYRK3|ETF1|OXA1L|DSTN|DHX8|SMARCE1|MRPL10|MRPL50|MRRF|MRPL51|NAPA|FRAT1|FZD2|MRPS34|VCP|MRPL9|SUPT16H|KIF18B|UBQLN1|WIBG|SMARCD3|MRPS30|MRPS23|PELO|MICAL2|MRPL41|KIF18A|MRPS6|MRPS18C|VAMP8|CKAP5|VAMP7|MRPL38|MRPS22|MRPL52|SMARCD2|KIF2A|MRPL21|MRPS18A|MRPS24|CFL2|MRPL27|MRPL23|MRPS7|MCTS1|NSF|MRPL36|ICT1|HIST3H2A|CAV1|MYC|MRPL22|MRPL49|LAMP2|MRPS2|CFL1|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|CSNK1A1|PPP1CA|MRPS27|MRPL11|EIF2D|MRPL16
REGULATION OF SEROTONIN UPTAKE%GOBP%GO:0051611,0.7206155478906869,0.9015043124805608,-0.507437204049731,-0.8444566528487091,5431,2,GPM6B
REGULATION OF GASTRIC ACID SECRETION%GOBP%GO:0060453,0.315873015873016,0.685583406115178,-0.582988937625614,-1.13842963724399,2387,3,SGK1|KCNQ1
REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:1904705,0.008863399374348279,0.11809071362717802,-0.38032420636347597,-1.7691182832042598,67,32,SOD2|TGFB3|MEF2C|DNMT1|IGF1|P2RY6|GPER1|FGF9|HTR1B|MMP9|IGFBP5|PPARG|PDGFB|ERN1|CNN1
KILLING BY SYMBIONT OF HOST CELLS%GOBP%GO:0001907,0.16909698996655498,0.541811331682474,-0.913542126157918,-1.21705746644275,1263,1,GAPDH
PROTEIN C-LINKED GLYCOSYLATION%GOBP%GO:0018103,0.163287374966207,0.534744357685457,0.5500323963358029,1.32282475902076,1207,5,DPY19L3|DPY19L1|DPY19L2|DPY19L4
PLASMA LIPOPROTEIN PARTICLE ASSEMBLY%GOBP%GO:0034377,0.166491872050341,0.53863486872938,-0.365219267638455,-1.29209236153504,1269,14,APOC2|DGAT1|APOC1|APOM|APOE|PRKACA|P4HB
NAD BIOSYNTHETIC PROCESS%GOBP%GO:0009435,0.0101062451412283,0.12884490052646802,-0.34618878559346505,-1.74448652629446,77,42,PGAM2|PARP10|PARP9|GPI|HK1|KYNU|HK3|HAAO|ENO1|PGAM1|GAPDH|NMNAT3|PNP|PGK1|QPRT|NNMT|ALDOA|ALDOC|PTGIS
MAPK EXPORT FROM NUCLEUS%GOBP%GO:0045204,0.538451232583065,0.8142313733497609,0.574970292898729,0.966024329489385,4018,2,DUSP16|STYX
NEGATIVE REGULATION OF PROTEIN HOMOTETRAMERIZATION%GOBP%GO:1901094,0.689174705251876,0.887051934478962,0.5009129025881699,0.8415983518309329,5143,2,PEX5|PEX14
"POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME, TELOMERIC REGION%GOBP%GO:1904816",0.362745098039216,0.717218429874338,-0.322444395816798,-1.07925158378375,2774,12,CCT2|GNL3L|CCT7|GNL3|CCT3|CCT8|CCT5|DKC1
REGULATION OF GLOMERULAR FILTRATION%GOBP%GO:0003093,0.0629993451211526,0.36006266503904,-0.588292693889927,-1.51324728656275,480,6,GAS6|F2R|PDGFB|EMP2
LOW-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034374,0.11198428290766198,0.459194647507502,-0.5491489160105879,-1.4125589450672,854,6,AGT|PLA2G2A|ABCG1|CETP|PLA2G7
ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0051017,0.16114904031946398,0.5313138078301111,-0.237349064071111,-1.25982319001974,1250,50,FSCN2|ITGB5|SHROOM1|RHOF|PDXP|ARRB1|AIF1L|RHOD|RND1|BAIAP2L1|CORO1B|PLS3|AIF1|NEDD9|FAM107A|EPS8
SMALL MOLECULE CATABOLIC PROCESS%GOBP%GO:0044282,0.10799080929282598,0.452482039948645,-0.156950252432814,-1.22320025719437,845,283,HK1|GALT|ADA|ACSF3|KYNU|BCKDK|NUDT1|HK3|PDXP|SLC9A1|FUT9|NUDT16|APOBEC3G|MCCC2|HAAO|ENO1|ACAD10|TYMP|APOBEC3C|NPL|LRP5|PGM5|ALDH1A1|SDSL|THNSL2|PGAM1|HPRT1|ACOX1|FTCD|ABHD10|CDA|DHDH|CYP46A1|SCARF1|APOE|GAPDH|NOS3|IL4I1|HYAL1|SYNJ2|NUDT18|SLC27A4|ALDH4A1|AFMID|IMPA2|IDNK|LYVE1|SRD5A3|LPIN3|HSD17B10|ENPP4|ABCD1|HEXB|PNP|BCAT2|SHMT2|HNMT|PGK1|ASRGL1|HADH|LPIN2|QPRT|CRYL1|ALDOA|RENBP|GALK1|ALDOC|ETFB
WHITE FAT CELL DIFFERENTIATION%GOBP%GO:0050872,0.912677538137822,0.972925642245441,-0.262509771888805,-0.6291858317424179,6939,5,PER2|PPARG
ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB%GOBP%GO:0002475,0.172485669619594,0.546371269738967,-0.430392344972577,-1.29472552186349,1323,9,HLA-F|CD1D|HLA-B|HLA-E|HLA-C|HLA-A
CELLULAR RESPONSE TO CHOLESTEROL%GOBP%GO:0071397,0.8677305923721941,0.9558022175108679,0.24363488469638198,0.6725475596617859,6415,7,GRAMD1B|LRP6|GRAMD1A|GPLD1
REGULATION OF NEUROFIBRILLARY TANGLE ASSEMBLY%GOBP%GO:1902996,0.749933669408331,0.914150706541393,-0.492087124345189,-0.8189116655580491,5652,2,SORL1|CLU
LEUKOCYTE ADHESIVE ACTIVATION%GOBP%GO:0050902,0.20111435394003702,0.5792408283906739,-0.7330576233802042,-1.21992511003235,1515,2,SELPLG|CX3CL1
SPINAL CORD PATTERNING%GOBP%GO:0021511,0.904918463966333,0.9701161756697599,-0.266669506443935,-0.6391559217206519,6880,5,FOXN4|CHRD
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN%GOBP%GO:0002585,0.1950119395065,0.5697855203224189,-0.7363661428177559,-1.22543101544847,1469,2,PYCARD|TREM2
NEGATIVE REGULATION OF SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1902804,0.33672240802675607,0.699462084003389,-0.8287935597706221,-1.10415202668403,2516,1,FMR1
REGULATION OF TRANS-SYNAPTIC SIGNALING%GOBP%GO:0099177,0.261816318688357,0.637592109988467,-0.155332408494305,-1.1094866826423202,2043,174,NPTX1|CDC20|SEPT5|SNCAIP|ACHE|ANAPC2|MPP2|IQSEC2|STX4|PXK|TOR1A|MCTP1|SHISA7|PLK2|NGF|SYT7|NAPA|INS|CLSTN2|CPLX2|GRIN1|FMR1|ADCY8|LILRB2|JPH4|CALB2|NPAS4|CBLN1|SYP|MEF2C|LGI1|VPS18|SYN1|DBN1|CAMK2B|ABL1|NTRK2|ARF1|NSMF|STX1B|GPER1|APOE|GIPC1|GRIN2C|EPHA4|GRIN2D|DTNBP1|TMEM108|CX3CL1|CAMK2A|FAM107A|PRRT2|LGMN|NPTX2|PSMC5|SQSTM1|NPTXR|ADGRB1
LIPID LOCALIZATION%GOBP%GO:0010876,0.0531481009431558,0.334163135808505,-0.19904544068823102,-1.3694982927634098,416,143,FABP3|PRELID1|ABCG1|GLTP|INHBA|SLCO2B1|ATP8B1|CETP|SLC51A|APOM|GHRL|RFT1|SLCO2A1|BSCL2|ABCA8|CEACAM1|LCN12|LCN1|APOE|FABP4|ABCA6|CD36|ATP8B4|SLC27A4|CAV1|LDLR|STOML2|PPARG|PPARA|OSBP|RPS6KB1|ABCD1|PCTP|ANXA1|ATP8A2|NPC2|OSBPL5|ABCC1
POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS%GOBP%GO:0031394,0.33417352082780605,0.6974768376198021,-0.667707668215832,-1.11117233439529,2518,2,ANXA1
REGULATION OF CORTICOTROPIN SECRETION%GOBP%GO:0051459,0.600575840858526,0.8464076674715391,-0.402652579448798,-0.8814906659250942,4588,4,CRHBP|GHRL
GLUTATHIONE DEGLYCATION%GOBP%GO:0036531,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
EXTRACELLULAR POLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0046379,0.409084871828928,0.7448505271608159,0.7969783855315401,1.0626631385362801,3079,1,HAS3
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX IV ASSEMBLY%GOBP%GO:0033617,0.513734022300789,0.8023339441082009,0.24330425186643898,0.9523966569960558,3777,18,COA5|SCO1|SMIM20|BCS1L
VITAMIN BIOSYNTHETIC PROCESS%GOBP%GO:0009110,0.30875455966649296,0.680809181688249,-0.37479623866802403,-1.1274788257046,2369,9,RFK|PNPO|PDXK
CONVERSION OF DS SIRNA TO SS SIRNA%GOBP%GO:0036404,0.8013377926421399,0.9325377000668108,-0.603826643140715,-0.8044420759907359,5989,1,DICER1
MITOCHONDRIAL RNA CATABOLIC PROCESS%GOBP%GO:0000957,0.966944369793066,0.9912626134248801,0.282723012548854,0.556082802173078,7195,3,PNPT1|SUPV3L1
NEGATIVE REGULATION OF CATECHOLAMINE SECRETION%GOBP%GO:0033604,0.28434839554682395,0.657052292263283,-0.448701450698714,-1.15418100513355,2170,6,SYT4|CHGA|ADRA2C
NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY%GOBP%GO:1901185,0.484293873312565,0.7872939093021379,-0.199906783048224,-0.9783352171277379,3730,38,SOCS4|TSG101|DAB2IP|HGS|RAB7A|SPRY1|SH3GL2|GRB2|EPS15L1|SNX6|VPS25|CHMP6|ERRFI1|LGMN|PTPRJ
UDP-N-ACETYLGALACTOSAMINE METABOLIC PROCESS%GOBP%GO:0019276,0.664657020364416,0.8804055751124069,0.515195878611023,0.865595595699009,4960,2,EXTL2
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN-ANGIOTENSIN%GOBP%GO:0001991,0.8370136698212409,0.946216977301937,-0.253312197020244,-0.6924175942586629,6367,7,PCSK5|ATP6AP2|CTSZ
MYELOID LEUKOCYTE ACTIVATION%GOBP%GO:0002274,0.000126710593005575,0.00518555396908895,-0.330209506684547,-2.7530728942005895,0,439,UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|UBD|CNN2|DNASE1L3|SBNO2|ATP6V1D|ATG7|MAN2B1|ADAM9|DNAJC3|PSEN1|RAB5C|HYAL2|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|TLR1|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|MT1G|B2M|NEU1|GYG1|ADAM8|FRMPD3|BATF|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|FCGR2B|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|S100A13|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|DYSF|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|BATF2|FCGR2A|PLD1|COPB1|TMEM173|CSF1|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|CHGA|TGFBR2|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|AIF1|PSMD2|NME2|COTL1|FOXP1|CD59|MMP9|PSMD6|CANT1|TYROBP|CX3CL1|B4GALT1|LTBR|PTAFR|C3AR1|LAMP2|CSTB|MILR1|ENPP4|PYGL|RAB9B|NFKB1|TLR4|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
CENTRAL NERVOUS SYSTEM MYELINATION%GOBP%GO:0022010,0.895320530159589,0.966332331854337,0.233866519580805,0.6455822499584829,6619,7,TENM4|CNTNAP1|MYRF|CLU|PTEN|SOX10|PLP1
PHOTORECEPTOR CELL MAINTENANCE%GOBP%GO:0045494,0.0670368364030336,0.36969598657030894,0.406767668355216,1.5003982525561002,494,15,NPHP3-ACAD11|BBS4|CDHR1|MKKS|NPHP3|SPATA7|BBS2|BBS10|DRAM2
POSITIVE REGULATION OF CD24 BIOSYNTHETIC PROCESS%GOBP%GO:2000560,0.5187959866220739,0.8047799431921201,-0.7429422143802379,-0.989777420500336,3877,1,PLCB1
LENS FIBER CELL APOPTOTIC PROCESS%GOBP%GO:1990086,0.936113693717625,0.9806508984207809,0.532752536391707,0.710353621456863,7047,1,SIX3
NEGATIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:2000587,0.882961569470572,0.9629606199413431,0.33873273655248604,0.666247319705934,6570,3,PTPN12|PTPN2
FLAVIN-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042726,0.3633613887427671,0.7178370462804441,-0.45026971017223905,-1.07921057591388,2762,5,ACP5|VCP|RFK
POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION%GOBP%GO:1905278,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
ENDOCARDIAL CUSHION CELL FATE COMMITMENT%GOBP%GO:0061445,0.0256342143710984,0.22470485454905398,0.9878694309660341,1.3171905901491598,192,1,ACVR1
NEGATIVE REGULATION OF VASCULAR SMOOTH MUSCLE CONTRACTION%GOBP%GO:1904694,0.254842133191828,0.6334930240678559,-0.7049352081610151,-1.1731249139953002,1920,2,DOCK4|DOCK5
REGULATION OF RNA-DIRECTED 5'-3' RNA POLYMERASE ACTIVITY%GOBP%GO:1900259,0.0786622073578595,0.393097409792852,-0.9581495368328191,-1.2764852483326699,587,1,EIF4A2
VESICLE TARGETING%GOBP%GO:0006903,0.0014122480421106698,0.0301860198914787,-0.310930483508804,-1.85619834470534,10,78,PEF1|MCFD2|SEPT5|TBC1D23|YKT6|TFG|PDCD6|TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|F8|WIPI1|SEC13|SEC24A|ARFGAP2|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|TRAPPC2|TMED9|GOSR2|PPP6C|SAR1B|GRIA1
"DNA DAMAGE RESPONSE, DETECTION OF DNA DAMAGE%GOBP%GO:0042769",0.232180020811655,0.615812511957369,-0.248848018500762,-1.18798378315624,1784,35,RAD18|RFC2|CUL4B|RPA2|RFC3|UBE2B|MRPS11|POLD4|PCNA|POLD1|POLD2|RFC5|DTL|UBC|DDB1|RFC4
POSITIVE REGULATION OF CAP-DEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:1903676,0.0425418060200669,0.29503134401102504,-0.97788928098809,-1.3027833273395801,317,1,NCK1
NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009117,0.00012683916793505801,0.00518555396908895,-0.21679349427914102,-1.78206925987032,0,396,NDUFB5|PARP9|NADK|TKT|GPD1|CROT|SURF1|ACSL5|DNPH1|ATP1B1|ABHD14B|UQCR10|ACOT1|PARP1|DCTPP1|NDUFA9|ATP5J|NDUFA7|ACSF2|DCAKD|GPI|ATP5F1|FAR1|COASY|OPA1|IMPDH2|ACSL4|PFKFB2|NUDT17|GPX1|ELOVL2|HK1|ADA|PDHA1|NDUFA3|VCP|NDUFB6|ACSF3|KYNU|NUDT1|ATP5B|HK3|ADCY8|PDE4D|SDHD|NPR2|ELOVL1|CYCS|SLC26A2|NDUFB9|PARK7|COA6|NUDT16|PDE2A|HAAO|ENO1|BST1|NDUFB10|SDHA|ADCY4|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|CTPS1|PGAM1|HPRT1|TPST2|MOCS2|PRPS1|MBIP|EPHA2|NPR1|RFK|GAPDH|NDUFS6|COQ7|HMGCS1|NUDT18|UMPS|FMO2|NDUFB4|HACD2|NUDT4|NDUFA12|SDHAF2|GMPS|NME2|LDHA|CMPK2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|ACOT2|STOML2|PDHX|ABCD1|NDUFA4|HINT1|ATP5H|NMNAT3|NDUFV1|PNP|UQCRQ|SULT1A4|PGK1|NDUFS3|GPHN|RRM1|SAMHD1|TALDO1|UQCRC2|FASN|QPRT|COX6A1|NNMT|UQCC3|NDUFA8|ADCY9|ALDOA|NDUFS8|ALDOC|AK1|ATP5G1|MTHFD1|BAD|PTGIS|NDUFV3
RESPONSE TO IRON ION STARVATION%GOBP%GO:1990641,0.804816053511706,0.932964969466025,-0.60200705778562,-0.8020179513895409,6015,1,EIF2AK1
FRUCTOSAMINE METABOLIC PROCESS%GOBP%GO:0030389,0.881259131358746,0.9622426269432679,0.5588883987648879,0.7452022673449351,6634,1,FN3K
POSITIVE REGULATION OF T CELL DIFFERENTIATION%GOBP%GO:0045582,0.00712804561949197,0.10176514095207499,-0.36208137617189706,-1.7880475480984899,54,39,NCKAP1L|IL18|ADAM8|RUNX1|CCL19|RUNX3|GATA3|LILRB2|SOCS1|NKAP|C10orf54|CD86|NLRP3|TGFBR2|LGALS9|BCL6|LILRB4|PNP|ANXA1|SART1
ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE%GOBP%GO:1903540,0.39261303890641397,0.737280445732591,-0.385300027911154,-1.0532004440856702,2986,7,ARHGAP44|STX1B|STX3
SPINDLE ASSEMBLY%GOBP%GO:0051225,0.878092783505155,0.960725750963158,-0.12701366779728698,-0.724257160813115,6813,65,RHOA|GOLGA2|HAUS1|BCCIP|INO80|ZNF207|HAUS6|GOLGA8N|TUBGCP5|RACGAP1|HAUS4|CSNK1D|CEP192|KIF11|NEK2|CCDC69|MAPRE2|OFD1|TUBGCP2|TPX2|KPNB1|HAUS8|KIF4A|RCC1|SPICE1|FLNA|KIFC1|KIF2A|CEP63|NEK6|HAUS7
RESPONSE TO AXON INJURY%GOBP%GO:0048678,0.634673301034438,0.8634223229282929,-0.250525591345689,-0.862357667811811,4846,13,APOD|P2RX4|SOD1|DHFR|RTN4RL1
ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN%GOBP%GO:0071169,0.31664037854889604,0.6861326333203311,-0.411494825674775,-1.12480275563219,2408,7,H2AFY|CCDC101
NEGATIVE REGULATION OF CHONDROCYTE PROLIFERATION%GOBP%GO:1902731,0.8235449735449741,0.941760803523009,-0.36705389699918894,-0.7167632314116509,6225,3,NOV
"POSITIVE REGULATION OF CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0032831",0.35553197134518394,0.7132037834765931,-0.659001929969672,-1.09668459380146,2679,2,FOXP3|LGALS9
EXTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0097191,0.9648059816939542,0.990916952887267,-0.10904958668771,-0.611531012404042,7483,61,DAB2IP|TNFRSF10A|TNFRSF10B|NGF|BCL2L2|TRAF2|DDX3X|BAG3|INHBA|TNFRSF10C|G0S2|FADD|SIVA1|TNFRSF1A|BAD
CELLULAR RESPONSE TO ACIDIC PH%GOBP%GO:0071468,0.511090073032188,0.8013029157896501,0.339752067653523,0.937876463278972,3778,7,RAB11FIP5|TRPV1|RAB11B|CHP1
POSITIVE REGULATION OF MESENCHYMAL STEM CELL MIGRATION%GOBP%GO:1905322,0.9115719063545149,0.9723824689260179,-0.543614909572122,-0.724225589187533,6813,1,FBXO5
MONOSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0046365,0.056163854180084995,0.34424567164700104,-0.274116540638863,-1.4549809834571799,435,50,GPI|HK1|GALT|HK3|FUT9|ENO1|LRP5|PGM5|ALDH1A1|PGAM1|DHDH|GAPDH|PGK1|CRYL1|ALDOA|GALK1|ALDOC
POSITIVE REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:1901610,0.0852090032154341,0.40376145987147494,0.8227736421284809,1.3823659513809,635,2,TRIM46|MAP2
REGULATION OF CAMP-MEDIATED SIGNALING%GOBP%GO:0043949,0.330568398150666,0.6957352559323989,0.255118945421834,1.09895631543672,2430,24,RASD2|PDE3A|ADCYAP1|ATP2B4|PRKCA|CDC34|CXCL9|GPR61
NEUROTRANSMITTER METABOLIC PROCESS%GOBP%GO:0042133,0.620453923981406,0.855212458292881,0.18334294590893999,0.8886658679643249,4537,35,TRH|SPR|GCSH|DDAH2|COLQ|NQO1|AMT|ATP7A|SHMT1
POLYOL CATABOLIC PROCESS%GOBP%GO:0046174,0.15046045503792002,0.517264655410678,0.3585715502152821,1.32262263993294,1110,15,INPP1|INPP5K|INPP5J|SORD|IMPA1
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY%GOBP%GO:0001911,0.0659197498697238,0.369007394574627,-0.506419653267729,-1.52343427460534,505,9,SERPINB9|MICA|LILRB1|HLA-E|FCGR2B|CEACAM1|LGALS9
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION%GOBP%GO:0051495,0.20512820512820498,0.5851419434522471,-0.166425112382215,-1.15747916786845,1591,152,HCLS1|CCL24|ARPC1A|WAS|FES|IQGAP2|PLEK|TGFB3|CDK5RAP2|LMOD1|PDXP|CD47|HAX1|BCAS3|S100A10|CTGF|PXN|MECP2|ABL1|RAPGEF3|HRAS|ARHGEF15|GSN|BAIAP2L1|NSFL1C|HCK|CDC42EP4|TEK|CFL2|SEMA5A|ARPC5L|ARL2|NAV3|CX3CL1|EVL|NF2|CDC42EP1|CDC42EP5|SYNPO|NCK1|ARF6|CDC42EP2|SERPINF2
PROTON-TRANSPORTING TWO-SECTOR ATPASE COMPLEX ASSEMBLY%GOBP%GO:0070071,0.205310199789695,0.58515351714347,-0.458190643274793,-1.2524436906715801,1561,7,OXA1L|TMEM70|ATPAF1|VMA21
REGULATION OF PROTEIN LOCALIZATION TO CILIUM%GOBP%GO:1903564,0.0866919123613741,0.406842536616055,0.5313456555149,1.46676541989779,640,7,CCDC88A|GAS8|LZTFL1|EFCAB7|CROCC
DENDRITIC CELL CHEMOTAXIS%GOBP%GO:0002407,0.8098534201954399,0.9348935237597009,0.22019086241400898,0.7245631433667759,5966,11,TRPM4
EPICARDIUM-DERIVED CARDIAC FIBROBLAST CELL DIFFERENTIATION%GOBP%GO:0060938,0.562830687830688,0.828541380171721,-0.473456703255675,-0.924540944350183,4254,3,SPRY1|TGFBR3
ENDOTHELIAL CELL CHEMOTAXIS TO VASCULAR ENDOTHELIAL GROWTH FACTOR%GOBP%GO:0090668,0.0883251427812459,0.41066453213355103,0.9567159241288051,1.2756515924133798,664,1,GAB1
NAD CATABOLIC PROCESS%GOBP%GO:0019677,0.964496248660236,0.990916952887267,0.333057337725349,0.5595793301521391,7198,2,NUDT12
INTERLEUKIN-21 PRODUCTION%GOBP%GO:0032625,0.12013377926421401,0.47223724623656504,-0.938134097926775,-1.24981987771951,897,1,FOXP1
POSITIVE REGULATION OF ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0046638,0.0490324267782427,0.317359880131657,-0.36161689892726007,-1.5368616257437,374,24,NCKAP1L|IL18|RUNX1|CCL19|RUNX3|SOCS1|NKAP|CD86|NLRP3|TGFBR2|LGALS9|PNP|ANXA1
DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:0000724,0.17816683831101998,0.5510029895926789,-0.20505036344448102,-1.21680398150898,1383,76,NIPBL|XRCC1|CDC7|MMS22L|BLM|ZFYVE26|RAD54B|UBE2N|INO80|DMC1|RAD51|RPA2|XRCC2|NABP2|PALB2|TONSL|NBN|YY1|GINS2|PARP1|RAD51C|AP5S1|RAD51AP1|SLX1B|AUNIP|SLX1A|RNF138|CDC45|BRCA1|POLQ|NUCKS1|RMI1|RAD51B|NSMCE1|MUS81|SAMHD1|XRCC3|FEN1
REGULATION OF CELLULAR EXTRAVASATION%GOBP%GO:0002691,0.0019607843137254897,0.0387291856838508,-0.5904137721793411,-1.97617017687083,14,12,PLCB1|ADAM8|RIPK3|THY1|PTGER4|ICAM1|BST1|PLVAP|FADD
PEPTIDYL-LYSINE MODIFICATION TO PEPTIDYL-HYPUSINE%GOBP%GO:0008612,0.293274383708467,0.6657871238651031,0.6873449131513649,1.1548282007883501,2188,2,DOHH|DHPS
TRAVERSING START CONTROL POINT OF MITOTIC CELL CYCLE%GOBP%GO:0007089,0.647642015005359,0.870171576465071,0.525753780885728,0.883334234706455,4833,2,CDK10
NUCLEAR SPECK ORGANIZATION%GOBP%GO:0035063,0.51830724330061,0.8047799431921201,-0.591673559415495,-0.984639418583356,3906,2,SRPK2|DYRK3
DUDP BIOSYNTHETIC PROCESS%GOBP%GO:0006227,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
REGULATION OF RESPIRATORY SYSTEM PROCESS%GOBP%GO:0044065,0.0514456359440749,0.327245273856257,0.6076029346528511,1.57220830543531,378,6,MTG2|MTG1|TSHZ3|NLGN2
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0002590,0.317192889360573,0.6861326333203311,-0.676040805073063,-1.1250400066945,2390,2,TAPBPL|HFE
DETECTION OF MONOSACCHARIDE STIMULUS%GOBP%GO:0034287,0.163719185423366,0.5351003413847161,0.7607940446650121,1.27823222513252,1221,2,GCK|NKX6-1
REGULATION OF ANIMAL ORGAN FORMATION%GOBP%GO:0003156,0.420466883821933,0.751774348695433,0.31062524880917797,1.02214780494881,3097,11,DKK1|GNG5|ROBO2|CITED2
REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0060390,0.0470634504457263,0.311393448993877,-0.440662285261455,-1.5589987255725801,358,14,SMAD4|TGFBR1|BMP4|RBPMS|NUP93|TGFB1|TGFB3|CILP|NOV|WWTR1|FAM89B|DAB2
NEGATIVE REGULATION OF MITOCHONDRIAL DNA REPLICATION%GOBP%GO:0090298,0.776331518129898,0.9241536998094619,0.6111601235112479,0.8148995591210799,5844,1,LIG3
"NUCLEOTIDE-EXCISION REPAIR, PREINCISION COMPLEX STABILIZATION%GOBP%GO:0006293",0.6532353327208299,0.873847362293187,-0.21033093747185996,-0.8568897537144059,4976,21,DDB1|XPA|GTF2H2
POSITIVE REGULATION OF DENSE CORE GRANULE TRANSPORT%GOBP%GO:1904811,0.0852090032154341,0.40376145987147494,0.8227736421284809,1.3823659513809,635,2,TRIM46|MAP2
NEGATIVE REGULATION OF HISTONE ACETYLATION%GOBP%GO:0035067,0.831412103746398,0.9443784929910591,-0.218124705378331,-0.706190469207871,6346,11,BRCA1|TAF7|SPI1
GAMMA-DELTA T CELL ACTIVATION%GOBP%GO:0046629,0.314095013741657,0.683550177109913,-0.520708101251861,-1.1399388811899098,2399,4,AMICA1|MICB|MICA|CXADR
EXTERNAL GENITALIA MORPHOGENESIS%GOBP%GO:0035261,0.910503751339764,0.9720943283119721,0.38158257513096205,0.6411079943405821,6795,2,LRP6|NIPBL
DERMATAN SULFATE BIOSYNTHETIC PROCESS%GOBP%GO:0030208,0.36558577405857706,0.719912723446385,-0.341452408773859,-1.0697258233391,2795,10,CSPG4|DSEL|NCAN|DCN|BGN|VCAN
CARDIAC LEFT VENTRICLE FORMATION%GOBP%GO:0003218,0.709921636339487,0.8963870249632699,0.644353771504191,0.8591588098059308,5344,1,HAND1
NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY%GOBP%GO:1905049,0.0941715782580223,0.42418410384356203,-0.56382162564704,-1.45030110687627,718,6,TIMP3|RECK|TIMP1
POSITIVE REGULATION OF MOTILE CILIUM ASSEMBLY%GOBP%GO:1905505,0.0483463939434188,0.315098240888217,0.9758491398323779,1.3011631538546398,363,1,ZMYND10
RESPIRATORY ELECTRON TRANSPORT CHAIN%GOBP%GO:0022904,0.00012745347947999,0.00518555396908895,-0.370622652710141,-2.25154633964289,0,83,NDUFV2|NDUFB8|SDHC|NDUFS4|UQCRC1|NDUFB5|UQCR10|NDUFA9|NDUFA7|SLC25A18|SDHB|NDUFA3|NDUFB6|SDHD|CYCS|NDUFB9|COA6|NDUFB10|SDHA|SLC25A22|MT-CO3|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|COQ7|LYRM5|NDUFB4|NDUFA12|SDHAF2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|NDUFA4|NDUFV1|UQCRQ|NDUFS3|COX6A1|UQCC3|NDUFA8|NDUFS8|NDUFV3
URIDINE TRANSPORT%GOBP%GO:0015862,0.517909259750597,0.8047565444482679,-0.5917838433967471,-0.984822948763893,3903,2,SLC29A1|SLC29A2
SKELETAL MUSCLE SATELLITE CELL ACTIVATION%GOBP%GO:0014719,0.825873289945544,0.9429360603094208,0.5857410674900749,0.7810066777826801,6217,1,EPHB1
CELLULAR RESPONSE TO ESTROGEN STIMULUS%GOBP%GO:0071391,0.6730416557505899,0.8821483794774391,-0.25563967175807,-0.8276471912425171,5137,11,RARA|SERPINB9|ARID5A|SRA1|CRHBP|BCAS3|WBP2
NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION%GOBP%GO:0090324,0.491931216931217,0.7910456783193008,-0.5064509894343039,-0.9889704228895899,3718,3,PPIF|PDE12
ACTIVATION OF PHOSPHOLIPASE D ACTIVITY%GOBP%GO:0031584,0.31239366575055605,0.68160868787154,-0.521902352622201,-1.14255334708297,2386,4,ARF4|ARL1|GNA13
MALE PRONUCLEUS ASSEMBLY%GOBP%GO:0035039,0.39638795986622105,0.7377402989373809,-0.801554918394354,-1.0678636159873398,2962,1,WBP2NL
RESPONSE TO ORGANOPHOSPHORUS%GOBP%GO:0046683,0.33988110622900003,0.701666791356079,-0.20614495406372302,-1.08067884073773,2629,48,TYMS|SSH1|AQP1|NDUFS4|JUNB|HSP90B1|RFC3|ZFP36L1|P2RX4|RAPGEF1|AHR|P2RX3|PDXP|CRHBP|PDE2A|RAPGEF3|P2RY6|RAP1A|KCNQ1|IGFBP5
NEGATIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY%GOBP%GO:0035795,0.45915792269889794,0.7735063645065241,0.7721658579620642,1.0295789810476,3456,1,ACAA2
CELLULAR RESPONSE TO INTERLEUKIN-11%GOBP%GO:0071348,0.581672240802676,0.8387093286508721,-0.7135531539479492,-0.950624135274963,4347,1,SBNO2
ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION%GOBP%GO:0086066,0.44723959749796005,0.768229288546963,0.31512690936940996,0.998343349915943,3288,10,SCN5A|ANK2|CACNA1C|CACNB2
ATRIOVENTRICULAR NODE CELL DIFFERENTIATION%GOBP%GO:0060922,0.12321070234113699,0.47697345522944606,-0.937141596823997,-1.24849762793704,920,1,MAML1
"SYNAPTIC TRANSMISSION, CHOLINERGIC%GOBP%GO:0007271",0.146324925413615,0.513872620660976,0.369236323937715,1.32717234893358,1078,14,CHRNB1|CHRNB2|CHRNA5|COLQ|NQO1|CHRNB4
POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0071073,0.44483706321162203,0.76693681188187,-0.46026075616661294,-1.00760700703294,3398,4,FABP3|ZP3
NEGATIVE REGULATION OF BONE DEVELOPMENT%GOBP%GO:1903011,0.8277668631303209,0.943061234519578,-0.27489335101027695,-0.7070997512477609,6319,6,FAM101A|FBXW7|GREM1|LILRB1|FBN1
GENERATION OF CATALYTIC SPLICEOSOME FOR SECOND TRANSESTERIFICATION STEP%GOBP%GO:0000350,0.0416556115680552,0.292809245831308,-0.868453193946107,-1.4452449908336398,313,2,ISY1
REGULATION OF HISTONE H2B CONSERVED C-TERMINAL LYSINE UBIQUITINATION%GOBP%GO:2001173,0.498996655518395,0.794989907195277,-0.7546316718129692,-1.00535058460499,3729,1,WDR70
CELLULAR RESPONSE TO WATER STIMULUS%GOBP%GO:0071462,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
LEUKOCYTE AGGREGATION%GOBP%GO:0070486,0.31370505471599797,0.68331834948726,-0.373215259687521,-1.1227228539511598,2407,9,IL1B|RAC2|CD44|MSN|S100A8|S100A9
MICROTUBULE SEVERING%GOBP%GO:0051013,0.16318327974276503,0.534744357685457,0.7610697546181421,1.2786954534521298,1217,2,KATNAL1|SPAST
REGULATION OF GLIAL CELL PROLIFERATION%GOBP%GO:0060251,0.7458426083540659,0.911646574429972,-0.22608624448457898,-0.7782326965911691,5695,13,IL6|RNF10|DICER1|IL1B|SOX11|TNF|PRKCH|HES1|NOTCH1
CYCLIC NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009187,0.23690773067331697,0.6217158626397761,-0.29358683364917604,-1.19607487421147,1804,21,ADCY8|PDE4D|NPR2|PDE2A|ADCY4|EPHA2|NPR1|ADCY9
REGULATION OF RENAL WATER TRANSPORT%GOBP%GO:2001151,0.115021915260991,0.4642646694217079,0.944199382443758,1.25896247296909,865,1,INPP5K
RESPONSE TO METHYLGLYOXAL%GOBP%GO:0051595,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
ACTIVATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0006919,0.159829721362229,0.529429183067871,-0.21804361566671104,-1.24690087019941,1238,66,TNFRSF10A|TNFRSF10B|CASP10|NGF|CASP1|VCP|TRAF2|TNFSF10|CYCS|CASP4|F3|IFI27L1|ANP32B|F2R|DLC1|FADD|PPARG|S100A8|S100A9|NGFRAP1|NGFR|BAD
SYNAPTIC VESICLE MEMBRANE ORGANIZATION%GOBP%GO:0048499,0.24695720455437803,0.6280519349499749,-0.556164884307146,-1.21756119109725,1886,4,SYNGR1|SYP|SYNGR2
POSITIVE REGULATION OF DNA-BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0051091,0.0358790363915941,0.268987198588135,-0.19184979858638,-1.38517304965383,279,184,TRIM38|DHX9|MTDH|TRIM52|CEBPG|PYCARD|TRIM21|SMARCA4|IL18|ARHGEF5|IRAK3|ADAM8|RIPK3|NFKB2|KDM1A|AGT|JUP|EDA|GTF2A2|FZD4|TLR2|HCLS1|SMO|TNFRSF11A|NPM1|TRIM34|TAF12|INS|FZD2|ARID5B|DDR2|TRAF2|ADCY8|STAT3|NFAM1|PRKD1|PARK7|TRIM32|MBTPS2|CARD16|IRAK1|HDAC5|MAP3K13|TMEM173|STK3|NLRP3|RAB7B|CD36|CD200|LGALS9|BEX1|SRF|UBC|CX3CL1|CAMK2A|PPARG|RELA|NFKB1|TLR4|S100A8|RPS6KA4|S100A9|PSMA6|MID2|SPHK1|PRKCB
NEGATIVE REGULATION OF CELL FATE SPECIFICATION%GOBP%GO:0009996,0.260010749798441,0.636098664976652,0.608730527951761,1.1973011135526799,1934,3,DKK1|FZD7
NEGATIVE REGULATION OF CAMP-MEDIATED SIGNALING%GOBP%GO:0043951,0.849358134660728,0.9492491301138911,-0.21364915401477802,-0.691700630874749,6483,11,UBE2B|PDE4D|PDE2A|APLNR
REGULATION OF GENE SILENCING%GOBP%GO:0060968,0.00561941251596424,0.0858969713520357,-0.28387394564946006,-1.71312023107154,43,81,SIRT6|ZC3H12A|HIST4H4|PUM1|MAP2K2|HIST1H3D|POLR2F|TNRC6A|TET1|HIST1H4H|AJUBA|TGFB1|POLR2C|DHX9|NAA40|H1F0|DND1|TERT|TRIM28|PHF2|ATAD2|POLR2J|FMR1|STAT3|FXR1|HIST1H4I|CDC45|DDX5|POLR2H|DNMT1|HIST2H3A|H1FX|HIST2H4A|PPARG|POLR2G|HIST2H3C|HIST1H3H|HIST1H1C|H2AFY|HIST2H4B|H3F3B|WTIP|POLR2L|EIF4G1
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION%GOBP%GO:0002566,0.7126708727655101,0.89739524968595,-0.289228004085038,-0.790591851227725,5421,7,EXO1|POLQ|SAMHD1
REGULATION OF PEPTIDYL-THREONINE PHOSPHORYLATION%GOBP%GO:0010799,0.599138493669234,0.8461100531812209,-0.199066875742811,-0.900084900845751,4589,29,RPTOR|PLK1|TNKS1BP1|DDIT4|SPHK1|EIF4G1
PROTEIN HETEROOLIGOMERIZATION%GOBP%GO:0051291,0.10670967741935498,0.44944531224362605,-0.24594998920024203,-1.3416157625127199,826,55,KRT10|HSD17B8|INSR|MAGI2|HBG2|HIST1H4J|HIST4H4|HBB|HIST1H3D|HBA1|HIST1H4H|MCCC1|CPSF6|FARSA|FGFRL1|TMCC1|CD74|RIPK3|ITPR3|GRIN1|SEPT7|HIST1H4I|S100A10|MCCC2|RCC1|HIST2H4A|COL6A1|HIST1H3H|ANXA2|SEPT9|HIST2H4B|CPSF7|COL6A2
MITOTIC RECOMBINATION-DEPENDENT REPLICATION FORK PROCESSING%GOBP%GO:1990426,0.226988975959623,0.609201573718782,0.887957653286281,1.18397171599476,1708,1,BRCA2
DNA LIGATION INVOLVED IN DNA REPAIR%GOBP%GO:0051103,0.9100494662848221,0.9720943283119721,-0.21711070660268103,-0.625031337398998,6990,8,POLB|LIG4|HMGB1|LIG3|XRCC4|XRCC1|HMGB2|C9orf142
L-ALPHA-AMINO ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1902475,0.0442176870748299,0.29950475077556604,-0.420853532536984,-1.5640546844819099,337,16,SLC7A2|SLC25A18|SLC1A2|SLC1A3|SLC25A22|SLC7A3|SLC3A2|ARL6IP5|PRAF2
MITOCHONDRIAL TRNA 3'-END PROCESSING%GOBP%GO:1990180,0.57962962962963,0.8386526275338391,-0.465056111049596,-0.9081367168930541,4381,3,HSD17B10
REGULATION OF CENTRAL TOLERANCE INDUCTION%GOBP%GO:0002646,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
HISTONE MRNA CATABOLIC PROCESS%GOBP%GO:0071044,0.717994020114162,0.900060477413567,0.212391031696393,0.799722675017979,5282,16,SSB|EXOSC10|ATM
NATURAL KILLER CELL DEGRANULATION%GOBP%GO:0043320,0.41031746031746,0.7452892204937491,-0.540995914606493,-1.05642790637558,3101,3,CORO1A|VAMP7
MITOCHONDRION LOCALIZATION%GOBP%GO:0051646,0.5646369704399951,0.8295590091625621,0.20169824281129398,0.9230978691732299,4144,29,TRAK2|DNM1L|HAP1|MFN1|BRAT1|LRPPRC|ATCAY|TRAK1|SPAST|MYO19|CLUH|NEFL|RHOT2|MFN2|MTM1
REGULATION OF BLOOD PRESSURE%GOBP%GO:0008217,0.00103052943449697,0.0240374619221188,-0.330265488885928,-1.89666771043142,7,67,AGT|PCSK5|KLK1|P2RX4|PLCB3|CD34|SOD2|PRCP|GAS6|SGK1|PDE4D|POMC|NPR2|TBXA2R|ATP6AP2|PTGS1|SOD1|LRP5|CTSZ|NPR1|F2R|NOS3|CHGA|COL1A2|PPARG|ACVRL1|PDGFB|SERPINF2|RENBP|EMP2
REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS%GOBP%GO:0060696,0.888539620170269,0.965159112268525,-0.254285340682857,-0.654090397173987,6783,6,APOC2|APOC1|LDLR
REGULATION OF VASCULAR PERMEABILITY INVOLVED IN ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002528,0.6256613756613759,0.858842084733938,-0.445269908059249,-0.8694992772454392,4729,3,C2CD4A|C2CD4B
IRON ION HOMEOSTASIS%GOBP%GO:0055072,0.0012923235978289,0.0284225379862475,-0.3808156925513379,-1.9963596151565302,9,48,ATP6V0D1|ABCB7|HAMP|SLC11A1|ACO1|HMOX1|SOD1|SKP1|NEDD8|CYBRD1|HFE|FTL|FXN|SLC22A17|MYC|ATP6AP1|TFRC|ATP6V1A|ATP6V1G1|FTH1
PLASMA LIPOPROTEIN PARTICLE ORGANIZATION%GOBP%GO:0071827,0.0498892796665364,0.32012215085927803,-0.355977069614779,-1.5346670268478602,382,25,APOC2|PLTP|DGAT1|AGT|ABCA5|APOC1|PLA2G2A|ABCG1|CETP|PLA2G7|APOM|APOE|PRKACA|P4HB
TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE%GOBP%GO:0043247,0.826217024748436,0.943041978946366,0.22338791278953501,0.707708007644629,6075,10,RIF1|ACD|RTEL1|DCLRE1A
POSITIVE REGULATION OF AORTIC SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1904831,0.48386239872493,0.787078399497453,0.758215703573004,1.01097833250397,3642,1,CTH
ENTRY INTO HOST CELL%GOBP%GO:0030260,0.0418574231523872,0.293009782616793,-0.33851609437803604,-1.5455982133267299,319,30,HYAL2|ZNF639|CTNND1|CD4|PPIA|CAV2|GAS6|PVRL2|CXCR4|GRB2|VAMP8|AXL|CAV1|ADRBK1|CD81
URONIC ACID METABOLIC PROCESS%GOBP%GO:0006063,0.46679764243614896,0.7806653415096191,-0.382055979733307,-0.982750900446629,3563,6,ABHD10|CRYL1
REGULATION OF BETA-CATENIN-TCF COMPLEX ASSEMBLY%GOBP%GO:1904863,0.0848160535117057,0.40376145987147494,-0.955337450374945,-1.272738873949,633,1,DACT1
INTRACILIARY TRANSPORT%GOBP%GO:0042073,0.000137061403508772,0.00526859796630401,0.5475469925835961,2.8906191645608597,0,47,DYNLRB2|DYNC2H1|TTC30B|WDR19|TTC21B|DYNC2LI1|RABL2B|IFT88|TTC30A|WDR35|TTC21A|LCA5|IFT46|IFT172|IFT20|IFT140|KIF3B|CLUAP1|IFT81|TNPO1|WDR60|PCM1|IFT52|RPGR|TRAF3IP1|KIF3C|IFT27
EOSINOPHIL CHEMOTAXIS%GOBP%GO:0048245,0.0244956772334294,0.219638825480684,-0.522835261959395,-1.6927072901766003,186,11,CCL3|CCL4|CCL8|CCL11|CCL24|CCL2|LGALS3|CX3CL1|CCL4L2
D-RIBOSE METABOLIC PROCESS%GOBP%GO:0006014,0.911173633440514,0.972245398885683,0.38087317466010495,0.63991610995514,6800,2,RPIA|NUDT5
RESPONSE TO PH%GOBP%GO:0009268,0.38029827315541603,0.729416463582188,-0.28469776620923104,-1.05804713629665,2906,16,IMPACT|CTSS|SLC9A1|PKD2L1|HYAL1|INSRR|LGMN
PYRIMIDINE NUCLEOBASE TRANSPORT%GOBP%GO:0015855,0.591705685618729,0.8417378833576942,-0.7080392589325101,-0.9432783031501271,4422,1,SLC29A2
CYSTEINE METABOLIC PROCESS%GOBP%GO:0006534,0.917795726941115,0.9759608985406322,-0.20393865842895,-0.613497403118045,7044,9,CSAD|CTH|GCLC|GGT7|CBS|MTRR|CDO1|GGT1|GGT5
POSITIVE REGULATION OF SALIVA SECRETION%GOBP%GO:0046878,0.589565217391304,0.8414799095069009,-0.709803705337451,-0.945628969430075,4406,1,AQP1
REGULATION OF SINGLE-STRANDED TELOMERIC DNA BINDING%GOBP%GO:0060380,0.31810333377606603,0.6867397844771489,0.8410895456550509,1.12147941851615,2394,1,ACD
NEGATIVE REGULATION OF HISTONE MODIFICATION%GOBP%GO:0031057,0.6705375782881,0.8815356925073421,-0.194818938147489,-0.8498357857371821,5138,26,BRCA1|TAF7|DNMT1|SPI1|H2AFY|OTUB1
REGULATION OF DOUBLE-STRAND BREAK REPAIR%GOBP%GO:2000779,0.42731958762886607,0.7555882650781178,-0.178211364466246,-1.01619659593604,3315,65,PML|RAD51|RPA2|SETMAR|DTX3L|DEK|WDR70|KDM1A|PARP9|PPP4R2|PARPBP|ANKRD32|KLHL15|WAS|RAD51AP1|USP51|AUNIP|FOXM1|NUDT16|POLQ|CXorf57|RMI2|PPP4C|OTUB1|MAGEF1
CENTRIOLE ELONGATION%GOBP%GO:0061511,0.39188102893890703,0.7371583053449839,0.6401985111662529,1.0756161581349901,2924,2,CENPJ|C2CD3
POSITIVE REGULATION OF MRNA BINDING%GOBP%GO:1902416,0.41338065194532103,0.748061280707938,-0.37865195745952,-1.0350282399725899,3144,7,EIF3C|FMR1|EIF4G1
REGULATION OF RUFFLE ASSEMBLY%GOBP%GO:1900027,0.6793144053382181,0.884536278926676,-0.219680020135638,-0.834837721544198,5191,17,HRAS|CAV1|EVL|EPS8
MINUS-END-DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072385,0.67072372726083,0.8815356925073421,-0.377707063318058,-0.826879716565144,5124,4,BICD2|BICD1|DYNC1H1
POSITIVE REGULATION OF TORC1 SIGNALING%GOBP%GO:1904263,0.535564853556485,0.8132910857498922,-0.295529207355562,-0.925854428130728,4095,10,RRAGB|KLHL22|RRAGA|SEC13|RRAGD
PEPTIDYL-CYSTEINE MODIFICATION TO L-CYSTEINE PERSULFIDE%GOBP%GO:0098822,0.516536060565812,0.804056180000979,0.741288045875607,0.988407585061692,3888,1,MOCS3
SPHINGOID METABOLIC PROCESS%GOBP%GO:0046519,0.771365294424179,0.9213545359508709,-0.24973548968876197,-0.751265481349854,5920,9,SPHK1
NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050859,0.801567991349013,0.9325377000668108,0.304492557046358,0.7323028535805601,5929,5,GPS2|FCRL3|CD22
NEGATIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:1902576,0.7081533830650442,0.89516234575314,-0.365550491447556,-0.800266439560525,5410,4,TERF2|BCL6
APOLIPOPROTEIN A-I-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038027,0.633337861703573,0.8631726958478259,0.39006231732201,0.8569835229895758,4661,4,ITGAV|ABCA7|ITGB3|RHOA
SUBSTRATE-INDEPENDENT TELENCEPHALIC TANGENTIAL INTERNEURON MIGRATION%GOBP%GO:0021843,0.287226822315732,0.6603864229308399,0.444630455371721,1.15050743654538,2115,6,DRD2|SLIT1|SLIT3
EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0060441,0.5844784714042671,0.8396554445633291,-0.407562263207244,-0.892238989980631,4465,4,FGF10|CTSH
NEURON PROJECTION REGENERATION%GOBP%GO:0031102,0.4847695912522779,0.7872939093021379,-0.335786302647053,-0.966681768522055,3723,8,MAPK8IP3|GAP43|APOD|DHFR|RTN4RL1
NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE%GOBP%GO:0045869,0.17964229352972103,0.553022925059495,-0.5392769887046049,-1.29254403840394,1365,5,APOBEC3G|APOBEC3C|APOBEC3F
SNARE COMPLEX ASSEMBLY%GOBP%GO:0035493,0.894667020429822,0.9661937088580559,-0.404631927212572,-0.6733722323918601,6743,2,UVRAG|VAMP4
EXON-EXON JUNCTION COMPLEX DISASSEMBLY%GOBP%GO:1903259,0.289632107023411,0.6622817015650171,-0.852503308337009,-1.13573910482082,2164,1,WIBG
PROTEIN LOCALIZATION TO CYTOSKELETON%GOBP%GO:0044380,0.8223648279628621,0.9412507273497192,0.15867954241869298,0.740218163128891,6022,31,BBS4|RTKN|KIAA0753|PIBF1
NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010868,0.253250198991775,0.632257972333528,-0.705604140262838,-1.17423812398302,1908,2,SIK1
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION%GOBP%GO:0071636,0.123823221757322,0.47832576509682107,-0.442942335322339,-1.3876805146753202,946,10,CD34|ATP6AP2|CD200|LGALS9|THBS1|SERPINF2
MORPHOGENESIS OF AN EPITHELIAL BUD%GOBP%GO:0060572,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
ATP-DEPENDENT CHROMATIN REMODELING%GOBP%GO:0043044,0.000644080896560608,0.0163600882996276,-0.34458092975951893,-1.9788792504779398,4,67,MIS18BP1|RBBP4|GATAD2B|MBD3|HIST1H4J|CENPQ|HIST4H4|NASP|MBD2|CASC5|INO80|CHD4|HIST1H4H|HJURP|ITGB3BP|ANP32E|CENPL|CENPU|SRCAP|CENPW|SMARCA4|OIP5|RUVBL1|CENPM|SMARCE1|NPM1|CENPI|PIWIL1|HIST1H4I|STRA13|RBBP7|CENPH|SMARCD2|SPTY2D1|HIST2H4A|CHD8|MTA2|ACTB|POLE3|HIST2H4B|CENPK|MIS18A|HNRNPC|CENPP
POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0034393,0.395284872298625,0.7377402989373809,-0.40674721629219607,-1.0462634123521601,3017,6,SOD2|CDKN2A|PPARG
NCRNA PROCESSING%GOBP%GO:0034470,0.125208681135225,0.479995594509368,0.149830824163873,1.19301489725502,899,294,FDXACB1|SSB|WDR12|PUS10|WDR75|INTS8|PUS7|USB1|IMP4|EBNA1BP2|CPSF3|SMAD3|PRKRA|QTRT1|TYW5|DDX27|ALKBH8|MPHOSPH6|DIS3L2|METTL1|PIH1D1|TFB1M|TRMT44|BTRC|RPL26|MDN1|SMAD1|EXOSC10|ELAC2|MRPS9|DCAF13|INTS9|NSUN6|INTS3|HEATR1|ADAT2|TSR1|PDCD11|WDR18|MTERF4|ISG20L2|PARN|MRPL44|TSEN34|AGO2|TPRKB|RPF1|FARS2|UTP20|XRN2|C1D|TRMT1|UTP3|PELP1|BMS1|DDX1|RNMTL1|NOP58|AGO3|ELP3|EXOSC8|WDR46|CTU1|INTS6|NSUN4|GAR1|RPF2|KIAA1456|CIRH1A|GTPBP3|ZNHIT6|NSUN3|NOL10|RPS24|UTP6|WBSCR22|TRMT1L|MPHOSPH10|MOCS3|GLTSCR2|TRMT61B|PIH1D2|MRTO4|POP5|RPS21|PUS1|THG1L|MTFMT|DIEXF|DIS3|SEPHS1|RPL14|TFB2M|RPS19|CPSF3L|ANKRD16|THUMPD3|QTRTD1|TRUB1|ZCCHC11|TRMT13|TRNT1|FTSJ3|SENP3|SMAD2|NOP14|THUMPD2|EMG1|PES1|DGCR8|AGO1|DHX37|NOL12|KIAA0391|MRPL1|NOLC1|C9orf64|RPS7|WDR55
NEURON MATURATION%GOBP%GO:0042551,0.141459437423563,0.50708003098953,0.347074226784748,1.3346038064982,1040,17,ADGRB3|FARP2|PICK1|KCNIP2|AGRN|NRCAM|CLN5
GALACTOLIPID CATABOLIC PROCESS%GOBP%GO:0019376,0.746354515050167,0.9118647019584949,-0.6322232024702249,-0.842273111433639,5578,1,GALC
CELLULAR RESPONSE TO LITHIUM ION%GOBP%GO:0071285,0.951634512325831,0.9858647066977451,0.34728425696167603,0.5834823913810671,7102,2,ADCY7|CDKN1B
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM TUBULAR NETWORK%GOBP%GO:1903420,0.8280936454849499,0.943061234519578,-0.5896007940008821,-0.7854898291086608,6189,1,GBF1
CAAX-BOX PROTEIN PROCESSING%GOBP%GO:0071586,0.6854603343061819,0.8858989071675258,-0.52285635511442,-0.8701165859279939,5166,2,ZMPSTE24|RCE1
EVASION OR TOLERANCE OF HOST DEFENSES%GOBP%GO:0044415,0.6752217145928511,0.882488012133495,0.421547863421082,0.829134901428522,5024,3,SMAD3|EIF2AK2
'DE NOVO' NAD BIOSYNTHETIC PROCESS FROM ASPARTATE%GOBP%GO:0034628,0.559656084656085,0.8268422944617521,-0.475265234859766,-0.928072548202521,4230,3,NMNAT3
ORGANELLE LOCALIZATION%GOBP%GO:0051640,0.9182509505703421,0.976131586905157,-0.0974231097335074,-0.8159712913761931,7244,456,ESPL1|DNM1|ATP2A1|STX4|OFD1|CEP70|TFG|PDCD6|TOR1A|CDC23|RAB27B|SYT4|GEM|BOD1|OPA1|KPNB1|TUBA4A|NPM1|TRAPPC5|SYT7|SDCCAG8|CAV2|PLEK|NAPA|HAUS8|SCFD1|CPLX2|CDK5RAP2|SLC9A3R1|SAPCD2|SEC23A|S100A13|VPS18|SERPINA1|NDC80|STX11|F8|WIPI1|KIF18A|SPICE1|CEP131|SEC13|SEC24A|ARFGAP2|VAMP8|NMD3|PPP6R3|CKAP5|CNIH2|RAN|TUBB4A|CNIH1|STX1B|TMED2|CTSZ|KIFC1|STX7|RAB3C|CCNB1|PLK1|NSFL1C|CTSC|CHGA|CHMP4A|SUN2|STX3|RAB1B|CHMP6|TMEM216|NSF|RAB34|DTNBP1|SYNE3|CD59|STX5|CNIH3|ATP6AP1|TMED10|PRRT2|SSNA1|MILR1|PRKACA|TRAPPC2|CETN2|HSP90AA1|NUP98|TMED9|CEP63|GOSR2|DYNC1I1|MARK2|KIF22|COPG1|PPP6C|SAR1B|TUBB4B|CDCA5|DCTN3|HAUS7|GRIA1|SNPH|DNM3
MUSCLE HYPERTROPHY IN RESPONSE TO STRESS%GOBP%GO:0003299,0.13367748947153898,0.495264631574533,0.621159227952933,1.3647132775175,983,4,HDAC4|INPP5F|CAMTA2|TCAP
POSITIVE REGULATION OF TELOMERIC DNA BINDING%GOBP%GO:1904744,0.814308681672026,0.9360565056688009,0.441168609962489,0.741220226321923,6077,2,ACD|PINX1
DISACCHARIDE CATABOLIC PROCESS%GOBP%GO:0046352,0.532474432195511,0.812079525085925,0.7324106749007501,0.976570808715744,4008,1,ATHL1
L-THREONINE CATABOLIC PROCESS TO GLYCINE%GOBP%GO:0019518,0.8992063492063491,0.967562624209366,-0.330667046151703,-0.645708933915948,6797,3,SDSL
PROTEIN DESUCCINYLATION%GOBP%GO:0036048,0.342143710984194,0.701955655133333,0.829234671371857,1.1056725432715602,2575,1,SIRT5
PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0099171,0.547290969899666,0.818317601346006,-0.7290471989413321,-0.971265923545751,4090,1,RAB26
POSITIVE REGULATION OF RELAXATION OF CARDIAC MUSCLE%GOBP%GO:1901899,0.151438127090301,0.518496345408823,-0.922088663431848,-1.22844350623624,1131,1,CHGA
CEREBRAL CORTEX TANGENTIAL MIGRATION USING CELL-CELL INTERACTIONS%GOBP%GO:0021823,0.346245688511542,0.703504080836324,-0.662641301350979,-1.1027410897591998,2609,2,ROBO1|SLIT2
PHOSPHATIDYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0046471,0.44486791956893196,0.76693681188187,-0.2538679825273,-1.00300871517107,3384,19,PLA2G2A|PLA2G2D|PLA2G4D|PLA2G4A|PTPMT1|PLA2G12A
CELLULAR RESPONSE TO HISTAMINE%GOBP%GO:0071420,0.152968346692026,0.52097307188263,0.6051398003639771,1.32951791287496,1125,4,GABRB3|GABRG2|HRH1|DIAPH1
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009140,0.481471642980476,0.7857362908355991,0.7596493162770179,1.0128898616033102,3624,1,ENTPD4
NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009132,0.0108864696734059,0.134645873234709,-0.35047030813122804,-1.73070921725027,83,39,GPI|PFKFB2|HK1|HK3|NUDT16|ENO1|PGAM1|GAPDH|NUDT18|NME2|LDHA|CMPK2|PGK1|ALDOA|ALDOC|AK1|BAD
ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0009066,0.614438063986875,0.852474178722926,0.18399728167307,0.8918374427248779,4493,35,AASS|AADAT|MTHFR|GCDH|AASDHPPT|MRI1|ENOPH1|PIPOX|NMNAT2|NIT2|HRSP12|CTH|ALDH7A1|MTAP
L-PROLINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1904555,0.535927746048612,0.8132910857498922,0.7305910895456551,0.9741446371665742,4034,1,SLC36A4
RESPONSE TO DOPAMINE%GOBP%GO:1903350,0.9366456361724499,0.9806508984207809,-0.216326828365918,-0.5913197383810329,7125,7,MAPK3|ABL1
NUCLEOTIDE TRANSPORT%GOBP%GO:0006862,0.237047643842749,0.6217158626397761,-0.421928654269599,-1.21467354232189,1820,8,SLC25A4|SLC25A42|SLC25A19
HAIR CYCLE PROCESS%GOBP%GO:0022405,0.7878128400435258,0.927797067038212,0.219013182196643,0.74438320779675,5791,12,FGFR2|HDAC1|ATP7A
PARAXIAL MESODERM FORMATION%GOBP%GO:0048341,0.7412671005445608,0.9098143075756671,0.6290802823114251,0.838793672862902,5580,1,LEF1
SUCCINATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0071422,0.937248051599033,0.9806508984207809,0.308320575209864,0.6064301872161519,6974,3,SLC25A30|SLC25A14
BONE DEVELOPMENT%GOBP%GO:0060348,0.0925589836660617,0.42100228741929396,-0.234428795287343,-1.3500491895750002,713,68,COL20A1|COCH|SBDS|SFRP4|MED1|ANXA6|PPIB|VWA1|COL14A1|PTGER4|MEF2C|FREM1|MBTPS2|COMP|SULF1|IGF1|LRP5|COL12A1|COL6A3|PLS3|COL21A1|BMP2|FOXP1|COL6A1|ANXA2|ZNF385A|COL6A2|VKORC1|COL13A1
REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0060372,0.48527679623085995,0.7872939093021379,-0.443025753237816,-0.969875982858884,3707,4,FLNA|KCNQ1
MONOUBIQUITINATED HISTONE DEUBIQUITINATION%GOBP%GO:0035521,0.6122235309514461,0.852045339927398,-0.39771297158839203,-0.870676831755102,4677,4,USP16|MYSM1
CELL-CELL ADHESION MEDIATED BY CADHERIN%GOBP%GO:0044331,0.904504260787231,0.9698755111576809,0.162767575105151,0.648935424172074,6686,19,CDHR3|MMP24|MLLT4|CDH4|CDH24|FER|PLEKHA7|CDH2|CDH13|CDH22
REGULATION OF MYD88-INDEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034127,0.00749211356466877,0.10497199047756302,-0.6769737868456259,-1.85047765712744,56,7,TICAM2|IRF7|TICAM1|TLR4|CD14|LY96
REGULATION OF WNT PROTEIN SECRETION%GOBP%GO:0061356,0.81918280711064,0.9389789016232991,-0.450926066014964,-0.7504130823484391,6174,2,WLS
INTRACILIARY ANTEROGRADE TRANSPORT%GOBP%GO:0035720,0.6350443429185699,0.863600910248377,0.436851023866978,0.8592344121338549,4725,3,IFT52|TTC26|ICK
REGULATION OF DENDRITIC SPINE MAINTENANCE%GOBP%GO:1902950,0.139984227129338,0.50441226838315,-0.49625303395910597,-1.3564855382390701,1064,7,FCGR2B|INS|APOE|PRNP
QUINOLINATE CATABOLIC PROCESS%GOBP%GO:0034213,0.0232775919732442,0.21209732484039803,-0.989137626819585,-1.31776882487424,173,1,QPRT
TIRAP-DEPENDENT TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0035665,0.9232301766502858,0.9776156396135859,0.539258932509925,0.719029022753894,6950,1,TIRAP
FOLLICULAR B CELL DIFFERENTIATION%GOBP%GO:0002316,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
CELLULAR HOMEOSTASIS%GOBP%GO:0019725,0.00012680699974638602,0.00518555396908895,-0.221162828948684,-1.84319044645953,0,438,GPR89B|TCIRG1|ZNF236|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|SLC12A8|ATP6V0A2|ERO1L|PTGER1|RAB7A|PLN|ITPR3|SLC8B1|ATP1A3|SLC12A2|POLD4|ATP1B3|WBP2NL|P2RX5|P2RX3|GAS6|GPX1|ANXA6|PCNA|SLC39A8|HK1|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ATP5B|HK3|ADCY8|CXCR4|JPH4|CALB2|CCDC22|BAG3|TAC1|POLD1|CALCB|DMXL1|RMDN3|ATP6V0D1|ABCB7|HAMP|CA2|SLC9A1|PTGER4|UBE2S|ORMDL3|TBXA2R|POLD2|SLC9A7|RFC5|HAAO|SLC11A1|NUCKS1|GHRL|ABL1|CALR|ACO1|HERPUD1|HMOX1|SOD1|ERP44|SKP1|SLC35G1|ARF1|SLC9A9|LRRC8A|MT1M|CCRL2|P2RY6|CCL2|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|FTL|APLNR|NOS3|GNA15|TMCO1|MTL5|CD36|F2RL3|ATP6V0E1|GRIN2C|FXN|MT2A|PDK3|SRF|TGM2|FITM2|GRIN2D|TRA2B|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|PLAA|ATP1B2|PRKACA|ATP6V0E2|S100A8|S100A9|POLA1|RAB20|PRDX4|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|PRDX5|GNG3|ATP2B2|PGK1|RFC4|TFRC|ATP6V1A|ATP6V1G1|POLA2|C5AR1|NGFR|FTH1|ERN1|ALDOA|FEN1|C1QTNF1|PRNP
CELL CYCLE ARREST%GOBP%GO:0007050,0.591928251121076,0.8417378833576942,-0.141814515430173,-0.926685883286418,4619,112,CDKN2B|NOTCH2|ABL1|HRAS|FAP|EIF4G2|RPTOR|CDK7|KAT2B|PLAGL1|THBS1|MYC|APBB1|GAS7|CDKN2C|CDKN3|SLC38A9|DHCR24|ERN1|RRAGD
POSITIVE REGULATION OF CHYLOMICRON REMNANT CLEARANCE%GOBP%GO:0090321,0.9360535117056858,0.9806508984207809,-0.531539479488311,-0.7081382168341429,6996,1,GPIHBP1
VENOUS ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0060843,0.309698996655518,0.680809181688249,-0.8423577415086021,-1.1222227737111201,2314,1,NOTCH1
MO-MOLYBDOPTERIN COFACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0006777,0.267111634602801,0.6417330323279019,-0.544103242275852,-1.19115573535456,2040,4,MOCS2|GPHN
ADENYLATE CYCLASE-MODULATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007188,0.11681643132220801,0.46712068687717895,-0.19687901628309,-1.26892582201495,909,106,ADGRE2|FPR1|MARCO|ADCY8|PDE4D|CALCB|OXER1|PTGER4|CALCRL|AKAP5|TBXA2R|PDE2A|ADCY4|FLNA|ADGRL4|GNAI2|CHRM2|GNAQ|GPER1|INSL3|GNA15|ADGRE5|CHGA|ADRA2C|HTR1B|ADGRG1|PTGIR|ADGRL1|ADCY9|ADGRB1
EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT/RIGHT ASYMMETRY%GOBP%GO:0060287,0.0928200928200928,0.421379812827181,0.476377729366975,1.4476679832319999,679,9,LRRC6|NPHP3-ACAD11|RFX3|NPHP3|CCDC40|CCDC103|CFAP53
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY%GOBP%GO:0007167,0.0018987341772151898,0.0379311661144279,-0.179137472939388,-1.5070579241727098,14,473,RAB14|DAB2IP|TCIRG1|NCBP2|CD4|ATP6V0B|FGFR4|DNM1|KDR|POLR2J|CLDN5|RAPGEF1|ATP6V0A2|FGR|USP9X|PDCD6|HGF|ATP6V1G2|ARPC1A|CFC1|VAV1|NGF|PDGFD|SMAD6|ITGB5|CAV2|EPHA8|VEGFC|ATP6V1F|TGFB3|INS|DDR2|IL6ST|BCAR1|KALRN|MATK|GRIN1|SHCBP1|ERBB2IP|FOXC2|EFNA1|MST1R|PDGFC|NDST1|FLT4|NPR2|ELMO1|SMAD5|MAPKAPK2|SLC33A1|ATP6V0D1|INHBA|GRB2|SMURF2|IRS1|STAT3|GCNT2|CHRD|LTBP2|NCBP1|PRKD1|HNRNPM|DDX5|NGEF|PXN|POLR2H|REPS2|PIK3CB|FGF10|MAPK3|LRRC32|CYBB|ABL1|HSPB1|DDR1|IRAK1|HRAS|SULF1|PIK3R3|IGF1|NTRK2|COL4A2|NCF4|HBEGF|CDH5|DOCK1|CSF1|CYFIP2|SDC2|EPHA2|NPR1|HFE|FMOD|NCF2|AXL|MVP|VEGFB|NRP2|HCK|FGF19|EFNA3|MUC20|TGFBR2|BMP2|ATP6V0E1|TGFBR3|FGF9|TEK|ATOH8|FGF7|COL1A2|COL1A1|UBC|PDGFRB|EPHA4|RARRES2|COL3A1|GDF11|ID1|FKBP1A|MMP9|DDIT4|POLR2G|PLAT|ATP6AP1|PTN|INSRR|FIBP|EPHB4|ATP6V0E2|PDGFA|HSP90AA1|EFEMP1|CSF1R|TIAM1|ACTB|PDGFRA|EPS8|ENG|NCK1|ATP6V1A|ACVRL1|ATP6V1G1|PDGFB|NGFR|AP2M1|EFNA5|PTPRJ|POLR2L
REGULATION OF AUTOPHAGOSOME ASSEMBLY%GOBP%GO:2000785,0.00435907914453072,0.0731407797055425,0.41366770962933297,1.89320331194886,31,29,IFT88|PHF23|RALB|PIP4K2C|IFT20|TBC1D14|KIAA1324|PIKFYVE|RAB3GAP1|SMCR8|NPRL3|SH3GLB1
THYROID HORMONE GENERATION%GOBP%GO:0006590,0.331613756613757,0.6961761803662729,-0.5761199762856851,-1.1250162966782098,2506,3,CPQ
PROTEIN CATABOLIC PROCESS IN THE VACUOLE%GOBP%GO:0007039,0.8064121722592041,0.9337214381011629,0.334489247407624,0.7348871216618371,5935,4,CCDC115|TMEM199
RESPONSE TO HYPEROXIA%GOBP%GO:0055093,0.264886794922131,0.640220404364478,-0.545656326094959,-1.19455576048743,2023,4,FAS|ATG7|CAV1
POSITIVE REGULATION OF PROTEIN K63-LINKED DEUBIQUITINATION%GOBP%GO:1903006,0.916025470947201,0.9747669359607141,-0.386607898517906,-0.6433773663850411,6904,2,VCP
PROTEIN LOCALIZATION TO M-BAND%GOBP%GO:0036309,0.0030814576634512303,0.0563267332940573,0.961014612627516,1.61462863083348,22,2,ANK2|OBSCN
CARDIAC VASCULAR SMOOTH MUSCLE CELL DEVELOPMENT%GOBP%GO:0060948,0.15096842663836602,0.5180663310314899,-0.763931866723452,-1.27130478811823,1137,2,NOTCH1
RESPONSE TO COPPER ION%GOBP%GO:0046688,0.106633520868769,0.449288135667161,-0.3667762673169771,-1.39383938117965,814,17,PARK7|MT1M|MT2A|MT1E|LOXL2|PRNP
REGULATION OF CELL SIZE%GOBP%GO:0008361,0.30027816411682895,0.673744299680098,0.173683492925789,1.09732068786747,2158,93,ISLR2|SLC12A5|SHTN1|SEMA4G|SEMA4F|RARG|SLC12A4|RTN4|SEMA6C|SLC12A9|VAV2|RAP1GAP2|PTPRS|CLCN3|SEMA4C|RUFY3|TRIM46|LIMK1|NRCAM|MAP2|KCNMA1|POU4F2|CLCN6|AKT1S1|NRP1|ZFYVE27|DCC|MEGF8|EZR
LONG-TERM MEMORY%GOBP%GO:0007616,0.394861038280021,0.7377402989373809,-0.29642243474316904,-1.0486992271678799,3011,14,SGK1|NPAS4|APOE|LDLR|PRNP
MESSENGER RIBONUCLEOPROTEIN COMPLEX ASSEMBLY%GOBP%GO:1990120,0.33690476190476193,0.699462084003389,-0.573601654883871,-1.1200986532464,2546,3,CPSF6|CPSF7
NEGATIVE REGULATION OF FORMATION OF TRANSLATION PREINITIATION COMPLEX%GOBP%GO:1901194,0.853898260061097,0.949296218452153,0.571901191001324,0.7625530699389971,6428,1,RPL13A
VESICLE TETHERING TO ENDOPLASMIC RETICULUM%GOBP%GO:0099044,0.516211146838157,0.804056180000979,0.584615384615385,0.9822293289015681,3852,2,STARD3|STARD3NL
MULTI-ORGANISM TRANSPORT%GOBP%GO:0044766,0.0698068893528184,0.37596389138254704,-0.334911863657844,-1.46094671037009,534,26,RAB7A|KPNB1|CAV2|RAB29|CLEC4M|IFIT1|RAN|THOC7|UBC|CAV1|THOC3
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION IN MUCOSAL TISSUE%GOBP%GO:2000558,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
RESPONSE TO INCREASED OXYGEN LEVELS%GOBP%GO:0036296,0.10230547550432302,0.441073279931729,-0.43931170416313203,-1.4222952780767,780,11,ATG7|ATP6V0A2|ATP6V0D1|CAV1|ATP6AP1|ATP6V1A|ATP6V1G1
REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035358,0.4603732756288879,0.7746638709296909,0.35660308913587896,0.984393255773161,3403,7,GPS2|ASXL1|CITED2|ASXL2|SIRT1
MULTIVESICULAR BODY-LYSOSOME FUSION%GOBP%GO:0061763,0.0939174705251876,0.42369033761036,0.8150241962904692,1.36934588180159,700,2,CHMP3|CHMP2B
TIGHT JUNCTION ASSEMBLY%GOBP%GO:0120192,0.9310578355681971,0.9793746057014829,0.14951218523098198,0.616311810270697,6873,21,RAB13|PARD3|MLLT4|STRN|CLDN3|PDCD6IP|PARD6A|PRKCI|PARD6B|RAMP2|INADL
POSITIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1905167,0.125497479437517,0.48053753037869495,-0.7813620071684592,-1.3003113291077502,945,2,LRP1|LDLR
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:1900017,0.523040874772195,0.807051143864932,-0.32511050661014196,-0.935947645920903,4017,8,TICAM1|TLR4
POSITIVE REGULATION OF MACROAUTOPHAGY%GOBP%GO:0016239,0.063738986784141,0.36187225235932796,0.269713547965172,1.4318903965113703,462,48,TSC2|PARK2|RALB|PIP4K2C|PAFAH1B2|KIAA1324|TRIM13|RAB3GAP1|HTT|GNAI3|SESN1|SMCR8
TETRAHYDROFOLYLPOLYGLUTAMATE BIOSYNTHETIC PROCESS%GOBP%GO:0046901,0.9545150501672242,0.9870180073166591,-0.52211071901191,-0.695576843900674,7134,1,FPGS
CIRCADIAN RHYTHM%GOBP%GO:0007623,0.000893883284382582,0.0214437672455875,-0.317978324840235,-1.9386410135270402,6,84,RORC|MTA1|ARNTL|PTEN|CSNK1D|TIMELESS|ID2|PML|ID3|NFIL3|NPAS2|LGR4|PER2|BHLHE40|NDUFA9|RORA|TOP1|HNRNPU|AHR|TNFRSF11A|IMPDH2|DYRK1A|OGT|PROKR1|ZFHX3|ARNTL2|NONO|USP2|CRY2|RBM4B|HEBP1|NR1D1|RELB|ID1|CCRN4L|SERPINE1|PRKCDBP|PPARA|MAGED1|ID4|RBM4|PRMT5|PPP1CA|CIART|NGFR
NEGATIVE REGULATION OF RECEPTOR CATABOLIC PROCESS%GOBP%GO:2000645,0.728968253968254,0.9064076322522902,-0.405741239700847,-0.7923098064412901,5510,3,ANXA2
NEGATIVE REGULATION OF LATE ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:1902823,0.372028157789879,0.7234654586828599,0.814788266431407,1.08641021157815,2800,1,VPS35
REGULATION OF HEPATOCYTE DIFFERENTIATION%GOBP%GO:0070366,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
REGULATION OF ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903959,0.268311892885272,0.6424975792471059,-0.320490255127138,-1.1636481652883501,2043,15,THBS1|ARL6IP1|ARL6IP5|PRNP
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001244,0.184156112690618,0.5568393978947089,-0.25434090114233604,-1.23557438809767,1424,37,SOD1|NACC2|BCAP31|CAV1|S100A8|S100A9|STYXL1|NCK1|BAD
FORMATION OF RADIAL GLIAL SCAFFOLDS%GOBP%GO:0021943,0.814308681672026,0.9360565056688009,0.44113592500689297,0.7411653113763951,6077,2,LEF1|ARL13B
RESPONSE TO TYPE III INTERFERON%GOBP%GO:0034342,0.8187848235606259,0.9389317625496709,-0.451302916845943,-0.7510402223941658,6171,2,IFNLR1
ENDOTHELIAL CELL FATE SPECIFICATION%GOBP%GO:0060847,0.0826390755173341,0.399980174480082,0.7295291445629029,1.4348977372521698,614,3,DLL1|NRP1|RBPJ
POSITIVE REGULATION OF SKELETAL MUSCLE CONTRACTION BY REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION%GOBP%GO:0014810,0.936588628762542,0.9806508984207809,-0.5313189236876931,-0.707844383549149,7000,1,GSTO1
REGULATION OF FRACTALKINE PRODUCTION%GOBP%GO:0032644,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|AZU1
NEGATIVE REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION%GOBP%GO:1905875,0.327892976588629,0.6950398637731511,-0.8341971768857521,-1.11135094216636,2450,1,LILRB2
REGULATION OF DENDRITE EXTENSION%GOBP%GO:1903859,0.246885157096425,0.6280519349499749,0.323195644577287,1.19213550653696,1822,15,CPNE9|SYT2|RIMS1|UNC13A|RIMS2
REGULATION OF GLUCAGON SECRETION%GOBP%GO:0070092,0.19234928359016001,0.566814321269863,0.530249350762723,1.2752466478635902,1422,5,PASK|UCN|AIMP1|CRH
CELL AGGREGATION%GOBP%GO:0098743,0.46682371417353796,0.7806653415096191,-0.450560890166379,-0.9863719727221272,3566,4,MGP|MPZ
NUCLEIC ACID TRANSPORT%GOBP%GO:0050657,0.172804893589907,0.546371269738967,-0.17445998021044698,-1.18934603711903,1355,137,FYTTD1|NXF2B|ZFP36L1|NCBP2|SLU7|CHTOP|TST|PHAX|SRSF9|TOMM20|NPM1|FMR1|MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|C14orf166|NUP37|NMD3|CKAP5|RAN|NXF1|NUP160|THOC7|ZC3H3|NUP214|TGFBR2|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE%GOBP%GO:0032287,0.238127090301003,0.6217283213739421,-0.877922364358183,-1.1696033909163102,1779,1,SOD1
ANATOMICAL STRUCTURE MATURATION%GOBP%GO:0071695,0.31915168757274,0.6869601115014491,-0.22055929688561898,-1.09799403325549,2467,40,S1PR1|MBTPS2|IGF1|RECK|RND1|SCARF1|BMP2|CX3CL1|CEND1|ANG|ACVRL1
DEPYRIMIDINATION%GOBP%GO:0045008,0.0594262295081967,0.35325117978652,0.533955229669553,1.5499786183703,434,8,NTHL1|NEIL1|OGG1|SMUG1|NEIL2|TDG
POSITIVE REGULATION OF THYMOCYTE MIGRATION%GOBP%GO:2000412,0.543006430868167,0.8161852878569359,0.573202041451165,0.963053438749293,4052,2,XCL1
REGULATION OF OOCYTE MATURATION%GOBP%GO:1900193,0.620456354470682,0.855212458292881,-0.551585332230494,-0.917926197957997,4676,2,YTHDF2|SIRT2
NEGATIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904339,0.7317725752508358,0.9074802896081321,-0.638343625937362,-0.850426985092207,5469,1,GSK3B
REGULATION OF HYDROGEN SULFIDE BIOSYNTHETIC PROCESS%GOBP%GO:1904826,0.252224731039979,0.632257972333528,0.8759373621526251,1.16794427970024,1898,1,SP1
REGULATION OF AORTIC SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1904829,0.48386239872493,0.787078399497453,0.758215703573004,1.01097833250397,3642,1,CTH
MELANOCYTE ADHESION%GOBP%GO:0097326,0.189666622393412,0.563467720122429,0.9076422584913979,1.21021848093577,1427,1,KIT
PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0046131,0.0862970711297071,0.406139467312843,-0.4697299977781021,-1.4716027642758402,659,10,APOBEC3G|APOBEC3C|CTPS1|CDA|UMPS
VIRAL TRANSCRIPTION%GOBP%GO:0019083,0.8837523655041899,0.96326332270073,0.275010568420793,0.661398840000866,6537,5,MON1B|CCNT2
REGULATION OF FORMATION OF TRANSLATION PREINITIATION COMPLEX%GOBP%GO:1901193,0.853898260061097,0.949296218452153,0.571901191001324,0.7625530699389971,6428,1,RPL13A
SECRETION BY TISSUE%GOBP%GO:0032941,0.8916689207465509,0.965443067117994,0.23534032624643603,0.649650653699673,6592,7,AQP5|VAMP3
STILBENE METABOLIC PROCESS%GOBP%GO:0009810,0.771151547350246,0.9213545359508709,0.613641376268196,0.818207974869947,5805,1,EPHX2
SNORNA LOCALIZATION%GOBP%GO:0048254,0.232794896158545,0.616523546447917,0.470527902485932,1.21751860308262,1714,6,PIH1D1|NOP58|ZNHIT6|PRPF31|FBL
PENTOSE BIOSYNTHETIC PROCESS%GOBP%GO:0019322,0.46428571428571397,0.778084974123226,-0.51949758164696,-1.0144471108356998,3509,3,TKT|TALDO1
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT%GOBP%GO:0048566,0.217385408190941,0.5996151428055749,0.340948391843776,1.2254950250906498,1602,14,RBPMS2|STRA6|FGFR2
NEGATIVE REGULATION OF MICROVILLUS ASSEMBLY%GOBP%GO:1903697,0.0338461538461538,0.262664551942902,-0.983017203352448,-1.30961495121567,252,1,RAP1GAP
HETEROCHROMATIN ORGANIZATION INVOLVED IN CHROMATIN SILENCING%GOBP%GO:0070868,0.317192889360573,0.6861326333203311,-0.676067924078828,-1.1250851370567398,2390,2,POLE3
CELL ADHESION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0061343,0.6243716886292621,0.857753590658582,0.39277857543177097,0.862951257735742,4595,4,ACVR1|FLRT2
REGULATION OF METAL ION TRANSPORT%GOBP%GO:0010959,0.0835988275774181,0.402388938341306,-0.17198016355834903,-1.2692701422764199,655,207,CD4|GLRX|ATP1B1|AMIGO1|P2RX4|KCNIP3|SPTBN4|PLN|TMBIM6|SLC8B1|ATP1B3|P2RX5|KCNN2|STAC3|P2RX3|THY1|PDE4B|STIM1|GRIN1|SLC9A3R1|FMR1|KCNIP4|LILRB2|MYLK|JPH4|PDE4D|TESC|HAMP|SEPN1|SLC9A1|UBQLN1|PKP2|CD63|CAMK2B|FLNA|FXYD1|P2RY6|CCL2|GPER1|HFE|F2R|CCR1|KCNQ1|APLNR|LGALS3|F2RL3|PDGFRB|FKBP1A|CX3CL1|CAMK2A|CAV1|SCN1B|CLIC2|SIK1|ATP1B2|PRKACA|KCNH2|KCNE4|ANXA2|FXYD5|AHNAK|PDGFB|FXYD7|WNK2|PRNP
REGULATION OF MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0010464,0.0802614379084967,0.39713464989621,-0.44211500777864293,-1.479800326971,613,12,CHRD|LRP5|TGFBR2|MYC|PDGFA
KILLING BY HOST OF SYMBIONT CELLS%GOBP%GO:0051873,0.0912708941363757,0.41778255328704206,-0.809374138406396,-1.3469279949642599,687,2,AZU1|GAPDH
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE%GOBP%GO:0002830,0.356417599583442,0.7143448949172672,-0.3762218594700179,-1.08309007723703,2737,8,RSAD2|CD86|NLRP3
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:1903077,0.139252092050209,0.504314492208813,-0.34365863129478,-1.33352329949283,1064,18,PID1|NUMB|CLTC|PPFIA1|TMEM59|DAB2|AP2M1
EMBRYONIC PLACENTA MORPHOGENESIS%GOBP%GO:0060669,0.0646120573127872,0.364923210784497,0.637701621842615,1.5336687436245,477,5,FGFR2|BMP7|ZNF568|IGF2|LEF1
REGULATION OF PERIPHERAL TOLERANCE INDUCTION%GOBP%GO:0002658,0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
"NEGATIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000562",0.38124671225670703,0.729499056535481,-0.442613185502436,-1.06085934727974,2898,5,CD274|TWSG1|C10orf54|LGALS9
SYNAPTIC VESICLE ENDOCYTOSIS%GOBP%GO:0048488,0.701251019853141,0.8931369333627571,0.191273382792888,0.8239336817876322,5156,24,SYT2|KIAA1109|SYT5|NLGN2|NLGN4X|CDK5|AMPH|PIP5K1C|SNCA|DNAJC6|FCHO2
"PHAGOCYTOSIS, ENGULFMENT%GOBP%GO:0006911",0.000260858223555498,0.00819882332206558,-0.46327747191153495,-2.36163200975332,1,44,CDC42|RAC3|IGHV2-26|IGHV1OR15-1|IGHV5-51|ARHGAP25|IGHV1-24|IGHV3-49|ITGB2|IGHG4|MSR1|FCGR1A|IGLL5|FCGR2B|C3|IGHV4-4|ELMO1|IGHV4-61|IGHV1-3|IGHV3-43|IGHV3-73|VAMP7|DOCK1|GSN|CD36|THBS1|IGHV3-15|AIF1|MYH9|ITGAM|IGHV1-18|IGHG2|IGHA1|ADGRB1
ERYTHROPOIETIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038162,0.189666622393412,0.563467720122429,0.9076422584913979,1.21021848093577,1427,1,KIT
REGULATION OF MRNA STABILITY INVOLVED IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:2000815,0.938312549747944,0.9806508984207809,-0.36772778541052403,-0.6119578390172711,7072,2,HNRNPM
HIGH-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034375,0.0405334728033473,0.288441534418227,-0.515420089080413,-1.6147438559211298,309,10,APOC2|PLTP|ABCA5|APOC1|ABCG1|CETP|APOM|APOE
POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION%GOBP%GO:1902035,0.0677920685959271,0.37163338232940996,0.8384891094568508,1.40876996559868,505,2,N4BP2L2|PDCD2
PROXIMAL TUBULE DEVELOPMENT%GOBP%GO:0072014,0.23774737680966898,0.6217158626397761,0.882829730921923,1.1771343234471001,1789,1,PKD1
PHYTOL METABOLIC PROCESS%GOBP%GO:0033306,0.220391211146838,0.6027391478106829,0.7241284052167858,1.21662921676716,1644,2,ALDH3A2|PECR
PROTEIN NEDDYLATION%GOBP%GO:0045116,0.973464052287582,0.9920058127185359,-0.15629774206398,-0.5231431770959211,7446,12,RNF7|DCUN1D3|NEDD8
PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007206,0.487979811395936,0.7882673024233101,0.756340979267755,1.0084786406048198,3673,1,HOMER1
DIGESTIVE SYSTEM PROCESS%GOBP%GO:0022600,0.0756302521008403,0.385018945189654,-0.363952193321305,-1.46016922867085,575,20,MUC4|GHRL|TJP2|KCNQ1|CD36|LDLR|TLR4
HISTONE H2A UBIQUITINATION%GOBP%GO:0033522,0.512402088772846,0.802184867798321,-0.22677475065532,-0.952132274765277,3924,23,PCGF2|PCGF5|UBE2A|CUL4B|DTX3L|UBE2B|BCOR|RNF168|SKP1|RING1|DDB1
DEATH-INDUCING SIGNALING COMPLEX ASSEMBLY%GOBP%GO:0071550,0.590073032188261,0.8414799095069009,0.318389622551022,0.8789060069750629,4362,7,TRADD|RIPK1|CASP8
HISTONE H3-R2 DEMETHYLATION%GOBP%GO:0070078,0.24200668896321104,0.625158460820442,-0.8759373621526251,-1.16695889135137,1808,1,JMJD6
IRES-DEPENDENT TRANSLATIONAL INITIATION OF LINEAR MRNA%GOBP%GO:0002192,0.0488294314381271,0.31702674791770696,-0.9736435818262019,-1.29712703660345,364,1,RBM4
NEGATIVE REGULATION OF NEURON MATURATION%GOBP%GO:0014043,0.175652173913043,0.548366806412612,-0.909902955447728,-1.21220921724036,1312,1,EDNRB
INTESTINAL EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0060575,0.16561872909699,0.5375245857985801,-0.9154719894133221,-1.21962850768644,1237,1,GATA6
GMP METABOLIC PROCESS%GOBP%GO:0046037,0.289098285564717,0.6622070134491391,-0.533706902453586,-1.1683959742581398,2208,4,GMPR2|HPRT1|GMPS
TRANSCRIPTION INITIATION FROM MITOCHONDRIAL PROMOTER%GOBP%GO:0006391,0.8918301531846279,0.965443067117994,0.334675195764862,0.6582666157979921,6636,3,TFB2M|POLRMT
PROTEIN DEADENYLYLATION%GOBP%GO:0044602,0.160936454849498,0.5311416159351421,-0.9178429642699599,-1.22278721550012,1202,1,FICD
ADULT BEHAVIOR%GOBP%GO:0030534,0.104591143710948,0.445049828108174,0.30415244058442603,1.3779596062013502,769,28,CHRNB1|DRD2|BBS4|PARK2|DRD4|CHRNB2|CHRNA5|BTBD9|BBS2|NLGN4X|SHANK2|CHRNA3
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS%GOBP%GO:0043524,0.36931818181818205,0.722131425100624,-0.201279348156525,-1.06052022296396,2859,49,SOD2|NGF|TGFB3|MEF2C|PARK7|SOD1|AARS|NTRK2|NAIP|NONO|CCL2|F2R|APOE|CX3CL1|LGMN
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:1903749,0.553053329649074,0.8231366946320219,0.17163375785333101,0.9361055305361969,4002,53,BBC3|HTRA2|PMAIP1|HPS4|CASP8|TP53BP2|BID|YWHAQ|SH3GLB1|YWHAB|YWHAE|VPS11|BCL2|YWHAH|HSPA1L|CSNK2A2|UBL4B|YWHAZ|MAPK8
POSITIVE REGULATION OF OVULATION%GOBP%GO:0060279,0.23215707084107198,0.615812511957369,-0.7172870140612081,-1.1936802942155,1749,2,INHBB|INHBA
GLUCOSE CATABOLIC PROCESS%GOBP%GO:0006007,0.0609660574412533,0.35631208031004796,-0.35714398307834605,-1.49949812333369,466,23,GPI|HK1|HK3|ENO1|LRP5|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
NEGATIVE REGULATION OF ENDOCYTOSIS%GOBP%GO:0045806,0.0118970645286435,0.143385281385281,-0.34856390960157,-1.73522992843601,91,40,RAC1|APOC2|LRPAP1|LILRB1|PSEN1|GNB2L1|UBQLN2|TLR2|APOC1|MCTP1|FCGR2B|PRKD1|CD47|NECAB2|DYSF|NR1H3|STX1B|CD300A|LGALS3|CD300LF|CAV1|ARF6|SIRPA
"FATTY ACID ELONGATION, UNSATURATED FATTY ACID%GOBP%GO:0019368",0.507759074171489,0.7987565605553191,-0.39487388553412395,-0.9464373547525979,3860,5,ELOVL2|ELOVL1
NEURON PROJECTION MAINTENANCE%GOBP%GO:1990535,0.18316831683168303,0.556308895147568,-0.42482264425611493,-1.2779704987991203,1405,9,APP|MAP1A|PSEN1|ATP1A3|INS|ABCD1|PRNP
"RETROGRADE TRANSPORT, ENDOSOME TO PLASMA MEMBRANE%GOBP%GO:1990126",0.119309688816415,0.47098246139817795,0.35666292788139203,1.37147521899548,877,17,FAM21C|MICALL1|LRRC7|WASH1|RAB11B|VPS35|RAB11A|ANKRD27|VPS39|ANKRD50|SNX27|SNX17|SCRIB|VPS26A
CARBOHYDRATE DERIVATIVE TRANSPORT%GOBP%GO:1901264,0.272336545975514,0.646711433596285,-0.250064810871763,-1.15244196691172,2090,31,SLC35B1|ABCG1|SLC37A2|VAMP8|RFT1|SLC35A2|SLC25A4|SLC25A42|NPC2|SLC25A19
CELLULAR RESPONSE TO HYDROXYUREA%GOBP%GO:0072711,0.651288117770768,0.872581710088317,-0.306615515375476,-0.838119837955139,4954,7,ATRX|BLM|TIMELESS|NDNL2|FMR1
AUDITORY RECEPTOR CELL FATE COMMITMENT%GOBP%GO:0009912,0.19371237458194,0.567690182346143,-0.9011358623731809,-1.20052934416187,1447,1,JAG2
ANTEROGRADE SYNAPTIC VESICLE TRANSPORT%GOBP%GO:0048490,0.5562026002166851,0.8257149029717741,0.24887298898683802,0.917989867026946,4106,15,BLOC1S3|AP3B2|AP3B1|AP3M1|BLOC1S5|AP3M2|AP3S2|BLOC1S6|AP3D1|SNAPIN|BLOC1S4|BLOC1S2
SYNAPTIC SIGNALING VIA NEUROPEPTIDE%GOBP%GO:0099538,0.226220735785953,0.608682632875901,-0.8838773709748571,-1.17753688961113,1690,1,NTRK2
POSITIVE REGULATION OF INTERLEUKIN-8 BIOSYNTHETIC PROCESS%GOBP%GO:0045416,0.683730158730159,0.885415243771438,-0.42339313791197397,-0.8267794897924109,5168,3,TLR4
FUNGIFORM PAPILLA FORMATION%GOBP%GO:0061198,0.305466237942122,0.677423587903087,0.6811690102012679,1.14445188642908,2279,2,HDAC1|HDAC2
REGULATION OF MACROPHAGE CHEMOTAXIS%GOBP%GO:0010758,0.173890271048841,0.548035161776014,-0.372567000319127,-1.2824478640009198,1327,13,CSF1|THBS1|RARRES2|CMKLR1
REGULATION OF DERMATOME DEVELOPMENT%GOBP%GO:0061183,0.930868167202572,0.9793746057014829,0.3642227333764289,0.611941218773068,6947,2,WNT4
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010667,0.7465166130760992,0.9118647019584949,0.475323959194927,0.7986056230080659,5571,2,HAND2|PPP1R10
IMPORT INTO NUCLEUS%GOBP%GO:0051170,0.23418043202032998,0.617951264290741,-0.183006666040102,-1.14832362231419,1842,94,POM121|CBLB|RPL23|DDX20|NUP107|KPNA1|PHB2|SNRPD3|SMN2|GEMIN5|AKT1|GEMIN7|HNRNPA1|TNF|SYK|HEATR3|NUP93|MMP12|SNRPE|TGFB1|NXT1|HTATIP2|PRICKLE1|GEMIN8|NCKIPSD|KPNB1|GEMIN2|IPO4|NUP188|IPO7|SNRPF|STAT3|SNRPD1|NUP85|KPNA4|RAN|RBM22|BCL3|KPNA2|NUP214|SEC61B|SNRPB|BCL6|NUP98|IPO11|SMN1
REGULATION OF SODIUM-DEPENDENT PHOSPHATE TRANSPORT%GOBP%GO:2000118,0.0371693121693122,0.274804008408919,-0.782838866218154,-1.52868589602904,280,3,SFRP4|CEBPB|CRY2
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS%GOBP%GO:0090287,0.0205338809034908,0.19725150907349803,-0.21173967044886605,-1.47494890040246,159,153,AGT|SKIL|DAB2IP|HGS|LEMD3|TMEM204|SEMA6A|SFRP4|PDCD6|SPRY1|CDKN1C|GATA3|SMAD6|CASK|VTN|ITGA5|DCN|SMOC2|NOTCH1|SMURF2|FAM129B|HTRA3|CHRD|CD63|FBN1|CDKN2B|LTBP1|SNW1|MMRN2|CREB3L1|SULF1|MEN1|LDLRAD4|SNX6|GIPC1|PCSK6|ADAMTSL2|CCBE1|TGFBR2|THBS1|NBL1|XIAP|UBC|SLIT2|FAM89B|TMEM108|CAV1|DAB2|ENG|ACVRL1|PRKCB|GRB10
CRD-MEDIATED MRNA STABILIZATION%GOBP%GO:0070934,0.18726985796949,0.5607261106188249,-0.5352967129936029,-1.28300407703118,1423,5,SYNCRIP|IGF2BP1|YBX1|DHX9|HNRNPU
REGULATION OF HEART MORPHOGENESIS%GOBP%GO:2000826,0.47631399317406103,0.7850084910380921,0.22557566890359398,0.9828142857756809,3488,25,DKK1|ACVR1|GNG5|RNF207|ROBO2
REGULATION OF CHONDROCYTE DIFFERENTIATION%GOBP%GO:0032330,0.208812761506276,0.589323132805971,-0.318146118617698,-1.23452526194809,1596,18,ANXA2|EFEMP1|ACVRL1|LOXL2
NITRATE METABOLIC PROCESS%GOBP%GO:0042126,0.266345123258307,0.641603173139009,0.7002636557064019,1.1765333562871798,1987,2,MARC2|MARC1
INDUCTION OF NEGATIVE CHEMOTAXIS%GOBP%GO:0050929,0.121070234113712,0.472999327000989,-0.937858403176003,-1.2494525861132701,904,1,SLIT2
ENDOTHELIAL CELL DEVELOPMENT%GOBP%GO:0001885,0.127659574468085,0.484643747394476,-0.294638726594967,-1.3322149555166598,977,29,SOX18|COL23A1|RAPGEF1|RAP2B|PDE4D|ICAM1|PDE2A|MSN|RAPGEF3|TJP2|RAP1A|RAB1B|ENG
"POSITIVE REGULATION OF WOUND HEALING, SPREADING OF EPIDERMAL CELLS%GOBP%GO:1903691",0.82448925444415,0.942178419436027,-0.447670258917614,-0.7449948986957491,6214,2,RREB1
NEGATIVE REGULATION OF BONE MINERALIZATION%GOBP%GO:0030502,0.655153657873266,0.874775007199212,0.265464527518107,0.841009567277552,4817,10,TRPM4|FAM101B|PTK2B
ORBITOFRONTAL CORTEX DEVELOPMENT%GOBP%GO:0021769,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
REGULATION OF INTERLEUKIN-12 PRODUCTION%GOBP%GO:0032655,0.26242337289683104,0.638240557311977,-0.263276468147696,-1.16117784764576,2011,27,RIPK2|JAK3|LILRB1|PLCB1|IRAK3|CCL19|TLR2|IRF5|CD47|LGALS9|THBS1|FOXP1|TLR4|CMKLR1
NEGATIVE REGULATION OF CGMP-MEDIATED SIGNALING%GOBP%GO:0010754,0.516666666666667,0.804108323152586,-0.49537914076901896,-0.967349908594798,3905,3,PDE2A|THBS1
EMBRYONIC BODY MORPHOGENESIS%GOBP%GO:0010172,0.7021164021164019,0.8931369333627571,-0.4161244071909121,-0.8125855009464051,5307,3,FUZ|IFT122|ZNF281
GLUCOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:0006680,0.7178595317725749,0.900060477413567,-0.6446846052051171,-0.8588746920357678,5365,1,GBA
CHIASMA ASSEMBLY%GOBP%GO:0051026,0.10991668906208,0.45483419590443,0.702106540200728,1.3809607105519899,817,3,RNF212|CCNB1IP1|MSH5
REGULATION OF SHORT-TERM NEURONAL SYNAPTIC PLASTICITY%GOBP%GO:0048172,0.8942123942123941,0.9658968257150641,0.21241682420727104,0.645515137563871,6550,9,RAB3GAP1|PPFIA3|SLC8A2|GRIK2|SHISA9
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE-GATED CALCIUM CHANNEL%GOBP%GO:1904879,0.3914198432726789,0.737044232454672,0.8054697838553159,1.0739852724324,2946,1,CACNB2
GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY%GOBP%GO:0097116,0.6392857142857139,0.865463150027443,-0.440566197309945,-0.8603141223026372,4832,3,NRXN2
LATERAL VENTRICLE DEVELOPMENT%GOBP%GO:0021670,0.239084692267228,0.622604781889171,-0.5076970954398761,-1.2168530602466698,1817,5,AQP1|CDK6|NUMB
MRNA STABILIZATION%GOBP%GO:0048255,0.18705129878605897,0.560277092850838,-0.27571311627262896,-1.2466424260495501,1432,29,FAM46C|YBX1|DHX9|HNRNPU|LARP1|MAPKAPK2|SLC11A1|E2F1|CCRN4L|YBX3|HNRNPA0|HNRNPC
NEGATIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS%GOBP%GO:1903243,0.7505291005291009,0.914270866779142,-0.397203257456609,-0.775637291060998,5673,3,LMNA
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0060307,0.402202412165705,0.740287621109606,-0.294533674937169,-1.04201707117462,3067,14,KCNQ1|SCN1B|KCNH2|KCNE4
EXTRACELLULAR STRUCTURE ORGANIZATION%GOBP%GO:0043062,0.000128155837498398,0.00518555396908895,-0.35783387295664204,-2.65534110317688,0,214,MMP12|ECM2|APOC2|CD44|ITGA9|TGFB1|GREM1|PLTP|HSPG2|COL15A1|ITGAX|ADAMTS4|LAMB2|DPT|LAMC1|COL27A1|FBLN5|NCAN|ADAM8|PLOD2|ITGA10|DGAT1|AGT|MYH11|ABCA5|ITGA11|ITGB2|LAMC2|COL18A1|COL23A1|SPOCK2|ST7|COL11A2|KDR|NID2|CTSV|LAMC3|TPSAB1|APOC1|CD34|CTSS|MFAP4|CYP1B1|PLA2G2A|ITGB5|MMP1|LAMA2|GAS6|ADAM12|POSTN|DDR2|VTN|TNXB|ABCG1|ITGA5|DCN|VWF|COL14A1|COL5A3|ELN|MADCAM1|CD47|ICAM1|HTRA1|BGN|FBN1|CETP|MMP14|PLA2G7|CREB3L1|APOM|SPP1|COL4A1|COMP|DDR1|VCAN|LAMA4|SPARC|SULF1|RECK|COL4A2|GPM6B|VCAM1|COL5A2|COL12A1|LUM|COL6A3|COL8A1|GSN|APOE|FN1|MFAP5|TNC|A2M|THBS1|SERPINH1|COL1A2|COL1A1|ITGA8|COL3A1|ADAM19|MMP9|SERPINE1|MYO1E|NID1|COL6A1|PRKACA|TGFBI|ITGAM|PDGFA|ANXA2|CTSL|TIMP1|COL16A1|CSGALNACT1|COL5A1|MMP19|COL6A2|PDGFB|COL13A1|LOXL2|ITGB4|SERPINF2|ICAM2|P4HB
NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002887,0.0189765737468918,0.19023670570355602,-0.7553080019853309,-1.65352710408568,144,4,CD84|FCGR2B|CD300A|LGALS9
CELL MIGRATION TO THE MIDLINE INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0003318,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
POSITIVE REGULATION OF ER-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:1903071,0.08767087276550999,0.40905715364188894,-0.534942955701288,-1.46224271396889,666,7,UBQLN2|UBQLN1|HERPUD1|BCAP31|CAV1
POLYOL BIOSYNTHETIC PROCESS%GOBP%GO:0046173,0.34173100365705,0.701955655133333,0.26338785347926,1.08572451489711,2522,21,CYP27B1|SPR|PTS|FGF2|QDPR|ASAH2B|ISYNA1
RESPONSE TO KAINIC ACID%GOBP%GO:1904373,0.853765440297516,0.949296218452153,0.572011468901632,0.762700110638946,6427,1,IREB2
REGULATION OF PROTEIN TYROSINE PHOSPHATASE ACTIVITY%GOBP%GO:1903613,0.449879064767536,0.7685627389741241,0.513308217495038,1.00961668945779,3347,3,MGAT5|PTPRC
TRANS-SYNAPTIC SIGNALING BY NEUROPEPTIDE%GOBP%GO:0099540,0.226220735785953,0.608682632875901,-0.8838773709748571,-1.17753688961113,1690,1,NTRK2
RESPONSE TO ETHANOL%GOBP%GO:0045471,0.37252508814754504,0.7234654586828599,0.29662342397290004,1.0661746443159799,2746,14,DRD2|DRD4|CHRNB2|ADCYAP1
REGULATION OF MONONUCLEAR CELL PROLIFERATION%GOBP%GO:0032944,0.000128221566867547,0.00518555396908895,-0.35816526692225104,-2.36178246477149,0,117,FOXP3|CD1D|SOX11|HLA-DMB|JAK3|SYK|NFATC2|CD274|MNDA|HLA-DPA1|CD38|LILRB1|HLA-E|LYN|GPR183|NDFIP1|CD209|TNFSF13B|PYCARD|NCKAP1L|VAV3|CD74|TNFRSF14|IL18|RIPK3|CCL19|TWSG1|CCDC88B|HLA-DPB1|PDCD1LG2|SPN|AHR|EBI3|FCGR2B|PLA2G2D|IL6ST|MAPK8IP1|MZB1|LILRB2|GPNMB|PRKAR1A|MEF2C|SDC4|FGF10|BST1|TNFRSF4|IGF1|CEBPB|ICOSLG|VCAM1|C10orf54|CSF1|CD300A|LST1|CD86|LGALS3|TGFBR2|TNFRSF21|LGALS9|ZP3|FADD|AIF1|PNP|ANXA1|CD55|NCK1|TFRC|CD81|TNFRSF1B|PRNP
"WOUND HEALING, SPREADING OF CELLS%GOBP%GO:0044319",0.166754201680672,0.53917243184018,-0.320453068603307,-1.2856515734598501,1269,20,RHOA|CYR61|LCP1|PDCD10|MMP12|CD44|TOR1A|ITGA5|DDR1|FLNA|CEACAM1|PDPN|CD151|COL5A1|ACVRL1
ALANINE METABOLIC PROCESS%GOBP%GO:0006522,0.758666489573649,0.9172140592138721,0.6206991618879579,0.827618579666726,5711,1,GPT2
POSITIVE REGULATION OF HISTAMINE SECRETION BY MAST CELL%GOBP%GO:1903595,0.0424603174603175,0.294833299013666,-0.7749531267232821,-1.51328704542802,320,3,SNX4|VAMP8|VAMP7
TORC2 SIGNALING%GOBP%GO:0038203,0.290636507101526,0.663162192629976,-0.48279733759958504,-1.1571730920146202,2209,5,PRR5L|SYAP1|MAPKAP1
"SUBSTRATE-DEPENDENT CELL MIGRATION, CELL EXTENSION%GOBP%GO:0006930",0.582462332021176,0.8388145295913921,0.341282915957385,0.8830896040321881,4290,6,SHTN1|NRP1|SDCBP
POSITIVE REGULATION OF TAU-PROTEIN KINASE ACTIVITY%GOBP%GO:1902949,0.524365413329714,0.808191308529864,0.358625299507002,0.927964040769942,3862,6,DKK1|NAB2
REGULATION OF CELLULAR PROTEIN LOCALIZATION%GOBP%GO:1903827,0.0831635252165054,0.401393889637745,-0.151235407508263,-1.2307500567938998,652,372,DTX3L|SREBF2|KDM1A|CDT1|TERT|CAMK1|JUP|PARP9|ECT2|ITGB2|GZMB|PPM1F|IQSEC2|PID1|TRIM28|STX4|TAX1BP3|NUMB|PARP1|MICALL2|LRP1|CNST|HCLS1|TOR1A|GDI1|ATG13|SHISA7|ATPIF1|PDCD5|STAC3|GAS6|PRR5L|NMT1|INS|MDFIC|UBE2G2|RAB29|CCT8|SAPCD2|PPP1R13B|BAG3|CLTC|PARK7|AKAP5|HAX1|CCT5|PDE2A|BCAS3|NDC80|MMP14|MSN|ANP32B|RHOG|HUWE1|CEP131|RAPGEF3|PPFIA1|FLNA|NECAB2|HRAS|IGF1|VAMP8|NKD2|NMD3|E2F1|TREM2|GPM6B|RBM22|EPB41L2|TMEM173|KAT7|DKC1|STX7|GPER1|EPHA2|HFE|GSN|RAP1A|PLK1|NSFL1C|TMEM59|ZC3H3|LGALS3|STX3|HDAC8|B3GAT3|BCAP31|DNAJA1|DERL3|ITGAM|LILRB4|DAB2|PARL|HSP90AA1|ACTB|H2AFY|RHOU|SAR1B|EMD|CDCA5|ARF6|NGFR|AP2M1|SQSTM1|CARD10|BAD|INSIG1|PRNP
CELLULAR RESPONSE TO GLUCOSE STARVATION%GOBP%GO:0042149,0.698881373569199,0.89251807739663,-0.17502631255141798,-0.835563900365489,5372,35,IFI16|PIK3R4|NIM1K|SIK1|HSPA5|RRP8
NEUROTRANSMITTER-GATED ION CHANNEL CLUSTERING%GOBP%GO:0072578,0.27928281638529,0.653204101106396,-0.538553175963236,-1.17900548002394,2133,4,APOE|GPHN
DOSAGE COMPENSATION%GOBP%GO:0007549,0.19847729062746103,0.575811726650469,-0.34309898486227197,-1.2457367981091898,1511,15,CDYL|PCGF5|RBM15B|RLIM|HNRNPU|BRCA1|RBM15|H2AFY
ENDOCRINE SYSTEM DEVELOPMENT%GOBP%GO:0035270,0.012641022155770001,0.14869950444299201,0.3755742010537171,1.73879455049411,92,30,STRA6|DRD2|DLL1|INSM1|PAX8|HESX1|RFX3|TG|ADCYAP1|WNT4|NF1|CITED2|DKK3|NKX6-1|EIF2AK3
ORGANIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1903825,0.42097107438016496,0.7520714091488578,-0.194114240208612,-1.0227680047255898,3259,49,SLC19A1|SLC36A1|SLC25A20|SLC7A2|SLC25A10|SLC25A18|SLC1A2|SLC1A3|SLC25A22|SLC38A6|SLC6A8|SLC7A3|SLC3A2|ARL6IP5|PRAF2|MPC1|SLC38A9
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN ESTABLISHMENT OF PLANAR POLARITY%GOBP%GO:0090176,0.5693997856377281,0.832269842301315,0.5620071684587811,0.9442446066935269,4249,2,BRSK1|BRSK2
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE%GOBP%GO:0002701,0.1355910041841,0.498614450236932,-0.344918391498901,-1.33841163760219,1036,18,TGFB2|FOXP3|TNF|JAK3|TGFB1|LILRB1|NDFIP1|IRAK3|FCGR2B|TGFB3|HFE|BST2
MRNA CLEAVAGE%GOBP%GO:0006379,0.28166426040162795,0.6546865707384361,-0.28126483293940896,-1.14587495459729,2145,21,NCBP1|RNASE4|CSTF3|TUT1|CPSF7|ERN1
OXIDATIVE SINGLE-STRANDED DNA DEMETHYLATION%GOBP%GO:0035552,0.274078004775803,0.648614723791378,-0.695366600763237,-1.15720122115003,2065,2,ALKBH3
NEGATIVE REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:2000225,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0062033,0.191547821536046,0.565967229895179,-0.329077327884383,-1.2505742053975901,1463,17,DLGAP5|CDT1|ANAPC5|ESPL1|ANKRD32|HNRNPU|H2AFY|ANAPC11
PURINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009183,0.30083676451055896,0.673988937137548,0.8507940008822229,1.13441900011172,2264,1,AK5
IDP CATABOLIC PROCESS%GOBP%GO:0046709,0.272240802675585,0.646576786621306,-0.860498456109396,-1.14639056140183,2034,1,NUDT16
"TRNA EXON LIGATION UTILIZING 2',3' CYCLIC PHOSPHATE OF 5'-EXON AS SOURCE OF LINKAGE PHOSPHATE%GOBP%GO:0000971",0.973568867047417,0.9920058127185359,0.512130569033966,0.682857010566275,7329,1,RTCB
DIOL METABOLIC PROCESS%GOBP%GO:0034311,0.6081466395112021,0.8494868840203281,0.24989819571300198,0.875195581947562,4478,13,SPR|PTS|QDPR|ASAH2B
TEMPERATURE HOMEOSTASIS%GOBP%GO:0001659,0.881537656903766,0.9622426269432679,-0.208368799393465,-0.652792247943925,6741,10,TNFRSF11A|STAT3|NR1D1
MUSCLE CELL PROLIFERATION%GOBP%GO:0033002,0.150360183366077,0.517264655410678,-0.519445147164171,-1.3361528498116002,1147,6,C3orf58|NOV|TGFBR3
GAMMA-AMINOBUTYRIC ACID METABOLIC PROCESS%GOBP%GO:0009448,0.8278403001071809,0.943061234519578,0.43358147229115,0.7284728554190741,6178,2,ABAT|ALDH5A1
NEGATIVE REGULATION OF RETINOIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:1900053,0.77991765174658,0.924704689181848,0.609726510807234,0.8129880300217339,5871,1,AKR1C3
RECEPTOR DIFFUSION TRAPPING%GOBP%GO:0098953,0.36134111578661604,0.716154857259883,0.41465152790657794,1.07293519971004,2661,6,CACNG7|CACNG4|DLG4
TRANS-SYNAPTIC SIGNALING BY ENDOCANNABINOID%GOBP%GO:0099542,0.0615547890687185,0.35631208031004796,-0.8394265232974909,-1.39693996916071,463,2,DAGLB|DAGLA
POLYSACCHARIDE ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX%GOBP%GO:0002506,0.39917750066330604,0.739115199741709,-0.6401985111662529,-1.06539269801983,3008,2,HLA-DRB1|HLA-DRA
REGULATION OF PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0010511,0.0124329276272739,0.14774543117424402,-0.771600154920419,-1.68919403253244,94,4,ZP3|PDGFA|PDGFB
NUCLEAR CELL CYCLE DNA REPLICATION INITIATION%GOBP%GO:1902315,0.0698327759197324,0.37596389138254704,-0.9637185707984119,-1.28390453877875,521,1,POLA1
POSITIVE REGULATION OF CELL FATE SPECIFICATION%GOBP%GO:0042660,0.17080621596493603,0.544378398009534,0.9165747684164091,1.2221287776316998,1285,1,FGF2
GDP METABOLIC PROCESS%GOBP%GO:0046710,0.154247491638796,0.5225398777782271,-0.9210961623290691,-1.22712125645377,1152,1,NUDT18
RESPONSE TO INTERFERON-ALPHA%GOBP%GO:0035455,0.0141287284144427,0.158957792983414,-0.47258608015355297,-1.75631286264694,107,16,KLHL20|IFNAR1|GATA3|GAS6|PDE12|AXL|BST2|IFITM1|IFITM2|IFITM3
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0010717,0.0121274674235583,0.14511776589707198,-0.296797848912164,-1.67839517837109,93,63,TGFB1|GREM1|VASN|RGCC|OLFM1|JAG1|EZH2|DAB2IP|KIAA2018|SFRP2|TGFB3|EFNA1|NOTCH1|PHLDB2|GCNT2|ADIPOR1|LDLRAD4|PDPN|PPP2CA|TGFBR2|BMP2|WWTR1|COL1A1|SDHAF2|FAM195B|SNAI1|DAB2|TIAM1|ENG|GLIPR2|LOXL2
BASEMENT MEMBRANE ASSEMBLY%GOBP%GO:0070831,0.761057245318103,0.9183912636605319,0.6194309660344071,0.825927611617305,5729,1,RAMP2
RESPONSE TO EXTERNAL BIOTIC STIMULUS%GOBP%GO:0043207,0.00012755102040816298,0.00518555396908895,-0.3545587400815611,-2.87710146876158,0,364,CXCL1|MX1|IGHV1OR15-1|CD274|SERINC3|MICA|TGFB1|CXCL2|LILRB1|IGHV5-51|HLA-E|SBNO2|EXOSC4|ATG7|CCL11|LYN|ADAM9|PIM2|CDK6|RPL39|HYAL2|C4B|FCN3|MTDH|BNIP3L|TLR1|PYCARD|AGBL4|JUNB|IGHV1-24|HIST1H2BE|TNFRSF14|GSDMD|IL18|IRAK3|CCL19|SLAMF8|IGHV3-49|IFIT3|HMGB2|BATF|TRIM56|OASL|OAS1|IFNGR1|DAB2IP|IFNAR1|IGHG4|CALCOCO2|SLFN13|TLR2|FGR|ODC1|IGLL5|MPEG1|PDCD1LG2|PLA2G2A|TICAM2|IRF5|SSC5D|SPN|GATA3|HYAL3|TNFRSF11A|AZU1|IL1RN|FCGR2B|GGT1|OAS2|SLFN11|PDE4B|CASP1|ERBB2IP|RAB29|TNFAIP3|FMR1|PLSCR1|HIST1H2BC|DDX3X|IGHV4-4|PDE12|LILRB2|SLC25A6|CXCR4|DDX60|MST1R|MAPKAPK2|IFIT2|HAMP|IGHV4-61|JCHAIN|MEF2C|MB21D1|IFI44L|ABCC9|CCT5|IFIH1|IGHV1-3|IFIT1|FCER1G|APOBEC3G|CTR9|ENO1|ISG15|SLC11A1|CARD16|IFI6|IGHV3-43|RSAD2|HSPB1|FLNA|IRF7|IRAK1|ROMO1|CEBPB|APOBEC3C|HMGN2|NR1H3|IGHV3-73|ARF1|IFI44|APOBEC3B|IFI16|BATF2|CHRM2|SERINC5|CLEC7A|TMEM173|EEF1G|CCL2|BCL3|F2R|BAIAP2L1|CD86|GAPDH|NLRP3|RNASE6|AXL|NOS3|HYAL1|HCK|RPS15A|CD36|CHGA|BST2|OTUD5|LGALS9|NR1D1|IGHV3-15|FADD|RARRES2|PABPN1|FOXP1|TICAM1|IFNLR1|RRP1B|CCRN4L|HIST1H2BG|SERPINE1|CAV1|STAB1|DDIT4|RELA|PLAA|CFL1|DHX58|IFITM1|BTBD17|NFKB1|TLR4|VIM|S100A8|CFP|RNASE1|IGHV1-18|S100A9|ACTA2|GSTP1|NPC2|IFITM2|CD14|FAM3A|IFITM3|IGHG2|LY96|PQBP1|HIST2H2BE|IGHA1|SAMHD1|HIST1H2BK|TNFRSF1B|HNRNPA0|BANF1|LYST|HIST1H2BJ|APOBEC3F|SIRPA|ADGRB1
POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION%GOBP%GO:1904181,0.512827473869961,0.802184867798321,0.362595555900269,0.938237312540376,3777,6,TRPM4
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS%GOBP%GO:1900182,0.0133951571354972,0.15383994266364,-0.31229435629246505,-1.6856301295091498,103,53,TGFB1|PSEN1|CCT3|HYAL2|DTX3L|TERT|JUP|PARP9|ECT2|TRIM28|HCLS1|INS|CCT8|BAG3|PARK7|CCT5|FLNA|IGF1|NMD3|RBM22|TMEM173|KAT7|DKC1|PLK1|NGFR|CARD10
REGULATION OF TOLL-LIKE RECEPTOR 2 SIGNALING PATHWAY%GOBP%GO:0034135,0.7121843269981779,0.8970554182702181,-0.275225540005955,-0.7923358089893459,5470,8,F2RL1|PJA2|LYN|TLR1|TNFAIP3
GASTRULATION%GOBP%GO:0007369,0.10879689521345401,0.45309795582492896,-0.241825390388867,-1.33157754465102,840,57,ITGB2|KLF4|SOX17|ITGB5|MESP1|VTN|ITGA5|INHBA|MMP14|CTR9|COL4A2|LRP5|COL12A1|COL8A1|FN1|ATOH8|ITGA8|MMP9|SNAI1|COL6A1|ITGB4
NEGATIVE REGULATION OF TRANSLATIONAL INITIATION%GOBP%GO:0045947,0.620175323825723,0.8551097775270831,-0.231437801430369,-0.8795201616698309,4739,17,EIF4EBP3|PAIP2B|EIF4EBP1|FMR1|PAIP2|EIF2S1|RBM4
MEIOTIC MISMATCH REPAIR%GOBP%GO:0000710,0.399892502015587,0.73962695174002,0.539649277600088,1.06142644623483,2975,3,ERCC1|MSH6|MSH3
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION%GOBP%GO:0032332,0.0756313460036449,0.385018945189654,-0.5200075120963421,-1.49702884684494,580,8,ANXA2|ACVRL1|LOXL2
LACTOSE METABOLIC PROCESS%GOBP%GO:0005988,0.11077208808702599,0.45638735792888,-0.793327819134271,-1.32022435369606,834,2,SLC2A1|B4GALT1
NCRNA TRANSCRIPTION%GOBP%GO:0098781,0.8307475317348381,0.943945788889238,-0.127633753447492,-0.785974804912159,6478,88,CCNT1|INTS12|GTF3C4|SNAPC1|GTF2E1|INTS2|SRRT|POLR2F|POU2F1|INTS1|POLR2C|NABP2|GTF3A|GTF3C1|INTS7|NCBP2|GTF2A2|BRF1|POLR2J|ELL2|ZNF143|PHAX|CCNK|GTF2A1|GTF3C5|NCBP1|POLR2H|CDK7|POLR2G|ANG|POU2F2|INTS5|PTRF|TAF9|AK6|POLR2L
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0007422,0.322290388548057,0.690574605349253,0.245977631927165,1.1008722122397099,2363,27,ALDH3A2|ETV1|ERBB3|NFASC|PARD3|NF1|ARHGEF10|SKI|ASIC2|GPC1|SCN8A|GSTM3|CNTNAP1|PMP22|SERPINI1|EGR2
REGULATION OF HISTONE H2B UBIQUITINATION%GOBP%GO:2001166,0.0432667017359285,0.29791299041195396,-0.657188882244357,-1.5751563475585,328,5,WDR70|CTR9|RNF20|RNF40
METAL INCORPORATION INTO METALLO-SULFUR CLUSTER%GOBP%GO:0018282,0.793274383708467,0.929621926733366,0.45378900234525005,0.7624241150097808,5920,2,NFS1
LOCOMOTORY EXPLORATION BEHAVIOR%GOBP%GO:0035641,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
NEUROBLAST MIGRATION%GOBP%GO:0097402,0.936113693717625,0.9806508984207809,0.532752536391707,0.710353621456863,7047,1,SIX3
LATERAL LINE SYSTEM DEVELOPMENT%GOBP%GO:0048925,0.9689632107023409,0.9912626134248801,-0.514832377591531,-0.6858803454958909,7242,1,PHOX2B
POSITIVE REGULATION OF DENDRITE DEVELOPMENT%GOBP%GO:1900006,0.762373530216024,0.918965574925946,0.163313889820767,0.79158474807252,5575,35,SS18L1|BMP7|PTPRD|CAPRIN2|CUX2|CUL7|FOXO6|VLDLR|C21orf91|OBSL1|SHANK2|LRP8|FBXW8|CDKL3|DLG5
PROTEIN URMYLATION%GOBP%GO:0032447,0.516536060565812,0.804056180000979,0.741288045875607,0.988407585061692,3888,1,MOCS3
NUCLEAR PORE LOCALIZATION%GOBP%GO:0051664,0.926719576719577,0.9790847380319629,-0.316127492211222,-0.617316870104986,7005,3,SEC13
FORMATION OF PRIMARY GERM LAYER%GOBP%GO:0001704,0.0208928107967817,0.199426996890779,-0.31463833120742196,-1.6386375708923,160,47,ITGB2|KLF4|SOX17|ITGB5|VTN|ITGA5|INHBA|MMP14|CTR9|COL4A2|COL12A1|COL8A1|FN1|ATOH8|ITGA8|MMP9|SNAI1|COL6A1|ITGB4
MEIOTIC CYTOKINESIS%GOBP%GO:0033206,0.382827196990056,0.730480369014206,0.5479665453278839,1.07778553035323,2848,3,SPIRE2|SPIRE1|FMN2
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION%GOBP%GO:2000179,0.0536830660505572,0.33572170046993605,0.411613510245662,1.5498613800122698,394,16,PTCHD2|GNG5|DRD2|INSM1|NES
NEGATIVE REGULATION OF HISTONE UBIQUITINATION%GOBP%GO:0033183,0.735582010582011,0.908157084784786,-0.403461004886932,-0.787857085772851,5560,3,OTUB1
OVARIAN FOLLICLE ATRESIA%GOBP%GO:0001552,0.39558528428093603,0.7377402989373809,-0.801996029995589,-1.06845128255732,2956,1,HYAL3
ASCENDING AORTA MORPHOGENESIS%GOBP%GO:0035910,0.783405313440649,0.92691610564026,-0.33987757127888396,-0.744063050706779,5985,4,HEY2|SOX4|TGFB2|HES1
MODULATION BY SYMBIONT OF HOST SIGNAL TRANSDUCTION PATHWAY%GOBP%GO:0052027,0.211772575250836,0.5937395205509979,-0.892258491398324,-1.1887025544408798,1582,1,TNIP1
CARNITINE TRANSPORT%GOBP%GO:0015879,0.848841774636828,0.9492491301138911,-0.316450538648533,-0.692776379149264,6485,4,SLC22A5|PDZK1|SLC22A4
N-GLYCAN PROCESSING%GOBP%GO:0006491,0.8930119176598051,0.965443067117994,0.176733015247522,0.6518952411301011,6593,15,ST8SIA2|MGAT4A|MAN1A2|MAN1B1|MAN2A2|GNPTAB|MAN2A1|MGAT4B|FUT8|PRKCSH|ST8SIA3|ST8SIA4|MAN1A1|MAN1C1
NEGATIVE REGULATION OF OVARIAN FOLLICLE DEVELOPMENT%GOBP%GO:2000355,0.39558528428093603,0.7377402989373809,-0.801996029995589,-1.06845128255732,2956,1,HYAL3
NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE%GOBP%GO:0002829,0.8507936507936509,0.949296218452153,-0.35546015921458796,-0.6941235999390881,6431,3,ANXA1
NEGATIVE REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905913,0.38438039580289507,0.7313561276300269,0.809660344067049,1.0795728190304898,2893,1,YWHAE
THYROID HORMONE TRANSPORT%GOBP%GO:0070327,0.528561872909699,0.8105400040230321,-0.7387516541685051,-0.984194588085461,3950,1,SLC16A2
TRICUSPID VALVE DEVELOPMENT%GOBP%GO:0003175,0.7324555449979641,0.9075412450030892,0.300999982119601,0.7788551450869721,5395,6,ZFPM1|BMPR1A|BMPR2|HEY2
SPERMATID DEVELOPMENT%GOBP%GO:0007286,0.00412711514651259,0.0706816483364994,0.367616719378118,1.84668288897077,29,40,SPAG6|DDX25|BBS4|CFAP44|CFAP43|PSME4|TSSK6|C9orf117|IQCG|NME5|CHD5|PCSK4|CEP57|MKKS|DNAH1|CATSPER2|BBS2|DPY19L2|SLC26A6
REGULATION OF COMPLEMENT ACTIVATION%GOBP%GO:0030449,0.00012960082944530802,0.00518555396908895,-0.589195264850409,-2.9095922021873504,0,39,C4A|C2|IGKV2-28|VTN|C3|C1QB|C1QA|CFB|C1QC|C7|IGKV2D-28|A2M|SUSD4|CD59|C3AR1|CFP|C1S|CFI|CD55|PHB|IGHG2|SERPING1|CD81|C1R|CFH|C5AR1
REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION%GOBP%GO:0070472,0.1838127090301,0.556308895147568,-0.906263784737538,-1.20736096803796,1373,1,GPER1
REGULATION OF TUMOR NECROSIS FACTOR PRODUCTION%GOBP%GO:0032680,0.000259268861809697,0.00819882332206558,-0.369015307179678,-2.1251178456471598,1,68,LILRB1|CLEC4A|HLA-E|DHX9|TLR1|PYCARD|IRAK3|CCL19|TLR2|CD34|SPN|AZU1|GAS6|TNFAIP3|POMC|MAPKAPK2|PTPN6|CD47|IFIH1|GHRL|HSPB1|C10orf54|LGALS9|THBS1|FADD|FOXP1|CX3CL1|HAVCR2|TLR4|C1QTNF4|GSTP1|CD14|LY96|PTPRJ|SIRPA
REGULATION OF VIRAL TRANSLATION%GOBP%GO:1904971,0.545819397993311,0.817297924969912,-0.7299845610939569,-0.972514715006973,4079,1,DHX9
PLASMA MEMBRANE LACTATE TRANSPORT%GOBP%GO:0035879,0.900902096046697,0.9684180373391851,-0.400220567962503,-0.666031025170363,6790,2,EMB|SLC16A1
POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0010828,0.7977971172151209,0.9308634013872809,0.174630815461327,0.752243770856638,5866,24,IRS2|RHOQ|CAPN10|CLTCL1
INFLAMMATORY CELL APOPTOTIC PROCESS%GOBP%GO:0006925,0.5920634920634921,0.8417378833576942,-0.46041963150938,-0.899082847461919,4475,3,CTSL
JAK-STAT CASCADE%GOBP%GO:0007259,0.8076621338912141,0.9339915228945179,-0.175311782784647,-0.7450701344481,6176,24,STAT5B|IFNAR2|CLCF1|PIAS1|NMI|PTPN1|JAK3|STAT5A|LYN|IFNAR1|STAT3|CTR9|IL15|CCL2
MAMMARY GLAND FORMATION%GOBP%GO:0060592,0.613879957127546,0.852182158593687,0.5426020733436789,0.911641541406907,4581,2,FGFR2
"DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION%GOBP%GO:0042772",0.859607843137255,0.951070228184264,-0.203052589820126,-0.6796360302669779,6575,12,FOXM1|BRCA1|KAT5
PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009193,0.481471642980476,0.7857362908355991,0.7596493162770179,1.0128898616033102,3624,1,ENTPD4
UBIQUINONE-6 METABOLIC PROCESS%GOBP%GO:1901004,0.43304347826087,0.761481529356367,-0.7848478164975742,-1.04560574464909,3236,1,NDUFA9
REGULATION OF HAIR FOLLICLE MATURATION%GOBP%GO:0048819,0.20608612960195602,0.5859847786236589,0.570846349581982,1.25417374102982,1516,4,SPINK5|GAL
REGULATION OF CORTISOL SECRETION%GOBP%GO:0051462,0.43757641624779203,0.7635570545514341,0.45746516577585294,1.00507045157084,3220,4,GAL|UCN|CRH
COMMISSURAL NEURON AXON GUIDANCE%GOBP%GO:0071679,0.455544997963893,0.7711961414599979,0.382308597274595,0.989245965735597,3355,6,EPHB2|NRP1|NCAM1|NFIB|VEGFA
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS%GOBP%GO:1902850,0.5860043417188101,0.840680691545843,-0.149622244651642,-0.9244733519758579,4588,89,TTK|EML1|RHOA|CENPE|GOLGA2|NDE1|TUBG1|BCCIP|ZNF207|AURKA|TUBGCP5|WDR62|TACC3|RACGAP1|CEP192|PCNT|KIF11|NUSAP1|NUF2|SPDL1|DYNC1H1|SBDS|ESPL1|OFD1|TUBGCP2|TUBG2|PLK2|TPX2|KPNB1|VCP|CDK5RAP2|SAPCD2|KIF4A|NDC80|RCC1|MECP2|SPICE1|FLNA|RAN|SPC25|KIFC1|PPP2R4|KIF2A|CCNB1|NSFL1C|SUN2
CHROMOSOME SEPARATION%GOBP%GO:0051304,0.265126657041606,0.64042627877276,-0.286048446687909,-1.16536343145232,2019,21,ESPL1|TOP2A|NCAPH2|STRA13|EME1|RMI1|FANCM|MUS81
POSITIVE REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER%GOBP%GO:1903142,0.8081914030819141,0.934193159096917,0.302213965213326,0.726822853288728,5978,5,PROC|ADD1|S1PR2
POSITIVE REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:1902228,0.19397993311036804,0.568081639653546,-0.9008050286722541,-1.2000885942343797,1449,1,CSF1
DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME%GOBP%GO:0009048,0.258478460128323,0.636098664976652,-0.342290407815675,-1.17822996130953,1973,13,CDYL|PCGF5|RBM15B|RLIM|HNRNPU|BRCA1|RBM15
CGMP METABOLIC PROCESS%GOBP%GO:0046068,0.217288801571709,0.5996151428055749,-0.48093700049538896,-1.23709952301982,1658,6,NPR2|PDE2A|NPR1
MAINTENANCE OF LENS TRANSPARENCY%GOBP%GO:0036438,0.41855726124167897,0.75036705317022,0.46349741028068103,1.018323549647,3080,4,FOXC1|CHMP4B
REGULATION OF ANTI-MULLERIAN HORMONE SIGNALING PATHWAY%GOBP%GO:1902612,0.424757603931465,0.7546031622730089,0.7889280988089991,1.05192916743995,3197,1,DKK3
NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION%GOBP%GO:0032480,0.0543873312564901,0.338357848587052,-0.304913209351206,-1.49223216104561,418,38,TNFAIP3|IKBKE|IFIH1|ISG15|NPLOC4|OTUD5|RELB|HAVCR2|DHX58|UBE2L6|NLRX1|SIRPA
FRUCTOSE METABOLIC PROCESS%GOBP%GO:0006000,0.227983324648254,0.609818988326981,-0.405267677885135,-1.21914437343831,1749,9,ALDH1A1|ALDOA|ALDOC
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:0014912,0.0612806075684169,0.35631208031004796,-0.44207533226687395,-1.5217090217532099,467,13,LRP1|MEF2C|CORO1B|AIF1|SLIT2|IGFBP5|SERPINE1
NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0030812,0.476115691663395,0.7850084910380921,-0.446616287349374,-0.9777364125855659,3637,4,CBFA2T3|PPARA
CELLULAR RESPONSE TO CADMIUM ION%GOBP%GO:0071276,0.262370389814936,0.638240557311977,-0.286874426949291,-1.16872848098453,1998,21,MAPK9|MAPK3|MT1M|MT2A|MMP9|MT1E
REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER%GOBP%GO:1903140,0.9303391384051329,0.9793746057014829,-0.175580945871181,-0.604383664680127,7104,13,IL1B|ROCK1|TNF|CLDN5|CDH5|TNFRSF1A
REGULATION OF AUTOPHAGY OF MITOCHONDRION%GOBP%GO:1903146,0.296250852079073,0.6687276080240239,0.251033013015202,1.12349755633502,2172,27,TSC2|PARK2|HTRA2|DNM1L|HTT|VPS13C|SREBF1|FBXO7
CELL PROLIFERATION IN EXTERNAL GRANULE LAYER%GOBP%GO:0021924,0.116343857787211,0.46625878958064004,-0.788640749931072,-1.31242432102322,876,2,RORA|ATF5
NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1901029,0.17635455023671803,0.548367950895659,-0.5418703503122261,-1.2987598313184698,1340,5,MPV17L|SLC25A5
REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905031,0.8107596647742629,0.935269673284207,0.301179165877565,0.7243341668202908,5997,5,RNF207|NOS1AP|KCNE3|DLG1
SOMATIC DIVERSIFICATION OF T CELL RECEPTOR GENES%GOBP%GO:0002568,0.6647629167220079,0.8804055751124069,0.665747684164094,0.887684705596167,5004,1,LIG4
NUCLEOBASE CATABOLIC PROCESS%GOBP%GO:0046113,0.52505359056806,0.808245162096538,0.580920871243452,0.97602206941879,3918,2,DPYD|ALDH6A1
REGULATION OF NEURON PROJECTION ARBORIZATION%GOBP%GO:0150011,0.542349726775956,0.8158646403067141,0.31661433208741196,0.919076015621735,3969,8,DVL2|GRIP1|DLG4|MOV10|DVL1
POSITIVE REGULATION OF CALCIUM-MEDIATED SIGNALING%GOBP%GO:0050850,0.265207763449264,0.6405287692115009,-0.26968411255513797,-1.16264599753848,2035,25,CCL3|SPPL3|TMEM110|TNF|CCL4|PTBP1|LMCD1|P2RX4|P2RX5|P2RX3|SLC9A1|IGF1|TREM2|P2RY6
REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION%GOBP%GO:1905874,0.502653223666755,0.7970718494574169,-0.598106786560624,-0.9953453373032192,3788,2,LILRB2
NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR-ACTIVATED RECEPTOR ACTIVITY%GOBP%GO:0007175,0.36402934241551005,0.718457761443038,-0.330715724257788,-1.07070995045217,2778,11,SNX6|VPS25|CHMP6|ERRFI1
GMP BIOSYNTHETIC PROCESS%GOBP%GO:0006177,0.0271955425842399,0.23271567002476898,-0.8924731182795699,-1.48521798599922,204,2,HPRT1|GMPS
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN URETERIC BUD FORMATION%GOBP%GO:2000702,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION%GOBP%GO:0021892,0.325987637731793,0.6940781026265961,0.574520871478525,1.13001475627489,2425,3,DRD2|ASCL1
CADMIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0070574,0.7842592592592591,0.927080511528825,-0.382850135620766,-0.747609281899371,5928,3,SLC11A2|SLC11A1
NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902931,0.217841236573225,0.6002776570531079,-0.380987914551469,-1.23346887127237,1662,11,REST|PLEK|SOD1|APOE|BMP2|NFKB1
CHOLESTEROL STORAGE%GOBP%GO:0010878,0.129153269024652,0.487666960400651,0.7859253828315659,1.32045611809074,963,2,STARD4|SOAT1
GALACTOSYLCERAMIDE METABOLIC PROCESS%GOBP%GO:0006681,0.19698755730189896,0.57371735849953,-0.49207430004324293,-1.2657476576906599,1503,6,ALDH5A1|CLN3|GALC|B3GALT2|B3GALT1
UMBILICAL CORD DEVELOPMENT%GOBP%GO:0061027,0.638665594855306,0.865463150027443,0.530245381858285,0.890880704274427,4766,2,HEY2|HEY1
AORTIC VALVE MORPHOGENESIS%GOBP%GO:0003180,0.134794592466203,0.496974190065009,-0.326987167010759,-1.3321480728202801,1026,21,TBX20|DLL4|ROCK1|ROBO1|TGFB1|JAG1|GATA3|SMAD6|EFNA1|NOTCH1|ELN|SNAI2|NOS3|SLIT2|SNAI1
UMP METABOLIC PROCESS%GOBP%GO:0046049,0.149030100334448,0.5157092501209121,-0.9231914424349359,-1.22991267266121,1113,1,UMPS
TELOMERIC 3' OVERHANG FORMATION%GOBP%GO:0031860,0.9534030702350229,0.986646769115929,0.268571702927362,0.590063469166118,7017,4,MRE11A|RAD50|DCLRE1B
CEREBELLAR PURKINJE CELL LAYER STRUCTURAL ORGANIZATION%GOBP%GO:0021693,0.012593783494104999,0.14869950444299201,0.9299161109752799,1.5623791327676397,93,2,DLL1|KIF14
CELLULAR RESPONSE TO INORGANIC SUBSTANCE%GOBP%GO:0071241,0.831499488229273,0.9443784929910591,-0.12194661460053399,-0.7936248621398659,6498,110,ZNF658|CDKN1B|AKT1|MT1X|ITPKB|CPNE7|GUCY1B3|HSF1|TIMELESS|CPNE4|IQGAP1|ALOX5AP|AQP1|RASA4|MT1G|B2M|GUCA1A|ECT2|PPIF|P2RX4|NDNL2|SYT4|SYT7|CACNA1H|SLC41A1|FMR1|CPNE6|ADCY8|CRHBP|MEF2C|MAPK9|CPNE5|MAPK3|DPEP1|MT1M|HFE|MT2A|MMP9|MT1E|LGMN|ADGRV1|PRNP
NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION%GOBP%GO:0070571,0.5683491062039959,0.831514598829999,-0.33042612910241803,-0.9032050887585721,4323,7,THY1|EPHA4|RTN4RL1
POSITIVE REGULATION OF RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:1903971,0.0406084656084656,0.288441534418227,-0.7777655233263481,-1.51877894319482,306,3,TLR2|CSF1|TLR4
DIRECTIONAL LOCOMOTION%GOBP%GO:0033058,0.650167224080268,0.8720434729248241,-0.6790913101014561,-0.904712684494741,4859,1,ARPIN
PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009212,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:0035791,0.0043398211467648605,0.0731407797055425,-0.7654510035369821,-1.8346399939827298,32,5,ABL1|PDGFRB|PDGFA|PDGFB
ADRENAL GLAND DEVELOPMENT%GOBP%GO:0030325,0.0069672131147541,0.10045820391703099,0.64461696480648,1.87121027563891,50,8,STRA6|INSM1|WNT4|NF1|CITED2|DKK3
REGULATION OF DEFINITIVE ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0010724,0.359941559304024,0.7155384949577859,0.821239523599471,1.0950120925252,2709,1,ZFPM1
CYTOSKELETON-DEPENDENT CYTOKINESIS%GOBP%GO:0061640,0.413759555246699,0.74818194067571,0.16885911221246802,1.02835381458581,2976,80,EFHC1|CHMP3|RHOC|CNTROB|BBS4|RTKN|TTC19|ARL3|TRIM36|SNX33|SEPT2|BRCA2|SPIRE2|SPTBN1|SEPT10|MYH10|CUL7|UNC119|SEPT4|BIN3|MITD1|SEPT12|SPAST|PDCD6IP|STAMBP|CHMP1A
CHORION DEVELOPMENT%GOBP%GO:0060717,0.662377288405413,0.879470077229378,-0.5336641852770889,-0.888102543620663,4992,2,E2F7|E2F8
GROWTH PLATE CARTILAGE MORPHOGENESIS%GOBP%GO:0003422,0.0040591855440618,0.0699620448571681,-0.564344886249957,-1.94258453730783,30,13,MATN2|COL20A1|COCH|VWA1|COL14A1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
GLOMERULUS VASCULATURE MORPHOGENESIS%GOBP%GO:0072103,0.0408730158730159,0.289643994810875,-0.777165282157383,-1.51760682432233,308,3,PDGFRB|PDGFRA
REGULATION OF EOSINOPHIL EXTRAVASATION%GOBP%GO:2000419,0.296989966555184,0.6689039624806751,-0.84836788707543,-1.13022973072719,2219,1,PTGER4
PROTON TRANSMEMBRANE TRANSPORT%GOBP%GO:1902600,0.0467602730903001,0.309882706141841,-0.280191913325921,-1.4872284053255702,362,50,SLC25A27|SLC36A1|TCIRG1|ATP6V0B|ATP5J|ATP1A3|ATP5F1|ATP6V1F|ATP5B|ATP6V0D1|SLC9A1|NDUFS7|ATP5O|ATP6V0E1|STOML2|ATP6AP1|ATP6V0E2|ATP5H|ATP5G1
NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION%GOBP%GO:0051481,0.207529474812433,0.5875035269006329,0.732285635511442,1.23033441688482,1548,2,SMAD3|SLC8A1
REGULATION OF MITOPHAGY%GOBP%GO:1901524,0.186049686049686,0.559093571852282,0.418197692206285,1.27086421624504,1362,9,TSC2|PARK2|VPS13C|HDAC6|OPTN|MFN2
HAIR FOLLICLE PLACODE FORMATION%GOBP%GO:0060789,0.305466237942122,0.677423587903087,0.6811690102012679,1.14445188642908,2279,2,HDAC1|HDAC2
INTERSPECIES QUORUM SENSING%GOBP%GO:0052097,0.8490969899665551,0.9492491301138911,-0.578683281870313,-0.770945081501486,6346,1,SLC22A5
NEGATIVE REGULATION OF ARGININE CATABOLIC PROCESS%GOBP%GO:1900082,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE%GOBP%GO:1902455,0.715936576189197,0.899551221015245,0.40818652336318106,0.802854722276494,5327,3,PAX8|ZNF706
MELANOSOME TRANSPORT%GOBP%GO:0032402,0.0014897074756229699,0.031468170285448994,0.5725490791761529,2.11189753937947,10,15,BBS5|BBS4|BLOC1S3|MKKS|RAB11B|RAB11A|MREG|BBS2|MYO5A|BBS7|BLOC1S5|ARL6
VIRAL CAPSID SECONDARY ENVELOPMENT%GOBP%GO:0046745,0.6287687607916059,0.8599421461284821,0.683281870313189,0.911064176888165,4733,1,IST1
POLE PLASM ASSEMBLY%GOBP%GO:0007315,0.77123745819398,0.9213545359508709,-0.6190449933833261,-0.824716572655282,5764,1,PLD6
LIPOATE METABOLIC PROCESS%GOBP%GO:0009106,0.0836764510559171,0.402388938341306,0.95892148213498,1.2785924064123702,629,1,LIAS
CELLULAR RESPONSE TO PROSTAGLANDIN D STIMULUS%GOBP%GO:0071799,0.8185971513034129,0.938835694095279,0.36792764971876,0.723670268677575,6091,3,AKR1C2|AKR1C3|PTGFR
CARBAMOYL PHOSPHATE METABOLIC PROCESS%GOBP%GO:0070408,0.206667552131757,0.586366512053115,0.898213498014998,1.19764650109008,1555,1,CAD
PROTEIN O-LINKED GLYCOSYLATION%GOBP%GO:0006493,0.17407561279601197,0.54811765844537,0.203390021039326,1.2192184694129098,1256,75,GALNT3|GALNT8|GALNTL6|GALNT12|POMGNT1|B3GNT2|B4GALT5|GALNT7|B3GALNT2|B3GNT7|MGAT5B|TET2|GALNT14|GALNT6|GALNT2|GALNT9|LARGE|TET3|ST3GAL4|GALNT15|PGM3|EOGT
MANNOSAMINE METABOLIC PROCESS%GOBP%GO:0006050,0.11621119660387401,0.466224231336423,-0.788672416629654,-1.31247701947355,875,2,RENBP
REGULATION OF NEUROTRANSMITTER UPTAKE%GOBP%GO:0051580,0.34622692725298604,0.703504080836324,0.330254957679431,1.08674160056083,2550,11,DRD2|PARK2|RAB3B|DRD4|FLOT1
U6 SNRNA 3'-END PROCESSING%GOBP%GO:0034477,0.0863328463275335,0.406139467312843,0.957487869430966,1.27668087731302,649,1,USB1
ESTROUS CYCLE%GOBP%GO:0044849,0.0888829928362961,0.41228493992510207,-0.8128016856789141,-1.35263198173175,669,2,ANXA1
EVASION OR TOLERANCE OF HOST DEFENSES BY VIRUS%GOBP%GO:0019049,0.6752217145928511,0.882488012133495,0.421547863421082,0.829134901428522,5024,3,SMAD3|EIF2AK2
REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0031946,0.587996755879968,0.8414799095069009,0.366824433049115,0.882210657924359,4349,5,WNT4|DGKQ|DKK3
NADH METABOLIC PROCESS%GOBP%GO:0006734,0.277043819489863,0.652442157557974,-0.251217748397218,-1.1470110565706002,2117,30,PGAM2|GPD1|GPI|NUDT17|HK1|VCP|HK3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
POSITIVE REGULATION OF NMDA GLUTAMATE RECEPTOR ACTIVITY%GOBP%GO:1904783,0.12830389161907302,0.485234242773114,0.9375275694750771,1.2500665106221298,965,1,EPHB2
CELL-CELL SIGNALING INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0060995,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
NEGATIVE REGULATION OF TOR SIGNALING%GOBP%GO:0032007,0.6714816343375981,0.8815356925073421,0.17150400817361702,0.861531863457932,4880,40,TSC2|TMEM127|ATM|SESN1|GATSL3|NPRL3|SH3BP4|TBC1D7|SESN2|AKT1S1|C12orf66|DEPDC5|SIRT1|PRKAA1|FLCN|TSC1|SZT2|GATS
REGULATION OF TETRAPYRROLE METABOLIC PROCESS%GOBP%GO:1901401,0.678394648829432,0.884536278926676,-0.665086016762241,-0.8860542708976591,5070,1,CLYBL
REGULATION OF CORE PROMOTER BINDING%GOBP%GO:1904796,0.311778290993072,0.68160868787154,0.511725139612889,1.12428192489498,2294,4,FOXC1|GTF2B|CTNNB1
POSITIVE REGULATION OF T CELL MIGRATION%GOBP%GO:2000406,0.779197824609109,0.924704689181848,0.182613709739442,0.7642297044829541,5730,22,TMEM102|XCL1|ADAM17
RESPONSE TO FLUID SHEAR STRESS%GOBP%GO:0034405,0.8436225183573571,0.948285501480553,0.18146882091315303,0.7103463957612141,6203,18,MAPK7|MAP2K5|NFE2L2|PKD2|CITED2
POSITIVE REGULATION OF HYPOXIA-INDUCIBLE FACTOR-1ALPHA SIGNALING PATHWAY%GOBP%GO:1902073,0.5744454774870501,0.835204333784353,0.710796206440229,0.9477508315256079,4324,1,RWDD3
POSITIVE REGULATION BY SYMBIONT OF HOST PROGRAMMED CELL DEATH%GOBP%GO:0052042,0.16909698996655498,0.541811331682474,-0.913542126157918,-1.21705746644275,1263,1,GAPDH
ICOSANOID BIOSYNTHETIC PROCESS%GOBP%GO:0046456,0.0315762004175365,0.25225926440657104,-0.37031069324964,-1.61536286952986,241,26,ALOX5AP|ALOX5|CD74|LTC4S|TBXAS1|PTGDS|GGT1|CBR1|PTGES2|PTGS1|GGT5|FADS1|PTGES|PTGIS
MAMMARY GLAND ALVEOLUS DEVELOPMENT%GOBP%GO:0060749,0.516052003183868,0.804056180000979,-0.5926360311950379,-0.9862411255353241,3889,2,ID2
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO CALCIUM ION%GOBP%GO:0061400,0.314118740868641,0.683550177109913,0.8435156594618441,1.12471431391504,2364,1,CARF
REGULATION OF CELLULAR KETONE METABOLIC PROCESS BY POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072366,0.0957859531772575,0.426542395958204,-0.9496029995588879,-1.26509920853917,715,1,PPARA
EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT%GOBP%GO:0045022,0.8323927024543901,0.9443921657118071,-0.176468551304034,-0.718934148646025,6341,21,RAB7A|EEA1|RILP|SNF8|EMP2
SPINDLE POLE BODY DUPLICATION%GOBP%GO:0030474,0.613425311753781,0.852045339927398,-0.554452715743038,-0.9226979826519699,4623,2,CETN3|EFCAB11
PROSTATE GLANDULAR ACINUS MORPHOGENESIS%GOBP%GO:0060526,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
FAT-SOLUBLE VITAMIN METABOLIC PROCESS%GOBP%GO:0006775,0.299973801414724,0.6733350671224229,-0.35042959997593703,-1.1345346837356298,2289,11,CBR1|ALDH1A2|LGMN|VKORC1
POSITIVE REGULATION OF INTERLEUKIN-10 SECRETION%GOBP%GO:2001181,0.10417484622431598,0.44419145940290994,-0.641021961448661,-1.40333107127616,795,4,CD274|PYCARD|LGALS9
POSITIVE REGULATION OF INTERLEUKIN-4 BIOSYNTHETIC PROCESS%GOBP%GO:0045404,0.16936454849498303,0.541894568706611,-0.9133215703573,-1.21676363315775,1265,1,CD86
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS%GOBP%GO:0051093,0.000253485424588086,0.00819882332206558,-0.206035724532798,-1.7256607459619497,1,456,KANK1|JAG1|CORO1C|RUNX1|REST|TERF2|TBX1|TERT|ZFPM2|ZFP36L1|RUNX3|SKIL|ABCA5|DAB2IP|BCOR|CCDC85B|SARS|KLF4|IL17D|HGS|KIAA2018|TLR2|SEMA6A|RORA|GDI1|MED1|SYNJ2BP|HNRNPU|SFRP2|GATA3|HYAL3|SMAD6|ARHGDIB|LILRB3|BAG5|TBX2|E2F2|FCGR2B|GAS6|TCTA|THY1|HES1|MESP1|RAB29|ABCG1|RC3H2|DCN|EFNA1|NOTCH1|INHBA|SRA1|PHLDB2|SOCS1|FAM129B|HSPA9|CHRD|ADIPOR1|FOXM1|HIST1H4I|TBXA2R|PKP2|DAAM2|C14orf169|FBN1|SNAI2|CETP|NGEF|CTR9|MMRN2|ANP32B|CREB3L1|MECP2|GHRL|CALR|DNMT1|SRGN|RAPGEF3|WWC3|SPARC|SULF1|IGF1|NFATC1|MEN1|COL4A2|E2F1|NR1H3|SEMA3B|ARHGEF15|LRP5|HDAC5|SEMA3D|MAFB|LDLRAD4|MEOX2|STX1B|SEMA7A|C1QC|COL5A2|STARD13|CEACAM1|GPER1|NPR1|EDNRB|CCR1|APOE|NFKBIA|NOS3|PPP2CA|NOV|ECSCR|EFNA3|ECM1|TNFRSF21|BMP2|FGF9|THBS1|TEK|SEMA5A|THBS2|SDHAF2|SEMA3E|EPHA4|COL3A1|SLIT2|ID1|CCRN4L|CX3CL1|SERPINE1|CAV1|HIST2H4A|MYC|STAB1|LDLR|FKBP4|SEMA3A|PPARG|PPARA|SEMA6B|RTN4RL1|TLR4|KIAA2022|ID4|ADGRG1|MYLIP|LILRB4|ANXA2|EFEMP1|TIMP1|ANXA1|HIST2H4B|COL5A1|DPF2|PGK1|ADGRV1|DTX1|ARHGDIA|PDGFB|NGFR|FBLN1|EFNA5|SERPINF1|LOXL2|CST3|CARD10|ADGRB1
REGULATION OF L-GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0002036,0.06600529100529098,0.369007394574627,-0.745946840189699,-1.45664511944103,498,3,PER2|ARL6IP1|ARL6IP5
INTERMEDIATE MESODERMAL CELL DIFFERENTIATION%GOBP%GO:0048392,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
REGULATION OF CARDIOBLAST PROLIFERATION%GOBP%GO:0003264,0.440204246170384,0.7653693162885199,0.518902800434764,1.0206205738960101,3275,3,GNG5|HAND2
DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002468,0.584347826086957,0.8396554445633291,-0.712505513895016,-0.949228427171244,4367,1,CLEC4A
FIBROBLAST MIGRATION%GOBP%GO:0010761,0.15933110367893,0.5293397224673839,-0.9182840758711949,-1.2233748820701102,1190,1,NOV
INDOLALKYLAMINE CATABOLIC PROCESS%GOBP%GO:0046218,0.21882322311897895,0.6013948176405761,-0.428890796315461,-1.23471657484746,1680,8,TDO2|KMO|CCBL1|KYNU|HAAO|AFMID
CENP-A CONTAINING NUCLEOSOME ASSEMBLY%GOBP%GO:0034080,0.000387697079348669,0.0111294649577428,-0.45647287693768396,-2.21752063105977,2,37,MIS18BP1|RBBP4|HIST1H4J|CENPQ|HIST4H4|NASP|CASC5|HIST1H4H|HJURP|ITGB3BP|CENPL|CENPU|CENPW|OIP5|RUVBL1|CENPM|NPM1|CENPI|HIST1H4I|STRA13|RBBP7|CENPH|HIST2H4A|POLE3|HIST2H4B|CENPK|MIS18A|CENPP
VITAMIN A METABOLIC PROCESS%GOBP%GO:0006776,0.6342531175378089,0.863354277348854,-0.545681749191775,-0.9081016917276609,4780,2,ALDH1A2
REGULATION OF L-DOPA BIOSYNTHETIC PROCESS%GOBP%GO:1903195,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
CELLULAR RESPONSE TO MENADIONE%GOBP%GO:0036245,0.165693817988856,0.5375245857985801,-0.7540115798180319,-1.25479584433446,1248,2,DCPS|NDOR1
VIRAL GENOME PACKAGING%GOBP%GO:0019072,0.701768488745981,0.8931369333627571,0.494844223876482,0.831402188036471,5237,2,DDX6|PC
REGULATION OF PROTEIN STABILITY%GOBP%GO:0031647,0.7213220164609051,0.901938862696805,-0.118490262754341,-0.8849706381657649,5608,223,PPIB|CCT8|EFNA1|TESC|BAG3|SEL1L|SENP2|GGA3|PRKD1|PARK7|CCT5|CALR|FLNA|IGF1|CREBL2|USP2|GNAQ|CTSH|TAF9B|STK3|FBXO4|GSN|PLK1|GIPC1|USP47|GAPDH|CDK7|SYVN1|HDAC8|EPHA4|CRYAB|USP18|FAM107A|LAMP2|ATP1B2|DACT1|TAF9|HSP90AA1|PHB|ADGRV1|CD81|AK6|PRNP
NEGATIVE REGULATION OF DNA LIGATION%GOBP%GO:0051107,0.971505016722408,0.9915747942934481,-0.513950154389061,-0.684705012355918,7261,1,TFIP11
POSITIVE REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:2000753,0.779784831982999,0.924704689181848,0.6098919276576971,0.813208591071659,5870,1,PRKCD
REGULATION OF FATTY ACID BETA-OXIDATION USING ACYL-COA DEHYDROGENASE%GOBP%GO:1904735,0.7359197324414721,0.908157084784786,-0.6367445963828849,-0.848296693776004,5500,1,METTL20
NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0042267,0.118666316618535,0.469617660353565,-0.3767424692384,-1.36789083631125,903,15,MICA|CEBPG|CORO1A|GZMB|VAMP7|HFE|TUBB4B|LYST
REGULATION OF SECRETION%GOBP%GO:0051046,0.000127437237160698,0.00518555396908895,-0.224020548302284,-1.83205887515037,0,384,SEPT5|CD74|TNFRSF14|GSDMD|DISP1|PER2|SNCAIP|ADAM8|CCL19|REST|RHBDF2|ACHE|TSG101|CD84|AGT|STXBP5L|ITGB2|ITPR2|RAB9A|SNX4|HGS|PIM3|STX4|TLR2|STXBP4|P2RX4|PPIA|FGR|RAB7A|CD34|STXBP2|WLS|GIPR|ITPR3|SLC2A1|RAB27B|SYT4|SLC8B1|GPI|MCTP1|CDK16|SSC5D|GATA3|FES|HYAL3|TNFRSF11A|SYT7|NAPA|DNAJC1|FCGR2B|OAS2|MYOM1|GAS6|TGFB3|INS|CACNA1H|CASP1|CPLX2|ADGRE2|TNFAIP3|FMR1|DHX36|PLA2R1|ADCY8|SLC25A6|SGK1|POMC|NOTCH1|INHBA|CRHBP|PTGER4|MEF2C|IRS1|VPS18|IFIH1|SDC4|SYN1|ENSA|CACNA1G|OSM|FGF10|SPP1|CARD16|GHRL|RSAD2|SRGN|RAPGEF3|TNFRSF4|UQCC2|IGF1|VAMP8|DPP4|FCN1|NR1H3|VAMP7|LRP5|SNX6|STX1B|CEACAM1|IL33|GPER1|CD300A|RAB3C|NPR1|HFE|CACNA1E|F2R|RAP1A|FN1|KCNQ1|GAPDH|NLRP3|NOV|CHGA|TNFRSF21|SNF8|CD200|LGALS9|ZP3|ADRA2C|NR1D1|CHMP6|HTR1B|ARL2|NSF|DTNBP1|FOXP1|SLC25A4|DOC2A|CX3CL1|CAMK2A|IL11|SIRT4|ATP6AP1|HAVCR2|ANG|TLR4|SERGEF|ITGAM|RAB11FIP1|ADRBK1|CSF1R|C1QTNF4|ANXA1|CACNA1I|TNFRSF1A|TMSB4X|CD14|TNFRSF1B|EFNA5|BAD|C1QTNF1|SLC25A5
NEGATIVE REGULATION OF CELL MATURATION%GOBP%GO:1903430,0.846378349694879,0.949216083775675,-0.433588385181435,-0.7215604089378258,6379,2,EDNRB
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030512,0.485984946794705,0.7872939093021379,-0.18794908527966397,-0.9788395182882729,3744,47,SMURF2|HTRA3|FBN1|LTBP1|LDLRAD4|SNX6|ADAMTSL2|TGFBR2|UBC|FAM89B|CAV1
NEURAL CREST CELL DIFFERENTIATION%GOBP%GO:0014033,0.0698280354351225,0.37596389138254704,-0.28275121387311497,-1.4341043706796297,535,43,SEMA4A|PEF1|JAG1|CORO1C|SOX10|TBX1|SEMA6A|PDCD6|ANXA6|MEF2C|SNAI2|SEMA3B|SEMA3D|SEMA7A|FN1|SEMA5A|TCOF1|SEMA3E|SEMA3A|SEMA6B
REGULATION OF SODIUM ION TRANSPORT%GOBP%GO:0002028,0.7045161290322579,0.894540490140552,-0.154470582835803,-0.842611009868003,5459,55,GLRX|ATP1B1|P2RX4|SPTBN4|ATP1B3|SLC9A3R1|TESC|SLC9A1|PKP2|FXYD1|SCN1B|SIK1|ATP1B2|FXYD5|FXYD7|WNK2
"NEGATIVE REGULATION OF MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0048025",0.8289904412727509,0.9433761342424741,-0.205103110223753,-0.7060046793760351,6330,13,SRSF4|SRSF12|PTBP1|SRSF10|SRSF9|RBMX
REGULATION OF INTERLEUKIN-5 SECRETION%GOBP%GO:2000662,0.0797619047619048,0.395958593986611,-0.7298963998139809,-1.4253026773546398,602,3,GATA3|TNFRSF21
REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY%GOBP%GO:0120032,0.340443329150983,0.701955655133333,0.153226811494225,1.06399790396855,2441,145,DYNC2LI1|IFT88|EPS8L1|PPP1R16B|RLTPR|ODF2L|ZMYND10|TBC1D1|BBS4|TBC1D19|CDK10|RHOQ|IFT20|CCDC88A|IFT140|TBC1D2|TBC1D14|AGRN|NDEL1|TBC1D17|HTT|TBC1D16|NCKAP1|TBC1D8|MARK4|HAP1|TBC1D7|TBC1D20|TWF1|CDC42EP3|WASH1
AUTOPHAGY OF PEROXISOME%GOBP%GO:0030242,0.8526628818599621,0.949296218452153,0.28675956188842305,0.6896551019157829,6307,5,ACBD5|TRAPPC8|RB1CC1|PIK3C3
CARBOHYDRATE CATABOLIC PROCESS%GOBP%GO:0016052,0.0493175379860932,0.31842017410826096,-0.244522493372571,-1.43946474785216,382,74,GAA|GPI|PFKFB2|HK1|GALT|HK3|FUT9|NEU4|ENO1|LRP5|PGM5|ALDH1A1|PGAM1|ABHD10|DHDH|GAPDH|LDHA|IDNK|PYGL|PYGM|PGK1|CRYL1|ALDOA|GALK1|ALDOC
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0036091,0.124966406879871,0.479403240873216,0.6879894121539649,1.35319398561472,929,3,SESN2|ATF4|CHD6
REGULATION OF CELLULAR RESPIRATION%GOBP%GO:0043457,0.15390665967488198,0.5225398777782271,-0.37110495123148,-1.31291504940179,1173,14,CBFA2T3|VCP|PRELID1|PARK7|CCNB1|SHMT2
RNA SECONDARY STRUCTURE UNWINDING%GOBP%GO:0010501,0.896250976308253,0.9669584637551129,-0.22237549830227799,-0.640187935839573,6884,8,DHX9|DHX36|DDX3X
PROTEIN TARGETING TO LYSOSOME INVOLVED IN CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:0061740,0.34100529100529103,0.701955655133333,-0.5717974123983149,-1.11657542495549,2577,3,LAMP2
ESTABLISHMENT OF IMPRINTING AT MATING-TYPE LOCUS%GOBP%GO:0071516,0.559702483729579,0.8268422944617521,0.7189567710630791,0.958631843321884,4213,1,RTFDC1
DEFENSE RESPONSE TO FUNGUS%GOBP%GO:0050832,0.000131509731720147,0.00518555396908895,-0.913743657621884,-2.19006918898131,0,5,GAPDH|RARRES2|S100A8|S100A9|FAM3A
REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL%GOBP%GO:0098902,0.18638771905991,0.5596024320796179,0.582706031556742,1.28022996740422,1371,4,RANGRF|PTPN3|SLMAP
GLYCYL-TRNA AMINOACYLATION%GOBP%GO:0006426,0.61819397993311,0.854944793214197,-0.694805910895457,-0.9256483060505221,4620,1,GARS
CORTICOSPINAL TRACT MORPHOGENESIS%GOBP%GO:0021957,0.000529100529100529,0.0139529201631112,-0.935370023160913,-1.8265405866754498,3,3,EPHA4|SLIT2|SCN1B
REGULATION OF VASCULAR WOUND HEALING%GOBP%GO:0061043,0.00789058390320884,0.10845506809166199,-0.7437810519117231,-1.7827012549443502,59,5,FOXC2|TNFAIP3|SMOC2|SERPINE1
ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0099638,0.247769667477697,0.62852193925262,0.497013797858657,1.19531533371896,1832,5,LRRC7|VPS35|RAB11A
TOXIN CATABOLIC PROCESS%GOBP%GO:0009407,0.933913043478261,0.9800972968717879,-0.53253198059109,-0.709460466616613,6980,1,ACAA1
"CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL LINEAGE COMMITMENT%GOBP%GO:0002362",0.6896321070234109,0.887051934478962,-0.658965593295104,-0.877900397239091,5154,1,FOXP3
CYSTEINE TRANSPORT%GOBP%GO:0042883,0.8269358480541908,0.943043973256125,0.585355094838994,0.780492035332857,6225,1,SLC1A1
REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE%GOBP%GO:0090259,0.33914571505812396,0.7008475401893671,0.455786866861196,1.0961648010863598,2508,5,PTPRO|POU4F2|NRP1
PHAGOSOME MATURATION INVOLVED IN APOPTOTIC CELL CLEARANCE%GOBP%GO:0090386,0.477725752508361,0.7850984235874658,-0.764005293339215,-1.01783849921721,3570,1,RAB14
PYRIMIDINE DEOXYRIBONUCLEOTIDE SALVAGE%GOBP%GO:0010139,0.863726922566078,0.9531672929044319,0.5666078517865021,0.7554951163414119,6502,1,HDDC2
POSITIVE REGULATION OF APOPTOTIC PROCESS IN OTHER ORGANISM%GOBP%GO:0044533,0.16909698996655498,0.541811331682474,-0.913542126157918,-1.21705746644275,1263,1,GAPDH
REGULATION OF ERBB SIGNALING PATHWAY%GOBP%GO:1901184,0.732112712634723,0.9075412450030892,-0.14420346959518499,-0.833274228034773,5637,69,SOCS4|RHBDF2|TSG101|AGT|DAB2IP|HGS|RAB7A|SPRY1|SH3GL2|GRB2|IFI6|MVB12B|EPS15L1|SNX6|CEACAM1|VPS25|GPER1|PLAUR|CHMP6|ERRFI1|MMP9|LGMN|PTPRJ
CELLULAR RESPONSE TO SORBITOL%GOBP%GO:0072709,0.0814715719063545,0.397722753303477,-0.9568813409792679,-1.27479570694395,608,1,MAPK13
REGULATION OF CORTICOSTERONE SECRETION%GOBP%GO:2000852,0.458869239013934,0.7735063645065241,0.609972932952501,1.02483328415352,3424,2,CRHR1
ACTIN NUCLEATION%GOBP%GO:0045010,0.9771593594119191,0.9927322181739301,-0.144522320388935,-0.52473711844089,7443,15,ARPC1A|IQGAP2|LMOD1|ARPC5L
NEURON REMODELING%GOBP%GO:0016322,0.401848476959125,0.740287621109606,-0.3616283169206321,-1.04107731075599,3086,8,EPHA8|RND1|SCARF1|CX3CL1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS%GOBP%GO:1904751,0.436068577411334,0.7626710012154501,-0.46375991324225396,-1.0152673933267602,3331,4,PINX1|TERT|NMD3
DETERMINATION OF LEFT/RIGHT SYMMETRY%GOBP%GO:0007368,0.0582112039446651,0.348278810884248,0.279730631704851,1.46046861429665,424,45,LRRC6|BBS5|DNAI1|NPHP3-ACAD11|DLL1|BBS4|AHI1|DYX1C1|RFX3|SETDB2|KIF3B|MKKS|NPHP3|PKD2|LEFTY1|CITED2|CCDC40|BBS7|MEGF8
CYTIDINE TO URIDINE EDITING%GOBP%GO:0016554,0.0047343503419253,0.0763442804407254,-0.762306551118186,-1.82710334155163,35,5,APOBEC3G|APOBEC3C|APOBEC3B|APOBEC3F
RETINA VASCULATURE MORPHOGENESIS IN CAMERA-TYPE EYE%GOBP%GO:0061299,0.394760969220694,0.7377402989373809,-0.406913142250461,-1.04669021861496,3013,6,FZD4|CYP1B1|COL4A1|LRP5
REGULATION OF NEURAL RETINA DEVELOPMENT%GOBP%GO:0061074,0.7961569470572429,0.9299728593747351,0.376640564685122,0.7408075442247959,5924,3,POU4F2|SIX3
MYELOID CELL HOMEOSTASIS%GOBP%GO:0002262,0.129391935692986,0.487857553689733,-0.261614035954517,-1.31019062153561,997,41,ACIN1|LYN|CEBPG|NCKAP1L|DYRK3|HCLS1|MED1|ATPIF1|PDE4B|INHBA|RPS14|HSPA9|TAL1|HMOX1|SOD1|TGFBR3|ANXA1
REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY%GOBP%GO:0022400,0.10310119695321002,0.44188895516100196,0.41501413781560204,1.4105523333787502,757,12,PDE6B|PPEF1|NMT2|METAP1
POSITIVE REGULATION OF PROSTAGLANDIN-E SYNTHASE ACTIVITY%GOBP%GO:2000363,0.14778455823826,0.514965886850433,-0.7655913978494621,-1.2740665132909,1113,2,ITGB2|ITGAM
POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY%GOBP%GO:1904668,0.976747348381833,0.9927322181739301,0.167862812898806,0.531800737966349,7182,10,CDC14B|RAB1A
RESPONSE TO METAL ION%GOBP%GO:0010038,0.381123364965376,0.729499056535481,-0.14905887779930999,-1.04051792461257,2971,155,MT1G|B2M|GUCA1A|RYR2|AQP3|ECT2|PPIF|P2RX4|PDCD6|ITPR3|SYT4|SYT7|CACNA1H|STIM1|SLC41A1|CPNE6|ADCY8|ANXA11|HAMP|CRHBP|MEF2C|MAPK9|PARK7|HAAO|CPNE5|MAPK3|DPEP1|ACO1|MT1M|HFE|PPP2CA|MTL5|THBS1|FXN|MT2A|MMP9|SLC30A5|CAV1|SNCB|MT1E|LGMN|ADGRV1|CRIP1|GPHN|PPP1CA|LOXL2|PRNP
CARDIAC CELL FATE COMMITMENT%GOBP%GO:0060911,0.598831680478196,0.845842758849687,0.400614162845308,0.8801663769824499,4407,4,ACVR1
SPINDLE POLE BODY ORGANIZATION%GOBP%GO:0051300,0.529100529100529,0.810782389252093,-0.49060200096640005,-0.958021365321389,3999,3,CETN3|EFCAB11
POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0045742,0.26660354389287194,0.641603173139009,0.29054946268252,1.15838697410736,1970,19,AFAP1L2|DOK1|ADAM17|HAP1|SHKBP1|CBL|RQCD1
STRIATED MUSCLE CELL PROLIFERATION%GOBP%GO:0014855,0.389870435806832,0.7358910495632479,-0.485225921154877,-1.06226097184935,2978,4,TGFB2|C3orf58|TGFBR3
METANEPHRIC GLOMERULUS VASCULATURE MORPHOGENESIS%GOBP%GO:0072276,0.0102149111170072,0.12936633073190199,-0.9344361731458509,-1.5550512196937099,76,2,PDGFRB|PDGFRA
POSITIVE REGULATION OF CARDIAC MUSCLE CELL CONTRACTION%GOBP%GO:0106134,0.05536146197258799,0.34165878259009896,0.7586058930435391,1.4920882702315101,411,3,TRPM4|RNF207|NOS1AP
TROPHOBLAST GIANT CELL DIFFERENTIATION%GOBP%GO:0060707,0.544708994708995,0.817297924969912,-0.48180213962721996,-0.940837466441657,4117,3,PLK4|E2F7|E2F8
MAINTENANCE OF EPITHELIAL CELL APICAL/BASAL POLARITY%GOBP%GO:0045199,0.242139209889815,0.625158460820442,0.6187823977059671,1.21707195516053,1801,3,WDR1|PDCD6IP|ANK1
NEGATIVE REGULATION OF NON-MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:1903996,0.887491638795987,0.965152724305326,-0.5583921482134979,-0.743912419282092,6633,1,DUSP22
PROTEIN DE-ADP-RIBOSYLATION%GOBP%GO:0051725,0.136375696471213,0.49989329554221995,-0.7729418467322591,-1.28629883565702,1027,2,MACROD2
MITOTIC NUCLEAR DIVISION%GOBP%GO:0140014,0.176072522982635,0.548366806412612,-0.17543601411252696,-1.1857028405922498,1378,132,MAD1L1|SPAG5|RHOA|KIF25|CENPE|KIF2C|CDCA8|NIPBL|GOLGA2|PAPD7|BECN1|VPS4A|NCAPG|NDE1|TUBG1|BCCIP|CHMP5|INO80|PINX1|ZNF207|ZWINT|TUBGCP5|RACGAP1|NCAPD3|KNSTRN|CEP192|KLHL22|KIF11|NCAPH|NUSAP1|NUF2|DLGAP5|NSL1|SPDL1|CDT1|SMC2|DSN1|ESPL1|OFD1|GSG2|TUBGCP2|TUBG2|CDC23|TPX2|BOD1|KPNB1|NCAPH2|KIF18B|UBE2S|KIF4A|NAA50|NDC80|SGOL1|KIF18A|SPICE1|FLNA|RAN|SMC4|KIFC1|KIF2A|CCNB1|PLK1|CHMP4A|CHMP6|SMC1A|EPS8|KIF22|CDCA5
REGULATION OF I-KAPPAB KINASE/NF-KAPPAB SIGNALING%GOBP%GO:0043122,0.0318495778971604,0.253761148815741,-0.195127203047492,-1.40191407305558,248,179,ZC3H12A|RHOA|S100B|C9orf89|TMEM101|TLE1|TRAF6|PPP5C|TRIM22|TRIM25|UBE2N|CD40|PPM1A|IL1B|TMED4|OTUD7B|AKT1|TERF2IP|RIPK2|TIFA|TNF|APOL3|ATP2C1|PIDD1|UBD|MUL1|ALPK1|BRD4|PIM2|TRIM59|TRIM38|GJA1|NDFIP1|MTDH|MAP3K3|PYCARD|EEF1D|CD74|CCL19|ECT2|DAB2IP|CD4|TNFRSF10B|TFG|RORA|CASP10|WLS|PLK2|TICAM2|IL1RN|CASP1|TNFAIP3|DHX36|IKBKE|TNFSF10|CCDC22|S100A13|ZDHHC13|PRKD1|TRIM32|CARD16|JMJD8|HMOX1|HSPB1|FLNA|IRAK1|TNIP1|GPRC5B|F2R|ECM1|BST2|LGALS9|FADD|TICAM1|FKBP1A|CANT1|CX3CL1|LTBR|RELA|CXXC5|NEK6|LGALS1|GSTP1|TNFRSF1A|S100A4|MID2|TMEM9B|SQSTM1|PRKCB|NLRX1|LITAF|SIRPA
"CD4-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0035710",0.0693915100538836,0.37596389138254704,-0.37368457874853706,-1.47639290893843,527,19,RORC|FOXP3|GPR183|BATF|RORA|SPN|PLA2G2D|PTGER4|STAT3|RSAD2|FOXP1|STOML2
RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:0000302,0.0116899618805591,0.141518610163698,-0.25753202849906104,-1.6159526766263201,91,94,APTX|AQP1|ADAM9|HYAL2|APOD|CCL19|IMPACT|ECT2|PPIF|HP|CYP1B1|SOD2|GPX1|TNFAIP3|MAPK9|PARK7|PXN|CAMKK2|SOD3|MAPK3|DPEP1|ABL1|HMOX1|SOD1|ROMO1|CCS|APOE|CAT|NOS3|HYAL1|FXN|MMP9|RELA|SIGMAR1|MAPK13|PDGFRA|ANXA1|PRDX5|GSTP1|NET1|SIRPA
ECTODERMAL PLACODE MORPHOGENESIS%GOBP%GO:0071697,0.133834990593926,0.495404845602596,0.681206573287747,1.33985294199252,995,3,HDAC1|PROX1|HDAC2
MODULATION BY HOST OF VIRAL GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:0044870,0.878929765886288,0.960725750963158,-0.563134097926776,-0.7502298349094499,6569,1,PTX3
POSITIVE REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION%GOBP%GO:0072513,0.0361269756939833,0.27047868194758395,0.981693868548743,1.30895631095198,271,1,GNG5
TRNA 3'-TERMINAL CCA ADDITION%GOBP%GO:0001680,0.626378005047151,0.858842084733938,0.6842743714159681,0.912387543187712,4715,1,TRNT1
NEGATIVE REGULATION OF GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:1905098,0.50998505637821,0.800479814110466,0.43014011226754906,0.945036145303584,3753,4,MET|STMN1|FAM65B
CARTILAGE DEVELOPMENT%GOBP%GO:0051216,0.0191911385883565,0.19157591691487197,-0.30224284607304996,-1.6313764162046103,148,53,MATN2|CD44|TGFB1|HYAL2|CHI3L1|COL20A1|RUNX3|COCH|COL11A2|CREB3L2|HYAL3|ANXA6|VWA1|COL14A1|MGP|MEF2C|GHRL|COMP|SULF1|COL12A1|COL6A3|COL21A1|HYAL1|NOV|BMP2|COL6A1|ANXA2|COL6A2
L-TRYPTOPHAN TRANSMEMBRANE TRANSPORT%GOBP%GO:1904556,0.535927746048612,0.8132910857498922,0.7305910895456551,0.9741446371665742,4034,1,SLC36A4
PYRIMIDINE RIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046133,0.244082062072593,0.626898732937999,-0.504673201193139,-1.20960536274938,1855,5,APOBEC3G|APOBEC3C|CDA
DITP METABOLIC PROCESS%GOBP%GO:0035862,0.272240802675585,0.646576786621306,-0.860498456109396,-1.14639056140183,2034,1,NUDT16
MODULATION OF MOLECULAR FUNCTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052205,0.665487884741323,0.8804055751124069,-0.32195484177250894,-0.8281545831999509,5080,6,RAB9A|NUCKS1|ANXA2
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY%GOBP%GO:0046902,0.3041924398625431,0.676707700393746,0.199504264092791,1.10830255285603,2212,56,TMEM102|HEBP2|BBC3|BOK|PMAIP1|ALKBH7|CASP8|TP53BP2|BID|YWHAQ|TMEM14A|YWHAB|YWHAE|ZNF205|ATF2|BAX|BCL2|YWHAH|ACAA2|YWHAZ|MAPK8|THEM4|BMF|C22orf29|SPG7|NAIF1|HIP1R|RHOT2
NEGATIVE REGULATION OF ATP METABOLIC PROCESS%GOBP%GO:1903579,0.089173640167364,0.41228493992510207,-0.46796991056958004,-1.46608864081411,681,10,PID1|PPIF|PARP1|CBFA2T3|PDE12|PPARA
POSITIVE REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0033141,0.724414715719064,0.9034590034658789,-0.6418725187472429,-0.855128317652101,5414,1,LIF
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH%GOBP%GO:0055022,0.968123256740603,0.9912626134248801,0.51532862814292,0.6871211908648149,7288,1,GSK3A
MESODERM DEVELOPMENT%GOBP%GO:0007498,0.0633238562936159,0.36006266503904,-0.29998966857958,-1.4573336397176901,489,37,MESDC2|TBX1|ZFP36L1|KLF4|SMO|MATK|FOXC2|MESP1|HCK|ITGA8|GDF11|SNAI1|TIE1|TCF15|ITGB4
NEGATIVE REGULATION OF MACROAUTOPHAGY BY TORC1 SIGNALING%GOBP%GO:1904766,0.24996679505910502,0.630643295704944,0.876874724305249,1.16919412564981,1881,1,CLEC16A
NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033144,0.34890396659707695,0.706981624190196,-0.24715823330224695,-1.0781493493246201,2673,26,BRCA1|CALR|CRY2|KANK2|FOXP1|DAB2|PHB
CELL-CELL SIGNALING VIA EXOSOME%GOBP%GO:0099156,0.390091645636871,0.7358910495632479,0.8061865902073221,1.07494103698207,2936,1,KLF5
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0090090,0.27133872416891297,0.646576786621306,-0.18108428527854398,-1.1208345951324,2113,90,STK3|APOE|BMP2|WWTR1|SDHAF2|DACT3|LATS2|IGFBP6|CAV1|CHD8|DACT1|DAB2|MCC|CSNK1A1|IGFBP4|EMD|AMER2
CAMKK-AMPK SIGNALING CASCADE%GOBP%GO:0061762,0.758423985141947,0.9172089687407471,-0.48675537037524297,-0.810038774340494,5716,2,CAMKK2
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007173,0.6068749147456011,0.849142908339126,0.187814962714287,0.8943837519546289,4448,33,NCK2|GAB1|ADAM17|SHC1|SOS1|SLC30A10|PTK2B|CBL|PLCG1|EPS15|EGFR|SRC
GENE CONVERSION%GOBP%GO:0035822,0.706055734190782,0.894711838238086,0.49282028250399607,0.8280017052090458,5269,2,RNF212
POSITIVE REGULATION OF EXIT FROM MITOSIS%GOBP%GO:0031536,0.391534391534392,0.7371240382543249,-0.54850321518509,-1.07108776168807,2959,3,CDCA5
NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1901380,0.330718954248366,0.6957352559323989,-0.331653900948457,-1.1100766597601202,2529,12,CAV1|KCNH2|KCNE4
NEGATIVE REGULATION OF PLASMACYTOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002737,0.147826086956522,0.514965886850433,-0.9243493603881779,-1.23145529740742,1104,1,BST2
METANEPHRIC COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072205,0.5389871382636661,0.8142313733497609,0.574757824541829,0.965667355216894,4022,2,PKD1|BMP4
NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0061179,0.29145661979304904,0.663837153945439,-0.687936448041638,-1.14483625885054,2196,2,PIM3
ALKALOID CATABOLIC PROCESS%GOBP%GO:0009822,0.9106377277599141,0.9720943283119721,0.38147229114971104,0.6409227030127379,6796,2,CYP2D6|CYP3A5
PROSTATE GLAND STROMAL MORPHOGENESIS%GOBP%GO:0060741,0.042943143812709,0.296325585284281,-0.9776135862373179,-1.30241603573334,320,1,CRIP1
REGULATION OF ACTIN PHOSPHORYLATION%GOBP%GO:0043538,0.319697170939036,0.687856118120141,0.839766210851346,1.11971493011675,2406,1,TWF1
CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS%GOBP%GO:0006921,0.422649404995423,0.753525330620002,-0.24666072539481398,-1.02148624293521,3231,22,BLCAP|DICER1|KPNA1|DNASE2|EXOG|ACIN1|DNASE1L3|H1F0|HMGB2|KPNB1|TOP2A|GPER1|ENDOG|FEN1
DUDP METABOLIC PROCESS%GOBP%GO:0046077,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
ORGANELLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072384,0.248349834983498,0.629072495919397,0.20714912793381401,1.15481351657975,1805,57,KIF13A|KIF3B|TRAK2|NDEL1|RAB1A|HTT|BLOC1S3|HAP1|AP3B2|LRPPRC|KIF5B|AP3B1|RAB6A|KIF5A|COPG2|TRAK1|SPAST|ARHGAP21|KIF1A|AP3M1|LOH12CR1|KIFAP3|BLOC1S5|AP3M2|FYCO1|NEFL|RHOT2|PAFAH1B1|AP3S2|BLOC1S6|TMEM201
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT%GOBP%GO:0021954,0.5381269539214351,0.8141714310152471,0.20324796944983398,0.9409764054262539,3958,30,DRD2|FGFR2|SLIT1|ROBO2|CHRNB2|SLIT3|ATP7A|MAP2
HINDBRAIN MATURATION%GOBP%GO:0021578,0.0964548494983278,0.427566585262796,-0.9493824437582711,-1.26480537525418,720,1,CEND1
DENDRITE EXTENSION%GOBP%GO:0097484,0.6789783889980351,0.884536278926676,-0.317513688289976,-0.8167307400578341,5183,6,LLPH|SH3GL2|TMEM108
DETECTION OF BACTERIAL LIPOPROTEIN%GOBP%GO:0042494,0.0747354497354497,0.383186929742657,-0.734972978934598,-1.43521594972352,564,3,TLR1|TLR2|SSC5D
POSITIVE REGULATION OF NEURON DIFFERENTIATION%GOBP%GO:0045666,0.499444135630906,0.794989907195277,0.13601136118429,0.9803210588573911,3593,172,RET|ISLR2|BRINP2|SHTN1|SLITRK1|CPNE9|SYT2|PLXNB1|SS18L1|PCP4|PTK7|TCF3|RIMS1|ROBO2|ASCL1|BMP7|PTPRD|UNC13A|SCARB2|RIMS2|RUFY3|MAP6|ADCYAP1|CAPRIN2|DVL2|CUX2|LIMK1|STMN2|CUL7|LRRC7|TWF1|PTK2B|NRCAM|FOXO6|GRIP1|DLG4|VLDLR|TCF12|CBFA2T2|TENM3|C21orf91|PLXNB2|CAMK1D|POU4F2|NEDD4L|NRP1|ZFYVE27|CPNE1|MEGF8|OBSL1|FGFR1
POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY%GOBP%GO:0051353,0.105820797907129,0.447796222692122,-0.298963851103632,-1.36501041394809,808,30,IL1B|AKT1|TNF|CHCHD10|S100A1|POR|TERF2|TERT|AGT|INS|PARK7|ABL1|DHFR|RFK|APOE|FXN|COX17
INTERLEUKIN-2-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038110,0.9252092050209201,0.9785037131586608,-0.19310658416589002,-0.604977719972299,7075,10,STAT5B|IL2RB|IL2RG|JAK3|SYK|STAT5A|IL2RA
NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0031111,0.282114153385097,0.654732517474162,0.248903045538955,1.13913670126863,2070,29,CLASP1|KATNB1|INPP5J|CLASP2|SPEF1|TTBK2|CAMSAP3|STMN2|MAP2|TAOK1|SNCA|STMN1|EML2|CIB1|CLIP3
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0032231,0.276230987367878,0.651382796781921,-0.19832740059145398,-1.12624573897416,2142,64,WAS|PLEK|TGFB3|PHLDB2|SLC9A1|PTGER4|CD47|S100A10|CTGF|PXN|ABL1|RAPGEF3|PPFIA1|ARHGEF15|DLC1|CX3CL1|EVL|NF2|SYNPO|SERPINF2
POSITIVE REGULATION OF HYDROGEN PEROXIDE-MEDIATED PROGRAMMED CELL DEATH%GOBP%GO:1901300,0.619471377340948,0.854944793214197,0.687141596823996,0.916210601386403,4663,1,HDAC6
DELAMINATION%GOBP%GO:0060232,0.766383656142213,0.919992400339549,-0.48122415219189396,-0.8008339427751109,5776,2,METTL3|YTHDF2
CARDIOLIPIN METABOLIC PROCESS%GOBP%GO:0032048,0.944034944034944,0.982694945797028,0.19420701657587,0.5901772116624571,6915,9,SLC27A1|PLA2G6|CRLS1|TAMM41|TAZ
BASAL DENDRITE MORPHOGENESIS%GOBP%GO:0150019,0.366931216931217,0.721190111986457,-0.559477320966464,-1.09251740890342,2773,3,TAOK2|SEMA3A
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING%GOBP%GO:0060054,0.40256510927889005,0.740287621109606,-0.47943149315459294,-1.04957575770366,3075,4,MMP12|FGF10
REGULATION OF CYTOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0001959,0.0284141814923845,0.23858105139263197,-0.22709739592721997,-1.48194623819468,221,111,PYCARD|CD74|GNB2L1|IRAK3|RUNX1|MADD|IFNGR1|SOCS3|PARP9|AGPAT1|TRIM44|TICAM2|IL1RN|GAS6|CASP1|TRAF2|TNFAIP3|CASP4|SOCS1|PTPN6|CARD16|IRAK1|NR1H3|TREM2|CSF1|AXL|FADD|CD300LF|SLIT2|USP18|PPARG|C1QTNF4|GSTP1|TNFRSF1A|AGPAT2|PELI3|SAMHD1|SPHK1|RNF113A|HIST1H2BJ
GENE SILENCING BY RNA%GOBP%GO:0031047,0.995878413189078,0.998675570643677,-0.0889907991336733,-0.497185834967118,7731,60,CNOT6|SRRT|TNRC6A|AJUBA|NOTCH4|C9orf114|DHX9|HELZ|TERT|LIN28B|PPP1R8|CELF1|HNRNPA2B1|STAT3|PIWIL1|NCBP1|CLP1|TNRC6C|RAN|RBM4|WTIP
NEGATIVE REGULATION OF RHO GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:2001107,0.844468056846859,0.948285501480553,0.5761468901632111,0.7682141368870591,6357,1,FAM65B
NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:1901032,0.6502992383025029,0.8720434729248241,0.250180618775035,0.850315262599709,4780,12,MET|PDE8A|NFE2L2|NR4A3|TRAP1
INOSINE BIOSYNTHETIC PROCESS%GOBP%GO:0046103,0.169174952969632,0.541811331682474,0.6584605639557579,1.2951142258422,1258,3,ADAL|CECR1
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0034145,0.5265225933202361,0.809730111932754,-0.36357619546632797,-0.9352159171148421,4019,6,WDFY1|TIRAP|F2RL1|PTPN22|TICAM2|NR1H3
'DE NOVO' AMP BIOSYNTHETIC PROCESS%GOBP%GO:0044208,0.5988981456597691,0.845842758849687,0.450129850638858,0.885352297389488,4456,3,ADSL|ADSS|ADSSL1
REGULATION OF ACTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0032956,0.0212303363601484,0.201150083379966,-0.19027175621665002,-1.4276759326190702,165,227,HCLS1|CCL24|ARPC1A|ARHGAP18|WAS|FES|ARHGDIB|IQGAP2|PLEK|TGFB3|TAOK2|RHOF|LMOD1|PHPT1|PDXP|PHLDB2|SLC9A1|PTGER4|ARHGAP44|CD47|HAX1|BCAS3|S100A10|CTGF|PXN|BST1|RHOD|ABL1|RAPGEF3|PPFIA1|HRAS|ARF1|ARHGEF15|GPM6B|KANK3|RND1|GSN|BAIAP2L1|CORO1B|DLC1|HCK|BST2|CDC42EP4|TEK|CFL2|SEMA5A|ARPC5L|PDGFRB|SEMA3E|SLIT2|CX3CL1|FAM107A|PDGFA|CSF1R|EVL|NF2|PDGFRA|EPS8|CDC42EP1|CDC42EP5|SYNPO|TMSB4X|NCK1|ARHGDIA|ARF6|EFNA5|CDC42EP2|SERPINF2
ENDOTHELIAL CELL MORPHOGENESIS%GOBP%GO:0001886,0.592448266595001,0.8417583856451459,0.452604168955034,0.8902189895286341,4408,3,MET
POSITIVE REGULATION OF MITOTIC METAPHASE/ANAPHASE TRANSITION%GOBP%GO:0045842,0.35213652944241797,0.7106060713647829,-0.35973084848784,-1.08215844445024,2702,9,DLGAP5|CDT1|ANAPC5|ESPL1|ANAPC11
POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION%GOBP%GO:0010831,0.0437908496732026,0.299062021084573,-0.478824669794868,-1.60267100292372,334,12,FAM129B|EHD1|MMP14|MAML1|EHD2|ADGRB1
MODULATION BY ORGANISM OF APOPTOTIC PROCESS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052433,0.9070802251014259,0.9709695261809209,-0.29216290141823,-0.6396056642237711,6930,4,GAPDH
NEGATIVE REGULATION OF CELL CYCLE PROCESS%GOBP%GO:0010948,0.0106151681800742,0.132978668857949,-0.19931893386952,-1.49556008973183,82,227,CDK9|TICRR|JADE1|YAF2|BMP4|RBBP4|RBBP8|FZR1|KAT2A|CUL1|PCBP4|GTSE1|WEE1|CNOT4|RBL1|ZFP36L2|ATRX|MAD1L1|BTG2|CBX3|CNOT10|CNOT6L|KIF25|RPL23|FOXN3|CDC7|PRMT2|VPS4A|FOXO4|BLM|EHMT1|SFN|PINX1|MDM1|ZNF207|PCGF2|CDKN1B|CDK4|CNOT6|AURKA|PTEN|FHL1|TRIP13|AURKAIP1|FBXL7|KLHL22|PIDD1|PRMT1|NEK2|UIMC1|PML|APC|PHC3|RGCC|RAD51|CLSPN|RPA2|RRM2|CDC20|UXT|TRIAP1|TFDP2|SETMAR|TERF2|DONSON|CDT1|ZFP36L1|EZH2|NBN|DAB2IP|KLF4|ESPL1|CDC6|NAA10|PLK2|STAG2|NPM1|CCNK|RAD1|PTTG1|SLFN11|RAD17|BRCC3|PCNA|ORC1|CDK5RAP2|MAD2L1|TAOK2|CDC25C|ZNF268|GPNMB|DCUN1D3|BRCA1|TOPBP1|FGF10|RBBP7|CALR|DTL|SKP1|E2F1|CCL2|KANK2|GPER1|MAX|NACC2|CCNB1|PLK1|USP47|RBM14|KAT2B|PLAGL1|RING1|SUSD2|TNKS1BP1|FAM107A|IK|SMC1A|DACT1|BCL6|CDK2AP2|H2AFY|ATF5|ZNF385A|CCND1
POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS%GOBP%GO:0060760,0.000389964903158716,0.0111294649577428,-0.464225238658356,-2.19939879386281,2,34,DHX9|CD74|PARP9|AGPAT1|TLR2|TRIM44|TICAM2|GAS6|CASP1|CASP4|IFIH1|TREM2|CSF1|AXL|FADD|CD300LF|TLR4|TAF9|C1QTNF4|AGPAT2|AK6
POSITIVE REGULATION OF NEUTROPHIL DIFFERENTIATION%GOBP%GO:0045660,0.962809364548495,0.9908714970603191,-0.518802382002647,-0.691169344625773,7196,1,EVI2B
ESTABLISHMENT OF VIRAL LATENCY%GOBP%GO:0019043,0.3843147472642,0.7313561276300269,-0.349770113849402,-1.05219411654446,2949,9,PSIP1|PPIA|IRF7|BANF1
ENDOTHELIUM DEVELOPMENT%GOBP%GO:0003158,0.0471831893773366,0.31186172609540996,-0.26345876470751395,-1.47743068086714,365,61,JAG1|SOX18|COL23A1|SOX17|KDR|RAPGEF1|CD34|RAP2B|MESP1|PDE4D|NOTCH1|ICAM1|PDE2A|MSN|RAPGEF3|TJP2|STARD13|PDPN|RAP1A|RAB1B|NR2F2|ANXA2|ENG|ACVRL1|EDF1
LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0034383,0.0395584176632935,0.28367988634143604,-0.40023953953909397,-1.5813090816625401,300,19,CLTA|CLTC|EHD1|HMOX1|CD36|LDLR|NPC2|AP2M1
REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR-ALPHA SIGNALING PATHWAY%GOBP%GO:2000583,0.271701155603332,0.646576786621306,0.602617052582399,1.18527662893871,2021,3,IFT20|CBL
ACTION POTENTIAL%GOBP%GO:0001508,0.35216910748825603,0.7106060713647829,0.196481589711503,1.07162777927788,2548,53,TRPM4|SCN5A|ANK2|KCNMB4|DMD|HCN2|KCNIP2|KCNJ8|SRI|CACNA1C|SCN3A|SCN9A|SCN2A|YWHAE|CACNB2|YWHAH|NEDD4L|KCNB1|SLC8A1|SNTA1|FGF12
PINOCYTOSIS%GOBP%GO:0006907,0.47876498176133403,0.7850984235874658,-0.324003562486121,-0.9746820231019699,3674,9,DOCK2|PPT1|PYCARD|SNX5|MAPKAPK2|RAB34
2-OXOBUTYRATE BIOSYNTHETIC PROCESS%GOBP%GO:0046360,0.21257525083612,0.5950741597527031,-0.8914865460961621,-1.1876741379434,1588,1,THNSL2
AXONEMAL DYNEIN COMPLEX ASSEMBLY%GOBP%GO:0070286,0.00339720070661775,0.0606261216619575,0.513254052418536,1.9736147463442502,24,17,LRRC6|DNALI1|DNAI1|ZMYND10|DYX1C1|CCDC65|LRRC49|DNAH1|CCDC40
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION%GOBP%GO:0032911,0.813227513227513,0.9356336309698571,-0.372070717793789,-0.726559810915502,6147,3,GATA6
CELLULAR CADMIUM ION HOMEOSTASIS%GOBP%GO:0006876,0.256588628762542,0.634929462604421,-0.868052492280547,-1.1564543514128502,1917,1,SLC11A1
REGULATION OF NEUTROPHIL MEDIATED KILLING OF BACTERIUM%GOBP%GO:0070950,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
RESPONSE TO OTHER ORGANISM%GOBP%GO:0051707,0.00012755102040816298,0.00518555396908895,-0.3545587400815611,-2.87710146876158,0,364,CXCL1|MX1|IGHV1OR15-1|CD274|SERINC3|MICA|TGFB1|CXCL2|LILRB1|IGHV5-51|HLA-E|SBNO2|EXOSC4|ATG7|CCL11|LYN|ADAM9|PIM2|CDK6|RPL39|HYAL2|C4B|FCN3|MTDH|BNIP3L|TLR1|PYCARD|AGBL4|JUNB|IGHV1-24|HIST1H2BE|TNFRSF14|GSDMD|IL18|IRAK3|CCL19|SLAMF8|IGHV3-49|IFIT3|HMGB2|BATF|TRIM56|OASL|OAS1|IFNGR1|DAB2IP|IFNAR1|IGHG4|CALCOCO2|SLFN13|TLR2|FGR|ODC1|IGLL5|MPEG1|PDCD1LG2|PLA2G2A|TICAM2|IRF5|SSC5D|SPN|GATA3|HYAL3|TNFRSF11A|AZU1|IL1RN|FCGR2B|GGT1|OAS2|SLFN11|PDE4B|CASP1|ERBB2IP|RAB29|TNFAIP3|FMR1|PLSCR1|HIST1H2BC|DDX3X|IGHV4-4|PDE12|LILRB2|SLC25A6|CXCR4|DDX60|MST1R|MAPKAPK2|IFIT2|HAMP|IGHV4-61|JCHAIN|MEF2C|MB21D1|IFI44L|ABCC9|CCT5|IFIH1|IGHV1-3|IFIT1|FCER1G|APOBEC3G|CTR9|ENO1|ISG15|SLC11A1|CARD16|IFI6|IGHV3-43|RSAD2|HSPB1|FLNA|IRF7|IRAK1|ROMO1|CEBPB|APOBEC3C|HMGN2|NR1H3|IGHV3-73|ARF1|IFI44|APOBEC3B|IFI16|BATF2|CHRM2|SERINC5|CLEC7A|TMEM173|EEF1G|CCL2|BCL3|F2R|BAIAP2L1|CD86|GAPDH|NLRP3|RNASE6|AXL|NOS3|HYAL1|HCK|RPS15A|CD36|CHGA|BST2|OTUD5|LGALS9|NR1D1|IGHV3-15|FADD|RARRES2|PABPN1|FOXP1|TICAM1|IFNLR1|RRP1B|CCRN4L|HIST1H2BG|SERPINE1|CAV1|STAB1|DDIT4|RELA|PLAA|CFL1|DHX58|IFITM1|BTBD17|NFKB1|TLR4|VIM|S100A8|CFP|RNASE1|IGHV1-18|S100A9|ACTA2|GSTP1|NPC2|IFITM2|CD14|FAM3A|IFITM3|IGHG2|LY96|PQBP1|HIST2H2BE|IGHA1|SAMHD1|HIST1H2BK|TNFRSF1B|HNRNPA0|BANF1|LYST|HIST1H2BJ|APOBEC3F|SIRPA|ADGRB1
REGULATION OF NERVE GROWTH FACTOR PRODUCTION%GOBP%GO:0032903,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
L-PROLINE BIOSYNTHETIC PROCESS%GOBP%GO:0055129,0.44842809364548497,0.768229288546963,-0.777238641376268,-1.0354684963168101,3351,1,PYCRL
SELENIUM COMPOUND METABOLIC PROCESS%GOBP%GO:0001887,0.771090884390708,0.9213545359508709,0.34621673788267604,0.760652917681655,5675,4,SCLY|SEPHS1
POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0046579,0.10815006468305301,0.452488212455009,-0.28184962141084896,-1.3571848025642,835,36,GPR35|ROBO1|RAC1|LYN|MAPRE2|LPAR6|RAPGEF1|VAV1|NGF|NOTCH1|GRB2|ARRB1|NOTCH2|FGF10|IGF1|F2R|F2RL3|COL3A1|GPR4|ADGRG1
REGULATION OF ESTABLISHMENT OF RNA LOCALIZATION TO TELOMERE%GOBP%GO:1904910,0.6392615221144909,0.865463150027443,0.6779885310983679,0.904006223290581,4812,1,TERF1
NEUROPILIN SIGNALING PATHWAY%GOBP%GO:0038189,0.8255463944509879,0.942692811039289,-0.325343964494825,-0.712245947386812,6307,4,CDC42|ABL1
REGULATION OF GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:1905097,0.765983439663364,0.9199689422195201,0.29199651359197804,0.755558141090537,5642,6,MET|STMN1|FAM65B|CTAGE5
ACTIVATION OF PHOSPHOLIPASE C ACTIVITY%GOBP%GO:0007202,0.0263848779207141,0.22913474737543102,-0.454768417073878,-1.65119040499118,200,15,NTRK2|P2RY6|GNAQ|GNA15|ANG|C5AR1
REGULATION OF KERATINOCYTE APOPTOTIC PROCESS%GOBP%GO:1902172,0.14409108755398498,0.510372098339109,-0.6122642615170351,-1.34037445468648,1100,4,ZFP36L1|SFRP4|GSN
POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034767,0.27846804150121696,0.653204101106396,-0.186005881596292,-1.1180460502542,2173,80,RYR2|GLRX|ATP1B1|AMIGO1|CTSS|ATP1B3|STAC3|THY1|STIM1|TESC|SLC9A1|FLNA|FXYD1|P2RY6|GPER1|F2R|KCNQ1|APLNR|F2RL3|COX17|CX3CL1|ARL6IP1|ATP1B2|KCNH2|TMSB4X|WNK2
NEGATIVE REGULATION OF OSTEOCLAST PROLIFERATION%GOBP%GO:0090291,0.25179092597506003,0.632068187660447,-0.7065343258891651,-1.1757861016131002,1897,2,GREM1|TNFAIP3
NEGATIVE REGULATION OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN URETERIC BUD FORMATION%GOBP%GO:2000734,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
NEGATIVE REGULATION OF PARKIN-MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:1905090,0.26045955638199,0.636316525692816,0.871801940891045,1.1624302534521298,1960,1,VPS13C
RESPONSE TO IONOMYCIN%GOBP%GO:1904636,0.789565217391304,0.9280333261332429,-0.60917512130569,-0.8115675331518271,5901,1,ZC3H12A
RETINOIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0002138,0.281976358082083,0.654732517474162,0.861380679311866,1.14853490730688,2122,1,ALDH1A3
ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0046632,0.10561357702349901,0.44738616127788,-0.329770069247892,-1.38456651490152,808,23,BLM|RORC|FOXP3|GPR183|TNFSF8|BATF|RORA|SPN|PLA2G2D|PTGER4|STAT3|RSAD2|FOXP1|ANXA1
REGULATION OF APOPTOTIC CELL CLEARANCE%GOBP%GO:2000425,0.0268159333506899,0.231542581971207,-0.58440369362231,-1.68241644054028,205,8,C4B|C4A|C2|C3|CCL2|CD300LF
FEMALE PREGNANCY%GOBP%GO:0007565,0.34216275259421103,0.701955655133333,0.232497026176605,1.0845665359638899,2505,31,TLE6|CRHR1|CYP27B1|TEAD3|PPARD|PRLHR|ADCYAP1|STOX2|TRO|BCL2|APOL2|TAC3|CRH
REGULATION OF CHEMOKINE PRODUCTION%GOBP%GO:0032642,0.0276557249935384,0.23535789394552398,-0.329833879375734,-1.60231520708298,213,37,PYCARD|APOD|CD74|KLF4|TLR2|AZU1|DDX3X|SNAI2|HMOX1|IL33|LGALS9|TLR4|CSF1R|GSTP1|SIRPA|ACKR1
TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002224,0.0043859649122807,0.0733696615275563,-0.308829044607469,-1.76606502917524,33,66,TLR1|IRAK3|HSP90B1|ITGB2|PIK3AP1|TLR2|CTSS|TICAM2|IKBKE|MAPKAPK2|UNC93B1|IRF7|IRAK1|TNIP1|PIK3R4|COLEC12|CD36|LGALS9|FADD|UBC|CD300LF|TLR5|TICAM1|TRAF3|TLR4|S100A8|ITGAM|S100A9|CD14|LY96
REGULATION OF TRANSLATIONAL TERMINATION%GOBP%GO:0006449,0.331035414977021,0.6957352559323989,0.4591737723697829,1.10431028941226,2448,5,MTRF1|OGFOD1
POSITIVE REGULATION OF WHITE FAT CELL PROLIFERATION%GOBP%GO:0070352,0.965466861468987,0.990916952887267,0.516541685046317,0.6887386385642621,7268,1,VSTM2A
NEGATIVE REGULATION OF APPETITE BY LEPTIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038108,0.0322493953238377,0.25578651147417397,0.7954119333848021,1.56448140818425,239,3,BBS4|MKKS|BBS2
GLYCOLYTIC PROCESS THROUGH FRUCTOSE-6-PHOSPHATE%GOBP%GO:0061615,0.108800836929515,0.45309795582492896,-0.333166647892361,-1.37972977612122,831,22,GPI|HK1|HK3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
REGULATION OF PH%GOBP%GO:0006885,0.24204648746916,0.625158460820442,-0.227530057176394,-1.16958290041622,1863,45,PPT1|CLN6|SLC9A5|ATP6V0A1|SLAMF8|GPR89B|TCIRG1|ATP6V0A2|RAB7A|ATP5B|DMXL1|ATP6V0D1|CA2|SLC9A1|SLC9A7|SLC11A1|SLC9A9|ATP6V0E1|ATP6AP1|ATP6V0E2|RAB20
ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE ORGANIZATION%GOBP%GO:1990809,0.893731187017406,0.965875893252105,-0.29847354205154697,-0.653420975731004,6828,4,ARL6IP1
GPI ANCHOR RELEASE%GOBP%GO:0006507,0.7870899189799442,0.9276917050905171,0.60603220114689,0.80806216657342,5925,1,GPLD1
PROTEIN LOCALIZATION TO GOLGI APPARATUS%GOBP%GO:0034067,0.0843686006825939,0.40376145987147494,0.32626122029416105,1.42149279555832,617,25,IFT20|SYS1-DBNDD2|GCC2|VPS13C|VPS13A|RAB33B|RAB6A|OBSL1|COG7|ARL5A|SYS1|OPTN|PAQR3|ARL5B|GAK
MONOUNSATURATED FATTY ACID CATABOLIC PROCESS%GOBP%GO:1903965,0.9399654668614692,0.9812919575525741,0.5302712836347601,0.707045205707996,7076,1,GLYATL2
RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY%GOBP%GO:0007168,0.263839811542992,0.6393694935562609,-0.546517399216897,-1.19644082954798,2015,4,GNG7|GUCA1B|NPR2|NPR1
HEXOSE BIOSYNTHETIC PROCESS%GOBP%GO:0019319,0.28131925433450705,0.654557203588677,-0.243239026617655,-1.14231913456659,2157,33,PGAM2|PER2|GOT1|GPI|SLC25A10|G6PC3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002292,0.236525379382522,0.62149045081524,-0.320659799592729,-1.19169597711281,1807,16,GPR183|BATF|RORA|SPN|PTGER4|STAT3|FCER1G|FOXP1
TRIPEPTIDE TRANSPORT%GOBP%GO:0042939,0.0712390554523746,0.3767214120425879,-0.8285084091535709,-1.3787704812875,536,2,SLC9A3R1|ABCC1
CELLULAR RESPONSE TO ACETYLCHOLINE%GOBP%GO:1905145,0.48091004184100394,0.7857006060206241,-0.252072227061322,-0.978133989170739,3677,18,CHRM2|GNAQ|GNA15|ADRBK1|LY6H
CELLULAR RESPONSE TO ANTIBIOTIC%GOBP%GO:0071236,0.13148387096774197,0.490819490032838,-0.238917562461617,-1.3032550592171699,1018,55,IMPACT|ECT2|PPIF|CYP1B1|AHR|LARP1|TNFAIP3|ADCY8|MEF2C|PARK7|ABL1|FXN|RELA|SIGMAR1|MAPK13|ANXA1|CRIP1|NET1|PDGFB|SIRPA
GLYCOLYTIC PROCESS%GOBP%GO:0006096,0.05054057574573401,0.32266864877606105,-0.35527295664499,-1.5316314971743301,387,25,GPI|PFKFB2|HK1|HK3|ENO1|PGAM1|GAPDH|LDHA|PGK1|ALDOA|ALDOC
C4-DICARBOXYLATE TRANSPORT%GOBP%GO:0015740,0.42887084097458705,0.7570379447218231,-0.313317656428359,-1.0143827698035401,3273,11,SLC25A10|SLC25A18|SLC1A2|SLC1A3|SLC25A22
POSITIVE REGULATION BY HOST OF SYMBIONT CATALYTIC ACTIVITY%GOBP%GO:0043947,0.167087262584673,0.539296853569433,0.9184494927216591,1.22462846953084,1257,1,SUGT1
CELLULAR RESPONSE TO LOW-DENSITY LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:0071404,0.0272358255859631,0.232741231955178,-0.487008120988821,-1.6763763939861398,207,13,SYK|ITGB1|SREBF2|ITGB2|FCER1G|CD36|LDLR|PPARG|CD81
NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033629,0.09893256964332199,0.43390420706119104,-0.500567344340462,-1.44106332473021,759,8,CYP1B1|SNAI2|SERPINE1|KIAA2022
REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001014,0.560911710767619,0.827698373164264,-0.280984867015711,-0.909703624511339,4281,11,TBX1|NR1D2|MEF2C|DDX5|UQCC2
REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE%GOBP%GO:1904350,0.35554679284963203,0.7132037834765931,-0.39783010375262395,-1.08745084762757,2704,7,LDLR|CD81
POSITIVE REGULATION OF INTERFERON-ALPHA PRODUCTION%GOBP%GO:0032727,0.5294348508634221,0.8108997701936519,-0.25383095889873003,-0.943334128476646,4046,16,IRF5|DHX36|IFIH1|IRF7|TLR4
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT OF VIRAL MATERIAL%GOBP%GO:1901254,0.33672240802675607,0.699462084003389,-0.8287935597706221,-1.10415202668403,2516,1,FMR1
N-GLYCAN PROCESSING TO LYSOSOME%GOBP%GO:0016256,0.709921636339487,0.8963870249632699,0.644133215703573,0.858864728406032,5344,1,GNPTAB
NEGATIVE REGULATION OF INTERLEUKIN-4 PRODUCTION%GOBP%GO:0032713,0.951772856948784,0.9858647066977451,0.269398334528208,0.591879613997466,7005,4,ZFPM1|LEF1|FOXP3|NDFIP1
"NUCLEOTIDE-EXCISION REPAIR, DNA DAMAGE RECOGNITION%GOBP%GO:0000715",0.333681462140992,0.6974768376198021,-0.261482817529189,-1.0978569225482702,2555,23,UBC|DDB1|CETN2|GPS1|XPA
NEGATIVE REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905457,0.0765455027858848,0.38654270614299796,-0.823655913978495,-1.3706951533438603,576,2,HES1|NOTCH1
CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:0061309,0.6771026797559039,0.8836483435332951,-0.526446016687789,-0.876090356816125,5103,2,JAG1
RESPONSE TO ODORANT%GOBP%GO:1990834,0.32527560100943,0.6930257594644499,0.836733568592854,1.11567131086813,2448,1,CFAP69
PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006646,0.7091947769314471,0.8960839116793909,0.23723423210149103,0.806313012393707,5213,12,LPIN1|SLC27A1|PISD|CHKB|EPT1
FILOPODIUM ASSEMBLY%GOBP%GO:0046847,0.6594124047878129,0.8774328166230891,0.24805512746950398,0.843091131064399,4847,12,FGD4|VSTM5|ARHGEF4|FGD5|EZR
PROTEIN KINASE A SIGNALING%GOBP%GO:0010737,0.469119044387132,0.780769690730001,0.378233875080298,0.978702382564992,3455,6,RAB13|GAL|EZR
NEGATIVE REGULATION OF ALDOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0032348,0.61005291005291,0.850714570847612,-0.45228383087048707,-0.8831956908243579,4611,3,REST|BMP2
TERMINATION OF RNA POLYMERASE II TRANSCRIPTION%GOBP%GO:0006369,0.0794228519433251,0.3955855191077921,-0.300336471370913,-1.42292925476276,610,34,CPSF1|SNRPE|LSM11|SSU72|NCBP2|LSM10|CPSF2|SNRPF|PAPOLA|NCBP1|CLP1|CSTF3|SNRPB|PABPN1|CPSF7|MAZ
POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS%GOBP%GO:0040038,0.382827196990056,0.730480369014206,0.5479665453278839,1.07778553035323,2848,3,SPIRE2|SPIRE1|FMN2
CHOLESTEROL BIOSYNTHETIC PROCESS VIA DESMOSTEROL%GOBP%GO:0033489,0.00510404397330192,0.0803498785568947,-0.8275102116132141,-1.8115928339346599,38,4,EBP|DHCR7|DHCR24
PROTEASOME CORE COMPLEX ASSEMBLY%GOBP%GO:0080129,0.220735785953177,0.603022518406817,-0.88630348478165,-1.18076905574606,1649,1,PSMG1
PROTEIN LOCALIZATION TO MITOTIC SPINDLE%GOBP%GO:1902480,0.8249435516004779,0.9422643049903799,0.586457873842082,0.781962442332353,6210,1,FAM83D
REGULATION OF HORMONE SECRETION%GOBP%GO:0046883,0.0579654510556622,0.347310359961223,-0.203426291032312,-1.37018525699348,452,130,ITPR2|SNX4|PIM3|STX4|STXBP4|GIPR|ITPR3|SLC2A1|SLC8B1|CDK16|SYT7|INS|ADCY8|SLC25A6|POMC|INHBA|CRHBP|IRS1|ENSA|OSM|SPP1|GHRL|RAPGEF3|UQCC2|VAMP8|DPP4|VAMP7|LRP5|SNX6|GPER1|HFE|CACNA1E|RAP1A|NOV|CHGA|ADRA2C|NR1D1|ARL2|SLC25A4|IL11|SIRT4|RAB11FIP1|ANXA1|EFNA5|BAD|C1QTNF1|SLC25A5
SYNAPTIC VESICLE TARGETING%GOBP%GO:0016080,0.52428093645485,0.808136316886519,-0.740681517423908,-0.986765629329154,3918,1,SEPT5
CGMP CATABOLIC PROCESS%GOBP%GO:0046069,0.43433271424781106,0.762034923704788,-0.625274172958247,-1.04055621266059,3273,2,PDE2A
SPHINGANINE-1-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0006668,0.94009828662505,0.9812919575525741,0.530050727834142,0.7067511243080961,7077,1,SPHK2
POSITIVE REGULATION OF MONOCYTE AGGREGATION%GOBP%GO:1900625,0.9287245444801719,0.9793746057014829,0.36598053792709706,0.614894557377523,6931,2,NR4A3|CD44
POSITIVE REGULATION OF CELL-MATRIX ADHESION%GOBP%GO:0001954,0.0539624608967675,0.33672656929591804,-0.32134655674068896,-1.4947775063030702,413,32,RAC1|UTRN|CDK6|JUP|PPM1F|KDR|THY1|S100A10|ABL1|CSF1|CD36|TEK|CX3CL1|COL16A1|PTPRJ|EMP2
SYNAPTIC VESICLE BUDDING%GOBP%GO:0070142,0.134799110064128,0.496974190065009,-0.617645500019931,-1.35215511065027,1029,4,DNM1|DNM3
REGULATION OF BASE-EXCISION REPAIR%GOBP%GO:1905051,0.6139559564871321,0.852182158593687,-0.5541770057899089,-0.922239157200627,4627,2,RPS3|FAM168A
ADENYLATE CYCLASE-ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007191,0.45108841709218,0.769517436697938,0.512388045331346,1.00780681939927,3356,3,GNAS|GNB1|GNG2
DETECTION OF MOLECULE OF BACTERIAL ORIGIN%GOBP%GO:0032490,0.0111724500525762,0.13736224596935,-0.6540483951785899,-1.78781212134884,84,7,C4B|TLR1|TLR2|SSC5D|TLR4|LY96
NEGATIVE REGULATION OF ENDODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042664,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
GOLGI LOCALIZATION%GOBP%GO:0051645,0.933856209150327,0.9800972968717879,-0.17835726540136396,-0.5969784671746241,7143,12,PDCD10|CDC42|TBCCD1|SLC9A3R1|COPG1
DETECTION OF BACTERIUM%GOBP%GO:0016045,0.5938441388343161,0.843040556302675,-0.34354483129542107,-0.8836898522960821,4533,6,CD1D|TLR1|TLR2|SSC5D
MITOCHONDRIAL TRNA PROCESSING%GOBP%GO:0090646,0.763530051672559,0.9191113740914171,0.24031113097900197,0.761321906795418,5614,10,ELAC2|TRMT61B|PUS1|TRNT1|KIAA0391|TRIT1
REGULATION OF LYSOSOMAL LUMEN PH%GOBP%GO:0035751,0.505601092896175,0.797902257689198,0.32581187733977696,0.945774880415104,3700,8,CCDC115|CLN5|TMEM199|VPS33A
CYTOCHROME C-HEME LINKAGE%GOBP%GO:0018063,0.30943143812709006,0.680809181688249,-0.84246801940891,-1.12236969035362,2312,1,HCCS
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS%GOBP%GO:0071549,0.225925925925926,0.608570227910676,-0.62747818437383,-1.22530586039002,1707,3,AQP1|NR3C1
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT%GOBP%GO:0043268,0.33971603490947,0.7015009045057019,-0.252034362644023,-1.0865554525772199,2607,25,ATP1B1|AMIGO1|ATP1B3|FLNA|KCNQ1|ATP1B2|KCNH2|WNK2
MAINTENANCE OF TRANSCRIPTIONAL FIDELITY DURING DNA-TEMPLATED TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0001193,0.8908361204013381,0.965159112268525,-0.55690339655933,-0.741929044608386,6658,1,POLR2I
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002866,0.267504253369978,0.6417330323279019,-0.543873087427406,-1.1906518782803,2043,4,HLA-E|PARK7|ZP3
POSITIVE REGULATION OF DNA REPAIR%GOBP%GO:0045739,0.8601079286010791,0.9512653536504921,0.134702734592438,0.7390842680087109,6215,54,MGMT|SPIDR|RIF1|EYA4|FAM175A|MMS19|SPIRE2|BRE|ACTR2|EYA1
POSITIVE REGULATION OF INTERLEUKIN-13 PRODUCTION%GOBP%GO:0032736,0.0991583377169911,0.434549148169116,-0.5948042196759761,-1.4256322154714,753,5,RARA|HLA-E|GATA3|LGALS9
FORMALDEHYDE METABOLIC PROCESS%GOBP%GO:0046292,0.17000929738345097,0.543216018944259,0.916795324217027,1.22242285903159,1279,1,KDM3A
RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL%GOBP%GO:0051209,0.5873037542662121,0.8414799095069009,0.208002069176528,0.906247584463381,4301,25,DRD2|XCL1|NOL3|FGF2|RYR1|PKD2|ITPR1
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND%GOBP%GO:1901099,0.25284398699891697,0.632257972333528,0.321252551689714,1.18496823784804,1866,15,EYA4|MAPK7|MAP2K5|UNC5B|EYA1
FATTY ACID DERIVATIVE METABOLIC PROCESS%GOBP%GO:1901568,0.0109100243871133,0.134836502891779,-0.26111495924392203,-1.62032856250071,84,91,GPX4|ALOX5|SCD5|CD74|LTC4S|DGAT1|ACSL5|TBXAS1|PTGDS|AACS|CYP1B1|FAR1|ACSL4|GGT1|GPX1|ELOVL2|CBR1|ACSF3|DAGLB|MAPKAPK2|ELOVL1|PTGR2|PLA2G4A|PTGES2|PTGS1|DPEP1|ACOX1|PLA2G4C|DAGLA|HACD2|GGT5|PLAA|ABCD1|MGLL|FADS1|FASN|PTGES|PTGIS|ABCC1
RETINA LAYER FORMATION%GOBP%GO:0010842,0.189556703834648,0.563467720122429,0.399761833825548,1.26647251149882,1393,10,AHI1|PTPRM|MEGF11|TFAP2B
CONNECTIVE TISSUE DEVELOPMENT%GOBP%GO:0061448,0.0120123998966675,0.14415750339761702,-0.282894632173759,-1.64265669436597,92,70,MATN2|CD44|TGFB1|HYAL2|SLC39A13|CHI3L1|COL20A1|RUNX3|COCH|COL11A2|CREB3L2|CD34|HYAL3|ANXA6|ARID5B|VWA1|COL14A1|MGP|MEF2C|GHRL|COMP|SULF1|LRP5|COL12A1|COL6A3|COL21A1|HYAL1|NOV|BMP2|PDGFRB|COL6A1|ANXA2|ACTA2|CRIP1|COL6A2|PDGFB
DETERMINATION OF DORSAL IDENTITY%GOBP%GO:0048263,0.25179092597506003,0.632068187660447,-0.7065343258891651,-1.1757861016131002,1897,2,GREM1|NBL1
CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY%GOBP%GO:0099004,0.8691212039774251,0.9566976576317809,0.345379537004475,0.6793207918209391,6467,3,PCP4|PRKAA1
OPTIC VESICLE MORPHOGENESIS%GOBP%GO:0003404,0.936113693717625,0.9806508984207809,0.532752536391707,0.710353621456863,7047,1,SIX3
OLIGODENDROCYTE DIFFERENTIATION%GOBP%GO:0048709,0.6780481423338571,0.884536278926676,-0.223844433336798,-0.831892588485878,5182,16,PTEN|SLC8A3|EIF2B5|SOX10|PLP1|EIF2B1|EIF2B2|EIF2B3
REGULATION OF MATURE B CELL APOPTOTIC PROCESS%GOBP%GO:0002905,0.48386239872493,0.787078399497453,0.758325981473313,1.01112537320392,3642,1,BCL10
REGULATION OF DEFENSE RESPONSE TO BACTERIUM%GOBP%GO:1900424,0.842714360862704,0.9481593344082329,-0.291608445712971,-0.698929800360907,6407,5,FOXP1
CORNIFICATION%GOBP%GO:0070268,0.288903394255875,0.66212691838798,-0.270619500823201,-1.1362180320783102,2212,23,KRT9|KRT18|PKP2|PERP|CAPN1|PCSK6|KRT7|KRT19
TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING%GOBP%GO:0010833,0.990601749118914,0.9970911567116291,-0.107044559167834,-0.4840041371279529,7588,29,NHP2|PINX1|PTGES3|TERF2IP|RAD51|RPA2|TERT|SLX1B|SLX1A|DKC1|TNKS1BP1|HSP90AA1
ATP METABOLIC PROCESS%GOBP%GO:0046034,0.00012745347947999,0.00518555396908895,-0.31309292742494704,-2.15074274835294,0,142,NDUFB5|NADK|SURF1|ATP1B1|UQCR10|PARP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|PFKFB2|HK1|NDUFA3|NDUFB6|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|GAPDH|NDUFS6|COQ7|NDUFB4|NDUFA12|SDHAF2|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
NEURAL CREST CELL MIGRATION%GOBP%GO:0001755,0.111516890569975,0.45838451842376793,-0.30870836323108597,-1.3615547006116,854,27,SEMA4A|CORO1C|SOX10|TBX1|SEMA6A|ANXA6|SEMA3B|SEMA3D|SEMA7A|FN1|SEMA5A|SEMA3E|SEMA3A|SEMA6B
EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY%GOBP%GO:0060136,0.00504715101607119,0.0801398542446357,0.9974084693427441,1.3299096106948,37,1,TLE6
ATP SYNTHESIS COUPLED PROTON TRANSPORT%GOBP%GO:0015986,0.40215251345320896,0.740287621109606,-0.25428079905830203,-1.03594180627147,3063,21,ATP5J|ATP5F1|ATP5B|ATP5O|STOML2|ATP5H|ATP5G1
REGULATION OF AMACRINE CELL DIFFERENTIATION%GOBP%GO:1902869,0.425952981803692,0.7547028278218628,0.7878804587560649,1.05053228079043,3206,1,POU4F2
REGULATION OF LYMPHOTOXIN A PRODUCTION%GOBP%GO:0032681,0.16936454849498303,0.541894568706611,-0.9133215703573,-1.21676363315775,1265,1,CD86
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE%GOBP%GO:0032212,0.13380666302566901,0.495404845602596,0.28293531855909804,1.31985420802065,979,31,HMBOX1|ATM|PARN|ACD|POT1|MAP2K7|MAP3K4|XRCC5|PNKP|TNKS|ATR|MAPK1|TNKS2|NEK7|TCP1
BONE MINERALIZATION INVOLVED IN BONE MATURATION%GOBP%GO:0035630,0.0326346511010878,0.25785422561312804,-0.8835401157981801,-1.4703520413756899,245,2,IGF1|BMP2
LUNG DEVELOPMENT%GOBP%GO:0030324,0.409463148316651,0.7448505271608159,-0.218482313837917,-1.03512195701431,3149,34,TGFB3|THRA|CEBPA|RCN3|FGF10|CTSH|PDPN|FGF7|ERRFI1|DNAAF1|PDGFA
DISTAL TUBULE MORPHOGENESIS%GOBP%GO:0072156,0.726554126473741,0.905101893109553,0.48411000044744396,0.8133673067239999,5422,2,PKD1|KLHL3
PLUS-END-DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072386,0.400570109949776,0.740287621109606,0.40134265841835,1.0384977176769699,2950,6,KIF13A|KIF3B|KIFAP3|FYCO1
RESPONSE TO DISACCHARIDE%GOBP%GO:0034285,0.442122186495177,0.7653693162885199,0.618790665649634,1.0396482135882499,3299,2,KHK
LYMPHOCYTE CHEMOTAXIS%GOBP%GO:0048247,0.00863874345549738,0.11593697760655802,-0.407906446139562,-1.821755810109,65,28,CCL3|CCL4|CCL8|CCL11|GPR183|ADAM8|CCL19|CCL24|SLC12A2|GAS6|CCL3L3|CCL18|CCL2|CXCL16|CYP7B1|CX3CL1|CCL4L2|CCL14
METAPHASE/ANAPHASE TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0007091,0.6357806569820699,0.8636797415465791,-0.38984915343265397,-0.8534612899788541,4857,4,TACC3|CDC23|CDC27
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY DIRECTED AGAINST TUMOR CELL TARGET%GOBP%GO:0002860,0.7608465608465609,0.9182611787042629,-0.392578637336635,-0.7666065800718391,5751,3,PVR|PVRL2
LUNG ALVEOLUS DEVELOPMENT%GOBP%GO:0048286,0.62867247007617,0.8598964527864159,0.254635669555235,0.8654571136855741,4621,12,STRA6|FGFR2|ATP7A|ATXN1L
CENTRIOLE-CENTRIOLE COHESION%GOBP%GO:0010457,0.821409140369967,0.9406008438023141,0.21078960011209902,0.716432851794087,6038,12,DCTN1|CEP68|CEP250|CROCC|ODF2|CEP135|SYNE2|RTTN|NIN|KIF3A|CNTLN
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY%GOBP%GO:0002716,0.12066246056782301,0.472686039512467,-0.508367115826844,-1.3895988408047601,917,7,SERPINB9|MICA|LILRB1|HLA-E|CEACAM1|LGALS9
PROTEIN LOCALIZATION TO NON-MOTILE CILIUM%GOBP%GO:0097499,0.44034206596986597,0.7653693162885199,0.387023843966457,1.0014469436906401,3243,6,BBIP1|SPATA7|TULP3
REGULATION OF PROTEIN K63-LINKED DEUBIQUITINATION%GOBP%GO:1903004,0.916025470947201,0.9747669359607141,-0.386607898517906,-0.6433773663850411,6904,2,VCP
TRICARBOXYLIC ACID CYCLE%GOBP%GO:0006099,0.7579634464751959,0.917143966125732,-0.18643755980101603,-0.7827732911272579,5805,23,FH|PDHA1|SDHD|SDHA|ACO1|SDHAF2
REGULATION OF MYOBLAST PROLIFERATION%GOBP%GO:2000291,0.7625033792917,0.9189883170402341,0.315866879434132,0.75965803369698,5640,5,ATF2|MEIS2|ZNF609
REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:1905475,0.100012756729175,0.43605057892447596,-0.19141264045898498,-1.2862875218368999,783,128,ITGB2|GZMB|IQSEC2|PID1|STX4|NUMB|LRP1|CNST|GDI1|SHISA7|PDCD5|STAC3|NMT1|INS|PPP1R13B|CLTC|AKAP5|MMP14|RHOG|PPFIA1|NECAB2|HRAS|VAMP8|NKD2|E2F1|TREM2|STX7|GPER1|EPHA2|GSN|RAP1A|TMEM59|LGALS3|STX3|ITGAM|DAB2|ACTB|ARF6|AP2M1|SQSTM1|BAD|PRNP
TRICARBOXYLIC ACID METABOLIC PROCESS%GOBP%GO:0072350,0.679921517331589,0.8847742762205949,-0.185034594289321,-0.844831732041176,5197,30,FH|PDHA1|SDHD|IDH3G|SDHA|ACO1|SDHAF2|SIRT4
POSITIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:1900039,0.5744454774870501,0.835204333784353,0.710796206440229,0.9477508315256079,4324,1,RWDD3
MOLYBDOPTERIN COFACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0032324,0.160047343503419,0.5296866239243959,-0.551461362072821,-1.32174765637512,1216,5,MOCS2|MBIP|GPHN
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0040037,0.490568509300498,0.7903790206418191,-0.29792193297096303,-0.964538286789501,3744,11,SPRY1|GATA3|CREB3L1|SULF1|THBS1
SKELETAL MUSCLE TISSUE REGENERATION%GOBP%GO:0043403,0.786014721345952,0.9274485629622209,-0.268504215466372,-0.7339442992027629,5979,7,IGF1|ANXA1
POSITIVE REGULATION OF OXIDATIVE STRESS-INDUCED NEURON DEATH%GOBP%GO:1903223,0.37447089947089895,0.725184325297951,-0.556468512187052,-1.08664196793668,2830,3,FBXW7|MCL1|TLR4
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE%GOBP%GO:1904850,0.6392615221144909,0.865463150027443,0.6779885310983679,0.904006223290581,4812,1,TERF1
FOREBRAIN ASTROCYTE DEVELOPMENT%GOBP%GO:0021897,0.316111037322354,0.685583406115178,0.842633436259374,1.12353798831544,2379,1,NF1
REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901990,0.00434171880985826,0.0731407797055425,-0.193695873800805,-1.5209816558380902,33,296,TUBB|CUL1|PCBP4|GTSE1|CDC25A|WEE1|CNOT4|RBL1|ZFP36L2|MAD1L1|BTG2|CNOT10|CNOT6L|PSME3|CENPE|FOXN3|PHB2|CDC7|PRMT2|VPS4A|HAUS1|BLM|NDE1|SFN|TUBG1|PSME1|INO80|PINX1|ZNF207|CEP72|HAUS6|CDKN1B|CDK4|CNOT6|AURKA|CEP78|PTEN|RCC2|HAUS4|FHL1|TRIP13|CEP76|DUSP1|CSNK1D|FBXL7|CEP192|PCNT|KLHL22|PIDD1|ID2|PRMT1|NEK2|NEDD1|ANLN|TMEM14B|LSM11|UBD|CCND2|BRD4|PML|APC|RGCC|CLSPN|RPA2|DLGAP5|CDC20|DYNC1H1|ANAPC10|PLCB1|TRIAP1|TFDP2|DONSON|CDT1|LCMT1|ZFP36L1|ANAPC2|NBN|ANAPC5|KLF4|ESPL1|CDC6|OFD1|CEP70|RAD51C|CDC23|PLK2|TPX2|TUBA4A|SDCCAG8|SLFN11|HAUS8|RAD17|PCNA|LSM10|ORC1|CDK5RAP2|MAD2L1|TAOK2|DDX3X|CDC25C|KNTC1|GPNMB|DCUN1D3|PTPN6|PSME2|CDC45|NDC80|TOPBP1|MECP2|FGF10|CEP131|CDC27|DTL|SKP1|E2F1|CKAP5|TUBB4A|RPTOR|RAD51B|CCL2|KANK2|USP44|NACC2|CCNB1|PLK1|USP47|PLAGL1|HYAL1|AIF1|TNKS1BP1|FAM107A|DDB1|CCND3|IK|SSNA1|DACT1|PRKACA|CETN2|CDK2AP2|HSP90AA1|CEP63|ANXA1|NEK6|ANAPC11|ZNF385A|TUBB4B|CCND1|CDCA5|DCTN3|HAUS7|XRCC3|EIF4G1
MYELOID CELL DIFFERENTIATION%GOBP%GO:0030099,0.0012833675564681698,0.0282630985407838,-0.28008447500267897,-1.80920390248976,9,107,UBD|SBNO2|LYN|GPR183|PIR|CEBPG|NCKAP1L|KAT6A|MT1G|CCL19|BATF|DYRK3|TLR2|PARP1|HCLS1|MED1|TNFRSF11A|CBFA2T3|ATPIF1|TCTA|OSCAR|INHBA|RPS14|MEF2C|CEBPA|HSPA9|TAL1|CDKN2B|TREM2|IFI16|BATF2|CSF1|EPHA2|PDE1B|TGFBR2|TGFBR3|LGALS9|FOXP1|MMP9|TYROBP|IL11|LTBR|PPARG|MYH9|KAT8|ANXA2|CSF1R|ZNF385A|ACTN1|SNX10
ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY%GOBP%GO:0061339,0.6861918999728189,0.8861293611544642,0.218704016337782,0.823493155929695,5048,16,RLTPR|CAMSAP3|MYO9A|FOXJ1|EZR
POSITIVE REGULATION OF PEROXIDASE ACTIVITY%GOBP%GO:2000470,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
PROTEIN TETRAMERIZATION%GOBP%GO:0051262,0.0879599948711373,0.409521734239444,-0.21660050750820498,-1.33383636408274,685,88,PKD2L1|HIST1H4I|DHRS4|S100A10|RCC1|HMGCR|KCNJ12|HPRT1|CDA|CAT|TK1|HSD17B10|GPX3|HIST2H4A|HIST1H3H|ANXA2|HIST2H4B|CPSF7|SHMT2|SAMHD1|APIP|ALDOA
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE%GOBP%GO:0060688,0.5126358517742571,0.802184867798321,-0.275879596403114,-0.9496310699164321,3914,13,AGT|HGF|SMO|SULF1|MAP3K13|PDGFA
NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT%GOBP%GO:0045683,0.1058855146466,0.447796222692122,0.7062569940253491,1.38912416343925,787,3,DLL1|SRSF6|CDH3
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN METANEPHRIC COLLECTING DUCT DEVELOPMENT%GOBP%GO:1900215,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
NEGATIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060160,0.0286709539121115,0.238792268557792,0.890914967316106,1.49685217577874,213,2,DRD2|PALM
REGULATION OF GLOMERULUS DEVELOPMENT%GOBP%GO:0090192,0.42344466273739395,0.753783909572009,-0.397363082808751,-1.0221248930775602,3232,6,PDGFA|PDGFB
RETINAL METABOLIC PROCESS%GOBP%GO:0042574,0.812568306010929,0.9356336309698571,0.245909251698879,0.713831536828631,5947,8,ALDH8A1|ALDH1A3|AKR1C1|AKR1C3|BCO2
REGULATION OF OSTEOCLAST DIFFERENTIATION%GOBP%GO:0045670,0.0798226164079823,0.395958593986611,-0.325526765785401,-1.43573207246811,611,27,LILRB3|TCTA|FBN1|NOTCH2|CEBPB|MAFB|CSF1|CCR1|ATP6AP1|TLR4|LILRB4
DORSAL/VENTRAL AXIS SPECIFICATION%GOBP%GO:0009950,0.768102160032604,0.920474726214876,0.347139303815605,0.762679834326206,5653,4,SFRP1|SMAD2
GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0042253,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING%GOBP%GO:0097119,0.6392857142857139,0.865463150027443,-0.440566197309945,-0.8603141223026372,4832,3,NRXN2
POSITIVE REGULATION OF APPETITE%GOBP%GO:0032100,0.55730963120191,0.8261372003522048,-0.576479778758142,-0.959354537901315,4200,2,GHRL
MRNA EXPORT FROM NUCLEUS IN RESPONSE TO HEAT STRESS%GOBP%GO:0031990,0.38076098606645203,0.729499056535481,0.6454370002757099,1.0844174962075899,2841,2,TPR|POLR2D
CELLULAR RESPONSE TO TYPE I INTERFERON%GOBP%GO:0071357,0.00232618247609201,0.0447432148508244,-0.370443425597505,-1.94198482107826,17,48,IRF8|OAS3|HLA-B|MX1|XAF1|HLA-E|SP100|IFIT3|OASL|OAS1|IFNAR1|HLA-C|IRF5|HLA-A|OAS2|IFIT2|IFIT1|ISG15|IFI6|RSAD2|IRF7|IRAK1|BST2|IFI35|IFITM1|IFITM2|IFITM3|SAMHD1
LONG-TERM SYNAPTIC POTENTIATION%GOBP%GO:0060291,0.873871516420254,0.9595052445364269,-0.17707330165833202,-0.6729217869311769,6678,17,NPTN|ARC|SLC8A3|MPP2|STX4|PLK2|GRIN2C|GRIN2D
REGULATION OF MRNA BINDING%GOBP%GO:1902415,0.41338065194532103,0.748061280707938,-0.37865195745952,-1.0350282399725899,3144,7,EIF3C|FMR1|EIF4G1
IMIDAZOLE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0052805,0.131481481481482,0.490819490032838,-0.6877136869968019,-1.34293053038731,993,3,C9orf41|FTCD|HNMT
UDP-N-ACETYLGLUCOSAMINE METABOLIC PROCESS%GOBP%GO:0006047,0.5274509803921571,0.810052447666581,-0.279464647891405,-0.935394343214861,4034,12,GNPNAT1|GFPT2|RENBP
ALPHA-AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:1901607,0.919270833333333,0.976687251055112,0.126434981742861,0.667477652598041,6706,47,AASS|ASL|GLS|CAD|GLUD1|MTHFR|SHMT1|AASDHPPT|MRI1|ENOPH1|NAGS|GLS2|CTH|SRR|MTAP
VIRAL TRANSLATIONAL TERMINATION-REINITIATION%GOBP%GO:0075525,0.887402000540687,0.965145106124274,0.273020806090668,0.65661347300723,6564,5,EIF3A|EIF3L|EIF3G|EIF3D
REGULATION OF POLYNUCLEOTIDE ADENYLYLTRANSFERASE ACTIVITY%GOBP%GO:1904245,0.12240802675585302,0.476255306135618,-0.9373070136744599,-1.24871800290079,914,1,PABPN1
RESPONSE TO HOST IMMUNE RESPONSE%GOBP%GO:0052572,0.8474396391615809,0.9492491301138911,-0.432917355800498,-0.720443708742283,6387,2,SLC25A6
REGULATION OF CORTISOL BIOSYNTHETIC PROCESS%GOBP%GO:2000064,0.587996755879968,0.8414799095069009,0.366824433049115,0.882210657924359,4349,5,WNT4|DGKQ|DKK3
POSITIVE REGULATION OF DIACYLGLYCEROL KINASE ACTIVITY%GOBP%GO:1905689,0.687892976588629,0.8866901918807819,-0.660123511248346,-0.879443021985307,5141,1,MAPT
ORNITHINE METABOLIC PROCESS%GOBP%GO:0006591,0.19125831410343397,0.5657618283915489,0.493050034851616,1.27579594432303,1408,6,ASL|AZIN2|ARG2|AZIN1|ALDH18A1
NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS%GOBP%GO:0070233,0.24342619109606894,0.626082056933819,-0.41835701227419303,-1.2043912849057,1869,8,BMP4|PRKCQ|BLM|JAK3|TNFRSF4|FADD
POSITIVE REGULATION OF T CELL COSTIMULATION%GOBP%GO:2000525,0.659184486651614,0.8772415412127091,0.668670048522276,0.891581284144833,4962,1,CCR7
POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT%GOBP%GO:1904179,0.18488745980707397,0.5582354096380949,0.7466532360783701,1.25447384091325,1379,2,TRPM4|SIRT1
CREATINE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015881,0.21257525083612,0.5950741597527031,-0.8916519629466251,-1.1878945129071499,1588,1,SLC6A8
PSEUDOURIDINE SYNTHESIS%GOBP%GO:0001522,0.33079434167573496,0.6957352559323989,0.32375606725345296,1.1003839014101102,2431,12,PUS10|PUS7|GAR1|PUS1|TRUB1|PUSL1|PUS3|RPUSD2
INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION%GOBP%GO:0060122,0.28762278978389,0.660471578149057,-0.44737506975721897,-1.15076919604342,2195,6,DFNB31|PDZD7|SOD1|ADGRV1
NEGATIVE REGULATION OF TIMING OF CATAGEN%GOBP%GO:0051796,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
PROTEIN DEGLUTATHIONYLATION%GOBP%GO:0080058,0.45993311036789297,0.774149829207065,-0.7711733568592851,-1.02738808097949,3437,1,GLRX
"ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU-RRNA FROM 5.8S RRNA AND LSU-RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000447",0.676088720584258,0.8831602225584391,0.29452604642061103,0.81303124560289,4998,7,UTP20|RPS21|NOP14|RPSA|KRI1
PARANODAL JUNCTION ASSEMBLY%GOBP%GO:0030913,0.16689062080085998,0.53917243184018,0.659755156060439,1.2976605357401798,1241,3,EPB41L3|CD9|CNTNAP1
LYSOPHOSPHOLIPID TRANSPORT%GOBP%GO:0051977,0.704343206269093,0.894436909245845,0.647441552712836,0.863275949404522,5302,1,MFSD2A
ERGOSTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006696,0.0489632107023411,0.317359880131657,-0.973533303925893,-1.29698011996096,365,1,C14orf1
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY%GOBP%GO:0070431,0.32764550264550296,0.694856853542345,-0.577809639351495,-1.12831578040239,2476,3,OTULIN|RIPK2|RELA
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN-CONTAINING COMPLEX LOCALIZATION TO TELOMERE%GOBP%GO:1904914,0.6392615221144909,0.865463150027443,0.6779885310983679,0.904006223290581,4812,1,TERF1
NEGATIVE REGULATION OF DENDRITIC SPINE MAINTENANCE%GOBP%GO:1902951,0.15892809763863097,0.5293397224673839,-0.7590280691870621,-1.2631440848415,1197,2,PRNP
INTESTINAL FOLATE ABSORPTION%GOBP%GO:0098829,0.573781378669146,0.835204333784353,0.7110719011910009,0.9481184332754821,4319,1,SLC46A1
REGULATION OF PROTEIN LOCALIZATION TO PRESYNAPSE%GOBP%GO:1905384,0.612963208925488,0.852045339927398,0.6903396559329511,0.920474781684944,4614,1,DVL1
REGULATION OF VESICLE FUSION%GOBP%GO:0031338,0.11339800734137401,0.46139171800540707,-0.39079883263902204,-1.3825891219122601,864,14,SEPT8|PRRT2|ANXA2|ANXA1
EPITHELIAL CELL MATURATION%GOBP%GO:0002070,0.333915614082236,0.6974768376198021,0.570857143912713,1.12280863650124,2484,3,NKX6-1|TMEM79|SIX3
OSSIFICATION INVOLVED IN BONE REMODELING%GOBP%GO:0043932,0.253250198991775,0.632257972333528,-0.7057071960297769,-1.1744096252590701,1908,2,TGFB1|TGFB3
MITOCHONDRION DISASSEMBLY%GOBP%GO:0061726,0.143210197710718,0.509384864704371,-0.271820739518564,-1.29765401556775,1100,35,ATG7|FUNDC1|ATG2B|FIS1|USP30|ATG13|WDR45B|ATG2A|WDR45|WIPI1|ATG3|MARK2|AMBRA1|FUNDC2|SQSTM1
POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900451,0.681728880157171,0.885373411161421,-0.31681902984441496,-0.8149438914045172,5204,6,ARC|NLGN3|ADRB2|NECAB2
CELL ENVELOPE ORGANIZATION%GOBP%GO:0043163,0.7491638795986619,0.913615832844878,-0.6310652845169828,-0.840730486687424,5599,1,TGM1
CELL WALL MACROMOLECULE BIOSYNTHETIC PROCESS%GOBP%GO:0044038,0.528561872909699,0.8105400040230321,-0.73869651521835,-0.984121129764213,3950,1,MPI
PUTRESCINE BIOSYNTHETIC PROCESS%GOBP%GO:0009446,0.9013720961825842,0.9684180373391851,0.295393479475204,0.648992054517862,6634,4,AZIN2|PAOX|AZIN1
CELL JUNCTION MAINTENANCE%GOBP%GO:0034331,0.7018828451882849,0.8931369333627571,-0.256824872145248,-0.804598798397958,5367,10,PKP2|F2R|CSF1R
POSITIVE REGULATION OF PROTEIN AUTOUBIQUITINATION%GOBP%GO:1902499,0.687759197324415,0.8866901918807819,-0.660233789148655,-0.8795899386278041,5140,1,MTA1
MAST CELL ACTIVATION%GOBP%GO:0045576,0.364748763342879,0.7192051755829771,-0.37353025234282794,-1.0753413170363701,2801,8,FCGR2B|S100A13|CHGA|MILR1
POSITIVE REGULATION OF GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:1905099,0.127090301003344,0.48362648780247897,-0.935266872518747,-1.2460000450146003,949,1,EPHA4
REGULATION OF CALCIUM ION IMPORT%GOBP%GO:0090279,0.141829124689258,0.5078130330642999,-0.349484540608679,-1.32812659711396,1083,17,CCL2|LGALS3|PDGFRB|PDGFB|PRNP
APOPTOTIC PROCESS INVOLVED IN ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:0003277,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
NON-CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE%GOBP%GO:0038031,0.7882727513929421,0.927903725560957,-0.467990074441687,-0.778810321110619,5941,2,FZD7|DVL3
RESPONSE TO LUTEINIZING HORMONE%GOBP%GO:0034699,0.14809364548495002,0.515403737647103,-0.924018526687252,-1.2310145474799299,1106,1,TGFBR3
DENSE CORE GRANULE LOCALIZATION%GOBP%GO:0032253,0.257845401440022,0.636098664976652,0.5414402592426399,1.1895673082183302,1897,4,KIF5B|KIF5A|KIF1A
CELLULAR RESPONSE TO L-GLUTAMATE%GOBP%GO:1905232,0.768294314381271,0.920474726214876,-0.620368328187031,-0.8264795723652429,5742,1,FYN
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS%GOBP%GO:0045732,0.0273357289527721,0.233474475083475,-0.20717769654645604,-1.44317082888303,212,153,LRP1|NRD1|RAB7A|PLK2|CBFA2T3|ATPIF1|VCP|RNF144B|TNFAIP3|FMR1|CCDC22|TNFSF12|SMURF2|CEBPA|UBQLN1|SUMO2|TRIM32|MSN|RILP|HERPUD1|UQCC2|NKD2|DTL|RCHY1|PSMD10|APOE|PLK1|ECSCR|TIPARP|CTSC|SNF8|NSF|BCAP31|CAV1|LDLR|STX5|DDB1|DACT1|DAB2|HSP90AA1|CSNK1A1|MAGEF1|CD81|TNFRSF1B|FAM122A
NEGATIVE REGULATION OF CELL ADHESION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0106089,0.43772575250836104,0.7635570545514341,-0.7826422584913979,-1.04266741179915,3271,1,SEMA6A
CYTOPLASM PROTEIN QUALITY CONTROL BY THE UBIQUITIN-PROTEASOME SYSTEM%GOBP%GO:0071629,0.601540709257538,0.847046653006894,0.6969011910013239,0.9292237033319491,4528,1,RNF126
PROTEIN LINEAR DEUBIQUITINATION%GOBP%GO:1990108,0.727626981994088,0.905828042456896,0.4041579353700229,0.7949309650986139,5414,3,SPATA2|OTULIN|CYLD
ALPHA-LINOLENIC ACID METABOLIC PROCESS%GOBP%GO:0036109,0.0188235294117647,0.18904576748831697,-0.5232800560951071,-1.7514673432996002,143,12,ELOVL2|ELOVL1|ACOX1|ABCD1|FADS1|FADS2
CELLULAR SPHINGOLIPID HOMEOSTASIS%GOBP%GO:0090156,0.561811341037356,0.8282270665374359,0.46430255583732893,0.9132283360256299,4180,3,ORMDL1
GLYOXYLATE CATABOLIC PROCESS%GOBP%GO:0009436,0.318368973303228,0.6867397844771489,0.8408138509042791,1.12111181676627,2396,1,HOGA1
POSITIVE REGULATION OF OXIDATIVE STRESS-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903378,0.6082515256036078,0.8495617369926091,-0.5564378274055689,-0.9260015259016441,4584,2,FBXW7|MCL1
DTTP CATABOLIC PROCESS%GOBP%GO:0046076,0.43959866220735794,0.7650340344477281,-0.7818703131892372,-1.04163899530167,3285,1,DCTPP1
PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA%GOBP%GO:0070918,0.38358026369444104,0.730673193816843,0.22696465453117,1.0507774584791898,2821,30,HENMT1|SMAD3|PRKRA|SMAD1|MRPL44|AGO2|AGO3|PUM2|ZCCHC11|SMAD2|DGCR8|ZC3H7A|AGO1
MEMBRANE DOCKING%GOBP%GO:0022406,0.32536942411269204,0.693136484786504,0.152520834961368,1.0712918761775898,2355,152,NPHP1|CC2D2A|DYNC1I2|CEP162|CLASP1|DCTN1|TMEM67|SFI1|AHI1|FGFR1OP|STX8|RAB3B|NINL|CEP89|RAB3D|RAB10|SNAP25|RPGRIP1L|TTBK2|UNC13A|CEP164|PCM1|CEP290|MARK4|TCTN2|CEP57|RAB15|B9D1|NPHP4|USO1|VAMP3|STX10|STX16|STX16-NPEPL1|RAB11A|CEP250|DCTN2|YWHAE|VPS11|STX6|ATG14|B9D2|HAUS2|EZR|KCNB1|CHP1|TCTN1|CENPJ
REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION%GOBP%GO:0032908,0.132561809573908,0.49289540376144997,-0.5708385177191441,-1.36819100095773,1007,5,ATP6AP2|GATA6|THBS1
REGULATION OF HEART RATE BY HORMONE%GOBP%GO:0003064,0.6304059432210141,0.8611032652135849,-0.54769627925441,-0.9114541918994641,4751,2,KCNH2
REGULATION OF ATPASE ACTIVITY%GOBP%GO:0043462,0.0285491824552297,0.238789399313666,-0.304524100312641,-1.58596261968319,219,47,TNNT2|DHX9|VCPKMT|SETMAR|RYR2|ATP1B1|TOR1AIP2|PPIF|OXA1L|CHTOP|PXK|PLN|HNRNPU|ATP1B3|ATPIF1|PLSCR1|DYNLL2|UHRF1|AHSA1|FGF10|ATP1B2|DNAJB11|TMSB4X|VMA21
EXTRACELLULAR MATRIX CONSTITUENT SECRETION%GOBP%GO:0070278,0.253779264214047,0.6331482968738821,-0.8697617997353331,-1.1587315593715501,1896,1,CREB3L1
ATP HYDROLYSIS COUPLED TRANSMEMBRANE TRANSPORT%GOBP%GO:0090662,0.13951053527025303,0.504314492208813,-0.614901009209728,-1.3461468465650799,1065,4,ATP6V1H|FXYD2|ATP1A1|ATP1A3
INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY%GOBP%GO:0035735,0.000137570504883753,0.00526859796630401,0.530548551933692,2.6651533539649104,0,40,DYNLRB2|DYNC2H1|TTC30B|WDR19|TTC21B|DYNC2LI1|IFT88|WDR35|IFT46|IFT172|IFT20|IFT140|KIF3B|CLUAP1|IFT81|TNPO1|WDR60|PCM1|IFT52|TRAF3IP1|KIF3C|IFT27
ADRENAL CORTEX FORMATION%GOBP%GO:0035802,0.35396466994288794,0.7118407891832621,0.8236104984561099,1.09817346757412,2664,1,CITED2
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT%GOBP%GO:0045992,0.15318981359936998,0.521260838919081,-0.360306560124689,-1.30821471456013,1166,15,SFRP2|GATA3|TBX2|MESP1|SULF1|COL5A2|COL5A1
GLUCURONOSIDE CATABOLIC PROCESS%GOBP%GO:0019391,0.103210400636774,0.441899546263084,-0.7989022917695748,-1.3295011675864,777,2,ABHD10
ATP TRANSPORT%GOBP%GO:0015867,0.312147272238646,0.68160868787154,0.581343934028634,1.1434349151366001,2322,3,SLC25A17|SLC25A24
POSITIVE REGULATION OF CHROMATIN SILENCING AT TELOMERE%GOBP%GO:0031940,0.7953177257525079,0.929656485793048,-0.606473312748125,-0.807968075410657,5944,1,SIRT6
NEUROTRANSMITTER RECEPTOR INTERNALIZATION%GOBP%GO:0099590,0.736266597240302,0.908157084784786,-0.268982913708501,-0.7743641615997021,5655,8,DNM3
REGULATION OF CARDIAC MUSCLE FIBER DEVELOPMENT%GOBP%GO:0055018,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION%GOBP%GO:0045657,0.0420609884332282,0.293912248709997,-0.5839363404832629,-1.5961639464416102,319,7,ACIN1|CD74|ZFP36L1|CD4|IL34|CSF1
MODULATION BY HOST OF SYMBIONT MOLECULAR FUNCTION%GOBP%GO:0052428,0.388216728037875,0.735276444766153,-0.43969792191488505,-1.05387201674388,2951,5,RAB9A|NUCKS1|ANXA2
CELLULAR CATION HOMEOSTASIS%GOBP%GO:0030003,0.000128667009778693,0.00518555396908895,-0.238853372248463,-1.8947636874564697,0,318,PPT1|PML|CCL11|CEMIP|PSEN1|PLCE1|CLN6|SLC39A13|SLC9A5|NDFIP1|FIS1|ATP6V0A1|MT1G|OCM|EDNRA|CCL19|SLAMF8|HSP90B1|FPR3|LPAR6|RYR2|GPR89B|TCIRG1|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|ATP6V0A2|ERO1L|PTGER1|RAB7A|PLN|ITPR3|SLC8B1|ATP1A3|ATP1B3|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ATP5B|ADCY8|CXCR4|JPH4|CALB2|CCDC22|TAC1|CALCB|DMXL1|RMDN3|ATP6V0D1|ABCB7|HAMP|CA2|SLC9A1|PTGER4|TBXA2R|SLC9A7|SLC11A1|GHRL|ABL1|CALR|ACO1|HERPUD1|HMOX1|SOD1|SKP1|SLC35G1|ARF1|SLC9A9|MT1M|CCRL2|P2RY6|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|FTL|APLNR|GNA15|TMCO1|MTL5|CD36|F2RL3|ATP6V0E1|GRIN2C|FXN|MT2A|TGM2|GRIN2D|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|ATP1B2|PRKACA|ATP6V0E2|S100A8|S100A9|RAB20|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|TFRC|ATP6V1A|ATP6V1G1|C5AR1|FTH1|C1QTNF1|PRNP
DIADENOSINE PENTAPHOSPHATE CATABOLIC PROCESS%GOBP%GO:1901907,0.7360293155346159,0.908157084784786,-0.35559109356837504,-0.7784632357147929,5623,4,NUDT11|NUDT4
MAINTENANCE OF PROTEIN LOCATION IN MEMBRANE%GOBP%GO:0072658,0.8358528428093649,0.945788393670804,-0.585796206440229,-0.780421204942524,6247,1,ANK3
LYMPHOCYTE ACTIVATION%GOBP%GO:0046649,0.0460358056265985,0.30746333312705,-0.190501752278941,-1.3637205850798797,359,176,EIF2AK4|IRF2BP2|PPP3CA|CD7|LFNG|PTPN22|PRDX1|ZFP36L2|HELLS|CD8B|MALT1|CLCF1|DLL4|MICB|LCP1|BLM|ITGA4|CD40|PLCG2|RORC|FOXP3|CD1D|MFNG|JAK3|CD180|PRF1|DOCK11|ITGB1|MICA|DOCK10|NCR3|LILRB1|SLA2|CLEC4A|HLA-E|GPR183|CEBPG|CD74|FNIP1|CORO1A|RIPK3|TNFSF8|CCL19|SLAMF8|BATF|ZFP36L1|CXADR|CD4|EXO1|RORA|LAT2|SPN|FCGR2B|PLA2G2D|INS|ADA|RAB29|AKAP17A|PTGER4|MEF2C|STAT3|NFAM1|RNF168|ICAM1|FCER1G|MSN|SLC11A1|NOTCH2|RSAD2|TNFRSF4|KLF6|DPP4|VAMP7|HDAC5|ICOSLG|VCAM1|CTPS1|LRRC8A|IL21R|CLEC7A|JAG2|HFE|FADD|RELB|EXOSC3|FOXP1|FKBP1A|IL11|STOML2|ANXA1|NCK1|PRKCB|PTPRJ
POSITIVE REGULATION OF MAST CELL ACTIVATION BY FC-EPSILON RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038097,0.36817638464603497,0.721642468110297,0.816993824437583,1.08935102557714,2771,1,NR4A3
PARENTAL BEHAVIOR%GOBP%GO:0060746,0.78801965732501,0.927797067038212,0.6056462284958101,0.807547524123596,5932,1,OXTR
T CELL EXTRAVASATION%GOBP%GO:0072683,0.19357859531772603,0.567519363754568,-0.901411557123952,-1.2008966357681101,1446,1,CCL2
CHRONIC INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002439,0.6709030100334449,0.8815356925073421,-0.668228936921041,-0.8902413952088148,5014,1,TNF
RESPONSE TO REDOX STATE%GOBP%GO:0051775,0.8111231982594509,0.935316201530063,0.22783799567522,0.721806171030259,5964,10,FKBP1B|ADH5|VIMP|GLRX2|SIRT2|CLOCK|ARNTL|NPAS2|RYR2|RNF7
REGULATION OF INTERLEUKIN-12 SECRETION%GOBP%GO:2001182,0.433850604944766,0.7617684338942181,-0.420552340416478,-1.00798371120541,3298,5,LGALS9|FOXP1
SCF-DEPENDENT PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0031146,0.22235973597359698,0.604959238589686,0.2444326136087,1.1923535168277501,1616,36,FBXO2|FBXL8|ATP5SL|FBXL2|BTRC|FBXO31|LRRC29|FBXO18|FBXL5|FBXL3|FBXO48|FBXL16|FBXO9|FBXL6|FBXL12
MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0072161,0.25817256162915303,0.636098664976652,0.7043939808375721,1.18347283579541,1926,2,WNT4|STAT1
POSITIVE REGULATION OF FLAGELLATED SPERM MOTILITY%GOBP%GO:1902093,0.32527560100943,0.6930257594644499,0.836733568592854,1.11567131086813,2448,1,CFAP69
POSITIVE REGULATION OF T CELL ACTIVATION%GOBP%GO:0050870,0.00064077918749199,0.0163600882996276,-0.27986273405182,-1.8637885054360301,4,123,RARA|GRAP2|HSPH1|IL1B|AKT1|FOXP3|CD1D|HLA-DMB|CDC42|PAK2|JAK3|SYK|RAC1|CD274|NFKBIZ|HLA-DPA1|LILRB1|HLA-E|LYN|CD209|PYCARD|NCKAP1L|TNFRSF14|IL18|ADAM8|RUNX1|CCL19|RUNX3|CCDC88B|HLA-DPB1|PDCD1LG2|VAV1|GATA3|EBI3|THY1|IL6ST|LILRB2|GRB2|SOCS1|PTPN6|CD47|IGF1|DPP4|NKAP|ICOSLG|VCAM1|C10orf54|CCL2|CD86|NLRP3|TGFBR2|LGALS9|ZP3|FADD|AIF1|CAV1|BCL6|LILRB4|PNP|ANXA1|CD55|NCK1|TFRC|SART1|SIRPA
RESPONSE TO UV-C%GOBP%GO:0010225,0.421286610878661,0.752472774240887,-0.325374807560437,-1.01935679751467,3221,10,IMPACT|YY1|DCUN1D3|CARD16|BCL3
DOPAMINE METABOLIC PROCESS%GOBP%GO:0042417,0.315438977983148,0.6851935987509761,0.297643961503076,1.12072823035414,2320,16,DRD2|PARK2|DRD4|ATP7A|MAOB
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS%GOBP%GO:0032102,0.000127877237851662,0.00518555396908895,-0.297191500406911,-2.12746687086764,0,176,KLF4|SIGLEC10|SEMA6A|CD34|RORA|TNFAIP6|GATA3|GP1BA|PLAU|FCGR2B|INS|CASK|FEM1A|VTN|TNFAIP3|NOTCH1|PHLDB2|PTGER4|IFIT1|SNAI2|CARD16|GHRL|NR1H3|NPLOC4|SEMA3B|SEMA3D|SEMA7A|CDH5|CCL2|CEACAM1|THBD|KANK2|GPER1|CORO1B|APOE|PLAUR|NLRP3|NOS3|NOV|SERPINE2|CD200|THBS1|TEK|SEMA5A|NBL1|AIF1|SEMA3E|EPHA4|SLIT2|CX3CL1|SERPINE1|LDLR|SEMA3A|PPARA|PLAT|SEMA6B|DHX58|RTN4RL1|ABCD1|PDGFA|ANXA2|PDGFRA|TFPI|GSTP1|TNFRSF1A|METRNL|FAM3A|CHID1|PDGFB|SERPINF2|SIRPA|PTGIS|C1QTNF1|RNF26
POSITIVE REGULATION OF ACTIN NUCLEATION%GOBP%GO:0051127,0.393075356415479,0.737478302661917,0.298529498391552,1.04551254292915,2894,13,CYFIP1|ABI2|NCKAP1|WIPF1|WIPF2
NEGATIVE REGULATION OF SECRETION BY CELL%GOBP%GO:1903531,0.000637999234400919,0.0163600882996276,-0.301614387134375,-1.91548517441278,4,99,REST|RHBDF2|CD84|PIM3|RAB7A|CD34|SYT4|SSC5D|FCGR2B|GAS6|INS|TNFAIP3|FMR1|NOTCH1|INHBA|CRHBP|PTGER4|IRS1|OSM|CARD16|RSAD2|SRGN|TNFRSF4|VAMP8|NR1H3|CEACAM1|CD300A|F2R|FN1|NLRP3|NOV|CHGA|TNFRSF21|CD200|LGALS9|ADRA2C|HTR1B|CX3CL1|IL11|SIRT4|SERGEF|RAB11FIP1|ANXA1|TNFRSF1A|TMSB4X|TNFRSF1B
PEPTIDYL-LYSINE HYDROXYLATION%GOBP%GO:0017185,0.9095628415300551,0.971886587430107,0.21627676805848103,0.6278136209066371,6657,8,VPS33B|P3H4|PLOD3|VIPAS39
REGULATION OF T-HELPER 17 CELL LINEAGE COMMITMENT%GOBP%GO:2000328,0.24638263665594898,0.6280519349499749,0.7092824282569541,1.19168605863296,1838,2,LOXL3|IL12RB1
NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY%GOBP%GO:0002710,0.42202551418901296,0.7527812076478722,-0.35437575322266796,-1.02019819494156,3241,8,FOXP3|LILRB1|FCGR2B|CEACAM1|HFE
NEGATIVE REGULATION OF CORTICOTROPIN-RELEASING HORMONE RECEPTOR ACTIVITY%GOBP%GO:1900011,0.29886287625418106,0.671387424531401,-0.8471548301720341,-1.12861364765973,2233,1,CRHBP
REGULATION OF GTP BINDING%GOBP%GO:1904424,0.7289487447698749,0.9064076322522902,-0.25008795255716,-0.783492908768959,5574,10,EPHA4|CSNK1A1
POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION%GOBP%GO:0060907,0.03847663918335299,0.279776552671739,-0.710086582473943,-1.5545279638001799,293,4,LILRB1|CD74|SEMA7A|GPRC5B
AUTOPHAGIC CELL DEATH%GOBP%GO:0048102,0.389077570982204,0.7357288939296949,0.476192190527728,1.04621452249048,2863,4,TP53INP1|SH3GLB1
POLYAMINE TRANSPORT%GOBP%GO:0015846,0.954716474066111,0.9870180073166591,0.295558783771887,0.5813292494481229,7104,3,AZIN2|ATP13A2
RIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009261,0.0381127612038376,0.278599757108718,-0.402617119448885,-1.59070267807747,289,19,PDE4D|NUDT16|PDE2A|HPRT1|NUDT18|NUDT4|ABCD1|HINT1
GLUCAGON SECRETION%GOBP%GO:0070091,0.8707692307692311,0.9574934752519241,-0.5673246581385091,-0.755812667324325,6508,1,IL6
DNA STRAND ELONGATION INVOLVED IN NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:1902319,0.24695652173913002,0.6280519349499749,-0.873400970445523,-1.16357980857394,1845,1,GINS1
NECROTIC CELL DEATH%GOBP%GO:0070265,0.0305814411340071,0.247447840028175,-0.39730329955112303,-1.61861650308971,232,21,RIPK3|PGAM5|PPIF|TICAM2|MLKL|TMEM123|FADD|ITPK1|TICAM1|TLR4|CD14|LY96
CELLULAR RESPONSE TO BENOMYL%GOBP%GO:0072755,0.48494983277591996,0.7872939093021379,-0.7604212615791801,-1.01306370833606,3624,1,IMPACT
SINOATRIAL NODE CELL DIFFERENTIATION%GOBP%GO:0060921,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
T CELL CHEMOTAXIS%GOBP%GO:0010818,0.273133543638276,0.647246599153167,-0.42896361561269497,-1.17255291391793,2077,7,CCL3|GPR183|SLC12A2|CXCL16
POSITIVE REGULATION OF PLASMA CELL DIFFERENTIATION%GOBP%GO:1900100,0.920133779264214,0.9768322640118741,-0.539534627260697,-0.7187896734151541,6877,1,XBP1
REGULATION OF EPINEPHRINE SECRETION%GOBP%GO:0014060,0.7191529795031899,0.900474259627538,0.304120873102456,0.7869306339362919,5297,6,UCN|CRH|CARTPT|VIP|ADRA2A
KYNURENINE METABOLIC PROCESS%GOBP%GO:0070189,0.5772247768460921,0.837152999580265,0.32171935550293396,0.8880976454135602,4267,7,AADAT|CCBL2
VESICLE FUSION%GOBP%GO:0006906,0.132990353697749,0.494045143021181,-0.23852819338240697,-1.29336818660219,1033,54,SNAP47|TAPBP|STX4|RAB7A|SYT7|CAV2|EEA1|STX11|CALR|NKD2|VAMP7|STX1B|STX7|RAB7B|STX3|RAB34|STX5|PRRT2|RAB20|GOSR2
RESPONSE TO MUSCLE INACTIVITY INVOLVED IN REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014877,0.11999462510077902,0.47202636254014396,0.6918663094157951,1.36081938502476,892,3,SCN5A|HDAC4
CEREBELLAR MOLECULAR LAYER DEVELOPMENT%GOBP%GO:0021679,0.222936763129689,0.605751556060834,0.7223049352081609,1.21356555171492,1663,2,DLL1|ZNF365
REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY%GOBP%GO:0070948,0.961972588013975,0.9905437927174009,0.287801919047094,0.566072411904716,7158,3,DNASE1|F2RL1|DNASE1L3
NOREPINEPHRINE BIOSYNTHETIC PROCESS%GOBP%GO:0042421,0.7032713451880009,0.8936451122273059,0.30832457919374,0.7978079705214108,5180,6,INSM1
LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0008610,0.20587861051024303,0.585932546425919,-0.13740855894922802,-1.12216602812432,1617,380,ABHD3|GPX4|SGPP1|PGS1|LBR|ALOX5|SCD5|ACP6|ADM|CD74|CES1|GPAA1|DPM2|LTC4S|PIK3C2A|ACHE|PTDSS2|TSPO|DGAT1|IDI1|RAB14|GPD1|TBXAS1|PYURF|AGPAT1|GPAM|CERS6|FDPS|SPTSSB|PTGDS|MED1|CERS4|PLA2G2A|FAR1|PPAP2C|ELOVL2|PLA2G2D|CBR1|CACNA1H|PCYT1A|HSD11B1|ACSF3|MTMR12|PLSCR1|CPNE6|CHPT1|PIGP|CYP51A1|ELOVL1|PLA2G4D|ETNK2|PLA2G4A|PRKD1|CDIPT|PTGES2|PTGS1|DGKE|PIK3CB|UGCG|ABHD5|MTMR1|ARF1|HMGCR|THNSL2|GK|PLD1|SLC44A1|CYP46A1|APOE|B3GALT2|SYNJ2|HMGCS1|CYP7B1|HACD2|PPAP2A|INPP4B|HSD17B1|FITM2|PIGH|PDSS1|PLEKHA4|B3GNT5|NDUFAB1|SRD5A3|LPIN3|EBP|DHCR7|ANG|OSBP|ABCD1|DOLK|PCTP|DHRS7B|SPTSSA|SMPD1|DOLPP1|C14orf1|A4GALT|B3GALT1|AGPAT2|ALDH3B1|FADS1|LPIN2|SPHK1|ST3GAL5|DHCR24|CNBP|NSDHL|HSD17B14|OSBPL3|PTGES|GBGT1|PTPMT1|PTGIS|AGPAT3|TM7SF2|PLA2G12A
PLASMA MEMBRANE FUSION%GOBP%GO:0045026,0.54350683491062,0.816444320780226,-0.338331235690561,-0.9248133450940649,4134,7,NSF|FOLR2
NEGATIVE REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS%GOBP%GO:0003340,0.991366715367247,0.997150662115148,0.504631671812969,0.672858242969697,7463,1,STAT1
ORGAN GROWTH%GOBP%GO:0035265,0.00325182101977107,0.0584727556008998,-0.400236615219146,-1.91070281037514,24,35,COL20A1|COCH|C3orf58|ANXA6|DDR2|MESP1|VWA1|NOTCH1|COL14A1|S1PR1|FGF10|COMP|COL12A1|COL6A3|COL21A1|TGFBR3|FGF7|COL6A1|ANXA2|COL6A2
PROTEIN O-LINKED GLYCOSYLATION VIA SERINE%GOBP%GO:0018242,0.37851487851487897,0.7285942545132281,0.348504690709112,1.05907361248011,2772,9,GALNT3|MGAT5B|GALNT2
AXONOGENESIS%GOBP%GO:0007409,0.0541370168829357,0.337307425356771,0.177249764524783,1.3155015389179499,387,199,TNR|RET|CNTN4|SHTN1|DRD2|ROBO3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|SEMA4F|PLXNB1|LLGL1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|SLIT1|EPHB2|EFNA4|PARD3|RAB10|GFRA1|CHN1|PTPRO|ROBO2|PTPRM|SLITRK6|CHRNB2|LYPLA2|EFNB2|NTNG1|EFNB3|SLIT3|CDK5R1|SHC1|SOS1
ACROSOME REACTION%GOBP%GO:0007340,0.156342980795239,0.5257250974517679,0.48354135007344295,1.33480291786921,1155,7,ADCY3|SPESP1|PCSK4|PRND
CATABOLISM BY ORGANISM OF MACROMOLECULE IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052361,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
RESPIRATORY TUBE DEVELOPMENT%GOBP%GO:0030323,0.498899889988999,0.794989907195277,0.198342712701017,0.9675248631297891,3627,36,STRA6|NPHP3-ACAD11|FGFR2|LOXL3|ASCL1|PKD1|ATP7A|HECA|NPHP3|ATXN1L|CCDC40|FOXJ1|PROX1|BMPR2
REGULATION OF MICROGLIAL CELL MIGRATION%GOBP%GO:1904139,0.129477314937649,0.487857553689733,-0.7792666115246759,-1.29682425567754,975,2,P2RX4|CSF1
REGULATION OF PHENOTYPIC SWITCHING BY TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0100057,0.252224731039979,0.632257972333528,0.8759373621526251,1.16794427970024,1898,1,SP1
ENDOCARDIAL CELL DIFFERENTIATION%GOBP%GO:0060956,0.40196463654224,0.740287621109606,-0.404465221582298,-1.04039350722063,3068,6,SOX18|SOX17|NOTCH1|ANXA2
FORMIN-NUCLEATED ACTIN CABLE ASSEMBLY%GOBP%GO:0070649,0.382827196990056,0.730480369014206,0.5479665453278839,1.07778553035323,2848,3,SPIRE2|SPIRE1|FMN2
POSITIVE REGULATION OF METANEPHRIC MESENCHYMAL CELL MIGRATION BY PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:0035793,0.000529100529100529,0.0139529201631112,-0.93448770265799,-1.8248176383564498,3,3,PDGFRB|PDGFA|PDGFB
REGULATION OF MIRNA CATABOLIC PROCESS%GOBP%GO:2000625,0.9392636388067719,0.980854185905783,0.307037755847707,0.603907032913434,6989,3,PNPT1|ZC3H12A|PAPD4
POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT%GOBP%GO:0051798,0.863877190599103,0.9532695997809,0.31318590415265,0.6880827692715681,6358,4,GAL|NUMA1|TGFB2|FST
REGULATION OF NEUTROPHIL APOPTOTIC PROCESS%GOBP%GO:0033029,0.15806878306878303,0.527990543848753,-0.668702831815034,-1.3058071484987501,1194,3,PIK3CB|ANXA1
GLIAL CELL DEVELOPMENT%GOBP%GO:0021782,0.7114516349705841,0.8966571213032921,0.17235691135877,0.826926942458188,5199,34,DLL1|PICK1|PARD3|TENM4|PRDM8|EIF2B4|NF1|ARHGEF10|MXRA8|SKI
MIDBRAIN DEVELOPMENT%GOBP%GO:0030901,0.202439657409811,0.5810727835229039,-0.232303931689712,-1.2098397193755,1559,47,BASP1|PLP1|NDRG2|ATP5J|ATP5F1|RAD1|NDST1|ZNF430|CNP|ZNF148|CKB|FGF9|WNT3|ACTB|HSPA5|NDUFS3|MAPKAP1
SINOATRIAL VALVE DEVELOPMENT%GOBP%GO:0003172,0.296588628762542,0.6687276080240239,-0.848698720776356,-1.13067048065468,2216,1,MEF2C
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL/VENTRAL NEURAL TUBE PATTERNING%GOBP%GO:1901621,0.103466595829459,0.442538815478223,0.9483348037053371,1.2644764992172,778,1,GPR161
NEGATIVE REGULATION OF CARDIAC CHAMBER MORPHOGENESIS%GOBP%GO:1901220,0.37404682274247497,0.724682900261831,-0.8110939567710631,-1.0805719055633,2795,1,TBX2
HISTONE H3-K27 TRIMETHYLATION%GOBP%GO:0098532,0.6506613756613759,0.8720947751965071,-0.43655588371198994,-0.852482996255633,4918,3,HIST1H1C
REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I%GOBP%GO:1901836,0.9480162367421759,0.984208682089217,-0.167285504452743,-0.575829146650062,7239,13,IPPK|SMARCA4|NOL11|H2AFY
RENAL VESICLE MORPHOGENESIS%GOBP%GO:0072077,0.5972856758935771,0.844862323067435,0.45076045899025896,0.8865926296000122,4444,3,PAX8
CARDIAC MUSCLE CELL-CARDIAC MUSCLE CELL ADHESION%GOBP%GO:0086042,0.0533068783068783,0.334780133348582,-0.761332303959413,-1.48668903075352,402,3,JUP|CXADR|PKP2
PREANTRAL OVARIAN FOLLICLE GROWTH%GOBP%GO:0001546,0.733962013547616,0.907913422943088,0.632168063520071,0.8429108124614921,5525,1,ZNF830
TRANSLOCATION OF MOLECULES INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051836,0.0851735015772871,0.40376145987147494,-0.53692474202122,-1.4676598384979298,647,7,THOC7|THOC3
ISOPRENOID CATABOLIC PROCESS%GOBP%GO:0008300,0.607119486978144,0.8492159043277758,-0.39985663238146707,-0.8753697533367599,4638,4,SRD5A3
POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS%GOBP%GO:0033089,1.0,1.0,-0.25650722228871903,-0.426869036477315,7537,2,ADAM8
COLLAGEN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0038065,0.16745531019979001,0.5398534927425961,-0.48007872108819394,-1.31227377528962,1273,7,ITGA11|DDR2|DDR1|COL4A2|COL1A1
BMP SIGNALING PATHWAY INVOLVED IN URETER MORPHOGENESIS%GOBP%GO:0061149,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
NEGATIVE REGULATION OF ANTIFUNGAL INNATE IMMUNE RESPONSE%GOBP%GO:1905035,0.0387959866220736,0.28020075641001296,-0.980094838994266,-1.30572166018951,289,1,FAM3A
NEGATIVE REGULATION OF G0 TO G1 TRANSITION%GOBP%GO:0070317,0.303492884864166,0.676536823078878,-0.231604898547143,-1.11524240101572,2345,36,YAF2|RBBP4|RBBP8|CBX3|CDC7|FOXO4|EHMT1|PCGF2|PHC3|RAD51|RRM2|UXT|TFDP2|EZH2|DAB2IP|BRCA1|RBBP7|E2F1|MAX|RING1
AMINO-ACID BETAINE BIOSYNTHETIC PROCESS%GOBP%GO:0006578,0.784268441787801,0.927080511528825,0.341349345406813,0.749959049121432,5772,4,ACADM|SHMT1|ALDH9A1
MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT ASSEMBLY%GOBP%GO:1902775,0.93899489384574,0.980854185905783,0.307268115142826,0.6043601224627471,6987,3,FASTKD2|DDX28|DHX30
NEGATIVE REGULATION OF INTERLEUKIN-1 BETA SECRETION%GOBP%GO:0050713,0.2,0.577896180140049,-0.490586560191246,-1.26192079001488,1526,6,TNFAIP3|CARD16|NLRP3
RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS%GOBP%GO:0071426,0.246023601847101,0.6280519349499749,-0.17099905367291598,-1.12883944439647,1917,118,MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|NUP37|NMD3|RAN|NXF1|NUP160|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
POSITIVE REGULATION OF TYPE IV HYPERSENSITIVITY%GOBP%GO:0001809,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
PROTON-TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY%GOBP%GO:0043461,0.259731720147291,0.636098664976652,-0.496571446940687,-1.19018700376326,1974,5,OXA1L|TMEM70|ATPAF1
RENAL SODIUM ION TRANSPORT%GOBP%GO:0003096,0.264285714285714,0.6396077326151851,-0.6071467960736739,-1.185603812009,1997,3,MAGED2|KLHL3|SGK1
L-GLUTAMATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015813,0.0463783220427306,0.30821484404079497,-0.529839339466931,-1.59388642318635,355,9,SLC25A18|SLC1A2|SLC1A3|SLC25A22|ARL6IP5|PRAF2
MATURE B CELL DIFFERENTIATION%GOBP%GO:0002335,0.38179916317991597,0.7297987005335401,-0.33679283781800107,-1.05512799579687,2919,10,MFNG|DOCK11|DOCK10|GPR183|SLAMF8|FCGR2B|NOTCH2
RESPONSE TO KETONE%GOBP%GO:1901654,0.15548112842973097,0.524424229719913,-0.23873502208621497,-1.26717970543156,1206,50,NR3C1|CCL19|DCPS|NDOR1|AHR|LARP1|TGFB3|ADCY8|PTGER4|PARK7|MSN|SPP1|NR1H3|WBP2|TGFBR3|THBS1|SLIT2|CAV1|YAP1
PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0030166,0.38118609406952997,0.729499056535481,0.20363999058123897,1.0568654409743499,2795,44,HS6ST3|CHST8|HS6ST1|NDST3|XYLT1|CHPF|HS6ST2|CHST15|CSPG5|CSGALNACT2|NDST2|GLCE
SKELETAL MUSCLE SATELLITE CELL MIGRATION%GOBP%GO:1902766,0.303858520900322,0.676707700393746,0.682043844866157,1.14592172162056,2267,2,RHOC|RHOA
MITOCHONDRIAL CITRATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0006843,0.526896002125116,0.809755446473093,0.735719011910013,0.980982029714234,3966,1,SLC25A1
AMINOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:0006023,0.265274753426412,0.640597140783729,-0.18784584133172003,-1.12910569899846,2070,80,HS3ST5|DCN|CHST7|NDST1|GCNT2|SDC4|BGN|VCAN|OGN|B4GALT7|LUM|SDC2|FMOD|HYAL1|EXT2|B3GAT3|B4GALT1|B3GNT5|B3GALT6|B4GAT1|CSGALNACT1|XYLT2
PEPTIDYL-LYSINE OXIDATION%GOBP%GO:0018057,0.18583954979714698,0.559093571852282,-0.588016444526665,-1.2872909145901201,1419,4,LOXL1|LOX|LOXL2
NEGATIVE REGULATION OF PLASMA MEMBRANE LONG-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0010748,0.65493818774623,0.874775007199212,0.383328211635115,0.842188406005807,4820,4,IRS2
MAINTENANCE OF PROTEIN LOCATION IN MAST CELL SECRETORY GRANULE%GOBP%GO:0033370,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
POSITIVE REGULATION OF OSTEOCLAST DEVELOPMENT%GOBP%GO:2001206,0.094448160535117,0.424465668011418,-0.9503749448610501,-1.2661276250366498,705,1,ATP6AP1
OCTOPAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006589,0.5600955160520029,0.827091649887284,-0.575254159290394,-0.957314911115694,4221,2,MOXD1
TUMOR NECROSIS FACTOR SECRETION%GOBP%GO:1990774,0.705272944614159,0.894639008000397,0.646890163211292,0.8625407459047729,5309,1,HMGB1
POSITIVE REGULATION OF GONADOTROPIN SECRETION%GOBP%GO:0032278,0.358465608465608,0.714938712241162,-0.563306496084703,-1.0999948174089,2709,3,INHA|INHBB|INHBA
NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0042532,0.506644085461178,0.7981861395854799,-0.31638093629497605,-0.951751297710167,3888,9,PARP14|SOCS3|SOCS1|PPP2CA|NF2
AVOIDANCE OF DEFENSES OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051832,0.6752217145928511,0.882488012133495,0.421547863421082,0.829134901428522,5024,3,SMAD3|EIF2AK2
PROPIONYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:1902860,0.334440164696507,0.6974768376198021,0.832432730480812,1.1099367235701,2517,1,ACAT1
ACTIN FILAMENT REORGANIZATION INVOLVED IN CELL CYCLE%GOBP%GO:0030037,0.8776729977420642,0.960725750963158,0.560377150419056,0.747187316794256,6607,1,ARAP1
POSITIVE REGULATION OF PROTEIN DEACETYLATION%GOBP%GO:0090312,0.798612020426869,0.931350348412063,-0.213363495917016,-0.734438528801976,6098,13,ZBTB7B|FNTA|AKAP8|ING2|VEGFA|PRKD2|CTBP1|AKAP8L|NIPBL|C6orf89|DYRK1A|PRKD1|BRMS1
RESPONSE TO INTERLEUKIN-8%GOBP%GO:0098758,0.981939799331104,0.993436724391485,-0.50904278782532,-0.6781672217648139,7339,1,EGR1
INVOLUNTARY SKELETAL MUSCLE CONTRACTION%GOBP%GO:0003011,0.41070234113712395,0.7453853667476059,-0.7951588001764449,-1.05934245072253,3069,1,GAA
REGULATION OF MACROPHAGE DIFFERENTIATION%GOBP%GO:0045649,0.40797385620915005,0.7445496113654559,-0.30944121831332694,-1.0357287311713101,3120,12,IL34|INHBA|C1QC|CSF1|FADD
NEGATIVE REGULATION OF INTERLEUKIN-13 PRODUCTION%GOBP%GO:0032696,0.44613955956487106,0.767797697802539,-0.620772576744442,-1.03306483670146,3362,2,TNFRSF21
LACTATE BIOSYNTHETIC PROCESS%GOBP%GO:0019249,0.179357919872645,0.552622606699698,-0.74590570719603,-1.2413063760649599,1351,2,PER2|PARK7
RESPONSE TO XENOBIOTIC STIMULUS%GOBP%GO:0009410,0.7787994891443171,0.924704689181848,-0.134379063791405,-0.8109497061691571,6097,81,AKR7L|STAT5A|AQP1|POR|CES1|NR3C1|CDO1|FMO3|RYR2|BCHE|RORA|CYP1B1|AHR|GGT1|NAT1|GRIN1|ADCY8|CRHBP|PTGS1|PDE2A|DPEP1|N6AMT1|CYP46A1|AIP|FMO2|GSTP1|AOC3|PDGFB
REGULATION OF APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001233,0.00012738853503184699,0.00518555396908895,-0.24608583050544103,-1.88496524732805,0,255,SP100|FIS1|PYCARD|APOPT1|CD74|GNB2L1|TRIAP1|BCL2A1|TFDP2|MADD|KDM1A|TERT|AGT|BCL2L11|DAB2IP|GZMB|PPIF|TNFRSF10A|STX4|TNFRSF10B|HGF|TMBIM6|SFRP2|SOD2|OPA1|PDCD5|BAG5|BCL2L2|WWOX|GPX1|NMT1|INS|TRAF2|PRELID1|TNFAIP3|CREB3|SLC9A3R1|DDX3X|PPP1R13B|SIAH2|TNFSF10|CAAP1|INHBA|TNFSF12|UBQLN1|PARK7|ICAM1|BRCA1|TRIM32|SNAI2|ENO1|CREB3L1|TIMP3|SCRT2|IFI6|HERPUD1|HMOX1|HSPB1|SOD1|TNFRSF4|G0S2|IGF1|E2F1|NONO|TAF9B|GPER1|CIDEB|GSN|NACC2|PSMD10|PLAUR|NOS3|LGALS3|SYVN1|LGALS9|THBS1|FXN|PEA15|FADD|MMP9|BCAP31|CX3CL1|SNAI1|SERPINE1|CAV1|YBX3|LTBR|DNAJA1|RELA|MPV17L|TNFRSF12A|S100A8|S100A9|TAF9|STYXL1|ZNF385A|GSTP1|NCK1|NDUFS3|PELI3|AK6|PTPMT1|BAD|P4HB|SLC25A5
KERATINOCYTE DIFFERENTIATION%GOBP%GO:0030216,0.29366106080207,0.6662639281174979,-0.23352598579085998,-1.12449297370949,2269,36,ST14|TGM1|KLK14|FURIN|CSTA|ADAM9|JAG1|JUP|MED1|KRT9|KRT18|PKP2|PERP|CAPN1|EPHA2|PCSK6|KRT7|ANXA1|KRT19
CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:0036474,0.44572748267898404,0.7673954889535091,0.45424584032158205,0.9979974564443359,3280,4,STK25|RNF112
T CELL MIGRATION%GOBP%GO:0072678,0.0437908496732026,0.299062021084573,-0.478670820484493,-1.60215605487674,334,12,CCL3|GPR183|SLC12A2|MYO1G|S1PR1|MSN|CCL2|CXCL16
MACROPHAGE APOPTOTIC PROCESS%GOBP%GO:0071888,0.5960466967365351,0.844548800900243,-0.561024981923973,-0.933635284561428,4492,2,CTSL
REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS%GOBP%GO:0070228,0.15990609103951997,0.529429183067871,-0.29081209776023104,-1.2826234267057,1225,27,JAK3|CD274|LYN|FNIP1|ADAM8|RIPK3|PRELID1|TNFRSF4|LGALS3|LGALS9|FADD|FOXP1|BCL6
NEURON CELLULAR HOMEOSTASIS%GOBP%GO:0070050,0.03981519228156,0.28475403983757397,0.412165649620589,1.5848997201183601,292,17,CALB1|SLC6A2|FGGY|DCTN1|PARK2|CLCN3|DNAJB2|TAOK1|NELL2
OCTOPAMINE METABOLIC PROCESS%GOBP%GO:0046333,0.5600955160520029,0.827091649887284,-0.575254159290394,-0.957314911115694,4221,2,MOXD1
ERROR-PRONE TRANSLESION SYNTHESIS%GOBP%GO:0042276,0.6171218487394959,0.8545874073761078,-0.21949451481960897,-0.88060778938262,4699,20,RFC2|RPA2|RFC3|PCNA|RFC5|UBC|POLE2|RFC4
MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002313,0.5648775403856179,0.8295590091625621,-0.301417204606375,-0.906736730081685,4335,9,MFNG|DOCK11|DOCK10|GPR183|FCGR2B|NOTCH2
POSITIVE REGULATION OF PEPTIDE SECRETION%GOBP%GO:0002793,0.22836261059110102,0.610121312048328,-0.171036858111969,-1.1440851684025901,1780,126,HLA-E|RGCC|ADAM9|HYAL2|DHX9|TLR1|PYCARD|TNFRSF14|GSDMD|ADAM8|CCL19|ACHE|STX4|TLR2|PPIA|FGR|CD34|WLS|GPI|GATA3|MYOM1|TGFB3|INS|CASP1|DHX36|ADCY8|PTGER4|IFIH1|OSM|GHRL|TNFRSF4|IGF1|FCN1|IL33|GPER1|HFE|F2R|GAPDH|NLRP3|LGALS9|HAVCR2|ANG|TLR4|CSF1R|C1QTNF4|CD14|BAD
RESPONSE TO BIOTIN%GOBP%GO:0070781,0.369230769230769,0.7221103884306529,-0.81318923687693,-1.08336332177074,2759,1,HLCS
NADP METABOLIC PROCESS%GOBP%GO:0006739,0.0698619008935825,0.37596389138254704,0.36453927366644395,1.47739506434151,515,20,DERA|IDH1|TP53I3|RPE|NUDT12|PGD|RPIA|RBKS|SHPK|G6PD|PGM2
REGULATION OF CENTRAL B CELL TOLERANCE INDUCTION%GOBP%GO:0002895,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
NEGATIVE REGULATION OF PROTEIN TYROSINE PHOSPHATASE ACTIVITY%GOBP%GO:1903614,0.587486602357985,0.8414799095069009,0.5546629108608689,0.931905305673552,4384,2,MGAT5
ESTABLISHMENT OR MAINTENANCE OF NEUROBLAST POLARITY%GOBP%GO:0045196,0.31913464122547697,0.6869601115014491,0.5782435598713039,1.13733684503736,2374,3,RAB10|DOCK7
NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:1901293,0.0115118956254797,0.139771630097924,-0.210958085030916,-1.5156528849425301,89,179,ATP5J|DCAKD|GPI|ATP5F1|COASY|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|ADA|PDHA1|ACSF3|KYNU|ATP5B|HK3|ADCY8|NPR2|ELOVL1|SLC26A2|HAAO|ENO1|ADCY4|ATP5O|CTPS1|PGAM1|HPRT1|PRPS1|NPR1|RFK|GAPDH|UMPS|HACD2|GMPS|NME2|LDHA|CMPK2|STOML2|PDHX|ATP5H|NMNAT3|PNP|PGK1|RRM1|FASN|QPRT|NNMT|ADCY9|ALDOA|ALDOC|AK1|ATP5G1|MTHFD1|PTGIS
WNT SIGNALING PATHWAY%GOBP%GO:0016055,0.7834095000692428,0.92691610564026,0.124369505798131,0.8316954515398208,5656,121,WNT6|SFRP1|LRP5L|TCF7L1|MET|WNT5B|RARG|RPS27A|WNT2B|ROR2|USP34|ARRB2|BTRC|DIXDC1|FRAT2|PPP3R1|CELSR3|DVL2|WNT4|AGO2|STRN|VPS35|ARHGEF19|PPP3CB|TNRC6B|AGO3|AP2S1|AP2B1|MOV10|NR4A2|LRP6|CELSR2
REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:2000696,0.673408443056875,0.8822393559380352,0.316308889881914,0.818467843707007,4960,6,PAX8|CTNNB1|STAT1|PRKX
MATURATION OF SSU-RRNA%GOBP%GO:0030490,0.7695694043197142,0.921135900129782,0.15804926721373,0.7939434252928,5593,40,BTRC|MRPS9|DCAF13|HEATR1|TSR1|UTP20|UTP3|BMS1|WDR46|CIRH1A|NOL10|UTP6|RPS21|DIEXF|RPS19
"NEGATIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2000515",0.687369246861925,0.8864984516746409,-0.21297528032369503,-0.826423295284705,5256,18,FOXP3|JAK3|CD274|RUNX1|TWSG1|RUNX3|RC3H2|C10orf54|LGALS9|ANXA1
GOLGI INHERITANCE%GOBP%GO:0048313,0.696652719665272,0.89107464564121,-0.257960291884138,-0.808155920221702,5327,10,STX5|VRK1
NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS%GOBP%GO:1900118,0.36069786313226904,0.7159057180409292,0.3907936166117229,1.07877528914282,2666,7,MTRNR2L12|RFFL|DFFA|FZD3|RNF34|BCL2L1
OOCYTE GROWTH%GOBP%GO:0001555,0.7800504715101608,0.924791743051025,0.609616232906926,0.8128409893217841,5872,1,KMT2D
INTERLEUKIN-6 PRODUCTION%GOBP%GO:0032635,0.48386239872493,0.787078399497453,0.758325981473313,1.01112537320392,3642,1,BCL10
EXOCYTIC INSERTION OF NEUROTRANSMITTER RECEPTOR TO PLASMA MEMBRANE%GOBP%GO:0098881,0.0252056248341735,0.22334422304908896,-0.896222773642128,-1.4914580121374899,189,2,STX1B|STX3
REGULATION OF BLOOD CIRCULATION%GOBP%GO:1903522,0.0299615877080666,0.244735657013286,-0.216771170788637,-1.4583589792304,233,129,GJA5|SCN4B|DOCK4|S100A1|TNNT2|CELF2|GJA1|ADM|PER2|AGT|RYR2|JUP|CXADR|ITPR2|ATP1B1|ATP2A1|P2RX4|FOXN4|SPTBN4|PLN|ADORA3|ITPR3|ATP1A3|TBX2|KCNN2|KCNK6|CACNA1H|PDE4B|STIM1|ATP2A3|DOCK5|PDE4D|NPR2|SLC9A1|TBXA2R|PKP2|CACNA1G|POPDC2|FLNA|FXYD1|KCNJ12|NPR1|HSPB7|F2R|KCNQ1|SMTNL1|CHGA|ASPH|CAV1|SCN1B|CLIC2|ATP1B2|PRKACA|KCNH2|KCNE4|ADRBK1|RGS2|ATP2B2
CELLULAR RESPONSE TO VITAMIN K%GOBP%GO:0071307,0.0860971079862032,0.4057980029059221,-0.8158808933002479,-1.3577562756159698,648,2,GAS6|POSTN
POSITIVE REGULATION OF HEMOPOIESIS%GOBP%GO:1903708,0.0006411078343377361,0.0163600882996276,-0.295377497877318,-1.87878367768118,4,100,PRMT1|ACIN1|NFKBIZ|TGFB1|HOXA5|NCKAP1L|CD74|IL18|ADAM8|RUNX1|CCL19|HMGB2|ZFP36L1|RUNX3|CD4|HCLS1|MED1|GATA3|FES|IL34|GAS6|DHX36|LILRB2|TESC|INHBA|SOCS1|STAT3|TAL1|HAX1|MMP14|NKAP|C10orf54|CSF1|CCR1|CD86|NLRP3|RAB7B|AXL|LGALS3|TGFBR2|LGALS9|FADD|ATP6AP1|BCL6|ZNF16|LILRB4|PNP|ANXA1|LGALS1|SART1
NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT%GOBP%GO:1901977,0.763044065963774,0.9191113740914171,0.315598734416676,0.7590131464676791,5644,5,THOC5|DDX39B|THOC1|PPP1R10
PROTEIN LINEAR POLYUBIQUITINATION%GOBP%GO:0097039,0.22923945176028,0.6113421192595799,0.624944342894031,1.2291917741880802,1705,3,RBCK1|RNF31|SHARPIN
PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE%GOBP%GO:0090179,0.6732061273851121,0.882195523984236,0.42243361019112297,0.830877060800197,5009,3,DVL2|DVL1
C-TERMINAL PROTEIN AMINO ACID MODIFICATION%GOBP%GO:0018410,0.796751296751297,0.930404613277269,0.240677405119153,0.7313964364819241,5836,9,TTL|ATG5|AGTPBP1|GPLD1|ATG12|ATG7|FOLH1|AGBL4|LCMT1
TAURINE BIOSYNTHETIC PROCESS%GOBP%GO:0042412,0.500066889632107,0.7951717058944731,-0.75402514336127,-1.00454254307126,3737,1,CDO1
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT%GOBP%GO:0090317,0.634947643979058,0.8635433959051629,-0.19552882773182803,-0.8732536132620621,4850,28,SP100|APOD|GDI1|GAS6|MDFIC|UBE2G2|PARK7|PDE2A|DERL3|INSIG1
REGULATION OF SUCCINATE DEHYDROGENASE ACTIVITY%GOBP%GO:1904229,0.141939799331104,0.5078130330642999,-0.927878253198059,-1.2361566299673201,1060,1,FXN
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS%GOBP%GO:0050775,0.341446831656242,0.701955655133333,0.278619930414768,1.09063729163749,2510,18,SS18L1|PTPRD|CAPRIN2|CUX2|CUL7|OBSL1|LRP8|FBXW8|CDKL3
REGULATION OF HISTONE H3-K9 METHYLATION%GOBP%GO:0051570,0.9393362350380849,0.980854185905783,0.175928219668762,0.597945800273442,6905,12,RIF1|PIH1D1|SMARCB1|SIRT1|ZNF274|ZNF304
POSITIVE REGULATION OF CATECHOLAMINE METABOLIC PROCESS%GOBP%GO:0045915,0.0474927036349164,0.312255783864335,-0.856906534325889,-1.42602950277589,357,2,PARK7|HPRT1
ENDOCARDIUM MORPHOGENESIS%GOBP%GO:0003160,0.22330352446081,0.606473710658924,-0.516121495268149,-1.2370447391115902,1697,5,SOX18|SOX17|NOTCH1
REGULATION OF FOCAL ADHESION DISASSEMBLY%GOBP%GO:0120182,0.610969899665552,0.8515630793099821,-0.698279664755183,-0.9302761802891691,4566,1,DUSP3
NEUTROPHIL MEDIATED IMMUNITY%GOBP%GO:0002446,0.000127518490181076,0.00518555396908895,-0.323956998841237,-2.66696917070735,0,403,UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|CNN2|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
NEURON PROJECTION DEVELOPMENT%GOBP%GO:0031175,0.0748855914574955,0.383578507779904,0.15136294366614803,1.24017227857999,539,356,TNR|RET|CNTN4|SLC12A5|IFT88|SHTN1|DRD2|ROBO3|FRY|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|TRAPPC4|BBS4|SEMA4F|PLXNB1|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|RAB13|ALS2|SLIT1|EPHB2|EFNA4|RTN4|PARD3|LAMB1|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|NYAP2|STK24|STMN3|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|BMP7|NTNG1|EFNB3|SLIT3|CDK5R1|NREP|BLOC1S3|SHC1|SOS1|NYAP1|MAP6|ADCYAP1|ATP7A|FRYL|DRAXIN|MICALL1|SPTBN1|PPP1R9A|STMN2|NEDD4|PAK1|EFNA2|EPB41L3|NRCAM|STRADB|STRN|MAP2|DLG4|BRSK1|VLDLR|TUBB3|ULK2|RAB11A|PPP3CB|ATCAY|PRKCA|PLCG1|KIF5A|PLXNB2|POU4F2|STMN4|RB1|MAP4|DOCK7|CELSR2|NRP1|ZFYVE27|DCC|CPNE1|LRP12|MEGF8|EZR|ATXN10
GAMMA-TUBULIN COMPLEX LOCALIZATION%GOBP%GO:0033566,0.9338156484458741,0.9800972968717879,0.36175774638310904,0.607799722356937,6969,2,MZT1|CEP72
SENSORY PERCEPTION OF SOUND%GOBP%GO:0007605,0.263661025707273,0.639029744876064,-0.22189910245136701,-1.14950717088304,2040,46,CEMIP|TMIE|MYO7A|TBX1|DFNB31|COL11A2|SPTBN4|PDZD7|NDUFB9|SNAI2|TMC2|TPRN|SOD1|KCNQ1|COL1A1|TIMM9|BIRC5|ATP2B2|ADGRV1|TIMM10
NUCLEOBASE TRANSPORT%GOBP%GO:0015851,0.485846560846561,0.7872939093021379,-0.509650380500717,-0.9952180227599621,3672,3,SLC23A2|VDAC3|SLC29A2
HEME TRANSPORT%GOBP%GO:0015886,0.47899489595602707,0.7850984235874658,-0.445243168697931,-0.974730368824188,3659,4,FLVCR2|SLC48A1
REGULATION OF METANEPHRIC S-SHAPED BODY MORPHOGENESIS%GOBP%GO:2000004,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021801,0.370029753854477,0.7226447402424641,0.387261831905706,1.06902589226051,2735,7,RTN4|LAMB1|MBOAT7
SULFATION%GOBP%GO:0051923,0.951404913804805,0.9858647066977451,0.22293462450083498,0.5768564439366489,7008,6,SULT1C4|TPST1
RETINOL METABOLIC PROCESS%GOBP%GO:0042572,0.833640189374014,0.944704747243947,-0.29473625255024893,-0.7064265565093829,6338,5,RDH10|CYP1B1|DHRS3
URACIL CATABOLIC PROCESS%GOBP%GO:0006212,0.3944746978350379,0.7376723208557521,0.8039810322011469,1.07200022298308,2969,1,DPYD
PROTEIN DEGLUTARYLATION%GOBP%GO:0061698,0.342143710984194,0.701955655133333,0.829234671371857,1.1056725432715602,2575,1,SIRT5
TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE%GOBP%GO:0019441,0.203042328042328,0.5817604087661171,-0.6401235248704089,-1.24999900543147,1534,3,TDO2|KYNU|AFMID
"MEMBRANE PROTEIN PROTEOLYSIS INVOLVED IN RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:1904211",0.947598832581587,0.9840421757603729,-0.35774110639249496,-0.595338408141224,7142,2,HM13
LUTEINIZATION%GOBP%GO:0001553,0.446296296296296,0.76790784030784,-0.5261107465825179,-1.02736094585509,3373,3,INHBA|PDGFRA
REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010915,0.11468253968254,0.463748809895271,-0.700176464100585,-1.36726717539312,866,3,APOC2|LRPAP1|APOC1
SODIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0036376,0.0141955835962145,0.159485747303544,-0.6417539988968559,-1.7542059373735,107,7,FXYD2|ATP1A1|ATP1B1|ATP1A3|ATP1B3|SLC9A1|ATP1B2
PROTEIN DEMETHYLATION%GOBP%GO:0006482,0.41357702349869496,0.748061280707938,-0.24543526775385296,-1.03047997679991,3167,23,KDM4B|HR|KDM1A|PHF2|KDM3B|KDM8|KDM2A|C14orf169|JMJD6|KDM5C
ACTIN FILAMENT UNCAPPING%GOBP%GO:0051695,0.38585209003215404,0.7332167375750358,0.643280971969048,1.08079509027631,2879,2,LRRC16A|ACTN2
PYRIMIDINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009196,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
NEUROTRANSMITTER CATABOLIC PROCESS%GOBP%GO:0042135,0.684933369594778,0.8857920062408181,0.258581437000052,0.8192034712531909,5036,10,GCSH|COLQ|AMT
CYTOKINETIC PROCESS%GOBP%GO:0032506,0.830013642564802,0.9435818887072471,0.15583084540892098,0.7345784725008421,6083,32,CHMP3|CNTROB|RTKN|SNX33|SPIRE2|MITD1|SPAST|PDCD6IP|CHMP1A
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR PRODUCTION%GOBP%GO:0032720,0.0155332202062394,0.16857513750690098,-0.377159312964221,-1.7053334541254601,118,29,LILRB1|CLEC4A|IRAK3|CD34|GAS6|TNFAIP3|POMC|PTPN6|GHRL|C10orf54|LGALS9|CX3CL1|HAVCR2|TLR4|GSTP1|SIRPA
PROTEIN DEPHOSPHORYLATION%GOBP%GO:0006470,0.0312025403838189,0.250729241129472,0.21925174711439602,1.4517663614393796,225,115,DUSP4|DUSP6|DUSP18|PTPRR|MTMR6|PPEF1|DUSP11|EYA4|PTPN4|DUSP10|PTPRK|CDC14B|PPP2R2C|PTPRO|PTPN12|PTPRM|UBASH3B|CTDNEP1|PTPRS|BTRC|PTPRD|PTPN3|PTPN9|PDP1|MTMR2|EYA1|PPM1B|DUSP16|PTPRH|PPP3CB|PPM1G|PTPN18|PTPRU|SHOC2|PPP2CB|PTPRN2|SBF1|PTPN21|CTDSP1|PPM1M
CELL PROLIFERATION IN FOREBRAIN%GOBP%GO:0021846,0.23142076502732198,0.6149950305002221,0.418519241012643,1.21488813836999,1693,8,FGFR2|PCM1|DOCK7|HOOK3|NUMBL|SIX3|KIF14
NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION%GOBP%GO:0035308,0.7190443686006829,0.900474259627538,0.187199456511214,0.8156123443760891,5266,25,FKBP1B|MGAT5|PPP1R16B
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS%GOBP%GO:0035924,0.00312174817898023,0.0570002994400128,-0.40281038049218104,-1.9229897935082099,23,35,NR4A1|FLT1|MT1G|DAB2IP|KDR|SEMA6A|VEGFC|FLT4|MAPKAPK2|NOTCH1|PRKD1|HSPB1|MAP2K3|GAS1|VEGFB|PDGFRB|RELA|PDGFRA|ANXA1|ERN1
PHAGOLYSOSOME ASSEMBLY%GOBP%GO:0001845,0.0147097110127571,0.162839254065689,-0.6106634807370389,-1.75801469231221,112,8,CORO1A|RAB14|RAB7A|SYT7|RAB7B|RAB34|RAB20
PEPTIDYL-SERINE MODIFICATION%GOBP%GO:0018209,0.189013510068825,0.5632471197622879,-0.17025273360688598,-1.16952444503893,1482,142,NAA10|PARP1|TOP1|PLK2|DYRK1A|GAS6|PKN1|IKBKE|SGK1|SBK1|MAPKAPK2|MAPK9|MAST4|PRKD1|DCLK3|PARP2|GALNT16|GALNT1|MAP3K13|PLK1|TGFBR2|PDK3|LATS2|TLK2|CAMK2A|RPS6KB1|MAPK13|PRKACA|RPS6KA4|ADRBK1|VRK1|NEK6|MARK2|CSNK1A1|PDGFB|PRKCB|ERN1|NTMT1
HISTONE H3 ACETYLATION%GOBP%GO:0043966,0.0366675304483027,0.272309852804637,-0.309698121621286,-1.56060572401521,282,42,WDR5|KAT7|TAF9B|SPI1|MBIP|KAT2B|TAF10|TAF9|POLE3|CCDC101|AK6
DENSE CORE GRANULE CYTOSKELETAL TRANSPORT%GOBP%GO:0099519,0.257845401440022,0.636098664976652,0.5414402592426399,1.1895673082183302,1897,4,KIF5B|KIF5A|KIF1A
REGULATION OF SMALL MOLECULE METABOLIC PROCESS%GOBP%GO:0062012,0.0019142419601837699,0.0381948928947029,-0.219096025873327,-1.6358451587671998,14,220,SLC7A7|GUCA1A|PGP|REST|SREBF2|IDI1|PID1|PPIF|GPAM|FGFR4|FDPS|PARP1|ODC1|APOC1|RORA|KPNB1|OGT|CBFA2T3|PHKG2|PFKFB2|ATPIF1|PFKFB3|PLEK|INS|VCP|FABP3|ABCG1|PPP1R3E|PDE12|CYP51A1|IRS1|ADIPOR1|CLTC|PARK7|BRCA1|SNAI2|ENO1|MBTPS2|JMJD8|SOD1|UQCC2|IGF1|NR1H3|RAN|HMGCR|PGAM1|P2RY6|CDA|CEACAM1|GPER1|APOE|CCNB1|NOS3|SLC45A3|HMGCS1|FGF19|ADIPOR2|BMP2|NR1D1|PDK3|COX7A1|SNAI1|CAV1|SIRT4|NFYB|PPARA|DHCR7|SIK1|ABCD1|NFKB1|ANXA1|SHMT2|TMSB4X|FASN|PDGFB|PPP1R3F|BAD|TM7SF2
IMMUNE RESPONSE-REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002768,0.000640286848508132,0.0163600882996276,-0.22171136766369498,-1.68881366012917,4,248,RAF1|RIPK2|SPPL3|CREBBP|CDC42|PAK2|MUC3A|BTNL9|SYK|IGHV2-26|HLA-DQB2|NFATC2|RPS6KA5|RAC1|WIPF3|EIF2B5|IGHV1OR15-1|IGKV3-11|NFKBIZ|MNDA|HLA-DPA1|ACTG1|NCR3|CD38|LILRB1|IGHV5-51|SLA2|CLEC4A|LYN|HLA-DRA|HLA-DRB5|PRAM1|CD209|IGHV1-24|NCKAP1L|VAV3|WASF2|IGHV3-49|FPR3|IGHG4|HLA-DPB1|CD4|NCKIPSD|HLA-DQA2|FGR|FCGR1A|IGLL5|ARPC1A|LAT2|VAV1|MYO1G|GATA3|WAS|EIF2B1|FCGR2B|THY1|PDE4B|BCAR1|IGKV2-28|FPR1|MYO10|IGHV4-4|RC3H2|LILRB2|PDE4D|CLEC4E|ELMO1|IGHV4-61|GRB2|MEF2C|MAPK9|CLEC10A|IGHV1-3|FCER1G|MUC4|PIK3CB|MAPK3|ABL1|IGHV3-43|HRAS|NFATC1|FCN1|IGHV3-73|ICOSLG|FCGR2A|DOCK1|CYFIP2|IGKV2D-28|HCK|MUC20|TNFRSF21|IGHV3-15|RELB|MUC15|EIF2B2|C3AR1|STOML2|RELA|NFKB1|PRKACA|IGHV1-18|HSP90AA1|ACTB|CMKLR1|NCK1|IGHG2|IGHA1|EIF2B3|C5AR1|PRKCB|PTPRJ|ICAM2
NEGATIVE REGULATION OF B CELL PROLIFERATION%GOBP%GO:0030889,0.34782608695652195,0.7054926914987092,-0.378805448436284,-1.09052786827066,2671,8,MNDA|LYN|FCGR2B|CD300A|TNFRSF21
PIGMENT BIOSYNTHETIC PROCESS%GOBP%GO:0046148,0.560627861347286,0.8273596711618421,-0.202721498833392,-0.925586675503535,4285,30,ATPIF1|ADA|NFE2L1|ALAD|HPRT1|PRPS1|FXN|GMPS|MTHFD1
POSITIVE REGULATION OF LIPOPHAGY%GOBP%GO:1904504,0.765475723072896,0.9197593738525891,-0.346491241680433,-0.7585417577212771,5848,4,SPTLC1|ADRB2|SPTLC2
"NEGATIVE REGULATION OF GLYCOGEN SYNTHASE ACTIVITY, TRANSFERRING GLUCOSE-1-PHOSPHATE%GOBP%GO:1904227",0.968123256740603,0.9912626134248801,0.51532862814292,0.6871211908648149,7288,1,GSK3A
T-HELPER CELL LINEAGE COMMITMENT%GOBP%GO:0002295,0.679942166140904,0.8847742762205949,-0.298486123763142,-0.8158985085078679,5172,7,BATF|SPN|STAT3
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:0034614,0.0171303451828954,0.17803435145825502,-0.275571846129214,-1.60613140292507,132,71,MAPK9|PARK7|PXN|CAMKK2|SOD3|MAPK3|DPEP1|ABL1|SOD1|ROMO1|CCS|NOS3|FXN|MMP9|RELA|SIGMAR1|MAPK13|PDGFRA|ANXA1|PRDX5|NET1|SIRPA
SEQUESTERING OF IRON ION%GOBP%GO:0097577,0.21772486772486802,0.6000568371428749,-0.632018053700565,-1.23417107455999,1645,3,FTL|FTH1
POSITIVE REGULATION OF ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1903949,0.0123258306538049,0.14674915992642998,0.9304659498207891,1.56330293302066,91,2,TRPM4|RNF207
POSITIVE REGULATION OF EXOSOMAL SECRETION%GOBP%GO:1903543,0.852910330361825,0.949296218452153,-0.19446518798152104,-0.6879893977120021,6505,14,TSG101|HGS|RAB7A|SDC4|SNF8
REGULATION OF METAPHASE PLATE CONGRESSION%GOBP%GO:0090235,0.522344900105153,0.807051143864932,-0.34458389463666605,-0.941904709489899,3973,7,MAD1L1|SPAG5|BECN1|DYNC1H1|HNRNPU
REGULATION OF CAP-INDEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:1903677,0.0858465608465609,0.4055062447746421,-0.723865248548357,-1.4135253675218897,648,3,NCK1
POSITIVE REGULATION OF PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900738,0.151438127090301,0.518496345408823,-0.922088663431848,-1.22844350623624,1131,1,CHGA
NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009134,0.44771626750425303,0.768229288546963,-0.45903885811203704,-1.00493201676888,3420,4,NUDT16|NUDT18
B CELL DIFFERENTIATION%GOBP%GO:0030183,0.805949593719873,0.9335756607396529,0.14707911191089199,0.771361129897576,5851,46,DLL1|NHEJ1|TPD52|ADAM17|TCF3|KIT|GPS2|ATM|HDAC4|PTK2B
MAINTENANCE OF DNA METHYLATION%GOBP%GO:0010216,0.319568648079958,0.687678843665824,-0.47016477058453604,-1.1268952393952,2429,5,UHRF1|DNMT1
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN%GOBP%GO:0002583,0.16319580877537698,0.534744357685457,-0.511775827005532,-1.3164252923552902,1245,6,HLA-DOA|TAPBPL|PYCARD|TREM2|HFE
FARNESYL DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0045337,0.13120191032103998,0.490819490032838,-0.7771712158808929,-1.29333718224733,988,2,FDPS|HMGCS1
ACTIVATION OF PROTEIN KINASE B ACTIVITY%GOBP%GO:0032148,0.17975771785853897,0.55315933910608,-0.291945606989349,-1.2586184193394399,1379,25,GAS6|INS|PARK7|IGF1|ADRA2C|ANG|MAPKAP1|PDGFB
POSITIVE REGULATION OF LEUKOCYTE ACTIVATION%GOBP%GO:0002696,0.00012750223128904799,0.00518555396908895,-0.2985579525969311,-2.193263340993,0,200,HSPH1|IL1B|AKT1|FOXP3|CD1D|HLA-DMB|CDC42|PAK2|JAK3|SYK|IGHV2-26|NFATC2|RAC1|IGHV1OR15-1|CD274|NFKBIZ|HLA-DPA1|TGFB1|CD38|LILRB1|IGHV5-51|HLA-E|LYN|GPR183|CD209|TNFSF13B|PYCARD|IGHV1-24|NCKAP1L|VAV3|CD74|TNFRSF14|IL18|ADAM8|RUNX1|CCL19|IGHV3-49|RUNX3|CCDC88B|ITGB2|IGHG4|HLA-DPB1|SNX4|STX4|FGR|IGLL5|PDCD1LG2|PAXIP1|VAV1|GATA3|EBI3|GAS6|THY1|IL6ST|PVRL2|IGHV4-4|LILRB2|IGHV4-61|GRB2|MEF2C|CEBPA|SOCS1|PTPN6|CD47|IGHV1-3|MMP14|FGF10|BST1|IGHV3-43|TNFRSF4|IGF1|VAMP8|DPP4|IGHV3-73|VAMP7|NKAP|ICOSLG|VCAM1|TNFSF13|C10orf54|CCL2|IL33|CD86|NLRP3|AXL|TGFBR2|LGALS9|THBS1|ZP3|IGHV3-15|FADD|AIF1|CAV1|BCL6|TLR4|ITGAM|IGHV1-18|LILRB4|PNP|ANXA1|CD55|NCK1|IGHG2|TFRC|IGHA1|CD81|SART1|SIRPA
CYTOSKELETAL ANCHORING AT NUCLEAR MEMBRANE%GOBP%GO:0090286,0.28732912723449,0.6604035198820261,-0.423520478353255,-1.1576743409524899,2185,7,SUN2|SYNE3
REGULATION OF LEUKOCYTE TETHERING OR ROLLING%GOBP%GO:1903236,0.9499867338816659,0.985204477413381,-0.354783567686793,-0.5904165907889379,7160,2,CCL21|CXCL12
NUCLEAR NCRNA SURVEILLANCE%GOBP%GO:0071029,0.43379174852652297,0.7617458538169591,-0.393726180354492,-1.01276980023422,3311,6,EXOSC3|EXOSC2
NEGATIVE REGULATION OF ATF6-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903892,0.373124330117899,0.724251292907001,0.649630644271598,1.09146335958397,2784,2,WFS1|ATF6B
NEGATIVE REGULATION OF TELOMERIC RNA TRANSCRIPTION FROM RNA POL II PROMOTER%GOBP%GO:1901581,0.803478260869565,0.932964969466025,-0.6027238641376271,-0.8029729095657689,6005,1,ATRX
NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS%GOBP%GO:2001170,0.21595688748685601,0.598994355749518,-0.452678199116796,-1.23737567038963,1642,7,PID1|PARP1|CBFA2T3|PPARA
VESICLE CYTOSKELETAL TRAFFICKING%GOBP%GO:0099518,0.0461158385945649,0.30746333312705,0.30112643028578995,1.50450358966699,335,39,KIF13A|KIF3B|TRAK2|NDEL1|RAB1A|HTT|BLOC1S3|HAP1|AP3B2|KIF5B|AP3B1|KIF5A|MYO5A|TRAK1|KIF1A|AP3M1|FNBP1L|KIFAP3|BLOC1S5|AP3M2|FYCO1
MYOBLAST DEVELOPMENT%GOBP%GO:0048627,0.372588424437299,0.7234654586828599,0.6501006234846,1.09225298534329,2780,2,SDC1|SOX15
PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION%GOBP%GO:0046838,0.260043431053203,0.636098664976652,0.35732691215023704,1.17582495403609,1915,11,INPP1|INPP5K|INPP5J|IMPA1
NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION%GOBP%GO:2000178,0.646255744795891,0.8696385300694521,0.348941841723186,0.839203128333417,4780,5,NF1|GATA2
PROTEASOME REGULATORY PARTICLE ASSEMBLY%GOBP%GO:0070682,0.48505291005291,0.7872939093021379,-0.5098457030113019,-0.9955994381188481,3666,3,PSMD10
REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LATERAL MESODERM LEFT/RIGHT ASYMMETRY%GOBP%GO:1900175,0.6336830920440961,0.8631726958478259,0.680359505955007,0.9071675983394991,4770,1,SMAD2
CHROMATIN REMODELING%GOBP%GO:0006338,0.00179625352835515,0.0362335623423746,-0.26126474985699805,-1.7361782709143099,13,122,SMARCD1|DAXX|MYB|TADA2A|RUVBL2|MIS18BP1|RBBP4|GATAD2B|KAT2A|MBD3|HIST1H4J|CENPQ|HELLS|SMCHD1|ATRX|CBX3|BAZ1B|HIST4H4|NASP|MBD2|CASC5|KDM6A|INO80|FOXP3|CHD4|HIST1H4H|NUDT5|BPTF|HJURP|ITGB3BP|ANP32E|CENPL|CENPU|SRCAP|ACTL6B|CENPW|SMARCA4|SMARCA2|HMGB2|TAF6L|TOP1|OIP5|RUVBL1|CENPM|CDKN2A|SMARCE1|NPM1|CENPI|ELOF1|PIWIL1|SMARCD3|HIST1H4I|STRA13|RBBP7|CENPH|HDAC5|SMARCD2|KAT2B|SPTY2D1|MYSM1|HIST2H4A|MYC|CHD8|HMGB3|MTA2|SUPT4H1|ACTB|POLE3|HIST2H4B|CENPK|MIS18A|HNRNPC|CENPP
NEGATIVE REGULATION OF MESODERM FORMATION%GOBP%GO:1905903,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
NUCLEAR BODY ORGANIZATION%GOBP%GO:0030575,0.8642076502732241,0.953570717314602,0.23117656792983604,0.67106513327199,6325,8,WRAP53|USPL1|ZPR1|HIPK2|SRPK2|ETS1|PML|DYRK3
POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DIFFERENTIATION%GOBP%GO:1902811,0.7106109324758839,0.8964108318214721,0.490919231161419,0.824807693498843,5303,2,RBM24
PYRIMIDINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0072527,0.48025806451612896,0.7857006060206241,-0.180095015480037,-0.982387973683853,3721,55,THTPA|APOBEC3G|TYMP|APOBEC3C|CTPS1|CDA|PRPS1|UMPS|CMPK2|TK1|ERH|SLC25A19|UCK1
POSITIVE REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 1 PRODUCTION%GOBP%GO:2000340,0.9232301766502858,0.9776156396135859,0.539258932509925,0.719029022753894,6950,1,TIRAP
REGULATION OF FIBRONECTIN-DEPENDENT THYMOCYTE MIGRATION%GOBP%GO:2000413,0.511571906354515,0.801504475859147,-0.7476290251433609,-0.996021377806446,3823,1,ADAM8
REGULATION OF CENTRIOLE ELONGATION%GOBP%GO:1903722,0.167612868342795,0.5400460530398901,0.547286873111637,1.31622179141087,1239,5,CENPJ|CHMP2A|CEP120|CEP295|VPS4B
RESPONSE TO ACID CHEMICAL%GOBP%GO:0001101,0.8908364479958759,0.965159112268525,-0.114956614860812,-0.754679940489794,6911,115,LAMTOR2|LAMTOR5|IGF2R|LAMTOR1|PTGER2|NEURL1|SCD|ZC3H12A|KLF2|FYN|CDKN2D|MICB|PPP5C|PTGFR|CPEB3|RARA|SETX|EPHA3|PDK4|RRAGB|KLHL22|SYNJ1|BRINP1|AQP1|LYN|CCL19|TBX1|AQP3|PID1|RRAGA|FGFR4|KDR|FZD4|TMBIM6|HLCS|BRINP3|GRIN1|TESC|PTGER4|SNW1|NSMF|RPTOR|CTSH|DHFR|CPEB1|CD36|TGFBR3|PDK3|PPARG|WNT3|SHMT2|SLC38A9|PDGFB|RRAGD
PEPTIDYL-LYSINE DIMETHYLATION%GOBP%GO:0018027,0.28517160073356,0.658219774180975,-0.356050559853734,-1.15273284375889,2176,11,EHMT1|SETD3|SETMAR|METTL12|SUV39H1
CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0003433,0.0011764705882352901,0.0261694927157725,-0.610591089836417,-2.0437055483036204,8,12,MATN2|COL20A1|COCH|VWA1|COL14A1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
HEMATOPOIETIC STEM CELL MIGRATION%GOBP%GO:0035701,0.757142857142857,0.916855605301775,-0.39401124958641204,-0.7694041087015719,5723,3,GPLD1|BCL11B|GAS6
RESPONSE TO INTERLEUKIN-15%GOBP%GO:0070672,0.13801230849810098,0.50277647185153,-0.390955079134211,-1.3457431971337102,1053,13,STAT5B|IL2RB|IL2RG|JAK3|STAT5A|PLCB1|CD4|IL15RA|GRB2|STAT3|IL15
PROTEIN FOLDING IN ENDOPLASMIC RETICULUM%GOBP%GO:0034975,0.33180688211435305,0.6961761803662729,-0.289331039987133,-1.0995286054950901,2535,17,DNAJC3|EMC1|HSP90B1|ERO1L|ERO1LB|CANX|CALR|HSPA5
STRIATUM DEVELOPMENT%GOBP%GO:0021756,0.225466342254663,0.6083599141984499,0.507898351441578,1.22149262266829,1667,5,BBS4|MKKS|BBS2
FOREBRAIN REGIONALIZATION%GOBP%GO:0021871,0.766326256382693,0.919992400339549,0.38883583470141403,0.764794201210298,5702,3,WNT2B|SIX3
NEGATIVE REGULATION OF PROTEIN REFOLDING%GOBP%GO:0061084,0.7065916398713828,0.894843171056815,0.49255874541296296,0.8275622891276899,5273,2,SNRNP70
CELLULAR RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:0036006,0.0451511582253632,0.304705921503765,-0.701766170159738,-1.5363128419657202,344,4,PDE2A|PDE1B|CSF1R
DETECTION OF FUNGUS%GOBP%GO:0016046,0.0805351170568562,0.397722753303477,-0.957432730480812,-1.27553029015644,601,1,TLR4
GALL BLADDER DEVELOPMENT%GOBP%GO:0061010,0.772307692307692,0.9215496572020819,-0.6184384649316279,-0.82390853112155,5772,1,NIPBL
PROTEIN LOCALIZATION TO JUXTAPARANODE REGION OF AXON%GOBP%GO:0071205,0.39315310419779903,0.7375199755844078,0.474328572216401,1.04212007369339,2893,4,EPB41L3|CNTNAP1|CNTNAP2|CNTN2
PIGMENT GRANULE LOCALIZATION%GOBP%GO:0051875,0.0013598041881969,0.0294375387721946,0.530743898293724,2.07755808038028,9,18,BBS5|BBS4|VPS33B|BLOC1S3|MKKS|RAB11B|RAB11A|MREG|BBS2|MYO5A|BBS7|VPS33A|BLOC1S5|ARL6
ANTERIOR COMMISSURE MORPHOGENESIS%GOBP%GO:0021960,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE%GOBP%GO:0070203,0.72216400314383,0.9019989179378242,-0.24402461923422103,-0.790042833783494,5512,11,CCT7|CCT3|CCT8|CCT5|DKC1
NK T CELL PROLIFERATION%GOBP%GO:0001866,0.992909698996655,0.997305769352475,-0.503584031760035,-0.6708948479612271,7421,1,ELF4
RESPONSE TO INTERLEUKIN-18%GOBP%GO:0070673,0.0433982114676486,0.29791299041195396,-0.657015221707479,-1.5747401163890902,329,5,AKT1|ALOX5|IL18|IL18BP|PDGFB
CITRATE TRANSPORT%GOBP%GO:0015746,0.796022574576727,0.9299728593747351,0.376708875729812,0.740941903988467,5923,3,SLC13A4|SLC25A1
REGULATION OF PATHWAY-RESTRICTED SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0060393,0.6538311940879039,0.8743526548195151,-0.17388925250501902,-0.8708556747984352,5042,41,INHA|SMAD4|TGFBR1|BMP4|SMAD7|RBPMS|BMP8B|TTK|TGFB2|GDF15|SNX25|TGFB1|GREM1|INHBB|TWSG1|SMAD6|TGFB3|INHBA|LDLRAD4|HFE|BMP2|GDF11|DAB2|ENG|ACVRL1
HAIR CELL DIFFERENTIATION%GOBP%GO:0035315,0.78844642389311,0.927903725560957,-0.228654147353498,-0.7402801041075151,6018,11,DFNB31|PDZD7|SOD1|JAG2
OXIDATIVE DNA DEMETHYLATION%GOBP%GO:0035511,0.30872922392357,0.680809181688249,-0.5235493655103979,-1.1461590025827901,2358,4,ALKBH3
REGULATION OF CELL CYCLE CHECKPOINT%GOBP%GO:1901976,0.18919624217119002,0.563438044703664,-0.28656270846558,-1.25003886597233,1449,26,DUSP1|RPA2|CDT1|LCMT1|CDK5RAP2|MAD2L1|WDR76|NDC80|USP44|CCNB1|XRCC3
EYE PHOTORECEPTOR CELL DEVELOPMENT%GOBP%GO:0042462,0.338247338247338,0.6998037279675999,0.36011658499420396,1.0943610882475798,2477,9,BBS4|GNGT1|CEP290
IRON ION IMPORT%GOBP%GO:0097286,0.58860510805501,0.8414799095069009,-0.34565379149897807,-0.889114666064205,4493,6,HFE|STEAP4
POSITIVE REGULATION OF MRNA CATABOLIC PROCESS%GOBP%GO:0061014,0.965607015620718,0.990916952887267,0.11801527919122301,0.5847829489941341,7046,38,RBM24|ZC3HAV1|MEX3D|PNPT1|AGO2|TNRC6B|MOV10|METTL14|NANOS1|RC3H1|FTO|PABPC1
NEGATIVE REGULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0071656,0.0937792642140468,0.42337598780415003,-0.9508160564622851,-1.26671529160663,700,1,HAVCR2
ESTABLISHMENT OF CHROMOSOME LOCALIZATION%GOBP%GO:0051303,0.308774193548387,0.680809181688249,-0.20241278536335,-1.10412764912335,2392,55,CENPQ|MAD1L1|CENPE|KIF2C|CDCA8|BECN1|VPS4A|NDE1|CHMP5|PINX1|NUF2|DLGAP5|SPDL1|CDT1|CDC23|GEM|BOD1|KPNB1|NDC80|KIF18A|SPICE1|KIFC1|CCNB1|CHMP4A|CHMP6|KIF22|CDCA5
POSITIVE REGULATION OF WNT SIGNALING PATHWAY%GOBP%GO:0030177,0.0428260033337607,0.29576373695179803,-0.235647944050964,-1.45113139628542,333,88,KANK1|SMARCA4|UBE2B|TERT|JUP|PRDM15|TLR2|SFRP4|WLS|RUVBL1|SFRP2|MLLT3|FRAT1|VCP|ILK|TNFAIP3|DDX3X|SMURF2|ATP6AP2|DAAM2|SULF1|GPRC5B|USP47|BMP2|COL1A1|SEMA5A|XIAP|CAV1|ADGRA2|DACT1|NFKB1|DAB2|DEPDC1B|WNK2
LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0060836,0.20859621451104102,0.5889127017588389,-0.45663382241988004,-1.2481881902901102,1586,7,PDPN|NR2F2|ACVRL1
CYTOPLASMIC SEQUESTERING OF NF-KAPPAB%GOBP%GO:0007253,0.0296005239030779,0.244495898433353,-0.635189402894172,-1.63387825544348,225,6,CCDC22|PSMD10|NFKBIA|TMSB4X
CELLULAR AMINO ACID METABOLIC PROCESS%GOBP%GO:0006520,0.400027731558514,0.739629257825225,0.13492209084138798,1.0263641110708999,2884,225,AASS|ASL|SCLY|AADAT|NAALAD2|GCSH|CCBL2|DDAH1|NFS1|PARS2|DDAH2|GLS|DARS|SEPSECS|PTS|ADHFE1|SARS2|BCKDHB|BLMH|CKMT1B|CAD|AZIN2|CARS2|CKMT1A|CTNS|RARS2|AMT|ATP7A|BPHL|GCAT|GLUD1|HIBCH|PCBD1|QDPR|MTHFR|HMGCLL1|DARS2|HOGA1|ACADSB|ACAT1|SHMT1|GSS|FARS2|GCDH|IARS2|GATB|SLC7A6|AASDHPPT|MRI1|ENOPH1|PIPOX|NMNAT2|CSAD|GCLM|NAGS|PCYOX1|NIT2|ACAD8|PEPD|HRSP12|GLS2|LARS2|AIMP1|CTH|HMGCL|SRR|ALDH7A1|MTAP|WARS2|HARS2|SLC25A32|TXN2|MPST|QARS|ATF4|SEPHS1|IVD|GSTZ1|YARS2|EGLN2|FARSB|PLOD3
PROSTANOID BIOSYNTHETIC PROCESS%GOBP%GO:0046457,0.0531135531135531,0.33407275089766497,-0.4129398854652371,-1.53464450774111,405,16,CD74|TBXAS1|PTGDS|CBR1|PTGES2|PTGS1|PTGES|PTGIS
CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION%GOBP%GO:0034401,0.36706349206349204,0.721193319737038,-0.5593911988529829,-1.09234923424335,2774,3,CTBP1|SMCHD1|POLE3
REGULATION OF CELL GROWTH BY EXTRACELLULAR STIMULUS%GOBP%GO:0001560,0.21091778456634303,0.592839346606112,0.8960079400088221,1.1947056870910802,1587,1,KIF26A
PLASMA LIPOPROTEIN PARTICLE OXIDATION%GOBP%GO:0034441,0.26193979933110395,0.637657653494401,-0.8660674900749891,-1.1538098518479099,1957,1,PLA2G7
NEGATIVE REGULATION OF AMYLOID-BETA FORMATION%GOBP%GO:1902430,0.485094142259414,0.7872939093021379,-0.308532532007872,-0.9665921468066301,3709,10,GGA3|APOE|PRNP
"REGULATION OF CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0032832",0.14648829431438098,0.513872620660976,-0.92550727834142,-1.23299792215364,1094,1,LGALS9
COMMON MYELOID PROGENITOR CELL PROLIFERATION%GOBP%GO:0035726,0.212830687830688,0.595429519818125,-0.634665310384807,-1.2393404959198602,1608,3,CEACAM1|GSTP1
NEGATIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032076,0.988612004287246,0.996050320421843,0.296663909567135,0.49843367190062604,7378,2,DFFA|GZMA
NEGATIVE REGULATION OF CELL-MATRIX ADHESION%GOBP%GO:0001953,0.00536649214659686,0.0829378624098312,-0.42329613493600704,-1.89048788150927,40,28,PTEN|RCC2|MMP12|APOD|JAG1|CORO1C|CDKN2A|CASK|PHLDB2|BCAS3|DLC1|THBS1|SEMA3E|SERPINE1|FAM107A|KIAA2022|NF2|ACVRL1
AUTOPHAGY INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0075071,0.5936693384051079,0.8429870456423729,0.40245041115022995,0.884200692709842,4369,4,ULK2|ATG5
POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE%GOBP%GO:0003065,0.37614557046088504,0.7266197487465021,0.812968681076312,1.08398404002898,2831,1,TPM1
POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION%GOBP%GO:0032930,0.062874251497006,0.36006266503904,-0.5328821551718259,-1.53409314231855,482,8,MAPT|TGFB1|ITGB2|SOD1|ITGAM|GSTP1
NITRIC OXIDE-CGMP-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038060,0.680802675585284,0.884781692722898,-0.663707543008381,-0.88421781286645,5088,1,GUCY1B3
FOAM CELL DIFFERENTIATION%GOBP%GO:0090077,0.664650184113624,0.8804055751124069,-0.345907098664535,-0.829073310349153,5053,5,PPARG
PHARYNX DEVELOPMENT%GOBP%GO:0060465,0.37404682274247497,0.724682900261831,-0.8110939567710631,-1.0805719055633,2795,1,TBX2
POSITIVE REGULATION OF MITOCHONDRIAL FUSION%GOBP%GO:0010636,0.37888531618435206,0.728771163917427,0.646795675820217,1.08670024654806,2827,2,PARK2|PLD6
NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0010512,0.00411249668347042,0.0705042003881507,-0.962393162393162,-1.60157612045995,30,2,PDGFA|PDGFB
MODULATION BY HOST OF SYMBIONT TRANSCRIPTION%GOBP%GO:0052472,0.8887290794979079,0.965159112268525,-0.157441223628956,-0.6691207618428969,6796,24,CHD1|CCNT1|CCL3|CCL4|SMARCA4|ZNF639|REST|SNW1|NUCKS1|RRP1B|PSMC3
ALDITOL BIOSYNTHETIC PROCESS%GOBP%GO:0019401,0.153042328042328,0.52097307188263,-0.6720008201195561,-1.3122472837857801,1156,3,PGP|GOT1
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ARSENIC-CONTAINING SUBSTANCE%GOBP%GO:0061395,0.560632222074645,0.8273596711618421,0.7183502426113809,0.9578231194721609,4220,1,ATF4
POSITIVE REGULATION OF RIG-I SIGNALING PATHWAY%GOBP%GO:1900246,0.754734350341925,0.9158903477696649,-0.31955240356265996,-0.765906135128663,5738,5,DDX60|DHX58
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002587,0.9020960466967359,0.968486494114721,-0.399007444168735,-0.664012193184451,6799,2,HLA-DOB|HLA-DOA
CUTICLE DEVELOPMENT%GOBP%GO:0042335,0.722406694116085,0.9019989179378242,0.6386193206881341,0.851512693408548,5438,1,DUOX1
AMACRINE CELL DIFFERENTIATION%GOBP%GO:0035881,0.43103678929765904,0.7595658935474069,-0.7860057344508159,-1.0471483693953,3221,1,FOXN4
REGULATION OF TRANSLATION AT POSTSYNAPSE%GOBP%GO:0140245,0.33672240802675607,0.699462084003389,-0.8287935597706221,-1.10415202668403,2516,1,FMR1
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0016479,0.32639706844653804,0.6941148928066879,-0.515533249690175,-1.12861004938305,2493,4,FLNA|H2AFY
MODULATION OF AGE-RELATED BEHAVIORAL DECLINE%GOBP%GO:0090647,0.7684348395546821,0.9205764885608431,-0.292451167652921,-0.752263185484492,5866,6,PRNP
"POSITIVE REGULATION OF SUBSTRATE-DEPENDENT CELL MIGRATION, CELL ATTACHMENT TO SUBSTRATE%GOBP%GO:1904237",0.173645484949833,0.5478649030775731,-0.9110057344508159,-1.2136783836653202,1297,1,FN1
SODIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098719,0.631284153005464,0.8616028929314681,0.29380042509026194,0.8528512348120129,4620,8,TRPM4|HCN2
REGULATION OF THYROID HORMONE GENERATION%GOBP%GO:2000609,0.596730975348339,0.844613508628182,0.550011015787944,0.9240895213205519,4453,2,PAX8
AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:0042987,0.987704918032787,0.996030692679047,0.17044514314082398,0.494772431832605,7229,8,PSENEN|PSEN2
MITOCHONDRIAL ACETYL-COA BIOSYNTHETIC PROCESS FROM PYRUVATE%GOBP%GO:0061732,0.4625661375661379,0.7763029797560609,-0.519907464663511,-1.0152475084826,3496,3,PDHX
"NEGATIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043371",0.69775967413442,0.8916368062640799,0.23285231802179898,0.815497364426645,5138,13,SOCS5|LOXL3|CBFB
PURINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009167,0.00038600102933607797,0.0111294649577428,-0.26971692113425894,-1.9098637052692802,2,167,NDUFB5|NADK|SURF1|ATP1B1|UQCR10|PARP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|NDUFA3|NDUFB6|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|HPRT1|GAPDH|NDUFS6|COQ7|NDUFB4|NUDT4|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
REGULATION OF TELOMERASE ACTIVITY%GOBP%GO:0051972,0.12904558600743699,0.487371482296275,0.24789537039082798,1.30009523797571,936,46,PARP4|PARP3|SMG6|HMBOX1|ATM|PARN|ACD|CERS1|PIF1|WRAP53|POT1|MAP2K7|MAP3K4|XRCC5|PNKP|HNRNPD|TNKS|SRC|MAPK1|NEK7|TCP1
NEGATIVE REGULATION OF PHENOTYPIC SWITCHING%GOBP%GO:1900240,0.0372777925179093,0.27499221464993107,-0.8766473669699479,-1.4588814050921002,280,2,DNMT1|FGF9
POSITIVE REGULATION OF HISTONE H4-K16 ACETYLATION%GOBP%GO:2000620,0.7708941363756969,0.9213545359508709,-0.477918274327233,-0.7953324333586981,5810,2,BRCA1
REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904956,0.97414255091104,0.9920058127185359,0.31794871794871804,0.534194898174537,7270,2,CSNK1E|CSNK1D
FAT-SOLUBLE VITAMIN BIOSYNTHETIC PROCESS%GOBP%GO:0042362,0.280948553054662,0.654124699443029,0.693245106148332,1.16474128682801,2096,2,CYP27B1|UBIAD1
REGULATION OF SCHWANN CELL PROLIFERATION INVOLVED IN AXON REGENERATION%GOBP%GO:1905044,0.456103068136539,0.7711961414599979,0.7731583590648431,1.03090234734715,3433,1,CERS2
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS%GOBP%GO:0043470,0.343978102189781,0.702174649119653,-0.23339027730945602,-1.08563956698478,2638,32,OGT|CBFA2T3|PHKG2|PFKFB2|PFKFB3|INS|JMJD8|IGF1|PGAM1|PPARA
REGULATION OF CELL-SUBSTRATE ADHESION%GOBP%GO:0010810,0.000127975428717686,0.00518555396908895,-0.318108365997052,-2.12530168281326,0,125,ROCK1|RAC2|CDC42|RAC3|PTEN|RCC2|ACTN4|RAC1|MMP12|ECM2|DUSP3|UTRN|CDK6|TBCD|APOD|KANK1|JAG1|PEAK1|CORO1C|JUP|PPM1F|KDR|FZD4|CDKN2A|PLAU|THY1|CASK|RREB1|DOCK5|NOTCH1|PHLDB2|SLC9A1|GCNT2|BCAS3|S100A10|RSU1|MMRN2|PIK3CB|BST1|ABL1|CALR|FLNA|MMRN1|GPM6B|DOCK1|CSF1|PDPN|FN1|DLC1|CD36|THBS1|TEK|ARL2|SEMA3E|NEDD9|EMILIN2|CX3CL1|SERPINE1|FAM107A|KIAA2022|NF2|FBLN2|COL16A1|ACVRL1|FBLN1|EFNA5|PTPRJ|COL26A1|EMP2
POSITIVE REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS%GOBP%GO:0090190,0.666213829642712,0.880719592999549,0.380052164432555,0.8349907907826659,4903,4,PAX8
REGULATION OF MRNA CLEAVAGE%GOBP%GO:0031437,0.987692307692308,0.996030692679047,-0.506120423467137,-0.674273930738651,7382,1,NUDT21
REGULATION OF INVADOPODIUM DISASSEMBLY%GOBP%GO:1905927,0.118127090301003,0.46891245025765,-0.9392368769298629,-1.25128904414448,882,1,NAV3
NEGATIVE REGULATION OF PROTEIN TETRAMERIZATION%GOBP%GO:1901091,0.689174705251876,0.887051934478962,0.5009129025881699,0.8415983518309329,5143,2,PEX5|PEX14
RESPONSE TO DEFENSES OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052173,0.9028664583616359,0.968731546286171,0.294620848442425,0.647294551234315,6645,4,SMAD3|EIF2AK2
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN%GOBP%GO:0048002,0.000127975428717686,0.00518555396908895,-0.32709785137586894,-2.18536099104095,0,125,PDIA3|HLA-DOA|HLA-F|CENPE|AP2A1|KIF2C|ERAP2|ERAP1|KLC1|CAPZA2|AP1S3|KIF3A|HLA-DRB1|HLA-DMA|HLA-DMB|RACGAP1|HLA-DQB2|HLA-B|AP1S2|KIF11|KIF15|HLA-DPA1|CLEC4A|HLA-E|HLA-DRA|HLA-DRB5|FCGR1B|ACTR10|CD209|DCTN4|DYNC1H1|CD74|B2M|AP2A2|TAPBP|LNPEP|HLA-DPB1|HLA-DQA2|CTSF|CTSV|FCGR1A|RAB7A|CTSS|HLA-C|KLC2|CANX|ITGB5|HLA-A|FCGR2B|CLTA|SH3GL2|CLEC4M|SEC23A|CLTC|DYNLL2|FCER1G|KIF4A|LAG3|SLC11A1|KIF18A|RILP|CALR|SEC13|SEC24A|VAMP8|ARF1|IFI30|HFE|KIF2A|AP1B1|DCTN5|CD36|BCAP31|CTSD|CTSL|DYNC1I1|SPTBN2|LGMN|KIF22|SAR1B|ABCB9|DCTN3|AP2M1
POSITIVE REGULATION OF BLOOD VESSEL REMODELING%GOBP%GO:2000504,0.23628635941027998,0.62149045081524,0.8834362593736221,1.1779430472968202,1778,1,TMBIM1
ANGIOTENSIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0038166,0.40181388012618297,0.740287621109606,-0.3827813034559579,-1.0463156231083002,3056,7,CA2|CAMK2A|CAV1
POSITIVE REGULATION OF TRANSLATIONAL FIDELITY%GOBP%GO:0045903,0.9302696241200692,0.9793746057014829,0.535509483899427,0.714029638955605,7003,1,RPS9
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS%GOBP%GO:1903428,0.552748691099477,0.8230597979948241,-0.20797444763234,-0.928837143698376,4222,28,INSR|CLU|ASS1|KLF2|PTGS2|HBB|IL1B|AKT1|TNF|DUOXA1|KLF4|P2RX4|GRIN1|CD36|TLR4|HSP90AA1|ADGRB1
RESPIRATORY CHAIN COMPLEX III ASSEMBLY%GOBP%GO:0017062,0.88015288015288,0.9616184093028008,0.21705833720404996,0.659620267474375,6447,9,TTC19|BCS1L|UQCC1
EATING BEHAVIOR%GOBP%GO:0042755,0.75503896801935,0.9161194064629179,0.392951185478728,0.7728886105459308,5618,3,TRH
NUCLEOTIDE-EXCISION REPAIR INVOLVED IN INTERSTRAND CROSS-LINK REPAIR%GOBP%GO:1901255,0.13770230830459002,0.50219949963275,-0.7720938971243649,-1.28488771191215,1037,2,XPA
MODULATION BY SYMBIONT OF HOST PHAGOCYTOSIS%GOBP%GO:0052190,0.32846327533537,0.6950398637731511,0.835410233789149,1.11390682246874,2472,1,ITGAV
POSITIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS%GOBP%GO:0070245,0.769954313356625,0.921326382088427,0.3876622885854001,0.762485974487652,5729,3,ZC3H8|TP53
ANIMAL ORGAN FORMATION%GOBP%GO:0048645,0.5096994535519129,0.8001926101728042,0.324872553469669,0.943048187551185,3730,8,FGFR2|PAX8
REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0032925,0.630334329980973,0.8611032652135849,0.229975388646082,0.865933610884509,4637,16,ACVR1|ACVR2A|IGSF1|SKI|ACVR2B|ACVR1B|SMAD2|DACT2
POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048386,0.0364149422198334,0.271526902825443,0.7895114150215071,1.5528757848706298,270,3,TRIM16|ASXL1|CTBP2
INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0099587,0.537574501166105,0.813781655741487,-0.187280666714322,-0.943729587191879,4148,42,ATP1B1|SLC12A8|ATP1A3|SLC12A2|ATP1B3|SLC39A8|SLC9A1|ABCC9|SLC9A7|SLC9A9|KCNJ12|HFE|ATP1B2|KCNH2|KCNJ9
RESPONSE TO INTERLEUKIN-12%GOBP%GO:0070671,0.0054453520031116295,0.0838108499289328,-0.363587928834122,-1.8208866077233001,41,41,HNRNPA2B1|HSPA9|PSME2|LMNB1|CD47|SNRPA1|MSN|SOD1|ARF1|AIP|CFL1|ANXA2|TALDO1|SIRPA|P4HB
AUXIN METABOLIC PROCESS%GOBP%GO:0009850,0.933913043478261,0.9800972968717879,-0.53253198059109,-0.709460466616613,6980,1,ACAA1
REGULATION OF HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:1902202,0.7234071457682378,0.9029503874787299,0.36166105994595504,0.79458475099189,5324,4,ESM1|PTPN2|ADAMTS12|PTPN1
NEGATIVE REGULATION OF FEMALE GONAD DEVELOPMENT%GOBP%GO:2000195,0.39558528428093603,0.7377402989373809,-0.801996029995589,-1.06845128255732,2956,1,HYAL3
DNA LIGATION INVOLVED IN DNA RECOMBINATION%GOBP%GO:0051102,0.6647629167220079,0.8804055751124069,0.665747684164094,0.887684705596167,5004,1,LIG4
NEGATIVE REGULATION OF CAMP-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:2000480,0.990887789638115,0.997150662115148,-0.16708036847040697,-0.481000996184341,7611,8,PKIG|PKIA|SIRT1|PRKAR1B|PKIB|PRKAR2B|PRKAR2A|PRKAR1A
GLUCAN CATABOLIC PROCESS%GOBP%GO:0009251,0.268561327168888,0.6426302758624399,0.3677681861415061,1.1651144730220901,1974,10,PYGB|FAM47E-STBD1|AGL|PGM2L1|PGM1|PGM2
ORGANIC HYDROXY COMPOUND TRANSPORT%GOBP%GO:0015850,0.27657378740970096,0.651912680514098,-0.197230154256484,-1.12787732958841,2143,66,SLC2A13|ABCA5|MSR1|APOC1|SYT7|ABCG1|SLCO2B1|ATP8B1|CETP|SLC51A|APOM|GHRL|CEACAM1|APOE|CD36|SLC5A3|CAV1|LDLR|OSBP|NPC2|OSBPL5
SMALL MOLECULE BIOSYNTHETIC PROCESS%GOBP%GO:0044283,0.00612401122735392,0.0916167569432775,-0.178180106806718,-1.44665516098902,47,365,ABHD3|GPX4|LBR|ST20-MTHFS|ALOX5|SCD5|ADM|CCBL1|PGAM2|IPPK|CD74|NCAN|CES1|PER2|NANP|PGP|PLOD2|LTC4S|CDO1|TKT|MOXD1|TBXAS1|DNPH1|FDPS|PYCRL|GOT1|DCTPP1|NDUFA9|PTGDS|GPT|GPI|AACS|IMPDH2|SLC25A10|PFKFB2|PHGDH|G6PC3|GGT1|NUDT17|GPX1|ELOVL2|HK1|CBR1|CACNA1H|ADA|VCP|ACSF3|KYNU|NUDT1|HK3|DCN|ADI1|PDE4D|CYP51A1|ELOVL1|COQ6|PARK7|NUDT16|PTGES2|PTGS1|BGN|PDE2A|SMPDL3A|HAAO|ENO1|TYMP|VCAN|HMGCR|THNSL2|CTPS1|PGAM1|HPRT1|SERINC5|CDA|DHFR|CYP46A1|PRPS1|RFK|APOE|GAPDH|COQ7|HYAL1|HMGCS1|NUDT18|CYP7B1|UMPS|HACD2|NUDT4|GGT5|GMPS|PDSS1|LDHA|TK1|NDUFAB1|SRD5A3|EBP|DHCR7|OSBP|ABCD1|PNPO|HINT1|PNP|BCAT2|SHMT2|C14orf1|PGK1|FADS1|SAMHD1|TALDO1|SPHK1|APIP|DHCR24|CNBP|NSDHL|PDXK|OSBPL3|UCK1|PTGES|ALDOA|COQ3|ALDOC|MTHFD1|PTGIS|TM7SF2
LYSOSOME ORGANIZATION%GOBP%GO:0007040,0.745624270711785,0.911446969830076,-0.161901441951821,-0.810819458078484,5750,41,PPT1|CLN6|FAM160A2|MYO7A|CORO1A|RAB14|RAB7A|GAA|SYT7|ARSB|VPS18|TPP1|TPCN2|RAB7B|RAB34|RAB20
ESTABLISHMENT OF CENTROSOME LOCALIZATION%GOBP%GO:0051660,0.309753483386924,0.680809181688249,0.679728235908564,1.14203119959143,2311,2,EZR|DLG1
NEGATIVE REGULATION OF KINASE ACTIVITY%GOBP%GO:0033673,0.135689410550755,0.498614450236932,-0.172943395410465,-1.2200910680378,1051,164,DUSP2|DUSP26|DEPTOR|PTPN1|SFN|GBA|NPRL2|IL1B|CDKN1B|AKT1|MAPT|PAK2|SH3BP5|ZFYVE28|PPM1E|DUSP1|DUSP8|ZNF675|DUSP7|DUSP3|HIPK3|APC|PRKAR2A|HEXIM2|LYN|HYAL2|PYCARD|SOCS4|CORO1C|IRAK3|TSG101|DAB2IP|PPM1F|DUSP5|SPRY1|CDKN1C|HNRNPU|CDKN2A|NPM1|HEXIM1|THY1|WARS|MAPK8IP1|HEG1|IPO7|PRKAR1A|CEBPA|PARK7|RGS4|TAF7|ABL1|HSPB1|C14orf166|MEN1|LRP5|SNX6|GNAQ|CEACAM1|VPS25|CD300A|MBIP|APOE|PLK1|PPP2CA|MVP|WWTR1|CHMP6|LATS2|ERRFI1|ADARB1|NR2F2|CAV1|DNAJA1|RASIP1|SMPD1|H2AFY|RGS2|GPS1|GSTP1|RGS3|PTPRJ
CALCITRIOL BIOSYNTHETIC PROCESS FROM CALCIOL%GOBP%GO:0036378,0.0358613361668216,0.268987198588135,0.9820247022496691,1.30939743305183,269,1,CYP27B1
MITOTIC SISTER CHROMATID SEPARATION%GOBP%GO:0051306,0.5796828809459821,0.8386526275338391,0.45763501440968,0.9001140688591001,4313,3,DIS3L2|TEX14
L-ORNITHINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1903352,0.801703163017032,0.9325377000668108,0.30442909855574896,0.7321502362745491,5930,5,SLC25A15|SLC25A29|SLC7A1
INNER CELL MASS CELL DIFFERENTIATION%GOBP%GO:0001826,0.678528428093645,0.884536278926676,-0.6648103220114691,-0.885686979291417,5071,1,TET1
SUCKLING BEHAVIOR%GOBP%GO:0001967,0.670953912111468,0.8815356925073421,0.51146068127265,0.8593199818996919,5007,2,PEX13|UBR3
MODIFICATION BY VIRUS OF HOST MRNA PROCESSING%GOBP%GO:0046778,0.682674449456089,0.885415243771438,-0.5238815363704099,-0.871822651476771,5145,2,PABPN1
POSITIVE REGULATION OF NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL%GOBP%GO:0070961,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
RRNA 2'-O-METHYLATION%GOBP%GO:0000451,0.9944907282988441,0.9981673303852829,0.24114922245505702,0.474312063088585,7400,3,RNMTL1|MRM1
NEGATIVE REGULATION OF AXON REGENERATION%GOBP%GO:0048681,0.51931892599869,0.8049078833377921,-0.365549737742149,-0.9402923994931209,3964,6,EPHA4|RTN4RL1
CELL-MATRIX ADHESION INVOLVED IN AMEBOIDAL CELL MIGRATION%GOBP%GO:0003366,0.6834704165561158,0.885415243771438,-0.5235180590019299,-0.8712177670112191,5151,2,ITGB7|ITGA4
CELLULAR HYPEROSMOTIC RESPONSE%GOBP%GO:0071474,0.11743819042609199,0.468392769062825,-0.581214487404631,-1.3930602203765903,892,5,ARHGEF2|RCSD1|AQP1|YBX3
NEGATIVE REGULATION OF CELLULAR RESPIRATION%GOBP%GO:1901856,0.260048231511254,0.636098664976652,0.703391232423491,1.18178808898966,1940,2,TRAP1|SNCA
RESPONSE TO FOOD%GOBP%GO:0032094,0.48386239872493,0.787078399497453,0.758325981473313,1.01112537320392,3642,1,BCL10
"TRANSCRIPTION, DNA-TEMPLATED%GOBP%GO:0006351",0.00480222418804499,0.0772132376487505,-0.16900040424403898,-1.42045343500339,37,469,MED10|TOPORS|GTF3C4|SNAPC1|CSTF2|ESRRG|RORC|CDK4|GTF2E1|INTS2|DDIT3|MED30|SRRT|TCFL5|POLR2F|HSF1|CREBBP|TFAM|FUBP3|MED26|ADRM1|POU2F1|PTEN|NR1I3|NCOA6|ZNF136|THAP1|TRIP13|GABPA|ZNF219|CCNH|POLR1E|INTS1|IKBKAP|TCEB2|NOTCH4|ETV7|DRG1|TCERG1|CPSF1|SNRPE|POLR2C|LSM11|HIPK3|NR2F1|PIR|NR4A1|YBX1|MED7|NABP2|GTF3A|TMF1|GTF3C1|SSU72|SOX5|EAF2|NR3C1|INTS7|DEK|LMO4|SOX18|RUNX3|MED13|NCBP2|RXRG|GTF2A2|MED8|BRF1|TRIM28|KLF4|SOX17|NFE2L3|POLR2J|PARP1|ELL2|PTMA|ZNF143|TAF3|RORA|PHAX|TAF6L|BTF3|NR1D2|TROVE2|MED1|NRL|RBMX|AHR|GATA3|MLLT3|MAF|VEZF1|CCNK|ZNRD1|E2F2|LMO2|GTF2A1|TWISTNB|TAF12|PTTG1|LSM10|RREB1|TRIP11|GTF3C5|SUPT16H|CPSF2|THRA|CEBPD|NFX1|ELOF1|NFE2L1|NOTCH1|SNRPF|GMEB2|CEBPA|PAPOLA|SMARCD3|ILF2|NCBP1|TTF1|ARRB1|ZFHX3|DDX5|CLP1|CTGF|SNW1|CTR9|POLR2H|NOTCH2|GTF2H1|NFIC|MECP2|MAPK3|TAF7|ZNF148|USF2|POLR3K|IRF7|CEBPB|NFATC1|E2F1|NR1H3|CREBL2|NOTCH3|CSTF3|PPM1D|MED6|TAF9B|BCL3|UBTF|SPI1|BDP1|MAX|NELFB|NFIX|CDK7|GATA6|KAT2B|PKNOX1|NR1D1|WWTR1|SRF|SNRPB|MAML1|PABPN1|MNAT1|CCRN4L|TAF10|PPARG|PPARA|POLR2G|ANG|RELA|POU2F2|INTS5|YAP1|NFKB1|SUPT4H1|PTRF|MRPL12|TAF9|TEAD2|CPSF7|PRMT5|SSRP1|DTX1|ESRRA|CCND1|ELP4|MED27|AK6|C5AR1|MAZ|POLR2L|SMN1|GTF2H2
POSITIVE REGULATION OF THYROID HORMONE GENERATION%GOBP%GO:2000611,0.596730975348339,0.844613508628182,0.550011015787944,0.9240895213205519,4453,2,PAX8
REGULATION OF CALCIUM-INDEPENDENT CELL-CELL ADHESION%GOBP%GO:0051040,0.013531440700451,0.154334841212238,-0.9236283429831821,-1.5370652620010399,101,2,BMP2|CX3CL1
MITOCHONDRIAL PROTEIN PROCESSING%GOBP%GO:0034982,0.18043251693590398,0.554078048020677,-0.4262717691377561,-1.2823298211489298,1384,9,IMMP1L|STOML2|UQCRC2
OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035672,0.000802675585284281,0.0194343718828845,-0.9996691662990741,-1.33179936423268,5,1,ABCC1
REGULATION OF PROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0043244,0.00331537505180274,0.0593577580896271,0.30640496029784997,1.7843020364202902,23,67,MTRF1|RLTPR|CLASP1|ADD3|PHF23|KATNB1|CLASP2|SPEF1|OGFOD1|UBQLN4|FAM21C|NES|TTBK2|CLEC16A|LRRC16A|SMCR8|CAMSAP3|WDR1|IGF1R|STMN2|TRIOBP|TWF1
T CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050852,0.24052739375320004,0.624461333747413,-0.182948604359155,-1.14258498792946,1878,93,PRKCQ|MALT1|ZC3H12A|FYN|TRAF6|HLA-DRB1|GRAP2|UBE2N|PLCG2|LCP2|RIPK2|SPPL3|PAK2|BTNL9|HLA-DQB2|EIF2B5|NFKBIZ|HLA-DPA1|HLA-DRA|HLA-DRB5|PRAM1|HLA-DPB1|CD4|HLA-DQA2|GATA3|WAS|EIF2B1|THY1|PDE4B|BCAR1|RC3H2|PDE4D|PIK3CB|ICOSLG|TNFRSF21|EIF2B2|STOML2|RELA|NFKB1|NCK1|EIF2B3|PTPRJ
GLYCOLATE BIOSYNTHETIC PROCESS%GOBP%GO:0046295,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009208,0.923379975546801,0.97763046765315,0.28464208826671,0.6253707901564329,6796,4,CAD|CTPS2|AK3
SEQUESTERING OF METAL ION%GOBP%GO:0051238,0.007627564439768541,0.106509354710798,-0.7460457999351129,-1.78812942380272,57,5,FTL|S100A8|S100A9|FTH1
CREATINE METABOLIC PROCESS%GOBP%GO:0006600,0.6893254747871639,0.887051934478962,-0.314712157358998,-0.80952444780985,5262,6,SLC6A8|CKB
POSITIVE REGULATION OF PHOSPHOLIPID EFFLUX%GOBP%GO:1902995,0.41642345449721396,0.7493091022753771,-0.633157837212356,-1.05367589067213,3138,2,APOE
HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE%GOBP%GO:0048873,0.0196338551339878,0.192628124925339,-0.909291425420458,-1.51320633853118,147,2,F2R|NOS3
RESPONSE TO FENOFIBRATE%GOBP%GO:1901557,0.0284234294062957,0.23858105139263197,0.9861601235112479,1.3149114592999398,213,1,ABCB4
SOMATIC HYPERMUTATION OF IMMUNOGLOBULIN GENES%GOBP%GO:0016446,0.7126708727655101,0.89739524968595,-0.289228004085038,-0.790591851227725,5421,7,EXO1|POLQ|SAMHD1
POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION%GOBP%GO:0031954,0.008760460251046029,0.11733137778745902,-0.47616162402108797,-1.8476841904541201,66,18,RAP2C|GREM1|NBN|PDGFD|INS|TAOK2|PDGFC|GPNMB|TNKS1BP1|PDGFA|PDGFB
EXTRACELLULAR MATRIX ASSEMBLY%GOBP%GO:0085029,0.0987493486190724,0.4335599052175129,-0.47776783768939,-1.43724260017078,757,9,TGFB1|FBLN5|MYH11|MFAP4|GAS6|TNXB|GPM6B
TRIGLYCERIDE-RICH LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034370,0.733692793266702,0.907913422943088,-0.32638213760612,-0.7822757043976272,5578,5,CETP|APOE
LEUKOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002366,0.00012659830358273202,0.00518555396908895,-0.318041716169464,-2.6615430550360597,0,451,DOCK11|RAC1|DOCK2|IQGAP1|CXCL1|UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|DOCK10|CNN2|LILRB1|DNASE1L3|SBNO2|ATP6V1D|ATG7|GPR183|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|CORO1A|ADAM8|FRMPD3|BATF|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|EXO1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|RORA|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|SPN|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|FCGR2B|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|S100A13|PTGER4|STAT3|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|RNF168|ORMDL3|CD47|ICAM1|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|NOTCH2|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|DYSF|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|CHGA|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|EXOSC3|COTL1|FOXP1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|MILR1|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
CELL PROLIFERATION INVOLVED IN ENDOCARDIAL CUSHION MORPHOGENESIS%GOBP%GO:1905315,0.14876254180602,0.5154128781388279,-0.9232465813850899,-1.22998613098246,1111,1,TGFBR2
FC-EPSILON RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038095,0.8432509015971149,0.9481593344082329,-0.134359322061441,-0.750656836156629,6546,60,MAPK10|CHUK|PPP3CA|NFATC3|PRKCQ|MALT1|MAP3K1|TRAF6|GRAP2|PLCG2|LCP2|PAK2|SYK|NFATC2|RAC1|IGKV3-11|LYN|VAV3|LAT2|VAV1|IGKV2-28|GRB2|MAPK9|FCER1G|PIK3CB|MAPK3|NFATC1|IGKV2D-28|RELA|NFKB1
RESPONSE TO INTERLEUKIN-21%GOBP%GO:0098756,0.547712933753943,0.8186230305367759,-0.336445373856774,-0.9196584258702171,4166,7,IL2RG|JAK3|STAT3|IL21R
SUPPRESSION BY VIRUS OF HOST MOLECULAR FUNCTION%GOBP%GO:0039507,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
NEGATIVE REGULATION OF TELOMERASE RNA REVERSE TRANSCRIPTASE ACTIVITY%GOBP%GO:1905662,0.15101607119139301,0.518122468407016,0.9267754741949709,1.23573004237704,1136,1,PARP3
NEGATIVE REGULATION OF INTERLEUKIN-10 PRODUCTION%GOBP%GO:0032693,0.31700288184438,0.6861326333203311,-0.34479697104271195,-1.11629874451761,2419,11,FOXP3|JAK3|CD274|LILRB1|PDCD1LG2|FCGR2B|C10orf54|TNFRSF21
POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT%GOBP%GO:0051272,0.000127844541038098,0.00518555396908895,-0.256669345177378,-2.0786491255217703,0,361,FLT1|MAPRE2|PYCARD|NCKAP1L|CD74|GNB2L1|TNFRSF14|F10|ADAM8|CCL19|PIK3C2A|AGT|DAB2IP|LAMC2|PPM1F|SPOCK2|KDR|STX4|NUMB|P2RX4|FGR|EMC10|SEMA6A|TRIP6|PDCD6|CCL24|HGF|MOSPD2|GPI|SOD2|SPN|GATA3|TNFRSF18|PDGFD|PLAU|SRPX2|VEGFC|GAS6|INS|THY1|DDR2|BCAR1|RREB1|FOXC2|VTN|CREB3|DOCK5|ATP5B|MYLK|SMOC2|PDGFC|ZNF268|FLT4|PHPT1|NOTCH1|GPNMB|SMURF2|STAT3|GCNT2|PRKD1|MADCAM1|ICAM1|DSCAM|F3|BCAS3|TRIM32|SNAI2|MMP14|PLA2G7|FGF10|RHOD|ABL1|CALR|HMOX1|HSPB1|NTN1|SPARC|HRAS|PIK3R3|IGF1|SEMA3B|SEMA3D|NSMF|SEMA7A|RHOJ|HBEGF|C10orf54|DOCK1|CSF1|CTSH|CXCL16|PDPN|GPER1|MAP2K3|PLVAP|F2R|CCR1|FN1|INSL3|SASH1|NOS3|HYAL1|VEGFB|NRP2|LGALS3|CD151|BMP2|FGF9|LGALS9|THBS1|ZP3|TEK|ATOH8|SUN2|FGF7|COL1A1|SEMA5A|FADD|AIF1|PDGFRB|SEMA3E|RARRES2|NEDD9|SYDE1|FAM89B|FOXP1|MMP9|IGFBP5|SNAI1|SERPINE1|CAV1|FAM107A|SEMA3A|SEMA6B|PLAA|PTRF|FERMT3|DAB2|PDGFA|CSF1R|TIAM1|PDGFRA|HSPA5|CMKLR1|ANXA1|LGMN|TMSB4X|GLIPR2|ARF6|SPHK1|PDGFB
MICROTUBULE NUCLEATION BY INTERPHASE MICROTUBULE ORGANIZING CENTER%GOBP%GO:0051415,0.533731505361748,0.8121958522738141,0.35610573692425707,0.92144452449914,3931,6,TUBGCP3|MZT1|TUBGCP6
NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS%GOBP%GO:2000669,0.20662460567823301,0.586366512053115,-0.457662948159896,-1.25100125960724,1571,7,CXCL12|LILRB1|CCL19|GAS6|AXL
REGULATION OF MACROPHAGE APOPTOTIC PROCESS%GOBP%GO:2000109,0.255128879537086,0.633820868480386,-0.499711642512186,-1.19771345334367,1939,5,CDKN2A|MEF2C|IRF7
REGULATION OF CELL-CELL ADHESION%GOBP%GO:0022407,0.00012750223128904799,0.00518555396908895,-0.25440291627258105,-1.9232664275948501,0,237,ETS1|RARA|GRAP2|ADTRP|HSPH1|IL1B|AKT1|FOXP3|CD1D|HLA-DMB|CXCL12|CDC42|PAK2|TNF|JAK3|SYK|PRKG1|MDGA1|RAC1|CD274|DUSP3|PPAP2B|NFKBIZ|CD44|HLA-DPA1|TGFB1|LILRB1|HLA-E|RGCC|LYN|NDFIP1|CD209|PYCARD|TNFAIP8L2|NCKAP1L|TNFRSF14|JAG1|IL18|ADAM8|RUNX1|CCL19|TWSG1|EPHB3|RUNX3|CCDC88B|PPM1F|HLA-DPB1|KLF4|PDCD1LG2|VAV1|SPN|GATA3|IL1RN|EBI3|FCGR2B|PLA2G2D|THY1|ADA|IL6ST|PIEZO1|RC3H2|LILRB2|GPNMB|GRB2|PRKAR1A|SOCS1|GCNT2|PTPN6|CD47|SDC4|SNAI2|IRAK1|IGF1|DPP4|CEBPB|NKAP|ICOSLG|VCAM1|C10orf54|CCL2|CEACAM1|PDPN|CD300A|HFE|CD86|NLRP3|LGALS3|SERPINE2|TGFBR2|TNFRSF21|BMP2|LGALS9|ZP3|SPINT2|FADD|AIF1|ADAM19|CX3CL1|CAV1|PPARA|HAVCR2|RELA|BCL6|KIAA2022|FERMT3|LILRB4|NF2|PNP|ANXA1|CD55|NCK1|TFRC|FXYD5|SART1|EFNA5|SERPINF2|SIRPA|C1QTNF1|PRNP
ALDONIC ACID CATABOLIC PROCESS%GOBP%GO:0046176,0.11933110367892999,0.47098246139817795,-0.9386854874283191,-1.250554460932,891,1,IDNK
MITOCHONDRIAL MRNA PROCESSING%GOBP%GO:0090615,0.326500535905681,0.6941148928066879,0.670967741935484,1.1273124386035,2436,2,PNPT1|TBRG4
RESPONSE TO DEXAMETHASONE%GOBP%GO:0071548,0.225925925925926,0.608570227910676,-0.62747818437383,-1.22530586039002,1707,3,AQP1|NR3C1
NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION INVOLVED IN URETER DEVELOPMENT%GOBP%GO:0072200,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
"ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I, TAP-INDEPENDENT%GOBP%GO:0002480",0.0257623554153523,0.225019807572435,-0.6094318808604521,-1.66585486910527,195,7,HLA-F|HLA-B|HLA-E|B2M|LNPEP|HLA-C|HLA-A
RESPONSE TO MYCOTOXIN%GOBP%GO:0010046,0.0753828032979976,0.38436410265336796,-0.6656229969882049,-1.4571878806126002,575,4,ACTB|PDGFB
NEGATIVE REGULATION OF PROTEIN KINASE C SIGNALING%GOBP%GO:0090038,0.58158662775272,0.8387093286508721,-0.565922249793218,-0.941785121427864,4383,2,MYADM|GPD1L
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL%GOBP%GO:0003044,0.423415146344665,0.753783909572009,-0.250147752601097,-1.0191037452454799,3225,21,ADRA1B|ECE1|ADRB2|AGT|PCSK5|SOD2|PDE4D|ATP6AP2|CTSZ|NOS3|SERPINF2
REGULATION OF N-TERMINAL PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000759,0.706335502722805,0.894843171056815,0.646449051610057,0.8619525831049749,5317,1,SOX4
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010660,0.189338235294118,0.563467720122429,-0.31251670781680296,-1.25381104599295,1441,20,SOD2|CDKN2A|BAG3|DNMT1|IGF1|CAMK2A|PPARG|ENG
ODONTOBLAST DIFFERENTIATION%GOBP%GO:0071895,0.7412671005445608,0.9098143075756671,0.6290802823114251,0.838793672862902,5580,1,LEF1
NUCLEOBASE-CONTAINING COMPOUND TRANSPORT%GOBP%GO:0015931,0.17420930830547698,0.54811765844537,-0.16988928663971498,-1.18370976572099,1354,154,FYTTD1|NXF2B|ZFP36L1|NCBP2|SLU7|CHTOP|TST|PHAX|SRSF9|TOMM20|NPM1|SLC35B1|FMR1|MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|C14orf166|NUP37|NMD3|CKAP5|RAN|NXF1|SLC35A2|NUP160|THOC7|ZC3H3|NUP214|TGFBR2|MAGOHB|EIF4A3|PABPN1|SLC25A4|SRSF2|RBM8A|DDX39A|SLC25A42|NUP98|THOC3|SLC25A19
REGULATION OF HEART RATE BY CHEMICAL SIGNAL%GOBP%GO:0003062,0.75894266175697,0.917242163810958,-0.31799291229504195,-0.762168332138505,5770,5,PDE4D|KCNH2
GLUCOSAMINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:1901072,0.272838333107099,0.64706797001098,0.45108692517290006,1.16721393163663,2009,6,GNPDA2|CTBS|AMDHD2|OVGP1
REGULATION OF MICROTUBULE DEPOLYMERIZATION%GOBP%GO:0031114,0.0454174598857764,0.305507129637833,0.39811611335515,1.5583963393448999,333,18,CLASP1|KATNB1|CLASP2|SPEF1|TTBK2|CAMSAP3|STMN2
POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY%GOBP%GO:0032430,0.35335689045936397,0.7118407891832621,-0.502822342085348,-1.100783215579,2699,4,ANG|PLAA
REGULATION OF HISTONE H3-K9 DIMETHYLATION%GOBP%GO:1900109,0.20779742765273299,0.5877597266194561,0.7317342156051829,1.2294079602456,1550,2,PIH1D1|SMARCB1
NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0032232,0.0270453927697744,0.23271567002476898,0.440094687930536,1.6571024599386999,198,16,MET|CLASP1|PARK2|TMEFF2|INPP5K|CLASP2
NEGATIVE REGULATION OF CYTOTOXIC T CELL DEGRANULATION%GOBP%GO:0043318,0.0876890421862563,0.40905715364188894,-0.813895781637717,-1.35445273236629,660,2,FCGR2B|CEACAM1
"GUANINE DEGLYCATION, GLYOXAL REMOVAL%GOBP%GO:0106046",0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
TYPE I PNEUMOCYTE DIFFERENTIATION%GOBP%GO:0060509,0.68559299548952,0.885899038297278,-0.522796177260194,-0.8700164403554,5167,2,THRA
NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY%GOBP%GO:1903347,0.812797174296971,0.9356336309698571,0.33182595268295395,0.7290357497283021,5982,4,IKBKB|ROCK2|ROCK1|TNF
POSITIVE REGULATION OF PODOSOME ASSEMBLY%GOBP%GO:0071803,0.18687532877432897,0.5601505529923929,-0.5354621663357599,-1.2834006371209299,1420,5,ASAP1|LCP1|FSCN1|CAPG|TNF
IMMUNE COMPLEX CLEARANCE%GOBP%GO:0002434,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
REGULATION OF PROTEIN MATURATION%GOBP%GO:1903317,0.00012873326467559198,0.00518555396908895,-0.520722383720817,-3.09005582398732,0,76,C2|IGKV2-28|VTN|C3|CLEC3B|C1QB|ENO1|CARD16|NKD2|C1QA|CFB|CAST|C1QC|CTSZ|C7|GSN|IGKV2D-28|TMEM59|GAS1|CCBE1|SERPINE2|A2M|THBS1|XIAP|SUSD4|CD59|SERPINE1|C3AR1|MYH9|BCL2L12|CFP|C1S|ANXA2|CFI|CD55|PHB|IGHG2|SERPING1|CD81|C1R|CFH|C5AR1|SERPINF2|PRNP
MAINTENANCE OF SYMBIONT-CONTAINING VACUOLE BY HOST%GOBP%GO:0085018,0.589565217391304,0.8414799095069009,-0.709803705337451,-0.945628969430075,4406,1,AQP1
REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON%GOBP%GO:1905274,0.787692307692308,0.927797067038212,-0.610002205558006,-0.812669407970552,5887,1,RHOA
POSITIVE REGULATION OF CYTOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0001961,0.009521325159775659,0.12396436004013,-0.40901394812358705,-1.8039513340508702,72,27,CD74|PARP9|AGPAT1|TRIM44|TICAM2|GAS6|CASP1|CASP4|TREM2|CSF1|AXL|FADD|CD300LF|C1QTNF4|AGPAT2
PYRIMIDINE NUCLEOTIDE-SUGAR TRANSMEMBRANE TRANSPORT%GOBP%GO:0090481,0.929404060248854,0.9793746057014829,-0.23779139402051103,-0.611663523118374,7095,6,SLC35B4|SLC35A3|SLC35B1|SLC35A2
POSITIVE REGULATION OF MEDIATOR COMPLEX ASSEMBLY%GOBP%GO:2001178,0.8132368703108249,0.9356336309698571,0.44172315665115297,0.7421519363592991,6069,2,MED25
REGULATION OF DENSE CORE GRANULE BIOGENESIS%GOBP%GO:2000705,0.6193121693121689,0.854944793214197,-0.44769954514274796,-0.874243742680524,4681,3,REST|CHGA
BASE CONVERSION OR SUBSTITUTION EDITING%GOBP%GO:0016553,0.00104602510460251,0.0240545523142212,-0.656808947171153,-2.05769669135496,7,10,NUDT16|APOBEC3G|APOBEC3C|APOBEC3B|ADARB1|APOBEC3F
OLIGOSACCHARIDE-LIPID INTERMEDIATE BIOSYNTHETIC PROCESS%GOBP%GO:0006490,0.18357740585774102,0.556308895147568,-0.32730056140671504,-1.27004790459796,1403,18,SRD5A3|DOLK|ALG6|DOLPP1
NEGATIVE REGULATION OF RESPONSE TO WOUNDING%GOBP%GO:1903035,0.0032295569047926602,0.058198794233157,-0.364645262573348,-1.8889771951577,24,46,SIGLEC10|CD34|GP1BA|PLAU|CASK|VTN|PHLDB2|CEACAM1|THBD|APOE|PLAUR|NOS3|SERPINE2|EPHA4|SERPINE1|PLAT|RTN4RL1|PDGFA|ANXA2|PDGFRA|TFPI|PDGFB|SERPINF2|C1QTNF1
CELLULAR RESPONSE TO OXYGEN LEVELS%GOBP%GO:0071453,0.19964552474996802,0.577735400526903,-0.18632545603171402,-1.17931071016053,1576,97,NOTCH1|ATP6V0D1|UBQLN1|CARD16|HMOX1|LMNA|HIF3A|GATA6|CPEB1|PDK3|UBC|CAV1|MYC|ATP6AP1|PGK1|ATP6V1A|ATP6V1G1|BAD|PTGIS|P4HB|SUV39H1
PLATELET ALPHA GRANULE ORGANIZATION%GOBP%GO:0070889,0.256873422765308,0.63510667803751,0.8735112483458309,1.16470938430135,1933,1,VPS33B
REGULATION OF TERMINAL BUTTON ORGANIZATION%GOBP%GO:2000331,0.372028157789879,0.7234654586828599,0.814788266431407,1.08641021157815,2800,1,VPS35
PROXIMAL/DISTAL PATTERN FORMATION%GOBP%GO:0009954,0.24697661918839,0.6280519349499749,0.6160933883719859,1.21178299112457,1837,3,DLL1|CYP26B1|SIX3
RESPONSE TO PSYCHOSOCIAL STRESS%GOBP%GO:1990911,0.612307692307692,0.852045339927398,-0.697783414203794,-0.929615055397933,4576,1,ADRB2
REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0062042,0.191505992704534,0.565967229895179,-0.421143682856462,-1.2669032824005901,1469,9,TGFB2|TGFB1|JAG1|TGFB3|NOTCH1|TGFBR2|ENG
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED EIF2 ALPHA PHOSPHORYLATION%GOBP%GO:1903912,0.745415025132455,0.91143284454225,0.354643991097396,0.779167951891211,5486,4,NCK2
PROTEIN LOCALIZATION TO SPINDLE MICROTUBULE%GOBP%GO:1902889,0.41123745819398,0.745702786067065,-0.794938244375827,-1.05904861743753,3073,1,HNRNPU
TETRAHYDROFOLATE BIOSYNTHETIC PROCESS%GOBP%GO:0046654,0.29459494830519606,0.667556940989968,-0.530753853846282,-1.16193113355868,2250,4,DHFR|MTHFD1
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY%GOBP%GO:0034141,0.856843483955468,0.949296218452153,-0.26577148992051697,-0.683635867222262,6541,6,CAV1
NUCLEAR HISTONE MRNA CATABOLIC PROCESS%GOBP%GO:0071045,0.0209855226457697,0.19985120214870103,0.990130127922364,1.32020492449813,157,1,SSB
DNA REPLICATION-DEPENDENT NUCLEOSOME ORGANIZATION%GOBP%GO:0034723,0.0128138075313808,0.149991146428462,-0.457515304981085,-1.7753295378270701,97,18,RBBP4|HIST1H4J|HIST4H4|NASP|HIST1H3D|HIST1H4H|ASF1B|CHAF1A|IPO4|HIST1H4I|CHAF1B|HIST2H4A|HIST1H3H|HIST2H4B
TRANSMISSION OF VIRUS%GOBP%GO:0019089,0.30960286890689304,0.680809181688249,0.846217468019409,1.1283168110638,2330,1,NEDD4
POSITIVE REGULATION OF RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:2000208,0.847892976588629,0.9492491301138911,-0.5794000882223199,-0.771900039677715,6337,1,RIOK2
PROPIONATE METABOLIC PROCESS%GOBP%GO:0019541,0.982999070261655,0.993436724391485,0.507829730921923,0.6771224232682379,7400,1,PCK2
MODIFICATION OF SYNAPTIC STRUCTURE%GOBP%GO:0099563,0.625834314880251,0.858842084733938,-0.39306725761396294,-0.8605063927363751,4781,4,ARHGAP44|SYNPO
NEURON DIFFERENTIATION%GOBP%GO:0030182,0.0036655857888058703,0.0646052543079676,0.17026375355922305,1.4525716686559098,25,482,TNR|RET|WNT6|CNTN4|SLC12A5|IFT88|HS6ST1|SHTN1|DRD2|ROBO3|ETV1|FRY|ADGRB3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|DLL1|TRAPPC4|C8orf46|BBS4|WNT5B|SEMA4F|PLXNB1|INSM1|LLGL1|FARP1|FARP2|GAB1|CYFIP1|GAB2|DOK1|CDHR1|NRBP2|PICK1|AHI1|MAPK7|RAB13|ALS2|SLIT1|EPHB2|GNGT1|SPINK5|ARL3|EFNA4|RTN4|POU3F2|PARD3|WNT2B|TENM4|SKOR1|LAMB1|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|RNF112|NYAP2|STK24|STMN3|ROBO2|KCNIP2|AGRN|PTPRM|NIF3L1|SLITRK6|CHRNB2|MINK1|ASCL1|LYPLA2|EFNB2|BMP7|PTPRD|NTNG1|CHD5|EFNB3|SLIT3|CDK5R1|NREP|BLOC1S3|SHC1|SOS1|CEP290|NYAP1|MAP6|ERCC3|ADCYAP1|MYEF2|ATP7A|FRYL|DRAXIN|MICALL1|SPTBN1|WNT4|PPP1R9A|STMN2|NEDD4|PAK1|EFNA2|EPB41L3|NRCAM|STRADB|STRN|ALK|MAP2|DLG4|BRSK1|VLDLR|TUBB3|ULK2|RAB11A|CLN5|PPP3CB|GATA2|ATCAY|SKI|PRKCA|PLCG1|TDP2|TENM3|KIF5A|C21orf91|PLXNB2|POU4F2|AGTPBP1|NR4A2|LRP6|STMN4|RB1|MAP4|DOCK7|C8orf37|CELSR2|NRP1|ZFYVE27|DCC|CPNE1|LRP12|MEGF8
REGULATION OF CELLULAR RESPONSE TO HEAT%GOBP%GO:1900034,0.190463783220427,0.564472210793396,-0.24115296573181302,-1.2231194958319198,1461,43,GSK3B|HSPH1|PTGES3|MAPT|HSF1|CREBBP|MLST8|DNAJB1|BAG1|RPA2|CHORDC1|DNAJC7|CD34|BAG5|BAG3|MAPKAPK2|MAPK3|RPTOR|CRYAB|FKBP4|HSP90AA1
LEFT/RIGHT PATTERN FORMATION%GOBP%GO:0060972,0.180859691808597,0.554494792588896,0.5383011020195619,1.29461106346343,1337,5,AHI1|SETDB2|CITED2|MEGF8
DOPAMINE BIOSYNTHETIC PROCESS FROM TYROSINE%GOBP%GO:0006585,0.9602675585284279,0.989779794259826,-0.5196846052051171,-0.692344677765747,7177,1,TH
REGULATION OF FAT CELL PROLIFERATION%GOBP%GO:0070344,0.477523659305994,0.7850984235874658,-0.35751542741118103,-0.977252477655563,3632,7,TFDP1|E2F3|PER2|PID1|E2F1
HISTONE H3-K9 DEMETHYLATION%GOBP%GO:0033169,0.8133821932681871,0.935640932327182,0.21896722939424001,0.7205366393719649,5992,11,KDM3A|KDM7A|KDM4A|KDM4C|KDM5A|JMJD1C|PHF8|KDM4B|HR|KDM1A|KDM3B
POSITIVE REGULATION OF ION TRANSPORT%GOBP%GO:0043270,0.009448416751787541,0.123500576027114,-0.233465619628224,-1.5779020617525898,73,132,GLRX|ATP1B1|SNX4|AMIGO1|P2RX4|CTSS|ATP1B3|TNFRSF11A|P2RX5|STAC3|P2RX3|THY1|STIM1|GRIN1|PRELID1|PLA2R1|MYLK|TESC|SLC9A1|PKP2|FLNA|FXYD1|VAMP8|CEBPB|VAMP7|P2RY6|CCL2|GPER1|F2R|CCR1|APOE|KCNQ1|APLNR|LGALS3|F2RL3|PDGFRB|COX17|CX3CL1|CAMK2A|CAV1|SCN1B|ARL6IP1|ATP1B2|KCNH2|ANXA2|TMSB4X|PDGFB|WNK2
REGULATION OF CILIUM BEAT FREQUENCY%GOBP%GO:0003356,0.103191777116581,0.441899546263084,0.517772033400272,1.42929580038767,762,7,BBS4|CFAP20|MKKS|CCDC40|BBS2
CELLULAR GLUCAN METABOLIC PROCESS%GOBP%GO:0006073,0.37140992167101794,0.7231271705612199,-0.253394243233924,-1.0638963840795699,2844,23,GYG1|PER2|GAA|PHKG2|PPP1R3C|PGM5|NR1D1|PYGL|PYGM|GYG2
BLEB ASSEMBLY%GOBP%GO:0032060,0.0128811777076761,0.149991146428462,-0.6462869281721529,-1.76659649740443,97,7,MYLK|EMP3|EMP1|EMP2
DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009263,0.7964369924024101,0.9302343628730029,-0.22676810551173102,-0.7341739421719721,6079,11,CMPK2|RRM1
REGULATION OF CALCINEURIN-MEDIATED SIGNALING%GOBP%GO:0106056,0.210147770367464,0.591474654268711,-0.296057354185963,-1.22605053535254,1606,22,GSK3B|SPPL3|TMEM110|TNF|PTBP1|LMCD1|RCAN2|SLC9A1|IGF1|RCAN3|FHL2|PRNP|RCAN1
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009200,0.156201146430433,0.525661258438322,-0.439092897634899,-1.32089891392729,1198,9,DCTPP1|NUDT1|NUDT16|CMPK2|SAMHD1
LACTATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035873,0.7435185185185191,0.910822559744447,-0.40024263813830396,-0.78157243120448,5620,3,EMB|SLC16A7|SLC16A1
NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:0045605,0.0484994640943194,0.31547510795994604,0.863115202775386,1.45014498197743,361,2,DLL1|SRSF6
RESPONSE TO CORTICOTROPIN-RELEASING HORMONE%GOBP%GO:0043435,0.174976226056242,0.54811765844537,0.5903351359086,1.29699143457079,1287,4,CRHR1|NR4A3|NR4A2
"NEGATIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043377",0.905677898646856,0.97046527419469,-0.39491946062822497,-0.657209134855324,6826,2,SOCS1
PROTEIN LOCALIZATION TO AXON%GOBP%GO:0099612,0.443768586104353,0.7664039155808309,0.414295168762409,0.996377505093374,3282,5,EPB41L3|CNTNAP1|CNTNAP2|CNTN2|ANK3
CERAMIDE METABOLIC PROCESS%GOBP%GO:0006672,0.324251033057851,0.692794968343412,-0.20756553157384303,-1.0936414780772301,2510,49,CLN3|DEGS1|B4GALNT1|ST8SIA3|ORMDL2|B4GALT6|GALC|ST8SIA4|GBA|SPTLC1|ST6GALNAC6|SPTLC2|CLN6|FUT7|NEU1|CERS6|CERS4|NSMAF|GLA|ORMDL3|NEU4|UGCG|B3GALT2|PPP2CA|SPTSSA|SMPD1|B3GALT1|ST3GAL5
HISTONE H2A PHOSPHORYLATION%GOBP%GO:1990164,0.9770900321543409,0.9927322181739301,0.31364764267990103,0.526968536388617,7292,2,VPRBP|RPS6KA5
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT%GOBP%GO:0090316,0.692614513638703,0.888747617562104,-0.132605525415514,-0.877738798431149,5382,120,ZC3H12A|EDEM1|FYN|PDZK1|OAZ1|GSK3B|ABLIM3|USP36|IL1B|PDCD10|RAC2|SEC16A|UBE2L3|PCNT|TGFB1|NPEPPS|CEMIP|PSEN1|HYAL2|FIS1|SREBF2|CAMK1|JUP|ECT2|ITGB2|TRIM28|MICALL2|HCLS1|ATG13|PDCD5|GAS6|PRR5L|RAB29|BAG3|BCAS3|ANP32B|HUWE1|CEP131|RAPGEF3|FLNA|HRAS|IGF1|RBM22|TMEM173|B3GAT3|BCAP31|ITGAM|RHOU|SAR1B|EMD|PRNP
MITOTIC SISTER CHROMATID BIORIENTATION%GOBP%GO:1990758,0.398127090301003,0.7388683667002129,-0.800672695191884,-1.0666882828473598,2975,1,BOD1
IRES-DEPENDENT VIRAL TRANSLATIONAL INITIATION%GOBP%GO:0075522,0.39069037656903793,0.7364714265545841,-0.334201208815602,-1.04700876044475,2987,10,DENR|PTBP1|EIF3B|MCTS1|EIF2D
NEGATIVE REGULATION OF INTERLEUKIN-10 SECRETION%GOBP%GO:2001180,0.246617139824887,0.6280519349499749,-0.7100082712985942,-1.18156730230003,1858,2,LILRB1|TNFRSF21
REGULATION OF RNA INTERFERENCE%GOBP%GO:1900368,0.994105037513398,0.9979011714304391,0.281279665877116,0.472586156161286,7419,2,XPO5
POSITIVE REGULATION OF CELL DEATH%GOBP%GO:0010942,0.00127145581691036,0.0281505077324231,-0.18180304012406898,-1.50942239112371,9,429,GZMA|MNDA|HOXA5|UBD|MUL1|SOS2|LILRB1|ING3|PML|APC|RGCC|ATG7|LYN|GNA13|HYAL2|ZNF746|FIS1|BNIP3L|PYCARD|APOPT1|VAV3|GNB2L1|FNIP1|ARHGEF5|TFDP2|ADAM8|RIPK3|UBE2Z|REST|AGT|BCL2L11|ECT2|DAB2IP|FGD1|ITGB2|GZMB|PPM1F|PPIF|TNFRSF10A|TNFRSF10B|LRP1|SFRP4|PDCD6|RASGRF2|CASP10|HP|VAV1|SFRP2|CYP1B1|SOD2|NGF|IRF5|CDKN2A|C3orf38|PDCD5|FCGR2B|WWOX|SLFN11|TGFB3|NMT1|CASP1|KALRN|VCP|TOP2A|TRAF2|PRELID1|SLC9A3R1|DDX3X|PPP1R13B|TNFSF10|ZNF622|MELK|ZNF268|NOTCH1|IFIT2|INHBA|TNFSF12|CYCS|MEF2C|CASP4|DCUN1D3|MAPK9|F3|IFI27L1|NGEF|PIK3CB|ANP32B|TIMP3|ABL1|SOD1|PNMA3|TNFRSF10C|G0S2|FAP|E2F1|GADD45B|CCL2|SAV1|STK3|PPP2R4|GPER1|CIDEB|GSN|F2R|NACC2|DLC1|GAPDH|PLAUR|NLRP3|BRMS1|ECSCR|CD36|PTRH2|GADD45G|BMP2|LGALS9|THBS1|MAP3K11|ARHGEF9|FADD|TGM2|UBC|LATS2|SLIT2|MMP9|BCAP31|RRP1B|CAMK2A|CAV1|EIF2S1|MYC|APBB1|LTBR|DNAJA1|DDIT4|PPARG|SIK1|TNFRSF12A|BCL6|TLR4|S100A8|ITGAM|S100A9|ARL6IP5|SAP30BP|TIAM1|STYXL1|ANXA1|TNFRSF1A|PHB|NCK1|STPG1|NGFRAP1|TNFRSF1B|NET1|NGFR|SQSTM1|EIF4G1|BAD|PTGIS|PRNP
REGULATION OF HISTONE H3-K4 TRIMETHYLATION%GOBP%GO:1905435,0.9487315712578029,0.984457616015067,0.525474194971328,0.700648935260185,7142,1,KMT2E
NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION%GOBP%GO:0048147,0.104210251046025,0.444228048281396,-0.35991551011095896,-1.3966060353948102,796,18,TRIM32|B4GALT7|CD300A|MYC|GSTP1|EMD|FTH1
MACROMOLECULE GLYCOSYLATION%GOBP%GO:0043413,0.686853359084012,0.8861361847538001,0.125098882565241,0.894144691760111,4978,164,GALNT3|GALNT8|GALNTL6|MGAT5|GALNT12|UGGT2|POMGNT1|SERP2|ST8SIA2|B3GNT9|B3GNT2|B4GALT5|GALNT7|B3GALNT2|ALG12|TUSC3|PMM1|DPAGT1|B3GNT7|MGAT5B|MOGS|TET2|GALNT14|GALNT6|GALNT2|GALNT9|SDF2|LARGE|FUT2|MPDU1|TET3|DPY19L3|ST3GAL4|ST3GAL6|ALG11|DPY19L1|GALNT15|PGM3|DHDDS|EOGT|DPY19L2|TRAK1|OST4|COG3|PMM2|MUC1|GFPT1|ALG13
REGULATION OF CILIUM-DEPENDENT CELL MOTILITY%GOBP%GO:1902019,0.0624493106244931,0.358856014313751,0.6394481716291011,1.53786918584539,461,5,BBS4|CFAP20|MKKS|BBS2
NEGATIVE REGULATION OF EPITHELIAL TUBE FORMATION%GOBP%GO:1905277,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
OXYGEN HOMEOSTASIS%GOBP%GO:0032364,0.295511058761942,0.6684308347279571,-0.530286091716315,-1.1609071044763302,2257,4,NARFL|HIF1A|SOD2
EYE DEVELOPMENT%GOBP%GO:0001654,0.00389646534929029,0.0677829439596601,0.26761980633137,1.7207824884178702,27,101,PDE6B|NPHP1|FOXC1|WNT6|STRA6|SH3PXD2B|LRP5L|DLL1|BBS4|WNT5B|RARG|AHI1|HDAC1|GNGT1|SDHAF4|WNT2B|MFAP2|IFT140|TWIST1|PTPRM|NES|RAB3GAP1|BLOC1S3|CEP290|ALDH1A3|CACNA1C|ZNF513|MEGF11|TFAP2B|NF1|PHACTR4|SKI|TENM3|CHD7|POU4F2|AGTPBP1|LRP6|NRP1
MITOCHONDRIAL MAGNESIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0045016,0.254314381270903,0.6334469481869079,-0.8694309660344071,-1.15829080944406,1900,1,MRS2
REGULATION OF TRANSMISSION OF NERVE IMPULSE%GOBP%GO:0051969,0.71436086270384,0.8984303043163959,-0.331388210423832,-0.794274305695065,5431,5,FMR1|TYMP
NEGATIVE REGULATION OF MUSCLE HYPERTROPHY%GOBP%GO:0014741,0.15581031787389302,0.524929617605427,-0.43947874802045706,-1.3220596463325902,1195,9,P2RX4|NOTCH1|LMNA|RGS2
METHYL-BRANCHED FATTY ACID METABOLIC PROCESS%GOBP%GO:0097089,0.42416934619507,0.754268592539614,0.626357871519162,1.05236209649056,3165,2,PHYH|SLC27A2
MORPHOGENESIS OF AN EPITHELIAL FOLD%GOBP%GO:0060571,0.342246707874227,0.701955655133333,0.567244683244412,1.1157033526650901,2546,3,FGFR2|BMP7
POSITIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS%GOBP%GO:2000670,0.31058201058201096,0.6814452407589661,-0.585065492256958,-1.1424846221384,2347,3,LYN|LGALS9
DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION%GOBP%GO:0006271,0.0168781891927254,0.17671843887293,-0.46089107660913103,-1.75149863896976,128,17,POLE|WRNIP1|RNASEH2A|RFC3|GINS2|PCNA|POLD2|GINS1|POLA1|RFC4|FEN1
REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902259,0.387816154473756,0.734887192861895,0.33141391877358506,1.0499416966303299,2851,10,RNF207|SUMO1|KCNG1|NOS1AP|KCNAB1|KCNE3|VAMP2
REGULATION OF BLOOD VESSEL DIAMETER BY RENIN-ANGIOTENSIN%GOBP%GO:0002034,0.6921957671957671,0.888433240372712,-0.420343143365681,-0.820823623461441,5232,3,SERPINF2
URATE METABOLIC PROCESS%GOBP%GO:0046415,0.424381904260915,0.7544212877270308,-0.42459913053121606,-1.0176830949118,3226,5,PRPS1|PNP
APOPTOTIC CHROMOSOME CONDENSATION%GOBP%GO:0030263,0.42952493129171604,0.758030944919235,-0.466403911060314,-1.02105565724534,3281,4,ACIN1|TOP2A|GPER1
CELLULAR RESPONSE TO PLATELET-DERIVED GROWTH FACTOR STIMULUS%GOBP%GO:0036120,0.0629931614939506,0.36006266503904,-0.6342295164840369,-1.5201271288812501,478,5,MTSS1L|SYAP1|CORO1B|HYAL1
NEGATIVE REGULATION OF FATTY ACID BETA-OXIDATION USING ACYL-COA DEHYDROGENASE%GOBP%GO:1904736,0.7359197324414721,0.908157084784786,-0.6367445963828849,-0.848296693776004,5500,1,METTL20
T CELL MEDIATED IMMUNITY%GOBP%GO:0002456,0.593901958207386,0.843040556302675,-0.22614422419666502,-0.893474732405307,4518,19,SLC11A1|CTSH|HFE|CD55|EMP2
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY%GOBP%GO:0051354,0.571447299423178,0.833809579360991,-0.256582090360386,-0.90774991474311,4358,14,NOSIP|METTL20|GZMA|OXA1L|HP|INS|GLA|NFKB1|AOC3
NEGATIVE REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0061048,0.6709030100334449,0.8815356925073421,-0.668228936921041,-0.8902413952088148,5014,1,TNF
CORONARY VASCULATURE MORPHOGENESIS%GOBP%GO:0060977,0.127310596198907,0.484353499575027,-0.478367276320619,-1.37715243603238,977,8,TBX1|NOTCH1|TGFBR3|PDGFRB
HISTONE H3-K23 ACETYLATION%GOBP%GO:0043972,0.994820029220348,0.9982558473047859,0.502922364358183,0.670579112120477,7489,1,BRPF1
HISTONE LYSINE METHYLATION%GOBP%GO:0034968,0.9176638917793959,0.975883369405932,-0.135471678707254,-0.646732726066203,7054,35,SETD1B|SETMAR|EZH2|PAXIP1|OGT|CTR9|WDR5|PAGR1|HIST1H1C|SUV39H1
L-GLUTAMATE IMPORT%GOBP%GO:0051938,0.145767195767196,0.512646109386394,-0.6769361697067571,-1.3218847706703798,1101,3,SLC1A2|SLC1A3
POSITIVE REGULATION OF NUCLEOBASE-CONTAINING COMPOUND TRANSPORT%GOBP%GO:0032241,0.529179810725552,0.810782389252093,-0.342636769026135,-0.93658232846434,4025,7,CPSF6|DHX9|NCBP2|RBM27
PHOSPHATE ION HOMEOSTASIS%GOBP%GO:0055062,0.6749083005026489,0.882488012133495,0.37706343986958296,0.8284244356350949,4967,4,XPR1|TFAP2B
NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM%GOBP%GO:1905331,0.5295502092050209,0.8108997701936519,-0.29716190075603494,-0.9309694434218871,4049,10,TNF|PTEN|GATA3|TBX2|PHLDB2|SULF1
POSITIVE REGULATION OF EXOCYTOSIS%GOBP%GO:0045921,0.10047661986345499,0.436743648703065,-0.254581488099739,-1.3512910350541398,779,50,TSG101|ITGB2|RAB9A|SNX4|HGS|STX4|FGR|RAB7A|RAB27B|SYT4|HYAL3|CACNA1H|SDC4|CACNA1G|VAMP8|VAMP7|SNF8|ZP3|ATP6AP1|ITGAM|CACNA1I
ALLANTOIS DEVELOPMENT%GOBP%GO:1905069,0.225793598087395,0.608423003242004,0.888509042787825,1.1847069194945,1699,1,BMP7
ORGAN INDUCTION%GOBP%GO:0001759,0.40819846113027297,0.7445496113654559,-0.6368529458685871,-1.0598251423684002,3076,2,BMP2
HORMONE-MEDIATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0008628,0.308896321070234,0.680809181688249,-0.8426885752095279,-1.12266352363861,2308,1,SST
MORPHOGENESIS OF AN ENDOTHELIUM%GOBP%GO:0003159,0.340088912133891,0.701745885104582,-0.34925182154837103,-1.09416036542284,2600,10,STARD13|ACVRL1
COBALT ION TRANSPORT%GOBP%GO:0006824,0.105284280936455,0.446622176380284,-0.94497132774592,-1.25892870955431,786,1,SLC30A5
REGULATION OF THYMOCYTE APOPTOTIC PROCESS%GOBP%GO:0070243,0.8884213384009771,0.965159112268525,0.252440571397055,0.6532048157503461,6544,6,ZC3H8|TP53|BMP4|BLM|JAK3|ADAM8
REGULATION OF CELL ADHESION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0106088,0.43772575250836104,0.7635570545514341,-0.7826422584913979,-1.04266741179915,3271,1,SEMA6A
PROTEIN LOCALIZATION TO PRESYNAPSE%GOBP%GO:1905383,0.870218579234973,0.9573965249923859,0.22906044739117604,0.664922405555198,6369,8,DLG2|KIF5B|KIF5A|KIF5C
DEACTIVATION OF MITOTIC SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:1902426,0.49377926421404705,0.7923145426459479,-0.7567269519188349,-1.00814200081242,3690,1,CDT1
REGULATION OF T-HELPER 17 CELL DIFFERENTIATION%GOBP%GO:2000319,0.528963829208594,0.810751501668073,0.295696343915004,0.936786005145451,3889,10,LOXL3|NFKBID
NEGATIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR%GOBP%GO:2000780,0.7961392982913791,0.9299728593747351,-0.171579799899689,-0.7567507424751709,6103,27,PARPBP|KLHL15|AUNIP|POLQ|CXorf57|RMI2|OTUB1|MAGEF1
REGULATION OF EOSINOPHIL DEGRANULATION%GOBP%GO:0043309,0.6066595914035551,0.848985084775586,-0.55682382133995,-0.926643881533525,4572,2,F2RL1|STX4
NEGATIVE REGULATION OF ZINC ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071583,0.710718554920972,0.8964108318214721,0.643857520952801,0.858497126656157,5350,1,SLC30A1
POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS%GOBP%GO:0140131,0.214256619144603,0.597438672438672,0.352098830408913,1.23312351217089,1577,13,XCL1|ADAM17|CXCL13|PTK2B|OXSR1|ADAM10
STEROID HORMONE SECRETION%GOBP%GO:0035929,0.0569116476518971,0.34436604181231795,-0.844389302453819,-1.4051988272848999,428,2,INHBA|GHRL
REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE%GOBP%GO:0099159,0.787692307692308,0.927797067038212,-0.610002205558006,-0.812669407970552,5887,1,RHOA
DISSEMINATION OR TRANSMISSION OF ORGANISM FROM OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051821,0.30960286890689304,0.680809181688249,0.846217468019409,1.1283168110638,2330,1,NEDD4
NEGATIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS%GOBP%GO:2001271,0.8966675624832041,0.967092901483838,0.332303959413257,0.6536026737186851,6672,3,RFFL|RNF34
INACTIVATION OF MAPK ACTIVITY INVOLVED IN OSMOSENSORY SIGNALING PATHWAY%GOBP%GO:0000173,0.18086956521739103,0.554494792588896,-0.9074768416409351,-1.20897705110543,1351,1,MBIP
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY DIRECTED AGAINST TUMOR CELL TARGET%GOBP%GO:0002859,0.192107023411371,0.5665036350989531,-0.902459197176886,-1.20229234387183,1435,1,CEACAM1
POSITIVE REGULATION OF CELLULAR AMINE METABOLIC PROCESS%GOBP%GO:0033240,0.24708807747676997,0.6280519349499749,-0.556072409102479,-1.2173587435434399,1887,4,PARK7|HPRT1
CYTOPLASMIC SEQUESTERING OF PROTEIN%GOBP%GO:0051220,0.381677385483659,0.7296501420979891,-0.258421743922924,-1.05281204546615,2907,21,CCDC22|DBN1|FLNA|MDFI|PSMD10|NFKBIA|TMSB4X
POSITIVE REGULATION OF ARP2/3 COMPLEX-MEDIATED ACTIN NUCLEATION%GOBP%GO:2000601,0.0213571235469046,0.201765729070329,0.711271691508697,1.71060433928305,157,5,CYFIP1|ABI2|NCKAP1
MUSCLE CONTRACTION%GOBP%GO:0006936,0.00435116457640133,0.0731407797055425,-0.248344498222485,-1.6592049641176498,33,125,SCN4B|UTRN|TNNT2|MYL12B|GJA1|PGAM2|SNTB1|EDNRA|PIK3C2A|RYR2|MYH11|ATP1B1|GAA|TNNI2|TNNC2|ITGB5|TLN1|KCNN2|STAC3|MYOM1|CACNA1H|MYLK2|MYLK|LMOD1|LTB4R|PKP2|PXN|CACNA1G|FXYD1|DYSF|SULF1|KCNJ12|SLC6A8|MYL12A|TPCN2|EDNRB|KCNQ1|CHRNE|ACTG2|ASPH|VCL|IGSF22|PABPN1|CRYAB|SCN1B|KCNH2|VIM|KCNE4|ADRBK1|MYOF|ACTA2|EMD|MYL9|ALDOA
POSTSYNAPTIC SPECIALIZATION ORGANIZATION%GOBP%GO:0099084,0.425604626708728,0.7547028278218628,-0.37421164963343606,-1.02289085654269,3237,7,TMEM108|NRXN2
BEHAVIORAL RESPONSE TO NICOTINE%GOBP%GO:0035095,0.0226871349001494,0.20908271623893998,0.7489659736392209,1.6455101407778099,166,4,CHRNB1|CHRNB2|CHRNA5|CHRNA3
REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901993,0.38121693121693107,0.729499056535481,-0.5531598103010921,-1.08018091174044,2881,3,CDC25B|CDC25A|CDC25C
REGULATION OF PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0043254,0.35594306962431105,0.713672237213954,-0.13110263073847,-1.04622400973391,2775,328,HCLS1|CCL24|ARPC1A|PAXIP1|ARHGAP18|WAS|FES|HCFC1|DYRK1A|SMAD6|IQGAP2|PLEK|MMP1|NAPA|INS|ATXN2L|VCP|PIEZO1|CDK5RAP2|DHX36|WARS|DDX3X|THRA|LMOD1|SEC23A|JCHAIN|PTGER4|TAL1|VPS18|PARK7|HAX1|GTF2H1|MECP2|TAF7|ABL1|ARF1|TUBB4A|LDLRAD4|STX1B|PSMC4|KANK3|PSMC6|GSN|BAIAP2L1|CORO1B|APOE|MITF|HCK|CD36|CDC42EP4|ARPC5L|SRF|ARL2|SLIT2|NAV3|CRYAB|SEPT8|RASIP1|DDB1|PRRT2|DACT1|TLR4|HSP90AA1|EPS8|STYXL1|CDC42EP1|CDC42EP5|TMSB4X|SAR1B|NCK1|ARF6|PSMC5|CDC42EP2|PSMC3|XPA|EIF4G1|INSIG1|FBLIM1|GTF2H2
PURINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009145,0.0829469345698094,0.40084160589746504,-0.257774020167934,-1.3913528894926501,643,53,ATP5J|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|PGAM1|GAPDH|LDHA|STOML2|ATP5H|PGK1|ALDOA|ALDOC|ATP5G1
POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS%GOBP%GO:1902730,0.32625638269282503,0.6940781026265961,0.574390647402669,1.1297586208851398,2427,3,PXYLP1|TCF7L2|CTNNB1
PROTEIN K29-LINKED UBIQUITINATION%GOBP%GO:0035519,0.869018653690187,0.9566976576317809,0.280882047764048,0.675519714151332,6428,5,PARK2|UBE2D4|ITCH
PROTEIN DEGLYCATION%GOBP%GO:0036525,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
INDOLALKYLAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0046219,0.398857750033205,0.7388683667002129,0.801720335244817,1.06898588863411,3002,1,DDC
POSITIVE REGULATION OF PROTEIN MATURATION%GOBP%GO:1903319,0.0319204604918891,0.25402919087274106,-0.437434899022005,-1.62567746276696,243,16,F12|ADAM8|CLEC3B|ENO1|NKD2|GSN|CCBE1|MYH9|PHB
"TRNA 3'-TRAILER CLEAVAGE, ENDONUCLEOLYTIC%GOBP%GO:0034414",0.24120069066277103,0.6244696312630601,0.8807344508160571,1.17434055014805,1815,1,ELAC2
NEGATIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0010751,0.7330856991244359,0.907846576175861,-0.5003122184228811,-0.832599537394764,5525,2,THBS1
VACUOLE ORGANIZATION%GOBP%GO:0007033,0.7247616376892879,0.903635192226391,0.134589864392595,0.8511946735642509,5168,94,CCDC115|TP53INP1|NAGPA|HPS1|RAB39A|GABARAP|KIAA1324|ATG4B|ZKSCAN3|HPS4|RAB1A|RAB23|UBXN2A|MAP1LC3B|ULK3|AKTIP|CLVS2|ULK2|CLN5|TMEM199|VPS11|VPS41|ATG5|ATG16L1|MAP1LC3A|ATG14|MBTPS1|TP53INP2
UROPORPHYRINOGEN III BIOSYNTHETIC PROCESS%GOBP%GO:0006780,0.835342979635584,0.945788393670804,0.429059829059829,0.720875910977466,6234,2,SUCLA2|UROS
REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY%GOBP%GO:0001910,0.200051860495268,0.577896180140049,-0.241906440310265,-1.21149290873168,1542,41,CD1D|HLA-B|PVR|SERPINB9|MICA|NCR3|LILRB1|DNASE1L3|HLA-E|RIPK3|PIK3R6|HLA-C|HLA-A|FCGR2B|PVRL2|ICAM1|CEACAM1|STX7|HFE|LGALS9|FADD
REGULATION OF SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:0014910,0.0023495627202715103,0.0450881902785822,-0.44282281930543,-2.00223232478775,17,29,LRP1|PLAU|VTN|DOCK5|MEF2C|IGF1|CORO1B|FGF9|AIF1|PDGFRB|SLIT2|IGFBP5|SERPINE1|PDGFA|PDGFB
CELL DIFFERENTIATION IN HINDBRAIN%GOBP%GO:0021533,0.900859822824388,0.9684180373391851,-0.20981704563856798,-0.631181030711778,6914,9,CBLN1|CEND1
REGULATION OF PROTEIN K48-LINKED DEUBIQUITINATION%GOBP%GO:1903093,0.446560846560847,0.768043844625006,-0.5260390259398771,-1.02722089361753,3375,3,PARK7|UBXN1
POSITIVE REGULATION OF PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE ACTIVITY%GOBP%GO:0060585,0.826537388763448,0.943041978946366,0.585575650639612,0.780786116732756,6222,1,EDN1
NUCLEAR MRNA SURVEILLANCE OF MRNA 3'-END PROCESSING%GOBP%GO:0071031,0.00955160520031839,0.12416337026881699,-0.9360352908740001,-1.55771240731151,71,2,EXOSC3|EXOSC2
REGULATION OF DNA METHYLATION%GOBP%GO:0044030,0.18309674027339604,0.556308895147568,-0.47114423107673203,-1.28785174527118,1392,7,FAM129B|MECP2|SPI1|MYC
MOVEMENT IN HOST ENVIRONMENT%GOBP%GO:0052126,0.670988867059594,0.8815356925073421,-0.320129401710009,-0.82345905961101,5122,6,VPS4A|PPIA|RAB7A
CELLULAR RESPONSE TO ARSENIC-CONTAINING SUBSTANCE%GOBP%GO:0071243,0.31698063840921004,0.6861326333203311,-0.299498757227289,-1.11305334997203,2422,16,GSTO1|DAXX|GSTO2|ZC3H12A|HSF1|HNRNPA1|ATF3|PPIF|VCP|DHX36|DDX3X|MAPK13
INTEGRIN BIOSYNTHETIC PROCESS%GOBP%GO:0045112,0.0531103678929766,0.33407275089766497,-0.971768857520953,-1.29462945368101,396,1,COL5A1
REGULATION OF CHOLESTEROL IMPORT%GOBP%GO:0060620,0.8109698996655519,0.935269673284207,-0.597981914424349,-0.7966554939384108,6061,1,LAMTOR1
POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0060261,0.00248366013071895,0.0470078804855275,-0.586086655954018,-1.96168691370986,18,12,SUB1|PSMC2|PAXIP1|DHX36|PSMC4|PSMC6|SRF|PSMC5|PSMC3
REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL%GOBP%GO:2000535,0.94106090373281,0.9814174827908729,-0.23204769138936499,-0.5968891726773821,7184,6,CAV1
VESICLE DOCKING INVOLVED IN EXOCYTOSIS%GOBP%GO:0006904,0.7221540558963871,0.9019989179378242,0.18191652174834302,0.814166890586832,5296,27,RAB3B|RAB3D|RAB10|SNAP25|UNC13A|RAB15|VAMP3|VPS11
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030858,0.192517749863463,0.566989663811688,0.264436040117174,1.23355762751149,1409,31,FOXC1|PROC|CYP27B1|TRIM16|PAX8|AHI1|RFX3|TMEM100|BTG1
OXIDISED LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0150024,0.154515050167224,0.5226559938356611,-0.9209307454786059,-1.22690088149003,1154,1,CD36
SEMICIRCULAR CANAL DEVELOPMENT%GOBP%GO:0060872,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
POSITIVE REGULATION OF TOLERANCE INDUCTION%GOBP%GO:0002645,0.21883219358232503,0.6013948176405761,-0.51817201481899,-1.24195944319982,1663,5,CD274|IRAK3|LILRB2|TGFBR2
PYRIDINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0072524,0.0351861295257522,0.267547057426989,-0.24305644156001396,-1.48690259411926,275,85,PARP9|NADK|TKT|GPD1|GPI|PFKFB2|NUDT17|HK1|VCP|KYNU|HK3|PDXP|HAAO|ENO1|BST1|PGAM1|GAPDH|FMO2|LDHA|PDHX|PNPO|NMNAT3|PNP|PGK1|TALDO1|QPRT|PDXK|NNMT|ALDOA|ALDOC|PTGIS
REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS%GOBP%GO:1900125,0.0777222514466071,0.39016617344869897,-0.6156518861681011,-1.4756000939521,590,5,AP2A1|TGFB1|CLTC|NFKB1|PDGFB
CELLULAR ALKENE METABOLIC PROCESS%GOBP%GO:0043449,0.346086956521739,0.703504080836324,-0.823775915306573,-1.09746731945042,2586,1,GRIN1
DNA DEALKYLATION%GOBP%GO:0035510,0.250656512605042,0.631479765290861,-0.29473761089490697,-1.1824816496730601,1908,20,APOBEC3G|APOBEC3C|APOBEC3B|APEX1|ALKBH3|APOBEC3F
MICROTUBULE-BASED PEROXISOME LOCALIZATION%GOBP%GO:0060152,0.167872454448017,0.5400872099036179,0.757871519161842,1.2733220049446499,1252,2,PEX13|PEX1
CERAMIDE TRANSPORT%GOBP%GO:0035627,0.17280917280917302,0.546371269738967,0.42557531995082704,1.2932841465221498,1265,9,ABCB1|ABCB4|PLEKHA3
GLYCOSYL COMPOUND CATABOLIC PROCESS%GOBP%GO:1901658,0.126334983068507,0.48219259151821897,-0.289518352012978,-1.33426649630434,969,31,ADA|GLA|APOBEC3G|TYMP|APOBEC3C|HPRT1|ABHD10|CDA|FUCA1|NUDT18|ENPP4|PNP
AXO-DENDRITIC TRANSPORT%GOBP%GO:0008088,0.701754385964912,0.8931369333627571,0.157777729530029,0.8467194931619809,5079,50,DCTN1|DLG2|KIF3B|TRAK2|BLOC1S3|HAP1|DST|AP3B2|KIF5B|AP3B1|KIF5A|SPG11|TRAK1|SPAST|KIF1A|AP3M1
DIENCEPHALON DEVELOPMENT%GOBP%GO:0021536,0.0217155266015201,0.20379481798657503,0.5181135463056971,1.7049117098525,159,11,DRD2|HESX1|PTCHD1|CHRNB2|RAB3GAP1|ADCYAP1|LRP6
CATECHOL-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0009712,0.229367777022434,0.61138898362603,0.28831586934614195,1.2065882235377299,1686,22,DRD2|INSM1|PARK2|DRD4|ATP7A|MAOB|DDC
PROTEIN TRANSPORT WITHIN LIPID BILAYER%GOBP%GO:0032594,0.24095730214849104,0.6244696312630601,0.304897094431041,1.1934973237678501,1771,18,RFTN1|CACNG7|RILPL1|LRRC7|CACNG4|VPS35|RAB11A
CHAPERONE-MEDIATED PROTEIN TRANSPORT INVOLVED IN CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:0061741,0.7163703900238789,0.899551221015245,-0.509567135373587,-0.8480011991732329,5399,2,HSPA8|CLU
DIADENOSINE HEXAPHOSPHATE CATABOLIC PROCESS%GOBP%GO:1901909,0.7360293155346159,0.908157084784786,-0.35559109356837504,-0.7784632357147929,5623,4,NUDT11|NUDT4
POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION%GOBP%GO:1901970,0.35213652944241797,0.7106060713647829,-0.35973084848784,-1.08215844445024,2702,9,DLGAP5|CDT1|ANAPC5|ESPL1|ANAPC11
REGULATION OF PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0042306,0.333376455368693,0.6971906052358929,-0.226244685257546,-1.08943147397339,2576,36,TGFB1|PSEN1|HYAL2|APOD|JUP|ECT2|TRIM28|HCLS1|GAS6|MDFIC|BAG3|PDE2A|FLNA|IGF1|RBM22|TMEM173
TROPANE ALKALOID METABOLIC PROCESS%GOBP%GO:0046448,0.43505016722408,0.762034923704788,-0.783579620644023,-1.0439162032603702,3251,1,BCHE
REGULATION OF GUANYLATE CYCLASE ACTIVITY%GOBP%GO:0031282,0.176306712655877,0.548366806412612,-0.7480562448304391,-1.24488521458544,1328,2,GUCA1A|NOS3
RESPONSE TO ALKALOID%GOBP%GO:0043279,0.260651968077912,0.6363935195840029,0.292442177243657,1.16593300731314,1926,19,DRD2|SPIDR|GSTM2|DRD4|CHRNB2|RYR1|TRPV1|SRR|SLC8A1|CASP3
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030511,0.329177057356608,0.695646600584197,-0.27006570286279397,-1.1002496180276298,2507,21,CDKN2B|SNW1|MEN1|GIPC1|THBS1|DAB2
OTIC VESICLE DEVELOPMENT%GOBP%GO:0071599,0.00905650175723168,0.12018006859095698,0.747904257666005,1.7987054508215201,66,5,FGFR2|PAX8|AHI1|CEP290|PROX1
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE%GOBP%GO:1900103,0.900576368876081,0.96834471139831,-0.197012906411494,-0.6378398841957149,6874,11,XBP1|TMEM33|BAK1|PTPN1|BCL2L11|DAB2IP|ERN1
ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE%GOBP%GO:0072666,0.22135630298058498,0.603834909184891,0.24679340584548898,1.19621115023689,1618,35,NAGPA|CACNG7|GCC2|VPS36|SCARB2|VPS13C|SNX16|NEDD4|VPS13A|CACNG4|AP4M1|ZFYVE16
REGULATION OF LEUKOCYTE PROLIFERATION%GOBP%GO:0070663,0.000128667009778693,0.00518555396908895,-0.367453622982226,-2.43223878118927,0,120,FOXP3|CD1D|SOX11|HLA-DMB|JAK3|SYK|NFATC2|CD274|MNDA|HLA-DPA1|GREM1|CD38|LILRB1|HLA-E|LYN|GPR183|NDFIP1|CD209|TNFSF13B|PYCARD|NCKAP1L|VAV3|CD74|TNFRSF14|IL18|RIPK3|CCL19|TWSG1|CCDC88B|HLA-DPB1|PDCD1LG2|SPN|AHR|EBI3|FCGR2B|PLA2G2D|IL6ST|TNFAIP3|MAPK8IP1|MZB1|LILRB2|GPNMB|PRKAR1A|MEF2C|SDC4|FGF10|BST1|TNFRSF4|IGF1|CEBPB|ICOSLG|VCAM1|C10orf54|CSF1|CD300A|LST1|CD86|LGALS3|TGFBR2|TNFRSF21|LGALS9|ZP3|FADD|AIF1|PNP|ANXA1|CD55|GSTP1|NCK1|TFRC|CD81|TNFRSF1B|PRNP
HEART MORPHOGENESIS%GOBP%GO:0003007,0.0157236757314087,0.16986287918320903,-0.23638284030295104,-1.55183229837306,121,115,TBX1|ZFPM2|SOX18|RYR2|SOX17|CLDN5|FOXN4|SPRY1|SMO|CPE|SFRP2|GATA3|SMAD6|TBX2|MYOM1|MYLK2|HES1|MESP1|EFNA1|NOTCH1|ELN|MEF2C|S1PR1|PKP2|SNAI2|NOTCH2|MICAL2|DLC1|GATA6|NOS3|NRP2|TGFBR2|BMP2|TGFBR3|TEK|SRF|IGSF22|DCHS1|SLIT2|FKBP1A|DNAAF1|SNAI1|EPHB4|ENG|ACVRL1
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION%GOBP%GO:0086065,0.324452901998097,0.692794968343412,0.237312852741036,1.09868647513759,2386,30,TRPM4|FKBP1B|SCN5A|ANK2|TNNI3K|RNF207|GJC3|CACNA1C
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS%GOBP%GO:0010714,0.109202936549554,0.45349438410841897,-0.39283966677602594,-1.38980929465023,832,14,TGFB1|RGCC|TGFB3|CREB3L1|C10orf54|F2R|VIM|SERPINF2
LYMPHOCYTE HOMEOSTASIS%GOBP%GO:0002260,0.0305854555001313,0.247447840028175,-0.44815525273982304,-1.62717907728008,232,15,AKT1|FOXP3|JAK3|DOCK11|DOCK10|LYN|NCKAP1L|RIPK3|TNFAIP3|MEF2C|FADD
INTERLEUKIN-8 SECRETION%GOBP%GO:0072606,0.7658092175777059,0.9198931204978891,0.46564155448356004,0.7823379329470942,5715,2,RAB1A
PTERIDINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0042559,0.43892508143322495,0.76475941858134,0.305978097793348,1.00685582456954,3233,11,SPR|PTS|QDPR|MTHFD1L|DHFRL1
CELLULAR RESPONSE TO INTERLEUKIN-8%GOBP%GO:0098759,0.981939799331104,0.993436724391485,-0.50904278782532,-0.6781672217648139,7339,1,EGR1
PURINE RIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009154,0.0237970711297071,0.215592612132976,-0.4320542124774229,-1.6765310296788702,181,18,PDE4D|NUDT16|PDE2A|HPRT1|NUDT18|NUDT4|ABCD1|HINT1
FACE MORPHOGENESIS%GOBP%GO:0060325,0.8924979614025551,0.965443067117994,0.173435245019724,0.6530412182744151,6566,16,STRA6|CRISPLD1|RAB3GAP1|SKI|LRP6
CENTROSOME DUPLICATION%GOBP%GO:0051298,0.9649146757679179,0.990916952887267,0.130370359063307,0.568012729173746,7067,25,CNTROB|BRCA2|PKD2|BRSK1|ARHGEF10
LOOP OF HENLE DEVELOPMENT%GOBP%GO:0072070,0.0723472668810289,0.378321151505122,0.8341328921974079,1.4014509581488401,539,2,PKD1|PKD2
REGULATION OF BONE TRABECULA FORMATION%GOBP%GO:1900154,0.595317725752508,0.8442752964756541,-0.706495368328187,-0.941221470155173,4449,1,GREM1
REGULATION OF CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1905310,0.314141682143805,0.683550177109913,-0.6779536548207641,-1.12822329456234,2367,2,ENG
REGULATION OF MRNA 3'-END PROCESSING%GOBP%GO:0031440,0.0070339976553341205,0.10102825149798,-0.43482826506103395,-1.8746055790974598,53,25,CCNT1|CPEB3|AHCYL1|HSF1|CPSF6|ZC3H14|ZFP36L1|NCBP2|DHX36|PAPOLA|NCBP1|CTR9|RNF20|CPEB1|RNF40|CPSF7
PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:0070585,0.027218782249742002,0.23271567002476898,-0.271528314402565,-1.5527576465703703,210,66,TOMM70A|TIMM21|ROMO1|AIP|IMMP1L|TIMM10B|TIMM9|TIMM17B|DNAJA1|HSP90AA1|TOMM5|HSPA4|TIMM10|UQCRC2|DNAJC19|BAD|DNAJC15
NEGATIVE REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:2000740,0.506488294314381,0.798168488166378,-0.7508270842523159,-1.00028196043885,3785,1,REST
GLYCEROLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0045017,0.476071922544952,0.7850084910380921,0.137984819453214,0.98991486182861,3441,167,GPAT2|PLD2|LPIN1|MTMR6|SLC44A5|PLEKHA1|INPP5K|PGAP2|LCAT|AGPAT4|FIG4|PIP4K2C|INPP5J|PIGF|PGAP1|SLC27A1|FGF2|PLEKHA3|PIKFYVE|MTMR9|LPCAT2|PIGU|PLA2G6|IMPA1|MTMR2|PIGL|CDS1|INPP5F|PGAP3|PI4K2B|LPCAT4|DGKQ|INPP4A|CPNE3|PIGO|PIGG|INPPL1|PIGT|PISD|DGAT2|CECR5|GNPAT|SLC44A3|SBF1|CPNE1|CHKB|PITPNM2|CRLS1|EPT1
NEGATIVE REGULATION OF PROTEIN ACTIVATION CASCADE%GOBP%GO:2000258,0.000925925925925926,0.0217816182659933,-0.923789566560053,-1.8039268899886298,6,3,A2M|CD55|SERPING1
REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0061050,0.46224316188980497,0.7760755275808051,-0.45264396752688296,-0.9909322645056741,3531,4,IGF1
"REGULATION OF PROTON-TRANSPORTING ATPASE ACTIVITY, ROTATIONAL MECHANISM%GOBP%GO:0010849",0.45297658862876294,0.769943206592495,-0.7745919717688579,-1.03194249689689,3385,1,PPIF
RESPONSE TO MUSCLE INACTIVITY%GOBP%GO:0014870,0.11999462510077902,0.47202636254014396,0.6918663094157951,1.36081938502476,892,3,SCN5A|HDAC4
GERMINAL CENTER FORMATION%GOBP%GO:0002467,0.43711367911851706,0.7635570545514341,0.520165479827428,1.0231041152554101,3252,3,ADAM17|CXCL13
POSITIVE REGULATION OF CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000724,0.1838127090301,0.556308895147568,-0.906263784737538,-1.20736096803796,1373,1,GPER1
GLUCOSE IMPORT%GOBP%GO:0046323,0.14991961414791,0.516823216049862,0.7714364488558041,1.29611283826947,1118,2,RAB4B|SORT1
GENITALIA MORPHOGENESIS%GOBP%GO:0035112,0.910503751339764,0.9720943283119721,0.38158257513096205,0.6411079943405821,6795,2,LRP6|NIPBL
GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009065,0.5322361262241571,0.812079525085925,0.274771647505573,0.933895386251924,3912,12,DDAH1|GLS|ADHFE1|GLUD1
NEURON APOPTOTIC PROCESS%GOBP%GO:0051402,0.7169021454735741,0.8997132791139629,-0.21683459188456602,-0.8058413033873599,5479,16,GAPDH|TNFRSF21|NGFR
CELL PROLIFERATION%GOBP%GO:0008283,0.000384418247052793,0.0111294649577428,-0.208901662789022,-1.6821136487403798,2,347,STC1|KITLG|ISG20|USP13|CD40|ARHGEF2|CTF1|TRAIP|FURIN|APPL1|C6orf89|TGFB2|DDX41|AKT1|PA2G4|ADRA1B|SRRT|RAF1|SIPA1|SOX11|FSCN1|SYK|CD180|TACC3|RACGAP1|UBE2L3|PTEN|THAP1|NRARP|SKP2|ARTN|MTSS1|FBXL7|VTI1B|CXCL1|ID2|KIF15|TMEM14B|SLC29A2|LILRB1|PAK4|PIM2|PLCE1|MKI67|DLGAP5|TNFSF13B|MAPRE2|CD74|SOX5|KANK1|HDGF|RPS6KA1|EDNRA|SETMAR|RUNX1|TNFSF8|ACHE|TBX1|BTBD10|TSPO|FTSJ2|TCF19|DNPH1|SBDS|NUMB|NRD1|CD34|RORA|SFRP2|C3orf58|CMC4|TPX2|FES|CBFA2T3|NUDC|LARP1|CDV3|HLCS|LY86|GAS6|PCNA|IL15RA|DDR2|BCAR1|MIA|MATK|VTN|ILK|CDC25C|MELK|ELN|SRA1|MEF2C|LGI1|PTPN6|PRKD1|IL2RA|UHRF1|MSN|SLC11A1|OSM|FGF10|PIM1|RBBP7|CDC27|HMOX1|PYY|RAPGEF3|TNFRSF4|IGF1|CEBPB|FAP|IFI16|CTPS1|NUPR1|CSF1|DKC1|CEACAM1|EPHA2|PLK1|CDK7|NOV|TGFBR2|BMP2|TGFBR3|BST2|CREG1|TEK|ATOH8|MAP3K11|FGF7|SEMA5A|PDGFRB|ERG|MNAT1|CX3CL1|TACC1|DDIT4|TRNP1|YAP1|EMP1|WNT3|DAB2|BOP1|POLA1|CSF1R|NF2|EPS8|ATF5|CSGALNACT1|GSTP1|PRMT5|CRIP1|IGFBP4|CD81|ACVRL1|MRPS27|PDXK|SERPINF1|LOXL2|ERN1|ALKBH3|BAD|INSIG1|EMP2
REGULATION OF B CELL APOPTOTIC PROCESS%GOBP%GO:0002902,0.7215997915581029,0.9019989179378242,-0.262895427690691,-0.79085379604984,5538,9,FOXP1|BCL6
CELLULAR RESPONSE TO TEMPERATURE STIMULUS%GOBP%GO:0071502,0.776588628762542,0.924260458565322,-0.6165637406263779,-0.821410948199106,5804,1,TRPM2
DTMP BIOSYNTHETIC PROCESS%GOBP%GO:0006231,0.282316581564096,0.654732517474162,0.5972707652660639,1.17476111269089,2100,3,DCTD|CDADC1
STRIATED MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051146,0.179193147278254,0.552217661346327,0.216491149750355,1.2233044747822701,1296,60,NEBL|CHRNB1|ACVR1|ADGRB3|CBY1|TMOD3|OBSCN|SDC1|ALPK3|DMD|NEB|MYEF2|WDR1|RYR1|AKAP13|TPM1|SKI|SORT1|OBSL1|PROX1|CFLAR|TMOD1|SLC8A1|KCNH1|TMOD2
CELL WALL MACROMOLECULE CATABOLIC PROCESS%GOBP%GO:0016998,0.123920839420906,0.47832576509682107,0.9394022937803259,1.25256620252128,932,1,MANBA
ESTABLISHMENT OF EPITHELIAL CELL APICAL/BASAL POLARITY%GOBP%GO:0045198,0.93371757925072,0.9800972968717879,-0.18520028756056398,-0.599595895123303,7127,11,SYNE4|RHOA|SH3BP1|CDC42|SLC9A3R1|MSN
DENDRITE ARBORIZATION%GOBP%GO:0140059,0.64281956864808,0.8685358462393961,-0.3526405572390421,-0.8452121256900859,4887,5,TAOK2|SEMA3A
NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:0032413,0.0209646478487257,0.199767280220222,0.32690905503396994,1.61988212514324,152,38,FKBP1B|CRHR1|TCAF2|GSTM2|C19orf26|EPHB2|DRD4|GNB5|PRKCE|SRI|SUMO1|NEDD4|PKD2|YWHAE|CAMK2D|NEDD4L
REGULATION OF EXOCYST LOCALIZATION%GOBP%GO:0060178,0.0931066542701554,0.422068646506606,0.954620644022938,1.27285781911433,700,1,RALB
REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036491,0.9672131147540981,0.9912626134248801,0.282232270872394,0.5551175712068089,7197,3,EIF2AK3|EIF2AK4|DNAJC3
ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0030218,0.28506256517205397,0.658128904006822,-0.244004145541135,-1.13501109798388,2186,32,FLVCR1|JAK3|ACIN1|LYN|CEBPG|NCKAP1L|DYRK3|HCLS1|MED1|ATPIF1|INHBA|RPS14|HSPA9|TAL1|TGFBR3
NEGATIVE REGULATION OF CHROMOSOME SEPARATION%GOBP%GO:1905819,0.736213235294118,0.908157084784786,-0.197756623569084,-0.793395786040777,5606,20,ZNF207|TRIP13|KLHL22|APC|CDC20|PTTG1|MAD2L1|PLK1|IK
"REGULATION OF CD8-POSITIVE, ALPHA-BETA CYTOTOXIC T CELL EXTRAVASATION%GOBP%GO:2000452",0.174714778455824,0.54811765844537,-0.749159084642956,-1.24672051639082,1316,2,RIPK3|FADD
VASCULATURE DEVELOPMENT%GOBP%GO:0001944,0.000127844541038098,0.00518555396908895,-0.322794420025848,-2.3804094748717404,0,206,FLT1|APOD|ADM|JAG1|IL18|ADAM8|ANGPT2|EPHB3|TBX1|SAT1|SOX18|COL23A1|SOX17|FGFR4|KDR|FZD4|TMEM204|PLXND1|LRP1|CD34|RORA|APOLD1|MED1|FOXS1|SFRP2|CYP1B1|EGFL7|AHR|PRCP|ATPIF1|TBX2|VEGFC|THY1|HES1|FOXC2|MESP1|ITGA5|ATP5B|MYLK|NDST1|FLT4|NOTCH1|MEF2C|S1PR1|CALCRL|HOXB3|COL4A1|JMJD6|HMOX1|LOX|PIK3R3|RECK|LRP5|CCL2|CEACAM1|PDPN|ROBO4|APLNR|GATA6|VEGFB|NOV|CCBE1|NRP2|ADIPOR2|TGFBR2|TGFBR3|THBS1|TEK|COL1A2|COL1A1|SEMA5A|SRF|PDGFRB|SEMA3E|ERRFI1|SLIT2|ID1|NR2F2|SERPINE1|CAV1|ADGRA2|RASIP1|MYH9|ANG|EPHB4|TGFBI|ADGRG1|PDGFA|ANXA2|PDGFRA|ACTA2|ENG|ACVRL1|PDGFB|LOXL2|SERPINF2
TRANSLATION REINITIATION%GOBP%GO:0002188,0.6072751322751321,0.8492159043277758,-0.45343403541867205,-0.885441748788818,4590,3,DENR|MCTS1
TRABECULA FORMATION%GOBP%GO:0060343,0.0015704750687082802,0.0323893370023386,-0.8763517584225841,-1.91851718961801,11,4,TGFBR3|TEK|FKBP1A
L-METHIONINE SALVAGE%GOBP%GO:0071267,0.731325618095739,0.9074802896081321,-0.327001753281015,-0.7837608049367958,5560,5,ADI1|APIP
PROTON-TRANSPORTING V-TYPE ATPASE COMPLEX ASSEMBLY%GOBP%GO:0070070,0.48898912178296605,0.788908801349022,-0.603755643954099,-1.0047459393261802,3685,2,VMA21
CELL RECOGNITION%GOBP%GO:0008037,0.00679574304398,0.0988965734194664,-0.27120259481214004,-1.6700786491939599,52,88,NPTN|NEXN|APP|IGHG1|EPHA3|GAP43|UBAP2L|ROBO1|IGHV2-26|PRF1|ST6GALNAC6|IGHV1OR15-1|PCDHA7|NCR3|IGHV5-51|FCN3|CD209|IGHV1-24|CORO1A|CCL19|IGHV3-49|EPHB3|IGHG4|AMIGO1|IGLL5|PCDHB6|IGHV4-4|CLEC4M|PCDH12|IGHV4-61|DSCAM|IGHV1-3|MSN|IGHV3-43|VCAN|FCN1|IGHV3-73|CLEC7A|ROBO4|COLEC12|ZP3|POMZP3|IGHV3-15|SEMA5A|EPHA4|B4GALT1|IGHV1-18|CSGALNACT1|FOLR2|IGHG2|IGHA1|ALDOA|ADGRB1
RESPONSE TO SALT STRESS%GOBP%GO:0009651,0.47528916929547793,0.784986345464663,-0.358408419168479,-0.979693430801737,3615,7,TNF|KMO|AQP1|ZFP36L1
POLARIZED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030859,0.7674102285092491,0.9202818175694271,0.224004331434775,0.7613471532689341,5641,12,RAB10|CAMSAP3|MYO9A|EZR
POSITIVE REGULATION OF SUBSTRATE ADHESION-DEPENDENT CELL SPREADING%GOBP%GO:1900026,0.265725120962469,0.641154728436237,-0.28104948033150606,-1.1638990247969099,2031,22,RREB1|DOCK5|S100A10|ABL1|CALR|FLNA|DOCK1|NEDD9
PROTEIN K29-LINKED DEUBIQUITINATION%GOBP%GO:0035523,0.7348514592330849,0.9080640961318549,-0.35587051232559397,-0.7790749417833599,5614,4,ZRANB1|YOD1|USP13|TNFAIP3
REGULATION OF SYNAPTIC MEMBRANE ADHESION%GOBP%GO:0099179,0.63438127090301,0.863354277348854,-0.6874724305249229,-0.915878349324491,4741,1,MDGA1
RNA INTERFERENCE%GOBP%GO:0016246,0.479144095341279,0.7851559026823699,0.26483726230029603,0.9768754905566991,3537,15,HENMT1|PRKRA|MRPL44|AGO2|AGO3
NEGATIVE REGULATION OF MALE GONAD DEVELOPMENT%GOBP%GO:2000019,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
BRANCH ELONGATION INVOLVED IN URETERIC BUD BRANCHING%GOBP%GO:0060681,0.454774870500731,0.77085243169122,0.7735443317159242,1.03141698979697,3423,1,FGF1
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902236,0.14285714285714302,0.509224524936966,-0.388620500343165,-1.33770712420896,1090,13,TMBIM6|OPA1|CREB3|PARK7|CREB3L1|HERPUD1|SYVN1
POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION%GOBP%GO:0045672,0.143942370661428,0.510346735286642,-0.5242076653190321,-1.3484033294621203,1098,6,CSF1|CCR1|ATP6AP1
PRIMITIVE STREAK FORMATION%GOBP%GO:0090009,0.442024173196972,0.7653693162885199,0.780381561535068,1.04053351319385,3327,1,LRP6
NEGATIVE REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0045843,0.6003525901817199,0.8464076674715391,0.246248171531911,0.8851072959109351,4426,14,DKK1|SOX6
POSITIVE REGULATION OF OOGENESIS%GOBP%GO:1905881,0.530278670953912,0.811490026766563,0.578594142211307,0.972112864228641,3957,2,PDE3A|SIRT2
POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0042307,0.265468281880943,0.640784173769173,-0.269488448309977,-1.1618024615609799,2037,25,TGFB1|PSEN1|HYAL2|JUP|ECT2|TRIM28|HCLS1|BAG3|FLNA|IGF1|RBM22|TMEM173
HYPOTONIC RESPONSE%GOBP%GO:0006971,0.5529872938632061,0.8231366946320219,0.377788624262344,0.9085794749178999,4090,5,SLC12A5|SLC12A6|CAB39
NOREPINEPHRINE METABOLIC PROCESS%GOBP%GO:0042415,0.500676223965377,0.795595753702803,0.34357455666623493,0.9484283415969609,3701,7,INSM1|ATP7A
IMMUNE RESPONSE-INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002767,0.102513227513228,0.44119583182083205,-0.7100474247270321,-1.38654265971189,774,3,LILRB1|LYN|LILRB2
CALCIUM ION REGULATED LYSOSOME EXOCYTOSIS%GOBP%GO:1990927,0.876227115945874,0.960725750963158,-0.41706145495896,-0.6940569541927789,6604,2,SYT7
NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS%GOBP%GO:0090305,0.288222478533897,0.66139011597615,-0.164829872927168,-1.09770964524792,2248,123,DNASE1L3|RFC2|CUL4B|RPA2|H1F0|SETMAR|RFC3|HMGB2|NCBP2|PARP1|ABT1|DNASE1L2|POLD4|KPNB1|PCNA|PDE12|POLD1|NCBP1|POLD2|NUDT16|RFC5|GTF2H1|RNASE4|CSTF3|RNASE6|UBC|EXOSC3|DDB1|RNASE1|TUT1|CPSF7|RFC4|MUS81|EXOSC2|ENDOG|DNASE1L1|XPA|ERN1|FEN1|GTF2H2
POSITIVE REGULATION OF FATTY ACID TRANSPORT%GOBP%GO:2000193,0.0931815207433582,0.422068646506606,-0.6496442949318921,-1.4222071616624798,711,4,IL1B|P2RX4|TNFRSF11A|PLA2R1
RDNA CONDENSATION%GOBP%GO:0070550,0.772307692307692,0.9215496572020819,-0.6184384649316279,-0.82390853112155,5772,1,NIPBL
GLANDULAR EPITHELIAL CELL MATURATION%GOBP%GO:0002071,0.479877805817506,0.785690196949452,0.7607520952801059,1.0143602686028101,3612,1,NKX6-1
COPPER ION HOMEOSTASIS%GOBP%GO:0055070,0.0475317533062721,0.312255783864335,-0.456270664937805,-1.5705721095925098,362,13,CCDC22|ARF1|MT2A|XIAP|ATOX1|PRNP
APICAL JUNCTION ASSEMBLY%GOBP%GO:0043297,0.8075251290410219,0.9339635213386659,0.166346674896663,0.753631955716245,5944,28,RHOC|RAB13|PARD3|WDR1|MLLT4|STRN|CLDN3|PDCD6IP|CTNNA1|PARD6A|PRKCI|PARD6B|RAMP2|INADL|PKN2
POSITIVE REGULATION OF PYRROLINE-5-CARBOXYLATE REDUCTASE ACTIVITY%GOBP%GO:1903168,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
DETERMINATION OF HEART LEFT/RIGHT ASYMMETRY%GOBP%GO:0061371,0.418487165483342,0.75036705317022,0.22014520680855804,1.02694700351155,3064,31,BBS5|NPHP3-ACAD11|DLL1|BBS4|AHI1|SETDB2|MKKS|NPHP3|PKD2|CCDC40|BBS7|MEGF8
IRON IMPORT INTO THE MITOCHONDRION%GOBP%GO:0048250,0.49852625937834905,0.794989907195277,0.591894127377998,0.9944585565392778,3720,2,SLC25A28|SLC25A37
REGULATION OF SYNAPSE ASSEMBLY%GOBP%GO:0051963,0.18796889919519802,0.561398185675687,0.260172352971826,1.2389530729763603,1377,33,SLITRK1|SLIT1|EPHB2|VSTM5|ROBO2|AGRN|CHRNB2|PTPRD|CUX2|VPS35|SYNDIG1|NLGN2
REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY%GOBP%GO:1904872,0.390036610878661,0.7358910495632479,-0.27059442997538896,-1.05000702506913,2982,18,SHQ1|NOP10|RUVBL2|CCT2|DCP2|NHP2|CCT7|CCT3|RUVBL1|CCT8|CCT5|DKC1
NEGATIVE REGULATION OF MONOCYTE EXTRAVASATION%GOBP%GO:2000438,0.5187959866220739,0.8047799431921201,-0.7429422143802379,-0.989777420500336,3877,1,PLCB1
NEGATIVE REGULATION OF NF-KAPPAB TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0032088,0.0833762886597938,0.40198233213653706,-0.24423017905328198,-1.37542919765877,646,62,PYCARD|PARP10|TRIM21|IRAK3|DAB2IP|KLF4|ADORA3|CYP1B1|CDKN2A|ERBB2IP|TNFAIP3|CCDC22|ARRB1|IRAK1|PSMD10|NLRP3|NFKBIA|BRMS1|CD200|TRAF3|HAVCR2|CMKLR1|TMSB4X|PTGIS
REGULATION OF B CELL CHEMOTAXIS%GOBP%GO:2000537,0.0716773847802787,0.3767214120425879,0.8351254480286742,1.40311858009944,534,2,XCL1|PTK2B
PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009220,0.8087539432176658,0.9342433549901921,-0.26134308307083304,-0.7143696631456959,6152,7,CTPS1|UMPS
INTERLEUKIN-23-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038155,0.312508185985593,0.68160868787154,-0.43844160672609,-1.1277899225765502,2385,6,STAT3|P4HB
BILE ACID AND BILE SALT TRANSPORT%GOBP%GO:0015721,0.329972502291476,0.6957352559323989,-0.32018757855880897,-1.10214773678464,2519,13,SLCO2B1|ATP8B1|SLC51A|CEACAM1
NEURONAL STEM CELL DIVISION%GOBP%GO:0036445,0.22355180853957002,0.606760475740296,0.38473495139619396,1.21886633221907,1643,10,FGFR2|TEAD3|RAB10
DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002371,0.020096463022508,0.195205495598712,0.907692307692308,1.5250402738208602,149,2,CAMK4|KIT
"POSITIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043372",0.19011506276150603,0.563750965709003,-0.324557291270856,-1.25940299622133,1453,18,MYB|IL12RB1|MALT1|RARA|FOXP3|NFKBIZ|NCKAP1L|IL18|CCL19|SOCS1|CD86|NLRP3|LGALS9|ANXA1
SARCOSINE CATABOLIC PROCESS%GOBP%GO:1901053,0.985016722408027,0.9944441562911079,-0.50766431407146,-0.676330763733605,7362,1,SARDH
"REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME, TELOMERIC REGION%GOBP%GO:1904814",0.339276350288411,0.701030023347021,-0.31042889028324,-1.0982520186526499,2587,14,CCT2|GNL3L|CCT7|GNL3|CCT3|CCT8|CCT5|DKC1|H2AFY
"REGULATION OF GLUTAMATE SECRETION, NEUROTRANSMISSION%GOBP%GO:1903294",0.22473103997874902,0.6078034241178771,0.8889501543890609,1.1852950822943,1691,1,RAB3GAP1
CENTROSOME LOCALIZATION%GOBP%GO:0051642,0.35553139440065207,0.7132037834765931,0.287504798899209,1.0825509204402401,2615,16,IFT20|NDEL1|RANBP2|GPSM2|KIF5B|EZR
GLOMERULAR MESANGIAL CELL DEVELOPMENT%GOBP%GO:0072144,0.00291854603343062,0.0539442420308532,-0.9667493796526049,-1.6088255625911798,21,2,ACTA2|PDGFB
PEPTIDYL-ASPARTIC ACID PHOSPHORYLATION%GOBP%GO:0018217,0.676716695444282,0.8835592822191172,0.6609505955006619,0.881288435148356,5094,1,ATP13A2
POSITIVE REGULATION OF MICROGLIAL CELL MIGRATION%GOBP%GO:1904141,0.129477314937649,0.487857553689733,-0.7792666115246759,-1.29682425567754,975,2,P2RX4|CSF1
PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046135,0.6633494827811971,0.879862677092874,-0.24437133275292802,-0.8411735162899769,5065,13,APOBEC3G|TYMP|APOBEC3C|CDA
RNA METHYLATION%GOBP%GO:0001510,0.21734327533830397,0.5996151428055749,0.20726824968353,1.1829713949606002,1573,62,FDXACB1|HENMT1|TRMT6|ALKBH8|ZC3H13|METTL1|TFB1M|TRMT44|MTERF4|TRMT1|RNMTL1|METTL14|NSUN4|GTPBP3|TGS1|NSUN3|WBSCR22|TRMT1L|TRMT61B|CMTR1|TFB2M|CMTR2|THUMPD3|TRMT13|FTSJ3|THUMPD2|EMG1
PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL%GOBP%GO:0070646,0.007013516959959189,0.100912992505547,-0.19796041427831698,-1.5066781229726398,54,245,USP25|UCHL5|USP9X|PSMD3|TOR1A|PSMB2|RUVBL1|USP30|GATA3|HCFC1|TOMM20|OGT|PSMF1|BRCC3|COPS6|VCP|TRAF2|TNFAIP3|SIAH2|PSMD4|SENP2|SENP5|USP51|SMURF2|PSME2|USP32|IFIH1|BRCA1|PSMB5|TFPT|RAD23B|TNIP1|FOXK2|PSMC4|USP2|NEDD8|INO80E|TAF9B|PSMC6|IL33|USP44|PSMD10|USP47|USP11|NLRP3|NFKBIA|PSMB3|OTUD5|PSMC1|PSMD2|UBC|USP20|PSMD6|MYSM1|USP18|TRAF3|MYC|TAF10|PSMD12|PSMA3|ACTB|GPS1|SHMT2|PSMA6|OTUB1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
EPIBOLY%GOBP%GO:0090504,0.239663997899987,0.623187683081912,-0.29257049494561,-1.19193430301516,1825,21,RHOA|CYR61|LCP1|PDCD10|MMP12|CD44|TOR1A|ITGA5|DDR1|FLNA|CEACAM1|PDPN|CD151|COL5A1|ACVRL1
NEGATIVE REGULATION OF NEURAL CREST FORMATION%GOBP%GO:0090301,0.830256342143711,0.9435818887072471,0.58392148213498,0.7785805062335109,6250,1,FUZ
VIRAL BUDDING%GOBP%GO:0046755,0.80635460251046,0.9337214381011629,-0.17564652379355597,-0.746492774298953,6166,24,MVB12B|CHMP4A|CHMP6|VPS37C
POSITIVE REGULATION OF SHELTERIN COMPLEX ASSEMBLY%GOBP%GO:1904792,0.6392615221144909,0.865463150027443,0.6779885310983679,0.904006223290581,4812,1,TERF1
CAP MRNA METHYLATION%GOBP%GO:0036451,0.252411575562701,0.632257972333528,0.7069754618141719,1.1878100571446002,1883,2,CMTR1|CMTR2
CELLULAR RESPONSE TO PEPTIDE%GOBP%GO:1901653,0.011769220928745,0.142241967951109,-0.21076092630160298,-1.5188438936332802,91,182,APC|ATP6V1D|PRKAR2A|LYN|INHBB|PSEN1|NR4A1|ATP6V0A1|PIK3C2A|ZFP36L1|AP3S1|TCIRG1|ATP6V0B|GOT1|PARP1|ATP6V0A2|LRP1|ATP6V1G2|ATP1A3|CAV2|FCGR2B|ATP6V1F|INS|BCAR1|GRIN1|FOXC2|SYAP1|ADCY8|ATP6V0D1|CA2|GRB2|CRHBP|PRKAR1A|CASP4|IRS1|STAT3|PXN|ADCY4|PIK3R3|IGF1|HDAC5|CEACAM1|GPER1|KAT2B|CPEB1|CD36|ATP6V0E1|EPHA4|RARRES2|CAMK2A|LPIN3|CAV1|PPARG|ATP6AP1|RELA|RPS6KB1|NFKB1|PRKACA|TLR4|ATP6V0E2|VIM|LGMN|ATP6V1A|LPIN2|ATP6V1G1|NGFR|ADCY9|PRNP
STEROID METABOLIC PROCESS%GOBP%GO:0008202,0.134036532029843,0.495641459539577,-0.19003298373989702,-1.24590791118268,1041,114,WWOX|CACNA1H|HSD11B1|ABCG1|CYP51A1|DHRS4|CETP|SPP1|HMGCR|STS|CYP46A1|SCARF1|APOE|HMGCS1|CYP7B1|HSD17B1|SRD5A3|EBP|DHCR7|OSBP|LGMN|C14orf1|DHCR24|CNBP|NSDHL|HSD17B14|OSBPL3|TM7SF2|OSBPL5
NEGATIVE REGULATION OF DEFENSE RESPONSE%GOBP%GO:0031348,0.000128221566867547,0.00518555396908895,-0.35533241126928905,-2.26013402930616,0,100,MICA|MUL1|LILRB1|HLA-E|NDFIP1|PYCARD|TNFAIP8L2|APOD|SEC14L1|IRAK3|SLAMF8|KLF4|SIGLEC10|RORA|TNFAIP6|GATA3|FCGR2B|INS|FEM1A|TNFAIP3|PTGER4|IFIT1|GHRL|NR1H3|TRAFD1|NPLOC4|IFI16|CDH5|CEACAM1|GPER1|APOE|NLRP3|NOV|A2M|CD200|LGALS9|TEK|CX3CL1|LDLR|PPARG|PPARA|DHX58|ABCD1|GSTP1|TNFRSF1A|METRNL|FAM3A|SERPING1|SAMHD1|CHID1|SIRPA|PTGIS|RNF26
HISTONE H3-T3 PHOSPHORYLATION%GOBP%GO:0072355,0.124436189970815,0.47848721859351595,-0.78240970499035,-1.3020548658228501,937,2,GSG2|VRK1
DETERMINATION OF INTESTINE LEFT/RIGHT ASYMMETRY%GOBP%GO:0071908,0.0716773847802787,0.3767214120425879,0.8351805900193,1.40321122576336,534,2,NPHP3-ACAD11|NPHP3
AZOLE TRANSPORT%GOBP%GO:0045117,0.36566771819137794,0.719988477109428,-0.39402934895531794,-1.07706165388137,2781,7,SLC35F3|SLC25A19
RENAL VESICLE FORMATION%GOBP%GO:0072033,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
POSITIVE REGULATION OF NAD+ ADP-RIBOSYLTRANSFERASE ACTIVITY%GOBP%GO:1901666,0.253250198991775,0.632257972333528,-0.7057071960297769,-1.1744096252590701,1908,2,TGFB1|DTX3L
REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0032885,0.250784518828452,0.631479765290861,-0.27686471514063205,-1.17666723398258,1917,24,INS|PPP1R3E|IRS1|CLTC|IGF1|NFKB1|PDGFB|PPP1R3F
REGULATION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY%GOBP%GO:0051342,0.4109110454178979,0.745437377934693,0.5329817889545179,1.04831228288441,3057,3,MAPK7|EGLN1
DNA 3' DEPHOSPHORYLATION INVOLVED IN DNA REPAIR%GOBP%GO:0098504,0.469119404967459,0.780769690730001,0.766541685046317,1.02207990535017,3531,1,PNKP
IRON COORDINATION ENTITY TRANSPORT%GOBP%GO:1901678,0.165833771699106,0.537721321518182,-0.548540412185518,-1.31474669686379,1260,5,FLVCR2|SLC48A1|SLC22A17
EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION%GOBP%GO:0045229,0.7491638795986619,0.913615832844878,-0.6310652845169828,-0.840730486687424,5599,1,TGM1
NEGATIVE CHEMOTAXIS%GOBP%GO:0050919,0.20994258872651397,0.591291692741505,-0.280610774592687,-1.22407544348567,1608,26,SEMA3B|SEMA3D|SEMA7A|SEMA3E|SLIT2|SEMA3A|SEMA6B|PDGFA
D-AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0046437,0.517332979147297,0.8044682962948779,0.740902073224526,0.9878929426118679,3894,1,SRR
NEGATIVE REGULATION OF PROTEIN ADP-RIBOSYLATION%GOBP%GO:0010836,0.983068783068783,0.9934465533562429,-0.265690915295178,-0.518827018485823,7431,3,XRCC1|TINF2
REGULATION OF OXYGEN METABOLIC PROCESS%GOBP%GO:2000374,0.796630405943221,0.930355360818174,-0.46217883501628204,-0.7691394894196899,6004,2,LIPT2
T-HELPER 17 TYPE IMMUNE RESPONSE%GOBP%GO:0072538,0.442166140904311,0.7653693162885199,-0.3688717072242779,-1.00829436209859,3363,7,IL6|RORC|BATF|RORA|STAT3
MITOCHONDRION MIGRATION ALONG ACTIN FILAMENT%GOBP%GO:0034642,0.547084606189401,0.818317601346006,0.7248014997794441,0.966425000419216,4118,1,MYO19
POSITIVE REGULATION OF INTERLEUKIN-1 BETA PRODUCTION%GOBP%GO:0032731,0.120962468942069,0.472999327000989,-0.327404889329296,-1.3558688347497703,924,22,CCL3|RIPK2|PYCARD|GSDMD|CCL19|AZU1|CASP1|HSPB1|IFI16|NLRP3|LGALS9|TLR4
NEGATIVE REGULATION OF NEUROTRANSMITTER UPTAKE%GOBP%GO:0051581,0.156481481481481,0.525982918868011,-0.6704835952298239,-1.30928452811521,1182,3,GPM6B|ARL6IP5
POSITIVE REGULATION OF TRANSCRIPTION VIA SERUM RESPONSE ELEMENT BINDING%GOBP%GO:0010735,0.44272486772486797,0.7657406302236591,-0.5281202609489231,-1.03128501810335,3346,3,MICAL2|SRF
INOSINE CATABOLIC PROCESS%GOBP%GO:0006148,0.0631438127090301,0.36006266503904,-0.9667512130569029,-1.2879447464474099,471,1,PNP
NEGATIVE REGULATION OF CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905916,0.0372777925179093,0.27499221464993107,-0.8766473669699479,-1.4588814050921002,280,2,DNMT1|FGF9
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:1900016,0.17965481171548103,0.553022925059495,-0.41216018413207106,-1.2912440533119198,1373,10,ABCD1|CHID1|SIRPA
POSITIVE REGULATION OF CIRCADIAN RHYTHM%GOBP%GO:0042753,0.439942678478374,0.7653693162885199,-0.333835626508271,-1.0042592782989301,3376,9,RORC|ARNTL|FBXW11|RORA|GHRL|ARNTL2
TRNA RE-EXPORT FROM NUCLEUS%GOBP%GO:0071528,0.633550272280515,0.8631726958478259,0.68052492280547,0.907388159389423,4769,1,XPOT
GLOBOSIDE METABOLIC PROCESS%GOBP%GO:0001575,0.8382608695652171,0.946300451776032,-0.584528010586678,-0.7787316635538121,6265,1,CLN3
ACTOMYOSIN CONTRACTILE RING CONTRACTION%GOBP%GO:0000916,0.757190635451505,0.916855605301775,-0.625661667401853,-0.8335315712050849,5659,1,VPS4A
NEGATIVE REGULATION OF WNT-FRIZZLED-LRP5/6 COMPLEX ASSEMBLY%GOBP%GO:1904723,0.004648691725328729,0.0752560935123842,0.9979047198941329,1.33057129384458,34,1,DKK1
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL-CELL SIGNALING%GOBP%GO:1905114,0.42280679351296097,0.7535830358827651,-0.14855292389715696,-1.0184290468014698,3310,141,MPP2|MERTK|FZD4|NPFF|PLCB3|SFRP4|WLS|CPE|SFRP2|GATA3|FRAT1|FZD2|FZD8|GRIN1|DDX3X|MST1R|NPAS4|CELSR1|MEF2C|SMURF2|CLTC|VPS29|VANGL1|TNRC6C|SKP1|NFATC1|LRP5|AXL|BMP2|GRIN2C|UBC|GRIN2D|CAMK2A|CAV1|WNT3|ITGAM|TIAM1|PRICKLE2|CSNK1A1|PPP1CA|AP2M1
METANEPHRIC NEPHRON TUBULE DEVELOPMENT%GOBP%GO:0072234,0.0165278151034668,0.17512293405535098,0.834178890481968,1.6407314379924598,122,3,PAX8|PKD1|PKD2
ASTROCYTE CELL MIGRATION%GOBP%GO:0043615,0.35606261607853495,0.7138061959661809,-0.658615936035291,-1.09604223816958,2683,2,CCL3|CCL2
PROTEOGLYCAN METABOLIC PROCESS%GOBP%GO:0006029,0.17679057116953797,0.548551967663807,-0.223453974668533,-1.2347951357546598,1364,58,ARSB|HS3ST5|DCN|CHST7|NDST1|BGN|VCAN|SULF1|IGF1|B4GALT7|HS3ST4|HYAL1|EXT2|B3GAT3|CANT1|HEXB|CSGALNACT1|XYLT2
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086012,0.0775288526816022,0.38994345969071,0.420540556450392,1.472820705988,570,13,TRPM4|SCN5A|ANK2|HCN2|CACNA1C|CACNB2
"PROTEIN DEGLYCATION, GLYOXAL REMOVAL%GOBP%GO:0036529",0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
DEFENSE RESPONSE TO PROTOZOAN%GOBP%GO:0042832,0.006180957390846921,0.0918052334975927,-0.755129053606883,-1.80990024960962,46,5,BATF|SLC11A1|BATF2|CLEC7A|LYST
REGULATION OF TRANSMEMBRANE TRANSPORT%GOBP%GO:0034762,0.0888263151158326,0.41228493992510207,-0.165079775332201,-1.25237085737043,693,242,PID1|GLRX|ATP1B1|PPIF|AMIGO1|KCNIP3|CTSS|PLN|SLC2A1|SHISA7|ATP1B3|KCNN2|STAC3|INS|THY1|PDE4B|STIM1|C3|SLC9A3R1|FMR1|KCNIP4|JPH4|PDE4D|TESC|HAMP|CA2|SEPN1|CRHBP|SLC9A1|MEF2C|IRS1|UBQLN1|CD63|CAPN1|FLNA|FXYD1|IGF1|CNIH2|CREBL2|P2RY6|GPER1|F2R|KCNQ1|APLNR|FGF19|F2RL3|THBS1|PEA15|COX17|FKBP1A|MMP9|CX3CL1|SLC30A5|CAV1|SCN1B|CNIH3|CLIC2|ARL6IP1|ATP1B2|PRKACA|KCNH2|KCNE4|ARL6IP5|ACTB|TMSB4X|FXYD5|AHNAK|PRKCB|GRB10|FXYD7|WNK2|PRNP
NMDA GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:0097114,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
REGULATION OF IMMATURE T CELL PROLIFERATION%GOBP%GO:0033083,0.8419078242229371,0.94808068996515,0.42558588365040007,0.7150392341503771,6283,2,KIAA0922|BMP4
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX%GOBP%GO:1904778,0.970015781167806,0.9915747942934481,-0.22694522998060898,-0.543944411127703,7375,5,EPB41L2
PROTEIN-PYRIDOXAL-5-PHOSPHATE LINKAGE VIA PEPTIDYL-N6-PYRIDOXAL PHOSPHATE-L-LYSINE%GOBP%GO:0018272,0.48386239872493,0.787078399497453,0.758215703573004,1.01097833250397,3642,1,CTH
URETER EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072192,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
POSITIVE REGULATION OF FEVER GENERATION BY POSITIVE REGULATION OF PROSTAGLANDIN SECRETION%GOBP%GO:0071812,0.3941137123745821,0.7376723208557521,-0.8027128363475959,-1.06940624073355,2945,1,TNFRSF11A
EMBRYONIC LUNG DEVELOPMENT%GOBP%GO:1990401,0.0727759197324415,0.37960378163431896,-0.9623400970445519,-1.28206808074754,543,1,PDGFA
MITOCHONDRIAL L-ORNITHINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1990575,0.28751339764201506,0.6604035198820261,0.6902122966639089,1.15964577531229,2145,2,SLC25A15|SLC25A29
DENSE CORE GRANULE EXOCYTOSIS%GOBP%GO:1990504,0.34378349410503806,0.702174649119653,0.6624069595248101,1.1129292188262099,2565,2,UNC13A|UNC13B
ER-DEPENDENT PEROXISOME LOCALIZATION%GOBP%GO:0106101,0.14943143812709,0.51590227091171,-0.92286060873401,-1.2294719227337199,1116,1,PEX16
GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035860,0.25281891047412003,0.632257972333528,0.544669628612756,1.19666237025569,1860,4,RET|SULF2
CELL CYCLE COMPRISING MITOSIS WITHOUT CYTOKINESIS%GOBP%GO:0033301,0.9016722408026759,0.9684180373391851,-0.549073665637406,-0.7314979629911199,6739,1,E2F8
SPLICEOSOMAL COMPLEX DISASSEMBLY%GOBP%GO:0000390,0.612496683470417,0.852045339927398,-0.5547632860004089,-0.9232148212241541,4616,2,DHX8
REGULATION OF MITOTIC SPINDLE ORGANIZATION%GOBP%GO:0060236,0.7222602271172529,0.9019989179378242,0.170842190720605,0.81965967771016,5278,34,CHMP3|DCTN1|FSD1|PARP3|MAP9|GPSM2|PSRC1|ANKRD53|PDCD6IP|CHMP1A
TRANSDIFFERENTIATION%GOBP%GO:0060290,0.577304394426581,0.837152999580265,0.5585225035520369,0.9383899197268979,4308,2,INSM1
CELLULAR RESPONSE TO ALKALOID%GOBP%GO:0071312,0.872443628736235,0.9587056110602221,-0.189154853468925,-0.669202210756375,6654,14,RAD51|RYR2|ADCY8|CRHBP|HTR1B|CASP6
NEGATIVE REGULATION OF MYELOID DENDRITIC CELL ACTIVATION%GOBP%GO:0030886,0.0937792642140468,0.42337598780415003,-0.9508160564622851,-1.26671529160663,700,1,HAVCR2
REGULATION OF MYOTUBE DIFFERENTIATION%GOBP%GO:0010830,0.0285041841004184,0.238789399313666,-0.385698086836177,-1.63920599546018,217,24,NOTCH1|FAM129B|EHD1|MMP14|HDAC5|NOV|MAML1|SIK1|EHD2|ADGRB1
INTERFERON-ALPHA PRODUCTION%GOBP%GO:0032607,0.23090301003344502,0.614196072785718,-0.8814512571680629,-1.1743047234761999,1725,1,IRF7
REGULATION OF XENOPHAGY%GOBP%GO:1904415,0.39255091103965706,0.737280445732591,0.639757375241246,1.07487499282362,2929,2,OPTN|LRSAM1
MOTOR BEHAVIOR%GOBP%GO:0061744,0.718355280838484,0.9001726548097869,0.407144716591029,0.800805611296959,5345,3,DCTN1|PRKAA1
POSITIVE REGULATION OF NEUTROPHIL MEDIATED KILLING OF GRAM-NEGATIVE BACTERIUM%GOBP%GO:0070963,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
CITRULLINE METABOLIC PROCESS%GOBP%GO:0000052,0.008110300081103,0.110912204494754,0.753069244763407,1.8111272151721,59,5,DDAH1|DDAH2|CAD
POSITIVE REGULATION OF LIPID TRANSPORT%GOBP%GO:0032370,0.0577225130890052,0.346230546637818,-0.33276251003303803,-1.4861545871028798,440,28,PLTP|TRIAP1|P2RX4|LRP1|TNFRSF11A|PRELID1|PLA2R1|SPP1|GHRL|NR1H3|APOE|NFKBIA|ANXA2|C1QTNF1
SENSORY PROCESSING%GOBP%GO:0050893,0.110039396821084,0.45500616482604295,0.6389582289881489,1.4038184408092902,809,4,BBS4|TTC8|CHRNA7|SHANK1
INTRASPECIES INTERACTION BETWEEN ORGANISMS%GOBP%GO:0051703,0.588155392556371,0.8414799095069009,0.200289142653239,0.9074079682101222,4329,28,GRID1|DRD4|PTCHD1|CHRNB2|MKKS|ATXN1L|PPP3CB|NLGN4X|SHANK2|MSS51
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, 3'-5' EXONUCLEOLYTIC NONSENSE-MEDIATED DECAY%GOBP%GO:0070478",0.562226059237615,0.828541380171721,0.717412880458756,0.956573273522588,4232,1,SKIV2L
"CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0002361",0.35553197134518394,0.7132037834765931,-0.659001929969672,-1.09668459380146,2679,2,FOXP3|PLA2G2D
MACROPHAGE CHEMOTAXIS%GOBP%GO:0048246,0.07308096740273401,0.380316689710452,-0.546081050119849,-1.4926881983658,555,7,AZU1|CCL2|EDNRB|LGALS3
POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY%GOBP%GO:0051388,0.11612040133779303,0.466085789276584,-0.939843405381562,-1.2520970856782099,867,1,TMEM108
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034123,0.20591313448456303,0.585932546425919,-0.33111368354069104,-1.23054665768397,1573,16,TLR1|TLR2|TICAM2|RSAD2|NR1H3|TLR5|CAV1
REGULATION OF SPINDLE ASSEMBLY%GOBP%GO:0090169,0.994639121338912,0.9982557716801239,-0.10380750736202801,-0.441178979749224,7606,24,CHMP1B|CEP97|SPAG5|STAG1|CHMP5|DYNC1H1|CCSAP|HNRNPU|STAG2|PLK1|SMC1A
RESPONSE TO OLEIC ACID%GOBP%GO:0034201,0.44295391154203706,0.7658968186518771,0.779940449933833,1.0399453503940501,3334,1,DGAT2
REPLICATION FORK REVERSAL%GOBP%GO:0071932,0.73190635451505,0.9074802896081321,-0.638288486987208,-0.850353526770958,5470,1,DNA2
MESENCHYMAL CELL DIFFERENTIATION%GOBP%GO:0048762,0.0243436145806781,0.21922894141495605,-0.254121623018374,-1.54379827014679,190,83,SEMA4A|OLFM1|PEF1|JAG1|CORO1C|SOX10|TBX1|TRIM28|SEMA6A|PDCD6|HGF|SPRY1|ANXA6|EFNA1|NOTCH1|MEF2C|DDX5|SNAI2|SEMA3B|SEMA3D|SEMA7A|FN1|BMP2|TGFBR3|SEMA5A|TCOF1|SEMA3E|SNAI1|SEMA3A|SEMA6B|ENG|S100A4|ACVRL1|LOXL2|HNRNPAB
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:1901031,0.372263766145479,0.7234654586828599,0.252867373108561,1.0582379499319599,2737,22,HEBP2|MET|RIPK1|BMP7|PDE8A|NFE2L2|NR4A3
RESPONSE TO LEAD ION%GOBP%GO:0010288,0.448722986247544,0.768229288546963,-0.38874650080494894,-0.9999607229763101,3425,6,PPP2CA|PPP1CA
POSITIVE REGULATION OF HEART INDUCTION BY NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0090082,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
SPECIFICATION OF AXIS POLARITY%GOBP%GO:0065001,0.6296891747052521,0.860897694974173,0.535483699350934,0.899681754008625,4699,2,AHI1
"NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS, TRANSLOCATION%GOBP%GO:0033159",0.0860971079862032,0.4057980029059221,-0.8158808933002479,-1.3577562756159698,648,2,GAS6|PDE2A
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1901228,0.25179092597506003,0.632068187660447,-0.7065343258891651,-1.1757861016131002,1897,2,GREM1|SRF
NEGATIVE REGULATION OF EXO-ALPHA-SIALIDASE ACTIVITY%GOBP%GO:1903016,0.878929765886288,0.960725750963158,-0.563134097926776,-0.7502298349094499,6569,1,PTX3
NEGATIVE REGULATION OF LONG-TERM SYNAPTIC POTENTIATION%GOBP%GO:1900272,0.0132285527177472,0.152455157660829,-0.679683621395729,-1.74832937155373,100,6,ABL1|APOE|EPHA4|FAM107A
NEGATIVE REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 5 PRODUCTION%GOBP%GO:0071650,0.24714778455823802,0.6280519349499749,-0.709622277364213,-1.1809249466681497,1862,2,MUL1|SIRPA
REGULATION OF SECONDARY METABOLIC PROCESS%GOBP%GO:0043455,0.989412243789874,0.9962702115525078,0.188424665900795,0.487559897727221,7288,6,SP1|ZEB2|TIGAR|RAPGEF2
MEMBRANE RAFT LOCALIZATION%GOBP%GO:0051665,0.342344790110039,0.701955655133333,0.496442949318921,1.09070630198673,2519,4,CD2|RALA|MAL|PTPRC
"POSITIVE REGULATION OF INOSITOL 1,4,5-TRISPHOSPHATE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0031587",0.216682515962505,0.599597524514766,0.564915827232933,1.24114413086202,1594,4,HTT|HAP1|PKD2
SIGNAL TRANSDUCTION BY TRANS-PHOSPHORYLATION%GOBP%GO:0023016,0.8130878796022579,0.9356336309698571,0.36985772581890397,0.727466500602593,6050,3,OXSR1|WNK1
DIAPEDESIS%GOBP%GO:0050904,0.596095098950724,0.844548800900243,0.6997132774591971,0.9329732411806659,4487,1,FER
SOFT PALATE DEVELOPMENT%GOBP%GO:0060023,0.167724867724868,0.5400872099036179,-0.662788132789236,-1.2942572403756798,1267,3,SOX11|TBX1|COL11A2
NEGATIVE REGULATION OF CYCLIN-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0045736,0.104147586026429,0.44419145940290994,-0.368098689328555,-1.3988649077541,795,17,APC|HEXIM2|CDKN2A|HEXIM1|IPO7|CEBPA|MEN1|PLK1|LATS2|NR2F2
REGULATION OF MITOTIC CELL CYCLE%GOBP%GO:0007346,0.0026595744680851102,0.049712429758417,-0.17304109191138503,-1.4560857499179098,20,476,GBF1|CCNA2|TUBB|CUL1|PCBP4|GTSE1|CDC25A|WEE1|CYLD|CNOT4|RBL1|ZFP36L2|ATRX|MAD1L1|MCPH1|BTG2|CNOT10|CNOT6L|KIF25|PSME3|CENPE|FOXN3|NIPBL|C17orf104|PHB2|CDC7|BECN1|PRMT2|VPS4A|APP|HAUS1|BLM|NDE1|STAG1|SFN|TUBG1|CHMP5|PSME1|CCNB2|INO80|STK33|PINX1|ZNF207|IL1B|CEP72|HAUS6|CDKN1B|ZWINT|CDK4|CNOT6|AURKA|ASNS|HSF1|TACC3|CEP78|PTEN|RCC2|HAUS4|FHL1|THAP1|TRIP13|CEP76|DUSP1|AURKAIP1|CSNK1D|FBXL7|CEP192|EME2|IQGAP1|PCNT|KLHL22|KIF11|PRCC|PIDD1|ID2|PRMT1|NEK2|NEDD1|DUSP3|YTHDC2|ANLN|RAD9A|BRINP1|TMEM14B|TGFB1|LSM11|UBD|CCND2|BRD4|PML|APC|RGCC|CLSPN|RPA2|NUSAP1|MKI67|DLGAP5|NABP2|CDC20|DYNC1H1|ANAPC10|PLCB1|TRIAP1|CCSAP|TFDP2|SETMAR|DONSON|GADD45GIP1|CDT1|EIF4EBP1|LCMT1|ZFP36L1|ANAPC2|NBN|ANAPC5|KLF4|ESPL1|CDC6|ANKRD32|PIM3|OFD1|NAA10|CEP70|RAD51C|CDC23|HNRNPU|PLK2|STAG2|TPX2|TUBA4A|SDCCAG8|CAV2|PTTG1|SLFN11|HAUS8|BRINP3|RAD17|PCNA|INS|LSM10|ORC1|PKMYT1|HES1|TOP2A|CDK5RAP2|MAD2L1|TAOK2|SLC9A3R1|DDX3X|SMOC2|CDC25C|KNTC1|ZNF268|GPNMB|PDXP|DCUN1D3|TAL1|PTPN6|CLTC|CKS2|PSME2|CDC45|NDC80|CDKN2B|TOPBP1|EME1|RCC1|MECP2|FGF10|CEP131|CDC27|RNF20|HRAS|IGF1|DTL|SKP1|FAP|E2F1|CKAP5|LRP5|TUBB4A|RPTOR|RAD51B|USP2|CCNI2|CCL2|KANK2|CCNI|USP44|NACC2|CCNB1|PLK1|NSFL1C|USP47|GAS1|PLAGL1|HYAL1|RNF40|AIF1|PDGFRB|TNKS1BP1|FAM107A|DDB1|CCND3|IK|SIK1|SSNA1|SMC1A|CCDC8|DACT1|RPS6KB1|PRKACA|BCL6|CETN2|CDK2AP2|HSP90AA1|CEP63|ANXA1|NEK6|H2AFY|LGMN|ANAPC11|ZNF385A|PRMT5|TUBB4B|CCND1|MUS81|CDCA5|SPHK1|DCTN3|PDGFB|HAUS7|XRCC3|EIF4G1
CALCIUM EXPORT FROM THE MITOCHONDRION%GOBP%GO:0099093,0.25404616609180203,0.633328402505013,-0.7052805442827141,-1.17369960852521,1914,2,SLC8B1
REGULATION OF ER TO GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:0060628,0.115883200209506,0.46559625491895207,-0.40414428960939003,-1.3911430172661001,884,13,SCFD1|SEC23A|GAS1|SAR1B|INSIG1
POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:0032414,0.705184776613348,0.894639008000397,0.153061959457463,0.8452874102925301,5113,55,ABCB1|ANK2|GSTM2|DMD|EPHB2|RNF207|DRD4|KCNIP2|HTT|GAL|HAP1
RESPONSE TO RADIATION%GOBP%GO:0009314,0.0339178292589274,0.26293361581113606,-0.179424963388703,-1.36603631144465,264,247,JUNB|EEF1D|TRIAP1|PER2|INTS7|UBE2B|KDM1A|IMPACT|H2AFX|ECT2|YY1|PARP1|BHLHE40|INIP|MFAP4|PAXIP1|NDNL2|HYAL3|NPM1|RAD51AP1|RAD1|GPX1|BRCC3|PCNA|GRIN1|FMR1|DHX36|POLD1|GRB2|CACNA2D4|RHNO1|DCUN1D3|RNF168|BRCA1|KIAA0101|TRIM32|TOPBP1|NUCKS1|MECP2|CARD16|GNGT2|HRAS|DTL|MEN1|IFI16|PPM1D|USP2|GNAQ|CRY2|BCL3|CAT|USP47|HYAL1|ADIRF|TMEM109|RBM4B|TLK2|COL3A1|HIST3H2A|CRYAB|TNKS1BP1|EIF2S1|ERCC8|MYC|DDB1|RELA|SIK1|SMC1A|YAP1|MAPK13|KAT5|POLA1|POLE3|ANXA1|RBM4|CRIP1|CCND1|PPP1CA|NET1|XPA|FEN1|GTF2H2
"NEGATIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000565",0.19598662207357898,0.571699341995829,-0.8999779444199381,-1.1989867194156498,1464,1,C10orf54
REGULATION OF VESICLE-MEDIATED TRANSPORT%GOBP%GO:0060627,0.00038382804503582404,0.0111294649577428,-0.21558238530058,-1.7021190564117301,2,307,PYCARD|NCKAP1L|SEPT5|GNB2L1|B2M|CCL19|REST|TSG101|CD84|STXBP5L|ITGB2|MERTK|RAB9A|UBQLN2|SNX4|HGS|STX4|TLR2|LRP1|FGR|SFRP4|RAB7A|CNST|APOC1|STXBP2|TOR1A|RAB27B|SYT4|MCTP1|TNK2|SGIP1|C4A|FES|HYAL3|SYT7|AZU1|NAPA|FCGR2B|C2|GAS6|SCFD1|CACNA1H|CPLX2|ADGRE2|VTN|C3|FMR1|SEC23A|VPS18|PRKD1|CD47|BET1L|CD63|ARRB1|SDC4|FCER1G|SYN1|EHD1|MSN|PIK3CB|SLC11A1|CACNA1G|MAPK3|ABL1|CALR|NECAB2|DYSF|VAMP8|NR1H3|ARF1|VAMP7|SNX6|STX1B|ARHGAP1|CCL2|CEACAM1|CD300A|RAB3C|HFE|APOE|AXL|GAS1|HCK|LGALS3|CD151|SNF8|LGALS9|ZP3|HNRNPK|CHMP6|CD300LF|NSF|DOC2A|SERPINE1|SEPT8|CAV1|LDLR|ATP6AP1|PRRT2|TUB|LMAN2|STON2|ITGAM|DAB2|ANXA2|RAB20|ANXA1|CACNA1I|SAR1B|EHD2|ARF6|PTPRJ|SIRPA|INSIG1
NEUTRAL LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046460,0.45200995155165596,0.769943206592495,-0.289285123725948,-0.995775494587022,3451,13,PLCE1|DGAT1|GPAM|GK|LPIN3|ANG|LPIN2
NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002762,0.0234986945169713,0.21335629380239102,-0.39971472415498494,-1.6782348496341801,179,23,RARA|CCL3|ZNF675|LILRB1|CDK6|LILRB3|TCTA|INHBA|FBN1|MAFB|C1QC|CEACAM1|MYC|TLR4|LILRB4
PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX%GOBP%GO:0030150,0.15399712154913,0.5225398777782271,-0.344049370289459,-1.30747162265292,1176,17,TOMM40|TOMM40L|DNLZ|TIMM17A|GRPEL2|TOMM20|TIMM21|ROMO1|TIMM17B|DNAJC19|DNAJC15
GLUTATHIONE TRANSMEMBRANE TRANSPORT%GOBP%GO:0034775,0.000802675585284281,0.0194343718828845,-0.9996691662990741,-1.33179936423268,5,1,ABCC1
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS%GOBP%GO:1902219,0.388962589546299,0.735662494422088,-0.644665012406948,-1.07282567033159,2931,2,ARHGEF2|YBX3
REGULATION OF PROTEIN TETRAMERIZATION%GOBP%GO:1901090,0.689174705251876,0.887051934478962,0.5009129025881699,0.8415983518309329,5143,2,PEX5|PEX14
POSITIVE REGULATION OF BINDING%GOBP%GO:0051099,0.0014180739976795199,0.0301860198914787,-0.2744143873506,-1.8055605416650802,10,116,DHX9|CEBPG|H1F0|B2M|DTX3L|HMGB2|CDT1|TERT|PARP9|EIF3C|LRP1|NGF|GATA3|GMNN|HES1|TRAF2|VTN|FMR1|SYAP1|MEF2C|FAM129B|NCBP1|PARK7|ABL1|IGF1|NMD3|MEN1|RAN|TMEM173|STK3|HFE|APOE|PLAUR|PPP2CA|LGALS3|BMP2|EPHA4|FKBP1A|MMP9|CAV1|PPARG|CLIC2|DACT1|ANXA2|TIAM1|STPG1|EDF1|NME1|EIF4G1
LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002521,0.00154619250096637,0.0323260517898055,-0.24730152449587603,-1.71997097486518,11,152,CLCF1|NRROS|TRPM2|JAGN1|DLL4|MAPK14|APP|BLM|ITGA4|PLCG2|RORC|FOXP3|DHRS2|CD1D|CDC42|MFNG|JAK3|DOCK11|ITGB1|GLO1|DOCK10|UBD|LILRB1|SBNO2|LYN|GPR183|PIR|CEBPG|CD74|FNIP1|MT1G|RIPK3|TNFSF8|CCL19|SLAMF8|BATF|ZFP36L1|CD4|TLR2|PARP1|RORA|SPN|TNFRSF11A|CBFA2T3|FCGR2B|GAS6|PLA2G2D|TCTA|OSCAR|PTGER4|CEBPA|STAT3|TAL1|NFAM1|FCER1G|NOTCH2|RSAD2|KLF6|TREM2|IFI16|HDAC5|VCAM1|LRRC8A|BATF2|CSF1|JAG2|EPHA2|PDE1B|AXL|TGFBR2|LGALS9|FADD|RELB|FOXP1|MMP9|TYROBP|IL11|LTBR|PPARG|MYH9|ANXA2|CSF1R|RRAS|ANXA1|SNX10|PTPRJ
MICROTUBULE POLYMERIZATION%GOBP%GO:0046785,0.8237053146663041,0.941760803523009,0.15973248344795002,0.7395129137649709,6059,30,CLASP1|CLASP2|NDEL1|TUBGCP3|TPPP3|MZT1|TUBGCP6|CENPJ|RANBP9|AKAP9|SLAIN2|MAP7D3|TUBGCP4|PIN1|CETN3|FGF13|NIN|GOLGA2|NDE1|TUBG1|ZNF207|MAPT|TUBGCP5|CSNK1D|CEP192|EFCAB11|TPPP|TUBGCP2|TUBG2
NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL%GOBP%GO:0046597,0.0128104575163399,0.149991146428462,-0.536100508780955,-1.7943785988386398,97,12,FCN1|GSN|IFITM1|IFITM2|IFITM3|MID2
POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:2000353,0.211241830065359,0.5931461423724009,-0.370755197199656,-1.2409523594298402,1615,12,CCL2|GPER1|ECSCR|THBS1
STARTLE RESPONSE%GOBP%GO:0001964,0.0967259883168048,0.4281954270287629,0.649899226834249,1.42785627902844,711,4,DRD2|CTNNA2|GLRB
ANTIGEN RECEPTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0050851,0.0040868454661558105,0.0702098005861062,-0.24252158877609498,-1.64303988990262,31,133,HLA-DRB1|GRAP2|UBE2N|PLCG2|LCP2|RIPK2|SPPL3|PAK2|BTNL9|SYK|IGHV2-26|HLA-DQB2|NFATC2|EIF2B5|IGHV1OR15-1|NFKBIZ|MNDA|HLA-DPA1|CD38|IGHV5-51|SLA2|HLA-DRA|HLA-DRB5|PRAM1|IGHV1-24|NCKAP1L|VAV3|IGHV3-49|IGHG4|HLA-DPB1|CD4|HLA-DQA2|IGLL5|LAT2|GATA3|WAS|EIF2B1|THY1|PDE4B|BCAR1|IGHV4-4|RC3H2|PDE4D|IGHV4-61|MEF2C|IGHV1-3|PIK3CB|IGHV3-43|IGHV3-73|ICOSLG|TNFRSF21|IGHV3-15|EIF2B2|STOML2|RELA|NFKB1|IGHV1-18|NCK1|IGHG2|IGHA1|EIF2B3|PRKCB|PTPRJ
MATURATION OF 5S RRNA%GOBP%GO:0000481,0.0167224080267559,0.17569702079137303,-0.991784296426996,-1.3212948242941598,124,1,SART1
REGULATION OF NAD(P)H OXIDASE ACTIVITY%GOBP%GO:0033860,0.124034053700065,0.47832576509682107,-0.540139122170463,-1.3893833281971202,946,6,SLAMF8|AGT|INS|PARK7|RFK
CYTOSOLIC TRANSPORT%GOBP%GO:0016482,0.122741173199889,0.47697345522944606,0.18421674468263,1.24478922585032,882,127,FAM21A|DCTN1|CCDC132|SGSM2|STX8|DOPEY2|TBC1D14|FAM21C|CLTCL1|HEATR5B|SYS1-DBNDD2|PIKFYVE|RIC1|CCDC91|GCC2|MYO1D|TBC1D17|VPS13C|EHD3|GGA1|DENND2A|SNX16|FAM109B|TRIM27|VPS13A|VAMP3|AKTIP|WASH1|STX10|AP4M1|STX16|KIF5B|VPS35|CLN5|TMEM87A|RAB6A|KIF5A|STX6|TMEM87B|SORT1|EPS15|ANKRD27|KIF1A|VPS52|TBC1D5
5-METHYLCYTOSINE METABOLIC PROCESS%GOBP%GO:0019857,0.341440472991131,0.701955655133333,0.5674948642684859,1.11619542921615,2540,3,TET2|TET3
POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0090314,0.484881503677472,0.7872939093021379,0.229803483322011,0.9756180027660111,3559,23,TCAF2|MFF|MIEF2|MYO1C
L-SERINE CATABOLIC PROCESS%GOBP%GO:0006565,0.398474487112046,0.7388683667002129,-0.435118232479674,-1.04289537505285,3029,5,SDSL|SHMT2
DNA LIGATION%GOBP%GO:0006266,0.9970076169749731,0.9992843289779879,0.130045994713177,0.44200104183134203,7329,12,MGMT|POLB|LIG4|HMGB1|LIG3|XRCC4|LIG1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN NEURAL CREST CELL DIFFERENTIATION%GOBP%GO:0044335,0.442024173196972,0.7653693162885199,0.780381561535068,1.04053351319385,3327,1,LRP6
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION%GOBP%GO:0048667,0.0591256072172103,0.35209607375915797,0.170380463963135,1.30205623075261,425,231,TNR|RET|CNTN4|SHTN1|DRD2|ROBO3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|SEMA4F|PLXNB1|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|CDHR1|MAPK7|SLIT1|EPHB2|EFNA4|PARD3|RAB10|GFRA1|CHN1|PTPRO|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|NTNG1|EFNB3|SLIT3|CDK5R1|SHC1|SOS1|MAP6|DRAXIN|SPTBN1|EFNA2|NRCAM|MAP2|DLG4|BRSK1|VLDLR|TUBB3|ULK2|PPP3CB|PRKCA|PLCG1|KIF5A|PLXNB2|POU4F2|RB1|DOCK7|C8orf37|CELSR2|NRP1|DCC|EZR|SRC|SHANK2|VSTM2L|GPC1|RANBP9|CDK5|NEFH|MAPK1
REGULATION OF CELLULAR GLUCURONIDATION%GOBP%GO:2001029,0.227254615486784,0.609201573718782,0.887792236435818,1.18375115494483,1710,1,PRKCE
NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050860,0.0130941469163284,0.15155329789659303,-0.5197257853639811,-1.7889969394372498,99,13,THY1|PHPT1|CEACAM1|LGALS3|LILRB4|PTPRJ|PRNP
PROTEIN IMPORT INTO MITOCHONDRIAL INNER MEMBRANE%GOBP%GO:0045039,0.156339494923197,0.5257250974517679,-0.46113087854943297,-1.32753125926296,1200,8,ROMO1|TIMM9|TIMM10
"NEUROTRANSMITTER RECEPTOR TRANSPORT, ENDOSOME TO POSTSYNAPTIC MEMBRANE%GOBP%GO:0098887",0.581306887651134,0.8387093286508721,0.40588063753068104,0.891737046152935,4278,4,LRRC7|RAB11A|SCRIB
PENTITOL METABOLIC PROCESS%GOBP%GO:0019519,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
POSITIVE REGULATION OF 1-PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE ACTIVITY%GOBP%GO:0090216,0.601739130434783,0.847181989214523,-0.7026907807675339,-0.936152845989037,4497,1,DGKZ
GLYCEROPHOSPHOLIPID CATABOLIC PROCESS%GOBP%GO:0046475,0.826822233875197,0.943041978946366,-0.20112151296498298,-0.711538502124369,6306,14,GDE1|PLA2G4D|PLA2G4A|PLA2G4C
REGULATION OF SYNAPTIC VESICLE RECYCLING%GOBP%GO:1903421,0.7421094160967909,0.909955740610127,-0.323543677983401,-0.7754724583099191,5642,5,ROCK1|TOR1A|PLAA
"DNA REPLICATION, OKAZAKI FRAGMENT PROCESSING%GOBP%GO:0033567",0.42724296005239004,0.755533439554473,-0.39606704923377795,-1.0187911455892902,3261,6,DNA2|WRNIP1|RNASEH2A|FEN1
"REGULATION OF TRANSLATION AT POSTSYNAPSE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099578",0.33672240802675607,0.699462084003389,-0.8287935597706221,-1.10415202668403,2516,1,FMR1
NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY%GOBP%GO:0090084,0.134027589937787,0.495641459539577,0.496847998129957,1.37153556265791,990,7,HSPA2|SACS|DNAJA4|DNAJB2|DNAJB6
PLASMA MEMBRANE TUBULATION%GOBP%GO:0097320,0.793917147351862,0.929656485793048,-0.20949301940071502,-0.741155667697513,6055,14,SDPR|CHMP4A|EHD2
ACTIN FILAMENT ORGANIZATION%GOBP%GO:0007015,0.0752508361204014,0.38436410265336796,-0.18699490464920604,-1.30698193760586,584,156,TTC17|DSTN|MICALL2|ARPC1A|COBL|WAS|FSCN2|ITGB5|IQGAP2|MYOM1|BCAR1|SHROOM1|RHOF|LMOD1|PDXP|ARRB1|DBN1|MICAL2|AIF1L|RHOG|RHOD|GHRL|FLNA|RHOJ|RND1|GSN|BAIAP2L1|CORO1B|PLS3|CFL2|ARPC5L|AIF1|IGSF22|NEDD9|FAM107A|EFS|ANG|CFL1|WASF3|GAS7|EVL|EPS8|RHOU|ACTN1|CDC42EP2|ALDOA|EMP2
REGULATION OF TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY%GOBP%GO:0034139,0.949492319708409,0.9848150752609108,-0.20010490505240303,-0.576074014875225,7293,8,TNFAIP3|CAV1
CELLULAR RESPONSE TO STEROL%GOBP%GO:0036315,0.733394351464435,0.907913422943088,-0.248912139751011,-0.7798092407384231,5608,10,OSBPL7|RORC|RORA|SMO|INSIG1
CELL WALL ORGANIZATION OR BIOGENESIS%GOBP%GO:0071554,0.609458735262594,0.8505496974657741,0.543987586060424,0.913969381661827,4548,2,MANBA
MEMBRANOUS SEPTUM MORPHOGENESIS%GOBP%GO:0003149,0.7613096046732779,0.9183912636605319,0.349699919493638,0.768305616021419,5603,4,FGFR2
HEXOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0008645,0.37214491992648996,0.7234654586828599,-0.292997492809315,-1.06382640185547,2834,15,SLC2A10|SLC2A6|SLC45A3|SLC2A3|SLC45A1
PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0043328,0.281638528988352,0.6546865707384361,-0.537194214640809,-1.1760304296151898,2151,4,VPS25|SNF8
SEQUESTERING OF ZINC ION%GOBP%GO:0032119,0.004510480233483679,0.0743264309917645,-0.9585332230493521,-1.59515256414114,33,2,S100A8|S100A9
ESTABLISHMENT OF MELANOSOME LOCALIZATION%GOBP%GO:0032401,0.0029899429192715397,0.0547143035205039,0.5310674215351,1.9996449735789998,21,16,BBS5|BBS4|BLOC1S3|MKKS|RAB11B|RAB11A|MREG|BBS2|MYO5A|BBS7
L-PHENYLALANINE CATABOLIC PROCESS%GOBP%GO:0006559,0.6316063525123671,0.8616028929314681,-0.29673460949619396,-0.8542574096329041,4851,8,IL4I1|ASRGL1
MESONEPHRIC TUBULE MORPHOGENESIS%GOBP%GO:0072171,0.45783460282916205,0.7722752961350329,0.29117751500750894,0.9896557389178849,3365,12,CITED1|PAX8|FGF2|PKD2|FGF1
POSTSYNAPTIC CYTOSKELETON ORGANIZATION%GOBP%GO:0099188,0.417484743963916,0.7499690687478492,-0.632782088379981,-1.0530505845283,3146,2,ACTB
ENDOCRINE PROCESS%GOBP%GO:0050886,0.38261554621848703,0.730480369014206,-0.26185478685307606,-1.05055638943623,2913,20,AGT|PCSK5|INHBA|FAM129B|ATP6AP2|GHRL|CTSZ|NOS3|SERPINF2
MODULATION BY SYMBIONT OF HOST IMMUNE RESPONSE%GOBP%GO:0052553,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001267,0.105973277443018,0.44793860330112895,-0.43681504797078996,-1.4142122193288897,808,11,CAAP1|PARK7|GSN|PLAUR|LGALS9|MMP9
POSITIVE REGULATION OF MYOBLAST FUSION%GOBP%GO:1901741,0.143664563617245,0.509982599740886,-0.494441064595506,-1.35153260078729,1092,7,EHD1|EHD2|ADGRB1
PROTEIN POLY-ADP-RIBOSYLATION%GOBP%GO:0070212,0.863661202185792,0.9531672929044319,0.231437647884807,0.6718230027063629,6321,8,PARP3|ZC3HAV1|TNKS|PARP15
DNA HYPOMETHYLATION%GOBP%GO:0044028,0.290969899665552,0.663296678175849,-0.851621085134539,-1.13456377168084,2174,1,FAM129B
POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION%GOBP%GO:1902732,0.7953177257525079,0.929656485793048,-0.606473312748125,-0.807968075410657,5944,1,SIRT6
CHEMOTAXIS%GOBP%GO:0006935,0.00753608379103334,0.105409699039952,-0.189306976865023,-1.4804779265217798,58,289,CORO1A|ADAM8|SPTBN5|FEZ1|CCL19|SLAMF8|HMGB2|EPHB3|NTN3|SPON2|ITGB2|CXADR|SBDS|PLXND1|SEMA6A|SPTBN4|CCL24|HGF|SMO|SLC12A2|SPN|NTN4|FES|TNFRSF11A|AZU1|PLAU|IL1RN|EPHA8|GAS6|PDE4B|CCL3L3|BCAR1|ADGRE2|CCL18|DOK2|CXCR4|EFNA1|GPNMB|GRB2|LGI1|S1PR1|FAM129B|DSCAM|FCER1G|PIK3CB|FGF10|MAPK3|RHOG|HRAS|SEMA3B|SEMA3D|PLD1|SEMA7A|CCRL2|HBEGF|CCL2|CXCL16|ROBO4|CYFIP2|EPHA2|CORO1B|EDNRB|CCR1|PLAUR|NOV|NRP2|LGALS3|EFNA3|CHGA|CYP7B1|FGF7|SEMA5A|PDGFRB|SEMA3E|EPHA4|SLIT2|CX3CL1|SCN1B|SEMA3A|CCL4L2|CCL14|SEMA6B|S100A8|S100A9|PDGFA|EVL|PDGFRA|CMKLR1|ANXA1|SPTBN2|FOLR2|RAP1GAP|PDGFB|C5AR1|LYST|EFNA5|PTPRJ|GRB10|ABCC1
REGULATION OF RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:2000200,0.847892976588629,0.9492491301138911,-0.5794000882223199,-0.771900039677715,6337,1,RIOK2
OKAZAKI FRAGMENT PROCESSING INVOLVED IN MITOTIC DNA REPLICATION%GOBP%GO:1903461,0.901979014477354,0.968486494114721,0.549018526687252,0.73204212469944,6790,1,LIG1
CALCIUM ION TRANSPORT INTO CYTOSOL%GOBP%GO:0060402,0.538978863573978,0.8142313733497609,0.189172998898607,0.945156011848274,3926,39,DRD2|XCL1|NOL3|FGF2|FAM155A|CACNA1C|RYR1|PKD2|TRPV1|ATP2B4|ITPR1|JPH3|SLC8A1|JPH1|CACNA2D1|CCR7|CACNB3|FAM155B|CCL21|IBTK
REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060159,0.43889980353634606,0.76475941858134,-0.391708870692894,-1.00758073634939,3350,6,CAV2|DTNBP1|PRMT5
POSITIVE REGULATION OF CARDIAC VENTRICLE DEVELOPMENT%GOBP%GO:1904414,0.4647363527692921,0.7785465206362571,0.7688575209528009,1.02516776004911,3498,1,BMPR1A
POSITIVE REGULATION OF CELL CYCLE ARREST%GOBP%GO:0071158,0.8815043791859871,0.9622426269432679,-0.125484274547044,-0.7313672886190798,6843,71,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|RPL23|FOXO4|SFN|CDKN1B|CNOT6|AURKA|PIDD1|ID2|PRMT1|PML|RGCC|TRIAP1|TFDP2|DAB2IP|PLK2|PCNA|CDC25C|BRCA1|FAP|E2F1|CCNB1|GATA6|PLAGL1|TNKS1BP1|PRKACA|RRP8|ZNF385A
NEGATIVE REGULATION OF GRANULOCYTE CHEMOTAXIS%GOBP%GO:0071623,0.121070234113712,0.472999327000989,-0.937858403176003,-1.2494525861132701,904,1,SLIT2
REGULATION OF APPETITE%GOBP%GO:0032098,0.596778596778597,0.844613508628182,0.289841067123116,0.8808002709478101,4371,9,BBS4|NENF|MKKS|BBS2
CATABOLISM BY ORGANISM OF PROTEIN IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052363,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
"REGULATION OF SUBSTRATE-DEPENDENT CELL MIGRATION, CELL ATTACHMENT TO SUBSTRATE%GOBP%GO:1904235",0.173645484949833,0.5478649030775731,-0.9110057344508159,-1.2136783836653202,1297,1,FN1
REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES%GOBP%GO:0048302,0.5446153846153851,0.817297924969912,-0.7306462284958092,-0.9733962148619529,4070,1,NDFIP1
BONE MATURATION%GOBP%GO:0070977,0.607786885245902,0.8493425539243421,0.29930076695007,0.868817764967932,4448,8,PLXNB1|XYLT1|RYR1
POSITIVE REGULATION OF MICROGLIA DIFFERENTIATION%GOBP%GO:0014008,0.5966555183946489,0.844613508628182,-0.705668284075871,-0.940119595336448,4459,1,TGFB1
THREONINE METABOLIC PROCESS%GOBP%GO:0006566,0.8992063492063491,0.967562624209366,-0.330667046151703,-0.645708933915948,6797,3,SDSL
REGULATION OF REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0045589,0.11723145361768901,0.46811801288741794,-0.361661200636262,-1.37440087871303,895,17,TNFRSF18|LILRB2|SOCS1|IL2RA|C10orf54|LGALS9|BCL6|LILRB4
BOX C/D SNORNA PROCESSING%GOBP%GO:0034963,0.8268771557442289,0.943041978946366,-0.44637441411635,-0.7428384057252809,6232,2,FBL|FBLL1
ENDOTHELIAL CELL-CELL ADHESION%GOBP%GO:0071603,0.14920634920634898,0.5157600394920371,-0.674809749641557,-1.31773241122199,1127,3,THBS4|JUP|NOV
REGULATION OF RELAXATION OF CARDIAC MUSCLE%GOBP%GO:1901897,0.0779852709100473,0.390894089449544,-0.615324497397372,-1.47481540554019,592,5,PLN|PDE4B|PDE4D|CHGA
SCARNA LOCALIZATION TO CAJAL BODY%GOBP%GO:0090666,0.988953182535508,0.9961107928457941,-0.207652878548485,-0.49770432606439596,7519,5,DKC1
POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0030810,0.014437590234938999,0.16079417073357402,-0.42826728968959293,-1.7447640218650702,109,21,GUCA1A|PID1|PFKFB2|PFKFB3|INS|VCP|ENO1|IGF1|NOS3|TMSB4X
ATP HYDROLYSIS COUPLED ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0099131,0.24801587301587302,0.62852193925262,-0.6148671004742471,-1.20067960980021,1874,3,ATP6V1H|ATP1A1|ATP1A3
"DNA CATABOLIC PROCESS, EXONUCLEOLYTIC%GOBP%GO:0000738",0.602595296025953,0.8480120088902141,0.361846459298478,0.870238659600323,4457,5,XRN2|ERI3|ERI1|GEN1
MICROTUBULE DEPOLYMERIZATION%GOBP%GO:0007019,0.8464163822525601,0.949216083775675,-0.19378115693862402,-0.7035879691556661,6447,15,KIF18B|KIF18A|CKAP5|KIF2A
DNA METHYLATION ON ADENINE%GOBP%GO:0032775,0.2,0.577896180140049,-0.897496691662991,-1.19568109495948,1494,1,N6AMT1
POSITIVE REGULATION OF HAIR FOLLICLE MATURATION%GOBP%GO:0048818,0.7173097534833871,0.900060477413567,0.487923555305336,0.8197745712732559,5353,2,GAL|TGFB2
CELLULAR RESPONSE TO VASOPRESSIN%GOBP%GO:1904117,0.358613361668216,0.714938712241162,0.821956329951478,1.09596785707488,2699,1,ADCY6
ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT%GOBP%GO:0010248,0.9016613076098609,0.9684180373391851,0.3884201819685689,0.652596056666916,6729,2,BAX|BAK1
PANCREATIC JUICE SECRETION%GOBP%GO:0030157,0.40916420317119107,0.7448505271608159,0.53475930728902,1.05180845168742,3044,3,AQP5|COPA|AQP1
INORGANIC ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098660,0.277998208114681,0.653204101106396,-0.14260504039125302,-1.08851358675139,2171,251,SLC25A27|SLC39A1|CCL19|KCNA3|KCND2|RYR2|GABRE|SLC36A1|TCIRG1|ITPR2|ATP6V0B|ATP1B1|CCDC109B|ATP2A1|APOL1|P2RX4|SLC12A8|ERO1L|SLC39A3|ATP5J|ITPR3|SLC8B1|ATP1A3|ATP5F1|SLC12A2|PMPCA|ATP1B3|SLC25A10|KCNN2|GAS6|ATP6V1F|KCNK6|SLC39A8|CACNA1H|ATP2A3|GRIN1|SLC41A1|ATP5B|SLC37A2|KCNK7|ATP6V0D1|SLC9A1|CACNA2D4|PKD2L1|SLC26A2|SLC39A11|ABCC9|SLC9A7|SLC11A1|CACNA1G|MRS2|NALCN|SLC1A3|NDUFS7|SLC9A9|ATP5O|KCNJ12|KCNN1|SLC24A3|HFE|F2R|KCNQ1|STEAP4|TMCO1|KCNB2|ATP6V0E1|GRIN2C|GRIN2D|FKBP1A|SCN1B|STOML2|ATP6AP1|ATP1B2|KCNH2|ATP6V0E2|KCNE4|ATP5H|KCNJ9|PHB|ATP5G1
NEGATIVE REGULATION OF INTERFERON-ALPHA PRODUCTION%GOBP%GO:0032687,0.778439153439154,0.924704689181848,-0.385505206701001,-0.7527939627940721,5884,3,HAVCR2
PATTERN SPECIFICATION PROCESS%GOBP%GO:0007389,0.11220800889877601,0.459194647507502,0.18611494915183802,1.26060586247808,806,129,LRRC6|BBS5|ACVR1|SFRP1|LRP5L|DNAI1|NPHP3-ACAD11|FGFR2|DLL1|BBS4|PAX8|TBX3|HES7|AHI1|DYX1C1|WNT2B|BMI1|RFX3|SETDB2|KIF3B|ASCL1|TTC8|SMAD1|ACVR2A|HES6|DVL2|MKKS|ACD|NPHP3|PKD2|LEFTY1|CITED2|CCDC40|SKI|HES4|LRP6|BBS7|CELSR2|BMPR1A|MEGF8|FOXJ1
PHOSPHATIDYLSERINE METABOLIC PROCESS%GOBP%GO:0006658,0.0128794848206072,0.149991146428462,-0.4508606484901211,-1.78130836059502,97,19,PLA1A|PTDSS2|PLA2G2A|PLA2G2D|PLSCR1|PLA2G4D|PLA2G4A|SERINC5|PLA2G16|OSBPL5|PLA2G12A
ERYTHROCYTE MATURATION%GOBP%GO:0043249,0.32248124330117894,0.6906261309079051,0.6735594154948988,1.13166678480783,2406,2,G6PD|ZBTB7A
WYBUTOSINE BIOSYNTHETIC PROCESS%GOBP%GO:0031591,0.630484988452656,0.8611032652135849,0.39088603428105495,0.858793264228759,4640,4,TYW5|TRMT12|TYW3
D-ASPARTATE TRANSPORT%GOBP%GO:0070777,0.145767195767196,0.512646109386394,-0.6769361697067571,-1.3218847706703798,1101,3,SLC1A2|SLC1A3
POSITIVE REGULATION OF METANEPHRIC MESENCHYMAL CELL MIGRATION%GOBP%GO:2000591,0.000529100529100529,0.0139529201631112,-0.93448770265799,-1.8248176383564498,3,3,PDGFRB|PDGFA|PDGFB
REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:0090266,0.0207131620346093,0.19828362800876603,-0.484695816116004,-1.71478291854923,157,14,CDT1|LCMT1|CDK5RAP2|MAD2L1|NDC80|USP44|CCNB1|XRCC3
PROTEIN METHYLATION%GOBP%GO:0006479,0.832841186288355,0.9443921657118071,-0.1298500560615,-0.7751811800544409,6486,78,SETD1B|VCPKMT|FAM173B|SETMAR|LCMT1|EZH2|ETF1|NSD1|PAXIP1|SETD8|OGT|METTL12|CTR9|TRMT112|N6AMT1|WDR5|PRMT3|SNRPB|PAGR1|HIST1H1C|PRMT5|NTMT1|SUV39H1
PROTEIN-CARBOHYDRATE COMPLEX ASSEMBLY%GOBP%GO:0065006,0.39917750066330604,0.739115199741709,-0.6401985111662529,-1.06539269801983,3008,2,HLA-DRB1|HLA-DRA
EXOCRINE SYSTEM DEVELOPMENT%GOBP%GO:0035272,0.62320800649175,0.8572215777001558,0.309645630755727,0.854768452326612,4607,7,FGFR2|IGSF3
POSITIVE REGULATION OF CATION CHANNEL ACTIVITY%GOBP%GO:2001259,0.253307870686127,0.632257972333528,0.244792088893535,1.1657115266501399,1856,33,ANK2|GSTM2|EPHB2|RNF207|KCNIP2|HTT|GAL|HAP1|PKD2|CACNB2|STAC2|STAC|NOS1AP|CACNA2D1|CACNB3
SECONDARY PALATE DEVELOPMENT%GOBP%GO:0062009,0.161188948540003,0.531339605249002,-0.378482942364776,-1.30281168375279,1230,13,TGFB2|SOX11|TBX1|COL11A2|TGFB3|LRRC32|TGFBR2|TGFBR3
RESPONSE TO IONIZING RADIATION%GOBP%GO:0010212,0.16437308868501502,0.535643394219061,-0.19842513632350697,-1.2204764301985902,1289,87,CLOCK|NIPBL|MAPK14|BLM|FIGNL1|INO80|MTA1|HSF1|FANCD2|XRRA1|UIMC1|RAD9A|RAD51|NABP2|EEF1D|INTS7|KDM1A|H2AFX|ECT2|INIP|PAXIP1|RAD51AP1|RAD1|BRCC3|GRB2|RHNO1|DCUN1D3|RNF168|BRCA1|TOPBP1|NUCKS1|HRAS|MEN1|IFI16|TMEM109|TLK2|CRYAB|TNKS1BP1|MYC|YAP1|KAT5|POLE3|ANXA1|NET1
POSITIVE REGULATION OF NEUROFIBRILLARY TANGLE ASSEMBLY%GOBP%GO:1902998,0.829163879598662,0.9433761342424741,-0.58893912659903,-0.7846083292536808,6197,1,CLU
POSITIVE REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS%GOBP%GO:0060697,0.910453701247015,0.9720943283119721,-0.390129583677971,-0.649238013651187,6862,2,PRKCD|APOC2
LYMPHOCYTE AGGREGATION%GOBP%GO:0071593,0.753439153439154,0.9155261442589929,-0.3956156658200129,-0.7725371269681729,5695,3,RAC2|MSN
S-ADENOSYL-L-METHIONINE TRANSPORT%GOBP%GO:0015805,0.16469650684021803,0.53617826809138,0.919497132774592,1.2260253561803602,1239,1,SLC25A26
PEPTIDYL-ASPARTIC ACID MODIFICATION%GOBP%GO:0018197,0.210292932007525,0.591484586782714,0.6353810521672,1.24971954971568,1564,3,HIF1AN|ATP13A2|NAT6
"REGULATION OF ACETYLCHOLINE SECRETION, NEUROTRANSMISSION%GOBP%GO:0014056",0.504183822552796,0.797772889025646,0.748842082046758,0.9984798730082449,3795,1,CHRNA3
HISTONE H3-K36 METHYLATION%GOBP%GO:0010452,0.261353226017537,0.637166314747009,-0.548109013673774,-1.19992520630128,1996,4,SETD2|SETD3|SETMAR
GDP-FUCOSE IMPORT INTO GOLGI LUMEN%GOBP%GO:0036085,0.7055518394648829,0.894639008000397,-0.650198500220556,-0.866220524160603,5273,1,SLC35C1
"REGULATION OF PHAGOCYTOSIS, ENGULFMENT%GOBP%GO:0060099",0.248461034708579,0.629072495919397,-0.4647998367074361,-1.1955903906295,1896,6,NCKAP1L|CD300A|ITGAM
NUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0009116,0.0955816050495942,0.42595828544352005,-0.234061165605852,-1.34417997038708,741,67,TYMP|APOBEC3C|RAN|CTPS1|HPRT1|CDA|MOCS2|MBIP|NUDT18|UMPS|MACROD2|GMPS|TK1|ENPP4|PNP|ERH|GPHN|UCK1
SPHINGOLIPID MEDIATED SIGNALING PATHWAY%GOBP%GO:0090520,0.97218489653319,0.9915747942934481,0.276263647654679,0.543377993681442,7234,3,EZR|S1PR2
PEPTIDYL-LYSINE MODIFICATION%GOBP%GO:0018205,0.21736342651962,0.5996151428055749,-0.158067412709225,-1.14219810663613,1694,185,NAA40|SETD1B|VCPKMT|FAM173B|KAT6A|KANSL1|LIPT2|SETMAR|PLOD2|KANSL2|JADE3|EZH2|TRIM28|YEATS4|TAF6L|BRPF3|RUVBL1|PAXIP1|SETD8|HCFC1|OGT|TAF12|MORF4L2|MSL2|METTL12|SENP2|SENP5|PHF20|SUMO2|LOXL1|PARK7|IFIH1|NAA50|CTR9|JMJD6|GLRX5|LOX|WDR5|KAT7|SUMO3|TAF9B|SPI1|MBIP|KAT2B|NDUFAB1|SIRT4|APBB1|TAF10|PAGR1|KAT8|KAT5|TAF9|POLE3|HIST1H1C|CCDC101|RNF113A|AK6|LOXL2|SUV39H1
CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS%GOBP%GO:0036295,0.10230547550432302,0.441073279931729,-0.43931170416313203,-1.4222952780767,780,11,ATG7|ATP6V0A2|ATP6V0D1|CAV1|ATP6AP1|ATP6V1A|ATP6V1G1
REGULATION OF PROTEIN DEPOLYMERIZATION%GOBP%GO:1901879,0.0196319018404908,0.192628124925339,0.311616470873852,1.6172495292548201,143,44,RLTPR|CLASP1|ADD3|KATNB1|CLASP2|SPEF1|FAM21C|NES|TTBK2|LRRC16A|CAMSAP3|WDR1|STMN2|TRIOBP|TWF1|ADD1
CELLULAR RESPONSE TO COPPER ION%GOBP%GO:0071280,0.0482053969085669,0.314649813998106,-0.48567361444462603,-1.57239445697656,367,11,MT1X|HSF1|AQP1|MT1G|MT1M|MT2A|MT1E|PRNP
SMOOTHENED SIGNALING PATHWAY%GOBP%GO:0007224,0.0010878433505575199,0.0248493430739077,0.490724733408524,2.1138572991065003,7,24,CC2D2A|STK36|PTCHD2|TMEM17|PTCHD1|SEPT2|TTBK2|TMEM231|TCTN2|B9D1|IFT27|PTCH2|MAP3K10
NEGATIVE REGULATION OF PEPTIDYL-CYSTEINE S-NITROSYLATION%GOBP%GO:1902083,0.0847890352055899,0.40376145987147494,0.728024704974082,1.4319386821165099,630,3,DMD|ATP2B4|SNTA1
LATERAL MESODERM DEVELOPMENT%GOBP%GO:0048368,0.746630022248397,0.911868716700273,-0.352639528665646,-0.7720016431548008,5704,4,SMO|MESP1
NEGATIVE REGULATION OF FOREBRAIN NEURON DIFFERENTIATION%GOBP%GO:2000978,0.34675585284280896,0.7038391566282349,-0.823610498456109,-1.09724694448668,2591,1,HES1
GLUCOSAMINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901073,0.200267558528428,0.578098211195516,-0.897441552712836,-1.19560763663823,1496,1,GNPNAT1
REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:2000116,0.000257102455328448,0.00819882332206558,-0.275694537822264,-1.9281975718979198,1,157,FIS1|PYCARD|APOPT1|GNB2L1|FNIP1|RPS6KA1|TRIAP1|IGBP1|REST|PPM1F|KLF4|TNFRSF10A|TNFRSF10B|PDCD6|HGF|CASP10|NGF|PDCD5|GAS6|GPX1|CASP1|GRIN1|VCP|TRAF2|DDX3X|SIAH2|TNFSF10|CAAP1|CYCS|CASP4|PARK7|F3|PERP|IFI27L1|ANP32B|DPEP1|CARD16|IFI6|IFI16|NAIP|CAST|CYFIP2|GPER1|CIDEB|GSN|F2R|USP47|DLC1|PLAUR|NLRP3|ASPH|LGALS9|THBS1|XIAP|FADD|MMP9|BCAP31|MYC|PPARG|BCL2L12|ARL6IP1|S100A8|S100A9|ARL6IP5|LGMN|NGFRAP1|DHCR24|NGFR|BAD
PROTEIN ARGINYLATION%GOBP%GO:0016598,0.6203108252947479,0.85518258472662,0.54030925937537,0.907789317902954,4629,2,ATE1|C17orf97
POSITIVE REGULATION OF OSSIFICATION%GOBP%GO:0045778,0.0630992485099767,0.36006266503904,-0.2895811888596839,-1.45923410363523,486,42,TGFB3|DDR2|IL6ST|MEF2C|PRKD1|ISG15|IGF1|LRP5|GPM6B|BMP2|ATP6AP1|IFITM1|TMEM119|ADGRV1|ZHX3
REGULATION OF RETINA DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:1902866,0.7961569470572429,0.9299728593747351,0.376640564685122,0.7408075442247959,5924,3,POU4F2|SIX3
CHROMATIN SILENCING AT TELOMERE%GOBP%GO:0006348,0.41050792797634994,0.7453853667476059,0.533086156179604,1.04851756090002,3054,3,RIF1|DOT1L|SIRT2
REGULATION OF CATECHOLAMINE METABOLIC PROCESS%GOBP%GO:0042069,0.47565593724641597,0.784986345464663,0.35166351945016494,0.9707577062415479,3516,7,PARK2|DRD4|CHRNB2
NEGATIVE REGULATION OF CHOLESTEROL EFFLUX%GOBP%GO:0090370,0.504214046822743,0.797772889025646,-0.7516541685046321,-1.00138383525758,3768,1,SREBF2
POSITIVE REGULATION OF PEPTIDYL-TYROSINE AUTOPHOSPHORYLATION%GOBP%GO:1900086,0.535449735449735,0.8132910857498922,-0.487258695489399,-0.9514927370820941,4047,3,ACE|GREM1
CAROTENE METABOLIC PROCESS%GOBP%GO:0016119,0.791074511887369,0.928357780000476,0.603936921041023,0.8052683932743759,5955,1,BCO2
MYELIN ASSEMBLY%GOBP%GO:0032288,0.0751961049499594,0.384240263522456,0.543237083186261,1.4995913868000001,555,7,TENM4|EPB41L3|GPC1|CD9|CNTNAP1|PMP22
REGULATION OF PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE ACTIVITY%GOBP%GO:0150073,0.146755852842809,0.514049001465687,-0.9252315835906478,-1.2326306305474,1096,1,CD200
HEAD DEVELOPMENT%GOBP%GO:0060322,0.181754777514298,0.554948538055731,0.147680677465871,1.15192728433301,1302,262,FOXC1|CNTN4|STRA6|EFHC1|SCN5A|DRD2|CTNNA2|FGFR2|DLL1|BBS4|SYNGR3|ROGDI|AHI1|FAT4|SLIT1|EPHB2|RTN4|HESX1|PAFAH1B2|WNT2B|ABCB6|TACC2|LAMB1|ROBO2|PTCHD1|NES|CHRNB2|ASCL1|CRISPLD1|KLHL17|RAB3GAP1|BMP7|TTBK2|CHD5|CTNS|SLIT3|GNB4|WDR11|CDK5R1|SEMA4C|PCM1|CEP290|YWHAQ|ADCYAP1|ATP7A|HAP1|MBOAT7|ADGRL2|GLUD1|DRAXIN|PEX13|SLC6A17|MKKS|KDM7A|NF1|CA10|ADCK4|MAOB|ATXN1L|SPATA5|CLN5|YWHAE|UTP3|SKI|BBS2|C21orf91|PLXNB2|CHD7|NNAT|AGTPBP1|METTL14|NR4A2|LRP6|YWHAH|DOCK7
REGULATION OF B CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002622,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
BUTYRATE CATABOLIC PROCESS%GOBP%GO:0046359,0.472174259529818,0.7831522581932591,0.7648323775915308,1.01980077450095,3554,1,ACADS
CELLULAR AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009063,0.34468380820013894,0.702388156466409,0.17629496103043102,1.0736382140857499,2479,80,AASS|AADAT|GCSH|DDAH1|GLS|ADHFE1|BCKDHB|BLMH|AMT|GLUD1|HIBCH|PCBD1|QDPR|HMGCLL1|HOGA1|ACADSB|ACAT1|SHMT1|GCDH|PIPOX|CSAD|PCYOX1|ACAD8|HRSP12|GLS2|CTH|HMGCL|ALDH7A1|TXN2|MPST|IVD|GSTZ1
T-HELPER 17 CELL DIFFERENTIATION%GOBP%GO:0072539,0.442166140904311,0.7653693162885199,-0.3688717072242779,-1.00829436209859,3363,7,IL6|RORC|BATF|RORA|STAT3
REGULATION OF APOPTOTIC PROCESS INVOLVED IN METANEPHRIC COLLECTING DUCT DEVELOPMENT%GOBP%GO:1900214,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
REGULATION OF BROOD SIZE%GOBP%GO:0060378,0.778589454110772,0.924704689181848,0.610277900308778,0.813723233521482,5861,1,TEKT3
REGULATION OF GROWTH%GOBP%GO:0040008,0.00154400411734431,0.0323260517898055,-0.199718708756295,-1.58431825138093,11,318,GOLGA4|PPIB|TAOK2|DDX3X|RERG|CPNE6|CHPT1|SGK1|NOTCH1|INHBA|MEF2C|LGI1|DCUN1D3|NCBP1|CISH|DSCAM|TRIM32|MMP14|ENO1|NOTCH2|CPNE5|PIM1|GHRL|RBBP7|ABL1|SOD1|NTN1|WWC3|IGF1|SEMA3B|SEMA3D|MAP3K13|EIF4G2|MT1M|RPTOR|SEMA7A|N6AMT1|CDA|CEACAM1|CXCL16|TAF9B|NPR1|PSMD10|APOE|USP47|PPP2CA|HYAL1|NOV|TGFBR3|BST2|ZP3|FXN|MT2A|WFDC1|SEMA5A|TMEM97|DACT3|LATS2|SEMA3E|SLIT2|APBB1|FAM107A|SEMA3A|SEMA6B|PLAA|OSBP|BCL6|S100A8|CDKN2C|S100A9|TAF9|OSGIN1|MT1E|H3F3B|PHB|NDUFS3|TFRC|ACVRL1|EXOSC2|SPHK1|AK6|NET1|FAM122A|PTPRJ|EIF4G1
REGULATION OF DNA DOUBLE-STRAND BREAK PROCESSING%GOBP%GO:1903775,0.920668612364022,0.9768961564057891,-0.38309267439519396,-0.6375274713182459,6939,2,WDR70
POSITIVE REGULATION OF RNA SPLICING%GOBP%GO:0033120,0.10294885177453,0.44146292546620297,-0.317053150805432,-1.38304374357692,788,26,RBMX|DYRK1A|NCBP1|SNW1|CELF4|RBM22|TRA2B|NUP98|ERN1
GTP METABOLIC PROCESS%GOBP%GO:0046039,0.47647538754419394,0.785008843326641,0.250548618734645,0.9807542000081709,3503,18,NFS1|RHOQ|GNAI3|RAB23|MFN1|EFTUD1|AK4|MOCS3
NEGATIVE REGULATION OF MICROTUBULE BINDING%GOBP%GO:1904527,0.0852090032154341,0.40376145987147494,0.8227736421284809,1.3823659513809,635,2,TTBK2|MAP2
NEGATIVE REGULATION OF TRANSCRIPTION BY TRANSCRIPTION FACTOR LOCALIZATION%GOBP%GO:0010621,0.56521164021164,0.829765064532093,-0.47238685825913795,-0.922451808223046,4272,3,ID1
LEADING EDGE CELL DIFFERENTIATION%GOBP%GO:0035026,0.0729096989966555,0.380062173460375,-0.96206440229378,-1.2817007891413,544,1,DAB2
PEPTIDYL-HISTIDINE DEPHOSPHORYLATION%GOBP%GO:0035971,0.309966555183947,0.680816461591689,-0.842137185707984,-1.12192894042613,2316,1,PHPT1
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION%GOBP%GO:0045987,0.0247108307045216,0.22073142788434805,-0.610526211096616,-1.66884617200486,187,7,GPER1|F2R|SRF|SPHK1
REGULATION OF CHAPERONE-MEDIATED PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0090034,0.293542336548767,0.666121490214324,0.6871794871794871,1.15455026379658,2190,2,STUB1|HDAC6
BONE MINERALIZATION%GOBP%GO:0030282,0.297260645511256,0.6692652587893061,0.316611680694682,1.1380198553765501,2191,14,TUFT1|CYP27B1|FGFR2
REGULATION OF INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE ACTIVITY%GOBP%GO:0010924,0.37618729096990006,0.7266197487465021,-0.810101455668284,-1.07924965578083,2811,1,PLEK
MELANOSOME ASSEMBLY%GOBP%GO:1903232,0.143594620296155,0.509884136342556,0.6127442036045,1.34622511064797,1056,4,HPS1|HPS4|RAB32|TRAPPC6A
CELLULAR RESPONSE TO COCAINE%GOBP%GO:0071314,0.29886287625418106,0.671387424531401,-0.8471548301720341,-1.12861364765973,2233,1,CRHBP
REGULATION OF AEROBIC RESPIRATION%GOBP%GO:1903715,0.0786428195686481,0.393097409792852,-0.613785651223759,-1.4711270849009197,597,5,CBFA2T3|VCP|SHMT2
REGULATION OF PROTEIN HOMODIMERIZATION ACTIVITY%GOBP%GO:0043496,0.0760172707052205,0.3854629577921479,-0.38532597331636204,-1.4643327937452502,580,17,TRAF2|SYAP1|MEF2C|PARK7|LGALS3|HSPA5|STPG1
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:1900748,0.501183587585481,0.795954687014814,-0.396936884756002,-0.9513819702309548,3810,5,ROBO1|KIAA1462|SMOC2|CCBE1
REGULATION OF NEURON APOPTOTIC PROCESS%GOBP%GO:0043523,0.7378990731204941,0.9086435088072349,-0.14091268949238098,-0.8362000375868229,5731,76,MEF2C|PARK7|SOD1|AARS|NTRK2|NSMF|NAIP|NONO|CCL2|F2R|APOE|CX3CL1|SIGMAR1|LGMN|PRNP
ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE%GOBP%GO:0061844,0.00196129707112971,0.0387291856838508,-0.479345144747789,-2.03720335148834,14,24,CXCL1|CXCL2|RPL39|HIST1H2BE|HIST1H2BC|ROMO1|HMGN2|GAPDH|RNASE6|HIST1H2BG|S100A9|FAM3A|HIST2H2BE|HIST1H2BK|HIST1H2BJ
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS%GOBP%GO:0071379,0.80999180999181,0.9349881065919259,0.236740412637326,0.7194322794384391,5933,9,SFRP1|ADCY6|AKR1C2|GNB1|AKR1C3
ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION%GOBP%GO:0051295,0.382827196990056,0.730480369014206,0.5479665453278839,1.07778553035323,2848,3,SPIRE2|SPIRE1|FMN2
NUCLEAR INNER MEMBRANE ORGANIZATION%GOBP%GO:0071765,0.9606688963210699,0.990064627444708,-0.519464049404499,-0.6920508444807529,7180,1,TARDBP
PEPTIDYL-THREONINE MODIFICATION%GOBP%GO:0018210,0.49282758620689704,0.791631198367838,0.169081954368901,0.981192093962899,3572,66,GALNT3|ACVR1|GALNTL6|CSNK1G1|CDK10|CAD|TTBK2|VRK3|CDK5R1|GALNT2|VRK2|CSNK1G2|PRKCA|CAMK2D|OXSR1|MAP3K10|VPRBP|TNKS|MAP2K1|CDK5|CSNK1E|MAPK1
CARDIAC CONDUCTION SYSTEM DEVELOPMENT%GOBP%GO:0003161,0.37936507936507896,0.728914030571579,-0.553980745621833,-1.08178399035665,2867,3,MESP1|MAML1
GUANINE BIOSYNTHETIC PROCESS%GOBP%GO:0046099,0.767577606792253,0.9202818175694271,-0.48006588419908097,-0.798906399614093,5785,2,HPRT1
RESPONSE TO ACTINOMYCIN D%GOBP%GO:0072716,0.764166993848973,0.9191113740914171,-0.34694193874118,-0.759528427799864,5838,4,KAT7
NEGATIVE REGULATION OF KERATINOCYTE MIGRATION%GOBP%GO:0051548,0.655117056856187,0.874775007199212,-0.6761689457432729,-0.900819393468578,4896,1,PTEN
TRANSPORT OF VIRUS%GOBP%GO:0046794,0.41740954378605105,0.7499690687478492,-0.291038329361808,-1.02965104966635,3183,14,KPNB1|CAV2|CLEC4M|RAN|UBC|CAV1
MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051817,0.16310504634397502,0.534744357685457,-0.20780155097409803,-1.2331299995841498,1266,76,SERPINB9|CCL4|YTHDC2|TGFB1|AQP1|ATG7|HYAL2|CD209|SMARCA4|ZNF639|REST|CD4|RAB9A|RRAGA|KPNB1|CCNK|AZU1|CAV2|PPIB|FMR1|SLC25A6|CLEC4M|SNW1|NUCKS1|KPNA4|TNIP1|KPNA2|APOE|GAPDH|PABPN1|RRP1B|CFL1|ANXA2|PSMC3
REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE%GOBP%GO:1903076,0.0109479649665121,0.135103761408649,-0.283897053273089,-1.6546536914587302,84,71,PID1|STX4|NUMB|LRP1|CNST|STAC3|INS|CLTC|AKAP5|MMP14|RHOG|PPFIA1|VAMP8|NKD2|TREM2|STX7|GPER1|EPHA2|TMEM59|LGALS3|STX3|DAB2|ACTB|ARF6|AP2M1|SQSTM1|PRNP
NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION%GOBP%GO:1904180,0.854743348562215,0.949296218452153,0.35288909179179495,0.6940911999018289,6360,3,BCL2|SRC
GLUCOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006679,0.22876254180602,0.610365144973336,-0.882443758270843,-1.17562697325867,1709,1,UGCG
MELANOCYTE PROLIFERATION%GOBP%GO:0097325,0.22113712374581895,0.603435805957244,-0.8860829289810319,-1.1804752224610702,1652,1,FAP
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051153,0.0979676915059927,0.43163319977057396,-0.269556601740481,-1.36718175461148,751,43,MESP1|NOTCH1|MEF2C|FAM129B|EHD1|MMP14|IGF1|HDAC5|NOV|BMP2|MAML1|SIK1|EHD2|ADGRB1
CELLULAR RESPONSE TO METHYLGLYOXAL%GOBP%GO:0097238,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
PRE-REPLICATIVE COMPLEX ASSEMBLY%GOBP%GO:0036388,0.9817460317460319,0.993436724391485,-0.267898030962178,-0.5231369559923079,7421,3,CDC45
NEGATIVE REGULATION OF FOLLICLE-STIMULATING HORMONE SECRETION%GOBP%GO:0046882,0.358465608465608,0.714938712241162,-0.563306496084703,-1.0999948174089,2709,3,INHA|INHBB|INHBA
CARTILAGE MORPHOGENESIS%GOBP%GO:0060536,0.0114053487152596,0.139192321351079,-0.5090188256133951,-1.8008341693069898,86,14,MATN2|COL20A1|COCH|VWA1|COL14A1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
MODULATION BY HOST OF VIRAL CATALYTIC ACTIVITY%GOBP%GO:0044867,0.878929765886288,0.960725750963158,-0.563134097926776,-0.7502298349094499,6569,1,PTX3
POSITIVE REGULATION OF CONNECTIVE TISSUE GROWTH FACTOR PRODUCTION%GOBP%GO:0032723,0.740603001726657,0.909493931144346,0.6293008381120421,0.8390877542628009,5575,1,ROCK2
POSITIVE REGULATION OF MAST CELL CHEMOTAXIS%GOBP%GO:0060754,0.338637559179379,0.7001468935792379,-0.46097703518140204,-1.10487399081517,2574,5,VEGFC|VEGFB
MAINTENANCE OF GOLGI LOCATION%GOBP%GO:0051684,0.9952380952380949,0.99843337141011,-0.240322046983567,-0.4692880483864871,7523,3,ARHGAP21|UVRAG|TBCCD1
VIRAL PROTEIN PROCESSING%GOBP%GO:0019082,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
ACTIVATION OF MAPKK ACTIVITY%GOBP%GO:0000186,0.9978243132988851,0.999635137169127,0.0989863992860729,0.426396120671878,7337,24,MAP3K5|CRK|MAP3K4|TAOK1|EIF2AK2|CARTPT|KIDINS220|MAP3K7|MAP3K12
SYNAPTIC VESICLE CLUSTERING%GOBP%GO:0097091,0.37986452384114794,0.729249457747391,0.81181076312307,1.08244011267951,2859,1,SYNDIG1
POLYAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006596,0.42496091714434603,0.7546470443593142,-0.338083686216011,-1.01703848170777,3261,9,AMD1|SRM|SAT1|ODC1|SMOX|SMS
POSITIVE REGULATION OF FEVER GENERATION%GOBP%GO:0031622,0.45318253550762805,0.769943206592495,-0.413555506716443,-0.991213635945181,3445,5,PTGS2|IL1B|TNF|TNFRSF11A
TRANSCRIPTION-COUPLED NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:0006283,0.0650406504065041,0.36649820053831705,-0.239676256129206,-1.4049262136096201,503,73,PCNA|COPS6|POLD1|POLD2|RFC5|POLR2H|GTF2H1|CDK7|UBC|MNAT1|ERCC8|DDB1|POLR2G|ISY1|GPS1|RFC4|XPA|POLR2L|PRPF19|GTF2H2
PHOSPHOLIPID EFFLUX%GOBP%GO:0033700,0.16345776031434198,0.5350520708025429,-0.511604979156723,-1.31598582566411,1247,6,APOC2|APOC1|ABCG1|APOE
NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION%GOBP%GO:0010936,0.437006838506049,0.7635056706929721,-0.41932699827340403,-1.0050467999052601,3322,5,TGFB2|TGFB1|IRAK3|TGFB3
RETINOIC ACID CATABOLIC PROCESS%GOBP%GO:0034653,0.700889892415992,0.8931369333627571,0.649150860167622,0.8655550802537421,5276,1,CYP26B1
REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION%GOBP%GO:0070507,0.519856978674499,0.8050637202008951,-0.141527656965052,-0.970266171797117,4070,141,HNRNPU|PLK2|STAG2|TPX2|FES|DYRK1A|NPM1|CDK5RAP2|PHLDB2|CLTC|BRCA1|MECP2|ABL1|SPICE1|CEP131|TUBB4A|PLK1|SKA1|NSFL1C|RBM14|KAT2B|ARL2|NAV3|FBXW5|FKBP4|FAM107A|SMC1A|CETN2|CDK2AP2|ATF5|MARK2|XRCC3|EFNA5|SKA2
POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:0010571,0.49605470804839596,0.794012168719884,-0.398577101257445,-0.9553132562027981,3771,5,WIZ|DBF4B|ATRX|CDC7|INO80
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN NOREPINEPHRINE BIOSYNTHETIC PROCESS%GOBP%GO:2000763,0.923097356886705,0.9776156396135859,0.53931407146008,0.719102543103869,6949,1,HAND2
NEGATIVE REGULATION OF HYDROLASE ACTIVITY%GOBP%GO:0051346,0.000127844541038098,0.00518555396908895,-0.265772471170199,-1.9599078214640702,0,206,NCKAP1L|VCPKMT|FNIP1|RPS6KA1|TRIAP1|IGBP1|TERF2|AGT|SYTL2|SERPINA3|DAB2IP|SERPINB8|SPOCK2|KLF4|PPIF|OXA1L|PXK|CNST|APOC1|ANGPTL4|PLN|SERPINB1|HGF|TMBIM6|NGF|BOD1|ATPIF1|LMTK3|GAS6|GPX1|PKMYT1|VTN|DDX3X|PLA2R1|CD2BP2|SIAH2|CAAP1|FKBP15|SERPINA1|PARK7|UBXN1|IFIT1|BCAS3|TIMP3|DPEP1|CARD16|ABL1|IFI6|HRAS|RECK|IFI16|NAIP|CAST|TMED2|CRY2|PPP2R4|USP47|GAPDH|PLAUR|FICD|LGALS3|ECM1|SERPINE2|THBS1|SERPINH1|XIAP|DLG3|ELFN2|ARL2|MNAT1|FKBP1A|MMP9|RRP1B|SERPINE1|CSTB|BCL2L12|ARL6IP1|CCDC8|STYXL1|TIMP1|ANXA1|RGS2|SERPING1|NGFRAP1|DHCR24|NGFR|SERPINF1|SERPINF2|CST3
LYMPHOCYTE DIFFERENTIATION%GOBP%GO:0030098,0.32462877624167896,0.692794968343412,-0.17301457335819098,-1.08054311157252,2535,93,BLM|ITGA4|PLCG2|RORC|FOXP3|CD1D|MFNG|JAK3|DOCK11|ITGB1|DOCK10|GPR183|CEBPG|CD74|FNIP1|RIPK3|TNFSF8|SLAMF8|BATF|ZFP36L1|CD4|RORA|SPN|FCGR2B|PLA2G2D|PTGER4|STAT3|NFAM1|FCER1G|NOTCH2|RSAD2|KLF6|HDAC5|VCAM1|LRRC8A|JAG2|FADD|RELB|FOXP1|IL11|ANXA1|PTPRJ
REGULATION OF CYTOLYSIS%GOBP%GO:0042268,0.611438293417092,0.8517857988964052,-0.39818698851750395,-0.87171455390027,4671,4,LILRB1|RRAGA
DOUBLE-STRAND BREAK REPAIR VIA SYNTHESIS-DEPENDENT STRAND ANNEALING%GOBP%GO:0045003,0.201998947922146,0.580549715779131,-0.527147420094285,-1.26347177697973,1535,5,BLM|DMC1|RAD51|XRCC3
REGULATION OF HAIR FOLLICLE CELL PROLIFERATION%GOBP%GO:0071336,0.253244147157191,0.632257972333528,-0.870533745037495,-1.15975997586903,1892,1,FGF10
REGULATION OF EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX ASSEMBLY%GOBP%GO:1905535,0.007759197324414721,0.10744152749969199,-0.9961954124393471,-1.32717148999403,57,1,EIF4G1
MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION%GOBP%GO:0071694,0.0336343410548358,0.261633782155535,-0.717766895361977,-1.57134177418593,256,4,FBN1|LTBP1|NBL1
PROSTAGLANDIN SECRETION%GOBP%GO:0032310,0.00610970912471776,0.0914854365410948,0.9963608292898101,1.32851272404528,45,1,ABCC4
LONG-CHAIN FATTY-ACYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0035338,0.21001573151546898,0.5913074684848161,-0.347666911128781,-1.22999469095009,1601,14,ACSL5|ACSL4|ELOVL2|ACSF3|ELOVL1|HACD2
REGULATION OF CELL PROLIFERATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:1901963,0.861236402228708,0.952004809592153,-0.4256961676316521,-0.708426496874511,6491,2,CTNNB1|BMP4
HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS%GOBP%GO:0030201,0.215227736233855,0.5981517938863679,0.29248826235641806,1.22404949017417,1582,22,HS6ST3|HS6ST1|NDST3|SULF2|XYLT1|HS6ST2|NDST2|GLCE|HPSE
LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL%GOBP%GO:0061756,0.0246460409019402,0.220509499393318,-0.47534168437356,-1.68168936833388,187,14,SELP|GOLPH3|ADD2|ITGA4|ROCK1|TNF|ITGB1|SELPLG|SPN|MADCAM1|VCAM1|PODXL2
REGULATION OF DIPEPTIDE TRANSPORT%GOBP%GO:0090089,0.8973202440965771,0.967166974453851,-0.402923115333027,-0.6705284961647321,6763,2,CA2
CALCIUM-DEPENDENT SELF PROTEOLYSIS%GOBP%GO:1990092,0.795723203612698,0.929859721636317,0.601400529333922,0.8018864571755341,5990,1,CAPN3
PROTEIN LOCALIZATION TO SECRETORY GRANULE%GOBP%GO:0033366,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
NEPHRON EPITHELIUM MORPHOGENESIS%GOBP%GO:0072088,0.24966023375917398,0.630296201866725,0.315359729766885,1.18743397340163,1836,16,CITED1|PAX8|AHI1|FGF2|PKD1|PKD2|FGF1
EYELID DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0061029,0.110492737885164,0.45598560481340505,0.5463223914593329,1.4136412981421598,813,6,STRA6|HDAC1|TWIST1
DRUG CATABOLIC PROCESS%GOBP%GO:0042737,0.22560132706663003,0.6083599141984499,0.19413168977269601,1.1681783212827601,1631,76,XPNPEP1|SULT1C4|GNPDA2|CTBS|GCSH|ADAL|CYP2D7|CECR1|PXDN|CYP2E1|PRDX3|COLQ|PXDNL|AMT|CYP2C8|PCBD1|QDPR|HBQ1|ACAT1|MAOB|PIPOX|DPYD|PM20D2
T FOLLICULAR HELPER CELL DIFFERENTIATION%GOBP%GO:0061470,0.23282037675776102,0.616523546447917,-0.7166804521643231,-1.19267087822254,1754,2,GPR183|FOXP1
NEGATIVE REGULATION OF AXON GUIDANCE%GOBP%GO:1902668,0.0859692873080457,0.4057980029059221,-0.35177647421013897,-1.43313988884197,654,21,SEMA3B|SEMA3D|SEMA7A|SEMA5A|SEMA3E|SLIT2|SEMA3A|SEMA6B
CELLULAR RESPONSE TO METAL ION%GOBP%GO:0071248,0.873931351282378,0.9595052445364269,-0.11926255439685801,-0.757409674585592,6848,99,ZNF658|CDKN1B|AKT1|MT1X|ITPKB|CPNE7|HSF1|CPNE4|IQGAP1|ALOX5AP|AQP1|RASA4|MT1G|B2M|GUCA1A|ECT2|PPIF|P2RX4|SYT4|SYT7|CACNA1H|SLC41A1|CPNE6|ADCY8|CRHBP|MEF2C|MAPK9|CPNE5|MAPK3|DPEP1|MT1M|HFE|MT2A|MMP9|MT1E|LGMN|ADGRV1|PRNP
MAINTENANCE OF PROTEIN LOCATION%GOBP%GO:0045185,0.0151630988786952,0.166148433567765,-0.25849397873995,-1.58994880510503,118,87,PML|TMSB15A|GET4|SP100|GPAA1|TONSL|JUP|CD4|TAF3|SPTBN4|HNRNPU|TLN1|HK1|CCDC22|PARK7|DBN1|FBN1|LTBP1|SRGN|FLNA|KDELR2|SKP1|KDELR1|BCL3|MDFI|GSN|PSMD10|NFKBIA|SUN2|NBL1|ARL2|SYNE3|CAV1|KDELR3|HSPA5|TMSB4X|INSIG1
CELLULAR SENESCENCE%GOBP%GO:0090398,0.592930742141646,0.8422269872864581,-0.204217725771884,-0.900699940755347,4545,27,ID2|PML|KAT6A|TERF2|CDKN2A|OPA1|TBX2|PLA2R1|CDKN2B|CALR|HRAS|SRF
NEGATIVE REGULATION OF INORGANIC ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903796,0.998007703546288,0.999656642395059,0.501268195853551,0.668373501621232,7513,1,ANO9
POSITIVE REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036494,0.5728428093645479,0.8348160652839041,-0.717798853109837,-0.956280426011086,4281,1,DNAJC3
POSITIVE REGULATION BY SYMBIONT OF HOST PHAGOCYTOSIS%GOBP%GO:0052191,0.32846327533537,0.6950398637731511,0.835410233789149,1.11390682246874,2472,1,ITGAV
RESPONSE TO POTASSIUM ION%GOBP%GO:0035864,0.414436334144363,0.748680069094768,0.42435264190031297,1.02056567031534,3065,5,DLG2|CARF|DLG4
RENAL TUBULE DEVELOPMENT%GOBP%GO:0061326,0.258868128892499,0.636098664976652,0.28852257848505797,1.16931662566196,1911,20,CITED1|PAX8|AHI1|FGF2|PKD1|TFAP2B|PKD2
REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034182,0.702291070033845,0.893221903911413,-0.27796503211443396,-0.8002224233491351,5394,8,ANKRD32|NAA10|H2AFY
NEGATIVE REGULATION OF ALDOSTERONE METABOLIC PROCESS%GOBP%GO:0032345,0.61005291005291,0.850714570847612,-0.45228383087048707,-0.8831956908243579,4611,3,REST|BMP2
CELLULAR RESPONSE TO SODIUM ARSENITE%GOBP%GO:1903936,0.150578642819569,0.517264655410678,-0.5570814030443421,-1.33521782218133,1144,5,DAXX|ZC3H12A|HSF1|HNRNPA1|MAPK13
DOUBLE-STRAND BREAK REPAIR VIA SINGLE-STRAND ANNEALING%GOBP%GO:0045002,0.217419777341192,0.5996151428055749,-0.48089917632880097,-1.23700222907405,1659,6,SLX1B|SLX1A|RNF138
POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS INVOLVED IN CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:2000777,0.764603429796356,0.9191113740914171,0.466035111024537,0.782999158750076,5706,2,PLK3|SIRT2
POSITIVE REGULATION OF METANEPHROS DEVELOPMENT%GOBP%GO:0072216,0.134835852006253,0.496999008474418,-0.452116915310208,-1.36007834701525,1034,9,PDGFRB|MYC|PDGFA|PDGFB
MITOTIC CYTOKINETIC PROCESS%GOBP%GO:1902410,0.788583795482213,0.92796987860677,0.18925974724390499,0.7545566386737691,5829,19,CHMP3|CNTROB
INTERLEUKIN-10 SECRETION%GOBP%GO:0072608,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
HISTAMINE TRANSPORT%GOBP%GO:0051608,0.140675241157556,0.505564604777695,0.7769506479183901,1.30537740466168,1049,2,ADCYAP1|SNAP23
REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED EIF2 ALPHA PHOSPHORYLATION%GOBP%GO:0060734,0.5328728914862529,0.812079525085925,0.7321901191001321,0.9762767273158441,4011,1,EIF2AK3
SUPERIOR TEMPORAL GYRUS DEVELOPMENT%GOBP%GO:0071109,0.695542584239851,0.890511436799833,-0.51872070581748,-0.86323420415784,5242,2,CNTNAP2|GSK3B
COENZYME A TRANSPORT%GOBP%GO:0015880,0.0699665551839465,0.37596389138254704,-0.9634980149977941,-1.28361070549376,522,1,SLC25A42
REGULATION OF INHIBITORY G PROTEIN-COUPLED RECEPTOR PHOSPHORYLATION%GOBP%GO:1904323,0.17123745819398,0.5448344947455329,-0.9122739303043671,-1.21536792505403,1279,1,APLNR
BASE-EXCISION REPAIR%GOBP%GO:0006284,0.898349148576628,0.967428248648255,-0.140690677562363,-0.666562006479209,6910,34,POLD1|POLQ|HUWE1|USP47|APEX1|XPA
HISTONE H3-K27 METHYLATION%GOBP%GO:0070734,0.7542206517471529,0.9156695413521451,-0.350267077666797,-0.7668078519869591,5762,4,EZH2|HIST1H1C
INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX%GOBP%GO:0021830,0.591910776672937,0.8417378833576942,0.452864529429808,0.8907310878579581,4404,3,DRD2
REGULATION OF CELLULAR RESPONSE TO THAPSIGARGIN%GOBP%GO:1905891,0.829163879598662,0.9433761342424741,-0.58893912659903,-0.7846083292536808,6197,1,CLU
PERIPHERAL NERVOUS SYSTEM AXON REGENERATION%GOBP%GO:0014012,0.532709030100334,0.812079525085925,-0.736821790913101,-0.9816235468417691,3981,1,APOD
SEMAPHORIN-PLEXIN SIGNALING PATHWAY%GOBP%GO:0071526,0.236351875808538,0.62149045081524,-0.246044899967721,-1.18477504888274,1826,36,FLNA|SEMA3B|SEMA3D|SEMA7A|NRP2|SEMA5A|SEMA3E|SEMA3A|SEMA6B|ARHGDIA
PYRUVATE METABOLIC PROCESS%GOBP%GO:0006090,0.32047786001817896,0.6884724140304929,-0.21365275828327998,-1.09824880200843,2467,45,GPI|PFKFB2|HK1|PDHA1|HK3|ENO1|PGAM1|GAPDH|LDHA|PDHX|PGK1|ALDOA|ALDOC
NEGATIVE REGULATION OF NEURON MIGRATION%GOBP%GO:2001223,0.000130872922392357,0.00518555396908895,-0.936690012684057,-2.05061024115766,0,4,COL3A1|CX3CL1|KIAA2022|ADGRG1
SULFUR OXIDATION%GOBP%GO:0019417,0.8268771557442289,0.943041978946366,-0.446339471357765,-0.742780255387228,6232,2,MICAL2
NEGATIVE REGULATION OF ASPARTIC-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902960,0.0241157556270096,0.21800274505398803,0.8977750585070279,1.50837801472171,179,2,BIN1|SORL1
POSITIVE REGULATION OF GROWTH%GOBP%GO:0045927,0.0008970908624887859,0.0214437672455875,-0.271841091424732,-1.81036715452364,6,123,SYT4|SFRP2|NGF|TBX2|INS|GOLGA4|PPIB|DDX3X|CPNE6|NOTCH1|MEF2C|LGI1|NCBP1|DSCAM|TRIM32|MMP14|CPNE5|PIM1|GHRL|NTN1|IGF1|MAP3K13|EIF4G2|RPTOR|SEMA7A|N6AMT1|CXCL16|TAF9B|PSMD10|USP47|HYAL1|TGFBR3|ZP3|FXN|SEMA5A|PLAA|OSBP|S100A8|S100A9|TAF9|H3F3B|EXOSC2|SPHK1|AK6|FAM122A|EIF4G1
POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:0038089,0.344468487963213,0.702208595415901,0.3963890885259829,1.09422143917089,2546,7,GAB1|MYO1C
REGULATION OF SENSORY PERCEPTION%GOBP%GO:0051931,0.13577193439208501,0.498614450236932,-0.473039264738131,-1.3618138363972399,1042,8,ZFHX2|F2R|NOV|MGLL
SEX DIFFERENTIATION%GOBP%GO:0007548,0.283503730312241,0.656107501076163,0.198737889562879,1.12298793688057,2051,60,LRRC6|STRA6|CDKL2|TBX3|RAB13|WNT2B|KIT|ROBO2|PTPRN|BRCA2|PKD1|SLIT3|EIF2B4|ADCYAP1|WNT4|MKKS
PROTEIN LOCALIZATION TO PARANODE REGION OF AXON%GOBP%GO:0002175,0.35048231511253997,0.7084508263857902,0.659718775847808,1.1084127231633998,2615,2,EPB41L3|CNTNAP1
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE%GOBP%GO:0070373,0.183326850771425,0.556308895147568,-0.24642756044491498,-1.23413515412055,1413,41,DAB2IP|SEMA6A|SPRY1|SYNJ2BP|SLC9A3R1|TIMP3|TNIP1|GPER1|C3orf33|TLR4|GSTP1|PHB|FBLN1|SIRPA|WNK2
TERTIARY ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902645,0.357859531772575,0.714938712241162,-0.818978826643141,-1.09107644550182,2674,1,CACNA1H
REGULATION OF MACROPHAGE TOLERANCE INDUCTION%GOBP%GO:0010932,0.513177257525084,0.802184867798321,-0.7463608292898101,-0.994331836417734,3835,1,IRAK3
POSITIVE REGULATION OF GONAD DEVELOPMENT%GOBP%GO:1905941,0.757760679225259,0.917143966125732,-0.48706213264310205,-0.8105492758091859,5711,2,ZP3
NEGATIVE REGULATION OF MOLECULAR FUNCTION IN OTHER ORGANISM%GOBP%GO:0044362,0.719653960529873,0.90068276850426,0.32813880850391103,0.7891719527362859,5323,5,SUGT1|CASP8
REGULATION OF LIPASE ACTIVITY%GOBP%GO:0060191,0.0163344051446945,0.174101838399886,-0.303948415755065,-1.6480953707451,126,54,APOC2|BICD1|ARL1|GNA13|FLT1|EDNRA|PCSK5|LRP1|APOC1|ANGPTL4|PLA2R1|ABL1|HRAS|NTRK2|NR1H3|P2RY6|GNAQ|PCSK6|GNA15|PDGFRB|ANG|PLAA|LMF1|PDGFRA|ANXA1|RGS2|C5AR1
MESODERM FORMATION%GOBP%GO:0001707,0.321737988973484,0.689829095076733,-0.30642349003015695,-1.11257402142663,2450,15,ITGA8|SNAI1|ITGB4
MITOCHONDRIAL TRNA METHYLATION%GOBP%GO:0070901,0.713756613756614,0.898267902818609,-0.41160143233275204,-0.803753277391684,5395,3,TRMT5|HSD17B10
SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENES INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002204,0.628399581589958,0.8598358835891559,-0.274256566077412,-0.859210019946344,4805,10,BATF|EXO1|RNF168|EXOSC3
PUTRESCINE METABOLIC PROCESS%GOBP%GO:0009445,0.7728826933193059,0.921900931578338,-0.314197443621136,-0.7530713179692371,5876,5,ODC1|SAT2
REGULATION OF LAMELLIPODIUM MORPHOGENESIS%GOBP%GO:2000392,0.159518828451883,0.5293397224673839,-0.42215612392738106,-1.3225600278162,1219,10,ARPIN|CD44|KANK1|CORO1C|RREB1|PDPN|CORO1B
CARDIAC LEFT VENTRICLE MORPHOGENESIS%GOBP%GO:0003214,0.124050301283731,0.47832576509682107,-0.425267629923767,-1.37682683212746,946,11,RYR2|CPE|SFRP2|NOTCH1|TGFBR2
NEGATIVE REGULATION OF ER-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:1903070,0.645659768879334,0.869260339192801,0.43277820668357797,0.851223661358155,4804,3,SGTA|USP14
CENTROMERIC SISTER CHROMATID COHESION%GOBP%GO:0070601,0.0483955812730142,0.31517882292381394,-0.652051600011598,-1.56284326233026,367,5,BOD1|NAA50|SGOL1
CELLULAR RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0071346,0.000127339870113332,0.00518555396908895,-0.36999889502070205,-2.34374316513127,0,98,TRIM22|TRIM25|HLA-DRB1|IRF8|CCL3|OAS3|HLA-DQB2|HLA-B|CCL4|CCL8|CD44|HLA-DPA1|PML|HLA-E|CCL11|HLA-DRA|HLA-DRB5|FCGR1B|TRIM38|SP100|TRIM21|B2M|CCL19|MID1|OASL|OAS1|IFNGR1|HLA-DPB1|TLR2|HLA-DQA2|FCGR1A|TRIM68|CCL24|HLA-C|IRF5|TRIM34|HLA-A|OAS2|CASP1|CCL3L3|CCL18|PDE12|CD47|ICAM1|CAMK2B|IRF7|IFI30|VCAM1|CCL2|GAPDH|HCK|LGALS9|MT2A|AIF1|CX3CL1|CAMK2A|PTAFR|CCL4L2|CCL14|TLR4|SIRPA
L-LYSINE CATABOLIC PROCESS TO ACETYL-COA%GOBP%GO:0019474,0.39181830256342104,0.7371240382543249,0.805359505955007,1.07383823173245,2949,1,PIPOX
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009162,0.6556264422424329,0.874869342420871,0.321131393721428,0.830946355835672,4829,6,DCTD|CDADC1|DUT
CAMP CATABOLIC PROCESS%GOBP%GO:0006198,0.321605351170569,0.689642136570735,-0.836733568592854,-1.11473002494379,2403,1,PDE4D
NOTCH RECEPTOR PROCESSING%GOBP%GO:0007220,0.118482118482119,0.46942161822544604,0.45657493177385705,1.38748910775839,867,9,ADAM17|PSENEN|PSEN2|APH1B|ADAM10|NCSTN|GALNT11|APH1A
CENTRIOLE ASSEMBLY%GOBP%GO:0098534,0.473345588235294,0.7835158707411,-0.244615332713889,-0.981392029624552,3604,20,OFD1|CDK5RAP2|RBM14|CETN2|CEP63
SPINAL CORD DEVELOPMENT%GOBP%GO:0021510,0.0713701988558976,0.3767214120425879,0.342954557786607,1.45599464320749,523,23,DLL1|LOXL3|DCTN1|ASCL1|PKD1|DRAXIN|NF1|PKD2|GATA2
PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE%GOBP%GO:0016254,0.843580715059588,0.948285501480553,0.18975356791115303,0.699922692630418,6228,15,PIGF|PIGL|PIGG|PIGQ|PIGN|PIGB|PIGZ
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 2 SIGNALING PATHWAY%GOBP%GO:0034137,0.850687622789784,0.949296218452153,-0.267994043351167,-0.689352873370907,6494,6,MFHAS1|CYBA|TIRAP|F2RL1|PJA2|TLR1
NEGATIVE REGULATION OF ADIPONECTIN SECRETION%GOBP%GO:0070164,0.609699769053118,0.8506518850285328,0.397303818414403,0.872893409287998,4487,4,RAB11FIP5|RAB11FIP3
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN NEGATIVE REGULATION OF APOPTOTIC PROCESS IN BONE MARROW%GOBP%GO:0035602,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032071,0.604009372559229,0.848175106515994,-0.30487064923603097,-0.877679929320189,4639,8,SIRT1|HMGB1|PRKCD|DDX11|RPS3|AKT1|GZMA|NPM1
NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION%GOBP%GO:0030853,0.140740740740741,0.5055981360970521,-0.6803762201184909,-1.3286023172473,1063,3,C1QC|CEACAM1
REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:1900542,0.00837952816810623,0.11356249262848402,-0.308473588121096,-1.72986593872951,64,61,PID1|PPIF|PARP1|OGT|CBFA2T3|PFKFB2|ATPIF1|PFKFB3|INS|VCP|PDE12|PARK7|ENO1|JMJD8|UQCC2|IGF1|PGAM1|CCNB1|NOS3|PDK3|COX7A1|PPARA|ABCD1|SHMT2|TMSB4X
PROTEIN HOMOTRIMERIZATION%GOBP%GO:0070207,0.814469537815126,0.936176430854824,-0.18263482876938802,-0.732727434938689,6202,20,HSF1|CLYBL|ALOX5AP|DISP1|P2RX3|TRAF2|SLC1A2|MLKL|SIGMAR1
NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY%GOBP%GO:1904667,0.921834288692027,0.9776156396135859,-0.202449249779347,-0.609016897333845,7075,9,BAG2|MAD2L2|RPS7|RPL5|FBXO5|RPL11|RPL23|MAD2L1|USP44
PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006655,0.4736338797814211,0.7837580618565259,0.33549556139997805,0.9738849211195509,3466,8,SLC27A1|PLA2G6|CRLS1|CDS2|TAMM41|TAZ
REGULATION OF PROTEIN NEDDYLATION%GOBP%GO:2000434,0.480687830687831,0.7857006060206241,-0.511525311569428,-0.9988792879378291,3633,3,RPL5|RPL11|DCUN1D1
PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT%GOBP%GO:0032292,0.28989071038251396,0.6622817015650171,0.39554818475882103,1.14820718076079,2121,8,PARD3|NF1|ARHGEF10|SKI
ACTIN CYTOSKELETON REORGANIZATION%GOBP%GO:0031532,0.689512478986163,0.887051934478962,-0.158336833479138,-0.8490423344556479,5331,52,PLEK|BCAR1|S1PR1|FGF10|FLNA|GSN|FGF7|NEDD9|DTNBP1|EFS|MYH9|INSRR|ANXA1
CELL PROLIFERATION INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:0061209,0.5923321836030779,0.8417378833576942,-0.5621856560242049,-0.935566831869957,4464,2,BMP2
EPITHELIAL-MESENCHYMAL CELL SIGNALING%GOBP%GO:0060684,0.0727759197324415,0.37960378163431896,-0.9623400970445519,-1.28206808074754,543,1,PDGFA
AMINO ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:0003333,0.04762526096033401,0.312365127431324,-0.354298990519945,-1.5455168981901597,364,26,SLC36A1|SLC7A2|SLC25A18|SLC1A2|SLC1A3|SLC25A22|SLC38A6|SLC6A8|SLC7A3|SLC3A2|ARL6IP5|PRAF2|SLC38A9
NEGATIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS%GOBP%GO:0031393,0.276661307609861,0.651933397172297,0.695285359801489,1.1681691763931201,2064,2,PIBF1|SIRT1
MYOBLAST FUSION%GOBP%GO:0007520,0.434902682798527,0.762034923704788,-0.42016801981867,-1.00706256806758,3306,5,ADAM12|CACNA1H|PGK1
ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002438,0.525700624252889,0.8088941780407042,0.736490957212175,0.9820113146138821,3957,1,CD6
SECONDARY METABOLITE BIOSYNTHETIC PROCESS%GOBP%GO:0044550,0.136554907017782,0.500328720159621,0.528483681040784,1.36748258645931,1005,6,BDH2|CITED1|CTH|MPST|CBS
"REGULATION OF MOLECULAR FUNCTION, EPIGENETIC%GOBP%GO:0040030",0.6305016722408029,0.8611032652135849,-0.6892920158800179,-0.9183024739256871,4712,1,CTCF
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 ACTIVATION%GOBP%GO:1901394,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
POSITIVE REGULATION OF SYNAPTIC PLASTICITY%GOBP%GO:0031915,0.13634577603143402,0.49989329554221995,-0.530435859279597,-1.36442392211761,1040,6,CDC20|ANAPC2|CPLX2|ADCY8|DBN1
POST-GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:0006892,0.268478713077243,0.642618292711696,0.178265309245977,1.12162172279133,1935,91,EXOC4|CCDC93|KIF13A|LLGL1|MYO1B|ARL3|DOPEY2|RAB10|SYS1-DBNDD2|CCDC91|GCC2|EXOC6B|VPS13C|EHD3|GGA1|GOLPH3L|SPTBN1|VPS13A|AP3B2|AP4M1|BBS2|MYO5A|BLZF1|EXOC1|SNAP23|GOLGA7|SORT1|EPS15
REGULATION OF T CELL PROLIFERATION%GOBP%GO:0042129,0.000127713920817369,0.00518555396908895,-0.380252322199359,-2.2947436918922297,0,81,FOXP3|CD1D|HLA-DMB|JAK3|SYK|CD274|HLA-DPA1|LILRB1|HLA-E|NDFIP1|CD209|PYCARD|NCKAP1L|TNFRSF14|IL18|RIPK3|CCL19|TWSG1|CCDC88B|HLA-DPB1|PDCD1LG2|SPN|EBI3|PLA2G2D|IL6ST|MAPK8IP1|LILRB2|GPNMB|PRKAR1A|SDC4|IGF1|CEBPB|ICOSLG|VCAM1|C10orf54|CD86|LGALS3|TGFBR2|TNFRSF21|LGALS9|ZP3|FADD|AIF1|PNP|ANXA1|CD55|NCK1|TFRC|TNFRSF1B|PRNP
"SYNAPTIC TRANSMISSION, DOPAMINERGIC%GOBP%GO:0001963",0.51338199513382,0.802184867798321,0.38967471329282,0.937165450875287,3797,5,SLC6A2|CRH|SNCA
CELLULAR RESPONSE TO ERYTHROPOIETIN%GOBP%GO:0036018,0.907539682539683,0.9710309567212472,-0.327303625880772,-0.639141026582184,6860,3,MT2A
RHODOPSIN MEDIATED SIGNALING PATHWAY%GOBP%GO:0016056,0.043336503192501,0.29791299041195396,0.711681000805127,1.56359346758234,318,4,PDE6B|GNGT1|GNB1|CNGB1
POSITIVE REGULATION OF DEACETYLASE ACTIVITY%GOBP%GO:0090045,0.946430910281598,0.9834855466269592,-0.229000055154156,-0.589049831289567,7225,6,FNTA|MAPK8|VEGFA|PRKD2|C6orf89|PRKD1
DENDRITIC SPINE MORPHOGENESIS%GOBP%GO:0060997,0.880254949823705,0.9616664835431351,0.184020305688904,0.661437257169246,6490,14,EPHB2|DLG4|SHANK2|ZNF365|EPHB1|SHANK1|PAK3|WASL|ARC|CDC42|PTEN|DOCK10|EPHB3|CTNND2
SECOND-MESSENGER-MEDIATED SIGNALING%GOBP%GO:0019932,0.0905958912849304,0.41591576627717103,-0.17674502915853896,-1.27236207846946,709,180,ADRB2|UCN3|ACKR3|AQP1|PTHLH|PRKAR2A|PLCE1|GNA13|LGR4|EFCAB11|FIS1|NDUFS4|ADM|AGT|GNAL|RYR2|ATP1B1|KDR|P2RX4|PTGER1|LAT2|MCTP1|AHR|AZU1|ADGRE2|FPR1|ADCY8|CXCR4|PDE4D|CALCB|PRKAR1A|SLC9A1|PTGER4|CALCRL|TBXA2R|PDE2A|CAMKK2|ADCY4|RAPGEF3|ADGRL4|NFATC1|VCAM1|CCRL2|GNAQ|GPER1|TPCN2|EDNRB|CCR1|APOE|NOS3|PPP2CA|ADGRE5|CD36|CHGA|ADRA2C|NUDT4|BCAP31|CLIC2|PRKACA|CETN2|ADGRG1|PTGIR|ADGRL1|SPHK1|PTPRJ|ADCY9|ADGRB1|PRNP
REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:1901608,0.0852090032154341,0.40376145987147494,0.8227736421284809,1.3823659513809,635,2,TRIM46|MAP2
REGULATION OF MITOCHONDRIAL MRNA STABILITY%GOBP%GO:0044528,0.583344654258932,0.8391117257440741,0.40527708587860295,0.89041101746948,4293,4,FASTKD1|FASTKD3|TBRG4
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0010719,0.117100614941777,0.46775284226984204,-0.36176484939390297,-1.3747947693026998,894,17,TGFB2|PTEN|VASN|DAB2IP|KIAA2018|SFRP2|EFNA1|ADIPOR1|LDLRAD4|PPP2CA|SDHAF2
POSITIVE REGULATION OF BASE-EXCISION REPAIR%GOBP%GO:1905053,0.6139559564871321,0.852182158593687,-0.5541770057899089,-0.922239157200627,4627,2,RPS3|FAM168A
N-TERMINAL PROTEIN MYRISTOYLATION%GOBP%GO:0006499,0.505230267626681,0.797902257689198,0.43165093837891294,0.948355494612768,3718,4,NMT2|PPM1B
KINETOCHORE ORGANIZATION%GOBP%GO:0051383,0.5074509803921571,0.7987565605553191,-0.28451976128024203,-0.9523142810456559,3881,12,NUF2|CENPW|CDT1|NDC80|CENPH
SYNAPTIC VESICLE DOCKING%GOBP%GO:0016081,0.493647675180092,0.7923145426459479,-0.374068629394618,-0.9622052836943199,3768,6,STX1B|SNPH
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN NEURAL PLATE ANTERIOR/POSTERIOR PATTERN FORMATION%GOBP%GO:2000313,0.830256342143711,0.9435818887072471,0.58392148213498,0.7785805062335109,6250,1,FUZ
RHO PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0007266,0.042794534673885005,0.29576373695179803,-0.262737121764696,-1.4920104986772702,331,64,CTNNAL1|RHOG|RHOD|NTN1|ARHGAP1|RHOJ|PDPN|RND1|CDC42EP4|COL1A2|CFL1|ADGRG1|EPS8|CDC42EP1|RHOU|CDC42EP5|ARHGDIA|NGFR|CDC42EP2
RESPONSE TO INTERLEUKIN-3%GOBP%GO:0036015,0.253174603174603,0.632257972333528,-0.612293875356639,-1.1956547533267499,1913,3,GSK3B|MT2A
CELLULAR RESPONSE TO ELECTRICAL STIMULUS%GOBP%GO:0071257,0.147089947089947,0.514131830678897,-0.6762435204588071,-1.32053220224036,1111,3,PTEN|REST|NSMF
NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903960,0.286240786240786,0.65912592615874,0.377739589844268,1.14791577461733,2096,9,TCAF2|IRS2
NEGATIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0051902,0.854743348562215,0.949296218452153,0.35288909179179495,0.6940911999018289,6360,3,BCL2|SRC
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS%GOBP%GO:1903844,0.182367304973654,0.5559553601324849,-0.205395793769501,-1.2146541451121,1418,75,SMURF2|HTRA3|FBN1|CDKN2B|LTBP1|SNW1|MEN1|LDLRAD4|SNX6|GIPC1|ADAMTSL2|TGFBR2|THBS1|UBC|FAM89B|CAV1|DAB2|ENG
PHOSPHATIDYLCHOLINE ACYL-CHAIN REMODELING%GOBP%GO:0036151,0.0333815218819819,0.261061407921079,-0.409955766758399,-1.61969698896194,253,19,PLA2G2A|PLA2G2D|TMEM86B|PLA2G4D|PLA2G4A|PLA2G4C|PLA2G16|PLBD1|PLA2G12A
CEREBELLAR GRANULE CELL PRECURSOR TANGENTIAL MIGRATION%GOBP%GO:0021935,0.238677115154735,0.622138010410922,0.882443758270843,1.17661968099727,1796,1,TTBK2
MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0006851,0.922328821132869,0.9776156396135859,-0.157391103157711,-0.621837565280985,7017,19,PHB2|AFG3L2|SLC8A3|MICU3|CCDC109B|SLC8B1|PMPCA|STOML2|PHB
POSITIVE REGULATION OF PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN%GOBP%GO:1901409,0.379531772575251,0.728914030571579,-0.8088883987648879,-1.0776335727133701,2836,1,CCNK
UTERUS DEVELOPMENT%GOBP%GO:0060065,0.552506452927591,0.822813841873357,0.41588590264097,0.9137190397008579,4066,4,STRA6
REGULATION OF ATP BIOSYNTHETIC PROCESS%GOBP%GO:2001169,0.0746442432082794,0.383186929742657,-0.29738079109099796,-1.43197173096393,576,36,PID1|PARP1|OGT|CBFA2T3|PFKFB2|PFKFB3|INS|VCP|ENO1|JMJD8|IGF1|PGAM1|PPARA|TMSB4X
REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION%GOBP%GO:1902903,0.45541645375574896,0.7711801339028691,-0.132065076018934,-0.996775184083193,3564,235,HCLS1|CCL24|ARPC1A|ARHGAP18|AEBP1|WAS|FES|DYRK1A|IQGAP2|PLEK|TGFB3|GPX1|CDK5RAP2|LMOD1|PDXP|PHLDB2|SLC9A1|PTGER4|CD47|PARK7|HAX1|S100A10|CTGF|PXN|MECP2|ABL1|RAPGEF3|PPFIA1|ARF1|ARHGEF15|TUBB4A|KANK3|GSN|BAIAP2L1|CORO1B|APOE|DLC1|HCK|CDC42EP4|CFL2|SEMA5A|ARPC5L|ARL2|SLIT2|NAV3|CX3CL1|CRYAB|LDLR|EVL|NF2|EPS8|CDC42EP1|CDC42EP5|SYNPO|TMSB4X|NCK1|ARF6|CDC42EP2|SERPINF2
POSITIVE REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905458,0.7043140407288321,0.894436909245845,0.4939068100358421,0.8298272117497958,5256,2,ZBTB1|NUDT21
DETERMINATION OF DIGESTIVE TRACT LEFT/RIGHT ASYMMETRY%GOBP%GO:0071907,0.18229944346409696,0.5559553601324849,0.498713928056929,1.29045160088858,1342,6,NPHP3-ACAD11|NPHP3|CCDC40|MEGF8|CCDC103
POSITIVE REGULATION OF CELL PROLIFERATION%GOBP%GO:0008284,0.000126871352448617,0.00518555396908895,-0.24708537162556196,-2.0857560871749197,0,488,PRKCH|HLA-DPA1|TGFB1|STAT5A|GREM1|CD38|AQP1|CCND2|PTHLH|HLA-E|KIAA1462|CCL11|LYN|GPR183|CDK6|NR4A1|DHX9|MAP3K3|CD209|FLT1|GRK5|TNFSF13B|NDUFS4|PYCARD|NCKAP1L|VAV3|LAMC1|CD74|IL18|CCL19|MYDGF|MEF2D|FBRS|HMGB2|TBX1|KDM1A|TERT|AGT|EZH2|CCDC88B|TCIRG1|LAMC2|HLA-DPB1|PID1|FGFR4|KDR|STX4|STXBP4|EMC10|CHTOP|HCLS1|PDCD6|LTBP3|CCL24|PDCD1LG2|HNRNPU|SFRP2|CDCA7L|EGFL7|TNFRSF11A|PDGFD|NPM1|EBI3|IL34|TBX2|VEGFC|GAS6|TGFB3|INS|DDR2|IL6ST|RREB1|MATK|HES1|SAPCD2|LILRB2|MST1R|PDGFC|ZNF268|FLT4|NOTCH1|RPS4X|TNFSF12|MEF2C|IRS1|GCNT2|SMARCD3|CHRD|FOXM1|PTPN6|PRKD1|CD47|NUDT16|F3|OSM|MECP2|FGF10|PIM1|BST1|RHOG|EAPP|CALR|CAPN1|DNMT1|CEP131|HMOX1|TNFRSF4|ROMO1|HRAS|IGF1|NTRK2|DPP4|E2F1|LRP5|ICOSLG|VCAM1|IL15|TNFSF13|GNAI2|HBEGF|P2RY6|CSF1|CCNI2|CTSH|CCNI|GPER1|F2R|NACC2|CCNB1|FN1|APLNR|CD86|GATA6|HYAL1|VEGFB|NRP2|HCK|RPS15A|FGF19|ECM1|TGFBR2|BMP2|TGFBR3|FGF9|LGALS9|THBS1|ZP3|TEK|FXN|FGF7|STX3|WWTR1|SEMA5A|FADD|MCTS1|AIF1|NME2|HTR1B|PDGFRB|SSR1|COX17|FOXP1|MMP9|CX3CL1|IGFBP5|IL11|FLT3LG|MYC|CCL14|PTN|ANG|CCND3|RELA|ZNF16|TMEM119|PDGFA|SERTAD1|ANXA2|CSF1R|TIAM1|PDGFRA|PNP|TIMP1|BIRC5|ANXA1|S100A6|LGMN|CLEC11A|OSMR|CD55|NCK1|FOLR2|CCND1|TFRC|CD81|SPHK1|CNBP|PDGFB|NME1|C5AR1|SERPINF2|ERN1|EIF4G1|BAD|EMP2|SLC25A5
MITOTIC CENTROSOME SEPARATION%GOBP%GO:0007100,0.10297513924738501,0.44146292546620297,0.644376715772008,1.41572308703399,757,4,KIF3B|NDEL1
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0008631,0.342763873775843,0.701955655133333,0.32072135219605497,1.0900694951880001,2519,12,MAP3K5|STK25|STK24
NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL%GOBP%GO:1904995,0.728968253968254,0.9064076322522902,-0.40583351952373997,-0.7924900055471751,5510,3,CXCL12|KLF4
POSITIVE REGULATION OF CELL CYCLE%GOBP%GO:0045787,0.00625718299067807,0.0925225067041246,-0.19509473254940599,-1.5104474983251002,48,272,CCNA2|SRPK2|RAD23A|PCBP4|GTSE1|CDC25A|CNOT4|ATRX|SPAG5|BTG2|CNOT10|CNOT6L|RHOA|SVIL|RPL23|NIPBL|SOX15|C17orf104|PHB2|CDC7|BECN1|APP|FOXO4|TGM1|RARA|SFN|CCNB2|RAD21|INO80|IL1B|C6orf89|TGFB2|CDKN1B|CDK4|CNOT6|AURKA|ASNS|HSF1|CDC42|RACGAP1|RCC2|PIDD1|ID2|PRMT1|DUSP3|YTHDC2|LSM11|CCND2|BRD4|PML|RGCC|NUSAP1|CIT|DLGAP5|DYNC1H1|TRIM21|PLCB1|TRIAP1|TFDP2|SETMAR|CDT1|EIF4EBP1|EZH2|ECT2|DAB2IP|DYRK3|ANAPC5|ESPL1|CDC6|ANKRD32|STXBP4|RAD51C|HNRNPU|PLK2|HCFC1|NPM1|CCNK|PCNA|INS|LSM10|HES1|MAD2L1|DDX3X|SMOC2|CDC25C|ZNF268|RHNO1|TAL1|CKS2|CDC45|BRCA1|NUDT16|TRIM32|NDC80|MECP2|FGF10|CALR|IGF1|DTL|FAP|E2F1|LRP5|RPTOR|RAD51B|USP2|CCNI2|CCNI|GPER1|PSMD10|CCNB1|GIPC1|NSFL1C|GATA6|PLAGL1|HYAL1|RPS15A|AIF1|PDGFRB|TNKS1BP1|CCND3|PAGR1|RPS6KB1|PRKACA|ZNF16|ANXA1|H2AFY|LGMN|ANAPC11|RRP8|ZNF385A|CCND1|CDCA5|SPHK1|PDGFB|XRCC3|FEN1|EIF4G1
RESPONSE TO AMINE%GOBP%GO:0014075,0.020096463022508,0.195205495598712,0.907251171767301,1.5242991085094801,149,2,DRD2|DRD4
CORTICAL CYTOSKELETON ORGANIZATION%GOBP%GO:0030865,0.299442707625391,0.6724163635232671,0.24226652215310504,1.12162046089723,2202,30,RTKN|LLGL1|RAB13|RHOQ|NCKAP1|FMNL2|EPB41L3|WIPF1|EZR|WIPF2|PDCD6IP|IKBKB|STRIP1
CELLULAR RESPONSE TO ZINC ION%GOBP%GO:0071294,0.153111924686192,0.5211028739679481,-0.426322500819387,-1.3356127427381599,1170,10,ZNF658|MT1X|MT1G|P2RX4|MT1M|MT2A|MT1E
MYOBLAST FATE COMMITMENT%GOBP%GO:0048625,0.23259876377317898,0.616483865437921,0.6232917083662262,1.22594123709559,1730,3,EPAS1|TCF7L2|IFRD1
RESPONSE TO ETHER%GOBP%GO:0045472,0.489922063961301,0.7898753213846479,0.49373924506525396,0.971126829979087,3645,3,ABCB4
CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN%GOBP%GO:0035967,0.36063475812643997,0.715866262655156,-0.15718913795425798,-1.05019036002733,2817,125,TSPYL2|HDGF|HSP90B1|MYDGF|HSPA13|DAB2IP|RNF121|TOR1A|TMBIM6|KLHL15|TLN1|VCP|CREB3|BAG3|ATP6V0D1|HSPA6|HSPA9|TPP1|MBTPS2|CREB3L1|WIPI1|CALR|HERPUD1|LMNA|CCL2|PDIA5|SRPRB|SYVN1|SSR1|EIF2S1|KDELR3|DERL3|HSPA5|GOSR2|DNAJB11|SERP1|YIF1A|ERN1
FOREBRAIN NEUROBLAST DIVISION%GOBP%GO:0021873,0.50998505637821,0.800479814110466,0.430164450720715,0.945089617921707,3753,4,FGFR2|LEF1|NUMBL
NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0002832,0.173345516251142,0.547365883994345,-0.27937428214770504,-1.2631964615280802,1327,29,TNFAIP3|IFIT1|CARD16|NPLOC4|CEACAM1|DHX58|FAM3A|RNF26
REGULATION OF FERTILIZATION%GOBP%GO:0080154,0.0230408747721947,0.21132547286123998,-0.5919045840845029,-1.704010454353,176,8,PLCB1|HYAL3|CACNA1H|ZP3|POMZP3|LHFPL2
REGULATION OF PROTEIN KINASE B SIGNALING%GOBP%GO:0051896,0.0219667943805875,0.205074417774411,-0.21849842889079701,-1.4864826052861801,171,136,MC1R|NRG1|AKT1|DDIT3|CCL3|RAC2|GDF15|NRG2|PIK3R5|TNF|PTEN|RAC1|ITGB1|KIAA1161|TGFB1|MUL1|TNFAIP8L3|HYAL2|CHI3L1|MTDH|GNB2L1|F10|IL18|ADAM8|CCL19|MYDGF|PIK3AP1|FGFR4|P2RX4|HCLS1|PDCD6|HGF|VAV1|GATA3|PHLPP1|GAS6|INS|SLC9A3R1|MST1R|GRB2|IRS1|GCNT2|PARK7|HAX1|F3|RCN3|PIK3CB|OSM|FGF10|RHOG|HBEGF|GPER1|EPHA2|CD86|FGF19|FGF9|THBS1|TEK|FGF7|SEMA5A|PDGFRB|CX3CL1|PDGFA|HSP90AA1|PDGFRA|RRAS|ENG|PDGFB|PTPRJ
BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0002043,0.226588081204977,0.6091952781136228,-0.475568179456257,-1.22328946902138,1729,6,SEMA5A|ACVRL1
REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE-SPECIFIC DNA BINDING%GOBP%GO:1903025,0.8103358500390521,0.9351896872820029,-0.249059065429922,-0.717006190956253,6224,8,TAF1|DDIT3|ZNF593|NSD1|TMSB4X
PEPTIDE HORMONE PROCESSING%GOBP%GO:0016486,0.201726844583987,0.5801004120776899,-0.332501872353542,-1.2357057048294198,1541,16,PCSK5|CPE|NGF|PCSK1|ATP6AP2|CTSZ|PCSK6|BACE2
ANTIBIOTIC BIOSYNTHETIC PROCESS%GOBP%GO:0017000,0.8992805755395681,0.967579626527468,0.24865641888051998,0.6434130986992621,6624,6,KDM3A|MAOB|DUOX1|CYBA
T CELL ACTIVATION%GOBP%GO:0042110,0.0843434987878015,0.40376145987147494,-0.209096528438096,-1.32792505042511,660,99,MICA|LILRB1|SLA2|CLEC4A|HLA-E|GPR183|CD74|RIPK3|TNFSF8|CCL19|BATF|ZFP36L1|CXADR|CD4|RORA|SPN|PLA2G2D|INS|ADA|RAB29|PTGER4|STAT3|ICAM1|FCER1G|MSN|SLC11A1|RSAD2|TNFRSF4|DPP4|ICOSLG|CTPS1|CLEC7A|JAG2|FADD|FOXP1|FKBP1A|STOML2|ANXA1|NCK1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TUNICAMYCIN%GOBP%GO:1905895,0.829163879598662,0.9433761342424741,-0.58893912659903,-0.7846083292536808,6197,1,CLU
FIBROUS RING OF HEART MORPHOGENESIS%GOBP%GO:1905285,0.4647363527692921,0.7785465206362571,0.7688575209528009,1.02516776004911,3498,1,BMPR1A
DISRUPTION OF CELLS OF OTHER ORGANISM%GOBP%GO:0044364,0.0102174482577941,0.12936633073190199,-0.557168197866363,-1.80386201735605,77,11,APOL1|AZU1|ROMO1|HMGN2|GAPDH|HIST1H2BK|HIST1H2BJ
CARDIAC MUSCLE CONTRACTION%GOBP%GO:0060048,0.696326211568525,0.891033775225429,-0.16607865418262302,-0.8423451859936879,5344,43,SCN4B|TNNT2|GJA1|RYR2|ATP1B1|GAA|TNNI2|KCNN2|MYLK2|PKP2|CACNA1G|KCNQ1|SCN1B|KCNH2|KCNE4|ADRBK1
IMMUNE RESPONSE-REGULATING SIGNALING PATHWAY%GOBP%GO:0002764,0.000127877237851662,0.00518555396908895,-0.24367552031153197,-1.9298329594831398,0,313,RAF1|RIPK2|SPPL3|CREBBP|CDC42|TIFA|PAK2|MUC3A|BTNL9|SYK|IGHV2-26|HLA-DQB2|NFATC2|RPS6KA5|RAC1|WIPF3|EIF2B5|IGHV1OR15-1|IGKV3-11|NFKBIZ|MNDA|HLA-DPA1|ACTG1|NCR3|CD38|LILRB1|S100A1|ALPK1|IGHV5-51|SLA2|CLEC4A|LYN|HLA-DRA|HLA-DRB5|PRAM1|CD209|TLR1|IGHV1-24|NCKAP1L|VAV3|WASF2|IRAK3|HSP90B1|IGHV3-49|FPR3|ITGB2|IGHG4|HLA-DPB1|CD4|NCKIPSD|PIK3AP1|TLR2|HLA-DQA2|FGR|FCGR1A|IGLL5|CTSS|ARPC1A|LAT2|VAV1|TICAM2|MYO1G|GATA3|WAS|EIF2B1|FCGR2B|THY1|PDE4B|BCAR1|IGKV2-28|FPR1|MYO10|TNFAIP3|IKBKE|IGHV4-4|RC3H2|LILRB2|PDE4D|CLEC4E|ELMO1|MAPKAPK2|UNC93B1|IGHV4-61|GRB2|MEF2C|MAPK9|CLEC10A|IFIH1|IGHV1-3|FCER1G|MUC4|PIK3CB|MAPK3|ABL1|IGHV3-43|IRF7|IRAK1|HRAS|NFATC1|FCN1|IGHV3-73|ICOSLG|TNIP1|FCGR2A|DOCK1|CTSH|PIK3R4|CYFIP2|IGKV2D-28|HCK|COLEC12|CD36|MUC20|TNFRSF21|LGALS9|IGHV3-15|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|EIF2B2|TRAF3|C3AR1|STOML2|RELA|NFKB1|PRKACA|TLR4|S100A8|ITGAM|IGHV1-18|S100A9|HSP90AA1|ACTB|CMKLR1|NCK1|CD14|IGHG2|LY96|IGHA1|EIF2B3|C5AR1|PRKCB|PTPRJ|ICAM2
APPENDAGE DEVELOPMENT%GOBP%GO:0048736,0.0619067271976888,0.357540960865252,0.263416711722452,1.4302436038014201,449,52,DKK1|KREMEN1|INTU|ITGA6|FGFR2|RARG|TBX3|HDAC1|KIAA1715|IQCE|TWIST1|CACNA1C|TFAP2B|ACD|SKI|CHD7|LRP6|MEGF8
GERM CELL DEVELOPMENT%GOBP%GO:0007281,0.0897542115437724,0.4139571687019651,0.23698605779383602,1.35258404411982,649,62,SPAG6|DDX25|BBS4|CFAP44|CFAP43|PSME4|TSSK6|C14orf39|DZIP1|C9orf117|IQCG|NME5|CHD5|PDE3A|PCSK4|CEP57|MKKS|DNAH1|CATSPER2|BBS2|DPY19L2
TIGHT JUNCTION ORGANIZATION%GOBP%GO:0120193,0.9310578355681971,0.9793746057014829,0.14951218523098198,0.616311810270697,6873,21,RAB13|PARD3|MLLT4|STRN|CLDN3|PDCD6IP|PARD6A|PRKCI|PARD6B|RAMP2|INADL
POSITIVE REGULATION OF INTERLEUKIN-1 BETA SECRETION%GOBP%GO:0050718,0.36163810022242604,0.716154857259883,-0.28198249834175604,-1.07160235275663,2763,17,CCL3|RIPK2|PYCARD|GSDMD|CCL19|CASP1|NLRP3|LGALS9|TLR4
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR (LIGAND) SUPERFAMILY MEMBER 11 PRODUCTION%GOBP%GO:2000309,0.511571906354515,0.801504475859147,-0.7476290251433609,-0.996021377806446,3823,1,ADAM8
CELLULAR RESPONSE TO DSRNA%GOBP%GO:0071359,0.010727367870225001,0.133934756708563,-0.48686567553303295,-1.8093813682411497,81,16,MUL1|DHX9|NPM1|PDE12|MB21D1|IFIH1|IFIT1|TMEM173|COLEC12|CAV1|PQBP1
PRIMARY MIRNA METHYLATION%GOBP%GO:1990744,0.962279187143047,0.9906325367238141,0.518802382002647,0.6917529729132299,7244,1,METTL3
REGULATION OF CALCIUM ION-DEPENDENT EXOCYTOSIS OF NEUROTRANSMITTER%GOBP%GO:1903233,0.22473103997874902,0.6078034241178771,0.8889501543890609,1.1852950822943,1691,1,RAB3GAP1
SUPRAMOLECULAR FIBER ORGANIZATION%GOBP%GO:0097435,0.10923293635548699,0.45349438410841897,-0.154803030639004,-1.21602098132514,852,298,TTC17|DSTN|MICALL2|TUBGCP2|ARPC1A|MFAP4|TUBG2|CYP1B1|COBL|WAS|KPNB1|FSCN2|ITGB5|IQGAP2|MYOM1|DDR2|KLHL24|BCAR1|SHROOM1|TNXB|RHOF|KRT9|LMOD1|COL14A1|PDXP|COL5A3|KIF18B|LTBP2|PKP2|ARRB1|DBN1|MICAL2|KIF18A|AIF1L|RHOG|RHOD|GHRL|FLNA|CKAP5|B4GALT7|RHOJ|COL5A2|COL12A1|LUM|RND1|GSN|BAIAP2L1|CORO1B|KIF2A|PLS3|CD36|SERPINH1|CFL2|COL1A2|COL1A1|ARPC5L|AIF1|PDGFRB|IGSF22|COL3A1|NEDD9|FKBP1A|FAM107A|EFS|ANG|CFL1|WASF3|GAS7|ANXA2|EVL|PDGFRA|EPS8|RHOU|COL5A1|ACTN1|KRT19|CDC42EP2|LOXL2|SERPINF2|ALDOA|CST3|EMP2
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:1904283,0.17953177257525102,0.5528496998175401,-0.908193647992942,-1.20993200928166,1341,1,HFE
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS%GOBP%GO:1903426,0.0663739669421488,0.3690551432905871,-0.272022626772019,-1.4332592957880699,513,49,INSR|SLC25A33|CLU|ASS1|ZC3H12A|KLF2|PTGS2|HBB|FYN|IL1B|AKT1|TNF|KHSRP|RAC1|DUOXA1|KLF4|P2RX4|CD34|INS|GRIN1|GLA|CD47|PARK7|CD36|CAV1|MPV17L|ABCD1|TLR4|HSP90AA1|SIRPA|ADGRB1|PTGIS
REGULATION OF TYPE I HYPERSENSITIVITY%GOBP%GO:0001810,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
RESPIRATORY CHAIN COMPLEX II ASSEMBLY%GOBP%GO:0034552,0.859965973040178,0.9511718746756421,-0.312619252273954,-0.6843888923925651,6570,4,SDHAF2
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION%GOBP%GO:1903829,0.22219377959810604,0.6049017459273871,-0.147903032929771,-1.12604684286413,1735,247,SDCCAG3|GSK3B|SFN|ABLIM3|EPHA3|LIF|USP36|SORBS1|PINX1|MAP1A|IL1B|GPD1L|PDCD10|AKT1|MAPT|CCT7|RAC2|SEC16A|TNF|UBE2L3|ITGB1|PCNT|BICD1|PRKCH|TGFB1|NPEPPS|GNL3|APC|CEMIP|PSEN1|CCT3|HYAL2|FIS1|MESDC2|GNB2L1|TFDP2|DTX3L|SREBF2|CDT1|TERT|CAMK1|JUP|PARP9|ECT2|ITGB2|GZMB|TRIM28|STX4|MICALL2|LRP1|CNST|HCLS1|ATG13|PDCD5|STAC3|GAS6|PRR5L|NMT1|INS|RAB29|CCT8|PPP1R13B|BAG3|PARK7|AKAP5|CCT5|BCAS3|NDC80|MSN|ANP32B|RHOG|HUWE1|CEP131|RAPGEF3|FLNA|NECAB2|HRAS|IGF1|NKD2|NMD3|E2F1|TREM2|RBM22|EPB41L2|TMEM173|KAT7|DKC1|GPER1|EPHA2|PLK1|LGALS3|STX3|B3GAT3|BCAP31|ITGAM|RHOU|SAR1B|EMD|ARF6|NGFR|SQSTM1|CARD10|BAD|PRNP
POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS%GOBP%GO:0060456,0.5524011674184129,0.822813841873357,-0.578715191618417,-0.963074622370207,4163,2,SLC22A5|AQP1
POSTNATAL OLFACTORY BULB INTERNEURON MIGRATION%GOBP%GO:0021827,0.346245688511542,0.703504080836324,-0.662641301350979,-1.1027410897591998,2609,2,ROBO1|SLIT2
"REGULATION OF VACUOLE FUSION, NON-AUTOPHAGIC%GOBP%GO:0032889",0.6423163766768499,0.868171925756234,0.676775474194971,0.902388775591134,4835,1,VPS16
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, NONSENSE-MEDIATED DECAY%GOBP%GO:0000184",0.931326073030109,0.9793746057014829,-0.109235964544196,-0.7138015878221171,7268,112,RPS10|RPS15|PNRC2|DCP1A|RPL29|RPL11|RPS6|RPL36|RPL17|UPF3B|RPL32|RPL23|RPLP0|RPL10A|RPL8|RPS23|CTIF|RPL3|GSPT2|RPL7A|RPS2|RPL15|RPL37|RPL27A|RPL18|RPL39|RPL27|SMG8|NCBP2|ETF1|RPLP2|MAGOH|RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|RPL10|RPL36A|RPL24|RPL35|PPP2CA|RPL38|RPS15A|MAGOHB|EIF4A3|RPS13|RBM8A|EIF4G1
POSITIVE REGULATION OF VIRAL GENOME REPLICATION%GOBP%GO:0045070,0.18065526693643105,0.554399730107893,-0.27733850668101595,-1.2539916616223201,1383,29,PPIA|LARP1|TOP2A|PPIB|DDX3X|PDE12|IFIT1|NUCKS1|ADARB1|DDB1
APPENDAGE MORPHOGENESIS%GOBP%GO:0035107,0.142603226688543,0.508674778494682,0.266783893996901,1.2931053307903502,1042,35,FGFR2|RARG|TBX3|HDAC1|IQCE|TWIST1|CACNA1C|TFAP2B|ACD|SKI|LRP6|MEGF8|BMPR1B|HDAC2|CYP26B1|ZNF141|SOX4|FBXW4|LEF1|MSX1
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL EXTRAVASATION%GOBP%GO:2000451",0.13578595317725803,0.498614450236932,-0.931076312307014,-1.24041721259972,1014,1,FADD
TISSUE MIGRATION%GOBP%GO:0090130,0.00012891581797086499,0.00518555396908895,-0.379163884397928,-2.12628475848268,0,61,KDR|PLXND1|CYP1B1|PKN1|ARSB|NUP188|TNFSF12|PXN|ABL1|PIK3R3|DPP4|FAP|STARD13|KANK2|CORO1B|GIPC1|NOS3|NOV|ACTG2|SRF|SLIT2|ID1|ADGRA2|MYH9|EPHB4|ACTA2|LOXL2|EMP2|PTP4A3
INTERLEUKIN-6-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070102,0.8238837239753829,0.94183325414208,-0.2067010304797,-0.7115050307687428,6291,13,SOCS3|IL6ST|STAT3|CTR9
THIAMINE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009229,0.591180767698234,0.8417378833576942,0.70213939126599,0.9362081365795591,4450,1,TPK1
POSITIVE REGULATION OF CELLULAR RESPIRATION%GOBP%GO:1901857,0.0932403997895844,0.422068646506606,-0.5995388456485,-1.43698021047775,708,5,PRELID1|PARK7|CCNB1
SERINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0042501,0.99840616283703,0.999656642395059,0.5009925011027789,0.6680058998713579,7516,1,NLK
CENTROMERE COMPLEX ASSEMBLY%GOBP%GO:0034508,0.00156331422615946,0.0323893370023386,-0.38776341108198403,-1.96672260042661,11,43,CENPF|MIS18BP1|RBBP4|HIST1H4J|CENPQ|HELLS|HIST4H4|CENPE|NASP|CASC5|HIST1H4H|HJURP|ITGB3BP|CENPL|CENPU|CENPW|OIP5|RUVBL1|CENPM|NPM1|CENPI|HIST1H4I|STRA13|RBBP7|CENPH|HIST2H4A|POLE3|HIST2H4B|CENPK|MIS18A|CENPP
MANNAN CATABOLIC PROCESS%GOBP%GO:0046355,0.123920839420906,0.47832576509682107,0.9394022937803259,1.25256620252128,932,1,MANBA
NEGATIVE REGULATION OF CELLULAR RESPONSE TO DRUG%GOBP%GO:2001039,0.6502992383025029,0.8720434729248241,0.250180618775035,0.850315262599709,4780,12,MET|PDE8A|NFE2L2|NR4A3|TRAP1
PYRIDOXAL 5'-PHOSPHATE SALVAGE%GOBP%GO:0009443,0.0224749163879599,0.20805315276747,-0.989358182620203,-1.31806265815924,167,1,PDXK
REGULATION OF ENDOSOME ORGANIZATION%GOBP%GO:1904978,0.418693112348866,0.75036705317022,0.4634420307551911,1.01820187847101,3081,4,PARK2|SCARB2
GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:0097688,0.7931812151764391,0.929621926733366,-0.46535984291759297,-0.77443319524888,5978,2,APOE
REGULATION OF STRESS FIBER ASSEMBLY%GOBP%GO:0051492,0.424579560155239,0.754564869291744,-0.18510476662320002,-1.0192533970356301,3281,57,PHLDB2|SLC9A1|PTGER4|CD47|S100A10|CTGF|PXN|ABL1|RAPGEF3|PPFIA1|ARHGEF15|DLC1|EVL|NF2|SERPINF2
REGULATION OF CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:1900037,0.705874354093011,0.894639008000397,0.2536719212159,0.803649793389807,5190,10,DDAH1|NOL3
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0034392,0.28531746031746,0.6583248923580091,-0.596032118214241,-1.16389966315305,2156,3,DNMT1|IGF1
RIBOFLAVIN METABOLIC PROCESS%GOBP%GO:0006771,0.717576233477294,0.900060477413567,-0.362163251193901,-0.7928510625848461,5482,4,ACP5|RFK
REGULATION OF BASEMENT MEMBRANE ORGANIZATION%GOBP%GO:0110011,0.187483103541498,0.5609377558550861,0.533835978022693,1.2838724658562701,1386,5,CLASP1|CLASP2|PHLDB1
EPIDERMIS MORPHOGENESIS%GOBP%GO:0048730,0.34644498513111704,0.70363936702924,0.45206888201184103,1.08722306884448,2562,5,FGFR2|ATP7A
NEGATIVE REGULATION OF LOCOMOTION%GOBP%GO:0040013,0.00012833675564681698,0.00518555396908895,-0.258706209109817,-1.9153344316866001,0,212,TRIM21|PLCB1|KANK1|JAG1|CORO1C|SLAMF8|ANGPT2|JUP|FRMD5|DAB2IP|TRIM28|KLF4|LRP1|SEMA6A|ADORA3|SYNJ2BP|MCTP1|SFRP2|CYP1B1|GATA3|WAS|ARHGDIB|THY1|CCDC125|DCN|PODN|NOTCH1|PHLDB2|PTGER4|MEF2C|CHRD|ADIPOR1|TBXA2R|TRIM32|MMRN2|MECP2|DPEP1|CALR|HMOX1|RNF20|SULF1|RECK|SEMA3B|HDAC5|SEMA3D|LDLRAD4|MEOX2|SEMA7A|STARD13|CCL2|CD300A|CORO1B|APOE|MITF|DLC1|NOV|BST2|CD200|THBS1|SPINT2|SEMA5A|VCL|NBL1|AIF1|SEMA3E|COL3A1|ADARB1|SLIT2|NAV3|CX3CL1|NR2F2|IGFBP5|SERPINE1|SEMA3A|PPARG|SEMA6B|IFITM1|KIAA2022|ADGRG1|EVL|MCC|NF2|TIMP1|ENG|MID2|ACVRL1|FBLN1|PTPRJ|CARD10|ADGRB1
TISSUE REGENERATION%GOBP%GO:0042246,0.25399528425465,0.633305616160985,-0.36759122936996996,-1.19009638222881,1938,11,IGF1|NOV|ANXA1|CPQ
REGULATION OF VIRAL PROCESS%GOBP%GO:0050792,0.000382360438439969,0.0111294649577428,-0.27021087375206304,-1.8561712077883703,2,142,TRIM38|DHX9|FCN3|CD74|PARP10|TRIM21|SMARCA4|ZNF639|REST|TSG101|OASL|OAS1|CD4|TRIM28|PPIA|RAB7A|LARP1|CCNK|CAV2|MDFIC|TOP2A|PPIB|PVRL2|FMR1|PLSCR1|DDX3X|HS3ST5|PDE12|IFIT1|APOBEC3G|TRIM32|SNW1|ISG15|NUCKS1|RSAD2|APOBEC3C|FCN1|IFI16|TNIP1|GSN|APOE|BST2|SNF8|LGALS9|ADARB1|RRP1B|DDB1|CFL1|IFITM1|BTBD17|ANXA2|LGALS1|IFITM2|IFITM3|MID2|BANF1|PSMC3|APOBEC3F|P4HB
REGULATION OF NEUROINFLAMMATORY RESPONSE%GOBP%GO:0150077,0.00261643118785976,0.049127796941208,-0.535895321635408,-1.99159451779614,19,16,IL33|CD200|MMP9|CX3CL1|LDLR|ITGAM|TNFRSF1B
PROTEIN-FAD LINKAGE%GOBP%GO:0018293,0.13351170568561901,0.495171568558794,-0.932234230260256,-1.24195983734594,997,1,SDHAF2
POSITIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0106071,0.393308250470304,0.7375199755844078,0.5429413364700151,1.06790153754346,2926,3,PRKCA|MRAP2|GSK3A
NUCLEAR MATRIX ANCHORING AT NUCLEAR MEMBRANE%GOBP%GO:0090292,0.5912698412698411,0.8417378833576942,-0.460888212987844,-0.8999978683278729,4469,3,SUN2
NEUROEPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0060563,0.6676717357105401,0.8809904880170709,-0.23723443697674598,-0.839300746350997,5092,14,BCCIP|SOX11|DFNB31|PDZD7|SOD1|JAG2|BMP2
PEPTIDYL-CYSTEINE MODIFICATION%GOBP%GO:0018198,0.11318051575931198,0.461102711313646,-0.294369596441258,-1.35662381099971,868,31,ZDHHC11|ZDHHC15|CHCHD4|ZDHHC9|ZDHHC4|ZDHHC12|PARK7|GAPDH|ZDHHC19|S100A8|S100A9|ZDHHC24|ZDHHC2
"CLEAVAGE IN ITS2 BETWEEN 5.8S RRNA AND LSU-RRNA OF TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000448",0.778461538461538,0.924704689181848,-0.615681517423908,-0.8202356150591329,5818,1,NOL9
POSITIVE REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS%GOBP%GO:0072108,0.39576634512325803,0.7377402989373809,0.6382355902109941,1.07231819748718,2953,2,PAX8|LIF
INOSITOL PHOSPHATE CATABOLIC PROCESS%GOBP%GO:0071545,0.24904787812839999,0.6299122386373679,0.34859834812349394,1.1848179822154699,1830,12,INPP1|INPP5K|INPP5J|IMPA1
REGULATION OF LEUKOTRIENE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0035490,0.10755852842809402,0.451309145449614,-0.944199382443758,-1.25790029305683,803,1,SERPINE1
"POSITIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000563",0.0806177201936919,0.397722753303477,-0.6613619659533921,-1.44785959296187,615,4,TGFBR2|LGALS9|CD55
SPERMATID DIFFERENTIATION%GOBP%GO:0048515,0.00231765507839128,0.0447202453104185,0.36507162741154,1.89467493781679,16,44,NPHP1|SPAG6|DDX25|BBS4|CFAP44|CFAP43|PSME4|TSSK6|C9orf117|IQCG|NME5|CHD5|PCSK4|CEP57|MKKS|DNAH1|MAST2|CATSPER2|BBS2|DPY19L2
POSITIVE REGULATION OF CENTROSOME DUPLICATION%GOBP%GO:0010825,0.151622098547577,0.518911670602691,0.518393910981192,1.34137471340125,1116,6,CENPJ|CEP120|CEP295|VPS4B|NUP62|PLK4
NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0032353,0.757825802226588,0.917143966125732,-0.295964470432967,-0.7613003466697271,5785,6,BMP2|NFKB1
SODIUM ION TRANSPORT%GOBP%GO:0006814,0.655746655746656,0.874869342420871,0.16952131194036402,0.873226481218294,4803,43,TRPM4|SCN5A|SLC5A2|SLC38A7|HCN2|ASIC1|SLC9B2|SCN3A|PKD2|SCN9A|SCN2A|NEDD4L|SLC8A2|HCN3
T CELL DIFFERENTIATION%GOBP%GO:0030217,0.58321479374111,0.8391117257440741,-0.171042653570987,-0.917174170333105,4509,52,CD74|RIPK3|TNFSF8|BATF|ZFP36L1|CD4|RORA|SPN|PLA2G2D|PTGER4|STAT3|FCER1G|RSAD2|JAG2|FADD|FOXP1|ANXA1
INTRACELLULAR CHOLESTEROL TRANSPORT%GOBP%GO:0032367,0.442635862431084,0.7656673901363249,-0.277610573368432,-1.00795899156645,3371,15,CES1|SYT7|ABCG1|LDLR|OSBP|NPC2
NEGATIVE REGULATION OF PROTEIN K63-LINKED UBIQUITINATION%GOBP%GO:1900045,0.517747216764899,0.8047565444482679,-0.36617044705483204,-0.941889031055807,3952,6,PLAA|OTUB1
POSITIVE REGULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY%GOBP%GO:0001815,0.5820735785953179,0.8387093286508721,-0.71344287604764,-0.9504772186324659,4350,1,HLA-E
NEGATIVE REGULATION OF BONE RESORPTION%GOBP%GO:0045779,0.9745877264125441,0.992088128046979,0.22275933519201302,0.535734923720924,7209,5,UBASH3B|CARTPT|P2RX7
REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT%GOBP%GO:1905600,0.171132926505704,0.544815916159356,-0.7513370426450521,-1.2503449867879801,1289,2,ANXA2
NEGATIVE REGULATION OF TRANSPOSON INTEGRATION%GOBP%GO:0070895,0.914924973204716,0.9740523336757891,0.378163771712159,0.6353639631774151,6828,2,ZNF91|ZNF93
POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION%GOBP%GO:0045663,0.975115583355997,0.992495186279802,0.168969326968978,0.535306249335581,7170,10,RBM24|BTG1|HIF1AN
MIDBODY ABSCISSION%GOBP%GO:0061952,0.9674254317111459,0.9912626134248801,-0.147483246599755,-0.548104850959464,7394,16,KIF20A|CHMP4A|CHMP6
POSITIVE REGULATION OF DETERMINATION OF DORSAL IDENTITY%GOBP%GO:2000017,0.0256342143710984,0.22470485454905398,0.9878694309660341,1.3171905901491598,192,1,ACVR1
LEUCINE METABOLIC PROCESS%GOBP%GO:0006551,0.798895899053628,0.931350348412063,-0.26461035483273,-0.723300604804937,6077,7,MCCC2|BCAT2
RIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009260,0.0439799974355687,0.299062021084573,-0.211085115587188,-1.41197255772642,342,126,ATP5J|DCAKD|GPI|ATP5F1|COASY|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|PDHA1|ACSF3|ATP5B|HK3|ADCY8|NPR2|ELOVL1|SLC26A2|ENO1|ADCY4|ATP5O|CTPS1|PGAM1|HPRT1|NPR1|RFK|GAPDH|UMPS|HACD2|GMPS|LDHA|STOML2|PDHX|ATP5H|PGK1|FASN|ADCY9|ALDOA|ALDOC|ATP5G1
RESPONSE TO ACETYLCHOLINE%GOBP%GO:1905144,0.48091004184100394,0.7857006060206241,-0.252072227061322,-0.978133989170739,3677,18,CHRM2|GNAQ|GNA15|ADRBK1|LY6H
FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0006633,0.3787898335698621,0.7286721377338231,-0.186037893398838,-1.05204638247676,2935,63,ABHD3|GPX4|ALOX5|SCD5|CD74|LTC4S|TBXAS1|PTGDS|ELOVL2|CBR1|ACSF3|ELOVL1|PTGES2|PTGS1|THNSL2|HACD2|NDUFAB1|ABCD1|FADS1|PTGES|PTGIS
AMINO SUGAR BIOSYNTHETIC PROCESS%GOBP%GO:0046349,0.541045751633987,0.815622645995152,-0.27565258814309,-0.9226350223079941,4138,12,GNPNAT1|GFPT2|RENBP
POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903052,0.281927096609738,0.654732517474162,-0.183900032830817,-1.1171995094003702,2211,83,CBFA2T3|ATPIF1|VCP|RNF144B|FMR1|CCDC22|CEBPA|UBQLN1|SUMO2|HERPUD1|NKD2|RCHY1|PSMD10|PLK1|ECSCR|CTSC|BCAP31|CAV1|DAB2|CSNK1A1|MAGEF1|FAM122A
REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:2000136,0.40463783220427296,0.7417763049739828,-0.343664488874455,-1.03382690213107,3105,9,NOTCH1|PIM1|ENG
REGULATION OF FRACTALKINE BIOSYNTHETIC PROCESS%GOBP%GO:0050752,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|AZU1
PHOTOREACTIVE REPAIR%GOBP%GO:0000719,0.19117056856187303,0.5657618283915489,-0.9028451698279659,-1.2028065521205702,1428,1,CRY2
REGULATION OF FAT CELL DIFFERENTIATION%GOBP%GO:0045598,0.28274347713769105,0.655080403592235,-0.192759196719916,-1.1192760444393701,2188,70,ZFPM2|ZFP36L1|CCDC85B|RORA|HNRNPU|SFRP2|GATA3|INS|SYAP1|MEDAG|CEBPB|E2F1|CREBL2|LRP5|GPER1|ADIRF|BMP2|NR1D1|RARRES2|CCRN4L|PPARG|CMKLR1|ZNF385A|METRNL
NICOTINAMIDE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0019359,0.00697584291435215,0.10045820391703099,-0.34712278593970797,-1.7982052527772001,53,46,PGAM2|PARP10|PARP9|GPI|PFKFB2|HK1|KYNU|HK3|HAAO|ENO1|PGAM1|GAPDH|LDHA|NMNAT3|PNP|PGK1|QPRT|NNMT|ALDOA|ALDOC|PTGIS
UROTHELIAL CELL PROLIFERATION%GOBP%GO:0050674,0.253244147157191,0.632257972333528,-0.870533745037495,-1.15975997586903,1892,1,FGF10
PROTEIN STABILIZATION%GOBP%GO:0050821,0.7904237613621821,0.928247620398227,-0.120825979100584,-0.831742661725588,6173,144,SMAD7|PER3|RPL11|CLU|GTSE1|TAF1|STX12|ZBED3|RPL23|NAPG|PHB2|DVL3|MORC3|USP13|PFN2|USP36|ZNF207|PTGES3|PDCD10|CCT7|VHL|SEC16A|DNLZ|PTEN|CCNH|USP27X|PPAP2B|MUL1|PIM2|CCT3|PEX6|TMEM88|UBE2B|ATP1B1|SOX17|STXBP4|USP9X|TRIM44|ATP1B3|HCFC1|BAG5|PPIB|CCT8|EFNA1|TESC|BAG3|SEL1L|PARK7|CCT5|CALR|FLNA|IGF1|CREBL2|USP2|GNAQ|TAF9B|STK3|GAPDH|CDK7|SYVN1|EPHA4|CRYAB|LAMP2|ATP1B2|TAF9|HSP90AA1|PHB|AK6
DTMP METABOLIC PROCESS%GOBP%GO:0046073,0.282316581564096,0.654732517474162,0.5972707652660639,1.17476111269089,2100,3,DCTD|CDADC1
REGULATION OF PROTEOLYSIS%GOBP%GO:0030162,0.00012647021626407,0.00518555396908895,-0.284615867610648,-2.38304387194744,0,453,INPP5B|FIS1|TMF1|PYCARD|F12|APOPT1|GNB2L1|TRIM21|FNIP1|RPS6KA1|TRIAP1|ADAM8|IGBP1|REST|AGT|SERPINA3|CHAC1|DAB2IP|IGHG4|PPM1F|SERPINB8|SPOCK2|KLF4|UBQLN2|TNFRSF10A|FGFR4|TNFRSF10B|NRD1|USP25|UCHL5|PDCD6|SERPINB1|HGF|CASP10|NGF|C4A|OGT|CBFA2T3|ATPIF1|PSMF1|PDCD5|BAG5|DNAJC1|C2|GAS6|GPX1|INS|CASP1|GRIN1|VCP|IGKV2-28|RNF144B|TRAF2|UBE2G2|VTN|C3|PRELID1|FMR1|DDX3X|CLEC3B|SIAH2|EFNA1|TNFSF10|CCDC22|CAAP1|CYCS|CASP4|CEBPA|STAT3|UBQLN1|SUMO2|SERPINA1|C1QB|PSME2|PARK7|UBXN1|F3|PERP|TRIM32|IFI27L1|RCN3|ENO1|ANP32B|TIMP3|DPEP1|CARD16|IFI6|ALAD|HERPUD1|RAD23B|NKD2|RECK|IFI16|TNIP1|NAIP|C1QA|RCHY1|CFB|CAST|C1QC|C10orf54|CTSZ|C7|CTSH|NEDD8|CYFIP2|GPER1|CIDEB|HFE|GSN|F2R|PSMD10|APOE|IGKV2D-28|PLK1|GIPC1|USP47|DLC1|TMEM59|GAPDH|PLAUR|NLRP3|GAS1|CCBE1|ECSCR|EFNA3|CTSC|ECM1|SERPINE2|A2M|ASPH|LGALS9|THBS1|SERPINH1|ARAF|XIAP|FADD|TLK2|EPHA4|SUSD4|CD59|MMP9|BCAP31|SERPINE1|CAV1|TRAF3|MYC|C3AR1|PPARG|PLAT|MYH9|SPOP|CSTB|BCL2L12|ARL6IP1|DERL3|PRKACA|S100A8|CFP|C1S|PSMA3|S100A9|DAB2|TAF9|ANXA2|ARL6IP5|PARL|CFI|TIMP1|LGMN|CD55|PHB|CSNK1A1|MAGEF1|IGHG2|SERPING1|CD81|NGFRAP1|C1R|TNFRSF1B|AK6|DHCR24|CFH|C5AR1|NGFR|FAM122A|SERPINF1|SERPINF2|CST3|BAD|PRNP
POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION%GOBP%GO:0010838,0.162414518674382,0.5335700386874099,-0.5502462795288989,-1.31883533537643,1234,5,TGM1|STXBP4|FGF10|FGF7
PROTEIN LOCALIZATION TO CELL JUNCTION%GOBP%GO:1902414,0.5309523809523811,0.811770899275515,-0.48956876500683894,-0.956003717364943,4013,3,KIF3A|HEG1
NEGATIVE REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT%GOBP%GO:2000077,0.5811886442027061,0.8387093286508721,-0.566071628921901,-0.942033712185511,4380,2,GSK3B
POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS%GOBP%GO:0045348,0.8786808009422851,0.960725750963158,-0.304803397121271,-0.667278351656072,6713,4,SIRT1|CIITA|XBP1|AZU1
NITROBENZENE METABOLIC PROCESS%GOBP%GO:0018916,0.11999462510077902,0.47202636254014396,0.691876745196764,1.3608399109744298,892,3,GSTM2|GSTM1|GSTM3
REGULATION OF CELL CYCLE PHASE TRANSITION%GOBP%GO:1901987,0.000899511693652018,0.0214651486434742,-0.201967662824073,-1.60521437240262,6,321,TUBB|CUL1|PCBP4|GTSE1|TAF1|CDC25A|WEE1|CNOT4|RBL1|ZFP36L2|MAD1L1|BTG2|CNOT10|CNOT6L|PSME3|CENPE|FOXN3|PHB2|CDC7|PRMT2|VPS4A|HAUS1|BLM|NDE1|SFN|TUBG1|PSME1|INO80|PINX1|ZNF207|CEP72|HAUS6|CDKN1B|CDK4|CNOT6|AURKA|CEP78|PTEN|RCC2|HAUS4|FHL1|TRIP13|CEP76|DUSP1|CSNK1D|FBXL7|CEP192|PCNT|KLHL22|PIDD1|ID2|PRMT1|NEK2|NEDD1|ANLN|UIMC1|TMEM14B|LSM11|UBD|CCND2|BRD4|PML|APC|RGCC|CLSPN|RPA2|DLGAP5|CDC20|DYNC1H1|ANAPC10|PLCB1|TRIAP1|TFDP2|DONSON|CDT1|LCMT1|ZFP36L1|EZH2|ANAPC2|NBN|DYRK3|ANAPC5|KLF4|ESPL1|CDC6|OFD1|STXBP4|CEP70|RAD51C|CDC23|C8orf4|PLK2|TPX2|TUBA4A|NPM1|SDCCAG8|SLFN11|HAUS8|RAD17|BRCC3|PCNA|LSM10|ORC1|CDK5RAP2|MAD2L1|TAOK2|DDX3X|CDC25C|KNTC1|GPNMB|DCUN1D3|PTPN6|PSME2|CDC45|BRCA1|NDC80|TOPBP1|MECP2|FGF10|CEP131|CDC27|DTL|SKP1|E2F1|CKAP5|TUBB4A|RPTOR|RAD51B|CCL2|KANK2|USP44|NACC2|CCNB1|PLK1|USP47|PLAGL1|HYAL1|SUSD2|AIF1|TNKS1BP1|FAM107A|DDB1|CCND3|IK|PAGR1|SSNA1|DACT1|PRKACA|CETN2|ZNF16|CDK2AP2|HSP90AA1|CEP63|ANXA1|NEK6|H2AFY|ATF5|ANAPC11|ZNF385A|TUBB4B|CCND1|CDCA5|DCTN3|HAUS7|XRCC3|EIF4G1
REGULATION OF EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:0045604,0.314588427057865,0.684165797143474,0.24412023770039104,1.10598430826675,2315,28,FOXC1|CYP27B1|DLL1|TRIM16|KLF7|CBFB|MAFF|NCOA3
REGULATION OF DNA RECOMBINATION%GOBP%GO:0000018,0.48561475938588594,0.7872939093021379,-0.17290132362714802,-0.977758932463376,3763,63,TGFB1|RAD51|RPA2|NDFIP1|H1F0|TERF2|KDM1A|PPP4R2|PARPBP|KLHL15|PAXIP1|WAS|RAD51AP1|USP51|POLQ|TNFSF13|KPNA2|CXorf57|RMI2|PPP4C|H1FX|HIST1H1C|MAGEF1|TFRC
REGULATION OF CAVEOLIN-MEDIATED ENDOCYTOSIS%GOBP%GO:2001286,0.0221437304714033,0.206019523582829,0.751116748469641,1.65023548467666,162,4,PROM2|UNC119|NEDD4L|SRC
NEGATIVE REGULATION OF PROTEIN GLUTATHIONYLATION%GOBP%GO:0010734,0.7886707349429559,0.92796987860677,-0.46780954560292604,-0.7785098922541891,5944,2,FXYD1
ACTOMYOSIN CONTRACTILE RING ASSEMBLY%GOBP%GO:0000915,0.789294932753702,0.9280333261332429,0.33929247024664605,0.745440006797087,5809,4,RTKN|PDCD6IP
POSITIVE REGULATION OF CATALYTIC ACTIVITY IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0043946,0.167087262584673,0.539296853569433,0.9184494927216591,1.22462846953084,1257,1,SUGT1
NEGATIVE REGULATION OF LEUKOCYTE CELL-CELL ADHESION%GOBP%GO:1903038,0.0096749226006192,0.12539147812585302,-0.29491728693888103,-1.68650946553296,74,66,ADTRP|AKT1|FOXP3|CXCL12|JAK3|CD274|DUSP3|LILRB1|NDFIP1|TNFAIP8L2|TNFRSF14|RUNX1|TWSG1|RUNX3|KLF4|PDCD1LG2|SPN|FCGR2B|PLA2G2D|RC3H2|LILRB2|GPNMB|PRKAR1A|SOCS1|SDC4|CEBPB|C10orf54|CEACAM1|CD300A|HFE|CD86|LGALS3|TNFRSF21|LGALS9|PPARA|HAVCR2|ANXA1|PRNP
NEGATIVE REGULATION BY ORGANISM OF PROGRAMMED CELL DEATH IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052490,0.683955925826391,0.885415243771438,0.41850115188845294,0.8231423793794559,5089,3,CASP8|BCL2L1
CEREBRAL CORTEX CELL MIGRATION%GOBP%GO:0021795,0.304990507187415,0.677423587903087,0.314402101855812,1.1300778091919799,2248,14,EFHC1|RTN4|LAMB1|MBOAT7|PEX13
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY%GOBP%GO:0051348,0.23602246617309197,0.6213269448976729,-0.155076007360574,-1.1280300280482,1848,190,DUSP2|DUSP26|DEPTOR|GSK3B|PTPN1|SFN|GBA|NPRL2|PINX1|IL1B|CDKN1B|AKT1|MAPT|PAK2|SH3BP5|ZFYVE28|PPM1E|DUSP1|DUSP8|ZNF675|DUSP7|DUSP3|HIPK3|APC|PRKAR2A|HEXIM2|LYN|HYAL2|PYCARD|SOCS4|CORO1C|IRAK3|DTX3L|TSG101|DAB2IP|PPM1F|DUSP5|SPRY1|CDKN1C|HNRNPU|CDKN2A|NPM1|BAG5|HEXIM1|THY1|MAD2L1|WARS|MAPK8IP1|HEG1|IPO7|PHPT1|PRKAR1A|CEBPA|PARK7|RGS4|TAF7|ABL1|HSPB1|C14orf166|MEN1|LRP5|SNX6|GNAQ|CEACAM1|VPS25|CD300A|MBIP|USP44|APOE|PLK1|PPP2CA|MVP|WWTR1|CHMP6|LATS2|ERRFI1|ADARB1|NR2F2|CAV1|DNAJA1|RASIP1|EIF4A2|SMPD1|H2AFY|RGS2|GPS1|GSTP1|RGS3|PTPRJ
PHENOL-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0019336,0.7638635771934391,0.9191113740914171,-0.261831815241696,-0.7537771499846609,5867,8,FAH|SULT1A3|MAOA|MOXD1|COMT
ACTIN CORTICAL PATCH ASSEMBLY%GOBP%GO:0000147,0.9684348395546821,0.9912626134248801,-0.21438420384976,-0.5514539244273959,7393,6,WIPF1|WIPF2|WASL|TIGD5|WIPF3|WAS
FILTRATION DIAPHRAGM ASSEMBLY%GOBP%GO:0036058,0.18023641917917396,0.553886683619651,0.9118879576532859,1.21587954788383,1356,1,PTPRO
DIET INDUCED THERMOGENESIS%GOBP%GO:0002024,0.8788683756142909,0.960725750963158,0.5598257609175121,0.7464521132945079,6616,1,OMA1
CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES%GOBP%GO:1902170,0.182318271119843,0.5559553601324849,-0.500611543715702,-1.2877077482310502,1391,6,GUCY1B3|AQP1|DPEP1
RESPONSE TO IRON ION%GOBP%GO:0010039,0.318169934640523,0.6867397844771489,-0.33569636969538896,-1.1236071811589199,2433,12,HAMP|ACO1|HFE|FXN
PEROXISOME ORGANIZATION%GOBP%GO:0007031,0.28581267217630896,0.658457633141178,0.189915450159403,1.11778766294521,2074,70,IDH1|MFF|PEX11A|PEX7|RPS27A|MPV17|NUDT7|DNM1L|GSTK1|PEX2|PEX5|PEX13|PIPOX|GNPAT|ACOX2|PEX1|HMGCL|ACOX3|EHHADH|PEX10|ACOT8|ABCD3|PHYH|ZFAND6|ECH1|HACL1|PAOX|PEX11G|PEX19|UBA52|PECR|PEX5L|SLC27A2|UBE2D3|PEX12
VIRAL RNA GENOME PACKAGING%GOBP%GO:0019074,0.701768488745981,0.8931369333627571,0.494844223876482,0.831402188036471,5237,2,DDX6|PC
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0110059,0.36140257670341297,0.716154857259883,0.820632995147772,1.09420336867548,2720,1,FOXJ2
REGULATION OF SYNAPSE ORGANIZATION%GOBP%GO:0050807,0.10202241401519999,0.441073279931729,-0.22246414526603098,-1.3231835250327602,791,77,MESDC2|CDC20|EPHB3|ANAPC2|CAMK1|DAB2IP|TLR2|SHISA7|SRPX2|FCGR2B|INS|CLSTN2|FMR1|DHX36|LILRB2|EFNA1|MEF2C|ARHGAP44|DBN1|NGEF|CAMK2B|GHRL|ABL1|IL1RAP|ARHGEF15|APOE|EPHA4|CFL1|CAPRIN1|ADGRL1|EIF4G1|PRNP
PROTEIN DEPALMITOLEYLATION%GOBP%GO:1990697,0.8090969899665551,0.934411105358167,-0.599525805028672,-0.798712326933365,6047,1,NOTUM
REGULATION OF TYPE I INTERFERON-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060338,0.741621763700881,0.909955740610127,-0.19989569226385698,-0.789769231510875,5642,19,FADD|USP18|SAMHD1
REGULATION OF ADENYLATE CYCLASE ACTIVITY%GOBP%GO:0045761,0.41881968996464497,0.75036705317022,0.26179807270491195,1.0247893628634202,3079,18,CRHR1|GNAI3|CAP2|CACNA1C|NF1|GABBR1
METAL ION TRANSPORT%GOBP%GO:0030001,0.0843358075249552,0.40376145987147494,-0.15913878439373902,-1.2480427332839599,658,294,TCIRG1|ITPR2|ATP6V0B|ATP1B1|CCDC109B|ATP2A1|P2RX4|SLC12A8|ATP6V0A2|ERO1L|SLC39A3|NDUFA9|ATP6V1G2|ITPR3|SLC8B1|ATP1A3|SLC12A2|SCNN1D|PMPCA|ATP1B3|KCNN2|GRIN3A|GAS6|ATP6V1F|ANXA6|KCNK6|SLC39A8|CACNA1H|STIM1|ATP2A3|GRIN1|SLC41A1|SGK1|KCNK7|JPH4|ATP6V0D1|SLC9A1|CACNA2D4|PKD2L1|CLTC|SLC39A11|CALCRL|ABCC9|SLC9A7|SLC11A1|CACNA1G|MRS2|NALCN|SLC1A3|SLC35G1|SLC9A9|KCNJ12|ARHGAP1|KCNN1|SLC24A3|HFE|CACNA1E|F2R|CCR1|KCNQ1|STEAP4|TMCO1|KCNB2|ATP6V0E1|GRIN2C|GRIN2D|FKBP1A|CAMK2A|SLC3A2|SLC30A5|CAV1|SCN1B|STOML2|ATP6AP1|ATP1B2|HEPH|KCNH2|ATP6V0E2|KCNE4|ATOX1|MAGT1|CACNA1I|KCNJ9|PHB|ATP2B2|TFRC|ATP6V1A|ATP6V1G1|NIPAL3|FTH1
EOSINOPHIL MEDIATED IMMUNITY%GOBP%GO:0002447,0.287135191728831,0.6603864229308399,-0.534671385277368,-1.17050742877253,2193,4,VAMP8|VAMP7
POSITIVE REGULATION OF MRNA POLYADENYLATION%GOBP%GO:1900365,0.259651878026436,0.636098664976652,-0.549247432323723,-1.2024174426982701,1983,4,CPEB3|HSF1|CPEB1
CELL DEATH IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0036473,0.29076381365113796,0.6632699060435939,0.31114047838094105,1.14766896776703,2146,15,MAP3K5|STK25|RNF112|STK24
PRIMARY AMINO COMPOUND METABOLIC PROCESS%GOBP%GO:1901160,0.0495712754555198,0.319063308518797,0.861262751585332,1.4470326247984902,369,2,AZIN2|ATP7A
BILE ACID METABOLIC PROCESS%GOBP%GO:0008206,0.7150516542434939,0.8990888031809949,-0.196465412424492,-0.8136143915209191,5467,22,CYP46A1|CYP7B1|OSBP|OSBPL3
PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0001844,0.7639816633922729,0.9191113740914171,-0.29394425836077,-0.756103817002972,5832,6,BAD
POSITIVE REGULATION OF CYCLIN-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0045737,0.281463030938647,0.654633920184298,-0.325757746203167,-1.15248326930182,2146,14,CKS2|PSMD10|CCND3|CCND1|PDGFB
REGULATION OF PHAGOCYTOSIS%GOBP%GO:0050764,0.00012923235978289,0.00518555396908895,-0.45120180053210207,-2.3653464667734703,0,48,C4B|PYCARD|NCKAP1L|GNB2L1|MERTK|TLR2|FGR|C4A|SYT7|AZU1|FCGR2B|C2|GAS6|C3|CD47|FCER1G|SLC11A1|CALR|DYSF|CCL2|CD300A|HCK|CD300LF|TUB|LMAN2|ITGAM|PTPRJ|SIRPA
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE%GOBP%GO:0050912,0.976047904191617,0.9926773910205121,-0.18237820367429397,-0.5250413226445809,7497,8,RTP5|TAS2R14|RTP4|TAS2R19|TAS2R4|TAS2R20|PKD2L1
MAGNESIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903830,0.0736269567524542,0.381997503376377,-0.8259718775847809,-1.37454928713514,554,2,SLC41A1|MRS2
INOSITOL METABOLIC PROCESS%GOBP%GO:0006020,0.323641126391618,0.69236669641359,-0.4326698584040011,-1.11294343106333,2470,6,SLC5A3|ITPK1
NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0033007,0.20246041094097603,0.5810727835229039,-0.579380791128975,-1.26838566412669,1546,4,CD84|CD300A|LGALS9
MANGANESE ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071421,0.275468189666622,0.65032483094354,0.864633877370975,1.1528726079554,2073,1,SLC30A10
"NEGATIVE REGULATION OF TRANSLATION, NCRNA-MEDIATED%GOBP%GO:0040033",0.521574267782427,0.8068178076540979,-0.298944742606215,-0.9365548542055351,3988,10,STAT3|TNRC6C|RBM4
VESICLE COATING%GOBP%GO:0006901,0.000128865979381443,0.00518555396908895,-0.39963066714428097,-2.2505969164039303,0,62,TFG|PDCD6|TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|F8|SEC13|SEC24A|ARFGAP2|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|TRAPPC2|TMED9|GOSR2|PPP6C|SAR1B|GRIA1
POSITIVE REGULATION OF REGULATION OF VASCULAR SMOOTH MUSCLE CELL MEMBRANE DEPOLARIZATION%GOBP%GO:1904199,0.00265639527161642,0.0497091097098751,0.9989523599470671,1.3319681804941002,19,1,TRPM4
WAX BIOSYNTHETIC PROCESS%GOBP%GO:0010025,0.6263397642015011,0.858842084733938,0.537778378403918,0.9035371110956449,4674,2,FAR2
NEGATIVE REGULATION OF PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900737,0.603076923076923,0.8480561198163299,-0.7021945302161451,-0.9354917210978021,4507,1,BICD1
POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035360,0.6521567596002111,0.873392212173628,-0.34976089380306696,-0.8383101219244158,4958,5,PTGIS
B CELL COSTIMULATION%GOBP%GO:0031296,0.8901580555186609,0.965159112268525,0.554587560652845,0.739467680046898,6701,1,CD320
UV-DAMAGE EXCISION REPAIR%GOBP%GO:0070914,0.139452664658897,0.504314492208813,-0.39027288591307796,-1.34339495577436,1064,13,HIST3H2A|DDB1|POLA1|XPA
POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050862,0.40216258467952104,0.740287621109606,-0.34430523792453105,-1.03575443211141,3086,9,RAB29|PVRL2|RELA
METANEPHRIC MESENCHYMAL CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072136,0.991366715367247,0.997150662115148,0.504631671812969,0.672858242969697,7463,1,STAT1
REGULATION OF MICROTUBULE MOTOR ACTIVITY%GOBP%GO:2000574,0.24935523279489602,0.630084224949081,0.46294404700154296,1.19789493127368,1836,6,DNAL4|MTCL1|MAP2|PAFAH1B1|DYNLL1
CORTISOL METABOLIC PROCESS%GOBP%GO:0034650,0.357859531772575,0.714938712241162,-0.818978826643141,-1.09107644550182,2674,1,CACNA1H
NEGATIVE REGULATION OF RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:1903970,0.685217160313455,0.8857920062408181,0.656815174239083,0.875774408900244,5158,1,PTPN2
ENDOMITOTIC CELL CYCLE%GOBP%GO:0007113,0.34954448017149004,0.70736446849153,0.659994485800937,1.10887595148301,2608,2,PLK3|CIB1
CARDIAC FIBROBLAST CELL DIFFERENTIATION%GOBP%GO:0060935,0.562830687830688,0.828541380171721,-0.473456703255675,-0.924540944350183,4254,3,SPRY1|TGFBR3
PROLACTIN SECRETION%GOBP%GO:0070459,0.256832050941894,0.63510667803751,-0.70376938276389,-1.17118479410499,1935,2,ANXA1
UBIQUITIN RECYCLING%GOBP%GO:0010992,0.7628811777076758,0.9191113740914171,-0.275858476142589,-0.7540468428026271,5803,7,UBE2S|PLAA
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS%GOBP%GO:1903846,0.329177057356608,0.695646600584197,-0.27006570286279397,-1.1002496180276298,2507,21,CDKN2B|SNW1|MEN1|GIPC1|THBS1|DAB2
ENDOPLASMIC RETICULUM POLARIZATION%GOBP%GO:0061163,0.0358613361668216,0.268987198588135,0.981859285399206,1.3091768720019,269,1,SHTN1
TONIC SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014820,0.349603174603175,0.70736446849153,-0.566766867852813,-1.1067520464444,2642,3,EDNRA|MYLK
KIDNEY VASCULATURE MORPHOGENESIS%GOBP%GO:0061439,0.209920167517341,0.591291692741505,-0.575180424459166,-1.25919018345209,1603,4,PDGFRB|PDGFRA
PROTEASE LOCALIZATION TO MAST CELL SECRETORY GRANULE%GOBP%GO:0033368,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
SPHINGOSINE BIOSYNTHETIC PROCESS%GOBP%GO:0046512,0.652471083070452,0.8734599956939421,-0.306130932024352,-0.836795250974527,4963,7,SPHK1
TETRAHYDROFOLATE INTERCONVERSION%GOBP%GO:0035999,0.735745899505337,0.908157084784786,-0.269367951874236,-0.7754726325887421,5651,8,MTHFD2|TYMS|ST20-MTHFS|MTHFD1
DISACCHARIDE TRANSPORT%GOBP%GO:0015766,0.0167153091005572,0.17569702079137303,-0.9174524400330849,-1.5267875718909498,125,2,SLC45A3|SLC45A4
POSITIVE REGULATION OF PHENOTYPIC SWITCHING%GOBP%GO:1900241,0.10427169010347599,0.44426701730497703,-0.7982905982905981,-1.32848321182025,785,2,SOD2|PDGFB
EMBRYO IMPLANTATION%GOBP%GO:0007566,0.43452225982817,0.762034923704788,-0.350465468982009,-1.0089410338978102,3337,8,SPP1|SOD1|EMP2
ACETATE ESTER METABOLIC PROCESS%GOBP%GO:1900619,0.8116291532690251,0.935317461845028,0.44297769518470503,0.7442597230756921,6057,2,COLQ
MITOTIC SPINDLE POLE BODY DUPLICATION%GOBP%GO:1903087,0.613425311753781,0.852045339927398,-0.554452715743038,-0.9226979826519699,4623,2,CETN3|EFCAB11
NEGATIVE REGULATION OF PROTEIN POLYMERIZATION%GOBP%GO:0032272,0.8712807244501941,0.95792870461526,-0.14592208663697698,-0.702655683377614,6734,36,TUBB4A|KANK3|GSN|SLIT2|EPS8|TMSB4X
PHOSPHOLIPASE C-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071882,0.972107849648028,0.9915747942934481,0.51306793118659,0.684106856515847,7318,1,ADRA2A
NEGATIVE REGULATION OF LIPOPROTEIN LIPID OXIDATION%GOBP%GO:0060588,0.532709030100334,0.812079525085925,-0.736821790913101,-0.9816235468417691,3981,1,APOD
GLYCEROL CATABOLIC PROCESS%GOBP%GO:0019563,0.700053064473335,0.8930679216759608,-0.51645988420182,-0.8594718354568229,5276,2,TKFC|TPI1
POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010663,0.657070841071902,0.875794784627105,-0.535864479932586,-0.8917641857809809,4952,2,CAMK2A
REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION%GOBP%GO:0003330,0.0524723829563388,0.331996459809677,-0.6458746966688729,-1.54803840367939,398,5,ADTRP|RGCC|NOTCH1|TNFRSF1A|TNFRSF1B
REGULATION OF HYPERSENSITIVITY%GOBP%GO:0002883,0.276010993325481,0.651140142171734,-0.540142647444818,-1.1824851653563602,2108,4,HLA-E|FCGR2B|ZP3
REGULATION OF INTERFERON-GAMMA-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060334,0.694703640425812,0.889726625344871,-0.20854596178896104,-0.8239456394055771,5285,19,IFNGR1|SOCS3|PARP9|SOCS1|NR1H3|PPARG
DETECTION OF STIMULUS%GOBP%GO:0051606,0.487077789150461,0.788128506704522,-0.153883416498732,-0.9820227049635271,3806,101,RFC2|CUL4B|RPA2|C4B|TLR1|RFC3|UBE2B|MRPS11|DFNB31|RYR2|JUP|TLR2|SMO|POLD4|SSC5D|PDZD7|TGFB3|PCNA|STIM1|PIEZO1|ABCG1|TAC1|POLD1|CACNA2D4|PKD2L1|POLD2|RFC5|TMC2|GNGT2|DTL|GNAQ|NLRP3|UBC|DDB1|TLR4|ADGRV1|RFC4|LY96
REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036490,0.7952393477117309,0.929656485793048,-0.307364613166093,-0.7366943271925591,6046,5,NCK1
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002581,0.569312169312169,0.832269842301315,-0.47007073556191603,-0.917929007614257,4303,3,THBS1
"CHEMICAL SYNAPTIC TRANSMISSION, POSTSYNAPTIC%GOBP%GO:0099565",0.626830543933054,0.8590556862985079,-0.224451663103258,-0.8709559286505151,4793,18,GSK3B|AKT1|NLGN3|MPP2|NPFF|GRIN1|NPAS4|MEF2C|GRIN2C|GRIN2D
CEREBRAL CORTEX GABAERGIC INTERNEURON MIGRATION%GOBP%GO:0021853,0.644024651661308,0.8688307429995409,0.527655506019731,0.886529378473251,4806,2,DRD2
REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0010827,0.609314359637775,0.8505496974657741,-0.18668240947767897,-0.898928044610887,4709,36,PID1|SLC2A1|INS|C3|IRS1|IGF1|CREBL2|FGF19|PEA15|PRKCB|GRB10
ACTIN FILAMENT-BASED TRANSPORT%GOBP%GO:0099515,0.8753043007844201,0.9605179470041941,0.24171801445477198,0.6672560908116271,6471,7,MYO5A|FNBP1L|MYO19|WASL|SYNE2
CARDIAC ATRIUM DEVELOPMENT%GOBP%GO:0003230,0.536442752243677,0.8132910857498922,0.238613178342793,0.9340337935961379,3944,18,ACVR1|NPHP3-ACAD11|ANK2|NPHP3|ZFPM1|PROX1|BMPR2
REGULATION OF FEMALE GONAD DEVELOPMENT%GOBP%GO:2000194,0.437962962962963,0.763806300508596,-0.530037760652827,-1.03502940903678,3310,3,HYAL3|ZP3
"REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043370",0.449288604620807,0.768229288546963,-0.22243103644900103,-1.00572642555499,3441,29,MYB|IL12RB1|SMAD7|MALT1|ZC3H12A|RARA|FOXP3|JAK3|NFKBIZ|NCKAP1L|IL18|RUNX1|CCL19|RUNX3|RC3H2|SOCS1|CD86|NLRP3|LGALS9|ANXA1
NEGATIVE REGULATION BY SYMBIONT OF HOST PROGRAMMED CELL DEATH%GOBP%GO:0052041,0.683955925826391,0.885415243771438,0.41850115188845294,0.8231423793794559,5089,3,CASP8|BCL2L1
REGULATION OF PROTEIN SUMOYLATION%GOBP%GO:0033233,0.138001083423619,0.50277647185153,0.36354588027212004,1.3409708930158202,1018,15,PIAS3|MAGEA2|RASD2|HDAC4
REGULATION OF CENTROMERE COMPLEX ASSEMBLY%GOBP%GO:0090230,0.14862111126205702,0.5154128781388279,0.608558980863619,1.3370299980475,1093,4,RB1|RNF4|SENP6|TRAPPC12
REGULATION OF ELASTIN CATABOLIC PROCESS%GOBP%GO:0060310,0.00882943143812709,0.117827730899938,-0.995644022937803,-1.32643690678155,65,1,CST3
NEURAL TUBE FORMATION%GOBP%GO:0001841,0.473806275579809,0.78388668630142,0.208921058351613,0.9848429655532199,3472,32,BBS4|TSC2|BMP7|SEMA4C|DVL2|MTHFR|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10
TAIL-ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE%GOBP%GO:0071816,0.8189110994213571,0.9389317625496709,-0.29980145598941105,-0.7185668826232751,6226,5,SGTA|BAG6|ASNA1|GET4|UBL4A
EXTRACELLULAR MATRIX DISASSEMBLY%GOBP%GO:0022617,0.292323597828896,0.664630848935249,-0.232098857165287,-1.12752373736256,2261,37,FURIN|CAPG|EXOC8|MMP12|CD44|ADAMTS4|LAMC1|ADAM8|CTSV|TPSAB1|CTSS|MMP1|HTRA1|MMP14|GSN|A2M|MMP9|CTSL|TIMP1|MMP19
DETECTION OF CELL DENSITY BY CONTACT STIMULUS INVOLVED IN CONTACT INHIBITION%GOBP%GO:0060248,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
EXOCYST ASSEMBLY%GOBP%GO:0001927,0.9283629609976121,0.9793746057014829,-0.37689550592776394,-0.6272143919866949,6997,2,EXOC2|EXOC8
REGULATION OF MAST CELL DIFFERENTIATION%GOBP%GO:0060375,0.359941559304024,0.7155384949577859,0.821239523599471,1.0950120925252,2709,1,ZFPM1
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0090263,0.302202756666237,0.675222663526765,-0.19275699456901302,-1.10697599313844,2345,67,KANK1|UBE2B|JUP|PRDM15|SFRP4|WLS|RUVBL1|SFRP2|FRAT1|VCP|ILK|DDX3X|SMURF2|DAAM2|GPRC5B|USP47|COL1A1|SEMA5A|XIAP|CAV1|ADGRA2|DACT1|NFKB1|WNK2
NEGATIVE REGULATION OF CELL CYCLE%GOBP%GO:0045786,0.0327055230338509,0.25829097137034,-0.157265680787184,-1.30275155670654,256,423,LAMTOR2|CUL1|LAMTOR5|PCBP4|GTSE1|WHAMM|WEE1|CNOT4|LAMTOR1|RBL1|ZFP36L2|CDK5RAP1|ATRX|MAD1L1|MCPH1|BTG2|CBX3|CNOT10|CNOT6L|KIF25|CLOCK|RPL23|FOXN3|C17orf104|CDKN2D|CDC7|PRMT2|VPS4A|PRKAB1|PPP1R15A|FOXO4|BLM|EHMT1|DNA2|SFN|ATRIP|PPM1A|STK33|PINX1|MDM1|ZNF207|PCGF2|TGFB2|CDKN1B|ZWINT|CDK4|CNOT6|AURKA|DDIT3|PA2G4|SIPA1|SOX11|PTEN|MLST8|FHL1|TRIP13|DUSP1|AURKAIP1|TIMELESS|FBXL7|RRAGB|EME2|KLHL22|PRCC|PIDD1|PRMT1|NEK2|YTHDC2|UIMC1|RAD9A|BRINP1|TGFB1|LILRB1|PML|APC|PHC3|RGCC|RAD51|HEXIM2|CLSPN|RPA2|CDK6|RRM2|NR4A1|NABP2|BRIP1|CDC20|TSPYL2|UXT|TRIAP1|TFDP2|SETMAR|INTS7|TERF2|DONSON|GADD45GIP1|CDT1|ZFP36L1|EZH2|FBXO6|RUNX3|H2AFX|NBN|DAB2IP|KLF4|RRAGA|ESPL1|CDC6|NAA10|PRR11|PLK2|STAG2|CDKN2A|GATA3|NPM1|PPP2R3B|CCNK|HEXIM1|RAD1|PTTG1|SLFN11|GAS6|BRINP3|RAD17|BRCC3|PCNA|STRADA|GMNN|ORC1|TOP2A|CDK5RAP2|MAD2L1|TAOK2|SLC9A3R1|PPP1R13B|CDC25C|KNTC1|IPO7|ZNF268|NOTCH1|GPNMB|INHBA|CEBPA|RHNO1|DCUN1D3|CDC45|BRCA1|CDKN2B|TOPBP1|EME1|NOTCH2|FGF10|RBBP7|ABL1|CALR|HRAS|DTL|SKP1|FAP|MEN1|E2F1|EIF4G2|RPTOR|CCL2|KANK2|GPER1|MAX|NACC2|CCNB1|PLK1|USP47|RBM14|CDK7|KAT2B|GAS1|PLAGL1|RING1|BMP2|SUSD2|THBS1|LATS2|NR2F2|TNKS1BP1|MYC|APBB1|FAM107A|IK|SMC1A|DACT1|GAS7|BCL6|CDKN2C|CDK2AP2|CEP63|H2AFY|ATF5|CDKN3|ZNF385A|CCND1|MUS81|SLC38A9|DHCR24|ERN1|PRPF19|RRAGD
REGULATION OF ANTIFUNGAL INNATE IMMUNE RESPONSE%GOBP%GO:1905034,0.0387959866220736,0.28020075641001296,-0.980094838994266,-1.30572166018951,289,1,FAM3A
EXTRACELLULAR TRANSPORT%GOBP%GO:0006858,0.621560846560847,0.856075054950132,-0.44693033051146797,-0.8727416614622819,4698,3,ARRDC1|TSG101
RESPONSE TO GROWTH FACTOR%GOBP%GO:0070848,0.009467758444216991,0.12365579463302599,-0.18390842259963397,-1.45203899801464,73,307,PTBP1|RAB35|FLT1|GNB2L1|SOX5|MT1G|HNRNPH1|MTSS1L|NR3C1|TWSG1|TBX1|ZFP36L1|RUNX3|RAB14|DAB2IP|NCBP2|KLF4|FGFR4|KDR|POLR2J|CLDN5|RAPGEF1|SEMA6A|USP9X|HGF|CFC1|MED1|NGF|SMAD6|ITGB5|PDCD5|ELK1|VEGFC|WWOX|TGFB3|SH3GL2|BCAR1|SHCBP1|SYAP1|CLEC3B|MXRA5|NDST1|FLT4|SMAD5|MAPKAPK2|NOTCH1|SLC33A1|GRB2|MEF2C|SMURF2|GCNT2|CHRD|LTBP2|NCBP1|PRKD1|ZFHX3|HNRNPM|DDX5|PDE2A|EHD1|SNAI2|PXN|POLR2H|FGF10|MAPK3|LRRC32|CILP|HSPB1|NTRK2|CDH5|CCL2|MAP2K3|EPHA2|HFE|CORO1B|RAP1A|FMOD|GATA6|GAS1|HYAL1|VEGFB|FGF19|TGFBR2|BMP2|TGFBR3|FGF9|FGF7|COL1A2|UBC|PDGFRB|COL3A1|ID1|TMEM108|MYC|DDIT4|POLR2G|RELA|FIBP|RPS6KB1|PDGFRA|ANXA1|LGMN|ENG|EMD|ACVRL1|PDGFB|NGFR|ERN1|POLR2L
RNA POLYMERASE II CORE COMPLEX ASSEMBLY%GOBP%GO:1990114,0.7525567804489308,0.915314007578303,0.6242831936479929,0.832397402415091,5665,1,GTF2B
REGULATION OF NETRIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:1902841,0.441303494307028,0.7653693162885199,-0.461523681376461,-1.0103718143160898,3371,4,SIAH2|NTN1
POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION%GOBP%GO:2000347,0.920133779264214,0.9768322640118741,-0.539534627260697,-0.7187896734151541,6877,1,XBP1
REGULATION OF REPRODUCTIVE PROCESS%GOBP%GO:2000241,0.11685773840541999,0.46712068687717895,-0.262034567224298,-1.32903025588475,896,43,HYAL3|ARHGDIB|RAD1|CACNA1H|CDC25C|INHBA|SMURF2|CALR|SULF1|IGF1|ZP3|POMZP3|SYDE1|TIMP1|LHFPL2
CELLULAR RESPONSE TO CALCIUM ION%GOBP%GO:0071277,0.904026475455047,0.96959927854485,0.12639565967545302,0.6980222925276961,6555,55,CPNE8|SCN5A|CPNE9|SYT2|SLC25A24|CPNE2|RYR1|CARF|PKD2|SYT5|ADD1|CPNE3|CAMK2D|CPNE1
INTERLEUKIN-1 PRODUCTION%GOBP%GO:0032612,0.148138505597501,0.515403737647103,-0.465503011077931,-1.34011801688691,1137,8,S100A13|CD36|TLR4
EMBRYONIC HEART TUBE MORPHOGENESIS%GOBP%GO:0003143,0.371459844027911,0.7231393531146391,0.221196070761894,1.06124546464026,2714,34,BBS5|ACVR1|NPHP3-ACAD11|DLL1|BBS4|AHI1|SETDB2|MKKS|NPHP3|PKD2|CCDC40|BBS7|MEGF8
REGULATION OF FC-GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:1905449,0.0375661375661376,0.276257905964833,-0.7812137190188331,-1.5255123954406398,283,3,CD47|PTPRJ
POSITIVE REGULATION OF INHIBITORY G PROTEIN-COUPLED RECEPTOR PHOSPHORYLATION%GOBP%GO:1904325,0.17123745819398,0.5448344947455329,-0.9122739303043671,-1.21536792505403,1279,1,APLNR
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007179,0.962986762626912,0.990916952887267,-0.10641531653671699,-0.629310868360798,7492,75,SMAD5|GCNT2|LTBP2|PXN|LRRC32|CDH5|FMOD|TGFBR2|TGFBR3|COL1A2|UBC|COL3A1|ID1|ACVRL1
SARCOMEROGENESIS%GOBP%GO:0048769,0.91101075840085,0.972245398885683,0.544883105425673,0.726528098451327,6858,1,TCAP
REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS%GOBP%GO:1902337,0.250920568122041,0.63148176332757,-0.501718004466118,-1.2025223200981499,1907,5,NOTCH1|TNFRSF1A|TNFRSF1B
COLUMNAR/CUBOIDAL EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0002066,0.943253138075314,0.9825021479202449,-0.185290074891079,-0.580489616784916,7213,10,CDK6|DFNB31|PDZD7|SOD1
RNA DESTABILIZATION%GOBP%GO:0050779,0.76968048946295,0.921135900129782,0.18447574008467202,0.772022213065711,5660,22,RBM24|MEX3D|DXO|MOV10|METTL14|RC3H1|FTO|GIGYF2|UPF1|METTL16|METTL3|YTHDF3|ZC3H12D|YTHDF2|ZFP36L2|ZC3H12A|PUM1|RBM23|CPEB3
NEGATIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0071072,0.159656084656085,0.529342225823707,-0.667522451619447,-1.3035021651429,1206,3,PDGFA|PDGFB
REGULATION OF CELL CYCLE G2/M PHASE TRANSITION%GOBP%GO:1902749,0.0609227631914351,0.35631208031004796,-0.19628719664697897,-1.3483641047248403,477,142,CDC7|VPS4A|HAUS1|BLM|NDE1|TUBG1|PINX1|CEP72|HAUS6|CDK4|AURKA|CEP78|RCC2|HAUS4|FHL1|CEP76|CSNK1D|FBXL7|CEP192|PCNT|NEK2|NEDD1|UIMC1|BRD4|CLSPN|DYNC1H1|DONSON|NBN|DYRK3|CDC6|OFD1|CEP70|RAD51C|TPX2|TUBA4A|NPM1|SDCCAG8|HAUS8|RAD17|BRCC3|ORC1|CDK5RAP2|TAOK2|CDC25C|BRCA1|TOPBP1|MECP2|CEP131|DTL|SKP1|CKAP5|TUBB4A|RAD51B|CCNB1|PLK1|USP47|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|H2AFY|ATF5|TUBB4B|CCND1|DCTN3|HAUS7
MITOCHONDRIAL MEMBRANE ORGANIZATION%GOBP%GO:0007006,0.47830551989730397,0.7850984235874658,-0.15299662189715196,-0.98609474931143,3725,106,TFDP2|APOOL|BCL2L11|GZMB|PPIF|ATP5J|ATP5F1|OPA1|TOMM20|CHCHD3|APOO|NMT1|ATP5B|PPP1R13B|ROMO1|E2F1|ATP5O|CHCHD6|TIMM9|CAMK2A|MPV17L|ATP5H|HSP90AA1|HSPA4|STPG1|TIMM10|UQCC3|ATP5G1|BAD|SLC25A5
NEGATIVE REGULATION OF COLD-INDUCED THERMOGENESIS%GOBP%GO:0120163,0.0287081339712919,0.238792268557792,-0.32220496795759196,-1.60400915897996,221,40,NOVA2|LGR4|PGAM5|LNPEP|NRD1|NOVA1|FOXC2|PLCL2|NOTCH1|ARRDC3|LAMA4|NR1H3|ALDH1A1|IL15|NR1D1|ID1|TLR4|PCTP|TFE3|PLCL1
DRINKING BEHAVIOR%GOBP%GO:0042756,0.76,0.9179084014002329,-0.624172915747684,-0.8315481965313791,5680,1,APLN
PREPULSE INHIBITION%GOBP%GO:0060134,0.041655468959957004,0.292809245831308,0.7796561509226642,1.5334916433858898,309,3,DRD2|CTNNA2
ASTROCYTE ACTIVATION%GOBP%GO:0048143,0.0693056286165176,0.37596389138254704,-0.626240900066181,-1.5009799396959702,526,5,APP|MAPT|TNF|PSEN1|LRP1
POSITIVE REGULATION OF BONE DEVELOPMENT%GOBP%GO:1903012,0.107936507936508,0.452480194746961,-0.704276772113047,-1.3752740377226698,815,3,ATP6AP1|TMEM119
CHONDROBLAST DIFFERENTIATION%GOBP%GO:0060591,0.17080621596493603,0.544378398009534,0.9165747684164091,1.2221287776316998,1285,1,FGF2
POSITIVE REGULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0097151,0.0385817144409727,0.279776552671739,0.718350665546006,1.57824700506333,283,4,RIMS1|RIMS2|NLGN2|UNC13B
NEGATIVE REGULATION OF INTERLEUKIN-2 SECRETION%GOBP%GO:1900041,0.8459448444504821,0.948909006295342,0.32031621828388696,0.703748373081138,6226,4,TRIM27|EZR
SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCUS ASSEMBLY%GOBP%GO:0035986,0.588485009286283,0.8414799095069009,-0.563281266837068,-0.937390103463903,4435,2,CDKN2A
NEGATIVE REGULATION OF VASCULAR WOUND HEALING%GOBP%GO:0061044,0.10755852842809402,0.451309145449614,-0.944199382443758,-1.25790029305683,803,1,SERPINE1
DCMP PHOSPHORYLATION%GOBP%GO:0061567,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
CYTOPLASMIC TRANSLATIONAL INITIATION%GOBP%GO:0002183,0.0196078431372549,0.192628124925339,-0.51993692150311,-1.74027755879715,149,12,DENR|EIF2S3|EIF3M|MCTS1|RBM4|EIF2D|EIF4G1
SECRETORY GRANULE ORGANIZATION%GOBP%GO:0033363,0.25248560962846694,0.632257972333528,-0.315611814283933,-1.1729357090883898,1929,16,RFX2|SRGN|F2R|F2RL3|LYST
MODULATION BY ORGANISM OF IMMUNE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052552,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY INVOLVED IN HEART INDUCTION%GOBP%GO:0035481,0.634780278670954,0.8634223229282929,0.5323433103630519,0.8944054950369491,4737,2,ROBO2|ROBO1
REGULATION OF DNA DUPLEX UNWINDING%GOBP%GO:1905462,0.0980238188718754,0.43163319977057396,-0.646239833641724,-1.41475408423803,748,4,TOP2A|MNAT1|GTF2H2
INTERFERON-BETA PRODUCTION%GOBP%GO:0032608,0.0585978835978836,0.34933029167190405,-0.755156060438955,-1.4746283925205501,442,3,TRIM56|IRF7|TMEM173
POSITIVE REGULATION OF TELOMERIC HETEROCHROMATIN ASSEMBLY%GOBP%GO:1905549,0.7953177257525079,0.929656485793048,-0.606473312748125,-0.807968075410657,5944,1,SIRT6
POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0032968,0.9233385661957091,0.97763046765315,-0.16831300700844298,-0.625516306074152,7057,16,WDR61|GTF2F2|SUPT6H|TCEB1|RTF1|CDK13|CDC73|LEO1|PAF1|CDK12|CDK9|ELL|BRD4|SUPT16H|CTR9|EAPP
MONOCYTE AGGREGATION%GOBP%GO:0070487,0.9091642031711898,0.9715233171195049,0.324572959695601,0.638396709592046,6765,3,BMP7|IL1B|CD44
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION%GOBP%GO:0060045,0.271966527196653,0.646576786621306,-0.374735949493805,-1.17399881156648,2079,10,TBX2|NOTCH1|MEF2C|PIM1|TGFBR3
REGULATION OF CATECHOLAMINE SECRETION%GOBP%GO:0050433,0.7654674298173891,0.9197593738525891,0.177119301165562,0.7832161814635951,5616,26,SYT2|PARK2|CHRNB2|HRH3|SYT5|UCN|KCNB1|CRH|STX1A|SNCA|CARTPT|SYT11|SYT17|VIP|SYT15
REGULATION OF T CELL APOPTOTIC PROCESS%GOBP%GO:0070232,0.0659426926599503,0.369007394574627,-0.392478662390685,-1.49151475888726,503,17,BMP4|PRKCQ|BLM|JAK3|CD274|ADAM8|RIPK3|PRELID1|TNFRSF4|LGALS3|LGALS9|FADD
REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME%GOBP%GO:1902965,0.8926130389064141,0.965443067117994,-0.234859349145063,-0.641977557484861,6790,7,EZR|ROCK2|SORL1|RDX|MGAT3|DTX3L|MSN
POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT%GOBP%GO:2000643,0.9009372559229369,0.9684180373391851,-0.22073673675806102,-0.635470170715559,6920,8,MSN|DAB2
NEGATIVE STRANDED VIRAL RNA REPLICATION%GOBP%GO:0039689,0.89884780278671,0.967428248648255,0.39053628845406,0.656151388784108,6708,2,ATG16L1|ATG16L2
REGULATION OF ACTIN FILAMENT POLYMERIZATION%GOBP%GO:0030833,0.731778425655977,0.9074802896081321,0.132982663502768,0.854046174176048,5270,100,NCK2|BIN1|RLTPR|ADD3|CYFIP1|PICK1|FCHSD1|ABI2|FAM21C|ARFGEF1|RHOBTB1|PRKCE|NCKAP1|LRRC16A|ACTR2|TRIM27|TRIOBP|TWF1|PTK2B|CDC42EP3|WASH1|TMSB10|ADD1|C15orf62
PHOSPHOLIPASE C-ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060158,0.7450074718108951,0.9112137767014771,0.354717842443269,0.779330206443249,5483,4,DRD2|GNA11
SCHWANN CELL DEVELOPMENT%GOBP%GO:0014044,0.28989071038251396,0.6622817015650171,0.39554818475882103,1.14820718076079,2121,8,PARD3|NF1|ARHGEF10|SKI
POLYAMINE CATABOLIC PROCESS%GOBP%GO:0006598,0.9127089413637571,0.972925642245441,-0.388500011586516,-0.646526145102837,6879,2,SMOX
C-TERMINAL PROTEIN METHYLATION%GOBP%GO:0006481,0.48762541806020093,0.788226301622024,-0.7594287604764008,-1.01174145855359,3644,1,LCMT1
REGULATION OF TELOMERIC DNA BINDING%GOBP%GO:1904742,0.680206493682924,0.8847768831854209,0.375250593825603,0.824441535671639,5006,4,ACD|TNKS|ERCC4|PINX1
REGULATION OF SISTER CHROMATID COHESION%GOBP%GO:0007063,0.22168263551647197,0.604285118926805,-0.298301440140676,-1.2152822150046,1688,21,ESPL1|ANKRD32|NAA10|HDAC8|H2AFY|CDCA5|FEN1
RESPONSE TO STEROID HORMONE%GOBP%GO:0048545,0.0991555783009212,0.434549148169116,-0.20371125475249105,-1.30000413283782,774,101,PIAS2|RNF14|ADTRP|ATP1A1|TGFB2|MED30|TNF|UBE2L3|PDCD7|NCOA6|TGFB1|AQP1|ABCA2|ADAM9|NR3C1|REST|ZFP36L1|BCL2L11|MED13|GOT1|MED1|HNRNPU|ATP1A3|IL1RN|TGFB3|BRCA1|DDX5|CALR|NR1H3|RAN|WBP2|NCOA4|GPER1|RBM14|CDK7|THBS1|FHL2|PPAP2A|SLIT2|CAV1|FAM107A|YAP1|KAT5|ANXA1|TFPI|PHB|SSTR2
POSITIVE REGULATION OF ABSCISIC ACID-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0009789,0.360267558528428,0.7155384949577859,-0.817765769739744,-1.08946036243435,2692,1,LANCL2
NEGATIVE REGULATION OF ION TRANSPORT%GOBP%GO:0043271,0.0354336136770991,0.26795254616732395,0.24785616666070998,1.47729082026434,256,73,FKBP1B|CRHR1|BIN1|TCAF2|IRS2|GSTM2|C19orf26|TRH|INPP5K|EPHB2|DRD4|PACSIN3|GNB5|PRKCE|SRI|ADCYAP1|SNX16|SUMO1|NEDD4|TRIM27|PTK2B|PKD2|HRH3
RENAL WATER ABSORPTION%GOBP%GO:0070295,0.5563879598662211,0.8257149029717741,-0.725077194530216,-0.965976924415869,4158,1,HYAL2
HISTONE H3-S10 PHOSPHORYLATION%GOBP%GO:0043987,0.0661375661375661,0.3690551432905871,-0.745727520971539,-1.4562168445941899,499,3,RPS6KA4|VRK1
ACTIN MODIFICATION%GOBP%GO:0030047,0.40233118971061105,0.740287621109606,0.635346015991177,1.0674633397098499,3002,2,TRIOBP|NAT6
"SPERMATOGENESIS, EXCHANGE OF CHROMOSOMAL PROTEINS%GOBP%GO:0035093",0.39274555087623997,0.737280445732591,0.47464211840318704,1.04280894801895,2890,4,PSME4|CHD5|RNF8
POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION%GOBP%GO:0045618,0.198123470220288,0.5753327705274761,0.395665753238144,1.25349585132297,1456,10,FOXC1|CYP27B1|TRIM16|NCOA3
DIBASIC PROTEIN PROCESSING%GOBP%GO:0090472,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
REGULATION OF PEPTIDE SECRETION%GOBP%GO:0002791,0.000383239652529382,0.0111294649577428,-0.22941711053010397,-1.7315500015136,2,235,LILRB1|HLA-E|RGCC|INHBB|ADAM9|HYAL2|LGR4|DHX9|TLR1|PYCARD|CD74|TNFRSF14|GSDMD|DISP1|PER2|ADAM8|CCL19|REST|RHBDF2|ACHE|ITPR2|PIM3|STX4|TLR2|STXBP4|PPIA|FGR|CD34|WLS|GIPR|ITPR3|SLC2A1|SLC8B1|GPI|CDK16|SSC5D|GATA3|SYT7|DNAJC1|FCGR2B|MYOM1|GAS6|TGFB3|INS|CASP1|TNFAIP3|DHX36|ADCY8|SLC25A6|CRHBP|PTGER4|IRS1|IFIH1|ENSA|OSM|CARD16|GHRL|RSAD2|SRGN|RAPGEF3|TNFRSF4|UQCC2|IGF1|DPP4|FCN1|NR1H3|LRP5|IL33|GPER1|HFE|CACNA1E|F2R|RAP1A|FN1|GAPDH|NLRP3|NOV|CHGA|TNFRSF21|CD200|LGALS9|ADRA2C|NR1D1|ARL2|FOXP1|SLC25A4|CX3CL1|SIRT4|HAVCR2|ANG|TLR4|SERGEF|RAB11FIP1|CSF1R|C1QTNF4|ANXA1|TMSB4X|CD14|TNFRSF1B|EFNA5|BAD|SLC25A5
CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0010644,0.23680756103964298,0.6217158626397761,-0.330026817399989,-1.198273877036,1803,15,ATP1A1|GJC1|GJA5|GJA1|RYR2|GJC2|ATP1B1|ATP1A3|PKP2|ATP1B2|PRKACA
NEGATIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:2000502,0.670336959405678,0.8815356925073421,-0.530100939876749,-0.882172733468717,5052,2,CCL2
MAST CELL MIGRATION%GOBP%GO:0097531,0.9082010582010579,0.971434329578746,-0.32661603808816303,-0.6377983418916279,6865,3,CHGA
POSITIVE REGULATION OF WNT PROTEIN SECRETION%GOBP%GO:0061357,0.81918280711064,0.9389789016232991,-0.450926066014964,-0.7504130823484391,6174,2,WLS
MONOVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0055083,0.158794788273616,0.529241394364932,0.39804357089607895,1.3098077629721399,1169,11,SLC12A5|SLC12A4|SLC12A9|XPR1|TFAP2B
POSITIVE REGULATION OF CARDIOBLAST PROLIFERATION%GOBP%GO:1905062,0.250033444816054,0.630643295704944,-0.8719673577415091,-1.16166989222149,1868,1,PIM1
NEGATIVE REGULATION OF RHO-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:2000299,0.0671265587689042,0.3700675565152539,-0.8333609043286461,-1.3868458092311498,505,2,HEG1|RASIP1
VESICLE-MEDIATED TRANSPORT IN SYNAPSE%GOBP%GO:0099003,0.970347789940418,0.9915747942934481,0.10198536707006099,0.618961339232154,7002,79,SYT2|RIMS1|SNAP25|DNAJC5|KIAA1109|UNC13A|RIMS2|BLOC1S3|CPLX1|AP3B2|SYT5|NLGN2|AP3B1|KIF5A|SPG11|SNAP23|OTOF|NLGN4X|AP3M1|CDK5|AMPH|PIP5K1C|STX1A|SNCA|DNAJC6|BLOC1S5|KIF5C|FCHO2|AP3M2|SYT11
AROMATIC AMINO ACID FAMILY BIOSYNTHETIC PROCESS%GOBP%GO:0009073,0.886571921901979,0.964939379509639,0.556296868107631,0.7417468108961179,6674,1,PAH
MODULATION BY HOST OF VIRAL GENOME REPLICATION%GOBP%GO:0044827,0.8367828137280591,0.9461941948757601,-0.216743679589113,-0.7017193239133249,6387,11,CCNK|PPIB|FMR1|NUCKS1
SIGNAL PEPTIDE PROCESSING%GOBP%GO:0006465,0.703844142259414,0.894167140223854,-0.256392542849764,-0.8032443671516651,5382,10,FURIN|SPPL3|SPCS2|PCSK5|HM13|SEC11C
DNA RECOMBINASE ASSEMBLY%GOBP%GO:0000730,0.533201058201058,0.812079525085925,-0.488572505770788,-0.9540582755778009,4030,3,DMC1|RAD51
SYNAPTIC VESICLE BUDDING FROM PRESYNAPTIC ENDOCYTIC ZONE MEMBRANE%GOBP%GO:0016185,0.0761904761904762,0.38622298016237394,-0.73353865133645,-1.4324150714531698,575,3,DNM1|DNM3
POSITIVE REGULATION OF DENDRITE EXTENSION%GOBP%GO:1903861,0.246885157096425,0.6280519349499749,0.323195644577287,1.19213550653696,1822,15,CPNE9|SYT2|RIMS1|UNC13A|RIMS2
POSITIVE REGULATION OF FOREBRAIN NEURON DIFFERENTIATION%GOBP%GO:2000979,0.506308938770089,0.798168488166378,0.7477393030436701,0.997009466008748,3811,1,PROX1
POSITIVE REGULATION OF DOPAMINE METABOLIC PROCESS%GOBP%GO:0045964,0.0474927036349164,0.312255783864335,-0.856906534325889,-1.42602950277589,357,2,PARK7|HPRT1
MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER%GOBP%GO:0072393,0.0265233949945593,0.23021695204659198,0.488238313988709,1.65942706594655,194,12,BBS4|DCTN1|CCDC68|NINL|PCM1
PLASMA MEMBRANE BOUNDED CELL PROJECTION MORPHOGENESIS%GOBP%GO:0120039,0.10009758817788901,0.43605057892447596,0.15681612912624598,1.2280591600211,717,268,TNR|RET|CNTN4|SHTN1|DRD2|ROBO3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|SEMA4F|PLXNB1|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|ALS2|SLIT1|EPHB2|EFNA4|PARD3|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|NYAP2|STK24|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|BMP7|NTNG1|EFNB3|SLIT3|CDK5R1|SHC1|SOS1|NYAP1|MAP6|ATP7A|DRAXIN|SPTBN1|PAK1|EFNA2|EPB41L3|NRCAM|STRADB|MAP2|DLG4|BRSK1|VLDLR|TUBB3|ULK2|PPP3CB|PRKCA|PLCG1|KIF5A|PLXNB2|POU4F2|DOCK7|CELSR2|NRP1|DCC|CPNE1|EZR|ANKRD27|SRC|SHANK2|VSTM2L|GPC1|RANBP9
VAGUS NERVE MORPHOGENESIS%GOBP%GO:0021644,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
REGULATION OF TRANSCRIPTION BY GALACTOSE%GOBP%GO:0000409,0.988311860804888,0.996030692679047,0.505513895015439,0.6740345685692951,7440,1,NCOA1
SULFUR COMPOUND TRANSPORT%GOBP%GO:0072348,0.6985834922364479,0.892206463710019,0.19448465076966603,0.8256738488453209,5128,23,SLC5A6|SLC25A26|CTNS|SLC25A30|SLC13A4|SLC35B2|SLC1A4|SLC26A6|LRRC8D|SLC26A1|SLC7A9
WNT SIGNALING PATHWAY INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0061289,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
POSITIVE REGULATION OF MONONUCLEAR CELL PROLIFERATION%GOBP%GO:0032946,0.00038555455596967,0.0111294649577428,-0.34667069779331794,-2.05011501129428,2,75,CD1D|HLA-DMB|JAK3|SYK|NFATC2|CD274|HLA-DPA1|CD38|HLA-E|GPR183|CD209|TNFSF13B|PYCARD|NCKAP1L|VAV3|CD74|IL18|CCL19|CCDC88B|HLA-DPB1|PDCD1LG2|EBI3|IL6ST|LILRB2|MEF2C|FGF10|BST1|TNFRSF4|IGF1|ICOSLG|VCAM1|CSF1|CD86|TGFBR2|LGALS9|ZP3|FADD|AIF1|PNP|ANXA1|CD55|NCK1|TFRC|CD81
REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:1901256,0.0562753566287135,0.344283775813862,-0.6873977032377081,-1.50485726432417,429,4,CD34|FOXP1|HAVCR2
CHROMATIN ASSEMBLY%GOBP%GO:0031497,0.000128008192524322,0.00518555396908895,-0.410650418289823,-2.56467112645359,0,93,HIST1H4J|CENPQ|HELLS|SMCHD1|ATRX|HIST1H2BF|HIST4H4|NASP|HIST1H3D|CASC5|SART3|HIST1H4H|HJURP|ITGB3BP|CTCF|CENPL|CENPU|CENPW|H1F0|HIST1H2BE|HMGB2|H2AFX|OIP5|RUVBL1|CENPM|CDKN2A|HIST1H2BN|NPM1|ASF1B|CHAF1A|CENPI|IPO4|HIST1H2BC|HIST1H4I|STRA13|ANP32B|RBBP7|CENPH|NAP1L4|HIST2H3A|HIST2H2BF|SPTY2D1|H1FX|HIST1H2BG|HIST1H2BD|CHAF1B|HIST2H4A|HIST2H3C|HIST1H3H|POLE3|HIST1H1C|H2AFY|HIST2H4B|CENPK|H3F3B|MIS18A|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ|CENPP
CARBOHYDRATE HOMEOSTASIS%GOBP%GO:0033500,0.00914006179196704,0.12051637208341301,-0.280814834415844,-1.66640333059688,70,76,GAS6|HK1|INS|HK3|ADCY8|IRS1|CEBPA|STAT3|ADIPOR1|PARK7|NUCKS1|GPRC5B|CRY2|GPER1|ADIPOR2|PDK3|TRA2B|PPARG|INSRR|PYGL|PRKACA|BACE2|NGFR|ERN1|BAD
BASIC AMINO ACID TRANSPORT%GOBP%GO:0015802,0.641167192429022,0.86744300905294,-0.309928295642581,-0.847175175083944,4877,7,SLC25A29|SLC7A1|SLC15A4|PQLC2|CLN3|SLC7A2|SLC7A3
EMBRYONIC MORPHOGENESIS%GOBP%GO:0048598,0.31997226074896,0.6880109854925379,0.148687999470553,1.07309117767241,2306,173,RBPMS2|STRA6|BBS5|ACVR1|LRP5L|NPHP3-ACAD11|FGFR2|DLL1|MMP15|BBS4|TSC2|RARG|PAX8|TBX3|AHI1|EPHB2|HDAC1|MFAP2|LAMB1|FGF2|TWIST1|SETDB2|COL11A1|BMP7|ZNF568|MMP2|WDR60|SEMA4C|CEP290|ALDH1A3|CACNA1C|DVL2|MKKS|MTHFR|ACD|ITGAV|NPHP3|PKD2|ITGA2|NR4A3|CCDC40|PHACTR4|SKI|SOX7|PLXNB2|CHD7|MTHFD1L|LRP6|BBS7
CALCITONIN CATABOLIC PROCESS%GOBP%GO:0010816,0.667959866220736,0.8810898721211949,-0.669386854874283,-0.8917840199550309,4992,1,ECE1
CALCIUM ION-REGULATED EXOCYTOSIS OF NEUROTRANSMITTER%GOBP%GO:0048791,0.23737785016286603,0.6217158626397761,0.365808341969359,1.20373406607923,1748,11,SYT2|RIMS1|RIMS2|SYT5
LEUKOTRIENE D4 METABOLIC PROCESS%GOBP%GO:1901748,0.26335978835978796,0.638950455433329,-0.60752323810197,-1.18633890788142,1990,3,GGT1|GGT5
NEGATIVE REGULATION OF IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:2000521,0.15505016722408,0.523290364662318,-0.9204344949272171,-1.22623975659879,1158,1,LGALS3
CARBOHYDRATE BIOSYNTHETIC PROCESS%GOBP%GO:0016051,0.05459216441875401,0.33896362399005303,-0.23762705249840302,-1.42344220335888,424,79,PGAM2|GYG1|PER2|PGP|TKT|GOT1|SLC2A1|GPI|SLC25A10|G6PC3|NDST1|PPP1R3C|ENO1|PGM5|PGAM1|GAPDH|B3GALT2|NR1D1|EXT2|B4GALT1|B3GNT5|NDUFAB1|B4GAT1|CSGALNACT1|B3GALT1|PGK1|TALDO1|GYG2|ALDOA|ALDOC
NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS%GOBP%GO:0050748,0.9829346949744691,0.993436724391485,0.263207235028124,0.517697570803068,7314,3,ITGAV|ITGB3|APOD
NEGATIVE REGULATION OF ATPASE ACTIVITY%GOBP%GO:0032780,0.241437908496732,0.6249321365425989,-0.35971629691925705,-1.20400412660144,1846,12,THADA|TNNT2|VCPKMT|PPIF|OXA1L|PXK|PLN|ATPIF1
BARBED-END ACTIN FILAMENT UNCAPPING%GOBP%GO:0051638,0.26351441094434896,0.638950455433329,0.870533745037495,1.16073928540271,1983,1,LRRC16A
ADRENAL CHROMAFFIN CELL DIFFERENTIATION%GOBP%GO:0061104,0.0787621198034268,0.39324071934415206,0.9613475959417729,1.28182730181126,592,1,INSM1
RNA SPLICING%GOBP%GO:0008380,0.000638488060273273,0.0163600882996276,-0.20870127332233301,-1.63881037858227,4,296,SF3A3|CSTF2|SART3|PUF60|GEMIN5|DDX41|SRSF12|PNN|HNRNPH3|SRRT|GEMIN7|POLR2F|HNRNPA1|SNRNP48|PDCD7|RBM41|DNAJC8|KHSRP|AAR2|SUGP1|SF3A2|SCNM1|PRCC|PPWD1|SF3B4|CPSF1|SNRPE|POLR2C|MBNL1|LSM5|PSIP1|CELF2|YBX1|WDR83|GEMIN8|DHX9|PTBP1|SRSF3|TXNL4A|SRPK3|HNRNPH1|SF3A1|DCPS|SRSF10|ELAVL2|HNRNPUL1|HNRNPL|NCBP2|PRPF4|POLR2J|SLU7|DDX23|RBM17|SNRNP35|DHX8|SNRPB2|SRSF9|HNRNPU|RBMX|LUC7L3|TSEN54|GEMIN2|NOVA1|CELF1|BCAS2|HNRNPH2|DDX42|MAGOH|CPSF2|CD2BP2|SRSF5|ZRSR2|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|SNRPA1|HNRNPM|DDX5|CLP1|SF1|SNW1|POLR2H|CELF4|EFTUD2|C14orf166|HNRNPR|RBM22|CSTF3|LSM3|FUS|WBP11|PPP2CA|SNRNP25|RBM4B|SMU1|ZMAT2|HNRNPK|MAGOHB|EIF4A3|SNRPB|TRA2B|PABPN1|SRSF2|RBM8A|DDX39A|POLR2G|IK|SF3B2|ISY1|CPSF7|RBM4|PRMT5|SKIV2L2|CWC27|PQBP1|RNF113A|HNRNPA0|GPKOW|SART1|HNRNPC|ERN1|POLR2L|SMN1|PRPF19
MEIOTIC DNA DOUBLE-STRAND BREAK PROCESSING%GOBP%GO:0000706,0.951365303627225,0.9858647066977451,0.269853748905522,0.592880178779446,7002,4,C14orf39|SLX4
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904954,0.18559299548952,0.559093571852282,-0.74217321595358,-1.2350949137673002,1398,2,WNT3
NOREPINEPHRINE-EPINEPHRINE VASOCONSTRICTION INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0001994,0.689765886287625,0.887051934478962,-0.658910454344949,-0.8778269389178429,5155,1,ADRA1B
AXON REGENERATION%GOBP%GO:0031103,0.4847695912522779,0.7872939093021379,-0.335786302647053,-0.966681768522055,3723,8,MAPK8IP3|GAP43|APOD|DHFR|RTN4RL1
ACTIVATION OF IMMUNE RESPONSE%GOBP%GO:0002253,0.000128139415684264,0.00518555396908895,-0.288191087846128,-2.30676184677555,0,334,RIPK2|SPPL3|CREBBP|CDC42|TIFA|PAK2|MUC3A|BTNL9|SYK|IGHV2-26|HLA-DQB2|NFATC2|COLEC11|RPS6KA5|RAC1|WIPF3|EIF2B5|IGHV1OR15-1|IGKV3-11|NFKBIZ|MNDA|HLA-DPA1|ACTG1|NCR3|CD38|S100A1|ALPK1|IGHV5-51|SLA2|CLEC4A|RGCC|LYN|HLA-DRA|HLA-DRB5|PRAM1|C4B|FCN3|CD209|TLR1|PYCARD|IGHV1-24|NCKAP1L|VAV3|WASF2|IRAK3|HSP90B1|IGHV3-49|FPR3|COL20A1|ITGB2|IGHG4|HLA-DPB1|CD4|NCKIPSD|PIK3AP1|TLR2|HLA-DQA2|FGR|FCGR1A|IGLL5|HMSD|CTSS|ARPC1A|LAT2|VAV1|TICAM2|MYO1G|C4A|GATA3|WAS|EIF2B1|HEXIM1|FCGR2B|C2|MATR3|THY1|PDE4B|BCAR1|IGKV2-28|FPR1|C3|MYO10|TNFAIP3|IKBKE|IGHV4-4|RC3H2|PDE4D|CLEC4E|ELMO1|MAPKAPK2|UNC93B1|IGHV4-61|GRB2|MEF2C|MB21D1|C1QB|CLEC10A|IFIH1|IGHV1-3|FCER1G|MUC4|PIK3CB|MAPK3|ABL1|IGHV3-43|IRF7|IRAK1|HRAS|FCN1|IGHV3-73|IFI16|ICOSLG|TNIP1|FCGR2A|C1QA|CFB|NONO|C1QC|TMEM173|DOCK1|C7|PIK3R4|CYFIP2|IGKV2D-28|RBM14|HCK|COLEC12|CD36|MUC20|TNFRSF21|LGALS9|IGHV3-15|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|EIF2B2|TRAF3|C3AR1|STOML2|RELA|NFKB1|PRKACA|TLR4|S100A8|CFP|C1S|ITGAM|IGHV1-18|S100A9|CFD|HSP90AA1|ACTB|CMKLR1|NCK1|CD14|IGHG2|LY96|PQBP1|IGHA1|EIF2B3|C1R|CFH|C5AR1|PRKCB|PTPRJ|ICAM2
POSITIVE REGULATION OF 1-PHOSPHATIDYLINOSITOL 4-KINASE ACTIVITY%GOBP%GO:0043128,0.031438127090301,0.25182426163873,-0.984340538156153,-1.3113779509256298,234,1,CD81
SPERM AXONEME ASSEMBLY%GOBP%GO:0007288,0.000542961856929551,0.0142956936607477,0.7955435442060559,2.0585156789126,3,6,CFAP44|CFAP43|C9orf117|IQCG|DNAH1|BBS2
ALPHA-BETA T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002293,0.405880808611184,0.743232206038237,-0.28571666698996,-1.03739090351836,3091,15,GPR183|BATF|RORA|SPN|PTGER4|STAT3|FOXP1
REGULATION OF CDP-DIACYLGLYCEROL-SERINE O-PHOSPHATIDYLTRANSFERASE ACTIVITY%GOBP%GO:1904217,0.595914035553197,0.8445090144443349,-0.5610456329517141,-0.933669651173936,4491,2,SERINC5
PROTEIN-DNA COMPLEX ASSEMBLY%GOBP%GO:0065004,0.000127713920817369,0.00518555396908895,-0.325441104978683,-2.21403212852256,0,136,HMGB2|CDT1|H2AFX|GTF2A2|PARP1|OIP5|RUVBL1|CENPM|HIST1H2BN|NPM1|TAF12|ASF1B|CHAF1A|GMNN|CENPI|IPO4|HIST1H2BC|HIST1H4I|CDC45|STRA13|ANP32B|GTF2H1|TAF7|RBBP7|RAD23B|CENPH|NAP1L4|MED6|HIST2H3A|BDP1|CDK7|HIST2H2BF|SPTY2D1|UBC|MNAT1|HIST1H2BG|HIST1H2BD|CHAF1B|HIST2H4A|DDB1|HIST2H3C|CETN2|HIST1H3H|POLE3|H2AFY|HIST2H4B|CENPK|H3F3B|MIS18A|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ|XPA|CENPP|GTF2H2
NEGATIVE REGULATION OF PEPTIDYL-TYROSINE AUTOPHOSPHORYLATION%GOBP%GO:1900085,0.10515050167224099,0.446168961873938,-0.9450264666960742,-1.25900216787556,785,1,CAV1
INACTIVATION OF X CHROMOSOME BY HETEROCHROMATIN ASSEMBLY%GOBP%GO:0060820,0.8040133779264209,0.932964969466025,-0.602503308337009,-0.8026790762807758,6009,1,SMCHD1
POLYUBIQUITINATED MISFOLDED PROTEIN TRANSPORT%GOBP%GO:0070845,0.619471377340948,0.854944793214197,0.687141596823996,0.916210601386403,4663,1,HDAC6
EXOGENOUS DRUG CATABOLIC PROCESS%GOBP%GO:0042738,0.0550446307817149,0.340910295578153,0.5658675576274891,1.56206220405757,406,7,CYP2D7|CYP2E1|CYP2C8|CYP2D6|CYP2U1|NUDT15|CYP2R1
PERK-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:0036499,0.20277705003929802,0.581404211513299,-0.38763119835994503,-1.25497686002427,1547,11,DDIT3|ASNS|ATF3|HERPUD1|CCL2|EIF2S1|HSPA5
REGULATION OF PENTOSE-PHOSPHATE SHUNT%GOBP%GO:0043456,0.547360042451579,0.8183469949481441,-0.5805547021057261,-0.966135861980932,4125,2,PGAM1
RESPONSE TO INTERLEUKIN-7%GOBP%GO:0098760,0.11869747899159698,0.469617660353565,-0.33988497553416697,-1.36361201187871,903,20,BRWD1|HIST1H3D|IL2RG|JAK3|STAT5A|SMARCA4|IRS1|SOCS1|STAT3|CISH|HIST2H3A|HIST2H3C|HIST1H3H
PROTEIN AUTO-ADP-RIBOSYLATION%GOBP%GO:0070213,0.9534030702350229,0.986646769115929,0.268517069672573,0.589943437578646,7017,4,TNKS|TNKS2
REGULATION OF RIG-I SIGNALING PATHWAY%GOBP%GO:0039535,0.9337436166033779,0.9800972968717879,-0.174368547335427,-0.600210353809429,7130,13,DDX60|NPLOC4|DHX58
POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION%GOBP%GO:2000767,0.0850420609884332,0.40376145987147494,-0.537044780194704,-1.4679879574921202,646,7,DHX9|DHX36|YBX3|NCK1
REGULATION OF ATP CITRATE SYNTHASE ACTIVITY%GOBP%GO:2000983,0.309966555183947,0.680816461591689,-0.842137185707984,-1.12192894042613,2316,1,PHPT1
REGULATION OF OXIDATIVE STRESS-INDUCED NEURON DEATH%GOBP%GO:1903203,0.863267973856209,0.9531672929044319,-0.201803134032804,-0.675453984758265,6603,12,PARK7|NONO|TLR4
DUMP METABOLIC PROCESS%GOBP%GO:0046078,0.131096318434995,0.490819490032838,0.622852824984222,1.36843418232154,964,4,DCTD|CDADC1|DUT|HDDC2
LUNG SECRETORY CELL DIFFERENTIATION%GOBP%GO:0061140,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
STORE-OPERATED CALCIUM ENTRY%GOBP%GO:0002115,0.654574132492114,0.874775007199212,-0.30571088388169004,-0.8356470681083399,4979,7,ORAI1|CRACR2A|STIM2|CRACR2B|STIM1
POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0032725,0.131499672560576,0.490819490032838,-0.533837074623573,-1.37317276422248,1003,6,DDX58|ISL1|RASGRP1|IL1B|IL18|IL17D
LUNG SACCULE DEVELOPMENT%GOBP%GO:0060430,0.49477491961414793,0.793143688290573,0.593506958209214,0.997168320576739,3692,2,STRA6
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0055024,0.48914675767918103,0.7890862511128891,0.22333565954303303,0.9730547527084391,3582,25,DKK1|FGFR2|FGF2|SOX6|EFNB2
POSITIVE REGULATION OF TELOMERE CAPPING%GOBP%GO:1904355,0.12041315574884501,0.472686039512467,0.362809958680021,1.3660998223950702,885,16,RTEL1|MAP2K7|MAP3K4|PNKP|HNRNPD|TNKS|MAPK1|TNKS2|NEK7
POSITIVE REGULATION OF HISTONE H4 ACETYLATION%GOBP%GO:0090240,0.49290220820189296,0.791674276988803,-0.35276271683376903,-0.9642611552363091,3749,7,BRCA1|ARRB1|KAT7
ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:0001935,0.0112890522446836,0.13802261153452697,-0.49630155287246996,-1.8019904886053701,85,15,HMOX1|TEK|SEMA5A|ACVRL1|LOXL2|ERN1
INTESTINAL HEXOSE ABSORPTION%GOBP%GO:0106001,0.8445484949832779,0.948285501480553,-0.580999117776798,-0.7740303309939169,6312,1,SLC2A5
NEGATIVE REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:1905447,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
ENDOCHONDRAL OSSIFICATION%GOBP%GO:0001958,0.5327292399242629,0.812079525085925,0.333797178261632,0.9214381509512339,3938,7,FOXC1|DLX5|INPPL1
SENSORY SYSTEM DEVELOPMENT%GOBP%GO:0048880,0.00863149102046499,0.11593697760655802,0.25061474832085,1.62501398870734,61,105,PDE6B|NPHP1|FOXC1|WNT6|STRA6|SH3PXD2B|LRP5L|DLL1|BBS4|WNT5B|RARG|AHI1|HDAC1|GNGT1|SDHAF4|WNT2B|MFAP2|IFT140|TWIST1|PTPRM|NES|RAB3GAP1|BLOC1S3|CEP290|ALDH1A3|CACNA1C|ZNF513|MEGF11|TFAP2B|NF1|PHACTR4|SKI|TENM3|CHD7|POU4F2|AGTPBP1|LRP6|NRP1
POSITIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:2001056,0.00230385255343658,0.0445205392502488,-0.27536585949171005,-1.76503170679624,17,103,FIS1|PYCARD|APOPT1|GNB2L1|REST|PPM1F|TNFRSF10A|TNFRSF10B|PDCD6|CASP10|NGF|PDCD5|CASP1|GRIN1|VCP|TRAF2|DDX3X|TNFSF10|CYCS|CASP4|F3|PERP|IFI27L1|ANP32B|IFI16|CYFIP2|GPER1|CIDEB|GSN|F2R|DLC1|NLRP3|ASPH|LGALS9|FADD|BCAP31|MYC|PPARG|S100A8|S100A9|ARL6IP5|LGMN|NGFRAP1|NGFR|BAD
PEPTIDYL-LYSINE PROPIONYLATION%GOBP%GO:0061921,0.5684685881259129,0.831514598829999,0.7133325981473309,0.9511327676244509,4279,1,EP300
NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE%GOBP%GO:0048843,0.119858062820344,0.47202636254014396,-0.34481617946185605,-1.3623365565409198,911,19,SEMA3B|SEMA3D|SEMA7A|SEMA5A|SEMA3E|SEMA3A|SEMA6B
PROGRAMMED CELL DEATH%GOBP%GO:0012501,0.00025419420437214,0.00819882332206558,-0.1967243081589,-1.63697685266256,1,436,GSDMD|BCL2A1|FASTK|MADD|RIPK3|TNFSF8|PGAM5|HMGB2|TBX1|TSPO|RYR2|BCL2L11|CHAC1|JUP|DAB2IP|ITGB2|GZMB|PPM1F|PPIF|TNFRSF10A|ESPL1|ATP2A1|TLR2|PARP1|P2RX4|TNFRSF10B|ERO1L|SEMA6A|PDCD6|CASP10|TOP1|BNIP1|CYP1B1|SOD2|TICAM2|NGF|AHR|KPNB1|OGT|IER3|LY86|YARS|BCL2L2|ANXA6|CASP1|TOP2A|TRAF2|TAOK2|PLSCR1|DDX3X|IKBKE|PPP1R13B|CXCR4|KRT9|ZNF622|MELK|CSRNP1|BAG3|ELMO1|SST|IFIT2|INHBA|TNFSF12|CYCS|MLKL|CASP4|FXR1|PTPN6|IL2RA|KRT18|MRPS30|PKP2|BRCA1|DDX5|PERP|IFI27L1|SNW1|NOTCH2|TFPT|ABL1|CAPN1|IFI6|SRGN|TNFRSF10C|G0S2|CEBPB|RNF152|FAP|E2F1|IFI16|HIC1|CYFIP2|STK3|BCL3|GPER1|EPHA2|CIDEB|GSN|RFK|PCSK6|DLC1|GAPDH|NLRP3|PDE1B|NFKBIA|PLAGL1|PPP2CA|TMEM109|TGFBR2|TNFRSF21|PHLDA2|FADD|ITPK1|MCM2|SLIT2|KRT7|TICAM1|CAMK2A|LTA|CAV1|MYC|DPF1|DDIT4|TLR4|ATG3|HINT1|ARL6IP5|CTSL|SIVA1|RRP8|ZNF385A|DPF2|TNFRSF1A|CRIP1|CD14|LY96|STPG1|KRT19|CASP6|APIP|ENDOG|DHCR24|MAGEH1|NGFR|EFNA5|FEN1|RNF130|BAD|PTGIS
NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY%GOBP%GO:0120033,0.696543566828755,0.89107464564121,-0.20823008299220103,-0.8226976317484699,5299,19,SLIT2|EVL|RAP1GAP
MACROPHAGE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:0038145,0.0690301003344482,0.37596389138254704,-0.9639942655491841,-1.28427183038499,515,1,CSF1R
NEGATIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS%GOBP%GO:2000393,0.311886442027063,0.68160868787154,-0.679128756548111,-1.13017885174954,2350,2,ARPIN|KANK1
PEPTIDYL-PROLINE HYDROXYLATION%GOBP%GO:0019511,0.158995815899582,0.5293397224673839,-0.422646608727434,-1.32409665266666,1215,10,P4HA2|P4HTM|P4HA3|P4HA1|P3H2|P4HB
"REGULATION OF MITOTIC CELL CYCLE, EMBRYONIC%GOBP%GO:0009794",0.696296296296296,0.891033775225429,-0.418605933605382,-0.8174312930935809,5263,3,FZD3|CTNNB1|HES1
MYELOID LEUKOCYTE CYTOKINE PRODUCTION%GOBP%GO:0061082,0.368292351582665,0.721642468110297,0.48530963082771006,1.06624592711979,2710,4,CAMK4|KIT|SIRT1
MRNA PROCESSING%GOBP%GO:0006397,0.000767263427109975,0.0191058847417112,-0.20275986746247399,-1.6179528766381002,5,327,RNMT|APP|PRPF8|PPIH|SNRPD3|SRSF4|RBMX2|SETX|SMN2|AHCYL1|SF3A3|CSTF2|SART3|PUF60|GEMIN5|DDX41|SRSF12|PNN|HNRNPH3|SRRT|GEMIN7|POLR2F|MTPAP|HNRNPA1|SNRNP48|CPSF6|PDCD7|RBM41|DNAJC8|AURKAIP1|CCNH|AAR2|SUGP1|SF3A2|SCNM1|PRCC|PPWD1|SF3B4|CPSF1|SNRPE|POLR2C|LSM11|LSM5|PSIP1|CELF2|YBX1|WDR83|GEMIN8|DHX9|PTBP1|SRSF3|SSU72|TXNL4A|SRPK3|HNRNPH1|SF3A1|DCPS|SRSF10|ELAVL2|HNRNPUL1|HNRNPL|NCBP2|SON|PRPF4|POLR2J|SLU7|DDX23|RBM17|SNRNP35|CHTOP|DHX8|SNRPB2|SRSF9|HNRNPU|RBMX|LUC7L3|GEMIN2|CELF1|BCAS2|HNRNPH2|DDX42|MAGOH|CPSF2|CD2BP2|SRSF5|ZRSR2|SNRPF|SRSF1|U2AF1|HNRNPA2B1|PAPOLA|NCBP1|SNRPD1|SNRPA1|HNRNPM|DDX5|CLP1|SF1|SNW1|POLR2H|GTF2H1|CELF4|EFTUD2|HNRNPR|RBM22|CSTF3|LSM3|FUS|WBP11|THOC7|CDK7|ZC3H3|SNRNP25|RBM4B|SMU1|ZMAT2|HNRNPK|MAGOHB|EIF4A3|SNRPB|TRA2B|PABPN1|MNAT1|SRSF2|RBM8A|DDX39A|POLR2G|IK|SF3B2|PRKACA|ISY1|TUT1|THOC3|CPSF7|RBM4|PRMT5|SKIV2L2|CWC27|PQBP1|HNRNPA0|GPKOW|SART1|HNRNPC|ERN1|POLR2L|SMN1|PRPF19|GTF2H2
GLIOGENESIS%GOBP%GO:0042063,0.719133015094827,0.900474259627538,-0.14834841279131197,-0.838911945152365,5573,63,TGFB2|CCL3|MAPT|SOX11|TNF|PTEN|SLC8A3|EIF2B5|PSEN1|CDK6|SOX10|DAB2IP|PLP1|TLR2|LRP1|EIF2B1|AZU1|HES1|STAT3|FGF10|SOD1|CCL2|CX3CL1|EIF2B2|ADGRG1|NF2|ANXA1|EIF2B3
INTERMEDIATE MESODERM FORMATION%GOBP%GO:0048391,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
POSITIVE REGULATION OF DERMATOME DEVELOPMENT%GOBP%GO:0061184,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
RIGHT VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0003221,0.49083612040133795,0.7904081687771529,-0.757829730921923,-1.00961116723739,3668,1,ZFPM2
METANEPHRIC TUBULE DEVELOPMENT%GOBP%GO:0072170,0.0165278151034668,0.17512293405535098,0.834178890481968,1.6407314379924598,122,3,PAX8|PKD1|PKD2
BMP SIGNALING PATHWAY INVOLVED IN HEART INDUCTION%GOBP%GO:0003130,0.40819846113027297,0.7445496113654559,-0.6368529458685871,-1.0598251423684002,3076,2,BMP2
MIRNA METABOLIC PROCESS%GOBP%GO:0010586,0.290975808643653,0.663296678175849,0.303869212193989,1.14416836384485,2140,16,PRKRA|DIS3L2|DDX17|PARN|AGO2|XPO5
FORMALDEHYDE BIOSYNTHETIC PROCESS%GOBP%GO:0046293,0.17000929738345097,0.543216018944259,0.916795324217027,1.22242285903159,1279,1,KDM3A
TELOMERASE RNA LOCALIZATION%GOBP%GO:0090672,0.360340018594767,0.7155384949577859,0.8211843846493159,1.0949385721752298,2712,1,WRAP53
POSITIVE REGULATION OF PROTEIN K63-LINKED UBIQUITINATION%GOBP%GO:1902523,0.8739281886388001,0.9595052445364269,0.407003032809484,0.6838176454086469,6522,2,BIRC2|PTPN22
GROWTH PLATE CARTILAGE CHONDROCYTE MORPHOGENESIS%GOBP%GO:0003429,0.0011764705882352901,0.0261694927157725,-0.610591089836417,-2.0437055483036204,8,12,MATN2|COL20A1|COCH|VWA1|COL14A1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
HYPOXANTHINE BIOSYNTHETIC PROCESS%GOBP%GO:0046101,0.0194444444444444,0.192337052905818,-0.8213300981581558,-1.60384951644524,146,3,ADA|HPRT1|PRPS1
MEIOTIC CELL CYCLE CHECKPOINT%GOBP%GO:0033313,0.31216931216931204,0.68160868787154,-0.584539262700343,-1.14145702918667,2359,3,TRIP13|RAD1
OLFACTORY BULB INTERNEURON DEVELOPMENT%GOBP%GO:0021891,0.206271965396053,0.5861479099046041,0.520651376067808,1.25216357376201,1525,5,SLIT1|ROBO2|SLIT3
REGULATION OF ZINC ION TRANSPORT%GOBP%GO:0071579,0.38437834941050397,0.7313561276300269,0.6438930245381861,1.08182341761777,2868,2,SLC30A10|SLC30A1
THYMINE CATABOLIC PROCESS%GOBP%GO:0006210,0.52505359056806,0.808245162096538,0.580920871243452,0.97602206941879,3918,2,DPYD|ALDH6A1
INTERLEUKIN-4-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035771,0.33032634651101095,0.6957352559323989,-0.669864902122967,-1.1147623165843998,2489,2,JAK3|STAT6
NEGATIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL%GOBP%GO:0010917,0.553663152203298,0.8235329139248091,0.377465687161394,0.907802813042002,4095,5,HEBP2|PMAIP1
HYDROGEN SULFIDE METABOLIC PROCESS%GOBP%GO:0070813,0.59110570424439,0.8417378833576942,0.36543505759798794,0.878869217931789,4372,5,ETHE1|CTH|MPST|CBS
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION%GOBP%GO:1902532,0.00562013028483842,0.0858969713520357,-0.17978376020567,-1.4565922764717298,43,362,SEC14L1|CD74|GNB2L1|FNIP1|KANK1|TRIAP1|BCL2A1|IRAK3|IGBP1|UBE2B|KDM1A|SOCS3|DAB2IP|PRDM15|DUSP5|PPIF|HGS|SEMA6A|PDCD6|RORA|SPRY1|TMBIM6|SYNJ2BP|SFRP2|SOD2|OPA1|DYRK1A|PHLPP1|PLEK|BAG5|BCL2L2|INS|ERBB2IP|CCDC125|TNFAIP3|CREB3|SLC9A3R1|MAPK8IP1|DDX3X|HEG1|PDE4D|CCDC22|ARHGAP44|SOCS1|ADIPOR1|FOXM1|PARK7|RGS4|PDE2A|TRIM32|SNAI2|ENO1|CREB3L1|TIMP3|HERPUD1|HSPB1|WWC3|RNF152|MEN1|NPLOC4|TNIP1|NONO|TAF9B|BCL3|GPER1|CD300A|MBIP|EPHA2|PSMD10|APOE|APLNR|DLC1|PLAUR|NLRP3|PPP2CA|NOV|SYVN1|THBS1|FHL2|C3orf33|TNFAIP8L1|SLIT2|FKBP1A|MMP9|SNAI1|NIM1K|CAV1|YBX3|MYC|DNAJA1|RASIP1|DDIT4|CLIC2|RELA|SIK1|DHX58|DACT1|TLR4|TAF9|NF2|SMPD1|RGS2|GPS1|ZNF385A|GSTP1|PHB|TMSB4X|NDUFS3|MAPKAP1|WTIP|RGS3|AK6|FBLN1|PTPRJ|NLRX1|SIRPA|WNK2|PRNP|RCAN1
REGULATION OF HEMOPOIESIS%GOBP%GO:1903706,0.000255721774709117,0.00819882332206558,-0.233716330545512,-1.7749808816503603,1,243,NCKAP1L|CD74|FNIP1|IL18|ADAM8|RUNX1|CCL19|SLAMF8|HMGB2|ZFP36L1|RUNX3|CD4|IL17D|HCLS1|MED1|GATA3|FES|TNFRSF18|GP1BA|LILRB3|IL34|LMO2|FCGR2B|GAS6|TCTA|HES1|PRELID1|DHX36|RC3H2|LILRB2|TESC|NOTCH1|INHBA|MEF2C|SOCS1|STAT3|HSPA9|TAL1|HIST1H4I|IL2RA|HAX1|SETD1A|FBN1|MMP14|CTR9|NOTCH2|ABL1|SOD1|RBM15|IRF7|CEBPB|TNRC6C|NKAP|MAFB|WDR5|C1QC|C10orf54|CSF1|CEACAM1|HIST2H3A|SPI1|CCR1|CD86|NLRP3|RAB7B|AXL|KAT2B|LGALS3|TGFBR2|LGALS9|THBS1|FADD|FOXP1|HIST2H4A|MYC|ATP6AP1|HIST2H3C|YAP1|BCL6|TLR4|ZNF16|HIST1H3H|LILRB4|PNP|ANXA1|HIST2H4B|LGALS1|DPF2|H3F3B|MYL9|SART1|PRKCB
CELL PART MORPHOGENESIS%GOBP%GO:0032990,0.075,0.383578507779904,0.159242954266123,1.25553696339095,536,278,TNR|RET|CNTN4|SHTN1|DRD2|ROBO3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|MFF|SEMA4F|PLXNB1|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|ALS2|SLIT1|EPHB2|EFNA4|PARD3|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|NYAP2|STK24|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|BMP7|DNM1L|NTNG1|EFNB3|SLIT3|PNPT1|CDK5R1|SHC1|SOS1|NYAP1|MAP6|ATP7A|DRAXIN|SPTBN1|PAK1|EFNA2|EPB41L3|NRCAM|STRADB|MAP2|DLG4|BRSK1|VLDLR|TUBB3|ULK2
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION%GOBP%GO:0070201,0.000892629431267534,0.0214437672455875,-0.18687945614210996,-1.5525572170374,6,432,LILRB1|NPEPPS|HLA-E|RGCC|INHBB|ADAM9|CEMIP|PSEN1|CCT3|HYAL2|LGR4|DHX9|NDFIP1|SP100|FIS1|TLR1|PYCARD|APOD|GNB2L1|TNFRSF14|GSDMD|DISP1|PER2|ARHGEF5|TFDP2|ADAM8|CCL19|REST|SREBF2|RHBDF2|GAPVD1|ACHE|CAMK1|JUP|ECT2|ITGB2|GZMB|PPM1F|ITPR2|TRIM28|PIM3|STX4|TLR2|STXBP4|PPIA|MICALL2|FGR|CNST|HCLS1|CD34|WLS|GIPR|ITPR3|GDI1|SLC2A1|SLC8B1|ATG13|GPI|CDK16|SSC5D|GATA3|SYT7|ATPIF1|PDCD5|DNAJC1|FCGR2B|MYOM1|GAS6|TGFB3|SCFD1|PRR5L|NMT1|INS|CASP1|MDFIC|UBE2G2|RAB29|TNFAIP3|DHX36|CCT8|ADCY8|PPP1R13B|SLC25A6|BAG3|PTGER4|IRS1|PARK7|HAX1|CCT5|IFIH1|PDE2A|BCAS3|ENSA|ANP32B|OSM|CARD16|GHRL|HUWE1|RSAD2|CEP131|SRGN|RAPGEF3|TNFRSF4|FLNA|UQCC2|HRAS|IGF1|DPP4|FCN1|E2F1|NR1H3|LRP5|RBM22|TMEM173|DKC1|IL33|GPER1|CACNA1E|F2R|RAP1A|FN1|GAPDH|NLRP3|NOV|ZC3H3|CHGA|TNFRSF21|CD200|LGALS9|ADRA2C|NR1D1|ARL2|B3GAT3|FOXP1|SLC25A4|BCAP31|CX3CL1|SIRT4|DNAJA1|HAVCR2|ANG|DERL3|TLR4|SERGEF|ITGAM|RAB11FIP1|PARL|CSF1R|C1QTNF4|ANXA1|RHOU|TMSB4X|SAR1B|CD14|EMD|TNFRSF1B|EFNA5|BAD|INSIG1|SLC25A5|PRNP|PTP4A3
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR PRODUCTION%GOBP%GO:0032760,0.004276827371695179,0.0724218181008629,-0.370366261808593,-1.82896036611081,32,39,HLA-E|DHX9|TLR1|PYCARD|CCL19|TLR2|SPN|AZU1|IFIH1|HSPB1|LGALS9|THBS1|FADD|HAVCR2|TLR4|C1QTNF4|CD14|LY96|PTPRJ
CARDIAC SEPTUM DEVELOPMENT%GOBP%GO:0003279,0.800386793756044,0.931890163905641,0.145909132291502,0.783026266822093,5793,50,STRA6|ACVR1|NPHP3-ACAD11|FGFR2|ANK2|CRELD1|ROBO2|BMP7|SLIT3|NPHP3|CITED2|ZFPM1
TRICARBOXYLIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:0035674,0.526896002125116,0.809755446473093,0.735719011910013,0.980982029714234,3966,1,SLC25A1
GLYCOGEN BIOSYNTHETIC PROCESS%GOBP%GO:0005978,0.30182008642137,0.674735752055117,-0.328700560146231,-1.1314510702621599,2304,13,GYG1|PER2|PPP1R3C|PGM5|NR1D1|GYG2
CATECHOLAMINE SECRETION%GOBP%GO:0050432,0.764510559171205,0.9191113740914171,0.6177767975297751,0.82372200111806,5755,1,VIP
POSITIVE REGULATION OF MRNA METABOLIC PROCESS%GOBP%GO:1903313,0.932380216383308,0.980055411497814,-0.117675939991022,-0.6574478603354661,7238,60,ZFP36L2|BTG2|ZC3H12A|PUM1|RBM23|CPEB3|NANOS3|HSF1|TNRC6A|KHSRP|SF3B4|ZFP36L1|NCBP2|RBMX|TOB1|PRR5L|DHX36|NCBP1|SNW1|CELF4|TNRC6C|CPEB1|TRA2B|POLR2G|NUP98
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0010718,0.0250519210799585,0.22281679108764302,-0.32996682127873,-1.61484346262929,192,38,TGFB1|RGCC|OLFM1|JAG1|EZH2|TGFB3|NOTCH1|GCNT2|PDPN|TGFBR2|BMP2|WWTR1|COL1A1|SNAI1|DAB2|TIAM1|ENG|GLIPR2|LOXL2
FOREBRAIN ASTROCYTE DIFFERENTIATION%GOBP%GO:0021896,0.316111037322354,0.685583406115178,0.842633436259374,1.12353798831544,2379,1,NF1
FATTY ACID BETA-OXIDATION USING ACYL-COA DEHYDROGENASE%GOBP%GO:0033539,0.273546273546274,0.647911875886704,0.382451556961397,1.1622350081016002,2003,9,ACADVL|ACADM|GCDH|ACAD11|ACADS|IVD
TYPE B PANCREATIC CELL DEVELOPMENT%GOBP%GO:0003323,0.618122537698682,0.854944793214197,0.39485982314614204,0.867523847599641,4549,4,DLL1|NKX6-1
CDC42 PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032488,0.469358232509206,0.780769690730001,-0.40717505586073494,-0.975920912746136,3568,5,WAS|NTN1|RHOU
CELLULAR UREA HOMEOSTASIS%GOBP%GO:0097277,0.311329525833444,0.68160868787154,0.845059550066167,1.12677288371433,2343,1,TFAP2B
EXTRACELLULAR EXOSOME BIOGENESIS%GOBP%GO:0097734,0.615706947823736,0.8539218792126291,0.35787206396573296,0.860680261616287,4554,5,RAB11A|COPS5|ATP13A2|RAB27A
NEGATIVE REGULATION OF T-HELPER 17 TYPE IMMUNE RESPONSE%GOBP%GO:2000317,0.92778607302837,0.979345221662042,0.235869345848715,0.6103257956659109,6834,6,LOXL3|RC3H1
CELLULAR RESPONSE TO DIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0071726,0.0406084656084656,0.288441534418227,-0.7777655233263481,-1.51877894319482,306,3,TLR2|CD36|CD14
RRNA IMPORT INTO MITOCHONDRION%GOBP%GO:0035928,0.9375661375661379,0.9806508984207809,-0.309448084256231,-0.604273679257876,7087,3,MRPL18|TST
AXON CHOICE POINT RECOGNITION%GOBP%GO:0016198,0.28683427953500895,0.6601254173678841,0.47885494230240894,1.15164339023834,2121,5,ROBO3|ROBO2
REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT%GOBP%GO:2000641,0.5718168229378989,0.8339813654491021,0.235952085075326,0.907306064786015,4207,17,CHMP3|MTMR2|VPS11|EZR|SRC|MAP2K1|MAPK1
SUBSTANCE P CATABOLIC PROCESS%GOBP%GO:0010814,0.667959866220736,0.8810898721211949,-0.669386854874283,-0.8917840199550309,4992,1,ECE1
POSITIVE REGULATION OF HIGH-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010983,0.7870899189799442,0.9276917050905171,0.60603220114689,0.80806216657342,5925,1,GPLD1
REGULATION OF SKELETAL MUSCLE CONTRACTION%GOBP%GO:0014819,0.40086556667568296,0.740287621109606,0.376364298222704,1.0389435430354799,2963,7,GSTM2|DMD|DMPK
TOXIN BIOSYNTHETIC PROCESS%GOBP%GO:0009403,0.20317119054017702,0.581783510781437,0.639296349398919,1.257420477335,1511,3,CTH|MPST|CBS
NEGATIVE REGULATION OF DNA-BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0043433,0.0879938429964084,0.409521734239444,-0.19747858822789496,-1.3036424180555801,685,118,SP100|CEBPG|PYCARD|PARP10|TRIM21|IRAK3|KDM1A|TONSL|DAB2IP|GLIS2|KLF4|SFRP4|TAF3|BHLHE40|ADORA3|FOXS1|CYP1B1|CDKN2A|GAS6|ERBB2IP|TNFAIP3|CCDC22|ARRB1|PIM1|TNFRSF4|FLNA|IRAK1|MEN1|MDFI|PSMD10|NLRP3|NFKBIA|BRMS1|CD200|ID1|TRAF3|HAVCR2|SIK1|CMKLR1|TMSB4X|PTGIS|PRNP
DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS%GOBP%GO:0045136,0.179799331103679,0.55315933910608,-0.908028231142479,-1.20971163431791,1343,1,IRF2BPL
RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032801,0.263157894736842,0.638950455433329,-0.28656654688565997,-1.16747417538846,2004,21,AP2A1|SMURF1|BECN1|SNX25|TGFB1|AP2A2|CLTA|CLTC|PIK3R4|GPRASP1|MYLIP|LGMN|AP2M1
REGULATION OF VITAMIN METABOLIC PROCESS%GOBP%GO:0030656,0.315673001822442,0.68553115436421,-0.39029117794206103,-1.12359367597003,2424,8,IL1B|CLYBL|TNF|SNAI2|SNAI1|NFKB1
NERVE GROWTH FACTOR PROCESSING%GOBP%GO:0032455,0.40040133779264203,0.7401048291681479,-0.7997904719894129,-1.06551294970739,2992,1,NGF
LUNG CILIATED CELL DIFFERENTIATION%GOBP%GO:0061141,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
B CELL CYTOKINE PRODUCTION%GOBP%GO:0002368,0.344136007437907,0.702174649119653,0.82851786501985,1.10471677872188,2590,1,HSPD1
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS%GOBP%GO:2000377,0.0017911975435005102,0.0361756372169658,-0.277673612667587,-1.77200245752969,13,101,AGT|ITGB2|PID1|KLF4|P2RX4|CD34|HP|CYP1B1|INS|GRIN1|GLA|GRB2|FOXM1|CD47|PARK7|BRCA1|BST1|SOD1|ROMO1|DHFR|NOXA1|COQ7|CD36|TGFBR2|THBS1|PDK3|PDGFRB|CAV1|MPV17L|ABCD1|TLR4|ITGAM|PARL|HSP90AA1|GSTP1|PDGFB|SIRPA|ADGRB1|PTGIS
REGULATION OF HEPATOCYTE GROWTH FACTOR PRODUCTION%GOBP%GO:0032646,0.573913043478261,0.835204333784353,-0.717247463608293,-0.955545842798603,4289,1,INHBB
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0051961,0.0801736244095493,0.396818707067109,-0.198338483598077,-1.32395415992699,627,124,THY1|HES1|RAB29|EFNA1|NOTCH1|CHRD|DAAM2|NGEF|CALR|SEMA3B|ARHGEF15|SEMA3D|STX1B|SEMA7A|EDNRB|APOE|TNFRSF21|SEMA5A|SEMA3E|EPHA4|COL3A1|SLIT2|ID1|CX3CL1|LDLR|FKBP4|SEMA3A|SEMA6B|RTN4RL1|KIAA2022|ID4|ADGRG1|MYLIP|DTX1|ARHGDIA|NGFR
NEGATIVE REGULATION OF GLUCOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046318,0.629831318900252,0.860897694974173,0.6827856197618,0.9104024937383921,4741,1,PRKAA1
NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION%GOBP%GO:0045653,0.122850442939031,0.47697345522944606,-0.460555259377898,-1.38546295144496,942,9,HIST1H4J|HIST4H4|HIST1H4H|PRMT1|HIST1H4I|HIST2H4A|HIST2H4B
CHORIO-ALLANTOIC FUSION%GOBP%GO:0060710,0.41814040728831703,0.75036705317022,0.629114971050455,1.05699437968666,3120,2,BMP7|LEF1
BLOOD VESSEL LUMENIZATION%GOBP%GO:0072554,0.95789613494488,0.988578419070365,0.521338773709749,0.6951349090120721,7211,1,RBPJ
POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION%GOBP%GO:1902527,0.36849026827985293,0.7217539780398442,-0.447964320124247,-1.0736849958777501,2801,5,PEF1|PDCD6|FANCM
HYPERMETHYLATION OF CPG ISLAND%GOBP%GO:0044027,0.181003344481605,0.554699553656526,-0.907366563740626,-1.20883013446293,1352,1,SPI1
MEIOTIC DNA DOUBLE-STRAND BREAK FORMATION%GOBP%GO:0042138,0.321275455519829,0.689291724169437,0.674386545354287,1.1330564697666599,2397,2,MRE11A|C11orf80
CHONDROITIN SULFATE METABOLIC PROCESS%GOBP%GO:0030204,0.13600104616189398,0.4990723078854679,-0.32015886652631603,-1.32586116896759,1039,22,ARSB|DCN|CHST7|BGN|VCAN|HYAL1|HEXB|CSGALNACT1
NEPHRON TUBULE FORMATION%GOBP%GO:0072079,0.596730975348339,0.844613508628182,0.550011015787944,0.9240895213205519,4453,2,PAX8
REGULATION OF RESPONSE TO DNA INTEGRITY CHECKPOINT SIGNALING%GOBP%GO:1902151,0.752822419976092,0.915314007578303,0.6240626378473749,0.8321033210151909,5667,1,TIGAR
CHEMOKINE (C-X-C MOTIF) LIGAND 12 SIGNALING PATHWAY%GOBP%GO:0038146,0.7161366313309779,0.899551221015245,-0.36262969960881003,-0.7938722156703191,5471,4,STK39|CXCL12|CXCR4
U2 SNRNA 3'-END PROCESSING%GOBP%GO:0034474,0.630903010033445,0.8613756250889949,-0.6889060432289369,-0.9177882656769479,4715,1,INTS1
HISTONE GLUTAMINE METHYLATION%GOBP%GO:1990258,0.8268771557442289,0.943041978946366,-0.44637441411635,-0.7428384057252809,6232,2,FBL|FBLL1
POSITIVE REGULATION OF CARDIOLIPIN METABOLIC PROCESS%GOBP%GO:1900210,0.0976588628762542,0.430598623028127,-0.948886193206881,-1.26414425036294,729,1,STOML2
NEGATIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:1904706,0.154249050674349,0.5225398777782271,-0.38240291016568395,-1.31630497309114,1177,13,APLN|CDKN1B|PTEN|PRKG1|SOD2|TGFB3|MEF2C|GPER1|PPARG|CNN1
ESTABLISHMENT OF EPITHELIAL CELL POLARITY%GOBP%GO:0090162,0.516975517381307,0.804437803565895,0.23857129790555603,0.95115606595238,3821,19,CLASP1|PARD3|MYO18A|CAMSAP3|MYO9A
NEUROFIBRILLARY TANGLE ASSEMBLY%GOBP%GO:1902988,0.687892976588629,0.8866901918807819,-0.660123511248346,-0.879443021985307,5141,1,MAPT
PROTEIN LOCALIZATION TO SITE OF DOUBLE-STRAND BREAK%GOBP%GO:1990166,0.756651437785542,0.9167299629693821,0.392418978514674,0.7718418222521909,5630,3,PARP3|FAM178A
ASCENDING THIN LIMB DEVELOPMENT%GOBP%GO:0072021,0.0723472668810289,0.378321151505122,0.8341328921974079,1.4014509581488401,539,2,PKD1|PKD2
CONVERSION OF METHIONYL-TRNA TO N-FORMYL-METHIONYL-TRNA%GOBP%GO:0071951,0.567273210253686,0.831087370400857,0.7141045434494929,0.952162052524098,4270,1,MTFMT
POSITIVE REGULATION OF FEAR RESPONSE%GOBP%GO:1903367,0.296588628762542,0.6687276080240239,-0.848698720776356,-1.13067048065468,2216,1,MEF2C
POSITIVE REGULATION OF CELL ACTIVATION%GOBP%GO:0050867,0.000127437237160698,0.00518555396908895,-0.298484678592127,-2.20291504918486,0,207,AKT1|FOXP3|CD1D|HLA-DMB|CDC42|PAK2|JAK3|SYK|IGHV2-26|NFATC2|RAC1|IGHV1OR15-1|CD274|NFKBIZ|HLA-DPA1|TGFB1|CD38|LILRB1|IGHV5-51|HLA-E|LYN|GPR183|CD209|TNFSF13B|PYCARD|IGHV1-24|NCKAP1L|VAV3|CD74|TNFRSF14|RPS6KA1|IL18|ADAM8|RUNX1|CCL19|IGHV3-49|RUNX3|CCDC88B|ITGB2|IGHG4|HLA-DPB1|SNX4|STX4|FGR|IGLL5|PDCD1LG2|PAXIP1|VAV1|GATA3|PLEK|EBI3|GAS6|THY1|IL6ST|PVRL2|IGHV4-4|LILRB2|IGHV4-61|GRB2|MEF2C|CEBPA|SOCS1|PTPN6|CD47|IGHV1-3|MMP14|FGF10|BST1|IGHV3-43|TNFRSF4|IGF1|VAMP8|DPP4|IGHV3-73|VAMP7|NKAP|ICOSLG|VCAM1|TNFSF13|C10orf54|CCL2|PDPN|IL33|CD86|NLRP3|AXL|TGFBR2|LGALS9|THBS1|ZP3|IGHV3-15|FADD|AIF1|CAV1|BCL6|TLR4|ITGAM|IGHV1-18|LILRB4|PNP|ANXA1|CD55|NCK1|IGHG2|TFRC|IGHA1|CD81|SART1|SIRPA
QUINOLINATE METABOLIC PROCESS%GOBP%GO:0046874,0.0173280423280423,0.17886971906195498,-0.8257417006727691,-1.6124642580402198,130,3,KYNU|HAAO|QPRT
INNATE IMMUNE RESPONSE-ACTIVATING SIGNAL TRANSDUCTION%GOBP%GO:0002758,0.00102629890955741,0.023972547589817,-0.273724437878777,-1.81020837010048,7,119,TNFAIP3|IKBKE|CLEC4E|MAPKAPK2|UNC93B1|CLEC10A|IFIH1|FCER1G|MUC4|IRF7|IRAK1|HRAS|FCN1|TNIP1|PIK3R4|HCK|COLEC12|CD36|MUC20|LGALS9|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|TRAF3|RELA|NFKB1|PRKACA|TLR4|S100A8|ITGAM|S100A9|CD14|LY96|ICAM2
REGULATION OF GAP JUNCTION ASSEMBLY%GOBP%GO:1903596,0.29325396825396804,0.6657871238651031,-0.5923246535940571,-1.15665992440288,2216,3,AGT|CAV1
CELLULAR RESPONSE TO GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:0097011,0.131919905771496,0.491539110043253,-0.62026101725221,-1.3578810246130602,1007,4,CD4|NPR2|PDE1B
REGULATION OF ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS%GOBP%GO:0002822,0.0178939237899073,0.182588584032443,-0.268548269454118,-1.5936114328692401,138,76,PRKCQ|MALT1|ZC3H12A|HLA-F|CLCF1|TRAF6|IL1B|FOXP3|CD1D|JAK3|HLA-B|PVR|CD274|NFKBIZ|TGFB1|LILRB1|HLA-E|NDFIP1|B2M|IL18|RIPK3|CCL19|HLA-C|PAXIP1|WAS|HLA-A|FCGR2B|TRAF2|PVRL2|TNFAIP3|RC3H2|MEF2C|SLC11A1|RSAD2|TNFSF13|CEACAM1|STX7|HFE|NLRP3|ZP3|FADD|IL1R1|BCL6|ANXA1|TFRC|TNFRSF1B
CATECHOLAMINE METABOLIC PROCESS%GOBP%GO:0006584,0.229367777022434,0.61138898362603,0.28831586934614195,1.2065882235377299,1686,22,DRD2|INSM1|PARK2|DRD4|ATP7A|MAOB|DDC
REGULATION OF HEPARAN SULFATE BINDING%GOBP%GO:1905853,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN%GOBP%GO:0070816,0.533540708682716,0.812141765487046,0.333558942618563,0.92078050785316,3944,7,GTF2H4|ERCC3|CDK13|GTF2H3|CDK12
CHROMATIN ASSEMBLY OR DISASSEMBLY%GOBP%GO:0006333,0.000127991808524254,0.00518555396908895,-0.41744757220089795,-2.72409490536334,0,111,H1F0|HIST1H2BE|SMARCA4|SET|HMGB2|H2AFX|OIP5|RUVBL1|CENPM|CDKN2A|SMARCE1|HIST1H2BN|NPM1|ASF1B|CHAF1A|CENPI|IPO4|HIST1H2BC|SUPT16H|SMARCD3|HIST1H4I|STRA13|ANP32B|RBBP7|CENPH|NAP1L4|SMARCD2|HIST2H3A|HIST2H2BF|HDAC8|SPTY2D1|H1FX|HIST3H2A|HIST1H2BG|HIST1H2BD|CHAF1B|HIST2H4A|HIST2H3C|MTA2|HIST1H3H|POLE3|HIST1H1C|H2AFY|HIST2H4B|CENPK|H3F3B|MIS18A|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ|HIRIP3|CENPP
REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM%GOBP%GO:0070861,0.177389705882353,0.549112321330401,-0.316895478886652,-1.27137859165668,1350,20,BCAP31|DERL3|SAR1B|INSIG1
AROMATIC AMINO ACID FAMILY METABOLIC PROCESS%GOBP%GO:0009072,0.218618697478992,0.6013948176405761,-0.303163274163611,-1.21628524932672,1664,20,KYNU|HAAO|FTCD|IL4I1|AFMID|HNMT|ASRGL1
NEGATIVE REGULATION OF AMYLOID-BETA CLEARANCE%GOBP%GO:1900222,0.25470947200849,0.6334469481869079,-0.7049903501516409,-1.17321667908557,1919,2,LRPAP1|SRF
PATHOGENESIS%GOBP%GO:0009405,0.22406694116084502,0.607427175080169,0.889336127040141,1.18580972474413,1686,1,TMEM181
REGULATION OF AUTOPHAGOSOME MATURATION%GOBP%GO:1901096,0.10416100081588302,0.44419145940290994,0.45018470817279294,1.4262155857699201,765,10,PHF23|UBQLN4|CLEC16A|SMCR8
"ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000479",0.9222677595628421,0.9776156396135859,0.21141719514026802,0.613707130888172,6750,8,UTP20|RPS21|NOP14|RPSA|KRI1
REGULATION OF SREBP SIGNALING PATHWAY%GOBP%GO:2000638,0.340079365079365,0.701745885104582,-0.572359193943379,-1.11767244193005,2570,3,INSIG1
NEGATIVE REGULATION OF HOMOTYPIC CELL-CELL ADHESION%GOBP%GO:0034111,0.07081489195522,0.3767214120425879,-0.523962949823817,-1.50841599845754,543,8,CEACAM1|SERPINE2|C1QTNF1
SYNAPTIC VESICLE BUDDING FROM ENDOSOME%GOBP%GO:0016182,0.843272678974632,0.9481593344082329,0.5772496691662989,0.7696845438865558,6348,1,AP3D1
RELEASE OF CYTOCHROME C FROM MITOCHONDRIA%GOBP%GO:0001836,0.33958418263351003,0.701467683185937,0.283784239902945,1.0912349508266999,2498,17,MFF|BBC3|BOK|DNM1L|BID|BAX|BCL2
POSITIVE REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION%GOBP%GO:0033138,0.129829984544049,0.48844033939890996,-0.230986371705077,-1.2905059084783301,1007,60,LIF|PFN2|PDCD10|AKT1|TERF2IP|RAF1|RIPK2|TNF|SH2D3C|CD44|TGFB1|FNIP1|CAMK1|HCLS1|SFRP2|GAS6|PRKD1|PARK7|HAX1|OSM|RAPGEF3|CREBL2|RPTOR|ARAF|IL11|TNKS1BP1|CAV1|HSP90AA1|EIF4G1
REGULATION OF NEUTROPHIL MIGRATION%GOBP%GO:1902622,0.23734797959984302,0.6217158626397761,-0.28885950800313,-1.19624238148954,1814,22,RAC2|THBS4|RAC1|NCKAP1L|CD74|ADAM8|CCL19|SLAMF8|MOSPD2|BST1|SLIT2|MPP1
NONASSOCIATIVE LEARNING%GOBP%GO:0046958,0.8396865453579492,0.9470274567210699,0.5798411998235551,0.773140000335373,6321,1,MAPK8IP2
PRESYNAPTIC ACTIVE ZONE ORGANIZATION%GOBP%GO:1990709,0.475590342265853,0.784986345464663,-0.60848556713288,-1.01261728786725,3584,2,CAST
CITRULLINE BIOSYNTHETIC PROCESS%GOBP%GO:0019240,0.0870846730975348,0.407749299171126,0.8212026993366991,1.3797265646580703,649,2,CAD|ALDH18A1
RNA POLYADENYLATION%GOBP%GO:0043631,0.8489039665970769,0.9492491301138911,-0.162303683092394,-0.707998305300489,6505,26,SCAF8|PCF11|PAPD7|APP|AHCYL1|MTPAP|CPSF1|SSU72|PAPD4|PAPOLA|CLP1|CSTF3|ZC3H3|TUT1
"SULFIDE OXIDATION, USING SULFIDE:QUINONE OXIDOREDUCTASE%GOBP%GO:0070221",0.7160704892162021,0.899551221015245,-0.330931334867352,-0.793179262166063,5444,5,SLC25A10|SQRDL
NEGATIVE REGULATION OF SODIUM ION TRANSPORT%GOBP%GO:0010766,0.678338762214984,0.884536278926676,0.251190711333242,0.826571681462158,4997,11,PRKCE|NEDD4|CAMK2D|NEDD4L|HECW2|COMMD1|HECW1
POSITIVE REGULATION OF VIRAL BUDDING VIA HOST ESCRT COMPLEX%GOBP%GO:1903774,0.228042328042328,0.609818988326981,-0.6257306716664829,-1.22189341097785,1723,3,VPS4A|VPS37B|TSG101
EMBRYONIC VISCEROCRANIUM MORPHOGENESIS%GOBP%GO:0048703,0.329563387690689,0.6957352559323989,-0.46574647316516293,-1.1163054235697099,2505,5,TBX1|NDST1|MTHFD1
REGULATION OF TRAIL RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045560,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048747,0.8002100288789709,0.9318153767588689,-0.204485708228787,-0.742454459695577,6095,15,MYH11|CXADR|CAV2|MYOM1|SEPN1|IGSF22
POSITIVE REGULATION OF CYCLASE ACTIVITY%GOBP%GO:0031281,0.455331412103746,0.7711801339028691,-0.306267374116227,-0.9915571014987209,3475,11,GUCA1A|STIM1|AKAP5|MAPK3|NOS3
LYMPHOCYTE PROLIFERATION%GOBP%GO:0046651,0.7956061200470771,0.929819740961342,-0.18174137088452802,-0.7526383044304208,6083,22,MEF2C|MSN|SLC11A1|TNFRSF4|CTPS1
MATURE RIBOSOME ASSEMBLY%GOBP%GO:0042256,0.777372262773723,0.924704689181848,0.31145466455642795,0.7490466822179979,5750,5,C1QBP|EFTUD1
REGULATION OF ADENYLATE CYCLASE-INHIBITING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0140193,0.0560535117056856,0.343943018657969,-0.970004411116012,-1.29227878740106,418,1,RGS2
BUTYRATE METABOLIC PROCESS%GOBP%GO:0019605,0.472174259529818,0.7831522581932591,0.7648323775915308,1.01980077450095,3554,1,ACADS
POSITIVE REGULATION OF INCLUSION BODY ASSEMBLY%GOBP%GO:0090261,0.829163879598662,0.9433761342424741,-0.58893912659903,-0.7846083292536808,6197,1,CLU
CARDIOCYTE DIFFERENTIATION%GOBP%GO:0035051,0.0187314300477974,0.18846367741286396,-0.31884326283828696,-1.65170842500675,144,46,JAG1|REST|SOX18|MYH11|CXADR|SOX17|SPRY1|TBX2|MYOM1|MESP1|NOTCH1|MEF2C|GATA6|BMP2|TGFBR3|SRF|PDGFRB|IGSF22|MAML1|SIK1|ANXA2|PDGFRA
RESPONSE TO NITRIC OXIDE%GOBP%GO:0071731,0.21886399166232395,0.6013948176405761,-0.408650480829245,-1.2293206727111299,1679,9,GUCY1B3|AQP1|CCL19|DPEP1
THYROID GLAND DEVELOPMENT%GOBP%GO:0030878,0.47661530143282005,0.78501147478174,0.40257966398220596,0.968201783279677,3525,5,PAX8|TG
NEGATIVE REGULATION OF CELL PROLIFERATION%GOBP%GO:0008285,0.00012742099898063202,0.00518555396908895,-0.257618989567211,-2.09551398466132,0,371,ADORA3|PDCD1LG2|CDKN1C|MED1|SYNJ2BP|SFRP2|CYP1B1|SOD2|NGF|CDKN2A|SPN|GATA3|CBFA2T3|NPM1|SMAD6|ATPIF1|TES|CAV2|PDCD5|FCGR2B|TGFB3|TOB1|PLA2G2D|CASK|CCL3L3|HES1|FABP3|TNFAIP3|SLC9A3R1|WARS|RERG|LILRB2|PODN|TESC|ZNF268|NOTCH1|SST|GPNMB|INHBA|PRKAR1A|MEF2C|CEBPA|FAM129B|PTPN6|SDC4|TRIM32|SNAI2|CDKN2B|OSM|GHRL|HMOX1|SPARC|HRAS|SULF1|CEBPB|FAP|MEN1|E2F1|LMNA|OGN|B4GALT7|PPM1D|C10orf54|CCL2|CEACAM1|PDPN|KANK2|GPER1|CD300A|F2R|NACC2|APOE|ALDH1A2|LST1|DLC1|CD86|KAT2B|NOS3|TNS2|NOV|TNFRSF21|BMP2|TGFBR3|CD200|LGALS9|THBS1|ATOH8|DLG3|PPAP2A|AIF1|ADARB1|IGFBP6|EMP3|IFNLR1|P3H2|NR2F2|IGFBP5|CAV1|MYC|HIST1H2AE|PPARG|ANG|MAGED1|IFITM1|CDKN2C|ADGRG1|PTGIR|MCC|NF2|ATF5|ADAMTS8|CDKN3|ZBTB7C|ATP8A2|GSTP1|PHB|HIST1H2AC|S100A11|IGFBP7|EMD|ACVRL1|SSTR2|NME1|NGFR|FBLN1|FTH1|PTPRJ|CNN1|ADGRB1|WNK2|PRNP
UMP BIOSYNTHETIC PROCESS%GOBP%GO:0006222,0.149030100334448,0.5157092501209121,-0.9231914424349359,-1.22991267266121,1113,1,UMPS
GOLGI TO LYSOSOME TRANSPORT%GOBP%GO:0090160,0.0812841530054645,0.397722753303477,0.513184202615721,1.48968396064224,594,8,CCDC91|EHD3|AP4M1|LAMP1|AP1G1|ANKFY1|GAK
REGULATION OF PRI-MIRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:1902893,0.0352434408040726,0.267552181261549,-0.348081034553664,-1.5738554307613601,269,29,STAT3|DDX5|SPI1|ATOH8|SRF|PPARA|RELA|LILRB4|PDGFB|NGFR
HEXITOL METABOLIC PROCESS%GOBP%GO:0006059,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
MITOTIC SPINDLE ASSEMBLY%GOBP%GO:0090307,0.426624449339207,0.75516540246971,0.20781504637078305,1.0205424778413699,3098,37,AURKC|CLASP1|CDC14B|PIBF1|MAP9|KIF3B|TUBGCP3|CDC14A|ARHGEF10|RAB11A|MZT1|TUBGCP6
INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0035773,0.00513652338469857,0.0806312452834056,0.775479814692257,1.8650245073373202,37,5,RAB11FIP5|PTPRN|RAB11FIP2|RAB11B|PTPRN2
GLOMERULAR PARIETAL EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072139,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
DNA STRAND ELONGATION%GOBP%GO:0022616,0.0202693866875899,0.195732543984359,-0.407535693327656,-1.6877113434776798,154,22,POLE|WRNIP1|RNASEH2A|RFC3|TERT|NBN|GINS2|PCNA|POLD2|GINS1|POLA1|RFC4|FEN1
POSITIVE REGULATION OF CELL MIGRATION%GOBP%GO:0030335,0.000128221566867547,0.00518555396908895,-0.269531012504228,-2.1673075237708797,0,343,FLT1|MAPRE2|PYCARD|NCKAP1L|CD74|GNB2L1|TNFRSF14|F10|ADAM8|CCL19|PIK3C2A|AGT|DAB2IP|LAMC2|PPM1F|KDR|STX4|NUMB|P2RX4|FGR|EMC10|SEMA6A|TRIP6|PDCD6|CCL24|HGF|MOSPD2|GPI|SOD2|SPN|GATA3|TNFRSF18|PDGFD|PLAU|SRPX2|VEGFC|GAS6|INS|THY1|DDR2|BCAR1|RREB1|FOXC2|VTN|CREB3|DOCK5|ATP5B|MYLK|SMOC2|PDGFC|ZNF268|FLT4|NOTCH1|GPNMB|SMURF2|STAT3|GCNT2|PRKD1|MADCAM1|ICAM1|F3|BCAS3|TRIM32|SNAI2|MMP14|PLA2G7|FGF10|RHOD|ABL1|CALR|HMOX1|HSPB1|SPARC|HRAS|PIK3R3|IGF1|SEMA3B|SEMA3D|NSMF|SEMA7A|RHOJ|HBEGF|C10orf54|DOCK1|CSF1|CTSH|CXCL16|PDPN|GPER1|MAP2K3|PLVAP|F2R|CCR1|FN1|INSL3|SASH1|NOS3|HYAL1|VEGFB|NRP2|LGALS3|CD151|BMP2|FGF9|LGALS9|THBS1|ZP3|TEK|ATOH8|SUN2|FGF7|COL1A1|SEMA5A|FADD|AIF1|PDGFRB|SEMA3E|RARRES2|NEDD9|SYDE1|FAM89B|FOXP1|MMP9|IGFBP5|SNAI1|SERPINE1|CAV1|FAM107A|SEMA3A|SEMA6B|PLAA|FERMT3|DAB2|PDGFA|CSF1R|TIAM1|PDGFRA|HSPA5|CMKLR1|ANXA1|LGMN|TMSB4X|GLIPR2|ARF6|SPHK1|PDGFB
RRNA TRANSCRIPTION%GOBP%GO:0009303,0.838543082359337,0.946300451776032,0.18659137340212603,0.702578404938183,6169,16,GTF3C2|GTF3C3|NIFK|TAF1B|CD3EAP|GTF3C6
CRANIAL NERVE FORMATION%GOBP%GO:0021603,0.214180602006689,0.597438672438672,-0.890769739744155,-1.1867191797671799,1600,1,MAFB
NEGATIVE REGULATION OF BONE REMODELING%GOBP%GO:0046851,0.445766837976738,0.7673954889535091,0.360760118545609,0.995868623877527,3295,7,SFRP1|UBASH3B
POSITIVE REGULATION OF G PROTEIN-COUPLED RECEPTOR INTERNALIZATION%GOBP%GO:1904022,0.76,0.9179084014002329,-0.624172915747684,-0.8315481965313791,5680,1,APLN
POST-EMBRYONIC ANIMAL ORGAN DEVELOPMENT%GOBP%GO:0048569,0.26749079431878,0.6417330323279019,-0.49252292553779403,-1.18048347048951,2033,5,KLF4|FBN1|EFEMP1
DEVELOPMENTAL MATURATION%GOBP%GO:0021700,0.5003209654641161,0.7951838300433041,-0.16263776348444,-0.9709178204711129,3896,78,SYP|S1PR1|CD63|MBTPS2|IGF1|RECK|RND1|SCARF1|AXL|BMP2|LHX6|CX3CL1|CEND1|PPARG|ANG|PRKACA|ACVRL1
REGULATION OF MRNA 3'-UTR BINDING%GOBP%GO:1903837,0.8734448160535121,0.959352672679547,-0.566056462284958,-0.7541231259356129,6528,1,CDK9
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0031668,0.852509258076874,0.949296218452153,-0.115319901816114,-0.790594588128947,6675,141,P2RX3|GAS6|WDR45B|POSTN|NUDT1|PDXP|WDR45|PRKD1|CDKN2B|WIPI1|MAPK3|PIM1|USF2|RNF152|IFI16|RPTOR|PIK3R4|WDR24|NIM1K|EIF2S1|FAM107A|LAMP2|SIK1|HSPA5|RRP8|FADS1|EIF4G1|RRAGD
REGULATION OF MITOTIC METAPHASE/ANAPHASE TRANSITION%GOBP%GO:0030071,0.041293338527463995,0.291251694784212,-0.29641874965630605,-1.5236945187070399,317,45,TRIP13|DUSP1|KLHL22|APC|DLGAP5|CDC20|CDT1|LCMT1|ANAPC5|ESPL1|CDC6|CDC23|CDK5RAP2|MAD2L1|NDC80|USP44|CCNB1|PLK1|IK|NEK6|ANAPC11|XRCC3
RNA SURVEILLANCE%GOBP%GO:0071025,0.865495542737284,0.9546737500514291,-0.19141317669929697,-0.677191828102438,6601,14,EXOSC3|EXOSC2
CDP-CHOLINE PATHWAY%GOBP%GO:0006657,0.0776067922525869,0.390053430594062,-0.8222773642128479,-1.3684010260871398,584,2,PCYT1A|CHPT1
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY%GOBP%GO:0032769,0.9313153250984121,0.9793746057014829,0.23411780037557003,0.605793568806606,6860,6,CYP27B1|ATP2B4|SNCA
NEGATIVE REGULATION OF NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY%GOBP%GO:0070425,0.5153886972671801,0.803478510349408,-0.593052109181142,-0.9869335458400741,3884,2,PTPN22|ERBB2IP
NUCLEAR CHROMOSOME SEGREGATION%GOBP%GO:0098813,0.137224584460765,0.502004935554393,-0.175724239504065,-1.22215417856144,1064,152,MAD1L1|SPAG5|KIF25|CENPE|KIF2C|CDCA8|NIPBL|PAPD7|PHB2|BECN1|VPS4A|NCAPG|BLM|TUBG1|CHMP5|CASC5|RAD21|INO80|PINX1|ZNF207|ZWINT|RACGAP1|TRIP13|NCAPD3|KNSTRN|EME2|KLHL22|NCAPH|NUSAP1|NUF2|DLGAP5|NSL1|SPDL1|ESCO2|CDT1|SMC2|DSN1|ESPL1|GSG2|RAD51C|TUBG2|CDC23|STAG2|GEM|BOD1|KPNB1|PTTG1|TOP2A|NCAPH2|KIF18B|STRA13|KIF4A|NAA50|NDC80|SGOL1|EME1|KIF18A|SPICE1|RMI1|REC8|RAN|SMC4|KIFC1|CCNB1|PLK1|CHMP4A|HDAC8|CHMP6|FANCM|SMC1A|KIF22|SYCE2|MUS81|CDCA5
MUCOSAL-ASSOCIATED LYMPHOID TISSUE DEVELOPMENT%GOBP%GO:0048537,0.004648691725328729,0.0752560935123842,0.998014997794442,1.3307183345445301,34,1,RET
C21-STEROID HORMONE METABOLIC PROCESS%GOBP%GO:0008207,0.8791982665222099,0.960892397008799,0.181161019754994,0.6682283244653271,6491,15,FDX1L|FDXR|AKR1C2|STARD3|AKR1C1|AKR1C3|STAR|STARD3NL|AKR1B1|FDX1|DHRS2|BZRAP1|ADM|TSPO|CACNA1H
NEGATIVE REGULATION OF T CELL ACTIVATION%GOBP%GO:0050868,0.00789133247089263,0.10845506809166199,-0.31724182464315,-1.7468475466519198,60,57,CD274|DUSP3|LILRB1|NDFIP1|TNFAIP8L2|TNFRSF14|RUNX1|TWSG1|RUNX3|PDCD1LG2|SPN|FCGR2B|PLA2G2D|RC3H2|LILRB2|GPNMB|PRKAR1A|SOCS1|SDC4|CEBPB|C10orf54|CEACAM1|CD300A|HFE|CD86|LGALS3|TNFRSF21|LGALS9|HAVCR2|ANXA1|PRNP
POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS%GOBP%GO:0045345,0.79047619047619,0.928247620398227,-0.379728686445351,-0.741513882787828,5975,3,NLRC5|CIITA|HSPH1
VERTEBRATE EYE-SPECIFIC PATTERNING%GOBP%GO:0150064,0.0739799331103679,0.38239128347091206,-0.961402734891928,-1.2808192892863202,552,1,ITGAM
REGULATION OF TYPE IIA HYPERSENSITIVITY%GOBP%GO:0001796,0.23879013000795998,0.622138010410922,-0.7134822167080229,-1.18734850298696,1799,2,HLA-E|FCGR2B
THIOESTER METABOLIC PROCESS%GOBP%GO:0035383,0.9287833827893179,0.9793746057014829,-0.11964359852365801,-0.6765858971723969,7198,63,DGAT1|ACSL5|ACOT1|ACSF2|FAR1|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|HMGCS1|HACD2|ACOT2|PDHX|ABCD1|FASN
RIBONUCLEOPROTEIN COMPLEX ASSEMBLY%GOBP%GO:0022618,0.0262889229198571,0.22854112990853198,-0.194737243225809,-1.41804908459166,205,191,PRPF8|DDX28|SNRPD3|SETX|RPLP0|SMN2|SF3A3|SART3|MRPL20|BRIX1|GEMIN5|PTGES3|SRSF12|GEMIN7|MAPT|RPS23|CPSF6|RPL3|AAR2|SF3A2|DHX30|BICD1|SNRPE|MPV17L2|PSIP1|CELF2|LSM14A|DENR|EIF2S3|GEMIN8|DHX9|DYNC1H1|TXNL4A|SRPK3|PPAN|SF3A1|MRPS11|SRSF10|SBDS|SLU7|DDX23|ABT1|RUVBL1|SRSF9|LUC7L3|NPM1|GEMIN2|CELF1|ATXN2L|DDX3X|CD2BP2|SRSF5|ZRSR2|SNRPF|SRSF1|RPS14|NCBP1|SNRPD1|PATL1|RPL10|CLP1|RPL24|SF1|CELF4|RBM22|LSM3|MRPS7|MCTS1|SNRPB|EIF2S1|MRPL22|MRPS2|TAF9|BOP1|ISY1|HSP90AA1|CPSF7|PRMT5|G3BP1|AK6|MRPL11|EIF2D|SART1|SMN1|PRPF19
PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION%GOBP%GO:0035845,0.0712174146734749,0.3767214120425879,0.7417282818465251,1.45889200069614,529,3,CDHR1|AHI1
NEGATIVE REGULATION OF PRO-B CELL DIFFERENTIATION%GOBP%GO:2000974,0.0765455027858848,0.38654270614299796,-0.823655913978495,-1.3706951533438603,576,2,HES1|NOTCH1
UTERINE WALL BREAKDOWN%GOBP%GO:0042704,0.36959405677898705,0.722232671030729,-0.652219465122691,-1.08539748769841,2785,2,TGFB2|TGFB3
PROTEIN OXIDATION%GOBP%GO:0018158,0.227154386878417,0.609201573718782,-0.42534385610615605,-1.22450543041619,1744,8,CHCHD4|SUMF1|LOXL1|LOX|LOXL2
TERTIARY ALCOHOL METABOLIC PROCESS%GOBP%GO:1902644,0.47633216121179295,0.7850084910380921,0.351490833099667,0.9702810102061701,3521,7,CBR4|AKR1C2|AKR7A2|AKR1C1|AKR1C3
REGULATION OF NOREPINEPHRINE SECRETION%GOBP%GO:0014061,0.5967829143011629,0.844613508628182,0.36376837556307795,0.8748608571954359,4414,5,HRH3|KCNB1|STX1A
REGULATION OF NATURAL KILLER CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0032826,0.8662207357859529,0.955293407436668,-0.5699713277459201,-0.759338666744246,6474,1,ZNF683
MHC CLASS II PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0002399,0.10469833791388601,0.44525070692259705,-0.640269122594165,-1.4016829496520702,799,4,HLA-DRB1|HLA-DMA|HLA-DMB|HLA-DRA
POSITIVE REGULATION OF CELLULAR RESPONSE TO ALCOHOL%GOBP%GO:1905959,0.360267558528428,0.7155384949577859,-0.817765769739744,-1.08946036243435,2692,1,LANCL2
POSITIVE REGULATION OF POTASSIUM ION EXPORT%GOBP%GO:1902304,0.356913183279743,0.714610778064251,0.6571847576592961,1.1041552454263701,2663,2,KCNIP2|ANO6
GLYCERALDEHYDE-3-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0019682,0.120684968741506,0.472686039512467,0.362639147205869,1.3654566605443001,887,16,KHK|DERA|RPE|PGD|RPIA|RBKS|SHPK|G6PD|PGM2
CELLULAR RESPONSE TO UV-C%GOBP%GO:0071494,0.24537037037037,0.62804240987169,-0.616686886511525,-1.2042331907081398,1854,3,ST20|IMPACT|CARD16
B-1 B CELL LINEAGE COMMITMENT%GOBP%GO:0002336,0.507826086956522,0.7987565605553191,-0.7498897220996908,-0.9990331689776291,3795,1,SLAMF8
REGULATION OF LIPID STORAGE%GOBP%GO:0010883,0.0746442432082794,0.383186929742657,-0.297328624758437,-1.43172053547393,576,36,OSBPL11|SREBF2|MSR1|PNPLA2|C3|ABCG1|IKBKE|EHD1|ABHD5|NR1H3|NFKBIA|FITM2|PPARG|PPARA|NFKB1
RESPONSE TO DITHIOTHREITOL%GOBP%GO:0072720,0.8324489254444151,0.9443921657118071,-0.44247607645069204,-0.7363509484585621,6274,2,KAT7
RESPONSE TO VITAMIN%GOBP%GO:0033273,0.11437908496732001,0.463748809895271,-0.41507479148072995,-1.3892941912031498,874,12,AQP3|HLCS|GAS6|POSTN|KYNU|PIM1|SPP1|ALPL
ADENINE NUCLEOTIDE TRANSPORT%GOBP%GO:0051503,0.574171488690163,0.835204333784353,-0.37444689695714206,-0.897477760961761,4365,5,SLC25A4|SLC25A42
ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0008608,0.969401570538857,0.991403495623311,0.135176905668709,0.547841364907759,7159,20,AURKC|MIS12|TEX14|RB1|FAM175B|BUB3|AURKB|CENPC|CHAMP1|SEH1L|MAD1L1|CENPE|KIF2C|CASC5|ZNF207|NUF2|CDT1|BOD1|NDC80|SGOL1
POSITIVE REGULATION OF GLUCONEOGENESIS%GOBP%GO:0045722,0.552506452927591,0.822813841873357,0.415761319141896,0.9134453244476759,4066,4,SUPT20H|PTPN2|PPARGC1A
REGULATION OF APOPTOTIC PROCESS IN BONE MARROW%GOBP%GO:0071865,0.258842443729904,0.636098664976652,0.7041324594383621,1.18303344607834,1931,2,FGFR2|LEF1
NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION%GOBP%GO:0045686,0.059836927932667,0.354269451186595,-0.638344396863701,-1.52998971195986,454,5,HES1|NOTCH1|DAAM2|LDLR
REGULATION OF INTERFERON-ALPHA SECRETION%GOBP%GO:1902739,0.653391167192429,0.8739146438276378,-0.30594914450038596,-0.836298342884465,4970,7,DHX9|DHX36|IFIH1
METABOLISM OF SUBSTANCE IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052214,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS%GOBP%GO:0046543,0.179799331103679,0.55315933910608,-0.908028231142479,-1.20971163431791,1343,1,IRF2BPL
EMBRYONIC CLEAVAGE%GOBP%GO:0040016,0.9520520653473241,0.9858647066977451,0.524095721217468,0.698810926510814,7167,1,CUL3
POLYPHOSPHATE METABOLIC PROCESS%GOBP%GO:0006797,0.436269852042894,0.7626864968659259,0.38811979482653997,1.00428278095591,3213,6,ATCAY|BNIP2|MINPP1|PRUNE|PRUNE2|BNIPL
NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS%GOBP%GO:0010727,0.5034681324433979,0.7974307327271519,-0.436483419549806,-0.9555534468223779,3846,4,HP|MPV17L
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE%GOBP%GO:0048754,0.0743058271411811,0.38299993877531896,-0.305750455082638,-1.43589044940698,569,33,FGF10|COL4A1|LRP5|CTSH|EPHA2|TGFBR2|BMP2|SEMA3E|SLIT2|MYC|RASIP1|ENG
TRYPTOPHAN TRANSPORT%GOBP%GO:0015827,0.574953568585832,0.8354258054828342,-0.569312450031934,-0.947426956758867,4333,2,SLC3A2
RESPONSE TO INDOLE-3-METHANOL%GOBP%GO:0071680,0.621908127208481,0.856215852913762,-0.394913935156184,-0.86454915590126,4751,4,JUP|BRCA1
CELLULAR RESPONSE TO BLEOMYCIN%GOBP%GO:1904976,0.8120191032104009,0.935317461845028,-0.45475599669148103,-0.756786699446126,6120,2,DDX11|TIMELESS
MITOTIC SPINDLE ORGANIZATION%GOBP%GO:0007052,0.554739824832561,0.824541934935562,-0.16058146116096803,-0.935926260686615,4306,71,TTK|EML1|RHOA|CENPE|GOLGA2|TUBG1|BCCIP|ZNF207|AURKA|TUBGCP5|WDR62|RACGAP1|CEP192|PCNT|KIF11|NUF2|DYNC1H1|SBDS|OFD1|TUBGCP2|TUBG2|PLK2|TPX2|KPNB1|VCP|KIF4A|NDC80|RCC1|MECP2|SPICE1|FLNA|RAN|SPC25|KIFC1|PPP2R4|KIF2A|CCNB1|SUN2
NEGATIVE REGULATION OF SREBP SIGNALING PATHWAY%GOBP%GO:2000639,0.10095516052003199,0.438215823332192,-0.8015535185765441,-1.33391323295624,760,2,INSIG1
REGULATION OF SYNAPTIC VESICLE PRIMING%GOBP%GO:0010807,0.138216728037875,0.503189103766816,-0.566381859494423,-1.35750924160174,1050,5,NAPA|STX1B
PROTEIN LOCALIZATION TO CHROMOSOME%GOBP%GO:0034502,0.9654698032741779,0.990916952887267,0.111354259449947,0.6046074916542801,7017,52,PARP3|PIH1D1|BRCA2|ACD|MTBP|MCM9|POT1|MIS12|MAU2|XRCC5|RB1|TNKS|ZW10|ATR|TNKS2|MSH2|FAM178A|LRWD1|MCM8|H2AFY2
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION%GOBP%GO:0051494,0.45122463261021706,0.7696705263835409,0.162419298751771,1.00421574343472,3223,86,MET|CLASP1|ADD3|PARK2|TMEFF2|TMEM67|INPP5K|PICK1|KATNB1|INPP5J|CLASP2|SPEF1|ARFGEF1|TTBK2|CAMSAP3|STMN2|TRIOBP|TWF1|TMSB10|MAP2|ADD1
ANTEROGRADE TRANS-SYNAPTIC SIGNALING%GOBP%GO:0098916,0.3720346078705,0.7234654586828599,0.137803097011678,1.04115611871849,2665,220,EXOC4|HTR3A|KCNQ3|CHRNB1|SLC12A5|DRD2|SLC6A2|GRIK3|SYT2|GRID1|KCNMB4|LIN7B|CHRM4|FCHSD1|SLC12A4|GABRA3|RIMS1|SNAP25|RIMBP2|DRD4|DLG2|KCNIP2|GABARAP|CHRNB2|MINK1|ARRB2|RAB3GAP1|LIN7A|DNAJC5|CHRNA5|COLQ|NQO1|UNC13A|GABRB3|CACNB4|RIMS2|HAP1|SLC18A3|KCNQ2|CPLX1|CHRNB4|PDE7B|PPFIA3|KCNK3|HRH3|SYT5|CHRM3|UNC119|DLG4|BRSK1|CACNB2|KIF5A|GRM4|SPG11|SLC1A4|LRP6|SNAP23|PTPRN2|KCNC4|ASIC2|NAAA|OTOF
CARDIAC SEPTUM CELL DIFFERENTIATION%GOBP%GO:0003292,0.12321070234113699,0.47697345522944606,-0.937141596823997,-1.24849762793704,920,1,MAML1
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY%GOBP%GO:0050803,0.04188415022278799,0.29304749127148,-0.24219898923315197,-1.4675676738773102,328,82,MESDC2|CDC20|EPHB3|ANAPC2|CAMK1|DAB2IP|DNM1|TLR2|SHISA7|SRPX2|FCGR2B|INS|CLSTN2|FMR1|DHX36|LILRB2|EFNA1|MEF2C|ARHGAP44|DBN1|NGEF|CAMK2B|GHRL|ABL1|IL1RAP|ARHGEF15|STX1B|APOE|EPHA4|CFL1|CAPRIN1|ADGRL1|EIF4G1|DNM3|PRNP
ESTABLISHMENT OF ANATOMICAL STRUCTURE ORIENTATION%GOBP%GO:0048560,0.214238278655864,0.597438672438672,0.894629466254963,1.19286767834171,1612,1,TTC8
MRNA-CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS%GOBP%GO:0071427,0.154298874104401,0.5225398777782271,-0.191703263519113,-1.22337391302282,1205,101,MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|NUP37|NXF1|NUP160|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
PYRIDINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0072525,0.0028409090909090897,0.052744725845903,-0.364013256273135,-1.9179484792668,21,49,GPI|PFKFB2|HK1|KYNU|HK3|HAAO|ENO1|PGAM1|GAPDH|LDHA|PNPO|NMNAT3|PNP|PGK1|QPRT|PDXK|NNMT|ALDOA|ALDOC|PTGIS
DOUBLE-STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING%GOBP%GO:0006303,0.8082174137042759,0.934193159096917,-0.139319678873988,-0.778370028616861,6274,60,SETMAR|H2AFX|NBN|PAXIP1|KDM2A|BRCC3|RNF168|HIST1H4I|BRCA1|POLQ|C9orf142|HIST2H4A|KAT5|POLA1|HIST2H4B|XRCC6BP1|PRPF19
NEGATIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010989,0.64494983277592,0.8689403010577621,-0.68190339655933,-0.908459058878407,4820,1,KHSRP
DGTP METABOLIC PROCESS%GOBP%GO:0046070,0.0708994708994709,0.3767214120425879,-0.7386277177805509,-1.44235272839991,535,3,NUDT1|SAMHD1
NATURAL KILLER CELL TOLERANCE INDUCTION%GOBP%GO:0002519,0.0985449735449735,0.43335191366922604,-0.7135215617072901,-1.3933267687179398,744,3,HLA-E|LGALS9|HAVCR2
RESPONSE TO HEXOSE%GOBP%GO:0009746,0.44756239493081607,0.768229288546963,-0.20172305151896897,-1.00422294623465,3460,40,GPER1|THBS1|PDK3|TRA2B|EIF2B2|PRKACA|EIF2B3|ERN1
CELLULAR BIOGENIC AMINE CATABOLIC PROCESS%GOBP%GO:0042402,0.11785527005768198,0.46862716515177505,-0.38839483637202005,-1.3740841346649098,898,14,KMO|CCBL1|SMOX|KYNU|HAAO|SLC44A1|AFMID|HNMT
POSITIVE REGULATION OF CAVEOLIN-MEDIATED ENDOCYTOSIS%GOBP%GO:2001288,0.453977951919246,0.7705917450640001,0.7742059991177771,1.0322992339966701,3417,1,NEDD4L
POSITIVE REGULATION OF TOLL-LIKE RECEPTOR 9 SIGNALING PATHWAY%GOBP%GO:0034165,0.657468824621916,0.876113711342416,-0.53538080254967,-0.890959269269979,4955,2,RSAD2
NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035024,0.509085977759696,0.7995232695759441,0.26576634109666797,0.955262839308967,3753,14,MET|TNFAIP1|ARAP3
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901019,0.33539689090659003,0.6985008974614949,0.199683910432989,1.08420089906732,2437,52,FKBP1B|CRHR1|ANK2|GSTM2|C19orf26|DMD|DRD4|GNB5|HTT|CACNB4|SRI|HAP1|PKD2|YWHAE|CACNB2|CAMK2D|JPH3|STAC2
NEGATIVE REGULATION OF INTERLEUKIN-4 BIOSYNTHETIC PROCESS%GOBP%GO:0045403,0.359941559304024,0.7155384949577859,0.821239523599471,1.0950120925252,2709,1,ZFPM1
NEGATIVE REGULATION OF CALCIUM-MEDIATED SIGNALING%GOBP%GO:0050849,0.316045168067227,0.685583406115178,-0.27792131929096603,-1.11501500984778,2406,20,FHL2|FKBP1A|CLIC2|PRNP|RCAN1
CELLULAR RESPONSE TO MERCURY ION%GOBP%GO:0071288,0.589565217391304,0.8414799095069009,-0.709803705337451,-0.945628969430075,4406,1,AQP1
STRESS-INDUCED PREMATURE SENESCENCE%GOBP%GO:0090400,0.9782255883148501,0.992937328049893,0.19111023723051998,0.5275546801762261,7232,7,CDKN1A|SIRT1|MAPKAPK5|TP53|MAPK14|ARNTL
REGULATION OF LIPID TRANSPORT BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072367,0.398769794529512,0.7388683667002129,-0.48093499886326,-1.05286724598909,3046,4,SREBF2|HNRNPK|PPARA
REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010665,0.214931237721022,0.5979177134734279,-0.48284511063391106,-1.24200769631446,1640,6,CAMK2A|ENG
REGULATION OF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY%GOBP%GO:2000312,0.328064816044627,0.6950398637731511,0.835520511689457,1.1140538631686898,2469,1,NETO1
SPERMIDINE METABOLIC PROCESS%GOBP%GO:0008216,0.595284872298625,0.8442752964756541,-0.34321029935979,-0.882829346039383,4544,6,AMD1|SRM|SAT1|SAT2
REGULATION OF GASTRIC MOTILITY%GOBP%GO:1905333,0.234515050167224,0.6183416248717399,-0.8795765328628141,-1.17180714055376,1752,1,TYMP
MRNA ALTERNATIVE POLYADENYLATION%GOBP%GO:0110104,0.34419578589189903,0.702174649119653,-0.506999533765024,-1.10992796135576,2629,4,CPSF7
REGULATION OF PLASMA LIPOPROTEIN OXIDATION%GOBP%GO:0034444,0.25137123745819395,0.6319002828696341,-0.8713608292898101,-1.16086185068776,1878,1,APOM
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY%GOBP%GO:1901203,0.7284332168771841,0.9062429404180642,0.40391767923266797,0.7944584096285251,5420,3,SMAD3|TGFB1|RGCC
REGULATION OF EPIDERMAL GROWTH FACTOR-ACTIVATED RECEPTOR ACTIVITY%GOBP%GO:0007176,0.507750883872722,0.7987565605553191,0.244650497707173,0.9576664376446651,3733,18,NCK2|SOCS5|ADAM17|SHC1|ZGPAT|CBL
L-CYSTEINE METABOLIC PROCESS%GOBP%GO:0046439,0.977448716207037,0.9927322181739301,0.246015551756466,0.5405066444304389,7194,4,CSAD|CBS
REGULATION OF INTERLEUKIN-1 BIOSYNTHETIC PROCESS%GOBP%GO:0045360,0.49615282568320507,0.794012168719884,-0.600683384655072,-0.9996332085613949,3739,2,AZU1
PHOSPHATIDYLINOSITOL METABOLIC PROCESS%GOBP%GO:0046488,0.533083124826244,0.812079525085925,0.14250577504940898,0.962939898371138,3834,127,MTMR6|SOCS5|PLEKHA1|TMEM150A|EFR3B|INPP5K|PGAP2|FIG4|PIP4K2C|INPP5J|PIGF|PGAP1|SLC27A1|FGF2|PLEKHA3|PIKFYVE|MTMR9|PIGU|IMPA1|MTMR2|PIGL|MBOAT7|CDS1|INPP5F|PGAP3|TTC7A|PI4K2B|INPP4A|PIGO|PIGG|INPPL1|PIGT
CATECHOL-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0009713,0.8675190424374319,0.9558022175108679,0.198841379310345,0.6758231732410941,6377,12,INSM1|DDC|SNCA|PAH|HAND2|DBH|GCH1|TH|PNMT|TGFB2|MOXD1|GATA3
REGULATION OF HISTONE H3-K14 ACETYLATION%GOBP%GO:0071440,0.8664021164021171,0.95535557958156,-0.348403891507408,-0.6803444975106651,6549,3,WBP2
APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0097190,0.0509798898424491,0.324972269315165,-0.18291609209556098,-1.33824907206632,397,197,FIS1|BNIP3L|PYCARD|APOPT1|BCL2A1|FASTK|RIPK3|BCL2L11|CHAC1|DAB2IP|GZMB|PPM1F|TNFRSF10A|ATP2A1|P2RX4|TNFRSF10B|ERO1L|PDCD6|CASP10|CYP1B1|SOD2|TICAM2|NGF|BCL2L2|ANXA6|TRAF2|DDX3X|IKBKE|PPP1R13B|ZNF622|BAG3|SST|INHBA|CYCS|CASP4|BRCA1|DDX5|IFI27L1|SNW1|TFPT|ABL1|IFI6|SRGN|TNFRSF10C|G0S2|CEBPB|E2F1|IFI16|HIC1|BCL3|EPHA2|CIDEB|TMEM109|FADD|TICAM1|CAV1|DDIT4|TLR4|HINT1|ARL6IP5|SIVA1|RRP8|DPF2|TNFRSF1A|CRIP1|CD14|LY96|BAD|PTGIS
MICROGLIAL CELL PROLIFERATION%GOBP%GO:0061518,0.381268240912709,0.729499056535481,-0.648093380256624,-1.07853102267069,2873,2,CX3CL1
NEGATIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905931,0.0372777925179093,0.27499221464993107,-0.8766473669699479,-1.4588814050921002,280,2,DNMT1|FGF9
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:2000649,0.81267787839586,0.9356336309698571,-0.156233748948976,-0.752309223123263,6281,36,SLC9A3R1|TESC|SLC9A1|FXYD1|SCN1B|FXYD5|FXYD7|WNK2
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0045913,0.15664679968903902,0.5259991179339351,-0.25121711425974996,-1.2659129620546101,1208,42,PHKG2|PFKFB2|PFKFB3|INS|PPP1R3E|IRS1|IGF1|P2RY6|GPER1|SLC45A3|NFKB1|PDGFB|BAD
ARTERY SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014824,0.868532767312285,0.9564313557722421,-0.421761142716911,-0.701877986158587,6546,2,EDNRA
NUCLEAR TRANSPORT%GOBP%GO:0051169,0.264054296324753,0.6395074119587459,-0.14727440968226999,-1.10019298087731,2061,222,NXF2|SLBP|POM121|MALT1|UPF3B|CBLB|RPL23|DDX20|NUP107|KPNA1|SMURF1|PHB2|SNRPD3|SRSF4|RBMX2|BCCIP|SMN2|GEMIN5|AKT1|RANBP3|PA2G4|GEMIN7|NEMF|HNRNPA1|TNF|SYK|NUP205|HEATR3|LSG1|NUP93|NUP210|MMP12|CPSF1|SNRPE|TGFB1|RBM15B|NXT1|HTATIP2|PSIP1|PRICKLE1|GEMIN8|SRSF3|ZNF593|FYTTD1|NXF2B|NCBP2|NCKIPSD|SLU7|CHTOP|PHAX|SRSF9|KPNB1|NPM1|GEMIN2|STRADA|IPO4|MAGOH|CPSF2|NUP188|SRSF5|RITA1|IPO7|SNRPF|SRSF1|U2AF1|HNRNPA2B1|STAT3|XPO6|NCBP1|SNRPD1|NUP85|KPNA4|CALR|GLE1|NUP37|NMD3|RAN|NXF1|RBM22|NUP160|BCL3|KPNA2|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|SEC61B|SNRPB|PABPN1|SRSF2|RBM8A|DDX39A|BCL6|NUP98|THOC3|IPO11|BANF1|SMN1
REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:0010569,0.729231568016615,0.906471456078912,-0.166847018914504,-0.8165421502353969,5617,38,RAD51|RPA2|KDM1A|PPP4R2|PARPBP|KLHL15|WAS|RAD51AP1|USP51|POLQ|CXorf57|RMI2|PPP4C|MAGEF1
NEGATIVE REGULATION OF INTERLEUKIN-3 PRODUCTION%GOBP%GO:0032712,0.0937792642140468,0.42337598780415003,-0.9508160564622851,-1.26671529160663,700,1,HAVCR2
REGULATION OF ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:0001936,0.0048284625158831,0.0774096492986835,-0.275347977099628,-1.72774354782597,37,94,STAT5A|RGCC|KIAA1462|CCL11|NR4A1|FLT1|MYDGF|HMGB2|KDR|EMC10|PDCD6|CCL24|SYNJ2BP|EGFL7|ATPIF1|CAV2|VEGFC|FLT4|TNFSF12|MEF2C|PRKD1|F3|GHRL|HMOX1|SPARC|SULF1|CCL2|APOE|APLNR|VEGFB|NRP2|ECM1|BMP2|THBS1|TEK|ATOH8|SEMA5A|NR2F2|CAV1|PPARG|ANG|ACVRL1|PDGFB|NGFR
REGULATION OF ANGIOTENSIN LEVELS IN BLOOD%GOBP%GO:0002002,0.8496398166339229,0.949296218452153,-0.26835339118077395,-0.6902772127919691,6486,6,ATP6AP2|CTSZ
"TRANS-SYNAPTIC SIGNALING, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099550",0.860790110185434,0.9519562614210999,0.349665343806509,0.6877504680420621,6405,3,EPHB2
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF-ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038033,0.0299842188321936,0.244735657013286,-0.6777647766854781,-1.62447284029183,227,5,KDR|PRKD1|HSPB1
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL%GOBP%GO:0097553,0.508798253989906,0.7992229805868191,0.20226032027011498,0.9631732291208429,3729,33,DRD2|XCL1|NOL3|FGF2|FAM155A|RYR1|PKD2|TRPV1|ATP2B4|ITPR1
COENZYME A METABOLIC PROCESS%GOBP%GO:0015936,0.881921824104235,0.9625350816521829,0.200151133525352,0.6586201301254639,6497,11,NUDT7|ACAT1|ACOT7|PPCDC|PANK2|ACLY
TRANSFERRIN TRANSPORT%GOBP%GO:0033572,0.0024746027611357102,0.0469437529520831,-0.423216582155165,-1.9504245666083402,18,31,ATP6V1D|ATP6V0A1|TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|ATP6V1F|ATP6V0D1|CLTC|ARHGAP1|HFE|ATP6V0E1|ATP6AP1|ATP6V0E2|TFRC|ATP6V1A|ATP6V1G1
TELOMERE MAINTENANCE VIA TELOMERASE%GOBP%GO:0007004,0.9721278042148199,0.9915747942934481,0.12928881185680802,0.5410675387913639,7149,22,SMG6|RFC1|MRE11A|WRAP53|POT1|GAR1
REGULATION OF HEPATOCYTE PROLIFERATION%GOBP%GO:2000345,0.90775709822035,0.9711476294332829,0.292134984034061,0.641833001262043,6681,4,SULF2|XBP1|FBXW7
ALANINE TRANSPORT%GOBP%GO:0032328,0.383235973373183,0.730480369014206,0.478772581735846,1.05188375186748,2820,4,SLC6A17|SLC1A4|SLC36A4
ANAEROBIC RESPIRATION%GOBP%GO:0009061,0.243210702341137,0.626082056933819,-0.8753308337009259,-1.1661508498176398,1817,1,SDHA
HYPOXIA-INDUCIBLE FACTOR-1ALPHA SIGNALING PATHWAY%GOBP%GO:0097411,0.401034757230035,0.740287621109606,-0.6394364601903979,-1.06412452333489,3022,2,PDK3
TRACHEA DEVELOPMENT%GOBP%GO:0060438,0.665143778554152,0.8804055751124069,0.42560935259733096,0.837123371350948,4949,3,LRP6|LEF1|BMP4
OOCYTE ANTERIOR/POSTERIOR AXIS SPECIFICATION%GOBP%GO:0007314,0.77123745819398,0.9213545359508709,-0.6190449933833261,-0.824716572655282,5764,1,PLD6
REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1905456,0.21689587426326104,0.599597524514766,-0.48138101299709,-1.238241642785,1655,6,FNIP1|HES1|NOTCH1
REGULATION OF CORTICOSTEROID HORMONE SECRETION%GOBP%GO:2000846,0.618891618891619,0.854944793214197,0.284333785603265,0.8640641503455129,4533,9,CRHR1|AGTR1|GAL|UCN|CRH
PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046134,0.131737310308739,0.491374233338519,-0.36037760765085897,-1.3393027308833998,1006,16,TYMP|CTPS1|CDA|UMPS|TK1|UCK1
REGULATION OF CELL DIAMETER%GOBP%GO:0060305,0.37618729096990006,0.7266197487465021,-0.810101455668284,-1.07924965578083,2811,1,PLEK
POSITIVE REGULATION OF HAIR FOLLICLE CELL PROLIFERATION%GOBP%GO:0071338,0.253244147157191,0.632257972333528,-0.870533745037495,-1.15975997586903,1892,1,FGF10
DEOXYRIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046120,0.468986585203878,0.780769690730001,0.7668173797970891,1.02244750710004,3530,1,DHFRL1
POSITIVE REGULATION OF CHROMOSOME SEPARATION%GOBP%GO:1905820,0.37120815899581605,0.7231271705612199,-0.339766667770947,-1.06444461683436,2838,10,DLGAP5|CDT1|ANAPC5|ESPL1|ANAPC11
SUSCEPTIBILITY TO T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0060370,0.31812151764393704,0.6867397844771489,-0.6757099531293079,-1.1244894161528798,2397,2,PVR|PVRL2
REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA DEPHOSPHORYLATION%GOBP%GO:0036496,0.28654815600955197,0.659741972984038,-0.689893231999958,-1.14809266027046,2159,2,PPP1CA
THIAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:0071934,0.939301368043565,0.980854185905783,0.530712395235995,0.7076333685077941,7071,1,SLC19A2
NEURAL FOLD ELEVATION FORMATION%GOBP%GO:0021502,0.225793598087395,0.608423003242004,0.888509042787825,1.1847069194945,1699,1,BMP7
EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0002064,0.42722823286965506,0.755533439554473,-0.182092531326425,-1.01733918686148,3316,60,JAG1|SOX18|DFNB31|COL23A1|RAPGEF1|RAP2B|PDZD7|PDE4D|ICAM1|PDE2A|MSN|SOD1|RAPGEF3|TJP2|EPHA2|RAP1A|RAB1B|MYO1E|ACTA2|ENG|PDGFB
REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:1904923,0.8321038251366121,0.9443921657118071,0.24070763790653305,0.6987321619912601,6090,8,PARK2|HDAC6|OPTN|MFN2|HK2|PINK1|TOMM7
NEGATIVE REGULATION OF RETINA DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:1902867,0.425952981803692,0.7547028278218628,0.7878804587560649,1.05053228079043,3206,1,POU4F2
REGULATION OF HIGH VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901841,0.32566946172572403,0.693686425162663,0.4036654756566311,1.1143077105354,2407,7,SRI|CACNB2|NOS1AP|CACNA2D1|CACNB3
VITAMIN A TRANSPORT%GOBP%GO:0071938,0.0193916854827998,0.19226875441368102,0.990681517423908,1.32094012799787,145,1,STRA6
PROGESTERONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050847,0.19282334384857996,0.5673027886794,-0.46603220732857703,-1.27387825632304,1466,7,WBP2|YAP1|PHB
POSITIVE REGULATION OF OPSONIZATION%GOBP%GO:1903028,0.233098685084341,0.616933025883855,0.884869872077636,1.1798545763961599,1754,1,MYO18A
REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE%GOBP%GO:1902683,0.004208311415044711,0.0714808670200569,-0.768916832120009,-1.84294692375528,31,5,IQSEC2|DBN1|HRAS|STX7|RAP1A
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR-BETA SECRETION%GOBP%GO:2001202,0.246617139824887,0.6280519349499749,-0.7100082712985942,-1.18156730230003,1858,2,LILRB1|FN1
RAB PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032482,0.0553714443523889,0.34165878259009896,0.250296856096178,1.42855464579086,400,62,RABL2B|RABL2A|RAB22A|RAB36|RAB28|RAB13|RAB3B|RAB40C|DNAJC27|RAB3D|RAB10|RAB39A|RAB1A|RAB23|RAB15|RAB4B|RAB33B|RAB11B|RAB11A|IFT27|RAB25|RAB6A
REGULATION OF MITOTIC CYTOKINETIC PROCESS%GOBP%GO:1903436,0.739683815648446,0.9093988038963969,0.47824648469809794,0.8035158431959342,5520,2,NUP62|KIF20B
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS%GOBP%GO:0010927,0.5801589476568921,0.8386526275338391,0.184675306174332,0.915093120917283,4233,38,NEBL|TMOD3|OBSCN|TENM4|NEB|WDR1|EPB41L3|TPM1|OBSL1|GPC1|PROX1|CFLAR|TMOD1|TMOD2|MYOM2|CD9|CNTNAP1|PMP22|TNNT1|PAFAH1B1
REGULATION OF T CELL EXTRAVASATION%GOBP%GO:2000407,0.174714778455824,0.54811765844537,-0.749159084642956,-1.24672051639082,1316,2,RIPK3|FADD
LYSOSOMAL TRANSPORT%GOBP%GO:0007041,0.0954513645906228,0.42562467662501496,0.21210424025132998,1.3114107679727,681,86,CHMP3|BIN1|KIF13A|PARK2|NAGPA|CACNG7|CCDC91|GCC2|CLEC16A|SCARB2|VPS33B|EHD3|SNX16|NEDD4|CACNG4|AKTIP|AP4M1|VPS35|ZFYVE16|VPS11|VPS41|ATG14|SORT1|TRAK1|AP3M1|VPS52|UBXN6|VPS33A|HGSNAT|LAMP1|M6PR|TGFBRAP1|VPS16|VIPAS39|SCYL2|AP1G1|NPC1|VPS39|ANKFY1
POSITIVE REGULATION OF RESPIRATORY BURST%GOBP%GO:0060267,0.287360838244925,0.6604035198820261,-0.44745103999194397,-1.15096461195246,2193,6,INS|JCHAIN|IGHA1
REGULATION OF FEAR RESPONSE%GOBP%GO:1903365,0.0535951180684532,0.33531875720878496,-0.8487455197132621,-1.41244826941612,403,2,MEF2C|APOE
RESPONSE TO DECREASED OXYGEN LEVELS%GOBP%GO:0036293,0.0948970456580125,0.42498053239300104,-0.18936569573588397,-1.2917819745285302,741,138,SLC8A3|TCEB2|MMP12|AQP1|NPEPPS|PML|RGCC|LONP1|FUNDC1|BNIP3L|ADAM8|HSP90B1|REST|PLOD2|TERT|KCND2|ZFP36L1|RYR2|AQP3|ITPR2|ANGPTL4|RORA|CBFA2T3|VEGFC|TGFB3|ADA|CXCR4|NOTCH1|UBQLN1|CARD16|HMOX1|DPP4|LMNA|HIF3A|GATA6|VEGFB|CPEB1|BMP2|THBS1|PDK3|SRF|UBC|CAV1|MYC|DDIT4|ANG|PGK1|WTIP|LOXL2|BAD|PTGIS|P4HB|SUV39H1
SERINE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0009069,0.5888743455497378,0.8414799095069009,-0.2024024322384,-0.9039518997558109,4498,28,CDO1|SARS|PHGDH|GGT1|SDSL|THNSL2|SERINC5|GGT5|SHMT2|MTHFD1
"NUCLEOTIDE-EXCISION REPAIR, DNA GAP FILLING%GOBP%GO:0006297",0.302301255230126,0.675222663526765,-0.26376503509325,-1.12099396308715,2311,24,POLE|RFC2|RPA2|RFC3|POLD4|PCNA|POLD1|POLD2|RFC5|UBC|RFC4
POSITIVE REGULATION OF AUTOPHAGY%GOBP%GO:0010508,0.965353450684549,0.990916952887267,0.103250426577711,0.636762696241587,6909,85,TSC2|PARK2|RALB|TP53INP1|PIP4K2C|PAFAH1B2|KIAA1324|TRIM13|RAB3GAP1|HTT|GNAI3|SESN1|SMCR8|SH3BP4
PRIMARY MIRNA PROCESSING%GOBP%GO:0031053,0.6212945335871639,0.855976969451052,0.273394761150847,0.8661330834709751,4568,10,SMAD3|SMAD1|MRPL44|SMAD2|DGCR8
MITOCHONDRIAL TRANSLATIONAL ELONGATION%GOBP%GO:0070125,0.000256443133735094,0.00819882332206558,-0.32702277463258395,-2.01382200672661,1,88,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|MRPL18|MRPL57|GFM2|MRPS18B|MRPS15|MRPL47|GADD45GIP1|MRPS11|MRPL13|OXA1L|MRPL10|MRPL50|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|GFM1|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
CHEMOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070098,0.113065976714101,0.46074941938046904,-0.279426185068202,-1.34551527837695,873,36,GPR35|CCL3|CXCL12|CCL4|CCL8|CXCL1|ACKR3|CXCL2|CCL11|CCL19|CCL24|CCL3L3|CCL18|CXCR4|RBM15|CCL2|CCR1|CX3CL1|CCL4L2|CCL14
CELL-CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION%GOBP%GO:0086019,0.35354908893119397,0.7118407891832621,0.275343775190423,1.07781302219078,2599,18,TRPM4|SCN5A|ANK2|RNF207|CACNA1C|CACNB2
NEGATIVE REGULATION OF THROMBIN-ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070495,0.11273851115291599,0.460292399693505,0.699294143597662,1.3754290583183997,838,3,MET|SNCA|STMN1
PROTEIN K33-LINKED DEUBIQUITINATION%GOBP%GO:1990168,0.8501322751322751,0.949296218452153,-0.35585088783500607,-0.694886593905003,6426,3,ZRANB1|YOD1|TNFAIP3
REGULATION OF INTERFERON-GAMMA BIOSYNTHETIC PROCESS%GOBP%GO:0045072,0.5502103049421659,0.821051798535521,-0.33579581230365396,-0.9178828783315469,4185,7,LILRB1|CEBPG|EBI3|INHBA
PROTEIN LOCALIZATION TO CAJAL BODY%GOBP%GO:1904867,0.360340018594767,0.7155384949577859,0.8211843846493159,1.0949385721752298,2712,1,WRAP53
POSITIVE REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE%GOBP%GO:1902336,0.31229903536977505,0.68160868787154,0.678208652446664,1.1394781031740802,2330,2,NRP1|VEGFA
PURINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0072521,0.000128057369701626,0.00518555396908895,-0.22613311102166697,-1.8023366735888702,0,325,NDUFB5|NADK|CROT|SURF1|ACSL5|DNPH1|ATP1B1|ABHD14B|UQCR10|ACOT1|PARP1|NDUFA9|ATP5J|NDUFA7|ACSF2|DCAKD|GPI|ATP5F1|FAR1|COASY|OPA1|IMPDH2|ACSL4|PFKFB2|GPX1|ELOVL2|HK1|ADA|PDHA1|NDUFA3|NDUFB6|ACSF3|NUDT1|ATP5B|HK3|ADCY8|PDE4D|SDHD|NPR2|ELOVL1|CYCS|SLC26A2|NDUFB9|COA6|NUDT16|PDE2A|ENO1|NDUFB10|SDHA|ADCY4|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|PGAM1|HPRT1|TPST2|MOCS2|PRPS1|MBIP|EPHA2|NPR1|GAPDH|NDUFS6|COQ7|HMGCS1|NUDT18|NDUFB4|HACD2|NUDT4|MACROD2|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|ACOT2|STOML2|ENPP4|PDHX|ABCD1|NDUFA4|HINT1|ATP5H|NDUFV1|PNP|UQCRQ|SULT1A4|PGK1|NDUFS3|GPHN|SAMHD1|UQCRC2|FASN|COX6A1|UQCC3|NDUFA8|ADCY9|ALDOA|NDUFS8|ALDOC|ATP5G1|MTHFD1|BAD|NDUFV3
REGULATION OF AMYLOID FIBRIL FORMATION%GOBP%GO:1905906,0.11027865404836999,0.455506454452105,-0.515263693395286,-1.4084503280396101,838,7,APOE|CRYAB|LDLR
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033628,0.0135834411384217,0.154714834039479,-0.353799164609511,-1.70364198810826,104,36,TGFB2|SYK|RAC3|LYN|ADAM9|NCKAP1L|SFRP2|CYP1B1|PLAU|EPHA8|ADA|PIEZO1|FOXC2|EFNA1|TESC|SNAI2|DPP4|EPHA2|SERPINE1|KIAA2022|FERMT3
POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS%GOBP%GO:1900378,0.44947594732598795,0.768229288546963,0.513854631857428,1.01069142202748,3344,3,SP1|ZEB2|CDH3
POSITIVE REGULATION OF APOPTOTIC PROCESS%GOBP%GO:0043065,0.00330284552845529,0.0592615653269209,-0.179368032888029,-1.47068874955371,25,391,ATF3|PANO1|PIDD1|CD274|USP27X|GZMA|MNDA|HOXA5|UBD|MUL1|SOS2|LILRB1|ING3|PML|APC|RGCC|ATG7|LYN|GNA13|HYAL2|FIS1|BNIP3L|PYCARD|APOPT1|VAV3|GNB2L1|FNIP1|ARHGEF5|TFDP2|ADAM8|UBE2Z|REST|AGT|BCL2L11|ECT2|DAB2IP|FGD1|GZMB|PPM1F|PPIF|TNFRSF10A|TNFRSF10B|SFRP4|PDCD6|RASGRF2|CASP10|VAV1|SFRP2|CYP1B1|SOD2|NGF|IRF5|CDKN2A|C3orf38|PDCD5|WWOX|TGFB3|NMT1|CASP1|KALRN|VCP|TOP2A|TRAF2|PRELID1|SLC9A3R1|DDX3X|PPP1R13B|TNFSF10|ZNF622|MELK|ZNF268|NOTCH1|IFIT2|INHBA|TNFSF12|CYCS|MEF2C|CASP4|DCUN1D3|MAPK9|F3|IFI27L1|NGEF|PIK3CB|ANP32B|TIMP3|ABL1|SOD1|PNMA3|TNFRSF10C|G0S2|FAP|E2F1|GADD45B|CCL2|SAV1|STK3|PPP2R4|GPER1|CIDEB|GSN|F2R|NACC2|DLC1|GAPDH|PLAUR|NLRP3|BRMS1|ECSCR|PTRH2|GADD45G|BMP2|LGALS9|THBS1|MAP3K11|ARHGEF9|FADD|TGM2|UBC|LATS2|SLIT2|MMP9|BCAP31|RRP1B|CAMK2A|CAV1|MYC|APBB1|LTBR|DNAJA1|PPARG|SIK1|TNFRSF12A|BCL6|S100A8|S100A9|ARL6IP5|TIAM1|STYXL1|ANXA1|TNFRSF1A|NCK1|STPG1|NGFRAP1|TNFRSF1B|NET1|NGFR|SQSTM1|BAD|PTGIS|PRNP
UREA HOMEOSTASIS%GOBP%GO:0097274,0.311329525833444,0.68160868787154,0.845059550066167,1.12677288371433,2343,1,TFAP2B
CLEAVAGE FURROW INGRESSION%GOBP%GO:0036090,0.971443750830124,0.9915747942934481,0.513233348037053,0.684327417565772,7313,1,ALKBH4
SEROTONIN SECRETION%GOBP%GO:0001820,0.667023411371237,0.880719592999549,-0.6703242170269079,-0.8930328114162521,4985,1,SYK
NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0045602,0.878684961282434,0.960725750963158,0.305851210500193,0.671968134949835,6467,4,FOXJ2|ZEB1|S1PR3
VIRUS MATURATION%GOBP%GO:0019075,0.7237994162907929,0.9033421872639971,-0.505882180962102,-0.8418688457640059,5455,2,MVB12B
ORNITHINE TRANSPORT%GOBP%GO:0015822,0.801703163017032,0.9325377000668108,0.30442909855574896,0.7321502362745491,5930,5,SLC25A15|SLC25A29|SLC7A1
INNER EAR RECEPTOR CELL DEVELOPMENT%GOBP%GO:0060119,0.49336110387919796,0.7921808455830329,-0.33384196450849,-0.961084291151552,3789,8,DFNB31|PDZD7|SOD1|ADGRV1
REGULATION OF ARGININE METABOLIC PROCESS%GOBP%GO:0000821,0.976554126473741,0.9927322181739301,0.31479479942161304,0.528895907830096,7288,2,ATP2B4
REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY%GOBP%GO:0099601,0.7688949522510229,0.9208716027443391,0.166419069295542,0.7844908073067031,5635,32,EPHB2|ANXA3|CACNG7|MINK1|CACNG4|NETO1|PTK2B|DLG4|NLGN2|DAPK1|SHANK2|CRH
LYMPHOID LINEAGE CELL MIGRATION INTO THYMUS%GOBP%GO:0097535,0.8109698996655519,0.935269673284207,-0.597871636524041,-0.796508577295914,6061,1,BCL11B
HISTONE H3-T11 PHOSPHORYLATION%GOBP%GO:0035407,0.35852842809364605,0.714938712241162,-0.818537715041906,-1.0904887789318298,2679,1,PKN1
REGULATION OF ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:2000027,0.116264294790343,0.46625878958064004,-0.20229795133435502,-1.2761341813323401,914,96,TBX1|AP2A2|AGT|BASP1|BCOR|FZD4|CD34|HGF|SMO|GATA3|MLLT3|TBX2|TGFB3|FZD2|MESP1|SAPCD2|NOTCH1|CELSR1|SMURF2|CLTC|PIM1|SULF1|VANGL1|CEACAM1|TGFBR2|BMP2|FGF7|MYC|DACT1|DAB2|PDGFA|TIAM1|PRICKLE2|ENG|AP2M1
REGULATION OF SYSTEM PROCESS%GOBP%GO:0044057,0.000256476019492177,0.00819882332206558,-0.22788528678194198,-1.74033979208078,1,252,AGT|RYR2|JUP|CXADR|ITPR2|ATP1B1|LMCD1|ATP2A1|PARP1|P2RX4|FOXN4|SPTBN4|PLN|ADORA3|ITPR3|ATP1A3|TNNC2|TBX2|KCNN2|GAS6|ANXA6|KCNK6|C12orf57|CACNA1H|PDE4B|MYLK2|STIM1|ATP2A3|IL6ST|GRIN1|FMR1|DOCK5|SGK1|PDE4D|POMC|NPR2|CBLN1|NOTCH1|INHBA|HAMP|CRHBP|SLC9A1|TBXA2R|PKP2|ENO1|ZFHX2|CACNA1G|FGF10|CAMK2B|GHRL|POPDC2|SOD1|TYMP|FLNA|FXYD1|IGF1|NR1H3|LMNA|KCNJ12|STX1B|CHRM2|GPER1|NPR1|HSPB7|F2R|KCNQ1|SMTNL1|NOS3|NOV|KCNB2|CHGA|TNFRSF21|ASPH|SRF|TMEM108|CAV1|SCN1B|CLIC2|ATP1B2|PRKACA|KCNH2|MGLL|KCNE4|RAB11FIP1|ADRBK1|RGS2|ATP2B2|NPTX2|MYL9|SPHK1|PDGFB|NPTXR|CNN1|EMP2|C1QTNF1
NEGATIVE REGULATION OF CALCIUM ION-DEPENDENT EXOCYTOSIS%GOBP%GO:0045955,0.471426632279082,0.782843322688648,0.377571713548041,0.97698900068156,3472,6,C19orf26|STXBP3
DSDNA LOOP FORMATION%GOBP%GO:0090579,0.7843321687718359,0.927080511528825,0.381603617514062,0.7505692834605551,5836,3,ZFPM1|RUVBL2|NIPBL
REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0010958,0.06600529100529098,0.369007394574627,-0.745946840189699,-1.45664511944103,498,3,PER2|ARL6IP1|ARL6IP5
NEGATIVE REGULATION OF EOSINOPHIL MIGRATION%GOBP%GO:2000417,0.0538604404351287,0.336343421586035,-0.848414667769507,-1.41189767887451,405,2,PTGER4|CD300A
FLAVIN ADENINE DINUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0072388,0.9308009031743921,0.9793746057014829,0.535123511248346,0.7135149965057808,7007,1,FLAD1
ESTROGEN METABOLIC PROCESS%GOBP%GO:0008210,0.40352260778128296,0.7412049911665691,-0.382157995819302,-1.04461183947951,3069,7,CYP1B1|HSD17B1|HSD17B14
CHROMOSOME BREAKAGE%GOBP%GO:0031052,0.9014046822742479,0.9684180373391851,-0.549349360388178,-0.731865254597361,6737,1,RFWD3
NEGATIVE REGULATION OF DENDRITIC CELL DENDRITE ASSEMBLY%GOBP%GO:2000548,0.708194979412937,0.89516234575314,0.645235994706661,0.860335135405528,5331,1,CCL21
MATURATION OF LSU-RRNA%GOBP%GO:0000470,0.980792641688083,0.993436724391485,0.13149848379735402,0.524269187557123,7250,19,WDR12|RPF2|ZNHIT6|FTSJ3|PES1|MRPL1|RPL7|NHP2L1|RPL7L1|RSL1D1|ZNHIT3|NOL9|URB1|NHP2|RPL10A|LAS1L|RPL7A
MESANGIAL CELL DEVELOPMENT%GOBP%GO:0072143,0.00291854603343062,0.0539442420308532,-0.9667493796526049,-1.6088255625911798,21,2,ACTA2|PDGFB
DEVELOPMENTAL INDUCTION%GOBP%GO:0031128,0.25462962962963,0.6334469481869079,-0.6115717567260761,-1.19424463866148,1924,3,BMP2
DITERPENOID BIOSYNTHETIC PROCESS%GOBP%GO:0016102,0.281976358082083,0.654732517474162,0.861380679311866,1.14853490730688,2122,1,ALDH1A3
EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0140115,0.0206090837490155,0.19785915128547601,-0.46663813125710296,-1.6942874131243202,156,15,KCNA3|ATP1B1|ATP1A3|ATP1B3|SLC9A1|KCNQ1|ATP1B2|KCNH2|KCNE4
NEGATIVE REGULATION OF FERROPTOSIS%GOBP%GO:0110076,0.559732441471572,0.8268422944617521,-0.723588442876048,-0.963993549742163,4183,1,GPX4
CELLULAR RESPONSE TO CHEMOKINE%GOBP%GO:1990869,0.154377279833246,0.5225398777782271,-0.250440745997121,-1.2702267958853402,1184,43,ZC3H12A|RHOA|STK39|GPR35|CCL3|CXCL12|CCL4|DUSP1|CCL8|CXCL1|ACKR3|CXCL2|CCL11|CCL19|CCL24|SLC12A2|CCL3L3|CCL18|CXCR4|RBM15|CCL2|CCR1|CX3CL1|CCL4L2|CCL14
DIAPHRAGM DEVELOPMENT%GOBP%GO:0060539,0.5260682612201021,0.8092343000247181,0.4781783849818879,0.940520454497408,3914,3,STRA6
NEURONAL ION CHANNEL CLUSTERING%GOBP%GO:0045161,0.0438524590163935,0.299062021084573,0.5516064657565799,1.6012170687168301,320,8,PICK1|KCNIP2|AGRN|NRCAM
DELTOID TUBEROSITY DEVELOPMENT%GOBP%GO:0035993,0.675378084372513,0.882488012133495,-0.5279294182519989,-0.878558974232716,5090,2,SCX|BMP4
REGULATION OF NOREPINEPHRINE UPTAKE%GOBP%GO:0051621,0.43433271424781106,0.762034923704788,-0.625275822599765,-1.04055895792787,3273,2,ACTB
NEGATIVE REGULATION OF PHOSPHORYLATION%GOBP%GO:0042326,0.0149827122550903,0.164650761550465,-0.181235784560415,-1.4183352045258102,116,291,PYCARD|SOCS4|GNB2L1|SAMSN1|CORO1C|IRAK3|IGBP1|TSG101|IMPACT|SOCS3|DAB2IP|PRDM15|PPM1F|PID1|DUSP5|PPIF|SEMA6A|SPRY1|CDKN1C|SYNJ2BP|HNRNPU|SFRP2|CDKN2A|CBFA2T3|NPM1|SMAD6|HEXIM1|PRR5L|THY1|SLC9A3R1|WARS|MAPK8IP1|PDE12|HEG1|PDE4D|IPO7|INHBA|PRKAR1A|CEBPA|SOCS1|FOXM1|PTPN6|PARK7|RGS4|CDKN2B|TIMP3|TAF7|ABL1|HSPB1|C14orf166|MEN1|LRP5|LDLRAD4|TNIP1|SNX6|GNAQ|CEACAM1|VPS25|GPER1|CD300A|MBIP|PSMD10|APOE|PLK1|PPP2CA|MVP|WWTR1|CHMP6|LATS2|C3orf33|ERRFI1|ADARB1|SLIT2|NR2F2|CAV1|MYC|DNAJA1|RASIP1|DDIT4|PPARA|DACT1|TLR4|CDKN2C|NF2|SMPD1|H2AFY|RGS2|GPS1|ENG|GSTP1|PHB|NCK1|RGS3|FBLN1|PTPRJ|EIF4G1|SIRPA|WNK2|PRNP
SKELETAL MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048741,0.875460284061021,0.9605256252569351,-0.278627372869872,-0.6678166457726881,6656,5,KIAA1161|CAV2|SEPN1
REGULATION OF SIGNAL TRANSDUCTION INVOLVED IN MITOTIC G2 DNA DAMAGE CHECKPOINT%GOBP%GO:1902504,0.786558639925621,0.927659709144581,0.6063630348478171,0.808503288673269,5921,1,RINT1
HEART INDUCTION%GOBP%GO:0003129,0.40819846113027297,0.7445496113654559,-0.6368529458685871,-1.0598251423684002,3076,2,BMP2
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:1904753,0.8920634920634921,0.965443067117994,-0.335042587055934,-0.654253256325629,6743,3,PRKG1|MEF2C
CELLULAR RESPONSE TO INDOLE-3-METHANOL%GOBP%GO:0071681,0.621908127208481,0.856215852913762,-0.394913935156184,-0.86454915590126,4751,4,JUP|BRCA1
REGULATION OF INTRACILIARY RETROGRADE TRANSPORT%GOBP%GO:1905799,0.7568070128835171,0.9167932806937259,0.6218570798412,0.8291625070161981,5697,1,TCTEX1D2
"MITOCHONDRIAL ELECTRON TRANSPORT, NADH TO UBIQUINONE%GOBP%GO:0006120",0.000259302476338649,0.00819882332206558,-0.469849258577648,-2.35305452888971,1,41,NDUFC2|NDUFV2|NDUFB8|NDUFS4|NDUFB5|NDUFA9|NDUFA7|NDUFA3|NDUFB6|NDUFB9|NDUFB10|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|NDUFB4|NDUFA2|NDUFAB1|NDUFA1|NDUFA4|NDUFV1|NDUFS3|NDUFA8|NDUFS8|NDUFV3
NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009133,0.853968253968254,0.949296218452153,-0.35385834673033795,-0.6909956661350539,6455,3,CMPK2
NUCLEOBASE-CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS%GOBP%GO:0034404,0.00609911054637865,0.0914854365410948,-0.272194754264384,-1.7079578189971798,47,94,GPI|IMPDH2|PFKFB2|NUDT17|GPX1|HK1|ADA|VCP|NUDT1|HK3|PDE4D|NUDT16|PDE2A|SMPDL3A|ENO1|TYMP|CTPS1|PGAM1|HPRT1|CDA|GAPDH|NUDT18|UMPS|NUDT4|GMPS|LDHA|TK1|ABCD1|HINT1|PNP|PGK1|SAMHD1|UCK1|ALDOA|ALDOC
NEGATIVE REGULATION OF DNA CATABOLIC PROCESS%GOBP%GO:1903625,0.484128038252092,0.7872939093021379,0.757995147772386,1.01068425110407,3644,1,DFFA
FOLATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1904447,0.9840806579994691,0.994044512176225,-0.312006462003415,-0.51922864635828,7417,2,SLC19A1
NEGATIVE REGULATION OF INTERLEUKIN-1 ALPHA PRODUCTION%GOBP%GO:0032690,0.112240802675585,0.459194647507502,-0.9416629907366559,-1.2545212102794099,838,1,CX3CL1
PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009174,0.149030100334448,0.5157092501209121,-0.9231914424349359,-1.22991267266121,1113,1,UMPS
REGULATION OF T-HELPER 1 CELL DIFFERENTIATION%GOBP%GO:0045625,0.7440125638005501,0.9111581800710571,-0.35326572974222703,-0.77337252821098,5684,4,JAK3|CCL19|ANXA1
AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0060414,0.907004510480233,0.9709695261809209,-0.39398304014517205,-0.65565078142663,6836,2,MYLK
REGULATION OF MONOCYTE DIFFERENTIATION%GOBP%GO:0045655,0.000785957558291852,0.0191134260247744,-0.632317040555201,-2.04716043871924,5,11,ACIN1|CDK6|CD74|ZFP36L1|CD4|IL34|IRF7|CSF1|FOXP1|MYC
TRANSMEMBRANE RECEPTOR PROTEIN SERINE/THREONINE KINASE SIGNALING PATHWAY%GOBP%GO:0007178,0.42968950474724105,0.758240584775606,-0.152302052848206,-1.01209028357415,3348,122,SMAD5|SLC33A1|INHBA|SMURF2|GCNT2|CHRD|LTBP2|DDX5|PXN|MAPK3|LRRC32|IRAK1|CDH5|HFE|FMOD|TGFBR2|BMP2|TGFBR3|ATOH8|COL1A2|UBC|COL3A1|GDF11|ID1|FKBP1A|ENG|ACVRL1
BOX C/D SNORNP ASSEMBLY%GOBP%GO:0000492,0.6284523189161021,0.8598358835891559,-0.285362059471275,-0.8584389236581971,4823,9,TAF9|AK6
TRNA 5'-LEADER REMOVAL%GOBP%GO:0001682,0.6309491433233609,0.8613756250889949,0.27070116400948896,0.8575995856531959,4639,10,SSB|POP5|KIAA0391|RPP21|RPP14|RPP30|POP4|RPP25|POP7|POP1
NEGATIVE REGULATION OF CARDIAC MYOFIBRIL ASSEMBLY%GOBP%GO:1905305,0.8778595317725749,0.960725750963158,-0.5636303484781651,-0.7508909598006851,6561,1,SMAD4
INTRACELLULAR TRANSPORT OF VIRUS%GOBP%GO:0075733,0.7807178412365731,0.925185557690081,-0.23038075689159,-0.7458700953821371,5959,11,CD209|KPNB1|CLEC4M|RAN|UBC
PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT%GOBP%GO:0010623,0.47917219421597207,0.7851559026823699,-0.60733388475324,-1.01070070421967,3611,2,NTRK1|DNASE1L3
POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I%GOBP%GO:1901838,0.961109600217569,0.990105504429159,0.17824240083852802,0.5646839741686321,7067,10,PIH1D1|SMARCB1|MTOR|MARS|NCL|DDX11|PWP1
REGULATION OF MALE GERM CELL PROLIFERATION%GOBP%GO:2000254,0.34954448017149004,0.70736446849153,0.659994485800937,1.10887595148301,2608,2,RHBDD1|CIB1
NEGATIVE REGULATION OF NAD(P)H OXIDASE ACTIVITY%GOBP%GO:0033861,0.358260869565217,0.714938712241162,-0.8188685487428321,-1.09092952885932,2677,1,INS
IMMUNE RESPONSE-INHIBITING SIGNAL TRANSDUCTION%GOBP%GO:0002765,0.22562491820442396,0.6083599141984499,-0.566243936818436,-1.23962634394498,1723,4,LILRB1|LYN|LILRB2
ENDOTHELIAL TUBE MORPHOGENESIS%GOBP%GO:0061154,0.340088912133891,0.701745885104582,-0.34925182154837103,-1.09416036542284,2600,10,STARD13|ACVRL1
CONSTITUTIVE SECRETORY PATHWAY%GOBP%GO:0045054,0.7281618435155409,0.906017151800216,0.48344175971209996,0.812244576008567,5434,2,RAB11B|RAB3A
POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY%GOBP%GO:0002708,0.208268933539413,0.5883094281426011,-0.22210251454259197,-1.19881350017778,1616,53,MALT1|HLA-F|CLCF1|TRAF6|MICB|IL1B|CD1D|HLA-B|PVR|MICA|TGFB1|NCR3|HLA-E|B2M|IL18|HLA-C|PAXIP1|HLA-A|TRAF2|PVRL2|RSAD2|TNFSF13|STX7|HFE|NLRP3|ZP3|FADD|IL1R1|TFRC
ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0060842,0.5753294389349269,0.83579217878959,0.40818203685975296,0.8967933184900708,4234,4,DLL1|HEY2|HEY1
REGULATION OF HEART RATE BY CARDIAC CONDUCTION%GOBP%GO:0086091,0.353772943575799,0.7118407891832621,0.256858887212659,1.07494224693445,2601,22,TRPM4|BIN1|SCN5A|ANK2|CACNA1C|YWHAE|CACNB2|CAMK2D
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1901213,0.7107524082270241,0.8964108318214721,-0.27572039376366303,-0.793760423697836,5459,8,GREM1|TBX2|NOTCH1|SRF
NEUROTRANSMITTER SECRETION%GOBP%GO:0007269,0.74109362054681,0.9098143075756671,0.144995835240741,0.8275552369459009,5366,62,SYT2|LIN7B|RIMS1|SNAP25|LIN7A|DNAJC5|UNC13A|RIMS2|SLC18A3|CPLX1|PPFIA3|HRH3|SYT5|BRSK1|GRM4|SNAP23|PTPRN2|NAAA|OTOF
STEM CELL PROLIFERATION%GOBP%GO:0072089,0.067211997273347,0.370415270164359,0.32636377379693104,1.46064016813169,492,27,ABCB1|FGFR2|TEAD3|MECOM|WNT2B|FGF2|RAB10|NES
MIRNA CATABOLIC PROCESS%GOBP%GO:0010587,0.5711958734898871,0.8335161565658671,0.34424416741802605,0.8907520162349258,4207,6,DIS3L2|PARN|ZCCHC11
BUD DILATION INVOLVED IN LUNG BRANCHING%GOBP%GO:0060503,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
REGULATION OF PROTEIN HOMOOLIGOMERIZATION%GOBP%GO:0032462,0.30103288937211203,0.674038850802402,0.300831973520586,1.1327321529221899,2214,16,RHOC|MIEF2|HRK|BID|PEX5
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF CARDIAC OUTFLOW TRACT CELL PROLIFERATION%GOBP%GO:0061324,0.84951520786293,0.9492491301138911,0.574327304808116,0.7657879653378901,6395,1,CTNNB1
INSULIN RECEPTOR SIGNALING PATHWAY VIA PHOSPHATIDYLINOSITOL 3-KINASE%GOBP%GO:0038028,0.13992664040211902,0.504314492208813,0.616445155241824,1.35435625900996,1029,4,IGF2|C2CD5|FER|PIK3CA
T-HELPER 1 CELL DIFFERENTIATION%GOBP%GO:0045063,0.855555555555556,0.949296218452153,-0.353148781294805,-0.689610064678078,6467,3,HMGB1|LEF1|SPN
SEROTONIN SECRETION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002442,0.667023411371237,0.880719592999549,-0.6703242170269079,-0.8930328114162521,4985,1,SYK
REGULATION OF RENAL SODIUM EXCRETION%GOBP%GO:0035813,0.8246031746031751,0.942178419436027,-0.366502204699858,-0.7156859161768979,6233,3,AGT|NPR1
REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION%GOBP%GO:0060371,0.6728705338948511,0.882087304031713,0.377557750821724,0.8295104578484841,4952,4,SCN5A
"NUCLEOTIDE-EXCISION REPAIR, DNA INCISION%GOBP%GO:0033683",0.31194919647485697,0.68160868787154,-0.224034665014858,-1.1063386847013799,2406,39,RFC2|CUL4B|RPA2|RFC3|PARP1|POLD4|PCNA|POLD1|POLD2|RFC5|GTF2H1|UBC|DDB1|RFC4|XPA|GTF2H2
GDP PHOSPHORYLATION%GOBP%GO:0061568,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION%GOBP%GO:0098957,0.0477022305831766,0.312622335056584,0.7675085474798721,1.5095987409254301,354,3,TRAK2|HAP1|TRAK1
ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0019882,0.00012745347947999,0.00518555396908895,-0.296812648355088,-2.0421689328195303,0,143,CENPE|AP2A1|KIF2C|ERAP2|ERAP1|KLC1|CAPZA2|AP1S3|KIF3A|HLA-DRB1|HLA-DMA|CD1D|HLA-DMB|RACGAP1|HLA-DQB2|HLA-B|AP1S2|KIF11|KIF15|HLA-DPA1|CLEC4A|HLA-E|HLA-DRA|HLA-DRB5|FCGR1B|ACTR10|RAB35|CD209|DCTN4|DYNC1H1|CD74|B2M|AP2A2|TAPBP|LNPEP|HLA-DPB1|HLA-DQA2|CTSF|CTSV|FCGR1A|RAB7A|CTSS|HLA-C|KLC2|CANX|ITGB5|HLA-A|FCGR2B|CLTA|SH3GL2|CLEC4M|SEC23A|CLTC|DYNLL2|FCER1G|KIF4A|LAG3|SLC11A1|KIF18A|RILP|CALR|SEC13|SEC24A|VAMP8|ARF1|IFI30|CTSH|RAB3C|HFE|KIF2A|AP1B1|DCTN5|CD36|RAB34|BCAP31|CTSD|CTSL|DYNC1I1|SPTBN2|LGMN|KIF22|SAR1B|ABCB9|DCTN3|AP2M1|RAB33A
HISTONE H4-K5 ACETYLATION%GOBP%GO:0043981,0.0255972696245734,0.22470485454905398,-0.455957869175414,-1.6555091127631298,194,15,KANSL1|KANSL2|JADE3|HCFC1|OGT|PHF20|WDR5|KAT7|KAT8
POSITIVE REGULATION OF MITOTIC CENTROSOME SEPARATION%GOBP%GO:0046604,0.26120986999204004,0.637033618828779,-0.7017693815464449,-1.1678564722549198,1968,2,NSFL1C
CYTOKINE METABOLIC PROCESS%GOBP%GO:0042107,0.9711995652764571,0.9915747942934481,0.254394731361955,0.558916058873174,7148,4,NOD1|BCL10
TETRAPYRROLE CATABOLIC PROCESS%GOBP%GO:0033015,0.0668760633424944,0.3690551432905871,-0.6749009417624189,-1.4774992411622598,510,4,BLVRA|HMOX1|BLVRB
KIDNEY SMOOTH MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0072194,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
REGULATION OF CYTOKINESIS%GOBP%GO:0032465,0.132385422418553,0.49246068748285293,0.222737888244394,1.2824124004686899,958,64,AURKC|DRD2|KIF13A|BBS4|KLHL13|FSD1|GIT1|ZFYVE19|MAP9|PKP4|CSPP1|PRKCE|RAB11FIP3|SH3GLB1|RAB11A|PLK3|ANKRD53|PRPF40A|SPAST
BMP SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061312,0.271701155603332,0.646576786621306,0.602680470482287,1.18540136446398,2021,3,ACVR1|BMPR1A
NITRIC OXIDE HOMEOSTASIS%GOBP%GO:0033484,0.0062350756168745,0.092360543194149,-0.9450785773366421,-1.5727618821155802,46,2,CAV1|GSTP1
REGULATION OF SUBSTRATE ADHESION-DEPENDENT CELL SPREADING%GOBP%GO:1900024,0.0945629552549428,0.424507034898303,-0.29037647643666,-1.3862378615473998,726,35,CDC42|RAC3|RCC2|ACTN4|RAC1|KANK1|CORO1C|RREB1|DOCK5|S100A10|ABL1|CALR|FLNA|DOCK1|PDPN|NEDD9|FBLN1|EFNA5
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043535,0.000257599175682638,0.00819882332206558,-0.36425472066588105,-2.12300695351458,1,71,RHOA|SH3BP1|PTGS2|DLL4|MAPK14|ETS1|CD40|VASH1|PDCD10|AKT1|TGFB1|STAT5A|RGCC|KIAA1462|MAP3K3|ANGPT2|PIK3C2A|JUP|KLF4|KDR|P2RX4|PRCP|SRPX2|FOXC2|ATP5B|NOTCH1|MEF2C|PRKD1|TBXA2R|MMRN2|MECP2|HMOX1|HSPB1|HDAC5|MEOX2|RHOJ|STARD13|MAP2K3|EPHA2|APOE|NOS3|THBS1|PPARG|ANXA1|TMSB4X|ACVRL1|PDGFB|CARD10
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY%GOBP%GO:0035794,0.679445244014131,0.884536278926676,-0.21961966246925801,-0.834608347672842,5192,17,STPG1|BAD
CEREBELLAR CORTEX MORPHOGENESIS%GOBP%GO:0021696,0.491785471826205,0.791031390725892,0.27573351349680103,0.965676251157992,3621,13,DLL1|ATP7A|ADCK4|AGTPBP1|PROX1|ZNF365
BODY MORPHOGENESIS%GOBP%GO:0010171,0.970982142857143,0.9915747942934481,-0.13465408323982303,-0.540229602870106,7394,20,TBX1|CLDN5|TGFB3|ATP6AP2|CRISPLD2|RRAS
REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1901532,0.499088304245897,0.794989907195277,-0.21018350577436898,-0.968646056046771,3831,31,FNIP1|RUNX1|GATA3|LMO2|HES1|DHX36|NOTCH1|TAL1|SETD1A|ABL1|YAP1|DPF2
GLUTAMATE CATABOLIC PROCESS VIA 2-OXOGLUTARATE%GOBP%GO:0006539,0.16416522778589498,0.535290477921284,0.9199933833259809,1.22668703933014,1235,1,ADHFE1
NEGATIVE REGULATION OF MEIOTIC CELL CYCLE%GOBP%GO:0051447,0.640715412940558,0.8671151388174041,-0.353494417610813,-0.8472586660696658,4871,5,TRIP13|DUSP1|RAD1
KIT SIGNALING PATHWAY%GOBP%GO:0038109,0.267282958199357,0.6417330323279019,0.6997518610421839,1.17567347517081,1994,2,KIT|FER
"POSITIVE REGULATION OF TERMINATION OF RNA POLYMERASE II TRANSCRIPTION, POLY(A)-COUPLED%GOBP%GO:2000806",0.7298996655518399,0.906544799850309,-0.639225849139832,-0.85160231823218,5455,1,SETX
POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION%GOBP%GO:1903393,0.0584542958022754,0.34885102442576,-0.3620413820735379,-1.49930756333186,446,22,ROCK1|RAC1|DUSP3|IQSEC1|MAPRE2|PPM1F|KDR|THY1|S100A10|ABL1|TEK|COL16A1|ARF6|PTPRJ
REGULATION OF GENE SILENCING BY MIRNA%GOBP%GO:0060964,0.0181182865277598,0.18433841711697999,-0.297524317915082,-1.6291988602198602,139,56,STAT3|FXR1|HIST1H4I|DDX5|POLR2H|HIST2H3A|HIST2H4A|PPARG|POLR2G|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|WTIP|POLR2L|EIF4G1
TENDON CELL DIFFERENTIATION%GOBP%GO:0035990,0.675378084372513,0.882488012133495,-0.5279294182519989,-0.878558974232716,5090,2,SCX|BMP4
PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT%GOBP%GO:1903546,0.769271037822275,0.921045232603723,-0.344963381371964,-0.7551969521258509,5877,4,TUB
NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY%GOBP%GO:0007194,0.122980719124544,0.47697345522944606,-0.460331160565425,-1.3847888073638202,943,9,AKAP5|GNAI2|EDNRB|ADGRV1
WNT SIGNALING PATHWAY INVOLVED IN SOMITOGENESIS%GOBP%GO:0090244,0.442024173196972,0.7653693162885199,0.780381561535068,1.04053351319385,3327,1,LRP6
NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0060266,0.567724867724868,0.83116084992853,-0.47110478843761494,-0.919948250800872,4291,3,SLAMF8|INS
NUCLEAR ENVELOPE ORGANIZATION%GOBP%GO:0006998,0.0867366783352781,0.406842536616055,-0.277451508321718,-1.3895063497175,668,41,LMNA|GPER1|CCNB1|PLK1|NSFL1C|SUN2|VRK1|NEK6|EMD|BANF1|PRKCB
REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051940,0.085698837523655,0.405270830448101,0.615332529130557,1.4798712039278101,633,5,DRD2|RAB3B|DRD4|SNCA
MULTIVESICULAR BODY ORGANIZATION%GOBP%GO:0036257,0.638325703073905,0.865463150027443,-0.19077629309014998,-0.8710472046742509,4879,30,VPS25|CHMP4A|SNF8|CHMP6|VPS37C
NEGATIVE REGULATION OF TRANSPORT%GOBP%GO:0051051,0.00025523226135783597,0.00819882332206558,-0.23373778850151997,-1.79607577172194,1,260,REST|SREBF2|RHBDF2|CD84|GABRE|PPM1F|PID1|UBQLN2|PPIF|PIM3|TLR2|SFRP4|PXK|RAB7A|APOC1|CD34|PLN|TMBIM6|GDI1|SYT4|MCTP1|SSC5D|FCGR2B|GAS6|INS|MDFIC|UBE2G2|TNFAIP3|FMR1|PLA2R1|LILRB2|NOTCH1|INHBA|HAMP|CRHBP|PTGER4|IRS1|UBQLN1|PRKD1|CD47|PARK7|PDE2A|OSM|CARD16|RSAD2|SRGN|TNFRSF4|NECAB2|DYSF|VAMP8|NR1H3|GPM6B|STX1B|ARHGAP1|CEACAM1|CD300A|F2R|FN1|NLRP3|NOV|LGALS3|CHGA|TNFRSF21|BST2|CD200|LGALS9|THBS1|ADRA2C|PEA15|HTR1B|CD300LF|FKBP1A|MMP9|CX3CL1|CRYAB|IL11|CAV1|SIRT4|CLIC2|PRRT2|DERL3|MPV17L|NFKB1|KCNH2|SERGEF|KCNE4|RAB11FIP1|ARL6IP5|ANXA1|TNFRSF1A|TMSB4X|ARF6|TNFRSF1B|PRKCB|GRB10|SIRPA|INSIG1|WNK2|SLC25A5
TRIGLYCERIDE HOMEOSTASIS%GOBP%GO:0070328,0.170385928065109,0.544006430438841,-0.35350370051398405,-1.2835146340488799,1297,15,APOC2|IL18|ANGPTL4|RORA|CETP|NR1H3|APOE|FITM2
INDUCTION BY SYMBIONT OF HOST DEFENSE RESPONSE%GOBP%GO:0044416,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION%GOBP%GO:0032912,0.276731228442558,0.65200538828243,-0.6941493560439209,-1.15517553128503,2085,2,GATA6
IRON ASSIMILATION%GOBP%GO:0033212,0.74943143812709,0.913740267011908,-0.630513895015439,-0.8399959034749399,5601,1,SLC11A2
RRNA MODIFICATION%GOBP%GO:0000154,0.935703582618172,0.9806508984207809,0.135614292898656,0.620656199376536,6868,29,FDXACB1|TFB1M|MTERF4|RNMTL1|NSUN4|GAR1|NSUN3|WBSCR22|TFB2M|FTSJ3|EMG1|METTL15|MRM1|NOP2|RPUSD2
REGULATION OF DIGESTIVE SYSTEM PROCESS%GOBP%GO:0044058,0.0119854090672225,0.143937896709407,-0.5997031031299941,-1.804053725009,91,9,SGK1|HAMP|FGF10|TYMP|NR1H3|KCNQ1
POSITIVE REGULATION OF AXON REGENERATION%GOBP%GO:0048680,0.17685618729097002,0.548551967663807,-0.9089655932951041,-1.2109604257791298,1321,1,SCARF1
REGULATION OF HISTONE H4 ACETYLATION%GOBP%GO:0090239,0.493057374901755,0.7917699200764059,-0.297525862603082,-0.963255987664108,3763,11,BRCA1|ARRB1|KAT7|SPI1
MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE%GOBP%GO:0072595,0.0703236708696217,0.3767214120425879,-0.30572320488954996,-1.4484504333139099,540,34,PML|SP100|GPAA1|TAF3|HNRNPU|HK1|PARK7|KDELR2|SKP1|KDELR1|BCL3|SUN2|ARL2|KDELR3|HSPA5|INSIG1
NEGATIVE REGULATION OF TRANSPORTER ACTIVITY%GOBP%GO:0032410,0.0496250852079073,0.319285561821349,0.286480868952733,1.48679897809983,363,44,FKBP1B|CRHR1|TCAF2|GSTM2|C19orf26|EPHB2|DRD4|GNB5|PRKCE|SRI|SUMO1|NEDD4|PKD2|YWHAE|NDFIP2|CAMK2D|NEDD4L
MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0071985,0.6926107036131489,0.888747617562104,0.18433816608305,0.8351422275474749,5098,28,CHMP3|TMEM50B|VPS36|MITD1|SORT1|LEPROTL1|SYTL4|UBXN6|CHMP1A|LAPTM4B
GMP CATABOLIC PROCESS%GOBP%GO:0046038,0.767577606792253,0.9202818175694271,-0.48006588419908097,-0.798906399614093,5785,2,HPRT1
RESPONSE TO AUDITORY STIMULUS%GOBP%GO:0010996,0.408353609083536,0.7445496113654559,0.42645391094793894,1.02561921032513,3020,5,STRA6|HTT|NRXN1
DNA METHYLATION%GOBP%GO:0006306,0.7713310580204781,0.9213545359508709,0.17838905430339103,0.7772261602837829,5649,25,TDRD12|PICK1|TET3|PRMT7|DNMT3A|GATAD2A|PIWIL4
CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS%GOBP%GO:0039528,0.38646773982463,0.733589579210772,-0.48704092553353795,-1.06623439583832,2952,4,IFIH1|IRF7
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:1905006,0.7014046822742479,0.8931369333627571,-0.652183502426114,-0.8688650237255441,5242,1,TGFB2
DNA METHYLATION OR DEMETHYLATION%GOBP%GO:0044728,0.247793354101765,0.62852193925262,-0.23790313569825197,-1.16428773636247,1908,38,APOBEC3G|DNMT1|APOBEC3C|APOBEC3B|N6AMT1|PPM1D|APEX1|ALKBH3|APOBEC3F
POSITIVE REGULATION OF CELL-SUBSTRATE ADHESION%GOBP%GO:0010811,0.0009024107257960551,0.021472448318834,-0.346229566598566,-1.94159486356031,6,61,THY1|RREB1|DOCK5|S100A10|RSU1|MMRN2|ABL1|CALR|FLNA|MMRN1|DOCK1|CSF1|FN1|CD36|TEK|ARL2|NEDD9|EMILIN2|CX3CL1|FBLN2|COL16A1|PTPRJ|COL26A1|EMP2
CELLULAR RESPONSE TO CORTISOL STIMULUS%GOBP%GO:0071387,0.93359011820959,0.9800972968717879,0.534131010145567,0.712191630206234,7028,1,KLF9
REGULATION OF CARDIAC VENTRICLE DEVELOPMENT%GOBP%GO:1904412,0.4647363527692921,0.7785465206362571,0.7688575209528009,1.02516776004911,3498,1,BMPR1A
G PROTEIN-COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0098664,0.130836120401338,0.49066507924967295,-0.933557565063961,-1.2437228370559,977,1,HTR1B
POSITIVE REGULATION OF COA-TRANSFERASE ACTIVITY%GOBP%GO:1905920,0.760260326736618,0.91797162753179,0.6196515218350239,0.826221693017205,5723,1,CHRNA7
"REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, SLEEP%GOBP%GO:0045187",0.9571278274592321,0.9880317864833471,-0.237262574652493,-0.568673117575639,7277,5,PTGDS|GHRL
REGULATION OF DNA LIGATION%GOBP%GO:0051105,0.790823944617891,0.928357780000476,0.28525729413711304,0.7381200146516909,5825,6,PARP3|HMGB1|APLF|TFIP11|XRCC1|RAD51
CORTISOL SECRETION%GOBP%GO:0043400,0.24521739130434803,0.62804240987169,-0.8741729157476841,-1.16460822507142,1832,1,GHRL
NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT%GOBP%GO:0032891,0.669396669396669,0.8815356925073421,0.273010889044715,0.829654912014741,4903,9,IRS2|TRH|HRH3
RESPONSE TO PLATELET AGGREGATION INHIBITOR%GOBP%GO:0061478,0.8411138411138409,0.9476390732504458,0.22842770487728398,0.694170727236643,6161,9,ADCY2|ADCY3|ADCY6|ADCY1
SPINDLE ASSEMBLY INVOLVED IN MEIOSIS%GOBP%GO:0090306,0.7696321070234109,0.921135900129782,-0.619816938685487,-0.8257449891527591,5752,1,GOLGA2
REGULATION OF EXTRATHYMIC T CELL DIFFERENTIATION%GOBP%GO:0033082,0.573228973202441,0.835084889620481,-0.570002757099531,-0.9485757381077491,4320,2,ZNF683|PRDM1
VESICLE TRANSPORT ALONG ACTIN FILAMENT%GOBP%GO:0030050,0.7000407553321559,0.8930679216759608,0.369052506419553,0.8108240736786378,5152,4,MYO5A|FNBP1L|WASL
"SYNAPTIC TRANSMISSION, GLYCINERGIC%GOBP%GO:0060012",0.766077170418006,0.919992400339549,0.465508684863524,0.7821146948299409,5717,2,GLRB|SLC6A9
REGULATION OF RESPIRATORY BURST%GOBP%GO:0060263,0.140428870292887,0.505135213058319,-0.43422665922103004,-1.36037543919815,1073,10,RAC2|RAC1|SLAMF8|INS|JCHAIN|NOXA1|IGHA1
RESPONSE TO ANISOMYCIN%GOBP%GO:0072739,0.0232157070841072,0.21183213499719,-0.901571546732837,-1.50035922589356,174,2,KAT7|MAPK13
RESPONSE TO COLD%GOBP%GO:0009409,0.35499476987447703,0.713132991738381,-0.27805618404459304,-1.07896140595833,2714,18,NFKBIA|YBX3|HSP90AA1|METRNL
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002586,0.46329014526894396,0.777045583937511,-0.452317184975141,-0.990216869190084,3539,4,HLA-DOA|PYCARD|TREM2
CELLULAR RESPONSE TO HYDROSTATIC PRESSURE%GOBP%GO:0071464,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
NEGATIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070563,0.043380206951446,0.29791299041195396,-0.86462641301351,-1.43887661541351,326,2,SNAI2|KANK2
L-ARGININE TRANSPORT%GOBP%GO:1902023,0.47899489595602707,0.7850984235874658,-0.445197698048001,-0.9746308240664169,3659,4,SLC7A2|SLC7A3
REGULATION OF OSTEOCLAST DEVELOPMENT%GOBP%GO:2001204,0.0766701735928459,0.386878103852997,-0.617918732446612,-1.4810332919276101,582,5,LILRB1|FBN1|NOTCH2|ATP6AP1
PURINE RIBONUCLEOTIDE TRANSPORT%GOBP%GO:0015868,0.574171488690163,0.835204333784353,-0.37444689695714206,-0.897477760961761,4365,5,SLC25A4|SLC25A42
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN METANEPHRIC KIDNEY DEVELOPMENT%GOBP%GO:0061290,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
ANIMAL ORGAN MATURATION%GOBP%GO:0048799,0.607786885245902,0.8493425539243421,0.29930076695007,0.868817764967932,4448,8,PLXNB1|XYLT1|RYR1
DETECTION OF DIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0042496,0.447759197324415,0.768229288546963,-0.7776797529775029,-1.0360561628868,3346,1,TLR2
REGULATION OF VIRAL GENOME REPLICATION%GOBP%GO:0045069,0.0057039149598133295,0.0869820770252933,-0.300244472682859,-1.7290743081413302,43,68,LARP1|CCNK|TOP2A|PPIB|FMR1|PLSCR1|DDX3X|PDE12|IFIT1|APOBEC3G|ISG15|NUCKS1|RSAD2|APOBEC3C|IFI16|TNIP1|BST2|ADARB1|DDB1|IFITM1|BTBD17|IFITM2|IFITM3|BANF1|APOBEC3F
MAST CELL SECRETORY GRANULE ORGANIZATION%GOBP%GO:0033364,0.0366144866012205,0.27230608441566395,-0.8780259167355942,-1.46117553234881,275,2,SRGN|LYST
POSITIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR%GOBP%GO:2000781,0.361774744027304,0.716154857259883,0.24584286109732104,1.07111674373744,2649,25,MGMT|SPIDR|RIF1|MMS19|SPIRE2|ACTR2|WRAP53|MAD2L2|FAM178A|FAM35A|C20orf196
REGULATION OF DENDRITIC SPINE DEVELOPMENT%GOBP%GO:0060998,0.0778783958602846,0.390713151724379,-0.29554660522979803,-1.4231396127462899,601,36,FMR1|DHX36|EFNA1|MEF2C|ARHGAP44|DBN1|NGEF|CAMK2B|APOE|EPHA4|CFL1|CAPRIN1|ARF6
RESPONSE TO VITAMIN B6%GOBP%GO:0034516,0.34287625418060197,0.701955655133333,-0.8256506396118221,-1.0999649023728701,2562,1,KYNU
CELLULAR BIOGENIC AMINE METABOLIC PROCESS%GOBP%GO:0006576,0.137530960761309,0.50219949963275,-0.279282519868141,-1.31158955382941,1054,33,KMO|MAOA|CCBL1|SAT1|MOXD1|GDE1|ODC1|SMOX|KYNU|GDPD1|HAAO|SLC44A1|SMS|AFMID|SAT2|HNMT
REGULATION OF ATP METABOLIC PROCESS%GOBP%GO:1903578,0.00282232200128287,0.0524584451888279,-0.357049509692225,-1.90655108696823,21,51,PID1|PPIF|PARP1|OGT|CBFA2T3|PFKFB2|ATPIF1|PFKFB3|INS|VCP|PDE12|PARK7|ENO1|JMJD8|UQCC2|IGF1|PGAM1|CCNB1|COX7A1|PPARA|ABCD1|SHMT2|TMSB4X
LUNG LOBE MORPHOGENESIS%GOBP%GO:0060463,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
EXTRACELLULAR EXOSOME ASSEMBLY%GOBP%GO:0071971,0.42715719063545204,0.755533439554473,-0.78743934715483,-1.04905828574776,3192,1,CD34
GOLGI RIBBON FORMATION%GOBP%GO:0090161,0.507480957562568,0.7987565605553191,0.28004841959058197,0.951830108226442,3730,12,GCC2|MYO18A|STX16|STX6|FHDC1|TMED5|OPTN
ACTIVATION OF JUN KINASE ACTIVITY%GOBP%GO:0007257,0.6376679274814139,0.864977246543067,-0.196906321344245,-0.8684530752596059,4888,27,RIPK2|MAP4K2|MUL1|CCL19|DAB2IP|PKN1|MDFIC|MLKL|MAP3K13|MAP3K11|DBNL|ERN1
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS%GOBP%GO:0044089,0.5142237530297229,0.8027202916321279,-0.120194191764578,-0.976617095079438,4030,369,UTP15|TPPP|GPM6A|PYCARD|NCKAP1L|DYNC1H1|CTTN|GNB2L1|FNIP1|WASF2|ARHGEF5|CCL19|CLIP1|EPHB3|TSG101|CDT1|AGT|BCL2L11|PPM1F|HGS|KDR|ANKRD32|PARP1|RAB7A|CCL24|ARPC1A|PAXIP1|WAS|FES|IQGAP2|PLEK|SRPX2|MMP1|TGFB3|THY1|CLSTN2|VCP|PIEZO1|SEPT7|CDK5RAP2|FMR1|DHX36|WARS|TENM2|LMOD1|SLX1B|PHLDB2|JCHAIN|TAL1|SLX1A|CD47|SDC4|BCAS3|S100A10|CTGF|PXN|GTF2H1|MECP2|GHRL|ABL1|RAPGEF3|IL1RAP|RIOK1|TRMT112|HRAS|ARHGEF15|PSMC4|PSMC6|EPHA2|GSN|BAIAP2L1|MITF|HYAL1|HCK|CD36|CHGA|CDC42EP4|SNF8|TEK|ARPC5L|SRF|ARL2|NAV3|CX3CL1|CAV1|RASIP1|DDB1|TLR4|HSP90AA1|EVL|NF2|EPS8|SEPT9|CDC42EP1|COL16A1|CDC42EP5|DIMT1|SYNPO|NCK1|ARF6|PSMC5|CDC42EP2|PSMC3|XPA|SERPINF2|PTPRJ|EIF4G1|GTF2H2
"MATURATION OF LSU-RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000463",0.946797385620915,0.9836832812589692,-0.17254274164939298,-0.5775167117536121,7242,12,RPL35|BOP1
REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902991,0.091644908616188,0.41890957046475896,-0.337103623417975,-1.41535703983385,701,23,EFNA1|GGA3|APOE|EFNA3|EPHA4|FKBP1A|TMED10|PRNP
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CILIARY MEMBRANE%GOBP%GO:1903568,0.40895205206534707,0.7448505271608159,0.79736435818262,1.0631777809861,3078,1,LZTFL1
CHAPERONE-MEDIATED PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0051131,0.813319349764027,0.9356336309698571,-0.20478658406796102,-0.7245049877297459,6203,14,HSP90AA1|HSPA4
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION%GOBP%GO:1903555,0.000128799587841319,0.00518555396908895,-0.372290741175854,-2.16984375878664,0,71,LILRB1|CLEC4A|HLA-E|DHX9|TLR1|PYCARD|IRAK3|ADAM8|CCL19|TLR2|CD34|SPN|AZU1|GAS6|TNFAIP3|POMC|MAPKAPK2|PTPN6|CD47|IFIH1|GHRL|HSPB1|C10orf54|CD86|LGALS9|THBS1|FADD|FOXP1|CX3CL1|HAVCR2|TLR4|C1QTNF4|GSTP1|CD14|LY96|PTPRJ|SIRPA
CALCIUM ION TRANSPORT%GOBP%GO:0006816,0.576529306373176,0.836604755247265,-0.140298361658993,-0.937342038129749,4504,125,ITPR2|CCDC109B|ATP2A1|P2RX4|ERO1L|ITPR3|SLC8B1|PMPCA|GRIN3A|GAS6|ANXA6|CACNA1H|STIM1|ATP2A3|GRIN1|JPH4|CACNA2D4|CALCRL|CACNA1G|NALCN|SLC35G1|SLC24A3|CACNA1E|F2R|CCR1|TMCO1|GRIN2C|GRIN2D|FKBP1A|CAMK2A|SLC3A2|CAV1|STOML2|CACNA1I|PHB|ATP2B2
RESPONSE TO MISFOLDED PROTEIN%GOBP%GO:0051788,0.20639021074099304,0.586182178028053,0.294693276941903,1.23327737151698,1517,22,UGGT2|ANKZF1|SDF2|STUB1|DNAJB12|RNF185|UGGT1|ATXN3|RNF126|HDAC6|BAG6|UBE2W
NERVE GROWTH FACTOR PRODUCTION%GOBP%GO:0032902,0.3829928362960999,0.730480369014206,-0.647422111938241,-1.07741392484503,2886,2,FURIN|PCSK6
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING%GOBP%GO:2000679,0.961800997637175,0.990509689812155,-0.152855974679078,-0.554995266293234,7326,15,TGFB1|H1F0|GATA3|FAM129B|PARK7|IGF1
REGULATION OF MITOTIC CELL CYCLE DNA REPLICATION%GOBP%GO:1903463,0.49469355266649,0.793143688290573,-0.601115891333168,-1.00035296883676,3728,2,BCL6
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS%GOBP%GO:1903845,0.485984946794705,0.7872939093021379,-0.18794908527966397,-0.9788395182882729,3744,47,SMURF2|HTRA3|FBN1|LTBP1|LDLRAD4|SNX6|ADAMTSL2|TGFBR2|UBC|FAM89B|CAV1
NEURAL PLATE AXIS SPECIFICATION%GOBP%GO:0021997,0.982999070261655,0.993436724391485,0.507774591971769,0.6770489029182629,7400,1,PTCH1
NEGATIVE REGULATION OF NERVE GROWTH FACTOR PRODUCTION%GOBP%GO:0032904,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
POSITIVE REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT%GOBP%GO:1905602,0.171132926505704,0.544815916159356,-0.7513370426450521,-1.2503449867879801,1289,2,ANXA2
POSITIVE REGULATION OF PROTEIN HOMOOLIGOMERIZATION%GOBP%GO:0032464,0.11083811083811099,0.45638735792888,0.462658690330567,1.40597708890722,811,9,RHOC|MIEF2|HRK|BID
"WNT SIGNALING PATHWAY, CALCIUM MODULATING PATHWAY%GOBP%GO:0007223",0.9633747547416609,0.990916952887267,-0.125752471419893,-0.574161165084676,7364,30,PPP3R1|AGO2|PPP3CB|TNRC6B|AGO3|MOV10|GNAO1|FZD6|GNB1|AGO1|MAP3K7|LEF1|TCF7L2|FZD3|CTNNB1|WNT11|FZD5|PLCB2|NLK|AGO4|GNG2|PPP3CA|TNRC6A|PLCB1|FZD4|PLCB3|FZD2|TNRC6C|NFATC1|CAMK2A
TRICUSPID VALVE FORMATION%GOBP%GO:0003195,0.359941559304024,0.7155384949577859,0.821239523599471,1.0950120925252,2709,1,ZFPM1
ANTIFUNGAL HUMORAL RESPONSE%GOBP%GO:0019732,0.00968426638365614,0.12539147812585302,-0.9355941549489941,-1.5569782865893602,72,2,RARRES2|FAM3A
PATTERN SPECIFICATION INVOLVED IN PRONEPHROS DEVELOPMENT%GOBP%GO:0039017,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
RETROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT%GOBP%GO:1990049,0.257845401440022,0.636098664976652,0.5414402592426399,1.1895673082183302,1897,4,KIF5B|KIF5A|KIF1A
THYMUS DEVELOPMENT%GOBP%GO:0048538,0.00209205020920502,0.0408245456317246,-0.6408569322421739,-2.0077211109656,15,10,RIPK3|EPHB3|TBX1|HES1|FGF10|SOD1|FADD
NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003085,0.411726213846355,0.7460988978563841,-0.474950566479314,-1.0397660725295,3145,4,ADRB2|SOD2|PRCP
RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009185,0.0286757038581856,0.238792268557792,-0.344646761861851,-1.6031608755248001,219,32,GPI|PFKFB2|HK1|HK3|NUDT16|ENO1|PGAM1|GAPDH|NUDT18|LDHA|PGK1|ALDOA|ALDOC|BAD
MAINTENANCE OF GRANZYME B LOCATION IN T CELL SECRETORY GRANULE%GOBP%GO:0033382,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT%GOBP%GO:0043267,0.5443686006825941,0.8171943796142529,-0.255194399869041,-0.9265694992244621,4146,15,CAV1|KCNH2|KCNE4
REGULATION OF VESICLE DOCKING%GOBP%GO:0106020,0.0931066542701554,0.422068646506606,0.954620644022938,1.27285781911433,700,1,RALB
INNATE IMMUNE RESPONSE%GOBP%GO:0045087,0.000127762872109365,0.00518555396908895,-0.36123714298313697,-2.7842490511167206,0,265,IRF8|CCL3|OAS3|RIPK2|TIFA|SYK|IGHV2-26|HLA-DQB2|HLA-B|TRIM14|COLEC11|CCL4|MSRB1|SKP2|CCL8|MX1|IGHV1OR15-1|SERINC3|CD44|HLA-DPA1|XAF1|MICA|UBD|ALPK1|IGHV5-51|PML|HLA-E|CCL11|HLA-DRA|HLA-DRB5|FCGR1B|C17orf62|RPL39|TRIM38|FCN3|SP100|CEBPG|F12|IGHV1-24|HIST1H2BE|TRIM21|B2M|CORO1A|CCL19|MID1|IGHV3-49|IFIT3|TRIM56|COL20A1|OASL|OAS1|IFNGR1|IFNAR1|IGHG4|GZMB|CALCOCO2|HLA-DPB1|TRIM28|TLR2|APOL1|HLA-DQA2|FCGR1A|IGLL5|TRIM68|CCL24|HLA-C|IRF5|TRIM34|HLA-A|OAS2|CASP1|CCL3L3|KYNU|CCL18|C3|HIST1H2BC|DDX3X|IGHV4-4|PDE12|IFIT2|IGHV4-61|JCHAIN|CD47|ICAM1|IFIH1|IGHV1-3|IFIT1|FCER1G|APOBEC3G|TRIM32|SIGLEC14|ISG15|SLC11A1|CAMK2B|CYBB|IFI6|IGHV3-43|RSAD2|IRF7|IRAK1|FCN1|IGHV3-73|ANKHD1|VAMP7|TREM2|IFI30|VCAM1|CFB|SERINC5|TMEM173|CCL2|CXCL16|HFE|GAPDH|RNASE6|NCF2|HCK|COLEC12|CHGA|BST2|LGALS9|MT2A|IGHV3-15|AIF1|RARRES2|IFI35|IFNLR1|TYROBP|CX3CL1|CAMK2A|HIST1H2BG|PTAFR|PPARG|CCL4L2|CCL14|IFITM1|TLR4|CFP|IGHV1-18|CFD|SHMT2|IFITM2|TUBB4B|PPP1R14B|IFITM3|IGHG2|HIST2H2BE|IGHA1|SAMHD1|MID2|HIST1H2BK|LYST|HIST1H2BJ|APOBEC3F|SIRPA
L-CYSTINE TRANSPORT%GOBP%GO:0015811,0.10803547433485601,0.452482039948645,0.7039263262380061,1.38454001493844,803,3,CTNS|SLC1A4|SLC7A9
NEGATIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA POLY(A) TAIL SHORTENING%GOBP%GO:0060212,0.36227424749163895,0.716544107573036,-0.8170489633877371,-1.0885054042581301,2707,1,TOB1
"TRANS-SYNAPTIC SIGNALING BY NITRIC OXIDE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099555",0.680802675585284,0.884781692722898,-0.663707543008381,-0.88421781286645,5088,1,GUCY1B3
INTERMEMBRANE LIPID TRANSFER%GOBP%GO:0120009,0.9816166531495001,0.993436724391485,0.214977258303229,0.517019073429805,7261,5,PLEKHA3|PLEKHA8|CPTP
NEGATIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION%GOBP%GO:0033600,0.9590163934426229,0.9889996530704799,0.29055861060189697,0.571494498882008,7136,3,BRCA2
REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035020,0.623706614276359,0.857551285930326,-0.335466461583367,-0.8629101091961201,4761,6,OGT|ARHGAP44|ARF6
GOLGI REASSEMBLY%GOBP%GO:0090168,0.372232033691075,0.7234654586828599,0.48376689100187303,1.06285646202078,2739,4,STK25|YWHAZ|VCPIP1
PHYSIOLOGICAL MUSCLE HYPERTROPHY%GOBP%GO:0003298,0.646972132904609,0.8697778704754799,0.526550868486352,0.88467344479165,4828,2,PDLIM5|SORBS2
OTIC PLACODE FORMATION%GOBP%GO:0043049,0.506308938770089,0.798168488166378,0.7477393030436701,0.997009466008748,3811,1,PROX1
NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0032435,0.0281413612565445,0.23765889024458603,-0.36160986474654494,-1.61499009964005,214,28,UCHL5|OGT|BAG5|PARK7|UBXN1|HFE|GIPC1|TLK2|TAF9|AK6
"REGULATION OF TERMINATION OF RNA POLYMERASE II TRANSCRIPTION, POLY(A)-COUPLED%GOBP%GO:2000804",0.7298996655518399,0.906544799850309,-0.639225849139832,-0.85160231823218,5455,1,SETX
REGULATION OF NAD+ ADP-RIBOSYLTRANSFERASE ACTIVITY%GOBP%GO:1901664,0.253250198991775,0.632257972333528,-0.7057071960297769,-1.1744096252590701,1908,2,TGFB1|DTX3L
T CELL PROLIFERATION%GOBP%GO:0042098,0.30674686192468603,0.6781517528146751,-0.361476741834568,-1.13245944483296,2345,10,MSN|SLC11A1|TNFRSF4|CTPS1
ALDITOL PHOSPHATE METABOLIC PROCESS%GOBP%GO:0052646,0.569262295081967,0.832269842301315,0.30922411975266306,0.897623522102444,4166,8,GPAT2|GPD2
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:1901724,0.00833333333333333,0.113028938028938,-0.863518801359111,-1.6862333611138303,62,3,MYC|PDGFB
POSITIVE REGULATION OF FILOPODIUM ASSEMBLY%GOBP%GO:0051491,0.9550531190411329,0.9870204197558861,0.137573147841449,0.5840592048086299,7011,23,RHOQ|AGRN|NRP1|FNBP1L|CCR7|CCL21|DPYSL3|FAM65B|ARAP1|RALA|WASL|PALM|TENM1|MIEN1|NEURL1|FSCN1|CDC42|DOCK11|GPM6A|TGFB3|FMR1|TENM2|BCAS3
INTRACELLULAR MRNA LOCALIZATION%GOBP%GO:0008298,0.198255662587868,0.575514816497402,-0.438102194213346,-1.26123490016417,1522,8,EXOSC3|ZNF385A|EXOSC2
SKIN EPIDERMIS DEVELOPMENT%GOBP%GO:0098773,0.29519543973941403,0.668293026992989,0.345406684704894,1.13660008624296,2174,11,FGFR2|DLL1|HDAC1|ATP7A
UDP-N-ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006048,0.44812680115273795,0.768229288546963,-0.308066362611411,-0.997381423541061,3420,11,GNPNAT1|GFPT2|RENBP
NEGATIVE REGULATION OF PEPTIDYL-TYROSINE PHOSPHORYLATION%GOBP%GO:0050732,0.0293357456707159,0.24279324540366198,-0.327992493277758,-1.59336985267463,226,37,SH3BP5|ZFYVE28|PARP14|HYAL2|SOCS4|SAMSN1|TSG101|SOCS3|SFRP2|THY1|SOCS1|PTPN6|SNX6|VPS25|CD300A|PPP2CA|MVP|CHMP6|ERRFI1|CAV1|NF2
MULTICELLULAR ORGANISM REPRODUCTION%GOBP%GO:0032504,0.0186968047997768,0.188344151027435,0.19433254183817497,1.44228545823661,133,199,TDRD12|TLE6|NPHP1|SPAG6|TSGA10|DDX25|CYP27B1|TDRD6|LRGUK|BBS4|SPATA6|PPARD|CFAP44|PICK1|CFAP43|PSME4|IFT20|TSSK6|ZNF296|KIT|ROBO2|C14orf39|DZIP1|C9orf117|AZIN2|IQCG|PTPRN|BRCA2|IFT81|NME5|CHD5|SPIRE2|PDE3A|SLIT3|TOB2|WDR33|TDRP|SPESP1|PCSK4|CEP57|STOX2|HSPA2|MKKS|TRIM27|PARN|C1orf111|HERC4|NDRG3|DNAH1|XRN2|ELL3|MAST2|MCM9|SPATA2|RHOXF1|PRMT7|CATSPER2|IFT27|BBS2|TEX14|DPY19L2|METTL14
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0072331,0.9741555783009209,0.9920058127185359,-0.0989608535495364,-0.631528772231385,7613,101,PIDD1|PRMT1|GREM1|PML|RGCC|SP100|PYCARD|TRIAP1|TFDP2|BATF|NBN|PAXIP1|PLK2|PCNA|PPP1R13B|CDC25C|FOXM1|BRCA1|DDX5|SNW1|E2F1|IFI16|BCL3|CCNB1|PLAGL1|TMEM109|TNKS1BP1|DDIT4|HINT1|KAT5|RRP8|ZNF385A
REGULATION OF EPHRIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:1901187,0.95789613494488,0.988578419070365,0.521338773709749,0.6951349090120721,7211,1,RBPJ
DIADENOSINE TETRAPHOSPHATE METABOLIC PROCESS%GOBP%GO:0015965,0.9298222340143271,0.9793746057014829,-0.375572098152743,-0.625012029820246,7008,2,KARS|GARS
POSITIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1900409,0.41492965085982303,0.7490461307518279,-0.340385796772796,-1.0239637937558101,3184,9,PARK7|SOD1|TLR4
REGULATION OF CHROMATIN SILENCING AT RDNA%GOBP%GO:0061187,0.185577803952362,0.559093571852282,-0.588222580635719,-1.2877421896230299,1417,4,NAA40|PHF2|H2AFY
NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0045647,0.139794844818517,0.504314492208813,-0.5647101965490451,-1.3535025845043103,1062,5,HOXA5|ZFP36L1|HSPA9|MAFB
ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT%GOBP%GO:1903513,0.0329497907949791,0.259512489684881,-0.41728808395757305,-1.61923295935153,251,18,HSP90B1|HM13|VCP|SEL1L|FAF2|HERPUD1|NPLOC4|SYVN1|SEC61B
PROTEIN IMPORT INTO PEROXISOME MEMBRANE%GOBP%GO:0045046,0.9054445028932141,0.9704288384943391,-0.26633690266072,-0.638358733918931,6884,5,PEX16
EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS%GOBP%GO:0048557,0.276503325641374,0.651912680514098,0.449514141383216,1.16314426114005,2036,6,RBPMS2|FGFR2
EQUILIBRIOCEPTION%GOBP%GO:0050957,0.29113756613756603,0.6634827621858029,-0.593360538215507,-1.15868274452469,2200,3,PCDH15|CDH23|MYO7A
"RESPONSE TO 2,3,7,8-TETRACHLORODIBENZODIOXINE%GOBP%GO:1904612",0.10108782170337,0.43836486389879703,-0.8012131237937691,-1.33334676160449,761,2,AHR|PDE2A
POSITIVE REGULATION OF LIPID STORAGE%GOBP%GO:0010884,0.0190089145254326,0.190317961363288,-0.488225418800368,-1.7272701366996002,144,14,OSBPL11|SREBF2|MSR1|C3|IKBKE|EHD1|FITM2|NFKB1
PEPTIDYL-GLUTAMIC ACID MODIFICATION%GOBP%GO:0018200,0.06587312322467201,0.369007394574627,0.37326266698391497,1.4881549164219299,486,19,TTLL4|CFAP20|TTLL1|TTLL7|AGBL5|GGCX|TTLL3
REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0010919,0.7032071503680339,0.8936321069095309,-0.291472654787313,-0.796727503823624,5349,7,PLEK|P2RY6|GPER1
LEUKOCYTE HOMEOSTASIS%GOBP%GO:0001776,0.0128676470588235,0.149991146428462,-0.43830292097890505,-1.75846292396141,97,20,AKT1|FOXP3|JAK3|DOCK11|DOCK10|LYN|GPR183|NCKAP1L|RIPK3|PDE4B|TNFAIP3|MEF2C|FADD|ANXA1
REGULATION OF ACTIN FILAMENT-BASED PROCESS%GOBP%GO:0032970,0.0223642172523962,0.2071441845173,-0.18315715430159804,-1.4030041339317,174,256,HCLS1|PLN|CCL24|ARPC1A|ARHGAP18|WAS|FES|ARHGDIB|IQGAP2|PLEK|TGFB3|PDE4B|MYLK2|TAOK2|RHOF|PDE4D|LMOD1|PHPT1|PDXP|PHLDB2|SLC9A1|PTGER4|ARHGAP44|CD47|HAX1|PKP2|BCAS3|S100A10|CTGF|PXN|BST1|RHOD|ABL1|RAPGEF3|PPFIA1|FLNA|HRAS|ARF1|ARHGEF15|GPM6B|KANK3|PDPN|RND1|GSN|BAIAP2L1|CORO1B|DLC1|HCK|BST2|CDC42EP4|TEK|CFL2|SEMA5A|ARPC5L|PDGFRB|SEMA3E|SLIT2|CX3CL1|CAV1|FAM107A|MYH9|PDGFA|CSF1R|EVL|NF2|PDGFRA|EPS8|CDC42EP1|CDC42EP5|SYNPO|TMSB4X|NCK1|ARHGDIA|ARF6|EFNA5|CDC42EP2|SERPINF2
MESANGIAL CELL-MATRIX ADHESION%GOBP%GO:0035759,0.886972671796232,0.965013712426871,-0.40930906536196393,-0.681155738203072,6685,2,CD34
"ENDONUCLEOLYTIC CLEAVAGE TO GENERATE MATURE 3'-END OF SSU-RRNA FROM (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000461",0.6387995712754561,0.865463150027443,0.530135097877033,0.890695412946583,4767,2,RPS21|RPSA
GENETIC IMPRINTING%GOBP%GO:0071514,0.0595140595140595,0.35364633642351595,0.507313287367111,1.5416782908081499,435,9,KDM1B|PRMT7|DNMT3A|PCGF3|IGF2|RTFDC1
RETINAL ROD CELL DEVELOPMENT%GOBP%GO:0046548,0.6482128460091371,0.8702993441108309,0.4316190996839221,0.848943834673458,4823,3,BBS4
RESPONSE TO TRIACYL BACTERIAL LIPOPEPTIDE%GOBP%GO:0071725,0.0747354497354497,0.383186929742657,-0.734972978934598,-1.43521594972352,564,3,TLR1|TLR2|CD14
GUANOSINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:1901069,0.20582010582010601,0.585932546425919,-0.638848481905855,-1.24750916968001,1555,3,HPRT1|NUDT18
POSITIVE REGULATION OF NEUTROPHIL ACTIVATION%GOBP%GO:1902565,0.14778455823826,0.514965886850433,-0.7655913978494621,-1.2740665132909,1113,2,ITGB2|ITGAM
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE%GOBP%GO:1902284,0.302395209580838,0.675222663526765,-0.395313018099176,-1.13805085092341,2322,8,NRP2|SLIT2|SEMA3A
NEGATIVE REGULATION OF CALCIUM ION BINDING%GOBP%GO:1901877,0.425551839464883,0.7547028278218628,-0.788156153506837,-1.05001324392399,3180,1,PLN
REGULATION OF BINDING%GOBP%GO:0051098,0.0029381706693919303,0.0541257446671854,-0.20950185704059301,-1.58926738799122,22,241,DHX9|SP100|CEBPG|H1F0|ZNF593|B2M|PER2|DTX3L|HMGB2|KDM1A|CDT1|TERT|CAMK1|PARP9|DAB2IP|EIF3C|LRP1|NSD1|PLN|TMBIM6|SMO|NGF|GATA3|GMNN|HES1|TRAF2|VTN|FMR1|SYAP1|IFIT2|MEF2C|FAM129B|NCBP1|PARK7|IFIT1|NUCKS1|CARD16|ABL1|IGF1|NMD3|MEN1|E2F1|RAN|IFI16|HDAC5|TMEM173|CTSZ|SUMO3|STK3|BCL3|MDFI|HFE|APOE|PLK1|PLAUR|NFKBIA|PPP2CA|LGALS3|CD36|BMP2|HDAC8|EPHA4|ID1|FKBP1A|MMP9|CAV1|PPARG|CLIC2|DACT1|PRKACA|ID4|DAB2|ANXA2|TIAM1|ACTB|HSPA5|MARK2|TMSB4X|CSNK1A1|STPG1|PPP1CA|CDCA5|EDF1|PDGFB|NME1|EIF4G1
METAPHASE/ANAPHASE TRANSITION OF CELL CYCLE%GOBP%GO:0044784,0.6357806569820699,0.8636797415465791,-0.38984915343265397,-0.8534612899788541,4857,4,TACC3|CDC23|CDC27
POSITIVE REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY%GOBP%GO:0070960,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
"POSITIVE REGULATION OF GLUTAMATE SECRETION, NEUROTRANSMISSION%GOBP%GO:1903296",0.22473103997874902,0.6078034241178771,0.8889501543890609,1.1852950822943,1691,1,RAB3GAP1
ACTIN-MYOSIN FILAMENT SLIDING%GOBP%GO:0033275,0.9707436001625359,0.9915747942934481,0.131229878255228,0.540949379504641,7166,21,DMD|NEB|TPM1|TPM2|TMOD1|MYL6B
REGULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY%GOBP%GO:0001813,0.23879013000795998,0.622138010410922,-0.7134822167080229,-1.18734850298696,1799,2,HLA-E|FCGR2B
NEGATIVE REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903765,0.31865216237728805,0.6867397844771489,-0.675302519088455,-1.1238113807553,2401,2,KCNH2
POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS%GOBP%GO:1900078,0.64369769874477,0.8688307429995409,-0.270609107095604,-0.847783007097258,4922,10,PTPN11|SORBS1|FAM132A|INS|IRS1|GKAP1
CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS%GOBP%GO:1901136,0.0907692307692308,0.416406989132751,-0.192421574986889,-1.29772305631805,707,131,NAGLU|ADA|ARSB|NUDT1|DCN|GLA|PDE4D|SLC9A1|NUDT16|SDC4|NEU4|APOBEC3G|BGN|PDE2A|TYMP|VCAN|APOBEC3C|NPL|OGN|HPRT1|ABHD10|CDA|LUM|SDC2|FMOD|FUCA1|HYAL1|NUDT18|NUDT4|LYVE1|ENPP4|ABCD1|HINT1|HEXB|PNP|SAMHD1|RENBP
DISTAL TUBULE DEVELOPMENT%GOBP%GO:0072017,0.027845363611787004,0.23617479560495197,0.6937259003984121,1.66840681227935,205,5,PAX8|PKD1|TFAP2B|PKD2
NON-CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0035567,0.912022703818369,0.9727576478351271,-0.120721589939679,-0.690356629279759,7069,66,FZD4|PLCB3|SFRP4|SFRP2|FZD2|FZD8|CELSR1|SMURF2|CLTC|VANGL1|TNRC6C|NFATC1|CAMK2A|TIAM1|PRICKLE2|AP2M1
BETA-CATENIN DESTRUCTION COMPLEX ASSEMBLY%GOBP%GO:1904885,0.309310889005786,0.680809181688249,-0.47403538057807604,-1.1361723529693502,2351,5,GSK3B|AMER1|APC|CSNK1A1
REGULATION OF INTERLEUKIN-1 BETA BIOSYNTHETIC PROCESS%GOBP%GO:0050722,0.49615282568320507,0.794012168719884,-0.600683384655072,-0.9996332085613949,3739,2,AZU1
SPECIFICATION OF URETERIC BUD ANTERIOR/POSTERIOR SYMMETRY BY BMP SIGNALING PATHWAY%GOBP%GO:0072101,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
REGULATION OF GERM CELL PROLIFERATION%GOBP%GO:1905936,0.34954448017149004,0.70736446849153,0.659994485800937,1.10887595148301,2608,2,RHBDD1|CIB1
NCRNA 3'-END PROCESSING%GOBP%GO:0043628,0.9783975936560021,0.992937328049893,0.11377406331434199,0.551464503997246,7155,35,SSB|USB1|CPSF3|ELAC2|PARN|EXOSC8|INTS6
PROTEIN DEALKYLATION%GOBP%GO:0008214,0.41357702349869496,0.748061280707938,-0.24543526775385296,-1.03047997679991,3167,23,KDM4B|HR|KDM1A|PHF2|KDM3B|KDM8|KDM2A|C14orf169|JMJD6|KDM5C
PEPTIDYL-SERINE ADP-RIBOSYLATION%GOBP%GO:0018312,0.461640211640212,0.775450927278973,-0.520269850439406,-1.01595515605663,3489,3,PARP1|PARP2
REGULATION OF STEROL TRANSPORT%GOBP%GO:0032371,0.0260858223555498,0.227301678500391,-0.371025455760765,-1.63640352354005,199,27,APOC2|ABCA2|PLTP|SREBF2|TSPO|LRP1|APOC1|CETP|NR1H3|APOE|NFKBIA|PPARG|NFKB1|ANXA2
MORPHOGENESIS OF A POLARIZED EPITHELIUM%GOBP%GO:0001738,0.253149126371394,0.632257972333528,0.28462642611030503,1.1732731192171102,1868,21,AHI1|PTK7|RAB10|CAMSAP3|MYO9A|BRSK1|TRAF3IP1|EZR
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000820,0.638665594855306,0.865463150027443,0.530245381858285,0.890880704274427,4766,2,HEY2|HEY1
ATRIAL SEPTUM MORPHOGENESIS%GOBP%GO:0060413,0.6741741741741739,0.882488012133495,0.271361789104704,0.8246434493935201,4938,9,ACVR1|ZFPM1|BMPR2|HEY2|SOX4
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003071,0.0447175732217573,0.302272542908377,-0.50962429498646,-1.59658638961032,341,10,AGT|PCSK5|GAS6|F2R|PDGFB|SERPINF2|EMP2
NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060766,0.5307399347116429,0.8115959426370749,0.275222294525545,0.9354270478210859,3901,12,SFRP1|HDAC1|NCOR1
FRUCTOSE CATABOLIC PROCESS TO HYDROXYACETONE PHOSPHATE AND GLYCERALDEHYDE-3-PHOSPHATE%GOBP%GO:0061624,0.3969569351990221,0.7377402989373809,0.472480599218057,1.0380599983152201,2921,4,KHK
PTERIDINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0042560,0.48780814576634496,0.788226301622024,0.597009740918925,1.00305344779164,3640,2,PM20D2|MTHFS
POSITIVE REGULATION OF ERK5 CASCADE%GOBP%GO:0070378,0.938060200668896,0.9806508984207809,-0.5308226731363039,-0.7071832586579141,7011,1,FAM150B
POSITIVE REGULATION OF T-HELPER 2 CELL CYTOKINE PRODUCTION%GOBP%GO:2000553,0.45896896370331397,0.7735063645065241,-0.41132505915072903,-0.9858676787387359,3489,5,RSAD2|NLRP3
HYPOXANTHINE METABOLIC PROCESS%GOBP%GO:0046100,0.0194444444444444,0.192337052905818,-0.8213300981581558,-1.60384951644524,146,3,ADA|HPRT1|PRPS1
MICROTUBULE PLUS-END DIRECTED MITOTIC CHROMOSOME MIGRATION%GOBP%GO:0099606,0.779397993311037,0.924704689181848,-0.6151852668725191,-0.819574490167898,5825,1,CENPE
GLYOXYLATE METABOLIC PROCESS%GOBP%GO:0046487,0.8150765606596001,0.9365491515356709,-0.328783049752597,-0.719774823914057,6227,4,ALDH4A1
PROTEIN TRANSMEMBRANE TRANSPORT%GOBP%GO:0071806,0.134999355919103,0.497031952671308,-0.24474473448219103,-1.29907860956852,1047,50,TIMM21|SRP19|ROMO1|PEX16|SEC61A1|SEC61B|TIMM9|TIMM17B|SRP9|TIMM10|DNAJC19|DNAJC15
REGULATION OF MIRNA METABOLIC PROCESS%GOBP%GO:2000628,0.18341577714136897,0.556308895147568,-0.446151796457053,-1.28440857839792,1408,8,PAPD4|RC3H2|HRAS|RELA|NFKB1
MEDULLA OBLONGATA DEVELOPMENT%GOBP%GO:0021550,0.9689632107023409,0.9912626134248801,-0.514832377591531,-0.6858803454958909,7242,1,PHOX2B
AXON TARGET RECOGNITION%GOBP%GO:0007412,0.938996655518395,0.980854185905783,-0.5303264225849139,-0.706522133766679,7018,1,STXBP1
REGULATION OF SKELETAL MUSCLE ADAPTATION%GOBP%GO:0014733,0.840374949055835,0.947151866837735,0.32232995905108003,0.7081726473071271,6185,4,CAMK2G|GTF2IRD2B|GTF2IRD2
ONE-CARBON COMPOUND TRANSPORT%GOBP%GO:0019755,0.28124160171996804,0.6545309395846519,0.5975107797338659,1.17523319282548,2092,3,AQP5|AQP11
VENTRICULAR SYSTEM DEVELOPMENT%GOBP%GO:0021591,0.18380630044259302,0.556308895147568,-0.44580506371007794,-1.28341038334825,1411,8,RAPGEF2|NUMBL|KDM2B|CENPF|AQP1|CDK6|NUMB|C12orf57
POSITIVE REGULATION OF RESPONSE TO DRUG%GOBP%GO:2001025,0.0209466811751904,0.199767280220222,0.49949295128585397,1.69767938907072,153,12,DRD2|RAB3B|DRD4|CHRNB2|RIPK1|GAL|UCN|CRH|KMT2A|HDAC6
REGULATION OF FAST-TWITCH SKELETAL MUSCLE FIBER CONTRACTION%GOBP%GO:0031446,0.44949832775919707,0.768229288546963,-0.7766872518747242,-1.03473391310433,3359,1,ATP2A1
SELENOCYSTEINE INCORPORATION%GOBP%GO:0001514,0.41618026333650104,0.7493091022753771,0.394382180013969,1.0204870707017,3065,6,TRNAU1AP|SEPSECS|SECISBP2L
REGULATION OF ADENYLATE CYCLASE-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0106070,0.36185455528521204,0.7162129985904979,0.44496985905968894,1.07014995935398,2676,5,ATP2B4|PRKCA|MRAP2|GSK3A
CDP PHOSPHORYLATION%GOBP%GO:0061508,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
RESPONSE TO CGMP%GOBP%GO:0070305,0.32631435946203,0.6940781026265961,0.504288844680965,1.1079440682353001,2401,4,HCN2|PDE3A
POSITIVE REGULATION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0043568,0.43044104174846204,0.7591623101593491,-0.465890917112447,-1.01993260625846,3288,4,PHIP|CDH3|KIAA1161|IGF1
NEGATIVE REGULATION OF HISTONE H3-K9 DIMETHYLATION%GOBP%GO:1900110,0.20779742765273299,0.5877597266194561,0.7317342156051829,1.2294079602456,1550,2,PIH1D1|SMARCB1
POSITIVE REGULATION OF CELL MATURATION%GOBP%GO:1903431,0.500265322366676,0.7951717058944731,-0.599199093278319,-0.9971631103544409,3770,2,MAP3K13
REGULATION OF METANEPHRIC CAP MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0090095,0.102207357859532,0.441073279931729,-0.946570357300397,-1.26105900087051,763,1,MYC
REGULATION OF PROTEIN KINASE D SIGNALING%GOBP%GO:1903570,0.971709390357285,0.9915747942934481,0.513178209086899,0.684253897215797,7315,1,VEGFA
MODULATION OF PROGRAMMED CELL DEATH IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052248,0.9070802251014259,0.9709695261809209,-0.29216290141823,-0.6396056642237711,6930,4,GAPDH
PROTEIN DESTABILIZATION%GOBP%GO:0031648,0.843231954052996,0.9481593344082329,-0.15901347039839403,-0.718982619296198,6459,29,MUL1|FBXW11|TRIM21|SOX17|SENP2|GGA3|CTSH|GSN|PLK1|PRNP
AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS%GOBP%GO:0030647,0.10899959277860699,0.45309795582492896,0.5478899892204321,1.4176975494849802,802,6,CBR4|AKR1C2|AKR7A2|AKR1C1|AKR1C3|AKR1B1
REGULATION OF RESPONSE TO WOUNDING%GOBP%GO:1903034,0.000127697612054655,0.00518555396908895,-0.39662764436889203,-2.45064955902581,0,89,GP1BA|PLAU|PLEK|CASK|RREB1|FOXC2|VTN|TNFAIP3|MYLK|SMOC2|PHLDB2|FCER1G|F3|HRAS|FAP|HBEGF|CEACAM1|THBD|PDPN|SCARF1|F2R|APOE|INSL3|PLAUR|NOS3|SERPINE2|THBS1|EPHA4|SERPINE1|CAV1|PLAT|ENPP4|RTN4RL1|TNFRSF12A|TLR4|PDGFA|ANXA2|PDGFRA|ANXA1|TFPI|PDGFB|SERPINF2|C1QTNF1
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048641,0.81577914431506,0.9368364474725541,-0.19137689236581698,-0.7272789245022909,6234,17,ARNTL|TGFB1|TBX1|NR1D2|MEF2C|FAM129B|DDX5|UQCC2
CELLULAR COMPONENT MACROMOLECULE BIOSYNTHETIC PROCESS%GOBP%GO:0070589,0.528561872909699,0.8105400040230321,-0.73869651521835,-0.984121129764213,3950,1,MPI
REGULATION OF MEIOTIC CELL CYCLE%GOBP%GO:0051445,0.0995011814124442,0.435475440108744,-0.387091289079531,-1.4054657236233703,757,15,FBXO5|YTHDF2|CDC25B|SIRT2|CDC25A|C17orf104|TRIP13|DUSP1|YTHDC2|PLCB1|RAD1|CDC25C
ATP HYDROLYSIS COUPLED PROTON TRANSPORT%GOBP%GO:0015991,0.24801587301587302,0.62852193925262,-0.6148671004742471,-1.20067960980021,1874,3,ATP6V1H|ATP1A1|ATP1A3
ENDOTHELIAL CELL-MATRIX ADHESION%GOBP%GO:0090673,0.842541806020067,0.9481593344082329,-0.582432730480812,-0.775940247346375,6297,1,ADAMTS9
ISOLEUCYL-TRNA AMINOACYLATION%GOBP%GO:0006428,0.909699892818864,0.971970317740207,0.3821574388330421,0.642073839583732,6789,2,IARS2|IARS
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS%GOBP%GO:2000379,0.0810322580645161,0.397722753303477,-0.255372939193991,-1.39301636749787,627,55,CLU|ASS1|ZC3H12A|KLF2|PTGS2|HBB|MAPK14|IL1B|AKT1|MAPT|TNF|TGFB1|DUOXA1|AGT|ITGB2|PID1|KLF4|P2RX4|GRIN1|GRB2|PARK7|SOD1|ROMO1|CD36|TGFBR2|THBS1|PDGFRB|TLR4|ITGAM|HSP90AA1|GSTP1|PDGFB|ADGRB1
KIDNEY EPITHELIUM DEVELOPMENT%GOBP%GO:0072073,0.18041804180418,0.554078048020677,0.255044317031683,1.2441178935577,1311,36,FOXC1|FGFR2|CITED1|PAX8|AHI1|FGF2|PTPRO|ROBO2|BMP7|PKD1|TFAP2B|PKD2
MITOCHONDRION-DERIVED VESICLE MEDIATED TRANSPORT%GOBP%GO:0099075,0.149556570814297,0.51590227091171,0.670414436169224,1.3186260818363502,1112,3,PARK2|VPS35
POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT%GOBP%GO:1901552,0.8081914030819141,0.934193159096917,0.302213965213326,0.726822853288728,5978,5,PROC|ADD1|S1PR2
REGULATION OF MACROPHAGE FUSION%GOBP%GO:0034239,0.572976588628763,0.8348640932853191,-0.717633436259374,-0.9560600510473409,4282,1,ADAM9
REGULATION OF LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER%GOBP%GO:1903000,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
PURINE RIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046130,0.154907576152044,0.523022297381039,-0.46202822230116597,-1.33011458633157,1189,8,ADA|HPRT1|NUDT18|ENPP4|PNP
CELL MIGRATION INVOLVED IN VASCULOGENESIS%GOBP%GO:0035441,0.12949832775919698,0.487857553689733,-0.934384649316277,-1.2448247118746298,967,1,PDGFRB
POSITIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY%GOBP%GO:0001912,0.801701570680628,0.9325377000668108,-0.16881848662365898,-0.7539622424972281,6124,28,F2RL1|IL12RB1|RASGRP1|HLA-F|MICB|CD1D|HLA-B|PVR|MICA|NCR3|HLA-E|HLA-C|HLA-A|PVRL2|STX7|HFE|FADD
LYMPHOID LINEAGE CELL MIGRATION%GOBP%GO:0097534,0.8109698996655519,0.935269673284207,-0.597871636524041,-0.796508577295914,6061,1,BCL11B
GDP-MANNOSE METABOLIC PROCESS%GOBP%GO:0019673,0.87606895615583,0.9607117102951591,0.256849469054457,0.664613097572985,6453,6,PMM1|GMDS|PMM2
POSITIVE REGULATION OF SODIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903278,0.0120403088600968,0.14428332491466297,-0.772403904483538,-1.69095360833996,91,4,ATP1B1|ATP1B3|FXYD1|ATP1B2
NEGATIVE REGULATION OF ANDROGEN RECEPTOR ACTIVITY%GOBP%GO:2000824,0.7056856187290971,0.894639008000397,-0.6500882223202471,-0.8660736075181059,5274,1,HEYL
RESPONSE TO WATER%GOBP%GO:0009415,0.112004287245445,0.459194647507502,0.799944858009374,1.3440106465171697,835,2,PKD2|ATP2B4
NEGATIVE REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL%GOBP%GO:2001189,0.102513227513228,0.44119583182083205,-0.7100474247270321,-1.38654265971189,774,3,LILRB1|LGALS3|HAVCR2
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0017015,0.182367304973654,0.5559553601324849,-0.205395793769501,-1.2146541451121,1418,75,SMURF2|HTRA3|FBN1|CDKN2B|LTBP1|SNW1|MEN1|LDLRAD4|SNX6|GIPC1|ADAMTSL2|TGFBR2|THBS1|UBC|FAM89B|CAV1|DAB2|ENG
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009130,0.7901452422967289,0.928247620398227,0.285396842967298,0.738481105451812,5820,6,DCTD|CDADC1|DUT
CYTOCHROME COMPLEX ASSEMBLY%GOBP%GO:0017004,0.301525224872898,0.6746525886974419,-0.238993211352182,-1.1223795875003701,2312,33,SURF1|UQCR10|SCO2|PET117|HCCS|COA6|COA3|TIMM21|MT-CO3|UQCC2|COX16|COX17|UQCC3
COMPLEMENT COMPONENT C5A SIGNALING PATHWAY%GOBP%GO:0038178,0.0202006688963211,0.19546415839676298,-0.9903506837229821,-1.31938490794171,150,1,C5AR1
REGULATION OF BMP SIGNALING PATHWAY%GOBP%GO:0030510,0.0466744457409568,0.30943774856524703,-0.30356236225237,-1.5202722538304299,359,41,GREM1|RNF165|UBE2O|SKIL|LEMD3|SFRP4|SMAD6|NOTCH1|SMURF2|HTRA3|CHRD|FBN1|SULF1|PCSK6|NBL1|XIAP|ENG|ACVRL1
SUCCINATE METABOLIC PROCESS%GOBP%GO:0006105,0.312001046983379,0.68160868787154,-0.5221687103235071,-1.1431364597698999,2383,4,ALDH5A1|SDHAF3|SDHA
METAPHASE PLATE CONGRESSION%GOBP%GO:0051310,0.28338678640153997,0.6560202082186041,-0.210957185392952,-1.1264562482143898,2208,51,CENPQ|MAD1L1|CENPE|KIF2C|CDCA8|BECN1|VPS4A|CHMP5|PINX1|NUF2|SPDL1|CDT1|CDC23|GEM|BOD1|KPNB1|NDC80|KIF18A|SPICE1|KIFC1|CCNB1|CHMP4A|CHMP6|KIF22|CDCA5
REGULATION OF CELL DEVELOPMENT%GOBP%GO:0060284,0.16559058108621302,0.5375245857985801,-0.136141230150196,-1.13930257317958,1307,451,BRINP3|INS|THY1|RREB1|HES1|ARSB|CDK5RAP2|RAB29|GOLGA4|FMR1|DHX36|DOCK5|CPNE6|CXCR4|EFNA1|NOTCH1|MEF2C|ARHGAP44|FAM129B|SMARCD3|PRKD1|DSCAM|DAAM2|ZFHX3|S100A10|TRIM32|DBN1|FBN1|NGEF|SNW1|NOTCH2|CPNE5|CAMK2B|ABL1|CALR|NTN1|FLNA|IGF1|NTRK2|SEMA3B|SEMA3D|NSMF|MAP3K13|STX1B|SEMA7A|GPRC5B|CDH5|DOCK1|CSF1|PDPN|GPER1|SDC2|SCARF1|EDNRB|APOE|RAP1A|SLC45A3|SERPINE2|TNFRSF21|BMP2|ADRA2C|SEMA5A|NBL1|SEMA3E|EPHA4|COL3A1|NEDD9|SLIT2|ID1|ZSWIM6|CX3CL1|CAMK2A|ADGRA2|SCN1B|LDLR|FKBP4|SEMA3A|ATP6AP1|SEMA6B|PLAA|CFL1|RTN4RL1|YAP1|KIAA2022|ID4|WNT3|ADGRG1|MYLIP|S100A9|TIAM1|STYXL1|MARK2|ENG|TNFRSF1A|CAPRIN1|DTX1|ARHGDIA|ARF6|NGFR|FBLN1|EFNA5|SERPINF1|BAD
TERMINATION OF MITOCHONDRIAL TRANSCRIPTION%GOBP%GO:0006393,0.586950696677385,0.84145520149534,0.5548938516680451,0.932293316047583,4380,2,MTERF2|MTERF1
REGULATION OF ENDOCYTIC RECYCLING%GOBP%GO:2001135,0.180599369085174,0.554384828808074,-0.47259264801645295,-1.29181092838468,1373,7,EHD1|ARHGAP1|EHD2
GDP CATABOLIC PROCESS%GOBP%GO:0046712,0.154247491638796,0.5225398777782271,-0.9210961623290691,-1.22712125645377,1152,1,NUDT18
TRACHEA CARTILAGE MORPHOGENESIS%GOBP%GO:0060535,0.442024173196972,0.7653693162885199,0.780381561535068,1.04053351319385,3327,1,LRP6
REGULATION OF PHAGOSOME MATURATION%GOBP%GO:1905162,0.665427015539912,0.8804055751124069,0.6653617115130129,0.8871700631463431,5009,1,SYT11
POSITIVE REGULATION OF HEART GROWTH%GOBP%GO:0060421,0.249671829876608,0.630296201866725,-0.325669890365776,-1.18245458122731,1901,15,BASP1|TBX2|NOTCH1|MEF2C|PIM1|IGF1|TGFBR3
NEGATIVE REGULATION OF GLUCOKINASE ACTIVITY%GOBP%GO:0033132,0.16827438370846695,0.54080963877274,0.757311964852146,1.27238188145738,1255,2,PARK2|MIDN
REGULATION OF TELOMERASE CATALYTIC CORE COMPLEX ASSEMBLY%GOBP%GO:1904882,0.172159699892819,0.5459855974578649,0.7550041356492969,1.2685044304207,1284,2,ATM|ATR
POSITIVE REGULATION OF CYTOKINE ACTIVITY%GOBP%GO:0060301,0.45929074246247903,0.7735063645065241,0.77211071901191,1.02950546069763,3457,1,NRP1
NEGATIVE REGULATION OF PROTEIN PROCESSING%GOBP%GO:0010955,0.000130770236694128,0.00518555396908895,-0.6358516163809449,-2.6332269867511897,0,22,CARD16|CAST|CTSZ|TMEM59|GAS1|SERPINE2|A2M|THBS1|XIAP|SERPINE1|BCL2L12|CD55|SERPING1|SERPINF2|PRNP
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:0055012,0.96832875278105,0.9912626134248801,-0.252302432030001,-0.55234276439778,7398,4,PROX1|HEY2|MEF2A|MEF2C
"PENTOSE-PHOSPHATE SHUNT, OXIDATIVE BRANCH%GOBP%GO:0009051",0.6011824778285411,0.846830230102787,0.449197061181562,0.8835176106033841,4473,3,PGD|G6PD
REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:1905446,0.409521304576539,0.744874500284685,-0.430488194625796,-1.03179805780965,3113,5,PARK7|CCNB1
MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS%GOBP%GO:0048609,0.0177777777777778,0.181851623086954,0.19575261375517,1.45007554333003,127,196,TDRD12|TLE6|NPHP1|SPAG6|TSGA10|DDX25|CYP27B1|TDRD6|LRGUK|BBS4|SPATA6|PPARD|CFAP44|PICK1|CFAP43|PSME4|IFT20|TSSK6|ZNF296|KIT|ROBO2|C14orf39|DZIP1|C9orf117|AZIN2|IQCG|PTPRN|BRCA2|IFT81|NME5|CHD5|SPIRE2|PDE3A|SLIT3|TOB2|WDR33|TDRP|PCSK4|CEP57|STOX2|HSPA2|MKKS|TRIM27|PARN|C1orf111|HERC4|NDRG3|DNAH1|XRN2|ELL3|MAST2|MCM9|SPATA2|RHOXF1|PRMT7|CATSPER2|IFT27|BBS2|TEX14|DPY19L2|METTL14
POSITIVE REGULATION OF MIRNA METABOLIC PROCESS%GOBP%GO:2000630,0.124276696475539,0.478357784842846,-0.576314939853193,-1.38131693981552,944,5,HRAS|RELA|NFKB1
REGULATION OF COLLAGEN BINDING%GOBP%GO:0033341,0.469119404967459,0.780769690730001,0.766596823996471,1.02215342570014,3531,1,GTPBP4
CHROMOSOME PASSENGER COMPLEX LOCALIZATION TO KINETOCHORE%GOBP%GO:0072356,0.31586627752719604,0.685583406115178,-0.6767025089605739,-1.1261411877777199,2380,2,RCC2|GSG2
ENDOCYTIC RECYCLING%GOBP%GO:0032456,0.274738219895288,0.6490641454616071,-0.256796161034004,-1.14688037613733,2098,28,SNF8|VPS51|EHD4|DENND1A|EHD2|ARF6
B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002312,0.386927418296364,0.733589579210772,-0.257108635478838,-1.04746243221012,2947,21,MFNG|CD180|DOCK11|DOCK10|GPR183|BATF|EXO1|FCGR2B|RNF168|NOTCH2|EXOSC3
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION%GOBP%GO:2000738,0.251023751023751,0.631552488419609,0.39118045715226896,1.18876133071526,1838,9,FOXC1|RBM24|SOX6
NEGATIVE REGULATION OF DNA BINDING%GOBP%GO:0043392,0.0457956015523933,0.307301846559637,-0.31395485660466904,-1.51178049465593,353,36,DDIT3|SOX11|ZNF675|ID2|GZMA|ID3|PSEN1|SP100|ZNF593|PER2|KDM1A|SMO|E2F1|IFI16|SUMO3|MDFI|NFKBIA|ID1|ID4|TMSB4X
RRNA EXPORT FROM NUCLEUS%GOBP%GO:0006407,0.8154761904761909,0.9367483658511608,-0.37067130567138,-0.723827113719983,6164,3,NPM1
PRE-B CELL ALLELIC EXCLUSION%GOBP%GO:0002331,0.23973967326338197,0.623187683081912,0.881947507719453,1.1759579978475,1804,1,ATM
NADPH REGENERATION%GOBP%GO:0006740,0.16890620800859998,0.541811331682474,0.6587534418120129,1.29569028202359,1256,3,IDH1|G6PD|NNT
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION%GOBP%GO:0010634,0.000640614990390775,0.0163600882996276,-0.290947168135213,-1.9011920794935602,4,112,PPAP2B|TGFB1|STAT5A|IQSEC1|KIAA1462|ADAM9|MAP3K3|MAPRE2|PIK3C2A|AGT|PPM1F|KDR|P2RX4|EMC10|PDCD6|GPI|GATA3|SRPX2|BCAR1|RREB1|FOXC2|DOCK5|ATP5B|SMOC2|FLT4|PRKD1|BCAS3|FGF10|ABL1|CALR|HMOX1|HSPB1|SPARC|RHOJ|DOCK1|CTSH|MAP2K3|INSL3|SASH1|NOS3|HYAL1|NRP2|THBS1|TEK|ATOH8|FGF7|SEMA5A|FOXP1|MMP9|ANXA1|LGMN|TMSB4X|GLIPR2|ARF6|PDGFB
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN HEMOPOIESIS%GOBP%GO:0035603,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
CHROMATIN SILENCING%GOBP%GO:0006342,0.0378719567177638,0.277419110172932,-0.2886436190368,-1.5320891461566202,293,50,HDAC5|PPM1D|HIST2H3A|SIRT4|HIST2H4A|HIST2H3C|HIST1H3H|POLE3|HIST2H4B|RRP8|H3F3B|SUV39H1
DNA METHYLATION INVOLVED IN GAMETE GENERATION%GOBP%GO:0043046,0.14193989071038302,0.5078130330642999,0.46388127998820394,1.3465662016063202,1038,8,TDRD12|PICK1|PRMT7|PIWIL4|MOV10L1
ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0095500,0.48091004184100394,0.7857006060206241,-0.252072227061322,-0.978133989170739,3677,18,CHRM2|GNAQ|GNA15|ADRBK1|LY6H
NCRNA POLYADENYLATION%GOBP%GO:0043629,0.7220748209074029,0.9019989179378242,-0.5067548938516679,-0.8433211795695279,5442,2,PAPD5|PAPD7
VOCALIZATION BEHAVIOR%GOBP%GO:0071625,0.74163179916318,0.909955740610127,-0.246869310972582,-0.7734093248473829,5671,10,NLGN4X|SHANK2|AUTS2|NRXN1|SHANK1|CNTNAP2|NLGN4Y|NLGN3|NRXN3|NRXN2
PROTEIN DENUCLEOTIDYLATION%GOBP%GO:0044601,0.160936454849498,0.5311416159351421,-0.9178429642699599,-1.22278721550012,1202,1,FICD
OLEFIN METABOLIC PROCESS%GOBP%GO:1900673,0.7421066595914041,0.909955740610127,-0.495473951166082,-0.8245478869823449,5593,2,GRIN1
STIMULATORY C-TYPE LECTIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002223,0.14293098991987602,0.509272638902788,-0.24461845370442897,-1.28236942870133,1105,48,ICAM3|MALT1|FYN|TRAF6|PLCG2|RAF1|CREBBP|PAK2|MUC3A|SYK|RPS6KA5|CLEC4A|LYN|CD209|CLEC4E|CLEC10A|FCER1G|MUC4|HRAS|MUC20|RELB|MUC15|RELA|NFKB1|PRKACA|ICAM2
POSITIVE REGULATION OF CHOLESTEROL EFFLUX%GOBP%GO:0010875,0.340319622740372,0.701955655133333,-0.33760713348703003,-1.09302125860345,2597,11,PLTP|LRP1|NR1H3|APOE|NFKBIA
NAIL DEVELOPMENT%GOBP%GO:0035878,0.488679492213061,0.7885629027127059,-0.44134600600927204,-0.966198665045345,3733,4,ITGB4
STRAND INVASION%GOBP%GO:0042148,0.6432404135584351,0.868818962935866,-0.387015291507775,-0.8472573738417192,4914,4,DMC1|RAD51|XRCC2
SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0009070,0.173798897348385,0.5479313799708,-0.35189435585226797,-1.27767136445499,1323,15,PHGDH|GGT1|SERINC5|GGT5|SHMT2|MTHFD1
REGULATION OF CHLORIDE TRANSPORT%GOBP%GO:2001225,0.555555555555556,0.825309970896623,-0.416564586123682,-0.9119469566683079,4244,4,PRNP
NEGATIVE REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:1903973,0.685217160313455,0.8857920062408181,0.656815174239083,0.875774408900244,5158,1,PTPN2
POSITIVE REGULATION OF B CELL PROLIFERATION%GOBP%GO:0030890,0.20535248041775503,0.58515351714347,-0.293117006163107,-1.23067564199268,1572,23,NFATC2|CD38|GPR183|TNFSF13B|NCKAP1L|VAV3|CD74|MEF2C|BST1|TNFRSF4|TFRC|CD81
REGULATION OF ODONTOBLAST DIFFERENTIATION%GOBP%GO:1901329,0.0317060228177235,0.253077647014974,-0.8844223876481941,-1.47182028281999,238,2,CEBPB|SERPINE1
PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009136,0.30083676451055896,0.673988937137548,0.8507940008822229,1.13441900011172,2264,1,AK5
CTP BIOSYNTHETIC PROCESS%GOBP%GO:0006241,0.430883523481029,0.759376613000886,-0.6266341204148821,-1.04281938270038,3247,2,CTPS1
DNA REWINDING%GOBP%GO:0036292,0.00388531618435155,0.0676600644890075,0.95709953129308,1.60805078869501,28,2,ZRANB3|SMARCAL1
HEPATICOBILIARY SYSTEM DEVELOPMENT%GOBP%GO:0061008,0.691042544515427,0.8879164853534021,0.181179371129735,0.838805493823774,5083,30,NPHP3-ACAD11|MET|SULF2|WNT4|NF1|NPHP3|PKD2|CITED2|CCDC40|RARB|PROX1
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN MYOCARDIAL PRECURSOR CELL DIFFERENTIATION%GOBP%GO:0003257,0.25179092597506003,0.632068187660447,-0.7065343258891651,-1.1757861016131002,1897,2,GREM1|SRF
MAINTENANCE OF PROTEIN LOCATION IN T CELL SECRETORY GRANULE%GOBP%GO:0033377,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
NUCLEOBASE-CONTAINING SMALL MOLECULE INTERCONVERSION%GOBP%GO:0015949,0.382306889352818,0.730431979069223,-0.24046980525877398,-1.04897320476844,2929,26,CTPS1|NME2|TAF9|AK6|NME1|AK1
CALCIUM-INDEPENDENT CELL-CELL ADHESION VIA PLASMA MEMBRANE CELL-ADHESION MOLECULES%GOBP%GO:0016338,0.5549421661409039,0.8246946530383629,-0.33427764419402,-0.913733033505604,4221,7,CLDN7|CLDN5|CLDN11|CLDN10
RESPONSE TO INTERLEUKIN-2%GOBP%GO:0070669,0.6015200868621071,0.847046653006894,0.268362145448853,0.8830762436520692,4431,11,CITED1|SHC1|PTK2B|JAK1
LEUKOTRIENE BIOSYNTHETIC PROCESS%GOBP%GO:0019370,0.5652683689421569,0.829765064532093,-0.301233874536725,-0.9061852283580292,4338,9,ALOX5AP|ALOX5|LTC4S|GGT1|GGT5
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN NEURAL PLATE ANTERIOR/POSTERIOR PATTERN FORMATION%GOBP%GO:2000314,0.830256342143711,0.9435818887072471,0.58392148213498,0.7785805062335109,6250,1,FUZ
NUCLEIC ACID-TEMPLATED TRANSCRIPTION%GOBP%GO:0097659,0.00404346727318676,0.0698267586144378,-0.17013266650644399,-1.43065939142032,31,470,MED10|TOPORS|GTF3C4|SNAPC1|CSTF2|ESRRG|RORC|CDK4|GTF2E1|INTS2|DDIT3|MED30|SRRT|TCFL5|POLR2F|HSF1|CREBBP|TFAM|FUBP3|MED26|ADRM1|POU2F1|PTEN|NR1I3|NCOA6|ZNF136|THAP1|TRIP13|GABPA|ZNF219|CCNH|POLR1E|INTS1|IKBKAP|TCEB2|NOTCH4|ETV7|DRG1|TCERG1|CPSF1|SNRPE|POLR2C|LSM11|HIPK3|NR2F1|PIR|NR4A1|YBX1|MED7|NABP2|GTF3A|TMF1|GTF3C1|SSU72|SOX5|EAF2|NR3C1|INTS7|DEK|LMO4|TERT|SOX18|RUNX3|MED13|NCBP2|RXRG|GTF2A2|MED8|BRF1|TRIM28|KLF4|SOX17|NFE2L3|POLR2J|PARP1|ELL2|PTMA|ZNF143|TAF3|RORA|PHAX|TAF6L|BTF3|NR1D2|TROVE2|MED1|NRL|RBMX|AHR|GATA3|MLLT3|MAF|VEZF1|CCNK|ZNRD1|E2F2|LMO2|GTF2A1|TWISTNB|TAF12|PTTG1|LSM10|RREB1|TRIP11|GTF3C5|SUPT16H|CPSF2|THRA|CEBPD|NFX1|ELOF1|NFE2L1|NOTCH1|SNRPF|GMEB2|CEBPA|PAPOLA|SMARCD3|ILF2|NCBP1|TTF1|ARRB1|ZFHX3|DDX5|CLP1|CTGF|SNW1|CTR9|POLR2H|NOTCH2|GTF2H1|NFIC|MECP2|MAPK3|TAF7|ZNF148|USF2|POLR3K|IRF7|CEBPB|NFATC1|E2F1|NR1H3|CREBL2|NOTCH3|CSTF3|PPM1D|MED6|TAF9B|BCL3|UBTF|SPI1|BDP1|MAX|NELFB|NFIX|CDK7|GATA6|KAT2B|PKNOX1|NR1D1|WWTR1|SRF|SNRPB|MAML1|PABPN1|MNAT1|CCRN4L|TAF10|PPARG|PPARA|POLR2G|ANG|RELA|POU2F2|INTS5|YAP1|NFKB1|SUPT4H1|PTRF|MRPL12|TAF9|TEAD2|CPSF7|PRMT5|SSRP1|DTX1|ESRRA|CCND1|ELP4|MED27|AK6|C5AR1|MAZ|POLR2L|SMN1|GTF2H2
OOCYTE AXIS SPECIFICATION%GOBP%GO:0007309,0.77123745819398,0.9213545359508709,-0.6190449933833261,-0.824716572655282,5764,1,PLD6
SENSORY PERCEPTION OF MECHANICAL STIMULUS%GOBP%GO:0050954,0.27944214876033097,0.653204101106396,-0.214967520036942,-1.13264179543298,2163,49,CEMIP|TMIE|MYO7A|TBX1|DFNB31|COL11A2|P2RX4|SPTBN4|PDZD7|NDUFB9|SNAI2|TMC2|TPRN|SOD1|KCNQ1|COL1A1|TIMM9|BIRC5|ATP2B2|ADGRV1|TIMM10
GROWTH%GOBP%GO:0040007,0.0792409283241441,0.395154776867254,-0.20972341399086397,-1.33397069805656,617,100,C3orf58|COBL|ANXA6|SH3GL2|DDR2|MESP1|VWA1|NOTCH1|COL14A1|S1PR1|FGF10|COMP|IGF1|COL12A1|COL6A3|GAS1|COL21A1|NOV|NRP2|TGFBR3|FGF7|SLIT2|TMEM108|MAP1B|SEMA3A|COL6A1|ANXA2|HSP90AA1|ANXA1|CPQ|COL6A2
CIRCULATORY SYSTEM DEVELOPMENT%GOBP%GO:0072359,0.000128567755206994,0.00518555396908895,-0.23542269058453602,-1.8998903057272198,0,353,JAG1|IL18|ADAM8|ANGPT2|REST|MEF2D|EPHB3|TBX1|SAT1|ZFPM2|SOX18|RYR2|MYH11|PCSK5|CXADR|COL23A1|BCOR|SOX17|FGFR4|KDR|FZD4|CLDN5|TMEM204|PLXND1|LRP1|CACYBP|FOXN4|CD34|RORA|SPRY1|CFC1|SMO|CPE|APOLD1|MED1|FOXS1|SFRP2|CYP1B1|C3orf58|EGFL7|AHR|GATA3|SMAD6|PRCP|ATPIF1|TBX2|VEGFC|MYOM1|THY1|MYLK2|HES1|FOXC2|MESP1|ITGA5|ATP5B|HEG1|MYLK|EFNA1|NDST1|FLT4|NOTCH1|ELN|MEF2C|S1PR1|CALCRL|PKP2|HOXB3|FBN1|SNAI2|NOTCH2|MICAL2|COL4A1|POPDC2|JMJD6|HMOX1|LOX|PIK3R3|RECK|LRP5|CCL2|CEACAM1|PDPN|ROBO4|APLNR|DLC1|GATA6|KAT2B|NOS3|VEGFB|NOV|CCBE1|NRP2|ADAP2|ADIPOR2|TGFBR2|BMP2|TGFBR3|THBS1|TEK|COL1A2|COL1A1|SEMA5A|SRF|PDGFRB|SEMA3E|IGSF22|ERRFI1|DCHS1|COL3A1|MAML1|SLIT2|ID1|FKBP1A|NR2F2|DNAAF1|SNAI1|SERPINE1|CAV1|ADGRA2|RASIP1|MYH9|ANG|SIK1|EPHB4|NXN|TGFBI|ADGRG1|PDGFA|ANXA2|PDGFRA|ACTA2|ENG|TNFRSF1A|CRIP1|ACVRL1|TNFRSF1B|PDGFB|LOXL2|SERPINF2|MTHFD1
REGULATION OF INCLUSION BODY ASSEMBLY%GOBP%GO:0090083,0.6457710089747081,0.869339430956766,0.26732800572204,0.8469131921896,4748,10,HSPA2|SACS|DNAJA4|DNAJB2
CELLULAR RESPONSE TO ARSENITE ION%GOBP%GO:1903843,0.0305555555555556,0.247447840028175,-0.797226094814876,-1.55678050705035,230,3,VCP|DHX36
RNA CAPPING%GOBP%GO:0036260,0.25237909007952,0.632257972333528,-0.24923872861276702,-1.1704954288316,1935,33,NCBP1|POLR2H|GTF2H1|CDK7|MNAT1|POLR2G|POLR2L|GTF2H2
NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION%GOBP%GO:0051250,0.0020607934054611,0.0403673671724775,-0.310069514247562,-1.8071961665097498,15,71,CD274|DUSP3|MNDA|MICA|LILRB1|SLA2|LYN|NDFIP1|TNFAIP8L2|TNFRSF14|SAMSN1|RUNX1|TWSG1|RUNX3|PDCD1LG2|SPN|FCGR2B|PLA2G2D|TNFAIP3|RC3H2|LILRB2|GPNMB|INHBA|PRKAR1A|SOCS1|SDC4|CEBPB|C10orf54|CEACAM1|CD300A|HFE|LST1|CD86|LGALS3|TNFRSF21|LGALS9|HAVCR2|ANXA1|PRNP
ASPARAGINE CATABOLIC PROCESS VIA L-ASPARTATE%GOBP%GO:0033345,0.0311705685618729,0.250729241129472,-0.98467137185708,-1.3118187008531201,232,1,ASRGL1
REGULATION OF CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0006109,0.190851334180432,0.565216191946018,-0.18977222753085896,-1.1907759233486899,1501,94,OGT|CBFA2T3|PHKG2|PFKFB2|PFKFB3|PLEK|INS|PPP1R3E|IRS1|ADIPOR1|MLXIP|CLTC|JMJD8|IGF1|PGAM1|P2RY6|GPER1|SLC45A3|NR1D1|PDK3|PPARA|SIK1|NFKB1|PDGFB|PPP1R3F|BAD
CARDIAC MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010659,0.131225926417851,0.490819490032838,0.935818262020291,1.24778737977291,987,1,GNGT1
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001243,0.0037342261138295103,0.0654418186996091,-0.29779840356672904,-1.75309149677206,28,74,CD74|TRIAP1|BCL2A1|KDM1A|PPIF|TMBIM6|SFRP2|SOD2|OPA1|BAG5|BCL2L2|INS|CREB3|DDX3X|PARK7|TRIM32|SNAI2|ENO1|CREB3L1|HERPUD1|HSPB1|NONO|TAF9B|PLAUR|SYVN1|MMP9|SNAI1|YBX3|DNAJA1|TAF9|ZNF385A|NDUFS3|AK6
REGULATION OF VASCULATURE DEVELOPMENT%GOBP%GO:1901342,0.000128172263522174,0.00518555396908895,-0.33298582214720696,-2.47907271985852,0,218,HOXA5|AQP1|S100A1|PML|RGCC|KIAA1462|PAK4|HTATIP2|HSPG2|CHI3L1|SP100|MTDH|MAP3K3|FLT1|TMEM2|RUNX1|MYDGF|PIK3C2A|JUP|DAB2IP|PIK3R6|SARS|KLF4|HGS|KDR|PLXND1|EMC10|SEMA6A|PDCD6|CD34|ANGPTL4|SYNJ2BP|SFRP2|CYP1B1|SOD2|SRPX2|E2F2|VEGFC|ADAM12|STIM1|FOXC2|TNFAIP3|ITGA5|WARS|DCN|SMOC2|NOTCH1|GPNMB|TNFSF12|FAM129B|PRKD1|TBXA2R|BRCA1|F3|MMRN2|CREB3L1|MECP2|GHRL|DNMT1|JMJD8|HMOX1|HSPB1|RAPGEF3|SPARC|SULF1|NFATC1|COL4A2|HDAC5|MEOX2|RHOJ|CDH5|STARD13|CTSH|CEACAM1|GPER1|EPHA2|NPR1|RAP1A|APLNR|GATA6|SASH1|NOS3|HYAL1|VEGFB|ECSCR|EFNA3|ECM1|FGF9|THBS1|TEK|SEMA5A|THBS2|SEMA3E|SERPINE1|ADGRA2|STAB1|PPARG|PDGFA|RRAS|ANXA1|RNH1|HSPB6|ENG|PGK1|SPHK1|PDGFB|NGFR|SERPINF1|PRKCB|CARD10|EMP2|ADGRB1|PTGIS
REGULATION OF MONOPHENOL MONOOXYGENASE ACTIVITY%GOBP%GO:0032771,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
REGULATION OF TUBULIN DEACETYLATION%GOBP%GO:0090043,0.946430910281598,0.9834855466269592,-0.229000055154156,-0.589049831289567,7225,6,FNTA|EP300|PRKAA1|PRKAA2|MAPT|BEX4
FMN BIOSYNTHETIC PROCESS%GOBP%GO:0009398,0.175919732441472,0.548366806412612,-0.9097926775474201,-1.2120623005978601,1314,1,RFK
HISTONE H3-K9 MODIFICATION%GOBP%GO:0061647,0.531562335612835,0.812079525085925,-0.38769718991824703,-0.929236184800912,4041,5,SUV39H1
PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY%GOBP%GO:0120031,0.00013861935126143602,0.00526859796630401,0.30093079095761893,2.44893812587621,0,341,DYNLRB2|DYNC2H1|NPHP1|ABCC4|CC2D2A|DYNC1I2|TTC30B|LRRC6|WDR19|TTC21B|DYNC2LI1|BBS5|RABL2B|INTU|IFT88|STK36|DNALI1|SHTN1|WDR35|DNAI1|ZMYND10|CBY1|CEP162|NPHP3-ACAD11|FAM161A|TBC1D32|RSPH9|LRGUK|BBS4|SPATA6|ABLIM2|CLASP1|BBIP1|CYFIP1|DCTN1|TMEM67|SFI1|IFT46|CFAP44|IFT172|INPP5K|AHI1|CFAP20|DYX1C1|FGFR1OP|ABLIM1|CFAP43|FGD4|ARL3|CCDC65|PIBF1|IFT20|TMEM17|ARHGEF7|MAP4K4|VSTM5|CCDC88A|NINL|LRRC49|CEP89|IFT140|RFX3|RSPH1|PTPRO|SPAG16|CCDC176|KIT|TMEM107|KIF3B|DZIP1|C9orf117|ARMC9|MINK1|SEPT2|CLUAP1|TTC8|TTLL3|IQCG|CCDC113|RAB1A|RPGRIP1L|IFT81|TTBK2|CEP164|CFAP46|TNPO1|WDR11|WDR60|LRRC16A|PCM1|EHD3|RILPL1|RAB23|TMEM231|CEP290|MARK4|WDPCP|RSPH4A|WDR90|ACTR2|TCTN2|POC1B|SEPT10|CEP57|MKKS|B9D1|TEKT2|ARHGEF4|GAS8|NPHP4|FGD5|NPHP3|IFT52|DNAH1|RPGR|RAB11A|CEP250|DCTN2|YWHAE|TRAF3IP1|SEPT4|CCDC40
POSITIVE REGULATION OF INTERLEUKIN-15 PRODUCTION%GOBP%GO:0032738,0.9232301766502858,0.9776156396135859,0.539258932509925,0.719029022753894,6950,1,TIRAP
"REGULATION OF RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:1904152",0.725228758169935,0.9040629990111769,-0.235798300405703,-0.7892389896302049,5547,12,BCAP31|DERL3
PROTEIN LOCALIZATION TO MAST CELL SECRETORY GRANULE%GOBP%GO:0033367,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
METALLO-SULFUR CLUSTER ASSEMBLY%GOBP%GO:0031163,0.6802112962210479,0.8847768831854209,0.20254728576065398,0.8349305052274569,5021,21,NFS1|HSCB|MMS19|CIAO1|CIAPIN1|NFU1
POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE%GOBP%GO:0006620,0.128791841004184,0.48652410558172704,-0.44021498599145004,-1.37913608525103,984,10,CHMP4A|SEC61A1|SEC61B|SGTB
POSITIVE REGULATION OF ACROSOME REACTION%GOBP%GO:2000344,0.00789058390320884,0.10845506809166199,-0.7431061107434369,-1.7810835497546003,59,5,PLCB1|HYAL3|CACNA1H|ZP3|POMZP3
CARDIAC MUSCLE ADAPTATION%GOBP%GO:0014887,0.13367748947153898,0.495264631574533,0.621159227952933,1.3647132775175,983,4,HDAC4|INPP5F|CAMTA2|TCAP
NEGATIVE REGULATION OF BINDING%GOBP%GO:0051100,0.5733111566018421,0.835107713312645,-0.143739223231632,-0.9354504968832141,4480,110,AKT1|AURKA|ROCK1|DDIT3|SOX11|ZNF675|ID2|ADRB2|GZMA|LRPAP1|ID3|PSEN1|SP100|ZNF593|B2M|PER2|KDM1A|CAMK1|PLN|TMBIM6|SMO|IFIT2|PARK7|IFIT1|CARD16|E2F1|IFI16|CTSZ|SUMO3|MDFI|HFE|NFKBIA|ID1|CAV1|DACT1|ID4|DAB2|ACTB|HSPA5|TMSB4X|PPP1CA|PDGFB
ADHERENS JUNCTION MAINTENANCE%GOBP%GO:0034334,0.47004483086537197,0.781244333716016,0.444169488074714,0.975859281429917,3459,4,KIFC3|CAMSAP3|PLEKHA7
REGULATION OF TRANSCRIPTION INVOLVED IN ANTERIOR/POSTERIOR AXIS SPECIFICATION%GOBP%GO:0044324,0.6920401337792641,0.888433240372712,-0.657807675341862,-0.8763577724928759,5172,1,DDIT3
INOSINE METABOLIC PROCESS%GOBP%GO:0046102,0.436353756283114,0.7626864968659259,0.457815543088883,1.00584024544931,3211,4,ADAL|CECR1
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME%GOBP%GO:0001977,0.0629993451211526,0.36006266503904,-0.588292693889927,-1.51324728656275,480,6,GAS6|F2R|PDGFB|EMP2
NEGATIVE REGULATION OF PROTEOLYSIS%GOBP%GO:0045861,0.000128369704749679,0.00518555396908895,-0.35712131836222405,-2.50809062695716,0,160,TRIM21|FNIP1|RPS6KA1|TRIAP1|IGBP1|AGT|SERPINA3|CHAC1|SERPINB8|SPOCK2|KLF4|USP25|UCHL5|SERPINB1|HGF|NGF|OGT|PSMF1|BAG5|DNAJC1|GAS6|GPX1|INS|UBE2G2|VTN|DDX3X|SIAH2|EFNA1|CAAP1|SERPINA1|PARK7|UBXN1|TIMP3|DPEP1|CARD16|IFI6|ALAD|RECK|IFI16|NAIP|CAST|CTSZ|HFE|GIPC1|USP47|TMEM59|GAPDH|PLAUR|GAS1|ECM1|SERPINE2|A2M|THBS1|SERPINH1|XIAP|TLK2|EPHA4|MMP9|SERPINE1|PLAT|CSTB|BCL2L12|ARL6IP1|DERL3|TAF9|TIMP1|CD55|SERPING1|NGFRAP1|AK6|DHCR24|NGFR|SERPINF1|SERPINF2|CST3|PRNP
POSITIVE REGULATION OF GLYCOLYTIC PROCESS%GOBP%GO:0045821,0.40172842739295506,0.740287621109606,-0.302201703735149,-1.0402368677865,3067,13,PFKFB2|PFKFB3|INS|IGF1
MALONYL-COA METABOLIC PROCESS%GOBP%GO:2001293,0.973511705685619,0.9920058127185359,-0.513012792236436,-0.6834562208946962,7276,1,MLYCD
EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS%GOBP%GO:0008625,0.5448851774530271,0.817297924969912,-0.213664719619308,-0.9320445261051721,4175,26,DAB2IP|TNFRSF10A|TNFRSF10B|NGF|DDX3X|BAG3|TNFRSF10C|FADD|TNFRSF1A
N-TERMINAL PEPTIDYL-GLYCINE METHYLATION%GOBP%GO:0018013,0.00989966555183947,0.126895016411775,-0.994816938685487,-1.32533503196282,73,1,NTMT1
GLUCOSE MEDIATED SIGNALING PATHWAY%GOBP%GO:0010255,0.7673122844255771,0.9202818175694271,-0.48025666060759,-0.799223882065292,5783,2,ADCY8
NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0090155,0.664040211927727,0.8804055751124069,0.3806023075947829,0.8361994787393809,4887,4,ORMDL1|PRKAA1
ANDROGEN CATABOLIC PROCESS%GOBP%GO:0006710,0.354608976081698,0.7124978659342509,0.560946599722937,1.10331576560111,2638,3,HSD17B11|HSD17B6
SELENOCYSTEINE METABOLIC PROCESS%GOBP%GO:0016259,0.753829615694706,0.915550465961143,0.393477287969768,0.773923392061629,5609,3,SEPSECS|SEPHS1
PEPTIDYL-CYSTEINE S-TRANS-NITROSYLATION%GOBP%GO:0035606,0.0181745821172725,0.18476933974472,-0.913592500689275,-1.5203640155721398,136,2,GAPDH|S100A9
SULFUR COMPOUND METABOLIC PROCESS%GOBP%GO:0006790,0.524638423140919,0.808245162096538,-0.126846608050973,-0.968228443524785,4098,251,CDO1|DGAT1|CHAC1|B4GALT4|ISCA1|CHAC2|ST3GAL1|ACSL5|ABHD14B|ACOT1|GAL3ST3|TST|ACSF2|PRELP|FAR1|ACSL4|SLC25A10|HLCS|GGT1|GPX1|ELOVL2|PDHA1|ARSB|ACSF3|HS3ST5|DCN|ADI1|CHST7|NDST1|ELOVL1|THTPA|HSPA9|SLC26A2|PARK7|BGN|MCCC2|MICAL2|DPEP1|SOD1|VCAN|OGN|ARSG|TPST2|LUM|FMOD|SMS|HYAL1|HMGCS1|SQRDL|HACD2|FXN|GGT5|B4GALT1|ACOT2|PDHX|PCCB|ABCD1|B4GAT1|HEXB|CSGALNACT1|GSTP1|SULT1A4|SLC25A19|ISCA2|FASN|APIP|PTGES|MTHFD1
ASTRAL MICROTUBULE ORGANIZATION%GOBP%GO:0030953,0.22275010180534802,0.6055424221927729,0.475302903774181,1.2298741995679099,1640,6,CLASP1|RAB11A|EZR
NK T CELL ACTIVATION%GOBP%GO:0051132,0.992909698996655,0.997305769352475,-0.503584031760035,-0.6708948479612271,7421,1,ELF4
BASAL PROTEIN LOCALIZATION%GOBP%GO:0045175,0.3458193979933111,0.7033175795366851,-0.8240516100573442,-1.0978346110566701,2584,1,ERBB2IP
NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002283,0.000127064803049555,0.00518555396908895,-0.327511111997425,-2.69678434958227,0,401,UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|CNN2|DNASE1L3|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
NEGATIVE REGULATION OF BRANCH ELONGATION INVOLVED IN URETERIC BUD BRANCHING BY BMP SIGNALING PATHWAY%GOBP%GO:0072097,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
POSITIVE REGULATION OF MYOSIN-LIGHT-CHAIN-PHOSPHATASE ACTIVITY%GOBP%GO:0035508,0.8685084340549871,0.9564313557722421,0.5647331274812529,0.752995424442268,6538,1,PPP1R12A
REGULATION OF MEIOTIC NUCLEAR DIVISION%GOBP%GO:0040020,0.8274185068349109,0.943061234519578,-0.255488141202427,-0.698365440645814,6294,7,FBXO43|NPM2|FBXO5|SIRT2|TRIP13|PLCB1|RAD1
REGULATION OF ENGULFMENT OF APOPTOTIC CELL%GOBP%GO:1901074,0.7989108779386371,0.931350348412063,0.6001874724305251,0.8002690094760871,6014,1,ABCA7
EXTRACELLULAR MATRIX-CELL SIGNALING%GOBP%GO:0035426,0.596095098950724,0.844548800900243,0.6997132774591971,0.9329732411806659,4487,1,FER
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION%GOBP%GO:0045599,0.49591169255928097,0.794012168719884,0.21905227935020302,0.9686425400537959,3638,26,BBS12|TRIB2|SMAD3|GPS2|ASXL1|ZADH2|ZFPM1|GATA2
NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY%GOBP%GO:0010923,0.564796905222437,0.8295590091625621,0.165367154761502,0.9344233269352141,4087,60,FKBP1B|MGAT5|ARFGEF3|FARP1|SFI1|TMEM132D|RIMBP2|DLG2|MYO1D|CAMSAP3|URI1|PPP1R11|RBM26|CSRNP2
POSITIVE REGULATION OF OXIDATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902177,0.35833006151027397,0.714938712241162,-0.500262868878074,-1.09517999370225,2737,4,FBXW7|MCL1|SOD1
TRYPTOPHAN CATABOLIC PROCESS%GOBP%GO:0006569,0.21882322311897895,0.6013948176405761,-0.428890796315461,-1.23471657484746,1680,8,TDO2|KMO|CCBL1|KYNU|HAAO|AFMID
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY INVOLVED IN SOMITOGENESIS%GOBP%GO:1902367,0.82247491638796,0.9412507273497192,-0.5923577415086021,-0.789162745171078,6147,1,LFNG
PROTEIN LOCALIZATION TO MICROTUBULE%GOBP%GO:0035372,0.313807531380753,0.6833560549363861,-0.358814679080861,-1.1241195497324499,2399,10,MAPRE2|MID1|HNRNPU|MID2
MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHRIC RENAL VESICLE FORMATION%GOBP%GO:0072285,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
REGIONALIZATION%GOBP%GO:0003002,0.7402298850574709,0.909493931144346,-0.138335797457714,-0.834827771051823,5795,81,HOXA5|GREM1|HOXB6|HOXC6|HOXB7|TBX1|HOXC5|PCSK5|BASP1|BHLHE40|FOXN4|WLS|CFC1|SMO|COBL|SMAD6|HOXA4|HES1|MESP1|MEF2C|CHRD|ATP6AP2|HOXB3|FGF10|LRP5|MDFI|BMP2|NBL1|DNAAF1|ITGAM
"NEGATIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2001186",0.11683038637852,0.46712068687717895,-0.545771032957056,-1.40387011989876,891,6,CD274|LILRB1|SOCS1|C10orf54|HFE
NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009142,0.0431701030927835,0.297767629037729,-0.260352729708912,-1.48458297519496,334,65,ATP5J|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|CTPS1|PGAM1|GAPDH|NME2|LDHA|CMPK2|STOML2|ATP5H|PGK1|ALDOA|ALDOC|AK1|ATP5G1
REGULATION OF CALCIUM:SODIUM ANTIPORTER ACTIVITY%GOBP%GO:1903279,0.137304324754577,0.502074833795661,-0.772318720705818,-1.28526185430368,1034,2,ATP1B1|SLC9A1
AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS%GOBP%GO:0042982,0.686797385620915,0.8861361847538001,-0.24396332228312698,-0.816568082358009,5253,12,PSEN1|ACHE|DYRK1A|ABCG1|APOE
PROTEIN POLYGLYCYLATION%GOBP%GO:0018094,0.21516801700093002,0.598086191599933,0.893802382002647,1.19176487309209,1619,1,TTLL3
MONOCYTE EXTRAVASATION%GOBP%GO:0035696,0.0562169312169312,0.34424567164700104,-0.7580743275871469,-1.4803270286291998,424,3,CD47|SIRPA
POSITIVE REGULATION OF MAST CELL ACTIVATION%GOBP%GO:0033005,0.28052590471231503,0.65378405684501,-0.40397700447340296,-1.16299325507945,2154,8,SNX4|FGR|PVRL2|VAMP8|VAMP7
POSITIVE REGULATION OF CYTOKINE PRODUCTION%GOBP%GO:0001819,0.00012750223128904799,0.00518555396908895,-0.2817895177355,-2.13030702261349,0,237,HLA-DPA1|TGFB1|LILRB1|STAT6|HLA-E|RGCC|HYAL2|DHX9|CEBPG|TLR1|PYCARD|CD74|TNFRSF14|PLCB1|GSDMD|B2M|IL18|ADAM8|RUNX1|CCL19|NFKB2|AGT|CCDC88B|HLA-DPB1|CD4|AGPAT1|IL17D|TLR2|FGR|CD34|RORA|CYP1B1|IRF5|SPN|GATA3|AZU1|IL1RN|EBI3|POLR3B|INS|PDE4B|CASP1|IL6ST|TRAF2|C3|DHX36|DDX3X|LILRB2|PDE4D|DDX60|FLT4|PTGER4|STAT3|MB21D1|IL17RA|NFAM1|PARK7|IFIH1|BRCA1|FCER1G|ATP6AP2|SLC11A1|OSM|RSAD2|HMOX1|HSPB1|SOD1|IRF7|IRAK1|SULF1|CEBPB|FCN1|IFI16|IL15|SEMA7A|GPRC5B|TMEM173|IL33|F2R|CD86|GAPDH|NLRP3|RAB7B|CCBE1|CD200|LGALS9|THBS1|ZP3|FADD|TLR5|TICAM1|SERPINE1|HAVCR2|RELA|IL1R1|DHX58|MAPK13|NFKB1|TLR4|CSF1R|C1QTNF4|ANXA1|CD14|AGPAT2|LY96|PQBP1|SERPINF2|PTPRJ
CELLULAR RESPONSE TO HORMONE STIMULUS%GOBP%GO:0032870,0.009211873080859771,0.121196525942361,-0.18427303947682802,-1.4549178108364498,71,307,ZFP36L1|BCL2L11|MED13|AP3S1|TCIRG1|ATP6V0B|GOT1|PARP1|ATP6V0A2|CTSS|ATP6V1G2|NR1D2|MED1|HNRNPU|ATP1A3|CAV2|LMO2|ATP6V1F|INS|CACNA1H|BCAR1|FOXC2|CTSB|SYAP1|THRA|ADCY8|NOTCH1|SST|ATP6V0D1|CA2|GRB2|CRHBP|PRKAR1A|PTGER4|MEF2C|IRS1|STAT3|ADIPOR1|BRCA1|DDX5|PXN|MSN|SPP1|GHRL|CALR|ADCY4|PIK3R3|RAN|HDAC5|NSMF|CHRM2|WBP2|GNAQ|CTSH|CEACAM1|NCOA4|GPER1|RBM14|CDK7|KAT2B|GNA15|CPEB1|ADIPOR2|ATP6V0E1|H2AFZ|FHL2|NR1D1|PPAP2A|LATS2|RARRES2|SLIT2|CAMK2A|LPIN3|CAV1|FAM107A|PPARG|PPARA|ATP6AP1|RELA|YAP1|RPS6KB1|NFKB1|PRKACA|ATP6V0E2|KAT5|ADRBK1|CTSL|LY6H|ANXA1|TFPI|PHB|ATP6V1A|LPIN2|ATP6V1G1|SSTR2|ADCY9
RESPONSE TO DNA INTEGRITY CHECKPOINT SIGNALING%GOBP%GO:0072402,0.19751146037983,0.574572493132077,-0.491821993815623,-1.2650986581054298,1507,6,EME1|SMC1A|MUS81
'DE NOVO' PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS%GOBP%GO:0006207,0.137057877813505,0.50183849535031,0.779928315412186,1.31038027051347,1022,2,CAD|DHODH
ACTIVATION OF PHOSPHOLIPASE A2 ACTIVITY BY CALCIUM-MEDIATED SIGNALING%GOBP%GO:0043006,0.48824545092309707,0.7882673024233101,0.756120423467137,1.0081845592049201,3675,1,EGFR
VASCULAR WOUND HEALING%GOBP%GO:0061042,0.20674603174603198,0.5864887001963061,-0.6378561411873979,-1.2455713797645802,1562,3,CD34|ADIPOR2
FARNESYL DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0045338,0.143386243386243,0.509575016463429,-0.678890481967575,-1.32570104719735,1083,3,FDFT1|FDPS|HMGCS1
MITOCHONDRION TO LYSOSOME TRANSPORT%GOBP%GO:0099074,0.149556570814297,0.51590227091171,0.670414436169224,1.3186260818363502,1112,3,PARK2|VPS35
SEROTONIN TRANSPORT%GOBP%GO:0006837,0.667023411371237,0.880719592999549,-0.6703242170269079,-0.8930328114162521,4985,1,SYK
RNA LOCALIZATION TO CHROMATIN%GOBP%GO:1990280,0.41123745819398,0.745702786067065,-0.794938244375827,-1.05904861743753,3073,1,HNRNPU
TYPE I INTERFERON SIGNALING PATHWAY%GOBP%GO:0060337,0.00232618247609201,0.0447432148508244,-0.370443425597505,-1.94198482107826,17,48,IRF8|OAS3|HLA-B|MX1|XAF1|HLA-E|SP100|IFIT3|OASL|OAS1|IFNAR1|HLA-C|IRF5|HLA-A|OAS2|IFIT2|IFIT1|ISG15|IFI6|RSAD2|IRF7|IRAK1|BST2|IFI35|IFITM1|IFITM2|IFITM3|SAMHD1
ANTEROGRADE DENDRITIC TRANSPORT%GOBP%GO:0098937,0.689868314969094,0.887051934478962,0.416871301914832,0.819936656816294,5133,3,KIF5A|KIF5C|KIF17
REGULATION OF CELL PROJECTION ASSEMBLY%GOBP%GO:0060491,0.340443329150983,0.701955655133333,0.153226811494225,1.06399790396855,2441,145,DYNC2LI1|IFT88|EPS8L1|PPP1R16B|RLTPR|ODF2L|ZMYND10|TBC1D1|BBS4|TBC1D19|CDK10|RHOQ|IFT20|CCDC88A|IFT140|TBC1D2|TBC1D14|AGRN|NDEL1|TBC1D17|HTT|TBC1D16|NCKAP1|TBC1D8|MARK4|HAP1|TBC1D7|TBC1D20|TWF1|CDC42EP3|WASH1
MRNA CATABOLIC PROCESS%GOBP%GO:0006402,0.9168369954011241,0.975254510940845,-0.103875160259163,-0.761050814774402,7176,198,MAGOH|PDE12|RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|PATL1|NUDT16|RPL10|DDX5|RPL36A|RPL24|PELO|LSM3|NT5C3B|RPL35|PPP2CA|RPL38|RPS15A|MAGOHB|EIF4A3|EXOSC3|RPS13|RBM8A|TNKS1BP1|POLR2G|TUT1|RNH1|EXOSC2|ERN1|EIF4G1
ZINC ION TRANSPORT%GOBP%GO:0006829,0.756410256410256,0.9166479040253371,-0.20950168269099803,-0.7785893734678391,5781,16,SLC39A7|SLC39A13|SLC39A1|SLC39A3|SLC39A8|SLC39A11|SLC30A5
LIPID DROPLET ORGANIZATION%GOBP%GO:0034389,0.5201359832635979,0.805333449898493,-0.299565782473406,-0.9385004910386209,3977,10,PPIA|FAF2|BSCL2|FITM2
VACUOLAR SEQUESTERING%GOBP%GO:0043181,0.41070234113712395,0.7453853667476059,-0.7951588001764449,-1.05934245072253,3069,1,GAA
PROTEIN LOCALIZATION TO CYTOSOLIC PROTEASOME COMPLEX INVOLVED IN ERAD PATHWAY%GOBP%GO:1904379,0.354635584137192,0.7124978659342509,0.658009374138406,1.10554070758182,2646,2,ATXN3|BAG6
NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS%GOBP%GO:0010897,0.7870899189799442,0.9276917050905171,0.60603220114689,0.80806216657342,5925,1,GPLD1
IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002418,0.533597883597884,0.812141765487046,-0.48846140126547605,-0.953841316638248,4033,3,PRF1|MICA
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT%GOBP%GO:1901296,0.004648691725328729,0.0752560935123842,0.9979047198941329,1.33057129384458,34,1,DKK1
"ESTABLISHMENT OF MITOCHONDRION LOCALIZATION, MICROTUBULE-MEDIATED%GOBP%GO:0034643",0.721966413867822,0.9019989179378242,0.21521908087191702,0.793854472659229,5330,15,TRAK2|HAP1|LRPPRC|TRAK1|SPAST|NEFL|RHOT2
CERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046513,0.23242467718794801,0.61627895720556,-0.270520784884006,-1.1931288236472,1781,27,DEGS1|B4GALNT1|ST8SIA3|B4GALT6|ST8SIA4|GBA|SPTLC1|ST6GALNAC6|SPTLC2|CERS6|CERS4|UGCG|B3GALT2|SPTSSA|SMPD1|B3GALT1|ST3GAL5
METANEPHRIC GLOMERULAR CAPILLARY FORMATION%GOBP%GO:0072277,0.0102149111170072,0.12936633073190199,-0.9344361731458509,-1.5550512196937099,76,2,PDGFRB|PDGFRA
REGULATION OF GLUCONEOGENESIS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0035947,0.7708941363756969,0.9213545359508709,-0.477939720657209,-0.795368123481303,5810,2,NR1D1
CIRCADIAN REGULATION OF TRANSLATION%GOBP%GO:0097167,0.584347598481874,0.8396554445633291,-0.40761747089799893,-0.892359851156175,4464,4,PER2|RBM4
SMOOTH MUSCLE HYPERPLASIA%GOBP%GO:0014806,0.0367471477845582,0.27241249528203604,-0.877474496829336,-1.46025788144613,276,2,HMOX1|NOS3
ESTABLISHMENT OF TISSUE POLARITY%GOBP%GO:0007164,0.8912631863673249,0.9651611606244209,0.23537423828498602,0.6497442669718381,6589,7,PTK7|BRSK1|FUZ|BRSK2
REGULATION OF DENDRITIC CELL DIFFERENTIATION%GOBP%GO:2001198,0.03540744597761,0.26787698165153,-0.566585785971661,-1.63112117821626,271,8,FCGR2B|LILRB2|LGALS3|LGALS9|LGALS1
PROTEIN LOCALIZATION TO T CELL SECRETORY GRANULE%GOBP%GO:0033374,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
REGULATION OF CELLULAR COMPONENT SIZE%GOBP%GO:0032535,0.398581954678159,0.7388683667002129,0.13576162551687002,1.0290667921919001,2866,222,ISLR2|SLC12A5|NCK2|BIN1|SHTN1|RLTPR|RAB22A|SEMA4G|SEMA4F|RARG|ADD3|PEX11A|CYFIP1|PICK1|ALS2|RAB3B|FCHSD1|SLC12A4|RTN4|SEMA6C|SLC12A9|NEB|ABI2|FAM21C|VAV2|ARFGEF1|RAP1GAP2|PTPRS|RHOBTB1|PRKCE|NCKAP1|CLCN3|SEMA4C|LRRC16A|RUFY3|WDR1|ACTR2|TRIM46|LIMK1|TRIM27|TRIOBP|TWF1|PTK2B|NRCAM|CDC42EP3|WASH1|TMSB10|MAP2|ADD1|RAB11A|C15orf62|KCNMA1|POU4F2|WIPF1|RHOBTB2|CLCN6|AKT1S1|NRP1|ZFYVE27|DCC|MEGF8|EZR|WIPF2
VENTRAL MIDLINE DEVELOPMENT%GOBP%GO:0007418,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
REGULATION OF COMPLEMENT-DEPENDENT CYTOTOXICITY%GOBP%GO:1903659,0.36959405677898705,0.722232671030729,-0.652219465122691,-1.08539748769841,2785,2,TGFB2|IL11
REGULATION OF MACROPHAGE ACTIVATION%GOBP%GO:0043030,0.0875179340028694,0.40905715364188894,-0.32138002894627504,-1.4174429371288002,670,27,FCGR2B|CEBPA|NR1H3|IL33|CD200|THBS1|CX3CL1|LDLR|TLR4|ITGAM
NEGATIVE REGULATION OF RYANODINE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0060315,0.161482282932107,0.531565908892591,0.4797334255247179,1.3242912443631298,1193,7,FKBP1B|GSTM2|SRI|PKD2
MUCOPOLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:1903510,0.39499484004128,0.7377402989373809,-0.181220963136842,-1.03632741524108,3061,66,CD44|TGFB1|CEMIP|HYAL2|TMEM2|NCAN|B4GALT4|ST3GAL1|PRELP|HYAL3|ARSB|DCN|CHST7|SLC9A1|BGN|VCAN|OGN|LUM|FMOD|HYAL1|LYVE1|B4GALT1|B4GAT1|HEXB|CSGALNACT1
MOTILE CILIUM ASSEMBLY%GOBP%GO:0044458,0.00203970628229535,0.0401182609751702,0.6479505448148759,2.05275112425273,14,10,LRRC6|BBS5|ZMYND10|RSPH9|SPATA6|CCDC176
ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION%GOBP%GO:0090158,0.958442924776433,0.988711428754361,-0.23585204168368898,-0.565292339203879,7287,5,ARL6IP1
POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION%GOBP%GO:0060143,0.0729602510460251,0.38011088999831294,-0.48067089843046,-1.5058791777896399,557,10,CD53|MAPK14|ADAM9|CAMK1|EHD1|RAPGEF3|EHD2|ADGRB1
KILLING OF CELLS OF OTHER ORGANISM%GOBP%GO:0031640,0.0102174482577941,0.12936633073190199,-0.557168197866363,-1.80386201735605,77,11,APOL1|AZU1|ROMO1|HMGN2|GAPDH|HIST1H2BK|HIST1H2BJ
CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS%GOBP%GO:0071560,0.8550196298373531,0.949296218452153,0.12177042680395801,0.773604275399366,6097,96,ACVR1|SFRP1|CGN|CITED1|XCL1|SMAD3|STK16|MAPK7|PTPRK|RPS27A|PARD3|SOX6|ARRB2|SMAD1|PDE3A|ACVR2A
RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0006979,0.0177999743885261,0.18196628138788898,-0.19477018488305398,-1.4468000132553798,138,215,NUDT1|TNFAIP3|PLA2R1|ZNF622|CYCS|MAPK9|PRKD1|PARK7|HNRNPM|PXN|CAMKK2|SOD3|MAPK3|DPEP1|CYBB|ABL1|HMOX1|SOD1|ROMO1|NDUFA6|CCS|GPX8|APOE|CAT|NOS3|HYAL1|MSRB3|NDUFB4|FXN|NDUFA12|SEPP1|MMP9|GPX3|EIF2S1|ERCC8|PDLIM1|RELA|SIGMAR1|MAPK13|ARL6IP5|PRDX4|ATOX1|PDGFRA|CYGB|ANXA1|PRDX5|GSTP1|ALDH3B1|NET1|DHCR24|NDUFS8|SIRPA|PRNP
LACTOSYLCERAMIDE METABOLIC PROCESS%GOBP%GO:0046478,0.7521070234113709,0.915314007578303,-0.6288045875606529,-0.8377186955162409,5621,1,B4GALT6
LEUKOCYTE CELL-CELL ADHESION%GOBP%GO:0007159,0.00323415265200517,0.0582182631194105,-0.40032928699235104,-1.92769754881235,24,36,GOLPH3|ITGAL|SEMA4D|ADD2|ITGA4|IL1B|ROCK1|RAC2|TNF|SYK|ITGB1|CD44|SELPLG|CD209|TSTA3|ITGB2|SPN|CLEC4M|MADCAM1|ICAM1|MSN|VCAM1|TNIP1|S100A8|FERMT3|CERCAM|S100A9|PODXL2
CARDIAC RIGHT VENTRICLE MORPHOGENESIS%GOBP%GO:0003215,0.777050039297878,0.9245438394146239,-0.231269998896613,-0.748749064216395,5931,11,BMPR1A|HEY2|SOX4|HAND1|ISL1|BMP4|TBX20|TGFB2|JAG1|ZFPM2|GATA3
POSITIVE REGULATION OF T-HELPER 17 CELL LINEAGE COMMITMENT%GOBP%GO:2000330,0.8804013377926421,0.961762965381527,-0.5624172915747679,-0.749274876733222,6580,1,IL12RB1
TETRAPYRROLE BIOSYNTHETIC PROCESS FROM GLUTAMATE%GOBP%GO:0033526,0.671669544428211,0.8815356925073421,0.662218791354213,0.882979403197778,5056,1,CPOX
POSITIVE REGULATION OF ANGIOGENESIS%GOBP%GO:0045766,0.00012863390789812198,0.00518555396908895,-0.32499655673486305,-2.10869351144759,0,109,AQP1|S100A1|KIAA1462|PAK4|CHI3L1|MTDH|MAP3K3|FLT1|RUNX1|MYDGF|PIK3C2A|JUP|PIK3R6|KLF4|KDR|EMC10|PDCD6|CD34|ANGPTL4|SFRP2|CYP1B1|SRPX2|VEGFC|ADAM12|STIM1|FOXC2|ITGA5|SMOC2|TNFSF12|PRKD1|BRCA1|F3|JMJD8|HMOX1|HSPB1|RAPGEF3|RHOJ|CDH5|CTSH|APLNR|GATA6|SASH1|NOS3|HYAL1|VEGFB|ECM1|THBS1|TEK|SEMA5A|SERPINE1|RRAS|ANXA1|HSPB6|SPHK1|PRKCB|PTGIS
IMMATURE B CELL DIFFERENTIATION%GOBP%GO:0002327,0.6193565828602329,0.854944793214197,0.35681255775395704,0.8581321552527149,4581,5,KIT|ATM
DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050962,0.612552642304035,0.852045339927398,0.396442986496104,0.871002124902697,4508,4,EYS|REEP6|CNGB1
TREHALOSE CATABOLIC PROCESS%GOBP%GO:0005993,0.532474432195511,0.812079525085925,0.7324106749007501,0.976570808715744,4008,1,ATHL1
POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0051987,0.13400841662283,0.495641459539577,-0.569711008162365,-1.3654885756987603,1018,5,SIRT2|BECN1|RCC2|HNRNPU|CCNB1
PEPTIDYL-ARGININE N-METHYLATION%GOBP%GO:0035246,0.53016653016653,0.811490026766563,0.306768110557246,0.932239994763048,3883,9,NDUFAF7|PRMT9|CARM1|PRMT7
RESPONSE TO LIPOPROTEIN PARTICLE%GOBP%GO:0055094,0.0226048100933106,0.20908271623893998,-0.426013584205933,-1.68313992763488,171,19,ADTRP|AKT1|SYK|ITGB1|SREBF2|ITGB2|FCER1G|CD36|TICAM1|LDLR|PPARG|TLR4|CD81
HYDROGEN PEROXIDE-MEDIATED PROGRAMMED CELL DEATH%GOBP%GO:0010421,0.5850750267952839,0.839854222268064,0.555669649408642,0.933596756419086,4366,2,STK25|PDCD10
INTERLEUKIN-13-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035772,0.12989966555183902,0.4885914969802439,-0.9342192324658141,-1.24460433691088,970,1,CD300LF
NOREPINEPHRINE-EPINEPHRINE-MEDIATED VASODILATION INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0002025,0.612307692307692,0.852045339927398,-0.697783414203794,-0.929615055397933,4576,1,ADRB2
XYLULOSE 5-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0051167,0.6751709626512359,0.882488012133495,-0.34305650942725396,-0.8222409918898811,5133,5,CRYL1
MITOCHONDRIAL PROTON-TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY%GOBP%GO:0033615,0.0625572569035467,0.359087664164358,-0.67928549145906,-1.4870979369837702,477,4,OXA1L|TMEM70|ATPAF1
PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0030046,0.382827196990056,0.730480369014206,0.5479665453278839,1.07778553035323,2848,3,SPIRE2|SPIRE1|FMN2
ACYL-COA METABOLIC PROCESS%GOBP%GO:0006637,0.9287833827893179,0.9793746057014829,-0.11964359852365801,-0.6765858971723969,7198,63,DGAT1|ACSL5|ACOT1|ACSF2|FAR1|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|HMGCS1|HACD2|ACOT2|PDHX|ABCD1|FASN
"PROTEIN DEGLYCATION, METHYLGLYOXAL REMOVAL%GOBP%GO:0036530",0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
NEGATIVE REGULATION OF MICROTUBULE MOTOR ACTIVITY%GOBP%GO:2000575,0.356621065214504,0.714406853878965,0.8227282752536391,1.0969971419745201,2684,1,MAP2
REGULATION OF PHENOTYPIC SWITCHING%GOBP%GO:1900239,0.163981663392272,0.535290477921284,-0.511358527749544,-1.3153518862542701,1251,6,SOD2|DNMT1|FGF9|PDGFB
NUCLEAR POLYADENYLATION-DEPENDENT NCRNA CATABOLIC PROCESS%GOBP%GO:0071046,0.43379174852652297,0.7617458538169591,-0.393726180354492,-1.01276980023422,3311,6,EXOSC3|EXOSC2
REGULATION OF HYDROGEN PEROXIDE-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903383,0.5228177235340941,0.807051143864932,-0.589649259982075,-0.9812706606163271,3940,2,PARK7
REGENERATION%GOBP%GO:0031099,0.0719254495340596,0.377545917506675,-0.35961494436726005,-1.46507387270172,547,21,IGF1|CEBPB|DHFR|NOV|RTN4RL1|ANXA1|CPQ
ADULT WALKING BEHAVIOR%GOBP%GO:0007628,0.47749196141479106,0.7850984235874658,0.601974140915169,1.0113942807649499,3563,2,DRD2
L-ARGININE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0097638,0.24603174603174602,0.6280519349499749,-0.616287711579718,-1.20345370323679,1859,3,SLC7A2|SLC7A3
PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING%GOBP%GO:0014065,0.519726962457338,0.8050637202008951,0.218849495917137,0.9535089137388,3806,25,PLEKHA1|ERBB3|NYAP2|NYAP1|IGF1R|NF1|C1QBP
CELLULAR RESPONSE TO INTERLEUKIN-6%GOBP%GO:0071354,0.0378002362514766,0.277240793870994,-0.389067231575901,-1.5850627028561801,287,21,SBNO2|SELPLG|SOCS3|PID1|IL6ST|STAT3|CTR9|RELA|NFKB1|PHB|PTGIS
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT%GOBP%GO:1904746,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS%GOBP%GO:1900377,0.890556514809404,0.965159112268525,0.554367004852228,0.739173598646999,6704,1,RAPGEF2
NEGATIVE REGULATION OF INTERLEUKIN-17 PRODUCTION%GOBP%GO:0032700,0.0424776433456076,0.294833299013666,-0.6591109640414741,-1.5797632108592299,322,5,FOXP3|NCKAP1L|C10orf54|TLR4|PRNP
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS%GOBP%GO:2001026,0.0231584456365302,0.21165950231047198,-0.444805405970177,-1.6903691624819,176,17,KDR|P2RX4|SMOC2|NOTCH1|PRKD1|HSPB1|THBS1|SEMA5A|LGMN|TMSB4X
TRANSLATIONAL ELONGATION%GOBP%GO:0006414,0.00115503080082136,0.0260318042492992,-0.283196225135316,-1.82930423287575,8,107,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|MRPL18|MRPL57|GFM2|MRPS18B|MRPS15|MRPL47|SECISBP2|EEF1D|GNB2L1|GADD45GIP1|MRPS11|MRPL13|OXA1L|MRPL10|MRPL50|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|EEF1G|GFM1|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|EEFSEC|MRPS27|MRPL11|MRPL16
REGULATION OF HYPOXIA-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903297,0.867163983771758,0.9557502153097349,-0.30946146084506604,-0.677475826857723,6625,4,TMBIM6|ENO1
HEPATIC IMMUNE RESPONSE%GOBP%GO:0002384,0.7220748209074029,0.9019989179378242,-0.5066997518610421,-0.84322941447926,5442,2,IL6R|IL6
NEPHRIC DUCT MORPHOGENESIS%GOBP%GO:0072178,0.840374949055835,0.947151866837735,0.322284726244795,0.7080732689053599,6185,4,AHI1|GPC3
MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052312,0.8887290794979079,0.965159112268525,-0.157441223628956,-0.6691207618428969,6796,24,CHD1|CCNT1|CCL3|CCL4|SMARCA4|ZNF639|REST|SNW1|NUCKS1|RRP1B|PSMC3
PURINE NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0034034,0.39632333062990005,0.7377402989373809,0.431845591736601,1.03858617170321,2931,5,NUDT7|ACAT1|ACOT7
NEGATIVE REGULATION OF EXONUCLEASE ACTIVITY%GOBP%GO:1905778,0.976253648182542,0.9926773910205121,-0.323533956058063,-0.53841223985011,7358,2,TERF2
HISTONE H4-K12 ACETYLATION%GOBP%GO:0043983,0.900327439423707,0.9682027743049351,-0.249572555292041,-0.641967843589906,6873,6,ING4|MEAF6|JADE2|JADE1|JADE3|KAT7
CARBOHYDRATE TRANSPORT%GOBP%GO:0008643,0.300945378151261,0.674038850802402,-0.281484810684438,-1.12931166906529,2291,20,SLC2A10|SLC2A6|SLC45A3|SLC2A3|SLC45A1|SLC45A4
NUCLEAR POLYADENYLATION-DEPENDENT RRNA CATABOLIC PROCESS%GOBP%GO:0071035,0.43379174852652297,0.7617458538169591,-0.393726180354492,-1.01276980023422,3311,6,EXOSC3|EXOSC2
GTP BIOSYNTHETIC PROCESS%GOBP%GO:0006183,0.6553462456885121,0.874775007199212,-0.536704664186741,-0.8931623867354581,4939,2,IMPDH2
OSTEOCLAST FUSION%GOBP%GO:0072675,0.6491157556270101,0.871221819348319,0.524935937138807,0.881960151615547,4844,2,SH3PXD2A
STEROL METABOLIC PROCESS%GOBP%GO:0016125,0.0612350135361609,0.35631208031004796,-0.255459305045215,-1.43257110996404,474,61,HMGCR|CYP46A1|SCARF1|APOE|HMGCS1|CYP7B1|EBP|DHCR7|C14orf1|DHCR24|CNBP|NSDHL|TM7SF2|OSBPL5
POSITIVE REGULATION OF TRAIL-ACTIVATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903984,0.147089947089947,0.514131830678897,-0.6762435204588071,-1.32053220224036,1111,3,PTEN|ATF3|TIMP3
POSITIVE REGULATION OF DNA LIGATION%GOBP%GO:0051106,0.829954041632874,0.9435818887072471,0.294022426182417,0.707122248893863,6139,5,PARP3|HMGB1|APLF|XRCC1|RAD51
MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION%GOBP%GO:0072656,0.404004711425206,0.7412049911665691,-0.478748406238363,-1.04808033765321,3086,4,PINK1|AKT1|HK1
REGULATION OF COA-TRANSFERASE ACTIVITY%GOBP%GO:1905918,0.760260326736618,0.91797162753179,0.6196515218350239,0.826221693017205,5723,1,CHRNA7
HAIR CYCLE%GOBP%GO:0042633,0.862457569585879,0.9527544063641651,0.194315451070113,0.6805332219205861,6351,13,FGFR2|HDAC1|ATP7A
REGULATION OF GLIAL CELL APOPTOTIC PROCESS%GOBP%GO:0034350,0.970246145523397,0.9915747942934481,0.19754057531657,0.545305455862404,7173,7,DLL1|PRKCA|PRKCI|PRKCD
NEGATIVE REGULATION OF DOPAMINE METABOLIC PROCESS%GOBP%GO:0045963,0.14778455823826,0.514965886850433,-0.7655913978494621,-1.2740665132909,1113,2,ITGB2|ITGAM
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME%GOBP%GO:0150033,0.740603001726657,0.909493931144346,0.6293008381120421,0.8390877542628009,5575,1,ROCK2
REGULATION OF RESPONSE TO TUMOR CELL%GOBP%GO:0002834,0.6840168243953728,0.885415243771438,-0.29737847526232897,-0.812870800725774,5203,7,PVR|CD274|PVRL2|CEACAM1
REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE%GOBP%GO:0031630,0.669540992305651,0.8815356925073421,-0.5303556658395371,-0.88259663820454,5046,2,STXBP1|RAB3A
PERICARDIUM MORPHOGENESIS%GOBP%GO:0003344,0.8333107099226279,0.9446656856458421,0.271617263072784,0.702825632576354,6138,6,BMP7|LRP6|FLRT3
PRONEPHROS DEVELOPMENT%GOBP%GO:0048793,0.14033419372367903,0.504904319412958,0.615969539819296,1.35331131167133,1032,4,PAX8|AHI1|CEP290
REGULATION OF RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:1903969,0.120664834445753,0.472686039512467,-0.6281810649294971,-1.37521966456606,921,4,TLR2|CSF1|TLR4
SECONDARY METABOLIC PROCESS%GOBP%GO:0019748,0.284186298402383,0.6569867235097528,0.281726986516505,1.1417756314293201,2098,20,BDH2|CITED1|CBR4|ETHE1|AS3MT|CTH|CYP2D6|MPST|AKR1C2|AKR7A2|CBS|AKR1C1|AKR1C3
REGULATION OF ASPARTIC-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902959,0.5639156469669361,0.8289882771095609,-0.314713363820057,-0.9060157270169309,4331,8,EFNA1|EFNA3|EPHA4
PRIMARY HEART FIELD SPECIFICATION%GOBP%GO:0003138,0.296588628762542,0.6687276080240239,-0.848698720776356,-1.13067048065468,2216,1,MEF2C
REGULATION OF ANTRAL OVARIAN FOLLICLE GROWTH%GOBP%GO:2000387,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
ENDOCRINE PANCREAS DEVELOPMENT%GOBP%GO:0031018,0.335690968443961,0.698765476168984,0.322378884727559,1.0957031258692802,2467,12,DLL1|INSM1|RFX3|NKX6-1|EIF2AK3
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION%GOBP%GO:0086004,0.110443686006826,0.455896780647818,0.31479651612765097,1.37154204026719,808,25,TRPM4|BIN1|SCN5A|ANK2|RANGRF|RNF207|SRI|CACNA1C
REGULATION OF NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY%GOBP%GO:0070424,0.480536559705418,0.7857006060206241,-0.40369669585009904,-0.967583947532823,3653,5,BIRC3|PTPN22|ERBB2IP|XIAP
PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE%GOBP%GO:0070782,0.441492894142648,0.7653693162885199,0.780822673136304,1.04112167599365,3323,1,XKR8
ORGANELLE FISSION%GOBP%GO:0048285,0.806771369721936,0.933810206759044,-0.11322638438265101,-0.84109544555246,6266,216,RHOA|KIF25|CENPE|KIF2C|CDCA8|NIPBL|GOLGA2|PAPD7|C17orf104|BECN1|VPS4A|NCAPG|BLM|NDE1|FIGNL1|TUBG1|RAD54B|BCCIP|CHMP5|RAD21|INO80|PINX1|ZNF207|ZWINT|TUBGCP5|RACGAP1|TRIP13|NCAPD3|KNSTRN|CEP192|EME2|KLHL22|MX1|KIF11|MYBL1|SLC25A46|DMC1|NCAPH|MUL1|RAD51|PIM2|RPA2|NUSAP1|MTFP1|NUF2|DLGAP5|MLH3|NSL1|FIS1|SPDL1|BRIP1|CDT1|SMC2|DSN1|ESPL1|OFD1|GSG2|TUBGCP2|RAD51C|TUBG2|CDC23|TPX2|BOD1|OPA1|KPNB1|PTTG1|TOP2A|NCAPH2|KIF18B|UBE2S|STRA13|KIF4A|NAA50|NDC80|SGOL1|EME1|KIF18A|SPICE1|RMI1|FLNA|REC8|RAN|RAD51B|SMC4|KIFC1|KIF2A|CCNB1|PLK1|CHMP4A|CHMP6|FANCM|SMC1A|EPS8|KIF22|SYCE2|MUS81|CDCA5
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED EIF2 ALPHA DEPHOSPHORYLATION%GOBP%GO:1903917,0.753846153846154,0.915550465961143,-0.627646669607411,-0.8361760707700259,5634,1,PPP1R15A
REGULATION OF PROTON TRANSPORT%GOBP%GO:0010155,0.0395598637673566,0.28367988634143604,-0.49671724576314,-1.6081488075397101,301,11,CHCHD10|ACTN4|DNAJC30|PPIF|SLC9A3R1|TESC|COX17|SLC30A5|TMSB4X
ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0032509,0.667072840509071,0.880719592999549,0.207979035173693,0.842891897385174,4926,20,CHMP3|TMEM50B|VPS36|SORT1|LEPROTL1|UBXN6|CHMP1A|LAPTM4B
ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME%GOBP%GO:0070199,0.77202614379085,0.9215496572020819,-0.22474290148210102,-0.7522355342982091,5905,12,H2AFY|CCDC101
WNT RECEPTOR CATABOLIC PROCESS%GOBP%GO:0038018,0.567140390490105,0.831087370400857,0.7141596823996469,0.9522355728740729,4269,1,ZNRF3
POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905932,0.40414715719063593,0.7412049911665691,-0.7982465813850899,-1.06345611671244,3020,1,SOD2
TERMINATION OF SIGNAL TRANSDUCTION%GOBP%GO:0023021,0.475,0.784986345464663,-0.51469442591037,-1.00506776503696,3590,3,SMPD1
BASOPHIL ACTIVATION%GOBP%GO:0045575,0.75242396068535,0.915314007578303,0.624448610498456,0.832617963465015,5664,1,KARS
"REGULATION OF MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0048024",0.13231715127449697,0.49242794208021295,-0.21139415027453895,-1.27065011457144,1032,80,SF3B4|RBM15B|MBNL1|CELF2|PTBP1|SRSF3|REST|SRSF10|HNRNPL|SON|RBM17|SRSF9|HNRNPU|RBMX|CELF1|FMR1|MAGOH|SRSF5|SRSF1|NCBP1|DDX5|SNW1|JMJD6|CELF4|RBM15|RBM4B|SMU1|TRA2B|SRSF2|RBM8A|RBFOX3|NUP98|RBM4
PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0003301,0.646972132904609,0.8697778704754799,0.526550868486352,0.88467344479165,4828,2,PDLIM5|SORBS2
AXIS ELONGATION%GOBP%GO:0003401,0.21382201785231303,0.597251886937452,0.450806973759652,1.24444055069701,1580,7,FGFR2|PTK7|LRP6|FGF1
REGULATION OF MITOTIC DNA DAMAGE CHECKPOINT%GOBP%GO:1904289,0.7465166130760992,0.9118647019584949,0.475323959194927,0.7986056230080659,5571,2,RINT1|PPP1R10
DETECTION OF ABIOTIC STIMULUS%GOBP%GO:0009582,0.036231884057971,0.27097761630552397,0.322531014673823,1.5633124180456999,264,35,PDE6B|PLEKHB1|GNGT1|EYS|PIEZO2|KIT|COL11A1|OPN3|MMP24|PKD1|CDS1|MKKS|PKD2|UNC119
CHEMOSENSORY BEHAVIOR%GOBP%GO:0007635,0.00366797989403614,0.0646052543079676,0.832625599735289,1.82931390217682,26,4,ADCY3|TAS2R5|CFAP69|TRPV1
NEGATIVE REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051945,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
"AROMATIC AMINO ACID FAMILY BIOSYNTHETIC PROCESS, PREPHENATE PATHWAY%GOBP%GO:0009095",0.886571921901979,0.964939379509639,0.556296868107631,0.7417468108961179,6674,1,PAH
POSITIVE REGULATION OF COFACTOR METABOLIC PROCESS%GOBP%GO:0051194,0.846677132391418,0.949216083775675,-0.189161610182931,-0.702997788202607,6471,16,PFKFB2|PFKFB3|INS|IGF1
LACTOSE BIOSYNTHETIC PROCESS%GOBP%GO:0005989,0.11077208808702599,0.45638735792888,-0.793327819134271,-1.32022435369606,834,2,SLC2A1|B4GALT1
MODULATION OF MOLECULAR FUNCTION IN OTHER ORGANISM%GOBP%GO:0044359,0.665487884741323,0.8804055751124069,-0.32195484177250894,-0.8281545831999509,5080,6,RAB9A|NUCKS1|ANXA2
CHROMATIN ORGANIZATION%GOBP%GO:0006325,0.00012664640324214799,0.00518555396908895,-0.23656715731908298,-1.97528734066917,0,443,SETD1B|USP16|H1F0|HIST1H2BE|KAT6A|KANSL1|SMARCA4|PER2|SETMAR|SMARCA2|SET|REST|DTX3L|KANSL2|HR|JADE3|UBE2B|HMGB2|KDM1A|EZH2|H2AFX|BCOR|HIST2H2AC|HIST1H2AD|KDM3B|GSG2|KDM8|NSD1|YEATS4|TAF6L|BRPF3|TOP1|OIP5|RUVBL1|PAXIP1|CENPM|KDM2A|HIST1H2AI|CDKN2A|HCFC1|SMARCE1|OGT|HIST1H2BN|NPM1|H2AFV|HLCS|TAF12|BRCC3|ASF1B|PKN1|CHAF1A|MORF4L2|CENPI|IPO4|HIST1H2BC|MSL2|SUPT16H|ELOF1|USP51|BRMS1L|PHF20|PIWIL1|SMARCD3|RNF168|HIST1H4I|STRA13|NAA50|C14orf169|UHRF1|CTR9|ANP32B|NUCKS1|RBBP7|JMJD6|HUWE1|RNF20|SKP1|CENPH|NAP1L4|HDAC5|MIER3|WDR5|SMARCD2|HIST1H2AK|PPM1D|KAT7|HIST2H3A|TAF9B|KDM5C|SPI1|MBIP|RBM14|PRMT3|BRMS1|KAT2B|HIST2H2BF|RING1|H2AFZ|RNF40|HDAC8|SPTY2D1|HIST2H2AA4|H1FX|HIST3H2A|HIST1H2BG|SNAI1|HIST1H2BD|CHAF1B|MYSM1|SIRT4|HIST2H4A|MYC|APBB1|HIST1H2AE|TAF10|DDB1|CHD8|HIST2H3C|PAGR1|HMGB3|MTA2|SUPT4H1|HIST1H3H|RPS6KA4|KAT8|KAT5|TAF9|ACTB|POLE3|VRK1|HIST1H1C|H2AFY|HIST2H4B|RRP8|CENPK|PRMT5|H3F3B|PHB|HIST1H2AC|CCDC101|MIS18A|HIST3H2BB|HIST2H2BE|H2AFJ|HIST1H2BK|AK6|HIST1H2BJ|HNRNPC|LOXL2|PRKCB|HIST2H2AA3|NTMT1|HIRIP3|CENPP|SUV39H1
PROGRAMMED NECROTIC CELL DEATH%GOBP%GO:0097300,0.0332500985674859,0.260356918381151,-0.410430750469789,-1.62157360529357,252,19,RIPK3|PGAM5|PPIF|TICAM2|MLKL|FADD|ITPK1|TICAM1|TLR4|CD14|LY96
CELLULAR RESPONSE TO PHEROMONE%GOBP%GO:0071444,0.516387959866221,0.804056180000979,-0.7445963828848701,-0.991981170137787,3859,1,GNG8
REGULATION OF CARDIAC MUSCLE MYOBLAST PROLIFERATION%GOBP%GO:0110022,0.8844396667562479,0.9635685363561758,0.33780452495543206,0.6644216370307039,6581,3,ATF2|MEIS2
FATTY ACID OMEGA-OXIDATION%GOBP%GO:0010430,0.224996679505911,0.6078034241178771,0.888784737538597,1.1850745212443798,1693,1,CYP4V2
NEGATIVE REGULATION OF CHOLESTEROL STORAGE%GOBP%GO:0010887,0.156209320489456,0.525661258438322,-0.461250091822076,-1.32787445758975,1199,8,ABCG1|NR1H3|PPARG|PPARA
REGULATION OF BEHAVIORAL FEAR RESPONSE%GOBP%GO:2000822,0.0535951180684532,0.33531875720878496,-0.8487455197132621,-1.41244826941612,403,2,MEF2C|APOE
REGULATION OF SENSORY PERCEPTION OF PAIN%GOBP%GO:0051930,0.13577193439208501,0.498614450236932,-0.473039264738131,-1.3618138363972399,1042,8,ZFHX2|F2R|NOV|MGLL
"NEGATIVE REGULATION OF COMPLEMENT ACTIVATION, LECTIN PATHWAY%GOBP%GO:0001869",0.013531440700451,0.154334841212238,-0.9237386269644331,-1.53724879218158,101,2,A2M|SERPING1
TRIGLYCERIDE TRANSPORT%GOBP%GO:0034197,0.043380206951446,0.29791299041195396,-0.8650675489385171,-1.4396107361356598,326,2,CETP|CD36
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:0001937,0.00247815312377723,0.046957315655462996,-0.455959795609115,-2.01100545674813,18,27,SYNJ2BP|ATPIF1|CAV2|MEF2C|GHRL|SPARC|SULF1|CCL2|APOE|THBS1|ATOH8|NR2F2|CAV1|PPARG|NGFR
RNA CATABOLIC PROCESS%GOBP%GO:0006401,0.8397648862765141,0.9470274567210699,-0.11032617700030999,-0.823776752424217,6571,221,RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|PATL1|NUDT16|RPL10|DDX5|RPL36A|RPL24|PELO|LSM3|NT5C3B|RPL35|RNASE6|PPP2CA|RPL38|RPS15A|MAGOHB|EIF4A3|EXOSC3|RPS13|RBM8A|TNKS1BP1|POLR2G|TUT1|RNH1|SKIV2L2|EXOSC2|ERN1|FEN1|EIF4G1|RNASEH2C
N-TERMINAL PEPTIDYL-GLUTAMIC ACID ACETYLATION%GOBP%GO:0018002,0.89479968161316,0.966256689108312,-0.40457162931803897,-0.673271887052999,6744,2,NAA10
"NEGATIVE REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION, TELOMERIC%GOBP%GO:1904908",0.8882636655948549,0.965159112268525,0.3972980424593329,0.667512008558366,6629,2,TNKS|ATRX
MODULATION OF SIGNAL TRANSDUCTION IN OTHER ORGANISM%GOBP%GO:0044501,0.211772575250836,0.5937395205509979,-0.892258491398324,-1.1887025544408798,1582,1,TNIP1
REGULATION OF MESODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042661,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
CELLULAR RESPONSE TO L-ARGININE%GOBP%GO:1903577,0.407148615963451,0.74431926580977,0.5358313095857921,1.05391695370057,3029,3,GATSL3|GATS|GATSL2
POSITIVE REGULATION OF NEUTROPHIL EXTRAVASATION%GOBP%GO:2000391,0.836030777394534,0.9458604798764101,-0.43968474642232397,-0.7317057289241271,6301,2,ADAM8
DIHYDROBIOPTERIN METABOLIC PROCESS%GOBP%GO:0051066,0.295922433258069,0.6687276080240239,0.8539920599911779,1.13868318041026,2227,1,QDPR
LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS%GOBP%GO:0097021,0.128191346412255,0.485140970734313,0.6858334550968389,1.34895347250303,953,3,RET|CCR7|WNK1
POSITIVE REGULATION OF HISTONE H3-K4 TRIMETHYLATION%GOBP%GO:1905437,0.9487315712578029,0.984457616015067,0.525474194971328,0.700648935260185,7142,1,KMT2E
REGULATION OF NEUTROPHIL MEDIATED KILLING OF GRAM-NEGATIVE BACTERIUM%GOBP%GO:0070951,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
MESENCHYME MIGRATION%GOBP%GO:0090131,0.0157866808171929,0.170321316621193,-0.919878687620623,-1.53082523586277,118,2,ACTG2|ACTA2
NEGATIVE REGULATION OF RIG-I SIGNALING PATHWAY%GOBP%GO:0039536,0.318402095612312,0.6867397844771489,-0.43524004887559103,-1.1195546533298601,2430,6,SEC14L1|NPLOC4|DHX58
NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS%GOBP%GO:0002689,0.0979827089337176,0.43163319977057396,-0.4426908119504899,-1.43323532134103,747,11,DUSP1|GREM1|SLAMF8|CCL2|NOV|NBL1|SLIT2
MODIFICATION-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0019941,0.628643852978454,0.8598964527864159,-0.11449024630931201,-0.936634294688823,4959,383,UBD|PCYOX1L|PML|CUL4B|FBXO45|DCAF11|FBXW11|LONP1|KLHL20|MARCH6|PSMD1|PSMC2|TTC3|ARRDC1|PCNP|CDC20|ANAPC10|TRIM3|UBE2Z|HSP90B1|RNF216|DTX3L|UBE2B|TSG101|FBXO6|ANAPC2|RLIM|TRIM9|HSPA13|ANAPC5|KCTD2|UBQLN2|RNF121|USP9X|PSMD3|KLHL15|PSMB2|UBAP1|CDC23|PSMF1|PTTG1|ARMC8|VCP|RNF144B|UBE2G2|MAD2L1|TNFAIP3|RNF7|SIAH2|PSMD4|RBBP6|SEL1L|SMURF2|UBE2S|UBQLN1|RNF168|UBXN1|ARRB1|PSMB5|UHRF1|TRIM32|UBE2R2|FAF2|HUWE1|MVB12B|CDC27|RAD23B|RNF20|SEC13|DTL|SKP1|NPLOC4|RCHY1|NEDD8|VPS25|PSMC6|USP44|FBXO4|CCNB1|PLK1|NSFL1C|PSMB3|SYVN1|SNF8|RNF40|KIAA0368|PSMD2|SEC61B|UBC|SGTB|PSMD6|ERCC8|FBXW5|DDB1|SPOP|PLAA|DERL3|MYLIP|PSMD12|PSMA3|KAT5|HSPA5|ANAPC11|UBE2L6|TOLLIP|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|SQSTM1|RMND5B|RNF130|SPSB1
REGULATION OF TYPE III INTERFERON PRODUCTION%GOBP%GO:0034344,0.47678429291589297,0.7850984235874658,-0.6079326416435121,-1.0116971314335101,3593,2,IFIH1
VITAMIN A IMPORT%GOBP%GO:0071939,0.0193916854827998,0.19226875441368102,0.990681517423908,1.32094012799787,145,1,STRA6
KETONE BODY BIOSYNTHETIC PROCESS%GOBP%GO:0046951,0.0826345685691101,0.399980174480082,0.536177363504812,1.48010322011332,610,7,BDH2|HMGCLL1|ACAT1|HMGCL|SLC27A5|BDH1
REGULATION OF MITOTIC COHESIN LOADING%GOBP%GO:1905405,0.772307692307692,0.9215496572020819,-0.6184384649316279,-0.82390853112155,5772,1,NIPBL
"CD4-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002294",0.405880808611184,0.743232206038237,-0.28571666698996,-1.03739090351836,3091,15,GPR183|BATF|RORA|SPN|PTGER4|STAT3|FOXP1
"NEUROTRANSMITTER RECEPTOR TRANSPORT, ENDOSOME TO PLASMA MEMBRANE%GOBP%GO:0099639",0.247769667477697,0.62852193925262,0.497013797858657,1.19531533371896,1832,5,LRRC7|VPS35|RAB11A
OSSIFICATION%GOBP%GO:0001503,0.0027851626788201,0.0518259315999323,-0.279982296860586,-1.7720934561235402,21,97,LGR4|DHX9|ACP5|PSMC2|ACHE|OSTF1|ITGA11|SBDS|HNRNPU|RBMX|TGFB3|DHX36|ATP5B|CLEC3B|MEF2C|CLTC|SNAI2|MMP14|CREB3L1|SPP1|MRC2|VCAN|IGF1|MEN1|LRP5|RRAS2|SEMA7A|CDH11|EPHA2|CAT|TNC|BMP2|EXT2|COL1A1|CCDC47|SNAI1|COL6A1|WNT3|CLEC11A|ALPL|PHB|FASN|RRBP1|COL13A1|HNRNPC
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL%GOBP%GO:1903322,0.6055888732933521,0.8484904679028091,-0.143387979326672,-0.921433750582603,4745,104,TRIB3|SMAD7|FZR1|BIRC3|PTPN22|MALT1|ZC3H12A|PIAS1|GOLGA2|TRAF6|AMER1|UBE2N|TOPORS|SART3|MTA1|RIPK2|UBE2L3|PTEN|SPRTN|RPS2|ADRB2|MUL1|GNL3|PRICKLE1|PEF1|NDFIP1|DCUN1D1|CDC20|KDM1A|PDCD6|PAXIP1|NDNL2|VCP|MAGEC2|SENP2|UBE2S|DCUN1D3|UBQLN1|BRCA1|STRA13|CTR9|ARRDC3|RNF20|TNIP1|RCHY1|FBXO4|PSMD10|PLK1|RNF40|XIAP|FKBP1A|FANCM|CAV1|FAM107A|SPHK1
POSITIVE REGULATION OF IMMUNOGLOBULIN SECRETION%GOBP%GO:0051024,0.385909568874869,0.7332167375750358,-0.387006537541967,-1.05786511206078,2935,7,HLA-E|STX4|GPI|TNFRSF4
PEPTIDYL-ARGININE OMEGA-N-METHYLATION%GOBP%GO:0035247,0.288661202185792,0.661755006838166,0.395882694010948,1.14917820259864,2112,8,NDUFAF7|PRMT9|CARM1|PRMT7|PRMT6
MACROMOLECULE METHYLATION%GOBP%GO:0043414,0.7927504150525729,0.9295725785163721,0.118358061649882,0.836599213821861,5729,156,TDRD12|FDXACB1|NDUFAF7|METTL21A|HENMT1|N6AMT2|PRDM5|TRMT6|PICK1|ALKBH8|ZC3H13|METTL1|SETDB2|PRMT9|METTL21B|TFB1M|TET2|TRMT44|CHD5|SETD6|MTERF4|CARM1|WDR61|TET3|TRMT1|PRMT7|RNMTL1|DPY30|CAMKMT|RAB6A|EEF2KMT|DNMT3A|METTL14|NSUN4|GTPBP3|GATAD2A|TGS1|DYDC2|NSUN3|WBSCR22|PIWIL4|TRMT1L|TRMT61B|CMTR1
REGULATION OF METANEPHROS DEVELOPMENT%GOBP%GO:0072215,0.13112391930835698,0.490819490032838,-0.421498487077968,-1.3646240293767602,1000,11,PDGFRB|MYC|PDGFA|PDGFB
RESPONSE TO HOST%GOBP%GO:0075136,0.9028664583616359,0.968731546286171,0.294620848442425,0.647294551234315,6645,4,SMAD3|EIF2AK2
NEGATIVE REGULATION OF TYPE I HYPERSENSITIVITY%GOBP%GO:0001811,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS%GOBP%GO:1901509,0.635388038214893,0.863600910248377,-0.389922829259212,-0.853622581764204,4854,4,FOXP1
ETHER METABOLIC PROCESS%GOBP%GO:0018904,0.15703451882845199,0.526766997431232,-0.42371350151131304,-1.32743908848589,1200,10,FAR1|TMEM86B|PLA2G16|DHRS7B|TMEM86A
DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT%GOBP%GO:0060600,0.193311036789298,0.567519363754568,-0.901742390824879,-1.2013373856956,1444,1,CTSH
CELLULAR RESPONSE TO X-RAY%GOBP%GO:0071481,0.908623952419573,0.9715076818387142,0.265120217598553,0.637612602989706,6721,5,ATM|XRCC5
CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098655,0.0915141430948419,0.418548943328826,-0.16453487190997101,-1.24823697019553,714,242,SLC25A27|SLC39A1|CCL19|KCNA3|KCND2|RYR2|SLC36A1|TCIRG1|ITPR2|ATP6V0B|ATP1B1|CCDC109B|ATP2A1|P2RX4|SLC12A8|ERO1L|SLC39A3|ATP5J|SLC7A2|ITPR3|SLC8B1|ATP1A3|ATP5F1|SLC12A2|PMPCA|ATP1B3|KCNN2|GAS6|ATP6V1F|KCNK6|SLC39A8|CACNA1H|ATP2A3|GRIN1|SLC41A1|ATP5B|KCNK7|ATP6V0D1|SLC9A1|RHBG|CACNA2D4|PKD2L1|SLC39A11|ABCC9|SLC9A7|SLC11A1|CACNA1G|MRS2|NALCN|SLC1A3|NDUFS7|SLC9A9|ATP5O|KCNJ12|KCNN1|SLC24A3|HFE|F2R|KCNQ1|STEAP4|SLC7A3|TMCO1|KCNB2|ATP6V0E1|GRIN2C|GRIN2D|FKBP1A|SLC3A2|RHCE|SCN1B|STOML2|ATP6AP1|ATP1B2|KCNH2|ATP6V0E2|KCNE4|ATP5H|KCNJ9|PHB|SLC25A19|ATP5G1
REGULATION OF COHESIN LOADING%GOBP%GO:0071922,0.18990005260389303,0.56366737984224,-0.533753484505162,-1.27930525281949,1443,5,HDAC8|CDCA5
NUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009163,0.127937336814621,0.485006465714925,-0.32077768022632397,-1.3468112366355902,979,23,IMPDH2|ADA|TYMP|CTPS1|HPRT1|CDA|UMPS|GMPS|TK1|UCK1
NEGATIVE REGULATION OF NETRIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:1902842,0.441303494307028,0.7653693162885199,-0.461523681376461,-1.0103718143160898,3371,4,SIAH2|NTN1
MESONEPHRIC EPITHELIUM DEVELOPMENT%GOBP%GO:0072163,0.017584201271473,0.180237022041183,0.431976354453479,1.72223957153922,129,19,FOXC1|FGFR2|CITED1|PAX8|FGF2|ROBO2|BMP7|PKD1|PKD2|FGF1|FOXJ1
POLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0005976,0.31055171514282,0.6814452407589661,-0.21716917374068398,-1.10705506598779,2380,44,GYG1|PER2|AOAH|GAL3ST3|GAA|PHKG2|CHST7|NDST1|PPP1R3C|PGM5|NR1D1|EXT2|B3GNT5|PYGL|PYGM|B4GAT1|CSGALNACT1|GYG2
"BASE-EXCISION REPAIR, DNA LIGATION%GOBP%GO:0006288",0.7977694168234352,0.9308634013872809,0.37608911437079495,0.7397229065319342,5936,3,POLB|LIG3|XRCC1
LUNG EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0060487,0.8969363074442349,0.967166974453851,0.33179773750424196,0.6526069949617691,6674,3,ASCL1|NFIB
MISMATCH REPAIR INVOLVED IN MAINTENANCE OF FIDELITY INVOLVED IN DNA-DEPENDENT DNA REPLICATION%GOBP%GO:0070716,0.387833709655997,0.734887192861895,0.8075650639611819,1.07677904573144,2919,1,MCM9
SEXUAL REPRODUCTION%GOBP%GO:0019953,0.0233398166157266,0.212379507128048,0.190559141250661,1.4185423582548702,167,201,TDRD12|NPHP1|SPAG6|TSGA10|DDX25|TDRD6|UBXN8|LRGUK|BBS4|SPATA6|CFAP44|PICK1|CFAP43|PSME4|IFT20|TSSK6|ZNF296|IGSF8|KIT|C14orf39|DZIP1|C9orf117|AZIN2|IQCG|BRCA2|IFT81|NME5|ADCY3|CHD5|SPIRE2|PDE3A|TOB2|WDR33|TDRP|SPESP1|PCSK4|CEP57|TUBGCP3|HSPA2|MKKS|TRIM27|PARN|C1orf111|LEPR|HERC4|NDRG3|DNAH1|XRN2|ELL3|CATSPERG|MAST2|MCM9|SPATA2|RHOXF1|PRMT7|CATSPER2|IFT27|BBS2|PRND|TEX14|DPY19L2|METTL14
REGULATION OF NEUTROPHIL ACTIVATION%GOBP%GO:1902563,0.0347185691741189,0.266191770413233,-0.67047209353629,-1.6069936703552499,263,5,SYK|ITGB2|FCGR2B|CD300A|ITGAM
NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS%GOBP%GO:0070229,0.34976402726796,0.7075366679683229,-0.30774510636172303,-1.0887571835980099,2667,14,TNFRSF4|FADD|FOXP1|BCL6
REGULATION OF EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT%GOBP%GO:1902954,0.6767148981779211,0.8835592822191172,0.5079680176454371,0.8534518560499191,5050,2,DNAJC13|SORL1
NICOTINAMIDE NUCLEOTIDE BIOSYNTHETIC PROCESS FROM ASPARTATE%GOBP%GO:0019355,0.559656084656085,0.8268422944617521,-0.475265234859766,-0.928072548202521,4230,3,NMNAT3
CELLULAR RESPONSE TO OXYGEN-GLUCOSE DEPRIVATION%GOBP%GO:0090650,0.5456859592711679,0.817297924969912,0.5720430107526879,0.9611061175273399,4072,2,TSC1|IREB2
NEGATIVE REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS%GOBP%GO:0032057,0.7983248265933779,0.9312571284928459,-0.334895833495061,-0.7331569853276941,6099,4,EIF2S1
TRNA AMINOACYLATION FOR PROTEIN TRANSLATION%GOBP%GO:0006418,0.8644553644553641,0.953780499050319,0.139624767520527,0.719225465148382,6332,43,PARS2|DARS|SARS2|CARS2|RARS2|DARS2|FARS2|IARS2|LARS2|AIMP1|WARS2|HARS2|QARS|YARS2|FARSB|VARS2|MARS|EPRS|KARS|MARS2|TARS2|EARS2
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010656,0.6581552892131322,0.8766757616551658,-0.278185537396912,-0.836850188643668,5051,9,BAG3|DNMT1|IGF1
ACTIVATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C%GOBP%GO:0008635,0.13967693769512698,0.504314492208813,0.526449938684839,1.36222015857956,1028,6,CASP9|BOK|APAF1|BAX
NEURAL CREST CELL DEVELOPMENT%GOBP%GO:0014032,0.0662097504202767,0.3690551432905871,-0.29094910560763204,-1.44841041139096,511,40,SEMA4A|PEF1|JAG1|CORO1C|SOX10|TBX1|SEMA6A|PDCD6|ANXA6|SNAI2|SEMA3B|SEMA3D|SEMA7A|FN1|SEMA5A|TCOF1|SEMA3E|SEMA3A|SEMA6B
GUANINE DEGLYCATION%GOBP%GO:0106044,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
POSITIVE REGULATION OF NECROTIC CELL DEATH%GOBP%GO:0010940,0.19470572426767002,0.569626484656312,0.643752931837806,1.26618604908096,1448,3,HEBP2|RIPK1
MHC PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0002396,0.0256712508185986,0.22470485454905398,-0.6403397496001321,-1.64712633460305,195,6,HLA-DRB1|HLA-DMA|HLA-DMB|HLA-DRA|TAPBP|CALR
PIGMENT ACCUMULATION%GOBP%GO:0043476,0.817908817908818,0.93826094282131,0.234897493555809,0.713831818322121,5991,9,BLOC1S3|AP1M1|BLOC1S5|AP1G1|BLOC1S6|AP3D1
POSITIVE REGULATION OF INTERLEUKIN-2 BIOSYNTHETIC PROCESS%GOBP%GO:0045086,0.731325618095739,0.9074802896081321,-0.326992570842903,-0.783738796384814,5560,5,IL1B|CD4|CD86
NEURAL PLATE REGIONALIZATION%GOBP%GO:0060897,0.4542435914464071,0.7707713235598309,0.7739854433171591,1.0320051525967702,3419,1,CELSR2
REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME%GOBP%GO:1904779,0.902588912133891,0.9686656000326079,-0.201603704418904,-0.631598088507133,6902,10,GSK3B|CEP72|BICD1|APC|NSFL1C
MUSCLE FILAMENT SLIDING%GOBP%GO:0030049,0.9707436001625359,0.9915747942934481,0.131229878255228,0.540949379504641,7166,21,DMD|NEB|TPM1|TPM2|TMOD1|MYL6B
REGULATION OF NEUTROPHIL EXTRAVASATION%GOBP%GO:2000389,0.836030777394534,0.9458604798764101,-0.43968474642232397,-0.7317057289241271,6301,2,ADAM8
POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0032106,0.64520350739432,0.86905852565918,-0.38645397181087204,-0.8460285276882992,4929,4,SNW1|GHRL
POSITIVE REGULATION OF CENTROSOME CYCLE%GOBP%GO:0046607,0.8216610257745379,0.9407209296821379,-0.24551823045948498,-0.7068126226531859,6311,8,CENPJ|CEP120|CEP295|UBXN2B|VPS4B|NUP62|PLK4|NSFL1C
MITOTIC CYTOKINESIS%GOBP%GO:0000281,0.367781155015198,0.721642468110297,0.17925378555198002,1.0586947293134998,2661,71,EFHC1|CHMP3|RHOC|CNTROB|BBS4|RTKN|TTC19|ARL3|TRIM36|SNX33|SEPT2|BRCA2|SPTBN1|SEPT10|MYH10|CUL7|UNC119|SEPT4|MITD1|SEPT12|SPAST|PDCD6IP|STAMBP|CHMP1A
UDP-GLUCOSE METABOLIC PROCESS%GOBP%GO:0006011,0.978042328042328,0.992911113511248,-0.272843443604021,-0.532794093472146,7393,3,UGP2|GALT
NEGATIVE REGULATION OF TELOMERIC DNA BINDING%GOBP%GO:1904743,0.82636655948553,0.943041978946366,0.435015164047422,0.7308816426810479,6167,2,TNKS|ERCC4
METANEPHRIC DISTAL CONVOLUTED TUBULE DEVELOPMENT%GOBP%GO:0072221,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
REGULATION OF PROTEIN OLIGOMERIZATION%GOBP%GO:0032459,0.33037784749693105,0.6957352559323989,0.22895540681598198,1.09029649618433,2421,33,RHOC|MIEF2|HRK|PMAIP1|DNM1L|BID|PEX5|SH3GLB1|BAX|SRC|EP300|HDAC6|BMF|TCL1A|TRABD2A
PROTEIN-CONTAINING COMPLEX REMODELING%GOBP%GO:0034367,0.1142221640717,0.463696586909637,-0.3631929170487,-1.38022177511964,872,17,APOC2|PLTP|AGT|ABCA5|APOC1|PLA2G2A|ABCG1|CETP|PLA2G7|APOM|APOE
INTERACTION WITH OTHER ORGANISM VIA SECRETED SUBSTANCE INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052047,0.173645484949833,0.5478649030775731,-0.9110057344508159,-1.2136783836653202,1297,1,FN1
SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE%GOBP%GO:0039692,0.533669810067738,0.812176596630381,0.731693868548743,0.9756150441660709,4017,1,SMARCB1
NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS%GOBP%GO:1901292,0.0230580960968698,0.21132547286123998,-0.269404216359365,-1.57476143336209,178,72,DNPH1|DCTPP1|GPI|PFKFB2|NUDT17|GPX1|HK1|VCP|NUDT1|HK3|PDE4D|NUDT16|PDE2A|SMPDL3A|ENO1|PGAM1|HPRT1|GAPDH|NUDT18|NUDT4|LDHA|ABCD1|HINT1|PNP|PGK1|SAMHD1|ALDOA|ALDOC
CELLULAR RESPONSE TO INTERFERON-BETA%GOBP%GO:0035458,0.543241773184661,0.8163350846796089,0.291736430399017,0.92424073145607,3994,10,HTRA2|PNPT1|CDC34|UBE2K
REGULATION OF MYOBLAST DIFFERENTIATION%GOBP%GO:0045661,0.508329947175945,0.798966294578331,0.23169117170474998,0.955066005065006,3752,21,DLL1|TBX3|RBM24|FLOT2|BTG1
REGULATION OF OSTEOBLAST PROLIFERATION%GOBP%GO:0033688,0.0746735582154516,0.383186929742657,0.434347297846404,1.47626198398624,548,12,NELL1|SFRP1|FGFR2|PLXNB1
ACETYL-COA METABOLIC PROCESS%GOBP%GO:0006084,0.922543823889115,0.9776156396135859,0.16082575571410998,0.618422945856242,6788,17,ACACB|NUDT7|ACAT1|PIPOX|DLD
POSITIVE REGULATION OF INTEGRIN BIOSYNTHETIC PROCESS%GOBP%GO:0045726,0.7014046822742479,0.8931369333627571,-0.652183502426114,-0.8688650237255441,5242,1,TGFB2
CELLULAR RESPONSE TO CALORIC RESTRICTION%GOBP%GO:0061433,0.866889632107023,0.9555750264459809,-0.569585355094839,-0.758824458495508,6479,1,SIRT2
DOLICHYL DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0046465,0.0598054679284963,0.354269451186595,-0.5607434694775191,-1.5327672678187299,454,7,SRD5A3|DOLK|DOLPP1
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT%GOBP%GO:0048706,0.19292520558673798,0.567400875461191,-0.27371576426551897,-1.23761135859262,1477,29,TBX1|PCSK5|HOXA4|NDST1|HOXB3|SULF1|DEAF1|TGFBR2|COL1A1|EIF4A3|PDGFRA|MTHFD1
POSITIVE REGULATION OF PROTEIN BINDING%GOBP%GO:0032092,0.0006450780544445879,0.0163600882996276,-0.347305595178879,-1.9640170523676699,4,63,TRAF2|VTN|SYAP1|MEF2C|PARK7|ABL1|NMD3|MEN1|RAN|TMEM173|STK3|HFE|APOE|PPP2CA|LGALS3|BMP2|EPHA4|FKBP1A|MMP9|CAV1|DACT1|ANXA2|TIAM1|STPG1
REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070562,0.263316319853422,0.638950455433329,-0.547037387244826,-1.1975791920381398,2011,4,SNAI2|SNW1|KANK2
NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY%GOBP%GO:0002713,0.679492213061118,0.884536278926676,-0.37501090891704003,-0.8209772709837858,5191,4,NDFIP1|FCGR2B
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO KINETOCHORE%GOBP%GO:1905341,0.49377926421404705,0.7923145426459479,-0.7567269519188349,-1.00814200081242,3690,1,CDT1
GABAERGIC NEURON DIFFERENTIATION%GOBP%GO:0097154,0.502649096590137,0.7970718494574169,0.433045060714337,0.9514184407560741,3699,4,DRD2|ASCL1
"POSITIVE REGULATION OF RETROGRADE TRANSPORT, ENDOSOME TO GOLGI%GOBP%GO:1905281",0.0924425554522513,0.420939346122012,0.955116894574327,1.2735195022641101,695,1,PARK2
ETHER LIPID METABOLIC PROCESS%GOBP%GO:0046485,0.106612861234054,0.449288135667161,-0.493370963540499,-1.42034595161574,818,8,FAR1|TMEM86B|PLA2G16|DHRS7B|TMEM86A
CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION%GOBP%GO:0086064,0.34176717357105396,0.701955655133333,-0.30982245217207,-1.09610652929702,2606,14,ATP1A1|GJC1|GJA5|GJA1|RYR2|ATP1B1|ATP1A3|PKP2|ATP1B2|PRKACA
EXIT FROM MITOSIS%GOBP%GO:0010458,0.7423830250272041,0.909955740610127,0.23010991995658397,0.782098861105728,5457,12,CLASP1|CLASP2|SPAST|PPP2R2D|UBE2C|CHMP2A|CHMP4B|CHMP7
RESPONSE TO JASMONIC ACID%GOBP%GO:0009753,0.25799516259070104,0.636098664976652,0.609793757582442,1.19939236076688,1919,3,AKR1C2|AKR1C1|AKR1C3
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION%GOBP%GO:1903828,0.260494463044038,0.636316525692816,-0.193014566339682,-1.13624583258527,2022,74,SP100|APOD|CDT1|PID1|TAX1BP3|NUMB|GDI1|GAS6|MDFIC|UBE2G2|SAPCD2|CLTC|PARK7|PDE2A|PPFIA1|GPM6B|NSFL1C|TMEM59|DNAJA1|DERL3|LILRB4|DAB2|H2AFY|AP2M1|INSIG1
REGULATION OF DNA REPAIR%GOBP%GO:0006282,0.33329080005104,0.6971906052358929,-0.166963547352229,-1.07293406581065,2611,104,UIMC1|FAM168A|PML|RAD51|RPA2|NPAS2|DHX9|WRNIP1|CEBPG|SETMAR|DTX3L|TERF2|DEK|WDR70|KDM1A|H2AFX|PARP9|PPP4R2|PARPBP|TRIM28|ANKRD32|PARP1|KLHL15|WAS|RAD51AP1|BRCC3|PCNA|USP51|AUNIP|FOXM1|RNF168|BRCA1|NUDT16|POLQ|FGF10|CXorf57|RMI2|PPP4C|OTUB1|MAGEF1
POSITIVE REGULATION OF LEUKOCYTE CELL-CELL ADHESION%GOBP%GO:1903039,0.00038314176245210697,0.0111294649577428,-0.286212197784829,-1.93903586196333,2,133,PTPN11|PRKCQ|MALT1|SIRPB1|RHOA|FYN|TRAF6|BLM|ETS1|RARA|GRAP2|HSPH1|IL1B|AKT1|FOXP3|CD1D|HLA-DMB|CDC42|PAK2|TNF|JAK3|SYK|RAC1|CD274|NFKBIZ|CD44|HLA-DPA1|LILRB1|HLA-E|LYN|CD209|PYCARD|NCKAP1L|TNFRSF14|IL18|ADAM8|RUNX1|CCL19|RUNX3|CCDC88B|HLA-DPB1|PDCD1LG2|VAV1|GATA3|EBI3|THY1|IL6ST|LILRB2|GRB2|SOCS1|PTPN6|CD47|IRAK1|IGF1|DPP4|NKAP|ICOSLG|VCAM1|C10orf54|CCL2|CD86|NLRP3|TGFBR2|LGALS9|ZP3|FADD|AIF1|CAV1|RELA|BCL6|LILRB4|PNP|ANXA1|CD55|NCK1|TFRC|SART1|SIRPA
POSITIVE REGULATION OF CELL CYCLE PROCESS%GOBP%GO:0090068,0.004613018964633521,0.0752560935123842,-0.213376804530337,-1.5672611036083501,35,201,PCBP4|GTSE1|CDC25A|CNOT4|ATRX|SPAG5|BTG2|CNOT10|CNOT6L|RHOA|SVIL|RPL23|NIPBL|SOX15|PHB2|CDC7|BECN1|FOXO4|SFN|RAD21|INO80|IL1B|CDKN1B|CDK4|CNOT6|AURKA|CDC42|RACGAP1|RCC2|PIDD1|ID2|PRMT1|LSM11|CCND2|BRD4|PML|RGCC|NUSAP1|CIT|DLGAP5|DYNC1H1|PLCB1|TRIAP1|TFDP2|CDT1|EZH2|ECT2|DAB2IP|DYRK3|ANAPC5|ESPL1|CDC6|ANKRD32|STXBP4|RAD51C|HNRNPU|PLK2|NPM1|PCNA|INS|LSM10|MAD2L1|DDX3X|CDC25C|RHNO1|CDC45|BRCA1|NUDT16|NDC80|MECP2|FGF10|IGF1|DTL|FAP|E2F1|LRP5|RPTOR|RAD51B|CCNB1|GIPC1|NSFL1C|GATA6|PLAGL1|HYAL1|AIF1|PDGFRB|TNKS1BP1|CCND3|PAGR1|PRKACA|ZNF16|ANXA1|H2AFY|ANAPC11|RRP8|ZNF385A|CCND1|CDCA5|PDGFB|XRCC3|FEN1|EIF4G1
"REGULATION OF SYNAPTIC TRANSMISSION, GABAERGIC%GOBP%GO:0032228",0.0434070434070434,0.29791299041195396,0.525141424492628,1.5958563552436498,317,9,DRD2|CNTNAP4|USP46|HAP1|NLGN2
LATERAL GENICULATE NUCLEUS DEVELOPMENT%GOBP%GO:0021771,0.20480807544162602,0.5845960940001321,0.8992059991177771,1.19896986738962,1541,1,CHRNB2
SNORNA METABOLIC PROCESS%GOBP%GO:0016074,0.12257980115123,0.47676000161238,-0.365360805135453,-1.35782222226677,936,16,NUDT16|DKC1|EXOSC3|EXOSC2|RNF113A
PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS%GOBP%GO:0046337,0.724133261105092,0.9034590034658789,0.21485633765394396,0.7925164624565642,5346,15,LPIN1|SLC27A1|PISD|CHKB|EPT1|NAPEPLD|PNPLA8|PLA2G15
RIPOPTOSOME ASSEMBLY%GOBP%GO:0097343,0.215964935582415,0.598994355749518,0.893140714600794,1.19088262889239,1625,1,RIPK1
HEME METABOLIC PROCESS%GOBP%GO:0042168,0.468026677128286,0.780769690730001,-0.23773619126846302,-0.9845274250282149,3578,22,TSPO|BLVRA|HPX|ATPIF1|NFE2L1|ALAD|HMOX1|FXN|BLVRB
TELOMERE MAINTENANCE%GOBP%GO:0000723,0.406237966884867,0.743639545659366,-0.166176462517515,-1.02856152205507,3164,90,RFC2|RAD51|RPA2|SP100|RFC3|TERF2|TERT|NBN|TINF2|EXO1|PARP1|POLD4|PCNA|POLD1|SLX1B|SLX1A|HIST1H4I|POLD2|RFC5|DKC1|TNKS1BP1|HIST2H4A|APEX1|POLA1|HSP90AA1|ORAOV1|HIST2H4B|RFC4|POLA2|XRCC3|FEN1
REGULATION OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:1902186,0.797546012269939,0.9308634013872809,0.16984998978427898,0.760163160112373,5849,27,CHMP3|TRIM62|TRIM11|TRIM13|ZNF502
MEIOTIC CELL CYCLE%GOBP%GO:0051321,0.6990758323838461,0.892576692023752,-0.137013162997916,-0.867198148861153,5521,97,PLD6|GOLGA2|C17orf104|BLM|FIGNL1|TUBG1|RAD54B|RAD21|STK35|TUBGCP5|TRIP13|NCAPD3|EME2|MYBL1|DMC1|RAD51|PIM2|RPA2|NUF2|PDIK1L|MLH3|XRCC2|BRIP1|EXO1|ESPL1|TUBGCP2|RAD51C|TUBG2|RAD1|PTTG1|PKMYT1|TOP2A|NCAPH2|STRA13|SGOL1|EME1|RMI1|REC8|RAD51B|FANCM|SMC1A|SYCE2|MUS81
U5 SNRNA 3'-END PROCESSING%GOBP%GO:0034476,0.94436979306638,0.982694945797028,0.303352817911106,0.596659194843427,7027,3,EXOSC8|EXOSC9|EXOSC7
PYRUVATE TRANSPORT%GOBP%GO:0006848,0.37248677248677203,0.7234654586828599,-0.557405977721407,-1.08847260052561,2815,3,MPC2|SLC16A7|MPC1
POSITIVE REGULATION OF SPHINGOMYELIN CATABOLIC PROCESS%GOBP%GO:2000755,0.779784831982999,0.924704689181848,0.6098919276576971,0.813208591071659,5870,1,PRKCD
NEGATIVE REGULATION OF FERTILIZATION%GOBP%GO:0060467,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
ANION TRANSPORT%GOBP%GO:0006820,0.17719588153044394,0.5489227448607701,-0.151152394643931,-1.1599750518241498,1393,257,SLC35B1|FABP3|PRELID1|SLC9A3R1|ABCG1|SLC37A2|CLIC3|SLC1A2|SLC16A13|CA2|SLCO2B1|ATP8B1|SLC26A2|CLCN4|CETP|SLC11A1|SLC51A|SLC1A3|SLC25A22|FXYD1|SLCO2A1|SLC38A6|SLC6A8|LRRC8A|SLC35A2|CEACAM1|PDPN|LCN12|LCN1|APOE|GIPC1|FABP4|SLC7A3|CD36|ATP8B4|CYB5R1|SLC27A4|BEST1|SLC25A4|SLC3A2|SLCO4A1|LDLR|PPARG|PPARA|RPS6KB1|ABCD1|PCTP|ARL6IP5|SLC25A42|PRAF2|ANXA1|ATP8A2|NPC2|MPC1|SLC25A19|FOLR2|SLC7A8|SLC38A9|OSBPL5|ABCC1
RESPONSE TO RETINOIC ACID%GOBP%GO:0032526,0.0956033420079441,0.42595828544352005,0.261025610199615,1.3628100322827699,697,45,RET|WNT6|BRINP2|TRIM16|WNT5B|RARG|HTRA2|PTK7|ASCL1|ATM|ASXL1|PTK2B
SYNTHESIS OF RNA PRIMER INVOLVED IN NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:1902318,0.0698327759197324,0.37596389138254704,-0.9637185707984119,-1.28390453877875,521,1,POLA1
CELLULAR RESPONSE TO OSMOTIC STRESS%GOBP%GO:0071470,0.499084728033473,0.794989907195277,-0.24850305898136998,-0.964284289611357,3816,18,STK39|ARHGEF2|RCSD1|AQP1|ZFP36L1|DDX3X|MYLK|MBIP|YBX3
AMPA GLUTAMATE RECEPTOR CLUSTERING%GOBP%GO:0097113,0.7931812151764391,0.929621926733366,-0.46535984291759297,-0.77443319524888,5978,2,APOE
AXONAL TRANSPORT%GOBP%GO:0098930,0.605670456101904,0.848532985661419,0.17325487710448398,0.904560607977685,4421,45,DCTN1|DLG2|KIF3B|TRAK2|BLOC1S3|HAP1|DST|AP3B2|KIF5B|AP3B1|KIF5A|TRAK1|SPAST|KIF1A|AP3M1
PYRIMIDINE NUCLEOTIDE SALVAGE%GOBP%GO:0032262,0.863726922566078,0.9531672929044319,0.5666078517865021,0.7554951163414119,6502,1,HDDC2
ZINC ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0071578,0.816436874831035,0.937396775102383,0.299131160066614,0.7194087245892671,6039,5,SLC39A10|SLC39A4|SLC39A6|SLC39A14
GLUTAMATE CATABOLIC PROCESS%GOBP%GO:0006538,0.10682612201021198,0.44970701744055097,0.70522811302773,1.3871004759328798,794,3,ADHFE1|GLUD1
REPRODUCTIVE SYSTEM DEVELOPMENT%GOBP%GO:0061458,0.0212676647544424,0.201150083379966,0.249231160937393,1.5240517317507198,151,82,LRRC6|STRA6|CYP27B1|FGFR2|CITED1|PPARD|TBX3|RAB13|WNT2B|ITGB8|KIT|ROBO2|PTPRN|BMP7|BRCA2|PKD1|SLIT3|ZNF568|EIF2B4|CASP8|ADCYAP1|STOX2|WNT4|MKKS|CUL7|PKD2
NEGATIVE REGULATION OF G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:2000134,0.292170591979631,0.664374182860726,-0.182696193052869,-1.10701959539036,2294,82,PCBP4|GTSE1|WEE1|CNOT4|RBL1|BTG2|CNOT10|CNOT6L|PRMT2|SFN|CDKN1B|CNOT6|AURKA|PTEN|FHL1|PIDD1|PRMT1|PML|RGCC|RPA2|TRIAP1|TFDP2|KLF4|PLK2|SLFN11|PCNA|CDC25C|GPNMB|DCUN1D3|E2F1|CCL2|KANK2|NACC2|CCNB1|PLAGL1|TNKS1BP1|FAM107A|DACT1|CDK2AP2|ZNF385A|CCND1
REGULATION OF DENDRITIC CELL DENDRITE ASSEMBLY%GOBP%GO:2000547,0.8981481481481479,0.967428248648255,-0.331366493878901,-0.647074778052869,6789,3,CCR7|CCL21|CCL19
KETONE BODY CATABOLIC PROCESS%GOBP%GO:0046952,0.15224402042461702,0.519849132875151,0.6690746663725601,1.31599091274955,1132,3,ACAT1|BDH1|OXCT1
CELLULAR RESPONSE TO VIRUS%GOBP%GO:0098586,0.10619003811276101,0.44869189060429,-0.351948873581697,-1.3905171655867299,807,19,FMR1|IFIH1|IFI6|IRF7|ARF1|LGALS9|RRP1B
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:2000138,0.461111111111111,0.7749605349209571,-0.520463538830856,-1.0163333803950099,3485,3,PIM1
POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:1904707,0.0048626626363516895,0.0777386494688773,-0.481748295140886,-1.90334257094886,36,19,DNMT1|IGF1|P2RY6|FGF9|HTR1B|MMP9|IGFBP5|PDGFB|ERN1
AMP SALVAGE%GOBP%GO:0044209,0.982733430734493,0.993436724391485,0.5078848698720779,0.677195943618212,7398,1,APRT
DIVALENT INORGANIC ANION HOMEOSTASIS%GOBP%GO:0072505,0.6749083005026489,0.882488012133495,0.37706343986958296,0.8284244356350949,4967,4,XPR1|TFAP2B
HISTAMINE CATABOLIC PROCESS%GOBP%GO:0001695,0.0480267558528428,0.313879677852774,-0.9741398323775909,-1.2977881614946898,358,1,HNMT
COLLAGEN METABOLIC PROCESS%GOBP%GO:0032963,0.0140771637122002,0.15880920179683097,-0.368229264560251,-1.7128573817934098,107,32,COL15A1|TRAM2|PLOD2|CTSS|MMP1|TNXB|CTSB|MMP14|RCN3|MRC2|COL1A1|MMP9|P3H2|CTSD|CTSL|COL5A1|COL13A1
POSITIVE REGULATION OF GLUCOKINASE ACTIVITY%GOBP%GO:0033133,0.26134253117537803,0.637166314747009,-0.701741750418515,-1.1678104896394998,1969,2,BAD
MACROPHAGE PROLIFERATION%GOBP%GO:0061517,0.381268240912709,0.729499056535481,-0.648093380256624,-1.07853102267069,2873,2,CX3CL1
POSITIVE REGULATION BY SYMBIONT OF HOST DEFENSE RESPONSE%GOBP%GO:0052509,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
PYRIMIDINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009197,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
METANEPHRIC NEPHRON TUBULE FORMATION%GOBP%GO:0072289,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS%GOBP%GO:0002683,0.00012820512820512802,0.00518555396908895,-0.31400505965569103,-2.36302196602268,0,232,AKT1|CCL3|FOXP3|SOX11|PVRIG|HIST1H4H|CXCL12|TNF|JAK3|TAPBPL|SERPINB9|DUSP1|ZNF675|PARP14|PRMT1|CD274|DUSP3|MNDA|MICA|TGFB1|HOXA5|GREM1|MUL1|LILRB1|SLA2|HLA-E|LYN|CDK6|LGR4|NDFIP1|TNFAIP8L2|APOD|SEC14L1|TNFRSF14|PLCB1|SAMSN1|IRAK3|RUNX1|SLAMF8|TWSG1|CD84|ZFP36L1|RUNX3|DAB2IP|IL17D|PDCD1LG2|TICAM2|SPN|LILRB3|FCGR2B|TGFB3|PLA2G2D|TCTA|INS|THY1|HES1|ERBB2IP|TNFAIP3|RC3H2|LILRB2|PHPT1|NOTCH1|GPNMB|INHBA|PRKAR1A|PTGER4|SOCS1|HSPA9|HIST1H4I|CD47|IFIT1|SDC4|FBN1|CTR9|HMOX1|TNFRSF4|CEBPB|NR1H3|TRAFD1|NPLOC4|IFI16|MAFB|C1QC|C10orf54|CCL2|CEACAM1|GPER1|CD300A|HFE|LST1|CD86|RAB7B|NOV|LGALS3|TNFRSF21|A2M|BST2|CD200|LGALS9|THBS1|NR1D1|NBL1|FADD|CD300LF|COL3A1|SLIT2|TICAM1|CX3CL1|HIST2H4A|MYC|LDLR|PPARG|HAVCR2|MILR1|DHX58|TLR4|LILRB4|ANXA1|HIST2H4B|CD55|DPF2|CD14|FAM3A|LY96|SERPING1|SAMHD1|PTPRJ|PRNP|RNF26
PROTEIN LIPIDATION%GOBP%GO:0006497,0.8674682144831399,0.9558022175108679,0.12575475678658,0.7519031670089971,6276,74,NMT2|PGAP2|PIGF|PGAP1|ZDHHC23|ATG10|PIGU|ZDHHC8|PIGL|ZDHHC6|ZDHHC22|PPM1B|PGAP3|PIGO|PIGG|ATG5|ZDHHC17|PIGT|GOLGA7|ZDHHC16|DPM1|ZDHHC14|PIGQ
SECRETION OF LYSOSOMAL ENZYMES%GOBP%GO:0033299,0.6059237614557049,0.8488160559522858,0.6942545213939131,0.925694726533157,4561,1,M6PR
IMMUNE COMPLEX CLEARANCE BY MONOCYTES AND MACROPHAGES%GOBP%GO:0002436,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0055025,0.48357974617296895,0.787078399497453,-0.25645699485114104,-0.974599206261024,3695,17,TGFB1|GREM1|TBX2|NOTCH1|MEF2C|PIM1|IGF1|TGFBR3
4-HYDROXYPROLINE METABOLIC PROCESS%GOBP%GO:0019471,0.16287581699346398,0.5343475446174241,-0.389547295713412,-1.3038512726896498,1245,12,P4HA2|P4HTM|P4HA3|P4HA1|ALDH4A1|P4HB
OSTEOBLAST DIFFERENTIATION%GOBP%GO:0001649,0.000644329896907217,0.0163600882996276,-0.35828411169249197,-2.0177458420139702,4,62,LGR4|DHX9|PSMC2|ACHE|ITGA11|HNRNPU|RBMX|ATP5B|MEF2C|CLTC|SNAI2|CREB3L1|SPP1|MRC2|VCAN|MEN1|LRP5|RRAS2|SEMA7A|EPHA2|CAT|TNC|BMP2|CCDC47|SNAI1|COL6A1|WNT3|ALPL|PHB|FASN|RRBP1|HNRNPC
PROLINE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905647,0.535927746048612,0.8132910857498922,0.7305910895456551,0.9741446371665742,4034,1,SLC36A4
CARDIAC RIGHT VENTRICLE FORMATION%GOBP%GO:0003219,0.709921636339487,0.8963870249632699,0.644353771504191,0.8591588098059308,5344,1,HAND1
NEGATIVE REGULATION OF LIPID BINDING%GOBP%GO:1900131,0.6655598353034929,0.8804055751124069,0.665251433612704,0.8870230224463941,5010,1,PEX19
CELLULAR RESPONSE TO ABIOTIC STIMULUS%GOBP%GO:0071214,0.00153629496863398,0.0322140470829666,-0.237371953529388,-1.70339429484409,11,178,REST|INTS7|KDM1A|ZFP36L1|IMPACT|ECT2|YY1|TNFRSF10A|PARP1|TNFRSF10B|MFAP4|NDNL2|HYAL3|NPM1|RAD51AP1|RAD1|PCNA|CASP1|PIEZO1|FMR1|DHX36|DDX3X|MYLK|POLD1|GRB2|SLC9A1|PTGER4|RHNO1|PKD2L1|PDE2A|NUCKS1|MAPK3|CARD16|HRAS|IFI16|NSMF|CRY2|MBIP|USP47|HYAL1|ADIRF|TMEM109|FADD|TLK2|TLR5|HIST3H2A|CRYAB|TNKS1BP1|EIF2S1|YBX3|MYC|LTBR|DDB1|INSRR|YAP1|MAPK13|NFKB1|TLR4|POLA1|POLE3|TNFRSF1A|CRIP1|NET1|XPA|BAD
POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING%GOBP%GO:0060148,0.41938025210084007,0.751092933388344,-0.254539688479773,-1.02120835487179,3193,20,FMR1|STAT3|FXR1|DDX5|WTIP|EIF4G1
NEGATIVE REGULATION OF DNA METHYLATION%GOBP%GO:1905642,0.556249169876478,0.8257149029717741,0.7209417732686371,0.961278575920978,4187,1,KMT2A
LEUKOTRIENE SIGNALING PATHWAY%GOBP%GO:0061737,0.525083612040134,0.808245162096538,-0.740405822673136,-0.986398337722912,3924,1,RGS1
REGULATION OF POSITIVE CHEMOTAXIS%GOBP%GO:0050926,0.21252297190863698,0.5950741597527031,-0.337514884058823,-1.22546183326778,1618,15,ANGPT2|KDR|AZU1|VEGFC|F3|VEGFB
SEMICIRCULAR CANAL MORPHOGENESIS%GOBP%GO:0048752,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:2000566",0.49946409431940003,0.794989907195277,0.591071440797649,0.993076336862928,3727,2,XCL1
FERROUS IRON TRANSMEMBRANE TRANSPORT%GOBP%GO:1903874,0.832775919732442,0.9443921657118071,-0.58706440229378,-0.7821107463312359,6224,1,SLC40A1
VENTRICULAR SEPTUM MORPHOGENESIS%GOBP%GO:0060412,0.8709897610921501,0.9576723830465479,0.158345422258336,0.689897735155051,6379,25,ACVR1|FGFR2|ROBO2|SLIT3|CITED2|ZFPM1
POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY%GOBP%GO:2000273,0.570737447698745,0.8330710930899928,-0.23531113889027697,-0.913094733451392,4364,18,FBXW7|NCF1|TAF1|ARC|NLGN3|ITGB1|ADRB2|GREM1|MED1|PARK7|HFE|ADRA2C
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY%GOBP%GO:0033108,0.001143583227446,0.0260082836197492,-0.302467522357496,-1.89791229151099,8,94,C17orf89|NDUFB5|SURF1|UQCR10|OXA1L|NDUFA11|NDUFA9|SCO2|NDUFA7|PET117|NDUFA3|NDUFB6|NDUFAF3|NDUFB9|COA3|NDUFB10|TIMM21|UQCC2|NDUFS7|NDUFB1|NDUFB7|NDUFA6|COX16|NDUFS6|NDUFB4|NDUFA12|SDHAF2|COX17|NDUFA2|NDUFAB1|NDUFA1|NDUFB11|NDUFV1|NDUFAF2|NDUFS3|UQCC3|NDUFA8|NDUFS8|NDUFV3
REGULATION OF PERK-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903897,0.31480021030494204,0.684263851274465,-0.41254871686010597,-1.12768352018969,2394,7,HSPA5|NCK1
"CD4-POSITIVE, ALPHA-BETA T CELL CYTOKINE PRODUCTION%GOBP%GO:0035743",0.0643406739188114,0.36404028041319897,-0.8362845068142042,-1.39171115128631,484,2,CD55
POSITIVE REGULATION OF LIPID KINASE ACTIVITY%GOBP%GO:0090218,0.00846684902956884,0.11427831033307999,-0.426021993715491,-1.83664050938636,64,25,DGKZ|TGFB1|TNFAIP8L3|FLT1|CCL19|FGR|EPHA8|IRS1|PRKD1|PIK3R4|TEK|PDGFRB|PDGFRA|AMBRA1|CD81|PDGFB
NADP BIOSYNTHETIC PROCESS%GOBP%GO:0006741,0.885886287625418,0.964636912970251,-0.559274371415968,-0.745087752422065,6621,1,ME1
ENKEPHALIN PROCESSING%GOBP%GO:0034230,0.19869836631690801,0.5760930750305171,0.9020732245258051,1.20279292558831,1495,1,PCSK2
REGULATION OF HEART INDUCTION BY REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0090081,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:1900211,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
GLANDULAR EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0002068,0.618122537698682,0.854944793214197,0.39485982314614204,0.867523847599641,4549,4,DLL1|NKX6-1
POSITIVE REGULATION OF HISTONE UBIQUITINATION%GOBP%GO:0033184,0.0427406628090479,0.29576373695179803,-0.6582817532062951,-1.5777757507153,324,5,KDM1A|CTR9|RNF20|RNF40
MEIOSIS I%GOBP%GO:0007127,0.8911159963791541,0.9651611606244209,-0.130398795622924,-0.699231476423832,6890,52,C17orf104|BLM|RAD54B|RAD21|TRIP13|EME2|MYBL1|DMC1|RAD51|RPA2|MLH3|BRIP1|RAD51C|PTTG1|TOP2A|STRA13|EME1|RMI1|REC8|RAD51B|FANCM|SYCE2|MUS81
CHAPERONE-MEDIATED PROTEIN TRANSPORT%GOBP%GO:0072321,0.3859051611213,0.7332167375750358,-0.324218064942585,-1.0496734288321299,2945,11,TOR1A|BAG3|TIMM9|TIMM10
SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0007435,0.77530226871349,0.923658792328905,0.34421792053301603,0.756261430839541,5706,4,FGFR2
DETOXIFICATION%GOBP%GO:0098754,0.258746736292428,0.636098664976652,-0.278126274960902,-1.16773583516364,1981,23,PARK7|SOD3|SOD1|MT1M|CCS|NOS3|MT2A|MT1E
POSITIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS%GOBP%GO:0031945,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
COMPARTMENT PATTERN SPECIFICATION%GOBP%GO:0007386,0.781245849382388,0.925413955483995,0.6092302602558449,0.8123263468719609,5881,1,PBX3
STEROL BIOSYNTHETIC PROCESS%GOBP%GO:0016126,0.009515119916579771,0.12396436004013,-0.379071719574791,-1.7632922083968703,72,32,HMGCR|APOE|HMGCS1|EBP|DHCR7|C14orf1|DHCR24|CNBP|NSDHL|TM7SF2
MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN RENAL VESICLE FORMATION%GOBP%GO:0072036,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
PEPTIDYL-THREONINE AUTOPHOSPHORYLATION%GOBP%GO:1990443,0.112240802675585,0.459194647507502,-0.941773268636965,-1.2546681269219,838,1,CAMK2A
PEROXISOME FISSION%GOBP%GO:0016559,0.11338797814207699,0.46139171800540707,0.48348810716641405,1.4034813907676202,829,8,MFF|PEX11A|DNM1L|ACOT8|PEX11G|PEX19
NADH REGENERATION%GOBP%GO:0006735,0.108800836929515,0.45309795582492896,-0.333166647892361,-1.37972977612122,831,22,GPI|HK1|HK3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
PEPTIDYL-LYSINE METHYLATION%GOBP%GO:0018022,0.894874621107743,0.966256689108312,0.130593703981638,0.6978172878107389,6494,49,METTL21A|N6AMT2|PRDM5|SETDB2|METTL21B|TET2|CHD5|SETD6|WDR61|TET3|DPY30|EEF2KMT
RESPONSE TO AMINO ACID STARVATION%GOBP%GO:1990928,0.760636837771068,0.91820552689264,0.159431968244993,0.796562322027383,5541,39,MAP3K5|MIOS|WDR59|CDKN1A|SESN1|NPRL3|SH3GLB1|SESN2|MAPK1|EIF2AK3|MAPK8|ATF4|C12orf66|DEPDC5|EIF2AK2
REGULATION OF CREATINE TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1905407,0.7501003344481608,0.914180498652832,-0.630183061314513,-0.83955515354745,5606,1,STK39
CEREBELLAR GRANULAR LAYER DEVELOPMENT%GOBP%GO:0021681,0.68992449882843,0.887051934478962,-0.281675023472205,-0.8109029692161329,5299,8,CBLN1|CEND1
REGULATION OF INTERLEUKIN-10 BIOSYNTHETIC PROCESS%GOBP%GO:0045074,0.0976225262319033,0.430598623028127,0.9518085575650641,1.2691082812656203,734,1,TRIB2
REGULATION OF PROTEIN HOMOTETRAMERIZATION%GOBP%GO:1901093,0.689174705251876,0.887051934478962,0.5009129025881699,0.8415983518309329,5143,2,PEX5|PEX14
"POSTTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE, TRANSLOCATION%GOBP%GO:0031204",0.130836120401338,0.49066507924967295,-0.93366784296427,-1.2438697536984,977,1,SEC61B
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION%GOBP%GO:2001251,0.30077677320769103,0.673988937137548,-0.172904543978455,-1.09525690109688,2361,98,XRN1|PINX1|ZNF207|FOXP3|TERF2IP|TET1|HNRNPA1|TRIP13|KLHL22|DNMT3B|APC|H1F0|CDC20|SETMAR|SET|TERF2|NBN|TINF2|BCOR|PHF2|ESPL1|ATAD2|NAA10|PARP1|HNRNPU|PTTG1|TOP2A|MAD2L1|SLX1B|SLX1A|BRCA1|TAF7|DNMT1|SPI1|PLK1|H1FX|MNAT1|IK|HIST1H1C|H2AFY|OTUB1|HNRNPC|NAT10
GLYOXAL METABOLIC PROCESS%GOBP%GO:1903189,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0043619,0.511605809691869,0.801504475859147,0.362968879702814,0.939203309821665,3768,6,ARNT|SESN2|ATF4|CHD6
MEMBRANE FUSION%GOBP%GO:0061025,0.395425667090216,0.7377402989373809,-0.164192979232582,-1.03576072694466,3111,96,SNAP47|TAPBP|CD4|STX4|PPIA|RAB7A|BNIP1|OPA1|SYT7|CAV2|NAPA|EEA1|GAS6|PVRL2|CXCR4|STX11|CALR|NKD2|VAMP7|STX1B|STX7|NSFL1C|RAB7B|STX3|NSF|RAB34|STX5|PRRT2|RAB20|GOSR2|FOLR2
NEGATIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT%GOBP%GO:1901551,0.9774206401912611,0.9927322181739301,0.510366122629025,0.6805043593670799,7358,1,S1PR3
DENDRITIC SPINE DEVELOPMENT%GOBP%GO:0060996,0.9336866422068221,0.9800972968717879,0.156719503357581,0.6026331821615,6870,17,SLC12A5|EPHB2|DLG4|SHANK2|ZNF365
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR%GOBP%GO:1902254,0.4534868507130711,0.7702341823050379,-0.26322016449562197,-1.0003009024504599,3465,17,CD44|CD74|TRIAP1|KDM1A|TAF9B|TAF9|ZNF385A|AK6
RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009199,0.000128402670775552,0.00518555396908895,-0.30017341807280606,-2.1138304244466,0,162,NDUFB5|NADK|SURF1|ATP1B1|UQCR10|PARP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|OPA1|IMPDH2|PFKFB2|HK1|NDUFA3|NDUFB6|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|CTPS1|PGAM1|MOCS2|MBIP|GAPDH|NDUFS6|COQ7|NDUFB4|NDUFA12|SDHAF2|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|GPHN|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
INNERVATION%GOBP%GO:0060384,0.6627180421765171,0.879640418088105,-0.288384763390199,-0.830219371341884,5090,8,FBXO45|NPTX1|SULF1|SEMA3A
NEGATIVE REGULATION OF ESTABLISHMENT OF RNA LOCALIZATION TO TELOMERE%GOBP%GO:1904911,0.6392615221144909,0.865463150027443,0.6779885310983679,0.904006223290581,4812,1,TERF1
3'-UTR-MEDIATED MRNA STABILIZATION%GOBP%GO:0070935,0.13125491223473898,0.490819490032838,-0.4213692949230561,-1.36420576282444,1001,11,MAPKAPK2|YBX3|HNRNPA0|HNRNPC
PUTRESCINE CATABOLIC PROCESS%GOBP%GO:0009447,0.620135476158852,0.8551097775270831,0.687031318923688,0.916063560686454,4668,1,PAOX
T-TUBULE ORGANIZATION%GOBP%GO:0033292,0.00214362272240086,0.0417653363596242,0.96961676316515,1.62908135440532,15,2,BIN1|ANK2
FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY%GOBP%GO:0002774,0.102513227513228,0.44119583182083205,-0.7100474247270321,-1.38654265971189,774,3,LILRB1|LYN|LILRB2
POSITIVE REGULATION OF SUCCINATE DEHYDROGENASE ACTIVITY%GOBP%GO:1904231,0.141939799331104,0.5078130330642999,-0.927878253198059,-1.2361566299673201,1060,1,FXN
INTERLEUKIN-15-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035723,0.13801230849810098,0.50277647185153,-0.390955079134211,-1.3457431971337102,1053,13,STAT5B|IL2RB|IL2RG|JAK3|STAT5A|PLCB1|CD4|IL15RA|GRB2|STAT3|IL15
NEGATIVE REGULATION OF ANOIKIS%GOBP%GO:2000811,0.150367068694284,0.517264655410678,-0.372962021451652,-1.31948509227449,1146,14,TLE1|MCL1|PDK4|ITGB1|ITGA5|NOTCH1|SNAI2|PTRH2|CAV1
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, NO-GO DECAY%GOBP%GO:0070966",0.6305555555555561,0.8611058427933991,-0.443280128874771,-0.865613742805614,4766,3,CNOT6|PELO
RETINOIC ACID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048384,0.9370399579390121,0.9806508984207809,-0.21610060771591197,-0.590701374322407,7128,7,RARA|ACTN4|TBX1|SNW1
REGULATION OF INTRACELLULAR CHOLESTEROL TRANSPORT%GOBP%GO:0032383,0.31879502292076,0.6867397844771489,-0.43490949971612497,-1.1187043918463602,2433,6,SCP2|ABCA2|ANXA2
NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION%GOBP%GO:1905208,0.512782159369051,0.802184867798321,0.299293899814089,0.9481833054108879,3770,10,DKK1|SOX6|EGFR|HEY2
POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION%GOBP%GO:0098735,0.556349206349206,0.8257149029717741,-0.47666771155300797,-0.930811229728168,4205,3,RYR2|SLC9A1
RELAXATION OF CARDIAC MUSCLE%GOBP%GO:0055119,0.332204273058885,0.696321347440602,-0.366466466431081,-1.10242083191717,2549,9,ATP1B1|P2RX4|PLN|CHGA|RGS2
CARDIAC FIBROBLAST CELL DEVELOPMENT%GOBP%GO:0060936,0.562830687830688,0.828541380171721,-0.473456703255675,-0.924540944350183,4254,3,SPRY1|TGFBR3
EAR DEVELOPMENT%GOBP%GO:0043583,0.168760240305844,0.5416353371521471,0.271250467646593,1.26534599135295,1235,31,STRA6|IFT88|FGFR2|PAX8|AHI1|EPHB2|MPV17|TWIST1
NEGATIVE REGULATION OF VIRAL-INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0039532,0.39304325169359006,0.737478302661917,-0.34699901209017603,-1.04385796416336,3016,9,SEC14L1|NPLOC4|DHX58
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002578,0.09253417455310199,0.42100228741929396,-0.530851067704944,-1.45105772060603,703,7,HLA-DOA|TAPBPL|FCGR2B|LILRB2|HFE|THBS1
NEGATIVE REGULATION OF DNA METABOLIC PROCESS%GOBP%GO:0051053,0.6948151950718691,0.889726625344871,-0.133461403854533,-0.8738302616618091,5413,113,NDFIP1|H1F0|TSPYL2|TERF2|DONSON|NBN|TINF2|PARPBP|CDC6|PARP1|KLHL15|HNRNPU|STAG2|SLFN11|RAD17|GMNN|SLX1B|AUNIP|FAM129B|SLX1A|POLQ|MEN1|GPER1|CXorf57|RMI2|H1FX|SMC1A|BCL6|HIST1H1C|S100A11|OTUB1|MAGEF1|ACVRL1|HNRNPC|NAT10
REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0030808,0.159281746544374,0.5293397224673839,-0.243745723803127,-1.26267954348838,1232,46,GUCA1A|PID1|PARP1|OGT|CBFA2T3|PFKFB2|PFKFB3|INS|VCP|ENO1|JMJD8|IGF1|PGAM1|NOS3|PDK3|PPARA|TMSB4X
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030947,0.032025200157501,0.254618021991538,-0.39594611402419605,-1.61308731948082,243,21,FLT1|DAB2IP|HGS|TMEM204|PDCD6|VTN|ITGA5|FAM129B|MMRN2|PRKCB|GRB10
CELLULAR RESPONSE TO INTERLEUKIN-4%GOBP%GO:0071353,0.954644808743169,0.9870180073166591,0.19879750675712898,0.577074383276605,6987,8,XCL1|SHPK|TCF7|LEF1
MYELOID LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002444,0.00012704865963664098,0.00518555396908895,-0.31830989040491303,-2.62982197422338,0,412,ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|S100A13|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|CHGA|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|MILR1|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
REGULATION OF GENE SILENCING BY RNA%GOBP%GO:0060966,0.0256443465872296,0.22470485454905398,-0.286278824202448,-1.58196201306831,197,58,ZC3H12A|HIST4H4|PUM1|MAP2K2|HIST1H3D|POLR2F|TNRC6A|HIST1H4H|AJUBA|TGFB1|POLR2C|DHX9|DND1|TERT|POLR2J|FMR1|STAT3|FXR1|HIST1H4I|DDX5|POLR2H|HIST2H3A|HIST2H4A|PPARG|POLR2G|HIST2H3C|HIST1H3H|HIST2H4B|H3F3B|WTIP|POLR2L|EIF4G1
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION%GOBP%GO:0002244,0.697762658641895,0.8916368062640799,-0.21589926120785002,-0.820469914371596,5332,17,FST|TGFB1|BATF|PLEK|INHBA|PLD4|MEOX1
NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0042790,0.450524638066144,0.7687932540972091,0.7761358623731801,1.03487244624579,3391,1,TAF1B
RESPIRATORY SYSTEM PROCESS%GOBP%GO:0003016,0.108516847970284,0.45309795582492896,-0.79520264681555,-1.3233443667651998,817,2,GAA|ECEL1
CELLULAR RESPONSE TO DSDNA%GOBP%GO:1990786,0.965201221941825,0.990916952887267,0.516817379797089,0.689106240314136,7266,1,RIOK3
REGULATION OF ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:0046640,0.0532165271966527,0.334339494273052,-0.394000461932448,-1.5288683249953798,406,18,BLM|SYK|CD274|HLA-E|TNFRSF14|IL18|TWSG1|EBI3|MAPK8IP1|C10orf54|TGFBR2|LGALS9|CD55
ENDODERM FORMATION%GOBP%GO:0001706,0.0425892159416515,0.295236502808577,-0.33387801667790395,-1.5387012547166699,326,31,ITGB2|SOX17|ITGB5|VTN|ITGA5|INHBA|MMP14|CTR9|COL4A2|COL12A1|COL8A1|FN1|MMP9|COL6A1
REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902235,0.30621632277565997,0.6775726086361429,-0.28478329191411794,-1.12515221841434,2329,19,BCL2L11|TMBIM6|OPA1|CREB3|PARK7|CREB3L1|HERPUD1|SYVN1|NCK1
NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034766,0.0563613758806465,0.34436604181231795,0.27001945560685603,1.44906849196228,407,50,FKBP1B|CRHR1|BIN1|TCAF2|IRS2|GSTM2|C19orf26|EPHB2|DRD4|GNB5|PRKCE|SRI|SUMO1|NEDD4|PKD2|YWHAE|CAMK2D|SESTD1|NEDD4L
REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0010640,0.494897959183674,0.7931873707578451,-0.26121595817083704,-0.970779645297677,3782,16,APOD|HGS|LRP1|SLC9A3R1|F3|PTGIR|PTPRJ
POSITIVE REGULATION OF HEPARAN SULFATE PROTEOGLYCAN BINDING%GOBP%GO:1905860,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
NUCLEAR MATRIX ORGANIZATION%GOBP%GO:0043578,0.765868341840073,0.9198974187128991,-0.346391987504723,-0.758324469582796,5851,4,SUN2
POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION%GOBP%GO:0043302,0.106535947712418,0.449288135667161,-0.420552340595233,-1.40762806096109,814,12,ITGB2|SNX4|STX4|FGR|VAMP8|VAMP7|ITGAM
HEXITOL CATABOLIC PROCESS%GOBP%GO:0019407,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND%GOBP%GO:0097192,0.311916677938591,0.68160868787154,0.279342571583926,1.11370640044877,2305,19,ERBB3|CASP9|BOK|ITGAV|BAX|BCL2|DCC
HISTAMINE METABOLIC PROCESS%GOBP%GO:0001692,0.761740514725391,0.9184699428006701,-0.48476676215215997,-0.8067294122549191,5741,2,HNMT
LIPOPOLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0008653,0.45137123745819396,0.769762028992395,-0.7756947507719449,-1.03341166332186,3373,1,AOAH
NUCLEOTIDE-SUGAR TRANSMEMBRANE TRANSPORT%GOBP%GO:0015780,0.7553890641430071,0.916183794263895,-0.278466184272025,-0.7611748966853579,5746,7,SLC35B4|SLC35C1|SLC35A3|SLC35B1|SLC35A2
CELLULAR RESPONSE TO INTERLEUKIN-2%GOBP%GO:0071352,0.9252092050209201,0.9785037131586608,-0.19310658416589002,-0.604977719972299,7075,10,STAT5B|IL2RB|IL2RG|JAK3|SYK|STAT5A|IL2RA
POSITIVE REGULATION OF GLIOGENESIS%GOBP%GO:0014015,0.176631853785901,0.548551967663807,-0.30107409642242,-1.26408413401933,1352,23,DICER1|CLCF1|APP|IL1B|TNF|PRKCH|SYNJ1|TGFB1|P2RX4|HES1|CXCR4|NOTCH1|CSF1|SERPINE2|BMP2
VISUAL SYSTEM DEVELOPMENT%GOBP%GO:0150063,0.00530355896720168,0.0827045574913625,0.260568152307039,1.67753957153341,37,102,PDE6B|NPHP1|FOXC1|WNT6|STRA6|SH3PXD2B|LRP5L|DLL1|BBS4|WNT5B|RARG|AHI1|HDAC1|GNGT1|SDHAF4|WNT2B|MFAP2|IFT140|TWIST1|PTPRM|NES|RAB3GAP1|BLOC1S3|CEP290|ALDH1A3|CACNA1C|ZNF513|MEGF11|TFAP2B|NF1|PHACTR4|SKI|TENM3|CHD7|POU4F2|AGTPBP1|LRP6|NRP1
REGULATION OF EOSINOPHIL CHEMOTAXIS%GOBP%GO:2000422,0.533138531013415,0.812079525085925,0.7318041464490519,0.975762084866021,4013,1,DAPK2
PROTEIN LOCALIZATION TO ADHERENS JUNCTION%GOBP%GO:0071896,0.90131491565945,0.9684180373391851,0.549294221438024,0.732409726449314,6785,1,SCRIB
ANTERIOR/POSTERIOR PATTERN SPECIFICATION%GOBP%GO:0009952,0.54775499610693,0.8186230305367759,-0.180294676162601,-0.938975327825315,4220,47,DDIT3|RIPPLY2|HOXC4|HOXA5|HOXB6|HOXC6|HOXB7|TBX1|HOXC5|PCSK5|BASP1|BHLHE40|WLS|CFC1|COBL|HOXA4|HES1|MESP1|ATP6AP2|HOXB3|LRP5|BMP2
MITOCHONDRIAL ATP SYNTHESIS COUPLED PROTON TRANSPORT%GOBP%GO:0042776,0.388460028784509,0.7352989049211659,-0.27629351733519103,-1.04998283570407,2968,17,ATP5A1|MT-ATP6|ATP5J2|ATP5C1|CYC1|ATP5J|ATP5F1|ATP5B|ATP5O|STOML2|ATP5H
ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS%GOBP%GO:0032469,0.385319900562606,0.7325545716011159,-0.276778627050837,-1.05182637108547,2944,17,THADA|ATP2A2|PML|PSEN1|FIS1|ATP2A1|HERPUD1|TMCO1|TGM2|BCAP31
ACETYL-COA BIOSYNTHETIC PROCESS FROM PYRUVATE%GOBP%GO:0006086,0.318675566025389,0.6867397844771489,-0.518569973596688,-1.13525807280375,2434,4,PDHA1|PDHX
GLYCOSAMINOGLYCAN METABOLIC PROCESS%GOBP%GO:0030203,0.253551772686548,0.632676044517391,-0.176327050922219,-1.1302157653750902,1980,103,CD44|TGFB1|CEMIP|HSPG2|CLN6|HYAL2|TMEM2|NCAN|SDC3|B4GALT4|ST3GAL1|PRELP|HYAL3|NAGLU|ARSB|HS3ST5|DCN|CHST7|NDST1|SLC9A1|GCNT2|SDC4|BGN|VCAN|OGN|B4GALT7|LUM|SDC2|FMOD|FUCA1|HYAL1|EXT2|B3GAT3|LYVE1|B4GALT1|B3GALT6|B4GAT1|HEXB|CSGALNACT1|XYLT2
RESPONSE TO ANTINEOPLASTIC AGENT%GOBP%GO:0097327,0.0070680628272251295,0.10117043083982302,-0.411930556395401,-1.8397279365818102,53,28,MAP4K1|ATRX|ZC3H12A|BLM|HSF1|HNRNPA1|TIMELESS|AQP1|RAD51|NR3C1|JUP|NDNL2|LARP1|FMR1|BRCA1|KAT7|DHFR|ADIRF|MAPK13|PDGFB
FATTY ACID TRANSPORT%GOBP%GO:0015908,0.0811266874350987,0.397722753303477,-0.288812585469018,-1.41343639873337,624,38,SLCO2A1|LCN12|LCN1|APOE|FABP4|CD36|SLC27A4|PPARG|PPARA|RPS6KB1|ABCD1|ANXA1
REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE%GOBP%GO:2000008,0.928873720136519,0.9793746057014829,0.144348718691762,0.628915270663832,6803,25,RAB11FIP5|RANGRF|SNX33|TM9SF4|RAB11B|NEDD4L|LEPROTL1|PICALM
GLIAL CELL DIFFERENTIATION%GOBP%GO:0010001,0.87751446679526,0.960725750963158,0.134361688823906,0.717951221400011,6368,49,DLL1|ERBB3|PICK1|PARD3|TENM4|PRDM8|MMP24|EIF2B4|NF1|ARHGEF10|MXRA8|SKI|METTL14
NEURON DEATH%GOBP%GO:0070997,0.7974617296872959,0.9308634013872809,-0.19591206650718598,-0.744513693711838,6094,17,GAPDH|TNFRSF21|NGFR
REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS%GOBP%GO:0060693,0.115017245953834,0.4642646694217079,-0.7897435897435899,-1.31425962282859,866,2,HGF|PDGFA
POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST%GOBP%GO:0002230,0.0414487447698745,0.291764737397192,-0.40727308368459597,-1.58037103361399,316,18,LILRB1|DTX3L|PARP9|TRIM44|MB21D1|APOBEC3G|TMEM173|PQBP1|APOBEC3F
POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0032927,0.10381184103811801,0.443813248472326,0.5975074260770401,1.43700193330235,767,5,ACVR2A|ACVR2B|ACVR1B|SMAD2|CSNK2B
POSTSYNAPTIC ACTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0098974,0.417484743963916,0.7499690687478492,-0.632782088379981,-1.0530505845283,3146,2,ACTB
CHROMOSOME LOCALIZATION%GOBP%GO:0050000,0.22389025495017498,0.607146964504641,-0.21551818860040198,-1.18014550771826,1729,56,CENPQ|MAD1L1|CENPE|KIF2C|CDCA8|BECN1|VPS4A|NDE1|CHMP5|PINX1|NUF2|DLGAP5|SPDL1|CDT1|CDC23|GEM|BOD1|KPNB1|NDC80|KIF18A|SPICE1|KIFC1|CCNB1|CHMP4A|CHMP6|NUP98|KIF22|CDCA5
DETERMINATION OF LIVER LEFT/RIGHT ASYMMETRY%GOBP%GO:0071910,0.123006217896729,0.47697345522944606,0.579629630709258,1.39400593796325,909,5,NPHP3-ACAD11|NPHP3|PKD2|CCDC40
MITOCHONDRIAL NUCLEOID ORGANIZATION%GOBP%GO:0090144,0.655250836120401,0.874775007199212,-0.675948389942656,-0.900525560183585,4897,1,CHCHD10
REGULATION OF IMMUNOGLOBULIN BIOSYNTHETIC PROCESS%GOBP%GO:0002640,0.333779264214047,0.6974768376198021,-0.830613145125717,-1.10657615128522,2494,1,MZB1
GLAND MORPHOGENESIS%GOBP%GO:0022612,0.0237970711297071,0.215592612132976,-0.43203281676450794,-1.6764480063554799,181,18,TGFB3|SLC9A3R1|MSN|FGF10|CEBPB|LRP5|EPHA2|CAV1|CSF1R|CRIP1
REGULATION OF HUMORAL IMMUNE RESPONSE%GOBP%GO:0002920,0.000130429111777749,0.00518555396908895,-0.557674724294791,-2.84283730545057,0,44,C4A|FCGR2B|C2|IGKV2-28|VTN|C3|C1QB|C1QA|CFB|C1QC|C7|IGKV2D-28|A2M|ZP3|SUSD4|CD59|C3AR1|CFP|C1S|CFI|CD55|PHB|IGHG2|SERPING1|CD81|C1R|CFH|C5AR1
ZYMOGEN GRANULE EXOCYTOSIS%GOBP%GO:0070625,0.9467558528428092,0.9836832812589692,-0.525308778120865,-0.699837426533079,7076,1,SDF4
PROTEIN LOCALIZATION TO MICROTUBULE CYTOSKELETON%GOBP%GO:0072698,0.9485602094240841,0.984457616015067,-0.133252212183224,-0.5951192829926751,7246,28,MID2|SNX10
ACYLGLYCEROL TRANSPORT%GOBP%GO:0034196,0.043380206951446,0.29791299041195396,-0.8650675489385171,-1.4396107361356598,326,2,CETP|CD36
MODULATION OF PHAGOCYTOSIS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052231,0.32846327533537,0.6950398637731511,0.835410233789149,1.11390682246874,2472,1,ITGAV
TELOMERIC LOOP FORMATION%GOBP%GO:0031627,0.64778455823826,0.870171576465071,-0.5395092362834301,-0.8978296431891469,4882,2,DCLRE1B|TERF2
CELLULAR ALCOHOL METABOLIC PROCESS%GOBP%GO:0044107,0.6838156484458741,0.885415243771438,0.504314703285414,0.84731381622657,5103,2,CYP27B1
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION%GOBP%GO:0045620,0.676450511945393,0.8835592822191172,0.193442245763418,0.8428116539912371,4954,25,SFRP1|SOCS5|LOXL3|CBFB|ZC3H8
POSITIVE REGULATION OF INTERLEUKIN-12 SECRETION%GOBP%GO:2001184,0.8880952380952379,0.965159112268525,-0.337213392254209,-0.6584922886895429,6713,3,LGALS9
GOLGI TO PLASMA MEMBRANE TRANSPORT%GOBP%GO:0006893,0.412764193949441,0.747325660434753,0.19164277625959802,1.02845740565558,2987,50,EXOC4|CCDC93|KIF13A|LLGL1|ARL3|RAB10|SYS1-DBNDD2|GCC2|EXOC6B|GGA1|GOLPH3L|SPTBN1|BBS2|BLZF1|EXOC1|GOLGA7
COLUMNAR/CUBOIDAL EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0002065,0.680611968589223,0.884781692722898,0.20611079307498298,0.8353203355398141,5026,20,FGFR2|DLL1|INSM1
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:1903727,0.00117724002616089,0.0261694927157725,-0.44827908879816,-2.04675455679937,8,30,APOC2|DGKZ|TGFB1|TNFAIP8L3|FLT1|CCL19|FGR|EPHA8|FABP3|IRS1|PRKD1|PIK3R4|ZP3|TEK|PDGFRB|STOML2|PDGFRA|AMBRA1|CD81|PDGFB
REGULATION OF AXON GUIDANCE%GOBP%GO:1902667,0.17374869655891598,0.5479109400550349,-0.271149499896296,-1.2612805856742801,1332,32,DSCAM|SEMA3B|SEMA3D|SEMA7A|SEMA5A|SEMA3E|SLIT2|ZSWIM6|SEMA3A|SEMA6B
POSITIVE REGULATION OF PEPTIDYL-SERINE DEPHOSPHORYLATION%GOBP%GO:1902310,0.42849562218095005,0.7566175497322429,-0.6276812792941829,-1.0445620225288301,3229,2,PPP1R15A|DUSP26
TRNA WOBBLE BASE 5-METHOXYCARBONYLMETHYL-2-THIOURIDINYLATION%GOBP%GO:0002926,0.4138663833178379,0.748257770101169,0.793835465372739,1.05847247858771,3115,1,ELP3
PENTITOL CATABOLIC PROCESS%GOBP%GO:0019527,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0001188,0.450524638066144,0.7687932540972091,0.7761358623731801,1.03487244624579,3391,1,TAF1B
REGULATION OF LYMPHOCYTE DIFFERENTIATION%GOBP%GO:0045619,0.0601455752777423,0.355105480276182,-0.23065892300069601,-1.40627462104468,470,84,NDFIP1|NCKAP1L|IL18|ADAM8|RUNX1|CCL19|SLAMF8|ZFP36L1|RUNX3|GATA3|TNFRSF18|GAS6|PRELID1|RC3H2|LILRB2|INHBA|SOCS1|IL2RA|MMP14|ABL1|SOD1|NKAP|C10orf54|CD86|NLRP3|AXL|TGFBR2|LGALS9|BCL6|LILRB4|PNP|ANXA1|SART1
REGULATION OF MITOTIC RECOMBINATION%GOBP%GO:0000019,0.535631871861002,0.8132910857498922,0.355481658757021,0.91982968556106,3945,6,MRE11A|ERCC3|RAD50|ERCC2
PROSTATE EPITHELIAL CORD ELONGATION%GOBP%GO:0060523,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001234,0.000128024580719498,0.00518555396908895,-0.293874003317606,-2.02297177768253,0,144,PPIF|TNFRSF10A|TNFRSF10B|HGF|TMBIM6|SFRP2|SOD2|OPA1|BAG5|BCL2L2|GPX1|INS|TRAF2|PRELID1|TNFAIP3|CREB3|DDX3X|SIAH2|TNFSF10|CAAP1|PARK7|ICAM1|BRCA1|TRIM32|SNAI2|ENO1|CREB3L1|SCRT2|IFI6|HERPUD1|HMOX1|HSPB1|TNFRSF4|IGF1|NONO|TAF9B|PSMD10|PLAUR|NOS3|LGALS3|SYVN1|THBS1|FXN|PEA15|FADD|MMP9|CX3CL1|SNAI1|SERPINE1|YBX3|DNAJA1|RELA|MPV17L|TAF9|ZNF385A|GSTP1|NDUFS3|PELI3|AK6|SLC25A5
CELLULAR RESPONSE TO BLUE LIGHT%GOBP%GO:0071483,0.3309896524277,0.6957352559323989,-0.6694854178050871,-1.11413079399534,2494,2,CRY2
INTESTINAL LIPID ABSORPTION%GOBP%GO:0098856,0.0599397984556995,0.354269451186595,-0.6823391960206321,-1.4937831346079902,457,4,CD36|LDLR
NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION%GOBP%GO:1905907,0.0439153439153439,0.299062021084573,-0.77298542926193,-1.50944463099687,331,3,CRYAB|LDLR
REGULATION OF FATTY ACID METABOLIC PROCESS%GOBP%GO:0019217,0.108592039160119,0.45309795582492896,-0.252185287807624,-1.33857226277774,842,50,INS|FABP3|IRS1|ADIPOR1|BRCA1|NR1H3|CEACAM1|SLC45A3|ADIPOR2|PDK3|CAV1|SIRT4|PPARA|ABCD1|ANXA1
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE%GOBP%GO:1904851,0.540402719665272,0.815082826992402,-0.29468316355580104,-0.9232038833490129,4132,10,CCT7|CCT3|CCT8|CCT5|DKC1
REGULATION OF CGMP-MEDIATED SIGNALING%GOBP%GO:0010752,0.22483968067006896,0.6078034241178771,-0.5668242525068751,-1.24089677629475,1717,4,MB21D1|PDE2A|THBS1
REGULATION OF STEROID METABOLIC PROCESS%GOBP%GO:0019218,0.0732553656342373,0.380904901183235,-0.23435600238616697,-1.3859168413629401,569,75,REST|SREBF2|IDI1|AGT|GPAM|FGFR4|FDPS|APOC1|RORA|KPNB1|ABCG1|CYP51A1|SNAI2|MBTPS2|SOD1|RAN|HMGCR|APOE|HMGCS1|FGF19|BMP2|NR1D1|SNAI1|NFYB|DHCR7|NFKB1|FASN|TM7SF2
EPITHELIAL TUBE MORPHOGENESIS%GOBP%GO:0060562,0.321775844421699,0.689829095076733,-0.16604254759065498,-1.08059985406441,2514,110,LMO4|SOX18|RYR2|SOX17|FOXN4|SMO|SFRP2|COBL|GATA3|TBX2|HES1|MESP1|NOTCH1|CELSR1|MEF2C|MICAL2|FGF10|COL4A1|LRP5|STARD13|CTSH|EPHA2|DLC1|DEAF1|LUZP1|TGFBR2|BMP2|SRF|SEMA3E|SLIT2|DNAAF1|MYC|RASIP1|CSF1R|ENG|ACVRL1|MTHFD1
ANTERIOR/POSTERIOR PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0072098,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
PROTEIN POLYMERIZATION%GOBP%GO:0051258,0.47455880458585603,0.7845830450979699,-0.17140860518578901,-0.9843752304930159,3683,67,NIN|PREX1|GOLGA2|NDE1|TUBG1|ZNF207|CCDC53|MAPT|TUBGCP5|MSRB2|MSRB1|CSNK1D|RAC1|CEP192|MX1|GPX4|EFCAB11|TPPP|PSTPIP2|TTC17|MICALL2|TUBGCP2|TUBG2|COBL|WAS|OPA1|UBE2S|CKAP5|GSN|CHMP4A|AIF1|FAM107A|ANG|WASF3|GAS7
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS%GOBP%GO:0006661,0.0354019158683882,0.26787698165153,0.23285737087797798,1.45172881047071,254,88,MTMR6|PLEKHA1|INPP5K|PGAP2|FIG4|PIP4K2C|INPP5J|PIGF|PGAP1|SLC27A1|FGF2|PLEKHA3|PIKFYVE|MTMR9|PIGU|IMPA1|MTMR2|PIGL|CDS1|INPP5F|PGAP3|PI4K2B|INPP4A|PIGO|PIGG|INPPL1|PIGT|SBF1|PITPNM2|DPM1|PIGQ|PIP5K1C|PIP5K1A|PLEKHA8|MTMR3|PIGN|PIGS|PIGB|PIK3CD|PIGZ
POSITIVE REGULATION OF URINE VOLUME%GOBP%GO:0035810,0.657791060997147,0.876331571166741,0.3823823383942229,0.8401102822130601,4841,4,INPP5K|TFAP2B
ORGANIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0016053,0.24525641025641,0.62804240987169,-0.15154771957551502,-1.1150458460455601,1912,203,SERINC3|ALOX5AP|PYCR1|GATM|FOLH1|CEMIP|ABHD3|GPX4|ST20-MTHFS|ALOX5|SCD5|CCBL1|PGAM2|CD74|NCAN|PER2|NANP|PLOD2|LTC4S|CDO1|TBXAS1|PYCRL|GOT1|PTGDS|GPT|GPI|PFKFB2|PHGDH|GGT1|ELOVL2|HK1|CBR1|ACSF3|KYNU|HK3|DCN|ADI1|ELOVL1|PARK7|PTGES2|PTGS1|BGN|HAAO|ENO1|VCAN|THNSL2|PGAM1|SERINC5|DHFR|CYP46A1|GAPDH|HYAL1|CYP7B1|HACD2|GGT5|LDHA|NDUFAB1|OSBP|ABCD1|BCAT2|SHMT2|PGK1|FADS1|APIP|OSBPL3|PTGES|ALDOA|ALDOC|MTHFD1|PTGIS
PROTEIN KINASE B SIGNALING%GOBP%GO:0043491,0.0336002100013125,0.261633782155535,-0.39455220055265205,-1.6074085059611,255,21,SETX|ADTRP|IL1B|AKT1|CCL3|TNF|PTEN|TGFB1|ZFP36L1|KDR|GAS6|PIK3R3|IGF1|CCL2|EPHA2
"REGULATION OF RETROGRADE TRANSPORT, ENDOSOME TO GOLGI%GOBP%GO:1905279",0.0924425554522513,0.420939346122012,0.955116894574327,1.2735195022641101,695,1,PARK2
"NOTCH RECEPTOR PROCESSING, LIGAND-DEPENDENT%GOBP%GO:0035333",0.242088179605085,0.625158460820442,0.43699578612559403,1.20631513794714,1789,7,PSENEN|PSEN2|APH1B|ADAM10|NCSTN|APH1A
MRNA POLYADENYLATION%GOBP%GO:0006378,0.859440376569038,0.9510351514339058,-0.164405271283691,-0.6987177680452131,6572,24,PAPOLA|CLP1|CSTF3|ZC3H3|TUT1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS%GOBP%GO:1902548,0.495528669121515,0.793890905419504,-0.39883827360678203,-0.955939236487887,3767,5,DAB2IP|SEMA6A|DCN
INTERMEDIATE-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0071831,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
SNRNA TRANSCRIPTION%GOBP%GO:0009301,0.856756408604921,0.949296218452153,-0.12851281060505199,-0.7512021176530009,6650,72,CCNT1|INTS12|SNAPC1|GTF2E1|INTS2|SRRT|POLR2F|POU2F1|INTS1|POLR2C|NABP2|INTS7|NCBP2|GTF2A2|POLR2J|ELL2|ZNF143|PHAX|CCNK|GTF2A1|NCBP1|POLR2H|CDK7|POLR2G|POU2F2|INTS5|TAF9|AK6|POLR2L
REGULATION OF MYOSIN LIGHT CHAIN KINASE ACTIVITY%GOBP%GO:0035504,0.707826086956522,0.89516234575314,-0.649536832818703,-0.8653390243056229,5290,1,IL1B
MELANOSOME ORGANIZATION%GOBP%GO:0032438,0.507988085567289,0.798783771845792,0.235278389215673,0.9535299927423191,3751,20,KIF13A|HPS1|HPS4|BLOC1S3|AP1M1|AP3B1
NEGATIVE REGULATION OF ANTI-MULLERIAN HORMONE SIGNALING PATHWAY%GOBP%GO:1902613,0.424757603931465,0.7546031622730089,0.7889280988089991,1.05192916743995,3197,1,DKK3
VERY-LOW-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034372,0.733692793266702,0.907913422943088,-0.32638213760612,-0.7822757043976272,5578,5,CETP|APOE
MYOTUBE CELL DEVELOPMENT%GOBP%GO:0014904,0.548264571054355,0.818959666222967,-0.35768621352035607,-0.9200652968705021,4185,6,KIAA1161|CAV2|SEPN1|IGF1
CELL WALL BIOGENESIS%GOBP%GO:0042546,0.528561872909699,0.8105400040230321,-0.73869651521835,-0.984121129764213,3950,1,MPI
NEGATIVE REGULATION OF PRESYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:1901630,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
NEGATIVE REGULATION OF MITOTIC METAPHASE/ANAPHASE TRANSITION%GOBP%GO:0045841,0.895255618346695,0.966332331854337,-0.16632572960975198,-0.657137440865853,6811,19,ZNF207|TRIP13|KLHL22|APC|CDC20|MAD2L1|PLK1|IK
MITOCHONDRIAL TRANSLATIONAL INITIATION%GOBP%GO:0070124,0.034967845659164,0.26702449097803305,0.879073614557486,1.47695717424531,260,2,MTIF2|MTIF3
POSITIVE REGULATION OF ERBB3 SIGNALING PATHWAY%GOBP%GO:1905580,0.147031478283969,0.514131830678897,0.928429642699603,1.2379356528762802,1106,1,RTN4
BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS%GOBP%GO:0060670,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
TRANS-SYNAPTIC SIGNALING BY TRANS-SYNAPTIC COMPLEX%GOBP%GO:0099545,0.0317524115755627,0.253300427795228,0.8860215053763442,1.48863052789949,236,2,EPHB2|PTPRD
L-LEUCINE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903801,0.109966555183946,0.45483419590443,-0.9424900749889721,-1.2556230850981298,821,1,SLC3A2
MALE MEIOSIS I%GOBP%GO:0007141,0.700683850604945,0.8931369333627571,-0.33592543569380107,-0.8051491688849101,5327,5,ING2|MOV10L1|CCNA1|C17orf104|MYBL1
"MITOTIC SISTER CHROMATID COHESION, CENTROMERIC%GOBP%GO:0071962",0.0284391534391534,0.23859210744975698,-0.8007610014337709,-1.5636832837586498,214,3,BOD1|NAA50|SGOL1
REGULATION OF DNA LIGASE ACTIVITY%GOBP%GO:1904875,0.705492172990183,0.894639008000397,-0.513978494623656,-0.8553424063947299,5317,2,TFIP11|XRCC1
REGULATION OF PSEUDOPODIUM ASSEMBLY%GOBP%GO:0031272,0.12549019607843098,0.48053753037869495,-0.407895536805659,-1.36526455360058,959,12,CDC42EP4|CDC42EP1|CDC42EP5|CDC42EP2
"NEGATIVE REGULATION OF PHAGOCYTOSIS, ENGULFMENT%GOBP%GO:0060101",0.1838127090301,0.556308895147568,-0.906374062637847,-1.2075078846804599,1373,1,CD300A
DADP PHOSPHORYLATION%GOBP%GO:0006174,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
REGULATION OF CYCLIN-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0000079,0.0124903425186711,0.148069121296859,-0.27885270396073103,-1.64156119814764,96,74,CDKN2A|CCNK|HEXIM1|PKMYT1|CDC25C|IPO7|CEBPA|CKS2|CDKN2B|GTF2H1|MEN1|CCNI2|CCNI|PSMD10|CCNB1|PLK1|CDK7|LATS2|MNAT1|NR2F2|CCND3|CDKN2C|SERTAD1|ACTB|CDKN3|CCND1|PDGFB
REGULATION OF OSTEOCLAST PROLIFERATION%GOBP%GO:0090289,0.25179092597506003,0.632068187660447,-0.7065343258891651,-1.1757861016131002,1897,2,GREM1|TNFAIP3
DEOXYRIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009192,0.154247491638796,0.5225398777782271,-0.9210961623290691,-1.22712125645377,1152,1,NUDT18
MITOCHONDRIAL TRNA 5'-END PROCESSING%GOBP%GO:0097745,0.548412698412698,0.818959666222967,-0.47967783729923097,-0.936689242397306,4145,3,HSD17B10
REGULATION OF CALCIUM-DEPENDENT CELL-CELL ADHESION%GOBP%GO:0046586,0.0303678929765886,0.246289263264096,-0.985498456109396,-1.31292057567185,226,1,FXYD5
POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION%GOBP%GO:0150012,0.7120638355423321,0.896971870420366,0.28537323224648803,0.787765147751118,5264,7,DVL2|GRIP1|DLG4|DVL1
EPITHELIAL CELL PROLIFERATION%GOBP%GO:0050673,0.00091563113145847,0.0216316222083933,-0.465686054120057,-2.12623135257889,6,30,THAP1|NRARP|MTSS1|ID2|RPS6KA1|BTBD10|CD34|MEF2C|FGF10|HMOX1|CEBPB|FAP|EPHA2|NOV|TEK|SEMA5A|ACVRL1|LOXL2|ERN1|BAD
REGULATION OF ADHERENS JUNCTION ORGANIZATION%GOBP%GO:1903391,0.0251159196290572,0.22314632241245497,-0.29486219098192495,-1.59153882597463,194,53,PTEN|RCC2|RAC1|DUSP3|IQSEC1|MAPRE2|APOD|PEAK1|CORO1C|PPM1F|KDR|THY1|PHLDB2|SLC9A1|BCAS3|S100A10|ABL1|GPM6B|DLC1|THBS1|TEK|FAM107A|COL16A1|ACVRL1|ARF6|EFNA5|PTPRJ
CELLULAR PIGMENTATION%GOBP%GO:0033059,0.0126512651265127,0.14869950444299201,0.349032214823018,1.70259517617657,91,36,BBS5|KIF13A|BBS4|HPS1|HPS4|VPS33B|BLOC1S3|AP1M1|MKKS|RAB11B|RAB11A|MREG|AP3B1|BBS2|MYO5A|BBS7
CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS%GOBP%GO:0071385,0.0139144132318194,0.15750963604385598,-0.485371600425435,-1.7623056030021,105,15,UBE2L3|AQP1|NR3C1|REST|ZFP36L1|BCL2L11|HNRNPU|FAM107A|ANXA1|SSTR2
SYNTHESIS OF RNA PRIMER INVOLVED IN CELL CYCLE DNA REPLICATION%GOBP%GO:1902295,0.0698327759197324,0.37596389138254704,-0.9637185707984119,-1.28390453877875,521,1,POLA1
PRIMARY MIRNA MODIFICATION%GOBP%GO:1990729,0.962279187143047,0.9906325367238141,0.518802382002647,0.6917529729132299,7244,1,METTL3
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE%GOBP%GO:0045089,0.000512229478806505,0.0139121625154964,-0.24466284515400802,-1.7720942089753797,3,187,RAF1|CD1D|RIPK2|CREBBP|TIFA|PAK2|MUC3A|SYK|PVR|RPS6KA5|MICA|NCR3|S100A1|ALPK1|CLEC4A|HLA-E|LYN|DHX9|CD209|TLR1|PYCARD|IRAK3|ADAM8|HSP90B1|HMGB2|PARP9|ITGB2|PIK3AP1|TLR2|CTSS|TICAM2|HEXIM1|POLR3B|MATR3|PVRL2|TNFAIP3|PLSCR1|IKBKE|DDX60|CLEC4E|MAPKAPK2|UNC93B1|MB21D1|CLEC10A|IFIH1|FCER1G|MUC4|RSAD2|IRF7|IRAK1|HRAS|FCN1|NR1H3|IFI16|TNIP1|NONO|TMEM173|PIK3R4|HFE|RBM14|HCK|COLEC12|CD36|MUC20|LGALS9|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|CAV1|TRAF3|RELA|HMGB3|DHX58|NFKB1|PRKACA|TLR4|S100A8|ITGAM|S100A9|CD14|LY96|PQBP1|ICAM2
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION%GOBP%GO:0071634,0.128024061723552,0.48506211077642203,-0.323685065036761,-1.3404640744869498,978,22,ATP6AP2|LTBP1|LRRC32|GATA6|CD200|LGALS9|THBS1|SERPINF2
NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:1904036,0.16563853524084501,0.5375245857985801,-0.315929340685421,-1.28709840875075,1261,21,KDR|GATA3|GAS6|TNFAIP3|ICAM1|CAST|TEK|SEMA5A|IL11|SERPINE1
REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS%GOBP%GO:0006521,0.738870792616721,0.9089185613230608,0.23775824751677901,0.782370627434233,5443,11,NQO1|OAZ3|ATCAY|ATP2B4
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER BY GLUCOSE%GOBP%GO:0000430,0.47267179623242206,0.7831522581932591,-0.609925558312655,-1.0150136634623,3562,2,USF1|USF2
NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0032926,0.476229508196721,0.7850084910380921,0.33481324927425204,0.9719042883863829,3485,8,ACVR1|IGSF1|SKI|DACT2
MYELOID LEUKOCYTE DIFFERENTIATION%GOBP%GO:0002573,0.00479150479150479,0.0771157539865023,-0.325043549654169,-1.80578272167897,36,59,UBD|SBNO2|GPR183|PIR|MT1G|CCL19|BATF|TLR2|PARP1|TNFRSF11A|CBFA2T3|TCTA|OSCAR|CEBPA|TAL1|TREM2|IFI16|BATF2|CSF1|EPHA2|PDE1B|TGFBR2|LGALS9|FOXP1|MMP9|TYROBP|LTBR|PPARG|MYH9|ANXA2|CSF1R|SNX10
POSITIVE REGULATION OF G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:1900087,0.00130770236694128,0.0284733155294161,-0.49371936988093196,-2.04462037236275,9,22,LSM11|CCND2|PLCB1|CDC6|LSM10|DDX3X|CDC45|FGF10|RPTOR|HYAL1|AIF1|CCND3|ANXA1|CCND1|EIF4G1
NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE%GOBP%GO:0150079,0.0017013479911006401,0.0346995370450957,-0.870466454364192,-1.9056330287846002,12,4,CD200|CX3CL1|LDLR
NEGATIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS%GOBP%GO:0032055,0.329404060248854,0.695646600584197,-0.430435229534101,-1.10719536363198,2514,6,EIF2S1|RBM4
RESPONSE TO BLEOMYCIN%GOBP%GO:1904975,0.8120191032104009,0.935317461845028,-0.45475599669148103,-0.756786699446126,6120,2,DDX11|TIMELESS
CELLULAR POLYSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0033692,0.311447591698212,0.68160868787154,-0.24698865906436998,-1.1167642124006498,2385,29,NDST1|PPP1R3C|PGM5|NR1D1|EXT2|B3GNT5|B4GAT1|CSGALNACT1|GYG2
DADP METABOLIC PROCESS%GOBP%GO:0046056,0.469094329481322,0.780769690730001,0.502891568021635,0.989128369189121,3490,3,AK9|AK5
ERBB2 SIGNALING PATHWAY%GOBP%GO:0038128,0.0315474571661681,0.252151273228238,0.3718496741156261,1.60178832303796,231,24,PTPRR|GAB1|ERBB3|PTPN12|SHC1|SOS1|CPNE3|STUB1|PRKCA|PTPN18|CUL5|CDC37|EGFR
HEPARIN METABOLIC PROCESS%GOBP%GO:0030202,0.7160052910052909,0.899551221015245,-0.41048807421902395,-0.801579171175028,5412,3,CSGALNACT1
PROTEIN HYDROXYLATION%GOBP%GO:0018126,0.655856092436975,0.874869342420871,-0.212579364030995,-0.852864336867587,4994,20,P4HA2|P4HTM|PLOD2|P4HA3|P4HA1|JMJD6|P3H2|P4HB
MITOCHONDRIAL RNA PROCESSING%GOBP%GO:0000963,0.42324382967182,0.753783909572009,0.28507781050396996,1.0246754256475,3120,14,ELAC2|PNPT1|TRMT61B|PUS1|TRNT1|TBRG4|KIAA0391|SUPV3L1|TRIT1
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION%GOBP%GO:0021953,0.5601374570446739,0.827091649887284,0.167698260863275,0.9316112187849691,4074,56,DRD2|FGFR2|SLIT1|ROBO2|CHRNB2|ASCL1|CHD5|SLIT3|ATP7A|DRAXIN|MAP2|GATA2|C21orf91|AGTPBP1|NR4A2|LRP6
POSITIVE REGULATION OF NEUTROPHIL MEDIATED KILLING OF BACTERIUM%GOBP%GO:0070962,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
SKELETAL SYSTEM MORPHOGENESIS%GOBP%GO:0048705,0.0750998325389669,0.38386676749315796,-0.24199345603649602,-1.38973398567435,582,67,WWOX|HOXA4|ANXA6|VWA1|NDST1|COL14A1|MGP|MEF2C|FREM1|HOXB3|COMP|LRP5|COL12A1|COL6A3|COL21A1|TGFBR2|EIF4A3|COL6A1|ANXA2|PDGFRA|COL6A2|COL13A1|MTHFD1
CALCIUM ION HOMEOSTASIS%GOBP%GO:0055074,0.021783700666324998,0.204049698379529,-0.192927708579589,-1.43090635472636,169,213,OCM|EDNRA|CCL19|HSP90B1|FPR3|LPAR6|RYR2|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|ERO1L|PTGER1|PLN|ITPR3|SLC8B1|WBP2NL|P2RX5|P2RX3|ANXA6|THY1|STIM1|ATP2A3|TMEM203|GRIN1|FPR1|ADCY8|CXCR4|JPH4|CALB2|TAC1|CALCB|RMDN3|SEPN1|PTGER4|TBXA2R|GHRL|ABL1|CALR|HERPUD1|SLC35G1|CCRL2|P2RY6|GPER1|SLC24A3|TPCN2|F2R|CCR1|APLNR|GNA15|TMCO1|CD36|F2RL3|GRIN2C|TGM2|GRIN2D|BCAP31|CX3CL1|CAV1|C3AR1|STOML2|CHRNA10|GPR4|CCL14|PRKACA|PTGIR|PDGFRA|CMKLR1|CD55|GNG3|ATP2B2|FAM20A|C5AR1|C1QTNF1
CELLULAR RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:0070301,0.128388946819604,0.48544201720890606,-0.28487232288722897,-1.3251137486553202,984,32,IMPACT|ECT2|PPIF|CYP1B1|TNFAIP3|PARK7|ABL1|FXN|RELA|SIGMAR1|MAPK13|ANXA1|NET1|SIRPA
SLEEP%GOBP%GO:0030431,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
FEEDING BEHAVIOR%GOBP%GO:0007631,0.442636289666396,0.7656673901363249,0.280162745921108,1.00700885986104,3263,14,STRA6|TRH|MCHR1|PEX13
POSITIVE REGULATION OF SREBP SIGNALING PATHWAY%GOBP%GO:2000640,0.42807809802098495,0.756202814008058,0.7867776797529781,1.04906187379093,3222,1,ZBTB7B
RESPONSE TO ARSENITE ION%GOBP%GO:1903842,0.0305555555555556,0.247447840028175,-0.797226094814876,-1.55678050705035,230,3,VCP|DHX36
VACUOLE FUSION%GOBP%GO:0097576,0.392615221144906,0.737280445732591,0.804808116453463,1.0731030282326999,2955,1,VPS41
CELLULAR RESPONSE TO BMP STIMULUS%GOBP%GO:0071773,0.6158075601374571,0.8539218792126291,0.162101184775819,0.9005178797805891,4479,56,ACVR1|SFRP1|ADAMTS7|FAM83G|DLX5|GDF1|BMP7|TMEM100|SMAD1|ACVR2A|PDCD4|ZFYVE16|SKI|BMPR1A|MEGF8|GDF9|USP9Y|BMPR2|ACVR2B|RGMA|BMPR1B
COENZYME A TRANSMEMBRANE TRANSPORT%GOBP%GO:0035349,0.0699665551839465,0.37596389138254704,-0.9634980149977941,-1.28361070549376,522,1,SLC25A42
POLYNUCLEOTIDE 5' DEPHOSPHORYLATION%GOBP%GO:0098507,0.0676052596626378,0.371075653877479,0.9667512130569029,1.2890322961088,508,1,DUSP11
"POSITIVE REGULATION OF CD4-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2000516",0.162285863737413,0.533363006420977,-0.310614903171121,-1.2863371334536,1240,22,MYB|IL12RB1|PRKCQ|MALT1|RARA|FOXP3|NFKBIZ|NCKAP1L|IL18|CCL19|SOCS1|CD86|NLRP3|TGFBR2|LGALS9|ANXA1|CD55
DENDRITIC SPINE ORGANIZATION%GOBP%GO:0097061,0.9426892950391641,0.982311546916479,-0.14201585146061801,-0.596265127899741,7220,23,LGMN|PRNP
RESPONSE TO INSULIN-LIKE GROWTH FACTOR STIMULUS%GOBP%GO:1990418,0.64778455823826,0.870171576465071,-0.539564378274056,-0.8979214082794159,4882,2,XBP1|AKT1
AORTA DEVELOPMENT%GOBP%GO:0035904,0.18955613577023497,0.563467720122429,-0.297264292071029,-1.24808835991741,1451,23,JAG1|TBX1|LRP1|TBX2|HES1|MYLK|NDST1|PDGFRB|ENG|ACVRL1
MULTICELLULAR ORGANISMAL SIGNALING%GOBP%GO:0035637,0.372362432767894,0.7234654586828599,0.18369071520483102,1.05394692003008,2699,63,TRPM4|FKBP1B|BIN1|SCN5A|ANK2|KCNMB4|TNNI3K|RNF207|CACNG7|GJC3|CACNA1C|CACNG4|SCN3A|KCNK3|SCN9A|SCN2A|YWHAE|CACNB2
TELOMERIC D-LOOP DISASSEMBLY%GOBP%GO:0061820,0.9786513928664409,0.992937328049893,-0.17964070367474302,-0.5171604432875789,7517,8,TERF2|SLX1B|SLX1A
VALYL-TRNA AMINOACYLATION%GOBP%GO:0006438,0.9847439639161579,0.9943582032224201,-0.31138682106424,-0.5181974647474571,7422,2,VARS2|VARS
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION%GOBP%GO:1902106,0.349308874822374,0.70736446849153,-0.207844016674718,-1.0766974041505502,2703,46,CCL3|FOXP3|JAK3|ZNF675|LILRB1|CDK6|RUNX1|RUNX3|LILRB3|FCGR2B|TCTA|RC3H2|INHBA|SOCS1|FBN1|MAFB|C1QC|CEACAM1|MYC|TLR4|LILRB4|ANXA1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME%GOBP%GO:1904781,0.7058425750608599,0.894639008000397,0.286927744070601,0.792056335916045,5218,7,MARK4|CEP250|PARD6A|NUP62|GSK3B|BICD1|APC
PEPTIDYL-CYSTEINE S-NITROSYLATION%GOBP%GO:0018119,0.0017195767195767198,0.0348566830512975,-0.913642880776442,-1.7841129843201797,12,3,GAPDH|S100A8|S100A9
POSITIVE REGULATION OF WNT-MEDIATED MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1905426,0.97414255091104,0.9920058127185359,0.31794871794871804,0.534194898174537,7270,2,CSNK1E|CSNK1D
HISTONE H2B ACETYLATION%GOBP%GO:0043969,0.5684685881259129,0.831514598829999,0.7133325981473309,0.9511327676244509,4279,1,EP300
RESPONSE TO NUTRIENT%GOBP%GO:0007584,0.00908383078120945,0.12034985725408802,-0.34007419509519005,-1.7711076423379901,69,47,HSP90B1|AQP3|P2RX4|GIPR|TMBIM6|OGT|P2RX3|HLCS|GAS6|POSTN|GRIN1|KYNU|SST|PDXP|CDKN2B|ENSA|PIM1|SPP1|USF2|GNAI2|SLC27A4|PPARG|ALPL
SYNCYTIOTROPHOBLAST CELL DIFFERENTIATION INVOLVED IN LABYRINTHINE LAYER DEVELOPMENT%GOBP%GO:0060715,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
"POSITIVE REGULATION OF ATP-DEPENDENT MICROTUBULE MOTOR ACTIVITY, PLUS-END-DIRECTED%GOBP%GO:2000582",0.46304756785810297,0.776796066784647,0.5059660215418401,0.9951754564539799,3445,3,DNAL4|DYNLL1
MODIFIED AMINO ACID TRANSPORT%GOBP%GO:0072337,0.500261643118786,0.7951717058944731,-0.260030878841388,-0.966375431638036,3823,16,SLC9A3R1|SLC6A8|PDPN|FOLR2|ABCC1
POSITIVE REGULATION OF C-C CHEMOKINE RECEPTOR CCR7 SIGNALING PATHWAY%GOBP%GO:1903082,0.21712374581939803,0.599597524514766,-0.8887295985884429,-1.1840012218809899,1622,1,TREM2
NEGATIVE REGULATION OF NEURON DEATH%GOBP%GO:1901215,0.221706026584075,0.604285118926805,-0.19993243283500797,-1.17195720751423,1717,73,GNB2L1|ADAM8|SET|BTBD10|CD34|SOD2|NGF|TGFB3|TRAF2|GPNMB|MEF2C|PARK7|SOD1|AARS|NTRK2|NAIP|NONO|CCL2|F2R|APOE|CHGA|CHMP4A|CD200|CX3CL1|LGMN|EIF4G1
LIPID OXIDATION%GOBP%GO:0034440,0.0202061855670103,0.19546415839676298,0.28543133996166303,1.58565173623303,146,56,ALDH3A2|BDH2|PPARD|HADHB|SLC25A17|HADHA|CYP4V2|PEX2|HIBCH|PEX13|ACADVL|ACADM|ACAT1|GCDH|ECHDC1|MCAT|ACOX2|ACAA2|ACAD11|ECI1|ACADS|ECHS1|MECR|ACOX3|EHHADH|ACOT8|ABCD3|PHYH|IVD|HACL1
POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION%GOBP%GO:0002726,0.159281594126901,0.5293397224673839,-0.368372060588155,-1.30324648194646,1214,14,IL6|MALT1|TRAF6|IL1B|B2M|IL18|TRAF2|RSAD2|NLRP3|IL1R1
L-CYSTEINE CATABOLIC PROCESS%GOBP%GO:0019448,0.9815909701693091,0.993436724391485,0.265542511996752,0.522290785019545,7304,3,CSAD|CBS
REGULATION OF HYDROGEN PEROXIDE-INDUCED CELL DEATH%GOBP%GO:1903205,0.37919826652221,0.728914030571579,0.28767813380968,1.0611260501897,2799,15,MET|RIPK1|PDE8A|NFE2L2|NR4A3|TRAP1|STK26|HDAC6
ANTEROGRADE AXONAL PROTEIN TRANSPORT%GOBP%GO:0099641,0.870218579234973,0.9573965249923859,0.22906044739117604,0.664922405555198,6369,8,DLG2|KIF5B|KIF5A|KIF5C
PYRIMIDINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0072529,0.18145875937286998,0.554948538055731,0.281287778284615,1.2589026747272298,1330,27,NT5M|NTHL1|TET2|CDADC1|NT5E|TET3|NEIL1|DPYD|ENTPD4|OGG1|DUT|SMUG1|NEIL2|UPP1
GRANZYME B LOCALIZATION TO T CELL SECRETORY GRANULE%GOBP%GO:0033380,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
CELLULAR HYPOTONIC RESPONSE%GOBP%GO:0071476,0.9189896610391309,0.976540762044854,-0.286439088953841,-0.627075042247447,7021,4,SLC12A6|CAB39|STK39|MYLK
METANEPHRIC NEPHRON MORPHOGENESIS%GOBP%GO:0072273,0.175047310083806,0.548208402653016,0.541821009842702,1.3030764215931399,1294,5,PAX8|PKD1|PKD2
POSITIVE REGULATION OF MACROPHAGE FUSION%GOBP%GO:0034241,0.572976588628763,0.8348640932853191,-0.717633436259374,-0.9560600510473409,4282,1,ADAM9
REGULATION OF ADENYLATE CYCLASE-INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1904990,0.0478929765886288,0.313376367160917,-0.9741949713277459,-1.29786161981594,357,1,PRMT5
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS%GOBP%GO:0045137,0.467947054243447,0.780769690730001,-0.19024466395320602,-0.990794900351769,3605,47,MEA1|SOD1|CEBPB|NCOA4|GATA6|FGF9|SLIT2|EIF2B2|ANG|PDGFRA|LHFPL2
ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098656,0.44505705859725603,0.76693681188187,-0.16314556939639902,-1.0046582789823701,3470,88,SLC19A1|GABRE|SLC36A1|SLC25A20|APOL1|SLC12A8|SLC7A2|SLC12A2|SLC25A10|SLC25A18|SLC35B1|SLC37A2|SLC1A2|SLC26A2|SLC1A3|SLC25A22|SLC38A6|SLC6A8|LRRC8A|SLC35A2|SLC7A3|SLC3A2|ARL6IP5|SLC25A42|PRAF2|MPC1|SLC25A19|SLC38A9|ABCC1
RESPONSE TO OSMOTIC STRESS%GOBP%GO:0006970,0.7224329627207329,0.9019989179378242,-0.179201049544388,-0.818196908808635,5522,30,STK39|TSC22D4|ARHGEF2|RCSD1|TNF|KMO|AQP1|ZFP36L1|DDX3X|MYLK|ICOSLG|LRRC8A|MBIP|YBX3|MAPK13
MITOCHONDRIAL TRICARBOXYLIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1990546,0.526896002125116,0.809755446473093,0.735719011910013,0.980982029714234,3966,1,SLC25A1
CELLULAR RESPONSE TO MYCOTOXIN%GOBP%GO:0036146,0.0753828032979976,0.38436410265336796,-0.6656229969882049,-1.4571878806126002,575,4,ACTB|PDGFB
MODULATION BY HOST OF VIRAL PROCESS%GOBP%GO:0044788,0.127480615061112,0.48455507597591796,-0.34183765803751803,-1.3505686962649,969,19,CCNK|CAV2|PPIB|FMR1|NUCKS1|APOE|CFL1|ANXA2
REGULATION OF AMINO ACID TRANSPORT%GOBP%GO:0051955,0.652471083070452,0.8734599956939421,-0.306175058148197,-0.83691586776628,4963,7,ARL6IP1|ARL6IP5
REGULATION OF INTERLEUKIN-1 BETA SECRETION%GOBP%GO:0050706,0.17193211488250698,0.545786420273949,-0.30296784002058896,-1.27203517087302,1316,23,PYCARD|GSDMD|CCL19|CASP1|TNFAIP3|CARD16|NLRP3|LGALS9|FOXP1|TLR4
SNARE COMPLEX DISASSEMBLY%GOBP%GO:0035494,0.0318783068783069,0.253815692409443,-0.7950141999030571,-1.5524612368900201,240,3,NAPA|NSF
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY%GOBP%GO:0090175,0.5913236060448149,0.8417378833576942,-0.178952979725775,-0.907643319565173,4538,43,AP2A2|FZD4|MLLT3|FZD2|SAPCD2|CELSR1|SMURF2|CLTC|VANGL1|DACT1|DAB2|TIAM1|PRICKLE2|AP2M1
HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048012,0.50951016154247,0.8000377154930172,-0.315481800049336,-0.9490464757995071,3910,9,HGF|BCAR1|MST1R|MUC20
CATABOLISM BY HOST OF SYMBIONT MACROMOLECULE%GOBP%GO:0052360,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
MODULATION OF APOPTOTIC PROCESS IN OTHER ORGANISM%GOBP%GO:0044532,0.9070802251014259,0.9709695261809209,-0.29216290141823,-0.6396056642237711,6930,4,GAPDH
REGULATION OF PEROXISOME ORGANIZATION%GOBP%GO:1900063,0.104273044880409,0.44426701730497703,0.707510753281129,1.3915901599420402,775,3,MFF|DNM1L|MAVS
REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002840,0.378617363344051,0.7285942545132281,0.6469258340226078,1.08691892913348,2825,2,HSPD1|HMGB1
REGULATION OF GROWTH OF SYMBIONT IN HOST%GOBP%GO:0044126,0.10175112762005802,0.44077960358770296,-0.8006788819499169,-1.33245769774462,766,2,OSBP
EOSINOPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002278,0.287135191728831,0.6603864229308399,-0.534671385277368,-1.17050742877253,2193,4,VAMP8|VAMP7
TORC1 SIGNALING%GOBP%GO:0038202,0.8838797814207651,0.9632754053770259,0.22460325244075197,0.651983948382786,6469,8,CLEC16A|NPRL3|AKT1S1|MTOR
CAROTENOID METABOLIC PROCESS%GOBP%GO:0016116,0.791074511887369,0.928357780000476,0.603936921041023,0.8052683932743759,5955,1,BCO2
REGULATION OF REPLICATIVE CELL AGING%GOBP%GO:1900062,0.702742474916388,0.8934528433311372,-0.6516321129245699,-0.8681304405130601,5252,1,NEK4
POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION%GOBP%GO:1902916,0.401656033663635,0.740287621109606,0.400702311445878,1.03684078224914,2958,6,PARK2|SPSB4|MARCH7|BIRC2
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000727,0.5721166362926321,0.8341248009192959,-0.313092736685195,-0.9013501683193521,4394,8,TGFB1|GREM1|MEF2C|IGF1
ENDOSOMAL VESICLE FUSION%GOBP%GO:0034058,0.24843024843024802,0.629072495919397,0.39265358088341296,1.1932380178680202,1819,9,VPS11|VPS41|SAMD9|TGFBRAP1|VPS39|ANKFY1
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION%GOBP%GO:0051480,0.0040785113433596705,0.0701393835486808,-0.23797967154786104,-1.63737864464665,31,143,OCM|EDNRA|CCL19|FPR3|LPAR6|RYR2|ITPR2|P2RX4|ERO1L|PTGER1|PLN|ITPR3|SLC8B1|WBP2NL|P2RX5|P2RX3|THY1|GRIN1|FPR1|ADCY8|CXCR4|JPH4|CALB2|TAC1|CALCB|PTGER4|TBXA2R|GHRL|ABL1|SLC35G1|CCRL2|P2RY6|GPER1|F2R|CCR1|APLNR|GNA15|CD36|F2RL3|GRIN2C|GRIN2D|BCAP31|CX3CL1|CAV1|C3AR1|CHRNA10|GPR4|PRKACA|PTGIR|PDGFRA|CMKLR1|CD55|GNG3|ATP2B2|C5AR1|C1QTNF1
POSITIVE REGULATION OF BEHAVIOR%GOBP%GO:0048520,0.505139302136868,0.797902257689198,0.34174775821360603,0.943385513502616,3734,7,STRA6|CFAP20|NR4A3|CRH
CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS%GOBP%GO:0071375,0.0704333375942733,0.3767214120425879,-0.1910095441681,-1.3229328034731298,550,148,APC|ATP6V1D|PRKAR2A|LYN|INHBB|NR4A1|ATP6V0A1|PIK3C2A|ZFP36L1|AP3S1|TCIRG1|ATP6V0B|GOT1|PARP1|ATP6V0A2|ATP6V1G2|CAV2|ATP6V1F|INS|BCAR1|FOXC2|SYAP1|ADCY8|ATP6V0D1|CA2|GRB2|CRHBP|PRKAR1A|IRS1|STAT3|PXN|ADCY4|PIK3R3|HDAC5|CEACAM1|GPER1|KAT2B|CPEB1|ATP6V0E1|RARRES2|CAMK2A|LPIN3|CAV1|PPARG|ATP6AP1|RELA|RPS6KB1|NFKB1|PRKACA|ATP6V0E2|ATP6V1A|LPIN2|ATP6V1G1|ADCY9
REGULATION OF DNA RECOMBINATION AT TELOMERE%GOBP%GO:0072695,0.355266648978509,0.7132037834765931,-0.659112213950924,-1.096868123982,2677,2,TERF2IP|TERF2
SENSORY ORGAN MORPHOGENESIS%GOBP%GO:0090596,0.007184305056645479,0.102315552754816,0.301647580276886,1.70448923748373,51,60,STRA6|FGFR2|DLL1|BBS4|RARG|PAX8|AHI1|EPHB2|HDAC1|GNGT1|WNT2B|MFAP2|TWIST1|PTPRM|CEP290|ALDH1A3|MEGF11|TFAP2B|NF1|PHACTR4|SKI|TENM3|CHD7|AGTPBP1|LRP6
MANNAN METABOLIC PROCESS%GOBP%GO:0010412,0.123920839420906,0.47832576509682107,0.9394022937803259,1.25256620252128,932,1,MANBA
NEGATIVE REGULATION OF CELLULAR ORGANOFLUORINE METABOLIC PROCESS%GOBP%GO:0090350,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
REGULATION OF STRIATED MUSCLE CONTRACTION%GOBP%GO:0006942,0.13215859030837,0.491948396065839,0.24331980982510198,1.29176788336389,959,48,TRPM4|FKBP1B|BIN1|SCN5A|ANK2|GSTM2|TNNI3K|DMD|RANGRF|RNF207
PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY%GOBP%GO:0071211,0.339615233608166,0.701467683185937,-0.509623338664314,-1.11567201875407,2594,4,HSPA8|CLU|SMURF1|LAMP2
REGULATION OF HYPOXIA-INDUCIBLE FACTOR-1ALPHA SIGNALING PATHWAY%GOBP%GO:1902071,0.5744454774870501,0.835204333784353,0.710796206440229,0.9477508315256079,4324,1,RWDD3
POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT%GOBP%GO:1905205,0.9355266648978509,0.9806508984207809,-0.370719602977668,-0.616936701876598,7051,2,ROCK2|ROCK1
HISTONE H2A-K13 UBIQUITINATION%GOBP%GO:0036351,0.283612040133779,0.656174769021447,-0.8551499779444199,-1.13926510424074,2119,1,RNF168
COENZYME A BIOSYNTHETIC PROCESS%GOBP%GO:0015937,0.9564207650273231,0.987856073943962,0.19774946218765502,0.574032093242683,7000,8,ACAT1|ACOT7|PPCDC|PANK2
REGULATION OF SOMITOGENESIS%GOBP%GO:0014807,0.27424973204716,0.6487430099175849,0.6962042635129179,1.16971305327278,2046,2,DLL1|LFNG
MYELOID DENDRITIC CELL DIFFERENTIATION%GOBP%GO:0043011,0.281176776881021,0.654472045246182,-0.40373553577595206,-1.16229810049556,2159,8,DHRS2|UBD|BATF|BATF2|TGFBR2|LTBR
NEGATIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION%GOBP%GO:0034092,0.993386243386243,0.9974705716496209,-0.24593855210166604,-0.480255659384764,7509,3,ATRX|NAA10
VERY LONG-CHAIN FATTY ACID METABOLIC PROCESS%GOBP%GO:0000038,0.11644105664344902,0.46625878958064004,-0.34638997119792303,-1.3685544608682998,885,19,ACOT1|ELOVL2|ELOVL1|ACOX1|HACD2|SLC27A4|ACOT2|ABCD1
RRNA ACETYLATION%GOBP%GO:1990882,0.0145819397993311,0.161640900278931,-0.992666519629466,-1.3224701574341398,108,1,NAT10
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0010649,0.8915520628683691,0.9654108613288259,-0.252831886914043,-0.650351722540348,6806,6,PDE4D|CAV1
NEGATIVE REGULATION OF ZINC ION TRANSPORT%GOBP%GO:0071582,0.710718554920972,0.8964108318214721,0.643857520952801,0.858497126656157,5350,1,SLC30A1
TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION%GOBP%GO:0071706,0.9786677136500458,0.992937328049893,-0.24171400209562696,-0.529162477891906,7477,4,BCL10|HMGB1|APP|TLR2
NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION%GOBP%GO:1904689,0.853898260061097,0.949296218452153,0.571901191001324,0.7625530699389971,6428,1,RPL13A
STRESS-ACTIVATED PROTEIN KINASE SIGNALING CASCADE%GOBP%GO:0031098,0.934751773049645,0.980518375568481,-0.108828161410756,-0.703923346641353,7248,108,PKN1|STRADA|MDFIC|TAOK2|PTGER4|MLKL|MAPK9|MAPK3|IRAK1|SKP1|MAP3K13|KAT7|STK3|MAP2K3|LGALS9|MAP3K11|UBC|MAPK13|NFKB1|GPS1|DBNL|ERN1
MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0031109,0.8875255623721879,0.965152724305326,0.13405626445333402,0.6957348241986221,6509,44,CLASP1|KATNB1|CLASP2|STMN3|NDEL1|TUBGCP3|STMN2|TPPP3|MZT1|STMN4|TUBGCP6|CENPJ|RANBP9
CHARGED-TRNA AMINO ACID MODIFICATION%GOBP%GO:0019988,0.567273210253686,0.831087370400857,0.7141045434494929,0.952162052524098,4270,1,MTFMT
CENTRAL NERVOUS SYSTEM VASCULOGENESIS%GOBP%GO:0022009,0.0528428093645485,0.333002194020657,-0.97198941332157,-1.2949232869660001,394,1,ENG
POSITIVE REGULATION OF COENZYME METABOLIC PROCESS%GOBP%GO:0051197,0.40172842739295506,0.740287621109606,-0.302201703735149,-1.0402368677865,3067,13,PFKFB2|PFKFB3|INS|IGF1
LONG-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0015909,0.0299542184434271,0.244735657013286,-0.350328378702061,-1.5995307909788101,228,30,LCN12|LCN1|APOE|FABP4|CD36|SLC27A4|PPARG|RPS6KB1|ABCD1|ANXA1
LAMELLIPODIUM MORPHOGENESIS%GOBP%GO:0072673,0.304722738126824,0.6770795415897549,-0.682161566032534,-1.13522593171432,2296,2,SNX1|SNX2
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION%GOBP%GO:0023014,0.309328549461814,0.680809181688249,-0.139823658298456,-1.06873570478874,2413,253,PKN1|STRADA|MDFIC|GRIN1|ILK|TAOK2|CSF2RB|MAPKAPK2|GRB2|PTGER4|MEF2C|MLKL|IRS1|MAPK9|IL2RA|CAMKK2|FGF10|MAPK3|CAMK2B|IRAK1|HRAS|IGF1|SKP1|MEN1|MAP3K13|HBEGF|CCL2|CTSH|STK3|CSF2RA|MAP2K3|PLVAP|IL3RA|FGF19|FGF9|LGALS9|TEK|MAP3K11|FGF7|ARAF|DLG3|PEA15|UBC|PDGFRB|PABPN1|CAMK2A|FLT3LG|MYC|MAPK13|NFKB1|PDGFA|PDGFRA|SPTBN2|GPS1|DBNL|PDGFB|ERN1
ATF6-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:0036500,0.370114643043252,0.7226447402424641,-0.354143332911141,-1.06534982992569,2840,9,MBTPS2|CALR|HSPA5
NECROPTOTIC SIGNALING PATHWAY%GOBP%GO:0097527,0.890328491035205,0.965159112268525,-0.29991606318194103,-0.65657895602653,6802,4,FAS|TNF|FADD
REGULATION OF CALCINEURIN-NFAT SIGNALING CASCADE%GOBP%GO:0070884,0.210147770367464,0.591474654268711,-0.296057354185963,-1.22605053535254,1606,22,GSK3B|SPPL3|TMEM110|TNF|PTBP1|LMCD1|RCAN2|SLC9A1|IGF1|RCAN3|FHL2|PRNP|RCAN1
ENDOCARDIAL CUSHION FORMATION%GOBP%GO:0003272,0.207673170092968,0.587709393354349,-0.35958818105466606,-1.23777225121528,1585,13,NOTCH1|SNAI2|DCHS1|SNAI1|ENG
OLIGOSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009312,0.219065077910174,0.601686354077891,-0.355684814735552,-1.2243361073966599,1672,13,B3GALT2|B4GALT1|NDUFAB1|B3GALT1
CXCL12-ACTIVATED CXCR4 SIGNALING PATHWAY%GOBP%GO:0038160,0.32428093645485,0.692794968343412,-0.8357410674900749,-1.11340777516132,2423,1,CXCR4
NON-RECOMBINATIONAL REPAIR%GOBP%GO:0000726,0.581914344685243,0.8387093286508721,-0.161361754049663,-0.922760847302098,4510,66,SETMAR|H2AFX|NBN|PAXIP1|KDM2A|BRCC3|SLX1B|SLX1A|RNF168|HIST1H4I|RNF138|BRCA1|POLQ|C9orf142|HIST2H4A|KAT5|POLA1|HIST2H4B|XRCC6BP1|PRPF19
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009168,0.256601829189746,0.634929462604421,-0.198797400822257,-1.14166518678402,1991,67,ATP5J|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|PGAM1|HPRT1|GAPDH|GMPS|LDHA|STOML2|ATP5H|PGK1|ALDOA|ALDOC|ATP5G1
COMMON-PARTNER SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0007182,0.9205026455026459,0.9768322640118741,-0.31967574721517605,-0.624245712826174,6958,3,SMAD2|BMP4|TGFB1
TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:0044342,0.204161758932077,0.5836566355384301,-0.578016946915555,-1.26539992404885,1559,4,BTBD10|NOV|BAD
NEGATIVE REGULATION OF METANEPHRIC COMMA-SHAPED BODY MORPHOGENESIS%GOBP%GO:2000007,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
COFACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0051188,0.0323745646846382,0.256518384872286,-0.20085520059236803,-1.4170048855005901,250,164,TSPO|CHAC1|PARP9|CHAC2|ACSL5|NDUFA9|DCAKD|GPI|COASY|ACSL4|PFKFB2|ATPIF1|GGT1|ELOVL2|HK1|PDHA1|ACSF3|KYNU|HK3|NFE2L1|ELOVL1|COQ6|HAAO|ENO1|ALAD|SOD1|SLC25A16|PGAM1|DHFR|MOCS2|MBIP|RFK|GAPDH|COQ7|HACD2|FXN|PDSS1|LDHA|PDHX|PNPO|NMNAT3|PNP|PGK1|GPHN|FASN|QPRT|PDXK|NNMT|ALDOA|COQ3|ALDOC|MTHFD1|PTGIS
INSULIN CATABOLIC PROCESS%GOBP%GO:1901143,0.0295834438843194,0.244476753576953,-0.888530371490587,-1.47865662484973,222,2,CEACAM1
"REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, NONSENSE-MEDIATED DECAY%GOBP%GO:2000622",0.11273851115291599,0.460292399693505,0.69945957869196,1.37575444962625,838,3,NBAS|DHX34|PABPC1
REGULATION OF INTERLEUKIN-8 BIOSYNTHETIC PROCESS%GOBP%GO:0045414,0.6043222003929271,0.848175106515994,-0.34086886213979495,-0.8768065387589,4613,6,TNF|KLF4|BCL3|TLR4
NEGATIVE REGULATION OF DNA DAMAGE CHECKPOINT%GOBP%GO:2000002,0.281891047412036,0.654732517474162,0.528277502351283,1.16064817075728,2074,4,THOC5|DDX39B|THOC1|PPP1R10
POSITIVE REGULATION OF HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:1902204,0.599681232567406,0.8464076674715391,0.697783414203794,0.9304000289315469,4514,1,ESM1
CHLORIDE ION HOMEOSTASIS%GOBP%GO:0055064,0.15350284014065502,0.52168285154307,0.48481866975613297,1.33832892456801,1134,7,SLC12A5|SLC12A4|SLC12A9|SLC12A6|SLC12A7
MESENCHYMAL CELL APOPTOTIC PROCESS%GOBP%GO:0097152,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM%GOBP%GO:1905552,0.258306538049303,0.636098664976652,0.70432864626413,1.18336306527634,1927,2,RTN4|DDRGK1
"BLOOD COAGULATION, EXTRINSIC PATHWAY%GOBP%GO:0007598",0.0675925925925926,0.371075653877479,-0.743355023712364,-1.45158395875398,510,3,F10|F3|TFPI
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN DETERMINATION OF LEFT/RIGHT SYMMETRY%GOBP%GO:1900094,0.35396466994288794,0.7118407891832621,0.8236104984561099,1.09817346757412,2664,1,CITED2
TELENCEPHALON GLIAL CELL MIGRATION%GOBP%GO:0022030,0.370029753854477,0.7226447402424641,0.387261831905706,1.06902589226051,2735,7,RTN4|LAMB1|MBOAT7
IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:0001771,0.622239747634069,0.856494784917583,-0.315329170810806,-0.8619382265076959,4733,7,PRF1|CORO1A|CCL19|MSN
POSITIVE REGULATION OF ENDOPEPTIDASE ACTIVITY%GOBP%GO:0010950,0.000386747453912595,0.0111294649577428,-0.29145191406090004,-1.9176621200578303,2,116,FIS1|PYCARD|APOPT1|GNB2L1|REST|PPM1F|TNFRSF10A|TNFRSF10B|PDCD6|CASP10|NGF|PDCD5|CASP1|GRIN1|VCP|TRAF2|PRELID1|DDX3X|EFNA1|TNFSF10|CYCS|CASP4|STAT3|PSME2|F3|PERP|IFI27L1|ANP32B|IFI16|C10orf54|CYFIP2|GPER1|CIDEB|GSN|F2R|DLC1|NLRP3|EFNA3|ASPH|LGALS9|FADD|EPHA4|BCAP31|MYC|PPARG|S100A8|S100A9|ARL6IP5|LGMN|NGFRAP1|NGFR|BAD
CATABOLISM OF SUBSTANCE IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052227,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
POSITIVE THYMIC T CELL SELECTION%GOBP%GO:0045059,0.356473305257438,0.7143700881375159,0.49037666133568597,1.07737840893868,2623,4,ZAP70|CD3E|CD3D|CD3G
PROTEIN SUMOYLATION%GOBP%GO:0016925,0.36529555979297207,0.7197032395461701,0.25177644440446695,1.0689029960839,2681,23,TRPM4|PIAS3|RNF212|RANBP2|EYA1|SUMO1
REGULATION OF CELLULAR KETONE METABOLIC PROCESS BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072365,0.7892150351972371,0.9280333261332429,0.605094838994266,0.806812320623848,5941,1,NCOR2
RESPONSE TO NICOTINE%GOBP%GO:0035094,0.317514420555847,0.686648774983727,-0.315702605547465,-1.11690965206251,2421,14,HMOX1|CHRNE|RELA|NFKB1|BAD
REGULATION OF LAMELLIPODIUM ORGANIZATION%GOBP%GO:1902743,0.546080852723255,0.8176154960627271,-0.197830688654068,-0.937279022726773,4200,34,FSCN1|RAC2|CDC42|ARPIN|RAC1|SSH1|CD44|KANK1|WASF2|CORO1C|WAS|RREB1|PDPN|EPHA2|CORO1B|SLIT2
GLUCOCORTICOID CATABOLIC PROCESS%GOBP%GO:0006713,0.45079027759330603,0.76916729726177,0.7758050286722541,1.03443132414594,3393,1,YWHAH
POSITIVE REGULATION OF HAIR CYCLE%GOBP%GO:0042635,0.858100999473961,0.9499338671315691,-0.28595950150127303,-0.6853903590032371,6524,5,TGFB2|FST|TERT
POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS%GOBP%GO:2000108,0.0272144445898208,0.23271567002476898,-0.43687465768670797,-1.6602303823460303,207,17,CD274|LYN|FNIP1|ADAM8|CDKN2A|PRELID1|MEF2C|PIK3CB|LGALS9|ANXA1
CALCIUM-MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE%GOBP%GO:0035584,0.0184482533036766,0.186740972764028,-0.45668141082871005,-1.7355008810197299,140,17,FIS1|RYR2|KDR|AZU1|VCAM1|BCAP31|PRKACA|ADGRL1|PTPRJ|PRNP
CDP-DIACYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0046341,0.29472705538584104,0.667556940989968,0.8548191442434939,1.13978598565988,2218,1,CDS1
POSITIVE REGULATION OF HISTONE H4-K20 METHYLATION%GOBP%GO:0070512,0.273979933110368,0.648567992029846,-0.860002205558006,-1.1457294365105901,2047,1,BRCA1
ERK5 CASCADE%GOBP%GO:0070375,0.929605525302165,0.9793746057014829,0.5360057344508161,0.714691322105379,6998,1,MEF2A
DENTINOGENESIS%GOBP%GO:0097187,0.10755852842809402,0.451309145449614,-0.944199382443758,-1.25790029305683,803,1,SERPINE1
T-HELPER 2 CELL DIFFERENTIATION%GOBP%GO:0045064,0.49859531772575294,0.794989907195277,-0.754962505513895,-1.00579133453248,3726,1,BATF
OUTFLOW TRACT MORPHOGENESIS%GOBP%GO:0003151,0.238021036229061,0.6217283213739421,-0.22828217209757198,-1.17344903028879,1832,45,JAG1|TBX1|ZFPM2|SOX18|SOX17|CLDN5|SFRP2|SMAD6|TBX2|HES1|NOTCH1|ELN|MEF2C|GATA6|NRP2|TGFBR2|TGFBR3|ENG
NEGATIVE REGULATION OF STRESS GRANULE ASSEMBLY%GOBP%GO:0062030,0.0619397993311037,0.357540960865252,-0.9671923246581391,-1.2885324130173998,462,1,STYXL1
HEART VALVE MORPHOGENESIS%GOBP%GO:0003179,0.18427518427518397,0.557097723034196,-0.248184937711639,-1.23552071755373,1424,40,HEYL|TGFB2|ROCK1|ROBO1|GJA5|TGFB1|OLFM1|JAG1|GATA3|SMAD6|EFNA1|NOTCH1|ELN|MEF2C|SNAI2|NOTCH2|NOS3|TGFBR2|BMP2|DCHS1|SLIT2|SNAI1
REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010988,0.0929773803261441,0.42197818459338793,-0.599950676206612,-1.4379672897410403,706,5,KHSRP|CNPY2|HNRNPK|ANXA2
REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION%GOBP%GO:1903760,0.17683418435904302,0.548551967663807,0.653131395307681,1.2846323799947,1315,3,RNF207|NOS1AP|DLG1
RESPONSE TO ALCOHOL%GOBP%GO:0097305,0.7994202098288241,0.931670998922663,0.137922805104758,0.794089936686918,5790,64,SFRP1|DRD2|SPIDR|ADCY2|DRD4|CHRNB2|CAD|GRAMD1B|ADCY3|SLIT3|ADCYAP1
PRENYLCYSTEINE METABOLIC PROCESS%GOBP%GO:0030329,0.9725348338692389,0.9915747942934481,0.320147066686413,0.5378884078941589,7258,2,PCYOX1|PCYOX1L
ANATOMICAL STRUCTURE REGRESSION%GOBP%GO:0060033,0.8207747413106931,0.940031154277066,-0.450289495450786,-0.7493537271343599,6186,2,AMH|AMHR2
NUCLEAR RNA SURVEILLANCE%GOBP%GO:0071027,0.827811968050282,0.943061234519578,-0.20555622889423497,-0.7075644017094681,6321,13,EXOSC3|EXOSC2
DRUG METABOLIC PROCESS%GOBP%GO:0017144,0.00012745347947999,0.00518555396908895,-0.20964618776638602,-1.73056804584726,0,411,SLC19A1|NDUFB5|NADK|MOXD1|ST3GAL1|SURF1|ATP1B1|UQCR10|PYCRL|PARP1|BCHE|NDUFA9|ATP5J|NDUFA7|COMT|GPI|ATP5F1|AACS|CYP1B1|FH|SMOX|ADH1B|PFKFB2|HLCS|GGT1|GPX1|ELOVL2|HK1|CBR1|CACNA1H|ALDH2|ADA|PDHA1|NDUFA3|NDUFB6|KYNU|ATP5B|HK3|DCN|CHPT1|ADI1|SDHD|PDXP|ELOVL1|THTPA|CYCS|PLA2G4A|GNE|NDUFB9|PARK7|COA6|BGN|MCCC2|PLA2G7|HAAO|ENO1|DPEP1|NDUFB10|SDHA|ACO1|SOD1|VCAN|MT-CO3|IGF1|NDUFS7|ATP5O|NPL|ALDH1A1|SDSL|NDUFB1|SLC6A8|NDUFB7|NDUFA6|CKB|PGAM1|ACOX1|CTSH|DHFR|RFK|CAT|SMS|GAPDH|NDUFS6|COQ7|NOS3|IL4I1|FMO2|SQRDL|NDUFB4|NDUFA12|GGT5|SDHAF2|LDHA|NDUFA2|NDUFAB1|COX4I2|GPX3|NDUFA1|STOML2|PCCB|ABCD1|PNPO|NDUFA4|ATP5H|SAT2|NDUFV1|PRDX4|MMAB|UQCRQ|SHMT2|PRDX5|PGK1|SLC25A19|NDUFS3|FOLR2|FADS1|FADS2|ASRGL1|UQCRC2|APIP|VKORC1|QPRT|COX6A1|PDXK|UQCC3|NDUFA8|ALDOA|NDUFS8|RENBP|ALDOC|ATP5G1|MTHFD1|BAD|NDUFV3|ABCC1
CELLULAR AMINE METABOLIC PROCESS%GOBP%GO:0044106,0.137530960761309,0.50219949963275,-0.279282519868141,-1.31158955382941,1054,33,KMO|MAOA|CCBL1|SAT1|MOXD1|GDE1|ODC1|SMOX|KYNU|GDPD1|HAAO|SLC44A1|SMS|AFMID|SAT2|HNMT
MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT%GOBP%GO:0060916,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
EMBRYONIC SKELETAL LIMB JOINT MORPHOGENESIS%GOBP%GO:0036023,0.84951520786293,0.9492491301138911,0.574327304808116,0.7657879653378901,6395,1,CTNNB1
TRIGLYCERIDE CATABOLIC PROCESS%GOBP%GO:0019433,0.0347565738089039,0.26620723045800804,-0.56896426799683,-1.6379684950733302,266,8,PNPLA2|FABP3|APOE|FABP4|PNPLA4
BOX H/ACA SNORNP ASSEMBLY%GOBP%GO:0000493,0.7566993897585571,0.9167299629693821,-0.488006617038875,-0.8121210488781639,5703,2,NAF1|SHQ1
TRNA DEMETHYLATION%GOBP%GO:1990983,0.573913043478261,0.835204333784353,-0.7171923246581391,-0.9554723844773539,4289,1,ALKBH1
REGULATION OF LIPOPROTEIN METABOLIC PROCESS%GOBP%GO:0050746,0.798485258317555,0.9313130757797751,0.26326530612244897,0.7267368110971328,5903,7,RAB3GAP1|ITGAV|SVIP|ITGB3|RAB3GAP2|GBA|APOD
DNA DEAMINATION%GOBP%GO:0045006,0.0819437206878583,0.398202308598866,-0.492339860313178,-1.48107881105272,628,9,APOBEC3G|APOBEC3C|EXOSC3|APOBEC3F
REGULATION OF OSSIFICATION%GOBP%GO:0030278,0.0603008669046405,0.355734936871271,-0.228972880182362,-1.40074612851619,472,85,SMAD6|TGFB3|DDR2|IL6ST|TXLNG|NOTCH1|MEF2C|S1PR1|CHRD|PRKD1|DDX5|C14orf169|SNAI2|ISG15|SRGN|IGF1|MEN1|LRP5|GPM6B|CCR1|ECM1|BMP2|CCRN4L|ATP6AP1|IFITM1|PRKACA|TMEM119|ADGRV1|ZHX3
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN%GOBP%GO:0019883,0.031069743051914,0.250509257391795,-0.46380025317306706,-1.64085747249288,236,14,HLA-F|ERAP2|ERAP1|CD1D|HLA-B|HLA-E|CD74|B2M|HLA-C|HLA-A
NEGATIVE REGULATION OF RNA CATABOLIC PROCESS%GOBP%GO:1902369,0.0578019699326076,0.34658161623965,-0.298740200701808,-1.47525312964379,445,39,FAM46C|YBX1|DHX9|PAPD4|HNRNPU|LARP1|TOB1|FMR1|DHX36|MAPKAPK2|SLC11A1|E2F1|DKC1|CCRN4L|SLIRP|YBX3|HNRNPA0|HNRNPC
NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0033865,0.852233676975945,0.949296218452153,-0.12428043111973598,-0.762754247168462,6695,86,DGAT1|CROT|ACSL5|ABHD14B|ACOT1|ACSF2|DCAKD|FAR1|COASY|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|SLC26A2|TPST2|HMGCS1|HACD2|ACOT2|PDHX|ABCD1|SULT1A4|FASN
POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0051901,0.0914801727522576,0.418509154958602,-0.6521003191260589,-1.42758391202481,698,4,GNB2L1|KDR|DCN
ANTERIOR/POSTERIOR AXIS SPECIFICATION%GOBP%GO:0009948,0.875985858036443,0.9607117102951591,0.20963204060241603,0.664128474726339,6441,10,TBX3|SKI|LRP6
PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS FROM GLUTAMATE%GOBP%GO:0019353,0.671669544428211,0.8815356925073421,0.662218791354213,0.882979403197778,5056,1,CPOX
TOOTH ERUPTION%GOBP%GO:0044691,0.0232775919732442,0.21209732484039803,-0.989027348919277,-1.31762190823174,173,1,FAM20A
POSITIVE REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS%GOBP%GO:0048260,0.112936610608021,0.46067566706389895,-0.27949790615215697,-1.3458606354673002,872,36,RAB21|BICD1|SYNJ1|GREM1|PPT1|B2M|CCL19|SFRP4|SGIP1|VTN|FMR1|CD63|ARRB1|HFE|HNRNPK|SERPINE1|DAB2|ANXA2
TRANSLATIONAL TERMINATION%GOBP%GO:0006415,0.000256016385048643,0.00819882332206558,-0.31785576638382396,-1.98513253637072,1,93,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|GSPT2|MRPL18|MRPL57|GFM2|MRPS18B|MRPS15|MRPL47|GADD45GIP1|MRPS11|MRPL13|ETF1|OXA1L|MRPL10|MRPL50|MRRF|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
ENERGY HOMEOSTASIS%GOBP%GO:0097009,0.466947036404258,0.7806653415096191,-0.24970794073387304,-0.986572778142913,3552,19,NR1D2|SGIP1|STAT3|CD36|METRNL|EIF4G1
DESMOSOME ORGANIZATION%GOBP%GO:0002934,0.11770120988953199,0.46862716515177505,-0.580842592454268,-1.3921688591446497,894,5,JUP|PKP2|PERP|SNAI2
NEGATIVE REGULATION OF CYTOKINE SECRETION%GOBP%GO:0050710,0.0150884495317378,0.165483319665635,-0.35498949966068,-1.69469610941003,115,35,CD34|SSC5D|FCGR2B|GAS6|TNFAIP3|PTGER4|CARD16|SRGN|TNFRSF4|FN1|NLRP3|TNFRSF21|CD200|CX3CL1|ANXA1|TMSB4X
POSITIVE REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL%GOBP%GO:0046726,0.8319591676482141,0.9443921657118071,-0.32301025552539697,-0.7071369706199129,6356,4,DDB1
L-METHYLMALONYL-COA METABOLIC PROCESS%GOBP%GO:0046491,0.5954310001328199,0.8443302331706161,0.699933833259815,0.9332673225805649,4482,1,MCEE
GRANZYME-MEDIATED APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0008626,0.9364767518009169,0.9806508984207809,-0.23471064127837,-0.603738997153604,7149,6,GZMB|SRGN
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN%GOBP%GO:0002924,0.951843990448395,0.9858647066977451,-0.3528723751113921,-0.5872360607207989,7174,2,FCGR2B
NUCLEOTIDE PHOSPHORYLATION%GOBP%GO:0046939,0.0475757181853633,0.312287542159256,-0.320266942242391,-1.5173555158650902,365,34,GPI|PFKFB2|HK1|HK3|ENO1|PGAM1|GAPDH|NME2|LDHA|CMPK2|PGK1|ALDOA|ALDOC|AK1
SYNAPTIC VESICLE ENDOSOMAL PROCESSING%GOBP%GO:0099532,0.6629079331387641,0.879680951980053,-0.533204719748295,-0.8873379195066892,4996,2,EEA1
PRESYNAPSE ASSEMBLY%GOBP%GO:0099054,0.536612021857923,0.8132910857498922,0.317888465993712,0.9227746034470241,3927,8,PTPRD|NLGN2|NLGN4X|DVL1|FZD1|NLGN4Y|PTEN|NLGN3
CARDIAC ATRIUM MORPHOGENESIS%GOBP%GO:0003209,0.8312794965915049,0.9443784929910591,-0.200049526697927,-0.7077459714720591,6340,14,MESP1|NOTCH1|NOTCH2|ENG
NUCLEOBASE METABOLIC PROCESS%GOBP%GO:0009112,0.146966527196653,0.514131830678897,-0.340500967526056,-1.32127038970356,1123,18,CTPS1|HPRT1|CDA|PRPS1|GMPS|MTHFD1
POSITIVE REGULATION OF CHAPERONE-MEDIATED PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0090035,0.293542336548767,0.666121490214324,0.6871794871794871,1.15455026379658,2190,2,STUB1|HDAC6
AV NODE CELL-BUNDLE OF HIS CELL ADHESION INVOLVED IN CELL COMMUNICATION%GOBP%GO:0086072,0.47010033444816096,0.781244333716016,-0.766982796647552,-1.02180524856462,3513,1,CXADR
POSITIVE REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 2 PRODUCTION%GOBP%GO:2000343,0.432404135584348,0.760841998450104,-0.46510095327535295,-1.01820321028695,3303,4,TNF|CD74
REGULATION OF SHORT-TERM SYNAPTIC POTENTIATION%GOBP%GO:1905512,0.0901672240802676,0.414794277220364,-0.9526907807675341,-1.26921287452908,673,1,PRRT2
REGULATION OF PROTEIN K48-LINKED UBIQUITINATION%GOBP%GO:0061945,0.9519766516317328,0.9858647066977451,-0.35276898733642204,-0.587064006930301,7175,2,TRIM44
POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION%GOBP%GO:0045836,0.8883597883597879,0.965159112268525,-0.337046432116466,-0.6581662578564039,6715,3,NPM2|SIRT2|PLCB1
REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY%GOBP%GO:0043551,0.0403750976816879,0.287963821148335,-0.33598802774259096,-1.5484253950029998,309,31,TGFB1|TNFAIP8L3|FLT1|CCL19|DAB2IP|FGR|EPHA8|IRS1|PRKD1|PIK3R3|PIK3R4|TEK|PDGFRB|PDGFRA|AMBRA1|PDGFB
NEGATIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS%GOBP%GO:1901624,0.670336959405678,0.8815356925073421,-0.530100939876749,-0.882172733468717,5052,2,CCL2
CEREBELLUM MATURATION%GOBP%GO:0021590,0.0964548494983278,0.427566585262796,-0.9493824437582711,-1.26480537525418,720,1,CEND1
POSITIVE REGULATION OF DIPEPTIDE TRANSPORT%GOBP%GO:2000880,0.8973202440965771,0.967166974453851,-0.402923115333027,-0.6705284961647321,6763,2,CA2
ACUTE-PHASE RESPONSE%GOBP%GO:0006953,0.37932829992189504,0.728914030571579,-0.368654446639682,-1.06130455483692,2913,8,INS|PLSCR1|CEBPB
REGULATION OF VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:1905063,0.0615424905067435,0.35631208031004796,-0.44181821904827706,-1.52082398819492,469,13,DNMT1|NFATC1|GPER1|FGF9|ENG|PDGFB
REGULATION OF METANEPHRIC GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072301,0.981939799331104,0.993436724391485,-0.50904278782532,-0.6781672217648139,7339,1,EGR1
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW%GOBP%GO:0035604,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
ONE-CARBON METABOLIC PROCESS%GOBP%GO:0006730,0.41357217573221794,0.748061280707938,-0.32769361231667893,-1.02662131011817,3162,10,SHMT2|MTHFD1
RESPONSE TO TYPE I INTERFERON%GOBP%GO:0034340,0.00245700245700246,0.0467168974631661,-0.358431292978884,-1.92199967023368,18,52,IRF8|OAS3|HLA-B|MX1|XAF1|HLA-E|SP100|IFIT3|TRIM56|OASL|OAS1|IFNAR1|HLA-C|IRF5|HLA-A|OAS2|IFIT2|IFIT1|ISG15|IFI6|RSAD2|IRF7|IRAK1|BST2|IFI35|IFITM1|SHMT2|IFITM2|IFITM3|SAMHD1
FAT PAD DEVELOPMENT%GOBP%GO:0060613,0.44295391154203706,0.7658968186518771,0.779940449933833,1.0399453503940501,3334,1,DGAT2
REGULATION OF TELOMERIC LOOP DISASSEMBLY%GOBP%GO:1904533,0.9153453372749258,0.974418855216947,0.321504330905519,0.6323610788839771,6811,3,RTEL1|TERF1
ENTRY OF BACTERIUM INTO HOST CELL%GOBP%GO:0035635,0.624154720043278,0.857740130996327,0.30946581280991,0.85427206971378,4614,7,MET|CBL|SRC
KETONE BODY METABOLIC PROCESS%GOBP%GO:1902224,0.0557377049180328,0.342757322822697,0.5383355617920921,1.5626939562002098,407,8,BDH2|HMGCLL1|ACAT1|HMGCL|SLC27A5|BDH1|OXCT1
TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB%GOBP%GO:0022028,0.5284608069555771,0.8105400040230321,0.42407275497248004,0.931705902931896,3889,4,SLIT1|SLIT3
INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:0097193,0.164087479217291,0.535290477921284,-0.18785752603064002,-1.20940742026729,1282,105,PYCARD|APOPT1|BCL2A1|BCL2L11|CHAC1|DAB2IP|PPM1F|ATP2A1|TNFRSF10B|ERO1L|CYP1B1|BCL2L2|TRAF2|DDX3X|IKBKE|PPP1R13B|ZNF622|CYCS|CASP4|BRCA1|DDX5|SNW1|ABL1|IFI6|CEBPB|E2F1|IFI16|HIC1|BCL3|EPHA2|CIDEB|TMEM109|DDIT4|HINT1|ARL6IP5|RRP8|CRIP1|BAD
SODIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0035725,0.694303219919176,0.889621324957948,-0.17784359820748602,-0.835203741839994,5325,33,SLC8A3|SCN4B|SCN7A|SLC9A5|ATP1B1|ATP1A3|SLC12A2|ATP1B3|SLC9A1|PKD2L1|SLC9A7|NALCN|SLC9A9|SCN1B|ATP1B2
CHEMOKINE (C-X-C MOTIF) LIGAND 2 PRODUCTION%GOBP%GO:0072567,0.30419209339347303,0.676707700393746,-0.682581244112189,-1.13592434315044,2292,2,FOXP1
NEGATIVE REGULATION OF GENE SILENCING BY RNA%GOBP%GO:0060967,0.7860878661087871,0.9274485629622209,-0.235093311644987,-0.736516656198218,6011,10,TGFB1|DND1|TERT|PPARG
REGULATION OF PHOSPHOLIPASE A2 ACTIVITY%GOBP%GO:0032429,0.108044164037855,0.452482039948645,-0.517232335316309,-1.4138315229403897,821,7,LRP1|PLA2R1|ANG|PLAA|ANXA1
REGULATION OF PROTEIN FOLDING IN ENDOPLASMIC RETICULUM%GOBP%GO:0060904,0.0638127090301003,0.36192038030965795,-0.9661446846052049,-1.28713670491368,476,1,HSPA5
POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING%GOBP%GO:0010739,0.5900458415193189,0.8414799095069009,-0.344961630917999,-0.887334242591486,4504,6,MC1R|ADRB2|C8orf4|ADGRV1
GLYCINE SECRETION%GOBP%GO:0061536,0.9296321070234109,0.9793746057014829,-0.5345169827966479,-0.712104966181554,6948,1,SLC6A9
ENDOPLASMIC RETICULUM STRESS-INDUCED PRE-EMPTIVE QUALITY CONTROL%GOBP%GO:0061857,0.82448925444415,0.942178419436027,-0.44765926618317103,-0.7449766050277651,6214,2,VCP
NEGATIVE REGULATION OF CYTOKINESIS%GOBP%GO:0032466,0.56353068396864,0.828821766028182,0.374420913302449,0.9004801493715279,4168,5,ZFYVE19|AURKB|E2F7|E2F8|VPS4A
REGULATION OF PROTEIN AUTOPHOSPHORYLATION%GOBP%GO:0031952,0.0126433785192909,0.14869950444299201,-0.370778323893558,-1.7247146009660899,96,32,IMPACT|NBN|PDGFD|INS|TAOK2|PDGFC|GPNMB|MVP|ERRFI1|TNKS1BP1|CAV1|PDGFA|ENG|PDGFB
GLYCOSPHINGOLIPID METABOLIC PROCESS%GOBP%GO:0006687,0.355148681989352,0.7132037834765931,-0.20846862707673497,-1.07160058116265,2734,45,GLTP|GLA|NEU4|UGCG|STS|B3GALT2|HEXB|SMPD1|A4GALT|B3GALT1|ST3GAL5
REGULATION OF CELLULAR ORGANOFLUORINE METABOLIC PROCESS%GOBP%GO:0090348,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
MESENDODERM DEVELOPMENT%GOBP%GO:0048382,0.48762541806020093,0.788226301622024,-0.759483899426555,-1.01181491687484,3644,1,ZFP36L1
NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0033869,0.39632333062990005,0.7377402989373809,0.431845591736601,1.03858617170321,2931,5,NUDT7|ACAT1|ACOT7
PIGMENT GRANULE AGGREGATION IN CELL CENTER%GOBP%GO:0051877,0.137459807073955,0.50219949963275,0.7793768955059279,1.30945381387425,1025,2,MKKS|BBS7
PHOSPHATIDYLETHANOLAMINE CATABOLIC PROCESS%GOBP%GO:0046338,0.365755627009646,0.7200759556474979,0.653101736972705,1.0972952434927499,2729,2,PNPLA8|PLA2G15
AMINO SUGAR METABOLIC PROCESS%GOBP%GO:0006040,0.7242642249836491,0.9034590034658789,-0.178885363679934,-0.8167555489555111,5536,30,CHST7|GNE|NPL|GNPNAT1|GFPT2|CSGALNACT1|RENBP
POSITIVE REGULATION OF MRNA CAP BINDING%GOBP%GO:1905612,0.007759197324414721,0.10744152749969199,-0.9961954124393471,-1.32717148999403,57,1,EIF4G1
REGULATION OF STRAND INVASION%GOBP%GO:0060542,0.120733165094966,0.472686039512467,0.941001323334804,1.25469829267055,908,1,WRN
REGULATION OF TRIGLYCERIDE METABOLIC PROCESS%GOBP%GO:0090207,0.13153765690376598,0.490850639022817,-0.346878318962069,-1.3460168850758303,1005,18,PNPLA2|C3|ABHD5|NR1H3|FITM2|LDLR|SIK1
DETERMINATION OF STOMACH LEFT/RIGHT ASYMMETRY%GOBP%GO:0071909,0.0716773847802787,0.3767214120425879,0.8351805900193,1.40321122576336,534,2,NPHP3-ACAD11|NPHP3
NEGATIVE REGULATION OF PROTEIN UBIQUITINATION%GOBP%GO:0031397,0.0159485530546624,0.171286632385385,-0.305179132358278,-1.6547686686842098,123,54,PARP10|PER2|DTX3L|TRIM44|OGT|BAG5|MAD2L1|TNFAIP3|SENP2|PARK7|UBXN1|ARRB1|ISG15|ABL1|USP44|PRMT3|HDAC8|CAV1|DNAJA1|PLAA|NXN|OTUB1|ADGRB1
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION%GOBP%GO:0032914,0.18968253968254,0.563467720122429,-0.647457814050954,-1.26432101333312,1433,3,FURIN|ATP6AP2|THBS1
NUCLEAR MIGRATION ALONG MICROFILAMENT%GOBP%GO:0031022,0.0252056248341735,0.22334422304908896,-0.8962646259762779,-1.4915276611142099,189,2,SUN2
REGULATION OF FAS SIGNALING PATHWAY%GOBP%GO:1902044,0.7915326902465171,0.9287638432175541,0.454676386125511,0.763915034335376,5907,2,TMBIM1
POSITIVE REGULATION OF NEUROBLAST PROLIFERATION%GOBP%GO:0002052,0.732933819697759,0.9078024129966441,-0.260008214824698,-0.782168353038785,5625,9,KDM1A|SMARCD3|CX3CL1
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND%GOBP%GO:2001240,0.25284398699891697,0.632257972333528,0.321252551689714,1.18496823784804,1866,15,EYA4|MAPK7|MAP2K5|UNC5B|EYA1
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS%GOBP%GO:1902041,0.0112928348909657,0.13802261153452697,-0.35242111340491494,-1.72473380465646,86,38,SP100|MADD|TNFRSF10A|STX4|TNFRSF10B|GPX1|TRAF2|TNFAIP3|TNFSF10|PARK7|ICAM1|BRCA1|TIMP3|SCRT2|HMOX1|NOS3|LGALS3|THBS1|PEA15|FADD|SERPINE1
POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:1903800,0.8272585264254101,0.943061234519578,-0.24397374372552302,-0.7023662615131531,6354,8,EGFR|MAP2K1|MYCN|TP53|BMP4|MAP2K2|TGFB1|DDX5
REGULATION OF PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE ACTIVITY%GOBP%GO:0060584,0.826537388763448,0.943041978946366,0.585575650639612,0.780786116732756,6222,1,EDN1
KIDNEY MORPHOGENESIS%GOBP%GO:0060993,0.0743600162535555,0.38312652841807104,0.356198387834162,1.4683035558769,548,21,NPHP3-ACAD11|CITED1|PAX8|AHI1|FGF2|PKD1|NPHP3|PKD2|FGF1|FOXJ1
SEQUESTERING OF TGFBETA IN EXTRACELLULAR MATRIX%GOBP%GO:0035583,0.182804232804233,0.556308895147568,-0.651351454129499,-1.2719243055675,1381,3,FBN1|LTBP1
DOLICHOL-LINKED OLIGOSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006488,0.130315321208949,0.489670335484323,-0.35470128380096794,-1.34795149515358,995,17,SRD5A3|DOLK|ALG6|DOLPP1
POSITIVE REGULATION OF MITOTIC SPINDLE ELONGATION%GOBP%GO:1902846,0.982876254180602,0.993436724391485,-0.508601676224085,-0.677579555194827,7346,1,NUMA1
POSITIVE REGULATION OF DNA-DIRECTED DNA POLYMERASE ACTIVITY%GOBP%GO:1900264,0.0683693516699411,0.37331514441341707,-0.5837515856819809,-1.5015663329404598,521,6,DSCC1|CHTF18|RFC2|RFC3|RFC5|RFC4
POSITIVE REGULATION OF HISTONE DEACETYLASE ACTIVITY%GOBP%GO:1901727,0.38646773982463,0.733589579210772,-0.48690233276346995,-1.06593098729355,2952,4,VEGFA|PRKD2|C6orf89|PRKD1
REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0010559,0.9746967523151171,0.9921298657093209,-0.12293018628239,-0.542182178765781,7472,27,NECAB2|IGF1|TMEM59|BACE2
LEUKOCYTE MEDIATED CYTOTOXICITY%GOBP%GO:0001909,0.0228466386554622,0.21008505428823396,-0.41908441972541494,-1.68135866503269,173,20,MICA|CEBPG|CORO1A|GZMB|STXBP2|AZU1|VAMP7|CTSH|HFE|TUBB4B|LYST|EMP2
NEGATIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0042997,0.6018543402311209,0.8472721632580409,0.44888055586191705,0.8828950819897281,4478,3,PKDCC|GOPC|CSK
MISFOLDED PROTEIN TRANSPORT%GOBP%GO:0070843,0.619471377340948,0.854944793214197,0.687141596823996,0.916210601386403,4663,1,HDAC6
REGULATION OF MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION%GOBP%GO:1903538,0.8977926421404681,0.9674268340009909,-0.551554918394354,-0.7348035874472959,6710,1,YTHDF2
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL LEADING EDGE%GOBP%GO:1905872,0.844468056846859,0.948285501480553,0.5761468901632111,0.7682141368870591,6357,1,FAM65B
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002504,0.000256706456167373,0.00819882332206558,-0.3131322390994,-1.9431177452326203,1,91,CENPE|AP2A1|KIF2C|KLC1|CAPZA2|AP1S3|KIF3A|HLA-DRB1|HLA-DMA|HLA-DMB|RACGAP1|HLA-DQB2|AP1S2|KIF11|KIF15|HLA-DPA1|HLA-DRA|HLA-DRB5|ACTR10|DCTN4|DYNC1H1|CD74|AP2A2|HLA-DPB1|HLA-DQA2|CTSF|CTSV|RAB7A|CTSS|KLC2|CANX|FCGR2B|CLTA|SH3GL2|SEC23A|CLTC|DYNLL2|FCER1G|KIF4A|LAG3|KIF18A|RILP|SEC13|SEC24A|ARF1|IFI30|KIF2A|AP1B1|DCTN5|CTSD|CTSL|DYNC1I1|SPTBN2|LGMN|KIF22|SAR1B|DCTN3|AP2M1
ESTABLISHMENT OF INTEGRATED PROVIRAL LATENCY%GOBP%GO:0075713,0.697214267117938,0.891282553279828,-0.279090702021313,-0.803463069461782,5355,8,PSIP1|PPIA|BANF1
REGULATION OF PROTEIN DEUBIQUITINATION%GOBP%GO:0090085,0.669411764705882,0.8815356925073421,-0.247920465082031,-0.829813009819558,5120,12,TRIM21|VCP|PARK7|UBXN1|TNIP1
STEM CELL DIFFERENTIATION%GOBP%GO:0048863,0.150457297436558,0.517264655410678,-0.21477185060674803,-1.25541623615927,1167,72,GREM1|SEMA4A|PEF1|GPM6A|JAG1|CORO1C|REST|SOX10|TBX1|BATF|SEMA6A|PDCD6|TBX2|ANXA6|NOTCH1|MEF2C|SNAI2|SEMA3B|SEMA3D|SEMA7A|MEOX1|FN1|SEMA5A|SRF|TCOF1|SEMA3E|SEMA3A|SEMA6B|WNT3
RELAXATION OF MUSCLE%GOBP%GO:0090075,0.10060256746135698,0.437176363087781,-0.440660293621205,-1.4266614090040202,767,11,ATP1B1|ATP2A1|P2RX4|PLN|SOD1|CHGA|RGS2
G PROTEIN-COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035588,0.199732441471572,0.577776238115407,-0.8976621085134541,-1.19590146992322,1492,1,GNAI2
POSITIVE REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0031948,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
REGULATION OF RECEPTOR CATABOLIC PROCESS%GOBP%GO:2000644,0.309674027339643,0.680809181688249,-0.414759938971036,-1.1337277972218702,2355,7,PTPN1|FURIN|DTX3L|APOE|ANXA2
MULTICELLULAR ORGANISM GROWTH%GOBP%GO:0035264,0.0201558720773985,0.195205495598712,0.82317748471589,1.6190929711018798,149,3,FGFR2|WDR11|STIL
HYPOXANTHINE TRANSPORT%GOBP%GO:0035344,0.591705685618729,0.8417378833576942,-0.7080392589325101,-0.9432783031501271,4422,1,SLC29A2
ALKANESULFONATE METABOLIC PROCESS%GOBP%GO:0019694,0.9442481350608559,0.982694945797028,-0.27034843936904,-0.591849246756231,7214,4,STAT5B|STAT5A|CDO1
REGULATION OF MRNA STABILITY INVOLVED IN RESPONSE TO STRESS%GOBP%GO:0010610,0.964550264550265,0.990916952887267,-0.288700401623877,-0.563758713555435,7291,3,HNRNPM
HYPEROSMOTIC SALINITY RESPONSE%GOBP%GO:0042538,0.9891638795986619,0.9962018371462809,-0.505513895015439,-0.6734658892049189,7393,1,AKR1B1
ESTABLISHMENT OR MAINTENANCE OF MICROTUBULE CYTOSKELETON POLARITY%GOBP%GO:0030951,0.4347598481874099,0.762034923704788,-0.464230077964117,-1.0162966821850101,3321,4,CKAP5|LMNA
NEGATIVE REGULATION OF TRANSLATION%GOBP%GO:0017148,0.8829909404108721,0.9629606199413431,-0.11813492894978099,-0.7502483788440741,6919,99,LARP1|TOB1|FMR1|DHX36|DDX3X|ZNF540|STAT3|FXR1|MALSU1|CALR|TNRC6C|DHFR|GAPDH|UNK|CPEB1|PAIP2|EIF4A3|IGFBP5|EIF2S1|RBM4|CAPRIN1
REGULATION OF INTESTINAL ABSORPTION%GOBP%GO:1904478,0.30327759197324394,0.6762596203943579,-0.8448941332157042,-1.12560185648854,2266,1,HAMP
REGULATION OF INTERLEUKIN-6 BIOSYNTHETIC PROCESS%GOBP%GO:0045408,0.300720366732155,0.673988937137548,-0.442636281803582,-1.13857975686304,2295,6,TNF|TLR1|STAT3|GHRL
REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN-1 PRODUCTION%GOBP%GO:0071637,0.58467583497053,0.839854222268064,-0.347126603821391,-0.8929031361126291,4463,6,LGALS9|GSTP1
RESPONSE TO TOXIC SUBSTANCE%GOBP%GO:0009636,0.19132326593294102,0.565804394127756,-0.17594267784950196,-1.1754839208337,1494,125,HP|CYP1B1|SOD2|AHR|GRIN3A|GPX1|SCFD1|GRIN1|TNFAIP3|CRHBP|PARK7|SOD3|ABL1|HMOX1|SOD1|MT1M|CCS|CAT|NOS3|CHRNE|ADIRF|FXN|MT2A|SRF|RELA|SIGMAR1|MAPK13|NFKB1|ACTB|ANXA1|MT1E|SLC7A8|NET1|PDGFB|SIRPA|BAD
"PROTEIN LOCALIZATION TO CHROMOSOME, CENTROMERIC REGION%GOBP%GO:0071459",0.8833071690214549,0.9630316014591379,-0.180453617350036,-0.6706355150368771,6751,16,MTBP|MIS12|RB1|ZW10|CDK1|BUB3|AURKB|CHAMP1|CENPA|CASC5|RCC2|CTCF|SPDL1|GSG2|BOD1|IK
NEGATIVE REGULATION OF PEPTIDYL-SERINE DEPHOSPHORYLATION%GOBP%GO:1902309,0.0996784565916399,0.43579063347786406,0.809704990350152,1.36040892903137,743,2,PPP1R16B|YWHAE
NONFUNCTIONAL RRNA DECAY%GOBP%GO:0070651,0.256321070234114,0.634929462604421,-0.8682730480811651,-1.15674818469785,1915,1,PELO
REGULATION OF GLUCOCORTICOID METABOLIC PROCESS%GOBP%GO:0031943,0.317904167232252,0.6867397844771489,0.43232947905286295,1.11867793732725,2341,6,WNT4|DGKQ|STUB1|DKK3
REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS BY EPITHELIAL-MESENCHYMAL SIGNALING%GOBP%GO:0060683,0.0727759197324415,0.37960378163431896,-0.9623400970445519,-1.28206808074754,543,1,PDGFA
ENDOTHELIAL TUBE LUMEN EXTENSION%GOBP%GO:0097498,0.472273812682409,0.7831522581932591,-0.610035842293907,-1.01519719364284,3559,2,RHOA|STARD13
MICROVILLUS ORGANIZATION%GOBP%GO:0032528,0.83744100681699,0.946216977301937,-0.19883114707519398,-0.703435522535004,6387,14,RAP2B|SLC9A3R1|RAP1A|FXYD5
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS%GOBP%GO:0033555,0.41978827361563503,0.7514346091901549,0.31076876437554496,1.02262005928648,3092,11,RET|DRD4|ADCYAP1
POSITIVE REGULATION OF ORGAN GROWTH%GOBP%GO:0046622,0.249671829876608,0.630296201866725,-0.325669890365776,-1.18245458122731,1901,15,BASP1|TBX2|NOTCH1|MEF2C|PIM1|IGF1|TGFBR3
OPTIC NERVE MORPHOGENESIS%GOBP%GO:0021631,0.20480807544162602,0.5845960940001321,0.8992059991177771,1.19896986738962,1541,1,CHRNB2
REGULATION OF IMMUNOGLOBULIN PRODUCTION%GOBP%GO:0002637,0.674191022964509,0.882488012133495,-0.19400853904628101,-0.8463006768638629,5166,26,TGFB1|HLA-E|NDFIP1|STX4|PAXIP1|GPI|FCGR2B|MZB1|TNFRSF4|TNFSF13|TFRC
POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE%GOBP%GO:2000427,0.0103838065194532,0.131171792348333,-0.658429357760245,-1.7997872871995602,78,7,C4B|C4A|C2|C3|CCL2|CD300LF
REGULATION OF LYMPHOCYTE PROLIFERATION%GOBP%GO:0050670,0.00012891581797086499,0.00518555396908895,-0.354671269278057,-2.3336256354976,0,116,FOXP3|CD1D|SOX11|HLA-DMB|JAK3|SYK|NFATC2|CD274|MNDA|HLA-DPA1|CD38|LILRB1|HLA-E|LYN|GPR183|NDFIP1|CD209|TNFSF13B|PYCARD|NCKAP1L|VAV3|CD74|TNFRSF14|IL18|RIPK3|CCL19|TWSG1|CCDC88B|HLA-DPB1|PDCD1LG2|SPN|AHR|EBI3|FCGR2B|PLA2G2D|IL6ST|MAPK8IP1|MZB1|LILRB2|GPNMB|PRKAR1A|MEF2C|SDC4|FGF10|BST1|TNFRSF4|IGF1|CEBPB|ICOSLG|VCAM1|C10orf54|CD300A|LST1|CD86|LGALS3|TGFBR2|TNFRSF21|LGALS9|ZP3|FADD|AIF1|PNP|ANXA1|CD55|NCK1|TFRC|CD81|TNFRSF1B|PRNP
SYNAPTIC VESICLE PRIMING%GOBP%GO:0016082,0.562483094400866,0.828541380171721,0.325335934249778,0.8980811139695741,4158,7,SNAP25|UNC13A|SNAP23
REGULATION OF CELLULAR AMINE CATABOLIC PROCESS%GOBP%GO:0033241,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
VIRAL ENTRY INTO HOST CELL%GOBP%GO:0046718,0.0148825065274151,0.16398482408551,-0.415740141437811,-1.74551887030874,113,23,HYAL2|ZNF639|CD4|PPIA|CAV2|GAS6|PVRL2|CXCR4|VAMP8|AXL|CAV1|ADRBK1|CD81
RESPONSE TO PHEROMONE%GOBP%GO:0019236,0.516387959866221,0.804056180000979,-0.7445963828848701,-0.991981170137787,3859,1,GNG8
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS IB%GOBP%GO:0002476,0.127832351015062,0.48497650625540295,-0.53721158094601,-1.3818529035288998,975,6,HLA-F|HLA-B|HLA-E|HLA-C|HLA-A
VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS%GOBP%GO:0003223,0.731613756613757,0.9074802896081321,-0.404832022501899,-0.790534335691897,5530,3,TGFBR3
CENTRAL TOLERANCE INDUCTION%GOBP%GO:0002508,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
LIPID TRANSLOCATION%GOBP%GO:0034204,0.642866517915737,0.8685358462393961,-0.21237376539105804,-0.8652122493662711,4897,21,ATP8B1|RFT1|ATP8B4|ATP8A2|ABCC1
REGULATION OF SEQUESTERING OF ZINC ION%GOBP%GO:0061088,0.689733942488578,0.887051934478962,0.416951582662402,0.8200945595730129,5132,3,SLC30A4|AP3D1|SLC30A3
HOMOCYSTEINE METABOLIC PROCESS%GOBP%GO:0050667,0.534699453551913,0.8126734651160049,0.318413618904008,0.924299030472185,3913,8,BLMH|MTHFR|CTH|CBS|NOX4|MUT
NEGATIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY%GOBP%GO:1900138,0.0681878482356063,0.372938888583182,-0.832092638544251,-1.3847352121549699,513,2,PLA2R1|ANXA1
S-ADENOSYLMETHIONINE BIOSYNTHETIC PROCESS%GOBP%GO:0006556,0.398683149690943,0.7388683667002129,0.54031101797728,1.06272801146626,2966,3,MAT2A|MAT2B|METTL16
PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE%GOBP%GO:1903608,0.5035163646199621,0.797430861095075,0.34257527256159404,0.945669844648454,3722,7,SSB|TIA1|DDX1
ARACHIDONIC ACID SECRETION%GOBP%GO:0050482,0.462467761639745,0.7762165400340341,0.38021012206623206,0.9838160377955291,3406,6,DRD2|DRD4
PEPTIDE CATABOLIC PROCESS%GOBP%GO:0043171,0.0951943277310924,0.42504444493541294,-0.35299707638369104,-1.41621750934525,724,20,ERAP2|ERAP1|ECE1|NPEPPS|CHAC1|CHAC2|LNPEP|GGT1|TPP1|CTSH|ANPEP|GGT5|CPQ
POSITIVE REGULATION OF OXIDATIVE PHOSPHORYLATION%GOBP%GO:1903862,0.0986322987901105,0.433390687254715,-0.59496921581906,-1.42602767974221,749,5,VCP|PARK7|CCNB1
BUNDLE OF HIS CELL-PURKINJE MYOCYTE ADHESION INVOLVED IN CELL COMMUNICATION%GOBP%GO:0086073,0.154417617405147,0.5225398777782271,-0.7612903225806451,-1.2669088362499399,1163,2,JUP|PKP2
SIGNAL TRANSDUCTION DOWNSTREAM OF SMOOTHENED%GOBP%GO:0007227,0.452304394426581,0.769943206592495,0.6133020599283872,1.03042664731399,3375,2,STK36
COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072044,0.296155413666621,0.6687276080240239,0.521657208654947,1.14610310356375,2179,4,PKD1|TFAP2B|DACT2
POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION%GOBP%GO:0045687,0.5359202936549551,0.8132910857498922,-0.263724758597708,-0.933019630467854,4087,14,HES1|CXCR4|NOTCH1|SERPINE2|BMP2
"POSITIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-DEPENDENT DECAY%GOBP%GO:1900153",0.500261643118786,0.7951717058944731,-0.26002347619064003,-0.9663479205214979,3823,16,ZFP36L2|BTG2|CPEB3|NANOS3|TNRC6A|ZFP36L1|TOB1|DHX36|TNRC6C|POLR2G
SPERM-EGG RECOGNITION%GOBP%GO:0035036,0.0879653906659675,0.409521734239444,-0.40575611539936995,-1.43550580105937,670,14,ZP3|POMZP3|B4GALT1|FOLR2|ALDOA
GLUTAMATE METABOLIC PROCESS%GOBP%GO:0006536,0.426784500339905,0.7552872526318829,0.242487903483472,1.0148003623839599,3138,22,AADAT|GLS|ADHFE1|GLUD1|GCLM|NAGS|GLS2|GCLC|CPOX|GGT7
HIGH-DENSITY LIPOPROTEIN PARTICLE ASSEMBLY%GOBP%GO:0034380,0.2896381150742,0.6622817015650171,-0.40107098819291204,-1.15462724093524,2224,8,APOM|APOE|PRKACA
GLYCOSYLCERAMIDE METABOLIC PROCESS%GOBP%GO:0006677,0.11124183006535901,0.4575946218858471,-0.416806258476753,-1.3950895733588702,850,12,ALDH5A1|CLN3|GALC|GBA|ST6GALNAC6|GLA|UGCG|B3GALT2|B3GALT1
SKELETAL MUSCLE TISSUE GROWTH%GOBP%GO:0048630,0.0613627307743392,0.35631208031004796,0.9693427437141601,1.2924877525576102,461,1,DLL1
POSITIVE REGULATION OF DNA N-GLYCOSYLASE ACTIVITY%GOBP%GO:1902546,0.8941806020066891,0.9658968257150641,-0.55414644905161,-0.7382561285459681,6683,1,RPS3
INTRACELLULAR PH ELEVATION%GOBP%GO:0051454,0.427707605482397,0.7559515106076821,0.52486604984283,1.03234958177195,3182,3,BCL2|SLC26A6|CLN3
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS%GOBP%GO:2000378,0.0368723849372385,0.273218598185954,-0.373348369254651,-1.58672004390171,281,24,CD34|HP|INS|GLA|PARK7|BRCA1|CAV1|MPV17L|ABCD1|SIRPA|PTGIS
POSITIVE REGULATION OF INTERLEUKIN-1 PRODUCTION%GOBP%GO:0032732,0.120962468942069,0.472999327000989,-0.327404889329296,-1.3558688347497703,924,22,CCL3|RIPK2|PYCARD|GSDMD|CCL19|AZU1|CASP1|HSPB1|IFI16|NLRP3|LGALS9|TLR4
REGULATION OF PROTEIN TARGETING%GOBP%GO:1903533,0.817039491853079,0.93769861570193,0.135058647140922,0.7804784401577571,5916,65,TCAF2|MFF|MIEF2|PARK2|MYO1C|INPP5K|HTRA2
NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION%GOBP%GO:0030837,0.5266380096391821,0.809755446473093,-0.21906072245780397,-0.944401469446517,4042,25,KANK3|GSN|SLIT2|EPS8|TMSB4X
CELLULAR RESPONSE TO BRAIN-DERIVED NEUROTROPHIC FACTOR STIMULUS%GOBP%GO:1990416,0.24787331501112397,0.62852193925262,-0.555840634979004,-1.2168513415376598,1893,4,MAPT|SH3GL2|TMEM108
URETER SMOOTH MUSCLE DEVELOPMENT%GOBP%GO:0072191,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
MODULATION OF SIGNAL TRANSDUCTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052250,0.211772575250836,0.5937395205509979,-0.892258491398324,-1.1887025544408798,1582,1,TNIP1
"NUCLEOTIDE-EXCISION REPAIR, DNA DUPLEX UNWINDING%GOBP%GO:0000717",0.386655948553055,0.733589579210772,0.642822144024679,1.0800242000881,2885,2,ERCC3|ERCC2
NEGATIVE REGULATION OF CELL DEVELOPMENT%GOBP%GO:0010721,0.0716197272843125,0.3767214120425879,-0.195726870827265,-1.3343288122313701,561,137,DAAM2|FBN1|NGEF|CALR|IGF1|SEMA3B|SEMA3D|STX1B|SEMA7A|EDNRB|APOE|SEMA5A|SEMA3E|EPHA4|COL3A1|SLIT2|ID1|CX3CL1|LDLR|FKBP4|SEMA3A|SEMA6B|RTN4RL1|KIAA2022|ID4|ADGRG1|MYLIP|DTX1|ARHGDIA|NGFR|FBLN1|EFNA5
RESPONSE TO FUNGICIDE%GOBP%GO:0060992,0.48494983277591996,0.7872939093021379,-0.7604212615791801,-1.01306370833606,3624,1,IMPACT
REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:1902226,0.599495887503317,0.84625395439332,-0.55954889089339,-0.931178833041835,4518,2,CSF1
CARDIAC VENTRICLE DEVELOPMENT%GOBP%GO:0003231,0.623647604327666,0.857551285930326,-0.16544131114936403,-0.8929807827769409,4841,53,HEYL|TGFB2|NRG1|ROBO1|SOX11|C5orf42|GJA5|TGFB1|TNNT2|JAG1|ZFPM2|RYR2|CPE|SFRP2|GATA3|HES1|MESP1|NOTCH1|MEF2C|PKP2|TGFBR2|TGFBR3|SLIT2|FKBP1A|ENG
TRANS-SYNAPTIC SIGNALING BY SOLUBLE GAS%GOBP%GO:0099543,0.680802675585284,0.884781692722898,-0.663707543008381,-0.88421781286645,5088,1,GUCY1B3
GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072110,0.14950915362165001,0.51590227091171,-0.7646823796880851,-1.2725537617074298,1126,2,PDGFRB
PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009215,0.19200420831141501,0.5665036350989531,-0.532321979903415,-1.2758742094453202,1459,5,NUDT1|NUDT16|SAMHD1
XDP CATABOLIC PROCESS%GOBP%GO:1901639,0.272240802675585,0.646576786621306,-0.860498456109396,-1.14639056140183,2034,1,NUDT16
REGULATION OF DNA-DEPENDENT DNA REPLICATION%GOBP%GO:0090329,0.5733454924439809,0.835107713312645,-0.181195581747528,-0.919017719402528,4400,43,E2F7|FBXO5|E2F8|FBXW7|TICRR|DSCC1|CHTF18|ATRX|CDC7|BLM|INO80|TIMELESS|RFC2|WRNIP1|RFC3|TERF2|DONSON|CDT1|NBN|STAG2|SLFN11|GMNN|RFC5|STOML2|SMC1A|BCL6|RFC4
NEGATIVE REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION%GOBP%GO:1902723,0.7859056806002142,0.9274485629622209,0.456741108354012,0.767384034266335,5865,2,EPHB1|AKIRIN1
RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:0000055,0.499478895257947,0.794989907195277,-0.31852677288567605,-0.9582064994166569,3833,9,BCCIP|PA2G4|ZNF593|NPM1|NMD3|RAN
MITOCHONDRIA-ASSOCIATED UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0072671,0.25381856820294896,0.633150972738219,0.875165416850463,1.1669149948005901,1910,1,ANKZF1
NEGATIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING%GOBP%GO:2001033,0.58035244608101,0.8387093286508721,-0.372553146771387,-0.8929388031273009,4412,5,C7orf49|HSF1|AUNIP
REGULATION OF CHOLESTEROL STORAGE%GOBP%GO:0010885,0.101610580070708,0.4404011558626021,-0.41395619083837704,-1.42491748403885,775,13,SREBF2|MSR1|ABCG1|EHD1|NR1H3|PPARG|PPARA
TUMOR NECROSIS FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0033209,0.0178455967929652,0.18232012861708605,-0.30544655015440997,-1.63788201580205,137,52,COMMD7|TNFSF13B|PYCARD|TNFRSF14|TNFSF8|EDA|TNFRSF11A|TNFRSF18|TRAF2|ILK|TNFSF12|TNFRSF4|TNFSF13|PLVAP|NFKBIA|TNFRSF11B|LTA|TRAF3|LTBR|RELA|TNFRSF12A|TNFRSF1A|TMSB4X|TNFRSF1B
REGULATION OF VIRAL TRANSCRIPTION%GOBP%GO:0046782,0.7284527518172379,0.9062429404180642,-0.167053570578129,-0.817553005212896,5611,38,DHX9|TRIM21|SMARCA4|ZNF639|REST|MDFIC|TRIM32|SNW1|NUCKS1|RRP1B|IFITM3|MID2|PSMC3
REGULATION OF DNA TOPOISOMERASE (ATP-HYDROLYZING) ACTIVITY%GOBP%GO:2000371,0.0106522882693319,0.13314154417238197,-0.7301455989410991,-1.75001967605768,80,5,DHX9|SETMAR|HNRNPU|PLSCR1|UHRF1
REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:1901626,0.10914801727522601,0.45349438410841897,-0.6374081833251221,-1.39541975554838,833,4,MESDC2|SHISA7|APOE
POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY%GOBP%GO:1904685,0.228840541257628,0.610474903957406,-0.71911183666732,-1.19671709084314,1724,2,STAT3
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT%GOBP%GO:1901862,0.6003525901817199,0.8464076674715391,0.246248171531911,0.8851072959109351,4426,14,DKK1|SOX6
RESPONSE TO GROWTH HORMONE%GOBP%GO:0060416,0.37860513896171993,0.7285942545132281,-0.300347833074719,-1.06258671243933,2887,14,PTPN1|AKT1|JAK3|STAT5A|LYN|STAT3|PXN|IGFBP5
NEGATIVE REGULATION OF CHOLESTEROL TRANSPORT%GOBP%GO:0032375,0.0460672686821097,0.30746333312705,-0.700215077483042,-1.5329171758598101,351,4,APOC2|SREBF2|APOC1|NFKB1
NEGATIVE REGULATION OF HEART CONTRACTION%GOBP%GO:0045822,0.43323361435953206,0.7614924524950341,0.318701509711814,1.00966792542613,3185,10,FKBP1B|BIN1|SRI
HISTONE SUCCINYLATION%GOBP%GO:0106077,0.8504279309876379,0.949296218452153,0.318535267192412,0.699835547686666,6259,4,DLD|OGDH|KAT2A|DLST
FARNESOL CATABOLIC PROCESS%GOBP%GO:0016488,0.77991765174658,0.924704689181848,0.609726510807234,0.8129880300217339,5871,1,AKR1C3
PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009216,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
POTASSIUM ION IMPORT%GOBP%GO:0010107,0.296194586112201,0.6687276080240239,-0.27351863992267,-1.1327118552017,2264,22,ATP1B1|SLC12A8|ATP1A3|SLC12A2|ATP1B3|ABCC9|KCNJ12|ATP1B2|KCNH2|KCNJ9
NEURAL PLATE PATTERN SPECIFICATION%GOBP%GO:0060896,0.423633440514469,0.7539810218549301,0.626512065207431,1.0526211617955998,3161,2,CELSR2|PTCH1
SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0006614,0.748170966499808,0.9129427774980341,-0.135233114700541,-0.837035379026532,5828,90,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|SRP19|RPL35|RPL38|RPS15A|SEC61A1|SEC61B|RPS13|SRP9|SRP68
POSITIVE REGULATION OF ANTEROGRADE SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1903744,0.356621065214504,0.714406853878965,0.8227282752536391,1.0969971419745201,2684,1,MAP2
ACTIN FILAMENT-BASED MOVEMENT%GOBP%GO:0030048,0.585123966942149,0.839854222268064,0.157181027376882,0.9251222746936341,4247,70,SCN5A|SHTN1|ANK2|MYO6|MYO1B|DMD|MYO9B|NEB|KCNJ8|CACNA1C|MYH10|TPM1|CACNB2|MYO5A|WIPF1|CAMK2D|TPM2|NEDD4L|WIPF2|FNBP1L|TMOD1|SNTA1|FGF12|MYL6B|MYO19
REGULATION OF LATE ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:1902822,0.5750267952840301,0.8354258054828342,0.5594154948993659,0.939890260489191,4291,2,VPS35|SNAPIN
AXONAL TRANSPORT OF MITOCHONDRION%GOBP%GO:0019896,0.47761397761397795,0.7850984235874658,0.32085230198445897,0.9750405535254829,3498,9,TRAK2|HAP1|TRAK1|SPAST|NEFL
SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR%GOBP%GO:0035581,0.218306154655445,0.600958814369817,-0.5183847025895241,-1.24246921520122,1659,5,FBN1|LTBP1|NBL1
NEGATIVE REGULATION OF VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901386,0.0270123523822452,0.23263212054205,0.6523276789545159,1.68793621002439,198,6,CRHR1|C19orf26|DRD4|GNB5
INTERLEUKIN-18 SECRETION%GOBP%GO:0072616,0.831584539779519,0.9443784929910591,0.5830943978826639,0.7774777009838891,6260,1,GBP5
ROUNDABOUT SIGNALING PATHWAY%GOBP%GO:0035385,0.633955123006218,0.863354277348854,0.352910051812082,0.8487466508414692,4689,5,MYO9B|SLIT3
ENDOPLASMIC RETICULUM MANNOSE TRIMMING%GOBP%GO:1904380,0.5391386782231851,0.814362974284401,0.25262850274861803,0.9318424092125359,3980,15,UGGT2|RNF103|TRIM13|DERL2|RNF185|UGGT1|MAN1B1
REGULATION OF GLYCOLYTIC PROCESS BY POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072363,0.0957859531772575,0.426542395958204,-0.9496029995588879,-1.26509920853917,715,1,PPARA
MITOTIC G1 DNA DAMAGE CHECKPOINT%GOBP%GO:0031571,0.992393966739719,0.997305769352475,-0.091693083972122,-0.514198780344758,7697,61,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|RPA2|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A|CCND1
CELLULAR RESPONSE TO INTERLEUKIN-12%GOBP%GO:0071349,0.0054453520031116295,0.0838108499289328,-0.363587928834122,-1.8208866077233001,41,41,HNRNPA2B1|HSPA9|PSME2|LMNB1|CD47|SNRPA1|MSN|SOD1|ARF1|AIP|CFL1|ANXA2|TALDO1|SIRPA|P4HB
DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0046385,0.31707650273224,0.6861326333203311,0.386140406937556,1.12089804759926,2320,8,DCTD|CDADC1|AK5|DUT|DTYMK
RESPONSE TO INTERLEUKIN-9%GOBP%GO:0071104,0.969125683060109,0.9912723387782391,0.188600536638693,0.547474362942467,7093,8,CITED1|JAK1
POSITIVE REGULATION OF INTERLEUKIN-8 PRODUCTION%GOBP%GO:0032757,0.0331549406082757,0.25998057358601,-0.35045795569087496,-1.58460272770929,253,29,IL1B|DDIT3|TNF|HYAL2|TLR1|PYCARD|IL17D|TLR2|PARK7|FCN1|F2R|LGALS9|FADD|TLR5|SERPINE1|TLR4|CD14
POSITIVE REGULATION OF CALCINEURIN-MEDIATED SIGNALING%GOBP%GO:0106058,0.21626932145664104,0.5991362048583871,-0.38166208260154605,-1.2356515266060901,1650,11,SPPL3|TMEM110|TNF|PTBP1|LMCD1|SLC9A1|IGF1
INTRACELLULAR DEFENSE RESPONSE%GOBP%GO:0002818,0.594235622260592,0.8432850163031421,0.7008160564622851,0.9344436481801629,4473,1,GNLY
DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI-CILIATED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0098535,0.0342887056667975,0.264364643644243,-0.7162077314282909,-1.5679284384112702,261,4,CEP63
NEGATIVE REGULATION OF CALCIUM ION IMPORT%GOBP%GO:0090281,0.9771566783122819,0.9927322181739301,0.271057356154067,0.533137832682557,7271,3,TRIM27|SLC30A1
FUNGIFORM PAPILLA DEVELOPMENT%GOBP%GO:0061196,0.305466237942122,0.677423587903087,0.6811690102012679,1.14445188642908,2279,2,HDAC1|HDAC2
PORE FORMATION IN MEMBRANE OF OTHER ORGANISM%GOBP%GO:0035915,0.518260869565217,0.8047799431921201,-0.7434384649316279,-0.990438545391571,3873,1,GSDMD
POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION%GOBP%GO:0090271,0.9084941050375129,0.971496795604459,0.38334711883099,0.6440726555860871,6780,2,ROCK2|PTGS2
MITOCHONDRIAL RNA 5'-END PROCESSING%GOBP%GO:0000964,0.859965973040178,0.9511718746756421,-0.31263050238734497,-0.6844135212424761,6570,4,HSD17B10
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0099623,0.29774986917844104,0.66997766079676,-0.3037372569080539,-1.12880525596391,2275,16,FLNA|KCNQ1|SCN1B|KCNH2|KCNE4
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NEUROTRANSMITTER%GOBP%GO:0003070,0.40414715719063593,0.7412049911665691,-0.7982465813850899,-1.06345611671244,3020,1,SOD2
NEGATIVE REGULATION OF RNA EXPORT FROM NUCLEUS%GOBP%GO:0046832,0.67510718113612,0.882488012133495,0.508629721532947,0.854563604016984,5038,2,TPR|NUP153
REGULATION OF ERBB3 SIGNALING PATHWAY%GOBP%GO:1905578,0.147031478283969,0.514131830678897,0.928429642699603,1.2379356528762802,1106,1,RTN4
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002220,0.10717975206611599,0.45108103531561405,-0.254796810138618,-1.34249823627498,829,49,ICAM3|MALT1|FYN|TRAF6|PLCG2|RAF1|CREBBP|PAK2|MUC3A|SYK|RPS6KA5|CLEC4A|LYN|CD209|CLEC4E|CLEC10A|FCER1G|MUC4|HRAS|FCN1|MUC20|RELB|MUC15|RELA|NFKB1|PRKACA|ICAM2
"POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS, TRANSLOCATION%GOBP%GO:0033160",0.539978958442925,0.81505408470595,-0.385114255267161,-0.9230453833115541,4105,5,PSEN1|IGF1|TMEM173
REGULATION OF VIRAL BUDDING VIA HOST ESCRT COMPLEX%GOBP%GO:1903772,0.12393665750556199,0.47832576509682107,-0.6257651795069761,-1.36993078636538,946,4,VPS4A|VPS37B|TSG101|SNF8
POSITIVE REGULATION OF EOSINOPHIL CHEMOTAXIS%GOBP%GO:2000424,0.533138531013415,0.812079525085925,0.7318041464490519,0.975762084866021,4013,1,DAPK2
CELLULAR ALDEHYDE METABOLIC PROCESS%GOBP%GO:0006081,0.548497736314995,0.8190128041756949,0.18584209873054103,0.94195455119801,3997,41,KHK|ALDH3A2|DERA|ALDH8A1|KDM3A|RPE|ALDH1A3|HOGA1|PGD|RPIA|RBKS|SHPK|G6PD|PGM2|AKR1A1|ALDH7A1
PEPTIDYL-HISTIDINE MODIFICATION%GOBP%GO:0018202,0.148363538003787,0.5154128781388279,0.48768640430942295,1.3462452288278701,1096,7,DPH2|DPH5|HIF1AN|DPH1|DPH6
NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:0035747,0.34163987138263696,0.701955655133333,0.663413289219741,1.11461998264618,2549,2,XCL1|PIK3CD
REGULATION OF NUCLEUS SIZE%GOBP%GO:0097298,0.533138531013415,0.812079525085925,0.731859285399206,0.975835605215995,4013,1,HP1BP3
NEGATIVE REGULATION OF SHORT-TERM SYNAPTIC POTENTIATION%GOBP%GO:1905513,0.0901672240802676,0.414794277220364,-0.9526907807675341,-1.26921287452908,673,1,PRRT2
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901018,0.274677528852682,0.649047934290704,0.330819926957581,1.15860035590655,2022,13,ANK2|RNF207|KCNIP2|GAL
RESPONSE TO LIGHT INTENSITY%GOBP%GO:0009642,0.754283437375482,0.9156786399630071,0.623566387295986,0.8314416378654179,5678,1,SLC24A1
LONG-TERM SYNAPTIC DEPRESSION%GOBP%GO:0060292,0.951867438190426,0.9858647066977451,-0.240749444697428,-0.577030479717302,7237,5,PLK2|ARF1
PHOSPHATIDYLINOSITOL CATABOLIC PROCESS%GOBP%GO:0031161,0.32939301368043605,0.695646600584197,0.834858844287605,1.11317161896899,2479,1,INPP5F
ANTERIOR COMPARTMENT PATTERN FORMATION%GOBP%GO:0007387,0.781245849382388,0.925413955483995,0.6092302602558449,0.8123263468719609,5881,1,PBX3
RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0031667,0.135166240409207,0.49744180164819607,-0.170364413334952,-1.21956598640491,1056,176,GIPR|TMBIM6|SGIP1|OGT|LARP1|P2RX3|HLCS|GAS6|WDR45B|POSTN|GRIN1|KYNU|POMC|SST|PDXP|WDR45|PRKD1|BCAS3|CDKN2B|ENSA|WIPI1|MAPK3|PIM1|SPP1|GHRL|USF2|RNF152|IFI16|RPTOR|GNAI2|PIK3R4|WDR24|APOE|SLC27A4|NIM1K|EIF2S1|LDLR|FAM107A|LAMP2|PPARG|PPARA|SIK1|HSPA5|ALPL|RRP8|FADS1|EIF4G1|RRAGD
REGULATION OF CARDIOCYTE DIFFERENTIATION%GOBP%GO:1905207,0.628067885117494,0.8598358835891559,-0.20831283471151502,-0.874618415866505,4810,23,TGFB1|GREM1|PRICKLE1|DHX36|MEF2C|IGF1|GPER1|BMP2|ENG
CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION%GOBP%GO:0086002,0.651748434237996,0.8731277964257759,-0.19778553850470898,-0.8627766382514159,4994,26,ATP1A1|GJC1|GPD1L|SCN4B|GJA1|RYR2|KCNN2|PKP2|CACNA1G|KCNQ1|SCN1B|KCNH2|KCNE4
TELOMERASE HOLOENZYME COMPLEX ASSEMBLY%GOBP%GO:1905323,0.34249443790079803,0.701955655133333,-0.508222975760448,-1.11260633162907,2616,4,HSP90AA1
THYMINE TRANSPORT%GOBP%GO:0035364,0.591705685618729,0.8417378833576942,-0.7080392589325101,-0.9432783031501271,4422,1,SLC29A2
REGULATION OF NEUROGENESIS%GOBP%GO:0050767,0.43416619876473905,0.762034923704788,0.12200176432619302,1.00794927279842,3092,382,RET|DKK1|ISLR2|CNTN4|BIN1|PTCHD2|BRINP2|SHTN1|DRD2|ADGRB3|SLITRK1|DLL1|CPNE9|SEMA4G|SYT2|SEMA4F|KIF13B|PLXNB1|ULK4|HES7|RTN4IP1|SS18L1|PCP4|RTN4|INPP5J|SEMA6C|TENM4|PTK7|TCF3|CCDC88A|RIMS1|CHN1|PTPRO|STK24|ROBO2|CHRNB2|NDEL1|ASCL1|PTPRS|ZSWIM4|EFNB2|BMP7|PTPRD|UNC13A|EFNB3|SCARB2|RIMS2|CDK5R1|NREP|HES6|SEMA4C|PCM1|PTPN9|SARM1|RUFY3|MAP6|ADCYAP1|CAPRIN2|DVL2|TRIM46|CUX2|LIMK1|STMN2|NEDD4|NF1|CUL7|LRRC7|PAK1|TWF1|CRMP1|PTK2B|NRCAM|INPP5F|FOXO6|SIPA1L1|MAP2|ADCY6|GRIP1|DLG4|BRSK1|VLDLR|LINGO1|FBXO7|TCF12|ZSWIM8|SKI|HES4|CBFA2T2|TENM3|C21orf91|PLXNB2|CAMK1D|POU4F2|MOV10|DYNLT1|YWHAH|DOCK7|NEDD4L|CERS2|NRP1|ZFYVE27|DCC|CPNE1|MEGF8
TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:0006366,0.000638732754215636,0.0163600882996276,-0.193391534177993,-1.5718705322546003,4,370,ESRRG|RORC|CDK4|GTF2E1|INTS2|DDIT3|MED30|SRRT|TCFL5|POLR2F|CREBBP|MED26|ADRM1|POU2F1|PTEN|NR1I3|ZNF136|TRIP13|GABPA|CCNH|INTS1|IKBKAP|TCEB2|NOTCH4|ETV7|TCERG1|CPSF1|SNRPE|POLR2C|LSM11|NR2F1|PIR|NR4A1|YBX1|MED7|NABP2|TMF1|SSU72|SOX5|EAF2|NR3C1|INTS7|DEK|LMO4|SOX18|RUNX3|MED13|NCBP2|RXRG|GTF2A2|MED8|TRIM28|KLF4|SOX17|NFE2L3|POLR2J|PARP1|ELL2|ZNF143|TAF3|RORA|PHAX|TAF6L|BTF3|NR1D2|MED1|NRL|RBMX|AHR|GATA3|MLLT3|MAF|VEZF1|CCNK|E2F2|LMO2|GTF2A1|TAF12|PTTG1|LSM10|RREB1|TRIP11|SUPT16H|CPSF2|THRA|CEBPD|NFX1|ELOF1|NFE2L1|NOTCH1|SNRPF|GMEB2|CEBPA|PAPOLA|NCBP1|ARRB1|ZFHX3|DDX5|CLP1|CTGF|SNW1|CTR9|POLR2H|NOTCH2|GTF2H1|NFIC|MECP2|TAF7|ZNF148|USF2|IRF7|CEBPB|NFATC1|NR1H3|NOTCH3|CSTF3|PPM1D|MED6|TAF9B|SPI1|MAX|NELFB|NFIX|CDK7|GATA6|KAT2B|PKNOX1|NR1D1|WWTR1|SRF|SNRPB|MAML1|PABPN1|MNAT1|CCRN4L|TAF10|PPARG|PPARA|POLR2G|RELA|POU2F2|INTS5|YAP1|NFKB1|SUPT4H1|TAF9|TEAD2|CPSF7|SSRP1|DTX1|ESRRA|CCND1|ELP4|MED27|AK6|C5AR1|MAZ|POLR2L|GTF2H2
SUBSTRATE-DEPENDENT CEREBRAL CORTEX TANGENTIAL MIGRATION%GOBP%GO:0021825,0.346245688511542,0.703504080836324,-0.662641301350979,-1.1027410897591998,2609,2,ROBO1|SLIT2
REGULATION OF TOLERANCE INDUCTION%GOBP%GO:0002643,0.322173006774362,0.690412417855875,-0.370182712566923,-1.11360020992843,2472,9,FOXP3|CD274|IRAK3|LILRB2|IL2RA|TGFBR2
5-PHOSPHORIBOSE 1-DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0006015,0.83784844915587,0.946216977301937,-0.32040825328566497,-0.7014406438009471,6401,4,PRPS1
POSITIVE REGULATION OF RECEPTOR CLUSTERING%GOBP%GO:1903911,0.540334448160535,0.81505408470595,-0.7331826202029109,-0.9767752976393771,4038,1,MESDC2
POSITIVE REGULATION OF PROTEIN ACETYLATION%GOBP%GO:1901985,0.333941605839416,0.6974768376198021,-0.234972676352629,-1.09300026354777,2561,32,LIF|IL1B|FOXP3|TERF2IP|ARNTL|RPS6KA5|CAMK1|PAXIP1|BRCA1|ARRB1|MAPK3|RAPGEF3|WBP2|KAT7|RPS6KA4|KAT5
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA%GOBP%GO:0061419,0.918356312516896,0.976180930140714,0.260346677666473,0.62613226682697,6793,5,NFE2L2|RBPJ|VEGFA
SEQUESTERING OF BMP FROM RECEPTOR VIA BMP BINDING%GOBP%GO:0038098,0.137123745819398,0.50191360557578,-0.930249228054698,-1.239315337781,1024,1,NBL1
FOLLICULAR DENDRITIC CELL ACTIVATION%GOBP%GO:0002266,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
ATRIOVENTRICULAR VALVE FORMATION%GOBP%GO:0003190,0.343240399789584,0.701955655133333,-0.4587824741426429,-1.09961404676606,2609,5,OLFM1|NOTCH1|DCHS1
HISTONE H4 ACETYLATION%GOBP%GO:0043967,0.483324648254299,0.787078399497453,-0.193335302749596,-0.980589964166473,3709,43,ING3|NAA40|KANSL1|KANSL2|JADE3|YEATS4|RUVBL1|HCFC1|OGT|MORF4L2|MSL2|PHF20|WDR5|KAT7|APBB1|KAT8
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY%GOBP%GO:0070423,0.876736584037047,0.960725750963158,0.160305104546249,0.680566472142889,6436,23,UBE2V1|RPS27A|MAP2K6|CASP8
REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS%GOBP%GO:0010896,0.238319591676482,0.62193677241636,-0.560534936278542,-1.22712814836763,1820,4,APOC2|PNPLA2|ABHD5
TYROSINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0007260,0.889935872268028,0.965159112268525,-0.30033640324270694,-0.657499168286406,6799,4,FER|JAK2|JAK3|IL15
OLFACTORY PLACODE MORPHOGENESIS%GOBP%GO:0071699,0.506308938770089,0.798168488166378,0.7477393030436701,0.997009466008748,3811,1,PROX1
REGULATION OF CYTOPLASMIC TRANSLATIONAL FIDELITY%GOBP%GO:0140018,0.227558528428094,0.60970664767799,-0.8832708425231579,-1.1767288480773999,1700,1,AARS
REGULATION OF MEMBRANE LIPID DISTRIBUTION%GOBP%GO:0097035,0.4110445428497,0.7455388982492049,-0.224117813121335,-1.03286333040259,3155,31,ATP10A|ATP11C|TRIAP1|ATP11B|PRELID1|PLSCR1|ATP8B1|RFT1|PLSCR4|ATP8B4|ATP8A2|ABCC1
NEUROTRANSMITTER RECEPTOR TRANSPORT%GOBP%GO:0099637,0.516409004610795,0.804056180000979,0.264299331613896,0.9499898629116429,3807,14,CACNG7|LRRC7|CACNG4|VPS35|RAB11A
GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046476,0.007198010731579641,0.102315552754816,-0.7988787345406121,-1.7489125455686998,54,4,UGCG|B3GALT2|B3GALT1
REGULATION OF TRANSCRIPTION INVOLVED IN LYMPHATIC ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060849,0.607322897320244,0.8492159043277758,-0.55663543865966,-0.9263303826288649,4577,2,NR2F2
PROTEIN MYRISTOYLATION%GOBP%GO:0018377,0.505230267626681,0.797902257689198,0.43165093837891294,0.948355494612768,3718,4,NMT2|PPM1B
PROCESS UTILIZING AUTOPHAGIC MECHANISM%GOBP%GO:0061919,0.360251636923867,0.7155384949577859,-0.149943320049092,-1.05196923973274,2805,159,SEC23A|ATG2A|WDR45|TMEM41B|UBQLN1|DYNLL2|ATG101|WIPI1|VAMP8|VAMP7|PIK3R4|VPS25|NSFL1C|CHMP4A|SNF8|CHMP6|LAMP2|PLAA|VPS51|S100A8|ATG3|S100A9|HSP90AA1|MARK2|AMBRA1|FUNDC2|VPS37C|ATG4A|SQSTM1|VMP1|ITGB4
ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT%GOBP%GO:1990048,0.5619457135178721,0.828264770520601,0.46422572055817296,0.913077210098691,4181,3,KIF5B|KIF1A
REPRODUCTIVE PROCESS%GOBP%GO:0022414,0.0545199719691661,0.33896362399005303,0.153343179661241,1.2684050904450301,388,385,TDRD12|TLE6|NPHP1|LRRC6|SPAG6|CRHR1|TSGA10|STRA6|DDX25|SYCE1|CYP27B1|TDRD6|UBXN8|FGFR2|LRGUK|BBS4|SPATA6|TEAD3|SRD5A1|CITED1|PPARD|CDKL2|TBX3|CFAP44|RNF212|PICK1|CFAP43|PSME4|RAB13|IFT20|WNT2B|TSSK6|ZNF296|IGSF8|ITGB8|PRLHR|KIT|ROBO2|C14orf39|DZIP1|C9orf117|AZIN2|RAD51D|IQCG|PTPRN|BMP7|BRCA2|IFT81|NME5|ADCY3|PKD1|CHD5|ATM|SPIRE2|PDE3A|SLIT3|MRE11A|TOB2|ZNF568|WDR33|TDRP|EIF2B4|CASP8|CCNB1IP1|SPESP1|ADCYAP1|PCSK4|MAFF|CEP57|TUBGCP3|STOX2|HSPA2|WNT4|MKKS|SYCP2|TRIM27|PARN|CUL7|C1orf111|LEPR|PKD2|HERC4|NDRG3|DNAH1|CITED2|CCNE1|XRN2|ELL3|CATSPERG|MAST2|MCM9|SPATA2|RHOXF1|PRMT7|CATSPER2|IFT27|BBS2|PRND|TRO|APITD1|CHD7|RQCD1|TEX14|DPY19L2|METTL14|LRP6|TUBGCP6|BCL2
POSITIVE REGULATION OF METAPHASE/ANAPHASE TRANSITION OF CELL CYCLE%GOBP%GO:1902101,0.35213652944241797,0.7106060713647829,-0.35973084848784,-1.08215844445024,2702,9,DLGAP5|CDT1|ANAPC5|ESPL1|ANAPC11
SISTER CHROMATID BIORIENTATION%GOBP%GO:0031134,0.9947089947089949,0.9982558473047859,-0.24164136906361103,-0.4718643500280061,7519,3,BOD1
NEURONAL ACTION POTENTIAL%GOBP%GO:0019228,0.500135611608354,0.7951717058944731,0.267890743339074,0.962898729202101,3687,14,SCN5A|KCNMB4|SCN3A|SCN9A|SCN2A
NEGATIVE REGULATION OF MITOCHONDRIAL TRANSLATION%GOBP%GO:0070130,0.26742474916388004,0.6417330323279019,-0.8624283193647991,-1.14896160264552,1998,1,MALSU1
REGULATION OF TROPHOBLAST CELL MIGRATION%GOBP%GO:1901163,0.10635251236657099,0.448854219496123,-0.493742420845065,-1.42141532520626,816,8,ARHGDIB|SMURF2|CALR|SYDE1|TIMP1
NADPH OXIDATION%GOBP%GO:0070995,0.32448925444415005,0.692794968343412,-0.6727754291258741,-1.1196058989455,2445,2,FMO2
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY%GOBP%GO:0002714,0.882938326568024,0.9629606199413431,-0.19072501754515397,-0.656512496149172,6742,13,TGFB1|HLA-E|PAXIP1|PVRL2|TNFSF13|TFRC
REGULATION OF PROTEIN FOLDING%GOBP%GO:1903332,0.268664563617245,0.642691584293687,-0.43135982053999605,-1.17910283322947,2043,7,PDCD5|BAG5|SGTB|HSPA5
REGULATION OF PROTEIN LIPIDATION%GOBP%GO:1903059,0.7424263007743509,0.909955740610127,0.35537417967241997,0.780772207287548,5464,4,RAB3GAP1|SVIP|RAB3GAP2|GBA
NIK/NF-KAPPAB SIGNALING%GOBP%GO:0038061,0.0366505804095474,0.27230608441566395,-0.35914288810267203,-1.5839955949667002,280,27,MAP3K14|CHUK|BIRC3|CUL1|DICER1|MALT1|TRAF6|AKT1|FBXW11|CHI3L1|NFKB2|TNFRSF10A|TNFRSF10B|TRAF2|IRAK1|SKP1|ZFP91|RELB|RELA|CARD10
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR%GOBP%GO:1902165,0.29640325544762397,0.6687276080240239,-0.312142743519237,-1.13333970376149,2257,15,CD44|CD74|TRIAP1|KDM1A|TAF9B|TAF9|ZNF385A|AK6
NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION%GOBP%GO:0010839,0.33758548132561794,0.699636319850872,-0.46190144665969796,-1.1070896287346998,2566,5,MED1|CASK|SNAI2
RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:0036005,0.0451511582253632,0.304705921503765,-0.701766170159738,-1.5363128419657202,344,4,PDE2A|PDE1B|CSF1R
MICROTUBULE SLIDING%GOBP%GO:0051012,0.45185283570195295,0.769943206592495,0.775474194971328,1.0339902020460898,3401,1,MAP4
CELLULAR DEFENSE RESPONSE%GOBP%GO:0006968,0.174444300012999,0.54811765844537,-0.265152270997908,-1.25623412184181,1341,34,BECN1|CD5L|FOSL1|PRF1|ITGB1|MNDA|CD300C|LSP1|TCIRG1|SPN|VEZF1|LILRB2|ZNF148|TNFRSF4|LGALS3BP|NCF2|TYROBP|RELA|LY96|C5AR1
URETERIC BUD DEVELOPMENT%GOBP%GO:0001657,0.0337231438672831,0.26217929082442604,0.41239335798726395,1.61428356677488,247,18,FOXC1|FGFR2|CITED1|PAX8|FGF2|ROBO2|BMP7|PKD2|FGF1|FOXJ1
GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901659,0.24977174905438895,0.6303541958147291,-0.266264997480427,-1.17435872204225,1914,27,LCMT2|IMPDH2|ADA|TYMP|CTPS1|HPRT1|CDA|UMPS|GMPS|TK1|UCK1
NEGATIVE REGULATION OF ARACHIDONIC ACID SECRETION%GOBP%GO:1900139,0.33177257525083603,0.6961761803662729,-0.8320467578297309,-1.10848606763768,2479,1,PLA2R1
METAL ION HOMEOSTASIS%GOBP%GO:0055065,0.000128254456842375,0.00518555396908895,-0.230041109754172,-1.81982389684329,0,312,MT1G|B2M|OCM|EDNRA|CCL19|HSP90B1|FPR3|LPAR6|RYR2|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|SLC12A8|ATP6V0A2|ERO1L|PTGER1|PLN|ITPR3|SLC8B1|ATP1A3|SLC12A2|ATP1B3|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ADCY8|CXCR4|JPH4|CALB2|CCDC22|TAC1|CALCB|RMDN3|ATP6V0D1|ABCB7|HAMP|SEPN1|SLC9A1|PTGER4|TBXA2R|SLC11A1|GHRL|ABL1|CALR|ACO1|HERPUD1|HMOX1|SOD1|SKP1|SLC35G1|ARF1|MT1M|CCRL2|P2RY6|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|FTL|APLNR|GNA15|TMCO1|MTL5|CD36|F2RL3|GRIN2C|FXN|MT2A|XIAP|TGM2|GRIN2D|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|ATP1B2|PRKACA|KCNH2|S100A8|S100A9|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|SLC7A8|TFRC|ATP6V1A|ATP6V1G1|FAM20A|C5AR1|FTH1|C1QTNF1|PRNP
REGULATION OF INTERLEUKIN-1 PRODUCTION%GOBP%GO:0032652,0.00025873221216041404,0.00819882332206558,-0.46947983922657793,-2.2606768095664798,1,36,PYCARD|GSDMD|CCL19|AZU1|GAS6|CASP1|TNFAIP3|CARD16|GHRL|HSPB1|IFI16|CEACAM1|F2R|NLRP3|LGALS9|FOXP1|CX3CL1|TLR4|ANXA1|GSTP1|SIRPA
HEXOSE CATABOLIC PROCESS%GOBP%GO:0019320,0.0518268981601451,0.32885259020312796,-0.295926910802805,-1.49121095236651,399,42,GPI|HK1|GALT|HK3|FUT9|ENO1|LRP5|PGM5|ALDH1A1|PGAM1|GAPDH|PGK1|ALDOA|GALK1|ALDOC
ESTABLISHMENT OF ORGANELLE LOCALIZATION%GOBP%GO:0051656,0.36959856814114006,0.722232671030729,-0.131984447886613,-1.0377565521799201,2890,299,NUF2|DLGAP5|PEF1|SPDL1|DCTN4|ZNF593|DYNC1H1|MCFD2|SEPT5|TBC1D23|UXT|YKT6|SNAP47|CDT1|AP3S1|ESPL1|DNM1|STX4|TFG|PDCD6|TOR1A|CDC23|RAB27B|SYT4|GEM|BOD1|OPA1|KPNB1|NPM1|TRAPPC5|SYT7|NAPA|SCFD1|CPLX2|CDK5RAP2|SLC9A3R1|SAPCD2|SEC23A|S100A13|SERPINA1|NDC80|STX11|F8|WIPI1|KIF18A|SPICE1|SEC13|SEC24A|ARFGAP2|NMD3|PPP6R3|CNIH2|RAN|CNIH1|STX1B|TMED2|CTSZ|KIFC1|CCNB1|NSFL1C|CTSC|CHGA|CHMP4A|SUN2|STX3|RAB1B|CHMP6|NSF|DTNBP1|SYNE3|CD59|STX5|CNIH3|ATP6AP1|TMED10|PRRT2|MILR1|TRAPPC2|TMED9|GOSR2|DYNC1I1|KIF22|COPG1|PPP6C|SAR1B|CDCA5|GRIA1|SNPH|DNM3
SKELETAL MUSCLE CELL DIFFERENTIATION%GOBP%GO:0035914,0.78721146192624,0.927748696800401,-0.46860993873520596,-0.7798418744187858,5933,2,MYLK2
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN METANEPHRIC NEPHRON MORPHOGENESIS%GOBP%GO:0072305,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
AXO-DENDRITIC PROTEIN TRANSPORT%GOBP%GO:0099640,0.870218579234973,0.9573965249923859,0.22906044739117604,0.664922405555198,6369,8,DLG2|KIF5B|KIF5A|KIF5C
POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION%GOBP%GO:0060452,0.41335952848722995,0.748061280707938,-0.400551673865759,-1.0303268082383101,3155,6,KCNQ1|CHGA|RGS2
NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY%GOBP%GO:1902902,0.9346164346164351,0.980482119883153,0.19853940932865802,0.6033429536616329,6846,9,PHF23|SMCR8
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION%GOBP%GO:0086069,0.0699215580200162,0.37596389138254704,0.5483236317384871,1.5136326675474798,516,7,TRPM4|SCN5A|TNNI3K
MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002275,0.00012745347947999,0.00518555396908895,-0.32651400278166304,-2.6952777236535495,0,411,UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|CNN2|DNASE1L3|SBNO2|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|S100A13|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|DYSF|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|CHGA|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|MILR1|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
NEGATIVE REGULATION OF ADENYLATE CYCLASE-INHIBITING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0140194,0.0560535117056856,0.343943018657969,-0.970004411116012,-1.29227878740106,418,1,RGS2
SIGNAL TRANSDUCTION INVOLVED IN DNA INTEGRITY CHECKPOINT%GOBP%GO:0072401,0.966933608886593,0.9912626134248801,-0.106694347509643,-0.619531671000653,7485,70,FZR1|PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|UIMC1|PML|RGCC|TRIAP1|TFDP2|PLK2|BRCC3|PCNA|CDC25C|BRCA1|DTL|E2F1|CCNB1|PLK1|PLAGL1|TNKS1BP1|ZNF385A|PRPF19
THROMBIN-ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0070493,0.545238095238095,0.817297924969912,-0.481386635458105,-0.940026092108475,4121,3,IQGAP2|PLEK
"FATTY ACID ELONGATION, MONOUNSATURATED FATTY ACID%GOBP%GO:0034625",0.507759074171489,0.7987565605553191,-0.39487388553412395,-0.9464373547525979,3860,5,ELOVL2|ELOVL1
AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING%GOBP%GO:0086027,0.10221256956698802,0.441073279931729,0.554332895190225,1.4343689473652899,752,6,TRPM4|SCN5A|CACNA1C|CACNB2
NEGATIVE REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:2000323,0.23745907007203698,0.6217158626397761,-0.470614244535396,-1.21054661388369,1812,6,CRY2|PHB
POLYURIDYLATION-DEPENDENT MRNA CATABOLIC PROCESS%GOBP%GO:1990074,0.36509002956194603,0.719535401591739,0.556114261408902,1.0938111263908399,2716,3,DIS3L2|ZCCHC11|ZCCHC6
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE%GOBP%GO:1902231,0.61119413123217,0.8515889287679592,0.396894366134629,0.8719938251917291,4498,4,RPL26|FBXO18
ISOPENTENYL DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0046490,0.458447847140427,0.773047151415595,-0.45414437765400106,-0.994216975916003,3502,4,MVD|PMVK|MVK|IDI1
STEM CELL DIVISION%GOBP%GO:0017145,0.5986681163359611,0.8457342552793521,0.235771822867583,0.887759108148495,4404,16,FGFR2|TEAD3|RAB10
PHOSPHATIDYLINOSITOL ACYL-CHAIN REMODELING%GOBP%GO:0036149,0.00026150627615062797,0.00819882332206558,-0.6777379028387549,-2.12326437738637,1,10,PLA2G2A|PLA2G2D|PLA2G4D|PLA2G4A|PLA2G4C|PLA2G16|PLBD1|PLA2G12A
ESTABLISHMENT OF VESICLE LOCALIZATION%GOBP%GO:0051650,0.40657084188911696,0.743829322696499,-0.14345495804696898,-1.02337203974976,3167,173,DYNC1H1|MCFD2|SEPT5|TBC1D23|YKT6|SNAP47|AP3S1|DNM1|STX4|TFG|PDCD6|TOR1A|RAB27B|SYT4|TRAPPC5|SYT7|NAPA|SCFD1|CPLX2|SEC23A|SERPINA1|STX11|F8|WIPI1|SEC13|SEC24A|ARFGAP2|PPP6R3|CNIH2|CNIH1|STX1B|TMED2|CTSZ|CTSC|STX3|RAB1B|NSF|DTNBP1|CD59|STX5|CNIH3|TMED10|PRRT2|TRAPPC2|TMED9|GOSR2|DYNC1I1|PPP6C|SAR1B|GRIA1|SNPH|DNM3
ACYLGLYCEROL HOMEOSTASIS%GOBP%GO:0055090,0.170385928065109,0.544006430438841,-0.35350370051398405,-1.2835146340488799,1297,15,APOC2|IL18|ANGPTL4|RORA|CETP|NR1H3|APOE|FITM2
REGULATION OF CELL SHAPE%GOBP%GO:0008360,0.00114839862192165,0.0260082836197492,-0.284549452063233,-1.8285596189587803,8,104,FGD1|ITGB2|COCH|TBCCD1|FMNL1|KDR|PLXND1|FGR|ARHGAP15|CCL24|ARHGAP18|FES|SEPT7|MYO10|TAOK2|SLC9A3R1|RHOF|SEC23A|MSN|RHOG|RHOD|RHOJ|CCL2|RND1|DLC1|HCK|CDC42EP4|SEMA3E|SYNE3|MYH9|WASF3|CSF1R|EPS8|CDC42EP1|ANXA1|MARK2|RHOU|CDC42EP5|CDC42EP2|ALDOA
I-KAPPAB KINASE/NF-KAPPAB SIGNALING%GOBP%GO:0007249,0.109866048428645,0.45483419590443,-0.247762814298333,-1.33731672167054,852,53,BCL3|NFKBIA|RELB|UBC|TICAM1|RELA|TLR4|PRDX4|TNFRSF1A|CD14|LY96
URINARY TRACT SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014848,0.386903971310931,0.733589579210772,0.808061314512572,1.07744072888122,2912,1,KCNMA1
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0045601,0.691382241401857,0.8879225792175841,-0.20015561603973,-0.8288964848519971,5286,22,IL1B|ROCK1|TNF|NOTCH4|CLDN5|APOLD1|VEZF1|CDH5|CEACAM1|ATOH8|TNFRSF1A
RESPONSE TO HYPOBARIC HYPOXIA%GOBP%GO:1990910,0.853765440297516,0.949296218452153,0.572011468901632,0.762700110638946,6427,1,IREB2
FATTY ALCOHOL METABOLIC PROCESS%GOBP%GO:1903173,0.220391211146838,0.6027391478106829,0.7241284052167858,1.21662921676716,1644,2,ALDH3A2|PECR
NEUTROPHIL DIFFERENTIATION%GOBP%GO:0030223,0.9106377277599141,0.9720943283119721,0.3813068651778329,0.6406447660209721,6796,2,LEF1|JAGN1
G1 DNA DAMAGE CHECKPOINT%GOBP%GO:0044783,0.993943298969072,0.9977992952795541,-0.0889967636009901,-0.5012023805920871,7712,62,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|RPA2|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A|CCND1
POSITIVE REGULATION OF PROTEIN SECRETION%GOBP%GO:0050714,0.14573444515715198,0.512646109386394,-0.18494383359338298,-1.2230799637899998,1135,119,HLA-E|RGCC|ADAM9|HYAL2|DHX9|TLR1|PYCARD|TNFRSF14|GSDMD|ADAM8|CCL19|ACHE|STX4|TLR2|PPIA|FGR|CD34|WLS|GPI|GATA3|MYOM1|TGFB3|INS|CASP1|DHX36|ADCY8|PTGER4|IFIH1|OSM|GHRL|TNFRSF4|IGF1|FCN1|IL33|GPER1|F2R|GAPDH|NLRP3|LGALS9|HAVCR2|ANG|TLR4|CSF1R|C1QTNF4|CD14|BAD
SINOATRIAL VALVE MORPHOGENESIS%GOBP%GO:0003185,0.296588628762542,0.6687276080240239,-0.848698720776356,-1.13067048065468,2216,1,MEF2C
NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING%GOBP%GO:0014067,0.382746382746383,0.730480369014206,0.34701022653163105,1.0545320736791601,2803,9,TSC2|TWIST1|PIK3IP1|STAMBP|GLTSCR2|NLRC3
DESMOSOME DISASSEMBLY%GOBP%GO:0035921,0.263545150501672,0.638950455433329,-0.864578738420821,-1.15182647717421,1969,1,SNAI2
SPERMIDINE ACETYLATION%GOBP%GO:0032918,0.16250994958875,0.5335700386874099,-0.756878963330576,-1.2595676290284399,1224,2,SAT1|SAT2
LENS FIBER CELL DIFFERENTIATION%GOBP%GO:0070306,0.882584498438985,0.9629606199413431,0.254463436336151,0.658439097674673,6501,6,WNT5B|PROX1|TDRD7|SIX3
3-KETO-SPHINGANINE METABOLIC PROCESS%GOBP%GO:0006666,0.700757072652411,0.8931369333627571,0.6492611380679311,0.8657021209536908,5275,1,KDSR
TRNA AMINOACYLATION%GOBP%GO:0043039,0.84588899600606,0.948909006295342,0.14079859204940398,0.738422741612798,6141,46,PARS2|DARS|SARS2|CARS2|RARS2|DARS2|FARS2|IARS2|GATB|LARS2|AIMP1|WARS2|HARS2|QARS|YARS2|FARSB|VARS2|QRSL1|MARS|EPRS|KARS|MARS2|TARS2|EARS2
REGULATION OF RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1902882,0.5667916720548299,0.8308398918711859,-0.173129592487522,-0.928364867094101,4382,52,HGF|MCTP1|SOD2|BAG5|INS|SEPN1|UBQLN1|PARK7|HSPB1|SOD1|NONO|DHFR|ABCD1|TLR4|H2AFY|P4HB
NEURONAL STEM CELL POPULATION MAINTENANCE%GOBP%GO:0097150,0.889617486338798,0.965159112268525,0.222907675031194,0.6470619837974151,6511,8,DLL1|MMP24|PROX1|CDH2
RESPONSE TO BLUE LIGHT%GOBP%GO:0009637,0.3309896524277,0.6957352559323989,-0.6694854178050871,-1.11413079399534,2494,2,CRY2
MAPK PHOSPHATASE EXPORT FROM NUCLEUS%GOBP%GO:0045208,0.339088856421836,0.700817490478225,0.8308337009263341,1.10780463342083,2552,1,DUSP16
"NEUROTRANSMITTER RECEPTOR TRANSPORT, POSTSYNAPTIC ENDOSOME TO LYSOSOME%GOBP%GO:0098943",0.17626385509597198,0.548366806412612,0.541064735101441,1.30125758517727,1303,5,CACNG7|CACNG4|CACNG2|AP3D1|CACNG3
NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST%GOBP%GO:0050689,0.466169349561576,0.7801364791925279,-0.45088540585040704,-0.9870824053904301,3561,4,MICB|MUL1|IFIT1
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051806,0.0418574231523872,0.293009782616793,-0.33851609437803604,-1.5455982133267299,319,30,HYAL2|ZNF639|CTNND1|CD4|PPIA|CAV2|GAS6|PVRL2|CXCR4|GRB2|VAMP8|AXL|CAV1|ADRBK1|CD81
REGULATION OF DEVELOPMENTAL GROWTH%GOBP%GO:0048638,0.187577639751553,0.5609377558550861,0.178132564110462,1.18167857699666,1358,116,ISLR2|DUSP6|SHTN1|WWC2|FGFR2|DLL1|CPNE9|SEMA4G|SYT2|SEMA4F|DUSP10|RTN4|CDKN1A|SEMA6C|FGF2|RIMS1|AGRN|PTPRS|UNC13A|RIMS2|GAL|SEMA4C|RUFY3|TRIM46|LIMK1|NRCAM|MAP2|MBD5|BBS2|POU4F2|NEDD4L|NRP1|ZFYVE27|DCC|BMPR1A|MEGF8
BILE ACID SECRETION%GOBP%GO:0032782,0.6873152378392909,0.8864984516746409,0.417651137227095,0.821470500848894,5114,3,ABCB4
POLYSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0000271,0.311447591698212,0.68160868787154,-0.24698865906436998,-1.1167642124006498,2385,29,NDST1|PPP1R3C|PGM5|NR1D1|EXT2|B3GNT5|B4GAT1|CSGALNACT1|GYG2
IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035235,0.952049180327869,0.9858647066977451,0.199705959107478,0.5797114615195121,6968,8,CDK5R1|PTK2B|GRIA2|CPEB4|CLN3|SULT1A3|APP
POSITIVE REGULATION OF ANTEROGRADE DENSE CORE GRANULE TRANSPORT%GOBP%GO:1901953,0.0852090032154341,0.40376145987147494,0.8227736421284809,1.3823659513809,635,2,TRIM46|MAP2
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE%GOBP%GO:0090151,0.0244444444444444,0.219638825480684,-0.509289912668183,-1.7046410233301599,186,12,ROMO1|TIMM9|HSP90AA1|HSPA4|TIMM10
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY%GOBP%GO:1904376,0.121323529411765,0.47375385823484295,-0.338485200140537,-1.35799613980998,923,20,PID1|NUMB|SAPCD2|CLTC|PPFIA1|TMEM59|DAB2|AP2M1
POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION%GOBP%GO:1904690,0.263447192775815,0.638950455433329,-0.546748840752098,-1.19694750344851,2012,4,NCK1
POSITIVE REGULATION OF GRANZYME A PRODUCTION%GOBP%GO:2000513,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
EYE PIGMENT GRANULE ORGANIZATION%GOBP%GO:0008057,0.647491638795987,0.8701703343423142,-0.680359505955007,-0.9064022258834531,4839,1,SHROOM2
TETRAHYDROBIOPTERIN METABOLIC PROCESS%GOBP%GO:0046146,0.139767504731008,0.504314492208813,0.5656167204925029,1.36030496924914,1033,5,SPR|PTS|QDPR
LEUKOCYTE MIGRATION%GOBP%GO:0050900,0.000127648710748021,0.00518555396908895,-0.32149716195990197,-2.33858518023238,0,190,ITGB1|CCL8|CXCL1|IGKV3-11|CD44|TGFB1|CXCL2|CCL11|LYN|GPR183|ITGAX|SELPLG|FLT1|NCKAP1L|CD74|SDC3|SLC7A7|ADAM8|CCL19|SLAMF8|ANGPT2|CD84|ITGB2|CXADR|MERTK|ATP1B1|SBDS|TNFRSF10A|TNFRSF10B|PPIA|CD34|CCL24|SLC12A2|SPN|MYO1G|GATA3|ATP1B3|TNFRSF11A|AZU1|IL1RN|MMP1|GYPC|GAS6|PDE4B|ESAM|CCL3L3|IGKV2-28|ADGRE2|CCL18|ITGA5|DOK2|CXCR4|OLR1|GRB2|JCHAIN|S1PR1|PTPN6|MADCAM1|CD47|ICAM1|SDC4|FCER1G|MSN|PIK3CB|VCAM1|CCL2|CEACAM1|CXCL16|SDC2|EDNRB|CCR1|IGKV2D-28|FN1|HCK|LGALS3|CHGA|CYP7B1|TEK|COL1A2|COL1A1|CX3CL1|SLC3A2|CAV1|CCL4L2|CCL14|MYH9|ATP1B2|S100A8|ITGAM|S100A9|EPS8|ANXA1|PODXL2|FOLR2|SLC7A8|IGHA1|PDGFB|LYST|SIRPA
CATABOLISM BY HOST OF SYMBIONT PROTEIN%GOBP%GO:0052362,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
KIDNEY MESENCHYME DEVELOPMENT%GOBP%GO:0072074,0.36163564733052594,0.716154857259883,0.487708380387941,1.0715160820607,2661,4,WNT4|PKD2
GPI ANCHOR METABOLIC PROCESS%GOBP%GO:0006505,0.228034327748263,0.609818988326981,0.26117243569112,1.19528913843247,1673,29,PGAP2|PIGF|PGAP1|PIGU|PIGL|PGAP3|PIGO|PIGG|PIGT|DPM1|PIGQ|PIGN|PIGS|PIGB|PIGZ
REGULATION OF CALCIDIOL 1-MONOOXYGENASE ACTIVITY%GOBP%GO:0060558,0.773807906534438,0.922601613703136,0.34480352508191103,0.7575480289729771,5695,4,CYP27B1
NEGATIVE REGULATION OF MEMBRANE INVAGINATION%GOBP%GO:1905154,0.1838127090301,0.556308895147568,-0.906374062637847,-1.2075078846804599,1373,1,CD300A
POSITIVE REGULATION OF CELL PROLIFERATION BY VEGF-ACTIVATED PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038091,0.00264550264550265,0.049561277502453996,-0.902000429578198,-1.76137822789713,19,3,PDGFRB|PDGFRA
LIPOATE BIOSYNTHETIC PROCESS%GOBP%GO:0009107,0.0836764510559171,0.402388938341306,0.95892148213498,1.2785924064123702,629,1,LIAS
NEGATIVE REGULATION OF IMMUNOGLOBULIN SECRETION%GOBP%GO:0051025,0.618010359941559,0.854944793214197,0.687858403176004,0.9171663659360759,4652,1,CD22
NEGATIVE REGULATION OF CAVEOLIN-MEDIATED ENDOCYTOSIS%GOBP%GO:2001287,0.0819935691318328,0.398202308598866,0.8248138957816379,1.38579384094602,611,2,PROM2|UNC119
NEGATIVE REGULATION OF PROSTATIC BUD FORMATION%GOBP%GO:0060686,0.22795986622073602,0.609818988326981,-0.882940008822232,-1.17628809814991,1703,1,SULF1
REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE%GOBP%GO:1900101,0.4822806329279461,0.786591447894397,-0.235224148713283,-0.974124403194572,3687,22,FICD|HSPA5|NCK1|ERN1
TRIPARTITE REGIONAL SUBDIVISION%GOBP%GO:0007351,0.5923222492565561,0.8417378833576942,0.36517068898500005,0.878233412933578,4381,5,TBX3|FZD5|HOXD8|PLD6|BASP1
MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0043653,0.281147540983607,0.654472045246182,0.39872546931009906,1.15743028195975,2057,8,MFF|DNM1L|VPS35|BAX
AMMONIA HOMEOSTASIS%GOBP%GO:0097272,0.311329525833444,0.68160868787154,0.845059550066167,1.12677288371433,2343,1,TFAP2B
PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX%GOBP%GO:0002501,0.0980238188718754,0.43163319977057396,-0.6462802625048261,-1.41484259147051,748,4,HLA-DMA|HLA-DMB|HLA-DRA|CALR
IRON CATION EXPORT%GOBP%GO:1903414,0.832775919732442,0.9443921657118071,-0.58706440229378,-0.7821107463312359,6224,1,SLC40A1
SNORNA POLYADENYLATION%GOBP%GO:0071050,0.7220748209074029,0.9019989179378242,-0.5067548938516679,-0.8433211795695279,5442,2,PAPD5|PAPD7
INORGANIC CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:0098662,0.19853789919199696,0.575829448076823,-0.152192185707336,-1.14502979376015,1547,231,SCN7A|SLC39A13|SLC9A5|MICU3|TMEM175|SLC25A27|SLC39A1|CCL19|KCNA3|KCND2|RYR2|SLC36A1|TCIRG1|ITPR2|ATP6V0B|ATP1B1|CCDC109B|ATP2A1|P2RX4|SLC12A8|ERO1L|SLC39A3|ATP5J|ITPR3|SLC8B1|ATP1A3|ATP5F1|SLC12A2|PMPCA|ATP1B3|KCNN2|GAS6|ATP6V1F|KCNK6|SLC39A8|CACNA1H|ATP2A3|GRIN1|SLC41A1|ATP5B|KCNK7|ATP6V0D1|SLC9A1|CACNA2D4|PKD2L1|SLC39A11|ABCC9|SLC9A7|SLC11A1|CACNA1G|MRS2|NALCN|SLC1A3|NDUFS7|SLC9A9|ATP5O|KCNJ12|KCNN1|SLC24A3|HFE|F2R|KCNQ1|STEAP4|TMCO1|KCNB2|ATP6V0E1|GRIN2C|GRIN2D|FKBP1A|SCN1B|STOML2|ATP6AP1|ATP1B2|KCNH2|ATP6V0E2|KCNE4|ATP5H|KCNJ9|PHB|ATP5G1
PARACRINE SIGNALING%GOBP%GO:0038001,0.29040701478864,0.663080262067683,-0.53305241173801,-1.1669631572686001,2218,4,CD34|MB21D1|PDGFB
POSITIVE REGULATION OF ATP METABOLIC PROCESS%GOBP%GO:1903580,0.0164490861618799,0.17512293405535098,-0.411869881118173,-1.72926926689645,125,23,PID1|PFKFB2|PFKFB3|INS|VCP|PARK7|ENO1|IGF1|CCNB1|TMSB4X
POSITIVE REGULATION OF CHROMATIN BINDING%GOBP%GO:0035563,0.5465299684542589,0.8178442945306751,-0.33694707114945893,-0.9210297930468979,4157,7,DTX3L|CDT1|PARP9|GMNN
POSITIVE REGULATION OF NOREPINEPHRINE SECRETION%GOBP%GO:0010701,0.25093783494105,0.63148176332757,0.707637165701682,1.18892180511166,1872,2,KCNB1|STX1A
CARNITINE BIOSYNTHETIC PROCESS%GOBP%GO:0045329,0.784268441787801,0.927080511528825,0.341349345406813,0.749959049121432,5772,4,ACADM|SHMT1|ALDH9A1
HEMOSTASIS%GOBP%GO:0007599,0.000127860887354558,0.00518555396908895,-0.282174798661991,-2.06165636016216,0,195,KDM1A|ZFPM2|SH2B1|DGKG|PIK3R6|ITPR2|P2RX4|RAD51C|ITPR3|RAP2B|GPI|VAV1|GATA3|WAS|TLN1|PRCP|GP1BA|P2RX5|PLEK|GP1BB|P2RX3|GAS6|AKAP1|ILK|PLSCR1|FLI1|VWF|PRKAR1A|DOCK6|PTPN6|SH2B3|ARRB1|FCER1G|F3|DGKE|EHD1|PIK3CB|F8|MAPK3|HSPB1|FLNA|MYL12A|RAD51B|DOCK1|GNAQ|HIST2H3A|THBD|PDPN|F2R|PLAUR|GATA6|GNA15|CD36|SERPINE2|A2M|F2RL3|F13A1|COL1A2|COL1A1|VCL|ITPK1|COL3A1|CD59|PLAT|MYH9|HIST2H3C|FIBP|PRKACA|FERMT3|HIST1H3H|ACTB|PDGFRA|TFPI|H3F3B|ACTN1|SERPING1|MYL9|EHD2|VKORC1|FBLN1|PRKCB
WYBUTOSINE METABOLIC PROCESS%GOBP%GO:0031590,0.630484988452656,0.8611032652135849,0.39088603428105495,0.858793264228759,4640,4,TYW5|TRMT12|TYW3
POSITIVE REGULATION OF NEUTROPHIL MIGRATION%GOBP%GO:1902624,0.7405897540426691,0.909493931144346,0.204525386313466,0.786461045028141,5449,17,XCL1|C1QBP|CAMK1D|DAPK2|CCR7|CCL21|FAM65B|TIRAP|CXCL8|RAC2|THBS4|RAC1|NCKAP1L|CD74|ADAM8|CCL19|MOSPD2
REGULATION OF MAPK CASCADE%GOBP%GO:0043408,0.000126151129052605,0.00518555396908895,-0.2065168304736,-1.73871800465884,0,474,ARHGEF5|IRAK3|ADAM8|IGBP1|MADD|CCL19|MID1|MYDGF|EPHB3|TBX1|TSG101|EZH2|DAB2IP|PRDM15|PIK3R6|MERTK|CD4|DUSP5|HGS|FGFR4|KDR|RAPGEF1|EMC10|SEMA6A|CCL24|SPRY1|SYNJ2BP|PLA2G2A|NGF|TNFRSF11A|PDGFD|PHLPP1|CAV2|IL1RN|EPHA8|FCGR2B|GAS6|TGFB3|PKN1|INS|CCL3L3|MDFIC|DDR2|TRAF2|FPR1|CCL18|TAOK2|SLC9A3R1|MAPK8IP1|MARCO|CXCR4|ZNF622|MST1R|PDGFC|NDST1|FLT4|MAPKAPK2|NOTCH1|GPNMB|INHBA|MLKL|GCNT2|FOXM1|PTPN6|RGS4|ICAM1|ARRB1|ATP6AP2|CTGF|PIK3CB|NOTCH2|OSM|FGF10|MAPK3|TIMP3|GHRL|SOD1|DDR1|IRAK1|NECAB2|HRAS|IGF1|NTRK2|MEN1|TREM2|TNIP1|MAP3K13|GADD45B|SEMA7A|P2RY6|CCL2|CEACAM1|GPER1|CD300A|MAP2K3|MBIP|EPHA2|F2R|PSMD10|CCR1|APOE|RAP1A|FN1|AXL|SASH1|PPP2CA|FGF19|CD36|MUC20|GADD45G|BMP2|TGFBR3|SNF8|LGALS9|THBS1|TEK|MAP3K11|ADRA2C|PEA15|UBC|PDGFRB|C3orf33|EPHA4|GDF11|CX3CL1|IL11|CAV1|MYC|LTBR|DNAJA1|SEMA3A|CCL4L2|CCL14|ATP6AP1|ARHGAP8|INSRR|EPHB4|DACT1|TLR4|PDGFA|ARL6IP5|CSF1R|PDGFRA|SMPD1|RRAS|RGS2|GPS1|GSTP1|PHB|GNG3|GLIPR2|TIE1|DBNL|CD81|RGS3|APIP|PDGFB|C5AR1|FBLN1|SERPINF2|PTPRJ|ERN1|SIRPA|WNK2
NEGATIVE REGULATION OF LIPID TRANSPORT%GOBP%GO:0032369,0.258216577189996,0.636098664976652,-0.342415136657315,-1.17865930217011,1971,13,AKT1|APOC2|SREBF2|APOC1|PLA2R1|NR1H3|THBS1|NFKB1
SKELETAL MYOFIBRIL ASSEMBLY%GOBP%GO:0014866,0.832205154907576,0.9443921657118071,-0.242601143697232,-0.6984147381414101,6392,8,MYH11|MYOM1|IGSF22
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY%GOBP%GO:0043467,0.0947964966512107,0.424763198333523,-0.23118808747819897,-1.34744696345654,735,71,OGT|CBFA2T3|PHKG2|PFKFB2|PFKFB3|INS|VCP|PRELID1|PPP1R3E|PDE12|IRS1|PARK7|JMJD8|UQCC2|IGF1|PGAM1|CCNB1|COX7A1|COX17|PPARA|ABCD1|SHMT2|PPP1R3F
GOLGI TO ENDOSOME TRANSPORT%GOBP%GO:0006895,0.33288006527060104,0.6971202277372819,0.280755108187159,1.098995288495,2447,18,DOPEY2|SYS1-DBNDD2|VPS13C|VPS13A|AP4M1|SORT1|EPS15
"RETROGRADE TRANSPORT, PLASMA MEMBRANE TO GOLGI%GOBP%GO:0035526",0.7084673097534829,0.895438229170987,0.491590846429556,0.8259360938650699,5287,2,USP6NL|RAB43
REGULATION OF INTERLEUKIN-12 BIOSYNTHETIC PROCESS%GOBP%GO:0045075,0.616005291005291,0.8540530451518309,-0.44948141814584097,-0.8777232890417092,4656,3,TLR4
CELLULAR RESPONSE TO RAPAMYCIN%GOBP%GO:0072752,0.389698996655518,0.7358910495632479,-0.804697838553154,-1.07205074029849,2912,1,LARP1
ESTABLISHMENT OF NEUROBLAST POLARITY%GOBP%GO:0045200,0.31913464122547697,0.6869601115014491,0.5782435598713039,1.13733684503736,2374,3,RAB10|DOCK7
REGULATION OF ANION CHANNEL ACTIVITY%GOBP%GO:0010359,0.139541197230895,0.504314492208813,0.526514299416513,1.3623866957555901,1027,6,ABCB1|TCAF2
DEFINITIVE ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0060318,0.14809364548495002,0.515403737647103,-0.924018526687252,-1.2310145474799299,1106,1,TGFBR3
HINDBRAIN TANGENTIAL CELL MIGRATION%GOBP%GO:0021934,0.31363879957127505,0.68331834948726,0.6774987313592761,1.1382853440856497,2340,2,TTBK2|PHOX2B
REGULATION OF PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:0071900,0.004879928085270321,0.0779329691611975,-0.184837242123447,-1.4761186931813899,37,330,C8orf4|NGF|CDKN2A|TNFRSF11A|PDGFD|CCNK|HEXIM1|PKN1|THY1|MDFIC|PKMYT1|TRAF2|FPR1|TAOK2|SYAP1|MAPK8IP1|DDX3X|HEG1|CXCR4|CDC25C|MST1R|PDGFC|IPO7|MAPKAPK2|PRKAR1A|MLKL|CEBPA|CKS2|RGS4|CDKN2B|PIK3CB|GTF2H1|FGF10|MAPK3|GHRL|ABL1|SOD1|IRAK1|HRAS|IGF1|MEN1|LRP5|MAP3K13|RPTOR|GADD45B|CCNI2|CCNI|CD300A|MAP2K3|MBIP|F2R|PSMD10|APOE|CCNB1|PLK1|CDK7|SASH1|PPP2CA|MUC20|GADD45G|BMP2|SNF8|THBS1|MAP3K11|PEA15|UBC|LATS2|PDGFRB|MNAT1|NR2F2|CAV1|DNAJA1|RASIP1|CCND3|TLR4|CDKN2C|PDGFA|SERTAD1|CSF1R|ACTB|SMPD1|H2AFY|RGS2|CDKN3|GPS1|GSTP1|GNG3|CCND1|DBNL|CD81|RGS3|PDGFB|C5AR1|PTPRJ|ERN1
CELLULAR BIOGENIC AMINE BIOSYNTHETIC PROCESS%GOBP%GO:0042401,0.532549019607843,0.812079525085925,-0.278027118395337,-0.930582797393334,4073,12,AMD1|SRM|SAT1|MOXD1|ODC1|SMOX|SMS
PURINE NUCLEOBASE TRANSPORT%GOBP%GO:0006863,0.5899442823029979,0.8414799095069009,-0.563054866280673,-0.93701333673389,4446,2,VDAC3|SLC29A2
MUSCLE TISSUE MORPHOGENESIS%GOBP%GO:0060415,0.139312483845955,0.504314492208813,-0.267696674491347,-1.3004560151154199,1077,37,SMAD4|TGFBR1|BMP4|SMAD7|TBX20|DLL4|TGFB2|NRG1|TGFB1|TNNT2|TBX1|ZFPM2|RYR2|MYOM1|MYLK2|MYLK|NOTCH1|S1PR1|PKP2|BMP2|TGFBR3|IGSF22|FKBP1A|ENG
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC DNA INTEGRITY CHECKPOINT%GOBP%GO:1902403,0.9923644363918729,0.997305769352475,-0.0952026996766654,-0.5213158066875929,7667,56,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A
PROTEASOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:0010498,0.8397239263803679,0.9470274567210699,-0.106733069845099,-0.8368951024369259,6569,293,PML|CUL4B|FBXO45|DCAF11|FBXW11|KLHL20|MARCH6|GET4|PSMD1|PCNP|CDC20|ANAPC10|TRIM3|HSP90B1|RNF216|UBE2B|FBXO6|ANAPC2|TRIM9|HSPA13|ANAPC5|KCTD2|UBQLN2|RNF121|HM13|TOR1A|KLHL15|PSMB2|CDC23|PTTG1|ARMC8|VCP|UBE2G2|MAD2L1|RNF7|SIAH2|PSMD4|SEL1L|SMURF2|UBE2S|UBQLN1|UBXN1|ARRB1|PSMB5|UBE2R2|RCN3|FAF2|HERPUD1|CDC27|RAD23B|SEC13|SKP1|NPLOC4|PSMC6|USP44|FBXO4|CCNB1|PLK1|NSFL1C|PSMB3|SYVN1|NR1D1|KIAA0368|PSMD2|SEC61B|UBC|SGTB|PSMD6|ERCC8|FBXW5|DDB1|SPOP|PLAA|DERL3|PSMD12|PSMA3|KAT5|HSPA5|ANAPC11|PSMA6|PSMB7|PSMA1|PSMC5|RMND5B|PRPF19|SPSB1
POSITIVE REGULATION OF NK T CELL PROLIFERATION%GOBP%GO:0051142,0.8538073759617941,0.949296218452153,-0.42959556660393394,-0.7149157203251679,6435,2,IL18
REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY%GOBP%GO:1904666,0.9718754106978579,0.9915747942934481,-0.135657934986051,-0.535971845360557,7394,19,FZR1|RPL11|RPL23|GOLGA2|PTEN|CDC20|MAD2L1|UBE2S|USP44|PLK1
LEARNING%GOBP%GO:0007612,0.386022386022386,0.7332167375750358,0.20398273399008499,1.05074177985427,2827,43,STRA6|DRD2|EPHB2|CHRNB2|HTT|ADCY3|NF1|NETO1|ATXN1L|DLG4|BRSK1|PPP3CB|SLC8A2|NLGN4X|SHANK2
PLATELET ACTIVATING FACTOR METABOLIC PROCESS%GOBP%GO:0046469,0.261835875854813,0.637592109988467,-0.49565706622229705,-1.1879954076611798,1990,5,CHPT1|PLA2G4A|PLA2G7
HISTONE ARGININE METHYLATION%GOBP%GO:0034969,0.8283211297071129,0.9431300260625299,-0.222889089230905,-0.6982824205195249,6334,10,PRMT3|PRMT5
PERICYTE CELL DIFFERENTIATION%GOBP%GO:1904238,0.0350529100529101,0.26702449097803305,-0.7875261938899308,-1.5378390589737099,264,3,CD34|ACTA2|PDGFB
CELL REDOX HOMEOSTASIS%GOBP%GO:0045454,0.208295172052859,0.5883094281426011,-0.323310429414502,-1.22865858295728,1591,17,GPX1|SLC11A1|ERP44|NOS3|PRDX4|PRDX5
POSITIVE REGULATION OF TOOTH MINERALIZATION%GOBP%GO:0070172,0.008234825342010891,0.11224439711032301,0.995533745037494,1.3274099187956598,61,1,WNT6
POSITIVE REGULATION OF REMOVAL OF SUPEROXIDE RADICALS%GOBP%GO:1904833,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|PARK7
REGULATION OF NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0006140,0.00579896907216495,0.0881070888111227,-0.306372727892115,-1.7469981451748202,44,65,PID1|PPIF|PARP1|OGT|CBFA2T3|PFKFB2|ATPIF1|PFKFB3|INS|VCP|PDE12|PARK7|ENO1|JMJD8|UQCC2|IGF1|PGAM1|CDA|CCNB1|NOS3|PDK3|COX7A1|PPARA|ABCD1|SHMT2|TMSB4X
REGULATION OF INTERFERON-GAMMA PRODUCTION%GOBP%GO:0032649,0.00141116100064144,0.0301860198914787,-0.379443394831483,-2.0261285822307102,10,51,CD274|HLA-DPA1|LILRB1|CEBPG|PYCARD|IL18|RIPK3|HLA-DPB1|PDCD1LG2|EBI3|GAS6|PDE4B|PDE4D|INHBA|CD47|ISG15|SLC11A1|C10orf54|AXL|LGALS9|ZP3|FADD|HAVCR2|IL1R1|TLR4|CD14|SIRPA|PRNP
MELANOCYTE MIGRATION%GOBP%GO:0097324,0.31229903536977505,0.68160868787154,0.678356768679349,1.13972695756905,2330,2,KIT|ZEB2
REGULATION OF CARDIAC MUSCLE ADAPTATION%GOBP%GO:0010612,0.7505291005291009,0.914270866779142,-0.397203257456609,-0.775637291060998,5673,3,LMNA
NEURON CELL-CELL ADHESION%GOBP%GO:0007158,0.28577257889009805,0.658457633141178,0.33698509562146,1.14534679576124,2100,12,RET|CNTN4|CDK5R1|NCAM2|NLGN2|NLGN4X
LEUCINE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098713,0.109966555183946,0.45483419590443,-0.9424900749889721,-1.2556230850981298,821,1,SLC3A2
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE/THREONINE KINASE SIGNALING PATHWAY%GOBP%GO:0090092,0.040485312899106,0.28837731910627695,-0.20987176727768697,-1.4218432558594098,316,133,NOTCH1|INHBA|SMURF2|HTRA3|CHRD|FBN1|CDKN2B|LTBP1|SNW1|CILP|SULF1|MEN1|LDLRAD4|SNX6|HFE|GIPC1|PCSK6|ADAMTSL2|NOV|TGFBR2|BMP2|THBS1|WWTR1|NBL1|XIAP|UBC|FAM89B|GDF11|FKBP1A|CAV1|DACT1|DAB2|ENG|ACVRL1
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL%GOBP%GO:0060078,0.517335146159076,0.8044682962948779,0.22652790992354502,0.9480085471404259,3804,22,DRD2|GABRA3|DRD4|ARRB2|RAB3GAP1|ADCYAP1
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY%GOBP%GO:0007185,0.6375729604995249,0.864977246543067,0.326059348079573,0.8436977273791749,4696,6,PTPRD|PTPRU|TRIO|PTPRF
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING%GOBP%GO:0010882,0.23144637053087802,0.6149950305002221,0.32811276907149,1.21027275188031,1708,15,FKBP1B|ANK2|GSTM2|DMD
MITOCHONDRIAL RNA MODIFICATION%GOBP%GO:1900864,0.86535690897184,0.954584411475564,-0.262699244388065,-0.6757332240925351,6606,6,TRMT61B|PUS1|TRIT1|MTO1|TRMT5|HSD17B10
METHYLGLYOXAL METABOLIC PROCESS%GOBP%GO:0009438,0.30167153091005605,0.6746768701419901,-0.6837055417700579,-1.1377953542418502,2273,2,TPI1|PARK7
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1904427,0.8534214618973559,0.949296218452153,-0.145839374438699,-0.7201909654627879,6584,39,RYR2|ATP1B1|STAC3|THY1|STIM1|SLC9A1|P2RY6|GPER1|F2R|APLNR|F2RL3|CX3CL1
NEGATIVE REGULATION OF VACUOLAR TRANSPORT%GOBP%GO:1903336,0.372028157789879,0.7234654586828599,0.814788266431407,1.08641021157815,2800,1,VPS35
PEPTIDE MODIFICATION%GOBP%GO:0031179,0.640809217577706,0.867171225061644,0.5291311948426389,0.889008726229632,4782,2,PAM
POSITIVE REGULATION OF MYELINATION%GOBP%GO:0031643,0.186672073533387,0.5597458283154859,0.534276243461532,1.28493130171197,1380,5,PARD3|TENM4|MYRF|RNF10|DICER1
REGULATION OF TELOMERE MAINTENANCE VIA RECOMBINATION%GOBP%GO:0032207,0.5031438127090301,0.797298314254545,-0.752315835906484,-1.00226533511256,3760,1,TERF2
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION%GOBP%GO:1901390,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
HISTONE-SERINE PHOSPHORYLATION%GOBP%GO:0035404,0.0954063604240283,0.425538576617919,-0.647993137472964,-1.4185924328309598,728,4,RPS6KA4|VRK1
CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE%GOBP%GO:0032286,0.771164021164021,0.9213545359508709,-0.38838645638028,-0.7584203131679741,5829,3,MYRF|CLU|PTEN
NEGATIVE REGULATION OF URINE VOLUME%GOBP%GO:0035811,0.358613361668216,0.714938712241162,0.821956329951478,1.09596785707488,2699,1,ADCY6
PALLIUM DEVELOPMENT%GOBP%GO:0021543,0.7298553719008269,0.906544799850309,-0.15603216864980302,-0.822117479024013,5651,49,NTRK2|KIRREL3|COL3A1|SLIT2|TMEM108|LHX6|TACC1|ADGRG1|NOTCH2NL
PURINE NUCLEOTIDE-SUGAR TRANSMEMBRANE TRANSPORT%GOBP%GO:0090480,0.42849562218095005,0.7566175497322429,-0.627626137303557,-1.04447025743856,3229,2,SLC35B4|SLC35C1
ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS%GOBP%GO:0060978,0.691666666666667,0.88816714481404,-0.42052506692788305,-0.821178874070084,5228,3,PDGFRB
RESPONSE TO BMP%GOBP%GO:0071772,0.6158075601374571,0.8539218792126291,0.162101184775819,0.9005178797805891,4479,56,ACVR1|SFRP1|ADAMTS7|FAM83G|DLX5|GDF1|BMP7|TMEM100|SMAD1|ACVR2A|PDCD4|ZFYVE16|SKI|BMPR1A|MEGF8|GDF9|USP9Y|BMPR2|ACVR2B|RGMA|BMPR1B
NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION%GOBP%GO:0045839,0.9052398331595409,0.970335072942082,-0.14126409853299401,-0.657104899697723,6944,32,CHEK1|FBXO5|CENPF|BMP4|ATRX|MAD1L1|KIF25|ZNF207|TRIP13|AURKAIP1|KLHL22|APC|RGCC|CDC20|NAA10|PTTG1|MAD2L1|PLK1|IK
MULTICELLULAR ORGANISMAL HOMEOSTASIS%GOBP%GO:0048871,0.307080554130323,0.6786107324984411,-0.164730262998315,-1.08745641899277,2393,118,ACTG1|AQP1|PRKAR2A|HYAL2|ACP5|B2M|BBS1|SERPINA3|DFNB31|AQP3|CXADR|P2RX4|CD34|NR1D2|SGIP1|TNFRSF11A|ADCY8|HAMP|JCHAIN|PRKAR1A|STAT3|GCNT2|TPP1|MUC4|RCN3|SLC11A1|ADCY4|HSPB1|SOD1|CTSH|LCN1|F2R|NOS3|CD36|NR1D1|PRKACA|TLR4|ACTB|METRNL|ADGRV1|IGHA1|ADCY9|EIF4G1
REGULATION OF SKELETAL MUSCLE CONTRACTION BY REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION%GOBP%GO:0014809,0.0167965600644988,0.176278727014046,0.8310029099657759,1.63448465910747,124,3,GSTM2|DMD
LEUKOCYTE DEGRANULATION%GOBP%GO:0043299,0.000126694539465349,0.00518555396908895,-0.32958146299452695,-2.72047760942152,0,407,UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|CNN2|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|CORO1A|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|S100A13|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|HCK|ADGRE5|LGALS3|CD36|CTSC|CHGA|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|MILR1|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0006360,0.0565693430656934,0.34436604181231795,-0.319019431953064,-1.48395263914972,433,32,ZNRD1|TWISTNB|TTF1|POLR2H|GTF2H1|MAPK3|UBTF|CDK7|MNAT1|PTRF|POLR2L|GTF2H2
NEGATIVE REGULATION OF POST-TRANSLATIONAL PROTEIN MODIFICATION%GOBP%GO:1901874,0.3685691318327971,0.7217539780398442,0.65183347118831,1.09516439322255,2750,2,CRTAP|P3H1
NUCLEOTIDE SALVAGE%GOBP%GO:0043173,0.522986247544204,0.807051143864932,-0.36427225561587395,-0.937006371328405,3992,6,ADA|HPRT1
REGULATION OF PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:1900371,0.159281746544374,0.5293397224673839,-0.243745723803127,-1.26267954348838,1232,46,GUCA1A|PID1|PARP1|OGT|CBFA2T3|PFKFB2|PFKFB3|INS|VCP|ENO1|JMJD8|IGF1|PGAM1|NOS3|PDK3|PPARA|TMSB4X
POSITIVE REGULATION OF MRNA CLEAVAGE%GOBP%GO:0031439,0.987692307692308,0.996030692679047,-0.506120423467137,-0.674273930738651,7382,1,NUDT21
TROPHECTODERMAL CELL DIFFERENTIATION%GOBP%GO:0001829,0.6178571428571429,0.854944793214197,-0.448823609626285,-0.8764387557239001,4670,3,HOPX|SRF
NEGATIVE REGULATION OF CELL ADHESION INVOLVED IN SUBSTRATE-BOUND CELL MIGRATION%GOBP%GO:0006933,0.698553054662379,0.892206463710019,0.49638819961400604,0.833996266626289,5213,2,ITGB1BP1|PTPRC
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING%GOBP%GO:0014068,0.0114838709677419,0.139771630097924,-0.313270301785662,-1.70883672802515,88,55,FLT1|IL18|MYDGF|AGT|PIK3AP1|KDR|FGR|HCLS1|HGF|PDGFD|INS|DCN|PDGFC|PTPN6|HCST|HAX1|PIK3CB|OSM|IGF1|NTRK2|GPER1|F2R|TEK|PDGFRB|PDGFA|PDGFRA|PDGFB
REGULATION OF INTEGRIN BIOSYNTHETIC PROCESS%GOBP%GO:0045113,0.440112540192926,0.7653693162885199,0.6198075379395931,1.0413566903290798,3284,2,TMEFF2|TGFB2
PROTEIN TARGETING TO MEMBRANE%GOBP%GO:0006612,0.732428626296249,0.9075412450030892,-0.125061010235788,-0.8608957966317271,5720,144,ZDHHC9|ZDHHC4|TRAM1|ZDHHC12|CHM|RPLP2|TAOK2|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|SRP19|RPL35|RPL38|RPS15A|PEX16|CHMP4A|SEC61A1|ZDHHC19|SEC61B|SSR1|SGTB|RPS13|ARL6IP1|ATG3|ZDHHC24|SRP9|ZDHHC2|SRP68
MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044144,0.10175112762005802,0.44077960358770296,-0.8006788819499169,-1.33245769774462,766,2,OSBP
REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS%GOBP%GO:0031392,0.8285564716660121,0.9433331312567601,-0.324282169240983,-0.709921455621067,6330,4,ANXA1
REGULATION OF PROTEIN OXIDATION%GOBP%GO:1904806,0.662239341213973,0.879470077229378,0.6671812968681079,0.889596234695513,4985,1,TRABD2A
CELLULAR ORGANOHALOGEN METABOLIC PROCESS%GOBP%GO:0090345,0.561204013377926,0.827957010954873,-0.723037053374504,-0.96325896652968,4194,1,POR
POSITIVE REGULATION OF PROTEIN NEDDYLATION%GOBP%GO:2000436,0.540468227424749,0.815107395900307,-0.732851786501985,-0.9763345477118871,4039,1,DCUN1D1
NUCLEOLUS ORGANIZATION%GOBP%GO:0007000,0.8431873152378391,0.9481593344082329,0.357725818903717,0.7036044713596271,6274,3,RPS19|NOL12|USP36
NEGATIVE REGULATION OF HISTONE DEACETYLATION%GOBP%GO:0031064,0.584239851419475,0.8396554445633291,-0.564823180954639,-0.939956095126147,4403,2,FOXP3
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043536,0.077866179731316,0.390713151724379,-0.276900602461901,-1.41154570628221,596,44,TGFB1|STAT5A|KIAA1462|MAP3K3|PIK3C2A|KDR|P2RX4|SRPX2|FOXC2|ATP5B|PRKD1|HMOX1|HSPB1|RHOJ|MAP2K3|NOS3|THBS1|ANXA1|TMSB4X|PDGFB
ENUCLEATE ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0043353,0.5388628762541811,0.8142313733497609,-0.7336788707543009,-0.977436422530612,4027,1,CEBPG
CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061308,0.6771026797559039,0.8836483435332951,-0.526446016687789,-0.876090356816125,5103,2,JAG1
MAINTENANCE OF PERMEABILITY OF BLOOD-BRAIN BARRIER%GOBP%GO:0035633,0.988179041041307,0.996030692679047,0.5057344508160561,0.674328649969194,7439,1,MBP
RETROGRADE AXONAL TRANSPORT%GOBP%GO:0008090,0.443448744059742,0.7663523583818629,0.28594586983832004,1.00144205221098,3265,13,DLG2|HAP1|DST|KIF5B|KIF5A|KIF1A
POSITIVE REGULATION OF INTERLEUKIN-23 PRODUCTION%GOBP%GO:0032747,0.904351286813478,0.9698755111576809,-0.397161625050435,-0.6609404550029321,6816,2,IL17RA
REGULATION OF AXON REGENERATION%GOBP%GO:0048679,0.40679510544129105,0.7440015175276891,-0.35952347917859895,-1.03501777749069,3124,8,SCARF1|EPHA4|RTN4RL1
REGULATION OF FOCAL ADHESION ASSEMBLY%GOBP%GO:0051893,0.0398390864261614,0.28475403983757397,-0.293310771493954,-1.5275635624972501,306,47,PTEN|RCC2|RAC1|DUSP3|APOD|PEAK1|CORO1C|PPM1F|KDR|THY1|PHLDB2|SLC9A1|BCAS3|S100A10|ABL1|GPM6B|DLC1|THBS1|TEK|FAM107A|COL16A1|ACVRL1|EFNA5|PTPRJ
LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER%GOBP%GO:1990379,0.704343206269093,0.894436909245845,0.647441552712836,0.863275949404522,5302,1,MFSD2A
REGULATION OF MITOCHONDRIAL FISSION%GOBP%GO:0090140,0.11843894479195001,0.46942161822544604,0.34868589007254,1.36490535409583,870,18,MFF|MIEF2|PARK2|MARCH5|DNM1L|STAT2|VPS35
NEGATIVE REGULATION OF GERMINAL CENTER FORMATION%GOBP%GO:0002635,0.212754555198285,0.5953748206554239,0.7285359801488829,1.2240345117381202,1587,2,FOXJ1|RC3H1
ELECTRON TRANSPORT COUPLED PROTON TRANSPORT%GOBP%GO:0015990,0.261772486772487,0.637592109988467,-0.607943859507739,-1.18716027488083,1978,3,NDUFS7
POSTSYNAPTIC DENSITY ASSEMBLY%GOBP%GO:0097107,0.885265225933202,0.9640874207062379,-0.25562331108899305,-0.6575320174892061,6758,6,NRXN2
CORTICAL ACTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0030866,0.579550102249489,0.8386526275338391,0.203177478804649,0.9093202451643729,4250,27,RTKN|LLGL1|RAB13|RHOQ|NCKAP1|FMNL2|WIPF1|WIPF2|PDCD6IP|IKBKB|STRIP1
SULFUR COMPOUND CATABOLIC PROCESS%GOBP%GO:0044273,0.083495397381045,0.402201069234289,-0.279174819415714,-1.3981368730191397,643,41,NCAN|CDO1|CHAC1|CHAC2|TST|PRELP|GGT1|ARSB|DCN|BGN|VCAN|OGN|LUM|FMOD|HYAL1|GGT5|ABCD1|HEXB
NEGATIVE REGULATION OF VIRAL TRANSCRIPTION%GOBP%GO:0032897,0.394832950087921,0.7377402989373809,0.261208211356955,1.04140681167394,2918,19,TRIM62|TRIM11|INPP5K|HDAC1|TRIM13|TRIM27
NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072160,0.30459007694348605,0.6770795415897549,-0.682326992004411,-1.13550122698513,2295,2,MTSS1|MEF2C
PROMOTER CLEARANCE FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0001111,0.275468189666622,0.65032483094354,0.864578738420821,1.15279908760543,2073,1,ERCC3
OUTER DYNEIN ARM ASSEMBLY%GOBP%GO:0036158,0.009229098805646041,0.121304051841511,0.557888793486383,1.8357966966747001,67,11,LRRC6|DNAI1|ZMYND10|DYX1C1|LRRC49
REGULATION OF CENTROSOME DUPLICATION%GOBP%GO:0010824,0.0647894668231,0.365484450623565,-0.31102570926828804,-1.4606645322495402,496,33,PLK2|NPM1|CDK5RAP2|BRCA1|SPICE1|CEP131|RBM14|KAT2B|FBXW5|CETN2|XRCC3
MITOCHONDRIAL RNA METABOLIC PROCESS%GOBP%GO:0000959,0.286163522012579,0.6590396451189421,0.233293098621033,1.1307749689978,2092,35,FASTKD1|ELAC2|PNPT1|FOXO3|C10orf2|MTERF4|DARS2|TRMT61B|WARS2|PUS1|TFB2M|YARS2|TRNT1|TBRG4|KIAA0391|SUPV3L1|TRIT1|MTERF2|TARS2|EARS2|POLRMT|MTERF3
OSTEOBLAST DEVELOPMENT%GOBP%GO:0002076,0.5710543549443349,0.83345652350693,-0.35106191350782295,-0.903025812743882,4359,6,PTHLH|ACHE|MEN1|LRP5
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN STEM CELL PROLIFERATION%GOBP%GO:1905474,0.07719063545150501,0.388912112477145,-0.959142037935598,-1.27780749811514,576,1,WNT3
RETINAL GANGLION CELL AXON GUIDANCE%GOBP%GO:0031290,0.5049545269444821,0.797902257689198,0.3656429964145301,0.9461227439851371,3719,6,ROBO2|PTPRM|NRP1|ALCAM|EPHB1
PROTEIN FOLDING%GOBP%GO:0006457,0.0154553582833057,0.16795025494083,-0.21901288777856198,-1.51059909142615,120,145,PFDN2|DNAJC3|CCT3|EMC1|TBCD|MLEC|MESDC2|HSP90B1|CHORDC1|HSPA13|DNAJC7|PPIA|CHCHD4|ERO1L|TOR1A|TTC1|ERO1LB|NUDC|CANX|DNAJC25|BAG5|PDIA4|VCP|PPIB|CCT8|DNAJC4|BAG3|HSPA6|PDCL|HSPA9|CCT5|UBXN1|CALR|HSPB1|RAD23B|ERP44|GNAI2|AIP|PDIA5|NUDCD2|PSMC1|TBCA|FKBP1A|FKBP4|HSP90AA1|HSPA5|HSPB6|DNAJB5|FKBP5|SPHK1|SIL1|DNAJC19|ENGASE|P4HB
SYNAPTIC VESICLE RECYCLING VIA ENDOSOME%GOBP%GO:0036466,0.843272678974632,0.9481593344082329,0.5772496691662989,0.7696845438865558,6348,1,AP3D1
NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER%GOBP%GO:0097756,0.060407949790795,0.355787695563881,-0.49270390491234295,-1.5435770163033602,461,10,EDNRA|PIK3C2A|INS|EDNRB|SMTNL1|CHGA
POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY%GOBP%GO:0010592,0.626224156692057,0.858842084733938,0.255172413793103,0.867281402952291,4603,12,RLTPR|NCKAP1|ARPC2|AUTS2|BRK1|TWF2|AKIRIN1|FSCN1|RAC2|CDC42|RAC1|WASF2
COMMISSURAL NEURON DIFFERENTIATION IN SPINAL CORD%GOBP%GO:0021528,0.291805020587063,0.6639751688226488,0.856583590648434,1.14213863685907,2196,1,DRAXIN
SKELETAL MUSCLE ADAPTATION%GOBP%GO:0043501,0.5456859592711679,0.817297924969912,0.5720430107526879,0.9611061175273399,4072,2,CFLAR|IREB2
INTEGRIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0007229,0.00012950012950013,0.00518555396908895,-0.38760509500209006,-2.1533440184683,0,59,ZYX|CDC42|SYK|RCC2|ITGB1|ITGBL1|ADAM9|PRAM1|ITGA10|ITGA11|ITGB2|FGR|ITGB5|PLEK|THY1|BCAR1|ERBB2IP|ILK|PRKD1|MADCAM1|CD47|ABL1|SEMA7A|DOCK1|CEACAM1|HCK|NME2|COL3A1|NEDD9|MYH9|FERMT3|DAB2|COL16A1|ADAM11|FBLN1|ITGB4
REGULATION OF HEPATOCYTE GROWTH FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0048176,0.573913043478261,0.835204333784353,-0.717247463608293,-0.955545842798603,4289,1,INHBB
HISTONE H3-K9 TRIMETHYLATION%GOBP%GO:0036124,0.0701058201058201,0.376178559435536,-0.7394446185423359,-1.44394792854503,529,3,SUV39H1
PHOSPHOLIPID SCRAMBLING%GOBP%GO:0017121,0.852914210870989,0.949296218452153,-0.266899155878123,-0.6865365278427671,6511,6,PLSCR1|PLSCR4
3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE TRANSPORT%GOBP%GO:0046963,0.437508301235224,0.7635570545514341,0.782807675341862,1.04376840859274,3293,1,SLC35B2
REPRODUCTIVE STRUCTURE DEVELOPMENT%GOBP%GO:0048608,0.0212676647544424,0.201150083379966,0.249231160937393,1.5240517317507198,151,82,LRRC6|STRA6|CYP27B1|FGFR2|CITED1|PPARD|TBX3|RAB13|WNT2B|ITGB8|KIT|ROBO2|PTPRN|BMP7|BRCA2|PKD1|SLIT3|ZNF568|EIF2B4|CASP8|ADCYAP1|STOX2|WNT4|MKKS|CUL7|PKD2
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM%GOBP%GO:0072599,0.8893737166324441,0.965159112268525,-0.11597868331952801,-0.749163574544097,6929,107,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|SRP19|RPL35|RPL38|RPS15A|CHMP4A|SEC61A1|SEC61B|SGTB|RPS13|SRP9|SRP68
NUCLEOSOME MOBILIZATION%GOBP%GO:0042766,0.397354497354497,0.738055881986572,-0.545972486440047,-1.06614588985957,3003,3,POLE3
REGULATION OF ANDROGEN RECEPTOR ACTIVITY%GOBP%GO:2000823,0.5617065829079959,0.8282270665374359,-0.41476131982764197,-0.9079992297958951,4291,4,TAF1|HEYL|PARK7
MAINTENANCE OF PROTEIN LOCATION IN PLASMA MEMBRANE%GOBP%GO:0072660,0.8358528428093649,0.945788393670804,-0.585796206440229,-0.780421204942524,6247,1,ANK3
"NON-REPLICATIVE TRANSPOSITION, DNA-MEDIATED%GOBP%GO:0098038",0.7421968388896271,0.909955740610127,0.628584031760035,0.8381319897131279,5587,1,PGBD5
CELLULAR RESPONSE TO MOLECULE OF FUNGAL ORIGIN%GOBP%GO:0071226,0.667023411371237,0.880719592999549,-0.6703242170269079,-0.8930328114162521,4985,1,SYK
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0060317,0.0094142259414226,0.12315086557338001,-0.470876646065196,-1.82717651044929,71,18,SPRY1|EFNA1|NOTCH1|SNAI2|BMP2|TGFBR3|SNAI1|ENG|ACVRL1
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR%GOBP%GO:1902167,0.23203612697569395,0.6157917821375749,0.8854764005293341,1.18066330024589,1746,1,RPL26
NEGATIVE REGULATION OF NLRP3 INFLAMMASOME COMPLEX ASSEMBLY%GOBP%GO:1900226,0.577840300107181,0.837456306123657,0.558312655086849,0.9380373472107499,4312,2,NLRC3|CPTP
KERATINIZATION%GOBP%GO:0031424,0.33285490605428003,0.6971202277372819,-0.250651854237989,-1.09338916184606,2550,26,KRT9|KRT18|PKP2|PERP|CAPN1|PCSK6|KRT7|KRT19
AV NODE CELL ACTION POTENTIAL%GOBP%GO:0086016,0.10221256956698802,0.441073279931729,0.554332895190225,1.4343689473652899,752,6,TRPM4|SCN5A|CACNA1C|CACNB2
NEGATIVE REGULATION OF DOUBLE-STRANDED TELOMERIC DNA BINDING%GOBP%GO:1905768,0.8753177257525079,0.9605179470041941,-0.5650088222320251,-0.752727417831895,6542,1,ERCC4
ARGININE CATABOLIC PROCESS TO PROLINE VIA ORNITHINE%GOBP%GO:0010121,0.750234113712375,0.914180498652832,-0.6301279223643579,-0.839481695226202,5607,1,OAT
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:1905581,0.171132926505704,0.544815916159356,-0.7513370426450521,-1.2503449867879801,1289,2,ANXA2
UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE N-END RULE PATHWAY%GOBP%GO:0071596,0.570502645502646,0.832944927459165,-0.46928421749200394,-0.9163931371659041,4312,3,UBR1|UBR2|UBR3
RRNA PROCESSING%GOBP%GO:0006364,0.606031262968599,0.8488511623671441,0.12982268712394301,0.932121156225078,4380,168,FDXACB1|WDR12|WDR75|IMP4|EBNA1BP2|DDX27|MPHOSPH6|DIS3L2|PIH1D1|TFB1M|BTRC|RPL26|MDN1|EXOSC10|MRPS9|DCAF13|HEATR1|TSR1|PDCD11|WDR18|MTERF4|ISG20L2|RPF1|UTP20|XRN2|C1D|UTP3|PELP1|BMS1|RNMTL1|NOP58|EXOSC8|WDR46|NSUN4|GAR1|RPF2|CIRH1A|ZNHIT6|NSUN3|NOL10|RPS24|UTP6|WBSCR22|MPHOSPH10|GLTSCR2|PIH1D2|MRTO4|POP5|RPS21|DIEXF|DIS3|RPL14|TFB2M|RPS19
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0051057,0.15563343717549302,0.5247242168288571,-0.260264920141326,-1.27372534975851,1198,38,LYN|MAPRE2|LPAR6|RAPGEF1|VAV1|NGF|NOTCH1|GRB2|ARRB1|NOTCH2|FGF10|IGF1|F2R|F2RL3|COL3A1|GPR4|ADGRG1
DOUBLE-STRAND BREAK REPAIR VIA ALTERNATIVE NONHOMOLOGOUS END JOINING%GOBP%GO:0097681,0.58968253968254,0.8414799095069009,-0.46145183378303206,-0.9010984768917709,4457,3,POLQ
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL%GOBP%GO:0010918,0.10068349106204,0.43729853015432596,-0.523601597946265,-1.4312416183061698,765,7,VCP|STOML2|BAD
DIHYDROFOLATE METABOLIC PROCESS%GOBP%GO:0046452,0.7630671265587691,0.9191113740914171,-0.483705256426261,-0.804962896979495,5751,2,DHFR
EMBRYONIC AXIS SPECIFICATION%GOBP%GO:0000578,0.818836782813728,0.9389317625496709,-0.22155959128357197,-0.7173110971298209,6250,11,PLD6|RIPPLY2|BASP1|COBL|SMAD6
AMMON GYRUS DEVELOPMENT%GOBP%GO:0021541,0.522778589454111,0.807051143864932,0.7384759594177329,0.9846580472129759,3935,1,LRP8
RESPONSE TO EPIDERMAL GROWTH FACTOR%GOBP%GO:0070849,0.906682966585167,0.9709695261809209,0.144451591575758,0.654436498554543,6674,28,FOXC1|INPP5K|PTPN12|PDE8A|PLCG1|EGFR|MAPK1|ERBB2|PDPK1|TPR|EEF1A1
RESPONSE TO SALT%GOBP%GO:1902074,0.102815979043877,0.441351847834537,-0.557112128398875,-1.43304247250865,784,6,DAXX|ZC3H12A|HSF1|HNRNPA1|MAPK13|ZNF16
CELLULAR GLUCOSE HOMEOSTASIS%GOBP%GO:0001678,0.0947614714675679,0.42472117157628997,-0.29278939892552397,-1.38717285754154,728,34,GAS6|HK1|HK3|ADCY8|NUCKS1|GPER1|PDK3|TRA2B|PRKACA|NGFR|ERN1
REGULATION OF RRNA PROCESSING%GOBP%GO:2000232,0.46078431372548995,0.774751791105461,-0.29485392263042,-0.9869036866887709,3524,12,NUDT16|RIOK1|TRMT112|DIMT1
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS%GOBP%GO:0002460,0.000127307447485678,0.00518555396908895,-0.388821756505181,-2.35600587167559,0,82,IGHV1OR15-1|IGKV3-11|MICA|IGHV5-51|SLA2|IGHV1-24|CD74|JAG1|IL18|IGHV3-49|BATF|IGHG4|EXO1|IGLL5|RORA|SPN|MYO1G|EBI3|FCGR2B|IGKV2-28|IGHV4-4|IGHV4-61|MEF2C|STAT3|IL18BP|RNF168|C1QB|IGHV1-3|FCER1G|SLC11A1|IGHV3-43|IGHV3-73|C1QA|C1QC|CTSH|HFE|IGKV2D-28|ZP3|IGHV3-15|EXOSC3|TLR4|C1S|IGHV1-18|CD55|IGHG2|IGHA1|C1R|EMP2
POSITIVE REGULATION OF COAGULATION%GOBP%GO:0050820,0.000392464678178964,0.0111294649577428,-0.59656078722601,-2.21705087804404,2,16,PLEK|F3|THBD|PDPN|F2R|THBS1|SERPINE1|ENPP4|TLR4|SERPINF2
MATING%GOBP%GO:0007618,0.227645502645503,0.6097423854621011,-0.6261718319179439,-1.2227548851373502,1720,3,APP|KLK14|TAC1
ANGIOTENSIN MATURATION%GOBP%GO:0002003,0.635323513940032,0.863600910248377,-0.355131677025197,-0.8511828644680931,4830,5,ATP6AP2|CTSZ
NEURAL PLATE DEVELOPMENT%GOBP%GO:0001840,0.982999070261655,0.993436724391485,0.507774591971769,0.6770489029182629,7400,1,PTCH1
PROTEIN SIALYLATION%GOBP%GO:1990743,0.5909523162613779,0.8417378833576942,0.4031875585948271,0.885820237038992,4349,4,ST3GAL4|ST3GAL2|ST6GALNAC2
REGULATION OF MRNA PROCESSING%GOBP%GO:0050684,0.0252609872406238,0.223514802128899,-0.228148329706958,-1.49777346953514,195,115,SF3B4|RBM15B|MBNL1|ZC3H14|CELF2|DHX9|PTBP1|SRSF3|SRPK3|REST|ZFP36L1|SRSF10|HNRNPL|NCBP2|SON|RBM17|SRSF9|HNRNPU|RBMX|CELF1|FMR1|DHX36|MAGOH|SRSF5|SRSF1|PAPOLA|NCBP1|DDX5|SNW1|CTR9|JMJD6|CELF4|RBM15|RNF20|CPEB1|RBM4B|SMU1|RNF40|TRA2B|PABPN1|SRSF2|RBM8A|RBFOX3|NUP98|CPSF7|RBM4|PTCD2
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901021,0.7945615227736229,0.929656485793048,0.179898770443541,0.7528678124390529,5843,22,ANK2|GSTM2|HTT|HAP1|PKD2|CACNB2|STAC2|STAC|CACNA2D1|CACNB3
MODULATION BY HOST OF RNA BINDING BY VIRUS%GOBP%GO:1990968,0.254715719063545,0.6334469481869079,-0.8692655491839442,-1.15807043448032,1903,1,NUCKS1
ENDODERMAL CELL DIFFERENTIATION%GOBP%GO:0035987,0.0217987207936301,0.20407496611832002,-0.366469102346386,-1.6569974508196899,166,29,ITGB2|SOX17|ITGB5|VTN|ITGA5|INHBA|MMP14|CTR9|COL4A2|COL12A1|COL8A1|FN1|MMP9|COL6A1
RIBONUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0034031,0.39632333062990005,0.7377402989373809,0.431845591736601,1.03858617170321,2931,5,NUDT7|ACAT1|ACOT7
MEMBRANE DISASSEMBLY%GOBP%GO:0030397,0.20346093340325103,0.582256180765724,-0.35115292534211406,-1.24232769946406,1551,14,CCNB1|PLK1|VRK1|NEK6|PRKCB
TRNA METABOLIC PROCESS%GOBP%GO:0006399,0.41204283131692404,0.746306769569813,0.147848661344298,1.025766072867,2962,144,SSB|PUS10|PUS7|PARS2|QTRT1|TYW5|GTF3C2|ALKBH8|DARS|GTF3C3|METTL1|SARS2|TRMT44|CARS2|ELAC2|NSUN6|RARS2|ADAT2|DARS2|TSEN34|TPRKB|FARS2|IARS2|GATB|TRMT1|DDX1|ELP3|EXOSC8|CTU1|KIAA1456|GTPBP3|LARS2|AIMP1|NSUN3|GTF3C6|TRMT1L|MOCS3|TRMT61B|POP5|WARS2|HARS2|PUS1|QARS|THG1L|MTFMT|SEPHS1|ANKRD16|THUMPD3|YARS2|QTRTD1|TRUB1|FARSB|TRMT13|VARS2|TRNT1
RESPONSE TO AMMONIUM ION%GOBP%GO:0060359,0.371197588380378,0.7231271705612199,0.213969294634749,1.06024911323524,2708,38,DRD2|PARK2|CHRM4|DRD4|AGRN|CHRNB2|GABRB3|CDK5R1|HRH3|CHRM3|CHRNA3|SRR|MAPK1|ATF4|RGS10|CASP3|GNA11|CHRM1|GNB1|GABRG2|HRH1
REGULATION OF CHROMATIN ASSEMBLY%GOBP%GO:0010847,0.556864284779479,0.82577269163977,-0.4159644722389229,-0.91063318192823,4254,4,SIRT6|PARP10|SPTY2D1
RRNA CATABOLIC PROCESS%GOBP%GO:0016075,0.587912087912088,0.8414799095069009,-0.24203249035575503,-0.899486450917396,4493,16,XRN1|EXOSC7|EXOSC4|SLFN13|PELO|EXOSC3|EXOSC2
SPLICEOSOMAL COMPLEX ASSEMBLY%GOBP%GO:0000245,0.0940236991241628,0.423823212083631,-0.25303450302750896,-1.3657710218403798,729,53,SETX|SMN2|SF3A3|SRSF12|SF3A2|SNRPE|PSIP1|CELF2|TXNL4A|SRPK3|SF3A1|SRSF10|SLU7|DDX23|SRSF9|LUC7L3|CELF1|SRSF5|ZRSR2|SRSF1|NCBP1|SNRPD1|SF1|CELF4|ISY1|SMN1|PRPF19
TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0034142,0.0031372549019607803,0.0571886039479394,-0.57934490461852,-1.93912164074898,23,12,ITGB2|PIK3AP1|TICAM2|IRAK1|LGALS9|TLR4|ITGAM|CD14|LY96
5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0042791,0.5416044522872271,0.815622645995152,0.35369540810415795,0.9152076570094301,3989,6,GTF3C2|GTF3C3|GTF3C6
REGULATION OF EXCITATORY SYNAPSE ASSEMBLY%GOBP%GO:1904889,0.16642316376676902,0.5386230242605929,0.9186700485222759,1.22492255093074,1252,1,VSTM5
T CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002457,0.14955505379200398,0.51590227091171,0.9274371415968241,1.23661228657674,1125,1,RFTN1
INSULIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0008286,0.16217262288736903,0.53309662716112,-0.220005264129876,-1.24413224652825,1256,63,APC|ATP6V1D|ATP6V0A1|PIK3C2A|AP3S1|TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|CAV2|ATP6V1F|INS|BCAR1|FOXC2|ATP6V0D1|GRB2|IRS1|PIK3R3|ATP6V0E1|RARRES2|ATP6AP1|ATP6V0E2|ATP6V1A|ATP6V1G1
MHC CLASS I PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0002397,0.24294314381270896,0.626082056933819,-0.8755513895015441,-1.1664446831026298,1815,1,CALR
REGULATION OF CONNECTIVE TISSUE GROWTH FACTOR PRODUCTION%GOBP%GO:0032643,0.740603001726657,0.909493931144346,0.6293008381120421,0.8390877542628009,5575,1,ROCK2
CELL CYCLE DNA REPLICATION%GOBP%GO:0044786,0.0347068763811257,0.266191770413233,-0.330702177332235,-1.56679540314181,266,34,RFC2|RPA2|RFC3|DONSON|CDT1|POLD4|PCNA|GMNN|POLD1|CDC45|POLD2|RFC5|GINS1|POLA1|RFC4|POLA2|FEN1
FORELIMB MORPHOGENESIS%GOBP%GO:0035136,0.0850229791835631,0.40376145987147494,0.616086224455593,1.4816838368624499,628,5,TBX3|CACNA1C|TFAP2B
RECEPTOR TRANSACTIVATION%GOBP%GO:0035624,0.3859529955169129,0.7332167375750358,0.4774483187440779,1.04897428967733,2840,4,ADAM17|NCOA3
RELEASE OF MATRIX ENZYMES FROM MITOCHONDRIA%GOBP%GO:0032976,0.448797981139594,0.768229288546963,0.7768526687251879,1.03582821079546,3378,1,BAX
NEGATIVE REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002740,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|LILRB1
CARBON CATABOLITE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0000429,0.456216931216931,0.7711961414599979,-0.5224370281736439,-1.02018710490266,3448,3,USF1|USF2
"G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY, COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER%GOBP%GO:0007187",0.0383329045536403,0.27941515506727005,-0.21982993064980302,-1.4412647968849799,297,114,ADGRE2|FPR1|MARCO|ADCY8|PDE4D|CALCB|OXER1|PTGER4|CALCRL|AKAP5|TBXA2R|PDE2A|ADCY4|FLNA|ADGRL4|GNAI2|CHRM2|GNAQ|CCL2|GPER1|CCR1|INSL3|GNA15|ADGRE5|CHGA|ADRA2C|HTR1B|ADGRG1|PTGIR|ANXA1|ADGRL1|SSTR2|ADCY9|ADGRB1
NEGATIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0031333,0.450481695568401,0.7687932540972091,-0.166698543763532,-0.99856367335564,3506,79,DYRK1A|SMAD6|INS|DDX3X|THRA|PTGER4|PARK7|TUBB4A|LDLRAD4|KANK3|GSN|SLIT2|CRYAB|PRRT2|DACT1|EPS8|STYXL1|TMSB4X|INSIG1
LYSYL-TRNA AMINOACYLATION%GOBP%GO:0006430,0.75242396068535,0.915314007578303,0.624448610498456,0.832617963465015,5664,1,KARS
HISTONE METHYLATION%GOBP%GO:0016571,0.825529185375241,0.942692811039289,-0.141566428332804,-0.755927736881008,6434,51,WDR5|PRMT3|PAGR1|HIST1H1C|PRMT5|NTMT1|SUV39H1
LYSOSOME LOCALIZATION%GOBP%GO:0032418,0.717655078391275,0.900060477413567,0.18242606728905103,0.8164473602467801,5263,27,KIT|NDEL1|VPS33B|MAP6|NR4A3|SNAP23|VPS33A|LOH12CR1|HDAC6|HPS6|PIK3CD|DEF8|C17orf59
POSITIVE REGULATION BY ORGANISM OF DEFENSE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052510,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
PRESYNAPTIC MEMBRANE ASSEMBLY%GOBP%GO:0097105,0.560200895887064,0.827091649887284,0.34776345209935394,0.8998583721947371,4126,6,PTPRD|NLGN2|NLGN4X
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009148,0.48303524460810104,0.787078399497453,-0.402757355777015,-0.965332528620225,3672,5,CTPS1|CMPK2
PSEUDOPODIUM ASSEMBLY%GOBP%GO:0031269,0.850312126444415,0.949296218452153,0.573886193206881,0.765199802538091,6401,1,SRGAP2C
TELOMERE MAINTENANCE VIA BASE-EXCISION REPAIR%GOBP%GO:0097698,0.0705016722408027,0.3767214120425879,-0.963277459197177,-1.28331687220876,526,1,APEX1
RESPONSE TO GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR%GOBP%GO:0097012,0.131919905771496,0.491539110043253,-0.62026101725221,-1.3578810246130602,1007,4,CD4|NPR2|PDE1B
NEGATIVE REGULATION OF T-HELPER 17 CELL LINEAGE COMMITMENT%GOBP%GO:2000329,0.0848718289281445,0.40376145987147494,0.958204675782973,1.2776366418627,638,1,LOXL3
POSITIVE REGULATION OF DNA CATABOLIC PROCESS%GOBP%GO:1903626,0.9084941050375129,0.971496795604459,0.38340226082161605,0.64416530125001,6780,2,BAX|ST20
INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0030520,0.9808215451577801,0.993436724391485,0.15287702954361598,0.5195992885393529,7210,12,RBFOX2|DDX17|POU4F2|EGLN2|TADA3|DDX54
REGULATION OF MELANOCYTE DIFFERENTIATION%GOBP%GO:0045634,0.638730243060167,0.865463150027443,0.6783193647992939,0.9044473453904301,4808,1,ZEB2
NEGATIVE REGULATION OF NON-CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:2000051,0.967592592592593,0.9912626134248801,-0.285871842946951,-0.558235255354647,7314,3,ZNRF3|RNF213|SFRP4
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION%GOBP%GO:0010608,0.255772190867111,0.6348055504295711,-0.135832746299242,-1.09432079547038,1993,349,FMR1|DHX36|DDX3X|PDE12|MAPKAPK2|RPS4X|ZNF540|HNRNPA2B1|STAT3|GCNT2|WIBG|FXR1|NCBP1|COA3|HNRNPM|RPL10|MALSU1|CLP1|SLC11A1|CALR|HSPB1|UQCC2|AARS|GLE1|TNRC6C|E2F1|RAN|EIF3B|EIF4G2|TNFSF13|DKC1|DHFR|BCL3|GAPDH|UNK|CPEB1|NUP214|PAIP2|RBM4B|EIF5|THBS1|MIF4GD|EIF4A3|TCOF1|UBC|EXOSC3|CCRN4L|IGFBP5|EIF2S1|EIF2B2|YBX3|POLR2G|CSDC2|RPS6KB1|EIF4A2|VIM|APEX1|SHMT2|ZNF385A|RBM4|CAPRIN1|NCK1|EEFSEC|PPP1CA|WTIP|EXOSC2|RPS6KB2|HNRNPA0|MRPS27|HNRNPC|EIF4G1
REGULATION OF LIPID LOCALIZATION%GOBP%GO:1905952,0.0459770114942529,0.30746333312705,-0.24134100184454998,-1.4564427598350802,359,81,OSBPL11|TRIAP1|SREBF2|TSPO|AGT|MSR1|P2RX4|LRP1|APOC1|TNFRSF11A|PNPLA2|C3|PRELID1|ABCG1|IKBKE|PLA2R1|POMC|EHD1|CETP|SPP1|GHRL|ABHD5|NR1H3|APOE|NFKBIA|THBS1|HNRNPK|FITM2|PPARG|PPARA|NFKB1|ANXA2|C1QTNF1
EIF2ALPHA PHOSPHORYLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036492,0.857583065380493,0.9495815083844671,0.416322029225255,0.699474762611473,6400,2,EIF2AK3|EIF2AK4
PROTEIN PROCESSING%GOBP%GO:0016485,0.000254744618519934,0.00819882332206558,-0.32213522076732204,-2.02595436391584,1,95,KLK1|HM13|CTSS|CPE|AEBP1|NGF|PMPCA|OGT|PLAU|CPZ|GGT1|CASP1|PCSK1|METAP2|CPM|ATP6AP2|F3|PERP|MMP14|SRGN|IFI16|SEC11C|C10orf54|CTSZ|CTSH|CYFIP2|CIDEB|PCSK6|ASPH|IMMP1L|FXN|FADD|C1RL|STOML2|PLAT|CPXM2|BACE2|LGMN|PGK1|C1R|UQCRC2|BAD
GLUTAMINYL-TRNA AMINOACYLATION%GOBP%GO:0006425,0.589764201500536,0.8414799095069009,0.55296388199614,0.9290507178103109,4401,2,QARS|LARS
POSITIVE REGULATION OF FIBRONECTIN-DEPENDENT THYMOCYTE MIGRATION%GOBP%GO:2000415,0.511571906354515,0.801504475859147,-0.7476290251433609,-0.996021377806446,3823,1,ADAM8
PURINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009206,0.0829469345698094,0.40084160589746504,-0.257774020167934,-1.3913528894926501,643,53,ATP5J|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|PGAM1|GAPDH|LDHA|STOML2|ATP5H|PGK1|ALDOA|ALDOC|ATP5G1
PROTEIN AUTOUBIQUITINATION%GOBP%GO:0051865,0.8512557236020541,0.949296218452153,0.13784695070414002,0.743467071262749,6134,51,TRIM17|PARK2|MARCH5|RNF112|TRIM13|UBE3D|SH3RF3|BFAR|SH3RF1|DDB2|STUB1|MARCH7|RNF185|RNF41|UHRF2|RNF146|WWP2|RNF4|MDM2|RNF8|LRSAM1|RNF187|UBE2D3|RNF115
POSITIVE REGULATION OF HIPPO SIGNALING%GOBP%GO:0035332,0.960075026795284,0.9897785432492959,0.337303556658395,0.566713526211176,7165,2,DLG5|SOX11
APOPTOTIC PROCESS INVOLVED IN LUTEOLYSIS%GOBP%GO:0061364,0.440472991131416,0.7653693162885199,0.5187261672588429,1.0202731572830601,3277,3,ROBO2|SLIT3
PURINE RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009180,0.30083676451055896,0.673988937137548,0.8507940008822229,1.13441900011172,2264,1,AK5
SUCCINATE TRANSPORT%GOBP%GO:0015744,0.937248051599033,0.9806508984207809,0.308320575209864,0.6064301872161519,6974,3,SLC25A30|SLC25A14
NEGATIVE REGULATION OF DEVELOPMENT OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044147,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
NEGATIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA SINGLE-STRAND ANNEALING%GOBP%GO:1901291,0.926982851018221,0.979171896286746,0.36823821339950397,0.6186877436714461,6918,2,OGG1|BLM
PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:0072657,0.47553516819571895,0.784986345464663,-0.122083389253375,-0.991685064555472,3731,368,KCNIP3|ZDHHC9|SPTBN4|ZDHHC4|TRAM1|CPE|ZDHHC12|SYNJ2BP|ATP1B3|GGA2|CHM|GAS6|THY1|RPLP2|RAB29|GOLGA4|TAOK2|SLC9A3R1|TM9SF1|KCNIP4|TESC|RPS14|RPS4X|ARHGAP44|GGA3|RPL35A|MADCAM1|RPS29|VAMP5|KRT18|PKP2|RPL10|S100A10|RPL36A|LIN7C|RPL24|SRP19|FLNA|ROMO1|NKD2|TTC7B|STX1B|TMED2|RAB3C|EPHA2|APOE|RPL35|RPL38|RPS15A|KCNB2|PEX16|UBL4A|CHMP4A|STX3|FAM126A|DLG3|SEC61A1|ZDHHC19|SEC61B|NSF|SSR1|RAB34|TIMM9|SYNE3|SGTB|RPS13|CAV1|TSPAN15|TUB|ARL6IP1|ATG3|ANXA2|HSP90AA1|ZDHHC24|NRXN2|TSPAN33|TNFRSF1A|SRP9|HSPA4|GPHN|ZDHHC2|EHD2|TIMM10|SRP68|BAD|EMP2
EOSINOPHIL DIFFERENTIATION%GOBP%GO:0030222,0.392880860672068,0.737280445732591,0.804642699603,1.0728824671827801,2957,1,GATA2
POSITIVE REGULATION OF HISTONE DEUBIQUITINATION%GOBP%GO:1903586,0.7079598662207359,0.89516234575314,-0.6493162770180861,-0.8650451910206289,5291,1,SART3
'DE NOVO' NAD BIOSYNTHETIC PROCESS FROM TRYPTOPHAN%GOBP%GO:0034354,0.25739130434782603,0.636027662086593,-0.867556241729158,-1.1557932265216202,1923,1,HAAO
REGULATION OF HISTONE METHYLATION%GOBP%GO:0031060,0.657179818887452,0.8757990649871321,-0.17953896002487302,-0.86453033640499,5079,36,BCOR|CHTOP|NSD1|PAXIP1|OGT|BRCA1|SNW1|CTR9|DNMT1|PHF19|H2AFY
REGULATION OF PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:1903214,0.9616381544841891,0.9904035744037719,-0.118007323933216,-0.5827494041457659,7419,39,ABLIM3|USP36|RAC2|UBE2L3|NPEPPS|SREBF2|MICALL2|ATG13|ATPIF1|PDCD5|HAX1|HUWE1|PARL|RHOU
GRANULOCYTE MIGRATION%GOBP%GO:0097530,0.0018179457213348899,0.0365376202561009,-0.37824951859274,-1.9443328698052702,13,45,IL1B|TGFB2|CCL3|SYK|CCL4|CCL8|CXCL1|CXCL2|CCL11|NCKAP1L|CCL19|ITGB2|CXADR|CCL24|IL1RN|PDE4B|CCL3L3|ADGRE2|CCL18|FCER1G|CCL2|LGALS3|CX3CL1|CCL4L2|CCL14|S100A8|S100A9|ANXA1
CELLULAR RESPONSE TO NITROGEN STARVATION%GOBP%GO:0006995,0.477835191732391,0.7850984235874658,0.307687234791657,0.974773957968105,3513,10,GABARAP|MAP1LC3B|ATG5|MAP1LC3A
REGULATION OF NUCLEOBASE-CONTAINING COMPOUND TRANSPORT%GOBP%GO:0032239,0.9852383531961,0.99458733327411,0.134101337063598,0.49464455375532107,7274,15,IWS1|RIPK1|RBM26
SPECIFICATION OF ANIMAL ORGAN IDENTITY%GOBP%GO:0010092,0.40979172301866396,0.7452026710126379,0.37315938811782395,1.03009647471578,3029,7,FGFR2|PAX8
SECONDARY HEART FIELD SPECIFICATION%GOBP%GO:0003139,0.271037822274571,0.6462219082477939,-0.5424364418463571,-1.18750676079051,2070,4,ISL1|BMP4|MESP1|MEF2C
NORADRENERGIC NEURON FATE COMMITMENT%GOBP%GO:0003359,0.21025368574843897,0.591474654268711,0.8964490516100571,1.1952938498908798,1582,1,ASCL1
REGULATION OF RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:2000206,0.847892976588629,0.9492491301138911,-0.5794000882223199,-0.771900039677715,6337,1,RIOK2
NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION%GOBP%GO:0043301,0.0060494476591267795,0.0909118899117954,-0.755349658063093,-1.8104289963959501,45,5,CD84|FCGR2B|CEACAM1|CD300A|LGALS9
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0007264,0.0863484731845009,0.406139467312843,-0.167962056785177,-1.25831490424105,672,226,RAB9A|TRIM28|TAX1BP3|RAPGEF1|RAB7A|RAP2B|GDI1|RAB27B|TNK2|ARHGAP18|PLK2|CDKN2A|WAS|KPNB1|ARHGDIB|RAB24|RREB1|RAB29|RHOF|RERG|SIAH2|ELMO1|GRB2|PRKD1|CTNNAL1|PARK7|RHOG|RHOD|DNMT1|NTN1|RAPGEF3|HRAS|IGF1|ARHGAP31|PLD1|ARHGAP1|RHOJ|PDPN|RND1|RAB3C|RAP1A|RAB7B|CDC42EP4|RUNDC3A|ARFIP2|COL1A2|RAB1B|AIF1|RAB34|CFL1|RAB9B|RABL3|ADGRG1|RAB20|TIAM1|EPS8|RRAS|CDC42EP1|RHOU|CDC42EP5|G3BP1|ARHGDIA|DBNL|NGFR|RAB33A|CDC42EP2|RAPGEF5
NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION%GOBP%GO:1901164,0.0248677248677249,0.22165467789795001,-0.806275504577038,-1.5744517107523701,187,3,ARHGDIB|CALR|TIMP1
NEGATIVE REGULATION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY%GOBP%GO:0051344,0.0204983922829582,0.197065764462746,0.9062682919738929,1.52264774355181,152,2,MAPK7|EGLN1
NEGATIVE REGULATION OF RAS GTPASE BINDING%GOBP%GO:1904476,0.844468056846859,0.948285501480553,0.5761468901632111,0.7682141368870591,6357,1,FAM65B
D-AMINO ACID METABOLIC PROCESS%GOBP%GO:0046416,0.517332979147297,0.8044682962948779,0.740902073224526,0.9878929426118679,3894,1,SRR
COPPER ION EXPORT%GOBP%GO:0060003,0.282640456899987,0.655069746883962,0.861215262461403,1.14831434625696,2127,1,ATP7A
POSITIVE REGULATION OF HISTONE H3-K36 TRIMETHYLATION%GOBP%GO:2001255,0.97519235871584,0.9925123311635341,-0.326606010476978,-0.5435246296616231,7350,2,WHSC1L1|BRD4
HISTONE H2A ACETYLATION%GOBP%GO:0043968,0.23733263323707,0.6217158626397761,-0.329820108155833,-1.1975233492777801,1807,15,BRD8|MORF4L1|EPC1|MSL3|MEAF6|EP400|TRRAP|ACTL6A|DMAP1|RUVBL2|ING3|NAA40|YEATS4|RUVBL1|MORF4L2
VENTRAL SPINAL CORD INTERNEURON FATE COMMITMENT%GOBP%GO:0060579,0.9161515721580219,0.9747758552206228,0.321016054675281,0.631400697159484,6817,3,ASCL1
BONE CELL DEVELOPMENT%GOBP%GO:0098751,0.15219384413883402,0.519849132875151,-0.5180593946797499,-1.33258832111921,1161,6,FOXP1|ANXA2|ZNF385A
REGULATION OF TRANSFORMING GROWTH FACTOR-BETA SECRETION%GOBP%GO:2001201,0.246617139824887,0.6280519349499749,-0.7100082712985942,-1.18156730230003,1858,2,LILRB1|FN1
POSITIVE REGULATION OF CELL CYCLE G1/S PHASE TRANSITION%GOBP%GO:1902808,0.00117724002616089,0.0261694927157725,-0.451567864985008,-2.06177046500238,8,30,LSM11|CCND2|PLCB1|EZH2|CDC6|STXBP4|LSM10|DDX3X|CDC45|FGF10|RPTOR|HYAL1|AIF1|CCND3|PAGR1|ANXA1|CCND1|EIF4G1
NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY%GOBP%GO:1903306,0.0326172386691119,0.25785422561312804,-0.508487239557567,-1.64625479569837,248,11,REST|CD84|SYT4|FCGR2B|FMR1|CEACAM1|CD300A|LGALS9
NEGATIVE REGULATION OF BLOOD VESSEL MORPHOGENESIS%GOBP%GO:2000181,0.000128799587841319,0.00518555396908895,-0.385966934346176,-2.2495535100978197,0,71,DAB2IP|SARS|KLF4|HGS|SEMA6A|SYNJ2BP|E2F2|DCN|NOTCH1|FAM129B|TBXA2R|MMRN2|CREB3L1|MECP2|GHRL|SPARC|SULF1|COL4A2|HDAC5|MEOX2|STARD13|NPR1|ECSCR|EFNA3|THBS1|TEK|THBS2|SEMA3E|SERPINE1|STAB1|PPARG|PGK1|NGFR|SERPINF1|CARD10|ADGRB1
REGULATION OF MESONEPHROS DEVELOPMENT%GOBP%GO:0061217,0.320715036803365,0.688713916558678,-0.409798099057587,-1.12016482908855,2439,7,AGT|BASP1|SMO|GATA3
POSITIVE REGULATION OF ACTIN BINDING%GOBP%GO:1904618,0.24334448160535102,0.626082056933819,-0.8750551389501541,-1.1657835582114,1818,1,ABL1
CYSTEINYL-TRNA AMINOACYLATION%GOBP%GO:0006423,0.7671796232422391,0.9202818175694271,-0.48055042593984404,-0.799712754554772,5782,2,CARS
CELLULAR RESPONSE TO ALCOHOL%GOBP%GO:0097306,0.8934268426842691,0.96560999423704,0.14026849345339998,0.6842361540879899,6496,36,SFRP1|SPIDR|ADCY2|GRAMD1B|ADCY3|ADCY6|LRP6|CTNNA1|ADCY1|AKR1C2|ADCY7|GNB1|GRAMD1A|AKR1C3|GPLD1|GNAI1|CTNNB1|IREB2|ADAM15
COENZYME A CATABOLIC PROCESS%GOBP%GO:0015938,0.206136273077434,0.5859847786236589,0.898434053815615,1.19794058248997,1551,1,NUDT7
REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS%GOBP%GO:0003339,0.30395055092717,0.676707700393746,0.585816936009131,1.15223278218328,2261,3,PAX8|STAT1
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:1900746,0.392323814514016,0.737280445732591,-0.322626691981643,-1.04452127325204,2994,11,ROBO1|KIAA1462|DAB2IP|SEMA6A|DCN|SMOC2|CD63|CCBE1
PROTEIN TRANSPORT INTO MEMBRANE RAFT%GOBP%GO:0032596,0.681806002143623,0.885390825805735,0.5052760749637659,0.8489290447739231,5088,2,RFTN1
COMPLEMENT-DEPENDENT CYTOTOXICITY%GOBP%GO:0097278,0.964669942887502,0.990916952887267,0.517423908248787,0.689914964163859,7262,1,RAB27A
BASOPHIL DIFFERENTIATION%GOBP%GO:0030221,0.290836120401338,0.663296678175849,-0.851786501985002,-1.13478414664459,2173,1,TAL1
NEGATIVE REGULATION OF INTERLEUKIN-6 BIOSYNTHETIC PROCESS%GOBP%GO:0045409,0.83510214911117,0.945788393670804,-0.440570135788521,-0.733179158413883,6294,2,GHRL
RESPIRATORY SYSTEM DEVELOPMENT%GOBP%GO:0060541,0.538629538629539,0.8142313733497609,0.18430774240592604,0.949393321230504,3945,43,STRA6|NPHP3-ACAD11|FGFR2|LOXL3|ASCL1|PKD1|ATP7A|NPHP3|ATXN1L|CCDC40|SKI|CHD7|LRP6|FOXJ1|PROX1|BMPR2
POSITIVE REGULATION OF PEPTIDYL-TYROSINE PHOSPHORYLATION%GOBP%GO:0050731,0.000256443133735094,0.00819882332206558,-0.339182890954059,-2.0887045890790303,1,88,PTPN1|CSPG4|LIF|CD40|ARHGEF2|CTF1|RIPK2|PAK2|TNF|THBS4|PARP14|CD44|TGFB1|GREM1|LYN|STAP2|CD74|TNFRSF14|IL18|AGT|SOCS3|PARP9|HCLS1|HGF|TNK2|TNFRSF18|GAS6|IL6ST|HES1|VTN|ITGA5|EFNA1|STAT3|HAX1|OSM|FGF10|ABL1|IGF1|NTRK2|TREM2|GPRC5B|FGF7|DLG3|EPHA4|NEDD9|IL11|CSF1R|TNFRSF1A|CD81|PDGFB|EFNA5|PTPRJ|PRNP
STRIATED MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010658,0.131225926417851,0.490819490032838,0.935818262020291,1.24778737977291,987,1,GNGT1
UTP METABOLIC PROCESS%GOBP%GO:0046051,0.246114683815648,0.6280519349499749,0.709828202136534,1.1926030292183798,1836,2,CAD|AK3
RESPONSE TO DRUG%GOBP%GO:0042493,0.000384664700602641,0.0111294649577428,-0.208609724117025,-1.66474540446545,2,328,APOD|JUNB|NCKAP1L|VAV3|PLCB1|NR3C1|CCL19|SLAMF8|HSP90B1|REST|DCPS|UBE2B|HMGB2|IMPACT|RYR2|JUP|SLC19A1|ECT2|SLC36A1|NDOR1|PPM1F|PPIF|KDR|P2RX4|SLC13A3|SLC7A2|TOP1|TMBIM6|SLC22A3|NDNL2|HP|CYP1B1|IRF5|AHR|SLC25A10|SLC25A18|LARP1|P2RX3|HLCS|GRIN3A|GAS6|TGFB3|GPX1|PDE4B|GRIN1|ERBB2IP|KYNU|TNFAIP3|FMR1|ADCY8|SLC1A2|INHBA|PDXP|CRHBP|MEF2C|ATP8B1|PARK7|ABCC9|BRCA1|PDE2A|MAPK3|TAF7|DPEP1|GHRL|ABL1|HMOX1|SOD1|SRP19|SLC1A3|SLC25A22|NR1H3|SLC6A8|CTPS1|RBM22|CHRM2|WBP2|GNAQ|KAT7|DHFR|PDPN|KCNQ1|CAT|USP47|SLC35F3|COQ7|GATA6|CHRNE|GNA15|SLC7A3|ADIRF|TGFBR2|THBS1|FXN|MT2A|HTR1B|SLIT2|CAV1|MYC|RELA|SIGMAR1|YAP1|MAPK13|NFKB1|KCNH2|VIM|ARL6IP5|ADRBK1|SLC25A42|PRAF2|ACTB|PNP|LY6H|CYGB|ANXA1|FOLR2|CCND1|TFRC|NET1|PDGFB|SRP68|SIRPA|BAD|ABCC1
REGULATION OF PEPTIDE HORMONE SECRETION%GOBP%GO:0090276,0.17874086421336102,0.55175028994035,-0.188209428564371,-1.19712843704603,1393,100,ITPR2|PIM3|STX4|STXBP4|GIPR|ITPR3|SLC2A1|SLC8B1|CDK16|SYT7|INS|ADCY8|SLC25A6|CRHBP|IRS1|ENSA|GHRL|RAPGEF3|UQCC2|DPP4|LRP5|GPER1|HFE|CACNA1E|RAP1A|NOV|CHGA|ADRA2C|NR1D1|ARL2|SLC25A4|SIRT4|EFNA5|BAD|SLC25A5
GLANDULAR EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0002067,0.100081146875845,0.43605057892447596,0.521353929159173,1.43918352748642,739,7,FGFR2|DLL1|INSM1
REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS%GOBP%GO:0090189,0.7274939172749392,0.90579856882868,0.325439133033177,0.782679248710489,5381,5,PAX8
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0045912,0.79798640167364,0.930993504622554,-0.17748095188880803,-0.75428904198761,6102,24,TGFB1|FAM132A|PGP|CBFA2T3|PLEK|INS|CLTC|PPARA|SIK1
NEGATIVE REGULATION OF PROTEIN MATURATION%GOBP%GO:1903318,0.000130770236694128,0.00518555396908895,-0.6358516163809449,-2.6332269867511897,0,22,CARD16|CAST|CTSZ|TMEM59|GAS1|SERPINE2|A2M|THBS1|XIAP|SERPINE1|BCL2L12|CD55|SERPING1|SERPINF2|PRNP
PLATELET MORPHOGENESIS%GOBP%GO:0036344,0.734366857738405,0.9079405785880958,-0.25955276998609805,-0.780798263483931,5636,9,MEF2C|MYH9|ACTN1
NEGATIVE REGULATION OF ATP CITRATE SYNTHASE ACTIVITY%GOBP%GO:2000984,0.309966555183947,0.680816461591689,-0.842137185707984,-1.12192894042613,2316,1,PHPT1
PHOSPHATIDYLSERINE EXPOSURE ON BLOOD PLATELET%GOBP%GO:0097045,0.843671138265374,0.948285501480553,0.576973974415527,0.769316942136682,6351,1,ANO6
CYTOLYSIS%GOBP%GO:0019835,0.0673995550320639,0.371075653877479,-0.674240335300281,-1.47605303552508,514,4,PRF1|GSDMD|APOL1|ROMO1
MULTI-ORGANISM METABOLIC PROCESS%GOBP%GO:0044033,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009127,0.256601829189746,0.634929462604421,-0.198797400822257,-1.14166518678402,1991,67,ATP5J|GPI|ATP5F1|IMPDH2|PFKFB2|HK1|ATP5B|HK3|ENO1|ATP5O|PGAM1|HPRT1|GAPDH|GMPS|LDHA|STOML2|ATP5H|PGK1|ALDOA|ALDOC|ATP5G1
CORTICAL COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072059,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
POSITIVE REGULATION OF EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX ASSEMBLY%GOBP%GO:1905537,0.007759197324414721,0.10744152749969199,-0.9961954124393471,-1.32717148999403,57,1,EIF4G1
POSITIVE REGULATION OF DENSE CORE GRANULE BIOGENESIS%GOBP%GO:2000707,0.7419739984080659,0.909955740610127,-0.495611587995307,-0.8247769366759591,5592,2,CHGA
HISTONE H3-K4 TRIMETHYLATION%GOBP%GO:0080182,0.9045502092050209,0.9698755111576809,-0.20063408052888698,-0.628560383434844,6917,10,OGT|CTR9|HIST1H1C
VEGF-ACTIVATED PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038086,0.00264550264550265,0.049561277502453996,-0.902000429578198,-1.76137822789713,19,3,PDGFRB|PDGFRA
REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL%GOBP%GO:1904997,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|KLF4
FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION%GOBP%GO:0021861,0.9873053265279409,0.996026042435992,-0.22868205692356897,-0.500632825744284,7543,4,HES1
MICROVILLUS ASSEMBLY%GOBP%GO:0030033,0.83744100681699,0.946216977301937,-0.19883114707519398,-0.703435522535004,6387,14,RAP2B|SLC9A3R1|RAP1A|FXYD5
POSITIVE REGULATION OF T-HELPER CELL DIFFERENTIATION%GOBP%GO:0045624,0.39478852952730104,0.7377402989373809,-0.304109172654074,-1.0468027457054399,3014,13,MYB|IL12RB1|MALT1|RARA|NFKBIZ|IL18|CCL19|CD86|NLRP3|ANXA1
REGULATION OF P38MAPK CASCADE%GOBP%GO:1900744,0.7588633993743481,0.917242163810958,-0.169694314472779,-0.789351056983991,5821,32,NCF1|RASGRP1|PTPN22|CYLD|PJA2|ZC3H12A|IL1B|DUSP1|PRMT1|DAB2IP|EMC10|PHLPP1|GADD45B|SASH1|GADD45G|BMP2|LGALS9
WATER TRANSPORT%GOBP%GO:0006833,0.7685658153241651,0.920666796931899,-0.29243369609882297,-0.7522182439407601,5867,6,AQP1|HYAL2|AQP3|PDPN
NEGATIVE REGULATION OF HYPOXIA-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903298,0.867163983771758,0.9557502153097349,-0.30946146084506604,-0.677475826857723,6625,4,TMBIM6|ENO1
RESPONSE TO SINGLET OXYGEN%GOBP%GO:0000304,0.768294314381271,0.920474726214876,-0.620368328187031,-0.8264795723652429,5742,1,FYN
VESICLE FUSION TO PLASMA MEMBRANE%GOBP%GO:0099500,0.222425988996594,0.604959238589686,-0.37942665735429293,-1.2284142170977599,1697,11,SNAP47|STX4|STX11|STX1B|STX3|PRRT2
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:1904754,0.16584222858630598,0.537721321518182,-0.45543925590462697,-1.3111458742705702,1273,8,DOCK5|FGF9|IGFBP5|PDGFB
REGULATION OF RECEPTOR INTERNALIZATION%GOBP%GO:0002090,0.611179277436946,0.8515889287679592,0.19869739914632603,0.88926966102862,4482,27,DKK1|PICK1|AHI1|ARRB2|MTMR2|FLOT1|DLG4
REGULATION OF PIGMENT CELL DIFFERENTIATION%GOBP%GO:0050932,0.27250739048642797,0.646838884025475,0.602128598213301,1.1843158968361,2027,3,BLOC1S5|ZEB2|BLOC1S6
POSITIVE REGULATION OF NEUROGENESIS%GOBP%GO:0050769,0.467559217301751,0.780769690730001,-0.134057533487382,-0.9958383946728789,3631,216,KDM1A|CAMK1|IMPACT|ECT2|DAB2IP|FZD4|AMIGO1|NUMB|P2RX4|RAPGEF1|PLXND1|SEMA6A|SYT4|NGF|COBL|FES|BRINP3|HES1|ARSB|GOLGA4|FMR1|DHX36|CPNE6|CXCR4|NOTCH1|MEF2C|SMARCD3|PRKD1|DSCAM|TRIM32|DBN1|SNW1|CPNE5|CAMK2B|NTN1|NTRK2|NSMF|MAP3K13|SEMA7A|GPRC5B|CSF1|GPER1|SCARF1|APOE|RAP1A|SERPINE2|BMP2|ADRA2C|SEMA5A|NBL1|SLIT2|CX3CL1|SCN1B|SEMA3A|PLAA|S100A9|STYXL1|MARK2|CAPRIN1|ARHGDIA|NGFR|SERPINF1
REGULATION OF JUN KINASE ACTIVITY%GOBP%GO:0043506,0.741499227202473,0.909955740610127,-0.151496202290922,-0.8177111047394009,5756,53,RIPK2|TNF|MAP4K2|ZNF675|MUL1|HIPK3|ARHGEF5|CCL19|DAB2IP|TNFRSF11A|PKN1|MDFIC|TRAF2|MAPK8IP1|MLKL|MAP3K13|SASH1|MAP3K11|DNAJA1|GSTP1|DBNL|ERN1
CALCIUM ION EXPORT%GOBP%GO:1901660,0.216991057338243,0.599597524514766,-0.519362137656504,-1.244811940545,1649,5,SLC8B1|SLC35G1
NEGATIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035359,0.30827467127108504,0.680258072074676,0.8470445522717249,1.12941961631343,2320,1,ASXL1
TRANSLATION%GOBP%GO:0006412,0.00996677740863787,0.12765645836384498,-0.18308882911999103,-1.44773457275854,77,309,MRPS10|RPS23|MRPL53|AIMP2|MRPS17|FARSA|MRPL37|RPL3|AURKAIP1|GSPT2|IARS|RPL7A|RPS2|EIF2B5|GARS|RPL15|MRPL18|RPL37|MRPL57|GFM2|RPL27A|YAE1D1|RPL18|EIF3J|RPL39|DENR|MRPS18B|RPL27|EIF2S3|MRPS15|MRPL47|SECISBP2|EEF1D|GNB2L1|VARS|GADD45GIP1|MRPS11|MRPL13|ETF1|SARS|OXA1L|GATC|EIF3C|NDUFA7|MRPL10|LARP1|MRPL50|MRRF|EIF2B1|EIF3M|MRPL51|YARS|RPLP2|MRPS34|MRPL9|WARS|DDX3X|RPS14|RPS4X|RPL35A|RPS29|MRPS30|RPL10|RPL36A|RPL24|MRPS23|MRPL41|MRPS6|MRPS18C|EIF1AX|AARS|MRPL38|EIF3B|MRPS22|MRPL52|TNIP1|EEF1G|GFM1|RPL35|MRPL21|FTSJ1|RPL38|RPS15A|MRPS18A|EIF5|MRPS24|MRPL27|MRPL23|MRPS7|MCTS1|MRPL36|ICT1|RPS13|EIF2S1|EIF2B2|CARS|MRPL22|MRPL49|MRPS2|MRPL39|EIF4A2|RPL26L1|MRPL3|MRPL12|MRPS36|ORAOV1|MRPL17|RBM4|IGHMBP2|EEFSEC|EIF2B3|RPS6KB2|MRPS27|RRBP1|MRPL11|EIF2D|TARSL2|EIF4G1|MRPL16
POSITIVE REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 2 SECRETION%GOBP%GO:1904209,0.988179041041307,0.996030692679047,0.5057344508160561,0.674328649969194,7439,1,MBP
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS IB VIA ER PATHWAY%GOBP%GO:0002488,0.954113712374582,0.9870180073166591,-0.522220996912219,-0.695723760543171,7131,1,TAP2
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF BITTER TASTE%GOBP%GO:0001580,0.504057343792264,0.797772889025646,0.342195256480971,0.944620820458121,3726,7,TAS2R5|RTP5|TAS2R14|RTP4|TAS2R19|TAS2R4|TAS2R20
NEGATIVE REGULATION OF AMACRINE CELL DIFFERENTIATION%GOBP%GO:1902870,0.425952981803692,0.7547028278218628,0.7878804587560649,1.05053228079043,3206,1,POU4F2
HYDROGEN PEROXIDE METABOLIC PROCESS%GOBP%GO:0042743,0.3369208557553481,0.699462084003389,-0.26827879504972,-1.0929697427308198,2566,21,GPX1|PARK7|SOD1|CAT|GPX3|PRDX4|PRDX5
POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY%GOBP%GO:0061365,0.292893600314095,0.665416463589539,-0.5316274196216839,-1.1638435516490901,2237,4,GPIHBP1|NR1H2|APOC2|NR1H3
REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0032489,0.34718569174118896,0.7045389340676179,-0.457316128704608,-1.0960994965555502,2639,5,ABL1|APOE
NEGATIVE REGULATION OF NMDA GLUTAMATE RECEPTOR ACTIVITY%GOBP%GO:1904782,0.12830389161907302,0.485234242773114,0.9375275694750771,1.2500665106221298,965,1,EPHB2
REGULATION OF PROTEIN AUTOUBIQUITINATION%GOBP%GO:1902498,0.80735505823845,0.9338972633573359,-0.331361281885586,-0.725419113000518,6168,4,TAF1|MTA1|SASH1
POSITIVE REGULATION OF SERINE C-PALMITOYLTRANSFERASE ACTIVITY%GOBP%GO:1904222,0.595914035553197,0.8445090144443349,-0.5610456329517141,-0.933669651173936,4491,2,SERINC5
TELOMERE CAPPING%GOBP%GO:0016233,0.996338912133891,0.9988721305072571,-0.10012100339375998,-0.42551144181394207,7619,24,TERF2|NBN|TINF2|HIST1H4I|HIST2H4A|HIST2H4B
STRIATED MUSCLE CONTRACTION%GOBP%GO:0006941,0.242272024729521,0.625158460820442,-0.21502449608199398,-1.1606094118424999,1880,53,ATP1A1|GJC1|RCSD1|GPD1L|MYH3|SCN4B|TNNT2|GJA1|PGAM2|RYR2|ATP1B1|GAA|TNNI2|TNNC2|KCNN2|STAC3|MYLK2|PKP2|CACNA1G|KCNQ1|SCN1B|KCNH2|KCNE4|ADRBK1|ALDOA
DADP CATABOLIC PROCESS%GOBP%GO:0046057,0.154247491638796,0.5225398777782271,-0.9210961623290691,-1.22712125645377,1152,1,NUDT18
DENTATE GYRUS DEVELOPMENT%GOBP%GO:0021542,0.636244082062073,0.8638876972230859,-0.354756501048239,-0.850283639241489,4837,5,PTEN|CDK6|TMEM108
NEUROINFLAMMATORY RESPONSE%GOBP%GO:0150076,0.0249082328264289,0.221777012816392,-0.47487414987769105,-1.6800352996568102,189,14,CLU|APP|MAPT|TNF|PSEN1|ITGB2|LRP1|AZU1|ADCY8|AIF1|CX3CL1|ITGAM
NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS%GOBP%GO:1900077,0.0906119246861925,0.41591576627717103,-0.33227433022238106,-1.41215653597314,692,24,SLA2|KANK1|SOCS3|PID1|IRS1|SOCS1|CISH|PTPRE|RPS6KB1|NCK1|PRKCB|GRB10
MODULATION BY SYMBIONT OF HOST APOPTOTIC PROCESS%GOBP%GO:0052150,0.683955925826391,0.885415243771438,0.41850115188845294,0.8231423793794559,5089,3,CASP8|BCL2L1
THYMIDINE METABOLIC PROCESS%GOBP%GO:0046104,0.844973544973545,0.9483976196751529,-0.35777455627134597,-0.6986430308094139,6387,3,TK1
ESTABLISHMENT OR MAINTENANCE OF APICAL/BASAL CELL POLARITY%GOBP%GO:0035088,0.8033165692537719,0.932964969466025,0.163576301213992,0.7573086232837181,5909,30,PARD3|DLG2|CAMSAP3|WDR1|MYO9A|LRRC7|MTCL1|FOXJ1|EZR|PDCD6IP|CLIC4
BMP SIGNALING PATHWAY INVOLVED IN NEPHRIC DUCT FORMATION%GOBP%GO:0071893,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR%GOBP%GO:1902253,0.705473159207245,0.894639008000397,-0.20197018340419895,-0.8228279814424939,5374,21,TAF9B|TAF9|ZNF385A|AK6
NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION%GOBP%GO:0031115,0.49728555917481,0.794989907195277,0.291925849747266,0.9606152998537809,3663,11,INPP5J|STMN2|MAP2|SNCA|STMN1|EML2|CLIP3|MAPRE1
PROSTHETIC GROUP METABOLIC PROCESS%GOBP%GO:0051189,0.214931237721022,0.5979177134734279,-0.4827031430633689,-1.2416425174789398,1640,6,MOCS2|MBIP|GPHN
REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002604,0.30783385909568894,0.67948577039568,-0.41542250171253703,-1.1355388829292,2341,7,CCL19|FCGR2B|SLC11A1|THBS1
HYPOXANTHINE SALVAGE%GOBP%GO:0043103,0.0795967100026532,0.395856190496679,-0.8212848083815829,-1.3667492544623,599,2,ADA|HPRT1
"NEGATIVE REGULATION OF RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:1904153",0.9360843530330641,0.9806508984207809,-0.20703788538017298,-0.596033094895894,7190,8,UBE2G2|DERL3
GLOMERULAR VISCERAL EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072112,0.273058884835852,0.647246599153167,-0.38817710075281797,-1.16773173412197,2095,9,NUP93|IQGAP1|JAG1|BASP1|KLF15|MYO1E
MIDBRAIN-HINDBRAIN BOUNDARY DEVELOPMENT%GOBP%GO:0030917,0.7332529474812428,0.907913422943088,0.48090660170983895,0.807985183237271,5472,2,LRP6|KDM2B
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION%GOBP%GO:1903748,0.31207259337190996,0.68160868787154,-0.472755349658063,-1.13310436310646,2372,5,BAG4|SIAH3|LMAN1|MAPT|DNAJA1
RESPONSE TO ATP%GOBP%GO:0033198,0.7760784313725491,0.9241536998094619,-0.223980779460969,-0.7496846405347749,5936,12,SSH1|HSP90B1|P2RX4|P2RX3|PDXP
SUBSTANTIA PROPRIA OF CORNEA DEVELOPMENT%GOBP%GO:1903701,0.7014046822742479,0.8931369333627571,-0.652183502426114,-0.8688650237255441,5242,1,TGFB2
"MATURATION OF 5.8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000466",0.97213825732685,0.9915747942934481,-0.13556887546881502,-0.535619979516479,7396,19,EXOSC3|EXOSC2
POSITIVE REGULATION OF BILE ACID BIOSYNTHETIC PROCESS%GOBP%GO:0070859,0.6616500940607359,0.8792094365513811,0.42688625038961603,0.839634878624521,4923,3,STARD4|STAR
POSITIVE REGULATION OF MITOTIC CELL CYCLE%GOBP%GO:0045931,0.000127893592531014,0.00518555396908895,-0.353488106180875,-2.27572005031969,0,105,NIPBL|PHB2|CDC7|BECN1|APP|IL1B|CDK4|AURKA|ASNS|HSF1|RCC2|DUSP3|LSM11|CCND2|BRD4|RGCC|NUSAP1|DLGAP5|PLCB1|CDT1|EIF4EBP1|ANAPC5|ESPL1|CDC6|ANKRD32|RAD51C|HNRNPU|INS|LSM10|HES1|MAD2L1|DDX3X|SMOC2|CDC25C|TAL1|CDC45|NDC80|MECP2|FGF10|IGF1|DTL|LRP5|RPTOR|RAD51B|USP2|CCNB1|NSFL1C|HYAL1|AIF1|PDGFRB|CCND3|RPS6KB1|ANXA1|H2AFY|LGMN|ANAPC11|CCND1|CDCA5|SPHK1|PDGFB|XRCC3|EIF4G1
PROTEIN K6-LINKED UBIQUITINATION%GOBP%GO:0085020,0.621448087431694,0.856074533157243,0.295800883890236,0.8586582167359641,4548,8,PARK2|BARD1|RNF4|UBE2D4|RNF6
POSITIVE REGULATION OF WOUND HEALING%GOBP%GO:0090303,0.000130072840790843,0.00518555396908895,-0.501845152440648,-2.39577516568908,0,35,PLEK|RREB1|FOXC2|VTN|MYLK|SMOC2|F3|HRAS|HBEGF|THBD|PDPN|F2R|INSL3|THBS1|SERPINE1|ENPP4|TLR4|ANXA1|SERPINF2
LYSINE TRANSPORT%GOBP%GO:0015819,0.8494983277591971,0.9492491301138911,-0.578407587119541,-0.770577789895245,6349,1,PQLC2
POSITIVE REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE%GOBP%GO:1902685,0.043380206951446,0.29791299041195396,-0.8645161290322579,-1.43869308523298,326,2,DBN1|STX7
CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061307,0.6771026797559039,0.8836483435332951,-0.526446016687789,-0.876090356816125,5103,2,JAG1
REGULATION OF COLLATERAL SPROUTING%GOBP%GO:0048670,0.88713165720465,0.965013712426871,0.27322085701017396,0.657094594321448,6562,5,PTPRS|DCC
POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0032962,0.12738095238095198,0.4845098650392629,-0.689989838624879,-1.3473752776286798,962,3,P2RY6|GPER1
"FRUCTOSE 2,6-BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0006003",0.389477817039655,0.7358910495632479,-0.48543248661952004,-1.0627131868314001,2975,4,PFKFB2|PFKFB3
POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0032436,0.482354456465739,0.786634382425318,-0.175765773734035,-0.9819920016824641,3744,60,VCP|RNF144B|CEBPA|UBQLN1|SUMO2|HERPUD1|NKD2|RCHY1|PSMD10|PLK1|BCAP31|CAV1|DAB2|CSNK1A1|FAM122A
POSITIVE REGULATION OF MEMBRANE INVAGINATION%GOBP%GO:1905155,0.492240925828511,0.791072486428528,-0.39990072799470594,-0.958485736920782,3742,5,ABCA7|ANO6|F2RL1|NCKAP1L|ITGAM
REGULATION OF METANEPHRIC GLOMERULUS DEVELOPMENT%GOBP%GO:0072298,0.0352357984994641,0.267552181261549,0.8788875912051679,1.47664463099497,262,2,RET|EGR1
REGULATION OF INTERFERON-BETA PRODUCTION%GOBP%GO:0032648,0.14359637774903,0.509884136342556,-0.268775956933501,-1.29423144944752,1109,36,LILRB1|DHX9|PYCARD|RNF216|YY1|TLR2|IRF5|POLR3B|DDX3X|IFIH1|IRF7|RELB|TRAF3|TLR4|SIRPA
LATE ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:1902774,0.381617844665413,0.7296501420979891,0.548472482629315,1.07878064932062,2839,3,VPS41|VPS39|C9orf72
NEGATIVE REGULATION OF ASPARTIC-TYPE PEPTIDASE ACTIVITY%GOBP%GO:1905246,0.0241157556270096,0.21800274505398803,0.8977750585070279,1.50837801472171,179,2,BIN1|SORL1
NEGATIVE REGULATION OF MESODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042662,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
NEGATIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0010614,0.15581031787389302,0.524929617605427,-0.43947874802045706,-1.3220596463325902,1195,9,P2RX4|NOTCH1|LMNA|RGS2
NEGATIVE REGULATION OF RUFFLE ASSEMBLY%GOBP%GO:1900028,0.198809523809524,0.576314462420711,-0.642274181096283,-1.25419869195902,1502,3,PFN2|KANK1|EVL
ANIMAL ORGAN REGENERATION%GOBP%GO:0031100,0.934112213014536,0.9800972968717879,0.27951184010022195,0.614099416449504,6875,4,SULF2
ENDODERM DEVELOPMENT%GOBP%GO:0007492,0.043936045755882,0.299062021084573,-0.32327166398368606,-1.53159123771597,337,34,LAMC1|ZFP36L1|ITGB2|SOX17|ITGB5|VTN|ITGA5|INHBA|MMP14|CTR9|COL4A2|COL12A1|COL8A1|FN1|MMP9|COL6A1
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:1904064,0.254723043310628,0.6334469481869079,-0.193019663612827,-1.1414651205495,1981,75,RYR2|GLRX|ATP1B1|AMIGO1|CTSS|ATP1B3|STAC3|THY1|STIM1|TESC|SLC9A1|FLNA|FXYD1|P2RY6|GPER1|F2R|KCNQ1|APLNR|F2RL3|COX17|CX3CL1|ATP1B2|KCNH2|TMSB4X|WNK2
SENSORY PERCEPTION%GOBP%GO:0007600,0.42125819500627704,0.752472774240887,0.152041320321891,1.02131672467002,3019,124,DRD2|PITPNA|BBS4|HOMER2|EYA4|KIFC3|ABLIM1|EYS|PIEZO2|KIT|WFS1|CHRNB2|ASIC1|TTC8|COL11A1|ADORA2A|MMP24|ADCY3|ADCYAP1|WDR1|EYA1|TAS2R5|MYO9A|DFNB59|MKKS|CDC14A|DFNA5|SCN9A|TRPV1|TIMM13
CELLULAR RESPONSE TO HYDROGEN SULFIDE%GOBP%GO:1904881,0.44949832775919707,0.768229288546963,-0.776742390824879,-1.0348073714255799,3359,1,KDR
POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT%GOBP%GO:0090267,0.22239747634069398,0.604959238589686,-0.4504374507393111,-1.2312506846245301,1691,7,MAD2L1|NDC80|XRCC3
REGULATION OF MYOFIBROBLAST DIFFERENTIATION%GOBP%GO:1904760,0.139335476956056,0.504314492208813,0.7778329197684041,1.30685973528443,1039,2,PDCD4|RB1
NEGATIVE REGULATION OF B CELL ACTIVATION%GOBP%GO:0050869,0.1640716995944,0.535290477921284,-0.340029766750931,-1.29219614763455,1253,17,MNDA|SLA2|LYN|NDFIP1|SAMSN1|FCGR2B|TNFAIP3|INHBA|CD300A|TNFRSF21
NEGATIVE REGULATION OF PROTEIN K48-LINKED UBIQUITINATION%GOBP%GO:0061944,0.41846153846153794,0.75036705317022,-0.79107851786502,-1.05390653495015,3127,1,TRIM44
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1901381,0.21105131907074398,0.5929592989748729,-0.30089011265449295,-1.22582848546521,1607,21,ATP1B1|AMIGO1|ATP1B3|FLNA|KCNQ1|ATP1B2|KCNH2|WNK2
G PROTEIN-COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007216,0.12407862407862401,0.47832576509682107,0.452325699696756,1.37457608338272,908,9,GRIK3|HOMER2|HOMER3|GRM4|HOMER1|GRM8
POSITIVE REGULATION OF BLOOD CIRCULATION%GOBP%GO:1903524,0.169712793733681,0.5427990685638271,-0.303791096677557,-1.27549168104996,1299,23,APLN|TGFB2|ADRA1B|ATP2A2|ADM|RYR2|PDE4D|TBXA2R|F2R|KCNQ1|SMTNL1|CHGA|CAV1|RGS2
REGULATION OF MICROTUBULE NUCLEATION BY RAN PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0090226,0.11289679904369801,0.46062672800263105,0.9450816056462289,1.26013879856869,849,1,RANGRF
ACTIVATION OF GTPASE ACTIVITY%GOBP%GO:0090630,0.43113689736151395,0.759661470071713,0.17466906882263597,1.01715838704734,3120,67,ZNF286A|TBC1D1|SGSM2|TBC1D2|TBC1D14|TBC1D17|TBC1D16|TBC1D9|TBC1D8|RANGAP1|TBC1D7|CXCL13|RALGAPB|SIPA1L1|ARHGEF10|TBC1D4|DOCK7|FOXJ1|TBC1D5|TBC1D3D|TBCK|SGSM1
CELLULAR RESPONSE TO TUMOR NECROSIS FACTOR%GOBP%GO:0071356,0.004642166344294001,0.0752560935123842,-0.260664157043917,-1.6860303748333503,35,108,CCL11|COMMD7|HYAL2|DHX9|CHI3L1|TNFSF13B|PYCARD|TNFRSF14|TNFSF8|CCL19|ZFP36L1|DAB2IP|EDA|PID1|CCL24|GATA3|HYAL3|TNFRSF11A|TNFRSF18|CCL3L3|ERBB2IP|TRAF2|CCL18|ILK|TNFSF12|CRHBP|BRCA1|TNFRSF4|TNFSF13|CCL2|GPER1|PLVAP|NFKBIA|HYAL1|TNFRSF21|TNFRSF11B|CX3CL1|LTA|YBX3|TRAF3|LTBR|CCL4L2|CCL14|RELA|TNFRSF12A|TNFRSF1A|TMSB4X|TNFRSF1B
NERVE DEVELOPMENT%GOBP%GO:0021675,0.6184781180181359,0.854944793214197,-0.221494630508828,-0.875104621513501,4705,19,FBXO45|NPTX1|TBX1|NGF|SULF1|MAFB|NRP2|SEMA3A
REGULATION OF T-HELPER 2 CELL DIFFERENTIATION%GOBP%GO:0045628,0.18966876971608804,0.563467720122429,-0.46750856435316995,-1.27791381241256,1442,7,CD86|NLRP3|ANXA1
MITOCHONDRIAL DOUBLE-STRAND BREAK REPAIR%GOBP%GO:0097551,0.249701155531943,0.630296201866725,0.877150419056021,1.16956172739969,1879,1,MRE11A
METANEPHRIC SMOOTH MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0072208,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
REGULATION OF INTERLEUKIN-2-MEDIATED SIGNALING PATHWAY%GOBP%GO:1902205,0.685217160313455,0.8857920062408181,0.656815174239083,0.875774408900244,5158,1,PTPN2
TYPE II PNEUMOCYTE DIFFERENTIATION%GOBP%GO:0060510,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0032604,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
PROTEIN LOCALIZATION TO CELL CORTEX%GOBP%GO:0072697,0.4584789035205589,0.773047151415595,0.5083410895110491,0.999846934872953,3411,3,RTKN|EZR
ASPARTATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015810,0.6881589618815901,0.88689701339094,0.33687153127536795,0.8101741009237451,5090,5,SLC25A13|SLC25A12|LRRC8D
NEGATIVE REGULATION OF HYPERSENSITIVITY%GOBP%GO:0002884,0.368294314381271,0.721642468110297,-0.813850904278782,-1.08424482162572,2752,1,FCGR2B
RETINA MORPHOGENESIS IN CAMERA-TYPE EYE%GOBP%GO:0060042,0.264355362946912,0.639661268021129,0.31774818486852097,1.17204207319957,1951,15,DLL1|AHI1|PTPRM|MEGF11|TFAP2B|LRP6|PROX1
EMBRYONIC CAMERA-TYPE EYE DEVELOPMENT%GOBP%GO:0031076,0.0223068552774755,0.206844249860175,0.49727314796390293,1.69013470933547,163,12,STRA6|TWIST1|NES|ALDH1A3|PHACTR4|LRP6|PROX1
RRNA METABOLIC PROCESS%GOBP%GO:0016072,0.7179129464285708,0.900060477413567,0.120286189437818,0.884589879334732,5145,190,FDXACB1|WDR12|WDR75|IMP4|EBNA1BP2|DDX27|GTF3C2|MPHOSPH6|GTF3C3|DIS3L2|PIH1D1|NIFK|TFB1M|BTRC|RPL26|MDN1|EXOSC10|MRPS9|DCAF13|HEATR1|TSR1|PDCD11|WDR18|MTERF4|ISG20L2|RPF1|UTP20|XRN2|C1D|UTP3|PELP1|BMS1|RNMTL1|NOP58|EXOSC8|WDR46|NSUN4|GAR1|TAF1B|RPF2|CIRH1A|ZNHIT6|CD3EAP|NSUN3|NOL10|RPS24|UTP6|WBSCR22|GTF3C6|MPHOSPH10|GLTSCR2|PIH1D2|MRTO4|POP5|RPS21|DIEXF|DIS3|RPL14|TFB2M|RPS19
POSITIVE REGULATION OF ENGULFMENT OF APOPTOTIC CELL%GOBP%GO:1901076,0.7989108779386371,0.931350348412063,0.6001874724305251,0.8002690094760871,6014,1,ABCA7
MICROSPIKE ASSEMBLY%GOBP%GO:0030035,0.5416666666666671,0.815622645995152,-0.483935238698323,-0.945002868295784,4094,3,FSCN1|MTSS1
RESPONSE TO UV-B%GOBP%GO:0010224,0.22685669456066898,0.609201573718782,-0.39085707920119606,-1.22450420648029,1734,10,HYAL2|MFAP4|HYAL3|HYAL1|RELA|CRIP1
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002719,0.120204268691895,0.472400580631237,-0.401337516241569,-1.38148155903922,917,13,TGFB2|FOXP3|TNF|JAK3|TGFB1|LILRB1|IRAK3|TGFB3|HFE|BST2
POSITIVE REGULATION OF INTERLEUKIN-10 PRODUCTION%GOBP%GO:0032733,0.615750816104461,0.8539218792126291,0.25781798388995203,0.8762731811429519,4526,12,XCL1|PIBF1|CD46|HSPD1
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:1905459,0.163643533123028,0.5351003413847161,-0.482412097830965,-1.3186519565605301,1244,7,SOD2|DNMT1|IGF1|PPARG
NEGATIVE REGULATION OF INTERLEUKIN-10 BIOSYNTHETIC PROCESS%GOBP%GO:0045081,0.0976225262319033,0.430598623028127,0.9518085575650641,1.2691082812656203,734,1,TRIB2
REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0010869,0.148763574512626,0.5154128781388279,-0.34627813893794895,-1.31594148777404,1136,17,PARK7|NR1H3|NR1D1|HNRNPK|PPARG|PPARA
SEPTIN CYTOSKELETON ORGANIZATION%GOBP%GO:0032185,0.6723997833152761,0.8820287375433101,0.22523799817756798,0.830810128645083,4964,15,RTKN|SEPT2|WDPCP|SEPT10|SEPT4|SEPT12
PEPTIDYL-LYSINE DEGLYCATION%GOBP%GO:0036528,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
INTERMEMBRANE SPHINGOLIPID TRANSFER%GOBP%GO:0120012,0.827826086956522,0.943061234519578,-0.5898213498015,-0.7857836623936539,6187,1,COL4A3BP
POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING%GOBP%GO:0090037,0.128094302554028,0.48509801008225,-0.537085248019699,-1.3815279412100903,977,6,CD40|MC1R|FLT4|ADGRV1
"REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL EXTRAVASATION%GOBP%GO:2000449",0.174714778455824,0.54811765844537,-0.749159084642956,-1.24672051639082,1316,2,RIPK3|FADD
DNA REPLICATION%GOBP%GO:0006260,0.0598663926002056,0.354269451186595,-0.190182386307007,-1.34085540880467,465,163,RFC2|RAD51|CLSPN|RPA2|MCM10|WRNIP1|BRIP1|SETMAR|RNASEH2A|SET|RFC3|TREX1|DONSON|ACHE|CDT1|MCM4|TONSL|NBN|MCM6|EXO1|GINS2|CDC6|PURA|TOP1|POLD4|SLFN11|RAD17|PCNA|GMNN|ORC1|ORC6|POLD1|MCM3|MCM5|CDC45|POLD2|BRCA1|STRA13|KIAA0101|WDHD1|RFC5|POLQ|EME1|NUCKS1|GINS1|RMI1|KAT7|RBM14|RMI2|MCM2|FANCM|KAT5|POLE2|POLA1|NUP98|POLE3|RFC4|IGHMBP2|SAMHD1|POLA2|FEN1|TOP1MT
ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE%GOBP%GO:0070200,0.37158691538253596,0.7233017049424281,0.44173823314150396,1.06237791755254,2748,5,BRCA2|ACD|POT1
PROLINE METABOLIC PROCESS%GOBP%GO:0006560,0.252497371188223,0.632257972333528,-0.43776387984550796,-1.19660804375614,1920,7,OAT|PYCR1|PYCRL|ALDH4A1
CELLULAR RESPONSE TO PH%GOBP%GO:0071467,0.7518659159355771,0.915314007578303,-0.22472505096116,-0.7735472045183169,5741,13,SLC9A1|PKD2L1|HYAL1|INSRR
HALOGENATED HYDROCARBON METABOLIC PROCESS%GOBP%GO:0042197,0.17160313454642098,0.54516008272075,0.916023378914866,1.22139357413195,1291,1,CYP2E1
REGULATION OF BARBED-END ACTIN FILAMENT CAPPING%GOBP%GO:2000812,0.0340986279038174,0.26378188727568896,0.726575856173827,1.5963180991641,250,4,RLTPR|FAM21C|LRRC16A|MTPN
MEMBRANE TO MEMBRANE DOCKING%GOBP%GO:0022614,0.176091530773277,0.548366806412612,-0.541941042424298,-1.29892926682181,1338,5,ICAM1|MSN|VCAM1
PEPTIDYL-TYROSINE SULFATION%GOBP%GO:0006478,0.8179888564606,0.9382680046989879,-0.45152315353717104,-0.751406731466865,6165,2,TPST2
REGULATION OF CATION CHANNEL ACTIVITY%GOBP%GO:2001257,0.0820584144645341,0.39829114945696004,0.21056497725018503,1.3303354382428,589,93,FKBP1B|CRHR1|ANK2|GSTM2|C19orf26|DMD|EPHB2|ANXA3|RNF207|CACNG7|DRD4|KCNIP2|MINK1|GNB5|HTT|CACNB4|SRI|GAL|HAP1|SUMO1|CACNG4|NETO1|PTK2B|PKD2|DLG4|NLGN2|CACNB2|KCNG1|CAMK2D|JPH3|STAC2|DAPK1|HOMER1|SHANK2|CRH|FGF12|STAC|JPH1
INTRACELLULAR LIPID TRANSPORT%GOBP%GO:0032365,0.9303235908141959,0.9793746057014829,-0.141324994854263,-0.6164854361096589,7129,26,LDLR|OSBP|NPC2
REGULATION OF MRNA STABILITY%GOBP%GO:0043488,0.472694717994629,0.7831522581932591,-0.153663105990967,-0.98926726298143,3695,105,HNRNPU|LARP1|NPM1|FMR1|DHX36|PDE12|MAPKAPK2|FXR1|HNRNPM|SLC11A1|HSPB1|E2F1|TNFSF13|NUP214|UBC|EXOSC3|CCRN4L|YBX3|CSDC2|VIM|APEX1|EXOSC2|HNRNPA0|HNRNPC|EIF4G1
POSITIVE REGULATION OF CENTRIOLE REPLICATION%GOBP%GO:0046601,0.151622098547577,0.518911670602691,0.518393910981192,1.34137471340125,1116,6,CENPJ|CEP120|CEP295|VPS4B|NUP62|PLK4
REGULATION OF ION TRANSPORT%GOBP%GO:0043269,0.00920010222335804,0.121196525942361,-0.183872999876246,-1.4487721792906398,71,303,CD4|GLRX|ATP1B1|PPIF|SNX4|AMIGO1|P2RX4|SFRP4|KCNIP3|PXK|SPTBN4|CTSS|PLN|TOR1A|TMBIM6|SYT4|SLC8B1|SHISA7|ATP1B3|TNFRSF11A|SYT7|P2RX5|KCNN2|STAC3|P2RX3|CLDN10|THY1|PDE4B|STIM1|GRIN1|PRELID1|SLC9A3R1|FMR1|KCNIP4|PLA2R1|LILRB2|MYLK|JPH4|PDE4D|TESC|HAMP|CA2|SEPN1|CRHBP|SLC9A1|MEF2C|UBQLN1|PKP2|CD63|CAMK2B|CAPN1|FLNA|FXYD1|VAMP8|CEBPB|CNIH2|VAMP7|GPM6B|SNX6|P2RY6|CCL2|CRY2|GPER1|HFE|F2R|CCR1|APOE|KCNQ1|APLNR|LGALS3|F2RL3|THBS1|HTR1B|PDGFRB|DTNBP1|COX17|FKBP1A|MMP9|CX3CL1|CAMK2A|SLC30A5|CAV1|SCN1B|CNIH3|CLIC2|SIK1|ARL6IP1|ATP1B2|PRKACA|KCNH2|KCNE4|ANXA2|ARL6IP5|TMSB4X|FXYD5|AHNAK|PDGFB|FXYD7|WNK2|PRNP
ESTABLISHMENT OF SISTER CHROMATID COHESION%GOBP%GO:0034085,0.9786677136500458,0.992937328049893,-0.241923815768673,-0.529621803881141,7477,4,NAA50
FOREBRAIN DEVELOPMENT%GOBP%GO:0030900,0.0193998604326588,0.19226875441368102,0.240261446188746,1.53810012022155,138,99,EFHC1|SCN5A|DRD2|FGFR2|BBS4|FAT4|SLIT1|EPHB2|RTN4|HESX1|WNT2B|TACC2|LAMB1|ROBO2|PTCHD1|CHRNB2|ASCL1|RAB3GAP1|CHD5|SLIT3|PCM1|ADCYAP1|ATP7A|MBOAT7|DRAXIN|PEX13|MKKS|NF1|SKI|BBS2|C21orf91|AGTPBP1|METTL14|LRP6|DOCK7
POSITIVE REGULATION OF INTERLEUKIN-4 PRODUCTION%GOBP%GO:0032753,0.0018331805682859801,0.0366658253519131,-0.588441800807973,-2.02553079013609,13,13,PRKCQ|RARA|SYK|HLA-E|GATA3|FCER1G|CEBPB|CD86|NLRP3|LGALS9|ZP3|HAVCR2
REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION%GOBP%GO:0150003,0.497850040311744,0.794989907195277,0.49026050969441,0.964284568022418,3704,3,PARK2|AGER
BODY FLUID SECRETION%GOBP%GO:0007589,0.9289638932496079,0.9793746057014829,-0.165820999679589,-0.616255041916616,7100,16,COPA|APLN|GUCA1B|SLC22A4|AQP1|FGF10|VAMP8|NPR1
REGULATION OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR SECRETION%GOBP%GO:1900166,0.47749196141479106,0.7850984235874658,0.602023097862262,1.0114765347571602,3563,2,DRD2
REGULATION OF LONG-TERM SYNAPTIC DEPRESSION%GOBP%GO:1900452,0.17573548555063798,0.548366806412612,-0.450079705963969,-1.2957164801163898,1349,8,ARC|MAPT|FMR1|ADCY8|LILRB2|CBLN1
EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION%GOBP%GO:1900115,0.44413774973711895,0.766503259003379,-0.36855134023984604,-1.00741865323321,3378,7,FBN1|LTBP1|NBL1
NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY%GOBP%GO:0043242,0.0147985749520417,0.163277281666064,0.33809467855439196,1.67530852377093,107,38,CLASP1|ADD3|PHF23|KATNB1|CLASP2|SPEF1|UBQLN4|TTBK2|CLEC16A|CAMSAP3|STMN2|TRIOBP|TWF1|ADD1
NEGATIVE REGULATION OF ENDOPEPTIDASE ACTIVITY%GOBP%GO:0010951,0.00012748597654258,0.00518555396908895,-0.388910071424056,-2.37916506292943,0,85,FNIP1|RPS6KA1|TRIAP1|IGBP1|AGT|SERPINA3|SERPINB8|SPOCK2|KLF4|SERPINB1|HGF|NGF|GAS6|GPX1|VTN|DDX3X|SIAH2|CAAP1|SERPINA1|PARK7|TIMP3|DPEP1|CARD16|IFI6|RECK|IFI16|NAIP|CAST|USP47|GAPDH|PLAUR|SERPINE2|THBS1|SERPINH1|XIAP|MMP9|SERPINE1|BCL2L12|ARL6IP1|TIMP1|SERPING1|NGFRAP1|DHCR24|NGFR|SERPINF1|SERPINF2
POSITIVE REGULATION OF CALCIUM ION TRANSPORT%GOBP%GO:0051928,0.0280927835051546,0.23736968756574803,-0.276806713150217,-1.5588902110729799,217,62,RYR2|ATP1B1|P2RX4|P2RX5|STAC3|P2RX3|THY1|STIM1|GRIN1|MYLK|SLC9A1|P2RY6|CCL2|GPER1|F2R|CCR1|APLNR|LGALS3|F2RL3|PDGFRB|CX3CL1|CAMK2A|CAV1|ANXA2|PDGFB
TRNA THIO-MODIFICATION%GOBP%GO:0034227,0.88713165720465,0.965013712426871,0.273253018486685,0.657171942488026,6562,5,CTU1|MOCS3|TRMU|CTU2
REGULATION OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN URETERIC BUD FORMATION%GOBP%GO:2000733,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
DTTP BIOSYNTHETIC PROCESS%GOBP%GO:0006235,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
AUTOPHAGY OF HOST CELLS INVOLVED IN INTERACTION WITH SYMBIONT%GOBP%GO:0075044,0.5936693384051079,0.8429870456423729,0.40245041115022995,0.884200692709842,4369,4,ULK2|ATG5
RESPONSE TO FUNGUS%GOBP%GO:0009620,0.00013144058885383798,0.00518555396908895,-0.831222192642096,-2.27210879576262,0,7,GAPDH|RARRES2|TLR4|S100A8|S100A9|FAM3A
NEGATIVE REGULATION OF GLIOGENESIS%GOBP%GO:0014014,0.6856209150326801,0.885899038297278,-0.24412655831978303,-0.817114448656749,5244,12,HES1|NOTCH1|DAAM2|LDLR
CHONDROCYTE DIFFERENTIATION%GOBP%GO:0002062,0.0117218025527481,0.141800417878789,-0.378761297636485,-1.74554913710778,89,31,COL20A1|RUNX3|COCH|CREB3L2|ANXA6|VWA1|COL14A1|MEF2C|SULF1|COL12A1|COL6A3|COL21A1|NOV|BMP2|COL6A1|COL6A2
DECIDUALIZATION%GOBP%GO:0046697,0.271702214373047,0.646576786621306,0.5336502528689671,1.17245233245739,1999,4,CYP27B1|PPARD
ACTOMYOSIN CONTRACTILE RING ORGANIZATION%GOBP%GO:0044837,0.8119762097864291,0.935317461845028,0.300573571586146,0.722877716022216,6006,5,RTKN|PDCD6IP|VPS4A|RACGAP1|ANLN
NEURON PROJECTION FASCICULATION%GOBP%GO:0106030,0.272034820457019,0.646576786621306,0.34136615926021396,1.1602371789439698,1999,12,CNTN4|EPHB2|RTN4|CDK5R1|NRCAM|MEGF8
REGULATION OF HEAT GENERATION%GOBP%GO:0031650,0.9660772757039949,0.9910924712218209,-0.21673067238999102,-0.557489673618892,7375,6,PTGS2|IL1B|TNF|TNFRSF11A
NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION%GOBP%GO:0033087,0.8419078242229371,0.94808068996515,0.42558588365040007,0.7150392341503771,6283,2,KIAA0922|BMP4
MAMMARY GLAND SPECIFICATION%GOBP%GO:0060594,0.613879957127546,0.852182158593687,0.5426020733436789,0.911641541406907,4581,2,FGFR2
POSITIVE REGULATION OF CYTOLYSIS%GOBP%GO:0045919,0.611438293417092,0.8517857988964052,-0.39818698851750395,-0.87171455390027,4671,4,LILRB1|RRAGA
GLUCOSE CATABOLIC PROCESS TO PYRUVATE%GOBP%GO:0061718,0.108800836929515,0.45309795582492896,-0.333166647892361,-1.37972977612122,831,22,GPI|HK1|HK3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
NEGATIVE REGULATION OF HISTONE H4 ACETYLATION%GOBP%GO:0090241,0.9759193822798058,0.9926773910205121,-0.24517422224610702,-0.536737623117276,7456,4,SPI1
CHOLINE METABOLIC PROCESS%GOBP%GO:0019695,0.6667989417989421,0.880719592999549,-0.43024927170118504,-0.840167781402775,5040,3,SLC44A1
MEIOTIC CHROMOSOME SEGREGATION%GOBP%GO:0045132,0.614454699077083,0.852474178722926,-0.188315892218858,-0.8921999747544341,4726,34,PTTG1|TOP2A|STRA13|SGOL1|EME1|RMI1|FANCM|SYCE2|MUS81
STRIATED MUSCLE HYPERTROPHY%GOBP%GO:0014897,0.554368406816338,0.824211795070057,0.327601307065009,0.9043346148198579,4098,7,HDAC4|INPP5F|CAMTA2|PDLIM5|TCAP|SORBS2
POSITIVE REGULATION OF CHAPERONE-MEDIATED PROTEIN FOLDING%GOBP%GO:1903646,0.540328999734678,0.81505408470595,-0.583025656807225,-0.970247925739591,4072,2,SGTB
NEGATIVE REGULATION OF L-GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0002037,0.0705016722408027,0.3767214120425879,-0.9631120423467141,-1.28309649724502,526,1,ARL6IP5
NEGATIVE REGULATION OF PROTEIN SECRETION%GOBP%GO:0050709,0.0185377236193933,0.18731131230065398,-0.278644170628277,-1.60468058659522,142,68,LILRB1|RGCC|INHBB|LGR4|REST|RHBDF2|PIM3|CD34|SSC5D|FCGR2B|GAS6|INS|TNFAIP3|PTGER4|IRS1|CARD16|RSAD2|SRGN|TNFRSF4|NR1H3|F2R|FN1|NLRP3|NOV|CHGA|TNFRSF21|CD200|CX3CL1|SIRT4|SERGEF|RAB11FIP1|ANXA1|TMSB4X
LIPID TUBE ASSEMBLY%GOBP%GO:0060988,0.187700964630225,0.561103912498404,0.744365866863787,1.2506307652985602,1400,2,BIN1|SNX9
POSITIVE REGULATION OF ANTRAL OVARIAN FOLLICLE GROWTH%GOBP%GO:2000388,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
SMOOTH ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS%GOBP%GO:0051563,0.572040133779264,0.8340866926851909,-0.7182951036612258,-0.9569415509023209,4275,1,PSEN1
NEUTROPHIL CHEMOTAXIS%GOBP%GO:0030593,0.00142616361986257,0.0302416078214392,-0.399062320877335,-1.99854609602299,10,41,IL1B|TGFB2|CCL3|SYK|CCL4|CCL8|CXCL1|CXCL2|CCL11|NCKAP1L|CCL19|ITGB2|CXADR|CCL24|IL1RN|PDE4B|CCL3L3|CCL18|FCER1G|CCL2|LGALS3|CX3CL1|CCL4L2|CCL14|S100A8|S100A9
CHORDATE EMBRYONIC DEVELOPMENT%GOBP%GO:0043009,0.6443391393442621,0.8688307429995409,-0.135057316872191,-0.9051707024451421,5030,127,BHLHE40|PDCD6|COBL|GATA3|TGFB3|HOXA4|HES1|MESP1|NDST1|CELSR1|CHRD|BRCA1|ATP6AP2|HOXB3|SULF1|ALDH1A2|DLC1|DEAF1|LUZP1|TGFBR2|BMP2|ZP3|COL1A1|SRF|EIF4A3|TCOF1|RARRES2|WDR74|DACT1|PDGFRA|PDGFB|MTHFD1
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION%GOBP%GO:0014911,0.00891452543261667,0.118676411326017,-0.5200331197030321,-1.839801131135,67,14,VTN|DOCK5|IGF1|FGF9|AIF1|PDGFRB|IGFBP5|PDGFB
GLOMERULAR MESANGIAL CELL DIFFERENTIATION%GOBP%GO:0072008,0.0350529100529101,0.26702449097803305,-0.7875261938899308,-1.5378390589737099,264,3,CD34|ACTA2|PDGFB
NEGATIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002605,0.0876890421862563,0.40905715364188894,-0.813895781637717,-1.35445273236629,660,2,FCGR2B|THBS1
REGULATION OF KIDNEY DEVELOPMENT%GOBP%GO:0090183,0.215665659087922,0.598994355749518,-0.30966972929258696,-1.2234762107968,1640,19,AGT|BASP1|SMO|GATA3|PDGFRB|MYC|PDGFA|PDGFB
MESENCHYMAL CELL PROLIFERATION INVOLVED IN URETERIC BUD DEVELOPMENT%GOBP%GO:0072138,0.5923321836030779,0.8417378833576942,-0.5621856560242049,-0.935566831869957,4464,2,BMP2
DOPAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0042416,0.7670153511751121,0.9202818175694271,0.347874041802239,0.7642940849735959,5645,4,SNCA|GCH1|TH|TGFB2
PROTEIN LOCALIZATION TO MICROTUBULE END%GOBP%GO:1905725,0.8781746031746029,0.960725750963158,-0.34245064519686796,-0.668719316310254,6638,3,MAPRE3|MAPRE1|MAPRE2
REGULATION OF RELAXATION OF MUSCLE%GOBP%GO:1901077,0.24060248853962,0.6244696312630601,-0.468860796139243,-1.20603627225415,1836,6,PLN|PDE4B|PDE4D|CHGA
PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:0097468,0.5850750267952839,0.839854222268064,0.555669649408642,0.933596756419086,4366,2,STK25|PDCD10
REGULATION OF PRO-T CELL DIFFERENTIATION%GOBP%GO:2000174,0.9820693319165892,0.993436724391485,0.508491398323776,0.678004667467936,7393,1,ZBTB1
POSITIVE REGULATION OF T CELL PROLIFERATION%GOBP%GO:0042102,0.00103452735031682,0.0240545523142212,-0.380856521644096,-2.04224944458022,7,52,IL1B|CD1D|HLA-DMB|JAK3|SYK|CD274|HLA-DPA1|HLA-E|CD209|PYCARD|NCKAP1L|IL18|CCL19|CCDC88B|HLA-DPB1|PDCD1LG2|EBI3|IL6ST|LILRB2|IGF1|ICOSLG|VCAM1|CD86|TGFBR2|LGALS9|ZP3|FADD|AIF1|PNP|ANXA1|CD55|NCK1|TFRC
INACTIVATION OF MAPK ACTIVITY%GOBP%GO:0000188,0.44015705388573,0.7653693162885199,0.24810824433033202,1.0055264880224302,3250,20,DUSP4|DUSP6|SPRED2|DUSP10|GPS2
GONAD DEVELOPMENT%GOBP%GO:0008406,0.446103273524175,0.767797697802539,0.19318879369947303,1.0086352292287,3256,45,LRRC6|RAB13|WNT2B|KIT|ROBO2|PTPRN|BRCA2|SLIT3|EIF2B4|ADCYAP1|WNT4|MKKS
MEIOTIC RECOMBINATION CHECKPOINT%GOBP%GO:0051598,0.31016184664367197,0.681045250505892,-0.6798456024262479,-1.13137179792304,2337,2,TRIP13|RAD1
ENDOPLASMIC RETICULUM ORGANIZATION%GOBP%GO:0007029,0.5775554946560699,0.83729927068764,0.184925505288493,0.9163328940790121,4214,38,SHTN1|LMAN2L|RTN4|KIAA1715|VAPB|DOPEY2|RAB10|DNM1L
RESPONSE TO BACTERIUM%GOBP%GO:0009617,0.000128139415684264,0.00518555396908895,-0.367930752742056,-2.72422082384678,0,211,CXCL1|IGHV1OR15-1|CD274|MICA|TGFB1|CXCL2|LILRB1|IGHV5-51|HLA-E|SBNO2|LYN|ADAM9|RPL39|C4B|MTDH|TLR1|PYCARD|JUNB|IGHV1-24|HIST1H2BE|TNFRSF14|GSDMD|IL18|IRAK3|SLAMF8|IGHV3-49|IFIT3|HMGB2|DAB2IP|IFNAR1|IGHG4|TLR2|FGR|IGLL5|MPEG1|PDCD1LG2|PLA2G2A|TICAM2|IRF5|SSC5D|SPN|TNFRSF11A|AZU1|IL1RN|FCGR2B|GGT1|PDE4B|CASP1|ERBB2IP|RAB29|TNFAIP3|HIST1H2BC|IGHV4-4|LILRB2|MAPKAPK2|HAMP|IGHV4-61|JCHAIN|MEF2C|IGHV1-3|IFIT1|FCER1G|CTR9|ISG15|SLC11A1|CARD16|IGHV3-43|IRAK1|ROMO1|CEBPB|NR1H3|IGHV3-73|CCL2|F2R|BAIAP2L1|CD86|NLRP3|RNASE6|AXL|NOS3|HCK|CD36|CHGA|OTUD5|LGALS9|NR1D1|IGHV3-15|RARRES2|PABPN1|FOXP1|TICAM1|CCRN4L|HIST1H2BG|SERPINE1|CAV1|STAB1|RELA|PLAA|NFKB1|TLR4|VIM|S100A8|CFP|IGHV1-18|S100A9|GSTP1|CD14|IGHG2|LY96|HIST2H2BE|IGHA1|HIST1H2BK|TNFRSF1B|HNRNPA0|LYST|HIST1H2BJ|SIRPA|ADGRB1
CYTOKINE PRODUCTION%GOBP%GO:0001816,0.0554123711340206,0.34165878259009896,-0.258232423486523,-1.45428552860398,429,62,LILRB1|RGCC|CHI3L1|IL18|CCL19|BATF|TRIM56|PCSK5|TLR2|LTBP3|SPN|PLA2R1|S100A13|SLC11A1|IRF7|NFATC1|TMEM173|CD36|CHGA|FOXP1|STOML2|TLR4|S100A8|ADGRG1|S100A9|PNP|CD55
NOTCH SIGNALING PATHWAY%GOBP%GO:0007219,0.568190648879679,0.831514598829999,-0.16877983161296498,-0.932668641935456,4386,58,MDK|PSEN1|DLGAP5|YBX1|JAG1|PLXND1|BHLHE40|HES1|NOTCH1|SNAI2|SNW1|NOTCH2|NOTCH3|JAG2|KAT2B|BMP2|MAML1|SNAI1|MYC|DTX1
POSITIVE REGULATION OF DEPHOSPHORYLATION%GOBP%GO:0035306,0.265446521287643,0.640784173769173,-0.23481537662571603,-1.14917637597436,2044,38,HSP90AB1|AKAP6|CDCA2|ITGA1|MAGI2|PPP1R15B|PPP1R15A|DUSP26|GBA|SPPL3|PPP1R7|TGFB1|PTBP1|RIPK3|PLEK|LILRB2|MEF2C|NSMF|PPP2R4|CD300A|DLC1|BMP2|PDGFRB|SMPD1
NEGATIVE REGULATION OF HISTONE H3-K9 METHYLATION%GOBP%GO:0051573,0.75920568122041,0.9173504513856129,-0.31783809221455,-0.7617972579479549,5772,5,DNMT3B|BRCA1|DNMT1
SINGLE STRAND BREAK REPAIR%GOBP%GO:0000012,0.8031299316149398,0.932964969466025,-0.30482020736818893,-0.7305958720122959,6106,5,SIRT1|LIG4|APLF|TDP1|APTX
METANEPHRIC CORTICAL COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072219,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
POSITIVE REGULATION OF CYTOCHROME-C OXIDASE ACTIVITY%GOBP%GO:1904960,0.317192889360573,0.6861326333203311,-0.675985663082437,-1.12494824160423,2390,2,CHCHD10|COX17
ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0032510,0.7867714472822529,0.9276917050905171,-0.28726782810213597,-0.7389302398402171,6006,6,VCP|LYST
NEGATIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS%GOBP%GO:0010894,0.0525072197427146,0.331996459809677,-0.42524726824458203,-1.5440038989341203,399,15,SNAI2|SOD1|APOE|FGF19|BMP2|SNAI1|NFKB1
CELLULAR RESPONSE TO ISOQUINOLINE ALKALOID%GOBP%GO:0071317,0.328294314381271,0.6950398637731511,-0.833976621085134,-1.11105710888137,2453,1,ADCY8
ENDOCARDIUM DEVELOPMENT%GOBP%GO:0003157,0.5222598281697479,0.807051143864932,-0.325387315145339,-0.936744538951491,4011,8,SOX18|SOX17|NOTCH1|ANXA2
HEMATOPOIETIC STEM CELL PROLIFERATION%GOBP%GO:0071425,0.38558290505815507,0.73297044199588,0.38224006469662003,1.05516343867194,2850,7,MECOM|WNT2B|ETV6
RENAL WATER TRANSPORT%GOBP%GO:0003097,0.246882462191563,0.6280519349499749,-0.709842845326716,-1.18129200702922,1860,2,AQP1|HYAL2
POTASSIUM ION TRANSPORT%GOBP%GO:0006813,0.429918203244143,0.7584017217646191,0.16776925791736,1.01576748498439,3100,78,KCNQ3|SLC12A5|KCNS3|KCNQ5|KCNAB3|KCNMB4|KCNH8|SLC12A4|SLC12A9|KCNK9|HCN2|KCNIP2|KCNJ8|KCNK10|KCNQ2|KCNK3|PKD2|SLC9A8|KCNMA1|KCNG1|KCNC3|KCNC4|HCN3|KCNB1|CHP1|KCNN4
ENDOMEMBRANE SYSTEM ORGANIZATION%GOBP%GO:0010256,0.0622528383722414,0.358473315814565,-0.16469334279622902,-1.28543859670223,487,285,VPS25|GPER1|SDPR|PLSCR4|F2R|CCNB1|PLK1|NSFL1C|UBL4A|F2RL3|CHMP4A|SNF8|ATP8B4|SUN2|CHMP6|SEC61A1|SYNGR2|COG1|CAV1|STX5|TMED10|RTN3|ARL6IP1|ABCD1|LMAN2|MYOF|TMED9|VRK1|NEK6|COL5A1|A4GALT|PRMT5|CSNK1A1|SURF4|VPS37C|EMD|EHD2|BANF1|AHNAK2|SNX10|SERP1|LYST|SQSTM1|VMP1|PRKCB|EMP2|RNF26
NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0046580,0.4786742732953,0.7850984235874658,0.21595367711168104,0.978375985735172,3523,28,MET|TNFAIP1|EPHB2|ARAP3|STMN3|SPRY2
REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS%GOBP%GO:0005979,0.8321724273886191,0.9443921657118071,-0.181421041347492,-0.7167776092732651,6331,19,INS|PPP1R3E|IRS1|IGF1|PPP1R3F
NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY%GOBP%GO:0032515,0.482217573221757,0.7865660622599749,-0.25160705621768303,-0.9763289532957509,3687,18,CRY2|PPP2R4|LGALS3|FKBP1A|STYXL1
BRANCHING MORPHOGENESIS OF A NERVE%GOBP%GO:0048755,0.0177371674281107,0.181548349676725,0.8291372293236309,1.6308150854491699,131,3,DRD2|FGFR2|EPHA7
SECONDARY ALCOHOL METABOLIC PROCESS%GOBP%GO:1902652,0.013085311096856999,0.15155329789659303,-0.316477103083359,-1.68990503699121,101,51,ABCG1|CYP51A1|CETP|HMGCR|CYP46A1|SCARF1|APOE|HMGCS1|EBP|DHCR7|C14orf1|DHCR24|CNBP|NSDHL|TM7SF2|OSBPL5
SKELETAL MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0007519,0.630863358259687,0.8613756250889949,0.20832447029170897,0.871828016608185,4639,22,BVES|POPDC3|DLL1|IGSF8|RYR1|SKI|CFLAR|MYL6B|ZBTB18|TAZ|SGCE|LEMD2
DITERPENOID CATABOLIC PROCESS%GOBP%GO:0016103,0.700889892415992,0.8931369333627571,0.649150860167622,0.8655550802537421,5276,1,CYP26B1
NEGATIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS%GOBP%GO:2000301,0.33672240802675607,0.699462084003389,-0.8287935597706221,-1.10415202668403,2516,1,FMR1
REGULATION OF AUTOPHAGY%GOBP%GO:0010506,0.9584026622296171,0.988711428754361,-0.0967410317031515,-0.7384306130857241,7487,251,PRKD1|PARK7|ATG101|HAX1|CISD2|CAMKK2|PIK3CB|VPS29|ABL1|CAPN1|HSPB1|RNF152|IFI16|EIF4G2|RPTOR|SNX6|WDR24|TPCN2|TMEM59|GAPDH|ATP6V0E1|CHMP4A|C10orf10|RAB1B|TLK2|TICAM1|RASIP1|PRKACA|ATP6V0E2|KAT8|TRIM65|ATP6V1A|SLC38A9|MID2|ATP6V1G1|ERN1|EIF4G1|BAD|RRAGD
GLUTATHIONE TRANSPORT%GOBP%GO:0034635,0.0712390554523746,0.3767214120425879,-0.8285084091535709,-1.3787704812875,536,2,SLC9A3R1|ABCC1
OVARIAN FOLLICLE DEVELOPMENT%GOBP%GO:0001541,0.343265949067997,0.701955655133333,-0.30042835363169396,-1.09080665296809,2614,15,INHBA|SOD1|CEBPB|EIF2B2|ANG
POSITIVE REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY%GOBP%GO:1901671,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|PARK7
REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL%GOBP%GO:2001188,0.0387953708574435,0.28020075641001296,-0.6636333553937789,-1.5906025199790002,294,5,HLA-DMB|LILRB1|LGALS3|LGALS9|HAVCR2
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002495,0.000256706456167373,0.00819882332206558,-0.3131322390994,-1.9431177452326203,1,91,CENPE|AP2A1|KIF2C|KLC1|CAPZA2|AP1S3|KIF3A|HLA-DRB1|HLA-DMA|HLA-DMB|RACGAP1|HLA-DQB2|AP1S2|KIF11|KIF15|HLA-DPA1|HLA-DRA|HLA-DRB5|ACTR10|DCTN4|DYNC1H1|CD74|AP2A2|HLA-DPB1|HLA-DQA2|CTSF|CTSV|RAB7A|CTSS|KLC2|CANX|FCGR2B|CLTA|SH3GL2|SEC23A|CLTC|DYNLL2|FCER1G|KIF4A|LAG3|KIF18A|RILP|SEC13|SEC24A|ARF1|IFI30|KIF2A|AP1B1|DCTN5|CTSD|CTSL|DYNC1I1|SPTBN2|LGMN|KIF22|SAR1B|DCTN3|AP2M1
DETECTION OF LIGHT STIMULUS%GOBP%GO:0009583,0.0400866738894908,0.28627658744452694,0.431482228112581,1.59156007577225,295,15,PDE6B|PLEKHB1|GNGT1|EYS|OPN3|CDS1|UNC119|REEP6
SPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0030148,0.47129402657721603,0.782701601899847,-0.174560869565619,-0.987143683436553,3652,63,CERS6|SPTSSB|CERS4|PPAP2C|ELOVL2|ELOVL1|PRKD1|UGCG|B3GALT2|HACD2|PPAP2A|SPTSSA|SMPD1|A4GALT|B3GALT1|ALDH3B1|SPHK1|ST3GAL5
B CELL LINEAGE COMMITMENT%GOBP%GO:0002326,0.67376741693462,0.882488012133495,0.509371549700993,0.8558099711206121,5028,2,TCF3
TETRAHYDROBIOPTERIN BIOSYNTHETIC PROCESS%GOBP%GO:0006729,0.139767504731008,0.504314492208813,0.5656167204925029,1.36030496924914,1033,5,SPR|PTS|QDPR
POSITIVE REGULATION OF G2/MI TRANSITION OF MEIOTIC CELL CYCLE%GOBP%GO:0110032,0.38121693121693107,0.729499056535481,-0.5531598103010921,-1.08018091174044,2881,3,CDC25B|CDC25A|CDC25C
COPI-COATED VESICLE BUDDING%GOBP%GO:0035964,0.00654878847413229,0.0957322763119865,-0.717002051608922,-1.8443224271286598,49,6,ARFGAP2|TMED2|TMED10|TMED9
CELLULAR RESPONSE TO TRIGLYCERIDE%GOBP%GO:0071401,0.7870899189799442,0.9276917050905171,0.60603220114689,0.80806216657342,5925,1,GPLD1
2'-DEOXYRIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009394,0.453105802047782,0.769943206592495,0.229397464311982,0.9994655280968601,3318,25,AK9|NT5M|NTHL1|DCTD|CDADC1|AK5|NEIL1|OGG1|DUT|DTYMK|SMUG1|NEIL2
MODIFICATION OF DENDRITIC SPINE%GOBP%GO:0098886,0.0534624568851154,0.335115832119604,-0.849076371657017,-1.41299885995774,402,2,ARHGAP44|SYNPO
SHORT-CHAIN FATTY ACID CATABOLIC PROCESS%GOBP%GO:0019626,0.25302338081161,0.632257972333528,0.612260010404923,1.20424318903172,1882,3,ACADS|MCEE|PCK2
NEGATIVE REGULATION OF SODIUM-DEPENDENT PHOSPHATE TRANSPORT%GOBP%GO:2000119,0.43719063545150505,0.7635570545514341,-0.782752536391707,-1.04281432844165,3267,1,SFRP4
ALDOSTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0032342,0.357859531772575,0.714938712241162,-0.818978826643141,-1.09107644550182,2674,1,CACNA1H
CELLULAR COMPONENT DISASSEMBLY%GOBP%GO:0022411,0.00012871669455528402,0.00518555396908895,-0.236462884425322,-1.87779846062419,0,320,MRPL53|CHCHD10|MRPS17|MRPL37|KIF24|AURKAIP1|GSPT2|EXOG|EXOC8|VTI1B|MMP12|MRPL18|ACIN1|MRPL57|GFM2|CD44|SYNJ1|DNASE1L3|APC|ATG7|FUNDC1|DENR|ATG2B|MRPS18B|ADAMTS4|MRPS15|MRPL47|FIS1|H1F0|LAMC1|SMARCA4|CCSAP|ADAM8|SET|GADD45GIP1|HMGB2|TSG101|MRPS11|MRPL13|DYRK3|ETF1|OXA1L|DSTN|CTSV|TPSAB1|DHX8|CTSS|USP30|ATG13|KPNB1|SMARCE1|MRPL10|MRPL50|MRRF|MRPL51|MMP1|NAPA|FRAT1|WDR45B|FZD2|MRPS34|VCP|MRPL9|TOP2A|SUPT16H|NEK9|ATG2A|WDR45|KIF18B|UBQLN1|WIBG|SMARCD3|MRPS30|HTRA1|SNAI2|MMP14|MRPS23|PELO|MICAL2|MRPL41|WIPI1|KIF18A|MRPS6|MRPS18C|VAMP8|CKAP5|VAMP7|MRPL38|MRPS22|MRPL52|SMARCD2|GPER1|GSN|KIF2A|CCNB1|PLK1|MRPL21|A2M|MRPS18A|MRPS24|CFL2|MRPL27|MRPL23|MRPS7|MCTS1|NSF|MRPL36|ICT1|MMP9|HIST3H2A|CX3CL1|CAV1|MYC|MRPL22|STX5|MRPL49|LAMP2|MRPS2|CFL1|MRPL39|ATG3|MRPL3|ITGAM|MRPL12|MRPS36|CTSL|VRK1|TIMP1|NEK6|MARK2|MRPL17|CSNK1A1|AMBRA1|FUNDC2|MMP19|PPP1CA|ENDOG|MRPS27|MRPL11|EIF2D|SQSTM1|PRKCB|FEN1|MRPL16
RESPONSE TO STEROL%GOBP%GO:0036314,0.430831589958159,0.759376613000886,-0.262210685850513,-1.01747497986664,3294,18,PMVK|TGFBR1|CCR5|OSBPL7|RORC|CCL3|TGFB1|ABCA2|RORA|SMO|TGFBR2|INSIG1
"NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION, GLUTAMATERGIC%GOBP%GO:0051967",0.0204246170384305,0.19665818765898102,0.82202524340716,1.61682664842103,151,3,DRD2|GRIK3
REGULATION OF ANGIOTENSIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0110061,0.9355266648978509,0.9806508984207809,-0.370719602977668,-0.616936701876598,7051,2,ROCK2|ROCK1
REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION%GOBP%GO:0099509,0.284163987138264,0.6569867235097528,0.691942065653636,1.16255201055455,2120,2,CALB1
REGULATION OF RESPONSE TO EXTERNAL STIMULUS%GOBP%GO:0032101,0.000126662444585181,0.00518555396908895,-0.331390378696745,-2.7796103128482996,0,461,PYCARD|TNFAIP8L2|APOD|F12|NCKAP1L|SEC14L1|CD74|C2CD4A|IL18|ADAM8|GUCA1A|CCL19|SLAMF8|RNF216|ANGPT2|DTX3L|C2CD4B|AGT|PARP9|ITGB2|IGHG4|PPM1F|KLF4|IL17D|SNX4|PIK3AP1|KDR|SIGLEC10|STX4|TLR2|P2RX4|SEMA6A|CD34|RORA|TRIM44|TNFAIP6|NR1D2|SLC8B1|MOSPD2|PLA2G2A|C4A|GATA3|TNFRSF11A|GP1BA|AZU1|PLAU|PLEK|FCGR2B|C2|LY86|VEGFC|GGT1|GAS6|NMT1|INS|CASK|CCL3L3|FEM1A|IL6ST|IGKV2-28|VTN|CCL18|C3|TNFAIP3|CREB3|METAP2|SMOC2|CXCR4|DDX60|NOTCH1|PHLDB2|PTGER4|CEBPA|MB21D1|PRKD1|C1QB|CD47|PARK7|DSCAM|IFIT1|FCER1G|APOBEC3G|F3|PDE2A|SNAI2|PLA2G7|SNW1|OSM|BST1|CARD16|GHRL|CALR|HSPB1|VAMP8|FAP|NR1H3|VAMP7|NPLOC4|SEMA3B|SEMA3D|TNIP1|IL15|SNX6|C1QA|SEMA7A|CFB|GPRC5B|C1QC|CDH5|TMEM173|CSF1|CCL2|C7|CEACAM1|THBD|PDPN|KANK2|IL33|GPER1|SCARF1|F2R|CORO1B|CCR1|APOE|IGKV2D-28|PLAUR|NLRP3|NFKBIA|SASH1|NOS3|VEGFB|NOV|HCK|CD36|SERPINE2|A2M|CD200|LGALS9|THBS1|ZP3|TEK|STX3|SEMA5A|NBL1|XIAP|AIF1|PDGFRB|SEMA3E|EPHA4|RARRES2|SUSD4|SLIT2|FOXP1|CD59|TICAM1|IFNLR1|MMP9|ZSWIM6|CX3CL1|SERPINE1|CAV1|ADGRA2|USP18|TRAF3|LDLR|C3AR1|SEMA3A|PPARA|CCL14|PLAT|SEMA6B|RELA|ENPP4|DHX58|RTN4RL1|MAPK13|ABCD1|BCL6|TLR4|S100A8|CFP|MGLL|C1S|ITGAM|S100A9|PDGFA|ANXA2|PDGFRA|CFI|CMKLR1|ANXA1|LGMN|OSMR|CD55|TFPI|GSTP1|TNFRSF1A|PHB|TMSB4X|METRNL|PSMA6|FAM3A|IGHG2|PDE6G|SERPING1|PQBP1|CD81|CHID1|C1R|TNFRSF1B|PDGFB|CFH|C5AR1|SERPINF2|APOBEC3F|SIRPA|PTGIS|C1QTNF1|MPP1|RNF26
GROWTH PLATE CARTILAGE DEVELOPMENT%GOBP%GO:0003417,0.001308386759126,0.0284733155294161,-0.54452655949672,-2.06933389741071,9,17,COL20A1|COCH|ANXA6|VWA1|COL14A1|COMP|COL12A1|COL6A3|COL21A1|COL6A1|ANXA2|COL6A2
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION%GOBP%GO:0010881,0.11468512486427801,0.463748809895271,0.42459980341092995,1.3971940745383302,844,11,FKBP1B|ANK2|GSTM2|DMD|CACNA1C|CAMK2D|SLC8A1
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0098679,0.807110639426904,0.933810206759044,-0.457219094794323,-0.7608856885682571,6083,2,PPARA
ISOPEPTIDE CROSS-LINKING VIA N6-GLYCYL-L-LYSINE%GOBP%GO:0018276,0.0271571906354515,0.23271567002476898,-0.986876929863255,-1.31475703370306,202,1,RNF113A
GLIAL CELL APOPTOTIC PROCESS%GOBP%GO:0034349,0.164499867338817,0.535643394219061,-0.755487542383432,-1.25725208206745,1239,2,TNFRSF21
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL%GOBP%GO:0051281,0.373759791122715,0.724682900261831,-0.252734462235154,-1.06112623977828,2862,23,P2RY6|GPER1|F2R|APLNR|F2RL3|CX3CL1
FARNESOL METABOLIC PROCESS%GOBP%GO:0016487,0.77991765174658,0.924704689181848,0.609726510807234,0.8129880300217339,5871,1,AKR1C3
REGULATION OF MRNA CAP BINDING%GOBP%GO:1905610,0.007759197324414721,0.10744152749969199,-0.9961954124393471,-1.32717148999403,57,1,EIF4G1
CIRCULATORY SYSTEM PROCESS%GOBP%GO:0003013,0.000256476019492177,0.00819882332206558,-0.273156733538259,-1.94162138006706,1,169,ADM|C2CD4A|PER2|EDNRA|PIK3C2A|C2CD4B|AGT|RYR2|PCSK5|ATP1B1|KLK1|P2RX4|PLCB3|CD34|PLN|GAA|TNNI2|SOD2|PRCP|AZU1|KCNN2|GAS6|GPX1|INS|MYLK2|DOCK5|SGK1|PDE4D|POMC|OLR1|NPR2|ELN|TBXA2R|PKP2|ATP6AP2|PTGS1|PDE2A|CACNA1G|HOXB2|HMOX1|SOD1|LRP5|MEOX2|CTSZ|CEACAM1|GPER1|NPR1|F2R|EDNRB|KCNQ1|SMTNL1|NOS3|CHGA|TEK|COL1A2|SLIT2|CAV1|SCN1B|C3AR1|PPARG|KCNH2|KCNE4|ADRBK1|MYOF|SERPING1|ACVRL1|PDGFB|SERPINF2|PTPRJ|RENBP|EMP2|RCAN1
ENTEROENDOCRINE CELL DIFFERENTIATION%GOBP%GO:0035883,0.19221411192214102,0.5666176410720151,0.530334658300224,1.2754518120020901,1421,5,DLL1|INSM1|NKX6-1
NADH OXIDATION%GOBP%GO:0006116,0.930663800053749,0.9793746057014829,0.31242023587821005,0.6144937359590009,6925,3,GPD2|GPD1L|GPD1
P38MAPK CASCADE%GOBP%GO:0038066,0.126554115953409,0.482810504800229,-0.6237798488942811,-1.3655844826455301,966,4,MAPK14|ZFP36L1|MAP2K3|LGALS9
LYMPHOCYTE APOPTOTIC PROCESS%GOBP%GO:0070227,0.9167232712946609,0.9751961777948921,0.287791096559559,0.632289295484652,6747,4,RIPK1|BAX
CORTISOL BIOSYNTHETIC PROCESS%GOBP%GO:0034651,0.357859531772575,0.714938712241162,-0.818978826643141,-1.09107644550182,2674,1,CACNA1H
INVADOPODIUM ORGANIZATION%GOBP%GO:1905863,0.189030100334448,0.5632471197622879,-0.9035068372298192,-1.20368805197555,1412,1,PDPN
EXTENSION OF A LEADING PROCESS INVOLVED IN CELL MOTILITY IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION%GOBP%GO:0021816,0.850312126444415,0.949296218452153,0.573886193206881,0.765199802538091,6401,1,SRGAP2C
REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT%GOBP%GO:1901295,0.004648691725328729,0.0752560935123842,0.9979047198941329,1.33057129384458,34,1,DKK1
OOCYTE MATURATION%GOBP%GO:0001556,0.832851130983693,0.9443921657118071,-0.295105445367417,-0.70731144124366,6332,5,ANG
REGULATION OF DNA STABILITY%GOBP%GO:0097752,0.789698996655518,0.928124695451851,-0.6090648434053821,-0.81142061650933,5902,1,DDIAS
JAK-STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY%GOBP%GO:0060397,0.221740273396425,0.604285118926805,-0.450639293120455,-1.23180241177235,1686,7,STAT5B|PTPN1|JAK3|STAT5A|LYN|STAT3
PYRIDINE NUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0070637,0.475590342265853,0.784986345464663,-0.608460444895451,-1.0125754804468199,3584,2,PNP
FIBROBLAST APOPTOTIC PROCESS%GOBP%GO:0044346,0.102207357859532,0.441073279931729,-0.946570357300397,-1.26105900087051,763,1,MYC
CYTOPLASM ORGANIZATION%GOBP%GO:0007028,0.77123745819398,0.9213545359508709,-0.6190449933833261,-0.824716572655282,5764,1,PLD6
ATRIOVENTRICULAR NODE DEVELOPMENT%GOBP%GO:0003162,0.12321070234113699,0.47697345522944606,-0.937141596823997,-1.24849762793704,920,1,MAML1
UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0006511,0.6452474869576279,0.86905852565918,-0.11378915347352302,-0.929274881953994,5070,380,VCP|RNF144B|UBE2G2|MAD2L1|TNFAIP3|RNF7|SIAH2|PSMD4|RBBP6|SEL1L|SMURF2|UBE2S|UBQLN1|RNF168|UBXN1|ARRB1|PSMB5|UHRF1|TRIM32|UBE2R2|FAF2|HUWE1|MVB12B|CDC27|RAD23B|RNF20|SEC13|DTL|SKP1|NPLOC4|RCHY1|NEDD8|VPS25|PSMC6|USP44|FBXO4|CCNB1|PLK1|NSFL1C|PSMB3|SYVN1|SNF8|RNF40|KIAA0368|PSMD2|SEC61B|UBC|SGTB|PSMD6|ERCC8|FBXW5|DDB1|SPOP|PLAA|DERL3|MYLIP|PSMD12|PSMA3|KAT5|HSPA5|ANAPC11|UBE2L6|TOLLIP|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|SQSTM1|RMND5B|RNF130|SPSB1
REGULATION OF ASTROCYTE CHEMOTAXIS%GOBP%GO:2000458,0.575652173913043,0.835967700120477,-0.716640935156595,-0.954737801264871,4302,1,GPR183
NEGATIVE REGULATION OF APOPTOTIC CELL CLEARANCE%GOBP%GO:2000426,0.446537543114885,0.768043844625006,-0.620619104357446,-1.03280943410742,3365,2,CD300LF
MITOCHONDRIAL GENOME MAINTENANCE%GOBP%GO:0000002,0.999593661113369,0.999671409271379,0.0938532650570031,0.38687733443087197,7379,21,MPV17|PRIMPOL|C10orf2
BRANCHED-CHAIN AMINO ACID TRANSPORT%GOBP%GO:0015803,0.607671957671958,0.849325284075052,-0.45321678562043605,-0.885017514994598,4593,3,SLC3A2
NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1902883,0.304471931493815,0.677044366877573,0.24140082418790898,1.11761254208909,2239,30,MET|PARK2|NOL3|HTRA2|MAPK7|NME5|PDE8A|NFE2L2|NR4A3|FBXO7
CELLULAR RESPONSE TO INSULIN STIMULUS%GOBP%GO:0032869,0.15973377703827,0.529429183067871,-0.189744511128654,-1.21621859351343,1247,103,PIK3C2A|ZFP36L1|AP3S1|TCIRG1|ATP6V0B|GOT1|PARP1|ATP6V0A2|ATP6V1G2|CAV2|ATP6V1F|INS|BCAR1|FOXC2|SYAP1|ATP6V0D1|GRB2|IRS1|PIK3R3|HDAC5|CEACAM1|KAT2B|CPEB1|ATP6V0E1|RARRES2|LPIN3|PPARG|ATP6AP1|RPS6KB1|ATP6V0E2|ATP6V1A|LPIN2|ATP6V1G1
POSITIVE REGULATION OF TORC2 SIGNALING%GOBP%GO:1904515,0.701022712179572,0.8931369333627571,0.6490957212174681,0.8654815599037671,5277,1,TELO2
POLYPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0006798,0.5178426601784271,0.8047565444482679,0.38809838958747,0.9333744014033639,3830,5,ATCAY|BNIP2|PRUNE|PRUNE2|BNIPL
CEREBELLAR GRANULE CELL DIFFERENTIATION%GOBP%GO:0021707,0.9240937050124329,0.9776627603891009,-0.282978810628916,-0.619499769666057,7060,4,CBLN1
TYROSYL-TRNA AMINOACYLATION%GOBP%GO:0006437,0.590118209589587,0.8414799095069009,0.702580502867225,0.9367962993793578,4442,1,YARS2
POSITIVE REGULATION OF SODIUM:PROTON ANTIPORTER ACTIVITY%GOBP%GO:0032417,0.910609971471268,0.9720943283119721,0.290681202149373,0.638638980548245,6702,4,DRD4|CHP1
REGULATION OF RHO-DEPENDENT PROTEIN SERINE/THREONINE KINASE ACTIVITY%GOBP%GO:2000298,0.0205026455026455,0.197065764462746,-0.8194000220580129,-1.60008056699743,154,3,THY1|HEG1|RASIP1
REGULATION OF SCHWANN CELL DIFFERENTIATION%GOBP%GO:0014038,0.890273311897106,0.965159112268525,0.39619520264681607,0.6656590952799251,6644,2,CDK1|DICER1
REGULATION OF OVARIAN FOLLICLE DEVELOPMENT%GOBP%GO:2000354,0.10015919342000501,0.43605057892447596,-0.802040253653157,-1.33472323795852,754,2,HYAL3|ZP3
MEIOTIC CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE%GOBP%GO:0016344,0.9439464882943142,0.982694945797028,-0.526852668725188,-0.701894259528033,7055,1,FMN2
HEME CATABOLIC PROCESS%GOBP%GO:0042167,0.0668760633424944,0.3690551432905871,-0.6749009417624189,-1.4774992411622598,510,4,BLVRA|HMOX1|BLVRB
POSITIVE REGULATION OF HEPARAN SULFATE BINDING%GOBP%GO:1905855,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION%GOBP%GO:0040001,0.6975484220506569,0.8915032734666559,0.199659233594695,0.8230255179797041,5149,21,CLASP1|DCTN1|NDEL1|HTT|GPSM2
NEGATIVE REGULATION OF TRANSLATIONAL INITIATION BY IRON%GOBP%GO:0045993,0.804816053511706,0.932964969466025,-0.60200705778562,-0.8020179513895409,6015,1,EIF2AK1
NEGATIVE REGULATION OF CYSTATHIONINE BETA-SYNTHASE ACTIVITY%GOBP%GO:1904042,0.8105685618729099,0.935197572326686,-0.598147331274813,-0.7968758689021559,6058,1,MTRR
REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ORGANIZATION%GOBP%GO:0120035,0.0482450006992029,0.314685095147499,0.152990728299685,1.2757029368597401,344,404,RET|ISLR2|DYNC2LI1|IFT88|EPS8L1|SHTN1|PPP1R16B|RLTPR|ODF2L|ADGRB3|ZMYND10|SLITRK1|TBC1D1|CPNE9|SEMA4G|BBS4|SYT2|SEMA4F|KIF13B|PLXNB1|ULK4|TBC1D19|CDK10|RTN4IP1|SS18L1|RHOQ|RTN4|INPP5J|IFT20|SEMA6C|PTK7|ARHGEF7|CCDC88A|IFT140|TBC1D2|RIMS1|CHN1|TBC1D14|PTPRO|STK24|ROBO2|AGRN|CHRNB2|NDEL1|PTPRS|ZSWIM4|EFNB2|BMP7|PTPRD|TBC1D17|HTT|TBC1D16|UNC13A|EFNB3|NCKAP1|SCARB2|RIMS2|CDK5R1|SEMA4C|LRRC16A|PTPN9|TBC1D8|SARM1|RUFY3|MAP6|MARK4|ADCYAP1|CAPRIN2|HAP1|DVL2|TRIM46|CUX2|LIMK1|TBC1D7|STMN2|NEDD4|TBC1D20|CUL7|LRRC7|PAK1|TWF1|CRMP1|PTK2B|NRCAM|INPP5F|CDC42EP3|FOXO6|WASH1|SIPA1L1|MAP2|ADCY6|GRIP1|DLG4|BRSK1|VLDLR|VPS35|LINGO1|FBXO7|C15orf62|ZSWIM8|ATG5|CBFA2T2|TENM3|C21orf91|PLXNB2|CAMK1D|POU4F2|MOV10|TAPT1|YWHAH|MAP4|KCTD17|NEDD4L|CERS2|NRP1|ZFYVE27|DCC|MEGF8
MITOTIC TELOMERE MAINTENANCE VIA SEMI-CONSERVATIVE REPLICATION%GOBP%GO:1902990,0.7849476973237329,0.9274485629622209,0.340817490217397,0.7487905406198259,5777,4,ACD|RTEL1
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I%GOBP%GO:0042590,0.0250423894613278,0.22281679108764302,-0.3727603053208,-1.6440550576565802,191,27,CLEC4A|HLA-E|FCGR1B|B2M|TAPBP|LNPEP|FCGR1A|HLA-C|ITGB5|HLA-A|FCER1G|CALR|VAMP8|IFI30|CD36
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002674,0.119449901768173,0.471120705968593,-0.5433426429474629,-1.3976236466195602,911,6,FCGR2B|INS|NLRP3|GSTP1
POSITIVE REGULATION OF GAMMA-AMINOBUTYRIC ACID SECRETION%GOBP%GO:0014054,0.0888564218355691,0.41228493992510207,0.956495368328187,1.27535751101348,668,1,TRH
PEPTIDYL-METHIONINE MODIFICATION%GOBP%GO:0018206,0.50435137340223,0.797795146880088,0.300973869056672,0.9535055615290721,3708,10,METAP1D|METAP1|NAA60
METHYLATION-DEPENDENT CHROMATIN SILENCING%GOBP%GO:0006346,0.48595086195194803,0.7872939093021379,0.372345706248966,0.9634663996352599,3579,6,HDAC1|SIRT1|MBD3|MBD1|HELLS|MBD2
CELLULAR EXTRAVASATION%GOBP%GO:0045123,0.0104616189355303,0.13160598312092803,-0.43513016071694394,-1.80198721278831,79,22,ADD2|ITGA4|ROCK1|TNF|ITGB1|SELPLG|SPN|AZU1|MADCAM1|CD47|VCAM1|CCL2|CX3CL1|PODXL2|SIRPA
NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS%GOBP%GO:2000279,0.7208827135267679,0.9017704221404029,0.17891670840217802,0.8188352559920808,5291,29,DACH1|PARP3|CTC1|EXOSC10|ACD|CERS1|TEN1|PIF1|POT1
NEGATIVE REGULATION OF MICROTUBULE DEPOLYMERIZATION%GOBP%GO:0007026,0.0454174598857764,0.305507129637833,0.39811611335515,1.5583963393448999,333,18,CLASP1|KATNB1|CLASP2|SPEF1|TTBK2|CAMSAP3|STMN2
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION%GOBP%GO:0031346,0.320668058455115,0.688707974858192,0.141188483005655,1.0664474936975898,2303,219,RET|ISLR2|EPS8L1|SHTN1|RLTPR|ZMYND10|SLITRK1|CPNE9|BBS4|SYT2|PLXNB1|SS18L1|RHOQ|PTK7|ARHGEF7|CCDC88A|RIMS1|ROBO2|AGRN|NDEL1|BMP7|PTPRD|HTT|UNC13A|NCKAP1|SCARB2|RIMS2|LRRC16A|RUFY3|MAP6|MARK4|ADCYAP1|CAPRIN2|HAP1|DVL2|CUX2|PROM2|LIMK1|STMN2|CUL7|LRRC7|TWF1|PTK2B|CDC42EP3|FOXO6|WASH1|GRIP1|DLG4|VLDLR|C15orf62|CBFA2T2|TENM3|C21orf91|PLXNB2|CAMK1D|POU4F2|TAPT1|KCTD17|NEDD4L|NRP1|ZFYVE27|MEGF8|OBSL1
NEGATIVE REGULATION OF INTERLEUKIN-6 SECRETION%GOBP%GO:1900165,0.823706614276359,0.941760803523009,-0.27639126131254305,-0.710952780061414,6288,6,PTPN22|ZC3H12A|GAS6|CD200
NUCLEAR MRNA SURVEILLANCE%GOBP%GO:0071028,0.827811968050282,0.943061234519578,-0.20555622889423497,-0.7075644017094681,6321,13,EXOSC3|EXOSC2
ORGANIC CATION TRANSPORT%GOBP%GO:0015695,0.7793384090312422,0.924704689181848,-0.20911408915020802,-0.7592593605663741,5936,15,SLC22A5|RALBP1|PDZK1|SLC22A18|SLC22A4|SEC14L1|SLC22A3|SLC44A1|SLC25A42|SLC25A19
CARDIAC VENTRICLE MORPHOGENESIS%GOBP%GO:0003208,0.0475635044064282,0.312287542159256,-0.30492589780415996,-1.50579963455955,366,39,SMAD4|TGFBR1|BMP4|SMAD7|TBX20|DLL4|HEYL|TGFB2|NRG1|SOX11|TGFB1|TNNT2|JAG1|ZFPM2|RYR2|CPE|SFRP2|GATA3|MESP1|NOTCH1|MEF2C|PKP2|TGFBR2|TGFBR3|FKBP1A|ENG
PYRIMIDINE NUCLEOBASE METABOLIC PROCESS%GOBP%GO:0006206,0.768927444794953,0.9208716027443391,-0.273471741859318,-0.7475228110742029,5849,7,CTPS1|CDA
NEGATIVE REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES%GOBP%GO:0048294,0.5446153846153851,0.817297924969912,-0.7306462284958092,-0.9733962148619529,4070,1,NDFIP1
REGULATION OF SHELTERIN COMPLEX ASSEMBLY%GOBP%GO:1904790,0.6392615221144909,0.865463150027443,0.6779885310983679,0.904006223290581,4812,1,TERF1
POSITIVE REGULATION OF INTERLEUKIN-6-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070105,0.0619397993311037,0.357540960865252,-0.967247463608293,-1.28860587133864,462,1,C1QTNF4
REGULATION OF HYDROGEN PEROXIDE-INDUCED NEURON DEATH%GOBP%GO:1903207,0.812197356366968,0.935317461845028,-0.329852382445294,-0.7221158167090641,6205,4,GNB2L1|PARK7
METABOLISM BY HOST OF SUBSTANCE IN SYMBIONT%GOBP%GO:0052419,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
NUCLEAR-TRANSCRIBED MRNA POLY(A) TAIL SHORTENING%GOBP%GO:0000289,0.22426619775463297,0.6076689301398029,0.304169796892884,1.21268966524506,1657,19,PAN2|PAN3|CNOT11|SAMD4A|PARN|SAMD4B|RQCD1
NEGATIVE REGULATION OF CYCLASE ACTIVITY%GOBP%GO:0031280,0.122980719124544,0.47697345522944606,-0.460331160565425,-1.3847888073638202,943,9,AKAP5|GNAI2|EDNRB|ADGRV1
POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY%GOBP%GO:1905050,0.9001439602146322,0.968131193993669,-0.295759113218993,-0.6474785235989711,6877,4,DDRGK1|KARS|MBP|STAT3
REGULATION OF RESPIRATORY GASEOUS EXCHANGE%GOBP%GO:0043576,0.0139302136867731,0.15758078474497902,0.6429916646851039,1.77496123145807,102,7,MTG2|PASK|MTG1|TSHZ3|NLGN2
POSITIVE REGULATION OF PHOSPHOLIPASE C ACTIVITY%GOBP%GO:0010863,0.0190899581589958,0.19079589443037398,-0.40073277041944,-1.70310297683151,145,24,HRAS|NTRK2|P2RY6|GNAQ|GNA15|PDGFRB|ANG|PDGFRA|C5AR1
CARBOHYDRATE PHOSPHORYLATION%GOBP%GO:0046835,0.7686322686322691,0.9206798062215391,0.248382189039728,0.7548105642043922,5630,9,FGGY|GNPTG|RBKS
REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048385,0.794941528419908,0.929656485793048,0.23249373049684197,0.73655585365,5845,10,TRIM16|ASXL1|CTBP2|PRAME|CYP26B1|AKR1C3|CNOT1
CELL-CELL SIGNALING INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072204,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
INTEGRIN ACTIVATION%GOBP%GO:0033622,0.00833116375943765,0.113028938028938,-0.632655787605296,-1.8213274657329699,63,8,MZB1|FN1|CX3CL1|FERMT3|COL16A1
NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS%GOBP%GO:0060457,0.304100529100529,0.676707700393746,-0.587588006053464,-1.14741045225448,2298,3,HAMP|NR1H3
MORPHOGENESIS OF AN EPITHELIAL SHEET%GOBP%GO:0002011,0.460766423357664,0.774751791105461,-0.21464020465628603,-0.9984216203299929,3534,32,ITGA5|NOTCH1|LIN7C|DDR1|FLNA|CEACAM1|PDPN|CD151|COL5A1|ACVRL1
ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:0046633,0.992909698996655,0.997305769352475,-0.503584031760035,-0.6708948479612271,7421,1,ELF4
PROTEIN DEUBIQUITINATION%GOBP%GO:0016579,0.0115030674846626,0.139771630097924,-0.19824385222164,-1.4904647642710098,89,229,USP25|UCHL5|USP9X|PSMD3|PSMB2|RUVBL1|USP30|GATA3|HCFC1|TOMM20|OGT|PSMF1|BRCC3|VCP|TRAF2|TNFAIP3|SIAH2|PSMD4|USP51|SMURF2|PSME2|USP32|IFIH1|BRCA1|PSMB5|TFPT|RAD23B|TNIP1|FOXK2|PSMC4|USP2|NEDD8|INO80E|TAF9B|PSMC6|IL33|USP44|PSMD10|USP47|USP11|NLRP3|NFKBIA|PSMB3|OTUD5|PSMC1|PSMD2|UBC|USP20|PSMD6|MYSM1|USP18|TRAF3|MYC|TAF10|PSMD12|PSMA3|ACTB|SHMT2|PSMA6|OTUB1|PSMD13|PSMB7|PSMA1|PSMC5|PSMC3
CELLULAR RESPONSE TO NUTRIENT%GOBP%GO:0031670,0.31027719665271997,0.681045250505892,-0.261995903381924,-1.11347520318935,2372,24,TAF1|PDK2|USF1|FYN|SSH1|HSP90B1|P2RX4|P2RX3|GAS6|POSTN|PDXP|CDKN2B|PIM1|USF2
FATTY-ACYL-COA METABOLIC PROCESS%GOBP%GO:0035337,0.516415958142577,0.804056180000979,-0.209611939231969,-0.957047077374953,3947,30,PPT1|SCD5|DGAT1|ACSL5|FAR1|ACSL4|ELOVL2|ACSF3|ELOVL1|HACD2|ABCD1|FASN
NEGATIVE REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1903817,0.290635232481991,0.663162192629976,-0.44595520042779796,-1.1471169096350902,2218,6,CAV1|KCNE4
REGULATION OF LYMPHOTOXIN A BIOSYNTHETIC PROCESS%GOBP%GO:0043016,0.16936454849498303,0.541894568706611,-0.9133215703573,-1.21676363315775,1265,1,CD86
NEGATIVE REGULATION OF CELLULAR AMINE CATABOLIC PROCESS%GOBP%GO:0033242,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
SULFUR AMINO ACID TRANSPORT%GOBP%GO:0000101,0.18217633473712802,0.5559553601324849,0.585451938454751,1.28626284180084,1340,4,CTNS|SLC1A4|SLC7A9|SLC1A1
N-TERMINAL PEPTIDYL-SERINE DIMETHYLATION%GOBP%GO:0035572,0.00989966555183947,0.126895016411775,-0.994816938685487,-1.32533503196282,73,1,NTMT1
GDP-FUCOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015783,0.42849562218095005,0.7566175497322429,-0.627626137303557,-1.04447025743856,3229,2,SLC35B4|SLC35C1
NEUROTRANSMITTER TRANSPORT%GOBP%GO:0006836,0.913188184717792,0.9732485698636558,0.11435541112695402,0.717325022570159,6584,90,SLC6A2|SYT2|SLC25A13|LIN7B|RIMS1|SNAP25|LIN7A|DNAJC5|UNC13A|RIMS2|ADCYAP1|SLC18A1|SLC18A3|CPLX1|SLC6A17|PPFIA3|HRH3|SYT5|BRSK1|SLC25A12|GRM4|SNAP23|PTPRN2|NAAA|OTOF
STEROL CATABOLIC PROCESS%GOBP%GO:0016127,0.11237721021611,0.45952567367629604,-0.548780100031595,-1.4116102510153299,857,6,CYP46A1|SCARF1|APOE
HEART VALVE FORMATION%GOBP%GO:0003188,0.21886399166232395,0.6013948176405761,-0.408760571061939,-1.2296518510781298,1679,9,GJA5|OLFM1|EFNA1|NOTCH1|DCHS1
IRON ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034755,0.7361364228065609,0.908157084784786,-0.26906530604078605,-0.7746013575926819,5654,8,HFE|STEAP4
REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE%GOBP%GO:1904505,0.42192958882021003,0.7527812076478722,0.5278460333374451,1.03821085764467,3139,3,RTEL1|ERCC1|ERCC4
RENAL VESICLE DEVELOPMENT%GOBP%GO:0072087,0.5972856758935771,0.844862323067435,0.45076045899025896,0.8865926296000122,4444,3,PAX8
BONE RESORPTION%GOBP%GO:0045453,0.8116040032458749,0.935317461845028,0.259981485886811,0.717671913479542,6000,7,RAB3D|PTK2B|SRC
CORTICAL MICROTUBULE ORGANIZATION%GOBP%GO:0043622,0.309753483386924,0.680809181688249,0.679728235908564,1.14203119959143,2311,2,EZR|DLG1
LACTATE METABOLIC PROCESS%GOBP%GO:0006089,0.8084656084656079,0.934193159096917,-0.373334291519854,-0.729027250151062,6111,3,PER2|PARK7
HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN%GOBP%GO:0002455,0.000130344108446298,0.00518555396908895,-0.57611903045725,-2.67987862205585,0,32,IGHV2-26|IGHV1OR15-1|IGKV3-11|IGHV5-51|IGHV1-24|IGHV3-49|IGHG4|EXO1|IGLL5|IGKV2-28|IGHV4-4|IGHV4-61|C1QB|IGHV1-3|IGHV3-43|IGHV3-73|C1QA|C1QC|IGKV2D-28|ZP3|IGHV3-15|C1S|IGHV1-18|IGHG2|IGHA1|C1R
CARDIAC MUSCLE FIBER DEVELOPMENT%GOBP%GO:0048739,0.189794324394689,0.5635975984042391,-0.44294853867754796,-1.2751868475801003,1457,8,MYH11|CXADR|MYOM1|IGSF22
MULTICELLULAR ORGANISMAL WATER HOMEOSTASIS%GOBP%GO:0050891,0.6791632708503119,0.884536278926676,0.186166141757209,0.8434238531536031,4999,28,MET|ADCY2|WFS1|ADCY3|RAB11FIP2|TFAP2B|ADCY6|RAB11A|ADCY1|STMN1|TMEM79|ADCY7
POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0045603,0.515561015561016,0.8036714964896441,0.310519335632432,0.943639621791078,3776,9,PROC|TMEM100|BTG1|ADD1
PLASMA LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0034369,0.0345234969808349,0.265648036188578,-0.44333028237662897,-1.6096603920131103,262,15,APOC2|PLTP|AGT|ABCA5|APOC1|PLA2G2A|ABCG1|CETP|PLA2G7|APOM|APOE
PROTEIN NITROSYLATION%GOBP%GO:0017014,0.0017195767195767198,0.0348566830512975,-0.913642880776442,-1.7841129843201797,12,3,GAPDH|S100A8|S100A9
BROWN FAT CELL DIFFERENTIATION%GOBP%GO:0050873,0.634391534391534,0.863354277348854,-0.441972060321436,-0.8630594164495631,4795,3,METRNL
NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0031665,0.816608060589667,0.9374638564993091,0.25867088918385894,0.7140540464595141,6037,7,NFKBIL1|CACTIN|CARD8
NEGATIVE REGULATION OF HISTONE H4-K16 ACETYLATION%GOBP%GO:2000619,0.276661307609861,0.651933397172297,0.695285359801489,1.1681691763931201,2064,2,PIH1D1|SIRT1
HOMOGENTISATE METABOLIC PROCESS%GOBP%GO:1901999,0.848695652173913,0.9492491301138911,-0.578958976621085,-0.771312373107728,6343,1,FAH
NEGATIVE REGULATION OF CELLULAR AMINE METABOLIC PROCESS%GOBP%GO:0033239,0.845831697421803,0.948909006295342,-0.317552732925262,-0.6951893128210219,6462,4,ITGB2|ITGAM
HEPATOCYTE DIFFERENTIATION%GOBP%GO:0070365,0.44792214623882204,0.768229288546963,-0.41528254594646796,-0.995353019430134,3405,5,ANXA1
NEGATIVE REGULATION OF NUCLEAR DIVISION%GOBP%GO:0051784,0.903678668919797,0.9693517997267149,-0.139566724072166,-0.6612369578932211,6951,34,ATRX|MAD1L1|KIF25|ZNF207|TRIP13|AURKAIP1|KLHL22|APC|RGCC|CDC20|NAA10|RAD1|PTTG1|MAD2L1|PLK1|IK
ENDOTHELIN MATURATION%GOBP%GO:0034959,0.667959866220736,0.8810898721211949,-0.669386854874283,-0.8917840199550309,4992,1,ECE1
POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE%GOBP%GO:0051582,0.0221681535550149,0.206019523582829,0.70855849411048,1.7040791150992,163,5,DRD2|PARK2|RAB3B|DRD4
INTERLEUKIN-2 BIOSYNTHETIC PROCESS%GOBP%GO:0042094,0.513444816053512,0.802184867798321,-0.74597485663873,-0.993817628168996,3837,1,IL18
DETECTION OF ENDOGENOUS STIMULUS%GOBP%GO:0009726,0.966967365348899,0.9912626134248801,-0.336382830249249,-0.559794821193712,7288,2,ABCG1
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME%GOBP%GO:0070202,0.949150326797386,0.9846453621956591,-0.17109166925274696,-0.572659836575808,7260,12,CCT8|CCT5|DKC1
AUTOPHAGOSOME ASSEMBLY%GOBP%GO:0000045,0.608431397905082,0.849741303820717,-0.168076417723958,-0.901268460001722,4704,52,RAB7A|ATG13|WDR45B|ATG2A|WDR45|TMEM41B|UBQLN1|ATG101|WIPI1|NSFL1C|ATG3|AMBRA1|ATG4A|VMP1
NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY%GOBP%GO:0010519,0.0203840084166228,0.19638136322727803,-0.7023494374586371,-1.6833975809800201,154,5,BICD1|PLA2R1|ABL1|ANXA1|RGS2
GOLGI VESICLE PREFUSION COMPLEX STABILIZATION%GOBP%GO:0048213,0.748124330117899,0.9129427774980341,0.474317033886013,0.796913858479701,5583,2,DNAJC28
SORBITOL CATABOLIC PROCESS%GOBP%GO:0006062,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
REGULATION OF CHEMOKINE (C-C MOTIF) LIGAND 2 SECRETION%GOBP%GO:1904207,0.988179041041307,0.996030692679047,0.5057344508160561,0.674328649969194,7439,1,MBP
REGULATION OF CELLULAR RESPONSE TO DRUG%GOBP%GO:2001038,0.27385159010600696,0.6484495544388879,0.309281891794753,1.16454889768739,2014,16,MET|RIPK1|PDE8A|NFE2L2|NR4A3|TRAP1|KMT2A|STK26|HDAC6
POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR-ACTIVATED RECEPTOR ACTIVITY%GOBP%GO:0045741,0.34180138568129304,0.701955655133333,0.496839236120958,1.09157696096773,2515,4,ADAM17|ADRA2A|FBXW7|NCF1
POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002842,0.344136007437907,0.702174649119653,0.82851786501985,1.10471677872188,2590,1,HSPD1
ENDOCARDIAL CUSHION CELL DIFFERENTIATION%GOBP%GO:0061443,0.38652197213290507,0.733589579210772,0.643053155872614,1.08041232981978,2884,2,ACVR1
TRNA-TYPE INTRON SPLICE SITE RECOGNITION AND CLEAVAGE%GOBP%GO:0000379,0.990056436441817,0.996737060420239,0.25065488009698,0.493008569928846,7367,3,TSEN34|TSEN2
"MITOCHONDRIAL ELECTRON TRANSPORT, SUCCINATE TO UBIQUINONE%GOBP%GO:0006121",0.031540374296557996,0.252151273228238,-0.721667677714664,-1.57988140216598,240,4,SDHC|SDHD|SDHA|SDHAF2
PROTEIN PALMITOYLATION%GOBP%GO:0018345,0.66189111747851,0.879388591781918,-0.18639940404370103,-0.859035284006653,5081,31,ABHD17A|ZDHHC11B|ABHD17B|ZDHHC11|ZDHHC15|ZDHHC9|ZDHHC4|ZDHHC12|ZDHHC19|ZDHHC24|ZDHHC2|ZDHHC5
REGULATION OF ABSCISIC ACID-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0009787,0.360267558528428,0.7155384949577859,-0.817765769739744,-1.08946036243435,2692,1,LANCL2
"NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION, DOPAMINERGIC%GOBP%GO:0032227",0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
PRIMARY ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:0034309,0.0826479172194216,0.399980174480082,-0.819023986765922,-1.3629868857612801,622,2,CACNA1H|PARK7
OPSONIZATION%GOBP%GO:0008228,0.552240802675585,0.822813841873357,-0.726621085134539,-0.968033757410823,4127,1,C4B
INOSITOL TRISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0032957,0.688160535117057,0.88689701339094,-0.659958094397883,-0.879222647021562,5143,1,ITPKB
MRNA TRANSCRIPTION%GOBP%GO:0009299,0.10231584456365302,0.441073279931729,-0.36930016658350495,-1.4034308147191,781,17,DDIT3|HSF1|HIPK3|SOX18|SOX17|MED1|LMO2|DDX5|SRF|C5AR1
CARDIOVASCULAR SYSTEM DEVELOPMENT%GOBP%GO:0072358,0.000128155837498398,0.00518555396908895,-0.31937869283229997,-2.3605668453095094,0,209,FLT1|APOD|ADM|JAG1|IL18|ADAM8|ANGPT2|EPHB3|TBX1|SAT1|SOX18|COL23A1|SOX17|FGFR4|KDR|FZD4|TMEM204|PLXND1|LRP1|CD34|RORA|APOLD1|MED1|FOXS1|SFRP2|CYP1B1|EGFL7|AHR|PRCP|ATPIF1|TBX2|VEGFC|THY1|HES1|FOXC2|MESP1|ITGA5|ATP5B|MYLK|NDST1|FLT4|NOTCH1|MEF2C|S1PR1|CALCRL|HOXB3|COL4A1|JMJD6|HMOX1|LOX|PIK3R3|RECK|LRP5|CCL2|CEACAM1|PDPN|ROBO4|APLNR|GATA6|VEGFB|NOV|CCBE1|NRP2|ADIPOR2|TGFBR2|TGFBR3|THBS1|TEK|COL1A2|COL1A1|SEMA5A|SRF|PDGFRB|SEMA3E|ERRFI1|SLIT2|ID1|NR2F2|SERPINE1|CAV1|ADGRA2|RASIP1|MYH9|ANG|EPHB4|NXN|TGFBI|ADGRG1|PDGFA|ANXA2|PDGFRA|ACTA2|ENG|ACVRL1|PDGFB|LOXL2|SERPINF2
HARD PALATE DEVELOPMENT%GOBP%GO:0060022,0.682408026755853,0.885415243771438,-0.662715041905602,-0.88289556308398,5100,1,SOX11
NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE%GOBP%GO:0010891,0.0107837980010521,0.134379592697836,-0.7286969462369051,-1.7465475319541002,81,5,PNPLA2|ABHD5|PPARG|PPARA
DEFENSE RESPONSE TO TUMOR CELL%GOBP%GO:0002357,0.345051737861502,0.702619184891717,-0.663192721257237,-1.1036587406618799,2600,2,RBMS3|PRF1
FOLATE IMPORT INTO MITOCHONDRION%GOBP%GO:1904947,0.544162571390623,0.817181843599117,0.7262902514336128,0.9684100498685371,4096,1,SLC25A32
NEGATIVE REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902268,0.23960685349980101,0.623187683081912,0.8820577856197621,1.17610503854745,1803,1,OAZ3
TISSUE MORPHOGENESIS%GOBP%GO:0048729,0.00768344218209758,0.106864945035751,-0.205322192531192,-1.52518287670219,59,215,SOX10|LMO4|TBX1|COL20A1|ZFPM2|SOX18|RYR2|COCH|KLF4|SOX17|FOXN4|TOR1A|SMO|SFRP2|COBL|GATA3|TBX2|MYOM1|MYLK2|HES1|MESP1|SLC9A3R1|ITGA5|MYLK|VWA1|NOTCH1|COL14A1|CELSR1|MEF2C|S1PR1|PKP2|LIN7C|SNAI2|MSN|MICAL2|FGF10|COL4A1|DDR1|FLNA|LRP5|STARD13|COL12A1|CTSH|CEACAM1|PDPN|COL6A3|EPHA2|DLC1|DEAF1|NOS3|COL21A1|ACTG2|LUZP1|CD151|TGFBR2|BMP2|TGFBR3|VCL|SRF|SEMA3E|IGSF22|DCHS1|ITGA8|SLIT2|FKBP1A|DNAAF1|SNAI1|MYC|RASIP1|COL6A1|CSF1R|ACTA2|COL5A1|ENG|COL6A2|ACVRL1|ITGB4|MTHFD1
CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT%GOBP%GO:0021894,0.644024651661308,0.8688307429995409,0.527655506019731,0.886529378473251,4806,2,DRD2
POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION%GOBP%GO:1905209,0.302483660130719,0.675222663526765,-0.339724423001265,-1.13708945272676,2313,12,TGFB2|TGFB1|GREM1|DHX36|MEF2C|IGF1|GPER1
NEGATIVE REGULATION OF CARGO LOADING INTO COPII-COATED VESICLE%GOBP%GO:1901303,0.00615384615384615,0.0917316347019317,-0.9973533303925891,-1.32871411474025,45,1,INSIG1
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH%GOBP%GO:0048640,0.236520784744135,0.62149045081524,0.232351742479693,1.1776921526530701,1723,41,WWC2|SEMA4G|SEMA4F|DUSP10|RTN4|CDKN1A|SEMA6C|PTPRS|GAL|SEMA4C|TRIM46
FEMALE SEX DETERMINATION%GOBP%GO:0030237,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
SPINDLE MIDZONE ASSEMBLY%GOBP%GO:0051255,0.32992082992083,0.6957352559323989,0.36258445333103606,1.1018607125117401,2416,9,AURKC|CDC14B|CDC14A
KIDNEY RUDIMENT FORMATION%GOBP%GO:0072003,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
NEGATIVE REGULATION OF CHONDROCYTE DEVELOPMENT%GOBP%GO:0061182,0.538699274388605,0.8142313733497609,0.473434316646356,0.931189431918314,4008,3,FAM101B|FAM101A|PTHLH
MEMBRANE RAFT DISTRIBUTION%GOBP%GO:0031580,0.484278419779629,0.7872939093021379,0.496415572956877,0.976390851114438,3603,3,CD2|MAL|PTPRC
POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS%GOBP%GO:2000573,0.19767141009055603,0.5747254604125179,-0.22043673832065303,-1.2138039363521202,1527,57,PTGES3|CCT7|HNRNPA1|NVL|PARM1|NEK2|GREM1|RFC2|RGCC|CCT3|RFC3|KLF4|FGFR4|HGF|CCT8|SMOC2|HNRNPA2B1|CCT5|RFC5|MAPK3|DKC1|FBXO4|PDGFRB|MYC|HSP90AA1|RFC4|PDGFB
POSITIVE REGULATION OF ESTRADIOL SECRETION%GOBP%GO:2000866,0.24909698996655497,0.6299122386373679,-0.8726290251433609,-1.1625513920764698,1861,1,SPP1
GLYCINE CATABOLIC PROCESS%GOBP%GO:0006546,0.0490353697749196,0.317359880131657,0.862200165425972,1.4486076010851598,365,2,GCSH|AMT
SKIN MORPHOGENESIS%GOBP%GO:0043589,0.000661375661375661,0.0166459609848668,-0.9290834895775892,-1.8142645799026,4,3,COL1A2|COL1A1|ERRFI1
ANTIFUNGAL INNATE IMMUNE RESPONSE%GOBP%GO:0061760,0.12655518394648801,0.482810504800229,-0.935542567269519,-1.24636733662084,945,1,RARRES2
CILIUM ORGANIZATION%GOBP%GO:0044782,0.00013984058173682,0.00527539834656828,0.34575064811727196,2.73538537912905,0,284,DYNLRB2|CFAP61|DYNC2H1|NPHP1|ABCC4|CC2D2A|DYNC1I2|TTC30B|LRRC6|WDR19|TTC21B|DYNC2LI1|BBS5|RABL2B|INTU|IFT88|STK36|DNALI1|TTC30A|WDR35|DNAI1|ZMYND10|CBY1|CEP162|NPHP3-ACAD11|TTC21A|FAM161A|TBC1D32|RSPH9|LRGUK|BBS4|SPATA6|CLASP1|LCA5|BBIP1|DCTN1|TMEM67|SFI1|IFT46|CFAP44|IFT172|AHI1|CFAP20|DYX1C1|FGFR1OP|ABLIM1|CFAP43|ARL3|CCDC65|PIBF1|IFT20|TMEM17|NINL|LRRC49|CEP89|IFT140|RFX3|RSPH1|SPAG16|CCDC176|TMEM107|KIF3B|DZIP1|C9orf117|ARMC9|SEPT2|CLUAP1|TTC8|TTLL3|IQCG|CCDC113|RAB1A|RPGRIP1L|IFT81|TTBK2|CEP164|CFAP46|TNPO1|WDR11|WDR60|PCM1|EHD3|RILPL1|RAB23|TMEM231|CEP290|MARK4|WDPCP|RSPH4A|WDR90|ACTR2|TCTN2|POC1B|SEPT10|CEP57|MKKS|B9D1|TEKT2|GAS8|NPHP4|NPHP3|IFT52|DNAH1|RPGR|RAB11A|CEP250|DCTN2|YWHAE|TRAF3IP1|SEPT4|CCDC40
GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION%GOBP%GO:0003418,0.00065470734581642,0.0165075321035167,-0.617418092649908,-2.1252728057937498,4,13,MATN2|COL20A1|COCH|ANXA6|VWA1|COL14A1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
RECEPTOR-MEDIATED ENDOCYTOSIS%GOBP%GO:0006898,0.000127975428717686,0.00518555396908895,-0.307148235006646,-2.05207636927976,0,125,COLEC11|SNX1|NLGN3|ITGB1|GRK4|IGKV3-11|ADRB2|ACKR3|SYNJ1|LILRB1|PPT1|FCGR1B|HSPG2|FCHO1|ADM|CTTN|HSP90B1|AP2A2|ITGB2|MSR1|DNM1|APOL1|HPX|LRP1|FCGR1A|HP|SGIP1|CANX|CAV2|FCGR2B|CLTA|IGKV2-28|MARCO|GRB2|JCHAIN|CLTC|CALCRL|ARRB1|FCER1G|CALR|SPARC|CEACAM1|CXCL16|SCARF1|APOE|IGKV2D-28|CD163|COLEC12|CD36|MRC1|TMEM108|CAV1|STAB1|LDLR|ADRBK1|HSP90AA1|FOLR2|TFRC|IGHA1|CD81|AP2M1|CLTB|DNM3|GTF2H2
NEGATIVE REGULATION OF FATTY ACID BETA-OXIDATION%GOBP%GO:0031999,0.40819846113027297,0.7445496113654559,-0.63677970774745,-1.0597032624231701,3076,2,METTL20|AKT1
POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS%GOBP%GO:0010898,0.11468253968254,0.463748809895271,-0.700176464100585,-1.36726717539312,866,3,APOC2|PNPLA2|ABHD5
FOREBRAIN GENERATION OF NEURONS%GOBP%GO:0021872,0.0743812890943704,0.38312652841807104,0.37536923626635404,1.4693553565824602,546,18,DRD2|FGFR2|SLIT1|ROBO2|ASCL1|SLIT3|ATP7A
DEOXYRIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0009120,0.161259799945931,0.531467372518322,0.5507757402382061,1.3246124968433202,1192,5,DERA|DGUOK|DPYD|DHFRL1
MAINTENANCE OF UNFOLDED PROTEIN%GOBP%GO:0036506,0.8611111111111109,0.951993398605548,-0.350988940360199,-0.685392442742227,6509,3,USP13|GET4
REGULATION OF SALIVA SECRETION%GOBP%GO:0046877,0.246882462191563,0.6280519349499749,-0.709842845326716,-1.18129200702922,1860,2,AQP1|FGF10
BASEMENT MEMBRANE ORGANIZATION%GOBP%GO:0071711,0.0605108055009823,0.355936982159638,-0.590261636006692,-1.51831193609272,461,6,NID2|CTSS|COL4A1|NID1
REGULATION OF BONE MINERALIZATION%GOBP%GO:0030500,0.559212231147966,0.8268422944617521,-0.184394276532263,-0.929184723257022,4315,42,TGFB3|DDR2|TXLNG|MEF2C|S1PR1|ISG15|SRGN|GPM6B|CCR1|ECM1|BMP2|TMEM119|ADGRV1
MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS%GOBP%GO:0044068,0.39178762913560905,0.7371240382543249,-0.252380480416324,-1.0451732367120998,2995,22,CD4|KPNB1|CCNK|SLC25A6|KPNA4|TNIP1|KPNA2|GAPDH|PABPN1
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HEAT STRESS%GOBP%GO:0061408,0.669338405108002,0.8815356925073421,0.37892074528644204,0.8325050147341859,4926,4,HSF4|HSFX1|HSF2
POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION%GOBP%GO:0070474,0.1838127090301,0.556308895147568,-0.906263784737538,-1.20736096803796,1373,1,GPER1
NEGATIVE REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060400,0.8829928362961,0.9629606199413431,-0.41207609594706396,-0.685760519578138,6655,2,LEPROT|GDF15
SKIN DEVELOPMENT%GOBP%GO:0043588,0.0647945381939972,0.365484450623565,-0.246972632412524,-1.4183286871335,502,67,APCDD1|KRT9|INHBA|COL5A3|KRT18|PKP2|PERP|CAPN1|COL5A2|EPHA2|PCSK6|COL1A2|COL1A1|ERRFI1|COL3A1|KRT7|PDGFA|ANXA1|COL5A1|KRT19|DHCR24|ITGB4
REGULATION OF PROTEIN BINDING%GOBP%GO:0043393,0.0155513065646909,0.168596495655607,-0.221096067045344,-1.51408102453353,121,140,TRAF2|VTN|SYAP1|IFIT2|MEF2C|PARK7|IFIT1|CARD16|ABL1|NMD3|MEN1|RAN|HDAC5|TMEM173|CTSZ|STK3|HFE|APOE|PLK1|PPP2CA|LGALS3|CD36|BMP2|EPHA4|FKBP1A|MMP9|CAV1|DACT1|PRKACA|DAB2|ANXA2|TIAM1|ACTB|HSPA5|MARK2|STPG1|PPP1CA|PDGFB
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER BY GALACTOSE%GOBP%GO:0000431,0.988311860804888,0.996030692679047,0.505513895015439,0.6740345685692951,7440,1,NCOA1
POSITIVE REGULATION OF CALCIUM-TRANSPORTING ATPASE ACTIVITY%GOBP%GO:1901896,0.48441471571906397,0.7872939093021379,-0.7605866784296429,-1.01328408329981,3620,1,RYR2
METENCEPHALON DEVELOPMENT%GOBP%GO:0022037,0.18864069735766797,0.562795638432777,0.29445445980600704,1.25009015454713,1384,23,FOXC1|SCN5A|DLL1|TTBK2|ATP7A|ADCK4|AGTPBP1|LRP6|NLGN4X|PROX1|ZNF365
REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010984,0.0123133350799057,0.14674915992642998,-0.55131148937238,-1.7849006085041499,93,11,KHSRP|CNPY2|APOC2|LRPAP1|APOC1|HNRNPK|LDLR|ANXA2
TRANSFORMATION OF HOST CELL BY VIRUS%GOBP%GO:0019087,0.569514460068984,0.8323008830498292,-0.571436448855804,-0.9509616304547359,4292,2,INSR|HYAL2
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION%GOBP%GO:0050805,0.454557767845049,0.770794980018249,0.241102209606754,0.993859724767179,3355,21,DRD2|GRIK3|PARK2|PICK1|MTMR2|PNKD|NLGN4X|SHANK2|SNCA|SYT11|SLC30A1|SLC24A1
FATTY ACID BETA-OXIDATION%GOBP%GO:0006635,0.0184547582977551,0.186740972764028,0.30980827898220503,1.6247994771148702,133,46,BDH2|PPARD|HADHB|SLC25A17|HADHA|PEX2|HIBCH|ACADVL|ACADM|ACAT1|GCDH|ECHDC1|MCAT|ACOX2|ACAA2|ACAD11|ECI1|ACADS|ECHS1|MECR|ACOX3|EHHADH|ACOT8|ABCD3|IVD
OXIDATIVE DEMETHYLATION%GOBP%GO:0070989,0.8084940072954659,0.934193159096917,-0.238782809701533,-0.718317139034027,6205,9,ALKBH3
POSITIVE REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1901980,0.804489308009032,0.932964969466025,0.5982024702249671,0.7976222768769928,6056,1,ALG10B
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC G1 DNA DAMAGE CHECKPOINT%GOBP%GO:0072431,0.9923644363918729,0.997305769352475,-0.0952026996766654,-0.5213158066875929,7667,56,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A
POSITIVE REGULATION OF INFLAMMATORY RESPONSE%GOBP%GO:0050729,0.000128799587841319,0.00518555396908895,-0.42775124718717406,-2.4930874485107597,0,71,NFKBIZ|HLA-E|HYAL2|DHX9|F12|C2CD4A|IL18|ADAM8|C2CD4B|AGT|ITGB2|IL17D|SNX4|TLR2|PLA2G2A|TNFRSF11A|CCL3L3|IL6ST|CCL18|PTGER4|CEBPA|CD47|PARK7|PDE2A|PLA2G7|OSM|VAMP8|VAMP7|TNIP1|IL15|GPRC5B|IL33|NFKBIA|ZP3|TICAM1|CX3CL1|SERPINE1|CCL14|MAPK13|TLR4|S100A8|ITGAM|S100A9|OSMR|TNFRSF1A
MINUS-END-DIRECTED VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0072382,0.526688963210702,0.809755446473093,-0.7399647110719009,-0.9858106711529251,3936,1,DYNC1H1
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION%GOBP%GO:0033598,0.271822764659061,0.646576786621306,-0.696388199614006,-1.15890132500365,2048,2,ID2|EPHA2
HOST-MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION%GOBP%GO:0048874,0.5377872227387439,0.81379229560463,0.729874283193648,0.9731888726169009,4048,1,NAPEPLD
CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM%GOBP%GO:0022412,0.0185987973709971,0.187699380415041,0.24420966014576603,1.54855629154077,132,95,TDRD12|NPHP1|SPAG6|DDX25|BBS4|CFAP44|PICK1|CFAP43|PSME4|TSSK6|ROBO2|C14orf39|DZIP1|C9orf117|IQCG|NME5|CHD5|SPIRE2|PDE3A|SLIT3|SPESP1|PCSK4|CEP57|HSPA2|MKKS|C1orf111|DNAH1|MAST2|PRMT7|CATSPER2|BBS2|TEX14|DPY19L2
RESPONSE TO LIGHT STIMULUS%GOBP%GO:0009416,0.22162300975860302,0.604285118926805,-0.162230124983113,-1.14242952008463,1725,162,TRIAP1|PER2|UBE2B|KDM1A|IMPACT|YY1|PARP1|BHLHE40|MFAP4|NDNL2|HYAL3|NPM1|GPX1|PCNA|GRIN1|FMR1|DHX36|POLD1|CACNA2D4|RHNO1|DCUN1D3|KIAA0101|TRIM32|CARD16|GNGT2|DTL|MEN1|USP2|GNAQ|CRY2|BCL3|CAT|USP47|HYAL1|RBM4B|HIST3H2A|EIF2S1|ERCC8|MYC|DDB1|RELA|SIK1|MAPK13|POLA1|RBM4|CRIP1|CCND1|PPP1CA|XPA|FEN1|GTF2H2
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS%GOBP%GO:0050774,0.810478061558612,0.935197572326686,-0.279877372936582,-0.719919998268476,6187,6,EFNA1|NGEF
NEUROLIGIN CLUSTERING INVOLVED IN POSTSYNAPTIC MEMBRANE ASSEMBLY%GOBP%GO:0097118,0.36415494826213896,0.718457761443038,-0.654584255212306,-1.0893328765659,2744,2,NRXN2
CELLULAR RESPONSE TO FATTY ACID%GOBP%GO:0071398,0.9943043124491461,0.998040712677756,0.125897320128215,0.45252168122871794,7331,14,SFRP1|ADCY6|DGAT2|AKR1C2|GNB1
POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE%GOBP%GO:0150078,0.115455020920502,0.46493596964429496,-0.44820195169692406,-1.40415820618423,882,10,IL6|APP|IL1B|TNF|IL18|ITGB2|IL33|ITGAM
MITOCHONDRIAL DNA METABOLIC PROCESS%GOBP%GO:0032042,0.779379760609358,0.924704689181848,0.22113103448275898,0.7515813757908721,5729,12,PRIMPOL|C10orf2|TOP3A|MGME1|LIG3|POLG|TEFM|POLG2|SSBP1|DNA2|LONP1|PARP1
SERINE FAMILY AMINO ACID CATABOLIC PROCESS%GOBP%GO:0009071,0.6843619246861931,0.8856747470877271,-0.260076435397494,-0.814785521606732,5233,10,SDSL|THNSL2|SHMT2
EMBRYONIC LIMB MORPHOGENESIS%GOBP%GO:0030326,0.24339056963750302,0.626082056933819,0.266926961964362,1.18034293554482,1785,26,RARG|TBX3|HDAC1|TWIST1|CACNA1C|ACD|SKI|LRP6|MEGF8|HDAC2|CYP26B1|FBXW4|LEF1|MSX1
POSTREPLICATION REPAIR%GOBP%GO:0006301,0.0484348834213577,0.31517882292381394,-0.279079629446908,-1.48132452266166,375,50,UBE2A|SPRTN|RAD18|RFC2|RPA2|RFC3|UBE2B|POLD4|TMEM189-UBE2V1|PCNA|VCP|POLD1|POLD2|BRCA1|KIAA0101|RFC5|ISG15|DTL|NPLOC4|RCHY1|UBC|NSMCE1|POLE2|UBE2L6|RFC4
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051150,0.164356694560669,0.535643394219061,-0.33409258495694605,-1.2964034819940902,1256,18,DNMT1|NFATC1|GPER1|FGF9|SRF|ENG|PDGFB
RESPONSE TO SUPEROXIDE%GOBP%GO:0000303,0.0667718191377497,0.3690551432905871,-0.55263380604467,-1.51059986447032,507,7,PRDX2|SOD2|SOD3|SOD1|CCS|NOS3
MYO-INOSITOL TRANSPORT%GOBP%GO:0015798,0.742328042328042,0.909955740610127,-0.40066055879844004,-0.782388524332171,5611,3,SLC2A13|SLC5A3
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS%GOBP%GO:0071322,0.0322412217726145,0.25578651147417397,-0.35126428235768803,-1.5882485500252301,246,29,GNB2L1|ZFP36L1|ZNF236|GAS6|ADCY8|CALCRL|CLEC7A|GPER1|COLEC12|PDK3|TRA2B|MAPK13|PRKACA|ERN1
INTERMEDIATE MESODERM MORPHOGENESIS%GOBP%GO:0048390,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
NEGATIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900450,0.8333775537277791,0.9446656856458421,-0.441392416118375,-0.7345475643752719,6281,2,CX3CL1
AXIS SPECIFICATION%GOBP%GO:0009798,0.299564862659777,0.6725994699713349,0.261000249593483,1.12429075836392,2202,24,SFRP1|TBX3|AHI1|SETDB2|TTC8|CITED2|SKI|LRP6
POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION%GOBP%GO:0071677,0.00340849501835343,0.0607622023670089,-0.5547914415287281,-1.9627709909158302,25,14,MOSPD2|CREB3|PLA2G7|CCR1|LGALS3|AIF1|SERPINE1|LGMN
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY%GOBP%GO:1905599,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
REGULATION OF VASCULAR PERMEABILITY%GOBP%GO:0043114,0.17507845188284502,0.548208402653016,-0.330009888327594,-1.28056110067665,1338,18,TGFB1|C2CD4A|C2CD4B|AZU1|PDE2A|CEACAM1|NPR1|TEK|SLIT2|PTPRJ
NEGATIVE REGULATION OF FOCAL ADHESION ASSEMBLY%GOBP%GO:0051895,0.0284851667104227,0.238789399313666,-0.45200786924018704,-1.6411673032884802,216,15,PTEN|RCC2|APOD|CORO1C|PHLDB2|BCAS3|DLC1|THBS1|FAM107A|ACVRL1
NEGATIVE REGULATION OF TRANSPOSITION%GOBP%GO:0010529,0.173273825150958,0.547365883994345,-0.35210846675286206,-1.27844876642793,1319,15,PIWIL1|APOBEC3G|APOBEC3C|APOBEC3B|APOBEC3F
GOLGI DISASSEMBLY%GOBP%GO:0090166,0.276096922069417,0.65115937430812,-0.451850268443684,-1.16228061262136,2107,6,STX5|VRK1
NUCLEAR POLYADENYLATION-DEPENDENT TRNA CATABOLIC PROCESS%GOBP%GO:0071038,0.261835875854813,0.637592109988467,-0.495513561181323,-1.18765145346124,1990,5,EXOSC3|EXOSC2
COFACTOR TRANSPORT%GOBP%GO:0051181,0.0347848829606382,0.26620723045800804,-0.385833583231271,-1.5978372588594698,265,22,FLVCR2|PDPN|SLC48A1|SLC22A17|SLC25A42|SLC25A19|FOLR2|ABCC1
REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES%GOBP%GO:0048296,0.220767195767196,0.603022518406817,-0.629454520238401,-1.22916514343327,1668,3,TGFB1|TNFSF13
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING%GOBP%GO:0086018,0.0862395241957286,0.40608835945563304,0.614710145249412,1.47837437426272,637,5,SCN5A|ANK2
ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0046631,0.0200261780104712,0.195205495598712,-0.37398848225126796,-1.6702743898829902,152,28,BLM|RORC|FOXP3|CLEC4A|HLA-E|GPR183|TNFSF8|BATF|RORA|SPN|PLA2G2D|INS|PTGER4|STAT3|RSAD2|FOXP1|STOML2|ANXA1
DITP CATABOLIC PROCESS%GOBP%GO:0035863,0.272240802675585,0.646576786621306,-0.860498456109396,-1.14639056140183,2034,1,NUDT16
ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0060350,0.0251826722338205,0.22334422304908896,-0.378213856314502,-1.6498379100823901,192,26,COL20A1|COCH|ANXA6|VWA1|COL14A1|MEF2C|COMP|COL12A1|COL6A3|COL21A1|COL6A1|ANXA2|COL6A2|COL13A1
ACROSOME ASSEMBLY%GOBP%GO:0001675,0.41735374950922705,0.7499690687478492,-0.47246148843650393,-1.034316960383,3188,4,CASC5|CCDC136|RFX2
UBIQUITIN-DEPENDENT ERAD PATHWAY%GOBP%GO:0030433,0.6789996132525461,0.884536278926676,-0.15453305392517902,-0.866594342877996,5266,61,HSP90B1|FBXO6|HSPA13|UBQLN2|RNF121|VCP|UBE2G2|SEL1L|UBQLN1|FAF2|SEC13|NPLOC4|PSMC6|SYVN1|KIAA0368|SEC61B|SGTB|DERL3|HSPA5
REGULATION OF ARGINASE ACTIVITY%GOBP%GO:0150070,0.146755852842809,0.514049001465687,-0.9252315835906478,-1.2326306305474,1096,1,CD200
TRANSFORMING GROWTH FACTOR BETA1 ACTIVATION%GOBP%GO:0036364,0.7860869565217391,0.9274485629622209,-0.611325540361712,-0.814432407680513,5875,1,NRROS
REGULATION OF SODIUM:PROTON ANTIPORTER ACTIVITY%GOBP%GO:0032415,0.915833771699106,0.9747669359607141,-0.26072755564863803,-0.6249141994929,6963,5,ACTN4|SLC9A3R1|TESC
CARDIAC MUSCLE THIN FILAMENT ASSEMBLY%GOBP%GO:0071691,0.0159431939978564,0.171286632385385,0.91938240970499,1.54468115457233,118,2,NEBL|NEB
REGULATION OF CARDIAC MUSCLE CONTRACTION%GOBP%GO:0055117,0.0621911037891269,0.358473315814565,0.282986638364716,1.44645676392934,452,42,TRPM4|FKBP1B|BIN1|SCN5A|ANK2|GSTM2|TNNI3K|DMD|RANGRF|RNF207
CELLULAR RESPONSE TO EXOGENOUS DSRNA%GOBP%GO:0071360,0.0320806599450046,0.254936568785615,-0.47643464474642894,-1.6399804383311698,244,13,MB21D1|IFIH1|IFIT1|TMEM173|COLEC12|CAV1|PQBP1
B CELL RECEPTOR APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1990117,0.448797981139594,0.768229288546963,0.7768526687251879,1.03582821079546,3378,1,BAX
REGULATION OF NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY%GOBP%GO:0070432,0.5153886972671801,0.803478510349408,-0.593052109181142,-0.9869335458400741,3884,2,PTPN22|ERBB2IP
ER TO GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:0006888,0.00460475825019187,0.0752560935123842,-0.223444633825775,-1.6053639462708,35,179,TFG|TMEM115|PDCD6|SPTBN4|TICAM2|TRAPPC5|NAPA|GAS6|SCFD1|INS|RAB29|ERGIC2|SEC23A|SERPINA1|DYNLL2|BET1L|F8|SEC13|KDELR2|SEC24A|ARFGAP2|COPB2|PPP6R3|CNIH2|VAMP7|KDELR1|CNIH1|COPB1|TMED2|CTSZ|DCTN5|CTSC|RAB1B|NSF|CD59|BCAP31|COG1|STX5|KDELR3|CNIH3|TMED10|LMAN2|TRAPPC2|TMED9|GOSR2|DYNC1I1|SPTBN2|CD55|COPG1|PPP6C|SAR1B|COPZ2|DCTN3|GRIA1|YIF1A|RAB33A
PURINE NUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0006152,0.154907576152044,0.523022297381039,-0.46202822230116597,-1.33011458633157,1189,8,ADA|HPRT1|NUDT18|ENPP4|PNP
TRANSITION BETWEEN FAST AND SLOW FIBER%GOBP%GO:0014883,0.480439442658092,0.7857006060206241,0.600385993934381,1.00872598878327,3585,2,GTF2IRD2B|GTF2IRD2
MICROTUBULE-BASED TRANSPORT%GOBP%GO:0099111,0.00013848497438028002,0.00526859796630401,0.31336537119816305,2.09556637073584,0,121,DYNLRB2|DYNC2H1|TTC30B|WDR19|TTC21B|DYNC2LI1|RABL2B|IFT88|TTC30A|WDR35|TTC21A|KIF13A|LCA5|DCTN1|IFT46|IFT172|IFT20|IFT140|DLG2|KIF3B|TRAK2|NDEL1|CLUAP1|RAB1A|IFT81|HTT|TNPO1|WDR60|BLOC1S3|PCM1|CAMSAP3|HAP1|DST|AP3B2|LRPPRC|IFT52|KIF5B|RPGR|TRAF3IP1|KIF3C|IFT27|AP3B1|RAB6A|KIF5A|SPG11|COPG2|TRAK1|SPAST|ARHGAP21|KIF1A|AP3M1
"NUCLEOTIDE-EXCISION REPAIR, PREINCISION COMPLEX ASSEMBLY%GOBP%GO:0006294",0.0817125701605535,0.397778328756298,-0.314838036667935,-1.42354654414152,625,29,GTF2H1|RAD23B|CDK7|UBC|MNAT1|DDB1|CETN2|XPA|GTF2H2
REGULATION OF RENAL OUTPUT BY ANGIOTENSIN%GOBP%GO:0002019,0.611966038737066,0.852045339927398,-0.555114419630549,-0.923799163735195,4612,2,ACE|AGT
MAINTENANCE OF PROTEIN LOCATION IN CELL%GOBP%GO:0032507,0.0663659793814433,0.3690551432905871,-0.252324778361002,-1.42101548955088,514,62,PML|TMSB15A|SP100|GPAA1|JUP|CD4|TAF3|SPTBN4|HNRNPU|TLN1|HK1|PARK7|KDELR2|SKP1|KDELR1|BCL3|GSN|SUN2|ARL2|SYNE3|CAV1|KDELR3|HSPA5|TMSB4X|INSIG1
POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS%GOBP%GO:0070234,0.3859671960426971,0.7332167375750358,-0.366551602707368,-1.05525076147075,2964,8,CD274|ADAM8|PRELID1|LGALS9
OSMOSENSORY SIGNALING PATHWAY%GOBP%GO:0007231,0.761342531175378,0.9183912636605319,-0.484966808253554,-0.807062320957417,5738,2,MBIP
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN-ANGIOTENSIN%GOBP%GO:0003081,0.47881799163179906,0.7850984235874658,-0.310215942960557,-0.9718660535681771,3661,10,AGT|PCSK5|ATP6AP2|CTSZ|SERPINF2
CELL DEDIFFERENTIATION%GOBP%GO:0043697,0.8894694533762059,0.965159112268525,0.396498592596279,0.666168829567286,6638,2,NCOA3
PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0006244,0.0753564154786151,0.38436410265336796,0.42264454162814297,1.4801893007343399,554,13,NT5M|NTHL1|NEIL1|ENTPD4|OGG1|DUT|SMUG1|NEIL2|TDG
REGULATION OF CILIUM MOVEMENT INVOLVED IN CELL MOTILITY%GOBP%GO:0060295,0.0624493106244931,0.358856014313751,0.6394481716291011,1.53786918584539,461,5,BBS4|CFAP20|MKKS|BBS2
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003073,0.130142302716688,0.4891708296166761,-0.27343270810570397,-1.31665500953109,1005,36,ADM|AGT|PCSK5|KLK1|PLCB3|SOD2|PRCP|GAS6|PDE4D|ATP6AP2|CTSZ|F2R|NOS3|PDGFB|SERPINF2|EMP2
N-TERMINAL PEPTIDYL-PROLINE METHYLATION%GOBP%GO:0035568,0.00989966555183947,0.126895016411775,-0.994816938685487,-1.32533503196282,73,1,NTMT1
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS%GOBP%GO:0032103,0.000128667009778693,0.00518555396908895,-0.356551624939116,-2.52473965912963,0,167,F12|NCKAP1L|CD74|C2CD4A|IL18|ADAM8|CCL19|C2CD4B|AGT|ITGB2|PPM1F|IL17D|SNX4|KDR|STX4|TLR2|P2RX4|MOSPD2|PLA2G2A|TNFRSF11A|AZU1|LY86|VEGFC|GAS6|CCL3L3|IL6ST|CCL18|CREB3|SMOC2|DDX60|PTGER4|CEBPA|PRKD1|CD47|PARK7|DSCAM|F3|PDE2A|PLA2G7|SNW1|OSM|GHRL|CALR|HSPB1|VAMP8|VAMP7|TNIP1|IL15|GPRC5B|CSF1|THBD|IL33|SCARF1|CCR1|NFKBIA|SASH1|VEGFB|LGALS9|THBS1|ZP3|STX3|SEMA5A|AIF1|PDGFRB|RARRES2|SLIT2|TICAM1|CX3CL1|SERPINE1|CCL14|DHX58|MAPK13|TLR4|S100A8|ITGAM|S100A9|CMKLR1|LGMN|OSMR|TNFRSF1A|TMSB4X|PDGFB|SERPINF2
PROTEIN SECRETION BY PLATELET%GOBP%GO:0070560,0.401963385513399,0.740287621109606,-0.63909984436304,-1.0635643407692499,3029,2,PLEK
REGULATION OF SYNAPSE STRUCTURAL PLASTICITY%GOBP%GO:0051823,0.733673743617307,0.907913422943088,0.40189667865554995,0.7904833399870941,5459,3,CTNNA2
NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901017,0.508891213389121,0.7992931890114979,-0.302207403255979,-0.9467763441120709,3891,10,CAV1|KCNE4
OXALOACETATE METABOLIC PROCESS%GOBP%GO:0006107,0.10786577910610001,0.45235886750471505,0.640516589467646,1.40724222514964,793,4,MDH1B|NIT2|MDH1|ACLY
REGULATION OF PROTEIN ADP-RIBOSYLATION%GOBP%GO:0010835,0.7269978969505779,0.905250513405619,-0.285985420647157,-0.7817283940012221,5530,7,TINF2|WARS|KAT2B
AMP PHOSPHORYLATION%GOBP%GO:0006756,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
GLUCURONOSIDE METABOLIC PROCESS%GOBP%GO:0019389,0.103210400636774,0.441899546263084,-0.7989022917695748,-1.3295011675864,777,2,ABHD10
REGULATION OF EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030856,0.36088154269972494,0.716154857259883,0.18049735000522601,1.06235543691049,2619,70,FOXC1|PROC|CYP27B1|DLL1|TRIM16|AJAP1|PAX8|AHI1|KLF7|RFX3|CBFB|TMEM100|BTG1|KIAA1109
CARBON CATABOLITE ACTIVATION OF TRANSCRIPTION%GOBP%GO:0045991,0.456216931216931,0.7711961414599979,-0.5224370281736439,-1.02018710490266,3448,3,USF1|USF2
BLOOD VESSEL REMODELING%GOBP%GO:0001974,0.4904898384575301,0.7903790206418191,-0.320835318641973,-0.965151170119986,3764,9,AGT|MEF2C|NOS3|ACVRL1
POSITIVE REGULATION OF GLUTATHIONE PEROXIDASE ACTIVITY%GOBP%GO:1903284,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
UBIQUINONE BIOSYNTHETIC PROCESS%GOBP%GO:0006744,0.655200433369448,0.874775007199212,0.22847723316879998,0.84275833126432,4837,15,COQ10B|COQ2|COQ10A|ADCK4|FDXR|PDSS2|COQ9|UBIAD1
EMBRYONIC BRAIN DEVELOPMENT%GOBP%GO:1990403,0.834126984126984,0.9450623920179921,-0.362816012961471,-0.7084877179732829,6305,3,TBC1D23|RPL10
TRANSCYTOSIS%GOBP%GO:0045056,0.9638979370249731,0.990916952887267,0.169076757652269,0.5563663525893741,7101,11,USO1|RAB11B|VPS35|PICALM|MFSD2A
POSITIVE REGULATION OF LYMPHOCYTE PROLIFERATION%GOBP%GO:0050671,0.000515065670873036,0.0139121625154964,-0.34095501129202,-2.00714753309255,3,74,CD1D|HLA-DMB|JAK3|SYK|NFATC2|CD274|HLA-DPA1|CD38|HLA-E|GPR183|CD209|TNFSF13B|PYCARD|NCKAP1L|VAV3|CD74|IL18|CCL19|CCDC88B|HLA-DPB1|PDCD1LG2|EBI3|IL6ST|LILRB2|MEF2C|FGF10|BST1|TNFRSF4|IGF1|ICOSLG|VCAM1|CD86|TGFBR2|LGALS9|ZP3|FADD|AIF1|PNP|ANXA1|CD55|NCK1|TFRC|CD81
MONOVALENT INORGANIC CATION TRANSPORT%GOBP%GO:0015672,0.6928901437371661,0.8888422672681031,-0.127079590676132,-0.885218637272888,5398,153,SLC36A1|TCIRG1|ATP6V0B|ATP1B1|SLC12A8|NDUFA9|ATP5J|ATP1A3|ATP5F1|SLC12A2|SCNN1D|ATP1B3|KCNN2|P2RX3|ATP6V1F|KCNK6|ATP5B|SGK1|KCNK7|ATP6V0D1|SLC9A1|PKD2L1|ABCC9|SLC9A7|NALCN|SLC1A3|NDUFS7|SLC9A9|ATP5O|KCNJ12|KCNN1|KCNQ1|KCNB2|ATP6V0E1|SCN1B|STOML2|ATP6AP1|ATP1B2|KCNH2|ATP6V0E2|KCNE4|ATP5H|KCNJ9|ATP5G1
GUANOSINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:1901068,0.306485355648536,0.677845082117441,-0.262927820987556,-1.1174358267406799,2343,24,RAN|HPRT1|MOCS2|MBIP|NUDT18|GMPS|GPHN
POSITIVE REGULATION OF NITRIC-OXIDE SYNTHASE BIOSYNTHETIC PROCESS%GOBP%GO:0051770,0.193743427970557,0.567690182346143,-0.465170415493012,-1.27152258677159,1473,7,KDR|TLR2|CCL2|TLR4
POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS%GOBP%GO:0031331,0.380040837161817,0.729249457747391,-0.134548419517561,-1.0338899754645399,2977,260,CBFA2T3|LARP1|PHKG2|PFKFB2|ATPIF1|PFKFB3|TOB1|PRR5L|INS|PNPLA2|VCP|RNF144B|FMR1|DHX36|DCN|CCDC22|BAG3|IRS1|CEBPA|UBQLN1|SUMO2|PRKD1|PARK7|CAMKK2|MSN|PIK3CB|HERPUD1|ABHD5|UQCC2|IGF1|NKD2|TNRC6C|RNF152|RCHY1|PSMD10|APOE|PLK1|TMEM59|ECSCR|CTSC|TICAM1|BCAP31|CAV1|LDLR|PPARA|POLR2G|DACT1|ABCD1|DAB2|HSP90AA1|CSNK1A1|TRIM65|MAGEF1|CD81|MID2|TNFRSF1B|FAM122A|BAD
NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION%GOBP%GO:0010596,0.000775895512737618,0.0191067003244251,-0.42723326336243705,-2.12686375321327,5,40,TGFB1|RGCC|SP100|ANGPT2|JUP|DAB2IP|KLF4|SYNJ2BP|DCN|NOTCH1|MEF2C|TBXA2R|MMRN2|MECP2|HDAC5|MEOX2|STARD13|APOE|THBS1|SLIT2|NR2F2|PPARG|ACVRL1|CARD10|ADGRB1
LAMELLIPODIUM ORGANIZATION%GOBP%GO:0097581,0.0925320250749523,0.42100228741929396,0.31683827207738696,1.4010492361078999,678,26,ABLIM2|CYFIP1|ABLIM1|ARHGEF7|CCDC88A|PTPRO|KIT|LRRC16A|ARHGEF4
SULFUR AMINO ACID CATABOLIC PROCESS%GOBP%GO:0000098,0.575489662676823,0.835951609822898,0.265608675865249,0.9027522278622571,4230,12,BLMH|CSAD|PCYOX1|CTH|TXN2|MPST
GENERATION OF PRECURSOR METABOLITES AND ENERGY%GOBP%GO:0006091,0.00012792631444288102,0.00518555396908895,-0.25473323652108604,-1.92967008388253,0,240,NDUFS4|PGAM2|COX6C|NRF1|GYG1|PER2|UQCRC1|NDUFB5|CROT|SURF1|PID1|UQCR10|OXA1L|NDUFA9|ATP5J|NDUFA7|GIPR|GAA|GPI|ATP5F1|AACS|FH|ADH1B|SLC25A18|SDHB|PHKG2|PFKFB2|ATPIF1|HK1|ALDH2|PDHA1|NDUFA3|NDUFB6|PHKA1|ATP5B|HK3|SDHD|POMC|PPP1R3C|THTPA|CYCS|CEBPA|NDUFB9|COA6|ENO1|NDUFB10|SDHA|ACO1|SLC25A22|MT-CO3|NDUFS7|ATP5O|PGM5|ALDH1A1|NDUFB1|NDUFB7|NDUFA6|PGAM1|ACOX1|GAPDH|NDUFS6|COQ7|LYRM5|NDUFB4|NR1D1|NDUFA12|SDHAF2|COX7A1|LDHA|COX17|GFPT2|SLC25A4|NDUFA2|NDUFAB1|COX4I2|NDUFA1|MYC|STOML2|PYGL|NDUFA4|ATP5H|NDUFV1|PYGM|UQCRQ|NDUFAF2|PGK1|NDUFS3|UQCRC2|COX6A1|COX8A|GYG2|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|NDUFV3
CARDIAC MUSCLE CELL PROLIFERATION%GOBP%GO:0060038,0.389870435806832,0.7358910495632479,-0.485225921154877,-1.06226097184935,2978,4,TGFB2|C3orf58|TGFBR3
POSITIVE REGULATION OF INTERFERON-BETA SECRETION%GOBP%GO:0035549,0.698207040963225,0.891932027568032,-0.36861322055068,-0.806971393792675,5334,4,DHX9|IFIH1
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903364,0.0460970329810264,0.30746333312705,-0.225047625107822,-1.42555515779573,361,98,CBFA2T3|ATPIF1|VCP|RNF144B|FMR1|CCDC22|CEBPA|UBQLN1|SUMO2|MSN|HERPUD1|UQCC2|NKD2|RCHY1|PSMD10|APOE|PLK1|ECSCR|CTSC|BCAP31|CAV1|LDLR|DACT1|DAB2|HSP90AA1|CSNK1A1|MAGEF1|CD81|FAM122A
REGULATION OF STEROL BIOSYNTHETIC PROCESS%GOBP%GO:0106118,0.0607784818311134,0.35631208031004796,-0.29436466003453104,-1.4654138133511103,469,40,SREBF2|IDI1|GPAM|FDPS|KPNB1|ABCG1|CYP51A1|MBTPS2|SOD1|RAN|HMGCR|APOE|HMGCS1|NFYB|DHCR7|FASN|TM7SF2
REGULATION OF PLATELET-DERIVED GROWTH FACTOR PRODUCTION%GOBP%GO:0090361,0.7763210702341141,0.9241536998094619,-0.616674018526687,-0.8215578648416031,5802,1,PTGS2
BMP SIGNALING PATHWAY INVOLVED IN RENAL SYSTEM SEGMENTATION%GOBP%GO:0061151,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
ASPARTATE BIOSYNTHETIC PROCESS%GOBP%GO:0006532,0.44816053511705706,0.768229288546963,-0.777569475077195,-1.0359092462443,3349,1,GOT1
REGULATION OF MDA-5 SIGNALING PATHWAY%GOBP%GO:0039533,0.633136869679109,0.8631726958478259,-0.33174660443968396,-0.853341634544739,4833,6,DDX60|DHX58
GLIAL CELL MIGRATION%GOBP%GO:0008347,0.828006287660466,0.943061234519578,-0.21912471223371902,-0.7094280452045579,6320,11,TGFB2|CCL3|DAB2IP|AZU1|CCL2|ADGRG1
CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0099622,0.614162978391044,0.8522366945817159,-0.302313275438019,-0.870317608086875,4717,8,ATP1B1|KCNN2|KCNQ1|KCNH2
WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0003306,0.84951520786293,0.9492491301138911,0.574327304808116,0.7657879653378901,6395,1,CTNNB1
REGULATION OF DNA-BINDING TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0051090,0.0067870405941862,0.09885679795982198,-0.189314450890362,-1.48711781287779,52,298,TRIM38|DHX9|SP100|MTDH|TRIM52|CEBPG|PYCARD|PARP10|TRIM21|SMARCA4|IL18|ARHGEF5|IRAK3|ADAM8|RIPK3|NFKB2|KDM1A|AGT|TONSL|JUP|DAB2IP|GLIS2|EDA|GTF2A2|KLF4|FZD4|TLR2|SFRP4|TAF3|BHLHE40|HCLS1|ADORA3|SMO|FOXS1|CYP1B1|CDKN2A|TNFRSF11A|NPM1|TRIM34|TAF12|GAS6|INS|FZD2|ARID5B|DDR2|ERBB2IP|TRAF2|TNFAIP3|ADCY8|SGK1|CCDC22|STAT3|NFAM1|PRKD1|PARK7|ARRB1|TRIM32|MBTPS2|MAPK3|PIM1|CARD16|HMOX1|TNFRSF4|FLNA|IRAK1|MEN1|HDAC5|MAP3K13|TMEM173|STK3|MDFI|PSMD10|NLRP3|RAB7B|NFKBIA|BRMS1|HCK|CD36|CD200|LGALS9|BEX1|SRF|UBC|C3orf33|ID1|CX3CL1|CAMK2A|TRAF3|PPARG|HAVCR2|RELA|SIK1|NFKB1|TLR4|S100A8|RPS6KA4|S100A9|CMKLR1|TMSB4X|PSMA6|MID2|SPHK1|PRKCB|PTGIS|PRNP
POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION%GOBP%GO:1901098,0.966477426331441,0.9912626134248801,0.23135892345025402,0.556416884167559,7149,5,SMCR8|FYCO1|UVRAG
REGULATION OF CELL PROLIFERATION INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:2000606,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
GLOMERULAR EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072311,0.434231171548117,0.762034923704788,-0.321788773952102,-1.00812222234218,3320,10,NUP93|IQGAP1|JAG1|BASP1|KLF15|MYO1E
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1901800,0.512688393662244,0.802184867798321,-0.164675043871855,-0.9625829603969092,3979,72,VCP|RNF144B|FMR1|CEBPA|UBQLN1|SUMO2|HERPUD1|NKD2|RCHY1|PSMD10|PLK1|ECSCR|BCAP31|CAV1|DAB2|CSNK1A1|FAM122A
PARATHYROID GLAND DEVELOPMENT%GOBP%GO:0060017,0.574953568585832,0.8354258054828342,-0.569341053212021,-0.9474745570245241,4333,2,TGFBR1|TBX1
VASCULAR SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014829,0.34310889005786405,0.701955655133333,-0.458819064066246,-1.09970174583094,2608,5,EDNRA|PIK3C2A|EDNRB
RESPONSE TO HISTAMINE%GOBP%GO:0034776,0.0530745215148636,0.33407275089766497,0.605206552313717,1.5660075252848,390,6,DRD2|DRD4|GABRB3|GABRG2|HRH1|DIAPH1
NEGATIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045715,0.688772775991426,0.887051934478962,0.501358989926112,0.842347836155343,5140,2,ITGAV|ITGB3
ETHER BIOSYNTHETIC PROCESS%GOBP%GO:1901503,0.8987375065754871,0.967428248648255,-0.269267951194601,-0.6453838979591031,6833,5,FAR1|DHRS7B
POSITIVE REGULATION OF HORMONE SECRETION%GOBP%GO:0046887,0.524111325434004,0.808028752377173,0.17874126915264302,0.955090053020353,3803,49,TRPM4|DRD2|IRS2|TRH|CAPN10|GAL|ADCYAP1|GLUD1|UCN|C1QTNF3|NLGN2|PPP3CB|NNAT|GCK|TM7SF3|AIMP1|MYRIP|CRH|BLK|RASL10B|CARTPT
POSITIVE REGULATION OF MEMBRANE TUBULATION%GOBP%GO:1903527,0.561273851115292,0.827957010954873,0.46470717988309296,0.914024183774869,4176,3,SH3GLB1|PLEKHM2|ASAP1
NEUTRAL LIPID CATABOLIC PROCESS%GOBP%GO:0046461,0.00315043318456288,0.0571886039479394,-0.5464636544113229,-1.9841209480776498,23,15,PNPLA2|FABP3|DAGLB|APOE|FABP4|DAGLA|MGLL|PNPLA4
L-ASCORBIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:0015882,0.980869565217391,0.993436724391485,-0.509594177326864,-0.6789018049772979,7331,1,SLC23A2
REGULATION OF HISTONE MODIFICATION%GOBP%GO:0031056,0.165575664227955,0.5375245857985801,-0.197111173176905,-1.22003420475706,1289,90,SET|WDR70|KDM1A|CAMK1|BCOR|CHTOP|NSD1|PAXIP1|OGT|FMR1|PRKD1|BRCA1|ARRB1|SNW1|CTR9|MAPK3|TAF7|DNMT1|RAPGEF3|RNF20|HDAC5|WBP2|KAT7|SPI1|PHF19|RNF40|RPS6KA4|H2AFY|OTUB1
N-ACETYLNEURAMINATE CATABOLIC PROCESS%GOBP%GO:0019262,0.5796987557301899,0.8386526275338391,-0.34857961942362004,-0.8966406836637759,4425,6,NPL|RENBP
ASYMMETRIC CELL DIVISION%GOBP%GO:0008356,0.265977699211314,0.641452843547192,0.3684488706014729,1.1672709274022,1955,10,TEAD3|PARD3|RAB10|DOCK7|ING2|RGS14
CARDIOBLAST ANTERIOR-LATERAL MIGRATION%GOBP%GO:0003259,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
"POSITIVE REGULATION OF ACTIVATED CD8-POSITIVE, ALPHA-BETA T CELL APOPTOTIC PROCESS%GOBP%GO:1905404",0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0042531,0.0163164077796632,0.174101838399886,-0.37564029751121997,-1.6984651950627898,124,29,LIF|CD40|CTF1|TNF|PARP14|LYN|STAP2|IL18|SOCS3|PARP9|HCLS1|TNFRSF18|IL6ST|HES1|STAT3|OSM|IGF1|CSF1R|TNFRSF1A
NEGATIVE REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA%GOBP%GO:2000360,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
MEIOTIC DNA DOUBLE-STRAND BREAK PROCESSING INVOLVED IN RECIPROCAL MEIOTIC RECOMBINATION%GOBP%GO:0010705,0.5915058949624871,0.8417378833576942,0.552133058724957,0.9276548274427899,4414,2,C14orf39|BLM
PHOSPHATIDIC ACID METABOLIC PROCESS%GOBP%GO:0046473,0.29522563767168103,0.668293026992989,-0.247965912882374,-1.1321638122438302,2256,30,GPD1|AGPAT1|GPAM|PLA2G2A|PLA2G2D|PLA2G4D|PLA2G4A|ABHD5|PLD1|AGPAT2|AGPAT3|PLA2G12A
POSITIVE REGULATION OF CONSTITUTIVE SECRETORY PATHWAY%GOBP%GO:1903435,0.964669942887502,0.990916952887267,0.517423908248787,0.689914964163859,7262,1,RAB27A
N-TERMINAL PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:0018076,0.7682539682539681,0.920474726214876,-0.38985076362540505,-0.7612797340905569,5807,3,CREBBP|KAT2B
CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0048738,0.225,0.6078034241178771,-0.20843054449570303,-1.17381667447724,1745,62,ZFPM2|RYR2|MYH11|CXADR|C3orf58|TBX2|MYOM1|MYLK2|MESP1|NOTCH1|MEF2C|S1PR1|PKP2|BMP2|TGFBR3|PDGFRB|IGSF22|MAML1|FKBP1A|SIK1|PDGFRA|ENG
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE%GOBP%GO:1902817,0.683681672025724,0.885415243771438,0.504595559402384,0.8477856907658801,5102,2,TTBK2|MAP1A
UNCOATING OF VIRUS%GOBP%GO:0019061,0.445083612040134,0.76693681188187,-0.77977503308337,-1.03884757909424,3326,1,PPIA
NEGATIVE REGULATION OF MITOTIC CENTROSOME SEPARATION%GOBP%GO:0046603,0.7840802675585291,0.927080511528825,-0.6124283193647989,-0.81590157410548,5860,1,KIF25
HEART CONTRACTION%GOBP%GO:0060047,0.476295052318822,0.7850084910380921,-0.19009528297944603,-0.984753378999387,3686,46,SCN4B|TNNT2|GJA1|RYR2|ATP1B1|GAA|TNNI2|KCNN2|GPX1|MYLK2|PKP2|CACNA1G|SOD1|KCNQ1|SCN1B|KCNH2|KCNE4|ADRBK1
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0003229,0.284257322175732,0.657025193656986,-0.267942113823587,-1.13874642993096,2173,24,SMAD4|TGFBR1|ADAMTS9|SMAD7|DLL4|TGFB2|NRG1|TGFB1|TNNT2|ZFPM2|RYR2|NOTCH1|PKP2|TGFBR3|FKBP1A|ENG
PURINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009182,0.469094329481322,0.780769690730001,0.502891568021635,0.989128369189121,3490,3,AK9|AK5
MAMMARY GLAND MORPHOGENESIS%GOBP%GO:0060443,0.11946326211568499,0.471120705968593,-0.46330427261432594,-1.39373265614282,916,9,FGF10|LRP5|EPHA2|CAV1|CSF1R
REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060765,0.9335677999218449,0.9800972968717879,-0.142048498357103,-0.6123909803454599,7166,25,PARK7|DDX5|FOXP1|DAB2|PHB
REGULATION OF CARDIOBLAST DIFFERENTIATION%GOBP%GO:0051890,0.181349206349206,0.554948538055731,-0.6522554317855961,-1.27368954481766,1370,3,TGFB2|PRICKLE1|DHX36
REGULATION OF EXTRACELLULAR EXOSOME ASSEMBLY%GOBP%GO:1903551,0.5519207275688879,0.8226405516396691,0.350163997529141,0.9060699245869941,4065,6,SDC1|PDCD6IP|SDCBP|STAM
ESTABLISHMENT OF PROTEIN-CONTAINING COMPLEX LOCALIZATION TO TELOMERE%GOBP%GO:0097695,0.172159699892819,0.5459855974578649,0.7550041356492969,1.2685044304207,1284,2,ATM|ATR
NEGATIVE REGULATION OF METAPHASE/ANAPHASE TRANSITION OF CELL CYCLE%GOBP%GO:1902100,0.895255618346695,0.966332331854337,-0.16632572960975198,-0.657137440865853,6811,19,ZNF207|TRIP13|KLHL22|APC|CDC20|MAD2L1|PLK1|IK
PURINE-CONTAINING COMPOUND SALVAGE%GOBP%GO:0043101,0.6655804480651729,0.8804055751124069,0.238824326094415,0.8364125817838399,4901,13,ADAL|DGUOK|AMPD2|PRTFDC1|GMPR|DCK|ADK
IMP SALVAGE%GOBP%GO:0032264,0.211103678929766,0.5929592989748729,-0.8924239082487869,-1.18892292940463,1577,1,HPRT1
ESTABLISHMENT OF SPINDLE ORIENTATION%GOBP%GO:0051294,0.264174031271244,0.639524357825329,0.278470558913395,1.16538606684699,1942,22,CLASP1|LLGL1|DCTN1|NDEL1|HTT|GPSM2|DYNLT1|MAP4|ZW10
TOOTH MINERALIZATION%GOBP%GO:0034505,0.0610205155181483,0.35631208031004796,-0.636754807068835,-1.5261797685432101,463,5,TBX1|STIM1|COL1A1|FAM20A
REGULATION OF MICROTUBULE-BASED PROCESS%GOBP%GO:0032886,0.911283615192681,0.972245398885683,0.10669862514536801,0.760121265375153,6573,162,CHMP3|MET|BBS4|CLASP1|DCTN1|TMEM67|RANGRF|CFAP20|KATNB1|FSD1|CCDC65|PARP3|INPP5J|CLASP2|MAP9|TRIM36|SPEF1|STMN3|TTBK2|CDK5R1|GPSM2|MAP6|MARK4|CAMSAP3|HAP1|TRIM46|MKKS|STMN2|PAK1|MAP2|CEP250|PSRC1|PHLDB1|TRAF3IP1|CCDC40
NEGATIVE REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL%GOBP%GO:2000536,0.32846327533537,0.6950398637731511,0.835410233789149,1.11390682246874,2472,1,ITGAV
MITOTIC NUCLEAR ENVELOPE REASSEMBLY%GOBP%GO:0007084,0.0132754994742376,0.152889810008936,-0.6445083450875401,-1.76173481985742,100,7,REEP3|LMNA|VRK1|EMD|BANF1
CHOLESTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006695,0.00587390680067876,0.0887570898960228,-0.40802512041501393,-1.84489382616227,44,29,HMGCR|APOE|HMGCS1|EBP|DHCR7|DHCR24|CNBP|NSDHL|TM7SF2
GAS TRANSPORT%GOBP%GO:0015669,0.353688524590164,0.7118407891832621,0.37322318086986295,1.08340160014248,2588,8,AQP5|NGB
REGULATION OF PROTEIN UBIQUITINATION%GOBP%GO:0031396,0.0158527230887241,0.170846085022373,-0.217420258808238,-1.50785961421598,123,149,PRICKLE1|PEF1|NDFIP1|DCUN1D1|CDC20|PARP10|ZER1|PER2|DTX3L|WDR70|KDM1A|PDCD6|TRIM44|PAXIP1|NDNL2|OGT|BAG5|FEM1A|MAD2L1|TNFAIP3|MAGEC2|SENP2|UBE2S|DCUN1D3|UBQLN1|PARK7|UBXN1|BRCA1|STRA13|ARRB1|CTR9|ISG15|ARRDC3|ABL1|RNF20|RCHY1|USP44|FBXO4|PSMD10|PLK1|PRMT3|SASH1|RNF40|HDAC8|XIAP|FKBP1A|FANCM|CAV1|DNAJA1|FAM107A|PLAA|NXN|HSP90AA1|OTUB1|SPHK1|ADGRB1
CELLULAR RESPONSE TO XENOBIOTIC STIMULUS%GOBP%GO:0071466,0.331962472689886,0.6961761803662729,-0.18282298746681103,-1.0811647866438199,2582,75,AKR7L|STAT5A|AQP1|POR|CES1|NR3C1|CDO1|FMO3|RYR2|BCHE|RORA|CYP1B1|AHR|GGT1|NAT1|GRIN1|ADCY8|CRHBP|PTGS1|PDE2A|DPEP1|N6AMT1|CYP46A1|AIP|FMO2|GSTP1|AOC3|PDGFB
PROTEASOME ASSEMBLY%GOBP%GO:0043248,0.157977469216662,0.527990543848753,-0.408572945461245,-1.32277689297262,1205,11,PSMD4|PSMG1|PSMD10|PSMD13
POSITIVE REGULATION OF INTERLEUKIN-1 ALPHA PRODUCTION%GOBP%GO:0032730,0.914916387959866,0.9740523336757891,-0.542346713718571,-0.72253604779882,6838,1,ISL1
NEGATIVE REGULATION OF AUTOPHAGY%GOBP%GO:0010507,0.156911581569116,0.5264612444015649,0.229614420450353,1.25984380626168,1133,54,MET|TSC2|PHF23|NRBP2|SNRNP70|TBC1D14|UBQLN4|ZKSCAN3|CTSA|MTMR9|LZTS1|CLEC16A|SMCR8|LEPR|WASH1
REGULATION OF MUSCLE FILAMENT SLIDING%GOBP%GO:0032971,0.355852842809365,0.713672237213954,-0.819750771945302,-1.09210486199929,2659,1,MYLK2
REGULATION OF CHEMOKINE (C-X-C MOTIF) LIGAND 1 PRODUCTION%GOBP%GO:2000338,0.9232301766502858,0.9776156396135859,0.539258932509925,0.719029022753894,6950,1,TIRAP
ALPHA-AMINO ACID CATABOLIC PROCESS%GOBP%GO:1901606,0.410334346504559,0.7452892204937491,0.182206675850262,1.0295766924415,2969,60,AASS|AADAT|GCSH|DDAH1|GLS|ADHFE1|BLMH|AMT|GLUD1|PCBD1|QDPR|HMGCLL1|HOGA1|ACAT1|SHMT1|GCDH|PIPOX|CSAD|HRSP12|GLS2|HMGCL|ALDH7A1|IVD|GSTZ1
LATE ENDOSOMAL MICROAUTOPHAGY%GOBP%GO:0061738,0.7163703900238789,0.899551221015245,-0.509567135373587,-0.8480011991732329,5399,2,HSPA8|VPS4A
CELLULAR RESPONSE TO ESTRADIOL STIMULUS%GOBP%GO:0071392,0.314630309386471,0.684165797143474,-0.316493692417836,-1.1197084017263101,2399,14,CRHBP|GPER1|H2AFZ|KAT5|SSTR2
HEMIDESMOSOME ASSEMBLY%GOBP%GO:0031581,0.80667014069828,0.933810206759044,-0.23962143468800398,-0.72083992826562,6191,9,LAMC1|LAMC2|CD151|ITGB4
CELLULAR RESPONSE TO PYRIMIDINE RIBONUCLEOTIDE%GOBP%GO:1905835,0.19799331103678897,0.5750614504600671,-0.8987648875165419,-1.19737063634819,1479,1,P2RY6
POSITIVE REGULATION OF N-TERMINAL PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000761,0.706335502722805,0.894843171056815,0.646449051610057,0.8619525831049749,5317,1,SOX4
POSITIVE REGULATION OF B CELL APOPTOTIC PROCESS%GOBP%GO:0002904,0.518127090301003,0.8047799431921201,-0.743493603881782,-0.99051200371282,3872,1,FNIP1
AGE-DEPENDENT RESPONSE TO OXIDATIVE STRESS%GOBP%GO:0001306,0.40414715719063593,0.7412049911665691,-0.7982465813850899,-1.06345611671244,3020,1,SOD2
CELL-CELL JUNCTION ASSEMBLY%GOBP%GO:0007043,0.9059476196619789,0.9705220236903108,-0.123712479216767,-0.699595463318888,7021,63,GJA5|APC|CDH6|TBCD|GJA1|JUP|CTNND1|ECT2|CLDN5|MICALL2|TLN1|CTNND2|PKP2|CDH8|CDH11|CDH5|CDH7|VCL|ARL2|GJA4|OCLN
GLYCOLIPID TRANSPORT%GOBP%GO:0046836,0.138725297735898,0.504314492208813,-0.6152609925966359,-1.3469349254490701,1059,4,RFT1|NPC2
EMBRYONIC HEART TUBE ANTERIOR/POSTERIOR PATTERN SPECIFICATION%GOBP%GO:0035054,0.148494983277592,0.5154128781388279,-0.9235774150860171,-1.23042688090995,1109,1,BMP2
PROLINE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035524,0.9877951711329269,0.996030692679047,-0.305475161221434,-0.50835951742354,7445,2,SLC36A1
POST-EMBRYONIC HEMOPOIESIS%GOBP%GO:0035166,0.455384615384615,0.7711801339028691,-0.773323775915307,-1.03025295550818,3403,1,KLF4
STABILIZATION OF MEMBRANE POTENTIAL%GOBP%GO:0030322,0.969855305466238,0.9915747942934481,0.324069478908189,0.5444785668698839,7238,2,KCNN4|CHCHD10
UDP-GALACTOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0072334,0.0749535685858318,0.383578507779904,-0.824703611800386,-1.37243869005896,564,2,SLC35B1|SLC35A2
REGULATION OF GLUTAMATE-CYSTEINE LIGASE ACTIVITY%GOBP%GO:0035227,0.41864789480674697,0.75036705317022,0.7919607410674899,1.05597278668857,3151,1,GCLM
MRNA LOCALIZATION RESULTING IN POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION%GOBP%GO:0010609,0.667020429822234,0.880719592999549,-0.531334896339183,-0.8842262343466809,5027,2,ZNF385A
UBIQUINONE METABOLIC PROCESS%GOBP%GO:0006743,0.655200433369448,0.874775007199212,0.22847723316879998,0.84275833126432,4837,15,COQ10B|COQ2|COQ10A|ADCK4|FDXR|PDSS2|COQ9|UBIAD1
POSITIVE REGULATION OF MITOTIC RECOMBINATION%GOBP%GO:0045951,0.8930800903174392,0.965443067117994,0.55276797529775,0.737041508497729,6723,1,ERCC2
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS%GOBP%GO:0048646,0.000128221566867547,0.00518555396908895,-0.23049903982945102,-1.8402596793375001,0,329,LMO4|EPHB3|TBX1|SAT1|SOX18|MYH11|DAB2IP|ITGB2|COL23A1|KLF4|SOX17|FGFR4|KDR|PLXND1|BHLHE40|FOXN4|PDCD6|CD34|RORA|SMO|APOLD1|MED1|SFRP2|COBL|GATA3|ITGB5|SDCCAG8|PRCP|ATPIF1|VEGFC|MYOM1|ADAM12|TCTA|CACNA1H|THY1|STIM1|HES1|FOXC2|MESP1|VTN|ITGA5|ATP5B|EFNA1|LMOD1|FLT4|CBLN1|NOTCH1|INHBA|CELSR1|MEF2C|RFX2|CALCRL|DSCAM|BCAS3|HOXB3|SNAI2|MMP14|CTR9|FGF10|COL4A1|JMJD6|HMOX1|PIK3R3|COL4A2|MAFB|COL12A1|CCL2|CEACAM1|PDPN|ROBO4|COL8A1|FN1|DLC1|DEAF1|VEGFB|NOV|CCBE1|NRP2|LUZP1|ADIPOR2|TGFBR2|TGFBR3|THBS1|ZP3|TEK|ATOH8|SEMA5A|SRF|TCOF1|PDGFRB|SEMA3E|IGSF22|DCHS1|ITGA8|SLIT2|ID1|FKBP1A|MMP9|SNAI1|SERPINE1|WDR74|ADGRA2|RASIP1|CEND1|MYH9|ANG|EPHB4|COL6A1|WNT3|TGFBI|ADGRG1|PDGFA|ANXA2|PDGFRA|ENG|PGK1|ACTN1|KRT19|ACVRL1|FAM20A|LOXL2|ITGB4|MTHFD1
MUSCLE HYPERPLASIA%GOBP%GO:0014900,0.0367471477845582,0.27241249528203604,-0.877474496829336,-1.46025788144613,276,2,HMOX1|NOS3
SNRNA 3'-END PROCESSING%GOBP%GO:0034472,0.8444328143399191,0.948285501480553,-0.184756334148066,-0.702119186559596,6453,17,INTS2|INTS1|EXOSC7|EXOSC4|INTS7|EXOSC3|EXOSC2
RADIAL GLIA GUIDED MIGRATION OF CEREBELLAR GRANULE CELL%GOBP%GO:0021933,0.0964548494983278,0.427566585262796,-0.9493824437582711,-1.26480537525418,720,1,CEND1
ADENYLATE CYCLASE-INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007195,0.24603601182477802,0.6280519349499749,0.616428993311887,1.21244308643737,1830,3,DRD2|DRD4
POSITIVE REGULATION OF L-DOPA BIOSYNTHETIC PROCESS%GOBP%GO:1903197,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
RESPONSE TO RAPAMYCIN%GOBP%GO:1901355,0.389698996655518,0.7358910495632479,-0.804697838553154,-1.07205074029849,2912,1,LARP1
POSITIVE REGULATION OF ACONITATE HYDRATASE ACTIVITY%GOBP%GO:1904234,0.141939799331104,0.5078130330642999,-0.927878253198059,-1.2361566299673201,1060,1,FXN
AROMATIC AMINO ACID TRANSPORT%GOBP%GO:0015801,0.7140978432403999,0.898428686580078,-0.331465678689693,-0.794459982346027,5429,5,SLC16A10|SLC3A2
PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:0035196,0.487503395816354,0.788226301622024,0.21470643128132802,0.9727253509090079,3588,28,SMAD3|PRKRA|SMAD1|MRPL44|AGO2|AGO3|PUM2|ZCCHC11|SMAD2|DGCR8|ZC3H7A|AGO1
FEMALE GAMETE GENERATION%GOBP%GO:0007292,0.8560240177522521,0.949296218452153,-0.15621669867739402,-0.706336959450524,6557,29,ZP3|POMZP3|ANG|DIAPH2
PORE COMPLEX ASSEMBLY%GOBP%GO:0046931,0.607498689040378,0.849316898805358,-0.249690444412795,-0.883368279171515,4633,14,NUP98|BAD
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009159,0.45939799331103703,0.7735063645065241,-0.7714490516100571,-1.02775537258574,3433,1,DNPH1
PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT%GOBP%GO:0044860,0.674338624338624,0.882488012133495,-0.427073108075765,-0.8339655388376899,5097,3,ATP1B1|CAV1
UROGENITAL SYSTEM DEVELOPMENT%GOBP%GO:0001655,0.0245638520586183,0.220067158953043,0.230534273841605,1.49094642433795,175,104,RET|FOXC1|STRA6|IFT88|NPHP3-ACAD11|ITGA6|FGFR2|DLL1|CITED1|PAX8|AGTR1|AHI1|EPHB2|ARL3|FGF2|IFT140|SULF2|MPV17|PTPRO|ROBO2|WFS1|BMP7|PKD1|CEP290|WNT4|TFAP2B|NF1|ACD|NPHP3|PKD2
SOCIAL BEHAVIOR%GOBP%GO:0035176,0.588155392556371,0.8414799095069009,0.200289142653239,0.9074079682101222,4329,28,GRID1|DRD4|PTCHD1|CHRNB2|MKKS|ATXN1L|PPP3CB|NLGN4X|SHANK2|MSS51
FATTY ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1902001,0.44576502732240403,0.7673954889535091,0.343970394059603,0.9984858776919121,3262,8,ACACB|CPT1B|CPT1A|SLC27A5
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL%GOBP%GO:0086010,0.157177880686461,0.526948420373268,0.30526851825095197,1.2960006427143997,1153,23,TRPM4|SCN5A|ANK2|HCN2|CACNA1C|SCN3A|SCN9A|SCN2A|CACNB2|YWHAH|SLC8A1|SCN8A|CACNA2D1
POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0031112,0.27158812312721303,0.646576786621306,0.271397564273068,1.15220337735538,1993,23,MET|CLASP1|DCTN1|KATNB1|CDK5R1|STMN2|PAK1|PSRC1|ANKRD53
REGULATION OF COLLAGEN BIOSYNTHETIC PROCESS%GOBP%GO:0032965,0.25938566552901,0.636098664976652,-0.323022933123191,-1.17284390854802,1975,15,TGFB1|RGCC|TGFB3|CREB3L1|F2R|VIM|SERPINF2
PROGRAMMED DNA ELIMINATION%GOBP%GO:0031049,0.9014046822742479,0.9684180373391851,-0.549349360388178,-0.731865254597361,6737,1,RFWD3
REGULATION OF CHEMOKINE SECRETION%GOBP%GO:0090196,0.23431398073418397,0.6181066955939499,-0.42282724079560896,-1.21726044716371,1799,8,F2RL1|C5|TNF|PYCARD|IL33|CSF1R
T-HELPER 1 CELL ACTIVATION%GOBP%GO:0035711,0.705272944614159,0.894639008000397,0.646890163211292,0.8625407459047729,5309,1,HMGB1
POSITIVE REGULATION OF TOLERANCE INDUCTION TO TUMOR CELL%GOBP%GO:0002845,0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010985,0.0600706713780919,0.35478972492602706,-0.682016213533337,-1.49307605842783,458,4,KHSRP|APOC2|LRPAP1|APOC1
CELLULAR RESPONSE TO CISPLATIN%GOBP%GO:0072719,0.3617724867724871,0.716154857259883,-0.561925023547016,-1.09729715167557,2734,3,TIMELESS|ADIRF
NEGATIVE REGULATION OF NEURON DIFFERENTIATION%GOBP%GO:0045665,0.227232199719781,0.609201573718782,-0.18373019986062103,-1.1555054405541498,1783,95,GDI1|MED1|BAG5|THY1|HES1|RAB29|EFNA1|NGEF|CALR|SEMA3B|SEMA3D|STX1B|SEMA7A|EDNRB|APOE|SEMA5A|SEMA3E|EPHA4|SLIT2|ID1|FKBP4|SEMA3A|SEMA6B|RTN4RL1|ID4|MYLIP|DTX1|ARHGDIA|NGFR
MITOCHONDRIAL NCRNA SURVEILLANCE%GOBP%GO:0035945,0.7069996015407092,0.894949003158309,0.6461182179091309,0.861511461005126,5322,1,SUPV3L1
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS%GOBP%GO:1900180,0.0499419279907085,0.3202045177909881,-0.247001415323262,-1.44786458529816,386,73,GSK3B|LIF|PINX1|OTUD7B|AKT1|CCT7|NVL|TGFB1|PSEN1|CCT3|HYAL2|APOD|DTX3L|TERT|JUP|PARP9|ECT2|TRIM28|HCLS1|GAS6|INS|MDFIC|CCT8|BAG3|PARK7|CCT5|PDE2A|FLNA|IGF1|NMD3|RBM22|TMEM173|KAT7|DKC1|PLK1|LILRB4|NGFR|CARD10
ACETYLCHOLINE-MEDIATED VASODILATION INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003069,0.40414715719063593,0.7412049911665691,-0.7982465813850899,-1.06345611671244,3020,1,SOD2
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0003308,0.5814297231926899,0.8387093286508721,0.45700525993036406,0.8988754161142031,4326,3,DKK1
REGULATION OF PEPTIDYL-SERINE PHOSPHORYLATION OF STAT PROTEIN%GOBP%GO:0033139,0.724414715719064,0.9034590034658789,-0.6418725187472429,-0.855128317652101,5414,1,LIF
POSITIVE REGULATION OF PROTEIN ACTIVATION CASCADE%GOBP%GO:2000259,0.0464214046822743,0.308253762206553,-0.975077194530216,-1.29903695295591,346,1,PHB
REGULATION OF FERROCHELATASE ACTIVITY%GOBP%GO:0010722,0.141939799331104,0.5078130330642999,-0.927878253198059,-1.2361566299673201,1060,1,FXN
DERMATAN SULFATE METABOLIC PROCESS%GOBP%GO:0030205,0.59680377259628,0.844613508628182,-0.27290573447867394,-0.8835469982491879,4555,11,CSPG4|DSEL|NCAN|DCN|BGN|VCAN
"NEGATIVE REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT, NADH TO UBIQUINONE%GOBP%GO:1902957",0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
DETECTION OF LIGHT STIMULUS INVOLVED IN VISUAL PERCEPTION%GOBP%GO:0050908,0.612552642304035,0.852045339927398,0.396442986496104,0.871002124902697,4508,4,EYS|REEP6|CNGB1
CERAMIDE 1-PHOSPHATE TRANSPORT%GOBP%GO:1902389,0.882587328994555,0.9629606199413431,0.558281870313189,0.744393543495212,6644,1,CPTP
GERM-LINE STEM CELL POPULATION MAINTENANCE%GOBP%GO:0030718,0.897257525083612,0.967166974453851,-0.5520511689457429,-0.7354647123385308,6706,1,PIWIL2
POSITIVE REGULATION OF MITOCHONDRIAL TRANSCRIPTION%GOBP%GO:1903109,0.655250836120401,0.874775007199212,-0.675948389942656,-0.900525560183585,4897,1,CHCHD10
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE/THREONINE KINASE SIGNALING PATHWAY%GOBP%GO:0090101,0.421955624355005,0.7527812076478722,-0.177701609670222,-1.0162016945835501,3270,66,NOTCH1|SMURF2|HTRA3|CHRD|FBN1|LTBP1|CILP|LDLRAD4|SNX6|ADAMTSL2|NOV|TGFBR2|NBL1|UBC|FAM89B|CAV1
HISTONE H2A K63-LINKED DEUBIQUITINATION%GOBP%GO:0070537,0.11468253968254,0.463748809895271,-0.700341899194883,-1.3675902282029297,866,3,UIMC1|USP16|BRCC3
REGULATION OF HEPATIC STELLATE CELL ACTIVATION%GOBP%GO:2000489,0.515183946488294,0.803478510349408,-0.745092633436259,-0.9926422950290219,3850,1,RPS6KA1
PEPTIDYL-GLUTAMIC ACID CARBOXYLATION%GOBP%GO:0017187,0.49087301587301596,0.7904081687771529,-0.507065815367139,-0.990171022109424,3710,3,VKORC1
DNA REPLICATION-INDEPENDENT NUCLEOSOME ASSEMBLY%GOBP%GO:0006336,0.000908383078120945,0.0215526248664197,-0.3926643934405779,-2.04499758619426,6,47,MIS18BP1|RBBP4|HIST1H4J|CENPQ|ATRX|HIST4H4|NASP|CASC5|HIST1H4H|HJURP|ITGB3BP|CENPL|CENPU|CENPW|OIP5|RUVBL1|CENPM|NPM1|ASF1B|CENPI|IPO4|HIST1H4I|STRA13|RBBP7|CENPH|HIST2H4A|POLE3|HIST2H4B|CENPK|H3F3B|MIS18A|CENPP
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL%GOBP%GO:0010524,0.164159581425768,0.535290477921284,-0.277977621062227,-1.2691913961963501,1254,30,P2RX4|P2RX5|P2RX3|THY1|GRIN1|P2RY6|GPER1|F2R|APLNR|F2RL3|CX3CL1|CAV1
GLUCOSE-6-PHOSPHATE TRANSPORT%GOBP%GO:0015760,0.9689599570008058,0.9912626134248801,0.280591505190743,0.551890378734089,7210,3,SLC37A3|SLC37A1
CELLULAR CHEMICAL HOMEOSTASIS%GOBP%GO:0055082,0.000128221566867547,0.00518555396908895,-0.22616399546850896,-1.8291112335804498,0,358,ATP6V0A1|GNB2L1|MT1G|OCM|EDNRA|CCL19|SLAMF8|HSP90B1|FPR3|LPAR6|RYR2|GPR89B|TCIRG1|ZNF236|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|ATP6V0A2|ERO1L|PTGER1|RAB7A|PLN|ITPR3|SLC8B1|ATP1A3|ATP1B3|WBP2NL|P2RX5|P2RX3|GAS6|ANXA6|SLC39A8|HK1|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ATP5B|HK3|ADCY8|CXCR4|JPH4|CALB2|CCDC22|TAC1|CALCB|DMXL1|RMDN3|ATP6V0D1|ABCB7|HAMP|CA2|SLC9A1|PTGER4|ORMDL3|TBXA2R|SLC9A7|SLC11A1|NUCKS1|GHRL|ABL1|CALR|ACO1|HERPUD1|HMOX1|SOD1|SKP1|SLC35G1|ARF1|SLC9A9|MT1M|CCRL2|P2RY6|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|FTL|APLNR|GNA15|TMCO1|MTL5|CD36|F2RL3|ATP6V0E1|GRIN2C|FXN|MT2A|PDK3|TGM2|FITM2|GRIN2D|TRA2B|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|ATP1B2|PRKACA|ATP6V0E2|S100A8|S100A9|RAB20|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|TFRC|ATP6V1A|ATP6V1G1|C5AR1|NGFR|FTH1|ERN1|C1QTNF1|PRNP
POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION%GOBP%GO:0048714,0.785675893576995,0.9274485629622209,0.380773216781628,0.7489359832135899,5846,3,TENM4|ZNF365
REGULATION OF MELANOSOME TRANSPORT%GOBP%GO:1902908,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
REGULATION OF GLUTAMATE UPTAKE INVOLVED IN TRANSMISSION OF NERVE IMPULSE%GOBP%GO:0051946,0.5137123745819401,0.8023339441082009,-0.7458645787384209,-0.9936707115264991,3839,1,PER2
RUFFLE ASSEMBLY%GOBP%GO:0097178,0.26797642436149305,0.6418798906350429,-0.4559463606064071,-1.1728168650942,2045,6,AIF1L|AIF1|ARF6
FATTY ACID METABOLIC PROCESS%GOBP%GO:0006631,0.32782475019215995,0.6950398637731511,-0.149691063883411,-1.0672116499361,2558,172,ABHD3|GPX4|ALOX5|SCD5|CD74|CES1|PER2|LTC4S|CROT|TBXAS1|ACOT1|GPAM|AOAH|ECHDC2|PTGDS|CRAT|CYP1B1|GGT1|GPX1|ELOVL2|CBR1|ACSF3|DAGLB|ELOVL1|PTGR2|PLA2G4A|ADIPOR1|PTGES2|PTGS1|ACAD10|THNSL2|ACOX1|PLA2G4C|DAGLA|CD36|ADIPOR2|HACD2|GGT5|SLC27A4|NDUFAB1|LPIN3|ACOT2|PPARG|PPARA|PLAA|ABCD1|MGLL|GSTP1|FADS1|FADS2|HADH|LPIN2|FASN|PTGES|ETFB|PTGIS
PROTEIN ACYLATION%GOBP%GO:0043543,0.0439953958306689,0.299062021084573,-0.20503253577828198,-1.39865529963604,343,138,YEATS2|DLST|ABHD17A|CPA4|ZDHHC11B|NAA25|ING3|NAA20|NAA40|ABHD17B|KAT6A|KANSL1|PORCN|ESCO2|KANSL2|JADE3|ZDHHC11|NAA30|ZDHHC15|NAA10|ZDHHC9|YEATS4|ZDHHC4|TAF6L|BRPF3|RUVBL1|ZDHHC12|HCFC1|OGT|TAF12|NMT1|MORF4L2|MSL2|PHF20|NAA50|WDR5|KAT7|TAF9B|SPI1|MBIP|KAT2B|ZDHHC19|APBB1|TAF10|KAT8|KAT5|TAF9|ZDHHC24|POLE3|ZDHHC2|CCDC101|NATD1|ZDHHC5|AK6
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION%GOBP%GO:0051129,0.00508001016002032,0.0803498785568947,-0.17152717984248703,-1.43340950250455,39,447,APOD|H1F0|CDC20|GNB2L1|KANK1|WASF2|TRIAP1|CORO1C|IRAK3|CORO1A|SETMAR|FEZ1|SET|TERF2|LCMT1|IMPACT|NBN|TINF2|BCOR|UBQLN2|PPIF|PHF2|ESPL1|ATAD2|TLR2|NAA10|PARP1|SEMA6A|RAB7A|APOC1|HGF|GDI1|HNRNPU|MCTP1|WAS|OPA1|DYRK1A|NPM1|SMAD6|BAG5|RAD1|FCGR2B|PTTG1|GPX1|SCFD1|INS|THY1|TOP2A|CDK5RAP2|RAB29|MAD2L1|PRELID1|DDX3X|THRA|LILRB2|EFNA1|NOTCH1|SLX1B|PHLDB2|PTGER4|SLX1A|PRKD1|CD47|PARK7|BRCA1|BCAS3|NGEF|APOM|TAF7|DNMT1|RAPGEF3|PPFIA1|NECAB2|DYSF|IGF1|DPP4|FAP|NR1H3|SEMA3B|ARHGEF15|TUBB4A|SEMA3D|LDLRAD4|STX1B|SEMA7A|KANK3|CD300A|SPI1|GSN|PSMD10|CORO1B|APOE|PLK1|DLC1|RBM14|KAT2B|LGALS3|CHMP4A|THBS1|FXN|SEMA5A|CD300LF|SEMA3E|EPHA4|H1FX|SLIT2|MNAT1|NAV3|CRYAB|CAV1|LDLR|FKBP4|FAM107A|SEMA3A|SEMA6B|IK|PRRT2|RTN4RL1|DACT1|MPV17L|MYLIP|EVL|EPS8|STYXL1|HIST1H1C|H2AFY|TNFRSF1A|TMSB4X|OTUB1|ARHGDIA|RAP1GAP|ACVRL1|ARF6|TNFRSF1B|NGFR|FBLN1|HNRNPC|NAT10|EFNA5|CST3|SIRPA|INSIG1|SLC25A5|PRNP
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS%GOBP%GO:1901522,0.7531870153765279,0.915498058528019,-0.197980557975962,-0.782202714605675,5730,19,CREB3|SMAD5|NOTCH1|BMP2|RELA
SPERM CAPACITATION%GOBP%GO:0048240,0.9545081967213109,0.9870180073166591,0.198855695780559,0.577243295831681,6986,8,PCSK4|CATSPER2|SLC26A6
RESPONSE TO LAMINAR FLUID SHEAR STRESS%GOBP%GO:0034616,0.535762850149579,0.8132910857498922,0.294041559658576,0.931543536765785,3939,10,MAPK7|MAP2K5|NFE2L2
REGULATION OF ANTIGEN RECEPTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0050854,0.0553395541731467,0.34165878259009896,-0.30072924509969895,-1.48507552370423,426,39,THY1|RAB29|PVRL2|PHPT1|NFAM1|CEACAM1|CD300A|LGALS3|RELA|LILRB4|PRKCB|PTPRJ|PRNP
ENDOTHELIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0086100,0.175652173913043,0.548366806412612,-0.909902955447728,-1.21220921724036,1312,1,EDNRB
POSITIVE REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT%GOBP%GO:2000078,0.586243386243386,0.840877942107805,-0.46250664051776796,-0.9031582471050429,4431,3,BAD
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION%GOBP%GO:0045600,0.0352514256091239,0.267552181261549,-0.31719225092215403,-1.56637392547896,271,39,HNRNPU|SFRP2|INS|SYAP1|MEDAG|CEBPB|CREBL2|LRP5|ADIRF|BMP2|RARRES2|CCRN4L|PPARG|CMKLR1|ZNF385A|METRNL
CONVERGENT EXTENSION INVOLVED IN GASTRULATION%GOBP%GO:0060027,0.0158559527008869,0.170846085022373,0.835226646079188,1.6427922496089,117,3,NPHP3-ACAD11|MKKS|NPHP3
CARGO LOADING INTO COPII-COATED VESICLE%GOBP%GO:0090110,0.887914102396229,0.965159112268525,-0.188981274524186,-0.650510194521033,6780,13,SEC23A|SEC13|SEC24A
TRIGLYCERIDE MOBILIZATION%GOBP%GO:0006642,0.11636656812684801,0.46625878958064004,0.69532370133451,1.36761966692979,865,3,LPIN1|SLC27A5|SIRT1
L-LYSINE METABOLIC PROCESS%GOBP%GO:0046440,0.39181830256342104,0.7371240382543249,0.805359505955007,1.07383823173245,2949,1,PIPOX
NEGATIVE REGULATION OF MAP KINASE ACTIVITY%GOBP%GO:0043407,0.282127604503688,0.654732517474162,-0.205427636440835,-1.12489114668802,2179,56,CD300A|MBIP|APOE|PPP2CA|CAV1|DNAJA1|SMPD1|RGS2|GPS1|GSTP1|RGS3|PTPRJ
CELL-CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033631,0.40489417989418,0.7419998354794191,-0.543068269548914,-1.06047469034193,3060,3,NPNT|ITGB1|ADAM9
POSITIVE REGULATION OF SPERMIDINE BIOSYNTHETIC PROCESS%GOBP%GO:1901307,0.620135476158852,0.8551097775270831,0.687031318923688,0.916063560686454,4668,1,PAOX
NEGATIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0106072,0.8667024993281379,0.9555750264459809,0.346862247711481,0.682237108810244,6449,3,ATP2B4|MRAP2
INTESTINAL EPITHELIAL CELL MIGRATION%GOBP%GO:0061582,0.344882943143813,0.7024647311177249,-0.8245478606087341,-1.0984957359479,2577,1,ARSB
CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS%GOBP%GO:0035729,0.24381904260915302,0.626320329556411,-0.505008676586537,-1.21040943325275,1853,5,HGF|BCAR1|LGMN
SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051145,0.016014702021528,0.17167030511103,-0.476859211565574,-1.7313984988997702,121,15,TMEM204|HES1|MESP1|NOTCH1|MEF2C|EDNRB|GATA6|ENG
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0045943,0.779197824609109,0.924704689181848,0.18260875892302497,0.7642089855513209,5730,22,WDR75|DHX33|PIH1D1|HEATR1|EIF2AK3|SMARCB1|ATF4|ERBB2|MTOR|MARS
REGULATION OF ENDODERMAL CELL DIFFERENTIATION%GOBP%GO:1903224,0.40256510927889005,0.740287621109606,-0.479336461791204,-1.0493677141840698,3075,4,MESP1|COL5A2|COL5A1
DETECTION OF CELL DENSITY%GOBP%GO:0060245,0.41672240802675603,0.7493091022753771,-0.7918504631671809,-1.05493495144763,3114,1,SMO
NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL%GOBP%GO:0002835,0.192107023411371,0.5665036350989531,-0.902459197176886,-1.20229234387183,1435,1,CEACAM1
REGULATION OF URINE VOLUME%GOBP%GO:0035809,0.526537260757432,0.809730111932754,0.35807595681513205,0.926542584266967,3878,6,INPP5K|TFAP2B|ADCY6
REGULATION OF HEART CONTRACTION%GOBP%GO:0008016,0.0272073921971253,0.23271567002476898,-0.22809396956279698,-1.49343111453993,211,113,AGT|RYR2|JUP|CXADR|ITPR2|ATP1B1|ATP2A1|P2RX4|FOXN4|SPTBN4|PLN|ADORA3|ITPR3|ATP1A3|TBX2|KCNN2|KCNK6|CACNA1H|PDE4B|STIM1|ATP2A3|PDE4D|NPR2|SLC9A1|PKP2|CACNA1G|POPDC2|FLNA|FXYD1|KCNJ12|NPR1|HSPB7|KCNQ1|CHGA|ASPH|CAV1|SCN1B|CLIC2|ATP1B2|PRKACA|KCNH2|KCNE4|ADRBK1|RGS2|ATP2B2
NEGATIVE REGULATION OF ACTIN FILAMENT BINDING%GOBP%GO:1904530,0.323947403373622,0.692691148776056,0.83756065284517,1.11677411611776,2438,1,CRMP1
NEGATIVE REGULATION OF NITRIC-OXIDE SYNTHASE ACTIVITY%GOBP%GO:0051001,0.9773809523809521,0.9927322181739301,-0.274122722903173,-0.535292201711382,7388,3,NOSIP|GLA
"NEGATIVE REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0043518",0.46499737808075503,0.7786333182377991,-0.27968255933153996,-0.9894759958956879,3546,14,CD44|CD74|KDM1A|DYRK1A|SNAI2|PSMD10|SNAI1
PRIMARY ALCOHOL CATABOLIC PROCESS%GOBP%GO:0034310,0.48118462165466597,0.7857362908355991,0.4399947998588,0.9666873136294409,3541,4,SULT1C4|AKR1C3|SULT1A3|SULT1A1
NEGATIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0035021,0.827304394426581,0.943061234519578,0.43426524791946397,0.7296216867604879,6174,2,STMN3
REGULATION OF SMOOTH MUSCLE CELL-MATRIX ADHESION%GOBP%GO:2000097,0.0727513227513227,0.37960378163431896,-0.736903055034741,-1.43898489917132,549,3,APOD|PLAU|SERPINE1
REGULATION OF INTERLEUKIN-17 PRODUCTION%GOBP%GO:0032660,0.0438653921697001,0.299062021084573,-0.46033127659731893,-1.5845495223661101,334,13,FOXP3|TGFB1|NCKAP1L|IL18|OSM|IL15|C10orf54|TLR4|PRNP
MAINTENANCE OF CELL POLARITY%GOBP%GO:0030011,0.8635245901639341,0.9531672929044319,0.23165450972802804,0.672452514698111,6320,8,WDR1|DST|PDCD6IP|DLG5|ANK1
TREHALOSE METABOLISM IN RESPONSE TO STRESS%GOBP%GO:0070413,0.92389427546819,0.9776627603891009,0.5387075430083811,0.718293819254146,6955,1,BRAF
FERRIC IRON IMPORT%GOBP%GO:0033216,0.875696471212523,0.9605516796761558,-0.417280810828985,-0.6944219974381421,6600,2,STEAP4
REGULATION OF CARDIAC MUSCLE TISSUE GROWTH%GOBP%GO:0055021,0.170911000262536,0.5445281022215971,-0.3533072455970229,-1.2828013380905,1301,15,TBX2|NOTCH1|MEF2C|PIM1|IGF1|TGFBR3
ENDOTHELIAL CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:0035768,0.327002257935981,0.6941148928066879,0.8358513453903841,1.1144949852685402,2461,1,CXCL13
REGULATION OF METANEPHRIC MESENCHYMAL CELL MIGRATION%GOBP%GO:2000589,0.000529100529100529,0.0139529201631112,-0.93448770265799,-1.8248176383564498,3,3,PDGFRB|PDGFA|PDGFB
MESONEPHROS DEVELOPMENT%GOBP%GO:0001823,0.0426655830963023,0.295642142953081,0.382451647626975,1.57652345811041,314,21,FOXC1|FGFR2|CITED1|PAX8|FGF2|ROBO2|BMP7|PKD1|PKD2|FGF1|FOXJ1
MODULATION BY VIRUS OF HOST AUTOPHAGY%GOBP%GO:0039519,0.5390023879013,0.8142313733497609,-0.583733112765371,-0.97142524558466,4062,2,EIF2AK4|ATG7
MONOCARBOXYLIC ACID METABOLIC PROCESS%GOBP%GO:0032787,0.0384909508029569,0.279776552671739,-0.17143468026158198,-1.33390263149634,301,280,HLCS|GGT1|GPX1|ELOVL2|HK1|CBR1|PDHA1|ACSF3|KYNU|HK3|DCN|DAGLB|ELOVL1|PTGR2|PLA2G4A|ADIPOR1|PARK7|PTGES2|PTGS1|BGN|MCCC2|ENO1|ACAD10|VCAN|IGF1|THNSL2|PGAM1|ACOX1|PLA2G4C|ABHD10|N6AMT1|CYP46A1|ALDH1A2|GAPDH|DAGLA|CD36|ADIPOR2|CYP7B1|HACD2|GGT5|SLC27A4|LDHA|ALDH4A1|IDNK|NDUFAB1|LPIN3|ACOT2|PPARG|PPARA|PLAA|OSBP|PDHX|PCCB|ABCD1|MGLL|GSTP1|PGK1|FADS1|FADS2|ASRGL1|HADH|LPIN2|FASN|OSBPL3|CRYL1|PTGES|ALDOA|ALDOC|ETFB|PTGIS
CARNOSINE METABOLIC PROCESS%GOBP%GO:0035498,0.634113712374582,0.863354277348854,-0.687637847375386,-0.9160987242882359,4739,1,C9orf41
REGULATION OF HIPPO SIGNALING%GOBP%GO:0035330,0.6715179542981501,0.8815356925073421,0.245577373378502,0.834669726837073,4936,12,NEK8|WWC2|MOB3B
POSITIVE REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060399,0.9562169312169309,0.9877474384126891,-0.295191977256762,-0.576435115483378,7228,3,GHRL
POSITIVE REGULATION OF CELL-CELL ADHESION MEDIATED BY CADHERIN%GOBP%GO:2000049,0.39332023575638503,0.7375199755844078,-0.407604442163193,-1.0484684282171,3002,6,ADAM19|SERPINF2
AUXIN CATABOLIC PROCESS%GOBP%GO:0009852,0.933913043478261,0.9800972968717879,-0.53253198059109,-0.709460466616613,6980,1,ACAA1
REGULATION OF FERROUS IRON BINDING%GOBP%GO:1904432,0.181745821172725,0.554948538055731,-0.744527157430383,-1.23901224880824,1369,2,B2M|HFE
EPINEPHRINE SECRETION%GOBP%GO:0048242,0.764510559171205,0.9191113740914171,0.6177767975297751,0.82372200111806,5755,1,VIP
METANEPHRIC PART OF URETERIC BUD DEVELOPMENT%GOBP%GO:0035502,0.154876741693462,0.523022297381039,0.7661428177557209,1.28721885453295,1155,2,PKD2|FOXJ1
CEREBELLUM DEVELOPMENT%GOBP%GO:0021549,0.18864069735766797,0.562795638432777,0.29445445980600704,1.25009015454713,1384,23,FOXC1|SCN5A|DLL1|TTBK2|ATP7A|ADCK4|AGTPBP1|LRP6|NLGN4X|PROX1|ZNF365
PROTEIN K27-LINKED UBIQUITINATION%GOBP%GO:0044314,0.9059205190592049,0.9705220236903108,0.266254043907665,0.640339448761181,6701,5,PARK2|UBE2D4|RNF6
INTERMEDIATE FILAMENT-BASED PROCESS%GOBP%GO:0045103,0.166951043444022,0.53917243184018,-0.315440643232669,-1.2851074518094598,1271,21,TOR1A|KLHL24|ERBB2IP|KRT9|KRT18|PKP2|SOD1|SYNM|CSNK1A1
NATURAL KILLER CELL PROLIFERATION%GOBP%GO:0001787,0.992909698996655,0.997305769352475,-0.503584031760035,-0.6708948479612271,7421,1,ELF4
NEGATIVE REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1903609,0.10515050167224099,0.446168961873938,-0.9450264666960742,-1.25900216787556,785,1,CAV1
POSTSYNAPTIC DENSITY ORGANIZATION%GOBP%GO:0097106,0.425604626708728,0.7547028278218628,-0.37421164963343606,-1.02289085654269,3237,7,TMEM108|NRXN2
NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION%GOBP%GO:0010823,0.249804636624121,0.6303541958147291,-0.25480117212526704,-1.17426983409529,1917,31,VAT1|AKT1|MAPT|MUL1|TRIAP1|PPIF|HGF|OPA1|GPX1|PRELID1|IGF1|PSMD10|FXN|MPV17L|SLC25A5
NEGATIVE REGULATION OF ISOPRENOID METABOLIC PROCESS%GOBP%GO:0045827,0.77991765174658,0.924704689181848,0.609726510807234,0.8129880300217339,5871,1,AKR1C3
REGULATION OF EPITHELIUM REGENERATION%GOBP%GO:1905041,0.11581883384247599,0.46559625491895207,0.9433722981914421,1.25785966771947,871,1,DUSP10
ANION HOMEOSTASIS%GOBP%GO:0055081,0.20959958262684197,0.591040130748022,-0.276430969816408,-1.21919562660638,1606,27,FGFR4|SLC12A8|SFRP4|SLC12A2|INS|FABP3|ABCG1|POLD1|CETP|RCN3|APOE|ABCD1
NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS%GOBP%GO:2000675,0.9149422198333779,0.9740523336757891,0.321742734201848,0.6328299900344151,6808,3,WFS1|TCF7L2
VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS%GOBP%GO:0003222,0.272715438687842,0.6469898816267529,-0.40718878699455296,-1.17223952743535,2094,8,TGFBR1|DLL4|TGFB2|NRG1|NOTCH1|ENG
PEPTIDYL-SERINE TRANS-AUTOPHOSPHORYLATION%GOBP%GO:1990579,0.0101672240802676,0.129323654372743,-0.9944309660344071,-1.32482082371408,75,1,ERN1
RESPONSE TO CAMP%GOBP%GO:0051591,0.585569158635061,0.8402019438706679,-0.19806875421357,-0.9128143375866541,4495,31,AQP1|NDUFS4|JUNB|ZFP36L1|RAPGEF1|AHR|CRHBP|PDE2A|RAPGEF3|RAP1A|KCNQ1|IGFBP5
NEGATIVE REGULATION OF ACTIN NUCLEATION%GOBP%GO:0051126,0.725821227588012,0.904327817490601,-0.3589285924134629,-0.7857697183492971,5545,4,ARPIN|CORO1A|CORO1B
DOPAMINE TRANSPORT%GOBP%GO:0015872,0.162456328943832,0.5335700386874099,0.663119002977832,1.30427682566664,1208,3,SLC6A2|SNCA|SLC18A2
HISTAMINE SECRETION BY MAST CELL%GOBP%GO:0002553,0.4486651613760129,0.768229288546963,0.7769078076753421,1.03590173114544,3377,1,SNAP23
CARBOXYLIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0046394,0.24525641025641,0.62804240987169,-0.15154771957551502,-1.1150458460455601,1912,203,SERINC3|ALOX5AP|PYCR1|GATM|FOLH1|CEMIP|ABHD3|GPX4|ST20-MTHFS|ALOX5|SCD5|CCBL1|PGAM2|CD74|NCAN|PER2|NANP|PLOD2|LTC4S|CDO1|TBXAS1|PYCRL|GOT1|PTGDS|GPT|GPI|PFKFB2|PHGDH|GGT1|ELOVL2|HK1|CBR1|ACSF3|KYNU|HK3|DCN|ADI1|ELOVL1|PARK7|PTGES2|PTGS1|BGN|HAAO|ENO1|VCAN|THNSL2|PGAM1|SERINC5|DHFR|CYP46A1|GAPDH|HYAL1|CYP7B1|HACD2|GGT5|LDHA|NDUFAB1|OSBP|ABCD1|BCAT2|SHMT2|PGK1|FADS1|APIP|OSBPL3|PTGES|ALDOA|ALDOC|MTHFD1|PTGIS
CYTOKINE SECRETION%GOBP%GO:0050663,0.46147788423677705,0.775419565832514,-0.243219878752564,-0.9908795373035191,3515,21,LILRB1|CHI3L1|CCL19|TLR2|S100A13|CD36|FOXP1|TLR4|PNP
PROTEIN LOCALIZATION TO CENTROSOME%GOBP%GO:0071539,0.48607147710286697,0.7872939093021379,0.252480520801441,0.9708628245024699,3576,17,BBS4|KIAA0753|PIBF1|PCM1|DCTN2
NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION%GOBP%GO:0046007,0.0804478000520698,0.397722753303477,-0.51615461408098,-1.48593689271202,617,8,FOXP3|CD274|PDCD1LG2|PRKAR1A|LGALS9|PRNP
GLYCOSAMINOGLYCAN CATABOLIC PROCESS%GOBP%GO:0006027,0.0188606123239892,0.189303394362172,-0.318814916726516,-1.6515615832287198,145,46,CD44|TGFB1|CEMIP|HSPG2|HYAL2|TMEM2|NCAN|SDC3|PRELP|HYAL3|NAGLU|ARSB|DCN|SLC9A1|SDC4|BGN|VCAN|OGN|LUM|SDC2|FMOD|FUCA1|HYAL1|LYVE1|HEXB
METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT%GOBP%GO:0072243,0.0165278151034668,0.17512293405535098,0.834178890481968,1.6407314379924598,122,3,PAX8|PKD1|PKD2
CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072202,0.622896950578339,0.857007260823118,-0.31508804065517,-0.8612791079803109,4738,7,CD34|SMO|PDGFB
REGULATION OF CYTOSKELETON ORGANIZATION%GOBP%GO:0051493,0.0198776758409786,0.194536746706525,-0.16757697056115697,-1.36309782872767,155,371,HCLS1|CCL24|ARPC1A|HNRNPU|ARHGAP18|PLK2|STAG2|TPX2|WAS|FES|DYRK1A|NPM1|ARHGDIB|IQGAP2|PLEK|TGFB3|CDK5RAP2|TAOK2|RHOF|LMOD1|PHPT1|PDXP|PHLDB2|SLC9A1|PTGER4|ARHGAP44|CLTC|CD47|HAX1|BRCA1|BCAS3|S100A10|CTGF|PXN|MECP2|MAPK3|BST1|RHOD|ABL1|SPICE1|CEP131|RAPGEF3|PPFIA1|HRAS|ARF1|ARHGEF15|TUBB4A|GPM6B|KANK3|RND1|GSN|BAIAP2L1|CORO1B|PLK1|SKA1|NSFL1C|DLC1|RBM14|KAT2B|HCK|BST2|CDC42EP4|TEK|CFL2|SEMA5A|ARPC5L|ARL2|PDGFRB|SEMA3E|SYDE1|SLIT2|NAV3|CX3CL1|FBXW5|FKBP4|FAM107A|SMC1A|S100A8|CETN2|S100A9|PDGFA|CDK2AP2|CSF1R|EVL|NF2|PDGFRA|EPS8|CDC42EP1|ATF5|MARK2|CDC42EP5|SYNPO|TMSB4X|NCK1|ARHGDIA|ARF6|XRCC3|EFNA5|CDC42EP2|SERPINF2|SKA2
POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS%GOBP%GO:1904261,0.187483103541498,0.5609377558550861,0.533835978022693,1.2838724658562701,1386,5,CLASP1|CLASP2|PHLDB1
ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS%GOBP%GO:1901616,0.689013544944589,0.887051934478962,0.17541393862686402,0.8415938228976608,5035,34,SULT1C4|INPP1|INPP5K|INPP5J|SORD|IMPA1|TRERF1
REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CONTROLLING TYPE B PANCREATIC CELL PROLIFERATION%GOBP%GO:2000079,0.0298844468056847,0.244735657013286,0.9855535950595501,1.31410273545021,224,1,SFRP1
OPTIC PLACODE FORMATION%GOBP%GO:0001743,0.506308938770089,0.798168488166378,0.7477393030436701,0.997009466008748,3811,1,PROX1
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN METANEPHRIC NEPHRON TUBULE DEVELOPMENT%GOBP%GO:1900218,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
LIVER REGENERATION%GOBP%GO:0097421,0.934112213014536,0.9800972968717879,0.27951184010022195,0.614099416449504,6875,4,SULF2
POSITIVE REGULATION OF POLYSOME BINDING%GOBP%GO:1905698,0.545819397993311,0.817297924969912,-0.7299845610939569,-0.972514715006973,4079,1,DHX9
GANGLION DEVELOPMENT%GOBP%GO:0061548,0.559423443024205,0.8268422944617521,0.28790633079883604,0.9121067170267471,4113,10,INSM1|ASCL1|POU4F2|NRP1|SEMA3F|FZD3|CTNNB1
REGULATION OF HISTAMINE SECRETION BY MAST CELL%GOBP%GO:1903593,0.15284872298624802,0.52097307188263,-0.517782023408208,-1.33187484748883,1166,6,SNX4|VAMP8|VAMP7|SNX6
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:2000795,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
GMP SALVAGE%GOBP%GO:0032263,0.211103678929766,0.5929592989748729,-0.8924239082487869,-1.18892292940463,1577,1,HPRT1
INFLAMMATORY RESPONSE%GOBP%GO:0006954,0.000128057369701626,0.00518555396908895,-0.36371460192924604,-2.64033398525061,0,189,PNMA1|CCL3|MAPT|RIPK2|TNF|SYK|CCL4|MMP25|RAC1|LTB4R2|CCL8|APOL3|CXCL1|CD44|TGFB1|NCR3|CXCL2|CCL11|PSEN1|HSPG2|CHI3L1|TLR1|F12|C2CD4A|IL18|ADAM8|CCL19|SLAMF8|FPR3|C2CD4B|CDO1|HMGB2|SERPINA3|ITGB2|IL17D|TLR2|LRP1|PTGER1|PXK|CCL24|ADORA3|TNFAIP6|HP|HYAL3|AZU1|FCGR2B|PLA2G2D|INS|CCL3L3|FPR1|CCL18|PLSCR1|ADCY8|CXCR4|NFX1|TAC1|NFE2L1|MAPKAPK2|IL10RB|CRHBP|PTGER4|LTB4R|STAT3|NFAM1|TBXA2R|SIGLEC1|F3|SLC11A1|CYBB|HMOX1|TNFRSF4|CEBPB|HDAC5|PLA2G4C|CCRL2|CCL2|F2R|CCR1|NLRP3|HYAL1|ADGRE5|CD36|BMP2|LGALS9|THBS1|GGT5|RELB|AIF1|CX3CL1|C3AR1|CCL4L2|CCL14|RELA|NFKB1|TLR4|S100A8|MGLL|ITGAM|S100A9|CSF1R|PTGIR|CMKLR1|ANXA1|PRDX5|TNFRSF1A|TOLLIP|CD14|FOLR2|AOC3|HNRNPA0|C5AR1|ACKR1
POSITIVE REGULATION OF HISTONE H3-K79 METHYLATION%GOBP%GO:2001162,0.9088617670469621,0.9715076818387142,-0.39228746864615904,-0.652829079310004,6850,2,CTR9
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051828,0.0418574231523872,0.293009782616793,-0.33851609437803604,-1.5455982133267299,319,30,HYAL2|ZNF639|CTNND1|CD4|PPIA|CAV2|GAS6|PVRL2|CXCR4|GRB2|VAMP8|AXL|CAV1|ADRBK1|CD81
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION%GOBP%GO:0071635,0.816806943713835,0.937561671392072,-0.30065223543541,-0.720606038611675,6210,5,CDH3|HSP90AB1|FURIN|GATA6
PROTEIN UNFOLDING%GOBP%GO:0043335,0.450517378615017,0.7687932540972091,-0.619204891551533,-1.03045595784875,3395,2,HSP90AA1
L-CYSTEINE CATABOLIC PROCESS TO HYPOTAURINE%GOBP%GO:0019449,0.410811528755479,0.7454201520455229,0.7961513012792242,1.0615603332866501,3092,1,CSAD
CELLULAR RESPONSE TO INTERLEUKIN-7%GOBP%GO:0098761,0.11869747899159698,0.469617660353565,-0.33988497553416697,-1.36361201187871,903,20,BRWD1|HIST1H3D|IL2RG|JAK3|STAT5A|SMARCA4|IRS1|SOCS1|STAT3|CISH|HIST2H3A|HIST2H3C|HIST1H3H
POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION%GOBP%GO:0045840,0.00852933574567072,0.114840918117116,-0.365518929863355,-1.7756712588326102,65,37,NIPBL|PHB2|BECN1|IL1B|AURKA|RGCC|NUSAP1|DLGAP5|CDT1|ANAPC5|ESPL1|ANKRD32|HNRNPU|INS|IGF1|LRP5|NSFL1C|PDGFRB|H2AFY|ANAPC11|CDCA5|PDGFB
TRYPTOPHAN METABOLIC PROCESS%GOBP%GO:0006568,0.4640437727983329,0.7777638773705721,-0.327935710712473,-0.986510887448367,3561,9,TDO2|KMO|CCBL1|KYNU|HAAO|AFMID
HISTAMINE SECRETION%GOBP%GO:0001821,0.140675241157556,0.505564604777695,0.7769506479183901,1.30537740466168,1049,2,ADCYAP1|SNAP23
LUTEOLYSIS%GOBP%GO:0001554,0.440472991131416,0.7653693162885199,0.5187261672588429,1.0202731572830601,3277,3,ROBO2|SLIT3
MEMBRANE BENDING%GOBP%GO:0097753,0.536060565812193,0.8132910857498922,0.730480811645346,0.973997596466624,4035,1,PICALM
KIDNEY DEVELOPMENT%GOBP%GO:0001822,0.0331438080710026,0.25998057358601,0.23505305780858,1.47443342064976,238,90,RET|FOXC1|STRA6|IFT88|NPHP3-ACAD11|FGFR2|DLL1|CITED1|PAX8|AGTR1|AHI1|ARL3|FGF2|SULF2|MPV17|PTPRO|ROBO2|WFS1|BMP7|PKD1|CEP290|WNT4|TFAP2B|NF1|NPHP3|PKD2
IMP METABOLIC PROCESS%GOBP%GO:0046040,0.29618569295506997,0.6687276080240239,0.441643038291891,1.14277731926511,2181,6,PFAS|AMPD2|NT5C2|ADSS
POSTTRANSCRIPTIONAL GENE SILENCING%GOBP%GO:0016441,0.935305466237942,0.9806508984207809,-0.11974230508728301,-0.649277076198778,7271,54,CNOT6|SRRT|TNRC6A|AJUBA|NOTCH4|C9orf114|DHX9|HELZ|TERT|LIN28B|PPP1R8|CELF1|HNRNPA2B1|STAT3|NCBP1|CLP1|TNRC6C|RAN|RBM4|WTIP
G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0000082,0.00533672172808132,0.0829378624098312,-0.274107192930225,-1.7199579201067798,41,94,ID2|POLE|TYMS|BRD4|CUL4B|PIM2|RPA2|CDK6|RRM2|MCM10|TFDP2|CDT1|MCM4|EIF4EBP1|MCM6|CDC6|PLK2|CDKN2A|PCNA|GMNN|ORC1|ORC6|MCM3|INHBA|MCM5|CDC45|RCC1|E2F1|DHFR|MAX|LATS2|MCM2|CAMK2A|MYC|RPS6KB1|CDKN2C|POLE2|POLA1|POLE3|CDKN3|PPP6C|CCND1|POLA2
SKELETAL SYSTEM DEVELOPMENT%GOBP%GO:0001501,0.00435339308578745,0.0731407797055425,-0.22919809254616502,-1.6320088273793403,33,171,TBX1|COL20A1|RUNX3|PCSK5|COCH|SBDS|COL11A2|SFRP4|CREB3L2|MED1|PRELP|AEBP1|HYAL3|ARSE|WWOX|ETS2|HOXA4|ANXA6|POSTN|PPIB|VWA1|NDST1|COL14A1|MGP|PTGER4|MEF2C|CHRD|FREM1|HOXB3|FBN1|MBTPS2|GHRL|COMP|SULF1|IGF1|LRP5|CDH11|COL5A2|COL12A1|COL6A3|DEAF1|PLS3|COL21A1|HYAL1|NOV|TGFBR2|BMP2|COL1A2|COL1A1|EIF4A3|TCOF1|TNFRSF11B|FOXP1|GDF11|EBP|COL6A1|TRAPPC2|ANXA2|PDGFRA|CMKLR1|ALPL|ZNF385A|IGFBP4|COL6A2|VKORC1|COL13A1|MTHFD1
APOPTOTIC MITOCHONDRIAL CHANGES%GOBP%GO:0008637,0.704839809134288,0.894639008000397,0.16174123941386598,0.839416294554777,5169,44,MFF|BBC3|AIFM2|BOK|PMAIP1|DNM1L|BID|HSPD1|VPS35|ATF2|BAX|BCL2|ACAA2|THEM4|NDUFS1|TIMM50|BMF|C22orf29|NAIF1|RHOT2
POSITIVE REGULATION OF CELLULAR GLUCURONIDATION%GOBP%GO:2001031,0.227254615486784,0.609201573718782,0.887792236435818,1.18375115494483,1710,1,PRKCE
REGULATION OF ROOT HAIR ELONGATION%GOBP%GO:1902890,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
GALACTOLIPID METABOLIC PROCESS%GOBP%GO:0019374,0.19698755730189896,0.57371735849953,-0.49207430004324293,-1.2657476576906599,1503,6,ALDH5A1|CLN3|GALC|B3GALT2|B3GALT1
GLYCOLATE METABOLIC PROCESS%GOBP%GO:0009441,0.0474927036349164,0.312255783864335,-0.856906534325889,-1.42602950277589,357,2,PARK7|IGF1
HETEROTYPIC CELL-CELL ADHESION%GOBP%GO:0034113,0.0271966527196653,0.23271567002476898,-0.42454270047377796,-1.64738356949857,207,18,CD58|ITGB3|ITGA7|ITGA4|CD1D|ITGB1|ITGAX|JUP|ITGB2|CXADR|ITGA5|LILRB2|MADCAM1|PKP2|CD200
NEGATIVE REGULATION OF DNA RECOMBINATION AT TELOMERE%GOBP%GO:0048239,0.355266648978509,0.7132037834765931,-0.659112213950924,-1.096868123982,2677,2,TERF2IP|TERF2
MEMBRANE INVAGINATION%GOBP%GO:0010324,0.000388500388500389,0.0111294649577428,-0.37249975193010904,-2.0694261325313703,2,59,CDC42|RAC3|IGHV2-26|IGHV1OR15-1|IGHV5-51|ARHGAP25|IGHV1-24|IGHV3-49|SNX18|ITGB2|IGHG4|HGS|MSR1|FCGR1A|IGLL5|FCGR2B|C3|IGHV4-4|ELMO1|IGHV4-61|IGHV1-3|IGHV3-43|IGHV3-73|VAMP7|DOCK1|GSN|CD36|CHMP4A|THBS1|IGHV3-15|AIF1|MYH9|ITGAM|IGHV1-18|IGHG2|IGHA1|ADGRB1
REGULATION OF EXO-ALPHA-SIALIDASE ACTIVITY%GOBP%GO:1903015,0.878929765886288,0.960725750963158,-0.563134097926776,-0.7502298349094499,6569,1,PTX3
CALCITONIN GENE-RELATED PEPTIDE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1990408,0.7879153269024649,0.927797067038212,0.45599767428799,0.7661349690467609,5880,2,RAMP1
REGULATION OF LEUKOCYTE DEGRANULATION%GOBP%GO:0043300,0.0053475935828877,0.0829378624098312,-0.436120995569964,-1.9235066563752299,40,27,SYK|UNC13D|LYN|CD84|ITGB2|SNX4|STX4|FGR|STXBP2|FES|FCGR2B|ADGRE2|VAMP8|VAMP7|SNX6|CEACAM1|CD300A|LGALS9|ITGAM
NEGATIVE REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1903946,0.207529474812433,0.5875035269006329,0.732005271597182,1.2298633693096102,1548,2,BIN1|KCNE3
ADULT HEART DEVELOPMENT%GOBP%GO:0007512,0.946996466431095,0.983766684265799,-0.26862626151216,-0.5880790394276689,7235,4,SCUBE1|TCAP|HAND2|MEF2D
REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS%GOBP%GO:1900076,0.0276557249935384,0.23535789394552398,-0.329403502055416,-1.6002244572593602,213,37,FAM132A|SIK2|SLA2|KANK1|SOCS3|PID1|OGT|INS|MZB1|IRS1|SOCS1|GKAP1|CISH|NUCKS1|PTPRE|RPS6KB1|NCK1|PRKCB|GRB10
CELLULAR RESPONSE TO RETINOIC ACID%GOBP%GO:0071300,0.0690879300928455,0.37596389138254704,0.311267179026422,1.45201842650453,505,31,RET|WNT6|BRINP2|WNT5B|RARG|HTRA2|PTK7|ATM
NEGATIVE REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905032,0.7449860539248242,0.9112137767014771,0.6272055580061761,0.8362939809637571,5608,1,KCNE3
CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0042398,0.5076842927845789,0.7987565605553191,-0.208908662735318,-0.9627708486783029,3897,31,OPLAH|GATM|ST20-MTHFS|PLOD2|PTDSS2|CHAC1|CHAC2|GGT1|PLSCR1|DHFR|TMLHE|MTHFD1
REGULATION OF ADENOSINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060167,0.0795967100026532,0.395856190496679,-0.8212848083815829,-1.3667492544623,599,2,ADA|NECAB2
ARGININE CATABOLIC PROCESS%GOBP%GO:0006527,0.8739301725309059,0.9595052445364269,0.308135053662517,0.676985835640949,6432,4,DDAH1|ARG2
EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030855,0.00639386189258312,0.0942909588629288,-0.210062826177238,-1.54713453269166,49,204,TBX1|SOX18|DFNB31|JUP|BASP1|COL23A1|DNPH1|SOX17|RAPGEF1|CDHR2|CD34|TST|SMO|RAP2B|MED1|GATA3|MAF|PDZD7|PCNA|CBR1|CNN3|MESP1|SLC9A3R1|CTSB|THRA|KRT9|PDE4D|NOTCH1|MEF2C|TPP1|ICAM1|KRT18|PKP2|PDE2A|PERP|MSN|CAPN1|SOD1|RAPGEF3|KLF15|TJP2|JAG2|PDPN|EPHA2|RAP1A|PCSK6|GATA6|PTER|TAGLN|LGALS3|BMP2|RAB1B|KRT7|NR2F2|MYO1E|PPARG|DAB2|ANXA2|ACTA2|CEP63|ANXA1|ENG|PGK1|TOLLIP|KRT19|CASP6|ACVRL1|EDF1|PDGFB|ALDOC
NEGATIVE REGULATION OF GLYCOLYTIC PROCESS%GOBP%GO:0045820,0.476115691663395,0.7850084910380921,-0.446616287349374,-0.9777364125855659,3637,4,CBFA2T3|PPARA
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:1902108,0.441422594142259,0.7653693162885199,-0.259944397937218,-1.008680939908,3375,18,CAMK2A|STPG1|BAD
NEGATIVE REGULATION OF DEATH-INDUCING SIGNALING COMPLEX ASSEMBLY%GOBP%GO:1903073,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
ESTABLISHMENT OF BLOOD-BRAIN BARRIER%GOBP%GO:0060856,0.599867724867725,0.8464076674715391,-0.45673546597642495,-0.8918886059239741,4534,3,ENG
RESPONSE TO OXYGEN RADICAL%GOBP%GO:0000305,0.0667718191377497,0.3690551432905871,-0.55263380604467,-1.51059986447032,507,7,PRDX2|SOD2|SOD3|SOD1|CCS|NOS3
NEGATIVE REGULATION OF TAU-PROTEIN KINASE ACTIVITY%GOBP%GO:1902948,0.982733430734493,0.993436724391485,0.507940008822232,0.677269463968187,7398,1,SORL1
MAINTENANCE OF UNFOLDED PROTEIN INVOLVED IN ERAD PATHWAY%GOBP%GO:1904378,0.8611111111111109,0.951993398605548,-0.350988940360199,-0.685392442742227,6509,3,USP13|GET4
REGULATION OF ESTRADIOL SECRETION%GOBP%GO:2000864,0.24909698996655497,0.6299122386373679,-0.8726290251433609,-1.1625513920764698,1861,1,SPP1
MICROTUBULE ANCHORING AT CENTROSOME%GOBP%GO:0034454,0.00584715800924667,0.0885144275970147,0.5916492483581071,1.8743848113861499,42,10,BBS4|DCTN1|CCDC68|NINL|PCM1
GLUCURONATE METABOLIC PROCESS%GOBP%GO:0019585,0.46679764243614896,0.7806653415096191,-0.382055979733307,-0.982750900446629,3563,6,ABHD10|CRYL1
CARDIAC PACEMAKER CELL DIFFERENTIATION%GOBP%GO:0060920,0.0741576014858052,0.38287566727393396,-0.825530741659774,-1.37381516641299,558,2,MESP1|MAML1
"NEGATIVE REGULATION OF GENE EXPRESSION, EPIGENETIC%GOBP%GO:0045814",0.0199637023593466,0.19502581020323298,-0.27715775597673403,-1.59612049100957,153,68,HIST1H4I|RBBP7|DNMT1|HDAC5|PPM1D|HIST2H3A|SPI1|PHF19|SIRT4|HIST2H4A|HIST2H3C|HIST1H3H|POLE3|H2AFY|HIST2H4B|RRP8|H3F3B|SUV39H1
SPEMANN ORGANIZER FORMATION%GOBP%GO:0060061,0.96281046619737,0.9908714970603191,0.518306131451257,0.691091289763456,7248,1,FZD5
STEROL IMPORT%GOBP%GO:0035376,0.43963703314045205,0.7650340344477281,-0.418231760675385,-1.00242172437338,3342,5,CD36|LDLR
REGULATION OF ANATOMICAL STRUCTURE SIZE%GOBP%GO:0090066,0.41493564419523404,0.7490461307518279,-0.131838221394033,-1.01603582112666,3255,264,SLC12A8|CDHR2|SEMA6A|HCLS1|CCL24|ARPC1A|VAV1|ARHGAP18|SLC12A2|SOD2|NGF|WAS|IQGAP2|PLEK|INS|GOLGA4|SLC9A3R1|DOCK5|LMOD1|PDXP|TBXA2R|HAX1|DSCAM|MSN|RILP|ABL1|HMOX1|SOD1|NTN1|TMEM123|ARF1|SEMA3B|SEMA3D|MAP3K13|LRRC8A|RPTOR|SEMA7A|KANK3|GPER1|NPR1|GSN|F2R|BAIAP2L1|CORO1B|EDNRB|APOE|SMTNL1|NOS3|HCK|CHGA|CDC42EP4|SNF8|CFL2|SEMA5A|ARPC5L|SEMA3E|SLIT2|CAV1|SEMA3A|SEMA6B|EPS8|CDC42EP1|CDC42EP5|TMSB4X|NCK1|PPP1CA|ARF6|AP2M1|CDC42EP2|SERPINF2
POSITIVE REGULATION OF MIRNA CATABOLIC PROCESS%GOBP%GO:2000627,0.6436227224008578,0.8688307429995409,0.527792011320808,0.8867587250039731,4803,2,PNPT1|ZC3H12A
GLUTAMATE BIOSYNTHETIC PROCESS%GOBP%GO:0006537,0.0493147003493685,0.31842017410826096,0.7654681813168629,1.50558558146184,366,3,GLS|GLUD1|GLS2
ORGANOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0090407,0.0151824445011483,0.166148433567765,-0.168782800752897,-1.37646150236635,118,378,SCD5|ACP6|ADM|PGAM2|IPPK|PARP10|GPAA1|LHPP|DPM2|PIK3C2A|ACHE|PTDSS2|IDI1|PARP9|RAB14|TKT|GPD1|ACSL5|PYURF|AGPAT1|GPAM|FDPS|ATP5J|DCAKD|GPI|ATP5F1|PLA2G2A|FAR1|COASY|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|PLA2G2D|ADA|PCYT1A|PDHA1|ACSF3|KYNU|MTMR12|PLSCR1|ATP5B|HK3|CPNE6|ADCY8|CHPT1|PIGP|NPR2|ELOVL1|PLA2G4D|ETNK2|PLA2G4A|SLC26A2|CDIPT|DGKE|HAAO|ENO1|PIK3CB|ADCY4|ABHD5|MTMR1|ARF1|ATP5O|CTPS1|PGAM1|HPRT1|GK|PLD1|SLC44A1|MOCS2|PRPS1|MBIP|NPR1|RFK|GAPDH|SYNJ2|HMGCS1|UMPS|HACD2|INPP4B|GMPS|NME2|FITM2|PIGH|LDHA|CMPK2|PLEKHA4|NDUFAB1|SRD5A3|LPIN3|STOML2|PDHX|PNPO|DOLK|PCTP|ATP5H|NMNAT3|PNP|DOLPP1|PGK1|AGPAT2|GPHN|RRM1|FADS1|LPIN2|FASN|QPRT|PDXK|CRYL1|NNMT|PTPMT1|ADCY9|ALDOA|ALDOC|AK1|ATP5G1|MTHFD1|PTGIS|AGPAT3|PLA2G12A
REGULATION OF PEROXISOME SIZE%GOBP%GO:0044375,0.47715667831228203,0.7850984235874658,0.49946130586651205,0.9823814483275609,3550,3,PEX11A|PEX11G|PEX11B
REGULATION OF GLIAL CELL DIFFERENTIATION%GOBP%GO:0045685,0.0359618150908853,0.269485800778349,-0.384657683665421,-1.59296755279798,274,22,HES1|CXCR4|NOTCH1|DAAM2|SLC45A3|SERPINE2|TNFRSF21|BMP2|EPHA4|LDLR
MITOTIC NUCLEAR ENVELOPE DISASSEMBLY%GOBP%GO:0007077,0.108627450980392,0.45309795582492896,-0.418712711633547,-1.4014706505789098,830,12,NEK9|CCNB1|PLK1|VRK1|NEK6|PRKCB
NEGATIVE REGULATION OF CELLULAR ORGANOHALOGEN METABOLIC PROCESS%GOBP%GO:0090349,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
5-PHOSPHORIBOSE 1-DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0046391,0.83784844915587,0.946216977301937,-0.32040825328566497,-0.7014406438009471,6401,4,PRPS1
AORTA MORPHOGENESIS%GOBP%GO:0035909,0.0770140622946511,0.3882587170964129,-0.3681077702733351,-1.45435945892326,585,19,JAG1|TBX1|LRP1|TBX2|HES1|MYLK|PDGFRB|ENG|ACVRL1
SECONDARY ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:1902653,0.00196206671026815,0.0387291856838508,-0.434552810386781,-1.9840830568601102,14,30,HMGCR|APOE|HMGCS1|EBP|DHCR7|C14orf1|DHCR24|CNBP|NSDHL|TM7SF2
SPINDLE ORGANIZATION%GOBP%GO:0007051,0.26087512794268203,0.636844486123047,-0.17235810986479996,-1.12170134142896,2038,110,TTK|SPAG5|EML1|RHOA|CENPE|GOLGA2|HAUS1|TUBG1|BCCIP|INO80|ZNF207|CEP72|HAUS6|GOLGA8N|AURKA|TUBGCP5|WDR62|RACGAP1|HAUS4|CSNK1D|KNSTRN|CEP192|PCNT|KIF11|NEK2|CCDC69|NUF2|MAPRE2|DYNC1H1|SBDS|OFD1|TUBGCP2|TUBG2|PLK2|TPX2|KPNB1|HAUS8|VCP|AUNIP|KIF4A|NDC80|RCC1|MECP2|SPICE1|FLNA|CKAP5|RAN|SPC25|KIFC1|PPP2R4|KIF2A|CCNB1|SUN2|CEP63|NEK6|HAUS7|NTMT1
VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0047496,0.05769756631118401,0.3462063027824339,0.303623586664605,1.47166784541442,421,35,KIF13A|KIF3B|TRAK2|NDEL1|RAB1A|HTT|BLOC1S3|HAP1|AP3B2|KIF5B|AP3B1|KIF5A|TRAK1|KIF1A|AP3M1|KIFAP3|BLOC1S5|AP3M2|FYCO1|PAFAH1B1|AP3S2|BLOC1S6
ISOLEUCINE METABOLIC PROCESS%GOBP%GO:0006549,0.334440164696507,0.6974768376198021,0.832432730480812,1.1099367235701,2517,1,ACAT1
REGULATION OF RESPONSE TO ALCOHOL%GOBP%GO:1901419,0.360267558528428,0.7155384949577859,-0.817765769739744,-1.08946036243435,2692,1,LANCL2
CAMERA-TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION%GOBP%GO:0060219,0.24931291715744,0.630084224949081,-0.554972337379314,-1.21495045658513,1904,4,TOPORS|THY1|DSCAM
RRNA METHYLATION%GOBP%GO:0031167,0.27403195234226896,0.648598422572577,0.28455673944444204,1.1532439787681201,2023,20,FDXACB1|TFB1M|MTERF4|RNMTL1|NSUN4|NSUN3|WBSCR22|TFB2M|FTSJ3|EMG1|METTL15|MRM1|NOP2
UDP-GLUCURONATE BIOSYNTHETIC PROCESS%GOBP%GO:0006065,0.4414135984950279,0.7653693162885199,0.51823982674392,1.0193165828821602,3284,3,SLC35D1|UGDH
REGULATION OF PRO-B CELL DIFFERENTIATION%GOBP%GO:2000973,0.23540241977906398,0.6200889890187811,-0.5095916866667419,-1.22139403389619,1789,5,FNIP1|HES1|NOTCH1
ISOPRENOID BIOSYNTHETIC PROCESS VIA MEVALONATE%GOBP%GO:1902767,0.15585284280936498,0.524929617605427,-0.9199933833259809,-1.2256520900288002,1164,1,HMGCS1
REGULATION OF UBIQUITIN-PROTEIN TRANSFERASE ACTIVITY%GOBP%GO:0051438,0.771775652623417,0.9215496572020819,-0.15108290223666399,-0.792025671382376,5971,48,TRIB3|SMAD7|FZR1|RPL11|RPL23|GOLGA2|UBE2N|TOPORS|UBE2L3|PTEN|RPS2|DCUN1D1|CDC20|ZER1|DTX3L|BAG5|FEM1A|MAD2L1|MAGEC2|UBE2S|DCUN1D3|PARK7|ARRDC3|ABL1|USP44|PLK1
METANEPHRIC MESANGIAL CELL DIFFERENTIATION%GOBP%GO:0072209,0.117670469620589,0.46862716515177505,-0.7874827681279292,-1.3104972541275801,886,2,CD34|PDGFB
NEGATIVE REGULATION OF CHEMOKINE PRODUCTION%GOBP%GO:0032682,0.17946030914330602,0.552835226882867,-0.397600197490459,-1.28725203106141,1369,11,MUL1|APOD|KLF4|LGALS9|GSTP1|SIRPA
ACETATE METABOLIC PROCESS%GOBP%GO:0006083,0.872508361204013,0.9587056110602221,-0.566442434936039,-0.754637334184352,6521,1,ALDH5A1
QUORUM SENSING INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0052106,0.8490969899665551,0.9492491301138911,-0.578683281870313,-0.770945081501486,6346,1,SLC22A5
NEGATIVE REGULATION OF INTERLEUKIN-12 SECRETION%GOBP%GO:2001183,0.589565217391304,0.8414799095069009,-0.7099691221879141,-0.9458493443938201,4406,1,LILRB1
REGULATION OF LEUKOCYTE DIFFERENTIATION%GOBP%GO:1902105,0.00038314176245210697,0.0111294649577428,-0.28217927800570103,-1.9197144366531202,2,136,CCL3|FOXP3|TNF|JAK3|SYK|NFATC2|BGLAP|ZNF675|ACIN1|NFKBIZ|PRDM1|TGFB1|LILRB1|CDK6|NDFIP1|NCKAP1L|CD74|IL18|ADAM8|RUNX1|CCL19|SLAMF8|ZFP36L1|RUNX3|CD4|HCLS1|GATA3|TNFRSF18|LILRB3|IL34|FCGR2B|GAS6|TCTA|PRELID1|RC3H2|LILRB2|TESC|INHBA|SOCS1|IL2RA|HAX1|FBN1|MMP14|NOTCH2|ABL1|SOD1|IRF7|CEBPB|NKAP|MAFB|C1QC|C10orf54|CSF1|CEACAM1|CCR1|CD86|NLRP3|AXL|LGALS3|TGFBR2|LGALS9|FADD|FOXP1|MYC|ATP6AP1|BCL6|TLR4|LILRB4|PNP|ANXA1|LGALS1|SART1
DETERMINATION OF LEFT/RIGHT ASYMMETRY IN LATERAL MESODERM%GOBP%GO:0003140,0.9671757770632371,0.9912626134248801,0.32872794248019704,0.552305387149438,7218,2,CITED2
MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002281,0.15661375661375698,0.5259991179339351,-0.670398147126944,-1.3091176696270101,1183,3,SYK|SBNO2|DYSF
NITROGEN CYCLE METABOLIC PROCESS%GOBP%GO:0071941,0.04235102484050499,0.294833299013666,0.622996982319417,1.61204130856172,311,6,SLC25A15|ASL|CAD|NAGS
CAAX-BOX PROTEIN MATURATION%GOBP%GO:0080120,0.6854603343061819,0.8858989071675258,-0.52285635511442,-0.8701165859279939,5166,2,ZMPSTE24|RCE1
NEURAL CREST FORMATION%GOBP%GO:0014029,0.498028391167193,0.794989907195277,-0.350694446622978,-0.958607630848307,3788,7,KBTBD8|PEF1|PDCD6|TCOF1
REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT%GOBP%GO:1904748,0.250920568122041,0.63148176332757,-0.501718004466118,-1.2025223200981499,1907,5,NOTCH1|TNFRSF1A|TNFRSF1B
LUNG CELL DIFFERENTIATION%GOBP%GO:0060479,0.8969363074442349,0.967166974453851,0.33179773750424196,0.6526069949617691,6674,3,ASCL1|NFIB
RESPONSE TO HYDROGEN SULFIDE%GOBP%GO:1904880,0.44949832775919707,0.768229288546963,-0.776742390824879,-1.0348073714255799,3359,1,KDR
PROGESTERONE BIOSYNTHETIC PROCESS%GOBP%GO:0006701,0.5321739130434779,0.812079525085925,-0.737097485663873,-0.9819908384480099,3977,1,ADM
ADAPTIVE THERMOGENESIS%GOBP%GO:1990845,0.9697445972495091,0.991546057544123,-0.21328112073244698,-0.548616497494401,7403,6,ZBTB7B|UCP3|OMA1|UCP2|THADA|HNRNPU
LEUKEMIA INHIBITORY FACTOR SIGNALING PATHWAY%GOBP%GO:0048861,0.37936507936507896,0.728914030571579,-0.553986985772582,-1.0817961757895,2867,3,LIFR|LIF|IL6ST
NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY%GOBP%GO:1904684,0.20128255463944503,0.5792408283906739,-0.5799697763924211,-1.26967507598841,1537,4,TIMP3|RECK
COLLAGEN BIOSYNTHETIC PROCESS%GOBP%GO:0032964,0.1524557956778,0.5200454031349211,-0.51795023955885,-1.3323075447433799,1163,6,TRAM2|RCN3|COL1A1|COL5A1
CELL WALL MACROMOLECULE METABOLIC PROCESS%GOBP%GO:0044036,0.609458735262594,0.8505496974657741,0.543987586060424,0.913969381661827,4548,2,MANBA
GLYCEROL METABOLIC PROCESS%GOBP%GO:0006071,0.216519020323085,0.5995270850310329,-0.40985060216916397,-1.23293093145824,1661,9,TPI1|PGP|GOT1|GK|COQ3
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR 2 SIGNALING PATHWAY%GOBP%GO:0034136,0.6940476190476189,0.889500280068691,-0.419464224730176,-0.8191073181273121,5246,3,LYN|TNFAIP3
REGULATION OF OLIGOPEPTIDE TRANSPORT%GOBP%GO:0090088,0.8973202440965771,0.967166974453851,-0.402923115333027,-0.6705284961647321,6763,2,CA2
CHONDROCYTE MORPHOGENESIS%GOBP%GO:0090171,0.0011764705882352901,0.0261694927157725,-0.610591089836417,-2.0437055483036204,8,12,MATN2|COL20A1|COCH|VWA1|COL14A1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS%GOBP%GO:0006515,0.47645051194539295,0.785008843326641,0.225512507000192,0.982539094655639,3489,25,UGGT2|ANKZF1|SDF2|STUB1|RNF185|UGGT1|ATXN3|RNF126|HDAC6|BAG6|UBE2W|YME1L1
CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT%GOBP%GO:0060706,0.453199293574243,0.769943206592495,0.451000937517234,0.990868266790435,3335,4,CASP8|PLK4|E2F7|E2F8
REGULATION OF DNA N-GLYCOSYLASE ACTIVITY%GOBP%GO:1902544,0.807475884244373,0.9339635213386659,0.44587813620071703,0.7491328384736909,6026,2,TDG|RPS3
PROPIONYL-COA METABOLIC PROCESS%GOBP%GO:1902858,0.334440164696507,0.6974768376198021,0.832432730480812,1.1099367235701,2517,1,ACAT1
POSITIVE REGULATION OF SPINDLE ASSEMBLY%GOBP%GO:1905832,0.964950414345877,0.990916952887267,0.26007831026305606,0.571403123769099,7102,4,GPSM2|NUMA1|SPAG5|DYNC1H1
POSITIVE REGULATION OF CORTISOL BIOSYNTHETIC PROCESS%GOBP%GO:2000066,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
KERATAN SULFATE BIOSYNTHETIC PROCESS%GOBP%GO:0018146,0.6660128154831961,0.880719592999549,-0.204530938508311,-0.847015833617018,5092,22,B4GALT4|ST3GAL1|PRELP|OGN|LUM|FMOD|B4GALT1|B4GAT1
CELLULAR KETONE BODY METABOLIC PROCESS%GOBP%GO:0046950,0.0557377049180328,0.342757322822697,0.5383355617920921,1.5626939562002098,407,8,BDH2|HMGCLL1|ACAT1|HMGCL|SLC27A5|BDH1|OXCT1
POSITIVE REGULATION OF ADENOSINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060168,0.22996655518394699,0.6125906579381271,-0.8818923687692991,-1.1748923900461898,1718,1,NECAB2
NEGATIVE REGULATION OF INTRACELLULAR CALCIUM ACTIVATED CHLORIDE CHANNEL ACTIVITY%GOBP%GO:1902939,0.998007703546288,0.999656642395059,0.501268195853551,0.668373501621232,7513,1,ANO9
NEGATIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0010920,0.37618729096990006,0.7266197487465021,-0.810101455668284,-1.07924965578083,2811,1,PLEK
T CELL COSTIMULATION%GOBP%GO:0031295,0.0890998959417274,0.41228493992510207,-0.293212860697207,-1.3997785701478898,684,35,PTPN11|FYN|GRAP2|AKT1|CDC42|PAK2|RAC1|CD274|LYN|TNFRSF14|CCL19|PDCD1LG2|VAV1|GRB2|PTPN6|DPP4|ICOSLG|CD86|CAV1
SULFATE TRANSPORT%GOBP%GO:0008272,0.8226863226863229,0.941309119110694,0.23360398238192998,0.709900957165227,6026,9,SLC25A30|SLC13A4|SLC26A6|SLC26A1|SLC26A11|SLC25A14
POSITIVE REGULATION OF TONGUE MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001037,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
POSITIVE REGULATION OF DNA RECOMBINATION%GOBP%GO:0045911,0.402366059287463,0.740287621109606,0.26490494167282896,1.03695097366993,2958,18,RIF1|WRN|MMS19|ACTR2|WRAP53|TP53BP1|MAD2L2|FAM35A|C20orf196
NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE%GOBP%GO:1904673,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
POSITIVE REGULATION OF ORGANIC ACID TRANSPORT%GOBP%GO:0032892,0.496319663512093,0.794012168719884,-0.351663136964689,-0.9612555026992451,3775,7,P2RX4|TNFRSF11A|PLA2R1|ARL6IP1
PROTEIN IMPORT INTO MITOCHONDRIAL OUTER MEMBRANE%GOBP%GO:0045040,0.0684465384112027,0.373613422092264,-0.672919731929043,-1.47316195868974,522,4,HSP90AA1|HSPA4
VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION%GOBP%GO:0099625,0.28015873015872994,0.653204101106396,-0.599075261011413,-1.16984214975456,2117,3,KCNQ1|KCNH2
LUNG MORPHOGENESIS%GOBP%GO:0060425,0.716201998947922,0.899551221015245,-0.33087389689714697,-0.793041594311655,5445,5,FGF10|CTSH
CELLULAR RESPONSE TO CAFFEINE%GOBP%GO:0071313,0.30715935334872996,0.6786107324984411,0.51426644226592,1.1298652750517701,2260,4,GSTM2|RYR1|SLC8A1
NEGATIVE REGULATION OF CENTRIOLE REPLICATION%GOBP%GO:0046600,0.0604009372559229,0.355787695563881,-0.534948187415461,-1.54004095998519,463,8,CDK5RAP2|BRCA1|RBM14|KAT2B
ADENOSINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0001973,0.199732441471572,0.577776238115407,-0.8976621085134541,-1.19590146992322,1492,1,GNAI2
REGULATION OF PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0032434,0.0480522808815992,0.31390740768334696,-0.229323964129118,-1.4280040199782602,374,92,OGT|CBFA2T3|BAG5|VCP|RNF144B|CEBPA|UBQLN1|SUMO2|PARK7|UBXN1|HERPUD1|RAD23B|NKD2|RCHY1|HFE|PSMD10|PLK1|GIPC1|ARAF|TLK2|BCAP31|CAV1|DAB2|TAF9|CSNK1A1|AK6|FAM122A
LEUKOCYTE APOPTOTIC PROCESS%GOBP%GO:0071887,0.6318349106204,0.8617160466758159,-0.31245032229318603,-0.854069022465197,4806,7,TNFRSF21|CTSL
SODIUM ION HOMEOSTASIS%GOBP%GO:0055078,0.284132360604482,0.6569867235097528,-0.383759521826572,-1.15444257541023,2180,9,ATP1B1|ATP1A3|ATP1B3|SLC9A1|ATP1B2
REGULATION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0043567,0.127670661803022,0.484643747394476,-0.45704430805352897,-1.37490115047712,979,9,CILP|IGF1|BMP2|IGFBP5
ENDOTHELIAL CELL MIGRATION%GOBP%GO:0043542,0.00025953802232027,0.00819882332206558,-0.408985536668462,-2.12999815936186,1,47,TNFSF12|PXN|ABL1|PIK3R3|DPP4|FAP|STARD13|CORO1B|GIPC1|NOS3|NOV|SRF|SLIT2|ID1|ADGRA2|MYH9|EPHB4|LOXL2|EMP2|PTP4A3
SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX%GOBP%GO:0035582,0.043380206951446,0.29791299041195396,-0.8645712710228841,-1.43878485032325,326,2,FBN1|NBL1
NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048011,0.20570904805551898,0.58585512379148,-0.3602205620429961,-1.2399490292096398,1570,13,NGF|BCAR1|GRB2|NTRK2|DDIT4|NGFR
POSITIVE REGULATION OF COLLATERAL SPROUTING%GOBP%GO:0048672,0.556778986468559,0.8257201392411401,-0.576840363937138,-0.95995460930107,4196,2,SEMA4D|NGF
REGULATION OF PEPTIDE TRANSPORT%GOBP%GO:0090087,0.000508259212198221,0.0139121625154964,-0.19379988169575402,-1.5996161394407902,3,408,LILRB1|NPEPPS|HLA-E|RGCC|INHBB|ADAM9|CEMIP|PSEN1|HYAL2|LGR4|DHX9|NDFIP1|SP100|FIS1|TLR1|PYCARD|APOD|CD74|GNB2L1|TNFRSF14|GSDMD|DISP1|PER2|ARHGEF5|ADAM8|CCL19|REST|SREBF2|RHBDF2|GAPVD1|ACHE|CAMK1|JUP|ECT2|ITGB2|PPM1F|ITPR2|TRIM28|PIM3|STX4|TLR2|STXBP4|PPIA|MICALL2|FGR|CNST|HCLS1|CD34|WLS|GIPR|ITPR3|GDI1|SLC2A1|SLC8B1|ATG13|GPI|CDK16|SSC5D|GATA3|SYT7|ATPIF1|PDCD5|DNAJC1|FCGR2B|MYOM1|GAS6|TGFB3|SCFD1|PRR5L|INS|CASP1|MDFIC|UBE2G2|RAB29|TNFAIP3|DHX36|ADCY8|SLC25A6|BAG3|CA2|CRHBP|PTGER4|IRS1|PARK7|HAX1|IFIH1|PDE2A|BCAS3|ENSA|ANP32B|OSM|CARD16|GHRL|HUWE1|RSAD2|CEP131|SRGN|RAPGEF3|TNFRSF4|FLNA|UQCC2|HRAS|IGF1|DPP4|FCN1|NR1H3|LRP5|RBM22|TMEM173|IL33|GPER1|HFE|CACNA1E|F2R|RAP1A|FN1|GAPDH|NLRP3|NOV|ZC3H3|CHGA|TNFRSF21|CD200|LGALS9|ADRA2C|NR1D1|ARL2|B3GAT3|FOXP1|SLC25A4|BCAP31|CX3CL1|SIRT4|DNAJA1|HAVCR2|ANG|DERL3|TLR4|SERGEF|ITGAM|RAB11FIP1|PARL|CSF1R|C1QTNF4|ANXA1|RHOU|TMSB4X|SAR1B|CD14|EMD|TNFRSF1B|EFNA5|BAD|INSIG1|SLC25A5|PRNP
TETRAPYRROLE BIOSYNTHETIC PROCESS%GOBP%GO:0033014,0.8470174489381851,0.9492491301138911,0.177012378142583,0.705727800020712,6261,19,HMBS|COX10|ABCB6|COX15|UROD|MMACHC|SUCLA2|PPOX|CPOX
T CELL APOPTOTIC PROCESS%GOBP%GO:0070231,0.662647374062165,0.8796297678152929,0.515926555250561,0.866823226794912,4945,2,RIPK1|AKT1
REGULATION OF TIMING OF ANAGEN%GOBP%GO:0051884,0.132819763580821,0.493743682303473,0.9348808998676659,1.24653753382334,999,1,SPINK5
REGULATION OF CELLULAR PH REDUCTION%GOBP%GO:0032847,0.450126178775402,0.768588477853328,0.776246140273489,1.03501948694574,3388,1,BCL2
REGULATION OF NK T CELL ACTIVATION%GOBP%GO:0051133,0.781794368041912,0.925666442349475,-0.28860036893867796,-0.7423578938397901,5968,6,HSPH1|IL18|CD300A
GLUTATHIONE DERIVATIVE METABOLIC PROCESS%GOBP%GO:1901685,0.0303030303030303,0.246004159239453,0.425879164106645,1.6376322690117402,222,17,GSTM2|GSTM4|GSTM1|GSTK1|MGST3|GSTT2B|AKR1A1|MGST2|GSTZ1|GSTM3
ASTROCYTE DEVELOPMENT%GOBP%GO:0014002,0.522798332464825,0.807051143864932,-0.312197685280133,-0.9391670547129449,4012,9,APP|MAPT|TNF|EIF2B5|PSEN1|CDK6|LRP1
POSITIVE REGULATION OF LUNG CILIATED CELL DIFFERENTIATION%GOBP%GO:1901248,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
NEUROTRANSMITTER REUPTAKE%GOBP%GO:0098810,0.6258660508083139,0.858842084733938,0.39239225728863103,0.862102500322884,4606,4,SLC6A2|SNCA
REGULATION OF PROTEIN MONOUBIQUITINATION%GOBP%GO:1902525,0.36849026827985293,0.7217539780398442,-0.447964320124247,-1.0736849958777501,2801,5,PEF1|PDCD6|FANCM
POSITIVE REGULATION OF CORTISOL SECRETION%GOBP%GO:0051464,0.43757641624779203,0.7635570545514341,0.45746516577585294,1.00507045157084,3220,4,GAL|UCN|CRH
INHIBITION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:1990001,0.41031036296686,0.7452892204937491,-0.43025982549824604,-1.03125070058776,3119,5,XIAP|BCL2L12
POSITIVE REGULATION OF G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0045745,0.0031463030938647103,0.0571886039479394,-0.558962682281761,-1.97752823072403,23,14,UBQLN2|CAV2|FZD2|C3|NECAB2|GPER1|CHGA|PRMT5|PHB
FLOOR PLATE DEVELOPMENT%GOBP%GO:0033504,0.0722222222222222,0.378321151505122,-0.7375035542283009,-1.44015752190045,545,3,COBL|CHRD
POSITIVE REGULATION OF NEURON PROJECTION REGENERATION%GOBP%GO:0070572,0.17685618729097002,0.548551967663807,-0.9089655932951041,-1.2109604257791298,1321,1,SCARF1
PHOSPHATIDYLSERINE ACYL-CHAIN REMODELING%GOBP%GO:0036150,0.0108681419405526,0.134645873234709,-0.528062009189883,-1.81769183842241,82,13,PLA2G2A|PLA2G2D|PLA2G4D|PLA2G4A|PLA2G16|OSBPL5|PLA2G12A
RESPONSE TO PROTOZOAN%GOBP%GO:0001562,0.006180957390846921,0.0918052334975927,-0.755129053606883,-1.80990024960962,46,5,BATF|SLC11A1|BATF2|CLEC7A|LYST
ANATOMICAL STRUCTURE HOMEOSTASIS%GOBP%GO:0060249,0.20997442455242998,0.591291692741505,-0.160423286448038,-1.1484017098961898,1641,176,BBS1|RFC3|TERF2|TERT|SERPINA3|DFNB31|NBN|TINF2|CXADR|EXO1|PARP1|P2RX4|CD34|POLD4|PCNA|CALB2|BAG3|POLD1|SLX1B|JCHAIN|GCNT2|SLX1A|TPP1|HIST1H4I|POLD2|RFC5|MUC4|RCN3|HAAO|HSPB1|SOD1|DKC1|CTSH|LCN1|F2R|NOS3|SRF|CX3CL1|TNKS1BP1|HIST2H4A|TLR4|APEX1|POLA1|HSP90AA1|ACTB|ORAOV1|HIST2H4B|PGK1|ADGRV1|RFC4|IGHA1|POLA2|XRCC3|ALDOA|FEN1
ANTIGEN PROCESSING AND PRESENTATION OF POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002505,0.39917750066330604,0.739115199741709,-0.6401985111662529,-1.06539269801983,3008,2,HLA-DRB1|HLA-DRA
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION%GOBP%GO:0045639,0.0229691149753439,0.21109406942656497,-0.31191808373580104,-1.6244705121871001,176,47,TRAF6|MAPK14|ETS1|LIF|TNF|PRMT1|ACIN1|TGFB1|HOXA5|NCKAP1L|CD74|RUNX1|HMGB2|ZFP36L1|CD4|HCLS1|MED1|FES|IL34|TESC|INHBA|STAT3|TAL1|HAX1|CSF1|CCR1|RAB7B|FADD|ATP6AP1|ZNF16
TELOMERIC DNA-CONTAINING DOUBLE MINUTES FORMATION%GOBP%GO:0061819,0.82636655948553,0.943041978946366,0.435015164047422,0.7308816426810479,6167,2,ERCC1|ERCC4
RESPONSE TO MURAMYL DIPEPTIDE%GOBP%GO:0032495,0.6164527115535761,0.854122579597827,-0.268817886834412,-0.8703123715665101,4705,11,PTPN22|CHMP5|ARHGEF2|RIPK2|IRF5|ERBB2IP|VIM
PROTEASE LOCALIZATION TO T CELL SECRETORY GRANULE%GOBP%GO:0033375,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
POSITIVE REGULATION OF ER TO GOLGI VESICLE-MEDIATED TRANSPORT%GOBP%GO:1902953,0.11179790378930399,0.459194647507502,0.7001918733336489,1.37719478677,831,3,TBC1D20|STX18|SORL1
REGULATION OF HOMOTYPIC CELL-CELL ADHESION%GOBP%GO:0034110,0.157509157509158,0.527393305546732,-0.348873243278305,-1.29654805830073,1203,16,CEACAM1|PDPN|SERPINE2|C1QTNF1
COPPER ION TRANSPORT%GOBP%GO:0006825,0.487578487578488,0.788226301622024,0.317901182120095,0.966072372439443,3571,9,ATP7B|STEAP3|ATP7A|SLC31A1
REGULATION OF MICROTUBULE BINDING%GOBP%GO:1904526,0.47108307045215597,0.7825081975685211,-0.35976769170471506,-0.983408941663644,3583,7,ABL1|PPP2CA|MARK2
REGULATION OF TRANSLATION IN RESPONSE TO STRESS%GOBP%GO:0043555,0.110383658504648,0.45576259498765503,-0.407986901475985,-1.40437003247753,842,13,EIF2S1|RBM4|NCK1|PPP1CA
FOREBRAIN DORSAL/VENTRAL PATTERN FORMATION%GOBP%GO:0021798,0.936113693717625,0.9806508984207809,0.532752536391707,0.710353621456863,7047,1,SIX3
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0045648,0.666228991596639,0.880719592999549,-0.210620869843249,-0.8450068956982351,5073,20,HIF1A|STAT5B|ANKRD54|MAPK14|ETS1|PRMT1|NCKAP1L|HMGB2|MED1|INHBA|STAT3|TAL1|ZNF16
NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0042308,0.804347826086957,0.932964969466025,-0.250812525129732,-0.7220541560170141,6178,8,APOD|GAS6|MDFIC|PDE2A
NEGATIVE REGULATION OF ANTIGEN RECEPTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0050858,0.0372646443514644,0.27499221464993107,-0.412630104045658,-1.60115826494416,284,18,THY1|PHPT1|CEACAM1|CD300A|LGALS3|LILRB4|PTPRJ|PRNP
REGULATION OF BLOOD VESSEL DIAMETER%GOBP%GO:0097746,0.0386360689744587,0.279777317018993,-0.310545352855393,-1.55524380558595,297,41,ADRB2|DOCK4|ADM|PER2|EDNRA|PIK3C2A|AGT|SOD2|INS|DOCK5|TBXA2R|HMOX1|SOD1|GPER1|NPR1|F2R|EDNRB|SMTNL1|NOS3|CHGA|CAV1|SERPINF2
POLYOL TRANSPORT%GOBP%GO:0015791,0.8467490158816341,0.949232413999577,0.267265793029803,0.691565948081353,6237,6,PGAP1|AQP11|SLC26A6
POSITIVE REGULATION OF CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS%GOBP%GO:2001114,0.44468056846858794,0.76693681188187,0.7788928098809,1.0385484637445301,3347,1,CNKSR3
POSITIVE REGULATION BY ORGANISM OF PROGRAMMED CELL DEATH IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052330,0.16909698996655498,0.541811331682474,-0.913542126157918,-1.21705746644275,1263,1,GAPDH
NEGATIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:2000042,0.47820950380677296,0.7850984235874658,-0.269807756605353,-0.97962822872676,3642,15,PARPBP|KLHL15|POLQ|CXorf57|RMI2|MAGEF1
TUBE MORPHOGENESIS%GOBP%GO:0035239,0.000128238009746089,0.00518555396908895,-0.244052252962341,-1.8638054837816,0,252,FLT1|APOD|ADM|JAG1|IL18|ADAM8|LMO4|EPHB3|TBX1|SAT1|SOX18|RYR2|DAB2IP|COL23A1|SOX17|FGFR4|KDR|PLXND1|LRP1|FOXN4|CD34|RORA|SMO|APOLD1|MED1|SFRP2|CYP1B1|EGFL7|COBL|GATA3|SDCCAG8|PRCP|ATPIF1|TBX2|VEGFC|THY1|HES1|MESP1|ITGA5|ATP5B|MYLK|FLT4|NOTCH1|CELSR1|MEF2C|CALCRL|BCAS3|HOXB3|MICAL2|FGF10|COL4A1|JMJD6|HMOX1|LOX|PIK3R3|LRP5|STARD13|CCL2|CTSH|CEACAM1|ROBO4|EPHA2|APLNR|DLC1|DEAF1|VEGFB|NOV|CCBE1|NRP2|LUZP1|ADIPOR2|TGFBR2|BMP2|TGFBR3|THBS1|TEK|ATOH8|SEMA5A|SRF|PDGFRB|SEMA3E|SLIT2|ID1|DNAAF1|SERPINE1|CAV1|ADGRA2|MYC|RASIP1|MYH9|ANG|EPHB4|DACT1|TGFBI|ADGRG1|PDGFA|ANXA2|CSF1R|PDGFRA|ENG|ACVRL1|LOXL2|SERPINF2|MTHFD1
POLYAMINE HOMEOSTASIS%GOBP%GO:0010509,0.5676716695444279,0.83116084992853,0.713663431848258,0.951573889724299,4273,1,EIF5A2
POSITIVE REGULATION OF HISTONE DEACETYLATION%GOBP%GO:0031065,0.863101464435147,0.95308264526335,-0.21332818447619603,-0.6683293540077829,6600,10,ZBTB7B|AKAP8|ING2|VEGFA|PRKD2|CTBP1|AKAP8L|NIPBL|C6orf89|PRKD1
T CELL DIFFERENTIATION IN THYMUS%GOBP%GO:0033077,0.7321568627450981,0.9075412450030892,-0.234313245450097,-0.784268371645718,5600,12,RIPK3|ZFP36L1|JAG2|FADD
RESPONSE TO HEPATOCYTE GROWTH FACTOR%GOBP%GO:0035728,0.24381904260915302,0.626320329556411,-0.505008676586537,-1.21040943325275,1853,5,HGF|BCAR1|LGMN
ASYMMETRIC GOLGI RIBBON FORMATION%GOBP%GO:0090164,0.5213022508038591,0.8066230566722141,0.582311913368505,0.9783591997935981,3890,2,MYO18A|GOLPH3
PROTEIN TYROSINYLATION%GOBP%GO:0018322,0.329924292734759,0.6957352559323989,0.8346382884869871,1.11287753756909,2483,1,TTL
NEGATIVE REGULATION OF INTRALUMENAL VESICLE FORMATION%GOBP%GO:1905366,0.60034833869239,0.8464076674715391,0.5484914713504789,0.921536490469288,4480,2,PARK2
REGULATION OF TELOMERIC D-LOOP DISASSEMBLY%GOBP%GO:1905838,0.976253648182542,0.9926773910205121,-0.323533956058063,-0.53841223985011,7358,2,TERF2
CELLULAR RESPONSE TO OXYGEN RADICAL%GOBP%GO:0071450,0.0667718191377497,0.3690551432905871,-0.55263380604467,-1.51059986447032,507,7,PRDX2|SOD2|SOD3|SOD1|CCS|NOS3
PROTEIN C-LINKED GLYCOSYLATION VIA TRYPTOPHAN%GOBP%GO:0018317,0.163287374966207,0.534744357685457,0.5500323963358029,1.32282475902076,1207,5,DPY19L3|DPY19L1|DPY19L2|DPY19L4
REGULATION OF HEART RATE%GOBP%GO:0002027,0.0960960960960961,0.427566585262796,0.264320083118301,1.36154736802602,703,43,TRPM4|FKBP1B|BIN1|SCN5A|DRD2|ANK2|TNNI3K|DMD|RANGRF
NEGATIVE REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034183,0.993386243386243,0.9974705716496209,-0.24593855210166604,-0.480255659384764,7509,3,ATRX|NAA10
CELL-CELL SIGNALING INVOLVED IN CELL FATE COMMITMENT%GOBP%GO:0045168,0.0613627307743392,0.35631208031004796,0.9693427437141601,1.2924877525576102,461,1,DLL1
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO KINETOCHORE%GOBP%GO:1905342,0.49928019892684206,0.794989907195277,-0.43779897368568704,-0.958433469826045,3814,4,CENPQ|CDT1|NDC80
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL%GOBP%GO:0086036,0.18388998035363502,0.556389345131177,-0.499746639228132,-1.28548298089577,1403,6,ATP2A2|PLN|SLC8B1|SLC9A1|FXYD1
FUCOSE CATABOLIC PROCESS%GOBP%GO:0019317,0.950315457413249,0.9852369031063491,-0.20904744147246,-0.5714218589273911,7229,7,FUT4|FUT7|FUT9
T-HELPER 1 TYPE IMMUNE RESPONSE%GOBP%GO:0042088,0.0523133543638276,0.33181212624256895,-0.57051423698827,-1.55947522508821,397,7,IL18|SPN|EBI3|IL18BP|TLR4
CELL ADHESION MOLECULE PRODUCTION%GOBP%GO:0060352,0.86180602006689,0.9523801880640441,-0.5712946625496249,-0.761101666454207,6441,1,GOLPH3
ECTODERMAL PLACODE DEVELOPMENT%GOBP%GO:0071696,0.133834990593926,0.495404845602596,0.681206573287747,1.33985294199252,995,3,HDAC1|PROX1|HDAC2
NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS%GOBP%GO:0070244,0.33478835978836,0.697851482247329,-0.5745009374655339,-1.1218547242061598,2530,3,BMP4|BLM|JAK3
AXIS ELONGATION INVOLVED IN SOMITOGENESIS%GOBP%GO:0090245,0.442024173196972,0.7653693162885199,0.780381561535068,1.04053351319385,3327,1,LRP6
VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086005,0.6993583868011,0.892627170717022,-0.236560070602149,-0.814285637192157,5340,13,PKP2|KCNQ1|KCNH2|KCNE4
PHARYNGEAL SYSTEM DEVELOPMENT%GOBP%GO:0060037,0.948154180238871,0.9842901886125459,0.17648681452057802,0.580749989758356,6985,11,BMP7|BMPR1A|BMPR2|PTCH1|ISL1|TGFBR1|BMP4|TGFB2|TBX1|GATA3|HES1
MEIOSIS II CELL CYCLE PROCESS%GOBP%GO:0061983,0.7319131832797429,0.9074802896081321,0.481555004135649,0.8090745830312571,5462,2,BUB1|BUB1B
BUNDLE OF HIS CELL ACTION POTENTIAL%GOBP%GO:0086043,0.0166621875839828,0.17569702079137303,0.8313558080191421,1.63517876793373,123,3,TRPM4|SCN5A|CACNA2D1
REGULATION OF PROTEIN KINASE A SIGNALING%GOBP%GO:0010738,0.7090647105056329,0.896056518175031,-0.24756468170472398,-0.801503976494189,5412,11,PJA2|MC1R|ADRB2|C8orf4|AKAP5|ADGRV1
PURINE-CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT%GOBP%GO:0072530,0.0699665551839465,0.37596389138254704,-0.9634980149977941,-1.28361070549376,522,1,SLC25A42
FOLIC ACID-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0006760,0.231463318948607,0.6149950305002221,-0.290675417966896,-1.20376253713421,1769,22,MTHFD2|ALDH1L2|TYMS|ST20-MTHFS|SLC19A1|GGH|FTCD|DHFR|SHMT2|FOLR2|MTHFD1
LEUKOTRIENE METABOLIC PROCESS%GOBP%GO:0006691,0.134345947361529,0.4962180106589171,-0.39288437686954103,-1.3523842140718099,1025,13,ALOX5AP|ALOX5|LTC4S|GGT1|MAPKAPK2|DPEP1|GGT5|ABCC1
PROSTAGLANDIN TRANSPORT%GOBP%GO:0015732,0.187449610319807,0.5609377558550861,0.648151426143719,1.27483736832422,1394,3,ABCC4|SLCO3A1
REGULATION OF HISTONE ACETYLATION%GOBP%GO:0035065,0.264018691588785,0.6395074119587459,-0.23503544889681696,-1.15025340022461,2033,38,BRCA1|ARRB1|MAPK3|TAF7|RAPGEF3|HDAC5|WBP2|KAT7|SPI1|RPS6KA4
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0008543,0.476843467011643,0.7850984235874658,-0.179135864056008,-0.9863864734594859,3685,57,POLR2C|FGFRL1|PTBP1|HNRNPH1|RAB14|NCBP2|FGFR4|POLR2J|SHCBP1|NDST1|GRB2|NCBP1|HNRNPM|POLR2H|FGF10|MAPK3|FGF19|FGF9|FGF7|POLR2G|FIBP|POLR2L
CELLULAR POLYSACCHARIDE METABOLIC PROCESS%GOBP%GO:0044264,0.356957761078,0.714610778064251,-0.211914637931651,-1.06786310238962,2754,42,GYG1|PER2|AOAH|GAL3ST3|GAA|PHKG2|NDST1|PPP1R3C|PGM5|NR1D1|EXT2|B3GNT5|PYGL|PYGM|B4GAT1|CSGALNACT1|GYG2
POSITIVE REGULATION OF PROTEIN TRANSPORT%GOBP%GO:0051222,0.12142492339121601,0.47376597884378,-0.160575708176168,-1.21506427461676,950,238,NPEPPS|HLA-E|RGCC|ADAM9|CEMIP|PSEN1|HYAL2|DHX9|FIS1|TLR1|PYCARD|GNB2L1|TNFRSF14|GSDMD|ARHGEF5|ADAM8|CCL19|SREBF2|ACHE|CAMK1|JUP|ECT2|ITGB2|TRIM28|STX4|TLR2|PPIA|MICALL2|FGR|CNST|HCLS1|CD34|WLS|ATG13|GPI|GATA3|PDCD5|MYOM1|GAS6|TGFB3|PRR5L|INS|CASP1|RAB29|DHX36|ADCY8|BAG3|PTGER4|IFIH1|BCAS3|ANP32B|OSM|GHRL|HUWE1|CEP131|RAPGEF3|TNFRSF4|FLNA|HRAS|IGF1|FCN1|RBM22|TMEM173|IL33|GPER1|F2R|GAPDH|NLRP3|LGALS9|B3GAT3|BCAP31|HAVCR2|ANG|TLR4|ITGAM|CSF1R|C1QTNF4|RHOU|SAR1B|CD14|EMD|BAD|PRNP
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002703,0.0031997952131063603,0.0579145448352508,-0.2705051591009,-1.73387573734216,24,103,FOXP3|CD1D|JAK3|SYK|HLA-B|PVR|SERPINB9|UNC13D|MICA|TGFB1|NCR3|LILRB1|DNASE1L3|HLA-E|LYN|NDFIP1|B2M|IL18|RIPK3|CD84|ITGB2|PIK3R6|SNX4|STX4|FGR|STXBP2|HLA-C|PAXIP1|WAS|FES|HLA-A|FCGR2B|TRAF2|ADGRE2|PVRL2|RSAD2|VAMP8|VAMP7|TNFSF13|SNX6|CEACAM1|STX7|CD300A|HFE|NLRP3|BST2|LGALS9|ZP3|FADD|TICAM1|IL1R1|ITGAM|TFRC|TNFRSF1B
POSITIVE REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS%GOBP%GO:1900127,0.004510480233483679,0.0743264309917645,-0.95709953129308,-1.59276667179416,33,2,NFKB1|PDGFB
CELLULAR METAL ION HOMEOSTASIS%GOBP%GO:0006875,0.00012756729174639598,0.00518555396908895,-0.24619979064693898,-1.92159991426702,0,285,MT1G|OCM|EDNRA|CCL19|HSP90B1|FPR3|LPAR6|RYR2|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|ATP6V0A2|ERO1L|PTGER1|PLN|ITPR3|SLC8B1|ATP1A3|ATP1B3|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ADCY8|CXCR4|JPH4|CALB2|CCDC22|TAC1|CALCB|RMDN3|ATP6V0D1|ABCB7|HAMP|SLC9A1|PTGER4|TBXA2R|SLC11A1|GHRL|ABL1|CALR|ACO1|HERPUD1|HMOX1|SOD1|SKP1|SLC35G1|ARF1|MT1M|CCRL2|P2RY6|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|FTL|APLNR|GNA15|TMCO1|MTL5|CD36|F2RL3|GRIN2C|FXN|MT2A|TGM2|GRIN2D|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|ATP1B2|PRKACA|S100A8|S100A9|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|TFRC|ATP6V1A|ATP6V1G1|C5AR1|FTH1|C1QTNF1|PRNP
NCRNA 5'-END PROCESSING%GOBP%GO:0034471,0.980309792596482,0.993436724391485,-0.142232062892661,-0.516421564719855,7467,15,RPP14|RPP30|TRMT10C|POP4|RPP25|POP7|POP1|ABT1|HSD17B10
L-ASCORBIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0019853,0.756296891747053,0.9166093439295571,0.469864902122967,0.7894337022797829,5644,2,AKR1A1|RGN
REGULATION OF ACTION POTENTIAL%GOBP%GO:0098900,0.124948847360524,0.479403240873216,0.280175063274152,1.33420692725351,915,33,TRPM4|BIN1|SCN5A|ANK2|RANGRF|RNF207|CHRNB2|PTPN3|CACNA1C|SUMO1
POSITIVE REGULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044148,0.0896321070234114,0.41359635676085704,-0.9528561976179971,-1.26943324949282,669,1,OSBP
DENDRITE MORPHOGENESIS%GOBP%GO:0048813,0.516247951938831,0.804056180000979,0.20481232414503,0.95542122225665,3780,31,CTNNA2|FARP1|EPHB2|MINK1|MAP6|MAP2|DLG4|CELSR2|NRP1|SHANK2|ZNF365
"VACUOLE FUSION, NON-AUTOPHAGIC%GOBP%GO:0042144",0.392615221144906,0.737280445732591,0.804808116453463,1.0731030282326999,2955,1,VPS41
NEGATIVE REGULATION OF UBIQUITIN-PROTEIN TRANSFERASE ACTIVITY%GOBP%GO:0051444,0.467970595956944,0.780769690730001,-0.27166816996621695,-0.9863830880693271,3564,15,DTX3L|BAG5|MAD2L1|PARK7|ABL1|USP44
CELLULAR RESPONSE TO INTERLEUKIN-13%GOBP%GO:0035963,0.6683470416556121,0.8811119744196031,-0.531030535599466,-0.88371972940485,5037,2,CD300LF
POLYPRENOL CATABOLIC PROCESS%GOBP%GO:0016095,0.326877155744229,0.6941148928066879,-0.671270482949755,-1.11710142784945,2463,2,SRD5A3
REGULATION OF PROTEIN ACETYLATION%GOBP%GO:1901983,0.25926876202694,0.636098664976652,-0.21499487523794397,-1.1480164569637201,2020,51,PARK7|BRCA1|ARRB1|MAPK3|TAF7|RAPGEF3|KLF15|HDAC5|WBP2|KAT7|SPI1|RPS6KA4|KAT5
LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002232,0.507826086956522,0.7987565605553191,-0.7498897220996908,-0.9990331689776291,3795,1,SLAMF8
REGULATION OF LIPID TRANSPORT BY POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072369,0.0108782170336959,0.134645873234709,-0.930631375792666,-1.54871942846517,81,2,HNRNPK|PPARA
POLYNUCLEOTIDE DEPHOSPHORYLATION%GOBP%GO:0098501,0.42032332563510405,0.751774348695433,0.46302079383394107,1.0172764030155401,3093,4,DUSP11|POLB|PNKP
CELLULAR RESPONSE TO ACTINOMYCIN D%GOBP%GO:0072717,0.7789572695511959,0.924704689181848,0.3838094187713689,0.7549078342320029,5796,3,MDM2|TP53|RPL23
REGULATION OF T-HELPER 1 CELL ACTIVATION%GOBP%GO:2000517,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
REGULATION OF PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE%GOBP%GO:0090065,0.491371237458194,0.790696900371285,-0.75766431407146,-1.00939079227365,3672,1,TERT
MEMBRANE RAFT POLARIZATION%GOBP%GO:0001766,0.6811361200428728,0.8849372624170401,0.505486628067273,0.8492828011734269,5083,2,CD2|MAL
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN MAMMARY GLAND ALVEOLUS DEVELOPMENT%GOBP%GO:0061030,0.6141806020066889,0.8522366945817159,-0.69634980149978,-0.927705139045476,4590,1,ID2
FOREBRAIN NEURON DIFFERENTIATION%GOBP%GO:0021879,0.015233949945593002,0.166148433567765,0.516794190402211,1.7564829357025802,111,12,DRD2|FGFR2|SLIT1|ROBO2|ASCL1|SLIT3|ATP7A
CELL DIVISION%GOBP%GO:0051301,0.537414965986395,0.8137306732814521,0.14491796074039903,0.961555005584396,3870,117,EFHC1|CHMP3|FGFR2|RHOC|CNTROB|BBS4|TEAD3|CLASP1|RTKN|TTC19|ARL3|PARD3|RAB10|TRIM36|SNX33|SEPT2|BRCA2|SPIRE2|TUBA1C|GNAI3|SPTBN1|SEPT10|MYH10|CUL7|UNC119|SEPT4|BIN3|MITD1|MAP4|DOCK7|SEPT12|SPAST|CENPJ|PDCD6IP|STAMBP|CHMP1A
CAP-INDEPENDENT TRANSLATIONAL INITIATION OF LINEAR MRNA%GOBP%GO:0110017,0.0488294314381271,0.31702674791770696,-0.9736435818262019,-1.29712703660345,364,1,RBM4
NEGATIVE REGULATION OF RENIN SECRETION INTO BLOOD STREAM%GOBP%GO:1900134,0.17632107023411397,0.548366806412612,-0.909241288045876,-1.2113277173853798,1317,1,F2R
HETEROCYCLE CATABOLIC PROCESS%GOBP%GO:0046700,0.0428260033337607,0.29576373695179803,-0.160041490141624,-1.29448205842066,333,359,NUDT17|GPX1|HK1|RPLP2|ADA|VCP|KYNU|NUDT1|HK3|MAGOH|PDE12|PDE4D|PDXP|RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|PATL1|NUDT16|APOBEC3G|RPL10|DDX5|PDE2A|RPL36A|SMPDL3A|RPL24|HAAO|ENO1|PELO|DPEP1|HMOX1|TYMP|APOBEC3C|PGAM1|HPRT1|FTCD|CDA|LSM3|NT5C3B|RPL35|GAPDH|RNASE6|PPP2CA|RPL38|RPS15A|NUDT18|NUDT4|MAGOHB|EIF4A3|LDHA|EXOSC3|ALDH4A1|AFMID|RPS13|RBM8A|TNKS1BP1|POLR2G|ENPP4|ABCD1|HINT1|TUT1|PNP|RNH1|HNMT|PGK1|SKIV2L2|MUS81|SAMHD1|EXOSC2|ENDOG|QPRT|BLVRB|DNASE1L1|ERN1|ALDOA|FEN1|ALDOC|EIF4G1|RNASEH2C
"MITOCHONDRIAL TRNA 3'-TRAILER CLEAVAGE, ENDONUCLEOLYTIC%GOBP%GO:0072684",0.24120069066277103,0.6244696312630601,0.8807344508160571,1.17434055014805,1815,1,ELAC2
MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION%GOBP%GO:0010742,0.664650184113624,0.8804055751124069,-0.345907098664535,-0.829073310349153,5053,5,PPARG
COLLATERAL SPROUTING%GOBP%GO:0048668,0.43194481294773207,0.760487817191567,-0.626137303556658,-1.0419926000013,3255,2,APP|COBL
"SYNAPTIC TRANSMISSION, GLUTAMATERGIC%GOBP%GO:0035249",0.263029315960912,0.638901217604674,0.35659931079751,1.17343069880919,1937,11,GRIK3|GRID1|UNC13A|SLC1A4|GRIK2
PHOSPHATIDYLINOSITOL PHOSPHORYLATION%GOBP%GO:0046854,0.853629823413996,0.949296218452153,-0.15511436404947102,-0.7082218184534559,6525,30,SOCS1|CISH|PIK3CB|PIK3R3|TTC7B|FAM126A
ADENINE BIOSYNTHETIC PROCESS%GOBP%GO:0046084,0.42552910052910103,0.7547028278218628,-0.535337407641712,-1.04537827641606,3216,3,GART|HPRT1
PROTEIN-LIPID COMPLEX ASSEMBLY%GOBP%GO:0065005,0.446624803767661,0.768074078421208,-0.270496754477903,-1.0052706779671299,3413,16,DGAT1|APOC1|APOM|APOE|PRKACA|P4HB
NUCLEOCYTOPLASMIC TRANSPORT%GOBP%GO:0006913,0.34233081744914895,0.701955655133333,-0.141829184122643,-1.05728256496254,2675,219,NXF2|SLBP|POM121|MALT1|UPF3B|CBLB|RPL23|DDX20|NUP107|KPNA1|SMURF1|PHB2|SNRPD3|SRSF4|RBMX2|BCCIP|SMN2|GEMIN5|AKT1|RANBP3|PA2G4|GEMIN7|NEMF|HNRNPA1|TNF|SYK|NUP205|HEATR3|LSG1|NUP93|NUP210|MMP12|CPSF1|SNRPE|TGFB1|RBM15B|NXT1|HTATIP2|PRICKLE1|GEMIN8|SRSF3|ZNF593|FYTTD1|NXF2B|NCBP2|NCKIPSD|SLU7|CHTOP|PHAX|SRSF9|KPNB1|NPM1|GEMIN2|STRADA|IPO4|MAGOH|CPSF2|NUP188|SRSF5|RITA1|IPO7|SNRPF|SRSF1|U2AF1|HNRNPA2B1|STAT3|XPO6|NCBP1|SNRPD1|NUP85|KPNA4|CALR|GLE1|NUP37|NMD3|RAN|NXF1|RBM22|NUP160|BCL3|KPNA2|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|SEC61B|SNRPB|PABPN1|SRSF2|RBM8A|DDX39A|BCL6|NUP98|THOC3|IPO11|SMN1
PULMONARY ARTERY ENDOTHELIAL TUBE MORPHOGENESIS%GOBP%GO:0061155,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0051882,0.09166887768638901,0.41890957046475896,-0.8091535704438929,-1.34656093460318,690,2,ATPIF1|ABL1
RESPONSE TO UV-A%GOBP%GO:0070141,0.7081799053129929,0.89516234575314,-0.333420255907094,-0.7991447309684769,5384,5,CCND1
INTERLEUKIN-9-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038113,0.530625657202944,0.8115959426370749,-0.34220132450331303,-0.9353920602795759,4036,7,STAT5B|IL2RG|JAK3|STAT5A|STAT3
FMN METABOLIC PROCESS%GOBP%GO:0046444,0.175919732441472,0.548366806412612,-0.9097926775474201,-1.2120623005978601,1314,1,RFK
NEGATIVE REGULATION OF ECTODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042666,0.937441891353433,0.9806508984207809,0.5320357300397001,0.7093978569071909,7057,1,FZD7
OXIDATIVE RNA DEMETHYLATION%GOBP%GO:0035513,0.46171967020023597,0.775450927278973,-0.452769527949084,-0.9912071425167159,3527,4,ALKBH3
POSITIVE REGULATION OF ARGINASE ACTIVITY%GOBP%GO:0150072,0.146755852842809,0.514049001465687,-0.9252315835906478,-1.2326306305474,1096,1,CD200
REGULATION OF TELOMERE CAPPING%GOBP%GO:1904353,0.100081588251292,0.43605057892447596,0.32427092629840604,1.3968370000076398,735,24,SMG6|ATM|RTEL1|MAP2K7|MAP3K4|PNKP|HNRNPD|TNKS|ERCC1|MAPK1|TNKS2|NEK7
REGULATION OF AXON EXTENSION%GOBP%GO:0030516,0.42347717496878007,0.753783909572009,0.189064478916998,1.01970492420923,3051,51,ISLR2|SHTN1|SEMA4G|SEMA4F|RTN4|SEMA6C|PTPRS|SEMA4C|RUFY3|TRIM46|LIMK1|NRCAM|MAP2|POU4F2|NRP1|ZFYVE27|MEGF8|SEMA6D
AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION%GOBP%GO:0086067,0.152570029915692,0.5202207670236311,0.41890313908817894,1.3271134604291999,1121,10,TRPM4|SCN5A|GJC3|CACNA1C|CACNB2
REGULATION OF COPII VESICLE COATING%GOBP%GO:0003400,0.225013150973172,0.6078034241178771,-0.514883508274757,-1.2340775205181,1710,5,SEC23B|PREB|SEC23A|SAR1B
SYNAPTIC VESICLE TRANSPORT ALONG MICROTUBULE%GOBP%GO:0099517,0.5562026002166851,0.8257149029717741,0.24887298898683802,0.917989867026946,4106,15,BLOC1S3|AP3B2|AP3B1|AP3M1|BLOC1S5|AP3M2|AP3S2|BLOC1S6|AP3D1|SNAPIN|BLOC1S4|BLOC1S2
MEIOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0045144,0.7319131832797429,0.9074802896081321,0.481555004135649,0.8090745830312571,5462,2,BUB1|BUB1B
NEGATIVE REGULATION OF SYNAPSE ORGANIZATION%GOBP%GO:1905809,0.0696882368352109,0.37596389138254704,-0.464051353897885,-1.5023912251356102,531,11,TLR2|LILRB2|EFNA1|NGEF|ARHGEF15|APOE|PRNP
NEGATIVE REGULATION OF MEMBRANE POTENTIAL%GOBP%GO:0045837,0.5422831546083889,0.815838601332624,0.35341816218546396,0.914490266899607,3994,6,HEBP2|PMAIP1
REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 ACTIVATION%GOBP%GO:1901392,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
MEIOTIC DNA INTEGRITY CHECKPOINT%GOBP%GO:0044778,0.9419577633151809,0.981919967159484,0.529278782531981,0.7057218394084491,7091,1,HUS1
NEGATIVE REGULATION OF CLATHRIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:1900186,0.9580653804930329,0.988629868922994,0.339603279311157,0.5705773571970261,7150,2,UNC119
REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE%GOBP%GO:1905244,0.060855908912445994,0.35631208031004796,-0.681230448673736,-1.4913558548958001,464,4,FMR1|ABL1|EPHA4
CARBON CATABOLITE ACTIVATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0000436,0.456216931216931,0.7711961414599979,-0.5224370281736439,-1.02018710490266,3448,3,USF1|USF2
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:1901797,0.230689071251791,0.613824182037422,-0.278065183624626,-1.19877796928016,1770,25,CD74|TRIAP1|KDM1A|DYRK1A|SNAI2|TAF9B|PSMD10|SNAI1|TAF9|ZNF385A|AK6
REGULATION OF RENAL PHOSPHATE EXCRETION%GOBP%GO:1903402,0.736722408026756,0.908157084784786,-0.6364689016321129,-0.8479294021697621,5506,1,STC1
EXOCYTIC INSERTION OF NEUROTRANSMITTER RECEPTOR TO POSTSYNAPTIC MEMBRANE%GOBP%GO:0098967,0.0252056248341735,0.22334422304908896,-0.896222773642128,-1.4914580121374899,189,2,STX1B|STX3
REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION%GOBP%GO:0099149,0.7691695409923058,0.9209902948719241,-0.478963330576234,-0.7970715740740941,5797,2,OPHN1|ITGB3
PROTEIN LOCALIZATION TO CYTOSOLIC PROTEASOME COMPLEX%GOBP%GO:1904327,0.354635584137192,0.7124978659342509,0.658009374138406,1.10554070758182,2646,2,ATXN3|BAG6
POSITIVE REGULATION OF INTERLEUKIN-17 PRODUCTION%GOBP%GO:0032740,0.546342098411872,0.817655622966367,-0.319126590121141,-0.918720787860655,4196,8,TGFB1|IL18|OSM|IL15
POSITIVE REGULATION OF EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT%GOBP%GO:1902955,0.982733430734493,0.993436724391485,0.507940008822232,0.677269463968187,7398,1,SORL1
GLYCEROLIPID METABOLIC PROCESS%GOBP%GO:0046486,0.21927036989958104,0.601686354077891,-0.14686587544167903,-1.1270794080238,1724,257,GPAA1|PGP|DPM2|PIK3C2A|ACHE|PTDSS2|DGAT1|SOCS3|RAB14|DGKG|GPD1|PYURF|AGPAT1|GPAM|TMEM55B|GDE1|PLA2G2A|FAR1|PLEK|PLA2G2D|PCYT1A|PNPLA2|MTMR12|FABP3|PLSCR1|CPNE6|CHPT1|PIGP|DAGLB|TMEM86B|SEL1L|APOBR|PLA2G4D|ETNK2|PLA2G4A|SOCS1|CDIPT|CISH|DGKE|CETP|PLA2G7|PIK3CB|ABHD5|PIK3R3|MTMR1|ARF1|TTC7B|GK|PLD1|PLA2G4C|SERINC5|SLC44A1|APOE|PLA2G16|FABP4|DAGLA|SYNJ2|FAM126A|INPP4B|PIGH|PDGFRB|PLEKHA4|LPIN3|CAV1|ANG|LMF1|MGLL|PCTP|CSF1R|PLBD1|AGPAT2|PNPLA4|LPIN2|PTPMT1|AGPAT3|OSBPL5|PLA2G12A
SUBSTANTIA NIGRA DEVELOPMENT%GOBP%GO:0021762,0.0850676378772112,0.40376145987147494,-0.294670821822081,-1.4067387789663401,653,35,BASP1|PLP1|NDRG2|ATP5J|ATP5F1|RAD1|ZNF430|CNP|ZNF148|CKB|FGF9|ACTB|HSPA5|NDUFS3|MAPKAP1
SMOOTH MUSCLE CONTRACTION INVOLVED IN MICTURITION%GOBP%GO:0060083,0.386903971310931,0.733589579210772,0.808061314512572,1.07744072888122,2912,1,KCNMA1
NEGATIVE REGULATION OF CHROMATIN SILENCING AT RDNA%GOBP%GO:0061188,0.5267975590342271,0.809755446473093,-0.587979046043562,-0.9784911575353521,3970,2,PHF8|PHF2
MITOCHONDRIAL TRANSLATION%GOBP%GO:0032543,0.0202227057468322,0.195509766417565,-0.23525066643135503,-1.53515120121618,157,111,MRPS10|MRPL53|MRPS17|MRPL37|AURKAIP1|GARS|MRPL18|MRPL57|GFM2|MRPS18B|MRPS15|MRPL47|GADD45GIP1|MRPS11|MRPL13|OXA1L|GATC|NDUFA7|MRPL10|MRPL50|MRRF|MRPL51|MRPS34|MRPL9|MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|GFM1|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
NEGATIVE REGULATION OF G1/S TRANSITION OF MITOTIC CELL CYCLE BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:1900477,0.17632107023411397,0.548366806412612,-0.909351565946184,-1.2114746340278701,1317,1,NACC2
OBSERVATIONAL LEARNING%GOBP%GO:0098597,0.408353609083536,0.7445496113654559,0.42645391094793894,1.02561921032513,3020,5,STRA6|HTT|NRXN1
LOCOMOTOR RHYTHM%GOBP%GO:0045475,0.0462344466273739,0.30787642565176504,-0.610572180642088,-1.57055612827348,352,6,MTA1|PTEN|ID2|USP2|CIART
PULMONARY ARTERY MORPHOGENESIS%GOBP%GO:0061156,0.45564461350359997,0.7711961414599979,0.44967661028420003,0.987958663459489,3353,4,STRA6|HEY2
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009138,0.78505291005291,0.9274485629622209,-0.382263757897904,-0.7464642348234449,5934,3,CMPK2
REGULATION OF DOPAMINE METABOLIC PROCESS%GOBP%GO:0042053,0.47565593724641597,0.784986345464663,0.35166351945016494,0.9707577062415479,3516,7,PARK2|DRD4|CHRNB2
GANGLIOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0001574,0.664931007550117,0.8804055751124069,-0.287850267637805,-0.8286806328790021,5107,8,B4GALNT1|ST8SIA3|ST8SIA4|ST6GALNAC6|ST3GAL5
REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION%GOBP%GO:0003266,0.0605573419078242,0.355936982159638,0.8485001199340559,1.42558975577427,451,2,GNG5|HAND2
MITOCHONDRIAL GENE EXPRESSION%GOBP%GO:0140053,0.130873340143003,0.49069354451172204,-0.182270662783163,-1.23697323869076,1024,134,MRPS30|MRPS23|MRPL41|MRPS6|MRPS18C|MRPL38|MRPS22|MRPL52|GFM1|MRPL21|MRPS18A|MRPS24|MRPL27|MRPL23|MRPS7|MRPL36|ICT1|HSD17B10|MRPL22|MRPL49|MRPS2|MRPL39|MRPL3|MRPL12|MRPS36|MRPL17|MRPS27|MRPL11|MRPL16
REGULATION OF OXIDATIVE STRESS-INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1903376,0.6913774973711879,0.8879225792175841,-0.295179896543853,-0.80686108384304,5259,7,PINK1|FBXW7|HIF1A|MCL1|PARK7|NONO
VEIN SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014826,0.371318652162377,0.7231271705612199,-0.6515586658970021,-1.08429781211712,2798,2,EDNRB
PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0006213,0.15562827225130899,0.5247242168288571,-0.28890311002550606,-1.29027360128418,1188,28,APOBEC3G|TYMP|APOBEC3C|CTPS1|CDA|UMPS|TK1|ERH|UCK1
P GRANULE ORGANIZATION%GOBP%GO:0030719,0.77123745819398,0.9213545359508709,-0.6190449933833261,-0.824716572655282,5764,1,PLD6
LYMPH NODE DEVELOPMENT%GOBP%GO:0048535,0.0412249705535925,0.291121725329476,-0.705785032813103,-1.5451109724071699,314,4,TGFB1|RIPK3|PDPN|FADD
NEGATIVE REGULATION OF PINOCYTOSIS%GOBP%GO:0048550,0.0891635981062599,0.41228493992510207,-0.6039893554763629,-1.4476472332997001,677,5,NR1H3|STX1B|CAV1
FASCICULATION OF MOTOR NEURON AXON%GOBP%GO:0097156,0.396524276996551,0.7377402989373809,-0.641411634960022,-1.0674115300057399,2988,2,EPHA3|EPHA4
TELENCEPHALON CELL MIGRATION%GOBP%GO:0022029,0.0278759858580364,0.23617479560495197,0.421845178140577,1.65128202384042,204,18,EFHC1|DRD2|SLIT1|RTN4|LAMB1|SLIT3|MBOAT7|PEX13
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY%GOBP%GO:0060135,0.375813590210883,0.7266197487465021,-0.36996237534482596,-1.0650698985207498,2886,8,SPP1|GHRL|LGALS9|HAVCR2
INTERLEUKIN-33-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038172,0.0355531971345184,0.26848905505917003,-0.879404466501241,-1.4634696596055299,267,2,IL1RAP|IL33
DORSAL AORTA DEVELOPMENT%GOBP%GO:0035907,0.0987118822292324,0.433510337204539,-0.5256007326443429,-1.4367061638532201,750,7,ENG|ACVRL1
PROTEIN CATABOLIC PROCESS%GOBP%GO:0030163,0.36483739837398405,0.7192943041037551,-0.122049870236142,-1.03303601987237,2871,499,UBE2D2|FBXL14|PSMB4|GZMA|RNF13|ENC1|UBD|PCYOX1L|PPT1|PML|CUL4B|FBXO45|DCAF11|FBXW11|LONP1|CLN6|KLHL20|MARCH6|GET4|PSMD1|PSMC2|TTC3|BNIP3L|ARRDC1|PCNP|CDC20|ANAPC10|TRIM3|LYPLAL1|UBE2Z|HSP90B1|RNF216|DTX3L|UBE2B|TSG101|CPVL|AP2A2|FBXO6|ANAPC2|RLIM|TRIM9|HSPA13|DAB2IP|TCIRG1|ANAPC5|KCTD2|UBQLN2|CTSF|CTSV|RNF121|RAB7A|HM13|USP9X|PSMD3|CTSS|TOR1A|KLHL15|PSMB2|UBAP1|CDC23|PSMF1|CLTA|PTTG1|ARMC8|VCP|RNF144B|UBE2G2|MAD2L1|TNFAIP3|CTSB|RNF7|MAGEC2|SIAH2|PSMD4|RBBP6|SEL1L|SMURF2|UBE2S|UBQLN1|TPP1|CLTC|RNF168|UBXN1|ARRB1|PSMB5|NEU4|UHRF1|TRIM32|UBE2R2|RCN3|FAF2|HUWE1|MVB12B|HERPUD1|CDC27|RAD23B|RNF20|SEC13|DTL|SKP1|FAP|NPLOC4|RCHY1|CTSZ|CTSH|NEDD8|CEACAM1|VPS25|PSMC6|USP44|FBXO4|APOE|CCNB1|PLK1|NSFL1C|PSMB3|CTSC|SYVN1|SNF8|NR1D1|RNF40|KIAA0368|PSMD2|SEC61B|UBC|SGTB|PSMD6|ERCC8|FBXW5|LAMP2|DDB1|SPOP|PLAA|DERL3|CTSD|MYLIP|PSMD12|PSMA3|KAT5|ANXA2|BACE2|HSP90AA1|CTSL|HSPA5|LGMN|ANAPC11|UBE2L6|TOLLIP|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|AP2M1|SQSTM1|RMND5B|RNF130|PRPF19|SPSB1
REGULATION OF RNA STABILITY%GOBP%GO:0043487,0.527610506085842,0.810052447666581,-0.146851018810613,-0.959596876703562,4117,112,FMR1|DHX36|PDE12|MAPKAPK2|FXR1|HNRNPM|SLC11A1|HSPB1|E2F1|TNFSF13|DKC1|NUP214|UBC|EXOSC3|CCRN4L|YBX3|CSDC2|VIM|APEX1|EXOSC2|HNRNPA0|HNRNPC|EIF4G1
POSITIVE REGULATION OF COLD-INDUCED THERMOGENESIS%GOBP%GO:0120162,0.08901197990467599,0.41228493992510207,-0.231466840071897,-1.35300426167492,690,72,ADRB2|GATM|STAT6|APC|GJA1|DYNC1H1|PER2|IL18|ACHE|KDM1A|EBF2|FH|OGT|THRA|CXCR4|PDGFC|ADIPOR1|GHRL|G0S2|CEBPB|BSCL2|HCRT|FABP4|CD36|GADD45G|ADIPOR2|CAV1|CMKLR1|HADH|GRB10
ISOLEUCINE CATABOLIC PROCESS%GOBP%GO:0006550,0.334440164696507,0.6974768376198021,0.832432730480812,1.1099367235701,2517,1,ACAT1
NEGATIVE REGULATION OF NECROTIC CELL DEATH%GOBP%GO:0060547,0.0694006309148265,0.37596389138254704,-0.550143818774442,-1.50379359530655,527,7,SLC25A4|YBX3|FTH1
DNA UNWINDING INVOLVED IN DNA REPLICATION%GOBP%GO:0006268,0.253419253024724,0.632440664457874,-0.5004701669618379,-1.1995314917097,1926,5,RAD51|RPA2|PURA
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 SIGNALING PATHWAY%GOBP%GO:0036324,0.14937649243831302,0.51590227091171,-0.7648745519713259,-1.2728735671173999,1125,2,DAB2IP|PDCD6
PROTEIN MATURATION BY COPPER ION TRANSFER%GOBP%GO:0015680,0.0210931281507031,0.200414971488121,-0.9061483319547841,-1.5079757283858601,158,2,CCS|ATOX1
SULFATE ASSIMILATION%GOBP%GO:0000103,0.266345123258307,0.641603173139009,0.7001957985123609,1.1764193474397902,1987,2,PAPSS1|PAPSS2
POSITIVE REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0061047,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0061052,0.968123256740603,0.9912626134248801,0.51532862814292,0.6871211908648149,7288,1,GSK3A
POSITIVE REGULATION OF CELL CYCLE G2/M PHASE TRANSITION%GOBP%GO:1902751,0.0367464365110501,0.27241249528203604,-0.38390463454829,-1.5898489804668001,280,22,CDC25A|CDC7|CDK4|RCC2|BRD4|DYRK3|RAD51C|NPM1|CDC25C|MECP2|DTL|RAD51B|CCNB1|CCND1
MAINTENANCE OF ORGANELLE LOCATION%GOBP%GO:0051657,0.888524590163934,0.965159112268525,0.223398974019527,0.648488138809725,6503,8,GPSM2|ARHGAP21|AKAP9|UVRAG|POLR2M|C9orf114|TBCCD1|ATP2A1
POSITIVE REGULATION OF DNA REPLICATION%GOBP%GO:0045740,0.8878676470588241,0.965159112268525,-0.16524688121468697,-0.6629673223881309,6761,20,OBFC1|NPM2|FAF1|WIZ|DBF4B|ATAD5|DBF4|E2F7|E2F8|ATRX|CDC7|DNA2|INO80|DHX9|CDT1|PCNA|FGF10|STOML2
CELLULAR RESPONSE TO TOXIC SUBSTANCE%GOBP%GO:0097237,0.045413495032899,0.305507129637833,-0.261610227878867,-1.4794087851168898,351,63,IMPACT|ECT2|PPIF|KDR|CYP1B1|SOD2|TNFAIP3|PARK7|SOD3|ABL1|SOD1|CCS|NOS3|ADIRF|FXN|RELA|SIGMAR1|MAPK13|NFKB1|ACTB|ANXA1|NET1|PDGFB|SIRPA|BAD
CELLULAR GLUCURONIDATION%GOBP%GO:0052695,0.20066889632107002,0.578325746675525,-0.897331274812528,-1.19546071999573,1499,1,ABHD10
CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0005975,0.160574579966654,0.530793536692166,-0.15644360705229002,-1.1770156942397,1251,231,SLC2A1|GAA|GPI|SLC25A10|PHKG2|PFKFB2|G6PC3|SIAE|HK1|GALT|ALDH2|HK3|GLA|CHST7|NDST1|PPP1R3C|FUT9|IDH3G|NEU4|ENO1|GHRL|LRP5|PGM5|ALDH1A1|PGAM1|GK|ABHD10|SLC35A2|DHDH|GAPDH|B3GALT2|FUCA1|SYNJ2|NR1D1|EXT2|SLC5A3|LDHA|ITPK1|IMPA2|IDNK|B4GALT1|B3GNT5|NDUFAB1|PYGL|SLC2A3|CYB5A|PYGM|B4GAT1|FUOM|CSGALNACT1|B3GALT1|PGK1|TALDO1|ST3GAL5|CRYL1|GYG2|ALDOA|COQ3|GALK1|ALDOC
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB%GOBP%GO:0002428,0.127832351015062,0.48497650625540295,-0.53721158094601,-1.3818529035288998,975,6,HLA-F|HLA-B|HLA-E|HLA-C|HLA-A
MUSCULAR SEPTUM MORPHOGENESIS%GOBP%GO:0003150,0.6137566137566141,0.852182158593687,-0.450340644470329,-0.879401140283417,4639,3,TGFBR3
MITOTIC CLEAVAGE FURROW FORMATION%GOBP%GO:1903673,0.787692307692308,0.927797067038212,-0.610002205558006,-0.812669407970552,5887,1,RHOA
REGULATION OF CARDIAC MUSCLE TISSUE REGENERATION%GOBP%GO:1905178,0.544212218649518,0.817181843599117,0.572648082269105,0.962122715798866,4061,2,CDKN1A|CDKN1B
MEMBRANE DEPOLARIZATION%GOBP%GO:0051899,0.28780421110199605,0.6607965534535091,0.23302186754326198,1.12946030810397,2104,35,TRPM4|SCN5A|ANK2|HCN2|CHRNB2|CACNB4|CACNA1C|CACNG4|SCN3A|SCN9A|SCN2A|CACNB2|YWHAH|CACNA1B|SLC8A1
NEGATIVE REGULATION OF BLOOD PRESSURE%GOBP%GO:0045776,0.803608786610879,0.932964969466025,-0.23020358682007802,-0.721197786628634,6145,10,RNLS|SCPEP1|APLN|ADRB2|SOD2|PRCP|NOS3
PLASMA MEMBRANE RAFT DISTRIBUTION%GOBP%GO:0044855,0.992508361204013,0.997305769352475,-0.50363917071019,-0.670968306282475,7418,1,PTPRC
NEGATIVE REGULATION OF LIPASE ACTIVITY%GOBP%GO:0060192,0.0187451184587347,0.18848688937164898,-0.6012080987322529,-1.7307939708998599,143,8,BICD1|APOC1|ANGPTL4|PLA2R1|ABL1|ANXA1|RGS2
UREA CYCLE%GOBP%GO:0000050,0.04235102484050499,0.294833299013666,0.622996982319417,1.61204130856172,311,6,SLC25A15|ASL|CAD|NAGS
VIRAL PROCESS%GOBP%GO:0016032,0.0258974358974359,0.22596809056766898,-0.19208004137143697,-1.4132713632339298,201,203,CDC42|PAK2|NUP205|VPS37B|AP1S2|NUP93|RAC1|DOCK2|NUP210|BICD1|TGFB1|NFIA|ATG7|PSIP1|HYAL2|DENR|DHX9|PTBP1|CD209|B2M|ZNF639|DEK|TSG101|AP2A2|PCSK5|RANBP1|CALCOCO2|CD4|RRAGA|PACS1|PPIA|RAB7A|UBAP1|HCFC1|KPNB1|CCNK|CAV2|EEA1|GAS6|VCP|RAB29|PVRL2|NUP188|SLC25A6|CLEC4M|CXCR4|ELMO1|ICAM1|NUP85|RCC1|NUCKS1|KPNA4|MVB12B|USF2|IRF7|VAMP8|NUP37|ARF1|RAN|EIF3B|CCL2|NUP160|KPNA2|APOE|AXL|AP1B1|HCK|NUP214|CHMP4A|RAB1B|CHMP6|MCTS1|UBC|PABPN1|CAV1|HCFC2|ADRBK1|NUP98|VPS37C|CD81|BANF1|AP2M1|EIF2D
MALE SEX DIFFERENTIATION%GOBP%GO:0046661,0.635459253202508,0.863600910248377,0.197664122456418,0.874064758520904,4662,26,LRRC6|TBX3|RAB13|WNT2B|KIT
NEGATIVE REGULATION OF RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0060331,0.32246186217780104,0.6906261309079051,-0.46894652138498605,-1.12397532852722,2451,5,NR1H3|PPARG
MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0086013,0.614162978391044,0.8522366945817159,-0.302313275438019,-0.870317608086875,4717,8,ATP1B1|KCNN2|KCNQ1|KCNH2
OPIOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038003,0.599495887503317,0.84625395439332,-0.559533550216967,-0.9311533037031071,4518,2,ADCY8
SPROUTING ANGIOGENESIS%GOBP%GO:0002040,0.00581320242862679,0.0881615800553922,-0.352760427865709,-1.82741001182858,44,46,JMJD6|PIK3R3|VEGFB|CCBE1|THBS1|TEK|SEMA5A|SRF|SEMA3E|SLIT2|ADGRA2|EPHB4|ENG|ACVRL1|LOXL2
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION BY ELECTRICAL COUPLING%GOBP%GO:0086021,0.38060493499602005,0.729499056535481,-0.648469809760132,-1.07915746156014,2868,2,GJC1|GJA5
REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0061046,0.561820111435394,0.8282270665374359,-0.574469258340226,-0.9560087104195151,4234,2,BMP4|TNF
HEART FORMATION%GOBP%GO:0060914,0.170831141504471,0.544378398009534,-0.544771626276004,-1.3057136361892299,1298,5,SOX17|MESP1|MEF2C
PROTEIN ALKYLATION%GOBP%GO:0008213,0.832841186288355,0.9443921657118071,-0.1298500560615,-0.7751811800544409,6486,78,SETD1B|VCPKMT|FAM173B|SETMAR|LCMT1|EZH2|ETF1|NSD1|PAXIP1|SETD8|OGT|METTL12|CTR9|TRMT112|N6AMT1|WDR5|PRMT3|SNRPB|PAGR1|HIST1H1C|PRMT5|NTMT1|SUV39H1
TRANS-SYNAPTIC SIGNALING%GOBP%GO:0099537,0.35377358490566,0.7118407891832621,0.13788982925423598,1.04988015573156,2549,226,EXOC4|HTR3A|KCNQ3|CHRNB1|SLC12A5|DRD2|SLC6A2|GRIK3|SYT2|GRID1|KCNMB4|EPHB2|LIN7B|CHRM4|FCHSD1|SLC12A4|GABRA3|RIMS1|SNAP25|RIMBP2|DRD4|DLG2|KCNIP2|GABARAP|CHRNB2|MINK1|ARRB2|RAB3GAP1|LIN7A|DNAJC5|CHRNA5|PTPRD|COLQ|NQO1|UNC13A|GABRB3|CACNB4|RIMS2|HAP1|SLC18A3|KCNQ2|CPLX1|CHRNB4|PDE7B|PPFIA3|KCNK3|HRH3|SYT5|CHRM3|UNC119|DLG4|BRSK1|CACNB2|KIF5A|GRM4|SPG11|SLC1A4|LRP6|SNAP23|PTPRN2|KCNC4|ASIC2|NAAA|OTOF
RESPONSE TO INORGANIC SUBSTANCE%GOBP%GO:0010035,0.0463474130183592,0.308133081893636,-0.17861984600167602,-1.3356713681623897,360,224,MT1G|B2M|GUCA1A|CCL19|IMPACT|RYR2|AQP3|ECT2|PPIF|KDR|P2RX4|PDCD6|NDNL2|ITPR3|SYT4|HP|CYP1B1|SOD2|SYT7|GPX1|CACNA1H|STIM1|VCP|SLC41A1|TNFAIP3|FMR1|DHX36|CPNE6|ADCY8|ANXA11|HAMP|CRHBP|MEF2C|MAPK9|PARK7|HAAO|CPNE5|SOD3|MAPK3|DPEP1|ABL1|ACO1|HMOX1|SOD1|MT1M|CCS|HFE|CAT|NOS3|PPP2CA|MTL5|THBS1|FXN|MT2A|SEPP1|MMP9|SLC30A5|CAV1|RELA|SIGMAR1|MAPK13|ANXA1|SNCB|MT1E|LGMN|ADGRV1|CRIP1|GPHN|PPP1CA|NET1|LOXL2|SIRPA|PRNP
INTERLEUKIN-1 ALPHA SECRETION%GOBP%GO:0050703,0.296989966555184,0.6689039624806751,-0.848257609175121,-1.13008281408469,2219,1,S100A13
PEYER'S PATCH MORPHOGENESIS%GOBP%GO:0061146,0.004648691725328729,0.0752560935123842,0.998014997794442,1.3307183345445301,34,1,RET
REGULATION OF INTEGRIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:2001044,0.0104602510460251,0.13160598312092803,-0.580181963989503,-1.8176343559673402,79,10,PRKD1|CD63|BST1|FLNA|TIMP1|EMP2
PROTEIN LOCALIZATION TO NUCLEOPLASM%GOBP%GO:1990173,0.0749798441279226,0.383578507779904,0.7382816808205579,1.45211294320374,557,3,WRAP53|TBRG1|GLTSCR2
DTDP METABOLIC PROCESS%GOBP%GO:0046072,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME%GOBP%GO:1900095,0.480936454849498,0.7857006060206241,-0.762351124834583,-1.01563474957976,3594,1,RLIM
REGULATION OF TRANSLATION INVOLVED IN CELLULAR RESPONSE TO UV%GOBP%GO:1904803,0.23203612697569395,0.6157917821375749,0.8854764005293341,1.18066330024589,1746,1,RPL26
RESPONSE TO CALCIUM ION%GOBP%GO:0051592,0.8489379541643379,0.9492491301138911,0.12521092160545,0.7687080545600659,6074,83,CPNE8|SCN5A|CPNE9|SYT2|KCNMB4|SLC25A13|SLC25A24|KCNIP2|D2HGDH|CPNE2|RYR1|NEDD4|CARF|PKD2|SYT5|ADD1|CPNE3|KCNMA1|SLC25A12|CAMK2D|CPNE1|ANXA5|HOMER1
TRNA IMPORT INTO MITOCHONDRION%GOBP%GO:0016031,0.394247491638796,0.7376723208557521,-0.802657697397441,-1.0693327824123,2946,1,TOMM20
RESPONSE TO ARSENIC-CONTAINING SUBSTANCE%GOBP%GO:0046685,0.22920226048100897,0.6113413811927839,-0.30554543268313394,-1.2071814996558,1743,19,SRRT|HSF1|HNRNPA1|ATF3|PPIF|VCP|DHX36|DDX3X|MAPK13|RBM4
"NEGATIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, REM SLEEP%GOBP%GO:0042322",0.8052533828601751,0.932964969466025,-0.458262207577985,-0.762621595046547,6069,2,GHRL
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001236,0.0490383390650873,0.317359880131657,-0.22635480413023398,-1.42357765825364,384,95,WWOX|GPX1|TRAF2|TNFAIP3|SIAH2|TNFSF10|INHBA|TNFSF12|PARK7|ICAM1|BRCA1|SNAI2|TIMP3|SCRT2|IFI6|HMOX1|TNFRSF4|G0S2|IGF1|GPER1|NOS3|LGALS3|THBS1|PEA15|FADD|SERPINE1|CAV1|LTBR|RELA|TNFRSF12A|GSTP1|PELI3
ACTIVATION OF PROTEIN KINASE C ACTIVITY%GOBP%GO:1990051,0.24334448160535102,0.626082056933819,-0.8750551389501541,-1.1657835582114,1818,1,ABL1
ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION%GOBP%GO:0071787,0.33202460410941,0.6961761803662729,-0.512797713812133,-1.12262138951628,2536,4,RTN3|ARL6IP1
MEIOTIC SPINDLE ORGANIZATION%GOBP%GO:0000212,0.23888888888888898,0.622245814546853,-0.61988529833462,-1.2104788783645,1805,3,GOLGA2|TUBG1|TUBG2
CORTICOSTEROID HORMONE SECRETION%GOBP%GO:0035930,0.24521739130434803,0.62804240987169,-0.8741729157476841,-1.16460822507142,1832,1,GHRL
POSITIVE REGULATION BLOOD VESSEL BRANCHING%GOBP%GO:1905555,0.7953177257525079,0.929656485793048,-0.606473312748125,-0.807968075410657,5944,1,SIRT6
NEGATIVE REGULATION OF EOSINOPHIL ACTIVATION%GOBP%GO:1902567,0.1838127090301,0.556308895147568,-0.906374062637847,-1.2075078846804599,1373,1,CD300A
CELLULAR DETOXIFICATION%GOBP%GO:1990748,0.495018353434714,0.793303556341427,-0.27233564631024,-0.9634836919927029,3775,14,SOD2|PARK7|SOD3|SOD1|CCS|NOS3
SIDEROPHORE BIOSYNTHETIC PROCESS%GOBP%GO:0019290,0.0353300571124983,0.267780812741458,0.9823555359505959,1.30983855515167,265,1,BDH2
PYRIMIDINE DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046127,0.3944746978350379,0.7376723208557521,0.8039810322011469,1.07200022298308,2969,1,DPYD
MYOBLAST DIFFERENTIATION%GOBP%GO:0045445,0.7729360808505049,0.921900931578338,-0.18883502725736603,-0.7693152607227192,5888,21,GREM1|MBNL1|JAG1|REST|TBX2|NOTCH1|DDX5|IGF1|SRF
FAT-SOLUBLE VITAMIN CATABOLIC PROCESS%GOBP%GO:0042363,0.700889892415992,0.8931369333627571,0.649150860167622,0.8655550802537421,5276,1,CYP26B1
ACYL CARNITINE TRANSPORT%GOBP%GO:0006844,0.28751339764201506,0.6604035198820261,0.6902122966639089,1.15964577531229,2145,2,SLC25A45|SLC25A29
EYE PIGMENT METABOLIC PROCESS%GOBP%GO:0042441,0.843272678974632,0.9481593344082329,0.5772496691662989,0.7696845438865558,6348,1,AP3D1
RETROGRADE TRANS-SYNAPTIC SIGNALING%GOBP%GO:0098917,0.0615547890687185,0.35631208031004796,-0.8394265232974909,-1.39693996916071,463,2,DAGLB|DAGLA
POSITIVE REGULATION OF INVADOPODIUM DISASSEMBLY%GOBP%GO:1905929,0.118127090301003,0.46891245025765,-0.9392368769298629,-1.25128904414448,882,1,NAV3
POSITIVE REGULATION OF INTEGRIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:2001046,0.123750657548659,0.478281129443019,-0.5768815618893901,-1.38267502471484,940,5,CD63|FLNA|EMP2
NEGATIVE REGULATION OF CELLULAR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:2000283,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
REGULATION OF INTEGRIN ACTIVATION%GOBP%GO:0033623,0.111082001571915,0.457050690194406,-0.431984191920586,-1.3985720629566398,847,11,PLEK|PIEZO1|PTGER4|RASIP1|FBLIM1
POSITIVE REGULATION OF PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE ACTIVITY%GOBP%GO:0150074,0.146755852842809,0.514049001465687,-0.9252315835906478,-1.2326306305474,1096,1,CD200
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE%GOBP%GO:0002821,0.0339070790733791,0.26293361581113606,-0.280384539471628,-1.5353439857673201,261,56,PRKCQ|MALT1|HLA-F|CLCF1|SASH3|TRAF6|IL1B|CD1D|HLA-B|PVR|CD274|NFKBIZ|TGFB1|HLA-E|PYCARD|B2M|IL18|CCL19|HLA-C|PAXIP1|HLA-A|IL6ST|TRAF2|PVRL2|SLC11A1|RSAD2|TNFSF13|STX7|NLRP3|ZP3|FADD|IL1R1|ANXA1|TFRC
MAGNESIUM ION HOMEOSTASIS%GOBP%GO:0010960,0.485939410406195,0.7872939093021379,0.438431383788244,0.96325242194023,3576,4,CNNM2|TFAP2B
ELASTIN CATABOLIC PROCESS%GOBP%GO:0060309,0.6185953177257529,0.854944793214197,-0.694585355094839,-0.925354472765529,4623,1,MMP12
REGULATION OF TELOMERE MAINTENANCE VIA SEMI-CONSERVATIVE REPLICATION%GOBP%GO:0032213,0.976253648182542,0.9926773910205121,-0.323533956058063,-0.53841223985011,7358,2,TERF2
POSITIVE REGULATION OF INTERLEUKIN-12 BIOSYNTHETIC PROCESS%GOBP%GO:0045084,0.257893340408597,0.636098664976652,-0.703153046683761,-1.17015911230811,1943,2,TLR4
REGULATION OF CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000722,0.5849031573361639,0.839854222268064,-0.564584390259487,-0.939558709223912,4408,2,GPER1
INTERNAL PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:0018393,0.0186255619781631,0.18774067676224002,-0.262734730270236,-1.5738431269616397,144,79,NAA40|KAT6A|KANSL1|KANSL2|JADE3|YEATS4|TAF6L|BRPF3|RUVBL1|HCFC1|OGT|TAF12|MORF4L2|MSL2|PHF20|NAA50|WDR5|KAT7|TAF9B|SPI1|MBIP|KAT2B|APBB1|TAF10|KAT8|KAT5|TAF9|POLE3|CCDC101|AK6
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0032233,0.178999478895258,0.551831758165591,-0.244029589663057,-1.2377096328505701,1373,43,PLEK|TGFB3|CD47|S100A10|CTGF|PXN|ABL1|RAPGEF3|ARHGEF15|CX3CL1|EVL|NF2|SYNPO|SERPINF2
ETHANOL CATABOLIC PROCESS%GOBP%GO:0006068,0.42045149153453404,0.751774348695433,0.528788544218412,1.04006466532393,3128,3,SULT1C4|SULT1A3|SULT1A1
CHONDROCYTE DEVELOPMENT%GOBP%GO:0002063,0.0269527672379956,0.23236063416368802,-0.437642439532516,-1.6631481408495101,205,17,COL20A1|COCH|VWA1|COL14A1|SULF1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
REGULATION OF UBIQUITIN-SPECIFIC PROTEASE ACTIVITY%GOBP%GO:2000152,0.49074074074074103,0.7904081687771529,-0.5071253494524061,-0.9902872770891,3709,3,PARK7|UBXN1
PHOTORECEPTOR CELL DIFFERENTIATION%GOBP%GO:0046530,0.0949143323361436,0.42498053239300104,0.36192005059508503,1.4167095052486798,697,18,BBS4|CDHR1|AHI1|GNGT1|ARL3|CEP290|AGTPBP1|C8orf37
REGULATION OF MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051147,0.0830140485312899,0.40104890832167206,-0.2245130822748,-1.35488976455815,649,81,NOTCH1|MEF2C|FAM129B|EHD1|MMP14|BOC|ABL1|DNMT1|IGF1|NFATC1|HDAC5|GPER1|NOV|BMP2|FGF9|SRF|MAML1|SIK1|ENG|RBM4|EHD2|PDGFB|ADGRB1
REGULATION OF KETONE BIOSYNTHETIC PROCESS%GOBP%GO:0010566,0.501774501774502,0.796500289838735,0.314327857873497,0.9552133696216971,3675,9,WNT4|SIRT5|DGKQ|DKK3
POSITIVE REGULATION OF ARACHIDONIC ACID SECRETION%GOBP%GO:0090238,0.33177257525083603,0.6961761803662729,-0.8320467578297309,-1.10848606763768,2479,1,PLA2R1
POSITIVE REGULATION OF POTASSIUM ION IMPORT%GOBP%GO:1903288,0.0149312377210216,0.16441238557037197,-0.670332521363486,-1.7242758232143798,113,6,ATP1B1|ATP1B3|ATP1B2|WNK2
"BASE-EXCISION REPAIR, GAP-FILLING%GOBP%GO:0006287",0.96558042141081,0.990916952887267,-0.254866109724946,-0.557955190776938,7377,4,POLE|POLD1
MONOCYTE CHEMOTAXIS%GOBP%GO:0002548,0.00613256784968685,0.0916619640421154,-0.43712735327602903,-1.90682934252168,46,26,CCL3|CCL4|CCL8|CCL11|FLT1|CCL19|CCL24|TNFRSF11A|CCL3L3|CCL18|CCL2|LGALS3|CX3CL1|CCL4L2|CCL14|ANXA1|FOLR2|PDGFB
POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN%GOBP%GO:0033630,0.8462846677132391,0.949216083775675,-0.18930604128559803,-0.703534550104902,6468,16,TGFB2|SYK|RAC3|ADAM9|NCKAP1L|SFRP2|PIEZO1|FOXC2
REGULATION OF NON-MOTILE CILIUM ASSEMBLY%GOBP%GO:1902855,0.7098886705959399,0.8963870249632699,-0.30832449966890396,-0.793093671484698,5419,6,SEPT7|SEPT9
T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0001913,0.320229107003385,0.6882058449368089,-0.38865432337369105,-1.11888140076258,2459,8,CTSH|HFE|EMP2
REGULATION OF DEPHOSPHORYLATION%GOBP%GO:0035303,0.8540089801154591,0.949296218452153,-0.118512773218184,-0.7837546976290971,6656,119,PPP1R15A|DUSP26|GSK3B|CASC5|GBA|TGFB2|ROCK1|SPPL3|PPP1R7|TNF|CEP192|SLC7A14|ZCCHC9|TGFB1|PPP1R2|PPP1R26|PTBP1|NCKAP1L|RIPK3|HSP90B1|SYTL2|PPP1R8|CNST|PPP1R17|BOD1|PLEK|LMTK3|PKMYT1|CD2BP2|LILRB2|NUAK1|FKBP15|MEF2C|ENSA|MTMR1|PPP6R3|NSMF|CRY2|PPP2R4|CD300A|DLC1|LGALS3|BMP2|DLG3|ELFN2|PDGFRB|FKBP1A|RRP1B|CCDC8|SMPD1|STYXL1
POSITIVE REGULATION OF UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:2000060,0.39488378132709995,0.7377402989373809,-0.17977684968746,-1.03883364292397,3040,69,VCP|RNF144B|CCDC22|CEBPA|UBQLN1|SUMO2|HERPUD1|NKD2|RCHY1|PSMD10|PLK1|BCAP31|CAV1|DAB2|CSNK1A1|MAGEF1|FAM122A
FLAVIN-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0042728,0.3458193979933111,0.7033175795366851,-0.82399647110719,-1.09776115273542,2584,1,VCP
TRNA EXPORT FROM NUCLEUS%GOBP%GO:0006409,0.47167504415161,0.7830987875884521,0.443577424406341,0.974558492335908,3471,4,SSB|XPOT|NOL6
"POSITIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, NON-REM SLEEP%GOBP%GO:0046010",0.24521739130434803,0.62804240987169,-0.8741729157476841,-1.16460822507142,1832,1,GHRL
NEGATIVE REGULATION OF NUCLEASE ACTIVITY%GOBP%GO:0032074,0.9517176088720591,0.9858647066977451,0.20888030888030898,0.576608485988862,7036,7,NEIL1|DFFA|TERF1|ABCE1|GZMA|TERF2|TMBIM6
BONE MARROW DEVELOPMENT%GOBP%GO:0048539,0.377264125439308,0.727975088287035,0.43943000771398905,1.05682664863591,2790,5,LRP5L|LRRC17
SEPTIN RING ASSEMBLY%GOBP%GO:0000921,0.827942909519445,0.943061234519578,-0.205491905673085,-0.707342988708591,6322,13,SEPT6|ANLN|SEPT5|SEPT7|SEPT8|SEPT9
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS%GOBP%GO:0097201,0.535825951016154,0.8132910857498922,-0.308567286525562,-0.9282459266376221,4112,9,VHL|DNAJB1|IMPACT|BAG3|NCK1
"POSITIVE REGULATION OF CIRCADIAN SLEEP/WAKE CYCLE, WAKEFULNESS%GOBP%GO:0010841",0.519856554655333,0.8050637202008951,0.7395787384208199,0.986128454212472,3913,1,CRH
NEGATIVE REGULATION OF ACTIVATION-INDUCED CELL DEATH OF T CELLS%GOBP%GO:0070236,0.0356858583178562,0.268987198588135,-0.8789081885856078,-1.4626437737931102,268,2,TNFRSF4|FADD
NEGATIVE REGULATION OF NEURAL RETINA DEVELOPMENT%GOBP%GO:0061076,0.425952981803692,0.7547028278218628,0.7878804587560649,1.05053228079043,3206,1,POU4F2
POSITIVE REGULATION OF ASPARTIC-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902961,0.209299279633268,0.5902938300419871,-0.48536085562662495,-1.24847887014247,1597,6,LYN|EFNA1|EFNA3|EPHA4
EOSINOPHIL FATE COMMITMENT%GOBP%GO:0035854,0.392880860672068,0.737280445732591,0.804642699603,1.0728824671827801,2957,1,GATA2
POSITIVE REGULATION OF GLOMERULAR FILTRATION%GOBP%GO:0003104,0.15753968253968303,0.527393305546732,-0.669054503889734,-1.30649387492972,1190,3,GAS6|PDGFB
RESPONSE TO INTERLEUKIN-11%GOBP%GO:0071105,0.48311897106109297,0.787078399497453,0.599054047385242,1.00648814660614,3605,2,CITED1
MAST CELL DIFFERENTIATION%GOBP%GO:0060374,0.34163987138263696,0.701955655133333,0.663413289219741,1.11461998264618,2549,2,KIT|PIK3CD
REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0033006,0.0169536075699829,0.17671843887293,-0.441699495495497,-1.7451134997734699,128,19,SYK|UNC13D|LYN|CD84|SNX4|FGR|STXBP2|FES|ADGRE2|VAMP8|VAMP7|SNX6|CD300A|LGALS9
REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN%GOBP%GO:1905634,0.218205631958088,0.600900183590521,-0.48035273645806603,-1.23559663852321,1665,6,HDAC8|CDCA5
"REGULATION OF COMPLEMENT ACTIVATION, LECTIN PATHWAY%GOBP%GO:0001868",0.013531440700451,0.154334841212238,-0.9237386269644331,-1.53724879218158,101,2,A2M|SERPING1
RESPONSE TO PARATHYROID HORMONE%GOBP%GO:0071107,0.634110396570204,0.863354277348854,0.532898365559181,0.895338059432524,4732,2,CITED1
ESTABLISHMENT OF CELL POLARITY%GOBP%GO:0030010,0.679745786128765,0.8846577574914319,0.14748077991918698,0.8710394812287571,4919,71,CLASP1|LLGL1|DCTN1|PARD3|RAB10|NDEL1|MYO18A|HTT|GPSM2|RAB11FIP2|CAMSAP3|MYO9A|AMOTL1|BRSK1|DYNLT1|MAP4|DOCK7|FOXJ1|EZR|ZW10
GLYCOPROTEIN CATABOLIC PROCESS%GOBP%GO:0006516,0.627208480565371,0.859069247760118,0.230456348546656,0.867744584423227,4614,16,FBXO2|MANBA|HPSE|GPC1|MAN1B1|EDEM2|MGEA5|NGLY1|ADAMTS12|ADAMTS9|STT3B|EDEM3|EDEM1|SGSH
NEGATIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001268,0.0612835349815886,0.35631208031004796,-0.63618638473584,-1.52481736867599,465,5,CAAP1|PARK7|PLAUR|MMP9
REGULATION OF DEACETYLASE ACTIVITY%GOBP%GO:0150065,0.784426229508197,0.9271255200460491,0.25402436088632996,0.737388279093472,5741,8,CAMK2D|FNTA|MAPK8
NEPHRON TUBULE MORPHOGENESIS%GOBP%GO:0072078,0.177004333694475,0.548637239437431,0.346874918261664,1.279478586191,1306,15,CITED1|PAX8|AHI1|FGF2|PKD1|PKD2|FGF1
CIS ASSEMBLY OF PRE-CATALYTIC SPLICEOSOME%GOBP%GO:0000354,0.9229635584137191,0.9776156396135859,0.372065756393466,0.6251185100953821,6888,2,SNRNP200
THREONINE CATABOLIC PROCESS%GOBP%GO:0006567,0.8992063492063491,0.967562624209366,-0.330667046151703,-0.645708933915948,6797,3,SDSL
REGULATION OF MULTIVESICULAR BODY SIZE%GOBP%GO:0010796,0.31547619047619,0.6851935987509761,-0.583417964895553,-1.13926741876567,2384,3,RILP|SNF8
NEGATIVE REGULATION OF GONADOTROPIN SECRETION%GOBP%GO:0032277,0.358465608465608,0.714938712241162,-0.563306496084703,-1.0999948174089,2709,3,INHA|INHBB|INHBA
PEPTIDYL-LYSINE HYDROXYLATION TO 5-HYDROXY-L-LYSINE%GOBP%GO:0018395,0.24200668896321104,0.625158460820442,-0.8759373621526251,-1.16695889135137,1808,1,JMJD6
REGULATION OF DEVELOPMENTAL PIGMENTATION%GOBP%GO:0048070,0.0985401459854015,0.43335191366922604,0.60219501433929,1.44827555619203,728,5,HPS4|VPS33A|BLOC1S5|ZEB2|BLOC1S6
DENDRITIC CELL HOMEOSTASIS%GOBP%GO:0036145,0.575652173913043,0.835967700120477,-0.716640935156595,-0.954737801264871,4302,1,GPR183
PURINE NUCLEOBASE SALVAGE%GOBP%GO:0043096,0.329668891506347,0.6957352559323989,-0.513940345254234,-1.12512284859592,2518,4,ADA|HPRT1
SUCROSE METABOLIC PROCESS%GOBP%GO:0005985,0.501459273016715,0.7962288610191579,-0.5986472124704489,-0.996244692437768,3779,2,GAA
POSITIVE REGULATION OF COLLAGEN BIOSYNTHETIC PROCESS%GOBP%GO:0032967,0.200471389288988,0.5782976272452409,-0.362358313018988,-1.24730758262575,1530,13,TGFB1|RGCC|TGFB3|CREB3L1|F2R|VIM|SERPINF2
REGULATION OF HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0046885,0.555721663495515,0.8254629302911409,0.24347950721312,0.9167810960063351,4088,16,CYP27B1|TRERF1|WNT4|ARNT|DGKQ|DKK3
NEGATIVE REGULATION OF INTERLEUKIN-1-MEDIATED SIGNALING PATHWAY%GOBP%GO:2000660,0.977751603193299,0.992737680122876,-0.242772087520364,-0.531478848066247,7470,4,IL6|ZNF675|IL1RN
POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL DEDIFFERENTIATION%GOBP%GO:1905176,0.0244816053511706,0.219638825480684,-0.9884208204675781,-1.31681386669801,182,1,PDGFB
OLFACTORY PLACODE FORMATION%GOBP%GO:0030910,0.506308938770089,0.798168488166378,0.7477393030436701,0.997009466008748,3811,1,PROX1
PROTEIN AUTOPROCESSING%GOBP%GO:0016540,0.34525212835625396,0.702940803750667,-0.4247593390351721,-1.09259544426269,2635,6,AFG3L2|PIDD1|F12|CASP1|FXN
NEGATIVE REGULATION OF HEART RATE%GOBP%GO:0010459,0.37510137875101396,0.725707235221442,0.440362270830303,1.05906873608457,2774,5,FKBP1B|SRI
POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION%GOBP%GO:0044829,0.626512361914782,0.858842084733938,-0.35833101571229703,-0.858851068811058,4763,5,YTHDC2|PPIB|NUCKS1
CELLULAR DIVALENT INORGANIC CATION HOMEOSTASIS%GOBP%GO:0072503,0.0044762757385855,0.0743264309917645,-0.20928541886918303,-1.5703421333191399,34,227,MT1G|OCM|EDNRA|CCL19|HSP90B1|FPR3|LPAR6|RYR2|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|ERO1L|PTGER1|PLN|ITPR3|SLC8B1|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ADCY8|CXCR4|JPH4|CALB2|TAC1|CALCB|RMDN3|PTGER4|TBXA2R|SLC11A1|GHRL|ABL1|CALR|HERPUD1|SLC35G1|MT1M|CCRL2|P2RY6|GPER1|SLC24A3|TPCN2|F2R|CCR1|APLNR|GNA15|TMCO1|CD36|F2RL3|GRIN2C|MT2A|TGM2|GRIN2D|BCAP31|CX3CL1|SLC30A5|CAV1|C3AR1|STOML2|CHRNA10|GPR4|CCL14|PRKACA|S100A8|S100A9|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|C5AR1|C1QTNF1
REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902267,0.0378930395055093,0.277429985521989,0.787350830449098,1.54862616998246,281,3,AZIN2|OAZ3|AZIN1
REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY%GOBP%GO:0032878,0.484294611427024,0.7872939093021379,0.23972893747367602,0.9715670562495121,3576,20,SHTN1|LLGL1|FLOT2|ARFGEF1|RUFY3|PTK2B
HISTONE UBIQUITINATION%GOBP%GO:0016574,0.18338071853192,0.556308895147568,-0.254544663692959,-1.2365642555852498,1418,37,UBE2N|PCGF2|PCGF5|UBE2A|CUL4B|DTX3L|UBE2B|BCOR|RNF168|UHRF1|CTR9|HUWE1|RNF20|SKP1|RING1|RNF40|DDB1
PMA-INDUCIBLE MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051088,0.6050792797635041,0.8484731812466321,0.4472480175219,0.8796840717271129,4502,3,ADAM17|ADAM10
CELLULAR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0008652,0.9461209687864269,0.983395403194261,-0.11616578258934598,-0.6419261214540289,7304,58,SERINC3|PYCR1|GATM|FOLH1|CCBL1|PLOD2|CDO1|PYCRL|GOT1|GPT|PHGDH|GGT1|ADI1|SERINC5|GGT5|BCAT2|SHMT2|APIP|MTHFD1
RIBONUCLEOPROTEIN COMPLEX LOCALIZATION%GOBP%GO:0071166,0.266709429121232,0.641722338468214,-0.16859971090148798,-1.1149921805869498,2078,119,MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|NUP37|NMD3|RAN|NXF1|NUP160|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
CAP2 MRNA METHYLATION%GOBP%GO:0097310,0.58254748306548,0.8388460887790121,0.706936479929422,0.94260440702737,4385,1,CMTR2
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:1901723,0.9847846759951091,0.9943582032224201,0.236947799904678,0.520584407437918,7248,4,BMP7|FLCN
RESPONSE TO CORTISOL%GOBP%GO:0051414,0.381334057872572,0.729499056535481,0.479975583357664,1.05452679766361,2806,4,CAD|SLIT3
REGULATION OF THE FORCE OF HEART CONTRACTION%GOBP%GO:0002026,0.31006025674613596,0.680931960213865,-0.347204738299257,-1.12409402055337,2366,11,RYR2|PLN|SLC9A1|CHGA|ADRBK1
B CELL APOPTOTIC PROCESS%GOBP%GO:0001783,0.7150437781905021,0.8990888031809949,-0.5101777390820321,-0.84901734138696,5389,2,TNFRSF21
5-METHYLCYTOSINE CATABOLIC PROCESS%GOBP%GO:0006211,0.341440472991131,0.701955655133333,0.5674948642684859,1.11619542921615,2540,3,TET2|TET3
ADENOSINE TO INOSINE EDITING%GOBP%GO:0006382,0.25920568122041004,0.636098664976652,-0.49685633307701,-1.19086982147074,1970,5,NUDT16|ADARB1
NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:2000650,0.15012172031376803,0.517196964867134,0.48648834322227097,1.3429380133546298,1109,7,PRKCE|NEDD4|CAMK2D|NEDD4L|HECW2|HECW1
REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:2001279,0.301420305102578,0.674570496324836,-0.477014532440271,-1.14331281150853,2291,5,ABCD1|ANXA1
GRANULOCYTE ACTIVATION%GOBP%GO:0036230,0.000127064803049555,0.00518555396908895,-0.3225324382096911,-2.66216929101827,0,408,UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|CNN2|DNASE1L3|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION%GOBP%GO:0031116,0.644182581606393,0.8688307429995409,0.20875068481585998,0.8605018531121691,4755,21,MET|CLASP1|DCTN1|CDK5R1|PAK1|PSRC1|ANKRD53
POSITIVE REGULATION OF STORE-OPERATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901341,0.105876194215417,0.447796222692122,-0.639497049578117,-1.39999272042768,808,4,CRACR2A|STIM2|TMEM110|STIM1
REGULATION OF CYTOTOXIC T CELL DIFFERENTIATION%GOBP%GO:0045583,0.0167224080267559,0.17569702079137303,-0.991784296426996,-1.3212948242941598,124,1,SART1
PARKIN-MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:0061734,0.127564189648146,0.484643747394476,0.6257651795069761,1.37483274923833,938,4,PARK2|HDAC6|OPTN|MFN2
ACTIN FILAMENT POLYMERIZATION%GOBP%GO:0030041,0.00287206266318538,0.0532038364261891,-0.47549117950389796,-1.99638847386491,21,23,CCDC53|MSRB2|MSRB1|RAC1|PSTPIP2|TTC17|MICALL2|COBL|WAS|GSN|AIF1|FAM107A|ANG|WASF3|GAS7
ESTABLISHMENT OF SYNAPTIC SPECIFICITY AT NEUROMUSCULAR JUNCTION%GOBP%GO:0007529,0.0196338551339878,0.192628124925339,-0.909291425420458,-1.51320633853118,147,2,F2R|GPHN
REGULATION OF NITRIC-OXIDE SYNTHASE ACTIVITY%GOBP%GO:0050999,0.388382391247721,0.7352989049211659,-0.22790773678282802,-1.05032947073505,2981,31,NOSIP|IL1B|NOSTRIN|AKT1|TNF|S100A1|TERF2|TERT|INS|GLA|DHFR|APOE|NOS3|CAV1|HSP90AA1|CYGB
PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:0006627,0.239347711730668,0.6231125413749761,-0.507330287348309,-1.21597389124461,1819,5,PMPCA|IMMP1L|UQCRC2
REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I%GOBP%GO:0006356,0.7168083714846311,0.899704384028684,-0.179897209209686,-0.8213754375484641,5479,30,UTP15|IPPK|SMARCA4|MED1|RASL11A|NOL11|FLNA|UBTF|H2AFY|POLR2L
RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM%GOBP%GO:0014808,0.534198432008651,0.812434061990131,0.382761342165526,0.920538832958947,3951,5,NOL3|RYR1
REGULATION OF LACTATION%GOBP%GO:1903487,0.64778455823826,0.870171576465071,-0.539564378274056,-0.8979214082794159,4882,2,XBP1|OAS2
NEGATIVE REGULATION OF HAIR FOLLICLE MATURATION%GOBP%GO:0048817,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
POSITIVE REGULATION OF CARDIOBLAST DIFFERENTIATION%GOBP%GO:0051891,0.36959405677898705,0.722232671030729,-0.652219465122691,-1.08539748769841,2785,2,TGFB2|DHX36
DNA PROTECTION%GOBP%GO:0042262,0.572593371909521,0.834525990688514,-0.37495560201116496,-0.898697029906394,4353,5,DCTPP1|NUDT1
NEUTROPHIL MEDIATED KILLING OF BACTERIUM%GOBP%GO:0070944,0.378060200668896,0.7281989978224692,-0.8093295103661229,-1.07822123928336,2825,1,AZU1
REGULATION OF ACROSOME REACTION%GOBP%GO:0060046,0.00789058390320884,0.10845506809166199,-0.7431061107434369,-1.7810835497546003,59,5,PLCB1|HYAL3|CACNA1H|ZP3|POMZP3
MIDBRAIN MORPHOGENESIS%GOBP%GO:1904693,0.52371382636656,0.807638018293751,0.5814722911497111,0.9769485260580111,3908,2,FZD6|FZD3
SPERMINE CATABOLIC PROCESS%GOBP%GO:0046208,0.9127089413637571,0.972925642245441,-0.388500011586516,-0.646526145102837,6879,2,SMOX
NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS%GOBP%GO:0000956,0.988367633900038,0.996030692679047,-0.08938275498377,-0.64837810473238,7731,188,MAGOH|PDE12|RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|PATL1|RPL10|DDX5|RPL36A|RPL24|PELO|LSM3|NT5C3B|RPL35|PPP2CA|RPL38|RPS15A|MAGOHB|EIF4A3|EXOSC3|RPS13|RBM8A|TNKS1BP1|POLR2G|TUT1|EXOSC2|EIF4G1
LEUCINE TRANSPORT%GOBP%GO:0015820,0.607671957671958,0.849325284075052,-0.45321678562043605,-0.885017514994598,4593,3,SLC3A2
POSITIVE REGULATION OF LONG-TERM SYNAPTIC POTENTIATION%GOBP%GO:1900273,0.18561697668325897,0.559093571852282,-0.39471511777452295,-1.2779114302580101,1416,11,SHISA7|INS|ADCY8|LGMN|SQSTM1
REGULATION OF EMBRYONIC DEVELOPMENT%GOBP%GO:0045995,0.21978021978022003,0.6022138020814389,0.21001219719515699,1.18267562746765,1599,59,DKK1|NPHP3-ACAD11|DLL1|CLASP1|GPR161|MAPK7|RNF207|TENM4|CLASP2|MAP2K5|TRIP12|WDPCP|DVL2|WNT4|NPHP3|RBM19|PHLDB1
ADHERENS JUNCTION ORGANIZATION%GOBP%GO:0034332,0.5354228726848851,0.8132910857498922,-0.17203593747250198,-0.9506617149287758,4133,58,CDH6|TBCD|CTTN|PEAK1|JUP|CTNND1|TRIP6|THY1|TAOK2|PVRL2|PKP2|CDH8|RHOD|CDH11|CDH5|CDH7|DLC1|VCL|ANG|ACTN1|CADM3
PROTEIN LIPOYLATION%GOBP%GO:0009249,0.569838468847564,0.8324048186805392,0.344649309170297,0.8918003443312371,4197,6,LIAS|GCSH|NNAT
STRESS-INDUCED MITOCHONDRIAL FUSION%GOBP%GO:1990046,0.0976588628762542,0.430598623028127,-0.948886193206881,-1.26414425036294,729,1,STOML2
POSITIVE REGULATION OF MICROTUBULE DEPOLYMERIZATION%GOBP%GO:0031117,0.0612272240085745,0.35631208031004796,0.847532395919493,1.4239638544819,456,2,KATNB1|STMN2
MEMBRANE RAFT ORGANIZATION%GOBP%GO:0031579,0.35639275400367604,0.7143448949172672,-0.297065798242305,-1.07859775941533,2714,15,CAV2|S100A10|CAV1|ANXA2|EMP2
EVASION OR TOLERANCE OF HOST DEFENSE RESPONSE%GOBP%GO:0030682,0.605525302164962,0.8484731812466321,0.694861049845611,0.92650345038288,4558,1,EIF2AK2
DETOXIFICATION OF COPPER ION%GOBP%GO:0010273,0.168575891694871,0.541253459162226,-0.45374885772958795,-1.30627945451351,1294,8,PARK7|MT1M|MT2A|MT1E
PRIMITIVE ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0060319,0.971709390357285,0.9915747942934481,0.513178209086899,0.684253897215797,7315,1,VEGFA
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS%GOBP%GO:1902043,0.605266730012217,0.8484731812466321,0.335672098036142,0.868571282883683,4458,6,SFRP1|PMAIP1
SPHINGOSINE METABOLIC PROCESS%GOBP%GO:0006670,0.697084092684197,0.891249402492146,-0.279124364172177,-0.803559978082752,5354,8,SPHK1
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051149,0.18153486560187002,0.554948538055731,-0.23989948929746602,-1.233166044007,1397,45,MESP1|MEF2C|FAM129B|EHD1|MMP14|BOC|ABL1|IGF1|GPER1|MAML1|ENG|RBM4|EHD2|ADGRB1
REGULATION OF INTERLEUKIN-18 PRODUCTION%GOBP%GO:0032661,0.0793650793650794,0.395545778489815,-0.730065071137091,-1.4256320496991102,599,3,DHX9|CD84|TLR2
RETINOIC ACID METABOLIC PROCESS%GOBP%GO:0042573,0.697027283833311,0.891249402492146,0.309645202517052,0.8012251609904609,5134,6,ALDH8A1|ALDH1A3|CYP26B1|BCO2
ALCOHOL CATABOLIC PROCESS%GOBP%GO:0046164,0.28877078222949,0.661914591626656,0.255913221952175,1.13164051102523,2118,26,SULT1C4|INPP1|INPP5K|INPP5J|SORD|IMPA1|TRERF1
POSITIVE REGULATION OF SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION%GOBP%GO:0014718,0.902228707880074,0.968486494114721,-0.39862145023435297,-0.66336983755257,6800,2,CAPN3|SOX15
ACYL CARNITINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902616,0.61322884845265,0.852045339927398,0.690174239082488,0.920254220635019,4616,1,SLC25A29
REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS%GOBP%GO:1904259,0.187483103541498,0.5609377558550861,0.533835978022693,1.2838724658562701,1386,5,CLASP1|CLASP2|PHLDB1
POSITIVE REGULATION OF MAPK CASCADE%GOBP%GO:0043410,0.00025568908207619504,0.00819882332206558,-0.217258371485848,-1.7429383873535902,1,338,FLT1|SCIMP|PYCARD|CD74|PLCB1|ARHGEF5|ADAM8|MADD|CCL19|MID1|MYDGF|EPHB3|TBX1|EZH2|DAB2IP|PIK3R6|MERTK|CD4|DUSP5|FGFR4|KDR|RAPGEF1|EMC10|CCL24|PLA2G2A|NGF|TNFRSF11A|PDGFD|CAV2|IL1RN|EPHA8|FCGR2B|GAS6|PKN1|INS|CCL3L3|MDFIC|DDR2|TRAF2|FPR1|CCL18|TAOK2|MAPK8IP1|MARCO|CXCR4|ZNF622|MST1R|PDGFC|NDST1|FLT4|MAPKAPK2|NOTCH1|GPNMB|MLKL|GCNT2|ICAM1|ARRB1|CTGF|PIK3CB|NOTCH2|OSM|FGF10|MAPK3|GHRL|SOD1|DDR1|IRAK1|NECAB2|HRAS|IGF1|NTRK2|TREM2|MAP3K13|GADD45B|SEMA7A|P2RY6|CCL2|GPER1|MAP2K3|EPHA2|F2R|CCR1|APOE|RAP1A|AXL|SASH1|FGF19|CD36|MUC20|GADD45G|BMP2|LGALS9|THBS1|TEK|MAP3K11|ADRA2C|PEA15|UBC|PDGFRB|EPHA4|CX3CL1|IL11|LTBR|SEMA3A|CCL4L2|CCL14|ATP6AP1|ARHGAP8|INSRR|EPHB4|TLR4|PDGFA|ARL6IP5|CSF1R|PDGFRA|PHB|GNG3|GLIPR2|TIE1|DBNL|CD81|PDGFB|C5AR1|SERPINF2|PTPRJ|ERN1
METANEPHRIC TUBULE FORMATION%GOBP%GO:0072174,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
GROWTH HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060396,0.344118417605449,0.702174649119653,-0.33661212247150396,-1.0897998569071,2626,11,PTPN1|JAK3|STAT5A|LYN|STAT3|PXN
CO-TRANSLATIONAL PROTEIN MODIFICATION%GOBP%GO:0043686,0.763773179252889,0.9191113740914171,0.389875372228962,0.7668388488534861,5683,3,PDF|STT3A
DETECTION OF CALCIUM ION%GOBP%GO:0005513,0.41197230894529707,0.746306769569813,0.39586850115962297,1.024333014025,3034,6,KCNMB4|KCNIP2
REGULATION OF NEURON MIGRATION%GOBP%GO:2001222,0.0147000918755742,0.162839254065689,-0.427998148857438,-1.74366754017696,111,21,CAMK2B|NSMF|COL3A1|CX3CL1|CAMK2A|SEMA3A|PLAA|KIAA2022|ADGRG1
TRANSEPITHELIAL TRANSPORT%GOBP%GO:0070633,0.141239260609216,0.506729504971671,-0.470354071960807,-1.3540835422120903,1084,8,AQP1|CXADR|SLC12A2|RHBG|BEST1
DEADENYLATION-DEPENDENT DECAPPING OF NUCLEAR-TRANSCRIBED MRNA%GOBP%GO:0000290,0.9983606557377049,0.999656642395059,0.141872138562524,0.411829998276201,7307,8,PAN3|DCP1B|PATL2|LSM1
REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL/VENTRAL NEURAL TUBE PATTERNING%GOBP%GO:1901620,0.103466595829459,0.442538815478223,0.9483348037053371,1.2644764992172,778,1,GPR161
REGULATION OF NEUROTRANSMITTER TRANSPORT%GOBP%GO:0051588,0.17561290322580597,0.548366806412612,-0.22677226387909402,-1.23700450124105,1360,55,SEPT5|PER2|SNCAIP|SNX4|TOR1A|MCTP1|NAPA|CPLX2|FMR1|MEF2C|VPS18|SYN1|VAMP8|VAMP7|GPM6B|SNX6|STX1B|GPER1|HTR1B|DTNBP1|CAMK2A|ARL6IP1|ARL6IP5
TOXIN TRANSPORT%GOBP%GO:1901998,0.998953016620861,0.999656642395059,-0.195169028842442,-0.427265801793168,7632,4,ANTXR1|ANTXR2|RAB40B|RAB29
INHIBITORY SYNAPSE ASSEMBLY%GOBP%GO:1904862,0.313846153846154,0.6833560549363861,-0.8402073224525799,-1.11935789918243,2345,1,NPAS4
REGULATION OF OSTEOBLAST DIFFERENTIATION%GOBP%GO:0045667,0.113065976714101,0.46074941938046904,-0.24022478070811998,-1.32276401227046,873,57,HGF|SMAD6|DDR2|IL6ST|NOTCH1|MEF2C|CHRD|PRKD1|DDX5|C14orf169|SNAI2|IGF1|MEN1|LRP5|BMP2|CCRN4L|ATP6AP1|IFITM1|PRKACA|TMEM119|ZHX3
PROTEIN-DNA COMPLEX DISASSEMBLY%GOBP%GO:0032986,0.0440638075313808,0.299196685743008,-0.403728766475492,-1.56661776467578,336,18,SMARCA4|SET|SMARCE1|SUPT16H|SMARCD3|SMARCD2|HIST3H2A|MYC
REGULATION OF MUSCLE HYPERPLASIA%GOBP%GO:0014738,0.16347826086956502,0.5350520708025429,-0.916795324217027,-1.2213915073964,1221,1,NOS3
ASSEMBLY OF LARGE SUBUNIT PRECURSOR OF PRERIBOSOME%GOBP%GO:1902626,0.313756613756614,0.683340778593277,-0.5840257055226911,-1.14045418217924,2371,3,RPL24
CELL GROWTH%GOBP%GO:0016049,0.730764257080047,0.907346443357524,-0.16448548102425,-0.818845903446303,5650,40,NRP2|SLIT2|TMEM108|MAP1B|SEMA3A|HSP90AA1
REGULATION OF LEUKOCYTE CELL-CELL ADHESION%GOBP%GO:1903037,0.00012768130745658798,0.00518555396908895,-0.276244339121569,-1.9804464145259397,0,177,ETS1|RARA|GRAP2|ADTRP|HSPH1|IL1B|AKT1|FOXP3|CD1D|HLA-DMB|CXCL12|CDC42|PAK2|TNF|JAK3|SYK|RAC1|CD274|DUSP3|NFKBIZ|CD44|HLA-DPA1|LILRB1|HLA-E|LYN|NDFIP1|CD209|PYCARD|TNFAIP8L2|NCKAP1L|TNFRSF14|IL18|ADAM8|RUNX1|CCL19|TWSG1|RUNX3|CCDC88B|HLA-DPB1|KLF4|PDCD1LG2|VAV1|SPN|GATA3|EBI3|FCGR2B|PLA2G2D|THY1|IL6ST|RC3H2|LILRB2|GPNMB|GRB2|PRKAR1A|SOCS1|PTPN6|CD47|SDC4|IRAK1|IGF1|DPP4|CEBPB|NKAP|ICOSLG|VCAM1|C10orf54|CCL2|CEACAM1|CD300A|HFE|CD86|NLRP3|LGALS3|TGFBR2|TNFRSF21|LGALS9|ZP3|FADD|AIF1|CAV1|PPARA|HAVCR2|RELA|BCL6|LILRB4|PNP|ANXA1|CD55|NCK1|TFRC|SART1|SIRPA|PRNP
RESPONSE TO NITROSATIVE STRESS%GOBP%GO:0051409,0.0334941050375134,0.261345744270986,0.881996140060656,1.4818673944331797,249,2,DUSP6|ATM
REGULATION OF PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:1900736,0.259883258158663,0.636098664976652,-0.7022332506203471,-1.16862842457214,1958,2,BICD1|CHGA
REGULATION OF DNA REPLICATION%GOBP%GO:0006275,0.21614315139031898,0.5991362048583871,-0.19803880484428,-1.17519619170558,1678,76,DHX9|WRNIP1|TSPYL2|ESCO2|RFC3|TERF2|DONSON|CDT1|NBN|CDC6|ZBTB38|STAG2|SLFN11|RAD17|PCNA|GMNN|RBBP6|RFC5|NUCKS1|FGF10|PPP2CA|STOML2|SMC1A|BCL6|S100A11|RFC4|ACVRL1
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002718,0.0513086291785437,0.326690583554734,-0.296157135368856,-1.4923710813776498,395,42,IL1B|TGFB2|FOXP3|TNF|JAK3|TGFB1|LILRB1|HLA-E|CD74|TNFRSF14|B2M|IL18|IRAK3|TGFB3|TRAF2|RSAD2|SEMA7A|GPRC5B|HFE|NLRP3|BST2|TICAM1|IL1R1|TNFRSF1B
DNA INTEGRITY CHECKPOINT%GOBP%GO:0031570,0.5252719129878439,0.8084598653338,-0.143258439278055,-0.9649224809762099,4104,130,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|CLOCK|FOXN3|BLM|DNA2|SFN|ATRIP|STK33|CDKN1B|CNOT6|AURKA|TIMELESS|EME2|PIDD1|PRMT1|UIMC1|RAD9A|PML|RGCC|CLSPN|RPA2|BRIP1|TRIAP1|TFDP2|SETMAR|INTS7|DONSON|CDT1|FBXO6|H2AFX|NBN|CDC6|PLK2|RAD1|RAD17|BRCC3|PCNA|ORC1|TOP2A|TAOK2|CDC25C|RHNO1|CDC45|BRCA1|TOPBP1|EME1|DTL|E2F1|CCNB1|PLK1|PLAGL1|TNKS1BP1|CEP63|ZNF385A|CCND1|MUS81|PRPF19
REGULATION OF MICROTUBULE NUCLEATION%GOBP%GO:0010968,0.244396141828556,0.627316259271964,0.54934410960975,1.2069324040812,1798,4,DCTN1|RANGRF|EML2
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE-GATED CALCIUM CHANNEL%GOBP%GO:1902514,0.0492291046794698,0.318097230821966,0.5726965186106129,1.58091336755146,363,7,BIN1|CACNB2|CAMK2D|SESTD1|NOS1AP|CACNA2D1
"TRANSCRIPTION, RNA-TEMPLATED%GOBP%GO:0001172",0.491371237458194,0.790696900371285,-0.75766431407146,-1.00939079227365,3672,1,TERT
NEGATIVE REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032078,0.6005351170568559,0.8464076674715391,-0.7033524481693871,-0.9370343458440171,4488,1,GZMA
POSITIVE REGULATION OF ALDOSTERONE METABOLIC PROCESS%GOBP%GO:0032346,0.306016735290211,0.677423587903087,0.848257609175121,1.13103706401287,2303,1,WNT4
NEGATIVE REGULATION OF GLUTAMATE SECRETION%GOBP%GO:0014050,0.0736870310825295,0.382002237820699,0.83264405845051,1.39894952522295,549,2,TRH|HRH3
NODAL SIGNALING PATHWAY%GOBP%GO:0038092,0.298729386320627,0.671387424531401,0.473009472964739,1.13758507000215,2209,5,SMAD3|CITED2|ACVR1B|SMAD2
POSITIVE REGULATION OF NEGATIVE CHEMOTAXIS%GOBP%GO:0050924,0.121070234113712,0.472999327000989,-0.937858403176003,-1.2494525861132701,904,1,SLIT2
RESPONSE TO EXOGENOUS DSRNA%GOBP%GO:0043330,0.0179248986000262,0.18267953582463603,-0.456942742797285,-1.7364940063165801,136,17,MB21D1|IFIH1|IFIT1|TMEM173|COLEC12|TICAM1|SLC3A2|CAV1|PQBP1
INTERFERON-GAMMA-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060333,0.000129015610888918,0.00518555396908895,-0.37636324362142803,-2.12833838158057,0,63,GBP1|GBP2|HLA-F|IFNGR2|TRIM22|TRIM25|HLA-DRB1|IRF8|OAS3|HLA-DQB2|HLA-B|CD44|HLA-DPA1|PML|HLA-E|HLA-DRA|HLA-DRB5|FCGR1B|TRIM38|SP100|TRIM21|B2M|MID1|OASL|OAS1|IFNGR1|HLA-DPB1|HLA-DQA2|FCGR1A|TRIM68|HLA-C|IRF5|TRIM34|HLA-A|OAS2|ICAM1|CAMK2B|IRF7|IFI30|VCAM1|HCK|MT2A|CAMK2A|PTAFR
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:1900015,0.110294117647059,0.455506454452105,-0.3444479002009,-1.38191837824597,839,20,TICAM1|ABCD1|TLR4|CHID1|SIRPA
ENZYME ACTIVE SITE FORMATION%GOBP%GO:0018307,0.516536060565812,0.804056180000979,0.741288045875607,0.988407585061692,3888,1,MOCS3
PROTEIN FARNESYLATION%GOBP%GO:0018343,0.923852480764128,0.9776627603891009,-0.38054247938605396,-0.6332835390161939,6963,2,FNTB
LIVER MORPHOGENESIS%GOBP%GO:0072576,0.18081719288936102,0.554494792588896,-0.745133719327268,-1.2400216648012,1362,2,RPS6KA1|CEBPB
NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION%GOBP%GO:0045986,0.0473759979060332,0.312255783864335,-0.697898858434898,-1.52784648818665,361,4,ADRB2|DOCK4|DOCK5|SOD1
CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0061049,0.646972132904609,0.8697778704754799,0.526550868486352,0.88467344479165,4828,2,PDLIM5|SORBS2
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002675,0.0168671548117155,0.17671843887293,-0.44607944427270896,-1.73095414516803,128,18,PTGS2|IL1B|TNF|HLA-E|F12|C2CD4A|ADAM8|C2CD4B|TNFRSF11A|IL6ST|PARK7|OSM|ZP3|OSMR
REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE%GOBP%GO:2000172,0.80131296891747,0.9325377000668108,0.44913967295616003,0.7546126413368921,5980,2,RTN4
PROEPICARDIUM DEVELOPMENT%GOBP%GO:0003342,0.867692307692308,0.9558022175108679,-0.569309660344067,-0.7584571668892659,6485,1,TGFBR1
PROTEIN TRANSPORT FROM CILIARY MEMBRANE TO PLASMA MEMBRANE%GOBP%GO:1903445,0.6429528403001071,0.8685816125467059,0.528284971277565,0.887586961379961,4798,2,RILPL1|RILPL2
REGULATION OF PROTEIN K63-LINKED UBIQUITINATION%GOBP%GO:1900044,0.38444502344971293,0.731395064141379,-0.349577006711146,-1.05161320300528,2950,9,SASH1|PLAA|OTUB1
SYNAPSE ASSEMBLY%GOBP%GO:0007416,0.597716065403582,0.844965920541931,-0.17430810546840197,-0.90779724592197,4605,47,GPM6A|ACHE|SPOCK2|PLXND1|PCDHB6|PCDHB11|PCDHB13|RAB29|NPAS4|DSCAM|PCDHB2|KIRREL3|PCDHB16|NRXN2|DBNL|DNM3
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0010804,0.25284797695430106,0.632257972333528,-0.34347682712180505,-1.1823138466339298,1930,13,GAS6|CARD16|GSTP1|PELI3|HIST1H2BJ
NADH DEHYDROGENASE COMPLEX ASSEMBLY%GOBP%GO:0010257,0.00025779840164991,0.00819882332206558,-0.373034000171323,-2.11835556727173,1,64,COA1|NDUFAF5|TIMMDC1|NDUFC2|NDUFAF4|NDUFV2|NDUFB8|NDUFS4|C17orf89|NDUFB5|OXA1L|NDUFA11|NDUFA9|NDUFA7|NDUFA3|NDUFB6|NDUFAF3|NDUFB9|NDUFB10|TIMM21|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|NDUFB4|NDUFA12|NDUFA2|NDUFAB1|NDUFA1|NDUFB11|NDUFV1|NDUFAF2|NDUFS3|NDUFA8|NDUFS8|NDUFV3
POST-EMBRYONIC CAMERA-TYPE EYE DEVELOPMENT%GOBP%GO:0031077,0.971709390357285,0.9915747942934481,0.513178209086899,0.684253897215797,7315,1,VEGFA
BLOOD VESSEL MATURATION%GOBP%GO:0001955,0.00981546917942678,0.126501155704659,-0.77993043000227,-1.7074307460269698,74,4,S1PR1|RECK|ACVRL1
POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0062043,0.453601472134595,0.7702341823050379,-0.36496565236988393,-0.997617335342137,3450,7,TGFB2|JAG1|NOTCH1|TGFBR2|ENG
CATECHOL-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0019614,0.851472134595163,0.949296218452153,-0.249489316959049,-0.681967922090289,6477,7,MAOA|MOXD1|COMT
REGULATION OF DNA METABOLIC PROCESS%GOBP%GO:0051052,0.0492201482996676,0.318097230821966,-0.166168945184068,-1.3065396294398102,384,299,PARM1|NEK2|UIMC1|FAM168A|GZMA|TGFB1|GREM1|PML|RFC2|GNL3|RGCC|RAD51|RPA2|CCT3|NPAS2|DHX9|WRNIP1|NDFIP1|NABP2|CEBPG|H1F0|TSPYL2|SETMAR|ESCO2|DTX3L|RFC3|TERF2|DEK|DONSON|WDR70|KDM1A|CDT1|H2AFX|NBN|PARP9|TINF2|PPP4R2|PARPBP|TRIM28|KLF4|FGFR4|CDC6|ANKRD32|PARP1|USP9X|ZBTB38|HGF|KLHL15|PAXIP1|HNRNPU|STAG2|WAS|NPM1|RAD51AP1|SLFN11|RAD17|BRCC3|PCNA|GMNN|DHX36|CCT8|SMOC2|RBBP6|USP51|SLX1B|HNRNPA2B1|AUNIP|FAM129B|SLX1A|FOXM1|RNF168|CCT5|BRCA1|NUDT16|RFC5|POLQ|NUCKS1|MECP2|FGF10|MAPK3|DNMT1|MEN1|TNFSF13|DKC1|KPNA2|GPER1|SPI1|FBXO4|CXorf57|PPP2CA|RMI2|HDAC8|PDGFRB|PPP4C|H1FX|MYC|STOML2|SMC1A|BCL6|PDGFA|HSP90AA1|HIST1H1C|S100A11|OTUB1|RFC4|MAGEF1|TFRC|ACVRL1|PDGFB|HNRNPC|NAT10
TRANSMISSION OF NERVE IMPULSE%GOBP%GO:0019226,0.5696219744356811,0.8323195269657071,0.21245107701826602,0.9151592110280609,4188,24,SCN5A|KCNMB4|CACNG7|CACNG4|SCN3A|SCN9A|SCN2A
NEGATIVE REGULATION OF MESODERMAL CELL DIFFERENTIATION%GOBP%GO:1905771,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN-1 PRODUCTION%GOBP%GO:0071638,0.622883597883598,0.857007260823118,-0.44629612671510493,-0.8715032221862758,4708,3,APOD|GSTP1
REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0060264,0.567724867724868,0.83116084992853,-0.47110478843761494,-0.919948250800872,4291,3,SLAMF8|INS
RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0032800,0.333377553727779,0.6971906052358929,-0.668265784394817,-1.11210112896661,2512,2,TNF|PPARG
NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY%GOBP%GO:0043553,0.719195761445456,0.900474259627538,0.362872299991108,0.7972458969549442,5293,4,WASH1|PIK3IP1|KIAA0226
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY%GOBP%GO:0010922,0.284400052569326,0.657079976367272,-0.290438148290827,-1.14749402840715,2163,19,PLEK|MEF2C|PPP2R4|CD300A|BMP2|PDGFRB
NEGATIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0062044,0.7014046822742479,0.8931369333627571,-0.652183502426114,-0.8688650237255441,5242,1,TGFB2
TERPENE METABOLIC PROCESS%GOBP%GO:0042214,0.791074511887369,0.928357780000476,0.603936921041023,0.8052683932743759,5955,1,BCO2
REGULATION OF SCHWANN CELL MIGRATION%GOBP%GO:1900147,0.456103068136539,0.7711961414599979,0.7731583590648431,1.03090234734715,3433,1,CERS2
INORGANIC ION HOMEOSTASIS%GOBP%GO:0098771,0.000128799587841319,0.00518555396908895,-0.223747692865212,-1.80244055978299,0,350,PPT1|PML|CCL11|CEMIP|PSEN1|PLCE1|CLN6|SLC39A13|SLC9A5|NDFIP1|FIS1|NEO1|ATP6V0A1|MT1G|B2M|OCM|EDNRA|CCL19|SLAMF8|HSP90B1|FPR3|LPAR6|RYR2|GPR89B|TCIRG1|ITPR2|ATP1B1|CCDC109B|FGFR4|ATP2A1|P2RX4|SLC12A8|ATP6V0A2|ERO1L|SFRP4|PTGER1|RAB7A|PLN|ITPR3|SLC8B1|ATP1A3|SLC12A2|ATP1B3|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ATP5B|ADCY8|CXCR4|JPH4|CALB2|CCDC22|TAC1|CALCB|DMXL1|RMDN3|ATP6V0D1|ABCB7|HAMP|CA2|SEPN1|SLC9A1|PTGER4|TBXA2R|SLC9A7|SLC11A1|GHRL|ABL1|CALR|ACO1|HERPUD1|HMOX1|SOD1|SKP1|SLC35G1|ARF1|SLC9A9|MT1M|CCRL2|P2RY6|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|FTL|APLNR|GNA15|TMCO1|MTL5|CD36|F2RL3|ATP6V0E1|GRIN2C|FXN|MT2A|XIAP|TGM2|GRIN2D|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|ATP1B2|PRKACA|KCNH2|ATP6V0E2|S100A8|S100A9|RAB20|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|SLC7A8|TFRC|ATP6V1A|ATP6V1G1|FAM20A|C5AR1|FTH1|C1QTNF1|PRNP
LEUKOTRIENE D4 BIOSYNTHETIC PROCESS%GOBP%GO:1901750,0.26335978835978796,0.638950455433329,-0.60752323810197,-1.18633890788142,1990,3,GGT1|GGT5
POSITIVE REGULATION OF CELL DEVELOPMENT%GOBP%GO:0010720,0.190927729369554,0.5652402799587389,-0.150248119894614,-1.1484145978072,1489,253,FZD4|AMIGO1|NUMB|P2RX4|CLDN5|RAPGEF1|PLXND1|SEMA6A|SYT4|NGF|COBL|FES|BRINP3|RREB1|HES1|ARSB|GOLGA4|FMR1|DHX36|DOCK5|CPNE6|CXCR4|NOTCH1|MEF2C|FAM129B|SMARCD3|PRKD1|DSCAM|S100A10|TRIM32|DBN1|SNW1|CPNE5|CAMK2B|ABL1|CALR|NTN1|FLNA|IGF1|NTRK2|NSMF|MAP3K13|SEMA7A|GPRC5B|CDH5|DOCK1|CSF1|GPER1|SCARF1|APOE|RAP1A|SERPINE2|BMP2|ADRA2C|SEMA5A|NBL1|NEDD9|SLIT2|CX3CL1|SCN1B|SEMA3A|ATP6AP1|PLAA|S100A9|STYXL1|MARK2|CAPRIN1|ARHGDIA|NGFR|SERPINF1|BAD
REGULATION OF LUNG CILIATED CELL DIFFERENTIATION%GOBP%GO:1901246,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
POSITIVE REGULATION OF INTERLEUKIN-6 SECRETION%GOBP%GO:2000778,0.189157259123129,0.563438044703664,-0.346806925118644,-1.2591997281275,1440,15,TNF|HYAL2|DHX9|PYCARD|IFIH1|F2R|LGALS9|C1QTNF4
T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002309,0.246617139824887,0.6280519349499749,-0.7100082712985942,-1.18156730230003,1858,2,LILRB1|SLC11A1
CHITIN CATABOLIC PROCESS%GOBP%GO:0006032,0.49825315775329204,0.794989907195277,0.49012489987513197,0.9640178395109109,3707,3,CTBS|OVGP1|CHIT1
POST-TRANSLATIONAL PROTEIN ACETYLATION%GOBP%GO:0034421,0.333994708994709,0.6974768376198021,-0.5750523877798609,-1.1229315669055302,2524,3,ESCO1|DSCC1|ESCO2
TIRAP-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035664,0.9232301766502858,0.9776156396135859,0.539258932509925,0.719029022753894,6950,1,TIRAP
EPITHELIAL CELL PROLIFERATION INVOLVED IN LIVER MORPHOGENESIS%GOBP%GO:0072575,0.18081719288936102,0.554494792588896,-0.745133719327268,-1.2400216648012,1362,2,RPS6KA1|CEBPB
REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:1902423,0.43632263199787696,0.7626864968659259,-0.624538185828508,-1.03933141238351,3288,2,BECN1|HNRNPU
NUCLEOTIDE-SUGAR METABOLIC PROCESS%GOBP%GO:0009225,0.5839005235602089,0.839558852248902,-0.20317394235387803,-0.9073975502198629,4460,28,GNPNAT1|GMPPB|GFPT2|NANS|CSGALNACT1|RENBP
REGULATION OF GOLGI ORGANIZATION%GOBP%GO:1903358,0.473591549295775,0.7837580618565259,0.26605331623551504,0.9813610122472339,3496,15,EHD3|CAMSAP3|RAB33B|MYO5A|STX18|MAP2K1|MAPK1
"POSITIVE REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR%GOBP%GO:1902164",0.663040594322101,0.879716013665144,-0.533079272964565,-0.8871291559981122,4997,2,ZNF385A
POSITIVE REGULATION OF IMMUNOLOGICAL SYNAPSE FORMATION%GOBP%GO:2000522,0.659184486651614,0.8772415412127091,0.668670048522276,0.891581284144833,4962,1,CCR7
T CELL SECRETORY GRANULE ORGANIZATION%GOBP%GO:0033371,0.23785953177257502,0.6217158626397761,-0.877977503308337,-1.16967684923756,1777,1,SRGN
ENDOCHONDRAL BONE GROWTH%GOBP%GO:0003416,0.00341700617689578,0.0608484293500764,-0.49365412962823496,-1.9503814122919598,25,19,COL20A1|COCH|ANXA6|DDR2|VWA1|COL14A1|COMP|COL12A1|COL6A3|COL21A1|COL6A1|ANXA2|COL6A2
RNA IMPORT INTO MITOCHONDRION%GOBP%GO:0035927,0.578981808663787,0.8381571445175691,-0.409300933930891,-0.8960453036421759,4423,4,MRPL18|TST|TOMM20
REGULATION OF NUCLEOTIDE-EXCISION REPAIR%GOBP%GO:2000819,0.469783503785363,0.7810597690409531,0.765935156594618,1.02127118150044,3536,1,RAD52
MULLERIAN DUCT REGRESSION%GOBP%GO:0001880,0.8207747413106931,0.940031154277066,-0.450289495450786,-0.7493537271343599,6186,2,AMH|AMHR2
REGULATION OF INTERLEUKIN-6 PRODUCTION%GOBP%GO:0032675,0.00181182865277598,0.036458923837937994,-0.35130349468137706,-1.92368562387397,13,56,HYAL2|DHX9|TLR1|PYCARD|NCKAP1L|IRAK3|IL17D|TLR2|IL1RN|GAS6|TNFAIP3|LILRB2|MAPKAPK2|STAT3|PTPN6|CD47|IFIH1|ARRB1|GHRL|F2R|RAB7B|CD200|LGALS9|CX3CL1|MAPK13|TLR4|C1QTNF4|SIRPA
PHOSPHOANANDAMIDE DEPHOSPHORYLATION%GOBP%GO:0035644,0.821137123745819,0.940381156652688,-0.593019408910454,-0.7900442450260592,6137,1,PTPN22
NEGATIVE REGULATION OF CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS%GOBP%GO:2001113,0.861003344481605,0.951993398605548,-0.5721217468019411,-0.762203541272932,6435,1,ADAMTS12
CELL PROLIFERATION IN HINDBRAIN%GOBP%GO:0021534,0.116343857787211,0.46625878958064004,-0.788640749931072,-1.31242432102322,876,2,RORA|ATF5
CELL AGING%GOBP%GO:0007569,0.57591079994814,0.8359897176758009,-0.18358713279790598,-0.9194236798068659,4441,41,KAT6A|TERF2|TERT|CDKN2A|OPA1|NPM1|TBX2|PLA2R1|CDKN2B|CALR|SOD1|ROMO1|HRAS|SRF|SERPINE1
MEMBRANE BIOGENESIS%GOBP%GO:0044091,0.41161879895561404,0.7460675199194391,-0.24583380116398498,-1.0321532518063399,3152,23,PEX16|CAV1|ANXA2|NRXN2|EMP2
NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT%GOBP%GO:0051799,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
INTRACELLULAR PROTEIN TRANSPORT IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051708,0.8814009020960469,0.9622426269432679,-0.4132468729201789,-0.687708879682717,6643,2,IFIT1
NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:1900038,0.48608660241618,0.7872939093021379,0.372306102988464,0.963363923871019,3580,6,DDAH1|NOL3
REGULATION OF MYOFIBROBLAST CONTRACTION%GOBP%GO:1904328,0.189030100334448,0.5632471197622879,-0.9035068372298192,-1.20368805197555,1412,1,PDPN
REGULATION OF RESTRICTION ENDODEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032072,0.705272944614159,0.894639008000397,0.646890163211292,0.8625407459047729,5309,1,HMGB1
REGULATION OF CALCIUM ION BINDING%GOBP%GO:1901876,0.425551839464883,0.7547028278218628,-0.788156153506837,-1.05001324392399,3180,1,PLN
POSITIVE REGULATION OF TRANSPORTER ACTIVITY%GOBP%GO:0032411,0.48811826471400893,0.7882673024233101,0.173364411682447,0.9796126115256341,3532,60,ABCB1|ANK2|SYNGR3|GSTM2|DMD|EPHB2|RNF207|DRD4|KCNIP2|HTT|GAL|HAP1|SGK2
REGULATION OF PINOCYTOSIS%GOBP%GO:0048548,0.0808383233532934,0.397722753303477,-0.51569253001232,-1.4846066173518402,620,8,NR1H3|STX1B|AXL|CAV1
ER-ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS%GOBP%GO:0071712,0.7103691639522259,0.8964108318214721,0.24402790992853002,0.8030016665931881,5233,11,UGGT2|SDF2|RNF185|UGGT1|BAG6
METANEPHRIC MESENCHYME DEVELOPMENT%GOBP%GO:0072075,0.36163564733052594,0.716154857259883,0.487708380387941,1.0715160820607,2661,4,WNT4|PKD2
DNA 3' DEPHOSPHORYLATION%GOBP%GO:0098503,0.469119404967459,0.780769690730001,0.766541685046317,1.02207990535017,3531,1,PNKP
REGULATION OF PROTEIN CATABOLIC PROCESS%GOBP%GO:0042176,0.0016649590163934401,0.0342526537521637,-0.20510790361858602,-1.5853773274196599,12,270,UBQLN2|HGS|LRP1|NRD1|USP25|RAB7A|ODC1|UCHL5|PLK2|OGT|CBFA2T3|ATPIF1|PSMF1|BAG5|GPX1|INS|VCP|RNF144B|UBE2G2|MAD2L1|TNFAIP3|FMR1|EFNA1|CCDC22|TNFSF12|SMURF2|CEBPA|UBQLN1|SUMO2|PSME2|PARK7|UBXN1|TRIM32|MSN|TIMP3|RILP|ALAD|HERPUD1|RAD23B|FLNA|UQCC2|NKD2|DTL|RCHY1|HFE|PSMD10|APOE|PLK1|GIPC1|ECSCR|TIPARP|CTSC|SNF8|ARAF|CHMP6|TLK2|NSF|EPHA4|BCAP31|CAV1|LDLR|STX5|DDB1|DERL3|DACT1|PRKACA|DAB2|TAF9|ANXA2|HSP90AA1|TIMP1|PHB|CSNK1A1|MAGEF1|CD81|TNFRSF1B|AK6|FAM122A|CST3|ADGRB1
RNA MODIFICATION%GOBP%GO:0009451,0.143271221532091,0.509384864704371,0.18455309267638398,1.2242704584824098,1037,116,FDXACB1|HENMT1|SSB|PUS10|PUS7|TRMT6|QTRT1|TYW5|ALKBH8|ZC3H13|METTL1|TFB1M|TRMT44|NSUN6|ADAT2|MTERF4|PARN|TPRKB|TRMT1|RNMTL1|ELP3|CTU1|METTL14|NSUN4|GAR1|KIAA1456|GTPBP3|TGS1|NSUN3|WBSCR22|TRMT1L|MOCS3|TRMT61B|CMTR1|PUS1|THG1L|MTFMT|FTO|SEPHS1|TFB2M|CMTR2|ANKRD16|THUMPD3|QTRTD1|TRUB1|TRMT13|FTSJ3|THUMPD2|EMG1
"RNA SPLICING, VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION%GOBP%GO:0000394",0.18238665971860302,0.5559553601324849,-0.42530221794910295,-1.27941317385405,1399,9,TSEN54|CLP1|C14orf166|ERN1
REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904338,0.655041903217086,0.874775007199212,0.346501829097721,0.8333349119614542,4845,5,DKK1|CSNK1E
REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS%GOBP%GO:0071671,0.0017195767195767198,0.0348566830512975,-0.909782728576155,-1.77657508542457,12,3,CORO1B|AIF1|SLIT2
CAVEOLIN-MEDIATED ENDOCYTOSIS%GOBP%GO:0072584,0.39222614840989395,0.737280445732591,-0.484162800756485,-1.05993357906518,2996,4,MAPK3|CAV1
HEME OXIDATION%GOBP%GO:0006788,0.47267179623242206,0.7831522581932591,-0.609859236449428,-1.0149032932762299,3562,2,HMOX1
POSITIVE REGULATION OF HISTONE H2B UBIQUITINATION%GOBP%GO:2001168,0.0208087946603848,0.19896908104539998,-0.747674909831803,-1.6368166697586701,158,4,CTR9|RNF20|RNF40
MEMBRANE DEPOLARIZATION DURING PURKINJE MYOCYTE CELL ACTION POTENTIAL%GOBP%GO:0086047,0.0924482665950013,0.420939346122012,0.7199824160962,1.41612044894624,687,3,TRPM4|SCN5A
POSITIVE REGULATION OF RENAL SODIUM EXCRETION%GOBP%GO:0035815,0.18020066889632103,0.553886683619651,-0.907752536391707,-1.20934434271167,1346,1,NPR1
BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS%GOBP%GO:0060442,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
GLUTAMYL-TRNA AMINOACYLATION%GOBP%GO:0006424,0.8121928542967192,0.935317461845028,0.593405381561535,0.7912260064291831,6114,1,EARS2
"EXONUCLEOLYTIC TRIMMING TO GENERATE MATURE 3'-END OF 5.8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000467",0.34568874868559396,0.7033175795366851,-0.4014792535811,-1.0974256359521901,2629,7,EXOSC3|EXOSC2
N-TERMINAL PROTEIN AMINO ACID METHYLATION%GOBP%GO:0006480,0.00989966555183947,0.126895016411775,-0.994816938685487,-1.32533503196282,73,1,NTMT1
PROLYL-TRNA AMINOACYLATION%GOBP%GO:0006433,0.37834941050375104,0.7285018704049091,0.64724470697933,1.08745467687213,2823,2,PARS2|EPRS
KINETOCHORE ASSEMBLY%GOBP%GO:0051382,0.719125683060109,0.900474259627538,0.27177450493684197,0.7889138419544491,5263,8,POGZ|MIS12|CENPC|CENPA|CENPT|CENPF|CENPE|CENPW
NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION%GOBP%GO:2001199,0.246617139824887,0.6280519349499749,-0.7100082712985942,-1.18156730230003,1858,2,LILRB1|FCGR2B
BONE GROWTH%GOBP%GO:0098868,0.007352941176470591,0.103812496865754,-0.458817252226758,-1.8407660280079,55,20,COL20A1|COCH|ANXA6|DDR2|VWA1|COL14A1|COMP|COL12A1|COL6A3|COL21A1|COL6A1|ANXA2|COL6A2
POSITIVE REGULATION OF BLOOD VESSEL DIAMETER%GOBP%GO:0097755,0.043956043956044,0.299062021084573,-0.42112691270179703,-1.56507067102916,335,16,ADRB2|DOCK4|ADM|SOD2|INS|DOCK5|HMOX1|SOD1|GPER1|NOS3
RESPONSE TO PAIN%GOBP%GO:0048265,0.566309216777521,0.830409681162788,0.34548238356821,0.8939559733000021,4171,6,RET
REGULATION OF INTRACELLULAR MRNA LOCALIZATION%GOBP%GO:1904580,0.15826479172194197,0.528194339395059,-0.7595257788806179,-1.26397235336134,1192,2,ZFP36L1|DHX36
PEPTIDYL-LYSINE MONOMETHYLATION%GOBP%GO:0018026,0.963392391870766,0.990916952887267,-0.18293640913142897,-0.5503174964592211,7394,9,EHMT1|SETD3|SETD8|METTL12
EMBRYONIC CAMERA-TYPE EYE MORPHOGENESIS%GOBP%GO:0048596,0.138564046777264,0.50401036210812,0.42808342007119,1.35619721112535,1018,10,STRA6|TWIST1|PHACTR4|LRP6|PROX1
L-METHIONINE SALVAGE FROM METHYLTHIOADENOSINE%GOBP%GO:0019509,0.731325618095739,0.9074802896081321,-0.327001753281015,-0.7837608049367958,5560,5,ADI1|APIP
GOLGI VESICLE FUSION TO TARGET MEMBRANE%GOBP%GO:0048210,0.44113756613756605,0.7653693162885199,-0.528671048183359,-1.03236056597576,3334,3,RAB8A|NKD2
CELL JUNCTION ASSEMBLY%GOBP%GO:0034329,0.141368664780036,0.506974113776998,-0.19008273008716398,-1.23332451149643,1098,109,GJA5|ACTG1|APC|CDH6|TBCD|GJA1|LAMC1|CTTN|PEAK1|JUP|CTNND1|ECT2|LAMC2|CLDN5|MICALL2|TRIP6|TLN1|CTNND2|THY1|ILK|TAOK2|PKP2|CDH8|RHOD|FLNA|CDH11|CDH5|LIMS2|CDH7|DLC1|CD151|VCL|ARL2|GJA4|ACTB|FLNC|ACTN1|OCLN|VMP1|ITGB4|FBLIM1
RNA-DEPENDENT DNA BIOSYNTHETIC PROCESS%GOBP%GO:0006278,0.98289817232376,0.993436724391485,-0.118128173551032,-0.49597076514026395,7528,23,NHP2|PINX1|PTGES3|TERF2IP|RPA2|TERT|PPIA|DKC1|TNKS1BP1|HSP90AA1
REGULATION OF ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0046634,0.0111897106109325,0.137472401652561,-0.31689919778238695,-1.7183182204143,86,54,PRKCQ|MALT1|ZC3H12A|BLM|RARA|HSPH1|FOXP3|JAK3|SYK|CD274|NFKBIZ|PRDM1|LILRB1|HLA-E|NCKAP1L|TNFRSF14|IL18|RUNX1|CCL19|TWSG1|RUNX3|EBI3|MAPK8IP1|RC3H2|SOCS1|NKAP|C10orf54|CD300A|HFE|CD86|NLRP3|TGFBR2|LGALS9|PNP|ANXA1|CD55
GAMETE GENERATION%GOBP%GO:0007276,0.0140433815350389,0.158536088344771,0.20621739318776502,1.48479031225627,100,171,TDRD12|NPHP1|SPAG6|TSGA10|DDX25|TDRD6|LRGUK|BBS4|SPATA6|CFAP44|PICK1|CFAP43|PSME4|IFT20|TSSK6|ZNF296|KIT|C14orf39|DZIP1|C9orf117|AZIN2|IQCG|BRCA2|IFT81|NME5|CHD5|SPIRE2|PDE3A|TOB2|WDR33|TDRP|PCSK4|CEP57|HSPA2|MKKS|TRIM27|PARN|C1orf111|HERC4|NDRG3|DNAH1|XRN2|ELL3|MAST2|MCM9|SPATA2|RHOXF1|PRMT7|CATSPER2|IFT27|BBS2|TEX14|DPY19L2|METTL14
RECOMBINATIONAL INTERSTRAND CROSS-LINK REPAIR%GOBP%GO:0036298,0.27465166130761,0.649047934290704,0.696002205679625,1.1693735700241101,2049,2,MCM9|MCM8
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0048635,0.6377302275189599,0.8649836443850529,0.231835416439155,0.8551452850529,4708,15,DKK1|SOX6
NEGATIVE REGULATION OF HEMOPOIESIS%GOBP%GO:1903707,0.0863337204800619,0.406139467312843,-0.231562888547781,-1.3573675485174599,668,73,CCL3|FOXP3|HIST1H4H|JAK3|ZNF675|PRMT1|HOXA5|LILRB1|CDK6|RUNX1|ZFP36L1|RUNX3|IL17D|LILRB3|FCGR2B|TCTA|HES1|RC3H2|NOTCH1|INHBA|SOCS1|HSPA9|HIST1H4I|FBN1|CTR9|MAFB|C1QC|CEACAM1|HIST2H4A|MYC|TLR4|LILRB4|ANXA1|HIST2H4B|DPF2
RESPONSE TO X-RAY%GOBP%GO:0010165,0.945988463555322,0.983395403194261,-0.164584530314146,-0.5822760004443671,7215,14,BRCC3|NUCKS1|ANXA1
RESPONSE TO FIBROBLAST GROWTH FACTOR%GOBP%GO:0071774,0.220408687829328,0.6027391478106829,-0.19807934347541298,-1.1713866734948701,1714,75,CD44|POLR2C|FGFRL1|HYAL2|NR4A1|PTBP1|HNRNPH1|TBX1|ZFP36L1|RAB14|NCBP2|FGFR4|POLR2J|ELK1|SHCBP1|NDST1|GRB2|NCBP1|HNRNPM|POLR2H|FGF10|MAPK3|CCL2|HYAL1|FGF19|FGF9|FGF7|POLR2G|FIBP|POLR2L
POSITIVE REGULATION OF INTERFERON-ALPHA SECRETION%GOBP%GO:1902741,0.653391167192429,0.8739146438276378,-0.30594914450038596,-0.836298342884465,4970,7,DHX9|DHX36|IFIH1
CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS%GOBP%GO:0071374,0.296588628762542,0.6687276080240239,-0.848698720776356,-1.13067048065468,2216,1,MEF2C
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME%GOBP%GO:0072663,0.33821497651284904,0.6998037279675999,0.19126215274091699,1.08074555275934,2447,60,IDH1|PEX7|RPS27A|MPV17|NUDT7|GSTK1|PEX2|PEX5|PEX13|PIPOX|GNPAT|ACOX2|PEX1|HMGCL|ACOX3|EHHADH|PEX10|ACOT8|PHYH|ZFAND6|ECH1|HACL1|PAOX|PEX19|UBA52|PECR|PEX5L|SLC27A2|UBE2D3|PEX12
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0045953,0.12066246056782301,0.472686039512467,-0.508367115826844,-1.3895988408047601,917,7,SERPINB9|MICA|LILRB1|HLA-E|CEACAM1|LGALS9
POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS%GOBP%GO:0031646,0.31085324232081896,0.6814986161073721,0.255411432419572,1.11280620712541,2276,25,PARD3|TENM4|RIMS1|RIMS2|CUX2|PTK2B|DLG4|NLGN2
NEGATIVE REGULATION OF CHROMATIN BINDING%GOBP%GO:0035562,0.347487234614351,0.704891731069116,0.564629976839087,1.11056053372148,2585,3,BTAF1|ZNF304|WAPAL
REGULATION OF CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM%GOBP%GO:1902080,0.425551839464883,0.7547028278218628,-0.788156153506837,-1.05001324392399,3180,1,PLN
REGULATION OF PROTEIN LOCALIZATION TO KINETOCHORE%GOBP%GO:1905340,0.49928019892684206,0.794989907195277,-0.43779897368568704,-0.958433469826045,3814,4,CENPQ|CDT1|NDC80
G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION%GOBP%GO:0070315,0.8100677380794259,0.935010580591956,0.5949492721658579,0.7932845762284779,6098,1,ZNF503
NEGATIVE REGULATION OF MUSCLE HYPERPLASIA%GOBP%GO:0014740,0.16347826086956502,0.5350520708025429,-0.916795324217027,-1.2213915073964,1221,1,NOS3
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION%GOBP%GO:0010639,0.34262796027501896,0.701955655133333,-0.138475230317617,-1.05334773737854,2690,244,H1F0|CDC20|KANK1|WASF2|TRIAP1|CORO1A|SETMAR|FEZ1|SET|TERF2|NBN|TINF2|BCOR|PPIF|PHF2|ESPL1|ATAD2|NAA10|PARP1|RAB7A|HGF|HNRNPU|WAS|OPA1|DYRK1A|NPM1|RAD1|PTTG1|GPX1|SCFD1|TOP2A|CDK5RAP2|MAD2L1|PRELID1|LILRB2|SLX1B|PHLDB2|SLX1A|BRCA1|TAF7|DNMT1|PPFIA1|IGF1|TUBB4A|KANK3|SPI1|GSN|PSMD10|CORO1B|PLK1|DLC1|RBM14|KAT2B|CHMP4A|FXN|H1FX|SLIT2|MNAT1|NAV3|FKBP4|IK|PRRT2|MPV17L|EPS8|STYXL1|HIST1H1C|H2AFY|TMSB4X|OTUB1|HNRNPC|NAT10|INSIG1|SLC25A5
NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0007263,0.45518499218342895,0.7711801339028691,-0.330056081271277,-0.9928894810975329,3493,9,AGT|FPR1|APOE|NOS3|CD36
REGULATION OF MICROVILLUS LENGTH%GOBP%GO:0032532,0.630007959671,0.860925969148563,-0.5477453607514801,-0.9115358713593109,4748,2,CDHR2
DSRNA PROCESSING%GOBP%GO:0031050,0.38358026369444104,0.730673193816843,0.22696465453117,1.0507774584791898,2821,30,HENMT1|SMAD3|PRKRA|SMAD1|MRPL44|AGO2|AGO3|PUM2|ZCCHC11|SMAD2|DGCR8|ZC3H7A|AGO1
GAS HOMEOSTASIS%GOBP%GO:0033483,0.0556647020301244,0.342572698001074,-0.597122998214772,-1.5359612080475402,424,6,SOD2|CAV1|GSTP1
REGULATION OF TUBE DIAMETER%GOBP%GO:0035296,0.0386360689744587,0.279777317018993,-0.310545352855393,-1.55524380558595,297,41,ADRB2|DOCK4|ADM|PER2|EDNRA|PIK3C2A|AGT|SOD2|INS|DOCK5|TBXA2R|HMOX1|SOD1|GPER1|NPR1|F2R|EDNRB|SMTNL1|NOS3|CHGA|CAV1|SERPINF2
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION%GOBP%GO:1901989,0.000129015610888918,0.00518555396908895,-0.40091168032843605,-2.26716006764266,0,63,LSM11|CCND2|BRD4|DLGAP5|PLCB1|CDT1|EZH2|DYRK3|ANAPC5|ESPL1|CDC6|STXBP4|RAD51C|NPM1|LSM10|DDX3X|CDC25C|CDC45|MECP2|FGF10|DTL|RPTOR|RAD51B|CCNB1|HYAL1|AIF1|CCND3|PAGR1|ZNF16|ANXA1|ANAPC11|CCND1|CDCA5|EIF4G1
PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009222,0.481471642980476,0.7857362908355991,0.7596493162770179,1.0128898616033102,3624,1,ENTPD4
BEHAVIORAL RESPONSE TO COCAINE%GOBP%GO:0048148,0.0370868046224133,0.27443903992483804,0.788189339122107,1.5502754175917302,275,3,DRD2|DRD4|ABAT
MODULATION BY VIRUS OF HOST MOLECULAR FUNCTION%GOBP%GO:0039506,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
REGULATION OF L-DOPA DECARBOXYLASE ACTIVITY%GOBP%GO:1903198,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
REGULATION OF RNA EXPORT FROM NUCLEUS%GOBP%GO:0046831,0.9434976402726801,0.98255739075553,-0.16580270546906398,-0.5865857260041899,7196,14,SETD2|AKAP8L|RIOK2|CPSF6|DHX9|NCBP2|ZC3H3|RBM27
RESPONSE TO UV%GOBP%GO:0009411,0.0698482119886802,0.37596389138254704,-0.205453573687157,-1.3470094917203603,542,114,UBE2B|KDM1A|IMPACT|YY1|PARP1|MFAP4|NDNL2|HYAL3|NPM1|GPX1|PCNA|FMR1|DHX36|POLD1|RHNO1|DCUN1D3|KIAA0101|TRIM32|CARD16|DTL|MEN1|BCL3|CAT|USP47|HYAL1|HIST3H2A|EIF2S1|ERCC8|MYC|DDB1|RELA|MAPK13|POLA1|CRIP1|CCND1|XPA|FEN1|GTF2H2
LONG-CHAIN FATTY ACID METABOLIC PROCESS%GOBP%GO:0001676,0.0141155141155141,0.158957792983414,-0.29698981030779803,-1.6499298895152101,108,59,GPX4|ALOX5|LTC4S|TBXAS1|ACOT1|PTGDS|CYP1B1|ELOVL2|CBR1|DAGLB|ELOVL1|PLA2G4A|PTGES2|PTGS1|ACOX1|PLA2G4C|DAGLA|SLC27A4|ACOT2|ABCD1|MGLL|GSTP1|FADS1|FADS2|PTGES|PTGIS
POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS%GOBP%GO:1900244,0.42274247491638794,0.7535830358827651,-0.789424349360388,-1.0517027853127,3159,1,TOR1A
NEGATIVE REGULATION OF GONAD DEVELOPMENT%GOBP%GO:1905940,0.933547695605573,0.9800972968717879,0.36191286412116497,0.608060340184934,6967,2,WNT4
NEGATIVE REGULATION OF HELICASE ACTIVITY%GOBP%GO:0051097,0.21122889674126397,0.5931461423724009,-0.574506455417938,-1.2577147243359998,1613,4,IFIT1|MNAT1
POSITIVE REGULATION OF SECRETION%GOBP%GO:0051047,0.0133689839572193,0.15364590098230999,-0.20391800445130703,-1.48741444054986,104,192,CD274|UNC13D|TGFB1|AQP1|HLA-E|RGCC|INHBB|ADAM9|HYAL2|DHX9|TLR1|PYCARD|TNFRSF14|GSDMD|ADAM8|CCL19|ACHE|TSG101|ITGB2|RAB9A|SNX4|HGS|STX4|TLR2|P2RX4|PPIA|FGR|RAB7A|CD34|WLS|RAB27B|SYT4|GPI|GATA3|HYAL3|TNFRSF11A|MYOM1|TGFB3|INS|CACNA1H|CASP1|DHX36|PLA2R1|ADCY8|INHBA|PTGER4|IFIH1|SDC4|CACNA1G|OSM|SPP1|GHRL|TNFRSF4|IGF1|VAMP8|FCN1|VAMP7|STX1B|IL33|GPER1|NPR1|HFE|F2R|GAPDH|NLRP3|SNF8|LGALS9|ZP3|DTNBP1|ATP6AP1|HAVCR2|ANG|TLR4|ITGAM|ADRBK1|CSF1R|C1QTNF4|CACNA1I|CD14|BAD|C1QTNF1
NEGATIVE REGULATION OF TOOTH MINERALIZATION%GOBP%GO:0070171,0.45210931281507,0.769943206592495,-0.6185277088502901,-1.02932901754422,3407,2,ASPN|BCOR
REGULATION OF PLASMACYTOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002736,0.147826086956522,0.514965886850433,-0.9243493603881779,-1.23145529740742,1104,1,BST2
TRANSLATIONAL READTHROUGH%GOBP%GO:0006451,0.41618026333650104,0.7493091022753771,0.394382180013969,1.0204870707017,3065,6,TRNAU1AP|SEPSECS|SECISBP2L
POSITIVE REGULATION OF ANOIKIS%GOBP%GO:2000210,0.168990005260389,0.541811331682474,-0.545896488621629,-1.3084097165881998,1284,5,BRMS1|PTRH2|SIK1
REGULATION OF METHYLATION-DEPENDENT CHROMATIN SILENCING%GOBP%GO:0090308,0.43569174118884796,0.7624950782868549,-0.41996658489033,-1.00657976698167,3312,5,TET1|TRIM28|DNMT1
REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0016202,0.761265580057526,0.9183912636605319,0.15379565893443697,0.802964378694895,5557,45,DKK1|FGFR2|DLL1|FGF2|RBM24|SOX6|EFNB2|DDX17
NEGATIVE REGULATION OF TUBULIN DEACETYLATION%GOBP%GO:1904428,0.7143044104174849,0.898428686580078,-0.363381885750152,-0.795518908368871,5457,4,MAPT|BEX4
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL%GOBP%GO:0051881,0.104745894219578,0.44525070692259705,-0.272517988260626,-1.3566561432236202,809,40,PID1|KDR|ATPIF1|VCP|PRELID1|DCN|PARK7|ABL1|IFI6|SOD1|STOML2|ABCD1|ARL6IP5|BAD
PEPTIDYL-S-DIACYLGLYCEROL-L-CYSTEINE BIOSYNTHETIC PROCESS FROM PEPTIDYL-CYSTEINE%GOBP%GO:0018231,0.426441741859553,0.755007255274521,-0.24583065683404698,-1.01804871304811,3260,22,ZDHHC11|ZDHHC15|ZDHHC9|ZDHHC4|ZDHHC12|ZDHHC19|ZDHHC24|ZDHHC2
EPITHELIUM MIGRATION%GOBP%GO:0090132,0.0005180005180005179,0.0139121625154964,-0.36061508680965504,-2.00340075546946,3,59,KDR|PLXND1|CYP1B1|PKN1|ARSB|NUP188|TNFSF12|PXN|ABL1|PIK3R3|DPP4|FAP|STARD13|KANK2|CORO1B|GIPC1|NOS3|NOV|SRF|SLIT2|ID1|ADGRA2|MYH9|EPHB4|LOXL2|EMP2|PTP4A3
REGULATION OF NITRIC OXIDE METABOLIC PROCESS%GOBP%GO:0080164,0.6354097489706471,0.863600910248377,0.6794772827525359,0.905991272739901,4783,1,VIMP
CARBON CATABOLITE REGULATION OF TRANSCRIPTION%GOBP%GO:0045990,0.456216931216931,0.7711961414599979,-0.5224370281736439,-1.02018710490266,3448,3,USF1|USF2
CILIUM MOVEMENT%GOBP%GO:0003341,0.00027196083763937997,0.008450175294832591,0.556436625789844,2.3969193782960496,1,24,CFAP61|LRRC6|DNAI1|NPHP3-ACAD11|RSPH9|MAATS1|DYX1C1|RFX3|WDR78|RSPH4A|WDR66|TEKT2|GAS8|NPHP3|CCDC40
MALONYL-COA CATABOLIC PROCESS%GOBP%GO:2001294,0.973511705685619,0.9920058127185359,-0.513012792236436,-0.6834562208946962,7276,1,MLYCD
RESPONSE TO BACTERIAL LIPOPROTEIN%GOBP%GO:0032493,0.0107400130975769,0.133934756708563,-0.692713216710542,-1.7818450006953799,81,6,TLR1|TLR2|SSC5D|CD36|CD14
POSITIVE REGULATION OF FIBRINOLYSIS%GOBP%GO:0051919,0.9991961414791,0.999656642395059,0.26269644334160497,0.4413639429246429,7457,2,KLKB1|F12
CELLULAR IRON ION HOMEOSTASIS%GOBP%GO:0006879,0.000391287335333246,0.0111294649577428,-0.432171974657024,-2.2030666953372298,2,44,ATP6V0D1|ABCB7|HAMP|SLC11A1|ACO1|HMOX1|SOD1|SKP1|NEDD8|CYBRD1|HFE|FTL|FXN|SLC22A17|MYC|ATP6AP1|TFRC|ATP6V1A|ATP6V1G1|FTH1
SNORNA SPLICING%GOBP%GO:0034247,0.689042186256302,0.887051934478962,-0.521573718333289,-0.8679820732151509,5193,2,RNF113A
ANTI-MULLERIAN HORMONE SIGNALING PATHWAY%GOBP%GO:1990262,0.7570568561872908,0.916855605301775,-0.6257168063520071,-0.8336050295263331,5658,1,AMHR2
"ANTERIOR/POSTERIOR AXIS SPECIFICATION, EMBRYO%GOBP%GO:0008595",0.5923222492565561,0.8417378833576942,0.36517068898500005,0.878233412933578,4381,5,TBX3|FZD5|HOXD8|PLD6|BASP1
PEPTIDYL-TYROSINE DEPHOSPHORYLATION%GOBP%GO:0035335,0.0122365737593474,0.146001367455729,0.423468963242343,1.77219750421893,89,22,DUSP4|DUSP6|DUSP18|DUSP10|PTPRO|PTPN12|UBASH3B|PTPRS|PTPN9
REGULATION OF HIGH-DENSITY LIPOPROTEIN PARTICLE ASSEMBLY%GOBP%GO:0090107,0.881204013377927,0.9622426269432679,-0.562031318923688,-0.7487606684844829,6586,1,ABCA1
HISTONE H3-K79 METHYLATION%GOBP%GO:0034729,0.763979280116882,0.9191113740914171,0.618107631230702,0.8241631232179091,5751,1,DOT1L
ACTIN POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0008154,0.0112928348909657,0.13802261153452697,-0.35234176833911,-1.72434549330955,86,38,PSTPIP2|TTC17|DSTN|MICALL2|COBL|WAS|MICAL2|GHRL|GSN|CFL2|AIF1|FAM107A|ANG|CFL1|WASF3|GAS7|EVL
"PEPTIDYL-PYROGLUTAMIC ACID BIOSYNTHETIC PROCESS, USING GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE%GOBP%GO:0017186",0.0442122186495177,0.29950475077556604,0.8688723462917008,1.4598177264197298,329,2,QPCT|QPCTL
REGULATION OF CILIUM MOVEMENT%GOBP%GO:0003352,0.0236145236145236,0.21429047976993199,0.563857804184208,1.71351186231496,172,9,BBS4|CFAP20|CCDC65|MKKS|CCDC40|BBS2|C21orf59
PEPTIDYL-ARGININE MODIFICATION%GOBP%GO:0018195,0.644788658440536,0.8688307429995409,-0.235861208526087,-0.85637381534486,4911,15,KRTCAP2|ART4|PARK7|PRMT3|PRMT5
NEGATIVE REGULATION OF PROTEIN DEPOLYMERIZATION%GOBP%GO:1901880,0.0551611141452758,0.34147376465329604,0.320750083978525,1.49625486919763,403,31,CLASP1|ADD3|KATNB1|CLASP2|SPEF1|TTBK2|CAMSAP3|STMN2|TRIOBP|TWF1|ADD1
POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTIONAL PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0045899,0.0037982973149967296,0.0663449174827586,-0.733857880316547,-1.88768015929072,28,6,PSMC4|PSMC6|PSMC5|PSMC3
SYMBIONT INTRACELLULAR PROTEIN TRANSPORT IN HOST%GOBP%GO:0030581,0.8814009020960469,0.9622426269432679,-0.4132468729201789,-0.687708879682717,6643,2,IFIT1
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION%GOBP%GO:0000904,0.14210086375034803,0.508169381250166,0.14798212719117904,1.1770678916371002,1019,293,TNR|RET|CNTN4|BVES|SHTN1|DRD2|ROBO3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|MET|SEMA4F|PLXNB1|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|CDHR1|MAPK7|SLIT1|EPHB2|CASP9|LAMA5|EFNA4|PARD3|LAMB1|NBEAL2|RAB10|GFRA1|CHN1|PTPRO|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|NTNG1|EFNB3|SLIT3|CDK5R1|RILPL1|SHC1|SOS1|MAP6|DRAXIN|SPTBN1|EFNA2|ITGAV|NRCAM|VAMP3|MAP2|ZFPM1|DLG4|BRSK1|VLDLR|TUBB3|ULK2|PPP3CB|ANTXR1|PRKCA|RAB25|PLCG1|KIF5A|SCARA3|PLXNB2|RADIL|POU4F2|RB1|DOCK7|C8orf37|CELSR2|NRP1|DCC|CLDN3|EZR|SRC|SHANK2|VSTM2L|GPC1|PROX1|RANBP9
POSITIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902261,0.424617038430529,0.754564869291744,0.526590496645345,1.03574136513438,3159,3,RNF207|NOS1AP|AKAP6
NEGATIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0032685,0.49819397993310993,0.794989907195277,-0.755183061314513,-1.00608516781747,3723,1,CD84
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS%GOBP%GO:1902338,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
CLUSTERING OF VOLTAGE-GATED POTASSIUM CHANNELS%GOBP%GO:0045163,0.370196183821553,0.7226447402424641,0.554377200598539,1.09039453276352,2754,3,KCNIP2|CNTNAP2|CNTN2
CHEMOKINE SECRETION%GOBP%GO:0090195,0.30419209339347303,0.676707700393746,-0.682581244112189,-1.13592434315044,2292,2,FOXP1
NEGATIVE REGULATION OF TRANSCRIPTION INVOLVED IN G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0071930,0.82473544973545,0.942178419436027,-0.36624606048259795,-0.7151857314400729,6234,3,E2F1
POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES%GOBP%GO:0048298,0.253250198991775,0.632257972333528,-0.7057071960297769,-1.1744096252590701,1908,2,TGFB1|TNFSF13
REGULATION OF CYSTATHIONINE BETA-SYNTHASE ACTIVITY%GOBP%GO:1904041,0.8105685618729099,0.935197572326686,-0.598147331274813,-0.7968758689021559,6058,1,MTRR
REGULATION OF T-CIRCLE FORMATION%GOBP%GO:1904429,0.902629523561573,0.9686656000326079,-0.220230601853541,-0.634013079164311,6933,8,TERF2|SLX1B|SLX1A
POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0010870,0.9316161087866109,0.979524752562698,-0.190534870704724,-0.596920877411085,7124,10,NR1H3|HNRNPK
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0031334,0.7526101349630759,0.915314007578303,-0.117992710683959,-0.8606599609641179,5910,192,PSMC2|TPPP|PYCARD|NCKAP1L|CTTN|GNB2L1|FNIP1|CLIP1|CDT1|BCL2L11|ANKRD32|PARP1|CCL24|ARPC1A|PAXIP1|WAS|FES|IQGAP2|PLEK|MMP1|VCP|PIEZO1|CDK5RAP2|DHX36|WARS|LMOD1|JCHAIN|TAL1|GTF2H1|MECP2|PSMC4|PSMC6|GSN|BAIAP2L1|MITF|HCK|CD36|CDC42EP4|ARPC5L|SRF|ARL2|NAV3|RASIP1|DDB1|TLR4|HSP90AA1|CDC42EP1|CDC42EP5|NCK1|ARF6|PSMC5|CDC42EP2|PSMC3|XPA|EIF4G1|GTF2H2
DIOL BIOSYNTHETIC PROCESS%GOBP%GO:0034312,0.558079434167573,0.8267682185551151,0.269656703246056,0.9165106855804251,4102,12,SPR|PTS|QDPR|ASAH2B
CELLULAR RESPONSE TO RAFFINOSE%GOBP%GO:0097403,0.48762541806020093,0.788226301622024,-0.759483899426555,-1.01181491687484,3644,1,ZFP36L1
POLYSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0000272,0.19015233949945604,0.563750965709003,0.372427370387752,1.26580819410053,1397,12,PYGB|MANBA|FAM47E-STBD1|AGL|PGM2L1|PGM1|PGM2
IRON INCORPORATION INTO METALLO-SULFUR CLUSTER%GOBP%GO:0018283,0.793274383708467,0.929621926733366,0.45378900234525005,0.7624241150097808,5920,2,NFS1
MITOTIC SPINDLE DISASSEMBLY%GOBP%GO:0051228,0.935261342531175,0.9806508984207809,-0.370766999441584,-0.61701557717182,7049,2,VCP
ASSOCIATIVE LEARNING%GOBP%GO:0008306,0.132926001357773,0.494027717344274,0.38600159821512997,1.35185807331943,978,13,DRD2|CHRNB2|ADCY3|NF1|NETO1|BRSK1
GOLGI VESICLE TRANSPORT%GOBP%GO:0048193,0.10408921933085499,0.44419145940290994,-0.153639746082934,-1.2168326930670201,811,314,KLHL20|YIF1B|EXOC6|GOLGA3|RAB26|PEF1|ACTR10|DCTN4|RAB6B|SNX8|DYNC1H1|MCFD2|GOLGA5|F10|DOPEY1|SPTBN5|YKT6|BBS1|TMED7|TAPBP|COG4|RAB14|TFG|TMEM115|PDCD6|SPTBN4|BNIP1|SCAMP3|KLC2|TICAM2|GGA2|TRAPPC5|NAPA|CYTH3|GAS6|SCFD1|INS|RAB29|GOLGA4|CCDC22|ERGIC2|SEC23A|GGA3|SERPINA1|PRKD1|DYNLL2|BET1L|EXOC5|VAMP5|KRT18|KIF4A|F8|WIPI1|KIF18A|SEC13|KDELR2|SEC24A|ARFGAP2|NKD2|COPB2|PPP6R3|CNIH2|ARF1|VAMP7|KDELR1|SNX2|CNIH1|COPB1|TMED2|CTSZ|KIF2A|RAB7B|DCTN5|CTSC|TRIM23|RAB1B|NSF|RAB34|CD59|BCAP31|COG1|STX5|KDELR3|CNIH3|TMED10|LMAN2|TRAPPC2|TMED9|GOSR2|DYNC1I1|SPTBN2|KIF22|CD55|COPG1|PPP6C|SURF4|SAR1B|COPZ2|DCTN3|GRIA1|SCYL1|YIF1A|RAB33A|OSBPL5
CADMIUM ION TRANSPORT%GOBP%GO:0015691,0.7842592592592591,0.927080511528825,-0.382850135620766,-0.747609281899371,5928,3,SLC11A2|SLC11A1
NEUROBLAST DIVISION IN SUBVENTRICULAR ZONE%GOBP%GO:0021849,0.6192624038206421,0.854944793214197,-0.5520137947585471,-0.9186392281209879,4667,2,NUMB
NEGATIVE REGULATION OF NEUROTROPHIN PRODUCTION%GOBP%GO:0032900,0.711705685618729,0.8966571213032921,-0.647386413762682,-0.862474149776937,5319,1,FURIN
DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050961,0.7473797366299381,0.912246154063119,0.395999069761836,0.7788834392567959,5561,3,MMP24|EPHB1
LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045713,0.0963210702341137,0.427566585262796,-0.949437582708425,-1.26487883357543,719,1,PPARG
ATRIOVENTRICULAR VALVE MORPHOGENESIS%GOBP%GO:0003181,0.580138688996467,0.8386526275338391,-0.23852810265385502,-0.906465037743778,4433,17,SMAD6|EFNA1|NOTCH1|TGFBR2|BMP2|DCHS1
POSITIVE REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902269,0.21864951768488697,0.6013948176405761,0.7247572970817429,1.2176858362998,1631,2,AZIN2|AZIN1
PEPTIDYL-ASPARAGINE MODIFICATION%GOBP%GO:0018196,0.186586638830898,0.5597458283154859,-0.28732326817723497,-1.25335656632683,1429,26,RPN2|VCP|UBE2G2|MGAT1|DAD1|SYVN1|DERL3|MAGT1|RPN1
FOLIC ACID METABOLIC PROCESS%GOBP%GO:0046655,0.43370815899581605,0.7617458538169591,-0.261675610097874,-1.0153986869464,3316,18,DHFR|SHMT2|FOLR2|MTHFD1
REGULATION OF ENDOPLASMIC RETICULUM STRESS-INDUCED EIF2 ALPHA DEPHOSPHORYLATION%GOBP%GO:1903916,0.753846153846154,0.915550465961143,-0.627646669607411,-0.8361760707700259,5634,1,PPP1R15A
LIPOPOLYSACCHARIDE TRANSPORT%GOBP%GO:0015920,0.8517725752508358,0.949296218452153,-0.577029113365682,-0.7687413318640359,6366,1,SCARB1
NEGATIVE REGULATION OF SCHWANN CELL MIGRATION%GOBP%GO:1900148,0.456103068136539,0.7711961414599979,0.7731583590648431,1.03090234734715,3433,1,CERS2
POSITIVE REGULATION OF CELLULAR RESPONSE TO HEAT%GOBP%GO:1900036,0.748439367777925,0.9131348696838739,0.625827084252316,0.834455972214386,5634,1,IER5
CELLULAR RESPONSE TO ALKALINE PH%GOBP%GO:0071469,0.0919063545150502,0.419763137651336,-0.9517534186149101,-1.2679640830678602,686,1,INSRR
SOMATIC CELL DNA RECOMBINATION%GOBP%GO:0016444,0.945309433468533,0.9830007238272249,-0.15493835442238002,-0.588803582164292,7224,17,HMGB2|BATF|EXO1|RNF168|EXOSC3
NUCLEOBASE-CONTAINING SMALL MOLECULE CATABOLIC PROCESS%GOBP%GO:0034656,0.41583257506824395,0.7493091022753771,-0.217237260121966,-1.02922316174615,3198,34,ADA|NUDT1|NUDT16|APOBEC3G|TYMP|APOBEC3C|HPRT1|CDA|NUDT18|ENPP4|PNP
L-ARGININE TRANSMEMBRANE TRANSPORT%GOBP%GO:1903400,0.47899489595602707,0.7850984235874658,-0.445197698048001,-0.9746308240664169,3659,4,SLC7A2|SLC7A3
POSITIVE REGULATION OF G0 TO G1 TRANSITION%GOBP%GO:0070318,0.446272220748209,0.76790784030784,-0.620733388475324,-1.03299962115497,3363,2,SOX15|RHNO1
REGULATION OF BLOOD VESSEL REMODELING%GOBP%GO:0060312,0.226722777485534,0.609201573718782,-0.51450389049973,-1.2331676491491,1723,5,FLT4|CEACAM1|CST3
REGULATION OF FREE UBIQUITIN CHAIN POLYMERIZATION%GOBP%GO:1904542,0.9181270903010028,0.976125232231811,-0.541188795765329,-0.7209934230526049,6862,1,PINK1
REGULATION OF CELLULAR RESPONSE TO MANGANESE ION%GOBP%GO:1905802,0.275468189666622,0.65032483094354,0.864633877370975,1.1528726079554,2073,1,SLC30A10
RESPONSE TO BILE ACID%GOBP%GO:1903412,0.435423365487674,0.7622670566428509,0.622021202075021,1.0450759318943499,3249,2,ABCB4
LEUKOCYTE TETHERING OR ROLLING%GOBP%GO:0050901,0.0246460409019402,0.220509499393318,-0.47534168437356,-1.68168936833388,187,14,SELP|GOLPH3|ADD2|ITGA4|ROCK1|TNF|ITGB1|SELPLG|SPN|MADCAM1|VCAM1|PODXL2
REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA%GOBP%GO:0070920,0.984811499864388,0.9943582032224201,0.138111791645975,0.496425023896439,7261,14,NCOR1|EGFR|MAP2K1|MYCN|ZC3H10|NCOR2|BCDIN3D
NEGATIVE REGULATION OF PANCREATIC JUICE SECRETION%GOBP%GO:0090188,0.220066889632107,0.60254214895295,-0.886689457432731,-1.1812832639948,1644,1,NR1H3
FORMIN-NUCLEATED ACTIN CABLE ORGANIZATION%GOBP%GO:0110009,0.382827196990056,0.730480369014206,0.5479665453278839,1.07778553035323,2848,3,SPIRE2|SPIRE1|FMN2
EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT%GOBP%GO:0061502,0.22207464470713198,0.604705893155408,0.8905491839435379,1.18742717244357,1671,1,MYO1D
"COMPLEMENT ACTIVATION, CLASSICAL PATHWAY%GOBP%GO:0006958",0.000130531262237306,0.00518555396908895,-0.5845064413322479,-2.64285768451981,0,29,IGHV2-26|IGHV1OR15-1|IGKV3-11|IGHV5-51|IGHV1-24|IGHV3-49|IGHG4|IGLL5|IGKV2-28|IGHV4-4|IGHV4-61|C1QB|IGHV1-3|IGHV3-43|IGHV3-73|C1QA|C1QC|IGKV2D-28|IGHV3-15|C1S|IGHV1-18|IGHG2|IGHA1|C1R
MRNA CLEAVAGE INVOLVED IN GENE SILENCING%GOBP%GO:0098795,0.11449040281157101,0.463748809895271,0.587117044155377,1.41201312436451,846,5,AGO2|AGO3|MOV10|AGO1
REGULATION OF ENDOTHELIAL CELL-MATRIX ADHESION VIA FIBRONECTIN%GOBP%GO:1904904,0.6185953177257529,0.854944793214197,-0.694585355094839,-0.925354472765529,4623,1,MMP12
POSITIVE REGULATION OF ALDOSTERONE SECRETION%GOBP%GO:2000860,0.00481605351170569,0.0772855253947266,-0.997959858844288,-1.32952215627398,35,1,C1QTNF1
NEGATIVE REGULATION OF INTEGRIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:2001045,0.4012485057776599,0.740287621109606,0.8005072783414209,1.06736844093467,3020,1,PHACTR4
PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE FROM MATRIX SIDE%GOBP%GO:0032979,0.660905680600214,0.878572722461081,0.517439158531832,0.8693645956075609,4932,2,C2orf47|COX18
POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0061051,0.5744708994708989,0.835204333784353,-0.467641148077041,-0.913184639032711,4342,3,IGF1
ACTIVATION OF ADENYLATE CYCLASE ACTIVITY%GOBP%GO:0007190,0.236126224156692,0.6214025740122321,0.35336185135038795,1.20100820317304,1735,12,ADORA2B|CRHR1|CAP2|ADCYAP1
ALCOHOL METABOLIC PROCESS%GOBP%GO:0006066,0.0988558940737884,0.43379768462003404,-0.18090848721595001,-1.26526738085179,768,157,PLCE1|CLN6|LBR|INPP5B|IPPK|PLCB1|CES1|PGP|DPM2|MOXD1|FDPS|GOT1|PLCB3|GDE1|CYP1B1|ADH1B|CACNA1H|ALDH2|GDPD1|ABCG1|CYP51A1|PARK7|DHRS4|CETP|PLD4|IGF1|ALDH1A1|HMGCR|GK|DHFR|CYP46A1|SCARF1|APOE|SYNJ2|HMGCS1|NUDT4|INPP4B|SLC5A3|ITPK1|IMPA2|SRD5A3|EBP|DHCR7|DHRS3|C14orf1|ALDH3B1|SPHK1|DHCR24|CNBP|NSDHL|COQ3|TM7SF2|OSBPL5
SPHINGOID CATABOLIC PROCESS%GOBP%GO:0046521,0.0279598662207358,0.23660876059356398,-0.986656374062638,-1.31446320041807,208,1,SPHK1
REGULATION OF GASTRULATION%GOBP%GO:0010470,0.0805905458485711,0.397722753303477,0.351379227606658,1.44843824951936,594,21,DKK1|CLASP1|MAPK7|TENM4|CLASP2|MAP2K5
SEROTONIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007210,0.130836120401338,0.49066507924967295,-0.933557565063961,-1.2437228370559,977,1,HTR1B
CILIARY NEUROTROPHIC FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070120,0.345504515115823,0.703195314591758,-0.506755638890421,-1.1093940244920601,2639,4,IL6R|LIFR|CNTFR|IL6ST
POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS%GOBP%GO:0046827,0.173207744636316,0.547317965831336,-0.343423747453897,-1.27629562173248,1323,16,CAMK1|GAS6|BAG3|ANP32B|RAPGEF3|RBM22|EMD
POSITIVE REGULATION OF LYMPHOTOXIN A BIOSYNTHETIC PROCESS%GOBP%GO:0043017,0.16936454849498303,0.541894568706611,-0.9133215703573,-1.21676363315775,1265,1,CD86
RESPONSE TO ANTIBIOTIC%GOBP%GO:0046677,0.0367217280813215,0.27241249528203604,-0.233615438340176,-1.46588171998348,288,94,HP|CYP1B1|AHR|HYAL3|LARP1|HID1|GRIN3A|GPX1|GRIN1|TNFAIP3|ADCY8|CRHBP|MEF2C|PARK7|ABL1|HMOX1|SOD1|KAT7|CAT|HYAL1|FXN|RELA|SIGMAR1|MAPK13|HSP90AA1|ANXA1|CRIP1|AOC3|NET1|PDGFB|SIRPA
REGULATION OF DEFENSE RESPONSE%GOBP%GO:0031347,0.00012664640324214799,0.00518555396908895,-0.31788425925491,-2.654268497031,0,443,NCR3|MUL1|LILRB1|S100A1|ALPK1|BRD4|DNASE1L3|CLEC4A|HLA-E|SBNO2|LYN|HYAL2|LGR4|C4B|DHX9|NDFIP1|CD209|TLR1|PYCARD|TNFAIP8L2|APOD|F12|SEC14L1|C2CD4A|IL18|IRAK3|ADAM8|SLAMF8|HSP90B1|RNF216|DTX3L|C2CD4B|HMGB2|AGT|IFNGR1|SOCS3|PARP9|DAB2IP|ITGB2|IGHG4|PIK3R6|KLF4|IL17D|SNX4|PIK3AP1|SIGLEC10|TLR2|FGR|CTSS|RORA|TRIM44|TNFAIP6|NR1D2|PLA2G2A|TICAM2|C4A|GATA3|TNFRSF11A|HEXIM1|POLR3B|FCGR2B|C2|GGT1|MATR3|INS|CCL3L3|FEM1A|IL6ST|ERBB2IP|IGKV2-28|VTN|CCL18|C3|PVRL2|TNFAIP3|PLSCR1|IKBKE|SLC25A6|DDX60|CLEC4E|MAPKAPK2|UNC93B1|PTGER4|MEF2C|CEBPA|SOCS1|MB21D1|PTPN6|C1QB|CD47|PARK7|CLEC10A|IFIH1|IFIT1|FCER1G|APOBEC3G|PDE2A|MUC4|PLA2G7|OSM|BST1|GHRL|RSAD2|IRF7|IRAK1|HRAS|VAMP8|FCN1|NR1H3|VAMP7|TRAFD1|NPLOC4|IFI16|TNIP1|IL15|SNX6|C1QA|SEMA7A|CFB|NONO|GPRC5B|C1QC|CDH5|TMEM173|C7|CEACAM1|PIK3R4|IL33|GPER1|CD300A|HFE|APOE|IGKV2D-28|RBM14|NLRP3|RAB7B|NFKBIA|NOV|HCK|COLEC12|CD36|MUC20|A2M|CD200|LGALS9|ZP3|TEK|NR1D1|XIAP|FADD|RELB|UBC|CD300LF|MUC15|SUSD4|TLR5|FOXP1|CD59|TICAM1|IFNLR1|MMP9|CX3CL1|SERPINE1|CAV1|USP18|TRAF3|LDLR|C3AR1|PPARG|PPARA|CCL14|RELA|HMGB3|DHX58|MAPK13|ABCD1|NFKB1|PRKACA|BCL6|TLR4|S100A8|CFP|MGLL|C1S|ITGAM|S100A9|CFI|ANXA1|OSMR|CD55|GSTP1|TNFRSF1A|PHB|TMSB4X|METRNL|PSMA6|CD14|FAM3A|IGHG2|LY96|SERPING1|PQBP1|CD81|SAMHD1|CHID1|C1R|TNFRSF1B|CFH|C5AR1|ICAM2|APOBEC3F|SIRPA|PTGIS|RNF26
"VESICLE TARGETING, TRANS-GOLGI TO PERICILIARY MEMBRANE COMPARTMENT%GOBP%GO:0097712",0.8258193979933108,0.9429360603094208,-0.590813850904279,-0.787105912176124,6172,1,CEP19
NEGATIVE REGULATION OF AXONOGENESIS%GOBP%GO:0050771,0.29419388284084996,0.6670516010031929,-0.22736976951889898,-1.12280825707804,2269,39,SEMA3B|SEMA3D|SEMA7A|SEMA5A|SEMA3E|SLIT2|SEMA3A|SEMA6B|ARHGDIA|NGFR
REGULATION OF OVULATION%GOBP%GO:0060278,0.23215707084107198,0.615812511957369,-0.7172870140612081,-1.1936802942155,1749,2,INHBB|INHBA
REGULATION OF TELOMERASE RNA REVERSE TRANSCRIPTASE ACTIVITY%GOBP%GO:1905661,0.658962644450417,0.8772415412127091,0.42800717325068294,0.841839601614639,4903,3,PARP3|HNRNPD
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS%GOBP%GO:0002200,0.8347258485639691,0.945546838445136,-0.17136495717018002,-0.7194897404318691,6393,23,HMGB2|BATF|EXO1|RNF168|POLQ|EXOSC3|SAMHD1
MOLTING CYCLE PROCESS%GOBP%GO:0022404,0.7878128400435258,0.927797067038212,0.219013182196643,0.74438320779675,5791,12,FGFR2|HDAC1|ATP7A
DOLICHYL MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0043048,0.0758528428093646,0.38531099082072706,-0.9601345390383771,-1.27912974789761,566,1,DOLK
SKELETAL MUSCLE THIN FILAMENT ASSEMBLY%GOBP%GO:0030240,0.81139489194499,0.935317461845028,-0.279713058895107,-0.7194973382898829,6194,6,MYOM1|IGSF22
FEMALE MEIOTIC NUCLEAR DIVISION%GOBP%GO:0007143,0.549743173830765,0.820502586680903,0.37872270019854404,0.910825922187993,4066,5,SPIRE2|KIAA0430|SPIRE1|FMN2|C17orf104
POSITIVE REGULATION OF MRNA PROCESSING%GOBP%GO:0050685,0.128138075313808,0.48509801008225,-0.31473344824098,-1.33760828206441,979,24,NCBP2|RBMX|DHX36|NCBP1|SNW1|CELF4|CPEB1|TRA2B|NUP98
RECEPTOR-MEDIATED VIRION ATTACHMENT TO HOST CELL%GOBP%GO:0046813,0.0215608465608466,0.20285300542357199,-0.815925885077755,-1.59329645799139,162,3,GAS6|ICAM1|CD81
PIRNA BIOSYNTHETIC PROCESS%GOBP%GO:1990511,0.171056167696856,0.544815916159356,0.65742238064022,1.29307224177422,1272,3,GPAT2|PIWIL2
REGULATION OF INTERLEUKIN-4-MEDIATED SIGNALING PATHWAY%GOBP%GO:1902214,0.275802600159193,0.650819624868901,-0.694789081885856,-1.1562401373858602,2078,2,PARP14|CD300LF
NEGATIVE REGULATION OF ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0046636,0.20449790794979103,0.584214223487405,-0.289150717038787,-1.22888239568299,1563,24,FOXP3|JAK3|CD274|LILRB1|TNFRSF14|RUNX1|TWSG1|RUNX3|RC3H2|SOCS1|C10orf54|CD300A|HFE|LGALS9|ANXA1
POSITIVE REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS%GOBP%GO:2001247,0.72971178111303,0.906544799850309,0.634539038376709,0.8460721875104101,5493,1,ACSL3
UDP METABOLIC PROCESS%GOBP%GO:0046048,0.481471642980476,0.7857362908355991,0.7596493162770179,1.0128898616033102,3624,1,ENTPD4
PROTEIN K6-LINKED DEUBIQUITINATION%GOBP%GO:0044313,0.814021164021164,0.93598587081542,-0.3713036580444621,-0.7250619376355609,6153,3,USP13|USP30
VENTRICULAR ZONE NEUROBLAST DIVISION%GOBP%GO:0021847,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
CELLULAR METABOLIC COMPOUND SALVAGE%GOBP%GO:0043094,0.22779369627507198,0.609818988326981,-0.259357447091031,-1.19526776045298,1748,31,ADA|ADI1|TYMP|HPRT1|CDA|TK1|PNP|APIP|PDXK|UCK1
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009149,0.972406473865747,0.9915747942934481,-0.33001822435435496,-0.549203099207603,7329,2,DCTPP1
NEGATIVE REGULATION OF INTERLEUKIN-13 SECRETION%GOBP%GO:2000666,0.14862876254180601,0.5154128781388279,-0.923522276135862,-1.2303534225886998,1110,1,TNFRSF21
FRUCTOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015755,0.8445484949832779,0.948285501480553,-0.580999117776798,-0.7740303309939169,6312,1,SLC2A5
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0051962,0.420582226762002,0.751774348695433,-0.133936330919086,-1.0134861158107802,3293,238,REST|EPHB3|KDM1A|ANAPC2|CAMK1|IMPACT|ECT2|DAB2IP|FZD4|AMIGO1|NUMB|P2RX4|RAPGEF1|PLXND1|SEMA6A|SYT4|NGF|COBL|FES|SRPX2|BRINP3|CLSTN2|HES1|ARSB|GOLGA4|FMR1|DHX36|CPNE6|CXCR4|NOTCH1|MEF2C|SMARCD3|PRKD1|DSCAM|TRIM32|DBN1|SNW1|CPNE5|CAMK2B|GHRL|NTN1|IL1RAP|NTRK2|NSMF|MAP3K13|SEMA7A|GPRC5B|CSF1|GPER1|SCARF1|APOE|RAP1A|SERPINE2|BMP2|ADRA2C|SEMA5A|NBL1|SLIT2|CX3CL1|SCN1B|SEMA3A|PLAA|S100A9|STYXL1|MARK2|CAPRIN1|ADGRL1|ARHGDIA|NGFR|SERPINF1
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE%GOBP%GO:1904351,0.635850577801666,0.8636797415465791,0.43647292378956704,0.8584907339003309,4731,3,LAPTM4B|ATP13A2|MGAT3
POSITIVE REGULATION OF TERMINATION OF RNA POLYMERASE II TRANSCRIPTION%GOBP%GO:1904595,0.7298996655518399,0.906544799850309,-0.639225849139832,-0.85160231823218,5455,1,SETX
RESPONSE TO HYDROSTATIC PRESSURE%GOBP%GO:0051599,0.112004287245445,0.459194647507502,0.799944858009374,1.3440106465171697,835,2,PKD2|ATP2B4
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY%GOBP%GO:0010518,0.0836918263590145,0.402388938341306,-0.301720221138789,-1.41696333308499,641,33,HRAS|NTRK2|P2RY6|GNAQ|GNA15|PDGFRB|ANG|PLAA|PDGFRA|C5AR1
LOW-DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS%GOBP%GO:0032799,0.125,0.479417554423344,-0.44231969337298793,-1.3857298587279498,955,10,AP2A2|CLTA|CLTC|PPARG|MYLIP|AP2M1
NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY%GOBP%GO:0010593,0.48049880604934997,0.7857006060206241,-0.606903378677513,-1.00998427326657,3621,2,SLIT2
REGULATION OF ADENYLATE CYCLASE ACTIVITY INVOLVED IN G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0010578,0.0175322087926684,0.180006763679715,0.991343184825761,1.3218223721975702,131,1,CRHR1
PIGMENT GRANULE ORGANIZATION%GOBP%GO:0048753,0.507988085567289,0.798783771845792,0.235278389215673,0.9535299927423191,3751,20,KIF13A|HPS1|HPS4|BLOC1S3|AP1M1|AP3B1
EPITHELIAL CILIUM MOVEMENT%GOBP%GO:0003351,0.0852829162132753,0.403996102805507,0.42617868759849,1.44849846656416,626,12,LRRC6|NPHP3-ACAD11|DYX1C1|RFX3|NPHP3|CCDC40|CCDC103|CFAP53
ER-DEPENDENT PEROXISOME ORGANIZATION%GOBP%GO:0032581,0.14943143812709,0.51590227091171,-0.92286060873401,-1.2294719227337199,1116,1,PEX16
RECRUITMENT OF 3'-END PROCESSING FACTORS TO RNA POLYMERASE II HOLOENZYME COMPLEX%GOBP%GO:0034402,0.47976956055734205,0.785690196949452,0.60093741384064,1.00965244542249,3580,2,POLR2D|CDC73
CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE%GOBP%GO:0051305,0.30231645072634494,0.675222663526765,-0.526939833452821,-1.15358144564389,2309,4,FMN2|CENPE|DLGAP5|KPNB1
RESPONSE TO VITAMIN D%GOBP%GO:0033280,0.4877049180327871,0.788226301622024,0.331317532434989,0.961756833963869,3569,8,SFRP1|CYP27B1
NEGATIVE REGULATION OF ROOT HAIR ELONGATION%GOBP%GO:1902891,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
CARDIAC CELL DEVELOPMENT%GOBP%GO:0055006,0.21349485476097402,0.5966399408870229,-0.283088595249539,-1.22043460067887,1638,25,JAG1|MYH11|CXADR|SPRY1|MYOM1|NOTCH1|TGFBR3|PDGFRB|IGSF22|MAML1|PDGFRA
GUANINE METABOLIC PROCESS%GOBP%GO:0046098,0.767577606792253,0.9202818175694271,-0.48006588419908097,-0.798906399614093,5785,2,HPRT1
CELLULAR RESPONSE TO DITHIOTHREITOL%GOBP%GO:0072721,0.32886173462611196,0.695565668856072,0.8351896779885308,1.1136127410688401,2475,1,CERS1
CYTOKINESIS%GOBP%GO:0000910,0.563733034839793,0.8289808906039609,0.15420162225982298,0.9429448892343292,4028,82,EFHC1|CHMP3|RHOC|CNTROB|BBS4|RTKN|TTC19|ARL3|TRIM36|SNX33|SEPT2|BRCA2|SPIRE2|SPTBN1|SEPT10|MYH10|CUL7|UNC119|SEPT4|BIN3|MITD1|SEPT12|SPAST|PDCD6IP|STAMBP|CHMP1A
POSITIVE REGULATION OF LIPID CATABOLIC PROCESS%GOBP%GO:0050996,0.25779407911972796,0.636098664976652,-0.366466798809764,-1.1864559777935302,1967,11,PNPLA2|IRS1|ABHD5|PPARA|ABCD1
CARDIAC MUSCLE CELL DEVELOPMENT%GOBP%GO:0055013,0.534138655462185,0.812434061990131,-0.234565700929189,-0.9410730993892928,4067,20,PDGFRB|IGSF22|MAML1|PDGFRA
REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS%GOBP%GO:2001245,0.72971178111303,0.906544799850309,0.634539038376709,0.8460721875104101,5493,1,ACSL3
REGULATION OF FATTY ACID BETA-OXIDATION%GOBP%GO:0031998,0.6423901673640171,0.868171925756234,-0.27094108406239603,-0.848823047597797,4912,10,IRS1|PPARA|ABCD1
PEPTIDYL-SERINE DEPHOSPHORYLATION%GOBP%GO:0070262,0.16156862745098,0.531682046847491,-0.39053501289875897,-1.30715725459054,1235,12,PPP2CA|PPP2R2B|NCK1|PPP1CA
POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY%GOBP%GO:0002711,0.0203177910914301,0.196085628359658,-0.36095971096903295,-1.6635092232083797,155,31,MALT1|HLA-F|TRAF6|IL1B|CD1D|HLA-B|PVR|HLA-E|B2M|IL18|HLA-C|HLA-A|TRAF2|PVRL2|RSAD2|STX7|NLRP3|ZP3|FADD|IL1R1
REGULATION OF STEROL IMPORT%GOBP%GO:2000909,0.8109698996655519,0.935269673284207,-0.597981914424349,-0.7966554939384108,6061,1,LAMTOR1
COBALAMIN TRANSPORT%GOBP%GO:0015889,0.828203767577607,0.943061234519578,-0.44543700027571,-0.741278399190713,6242,2,CD320|TCN2
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN%GOBP%GO:0002478,0.00025776517592473303,0.00819882332206558,-0.315943929090643,-2.0741437619134397,1,115,PDIA3|HLA-DOA|HLA-F|CENPE|AP2A1|KIF2C|KLC1|CAPZA2|AP1S3|KIF3A|HLA-DRB1|HLA-DMA|HLA-DMB|RACGAP1|HLA-DQB2|HLA-B|AP1S2|KIF11|KIF15|HLA-DPA1|CLEC4A|HLA-E|HLA-DRA|HLA-DRB5|FCGR1B|ACTR10|DCTN4|DYNC1H1|CD74|B2M|AP2A2|TAPBP|LNPEP|HLA-DPB1|HLA-DQA2|CTSF|CTSV|FCGR1A|RAB7A|CTSS|HLA-C|KLC2|CANX|ITGB5|HLA-A|FCGR2B|CLTA|SH3GL2|SEC23A|CLTC|DYNLL2|FCER1G|KIF4A|LAG3|KIF18A|RILP|CALR|SEC13|SEC24A|VAMP8|ARF1|IFI30|KIF2A|AP1B1|DCTN5|CD36|CTSD|CTSL|DYNC1I1|SPTBN2|LGMN|KIF22|SAR1B|DCTN3|AP2M1
STRESS RESPONSE TO METAL ION%GOBP%GO:0097501,0.168575891694871,0.541253459162226,-0.45374885772958795,-1.30627945451351,1294,8,PARK7|MT1M|MT2A|MT1E
NEGATIVE REGULATION OF PLATELET AGGREGATION%GOBP%GO:0090331,0.0563195808775377,0.34436604181231795,-0.595815645843601,-1.53259834556633,429,6,CEACAM1|SERPINE2|C1QTNF1
HEAD MORPHOGENESIS%GOBP%GO:0060323,0.912992280518121,0.9731650355706121,-0.165935585395525,-0.63059574534439,6977,17,TBX1|CLDN5|TGFB3|ATP6AP2|CRISPLD2|RRAS
MRNA CLEAVAGE INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:0035279,0.11449040281157101,0.463748809895271,0.587117044155377,1.41201312436451,846,5,AGO2|AGO3|MOV10|AGO1
VESICLE TETHERING TO GOLGI%GOBP%GO:0099041,0.9694335008830319,0.991403495623311,0.25616279711024104,0.562800574619904,7135,4,WDR11|FAM91A1|C17orf75|TBC1D23
NEGATIVE REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:1904848,0.327002257935981,0.6941148928066879,0.8358513453903841,1.1144949852685402,2461,1,CXCL13
MODIFICATION OF POSTSYNAPTIC STRUCTURE%GOBP%GO:0099010,0.0534624568851154,0.335115832119604,-0.849076371657017,-1.41299885995774,402,2,ARHGAP44|SYNPO
CELLULAR RESPONSE TO SODIUM DODECYL SULFATE%GOBP%GO:0072707,0.0774581939799331,0.38990430106433793,-0.958976621085134,-1.27758712315139,578,1,ZNF16
PROTEIN LOCALIZATION TO CELL DIVISION SITE%GOBP%GO:0072741,0.47293676312968896,0.7831522581932591,0.604324346991733,1.01534293042097,3529,2,RTKN
GROWTH INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0003241,0.0173280423280423,0.17886971906195498,-0.825576265578471,-1.6121412052304,130,3,MESP1|NOTCH1|S1PR1
NEGATIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0034244,0.0301244269810085,0.24551704489787501,-0.634752214569406,-1.6327536892997199,229,6,HNRNPU|RNF168|EAPP|NELFB
POSITIVE REGULATION OF URETERIC BUD FORMATION%GOBP%GO:0072107,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
EYE PHOTORECEPTOR CELL DIFFERENTIATION%GOBP%GO:0001754,0.794297352342159,0.929656485793048,0.211074141586118,0.739225650079124,5849,13,BBS4|GNGT1|CEP290|AGTPBP1
SYNAPTIC VESICLE CYCLE%GOBP%GO:0099504,0.8422063666300771,0.9481593344082329,0.130982150229878,0.7662530215122281,6137,68,PLD2|SYT2|RIMS1|SNAP25|DNAJC5|KIAA1109|UNC13A|RIMS2|CLCN3|SLC18A1|CPLX1|SYT5|BRSK1|SYNDIG1|NLGN2|SNAP23|OTOF|NLGN4X|CDK5|AMPH|PIP5K1C|STX1A|SNCA|DNAJC6
INORGANIC ANION TRANSPORT%GOBP%GO:0015698,0.554634618041166,0.8244794431799929,0.174212600534871,0.934917781278136,4014,50,SLC12A5|SLC12A4|GABRA3|SLC12A9|SLC25A30|GABRB3|XPR1|CLCN3|SLC37A3|CLIC1|SLC20A1|SLC13A4|CLCN6|SLC26A6|SLC20A2|SLC12A6|CLIC4|GLRB|SLC26A1|ANO10|GABRG2|SLC12A7|TTYH3|SLC26A11|SLC37A1
DNA ALKYLATION%GOBP%GO:0006305,0.7713310580204781,0.9213545359508709,0.17838905430339103,0.7772261602837829,5649,25,TDRD12|PICK1|TET3|PRMT7|DNMT3A|GATAD2A|PIWIL4
REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT%GOBP%GO:0060850,0.269150599270453,0.643111105831479,-0.389842217015413,-1.17274081141443,2065,9,SOX17|RORA|CEBPB|NR2F2|PPARG
GLYCINE METABOLIC PROCESS%GOBP%GO:0006544,0.46297814207650295,0.776796066784647,0.33856719408495894,0.982801333434034,3388,8,GCSH|AMT|SHMT1|HRSP12|SLC25A32
SINGLE FERTILIZATION%GOBP%GO:0007338,0.87742103210711,0.960725750963158,-0.14595650800265697,-0.6915103723899899,6749,34,ZP3|POMZP3|B4GALT1|FOLR2|ALDOA
POSITIVE REGULATION OF CAP-INDEPENDENT TRANSLATIONAL INITIATION%GOBP%GO:1903679,0.0858465608465609,0.4055062447746421,-0.723865248548357,-1.4135253675218897,648,3,NCK1
POSITIVE REGULATION OF IRE1-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903896,0.51931892599869,0.8049078833377921,-0.36547898512247795,-0.9401104046955551,3964,6,TMEM33|BAK1|PTPN1|BCL2L11|DAB2IP
PODOSOME ASSEMBLY%GOBP%GO:0071800,0.23824240795485102,0.621833336192322,0.6204083232331271,1.22026995880062,1772,3,SH3PXD2B|FARP2
REGULATION OF RESPONSE TO DRUG%GOBP%GO:2001023,0.23357664233576603,0.617659277783149,0.22404927326033802,1.17503361510321,1695,46,DRD2|MET|SYT2|PARK2|RAB3B|DRD4|CHRNB2|RIPK1|PDE8A|GAL|NFE2L2|SYT5|NR4A3|UCN|GDF9|CHRNA3|CRH|TRAP1|KMT2A|SNCA|STK26|HDAC6
SOMATIC RECOMBINATION OF T CELL RECEPTOR GENE SEGMENTS%GOBP%GO:0002681,0.6647629167220079,0.8804055751124069,0.665747684164094,0.887684705596167,5004,1,LIG4
PLASMA MEMBRANE RAFT ASSEMBLY%GOBP%GO:0044854,0.22514466070489197,0.60796033359428,-0.514878992389804,-1.23406669680357,1711,5,CAV2|CAV1|EMP2
METANEPHRIC GLOMERULAR MESANGIAL CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:0072262,0.12949832775919698,0.487857553689733,-0.934384649316277,-1.2448247118746298,967,1,PDGFRB
NEGATIVE REGULATION OF ENDOCYTIC RECYCLING%GOBP%GO:2001136,0.202541806020067,0.5810727835229039,-0.8964490516100571,-1.1942853868557601,1513,1,ARHGAP1
CHANGES TO DNA METHYLATION INVOLVED IN EMBRYO DEVELOPMENT%GOBP%GO:1901538,0.0877545551982851,0.40905715364188894,0.8202371105596908,1.37810425084048,654,2,PICK1|TET3
POSITIVE REGULATION OF CYTOKINESIS%GOBP%GO:0032467,0.266621160409556,0.641603173139009,0.265177510531356,1.15535619104395,1952,25,AURKC|DRD2|PKP4|CSPP1|PRKCE
LYTIC VACUOLE ORGANIZATION%GOBP%GO:0080171,0.745624270711785,0.911446969830076,-0.161901441951821,-0.810819458078484,5750,41,PPT1|CLN6|FAM160A2|MYO7A|CORO1A|RAB14|RAB7A|GAA|SYT7|ARSB|VPS18|TPP1|TPCN2|RAB7B|RAB34|RAB20
"REGULATION OF ACTIVATED CD8-POSITIVE, ALPHA-BETA T CELL APOPTOTIC PROCESS%GOBP%GO:1905402",0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
REGULATION OF PROTEIN GLYCOSYLATION%GOBP%GO:0060049,0.7621584699453549,0.918894867010027,0.260724055235241,0.756836319703272,5578,8,RAMP1|ARFGEF1|CHP1
PRESYNAPTIC DENSE CORE VESICLE EXOCYTOSIS%GOBP%GO:0099525,0.34378349410503806,0.702174649119653,0.6624069595248101,1.1129292188262099,2565,2,UNC13A|UNC13B
REGULATION OF CELL PROJECTION ORGANIZATION%GOBP%GO:0031344,0.0331367593372648,0.25998057358601,0.156916288921457,1.30846701418599,235,406,RET|ISLR2|DYNC2LI1|IFT88|EPS8L1|SHTN1|PPP1R16B|RLTPR|ODF2L|ADGRB3|ZMYND10|SLITRK1|TBC1D1|CPNE9|SEMA4G|BBS4|SYT2|SEMA4F|KIF13B|PLXNB1|ULK4|TBC1D19|CDK10|RTN4IP1|SS18L1|RHOQ|RTN4|INPP5J|IFT20|SEMA6C|PTK7|ARHGEF7|CCDC88A|IFT140|TBC1D2|RIMS1|CHN1|TBC1D14|PTPRO|STK24|ROBO2|AGRN|SPRY2|CHRNB2|NDEL1|PTPRS|ZSWIM4|EFNB2|BMP7|PTPRD|TBC1D17|HTT|TBC1D16|UNC13A|EFNB3|NCKAP1|SCARB2|RIMS2|CDK5R1|SEMA4C|LRRC16A|PTPN9|TBC1D8|SARM1|RUFY3|MAP6|MARK4|ADCYAP1|CAPRIN2|HAP1|DVL2|TRIM46|CUX2|PROM2|LIMK1|TBC1D7|STMN2|NEDD4|TBC1D20|CUL7|LRRC7|PAK1|TWF1|CRMP1|PTK2B|NRCAM|INPP5F|CDC42EP3|FOXO6|WASH1|SIPA1L1|MAP2|ADCY6|GRIP1|DLG4|BRSK1|VLDLR|VPS35|LINGO1|FBXO7|C15orf62|ZSWIM8|ATG5|CBFA2T2|TENM3|C21orf91|PLXNB2|CAMK1D|POU4F2|MOV10|TAPT1|YWHAH|MAP4|KCTD17|NEDD4L|CERS2|NRP1|ZFYVE27|DCC|MEGF8
REGULATION OF RETROGRADE TRANS-SYNAPTIC SIGNALING BY ENDOCANABINOID%GOBP%GO:0099178,0.7883612040133778,0.927903725560957,-0.609726510807234,-0.81230211636431,5892,1,FABP5
REGULATION OF CELLULAR RESPONSE TO ALCOHOL%GOBP%GO:1905957,0.360267558528428,0.7155384949577859,-0.817765769739744,-1.08946036243435,2692,1,LANCL2
REGULATION OF LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVITY%GOBP%GO:1902606,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
POSITIVE REGULATION OF TRANSCRIPTION BY GALACTOSE%GOBP%GO:0000411,0.988311860804888,0.996030692679047,0.505513895015439,0.6740345685692951,7440,1,NCOA1
REGULATION OF FIBROBLAST APOPTOTIC PROCESS%GOBP%GO:2000269,0.597540983606557,0.8449219534562551,0.301832419561065,0.876166709595016,4373,8,SFRP1|BTG1
HYPOMETHYLATION OF CPG ISLAND%GOBP%GO:0044029,0.290969899665552,0.663296678175849,-0.851621085134539,-1.13456377168084,2174,1,FAM129B
RESPONSE TO CATECHOLAMINE%GOBP%GO:0071869,0.68999474789916,0.887051934478962,-0.20670994191888,-0.8293163277733689,5254,20,PDE4B|SLC9A1|MAPK3|ABL1|KCNQ1|PRKACA
NEGATIVE REGULATION OF DNA HELICASE ACTIVITY%GOBP%GO:1905775,0.119197324414716,0.47098246139817795,-0.9387406263784741,-1.2506279192532501,890,1,MNAT1
NEPHRON DEVELOPMENT%GOBP%GO:0072006,0.295569047926624,0.6684308347279571,-0.216431861213215,-1.1211851410110198,2287,46,KLHL3|MTSS1|NUP93|IQGAP1|PLCE1|JAG1|ANGPT2|BASP1|CD34|SMO|GATA3|MEF2C|SULF1|KLF15|BMP2|TEK|SEC61A1|PDGFRB|MYO1E|MYC|PDGFRA|ACTA2|PDGFB
NEGATIVE REGULATION OF ICOSANOID SECRETION%GOBP%GO:0032304,0.33177257525083603,0.6961761803662729,-0.8320467578297309,-1.10848606763768,2479,1,PLA2R1
SIALIC ACID TRANSPORT%GOBP%GO:0015739,0.771948465931731,0.9215496572020819,0.61331054256727,0.817766852770098,5811,1,SLC17A5
MATING BEHAVIOR%GOBP%GO:0007617,0.7566555183946491,0.9167299629693821,-0.626102779003088,-0.834119237775072,5655,1,APP
MODULATION BY SYMBIONT OF HOST MOLECULAR FUNCTION%GOBP%GO:0052055,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
PROTEIN LOCALIZATION TO PEROXISOME%GOBP%GO:0072662,0.33821497651284904,0.6998037279675999,0.19126215274091699,1.08074555275934,2447,60,IDH1|PEX7|RPS27A|MPV17|NUDT7|GSTK1|PEX2|PEX5|PEX13|PIPOX|GNPAT|ACOX2|PEX1|HMGCL|ACOX3|EHHADH|PEX10|ACOT8|PHYH|ZFAND6|ECH1|HACL1|PAOX|PEX19|UBA52|PECR|PEX5L|SLC27A2|UBE2D3|PEX12
REGULATION OF LYMPHOCYTE ANERGY%GOBP%GO:0002911,0.6896321070234109,0.887051934478962,-0.658965593295104,-0.877900397239091,5154,1,FOXP3
"POSITIVE REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0043517",0.411724700761697,0.7460988978563841,0.302472360285472,1.02804472114832,3026,12,SPRED2|PMAIP1|RPL26|ATM
REGULATION OF ENDOCRINE PROCESS%GOBP%GO:0044060,0.519490746817168,0.804986496071906,-0.23265706129427202,-0.947846542922573,3957,21,POMC|INHBA|CRHBP|GHRL|F2R|RAB11FIP1|C1QTNF1
POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION%GOBP%GO:1901881,0.0382892057026477,0.27921952251939597,0.46025978119661504,1.61192571199693,281,13,RLTPR|KATNB1|FAM21C|NES|LRRC16A|WDR1|STMN2
ERYTHROCYTE DEVELOPMENT%GOBP%GO:0048821,0.8835625409299279,0.963183204340478,-0.25641167061938097,-0.659559890574469,6745,6,G6PD|ZBTB7A|DMTN|LYAR|NCKAP1L|MED1
SURFACTANT HOMEOSTASIS%GOBP%GO:0043129,0.363172359638791,0.7177204591859201,-0.49839645733665505,-1.09109402868798,2774,4,RCN3|CTSH
TRANSCRIPTIONAL OPEN COMPLEX FORMATION AT RNA POLYMERASE II PROMOTER%GOBP%GO:0001113,0.7546891747052521,0.9158903477696649,0.47097227858632507,0.7912942377173879,5632,2,ERCC3|GTF2E1
NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS%GOBP%GO:0046826,0.539872299959245,0.81502508291933,0.41977867367601596,0.9222716234487809,3973,4,BARD1|RANGAP1
FC-GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:0038096,0.221048563699601,0.6033929888625489,-0.19597010023638897,-1.16560090041352,1715,77,RAC1|WIPF3|IGKV3-11|ACTG1|LYN|NCKAP1L|VAV3|WASF2|IGHG4|NCKIPSD|FGR|FCGR1A|ARPC1A|VAV1|MYO1G|WAS|FCGR2B|IGKV2-28|MYO10|ELMO1|GRB2|PIK3CB|MAPK3|ABL1|FCGR2A|DOCK1|CYFIP2|IGKV2D-28|HCK|HSP90AA1|ACTB|NCK1|IGHG2
NEGATIVE REGULATION OF PHAGOCYTOSIS%GOBP%GO:0050765,0.00169979079497908,0.0346995370450957,-0.6427256117670439,-2.01357543997876,12,10,GNB2L1|TLR2|FCGR2B|CD47|DYSF|CD300A|CD300LF|SIRPA
REGULATION OF MEMORY T CELL ACTIVATION%GOBP%GO:2000567,0.30256342143710996,0.675222663526765,0.849580943978827,1.13280155241227,2277,1,FAM49B
CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY%GOBP%GO:0033962,0.6028294472098511,0.8480120088902141,-0.271653977711575,-0.8794943683686859,4601,11,RC3H1|LIMD1|PATL2|LSM4|DDX6|ATXN2|EDC3|LSM14A|DYNC1H1|PATL1|LSM3
REGULATION OF MRNA STABILITY INVOLVED IN CELLULAR RESPONSE TO UV%GOBP%GO:1902629,0.3884949832775921,0.7352989049211659,-0.8054697838553159,-1.0730791567959699,2903,1,NPM1
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0048485,0.7246749729144101,0.903635192226391,0.21474571799066897,0.792108432117902,5350,15,INSM1|ASCL1|TFAP2B|NF1|NRP1
NEGATIVE REGULATION OF RENAL PHOSPHATE EXCRETION%GOBP%GO:1903403,0.736722408026756,0.908157084784786,-0.6364689016321129,-0.8479294021697621,5506,1,STC1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX%GOBP%GO:1904777,0.332040133779264,0.6961761803662729,-0.8318262020291128,-1.10819223435268,2481,1,SAPCD2
POSITIVE REGULATION OF CYTOTOXIC T CELL DIFFERENTIATION%GOBP%GO:0045585,0.0167224080267559,0.17569702079137303,-0.991784296426996,-1.3212948242941598,124,1,SART1
ACTIVATION-INDUCED CELL DEATH OF T CELLS%GOBP%GO:0006924,0.692709030100335,0.888747617562104,-0.656870313189237,-0.875108981031654,5177,1,AKT1
MITOCHONDRIAL FISSION%GOBP%GO:0000266,0.40167930660888396,0.740287621109606,0.281671871643906,1.03897142493553,2965,15,MFF|PARK2|MX2|DNM1L
MANNOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0006057,0.528561872909699,0.8105400040230321,-0.73869651521835,-0.984121129764213,3950,1,MPI
ACIDIC AMINO ACID TRANSPORT%GOBP%GO:0015800,0.18121156613895104,0.554889181766802,-0.33309878226926004,-1.26585671408405,1384,17,SLC25A18|SLC1A2|SLC1A3|SLC25A22|GIPC1|ARL6IP5|PRAF2
INOSITOL LIPID-MEDIATED SIGNALING%GOBP%GO:0048017,0.7210954657021059,0.901895642353625,-0.159710420390468,-0.8273502302418091,5581,46,PIK3C2A|ZFP36L1|PIK3R6|NGF|GATA3|OGT|IRS1|PIK3CB|IGF1|ZP3|PDGFRB|PTAFR|RPS6KB1|CSF1R|PDGFRA
PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM%GOBP%GO:1905719,0.000132661183337755,0.00521853172745028,-0.99228012131238,-1.6513127993856,0,2,SQSTM1|RNF26
ASTROCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002265,0.227645502645503,0.6097423854621011,-0.6261718319179439,-1.2227548851373502,1720,3,APP|PSEN1|LRP1
MITOCHONDRIA-NUCLEUS SIGNALING PATHWAY%GOBP%GO:0031930,0.84428093645485,0.948285501480553,-0.581495368328187,-0.774691455885153,6310,1,SLC25A33
NEGATIVE REGULATION OF INTERLEUKIN-12 PRODUCTION%GOBP%GO:0032695,0.619500130174434,0.854944793214197,-0.300622306944177,-0.8654495464617992,4758,8,JAK3|LILRB1|IRAK3|THBS1|CMKLR1
MEMBRANE REPOLARIZATION%GOBP%GO:0086009,0.110980392156863,0.456746092075001,-0.4169730136278211,-1.39564771846304,848,12,ATP1B1|ATP1B3|KCNN2|KCNQ1|ATP1B2|KCNH2|KCNE4
'DE NOVO' POSTTRANSLATIONAL PROTEIN FOLDING%GOBP%GO:0051084,0.34898012552301305,0.706981624190196,-0.254028320559306,-1.0796132008151702,2668,24,HSPA14|PTGES3|DNAJB1|BAG1|HSPA13|DNAJC7|CHCHD4|ERO1L|HSPA6|HSPA9|HSPA5|DNAJB5
REGULATION OF HYDROGEN PEROXIDE CATABOLIC PROCESS%GOBP%GO:2000295,0.936587954364553,0.9806508984207809,-0.368957856177885,-0.6140048734772651,7059,2,HP
B CELL MEDIATED IMMUNITY%GOBP%GO:0019724,0.000129769011160135,0.00518555396908895,-0.503590782090646,-2.62270262088559,0,47,IGHV1OR15-1|IGKV3-11|IGHV5-51|SLA2|IGHV1-24|CD74|IGHV3-49|BATF|IGHG4|EXO1|IGLL5|FCGR2B|IGKV2-28|IGHV4-4|IGHV4-61|RNF168|C1QB|IGHV1-3|FCER1G|IGHV3-43|IGHV3-73|C1QA|C1QC|IGKV2D-28|ZP3|IGHV3-15|EXOSC3|C1S|IGHV1-18|IGHG2|IGHA1|C1R
EPITHELIAL CELL-CELL ADHESION%GOBP%GO:0090136,0.449239956568947,0.768229288546963,0.303271965175508,0.9979509865828341,3309,11,BVES|KIFC3|KIT|CAMSAP3
NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:1901166,0.16607773851590102,0.538143527851939,-0.5982365008760171,-1.30966475431447,1268,4,FN1|SEMA3A
REGULATION OF TROPHECTODERMAL CELL PROLIFERATION%GOBP%GO:1904073,0.227157190635452,0.609201573718782,-0.8834913983237759,-1.1770226813623899,1697,1,IGF1
REGULATION OF COBALAMIN METABOLIC PROCESS%GOBP%GO:0106064,0.678394648829432,0.884536278926676,-0.665086016762241,-0.8860542708976591,5070,1,CLYBL
RNA POLYMERASE III PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0070898,0.914814814814815,0.9740523336757891,-0.322822307070818,-0.6303901467319261,6915,3,BDP1
GDP-L-FUCOSE METABOLIC PROCESS%GOBP%GO:0046368,0.539600597744872,0.81476344814486,0.41991236889693395,0.9225653575429019,3971,4,FUK|GMDS|FUT8
NEGATIVE REGULATION BY SYMBIONT OF HOST MOLECULAR FUNCTION%GOBP%GO:0052056,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
ASPARTATE CATABOLIC PROCESS%GOBP%GO:0006533,0.551870522685062,0.822639759332792,-0.579006032584783,-0.9635586282472071,4159,2,GOT1
REGULATION OF POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING%GOBP%GO:1902897,0.886306282374817,0.964939379509639,0.556737979708866,0.7423349736959169,6672,1,CRIPT
POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS%GOBP%GO:0070875,0.5677766124803361,0.831163129080424,-0.25739012312786397,-0.9106086165128149,4330,14,PHKG2|INS|PPP1R3E|IRS1|IGF1
POSITIVE REGULATION OF TELOMERIC LOOP DISASSEMBLY%GOBP%GO:1904535,0.398592110506043,0.7388683667002129,0.8019408910454351,1.0692799700340099,3000,1,RTEL1
CELLULAR RESPONSE TO BILE ACID%GOBP%GO:1903413,0.0284234294062957,0.23858105139263197,0.9861601235112479,1.3149114592999398,213,1,ABCB4
SPINAL CORD DORSAL/VENTRAL PATTERNING%GOBP%GO:0021513,0.8424290014396021,0.9481593344082329,-0.31890523271175103,-0.6981502175768989,6436,4,DLL4|FOXN4|CHRD
REGULATION OF PEPTIDASE ACTIVITY%GOBP%GO:0052547,0.000128155837498398,0.00518555396908895,-0.322648240397513,-2.39424269009609,0,214,PYCARD|APOPT1|GNB2L1|FNIP1|RPS6KA1|TRIAP1|IGBP1|REST|AGT|SERPINA3|PPM1F|SERPINB8|SPOCK2|KLF4|TNFRSF10A|TNFRSF10B|NRD1|PDCD6|SERPINB1|HGF|CASP10|NGF|PDCD5|GAS6|GPX1|CASP1|GRIN1|VCP|TRAF2|VTN|PRELID1|DDX3X|SIAH2|EFNA1|TNFSF10|CAAP1|CYCS|CASP4|STAT3|SERPINA1|PSME2|PARK7|UBXN1|F3|PERP|IFI27L1|RCN3|ANP32B|TIMP3|DPEP1|CARD16|IFI6|RECK|IFI16|NAIP|CAST|C10orf54|CTSH|CYFIP2|GPER1|CIDEB|GSN|F2R|USP47|DLC1|GAPDH|PLAUR|NLRP3|EFNA3|ECM1|SERPINE2|ASPH|LGALS9|THBS1|SERPINH1|XIAP|FADD|EPHA4|MMP9|BCAP31|SERPINE1|CAV1|MYC|PPARG|CSTB|BCL2L12|ARL6IP1|S100A8|PSMA3|S100A9|ARL6IP5|TIMP1|LGMN|SERPING1|NGFRAP1|DHCR24|NGFR|SERPINF1|SERPINF2|CST3|BAD
CEREBELLAR GRANULAR LAYER MATURATION%GOBP%GO:0021686,0.0964548494983278,0.427566585262796,-0.9493824437582711,-1.26480537525418,720,1,CEND1
REGULATION OF RIBOSOME BIOGENESIS%GOBP%GO:0090069,0.246300903496137,0.6280519349499749,-0.34587582839893394,-1.1905716742487,1880,13,NUDT16|MALSU1|RIOK1|TRMT112|DIMT1
POSITIVE REGULATION OF MEIOTIC CELL CYCLE%GOBP%GO:0051446,0.199817755792762,0.5778211722863521,-0.437428564975823,-1.25929561587078,1534,8,CDC25B|SIRT2|CDC25A|C17orf104|YTHDC2|PLCB1|CDC25C
POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY%GOBP%GO:0032770,0.0500784518828452,0.320955588866795,-0.396952256586059,-1.54032238605324,382,18,IL1B|AKT1|TNF|S100A1|POR|TERF2|TERT|INS|PARK7|DHFR|APOE
REGULATION OF PROTEIN IMPORT%GOBP%GO:1904589,0.1850699844479,0.5585505203054311,-0.24962339609273101,-1.2327021788597299,1427,39,TGFB1|PSEN1|HYAL2|APOD|ARHGEF5|JUP|ECT2|TRIM28|HCLS1|PDCD5|GAS6|MDFIC|BAG3|PDE2A|FLNA|IGF1|RBM22|TMEM173
TERMINAL BUTTON ORGANIZATION%GOBP%GO:0072553,0.390091645636871,0.7358910495632479,0.806076312307014,1.07479399628212,2936,1,NLGN2
REGULATION OF MRNA CATABOLIC PROCESS%GOBP%GO:0061013,0.5363321799307961,0.8132910857498922,-0.14351010438917003,-0.955727399293305,4184,123,LARP1|NPM1|TOB1|PRR5L|FMR1|DHX36|PDE12|MAPKAPK2|FXR1|HNRNPM|SLC11A1|HSPB1|TNRC6C|E2F1|TNFSF13|NUP214|UBC|EXOSC3|CCRN4L|YBX3|POLR2G|CSDC2|VIM|APEX1|EXOSC2|HNRNPA0|HNRNPC|EIF4G1
REGULATION OF URETERIC BUD FORMATION%GOBP%GO:0072106,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
REGULATION OF ASTROCYTE ACTIVATION%GOBP%GO:0061888,0.624013677012099,0.857688646775448,-0.35930950805206296,-0.861196328235953,4744,5,AGER|TTBK1|IL6|APP|LDLR
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM%GOBP%GO:1903566,0.16193565828602302,0.532529078013271,0.55048309994316,1.32390869861189,1197,5,CCDC88A|GAS8|EFCAB7|CROCC
POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION%GOBP%GO:0061092,0.0284234294062957,0.23858105139263197,0.9861601235112479,1.3149114592999398,213,1,ABCB4
NEGATIVE REGULATION OF SINGLE STRAND BREAK REPAIR%GOBP%GO:1903517,0.5031438127090301,0.797298314254545,-0.752315835906484,-1.00226533511256,3760,1,TERF2
POSITIVE REGULATION OF PROTEIN PROCESSING IN PHAGOCYTIC VESICLE%GOBP%GO:1903923,0.0196338551339878,0.192628124925339,-0.909181141439206,-1.5130228083506398,147,2,GSN|MYH9
CELLULAR DETOXIFICATION OF METHYLGLYOXAL%GOBP%GO:0140041,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
PRINCIPAL SENSORY NUCLEUS OF TRIGEMINAL NERVE DEVELOPMENT%GOBP%GO:0021740,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
RESPONSE TO ERYTHROPOIETIN%GOBP%GO:0036017,0.907539682539683,0.9710309567212472,-0.327303625880772,-0.639141026582184,6860,3,MT2A
NEGATIVE REGULATION OF FEEDING BEHAVIOR%GOBP%GO:2000252,0.969089944282303,0.9912723387782391,-0.33404200464988104,-0.555899313070206,7304,2,INS
NEGATIVE REGULATION OF POSITIVE THYMIC T CELL SELECTION%GOBP%GO:1902233,0.685217160313455,0.8857920062408181,0.656815174239083,0.875774408900244,5158,1,PTPN2
NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS%GOBP%GO:0046137,0.23342977380326102,0.6175448057437399,-0.510624438439259,-1.22386934282774,1774,5,SNAI2|SNAI1|NFKB1
NEGATIVE REGULATION OF PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:1900372,0.21595688748685601,0.598994355749518,-0.452678199116796,-1.23737567038963,1642,7,PID1|PARP1|CBFA2T3|PPARA
POSITIVE REGULATION OF NAD(P)H OXIDASE ACTIVITY%GOBP%GO:0033864,0.4437900798324829,0.7664039155808309,-0.4606635528298621,-1.0084888131284202,3390,4,AGT|PARK7|RFK
UDP-XYLOSE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015790,0.7539799331103679,0.915645792494009,-0.6275915306572559,-0.8361026124487769,5635,1,SLC35B4
NEGATIVE REGULATION OF VIRAL PROCESS%GOBP%GO:0048525,0.0753035391371739,0.38436410265336796,-0.23850107839672402,-1.3848809715175,582,70,ISG20|FAM111A|CCL3|OAS3|TNF|TRIM14|CCL4|MX1|PML|FCN3|PARP10|TRIM21|ZNF639|REST|OASL|OAS1|TRIM28|CCNK|PLSCR1|IFIT1|APOBEC3G|TRIM32|ISG15|RSAD2|APOBEC3C|FCN1|IFI16|TNIP1|GSN|BST2|IFITM1|BTBD17|IFITM2|IFITM3|MID2|BANF1|APOBEC3F
MRNA EXPORT FROM NUCLEUS%GOBP%GO:0006406,0.154298874104401,0.5225398777782271,-0.191703263519113,-1.22337391302282,1205,101,MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|NUP37|NXF1|NUP160|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
CELLULAR RESPONSE TO FLUID SHEAR STRESS%GOBP%GO:0071498,0.447475570032573,0.768229288546963,0.303789089275739,0.999652642407542,3296,11,MAPK7|MAP2K5|NFE2L2|PKD2
POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051152,0.569875573018992,0.8324048186805392,-0.35154578004117304,-0.904270447814581,4350,6,SOD2|GPER1|ENG
POSITIVE REGULATION OF ANION CHANNEL ACTIVITY%GOBP%GO:1901529,0.0963290460878885,0.427566585262796,0.8126743243026658,1.36539779345782,718,2,ABCB1|TCAF1
RESPONSE TO CARBOHYDRATE%GOBP%GO:0009743,0.0880072370121478,0.409521734239444,-0.26236263412335104,-1.37539018883613,680,48,GNB2L1|CDT1|ZFP36L1|ZNF236|EIF2B1|GAS6|ADCY8|CALCRL|CLEC7A|KAT7|GPER1|COLEC12|THBS1|PDK3|TRA2B|EIF2B2|MAPK13|PRKACA|EIF2B3|ERN1
POSITIVE REGULATION OF FOLLICLE-STIMULATING HORMONE SECRETION%GOBP%GO:0046881,0.358465608465608,0.714938712241162,-0.563306496084703,-1.0999948174089,2709,3,INHA|INHBB|INHBA
MITOCHONDRIAL PYRUVATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0006850,0.18917484743963897,0.563438044703664,-0.740302595949123,-1.23198190294525,1425,2,MPC1
CARBON DIOXIDE TRANSPORT%GOBP%GO:0015670,0.334539121114684,0.697556995918323,0.666772299776401,1.12026355408077,2496,2,AQP5
HINDGUT DEVELOPMENT%GOBP%GO:0061525,0.0848160535117057,0.40376145987147494,-0.955337450374945,-1.272738873949,633,1,DACT1
ACETYLCHOLINE METABOLIC PROCESS%GOBP%GO:0008291,0.8116291532690251,0.935317461845028,0.44297769518470503,0.7442597230756921,6057,2,COLQ
ATRIOVENTRICULAR NODE CELL DEVELOPMENT%GOBP%GO:0060928,0.12321070234113699,0.47697345522944606,-0.937141596823997,-1.24849762793704,920,1,MAML1
SNRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:0042795,0.7858062854198872,0.9274485629622209,-0.137085776064109,-0.798984994017416,6100,71,CCNT1|INTS12|SNAPC1|GTF2E1|INTS2|SRRT|POLR2F|POU2F1|INTS1|POLR2C|NABP2|INTS7|NCBP2|GTF2A2|POLR2J|ELL2|ZNF143|PHAX|CCNK|GTF2A1|NCBP1|POLR2H|CDK7|POLR2G|POU2F2|INTS5|TAF9|AK6|POLR2L
NEGATIVE REGULATION OF LIPID KINASE ACTIVITY%GOBP%GO:0090219,0.755339280886726,0.916183794263895,0.317243292534923,0.762968299311326,5587,5,WASH1|PIK3IP1|KIAA0226|PPP2R5A
CELLULAR RESPONSE TO FORSKOLIN%GOBP%GO:1904322,0.566803278688525,0.8308398918711859,0.310096610184182,0.900156209186385,4148,8,ADCY2|ADCY3|ADCY6|ADCY1
THYMIDINE CATABOLIC PROCESS%GOBP%GO:0006214,0.3944746978350379,0.7376723208557521,0.8039810322011469,1.07200022298308,2969,1,DPYD
REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS%GOBP%GO:0106049,0.388962589546299,0.735662494422088,-0.644665012406948,-1.07282567033159,2931,2,ARHGEF2|YBX3
NEGATIVE REGULATION OF ANION CHANNEL ACTIVITY%GOBP%GO:0010360,0.0380274119860253,0.278290751171261,0.787108110595858,1.54814876867396,282,3,TCAF2|GOPC|ANO9
HISTONE H3-R17 METHYLATION%GOBP%GO:0034971,0.309868508434055,0.680816461591689,0.8459969122187909,1.12802272966391,2332,1,CARM1
POSITIVE REGULATION OF INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE%GOBP%GO:0060731,0.8490969899665551,0.9492491301138911,-0.578683281870313,-0.770945081501486,6346,1,SLC22A5
PHENYLALANYL-TRNA AMINOACYLATION%GOBP%GO:0006432,0.753829615694706,0.915550465961143,0.3935454511809339,0.774057461054203,5609,3,FARS2|FARSB
NEGATIVE REGULATION OF GENE SILENCING%GOBP%GO:0060969,0.18500525210083998,0.55848924171382,-0.314461644245834,-1.2616140936940101,1408,20,TET1|TGFB1|H1F0|DND1|TERT|PHF2|ATAD2|H1FX|PPARG|HIST1H1C
POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0046886,0.6188407764354561,0.854944793214197,0.331862555843583,0.8587138685536009,4558,6,WNT4|ARNT|EGR1|HIF1A|IL1B|TNF
SALIVARY GLAND DEVELOPMENT%GOBP%GO:0007431,0.617175170962651,0.8545874073761078,-0.361152936967216,-0.86561467558696,4692,5,TGFB2|TGFB1|TGFB3|FGF10
POSITIVE REGULATION OF AMYLOID-BETA CLEARANCE%GOBP%GO:1900223,0.166885849552867,0.53917243184018,-0.5481894543185021,-1.31390551782548,1268,5,ROCK1|LRPAP1|LRP1|LDLR
POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0010676,0.5113145846958801,0.801504475859147,-0.21046835455422602,-0.960957302070113,3908,30,PHKG2|INS|PPP1R3E|IRS1|IGF1|P2RY6|GPER1|SLC45A3|BAD
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER BY GLUCOSE%GOBP%GO:0000432,0.47267179623242206,0.7831522581932591,-0.609925558312655,-1.0150136634623,3562,2,USF1|USF2
MUSCULOSKELETAL MOVEMENT%GOBP%GO:0050881,0.0739141810570382,0.38239128347091206,-0.395718150854462,-1.47064187354552,564,16,JSRP1|TNNT3|VTI1A|XRCC1|MAP1A|RCSD1|MYH3|TNNT2|GAA|TNNI2|TNNC2|STAC3
AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS%GOBP%GO:0009074,0.13650627615062802,0.5002612169352829,-0.344596732706928,-1.33716348186123,1043,18,C9orf41|KMO|CCBL1|KYNU|HAAO|FTCD|IL4I1|AFMID|HNMT|ASRGL1
POSITIVE REGULATION OF TRANSCRIPTION INVOLVED IN G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0071931,0.9010347572300351,0.9684180373391851,-0.40005514199062603,-0.665755729899557,6791,2,ZPR1|ID2
MESANGIAL CELL DIFFERENTIATION%GOBP%GO:0072007,0.0350529100529101,0.26702449097803305,-0.7875261938899308,-1.5378390589737099,264,3,CD34|ACTA2|PDGFB
NEGATIVE REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY%GOBP%GO:1902569,0.1838127090301,0.556308895147568,-0.906374062637847,-1.2075078846804599,1373,1,CD300A
REGULATION OF ESTABLISHMENT OF BLOOD-BRAIN BARRIER%GOBP%GO:0090210,0.10448160535117099,0.444812304941063,-0.945191883546537,-1.2592225428393,780,1,ADGRA2
POSITIVE REGULATION OF GLUCOCORTICOID SECRETION%GOBP%GO:2000851,0.43757641624779203,0.7635570545514341,0.45746516577585294,1.00507045157084,3220,4,GAL|UCN|CRH
POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:0045606,0.28540393754243,0.6583248923580091,0.32773244644832694,1.14778735546316,2101,13,FOXC1|CYP27B1|TRIM16
TOLERANCE INDUCTION%GOBP%GO:0002507,0.0823837590045842,0.3992851720441671,-0.573087689455253,-1.47413591913984,628,6,HLA-E|LYN|TNFAIP3|LGALS9|HAVCR2
CUT CATABOLIC PROCESS%GOBP%GO:0071034,0.27875932469571996,0.653204101106396,-0.5390357216023121,-1.1800618732980401,2129,4,EXOSC3|EXOSC2
DNA STRAND RENATURATION%GOBP%GO:0000733,0.5011904761904761,0.795954687014814,-0.5020955111944411,-0.980465277778561,3788,3,RECQL|TP53|WRNIP1
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ACETYLCHOLINE%GOBP%GO:0003068,0.40414715719063593,0.7412049911665691,-0.7982465813850899,-1.06345611671244,3020,1,SOD2
MIRNA LOADING ONTO RISC INVOLVED IN GENE SILENCING BY MIRNA%GOBP%GO:0035280,0.344468487963213,0.702208595415901,0.396304467733039,1.09398784574333,2546,7,AGO2|AGO3|AGO1|TARBP2|ADAR|AGO4
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR%GOBP%GO:0042771,0.6367459587330789,0.8642856997441619,-0.218124386831922,-0.861789103162059,4844,19,SNW1|IFI16|BCL3|TMEM109|DDIT4
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS%GOBP%GO:0045833,0.0345227360556486,0.265648036188578,-0.291212009524034,-1.5457218853861103,267,50,ORMDL3|BRCA1|SNAI2|SOD1|BSCL2|CEACAM1|GPER1|APOE|FGF19|BMP2|SNAI1|SIRT4|SIK1|NFKB1|PDGFA|PDGFB
HOMOSERINE METABOLIC PROCESS%GOBP%GO:0009092,0.3942926045016079,0.7376723208557521,0.639261097325614,1.07404118184832,2942,2,CTH|CBS
EXTRAEMBRYONIC MEMBRANE DEVELOPMENT%GOBP%GO:1903867,0.5192152647137871,0.8049078833377921,0.480607608315475,0.9452984501273599,3863,3,BMP7|E2F7|E2F8
REGULATION OF MUSCLE HYPERTROPHY%GOBP%GO:0014743,0.134394572025052,0.4962180106589171,-0.30457331780365804,-1.32860443297508,1029,26,AGT|LMCD1|PARP1|P2RX4|IL6ST|NOTCH1|SLC9A1|IGF1|LMNA|RGS2
PROTEIN O-LINKED MANNOSYLATION%GOBP%GO:0035269,0.784911087866109,0.9274485629622209,-0.235472109491936,-0.7377033804042711,6002,10,DPM3|POMGNT2|FKTN|DPM2|B4GAT1
POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0001916,0.24586505644526102,0.6280519349499749,-0.327172100614296,-1.18790886313324,1872,15,CD1D|HLA-B|PVR|HLA-E|HLA-C|HLA-A|PVRL2|STX7|FADD
REGULATION OF CELL PROJECTION SIZE%GOBP%GO:0032536,0.630007959671,0.860925969148563,-0.5477453607514801,-0.9115358713593109,4748,2,CDHR2
BLASTOCYST FORMATION%GOBP%GO:0001825,0.0736083824492469,0.381997503376377,-0.5795473266645861,-1.4907518461787501,561,6,ZP3|SRF|WDR74
REGULATION OF SOMATOSTATIN SECRETION%GOBP%GO:0090273,0.27825740470182003,0.653204101106396,0.8633105425672699,1.151108119556,2094,1,ADCYAP1
REGULATION OF T CELL DIFFERENTIATION IN THYMUS%GOBP%GO:0033081,0.532091378841447,0.812079525085925,0.294955985678797,0.934440500208561,3912,10,CAMK4|ZC3H8|FOXJ1|TESPA1|KIAA0922|PTPN2
NEGATIVE REGULATION OF MOLECULAR FUNCTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052204,0.719653960529873,0.90068276850426,0.32813880850391103,0.7891719527362859,5323,5,SUGT1|CASP8
DNA DEALKYLATION INVOLVED IN DNA REPAIR%GOBP%GO:0006307,0.9020940984498229,0.968486494114721,0.20143801762556002,0.638169256059888,6633,10,MGMT|ASCC1|FTO|ASCC3|ALKBH5
REGULATION OF RECEPTOR BINDING%GOBP%GO:1900120,0.199583116206358,0.577735400526903,-0.41760445744763397,-1.25625642606598,1531,9,HFE|MMP9|ANXA2
INDOLE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0042435,0.398857750033205,0.7388683667002129,0.801720335244817,1.06898588863411,3002,1,DDC
LACTATION%GOBP%GO:0007595,0.5579886455798871,0.8267682185551151,0.375909993381866,0.904061378423381,4127,5,ZBTB7B|OXTR|AGPAT6|VEGFA
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING%GOBP%GO:1904357,0.9415677579235691,0.9817325191902121,-0.137514311480506,-0.6065052959303721,7218,27,TERF2|TINF2|PARP1|HNRNPU|SLX1B|SLX1A|HNRNPC|NAT10
POSITIVE REGULATION OF OOCYTE DEVELOPMENT%GOBP%GO:0060282,0.530278670953912,0.811490026766563,0.578594142211307,0.972112864228641,3957,2,PDE3A|SIRT2
POSITIVE REGULATION OF EYE PIGMENTATION%GOBP%GO:0048075,0.220215168017001,0.602707552062395,0.8914865460961621,1.1886770183931399,1657,1,HPS4
MAST CELL MEDIATED IMMUNITY%GOBP%GO:0002448,0.6175475136683161,0.854902982016298,-0.301401321309912,-0.867692219789557,4743,8,S100A13|CHGA|MILR1
POSITIVE REGULATION OF SCHWANN CELL DIFFERENTIATION%GOBP%GO:0014040,0.8013377926421399,0.9325377000668108,-0.603826643140715,-0.8044420759907359,5989,1,DICER1
CHLORIDE TRANSPORT%GOBP%GO:0006821,0.499453103636861,0.794989907195277,0.20016375628311303,0.9701965752239939,3652,35,SLC12A5|SLC12A4|GABRA3|SLC12A9|GABRB3|CLCN3|CLIC1|CLCN6|SLC26A6|SLC12A6|CLIC4|GLRB|SLC26A1|ANO10|GABRG2|SLC12A7|TTYH3
SPERMATOGENESIS%GOBP%GO:0007283,0.00711297071129707,0.10163753921466,0.23311643537082602,1.5916290975924001,50,134,TDRD12|NPHP1|SPAG6|TSGA10|DDX25|TDRD6|LRGUK|BBS4|SPATA6|CFAP44|CFAP43|PSME4|IFT20|TSSK6|ZNF296|KIT|C14orf39|C9orf117|AZIN2|IQCG|BRCA2|IFT81|NME5|CHD5|WDR33|TDRP|PCSK4|CEP57|HSPA2|MKKS|TRIM27|C1orf111|HERC4|NDRG3|DNAH1|XRN2|ELL3|MAST2|SPATA2|CATSPER2|IFT27|BBS2|DPY19L2|METTL14
REGULATION OF GAMMA-DELTA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:2001191,0.589565217391304,0.8414799095069009,-0.7099691221879141,-0.9458493443938201,4406,1,LILRB1
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO UV-INDUCED DNA DAMAGE%GOBP%GO:0010767,0.71983337812416,0.900797988145248,0.40636373662733005,0.799269515870062,5356,3,NEDD4|CHEK1|TAF1
MONOSACCHARIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015749,0.37571951857666097,0.726563632315284,-0.285978194373505,-1.06280570314626,2871,16,SLC2A10|SLC2A6|SLC45A3|SLC2A3|SLC45A1
LYMPHOCYTE COSTIMULATION%GOBP%GO:0031294,0.101034928848642,0.43836486389879703,-0.28449861202837895,-1.3699404337062702,780,36,PTPN11|FYN|GRAP2|AKT1|CDC42|PAK2|RAC1|CD274|LYN|TNFRSF14|CCL19|PDCD1LG2|VAV1|GRB2|PTPN6|DPP4|ICOSLG|CD86|CAV1
POSITIVE REGULATION OF KIDNEY DEVELOPMENT%GOBP%GO:0090184,0.0762978500262192,0.38654270614299796,-0.414740733277317,-1.4672920652575099,581,14,AGT|BASP1|SMO|GATA3|PDGFRB|MYC|PDGFA|PDGFB
POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET%GOBP%GO:0007221,0.0943346853329844,0.424416387883606,-0.374002168199063,-1.4212995690691999,720,17,HEYL|CREBBP|NOTCH4|DLGAP5|PLXND1|NOTCH1|SNW1|NOTCH3|KAT2B|MAML1
METANEPHRIC PROXIMAL TUBULE DEVELOPMENT%GOBP%GO:0072237,0.23774737680966898,0.6217158626397761,0.882829730921923,1.1771343234471001,1789,1,PKD1
INTERLEUKIN-10 PRODUCTION%GOBP%GO:0032613,0.751276538564902,0.914912181423144,0.394594987772447,0.7761217756762441,5590,3,CD46
SYNAPTIC VESICLE LUMEN ACIDIFICATION%GOBP%GO:0097401,0.259529818036924,0.636098664976652,0.8723533303925891,1.16316545695188,1953,1,CLCN3
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009202,0.8873958613276001,0.965145106124274,0.33634329021274895,0.661547560728891,6603,3,AK9|DTYMK
OXALOACETATE TRANSPORT%GOBP%GO:0015729,0.937248051599033,0.9806508984207809,0.308320575209864,0.6064301872161519,6974,3,SLC25A30|SLC25A14
NADP CATABOLIC PROCESS%GOBP%GO:0006742,0.964496248660236,0.990916952887267,0.333057337725349,0.5595793301521391,7198,2,NUDT12
LACTATE OXIDATION%GOBP%GO:0019516,0.211449063620667,0.5936273847468829,0.8959528010586679,1.1946321667411102,1591,1,D2HGDH
VESICLE-MEDIATED CHOLESTEROL TRANSPORT%GOBP%GO:0090119,0.181082515256036,0.5547368729476899,-0.7450785773366422,-1.23992989971093,1364,2,CES1|SYT7
SKELETAL MUSCLE CONTRACTION%GOBP%GO:0003009,0.194709964645803,0.569626484656312,-0.36427296174901597,-1.25389817484683,1486,13,RCSD1|MYH3|TNNT2|GAA|TNNI2|TNNC2|STAC3
U4 SNRNA 3'-END PROCESSING%GOBP%GO:0034475,0.36370736787295,0.718092241218875,-0.37392542778702403,-1.07647897183128,2793,8,EXOSC7|EXOSC4|EXOSC3|EXOSC2
GLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006114,0.153042328042328,0.52097307188263,-0.6720008201195561,-1.3122472837857801,1156,3,PGP|GOT1
MYELOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:0002318,0.798113959357152,0.931076731538025,0.600573445081606,0.8007836519259108,6008,1,MLF1
REGULATION OF COAGULATION%GOBP%GO:0050818,0.000128816179312122,0.00518555396908895,-0.5253153227683979,-2.78831698067303,0,50,GP1BA|PLAU|PLEK|VTN|HS3ST5|FCER1G|F3|FAP|CEACAM1|THBD|PDPN|F2R|APOE|PLAUR|NOS3|SERPINE2|THBS1|SERPINE1|CAV1|PLAT|ENPP4|TLR4|PDGFA|ANXA2|PDGFRA|TFPI|PDGFB|SERPINF2|C1QTNF1
LATERAL SPROUTING FROM AN EPITHELIUM%GOBP%GO:0060601,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
POSITIVE REGULATION OF LIPID LOCALIZATION%GOBP%GO:1905954,0.00246177766260689,0.0467540136128816,-0.375195797450204,-1.8906563141615,18,42,PLTP|OSBPL11|TRIAP1|SREBF2|MSR1|P2RX4|LRP1|TNFRSF11A|C3|PRELID1|IKBKE|PLA2R1|EHD1|SPP1|GHRL|NR1H3|APOE|NFKBIA|FITM2|NFKB1|ANXA2|C1QTNF1
REGULATION OF EPIDERMIS DEVELOPMENT%GOBP%GO:0045682,0.242711771177118,0.625903089763975,0.240190086062279,1.1716582725821898,1764,36,FOXC1|CYP27B1|DLL1|TRIM16|KLF7|SPINK5|CBFB|GAL|MAFF|NCOA3
CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0003413,0.00065470734581642,0.0165075321035167,-0.617418092649908,-2.1252728057937498,4,13,MATN2|COL20A1|COCH|ANXA6|VWA1|COL14A1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061314,0.15190203230849403,0.519318984997959,-0.44209147999455295,-1.32991938363546,1165,9,JAG1|NOTCH1|NOTCH2|SNAI1
NEGATIVE REGULATION OF ARP2/3 COMPLEX-MEDIATED ACTIN NUCLEATION%GOBP%GO:0034316,0.758306538049303,0.917143966125732,0.468673264106938,0.787431596554243,5659,2,PICK1
PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS%GOBP%GO:0019856,0.7747588642847439,0.923210645518754,0.344361838228181,0.7565776241449329,5702,4,CAD|DHODH|CTPS2
NEGATIVE REGULATION OF INTERFERON-GAMMA SECRETION%GOBP%GO:1902714,0.789565217391304,0.9280333261332429,-0.60917512130569,-0.8115675331518271,5901,1,ZC3H12A
NEGATIVE REGULATION OF HISTONE DEACETYLASE ACTIVITY%GOBP%GO:1901726,0.962013547615885,0.9905437927174009,0.518912659902956,0.6919000136131801,7242,1,KDM5A
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING%GOBP%GO:1904358,0.20796278560678602,0.588026582283419,0.252844423535692,1.2130866376269298,1519,34,HMBOX1|ATM|PARN|ACD|RTEL1|POT1|MAP2K7|MAP3K4|XRCC5|PNKP|TNKS|ATR|MAPK1|TNKS2|NEK7|TCP1
POSITIVE REGULATION OF MYELOID DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002735,0.545238095238095,0.817297924969912,-0.481412743052818,-0.940077073624007,4121,3,TICAM1
FATTY ACID DERIVATIVE TRANSPORT%GOBP%GO:1901571,0.0776685776685777,0.390053430594062,0.48740801955367996,1.48118801778582,568,9,ABCC4|DRD2|SLCO3A1|DRD4
LONG-CHAIN FATTY-ACYL-COA CATABOLIC PROCESS%GOBP%GO:0036116,0.44016469650684,0.7653693162885199,0.7818151742390831,1.0424450422932,3313,1,ACOT7
G PROTEIN-COUPLED RECEPTOR CATABOLIC PROCESS%GOBP%GO:1990172,0.13752508361204,0.50219949963275,-0.930083811204235,-1.23909496281725,1027,1,GPRASP1
RAS PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0007265,0.15019762845849802,0.517264655410678,-0.16239629376758802,-1.19299397231076,1177,200,RAB9A|TRIM28|TAX1BP3|RAPGEF1|RAB7A|RAP2B|GDI1|RAB27B|PLK2|CDKN2A|WAS|KPNB1|ARHGDIB|RAB24|RREB1|RAB29|RHOF|ELMO1|GRB2|PRKD1|CTNNAL1|PARK7|RHOG|RHOD|DNMT1|NTN1|RAPGEF3|HRAS|IGF1|PLD1|ARHGAP1|RHOJ|PDPN|RND1|RAB3C|RAP1A|RAB7B|CDC42EP4|COL1A2|RAB1B|AIF1|RAB34|CFL1|RAB9B|RABL3|ADGRG1|RAB20|TIAM1|EPS8|RRAS|CDC42EP1|RHOU|CDC42EP5|G3BP1|ARHGDIA|DBNL|NGFR|RAB33A|CDC42EP2
RESPONSE TO MOLECULE OF FUNGAL ORIGIN%GOBP%GO:0002238,0.667023411371237,0.880719592999549,-0.6703242170269079,-0.8930328114162521,4985,1,SYK
LEUKOCYTE PROLIFERATION%GOBP%GO:0070661,0.7375766271031691,0.9083815365104179,-0.18151609841786298,-0.80057467329616,5654,27,MEF2C|MSN|SLC11A1|TNFRSF4|CTPS1|CX3CL1
REGULATION OF PROSTAGLANDIN-E SYNTHASE ACTIVITY%GOBP%GO:2000361,0.14778455823826,0.514965886850433,-0.7655913978494621,-1.2740665132909,1113,2,ITGB2|ITGAM
HISTONE H4-R3 DEMETHYLATION%GOBP%GO:0070079,0.24200668896321104,0.625158460820442,-0.8759373621526251,-1.16695889135137,1808,1,JMJD6
REGULATION OF PHOSPHOLIPID EFFLUX%GOBP%GO:1902994,0.41642345449721396,0.7493091022753771,-0.633157837212356,-1.05367589067213,3138,2,APOE
REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0071071,0.307602186930487,0.6792715063520871,-0.393061691963781,-1.1315695980762,2362,8,FABP3|ZP3|PDGFA|PDGFB
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:2000544,0.0190191550061133,0.190317961363288,0.7590580709204209,1.6676829083032,139,4,FGF2|CXCL13|FGF1|FGFR1
"PEPTIDYL-ARGININE METHYLATION, TO SYMMETRICAL-DIMETHYL ARGININE%GOBP%GO:0019918",0.016336830920441,0.174101838399886,0.99183943537715,1.32248405534735,122,1,NDUFAF7
GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0009101,0.3869130313976111,0.733589579210772,0.13755216495799,1.0330512176319302,2784,211,HS6ST3|CHST8|GALNT3|GALNT8|GALNTL6|MGAT5|HS6ST1|GALNT12|UGGT2|POMGNT1|NDST3|SERP2|ST8SIA2|B3GNT9|B3GNT2|B4GALT5|GALNT7|B3GALNT2|ALG12|TUSC3|PMM1|XYLT1|DPAGT1|B3GNT7|MGAT5B|MOGS|CHPF|HS6ST2|TET2|GALNT14|GALNT6|CHST15|CSPG5|GALNT2|GALNT9|SDF2|ATP7A|LARGE|CSGALNACT2|FUT2|NDST2|MPDU1|GLCE|TET3|DPY19L3|ST3GAL4|ST3GAL6|ALG11|DPY19L1|GALNT15|PGM3|DHDDS
"CD4-POSITIVE OR CD8-POSITIVE, ALPHA-BETA T CELL LINEAGE COMMITMENT%GOBP%GO:0043369",0.7900286383754229,0.928247620398227,-0.25503411532876996,-0.7342075233444201,6068,8,FOXP3|BATF|SPN|STAT3
NUCLEAR RETENTION OF PRE-MRNA AT THE SITE OF TRANSCRIPTION%GOBP%GO:0071033,0.281825355076276,0.654732517474162,-0.48700157454119,-1.1672498457214,2142,5,EXOSC3|EXOSC2
POSITIVE REGULATION OF SPINDLE CHECKPOINT%GOBP%GO:0090232,0.22239747634069398,0.604959238589686,-0.4504374507393111,-1.2312506846245301,1691,7,MAD2L1|NDC80|XRCC3
NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT%GOBP%GO:0051271,0.00012820512820512802,0.00518555396908895,-0.272270510310248,-2.0032904643667098,0,203,PLCB1|KANK1|JAG1|CORO1C|SLAMF8|ANGPT2|JUP|FRMD5|DAB2IP|KLF4|LRP1|SEMA6A|ADORA3|SYNJ2BP|MCTP1|SFRP2|CYP1B1|GATA3|WAS|ARHGDIB|THY1|CCDC125|DCN|PODN|NOTCH1|PHLDB2|PTGER4|MEF2C|CHRD|ADIPOR1|TBXA2R|MMRN2|MECP2|DPEP1|CALR|HMOX1|RNF20|SULF1|RECK|SEMA3B|HDAC5|SEMA3D|LDLRAD4|MEOX2|SEMA7A|STARD13|CCL2|CD300A|CORO1B|APOE|MITF|DLC1|NOV|TGFBR3|BST2|CD200|THBS1|SPINT2|SEMA5A|VCL|NBL1|AIF1|SEMA3E|COL3A1|ADARB1|SLIT2|NAV3|CX3CL1|NR2F2|IGFBP5|SERPINE1|SEMA3A|PPARG|SEMA6B|IFITM1|KIAA2022|ADGRG1|EVL|MCC|NF2|TIMP1|ENG|ACTN1|ACVRL1|FBLN1|PTPRJ|CARD10|ADGRB1
RECEPTOR RECYCLING%GOBP%GO:0001881,0.0543684068163376,0.338357848587052,0.566992793863007,1.56516838848261,401,7,EHD3|FAM109B|RAB11B|ARFGEF2|PLEKHJ1
PROTEIN RETENTION IN ER LUMEN%GOBP%GO:0006621,0.18055193959906302,0.554341985854668,-0.44759834797288595,-1.2885729977520202,1386,8,GPAA1|KDELR2|KDELR1|KDELR3
GOLGI TO VACUOLE TRANSPORT%GOBP%GO:0006896,0.522104692161649,0.807051143864932,0.262954077656772,0.9451545210494229,3849,14,CCDC91|EHD3|AP4M1|VPS52|LAMP1|AP1G1|ANKFY1|VPS54|GAK|AP3D1
MITOCHONDRIAL RNA 3'-END PROCESSING%GOBP%GO:0000965,0.926091530773277,0.9788742558805359,-0.255561523210506,-0.6125322055084179,7041,5,HSD17B10
CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS%GOBP%GO:0044270,0.0699309639478394,0.37596389138254704,-0.15393242447205302,-1.24662919639723,546,361,NUDT17|GPX1|HK1|RPLP2|ADA|VCP|KYNU|NUDT1|HK3|MAGOH|PDE12|PDE4D|PDXP|RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|PATL1|NUDT16|APOBEC3G|RPL10|DDX5|PDE2A|RPL36A|SMPDL3A|RPL24|HAAO|ENO1|PELO|DPEP1|HMOX1|TYMP|APOBEC3C|PGAM1|HPRT1|FTCD|CDA|LSM3|NT5C3B|RPL35|GAPDH|RNASE6|PPP2CA|RPL38|RPS15A|NUDT18|NUDT4|MAGOHB|EIF4A3|LDHA|EXOSC3|AFMID|RPS13|RBM8A|TNKS1BP1|POLR2G|ENPP4|ABCD1|HINT1|TUT1|PNP|RNH1|HNMT|PGK1|SKIV2L2|MUS81|SAMHD1|EXOSC2|ENDOG|QPRT|BLVRB|DNASE1L1|ERN1|ALDOA|FEN1|ALDOC|EIF4G1|RNASEH2C
NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0045717,0.9293903074517981,0.9793746057014829,-0.199682821208209,-0.6006948030463809,7133,9,APOC1|BRCA1|CEACAM1
REGULATION OF EPITHELIAL TUBE FORMATION%GOBP%GO:1905276,0.297271616668929,0.6692652587893061,0.44086340661426904,1.1407599764762,2189,6,NPHP3-ACAD11|DVL2|NPHP3|DVL1
CELLULAR RESPONSE TO HYDROPEROXIDE%GOBP%GO:0071447,0.927758146839419,0.979345221662042,-0.280998458260773,-0.615164364364169,7088,4,PRKD1
XYLULOSE METABOLIC PROCESS%GOBP%GO:0005997,0.0687082842559874,0.3746716811206479,-0.6725563982899371,-1.47236654540336,524,4,DCXR|TKT|TALDO1
REGULATION OF EYE PIGMENTATION%GOBP%GO:0048073,0.220215168017001,0.602707552062395,0.8914865460961621,1.1886770183931399,1657,1,HPS4
CELL CYCLE PHASE TRANSITION%GOBP%GO:0044770,0.0168819542140939,0.17671843887293,-0.193121889368692,-1.44906148445734,131,227,CEP72|HAUS6|POLE4|CDKN1B|CDK4|AURKA|TACC3|PRIM2|AJUBA|CEP78|UBE2L3|HAUS4|SKP2|CEP76|CSNK1D|TIMELESS|FBXL7|CEP192|PCNT|ID2|NEK2|NEDD1|POLE|TYMS|BRD4|CUL4B|PIM2|FBXW11|RPA2|CDK6|RRM2|MCM10|DYNC1H1|PLCB1|TFDP2|CDT1|MCM4|EIF4EBP1|LCMT1|MCM6|CDC6|OFD1|CEP70|KDM8|CDC23|PLK2|CDKN2A|TUBA4A|SDCCAG8|HAUS8|PCNA|GMNN|ORC1|PKMYT1|CDK5RAP2|CDC25C|ORC6|MELK|MCM3|INHBA|UBE2S|FOXM1|MCM5|CDC45|CDKN2B|ENSA|RCC1|CEP131|CDC27|SKP1|E2F1|CKAP5|TUBB4A|DHFR|MAX|CCNB1|PLK1|LATS2|MCM2|CAMK2A|MYC|SSNA1|RPS6KB1|PRKACA|CETN2|CDKN2C|POLE2|POLA1|HSP90AA1|EPS8|POLE3|CEP63|CDKN3|PPP6C|TUBB4B|CCND1|DCTN3|POLA2|HAUS7
CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS%GOBP%GO:0006575,0.0212957023733162,0.20130030080164998,-0.229101677677363,-1.5151068634920002,165,119,CPT1C|C9orf41|MTHFD2|P4HA2|ALDH1L2|OPLAH|TYMS|GATM|PCYOX1L|P4HTM|PLA1A|ST20-MTHFS|PLOD2|PTDSS2|CHAC1|SLC19A1|CROT|CHAC2|P4HA3|CRAT|PLA2G2A|GGT1|GPX1|PLA2G2D|P4HA1|GGH|PLSCR1|PLA2G4D|PLA2G4A|PARK7|DPEP1|SOD1|SLC6A8|CKB|FTCD|SERINC5|DHFR|PLA2G16|GGT5|ALDH4A1|TMLHE|SHMT2|GSTP1|FOLR2|CPQ|PTGES|MTHFD1|OSBPL5|P4HB|PLA2G12A
SENSORY PERCEPTION OF BITTER TASTE%GOBP%GO:0050913,0.504057343792264,0.797772889025646,0.342195256480971,0.944620820458121,3726,7,TAS2R5|RTP5|TAS2R14|RTP4|TAS2R19|TAS2R4|TAS2R20
PYRIMIDINE-CONTAINING COMPOUND SALVAGE%GOBP%GO:0008655,0.228451663610165,0.6101254638038941,-0.377253741115942,-1.2213792838688602,1743,11,TYMP|CDA|TK1|UCK1
PRIMARY NEURAL TUBE FORMATION%GOBP%GO:0014020,0.35965746907706997,0.7155384949577859,0.230884236423146,1.06892393290385,2645,30,BBS4|TSC2|BMP7|SEMA4C|DVL2|MTHFR|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10
NEGATIVE REGULATION OF DNA-DEPENDENT DNA REPLICATION%GOBP%GO:2000104,0.9394255874673629,0.9808856411353001,-0.143520486752761,-0.6025824618148261,7195,23,TERF2|DONSON|STAG2|SLFN11|GMNN|SMC1A|BCL6
NEGATIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING%GOBP%GO:1903237,0.9499867338816659,0.985204477413381,-0.354783567686793,-0.5904165907889379,7160,2,CCL21|CXCL12
CARDIAC MYOFIBRIL ASSEMBLY%GOBP%GO:0055003,0.504977731202515,0.797902257689198,-0.29472806218855396,-0.9541979582948141,3854,11,PDGFRB|IGSF22|PDGFRA
POSITIVE REGULATION OF GTPASE ACTIVITY%GOBP%GO:0043547,0.6198290126861561,0.8551097775270831,0.13148429897506,0.922735542954323,4494,151,SFRP1|ZNF286A|ITGA6|TBC1D1|PLXNB1|XCL1|SGSM2|ALS2|ARHGEF7|MAP4K4|TBC1D2|TBC1D14|AGRN|PKP4|NDEL1|RIC1|GNB5|RAB3GAP1|TBC1D17|TBC1D16|TBC1D9|TBC1D8|RANGAP1|ADCYAP1|MLLT4|RAP1GDS1|TBC1D7|NF1|TBC1D20|CXCL13|RALGAPB|SIPA1L1|ARHGEF10|TBC1D4
"REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, DEADENYLATION-DEPENDENT DECAY%GOBP%GO:1900151",0.500261643118786,0.7951717058944731,-0.26002347619064003,-0.9663479205214979,3823,16,ZFP36L2|BTG2|CPEB3|NANOS3|TNRC6A|ZFP36L1|TOB1|DHX36|TNRC6C|POLR2G
REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1905066,0.004648691725328729,0.0752560935123842,0.9979047198941329,1.33057129384458,34,1,DKK1
ENTRY OF SYMBIONT INTO HOST CELL BY PROMOTION OF HOST PHAGOCYTOSIS%GOBP%GO:0052066,0.32846327533537,0.6950398637731511,0.835410233789149,1.11390682246874,2472,1,ITGAV
MALE MEIOTIC NUCLEAR DIVISION%GOBP%GO:0007140,0.4336859235150529,0.7617458538169591,0.282458754069415,1.01526156505229,3197,14,TDRD12|HSPA2|TEX14|ING2|MOV10L1|CYP26B1|CCNA1|UBR2|TDRKH|SPDYA|C17orf104|FIGNL1|MYBL1|PIM2
REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010662,0.39677167404321795,0.7377402989373809,-0.36277443035758794,-1.0443768109304399,3047,8,BAG3|CAMK2A|ENG
NEGATIVE REGULATION OF CATABOLIC PROCESS%GOBP%GO:0009895,0.135024862935101,0.497031952671308,-0.164338324227397,-1.2072604963726499,1058,200,USP25|UCHL5|APOC1|HGF|HNRNPU|HP|OGT|CBFA2T3|LARP1|PSMF1|BAG5|TOB1|SCFD1|INS|UBE2G2|MAD2L1|FMR1|DHX36|EFNA1|MAPKAPK2|PARK7|UBXN1|SLC11A1|TIMP3|RILP|ALAD|FLNA|E2F1|BSCL2|EIF4G2|DKC1|HFE|GIPC1|CHMP4A|TLK2|EPHA4|CCRN4L|SLIRP|YBX3|RASIP1|PPARA|DERL3|TAF9|ANXA2|TIMP1|PHB|AK6|HNRNPA0|HNRNPC|CST3|EIF4G1|ADGRB1
HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION%GOBP%GO:0021932,0.7049313951908709,0.894639008000397,0.3674983172521579,0.8074094538886241,5188,4,CTNNA2|LEF1
PROTEIN LOCALIZATION TO MITOTIC ACTOMYOSIN CONTRACTILE RING%GOBP%GO:1904498,0.47293676312968896,0.7831522581932591,0.604324346991733,1.01534293042097,3529,2,RTKN
REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0003307,0.5814297231926899,0.8387093286508721,0.45700525993036406,0.8988754161142031,4326,3,DKK1
POSITIVE REGULATION OF STRESS-ACTIVATED MAPK CASCADE%GOBP%GO:0032874,0.522501611863314,0.807051143864932,-0.148844281925962,-0.9627559971935441,4051,108,PYCARD|PLCB1|ARHGEF5|CCL19|MID1|DAB2IP|EMC10|TNFRSF11A|IL1RN|FCGR2B|PKN1|MDFIC|TRAF2|TAOK2|MAPK8IP1|ZNF622|FLT4|MLKL|CTGF|HRAS|MAP3K13|GADD45B|SASH1|FGF19|GADD45G|BMP2|MAP3K11|LTBR|SEMA3A|ARL6IP5|DBNL|SERPINF2|ERN1
D-GLUCURONATE CATABOLIC PROCESS%GOBP%GO:0042840,0.525036525434985,0.808245162096538,0.737097485663873,0.982820038463605,3952,1,AKR1A1
NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION%GOBP%GO:0090278,0.7174398738336178,0.900060477413567,-0.205112487132519,-0.8103803013529142,5458,19,INHBB|REST|PIM3|CRHBP|IRS1|NOV|CHGA|SIRT4
REGULATION OF MONOCYTE EXTRAVASATION%GOBP%GO:2000437,0.5187959866220739,0.8047799431921201,-0.7429422143802379,-0.989777420500336,3877,1,PLCB1
PROTEIN K48-LINKED UBIQUITINATION%GOBP%GO:0070936,0.944743749136621,0.9827827405434408,0.11825921703214999,0.6346420664402901,6838,50,PARK2|ZNRF1|UBE2G1|BFAR|RFFL|CDC34|UBE2Q2|NEDD4L|UBE2K|UBR5|UBE2E3|PELI1|RNF146|RNF126|HACE1|RNF4|UBE2D4|RNF8|UBE2H|UBE2C|RNF187|UBE2D3|RNF115|RNF6
PYRIDINE NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0019364,0.964496248660236,0.990916952887267,0.333057337725349,0.5595793301521391,7198,2,NUDT12
POSITIVE REGULATION OF CLATHRIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:2000370,0.574270383457663,0.835204333784353,-0.41068849627985105,-0.899082967676694,4387,4,DAB2
AUTOCRINE SIGNALING%GOBP%GO:0035425,0.5343915343915341,0.8124537043108601,-0.487948546629206,-0.9528398415160849,4039,3,CX3CL1
APOPTOTIC DNA FRAGMENTATION%GOBP%GO:0006309,0.182354483481909,0.5559553601324849,-0.35908145758967297,-1.2703776871372099,1390,14,DICER1|KPNA1|DNASE2|EXOG|DNASE1L3|H1F0|HMGB2|KPNB1|ENDOG|FEN1
ESTABLISHMENT OF RNA LOCALIZATION%GOBP%GO:0051236,0.225496476617553,0.6083599141984499,-0.16704516447712198,-1.1413348286021698,1759,139,FYTTD1|NXF2B|ZFP36L1|NCBP2|SLU7|CHTOP|TST|PHAX|SRSF9|TOMM20|NPM1|FMR1|MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|C14orf166|NUP37|NMD3|CKAP5|RAN|NXF1|NUP160|THOC7|ZC3H3|NUP214|TGFBR2|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
RIGHTING REFLEX%GOBP%GO:0060013,0.627174923628636,0.859069247760118,0.683833259814733,0.911799380387913,4721,1,AUTS2
TELOMERE FORMATION VIA TELOMERASE%GOBP%GO:0032203,0.360340018594767,0.7155384949577859,0.8211843846493159,1.0949385721752298,2712,1,WRAP53
ENTRAINMENT OF CIRCADIAN CLOCK%GOBP%GO:0009649,0.0108539296456127,0.134645873234709,-0.43269614889757296,-1.7919073365345999,82,22,ARNTL2|USP2|GNAQ|CRY2|RBM4B|SIK1|RBM4|PPP1CA
POSITIVE REGULATION OF ELECTRON TRANSFER ACTIVITY%GOBP%GO:1904734,0.317192889360573,0.6861326333203311,-0.675985663082437,-1.12494824160423,2390,2,CHCHD10|COX17
BRANCH ELONGATION OF AN EPITHELIUM%GOBP%GO:0060602,0.592717011556033,0.8420679787577819,0.45240008874279997,0.8898175878342192,4410,3,FGFR2|FGF1
PYRIDOXAL PHOSPHATE METABOLIC PROCESS%GOBP%GO:0042822,0.0112433862433862,0.13791712836645198,-0.844601301422742,-1.64929227835875,84,3,PDXP|PNPO|PDXK
NEGATIVE REGULATION OF INTERFERON-BETA SECRETION%GOBP%GO:0035548,0.589565217391304,0.8414799095069009,-0.7099691221879141,-0.9458493443938201,4406,1,LILRB1
PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE%GOBP%GO:1903539,0.39261303890641397,0.737280445732591,-0.385300027911154,-1.0532004440856702,2986,7,ARHGAP44|STX1B|STX3
HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS%GOBP%GO:0030200,0.49193765116904103,0.7910456783193008,0.49293715145984596,0.9695492065105219,3660,3,HPSE|GPC1
CAVEOLA ASSEMBLY%GOBP%GO:0070836,0.0866378746237404,0.406842536616055,-0.6572591426003571,-1.4388776549979099,661,4,CAV2|CAV1|EMP2
ASYMMETRIC STEM CELL DIVISION%GOBP%GO:0098722,0.503786854206113,0.7975731804297109,0.342482501989562,0.945413753974467,3724,7,TEAD3|RAB10|DOCK7|ING2
REGULATION OF GROOMING BEHAVIOR%GOBP%GO:2000821,0.130429007836366,0.489803809246725,0.9362593736215259,1.2483755425727099,981,1,CNTNAP4
POSITIVE REGULATION OF LIPASE ACTIVITY%GOBP%GO:0060193,0.0843717549325026,0.40376145987147494,-0.28698413741076195,-1.40448805240513,649,38,HRAS|NTRK2|NR1H3|P2RY6|GNAQ|GNA15|PDGFRB|ANG|PLAA|PDGFRA|C5AR1
LIMB JOINT MORPHOGENESIS%GOBP%GO:0036022,0.84951520786293,0.9492491301138911,0.574327304808116,0.7657879653378901,6395,1,CTNNB1
ISG15-PROTEIN CONJUGATION%GOBP%GO:0032020,0.153372626064178,0.521561408675329,-0.517125365396283,-1.33018574618762,1170,6,UBE2E2|UBE2E1|UBA7|HERC5|ISG15|UBE2L6
NEGATIVE REGULATION OF BLOOD VESSEL REMODELING%GOBP%GO:0060313,0.00882943143812709,0.117827730899938,-0.995644022937803,-1.32643690678155,65,1,CST3
RNA EXPORT FROM NUCLEUS%GOBP%GO:0006405,0.286595553270788,0.6597593769415511,-0.166221751511041,-1.10253476953266,2229,121,SRSF3|ZNF593|FYTTD1|NXF2B|NCBP2|SLU7|CHTOP|PHAX|SRSF9|NPM1|MAGOH|CPSF2|NUP188|SRSF5|SRSF1|U2AF1|HNRNPA2B1|NCBP1|NUP85|GLE1|NUP37|NMD3|RAN|NXF1|NUP160|THOC7|ZC3H3|NUP214|MAGOHB|EIF4A3|PABPN1|SRSF2|RBM8A|DDX39A|NUP98|THOC3
GALACTOSE CATABOLIC PROCESS%GOBP%GO:0019388,0.5707399687337161,0.8330710930899928,-0.300112240005537,-0.902811077142989,4380,9,GALT|PGM5|GALK1
PIGMENT METABOLIC PROCESS INVOLVED IN DEVELOPMENTAL PIGMENTATION%GOBP%GO:0043324,0.843272678974632,0.9481593344082329,0.5772496691662989,0.7696845438865558,6348,1,AP3D1
ULTRADIAN RHYTHM%GOBP%GO:0007624,0.7230769230769231,0.902606235251144,-0.64258932509925,-0.8560832758283299,5404,1,ENOX2
ORGANOPHOSPHATE ESTER TRANSPORT%GOBP%GO:0015748,0.186350686350686,0.5595926956761049,-0.21945427988636804,-1.2191804674756201,1438,59,PRELID1|ABCG1|SLC37A2|ATP8B1|CETP|APOE|ATP8B4|SLC25A4|LDLR|PCTP|SLC25A42|ATP8A2|NPC2|SLC25A19|OSBPL5|ABCC1
CELLULAR LACTAM CATABOLIC PROCESS%GOBP%GO:0072340,0.24668896321070197,0.6280519349499749,-0.873456109395677,-1.1636532668951898,1843,1,DPEP1
EPINEPHRINE METABOLIC PROCESS%GOBP%GO:0042414,0.401795284030011,0.740287621109606,0.635549033273313,1.06780443495646,2998,2,ATP7A|TH
NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION%GOBP%GO:0060253,0.958333333333333,0.988711428754361,0.19656275272503101,0.570587283282822,7014,8,ADCYAP1|SKI|CERS2
PROTEIN DEGLUTAMYLATION%GOBP%GO:0035608,0.8087320897539879,0.9342433549901921,0.30191691750423805,0.726108455251795,5982,5,AGBL5|AGTPBP1
REGULATION OF NEURON PROJECTION REGENERATION%GOBP%GO:0070570,0.46313183949974,0.776858745462897,-0.32819414194120194,-0.9872883118412271,3554,9,THY1|SCARF1|EPHA4|RTN4RL1
SEQUESTERING OF TRIGLYCERIDE%GOBP%GO:0030730,0.377819050145927,0.7281989978224692,-0.64957264957265,-1.0809927633655099,2847,2,IL1B|TNF
CELLULAR PROTEIN-CONTAINING COMPLEX LOCALIZATION%GOBP%GO:0034629,0.9958011648381421,0.998675570643677,0.106688111483426,0.43978451001254404,7351,21,MIOS|NDC1|MZT1|EXOC1|EZR|EXOC3L1
SYNAPTIC VESICLE LOCALIZATION%GOBP%GO:0097479,0.983706158519746,0.9939087115639991,0.0990001270386958,0.572103055689277,7123,65,SYT2|RIMS1|SNAP25|DNAJC5|UNC13A|RIMS2|BLOC1S3|CPLX1|AP3B2|SYT5|SYNDIG1|AP3B1|KIF5A|SPG11|SNAP23|OTOF|AP3M1|CDK5|PIP5K1C|STX1A|BLOC1S5|KIF5C|AP3M2|SYT11
"REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL ACTIVATION%GOBP%GO:2001185",0.14544499868732003,0.512552662440151,-0.363858976828354,-1.32111296376874,1107,15,CD274|LILRB1|HLA-E|NCKAP1L|RUNX1|RUNX3|MAPK8IP1|SOCS1|C10orf54|HFE
REGULATION OF MESODERMAL CELL DIFFERENTIATION%GOBP%GO:1905770,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
"REGULATION OF PROTEIN IMPORT INTO NUCLEUS, TRANSLOCATION%GOBP%GO:0033158",0.301589369463262,0.674675340764701,-0.377164650886325,-1.13460358937929,2314,9,PSEN1|GAS6|PDE2A|IGF1|TMEM173
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1905313,0.5966555183946489,0.844613508628182,-0.705668284075871,-0.940119595336448,4459,1,TGFB1
PROTEIN BRANCHING POINT DEGLUTAMYLATION%GOBP%GO:0035611,0.18448665161376,0.557533473973628,0.9103992059991179,1.2138944984345101,1388,1,AGBL5
NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION%GOBP%GO:0045988,0.6939274555087629,0.889500280068691,0.37121172109545,0.815567960277439,5107,4,BIN1|KCNE3
CEREBELLAR MOLECULAR LAYER MORPHOGENESIS%GOBP%GO:0021687,0.222936763129689,0.605751556060834,0.7223049352081609,1.21356555171492,1663,2,DLL1|ZNF365
REGULATION OF CILIUM ASSEMBLY%GOBP%GO:1902017,0.000138159712627798,0.00526859796630401,0.36660730229996996,2.07155051792445,0,60,DYNC2LI1|IFT88|ODF2L|ZMYND10|TBC1D1|BBS4|TBC1D19|CDK10|IFT20|CCDC88A|IFT140|TBC1D2|TBC1D14|TBC1D17|HTT|TBC1D16|TBC1D8|MARK4|HAP1|TBC1D7|TBC1D20|ATG5|TAPT1|MAP4|KCTD17
ETHANOL METABOLIC PROCESS%GOBP%GO:0006067,0.7345711297071129,0.9079405785880958,-0.24854238181153898,-0.7786508373824209,5617,10,SULT1A3|SULT1A1|ACSS1|ADH1B|ALDH2|ALDH1A1
REGULATION OF CELL PROLIFERATION INVOLVED IN HEART VALVE MORPHOGENESIS%GOBP%GO:0003250,0.878217033695941,0.960725750963158,-0.4157134884557971,-0.6918137223754661,6619,2,NOTCH1
REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR%GOBP%GO:0090325,0.976225262319033,0.9926773910205121,0.51080723423026,0.681092522166879,7349,1,GNB3
POSITIVE REGULATION OF INTERLEUKIN-1 BETA BIOSYNTHETIC PROCESS%GOBP%GO:0050725,0.49615282568320507,0.794012168719884,-0.600683384655072,-0.9996332085613949,3739,2,AZU1
INTERMEDIATE FILAMENT ORGANIZATION%GOBP%GO:0045109,0.5557582073996871,0.8254629302911409,-0.303589259312888,-0.913270802298015,4265,9,NEFM|KLHL24|KRT9|PKP2
REGULATION OF T CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002625,0.396521739130435,0.7377402989373809,-0.8014446404940451,-1.06771669934484,2963,1,WAS
REGULATION OF CELL ACTIVATION%GOBP%GO:0050865,0.000128584287000129,0.00518555396908895,-0.31764772213896997,-2.52505443484375,0,322,IGHV1OR15-1|CD274|UNC13D|DUSP3|NFKBIZ|PRDM1|MNDA|HLA-DPA1|MICA|TGFB1|CD38|LILRB1|IGHV5-51|SLA2|HLA-E|LYN|GPR183|NDFIP1|CD209|TNFSF13B|PYCARD|TNFAIP8L2|IGHV1-24|NCKAP1L|VAV3|CD74|TNFRSF14|SAMSN1|RPS6KA1|IL18|ADAM8|RUNX1|RIPK3|CCL19|SLAMF8|TWSG1|IGHV3-49|CD84|ZFP36L1|RUNX3|CCDC88B|ITGB2|IGHG4|HLA-DPB1|CD4|SNX4|STX4|FGR|IGLL5|STXBP2|PDCD1LG2|PAXIP1|VAV1|SPN|AHR|GATA3|FES|TNFRSF18|PLEK|EBI3|FCGR2B|GAS6|PLA2G2D|THY1|IL6ST|ADGRE2|PRELID1|PVRL2|TNFAIP3|PLSCR1|MAPK8IP1|MZB1|IGHV4-4|RC3H2|LILRB2|GPNMB|INHBA|IGHV4-61|GRB2|PRKAR1A|MEF2C|CEBPA|SOCS1|PTPN6|CD47|IL2RA|IGHV1-3|SDC4|FCER1G|MMP14|FGF10|BST1|ABL1|IGHV3-43|SOD1|TNFRSF4|IGF1|VAMP8|DPP4|CEBPB|NR1H3|IGHV3-73|VAMP7|NKAP|ICOSLG|VCAM1|TNFSF13|SNX6|C10orf54|CCL2|CEACAM1|THBD|PDPN|IL33|GPER1|CD300A|HFE|GSN|APOE|LST1|CD86|NLRP3|AXL|NOS3|LGALS3|SERPINE2|TGFBR2|TNFRSF21|CD200|LGALS9|THBS1|ZP3|IGHV3-15|FADD|AIF1|CD300LF|CX3CL1|CAV1|LDLR|HAVCR2|MILR1|BCL6|TLR4|ITGAM|IGHV1-18|LILRB4|PDGFA|PDGFRA|PNP|ANXA1|CD55|NCK1|IGHG2|TFRC|IGHA1|CD81|TNFRSF1B|PDGFB|SART1|SIRPA|C1QTNF1|PRNP
POSITIVE REGULATION OF HISTONE H3-K9 ACETYLATION%GOBP%GO:2000617,0.9104741203640809,0.9720943283119721,0.290864065902469,0.6390407400015339,6701,4,PIH1D1|SMARCB1
CILIUM MOVEMENT INVOLVED IN CELL MOTILITY%GOBP%GO:0060294,0.037359054476294,0.27534637346769203,0.7203454882442459,1.5826297154861497,274,4,RSPH9|TEKT2|GAS8|TEKT3
NEGATIVE REGULATION OF G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0010972,0.629273365397114,0.860490149809397,-0.18638555636148496,-0.8830544608898141,4840,34,FOXN3|VPS4A|BLM|PINX1|AURKA|FHL1|FBXL7|CLSPN|DONSON|NBN|CDC6|RAD17|ORC1|TAOK2|TOPBP1|SKP1|USP47
STRESS GRANULE DISASSEMBLY%GOBP%GO:0035617,0.6770120988953181,0.8836483435332951,-0.34249598277303495,-0.82089751645805,5147,5,KLC1|DYRK3|VCP
AUTOPHAGOSOME MEMBRANE DOCKING%GOBP%GO:0016240,0.9377044889412379,0.9806508984207809,-0.27518910170072397,-0.602446468480518,7164,4,STX17|SNAP29|VAMP8
SKELETAL MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0060538,0.38675388389206894,0.733589579210772,0.23725880775366198,1.04915125683411,2837,26,STRA6|BVES|POPDC3|DLL1|IGSF8|LARGE|RYR1|SKI|CFLAR|MYL6B|ZBTB18
CATECHOLAMINE UPTAKE%GOBP%GO:0090493,0.260048231511254,0.636098664976652,0.703391232423491,1.18178808898966,1940,2,SLC6A2|SNCA
NEGATIVE REGULATION OF CELL CYCLE ARREST%GOBP%GO:0071157,0.136072222949104,0.499189931577426,-0.351619251270964,-1.3362390189189,1039,17,SETMAR|CCNK|ZNF268|FGF10|CALR|GPER1|CCND1
REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002864,0.504468980021031,0.797795146880088,-0.348969886605482,-0.953893622946137,3837,7,HLA-E|FCGR2B|PARK7|ZP3
NEGATIVE REGULATION OF CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000723,0.678974631425156,0.884536278926676,0.6601786501985,0.8802591502487092,5111,1,HEY2
INTERLEUKIN-18 PRODUCTION%GOBP%GO:0032621,0.831584539779519,0.9443784929910591,0.5830943978826639,0.7774777009838891,6260,1,GBP5
SYNAPTIC SIGNALING%GOBP%GO:0099536,0.40072252327358604,0.740287621109606,0.134588818998359,1.02597606910774,2883,228,EXOC4|HTR3A|KCNQ3|CHRNB1|SLC12A5|DRD2|SLC6A2|GRIK3|SYT2|GRID1|KCNMB4|EPHB2|LIN7B|CHRM4|FCHSD1|SLC12A4|GABRA3|RIMS1|SNAP25|RIMBP2|DRD4|DLG2|KCNIP2|GABARAP|CHRNB2|MINK1|ARRB2|RAB3GAP1|LIN7A|DNAJC5|CHRNA5|PTPRD|COLQ|NQO1|UNC13A|GABRB3|CACNB4|RIMS2|HAP1|SLC18A3|KCNQ2|CPLX1|CHRNB4|PDE7B|PPFIA3|KCNK3|HRH3|SYT5|CHRM3|UNC119|DLG4|BRSK1|CACNB2|KIF5A|GRM4|SPG11|SLC1A4|LRP6|SNAP23|PTPRN2|KCNC4|ASIC2|NAAA|OTOF
AMP METABOLIC PROCESS%GOBP%GO:0046033,0.19918032786885198,0.577166177580918,0.434012293316676,1.2598617587602299,1457,8,AK9|ADSL|AK4|ADSS|APRT|AK3|AMPD3
TOLL-LIKE RECEPTOR 7 SIGNALING PATHWAY%GOBP%GO:0034154,0.13213053860440402,0.491948396065839,-0.775958092087124,-1.2913183502614098,995,2,PIK3AP1|UNC93B1
DE NOVO CENTRIOLE ASSEMBLY%GOBP%GO:0097742,0.0342887056667975,0.264364643644243,-0.7162077314282909,-1.5679284384112702,261,4,CEP63
NEGATIVE REGULATION OF INTERLEUKIN-5 PRODUCTION%GOBP%GO:0032714,0.44613955956487106,0.767797697802539,-0.620772576744442,-1.03306483670146,3362,2,TNFRSF21
NEGATIVE REGULATION OF MAST CELL DIFFERENTIATION%GOBP%GO:0060377,0.359941559304024,0.7155384949577859,0.821239523599471,1.0950120925252,2709,1,ZFPM1
"DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST%GOBP%GO:0006977",0.9872258064516128,0.996006492881216,-0.0984176536234361,-0.536851722742786,7650,55,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS%GOBP%GO:0032805,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
REGULATION OF HEART GROWTH%GOBP%GO:0060420,0.530726987447699,0.8115959426370749,-0.242187571460785,-0.9397778492387501,4058,18,BASP1|TBX2|NOTCH1|MEF2C|PIM1|IGF1|TGFBR3
REGULATION OF LIPOPROTEIN OXIDATION%GOBP%GO:0034442,0.532709030100334,0.812079525085925,-0.736821790913101,-0.9816235468417691,3981,1,APOD
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE%GOBP%GO:0070973,0.965160445317616,0.990916952887267,-0.21725006087694101,-0.55882568072337,7368,6,BCAP31
NUCLEUS LOCALIZATION%GOBP%GO:0051647,0.7449673202614381,0.9112137767014771,-0.23113905173328303,-0.773644048070703,5698,12,DCTN4|SLC9A3R1|SUN2|SYNE3
NEGATIVE REGULATION OF CILIUM ASSEMBLY%GOBP%GO:1902018,0.17540267540267498,0.548366806412612,0.42430942694370294,1.2894372144268,1284,9,ODF2L|CDK10|TBC1D7|MAP4
RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING%GOBP%GO:0072396,0.19751146037983,0.574572493132077,-0.491821993815623,-1.2650986581054298,1507,6,EME1|SMC1A|MUS81
ISOPEPTIDE CROSS-LINKING%GOBP%GO:0018262,0.0271571906354515,0.23271567002476898,-0.986876929863255,-1.31475703370306,202,1,RNF113A
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION%GOBP%GO:0051985,0.616647127784291,0.854159296508911,-0.205186195249977,-0.8845864385458,4733,25,ATRX|MAD1L1|ZNF207|TRIP13|KLHL22|APC|CDC20|ESPL1|NAA10|PTTG1|MAD2L1|PLK1|IK
PROTEIN O-LINKED FUCOSYLATION%GOBP%GO:0036066,0.0979232386961094,0.43163319977057396,-0.526517030946394,-1.4392108244001398,744,7,POFUT1|LFNG|RFNG|SLC35C1|MFNG|B3GLCT
ISOPRENOID BIOSYNTHETIC PROCESS%GOBP%GO:0008299,0.17271179782637197,0.546371269738967,-0.373071836061618,-1.2841856065252801,1318,13,IDI1|FDPS|HMGCR|HMGCS1|PDSS1|SRD5A3
POSITIVE REGULATION OF VASCULOGENESIS%GOBP%GO:2001214,0.279705573080967,0.653204101106396,-0.426466617152463,-1.1657274799789399,2127,7,KDR|CD34|CEACAM1|RAP1A
REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS%GOBP%GO:0050690,0.10725469728601299,0.45128176873822495,-0.315741112421242,-1.3773203925426298,821,26,CD8B|ATP6V1H|AP2A1|FYN|AP1S3|PAK2|AP1S2|RAC1|DOCK2|B2M|AP2A2|CD4|PACS1|ELMO1|ARF1|AP1B1|HCK|AP2M1
"HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS, POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS%GOBP%GO:0015014",0.43086225026288105,0.759376613000886,-0.37252928724309003,-1.01829219397256,3277,7,NDST1|EXT2|CSGALNACT1
POSTSYNAPTIC MEMBRANE ASSEMBLY%GOBP%GO:0097104,0.90347085789129,0.969254445652501,-0.24868278902616398,-0.6396791250634001,6897,6,NRXN2
POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:1904340,0.97414255091104,0.9920058127185359,0.31794871794871804,0.534194898174537,7270,2,CSNK1E|CSNK1D
POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:1904037,0.153453689167975,0.52168285154307,-0.350540104292734,-1.3027427592511598,1172,16,CCL2|GPER1|GSN|ECSCR|THBS1
REGULATION OF MORPHOGENESIS OF AN EPITHELIUM%GOBP%GO:1905330,0.409582689335394,0.744904339785137,-0.175647688763047,-1.0237376304445,3179,71,AP2A2|AGT|FZD4|HGF|SMO|GATA3|MLLT3|TBX2|FZD2|RREB1|SAPCD2|CELSR1|PHLDB2|SMURF2|CLTC|SULF1|VANGL1|FOXP1|DACT1|DAB2|PDGFA|TIAM1|PRICKLE2|AP2M1
"FATTY ACID ELONGATION, POLYUNSATURATED FATTY ACID%GOBP%GO:0034626",0.507759074171489,0.7987565605553191,-0.39487388553412395,-0.9464373547525979,3860,5,ELOVL2|ELOVL1
NEGATIVE REGULATION OF CARDIOBLAST DIFFERENTIATION%GOBP%GO:0051892,0.558528428093645,0.8268422944617521,-0.724139832377592,-0.964728132954647,4174,1,PRICKLE1
DNA RECOMBINATION%GOBP%GO:0006310,0.158365261813538,0.528235065638267,-0.178052367141459,-1.20627257631523,1239,133,RAD51|RPA2|MLH3|XRCC2|WRNIP1|NABP2|BRIP1|PALB2|TREX1|HMGB2|BATF|TONSL|NBN|YY1|EXO1|GINS2|PARP1|RAD51C|AP5S1|RAD51AP1|TOP2A|SLX1B|RHNO1|AUNIP|SLX1A|RNF168|RNF138|CDC45|BRCA1|STRA13|POLQ|EME1|NUCKS1|RMI1|REC8|RAD51B|RBM14|EXOSC3|FANCM|HMGB3|NSMCE1|IGHMBP2|MUS81|SAMHD1|ENDOG|XRCC3|FEN1
REGULATION OF CATION TRANSMEMBRANE TRANSPORT%GOBP%GO:1904062,0.152907947104892,0.52097307188263,-0.165233342450355,-1.19493458143353,1190,186,GLRX|ATP1B1|PPIF|AMIGO1|KCNIP3|CTSS|PLN|SHISA7|ATP1B3|KCNN2|STAC3|THY1|PDE4B|STIM1|SLC9A3R1|FMR1|KCNIP4|JPH4|PDE4D|TESC|HAMP|SEPN1|CRHBP|SLC9A1|MEF2C|UBQLN1|CD63|CAPN1|FLNA|FXYD1|CNIH2|P2RY6|GPER1|F2R|KCNQ1|APLNR|F2RL3|COX17|FKBP1A|MMP9|CX3CL1|SLC30A5|CAV1|SCN1B|CNIH3|CLIC2|ATP1B2|PRKACA|KCNH2|KCNE4|TMSB4X|FXYD5|AHNAK|FXYD7|WNK2|PRNP
MEDIUM-CHAIN FATTY ACID CATABOLIC PROCESS%GOBP%GO:0051793,0.87875101378751,0.960725750963158,0.276693139201412,0.665445413079534,6500,5,ACADM|ABHD1|GLYATL2
RESPONSE TO ISCHEMIA%GOBP%GO:0002931,0.8050669467051721,0.932964969466025,-0.20340848282771698,-0.7385432288812142,6132,15,PER2|PPIF|P2RX4|CX3CL1|CAMK2A
HISTONE DEPHOSPHORYLATION%GOBP%GO:0016576,0.0288900833109379,0.24018507515684898,0.801190110115403,1.5758463999436298,214,3,EYA4|EYA1|EYA3
NEGATIVE REGULATION OF CALCIUM-DEPENDENT CELL-CELL ADHESION%GOBP%GO:0046588,0.0303678929765886,0.246289263264096,-0.985498456109396,-1.31292057567185,226,1,FXYD5
RESPIRATORY GASEOUS EXCHANGE%GOBP%GO:0007585,0.0555191829252324,0.341931271262467,-0.448034816735956,-1.54222272297037,423,13,COX11|EDNRA|GAA|CSF2RB|NDST1|ELN|ECEL1|NDUFA12|HNMT
REGULATION OF NATURAL KILLER CELL DEGRANULATION%GOBP%GO:0043321,0.32462486602358004,0.692794968343412,0.6720705817480009,1.12916535188194,2422,2,LAMP1|AP1G1
REGULATION OF CARDIAC MUSCLE HYPERTROPHY%GOBP%GO:0010611,0.134394572025052,0.4962180106589171,-0.30457331780365804,-1.32860443297508,1029,26,AGT|LMCD1|PARP1|P2RX4|IL6ST|NOTCH1|SLC9A1|IGF1|LMNA|RGS2
MEDIUM-CHAIN FATTY-ACYL-COA CATABOLIC PROCESS%GOBP%GO:0036114,0.44016469650684,0.7653693162885199,0.7818151742390831,1.0424450422932,3313,1,ACOT7
DNA HYPERMETHYLATION%GOBP%GO:0044026,0.181003344481605,0.554699553656526,-0.907366563740626,-1.20883013446293,1352,1,SPI1
SECRETORY GRANULE MATURATION%GOBP%GO:0061792,0.455925826390755,0.7711961414599979,0.509986694415034,1.00308364552494,3392,3,PTPRN|BAIAP3|SNX19
HISTONE H3-T6 PHOSPHORYLATION%GOBP%GO:0035408,0.40620854338020707,0.743639545659366,-0.637552397009303,-1.06098914091719,3061,2,PRKCB
INTERNAL PROTEIN AMINO ACID ACETYLATION%GOBP%GO:0006475,0.0243436145806781,0.21922894141495605,-0.253961376548443,-1.5428247669079098,190,83,NAA40|KAT6A|KANSL1|KANSL2|JADE3|NAA10|YEATS4|TAF6L|BRPF3|RUVBL1|HCFC1|OGT|TAF12|MORF4L2|MSL2|PHF20|NAA50|WDR5|KAT7|TAF9B|SPI1|MBIP|KAT2B|APBB1|TAF10|KAT8|KAT5|TAF9|POLE3|CCDC101|AK6
RESPONSE TO PHORBOL 13-ACETATE 12-MYRISTATE%GOBP%GO:1904627,0.8420005306447329,0.94808068996515,-0.435787151916184,-0.725219508393687,6346,2,ADAM15|MAP4K1
NEGATIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1905166,0.635850577801666,0.8636797415465791,0.43647292378956704,0.8584907339003309,4731,3,LAPTM4B|ATP13A2|MGAT3
REGULATION OF SARCOMERE ORGANIZATION%GOBP%GO:0060297,0.30448804084923403,0.677044366877573,0.585640233814933,1.15188522981952,2265,3,AKAP13|PROX1|EDN1
CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY%GOBP%GO:0030038,0.583475186591594,0.8391117257440741,-0.26117089965670703,-0.8990008833768042,4455,13,RHOA|SORBS1|PDCD10|ZYX|PHACTR1|ITGB1|ITGB5|ARRB1
NEGATIVE REGULATION OF MRNA CATABOLIC PROCESS%GOBP%GO:1902373,0.20388476078738102,0.583066054809155,-0.25993928075226397,-1.2207482424090401,1563,33,HNRNPU|LARP1|TOB1|FMR1|MAPKAPK2|SLC11A1|E2F1|CCRN4L|YBX3|HNRNPA0|HNRNPC
NEGATIVE REGULATION OF PROTEIN ACETYLATION%GOBP%GO:1901984,0.52940404305592,0.8108997701936519,-0.258558878937848,-0.938785377345355,4032,15,PARK7|BRCA1|TAF7|KLF15|SPI1
TRYPSINOGEN ACTIVATION%GOBP%GO:0032023,0.395138796652942,0.7377402989373809,0.803098808998677,1.0708238973834798,2974,1,CUZD1
METANEPHROS DEVELOPMENT%GOBP%GO:0001656,0.160855352764914,0.5311416159351421,0.30370716613156606,1.28937200848175,1180,23,RET|CITED1|PAX8|ROBO2|BMP7|PKD1|WNT4|NF1|PKD2
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS%GOBP%GO:0002865,0.928379467884977,0.9793746057014829,0.313619306180557,0.616852165744111,6908,3,ADCYAP1|VIMP
NEGATIVE REGULATION OF B CELL DIFFERENTIATION%GOBP%GO:0045578,0.47661918839021794,0.78501147478174,0.499814025763164,0.9830752067405891,3546,3,SFRP1
REGULATION OF OXIDATIVE STRESS-INDUCED CELL DEATH%GOBP%GO:1903201,0.6022508921218779,0.8477583531177572,0.18064199778445103,0.9025329787670541,4387,39,MET|PARK2|NOL3|HTRA2|MAPK7|RIPK1|NME5|PDE8A|NFE2L2
AMMONIUM TRANSMEMBRANE TRANSPORT%GOBP%GO:0072488,0.334118570867688,0.6974768376198021,-0.5116741614175,-1.12016169845978,2552,4,RHBG|RHCE
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY%GOBP%GO:0007163,0.567612687813022,0.83116084992853,0.139872704673392,0.9415339297386591,4079,125,SHTN1|RLTPR|RHOC|CLASP1|LLGL1|DCTN1|FAT1|RHOQ|PARD3|CLASP2|RAB10|DLG2|NDEL1|MYO18A|HTT|MAP7|CAP2|GPSM2|RAB11FIP2|CAMSAP3|WDR1|DST|MYO9A|LRRC7|MTCL1|AMOTL1|BRSK1|RND3
RNA REPAIR%GOBP%GO:0042245,0.994958875033165,0.998334682182626,-0.289054314860767,-0.48103260318862495,7499,2,FTO|ALKBH1
ACTIVATION OF NF-KAPPAB-INDUCING KINASE ACTIVITY%GOBP%GO:0007250,0.10540788267644399,0.44703199615994393,-0.41156426489506603,-1.41668401109514,804,13,CHI3L1|TNFRSF10A|TNFRSF10B|TRAF2|IRAK1|ZFP91|CARD10
CELL-SUBSTRATE ADHESION%GOBP%GO:0031589,0.00359342915811088,0.0636478933555875,-0.265486766942141,-1.7149100991996002,27,107,RAC1|ITGB1|ECM2|CD44|ITGBL1|FGFRL1|ADAM9|LAMC1|CTTN|FBLN5|PEAK1|CORO1A|EPHB3|ITGA10|ITGA11|ITGB2|MICALL2|TRIP6|CD34|BCAM|SMAD6|ITGB5|THY1|VTN|ILK|TAOK2|ITGA5|EFNA1|VWF|MADCAM1|CD63|SIGLEC1|RHOD|PPFIA1|DDR1|VCAM1|FN1|DLC1|TEK|TIMM10B|VCL|ITGA8|COL3A1|LYVE1|FERMT3|TIAM1|ACTN1|COL13A1|ITGB4|EMP2
EPITHELIUM DEVELOPMENT%GOBP%GO:0060429,0.0014151550238003302,0.0301860198914787,-0.19314705330560397,-1.55811349698982,10,352,SOX10|LMO4|TBX1|SOX18|DFNB31|RYR2|JUP|BASP1|COL23A1|DNPH1|SOX17|KDR|RAPGEF1|CDHR2|BHLHE40|FOXN4|CD34|TST|TOR1A|SMO|RAP2B|MED1|SFRP2|COBL|GATA3|MAF|TBX2|PDZD7|PCNA|CBR1|CNN3|APCDD1|HES1|MESP1|SLC9A3R1|CTSB|ITGA5|THRA|KRT9|PDE4D|NOTCH1|INHBA|CELSR1|MEF2C|TPP1|CHRD|ICAM1|KRT18|PKP2|ATP6AP2|PDE2A|PERP|LIN7C|SNAI2|MSN|RCN3|MICAL2|FGF10|COL4A1|CAPN1|SOD1|RAPGEF3|DDR1|FLNA|KLF15|LRP5|MEOX2|TJP2|STARD13|JAG2|CTSH|CEACAM1|PDPN|KANK2|MEOX1|EPHA2|RAP1A|ALDH1A2|PCSK6|DLC1|DEAF1|GATA6|PTER|TAGLN|LGALS3|LUZP1|CD151|TGFBR2|BMP2|RAB1B|VCL|SRF|SEMA3E|ERRFI1|SLIT2|KRT7|NR2F2|DNAAF1|MYO1E|MYC|RASIP1|PPARG|DACT1|WNT3|DAB2|PDGFA|ANXA2|CSF1R|ACTA2|CEP63|ANXA1|COL5A1|ENG|PGK1|TOLLIP|KRT19|CASP6|ACVRL1|EDF1|PDGFB|ALDOC|MTHFD1
RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009188,0.30083676451055896,0.673988937137548,0.8507940008822229,1.13441900011172,2264,1,AK5
DNA INTEGRATION%GOBP%GO:0015074,0.919304442331205,0.976687251055112,0.28663798007712704,0.62975584946424,6766,4,THAP9|SMARCB1
TOLL-LIKE RECEPTOR TLR6:TLR2 SIGNALING PATHWAY%GOBP%GO:0038124,0.0406084656084656,0.288441534418227,-0.7777655233263481,-1.51877894319482,306,3,TLR2|CD36|CD14
MAMMARY GLAND EPITHELIUM DEVELOPMENT%GOBP%GO:0061180,0.540162218733647,0.81505408470595,-0.251839846564733,-0.9359343840702121,4128,16,LRP5|EPHA2|WNT3|CSF1R
CELL MORPHOGENESIS%GOBP%GO:0000902,0.23679060665362,0.6217158626397761,0.133872492962604,1.1002692790655,1693,368,TNR|RET|CNTN4|BVES|SHTN1|DRD2|ROBO3|FRY|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|MET|SEMA4F|PLXNB1|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|CDHR1|MAPK7|ALS2|SLIT1|EPHB2|CASP9|LAMA5|EFNA4|PARD3|LAMB1|NBEAL2|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|NYAP2|STK24|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|RHOBTB1|BMP7|NTNG1|EFNB3|SLIT3|NCKAP1|CDK5R1|CAP2|RILPL1|SHC1|SOS1|NYAP1|MAP6|ATP7A|FRYL|DRAXIN|SPTBN1|PAK1|EFNA2|EPB41L3|ITGAV|NRCAM|STRADB|VAMP3|MAP2|ZFPM1|DLG4|BRSK1|VLDLR|TUBB3|ULK2|PPP3CB|ANTXR1|PRKCA|RAB25|PLCG1|KIF5A|BIN3|SCARA3|PLXNB2|RADIL|POU4F2|RHOBTB2|RB1|DOCK7|C8orf37|CELSR2|NRP1|DCC|CPNE1|CLDN3
DETECTION OF GLUCOSE%GOBP%GO:0051594,0.163719185423366,0.5351003413847161,0.7607940446650121,1.27823222513252,1221,2,GCK|NKX6-1
CELLULAR RESPONSE TO INTERLEUKIN-3%GOBP%GO:0036016,0.253174603174603,0.632257972333528,-0.612293875356639,-1.1956547533267499,1913,3,GSK3B|MT2A
REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1900407,0.6847541660928249,0.8857920062408181,0.162737670024648,0.85348294122937,4971,46,MET|PARK2|NOL3|HTRA2|MAPK7|RIPK1|BMP7|NME5|PDE8A|NFE2L2
POSITIVE REGULATION BY HOST OF VIRAL PROCESS%GOBP%GO:0044794,0.0584313725490196,0.34885102442576,-0.462266051468118,-1.5472477569741498,446,12,CAV2|PPIB|NUCKS1|APOE|CFL1|ANXA2
NEGATIVE REGULATION OF PROTEIN SUMOYLATION%GOBP%GO:0033234,0.0936609203203475,0.42337598780415003,0.5611023121600529,1.45188521164897,689,6,PIAS3|MAGEA2
POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050861,0.44967936134013897,0.7683008256632661,-0.457820151999678,-1.00226401433358,3435,4,PRKCH|NFAM1|PRKCB
CELL MIGRATION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:0003273,0.0115079365079365,0.139771630097924,-0.8424506451968679,-1.6450925918311998,86,3,NOTCH1|SNAI2|DCHS1
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION%GOBP%GO:0090272,0.580735785953177,0.8387093286508721,-0.7139942655491841,-0.95121180184495,4340,1,RGCC
RESPONSE TO MITOCHONDRIAL DEPOLARISATION%GOBP%GO:0098780,0.598271572607045,0.84557799939374,-0.257995496031064,-0.888070528317018,4568,13,AMBRA1|SQSTM1
CELLULAR RESPONSE TO UV%GOBP%GO:0034644,0.0737566549798727,0.3820872795228811,-0.23970083862467,-1.3851021187282802,567,69,AQP1|CUL4B|HYAL2|TRIAP1|KDM1A|IMPACT|YY1|PARP1|MFAP4|NDNL2|HYAL3|NPM1|PCNA|FMR1|DHX36|POLD1|RHNO1|CARD16|USP47|HYAL1|HIST3H2A|EIF2S1|MYC|DDB1|MAPK13|POLA1|CRIP1|XPA
HISTONE H2A-T120 PHOSPHORYLATION%GOBP%GO:1990245,0.47934652676318196,0.7852861637872259,0.760972651080723,1.0146543500027099,3608,1,VPRBP
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION%GOBP%GO:1904468,0.6010582010582011,0.8467992231156841,-0.45628465528580203,-0.8910082869026891,4543,3,CX3CL1
NEGATIVE REGULATION OF CYTOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0001960,0.102203102594186,0.441073279931729,-0.29357627174264694,-1.3787170477108202,783,33,IL1RN|GAS6|CARD16|NR1H3|SLIT2|PPARG|GSTP1|PELI3|SAMHD1|RNF113A|HIST1H2BJ
NEGATIVE REGULATION OF CELL MIGRATION%GOBP%GO:0030336,0.000256476019492177,0.00819882332206558,-0.26946562923357104,-1.91538469557751,1,169,VASH1|SCAI|PDCD10|AKT1|ROBO1|CXCL12|PTEN|ARPIN|PRKG1|DUSP1|ARHGAP4|RAP2C|DUSP3|TGFB1|GREM1|RGCC|HYAL2|SP100|APOD|PLCB1|KANK1|JAG1|CORO1C|SLAMF8|ANGPT2|JUP|DAB2IP|KLF4|LRP1|ADORA3|SYNJ2BP|MCTP1|SFRP2|CYP1B1|ARHGDIB|THY1|DCN|PODN|NOTCH1|PHLDB2|PTGER4|MEF2C|CHRD|ADIPOR1|TBXA2R|MMRN2|MECP2|DPEP1|CALR|HMOX1|RNF20|SULF1|RECK|HDAC5|LDLRAD4|MEOX2|STARD13|CCL2|CD300A|CORO1B|APOE|MITF|DLC1|NOV|BST2|CD200|THBS1|VCL|NBL1|AIF1|COL3A1|ADARB1|SLIT2|NAV3|CX3CL1|NR2F2|IGFBP5|SERPINE1|PPARG|IFITM1|KIAA2022|ADGRG1|EVL|MCC|NF2|TIMP1|ENG|ACVRL1|PTPRJ|CARD10|ADGRB1
REGULATION OF OXIDATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1902175,0.34283472803347304,0.701955655133333,-0.255119904062712,-1.08425239993075,2621,24,SOD2|BAG5|INS|UBQLN1|PARK7|HSPB1|SOD1|NONO|P4HB
MEMORY%GOBP%GO:0007613,0.415661869570854,0.7493091022753771,-0.204725345262722,-1.02528607219106,3205,41,INSR|ATAD1|FGF13|EIF4EBP2|EIF2AK4|KAT2A|PJA2|CPEB3|MAP1A|CIC|ARC|MAPT|SLC8A3|PSEN1|PLCB1|SHISA7|PLK2|NGF|ADCY8|SGK1|NPAS4|APOE|LDLR|LGMN|FEN1|PRNP
CRANIAL NERVE DEVELOPMENT%GOBP%GO:0021545,0.556010928961749,0.825690189610431,0.312987462186516,0.9085478468060111,4069,8,ERBB3|CHRNB2|CHD7
CARTILAGE CONDENSATION%GOBP%GO:0001502,0.9598226283257191,0.9895799382246301,0.28983455283497805,0.570070362698917,7142,3,BMP1|BMPR1B
REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION%GOBP%GO:1903371,0.251284130846175,0.631873138618812,0.49499904498854397,1.1904698646199598,1858,5,KIAA1715|RAB3GAP1|TMEM33|RAB3GAP2|ATL3
REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY%GOBP%GO:1901201,0.408600736454498,0.744700417001765,-0.430917318018801,-1.0328265846984,3106,5,TGFB1|RGCC|AGT|NOTCH1
REGULATION OF KERATINOCYTE DIFFERENTIATION%GOBP%GO:0045616,0.536028350177189,0.8132910857498922,-0.22977306127534503,-0.936097106079687,4083,21,RUNX1|ZFP36L1|AQP3|CTSV|MED1|NME2|ERRFI1|CTSL|H2AFY
EMBRYONIC EYE MORPHOGENESIS%GOBP%GO:0048048,0.0847778981581799,0.40376145987147494,0.393060117022664,1.44983674615775,625,15,STRA6|RARG|MFAP2|TWIST1|ALDH1A3|PHACTR4|LRP6|PROX1
ATP GENERATION FROM ADP%GOBP%GO:0006757,0.0815501043841336,0.397722753303477,-0.32740821590856395,-1.428214428583,624,26,GPI|PFKFB2|HK1|HK3|ENO1|PGAM1|GAPDH|LDHA|PGK1|ALDOA|ALDOC
REGULATION OF RIBONUCLEASE ACTIVITY%GOBP%GO:0060700,0.019453207150368,0.192337052905818,-0.6234004830514761,-1.70403742027351,147,7,OAS3|OASL|OAS1|TMBIM6|NPM1|OAS2
ARTERY MORPHOGENESIS%GOBP%GO:0048844,0.648920863309353,0.8711014361081449,-0.189426105508621,-0.864882512512416,4960,30,JAG1|TBX1|LRP1|TBX2|HES1|MYLK|NOTCH1|PDGFRB|ENG|ACVRL1
NUCLEOSOME ASSEMBLY%GOBP%GO:0006334,0.000128386185646424,0.00518555396908895,-0.438905148548341,-2.62018378199645,0,78,OIP5|RUVBL1|CENPM|HIST1H2BN|NPM1|ASF1B|CHAF1A|CENPI|IPO4|HIST1H2BC|HIST1H4I|STRA13|ANP32B|RBBP7|CENPH|NAP1L4|HIST2H3A|HIST2H2BF|SPTY2D1|HIST1H2BG|HIST1H2BD|CHAF1B|HIST2H4A|HIST2H3C|HIST1H3H|POLE3|H2AFY|HIST2H4B|CENPK|H3F3B|MIS18A|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ|CENPP
POSITIVE REGULATION OF DNA TOPOISOMERASE (ATP-HYDROLYZING) ACTIVITY%GOBP%GO:2000373,0.0106522882693319,0.13314154417238197,-0.7301455989410991,-1.75001967605768,80,5,DHX9|SETMAR|HNRNPU|PLSCR1|UHRF1
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS%GOBP%GO:0030206,0.580062794348509,0.8386526275338391,-0.24352022796361397,-0.9050154599311151,4433,16,DCN|CHST7|BGN|VCAN|CSGALNACT1
ESCRT III COMPLEX DISASSEMBLY%GOBP%GO:1904903,0.295349469676367,0.6682992987170799,0.358746621062503,1.13653354503826,2171,10,CHMP1A|IST1|VTA1|CHMP2A|CHMP7|VPS4B|CHMP2B|CHMP1B|VPS4A|CHMP5
REGULATION OF SYNAPTIC VESICLE CYCLE%GOBP%GO:0098693,0.71151832460733,0.8966571213032921,-0.183556556125466,-0.819784109248313,5435,28,TOR1A|NAPA|FMR1|VPS18|SYN1|STX1B|PLD1|PLAA
DICARBOXYLIC ACID CATABOLIC PROCESS%GOBP%GO:0043649,0.888496056567854,0.965159112268525,0.205714076558983,0.6517160998015861,6533,10,ADHFE1|GLUD1|PM20D2|ACOT8
HISTONE BIOTINYLATION%GOBP%GO:0071110,0.369230769230769,0.7221103884306529,-0.81318923687693,-1.08336332177074,2759,1,HLCS
AGGREPHAGY%GOBP%GO:0035973,0.788081204977079,0.9278035711683659,-0.286863184718014,-0.7378893880509501,6016,6,UBQLN1|SQSTM1
INNER MEDULLARY COLLECTING DUCT DEVELOPMENT%GOBP%GO:0072061,0.649488643910214,0.871510406076572,0.6730811645346271,0.8974629121428209,4889,1,DACT2
POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:1904925,0.8321038251366121,0.9443921657118071,0.24070763790653305,0.6987321619912601,6090,8,PARK2|HDAC6|OPTN|MFN2|HK2|PINK1|TOMM7
NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY%GOBP%GO:0001915,0.10469833791388601,0.44525070692259705,-0.640159381045246,-1.4014427024613798,799,4,LILRB1|FCGR2B|CEACAM1
NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS%GOBP%GO:0061002,0.147089947089947,0.514131830678897,-0.6762435204588071,-1.32053220224036,1111,3,PTEN|EFNA1|NGEF
PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009219,0.14617895023116698,0.513872620660976,0.336337166667736,1.31656718162788,1074,18,NT5M|NTHL1|DCTD|CDADC1|NEIL1|OGG1|DUT|DTYMK|SMUG1|NEIL2|TDG
NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY%GOBP%GO:2000272,0.394427001569859,0.7376723208557521,-0.281492074420268,-1.0461335443414899,3014,16,CRHBP|SNX6|VPS25|HFE|CHMP6|ERRFI1
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION%GOBP%GO:0032471,0.18611656843484,0.559093571852282,-0.498481341025514,-1.2822282930648798,1420,6,THADA|FIS1|ATP2A1|TGM2|BCAP31
CHOLESTEROL TRANSPORT INVOLVED IN CHOLESTEROL STORAGE%GOBP%GO:0010879,0.0676052596626378,0.371075653877479,0.966806352007058,1.28910581645877,508,1,STARD4
MAMMARY GLAND DEVELOPMENT%GOBP%GO:0030879,0.679545751207414,0.8845364446864721,-0.18653693627311102,-0.8434305263642851,5205,29,FGF10|LRP5|EPHA2|CAV1|WNT3|CSF1R
BRUSH BORDER ASSEMBLY%GOBP%GO:1904970,0.44147157190635494,0.7653693162885199,-0.7807675341861491,-1.0401698288767098,3299,1,CDHR2
POLYADENYLATION-DEPENDENT SNORNA 3'-END PROCESSING%GOBP%GO:0071051,0.24165029469548102,0.625158460820442,-0.46828232717618606,-1.20454829424967,1844,6,EXOSC3|EXOSC2
IMIDAZOLE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0052803,0.47768616673210296,0.7850984235874658,-0.44599226329950603,-0.9763702934959421,3649,4,FTCD|HNMT
ORGANELLE DISASSEMBLY%GOBP%GO:1903008,0.0831824062095731,0.401393889637745,-0.251374868216739,-1.3841604029616699,642,57,GFM2|ATG7|FUNDC1|DENR|ATG2B|FIS1|DYRK3|USP30|ATG13|MRRF|WDR45B|VCP|ATG2A|WDR45|PELO|WIPI1|MCTS1|STX5|ATG3|VRK1|MARK2|AMBRA1|FUNDC2|EIF2D|SQSTM1
RESPONSE TO INTERLEUKIN-17%GOBP%GO:0097396,0.898704358068316,0.967428248648255,-0.296503576448664,-0.649108309229496,6866,4,IL17RE|IL17RA
REGULATION OF ROOT DEVELOPMENT%GOBP%GO:2000280,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
POSTERIOR MIDGUT DEVELOPMENT%GOBP%GO:0007497,0.004648691725328729,0.0752560935123842,0.998014997794442,1.3307183345445301,34,1,RET
REGULATION OF GLUCONEOGENESIS%GOBP%GO:0006111,0.926237038981494,0.978965575504022,-0.15207551335835698,-0.619556736417195,7056,21,SUPT20H|DGKQ|C1QTNF3|GCK|VIMP|PTPN2|CLK2|PPARGC1A|FBP1|SOGA1|CRY1|GNMT|ARPP19|PDK2|SDHAF3|FAM132A|PGP|OGT|INS|NR1D1|SIK1
"POSITIVE REGULATION OF WNT SIGNALING PATHWAY, PLANAR CELL POLARITY PATHWAY%GOBP%GO:2000096",0.607632356893308,0.849325284075052,0.446599844849384,0.8784091925696831,4521,3,DKK1
REGULATION OF DNA BIOSYNTHETIC PROCESS%GOBP%GO:2000278,0.525603371216958,0.808819683211675,-0.15494210182387,-0.9573432384255149,4115,89,XRN1|PINX1|PTGES3|CCT7|HNRNPA1|NVL|PARM1|NEK2|GREM1|RFC2|RGCC|CCT3|NABP2|RFC3|TERF2|TINF2|KLF4|FGFR4|HGF|HNRNPU|CCT8|SMOC2|HNRNPA2B1|FAM129B|CCT5|RFC5|MAPK3|MEN1|DKC1|FBXO4|PDGFRB|MYC|PDGFA|HSP90AA1|RFC4|ACVRL1|PDGFB|HNRNPC|NAT10
MODULATION BY SYMBIONT OF HOST PROGRAMMED CELL DEATH%GOBP%GO:0052040,0.9070802251014259,0.9709695261809209,-0.29216290141823,-0.6396056642237711,6930,4,GAPDH
AMINE TRANSPORT%GOBP%GO:0015837,0.34297963558413697,0.701955655133333,0.6630824372759859,1.11406410866264,2559,2,SLC18A1|SLC18A2
REGULATION OF ACETYLCHOLINE METABOLIC PROCESS%GOBP%GO:0060408,0.904635409748971,0.9698755111576809,0.547529775033083,0.730057075250119,6810,1,PEBP1
REGULATION OF CELL FATE SPECIFICATION%GOBP%GO:0042659,0.11302812117918801,0.46074941938046904,0.636417665705098,1.39823671507984,831,4,DKK1|FGF2
CELLULAR RESPONSE TO NERVE GROWTH FACTOR STIMULUS%GOBP%GO:1990090,0.167301879353397,0.5396740210307,-0.32551960120927803,-1.28609757607699,1272,19,MAGI2|NTRK1|AKT1|MAPT|RAB35|RAPGEF1|NGF|SH3GL2|EHD1|NTRK2|RAP1A|TMEM108
N-TERMINAL PEPTIDYL-PROLINE DIMETHYLATION%GOBP%GO:0018016,0.00989966555183947,0.126895016411775,-0.994816938685487,-1.32533503196282,73,1,NTMT1
POSITIVE REGULATION OF FEEDING BEHAVIOR%GOBP%GO:2000253,0.438591776404192,0.764387115513764,0.519712694743113,1.0222135404267199,3263,3,CFAP20|NR4A3
BEHAVIORAL FEAR RESPONSE%GOBP%GO:0001662,0.16111941312321698,0.5313138078301111,0.5990319500180501,1.31609870554604,1185,4,DRD4|ADCYAP1|MAPK8IP2|GNG7
INACTIVATION OF X CHROMOSOME BY GENETIC IMPRINTING%GOBP%GO:0060819,0.9049986562751949,0.9701393453669169,0.32728576155288397,0.6437324707136409,6734,3,PCGF3|PCGF6
REGULATION OF MAST CELL CYTOKINE PRODUCTION%GOBP%GO:0032763,0.16693461950696697,0.53917243184018,0.758367797077475,1.27415581591995,1245,2,NR4A3|BCL10
COLLAGEN FIBRIL ORGANIZATION%GOBP%GO:0030199,0.00182743767132228,0.0366658253519131,-0.44561511376872703,-2.01485774062226,13,29,DPT|PLOD2|COL11A2|CYP1B1|DDR2|COL14A1|COL5A3|COL5A2|COL12A1|LUM|SERPINH1|COL1A2|COL1A1|COL3A1|ANXA2|COL5A1|LOXL2|SERPINF2
NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0033866,0.715988598082405,0.899551221015245,-0.165215330645612,-0.8325397304666311,5525,42,ACSL5|DCAKD|COASY|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|SLC26A2|HACD2|PDHX|FASN
REGULATION OF ACUTE INFLAMMATORY RESPONSE TO NON-ANTIGENIC STIMULUS%GOBP%GO:0002877,0.27825740470182003,0.653204101106396,0.8633105425672699,1.151108119556,2094,1,ADCYAP1
REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903764,0.682798527091005,0.885415243771438,-0.340732165792594,-0.8166699837231921,5191,5,KCNH2
REGULATION OF NATURAL KILLER CELL PROLIFERATION%GOBP%GO:0032817,0.29166666666666696,0.663837153945439,-0.5930848130583439,-1.15814432317501,2204,3,PTPN22|HLA-E|IL18
REGULATION OF SA NODE CELL ACTION POTENTIAL%GOBP%GO:0098907,0.504823151125402,0.797902257689198,0.588787103368171,0.98923835503866,3767,2,ANK2
PROTEIN COMPLEX OLIGOMERIZATION%GOBP%GO:0051259,0.0696726531652019,0.37596389138254704,-0.163500838575322,-1.27564531829972,546,284,PYCARD|USP16|TMCC1|CD74|TRIM21|GSDMD|DISP1|SPTBN5|RIPK3|KHDRBS3|ECT2|MPP2|TOR1B|TRIM28|OXA1L|HM13|TOR1A|ITPR3|SOD2|RBMX|OPA1|NPM1|TRIM34|ATPIF1|P2RX3|ANXA6|GRIN1|SEPT7|TRAF2|TNFAIP3|IKBKE|ADCY8|SLC1A2|VWF|SLC9A1|MLKL|PKD2L1|HIST1H4I|FCER1G|DHRS4|S100A10|EHD1|MCCC2|POLQ|RCC1|ALAD|HMOX1|IRAK1|HMGCR|KCNJ12|HPRT1|TOR2A|SNX2|LRRC8A|CDA|NACC2|CAT|NLRP3|COLEC12|MUC20|CHMP4A|TEK|TRA2B|TK1|B4GALT1|CRYAB|HSD17B10|GPX3|CAV1|HIST2H4A|TAF10|STOML2|SIGMAR1|EHD4|COL6A1|STOM|HIST1H3H|ANXA2|SEPT9|HIST2H4B|CPSF7|SHMT2|IGHMBP2|COL6A2|SAMHD1|APIP|AHNAK|QPRT|ALDOA|PRNP
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE%GOBP%GO:0032211,0.8562237394957979,0.949296218452153,-0.17370970410379097,-0.696920005727098,6520,20,HNRNPC|NAT10
NEGATIVE REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE-SPECIFIC DNA BINDING%GOBP%GO:1903026,0.355076275644398,0.7132037834765931,-0.454523999156914,-1.08940729481709,2699,5,TAF1|DDIT3|ZNF593|TMSB4X
INTERMICROVILLAR ADHESION%GOBP%GO:0090675,0.44147157190635494,0.7653693162885199,-0.7807675341861491,-1.0401698288767098,3299,1,CDHR2
NEGATIVE REGULATION OF DERMATOME DEVELOPMENT%GOBP%GO:0061185,0.406421404682274,0.7437287163473091,-0.7973092192324659,-1.06220732525121,3037,1,SFRP2
HISTONE EXCHANGE%GOBP%GO:0043486,0.0015501873143004801,0.0323260517898055,-0.38641955837136405,-2.00177489863752,11,46,MIS18BP1|RBBP4|HIST1H4J|CENPQ|HIST4H4|NASP|CASC5|HIST1H4H|HJURP|ITGB3BP|ANP32E|CENPL|CENPU|SRCAP|CENPW|OIP5|RUVBL1|CENPM|NPM1|CENPI|PIWIL1|HIST1H4I|STRA13|RBBP7|CENPH|SPTY2D1|HIST2H4A|POLE3|HIST2H4B|CENPK|MIS18A|CENPP
SERTOLI CELL DIFFERENTIATION%GOBP%GO:0060008,0.208065380493033,0.588125467895907,0.7316034587881229,1.22918827191024,1552,2,RAB13|SCX
NEURON MIGRATION%GOBP%GO:0001764,0.700655200655201,0.8931369333627571,0.163875695667554,0.844145172350482,5132,43,DRD2|DYX1C1|NAV1|CDK5R1|PEX13|DNER|NRCAM|SH3RF1|ELP3|NR4A2|NRP1|LRP12|FGFR1|KIAA0319|CDK5
PEPTIDYL-SERINE PHOSPHORYLATION%GOBP%GO:0018105,0.244291363694349,0.627241747929009,-0.16817127293749698,-1.1301061904387801,1914,128,TOP1|PLK2|DYRK1A|GAS6|PKN1|IKBKE|SGK1|SBK1|MAPKAPK2|MAPK9|MAST4|PRKD1|DCLK3|MAP3K13|PLK1|TGFBR2|PDK3|LATS2|TLK2|CAMK2A|RPS6KB1|MAPK13|PRKACA|RPS6KA4|ADRBK1|VRK1|NEK6|MARK2|CSNK1A1|PDGFB|PRKCB|ERN1
NEGATIVE REGULATION OF HISTONE H3-K14 ACETYLATION%GOBP%GO:0071441,0.604595563819896,0.848175106515994,0.6952470224966919,0.9270180928327041,4551,1,SIRT1
ESTABLISHMENT OF SKIN BARRIER%GOBP%GO:0061436,0.38010273046769394,0.729249457747391,0.438004420043638,1.05339811846377,2811,5,MET|STMN1|TMEM79|CLDN4
MITOTIC CELL CYCLE ARREST%GOBP%GO:0071850,0.4856754921928039,0.7872939093021379,0.277077658182633,0.970383726084662,3576,13,CDC14B|CDKN1A|PNPT1|CDC14A
NEGATIVE REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER%GOBP%GO:1903141,0.9774206401912611,0.9927322181739301,0.510366122629025,0.6805043593670799,7358,1,S1PR3
SENSORY PERCEPTION OF SOUR TASTE%GOBP%GO:0050915,0.701263415296835,0.8931369333627571,0.36862530678868605,0.8098854978961991,5161,4,ASIC1|ASIC2
RETROTRAPEZOID NUCLEUS DEVELOPMENT%GOBP%GO:0061451,0.9689632107023409,0.9912626134248801,-0.514832377591531,-0.6858803454958909,7242,1,PHOX2B
INTRACILIARY RETROGRADE TRANSPORT%GOBP%GO:0035721,0.00013598041881968998,0.00526859796630401,0.8301678829479431,2.63002796845673,0,10,DYNC2H1|WDR19|TTC21B|DYNC2LI1|WDR35|TTC21A|IFT140
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN NEPHRON MORPHOGENESIS%GOBP%GO:0072040,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
INSULIN METABOLIC PROCESS%GOBP%GO:1901142,0.15412940557601298,0.5225398777782271,-0.554542552018372,-1.32913268072945,1171,5,CPE|CEACAM1|ERN1
METANEPHRIC DISTAL TUBULE MORPHOGENESIS%GOBP%GO:0072287,0.23774737680966898,0.6217158626397761,0.882829730921923,1.1771343234471001,1789,1,PKD1
DISRUPTION BY HOST OF SYMBIONT CELLS%GOBP%GO:0051852,0.0912708941363757,0.41778255328704206,-0.809374138406396,-1.3469279949642599,687,2,AZU1|GAPDH
SCLEROTOME DEVELOPMENT%GOBP%GO:0061056,0.105067657203502,0.446168961873938,-0.7973531844499591,-1.32692320528568,791,2,SFRP2|MEOX1
RESPONSE TO LINOLEIC ACID%GOBP%GO:0070543,0.154515050167224,0.5226559938356611,-0.9209307454786059,-1.22690088149003,1154,1,CD36
POSITIVE REGULATION OF PRO-T CELL DIFFERENTIATION%GOBP%GO:2000176,0.9820693319165892,0.993436724391485,0.508491398323776,0.678004667467936,7393,1,ZBTB1
CMP-N-ACETYLNEURAMINATE BIOSYNTHETIC PROCESS%GOBP%GO:0006055,0.0612709030100335,0.35631208031004796,-0.967798853109837,-1.28934045455113,457,1,NANS
REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0060398,0.993819042609153,0.9977350366543521,-0.197771894992279,-0.47402149394537607,7556,5,MBD5|JAK2|LEPROT|GDF15|GHRL
NEGATIVE REGULATION OF PROTEIN BINDING%GOBP%GO:0032091,0.7816956183562359,0.925666442349475,-0.139667738406724,-0.8043308707646271,6029,68,IFIT2|PARK7|IFIT1|CARD16|CTSZ|HFE|CAV1|DACT1|DAB2|ACTB|HSPA5|PPP1CA|PDGFB
REGULATION OF PHOSPHOLIPID SCRAMBLASE ACTIVITY%GOBP%GO:1900161,0.779784831982999,0.924704689181848,0.6098919276576971,0.813208591071659,5870,1,PRKCD
FAD BIOSYNTHETIC PROCESS%GOBP%GO:0006747,0.9308009031743921,0.9793746057014829,0.535123511248346,0.7135149965057808,7007,1,FLAD1
REGULATION OF DENDRITE DEVELOPMENT%GOBP%GO:0050773,0.334853510226645,0.697899444105646,0.18042383510464602,1.078776314198,2422,74,ADGRB3|RTN4IP1|SS18L1|CHRNB2|PTPRS|BMP7|PTPRD|CDK5R1|SARM1|CAPRIN2|CUX2|NEDD4|CUL7|FOXO6|SIPA1L1|VLDLR|C21orf91|CAMK1D|YWHAH|NEDD4L|DCC|OBSL1|SHANK2|CHRNA3|LRP8|KIAA0319|CDK5|FBXW8|GORASP1
POSITIVE REGULATION OF BONE RESORPTION%GOBP%GO:0045780,0.556625878677428,0.8257149029717741,-0.31680111750387396,-0.912026077669715,4275,8,SYK|ADAM8|SPP1|ATP6AP1
CENTRIOLE REPLICATION%GOBP%GO:0007099,0.706436420722135,0.894843171056815,-0.218938136412518,-0.813658889361098,5399,16,CEP72|WDR62|OFD1|CDK5RAP2|CETN2|CEP63
ANTERIOR/POSTERIOR PATTERN SPECIFICATION INVOLVED IN URETERIC BUD DEVELOPMENT%GOBP%GO:0072099,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
FOLLICLE-STIMULATING HORMONE SECRETION%GOBP%GO:0046884,0.0943020321423828,0.424384770192935,0.953683281870313,1.27160797316476,709,1,TBX3
CARBOXYLIC ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1905039,0.42097107438016496,0.7520714091488578,-0.194114240208612,-1.0227680047255898,3259,49,SLC19A1|SLC36A1|SLC25A20|SLC7A2|SLC25A10|SLC25A18|SLC1A2|SLC1A3|SLC25A22|SLC38A6|SLC6A8|SLC7A3|SLC3A2|ARL6IP5|PRAF2|MPC1|SLC38A9
POSITIVE REGULATION OF RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0060332,0.79047619047619,0.928247620398227,-0.379728686445351,-0.741513882787828,5975,3,NLRC5|TXK|PARP9
REGULATION OF NOTCH SIGNALING PATHWAY%GOBP%GO:0008593,0.075,0.383578507779904,-0.24322591926705603,-1.38692250038527,581,65,TGFB2|PDCD10|AKT1|ROBO1|CREBBP|MFNG|NRARP|NOTCH4|C3orf17|ARRDC1|JAG1|CHAC1|SYNJ2BP|C8orf4|EGFL7|MESP1|PEAR1|RITA1|NOTCH1|STAT3|FAM129B|ARRB1|MMP14|SNW1|NOTCH3|JAG2|KAT2B|NOV|MAML1|TSPAN15|NOTCH2NL|DTX1|DLK2
REGULATION OF LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046890,0.0011580030880082302,0.0260481000924841,-0.27331088001058196,-1.8090917604447099,8,120,INS|NSMAF|FABP3|C3|ABCG1|CYP51A1|ADIPOR1|ORMDL3|BRCA1|SNAI2|MBTPS2|SOD1|NR1H3|CREBL2|RAN|HMGCR|CEACAM1|GPER1|APOE|SLC45A3|HMGCS1|FGF19|ADIPOR2|BMP2|ZP3|NR1D1|FITM2|SNAI1|SIRT4|NFYB|LDLR|DHCR7|SIK1|ABCD1|NFKB1|PDGFA|ANXA1|TNFRSF1A|FASN|PDGFB|TM7SF2
GUANINE TRANSPORT%GOBP%GO:0015854,0.591705685618729,0.8417378833576942,-0.7080392589325101,-0.9432783031501271,4422,1,SLC29A2
HINDLIMB MORPHOGENESIS%GOBP%GO:0035137,0.0548239720505241,0.33979782976374606,0.7593806126375892,1.4936120522500802,407,3,RARG|TFAP2B|AFF3
POSITIVE REGULATION OF MIRNA MEDIATED INHIBITION OF TRANSLATION%GOBP%GO:1905618,0.4206686123640221,0.751774348695433,-0.631297959782432,-1.0505807572119699,3170,2,EIF4G1
METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT%GOBP%GO:0072223,0.0350529100529101,0.26702449097803305,-0.7875261938899308,-1.5378390589737099,264,3,CD34|PDGFRB|PDGFB
POSITIVE REGULATION OF UBIQUITIN-SPECIFIC PROTEASE ACTIVITY%GOBP%GO:2000158,0.20480807544162602,0.5845960940001321,0.899261138067931,1.1990433877396,1541,1,TANK
FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA%GOBP%GO:0001325,0.686928104575163,0.8861361847538001,-0.24391739685873,-0.816414365662482,5254,12,NBN|EXO1|SLX1B|SLX1A|XRCC3
ODONTOGENESIS OF DENTIN-CONTAINING TOOTH%GOBP%GO:0042475,0.0734294261626326,0.381450667088883,0.376897561698209,1.4753378744420298,539,18,FOXC1|WNT6|SCN5A|ITGA6|ROGDI|HDAC1
FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY%GOBP%GO:0002431,0.21066152858060397,0.592420712315058,-0.19672239776667003,-1.17841365443403,1639,79,RAC1|WIPF3|IGKV3-11|ACTG1|LYN|NCKAP1L|VAV3|WASF2|IGHG4|NCKIPSD|FGR|FCGR1A|ARPC1A|VAV1|MYO1G|WAS|FCGR2B|IGKV2-28|MYO10|ELMO1|GRB2|FCER1G|PIK3CB|MAPK3|ABL1|FCGR2A|DOCK1|CYFIP2|IGKV2D-28|HCK|HSP90AA1|ACTB|NCK1|IGHG2
REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:0061097,0.0596418910215123,0.35402485921407395,-0.272015490355117,-1.44382883553859,462,50,NTRK2|SNX6|GPRC5B|VPS25|MVP|DLG3|CHMP6|EPHA4|ERRFI1|NEDD9|CAV1|CSF1R|PDGFB|PRNP
NEUROBLAST DIFFERENTIATION%GOBP%GO:0014016,0.936113693717625,0.9806508984207809,0.532752536391707,0.710353621456863,7047,1,SIX3
PLASMA MEMBRANE INVAGINATION%GOBP%GO:0099024,0.000258631837579206,0.00819882332206558,-0.40224895563696006,-2.15696111146084,1,52,CDC42|RAC3|IGHV2-26|IGHV1OR15-1|IGHV5-51|ARHGAP25|IGHV1-24|IGHV3-49|SNX18|ITGB2|IGHG4|MSR1|FCGR1A|IGLL5|FCGR2B|C3|IGHV4-4|ELMO1|IGHV4-61|IGHV1-3|IGHV3-43|IGHV3-73|VAMP7|DOCK1|GSN|CD36|THBS1|IGHV3-15|AIF1|MYH9|ITGAM|IGHV1-18|IGHG2|IGHA1|ADGRB1
REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY%GOBP%GO:0051386,0.49947089947089895,0.794989907195277,-0.503010728070691,-0.9822524643771109,3775,3,AGT|TMEM108
RRNA 3'-END PROCESSING%GOBP%GO:0031125,0.42496091714434603,0.7546470443593142,-0.338090389350436,-1.01705864637686,3261,9,EXOSC3|EXOSC2
POSITIVE REGULATION OF STEROL TRANSPORT%GOBP%GO:0032373,0.432922026778682,0.761429660735106,-0.27967408512469,-1.01545126826069,3297,15,NR1H3|APOE|NFKBIA|ANXA2
LIPOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0042158,0.9169090153718321,0.97526102754601,0.117952591170462,0.7070650611827791,6620,75,NMT2|PGAP2|PIGF|PGAP1|ZDHHC23|ATG10|PIGU|ZDHHC8|PIGL|ZDHHC6|ZDHHC22|PPM1B|PGAP3|PIGO|PIGG|ATG5|ZDHHC17|PIGT|GOLGA7|ZDHHC16|DPM1|ZDHHC14|PIGQ
DOXORUBICIN METABOLIC PROCESS%GOBP%GO:0044598,0.10899959277860699,0.45309795582492896,0.5478899892204321,1.4176975494849802,802,6,CBR4|AKR1C2|AKR7A2|AKR1C1|AKR1C3|AKR1B1
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:1905067,0.004648691725328729,0.0752560935123842,0.9979047198941329,1.33057129384458,34,1,DKK1
NEGATIVE REGULATION OF RECEPTOR-MEDIATED ENDOCYTOSIS%GOBP%GO:0048261,0.468364400105014,0.780769690730001,-0.271466651759703,-0.98565140812733,3567,15,RAC1|APOC2|LRPAP1|PSEN1|UBQLN2|APOC1|NECAB2|ARF6
REGULATION OF INTERLEUKIN-2 BIOSYNTHETIC PROCESS%GOBP%GO:0045076,0.494695481335953,0.793143688290573,-0.37356989452260597,-0.960922403251258,3776,6,IL1B|FOXP3|CD4|CD86
"RETROGRADE TRANSPORT, VESICLE RECYCLING WITHIN GOLGI%GOBP%GO:0000301",0.520133779264214,0.805333449898493,-0.74233568592854,-0.988969378966604,3887,1,GOLGA5
POSITIVE REGULATION OF PROTEIN IMPORT INTO MITOCHONDRIAL OUTER MEMBRANE%GOBP%GO:1903638,0.37618729096990006,0.7266197487465021,-0.81004631671813,-1.07917619745958,2811,1,PDCD5
PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:0018394,0.0325907065563335,0.25785422561312804,-0.24776338794957198,-1.5012842955140802,255,82,NAA40|KAT6A|KANSL1|KANSL2|JADE3|YEATS4|TAF6L|BRPF3|RUVBL1|HCFC1|OGT|TAF12|MORF4L2|MSL2|PHF20|NAA50|WDR5|KAT7|TAF9B|SPI1|MBIP|KAT2B|APBB1|TAF10|KAT8|KAT5|TAF9|POLE3|CCDC101|AK6
AMEBOIDAL-TYPE CELL MIGRATION%GOBP%GO:0001667,0.0011463507833397,0.0260082836197492,-0.301049931668528,-1.8933459724385802,8,95,KANK1|CORO1C|SOX10|TBX1|SOX18|KDR|PLXND1|SEMA6A|CYP1B1|ANXA6|PKN1|ARSB|NUP188|TNFSF12|PXN|ABL1|PIK3R3|DPP4|FAP|SEMA3B|SEMA3D|SEMA7A|STARD13|KANK2|CORO1B|FN1|GIPC1|NOS3|NOV|SEMA5A|SRF|SEMA3E|SLIT2|ID1|ADGRA2|SEMA3A|MYH9|SEMA6B|EPHB4|LOXL2|EMP2|PTP4A3
DETERMINATION OF BILATERAL SYMMETRY%GOBP%GO:0009855,0.0932017543859649,0.422068646506606,0.259279088090466,1.36879046210767,679,47,LRRC6|BBS5|DNAI1|NPHP3-ACAD11|DLL1|BBS4|AHI1|DYX1C1|RFX3|SETDB2|KIF3B|MKKS|NPHP3|PKD2|LEFTY1|CITED2|CCDC40
DOLICHYL DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0006489,0.0598054679284963,0.354269451186595,-0.5607434694775191,-1.5327672678187299,454,7,SRD5A3|DOLK|DOLPP1
NEGATIVE REGULATION BY HOST OF SYMBIONT CATALYTIC ACTIVITY%GOBP%GO:0052403,0.878929765886288,0.960725750963158,-0.563134097926776,-0.7502298349094499,6569,1,PTX3
GLUTAMATE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007215,0.6603209137884151,0.8781478080181429,0.197920618229163,0.8525674680821401,4855,24,GRIK3|HOMER2|HOMER3|CDK5R1|PTK2B|GRM4|KCNB1|HOMER1|GRM8|GRIK2
POSITIVE REGULATION OF GENE SILENCING BY MIRNA%GOBP%GO:2000637,0.335129451964779,0.698243193474341,-0.278069350915868,-1.09862606388572,2549,19,PUM1|MAP2K2|AJUBA|TGFB1|DHX9|FMR1|STAT3|FXR1|DDX5|WTIP|EIF4G1
CELLULAR RESPONSE TO MAGNESIUM ION%GOBP%GO:0071286,0.586904761904762,0.84145520149534,-0.46233594353148794,-0.9028249191538109,4436,3,FBP1|ANK3|SLC41A1
POSITIVE REGULATION OF RENIN SECRETION INTO BLOOD STREAM%GOBP%GO:1900135,0.890969899665552,0.965159112268525,-0.5567931186590209,-0.7417821279658889,6659,1,F2RL1
POSITIVE T CELL SELECTION%GOBP%GO:0043368,0.8776470588235301,0.960725750963158,-0.19742272764226299,-0.660792354424662,6713,12,ZAP70|CD3E|SLAMF6|LY9|CD3D|CD3G|IL6|FOXP3|BATF|SPN|STAT3
POLYOL METABOLIC PROCESS%GOBP%GO:0019751,0.14050493962678398,0.505299089068223,0.216011125641738,1.26367735918786,1023,68,PLCD1|CYP27B1|PLCD4|INPP1|SPR|INPP5K|COQ2|INPP5J|PTS|FGF2|SORD|PLCD3|IMPA1|PLCB4|QDPR|INPP4A|ASAH2B|INPPL1|PLCG1|ITPKC|ISYNA1
REGULATION OF NEUTROPHIL DEGRANULATION%GOBP%GO:0043313,0.15661375661375698,0.5259991179339351,-0.670398147126944,-1.3091176696270101,1183,3,SYK|ITGB2|ITGAM
REGULATION OF MRNA POLYADENYLATION%GOBP%GO:1900363,0.0035326442496401897,0.0627053820131739,-0.5129933405677379,-1.94949996518797,26,17,CCNT1|CPEB3|HSF1|CPSF6|ZC3H14|NCBP2|NCBP1|CTR9|RNF20|CPEB1|RNF40|CPSF7
ENDOTHELIAL TIP CELL FATE SPECIFICATION%GOBP%GO:0097102,0.14911575562701002,0.5157600394920371,0.7721532947339399,1.29731723190046,1112,2,DLL1|NRP1
REGULATION OF PROTEIN DEPHOSPHORYLATION%GOBP%GO:0035304,0.385071548278974,0.7322123809952751,-0.186370375425254,-1.04513247438811,2986,61,PPP1R15A|DUSP26|GSK3B|GBA|ROCK1|SPPL3|PPP1R7|TNF|TGFB1|PPP1R2|PTBP1|NCKAP1L|HSP90B1|PPP1R8|BOD1|LILRB2|NUAK1|ENSA|PPP6R3|NSMF|CRY2|PPP2R4|CD300A|DLC1|LGALS3|PDGFRB|FKBP1A|SMPD1|STYXL1
RNA LOCALIZATION TO NUCLEUS%GOBP%GO:0090685,0.988953182535508,0.9961107928457941,-0.207652878548485,-0.49770432606439596,7519,5,DKC1
POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION%GOBP%GO:0048711,0.315398645127671,0.6851935987509761,-0.372586259262476,-1.1208306667106498,2420,9,HES1|NOTCH1|SERPINE2|BMP2
PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:0006626,0.0157793457344452,0.170321316621193,-0.311449566443972,-1.6630593050005502,122,51,TOMM70A|TIMM21|ROMO1|AIP|IMMP1L|TIMM10B|TIMM9|TIMM17B|HSP90AA1|TOMM5|HSPA4|TIMM10|UQCRC2|DNAJC19|DNAJC15
REGULATION OF PROTEIN REFOLDING%GOBP%GO:0061083,0.7065916398713828,0.894843171056815,0.49255874541296296,0.8275622891276899,5273,2,SNRNP70
NEGATIVE REGULATION OF GLUCONEOGENESIS%GOBP%GO:0045721,0.5965346534653471,0.844613508628182,-0.293171301304826,-0.8819310345807241,4578,9,FAM132A|PGP|INS|SIK1
REGULATION OF RESPONSE TO BIOTIC STIMULUS%GOBP%GO:0002831,0.0329501915708812,0.259512489684881,-0.24970523410015502,-1.5069191621751201,257,81,LY86|PVRL2|TNFAIP3|DDX60|MB21D1|IFIT1|APOBEC3G|CARD16|NPLOC4|TMEM173|CEACAM1|SASH1|CD36|FOXP1|IFNLR1|CX3CL1|TRAF3|DHX58|CD55|FAM3A|PQBP1|APOBEC3F|RNF26
NEGATIVE REGULATION OF COAGULATION%GOBP%GO:0050819,0.00013080444735121002,0.00518555396908895,-0.560953200784278,-2.56120249314901,0,30,CD34|GP1BA|PLAU|VTN|HS3ST5|CEACAM1|THBD|APOE|PLAUR|NOS3|SERPINE2|SERPINE1|PLAT|PDGFA|ANXA2|PDGFRA|TFPI|PDGFB|SERPINF2|C1QTNF1
GLYCINE RECEPTOR CLUSTERING%GOBP%GO:0072579,0.0363879598662207,0.271450902407424,-0.981638729598588,-1.30777849318447,271,1,GPHN
RNA EXON LIGATION%GOBP%GO:0000378,0.973568867047417,0.9920058127185359,0.512130569033966,0.682857010566275,7329,1,RTCB
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000725,0.541440953412784,0.815622645995152,0.251966943757343,0.9294021907987049,3997,15,DKK1|SOX6|EFNB2
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903169,0.200138985406532,0.577942761520067,0.19493042266165198,1.18712837641066,1439,80,FKBP1B|CRHR1|BIN1|ANK2|XCL1|GSTM2|C19orf26|DMD|DRD4|UBASH3B|GNB5|HTT|CACNB4|SRI|LIME1|CACNA1C|HAP1|PTK2B|PKD2|RAMP3|YWHAE|CACNB2|PLCG1|CXCL9|CAMK2D|SESTD1|JPH3
DEFENSE RESPONSE TO GRAM-POSITIVE BACTERIUM%GOBP%GO:0050830,0.000782574670666493,0.0191134260247744,-0.480648235085774,-2.11989353632065,5,27,HLA-E|RPL39|HIST1H2BE|TNFRSF14|GSDMD|HMGB2|TLR2|FGR|PLA2G2A|HIST1H2BC|ROMO1|RNASE6|CHGA|RARRES2|HIST1H2BG|HIST2H2BE|HIST1H2BK|HIST1H2BJ
NETRIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0038007,0.0927170115560333,0.421303871141266,0.7195133296214891,1.4151978112063301,689,3,SHTN1|UNC5A|PTK2
CELL-CELL SIGNALING INVOLVED IN CELL-CELL JUNCTION ORGANIZATION%GOBP%GO:1901350,0.8793311036789301,0.960922253956646,-0.562803264225849,-0.74978908498196,6572,1,TJP1
REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION%GOBP%GO:0010749,0.7779960707269159,0.924704689181848,-0.28931956827516997,-0.7442078682755551,5939,6,INS|THBS1
EPITHELIAL CELL MIGRATION%GOBP%GO:0010631,0.0005180005180005179,0.0139121625154964,-0.36061508680965504,-2.00340075546946,3,59,KDR|PLXND1|CYP1B1|PKN1|ARSB|NUP188|TNFSF12|PXN|ABL1|PIK3R3|DPP4|FAP|STARD13|KANK2|CORO1B|GIPC1|NOS3|NOV|SRF|SLIT2|ID1|ADGRA2|MYH9|EPHB4|LOXL2|EMP2|PTP4A3
REGULATION OF PURKINJE MYOCYTE ACTION POTENTIAL%GOBP%GO:0098906,0.602943143812709,0.8480120088902141,-0.7022496691662989,-0.93556517941905,4506,1,GJA5
RESPONSE TO LIPID%GOBP%GO:0033993,0.000385752861000386,0.0111294649577428,-0.206798636544278,-1.64388968637817,2,322,IL18|IRAK3|NR3C1|CCL19|REST|HMGB2|TBX1|ZFP36L1|BCL2L11|MED13|AQP3|DAB2IP|IFNAR1|PID1|FGFR4|FZD4|GOT1|RORA|PDCD1LG2|SMO|NR1D2|MED1|HNRNPU|ATP1A3|TICAM2|AHR|TNFRSF11A|IL1RN|GGT1|TGFB3|BRINP3|PDE4B|CASP1|ERBB2IP|TNFAIP3|ABCG1|THRA|ADCY8|LILRB2|TESC|MAPKAPK2|CRHBP|PTGER4|MEF2C|STAT3|BRCA1|DDX5|MSN|SNW1|CTR9|SLC11A1|PIM1|SPP1|CARD16|CALR|IRAK1|NR1H3|RAN|WBP2|CCL2|CTSH|NCOA4|GPER1|F2R|CD86|RBM14|NLRP3|CDK7|AXL|NOS3|HCK|CD36|TGFBR2|TGFBR3|OTUD5|LGALS9|THBS1|H2AFZ|FHL2|NR1D1|PDK3|PPAP2A|PABPN1|SLIT2|FOXP1|TICAM1|CCRN4L|SERPINE1|CAV1|FAM107A|PPARG|PPARA|PLAA|YAP1|NFKB1|TLR4|VIM|WNT3|KAT5|ANXA1|ALPL|TFPI|GSTP1|PHB|CD14|LY96|TNFRSF1B|SSTR2|HNRNPA0|SIRPA|INSIG1
NEGATIVE REGULATION OF STORE-OPERATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901340,0.29150501672240803,0.663837153945439,-0.851179973533304,-1.13397610511086,2178,1,UBQLN1
REGULATION OF TELOMERIC HETEROCHROMATIN ASSEMBLY%GOBP%GO:1905547,0.7953177257525079,0.929656485793048,-0.606473312748125,-0.807968075410657,5944,1,SIRT6
SEMINAL CLOT LIQUEFACTION%GOBP%GO:0070684,0.726020066889632,0.904507509799082,-0.6411557123952359,-0.8541733594758729,5426,1,KLK14
DOXORUBICIN TRANSPORT%GOBP%GO:1900753,0.823678929765886,0.941760803523009,-0.591916629907367,-0.7885750786010921,6156,1,RALBP1
POSITIVE REGULATION OF PENILE ERECTION%GOBP%GO:0060406,0.764510559171205,0.9191113740914171,0.6177767975297751,0.82372200111806,5755,1,VIP
REGULATION OF INTERLEUKIN-4 BIOSYNTHETIC PROCESS%GOBP%GO:0045402,0.7870788007429029,0.9276917050905171,-0.468998886906289,-0.7804891463729592,5932,2,CD86
NUCLEAR PORE DISTRIBUTION%GOBP%GO:0031081,0.926719576719577,0.9790847380319629,-0.316127492211222,-0.617316870104986,7005,3,SEC13
SINOATRIAL NODE DEVELOPMENT%GOBP%GO:0003163,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
NEGATIVE REGULATION OF TELOMERE CAPPING%GOBP%GO:1904354,0.705301595888558,0.894639008000397,0.287158677174614,0.7926938205510649,5214,7,SMG6|ATM|ERCC1
CHOLESTEROL METABOLIC PROCESS%GOBP%GO:0008203,0.0142045454545455,0.159485747303544,-0.317075995833765,-1.6706408723891801,109,49,ABCG1|CYP51A1|CETP|HMGCR|CYP46A1|SCARF1|APOE|HMGCS1|EBP|DHCR7|DHCR24|CNBP|NSDHL|TM7SF2|OSBPL5
TUBE DEVELOPMENT%GOBP%GO:0035295,0.000127697612054655,0.00518555396908895,-0.23419508669536,-1.83899854840157,0,296,JAG1|IL18|ADAM8|LMO4|EPHB3|TBX1|SAT1|SOX18|RYR2|PCSK5|DAB2IP|COL23A1|SOX17|FGFR4|KDR|PLXND1|LRP1|FOXN4|CD34|RORA|SMO|APOLD1|MED1|SFRP2|CYP1B1|EGFL7|COBL|GATA3|SDCCAG8|PRCP|ATPIF1|TBX2|VEGFC|TGFB3|THY1|HES1|MESP1|ITGA5|ATP5B|THRA|MYLK|FLT4|NOTCH1|CELSR1|MEF2C|CEBPA|CHRD|CALCRL|ATP6AP2|BCAS3|HOXB3|RCN3|MICAL2|FGF10|COL4A1|JMJD6|HMOX1|LOX|PIK3R3|LRP5|STARD13|CCL2|CTSH|CEACAM1|PDPN|ROBO4|EPHA2|EDNRB|APLNR|ALDH1A2|DLC1|DEAF1|GATA6|VEGFB|NOV|CCBE1|NRP2|LUZP1|ADIPOR2|TGFBR2|BMP2|TGFBR3|THBS1|TEK|ATOH8|FGF7|SEMA5A|SRF|PDGFRB|SEMA3E|RARRES2|ERRFI1|SLIT2|ID1|DNAAF1|SERPINE1|CAV1|ADGRA2|MYC|RASIP1|MYH9|CHD8|ANG|EPHB4|DACT1|TGFBI|ADGRG1|PDGFA|ANXA2|CSF1R|PDGFRA|ENG|ACVRL1|LOXL2|ITGB4|SERPINF2|MTHFD1
INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0032958,0.8023366390436079,0.932946245893631,0.33570341660051695,0.7375547030872209,5905,4,FGF2|PPIP5K1|PPIP5K2
MALE GAMETE GENERATION%GOBP%GO:0048232,0.00903154091982771,0.119944947211922,0.2271667781698,1.5645738250691,64,139,TDRD12|NPHP1|SPAG6|TSGA10|DDX25|TDRD6|LRGUK|BBS4|SPATA6|CFAP44|CFAP43|PSME4|IFT20|TSSK6|ZNF296|KIT|C14orf39|C9orf117|AZIN2|IQCG|BRCA2|IFT81|NME5|CHD5|WDR33|TDRP|PCSK4|CEP57|HSPA2|MKKS|TRIM27|C1orf111|HERC4|NDRG3|DNAH1|XRN2|ELL3|MAST2|SPATA2|CATSPER2|IFT27|BBS2|TEX14|DPY19L2|METTL14
APOPTOTIC CELL CLEARANCE%GOBP%GO:0043277,0.113051470588235,0.46074941938046904,-0.34300605605027007,-1.37613372712991,860,20,FCN3|RAB14|LRP1|TXNDC5|GAS6|FCN1|NR1H3|THBS1|TGM2|ADGRB1
RRNA 5'-END PROCESSING%GOBP%GO:0000967,0.9367105616769681,0.9806508984207809,0.308539336757099,0.6068604653640021,6970,3,UTP20|NOP14
NEGATIVE REGULATION OF MEMBRANE TUBULATION%GOBP%GO:1903526,0.6714898177920691,0.8815356925073421,0.510780259167356,0.8581767849099441,5011,2,WASL|DNM2
REGULATION OF CHONDROCYTE DEVELOPMENT%GOBP%GO:0061181,0.538699274388605,0.8142313733497609,0.473434316646356,0.931189431918314,4008,3,FAM101B|FAM101A|PTHLH
POSITIVE REGULATION OF SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION%GOBP%GO:0045887,0.195112232700226,0.5697855203224189,0.9043890604322891,1.20588078028726,1468,1,AGRN
"FAST, CALCIUM ION-DEPENDENT EXOCYTOSIS OF NEUROTRANSMITTER%GOBP%GO:0098746",0.892548811263116,0.965443067117994,0.5528782531980589,0.737188549197678,6719,1,SYT1
MITOCHONDRIAL THREONYL-TRNA AMINOACYLATION%GOBP%GO:0070159,0.809669278788684,0.9347733010395931,0.5952801058667839,0.7937256983283271,6095,1,TARS2
PERICARDIUM DEVELOPMENT%GOBP%GO:0060039,0.950446898002103,0.985300779592887,-0.208939782730417,-0.571127578556989,7230,7,NOTCH1|BMP2
THREONINE TRANSPORT%GOBP%GO:0015826,0.43777394076238496,0.7635570545514341,0.782697397441553,1.04362136789279,3295,1,SLC1A4
PROLINE TRANSPORT%GOBP%GO:0015824,0.38131927547985905,0.729499056535481,0.437391111091195,1.05192311395017,2820,5,SLC6A17|SLC1A4|SLC36A4
DETECTION OF BIOTIC STIMULUS%GOBP%GO:0009595,0.0418300653594771,0.293009782616793,-0.481059338709234,-1.61015064901573,319,12,C4B|TLR1|TLR2|SMO|SSC5D|NLRP3|TLR4|LY96
REGULATION OF CELLULAR SENESCENCE%GOBP%GO:2000772,0.716816464764882,0.899704384028684,-0.18911815946747898,-0.8153148848238242,5502,25,RBL1|EEF1E1|NEK4|VASH1|ARNTL|CDK6|MAP3K3|TERF2|YPEL3|TERT|CDKN2A|NUAK1|MB21D1|NEK6
HISTONE DEUBIQUITINATION%GOBP%GO:0016578,0.705897737674905,0.894639008000397,-0.19778606999793696,-0.8190835781567021,5397,22,UIMC1|USP15|USP16|BRCC3|USP51|MYSM1|TAF10
PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0009221,0.5485528807140929,0.819021299811223,0.329255961214635,0.9089022431863871,4055,7,DCTD|CDADC1|DUT|DTYMK
POSITIVE REGULATION OF EPINEPHRINE SECRETION%GOBP%GO:0032812,0.44399785637727796,0.766503259003379,0.6178108629721529,1.03800201858264,3313,2,CARTPT|VIP
RESPONSE TO MERCURY ION%GOBP%GO:0046689,0.246882462191563,0.6280519349499749,-0.709842845326716,-1.18129200702922,1860,2,AQP1|PARK7
REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION%GOBP%GO:0034091,0.702291070033845,0.893221903911413,-0.27796503211443396,-0.8002224233491351,5394,8,ANKRD32|NAA10|H2AFY
NUCLEOID ORGANIZATION%GOBP%GO:0090143,0.655250836120401,0.874775007199212,-0.675948389942656,-0.900525560183585,4897,1,CHCHD10
REGULATION OF SYNAPSE MATURATION%GOBP%GO:0090128,0.0893043933054393,0.412774227611326,-0.46775083505162107,-1.46540230581456,682,10,CDC20|ANAPC2|DAB2IP|CAMK2B|ARHGEF15|ADGRL1
REGULATION OF HAIR CYCLE BY CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0060901,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0070588,0.869492614001285,0.956852095187406,-0.12475012022983697,-0.747282702630997,6768,79,CCL19|RYR2|ITPR2|CCDC109B|ATP2A1|P2RX4|ERO1L|ITPR3|SLC8B1|PMPCA|GAS6|ATP2A3|GRIN1|CACNA2D4|CACNA1G|NALCN|SLC24A3|F2R|TMCO1|GRIN2C|GRIN2D|FKBP1A|STOML2|PHB
REGULATION OF POSTSYNAPSE ORGANIZATION%GOBP%GO:0099175,0.00912527701733803,0.12051332749931,-0.37612149222425295,-1.7663727053342801,69,33,SHISA7|FCGR2B|INS|DHX36|LILRB2|EFNA1|ARHGAP44|DBN1|NGEF|CAMK2B|APOE|EPHA4|CFL1|CAPRIN1|PRNP
L-FUCOSE METABOLIC PROCESS%GOBP%GO:0042354,0.950315457413249,0.9852369031063491,-0.20904744147246,-0.5714218589273911,7229,7,FUT4|FUT7|FUT9
POSITIVE REGULATION OF ISOMERASE ACTIVITY%GOBP%GO:0010912,0.00236593059936909,0.0452973140533542,-0.730226144511859,-1.99604060205309,17,7,DHX9|SETMAR|ITGB2|HNRNPU|PLSCR1|UHRF1|ITGAM
NECROPTOTIC PROCESS%GOBP%GO:0070266,0.0143828451882845,0.16072489822076902,-0.45058127165079,-1.7484229096694397,109,18,RIPK3|PGAM5|PPIF|TICAM2|MLKL|FADD|ITPK1|TICAM1|TLR4|CD14|LY96
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE%GOBP%GO:2000009,0.743676910524884,0.9108818367874129,0.245157629808068,0.776675942685453,5468,10,SNX33|NEDD4L|LEPROTL1|PICALM|COMMD1|LEPROT|ACTN2
OUTFLOW TRACT SEPTUM MORPHOGENESIS%GOBP%GO:0003148,0.673710460690379,0.882488012133495,-0.207185180734379,-0.8440739181153929,5132,21,TBX1|ZFPM2|SMAD6|TBX2|GATA6|NRP2|TGFBR2|ENG
NEGATIVE REGULATION OF TISSUE REMODELING%GOBP%GO:0034104,0.764344262295082,0.9191113740914171,0.260139183935406,0.7551385406407779,5594,8,SFRP1|UBASH3B
'DE NOVO' GDP-L-FUCOSE BIOSYNTHETIC PROCESS%GOBP%GO:0042351,0.982047159699893,0.993436724391485,0.30625722851551695,0.514551686377454,7329,2,GMDS
ACTIN CORTICAL PATCH ORGANIZATION%GOBP%GO:0044396,0.9684348395546821,0.9912626134248801,-0.21438420384976,-0.5514539244273959,7393,6,WIPF1|WIPF2|WASL|TIGD5|WIPF3|WAS
REGULATION OF AMYLOID-BETA FORMATION%GOBP%GO:1902003,0.18123275068997197,0.554889181766802,-0.32079591763373105,-1.26743474295082,1378,19,EFNA1|GGA3|APOE|EPHA4|TMED10|PRNP
CHOLESTEROL IMPORT%GOBP%GO:0070508,0.43963703314045205,0.7650340344477281,-0.418231760675385,-1.00242172437338,3342,5,CD36|LDLR
NEGATIVE REGULATION OF CELL KILLING%GOBP%GO:0031342,0.0659197498697238,0.369007394574627,-0.506419653267729,-1.52343427460534,505,9,SERPINB9|MICA|LILRB1|HLA-E|FCGR2B|CEACAM1|LGALS9
ASTROCYTE DIFFERENTIATION%GOBP%GO:0048708,0.338258368200837,0.6998037279675999,-0.349747225088258,-1.0957124000431,2586,10,APP|MAPT|TNF|EIF2B5|PSEN1|CDK6|LRP1|STAT3
SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT%GOBP%GO:0070296,0.265079794427915,0.640406488040947,0.426397648297282,1.17705926294274,1959,7,ANK2|NOL3|RYR1
SPECIFICATION OF URETERIC BUD ANTERIOR/POSTERIOR SYMMETRY%GOBP%GO:0072100,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
NUCLEAR DNA REPLICATION%GOBP%GO:0033260,0.0293312475557294,0.24279324540366198,-0.34021521711363,-1.59774670119247,224,33,RFC2|RPA2|RFC3|DONSON|CDT1|POLD4|PCNA|GMNN|POLD1|CDC45|POLD2|RFC5|GINS1|POLA1|RFC4|POLA2|FEN1
RIBOSE PHOSPHATE METABOLIC PROCESS%GOBP%GO:0019693,0.00012809017548354,0.00518555396908895,-0.227310332688488,-1.7983179071175,0,311,NDUFB5|NADK|TKT|CROT|SURF1|ACSL5|ATP1B1|ABHD14B|UQCR10|ACOT1|PARP1|NDUFA9|ATP5J|NDUFA7|ACSF2|DCAKD|GPI|ATP5F1|FAR1|COASY|OPA1|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|PDHA1|NDUFA3|NDUFB6|ACSF3|ATP5B|HK3|ADCY8|PDE4D|SDHD|NPR2|ELOVL1|CYCS|SLC26A2|NDUFB9|COA6|NUDT16|PDE2A|ENO1|NDUFB10|SDHA|ADCY4|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|CTPS1|PGAM1|HPRT1|TPST2|MOCS2|PRPS1|MBIP|EPHA2|NPR1|RFK|GAPDH|NDUFS6|COQ7|HMGCS1|NUDT18|UMPS|NDUFB4|HACD2|NUDT4|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|ACOT2|STOML2|PDHX|ABCD1|NDUFA4|HINT1|ATP5H|NDUFV1|UQCRQ|SULT1A4|PGK1|NDUFS3|GPHN|TALDO1|UQCRC2|FASN|COX6A1|UQCC3|NDUFA8|ADCY9|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN%GOBP%GO:0050966,0.89002523575508,0.965159112268525,0.554642699603,0.7395412003968729,6700,1,SCN1A
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY VASOPRESSIN%GOBP%GO:0001992,0.78801965732501,0.927797067038212,0.6056462284958101,0.807547524123596,5932,1,OXTR
HOMEOSTASIS OF NUMBER OF CELLS%GOBP%GO:0048872,0.00764050764050764,0.106600208116636,-0.312335117966146,-1.73518090113435,58,59,FLVCR1|AKT1|FOXP3|UBAP2L|JAK3|DOCK11|ACIN1|DOCK10|LYN|GPR183|CEBPG|NCKAP1L|RIPK3|DYRK3|HCLS1|MED1|ATPIF1|PDE4B|TNFAIP3|INHBA|RPS14|MEF2C|HSPA9|TAL1|HMOX1|SOD1|F2R|NOS3|NOV|TGFBR3|FADD|ANXA1
REGULATION OF PROTEIN TRANSPORT%GOBP%GO:0051223,0.000253678335870117,0.00819882332206558,-0.19996083594952102,-1.64215405993148,1,394,LILRB1|NPEPPS|HLA-E|RGCC|INHBB|ADAM9|CEMIP|PSEN1|HYAL2|LGR4|DHX9|NDFIP1|SP100|FIS1|TLR1|PYCARD|APOD|GNB2L1|TNFRSF14|GSDMD|DISP1|PER2|ARHGEF5|ADAM8|CCL19|REST|SREBF2|RHBDF2|GAPVD1|ACHE|CAMK1|JUP|ECT2|ITGB2|PPM1F|ITPR2|TRIM28|PIM3|STX4|TLR2|STXBP4|PPIA|MICALL2|FGR|CNST|HCLS1|CD34|WLS|GIPR|ITPR3|GDI1|SLC2A1|SLC8B1|ATG13|GPI|CDK16|SSC5D|GATA3|SYT7|ATPIF1|PDCD5|DNAJC1|FCGR2B|MYOM1|GAS6|TGFB3|SCFD1|PRR5L|INS|CASP1|MDFIC|UBE2G2|RAB29|TNFAIP3|DHX36|ADCY8|SLC25A6|BAG3|PTGER4|IRS1|PARK7|HAX1|IFIH1|PDE2A|BCAS3|ENSA|ANP32B|OSM|CARD16|GHRL|HUWE1|RSAD2|CEP131|SRGN|RAPGEF3|TNFRSF4|FLNA|UQCC2|HRAS|IGF1|DPP4|FCN1|NR1H3|LRP5|RBM22|TMEM173|IL33|GPER1|CACNA1E|F2R|RAP1A|FN1|GAPDH|NLRP3|NOV|ZC3H3|CHGA|TNFRSF21|CD200|LGALS9|ADRA2C|NR1D1|ARL2|B3GAT3|FOXP1|SLC25A4|BCAP31|CX3CL1|SIRT4|DNAJA1|HAVCR2|ANG|DERL3|TLR4|SERGEF|ITGAM|RAB11FIP1|PARL|CSF1R|C1QTNF4|ANXA1|RHOU|TMSB4X|SAR1B|CD14|EMD|TNFRSF1B|EFNA5|BAD|INSIG1|SLC25A5|PRNP
GOLGI CALCIUM ION HOMEOSTASIS%GOBP%GO:0032468,0.621672240802676,0.856075054950132,-0.6933722981914421,-0.9237383896980649,4646,1,ATP2C1
ESTABLISHMENT OF PLANAR POLARITY%GOBP%GO:0001736,0.8912631863673249,0.9651611606244209,0.23537423828498602,0.6497442669718381,6589,7,PTK7|BRSK1|FUZ|BRSK2
POSITIVE REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:1905168,0.262522057825438,0.638240557311977,0.45596612084876204,1.1798391372239199,1933,6,MMS19|ACTR2|WRAP53
VALINE METABOLIC PROCESS%GOBP%GO:0006573,0.346551498494961,0.7036831003647691,-0.505904723179351,-1.10753119212719,2647,4,BCAT2
MONOCARBOXYLIC ACID TRANSPORT%GOBP%GO:0015718,0.199248120300752,0.577166177580918,-0.208633829983308,-1.2014988719353001,1536,68,FABP3|SLC9A3R1|SLC16A13|SLCO2B1|ATP8B1|SLC51A|SLCO2A1|CEACAM1|LCN12|LCN1|APOE|FABP4|CD36|SLC27A4|PPARG|PPARA|RPS6KB1|ABCD1|ANXA1|MPC1
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION%GOBP%GO:0060043,0.30770238407126,0.679357310039213,-0.34798086782771603,-1.1266067816590801,2348,11,TBX2|NOTCH1|MEF2C|PIM1|TGFBR3
REGULATION OF PROTEIN KINASE C SIGNALING%GOBP%GO:0090036,0.54833246482543,0.818959666222967,-0.305541963029031,-0.9191450130442329,4208,9,CD40|MC1R|GPD1L|FLT4|ADGRV1
SENSORY PERCEPTION OF TOUCH%GOBP%GO:0050975,0.445484949832776,0.7671494493272959,-0.7792236435818259,-1.0381129958817499,3329,1,P2RX4
ESOPHAGUS SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014846,0.829448017148982,0.943504776751861,0.43268041190571993,0.7269589576309359,6190,2,SULF2
RESPONSE TO ANTIMETABOLITE%GOBP%GO:0097329,0.255732152162585,0.6348055504295711,-0.39444445259276795,-1.1865854625315602,1962,9,ATRX|BLM|TIMELESS|NDNL2|FMR1|KAT7|DHFR
POSITIVE REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS%GOBP%GO:0071673,0.134046822742475,0.495641459539577,-0.932068813409793,-1.24173946238219,1001,1,AIF1
ECTODERM DEVELOPMENT%GOBP%GO:0007398,0.512355415352261,0.802184867798321,-0.3471822729055639,-0.949007260614905,3897,7,ITGAM|AMER2
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098901,0.18368456832087,0.556308895147568,0.300625142843125,1.2581019486595801,1350,22,TRPM4|BIN1|ANK2|RANGRF|RNF207
REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION%GOBP%GO:0060304,0.633684779670181,0.8631726958478259,0.353086573584003,0.8491711846906729,4687,5,MTMR9|MTMR2|MTMR3
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM MEMBRANE%GOBP%GO:0097051,0.0999731255038968,0.43605057892447596,0.712917245785059,1.40222409268918,743,3,RAB10|RAB3GAP1
CLATHRIN-COATED PIT ASSEMBLY%GOBP%GO:1905224,0.778058175056448,0.924704689181848,0.6103881782090871,0.8138702742214321,5857,1,GAK
REGULATION OF LUNG BLOOD PRESSURE%GOBP%GO:0014916,0.52756010094302,0.810052447666581,0.7351676224084692,0.980246826214485,3971,1,BMPR2
REGULATION OF PLASMA MEMBRANE RAFT POLARIZATION%GOBP%GO:1903906,0.17632107023411397,0.548366806412612,-0.9091310101455671,-1.21118080074288,1317,1,GSN
MAMMARY GLAND BUD MORPHOGENESIS%GOBP%GO:0060648,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
REGULATION OF GLYCOGEN (STARCH) SYNTHASE ACTIVITY%GOBP%GO:2000465,0.6754420432220041,0.882488012133495,-0.318893109289226,-0.8202789824647551,5156,6,PPP1R3F
MITOTIC G2/M TRANSITION CHECKPOINT%GOBP%GO:0044818,0.898302872062663,0.967428248648255,-0.15712702779474602,-0.659710633432499,6880,23,CLSPN|DONSON|NBN|CDC6|RAD17|ORC1|TAOK2|TOPBP1
POSITIVE REGULATION OF LENS EPITHELIAL CELL PROLIFERATION%GOBP%GO:2001111,0.682408026755853,0.885415243771438,-0.662715041905602,-0.88289556308398,5100,1,SOX11
CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0060351,0.001308386759126,0.0284733155294161,-0.54452655949672,-2.06933389741071,9,17,COL20A1|COCH|ANXA6|VWA1|COL14A1|COMP|COL12A1|COL6A3|COL21A1|COL6A1|ANXA2|COL6A2
NUCLEAR RETENTION OF UNSPLICED PRE-MRNA AT THE SITE OF TRANSCRIPTION%GOBP%GO:0071048,0.15179528403001097,0.519162563817466,0.769183539624649,1.29232765987625,1132,2,EXOSC10|PRPF18
MODULATION OF DEVELOPMENT OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044145,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION%GOBP%GO:0045651,0.808513407966675,0.934193159096917,-0.249543365232343,-0.7184004223046109,6210,8,LIF|TGFB1|IL34|CSF1|FADD
PROLINE CATABOLIC PROCESS%GOBP%GO:0006562,0.248607057574954,0.629153649220478,-0.708309822228432,-1.17874081144485,1873,2,ALDH4A1
REGULATION OF T CELL ACTIVATION%GOBP%GO:0050863,0.000128122998078155,0.00518555396908895,-0.280882785633188,-2.02721691590276,0,183,CLPTM1|HSPH1|IL1B|AKT1|FOXP3|CD1D|HLA-DMB|CDC42|PAK2|JAK3|SYK|NFATC2|RAC1|CD274|DUSP3|NFKBIZ|PRDM1|HLA-DPA1|LILRB1|HLA-E|LYN|NDFIP1|CD209|PYCARD|TNFAIP8L2|NCKAP1L|TNFRSF14|IL18|ADAM8|RUNX1|RIPK3|CCL19|TWSG1|RUNX3|CCDC88B|HLA-DPB1|CD4|PDCD1LG2|VAV1|SPN|GATA3|TNFRSF18|EBI3|FCGR2B|PLA2G2D|THY1|IL6ST|PRELID1|MAPK8IP1|RC3H2|LILRB2|GPNMB|GRB2|PRKAR1A|SOCS1|PTPN6|CD47|IL2RA|SDC4|ABL1|SOD1|IGF1|DPP4|CEBPB|NKAP|ICOSLG|VCAM1|C10orf54|CCL2|CEACAM1|CD300A|HFE|GSN|CD86|NLRP3|LGALS3|TGFBR2|TNFRSF21|LGALS9|ZP3|FADD|AIF1|CAV1|HAVCR2|BCL6|LILRB4|PNP|ANXA1|CD55|NCK1|TFRC|TNFRSF1B|SART1|SIRPA|PRNP
REGULATION OF MYELOID DENDRITIC CELL CHEMOTAXIS%GOBP%GO:2000527,0.708194979412937,0.89516234575314,0.645235994706661,0.860335135405528,5331,1,CCL21
GLYCOGEN CATABOLIC PROCESS%GOBP%GO:0005980,0.268561327168888,0.6426302758624399,0.3677681861415061,1.1651144730220901,1974,10,PYGB|FAM47E-STBD1|AGL|PGM2L1|PGM1|PGM2
PRESYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:0097090,0.591966459291317,0.8417378833576942,0.31787093215664597,0.8774741760638539,4376,7,PTPRD|NLGN2|NLGN4X|CNTN2|NLGN4Y|PTEN|NLGN3
REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION%GOBP%GO:1902033,0.21545985599782602,0.598595986441873,0.5657055566340511,1.2428791999889799,1585,4,N4BP2L2|PDCD2|EIF2AK2
MULTICELLULAR ORGANISM AGING%GOBP%GO:0010259,0.49063523248199103,0.7904081687771529,-0.37511549323666704,-0.964898099506643,3745,6,CISD2|COQ7
POSITIVE REGULATION OF LIPID METABOLIC PROCESS%GOBP%GO:0045834,0.0183884561358703,0.18646534178457302,-0.258827598971707,-1.5780125863968602,143,84,EPHA8|INS|PNPLA2|NSMAF|FABP3|ABCG1|IRS1|PRKD1|ABHD5|NR1H3|CREBL2|PIK3R4|APOE|SLC45A3|ZP3|TEK|NR1D1|PDGFRB|SIRT4|LDLR|STOML2|PPARA|ABCD1|PDGFRA|ANXA1|TNFRSF1A|AMBRA1|CD81|PDGFB
CD40 SIGNALING PATHWAY%GOBP%GO:0023035,0.20096463022508,0.579014481760187,0.7361733008819209,1.23686619666402,1499,2,TNIP2|RNF31
NEGATIVE REGULATION OF ODONTOGENESIS%GOBP%GO:0042483,0.45210931281507,0.769943206592495,-0.6185277088502901,-1.02932901754422,3407,2,ASPN|BCOR
NEGATIVE REGULATION OF ALPHA-BETA T CELL PROLIFERATION%GOBP%GO:0046642,0.40917455310199796,0.7448505271608159,-0.380575843381276,-1.04028709634525,3112,7,CD274|TNFRSF14|TWSG1|C10orf54|LGALS9
TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0070897,0.5219326960848499,0.807051143864932,-0.274065396547343,-0.9433862421997741,3985,13,GTF2A2|TAF12|TAF7|MED6|BDP1
SUPPRESSION BY VIRUS OF HOST CATALYTIC ACTIVITY%GOBP%GO:0039513,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
MITRAL VALVE FORMATION%GOBP%GO:0003192,0.3916666666666671,0.7371240382543249,-0.548465862810729,-1.07101482196787,2960,3,NOTCH1|DCHS1
DEFINITIVE HEMOPOIESIS%GOBP%GO:0060216,0.0187295350360183,0.18846367741286396,-0.660596940626711,-1.69923328692922,142,6,MFAP5|TGFBR3|TEK
INTESTINE SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014827,0.545623588790012,0.817297924969912,0.725738861932069,0.9676748463687891,4107,1,PTGER3
CATION HOMEOSTASIS%GOBP%GO:0055080,0.000256278831368529,0.00819882332206558,-0.22257858972456798,-1.7922427169533999,1,347,PPT1|PML|CCL11|CEMIP|PSEN1|PLCE1|CLN6|SLC39A13|SLC9A5|NDFIP1|FIS1|NEO1|ATP6V0A1|MT1G|B2M|OCM|EDNRA|CCL19|SLAMF8|HSP90B1|FPR3|LPAR6|RYR2|GPR89B|TCIRG1|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|SLC12A8|ATP6V0A2|ERO1L|PTGER1|RAB7A|PLN|ITPR3|SLC8B1|ATP1A3|SLC12A2|ATP1B3|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|ATP5B|ADCY8|CXCR4|JPH4|CALB2|CCDC22|TAC1|CALCB|DMXL1|RMDN3|ATP6V0D1|ABCB7|HAMP|CA2|SEPN1|SLC9A1|PTGER4|TBXA2R|SLC9A7|SLC11A1|GHRL|ABL1|CALR|ACO1|HERPUD1|HMOX1|SOD1|SKP1|SLC35G1|ARF1|SLC9A9|MT1M|CCRL2|P2RY6|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|FTL|APLNR|GNA15|TMCO1|MTL5|CD36|F2RL3|ATP6V0E1|GRIN2C|FXN|MT2A|XIAP|TGM2|GRIN2D|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|ATP1B2|PRKACA|KCNH2|ATP6V0E2|S100A8|S100A9|RAB20|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|SLC7A8|TFRC|ATP6V1A|ATP6V1G1|FAM20A|C5AR1|FTH1|C1QTNF1|PRNP
BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS%GOBP%GO:0001569,0.0860130718954249,0.4057980029059221,-0.437125711668691,-1.4631006857352098,657,12,DLL4|NRARP|NOTCH4|SFRP2|COL4A1|TGFBR2|SEMA3E|ENG
ZYGOTIC SPECIFICATION OF DORSAL/VENTRAL AXIS%GOBP%GO:0007352,0.89891217829663,0.9674346623843579,-0.40166531833421903,-0.6684353208218531,6775,2,SMAD6
ASPARTATE METABOLIC PROCESS%GOBP%GO:0006531,0.7329404060248851,0.9078024129966441,-0.302618145633315,-0.7784153916926729,5595,6,GOT1|NMNAT3
REGULATION OF EXONUCLEASE ACTIVITY%GOBP%GO:1905777,0.976253648182542,0.9926773910205121,-0.323533956058063,-0.53841223985011,7358,2,TERF2
DNA PACKAGING%GOBP%GO:0006323,0.00012830382345393898,0.00518555396908895,-0.36341111931349,-2.41496983081749,0,122,HIST1H4J|CENPQ|HELLS|SMCHD1|ATRX|HIST1H2BF|HIST4H4|NIPBL|PAPD7|NASP|NCAPG|HIST1H3D|CASC5|SART3|AIFM1|HIST1H4H|HJURP|NCAPD3|ITGB3BP|CTCF|CENPL|CENPU|ACIN1|NCAPH|NUSAP1|CENPW|H1F0|HIST1H2BE|KAT6A|HMGB2|SMC2|H2AFX|NAA10|OIP5|RUVBL1|CENPM|CDKN2A|HIST1H2BN|NPM1|ASF1B|CHAF1A|TOP2A|CENPI|IPO4|HIST1H2BC|NCAPH2|PIWIL1|HIST1H4I|STRA13|ANP32B|RBBP7|CENPH|NAP1L4|SMC4|HIST2H3A|GPER1|HIST2H2BF|SPTY2D1|H1FX|HIST1H2BG|HIST1H2BD|CHAF1B|HIST2H4A|HIST2H3C|HIST1H3H|POLE3|HIST1H1C|H2AFY|HIST2H4B|CENPK|H3F3B|MIS18A|HIST3H2BB|HIST2H2BE|CDCA5|HIST1H2BK|HIST1H2BJ|CENPP
POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION%GOBP%GO:0032461,0.15914939726398497,0.5293397224673839,0.31491423344741,1.29812403581781,1174,21,RHOC|MIEF2|HRK|PMAIP1|BID|SH3GLB1|BAX|HDAC6|BMF|TCL1A|TRABD2A
REGULATION OF CHROMOSOME CONDENSATION%GOBP%GO:0060623,0.8690397131093108,0.9566976576317809,0.56456771063079,0.7527748633923441,6542,1,WAPAL
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT%GOBP%GO:0032387,0.0561171591498186,0.34420602691857205,-0.300058160014219,-1.4817615392780101,432,39,SP100|APOD|CD84|PLN|GDI1|GAS6|MDFIC|UBE2G2|FMR1|PARK7|PDE2A|ARHGAP1|CD300A|LGALS9|CRYAB|DERL3|INSIG1
POSITIVE REGULATION OF MACROPHAGE TOLERANCE INDUCTION%GOBP%GO:0010933,0.513177257525084,0.802184867798321,-0.7463608292898101,-0.994331836417734,3835,1,IRAK3
LATERAL ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0099607,0.779397993311037,0.924704689181848,-0.6151852668725191,-0.819574490167898,5825,1,CENPE
POSITIVE REGULATION OF PLASMINOGEN ACTIVATION%GOBP%GO:0010756,0.33771699105733805,0.699636319850872,-0.461840683006242,-1.10694398985214,2567,5,F12|CLEC3B|ENO1
"REGULATION OF SYMBIOSIS, ENCOMPASSING MUTUALISM THROUGH PARASITISM%GOBP%GO:0043903",0.000387096774193548,0.0111294649577428,-0.26774040726507103,-1.8596938588103,2,151,TRIM38|DHX9|FCN3|CD74|PARP10|TRIM21|SMARCA4|ZNF639|REST|TSG101|OASL|OAS1|CD4|TRIM28|PPIA|RAB7A|LARP1|CCNK|CAV2|MDFIC|TOP2A|PPIB|PVRL2|FMR1|PLSCR1|DDX3X|HS3ST5|PDE12|IFIT1|APOBEC3G|TRIM32|SNW1|ISG15|NUCKS1|RSAD2|APOBEC3C|FCN1|IFI16|TNIP1|GSN|APOE|GAPDH|BST2|SNF8|LGALS9|ADARB1|RRP1B|CAV1|DDB1|OSBP|CFL1|IFITM1|BTBD17|ANXA2|LGALS1|IFITM2|IFITM3|MID2|BANF1|PSMC3|APOBEC3F|P4HB
REGULATION OF B CELL TOLERANCE INDUCTION%GOBP%GO:0002661,0.70270628814009,0.8934528433311372,-0.515512799203831,-0.8578957345698921,5296,2,TGFBR2
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0045945,0.35837021608956,0.714938712241162,-0.375513339121418,-1.08105034631823,2752,8,CEBPA|RPTOR|CHD8
NEURON FATE COMMITMENT%GOBP%GO:0048663,0.378664495114007,0.7286002908775491,0.320809312349192,1.05565962741911,2789,11,DLL1|POU3F2|ASCL1
DEFENSE RESPONSE TO BACTERIUM%GOBP%GO:0042742,0.00012748597654258,0.00518555396908895,-0.414311479713889,-2.5345586811278102,0,85,IGHV1OR15-1|MICA|IGHV5-51|HLA-E|RPL39|PYCARD|IGHV1-24|HIST1H2BE|TNFRSF14|GSDMD|SLAMF8|IGHV3-49|HMGB2|IGHG4|TLR2|FGR|IGLL5|MPEG1|PLA2G2A|SPN|AZU1|HIST1H2BC|IGHV4-4|HAMP|IGHV4-61|JCHAIN|IGHV1-3|FCER1G|ISG15|SLC11A1|IGHV3-43|ROMO1|CEBPB|IGHV3-73|RNASE6|CHGA|IGHV3-15|RARRES2|HIST1H2BG|SERPINE1|STAB1|TLR4|S100A8|CFP|IGHV1-18|S100A9|IGHG2|HIST2H2BE|IGHA1|HIST1H2BK|LYST|HIST1H2BJ|ADGRB1
FOCAL ADHESION ASSEMBLY%GOBP%GO:0048041,0.36048640167364,0.715657551920062,-0.276983101919782,-1.07479744822413,2756,18,CTTN|PEAK1|TRIP6|THY1|TAOK2|RHOD|DLC1|ACTN1
VASCULOGENESIS%GOBP%GO:0001570,0.0131561807997916,0.151938291649476,-0.407146011021623,-1.75526350307812,100,25,TGFB1|ADM|SOX18|SOX17|KDR|EGFL7|NOTCH1|APLNR|TGFBR2|TGFBR3|PDGFRB|CAV1|RASIP1|ENG
VISUAL BEHAVIOR%GOBP%GO:0007632,0.0050312754963285295,0.0799644467319547,0.5993196409390911,1.89868513356363,36,10,NPHP1|DRD2|CHRNB2|NF1|NPHP4|NETO1
VENTRICULAR SEPTUM DEVELOPMENT%GOBP%GO:0003281,0.785451573355129,0.9274485629622209,0.168540171658567,0.7713457051466271,5765,29,STRA6|ACVR1|FGFR2|ROBO2|SLIT3|CITED2|ZFPM1
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:1903751,0.8904761904761909,0.965159112268525,-0.335811946052103,-0.6557556194519101,6731,3,PARK7
POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION%GOBP%GO:1902038,0.00610970912471776,0.0914854365410948,0.996415968239965,1.32858624439526,45,1,FOXC1
MODULATION BY SYMBIONT OF HOST CATALYTIC ACTIVITY%GOBP%GO:0052148,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
NEGATIVE REGULATION OF APOPTOTIC PROCESS IN BONE MARROW%GOBP%GO:0071866,0.258842443729904,0.636098664976652,0.7041324594383621,1.18303344607834,1931,2,FGFR2|LEF1
REGULATION OF RECEPTOR CLUSTERING%GOBP%GO:1903909,0.0763227513227513,0.38654270614299796,-0.7332634829601851,-1.43187773735547,576,3,MESDC2|SHISA7|GSN
"PEPTIDYL-ARGININE METHYLATION, TO ASYMMETRICAL-DIMETHYL ARGININE%GOBP%GO:0019919",0.6934000540979169,0.8891520167182042,0.290119663481907,0.8008675437748299,5126,7,PRMT9|CARM1|PRMT7|PRMT6
REGULATION OF T CELL COSTIMULATION%GOBP%GO:2000523,0.659184486651614,0.8772415412127091,0.668670048522276,0.891581284144833,4962,1,CCR7
REGULATION OF TRANSLATIONAL ELONGATION%GOBP%GO:0006448,0.476332970620239,0.7850084910380921,0.28715899124748306,0.97599755826824,3501,12,DPH2|CPEB2|DPH5
MAINTENANCE OF CELL NUMBER%GOBP%GO:0098727,0.841065056272303,0.9476390732504458,0.146597595084849,0.7324385568957851,6127,39,DLL1|SALL4|DIS3L2|FGF2|KIT|MMP24|SETD6
REGULATION OF DNA ENDOREDUPLICATION%GOBP%GO:0032875,0.8817092235539341,0.9623664701296191,-0.21654983151965398,-0.651434898642536,6767,9,E2F7|FBXO5|E2F8|FBXW7|STAG2|SMC1A
REGULATION OF ENDOTHELIAL CELL DEVELOPMENT%GOBP%GO:1901550,0.9303391384051329,0.9793746057014829,-0.175580945871181,-0.604383664680127,7104,13,IL1B|ROCK1|TNF|CLDN5|CDH5|TNFRSF1A
RESPONSE TO MERCAPTOETHANOL%GOBP%GO:0072704,0.853765440297516,0.949296218452153,0.572011468901632,0.762700110638946,6427,1,IREB2
REGULATION OF HISTONE DEACETYLATION%GOBP%GO:0031063,0.77674357629785,0.924378439714623,-0.21337526899519899,-0.7548904990470241,5924,14,ZBTB7B|CAMK2D|AKAP8|ING2|ZNHIT1|KDM5A|VEGFA|PRKD2|CTBP1|AKAP8L|NIPBL|C6orf89|FOXP3|PRKD1
PROTEIN REFOLDING%GOBP%GO:0042026,0.47606744628773495,0.7850084910380921,0.250648034819213,0.9811433569828941,3500,18,FKBP1B|PPIG|HSPA2|HSPD1|NKTR|DNAJA4|DNAJB2|HSPA1L
CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS%GOBP%GO:0071389,0.1838127090301,0.556308895147568,-0.906263784737538,-1.20736096803796,1373,1,GPER1
EMBRYONIC APPENDAGE MORPHOGENESIS%GOBP%GO:0035113,0.24339056963750302,0.626082056933819,0.266926961964362,1.18034293554482,1785,26,RARG|TBX3|HDAC1|TWIST1|CACNA1C|ACD|SKI|LRP6|MEGF8|HDAC2|CYP26B1|FBXW4|LEF1|MSX1
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN REGULATION OF HEART RATE%GOBP%GO:0140200,0.321605351170569,0.689642136570735,-0.836733568592854,-1.11473002494379,2403,1,PDE4D
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT%GOBP%GO:0046822,0.34638670617029493,0.703607290676592,-0.18272496409202102,-1.06809102787297,2688,72,TGFB1|PSEN1|HYAL2|DHX9|SP100|APOD|CAMK1|JUP|ECT2|NCBP2|TRIM28|HCLS1|GAS6|MDFIC|BAG3|PARK7|PDE2A|ANP32B|RAPGEF3|FLNA|IGF1|RBM22|TMEM173|ZC3H3|RBM27|NUP214|RBM4|EMD
REGULATION OF RHO GUANYL-NUCLEOTIDE EXCHANGE FACTOR ACTIVITY%GOBP%GO:2001106,0.25921995224197397,0.636098664976652,-0.702565262889671,-1.16918094608105,1953,2,EPHA4
HYDROXYLYSINE METABOLIC PROCESS%GOBP%GO:0046946,0.9461640211640211,0.983395403194261,-0.303904268225433,-0.5934480116241241,7152,3,PLOD3|PLOD1|PLOD2
SIALYLATION%GOBP%GO:0097503,0.93688068413194,0.9806508984207809,0.230930450609453,0.597546113949464,6901,6,ST3GAL4|ST3GAL2|ST6GALNAC2|ST6GAL1|ST8SIA3
POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED SIGNALING PATHWAY%GOBP%GO:0051482,0.0373856209150327,0.275419603191217,-0.48523797064411206,-1.62413692135377,285,12,F2R|GNA15|F2RL3|C3AR1|GPR4
POSITIVE REGULATION OF DNA ENDOREDUPLICATION%GOBP%GO:0032877,0.662377288405413,0.879470077229378,-0.5336641852770889,-0.888102543620663,4992,2,E2F7|E2F8
MICROTUBULE ORGANIZING CENTER LOCALIZATION%GOBP%GO:0061842,0.35553139440065207,0.7132037834765931,0.287504798899209,1.0825509204402401,2615,16,IFT20|NDEL1|RANBP2|GPSM2|KIF5B|EZR
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS%GOBP%GO:0001658,0.216216216216216,0.5991362048583871,0.40469809592413997,1.22984018821126,1583,9,CITED1|PAX8|FGF2|PKD2|FGF1
EXECUTION PHASE OF APOPTOSIS%GOBP%GO:0097194,0.5254105780421571,0.808598139852817,-0.19111706157395,-0.9514239310000359,4062,40,COLEC11|EXOG|ACIN1|DNASE1L3|H1F0|MADD|HMGB2|CASP10|BNIP1|KPNB1|CASP1|TOP2A|CASP4|GPER1|CIDEB|CASP6|ENDOG|FEN1
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030857,0.862795757410933,0.9529453970190659,0.21326595003649,0.67564094544794,6344,10,DLL1|FOXJ2
NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING%GOBP%GO:0051898,0.43122017723244704,0.759710440121244,0.22649383090589,1.01367251458802,3162,27,DRD2|PHLDA3|TSC2|PLEKHA1|INPP5K
RETROGRADE TRANS-SYNAPTIC SIGNALING BY LIPID%GOBP%GO:0098920,0.0615547890687185,0.35631208031004796,-0.8394265232974909,-1.39693996916071,463,2,DAGLB|DAGLA
SIGNAL TRANSDUCTION INVOLVED IN INTRA-S DNA DAMAGE CHECKPOINT%GOBP%GO:0072428,0.555850710585735,0.8255262862532831,0.721217468019409,0.9616461776708521,4184,1,CHEK2
MUSCLE CELL FATE DETERMINATION%GOBP%GO:0007521,0.0899442823029981,0.414459448864761,-0.8111386821064241,-1.3498644778528601,677,2,TBX2|MEF2C
REGULATION OF MEGAKARYOCYTE DIFFERENTIATION%GOBP%GO:0045652,0.0216125275009706,0.203020458277694,-0.292387512321639,-1.6010704777177098,166,56,TESC|MEF2C|HIST1H4I|SETD1A|RBM15|TNRC6C|WDR5|HIST2H3A|RAB7B|KAT2B|THBS1|HIST2H4A|HIST2H3C|ZNF16|HIST1H3H|HIST2H4B|H3F3B|MYL9
MACROMOLECULE DEACYLATION%GOBP%GO:0098732,0.769599780701754,0.921135900129782,0.15170078845926002,0.800861318460042,5614,47,PRDM5|HDAC11|HDAC1|MTA3|HDAC10|LYPLA2|TBL1XR1|SMARCAD1|HDAC4|SIRT5|SIN3A|SIN3B|TBL1X|SUDS3|LYPLA1|MIER1|SIRT1|HDAC6|HDAC2
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO UV-INDUCED DNA DAMAGE%GOBP%GO:0010768,0.6968113612004289,0.8911114249297529,0.49713199331648206,0.83524593608154,5200,2,NEDD4|TAF1
POSITIVE REGULATION OF HISTONE MODIFICATION%GOBP%GO:0031058,0.07470376094796499,0.383186929742657,-0.249875273636853,-1.39603698101601,579,60,CTBP1|MYB|SMAD4|TADA2A|CDK9|RUVBL2|AKAP8L|JARID2|NIPBL|LIF|UBE2N|SART3|IL1B|C6orf89|FOXP3|TET1|RPS6KA5|BRD4|DNMT3B|KDM1A|CHTOP|PAXIP1|OGT|FMR1|PRKD1|BRCA1|ARRB1|SNW1|CTR9|MAPK3|DNMT1|RNF20|WBP2|KAT7|PHF19|RNF40|RPS6KA4
STRIATED MUSCLE ADAPTATION%GOBP%GO:0014888,0.42182850960238,0.7527812076478722,0.368989983049891,1.01858694393912,3118,7,HDAC4|INPP5F|CFLAR|CAMTA2|IREB2|TCAP
FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION%GOBP%GO:0007342,0.9110674525212831,0.972245398885683,-0.24582547358376,-0.6323293400244581,6955,6,FOLR2
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION%GOBP%GO:2000177,0.11748708186021199,0.468392769062825,0.31598310340352903,1.3611361809387699,863,24,PTCHD2|GNG5|DRD2|INSM1|NES|ADCYAP1|NF1|GATA2
LYMPHOCYTE MEDIATED IMMUNITY%GOBP%GO:0002449,0.000128816179312122,0.00518555396908895,-0.412485411343447,-2.45340164795244,0,77,IGHV1OR15-1|IGKV3-11|MICA|IGHV5-51|SLA2|CEBPG|IGHV1-24|CD74|JAG1|CORO1A|IGHV3-49|BATF|IGHG4|GZMB|EXO1|IGLL5|MYO1G|FCGR2B|IGKV2-28|IGHV4-4|IGHV4-61|RNF168|C1QB|IGHV1-3|FCER1G|SLC11A1|IGHV3-43|IGHV3-73|VAMP7|C1QA|C1QC|CTSH|HFE|IGKV2D-28|ZP3|IGHV3-15|EXOSC3|C1S|IGHV1-18|CD55|TUBB4B|IGHG2|IGHA1|C1R|LYST|EMP2
REGULATION OF CHOLESTEROL METABOLIC PROCESS%GOBP%GO:0090181,0.143135219309629,0.509384864704371,-0.24527199577511702,-1.2773774441992198,1102,47,SREBF2|IDI1|GPAM|FDPS|KPNB1|ABCG1|CYP51A1|MBTPS2|SOD1|RAN|HMGCR|APOE|HMGCS1|NFYB|DHCR7|FASN|TM7SF2
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE VIA TNFSF11-MEDIATED SIGNALING%GOBP%GO:0071848,0.3941137123745821,0.7376723208557521,-0.8027128363475959,-1.06940624073355,2945,1,TNFRSF11A
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS%GOBP%GO:0071384,0.011775480832133998,0.142241967951109,-0.473623018591901,-1.79988312759629,89,17,UBE2L3|AQP1|NR3C1|REST|ZFP36L1|BCL2L11|HNRNPU|GPER1|FAM107A|ANXA1|SSTR2
OXIDOREDUCTION COENZYME METABOLIC PROCESS%GOBP%GO:0006733,0.0661062285059228,0.3690551432905871,-0.21814472780332397,-1.37194331686444,518,95,PARP9|NADK|TKT|GPD1|NDUFA9|GPI|PFKFB2|NUDT17|HK1|VCP|KYNU|HK3|COQ6|HAAO|ENO1|BST1|PGAM1|GAPDH|COQ7|FMO2|PDSS1|LDHA|PDHX|NMNAT3|PNP|PGK1|TALDO1|QPRT|NNMT|ALDOA|COQ3|ALDOC|PTGIS
POSITIVE REGULATION OF LYASE ACTIVITY%GOBP%GO:0051349,0.118331589958159,0.469161949077585,-0.446473205530572,-1.3987422701163401,904,10,GUCA1A|STIM1|PARK7|AKAP5|NOS3|FXN
NEGATIVE REGULATION OF ESTROGEN RECEPTOR BINDING%GOBP%GO:0071899,0.835744908896034,0.945788393670804,0.42889440308795207,0.7205979739857,6237,2,LEF1|RUVBL2
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION%GOBP%GO:1904469,0.0308513407966675,0.249355322075945,-0.577052775299521,-1.66125417552673,236,8,IFIH1|LGALS9|HAVCR2|C1QTNF4
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY%GOBP%GO:1904377,0.19449470147324902,0.569387794077864,-0.23254023444754499,-1.21905147826209,1504,48,STX4|LRP1|CNST|STAC3|AKAP5|RHOG|NKD2|TREM2|EPB41L2|GPER1|EPHA2|LGALS3|STX3|ARF6|SQSTM1|PRNP
DNA-DEPENDENT DNA REPLICATION%GOBP%GO:0006261,0.443023404527433,0.7659370082867549,-0.156153715825534,-1.00530155278904,3463,105,RFC2|RAD51|RPA2|MCM10|WRNIP1|SETMAR|RNASEH2A|RFC3|DONSON|CDT1|TONSL|GINS2|PURA|POLD4|SLFN11|PCNA|GMNN|ORC1|ORC6|POLD1|CDC45|POLD2|STRA13|WDHD1|RFC5|POLQ|EME1|NUCKS1|GINS1|MCM2|FANCM|POLE2|POLA1|RFC4|SAMHD1|POLA2|FEN1
"REGULATION OF PROTEIN CATABOLIC PROCESS AT PRESYNAPSE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099575",0.547290969899666,0.818317601346006,-0.7290471989413321,-0.971265923545751,4090,1,RAB26
THYMIDINE BIOSYNTHETIC PROCESS%GOBP%GO:0046105,0.468986585203878,0.780769690730001,0.7668173797970891,1.02244750710004,3530,1,DHFRL1
C-TERMINAL PROTEIN DEGLUTAMYLATION%GOBP%GO:0035609,0.823809523809524,0.9418134422069259,-0.36687730070143604,-0.7164183836002881,6227,3,FOLH1|AGBL4
CELLULAR RESPONSE TO POTASSIUM ION%GOBP%GO:0035865,0.414436334144363,0.748680069094768,0.42435264190031297,1.02056567031534,3065,5,DLG2|CARF|DLG4
EFFERENT AXON DEVELOPMENT IN A LATERAL LINE NERVE%GOBP%GO:0048894,0.9689632107023409,0.9912626134248801,-0.514832377591531,-0.6858803454958909,7242,1,PHOX2B
PURINE NUCLEOBASE BIOSYNTHETIC PROCESS%GOBP%GO:0009113,0.17906733036416,0.551932636918083,-0.397843420038395,-1.28803947714621,1366,11,ADA|HPRT1|PRPS1|GMPS|MTHFD1
POSITIVE REGULATION OF NEUTROPHIL APOPTOTIC PROCESS%GOBP%GO:0033031,0.15806878306878303,0.527990543848753,-0.668702831815034,-1.3058071484987501,1194,3,PIK3CB|ANXA1
CARBOXYLIC ACID TRANSPORT%GOBP%GO:0046942,0.143039591315453,0.509375437970093,-0.180612997894939,-1.2236203864319,1119,133,FABP3|SLC9A3R1|SLC1A2|SLC16A13|SLCO2B1|ATP8B1|SLC51A|SLC1A3|SLC25A22|SLCO2A1|SLC38A6|SLC6A8|CEACAM1|PDPN|LCN12|LCN1|APOE|GIPC1|FABP4|SLC7A3|CD36|SLC27A4|SLC3A2|PPARG|PPARA|RPS6KB1|ABCD1|ARL6IP5|PRAF2|ANXA1|MPC1|FOLR2|SLC7A8|SLC38A9
PROTEIN LOCALIZATION TO SYNAPSE%GOBP%GO:0035418,0.794774159663866,0.929656485793048,-0.18653805593220302,-0.748387107555703,6052,20,RAB27B|ARHGAP44|HSPB1|STX1B|STX3|NRXN2
ESTABLISHMENT OF BLOOD-NERVE BARRIER%GOBP%GO:0008065,0.624120069066277,0.857740130996327,0.685101455668284,0.9134903484373349,4698,1,GSTM3
RESPONSE TO DENERVATION INVOLVED IN REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014894,0.11999462510077902,0.47202636254014396,0.6918663094157951,1.36081938502476,892,3,SCN5A|HDAC4
NEPHRON EPITHELIUM DEVELOPMENT%GOBP%GO:0072009,0.440196613872201,0.7653693162885199,0.21639294761015804,1.0094432322686602,3223,31,FOXC1|CITED1|PAX8|AHI1|FGF2|PTPRO|PKD1|TFAP2B|PKD2
CELLULAR RESPONSE TO MERCAPTOETHANOL%GOBP%GO:0072705,0.853765440297516,0.949296218452153,0.572011468901632,0.762700110638946,6427,1,IREB2
INNER EAR RECEPTOR CELL FATE COMMITMENT%GOBP%GO:0060120,0.19371237458194,0.567690182346143,-0.9011358623731809,-1.20052934416187,1447,1,JAG2
ENDOTHELIAL CELL CHEMOTAXIS%GOBP%GO:0035767,0.5345345345345349,0.8125965142671591,0.305209043226682,0.9275021329382321,3915,9,RAB13|PLEKHG5|CXCL13|NRP1
MEMBRANE DEPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098912,0.027411986025262,0.234005103383693,0.805558619168413,1.5844387417329198,203,3,SCN5A|CACNA1C|CACNB2
INTERLEUKIN-1 SECRETION%GOBP%GO:0050701,0.148138505597501,0.515403737647103,-0.465503011077931,-1.34011801688691,1137,8,S100A13|CD36|TLR4
REGULATION OF CIRCADIAN RHYTHM%GOBP%GO:0042752,0.00450798557444616,0.0743264309917645,-0.299785464519926,-1.74725704192642,34,71,RORC|MTA1|ARNTL|CSNK1D|TIMELESS|ID2|PML|ATG7|FBXW11|PER2|EZH2|BHLHE40|PTGDS|USP9X|RORA|NR1D2|TOP2A|SIAH2|MAPK9|CIPC|ZFHX3|GHRL|NR1H3|ARNTL2|NONO|USP2|GNAQ|CRY2|RBM4B|NR1D1|CCRN4L|PPARG|PPARA|SIK1|RBM4|PPP1CA|SUV39H1
PYRIMIDINE NUCLEOSIDE SALVAGE%GOBP%GO:0043097,0.21678870292886998,0.599597524514766,-0.39485453957034106,-1.23702772798656,1657,10,TYMP|CDA|TK1|UCK1
CHYLOMICRON ASSEMBLY%GOBP%GO:0034378,0.102645502645503,0.441229839424518,-0.709863721607413,-1.3861839340786397,775,3,APOE|P4HB
VERY LONG-CHAIN FATTY-ACYL-COA CATABOLIC PROCESS%GOBP%GO:0036113,0.0814715719063545,0.397722753303477,-0.956936479929422,-1.2748691652652,608,1,ABCD1
LABYRINTHINE LAYER MORPHOGENESIS%GOBP%GO:0060713,0.0950013437248052,0.42498053239300104,0.717603865114851,1.4114421198534097,706,3,FGFR2|BMP7|LEF1
POSITIVE REGULATION OF DNA METABOLIC PROCESS%GOBP%GO:0051054,0.269388803287108,0.6434418809581031,-0.157151221522966,-1.1066637260119498,2097,162,PARM1|NEK2|UIMC1|FAM168A|TGFB1|GREM1|PML|RFC2|GNL3|RGCC|RAD51|CCT3|NPAS2|DHX9|NABP2|CEBPG|SETMAR|DTX3L|RFC3|CDT1|H2AFX|NBN|PARP9|TRIM28|KLF4|FGFR4|ANKRD32|PARP1|USP9X|HGF|PAXIP1|WAS|BRCC3|PCNA|DHX36|CCT8|SMOC2|SLX1B|HNRNPA2B1|SLX1A|FOXM1|RNF168|CCT5|BRCA1|NUDT16|RFC5|MECP2|FGF10|MAPK3|DNMT1|TNFSF13|DKC1|FBXO4|PDGFRB|MYC|STOML2|HSP90AA1|RFC4|TFRC|PDGFB
NEGATIVE REGULATION OF SYNAPTIC PLASTICITY%GOBP%GO:0031914,0.732368176384646,0.9075412450030892,0.633105425672695,0.8441606584110641,5513,1,RGS14
PRENYLATED PROTEIN CATABOLIC PROCESS%GOBP%GO:0030327,0.9725348338692389,0.9915747942934481,0.320147066686413,0.5378884078941589,7258,2,PCYOX1|PCYOX1L
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS INVOLVED IN METANEPHROS DEVELOPMENT%GOBP%GO:1900212,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
REGULATION OF DNA-DIRECTED DNA POLYMERASE ACTIVITY%GOBP%GO:1900262,0.0683693516699411,0.37331514441341707,-0.5837515856819809,-1.5015663329404598,521,6,DSCC1|CHTF18|RFC2|RFC3|RFC5|RFC4
"ALTERNATIVE MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0000380",0.0108681419405526,0.134645873234709,-0.528084250313314,-1.8177683966823,82,13,SCNM1|DHX9|SLU7|RBM17|SRSF1|HNRNPM|DDX5|CELF4|PQBP1
FC-GAMMA RECEPTOR SIGNALING PATHWAY%GOBP%GO:0038094,0.17537552959301597,0.548366806412612,-0.203836171594505,-1.21686481182242,1365,78,RAC1|WIPF3|IGKV3-11|ACTG1|LYN|NCKAP1L|VAV3|WASF2|IGHG4|NCKIPSD|FGR|FCGR1A|ARPC1A|VAV1|MYO1G|WAS|FCGR2B|IGKV2-28|MYO10|ELMO1|GRB2|FCER1G|PIK3CB|MAPK3|ABL1|FCGR2A|DOCK1|CYFIP2|IGKV2D-28|HCK|HSP90AA1|ACTB|NCK1|IGHG2
REGULATION OF OXIDATIVE PHOSPHORYLATION UNCOUPLER ACTIVITY%GOBP%GO:2000275,0.45297658862876294,0.769943206592495,-0.7745919717688579,-1.03194249689689,3385,1,PPIF
LYMPHOCYTE MIGRATION%GOBP%GO:0072676,0.011254851228978001,0.13791712836645198,-0.35881617160122103,-1.7278002807801598,86,36,CCL3|CCL4|CCL8|CCL11|GPR183|ADAM8|CCL19|CCL24|SLC12A2|MYO1G|GATA3|GAS6|CCL3L3|CCL18|S1PR1|MSN|CCL2|CXCL16|CYP7B1|CX3CL1|CCL4L2|CCL14
SITE-SPECIFIC DNA REPLICATION TERMINATION%GOBP%GO:0071170,0.559702483729579,0.8268422944617521,0.7189567710630791,0.958631843321884,4213,1,RTFDC1
POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS%GOBP%GO:2000394,0.6791093647675179,0.884536278926676,-0.317433220839459,-0.8165237560982909,5184,6,CORO1C|RREB1|CORO1B
REGULATION OF CYTOKINETIC PROCESS%GOBP%GO:0032954,0.739683815648446,0.9093988038963969,0.47824648469809794,0.8035158431959342,5520,2,NUP62|KIF20B
METHIONINE METABOLIC PROCESS%GOBP%GO:0006555,0.390980392156863,0.736887023387937,-0.314145640220443,-1.05147487177698,2990,12,ADI1|SMS|APIP|MTHFD1
POSITIVE REGULATION OF CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905917,0.40414715719063593,0.7412049911665691,-0.7982465813850899,-1.06345611671244,3020,1,SOD2
RETINAL CONE CELL DIFFERENTIATION%GOBP%GO:0042670,0.38312549747943797,0.730480369014206,-0.6471464019851121,-1.0769550993936898,2887,2,TOPORS|THY1
MITOPHAGY%GOBP%GO:0000423,0.193582325092057,0.567519363754568,-0.531510115135859,-1.27392832451555,1471,5,AMBRA1|SQSTM1
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION%GOBP%GO:0003332,0.0464598874492867,0.30838564971849197,-0.6995563565296371,-1.53147509799538,354,4,NOTCH1|TNFRSF1A|TNFRSF1B
DIADENOSINE HEXAPHOSPHATE METABOLIC PROCESS%GOBP%GO:1901908,0.7360293155346159,0.908157084784786,-0.35559109356837504,-0.7784632357147929,5623,4,NUDT11|NUDT4
REGULATION OF CALCIUM ION TRANSPORT%GOBP%GO:0051924,0.17694369973190402,0.548551967663807,-0.178538250452904,-1.1917831330818,1385,124,CD4|ATP1B1|P2RX4|PLN|TMBIM6|SLC8B1|P2RX5|STAC3|P2RX3|THY1|PDE4B|STIM1|GRIN1|FMR1|LILRB2|MYLK|JPH4|PDE4D|SEPN1|SLC9A1|UBQLN1|CAMK2B|P2RY6|CCL2|GPER1|F2R|CCR1|APLNR|LGALS3|F2RL3|PDGFRB|FKBP1A|CX3CL1|CAMK2A|CAV1|CLIC2|PRKACA|ANXA2|AHNAK|PDGFB|PRNP
POSITIVE REGULATION OF PEPTIDASE ACTIVITY%GOBP%GO:0010952,0.00064077918749199,0.0163600882996276,-0.280633816402805,-1.8689236458018201,4,123,FIS1|PYCARD|APOPT1|GNB2L1|REST|PPM1F|TNFRSF10A|TNFRSF10B|PDCD6|CASP10|NGF|PDCD5|CASP1|GRIN1|VCP|TRAF2|PRELID1|DDX3X|EFNA1|TNFSF10|CYCS|CASP4|STAT3|PSME2|F3|PERP|IFI27L1|RCN3|ANP32B|IFI16|C10orf54|CTSH|CYFIP2|GPER1|CIDEB|GSN|F2R|DLC1|NLRP3|EFNA3|ASPH|LGALS9|FADD|EPHA4|BCAP31|MYC|PPARG|S100A8|S100A9|ARL6IP5|LGMN|NGFRAP1|NGFR|BAD
NEGATIVE REGULATION OF SPONTANEOUS NEUROTRANSMITTER SECRETION%GOBP%GO:1904049,0.0924425554522513,0.420939346122012,0.955116894574327,1.2735195022641101,695,1,PARK2
NEGATIVE REGULATION OF SMAD PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0010991,0.453998167779087,0.7705917450640001,-0.456304369176745,-0.998945648878641,3468,4,PPM1A|SMAD6|LDLRAD4
INDUCTION BY VIRUS OF HOST AUTOPHAGY%GOBP%GO:0039520,0.8402675585284279,0.947151866837735,-0.5837009263343629,-0.777629788735087,6280,1,EIF2AK4
ZYGOTE ASYMMETRIC CELL DIVISION%GOBP%GO:0010070,0.732368176384646,0.9075412450030892,0.633105425672695,0.8441606584110641,5513,1,RGS14
POSITIVE REGULATION OF MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:1901258,0.6418148049880611,0.868035523512231,-0.542376619795975,-0.9026014278831209,4837,2,ISL1|CD34
DIADENOSINE POLYPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0015961,0.7360293155346159,0.908157084784786,-0.35559109356837504,-0.7784632357147929,5623,4,NUDT11|NUDT4
POST-EMBRYONIC DEVELOPMENT%GOBP%GO:0009791,0.36520674646354706,0.719679786789958,0.31447946613096395,1.06885453851172,2684,12,STK36|FGFR2|MFAP2
REGULATION OF CELLULAR KETONE METABOLIC PROCESS%GOBP%GO:0010565,0.42496457555068895,0.7546470443593142,-0.170644360245762,-1.01496717975355,3298,77,FGFR4|ODC1|APOC1|INS|FABP3|IRS1|ADIPOR1|PARK7|BRCA1|NR1H3|CEACAM1|SLC45A3|FGF19|ADIPOR2|BMP2|NR1D1|PDK3|CAV1|SIRT4|PPARA|ABCD1|ANXA1
ENDODERMAL-MESODERMAL CELL SIGNALING INVOLVED IN HEART INDUCTION%GOBP%GO:0003134,0.40819846113027297,0.7445496113654559,-0.6368529458685871,-1.0598251423684002,3076,2,BMP2
PEPTIDYL-CYSTEINE METHYLATION%GOBP%GO:0018125,0.41532740071722707,0.7493091022753771,0.7932289369210409,1.0576637547379901,3126,1,RAB6A
POSITIVE REGULATION OF PROTEIN POLYMERIZATION%GOBP%GO:0032273,0.48825831702544004,0.7882673024233101,0.158421586170915,0.9829763439977092,3492,87,NCK2|BIN1|RLTPR|MET|CLASP1|CYFIP1|DCTN1|ABI2|FAM21C|RHOBTB1|PRKCE|NCKAP1|CDK5R1|LRRC16A|ACTR2|TRIM27|TPPP3|PAK1|PTK2B|CDC42EP3|WASH1|C15orf62|PSRC1|WIPF1|ANKRD53|RHOBTB2|WIPF2|JMY|ACTR3
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION%GOBP%GO:0070665,0.000386199794026777,0.0111294649577428,-0.35050528153194704,-2.0799583816562,2,76,CD1D|HLA-DMB|JAK3|SYK|NFATC2|CD274|HLA-DPA1|CD38|HLA-E|LYN|GPR183|CD209|TNFSF13B|PYCARD|NCKAP1L|VAV3|CD74|IL18|CCL19|CCDC88B|HLA-DPB1|PDCD1LG2|EBI3|IL6ST|LILRB2|MEF2C|FGF10|BST1|TNFRSF4|IGF1|ICOSLG|VCAM1|CSF1|CD86|TGFBR2|LGALS9|ZP3|FADD|AIF1|PNP|ANXA1|CD55|NCK1|TFRC|CD81
CELLULAR RESPONSE TO CYTOCHALASIN B%GOBP%GO:0072749,0.0667558528428094,0.3690551432905871,-0.9648213498015,-1.28537370520372,498,1,ACTB
TAURINE TRANSPORT%GOBP%GO:0015734,0.9927652733118969,0.997305769352475,0.28480838158257504,0.478514854157385,7409,2,LRRC8D|SLC6A6
CELLULAR RESPONSE TO BACTERIAL LIPOPROTEIN%GOBP%GO:0071220,0.0282745923198317,0.23806191359062198,-0.683956551071046,-1.63931334199474,214,5,TLR1|TLR2|CD36|CD14
MAINTENANCE OF TRANSLATIONAL FIDELITY%GOBP%GO:1990145,0.664882943143813,0.8804055751124069,-0.671041023378915,-0.8939877695924809,4969,1,RPS23
POSITIVE REGULATION OF EXCITATORY SYNAPSE ASSEMBLY%GOBP%GO:1904891,0.16642316376676902,0.5386230242605929,0.9186700485222759,1.22492255093074,1252,1,VSTM5
DISACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046351,0.117063492063492,0.46771736841097494,-0.698754155500162,-1.36448976717913,884,3,SLC2A1|B4GALT1
POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY%GOBP%GO:0032793,0.6354003139717429,0.863600910248377,-0.23283769953998498,-0.8653150479555541,4856,16,ADCY8|PRKD1|CD200|RPS6KA4
NUCLEOBASE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0034655,0.22141119221411198,0.6038851703323299,-0.139762445304405,-1.1180161642709598,1728,333,NUDT17|GPX1|HK1|RPLP2|ADA|VCP|NUDT1|HK3|MAGOH|PDE12|PDE4D|RPS14|RPS4X|WIBG|RPL35A|NCBP1|RPS29|PATL1|NUDT16|APOBEC3G|RPL10|DDX5|PDE2A|RPL36A|SMPDL3A|RPL24|ENO1|PELO|TYMP|APOBEC3C|PGAM1|HPRT1|CDA|LSM3|NT5C3B|RPL35|GAPDH|RNASE6|PPP2CA|RPL38|RPS15A|NUDT18|NUDT4|MAGOHB|EIF4A3|LDHA|EXOSC3|RPS13|RBM8A|TNKS1BP1|POLR2G|ENPP4|ABCD1|HINT1|TUT1|PNP|RNH1|PGK1|SKIV2L2|MUS81|SAMHD1|EXOSC2|ENDOG|DNASE1L1|ERN1|ALDOA|FEN1|ALDOC|EIF4G1|RNASEH2C
NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL%GOBP%GO:0070943,0.378060200668896,0.7281989978224692,-0.8093295103661229,-1.07822123928336,2825,1,AZU1
MDA-5 SIGNALING PATHWAY%GOBP%GO:0039530,0.367460317460318,0.721642468110297,-0.559302754904766,-1.0921765256285099,2777,3,IFIH1|IRF7
REGULATION OF OXIDOREDUCTASE ACTIVITY%GOBP%GO:0051341,0.0625566636446056,0.359087664164358,-0.258843790283744,-1.4303574310404799,482,58,NOSIP|METTL20|IL1B|NOSTRIN|AKT1|TNF|CHCHD10|GZMA|S100A1|POR|SLAMF8|TERF2|TERT|AGT|OXA1L|HP|INS|GLA|PARK7|ABL1|DHFR|RFK|APOE|NOS3|FXN|COX17|CAV1|SIRT4|NFKB1|HSP90AA1|CYGB|AOC3
CARBON TETRACHLORIDE METABOLIC PROCESS%GOBP%GO:0018885,0.17160313454642098,0.54516008272075,0.916023378914866,1.22139357413195,1291,1,CYP2E1
POSITIVE REGULATION OF SULFUR METABOLIC PROCESS%GOBP%GO:0051176,0.252224731039979,0.632257972333528,0.8759373621526251,1.16794427970024,1898,1,SP1
POSITIVE REGULATION OF PROGRAMMED CELL DEATH%GOBP%GO:0043068,0.0049467275494672796,0.07892365601804201,-0.176110622369562,-1.44765103540113,38,396,ATF3|PANO1|PIDD1|CD274|USP27X|GZMA|MNDA|HOXA5|UBD|MUL1|SOS2|LILRB1|ING3|PML|APC|RGCC|ATG7|LYN|GNA13|HYAL2|FIS1|BNIP3L|PYCARD|APOPT1|VAV3|GNB2L1|FNIP1|ARHGEF5|TFDP2|ADAM8|RIPK3|UBE2Z|REST|AGT|BCL2L11|ECT2|DAB2IP|FGD1|GZMB|PPM1F|PPIF|TNFRSF10A|TNFRSF10B|SFRP4|PDCD6|RASGRF2|CASP10|VAV1|SFRP2|CYP1B1|SOD2|NGF|IRF5|CDKN2A|C3orf38|PDCD5|WWOX|TGFB3|NMT1|CASP1|KALRN|VCP|TOP2A|TRAF2|PRELID1|SLC9A3R1|DDX3X|PPP1R13B|TNFSF10|ZNF622|MELK|ZNF268|NOTCH1|IFIT2|INHBA|TNFSF12|CYCS|MEF2C|CASP4|DCUN1D3|MAPK9|F3|IFI27L1|NGEF|PIK3CB|ANP32B|TIMP3|ABL1|SOD1|PNMA3|TNFRSF10C|G0S2|FAP|E2F1|GADD45B|CCL2|SAV1|STK3|PPP2R4|GPER1|CIDEB|GSN|F2R|NACC2|DLC1|GAPDH|PLAUR|NLRP3|BRMS1|ECSCR|PTRH2|GADD45G|BMP2|LGALS9|THBS1|MAP3K11|ARHGEF9|FADD|TGM2|UBC|LATS2|SLIT2|MMP9|BCAP31|RRP1B|CAMK2A|CAV1|MYC|APBB1|LTBR|DNAJA1|PPARG|SIK1|TNFRSF12A|BCL6|S100A8|S100A9|ARL6IP5|TIAM1|STYXL1|ANXA1|TNFRSF1A|NCK1|STPG1|NGFRAP1|TNFRSF1B|NET1|NGFR|SQSTM1|BAD|PTGIS|PRNP
REGULATION OF OPSONIZATION%GOBP%GO:1903027,0.233098685084341,0.616933025883855,0.884869872077636,1.1798545763961599,1754,1,MYO18A
FATTY ACID OXIDATION%GOBP%GO:0019395,0.0142029784886928,0.159485747303544,0.298152613868948,1.6465531458145901,102,55,ALDH3A2|BDH2|PPARD|HADHB|SLC25A17|HADHA|CYP4V2|PEX2|HIBCH|PEX13|ACADVL|ACADM|ACAT1|GCDH|ECHDC1|MCAT|ACOX2|ACAA2|ACAD11|ECI1|ACADS|ECHS1|MECR|ACOX3|EHHADH|ACOT8|ABCD3|PHYH|IVD|HACL1
"REGULATION OF DNA-TEMPLATED TRANSCRIPTION, TERMINATION%GOBP%GO:0031554",0.7298996655518399,0.906544799850309,-0.639225849139832,-0.85160231823218,5455,1,SETX
RENAL PHOSPHATE ION ABSORPTION%GOBP%GO:0097291,0.337123745819398,0.699462084003389,-0.828462726069696,-1.10371127675653,2519,1,SLC9A3R1
NEGATIVE REGULATION OF NEUROGENESIS%GOBP%GO:0050768,0.0899832409436638,0.41452363095076894,-0.19816741421265197,-1.30387938912628,697,116,GDI1|MED1|BAG5|THY1|HES1|RAB29|EFNA1|NOTCH1|DAAM2|NGEF|CALR|SEMA3B|SEMA3D|STX1B|SEMA7A|EDNRB|APOE|SEMA5A|SEMA3E|EPHA4|COL3A1|SLIT2|ID1|CX3CL1|LDLR|FKBP4|SEMA3A|SEMA6B|RTN4RL1|KIAA2022|ID4|ADGRG1|MYLIP|DTX1|ARHGDIA|NGFR
MAST CELL DEGRANULATION%GOBP%GO:0043303,0.5109095688748689,0.8011667213092171,-0.347665648631424,-0.950328546605711,3886,7,S100A13|CHGA|MILR1
RESPONSE TO OXYGEN-GLUCOSE DEPRIVATION%GOBP%GO:0090649,0.5456859592711679,0.817297924969912,0.5720430107526879,0.9611061175273399,4072,2,TSC1|IREB2
DETOXIFICATION OF NITROGEN COMPOUND%GOBP%GO:0051410,0.0444714787780481,0.300731792586058,0.6644470364595401,1.59799131240633,328,5,MARC2|GSTM2|GSTM1|GSTM3|MARC1
CELLULAR RESPONSE TO IONIZING RADIATION%GOBP%GO:0071479,0.0764835735618751,0.38654270614299796,-0.275130522216307,-1.4142656937729698,588,45,CLOCK|NIPBL|MAPK14|BLM|FIGNL1|INO80|HSF1|RAD9A|RAD51|EEF1D|INTS7|KDM1A|ECT2|RAD51AP1|RAD1|GRB2|RHNO1|NUCKS1|HRAS|IFI16|TMEM109|TLK2|CRYAB|TNKS1BP1|YAP1|POLE3|NET1
REGULATION OF PLATELET ACTIVATION%GOBP%GO:0010543,0.00026154047338825697,0.00819882332206558,-0.568643763403963,-2.3549017806475,1,22,FCER1G|CEACAM1|THBD|PDPN|APOE|NOS3|SERPINE2|TLR4|PDGFA|PDGFRA|PDGFB|C1QTNF1
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY REGULATING CELL SHAPE%GOBP%GO:0071963,0.22366675510745604,0.606938412474942,-0.722138507399523,-1.20175395494257,1685,2,MARK2
REGULATION OF MULTICELLULAR ORGANISM GROWTH%GOBP%GO:0040014,0.65921568627451,0.8772415412127091,-0.249841621697829,-0.8362433008936009,5042,12,APP|GDF15|STAT5A|PPIB|GHRL|SOD1|IGF1
DEMETHYLATION%GOBP%GO:0070988,0.21961648095361497,0.601964339800201,-0.236653645349228,-1.19252590751163,1694,42,ALKBH1|KDM4B|HR|KDM1A|PHF2|KDM3B|KDM8|KDM2A|APOBEC3G|C14orf169|JMJD6|APOBEC3C|APOBEC3B|KDM5C|APEX1|ALKBH3|APOBEC3F
CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002374,0.447759197324415,0.768229288546963,-0.7776797529775029,-1.0360561628868,3346,1,TLR2
CHEMICAL HOMEOSTASIS WITHIN A TISSUE%GOBP%GO:0048875,0.363172359638791,0.7177204591859201,-0.49839645733665505,-1.09109402868798,2774,4,RCN3|CTSH
POSITIVE REGULATION OF LONG-TERM NEURONAL SYNAPTIC PLASTICITY%GOBP%GO:0048170,0.49389758556646296,0.7924276220273391,-0.601488833746898,-1.00097360465119,3722,2,NEURL1|NPTN
REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION%GOBP%GO:0014842,0.439342480641217,0.7650340344477281,0.45679148513759493,1.00359034651812,3233,4,FGF2|CFLAR|EPHB1|AKIRIN1
RETICULOPHAGY%GOBP%GO:0061709,0.793579198726453,0.929656485793048,-0.46523297491039395,-0.7742220665971831,5981,2,RB1CC1|FAM134B
PHENOL-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0018958,0.33075251290410196,0.6957352559323989,0.241484390640123,1.09404262938299,2434,28,DRD2|CITED1|INSM1|PARK2|DRD4|ATP7A|MAOB|DDC
MUSCLE CELL FATE COMMITMENT%GOBP%GO:0042693,0.616804083235179,0.854302285059613,-0.39637016999281305,-0.8677371583664151,4712,4,TBX1|TBX2|MEF2C
REGULATION OF IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002837,0.6840168243953728,0.885415243771438,-0.29737847526232897,-0.812870800725774,5203,7,PVR|CD274|PVRL2|CEACAM1
ENDOSOME TO PIGMENT GRANULE TRANSPORT%GOBP%GO:0043485,0.5319672131147539,0.812079525085925,0.319318195569565,0.926924858280179,3893,8,BLOC1S3|AP1M1|BLOC1S5|AP1G1|BLOC1S6|AP3D1
RIBONUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0009119,0.0507903601969422,0.323888777520816,-0.29673488573076695,-1.49528243426907,391,42,OPA1|IMPDH2|ADA|APOBEC3G|APOBEC3C|RAN|CTPS1|HPRT1|CDA|MOCS2|MBIP|NUDT18|UMPS|GMPS|ENPP4|PNP|GPHN
RESPONSE TO NOREPINEPHRINE%GOBP%GO:0071873,0.699397993311037,0.892627170717022,-0.6531760035288929,-0.8701872735080141,5227,1,APLP1
POSITIVE REGULATION OF HEART INDUCTION%GOBP%GO:1901321,0.245211248471675,0.62804240987169,0.548659177929897,1.20542758001094,1804,4,DKK1|ROBO2
LATERAL LINE NERVE DEVELOPMENT%GOBP%GO:0048892,0.9689632107023409,0.9912626134248801,-0.514832377591531,-0.6858803454958909,7242,1,PHOX2B
REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:1904847,0.0190191550061133,0.190317961363288,0.7590580709204209,1.6676829083032,139,4,FGF2|CXCL13|FGF1|FGFR1
ORGANELLE LOCALIZATION BY MEMBRANE TETHERING%GOBP%GO:0140056,0.19256567915036302,0.566989663811688,0.16851106436309699,1.16710041329919,1377,143,NPHP1|CC2D2A|DYNC1I2|CEP162|CLASP1|DCTN1|TMEM67|SFI1|AHI1|FGFR1OP|STX8|RAB3B|NINL|CEP89|RAB3D|RAB10|SNAP25|RPGRIP1L|TTBK2|UNC13A|CEP164|PCM1|CEP290|MARK4|TCTN2|CEP57|RAB15|B9D1|NPHP4|USO1|VAMP3|STX10|STX16|STX16-NPEPL1|RAB11A|CEP250|DCTN2|YWHAE|VPS11
STRESS GRANULE ASSEMBLY%GOBP%GO:0034063,0.0928104575163399,0.421379812827181,-0.432356161897351,-1.4471365560699498,709,12,MAPT|RPS23|BICD1|DYNC1H1|ATXN2L|DDX3X|EIF2S1|G3BP1
PURINE DEOXYRIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009184,0.154247491638796,0.5225398777782271,-0.9210961623290691,-1.22712125645377,1152,1,NUDT18
VISUAL LEARNING%GOBP%GO:0008542,0.10224506356505302,0.441073279931729,0.519341996946562,1.43362964261692,755,7,DRD2|CHRNB2|NF1|NETO1
NEGATIVE REGULATION OF SENSORY PERCEPTION OF PAIN%GOBP%GO:1904057,0.15933110367893,0.5293397224673839,-0.9182840758711949,-1.2233748820701102,1190,1,NOV
NEGATIVE REGULATION OF MITOPHAGY%GOBP%GO:1901525,0.0718554920972241,0.377537691821741,0.965097044552272,1.28682668560955,540,1,TSC2
PENETRATION OF ZONA PELLUCIDA%GOBP%GO:0007341,0.39558528428093603,0.7377402989373809,-0.801996029995589,-1.06845128255732,2956,1,HYAL3
REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE%GOBP%GO:0051988,0.00444444444444444,0.0741980286738351,-0.5699310344827591,-1.90761253596885,33,12,SIRT2|SPAG5|BECN1|CDC42|RACGAP1|RCC2|KNSTRN|NEK2|APC|ECT2|HNRNPU|CCNB1
D-SERINE METABOLIC PROCESS%GOBP%GO:0070178,0.517332979147297,0.8044682962948779,0.740902073224526,0.9878929426118679,3894,1,SRR
NEGATIVE REGULATION OF BETA-GALACTOSIDASE ACTIVITY%GOBP%GO:1903770,0.5031438127090301,0.797298314254545,-0.752315835906484,-1.00226533511256,3760,1,TERF2
MRNA METHYLATION%GOBP%GO:0080009,0.0946367956551256,0.424507034898303,0.409231053879345,1.43321247009833,696,13,TRMT6|ZC3H13|METTL14|TRMT61B|CMTR1|CMTR2
REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS%GOBP%GO:2001020,0.0886189258312021,0.41190514473492496,-0.178864401013242,-1.28041376355731,692,176,UIMC1|FAM168A|CD44|ACKR3|PML|RAD51|RPA2|NPAS2|DHX9|WRNIP1|CEBPG|CD74|TRIAP1|SETMAR|DTX3L|TERF2|DEK|WDR70|KDM1A|H2AFX|PARP9|PPP4R2|PARPBP|TRIM28|ANKRD32|PARP1|KLHL15|SFRP2|SETD8|WAS|DYRK1A|IER3|RAD51AP1|BRCC3|PCNA|FMR1|WDR76|PLA2R1|USP51|AUNIP|FOXM1|RNF168|BRCA1|NUDT16|DDX5|TRIM32|SNAI2|POLQ|FGF10|ABL1|HIC1|TAF9B|NACC2|PSMD10|CXorf57|RMI2|PPP4C|SNAI1|MYC|NSMCE1|TAF9|ZNF385A|OTUB1|EID3|MAGEF1|AK6
REGULATION OF T-HELPER 1 CELL CYTOKINE PRODUCTION%GOBP%GO:2000554,0.8273786153644809,0.943061234519578,-0.32469646912121697,-0.7108284446631329,6321,4,IL1B|IL18|IL1R1
NEGATIVE REGULATION OF CONSTITUTIVE SECRETORY PATHWAY%GOBP%GO:1903434,0.356886704741666,0.714610778064251,0.82261799735333,1.09685010127458,2686,1,RAB33B
REGULATION OF APOPTOTIC PROCESS INVOLVED IN METANEPHRIC NEPHRON TUBULE DEVELOPMENT%GOBP%GO:1900217,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
REGULATION OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLE REMODELING%GOBP%GO:0010901,0.606153846153846,0.8488511623671441,-0.700099250110278,-0.9327003048903639,4530,1,APOC2
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION%GOBP%GO:1904951,0.158600434171881,0.528806480837633,-0.15109768427891299,-1.16981692042353,1241,272,NPEPPS|HLA-E|RGCC|ADAM9|CEMIP|PSEN1|CCT3|HYAL2|DHX9|FIS1|TLR1|PYCARD|GNB2L1|TNFRSF14|GSDMD|ARHGEF5|TFDP2|ADAM8|CCL19|SREBF2|ACHE|CAMK1|JUP|ECT2|ITGB2|GZMB|TRIM28|STX4|TLR2|PPIA|MICALL2|FGR|CNST|HCLS1|CD34|WLS|ATG13|GPI|GATA3|PDCD5|MYOM1|GAS6|TGFB3|PRR5L|NMT1|INS|CASP1|RAB29|DHX36|CCT8|ADCY8|PPP1R13B|BAG3|PTGER4|CCT5|IFIH1|BCAS3|ANP32B|OSM|GHRL|HUWE1|CEP131|RAPGEF3|TNFRSF4|FLNA|HRAS|IGF1|FCN1|E2F1|RBM22|TMEM173|DKC1|IL33|GPER1|F2R|GAPDH|NLRP3|LGALS9|B3GAT3|BCAP31|HAVCR2|ANG|TLR4|ITGAM|CSF1R|C1QTNF4|RHOU|SAR1B|CD14|EMD|BAD|PRNP|PTP4A3
RIBOFLAVIN BIOSYNTHETIC PROCESS%GOBP%GO:0009231,0.175919732441472,0.548366806412612,-0.9097926775474201,-1.2120623005978601,1314,1,RFK
HEME EXPORT%GOBP%GO:0097037,0.392544441496418,0.737280445732591,-0.6429004687069201,-1.0698891874429999,2958,2,FLVCR1|FLVCR2
TRANSEPITHELIAL L-ASCORBIC ACID TRANSPORT%GOBP%GO:0070904,0.980869565217391,0.993436724391485,-0.509594177326864,-0.6789018049772979,7331,1,SLC23A2
INTERNEURON MIGRATION%GOBP%GO:1904936,0.644024651661308,0.8688307429995409,0.527655506019731,0.886529378473251,4806,2,DRD2
LYMPHATIC ENDOTHELIAL CELL FATE COMMITMENT%GOBP%GO:0060838,0.176190476190476,0.548366806412612,-0.656414158967536,-1.28181048497892,1331,3,PDPN|NR2F2
BIOTIN METABOLIC PROCESS%GOBP%GO:0006768,0.4837013669821239,0.787078399497453,-0.35548132009249,-0.971692336009641,3679,7,HLCS|MCCC2|PCCB
CELL-SUBSTRATE ADHERENS JUNCTION ASSEMBLY%GOBP%GO:0007045,0.36048640167364,0.715657551920062,-0.276983101919782,-1.07479744822413,2756,18,CTTN|PEAK1|TRIP6|THY1|TAOK2|RHOD|DLC1|ACTN1
LYSOBISPHOSPHATIDIC ACID METABOLIC PROCESS%GOBP%GO:2001311,0.5321739130434779,0.812079525085925,-0.7369320688134101,-0.9817704634842651,3977,1,ACP6
CELLULAR RESPONSE TO NICOTINE%GOBP%GO:0071316,0.00575840858526371,0.0876516586218311,-0.8129011029352181,-1.7796104411861298,43,4,RELA|NFKB1|BAD
AXON EXTENSION%GOBP%GO:0048675,0.334164588528678,0.6974768376198021,-0.268831015124634,-1.0952194912922,2545,21,NRP2|SLIT2|MAP1B|SEMA3A|HSP90AA1
TYPE B PANCREATIC CELL DIFFERENTIATION%GOBP%GO:0003309,0.19221411192214102,0.5666176410720151,0.530334658300224,1.2754518120020901,1421,5,DLL1|INSM1|NKX6-1
POSITIVE REGULATION OF PROTEIN LIPIDATION%GOBP%GO:1903061,0.7424263007743509,0.909955740610127,0.35537417967241997,0.780772207287548,5464,4,RAB3GAP1|SVIP|RAB3GAP2|GBA
RESPONSE TO CALORIC RESTRICTION%GOBP%GO:0061771,0.0630952380952381,0.36006266503904,-0.7494021654959542,-1.46339249401555,476,3,APOE|LDLR
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION%GOBP%GO:0070664,0.00103680663556247,0.0240545523142212,-0.42500051630915797,-2.0987578515124,7,39,CD274|MNDA|GREM1|LILRB1|LYN|NDFIP1|TNFRSF14|TWSG1|PDCD1LG2|SPN|FCGR2B|PLA2G2D|TNFAIP3|LILRB2|GPNMB|PRKAR1A|SDC4|CEBPB|C10orf54|CD300A|LST1|CD86|TNFRSF21|LGALS9|GSTP1|PRNP
NEGATIVE REGULATION OF T-HELPER CELL DIFFERENTIATION%GOBP%GO:0045623,0.618209118209118,0.854944793214197,0.28448587035280204,0.8645263218725799,4528,9,SOCS5|LOXL3
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051043,0.37297936653962394,0.7241297850093872,-0.26902587659745303,-1.06289614053542,2837,19,FURIN|IL1B|ROCK1|TNF|ADAM9|ADAM8|NRD1|TIMP3|APOE|TIMP1|TNFRSF1B
REGULATION OF NEURONAL ACTION POTENTIAL%GOBP%GO:0098908,0.89457671957672,0.96615919218143,-0.333620619868694,-0.651476514805051,6762,3,GBA|FMR1
VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION%GOBP%GO:0021514,0.678168727075126,0.884536278926676,0.37586440056329795,0.825790095214933,4991,4,ASCL1|GATA2
DNA SYNTHESIS INVOLVED IN UV-DAMAGE EXCISION REPAIR%GOBP%GO:1904161,0.0698327759197324,0.37596389138254704,-0.9637185707984119,-1.28390453877875,521,1,POLA1
EGG ACTIVATION%GOBP%GO:0007343,0.18347041655611604,0.556308895147568,-0.7429831816928589,-1.2364428262807199,1382,2,PLCB1|WBP2NL
MITOCHONDRION-ENDOPLASMIC RETICULUM MEMBRANE TETHERING%GOBP%GO:1990456,0.9276254180602009,0.979345221662042,-0.5357851786501989,-0.713794507570266,6933,1,PDZD8
CGMP-MEDIATED SIGNALING%GOBP%GO:0019934,0.109248100602567,0.45349438410841897,-0.43323716701155396,-1.40262863722621,833,11,GUCY1B3|AQP1|PRKAR2A|PRKAR1A|PDE2A|APOE|CD36
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION%GOBP%GO:0060373,0.361363945116153,0.716154857259883,0.487817647034843,1.07175614553735,2659,4,SCN5A|SCN3B|SMAD7|GPD1L
EOSINOPHIL DEGRANULATION%GOBP%GO:0043308,0.287135191728831,0.6603864229308399,-0.534671385277368,-1.17050742877253,2193,4,VAMP8|VAMP7
NITRIC OXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006809,0.312312312312312,0.68160868787154,0.3697023073520879,1.1234912144021,2287,9,SPR|DDAH2|NQO1
FRUCTOSE 6-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0006002,0.26591556943124695,0.641396409168495,0.4541876013749871,1.17523711355259,1958,6,PFKL|PFKP|PFKM|GFPT1
HISTONE LYSINE DEMETHYLATION%GOBP%GO:0070076,0.69378367722434,0.889500280068691,-0.208742499147578,-0.8247221401741551,5278,19,KDM4B|HR|KDM1A|KDM3B|KDM8|KDM2A|C14orf169|KDM5C
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:1903589,0.45266432242358706,0.769943206592495,0.35883136302188395,0.990544346025109,3346,7,PPP1R16B|AGTR1|GATA2
GENE LOOPING%GOBP%GO:0090202,0.7843321687718359,0.927080511528825,0.381603617514062,0.7505692834605551,5836,3,ZFPM1|RUVBL2|NIPBL
REGULATION OF VACUOLE ORGANIZATION%GOBP%GO:0044088,0.00930359830346149,0.121992788205563,0.36533863347651796,1.7528067587248302,67,34,IFT88|PHF23|RALB|PIP4K2C|IFT20|TBC1D14|KIAA1324|PIKFYVE|RAB3GAP1|SCARB2|SMCR8|NPRL3|SH3GLB1
CHRONIC INFLAMMATORY RESPONSE%GOBP%GO:0002544,0.873280423280423,0.959352672679547,-0.3448383869689389,-0.6733819708204439,6601,3,THBS1
REGULATION OF HEPARAN SULFATE PROTEOGLYCAN BINDING%GOBP%GO:1905858,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0042996,0.51931892599869,0.8049078833377921,-0.365561745077492,-0.9403232855942308,3964,6,ACSL3|PKDCC|GOPC|CSK|GNB2L1|CNST
POSITIVE REGULATION OF OLIGOPEPTIDE TRANSPORT%GOBP%GO:2000878,0.8973202440965771,0.967166974453851,-0.402923115333027,-0.6705284961647321,6763,2,CA2
MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:0072497,0.193552666489785,0.567519363754568,-0.7375109786715,-1.2273362053821202,1458,2,WNT3
CELLULAR RESPONSE TO MURAMYL DIPEPTIDE%GOBP%GO:0071225,0.7925019526165059,0.929506008306088,-0.254283465155118,-0.732046506555805,6087,8,PTPN22|CHMP5|ARHGEF2|RIPK2|VIM
NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS%GOBP%GO:0090209,0.39576719576719604,0.7377402989373809,-0.546783884226466,-1.06773034408852,2991,3,SIK1
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY%GOBP%GO:0030178,0.0831627430910952,0.401393889637745,-0.203729902871274,-1.3258680169976202,649,110,CTNND1|DAB2IP|SOX17|TAX1BP3|LRP1|SFRP4|SFRP2|MLLT3|CBY3|WWOX|APCDD1|MESP1|SLC9A3R1|SIAH2|SNAI2|NKD2|NFATC1|HIC1|STK3|MDFI|APOE|BMP2|WWTR1|SDHAF2|DACT3|LATS2|IGFBP6|CAV1|CHD8|DACT1|NXN|DAB2|MCC|CSNK1A1|IGFBP4|EMD|AMER2|GRB10
MUSCLE HYPERTROPHY%GOBP%GO:0014896,0.9475839475839479,0.9840421757603729,0.19208490906723302,0.5837283226656701,6941,9,HDAC4|INPP5F|CAMTA2|CYBA|PDLIM5|TCAP|SORBS2
REGULATION OF PRESYNAPSE ASSEMBLY%GOBP%GO:1905606,0.669732215309711,0.8815356925073421,0.296595484369274,0.8187438735132121,4951,7,SLITRK1|PTPRD|VPS35|SNCA
HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0042446,0.140149965916837,0.504613420930072,0.294674123861882,1.31881322738193,1027,27,CHST8|CYP27B1|HSD17B3|SRD5A1|HSD17B11|FDX1L|HSD17B6|HSD11B2
CELLULAR RESPONSE TO ORGANONITROGEN COMPOUND%GOBP%GO:0071417,0.0015339383868081301,0.0322140470829666,-0.200347581916143,-1.56534687747197,11,287,ZFP36L1|IMPACT|RYR2|JUP|AP3S1|TCIRG1|ATP6V0B|RRAGA|GOT1|PARP1|P2RX4|RAPGEF1|ATP6V0A2|LRP1|ATP6V1G2|ATP1A3|AHR|LARP1|CAV2|P2RX3|FCGR2B|ATP6V1F|INS|PDE4B|BCAR1|GRIN1|FOXC2|SYAP1|ADCY8|ATP6V0D1|PDXP|CA2|GRB2|CRHBP|PRKAR1A|SLC9A1|MEF2C|CASP4|IRS1|STAT3|BRCA1|PDE2A|PXN|MAPK3|ABL1|ADCY4|RAPGEF3|PIK3R3|IGF1|HDAC5|NSMF|RPTOR|P2RY6|CEACAM1|GPER1|RAP1A|KCNQ1|KAT2B|CPEB1|CD36|ATP6V0E1|HTR1B|EPHA4|RARRES2|SLIT2|CAMK2A|IGFBP5|LPIN3|CAV1|PPARG|ATP6AP1|RELA|RPS6KB1|MAPK13|NFKB1|PRKACA|TLR4|ATP6V0E2|VIM|ACTB|LGMN|SHMT2|ATP6V1A|SLC38A9|CASP6|LPIN2|ATP6V1G1|NGFR|ADCY9|RRAGD|PRNP
REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS%GOBP%GO:1903409,0.6726706392199351,0.8820330910931731,0.225164570359537,0.830539283692461,4966,15,SPR|DDAH2|NQO1|MAOB
CLATHRIN COAT DISASSEMBLY%GOBP%GO:0072318,0.95489417989418,0.9870180073166591,-0.297011139296349,-0.579987477881969,7218,3,DNAJC6|GAK|SYNJ1
REGULATION OF PRESYNAPTIC MEMBRANE ORGANIZATION%GOBP%GO:1901629,0.17498327759197302,0.54811765844537,-0.910123511248346,-1.2125030505253502,1307,1,APOE
NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY%GOBP%GO:0034356,0.13788136702893802,0.502741814039243,-0.39103642813297207,-1.3460232161628003,1052,13,PNP|NNMT|PTGIS
B CELL ADHESION%GOBP%GO:0097323,0.537257525083612,0.8137043915765061,-0.734395677106308,-0.978391380706841,4015,1,CD209
INDUCTION BY VIRUS OF HOST CELL-CELL FUSION%GOBP%GO:0006948,0.46127090301003293,0.7751504236173679,-0.7707322452580501,-1.02680041440951,3447,1,CD4
NEGATIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0010561,0.502084418968213,0.796769413401376,-0.317650258480414,-0.9555697295390571,3853,9,TMEM59|BACE2
BRAINSTEM DEVELOPMENT%GOBP%GO:0003360,0.189733942488578,0.563519336720471,0.6465614420765861,1.2717100572946298,1411,3,SCN5A|NLGN4X|PHOX2B
POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051044,0.5516518091242789,0.8225828340810141,-0.260551374026288,-0.9217926599099789,4207,14,FURIN|IL1B|TNF|ADAM9|ADAM8|NRD1|APOE|TNFRSF1B
B CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050853,0.00852603022865263,0.114840918117116,-0.341013428766523,-1.76655686032099,65,46,SYK|IGHV2-26|NFATC2|IGHV1OR15-1|MNDA|CD38|IGHV5-51|IGHV1-24|NCKAP1L|VAV3|IGHV3-49|IGHG4|IGLL5|LAT2|BCAR1|IGHV4-4|IGHV4-61|MEF2C|IGHV1-3|IGHV3-43|IGHV3-73|IGHV3-15|IGHV1-18|IGHG2|IGHA1|PRKCB
GLOMERULAR MESANGIUM DEVELOPMENT%GOBP%GO:0072109,0.00828511309836928,0.112744254742887,-0.7397258040961149,-1.77298159974285,62,5,CD34|PDGFRB|ACTA2|PDGFB
NEUROMUSCULAR PROCESS CONTROLLING POSTURE%GOBP%GO:0050884,0.438359788359788,0.764176468950153,-0.529764318990244,-1.0344954467732599,3313,3,PRRT2
PURINE NUCLEOSIDE METABOLIC PROCESS%GOBP%GO:0042278,0.180336351875809,0.553994656967381,-0.258843573198089,-1.24640424218906,1393,36,OPA1|IMPDH2|ADA|RAN|HPRT1|MOCS2|MBIP|NUDT18|MACROD2|GMPS|ENPP4|PNP|GPHN
STEM CELL POPULATION MAINTENANCE%GOBP%GO:0019827,0.789257330775555,0.9280333261332429,0.157172039832166,0.778810418298053,5759,38,DLL1|SALL4|DIS3L2|FGF2|KIT|MMP24|SETD6
POTASSIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071805,0.496900025833118,0.794550673730064,-0.166933835341886,-0.969318435042302,3846,70,SLC9A5|TMEM175|KCNA3|KCND2|ATP1B1|SLC12A8|ATP1A3|SLC12A2|ATP1B3|KCNN2|KCNK6|KCNK7|SLC9A1|PKD2L1|ABCC9|SLC9A7|NALCN|SLC1A3|SLC9A9|KCNJ12|KCNN1|KCNQ1|KCNB2|ATP1B2|KCNH2|KCNE4|KCNJ9
ADENOSINE METABOLIC PROCESS%GOBP%GO:0046085,0.12443961418285601,0.47848721859351595,0.6280430107651359,1.3798372415199598,915,4,ADAL|CECR1|NT5C2
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUR TASTE%GOBP%GO:0001581,0.28561872909699,0.658457633141178,-0.8542677547419499,-1.13808977110077,2134,1,PKD2L1
REGULATION OF LENS EPITHELIAL CELL PROLIFERATION%GOBP%GO:2001109,0.682408026755853,0.885415243771438,-0.662715041905602,-0.88289556308398,5100,1,SOX11
CELLULAR RESPONSE TO UV-B%GOBP%GO:0071493,0.16088328075709804,0.5311416159351421,-0.4837964319717629,-1.3224359722008998,1223,7,HYAL2|MFAP4|HYAL3|HYAL1|CRIP1
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0042985,0.503419253024724,0.7974295790858391,-0.39609530112508295,-0.9493648548565792,3827,5,ITM2B|ABCA7|ITM2C|ITM2A|BACE2
KERATAN SULFATE CATABOLIC PROCESS%GOBP%GO:0042340,0.0465085982282439,0.30858529457449796,-0.5296458227538771,-1.5933042775459298,356,9,PRELP|OGN|LUM|FMOD|HEXB
POSITIVE REGULATION OF CELL CYCLE CHECKPOINT%GOBP%GO:1901978,0.205545430877376,0.585489831572105,-0.435035063200117,-1.25240505925408,1578,8,MAD2L1|NDC80|XRCC3
PANCREAS DEVELOPMENT%GOBP%GO:0031016,0.129311510888678,0.487857553689733,0.337792168527587,1.3467381573009398,955,19,NPHP3-ACAD11|DLL1|INSM1|RFX3|NPHP3|CCDC40|NKX6-1|PROX1|EIF2AK3
CELLULAR ALCOHOL BIOSYNTHETIC PROCESS%GOBP%GO:0044108,0.6838156484458741,0.885415243771438,0.504314703285414,0.84731381622657,5103,2,CYP27B1
POSITIVE REGULATION OF PHAGOCYTOSIS%GOBP%GO:0050766,0.000775394158697338,0.0191067003244251,-0.439513852163599,-2.13513460284385,5,37,C4B|PYCARD|NCKAP1L|MERTK|C4A|AZU1|FCGR2B|C2|GAS6|C3|CD47|FCER1G|SLC11A1|CALR|CCL2|CD300LF|TUB|LMAN2|ITGAM|PTPRJ|SIRPA
POSITIVE REGULATION OF CELL ADHESION%GOBP%GO:0045785,0.000127942681678608,0.00518555396908895,-0.272208827810565,-2.0521097116352798,0,234,DUSP26|BLM|ETS1|GSK3B|RARA|GRAP2|HSPH1|IL1B|TGFB2|AKT1|ROCK1|FOXP3|CD1D|HLA-DMB|CXCL12|CDC42|PAK2|TNF|JAK3|SYK|RAC3|RAC1|ECM2|CD274|PPAP2B|NFKBIZ|CD44|HLA-DPA1|UTRN|LILRB1|HLA-E|LYN|ADAM9|CDK6|CD209|PYCARD|NCKAP1L|TNFRSF14|IL18|ADAM8|RUNX1|CCL19|RUNX3|JUP|FRMD5|CCDC88B|PPM1F|HLA-DPB1|KDR|STX4|PDCD1LG2|VAV1|SFRP2|GATA3|TNFRSF18|AZU1|EBI3|THY1|IL6ST|RREB1|PIEZO1|FOXC2|DOCK5|LILRB2|GRB2|SOCS1|GCNT2|CHRD|PTPN6|CD47|ZFHX3|S100A10|RSU1|MMRN2|RHOD|ABL1|CALR|FLNA|IRAK1|IGF1|MMRN1|DPP4|NKAP|ICOSLG|VCAM1|C10orf54|DOCK1|CSF1|CCL2|PDPN|FN1|CD86|NLRP3|HYAL1|CD36|TGFBR2|LGALS9|ZP3|TEK|STX3|FADD|AIF1|TGM2|ARL2|NEDD9|EMILIN2|ADAM19|CX3CL1|CAV1|RELA|BCL6|ADGRG1|LILRB4|PNP|FBLN2|ANXA1|COL16A1|CD55|NCK1|TFRC|TFE3|SART1|SERPINF2|PTPRJ|COL26A1|SIRPA|EMP2
MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0098828,0.0385817144409727,0.279776552671739,0.718350665546006,1.57824700506333,283,4,RIMS1|RIMS2|NLGN2|UNC13B
STRIATED MUSCLE MYOSIN THICK FILAMENT ASSEMBLY%GOBP%GO:0071688,0.423837590045842,0.7540202308249201,-0.397254315084084,-1.0218451131892,3235,6,MYH11|MYOM1|IGSF22
NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION%GOBP%GO:2000766,0.661025774537881,0.878661839001673,-0.28892105078450103,-0.8317632676910591,5077,8,FMR1|UNK|CPEB1
MYELIN MAINTENANCE%GOBP%GO:0043217,0.36225026288117795,0.716544107573036,-0.39530794777684203,-1.08055664674171,2755,7,CXCR4|SOD1|ABCD1
"REGULATION OF WOUND HEALING, SPREADING OF EPIDERMAL CELLS%GOBP%GO:1903689",0.5283018867924529,0.8105400040230321,0.35737288341240503,0.9247233405140892,3891,6,CLASP1|CLASP2
NEGATIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS%GOBP%GO:0045719,0.192754798594215,0.567302686959088,0.529726132595577,1.27398831117201,1425,5,INPP5K|PASK|VIMP|GSK3A
INTERCELLULAR TRANSPORT%GOBP%GO:0010496,0.699397993311037,0.892627170717022,-0.653231142479047,-0.870260731829263,5227,1,ARC
NEGATIVE REGULATION OF EXOCYTOSIS%GOBP%GO:0045920,0.0659426926599503,0.369007394574627,-0.39248374457324,-1.49153407242202,503,17,REST|CD84|RAB7A|SYT4|FCGR2B|FMR1|CEACAM1|CD300A|LGALS9|ANXA1
NEGATIVE REGULATION OF MDA-5 SIGNALING PATHWAY%GOBP%GO:0039534,0.454521659468656,0.770794980018249,-0.455982538281974,-0.9982410937752441,3472,4,DHX58
TENDON FORMATION%GOBP%GO:0035992,0.675378084372513,0.882488012133495,-0.5279294182519989,-0.878558974232716,5090,2,SCX|BMP4
PROTEIN TO MEMBRANE DOCKING%GOBP%GO:0022615,0.237037037037037,0.6217158626397761,-0.620889307456452,-1.2124394537143799,1791,3,RAB7A|PEX16
SEQUESTERING OF CALCIUM ION%GOBP%GO:0051208,0.8327062617575921,0.9443921657118071,0.36166900994778706,0.7113602628161549,6196,3,ATP7B
REGULATION OF CORTICOTROPIN-RELEASING HORMONE RECEPTOR ACTIVITY%GOBP%GO:1900010,0.29886287625418106,0.671387424531401,-0.8471548301720341,-1.12861364765973,2233,1,CRHBP
"FATTY ACID ELONGATION, SATURATED FATTY ACID%GOBP%GO:0019367",0.507759074171489,0.7987565605553191,-0.39487388553412395,-0.9464373547525979,3860,5,ELOVL2|ELOVL1
G PROTEIN-COUPLED RECEPTOR INTERNALIZATION%GOBP%GO:0002031,0.34053134406491303,0.701955655133333,-0.509262258238583,-1.1148815382227801,2601,4,ADM|ARRB1|GTF2H2
POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:0061098,0.0622390396659708,0.358473315814565,-0.34144042833832206,-1.4894255017428701,476,26,GAS6|EFNA1|NTRK2|GPRC5B|DLG3|EPHA4|NEDD9|CSF1R|PDGFB|PRNP
GENITALIA DEVELOPMENT%GOBP%GO:0048806,0.139890710382514,0.504314492208813,0.465053378843161,1.3499685995281898,1023,8,STRA6|TBX3|PKD1|CHD7|LRP6
GLYCOSYLATION%GOBP%GO:0070085,0.600514138817481,0.8464076674715391,-0.130998241846815,-0.9315327854794719,4671,170,RPN2|C1GALT1C1|VCP|ST6GALNAC4|UBE2G2|B3GLCT|KRTCAP2|GALNT10|MGAT1|DAD1|GALNT18|GCNT2|FUT9|GALNT16|MUC4|GALNT1|B4GALT7|B3GALT2|MUC20|SYVN1|MUC15|GFPT2|B4GALT1|B3GNT5|SRD5A3|B3GALT6|DERL3|DOLK|B4GAT1|FUOM|ALG6|MAGT1|DOLPP1|B3GALT1|ST3GAL5|SERP1|GBGT1|RPN1
BONE REGENERATION%GOBP%GO:1990523,0.15933110367893,0.5293397224673839,-0.9182840758711949,-1.2233748820701102,1190,1,NOV
POSITIVE REGULATION OF MEMORY T CELL ACTIVATION%GOBP%GO:2000568,0.30256342143710996,0.675222663526765,0.849580943978827,1.13280155241227,2277,1,FAM49B
NEGATIVE REGULATION OF PLASMA LIPOPROTEIN OXIDATION%GOBP%GO:0034445,0.25137123745819395,0.6319002828696341,-0.8713608292898101,-1.16086185068776,1878,1,APOM
REGULATION OF FOLLICLE-STIMULATING HORMONE SECRETION%GOBP%GO:0046880,0.358465608465608,0.714938712241162,-0.563306496084703,-1.0999948174089,2709,3,INHA|INHBB|INHBA
GLUCOSE HOMEOSTASIS%GOBP%GO:0042593,0.00912479115794885,0.12051332749931,-0.282579452899399,-1.6710970438516,70,75,GAS6|HK1|INS|HK3|ADCY8|IRS1|CEBPA|STAT3|ADIPOR1|PARK7|NUCKS1|GPRC5B|CRY2|GPER1|ADIPOR2|PDK3|TRA2B|PPARG|INSRR|PYGL|PRKACA|BACE2|NGFR|ERN1|BAD
CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0007268,0.3720346078705,0.7234654586828599,0.137803097011678,1.04115611871849,2665,220,EXOC4|HTR3A|KCNQ3|CHRNB1|SLC12A5|DRD2|SLC6A2|GRIK3|SYT2|GRID1|KCNMB4|LIN7B|CHRM4|FCHSD1|SLC12A4|GABRA3|RIMS1|SNAP25|RIMBP2|DRD4|DLG2|KCNIP2|GABARAP|CHRNB2|MINK1|ARRB2|RAB3GAP1|LIN7A|DNAJC5|CHRNA5|COLQ|NQO1|UNC13A|GABRB3|CACNB4|RIMS2|HAP1|SLC18A3|KCNQ2|CPLX1|CHRNB4|PDE7B|PPFIA3|KCNK3|HRH3|SYT5|CHRM3|UNC119|DLG4|BRSK1|CACNB2|KIF5A|GRM4|SPG11|SLC1A4|LRP6|SNAP23|PTPRN2|KCNC4|ASIC2|NAAA|OTOF
POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0045743,0.999459313327927,0.999671409271379,0.165177586587249,0.39725114852964,7393,5,FGFBP3|DSTYK|PRKD2
L-PHENYLALANINE METABOLIC PROCESS%GOBP%GO:0006558,0.6316063525123671,0.8616028929314681,-0.29673460949619396,-0.8542574096329041,4851,8,IL4I1|ASRGL1
MEMBRANE RAFT ASSEMBLY%GOBP%GO:0001765,0.186425221469515,0.5596135749060439,-0.42326186597111404,-1.27327529568232,1430,9,CAV2|S100A10|CAV1|ANXA2|EMP2
REGULATION OF MELANIN BIOSYNTHETIC PROCESS%GOBP%GO:0048021,0.545283525933889,0.817297924969912,0.470717988309253,0.9258467346270659,4057,3,ZEB2|RAPGEF2|CDH3
NEGATIVE REGULATION OF HISTONE H3-K4 METHYLATION%GOBP%GO:0051572,0.142610772088087,0.508674778494682,-0.769285911221395,-1.2802147743388999,1074,2,BCOR|H2AFY
NEGATIVE REGULATION BY HOST OF VIRAL EXO-ALPHA-SIALIDASE ACTIVITY%GOBP%GO:0044869,0.878929765886288,0.960725750963158,-0.563134097926776,-0.7502298349094499,6569,1,PTX3
MESENCHYME DEVELOPMENT%GOBP%GO:0060485,0.00677836040414375,0.0988172769832964,-0.259084091673996,-1.66795671999127,52,105,SEMA4A|OLFM1|PEF1|JAG1|CORO1C|SOX10|TBX1|BASP1|TRIM28|SEMA6A|PDCD6|HGF|SPRY1|SMO|SFRP2|TBX2|ANXA6|MESP1|EFNA1|NOTCH1|MEF2C|DDX5|SNAI2|SEMA3B|SEMA3D|SEMA7A|MEOX1|FN1|NOS3|ACTG2|TGFBR2|BMP2|TGFBR3|SEMA5A|TCOF1|SEMA3E|DCHS1|SNAI1|SEMA3A|SEMA6B|ACTA2|ENG|S100A4|ACVRL1|LOXL2|HNRNPAB
POSITIVE REGULATION OF PROTEIN HOMODIMERIZATION ACTIVITY%GOBP%GO:0090073,0.009640437727983321,0.12521983467696599,-0.609375966408825,-1.8331520654021,73,9,TRAF2|SYAP1|MEF2C|PARK7|LGALS3|STPG1
RETINA VASCULATURE DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0061298,0.0820015719151166,0.398202308598866,-0.454584532934753,-1.47174188293356,625,11,FZD4|CYP1B1|COL4A1|LRP5|PDGFRB|PDGFRA|ACVRL1
POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS%GOBP%GO:0032056,0.113887427669648,0.46290587669685995,-0.5838296933598061,-1.3993283700239099,865,5,EIF2AK4|PPP1R15A|DNAJC3|IMPACT|NCK1
NEGATIVE REGULATION OF MRNA PROCESSING%GOBP%GO:0050686,0.40748005753890404,0.7445496113654559,-0.24938165881761604,-1.03275433620334,3115,22,CCNT1|SRSF4|SRSF12|ZC3H14|PTBP1|SRSF10|SRSF9|RBMX|CTR9|RNF20|RNF40
ANTIBIOTIC TRANSPORT%GOBP%GO:0042891,0.593944309272776,0.843040556302675,0.36476180881625897,0.877250058472484,4393,5,SLC13A4|SLC26A6|SLC25A1
ENDOCARDIAL CELL FATE COMMITMENT%GOBP%GO:0060957,0.0256342143710984,0.22470485454905398,0.9878694309660341,1.3171905901491598,192,1,ACVR1
CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION%GOBP%GO:0060379,0.0165615141955836,0.17536779833315902,-0.635107585736184,-1.73603826339136,125,7,NRG1|GREM1|REST|TBX2|NOTCH1|SRF
METANEPHRIC NEPHRON DEVELOPMENT%GOBP%GO:0072210,0.262636789994789,0.6382897491935179,-0.391847688866169,-1.17877376162575,2015,9,CD34|SMO|PDGFRB|PDGFRA|PDGFB
POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY%GOBP%GO:0051894,0.11603872318158001,0.4659838250752071,-0.369422181132264,-1.37291586806549,886,16,PPM1F|KDR|THY1|S100A10|ABL1|TEK|COL16A1|PTPRJ
POSITIVE REGULATION OF MONOPHENOL MONOOXYGENASE ACTIVITY%GOBP%GO:0032773,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
LOCALIZATION WITHIN MEMBRANE%GOBP%GO:0051668,0.736862442040185,0.9082449317227979,-0.14261357574901,-0.8312029901142909,5720,71,ITGB2|ATP1B1|DNM1|SYNJ2BP|THY1|SEC23A|ARHGAP44|MADCAM1|FLNA|SEC13|SEC24A|STX1B|APOE|STX3|DLG3|NRXN2|GPHN|DNM3
CYTOSOL TO ER TRANSPORT%GOBP%GO:0046967,0.7406216505894959,0.909493931144346,0.477805348773091,0.802774677884558,5527,2,TAP1|TAP2
POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE%GOBP%GO:1902459,0.312790543232833,0.6819542109635269,0.844011910013233,1.12537599706481,2354,1,NCOA3
REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT/RIGHT ASYMMETRY%GOBP%GO:1900145,0.6336830920440961,0.8631726958478259,0.680359505955007,0.9071675983394991,4770,1,SMAD2
DETECTION OF OTHER ORGANISM%GOBP%GO:0098543,0.31742902208201895,0.6865537462061271,-0.41075372824555895,-1.1227769988582,2414,7,CD1D|TLR1|TLR2|SSC5D|TLR4
REGULATION OF TONGUE MUSCLE CELL DIFFERENTIATION%GOBP%GO:2001035,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
MONONUCLEAR CELL DIFFERENTIATION%GOBP%GO:1903131,0.0231433054393305,0.21165950231047198,-0.545245428624691,-1.70818275130025,176,10,PIR|MT1G|IFI16|PDE1B|PPARG|MYH9|CSF1R
PHOSPHATIDYLCHOLINE METABOLIC PROCESS%GOBP%GO:0046470,0.11540449728612,0.46493596964429496,-0.252940449402535,-1.32599603457437,892,48,PLA2G2A|PLA2G2D|PCYT1A|CHPT1|TMEM86B|PLA2G4D|PLA2G4A|CETP|PLA2G4C|SLC44A1|PLA2G16|LPIN3|PCTP|PLBD1|LPIN2|PLA2G12A
NEGATIVE REGULATION OF CELL SIZE%GOBP%GO:0045792,0.7334414706677479,0.907913422943088,0.323902492830355,0.778983637834583,5425,5,AKT1S1|RDX|RHOA|DEPTOR|PTEN
FERROUS IRON EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903988,0.832775919732442,0.9443921657118071,-0.58706440229378,-0.7821107463312359,6224,1,SLC40A1
PUTRESCINE BIOSYNTHETIC PROCESS FROM ORNITHINE%GOBP%GO:0033387,0.764579414135985,0.9191113740914171,0.38972014627416207,0.766533537718262,5689,3,AZIN2|AZIN1
PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS%GOBP%GO:0006782,0.5456859592711679,0.817297924969912,0.5720430107526879,0.9611061175273399,4072,2,CPOX|IREB2
NEGATIVE REGULATION OF CELLULAR PH REDUCTION%GOBP%GO:0032848,0.450126178775402,0.768588477853328,0.776246140273489,1.03501948694574,3388,1,BCL2
REGULATION OF SPINDLE ELONGATION%GOBP%GO:0032887,0.982876254180602,0.993436724391485,-0.508601676224085,-0.677579555194827,7346,1,NUMA1
OLIGOPEPTIDE TRANSPORT%GOBP%GO:0006857,0.0712390554523746,0.3767214120425879,-0.8285084091535709,-1.3787704812875,536,2,SLC9A3R1|ABCC1
EVASION OR TOLERANCE OF HOST IMMUNE RESPONSE%GOBP%GO:0020012,0.605525302164962,0.8484731812466321,0.694861049845611,0.92650345038288,4558,1,EIF2AK2
REGULATION OF CONSTITUTIVE SECRETORY PATHWAY%GOBP%GO:1903433,0.147775991425509,0.514965886850433,0.772750279130345,1.29832024276619,1102,2,RAB33B|RAB27A
ALPHA-BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002287,0.405880808611184,0.743232206038237,-0.28571666698996,-1.03739090351836,3091,15,GPR183|BATF|RORA|SPN|PTGER4|STAT3|FOXP1
CELLULAR RESPONSE TO OLEIC ACID%GOBP%GO:0071400,0.44295391154203706,0.7658968186518771,0.779940449933833,1.0399453503940501,3334,1,DGAT2
TRIGEMINAL NERVE DEVELOPMENT%GOBP%GO:0021559,0.914916387959866,0.9740523336757891,-0.542346713718571,-0.72253604779882,6838,1,ISL1
HIGH-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0034384,0.47659126775381394,0.78501147478174,-0.40541678467742204,-0.9717066722287578,3623,5,APOC2|APOM|APOE
ADHESION OF SYMBIONT TO HOST%GOBP%GO:0044406,0.0612298071912454,0.35631208031004796,-0.512642862069462,-1.54215520995097,469,9,CD209|GAS6|PVRL2|CLEC4M|ICAM1|CD81
GUANINE SALVAGE%GOBP%GO:0006178,0.767577606792253,0.9202818175694271,-0.48006588419908097,-0.798906399614093,5785,2,HPRT1
DSRNA TRANSPORT%GOBP%GO:0033227,0.0811897106109325,0.397722753303477,0.8258064516129029,1.3874614628966102,605,2,RFTN1|FLOT1
CORONARY VASCULATURE DEVELOPMENT%GOBP%GO:0060976,0.0337519623233909,0.26217929082442604,-0.435019388482363,-1.6167004902982602,257,16,MESP1|NDST1|NOTCH1|APLNR|GATA6|TGFBR3|PDGFRB
PHOSPHOLIPASE C-ACTIVATING G PROTEIN-COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007207,0.137169312169312,0.50191360557578,-0.6825734121599971,-1.33289287642833,1036,3,CHRM2|GNA15
REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED PROTON TRANSPORT%GOBP%GO:1905706,0.6258193979933111,0.858842084733938,-0.6910564622849581,-0.920653140205634,4677,1,DNAJC30
PROTEIN-DNA COMPLEX REMODELING%GOBP%GO:0001120,0.7546891747052521,0.9158903477696649,0.47097227858632507,0.7912942377173879,5632,2,ERCC3|GTF2E1
POSITIVE REGULATION OF HISTONE H3-K27 METHYLATION%GOBP%GO:0061087,0.38690163072067296,0.733589579210772,-0.44024233149361996,-1.0551768626212,2941,5,OGT|PHF19
MICROTUBULE-BASED MOVEMENT%GOBP%GO:0007018,0.000139024051160851,0.00526859796630401,0.306982222326015,2.25093714734023,0,187,DYNLRB2|CFAP61|DYNC2H1|DYNC1I2|TTC30B|LRRC6|WDR19|TTC21B|DYNC2LI1|RABL2B|IFT88|DNAL4|TTC30A|WDR35|DNAI1|NPHP3-ACAD11|TTC21A|KIF9|RSPH9|KIF13A|MAATS1|KIF13B|LCA5|DCTN1|IFT46|IFT172|DYX1C1|KIFC3|KIF26B|KIF7|KIFC2|IFT20|IFT140|RFX3|DLG2|KIF3B|TRAK2|NDEL1|KIF26A|CLUAP1|RAB1A|WDR78|IFT81|HTT|TNPO1|WDR60|BLOC1S3|PCM1|CAMSAP3|RSPH4A|HAP1|DST|WDR66|TEKT2|GAS8|NPHP3|AP3B2|LRPPRC|IFT52|DNAH1|KIF5B|RPGR|TRAF3IP1|CCDC40|KIF3C|IFT27|AP3B1|RAB6A|KIF5A|SPG11|KIF21A|COPG2|MAP4|TRAK1|SPAST|ARHGAP21|KIF1A|AP3M1
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS%GOBP%GO:1903672,0.503256056264652,0.797399880195073,-0.209598328511853,-0.96594922384133,3863,31,S100A1|KIAA1462|MAP3K3|PIK3C2A|KLF4|KDR|SRPX2|FOXC2|ITGA5|JMJD8|HMOX1|RHOJ|APLNR|ANXA1
T-HELPER CELL DIFFERENTIATION%GOBP%GO:0042093,0.405880808611184,0.743232206038237,-0.28571666698996,-1.03739090351836,3091,15,GPR183|BATF|RORA|SPN|PTGER4|STAT3|FOXP1
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:1901020,0.0286918683709546,0.238792268557792,0.420224497997365,1.6449379902338799,210,18,FKBP1B|CRHR1|GSTM2|C19orf26|DRD4|GNB5|SRI|PKD2|YWHAE
REGULATION OF ACTIN FILAMENT LENGTH%GOBP%GO:0030832,0.755225028849853,0.916183794263895,-0.12802706847016498,-0.844225035909391,5889,117,KANK3|GSN|BAIAP2L1|CORO1B|HCK|CDC42EP4|CFL2|SEMA5A|ARPC5L|SLIT2|EPS8|CDC42EP1|CDC42EP5|TMSB4X|NCK1|ARF6|CDC42EP2
REVERSE CHOLESTEROL TRANSPORT%GOBP%GO:0043691,0.165402719665272,0.5375245857985801,-0.41819158678474894,-1.31013965048077,1264,10,ABCA1|SCARB1|CLU|APOC2|ABCA5|ABCG1|CETP|APOM|APOE
REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:1905562,0.7405200433369449,0.909493931144346,0.21142082884761804,0.7798442866405849,5467,15,ADAM17|FGF2|SP1|PLCG1|AKT3|FGFR1|PDPK1
TRANSCRIPTIONAL START SITE SELECTION AT RNA POLYMERASE II PROMOTER%GOBP%GO:0001174,0.7525567804489308,0.915314007578303,0.6242831936479929,0.832397402415091,5665,1,GTF2B
XYLULOSE 5-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:1901159,0.6751709626512359,0.882488012133495,-0.34305650942725396,-0.8222409918898811,5133,5,CRYL1
REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION%GOBP%GO:0060142,0.13990044537595003,0.504314492208813,-0.41702549420254,-1.3501424742866,1067,11,CD53|MAPK14|ADAM9|CAMK1|EHD1|RAPGEF3|EHD2|ADGRB1
RESPONSE TO MUSCLE ACTIVITY INVOLVED IN REGULATION OF MUSCLE ADAPTATION%GOBP%GO:0014873,0.49056856187291,0.7903790206418191,-0.757995147772386,-1.0098315422011401,3666,1,AGT
CELLULAR RESPONSE TO BACTERIAL LIPOPEPTIDE%GOBP%GO:0071221,0.0282745923198317,0.23806191359062198,-0.683956551071046,-1.63931334199474,214,5,TLR1|TLR2|CD36|CD14
NEGATIVE REGULATION OF OLIGODENDROCYTE PROGENITOR PROLIFERATION%GOBP%GO:0070446,0.866889632107023,0.9555750264459809,-0.569585355094839,-0.758824458495508,6479,1,SIRT2
NEGATIVE REGULATION OF METHYLATION-DEPENDENT CHROMATIN SILENCING%GOBP%GO:0090310,0.678528428093645,0.884536278926676,-0.6648103220114691,-0.885686979291417,5071,1,TET1
COBALAMIN METABOLIC PROCESS%GOBP%GO:0009235,0.46759198638208704,0.780769690730001,-0.285839791378037,-0.9839159925201,3570,13,MMAB|ABCC1
"PHAGOCYTOSIS, RECOGNITION%GOBP%GO:0006910",0.00013048016701461398,0.00518555396908895,-0.558310260796718,-2.43545131536497,0,26,IGHV2-26|IGHV1OR15-1|IGHV5-51|FCN3|IGHV1-24|IGHV3-49|IGHG4|IGLL5|IGHV4-4|IGHV4-61|IGHV1-3|IGHV3-43|FCN1|IGHV3-73|CLEC7A|COLEC12|IGHV3-15|IGHV1-18|IGHG2|IGHA1|ADGRB1
DENDRITIC TRANSPORT%GOBP%GO:0098935,0.689868314969094,0.887051934478962,0.416871301914832,0.819936656816294,5133,3,KIF5A|KIF5C|KIF17
REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY%GOBP%GO:0032412,0.570079177663564,0.8324048186805392,0.13575275072637902,0.9461676172665409,4103,147,FKBP1B|CRHR1|ABCB1|TCAF2|ANK2|GSTM2|C19orf26|DMD|RANGRF|EPHB2|ANXA3|RNF207|CACNG7|DRD4|KCNIP2|MINK1|RIPK1|GNB5|PRKCE|HTT|CACNB4|SRI|PTPN3|GAL|HAP1|SUMO1|NEDD4|CACNG4|NETO1|PTK2B|PKD2|DLG4|YWHAE|NLGN2|CACNB2|KCNG1|CAMK2D|JPH3|YWHAH|NEDD4L|STAC2|CHP1|DAPK1|HOMER1|SHANK2
ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0009067,0.774697649137111,0.923210645518754,0.197911581872531,0.7610289964889091,5700,17,AASS|MTHFR|AASDHPPT|MRI1|ENOPH1|CTH|MTAP|PLOD3
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002285,0.10554191964862401,0.44738616127788,-0.26004714788787,-1.34712604946343,816,46,RORC|MFNG|CD180|DOCK11|DOCK10|LILRB1|GPR183|CORO1A|BATF|EXO1|RORA|SPN|FCGR2B|PTGER4|STAT3|RNF168|ICAM1|FCER1G|SLC11A1|NOTCH2|VAMP7|EXOSC3|FOXP1
NEGATIVE REGULATION OF NITROSATIVE STRESS-INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1905259,0.0474927036349164,0.312255783864335,-0.856906534325889,-1.42602950277589,357,2,PARK7|DNAJA1
POSITIVE REGULATION OF CARDIAC CONDUCTION%GOBP%GO:1903781,0.0123258306538049,0.14674915992642998,0.9304659498207891,1.56330293302066,91,2,TRPM4|RNF207
SUPPRESSION BY VIRUS OF HOST AUTOPHAGY%GOBP%GO:0039521,0.580602006688963,0.8387093286508721,-0.7141596823996469,-0.9514321768086949,4339,1,ATG7
ACTIN FILAMENT CAPPING%GOBP%GO:0051693,0.515336590662324,0.803478510349408,0.287203712886438,0.9450765700001501,3796,11,ADD3|TRIOBP|TWF1|ADD1
METANEPHRIC S-SHAPED BODY MORPHOGENESIS%GOBP%GO:0072284,0.0723472668810289,0.378321151505122,0.8341328921974079,1.4014509581488401,539,2,PAX8|PKD2
HYDROGEN PEROXIDE CATABOLIC PROCESS%GOBP%GO:0042744,0.431449502878074,0.759969710398191,-0.273472316234661,-1.01632901761458,3297,16,CAT|GPX3|PRDX4|PRDX5
CELL PROLIFERATION INVOLVED IN HEART VALVE DEVELOPMENT%GOBP%GO:2000793,0.17598618674458802,0.548366806412612,0.9138729598588441,1.21852628048293,1324,1,TWIST1
PTERIDINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042558,0.687369519832985,0.8864984516746409,-0.191808095495669,-0.8367019402544409,5267,26,MTHFD2|ALDH1L2|TYMS|ST20-MTHFS|SLC19A1|GGH|FTCD|DHFR|SHMT2|FOLR2|MTHFD1
POSITIVE REGULATION OF I-KAPPAB PHOSPHORYLATION%GOBP%GO:1903721,0.6940476190476189,0.889500280068691,-0.419489697360757,-0.819157059718824,5246,3,CX3CL1
REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:1903050,0.0319681602259597,0.25428660014511,-0.202514290536008,-1.42079556582067,248,159,OGT|CBFA2T3|ATPIF1|PSMF1|BAG5|GPX1|VCP|RNF144B|UBE2G2|FMR1|EFNA1|CCDC22|CEBPA|UBQLN1|SUMO2|PSME2|PARK7|UBXN1|ALAD|HERPUD1|RAD23B|NKD2|RCHY1|HFE|PSMD10|APOE|PLK1|GIPC1|ECSCR|CTSC|ARAF|TLK2|EPHA4|BCAP31|CAV1|DERL3|PRKACA|DAB2|TAF9|CSNK1A1|MAGEF1|AK6|FAM122A
"FRUCTOSE 1,6-BISPHOSPHATE METABOLIC PROCESS%GOBP%GO:0030388",0.17823343848580397,0.551106044578679,-0.473797647293813,-1.29510474017316,1355,7,ALDOA|ALDOC
REGULATION OF ENDODERMAL CELL FATE SPECIFICATION%GOBP%GO:0042663,0.37124866023579906,0.7231271705612199,0.6508311237622559,1.09348032012846,2770,2,DKK1
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY%GOBP%GO:0030514,0.24609528809555103,0.6280519349499749,-0.29079686035065805,-1.1847085029045499,1874,21,SKIL|LEMD3|SMAD6|NOTCH1|SMURF2|HTRA3|CHRD|FBN1|NBL1
NEGATIVE REGULATION OF INSULIN SECRETION%GOBP%GO:0046676,0.534917301128905,0.8128799251234909,-0.25730945386376997,-0.9342489174316551,4074,15,INHBB|REST|PIM3|IRS1|NOV|CHGA|SIRT4
TRANSEPITHELIAL CHLORIDE TRANSPORT%GOBP%GO:0030321,0.447486772486772,0.768229288546963,-0.525643912893283,-1.02644933797852,3382,3,SLC12A2|BEST1
INTERLEUKIN-17 SECRETION%GOBP%GO:0072615,0.42807809802098495,0.756202814008058,0.7867776797529781,1.04906187379093,3222,1,ZBTB7B
LIPOPROTEIN TRANSPORT%GOBP%GO:0042953,0.238089039312679,0.6217283213739421,-0.42125602519226396,-1.21273713734971,1828,8,CD36|PPARG|PRKCB
REGULATION OF CELL-CELL ADHESION INVOLVED IN GASTRULATION%GOBP%GO:0070587,0.368677305923722,0.721792732107131,0.38796476818806797,1.0709663290000602,2725,7,MAPK7|MAP2K5
ICOSANOID CATABOLIC PROCESS%GOBP%GO:1901523,0.9378403506441758,0.9806508984207809,0.531815174239083,0.709103775507291,7060,1,ABHD16A
HETERODUPLEX FORMATION%GOBP%GO:0030491,0.57056856187291,0.832967732120703,-0.718736215262462,-0.957529217472308,4264,1,RPA2
IMMUNOGLOBULIN PRODUCTION%GOBP%GO:0002377,0.0015501873143004801,0.0323260517898055,-0.38389547501531496,-1.98869935265454,11,46,BATF|IGKV1-8|EXO1|IGLV3-9|IGLV11-55|IGLV8-61|IGKV2-28|IGLV4-60|IGKV2D-29|RNF168|POLQ|IGLV7-46|IGLV5-45|IGKV2D-28|IGKV2-24|IGLV4-69|IGLV9-49|EXOSC3|IGLV3-10|IGKV1-6|IGKV1-27|SAMHD1
AXON EXTENSION INVOLVED IN AXON GUIDANCE%GOBP%GO:0048846,0.302395209580838,0.675222663526765,-0.395313018099176,-1.13805085092341,2322,8,NRP2|SLIT2|SEMA3A
MEMBRANE FUSION INVOLVED IN VIRAL ENTRY INTO HOST CELL%GOBP%GO:0039663,0.0152471083070452,0.166148433567765,-0.6387085015856769,-1.7458812062854,115,7,HYAL2|CD4|PPIA|GAS6|PVRL2|CXCR4
REGULATION OF NEURON PROJECTION DEVELOPMENT%GOBP%GO:0010975,0.0406162464985994,0.288441534418227,0.17116704511607997,1.33144044472006,289,259,RET|ISLR2|SHTN1|ADGRB3|SLITRK1|CPNE9|SEMA4G|SYT2|SEMA4F|KIF13B|PLXNB1|ULK4|RTN4IP1|SS18L1|RTN4|INPP5J|SEMA6C|PTK7|CCDC88A|RIMS1|CHN1|PTPRO|STK24|ROBO2|CHRNB2|NDEL1|PTPRS|ZSWIM4|EFNB2|BMP7|PTPRD|UNC13A|EFNB3|SCARB2|RIMS2|CDK5R1|SEMA4C|PTPN9|SARM1|RUFY3|MAP6|ADCYAP1|CAPRIN2|DVL2|TRIM46|CUX2|LIMK1|STMN2|NEDD4|CUL7|LRRC7|PAK1|TWF1|CRMP1|PTK2B|NRCAM|INPP5F|FOXO6|SIPA1L1|MAP2|ADCY6|GRIP1|DLG4|BRSK1|VLDLR|LINGO1|FBXO7|ZSWIM8|CBFA2T2|TENM3|C21orf91|PLXNB2|CAMK1D|POU4F2|MOV10|YWHAH|NEDD4L|CERS2|NRP1|ZFYVE27|DCC|MEGF8|OBSL1
ANGIOGENESIS%GOBP%GO:0001525,0.00012768130745658798,0.00518555396908895,-0.33436293371277803,-2.25982722132359,0,132,JAG1|IL18|ADAM8|EPHB3|TBX1|SAT1|SOX18|COL23A1|SOX17|FGFR4|KDR|PLXND1|CD34|RORA|APOLD1|MED1|SFRP2|PRCP|ATPIF1|VEGFC|THY1|ITGA5|ATP5B|FLT4|CALCRL|HOXB3|COL4A1|JMJD6|HMOX1|PIK3R3|CCL2|CEACAM1|ROBO4|VEGFB|NOV|CCBE1|NRP2|ADIPOR2|TGFBR2|THBS1|TEK|SEMA5A|SRF|PDGFRB|SEMA3E|SLIT2|ID1|SERPINE1|ADGRA2|RASIP1|MYH9|ANG|EPHB4|TGFBI|ADGRG1|PDGFA|ANXA2|PDGFRA|ENG|ACVRL1|LOXL2
VENTRAL SPINAL CORD DEVELOPMENT%GOBP%GO:0021517,0.503685503685504,0.797546192421419,0.31360901000827,0.953028857258607,3689,9,DCTN1|ASCL1|GATA2
HEPARIN CATABOLIC PROCESS%GOBP%GO:0030211,0.47894806747244,0.7850984235874658,0.761138067931187,1.01487491105263,3605,1,IDUA
CELLULAR RESPONSE TO INTERLEUKIN-18%GOBP%GO:0071351,0.0433982114676486,0.29791299041195396,-0.657015221707479,-1.5747401163890902,329,5,AKT1|ALOX5|IL18|IL18BP|PDGFB
REGULATION OF INTERLEUKIN-4 PRODUCTION%GOBP%GO:0032673,0.00693444982336779,0.10038585972447,-0.49342443366949,-1.8751333403216899,52,17,RARA|FOXP3|SYK|HLA-E|NDFIP1|GATA3|FCER1G|CEBPB|CD86|NLRP3|LGALS9|ZP3|HAVCR2
CELLULAR RESPONSE TO OXIDISED LOW-DENSITY LIPOPROTEIN PARTICLE STIMULUS%GOBP%GO:0140052,0.16745531019979001,0.5398534927425961,-0.480045236636682,-1.3121822470346298,1273,7,CD36|TICAM1|TLR4
CELLULAR RESPONSE TO HYPEROXIA%GOBP%GO:0071455,0.264886794922131,0.640220404364478,-0.545656326094959,-1.19455576048743,2023,4,FAS|ATG7|CAV1
REGULATION OF FATTY ACID OXIDATION%GOBP%GO:0046320,0.725319553984226,0.9040629990111769,0.203940319408303,0.798309429207178,5333,18,PRKAG2|IRS2|TWIST1|ACADVL|NR4A3
POLY-N-ACETYLLACTOSAMINE METABOLIC PROCESS%GOBP%GO:0030309,0.436065573770492,0.7626710012154501,0.34737908953460106,1.00838072431801,3191,8,B3GNT9|B3GNT2|B3GNT7
METABOLISM OF MACROMOLECULE IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052229,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
REGULATION OF FIBROBLAST MIGRATION%GOBP%GO:0010762,0.557679717166427,0.826537837479255,-0.26687715418069397,-0.9186429180161129,4258,13,TGFB1|GNA12|HYAL2|CORO1C|PRR5L|DDR2|THBS1
NEGATIVE REGULATION OF MITOTIC DNA DAMAGE CHECKPOINT%GOBP%GO:1904290,0.9479598662207359,0.984208682089217,-0.524702249669166,-0.6990293849993471,7085,1,PPP1R10
AMINO ACID SALVAGE%GOBP%GO:0043102,0.731325618095739,0.9074802896081321,-0.327001753281015,-0.7837608049367958,5560,5,ADI1|APIP
NEGATIVE REGULATION OF TELOMERE MAINTENANCE%GOBP%GO:0032205,0.730060506050605,0.9066085813365379,0.16796117260195598,0.8193223149962141,5308,36,CTC1|SMG6|EXOSC10|ATM|ACD|TEN1|PIF1|RTEL1|POT1|XRCC5|TNKS|SRC|ERCC1|TNKS2
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS%GOBP%GO:2001028,0.0294618305617389,0.24359329801945,-0.481785118430816,-1.6583978063268798,224,13,KDR|P2RX4|SMOC2|PRKD1|HSPB1|SEMA5A|LGMN|TMSB4X
CGMP BIOSYNTHETIC PROCESS%GOBP%GO:0006182,0.481743227326266,0.786054133284731,-0.444287588391062,-0.9726384037802801,3680,4,GUCY1B3|NPR2|NPR1
POSITIVE REGULATION OF OVARIAN FOLLICLE DEVELOPMENT%GOBP%GO:2000386,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION%GOBP%GO:1904465,0.146755852842809,0.514049001465687,-0.9252315835906478,-1.2326306305474,1096,1,CD200
T CELL CYTOKINE PRODUCTION%GOBP%GO:0002369,0.0353174603174603,0.267780812741458,-0.7865752331767539,-1.5359820737208798,266,3,SLC11A1|CD55
POSITIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0010641,0.9160052910052909,0.9747669359607141,-0.32205687173018394,-0.6288954455104571,6924,3,F3
NEPHRON MORPHOGENESIS%GOBP%GO:0072028,0.24966023375917398,0.630296201866725,0.315359729766885,1.18743397340163,1836,16,CITED1|PAX8|AHI1|FGF2|PKD1|PKD2|FGF1
NEGATIVE REGULATION OF LONG-TERM SYNAPTIC DEPRESSION%GOBP%GO:1900453,0.7789864685593,0.924704689181848,-0.47317808552403395,-0.7874440011769921,5871,2,FMR1
SNRNA TRANSCRIPTION BY RNA POLYMERASE III%GOBP%GO:0042796,0.548391475498846,0.818959666222967,0.351442281175887,0.909377558654404,4039,6,ZC3H8|ICE2|SNAPC4|ICE1|ELL|SNAPC1
POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION%GOBP%GO:0002666,0.0660652693022022,0.369007394574627,-0.8342431761786601,-1.3883140506754499,497,2,LILRB2|TGFBR2
CENTROSOME SEPARATION%GOBP%GO:0051299,0.0534817429075607,0.335115832119604,0.6048776981641789,1.5651565958443898,393,6,CNTROB|KIF3B|NDEL1
REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0046626,0.0222509702457956,0.20655735327389102,-0.3383330413054261,-1.62916827621247,171,36,FAM132A|SIK2|SLA2|KANK1|SOCS3|PID1|OGT|INS|MZB1|IRS1|SOCS1|GKAP1|CISH|NUCKS1|PTPRE|RPS6KB1|NCK1|PRKCB|GRB10
NUCLEAR DIVISION%GOBP%GO:0000280,0.45719046398359403,0.7719619284439659,-0.136944419214893,-1.00087397402089,3566,196,MAD1L1|SPAG5|RHOA|KIF25|CENPE|KIF2C|CDCA8|NIPBL|GOLGA2|PAPD7|C17orf104|BECN1|VPS4A|NCAPG|BLM|NDE1|FIGNL1|TUBG1|RAD54B|BCCIP|CHMP5|RAD21|INO80|PINX1|ZNF207|ZWINT|TUBGCP5|RACGAP1|TRIP13|NCAPD3|KNSTRN|CEP192|EME2|KLHL22|KIF11|MYBL1|DMC1|NCAPH|RAD51|PIM2|RPA2|NUSAP1|NUF2|DLGAP5|MLH3|NSL1|SPDL1|BRIP1|CDT1|SMC2|DSN1|ESPL1|OFD1|GSG2|TUBGCP2|RAD51C|TUBG2|CDC23|TPX2|BOD1|KPNB1|PTTG1|TOP2A|NCAPH2|KIF18B|UBE2S|STRA13|KIF4A|NAA50|NDC80|SGOL1|EME1|KIF18A|SPICE1|RMI1|FLNA|REC8|RAN|RAD51B|SMC4|KIFC1|KIF2A|CCNB1|PLK1|CHMP4A|CHMP6|FANCM|SMC1A|EPS8|KIF22|SYCE2|MUS81|CDCA5
HISTONE H3-K9 METHYLATION%GOBP%GO:0051567,0.531562335612835,0.812079525085925,-0.38769718991824703,-0.929236184800912,4041,5,SUV39H1
PHOSPHOLIPID CATABOLIC PROCESS%GOBP%GO:0009395,0.349600942038467,0.70736446849153,-0.284929425365559,-1.08280139507549,2671,17,GDE1|PLA2G4D|PLA2G4A|SMPDL3A|PLA2G4C|SMPD1
REGULATION OF EXTENT OF CELL GROWTH%GOBP%GO:0061387,0.41898436418984397,0.7505462471982691,0.18651927121423698,1.02339020400727,3027,54,ISLR2|SHTN1|SEMA4G|SEMA4F|RTN4|SEMA6C|PTPRS|SEMA4C|RUFY3|TRIM46|LIMK1|NRCAM|MAP2|POU4F2|NRP1|ZFYVE27|DCC|MEGF8
CELL VOLUME HOMEOSTASIS%GOBP%GO:0006884,0.260969664138678,0.6368800456015129,0.318960001944997,1.1765119668647,1926,15,SLC12A5|SLC12A4|SLC12A9|CLCN3|KCNMA1|CLCN6|SLC12A6|SLC12A7
REGULATION OF CARGO LOADING INTO COPII-COATED VESICLE%GOBP%GO:1901301,0.00615384615384615,0.0917316347019317,-0.9973533303925891,-1.32871411474025,45,1,INSIG1
POSITIVE REGULATION OF MELANIN BIOSYNTHETIC PROCESS%GOBP%GO:0048023,0.7554930332261519,0.916183794263895,0.470692031982355,0.790823387238614,5638,2,ZEB2|CDH3
DNA-TEMPLATED TRANSCRIPTIONAL START SITE SELECTION%GOBP%GO:0001173,0.7525567804489308,0.915314007578303,0.6242831936479929,0.832397402415091,5665,1,GTF2B
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035357,0.251446607048922,0.63199381686708,-0.5016423973497189,-1.2023411042673,1911,5,PDK3|PPARG
REGULATION OF ERK1 AND ERK2 CASCADE%GOBP%GO:0070372,0.000128008192524322,0.00518555396908895,-0.305732115196409,-2.24819704207961,0,202,CD44|ACKR3|TGFB1|TNFAIP8L3|CCL11|LYN|GPR183|CHI3L1|FLT1|SCIMP|PYCARD|CD74|ARHGEF5|CCL19|EPHB3|DAB2IP|MERTK|CD4|FGFR4|KDR|SEMA6A|CCL24|SPRY1|SYNJ2BP|PLA2G2A|TNFRSF11A|PDGFD|EPHA8|GAS6|CCL3L3|DDR2|CCL18|SLC9A3R1|MARCO|MST1R|PDGFC|FLT4|NOTCH1|GPNMB|GCNT2|PTPN6|ICAM1|ARRB1|CTGF|NOTCH2|FGF10|MAPK3|TIMP3|DDR1|NECAB2|HRAS|NTRK2|TREM2|TNIP1|SEMA7A|P2RY6|CCL2|CEACAM1|GPER1|EPHA2|F2R|CCR1|APOE|RAP1A|FN1|AXL|FGF19|CD36|BMP2|TGFBR3|LGALS9|TEK|PDGFRB|C3orf33|EPHA4|CX3CL1|CCL4L2|CCL14|ATP6AP1|ARHGAP8|INSRR|EPHB4|TLR4|PDGFA|CSF1R|PDGFRA|RRAS|GSTP1|PHB|GLIPR2|TIE1|APIP|PDGFB|C5AR1|FBLN1|SERPINF2|SIRPA|WNK2
NEGATIVE REGULATION OF PROTEIN TRANSPORT%GOBP%GO:0051224,0.0257751690697971,0.225019807572435,-0.234891632347636,-1.5094506442653501,201,104,LILRB1|RGCC|INHBB|LGR4|NDFIP1|SP100|APOD|REST|RHBDF2|PPM1F|PIM3|CD34|GDI1|SSC5D|FCGR2B|GAS6|INS|MDFIC|UBE2G2|TNFAIP3|PTGER4|IRS1|PARK7|PDE2A|CARD16|RSAD2|SRGN|TNFRSF4|NR1H3|F2R|FN1|NLRP3|NOV|CHGA|TNFRSF21|CD200|CX3CL1|SIRT4|DERL3|SERGEF|RAB11FIP1|ANXA1|TMSB4X|INSIG1
SUBSTRATE-DEPENDENT CELL MIGRATION%GOBP%GO:0006929,0.875457875457876,0.9605256252569351,-0.182383929763279,-0.677809303395613,6691,16,ITGA11|EPHA8|VEGFC|NTN1|SLIT2
REGULATION OF SINGLE STRAND BREAK REPAIR%GOBP%GO:1903516,0.23161375661375697,0.6150986887877521,-0.6240211756920699,-1.2185551986098,1750,3,XRCC1|TERF2|PARP1
COUMARIN METABOLIC PROCESS%GOBP%GO:0009804,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION%GOBP%GO:0046940,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
DCTP CATABOLIC PROCESS%GOBP%GO:0006253,0.43959866220735794,0.7650340344477281,-0.7818703131892372,-1.04163899530167,3285,1,DCTPP1
RESPONSE TO BENOMYL%GOBP%GO:1901561,0.48494983277591996,0.7872939093021379,-0.7604212615791801,-1.01306370833606,3624,1,IMPACT
CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE%GOBP%GO:0070192,0.454422321549506,0.770794980018249,0.24116707482807997,0.9941271090069158,3354,21,SYCE1|RNF212|C14orf39|CCNB1IP1|SYCP2|CCNE1|P3H4|MSH5|STAG3|BAG6
LEPTIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0033210,0.14809284647753498,0.515403737647103,0.5213924275249759,1.3491335511968798,1090,6,BBS4|MKKS|LEPR|BBS2|SIRT1
SINUS VENOSUS DEVELOPMENT%GOBP%GO:0003235,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
NEGATIVE REGULATION OF DNA LIGASE ACTIVITY%GOBP%GO:1904876,0.971505016722408,0.9915747942934481,-0.513950154389061,-0.684705012355918,7261,1,TFIP11
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:0036481,0.5850750267952839,0.839854222268064,0.555669649408642,0.933596756419086,4366,2,STK25|PDCD10
ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0034220,0.0668023921618527,0.3690551432905871,-0.153033563453722,-1.2497697915166102,524,380,KCND2|RYR2|SLC19A1|GABRE|SLC36A1|TCIRG1|ITPR2|SLC25A20|ATP6V0B|ATP1B1|CCDC109B|ATP2A1|APOL1|P2RX4|SLC12A8|ATP6V0A2|ERO1L|SLC39A3|ATP5J|SLC7A2|ATP6V1G2|ITPR3|SLC8B1|ATP1A3|ATP11B|ATP5F1|SLC12A2|PMPCA|ATP1B3|SLC25A10|SLC25A18|P2RX5|KCNN2|P2RX3|GAS6|ATP6V1F|ANXA6|KCNK6|SLC39A8|CACNA1H|ATP2A3|GRIN1|SLC35B1|SLC41A1|ATP5B|SLC37A2|SGK1|KCNK7|SLC1A2|ATP6V0D1|SLC9A1|RHBG|CACNA2D4|PKD2L1|ATP8B1|SLC26A2|SLC39A11|ABCC9|CLCN4|SLC9A7|SLC11A1|CACNA1G|MRS2|NALCN|SLC1A3|SLC25A22|NDUFS7|SLC38A6|SLC9A9|ATP5O|KCNJ12|SLC6A8|LRRC8A|SLC35A2|KCNN1|SLC24A3|HFE|TPCN2|F2R|KCNQ1|TSC22D3|STEAP4|CHRNE|SLC7A3|TMCO1|KCNB2|ATP6V0E1|ASPH|GRIN2C|BEST1|GRIN2D|FKBP1A|SLC3A2|RHCE|SCN1B|STOML2|CHRNA10|ATP6AP1|ATP1B2|KCNH2|ATP6V0E2|KCNE4|ATP5H|ARL6IP5|SLC25A42|PRAF2|KCNJ9|MPC1|PHB|ATP2B2|SLC25A19|ATP6V1A|SLC38A9|GABRQ|ATP6V1G1|ATP5G1|ABCC1
REGULATION OF HISTONE H3-K36 METHYLATION%GOBP%GO:0000414,0.5146037982973151,0.8030810575910721,-0.3671955147042751,-0.944525781189155,3928,6,BRD4|BCOR|NSD1|PAXIP1
DNA ENDOREDUPLICATION%GOBP%GO:0042023,0.7997077965201221,0.931670998922663,0.599966916629907,0.799974928076188,6020,1,ZPR1
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002582,0.1950119395065,0.5697855203224189,-0.7363661428177559,-1.22543101544847,1469,2,PYCARD|TREM2
GOLGI CALCIUM ION TRANSPORT%GOBP%GO:0032472,0.556778986468559,0.8257201392411401,-0.576785221946512,-0.9598628442108009,4196,2,TMEM165|ATP2C1
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT%GOBP%GO:0061311,0.836392239119035,0.946051571565932,-0.19908253608531895,-0.7043249000912779,6379,14,TGFB1|JAG1|NOTCH1|NOTCH2|SNAI1
C-X-C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY%GOBP%GO:0038159,0.32428093645485,0.692794968343412,-0.8357410674900749,-1.11340777516132,2423,1,CXCR4
PEPTIDYL-CYSTEINE DEGLYCATION%GOBP%GO:0036526,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
HISTONE H3 DEACETYLATION%GOBP%GO:0070932,0.7527800379712499,0.915314007578303,0.214680624852836,0.771641820387444,5550,14,HDAC1|SMARCAD1|HDAC4|SIRT1|HDAC2
NEGATIVE REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS%GOBP%GO:1901859,0.776331518129898,0.9241536998094619,0.6111601235112479,0.8148995591210799,5844,1,LIG3
MHC CLASS IB PROTEIN COMPLEX ASSEMBLY%GOBP%GO:0002398,0.48842809364548495,0.788277714516235,-0.7590427878253199,-1.01122725030486,3650,1,TAPBP
LYMPHOCYTE CHEMOTAXIS ACROSS HIGH ENDOTHELIAL VENULE%GOBP%GO:0002518,0.327002257935981,0.6941148928066879,0.8358513453903841,1.1144949852685402,2461,1,CXCL13
TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY%GOBP%GO:0034138,0.4866229866229871,0.787854460989665,0.318229963918589,0.9670715100015229,3564,9,RFTN1|RIPK1|CASP8|TNIP2|SCARA3
POSITIVE REGULATION OF ODONTOBLAST DIFFERENTIATION%GOBP%GO:1901331,0.10755852842809402,0.451309145449614,-0.944199382443758,-1.25790029305683,803,1,SERPINE1
SUBSTRATE ADHESION-DEPENDENT CELL SPREADING%GOBP%GO:0034446,0.7947678221059521,0.929656485793048,-0.166342426676923,-0.759486954216043,6075,30,RAC1|FGFRL1|LAMC1|PEAK1|EPHB3|MICALL2|ILK|EFNA1|FN1|TEK|ITGA8|FERMT3
SYNAPSE ASSEMBLY INVOLVED IN INNERVATION%GOBP%GO:0060386,0.579397993311037,0.838539733218918,-0.714766210851345,-0.952240218342427,4330,1,FBXO45
SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY%GOBP%GO:0000491,0.6230023578726751,0.8570098885895309,-0.26725474530579196,-0.865251616767461,4755,11,TAF9|AK6
REGULATION OF TRANSLATION AT SYNAPSE%GOBP%GO:0140243,0.33672240802675607,0.699462084003389,-0.8287935597706221,-1.10415202668403,2516,1,FMR1
REGULATION OF MULTI-ORGANISM PROCESS%GOBP%GO:0043900,0.000127599846880184,0.00518555396908895,-0.27603235758337896,-2.09114046030796,0,239,SEC14L1|CD74|PARP10|TRIM21|PLCB1|SMARCA4|ZNF639|RNF216|REST|DTX3L|TSG101|OASL|OAS1|PARP9|CD4|TRIM28|PPIA|RAB7A|TRIM44|HYAL3|LARP1|ARHGDIB|CCNK|CAV2|LY86|CACNA1H|MDFIC|TOP2A|PPIB|PVRL2|TNFAIP3|FMR1|PLSCR1|DDX3X|HS3ST5|PDE12|DDX60|INHBA|SMURF2|MB21D1|IFIT1|APOBEC3G|TRIM32|SNW1|ISG15|NUCKS1|CARD16|CALR|RSAD2|IGF1|APOBEC3C|FCN1|NPLOC4|IFI16|TNIP1|TMEM173|GSN|APOE|GAPDH|SASH1|CD36|BST2|SNF8|LGALS9|ZP3|POMZP3|ADARB1|SYDE1|FOXP1|IFNLR1|RRP1B|CX3CL1|CAV1|TRAF3|DDB1|OSBP|CFL1|DHX58|IFITM1|BTBD17|ANXA2|TIMP1|LGALS1|CD55|IFITM2|FAM3A|IFITM3|PQBP1|MID2|LHFPL2|BANF1|PSMC3|APOBEC3F|P4HB|RNF26
CELLULAR STRESS RESPONSE TO ACID CHEMICAL%GOBP%GO:0097533,0.758158662775272,0.917143966125732,-0.4868486352357321,-0.810193981982521,5714,2,VEGFA|KLF2
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT%GOBP%GO:0010976,0.41503633314700894,0.749146235776308,0.14789268250030302,1.02429838374358,2969,143,RET|ISLR2|SHTN1|SLITRK1|CPNE9|SYT2|PLXNB1|SS18L1|PTK7|RIMS1|ROBO2|BMP7|PTPRD|UNC13A|SCARB2|RIMS2|RUFY3|MAP6|ADCYAP1|CAPRIN2|DVL2|CUX2|LIMK1|STMN2|CUL7|LRRC7|TWF1|PTK2B|FOXO6|GRIP1|DLG4|VLDLR|CBFA2T2|TENM3|C21orf91|PLXNB2|CAMK1D|POU4F2|NEDD4L|NRP1|ZFYVE27|MEGF8|OBSL1
TELOMERE TETHERING AT NUCLEAR PERIPHERY%GOBP%GO:0034398,0.0663545150501672,0.3690551432905871,-0.964986766651963,-1.28559408016746,495,1,NUP98
NEGATIVE REGULATION OF DEACETYLASE ACTIVITY%GOBP%GO:0150066,0.962013547615885,0.9905437927174009,0.518912659902956,0.6919000136131801,7242,1,KDM5A
REGULATION OF INTRACELLULAR LIPID TRANSPORT%GOBP%GO:0032377,0.31879502292076,0.6867397844771489,-0.43490949971612497,-1.1187043918463602,2433,6,SCP2|ABCA2|ANXA2
COCHLEA MORPHOGENESIS%GOBP%GO:0090103,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
TRANSEPITHELIAL WATER TRANSPORT%GOBP%GO:0035377,0.589565217391304,0.8414799095069009,-0.709803705337451,-0.945628969430075,4406,1,AQP1
ONCOGENE-INDUCED CELL SENESCENCE%GOBP%GO:0090402,0.964414715719064,0.990916952887267,-0.5177547419497129,-0.6897736365220539,7208,1,HMGA1
ONCOSIS%GOBP%GO:0070267,0.23304347826087,0.616933025883855,-0.880348478164976,-1.17283555705124,1741,1,TMEM123
BONE REMODELING%GOBP%GO:0046849,0.532363339679086,0.812079525085925,0.23975239078936,0.9384931572011529,3914,18,LRP5L|EFNA4|RAB3D|EFNA2|PTK2B|LRP6|P3H4|SRC
ERROR-FREE TRANSLESION SYNTHESIS%GOBP%GO:0070987,0.063214614272572,0.36006266503904,-0.378346410941909,-1.49481137302385,480,19,SPRTN|RFC2|RPA2|RFC3|PCNA|VCP|RFC5|NPLOC4|RCHY1|UBC|RFC4
RELEASE FROM VIRAL LATENCY%GOBP%GO:0019046,0.10002653223666802,0.43605057892447596,-0.8022056796250351,-1.33499853322932,753,2,HCFC1|NUCKS1
MUSCLE CELL DEVELOPMENT%GOBP%GO:0055001,0.19397807686970997,0.568081639653546,0.22551317333200802,1.2162881924618603,1397,51,NEBL|CHRNB1|BIN1|TMOD3|ANK2|OBSCN|SDC1|ALPK3|DMD|NEB
REGULATION OF CARDIAC CONDUCTION%GOBP%GO:1903779,0.38969580707043,0.7358910495632479,0.211455772406305,1.04779424339817,2843,38,TRPM4|FKBP1B|TMEM65|ANK2|TNNI3K|RANGRF|RNF207|SRI|RYR1|DMPK|ATP2B4|ITPR1|CAMK2D|SLC8A2
POSITIVE REGULATION OF MESODERM DEVELOPMENT%GOBP%GO:2000382,0.6336830920440961,0.8631726958478259,0.680359505955007,0.9071675983394991,4770,1,SMAD2
MEDULLARY RETICULAR FORMATION DEVELOPMENT%GOBP%GO:0021723,0.9689632107023409,0.9912626134248801,-0.514832377591531,-0.6858803454958909,7242,1,PHOX2B
RESPONSE TO INTERLEUKIN-1%GOBP%GO:0070555,0.00460593654042989,0.0752560935123842,-0.266626599863249,-1.7015048194949098,35,101,CCL11|FBXW11|HYAL2|CHI3L1|MAP3K3|PYCARD|PLCB1|IRAK3|IGBP1|CCL19|DAB2IP|CCL24|RBMX|HYAL3|TNFRSF11A|IL1RN|CCL3L3|CCL18|CD47|MAPK3|IL1RAP|IRAK1|SKP1|CCL2|NFKBIA|HYAL1|LGALS9|UBC|CX3CL1|CCL4L2|CCL14|RELA|IL1R1|MAPK13|NFKB1|RPS6KA4|TAF9|ANXA1|TOLLIP|PELI3|AK6|SQSTM1|SIRPA|PTGIS
NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR%GOBP%GO:2000545,0.327002257935981,0.6941148928066879,0.8358513453903841,1.1144949852685402,2461,1,CXCL13
NCRNA METABOLIC PROCESS%GOBP%GO:0034660,0.3732867132867129,0.72448157257017,0.122376722338372,1.0300161456213,2668,433,GPAT2|TDRD12|FDXACB1|HENMT1|SSB|WDR12|PUS10|WDR75|INTS8|PUS7|USB1|IMP4|EBNA1BP2|SNAPC2|CPSF3|SMAD3|PARS2|PRKRA|QTRT1|TYW5|DDX27|GTF3C2|ALKBH8|MPHOSPH6|DARS|GTF3C3|DIS3L2|METTL1|SARS2|PIH1D1|NIFK|TFB1M|TRMT44|GTF2E2|CARS2|BTRC|ZC3H8|RPL26|MDN1|SMAD1|EXOSC10|ELAC2|MRPS9|DCAF13|SP1|INTS9|NSUN6|RARS2|INTS3|HEATR1|DDX17|ADAT2|TSR1|PDCD11|WDR18|MTERF4|ISG20L2|PARN|DARS2|MRPL44|CCNT2|TSEN34|AGO2|TPRKB|RPF1|FARS2|IARS2|GATB|UTP20|XRN2|ELL3|USPL1|C1D|TRMT1|UTP3|PELP1|BMS1|DDX1|RNMTL1|NOP58|AGO3|TBP|ELP3|EXOSC8|WDR46|CTU1|SNAPC5|INTS6|XPO5|NSUN4|GAR1|TAF1B|RPF2|KIAA1456|CIRH1A|GTPBP3|ZNHIT6|LARS2|AIMP1|CD3EAP|NSUN3|NOL10|RPS24|UTP6|WBSCR22|PIWIL4|TAF8|GTF3C6|TRMT1L|TAF6|MPHOSPH10|RPAP2|MOCS3|GTF2F2|GLTSCR2|TRMT61B|POLR2B|PIH1D2|MRTO4|POP5|WARS2|RPS21|HARS2|PUS1|QARS|THG1L|MTFMT|DIEXF|DIS3|SEPHS1|RPL14|TFB2M|RPS19|CPSF3L|ANKRD16|THUMPD3|YARS2|QTRTD1|TRUB1|FARSB
CENTRAL NERVOUS SYSTEM MATURATION%GOBP%GO:0021626,0.0964548494983278,0.427566585262796,-0.9493824437582711,-1.26480537525418,720,1,CEND1
NEUROFILAMENT BUNDLE ASSEMBLY%GOBP%GO:0033693,0.9787691480784741,0.9929540748232929,0.269348692303949,0.529777092524975,7283,3,NEFH|NEFL
CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS%GOBP%GO:0036294,0.5861015654830091,0.84074733875826,-0.15054015838051799,-0.9239197526079279,4604,86,CARD16|HMOX1|LMNA|HIF3A|GATA6|CPEB1|PDK3|UBC|MYC|PGK1|BAD|PTGIS|P4HB|SUV39H1
GROWTH HORMONE SECRETION%GOBP%GO:0030252,0.618767177071064,0.854944793214197,-0.395712889811891,-0.8662982346541329,4727,4,CDK16|GHRL
ADENINE TRANSPORT%GOBP%GO:0015853,0.5899442823029979,0.8414799095069009,-0.563054866280673,-0.93701333673389,4446,2,VDAC3|SLC29A2
HISTONE H2B UBIQUITINATION%GOBP%GO:0033523,0.17207112970711302,0.5459855974578649,-0.41499758126854097,-1.3001332481453998,1315,10,DTX3L|CTR9|RNF20|RNF40
FUCOSE METABOLIC PROCESS%GOBP%GO:0006004,0.45546240503012797,0.7711801339028691,-0.306264088167061,-0.9915464630615041,3476,11,FUT9|FUCA1|FUOM
NEGATIVE REGULATION OF FIBRINOLYSIS%GOBP%GO:0051918,0.0013150973172014698,0.0285443337748016,-0.804481746868573,-1.92818923799721,9,5,THBD|THBS1|SERPINE1|SERPINF2
REGULATION OF GERMINAL CENTER FORMATION%GOBP%GO:0002634,0.23737506575486605,0.6217158626397761,-0.508686470119339,-1.21922440256328,1804,5,TNFAIP3|MEF2C|BCL6
POSITIVE REGULATION OF CELL FATE COMMITMENT%GOBP%GO:0010455,0.386655948553055,0.733589579210772,0.642816198031894,1.0800142100525,2885,2,FGF2|IL12RB1
REGULATION OF RHODOPSIN GENE EXPRESSION%GOBP%GO:0007468,0.408428093645485,0.744594988699055,-0.7961513012792242,-1.060664700505,3052,1,NRL
REGULATION OF CHOLESTEROL TRANSPORT%GOBP%GO:0032374,0.0260858223555498,0.227301678500391,-0.371025455760765,-1.63640352354005,199,27,APOC2|ABCA2|PLTP|SREBF2|TSPO|LRP1|APOC1|CETP|NR1H3|APOE|NFKBIA|PPARG|NFKB1|ANXA2
NEGATIVE REGULATION OF SECRETION OF LYSOSOMAL ENZYMES%GOBP%GO:0090341,0.220066889632107,0.60254214895295,-0.886689457432731,-1.1812832639948,1644,1,NR1H3
EXTRACELLULAR VESICLE BIOGENESIS%GOBP%GO:0140112,0.945631593183662,0.98327398849216,0.212630998345284,0.586962163582536,6991,7,RAB11A|COPS5|ATP13A2|ARRDC4|RAB27A
SUCROSE TRANSPORT%GOBP%GO:0015770,0.0167153091005572,0.17569702079137303,-0.9174524400330849,-1.5267875718909498,125,2,SLC45A3|SLC45A4
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051155,0.0765013054830287,0.38654270614299796,-0.34629096559836997,-1.4539308448275199,585,23,MESP1|MEF2C|FAM129B|EHD1|MMP14|IGF1|MAML1|EHD2|ADGRB1
PALMITIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:1900535,0.5365755627009651,0.8132910857498922,0.575406672180866,0.966757503026585,4004,2,ACOT7|ACOT11
REGULATION OF HISTONE H3-K27 TRIMETHYLATION%GOBP%GO:1902464,0.817372825076371,0.9378212107586109,0.590924128804588,0.7879175906803149,6153,1,ZNF304
DESMOSOME ASSEMBLY%GOBP%GO:0002159,0.6272486772486771,0.859069247760118,-0.44466159771731195,-0.868311401323258,4741,3,JUP|PKP2
CENTRAL NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0007417,0.13254847645429402,0.49289540376144997,0.14331709090821698,1.17322486237153,956,354,CHST8|FOXC1|CNTN4|EFHC1|ALDH3A2|SCN5A|DRD2|CTNNA2|FGFR2|DLL1|JRKL|BBS4|SYNGR3|PAX8|LOXL3|DCTN1|PARK2|NHEJ1|ROGDI|AHI1|RNF103|FAT4|SLIT1|EPHB2|RTN4|HESX1|PAFAH1B2|WNT2B|TENM4|ABCB6|PTS|TACC2|LAMB1|HAPLN4|ROBO2|PTCHD1|NES|CHRNB2|ASCL1|KLHL17|PRDM8|ADORA2A|RAB3GAP1|BMP7|PKD1|TTBK2|CHD5|CTNS|SLIT3|ADAM23|NCKAP1|GNB4|CDK5R1|EIF2B4|SEMA4C|PCM1|CEP290|YWHAQ|ADCYAP1|ATP7A|HAP1|MBOAT7|ADGRL2|GLUD1|DRAXIN|PEX13|DCLK1|SLC6A17|MKKS|DNER|KDM7A|NF1|CA10|NPAS1|ADCK4|NRCAM|PKD2|MAOB|ATXN1L|MAP2|SPATA5|SNTG2|CLN5|YWHAE|UTP3|GATA2|SKI|BBS2|ELP3|C21orf91|PLXNB2|CHD7|NNAT|AGTPBP1|METTL14|NR4A2|LRP6|YWHAH|DOCK7|ASIC2|BTD
UDP-GLUCURONATE METABOLIC PROCESS%GOBP%GO:0046398,0.773066352571653,0.9219899081765189,-0.343793641219304,-0.752636146412053,5906,4,CSGALNACT1
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009139,0.5822499336694079,0.8387093286508721,-0.565578867310448,-0.9412136780655479,4388,2,CMPK2
NEGATIVE REGULATION OF IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002838,0.192107023411371,0.5665036350989531,-0.902459197176886,-1.20229234387183,1435,1,CEACAM1
RESPONSE TO BREFELDIN A%GOBP%GO:0031001,0.368561872909699,0.7217539780398442,-0.813630348478165,-1.08395098834073,2754,1,HID1
HISTONE H4-K20 DEMETHYLATION%GOBP%GO:0035574,0.6890407288317261,0.887051934478962,0.5011748143173379,0.8420383973527281,5142,2,KDM7A|PHF8
SECRETION BY LUNG EPITHELIAL CELL INVOLVED IN LUNG GROWTH%GOBP%GO:0061033,0.0407269832846909,0.288980107188417,-0.870581748001103,-1.44878724516254,306,2,FGF10|FGF7
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002855,0.39131003795314795,0.7369216590772479,-0.4845041725981551,-1.0606809133861301,2989,4,PVR|PVRL2|CEACAM1
PROTEIN CARBOXYLATION%GOBP%GO:0018214,0.49087301587301596,0.7904081687771529,-0.507065815367139,-0.990171022109424,3710,3,VKORC1
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION%GOBP%GO:0010743,0.000915391656858899,0.0216316222083933,-0.510482771418277,-2.11404197982696,6,22,IL18|AGT|ABCA5|MSR1|PLA2G2A|ABCG1|MAPK9|CETP|NR1H3|CSF1|NFKBIA|CD36|PPARG|PPARA|NFKB1
POSITIVE REGULATION OF SYNAPTIC VESICLE TRANSPORT%GOBP%GO:1902805,0.528804930332262,0.8106205307336929,0.579423713252443,0.9735066506880021,3946,2,MAP2|UNC13B
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS%GOBP%GO:0045936,0.0104738791671989,0.13160691417904402,-0.174986015176841,-1.41772136652148,81,362,PYCARD|NCKAP1L|SOCS4|GNB2L1|SAMSN1|CORO1C|IRAK3|IGBP1|TSG101|SYTL2|IMPACT|SOCS3|DAB2IP|PRDM15|PPM1F|PID1|DUSP5|PPIF|PARP1|PPP1R8|SEMA6A|CNST|APOC1|SPRY1|CDKN1C|SYNJ2BP|HNRNPU|SFRP2|CDKN2A|BOD1|CBFA2T3|NPM1|SMAD6|PLEK|HEXIM1|LMTK3|PRR5L|THY1|PKMYT1|SLC9A3R1|WARS|MAPK8IP1|CD2BP2|PDE12|HEG1|PDE4D|IPO7|INHBA|FKBP15|PRKAR1A|CEBPA|SOCS1|FOXM1|PTPN6|PARK7|RGS4|CDKN2B|ENSA|TIMP3|TAF7|ABL1|HSPB1|C14orf166|MEN1|LRP5|LDLRAD4|TNIP1|SNX6|GNAQ|CDA|CEACAM1|CRY2|VPS25|PPP2R4|GPER1|CD300A|MBIP|PSMD10|APOE|PLK1|PPP2CA|MVP|LGALS3|WWTR1|DLG3|CHMP6|ELFN2|LATS2|C3orf33|ERRFI1|ADARB1|SLIT2|FKBP1A|RRP1B|NR2F2|CAV1|MYC|DNAJA1|RASIP1|DDIT4|PPARA|CCDC8|DACT1|TLR4|CDKN2C|PDGFA|NF2|SMPD1|STYXL1|H2AFY|RGS2|GPS1|ENG|GSTP1|PHB|NCK1|RGS3|PDGFB|FBLN1|PTPRJ|EIF4G1|SIRPA|WNK2|PRNP
SEQUESTERING OF ACTIN MONOMERS%GOBP%GO:0042989,0.54521556256572,0.817297924969912,-0.33753168819112206,-0.9226278176596608,4147,7,GSN|TMSB4X
MITOTIC SISTER CHROMATID SEGREGATION%GOBP%GO:0000070,0.0697822488221062,0.37596389138254704,-0.214367519062704,-1.35790245427962,547,98,MAD1L1|SPAG5|KIF25|CENPE|KIF2C|CDCA8|NIPBL|PAPD7|BECN1|VPS4A|NCAPG|TUBG1|CHMP5|INO80|PINX1|ZNF207|ZWINT|RACGAP1|NCAPD3|KNSTRN|KLHL22|NCAPH|NUSAP1|NUF2|DLGAP5|NSL1|SPDL1|CDT1|SMC2|DSN1|ESPL1|GSG2|TUBG2|CDC23|BOD1|KPNB1|NCAPH2|KIF18B|KIF4A|NAA50|NDC80|SGOL1|KIF18A|RAN|SMC4|KIFC1|CCNB1|PLK1|CHMP4A|CHMP6|SMC1A|KIF22|CDCA5
REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT%GOBP%GO:1904396,0.1722655200215,0.546112036193732,0.6563852574696889,1.29103234288638,1281,3,DCTN1|AGRN
SPHINGOMYELIN CATABOLIC PROCESS%GOBP%GO:0006685,0.559481743227326,0.8268422944617521,-0.415254231611999,-0.909078316728927,4274,4,SMPDL3A|SMPD1
HISTONE ACETYLATION%GOBP%GO:0016573,0.0149426768002061,0.16442901693569,-0.270669802675904,-1.6099035788276899,115,77,NAA40|KAT6A|KANSL1|KANSL2|JADE3|YEATS4|TAF6L|BRPF3|RUVBL1|HCFC1|OGT|TAF12|MORF4L2|MSL2|PHF20|NAA50|WDR5|KAT7|TAF9B|SPI1|MBIP|KAT2B|APBB1|TAF10|KAT8|KAT5|TAF9|POLE3|CCDC101|AK6
METANEPHRIC RENAL VESICLE MORPHOGENESIS%GOBP%GO:0072283,0.5972856758935771,0.844862323067435,0.45076045899025896,0.8865926296000122,4444,3,PAX8
REFLEX%GOBP%GO:0060004,0.760281241708676,0.91797162753179,-0.485878461076312,-0.808579457038732,5730,2,TMC2
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0048483,0.823107138019775,0.941660494110631,0.177418526180492,0.731345962718223,6076,21,INSM1|ASCL1|KIF26A|TFAP2B|NF1|PHACTR4|NRP1
NEGATIVE REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL%GOBP%GO:0003108,0.0703678929765886,0.3767214120425879,-0.9633877370974859,-1.28346378885126,525,1,ADRBK1
NEGATIVE REGULATION OF DNA ENDOREDUPLICATION%GOBP%GO:0032876,0.801787592008412,0.9325377000668108,-0.26375375549391394,-0.720959128711787,6099,7,STAG2|SMC1A
REGULATION OF MONOCYTE CHEMOTAXIS%GOBP%GO:0090025,0.000131423314495992,0.00518555396908895,-0.576753745599833,-2.27870024248521,0,19,CXCL12|DUSP1|GREM1|LYN|SLAMF8|MOSPD2|CREB3|PLA2G7|CCR1|NOV|NBL1|AIF1|SLIT2|SERPINE1|LGMN
NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION%GOBP%GO:0045590,0.729501607717042,0.906544799850309,0.48282326992004404,0.8112054333014642,5444,2,CTLA4|IRF1
REGULATION OF PLANT ORGAN MORPHOGENESIS%GOBP%GO:1905421,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
CAMERA-TYPE EYE MORPHOGENESIS%GOBP%GO:0048593,0.0488337198199427,0.31702674791770696,0.31655001249291,1.5074261590402902,357,33,STRA6|DLL1|AHI1|WNT2B|TWIST1|PTPRM|MEGF11|TFAP2B|NF1|PHACTR4|SKI|TENM3|LRP6
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE%GOBP%GO:0008630,0.380976996639959,0.729499056535481,-0.200550452898233,-1.0513506475666299,2947,48,BCL2L2|IKBKE|BRCA1|SNW1|ABL1|E2F1|IFI16|HIC1|BCL3|EPHA2|CIDEB|TMEM109|DDIT4|CRIP1
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009147,0.690054673262171,0.8870601136299642,-0.28158679922821006,-0.8106489839655759,5300,8,DCTPP1|CTPS1|CMPK2
NEGATIVE REGULATION OF NK T CELL PROLIFERATION%GOBP%GO:0051141,0.42807809802098495,0.756202814008058,0.7867776797529781,1.04906187379093,3222,1,ZBTB7B
HEMOGLOBIN METABOLIC PROCESS%GOBP%GO:0020027,0.29841269841269796,0.6711955314970389,-0.5904498695232181,-1.1529989462746,2255,3,HPX|INHBA
LIPOPROTEIN PARTICLE MEDIATED SIGNALING%GOBP%GO:0055095,0.487540192926045,0.788226301622024,0.597242900468707,1.00344518593972,3638,2,LPL|CDH13
CYCLIC NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009214,0.116666666666667,0.46669484702093395,-0.699309413033309,-1.36557404441192,881,3,PDE4D|PDE2A
PURINE-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0072523,0.0250877421032107,0.223015618342068,-0.340316216579149,-1.61234464209514,192,34,GPX1|ADA|NUDT1|PDE4D|NUDT16|PDE2A|HPRT1|NUDT18|NUDT4|ENPP4|ABCD1|HINT1|PNP|SAMHD1
ARSONOACETATE METABOLIC PROCESS%GOBP%GO:0018872,0.8420005306447329,0.94808068996515,-0.435749385109739,-0.725156658388395,6346,2,N6AMT1
RNA 5'-END PROCESSING%GOBP%GO:0000966,0.991574942247588,0.997235235231815,0.122182624995746,0.46982859521976894,7296,17,SSB|PNPT1|UTP20|POP5|NOP14|KIAA0391
PEPTIDYL-TYROSINE PHOSPHORYLATION%GOBP%GO:0018108,0.0384217335058215,0.27969333124831197,-0.275690015642435,-1.51804834688216,296,57,FGFR4|KDR|FGR|TNK2|FES|DYRK1A|DDR2|FLT4|ABI3|PTPN6|MAPK3|ABL1|DDR1|IL15|HCK|TEK|PDGFRB|EPHA4|EFEMP1|CSF1R|PDGFRA|PDGFB
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:0048660,0.00038659793814433,0.0111294649577428,-0.36385856462849997,-2.07479380389172,2,65,DNMT1|HMOX1|IGF1|OGN|P2RY6|GPER1|FGF9|THBS1|AIF1|HTR1B|PDGFRB|FOXP1|MMP9|CX3CL1|IGFBP5|PPARG|ANG|PTGIR|PDGFB|SERPINF2|ERN1|CNN1
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY%GOBP%GO:0034140,0.6066595914035551,0.848985084775586,-0.55682382133995,-0.926643881533525,4572,2,F2RL1|TNFAIP3
POSITIVE REGULATION OF SUMO TRANSFERASE ACTIVITY%GOBP%GO:1903755,0.8192323017665029,0.9389789016232991,0.589655932951037,0.786226622630894,6167,1,UBE2I
REGULATION OF DNA-DEPENDENT DNA REPLICATION INITIATION%GOBP%GO:0030174,0.6052077853761179,0.8484731812466321,-0.36437641276010996,-0.8733407319667309,4601,5,WRNIP1|CDT1|NBN
POSITIVE REGULATION OF NEUTROPHIL CHEMOTAXIS%GOBP%GO:0090023,0.757406904050014,0.9169833860642059,0.20451409966337397,0.77006341348482,5572,16,XCL1|C1QBP|CAMK1D|DAPK2|CCR7|CCL21|FAM65B|TIRAP|CXCL8|RAC2|THBS4|RAC1|NCKAP1L|CD74|CCL19|MOSPD2
RESPONSE TO HEPARIN%GOBP%GO:0071503,0.47018068197255797,0.781244333716016,0.44404635115888996,0.975588744381742,3460,4,SFRP1|EGR1|GPIHBP1
REGULATION OF BLEB ASSEMBLY%GOBP%GO:1904170,0.824754576810825,0.942178419436027,-0.44731182795698904,-0.7443984122598492,6216,2,P2RX7|ANLN
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY%GOBP%GO:0061245,0.8033165692537719,0.932964969466025,0.163576301213992,0.7573086232837181,5909,30,PARD3|DLG2|CAMSAP3|WDR1|MYO9A|LRRC7|MTCL1|FOXJ1|EZR|PDCD6IP|CLIC4
PIGMENT CATABOLIC PROCESS%GOBP%GO:0046149,0.0668760633424944,0.3690551432905871,-0.6749009417624189,-1.4774992411622598,510,4,BLVRA|HMOX1|BLVRB
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF WOUND HEALING%GOBP%GO:0044330,0.603745819397993,0.848175106515994,-0.7015328628142921,-0.934610221242822,4512,1,PPAP2B
INSULIN RECEPTOR INTERNALIZATION%GOBP%GO:0038016,0.192107023411371,0.5665036350989531,-0.902459197176886,-1.20229234387183,1435,1,CEACAM1
MULTI-ORGANISM BEHAVIOR%GOBP%GO:0051705,0.468533369579992,0.780769690730001,0.21319860389473497,0.9870448225278841,3446,30,GRID1|DRD4|PTCHD1|CHRNB2|PEX13|MKKS|ATXN1L|PPP3CB|NLGN4X|SHANK2|MSS51
NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:2000352,0.165271966527197,0.537523377387452,-0.33387701956175103,-1.29556700808981,1263,18,KDR|GATA3|GAS6|TNFAIP3|ICAM1|TEK|SEMA5A|IL11|SERPINE1
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0042535,0.0036673215455140795,0.0646052543079676,-0.7350945893773101,-1.89086130814724,27,6,TLR1|SPN|AZU1|HSPB1|THBS1|TLR4
3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE METABOLIC PROCESS%GOBP%GO:0050427,0.41859200869801594,0.75036705317022,0.272067900355464,1.02442587768875,3079,16,PAPSS1|SULT1C4|SULT4A1|TPST1|SLC35B2|BPNT1|SLC35B3|SLC26A1|PAPSS2
HAIR FOLLICLE MORPHOGENESIS%GOBP%GO:0031069,0.224561880179323,0.6078034241178771,0.559955492628014,1.2302460644860702,1652,4,FGFR2|ATP7A|KRT17
CMP PHOSPHORYLATION%GOBP%GO:0061566,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
NEGATIVE REGULATION OF SUBSTRATE ADHESION-DEPENDENT CELL SPREADING%GOBP%GO:1900025,0.0779407911972754,0.390894089449544,-0.457392928864375,-1.48083421585303,594,11,RCC2|ACTN4|KANK1|CORO1C|FBLN1|EFNA5
GALACTOSE CATABOLIC PROCESS VIA UDP-GALACTOSE%GOBP%GO:0033499,0.23439153439153398,0.618169153148464,-0.622715043572607,-1.21600465361831,1771,3,GALK1
L-LYSINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1903401,0.61322884845265,0.852045339927398,0.690174239082488,0.920254220635019,4616,1,SLC25A29
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE%GOBP%GO:0070374,0.000128567755206994,0.00518555396908895,-0.31687568736960603,-2.20784284328892,0,154,CD44|ACKR3|TGFB1|TNFAIP8L3|CCL11|GPR183|CHI3L1|FLT1|SCIMP|PYCARD|CD74|CCL19|EPHB3|MERTK|CD4|FGFR4|KDR|CCL24|PLA2G2A|TNFRSF11A|PDGFD|EPHA8|GAS6|CCL3L3|DDR2|CCL18|MARCO|MST1R|PDGFC|FLT4|NOTCH1|GPNMB|GCNT2|ICAM1|ARRB1|CTGF|NOTCH2|FGF10|MAPK3|DDR1|NECAB2|HRAS|NTRK2|TREM2|SEMA7A|P2RY6|CCL2|GPER1|EPHA2|F2R|CCR1|APOE|RAP1A|AXL|FGF19|CD36|BMP2|LGALS9|TEK|PDGFRB|EPHA4|CX3CL1|CCL4L2|CCL14|ATP6AP1|ARHGAP8|INSRR|EPHB4|PDGFA|CSF1R|PDGFRA|PHB|GLIPR2|TIE1|PDGFB|C5AR1|SERPINF2
REGULATION OF MEMBRANE TUBULATION%GOBP%GO:1903525,0.31711273317112704,0.6861326333203311,0.46475843812045,1.11774137851729,2345,5,SH3GLB1|WASL|DNM2|PLEKHM2|ASAP1
POSITIVE REGULATION OF BLOOD COAGULATION%GOBP%GO:0030194,0.000392464678178964,0.0111294649577428,-0.59656078722601,-2.21705087804404,2,16,PLEK|F3|THBD|PDPN|F2R|THBS1|SERPINE1|ENPP4|TLR4|SERPINF2
NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051154,0.48695297635227003,0.7880171277015351,0.25732813691711104,0.9689257798178449,3582,16,DKK1|HDAC1|SOX6|HDAC4
OPTIC NERVE DEVELOPMENT%GOBP%GO:0021554,0.34807073954983897,0.705902463591096,0.660650799492411,1.10997864322478,2597,2,CHRNB2|TMEM126A
NEGATIVE REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034122,0.0401412133891213,0.286542515059155,-0.36942227508881004,-1.57003425438126,306,24,LYN|LGR4|IRAK3|DAB2IP|TICAM2|TNFAIP3|CD300A|RAB7B|NR1D1|CD300LF|TICAM1|TLR4|CD14|LY96
POSITIVE REGULATION OF HYDROLASE ACTIVITY%GOBP%GO:0051345,0.00114329268292683,0.0260082836197492,-0.189391675226693,-1.54314192152262,8,374,CCL11|TNNT2|LYN|ARL1|RPA2|GNA13|DHX9|FIS1|FLT1|MAPRE2|PYCARD|APOPT1|RABGAP1|RGS1|SNX13|GNB2L1|CORO1C|EDNRA|SETMAR|MTSS1L|RIPK3|CCL19|REST|HMGB2|EZH2|RYR2|SNX18|ECT2|PPM1F|ATP1B1|RGS16|TOR1AIP2|TNFRSF10A|TAX1BP3|TNFRSF10B|RAPGEF1|CHTOP|TBC1D12|PDCD6|CCL24|CASP10|HNRNPU|NGF|ATP1B3|CAV2|PDCD5|PLEK|PCNA|THY1|CASP1|CCL3L3|GRIN1|VCP|TRAF2|CCL18|CCDC125|PRELID1|PLSCR1|DDX3X|EFNA1|TNFSF10|CYCS|MEF2C|CASP4|STAT3|PRKD1|PSME2|DYNLL2|F3|BCAS3|PERP|UHRF1|S100A10|RSU1|IFI27L1|AHSA1|RCN3|ANP32B|ARHGAP42|FGF10|RHOG|RAPGEF3|SEC13|HRAS|NTRK2|NR1H3|IFI16|P2RY6|C10orf54|GNAQ|CCL2|CTSH|CYFIP2|PPP2R4|GPER1|CD300A|EPHA2|CIDEB|GSN|F2R|RAP1A|TBC1D10B|DLC1|NLRP3|GNA15|EFNA3|BMP2|ASPH|CD200|LGALS9|FADD|PDGFRB|EPHA4|SYDE1|BCAP31|CX3CL1|MYC|PPARG|CCL4L2|CCL14|ANG|PLAA|ATP1B2|S100A8|S100A9|ARL6IP5|TIAM1|PDGFRA|DNAJB11|LGMN|TMSB4X|RAP1GAP|NGFRAP1|NET1|C5AR1|NGFR|BAD|GTF2H2
POSITIVE REGULATION OF PROTEIN GLYCOSYLATION%GOBP%GO:0060050,0.219653960529873,0.6019674400687121,0.5116214857285429,1.2304467392780902,1624,5,RAMP1|ARFGEF1|CHP1|ALG10B
ENDOPLASMIC RETICULUM TUBULAR NETWORK MAINTENANCE%GOBP%GO:0071788,0.15832115818833803,0.528194339395059,0.92286060873401,1.2305100975288301,1191,1,KIAA1715
UBIQUITIN-INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0090611,0.682923515826654,0.885415243771438,0.374400264710748,0.8225733263927941,5026,4,PDCD6IP|CHMP4B|VPS4B
SEMINIFEROUS TUBULE DEVELOPMENT%GOBP%GO:0072520,0.6683490503386911,0.8811119744196031,0.6641486546096159,0.885552615446897,5031,1,ING2
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY%GOBP%GO:0007169,0.0007695267410542519,0.0191058847417112,-0.19641871550848303,-1.5821190040813402,5,348,NCKAP1L|VAV3|ATP6V0A1|PLCB1|WASF2|HNRNPH1|ANGPT2|PIK3C2A|EPHB3|AP2A2|AP3S1|RAB14|DAB2IP|TCIRG1|NCBP2|CD4|ATP6V0B|FGFR4|DNM1|KDR|POLR2J|RAPGEF1|ATP6V0A2|FGR|PDCD6|HGF|ATP6V1G2|ARPC1A|VAV1|NGF|PDGFD|CAV2|EPHA8|VEGFC|ATP6V1F|INS|DDR2|BCAR1|KALRN|MATK|GRIN1|SHCBP1|ERBB2IP|FOXC2|EFNA1|MST1R|PDGFC|NDST1|FLT4|ELMO1|MAPKAPK2|ATP6V0D1|GRB2|IRS1|STAT3|NCBP1|PRKD1|HNRNPM|NGEF|PXN|POLR2H|REPS2|PIK3CB|FGF10|MAPK3|CYBB|ABL1|HSPB1|DDR1|HRAS|SULF1|PIK3R3|IGF1|NTRK2|COL4A2|NCF4|HBEGF|DOCK1|CSF1|CYFIP2|SDC2|EPHA2|NCF2|AXL|MVP|VEGFB|NRP2|HCK|FGF19|EFNA3|MUC20|ATP6V0E1|FGF9|TEK|FGF7|COL1A1|PDGFRB|EPHA4|RARRES2|MMP9|DDIT4|POLR2G|PLAT|ATP6AP1|INSRR|FIBP|EPHB4|ATP6V0E2|PDGFA|HSP90AA1|EFEMP1|CSF1R|TIAM1|ACTB|PDGFRA|EPS8|NCK1|ATP6V1A|ATP6V1G1|PDGFB|NGFR|AP2M1|EFNA5|PTPRJ|POLR2L
DNA CONFORMATION CHANGE%GOBP%GO:0071103,0.000128369704749679,0.00518555396908895,-0.290504906724181,-2.04328063694745,0,161,NCAPD3|ITGB3BP|CTCF|CENPL|CENPU|ACIN1|NCAPH|RAD51|RPA2|NUSAP1|CENPW|DHX9|WRNIP1|H1F0|HIST1H2BE|KAT6A|HMGB2|SMC2|H2AFX|NBN|PURA|NAA10|TOP1|OIP5|RUVBL1|CENPM|CDKN2A|HIST1H2BN|NPM1|ASF1B|CHAF1A|TOP2A|CENPI|IPO4|DHX36|HIST1H2BC|NCAPH2|HNRNPA2B1|PIWIL1|HIST1H4I|STRA13|ANP32B|RBBP7|CENPH|NAP1L4|SMC4|HIST2H3A|GPER1|HIST2H2BF|SPTY2D1|H1FX|HIST1H2BG|HIST1H2BD|CHAF1B|HIST2H4A|HIST2H3C|HMGB3|HIST1H3H|POLE3|HIST1H1C|ANXA1|H2AFY|HIST2H4B|CENPK|H3F3B|MIS18A|HIST3H2BB|HIST2H2BE|CDCA5|HIST1H2BK|HIST1H2BJ|CENPP|TOP1MT
BICARBONATE TRANSPORT%GOBP%GO:0015701,0.501767745444656,0.796500289838735,0.24563052273075,0.961502673752612,3689,18,SLC4A2|CYB5R2|SLC4A3|SLC4A5|CYB5R4|SLC26A6|SLC4A7|SLC4A8
NEURAL TUBE CLOSURE%GOBP%GO:0001843,0.3906547133931,0.7364714265545841,0.23019893975257397,1.04291400641047,2875,28,BBS4|TSC2|SEMA4C|DVL2|MTHFR|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10
CHONDROCYTE MORPHOGENESIS INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS%GOBP%GO:0003414,0.0011764705882352901,0.0261694927157725,-0.610591089836417,-2.0437055483036204,8,12,MATN2|COL20A1|COCH|VWA1|COL14A1|COL12A1|COL6A3|COL21A1|COL6A1|COL6A2
TRNA 3'-TRAILER CLEAVAGE%GOBP%GO:0042779,0.24120069066277103,0.6244696312630601,0.8807344508160571,1.17434055014805,1815,1,ELAC2
REGULATION OF VASCULAR SMOOTH MUSCLE CELL DEDIFFERENTIATION%GOBP%GO:1905174,0.42186256301406205,0.7527812076478722,-0.6305807282073261,-1.04938716917704,3179,2,PDGFB
NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS%GOBP%GO:0010760,0.898704358068316,0.967428248648255,-0.296476038162466,-0.649048022164473,6866,4,MIF|DDT|C5|SLAMF8
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION%GOBP%GO:2001252,0.229874776386404,0.612444686572594,-0.16769321814956198,-1.1396479835795401,1798,135,LIF|UBE2N|RAD21|SART3|IL1B|C6orf89|FOXP3|CCT7|TET1|HNRNPA1|RPS6KA5|NEK2|BRD4|PML|DNMT3B|GNL3|CCT3|DLGAP5|NABP2|KDM1A|CDT1|NBN|ANAPC5|TRIM28|ESPL1|ANKRD32|CHTOP|PAXIP1|HNRNPU|OGT|FMR1|DHX36|CCT8|SLX1B|HNRNPA2B1|TAL1|SLX1A|PRKD1|CCT5|BRCA1|ARRB1|SNW1|CTR9|MAPK3|DNMT1|RNF20|WBP2|KAT7|PHF19|FBXO4|RNF40|RPS6KA4|H2AFY|ANAPC11|FEN1|GTF2H2
PROTEIN LOCALIZATION TO NUCLEUS%GOBP%GO:0034504,0.855259790120297,0.949296218452153,-0.117750383518185,-0.786697600544793,6682,125,NCKIPSD|TOR1AIP2|TAF3|TOR1A|HNRNPU|KPNB1|IPO4|NUP188|IPO7|STAT3|PARK7|NUP85|KPNA4|CALR|SKP1|LMNA|RAN|RBM22|BCL3|KPNA2|PLK1|NUP214|SUN2|COL1A1|SEC61B|ARL2|BCL6|NUP98|IPO11|XPA
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903170,0.0128621716761441,0.149991146428462,0.43621180797700004,1.7678676034845802,94,20,FKBP1B|CRHR1|BIN1|GSTM2|C19orf26|DRD4|GNB5|SRI|PKD2|YWHAE|SESTD1
REGULATION OF RESPONSE TO FOOD%GOBP%GO:0032095,0.41844262295082,0.75036705317022,0.35304801925592993,1.02483663554214,3062,8,BBS4|NENF|MKKS|BBS2|CARTPT
DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009186,0.582982640715413,0.8390349798286221,-0.37156810674562796,-0.890577850148495,4432,5,NUDT18|CMPK2
CELL-CELL FUSION%GOBP%GO:0140253,0.498177557927623,0.794989907195277,-0.33250165267620096,-0.957225720977028,3826,8,ADAM12|TCTA|CACNA1H|PGK1
NEGATIVE REGULATION OF INTERLEUKIN-1 PRODUCTION%GOBP%GO:0032692,0.000130992926381975,0.00518555396908895,-0.66189282543141,-2.14291363349236,0,11,GAS6|TNFAIP3|CARD16|GHRL|CEACAM1|NLRP3|CX3CL1|GSTP1
DOPAMINERGIC NEURON DIFFERENTIATION%GOBP%GO:0071542,0.8374121322572249,0.946216977301937,-0.240986777647008,-0.693767204230196,6432,8,WNT3
PLASMA MEMBRANE RAFT LOCALIZATION%GOBP%GO:0044856,0.992508361204013,0.997305769352475,-0.50363917071019,-0.670968306282475,7418,1,PTPRC
REGULATION OF RESPONSE TO OSMOTIC STRESS%GOBP%GO:0047484,0.6310131685030911,0.8613756250889949,0.438361364745452,0.8622050744098629,4695,3,ABCB1
EPINEPHRINE BIOSYNTHETIC PROCESS%GOBP%GO:0042418,0.9602675585284279,0.989779794259826,-0.5196846052051171,-0.692344677765747,7177,1,TH
L-SERINE TRANSPORT%GOBP%GO:0015825,0.43777394076238496,0.7635570545514341,0.782697397441553,1.04362136789279,3295,1,SLC1A4
REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1900825,0.44342918570276796,0.7663523583818629,0.517030130328911,1.01693725278741,3299,3,RANGRF|SLMAP|ANK3
POSITIVE REGULATION OF LATE ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:1902824,0.879399654668615,0.960922253956646,0.559384649316277,0.7458639504947092,6620,1,SNAPIN
REGULATION OF HISTONE H4-K20 METHYLATION%GOBP%GO:0070510,0.273979933110368,0.648567992029846,-0.860002205558006,-1.1457294365105901,2047,1,BRCA1
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN MYOCARDIAL PRECURSOR CELL DIFFERENTIATION%GOBP%GO:0003256,0.028537611783272004,0.238789399313666,-0.682030948862251,-1.6346980409389698,216,5,GREM1|TBX2|NOTCH1|SRF
NEGATIVE REGULATION OF CALCIUM-TRANSPORTING ATPASE ACTIVITY%GOBP%GO:1901895,0.33218360307773903,0.696321347440602,-0.668706920319824,-1.1128352496887601,2503,2,THADA|PLN
REGULATION OF SCF-DEPENDENT PROTEASOMAL UBIQUITIN-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0062025,0.943678929765886,0.9826008648760041,-0.5274591971768859,-0.702702301061764,7053,1,STYX
"REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION, TELOMERIC%GOBP%GO:1904907",0.8882636655948549,0.965159112268525,0.3972980424593329,0.667512008558366,6629,2,TNKS|ATRX
MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS%GOBP%GO:0003337,0.5972856758935771,0.844862323067435,0.45076045899025896,0.8865926296000122,4444,3,PAX8
HISTONE H4-K16 ACETYLATION%GOBP%GO:0043984,0.0403469575502694,0.28788710210685603,-0.39920943823924104,-1.57723924752679,306,19,KANSL1|KANSL2|JADE3|HCFC1|OGT|MSL2|PHF20|WDR5|KAT7|KAT8
POSITIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA POLY(A) TAIL SHORTENING%GOBP%GO:0060213,0.8755567199371229,0.9605256252569351,-0.20606442111618203,-0.6671446500417421,6683,11,BTG2|CPEB3|TNRC6A|TOB1|TNRC6C|POLR2G
INITIATION OF NEURAL TUBE CLOSURE%GOBP%GO:0021993,0.9268227424749158,0.9790847380319629,-0.536281429201588,-0.7144556324615021,6927,1,KDM2B
NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL%GOBP%GO:1904998,0.455384615384615,0.7711801339028691,-0.773323775915307,-1.03025295550818,3403,1,KLF4
REGULATION OF HISTONE H3-K27 METHYLATION%GOBP%GO:0061085,0.24119348054679302,0.6244696312630601,-0.44226856777553997,-1.2089214073291998,1834,7,OGT|PHF19|H2AFY
TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0006368,0.26100506427736697,0.6368800456015129,-0.197195721788026,-1.13948792845247,2009,69,MLLT3|CCNK|SUPT16H|ELOF1|NCBP1|CTR9|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|ELP4|POLR2L|GTF2H2
MODIFICATION BY HOST OF SYMBIONT MORPHOLOGY OR PHYSIOLOGY%GOBP%GO:0051851,0.37697079348668894,0.727766947967183,-0.20107700373813198,-1.05411099818416,2916,48,SMARCA4|ZNF639|REST|RAB9A|CCNK|AZU1|CAV2|PPIB|FMR1|SNW1|NUCKS1|APOE|GAPDH|RRP1B|CFL1|ANXA2|PSMC3
"VESICLE TARGETING, TRANS-GOLGI TO ENDOSOME%GOBP%GO:0048203",0.097638630936588,0.430598623028127,-0.8042425035882521,-1.33838813401676,735,2,WIPI1
MONOCYTE DIFFERENTIATION%GOBP%GO:0030224,0.0231433054393305,0.21165950231047198,-0.545245428624691,-1.70818275130025,176,10,PIR|MT1G|IFI16|PDE1B|PPARG|MYH9|CSF1R
DAUNORUBICIN METABOLIC PROCESS%GOBP%GO:0044597,0.10899959277860699,0.45309795582492896,0.5478899892204321,1.4176975494849802,802,6,CBR4|AKR1C2|AKR7A2|AKR1C1|AKR1C3|AKR1B1
FRUCTOSE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1990539,0.8445484949832779,0.948285501480553,-0.580999117776798,-0.7740303309939169,6312,1,SLC2A5
REGULATION OF BILE ACID BIOSYNTHETIC PROCESS%GOBP%GO:0070857,0.7248948475289171,0.903717522578018,-0.286407598773633,-0.782882399083178,5514,7,FGF19|NR1D1
NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE%GOBP%GO:0098877,0.557406925279875,0.826207472438916,-0.316668545513076,-0.9116444214630441,4281,8,ARHGAP44|STX1B|STX3
POSITIVE REGULATION OF PROTEIN K48-LINKED UBIQUITINATION%GOBP%GO:1902524,0.562491698764776,0.828541380171721,0.717302602558447,0.956426232822639,4234,1,BIRC2
NEGATIVE REGULATION OF VASCULAR PERMEABILITY%GOBP%GO:0043116,0.133149316508938,0.494192252511099,-0.500611016742255,-1.3683978898353402,1012,7,PDE2A|CEACAM1|SLIT2|PTPRJ
DEPHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN%GOBP%GO:0070940,0.923763179237632,0.9776627603891009,0.258107213765718,0.620746368987885,6833,5,RPAP2|RPRD1A|CTDP1|RPRD1B|SSU72
EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION%GOBP%GO:0098976,0.0346813244339746,0.266191770413233,-0.714813599399505,-1.56487639197431,264,4,GRIN1|GRIN2C|GRIN2D
MODULATION BY VIRUS OF HOST PROCESS%GOBP%GO:0019054,0.6051255230125521,0.8484731812466321,-0.22855429024811105,-0.8868756477804541,4627,18,CD4|KPNB1|CCNK|SLC25A6|KPNA4|KPNA2|PABPN1
NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS%GOBP%GO:1903671,0.00143603133159269,0.0304119116144585,-0.49094629283599706,-2.06127802691755,10,23,KLF4|SEMA6A|SYNJ2BP|E2F2|NOTCH1|TBXA2R|MMRN2|CREB3L1|HDAC5|MEOX2|STARD13|THBS1|NGFR|CARD10
HYALURONAN BIOSYNTHETIC PROCESS%GOBP%GO:0030213,0.681351920042083,0.885148191701988,-0.341288678446621,-0.8180038383625041,5180,5,ABCC5|IL1B|CEMIP|HYAL1
CELLULAR HYPEROSMOTIC SALINITY RESPONSE%GOBP%GO:0071475,0.9891638795986619,0.9962018371462809,-0.505513895015439,-0.6734658892049189,7393,1,AKR1B1
POSITIVE REGULATION OF MRNA 3'-END PROCESSING%GOBP%GO:0031442,0.0904811715481171,0.41577654883695,-0.46663262321593607,-1.46189909410523,691,10,CPEB3|HSF1|NCBP2|DHX36|NCBP1|CPEB1
POSITIVE REGULATION OF ALPHA-BETA T CELL ACTIVATION%GOBP%GO:0046635,0.0226179643832055,0.20908271623893998,-0.34368312849111604,-1.62829634265245,173,34,PRKCQ|MALT1|BLM|RARA|HSPH1|FOXP3|SYK|NFKBIZ|HLA-E|NCKAP1L|IL18|RUNX1|CCL19|RUNX3|EBI3|SOCS1|NKAP|CD86|NLRP3|TGFBR2|LGALS9|PNP|ANXA1|CD55
NEGATIVE REGULATION OF PROTEIN NEDDYLATION%GOBP%GO:2000435,0.7113292650570441,0.8966571213032921,-0.511497105045492,-0.8512129773326379,5361,2,RPL5|RPL11
ORNITHINE BIOSYNTHETIC PROCESS%GOBP%GO:0006592,0.958693053526365,0.9889078579539159,0.5205668284075871,0.694105624112425,7217,1,ALDH18A1
NEGATIVE REGULATION OF JNK CASCADE%GOBP%GO:0046329,0.5505112474437629,0.8214268644847421,0.20785038552301802,0.9302338262747191,4037,27,PARK2|MECOM|DUSP10|NCOR1|DUSP19|GPS2
POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL MIGRATION%GOBP%GO:2000473,0.992508361204013,0.997305769352475,-0.50363917071019,-0.670968306282475,7418,1,PTPRC
RADIAL GLIA GUIDED MIGRATION OF PURKINJE CELL%GOBP%GO:0021942,0.0515340682693585,0.32749643308090803,0.974580943978827,1.29947218580522,387,1,CTNNA2
LIPID PHOSPHORYLATION%GOBP%GO:0046834,0.613289310771771,0.852045339927398,0.17909587826127898,0.8996688029581029,4457,40,DGKB|SOCS5|TMEM150A|DGKK|EFR3B|DGKH|TTC7A|PI4K2B|DGKQ
REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905912,0.38438039580289507,0.7313561276300269,0.809660344067049,1.0795728190304898,2893,1,YWHAE
POSITIVE REGULATION OF INTERLEUKIN-2 SECRETION%GOBP%GO:1900042,0.295922433258069,0.6687276080240239,0.8541574768416409,1.13890374146018,2227,1,SPTBN1
HEART DEVELOPMENT%GOBP%GO:0007507,0.0567730360117903,0.34436604181231795,-0.178287404743247,-1.31774393852307,442,209,REST|MEF2D|TBX1|ZFPM2|SOX18|RYR2|MYH11|PCSK5|CXADR|BCOR|SOX17|CLDN5|CACYBP|FOXN4|SPRY1|CFC1|SMO|CPE|SFRP2|C3orf58|GATA3|SMAD6|TBX2|MYOM1|MYLK2|HES1|FOXC2|MESP1|HEG1|EFNA1|NDST1|NOTCH1|ELN|MEF2C|S1PR1|PKP2|FBN1|SNAI2|NOTCH2|MICAL2|POPDC2|APLNR|DLC1|GATA6|KAT2B|NOS3|NRP2|ADAP2|TGFBR2|BMP2|TGFBR3|TEK|SRF|PDGFRB|IGSF22|DCHS1|COL3A1|MAML1|SLIT2|FKBP1A|DNAAF1|SNAI1|SIK1|EPHB4|ANXA2|PDGFRA|ENG|TNFRSF1A|CRIP1|ACVRL1|TNFRSF1B|PDGFB|MTHFD1
ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:0007171,0.886971878820812,0.965013712426871,0.30226658578282695,0.6640925617850789,6528,4,CHRNA3|PILRB|NRG1|ADRB2
POSITIVE REGULATION OF INTERLEUKIN-4-MEDIATED SIGNALING PATHWAY%GOBP%GO:1902216,0.275802600159193,0.650819624868901,-0.694789081885856,-1.1562401373858602,2078,2,PARP14|CD300LF
DIGESTIVE TRACT DEVELOPMENT%GOBP%GO:0048565,0.24088791449712302,0.6244696312630601,0.23679777166235896,1.1733675518708002,1757,38,RET|RBPMS2|STRA6|NPHP3-ACAD11|ITGA6|FGFR2|AHI1|KIT|PKD1|CLMP|NPHP3|CCDC40|BBS7|MEGF8|RARB
REGULATION OF BLOOD VESSEL SIZE%GOBP%GO:0050880,0.0667797052302074,0.3690551432905871,-0.282216566643089,-1.4386446954068,511,44,ADM|PER2|EDNRA|PIK3C2A|AGT|SOD2|INS|DOCK5|TBXA2R|HMOX1|SOD1|GPER1|NPR1|F2R|EDNRB|SMTNL1|NOS3|CHGA|CAV1|SERPINF2
POSITIVE REGULATION OF SENSORY PERCEPTION OF PAIN%GOBP%GO:1904058,0.5236120401337789,0.807607680441131,-0.740846934274371,-0.9869860042928991,3913,1,FAM173B
REGULATION OF CELL CYCLE G1/S PHASE TRANSITION%GOBP%GO:1902806,0.00446827524575514,0.0743264309917645,-0.24802119160437,-1.6555974534930802,34,124,PCBP4|GTSE1|TAF1|WEE1|CNOT4|RBL1|BTG2|CNOT10|CNOT6L|PSME3|PHB2|PRMT2|SFN|PSME1|INO80|CDKN1B|CNOT6|AURKA|PTEN|FHL1|PIDD1|ID2|PRMT1|TMEM14B|LSM11|CCND2|PML|RGCC|RPA2|PLCB1|TRIAP1|TFDP2|EZH2|KLF4|CDC6|STXBP4|C8orf4|PLK2|SLFN11|PCNA|LSM10|DDX3X|CDC25C|GPNMB|DCUN1D3|PTPN6|PSME2|CDC45|FGF10|E2F1|RPTOR|CCL2|KANK2|NACC2|CCNB1|PLAGL1|HYAL1|SUSD2|AIF1|TNKS1BP1|FAM107A|CCND3|PAGR1|DACT1|CDK2AP2|ANXA1|ZNF385A|CCND1|EIF4G1
GANGLIOSIDE METABOLIC PROCESS%GOBP%GO:0001573,0.22836601307189497,0.610121312048328,-0.36484507614606104,-1.2211706308893602,1746,12,B4GALNT1|ST8SIA3|ST8SIA4|ST6GALNAC6|CLN6|NEU1|NEU4|ST3GAL5
REGULATION OF INTERLEUKIN-10 SECRETION%GOBP%GO:2001179,0.0172888015717092,0.17886971906195498,-0.6635892341056829,-1.70693027183942,131,6,CD274|LILRB1|PYCARD|TNFRSF21|LGALS9
RETROTRAPEZOID NUCLEUS NEURON DIFFERENTIATION%GOBP%GO:0061452,0.9689632107023409,0.9912626134248801,-0.514832377591531,-0.6858803454958909,7242,1,PHOX2B
INFLAMMATORY RESPONSE TO WOUNDING%GOBP%GO:0090594,0.202591283863369,0.5810727835229039,-0.579075162784474,-1.26771657979277,1547,4,TGFB1|HMOX1|F2R
REGULATION OF MONOOXYGENASE ACTIVITY%GOBP%GO:0032768,0.36146291031274197,0.716154857259883,-0.21989954754670396,-1.0682601488107601,2796,37,IL1B|NOSTRIN|AKT1|TNF|S100A1|POR|TERF2|TERT|INS|GLA|PARK7|DHFR|APOE|NOS3|CAV1|NFKB1|HSP90AA1|CYGB
REGULATION OF GLYCOLYTIC PROCESS BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072362,0.131225926417851,0.490819490032838,0.935542567269519,1.24741977802304,987,1,NCOR1
ACTIVATION OF MEIOSIS INVOLVED IN EGG ACTIVATION%GOBP%GO:0060466,0.5187959866220739,0.8047799431921201,-0.7429422143802379,-0.989777420500336,3877,1,PLCB1
NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS%GOBP%GO:2000629,0.513177257525084,0.802184867798321,-0.7465262461402741,-0.9945522113814791,3835,1,PAPD4
"REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0043516",0.53782722513089,0.81379229560463,-0.21037483280903102,-0.9395575323647521,4108,28,CD74|KDM1A|SETD8|DYRK1A|PLA2R1|DDX5|SNAI2|HIC1|PSMD10|SNAI1|ZNF385A
COP9 SIGNALOSOME ASSEMBLY%GOBP%GO:0010387,0.4809403639261521,0.7857006060206241,0.7600904278782529,1.01347802440311,3620,1,TESPA1
POSITIVE REGULATION OF HYPERSENSITIVITY%GOBP%GO:0002885,0.558862433862434,0.8268422944617521,-0.47586722602344295,-0.92924808437115,4224,3,HLA-E|ZP3
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II%GOBP%GO:0002580,0.259600210415571,0.636098664976652,-0.496680001235784,-1.19044718769454,1973,5,HLA-DOA|PYCARD|TREM2|THBS1
POSITIVE REGULATION OF DNA STRAND ELONGATION%GOBP%GO:0060383,0.398857750033205,0.7388683667002129,0.8017754741949709,1.06905940898409,3002,1,POT1
MOTOR NEURON AXON GUIDANCE%GOBP%GO:0008045,0.5921883219358229,0.8417378833576942,-0.368717127827573,-0.8837445976987679,4502,5,EPHA4|SLIT2
ISOPRENOID TRANSPORT%GOBP%GO:0046864,0.0193916854827998,0.19226875441368102,0.990681517423908,1.32094012799787,145,1,STRA6
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:0060994,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
REGULATION OF HORMONE LEVELS%GOBP%GO:0010817,0.151090144077521,0.518269236965168,-0.157540182220859,-1.18576496454942,1184,230,REST|ACHE|TSPO|AGT|PCSK5|ITPR2|SNX4|PIM3|STX4|STXBP4|GIPR|ITPR3|CPE|SLC2A1|MED1|SLC8B1|CDK16|CYP1B1|NGF|GATA3|SYT7|INS|CACNA1H|PCSK1|HSD11B1|ADCY8|SLC25A6|POMC|INHBA|CRHBP|IRS1|FAM129B|PARK7|ATP6AP2|ENSA|OSM|STC2|SPP1|GHRL|RAPGEF3|UQCC2|VAMP8|DPP4|VAMP7|LRP5|SNX6|CTSZ|GPER1|HFE|CACNA1E|RAP1A|ALDH1A2|PCSK6|NOV|CHGA|BMP2|ADRA2C|NR1D1|HSD17B1|ARL2|SLC25A4|SRD5A3|IL11|SIRT4|DHCR7|NFKB1|DHRS3|RAB11FIP1|BACE2|ANXA1|CPQ|HSD17B14|EFNA5|BAD|C1QTNF1|SLC25A5
NEGATIVE REGULATION OF SCF-DEPENDENT PROTEASOMAL UBIQUITIN-DEPENDENT CATABOLIC PROCESS%GOBP%GO:0062026,0.943678929765886,0.9826008648760041,-0.5274591971768859,-0.702702301061764,7053,1,STYX
TYROSINE METABOLIC PROCESS%GOBP%GO:0006570,0.629497354497354,0.860725370527633,-0.44375206793867894,-0.866535320184962,4758,3,PAH|TH|FAH
G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007186,0.0346534653465347,0.266191770413233,-0.159971381105792,-1.3076935520615802,272,382,GRK5|ADM|VAV3|RGS1|PLCB1|GNG8|WASF2|ARHGEF5|EDNRA|CCL19|FPR3|LPAR6|AGT|GNAL|GABRE|ECT2|P2RY14|FGD1|PIK3R6|RGS16|NPFF|PLCB3|PTGER1|RASGRF2|CCL24|ADORA3|GIPR|ITPR3|CPE|VAV1|GPR132|AZU1|IQGAP2|PLEK|INS|PDE4B|CCL3L3|BCAR1|KALRN|ADGRE2|FPR1|CCL18|C3|GPR171|MARCO|ADCY8|CXCR4|PDE4D|POMC|DAGLB|TAC1|CALCB|SST|OXER1|CELSR1|CA2|PTGER4|LTB4R|S1PR1|PROKR1|PTPN6|CALCRL|AKAP5|TBXA2R|ARRB1|PDE2A|NGEF|PIK3CB|GNGT2|GHRL|ADCY4|PYY|FLNA|ADGRL4|FCN1|PDE1A|CYSLTR2|GNAI2|CHRM2|P2RY6|GNAQ|CCL2|CXCL16|MRGPRF|GPER1|HCRT|F2R|EDNRB|CCR1|APOE|INSL3|GIPC1|APLNR|PDE1B|DAGLA|GNA15|ADGRE5|CHGA|F2RL3|HEBP1|ADRA2C|PPAP2A|ARHGEF9|HTR1B|GRK6|CX3CL1|CAMK2A|CAV1|PTAFR|C3AR1|NXPH4|GPR34|GPR4|CCL4L2|CCL14|RIC8A|PDE4A|ADGRG1|ADRBK1|TIAM1|PTGIR|CMKLR1|ANXA1|GNG3|ADGRL1|SSTR2|NET1|C5AR1|ADCY9|ADGRB1
RESPONSE TO GAMMA RADIATION%GOBP%GO:0010332,0.0775366108786611,0.38994345969071,-0.339465455285417,-1.44271861475897,592,24,DCUN1D3|HRAS|MEN1|TMEM109|TLK2|CRYAB|MYC|YAP1|POLE3
POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE%GOBP%GO:0048842,0.42688058916359795,0.7553765826625011,-0.42346834482924395,-1.01497281735795,3245,5,DSCAM|SEMA5A
POSITIVE REGULATION OF RENAL WATER TRANSPORT%GOBP%GO:2001153,0.115021915260991,0.4642646694217079,0.944199382443758,1.25896247296909,865,1,INPP5K
POSITIVE REGULATION OF METANEPHRIC GLOMERULUS DEVELOPMENT%GOBP%GO:0072300,0.0352357984994641,0.267552181261549,0.8788875912051679,1.47664463099497,262,2,RET|EGR1
CELLULAR RESPONSE TO NITROSATIVE STRESS%GOBP%GO:0071500,0.23973967326338197,0.623187683081912,0.881947507719453,1.1759579978475,1804,1,ATM
ENTERIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0048484,0.9011895106785621,0.9684180373391851,0.26783543347416106,0.6441426816001079,6666,5,KIF26A|PHACTR4
PROTEIN LOCALIZATION TO CELL LEADING EDGE%GOBP%GO:1902463,0.175919732441472,0.548366806412612,-0.909682399647111,-1.21191538395536,1314,1,CORO1B
RESPONSE TO SODIUM ARSENITE%GOBP%GO:1903935,0.150578642819569,0.517264655410678,-0.5570814030443421,-1.33521782218133,1144,5,DAXX|ZC3H12A|HSF1|HNRNPA1|MAPK13
RESPONSE TO INSULIN%GOBP%GO:0032868,0.38796201232032895,0.735046205930324,-0.158461304240995,-1.03751555842395,3022,113,PIK3C2A|ZFP36L1|AP3S1|TCIRG1|ATP6V0B|GOT1|PARP1|ATP6V0A2|ATP6V1G2|OGT|CAV2|ATP6V1F|INS|BCAR1|FOXC2|SYAP1|ATP6V0D1|GRB2|IRS1|PIK3R3|HDAC5|CEACAM1|KAT2B|CPEB1|ATP6V0E1|RARRES2|LPIN3|PPARG|ATP6AP1|RPS6KB1|ATP6V0E2|ATP6V1A|LPIN2|ATP6V1G1
POSITIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS%GOBP%GO:2000676,0.8707692307692311,0.9574934752519241,-0.5673246581385091,-0.755812667324325,6508,1,IL6
ACTIN ROD ASSEMBLY%GOBP%GO:0031247,0.17299018307243302,0.546839171953152,-0.750151640474221,-1.2483722880156498,1303,2,HSP90B1|PDXP
NEUROFILAMENT CYTOSKELETON ORGANIZATION%GOBP%GO:0060052,0.238127090301003,0.6217283213739421,-0.877922364358183,-1.1696033909163102,1779,1,SOD1
REGULATION OF LAMELLIPODIUM ASSEMBLY%GOBP%GO:0010591,0.9766318537859009,0.9927322181739301,-0.123458934148966,-0.5183523980146171,7480,23,FSCN1|RAC2|CDC42|RAC1|SSH1|WASF2|WAS|EPHA2|SLIT2
REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY%GOBP%GO:0060368,0.028537611783272004,0.238789399313666,-0.6820766476393771,-1.63480757218761,216,5,PLSCR1|CD47|PTPRJ
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION%GOBP%GO:1903054,0.0022146951537259,0.0428977385273153,-0.671945753430954,-2.02137730012433,16,9,NOTCH1|DPP4|FAP|TNFRSF1A|TNFRSF1B|CST3
BETA-CATENIN-TCF COMPLEX ASSEMBLY%GOBP%GO:1904837,0.57798665032012,0.8375951099012521,0.19977859409086302,0.914312350674442,4242,29,TLE2|TCF7L1|TLE3|HDAC1
ACYLGLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0046463,0.45200995155165596,0.769943206592495,-0.289285123725948,-0.995775494587022,3451,13,PLCE1|DGAT1|GPAM|GK|LPIN3|ANG|LPIN2
POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION%GOBP%GO:0045654,0.0189765737468918,0.19023670570355602,-0.7548116693321569,-1.65244052815572,144,4,HMGB2|TESC|RAB7B|ZNF16
CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS%GOBP%GO:0071363,0.0204734484964811,0.19701381786764896,-0.177612894569987,-1.3913865922686397,159,292,PTBP1|RAB35|FLT1|GNB2L1|SOX5|MT1G|HNRNPH1|MTSS1L|NR3C1|TWSG1|TBX1|ZFP36L1|RAB14|DAB2IP|NCBP2|KLF4|FGFR4|KDR|POLR2J|CLDN5|RAPGEF1|SEMA6A|USP9X|HGF|CFC1|MED1|NGF|SMAD6|ITGB5|PDCD5|VEGFC|WWOX|TGFB3|SH3GL2|BCAR1|SHCBP1|SYAP1|CLEC3B|NDST1|FLT4|SMAD5|MAPKAPK2|NOTCH1|SLC33A1|GRB2|MEF2C|SMURF2|GCNT2|CHRD|LTBP2|NCBP1|PRKD1|HNRNPM|DDX5|PDE2A|EHD1|SNAI2|PXN|POLR2H|FGF10|MAPK3|LRRC32|CILP|HSPB1|NTRK2|CDH5|CCL2|MAP2K3|HFE|CORO1B|RAP1A|FMOD|GAS1|HYAL1|VEGFB|FGF19|TGFBR2|BMP2|TGFBR3|FGF9|FGF7|COL1A2|UBC|PDGFRB|COL3A1|ID1|TMEM108|DDIT4|POLR2G|RELA|FIBP|RPS6KB1|PDGFRA|ANXA1|LGMN|ENG|EMD|ACVRL1|PDGFB|NGFR|ERN1|POLR2L
ADENYLATE CYCLASE-INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007198,0.130836120401338,0.49066507924967295,-0.933557565063961,-1.2437228370559,977,1,HTR1B
REGULATION OF CAMKK-AMPK SIGNALING CASCADE%GOBP%GO:1905289,0.23469252224731,0.618458039041616,0.884097926775474,1.17882529149652,1766,1,HTT
CELL JUNCTION ORGANIZATION%GOBP%GO:0034330,0.140171377413992,0.504613420930072,-0.17930851505580603,-1.2231756481999099,1095,138,GJA5|TGFB1|ACTG1|APC|CDH6|TBCD|GJA1|LAMC1|CTTN|PEAK1|JUP|CTNND1|ECT2|CXADR|LAMC2|CLDN5|MICALL2|TRIP6|TLN1|CTNND2|TGFB3|THY1|ILK|TAOK2|PVRL2|PKP2|PERP|CDH8|SNAI2|RHOD|FLNA|CDH11|CDH5|LIMS2|F2R|CDH7|DLC1|CD151|VCL|ARL2|GJA4|ANG|CSF1R|ACTB|FLNC|ACTN1|OCLN|VMP1|ITGB4|CADM3|FBLIM1
POTASSIUM ION HOMEOSTASIS%GOBP%GO:0055075,0.578760829614072,0.8381193804335091,-0.248178756354969,-0.9010968348520949,4408,15,ATP1B1|SLC12A8|ATP1A3|SLC12A2|ATP1B3|ATP1B2|KCNH2
REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE-GATED CHANNEL CLUSTERING%GOBP%GO:1904393,0.540334448160535,0.81505408470595,-0.7331826202029109,-0.9767752976393771,4038,1,MESDC2
CELLULAR CARBOHYDRATE CATABOLIC PROCESS%GOBP%GO:0044275,0.24763065258597303,0.6284111611211011,0.291360383126656,1.18081760477155,1828,20,PYGB|MANBA|FAM47E-STBD1|SORD|AGL|PGM2L1|PGM1|ENOSF1|PGM2|ATHL1
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE GROWTH%GOBP%GO:0048633,0.0613627307743392,0.35631208031004796,0.9693427437141601,1.2924877525576102,461,1,DLL1
REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0090153,0.541893362350381,0.815622645995152,0.272687308914477,0.9268111247886959,3983,12,SMPD2|ORMDL1
EXTRACELLULAR NEGATIVE REGULATION OF SIGNAL TRANSDUCTION%GOBP%GO:1900116,0.44413774973711895,0.766503259003379,-0.36855134023984604,-1.00741865323321,3378,7,FBN1|LTBP1|NBL1
NEGATIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTIONAL PREINITIATION COMPLEX ASSEMBLY%GOBP%GO:0017055,0.778057840275935,0.924704689181848,-0.47386852250500394,-0.788592998722501,5864,2,THRA
NEGATIVE REGULATION OF MYELINATION%GOBP%GO:0031642,0.6505704430883521,0.8720434729248241,-0.5384781993,-0.896113832773511,4903,2,TNFRSF21
"POSITIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, ELONGATION%GOBP%GO:0032786",0.9796530585626709,0.993436724391485,-0.119955486588358,-0.529062299832389,7510,27,HMGN1|CCNK|SUPT16H|CTR9|EAPP|SUPT4H1
POSITIVE REGULATION OF CATECHOLAMINE SECRETION%GOBP%GO:0033605,0.527623184471291,0.810052447666581,0.357717911851557,0.9256161218795308,3886,6,CHRNB2|KCNB1|STX1A|CARTPT|VIP
CALCINEURIN-NFAT SIGNALING CASCADE%GOBP%GO:0033173,0.9657426778242679,0.9909947634579399,-0.17290565006298003,-0.54169083046681,7385,10,ADGRB2|PPP3CA|NFATC3|NFATC4|NFATC2|NFATC1
REGULATION OF STRESS-ACTIVATED PROTEIN KINASE SIGNALING CASCADE%GOBP%GO:0070302,0.475386597938144,0.784986345464663,-0.14146115448451502,-0.9901136418683091,3688,158,TNFRSF11A|PHLPP1|IL1RN|FCGR2B|PKN1|MDFIC|TRAF2|TAOK2|MAPK8IP1|ZNF622|FLT4|MLKL|FOXM1|CTGF|MAPK3|HRAS|MEN1|MAP3K13|GADD45B|SASH1|FGF19|GADD45G|BMP2|TGFBR3|LGALS9|MAP3K11|MYC|LTBR|DNAJA1|SEMA3A|DACT1|ARL6IP5|GSTP1|DBNL|SERPINF2|ERN1|SIRPA
REGULATION OF CYTOKINE PRODUCTION%GOBP%GO:0001817,0.000127648710748021,0.00518555396908895,-0.29109785692261103,-2.38253151659233,0,387,MUL1|LILRB1|STAT6|CLEC4A|HLA-E|RGCC|LYN|INHBB|HYAL2|LGR4|DHX9|NDFIP1|CEBPG|TLR1|PYCARD|APOD|NCKAP1L|SEC14L1|CD74|TRIM21|TNFRSF14|PLCB1|GSDMD|B2M|IL18|IRAK3|ADAM8|RUNX1|RIPK3|CCL19|RNF216|TWSG1|TREX1|TRIM56|CD84|NFKB2|AGT|CCDC88B|YY1|HLA-DPB1|CD4|AGPAT1|SARS|KLF4|IL17D|TLR2|FGR|CD34|RORA|PDCD1LG2|CYP1B1|IRF5|SSC5D|SPN|GATA3|AZU1|IL1RN|EBI3|POLR3B|FCGR2B|GAS6|TGFB3|INS|PDE4B|CASP1|IL6ST|TRAF2|C3|TNFAIP3|DHX36|DDX3X|IKBKE|LILRB2|PDE4D|DDX60|POMC|FLT4|MAPKAPK2|GPNMB|INHBA|PTGER4|STAT3|MB21D1|IL17RA|NFAM1|PTPN6|CD47|PARK7|IFIH1|BRCA1|ARRB1|FCER1G|ATP6AP2|TRIM32|SNAI2|LTBP1|ISG15|SLC11A1|OSM|LRRC32|CARD16|GHRL|RSAD2|HMOX1|HSPB1|SOD1|SRGN|TNFRSF4|IRF7|IRAK1|SULF1|CEBPB|FCN1|NPLOC4|IFI16|IL15|SEMA7A|GPRC5B|TMEM173|C10orf54|CEACAM1|BCL3|IL33|HFE|F2R|FN1|CD86|GAPDH|NLRP3|RAB7B|GATA6|AXL|CCBE1|TNFRSF21|BST2|OTUD5|CD200|LGALS9|THBS1|ZP3|FADD|RELB|TLR5|FOXP1|NAV3|TICAM1|CX3CL1|SERPINE1|TRAF3|HAVCR2|RELA|IL1R1|DHX58|MAPK13|ABCD1|NFKB1|TLR4|RPS6KA4|KAT5|CSF1R|CMKLR1|C1QTNF4|ANXA1|UBE2L6|GSTP1|TMSB4X|CD14|AGPAT2|LY96|PQBP1|CHID1|TNFRSF1B|SERPINF2|PTPRJ|NLRX1|SIRPA|PRNP|ACKR1|RNF26
ARGININE CATABOLIC PROCESS TO PROLINE%GOBP%GO:0019493,0.750234113712375,0.914180498652832,-0.6301279223643579,-0.839481695226202,5607,1,OAT
2-OXOBUTYRATE METABOLIC PROCESS%GOBP%GO:0046361,0.21257525083612,0.5950741597527031,-0.8914865460961621,-1.1876741379434,1588,1,THNSL2
POSITIVE REGULATION OF FREE UBIQUITIN CHAIN POLYMERIZATION%GOBP%GO:1904544,0.9181270903010028,0.976125232231811,-0.541188795765329,-0.7209934230526049,6862,1,PINK1
MEIOTIC GENE CONVERSION%GOBP%GO:0006311,0.111834240935051,0.459194647507502,0.9456881340979271,1.26094752241841,841,1,RNF212
"BASE-EXCISION REPAIR, AP SITE FORMATION%GOBP%GO:0006285",0.0765569757954855,0.38654270614299796,0.470117241082151,1.48936319736824,562,10,NTHL1|NEIL1|MUTYH|OGG1|SMUG1|NEIL2|TDG
RESPONSE TO L-GLUTAMATE%GOBP%GO:1902065,0.44693552666489794,0.768229288546963,-0.620402536531569,-1.03244903061336,3368,2,FYN|TMBIM6
REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION%GOBP%GO:1903952,0.142249966795059,0.508373262859943,0.9304146449051608,1.24058238547538,1070,1,RNF207
NEGATIVE REGULATION OF SECRETION%GOBP%GO:0051048,0.00114839862192165,0.0260082836197492,-0.286791573761616,-1.8429678463116201,8,104,PIM3|RAB7A|CD34|SYT4|SSC5D|FCGR2B|GAS6|INS|TNFAIP3|FMR1|PLA2R1|NOTCH1|INHBA|CRHBP|PTGER4|IRS1|OSM|CARD16|RSAD2|SRGN|TNFRSF4|VAMP8|NR1H3|CEACAM1|CD300A|F2R|FN1|NLRP3|NOV|CHGA|TNFRSF21|CD200|LGALS9|ADRA2C|HTR1B|CX3CL1|IL11|SIRT4|SERGEF|RAB11FIP1|ANXA1|TNFRSF1A|TMSB4X|TNFRSF1B
CELLULAR CALCIUM ION HOMEOSTASIS%GOBP%GO:0006874,0.023392560398823994,0.21274255506036496,-0.19272610311362198,-1.42332724314131,182,208,OCM|EDNRA|CCL19|HSP90B1|FPR3|LPAR6|RYR2|ITPR2|ATP1B1|CCDC109B|ATP2A1|P2RX4|ERO1L|PTGER1|PLN|ITPR3|SLC8B1|WBP2NL|P2RX5|P2RX3|ANXA6|THY1|STIM1|ATP2A3|TMEM203|GRIN1|FPR1|ADCY8|CXCR4|JPH4|CALB2|TAC1|CALCB|RMDN3|PTGER4|TBXA2R|GHRL|ABL1|CALR|HERPUD1|SLC35G1|CCRL2|P2RY6|GPER1|SLC24A3|TPCN2|F2R|CCR1|APLNR|GNA15|TMCO1|CD36|F2RL3|GRIN2C|TGM2|GRIN2D|BCAP31|CX3CL1|CAV1|C3AR1|STOML2|CHRNA10|GPR4|CCL14|PRKACA|PTGIR|PDGFRA|CMKLR1|CD55|GNG3|ATP2B2|C5AR1|C1QTNF1
GLYCOSIDE TRANSPORT%GOBP%GO:1901656,0.823678929765886,0.941760803523009,-0.591916629907367,-0.7885750786010921,6156,1,RALBP1
POSITIVE REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY%GOBP%GO:2000324,0.8452173913043479,0.948607022051457,-0.580723423026026,-0.7736630393876751,6317,1,LMO3
RESPONSE TO FATTY ACID%GOBP%GO:0070542,0.71072319201995,0.8964108318214721,-0.20110929913932998,-0.8193207327487572,5414,21,PTGER2|SCD|ZC3H12A|PPP5C|PTGFR|PDK4|CCL19|PID1|PTGER4|CD36|TGFBR3|PDK3
MITRAL VALVE MORPHOGENESIS%GOBP%GO:0003183,0.652813965607087,0.873565940887118,-0.279362772374034,-0.8403915996095329,5010,9,SMAD6|EFNA1|NOTCH1|DCHS1
REGULATION OF IMMUNOGLOBULIN PRODUCTION IN MUCOSAL TISSUE%GOBP%GO:2000557,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
CELL CYCLE DNA REPLICATION INITIATION%GOBP%GO:1902292,0.0698327759197324,0.37596389138254704,-0.9637185707984119,-1.28390453877875,521,1,POLA1
CLOACA DEVELOPMENT%GOBP%GO:0035844,0.221864951768489,0.604425969113003,0.723016401762535,1.21476090738744,1655,2,AHI1|WNT11
DETECTION OF NODAL FLOW%GOBP%GO:0003127,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
VITAMIN CATABOLIC PROCESS%GOBP%GO:0009111,0.990969768354927,0.997150662115148,-0.223736223730463,-0.489805363019687,7571,4,PDXP
AXON GUIDANCE%GOBP%GO:0007411,0.11458915595304599,0.463748809895271,0.180640360401323,1.25110739807937,819,143,TNR|RET|CNTN4|ROBO3|IRS2|UNC5C|IGSF9|SEMA4F|PLXNB1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|SLIT1|EPHB2|EFNA4|GFRA1|CHN1|PTPRO|ROBO2|PTPRM|LYPLA2|EFNB2|EFNB3|SLIT3|CDK5R1|SHC1|SOS1|DRAXIN|SPTBN1
PHAGOCYTOSIS%GOBP%GO:0006909,0.00012863390789812198,0.00518555396908895,-0.32125964433031395,-2.2454117303842103,0,156,RAC1|ITGB1|WIPF3|IGHV1OR15-1|IGKV3-11|ACTG1|IGHV5-51|LYN|C4B|ARHGAP25|FCN3|MESDC2|IGHV1-24|NCKAP1L|VAV3|WASF2|CORO1C|CORO1A|IGHV3-49|RAB14|ITGB2|IGHG4|MERTK|NCKIPSD|MSR1|LRP1|FGR|FCGR1A|RAB7A|IGLL5|ARPC1A|VAV1|MYO1G|WAS|TXNDC5|SYT7|FCGR2B|GAS6|IGKV2-28|C3|MYO10|IGHV4-4|ELMO1|ANXA11|IGHV4-61|GRB2|IGHV1-3|CD93|PIK3CB|SLC11A1|PLD4|MAPK3|ABL1|IGHV3-43|FCN1|NR1H3|IGHV3-73|VAMP7|FCGR2A|P2RY6|CLEC7A|DOCK1|CYFIP2|GSN|IGKV2D-28|RAB7B|AXL|HCK|COLEC12|CD36|THBS1|IGHV3-15|AIF1|TGM2|RAB34|MYH9|ITGAM|IGHV1-18|HSP90AA1|RAB20|ACTB|ANXA1|NCK1|CD14|IGHG2|IGHA1|ADGRB1
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS%GOBP%GO:0048704,0.32747079669247897,0.6946642582328871,-0.27039081239914303,-1.1015741166196202,2494,21,HOXA4|NDST1|HOXB3|TGFBR2|EIF4A3|PDGFRA|MTHFD1
SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE%GOBP%GO:0031629,0.222425988996594,0.604959238589686,-0.37942665735429293,-1.2284142170977599,1697,11,SNAP47|STX4|STX11|STX1B|STX3|PRRT2
NUCLEOSIDE TRANSPORT%GOBP%GO:0015858,0.517909259750597,0.8047565444482679,-0.5917838433967471,-0.984822948763893,3903,2,SLC29A1|SLC29A2
NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT%GOBP%GO:1902306,0.0952185792349727,0.42504444493541294,0.49771346138723904,1.44477510540109,696,8,PRKCE|NEDD4|CAMK2D|NEDD4L|HECW2|COMMD1|HECW1
REGULATION OF ERYTHROCYTE DIFFERENTIATION%GOBP%GO:0045646,0.139798981856155,0.504314492208813,-0.289522236048388,-1.3090806401308799,1070,29,PRMT1|HOXA5|LYN|CDK6|NCKAP1L|HMGB2|ZFP36L1|MED1|INHBA|STAT3|HSPA9|TAL1|MAFB|SPI1|ZNF16
MELANIN METABOLIC PROCESS%GOBP%GO:0006582,0.372454448017149,0.7234654586828599,0.650335927211928,1.0926483259864899,2779,2,CITED1|TRPC1
REGULATION OF OOCYTE DEVELOPMENT%GOBP%GO:0060281,0.9774898573485149,0.9927322181739301,-0.242855668996217,-0.531661825388557,7468,4,IGF1
HISTONE H3-K9 DIMETHYLATION%GOBP%GO:0036123,0.0311753780843725,0.250729241129472,-0.8854153113555941,-1.4734726666495401,234,2,SUV39H1
RESPONSE TO ANESTHETIC%GOBP%GO:0072347,0.22626453881525602,0.608701596380677,0.44472633609376705,1.22765511363419,1672,7,DRD2|DRD4|CHRNB2|SRR
REGULATION OF ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002673,0.000128865979381443,0.00518555396908895,-0.49246088789261294,-2.80810979371015,0,65,DNASE1L3|HLA-E|C4B|F12|C2CD4A|ADAM8|C2CD4B|IGHG4|C4A|TNFRSF11A|FCGR2B|C2|INS|IL6ST|IGKV2-28|VTN|C3|C1QB|PARK7|OSM|C1QA|CFB|C1QC|C7|IGKV2D-28|NLRP3|A2M|ZP3|SUSD4|CD59|C3AR1|CFP|C1S|CFI|OSMR|CD55|GSTP1|PHB|IGHG2|SERPING1|CD81|C1R|CFH|C5AR1
REGULATION OF TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0034143,0.138143249967265,0.503032181773938,-0.390733178962409,-1.34497937371106,1054,13,LYN|DAB2IP|TICAM2|TNFAIP3|NR1H3|RAB7B|NR1D1
TERPENOID BIOSYNTHETIC PROCESS%GOBP%GO:0016114,0.6193121693121689,0.854944793214197,-0.447737262922336,-0.874317395944527,4681,3,FDPS|HMGCS1
PRESYNAPTIC ENDOCYTOSIS%GOBP%GO:0140238,0.701251019853141,0.8931369333627571,0.191273382792888,0.8239336817876322,5156,24,SYT2|KIAA1109|SYT5|NLGN2|NLGN4X|CDK5|AMPH|PIP5K1C|SNCA|DNAJC6|FCHO2
NEGATIVE REGULATION OF GLIAL CELL MIGRATION%GOBP%GO:1903976,0.456103068136539,0.7711961414599979,0.7731583590648431,1.03090234734715,3433,1,CERS2
NEGATIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0010871,0.0494476591267754,0.318857627587799,-0.650824368663466,-1.55990182296608,375,5,NR1D1|PPARG|PPARA
CELLULAR POTASSIUM ION HOMEOSTASIS%GOBP%GO:0030007,0.192796332678454,0.5673027886794,-0.49422820567441605,-1.27128808320628,1471,6,ATP1B1|ATP1A3|ATP1B3|ATP1B2
GLYCOSIDE CATABOLIC PROCESS%GOBP%GO:0016139,0.36618068211403293,0.720655766665538,-0.372969750159086,-1.07372770969751,2812,8,GLA|ABHD10|FUCA1
POSITIVE REGULATION OF COLLAGEN FIBRIL ORGANIZATION%GOBP%GO:1904028,0.454849946409432,0.77085243169122,0.6119106699751861,1.02808893254298,3394,2,RB1|COLGALT1
LIPOPOLYSACCHARIDE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0031663,0.0452701818657595,0.305260375357835,-0.41023174604581103,-1.5589808120125201,345,17,IL1B|CCL3|TNF|TGFB1|LYN|MTDH|IL18|IRAK1|CCL2|HCK|TLR4|CD14
GLUCURONATE CATABOLIC PROCESS%GOBP%GO:0006064,0.6751709626512359,0.882488012133495,-0.34305650942725396,-0.8222409918898811,5133,5,CRYL1
PURINE RIBONUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0034036,0.224921949233066,0.6078034241178771,0.47423392304585704,1.22710814910375,1656,6,PAPSS1|SLC35B2|SLC35B3|SLC26A1|PAPSS2
REGULATION OF ORGANIC ACID TRANSPORT%GOBP%GO:0032890,0.545335601203716,0.817297924969912,-0.24443191889941196,-0.9289009811664571,4167,17,STK39|IL1B|AKT1|SYK|PER2|P2RX4|TNFRSF11A|PLA2R1|THBS1|ARL6IP1|ARL6IP5
PROTEIN-PYRIDOXAL-5-PHOSPHATE LINKAGE%GOBP%GO:0018352,0.48386239872493,0.787078399497453,0.758215703573004,1.01097833250397,3642,1,CTH
THIAMINE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0042357,0.8328469089944279,0.9443921657118071,-0.4421106012131721,-0.735742739219445,6277,2,THTPA
REGULATION OF INTERFERON-GAMMA SECRETION%GOBP%GO:1902713,0.39347711730668106,0.73762759729289,-0.43753868480945507,-1.04869673742252,2991,5,RASGRP1|PTPN22|ZC3H12A|LGALS9
CELLULAR RESPONSE TO VITAMIN D%GOBP%GO:0071305,0.5333601286173629,0.812079525085925,0.577038486466932,0.969499161719248,3980,2,SFRP1
POSITIVE REGULATION OF XENOPHAGY%GOBP%GO:1904417,0.39255091103965706,0.737280445732591,0.639757375241246,1.07487499282362,2929,2,OPTN|LRSAM1
REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION%GOBP%GO:0014857,0.439342480641217,0.7650340344477281,0.45679148513759493,1.00359034651812,3233,4,FGF2|CFLAR|EPHB1|AKIRIN1
NEGATIVE REGULATION OF HEPATOCYTE PROLIFERATION%GOBP%GO:2000346,0.42040328999734705,0.751774348695433,-0.6314076242607239,-1.05076325644052,3168,2,CEACAM1
ADENOHYPOPHYSIS DEVELOPMENT%GOBP%GO:0021984,0.627143622722401,0.859069247760118,0.5372872187300229,0.902711899427309,4680,2,DRD2
VITAMIN K BIOSYNTHETIC PROCESS%GOBP%GO:0042371,0.608048877672998,0.849421970741672,0.6932068813409791,0.924297839883635,4577,1,UBIAD1
NEGATIVE REGULATION OF INTERLEUKIN-8 PRODUCTION%GOBP%GO:0032717,0.338823529411765,0.7004439483944871,-0.329317947307467,-1.10225800420465,2591,12,KLF4|SSC5D|ARRB1|BCL3|ANXA1|TMSB4X
NEGATIVE REGULATION OF RENAL ALBUMIN ABSORPTION%GOBP%GO:2000533,0.36428093645485,0.718457761443038,-0.8158359064843409,-1.08688932119066,2722,1,GAS6
POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1905665,0.342940629565679,0.701955655133333,0.829124393471548,1.10552550257161,2581,1,RAMP3
GLYCOSYLCERAMIDE CATABOLIC PROCESS%GOBP%GO:0046477,0.771365004580552,0.9213545359508709,-0.344254955153741,-0.753646059046475,5893,4,GALC|GBA|GLA
URETERIC BUD ELONGATION%GOBP%GO:0060677,0.454774870500731,0.77085243169122,0.7735443317159242,1.03141698979697,3423,1,FGF1
INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT%GOBP%GO:0065002,0.12134918583613301,0.47375385823484295,-0.25149466301551504,-1.31841675249213,938,48,TIMM21|SRP19|ROMO1|PEX16|SEC61A1|SEC61B|TIMM9|TIMM17B|SRP9|TIMM10|DNAJC19|DNAJC15
POSITIVE REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034184,0.701735928458706,0.8931369333627571,-0.335516596156322,-0.804169258527336,5335,5,ANKRD32|H2AFY
ATRIAL SEPTUM DEVELOPMENT%GOBP%GO:0003283,0.186150712830957,0.559093571852282,0.3635384728660379,1.2731875250741,1370,13,ACVR1|NPHP3-ACAD11|ANK2|NPHP3|ZFPM1|BMPR2|HEY2|SOX4
NEGATIVE REGULATION OF KIDNEY DEVELOPMENT%GOBP%GO:0090185,0.365413329713588,0.7198299218968391,0.41322205015526203,1.06923634201058,2691,6,PAX8|BMP7|FLCN
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1901030,0.112409949707761,0.459546081735432,0.29416702064163597,1.36190401521644,826,30,BBC3|BOK|PMAIP1|CASP8|TP53BP2|BID|YWHAQ|YWHAB|YWHAE|ZNF205|BAX|BCL2|YWHAH|YWHAZ|MAPK8
REPLICATIVE SENESCENCE%GOBP%GO:0090399,0.5050807712350179,0.797902257689198,-0.31684804535779604,-0.953156476106557,3876,9,TERT|CDKN2A|PLA2R1|SERPINE1
POSITIVE REGULATION OF INTERLEUKIN-18 PRODUCTION%GOBP%GO:0032741,0.206022817723534,0.585942621384071,-0.7300248138957819,-1.2148780300675701,1552,2,DHX9|TLR2
NEGATIVE REGULATION OF MYD88-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034125,0.0206951446006898,0.19828362800876603,-0.9064240419079129,-1.5084345538371997,155,2,CD300A|CD300LF
REGULATION OF POLYAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0010967,0.620135476158852,0.8551097775270831,0.687031318923688,0.916063560686454,4668,1,PAOX
MRNA TRANSCRIPTION BY RNA POLYMERASE II%GOBP%GO:0042789,0.219588843786827,0.601964339800201,-0.35545980622624,-1.2235615844735301,1676,13,SOX18|SOX17|MED1|LMO2|SRF|C5AR1
"BLOOD COAGULATION, INTRINSIC PATHWAY%GOBP%GO:0007597",0.0156903765690377,0.16961379005211,-0.563813896095677,-1.76635533595085,119,10,F12|PRCP|GP1BA|GP1BB|VWF|F8|A2M|SERPING1
GLUTATHIONE CATABOLIC PROCESS%GOBP%GO:0006751,0.0629931614939506,0.36006266503904,-0.633879391481225,-1.5192879460595101,478,5,CHAC1|CHAC2|GGT1|GGT5
DETERMINATION OF DORSAL/VENTRAL ASYMMETRY%GOBP%GO:0048262,0.25179092597506003,0.632068187660447,-0.7065343258891651,-1.1757861016131002,1897,2,GREM1|NBL1
NEGATIVE REGULATION OF RNA SPLICING%GOBP%GO:0033119,0.9302420451454989,0.9793746057014829,0.155774152843683,0.609766501311114,6840,18,PTBP2|RNPS1|RPS26|C1QBP
REGULATION OF MEMBRANE PERMEABILITY%GOBP%GO:0090559,0.4959955813311239,0.794012168719884,0.17080732095853798,0.9748727798508531,3591,62,TMEM102|HEBP2|BBC3|BOK|PMAIP1|ALKBH7|CASP8|TP53BP2|BID|YWHAQ|TMEM14A|YWHAB|YWHAE|ZNF205|ATF2|BAX|BCL2|YWHAH|ACAA2|PDCD6IP|LAPTM4B|YWHAZ|MAPK8|THEM4
NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION%GOBP%GO:0046929,0.42214111922141095,0.7527812076478722,0.42129696776008,1.01321679153088,3122,5,PARK2|PNKD|SYT11|SLC30A1
NEURAL TUBE PATTERNING%GOBP%GO:0021532,0.965807469752762,0.9909998455127321,-0.230292038597626,-0.5519660727528289,7343,5,ATP6AP2
RESPONSE TO HYDROGEN PEROXIDE%GOBP%GO:0042542,0.102906825849987,0.44146292546620297,-0.258683337032493,-1.34722375814343,792,47,APTX|AQP1|ADAM9|IMPACT|ECT2|PPIF|HP|CYP1B1|GPX1|TNFAIP3|PARK7|ABL1|HMOX1|SOD1|CAT|FXN|RELA|SIGMAR1|MAPK13|ANXA1|NET1|SIRPA
POSITIVE REGULATION OF GRANZYME B PRODUCTION%GOBP%GO:0071663,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
LIMB MORPHOGENESIS%GOBP%GO:0035108,0.142603226688543,0.508674778494682,0.266783893996901,1.2931053307903502,1042,35,FGFR2|RARG|TBX3|HDAC1|IQCE|TWIST1|CACNA1C|TFAP2B|ACD|SKI|LRP6|MEGF8|BMPR1B|HDAC2|CYP26B1|ZNF141|SOX4|FBXW4|LEF1|MSX1
REGULATION OF CITRULLINE BIOSYNTHETIC PROCESS%GOBP%GO:1903248,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
DIGESTIVE SYSTEM DEVELOPMENT%GOBP%GO:0055123,0.24088791449712302,0.6244696312630601,0.23679777166235896,1.1733675518708002,1757,38,RET|RBPMS2|STRA6|NPHP3-ACAD11|ITGA6|FGFR2|AHI1|KIT|PKD1|CLMP|NPHP3|CCDC40|BBS7|MEGF8|RARB
REGULATION OF METANEPHRIC DCT CELL DIFFERENTIATION%GOBP%GO:2000592,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
GLUCAN BIOSYNTHETIC PROCESS%GOBP%GO:0009250,0.30182008642137,0.674735752055117,-0.328700560146231,-1.1314510702621599,2304,13,GYG1|PER2|PPP1R3C|PGM5|NR1D1|GYG2
HISTAMINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002349,0.4486651613760129,0.768229288546963,0.7769078076753421,1.03590173114544,3377,1,SNAP23
CELLULAR RESPONSE TO SUCROSE STIMULUS%GOBP%GO:0071329,0.28066889632107,0.653918409964198,-0.856583590648434,-1.1411750205931999,2097,1,CALCRL
POLYSACCHARIDE DIGESTION%GOBP%GO:0044245,0.859531772575251,0.951070228184264,-0.5733348037053371,-0.763819624340396,6424,1,CHIT1
VACUOLAR TRANSPORT%GOBP%GO:0007034,0.289637091210156,0.6622817015650171,0.16872248466825102,1.10269392438948,2098,108,CHMP3|BIN1|KIF13A|PARK2|NAGPA|CACNG7|TMEM50B|CCDC91|GCC2|VPS36|CLEC16A|SCARB2|VPS33B|VPS13C|EHD3|SNX16|NEDD4|VPS13A|CACNG4|AKTIP|AP4M1|VPS35|ZFYVE16|VPS11|VPS41|ATG14|SORT1|TRAK1|LEPROTL1|AP3M1|VPS52|UBXN6|CHMP1A|VPS33A|HGSNAT|LAMP1|M6PR|TGFBRAP1|VPS16|VIPAS39|SCYL2|AP1G1|NPC1|VPS39|ANKFY1
REGULATION OF TRANSPOSON INTEGRATION%GOBP%GO:0070894,0.914924973204716,0.9740523336757891,0.378163771712159,0.6353639631774151,6828,2,ZNF91|ZNF93
REGULATION OF MUSCLE SYSTEM PROCESS%GOBP%GO:0090257,0.0104631874441751,0.13160598312092803,-0.252734155862171,-1.6241095120383602,81,104,AGT|RYR2|JUP|ATP1B1|LMCD1|ATP2A1|PARP1|P2RX4|PLN|TNNC2|ANXA6|C12orf57|PDE4B|MYLK2|IL6ST|DOCK5|PDE4D|NOTCH1|SLC9A1|PKP2|ENO1|CAMK2B|SOD1|FLNA|IGF1|LMNA|CHRM2|GPER1|F2R|KCNQ1|NOS3|KCNB2|CHGA|SRF|CAV1|CLIC2|PRKACA|ADRBK1|RGS2|MYL9|SPHK1|CNN1
VITAMIN B6 METABOLIC PROCESS%GOBP%GO:0042816,0.043973301923831996,0.299062021084573,-0.7034466335449411,-1.5399917275958899,335,4,PDXP|PNPO|PDXK
REGULATION OF CENTRIOLE REPLICATION%GOBP%GO:0046599,0.0441582336706532,0.29950475077556604,-0.39500800583910706,-1.56063978007294,335,19,PLK2|NPM1|CDK5RAP2|BRCA1|SPICE1|RBM14|KAT2B
REGULATION OF DNA DAMAGE CHECKPOINT%GOBP%GO:2000001,0.542709466811752,0.816099720857136,0.272638981819233,0.926646870391673,3989,12,ETAA1|THOC5|RINT1|FEM1B|CCAR2|DDX39B|THOC1|PPP1R10|CRY1|RFWD3
CARDIAC RIGHT ATRIUM MORPHOGENESIS%GOBP%GO:0003213,0.309698996655518,0.680809181688249,-0.8423577415086021,-1.1222227737111201,2314,1,NOTCH1
NCRNA DEADENYLATION%GOBP%GO:0110008,0.31637667684951504,0.6860696798880219,0.842412880458756,1.12324390691554,2381,1,PARN
NEGATIVE REGULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST%GOBP%GO:0044146,0.9232301766502858,0.9776156396135859,0.539258932509925,0.719029022753894,6950,1,TIRAP
GLOMERULAR PARIETAL EPITHELIAL CELL DEVELOPMENT%GOBP%GO:0072016,0.469517864258202,0.780769690730001,0.766100573445082,1.02149174255037,3534,1,FOXJ1
NEGATIVE REGULATION OF CELL FATE COMMITMENT%GOBP%GO:0010454,0.0614047004483087,0.35631208031004796,0.688433611781549,1.5125179638461297,451,4,DKK1|LOXL3
PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS%GOBP%GO:0034727,0.26944444444444393,0.6434418809581031,-0.604966774117342,-1.18134678165258,2036,3,ATG7|ATG13
DNA DOUBLE-STRAND BREAK PROCESSING INVOLVED IN REPAIR VIA SINGLE-STRAND ANNEALING%GOBP%GO:0010792,0.217419777341192,0.5996151428055749,-0.48089917632880097,-1.23700222907405,1659,6,SLX1B|SLX1A|RNF138
THYROID HORMONE METABOLIC PROCESS%GOBP%GO:0042403,0.331613756613757,0.6961761803662729,-0.5761199762856851,-1.1250162966782098,2506,3,CPQ
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002720,0.08099647841398198,0.397722753303477,-0.32474610311805496,-1.43228896871416,620,27,LILRB1|HLA-E|CD74|TNFRSF14|B2M|IL18|TRAF2|RSAD2|SEMA7A|GPRC5B|NLRP3|TICAM1|IL1R1
NEGATIVE REGULATION OF MATURE B CELL APOPTOTIC PROCESS%GOBP%GO:0002906,0.48386239872493,0.787078399497453,0.758325981473313,1.01112537320392,3642,1,BCL10
MITOCHONDRIAL TRYPTOPHANYL-TRNA AMINOACYLATION%GOBP%GO:0070183,0.541373356355426,0.815622645995152,0.728164975738862,0.970909741767681,4075,1,WARS2
REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION%GOBP%GO:0110020,0.542606677839371,0.816099720857136,-0.16832362292899802,-0.9439294422643321,4208,61,PHLDB2|SLC9A1|PTGER4|CD47|S100A10|CTGF|PXN|ABL1|RAPGEF3|PPFIA1|ARHGEF15|DLC1|EVL|NF2|SERPINF2
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY INVOLVED IN URETERIC BUD FORMATION%GOBP%GO:2000703,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS%GOBP%GO:0021692,0.15877738707059802,0.529241394364932,0.481293523615514,1.32859785326729,1173,7,DLL1|ATP7A|ADCK4|AGTPBP1
RESPONSE TO SUCROSE%GOBP%GO:0009744,0.442122186495177,0.7653693162885199,0.618790665649634,1.0396482135882499,3299,2,KHK
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS%GOBP%GO:0010563,0.00999871811306243,0.12796659248101,-0.17490323614253,-1.41745124144096,77,363,PYCARD|NCKAP1L|SOCS4|GNB2L1|SAMSN1|CORO1C|IRAK3|IGBP1|TSG101|SYTL2|IMPACT|SOCS3|DAB2IP|PRDM15|PPM1F|PID1|DUSP5|PPIF|PARP1|PPP1R8|SEMA6A|CNST|APOC1|SPRY1|CDKN1C|SYNJ2BP|HNRNPU|SFRP2|CDKN2A|BOD1|CBFA2T3|NPM1|SMAD6|PLEK|HEXIM1|LMTK3|PRR5L|THY1|PKMYT1|SLC9A3R1|WARS|MAPK8IP1|CD2BP2|PDE12|HEG1|PDE4D|IPO7|INHBA|FKBP15|PRKAR1A|CEBPA|SOCS1|FOXM1|PTPN6|PARK7|RGS4|CDKN2B|ENSA|TIMP3|TAF7|ABL1|HSPB1|C14orf166|MEN1|LRP5|LDLRAD4|TNIP1|SNX6|GNAQ|CDA|CEACAM1|CRY2|VPS25|PPP2R4|GPER1|CD300A|MBIP|PSMD10|APOE|PLK1|PPP2CA|MVP|LGALS3|WWTR1|DLG3|CHMP6|ELFN2|LATS2|C3orf33|ERRFI1|ADARB1|SLIT2|FKBP1A|RRP1B|NR2F2|CAV1|MYC|DNAJA1|RASIP1|DDIT4|PPARA|CCDC8|DACT1|TLR4|CDKN2C|PDGFA|NF2|SMPD1|STYXL1|H2AFY|RGS2|GPS1|ENG|GSTP1|PHB|NCK1|RGS3|PDGFB|FBLN1|PTPRJ|EIF4G1|SIRPA|WNK2|PRNP
URETER SMOOTH MUSCLE CELL DIFFERENTIATION%GOBP%GO:0072193,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
EMBRYONIC DIGIT MORPHOGENESIS%GOBP%GO:0042733,0.27218127218127197,0.646576786621306,0.38317460914716495,1.16443229700705,1993,9,TBX3|HDAC1|TWIST1
CAJAL BODY ORGANIZATION%GOBP%GO:0030576,0.22655200214996,0.6091952781136228,0.626357544307727,1.23197137460008,1685,3,WRAP53|USPL1|ZPR1
MATURATION OF 5.8S RRNA%GOBP%GO:0000460,0.9236680995180409,0.9776627603891009,-0.145651017641057,-0.627921945765929,7090,25,EXOSC3|SKIV2L2|EXOSC2
BASIC AMINO ACID TRANSMEMBRANE TRANSPORT%GOBP%GO:1990822,0.47899489595602707,0.7850984235874658,-0.445197698048001,-0.9746308240664169,3659,4,SLC7A2|SLC7A3
DETECTION OF BACTERIAL LIPOPEPTIDE%GOBP%GO:0070340,0.19779782435659302,0.574790273586514,-0.7349324510614829,-1.22304512310149,1490,2,TLR1|TLR2
STAT CASCADE%GOBP%GO:0097696,0.8076621338912141,0.9339915228945179,-0.175311782784647,-0.7450701344481,6176,24,STAT5B|IFNAR2|CLCF1|PIAS1|NMI|PTPN1|JAK3|STAT5A|LYN|IFNAR1|STAT3|CTR9|IL15|CCL2
NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION%GOBP%GO:0045671,0.0631882538017829,0.36006266503904,-0.424753018311762,-1.5027140655757498,481,14,CCL3|ZNF675|LILRB1|LILRB3|TCTA|FBN1|MAFB|TLR4|LILRB4
REGULATION OF INTERFERON-ALPHA PRODUCTION%GOBP%GO:0032647,0.465501379944802,0.7791761020078699,-0.25002322876198,-0.9878184517281831,3541,19,IRF5|DHX36|IFIH1|IRF7|HAVCR2|TLR4
REGULATION OF CELLULAR KETONE METABOLIC PROCESS BY REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0072364,0.293048553993102,0.665548149023554,-0.6870613409413029,-1.14337994069543,2208,2,PPARA
POSITIVE REGULATION OF PEPTIDYL-CYSTEINE S-NITROSYLATION%GOBP%GO:2000170,0.8090836012861741,0.934411105358167,0.44494072236007703,0.747557862187017,6038,2,NOS1AP|ACE
GLIAL CELL ACTIVATION%GOBP%GO:0061900,0.018562091503268,0.187443169137574,-0.523463088932574,-1.75207997134426,141,12,CLU|APP|MAPT|TNF|PSEN1|ITGB2|LRP1|AZU1|AIF1|CX3CL1|ITGAM
REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS%GOBP%GO:0043281,0.000638488060273273,0.0163600882996276,-0.26302937835343104,-1.80324124258044,4,141,FIS1|PYCARD|APOPT1|GNB2L1|FNIP1|RPS6KA1|TRIAP1|IGBP1|REST|PPM1F|KLF4|TNFRSF10A|TNFRSF10B|PDCD6|HGF|CASP10|NGF|PDCD5|GAS6|GPX1|CASP1|VCP|TRAF2|DDX3X|SIAH2|TNFSF10|CAAP1|CYCS|CASP4|PARK7|F3|IFI27L1|ANP32B|DPEP1|CARD16|IFI6|NAIP|GPER1|GSN|F2R|USP47|DLC1|PLAUR|NLRP3|LGALS9|THBS1|XIAP|FADD|MMP9|BCAP31|MYC|PPARG|BCL2L12|ARL6IP1|S100A8|S100A9|ARL6IP5|NGFRAP1|DHCR24|NGFR|BAD
ATRIAL SEPTUM PRIMUM MORPHOGENESIS%GOBP%GO:0003289,0.37395861327600105,0.724682900261831,0.552336277288902,1.08638027745826,2782,3,ACVR1|SOX4
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION%GOBP%GO:0010771,0.268387096774194,0.6425780801490849,-0.20896610413978503,-1.13987489918758,2079,55,SEMA3B|SEMA3D|SEMA7A|SEMA5A|SEMA3E|SLIT2|SEMA3A|SEMA6B|ARHGDIA|NGFR|FBLN1|EFNA5
EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS%GOBP%GO:0060502,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
DENDRITIC CELL MIGRATION%GOBP%GO:0036336,0.826013071895425,0.942965636152211,-0.21189405360606,-0.709229237398907,6318,12,GPR183|CCL19|CXCR4|CCR1|EPS8
PHOSPHATIDIC ACID BIOSYNTHETIC PROCESS%GOBP%GO:0006654,0.21824827046077502,0.600900183590521,-0.26720054156207396,-1.20815264749799,1671,29,GPD1|AGPAT1|GPAM|PLA2G2A|PLA2G2D|PLA2G4D|PLA2G4A|ABHD5|PLD1|AGPAT2|AGPAT3|PLA2G12A
ERBB SIGNALING PATHWAY%GOBP%GO:0038127,0.118800939356265,0.46989786402653394,0.24498890118588898,1.3147411796349,859,50,NCK2|PTPRR|GAB1|ERBB3|ADAM17|PTPN12|SHC1|SOS1|SLC30A10|PTK2B|CBL|CPNE3|STUB1|PRKCA|PTPN18|PLCG1|CUL5|CDC37|EPS15|EGFR|SRC|MAPK1|ERBB2|PDPK1
REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE%GOBP%GO:1904672,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION%GOBP%GO:0002730,0.240268279852709,0.6242678039913271,-0.506703250732705,-1.2144710041266102,1826,5,BST2|TICAM1
TRABECULA MORPHOGENESIS%GOBP%GO:0061383,0.15347376684548003,0.52168285154307,-0.344269448848086,-1.30830797491805,1172,17,NOTCH1|S1PR1|TGFBR3|TEK|FKBP1A|ENG
NUCLEOSIDE DIPHOSPHATE PHOSPHORYLATION%GOBP%GO:0006165,0.0363707469691044,0.271450902407424,-0.33371518030416397,-1.5672206933964,278,33,GPI|PFKFB2|HK1|HK3|ENO1|PGAM1|GAPDH|NME2|LDHA|CMPK2|PGK1|ALDOA|ALDOC|AK1
HISTONE H3-K14 ACETYLATION%GOBP%GO:0044154,0.802364191791739,0.932946245893631,0.5989744155271279,0.798651561776641,6040,1,MEAF6
SNRNA EXPORT FROM NUCLEUS%GOBP%GO:0006408,0.14420270628814,0.510504706891383,-0.767907361455749,-1.27792064708218,1086,2,NCBP2|PHAX
RENAL CONTROL OF PERIPHERAL VASCULAR RESISTANCE INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0003072,0.6921957671957671,0.888433240372712,-0.420343143365681,-0.820823623461441,5232,3,SERPINF2
ENGULFMENT OF APOPTOTIC CELL%GOBP%GO:0043652,0.45998690242305196,0.774149829207065,-0.38483299468770793,-0.9898941309985941,3511,6,THBS1|ADGRB1
STEROID ESTERIFICATION%GOBP%GO:0034433,0.20123258306538103,0.5792408283906739,0.73575305664721,1.23616013208977,1501,2,LCAT|SOAT1
TISSUE HOMEOSTASIS%GOBP%GO:0001894,0.26107676455435297,0.6369611517066359,-0.20434753959475302,-1.14167647763542,2026,60,ACP5|B2M|BBS1|SERPINA3|DFNB31|CXADR|P2RX4|CD34|JCHAIN|GCNT2|TPP1|MUC4|RCN3|HSPB1|SOD1|CTSH|LCN1|F2R|NOS3|TLR4|ACTB|ADGRV1|IGHA1
POSITIVE REGULATION OF T-HELPER 1 CELL DIFFERENTIATION%GOBP%GO:0045627,0.815343915343915,0.93672636711832,-0.37076141172984706,-0.72400306801488,6163,3,CCL19|ANXA1
REGULATION OF PYRUVATE DEHYDROGENASE ACTIVITY%GOBP%GO:1904182,0.10287625418060198,0.44146292546620297,-0.9461843846493159,-1.26054479262177,768,1,SIRT4
NUCLEAR PORE COMPLEX ASSEMBLY%GOBP%GO:0051292,0.9579820505847159,0.9886054797939609,0.17977134335554998,0.569527767411573,7044,10,RTN4|NDC1|TMEM170A|TPR|AHCTF1
NEGATIVE REGULATION OF ENDOSOME ORGANIZATION%GOBP%GO:1904979,0.60034833869239,0.8464076674715391,0.5484914713504789,0.921536490469288,4480,2,PARK2
POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS%GOBP%GO:0010759,0.0055205047318612,0.0848099061821459,-0.693691450128921,-1.89617464419877,41,7,CSF1|THBS1|RARRES2|CMKLR1
ANDROGEN BIOSYNTHETIC PROCESS%GOBP%GO:0006702,0.19735063530683997,0.574498834824499,0.526721498106693,1.26676218245635,1459,5,HSD17B3|SRD5A1|HSD17B6
REGULATION OF TELOMERE MAINTENANCE%GOBP%GO:0032204,0.927149571468067,0.9792426054261899,0.115227528370719,0.6933762376213579,6706,76,CTC1|SMG6|HMBOX1|EXOSC10|ATM|MRE11A|PARN|ACD|TEN1|PIF1|RTEL1|POT1|MAP2K7|MAP3K4|XRCC5|PNKP|HNRNPD|TNKS|ATR|SRC|ERCC1|MAPK1|TNKS2|NEK7|SMG5|TCP1
STEROL HOMEOSTASIS%GOBP%GO:0055092,0.00782574670666493,0.108091902593059,-0.347192916446793,-1.7698721711141798,59,44,FABP3|ABCG1|EHD1|CETP|MALL|APOM|NR1H3|LRP5|APOE|CYP7B1|NR1D1|TMEM97|CAV1|LDLR|ABCD1|NPC2|INSIG1
REGULATION OF UDP-GLUCOSE CATABOLIC PROCESS%GOBP%GO:0010904,0.968123256740603,0.9912626134248801,0.51532862814292,0.6871211908648149,7288,1,GSK3A
ESTABLISHMENT OF RNA LOCALIZATION TO TELOMERE%GOBP%GO:0097694,0.172159699892819,0.5459855974578649,0.7550041356492969,1.2685044304207,1284,2,ATM|ATR
ALDITOL METABOLIC PROCESS%GOBP%GO:0019400,0.483525104602511,0.787078399497453,-0.308759722324273,-0.967303904410389,3697,10,TPI1|PGP|GOT1|GK|COQ3
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT%GOBP%GO:0034764,0.3415860735009669,0.701955655133333,-0.16493174775584,-1.06681309637768,2648,108,GLRX|ATP1B1|AMIGO1|CTSS|ATP1B3|STAC3|INS|THY1|STIM1|C3|TESC|CA2|SLC9A1|IRS1|FLNA|FXYD1|IGF1|CREBL2|P2RY6|GPER1|F2R|KCNQ1|APLNR|FGF19|F2RL3|COX17|CX3CL1|ARL6IP1|ATP1B2|KCNH2|TMSB4X|WNK2
MICROGLIA DEVELOPMENT%GOBP%GO:0014005,0.25515873015873,0.633820868480386,-0.6113929634939891,-1.1938955007941698,1928,3,NRROS|APP|TLR2
REGULATION OF CHROMOSOME SEGREGATION%GOBP%GO:0051983,0.00204316179287447,0.0401385556960785,-0.296913268265705,-1.83454275130533,15,89,ATRX|MAD1L1|SPAG5|CENPE|PUM1|KIF2C|NIPBL|BECN1|RAD21|ZNF207|CDC42|TACC3|RACGAP1|RCC2|TRIP13|DUSP1|KNSTRN|CTCF|KLHL22|NEK2|RAD18|APC|MKI67|DLGAP5|CDC20|DYNC1H1|CDT1|LCMT1|ECT2|ANAPC5|ESPL1|CDC6|ANKRD32|NAA10|CDC23|HNRNPU|PTTG1|CDK5RAP2|MAD2L1|NDC80|CDC27|USP44|CCNB1|PLK1|RMI2|HDAC8|IK|NEK6|H2AFY|ANAPC11|CDCA5|XRCC3|FEN1
RESPONSE TO STEROL DEPLETION%GOBP%GO:0006991,0.330451866404715,0.6957352559323989,-0.430240729153186,-1.10669505625656,2522,6,INSIG1
MELANOCYTE APOPTOTIC PROCESS%GOBP%GO:1902362,0.22113712374581895,0.603435805957244,-0.8860829289810319,-1.1804752224610702,1652,1,FAP
MONOVALENT INORGANIC CATION HOMEOSTASIS%GOBP%GO:0055067,0.26056701030927804,0.636316525692816,-0.20297911512323,-1.14311590212823,2021,62,PPT1|CLN6|SLC9A5|ATP6V0A1|SLAMF8|GPR89B|TCIRG1|ATP1B1|SLC12A8|ATP6V0A2|RAB7A|ATP1A3|SLC12A2|ATP1B3|ATP5B|DMXL1|ATP6V0D1|CA2|SLC9A1|SLC9A7|SLC11A1|SLC9A9|ATP6V0E1|ATP6AP1|ATP1B2|KCNH2|ATP6V0E2|RAB20
LEUCYL-TRNA AMINOACYLATION%GOBP%GO:0006429,0.589764201500536,0.8414799095069009,0.55296388199614,0.9290507178103109,4401,2,LARS2|LARS
CARDIAC CHAMBER DEVELOPMENT%GOBP%GO:0003205,0.40150629788339204,0.740287621109606,-0.17899084260766399,-1.03429173110669,3091,69,HEYL|TGFB2|NRG1|ROBO1|SOX11|C5orf42|GJA5|TGFB1|TNNT2|JAG1|TBX1|ZFPM2|RYR2|CPE|SFRP2|GATA3|SMAD6|TBX2|HES1|MESP1|NDST1|NOTCH1|MEF2C|PKP2|NOTCH2|GATA6|NRP2|TGFBR2|TGFBR3|TEK|MAML1|SLIT2|FKBP1A|ENG
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE%GOBP%GO:0002820,0.7286872384937242,0.9063984795474359,-0.20552489034311802,-0.797513011285801,5572,18,FOXP3|JAK3|LILRB1|NDFIP1|SAMSN1|FCGR2B|RC3H2|CEACAM1|HFE
NEGATIVE REGULATION OF PEPTIDYL-LYSINE CROTONYLATION%GOBP%GO:0120094,0.672775919732441,0.8820330910931731,-0.6669607410674899,-0.8885518538201029,5028,1,CDYL
INNER DYNEIN ARM ASSEMBLY%GOBP%GO:0036159,0.0245700245700246,0.220067158953043,0.5609546426472141,1.70468942216261,179,9,LRRC6|DNALI1|ZMYND10|DYX1C1|DNAH1|CCDC40
POSITIVE REGULATION OF DNA HELICASE ACTIVITY%GOBP%GO:1905776,0.3179888564606,0.6867397844771489,-0.675773773359633,-1.12459562322177,2396,2,GTF2H2
EGG COAT FORMATION%GOBP%GO:0035803,0.0128681347837623,0.149991146428462,-0.92605459057072,-1.54110292597287,96,2,ZP3|POMZP3
REGULATION OF ACTIVATED T CELL PROLIFERATION%GOBP%GO:0046006,0.0503916449086162,0.322183465117595,-0.36697125638477707,-1.54075873132004,385,23,FOXP3|CD274|PYCARD|IL18|RIPK3|PDCD1LG2|PRKAR1A|IGF1|ICOSLG|LGALS9|FADD|PRNP
DETECTION OF EXTERNAL BIOTIC STIMULUS%GOBP%GO:0098581,0.142390167364017,0.508674778494682,-0.432658374571397,-1.35546220811543,1088,10,CD1D|C4B|TLR1|TLR2|SSC5D|TLR4|LY96
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION%GOBP%GO:0032470,0.30512072167683696,0.677423587903087,-0.6819961400606561,-1.13495063644352,2299,2,ATP2A2|ATP2A1
"NEGATIVE REGULATION OF WOUND HEALING, SPREADING OF EPIDERMAL CELLS%GOBP%GO:1903690",0.30389892677625296,0.676707700393746,0.5167487973863,1.13531911496889,2236,4,CLASP1|CLASP2
VOLUNTARY MUSCULOSKELETAL MOVEMENT%GOBP%GO:0050882,0.24232804232804198,0.625205594172723,-0.618396382485938,-1.2075714030762,1831,3,VTI1A|XRCC1|MAP1A
CARNITINE SHUTTLE%GOBP%GO:0006853,0.510954828239113,0.8011667213092171,0.339821826548177,0.9380690308352259,3777,7,ACACB|CPT1B|CPT1A
TRIF-DEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035666,0.0201386164508958,0.195205495598712,-0.408106636529427,-1.6900757678309,153,22,TICAM2|IKBKE|IRF7|FADD|UBC|CD300LF|TICAM1|TRAF3|TLR4|CD14|LY96
PROTEIN TARGETING TO PEROXISOME%GOBP%GO:0006625,0.33821497651284904,0.6998037279675999,0.19126215274091699,1.08074555275934,2447,60,IDH1|PEX7|RPS27A|MPV17|NUDT7|GSTK1|PEX2|PEX5|PEX13|PIPOX|GNPAT|ACOX2|PEX1|HMGCL|ACOX3|EHHADH|PEX10|ACOT8|PHYH|ZFAND6|ECH1|HACL1|PAOX|PEX19|UBA52|PECR|PEX5L|SLC27A2|UBE2D3|PEX12
NEGATIVE REGULATION OF EXOSOMAL SECRETION%GOBP%GO:1903542,0.496103198065036,0.794012168719884,0.49099000264345793,0.965719394567365,3691,3,PARK2|VPS4B
JUN PHOSPHORYLATION%GOBP%GO:0007258,0.5587727453845129,0.8268422944617521,0.7196735774150859,0.9595876078715558,4206,1,MAPK8
MULTI-ORGANISM INTRACELLULAR TRANSPORT%GOBP%GO:1902583,0.543253968253968,0.8163350846796089,-0.4830759134506679,-0.9433248238822042,4106,3,RAB7A|IFIT1
REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS BY MESENCHYMAL-EPITHELIAL SIGNALING%GOBP%GO:0060665,0.42180602006689005,0.7527812076478722,-0.78970004411116,-1.05207007691894,3152,1,HGF
HYALURONAN CATABOLIC PROCESS%GOBP%GO:0030214,0.0143082173798897,0.160215272500577,-0.483426517360276,-1.75524332168809,108,15,CD44|TGFB1|CEMIP|HYAL2|TMEM2|HYAL3|SLC9A1|HYAL1|LYVE1|HEXB
NEGATIVE REGULATION OF INTERLEUKIN-2-MEDIATED SIGNALING PATHWAY%GOBP%GO:1902206,0.685217160313455,0.8857920062408181,0.656815174239083,0.875774408900244,5158,1,PTPN2
PURINE-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0072522,0.125302740599108,0.48024500973428,-0.18110504721419202,-1.24021977911539,982,140,ATP5J|DCAKD|GPI|ATP5F1|COASY|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|ADA|PDHA1|ACSF3|ATP5B|HK3|ADCY8|NPR2|ELOVL1|SLC26A2|ENO1|ADCY4|ATP5O|PGAM1|HPRT1|PRPS1|NPR1|GAPDH|HACD2|GMPS|LDHA|STOML2|PDHX|ATP5H|PNP|PGK1|FASN|ADCY9|ALDOA|ALDOC|ATP5G1|MTHFD1
CATABOLISM BY HOST OF SUBSTANCE IN SYMBIONT%GOBP%GO:0052364,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS%GOBP%GO:0071672,0.0017195767195767198,0.0348566830512975,-0.909782728576155,-1.77657508542457,12,3,CORO1B|AIF1|SLIT2
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY%GOBP%GO:0045879,0.05761652398423699,0.34590110360017606,0.39769618638118,1.52926032304703,423,17,GPR161|KIF7|BTRC|SUFU|ULK3|TULP3|PTCH2|MEGF8|GPC3|KCTD21|KCTD6
MYOBLAST PROLIFERATION%GOBP%GO:0051450,0.0326346511010878,0.25785422561312804,-0.8835401157981801,-1.4703520413756899,245,2,IGF1|ATOH8
TRNA METHYLTHIOLATION%GOBP%GO:0035600,0.9289632107023409,0.9793746057014829,-0.5349029554477279,-0.712619174430293,6943,1,CDKAL1
PRO-B CELL DIFFERENTIATION%GOBP%GO:0002328,0.379019292604502,0.7288595569929351,0.6464846980976011,1.08617776382211,2828,2,LIG4|SOX4
MORPHOGENESIS OF A BRANCHING STRUCTURE%GOBP%GO:0001763,0.0583441138421734,0.34882197449105895,-0.306220609220557,-1.4745379290762999,450,36,FGF10|COL4A1|LRP5|CTSH|EPHA2|TGFBR2|BMP2|SEMA3E|SLIT2|MYC|RASIP1|ENG|COL13A1
REGULATION OF MESODERM DEVELOPMENT%GOBP%GO:2000380,0.15463638821303102,0.522941892598803,0.55530910410789,1.33551521095329,1143,5,DKK1|PUS7|RPS6KA6|SMAD2
B CELL PROLIFERATION%GOBP%GO:0042100,0.9486274509803921,0.984457616015067,-0.171586206896552,-0.574315100373973,7256,12,HSPD1|BCL2|CR2|MS4A1|LEF1|CD79A|GAPT|PTPRC|CD40|CD180|MEF2C|CTPS1
HEART FIELD SPECIFICATION%GOBP%GO:0003128,0.271037822274571,0.6462219082477939,-0.5424364418463571,-1.18750676079051,2070,4,ISL1|BMP4|MESP1|MEF2C
RESPONSE TO PYRIMIDINE RIBONUCLEOTIDE%GOBP%GO:1905834,0.19799331103678897,0.5750614504600671,-0.8987648875165419,-1.19737063634819,1479,1,P2RY6
DNA STRAND ELONGATION INVOLVED IN CELL CYCLE DNA REPLICATION%GOBP%GO:1902296,0.24695652173913002,0.6280519349499749,-0.873400970445523,-1.16357980857394,1845,1,GINS1
POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM%GOBP%GO:0051712,0.9242245779348249,0.977712119781452,-0.282910724239411,-0.619350714326817,7061,4,F2RL1|PRF1|GAPDH
ASPARAGINE CATABOLIC PROCESS%GOBP%GO:0006530,0.0311705685618729,0.250729241129472,-0.98467137185708,-1.3118187008531201,232,1,ASRGL1
WNT PROTEIN SECRETION%GOBP%GO:0061355,0.41979933110367895,0.7514346091901549,-0.7904719894133221,-1.05309849341642,3137,1,WLS
ACETYL-COA CATABOLIC PROCESS%GOBP%GO:0046356,0.0736870310825295,0.382002237820699,0.832478632478633,1.39867158823118,549,2,NUDT7|ACAT1
NEGATIVE REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS%GOBP%GO:0090191,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
ACUTE INFLAMMATORY RESPONSE%GOBP%GO:0002526,0.184613371712678,0.557712887437735,-0.33190455087042,-1.26131834314167,1410,17,F12|C2CD4A|C2CD4B|HP|INS|PLSCR1|F3|CEBPB
REGULATION OF VASCULAR SMOOTH MUSCLE CONTRACTION%GOBP%GO:0003056,0.852248677248677,0.949296218452153,-0.354904158615899,-0.693037871687621,6442,3,DOCK4|DOCK5
LIPID DIGESTION%GOBP%GO:0044241,0.0599397984556995,0.354269451186595,-0.6823391960206321,-1.4937831346079902,457,4,CD36|LDLR
ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION INVOLVED IN HEART VALVE FORMATION%GOBP%GO:0003199,0.32401337792642104,0.6927427771545911,-0.835796206440229,-1.11348123348257,2421,1,EFNA1
HISTONE H4-R3 METHYLATION%GOBP%GO:0043985,0.44784714042664603,0.768229288546963,-0.4588837335954529,-1.00459241677523,3421,4,PRMT5
REGULATION OF MICROGLIAL CELL ACTIVATION%GOBP%GO:1903978,0.115455020920502,0.46493596964429496,-0.448292765296198,-1.4044427133359,882,10,CX3CL1|LDLR|ITGAM
MESENCHYME MORPHOGENESIS%GOBP%GO:0072132,0.0104384133611691,0.13160598312092803,-0.41486617387851904,-1.80972201268706,79,26,TBX2|NOTCH1|SNAI2|NOS3|ACTG2|TGFBR2|BMP2|DCHS1|SNAI1|ACTA2|ENG|ACVRL1
ENDOCARDIAL CUSHION DEVELOPMENT%GOBP%GO:0003197,0.0874039338283184,0.408874392525297,-0.329417330866379,-1.4201642715356397,670,25,TBX2|NOTCH1|SNAI2|NOS3|TGFBR2|BMP2|DCHS1|SNAI1|ENG|ACVRL1
MULTI-ORGANISM REPRODUCTIVE PROCESS%GOBP%GO:0044703,0.014218009478673,0.159528763534081,0.18945079948091897,1.45012972847925,101,235,TDRD12|TLE6|NPHP1|SPAG6|CRHR1|TSGA10|DDX25|CYP27B1|TDRD6|UBXN8|LRGUK|BBS4|SPATA6|TEAD3|PPARD|CFAP44|PICK1|CFAP43|PSME4|IFT20|TSSK6|ZNF296|IGSF8|PRLHR|KIT|C14orf39|DZIP1|C9orf117|AZIN2|IQCG|BRCA2|IFT81|NME5|ADCY3|CHD5|SPIRE2|PDE3A|TOB2|WDR33|TDRP|SPESP1|ADCYAP1|PCSK4|MAFF|CEP57|TUBGCP3|STOX2|HSPA2|MKKS|TRIM27|PARN|C1orf111|LEPR|HERC4|NDRG3|DNAH1|XRN2|ELL3|CATSPERG|MAST2|MCM9|SPATA2|RHOXF1|PRMT7|CATSPER2|IFT27|BBS2|PRND|TRO|TEX14|DPY19L2|METTL14|BCL2|FOXJ1|APOL2|SLC26A6|GDF9|TAC3|PIWIL4|VDAC2
REGULATION OF PHOSPHATASE ACTIVITY%GOBP%GO:0010921,0.7267404861906579,0.905145599593318,-0.13746375402280803,-0.843665098905237,5709,86,CEP192|SLC7A14|ZCCHC9|PPP1R2|PPP1R26|NCKAP1L|RIPK3|HSP90B1|SYTL2|CNST|PPP1R17|BOD1|PLEK|LMTK3|PKMYT1|CD2BP2|NUAK1|FKBP15|MEF2C|PPP6R3|CRY2|PPP2R4|CD300A|LGALS3|BMP2|DLG3|ELFN2|PDGFRB|FKBP1A|RRP1B|CCDC8|STYXL1
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE REGENERATION%GOBP%GO:1905179,0.544212218649518,0.817181843599117,0.572648082269105,0.962122715798866,4061,2,CDKN1A|CDKN1B
NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION%GOBP%GO:1902744,0.36147101164769,0.716154857259883,-0.49921433319489295,-1.09288452990843,2761,4,ARPIN|KANK1|SLIT2
PHOSPHOLIPID BIOSYNTHETIC PROCESS%GOBP%GO:0008654,0.6818879508825789,0.885415243771438,-0.124209017342575,-0.892394123901726,5330,179,GPAA1|DPM2|PIK3C2A|ACHE|PTDSS2|IDI1|RAB14|GPD1|PYURF|AGPAT1|GPAM|FDPS|PLA2G2A|FAR1|PLA2G2D|PCYT1A|MTMR12|PLSCR1|CPNE6|CHPT1|PIGP|PLA2G4D|ETNK2|PLA2G4A|CDIPT|DGKE|PIK3CB|ABHD5|MTMR1|ARF1|PLD1|SLC44A1|SYNJ2|HMGCS1|INPP4B|FITM2|PIGH|PLEKHA4|NDUFAB1|SRD5A3|LPIN3|DOLK|PCTP|DOLPP1|AGPAT2|FADS1|LPIN2|PTPMT1|AGPAT3|PLA2G12A
CELLULAR RESPONSE TO HEXOSE STIMULUS%GOBP%GO:0071331,0.39709728033472796,0.737835527838374,-0.244495227856691,-1.0390978255858399,3036,24,GNB2L1|ZNF236|GAS6|ADCY8|GPER1|PDK3|TRA2B|PRKACA|ERN1
HEART VALVE DEVELOPMENT%GOBP%GO:0003170,0.0820160663384296,0.398202308598866,-0.278473466585382,-1.4032609680175598,632,42,HEYL|TGFB2|ROCK1|ROBO1|GJA5|TGFB1|OLFM1|JAG1|GATA3|SMAD6|EFNA1|NOTCH1|ELN|MEF2C|SNAI2|NOTCH2|NOS3|TGFBR2|BMP2|DCHS1|SLIT2|SNAI1|TNFRSF1A|TNFRSF1B
POSITIVE REGULATION OF PROSTAGLANDIN SECRETION%GOBP%GO:0032308,0.186111111111111,0.559093571852282,-0.649608470276828,-1.26852069986068,1406,3,IL1B|P2RX4|TNFRSF11A
PYRUVATE TRANSMEMBRANE TRANSPORT%GOBP%GO:1901475,0.37248677248677203,0.7234654586828599,-0.557405977721407,-1.08847260052561,2815,3,MPC2|SLC16A7|MPC1
TRANSFORMING GROWTH FACTOR BETA PRODUCTION%GOBP%GO:0071604,0.46895728309896506,0.780769690730001,-0.611359250068928,-1.01739955580929,3534,2,NRROS|LTBP3
INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA%GOBP%GO:0048312,0.8051599032518141,0.932964969466025,0.372993385496292,0.7336339731558291,5991,3,DNM1L|CLUH
IRON-SULFUR CLUSTER ASSEMBLY%GOBP%GO:0016226,0.6802112962210479,0.8847768831854209,0.20254728576065398,0.8349305052274569,5021,21,NFS1|HSCB|MMS19|CIAO1|CIAPIN1|NFU1
FATTY ACID ELONGATION%GOBP%GO:0030497,0.23757845188284502,0.6217158626397761,-0.3860793823675971,-1.20953630598329,1816,10,ELOVL2|ELOVL1|HACD2|ABCD1
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT%GOBP%GO:2000171,0.624694044057656,0.85807802168034,0.272724276672997,0.8640089433236859,4593,10,PTPRS|YWHAH|DCC|KIAA0319|GORASP1
PARAXIAL MESODERM MORPHOGENESIS%GOBP%GO:0048340,0.41814040728831703,0.75036705317022,0.629114971050455,1.05699437968666,3120,2,SMAD2|LEF1
NEGATIVE REGULATION OF T-HELPER 1 CELL ACTIVATION%GOBP%GO:2000518,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
REGULATION OF PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN SERINE 2 RESIDUES%GOBP%GO:2001163,0.379531772575251,0.728914030571579,-0.8088883987648879,-1.0776335727133701,2836,1,CCNK
THIAMINE TRANSPORT%GOBP%GO:0015888,0.13120191032103998,0.490819490032838,-0.7772947558611999,-1.29354277253008,988,2,SLC35F3
POSITIVE REGULATION OF FERROUS IRON BINDING%GOBP%GO:1904434,0.181745821172725,0.554948538055731,-0.744527157430383,-1.23901224880824,1369,2,B2M|HFE
CELLULAR RESPONSE TO ALDEHYDE%GOBP%GO:0110096,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
GLOMERULUS MORPHOGENESIS%GOBP%GO:0072102,0.0949500263019464,0.42498053239300104,-0.598047708022937,-1.4334062381245198,721,5,MEF2C|PDGFRB|PDGFRA
REGULATION OF PEROXIDASE ACTIVITY%GOBP%GO:2000468,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
REGULATION OF GLUTAMATE SECRETION%GOBP%GO:0014048,0.0166621875839828,0.17569702079137303,0.8326899746332859,1.63780291622173,123,3,TRH|RAB3GAP1|HRH3
COCHLEA DEVELOPMENT%GOBP%GO:0090102,0.16503051207216798,0.536843510199797,-0.754948993658671,-1.25635585086903,1243,2,TBX1|MCM2
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS%GOBP%GO:1901615,0.348609680741504,0.70664931735129,-0.141438270339741,-1.05066575832304,2707,216,IGF1|ALDH1A1|HMGCR|GK|DHFR|CYP46A1|SCARF1|APOE|SYNJ2|HMGCS1|CYP7B1|NUDT4|INPP4B|SLC5A3|ITPK1|IMPA2|SRD5A3|EBP|DHCR7|OSBP|DHRS3|PNPO|LGMN|C14orf1|CPQ|ALDH3B1|SPHK1|DHCR24|CNBP|NSDHL|PDXK|OSBPL3|COQ3|TM7SF2|OSBPL5
REGULATION OF MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT%GOBP%GO:2000790,0.79452782574047,0.929656485793048,0.6022276135862371,0.8029892624251559,5981,1,NFIB
VITAMIN B6 BIOSYNTHETIC PROCESS%GOBP%GO:0042819,0.0424603174603175,0.294833299013666,-0.7752530426714129,-1.51387270526133,320,3,PNPO|PDXK
MODULATION BY HOST OF VIRAL RNA GENOME REPLICATION%GOBP%GO:0044830,0.756162915326903,0.9166093439295571,0.47022126126665004,0.790032431652562,5643,2,FBXL2
REGULATION OF NATURAL KILLER CELL ACTIVATION%GOBP%GO:0032814,0.49482781196805,0.793151702865165,-0.279476319250112,-0.9620116874391441,3778,13,PRDM1|MICA|HLA-E|IL18|GAS6|AXL
REGULATION OF SODIUM ION EXPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1903276,0.0120403088600968,0.14428332491466297,-0.772403904483538,-1.69095360833996,91,4,ATP1B1|ATP1B3|FXYD1|ATP1B2
PML BODY ORGANIZATION%GOBP%GO:0030578,0.7141534391534391,0.898428686580078,-0.41105106429910704,-0.8026785481121791,5398,3,HIPK2|ETS1|PML
CELL CYCLE G1/S PHASE TRANSITION%GOBP%GO:0044843,0.00534963698891861,0.0829378624098312,-0.27023587339816296,-1.69955196359316,41,95,ID2|POLE|TYMS|BRD4|CUL4B|PIM2|RPA2|CDK6|RRM2|MCM10|TFDP2|CDT1|MCM4|EIF4EBP1|MCM6|CDC6|PLK2|CDKN2A|PCNA|GMNN|ORC1|ORC6|MCM3|INHBA|MCM5|CDC45|RCC1|E2F1|DHFR|MAX|LATS2|MCM2|CAMK2A|MYC|RPS6KB1|CDKN2C|POLE2|POLA1|POLE3|CDKN3|PPP6C|CCND1|POLA2
ADRENAL CORTEX DEVELOPMENT%GOBP%GO:0035801,0.35396466994288794,0.7118407891832621,0.8236104984561099,1.09817346757412,2664,1,CITED2
L-HISTIDINE TRANSMEMBRANE TRANSPORT%GOBP%GO:0089709,0.61322884845265,0.852045339927398,0.690174239082488,0.920254220635019,4616,1,SLC25A29
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT%GOBP%GO:1904018,0.00012851818532322299,0.00518555396908895,-0.325972529323036,-2.16214811975001,0,121,AQP1|S100A1|KIAA1462|PAK4|CHI3L1|MTDH|MAP3K3|FLT1|RUNX1|MYDGF|PIK3C2A|JUP|PIK3R6|KLF4|KDR|EMC10|PDCD6|CD34|ANGPTL4|SFRP2|CYP1B1|SOD2|SRPX2|VEGFC|ADAM12|STIM1|FOXC2|ITGA5|SMOC2|TNFSF12|PRKD1|BRCA1|F3|JMJD8|HMOX1|HSPB1|RAPGEF3|RHOJ|CDH5|CTSH|CEACAM1|GPER1|RAP1A|APLNR|GATA6|SASH1|NOS3|HYAL1|VEGFB|ECM1|THBS1|TEK|SEMA5A|SERPINE1|RRAS|ANXA1|HSPB6|ENG|SPHK1|PDGFB|PRKCB|PTGIS
TRANSITION METAL ION HOMEOSTASIS%GOBP%GO:0055076,0.000255427841634738,0.00819882332206558,-0.351381465746713,-2.12051407682757,1,81,CCDC22|ATP6V0D1|ABCB7|HAMP|SLC11A1|ACO1|HMOX1|SOD1|SKP1|ARF1|MT1M|NEDD8|CYBRD1|HFE|FTL|FXN|MT2A|XIAP|SLC22A17|SLC30A5|MYC|ATP6AP1|S100A8|S100A9|ATOX1|MT1E|TFRC|ATP6V1A|ATP6V1G1|FTH1|PRNP
POSITIVE REGULATION OF VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901387,0.344468487963213,0.702208595415901,0.39633119654265797,1.09406162990483,2546,7,CACNB2|STAC2|STAC|CACNA2D1|CACNB3
POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS%GOBP%GO:0010726,0.8009943563558181,0.9325319884434939,0.374805630994912,0.7371984461925749,5960,3,ZNF205|SNCA
POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING%GOBP%GO:1903423,0.11528256832050901,0.46493596964429496,-0.7894678797904601,-1.31380079737725,868,2,TOR1A|PLAA
NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS%GOBP%GO:0010957,0.220390001308729,0.6027391478106829,-0.5693730991597429,-1.24647673442255,1683,4,SNAI2|SNAI1|NFKB1
"REGULATION OF ACTIVATED CD4-POSITIVE, ALPHA-BETA T CELL APOPTOTIC PROCESS%GOBP%GO:1905399",0.613244147157191,0.852045339927398,-0.696956329951478,-0.928513180579208,4583,1,CD274
"CD4-POSITIVE, ALPHA-BETA T CELL LINEAGE COMMITMENT%GOBP%GO:0043373",0.7900286383754229,0.928247620398227,-0.25503411532876996,-0.7342075233444201,6068,8,FOXP3|BATF|SPN|STAT3
NEGATIVE REGULATION OF STRESS-ACTIVATED MAPK CASCADE%GOBP%GO:0032873,0.6261706555671179,0.858842084733938,-0.18547787873248398,-0.8854589777162991,4813,35,MYC|DNAJA1|DACT1|GSTP1|SIRPA
POSITIVE REGULATION OF PROTEIN FOLDING%GOBP%GO:1903334,0.540328999734678,0.81505408470595,-0.583025656807225,-0.970247925739591,4072,2,SGTB
REGULATION OF CHROMOSOME ORGANIZATION%GOBP%GO:0033044,0.0007631645891630629,0.0191058847417112,-0.21470807225673003,-1.64918164276471,5,259,LIF|UBE2N|XRN1|RAD21|PINX1|ZNF207|SART3|IL1B|C6orf89|FOXP3|TERF2IP|MAPT|CCT7|TET1|HNRNPA1|TACC3|TRIP13|DUSP1|RPS6KA5|CTCF|KLHL22|NEK2|MAP1S|BRD4|PML|DNMT3B|GNL3|APC|CCT3|MKI67|DLGAP5|NABP2|NAA40|H1F0|CDC20|PARP10|SETMAR|SET|TERF2|WDR70|KDM1A|CDT1|LCMT1|CAMK1|NBN|TINF2|BCOR|ANAPC5|TRIM28|PHF2|ESPL1|CDC6|ANKRD32|ATAD2|NAA10|PARP1|CHTOP|NSD1|PAXIP1|CDC23|HNRNPU|OGT|PTTG1|TOP2A|CDK5RAP2|MAD2L1|FMR1|DHX36|CCT8|SLX1B|HNRNPA2B1|TAL1|SLX1A|PRKD1|SETD1A|CDC45|CCT5|BRCA1|ARRB1|NDC80|SNW1|CTR9|MAPK3|TAF7|DNMT1|CDC27|RAPGEF3|RNF20|HDAC5|WBP2|KAT7|SPI1|USP44|PHF19|FBXO4|CCNB1|PLK1|RMI2|RNF40|HDAC8|SPTY2D1|TLK2|H1FX|MNAT1|MYC|IK|RPS6KA4|HIST1H1C|NEK6|H2AFY|ANAPC11|OTUB1|CDCA5|XRCC3|HNRNPC|NAT10|FEN1|GTF2H2
ACTIVATION OF PHOSPHOLIPASE A2 ACTIVITY%GOBP%GO:0032431,0.5788007429026271,0.8381193804335091,-0.567338799657015,-0.9441424869245779,4362,2,ANG
L-CYSTEINE CATABOLIC PROCESS TO TAURINE%GOBP%GO:0019452,0.410811528755479,0.7454201520455229,0.7961513012792242,1.0615603332866501,3092,1,CSAD
NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION%GOBP%GO:0071676,0.006834910620399579,0.0992920656003837,-0.681467181467181,-1.86276015094539,51,7,DUSP1|GREM1|PLCB1|SLAMF8|NOV|NBL1|SLIT2
NEGATIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION%GOBP%GO:2000816,0.736213235294118,0.908157084784786,-0.197756623569084,-0.793395786040777,5606,20,ZNF207|TRIP13|KLHL22|APC|CDC20|PTTG1|MAD2L1|PLK1|IK
ESTABLISHMENT OF CELL POLARITY INVOLVED IN AMEBOIDAL CELL MIGRATION%GOBP%GO:0003365,0.7473797366299381,0.912246154063119,0.39594351980518,0.7787741790473799,5561,3,AMOTL1|AMOTL2
NEGATIVE REGULATION OF PROTEIN OLIGOMERIZATION%GOBP%GO:0032460,0.9935813466072829,0.997556876699801,-0.14111177966494198,-0.4568569787613,7584,11,CLU|PEX14|GBA|INS|CRYAB
NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION%GOBP%GO:0044387,0.21608832807571,0.5991362048583871,-0.452448708428648,-1.2367483678275701,1643,7,CORO1C|PPM1F|NPM1|ADARB1
POSITIVE REGULATION OF RAS GTPASE BINDING%GOBP%GO:1904477,0.127090301003344,0.48362648780247897,-0.935266872518747,-1.2460000450146003,949,1,EPHA4
NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION%GOBP%GO:1901991,0.0994891443167305,0.435475440108744,-0.189576180484435,-1.28434432696578,778,133,CUL1|PCBP4|GTSE1|WEE1|CNOT4|RBL1|ZFP36L2|MAD1L1|BTG2|CNOT10|CNOT6L|FOXN3|PRMT2|VPS4A|BLM|SFN|PINX1|ZNF207|CDKN1B|CNOT6|AURKA|PTEN|FHL1|TRIP13|FBXL7|KLHL22|PIDD1|PRMT1|PML|APC|RGCC|CLSPN|RPA2|CDC20|TRIAP1|TFDP2|DONSON|ZFP36L1|NBN|KLF4|CDC6|PLK2|SLFN11|RAD17|PCNA|ORC1|MAD2L1|TAOK2|CDC25C|GPNMB|DCUN1D3|TOPBP1|SKP1|E2F1|CCL2|KANK2|NACC2|CCNB1|PLK1|USP47|PLAGL1|TNKS1BP1|FAM107A|IK|DACT1|CDK2AP2|ZNF385A|CCND1
EXIT FROM HOST%GOBP%GO:0035890,0.670988867059594,0.8815356925073421,-0.320129401710009,-0.82345905961101,5122,6,VPS4A|PPIA|RAB7A
PORPHYRIN-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0006779,0.8680989937449008,0.95608082964749,0.17577629667194103,0.6880634269449679,6383,18,HMBS|COX10|ABCB6|COX15|UROD|SUCLA2|PPOX|CPOX
HOMOTYPIC CELL-CELL ADHESION%GOBP%GO:0034109,0.0009099181073703369,0.0215581599086697,-0.445708397254406,-2.1116700034857603,6,34,JUP|CXADR|RAP2B|TLN1|GP1BA|PLEK|GAS6|ILK|PKP2|PIK3CB|HSPB1|FLNA|MYL12A|VCL|MYH9|FIBP|FERMT3|ACTB|PDGFRA|ACTN1|MYL9
REGULATION OF NEURON DEATH%GOBP%GO:1901214,0.328470889315419,0.6950398637731511,-0.15906263684938096,-1.07137223435348,2566,130,SOD2|NGF|FCGR2B|TGFB3|TRAF2|RAB29|GPNMB|MEF2C|PARK7|SOD1|AARS|NTRK2|NSMF|RRAS2|NAIP|NONO|CTSZ|CCL2|F2R|APOE|CHGA|CHMP4A|CD200|CX3CL1|EIF2S1|DDIT4|SIGMAR1|TLR4|ITGAM|LGMN|DHCR24|EIF4G1|PRNP
MODULATION BY VIRUS OF HOST CATALYTIC ACTIVITY%GOBP%GO:0039516,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
MALTOSE METABOLIC PROCESS%GOBP%GO:0000023,0.41070234113712395,0.7453853667476059,-0.7951588001764449,-1.05934245072253,3069,1,GAA
NEGATIVE REGULATION OF ISOTYPE SWITCHING%GOBP%GO:0045829,0.574422923852481,0.835204333784353,-0.569469463354402,-0.947688252035771,4329,2,NDFIP1
RESPONSE TO HERBICIDE%GOBP%GO:0009635,0.150578642819569,0.517264655410678,-0.5570814030443421,-1.33521782218133,1144,5,DAXX|ZC3H12A|HSF1|HNRNPA1|MAPK13
REGULATION OF CELLULAR ORGANOHALOGEN METABOLIC PROCESS%GOBP%GO:0090347,0.505644839952185,0.797902257689198,0.7482355535950601,0.9976711491585221,3806,1,CYP2D6
RESPIRATORY CHAIN COMPLEX IV ASSEMBLY%GOBP%GO:0008535,0.5136202669572321,0.8023339441082009,0.224885144091296,0.954737465065577,3770,23,COA5|COX10|SCO1|SMIM20|BCS1L
QUATERNARY AMMONIUM GROUP TRANSPORT%GOBP%GO:0015697,0.8421741977734121,0.9481593344082329,-0.270972367767911,-0.697013926089991,6429,6,SLC25A45|SLC25A29|SLC22A5|PDZK1|SLC22A4|SLC22A3
RIBOSOME DISASSEMBLY%GOBP%GO:0032790,0.221817235095027,0.6043953982245389,-0.4276994427532221,-1.23128683468414,1703,8,GFM2|DENR|MRRF|PELO|MCTS1|EIF2D
PRE-REPLICATIVE COMPLEX ASSEMBLY INVOLVED IN NUCLEAR CELL CYCLE DNA REPLICATION%GOBP%GO:0006267,0.9817460317460319,0.993436724391485,-0.267898030962178,-0.5231369559923079,7421,3,CDC45
NEGATIVE REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE%GOBP%GO:0090260,0.8142743433271421,0.9360565056688009,-0.4535722336264621,-0.754816728407989,6137,2,SLIT2
CELL DIFFERENTIATION IN SPINAL CORD%GOBP%GO:0021515,0.7725047593146591,0.9216519933009191,0.23782877898711896,0.75345764789031,5680,10,ASCL1|DRAXIN|GATA2
MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM%GOBP%GO:0035821,0.0312181447502548,0.250729241129472,-0.244759495564489,-1.5054705312976298,244,87,YTHDC2|TGFB1|AQP1|ATG7|HYAL2|CD209|GSDMD|SMARCA4|ZNF639|REST|CD4|RAB9A|RRAGA|APOL1|KPNB1|CCNK|AZU1|CAV2|PPIB|FMR1|SLC25A6|CLEC4M|SNW1|NUCKS1|KPNA4|ROMO1|HMGN2|TNIP1|KPNA2|APOE|GAPDH|PABPN1|RRP1B|CFL1|S100A9|ANXA2|HIST1H2BK|HIST1H2BJ|PSMC3
RESPONSE TO LEPTIN%GOBP%GO:0044321,0.334375849877618,0.6974768376198021,0.346568852805323,1.0979535520421,2458,10,BBS4|MKKS|LEPR|NR4A3|BBS2|GCK|SIRT1
SOMITE DEVELOPMENT%GOBP%GO:0061053,0.353864260494312,0.7118407891832621,-0.260406162846776,-1.07840967587262,2705,22,BHLHE40|SMO|SFRP2|COBL|HES1|MESP1|MEOX2|MEOX1|MTHFD1
NUCLEOSOME DISASSEMBLY%GOBP%GO:0006337,0.0699895342752486,0.37596389138254704,-0.39914267375903,-1.48336872665928,534,16,SMARCA4|SET|SMARCE1|SUPT16H|SMARCD3|SMARCD2|HIST3H2A
MEMBRANE TUBULATION%GOBP%GO:0097749,0.39451505016722405,0.7376723208557521,-0.8026025584472869,-1.06925932409106,2948,1,OPA1
POSITIVE REGULATION OF CELLULAR EXTRAVASATION%GOBP%GO:0002693,0.0128356254092993,0.149991146428462,-0.681088476393947,-1.75194303705757,97,6,ADAM8|THY1|ICAM1|PLVAP|FADD
MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY%GOBP%GO:0044003,0.426231639152476,0.755007255274521,-0.215530808095198,-1.0211383610569302,3278,34,TGFB1|ATG7|HYAL2|CD209|CD4|RRAGA|KPNB1|CCNK|SLC25A6|CLEC4M|KPNA4|TNIP1|KPNA2|GAPDH|PABPN1
REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:2000303,0.541893362350381,0.815622645995152,0.272687308914477,0.9268111247886959,3983,12,SMPD2|ORMDL1
REGULATION OF EOSINOPHIL ACTIVATION%GOBP%GO:1902566,0.267857142857143,0.6418798906350429,-0.605657904163938,-1.18269638346739,2024,3,STX4|CD300A
N-TERMINAL PEPTIDYL-GLYCINE N-MYRISTOYLATION%GOBP%GO:0018008,0.563504823151125,0.828821766028182,0.564462868058487,0.9483704990892421,4205,2,NMT2
OLIGODENDROCYTE DEVELOPMENT%GOBP%GO:0014003,0.692186680650236,0.888433240372712,-0.231905978829555,-0.8204494406264581,5279,14,CLU|ZNF488|PTEN|EIF2B5|SOX10|PLP1|EIF2B1|EIF2B2|EIF2B3
LIMB BUD FORMATION%GOBP%GO:0060174,0.8225784540144001,0.9412507273497192,0.328454730247408,0.721629030465004,6054,4,FGFR2|SOX4
"REGULATION OF GENE EXPRESSION, EPIGENETIC%GOBP%GO:0040029",0.333460949464012,0.6971906052358929,-0.146388725194996,-1.06598200898118,2612,191,HNRNPA2B1|STAT3|NCBP1|HIST1H4I|BRCA1|CLP1|POLR2H|RBBP7|DNMT1|RBM15|TNRC6C|RAN|IFI16|HDAC5|PPM1D|WBP2|HIST2H3A|SPI1|PHF19|KAT2B|H1FX|SIRT4|HIST2H4A|HIST2H3C|HIST1H3H|ACTB|POLE3|HIST1H1C|H2AFY|HIST2H4B|RRP8|RBM4|H3F3B|WTIP|POLR2L|SUV39H1
POSITIVE REGULATION OF RESPONSE TO TUMOR CELL%GOBP%GO:0002836,0.8788795370857451,0.960725750963158,-0.277075567553252,-0.664097264540461,6682,5,PVR|CD274|PVRL2
"HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS, ENZYMATIC MODIFICATION%GOBP%GO:0015015",0.0498783454987835,0.32012215085927803,0.656172918880001,1.57809210707556,368,5,HS6ST3|HS6ST1|HS6ST2
CYCLIC PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0052652,0.7346938775510201,0.9079405785880958,-0.21381598684462197,-0.7946229982329179,5615,16,ADCY8|NPR2|ADCY4|NPR1|ADCY9
ENDOPLASMIC RETICULUM LOCALIZATION%GOBP%GO:0051643,0.761605351170569,0.9184699428006701,-0.623290692545214,-0.8303728633914059,5692,1,POLR2M
NEURON PROJECTION MORPHOGENESIS%GOBP%GO:0048812,0.0816297955754691,0.397722753303477,0.159892867259046,1.24980047449012,582,266,TNR|RET|CNTN4|SHTN1|DRD2|ROBO3|IRS2|UNC5C|CTNNA2|SLITRK1|IGSF9|FGFR2|SEMA4F|PLXNB1|LLGL1|FARP1|GAB1|CYFIP1|GAB2|DOK1|MAPK7|ALS2|SLIT1|EPHB2|EFNA4|PARD3|MAP4K4|RAB10|GFRA1|CHN1|PTPRO|NYAP2|STK24|ROBO2|PTPRM|SLITRK6|CHRNB2|MINK1|LYPLA2|EFNB2|BMP7|NTNG1|EFNB3|SLIT3|CDK5R1|SHC1|SOS1|NYAP1|MAP6|ATP7A|DRAXIN|SPTBN1|PAK1|EFNA2|EPB41L3|NRCAM|STRADB|MAP2|DLG4|BRSK1|VLDLR|TUBB3|ULK2|PPP3CB|PRKCA|PLCG1|KIF5A|PLXNB2|POU4F2|DOCK7|CELSR2|NRP1|DCC|CPNE1|EZR|ANKRD27|SRC|SHANK2|VSTM2L|GPC1|RANBP9
REGULATION OF ORGANELLE ASSEMBLY%GOBP%GO:1902115,0.0449750138811771,0.30388870048395505,0.19489552189469897,1.37490940664025,323,155,DYNC2LI1|CHMP3|IFT88|ODF2L|ZMYND10|KIF9|TBC1D1|BBS4|SDC1|PHF23|RALB|TBC1D19|CDK10|PIP4K2C|IFT20|CCDC88A|IFT140|TBC1D2|TBC1D14|KIAA1324|PIKFYVE|PAN3|RAB3GAP1|TBC1D17|HTT|TBC1D16|TBC1D8|GPSM2|SMCR8|MARK4|HAP1|NPRL3|AKAP13|TBC1D7|TBC1D20|SH3GLB1
B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002322,0.7419739984080659,0.909955740610127,-0.49561621174524395,-0.824784631335247,5592,2,GAPT|CD180
NEGATIVE REGULATION OF NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY%GOBP%GO:0070433,0.5153886972671801,0.803478510349408,-0.593052109181142,-0.9869335458400741,3884,2,PTPN22|ERBB2IP
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0045428,0.12280015643332001,0.47697345522944606,-0.28500221433677303,-1.3384508537048798,941,33,CLU|ASS1|ZC3H12A|KLF2|PTGS2|HBB|IL1B|AKT1|TNF|KHSRP|RAC1|KLF4|P2RX4|CD34|GLA|CD47|CD36|CAV1|TLR4|HSP90AA1|SIRPA|PTGIS
INTERLEUKIN-8 BIOSYNTHETIC PROCESS%GOBP%GO:0042228,0.4198432726789749,0.7514346091901549,0.7911336568151741,1.05486998143894,3160,1,NOD1
TRIGLYCERIDE METABOLIC PROCESS%GOBP%GO:0006641,0.0058693100299987,0.0887570898960228,-0.43141682839400003,-1.9027589809191499,44,27,PNPLA2|FABP3|SEL1L|APOBR|CETP|GK|APOE|PLA2G16|FABP4|LPIN3|CAV1|LMF1|PNPLA4|LPIN2
REGULATION OF PRE-MIRNA PROCESSING%GOBP%GO:2000631,0.848983928808607,0.9492491301138911,0.5746029995588879,0.766155567087764,6391,1,BCDIN3D
HISTONE H2A K63-LINKED UBIQUITINATION%GOBP%GO:0070535,0.737463518174582,0.908309781681485,-0.49801306945721097,-0.8287733858543271,5558,2,RNF168
POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0032109,0.64520350739432,0.86905852565918,-0.38645397181087204,-0.8460285276882992,4929,4,SNW1|GHRL
REGULATION OF MITOCHONDRIAL DNA REPLICATION%GOBP%GO:0090296,0.312549747943752,0.68160868787154,-0.678645026494113,-1.12937384758544,2355,2,STOML2
PYRAMIDAL NEURON DIFFERENTIATION%GOBP%GO:0021859,0.0495712754555198,0.319063308518797,0.861262751585332,1.4470326247984902,369,2,FGFR2|ATP7A
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE%GOBP%GO:0032210,0.242160519408758,0.625158460820442,0.21704951830099198,1.1648035415029199,1752,50,CTC1|SMG6|HMBOX1|EXOSC10|ATM|PARN|ACD|TEN1|PIF1|POT1|MAP2K7|MAP3K4|XRCC5|PNKP|TNKS|ATR|SRC|MAPK1|TNKS2|NEK7|SMG5|TCP1|OBFC1|TERF1
POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION%GOBP%GO:0007204,0.0048630662912720795,0.0777386494688773,-0.245719708536357,-1.6416685817610401,37,125,EDNRA|CCL19|FPR3|LPAR6|RYR2|ITPR2|P2RX4|ERO1L|PTGER1|ITPR3|SLC8B1|P2RX5|P2RX3|THY1|GRIN1|FPR1|ADCY8|CXCR4|JPH4|TAC1|PTGER4|TBXA2R|GHRL|ABL1|CCRL2|P2RY6|GPER1|F2R|CCR1|APLNR|GNA15|CD36|F2RL3|GRIN2C|GRIN2D|BCAP31|CX3CL1|CAV1|C3AR1|CHRNA10|GPR4|PTGIR|PDGFRA|CMKLR1|CD55|GNG3|C5AR1|C1QTNF1
TRAM-DEPENDENT TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY%GOBP%GO:0035669,0.839496248660236,0.946999344326828,0.426785490596831,0.717054728707903,6265,2,PRKCE
CELLULAR ANION HOMEOSTASIS%GOBP%GO:0030002,0.0385852090032154,0.279776552671739,0.8749379652605459,1.4700087494511598,287,2,SLC12A5|XPR1
POSITIVE REGULATION OF ADENYLATE CYCLASE-INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY%GOBP%GO:1904992,0.0478929765886288,0.313376367160917,-0.9741949713277459,-1.29786161981594,357,1,PRMT5
REGULATION OF G0 TO G1 TRANSITION%GOBP%GO:0070316,0.178089304257529,0.550866075421915,-0.253281548476872,-1.23954902852794,1371,38,YAF2|RBBP4|RBBP8|CBX3|SOX15|CDC7|FOXO4|EHMT1|PCGF2|PHC3|RAD51|RRM2|UXT|TFDP2|EZH2|DAB2IP|RHNO1|BRCA1|RBBP7|E2F1|MAX|RING1
NEGATIVE REGULATION OF GASTRULATION%GOBP%GO:2000542,0.350078905839032,0.7077980036270408,-0.456275014986822,-1.0936041456368,2661,5,MESP1|COL5A2|COL5A1
POSITIVE REGULATION OF HISTONE H3-K14 ACETYLATION%GOBP%GO:0071442,0.19478260869565198,0.569626484656312,-0.9005293339214822,-1.19972130262813,1455,1,WBP2
POSITIVE REGULATION OF GLIAL CELL MIGRATION%GOBP%GO:1903977,0.13928571428571399,0.504314492208813,-0.6812909670132039,-1.33038858609103,1052,3,P2RX4|CSF1
PROTEIN DEAMINATION%GOBP%GO:0018277,0.288561872909699,0.661710492558505,-0.8532752536391708,-1.1367675213182902,2156,1,LOXL1
REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION%GOBP%GO:1904688,0.306417674907943,0.6777859107987779,-0.47501593483554,-1.13852255441752,2329,5,NCK1
DOPAMINE CATABOLIC PROCESS%GOBP%GO:0042420,0.9296422935297209,0.9793746057014829,-0.253558809935091,-0.607732083940117,7068,5,SULT1A3|MAOA|MOXD1
REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE%GOBP%GO:0098696,0.0470899470899471,0.311444334567338,-0.7688320282342559,-1.50133409146499,355,3,IQSEC2|HRAS|RAP1A
DNA SYNTHESIS INVOLVED IN DNA REPAIR%GOBP%GO:0000731,0.0908151401627697,0.416502225487574,-0.265589027982625,-1.3758347320976498,702,46,SPRTN|POLE|RFC2|RPA2|WRNIP1|RFC3|POLD4|PCNA|VCP|POLD1|POLD2|KIAA0101|RFC5|ISG15|DTL|NPLOC4|RCHY1|UBC|POLE2|POLA1|UBE2L6|RFC4
ROSTROCAUDAL NEURAL TUBE PATTERNING%GOBP%GO:0021903,0.911243386243386,0.972245398885683,-0.324989096496326,-0.6346213373094219,6888,3,ATP6AP2
BETA-CATENIN DESTRUCTION COMPLEX DISASSEMBLY%GOBP%GO:1904886,0.46303807405469105,0.776796066784647,-0.261413057879749,-0.993433456021553,3538,17,DVL3|GSK3B|AMER1|APC|FRAT1|FZD2|CAV1|CSNK1A1|PPP1CA
REGULATION OF CHROMATIN ORGANIZATION%GOBP%GO:1902275,0.0168879721541833,0.17671843887293,-0.23427455237212,-1.5414530257078503,130,116,MAP1S|BRD4|DNMT3B|MKI67|NAA40|H1F0|PARP10|SET|WDR70|KDM1A|CAMK1|BCOR|TRIM28|PHF2|ATAD2|CHTOP|NSD1|PAXIP1|HNRNPU|OGT|FMR1|TAL1|PRKD1|SETD1A|CDC45|BRCA1|ARRB1|SNW1|CTR9|MAPK3|TAF7|DNMT1|RAPGEF3|RNF20|HDAC5|WBP2|KAT7|SPI1|PHF19|RNF40|SPTY2D1|TLK2|H1FX|RPS6KA4|HIST1H1C|H2AFY|OTUB1
POSITIVE REGULATION OF VASOCONSTRICTION%GOBP%GO:0045907,0.21267087276551,0.5952412242470191,-0.454536359584698,-1.24245486916516,1617,7,TBXA2R|F2R|SMTNL1|CAV1
HYDROXYPROLINE TRANSPORT%GOBP%GO:0034589,0.43777394076238496,0.7635570545514341,0.782697397441553,1.04362136789279,3295,1,SLC1A4
POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE%GOBP%GO:0046016,0.47267179623242206,0.7831522581932591,-0.609925558312655,-1.0150136634623,3562,2,USF1|USF2
CALCIUM-DEPENDENT CELL-CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES%GOBP%GO:0016339,0.21402502606882198,0.597438672438672,-0.25995838733389004,-1.20922394159986,1641,32,PCDHB6|PCDHB11|PCDHB13|CDH8|PCDHB2|CDH11|CDH5|PCDHB16|CDH7|PCDHGB4|DCHS1
UNSATURATED FATTY ACID METABOLIC PROCESS%GOBP%GO:0033559,0.0051766532936456605,0.0809542541983624,-0.331344402589817,-1.8143926077116002,39,56,SCD5|CD74|TBXAS1|PTGDS|CYP1B1|ELOVL2|CBR1|DAGLB|ELOVL1|PTGR2|PLA2G4A|PTGES2|PTGS1|ACOX1|PLA2G4C|DAGLA|PLAA|ABCD1|MGLL|GSTP1|FADS1|FADS2|PTGES|PTGIS
POSITIVE REGULATION OF ASTROCYTE ACTIVATION%GOBP%GO:0061890,0.8031443160440741,0.932964969466025,0.373938458144921,0.735492819529772,5976,3,AGER|TTBK1|APP
HIPPO SIGNALING%GOBP%GO:0035329,0.15044363256785,0.517264655410678,-0.29899338171619394,-1.3042637327621298,1152,26,TJP2|SAV1|STK3|WWTR1|LATS2|DCHS1|YAP1|TEAD2
POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046889,0.118296325152578,0.4691344446484289,-0.257627841115492,-1.32429588151612,910,45,INS|NSMAF|FABP3|ABCG1|NR1H3|CREBL2|APOE|SLC45A3|ZP3|NR1D1|SIRT4|LDLR|ABCD1|ANXA1|TNFRSF1A
NEGATIVE REGULATION OF SYNAPSE MATURATION%GOBP%GO:2000297,0.216588628762542,0.599597524514766,-0.889005293339215,-1.18436851348723,1618,1,ARHGEF15
POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY%GOBP%GO:0032516,0.311902579546943,0.68160868787154,-0.325412757969793,-1.1201338175939999,2381,13,PPP2R4|CD300A|PDGFRB
PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009213,0.972406473865747,0.9915747942934481,-0.33001822435435496,-0.549203099207603,7329,2,DCTPP1
DNA REPLICATION TERMINATION%GOBP%GO:0006274,0.559702483729579,0.8268422944617521,0.7189567710630791,0.958631843321884,4213,1,RTFDC1
NCRNA POLYADENYLATION INVOLVED IN POLYADENYLATION-DEPENDENT NCRNA CATABOLIC PROCESS%GOBP%GO:0043630,0.986889632107023,0.995849329595687,-0.506726951918835,-0.675081972272383,7376,1,PAPD5
REGULATION OF RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0060330,0.694703640425812,0.889726625344871,-0.20854596178896104,-0.8239456394055771,5285,19,IFNGR1|SOCS3|PARP9|SOCS1|NR1H3|PPARG
NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0072201,0.665143778554152,0.8804055751124069,0.42560935259733096,0.837123371350948,4949,3,CTNNBIP1|NFIB|BMP4
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION%GOBP%GO:0031345,0.22595847662718102,0.608570227910676,-0.183964071780402,-1.15697629442524,1773,95,SEMA3B|SEMA3D|STX1B|SEMA7A|APOE|SEMA5A|SEMA3E|EPHA4|SLIT2|FKBP4|SEMA3A|SEMA6B|RTN4RL1|MYLIP|EVL|ARHGDIA|RAP1GAP|NGFR|PRNP
SPINE APPARATUS ASSEMBLY%GOBP%GO:1905355,0.048428093645485,0.31517882292381394,-0.9740295544772829,-1.29764124485219,361,1,SYNPO
REGULATION OF IMMUNOGLOBULIN SECRETION%GOBP%GO:0051023,0.563785472533195,0.8289843923130809,-0.314743577887013,-0.906102709086923,4330,8,HLA-E|STX4|GPI|TNFRSF4
"CD8-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043374",0.508628762541806,0.7990325304927759,-0.7492831936479929,-0.998225127443897,3801,1,TNFSF8
REGULATION OF NUCLEAR-TRANSCRIBED MRNA POLY(A) TAIL SHORTENING%GOBP%GO:0060211,0.8755567199371229,0.9605256252569351,-0.20606442111618203,-0.6671446500417421,6683,11,BTG2|CPEB3|TNRC6A|TOB1|TNRC6C|POLR2G
PORPHYRIN-CONTAINING COMPOUND CATABOLIC PROCESS%GOBP%GO:0006787,0.0668760633424944,0.3690551432905871,-0.6749009417624189,-1.4774992411622598,510,4,BLVRA|HMOX1|BLVRB
REGULATION OF ANTEROGRADE DENSE CORE GRANULE TRANSPORT%GOBP%GO:1901951,0.0852090032154341,0.40376145987147494,0.8227736421284809,1.3823659513809,635,2,TRIM46|MAP2
SIGNAL TRANSDUCTION INVOLVED IN CELLULAR RESPONSE TO AMMONIUM ION%GOBP%GO:1903831,0.48091004184100394,0.7857006060206241,-0.252072227061322,-0.978133989170739,3677,18,CHRM2|GNAQ|GNA15|ADRBK1|LY6H
POSITIVE REGULATION OF NEURON MATURATION%GOBP%GO:0014042,0.209765886287625,0.591207086931478,-0.8931958535509481,-1.1899513459021,1567,1,MAP3K13
NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION%GOBP%GO:0002638,0.9522619673855871,0.985958764731022,-0.24041166477204898,-0.576220885690511,7240,5,NDFIP1|FCGR2B
GLYCINE DECARBOXYLATION VIA GLYCINE CLEAVAGE SYSTEM%GOBP%GO:0019464,0.280780980209855,0.653918409964198,0.862152624614027,1.14956419220653,2113,1,AMT
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION%GOBP%GO:1903055,0.29875406283857,0.671387424531401,0.308775552373011,1.1389457305833302,2205,15,RLTPR|CLASP1|SMAD3|CLASP2|PHLDB1|RB1
POSITIVE REGULATION OF GLUCAGON SECRETION%GOBP%GO:0070094,0.47894806747244,0.7850984235874658,0.7610829289810319,1.01480139070266,3605,1,AIMP1
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION%GOBP%GO:1903557,0.00155581485803189,0.0323691581204349,-0.39073564333418104,-1.9568452186759902,11,41,HLA-E|DHX9|TLR1|PYCARD|ADAM8|CCL19|TLR2|SPN|AZU1|IFIH1|HSPB1|CD86|LGALS9|THBS1|FADD|HAVCR2|TLR4|C1QTNF4|CD14|LY96|PTPRJ
REGULATION OF G2/M TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0010389,0.0756507244518528,0.385018945189654,-0.19888039968083,-1.33033381267949,589,126,CDC7|VPS4A|HAUS1|BLM|NDE1|TUBG1|PINX1|CEP72|HAUS6|CDK4|AURKA|CEP78|RCC2|HAUS4|FHL1|CEP76|CSNK1D|FBXL7|CEP192|PCNT|NEK2|NEDD1|BRD4|CLSPN|DYNC1H1|DONSON|NBN|CDC6|OFD1|CEP70|RAD51C|TPX2|TUBA4A|SDCCAG8|HAUS8|RAD17|ORC1|CDK5RAP2|TAOK2|CDC25C|TOPBP1|MECP2|CEP131|DTL|SKP1|CKAP5|TUBB4A|RAD51B|CCNB1|PLK1|USP47|SSNA1|PRKACA|CETN2|HSP90AA1|CEP63|TUBB4B|CCND1|DCTN3|HAUS7
HYPEROSMOTIC RESPONSE%GOBP%GO:0006972,0.056188605108055,0.34424567164700104,-0.596331089931966,-1.53392420661508,428,6,ARHGEF2|RCSD1|AQP1|ICOSLG|YBX3
SYNAPSE MATURATION%GOBP%GO:0060074,0.673412698412698,0.8822393559380352,-0.4274842836660421,-0.8347684605534771,5090,3,SHANK1|IGSF21|PTEN
REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL%GOBP%GO:1904994,0.0619769874476987,0.35763097181928205,-0.490424891437865,-1.53643716459125,473,10,RHOA|TRAF6|ETS1|CXCL12|TNF|KLF4|IRAK1|RELA
POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT%GOBP%GO:0051590,0.154252437703142,0.5225398777782271,0.3568886213362879,1.31641500902798,1138,15,DRD2|TRH|PARK2|RAB3B|DRD4|RAB3GAP1
CELL-CELL ADHESION%GOBP%GO:0098609,0.00499168053244592,0.0794877127863817,-0.200059065670904,-1.52706391399701,38,251,JUP|CTNND1|ITGB2|CXADR|SERPINB8|AMIGO1|CLDN5|CDHR2|HMCN1|CLDN11|CD34|PCDHB6|RAP2B|SYNJ2BP|PCDHB11|SPN|ITGB5|TLN1|GP1BA|PCDHB13|PLEK|SRPX2|GAS6|CTNND2|CLDN10|THY1|ILK|PVRL2|ITGA5|LILRB2|CLEC4M|TENM2|CBLN1|COL14A1|MPZL2|MADCAM1|ICAM1|DSCAM|PKP2|SIGLEC1|CD93|CDH8|MSN|PIK3CB|PCDHB2|HSPB1|FLNA|VCAM1|TNIP1|MYL12A|CDH11|CDH5|KIRREL3|PCDHB16|CEACAM1|ROBO4|CYFIP2|CDH7|PCDHGB4|MPZ|NOV|TGFBR2|CD200|VCL|DLG3|NINJ2|DCHS1|ITGA8|CX3CL1|MYH9|FIBP|S100A8|FERMT3|CERCAM|ITGAM|S100A9|ACTB|PDGFRA|NRXN2|PODXL2|ADGRV1|ADGRL1|ACTN1|MYL9|COL13A1|VMP1|CADM3|FBLIM1
TETRAHYDROFOLYLPOLYGLUTAMATE METABOLIC PROCESS%GOBP%GO:0046900,0.536747147784558,0.8133470138585479,-0.584576747595221,-0.9728291888488841,4045,2,GGH
"DNA REPLICATION, REMOVAL OF RNA PRIMER%GOBP%GO:0043137",0.6075121057453211,0.849316898805358,-0.399714057562272,-0.8750576272540501,4641,4,DNA2|RNASEH2A|FEN1
PROTEIN GERANYLGERANYLATION%GOBP%GO:0018344,0.8675173069091899,0.9558022175108679,0.260227550205509,0.673354081098932,6390,6,FNTA|CHML|RABGGTB
CARDIAC MUSCLE CELL FATE COMMITMENT%GOBP%GO:0060923,0.0256342143710984,0.22470485454905398,0.9878694309660341,1.3171905901491598,192,1,ACVR1
SELENOCYSTEINE BIOSYNTHETIC PROCESS%GOBP%GO:0016260,0.5749767565413729,0.8354258054828342,0.710465372739303,0.947309709425759,4328,1,SEPHS1
REGULATION OF SULFUR METABOLIC PROCESS%GOBP%GO:0042762,0.54013104013104,0.81505408470595,0.30343034908019895,0.9220968454760171,3956,9,PDPR|SP1|PDP1
REGULATION OF POLYSOME BINDING%GOBP%GO:1905696,0.206022817723534,0.585942621384071,-0.7300248138957819,-1.2148780300675701,1552,2,DHX9|EIF4G1
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT OF VIRAL MATERIAL%GOBP%GO:1901253,0.147826086956522,0.514965886850433,-0.9243493603881779,-1.23145529740742,1104,1,BST2
REGULATION OF GLUTATHIONE PEROXIDASE ACTIVITY%GOBP%GO:1903282,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
CELLULAR RESPONSE TO EXTERNAL STIMULUS%GOBP%GO:0071496,0.257289002557545,0.635964652441119,-0.15560053486201503,-1.1138776935241201,2011,176,P2RX3|GAS6|WDR45B|POSTN|CASP1|PIEZO1|NUDT1|PDXP|SLC9A1|PTGER4|WDR45|PRKD1|PDE2A|CDKN2B|WIPI1|MAPK3|PIM1|USF2|RNF152|IFI16|RPTOR|PIK3R4|WDR24|FADD|TLR5|NIM1K|EIF2S1|LTBR|FAM107A|LAMP2|SIK1|NFKB1|TLR4|HSPA5|RRP8|TNFRSF1A|FADS1|EIF4G1|BAD|RRAGD
INDUCTION OF POSITIVE CHEMOTAXIS%GOBP%GO:0050930,0.46847316310578396,0.780769690730001,-0.32663496560662103,-0.9825979277834069,3595,9,AZU1|VEGFC|VEGFB
RESPONSE TO SELENIUM ION%GOBP%GO:0010269,0.228373249574663,0.610121312048328,-0.564993003165697,-1.23688778868702,1744,4,GPX1|SEPP1
TRNA WOBBLE ADENOSINE TO INOSINE EDITING%GOBP%GO:0002100,0.279851241864789,0.653204101106396,0.8623731804146451,1.14985827360643,2106,1,ADAT2
POSITIVE REGULATION OF MDA-5 SIGNALING PATHWAY%GOBP%GO:1900245,0.46084656084656106,0.774751791105461,-0.520562516490512,-1.01652665867853,3483,3,DDX60|DHX58
MUSCLE CELL CELLULAR HOMEOSTASIS%GOBP%GO:0046716,0.0819822175732218,0.398202308598866,-0.47351851768043707,-1.48347170257478,626,10,BAG3|SOD1|SRF|PGK1|ALDOA
GRANULOCYTE COLONY-STIMULATING FACTOR SIGNALING PATHWAY%GOBP%GO:0038158,0.451578668081719,0.7698779413322371,-0.618748276812793,-1.0296960779053002,3403,2,JAGN1|CEACAM1
CATECHOLAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0042423,0.8675190424374319,0.9558022175108679,0.198841379310345,0.6758231732410941,6377,12,INSM1|DDC|SNCA|PAH|HAND2|DBH|GCH1|TH|PNMT|TGFB2|MOXD1|GATA3
POSITIVE REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION%GOBP%GO:1903954,0.142249966795059,0.508373262859943,0.9304146449051608,1.24058238547538,1070,1,RNF207
REGULATION OF TELOMERIC RNA TRANSCRIPTION FROM RNA POL II PROMOTER%GOBP%GO:1901580,0.803478260869565,0.932964969466025,-0.6027238641376271,-0.8029729095657689,6005,1,ATRX
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN%GOBP%GO:0002483,0.0351725941422594,0.267547057426989,-0.521563993720485,-1.63399190713043,268,10,HLA-F|ERAP2|ERAP1|HLA-B|HLA-E|B2M|HLA-C|HLA-A
REGULATION OF HIGH-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0010982,0.7870899189799442,0.9276917050905171,0.60603220114689,0.80806216657342,5925,1,GPLD1
MODULATION BY ORGANISM OF DEFENSE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052255,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
NEGATIVE REGULATION OF FATTY ACID OXIDATION%GOBP%GO:0046322,0.7266064651223659,0.905101893109553,-0.35838000110872,-0.784568737307028,5551,4,METTL20|AKT1|SIRT4
VAGUS NERVE DEVELOPMENT%GOBP%GO:0021564,0.49859531772575294,0.794989907195277,-0.754907366563741,-1.00571787621123,3726,1,TBX1
HEPATOCYTE APOPTOTIC PROCESS%GOBP%GO:0097284,0.17632107023411397,0.548366806412612,-0.9091310101455671,-1.21118080074288,1317,1,GSN
DNA BIOSYNTHETIC PROCESS%GOBP%GO:0071897,0.168654394607208,0.541400548379524,-0.214739852323463,-1.2366627710704299,1300,68,CDKN2D|NHP2|BLM|TRIM25|PINX1|PTGES3|TERF2IP|SPRTN|POLE|TYMS|RFC2|RPA2|WRNIP1|RFC3|TERT|PPIA|POLD4|PCNA|VCP|POLD1|POLD2|KIAA0101|RFC5|ISG15|DTL|NPLOC4|RCHY1|DKC1|UBC|TNKS1BP1|POLE2|POLA1|HSP90AA1|UBE2L6|RFC4
NEGATIVE REGULATION OF PROTEIN AUTOUBIQUITINATION%GOBP%GO:1905524,0.8747320471597,0.9601297344254901,0.406341328921974,0.682705897441582,6528,2,MARCH7|TAF1
DNA METHYLATION ON CYTOSINE WITHIN A CG SEQUENCE%GOBP%GO:0010424,0.241070234113712,0.6244696312630601,-0.876599029554477,-1.16784039120635,1801,1,DNMT1
NEGATIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION%GOBP%GO:0072125,0.519292604501608,0.8049078833377921,0.583620904831139,0.9805584744615521,3875,2,BMP7|BMP4
AMINOGLYCAN CATABOLIC PROCESS%GOBP%GO:0006026,0.0440340909090909,0.29911754698336895,-0.284155972439967,-1.49718864855537,340,49,CD44|TGFB1|CEMIP|HSPG2|HYAL2|TMEM2|NCAN|SDC3|PRELP|HYAL3|NAGLU|ARSB|DCN|SLC9A1|SDC4|BGN|VCAN|OGN|LUM|SDC2|FMOD|FUCA1|HYAL1|LYVE1|HEXB
SEMAPHORIN-PLEXIN SIGNALING PATHWAY INVOLVED IN BONE TRABECULA MORPHOGENESIS%GOBP%GO:1900220,0.268756698821008,0.642726308906095,0.698728661550897,1.1739543679148101,2005,2,PLXNB1|SEMA4D
POSITIVE REGULATION OF CELLULAR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:2000284,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
MEDIUM-CHAIN FATTY ACID METABOLIC PROCESS%GOBP%GO:0051791,0.7939896654881701,0.929656485793048,0.232801897721631,0.7375321482487242,5838,10,ACADM|ACOT7|OXSM|ABHD1|GLYATL2|ABHD2|ACAD9|ABHD3|CES1|CROT
RESPONSE TO ARACHIDONIC ACID%GOBP%GO:1904550,0.753846153846154,0.915550465961143,-0.627701808557565,-0.836249529091274,5634,1,PPP5C
HISTONE H3-K4 DEMETHYLATION%GOBP%GO:0034720,0.766955835962145,0.9202818175694271,-0.27448226042537904,-0.7502850185110991,5834,7,KDM1A|C14orf169|KDM5C
MISMATCH REPAIR%GOBP%GO:0006298,0.542017949415284,0.815689901219835,0.217237028424083,0.935775286851435,3985,24,PMS1|MCM9|MUTYH|MLH1|ERCC1|PMS2|MSH2|POLD3|MSH5|RPA3|XPC|TDG|MSH6
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION%GOBP%GO:0003198,0.0166929547844374,0.17569702079137303,-0.6339207514742471,-1.7327941048624798,126,7,NOTCH1|SNAI2|SNAI1|ENG
ARGININE CATABOLIC PROCESS TO GLUTAMATE%GOBP%GO:0019544,0.750234113712375,0.914180498652832,-0.6301279223643579,-0.839481695226202,5607,1,OAT
NEGATIVE REGULATION OF TORC1 SIGNALING%GOBP%GO:1904262,0.10238353196099699,0.44115166704562797,0.382351370109321,1.4103365931076899,755,15,ATM|SESN1|GATSL3|SESN2|C12orf66|DEPDC5|SZT2|GATS|STK11|SESN3
POSITIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY%GOBP%GO:0051006,0.292893600314095,0.665416463589539,-0.5316274196216839,-1.1638435516490901,2237,4,GPIHBP1|NR1H2|APOC2|NR1H3
ESTABLISHMENT OF APICAL/BASAL CELL POLARITY%GOBP%GO:0035089,0.955519392459995,0.987356127692642,0.156496144653674,0.562505209899394,7045,14,CAMSAP3|MYO9A|FOXJ1|EZR
POSITIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0045429,0.7782136785667579,0.924704689181848,-0.18503827119997304,-0.766291626462802,5950,22,INSR|CLU|ASS1|KLF2|PTGS2|HBB|IL1B|AKT1|TNF|KLF4|P2RX4|CD36|TLR4|HSP90AA1
POSITIVE REGULATION OF AXON EXTENSION%GOBP%GO:0045773,0.35716219875440003,0.7146993813561079,0.265337864170504,1.07535423266112,2637,20,ISLR2|SHTN1|RUFY3|LIMK1|POU4F2|NRP1|ZFYVE27|MEGF8
POSITIVE REGULATION OF RUFFLE ASSEMBLY%GOBP%GO:1900029,0.31533859124286107,0.6851643150843639,0.352549959296567,1.11690210169982,2318,10,EPS8L1|RLTPR|NDEL1
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN CARDIAC FIBROBLAST DEVELOPMENT%GOBP%GO:0060940,0.9374330117899251,0.9806508984207809,0.358522592433235,0.602364246013514,6996,2,PDCD4
REGULATION OF GLUTAMATE METABOLIC PROCESS%GOBP%GO:2000211,0.392880860672068,0.737280445732591,0.8045875606528449,1.0728089468328001,2957,1,ATCAY
NEGATIVE REGULATION OF GTPASE ACTIVITY%GOBP%GO:0034260,0.562541015881349,0.828541380171721,-0.225416434811816,-0.918348178498083,4285,21,BCAS3|HRAS|TMED2|FICD|ARL2|RRP1B
REGULATION OF RENIN SECRETION INTO BLOOD STREAM%GOBP%GO:1900133,0.39745290527991495,0.738082256597968,-0.6408736963361921,-1.06651631411283,2995,2,F2R
SUBPALLIUM DEVELOPMENT%GOBP%GO:0021544,0.225466342254663,0.6083599141984499,0.507898351441578,1.22149262266829,1667,5,BBS4|MKKS|BBS2
EPOXYGENASE P450 PATHWAY%GOBP%GO:0019373,0.39940225512837896,0.7392155506460759,0.470766326439573,1.0342936680140602,2939,4,CYP2E1|CYP2C8|EPHX2
INNER EAR DEVELOPMENT%GOBP%GO:0048839,0.38293515358361796,0.730480369014206,0.241762593649002,1.0533393603987,2804,25,IFT88|FGFR2|PAX8|AHI1|EPHB2|MPV17
HISTONE ARGININE DEMETHYLATION%GOBP%GO:0070077,0.24200668896321104,0.625158460820442,-0.8759373621526251,-1.16695889135137,1808,1,JMJD6
DGDP METABOLIC PROCESS%GOBP%GO:0046066,0.8160503751339759,0.9370829470665502,0.4404500295932079,0.740012918521864,6090,2,AK9
POSITIVE REGULATION OF CD40 SIGNALING PATHWAY%GOBP%GO:2000350,0.21712374581939803,0.599597524514766,-0.8887295985884429,-1.1840012218809899,1622,1,TREM2
REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE%GOBP%GO:0048841,0.16788511749347304,0.5400872099036179,-0.304490978413292,-1.27843019156397,1285,23,DSCAM|SEMA3B|SEMA3D|SEMA7A|SEMA5A|SEMA3E|SEMA3A|SEMA6B
POSITIVE REGULATION OF HEMOSTASIS%GOBP%GO:1900048,0.000392464678178964,0.0111294649577428,-0.59656078722601,-2.21705087804404,2,16,PLEK|F3|THBD|PDPN|F2R|THBS1|SERPINE1|ENPP4|TLR4|SERPINF2
CELLULAR RESPONSE TO GONADOTROPIN STIMULUS%GOBP%GO:0071371,0.605291005291005,0.8484731812466321,-0.45454457168892204,-0.8876103446603559,4575,3,NOTCH1|NSMF
COLLAGEN CATABOLIC PROCESS%GOBP%GO:0030574,0.0231584456365302,0.21165950231047198,-0.4446551550354671,-1.68979817223929,176,17,CTSK|MMP11|PHYKPL|FURIN|MMP12|COL15A1|CTSS|MMP1|CTSB|MMP14|MRC2|MMP9|CTSD|CTSL|COL13A1
LIPOOLIGOSACCHARIDE METABOLIC PROCESS%GOBP%GO:1901269,0.10969899665551801,0.454522162524904,-0.9426003528892809,-1.25577000174063,819,1,NDUFAB1
POSITIVE REGULATION OF ESTABLISHMENT OF T CELL POLARITY%GOBP%GO:1903905,0.336012861736334,0.6992597390318461,0.66603029051184,1.1190168827116203,2507,2,FLOT2|DOCK8
LIPOOLIGOSACCHARIDE BIOSYNTHETIC PROCESS%GOBP%GO:1901271,0.10969899665551801,0.454522162524904,-0.9426003528892809,-1.25577000174063,819,1,NDUFAB1
MAINTENANCE OF DNA REPEAT ELEMENTS%GOBP%GO:0043570,0.430116247634496,0.7586702712828721,0.418486653430399,1.0064580016837799,3181,5,MSH2|MSH6|TCF7L2|MSH3
DIACYLGLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0006651,0.22751392942425103,0.60968579048463,-0.720154397573753,-1.19845207890947,1714,2,PLCE1|ANG
DETECTION OF MUSCLE STRETCH%GOBP%GO:0035995,0.91101075840085,0.972245398885683,0.544883105425673,0.726528098451327,6858,1,TCAP
CYTOPLASMIC ACTIN-BASED CONTRACTION INVOLVED IN CELL MOTILITY%GOBP%GO:0060327,0.0358613361668216,0.268987198588135,0.981859285399206,1.3091768720019,269,1,SHTN1
INTRA-S DNA DAMAGE CHECKPOINT%GOBP%GO:0031573,0.285092491838955,0.658128904006822,0.33718377931138,1.1460220829789098,2095,12,NEK11|MDC1|MRE11A|ATF2|TIPIN|CHEK2|MSH2
RESPONSE TO MORPHINE%GOBP%GO:0043278,0.6271163665681271,0.859069247760118,0.44026249036289,0.8659443641517809,4666,3,DRD2|SRR
N-TERMINAL PEPTIDYL-SERINE ACETYLATION%GOBP%GO:0017198,0.44709030100334396,0.768229288546963,-0.7780657256285842,-1.03657037113554,3341,1,NAA10
REGULATION OF B CELL DIFFERENTIATION%GOBP%GO:0045577,0.7366762929902859,0.908157084784786,-0.218370821180422,-0.792869054063143,5611,15,XBP1|BTK|INHA|ZFP36L2|SYK|NCKAP1L|SLAMF8|ZFP36L1|INHBA|MMP14
MODULATION BY VIRUS OF HOST IMMUNE RESPONSE%GOBP%GO:0075528,0.325083612040134,0.692794968343412,-0.835244816938685,-1.11274665027008,2429,1,SLC25A6
"NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, ENDONUCLEOLYTIC CLEAVAGE-DEPENDENT DECAY%GOBP%GO:0000294",0.8069779782435659,0.933810206759044,-0.45751309622277403,-0.761374953959562,6082,2,UPF1|ZC3H12A
MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:0042775,0.000128799587841319,0.00518555396908895,-0.406950895527847,-2.3718555503281604,0,71,COX7C|CYC1|NDUFC2|NDUFV2|NDUFB8|SDHC|NDUFS4|UQCRC1|NDUFB5|UQCR10|NDUFA9|NDUFA7|NDUFA3|NDUFB6|SDHD|CYCS|NDUFB9|NDUFB10|SDHA|MT-CO3|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|COQ7|NDUFB4|NDUFA12|SDHAF2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|NDUFA4|NDUFV1|UQCRQ|NDUFS3|COX6A1|UQCC3|NDUFA8|NDUFS8|NDUFV3
URETER MORPHOGENESIS%GOBP%GO:0072197,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0060260,0.0119595216191352,0.1437312318828,-0.453425718254471,-1.7914427119340601,90,19,ATF7IP|SUB1|PSMC2|PAXIP1|DHX36|THRA|TAF7|PSMC4|PSMC6|SRF|PSMC5|PSMC3
PROTEIN K63-LINKED UBIQUITINATION%GOBP%GO:0070534,0.644372574385511,0.8688307429995409,-0.181603547674496,-0.87447190371171,4980,36,UBE2T|HECTD1|UBE2O|UBE2B|TRIM56|TMEM189-UBE2V1|TRAF2|UBE2S|RNF168|RNF152|ZFP91|PELI3|PRPF19
REGULATION OF INTERLEUKIN-3 PRODUCTION%GOBP%GO:0032672,0.0937792642140468,0.42337598780415003,-0.9508160564622851,-1.26671529160663,700,1,HAVCR2
NEGATIVE REGULATION OF METANEPHRIC S-SHAPED BODY MORPHOGENESIS%GOBP%GO:2000005,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
HEPATOCYTE PROLIFERATION%GOBP%GO:0072574,0.18081719288936102,0.554494792588896,-0.745133719327268,-1.2400216648012,1362,2,RPS6KA1|CEBPB
STRIATED MUSCLE CELL DEVELOPMENT%GOBP%GO:0055002,0.246353101567826,0.6280519349499749,0.22539770113913302,1.16978516905786,1806,44,NEBL|CHRNB1|TMOD3|OBSCN|SDC1|ALPK3|DMD|NEB|WDR1|RYR1|TPM1|SKI|OBSL1|PROX1|CFLAR|TMOD1|SLC8A1|TMOD2
NEGATIVE REGULATION OF RIBOSOME BIOGENESIS%GOBP%GO:0090071,0.12367724867724901,0.478108990509784,-0.693186452026123,-1.3536174534229801,934,3,NUDT16|MALSU1
POSITIVE REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE-GATED CHANNEL CLUSTERING%GOBP%GO:1904395,0.540334448160535,0.81505408470595,-0.7331826202029109,-0.9767752976393771,4038,1,MESDC2
HEART LOOPING%GOBP%GO:0001947,0.441595814257685,0.7653693162885199,-0.221319015476933,-1.01049929553534,3375,30,SOX18|SOX17|FOXN4|SMO|TBX2|MESP1|NOTCH1|MEF2C|MICAL2|TGFBR2|SRF|DNAAF1|ENG
NEGATIVE REGULATION OF NK T CELL ACTIVATION%GOBP%GO:0051134,0.77129211992571,0.9213545359508709,-0.477672709004981,-0.7949237733936221,5813,2,CD300A
REGULATION OF FLAGELLATED SPERM MOTILITY%GOBP%GO:1901317,0.15648445873526298,0.525982918868011,0.764929693961952,1.2851806499266698,1167,2,CFAP69|ANXA5
NEGATIVE REGULATION OF DNA REPLICATION%GOBP%GO:0008156,0.716371220020855,0.899551221015245,-0.17631915687459598,-0.8201672123070141,5495,32,TSPYL2|TERF2|DONSON|CDC6|STAG2|SLFN11|RAD17|GMNN|SMC1A|BCL6|S100A11
REGULATION OF CARDIAC CHAMBER FORMATION%GOBP%GO:1901210,0.37404682274247497,0.724682900261831,-0.8110939567710631,-1.0805719055633,2795,1,TBX2
POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL%GOBP%GO:1904996,0.0712407991587802,0.3767214120425879,-0.548107612548715,-1.49822771639184,541,7,RHOA|TRAF6|ETS1|TNF|IRAK1|RELA
REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY%GOBP%GO:0060296,0.0624493106244931,0.358856014313751,0.6394481716291011,1.53786918584539,461,5,BBS4|CFAP20|MKKS|BBS2
"DNA-TEMPLATED TRANSCRIPTION, ELONGATION%GOBP%GO:0006354",0.28532678894342495,0.6583248923580091,-0.19233784633092502,-1.11682943019353,2208,70,MLLT3|CCNK|SUPT16H|ELOF1|NCBP1|CTR9|POLR2H|GTF2H1|NELFB|CDK7|MNAT1|POLR2G|SUPT4H1|SSRP1|ELP4|POLR2L|GTF2H2
OSSIFICATION INVOLVED IN BONE MATURATION%GOBP%GO:0043931,0.4253448742223421,0.7547028278218628,0.368168204374457,1.01631844596341,3144,7,PLXNB1|XYLT1|RYR1
NEGATIVE REGULATION OF EOSINOPHIL EXTRAVASATION%GOBP%GO:2000420,0.296989966555184,0.6689039624806751,-0.84836788707543,-1.13022973072719,2219,1,PTGER4
MELANIN BIOSYNTHETIC PROCESS%GOBP%GO:0042438,0.372454448017149,0.7234654586828599,0.650335927211928,1.0926483259864899,2779,2,CITED1|TRPC1
GLOMERULAR ENDOTHELIUM DEVELOPMENT%GOBP%GO:0072011,0.42715719063545204,0.755533439554473,-0.78743934715483,-1.04905828574776,3192,1,CD34
NOTOCHORD DEVELOPMENT%GOBP%GO:0030903,0.0695767195767196,0.37596389138254704,-0.7402593395625571,-1.4455388722073301,525,3,COBL|COL5A2
SIGNAL RELEASE FROM SYNAPSE%GOBP%GO:0099643,0.74109362054681,0.9098143075756671,0.144995835240741,0.8275552369459009,5366,62,SYT2|LIN7B|RIMS1|SNAP25|LIN7A|DNAJC5|UNC13A|RIMS2|SLC18A3|CPLX1|PPFIA3|HRH3|SYT5|BRSK1|GRM4|SNAP23|PTPRN2|NAAA|OTOF
DENSE CORE GRANULE MATURATION%GOBP%GO:1990502,0.455925826390755,0.7711961414599979,0.509986694415034,1.00308364552494,3392,3,PTPRN|BAIAP3|SNX19
RENAL TUBULE MORPHOGENESIS%GOBP%GO:0061333,0.422627141691596,0.753525330620002,0.261101046544786,1.02206090505945,3107,18,CITED1|PAX8|AHI1|FGF2|PKD1|PKD2
ZINC ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0071577,0.6486840382349089,0.870854114559689,-0.24766515562333397,-0.85251149335432,4953,13,SLC30A3|TRPM2|SLC39A7|SLC39A13|SLC39A1|SLC39A3|SLC39A8|SLC39A11
NEGATIVE REGULATION OF GLUCAGON SECRETION%GOBP%GO:0070093,0.195471596998928,0.570533154370682,0.739619520264682,1.24265629018645,1458,2,UCN|CRH
ACTIVATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY%GOBP%GO:0097202,0.000522875816993464,0.0139121625154964,-0.6324046450798371,-2.11671756014144,3,12,PERP|IFI16|CYFIP2|CIDEB|ASPH|FADD|LGMN|BAD
L-PROLINE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:1904271,0.535927746048612,0.8132910857498922,0.7305910895456551,0.9741446371665742,4034,1,SLC36A4
NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY%GOBP%GO:0051490,0.328809459822628,0.695543934617773,0.5733428918054481,1.1276978092686998,2446,3,PRKCD|SRGAP2C|CAPZB
"DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR%GOBP%GO:0006978",0.752816347917213,0.915314007578303,-0.23710282298921,-0.7676331460337851,5746,11,FOXM1|BRCA1|KAT5
"CELL CYCLE SWITCHING, MITOTIC TO MEIOTIC CELL CYCLE%GOBP%GO:0051728",0.44481294773149394,0.76693681188187,-0.621395092362834,-1.0341008022382001,3352,2,C17orf104|YTHDC2
ENAMEL MINERALIZATION%GOBP%GO:0070166,0.163067661300877,0.534744357685457,-0.6003792205357089,-1.31435561555842,1245,4,TBX1|STIM1|FAM20A
NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION%GOBP%GO:1901097,0.0077435131096318405,0.10744152749969199,0.808783577923503,1.7769319648808999,56,4,PHF23|UBQLN4|CLEC16A
COENZYME CATABOLIC PROCESS%GOBP%GO:0009109,0.5224367691052489,0.807051143864932,0.29719909841176195,0.941546832970015,3841,10,NUDT7|NUDT12|ACAT1|PM20D2|ACOT7
POSITIVE REGULATION OF GLUCOSE IMPORT%GOBP%GO:0046326,0.546598133369403,0.817872396704977,0.23326206400415198,0.929988766804433,4040,19,IRS2|RHOQ|CAPN10|CLTCL1
REGULATION OF SMOOTH MUSCLE CONTRACTION%GOBP%GO:0006940,0.0031541595479038,0.0571886039479394,-0.500109883317054,-1.97588749284778,23,19,ADRB2|DOCK4|PLCE1|CTTN|DOCK5|SOD1|CHRM2|GPER1|F2R|KCNB2|SRF|CAV1|SPHK1|CNN1
CHOLESTEROL TRANSPORT%GOBP%GO:0030301,0.0557567917205692,0.342757322822697,-0.307697761555519,-1.48165083094946,430,36,CES1|ABCA5|MSR1|APOC1|SYT7|ABCG1|CETP|APOM|APOE|CD36|CAV1|LDLR|OSBP|NPC2|OSBPL5
REGULATION OF CALCIUM ION-DEPENDENT EXOCYTOSIS%GOBP%GO:0017158,0.134923738756355,0.497031952671308,-0.28016948103307,-1.31575497384612,1034,33,SEPT5|REST|SYT4|HYAL3|NAPA|CACNA1H|FMR1|VPS18|SYN1|CACNA1G|STX1B|ZP3|DOC2A|CACNA1I
RRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0031118,0.955075311067452,0.9870204197558861,-0.22496600957003002,-0.578673179331365,7291,6,DKC1
OSTEOCLAST DIFFERENTIATION%GOBP%GO:0030316,0.0571465934353341,0.34436604181231795,-0.363329369886751,-1.5046414559901202,436,22,TNFRSF11A|TCTA|OSCAR|TREM2|CSF1|EPHA2|FOXP1|TYROBP|ANXA2|CSF1R|SNX10
NEGATIVE REGULATION OF CELL-CELL ADHESION MEDIATED BY CADHERIN%GOBP%GO:2000048,0.56273014203051,0.828541380171721,-0.378566568560049,-0.90735182768823,4278,5,RGCC|PPM1F|KIAA2022
REGULATION OF CELL ADHESION MOLECULE PRODUCTION%GOBP%GO:0060353,0.306635257165293,0.6779955265573311,-0.524663943434185,-1.1485990466466,2342,4,COLEC12|CAV1
REGULATION OF SMOOTHENED SIGNALING PATHWAY%GOBP%GO:0008589,0.0174642464246425,0.179978459887059,0.341636122741031,1.66651669927227,126,36,INTU|STK36|SFRP1|EVC|FGFR2|GPR161|KIF7|BTRC|IFT81|WDR11|SUFU|ULK3|GAS8|TULP3|PTCH2|MEGF8
RESPONSE TO INTERFERON-GAMMA%GOBP%GO:0034341,0.000128122998078155,0.00518555396908895,-0.36129275538291705,-2.36086478969675,0,112,IRF8|CCL3|OAS3|HLA-DQB2|HLA-B|CCL4|CCL8|CD44|HLA-DPA1|UBD|PML|HLA-E|CCL11|HLA-DRA|HLA-DRB5|FCGR1B|TRIM38|SP100|TRIM21|B2M|CCL19|MID1|OASL|OAS1|IFNGR1|CALCOCO2|HLA-DPB1|TLR2|HLA-DQA2|FCGR1A|TRIM68|CCL24|HLA-C|IRF5|TRIM34|HLA-A|OAS2|CASP1|CCL3L3|KYNU|CCL18|PDE12|CD47|ICAM1|SLC11A1|CAMK2B|IRF7|IFI30|VCAM1|CCL2|CXCL16|GAPDH|HCK|BST2|LGALS9|MT2A|AIF1|CX3CL1|CAMK2A|PTAFR|CCL4L2|CCL14|IFITM1|TLR4|IFITM2|IFITM3|SIRPA
CELLULAR RESPONSE TO CATECHOLAMINE STIMULUS%GOBP%GO:0071870,0.68999474789916,0.887051934478962,-0.20670994191888,-0.8293163277733689,5254,20,PDE4B|SLC9A1|MAPK3|ABL1|KCNQ1|PRKACA
PROTEIN TARGETING TO ER%GOBP%GO:0045047,0.7711506463586328,0.9213545359508709,-0.12926804758178698,-0.828578397767453,6024,103,RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|SRP19|RPL35|RPL38|RPS15A|CHMP4A|SEC61A1|SEC61B|SGTB|RPS13|SRP9|SRP68
PURKINJE MYOCYTE ACTION POTENTIAL%GOBP%GO:0086017,0.0924482665950013,0.420939346122012,0.7199824160962,1.41612044894624,687,3,TRPM4|SCN5A
SECRETORY GRANULE LOCALIZATION%GOBP%GO:0032252,0.257845401440022,0.636098664976652,0.5414402592426399,1.1895673082183302,1897,4,KIF5B|KIF5A|KIF1A
OLFACTORY LEARNING%GOBP%GO:0008355,0.23774737680966898,0.6217158626397761,0.882884869872078,1.17720784379707,1789,1,ADCY3
CHROMOSOME SEGREGATION%GOBP%GO:0007059,0.0149827122550903,0.164650761550465,-0.203697174957638,-1.47871042539231,116,189,KIF25|CENPE|KIF2C|CDCA8|NIPBL|PAPD7|PHB2|BECN1|VPS4A|NCAPG|BLM|NDE1|TUBG1|CHMP5|CASC5|RAD21|INO80|PINX1|ZNF207|ZWINT|HJURP|RACGAP1|TRIP13|NCAPD3|KNSTRN|EME2|KLHL22|NEK2|SKA3|NCAPH|NUSAP1|NUF2|DLGAP5|CENPW|NSL1|SPDL1|ESCO2|CDT1|SMC2|DSN1|ESPL1|GSG2|RAD51C|TOP1|TUBG2|OIP5|CDC23|STAG2|GEM|BOD1|KPNB1|PTTG1|TOP2A|CDK5RAP2|DDX3X|NCAPH2|KIF18B|INCENP|BRCA1|STRA13|KIF4A|NAA50|NDC80|SGOL1|EME1|RCC1|KIF18A|SPICE1|RMI1|REC8|RAN|BEX4|SMC4|SPC25|KIFC1|CCNB1|PLK1|SKA1|CHMP4A|HDAC8|CHMP6|TLK2|FANCM|SMC1A|NEK6|KIF22|SYCE2|MUS81|MIS18A|CDCA5|NTMT1|SKA2
NEGATIVE REGULATION OF ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0046639,0.8572589382448541,0.9493824579559329,0.186853187110812,0.689224383440371,6329,15,SOCS5|LOXL3|CBFB
GLYCEROL ETHER BIOSYNTHETIC PROCESS%GOBP%GO:0046504,0.8987375065754871,0.967428248648255,-0.269267951194601,-0.6453838979591031,6833,5,FAR1|DHRS7B
NEGATIVE REGULATION OF MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION%GOBP%GO:0071641,0.00655518394648829,0.0957322763119865,-0.9969673577415091,-1.32819990649151,48,1,SIRPA
POSITIVE REGULATION OF METANEPHRIC URETERIC BUD DEVELOPMENT%GOBP%GO:2001076,0.47812709030100303,0.7850984235874658,-0.7638950154389059,-1.01769158257471,3573,1,BASP1
CYTOPLASMIC RNA SURVEILLANCE%GOBP%GO:0071026,0.7069996015407092,0.894949003158309,0.6461182179091309,0.861511461005126,5322,1,SUPV3L1
EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX ASSEMBLY%GOBP%GO:0097010,0.63531440700451,0.863600910248377,-0.5450234353460159,-0.907006152216019,4788,2,EIF4H|EIF4B
POSITIVE REGULATION OF PROTEOLYSIS%GOBP%GO:0045862,0.0005103993875207349,0.0139121625154964,-0.228643447279239,-1.73213592701893,3,239,UBQLN2|TNFRSF10A|FGFR4|TNFRSF10B|NRD1|PDCD6|CASP10|NGF|OGT|CBFA2T3|ATPIF1|PDCD5|CASP1|GRIN1|VCP|RNF144B|TRAF2|PRELID1|FMR1|DDX3X|CLEC3B|EFNA1|TNFSF10|CCDC22|CYCS|CASP4|CEBPA|STAT3|UBQLN1|SUMO2|PSME2|F3|PERP|TRIM32|IFI27L1|RCN3|ENO1|ANP32B|HERPUD1|NKD2|IFI16|TNIP1|RCHY1|C10orf54|CTSH|CYFIP2|GPER1|CIDEB|GSN|F2R|PSMD10|APOE|PLK1|DLC1|NLRP3|CCBE1|ECSCR|EFNA3|CTSC|ASPH|LGALS9|FADD|EPHA4|BCAP31|CAV1|MYC|PPARG|MYH9|S100A8|S100A9|DAB2|ARL6IP5|LGMN|PHB|CSNK1A1|MAGEF1|NGFRAP1|TNFRSF1B|NGFR|FAM122A|BAD
HEART TRABECULA FORMATION%GOBP%GO:0060347,0.0015704750687082802,0.0323893370023386,-0.8763517584225841,-1.91851718961801,11,4,TGFBR3|TEK|FKBP1A
MANNITOL TRANSPORT%GOBP%GO:0015797,0.480674724398991,0.7857006060206241,0.760200705778562,1.01362506510306,3618,1,SLC26A6
LIPID GLYCOSYLATION%GOBP%GO:0030259,0.0990708022510143,0.43439543449273205,-0.645517069442426,-1.4131718023209,756,4,B3GALT1|GBGT1
CELLULAR RESPONSE TO GLYOXAL%GOBP%GO:0036471,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
STEROID HORMONE MEDIATED SIGNALING PATHWAY%GOBP%GO:0043401,0.20595054095826898,0.58593831108227,-0.21415824136998898,-1.19648823347107,1598,60,BRCA1|DDX5|CALR|RAN|WBP2|NCOA4|GPER1|RBM14|CDK7|FHL2|PPAP2A|YAP1|KAT5|PHB
CELL FATE COMMITMENT%GOBP%GO:0045165,0.5025556016024311,0.7970718494574169,0.161102859594667,0.973243157035292,3637,77,WNT6|ACVR1|FGFR2|DLL1|EPAS1|WNT5B|TEAD3|POU3F2|WNT2B|TCF3|RAB10|SOX6|ASCL1|CHD5
POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0060391,0.15945805106826502,0.5293397224673839,-0.437275343553517,-1.31543126636334,1223,9,SMAD4|TGFBR1|BMP4|RBPMS|NUP93|TGFB1|TGFB3|DAB2
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS%GOBP%GO:2000106,0.0130474098953624,0.151381528985436,-0.32936969376452,-1.7062386493286898,100,46,CXCL12|JAK3|CD274|LILRB1|LYN|FNIP1|ADAM8|RIPK3|CCL19|MERTK|HCLS1|CDKN2A|GAS6|PRELID1|MEF2C|PIK3CB|TNFRSF4|IRF7|AXL|LGALS3|LGALS9|FADD|FOXP1|BCL6|ANXA1
POSITIVE REGULATION OF SOMATOSTATIN SECRETION%GOBP%GO:0090274,0.27825740470182003,0.653204101106396,0.8633105425672699,1.151108119556,2094,1,ADCYAP1
"MEIOTIC SISTER CHROMATID COHESION, CENTROMERIC%GOBP%GO:0051754",0.7319131832797429,0.9074802896081321,0.481555004135649,0.8090745830312571,5462,2,BUB1|BUB1B
DETECTION OF VIRUS%GOBP%GO:0009597,0.17694019107446696,0.548551967663807,-0.59221523264038,-1.29648293947546,1351,4,SERINC3|IFIH1|SERINC5
POSITIVE REGULATION OF VIRAL TRANSLATION%GOBP%GO:1904973,0.545819397993311,0.817297924969912,-0.7299845610939569,-0.972514715006973,4079,1,DHX9
POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION%GOBP%GO:0048087,0.157994837657927,0.527990543848753,0.6021618044449351,1.32297512901501,1162,4,HPS4|BLOC1S5|ZEB2|BLOC1S6
SNRNA TRANSPORT%GOBP%GO:0051030,0.0476190476190476,0.312365127431324,-0.7679497077313331,-1.49961114314599,359,3,NCBP2|PHAX|RAN
REGULATION OF NEUROBLAST PROLIFERATION%GOBP%GO:1902692,0.930374592833876,0.9793746057014829,0.183488451957856,0.603789676213327,6854,11,DRD2|NF1|FZD3|DISC1|CTNNB1|ZNF335|SIX3|VEGFA
MITRAL VALVE DEVELOPMENT%GOBP%GO:0003174,0.76032949790795,0.91797162753179,-0.241948630154233,-0.757993474191359,5814,10,SMAD6|EFNA1|NOTCH1|DCHS1
"CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS, POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS%GOBP%GO:0050653",0.611966038737066,0.852045339927398,-0.555095954991396,-0.923768435622927,4612,2,CSGALNACT1
REGULATION OF KERATINOCYTE MIGRATION%GOBP%GO:0051547,0.138721509038512,0.504314492208813,-0.417379461563135,-1.3512884626606798,1058,11,PTEN|IQSEC1|ADAM9|MAPRE2|FGF10|FGF7|MMP9|ARF6
"TRANS-SYNAPTIC SIGNALING BY SOLUBLE GAS, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099554",0.680802675585284,0.884781692722898,-0.663707543008381,-0.88421781286645,5088,1,GUCY1B3
REGULATION OF T CELL ANERGY%GOBP%GO:0002667,0.6896321070234109,0.887051934478962,-0.658965593295104,-0.877900397239091,5154,1,FOXP3
REGULATION OF BLOOD VOLUME BY RENIN-ANGIOTENSIN%GOBP%GO:0002016,0.597420048374093,0.8449219534562551,0.450728296391621,0.8865293695639279,4445,3,AGTR1|ACE
REGULATION OF CHROMOSOME SEPARATION%GOBP%GO:1905818,0.0422863054442002,0.294833299013666,-0.28146384570358196,-1.50928066053891,326,52,TACC3|TRIP13|DUSP1|KLHL22|APC|DLGAP5|CDC20|CDT1|LCMT1|ANAPC5|ESPL1|CDC6|CDC23|PTTG1|CDK5RAP2|MAD2L1|NDC80|CDC27|USP44|CCNB1|PLK1|IK|NEK6|ANAPC11|XRCC3
REGULATION OF DOPAMINE BIOSYNTHETIC PROCESS%GOBP%GO:1903179,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
MESODERM MORPHOGENESIS%GOBP%GO:0048332,0.465070643642072,0.7786333182377991,-0.26687479185727997,-0.9918100624184059,3554,16,ITGA8|SNAI1|ITGB4
ESTABLISHMENT OF MITOTIC SPINDLE ORIENTATION%GOBP%GO:0000132,0.736920777279522,0.9082492366247049,0.20538906956409198,0.7897821644456591,5422,17,DCTN1|NDEL1|HTT|GPSM2|DYNLT1|ZW10
INTERLEUKIN-1-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070498,0.0423717865908797,0.294833299013666,-0.29328279413723496,-1.5192971545761698,327,46,MAPK3|IL1RAP|IRAK1|SKP1|NFKBIA|UBC|RELA|IL1R1|NFKB1|RPS6KA4|TOLLIP|PELI3|SQSTM1
NEGATIVE REGULATION OF G PROTEIN-COUPLED RECEPTOR INTERNALIZATION%GOBP%GO:1904021,0.13478376227115899,0.496974190065009,-0.7739729804245931,-1.28801480701174,1015,2,UBQLN2|NECAB2
REGULATION OF MULTIVESICULAR BODY SIZE INVOLVED IN ENDOSOME TRANSPORT%GOBP%GO:0010797,0.147290969899666,0.514617247364633,-0.924735333039259,-1.23196950565616,1100,1,SNF8
HYPOTHALAMUS DEVELOPMENT%GOBP%GO:0021854,0.22473103997874902,0.6078034241178771,0.8889501543890609,1.1852950822943,1691,1,RAB3GAP1
NEGATIVE REGULATION OF HYDROGEN PEROXIDE-INDUCED CELL DEATH%GOBP%GO:1903206,0.6502992383025029,0.8720434729248241,0.250180618775035,0.850315262599709,4780,12,MET|PDE8A|NFE2L2|NR4A3|TRAP1
METANEPHRIC GLOMERULUS MORPHOGENESIS%GOBP%GO:0072275,0.0102149111170072,0.12936633073190199,-0.9344361731458509,-1.5550512196937099,76,2,PDGFRB|PDGFRA
CELLULAR CHLORIDE ION HOMEOSTASIS%GOBP%GO:0030644,0.0148758135210519,0.16398482408551,0.992280546978385,1.32307221814714,111,1,SLC12A5
LYSOSOMAL LUMEN ACIDIFICATION%GOBP%GO:0007042,0.33948690104520196,0.7013775658944089,0.42392035435875103,1.09691883293273,2500,6,CCDC115|CLN5|TMEM199
MYOBLAST FATE DETERMINATION%GOBP%GO:0007518,0.9464882943143811,0.9834855466269592,-0.5253639170710189,-0.699910884854327,7074,1,IFRD1
PHOSPHATE ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0035435,0.36905085667663895,0.72201432219986,0.336566289727199,1.06626475608639,2713,10,SLC25A30|XPR1|SLC37A3|SLC20A1|SLC20A2|SLC37A1|SLC25A14
EMBRYONIC OLFACTORY BULB INTERNEURON PRECURSOR MIGRATION%GOBP%GO:0021831,0.41883902176834203,0.75036705317022,0.529339709365713,1.0411487421269,3116,3,SLIT1|SLIT3
REGULATION OF PRESYNAPSE ORGANIZATION%GOBP%GO:0099174,0.669732215309711,0.8815356925073421,0.296595484369274,0.8187438735132121,4951,7,SLITRK1|PTPRD|VPS35|SNCA
PROSTAGLANDIN BIOSYNTHETIC PROCESS%GOBP%GO:0001516,0.0531135531135531,0.33407275089766497,-0.4129398854652371,-1.53464450774111,405,16,CD74|TBXAS1|PTGDS|CBR1|PTGES2|PTGS1|PTGES|PTGIS
CELLULAR RESPONSE TO DISACCHARIDE STIMULUS%GOBP%GO:0071324,0.28066889632107,0.653918409964198,-0.856583590648434,-1.1411750205931999,2097,1,CALCRL
ENDOSOME TO LYSOSOME TRANSPORT%GOBP%GO:0008333,0.314014317180617,0.683550177109913,0.207470270193725,1.1014451802412801,2280,48,CHMP3|BIN1|KIF13A|CACNG7|CLEC16A|VPS33B|SNX16|CACNG4|AKTIP|VPS11|VPS41|ATG14|SORT1|TRAK1|UBXN6|VPS33A|M6PR|TGFBRAP1|VPS16|VIPAS39|SCYL2|VPS39
NEUROTRANSMITTER BIOSYNTHETIC PROCESS%GOBP%GO:0042136,0.46495815899581605,0.7786333182377991,-0.255255532103369,-0.990486396636745,3555,18,ACHE|MOXD1|CYP1B1|DAGLB|DAGLA|NOS3|SHMT2
REGULATION OF INTERLEUKIN-1 SECRETION%GOBP%GO:0050704,0.10473326359832599,0.44525070692259705,-0.324563112366089,-1.37938407747841,800,24,PYCARD|GSDMD|CCL19|GAS6|CASP1|TNFAIP3|CARD16|NLRP3|LGALS9|FOXP1|TLR4
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:0061136,0.0404749744637385,0.28837731910627695,-0.20841925066265699,-1.4144296814479098,316,134,OGT|CBFA2T3|PSMF1|BAG5|GPX1|VCP|RNF144B|UBE2G2|FMR1|CEBPA|UBQLN1|SUMO2|PSME2|PARK7|UBXN1|ALAD|HERPUD1|RAD23B|NKD2|RCHY1|HFE|PSMD10|APOE|PLK1|GIPC1|ECSCR|ARAF|TLK2|BCAP31|CAV1|DERL3|PRKACA|DAB2|TAF9|CSNK1A1|AK6|FAM122A
MRNA MODIFICATION%GOBP%GO:0016556,0.0678542289910253,0.3717128095954961,0.380774095170674,1.49051228052654,498,18,PUS7|TRMT6|ZC3H13|METTL14|TRMT61B|CMTR1|PUS1|CMTR2|TRUB1
TRANSFORMING GROWTH FACTOR BETA RECEPTOR COMPLEX ASSEMBLY%GOBP%GO:0007181,0.47267179623242206,0.7831522581932591,-0.609863753721455,-1.01491081073925,3562,2,FMOD
CARDIAC SEPTUM MORPHOGENESIS%GOBP%GO:0060411,0.619423251002198,0.854944793214197,-0.17873705478941299,-0.8897934589545341,4789,40,JAG1|TBX1|ZFPM2|SMAD6|TBX2|HES1|NOTCH1|NOTCH2|GATA6|NRP2|TGFBR2|TGFBR3|SLIT2|ENG
GDP-L-FUCOSE SALVAGE%GOBP%GO:0042352,0.23695045822818397,0.6217158626397761,0.8831054256726949,1.17750192519697,1783,1,FUK
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN DORSAL/VENTRAL AXIS SPECIFICATION%GOBP%GO:2000054,0.0298844468056847,0.244735657013286,0.9855535950595501,1.31410273545021,224,1,SFRP1
MITOCHONDRIAL ASPARAGINYL-TRNA AMINOACYLATION%GOBP%GO:0070145,0.31677513614025804,0.6861326333203311,0.8420820467578299,1.1228027848156898,2384,1,DARS2
MEVALONATE TRANSPORT%GOBP%GO:0015728,0.681471571906355,0.885234191100568,-0.6633215703573,-0.883703604617712,5093,1,SLC16A1
POSTTRANSCRIPTIONAL TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY%GOBP%GO:0000973,0.683597883597884,0.885415243771438,-0.423502314661754,-0.8269926843139971,5167,3,NUP98
PURINE NUCLEOBASE METABOLIC PROCESS%GOBP%GO:0006144,0.260261437908497,0.636284274166314,-0.353168039710335,-1.18208649659937,1990,12,ADA|HPRT1|PRPS1|GMPS|MTHFD1
BRANCHED-CHAIN AMINO ACID METABOLIC PROCESS%GOBP%GO:0009081,0.728121195725687,0.906017151800216,0.200004757415539,0.797395746702244,5382,19,BCKDHB|HIBCH|HMGCLL1|ACADSB|ACAT1|ACAD8|HMGCL|IVD|BCKDHA|BCAT1|AUH
REGULATION OF MONONUCLEAR CELL MIGRATION%GOBP%GO:0071675,0.00013089005235602098,0.00518555396908895,-0.572079691186845,-2.55497188418646,0,28,CXCL12|TNF|DUSP1|GREM1|LYN|PLCB1|SLAMF8|MOSPD2|CREB3|PLA2G7|CSF1|CCR1|NOV|LGALS3|THBS1|NBL1|AIF1|RARRES2|SLIT2|SERPINE1|CMKLR1|LGMN
DENDRITE DEVELOPMENT%GOBP%GO:0016358,0.412064453931965,0.746306769569813,0.196861498928417,1.0324464587381599,2991,46,SLC12A5|CTNNA2|TRAPPC4|BBS4|FARP1|EPHB2|MINK1|BMP7|MAP6|STRN|MAP2|DLG4
POSITIVE REGULATION OF T-HELPER 2 CELL DIFFERENTIATION%GOBP%GO:0045630,0.0950815360336665,0.42498053239300104,-0.5977204405676011,-1.43262184048246,722,5,RARA|IL18|CD86|NLRP3
THIOESTER BIOSYNTHETIC PROCESS%GOBP%GO:0035384,0.43506069703694,0.762034923704788,-0.22478054815152101,-1.01634979019015,3332,29,PPT1|SCD5|ACSL5|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|HACD2|PDHX|FASN
GLYCINE BIOSYNTHETIC PROCESS%GOBP%GO:0006545,0.588617670469621,0.8414799095069009,-0.5632550079202541,-0.9373464044272091,4436,2,SHMT2
POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002606,0.9633087848500791,0.990916952887267,-0.23231223237194298,-0.556808091741413,7324,5,CCL19|SLC11A1
MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:0010657,0.079983922829582,0.39647223764762296,0.827681279294183,1.39061141546996,596,2,GNGT1|DMPK
RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:0000056,0.947468440342066,0.9840421757603729,0.22518622509413802,0.5826825928102329,6979,6,NUP88|XPO1|LTV1
CELLULAR RESPONSE TO UNFOLDED PROTEIN%GOBP%GO:0034620,0.10882956878850099,0.45309795582492896,-0.19817705867015198,-1.2801234624895002,847,107,TSPYL2|HDGF|HSP90B1|MYDGF|HSPA13|DAB2IP|RNF121|TMBIM6|TLN1|VCP|CREB3|BAG3|ATP6V0D1|HSPA6|HSPA9|TPP1|MBTPS2|CREB3L1|WIPI1|CALR|HERPUD1|LMNA|CCL2|PDIA5|SRPRB|SYVN1|SSR1|EIF2S1|KDELR3|DERL3|HSPA5|GOSR2|DNAJB11|SERP1|YIF1A|ERN1
OLIGOSACCHARIDE CATABOLIC PROCESS%GOBP%GO:0009313,0.5510928961748629,0.8220725503109271,0.31464761599100394,0.913366982863083,4033,8,MANBA|MAN2B2|MAN2C1|ATHL1
COPULATION%GOBP%GO:0007620,0.396789599363226,0.7377402989373809,-0.641191066997519,-1.0670444696446701,2990,2,KLK14|TAC1
FOLIC ACID-CONTAINING COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:0009396,0.383280757097792,0.730480369014206,-0.387913211069007,-1.06034346371442,2915,7,DHFR|MTHFD1
HEME A METABOLIC PROCESS%GOBP%GO:0046160,0.09244372990353698,0.420939346122012,0.8164323132065071,1.3717117000298602,689,2,COX10|COX15
TRANS-SYNAPTIC SIGNALING BY LIPID%GOBP%GO:0099541,0.0615547890687185,0.35631208031004796,-0.8394265232974909,-1.39693996916071,463,2,DAGLB|DAGLA
REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY%GOBP%GO:0098962,0.0749901845308206,0.383578507779904,-0.6660854059456629,-1.4582001904813102,572,4,NPTX2|NPTXR
GLUTATHIONE BIOSYNTHETIC PROCESS%GOBP%GO:0006750,0.926031487513572,0.9788732664014979,0.185203574975174,0.609433484094655,6822,11,GSS|GCLM|MGST2|GCLC|CNDP2|HAGH|GGCT|OPLAH|CHAC1|CHAC2|GGT1
NEGATIVE REGULATION OF NON-MOTILE CILIUM ASSEMBLY%GOBP%GO:1902856,0.45185283570195295,0.769943206592495,0.775474194971328,1.0339902020460898,3401,1,MAP4
RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION%GOBP%GO:0071826,0.0190537084398977,0.190548590261561,-0.196116910006178,-1.4444214116177498,148,204,KLC1|PRPF8|DDX28|SNRPD3|SETX|RPLP0|SMN2|SF3A3|SART3|MRPL20|BRIX1|GEMIN5|PTGES3|SRSF12|GEMIN7|MAPT|RPS23|CPSF6|RPL3|AAR2|SF3A2|DHX30|GFM2|BICD1|SNRPE|MPV17L2|PSIP1|CELF2|LSM14A|DENR|EIF2S3|GEMIN8|DHX9|DYNC1H1|TXNL4A|SRPK3|PPAN|SF3A1|MRPS11|SRSF10|DYRK3|SBDS|SLU7|DDX23|DHX8|ABT1|RUVBL1|SRSF9|LUC7L3|NPM1|MRRF|GEMIN2|CELF1|ATXN2L|VCP|DDX3X|CD2BP2|SRSF5|ZRSR2|SNRPF|SRSF1|RPS14|NCBP1|SNRPD1|PATL1|RPL10|CLP1|RPL24|SF1|PELO|CELF4|RBM22|LSM3|MRPS7|MCTS1|SNRPB|EIF2S1|MRPL22|MRPS2|TAF9|BOP1|ISY1|HSP90AA1|CPSF7|PRMT5|G3BP1|AK6|MRPL11|EIF2D|SART1|SMN1|PRPF19
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS%GOBP%GO:1904035,0.101383680331049,0.439532756534685,-0.274458582656932,-1.36631686076398,783,40,ZFP36L1|KDR|SFRP4|GATA3|GAS6|TNFAIP3|ICAM1|CAST|CCL2|GPER1|GSN|ECSCR|THBS1|TEK|SEMA5A|IL11|SERPINE1
ACTIN CROSSLINK FORMATION%GOBP%GO:0051764,0.089849377865095,0.41413736343552393,-0.567457141889928,-1.45965263401054,685,6,FLNA|BAIAP2L1|EPS8
POSITIVE REGULATION OF CATABOLIC PROCESS%GOBP%GO:0009896,0.134772611139499,0.496974190065009,-0.151347846400645,-1.19120634923999,1054,300,CBFA2T3|LARP1|PHKG2|PFKFB2|ATPIF1|PFKFB3|TOB1|PRR5L|INS|PNPLA2|VCP|RNF144B|TNFAIP3|FMR1|DHX36|DCN|CCDC22|BAG3|TNFSF12|SMURF2|IRS1|CEBPA|UBQLN1|SUMO2|PRKD1|PARK7|TRIM32|CAMKK2|MSN|PIK3CB|RILP|HERPUD1|ABHD5|UQCC2|IGF1|NKD2|DTL|TNRC6C|RNF152|RCHY1|C10orf54|PSMD10|APOE|PLK1|TMEM59|ECSCR|TIPARP|CTSC|SNF8|NSF|TICAM1|BCAP31|CAV1|LDLR|STX5|DDB1|PPARA|POLR2G|DACT1|ABCD1|DAB2|HSP90AA1|CSNK1A1|TRIM65|MAGEF1|CD81|MID2|TNFRSF1B|FAM122A|BAD
MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:0098915,0.28015873015872994,0.653204101106396,-0.599075261011413,-1.16984214975456,2117,3,KCNQ1|KCNH2
REGULATION OF CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:1904714,0.0350284014065459,0.26702449097803305,0.594998362443625,1.64247700883601,258,7,SNRNP70|CTSA|PLK3|SNCA|EEF1A1|ATP13A2|EEF1A2
REGULATION OF SYNAPTIC VESICLE CLUSTERING%GOBP%GO:2000807,0.910239183015318,0.9720943283119721,0.32386676960405897,0.637007717017896,6773,3,BRSK1|BRSK2
POSITIVE REGULATION OF GLUCOSE MEDIATED SIGNALING PATHWAY%GOBP%GO:1902661,0.6636656812684761,0.8801927882988101,0.4259498604003061,0.837793110016835,4938,3,PIH1D1|SMARCB1
PROTEIN MATURATION%GOBP%GO:0051604,0.000128567755206994,0.00518555396908895,-0.284269037989336,-1.98065483124718,0,154,NAA10|KLK1|CHCHD4|HM13|CTSS|CPE|AEBP1|NGF|PMPCA|OGT|PLAU|CPZ|GGT1|CASP1|PCSK1|METAP2|CPM|TESC|ATP6AP2|NAA50|F3|PERP|MMP14|CALR|SRGN|GLRX5|IFI16|SEC11C|C10orf54|CTSZ|CTSH|CYFIP2|CCS|AIP|CIDEB|PCSK6|KAT2B|ASPH|IMMP1L|FXN|FADD|FKBP1A|NDUFAB1|TSPAN15|C1RL|STOML2|PLAT|LMF1|CPXM2|BACE2|ATOX1|DNAJB11|ORAOV1|LGMN|TSPAN33|PGK1|MAGEF1|ASRGL1|ISCA2|C1R|UQCRC2|BAD
REGULATION OF HISTONE DEACETYLASE ACTIVITY%GOBP%GO:1901725,0.954813359528487,0.9870180073166591,-0.225073138475037,-0.57894874373408,7289,6,C6orf89|PRKD1
POSITIVE REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS%GOBP%GO:0010729,0.9543140407288321,0.9870180073166591,0.34432219206615905,0.578505739908919,7122,2,ZNF205|DUOXA1
SIGNAL TRANSDUCTION INVOLVED IN MITOTIC CELL CYCLE CHECKPOINT%GOBP%GO:0072413,0.9923644363918729,0.997305769352475,-0.0952026996766654,-0.5213158066875929,7667,56,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|TRIAP1|TFDP2|PLK2|PCNA|CDC25C|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A
HISTONE H4-K8 ACETYLATION%GOBP%GO:0043982,0.0255972696245734,0.22470485454905398,-0.455957869175414,-1.6555091127631298,194,15,KANSL1|KANSL2|JADE3|HCFC1|OGT|PHF20|WDR5|KAT7|KAT8
POSITIVE REGULATION OF CHOLESTEROL STORAGE%GOBP%GO:0010886,0.314965807469753,0.68444413298866,-0.471929822232345,-1.13112573139215,2394,5,SREBF2|MSR1|EHD1
NEGATIVE REGULATION OF LIPID STORAGE%GOBP%GO:0010888,0.0901478477037812,0.414794277220364,-0.37648192230050703,-1.43072324020125,688,17,PNPLA2|ABCG1|ABHD5|NR1H3|NFKBIA|PPARG|PPARA
PRE-MRNA CATABOLIC PROCESS%GOBP%GO:1990261,0.7997077965201221,0.931670998922663,0.599966916629907,0.799974928076188,6020,1,ZPR1
POSITIVE REGULATION OF DOPAMINE BIOSYNTHETIC PROCESS%GOBP%GO:1903181,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
UDP CATABOLIC PROCESS%GOBP%GO:0006256,0.481471642980476,0.7857362908355991,0.7596493162770179,1.0128898616033102,3624,1,ENTPD4
CHEMOKINE (C-C MOTIF) LIGAND 2 SECRETION%GOBP%GO:0035926,0.30419209339347303,0.676707700393746,-0.682581244112189,-1.13592434315044,2292,2,FOXP1
NEGATIVE REGULATION OF LIPID LOCALIZATION%GOBP%GO:1905953,0.0758089770354906,0.38531099082072706,-0.330952106369005,-1.44367352595133,580,26,SREBF2|APOC1|PNPLA2|ABCG1|PLA2R1|ABHD5|NR1H3|NFKBIA|THBS1|PPARG|PPARA|NFKB1
LYMPHOID PROGENITOR CELL DIFFERENTIATION%GOBP%GO:0002320,0.8001570475068709,0.9318153767588689,-0.33430761594882297,-0.7318692541594191,6113,4,LIG4|SOX4|BMP4|BATF
CELLULAR RESPONSE TO MYCOPHENOLIC ACID%GOBP%GO:0071506,0.0562483417352083,0.34424567164700104,-0.845359028176015,-1.40681260595743,423,2,PDGFB
MONOCARBOXYLIC ACID CATABOLIC PROCESS%GOBP%GO:0072329,0.0501676914477362,0.32127886236115993,0.23018988735730397,1.4132059585617802,358,83,ALDH3A2|LPIN1|BDH2|PPARD|HADHB|SLC25A17|ACBD5|SORD|HADHA|NUDT7|PEX2|HIBCH|PEX13|ACADVL|HOGA1|ACADM|ACAT1|GCDH|ECHDC1|MCAT|ACOT7|ACOX2|ACAA2|ACAD11|ECI1|ACADS|IDUA|ECHS1|MECR|ACOX3|AKR1A1|EHHADH|ACOT8|ABCD3|PHYH|IVD|MCEE|HACL1
REGULATION OF MAST CELL APOPTOTIC PROCESS%GOBP%GO:0033025,0.12458493823881,0.47882366260685294,0.9390714600794001,1.25212508042143,937,1,ADAM17
POSITIVE REGULATION OF ACROSOMAL VESICLE EXOCYTOSIS%GOBP%GO:2000368,0.10015919342000501,0.43605057892447596,-0.802040253653157,-1.33472323795852,754,2,HYAL3|ZP3
N-TERMINAL PEPTIDYL-SERINE TRIMETHYLATION%GOBP%GO:0035573,0.00989966555183947,0.126895016411775,-0.994816938685487,-1.32533503196282,73,1,NTMT1
NEGATIVE REGULATION OF ERAD PATHWAY%GOBP%GO:1904293,0.5772549019607839,0.837152999580265,-0.268057991951281,-0.8972151977598091,4415,12,USP25|UBE2G2|UBXN1|DERL3
TEAR SECRETION%GOBP%GO:0070075,0.253244147157191,0.632257972333528,-0.870533745037495,-1.15975997586903,1892,1,FGF10
NEGATIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS%GOBP%GO:0010677,0.891913856156034,0.965443067117994,0.16092039882449602,0.663338189832411,6584,21,PARK2|INPP5K|PASK|HDAC4|C1QTNF3|GCK
OSTEOBLAST PROLIFERATION%GOBP%GO:0033687,0.626741693461951,0.8590240079173431,0.5375727414338729,0.903191614435104,4677,2,LRRC17|FIGNL1
CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN%GOBP%GO:0071219,0.000128221566867547,0.00518555396908895,-0.36479396482459203,-2.24641881627415,0,88,CXCL1|CD274|TGFB1|CXCL2|LILRB1|SBNO2|LYN|ADAM9|MTDH|TLR1|PYCARD|IL18|HMGB2|DAB2IP|TLR2|PDCD1LG2|TICAM2|IL1RN|FCGR2B|PDE4B|CASP1|TNFAIP3|LILRB2|MEF2C|CTR9|CARD16|IRAK1|NR1H3|CCL2|CD86|NLRP3|AXL|HCK|CD36|NR1D1|PABPN1|TICAM1|SERPINE1|RELA|PLAA|NFKB1|TLR4|VIM|GSTP1|CD14|TNFRSF1B|SIRPA
POSITIVE REGULATION OF NON-MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:1903997,0.948376579269121,0.984457616015067,0.271843367490912,0.597251455544707,6980,4,DOCK3|SRC
REGULATION OF NUCLEASE ACTIVITY%GOBP%GO:0032069,0.19143907563025198,0.565967229895179,-0.311643187438027,-1.25030649896422,1457,20,AKT1|OAS3|GZMA|TERF2|HMGB2|OASL|OAS1|TMBIM6|NPM1|OAS2|PCNA
HISTIDINE TRANSPORT%GOBP%GO:0015817,0.9574976756541371,0.9883519699892901,0.521504190560212,0.695355470061997,7208,1,SLC15A4
N-GLYCAN FUCOSYLATION%GOBP%GO:0036071,0.8722273874352511,0.958587680888923,0.563078958976621,0.7507898139430229,6566,1,FUT8
CELLULAR RESPONSE TO MORPHINE%GOBP%GO:0071315,0.328294314381271,0.6950398637731511,-0.833976621085134,-1.11105710888137,2453,1,ADCY8
ISLET AMYLOID POLYPEPTIDE PROCESSING%GOBP%GO:0034231,0.19869836631690801,0.5760930750305171,0.9020732245258051,1.20279292558831,1495,1,PCSK2
REGULATION OF GTPASE ACTIVITY%GOBP%GO:0043087,0.423899371069182,0.754049139020057,0.135938491033744,1.01683941279594,3032,207,BVES|SFRP1|ZNF286A|ARHGAP12|ITGA6|TBC1D1|PLXNB1|XCL1|CPEB2|SGSM2|ALS2|FGD4|CRK|ARHGEF7|LRCH1|MAP4K4|TBC1D2|TBC1D14|STMN3|AGRN|VAV2|ARFGEF1|PKP4|NDEL1|RIC1|GNB5|RAB3GAP1|TBC1D17|TBC1D16|TBC1D9|TBC1D8|RANGAP1|ADCYAP1|MLLT4|GMIP|RAP1GDS1|SH3BP4|PROM2|TBC1D7|NF1|TBC1D20|FGD5|CXCL13|RALGAPB|SIPA1L1
NEGATIVE REGULATION OF FIBROBLAST MIGRATION%GOBP%GO:0010764,0.6800591238914271,0.8847768831854209,0.419996534734807,0.8260836209714492,5060,3,FGF2|ITGB1BP1
THIAMINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:0042723,0.19931946080355997,0.577166177580918,-0.581250474041004,-1.27247879085507,1522,4,THTPA|SLC25A19
POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1902884,0.320670683783076,0.688707974858192,-0.34342603429154406,-1.1118602630265702,2447,11,SEPN1|PARK7|SOD1|TLR4
CELLULAR RESPONSE TO IRON(III) ION%GOBP%GO:0071283,0.853765440297516,0.949296218452153,0.572011468901632,0.762700110638946,6427,1,IREB2
REGULATION OF ADAPTIVE IMMUNE RESPONSE%GOBP%GO:0002819,0.0145259938837921,0.161453009872134,-0.25900229693321997,-1.5930753765940202,113,87,PRKCQ|MALT1|ZC3H12A|HLA-F|CLCF1|SASH3|TRAF6|IL1B|FOXP3|CD1D|JAK3|HLA-B|PVR|CD274|NFKBIZ|TGFB1|LILRB1|HLA-E|NDFIP1|PYCARD|SAMSN1|B2M|IL18|RIPK3|CCL19|HLA-C|PAXIP1|WAS|HLA-A|FCGR2B|IL6ST|TRAF2|PVRL2|TNFAIP3|RC3H2|MEF2C|SLC11A1|RSAD2|IRF7|TNFSF13|CEACAM1|STX7|HFE|NLRP3|ZP3|FADD|IL1R1|BCL6|ANXA1|TFRC|TNFRSF1B
POSITIVE REGULATION OF CHROMOSOME SEGREGATION%GOBP%GO:0051984,0.0668058455114822,0.3690551432905871,-0.33713601265781895,-1.47064885447868,511,26,NIPBL|BECN1|RAD21|RCC2|RAD18|DLGAP5|CDT1|ANAPC5|ESPL1|CDC6|ANKRD32|HNRNPU|CCNB1|H2AFY|ANAPC11|FEN1
TELOMERE MAINTENANCE VIA TELOMERE TRIMMING%GOBP%GO:0090737,0.686928104575163,0.8861361847538001,-0.24391739685873,-0.816414365662482,5254,12,NBN|EXO1|SLX1B|SLX1A|XRCC3
NEGATIVE REGULATION OF NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0072183,0.991366715367247,0.997150662115148,0.504631671812969,0.672858242969697,7463,1,STAT1
SOMATIC MUSCLE DEVELOPMENT%GOBP%GO:0007525,0.697134518439905,0.891249402492146,-0.517769204639239,-0.8616507540407691,5254,2,PGK1
PRONEPHRIC FIELD SPECIFICATION%GOBP%GO:0039003,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
SLOW AXONAL TRANSPORT%GOBP%GO:1990832,0.981003344481605,0.993436724391485,-0.509539038376709,-0.6788283466560489,7332,1,HSPA8
EPITHELIAL FLUID TRANSPORT%GOBP%GO:0042045,0.9915594855305471,0.997235235231815,0.29021229666390996,0.48759412922174605,7400,2,SLC26A6|AQP1
ISOTYPE SWITCHING TO IGG ISOTYPES%GOBP%GO:0048291,0.344136007437907,0.702174649119653,0.82851786501985,1.10471677872188,2590,1,HSPD1
POSITIVE REGULATION OF STEROID HORMONE SECRETION%GOBP%GO:2000833,0.536559705418201,0.8132910857498922,-0.38618411618035,-0.9256096357722159,4079,5,GHRL|C1QTNF1
REGULATION OF MALE GONAD DEVELOPMENT%GOBP%GO:2000018,0.0834673097534834,0.402201069234289,0.823655913978495,1.3838482820036497,622,2,WNT4|CITED2
N-ACETYLGLUCOSAMINE CATABOLIC PROCESS%GOBP%GO:0006046,0.626444504165547,0.858842084733938,0.44032779956287504,0.866072819641158,4661,3,GNPDA2|AMDHD2
DEVELOPMENTAL CELL GROWTH%GOBP%GO:0048588,0.686365992742354,0.8861361847538001,-0.17170562171713502,-0.847924903379443,5295,39,NRP2|SLIT2|TMEM108|MAP1B|SEMA3A|HSP90AA1
POSITIVE REGULATION OF T-HELPER 17 CELL DIFFERENTIATION%GOBP%GO:2000321,0.635375628311371,0.863600910248377,0.389426200781601,0.855585947859595,4676,4,NFKBID|IL12RB1|MALT1|NFKBIZ
PROTEIN DEACETYLATION%GOBP%GO:0006476,0.659756413578647,0.8776790075729759,-0.17174139836039004,-0.8654253630228679,5091,42,HDAC5|MIER3|RBM14|BRMS1|HDAC8|SIRT4|MTA2|PHB
MONOSACCHARIDE METABOLIC PROCESS%GOBP%GO:0005996,0.114098276305634,0.463473523153693,-0.195832301992554,-1.27062978356547,886,109,DCXR|MAN2B1|FUT7|APOD|PGAM2|PER2|OAS1|TKT|GOT1|GAL3ST3|SLC2A1|GAA|GPI|SLC25A10|G6PC3|HK1|GALT|HK3|FUT9|ENO1|GHRL|LRP5|PGM5|ALDH1A1|PGAM1|ABHD10|SLC35A2|DHDH|GAPDH|FUCA1|SLC2A3|CYB5A|FUOM|PGK1|TALDO1|CRYL1|ALDOA|GALK1|ALDOC
NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS%GOBP%GO:0002903,0.48120497707924,0.7857362908355991,-0.37776073272405997,-0.971702368058982,3673,6,FOXP1|BCL6
REGULATION OF VOLTAGE-GATED CALCIUM CHANNEL ACTIVITY%GOBP%GO:1901385,0.104429093864283,0.444812304941063,0.336735767596498,1.38807569556735,770,21,CRHR1|C19orf26|DMD|DRD4|GNB5|CACNB4|SRI|CACNB2|STAC2|STAC|NOS1AP|CACNA2D1|CACNB3
POSTSYNAPTIC ENDOCYTOSIS%GOBP%GO:0140239,0.0708022510142652,0.3767214120425879,-0.670644266659826,-1.4681804895577197,540,4,SYNJ1|DNM1|DNM3
VESICLE-MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS%GOBP%GO:0098927,0.928207140054923,0.9793746057014829,-0.149794587320534,-0.62033836140376,7097,22,RAB7A|EEA1|RILP|SNF8|EMP2
NEGATIVE REGULATION OF GOLGI TO PLASMA MEMBRANE CFTR PROTEIN TRANSPORT%GOBP%GO:0043002,0.9954841280382521,0.9984987368688449,0.5025363917071021,0.6700644696706529,7494,1,GOPC
DETECTION OF LIPOPOLYSACCHARIDE%GOBP%GO:0032497,0.0247354497354497,0.220832228069425,-0.807260086301658,-1.57637434931934,186,3,TLR4|LY96
INTRACELLULAR TRANSPORT OF VIRAL PROTEIN IN HOST CELL%GOBP%GO:0019060,0.8814009020960469,0.9622426269432679,-0.4132468729201789,-0.687708879682717,6643,2,IFIT1
RESPONSE TO INACTIVITY%GOBP%GO:0014854,0.11999462510077902,0.47202636254014396,0.6918663094157951,1.36081938502476,892,3,SCN5A|HDAC4
"RNA PHOSPHODIESTER BOND HYDROLYSIS, EXONUCLEOLYTIC%GOBP%GO:0090503",0.6372549019607839,0.864763883265532,-0.254711036744388,-0.852541688985558,4874,12,PDE12|EXOSC3|EXOSC2
POSITIVE REGULATION OF TRANSFERASE ACTIVITY%GOBP%GO:0051347,0.0108211330362826,0.134645873234709,-0.166448029509361,-1.38022169757705,84,425,NEK4|TGFB2|NRG1|PTGES3|LCP2|PDCD10|AKT1|RAF1|MAPT|RIPK2|ROBO1|GDF15|PIK3R5|PAK2|TNF|NVL|UBE2L3|PTEN|MLST8|MAP4K2|DUSP7|RPS2|IQGAP1|PARM1|NEK2|ADRB2|DGKZ|TGFB1|GREM1|MUL1|TNFAIP8L3|CCND2|RFC2|RGCC|PRKAR2A|PAK4|CLSPN|ADAM9|CEMIP|PLCE1|CHI3L1|MAP3K3|DCUN1D1|FLT1|CDC20|CD74|IL18|ARHGEF5|ADAM8|MADD|RIPK3|CCL19|DTX3L|RFC3|LMO4|AGT|EZH2|CAMK1|NBN|ECT2|DAB2IP|PIK3R6|CD4|DUSP5|KLF4|TNFRSF10A|TNFRSF10B|RAPGEF1|FGR|ATG13|C8orf4|TPX2|NGF|TNFRSF11A|PDGFD|JTB|AZU1|EPHA8|GAS6|PKN1|INS|STRADA|MDFIC|DDR2|TRAF2|FPR1|TAOK2|SYAP1|DDX3X|MAGEC2|ADCY8|CXCR4|EFNA1|ZNF622|MST1R|PDGFC|MAPKAPK2|PRKAR1A|MLKL|HNRNPA2B1|UBE2S|IRS1|DCUN1D3|PRKD1|CKS2|PARK7|RFC5|PIK3CB|SLC11A1|FGF10|MAPK3|ARRDC3|GHRL|ABL1|SOD1|IRAK1|HRAS|IGF1|NTRK2|MAP3K13|RPTOR|GADD45B|SERINC5|GPRC5B|CSF1|DKC1|PIK3R4|STK3|MAP2K3|F2R|PSMD10|RAP1A|PLK1|SASH1|PPP2CA|MUC20|GADD45G|TGFBR2|BMP2|CD200|THBS1|TEK|MAP3K11|ZFP91|ADRA2C|DLG3|PEA15|UBC|PDGFRB|EPHA4|NEDD9|PABPN1|MYC|ANG|CCND3|PRKACA|TLR4|ZNF16|PDGFA|HSP90AA1|CSF1R|PDGFRA|MARK2|GNG3|AMBRA1|RFC4|MAPKAP1|CCND1|DBNL|CD81|PDGFB|C5AR1|ERN1|CARD10|BAD|EMP2|PRNP
NEGATIVE REGULATION OF GENE SILENCING BY MIRNA%GOBP%GO:0060965,0.9809796769150602,0.993436724391485,-0.170189038719056,-0.511970286053799,7529,9,TGFB1|DND1|PPARG
POSITIVE REGULATION OF STRESS FIBER ASSEMBLY%GOBP%GO:0051496,0.39122533748702004,0.7369216590772479,-0.2137041062345,-1.04585872468161,3013,38,CD47|S100A10|CTGF|PXN|ABL1|RAPGEF3|ARHGEF15|EVL|NF2|SERPINF2
INTERLEUKIN-12 SECRETION%GOBP%GO:0072610,0.9714778455823829,0.9915747942934481,-0.331348221670802,-0.5514164274247328,7322,2,CCR7|CCL19
REGULATION OF TOLL-LIKE RECEPTOR 7 SIGNALING PATHWAY%GOBP%GO:0034155,0.24066889632107,0.6244696312630601,-0.876874724305249,-1.1682076828125902,1798,1,RSAD2
ALPHA-AMINO ACID METABOLIC PROCESS%GOBP%GO:1901605,0.6648302370275461,0.8804055751124069,-0.131610451224602,-0.8992274170932808,5188,139,P4HA3|SARS|PYCRL|GOT1|ODC1|GLYATL1|PHGDH|GGT1|P4HA1|KYNU|ADI1|ART4|MCCC2|HAAO|DPEP1|SDSL|THNSL2|SLC6A8|CKB|FTCD|SERINC5|SMS|NOS3|IL4I1|GGT5|ALDH4A1|AFMID|SIRT4|NMNAT3|BCAT2|SHMT2|HNMT|ASRGL1|APIP|MTHFD1|P4HB
LIPID A METABOLIC PROCESS%GOBP%GO:0046493,0.10969899665551801,0.454522162524904,-0.9426003528892809,-1.25577000174063,819,1,NDUFAB1
NEGATIVE REGULATION OF PLATELET ACTIVATION%GOBP%GO:0010544,0.000130718954248366,0.00518555396908895,-0.7687476099594,-2.57307022960338,0,12,CEACAM1|THBD|APOE|NOS3|SERPINE2|PDGFA|PDGFRA|PDGFB|C1QTNF1
GLOMERULAR FILTRATION%GOBP%GO:0003094,0.14957042436865398,0.51590227091171,-0.464880040064163,-1.33832457052957,1148,8,CD34|JCHAIN|SULF1|MYO1E|IGHA1
UBIQUITIN-DEPENDENT GLYCOPROTEIN ERAD PATHWAY%GOBP%GO:0097466,0.64243988588507,0.868171925756234,0.387415209838416,0.851167715114063,4728,4,MAN1B1|EDEM2|EDEM3|EDEM1
NEGATIVE REGULATION OF PRIMARY AMINE OXIDASE ACTIVITY%GOBP%GO:1902283,0.734677633324489,0.9079405785880958,-0.49950002226523993,-0.831247913108518,5537,2,AOC3
"DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR%GOBP%GO:0030330",0.9396051103368179,0.98101123643223,-0.11407788096269197,-0.6686978841622281,7280,73,PCBP4|GTSE1|CNOT4|ATRX|BTG2|CNOT10|CNOT6L|SFN|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|PML|RGCC|SP100|TRIAP1|TFDP2|BATF|NBN|PAXIP1|PLK2|PCNA|CDC25C|FOXM1|BRCA1|E2F1|BCL3|CCNB1|PLAGL1|TNKS1BP1|KAT5|ZNF385A
INTERKINETIC NUCLEAR MIGRATION%GOBP%GO:0022027,0.288363343187315,0.661438410876056,0.5949803187485949,1.1702560746815,2145,3,PCM1|DOCK7|HOOK3
MITOCHONDRIAL DOUBLE-STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION%GOBP%GO:0097552,0.249701155531943,0.630296201866725,0.877150419056021,1.16956172739969,1879,1,MRE11A
POSITIVE REGULATION OF GROWTH HORMONE SECRETION%GOBP%GO:0060124,0.34654662725073904,0.7036831003647691,0.565285923134214,1.11185070267724,2578,3,DRD2|ADCYAP1
TERPENOID METABOLIC PROCESS%GOBP%GO:0006721,0.480753480753481,0.7857006060206241,0.19149168636884,0.986398757515778,3521,43,STRA6|ALDH3A2|GPC6|RETSAT|SDC1|ALDH8A1|CYP2E1|AGRN|CYP4V2|ALDH1A3
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY%GOBP%GO:0045747,0.376660588694973,0.7274490973034922,-0.23001328945840602,-1.06003306420916,2891,31,TGFB2|PDCD10|ROBO1|CREBBP|NOTCH4|C3orf17|JAG1|MESP1|NOTCH1|STAT3|SNW1|JAG2|KAT2B|NOV|MAML1|NOTCH2NL
REGULATION OF PEPTIDYL-LYSINE ACETYLATION%GOBP%GO:2000756,0.198497019953356,0.575811726650469,-0.241015432617908,-1.21450547310539,1531,42,BRCA1|ARRB1|MAPK3|TAF7|RAPGEF3|KLF15|HDAC5|WBP2|KAT7|SPI1|RPS6KA4
NEUROTROPHIN PRODUCTION%GOBP%GO:0032898,0.3829928362960999,0.730480369014206,-0.647422111938241,-1.07741392484503,2886,2,FURIN|PCSK6
NLRP1 INFLAMMASOME COMPLEX ASSEMBLY%GOBP%GO:1904784,0.494222340284234,0.792795057869741,0.753418614909572,1.00458206205616,3720,1,NLRP1
RENIN-ANGIOTENSIN REGULATION OF ALDOSTERONE PRODUCTION%GOBP%GO:0002018,0.59887459807074,0.845842758849687,0.549054893669508,0.922483112711656,4469,2,AGTR1
REGULATION OF LIPOPROTEIN LIPASE ACTIVITY%GOBP%GO:0051004,0.09607843137254901,0.427566585262796,-0.42890700854325897,-1.43559191684406,734,12,FURIN|APOC2|PCSK5|APOC1|ANGPTL4|NR1H3|PCSK6|LMF1
TRIGLYCERIDE BIOSYNTHETIC PROCESS%GOBP%GO:0019432,0.401737242128122,0.740287621109606,0.31517889997673704,1.03713211341461,2959,11,GPAT2|LPIN1
MUSCLE ADAPTATION%GOBP%GO:0043500,0.683921568627451,0.885415243771438,-0.24450112774492602,-0.818368167594237,5231,12,HMOX1|GSN|NOS3
REGULATION OF DOUBLE-STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING%GOBP%GO:2001032,0.9476475387544191,0.9840421757603729,0.14890446492632,0.5828756115839019,6968,18,RIF1|ACTR2|WRAP53|MAD2L2|FAM35A|C20orf196|NUDT16L1|C5orf45|TFIP11|SMCHD1|C7orf49|HSF1|SETMAR|DTX3L|PARP9|WAS|USP51|AUNIP
RESPONSE TO LITHIUM ION%GOBP%GO:0010226,0.951634512325831,0.9858647066977451,0.34728425696167603,0.5834823913810671,7102,2,ADCY7|CDKN1B
INOSITOL PHOSPHORYLATION%GOBP%GO:0052746,0.190501459273017,0.56448285328689,-0.7397849462365591,-1.23112045104513,1435,2,IPPK|ITPK1
"REGULATION OF WNT SIGNALING PATHWAY, CALCIUM MODULATING PATHWAY%GOBP%GO:0008591",0.004648691725328729,0.0752560935123842,0.9979047198941329,1.33057129384458,34,1,DKK1
REGULATION OF TERMINATION OF RNA POLYMERASE II TRANSCRIPTION%GOBP%GO:1904594,0.7298996655518399,0.906544799850309,-0.639225849139832,-0.85160231823218,5455,1,SETX
GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT%GOBP%GO:0043001,0.661954601060215,0.8794023863435121,0.185299185952959,0.857878985942159,4869,30,KIF13A|RAB10|SYS1-DBNDD2|GCC2|GGA1|GOLPH3L|SPTBN1|BBS2|BLZF1|GOLGA7
POSITIVE REGULATION OF INTERLEUKIN-17 SECRETION%GOBP%GO:1905078,0.253913043478261,0.633195891137401,-0.8695963828848701,-1.1585111844078102,1897,1,OSM
CARDIAC ATRIUM FORMATION%GOBP%GO:0003210,0.343010033444816,0.701955655133333,-0.825485222761359,-1.09974452740912,2563,1,MESP1
SNORNA 3'-END PROCESSING%GOBP%GO:0031126,0.366535947712418,0.7210978652964309,-0.32134930094317304,-1.07558619870624,2803,12,DKC1|EXOSC3|EXOSC2
EPITHELIAL TUBE FORMATION%GOBP%GO:0072175,0.191600329398847,0.565967229895179,0.245562975608108,1.2268945570173702,1395,39,FGFR2|BBS4|TSC2|PAX8|BMP7|SEMA4C|CEP290|DVL2|MTHFR|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10|PROX1
MODULATION BY VIRUS OF HOST GENE EXPRESSION%GOBP%GO:0039656,0.682674449456089,0.885415243771438,-0.5238815363704099,-0.871822651476771,5145,2,PABPN1
REGULATION OF FEEDING BEHAVIOR%GOBP%GO:0060259,0.386431886431886,0.733589579210772,0.34594558372728695,1.05129672238876,2830,9,CFAP20|LEPR|NR4A3|UCN
DICARBOXYLIC ACID METABOLIC PROCESS%GOBP%GO:0043648,0.851253252979044,0.949296218452153,0.129324756963208,0.759452815412057,6214,69,MDH1B|IDH1|AADAT|GLS|ADHFE1|D2HGDH|GLUD1|MTHFR|HOGA1|SHMT1|NMNAT2|PM20D2|GCLM|NAGS|NIT2|MTHFD1L|MDH1|DHFRL1|GLS2|ACOT8|SLC25A32|MTHFD2L|PHYH|SLC46A1
POSITIVE REGULATION OF ACTIN FILAMENT-BASED MOVEMENT%GOBP%GO:1903116,0.05536146197258799,0.34165878259009896,0.7586058930435391,1.4920882702315101,411,3,TRPM4|RNF207|NOS1AP
RESPONSE TO IMMUNE RESPONSE OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052564,0.8474396391615809,0.9492491301138911,-0.432917355800498,-0.720443708742283,6387,2,SLC25A6
LIPID TRANSPORT%GOBP%GO:0006869,0.0711099783356697,0.3767214120425879,-0.195899444714308,-1.3355053002053898,557,137,FABP3|PRELID1|ABCG1|GLTP|INHBA|SLCO2B1|ATP8B1|CETP|SLC51A|APOM|GHRL|RFT1|SLCO2A1|ABCA8|CEACAM1|LCN12|LCN1|APOE|FABP4|ABCA6|CD36|ATP8B4|SLC27A4|CAV1|LDLR|PPARG|PPARA|OSBP|RPS6KB1|ABCD1|PCTP|ANXA1|ATP8A2|NPC2|OSBPL5|ABCC1
MITOTIC CHROMOSOME CONDENSATION%GOBP%GO:0007076,0.41531200839014204,0.7493091022753771,-0.29159803861290007,-1.0316312191483499,3167,14,NCAPD2|AKAP8L|NIPBL|PAPD7|NCAPG|NCAPD3|NCAPH|NUSAP1|SMC2|SMC4|CDCA5
TRYPTOPHANYL-TRNA AMINOACYLATION%GOBP%GO:0006436,0.8978508888299291,0.9674268340009909,-0.40268621513914205,-0.670134256358917,6767,2,WARS
POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT%GOBP%GO:1904747,0.0115079365079365,0.139771630097924,-0.8424506451968679,-1.6450925918311998,86,3,NOTCH1|TNFRSF1A|TNFRSF1B
POSITIVE REGULATION OF HISTONE H3-K9 METHYLATION%GOBP%GO:0051574,0.468505001351717,0.780769690730001,0.40519523494374604,0.97449221644316,3465,5,RIF1|SIRT1|ZNF304|MYB|JARID2
POSITIVE REGULATION OF T CELL CHEMOTAXIS%GOBP%GO:0010820,0.15121022572749498,0.518359045388749,0.419812765145322,1.32999521726449,1111,10,XCL1|ADAM17|CXCL13|OXSR1|ADAM10|CCL21|CCL5|WNK1
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN MESENCHYMAL STEM CELL DIFFERENTIATION%GOBP%GO:0044338,0.193552666489785,0.567519363754568,-0.7375109786715,-1.2273362053821202,1458,2,WNT3
CELL KILLING%GOBP%GO:0001906,0.00195363375879135,0.0387011108604588,-0.43431277494598297,-2.0015621824948,14,31,CEBPG|CORO1A|GZMB|APOL1|STXBP2|AZU1|ROMO1|HMGN2|VAMP7|CTSH|HFE|GAPDH|TUBB4B|HIST1H2BK|LYST|HIST1H2BJ|EMP2
REPLICATION FORK PROTECTION%GOBP%GO:0048478,0.384016393442623,0.7312516375535559,0.36387942987299204,1.05627832565093,2810,8,ZRANB3|SMARCAL1|FBXO18|TIPIN|ZNF830
KIDNEY MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0072135,0.991366715367247,0.997150662115148,0.504631671812969,0.672858242969697,7463,1,STAT1
REGULATION OF PROTEIN LINEAR POLYUBIQUITINATION%GOBP%GO:1902528,0.742229367631297,0.909955740610127,0.476966727091495,0.801365685180648,5539,2,PARK2
PROTEIN LOCALIZATION TO NUCLEAR PORE%GOBP%GO:0090204,0.8705007305087,0.9574934752519241,0.5640163211292459,0.7520396598925949,6553,1,NUTF2
CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098703,0.127460295914212,0.48455507597591796,0.534537873543359,1.38314816539647,938,6,FAM155A|TRPV1|ATP2B4|CACNA2D1|FAM155B
MAINTENANCE OF GASTROINTESTINAL EPITHELIUM%GOBP%GO:0030277,0.18779589689636997,0.561187808256183,-0.535077910115923,-1.28247964828482,1427,5,SERPINA3|MUC4|TLR4
7-METHYLGUANOSINE RNA CAPPING%GOBP%GO:0009452,0.20724713242961398,0.587285451772193,-0.261849652023378,-1.21802135939386,1589,32,NCBP1|POLR2H|GTF2H1|CDK7|MNAT1|POLR2G|POLR2L|GTF2H2
PHOSPHOLIPASE C-ACTIVATING ANGIOTENSIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0086097,0.171221864951769,0.5448344947455329,0.7556056038184521,1.26951497460358,1277,2,AGTR1|ACTN2
DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050906,0.37503399510470503,0.725661641889125,0.24632148884771998,1.0610601864529698,2757,24,EYS|PIEZO2|KIT|COL11A1|MMP24|TAS2R5|MKKS
PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009137,0.0459007694348634,0.30746333312705,-0.860545905707196,-1.4320859987336299,345,2,NUDT16|NUDT18
ANTIBIOTIC METABOLIC PROCESS%GOBP%GO:0016999,0.35759371377044996,0.714938712241162,-0.178453974933171,-1.06141760204015,2775,77,FH|ADH1B|GPX1|ALDH2|PDHA1|SDHD|GNE|PARK7|DPEP1|SDHA|ACO1|SOD1|NPL|ALDH1A1|CAT|SDHAF2|GPX3|PRDX4|PRDX5|RENBP
POSITIVE REGULATION OF NECROPTOTIC PROCESS%GOBP%GO:0060545,0.77398177920686,0.922671217932792,0.46117646411906704,0.7748360046235931,5776,2,RIPK1
CARDIAC MUSCLE TISSUE GROWTH%GOBP%GO:0055017,0.24539957939011603,0.62804240987169,-0.44093402891525396,-1.20527350486751,1866,7,C3orf58|S1PR1|TGFBR3
DNA STRAND ELONGATION INVOLVED IN MITOTIC DNA REPLICATION%GOBP%GO:1902983,0.24695652173913002,0.6280519349499749,-0.873400970445523,-1.16357980857394,1845,1,GINS1
REGULATION OF MICROTUBULE POLYMERIZATION%GOBP%GO:0031113,0.420016519823789,0.7516634519993259,0.20876274614597198,1.02519646172614,3050,37,MET|CLASP1|DCTN1|RANGRF|INPP5J|CDK5R1|CAMSAP3|STMN2|PAK1|MAP2|PSRC1|ANKRD53|SNCA|STMN1|EML2|AKAP9|SLAIN2|CLIP3|FAM179B
REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION%GOBP%GO:0030834,0.368737201365188,0.721792732107131,0.24443954660251999,1.0650026200838199,2700,25,RLTPR|ADD3|FAM21C|LRRC16A|WDR1|TRIOBP|TWF1|ADD1
"REGULATION OF DNA DAMAGE RESPONSE, SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR%GOBP%GO:1902162",0.663040594322101,0.879716013665144,-0.533079272964565,-0.8871291559981122,4997,2,ZNF385A
POSITIVE REGULATION OF OXYGEN METABOLIC PROCESS%GOBP%GO:2000376,0.513177257525084,0.802184867798321,-0.746415968239965,-0.994405294738982,3835,1,LIPT2
BENZENE METABOLIC PROCESS%GOBP%GO:0018910,0.17160313454642098,0.54516008272075,0.916023378914866,1.22139357413195,1291,1,CYP2E1
ACTIN FILAMENT BUNDLE DISTRIBUTION%GOBP%GO:0070650,0.0358613361668216,0.268987198588135,0.981859285399206,1.3091768720019,269,1,SHTN1
NEGATIVE REGULATION OF CELL-CELL ADHESION BY NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:1900387,0.263545150501672,0.638950455433329,-0.864578738420821,-1.15182647717421,1969,1,SNAI2
U1 SNRNA 3'-END PROCESSING%GOBP%GO:0034473,0.94436979306638,0.982694945797028,0.303352817911106,0.596659194843427,7027,3,EXOSC8|EXOSC9|EXOSC7
POSITIVE REGULATION OF HOMOPHILIC CELL ADHESION%GOBP%GO:1903387,0.776331518129898,0.9241536998094619,0.6112152624614029,0.8149730794710551,5844,1,PTPN23
REGULATION OF CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING%GOBP%GO:1905915,0.0298941798941799,0.244735657013286,-0.798334620050733,-1.55894517588141,225,3,SOD2|DNMT1|FGF9
PARTURITION%GOBP%GO:0007567,0.43450522600787295,0.762034923704788,0.38848944655821793,1.005239276538,3200,6,CRHR1|MAFF|CRH
VESICLE BUDDING FROM MEMBRANE%GOBP%GO:0006900,0.00012748597654258,0.00518555396908895,-0.35721109210278007,-2.1852459292449997,0,85,DNM1|TFG|PDCD6|TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|S100A10|F8|RILP|SEC13|SEC24A|ARFGAP2|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|CHMP4A|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|TRAPPC2|ANXA2|TMED9|GOSR2|PPP6C|SAR1B|AP2M1|GRIA1|DNM3
METANEPHRIC ASCENDING THIN LIMB DEVELOPMENT%GOBP%GO:0072218,0.0723472668810289,0.378321151505122,0.8341328921974079,1.4014509581488401,539,2,PKD1|PKD2
PROSTANOID METABOLIC PROCESS%GOBP%GO:0006692,0.0119000915391657,0.143385281385281,-0.429823710688668,-1.78001182252692,90,22,CD74|TBXAS1|PTGDS|CBR1|PTGR2|PTGES2|PTGS1|ACOX1|PLAA|PTGES|PTGIS
GLYCOSPHINGOLIPID CATABOLIC PROCESS%GOBP%GO:0046479,0.30126182965299697,0.674306955113297,-0.41787791865263796,-1.14225065563721,2291,7,GALC|GBA|NEU1|GLA|NEU4
PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:0051603,0.432031448135937,0.7605094401125909,-0.121287086912828,-1.01081723786641,3406,438,UBE2D2|FBXL14|PSMB4|GZMA|RNF13|ENC1|UBD|PCYOX1L|PML|CUL4B|FBXO45|DCAF11|FBXW11|LONP1|KLHL20|MARCH6|GET4|PSMD1|PSMC2|TTC3|ARRDC1|PCNP|CDC20|ANAPC10|TRIM3|UBE2Z|HSP90B1|RNF216|DTX3L|UBE2B|TSG101|CPVL|FBXO6|ANAPC2|RLIM|TRIM9|HSPA13|ANAPC5|KCTD2|UBQLN2|CTSF|CTSV|RNF121|HM13|USP9X|PSMD3|CTSS|TOR1A|KLHL15|PSMB2|UBAP1|CDC23|PSMF1|PTTG1|ARMC8|VCP|RNF144B|UBE2G2|MAD2L1|TNFAIP3|CTSB|RNF7|SIAH2|PSMD4|RBBP6|SEL1L|SMURF2|UBE2S|UBQLN1|RNF168|UBXN1|ARRB1|PSMB5|UHRF1|TRIM32|UBE2R2|RCN3|FAF2|HUWE1|MVB12B|HERPUD1|CDC27|RAD23B|RNF20|SEC13|DTL|SKP1|FAP|NPLOC4|RCHY1|CTSZ|CTSH|NEDD8|VPS25|PSMC6|USP44|FBXO4|CCNB1|PLK1|NSFL1C|PSMB3|CTSC|SYVN1|SNF8|NR1D1|RNF40|KIAA0368|PSMD2|SEC61B|UBC|SGTB|PSMD6|ERCC8|FBXW5|DDB1|SPOP|PLAA|DERL3|MYLIP|PSMD12|PSMA3|KAT5|CTSL|HSPA5|LGMN|ANAPC11|UBE2L6|TOLLIP|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|SQSTM1|RMND5B|RNF130|PRPF19|SPSB1
DETECTION OF CARBOHYDRATE STIMULUS%GOBP%GO:0009730,0.163719185423366,0.5351003413847161,0.7607940446650121,1.27823222513252,1221,2,GCK|NKX6-1
NEGATIVE REGULATION OF CATALYTIC ACTIVITY IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052199,0.5413987138263671,0.815622645995152,0.574028484854087,0.964441970372628,4040,2,CASP8|PTX3
UROPORPHYRINOGEN III METABOLIC PROCESS%GOBP%GO:0046502,0.835342979635584,0.945788393670804,0.429059829059829,0.720875910977466,6234,2,SUCLA2|UROS
CELLULAR POTASSIUM ION TRANSPORT%GOBP%GO:0071804,0.496900025833118,0.794550673730064,-0.166933835341886,-0.969318435042302,3846,70,SLC9A5|TMEM175|KCNA3|KCND2|ATP1B1|SLC12A8|ATP1A3|SLC12A2|ATP1B3|KCNN2|KCNK6|KCNK7|SLC9A1|PKD2L1|ABCC9|SLC9A7|NALCN|SLC1A3|SLC9A9|KCNJ12|KCNN1|KCNQ1|KCNB2|ATP1B2|KCNH2|KCNE4|KCNJ9
POSITIVE REGULATION OF INTERFERON-GAMMA SECRETION%GOBP%GO:1902715,0.583954979714697,0.839558852248902,-0.40768290288286,-0.8925030954487779,4461,4,RASGRP1|PTPN22|LGALS9
SPINDLE DISASSEMBLY%GOBP%GO:0051230,0.935261342531175,0.9806508984207809,-0.370766999441584,-0.61701557717182,7049,2,VCP
"MITOCHONDRIAL ELECTRON TRANSPORT, CYTOCHROME C TO OXYGEN%GOBP%GO:0006123",0.527563179258871,0.810052447666581,-0.272941847312518,-0.9395187678526992,4028,13,COX5A|COX4I1|MT-CO2|COX7C|CYCS|MT-CO3|COX4I2|COX6A1
REGULATION OF INTERMEDIATE FILAMENT DEPOLYMERIZATION%GOBP%GO:0030842,0.20069066277061998,0.578325746675525,0.9013564181737981,1.2018371610386398,1510,1,NES
POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION%GOBP%GO:0032825,0.05899470899470901,0.35156940470002696,-0.754089891644217,-1.4725464350838,445,3,GAS6|AXL
7-METHYLGUANOSINE CAP HYPERMETHYLATION%GOBP%GO:0036261,0.478416788418117,0.7850984235874658,0.7614137626819591,1.01524251280251,3601,1,TGS1
CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE%GOBP%GO:0098704,0.8445484949832779,0.948285501480553,-0.580999117776798,-0.7740303309939169,6312,1,SLC2A5
REGULATION OF TRANSCRIPTION INVOLVED IN G1/S TRANSITION OF MITOTIC CELL CYCLE%GOBP%GO:0000083,0.0707374476987448,0.3767214120425879,-0.34383054947945096,-1.46127014202296,540,24,ID2|TYMS|BRD4|RRM2|TFDP2|CDT1|CDC6|PCNA|ORC1|CDC45|E2F1|DHFR|POLA1
RIBOSOMAL LARGE SUBUNIT BIOGENESIS%GOBP%GO:0042273,0.5976522187822499,0.844947788565207,-0.15981818130210299,-0.913933795905692,4632,66,ZNHIT3|NOP16|NOL9|DDX28|URB1|NHP2|RPLP0|RPL10A|MRPL20|BRIX1|NVL|RPL3|HEATR3|LAS1L|RPL7A|DHX30|YAE1D1|GTF3A|PPAN|NPM1|SURF6|ZNF622|RPL35A|RPL10|MALSU1|RPL24|RPL35|WDR74|RPL26L1|BOP1|ORAOV1|MRPL11
NEGATIVE REGULATION OF CENTROSOME CYCLE%GOBP%GO:0046606,0.236349351839728,0.62149045081524,-0.34881322474302395,-1.20068276209056,1804,13,KAT2A|KIF25|MDM1|NEK2|NPM1|CDK5RAP2|BRCA1|RBM14|KAT2B
POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS%GOBP%GO:0045542,0.967078742273582,0.9912626134248801,0.282410328010277,0.555467788584899,7196,3,FGF1|PRKAA1
CELLULAR RESPONSE TO CAMP%GOBP%GO:0071320,0.29255807848799104,0.6650726613369411,-0.278538739350685,-1.13476882968803,2228,21,ZFP36L1|RAPGEF1|AHR|CRHBP|PDE2A|RAPGEF3|RAP1A|KCNQ1|IGFBP5
NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY%GOBP%GO:0002707,0.173338566195709,0.547365883994345,-0.343298580045908,-1.27583045117865,1324,16,FOXP3|SERPINB9|MICA|LILRB1|HLA-E|NDFIP1|FCGR2B|CEACAM1|HFE|LGALS9
POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION%GOBP%GO:0030854,0.0838244924688933,0.40273206259859,-0.5720804110262879,-1.4715449276737198,639,6,RUNX1|HCLS1|TESC|HAX1
FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX%GOBP%GO:0001732,0.525036525434985,0.808245162096538,0.7369872077635642,0.982672997763655,3952,1,EIF3A
REGULATION OF SPINDLE CHECKPOINT%GOBP%GO:0090231,0.0207131620346093,0.19828362800876603,-0.484695816116004,-1.71478291854923,157,14,CDT1|LCMT1|CDK5RAP2|MAD2L1|NDC80|USP44|CCNB1|XRCC3
MULTI-ORGANISM CELLULAR PROCESS%GOBP%GO:0044764,0.0134869713238183,0.154334841212238,-0.518608187643232,-1.78514995135575,102,13,HYAL2|CD4|PPIA|GAS6|PVRL2|CXCR4|IFIH1|IRF7|ROMO1
RAN PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0031291,0.3183284063423811,0.6867397844771489,0.578732444670099,1.1382984237443798,2368,3,RANGRF|GPSM2
NEGATIVE REGULATION OF CALCINEURIN-MEDIATED SIGNALING%GOBP%GO:0106057,0.208181344450235,0.588242833209407,-0.41298885023922705,-1.24237154980964,1597,9,FHL2|PRNP|RCAN1
NEGATIVE REGULATION OF MYOBLAST FUSION%GOBP%GO:1901740,0.524770885907823,0.808245162096538,0.737207763564182,0.982967079163554,3950,1,CFLAR
RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009191,0.44771626750425303,0.768229288546963,-0.45903885811203704,-1.00493201676888,3420,4,NUDT16|NUDT18
T-CIRCLE FORMATION%GOBP%GO:0090656,0.686928104575163,0.8861361847538001,-0.24391739685873,-0.816414365662482,5254,12,NBN|EXO1|SLX1B|SLX1A|XRCC3
NEGATIVE REGULATION OF HISTONE H3-K36 METHYLATION%GOBP%GO:0000415,0.46474916387959897,0.7785465206362571,-0.769243493603882,-1.0248170397358,3473,1,BCOR
"REGULATION OF SYNAPTIC TRANSMISSION, DOPAMINERGIC%GOBP%GO:0032225",0.0069672131147541,0.10045820391703099,0.643609217531393,1.86828496160074,50,8,DRD2|RAB3B|CNTNAP4|DRD4|CHRNB2|FLOT1
POSITIVE REGULATION OF HISTONE H3-K4 METHYLATION%GOBP%GO:0051571,0.30561738902710495,0.677423587903087,-0.327638072969805,-1.12779378336136,2333,13,DNMT3B|PAXIP1|BRCA1|SNW1|CTR9|DNMT1
ADENYLATE CYCLASE-INHIBITING G PROTEIN-COUPLED RECEPTOR SIGNALING PATHWAY%GOBP%GO:0007193,0.346293416277864,0.703504080836324,-0.218974325874338,-1.08134947623003,2671,39,MARCO|ADCY8|OXER1|AKAP5|PDE2A|ADCY4|FLNA|GNAI2|CHRM2|INSL3|HTR1B|ADCY9
MONONUCLEAR CELL MIGRATION%GOBP%GO:0071674,0.00156637514684767,0.0323893370023386,-0.45100570541247703,-2.03923140965714,11,29,CCL3|CCL4|CCL8|CCL11|FLT1|CCL19|CCL24|TNFRSF11A|CCL3L3|CCL18|CD47|CCL2|LGALS3|CX3CL1|CCL4L2|CCL14|ANXA1|FOLR2|PDGFB|SIRPA
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE%GOBP%GO:0002702,0.0547802269466545,0.339653814475307,-0.28927947705180296,-1.47464902610394,419,44,TGFB1|LILRB1|HLA-E|CD74|TNFRSF14|B2M|IL18|STX4|PAXIP1|GPI|TRAF2|MZB1|RSAD2|TNFRSF4|TNFSF13|SEMA7A|GPRC5B|NLRP3|TICAM1|IL1R1|TFRC
REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE SIGNALING%GOBP%GO:0014066,0.117886696371738,0.4686321600125661,-0.21271137153450898,-1.2888919715087799,925,82,FLT1|IL18|MYDGF|AGT|DAB2IP|PIK3AP1|KDR|FGR|HCLS1|HGF|C3orf58|PDGFD|IER3|INS|SLC9A3R1|DCN|PDGFC|PTPN6|HCST|HAX1|PIK3CB|OSM|MAPK3|IGF1|NTRK2|CEACAM1|GPER1|F2R|TEK|PDGFRB|PDGFA|PDGFRA|PDGFB
MITOCHONDRIAL MEMBRANE FUSION%GOBP%GO:1990613,0.404206859592712,0.7412323997026801,0.63424317617866,1.06561042643141,3016,2,MFN1|WBSCR16
POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY%GOBP%GO:0045762,0.8483779014524231,0.9492491301138911,0.266445668231006,0.689443826961417,6249,6,CACNA1C|NF1
TUBE FORMATION%GOBP%GO:0035148,0.587660101914337,0.8414799095069009,0.174785276609766,0.9166670012044391,4266,46,FGFR2|BBS4|TSC2|PAX8|BMP7|SEMA4C|CEP290|DVL2|MTHFR|PHACTR4|SKI|PLXNB2|MTHFD1L|LRP6|BCL10|PROX1
REGULATION OF ODONTOGENESIS%GOBP%GO:0042481,0.71462388216728,0.898692847791961,-0.331329197687063,-0.794132863425695,5433,5,BCOR|CD34|BMP2
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION%GOBP%GO:0045621,0.00297119235240925,0.05456914496596799,-0.36711125652481297,-1.9017518197472,22,46,NCKAP1L|IL18|ADAM8|RUNX1|CCL19|RUNX3|GATA3|GAS6|LILRB2|SOCS1|MMP14|NKAP|C10orf54|CD86|NLRP3|AXL|TGFBR2|LGALS9|BCL6|LILRB4|PNP|ANXA1|SART1
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA RECOMBINATION%GOBP%GO:0032208,0.5031438127090301,0.797298314254545,-0.752315835906484,-1.00226533511256,3760,1,TERF2
POSITIVE REGULATION OF EOSINOPHIL ACTIVATION%GOBP%GO:1902568,0.6066595914035551,0.848985084775586,-0.55682382133995,-0.926643881533525,4572,2,F2RL1|STX4
INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION%GOBP%GO:0042491,0.183753943217666,0.556308895147568,-0.4706162607873,-1.28640856202952,1397,7,DFNB31|PDZD7|SOD1|JAG2
MESODERMAL CELL DIFFERENTIATION%GOBP%GO:0048333,0.37793121417404896,0.7281989978224692,-0.35128671415543494,-1.05675642148697,2900,9,BMP4|ITGB3|ITGB1|KLF4|ITGA8|ITGB4
MEGAKARYOCYTE DEVELOPMENT%GOBP%GO:0035855,0.590740740740741,0.8417378833576942,-0.46107706612933397,-0.9003666506485699,4465,3,MED1|ZNF385A
GLUTATHIONE DERIVATIVE BIOSYNTHETIC PROCESS%GOBP%GO:1901687,0.0303030303030303,0.246004159239453,0.425879164106645,1.6376322690117402,222,17,GSTM2|GSTM4|GSTM1|GSTK1|MGST3|GSTT2B|AKR1A1|MGST2|GSTZ1|GSTM3
INTERLEUKIN-35-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070757,0.260943199583116,0.6368800456015129,-0.39270714830079706,-1.1813592259771002,2002,9,CANX|EBI3|IL6ST|STAT3
NEGATIVE REGULATION OF MAST CELL ACTIVATION%GOBP%GO:0033004,0.0162409954158481,0.17341529663562902,-0.6668817023477529,-1.7153993871032198,123,6,CD300A|LGALS9|CD300LF|MILR1
REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS%GOBP%GO:0110089,0.112240802675585,0.459194647507502,-0.9416629907366559,-1.2545212102794099,838,1,CX3CL1
POSITIVE REGULATION OF GUANYLATE CYCLASE ACTIVITY%GOBP%GO:0031284,0.176306712655877,0.548366806412612,-0.7480562448304391,-1.24488521458544,1328,2,GUCA1A|NOS3
"FARNESYL DIPHOSPHATE BIOSYNTHETIC PROCESS, MEVALONATE PATHWAY%GOBP%GO:0010142",0.15585284280936498,0.524929617605427,-0.9199933833259809,-1.2256520900288002,1164,1,HMGCS1
AUDITORY RECEPTOR CELL MORPHOGENESIS%GOBP%GO:0002093,0.10849365266326401,0.45309795582492896,-0.637869285190249,-1.39642920391875,828,4,DFNB31|PDZD7|SOD1
PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009135,0.015565729234793999,0.168596495655607,-0.372436477091507,-1.7004720399718898,118,30,GPI|PFKFB2|HK1|HK3|NUDT16|ENO1|PGAM1|GAPDH|NUDT18|LDHA|PGK1|ALDOA|ALDOC|BAD
CELLULAR RESPONSE TO NITRIC OXIDE%GOBP%GO:0071732,0.182318271119843,0.5559553601324849,-0.500611543715702,-1.2877077482310502,1391,6,GUCY1B3|AQP1|DPEP1
REGULATION OF NATURAL KILLER CELL CYTOKINE PRODUCTION%GOBP%GO:0002727,0.5820735785953179,0.8387093286508721,-0.71344287604764,-0.9504772186324659,4350,1,HLA-E
POSITIVE REGULATION OF 3'-UTR-MEDIATED MRNA STABILIZATION%GOBP%GO:1905870,0.177314384380396,0.548981775981255,0.913101014556683,1.21749699558328,1334,1,RBM24
CELL-CELL RECOGNITION%GOBP%GO:0009988,0.143789144050104,0.510100773357357,-0.301166373234106,-1.31374271859166,1101,26,UBAP2L|PRF1|ST6GALNAC6|PCDHA7|CD209|CORO1A|CCL19|PCDHB6|CLEC4M|MSN|ZP3|POMZP3|B4GALT1|FOLR2|ALDOA
MAINTENANCE OF MITOCHONDRION LOCATION%GOBP%GO:0051659,0.44949832775919707,0.768229288546963,-0.7766872518747242,-1.03473391310433,3359,1,ATP2A1
NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT%GOBP%GO:2001205,0.37447089947089895,0.725184325297951,-0.556468512187052,-1.08664196793668,2830,3,FBXW7|LILRB1|FBN1
EMBRYONIC SKELETAL JOINT DEVELOPMENT%GOBP%GO:0072498,0.84951520786293,0.9492491301138911,0.574327304808116,0.7657879653378901,6395,1,CTNNB1
PROTEIN UFMYLATION%GOBP%GO:0071569,0.203067734491652,0.5817604087661171,0.486899789647056,1.25988182337397,1495,6,UFM1|UFC1|CDK5RAP3|DDRGK1
SEGMENT SPECIFICATION%GOBP%GO:0007379,0.38880586876782997,0.7356350957002221,0.47636792427702895,1.04660061702178,2861,4,BMI1|DVL2|MTF2
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002705,0.0503095975232198,0.321938657102799,-0.254676031435067,-1.45638644013642,389,66,MALT1|HLA-F|CLCF1|TRAF6|MICB|IL1B|CD1D|SYK|HLA-B|PVR|MICA|TGFB1|NCR3|HLA-E|B2M|IL18|ITGB2|SNX4|STX4|FGR|HLA-C|PAXIP1|HLA-A|TRAF2|PVRL2|RSAD2|VAMP8|VAMP7|TNFSF13|STX7|HFE|NLRP3|ZP3|FADD|TICAM1|IL1R1|ITGAM|TFRC
ANTIBIOTIC CATABOLIC PROCESS%GOBP%GO:0017001,0.443589409156124,0.7664039155808309,-0.22755173443887397,-1.00361431875317,3400,27,NPL|CAT|GPX3|PRDX4|PRDX5|RENBP
THROMBOPOIETIN-MEDIATED SIGNALING PATHWAY%GOBP%GO:0038163,0.6781639692226049,0.884536278926676,-0.526010695661046,-0.8753659130145591,5111,2,RBM15
PROTEIN DEMANNOSYLATION%GOBP%GO:0036507,0.854995938261576,0.949296218452153,0.17166165979465697,0.695705805211412,6314,20,UGGT2|RNF103|TRIM13|DERL2|RNF185|UGGT1|MAN1A2|MAN1B1
CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS%GOBP%GO:0014898,0.13367748947153898,0.495264631574533,0.621159227952933,1.3647132775175,983,4,HDAC4|INPP5F|CAMTA2|TCAP
REGULATION OF CYTOKINE ACTIVITY%GOBP%GO:0060300,0.45929074246247903,0.7735063645065241,0.77211071901191,1.02950546069763,3457,1,NRP1
REGULATION OF HISTONE H3-K9 ACETYLATION%GOBP%GO:2000615,0.669586820083682,0.8815356925073421,-0.263664367464428,-0.826026044402187,5120,10,CAMK1|BRCA1|RAPGEF3|HDAC5
REGULATION OF MAST CELL ACTIVATION%GOBP%GO:0033003,0.003922594142259411,0.0680498152643996,-0.45577160171747105,-1.9370164581943998,29,24,SYK|UNC13D|LYN|CD84|SNX4|FGR|STXBP2|FES|ADGRE2|PVRL2|PLSCR1|VAMP8|VAMP7|SNX6|CD300A|LGALS9|CD300LF|MILR1
ENDOCARDIAL CUSHION CELL DEVELOPMENT%GOBP%GO:0061444,0.517056856187291,0.8044475278572141,-0.7444309660344071,-0.991760795174042,3864,1,JAG1
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS%GOBP%GO:0043255,0.291451446280992,0.663837153945439,-0.212492443845629,-1.11960087306164,2256,49,OGT|PLEK|INS|PPP1R3E|IRS1|CLTC|IGF1|P2RY6|GPER1|NR1D1|SIK1|NFKB1|PDGFB|PPP1R3F
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048010,0.0317092034029389,0.253077647014974,-0.27194741753317103,-1.5443131877308403,245,64,FLT1|NCKAP1L|VAV3|WASF2|DAB2IP|KDR|PDCD6|VAV1|VEGFC|BCAR1|FLT4|ELMO1|MAPKAPK2|PRKD1|PXN|PIK3CB|CYBB|HSPB1|SULF1|NCF4|DOCK1|CYFIP2|NCF2|AXL|VEGFB|NRP2|HSP90AA1|NCK1
HISTONE H3-S28 PHOSPHORYLATION%GOBP%GO:0043988,0.516402116402117,0.804056180000979,-0.495619639576152,-0.967819541810956,3903,3,RPS6KA5|RPS6KA4
ARACHIDONATE TRANSPORT%GOBP%GO:1903963,0.462467761639745,0.7762165400340341,0.38021012206623206,0.9838160377955291,3406,6,DRD2|DRD4
NEGATIVE REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS%GOBP%GO:0031947,0.61005291005291,0.850714570847612,-0.45228383087048707,-0.8831956908243579,4611,3,REST|BMP2
REGULATION OF IP-10 PRODUCTION%GOBP%GO:0071658,0.5820162040111571,0.8387093286508721,0.707432730480812,0.9432660901771429,4381,1,MAVS
POLYAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902047,0.676716695444282,0.8835592822191172,0.6609505955006619,0.881288435148356,5094,1,ATP13A2
NAD SALVAGE%GOBP%GO:0034355,0.938770088989242,0.980854185905783,0.531263784737539,0.708368572007543,7067,1,NAPRT
REGULATION OF TYPE IV HYPERSENSITIVITY%GOBP%GO:0001807,0.14528428093645498,0.5122531353179961,-0.92600352889281,-1.23365904704488,1085,1,ZP3
CARDIAC CELL FATE DETERMINATION%GOBP%GO:0060913,0.26944444444444393,0.6434418809581031,-0.6045989996416271,-1.18062861131356,2036,3,SOX17|MESP1
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION%GOBP%GO:0002577,0.0341296928327645,0.26378188727568896,-0.443748781000311,-1.61117989267759,259,15,PYCARD|CCL19|WAS|FCGR2B|LILRB2|SLC11A1|TREM2|HFE|THBS1
HISTONE DEMETHYLATION%GOBP%GO:0016577,0.485425420168067,0.7872939093021379,-0.24268376128322303,-0.973642602040945,3696,20,KDM4B|HR|KDM1A|KDM3B|KDM8|KDM2A|C14orf169|JMJD6|KDM5C
NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:1900060,0.664040211927727,0.8804055751124069,0.3806023075947829,0.8361994787393809,4887,4,ORMDL1|PRKAA1
PROXIMAL/DISTAL AXIS SPECIFICATION%GOBP%GO:0009946,0.936113693717625,0.9806508984207809,0.532752536391707,0.710353621456863,7047,1,SIX3
PLATELET-DERIVED GROWTH FACTOR RECEPTOR-ALPHA SIGNALING PATHWAY%GOBP%GO:0035790,0.0652842809364548,0.366933938653309,-0.9655381561535071,-1.28632866337995,487,1,PDGFRA
REGULATION OF MUSCLE TISSUE DEVELOPMENT%GOBP%GO:1901861,0.761265580057526,0.9183912636605319,0.15379565893443697,0.802964378694895,5557,45,DKK1|FGFR2|DLL1|FGF2|RBM24|SOX6|EFNB2|DDX17
PHYTOSTEROID METABOLIC PROCESS%GOBP%GO:0016128,0.00517378615017246,0.0809542541983624,-0.950758202371106,-1.5822136864132499,38,2,DHCR7|C14orf1
METAL INCORPORATION INTO METALLO-MOLYBDOPTERIN COMPLEX%GOBP%GO:0042040,0.0363879598662207,0.271450902407424,-0.981638729598588,-1.30777849318447,271,1,GPHN
OLFACTORY LOBE DEVELOPMENT%GOBP%GO:0021988,0.232732732732733,0.616523546447917,0.398119507886575,1.20984846590822,1704,9,SLIT1|ROBO2|SLIT3|SKI|AGTPBP1
NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION%GOBP%GO:0010700,0.0462987529848766,0.30805382986873603,-0.860103284184545,-1.43134940573944,348,2,ADRA2C
FEMALE SEX DIFFERENTIATION%GOBP%GO:0046660,0.225630538513974,0.6083599141984499,0.26868775761046104,1.20251131700439,1654,27,STRA6|TBX3|KIT|ROBO2|PTPRN|BRCA2|SLIT3|EIF2B4|ADCYAP1
RESPONSE TO CHOLESTEROL%GOBP%GO:0070723,0.92360199527435,0.9776627603891009,-0.16980776692818,-0.616544476084938,7035,15,PMVK|TGFBR1|CCR5|OSBPL7|CCL3|TGFB1|ABCA2|SMO|TGFBR2
ADULT FEEDING BEHAVIOR%GOBP%GO:0008343,0.8342592592592591,0.945147598344,-0.362634057628771,-0.7081324053249091,6306,3,GHRL
POSITIVE REGULATION OF INTERLEUKIN-1 BIOSYNTHETIC PROCESS%GOBP%GO:0045362,0.49615282568320507,0.794012168719884,-0.600683384655072,-0.9996332085613949,3739,2,AZU1
CONVERSION OF DS SIRNA TO SS SIRNA INVOLVED IN RNA INTERFERENCE%GOBP%GO:0033168,0.8013377926421399,0.9325377000668108,-0.603826643140715,-0.8044420759907359,5989,1,DICER1
POSITIVE REGULATION OF LEUKOTRIENE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0035491,0.10755852842809402,0.451309145449614,-0.944199382443758,-1.25790029305683,803,1,SERPINE1
PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT%GOBP%GO:0048486,0.7040328999734681,0.8942697389523392,-0.51486076647367,-0.85681064783903,5306,2,PHOX2B|TBX1
CARDIOGENIC PLATE MORPHOGENESIS%GOBP%GO:0003142,0.453244147157191,0.769943206592495,-0.7742059991177771,-1.03142828864815,3387,1,SOX17
REGULATION OF STEM CELL POPULATION MAINTENANCE%GOBP%GO:2000036,0.159432159432159,0.5293397224673839,0.43187812684105603,1.31243779535373,1167,9,PAX8|ZC3H13|NCOA3|ZNF706
DNA DEMETHYLATION%GOBP%GO:0080111,0.0411641321447299,0.29083583295600396,-0.45079082856865504,-1.5948320306589499,313,14,APOBEC3G|APOBEC3C|APOBEC3B|APEX1|ALKBH3|APOBEC3F
REGULATION OF ENDOSOME SIZE%GOBP%GO:0051036,0.6203314045239351,0.85518258472662,-0.36005949649624697,-0.8629939074256959,4716,5,RILP|SNF8
HETEROCHROMATIN MAINTENANCE%GOBP%GO:0070829,0.307344932926019,0.678930163290357,0.847430524922805,1.12993425876325,2313,1,MTHFR
NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT%GOBP%GO:0034763,0.134982039237358,0.497031952671308,0.226837899253476,1.28176979764288,976,60,FKBP1B|CRHR1|BIN1|TCAF2|IRS2|GSTM2|C19orf26|INPP5K|EPHB2|DRD4|GNB5|PRKCE|OAZ3|SRI|SUMO1|NEDD4|PKD2|YWHAE|CAMK2D|SESTD1|NEDD4L
CELLULAR RESPONSE TO KETONE%GOBP%GO:1901655,0.739045127534336,0.9089185613230608,-0.176116979258578,-0.804115647673091,5649,30,NR3C1|DCPS|NDOR1|AHR|LARP1|ADCY8|PTGER4|PARK7|MSN|SPP1
NEGATIVE REGULATION OF HEXOKINASE ACTIVITY%GOBP%GO:1903300,0.16827438370846695,0.54080963877274,0.757311964852146,1.27238188145738,1255,2,PARK2|MIDN
REGULATION OF FIBRINOLYSIS%GOBP%GO:0051917,0.0088518614944025,0.118031947028019,-0.628319169430128,-1.8088429489616498,67,8,FAP|THBD|THBS1|SERPINE1|SERPINF2
CARBOHYDRATE MEDIATED SIGNALING%GOBP%GO:0009756,0.051694804344981,0.328140151305953,-0.6927841117743211,-1.51664923857249,394,4,ADCY8|CLEC7A|COLEC12
LIPID MODIFICATION%GOBP%GO:0030258,0.0423964414790103,0.294833299013666,0.20695927397535,1.3984650248713801,304,127,DGKB|ALDH3A2|BDH2|MTMR6|PPARD|SOCS5|TMEM150A|HADHB|DGKK|SLC25A17|EFR3B|INPP5K|LCAT|INPP5J|HADHA|DGKH|PPAPDC1B|CYP4V2|PEX2|MTMR2|CYP2C8|HIBCH|PEX13|ACADVL|ACADM|INPP5F|ACAT1|TTC7A|PPAPDC1A|PI4K2B|GCDH|ECHDC1|DGKQ|ST3GAL4|MCAT|ACOX2|ACAA2|ACAD11|ECI1|ACADS|PIK3R2|ECHS1|SOCS2|MECR|ACOX3|DGKI|EHHADH|ACOT8|ABCD3|PHYH
DEVELOPMENTAL GROWTH%GOBP%GO:0048589,0.0734975118029858,0.381564982122021,-0.212240833535182,-1.3478938253052601,575,99,C3orf58|COBL|ANXA6|SH3GL2|DDR2|MESP1|VWA1|NOTCH1|COL14A1|S1PR1|FGF10|COMP|IGF1|COL12A1|COL6A3|GAS1|COL21A1|NOV|NRP2|TGFBR3|FGF7|SLIT2|TMEM108|MAP1B|SEMA3A|COL6A1|ANXA2|HSP90AA1|ANXA1|CPQ|COL6A2
POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS%GOBP%GO:1902339,0.0115079365079365,0.139771630097924,-0.8424506451968679,-1.6450925918311998,86,3,NOTCH1|TNFRSF1A|TNFRSF1B
REGULATION OF TUBE SIZE%GOBP%GO:0035150,0.0667797052302074,0.3690551432905871,-0.282216566643089,-1.4386446954068,511,44,ADM|PER2|EDNRA|PIK3C2A|AGT|SOD2|INS|DOCK5|TBXA2R|HMOX1|SOD1|GPER1|NPR1|F2R|EDNRB|SMTNL1|NOS3|CHGA|CAV1|SERPINF2
CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING%GOBP%GO:0002248,0.366798941798942,0.721190111986457,-0.559611778978714,-1.0927799713231001,2772,3,HIF1A|TGFB1|F2R
AVOIDANCE OF HOST DEFENSES%GOBP%GO:0044413,0.6752217145928511,0.882488012133495,0.421547863421082,0.829134901428522,5024,3,SMAD3|EIF2AK2
POSITIVE REGULATION OF TIMING OF CATAGEN%GOBP%GO:0051795,0.7173097534833871,0.900060477413567,0.487923555305336,0.8197745712732559,5353,2,GAL|TGFB2
ALVEOLAR PRIMARY SEPTUM DEVELOPMENT%GOBP%GO:0061143,0.0193916854827998,0.19226875441368102,0.990681517423908,1.32094012799787,145,1,STRA6
REGULATION OF RNA SPLICING%GOBP%GO:0043484,0.0213746320235505,0.20181600965907603,-0.23432244498744,-1.5290940015226,166,111,SF3B4|RBM15B|CLK4|MBNL1|CELF2|PTBP1|SRSF3|FASTK|HNRNPH1|REST|SRSF10|HNRNPL|SON|RBM17|TMBIM6|SRSF9|HNRNPU|RBMX|DYRK1A|CELF1|FMR1|MAGOH|SRSF5|SRSF1|AKAP17A|NCBP1|DDX5|SNW1|JMJD6|CELF4|RBM15|RBM22|RBM4B|SMU1|TRA2B|RPS13|RRP1B|SRSF2|RBM8A|RBFOX3|NUP98|PRX|RBM4|PQBP1|AHNAK|AHNAK2|ERN1
REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE%GOBP%GO:0045091,0.0598802395209581,0.354269451186595,-0.535608854892124,-1.5419429291831899,459,8,TOP2A|APOBEC3G|APOBEC3C|APOBEC3F
POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:1905898,0.343427750946352,0.702074680091659,-0.240192794195875,-1.0860365720863299,2630,29,BAK1|EDEM1|PPP1R15A|PTPN1|USP13|DDIT3|BCL2L11|DAB2IP|UBQLN2|FCGR2B|UBQLN1|HERPUD1|BCAP31|CAV1|NCK1|ERN1
PROTEIN-LIPID COMPLEX SUBUNIT ORGANIZATION%GOBP%GO:0071825,0.131472544671971,0.490819490032838,-0.30114149025954196,-1.3281810940286698,1007,27,APOC2|PLTP|DGAT1|AGT|ABCA5|APOC1|PLA2G2A|ABCG1|CETP|PLA2G7|APOM|APOE|PRKACA|P4HB
POSITIVE REGULATION OF VESICLE FUSION%GOBP%GO:0031340,0.0468525062164638,0.310369742180343,-0.698980347528421,-1.53021409388421,357,4,ANXA2|ANXA1
NUCLEAR ENVELOPE REASSEMBLY%GOBP%GO:0031468,0.0770543449724337,0.38834358097640703,-0.40208233169642105,-1.45989576933562,586,15,REEP3|LMNA|NSFL1C|VRK1|EMD|BANF1
POSITIVE REGULATION OF PROTEIN SERINE/THREONINE PHOSPHATASE ACTIVITY%GOBP%GO:1905184,0.4008500464869171,0.740287621109606,0.800838112042347,1.06780956303451,3017,1,FCRL3
OOCYTE DEVELOPMENT%GOBP%GO:0048599,0.666448744769875,0.880719592999549,-0.264640116631457,-0.8290829391677579,5096,10,ZP3|ANG
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT%GOBP%GO:0061037,0.57885450597177,0.8381193804335091,0.27354263977481,0.9001232510158509,4264,11,ADAMTS7|FAM101B
MALE GERM-LINE STEM CELL ASYMMETRIC DIVISION%GOBP%GO:0048133,0.6683490503386911,0.8811119744196031,0.6641486546096159,0.885552615446897,5031,1,ING2
CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR%GOBP%GO:0042994,0.573772643738514,0.835204333784353,-0.249397497136118,-0.905521885072058,4370,15,CCDC22|MDFI|PSMD10|NFKBIA|TMSB4X
EVASION OR TOLERANCE OF DEFENSES OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0051834,0.6752217145928511,0.882488012133495,0.421547863421082,0.829134901428522,5024,3,SMAD3|EIF2AK2
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:0038084,0.168127698547691,0.540548013133043,-0.33835176199096695,-1.28581931978428,1284,17,KDR|VEGFC|FLT4|PRKD1|HSPB1|VEGFB|PDGFRB|PDGFRA
REGULATION OF PROTECTION FROM NON-HOMOLOGOUS END JOINING AT TELOMERE%GOBP%GO:1905764,0.82636655948553,0.943041978946366,0.435015164047422,0.7308816426810479,6167,2,ERCC1|ERCC4
NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION%GOBP%GO:1903147,0.18153804930332298,0.554948538055731,0.74895022593163,1.2583330804431,1354,2,TSC2|PINK1
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING%GOBP%GO:1904356,0.606510094767202,0.848985084775586,0.16175076706389,0.9067700436555071,4415,58,CTC1|SMG6|HMBOX1|EXOSC10|ATM|PARN|ACD|TEN1|PIF1|RTEL1|POT1|MAP2K7|MAP3K4|XRCC5|PNKP|TNKS|ATR|SRC|MAPK1|TNKS2|NEK7|SMG5|TCP1
C-TERMINAL PROTEIN LIPIDATION%GOBP%GO:0006501,0.9207988045102571,0.9768961564057891,0.28588760822809195,0.6281072505553461,6777,4,ATG5|GPLD1|ATG12
REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY%GOBP%GO:1900739,0.170632222977566,0.544171946973796,0.304739517804002,1.27532041251407,1254,22,BBC3|PMAIP1|CASP8|TP53BP2|BID|YWHAQ|YWHAB|YWHAE|BCL2|YWHAH|YWHAZ|MAPK8
POSITIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903961,0.5260682612201021,0.8092343000247181,0.47813410362639097,0.9404333582966891,3914,3,ABCB1|TCAF1
POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0033145,0.10396039603960401,0.44419145940290994,-0.47457176483262503,-1.42762803070707,797,9,PARK7|WBP2|PAGR1|YAP1
REGULATION OF PLASMA MEMBRANE LONG-CHAIN FATTY ACID TRANSPORT%GOBP%GO:0010746,0.65493818774623,0.874775007199212,0.383328211635115,0.842188406005807,4820,4,IRS2
ERBB3 SIGNALING PATHWAY%GOBP%GO:0038129,0.7000668896321071,0.8930679216759608,-0.652845169827967,-0.8697465235805241,5232,1,NRG1
BLOOD VESSEL DEVELOPMENT%GOBP%GO:0001568,0.000128172263522174,0.00518555396908895,-0.31218478413678197,-2.28163825381979,0,196,FLT1|APOD|ADM|JAG1|IL18|ADAM8|ANGPT2|EPHB3|TBX1|SAT1|SOX18|COL23A1|SOX17|FGFR4|KDR|PLXND1|LRP1|CD34|RORA|APOLD1|MED1|FOXS1|SFRP2|CYP1B1|EGFL7|AHR|PRCP|ATPIF1|TBX2|VEGFC|THY1|HES1|MESP1|ITGA5|ATP5B|MYLK|NDST1|FLT4|NOTCH1|MEF2C|S1PR1|CALCRL|HOXB3|COL4A1|JMJD6|HMOX1|LOX|PIK3R3|RECK|LRP5|CCL2|CEACAM1|ROBO4|APLNR|GATA6|VEGFB|NOV|CCBE1|NRP2|ADIPOR2|TGFBR2|TGFBR3|THBS1|TEK|COL1A2|COL1A1|SEMA5A|SRF|PDGFRB|SEMA3E|SLIT2|ID1|SERPINE1|CAV1|ADGRA2|RASIP1|MYH9|ANG|EPHB4|TGFBI|ADGRG1|PDGFA|ANXA2|PDGFRA|ACTA2|ENG|ACVRL1|PDGFB|LOXL2|SERPINF2
VIRAL BUDDING VIA HOST ESCRT COMPLEX%GOBP%GO:0039702,0.696165966386555,0.891033775225429,-0.205795558394855,-0.825647838588563,5301,20,CHMP4A|CHMP6|VPS37C
NEGATIVE REGULATION OF NUCLEOBASE-CONTAINING COMPOUND TRANSPORT%GOBP%GO:0032240,0.67510718113612,0.882488012133495,0.508629721532947,0.854563604016984,5038,2,TPR|NUP153
SHORT-TERM SYNAPTIC POTENTIATION%GOBP%GO:1990926,0.38287625418060206,0.730480369014206,-0.8075099250110279,-1.07579711468216,2861,1,SYT7
BLASTOCYST GROWTH%GOBP%GO:0001832,0.7997077965201221,0.931670998922663,0.599966916629907,0.799974928076188,6020,1,ZPR1
POSITIVE REGULATION OF UBIQUITIN-DEPENDENT ENDOCYTOSIS%GOBP%GO:2000397,0.965351170568562,0.990916952887267,-0.516927657697397,-0.6886717617033289,7215,1,VPS28
REGULATION OF DNA REPLICATION ORIGIN BINDING%GOBP%GO:1902595,0.990050411249668,0.996737060420239,-0.29889140344817,-0.49740309166680297,7462,2,CDT1
SPERMINE BIOSYNTHETIC PROCESS%GOBP%GO:0006597,0.454629875298488,0.770794980018249,-0.6174248690377719,-1.02749371573885,3426,2,AMD1|SMS
REGULATION OF FATTY ACID TRANSPORT%GOBP%GO:2000191,0.445214435146444,0.7670026277395459,-0.319488688027964,-1.0009163533960999,3404,10,IL1B|AKT1|SYK|P2RX4|TNFRSF11A|PLA2R1|THBS1
ALKANESULFONATE BIOSYNTHETIC PROCESS%GOBP%GO:0046305,0.500066889632107,0.7951717058944731,-0.75402514336127,-1.00454254307126,3737,1,CDO1
POSITIVE REGULATION OF INTERLEUKIN-8 SECRETION%GOBP%GO:2000484,0.0040607807178412395,0.0699620448571681,-0.59013811133712,-1.91060388606493,30,11,HYAL2|TLR1|PYCARD|TLR2|FCN1|F2R|LGALS9|CD14
PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT%GOBP%GO:0048935,0.623964135307703,0.857688646775448,0.392966774635636,0.863364739401592,4592,4,ETV1|ISL1|RUNX1|RUNX3
ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN TRNA PROCESSING%GOBP%GO:1905267,0.24120069066277103,0.6244696312630601,0.8807344508160571,1.17434055014805,1815,1,ELAC2
ALPHA-TUBULIN ACETYLATION%GOBP%GO:0071929,0.9531772575250842,0.986646769115929,-0.5227172474636079,-0.6963848854344059,7124,1,ATAT1
FUCOSYLATION%GOBP%GO:0036065,0.16810570381998996,0.540548013133043,-0.345331967386731,-1.28338730587964,1284,16,POFUT1|LFNG|RFNG|FUT4|SLC35C1|MFNG|FUT7|B3GLCT|FUT9|FUOM
CYTOPLASMIC MICROTUBULE ORGANIZATION%GOBP%GO:0031122,0.00315543970366305,0.0571886039479394,0.37062758487876507,1.87855358264261,22,41,WDR73|CLASP1|KATNAL1|FSD1|CCDC88A|KATNAL2|STMN3|CCDC88C|PCM1|CAMSAP3|TUBGCP3|DST|RAB11A|PLK3|TUBGCP6|EZR|SPAST|CHP1|CEP126|KATNA1|SLK
ESTABLISHMENT OF MONOPOLAR CELL POLARITY%GOBP%GO:0061162,0.947624048306642,0.9840421757603729,-0.160126946565151,-0.5813949865959169,7218,15,GBF1|SYNE4|RHOA|SH3BP1|FSCN1|CDC42|SLC9A3R1|MSN
POSITIVE REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS%GOBP%GO:0045764,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL%GOBP%GO:1902188,0.9505017629509089,0.985300779592887,0.159263068581948,0.5724505611314921,7008,14,CHMP3|ZNF502
HISTONE H3-T3 PHOSPHORYLATION INVOLVED IN CHROMOSOME PASSENGER COMPLEX LOCALIZATION TO KINETOCHORE%GOBP%GO:2000751,0.438528428093646,0.764387115513764,-0.782366563740626,-1.04230012019291,3277,1,GSG2
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PHAGOCYTIC VESICLE%GOBP%GO:1905171,0.665427015539912,0.8804055751124069,0.6653617115130129,0.8871700631463431,5009,1,SYT11
"REGULATION OF DNA-TEMPLATED TRANSCRIPTION, INITIATION%GOBP%GO:2000142",0.0427974947807933,0.29576373695179803,-0.359148767051019,-1.56667250907751,327,26,FOSL1|SETX|ATF7IP|SUB1|PSMC2|PAXIP1|DHX36|THRA|TAF7|PSMC4|PSMC6|MITF|SRF|PSMC5|PSMC3
NEUROBLAST DIVISION%GOBP%GO:0055057,0.22355180853957002,0.606760475740296,0.38473495139619396,1.21886633221907,1643,10,FGFR2|TEAD3|RAB10
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0070059,0.898801416507764,0.967428248648255,0.15422629562223902,0.654759224420152,6598,23,MAP3K5|BBC3|DNAJC10|ITPR1|BAX|BCL2|ATF4|TMEM117
"REGULATION OF CD8-POSITIVE, ALPHA-BETA T CELL DIFFERENTIATION%GOBP%GO:0043376",0.478061558611657,0.7850984235874658,-0.37857827607138894,-0.97380530978313,3649,6,NCKAP1L|RUNX1|RUNX3|SOCS1
LIPOPHAGY%GOBP%GO:0061724,0.43277591973244206,0.7613343962915831,-0.785013233348037,-1.04582611961283,3234,1,RAB7A
REGULATION OF ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0140192,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
POSITIVE REGULATION OF NEUROEPITHELIAL CELL DIFFERENTIATION%GOBP%GO:1902913,0.10755852842809402,0.451309145449614,-0.944199382443758,-1.25790029305683,803,1,SERPINE1
EXCITATORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0060079,0.332764505119454,0.6971202277372819,-0.30322218250767,-1.1009505927405099,2534,15,MPP2|NPFF|GRIN1|NPAS4|MEF2C|GRIN2C|GRIN2D
REGULATION OF NEGATIVE CHEMOTAXIS%GOBP%GO:0050923,0.880952380952381,0.9622426269432679,-0.34116028302694107,-0.666199566033335,6659,3,SLIT2
POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION%GOBP%GO:0051284,0.208708708708709,0.5891298661879879,0.408052331054435,1.2400333994111399,1528,9,FKBP1B|GSTM2|SRI|PKD2
DRUG TRANSPORT%GOBP%GO:0015893,0.24708322530464102,0.6280519349499749,-0.200207735707427,-1.15297393823638,1905,68,SLC19A1|SLC36A1|SLC13A3|SLC7A2|SLC22A3|SLC25A10|SLC25A18|SLC1A2|INHBA|ATP8B1|TAF7|GHRL|SLC1A3|SLC25A22|SLC6A8|PDPN|SLC35F3|SLC7A3|MYC|ARL6IP5|SLC25A42|PRAF2|CYGB|FOLR2|ABCC1
TDP PHOSPHORYLATION%GOBP%GO:0061571,0.139859211050604,0.504314492208813,0.93190339655933,1.2425674349247,1052,1,AK9
MESONEPHRIC TUBULE FORMATION%GOBP%GO:0072172,0.39692307692307705,0.7377402989373809,-0.8012792236435821,-1.0674963243811,2966,1,GATA3
"NEGATIVE REGULATION OF NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS, NONSENSE-MEDIATED DECAY%GOBP%GO:2000623",0.11273851115291599,0.460292399693505,0.69945957869196,1.37575444962625,838,3,NBAS|DHX34|PABPC1
CEREBRAL CORTEX NEURON DIFFERENTIATION%GOBP%GO:0021895,0.08646667571603099,0.406514851433408,0.565499126806018,1.46326222796933,636,6,DRD2|ASCL1|CHD5|C21orf91
RENAL ABSORPTION%GOBP%GO:0070293,0.0618462343096234,0.357540960865252,-0.49087077170095705,-1.5378340492501101,472,10,MAGED2|HBB|KLHL3|HYAL2|SLC9A3R1|SGK1|GSN|KCNQ1
EPHRIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:0048013,0.731730902058295,0.9074802896081321,0.14180536454255202,0.841693109548178,5296,72,NCK2|ARHGEF28|GIT1|EPHB2|EFNA4|CRK|ARHGEF7|CHN1|VAV2|EFNB2|EFNB3|CDK5R1|MMP2|ACTR2|PAK1|EFNA2|SIPA1L1
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY%GOBP%GO:0002704,0.024422268907563,0.219638825480684,-0.41584386322718003,-1.66835761442956,185,20,FOXP3|JAK3|SERPINB9|MICA|LILRB1|HLA-E|NDFIP1|CD84|FCGR2B|CEACAM1|CD300A|HFE|BST2|LGALS9
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN%GOBP%GO:0120187,0.772307692307692,0.9215496572020819,-0.6184384649316279,-0.82390853112155,5772,1,NIPBL
CELLULAR RESPONSE TO LIPOTEICHOIC ACID%GOBP%GO:0071223,0.10625986322987899,0.44869189060429,-0.5898671791715779,-1.4137990714564,807,5,TLR2|RELA|CD14
HEXOSE METABOLIC PROCESS%GOBP%GO:0019318,0.44809092069978296,0.768229288546963,-0.16233011859531699,-1.00299169561218,3508,89,DCXR|MAN2B1|FUT7|APOD|PGAM2|PER2|OAS1|GOT1|GAA|GPI|SLC25A10|G6PC3|HK1|GALT|HK3|FUT9|ENO1|GHRL|LRP5|PGM5|ALDH1A1|PGAM1|SLC35A2|GAPDH|FUCA1|FUOM|PGK1|ALDOA|GALK1|ALDOC
MULTICELLULAR ORGANISMAL IRON ION HOMEOSTASIS%GOBP%GO:0060586,0.187802643633032,0.561187808256183,-0.587161528704572,-1.28541932514605,1434,4,SLC40A1|SLC11A2|HAMP|SLC11A1
SPHINGANINE-1-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0006669,0.94009828662505,0.9812919575525741,0.530050727834142,0.7067511243080961,7077,1,SPHK2
PROTEIN LOCALIZATION TO ACTOMYOSIN CONTRACTILE RING%GOBP%GO:1990179,0.47293676312968896,0.7831522581932591,0.604324346991733,1.01534293042097,3529,2,RTKN
RETINA DEVELOPMENT IN CAMERA-TYPE EYE%GOBP%GO:0060041,0.100974070517218,0.438215823332192,0.26811521228255397,1.35896196922075,735,41,PDE6B|NPHP1|LRP5L|DLL1|AHI1|SDHAF4|IFT140|PTPRM|ZNF513|MEGF11|TFAP2B|SKI|CHD7|POU4F2|LRP6|NRP1|PROX1|BMPR2|ACVR2B
POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:0110110,0.20539202917426397,0.58515351714347,-0.264030969229771,-1.21680602898104,1576,31,JAG1|AGT|BASP1|CD34|SMO|GATA3|MESP1|NOTCH1|PIM1|TGFBR2|BMP2|FGF7|MYC|ENG
GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5-PHOSPHATE%GOBP%GO:0019640,0.6751709626512359,0.882488012133495,-0.34305650942725396,-0.8222409918898811,5133,5,CRYL1
NUCLEAR ENVELOPE DISASSEMBLY%GOBP%GO:0051081,0.20346093340325103,0.582256180765724,-0.35115292534211406,-1.24232769946406,1551,14,CCNB1|PLK1|VRK1|NEK6|PRKCB
BOX H/ACA SNORNA 3'-END PROCESSING%GOBP%GO:0000495,0.837755372777925,0.946216977301937,-0.438387948194218,-0.72954764929893,6314,2,DKC1
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS%GOBP%GO:0010907,0.797479984249902,0.9308634013872809,-0.18388518103377302,-0.7491495515672291,6075,21,PHKG2|INS|PPP1R3E|IRS1|IGF1|SLC45A3
IMITATIVE LEARNING%GOBP%GO:0098596,0.408353609083536,0.7445496113654559,0.42645391094793894,1.02561921032513,3020,5,STRA6|HTT|NRXN1
POSITIVE REGULATION OF MINERALOCORTICOID SECRETION%GOBP%GO:2000857,0.00481605351170569,0.0772855253947266,-0.997959858844288,-1.32952215627398,35,1,C1QTNF1
3'-UTR-MEDIATED MRNA DESTABILIZATION%GOBP%GO:0061158,0.892679738562092,0.965443067117994,-0.192486361134119,-0.644269873522009,6828,12,ZFP36L2|ZC3H12A|RBM23|CPEB3|KHSRP|ZFP36L1|DHX36
HISTONE-TYROSINE PHOSPHORYLATION%GOBP%GO:0035406,0.688537654402975,0.887051934478962,0.655105866784296,0.8734952780510241,5183,1,JAK2
DNA REPLICATION CHECKPOINT%GOBP%GO:0000076,0.05841428196377,0.34885102442576,-0.41848406780124897,-1.5194478144308998,444,15,DNA2|TIMELESS|RAD9A|CLSPN|CDT1|CDC6|RAD17|ORC1|CDC45|TOPBP1
PROTEIN-DNA COMPLEX SUBUNIT ORGANIZATION%GOBP%GO:0071824,0.00012853470437018,0.00518555396908895,-0.31406192526489196,-2.23330463012748,0,170,CCNH|ITGB3BP|CTCF|ANP32E|CENPL|CENPU|SRCAP|DMC1|CUL4B|RAD51|RPA2|CENPW|H1F0|HIST1H2BE|SMARCA4|SET|HMGB2|CDT1|H2AFX|GTF2A2|PARP1|OIP5|RUVBL1|CENPM|SMARCE1|HIST1H2BN|NPM1|TAF12|ASF1B|CHAF1A|GMNN|CENPI|IPO4|HIST1H2BC|SUPT16H|PIWIL1|SMARCD3|HIST1H4I|CDC45|STRA13|ANP32B|GTF2H1|TAF7|RBBP7|RAD23B|CENPH|NAP1L4|SMARCD2|MED6|HIST2H3A|BDP1|CDK7|HIST2H2BF|SPTY2D1|UBC|H1FX|MNAT1|HIST3H2A|HIST1H2BG|HIST1H2BD|CHAF1B|HIST2H4A|MYC|DDB1|HIST2H3C|CETN2|HIST1H3H|POLE3|HIST1H1C|H2AFY|HIST2H4B|CENPK|H3F3B|MIS18A|HIST3H2BB|HIST2H2BE|HIST1H2BK|HIST1H2BJ|XPA|CENPP|GTF2H2
REGULATION OF CELL-CELL ADHESION MEDIATED BY CADHERIN%GOBP%GO:2000047,0.35197799318836803,0.7106060713647829,-0.33437991989709104,-1.08257298097547,2686,11,ADAM19|KIAA2022|SERPINF2
SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION%GOBP%GO:0021527,0.63438127090301,0.863354277348854,-0.6874724305249229,-0.915878349324491,4741,1,MDGA1
LIPID HOMEOSTASIS%GOBP%GO:0055088,0.0005152647172484861,0.0139121625154964,-0.335024328496355,-1.9583338333886102,3,72,FGFR4|ANGPTL4|RORA|NR1D2|INS|PNPLA2|FABP3|ABCG1|POLD1|CEBPA|ORMDL3|EHD1|CETP|RCN3|MALL|APOM|USF2|ABHD5|NR1H3|LRP5|ACOX1|APOE|CYP7B1|NR1D1|TMEM97|FITM2|CAV1|LDLR|PPARG|ABCD1|NPC2|INSIG1
"GLYCINE SECRETION, NEUROTRANSMISSION%GOBP%GO:0061537",0.9296321070234109,0.9793746057014829,-0.5345169827966479,-0.712104966181554,6948,1,SLC6A9
REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION%GOBP%GO:1900157,0.533055630206934,0.812079525085925,0.475112135295179,0.934489503204922,3966,3,FAM101B|FAM101A|GREM1
ACTIN FILAMENT BUNDLE RETROGRADE TRANSPORT%GOBP%GO:0061573,0.0358613361668216,0.268987198588135,0.981859285399206,1.3091768720019,269,1,SHTN1
PROTEIN-CONTAINING COMPLEX LOCALIZATION%GOBP%GO:0031503,0.0345353675450763,0.265648036188578,0.182276230317906,1.3707853116297,248,212,DYNLRB2|DYNC2H1|TTC30B|WDR19|TTC21B|DYNC2LI1|SSB|DDX25|RABL2B|IFT88|TTC30A|WDR35|TTC21A|LCA5|NUP88|IFT46|CPSF3|IFT172|MIOS|NUP35|SMG6|IFT20|CACNG7|IFT140|DLG2|KIF3B|AGFG1|CLUAP1|THOC5|IFT81|ATM|RNPS1|WDR33|TNPO1|WDR60|PCM1|RANBP2|SRSF11|PCID2|UPF2|LRRC7|CACNG4|SRRM1|IFT52|NDC1|DLG4|RPGR|VPS35|RAB11A|XPO1|TRAF3IP1|CDC40|KIF3C|IFT27|KIF5A|MZT1|CPSF4
REGULATION OF GTP CYCLOHYDROLASE I ACTIVITY%GOBP%GO:0043095,0.891220613627308,0.9651611606244209,0.5540913101014561,0.7388059968971249,6709,1,GCHFR
POSITIVE REGULATION OF VIRAL TRANSCRIPTION%GOBP%GO:0050434,0.688681722689076,0.887051934478962,-0.206948711121424,-0.8302742652407241,5244,20,DHX9|SMARCA4|ZNF639|MDFIC|SNW1|NUCKS1|RRP1B
REGULATION OF B CELL CYTOKINE PRODUCTION%GOBP%GO:0002721,0.885217391304348,0.9640874207062379,-0.5599911777679749,-0.7460427105982942,6616,1,BTK
MITOCHONDRIAL TRNA WOBBLE URIDINE MODIFICATION%GOBP%GO:0070899,0.959091512817107,0.9889996530704799,0.520291133656815,0.6937380223625511,7220,1,MTO1
PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009217,0.0147886402303363,0.16327644723639997,-0.7637011327803442,-1.6719014218755202,112,4,NUDT1|NUDT16|SAMHD1
REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY%GOBP%GO:0050855,0.9652014652014649,0.990916952887267,-0.149002660048477,-0.553751579662944,7377,16,PRKCH|LYN|RUNX1|NFAM1|CD300A|PRKCB
NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING%GOBP%GO:2000678,0.518528217886605,0.8047799431921201,-0.274877560754127,-0.9461818688959549,3959,13,DDIT3|SOX11|ZNF675|PSEN1|ZNF593|PER2|TMSB4X
HAIR FOLLICLE DEVELOPMENT%GOBP%GO:0001942,0.653929834103889,0.8743526548195151,0.26590786344022305,0.84241408544615,4808,10,FGFR2|HDAC1|ATP7A
EXONUCLEOLYTIC NUCLEAR-TRANSCRIBED MRNA CATABOLIC PROCESS INVOLVED IN DEADENYLATION-DEPENDENT DECAY%GOBP%GO:0043928,0.567070786077434,0.831084892763575,-0.196208755197846,-0.9214517034896029,4349,33,SKIV2L|DIS3|DCP1B|LSM7|CNOT7|LSM4|EXOSC1|EXOSC5|EXOSC6|LSM2|DDX6|LSM1|EDC4|HBS1L|CNOT8|LSM6|EDC3|DCP1A|EXOSC9|DCP2|CNOT6|TTC37|EXOSC7|LSM5|EXOSC4|DCPS|PATL1|LSM3|NT5C3B|EXOSC3|EXOSC2
REGULATION OF HISTONE PHOSPHORYLATION%GOBP%GO:0033127,0.32989016736401694,0.6957352559323989,-0.352311707138594,-1.10374658753818,2522,10,FMR1|MAPK3|RPS6KA4|H2AFY
REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY%GOBP%GO:0042269,0.474865467909175,0.7849333280810301,-0.24077253064005602,-0.980909023471428,3617,21,PVR|SERPINB9|MICA|NCR3|LILRB1|HLA-E|PIK3R6|PVRL2|CEACAM1|HFE|LGALS9
NEGATIVE REGULATION OF PHOSPHOLIPASE C ACTIVITY%GOBP%GO:1900275,0.259883258158663,0.636098664976652,-0.7022332506203471,-1.16862842457214,1958,2,BICD1|ABL1
REGULATION OF GAMMA-DELTA T CELL ACTIVATION%GOBP%GO:0046643,0.246617139824887,0.6280519349499749,-0.7100082712985942,-1.18156730230003,1858,2,LILRB1|NCKAP1L
HISTONE-THREONINE PHOSPHORYLATION%GOBP%GO:0035405,0.14669286182056301,0.514049001465687,-0.522185691814947,-1.3432022689180498,1119,6,GSG2|PKN1|VRK1|PRKCB
NEGATIVE REGULATION OF P38MAPK CASCADE%GOBP%GO:1903753,0.6633636487036789,0.879862677092874,0.318846175059291,0.825033218233068,4886,6,DUSP10|EZR|DLG1|PTPN22|CYLD|DUSP1
REGULATION OF MICROVILLUS ASSEMBLY%GOBP%GO:0032534,0.11796422935297199,0.468715355641692,-0.580464752239454,-1.39126324824829,896,5,ATP8B1|PLD1|RAP1GAP
FEMALE MEIOSIS I%GOBP%GO:0007144,0.7662876254180602,0.919992400339549,-0.6213608292898101,-0.827801822147713,5727,1,C17orf104
ANTIMICROBIAL HUMORAL RESPONSE%GOBP%GO:0019730,0.000777604976671851,0.0191067003244251,-0.441906581160829,-2.18224418854972,5,39,COLEC11|CXCL1|CXCL2|HLA-E|RPL39|HIST1H2BE|PLA2G2A|AZU1|HIST1H2BC|JCHAIN|SLC11A1|ROMO1|HMGN2|GAPDH|RNASE6|CHGA|RARRES2|HIST1H2BG|S100A8|S100A9|FAM3A|HIST2H2BE|IGHA1|HIST1H2BK|HIST1H2BJ
POSITIVE REGULATION OF RESPONSE TO FOOD%GOBP%GO:0032097,0.55730963120191,0.8261372003522048,-0.576479778758142,-0.959354537901315,4200,2,GHRL
MITOTIC DNA DAMAGE CHECKPOINT%GOBP%GO:0044773,0.998598369011213,0.999656642395059,-0.0777945873619363,-0.47850016399872897,7836,87,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|FOXN3|BLM|SFN|STK33|CDKN1B|CNOT6|AURKA|EME2|PIDD1|PRMT1|RAD9A|PML|RGCC|CLSPN|RPA2|TRIAP1|TFDP2|DONSON|NBN|PLK2|PCNA|TAOK2|CDC25C|EME1|E2F1|CCNB1|PLAGL1|TNKS1BP1|ZNF385A|CCND1|MUS81
PROTEIN IMPORT INTO PEROXISOME MATRIX%GOBP%GO:0016558,0.29447769314472305,0.6674209766210141,0.333873173218233,1.1347699767876298,2164,12,PEX7|PEX2|PEX5|PEX13|PEX1|PEX10|PEX5L|PEX12
POSITIVE REGULATION OF SYNAPSE MATURATION%GOBP%GO:0090129,0.0933350689924499,0.42232843649835,-0.5035592294889749,-1.4496765433272099,716,8,CDC20|ANAPC2|DAB2IP|CAMK2B|ADGRL1
POSITIVE REGULATION OF T CELL EXTRAVASATION%GOBP%GO:2000409,0.13578595317725803,0.498614450236932,-0.931076312307014,-1.24041721259972,1014,1,FADD
ARGININE TRANSMEMBRANE TRANSPORT%GOBP%GO:1903826,0.47899489595602707,0.7850984235874658,-0.445197698048001,-0.9746308240664169,3659,4,SLC7A2|SLC7A3
EPIDERMIS DEVELOPMENT%GOBP%GO:0008544,0.25064366632337803,0.631479765290861,-0.19251891624618203,-1.14244022721557,1946,76,DFNB31|JUP|LAMC2|MED1|WAS|PDZD7|APCDD1|KRT9|INHBA|KRT18|PKP2|PERP|CTGF|CAPN1|SOD1|UGCG|STS|JAG2|EPHA2|PCSK6|FGF7|KRT7|EMP1|PDGFA|ANXA1|KRT19
REGULATION OF HISTONE H3-K27 ACETYLATION%GOBP%GO:1901674,0.844721329046088,0.9483360183395692,0.424131098408442,0.7125950071089621,6304,2,SIN3A|LIF
REGULATION OF CELL ADHESION%GOBP%GO:0030155,0.000127291242362525,0.00518555396908895,-0.266080945349302,-2.19983281805598,0,418,AKT1|ROCK1|FOXP3|CD1D|SIPA1|RAC2|HLA-DMB|CXCL12|CDC42|PAK2|TNF|JAK3|SYK|RAC3|PTEN|RCC2|PRKG1|ACTN4|DUSP1|MDGA1|RAC1|MMP12|ECM2|CD274|DUSP3|PPAP2B|NFKBIZ|CD44|HLA-DPA1|UTRN|TGFB1|LILRB1|HLA-E|RGCC|LYN|ADAM9|CDK6|TBCD|NDFIP1|CD209|PYCARD|TNFAIP8L2|APOD|NCKAP1L|C2CD4A|TNFRSF14|KANK1|JAG1|PEAK1|CORO1C|IL18|ADAM8|RUNX1|CCL19|TWSG1|C2CD4B|EPHB3|RUNX3|JUP|FRMD5|CCDC88B|PPM1F|HLA-DPB1|KLF4|KDR|FZD4|STX4|PLXND1|SEMA6A|PDCD1LG2|VAV1|SFRP2|CYP1B1|CDKN2A|SPN|GATA3|FES|TNFRSF18|ARHGDIB|AZU1|PLAU|IL1RN|EBI3|EPHA8|FCGR2B|PLA2G2D|THY1|CASK|ADA|IL6ST|RREB1|PIEZO1|FOXC2|DOCK5|RC3H2|LILRB2|EFNA1|TESC|NUAK1|NOTCH1|GPNMB|GRB2|PHLDB2|PRKAR1A|SLC9A1|SOCS1|GCNT2|CHRD|PTPN6|CD47|DSCAM|SDC4|ZFHX3|BCAS3|S100A10|RSU1|SNAI2|MMRN2|PIK3CB|BST1|RHOD|ABL1|CALR|FLNA|IRAK1|CYTH1|IGF1|MMRN1|DPP4|CEBPB|NKAP|GPM6B|ICOSLG|VCAM1|C10orf54|DOCK1|CSF1|CCL2|CEACAM1|PDPN|RND1|CD300A|EPHA2|HFE|FN1|DLC1|CD86|NLRP3|PPP2CA|HYAL1|LGALS3|CD36|SERPINE2|TGFBR2|TNFRSF21|BMP2|LGALS9|THBS1|ZP3|SPINT2|TEK|STX3|SEMA5A|FADD|AIF1|TGM2|ARL2|SEMA3E|NEDD9|EMILIN2|ADAM19|CX3CL1|SERPINE1|CAV1|FAM107A|PPARA|HAVCR2|RELA|BCL6|KIAA2022|FERMT3|TGFBI|ADGRG1|LILRB4|ADAMDEC1|NF2|PNP|FBLN2|ANXA1|COL16A1|CD55|NCK1|ARHGDIA|TFRC|TFE3|FXYD5|ACVRL1|SART1|FBLN1|EFNA5|SERPINF2|PTPRJ|COL26A1|SIRPA|EMP2|C1QTNF1|PRNP
RESPONSE TO MONOAMINE%GOBP%GO:0071867,0.68999474789916,0.887051934478962,-0.20670994191888,-0.8293163277733689,5254,20,PDE4B|SLC9A1|MAPK3|ABL1|KCNQ1|PRKACA
NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009141,0.000128024580719498,0.00518555396908895,-0.310674802900601,-2.2294196047351296,0,178,NDUFB5|NADK|SURF1|ATP1B1|UQCR10|PARP1|DCTPP1|NDUFA9|ATP5J|NDUFA7|GPI|ATP5F1|OPA1|IMPDH2|PFKFB2|HK1|NDUFA3|NDUFB6|NUDT1|ATP5B|HK3|SDHD|CYCS|NDUFB9|COA6|NUDT16|SMPDL3A|ENO1|NDUFB10|SDHA|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|CTPS1|PGAM1|MOCS2|MBIP|GAPDH|NDUFS6|COQ7|NDUFB4|NDUFA12|SDHAF2|NME2|LDHA|CMPK2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|STOML2|NDUFA4|ATP5H|NDUFV1|UQCRQ|PGK1|NDUFS3|GPHN|SAMHD1|UQCRC2|COX6A1|UQCC3|NDUFA8|ALDOA|NDUFS8|ALDOC|AK1|ATP5G1|BAD|NDUFV3
GLUTAMATE SECRETION%GOBP%GO:0014047,0.613362970711297,0.852045339927398,-0.277714975529221,-0.870044765296553,4690,10,SLC1A2|SLC1A3|GIPC1
REGULATION OF LIPID BINDING%GOBP%GO:1900130,0.6655598353034929,0.8804055751124069,0.665251433612704,0.8870230224463941,5010,1,PEX19
POSITIVE REGULATION OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR-BETA SIGNALING PATHWAY%GOBP%GO:2000588,0.3770096463022511,0.727766947967183,0.6478632478632479,1.08849390542016,2813,2,HIP1|HIP1R
INTERLEUKIN-8 PRODUCTION%GOBP%GO:0032637,0.47594732598763795,0.7850084910380921,0.499960025386358,0.9833623707703221,3541,3,RAB1A|NOD1
TRNA N1-GUANINE METHYLATION%GOBP%GO:0002939,0.6339799331103679,0.863354277348854,-0.687803264225849,-0.916319099251981,4738,1,TRMT5
T-HELPER 1 CELL LINEAGE COMMITMENT%GOBP%GO:0002296,0.39826086956521706,0.7388683667002129,-0.800562417291575,-1.06654136620487,2976,1,SPN
REGULATION OF NEURONAL SYNAPTIC PLASTICITY%GOBP%GO:0048168,0.653896443514644,0.8743526548195151,-0.20177992685733803,-0.8575590005675929,5000,24,MCTP1|SHISA7|SYP|DBN1|CAMK2B|NSMF|APOE|CAMK2A
NEGATIVE REGULATION OF DEPHOSPHORYLATION%GOBP%GO:0035305,0.4267288693743139,0.7552695100681859,0.17387014200064999,1.01715021035261,3109,68,FKBP1B|MGAT5|PPP1R16B|ARFGEF3|FARP1|SFI1|TMEM132D|INPP5K|RIMBP2|DLG2|MYO1D|CAMSAP3|URI1|PPP1R11|RBM26|CSRNP2|YWHAB|YWHAE|GPATCH2|CHP1|MPHOSPH10|TIPRL|MFHAS1|IKBKB|PCIF1|KIAA0430
POSTSYNAPTIC SIGNAL TRANSDUCTION%GOBP%GO:0098926,0.446537543114885,0.768043844625006,-0.620567962503446,-1.03272432588416,3365,2,KPNA1|KPNA2
VIRION ATTACHMENT TO HOST CELL%GOBP%GO:0019062,0.00696635120925342,0.10045820391703099,-0.681248755231142,-1.8621630925697499,52,7,CD209|GAS6|PVRL2|CLEC4M|ICAM1|CD81
RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS%GOBP%GO:0000054,0.8147178211339531,0.936266868072958,-0.2087683187362,-0.7186210378400941,6221,13,BCCIP|PA2G4|ZNF593|NPM1|NMD3|RAN
EYE MORPHOGENESIS%GOBP%GO:0048592,0.0220264317180617,0.20539399531690303,0.301073941080935,1.5983805341854298,159,48,STRA6|DLL1|BBS4|RARG|AHI1|GNGT1|WNT2B|MFAP2|TWIST1|PTPRM|CEP290|ALDH1A3|MEGF11|TFAP2B|NF1|PHACTR4|SKI|TENM3|AGTPBP1|LRP6
BICELLULAR TIGHT JUNCTION ASSEMBLY%GOBP%GO:0070830,0.9310578355681971,0.9793746057014829,0.14951218523098198,0.616311810270697,6873,21,RAB13|PARD3|MLLT4|STRN|CLDN3|PDCD6IP|PARD6A|PRKCI|PARD6B|RAMP2|INADL
REGULATION OF NOTCH SIGNALING PATHWAY INVOLVED IN HEART INDUCTION%GOBP%GO:0035480,0.634780278670954,0.8634223229282929,0.5323433103630519,0.8944054950369491,4737,2,ROBO2|ROBO1
POSITIVE REGULATION OF CALCIUM ION-DEPENDENT EXOCYTOSIS%GOBP%GO:0045956,0.0546548117154812,0.339130137437274,-0.49798430112857106,-1.56011980834353,417,10,SYT4|HYAL3|CACNA1H|CACNA1G|ZP3|CACNA1I
NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING%GOBP%GO:0060149,0.7860878661087871,0.9274485629622209,-0.235093311644987,-0.736516656198218,6011,10,TGFB1|DND1|TERT|PPARG
ABDUCENS NERVE MORPHOGENESIS%GOBP%GO:0021598,0.214180602006689,0.597438672438672,-0.890769739744155,-1.1867191797671799,1600,1,MAFB
NEGATIVE REGULATION OF CALCIDIOL 1-MONOOXYGENASE ACTIVITY%GOBP%GO:0010956,0.659030010718114,0.8772415412127091,0.518665253911971,0.871424594153779,4918,2,CYP27B1
HEMATOPOIETIC STEM CELL DIFFERENTIATION%GOBP%GO:0060218,0.6787121315038721,0.884536278926676,0.375606206883274,0.8252228327040609,4995,4,SFRP1
GLYCEROL-3-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0006072,0.46104949959426594,0.774935630039646,0.35631011520601896,0.9835845091036619,3408,7,GPAT2|GPD2
NEGATIVE REGULATION OF HIPPO SIGNALING%GOBP%GO:0035331,0.7641239260609219,0.9191113740914171,-0.26164268073797403,-0.753232658219793,5869,8,WWC3|WTIP
PROTEIN ACETYLATION%GOBP%GO:0006473,0.0419803496235805,0.293516895676511,-0.226498642220615,-1.4384419633302301,328,99,KAT6A|KANSL1|ESCO2|KANSL2|JADE3|NAA30|NAA10|YEATS4|TAF6L|BRPF3|RUVBL1|HCFC1|OGT|TAF12|MORF4L2|MSL2|PHF20|NAA50|WDR5|KAT7|TAF9B|SPI1|MBIP|KAT2B|APBB1|TAF10|KAT8|KAT5|TAF9|POLE3|CCDC101|NATD1|AK6
CILIARY BASAL BODY-PLASMA MEMBRANE DOCKING%GOBP%GO:0097711,0.159422321929333,0.5293397224673839,0.19289735387445997,1.2199521925635701,1136,94,NPHP1|CC2D2A|DYNC1I2|CEP162|CLASP1|DCTN1|TMEM67|SFI1|AHI1|FGFR1OP|NINL|CEP89|RPGRIP1L|TTBK2|CEP164|PCM1|CEP290|MARK4|TCTN2|CEP57|B9D1|NPHP4|RAB11A|CEP250|DCTN2|YWHAE
NEGATIVE REGULATION OF CATALYTIC ACTIVITY%GOBP%GO:0043086,0.00012700025400050801,0.00518555396908895,-0.21092982313323003,-1.7437690264883101,0,415,NCKAP1L|SOCS4|VCPKMT|FNIP1|RPS6KA1|TRIAP1|CORO1C|IRAK3|IGBP1|DTX3L|TERF2|TSG101|AGT|SYTL2|SERPINA3|PARP9|DAB2IP|PPM1F|DUSP5|SERPINB8|SPOCK2|KLF4|PPIF|OXA1L|PXK|CNST|APOC1|ANGPTL4|PLN|SERPINB1|HGF|SPRY1|TMBIM6|CDKN1C|HNRNPU|HP|NGF|CDKN2A|BOD1|NPM1|ATPIF1|BAG5|HEXIM1|LMTK3|GAS6|GPX1|INS|THY1|PKMYT1|VTN|MAD2L1|WARS|MAPK8IP1|DDX3X|PLA2R1|CD2BP2|HEG1|GLA|SIAH2|CAAP1|IPO7|PHPT1|NOTCH1|FKBP15|PRKAR1A|CEBPA|SERPINA1|PARK7|AKAP5|RGS4|UBXN1|IFIT1|BCAS3|TIMP3|TAF7|DPEP1|CARD16|ABL1|IFI6|HSPB1|HRAS|RECK|C14orf166|MEN1|LRP5|IFI16|NAIP|SNX6|GNAI2|CAST|TMED2|GNAQ|CEACAM1|CRY2|VPS25|PPP2R4|CD300A|MBIP|USP44|EDNRB|APOE|PLK1|USP47|GAPDH|PLAUR|PPP2CA|FICD|MVP|LGALS3|ECM1|SERPINE2|THBS1|SERPINH1|WWTR1|XIAP|DLG3|CHMP6|ELFN2|ARL2|LATS2|ERRFI1|ADARB1|MNAT1|FKBP1A|MMP9|RRP1B|NR2F2|SERPINE1|CAV1|DNAJA1|RASIP1|CSTB|BCL2L12|ARL6IP1|CCDC8|NFKB1|EIF4A2|SMPD1|STYXL1|TIMP1|ANXA1|H2AFY|RGS2|GPS1|GSTP1|ADGRV1|AOC3|SERPING1|RGS3|NGFRAP1|DHCR24|NGFR|SERPINF1|SERPINF2|PTPRJ|CST3|PRNP
"SYNAPTIC TRANSMISSION, GABAERGIC%GOBP%GO:0051932",0.803009943563558,0.932964969466025,0.374093464348682,0.735797698440634,5975,3,GABRA3|GABRG2
BMP SIGNALING PATHWAY INVOLVED IN SPINAL CORD DORSAL/VENTRAL PATTERNING%GOBP%GO:0021919,0.28575250836120397,0.658457633141178,-0.8541574768416409,-1.1379428544582701,2135,1,CHRD
POSITIVE REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905033,0.28336012861736304,0.6560202082186041,0.6921422663358149,1.16288837354956,2114,2,RNF207|NOS1AP
REGULATION OF RESPONSE TO NUTRIENT LEVELS%GOBP%GO:0032107,0.410326797385621,0.7452892204937491,-0.308752974511854,-1.03342511472641,3138,12,SNAI2|SNW1|GHRL|KANK2|PPARA
TRANSCRIPTION INITIATION FROM RNA POLYMERASE III PROMOTER%GOBP%GO:0006384,0.837704918032787,0.946216977301937,0.238862003605362,0.6933746085013969,6131,8,POLR3H|CRCP|TBP|TBPL1
KIDNEY FIELD SPECIFICATION%GOBP%GO:0072004,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE%GOBP%GO:0051971,0.9423901393354771,0.9821945878594591,0.355334987593052,0.597008658313686,7033,2,CARTPT|GBA
REGULATION OF PROTEIN LOCALIZATION TO CELL LEADING EDGE%GOBP%GO:1905871,0.844468056846859,0.948285501480553,0.5761468901632111,0.7682141368870591,6357,1,FAM65B
NEGATIVE REGULATION OF CELL CYCLE G2/M PHASE TRANSITION%GOBP%GO:1902750,0.389177264469245,0.735806837462884,-0.20094281593253896,-1.04651091468854,2998,47,FOXN3|VPS4A|BLM|PINX1|AURKA|FHL1|FBXL7|UIMC1|CLSPN|DONSON|NBN|CDC6|RAD17|BRCC3|ORC1|TAOK2|BRCA1|TOPBP1|DTL|SKP1|PLK1|USP47|H2AFY|ATF5
REGULATION OF INHIBITORY SYNAPSE ASSEMBLY%GOBP%GO:1905702,0.7530434782608699,0.915448362583738,-0.627977503308337,-0.8366168206975161,5628,1,LHFPL4
POSITIVE REGULATION OF CALCIUM:SODIUM ANTIPORTER ACTIVITY%GOBP%GO:1903281,0.137304324754577,0.502074833795661,-0.772318720705818,-1.28526185430368,1034,2,ATP1B1|SLC9A1
NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION%GOBP%GO:0010832,0.705184992183429,0.894639008000397,-0.266653225540058,-0.802158171786098,5412,9,NOTCH1|HDAC5|NOV
GLYCOLYTIC PROCESS THROUGH GLUCOSE-6-PHOSPHATE%GOBP%GO:0061620,0.108800836929515,0.45309795582492896,-0.333166647892361,-1.37972977612122,831,22,GPI|HK1|HK3|ENO1|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
FLUID TRANSPORT%GOBP%GO:0042044,0.8631322694076279,0.95308264526335,0.245519767131323,0.6777507270302379,6381,7,AQP5|AQP11|SLC26A6
PLASMA MEMBRANE ATP SYNTHESIS COUPLED ELECTRON TRANSPORT%GOBP%GO:0042774,0.279063545150502,0.653204101106396,-0.8574658138509041,-1.1423503537331698,2085,1,COA6
PROTEIN DEACYLATION%GOBP%GO:0035601,0.769599780701754,0.921135900129782,0.15170078845926002,0.800861318460042,5614,47,PRDM5|HDAC11|HDAC1|MTA3|HDAC10|LYPLA2|TBL1XR1|SMARCAD1|HDAC4|SIRT5|SIN3A|SIN3B|TBL1X|SUDS3|LYPLA1|MIER1|SIRT1|HDAC6|HDAC2
REGULATION OF B CELL PROLIFERATION%GOBP%GO:0030888,0.0516389177939646,0.328036869039451,-0.314645866697769,-1.50209830613116,396,35,MNDA|CD38|LYN|GPR183|TNFSF13B|NCKAP1L|VAV3|CD74|AHR|FCGR2B|MZB1|MEF2C|BST1|TNFRSF4|CD300A|TNFRSF21|TFRC|CD81
REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS%GOBP%GO:0032104,0.410326797385621,0.7452892204937491,-0.308752974511854,-1.03342511472641,3138,12,SNAI2|SNW1|GHRL|KANK2|PPARA
BIOLOGICAL ADHESION%GOBP%GO:0022610,0.00012664640324214799,0.00518555396908895,-0.234031533024767,-1.9693009128913603,0,476,ROCK1|PNN|LRRC4C|SPECC1L|CD1D|ROBO1|RAC2|ZYX|CXCL12|TNF|SYK|THBS4|PVR|RCC2|CSTA|CCL4|ATP2A2|NLGN3|MTSS1|PCDHA4|PCDHA6|ITGB3BP|BGLAP|RAC1|ITGB1|ATP2C1|ROPN1B|ECM2|PCDHA7|NRXN3|PPAP2B|CD44|ITGA9|ITGBL1|ACTG1|FGFRL1|PCDHB12|CLEC4A|APC|CCL11|CDH6|ADAM9|PSEN1|CLDN7|PARD3B|ITGAX|SELPLG|CD209|TSTA3|LAMC1|CTTN|FBLN5|PEAK1|CORO1A|FEZ1|PCDHGC5|ACHE|EPHB3|CD84|ITGA10|PCDHB8|PCDH18|JUP|CTNND1|ITGA11|ITGB2|CXADR|SERPINB8|AMIGO1|NID2|CLDN5|MICALL2|PCDHGA5|CDHR2|TRIP6|HMCN1|CLDN11|CD34|TOR1A|PCDHB6|RAP2B|SYNJ2BP|PCDHB11|BCAM|CYP1B1|SPN|FES|SMAD6|ITGB5|TLN1|GP1BA|PCDHB13|PLEK|SRPX2|PCDHGB1|GAS6|CTNND2|PCDHB7|POSTN|CLDN10|THY1|CASK|DDR2|PCDHGB7|ERBB2IP|PCDHB15|ADGRE2|VTN|ILK|TAOK2|PVRL2|TNXB|ITGA5|LILRB2|CLEC4M|EFNA1|TENM2|PCDH12|VWF|CBLN1|GPNMB|COL14A1|MPZL2|MAGI1|COL5A3|PCDHGA12|S1PR1|GNE|PCDH1|IL32|MADCAM1|ICAM1|DSCAM|PKP2|CD63|PCDHGB5|SIGLEC1|CD93|CTGF|CDH8|FBN1|PXN|MSN|PIK3CB|PCDHGA6|SPP1|PCDHB2|RHOD|HSPB1|PPFIA1|DDR1|FLNA|PPFIBP1|MMRN1|WISP1|VCAM1|TNIP1|MYL12A|CDH11|CDH5|KIRREL3|PCDHB16|CCL2|CEACAM1|ROBO4|CYFIP2|PCDH8|CCR1|FN1|CDH7|PCDHGB4|DLC1|APBA1|MPZ|NOV|NRP2|HCK|CD151|TGFBR2|CD200|THBS1|TEK|TIMM10B|SEMA5A|VCL|DLG3|NINJ2|NME2|DCHS1|ITGA8|COL3A1|LYVE1|CX3CL1|STAB1|MYH9|FIBP|EPHB4|S100A8|FERMT3|TGFBI|ADGRG1|CERCAM|ITGAM|S100A9|TIAM1|ACTB|PDGFRA|COL16A1|NRXN2|PODXL2|COL5A1|THEMIS2|TINAGL1|ADGRV1|IGFBP7|ADGRL1|FOLR2|ACTN1|AOC3|MYL9|CD81|ARF6|COL13A1|VMP1|LOXL2|ITGB4|ICAM2|CADM3|SIRPA|FBLIM1|EMP2|ADGRB1
CARBON DIOXIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035378,0.589565217391304,0.8414799095069009,-0.709803705337451,-0.945628969430075,4406,1,AQP1
NUCLEOSIDE SALVAGE%GOBP%GO:0043174,0.0947078857741682,0.42459591129019997,-0.44485404513892407,-1.44023890517486,722,11,TYMP|HPRT1|CDA|TK1|UCK1
PROTEIN ADENYLYLATION%GOBP%GO:0018117,0.160936454849498,0.5311416159351421,-0.9178429642699599,-1.22278721550012,1202,1,FICD
AUTOPHAGY OF NUCLEUS%GOBP%GO:0044804,0.456733298264072,0.7715177634181241,-0.41269578645488597,-0.9891530505279559,3472,5,ATG9B|RB1CC1|ATG9A|ATG7|ATG13
PEPTIDE SECRETION%GOBP%GO:0002790,0.5418111753371869,0.815622645995152,-0.15795089964420003,-0.946163217731988,4217,79,TLR2|WLS|CDK16|CANX|PLEK|PDIA4|SEL1L|S100A13|LTBP2|PARK7|ARL4D|RCN3|GHRL|RAB3C|CD36|FOXP1|MON1A|TLR4|TVP23A|PNP|ANXA1|TVP23C|COPG1
DUTP METABOLIC PROCESS%GOBP%GO:0046080,0.536857484393678,0.813365364472024,0.7302051168945741,0.9736299947167499,4041,1,DUT
NEGATIVE REGULATION OF HEART LOOPING%GOBP%GO:1901208,0.37404682274247497,0.724682900261831,-0.8110939567710631,-1.0805719055633,2795,1,TBX2
REGULATION OF LEUKOCYTE MIGRATION%GOBP%GO:0002685,0.000128369704749679,0.00518555396908895,-0.34557524005794504,-2.2273036194371096,0,106,ADTRP|GPSM3|AKT1|CCL3|RAC2|CXCL12|TNF|THBS4|CCL4|DUSP1|RAC1|GREM1|LYN|PYCARD|APOD|NCKAP1L|CD74|TNFRSF14|PLCB1|ADAM8|RIPK3|CCL19|SLAMF8|P2RX4|SLC8B1|MOSPD2|SPN|TNFRSF18|VEGFC|GAS6|THY1|CREB3|PTGER4|MADCAM1|ICAM1|MSN|PLA2G7|BST1|CALR|HMOX1|CSF1|CCL2|CD300A|PLVAP|CCR1|VEGFB|NOV|LGALS3|CD200|LGALS9|THBS1|ZP3|NBL1|FADD|AIF1|RARRES2|SLIT2|SERPINE1|CMKLR1|ANXA1|LGMN|MPP1
SLOW ENDOCYTIC RECYCLING%GOBP%GO:0032458,0.29260193916854804,0.665081075291014,0.85603220114689,1.1414034333593301,2202,1,MICALL1
NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT%GOBP%GO:1904178,0.12591313587461803,0.481582257349077,0.9386854874283191,1.2516104379716002,947,1,KLF7
AUDITORY RECEPTOR CELL DEVELOPMENT%GOBP%GO:0060117,0.42056319580877505,0.751774348695433,-0.39839431869149,-1.02477750956858,3210,6,DFNB31|PDZD7|SOD1
MEIOTIC NUCLEAR DIVISION%GOBP%GO:0140013,0.987212606561612,0.996006492881216,-0.0963786460018431,-0.5596324922546221,7642,70,GOLGA2|C17orf104|BLM|FIGNL1|RAD54B|RAD21|TRIP13|EME2|MYBL1|DMC1|RAD51|PIM2|RPA2|NUF2|MLH3|BRIP1|ESPL1|RAD51C|PTTG1|TOP2A|STRA13|SGOL1|EME1|RMI1|REC8|RAD51B|FANCM|SYCE2|MUS81
SEROTONIN SECRETION BY PLATELET%GOBP%GO:0002554,0.667023411371237,0.880719592999549,-0.6703242170269079,-0.8930328114162521,4985,1,SYK
POSITIVE REGULATION OF MAST CELL DEGRANULATION%GOBP%GO:0043306,0.275834970530452,0.650819624868901,-0.45196761536455393,-1.16258246051347,2105,6,SYK|SNX4|FGR|VAMP8|VAMP7
NEGATIVE REGULATION OF UBIQUITIN-SPECIFIC PROTEASE ACTIVITY%GOBP%GO:2000157,0.0474927036349164,0.312255783864335,-0.856906534325889,-1.42602950277589,357,2,PARK7|UBXN1
INSEMINATION%GOBP%GO:0007320,0.396789599363226,0.7377402989373809,-0.641191066997519,-1.0670444696446701,2990,2,KLK14|TAC1
VALINE BIOSYNTHETIC PROCESS%GOBP%GO:0009099,0.266914300875564,0.6417330323279019,-0.699290448987104,-1.16373113206506,2011,2,BCAT2
NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY%GOBP%GO:0061099,0.0645288474175319,0.364731140642234,-0.376904243228544,-1.48911350293073,490,19,SH3BP5|ZFYVE28|HYAL2|SOCS4|TSG101|THY1|SNX6|VPS25|MVP|CHMP6|ERRFI1|CAV1
REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING%GOBP%GO:0106014,0.4493645484949829,0.768229288546963,-0.776962946625496,-1.0351012047105699,3358,1,SIGLEC10
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT%GOBP%GO:0051926,0.0110024449877751,0.13557402637094002,0.387972180041348,1.75770410192865,80,28,FKBP1B|CRHR1|BIN1|GSTM2|C19orf26|INPP5K|DRD4|PACSIN3|GNB5|SRI|TRIM27|PKD2|YWHAE|SESTD1
PENTOSE-PHOSPHATE SHUNT%GOBP%GO:0006098,0.0736970684039088,0.382002237820699,0.453777966207918,1.4932081467031597,542,11,DERA|RPE|PGD|RPIA|RBKS|SHPK|G6PD|PGM2
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING%GOBP%GO:0086028,0.0166621875839828,0.17569702079137303,0.8313558080191421,1.63517876793373,123,3,TRPM4|SCN5A|CACNA2D1
THYMINE METABOLIC PROCESS%GOBP%GO:0019859,0.52505359056806,0.808245162096538,0.580920871243452,0.97602206941879,3918,2,DPYD|ALDH6A1
NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION%GOBP%GO:0014859,0.7859056806002142,0.9274485629622209,0.456741108354012,0.767384034266335,5865,2,EPHB1|AKIRIN1
ADRENOMEDULLIN RECEPTOR SIGNALING PATHWAY%GOBP%GO:1990410,0.89059023687999,0.965159112268525,-0.299726845441849,-0.6561647188398549,6804,4,ADM|CALCRL
POSITIVE REGULATION OF AMYLOID-BETA FORMATION%GOBP%GO:1902004,0.6469665271966529,0.8697778704754799,-0.269653003806477,-0.8447876603025719,4947,10,PICALM|CASP3|GSAP|ROCK2|CHRNA7|GSK3A|CLU|APP|EFNA1|EPHA4
NEGATIVE REGULATION OF FAS SIGNALING PATHWAY%GOBP%GO:1902045,0.23628635941027998,0.62149045081524,0.8834362593736221,1.1779430472968202,1778,1,TMBIM1
DORSAL SPINAL CORD DEVELOPMENT%GOBP%GO:0021516,0.9745958429561199,0.992088128046979,0.249595038197956,0.548370928584268,7173,4,DRAXIN|PROX1
TRANSCRIPTION FACTOR CATABOLIC PROCESS%GOBP%GO:0036369,0.8747320471597,0.9601297344254901,0.406341328921974,0.682705897441582,6528,2,MDM2|TAF1
PRE-REPLICATIVE COMPLEX ASSEMBLY INVOLVED IN CELL CYCLE DNA REPLICATION%GOBP%GO:1902299,0.9817460317460319,0.993436724391485,-0.267898030962178,-0.5231369559923079,7421,3,CDC45
FUSION OF VIRUS MEMBRANE WITH HOST PLASMA MEMBRANE%GOBP%GO:0019064,0.0152471083070452,0.166148433567765,-0.6387085015856769,-1.7458812062854,115,7,HYAL2|CD4|PPIA|GAS6|PVRL2|CXCR4
NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT%GOBP%GO:0070168,0.290723537877797,0.66326939121011,-0.299783542244282,-1.1392506665337099,2221,17,ROCK1|CCL3|TGFB1|GREM1|BCOR|GAS6|NOTCH1|SRGN|CCR1|NOS3|ECM1
POLY-N-ACETYLLACTOSAMINE BIOSYNTHETIC PROCESS%GOBP%GO:0030311,0.33053827427644,0.6957352559323989,0.40166081973351503,1.10877391166775,2443,7,B3GNT9|B3GNT2|B3GNT7
CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:0061684,0.0318021201413428,0.253574825065372,-0.720856892869186,-1.57810642465474,242,4,LAMP2|HSP90AA1
DNA CYTOSINE DEAMINATION%GOBP%GO:0070383,0.130063124671226,0.48898420151649696,-0.572313853408244,-1.37172709908454,988,5,APOBEC3G|APOBEC3C|APOBEC3F
POSITIVE REGULATION OF VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION%GOBP%GO:1903762,0.28336012861736304,0.6560202082186041,0.6921422663358149,1.16288837354956,2114,2,RNF207|NOS1AP
MITOCHONDRIAL TRANSPORT%GOBP%GO:0006839,0.67883679221112,0.884536278926676,-0.12574140552539398,-0.8964642870101899,5298,172,GZMB|SLC25A20|PPIF|CCDC109B|CHCHD4|TST|ATP5J|SLC8B1|ATP5F1|PMPCA|TOMM20|SLC25A18|NMT1|ATP5B|PPP1R13B|SLC25A6|MRS2|TOMM70A|TIMM21|SLC25A16|SLC25A22|ROMO1|E2F1|ATP5O|AIP|IMMP1L|TIMM10B|TIMM9|TIMM17B|CAMK2A|STOML2|MPV17L|ATP5H|HSP90AA1|MPC1|TOMM5|HSPA4|STPG1|TIMM10|UQCRC2|DNAJC19|BAD|SLC25A5|DNAJC15
POSITIVE REGULATION OF SYNAPSE STRUCTURAL PLASTICITY%GOBP%GO:0051835,0.48561872909699,0.7872939093021379,-0.760200705778562,-1.01276987505107,3629,1,CAMK1
MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0006509,0.835720856880011,0.945788393670804,-0.180585141515675,-0.713475047020332,6358,19,SPPL2A|SPPL2B|PRKCQ|ERAP1|SPPL3|ADAM9|PSEN1|HM13|RBMX|MYH9|BACE2
PEROXISOME TRANSPORT ALONG MICROTUBULE%GOBP%GO:0036250,0.766822742474917,0.9202428578352959,-0.6209197176885749,-0.8272141555777259,5731,1,PEX14
ORGANELLE INHERITANCE%GOBP%GO:0048308,0.696652719665272,0.89107464564121,-0.257960291884138,-0.808155920221702,5327,10,STX5|VRK1
POSITIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES%GOBP%GO:1901033,0.9964678712131501,0.9989409452276621,0.20932653573610802,0.45989931373514703,7334,4,RIPK1|HDAC6
NEUROLOGICAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE%GOBP%GO:0001976,0.484144047299113,0.7872939093021379,0.49641768308897793,0.9763950014952691,3602,3,DRD2|TNNI3
NEGATIVE REGULATION OF DOPAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051585,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
CTP METABOLIC PROCESS%GOBP%GO:0046036,0.430883523481029,0.759376613000886,-0.6266341204148821,-1.04281938270038,3247,2,CTPS1
TRACHEA CARTILAGE DEVELOPMENT%GOBP%GO:0060534,0.442024173196972,0.7653693162885199,0.780381561535068,1.04053351319385,3327,1,LRP6
REGULATION OF ADENYLATE CYCLASE-INHIBITING ADRENERGIC RECEPTOR SIGNALING PATHWAY%GOBP%GO:0071877,0.0560535117056856,0.343943018657969,-0.970004411116012,-1.29227878740106,418,1,RGS2
CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS%GOBP%GO:0071499,0.280091966459291,0.653204101106396,0.421139281388236,1.1625436822331299,2070,7,MAPK7|MAP2K5|NFE2L2
PROTEIN LOCALIZATION TO CELL PERIPHERY%GOBP%GO:1990778,0.151162790697674,0.518359045388749,0.17084671929201997,1.2044149837523401,1091,154,ANK2|KIF13A|RTKN|BBIP1|TMEM150A|EFR3B|INPP5K|RAB13|RAB3B|ARL3|LIN7B|CLASP2|RAMP1|RAB3D|RAB10|ZDHHC23|FLOT2|SYS1-DBNDD2|GCC2|LIN7A|MAP7|PPIL2|EHD3|RILPL1|GGA1|GOLPH3L|SPTBN1|MLLT4|RAB15|ZDHHC22|LRRC7|EPB41L3|RAMP3|TTC7A|FLOT1|AP4M1|GORASP2|TSPAN5|VPS35|RAB11A|CACNB2|BBS2|MYO5A|BLZF1|TULP3|LRP6|GOLGA7|ZFYVE27|EZR|KCNB1
NEGATIVE REGULATION OF RESPIRATORY BURST%GOBP%GO:0060268,0.567724867724868,0.83116084992853,-0.47110478843761494,-0.919948250800872,4291,3,SLAMF8|INS
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE%GOBP%GO:1902474,0.767938726148885,0.920474726214876,0.388431143891566,0.7639982221439839,5714,3,NLGN2|DVL1
FIBROBLAST ACTIVATION%GOBP%GO:0072537,0.23706553462456897,0.6217158626397761,-0.714033636614282,-1.1882661538896397,1786,2,RGCC|IL17RA
REGULATION OF 1-PHOSPHATIDYLINOSITOL-3-KINASE ACTIVITY%GOBP%GO:0061901,0.542701553991234,0.816099720857136,0.7271173356859291,0.9695128551181601,4085,1,AGAP2
REGULATION OF IRON ION TRANSPORT%GOBP%GO:0034756,0.22798063080748604,0.609818988326981,-0.5652618148410999,-1.23747627363621,1741,4,B2M|HAMP|HFE
AMYLOID FIBRIL FORMATION%GOBP%GO:1990000,0.298359802134861,0.6711955314970389,-0.397305833546136,-1.1437878876798702,2291,8,APP|MAPT|RIPK3|GSN|CD36|FKBP1A
SOMITOGENESIS%GOBP%GO:0001756,0.610862186014936,0.8515562847300799,0.249417117559188,0.8735107459542959,4498,13,DLL1|HES7|HES6|HES4|LRP6
"PROTEIN IMPORT INTO PEROXISOME MATRIX, TRANSLOCATION%GOBP%GO:0016561",0.445476253648183,0.7671494493272959,-0.620953956437827,-1.03336668151605,3357,2,PEX14|PEX6
METANEPHRIC GLOMERULAR MESANGIAL CELL DIFFERENTIATION%GOBP%GO:0072254,0.117670469620589,0.46862716515177505,-0.7874827681279292,-1.3104972541275801,886,2,CD34|PDGFB
POSITIVE REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY-STIMULATING FACTOR STIMULUS%GOBP%GO:1903974,0.0406084656084656,0.288441534418227,-0.7777655233263481,-1.51877894319482,306,3,TLR2|CSF1|TLR4
POSITIVE REGULATION OF RNA INTERFERENCE%GOBP%GO:1900370,0.438172400053128,0.764010646165493,0.782587119541244,1.04347432719284,3298,1,XPO5
GLYCINE BIOSYNTHETIC PROCESS FROM SERINE%GOBP%GO:0019264,0.588617670469621,0.8414799095069009,-0.5632550079202541,-0.9373464044272091,4436,2,SHMT2
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA%GOBP%GO:0061428,0.6865914957206899,0.8861361847538001,0.37347541982585,0.820541402793711,5053,4,CITED2|HIF1AN|SIRT2|VHL
CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY%GOBP%GO:0097646,0.7956204379562041,0.929819740961342,0.305924607709265,0.7357469272127422,5885,5,RAMP1|RAMP3|RAMP2
OVARIAN CUMULUS EXPANSION%GOBP%GO:0001550,0.5849382388099351,0.839854222268064,0.7058337009263341,0.941134000027873,4403,1,BMPR1B
SMAD PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0060395,0.868672334859385,0.956481047534325,-0.151591758110185,-0.6921382893792529,6640,30,INHA|SMAD4|BMP4|MAGI2|BMP8B|TGFB2|GDF15|SMAD9|NUP93|TGFB1|INHBB|TGFB3|SMAD5|SLC33A1|INHBA|BMP2|ATOH8|GDF11
REGULATION OF DENDRITE MORPHOGENESIS%GOBP%GO:0048814,0.46819933920704904,0.780769690730001,0.186643710926848,0.990878431067567,3400,48,ADGRB3|SS18L1|CHRNB2|PTPRD|CDK5R1|SARM1|CAPRIN2|CUX2|NEDD4|CUL7|SIPA1L1|YWHAH|NEDD4L|OBSL1|CHRNA3|LRP8|CDK5|FBXW8|GORASP1|CDKL3
REGULATION OF G PROTEIN-COUPLED RECEPTOR INTERNALIZATION%GOBP%GO:1904020,0.231084656084656,0.614511437916015,-0.6242417558178011,-1.21898593568955,1746,3,APLN|UBQLN2|NECAB2
CLUSTERING OF VOLTAGE-GATED SODIUM CHANNELS%GOBP%GO:0045162,0.41346412254770204,0.748061280707938,0.532035824850372,1.04645168312267,3076,3,AGRN|NRCAM
METANEPHRIC GLOMERULUS DEVELOPMENT%GOBP%GO:0072224,0.00863761287789556,0.11593697760655802,-0.7875696244416259,-1.72415453953327,65,4,CD34|PDGFRB|PDGFRA|PDGFB
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001235,0.0989109545163357,0.43390420706119104,-0.198480355766488,-1.2969683902987599,771,112,HYAL2|FIS1|PYCARD|APOPT1|GNB2L1|TFDP2|AGT|BCL2L11|DAB2IP|GZMB|PPIF|PDCD5|WWOX|NMT1|TRAF2|SLC9A3R1|PPP1R13B|TNFSF10|INHBA|TNFSF12|TIMP3|SOD1|G0S2|E2F1|GPER1|CIDEB|GSN|NACC2|PLAUR|LGALS9|THBS1|FADD|MMP9|BCAP31|CAV1|LTBR|TNFRSF12A|S100A8|S100A9|STYXL1|NCK1|BAD
LEUKOCYTE MIGRATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002522,0.157591973244147,0.527461735831916,-0.919276576973975,-1.2246971318525801,1177,1,HCK
RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0046390,0.0461538461538462,0.30746333312705,-0.20798166126072798,-1.4026628621440602,359,131,ATP5J|DCAKD|GPI|ATP5F1|COASY|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|PDHA1|ACSF3|ATP5B|HK3|ADCY8|NPR2|ELOVL1|SLC26A2|ENO1|ADCY4|ATP5O|CTPS1|PGAM1|HPRT1|PRPS1|NPR1|RFK|GAPDH|UMPS|HACD2|GMPS|LDHA|STOML2|PDHX|ATP5H|PGK1|FASN|ADCY9|ALDOA|ALDOC|ATP5G1
NEGATIVE REGULATION BY SYMBIONT OF HOST CATALYTIC ACTIVITY%GOBP%GO:0052053,0.259795457564086,0.636098664976652,0.872022496691663,1.16272433485203,1955,1,CASP8
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT%GOBP%GO:2000697,0.991366715367247,0.997150662115148,0.504631671812969,0.672858242969697,7463,1,STAT1
POSITIVE REGULATION OF OXIDATIVE STRESS-INDUCED CELL DEATH%GOBP%GO:1903209,0.589905362776025,0.8414799095069009,-0.32413829170873304,-0.8860175656450409,4487,7,SOD1|TLR4
POSITIVE REGULATION OF SEMAPHORIN-PLEXIN SIGNALING PATHWAY%GOBP%GO:2001262,0.923097356886705,0.9776156396135859,0.53931407146008,0.719102543103869,6949,1,HAND2
PEROXISOMAL LONG-CHAIN FATTY ACID IMPORT%GOBP%GO:0015910,0.0814715719063545,0.397722753303477,-0.956936479929422,-1.2748691652652,608,1,ABCD1
WATER-SOLUBLE VITAMIN METABOLIC PROCESS%GOBP%GO:0006767,0.0404639175257732,0.28837731910627695,-0.266512837674045,-1.50091827270781,313,62,HLCS|KYNU|PDXP|THTPA|MCCC2|DHFR|RFK|PCCB|SLC2A3|PNPO|CYB5A|MMAB|SHMT2|SLC25A19|FOLR2|PDXK|MTHFD1|ABCC1
ALKALOID METABOLIC PROCESS%GOBP%GO:0009820,0.977248677248677,0.9927322181739301,-0.27418686005020804,-0.535417445304049,7387,3,CYP3A5|BCHE
SMOOTH MUSCLE HYPERTROPHY%GOBP%GO:0014895,0.814982069331917,0.936505554413397,0.591696074106749,0.788946875579963,6135,1,CYBA
NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION%GOBP%GO:1903215,0.5646825396825401,0.8295590091625621,-0.472703209440829,-0.9230695619020121,4268,3,BAG4|SIAH3|LMAN1
RESPONSE TO HORMONE%GOBP%GO:0009725,0.0008973208563004741,0.0214437672455875,-0.19395947677541397,-1.57188687418287,6,363,TGFB1|STAT5A|AQP1|APC|ABCA2|ATP6V1D|PRKAR2A|LYN|INHBB|ADAM9|POR|NR4A1|LGR4|JUNB|STRN3|ATP6V0A1|PLCB1|NR3C1|CCL19|REST|PIK3C2A|ZFP36L1|BCL2L11|MED13|AP3S1|TCIRG1|ATP6V0B|GOT1|PARP1|ATP6V0A2|SFRP4|HCLS1|CTSS|ATP6V1G2|NR1D2|MED1|HNRNPU|ATP1A3|OGT|EIF2B1|CAV2|IL1RN|LMO2|GGT1|ATP6V1F|TGFB3|INS|CACNA1H|BCAR1|FOXC2|CTSB|SYAP1|ABCG1|RERG|THRA|ADCY8|NOTCH1|SST|ATP6V0D1|CA2|GRB2|CRHBP|PRKAR1A|PTGER4|MEF2C|IRS1|STAT3|ADIPOR1|BRCA1|DDX5|PXN|MSN|TIMP3|SPP1|GHRL|CALR|ADCY4|PIK3R3|NR1H3|RAN|HDAC5|NSMF|CHRM2|WBP2|GNAQ|CTSH|CEACAM1|NCOA4|GPER1|RBM14|CDK7|KAT2B|NOS3|GNA15|CPEB1|ADIPOR2|ATP6V0E1|TGFBR3|THBS1|H2AFZ|FHL2|NR1D1|SRF|PPAP2A|LATS2|RARRES2|SLIT2|CAMK2A|IGFBP5|LPIN3|CAV1|EIF2B2|FAM107A|PPARG|PPARA|ATP6AP1|ANG|RELA|YAP1|RPS6KB1|NFKB1|PRKACA|ATP6V0E2|KAT5|ADRBK1|CTSL|LY6H|TIMP1|ANXA1|TFPI|PHB|CCND1|ATP6V1A|EIF2B3|LPIN2|ATP6V1G1|SSTR2|ADCY9
S-ADENOSYLMETHIONINE METABOLIC PROCESS%GOBP%GO:0046500,0.398805483914755,0.7388683667002129,0.40196348794881703,1.0401041505764699,2937,6,MAT2A|MAT2B|METTL16|GAMT|GNMT|MTRR
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION%GOBP%GO:2000691,0.558528428093645,0.8268422944617521,-0.724139832377592,-0.964728132954647,4174,1,PRICKLE1
NEUTROPHIL DEGRANULATION%GOBP%GO:0043312,0.000126984126984127,0.00518555396908895,-0.32959081253700395,-2.7101987246889,0,398,RAC1|DOCK2|IQGAP1|CXCL1|UNC13D|BRI3|RAP2C|NDUFC2|GM2A|CD44|MNDA|CNN2|ATP6V1D|ATG7|MAN2B1|DNAJC3|PSEN1|RAB5C|ITGAX|MLEC|ALOX5|PSMD1|CHI3L1|PSMC2|ACTR10|PYCARD|NCKAP1L|ATP6V0A1|DYNC1H1|GSDMD|B2M|NEU1|GYG1|ADAM8|FRMPD3|DGAT1|DSN1|AP2A2|SERPINA3|JUP|RAB14|OSTF1|ITGB2|TCIRG1|FGL2|METTL7A|TLR2|PPIA|FGR|RAB7A|PSMD3|GMFG|CTSS|STXBP2|SERPINB1|TNFAIP6|RAP2B|GAA|HP|MOSPD2|ATP11B|GPI|CKAP4|TICAM2|IMPDH2|TXNDC5|KPNB1|PRCP|AZU1|IQGAP2|PLAU|LILRB3|RAB24|ARMC8|LAIR1|GGH|VCP|ARSB|FPR1|C3|RHOF|CTSB|CCT8|OSCAR|DDX3X|HK3|GLA|LILRB2|OLR1|HSPA6|DOK3|NFAM1|ILF2|SERPINA1|PTPN6|ORMDL3|CD47|CD63|FCER1G|ATP6AP2|PTGES2|SIGLEC14|CD93|GRN|SLC11A1|FAF2|BST1|RHOG|SIGLEC9|CYBB|CAPN1|HUWE1|ALAD|ERP44|VAMP8|FCN1|VAMP7|PGAM1|CRISPLD2|FCGR2A|PLD1|COPB1|TMEM173|CTSZ|CTSH|CDA|CEACAM1|CD300A|GSN|FTL|RAP1A|CAT|PLAUR|FUCA1|MVP|ADGRE5|LGALS3|CD36|CTSC|BST2|CREG1|ATP8B4|ANPEP|GLIPR1|VCL|PSMD2|NME2|COTL1|CD59|MMP9|PSMD6|CANT1|TYROBP|B4GALT1|PTAFR|C3AR1|LAMP2|CSTB|ENPP4|PYGL|RAB9B|NFKB1|CTSD|STOM|SLC2A3|S100A8|CFP|PSMD12|TMEM179B|ITGAM|S100A9|CFD|ANXA2|HSP90AA1|CD68|PRDX4|HEXB|PNP|MAGT1|COMMD9|CD55|GSTP1|NPC2|TOLLIP|SURF4|S100A11|TUBB4B|CD14|AGPAT2|PSMD13|ALDH3B1|PSMB7|DBNL|TNFRSF1B|PGRMC1|PDXK|C5AR1|DNASE1L1|PSMC3|FTH1|PTPRJ|ALDOA|CST3|ALDOC|SIRPA
TAXIS%GOBP%GO:0042330,0.00753608379103334,0.105409699039952,-0.189306976865023,-1.4804779265217798,58,289,CORO1A|ADAM8|SPTBN5|FEZ1|CCL19|SLAMF8|HMGB2|EPHB3|NTN3|SPON2|ITGB2|CXADR|SBDS|PLXND1|SEMA6A|SPTBN4|CCL24|HGF|SMO|SLC12A2|SPN|NTN4|FES|TNFRSF11A|AZU1|PLAU|IL1RN|EPHA8|GAS6|PDE4B|CCL3L3|BCAR1|ADGRE2|CCL18|DOK2|CXCR4|EFNA1|GPNMB|GRB2|LGI1|S1PR1|FAM129B|DSCAM|FCER1G|PIK3CB|FGF10|MAPK3|RHOG|HRAS|SEMA3B|SEMA3D|PLD1|SEMA7A|CCRL2|HBEGF|CCL2|CXCL16|ROBO4|CYFIP2|EPHA2|CORO1B|EDNRB|CCR1|PLAUR|NOV|NRP2|LGALS3|EFNA3|CHGA|CYP7B1|FGF7|SEMA5A|PDGFRB|SEMA3E|EPHA4|SLIT2|CX3CL1|SCN1B|SEMA3A|CCL4L2|CCL14|SEMA6B|S100A8|S100A9|PDGFA|EVL|PDGFRA|CMKLR1|ANXA1|SPTBN2|FOLR2|RAP1GAP|PDGFB|C5AR1|LYST|EFNA5|PTPRJ|GRB10|ABCC1
NEGATIVE REGULATION OF T-HELPER 17 CELL DIFFERENTIATION%GOBP%GO:2000320,0.92778607302837,0.979345221662042,0.235869345848715,0.6103257956659109,6834,6,LOXL3|RC3H1
DIPHOSPHOINOSITOL POLYPHOSPHATE METABOLIC PROCESS%GOBP%GO:0071543,0.7360293155346159,0.908157084784786,-0.35559109356837504,-0.7784632357147929,5623,4,NUDT11|NUDT4
POSITIVE REGULATION OF IMMUNE RESPONSE TO TUMOR CELL%GOBP%GO:0002839,0.8788795370857451,0.960725750963158,-0.277075567553252,-0.664097264540461,6682,5,PVR|CD274|PVRL2
MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL%GOBP%GO:0098815,0.37559257754300396,0.726487815544229,0.25653228668963896,1.05746483310586,2772,21,RIMS1|RIMS2|MTMR2|CUX2|PTK2B|DLG4|NLGN2|NLGN4X|SHANK2
"RETROGRADE PROTEIN TRANSPORT, ER TO CYTOSOL%GOBP%GO:0030970",0.0329497907949791,0.259512489684881,-0.41728808395757305,-1.61923295935153,251,18,HSP90B1|HM13|VCP|SEL1L|FAF2|HERPUD1|NPLOC4|SYVN1|SEC61B
POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION%GOBP%GO:0043382,0.37473204715970004,0.7254164153140609,0.649003844741035,1.09041025544327,2796,2,CD46|IL12RB1
NEGATIVE REGULATION OF PROTEIN HOMOOLIGOMERIZATION%GOBP%GO:0032463,0.9529442691903259,0.9865418542264789,-0.207480744573379,-0.567139362819605,7249,7,CLU|PEX14|GBA|CRYAB
POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM%GOBP%GO:0070863,0.282699322563835,0.655069746883962,-0.38438945244863304,-1.15633756091105,2169,9,BCAP31|SAR1B
MUSCLE CELL DIFFERENTIATION%GOBP%GO:0042692,0.100111544896821,0.43605057892447596,0.214633732757213,1.30924489070042,717,81,NEBL|CHRNB1|ACVR1|BIN1|ADGRB3|CBY1|TMOD3|ANK2|OBSCN|SDC1|ALPK3|DMD|SPEG|NEB|MKL1|GLMN|SEMA4C|MYEF2|WDR1|RYR1|AKAP13
CARDIAC MUSCLE CELL CONTRACTION%GOBP%GO:0086003,0.758314855875832,0.917143966125732,-0.17797768077295698,-0.7849685227963059,5813,27,ATP1A1|GJC1|GPD1L|SCN4B|GJA1|RYR2|KCNN2|PKP2|CACNA1G|KCNQ1|SCN1B|KCNH2|KCNE4
"POSITIVE REGULATION OF DNA-TEMPLATED TRANSCRIPTION, TERMINATION%GOBP%GO:0060566",0.7298996655518399,0.906544799850309,-0.639225849139832,-0.85160231823218,5455,1,SETX
NEGATIVE REGULATION OF MIRNA CATABOLIC PROCESS%GOBP%GO:2000626,0.513177257525084,0.802184867798321,-0.7465262461402741,-0.9945522113814791,3835,1,PAPD4
MONOUBIQUITINATED HISTONE H2A DEUBIQUITINATION%GOBP%GO:0035522,0.6122235309514461,0.852045339927398,-0.39771297158839203,-0.870676831755102,4677,4,USP16|MYSM1
ER-NUCLEUS SIGNALING PATHWAY%GOBP%GO:0006984,0.13237410071942401,0.49246068748285293,-0.288712182654065,-1.3182033028463798,1011,30,MBTPS2|CALR|HERPUD1|CCL2|TMCO1|EIF2S1|HSPA5|INSIG1
MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS%GOBP%GO:0031293,0.729136548823761,0.906471456078912,-0.20215858194583497,-0.7987096975353791,5547,19,RELA|NFKB1|NGFR
MRNA 3'-SPLICE SITE RECOGNITION%GOBP%GO:0000389,0.0227897838899804,0.20967867277886898,-0.6476200981743979,-1.6658533523608101,173,6,SF3A3|SF3A2|SF3A1|SLU7|SF1|ISY1
POSITIVE REGULATION OF L-DOPA DECARBOXYLASE ACTIVITY%GOBP%GO:1903200,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:0002042,0.254873740677744,0.6334930240678559,-0.308990068837399,-1.17423771578648,1947,17,ADTRP|AKT1|ROBO1|GREM1|NR4A1|KDR|PIK3R3|SRF|SLIT2|EPHB4
CELLULAR COMPONENT MAINTENANCE%GOBP%GO:0043954,0.24203214383001898,0.625158460820442,0.278995422928343,1.18445966685718,1776,23,DCTN1|PICK1|KIFC3|KIAA1715|CAMSAP3|MTMR2|IGF1R|MTHFR|NLGN2
PHOSPHORELAY SIGNAL TRANSDUCTION SYSTEM%GOBP%GO:0000160,0.167352902111834,0.539733478456492,0.9180083811204229,1.2240403067310401,1259,1,MMS19
REGULATION OF SPINDLE ORGANIZATION%GOBP%GO:0090224,0.80272577092511,0.932964969466025,0.155528506217339,0.763772642462165,5830,37,CHMP3|DCTN1|FSD1|PARP3|MAP9
CARDIAC CONDUCTION%GOBP%GO:0061337,0.348879624804586,0.706981624190196,-0.212257499850122,-1.07656269295873,2677,43,RYR2|JUP|CXADR|ATP1B1|SPTBN4|ATP1A3|KCNN2|KCNK6|SLC9A1|PKP2|CACNA1G|KCNQ1|CAV1|SCN1B|ATP1B2|PRKACA|KCNH2|KCNE4
LOCOMOTORY BEHAVIOR%GOBP%GO:0007626,0.502184598580011,0.796769413401376,0.20663035235698898,0.963902072926244,3677,31,DRD2|RASD2|PARK2|DRD4|CHRNB2|BTBD9|ATP7A|PEX13|STRN
CHONDROITIN SULFATE CATABOLIC PROCESS%GOBP%GO:0030207,0.0605228758169935,0.355936982159638,-0.46020165586508605,-1.54033803159814,462,12,ARSB|DCN|BGN|VCAN|HYAL1|HEXB
CELLULAR RESPONSE TO FRUCTOSE STIMULUS%GOBP%GO:0071332,0.6820747110991671,0.885415243771438,0.419047093856844,0.8242161828058892,5075,3,SLC26A6|XBP1|SLC2A5
POSITIVE REGULATION OF ODONTOGENESIS%GOBP%GO:0042482,0.6044074173609251,0.848175106515994,0.447568130768404,0.880313696707139,4497,3,WNT6
MEMBRANE LIPID CATABOLIC PROCESS%GOBP%GO:0046466,0.379858193277311,0.729249457747391,-0.262351850795223,-1.05255060045164,2892,20,PPT1|NEU1|CYP1B1|GLA|NEU4|SMPDL3A|FUCA1|SMPD1|SPHK1
VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION%GOBP%GO:0010573,0.24051472539135102,0.624461333747413,-0.7128991056369759,-1.18637811291826,1812,2,ADGRG1
PROTEIN DEMALONYLATION%GOBP%GO:0036046,0.342143710984194,0.701955655133333,0.829234671371857,1.1056725432715602,2575,1,SIRT5
SMALL RNA LOADING ONTO RISC%GOBP%GO:0070922,0.9822824387701931,0.993436724391485,-0.16874448367166797,-0.507624710883987,7539,9,AGO2|AGO3|AGO1|TARBP2|ADAR|AGO4|DICER1|DHX9|CLP1
REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS%GOBP%GO:0046984,0.662871351917288,0.879680951980053,-0.380593371256437,-0.833198447989018,5064,4,EIF2AK1|PRMT1|KLF4
NEGATIVE REGULATION OF CYCLIN-DEPENDENT PROTEIN KINASE ACTIVITY%GOBP%GO:1904030,0.14259453781512602,0.508674778494682,-0.33016347845322996,-1.32460955179005,1085,20,APC|HEXIM2|CDKN1C|CDKN2A|HEXIM1|IPO7|CEBPA|MEN1|PLK1|LATS2|NR2F2
REGULATION OF INTERMEDIATE FILAMENT POLYMERIZATION OR DEPOLYMERIZATION%GOBP%GO:0045108,0.20069066277061998,0.578325746675525,0.9013564181737981,1.2018371610386398,1510,1,NES
HETEROCHROMATIN ASSEMBLY INVOLVED IN CHROMATIN SILENCING%GOBP%GO:0070869,0.0634113712374582,0.360259251822829,-0.966365240405823,-1.28743053819867,473,1,POLE3
DISRUPTION BY SYMBIONT OF HOST CELL%GOBP%GO:0044004,0.16909698996655498,0.541811331682474,-0.913542126157918,-1.21705746644275,1263,1,GAPDH
SOMATIC STEM CELL POPULATION MAINTENANCE%GOBP%GO:0035019,0.9646354733405881,0.990916952887267,0.16349648908517403,0.555692766015587,7091,12,SALL4|FGF2|SKI|SMAD2|LIG4|EPHA1
EMBRYONIC ORGAN DEVELOPMENT%GOBP%GO:0048568,0.0721921421629876,0.378321151505122,0.199813930807725,1.32579898566087,519,117,RBPMS2|STRA6|BBS5|ACVR1|NPHP3-ACAD11|FGFR2|DLL1|BBS4|RARG|PAX8|AHI1|EPHB2|MFAP2|TWIST1|RNF112|SETDB2|KIT|NES|THOC5|BMP7|PKD1|ZNF568|WDR60|CASP8|CEP290|ERCC3|ALDH1A3|MKKS|NPHP3|PKD2|CITED2|ZFPM1|CCDC40|PHACTR4|CHD7|MTHFD1L|LRP6|BBS7|MEGF8|RARB
REGULATION OF MITOTIC CYTOKINESIS%GOBP%GO:1902412,0.159760902051352,0.529429183067871,0.6000487207778771,1.3183325942072401,1175,4,MAP9|ANKRD53|NUP62|KIF20B
"ENDONUCLEOLYTIC CLEAVAGE TO GENERATE MATURE 5'-END OF SSU-RRNA FROM (SSU-RRNA, 5.8S RRNA, LSU-RRNA)%GOBP%GO:0000472",0.9367105616769681,0.9806508984207809,0.308539336757099,0.6068604653640021,6970,3,UTP20|NOP14
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION%GOBP%GO:1901844,0.669807616804083,0.8815356925073421,-0.37830061788822295,-0.8281791315944341,5117,4,PDE4D|CAV1
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF HEART RATE%GOBP%GO:0086024,0.321605351170569,0.689642136570735,-0.836733568592854,-1.11473002494379,2403,1,PDE4D
NEGATIVE REGULATION OF ALKALINE PHOSPHATASE ACTIVITY%GOBP%GO:0010693,0.556778986468559,0.8257201392411401,-0.576840363937138,-0.95995460930107,4196,2,SEMA4D|TGFB2
INOSITOL PHOSPHATE DEPHOSPHORYLATION%GOBP%GO:0046855,0.260043431053203,0.636098664976652,0.35732691215023704,1.17582495403609,1915,11,INPP1|INPP5K|INPP5J|IMPA1
GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0009064,0.563442038914771,0.828821766028182,0.186949619493246,0.926362675662108,4111,38,ASL|AADAT|DDAH1|DDAH2|GLS|ADHFE1|CAD|GLUD1|GCLM|NAGS|NIT2|GLS2
ORGANIC ACID CATABOLIC PROCESS%GOBP%GO:0016054,0.25821269487750603,0.636098664976652,0.15269158460284302,1.10886559844222,1854,179,AASS|ALDH3A2|LPIN1|BDH2|PPARD|AADAT|HADHB|GNPDA2|GCSH|SLC25A17|DDAH1|GLS|ADHFE1|ACBD5|FGF2|SORD|BCKDHB|BLMH|HADHA|NUDT7|PEX2|AMT|GLUD1|HIBCH|PEX13|PCBD1|QDPR|ACADVL|HMGCLL1|HOGA1|ACADSB|ACADM|ACAT1|SHMT1|GCDH|ECHDC1|PIPOX|MCAT|CSAD|PM20D2|PCYOX1|ACAD8|ACOT7|ACOX2|ACAA2|HRSP12|ACAD11|ECI1|GLS2|ACADS|IDUA|CHP1|CTH|ECHS1|HMGCL|MECR|ACOX3|AKR1A1|ALDH7A1|EHHADH|ACOT8|ABCD3|TXN2|MPST|PHYH|AMDHD2|IVD|GSTZ1
POSITIVE REGULATION OF INTERFERON-GAMMA-MEDIATED SIGNALING PATHWAY%GOBP%GO:0060335,0.79047619047619,0.928247620398227,-0.379728686445351,-0.741513882787828,5975,3,NLRC5|TXK|PARP9
POSITIVE REGULATION OF CELLULAR RESPONSE TO DRUG%GOBP%GO:2001040,0.125638269282451,0.480863271917419,0.687217381713908,1.3516754928447199,934,3,RIPK1|KMT2A|HDAC6
CEREBROSPINAL FLUID SECRETION%GOBP%GO:0033326,0.589565217391304,0.8414799095069009,-0.709803705337451,-0.945628969430075,4406,1,AQP1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS%GOBP%GO:1904750,0.21583211581883396,0.598994355749518,0.893361270401412,1.19117671029229,1624,1,POLR1A
POSITIVE REGULATION OF DNA BINDING%GOBP%GO:0043388,0.27010819971320604,0.6446551225609449,-0.245223769771307,-1.15164004870255,2071,33,CEBPG|H1F0|HMGB2|NGF|GATA3|HES1|FAM129B|PARK7|IGF1|PLAUR|MMP9|PPARG|EDF1|NME1
REGULATION OF LIGASE ACTIVITY%GOBP%GO:0051340,0.47414144156373,0.784206173348341,0.376151343003695,0.9733137084154159,3492,6,NHEJ1|GCLM|XRCC4|TFIP11|MID1IP1|XRCC1
PEPTIDYL-SERINE ACETYLATION%GOBP%GO:0030920,0.44709030100334396,0.768229288546963,-0.7780657256285842,-1.03657037113554,3341,1,NAA10
POSITIVE REGULATION OF ISOTYPE SWITCHING%GOBP%GO:0045830,0.9502311667119939,0.9852369031063491,0.18366164693785297,0.581852512125751,6987,10,RIF1|TP53BP1|MAD2L2|FAM35A|C20orf196
POSITIVE REGULATION OF RECEPTOR BINDING%GOBP%GO:1900122,0.0932403997895844,0.422068646506606,-0.599642284177891,-1.4372281328948102,708,5,HFE|MMP9|ANXA2
CHEMOKINE (C-C MOTIF) LIGAND 21 SIGNALING PATHWAY%GOBP%GO:0038116,0.403789303950551,0.7412049911665691,0.537498621374214,1.05719635923266,3004,3,OXSR1|CCL21|WNK1
NEGATIVE REGULATION OF CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM%GOBP%GO:1902081,0.425551839464883,0.7547028278218628,-0.788156153506837,-1.05001324392399,3180,1,PLN
REGULATION OF PROTEIN GLYCOSYLATION IN GOLGI%GOBP%GO:0090283,0.8892857142857141,0.965159112268525,-0.33642224658136405,-0.6569473817055239,6722,3,TMEM59
NEGATIVE REGULATION OF CELL AGING%GOBP%GO:0090344,0.55017629509086,0.821051798535521,0.25684629762037603,0.923200893380222,4056,14,MARCH5|TWIST1|ZKSCAN3|SLC30A10|AKT3|MIF|SIRT1
SPERM MOTILITY%GOBP%GO:0097722,0.000135961930659415,0.00526859796630401,0.638898118514255,2.67375829012802,0,22,LRRC6|DNAI1|CFAP44|CFAP43|SORD|C9orf117|IQCG|ADCY3|SLC9B2|TEKT2|GAS8|DNAH1|CCDC40|ATP2B4|CATSPER2|BBS2
CONSTITUTIVE PROTEIN ECTODOMAIN PROTEOLYSIS%GOBP%GO:0051089,0.539513879665294,0.8147375278305091,0.7289920599911779,0.972012547017304,4061,1,ADAM10
POSITIVE REGULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION%GOBP%GO:0071657,0.6418148049880611,0.868035523512231,-0.542376619795975,-0.9026014278831209,4837,2,ISL1|CD34
SPLICEOSOMAL TRI-SNRNP COMPLEX ASSEMBLY%GOBP%GO:0000244,0.186143790849673,0.559093571852282,-0.3804141092367879,-1.27328164239751,1423,12,PRPF3|DDX20|PRPF8|SART3|SRSF12|AAR2|SRSF10|CD2BP2|PRPF19
"REGULATION OF INOSITOL 1,4,5-TRISPHOSPHATE-SENSITIVE CALCIUM-RELEASE CHANNEL ACTIVITY%GOBP%GO:0031585",0.216682515962505,0.599597524514766,0.564915827232933,1.24114413086202,1594,4,HTT|HAP1|PKD2
POSITIVE REGULATION OF MITOTIC COHESIN LOADING%GOBP%GO:1905406,0.772307692307692,0.9215496572020819,-0.6184384649316279,-0.82390853112155,5772,1,NIPBL
NEGATIVE REGULATION OF INTERLEUKIN-1 SECRETION%GOBP%GO:0050711,0.0889852786540484,0.41228493992510207,-0.533852295457573,-1.45926144283,676,7,GAS6|TNFAIP3|CARD16|NLRP3
HYPOTONIC SALINITY RESPONSE%GOBP%GO:0042539,0.5676716695444279,0.83116084992853,0.713608292898103,0.951500369374325,4273,1,SLC12A6
NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION%GOBP%GO:1901533,0.232430310168826,0.61627895720556,-0.5634324084483211,-1.2334713206277799,1775,4,HES1|NOTCH1|DPF2
N-ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS%GOBP%GO:0070292,0.5377872227387439,0.81379229560463,0.729874283193648,0.9731888726169009,4048,1,NAPEPLD
PALMITIC ACID METABOLIC PROCESS%GOBP%GO:1900533,0.5365755627009651,0.8132910857498922,0.575406672180866,0.966757503026585,4004,2,ACOT7|ACOT11
REGULATION OF TYROSINE 3-MONOOXYGENASE ACTIVITY%GOBP%GO:1903176,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
"POSITIVE REGULATION OF CD8-POSITIVE, ALPHA-BETA CYTOTOXIC T CELL EXTRAVASATION%GOBP%GO:2000454",0.13578595317725803,0.498614450236932,-0.931076312307014,-1.24041721259972,1014,1,FADD
POSITIVE REGULATION OF INTERLEUKIN-5 SECRETION%GOBP%GO:2000664,0.369328734412311,0.722131425100624,-0.6524316240012049,-1.08575055399901,2783,2,GATA3
REGULATION OF ATP:ADP ANTIPORTER ACTIVITY%GOBP%GO:0070926,0.215964935582415,0.598994355749518,0.893140714600794,1.19088262889239,1625,1,RIPK1
COLON EPITHELIAL CELL MIGRATION%GOBP%GO:0061580,0.344882943143813,0.7024647311177249,-0.8245478606087341,-1.0984957359479,2577,1,ARSB
NEGATIVE REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1905025,0.7449860539248242,0.9112137767014771,0.6272055580061761,0.8362939809637571,5608,1,KCNE3
GLUCOSAMINE-CONTAINING COMPOUND METABOLIC PROCESS%GOBP%GO:1901071,0.6217024748436228,0.856075054950132,0.22289045654539605,0.872488351772374,4571,18,EXTL2|GNPDA2|CTBS|LARGE|PGM3|AMDHD2|CHST1|OVGP1
MODULATION BY HOST OF VIRAL TRANSCRIPTION%GOBP%GO:0043921,0.8887290794979079,0.965159112268525,-0.157441223628956,-0.6691207618428969,6796,24,CHD1|CCNT1|CCL3|CCL4|SMARCA4|ZNF639|REST|SNW1|NUCKS1|RRP1B|PSMC3
"POSITIVE REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT, NADH TO UBIQUINONE%GOBP%GO:1902958",0.5228177235340941,0.807051143864932,-0.589649259982075,-0.9812706606163271,3940,2,PARK7
ZONULA ADHERENS MAINTENANCE%GOBP%GO:0045218,0.161381349099704,0.531565908892591,0.664001323480754,1.30601224597522,1200,3,KIFC3|CAMSAP3|PLEKHA7
PRONEPHROS MORPHOGENESIS%GOBP%GO:0072114,0.11555319431531401,0.46493596964429496,0.943537715041906,1.2580802287693897,869,1,AHI1
POSITIVE REGULATION OF RESPONSE TO WOUNDING%GOBP%GO:1903036,0.00012936610608020702,0.00518555396908895,-0.512821937732173,-2.4693811431348,0,36,PLEK|RREB1|FOXC2|VTN|MYLK|SMOC2|F3|HRAS|HBEGF|THBD|PDPN|SCARF1|F2R|INSL3|THBS1|SERPINE1|ENPP4|TLR4|ANXA1|SERPINF2
CEREBRAL CORTEX TANGENTIAL MIGRATION%GOBP%GO:0021800,0.11098023818871901,0.456746092075001,-0.636056045973162,-1.3924596442374502,847,4,SLIT2|LHX6
NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION%GOBP%GO:0007406,0.316111037322354,0.685583406115178,0.842633436259374,1.12353798831544,2379,1,NF1
THERMOCEPTION%GOBP%GO:0050955,0.334440164696507,0.6974768376198021,0.832487869430966,1.11001024392007,2517,1,TRPV1
NEGATIVE REGULATION OF CENTROSOME DUPLICATION%GOBP%GO:0010826,0.170290804296568,0.543912441650041,-0.40253259853914297,-1.30322094482957,1299,11,NPM1|CDK5RAP2|BRCA1|RBM14|KAT2B
PHENYLACETATE CATABOLIC PROCESS%GOBP%GO:0010124,0.933913043478261,0.9800972968717879,-0.53253198059109,-0.709460466616613,6980,1,ACAA1
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY%GOBP%GO:1901889,0.06381302521008402,0.36192038030965795,-0.37227718984936103,-1.4935689552891398,485,20,ROCK1|TNF|PTEN|RCC2|APOD|CORO1C|PHLDB2|BCAS3|DLC1|THBS1|FAM107A|ACVRL1
NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS%GOBP%GO:0032351,0.7751051524710829,0.9234903906527769,-0.27178603450265,-0.742915005187795,5896,7,BMP2|NFKB1
COFACTOR CATABOLIC PROCESS%GOBP%GO:0051187,0.0427939646201873,0.29576373695179803,-0.320232902013055,-1.52877043874635,328,35,CHAC1|CHAC2|BLVRA|GGT1|NUDT17|GPX1|VCP|PDXP|HMOX1|CAT|GGT5|GPX3|ABCD1|PRDX4|PRDX5|BLVRB
DIACYLGLYCEROL METABOLIC PROCESS%GOBP%GO:0046339,0.671333246107549,0.8815356925073421,-0.221389249352575,-0.841333209955862,5130,17,DGKZ|PLCE1|PGS1|DGAT1|DGKG|DAGLB|DGKE|DAGLA|ANG
DISACCHARIDE METABOLIC PROCESS%GOBP%GO:0005984,0.3537066246056779,0.7118407891832621,-0.39906185148098794,-1.09081777511405,2690,7,SLC2A1|GAA|B4GALT1
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:1905476,0.26331592689295,0.638950455433329,-0.277108101838676,-1.1634609523199,2016,23,PID1|NUMB|GDI1|CLTC|PPFIA1|TMEM59|DAB2|AP2M1
SUCCINYL-COA PATHWAY%GOBP%GO:0006781,0.645371231239208,0.86907298954767,0.6756175562417289,0.900844848241663,4858,1,SUCLA2
REGULATION OF CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0060828,0.216101694915254,0.5991362048583871,-0.16293800274350698,-1.14741441700294,1682,162,JUP|CTNND1|DAB2IP|PRDM15|SOX17|SFRP4|WLS|RUVBL1|SFRP2|MLLT3|FRAT1|CTNND2|VCP|MESP1|ILK|SLC9A3R1|DDX3X|SIAH2|SMURF2|DAAM2|SNAI2|NKD2|GPRC5B|GNAQ|STK3|APOE|USP47|BMP2|WWTR1|COL1A1|SEMA5A|XIAP|SDHAF2|DACT3|LATS2|IGFBP6|CAV1|ADGRA2|CHD8|DACT1|NFKB1|DAB2|MCC|CSNK1A1|IGFBP4|EMD|PPP1CA|AMER2|WNK2
CELLULAR RESPONSE TO HYPOXIA%GOBP%GO:0071456,0.49847055824624004,0.794989907195277,-0.160034232640762,-0.9722138894776879,3910,83,CARD16|HMOX1|LMNA|HIF3A|GATA6|CPEB1|PDK3|UBC|MYC|PGK1|BAD|PTGIS|P4HB|SUV39H1
NEGATIVE REGULATION OF GASTRIC ACID SECRETION%GOBP%GO:0060455,0.545623588790012,0.817297924969912,0.725738861932069,0.9676748463687891,4107,1,PTGER3
FORMATION OF TRANSLATION PREINITIATION COMPLEX%GOBP%GO:0001731,0.0741324921135647,0.38287566727393396,-0.5451737451737451,-1.4902081207563098,563,7,EIF4H|TICRR|EIF4B|DENR|EIF2S3|MCTS1|EIF2D
NEUTRAL AMINO ACID TRANSPORT%GOBP%GO:0015804,0.94465524008897,0.9827523984618031,-0.155059908633061,-0.589265517847957,7219,17,SLC3A2|SLC7A8
RNA BIOSYNTHETIC PROCESS%GOBP%GO:0032774,0.0036708860759493704,0.0646052543079676,-0.170405234793393,-1.43359485428705,28,473,MED10|TOPORS|GTF3C4|SNAPC1|CSTF2|ESRRG|RORC|CDK4|GTF2E1|INTS2|DDIT3|MED30|SRRT|TCFL5|POLR2F|HSF1|CREBBP|TFAM|FUBP3|MED26|ADRM1|POU2F1|PTEN|NR1I3|NCOA6|ZNF136|THAP1|TRIP13|GABPA|ZNF219|CCNH|POLR1E|INTS1|IKBKAP|TCEB2|NOTCH4|ETV7|DRG1|TCERG1|CPSF1|SNRPE|POLR2C|LSM11|HIPK3|NR2F1|PIR|NR4A1|YBX1|MED7|NABP2|GTF3A|TMF1|GTF3C1|SSU72|SOX5|EAF2|NR3C1|INTS7|DEK|LMO4|TERT|SOX18|RUNX3|MED13|NCBP2|RXRG|GTF2A2|MED8|BRF1|TRIM28|KLF4|SOX17|NFE2L3|POLR2J|PARP1|ELL2|PTMA|ZNF143|TAF3|RORA|PHAX|TAF6L|BTF3|NR1D2|TROVE2|MED1|NRL|RBMX|AHR|GATA3|MLLT3|MAF|VEZF1|CCNK|ZNRD1|E2F2|LMO2|GTF2A1|TWISTNB|TAF12|PTTG1|LSM10|RREB1|TRIP11|GTF3C5|SUPT16H|CPSF2|THRA|CEBPD|NFX1|ELOF1|NFE2L1|NOTCH1|SNRPF|GMEB2|CEBPA|PAPOLA|SMARCD3|ILF2|NCBP1|TTF1|ARRB1|ZFHX3|DDX5|CLP1|CTGF|SNW1|CTR9|POLR2H|NOTCH2|GTF2H1|NFIC|MECP2|MAPK3|TAF7|ZNF148|USF2|POLR3K|IRF7|CEBPB|NFATC1|E2F1|NR1H3|CREBL2|NOTCH3|CSTF3|PPM1D|MED6|TAF9B|BCL3|UBTF|SPI1|BDP1|MAX|NELFB|NFIX|CDK7|GATA6|KAT2B|PKNOX1|NR1D1|WWTR1|SRF|SNRPB|MAML1|PABPN1|MNAT1|CCRN4L|TAF10|PPARG|PPARA|POLR2G|ANG|RELA|POU2F2|INTS5|YAP1|NFKB1|SUPT4H1|PTRF|MRPL12|TAF9|POLA1|TEAD2|CPSF7|PRMT5|SSRP1|DTX1|ESRRA|CCND1|ELP4|MED27|AK6|C5AR1|MAZ|POLR2L|SMN1|GTF2H2
UDP-N-ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORT%GOBP%GO:1990569,0.42849562218095005,0.7566175497322429,-0.627626137303557,-1.04447025743856,3229,2,SLC35B4|SLC35A3
METHIONYL-TRNA AMINOACYLATION%GOBP%GO:0006431,0.44547159699892797,0.7671494493272959,0.6168183071408879,1.03633439663204,3324,2,MARS|MARS2
MOLYBDENUM INCORPORATION INTO MOLYBDENUM-MOLYBDOPTERIN COMPLEX%GOBP%GO:0018315,0.0363879598662207,0.271450902407424,-0.981638729598588,-1.30777849318447,271,1,GPHN
REGULATION OF MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0048634,0.780195565349126,0.924883543341693,0.15074601313147198,0.790592311212043,5664,46,DKK1|FGFR2|DLL1|FGF2|RBM24|SOX6|EFNB2|DDX17
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS%GOBP%GO:0071383,0.163590070019096,0.5351003413847161,-0.202736965181695,-1.22845358414865,1284,82,BRCA1|DDX5|CALR|RAN|WBP2|NCOA4|GPER1|RBM14|CDK7|FHL2|PPAP2A|FAM107A|YAP1|KAT5|ANXA1|TFPI|PHB|SSTR2
INTERLEUKIN-6 BIOSYNTHETIC PROCESS%GOBP%GO:0042226,0.48386239872493,0.787078399497453,0.758325981473313,1.01112537320392,3642,1,BCL10
GOLGI VESICLE DOCKING%GOBP%GO:0048211,0.738657468824622,0.9089185613230608,-0.497593177997808,-0.828074619320187,5567,2,NSF
CELLULAR ORGANOFLUORINE METABOLIC PROCESS%GOBP%GO:0090346,0.561204013377926,0.827957010954873,-0.723037053374504,-0.96325896652968,4194,1,POR
CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS%GOBP%GO:0030004,0.16707458456782198,0.539296853569433,-0.23586303534189604,-1.25193551006858,1296,50,PPT1|CLN6|SLC9A5|ATP6V0A1|SLAMF8|GPR89B|TCIRG1|ATP1B1|ATP6V0A2|RAB7A|ATP1A3|ATP1B3|ATP5B|DMXL1|ATP6V0D1|CA2|SLC9A1|SLC9A7|SLC11A1|SLC9A9|ATP6V0E1|ATP1B2|ATP6V0E2|RAB20
NEGATIVE REGULATION OF PEPTIDE SECRETION%GOBP%GO:0002792,0.0152003091588304,0.166148433567765,-0.276330303096888,-1.61524682154852,117,72,LILRB1|RGCC|INHBB|LGR4|CD74|REST|RHBDF2|PIM3|CD34|SSC5D|FCGR2B|GAS6|INS|TNFAIP3|CRHBP|PTGER4|IRS1|CARD16|RSAD2|SRGN|TNFRSF4|NR1H3|F2R|FN1|NLRP3|NOV|CHGA|TNFRSF21|CD200|CX3CL1|SIRT4|SERGEF|RAB11FIP1|ANXA1|TMSB4X
SPERM CHROMATIN CONDENSATION%GOBP%GO:0035092,0.114157730419438,0.463601317674427,0.544039095848721,1.40773313654841,840,6,PSME4|TSSK6|CHD5
CHOLINE CATABOLIC PROCESS%GOBP%GO:0042426,0.6667989417989421,0.880719592999549,-0.43024927170118504,-0.840167781402775,5040,3,SLC44A1
NEGATIVE REGULATION OF HISTONE H2A K63-LINKED UBIQUITINATION%GOBP%GO:1901315,0.735582010582011,0.908157084784786,-0.403461004886932,-0.787857085772851,5560,3,OTUB1
POSITIVE REGULATION OF PLATELET ACTIVATION%GOBP%GO:0010572,0.0439242503945292,0.299062021084573,-0.6561490133724549,-1.5726639802978,333,5,PLEK|PDPN|TLR4
SARCOMERE ORGANIZATION%GOBP%GO:0045214,0.9425045943817281,0.9822426900481899,-0.162209047593863,-0.5889547579251401,7179,15,IGSF22|KRT19
"NUCLEOTIDE-BINDING DOMAIN, LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY%GOBP%GO:0035872",0.8891759586619531,0.965159112268525,0.15601055984728399,0.6720347237854231,6538,24,UBE2V1|RPS27A|MAP2K6|CASP8
POSITIVE REGULATION OF GTP BINDING%GOBP%GO:1904426,0.7182276465906079,0.900080821429213,-0.508939929690328,-0.8469574286185608,5413,2,EPHA4
PEPTIDYL-GLUTAMINE METHYLATION%GOBP%GO:0018364,0.139641408192645,0.504314492208813,-0.6148083403419661,-1.34594397504228,1066,4,TRMT112|N6AMT1
S-ADENOSYLHOMOCYSTEINE METABOLIC PROCESS%GOBP%GO:0046498,0.54484126984127,0.817297924969912,-0.481744762069875,-0.940725422614446,4118,3,GNMT|MTRR
POSITIVE REGULATION OF HISTONE H3-K27 ACETYLATION%GOBP%GO:1901676,0.724414715719064,0.9034590034658789,-0.6418725187472429,-0.855128317652101,5414,1,LIF
NEGATIVE REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS%GOBP%GO:0045763,0.112004287245445,0.459194647507502,0.799944858009374,1.3440106465171697,835,2,ATCAY|ATP2B4
POSITIVE REGULATION OF OOCYTE MATURATION%GOBP%GO:1900195,0.866889632107023,0.9555750264459809,-0.569585355094839,-0.758824458495508,6479,1,SIRT2
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN MESONEPHROS DEVELOPMENT%GOBP%GO:0061216,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
PROTEIN PALMITOLEYLATION%GOBP%GO:0045234,0.510903010033445,0.8011667213092171,-0.747959858844288,-0.9964621277339358,3818,1,PORCN
POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION%GOBP%GO:2000491,0.515183946488294,0.803478510349408,-0.745092633436259,-0.9926422950290219,3850,1,RPS6KA1
DEFENSE RESPONSE TO GRAM-NEGATIVE BACTERIUM%GOBP%GO:0050829,0.000261096605744125,0.00819882332206558,-0.5647741136665501,-2.3712501502920698,1,23,PYCARD|TNFRSF14|GSDMD|HMGB2|AZU1|SLC11A1|ROMO1|RNASE6|CHGA|RARRES2|SERPINE1|TLR4|HIST1H2BK|HIST1H2BJ|ADGRB1
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS%GOBP%GO:1902042,0.007045929018789141,0.10102825149798,-0.430002913446449,-1.8757512349307002,53,26,TNFRSF10A|TNFRSF10B|GPX1|TRAF2|TNFAIP3|TNFSF10|PARK7|ICAM1|BRCA1|SCRT2|HMOX1|NOS3|PEA15|FADD|SERPINE1
TRIPEPTIDE TRANSMEMBRANE TRANSPORT%GOBP%GO:0035443,0.000802675585284281,0.0194343718828845,-0.9996691662990741,-1.33179936423268,5,1,ABCC1
MITOCHONDRIAL MRNA CATABOLIC PROCESS%GOBP%GO:0000958,0.966944369793066,0.9912626134248801,0.282723012548854,0.556082802173078,7195,3,PNPT1|SUPV3L1
PYRUVATE BIOSYNTHETIC PROCESS%GOBP%GO:0042866,0.114267015706806,0.463696586909637,-0.304835172927847,-1.3614279761023602,872,28,GPI|PFKFB2|HK1|HK3|ENO1|PGAM1|GAPDH|LDHA|PGK1|ALDOA|ALDOC
PEPTIDYL-ARGININE METHYLATION%GOBP%GO:0018216,0.595548317046688,0.8444242875522441,0.269792824266328,0.8877840554557641,4387,11,NDUFAF7|PRMT9|CARM1|PRMT7
POSITIVE REGULATION OF ALKALINE PHOSPHATASE ACTIVITY%GOBP%GO:0010694,0.647651897054922,0.870171576465071,-0.53972381510608,-0.898186736663771,4881,2,MEF2C
POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY%GOBP%GO:0031274,0.12549019607843098,0.48053753037869495,-0.407895536805659,-1.36526455360058,959,12,CDC42EP4|CDC42EP1|CDC42EP5|CDC42EP2
PROTEIN TARGETING TO LYSOSOME%GOBP%GO:0006622,0.244900734294262,0.62804240987169,0.30388382826564897,1.1895309676472199,1800,18,NAGPA|GCC2|SCARB2|SNX16|NEDD4|AP4M1|ZFYVE16|AP3M1
PENTOSE CATABOLIC PROCESS%GOBP%GO:0019323,0.927758146839419,0.979345221662042,-0.280914383004273,-0.614980306052804,7088,4,DHDH
HISTONE MRNA METABOLIC PROCESS%GOBP%GO:0008334,0.4586868555018929,0.773319048556128,-0.22035803260926,-0.996353296808262,3513,29,SLBP|DCP2|PAPD7|SNRPD3|XRN1|MTPAP|SNRPE|LSM11|EXOSC4|PAPD4|NCBP2|LSM10|CPSF2|SNRPF|NCBP1|SNRPB|TUT1
RESPONSE TO ALKALINE PH%GOBP%GO:0010446,0.0919063545150502,0.419763137651336,-0.9517534186149101,-1.2679640830678602,686,1,INSRR
MUCUS SECRETION%GOBP%GO:0070254,0.9334656084656079,0.9800972968717879,-0.312437044590055,-0.610110361240952,7056,3,VAMP8
REGULATION OF OXIDATIVE PHOSPHORYLATION%GOBP%GO:0002082,0.0270800627943485,0.23271567002476898,-0.44494301053521795,-1.6535805123459097,206,16,PPIF|VCP|PDE12|PARK7|UQCC2|CCNB1|COX7A1|ABCD1|SHMT2
NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS%GOBP%GO:0051195,0.20059880239521,0.578325746675525,-0.437201202721046,-1.258641071761,1540,8,HP|CBFA2T3|PPARA|MPV17L
SYNAPTIC VESICLE TO ENDOSOME FUSION%GOBP%GO:0016189,0.36816053511705704,0.721642468110297,-0.814126599029555,-1.08461211323196,2751,1,EEA1
REGULATION OF SCHWANN CELL PROLIFERATION%GOBP%GO:0010624,0.613096046732781,0.852045339927398,0.3962389014503939,0.870553741365771,4512,4,SKI|CERS2|RNF10|DICER1
NLS-BEARING PROTEIN IMPORT INTO NUCLEUS%GOBP%GO:0006607,0.21076964917051896,0.592523537584956,0.28354647385580106,1.22141139948824,1549,24,KPNA3|NUP35|IPO5|TNPO1|RGPD1|RANBP2|KPNA5|RGPD2|NUP54|RGPD6|RGPD5|RANBP6|TNPO2|KPNA6
NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS%GOBP%GO:1900408,0.219369736484651,0.601686354077891,0.26652097415642606,1.20747062192666,1614,28,MET|PARK2|NOL3|HTRA2|MAPK7|NME5|PDE8A|NFE2L2|NR4A3|FBXO7
NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION%GOBP%GO:0060392,0.0314095013741657,0.25182426163873,-0.722598407372412,-1.58191896394424,239,4,CILP|NOV|FAM89B
NEGATIVE REGULATION OF CIRCADIAN RHYTHM%GOBP%GO:0042754,0.08289748953974901,0.40083659102709,-0.47282050774427703,-1.48128492856332,633,10,CIPC|GHRL|CRY2|SUV39H1
MULTIVESICULAR BODY ASSEMBLY%GOBP%GO:0036258,0.648218248270461,0.8702993441108309,-0.19143576212838198,-0.8655806664503699,4965,29,VPS25|CHMP4A|SNF8|CHMP6|VPS37C
REGULATION OF RENAL SYSTEM PROCESS%GOBP%GO:0098801,0.261592873984805,0.637469038561264,-0.365069557842482,-1.18193233498759,1996,11,NPR1|F2R|PDGFB|EMP2
COPPER ION TRANSMEMBRANE TRANSPORT%GOBP%GO:0035434,0.282640456899987,0.655069746883962,0.861215262461403,1.14831434625696,2127,1,ATP7A
"RETROGRADE TRANSPORT, ENDOSOME TO GOLGI%GOBP%GO:0042147",0.243363446838082,0.626082056933819,0.18837723606549103,1.14721939936135,1750,80,FAM21A|DCTN1|CCDC132|SGSM2|TBC1D14|FAM21C|CLTCL1|HEATR5B|PIKFYVE|RIC1|GCC2|TBC1D17|EHD3|GGA1|DENND2A|FAM109B|TRIM27|VAMP3|WASH1|STX10|STX16|VPS35|CLN5|TMEM87A|RAB6A|STX6|TMEM87B|VPS52|TBC1D5|PLEKHJ1|GOSR1
PROTEIN TARGETING TO VACUOLE%GOBP%GO:0006623,0.4173142467621,0.7499690687478492,0.229277433429352,1.0261305199927802,3060,27,NAGPA|GCC2|SCARB2|VPS13C|SNX16|NEDD4|VPS13A|AP4M1|ZFYVE16
REGULATION OF INORGANIC ANION TRANSMEMBRANE TRANSPORT%GOBP%GO:1903795,0.0196338551339878,0.192628124925339,-0.9087351927104591,-1.51228067835344,147,2,PRNP
REGULATION OF MICROGLIA DIFFERENTIATION%GOBP%GO:0014006,0.5966555183946489,0.844613508628182,-0.705668284075871,-0.940119595336448,4459,1,TGFB1
POSITIVE REGULATION OF BLOOD PRESSURE%GOBP%GO:0045777,0.701104100946372,0.8931369333627571,-0.292224109896876,-0.7987815728549509,5333,7,ADRA1B|ID2|PDE4D|TBXA2R
AUDITORY BEHAVIOR%GOBP%GO:0031223,0.408353609083536,0.7445496113654559,0.42645391094793894,1.02561921032513,3020,5,STRA6|HTT|NRXN1
PURINE RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009169,0.502760252365931,0.7970718494574169,-0.34922847830453,-0.9546004718237511,3824,7,HPRT1|NUDT4
POSITIVE REGULATION OF STEROL BIOSYNTHETIC PROCESS%GOBP%GO:0106120,0.967078742273582,0.9912626134248801,0.282410328010277,0.555467788584899,7196,3,FGF1|PRKAA1
STRIATAL MEDIUM SPINY NEURON DIFFERENTIATION%GOBP%GO:0021773,0.304749163879599,0.6770795415897549,-0.8443427437141601,-1.12486727327606,2277,1,INHBA
PYRIMIDINE DEOXYRIBONUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0046126,0.468986585203878,0.780769690730001,0.7668173797970891,1.02244750710004,3530,1,DHFRL1
FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION%GOBP%GO:0021869,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION%GOBP%GO:0030838,0.5715665976535539,0.833854868733934,0.163732257433639,0.9296378460430871,4140,61,NCK2|BIN1|RLTPR|CYFIP1|ABI2|FAM21C|RHOBTB1|PRKCE|NCKAP1|LRRC16A|ACTR2|TRIM27|PTK2B|CDC42EP3|WASH1|C15orf62|WIPF1|RHOBTB2|WIPF2|JMY|ACTR3
NEGATIVE REGULATION OF ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0140199,0.40284234294063004,0.740287621109606,0.799900749889722,1.06655971708494,3032,1,ATP2B4
PROTEIN SULFATION%GOBP%GO:0006477,0.430555555555556,0.759202571928828,-0.533092238735839,-1.04099403057861,3254,3,HS3ST5|TPST2
REGULATION OF THE FORCE OF HEART CONTRACTION BY CARDIAC CONDUCTION%GOBP%GO:0086092,0.297658862876254,0.66986389836848,-0.8478716365240409,-1.12956860583596,2224,1,SLC9A1
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS%GOBP%GO:0043525,0.713412148389727,0.89812380003666,0.210230790167731,0.8084000226700481,5249,17,CDK5R1|FOXO3|TFAP2B|NF1|BAX|CDK5|ATF4
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE%GOBP%GO:1905477,0.670364720565802,0.8815356925073421,0.14071621940808499,0.882680270816678,4833,90,TCAF2|MFF|MIEF2|PARK2|MYO1C|BBC3|RANGRF|EPHB2|PMAIP1|PRKCE|CASP8|TP53BP2|PTPN9|BID|YWHAQ|SPTBN1|RAMP3|MTCL1|YWHAB|KIF5B|YWHAE|CNPY4|EFCAB7|BCL2|YWHAH|STAC2|KCNB1|CHP1|EGFR|YWHAZ|STAC|MAPK8|ERBB2|PDPK1|C2CD5
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:1900747,0.409370501243293,0.7448505271608159,-0.4759983516925229,-1.0420598933876801,3127,4,DAB2IP|SEMA6A|DCN
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION%GOBP%GO:1904046,0.45685618729096994,0.771646641277486,-0.772496691662991,-1.02915108068945,3414,1,SARS
NEGATIVE REGULATION OF CELL VOLUME%GOBP%GO:0045794,0.23719603314767004,0.6217158626397761,0.5533637873167989,1.21576380719216,1745,4,CLCN3|KCNMA1|ANO6|P2RX7
REGULATION OF TRAIL PRODUCTION%GOBP%GO:0032679,0.5820735785953179,0.8387093286508721,-0.71344287604764,-0.9504772186324659,4350,1,HLA-E
PROEPICARDIUM CELL MIGRATION INVOLVED IN PERICARDIUM MORPHOGENESIS%GOBP%GO:0003345,0.5587727453845129,0.8268422944617521,0.7197287163652399,0.9596611282215309,4206,1,FLRT3
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:1905563,0.0266980761680408,0.231248346976425,-0.7349583632052059,-1.6089774909571999,203,4,FLT1|MEF2C|CCL2|PPARG
SYMMETRIC CELL DIVISION%GOBP%GO:0098725,0.332040133779264,0.6961761803662729,-0.8318262020291128,-1.10819223435268,2481,1,SAPCD2
RESPONSE TO PLATELET-DERIVED GROWTH FACTOR%GOBP%GO:0036119,0.146823837590046,0.514131830678897,-0.521856198819395,-1.34235472417265,1120,6,MTSS1L|SYAP1|CORO1B|HYAL1
SPLICEOSOMAL SNRNP ASSEMBLY%GOBP%GO:0000387,0.0246833807185319,0.22072433481620302,-0.33280733494452597,-1.616760093959,190,37,DDX20|PRPF8|SNRPD3|SMN2|SART3|GEMIN5|SRSF12|GEMIN7|AAR2|SNRPE|GEMIN8|SRSF10|GEMIN2|CD2BP2|SNRPF|SNRPD1|RBM22|SNRPB|PRMT5|SART1|SMN1|PRPF19
PHAGOSOME-LYSOSOME FUSION%GOBP%GO:0090385,0.04400785854616901,0.299062021084573,-0.61375930205005,-1.5787542631009799,335,6,RAB7A|SYT7|RAB7B|RAB34|RAB20
INTERLEUKIN-17-MEDIATED SIGNALING PATHWAY%GOBP%GO:0097400,0.898704358068316,0.967428248648255,-0.296503576448664,-0.649108309229496,6866,4,IL17RE|IL17RA
NEGATIVE REGULATION OF UDP-GLUCOSE CATABOLIC PROCESS%GOBP%GO:0010905,0.968123256740603,0.9912626134248801,0.51532862814292,0.6871211908648149,7288,1,GSK3A
CELLULAR RESPONSE TO FIBROBLAST GROWTH FACTOR STIMULUS%GOBP%GO:0044344,0.277197057684863,0.652442157557974,-0.191306146574076,-1.12139193296508,2147,73,CD44|POLR2C|FGFRL1|HYAL2|NR4A1|PTBP1|HNRNPH1|TBX1|ZFP36L1|RAB14|NCBP2|FGFR4|POLR2J|SHCBP1|NDST1|GRB2|NCBP1|HNRNPM|POLR2H|FGF10|MAPK3|CCL2|HYAL1|FGF19|FGF9|FGF7|POLR2G|FIBP|POLR2L
PROTEIN EXIT FROM ENDOPLASMIC RETICULUM%GOBP%GO:0032527,0.0476748729972646,0.312566734642794,-0.35798047639415503,-1.5433039941924098,365,25,HSP90B1|HM13|VCP|SEL1L|FAF2|HERPUD1|NPLOC4|SYVN1|SEC61B|TMED9|SURF4
AXONAL FASCICULATION%GOBP%GO:0007413,0.272034820457019,0.646576786621306,0.34136615926021396,1.1602371789439698,1999,12,CNTN4|EPHB2|RTN4|CDK5R1|NRCAM|MEGF8
POSITIVE REGULATION OF LOW-DENSITY LIPOPROTEIN PARTICLE RECEPTOR BIOSYNTHETIC PROCESS%GOBP%GO:0045716,0.36613756613756604,0.720655766665538,-0.5599426491673101,-1.09342607694272,2767,3,SCAP|CNPY2|HNRNPK
REACTIVE NITROGEN SPECIES METABOLIC PROCESS%GOBP%GO:2001057,0.12242128121607,0.476255306135618,0.420209667117715,1.38274783041382,901,11,MARC2|SPR|DDAH2|NQO1
REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0034121,0.0182600756488848,0.18550129019106798,-0.3248605967978,-1.65602955166306,139,44,LYN|LGR4|TLR1|IRAK3|DAB2IP|TLR2|TICAM2|TNFAIP3|RSAD2|IRF7|NR1H3|CD300A|RAB7B|CD36|NR1D1|CD300LF|TLR5|TICAM1|CAV1|TLR4|CD14|LY96
CHOLINE TRANSPORT%GOBP%GO:0015871,0.460449735449735,0.7747138137542491,-0.520802887074697,-1.01699604150777,3480,3,SEC14L1|SLC44A1
ENDODERMAL-MESODERMAL CELL SIGNALING%GOBP%GO:0003133,0.40819846113027297,0.7445496113654559,-0.6368529458685871,-1.0598251423684002,3076,2,BMP2
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY%GOBP%GO:2001242,0.0005156632718834599,0.0139121625154964,-0.285549387665703,-1.87882534893151,3,116,FIS1|PYCARD|CD74|GNB2L1|TRIAP1|BCL2A1|KDM1A|BCL2L11|PPIF|TMBIM6|SFRP2|SOD2|OPA1|BAG5|BCL2L2|INS|CREB3|SLC9A3R1|DDX3X|UBQLN1|PARK7|TRIM32|SNAI2|ENO1|CREB3L1|HERPUD1|HSPB1|SOD1|NONO|TAF9B|NACC2|PLAUR|SYVN1|MMP9|BCAP31|SNAI1|CAV1|YBX3|DNAJA1|S100A8|S100A9|TAF9|STYXL1|ZNF385A|NCK1|NDUFS3|AK6|PTPMT1|BAD|P4HB
HISTONE MONOUBIQUITINATION%GOBP%GO:0010390,0.182874298394465,0.556308895147568,-0.276676757931622,-1.2509995512812,1400,29,RNF168|UHRF1|CTR9|RNF20|SKP1|RING1|RNF40|DDB1
NEGATIVE REGULATION OF SYNAPTIC VESICLE CLUSTERING%GOBP%GO:2000808,0.655117056856187,0.874775007199212,-0.6761689457432729,-0.900819393468578,4896,1,PTEN
INACTIVATION OF MAPKK ACTIVITY%GOBP%GO:0051389,0.0602893890675241,0.355734936871271,0.848690377722636,1.42590941342426,449,2,EPHB2|IGF1R
STEROID CATABOLIC PROCESS%GOBP%GO:0006706,0.0573856209150327,0.34495944391065597,-0.46355539293719106,-1.55156330359424,438,12,SPP1|STS|CYP46A1|SCARF1|APOE|HSD17B14
QUINOLINATE BIOSYNTHETIC PROCESS%GOBP%GO:0019805,0.073759617935792,0.3820872795228811,-0.8256961676316519,-1.3740904616838,555,2,KYNU|HAAO
POSITIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT%GOBP%GO:0048636,0.786211604095563,0.9274485629622209,0.176214088377515,0.767750016010708,5758,25,FGFR2|DLL1|FGF2|RBM24|EFNB2|FLOT1|BMPR1A|GPC1|MKL2
POSITIVE REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL%GOBP%GO:1903947,0.28336012861736304,0.6560202082186041,0.6921422663358149,1.16288837354956,2114,2,RNF207|NOS1AP
INTERLEUKIN-1 BETA SECRETION%GOBP%GO:0050702,0.21293375394321803,0.595473809364003,-0.454412513796945,-1.24211634222716,1619,7,CD36|TLR4
REGULATION OF NODAL SIGNALING PATHWAY%GOBP%GO:1900107,0.587169312169312,0.8414799095069009,-0.462303117966007,-0.9027608191440329,4438,3,DACT1
AMINO-ACID BETAINE METABOLIC PROCESS%GOBP%GO:0006577,0.92042042042042,0.9768322640118741,0.20392001136187402,0.619694106987692,6742,9,ACADM|SHMT1|CPT1B|CPT1A
GAP JUNCTION ASSEMBLY%GOBP%GO:0016264,0.18783068783068801,0.561187808256183,-0.648505569648175,-1.26636701446193,1419,3,GJC1|GJA5|GJA1
LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING%GOBP%GO:0098598,0.408353609083536,0.7445496113654559,0.42645391094793894,1.02561921032513,3020,5,STRA6|HTT|NRXN1
REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS%GOBP%GO:1901858,0.312549747943752,0.68160868787154,-0.678645026494113,-1.12937384758544,2355,2,STOML2
ANATOMICAL STRUCTURE ARRANGEMENT%GOBP%GO:0048532,0.012593783494104999,0.14869950444299201,0.9299161109752799,1.5623791327676397,93,2,DLL1|KIF14
REGULATION OF AMINO ACID UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION%GOBP%GO:0051941,0.5137123745819401,0.8023339441082009,-0.7458645787384209,-0.9936707115264991,3839,1,PER2
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY%GOBP%GO:0045746,0.320203469414373,0.6882058449368089,-0.250624478343114,-1.1053763915069599,2454,27,ARRDC1|CHAC1|C8orf4|EGFL7|PEAR1|RITA1|FAM129B|ARRB1|MMP14|NOTCH3|DLK2
PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901162,0.211847522911409,0.5937395205509979,0.895511689457433,1.19404400394131,1594,1,AZIN2
'DE NOVO' NAD BIOSYNTHETIC PROCESS%GOBP%GO:0034627,0.313048030362518,0.68242575106406,-0.521423209418315,-1.1415044024507401,2391,4,HAAO|NMNAT3
ENDOTHELIAL CELL ACTIVATION%GOBP%GO:0042118,0.0704521556256572,0.3767214120425879,-0.548603221590873,-1.49958244160721,535,7,P2RX4|C8orf4|FOXP1|PRMT5
NEGATIVE REGULATION OF CELL-SUBSTRATE ADHESION%GOBP%GO:0010812,0.000521716447110995,0.0139121625154964,-0.42059493466072095,-2.14405085733273,3,44,PTEN|RCC2|ACTN4|MMP12|TBCD|APOD|KANK1|JAG1|CORO1C|FZD4|CDKN2A|CASK|NOTCH1|PHLDB2|GCNT2|BCAS3|DLC1|THBS1|SEMA3E|CX3CL1|SERPINE1|FAM107A|KIAA2022|NF2|ACVRL1|FBLN1|EFNA5
POSITIVE REGULATION OF HISTONE H3-K27 TRIMETHYLATION%GOBP%GO:1902466,0.817372825076371,0.9378212107586109,0.590924128804588,0.7879175906803149,6153,1,ZNF304
CELLULAR AMMONIA HOMEOSTASIS%GOBP%GO:0097275,0.311329525833444,0.68160868787154,0.845059550066167,1.12677288371433,2343,1,TFAP2B
POSITIVE REGULATION OF MACROPHAGE ACTIVATION%GOBP%GO:0043032,0.124967320261438,0.479403240873216,-0.4082164852202971,-1.3663387979952901,955,12,CEBPA|IL33|THBS1|TLR4|ITGAM
CHYLOMICRON REMODELING%GOBP%GO:0034371,0.587962962962963,0.8414799095069009,-0.461960587687097,-0.9020919443232641,4444,3,APOC2|APOE
RECEPTOR METABOLIC PROCESS%GOBP%GO:0043112,0.02344152498712,0.21307085362881198,-0.267174586758903,-1.55718916821347,181,71,TNF|SYK|SNX25|SNX1|ITGB1|GRK4|ACKR3|SYNJ1|TGFB1|LILRB1|ADM|AP2A2|ITGB2|DNM1|LRP1|CLTA|GRB2|CLTC|CALCRL|ARRB1|FCER1G|CEACAM1|PIK3R4|CD36|GPRASP1|CAV1|PPARG|MYLIP|ADRBK1|LGMN|TFRC|CD81|AP2M1|DNM3|GTF2H2
CHEMOKINE PRODUCTION%GOBP%GO:0032602,0.0227511835875855,0.209556368962182,-0.6931575331015619,-1.66136634021291,172,5,FOXP1|S100A8|S100A9
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION%GOBP%GO:1903053,0.05026178010471201,0.321756992777014,-0.338110838227818,-1.5100408189960501,383,28,TGFB1|RGCC|AGT|FGFR4|LRP1|AEBP1|DDR2|NOTCH1|PHLDB2|DDR1|DPP4|FAP|PDPN|TNFRSF1A|TNFRSF1B|CST3
POSITIVE REGULATION OF MUSCLE CONTRACTION%GOBP%GO:0045933,0.0278649921507064,0.23617479560495197,-0.44335844504440897,-1.64769165342668,212,16,ENO1|GPER1|F2R|KCNQ1|CHGA|SRF|RGS2|SPHK1
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER%GOBP%GO:0006367,0.00562228469205213,0.0858969713520357,-0.237955857653387,-1.61715492342545,43,135,RXRG|GTF2A2|MED8|TRIM28|POLR2J|TAF3|RORA|NR1D2|MED1|E2F2|GTF2A1|TAF12|THRA|NOTCH1|CTGF|SNW1|POLR2H|NOTCH2|GTF2H1|MECP2|TAF7|NR1H3|NOTCH3|PPM1D|MED6|TAF9B|CDK7|KAT2B|NR1D1|WWTR1|MAML1|MNAT1|TAF10|PPARG|PPARA|POLR2G|YAP1|TAF9|TEAD2|ESRRA|CCND1|MED27|AK6|MAZ|POLR2L|GTF2H2
DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS%GOBP%GO:0050655,0.318563188253802,0.6867397844771489,-0.315461096429645,-1.11605522812043,2429,14,DCN|BGN|VCAN|B3GAT3|CSGALNACT1
ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS%GOBP%GO:1901617,0.0710292249047014,0.3767214120425879,-0.21616380221895498,-1.3563768235791103,558,94,HMGCR|DHFR|CYP46A1|APOE|HMGCS1|CYP7B1|SRD5A3|EBP|DHCR7|OSBP|PNPO|C14orf1|SPHK1|DHCR24|CNBP|NSDHL|PDXK|OSBPL3|TM7SF2
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION%GOBP%GO:0044339,0.193552666489785,0.567519363754568,-0.7375109786715,-1.2273362053821202,1458,2,WNT3
POSITIVE REGULATION OF STAT CASCADE%GOBP%GO:1904894,0.0329542517446369,0.259512489684881,-0.324638892406992,-1.57707824041246,254,37,LIF|CD40|CTF1|TNF|PARP14|LYN|STAP2|IL18|AGT|SOCS3|PARP9|HCLS1|CYP1B1|TNFRSF18|IL6ST|HES1|NOTCH1|STAT3|OSM|IGF1|F2R|CSF1R|TNFRSF1A
ASPARAGINYL-TRNA AMINOACYLATION%GOBP%GO:0006421,0.5376473740621649,0.81379229560463,0.575130962227736,0.9662942747069749,4012,2,DARS2|NARS2
PEPTIDYL-DIPHTHAMIDE METABOLIC PROCESS%GOBP%GO:0017182,0.289805891136148,0.6622817015650171,0.443910205931313,1.14864374878548,2134,6,DPH2|DPH5|DPH1|DPH6|DPH3
NEGATIVE REGULATION OF ASTROCYTE ACTIVATION%GOBP%GO:0061889,0.10046822742474901,0.436743648703065,-0.9474525805028671,-1.26223433401049,750,1,LDLR
REGULATION OF MAST CELL DEGRANULATION%GOBP%GO:0043304,0.0169536075699829,0.17671843887293,-0.441699495495497,-1.7451134997734699,128,19,SYK|UNC13D|LYN|CD84|SNX4|FGR|STXBP2|FES|ADGRE2|VAMP8|VAMP7|SNX6|CD300A|LGALS9
REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NEUROLOGICAL SYSTEM PROCESS%GOBP%GO:0002087,0.4265724765656839,0.7551541191239219,0.460953836158906,1.01273520897664,3139,4,TSHZ3|NLGN2
MICROTUBULE-BASED PROCESS%GOBP%GO:0007017,0.000140884756269372,0.00530271011040242,0.23193419501108398,1.9780959459623302,0,481,DYNLRB2|CFAP61|DYNC2H1|DYNC1I2|TTC30B|LRRC6|WDR19|TTC21B|DYNC2LI1|EFHC1|AURKC|RABL2B|IFT88|DNAL4|DNALI1|TTC30A|WDR35|DNAI1|ZMYND10|NPHP3-ACAD11|TTC21A|WDR73|KIF9|CNTROB|RSPH9|LRGUK|KIF13A|BBS4|EML4|MAATS1|KIF13B|CLASP1|LCA5|LLGL1|ULK4|DCTN1|IFT46|CFAP44|KATNAL1|IFT172|KATNB1|DYX1C1|KIFC3|STARD9|CFAP43|FSD1|CDC14B|KIF26B|KIF7|NCOR1|CCDC65|CCDC68|KIFC2|PARD3|PIBF1|IFT20|NAV1|CLASP2|TACC2|CCDC88A|NINL|LRRC49|IFT140|RFX3|MAP9|TRIM36|RSPH1|SPAG16|KATNAL2|DLG2|STMN3|KIF3B|C9orf117|TRAK2|NDEL1|KIF26A|CLUAP1|TTLL3|IQCG|GCC2|RAB1A|BRCA2|WDR78|IFT81|HTT|TTBK2|SPIRE2|TUBA1C|MAP7|CFAP46|TNPO1|CDK5R1|WDR60|CCDC88C|BLOC1S3|PCM1|DCLK2|GPSM2|MARK4|CAMSAP3|RSPH4A|HAP1|PEX13|SAXO2|TUBE1|TUBGCP3|DST|WDR66|STMN2|TEKT2|CDC14A|TPPP3|GAS8|CUL7|NPHP3|PKD2|AP3B2|MTCL1|LRPPRC|IFT52|DNAH1|MAP2|BRSK1|ARHGEF10|KIF5B|RPGR|TUBB3|CEP68|RNF19A|RAB11A|CEP250|DCTN2|PSRC1|TRAF3IP1|CCDC40|PLK3|KIF3C|IFT27|AP3B1|BBS2|RAB6A|KIF5A|MZT1|SPG11|KIF21A|SRRD|STMN4|DYNLT1|TUBGCP6|GOLGA8B|COPG2|MAP4|DOCK7|HAUS2|TRAK1|EZR|OBSL1|SPAST|ARHGAP21|CHP1|TNKS|PEX1|CUL9|TAOK1|ZW10|KIF1A|CENPJ
RIBONUCLEOTIDE METABOLIC PROCESS%GOBP%GO:0009259,0.000127975428717686,0.00518555396908895,-0.2390401077778,-1.87536674159718,0,295,NDUFB5|NADK|CROT|SURF1|ACSL5|ATP1B1|ABHD14B|UQCR10|ACOT1|PARP1|NDUFA9|ATP5J|NDUFA7|ACSF2|DCAKD|GPI|ATP5F1|FAR1|COASY|OPA1|IMPDH2|ACSL4|PFKFB2|ELOVL2|HK1|PDHA1|NDUFA3|NDUFB6|ACSF3|ATP5B|HK3|ADCY8|PDE4D|SDHD|NPR2|ELOVL1|CYCS|SLC26A2|NDUFB9|COA6|NUDT16|PDE2A|ENO1|NDUFB10|SDHA|ADCY4|MT-CO3|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|CTPS1|PGAM1|HPRT1|TPST2|MOCS2|MBIP|EPHA2|NPR1|RFK|GAPDH|NDUFS6|COQ7|HMGCS1|NUDT18|UMPS|NDUFB4|HACD2|NUDT4|NDUFA12|SDHAF2|GMPS|LDHA|NDUFA2|NDUFAB1|COX4I2|NDUFA1|ACOT2|STOML2|PDHX|ABCD1|NDUFA4|HINT1|ATP5H|NDUFV1|UQCRQ|SULT1A4|PGK1|NDUFS3|GPHN|UQCRC2|FASN|COX6A1|UQCC3|NDUFA8|ADCY9|ALDOA|NDUFS8|ALDOC|ATP5G1|BAD|NDUFV3
VESTIBULOCOCHLEAR NERVE DEVELOPMENT%GOBP%GO:0021562,0.20480807544162602,0.5845960940001321,0.8992059991177771,1.19896986738962,1541,1,CHRNB2
NEGATIVE REGULATION OF MESODERM DEVELOPMENT%GOBP%GO:2000381,0.44410104810534795,0.766503259003379,0.516498036276065,1.01589068657669,3304,3,DKK1|RPS6KA6
CANONICAL WNT SIGNALING PATHWAY%GOBP%GO:0060070,0.7860567045610191,0.9274485629622209,0.150437355790004,0.7854307381713491,5738,45,SFRP1|LRP5L|TCF7L1|RARG|WNT2B|DIXDC1|FRAT2|DVL2|WNT4
PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE%GOBP%GO:0002440,0.000771704180064309,0.0191058847417112,-0.373730804173706,-2.02647546865282,5,54,BATF|IGKV1-8|EXO1|TLR2|IGLV3-9|IGLV11-55|IGLV8-61|IGKV2-28|IGLV4-60|IGKV2D-29|RNF168|POLQ|SLC11A1|IGLV7-46|IGLV5-45|IGKV2D-28|IGKV2-24|IGLV4-69|CHGA|IGLV9-49|EXOSC3|IGLV3-10|IGKV1-6|CD55|IGKV1-27|SAMHD1
EPIDERMAL GROWTH FACTOR CATABOLIC PROCESS%GOBP%GO:0007174,0.43277591973244206,0.7613343962915831,-0.785013233348037,-1.04582611961283,3234,1,RAB7A
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER%GOBP%GO:0060795,0.247239747634069,0.628189239117494,-0.44010630675588797,-1.20301096325663,1880,7,KLF4|SOX17|CTR9
RESPONSE TO ACIDIC PH%GOBP%GO:0010447,0.480719124544033,0.7857006060206241,-0.32350353992459496,-0.9731778328451569,3689,9,IMPACT|CTSS|SLC9A1|PKD2L1|LGMN
NEGATIVE REGULATION OF IRE1-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903895,0.506613756613757,0.7981861395854799,-0.49973516912080296,-0.975856127934984,3829,3,HSPA5
PEPTIDE ANTIGEN TRANSPORT%GOBP%GO:0046968,0.29841269841269796,0.6711955314970389,-0.590455588591355,-1.1530101141651798,2255,3,CD209|CLEC4M
NEGATIVE REGULATION OF SISTER CHROMATID SEGREGATION%GOBP%GO:0033046,0.616647127784291,0.854159296508911,-0.205186195249977,-0.8845864385458,4733,25,ATRX|MAD1L1|ZNF207|TRIP13|KLHL22|APC|CDC20|ESPL1|NAA10|PTTG1|MAD2L1|PLK1|IK
PHOTOPERIODISM%GOBP%GO:0009648,0.0493697478991597,0.318633045579884,-0.3847280251310661,-1.54352146796309,375,20,MTA1|ID2|PML|PER2|BHLHE40|USP2|CRY2|RBM4B|SIK1|RBM4|PPP1CA
ENDODERMAL DIGESTIVE TRACT MORPHOGENESIS%GOBP%GO:0061031,0.271822764659061,0.646576786621306,-0.696388199614006,-1.15890132500365,2048,2,ID2|SOX17
HISTONE H4-K20 METHYLATION%GOBP%GO:0034770,0.786027360871298,0.9274485629622209,0.606638729598588,0.8088708904231429,5917,1,BEND3
SPINDLE ELONGATION%GOBP%GO:0051231,0.26904176904176896,0.643036619584462,0.384771100300126,1.16928388637653,1970,9,AURKC|CDC14B|CDC14A
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS%GOBP%GO:0002824,0.044441581862682,0.30065238448851095,-0.282312662444676,-1.4984851125322198,344,50,PRKCQ|MALT1|HLA-F|CLCF1|TRAF6|IL1B|CD1D|HLA-B|PVR|CD274|NFKBIZ|TGFB1|HLA-E|B2M|IL18|CCL19|HLA-C|PAXIP1|HLA-A|TRAF2|PVRL2|SLC11A1|RSAD2|TNFSF13|STX7|NLRP3|ZP3|FADD|IL1R1|ANXA1|TFRC
REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS%GOBP%GO:0090030,0.7335414687118229,0.907913422943088,0.30065553979720094,0.7779638803330741,5403,6,WNT4|DGKQ|DKK3
PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009209,0.9130610051061541,0.973175653595252,0.32272540011841,0.634762777930085,6794,3,CAD|CTPS2
GUANOSINE METABOLIC PROCESS%GOBP%GO:0008617,0.117412671005446,0.468392769062825,0.942159241288046,1.25624222002002,883,1,DGUOK
REGULATION OF SUPEROXIDE ANION GENERATION%GOBP%GO:0032928,0.0525627615062762,0.331996459809677,-0.499603715301409,-1.56519322154798,401,10,F2RL1|AATF|MAPT|SYK|TGFB1|ITGB2|SOD1|ITGAM|GSTP1
MITOCHONDRIAL MRNA POLYADENYLATION%GOBP%GO:0097222,0.25023243458626604,0.6308569567945129,0.876599029554477,1.16882652389994,1883,1,PNPT1
MAST CELL PROLIFERATION%GOBP%GO:0070662,0.189666622393412,0.563467720122429,0.9076422584913979,1.21021848093577,1427,1,KIT
VESICLE LOCALIZATION%GOBP%GO:0051648,0.514066496163683,0.8026261188806211,-0.136006176140342,-0.973610058079703,4019,176,DYNC1H1|MCFD2|SEPT5|TBC1D23|YKT6|SNAP47|AP3S1|DNM1|STX4|TFG|PDCD6|TOR1A|RAB27B|SYT4|TRAPPC5|SYT7|NAPA|SCFD1|CPLX2|SEC23A|SERPINA1|STX11|F8|WIPI1|SEC13|SEC24A|ARFGAP2|PPP6R3|CNIH2|CNIH1|STX1B|TMED2|CTSZ|CTSC|STX3|RAB1B|NSF|DTNBP1|CD59|STX5|CNIH3|TMED10|PRRT2|TRAPPC2|TMED9|GOSR2|DYNC1I1|PPP6C|SAR1B|GRIA1|SNPH|DNM3
DISTAL CONVOLUTED TUBULE DEVELOPMENT%GOBP%GO:0072025,0.081551334838624,0.397722753303477,0.9601345390383771,1.28020985411182,613,1,PAX8
TOLL-LIKE RECEPTOR 9 SIGNALING PATHWAY%GOBP%GO:0034162,0.45763598326359795,0.7720975467429151,-0.316060110934912,-0.9901750689315442,3499,10,PIK3AP1|UNC93B1|IRAK1|PIK3R4
EAR MORPHOGENESIS%GOBP%GO:0042471,0.23962571196094398,0.623187683081912,0.334340298782404,1.20174308677455,1766,14,FGFR2|PAX8|EPHB2|TWIST1|CEP290|CHD7|PROX1
PROGESTERONE METABOLIC PROCESS%GOBP%GO:0042448,0.9057714958775028,0.97046527419469,-0.29300170959025,-0.6414419906547328,6920,4,AKR1C2|AKR1C1|AKR1C3|ADM
NEGATIVE REGULATION OF AMNIOTIC STEM CELL DIFFERENTIATION%GOBP%GO:2000798,0.506488294314381,0.798168488166378,-0.7508270842523159,-1.00028196043885,3785,1,REST
REGULATION OF MEMBRANE LIPID METABOLIC PROCESS%GOBP%GO:1905038,0.541893362350381,0.815622645995152,0.272687308914477,0.9268111247886959,3983,12,SMPD2|ORMDL1
POSITIVE REGULATION OF MELANOSOME TRANSPORT%GOBP%GO:1902910,0.9407357859531771,0.9812919575525741,-0.529333921482135,-0.7051998839842092,7031,1,CDH3
HEMATOPOIETIC STEM CELL HOMEOSTASIS%GOBP%GO:0061484,0.34743963916158105,0.704881522008447,-0.6622553074165981,-1.10209873412732,2618,2,UBAP2L|NOV
SEX DETERMINATION%GOBP%GO:0007530,0.0252683059366934,0.223514802128899,0.7449711120926759,1.63673325982833,185,4,SRD5A1|WNT4|CITED2
PEPTIDYL-TYROSINE AUTOPHOSPHORYLATION%GOBP%GO:0038083,0.4355868177673571,0.762423981601725,-0.23436535966685199,-1.01038190495044,3343,25,SLA|LYN|KDR|FGR|TNK2|DYRK1A|MAPK3|ABL1|DDR1|HCK
ACETYLCHOLINE CATABOLIC PROCESS IN SYNAPTIC CLEFT%GOBP%GO:0001507,0.8116291532690251,0.935317461845028,0.44297769518470503,0.7442597230756921,6057,2,COLQ
MESODERMAL CELL FATE COMMITMENT%GOBP%GO:0001710,0.455384615384615,0.7711801339028691,-0.773323775915307,-1.03025295550818,3403,1,KLF4
POSITIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0060265,0.579094169212379,0.838246528828442,0.7087009263343629,0.9449570582265641,4359,1,RPS19
REGULATION OF DNA BINDING%GOBP%GO:0051101,0.0167305236270754,0.17569702079137303,-0.262744893861649,-1.58561079726899,130,81,ZNF675|ID2|GZMA|TGFB1|ID3|PSEN1|SP100|CEBPG|H1F0|ZNF593|PER2|HMGB2|KDM1A|CDT1|NSD1|SMO|NGF|GATA3|HES1|FAM129B|PARK7|IGF1|E2F1|IFI16|SUMO3|BCL3|MDFI|PLAUR|NFKBIA|HDAC8|ID1|MMP9|PPARG|ID4|TMSB4X|CDCA5|EDF1|NME1
POSTSYNAPSE ASSEMBLY%GOBP%GO:0099068,0.9431995831162059,0.9825021479202449,-0.19400926743159802,-0.583627364556712,7239,9,NLGN2|NLGN4X|SHANK2|NRXN1|SHANK1|NLGN4Y|PTEN|NLGN3|NRXN2
PIGMENT CELL DIFFERENTIATION%GOBP%GO:0050931,0.637673280782821,0.864977246543067,0.22846590432907998,0.860249901802029,4691,16,CITED1|KIT|BLOC1S3|AP1M1|MREG|BLOC1S5|HPS6|AP1G1
POST-EMBRYONIC EYE MORPHOGENESIS%GOBP%GO:0048050,0.433201058201058,0.7614924524950341,-0.5315953888411971,-1.03807106210942,3274,3,FBN1|EFEMP1
COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY%GOBP%GO:0002430,0.0128356254092993,0.149991146428462,-0.681502284942213,-1.75300746411798,97,6,FPR3|FPR1|C3AR1|CMKLR1|C5AR1
POSITIVE REGULATION OF TELOMERASE RNA REVERSE TRANSCRIPTASE ACTIVITY%GOBP%GO:1905663,0.892411780313081,0.965443067117994,-0.406619017015707,-0.676679067583828,6726,2,HNRNPA2B1
NEGATIVE REGULATION OF BLOOD CIRCULATION%GOBP%GO:1903523,0.596744552375952,0.844613508628182,-0.24514812845529602,-0.8900931162094571,4545,15,DOCK4|ADM|SPTBN4|PLN|DOCK5|PDE4D|F2R|ADRBK1
NEGATIVE REGULATION OF INTERLEUKIN-2 PRODUCTION%GOBP%GO:0032703,0.274612759254398,0.649047934290704,-0.31809659988732397,-1.15495719112118,2091,15,NAV3|HAVCR2|KAT5|PRNP
CILIUM-DEPENDENT CELL MOTILITY%GOBP%GO:0060285,0.0008143322475570031,0.0196591200463433,0.6663652740822211,2.19275092674672,5,11,RSPH9|CFAP44|CCDC65|RFX3|SPEF1|TEKT2|GAS8|DNAH1
CELLULAR RESPONSE TO IRON ION%GOBP%GO:0071281,0.601394003156234,0.847046653006894,-0.3654683929888479,-0.875958000206009,4572,5,B2M|HFE
AEROBIC ELECTRON TRANSPORT CHAIN%GOBP%GO:0019646,0.527563179258871,0.810052447666581,-0.272941847312518,-0.9395187678526992,4028,13,COX5A|COX4I1|MT-CO2|COX7C|CYCS|MT-CO3|COX4I2|COX6A1
NEGATIVE REGULATION OF PERK-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:1903898,0.155215285957335,0.523634212821233,-0.605194948436552,-1.32489825060136,1185,4,PPP1R15B|PPP1R15A|PTPN1|NCK1
POSITIVE REGULATION OF MALE GONAD DEVELOPMENT%GOBP%GO:2000020,0.35396466994288794,0.7118407891832621,0.8236104984561099,1.09817346757412,2664,1,CITED2
REGULATION OF INTERLEUKIN-18-MEDIATED SIGNALING PATHWAY%GOBP%GO:2000492,0.402006688963211,0.740287621109606,-0.7993493603881779,-1.0649252831374,3004,1,TICAM2
MAMMARY GLAND INVOLUTION%GOBP%GO:0060056,0.10515050167224099,0.446168961873938,-0.9450264666960742,-1.25900216787556,785,1,CAV1
POSITIVE REGULATION OF T-CIRCLE FORMATION%GOBP%GO:1904431,0.42311215809449004,0.753783909572009,-0.469240782835836,-1.0272661625747,3232,4,SLX1B|SLX1A
MACROPHAGE MIGRATION%GOBP%GO:1905517,0.07308096740273401,0.380316689710452,-0.546081050119849,-1.4926881983658,555,7,AZU1|CCL2|EDNRB|LGALS3
POSITIVE REGULATION OF POLYNUCLEOTIDE ADENYLYLTRANSFERASE ACTIVITY%GOBP%GO:1904247,0.12240802675585302,0.476255306135618,-0.9373070136744599,-1.24871800290079,914,1,PABPN1
PROTEIN INSERTION INTO MEMBRANE%GOBP%GO:0051205,0.9692730125523008,0.9913618058843051,-0.139541121551436,-0.541471448353018,7412,18,UBL4A|BAD
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS%GOBP%GO:2000300,0.694037656903766,0.889500280068691,-0.21176427527612102,-0.8217241453152759,5307,18,NAPA|FMR1|VPS18|SYN1|STX1B
MUSCLE CELL MIGRATION%GOBP%GO:0014812,0.0335341891537857,0.261345744270986,-0.507110310931598,-1.64179691519028,255,11,DDR1|NOV|PDGFRB|PLAT|ANXA1
GLUCOSE 6-PHOSPHATE METABOLIC PROCESS%GOBP%GO:0051156,0.14279902359642002,0.509126938596407,0.37071254272110604,1.3324784269743302,1052,14,DERA|RPE|PGD|RPIA|RBKS|SHPK|GCK|G6PD|PGM2
SMOOTH MUSCLE CONTRACTION%GOBP%GO:0006939,0.780988493723849,0.925307658074164,-0.195167889442608,-0.757323995919995,5972,18,EDNRA|PIK3C2A|MYH11|MYLK|SULF1|TPCN2|EDNRB
T-HELPER 2 CELL CYTOKINE PRODUCTION%GOBP%GO:0035745,0.929738345065746,0.9793746057014829,0.535840317600353,0.7144707610554542,6999,1,DENND1B
VESICLE-MEDIATED INTERCELLULAR TRANSPORT%GOBP%GO:0110077,0.699397993311037,0.892627170717022,-0.653231142479047,-0.870260731829263,5227,1,ARC
RELAXATION OF VASCULAR SMOOTH MUSCLE%GOBP%GO:0060087,0.238127090301003,0.6217283213739421,-0.877922364358183,-1.1696033909163102,1779,1,SOD1
ESTABLISHMENT OF LYMPHOCYTE POLARITY%GOBP%GO:0001767,0.807224185316058,0.933811101775582,-0.33138476810235495,-0.725470529238526,6167,4,CCR7|CCL21|SNX27|CCL19
CELLULAR RESPONSE TO GLUCOSE STIMULUS%GOBP%GO:0071333,0.27160978161370497,0.646576786621306,-0.279278921064094,-1.15656667818572,2076,22,GNB2L1|ZNF236|GAS6|ADCY8|GPER1|PDK3|TRA2B|PRKACA|ERN1
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION%GOBP%GO:0050806,0.6711724137931031,0.8815356925073421,0.150295215626323,0.8721715920745309,4865,66,DRD2|EPHB2|RAB3B|CACNG7|RIMS1|DRD4|RAB3GAP1|RIMS2|ADCYAP1|HAP1|CUX2|TSHZ3|CACNG4|PTK2B|FLOT1|DLG4|NLGN2
CREATININE HOMEOSTASIS%GOBP%GO:0097273,0.311329525833444,0.68160868787154,0.845059550066167,1.12677288371433,2343,1,TFAP2B
CARDIAC ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0003348,0.40196463654224,0.740287621109606,-0.404465221582298,-1.04039350722063,3068,6,SOX18|SOX17|NOTCH1|ANXA2
POLYADENYLATION-DEPENDENT RNA CATABOLIC PROCESS%GOBP%GO:0043633,0.579796927883364,0.8386526275338391,-0.31139860909892997,-0.8964730121093399,4453,8,EXOSC3|EXOSC2
AMINOPHOSPHOLIPID TRANSPORT%GOBP%GO:0015917,0.82907820478366,0.9433761342424741,0.36342253827989207,0.714809246115449,6169,3,SCARB2|TMEM30A
MAPK CASCADE%GOBP%GO:0000165,0.123893805309735,0.47832576509682107,-0.160990931928285,-1.21122784804195,965,231,PKN1|STRADA|MDFIC|GRIN1|ILK|TAOK2|CSF2RB|MAPKAPK2|GRB2|PTGER4|MEF2C|MLKL|IRS1|MAPK9|IL2RA|CAMKK2|FGF10|MAPK3|CAMK2B|IRAK1|HRAS|IGF1|SKP1|MEN1|MAP3K13|HBEGF|CCL2|CTSH|CSF2RA|MAP2K3|PLVAP|IL3RA|FGF19|FGF9|LGALS9|TEK|MAP3K11|FGF7|ARAF|DLG3|PEA15|UBC|PDGFRB|PABPN1|CAMK2A|FLT3LG|MYC|MAPK13|NFKB1|PDGFA|PDGFRA|SPTBN2|GPS1|DBNL|PDGFB|ERN1
PYRIMIDINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009223,0.12867247007617,0.48618406957140003,0.401520094412891,1.36468870447061,945,12,NT5M|NTHL1|NEIL1|OGG1|DUT|SMUG1|NEIL2|TDG
SPONTANEOUS SYNAPTIC TRANSMISSION%GOBP%GO:0098814,0.254748306548014,0.6334469481869079,0.874834583149537,1.16647387270074,1917,1,RIMS2
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA%GOBP%GO:1990144,0.886970381192722,0.965013712426871,0.556076312307014,0.7414527294962192,6677,1,BNIP3
SPINDLE CHECKPOINT%GOBP%GO:0031577,0.845842050209205,0.948909006295342,-0.18112837669182102,-0.702845465012262,6468,18,ZNF207|TRIP13|KLHL22|APC|CDC20|MAD2L1|PLK1|IK
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND%GOBP%GO:0038034,0.311916677938591,0.68160868787154,0.279342571583926,1.11370640044877,2305,19,ERBB3|CASP9|BOK|ITGAV|BAX|BCL2|DCC
NEGATIVE REGULATION OF GROWTH%GOBP%GO:0045926,0.0755925688661115,0.385018945189654,-0.193818954952585,-1.3242665504451399,589,139,TGFB1|MUL1|PPT1|PML|SEMA4A|HYAL2|GJA1|TSPYL2|GNB2L1|MT1G|SMARCA4|SMARCA2|CCDC85B|SOX17|CDHR2|SEMA6A|SFRP2|CDKN2A|DDX3X|RERG|NOTCH1|INHBA|DCUN1D3|ENO1|NOTCH2|RBBP7|WWC3|SEMA3B|SEMA3D|MT1M|SEMA7A|CDA|NPR1|PPP2CA|HYAL1|NOV|BST2|MT2A|WFDC1|SEMA5A|DACT3|SEMA3E|SLIT2|APBB1|SEMA3A|SEMA6B|BCL6|CDKN2C|OSGIN1|MT1E|PHB|NDUFS3|ACVRL1|PTPRJ
"ZYGOTIC DETERMINATION OF ANTERIOR/POSTERIOR AXIS, EMBRYO%GOBP%GO:0007354",0.47812709030100303,0.7850984235874658,-0.7638950154389059,-1.01769158257471,3573,1,BASP1
CELLULAR RESPONSE TO ANGIOTENSIN%GOBP%GO:1904385,0.13204086979303098,0.49184184539864795,-0.420760048561771,-1.3622332949511102,1007,11,CAMK2A|CAV1|RELA|NFKB1
RESPONSE TO PURINE-CONTAINING COMPOUND%GOBP%GO:0014074,0.590909090909091,0.8417378833576942,-0.17300450419681002,-0.9115429727141758,4575,49,SSH1|AQP1|NDUFS4|JUNB|HSP90B1|ZFP36L1|RYR2|P2RX4|RAPGEF1|AHR|P2RX3|PDXP|CRHBP|PDE2A|RAPGEF3|P2RY6|RAP1A|KCNQ1|IGFBP5
REGULATION OF PARKIN-MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION%GOBP%GO:1905089,0.26045955638199,0.636316525692816,0.871801940891045,1.1624302534521298,1960,1,VPS13C
CEREBELLAR GRANULAR LAYER STRUCTURAL ORGANIZATION%GOBP%GO:0021685,0.963607384778855,0.990916952887267,0.518030436700485,0.6907236880135821,7254,1,KIF14
PHAGOSOME ACIDIFICATION%GOBP%GO:0090383,0.407407407407407,0.7445496113654559,-0.47723076835537104,-1.04475791108402,3112,4,SLAMF8|RAB7A|RAB20
CARDIOLIPIN ACYL-CHAIN REMODELING%GOBP%GO:0035965,0.767857142857143,0.920474726214876,-0.3901477951943921,-0.761859761462447,5804,3,PLA2G4A
ENTRY INTO HOST%GOBP%GO:0044409,0.0418574231523872,0.293009782616793,-0.33851609437803604,-1.5455982133267299,319,30,HYAL2|ZNF639|CTNND1|CD4|PPIA|CAV2|GAS6|PVRL2|CXCR4|GRB2|VAMP8|AXL|CAV1|ADRBK1|CD81
REGULATION OF CHROMATIN BINDING%GOBP%GO:0035561,0.7949790794979079,0.929656485793048,-0.232675729451469,-0.728942686778182,6079,10,DTX3L|CDT1|PARP9|GMNN
TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION%GOBP%GO:0002949,0.69895498392283,0.892543256129693,0.49598250072162203,0.83331464010518,5216,2,TPRKB|OSGEP
MEMBRANE LIPID BIOSYNTHETIC PROCESS%GOBP%GO:0046467,0.617216350439323,0.8545874073761078,-0.144266417178362,-0.913849835148412,4846,98,B3GALT2|HACD2|PPAP2A|PIGH|B3GNT5|NDUFAB1|SPTSSA|SMPD1|A4GALT|B3GALT1|ALDH3B1|SPHK1|ST3GAL5|GBGT1
GLUCOSE METABOLIC PROCESS%GOBP%GO:0006006,0.42644392644392604,0.755007255274521,-0.182961941937522,-1.0164469155814,3292,59,APOD|PGAM2|PER2|OAS1|GOT1|GAA|GPI|SLC25A10|G6PC3|HK1|HK3|ENO1|GHRL|LRP5|PGM5|PGAM1|GAPDH|PGK1|ALDOA|ALDOC
HEART GROWTH%GOBP%GO:0060419,0.0369984366857738,0.274030013395841,-0.544299884762277,-1.63738728297776,283,9,C3orf58|MESP1|NOTCH1|S1PR1|TGFBR3
NERVE GROWTH FACTOR SIGNALING PATHWAY%GOBP%GO:0038180,0.37039957939011603,0.7228597023662159,-0.39203589964508206,-1.0716126490884499,2817,7,MAGI2|NTRK1|RAPGEF1|NGF|RAP1A
RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN%GOBP%GO:0035966,0.0466487248494169,0.309391082191107,-0.19955130667650897,-1.38017132355388,363,147,F12|TSPYL2|HDGF|HSPB2|HSP90B1|MYDGF|HSPA13|DAB2IP|TOR1B|RNF121|TOR1A|TMBIM6|KLHL15|TLN1|VCP|CREB3|DNAJC4|BAG3|ATP6V0D1|HSPA6|HSPA9|TPP1|MBTPS2|CREB3L1|WIPI1|CALR|HERPUD1|HSPB1|ERP44|LMNA|CCL2|HSPB7|PDIA5|SRPRB|SYVN1|SERPINH1|SSR1|EIF2S1|KDELR3|DNAJA1|DERL3|HSP90AA1|HSPA5|GOSR2|DNAJB11|DNAJB5|HSPA4|SERP1|YIF1A|ERN1
REGULATION OF MACROPINOCYTOSIS%GOBP%GO:1905301,0.20307692307692302,0.5817604087661171,-0.8961733568592858,-1.19391809524952,1517,1,STX1B
DN2 THYMOCYTE DIFFERENTIATION%GOBP%GO:1904155,0.992508361204013,0.997305769352475,-0.50363917071019,-0.670968306282475,7418,1,PTPRC
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR-MEDIATED SIGNALING PATHWAY%GOBP%GO:1903265,0.43646931603135997,0.7628079720130171,0.41645589990303206,1.00157405109584,3228,5,PARK2|ADAM17|CPNE1
REGULATION OF VOLTAGE-GATED SODIUM CHANNEL ACTIVITY%GOBP%GO:1905150,0.47548231511253997,0.784986345464663,0.6028122415219189,1.01280239799584,3548,2,FGF12|SLMAP
OLFACTORY BEHAVIOR%GOBP%GO:0042048,0.070069667738478,0.37615032979479207,0.83677970774745,1.4058979500171,522,2,ADCY3|CFAP69
"TRNA SPLICING, VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION%GOBP%GO:0006388",0.5299401197604791,0.8114218124402081,-0.322826299650609,-0.929371733783018,4070,8,TSEN54|CLP1|C14orf166
POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS%GOBP%GO:0090208,0.693202614379085,0.8891053668472759,-0.242782439469105,-0.8126155570115309,5302,12,PNPLA2|ABHD5|NR1H3|LDLR
REGULATION OF MAINTENANCE OF PERMEABILITY OF BLOOD-BRAIN BARRIER%GOBP%GO:1905603,0.8707692307692311,0.9574934752519241,-0.5673246581385091,-0.755812667324325,6508,1,IL6
LIPID TRANSPORT INVOLVED IN LIPID STORAGE%GOBP%GO:0010877,0.6710878885316179,0.8815356925073421,0.511343187228399,0.8591225767350799,5008,2,STARD4
POST-TRANSLATIONAL PROTEIN MODIFICATION%GOBP%GO:0043687,0.0411327524346489,0.29073816178840006,-0.168184422273264,-1.3229841383191399,320,301,CHM|GAS6|PTP4A2|COPS6|FEM1A|PNPLA2|DCAF5|C3|RNF7|VWA1|PSMD4|FN3KRP|CCDC22|DCAF10|BTBD6|NUCB1|DCUN1D3|SERPINA1|PSME2|EVA1A|CISH|PSMB5|FBN1|LTBP1|STC2|SPP1|RBBP7|VCAN|DTL|SKP1|MEN1|PSMC4|WDR5|CSF1|NEDD8|HIF3A|PSMC6|SDC2|FBXO4|PSMD10|APOE|FN1|PSMB3|DCAF4|TNC|PSMC1|RAB1B|MFGE8|PSMD2|FBXO17|PSMD6|IGFBP5|ERCC8|PRSS23|FBXW5|DDB1|CCDC8|PSMD12|PSMA3|TIMP1|SPARCL1|LGALS1|GPS1|PSMA6|LRR1|IGFBP4|IGFBP7|PSMD13|PSMB7|TMEM132A|PSMA1|PSMC5|PSMC3|CST3|P4HB|SPSB1
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING%GOBP%GO:0051897,0.0115503080082136,0.140084987142734,-0.24800031720318103,-1.6019564872290801,89,107,MC1R|NRG1|CCL3|RAC2|GDF15|NRG2|PIK3R5|TNF|RAC1|ITGB1|KIAA1161|TGFB1|TNFAIP8L3|CHI3L1|MTDH|F10|IL18|ADAM8|CCL19|MYDGF|PIK3AP1|FGFR4|P2RX4|HCLS1|HGF|VAV1|GATA3|GAS6|INS|MST1R|GRB2|IRS1|GCNT2|PARK7|HAX1|F3|PIK3CB|OSM|FGF10|RHOG|HBEGF|CD86|FGF19|FGF9|THBS1|TEK|FGF7|SEMA5A|PDGFRB|CX3CL1|PDGFA|HSP90AA1|PDGFRA|ENG|PDGFB|PTPRJ
CILIUM ASSEMBLY%GOBP%GO:0060271,0.000138985406532314,0.00526859796630401,0.342733126761924,2.69853269399154,0,274,DYNLRB2|DYNC2H1|NPHP1|ABCC4|CC2D2A|DYNC1I2|TTC30B|LRRC6|WDR19|TTC21B|DYNC2LI1|BBS5|RABL2B|INTU|IFT88|STK36|DNALI1|WDR35|DNAI1|ZMYND10|CBY1|CEP162|NPHP3-ACAD11|FAM161A|TBC1D32|RSPH9|LRGUK|BBS4|SPATA6|CLASP1|BBIP1|DCTN1|TMEM67|SFI1|IFT46|CFAP44|IFT172|AHI1|CFAP20|DYX1C1|FGFR1OP|ABLIM1|CFAP43|ARL3|CCDC65|PIBF1|IFT20|TMEM17|NINL|LRRC49|CEP89|IFT140|RFX3|RSPH1|SPAG16|CCDC176|TMEM107|KIF3B|DZIP1|C9orf117|ARMC9|SEPT2|CLUAP1|TTC8|TTLL3|IQCG|CCDC113|RAB1A|RPGRIP1L|IFT81|TTBK2|CEP164|CFAP46|TNPO1|WDR11|WDR60|PCM1|EHD3|RILPL1|RAB23|TMEM231|CEP290|MARK4|WDPCP|RSPH4A|WDR90|ACTR2|TCTN2|POC1B|SEPT10|CEP57|MKKS|B9D1|TEKT2|GAS8|NPHP4|NPHP3|IFT52|DNAH1|RPGR|RAB11A|CEP250|DCTN2|YWHAE|TRAF3IP1|SEPT4|CCDC40
SYNAPTIC VESICLE TRANSPORT%GOBP%GO:0048489,0.988656870327404,0.996050320421843,-0.0955604518484384,-0.542661031142393,7669,64,SEPT5|SNAP47|AP3S1|DNM1|STX4|TOR1A|SYT4|SYT7|CPLX2|STX11|STX1B|STX3|DTNBP1|PRRT2|SNPH|DNM3
CORTICOTROPIN SECRETION%GOBP%GO:0051458,0.0175322087926684,0.180006763679715,0.991343184825761,1.3218223721975702,131,1,CRHR1
VISCERAL MOTOR NEURON DIFFERENTIATION%GOBP%GO:0021524,0.804816053511706,0.932964969466025,-0.601951918835465,-0.801944493068292,6015,1,TBX20
PRE-MRNA CLEAVAGE REQUIRED FOR POLYADENYLATION%GOBP%GO:0098789,0.316078431372549,0.685583406115178,-0.336094833977793,-1.12494087842097,2417,12,CSTF2|CPSF6|CPSF1|NCBP2|NCBP1|TUT1|CPSF7
SYNAPTIC TRANSMISSION INVOLVED IN MICTURITION%GOBP%GO:0060084,0.0644987906476754,0.364712161390154,0.7489246718870629,1.47304645067598,479,3,CHRNB2|CHRNB4|CHRNA3
REGULATION OF SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION%GOBP%GO:0008582,0.195112232700226,0.5697855203224189,0.9043890604322891,1.20588078028726,1468,1,AGRN
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART VALVE MORPHOGENESIS%GOBP%GO:0003252,0.878217033695941,0.960725750963158,-0.4157134884557971,-0.6918137223754661,6619,2,NOTCH1
AMP TRANSPORT%GOBP%GO:0080121,0.0699665551839465,0.37596389138254704,-0.9634980149977941,-1.28361070549376,522,1,SLC25A42
REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION%GOBP%GO:0033599,0.420853944285342,0.752024403464561,-0.35461244533597996,-1.0208795984082502,3232,8,GATA3|GPX1|RREB1|DEAF1
REGULATION OF POLARIZED EPITHELIAL CELL DIFFERENTIATION%GOBP%GO:0030860,0.00736870310825295,0.103946415822638,0.943589743589744,1.5853526010341101,54,2,AJAP1|AHI1
REGULATION OF TOR SIGNALING%GOBP%GO:0032006,0.901862556197816,0.968486494114721,-0.119770206080324,-0.7174518399619859,7020,79,SEC13|RNF152|RPTOR|WDR24|ARAF|TNFAIP8L1|NIM1K|DDIT4|SIK1|SLC38A9|RRAGD
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND%GOBP%GO:0050910,0.5776813880126179,0.83729927068764,-0.32807089201635403,-0.8967671532141159,4394,7,DFNB31|PDZD7|TMC2|ADGRV1
NEGATIVE REGULATION OF T-HELPER 1 TYPE IMMUNE RESPONSE%GOBP%GO:0002826,0.448285101822079,0.768229288546963,0.615001330898458,1.03328164194546,3345,2,XCL1|JAK3
MYOSIN FILAMENT ASSEMBLY%GOBP%GO:0031034,0.423837590045842,0.7540202308249201,-0.397254315084084,-1.0218451131892,3235,6,MYH11|MYOM1|IGSF22
POSITIVE REGULATION OF GROWTH RATE%GOBP%GO:0040010,0.14955505379200398,0.51590227091171,0.9274371415968241,1.23661228657674,1125,1,RFTN1
NEGATIVE REGULATION OF STRESS FIBER ASSEMBLY%GOBP%GO:0051497,0.0804176837537293,0.397722753303477,0.4066310275126,1.46158278843716,592,14,MET|CLASP1|TMEFF2|INPP5K|CLASP2
AMINOACYL-TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY%GOBP%GO:0106074,0.0932441471571906,0.422068646506606,-0.9510366122629019,-1.2670091248916298,696,1,DTD2
"SUBSTRATE-DEPENDENT CELL MIGRATION, CELL ATTACHMENT TO SUBSTRATE%GOBP%GO:0006931",0.395138796652942,0.7377402989373809,0.803098808998677,1.0708238973834798,2974,1,CUZD1
NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LATERAL MESODERM LEFT/RIGHT ASYMMETRY%GOBP%GO:1900164,0.35396466994288794,0.7118407891832621,0.8236104984561099,1.09817346757412,2664,1,CITED2
REGULATION OF CHOLINE O-ACETYLTRANSFERASE ACTIVITY%GOBP%GO:1902769,0.982733430734493,0.993436724391485,0.507940008822232,0.677269463968187,7398,1,SORL1
SMOOTH MUSCLE CELL PROLIFERATION%GOBP%GO:0048659,0.0396656938179889,0.284127835345897,-0.872042460525812,-1.4512181043891499,298,2,NOV
XENOPHAGY%GOBP%GO:0098792,0.380737596179358,0.729499056535481,-0.6483798913082289,-1.07900782287713,2869,2,CALCOCO2
CORTICOSPINAL NEURON AXON GUIDANCE%GOBP%GO:0021966,0.009020960466967359,0.119944947211922,-0.93791011855528,-1.56083242038064,67,2,SLIT2|SCN1B
POSITIVE REGULATION OF CHEMOKINE PRODUCTION%GOBP%GO:0032722,0.25117432150313196,0.631788872784532,-0.26973686779087397,-1.17664147623986,1924,26,PYCARD|CD74|TLR2|AZU1|DDX3X|HMOX1|IL33|LGALS9|TLR4|CSF1R
RESPONSE TO ESTRADIOL%GOBP%GO:0032355,0.200340002615405,0.578120018002042,-0.298763484375985,-1.23725732458205,1531,22,GGT1|CRHBP|STAT3|GPER1|H2AFZ|KAT5|ANXA1|SSTR2
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE%GOBP%GO:0002922,0.0747284386860359,0.383186929742657,-0.666220913030145,-1.45849684381531,570,4,FCGR2B|ZP3|PHB
VERY-LOW-DENSITY LIPOPROTEIN PARTICLE CLEARANCE%GOBP%GO:0034447,0.24800418793351697,0.62852193925262,-0.555726868104975,-1.21660228206886,1894,4,APOC1|APOBR|APOE
REGULATION OF GLUCOSE METABOLIC PROCESS%GOBP%GO:0010906,0.796895213454075,0.9304414572767159,-0.142024900194754,-0.782040163675645,6159,57,RORA|OGT|PHKG2|INS|PPP1R3E|IRS1|ADIPOR1|IGF1|SLC45A3|NR1D1|PDK3|SIK1|PPP1R3F|BAD
CORPUS CALLOSUM DEVELOPMENT%GOBP%GO:0022038,0.9678295099769241,0.9912626134248801,0.211567267064131,0.5474427384497771,7129,6,EPHB2|SZT2|PAFAH1B1|RTN4R
ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION%GOBP%GO:0034087,0.45237463518174603,0.769943206592495,-0.6184725668596639,-1.02923725245395,3409,2,NIPBL|NAA50
GLYCERALDEHYDE-3-PHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0046166,0.30167153091005605,0.6746768701419901,-0.6837055417700579,-1.1377953542418502,2273,2,TPI1|TKT
DNA MODIFICATION%GOBP%GO:0006304,0.775937904269082,0.9241501353901659,-0.14471437622119102,-0.7968493856432879,5997,57,APOBEC3G|DNMT1|APOBEC3C|APOBEC3B|N6AMT1|PPM1D|EXOSC3|APEX1|ALKBH3|APOBEC3F
POSITIVE REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL%GOBP%GO:1904999,0.6709030100334449,0.8815356925073421,-0.668228936921041,-0.8902413952088148,5014,1,TNF
IMMUNE RESPONSE-REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:0002433,0.221048563699601,0.6033929888625489,-0.19597010023638897,-1.16560090041352,1715,77,RAC1|WIPF3|IGKV3-11|ACTG1|LYN|NCKAP1L|VAV3|WASF2|IGHG4|NCKIPSD|FGR|FCGR1A|ARPC1A|VAV1|MYO1G|WAS|FCGR2B|IGKV2-28|MYO10|ELMO1|GRB2|PIK3CB|MAPK3|ABL1|FCGR2A|DOCK1|CYFIP2|IGKV2D-28|HCK|HSP90AA1|ACTB|NCK1|IGHG2
PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS%GOBP%GO:0042451,0.35265509989484795,0.7111578119705879,-0.399316824672856,-1.09151473296365,2682,7,IMPDH2|ADA|HPRT1|GMPS
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION%GOBP%GO:0044334,0.540594855305466,0.8151499042806,0.574358974358974,0.964997235412066,4034,2,TCF7L2|CTNNB1
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE%GOBP%GO:0050728,0.000128799587841319,0.00518555396908895,-0.386995114583896,-2.16211665751616,0,60,NDFIP1|PYCARD|TNFAIP8L2|APOD|SLAMF8|KLF4|SIGLEC10|RORA|TNFAIP6|GATA3|FCGR2B|INS|FEM1A|TNFAIP3|PTGER4|GHRL|NR1H3|CDH5|GPER1|APOE|NLRP3|NOV|CD200|TEK|CX3CL1|LDLR|PPARA|ABCD1|GSTP1|TNFRSF1A|METRNL|CHID1|SIRPA|PTGIS
SORBITOL METABOLIC PROCESS%GOBP%GO:0006060,0.17890822154336603,0.55175028994035,0.912770180855756,1.21705587348343,1346,1,SORD
ADENYLATE CYCLASE-ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS%GOBP%GO:0086023,0.4571428571428571,0.7719619284439659,-0.5218989113207341,-1.01913629907408,3455,3,PDE4D|CHGA
POSITIVE REGULATION OF MICROTUBULE BINDING%GOBP%GO:1904528,0.277910052910053,0.653204101106396,-0.6001966850341851,-1.17203200664728,2100,3,ABL1|PPP2CA
REGULATION OF CELL-MATRIX ADHESION%GOBP%GO:0001952,0.0007685410529012429,0.0191058847417112,-0.318794740721297,-1.91621467905433,5,80,PTEN|RCC2|RAC1|MMP12|DUSP3|UTRN|CDK6|APOD|JAG1|PEAK1|CORO1C|JUP|PPM1F|KDR|CDKN2A|PLAU|THY1|CASK|PHLDB2|SLC9A1|BCAS3|S100A10|PIK3CB|BST1|ABL1|GPM6B|CSF1|DLC1|CD36|THBS1|TEK|SEMA3E|CX3CL1|SERPINE1|FAM107A|KIAA2022|NF2|COL16A1|ACVRL1|EFNA5|PTPRJ|EMP2
POSITIVE REGULATION OF CELL DIVISION%GOBP%GO:0051781,0.21018934750034102,0.591474654268711,0.26544651878440695,1.2148500277148502,1542,29,AURKC|DRD2|FGFR2|PKP4|CSPP1|PRKCE
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH%GOBP%GO:0055023,0.16158177294749201,0.531682046847491,-0.37820998250909604,-1.3018721029966398,1233,13,TBX2|NOTCH1|MEF2C|PIM1|IGF1|TGFBR3
POSITIVE REGULATION OF RESPONSE TO ALCOHOL%GOBP%GO:1901421,0.360267558528428,0.7155384949577859,-0.817765769739744,-1.08946036243435,2692,1,LANCL2
"BASE-EXCISION REPAIR, BASE-FREE SUGAR-PHOSPHATE REMOVAL%GOBP%GO:0006286",0.564871318652162,0.8295590091625621,-0.573326898037117,-0.954107640197995,4257,2,APEX1
CHROMATIN SILENCING AT RDNA%GOBP%GO:0000183,0.0010500065625410199,0.0240545523142212,-0.523281650895997,-2.13185321355556,7,21,HIST1H4I|HIST2H3A|HIST2H4A|HIST2H3C|HIST1H3H|HIST2H4B|RRP8|H3F3B|SUV39H1
INTERLEUKIN-3 PRODUCTION%GOBP%GO:0032632,0.256588628762542,0.634929462604421,-0.868052492280547,-1.1564543514128502,1917,1,SLC11A1
THYMIC T CELL SELECTION%GOBP%GO:0045061,0.7496054708048401,0.9138851738809591,-0.32147584381204497,-0.770516254380256,5699,5,ZAP70|CD3E|CD3D|CD3G|JAG2
CELLULAR RESPONSE TO LEUCINE STARVATION%GOBP%GO:1990253,0.79380230125523,0.929656485793048,-0.23295418399141302,-0.7298150485022479,6070,10,RRAGD
VESICLE UNCOATING%GOBP%GO:0072319,0.897657374689177,0.9674268340009909,-0.297027518888215,-0.650255328753321,6858,4,DNAJC6|GAK|VPS4A|SYNJ1
BLASTOCYST DEVELOPMENT%GOBP%GO:0001824,0.171313183949974,0.544970733652616,-0.430929935465992,-1.29634272565502,1314,9,ZP3|SRF|WDR74
MONOACYLGLYCEROL CATABOLIC PROCESS%GOBP%GO:0052651,0.694801714898178,0.889726625344871,0.497766749379653,0.8363124082243399,5185,2,ABHD16A|ABHD12
REGULATION OF PHOSPHORYLATION OF RNA POLYMERASE II C-TERMINAL DOMAIN%GOBP%GO:1901407,0.655952380952381,0.874869342420871,-0.434591210070436,-0.8486464865781659,4958,3,BRD4|CCNK
REGULATION OF INTERLEUKIN-6-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070103,0.0619397993311037,0.357540960865252,-0.967247463608293,-1.28860587133864,462,1,C1QTNF4
"REGULATION OF RETROGRADE VESICLE-MEDIATED TRANSPORT, GOLGI TO ER%GOBP%GO:2000156",0.920270628814009,0.9768322640118741,-0.383709826628289,-0.638554511324179,6936,2,BET1L
FATTY ACID HOMEOSTASIS%GOBP%GO:0055089,0.146300156331423,0.513872620660976,-0.4453255973051529,-1.33964840012854,1122,9,INS|POLD1|APOE|ABCD1
NICOTINAMIDE RIBOSIDE CATABOLIC PROCESS%GOBP%GO:0006738,0.475590342265853,0.784986345464663,-0.608460444895451,-1.0125754804468199,3584,2,PNP
ENDOCYTOSIS%GOBP%GO:0006897,0.000128849375080531,0.00518555396908895,-0.23413543486471103,-1.8696916954698102,0,331,RAC1|ITGB1|DOCK2|WIPF3|GRK4|IGHV1OR15-1|IGKV3-11|ADRB2|ACKR3|SYNJ1|ACTG1|LILRB1|IGHV5-51|PPT1|LYN|FCGR1B|HSPG2|C4B|ARHGAP25|FCN3|FCHO1|MESDC2|PYCARD|ADM|IGHV1-24|NCKAP1L|VAV3|CTTN|WASF2|CORO1C|CORO1A|HSP90B1|IGHV3-49|PIK3C2A|AP2A2|SNX18|RAB14|ITGB2|IGHG4|MERTK|NCKIPSD|MSR1|DNM1|APOL1|HPX|LRP1|FGR|SNX5|FCGR1A|RAB7A|IGLL5|ARPC1A|HP|VAV1|SGIP1|MYO1G|WAS|TXNDC5|CANX|SYT7|CAV2|FCGR2B|EEA1|CLTA|GAS6|RIN3|IGKV2-28|C3|MYO10|IGHV4-4|MARCO|ELMO1|ANXA11|MAPKAPK2|IGHV4-61|SYP|GRB2|JCHAIN|CLTC|CALCRL|IGHV1-3|ARRB1|FCER1G|CD93|EHD1|PIK3CB|SLC11A1|PLD4|MAPK3|ABL1|CALR|IGHV3-43|SPARC|FCN1|NR1H3|IGHV3-73|VAMP7|FCGR2A|RHOJ|P2RY6|CLEC7A|DOCK1|CEACAM1|NEURL1B|CXCL16|CYFIP2|SCARF1|GSN|APOE|IGKV2D-28|RAB7B|CD163|AXL|HCK|COLEC12|CD36|THBS1|MRC1|IGHV3-15|AIF1|TGM2|RAB34|TMEM108|MYO1E|CAV1|STAB1|LDLR|MYH9|STON2|ITGAM|IGHV1-18|ADRBK1|HSP90AA1|RAB20|ACTB|ANXA1|RHOU|DENND1A|NCK1|CD14|FOLR2|IGHG2|TFRC|IGHA1|CD81|AP2M1|CLTB|DNM3|ADGRB1|GTF2H2
PROTEIN K69-LINKED UFMYLATION%GOBP%GO:1990592,0.372397945390646,0.7234654586828599,0.441296514776407,1.06131558741752,2754,5,UFM1|UFC1|DDRGK1
INTERLEUKIN-18-MEDIATED SIGNALING PATHWAY%GOBP%GO:0035655,0.0433982114676486,0.29791299041195396,-0.657015221707479,-1.5747401163890902,329,5,AKT1|ALOX5|IL18|IL18BP|PDGFB
POSITIVE REGULATION OF FATTY ACID BETA-OXIDATION%GOBP%GO:0032000,0.40327439423706607,0.740999361251531,-0.40383880066282896,-1.03878218386666,3078,6,IRS1|PPARA|ABCD1
POSITIVE REGULATION OF CYSTEINE-TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS%GOBP%GO:2001272,0.8941806020066891,0.9658968257150641,-0.55414644905161,-0.7382561285459681,6683,1,RPS3
PROTEIN KINASE C DEACTIVATION%GOBP%GO:0042313,0.826537388763448,0.943041978946366,0.585575650639612,0.780786116732756,6222,1,EDN1
REGULATION OF TRANSPOSITION%GOBP%GO:0010528,0.264652014652015,0.6400265792424089,-0.31250916503865006,-1.1614050631243702,2022,16,PIWIL1|APOBEC3G|APOBEC3C|APOBEC3B|APOBEC3F
ION HOMEOSTASIS%GOBP%GO:0050801,0.000127307447485678,0.00518555396908895,-0.22357970432845897,-1.8321442448573602,0,389,SLC39A13|SLC9A5|NDFIP1|FIS1|NEO1|ATP6V0A1|GNB2L1|MT1G|B2M|OCM|EDNRA|CCL19|SLAMF8|HSP90B1|FPR3|LPAR6|RYR2|GPR89B|TCIRG1|ITPR2|ATP1B1|CCDC109B|FGFR4|ATP2A1|KDR|P2RX4|SLC12A8|ATP6V0A2|ERO1L|SFRP4|PTGER1|RAB7A|PLN|ITPR3|SLC8B1|ATP1A3|SLC12A2|ATP1B3|WBP2NL|P2RX5|P2RX3|ANXA6|SLC39A8|INS|THY1|STIM1|ATP2A3|TMEM203|GRIN1|SLC41A1|FPR1|FABP3|ABCG1|ATP5B|DCN|ADCY8|CXCR4|JPH4|CALB2|CCDC22|TAC1|POLD1|CALCB|DMXL1|RMDN3|ATP6V0D1|ABCB7|HAMP|CA2|SEPN1|SLC9A1|PTGER4|TBXA2R|SLC9A7|CETP|RCN3|SLC11A1|GHRL|ABL1|CALR|ACO1|IFI6|HERPUD1|HMOX1|SOD1|SKP1|SLC35G1|ARF1|SLC9A9|MT1M|CCRL2|P2RY6|NEDD8|CYBRD1|GPER1|SLC24A3|HFE|TPCN2|F2R|CCR1|APOE|FTL|APLNR|GNA15|TMCO1|MTL5|CD36|F2RL3|ATP6V0E1|GRIN2C|FXN|MT2A|XIAP|TGM2|GRIN2D|SLC22A17|BCAP31|CX3CL1|SLC30A5|CAV1|SCN1B|MYC|C3AR1|STOML2|CHRNA10|GPR4|CCL14|ATP6AP1|ATP1B2|ABCD1|PRKACA|KCNH2|ATP6V0E2|S100A8|S100A9|RAB20|ATOX1|PTGIR|PDGFRA|CMKLR1|MT1E|CD55|GNG3|ATP2B2|SLC7A8|TFRC|ATP6V1A|ATP6V1G1|FAM20A|C5AR1|FTH1|C1QTNF1|WNK2|PRNP
POSITIVE REGULATION OF LEUKOCYTE MIGRATION%GOBP%GO:0002687,0.0024418455211412398,0.0465891747414978,-0.30600718779264396,-1.80964221450198,18,75,GPSM3|CCL3|RAC2|CXCL12|TNF|THBS4|CCL4|RAC1|PYCARD|NCKAP1L|CD74|TNFRSF14|ADAM8|CCL19|P2RX4|MOSPD2|SPN|TNFRSF18|VEGFC|GAS6|THY1|CREB3|MADCAM1|ICAM1|PLA2G7|CALR|CSF1|PLVAP|CCR1|VEGFB|LGALS3|LGALS9|THBS1|ZP3|FADD|AIF1|RARRES2|SERPINE1|CMKLR1|LGMN
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN SPERMATOGENESIS%GOBP%GO:1902064,0.336321070234114,0.699462084003389,-0.8290141155712389,-1.1044458599690201,2513,1,DHX36
"REGULATION OF ALTERNATIVE MRNA SPLICING, VIA SPLICEOSOME%GOBP%GO:0000381",0.0932521694081077,0.422068646506606,-0.245918389018103,-1.3589323304838001,719,58,RBM15B|MBNL1|CELF2|PTBP1|SRSF3|REST|SRSF10|HNRNPL|RBM17|SRSF9|HNRNPU|RBMX|CELF1|FMR1|MAGOH|SRSF5|SRSF1|DDX5|CELF4|RBM15|RBM4B|SMU1|TRA2B|SRSF2|RBM8A|RBFOX3|RBM4
"REGULATION OF TRANSLATION AT SYNAPSE, MODULATING SYNAPTIC TRANSMISSION%GOBP%GO:0099547",0.33672240802675607,0.699462084003389,-0.8287935597706221,-1.10415202668403,2516,1,FMR1
PLASMA KALLIKREIN-KININ CASCADE%GOBP%GO:0002353,0.9991961414791,0.999656642395059,0.26269644334160497,0.4413639429246429,7457,2,KLKB1|F12
METANEPHRIC GLOMERULAR MESANGIAL CELL DEVELOPMENT%GOBP%GO:0072255,0.0244816053511706,0.219638825480684,-0.9884208204675781,-1.31681386669801,182,1,PDGFB
POSITIVE REGULATION OF VITAMIN METABOLIC PROCESS%GOBP%GO:0046136,0.377819050145927,0.7281989978224692,-0.64957264957265,-1.0809927633655099,2847,2,IL1B|TNF
NEGATIVE REGULATION OF APOPTOTIC DNA FRAGMENTATION%GOBP%GO:1902511,0.484128038252092,0.7872939093021379,0.757995147772386,1.01068425110407,3644,1,DFFA
RENAL ARTERY MORPHOGENESIS%GOBP%GO:0061441,0.33125249037056703,0.6957352559323989,0.834086898985443,1.1121423340693402,2493,1,PKD2
REGULATION OF NEUTROPHIL CHEMOTAXIS%GOBP%GO:0090022,0.43723739495798297,0.7635570545514341,-0.251249015929362,-1.00800623962722,3329,20,RAC2|THBS4|RAC1|NCKAP1L|CD74|CCL19|MOSPD2|BST1|SLIT2|MPP1
HEXOSE MEDIATED SIGNALING%GOBP%GO:0009757,0.7673122844255771,0.9202818175694271,-0.48025666060759,-0.799223882065292,5783,2,ADCY8
COHESIN LOADING%GOBP%GO:0071921,0.910503751339764,0.9720943283119721,0.381594776877399,0.641128494850027,6795,2,MAU2|NIPBL
NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE%GOBP%GO:0098700,0.34297963558413697,0.701955655133333,0.6630824372759859,1.11406410866264,2559,2,SLC18A1|SLC18A2
NEGATIVE REGULATION OF HETEROTYPIC CELL-CELL ADHESION%GOBP%GO:0034115,0.368677305923722,0.721792732107131,0.38796476818806797,1.0709663290000602,2725,7,MAPK7|MAP2K5
PROTEIN MONOUBIQUITINATION%GOBP%GO:0006513,0.261221864951768,0.637033618828779,-0.211260484584595,-1.14551485915891,2030,54,TRIM25|TOPORS|PCGF2|PCGF5|KBTBD8|KLHL22|RAD18|CUL4B|UBE2T|UBE2O|TRIM21|DTX3L|UBE2B|BCOR|RNF168|UHRF1|UBE2R2|CTR9|HUWE1|RNF20|DTL|SKP1|RING1|RNF40|DDB1
SIGNAL CLUSTERING%GOBP%GO:1990256,0.137658862876254,0.50219949963275,-0.929863255403617,-1.23880112953226,1028,1,SEMA5A
FRUCTOSE BIOSYNTHETIC PROCESS%GOBP%GO:0046370,0.18019828510182198,0.553886683619651,0.749570737196545,1.25937561948561,1344,2,SORD|AKR1B1
NEGATIVE REGULATION OF GROWTH RATE%GOBP%GO:0045967,0.0592995489519767,0.352751375787962,-0.842404190791288,-1.40189528403522,446,2,NOTCH1|NOTCH2
OPTIC PLACODE FORMATION INVOLVED IN CAMERA-TYPE EYE FORMATION%GOBP%GO:0046619,0.506308938770089,0.798168488166378,0.7477393030436701,0.997009466008748,3811,1,PROX1
REGULATION OF EMBRYONIC CELL SHAPE%GOBP%GO:0016476,0.93765116904058,0.9806508984207809,0.307990516985496,0.605781001638253,6977,3,WDPCP|DAG1
DETOXIFICATION OF INORGANIC COMPOUND%GOBP%GO:0061687,0.168575891694871,0.541253459162226,-0.45374885772958795,-1.30627945451351,1294,8,PARK7|MT1M|MT2A|MT1E
CELLULAR RESPONSE TO DOPAMINE%GOBP%GO:1903351,0.9366456361724499,0.9806508984207809,-0.216326828365918,-0.5913197383810329,7125,7,MAPK3|ABL1
LABYRINTHINE LAYER DEVELOPMENT%GOBP%GO:0060711,0.038274276440357004,0.27921952251939597,0.590557396956641,1.63021784281167,282,7,FGFR2|BMP7|CASP8|HEY2|LEF1|HEY1|RBPJ
IDP METABOLIC PROCESS%GOBP%GO:0046707,0.272240802675585,0.646576786621306,-0.860498456109396,-1.14639056140183,2034,1,NUDT16
ZYMOGEN ACTIVATION%GOBP%GO:0031638,0.000130429111777749,0.00518555396908895,-0.519025421224005,-2.2891556762764798,0,27,KLK1|PLAU|GGT1|PERP|MMP14|IFI16|C10orf54|CTSH|CYFIP2|CIDEB|ASPH|FADD|C1RL|PLAT|LGMN|PGK1|C1R|BAD
NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION%GOBP%GO:0045900,0.429796355841372,0.7582675454446529,0.624455685868171,1.04916617899576,3207,2,CPEB2|CPEB3
NICOTINAMIDE RIBOSIDE METABOLIC PROCESS%GOBP%GO:0046495,0.475590342265853,0.784986345464663,-0.608460444895451,-1.0125754804468199,3584,2,PNP
REGULATION OF SPERMIDINE BIOSYNTHETIC PROCESS%GOBP%GO:1901304,0.620135476158852,0.8551097775270831,0.687031318923688,0.916063560686454,4668,1,PAOX
CHYLOMICRON REMNANT CLEARANCE%GOBP%GO:0034382,0.0460672686821097,0.30746333312705,-0.700215077483042,-1.5329171758598101,351,4,APOC2|APOC1|APOE|LDLR
REGULATION OF LEUKOCYTE CHEMOTAXIS%GOBP%GO:0002688,0.0070976900245192905,0.10150677417622099,-0.291259588442362,-1.7072956552994298,54,73,GPSM3|CCL3|RAC2|CXCL12|THBS4|CCL4|DUSP1|RAC1|GREM1|LYN|NCKAP1L|CD74|CCL19|SLAMF8|SLC8B1|MOSPD2|VEGFC|GAS6|CREB3|PLA2G7|BST1|CALR|CSF1|CCL2|CCR1|VEGFB|NOV|LGALS9|THBS1|NBL1|AIF1|RARRES2|SLIT2|SERPINE1|CMKLR1|LGMN|MPP1
POSITIVE REGULATION OF DEFENSE RESPONSE%GOBP%GO:0031349,0.000128057369701626,0.00518555396908895,-0.281110049003015,-2.14126364271945,0,248,NFKBIZ|MICA|NCR3|S100A1|ALPK1|CLEC4A|HLA-E|LYN|HYAL2|DHX9|CD209|TLR1|PYCARD|F12|C2CD4A|IL18|IRAK3|ADAM8|HSP90B1|C2CD4B|HMGB2|AGT|PARP9|ITGB2|IL17D|SNX4|PIK3AP1|TLR2|CTSS|PLA2G2A|TICAM2|TNFRSF11A|HEXIM1|POLR3B|MATR3|CCL3L3|IL6ST|CCL18|PVRL2|TNFAIP3|PLSCR1|IKBKE|SLC25A6|DDX60|CLEC4E|MAPKAPK2|UNC93B1|PTGER4|MEF2C|CEBPA|MB21D1|CD47|PARK7|CLEC10A|IFIH1|FCER1G|PDE2A|MUC4|PLA2G7|OSM|RSAD2|IRF7|IRAK1|HRAS|VAMP8|FCN1|NR1H3|VAMP7|IFI16|TNIP1|IL15|NONO|GPRC5B|TMEM173|PIK3R4|IL33|HFE|RBM14|NFKBIA|HCK|COLEC12|CD36|MUC20|LGALS9|ZP3|FADD|RELB|UBC|CD300LF|MUC15|TLR5|TICAM1|CX3CL1|SERPINE1|CAV1|TRAF3|CCL14|RELA|HMGB3|DHX58|MAPK13|NFKB1|PRKACA|TLR4|S100A8|ITGAM|S100A9|OSMR|TNFRSF1A|CD14|LY96|PQBP1|ICAM2
PROTEIN SUCCINYLATION%GOBP%GO:0018335,0.8504279309876379,0.949296218452153,0.318535267192412,0.699835547686666,6259,4,DLD|OGDH|KAT2A|DLST
SKELETAL MUSCLE ACETYLCHOLINE-GATED CHANNEL CLUSTERING%GOBP%GO:0071340,0.883879598662207,0.9632754053770259,-0.5608182620202911,-0.747144585417019,6606,1,DNAJA3
POSITIVE REGULATION OF INTERLEUKIN-18-MEDIATED SIGNALING PATHWAY%GOBP%GO:2000494,0.402006688963211,0.740287621109606,-0.7993493603881779,-1.0649252831374,3004,1,TICAM2
EXCITATORY SYNAPSE ASSEMBLY%GOBP%GO:1904861,0.885265225933202,0.9640874207062379,-0.25562331108899305,-0.6575320174892061,6758,6,NRXN2
POSITIVE REGULATION OF CALCIUM-INDEPENDENT CELL-CELL ADHESION%GOBP%GO:0051041,0.112240802675585,0.459194647507502,-0.9416629907366559,-1.2545212102794099,838,1,CX3CL1
REGULATION OF SPONTANEOUS NEUROTRANSMITTER SECRETION%GOBP%GO:1904048,0.0924425554522513,0.420939346122012,0.955116894574327,1.2735195022641101,695,1,PARK2
PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE%GOBP%GO:0090435,0.6815979043876881,0.8853288544756479,-0.316849418858148,-0.815022060134216,5203,6,TOR1AIP2|PLK1
METABOLISM BY ORGANISM OF PROTEIN IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION%GOBP%GO:0052418,0.07143812709030099,0.3767214120425879,-0.962781208645787,-1.28265574731753,533,1,ANXA2
BOX H/ACA SNORNA PROCESSING%GOBP%GO:0034964,0.837755372777925,0.946216977301937,-0.438387948194218,-0.72954764929893,6314,2,DKC1
XYLULOSE BIOSYNTHETIC PROCESS%GOBP%GO:0005999,0.14645794640488197,0.513872620660976,-0.7666390956713539,-1.275810050006,1103,2,TKT|TALDO1
PHYTOSPHINGOSINE BIOSYNTHETIC PROCESS%GOBP%GO:0071602,0.738743525036525,0.9089185613230608,0.6300727834142039,0.8401170391624481,5561,1,ACER3
ADP TRANSPORT%GOBP%GO:0015866,0.00822499336694083,0.112202730765986,-0.9403915081334441,-1.56496184944273,61,2,SLC25A4|SLC25A42
PIGMENT METABOLIC PROCESS INVOLVED IN PIGMENTATION%GOBP%GO:0043474,0.843272678974632,0.9481593344082329,0.5772496691662989,0.7696845438865558,6348,1,AP3D1
PYRIDINE NUCLEOTIDE SALVAGE%GOBP%GO:0019365,0.938770088989242,0.980854185905783,0.531263784737539,0.708368572007543,7067,1,NAPRT
NUCLEOBASE-CONTAINING SMALL MOLECULE METABOLIC PROCESS%GOBP%GO:0055086,0.000126151129052605,0.00518555396908895,-0.204575742472677,-1.72237548841891,0,474,NDUFB5|PARP9|NADK|TKT|GPD1|CROT|SURF1|ACSL5|GLRX|DNPH1|ATP1B1|ABHD14B|UQCR10|ACOT1|PARP1|DCTPP1|NDUFA9|ATP5J|NDUFA7|NUDT9|ACSF2|DCAKD|GPI|ATP5F1|FAR1|COASY|OPA1|IMPDH2|ACSL4|PFKFB2|NUDT17|GPX1|ELOVL2|HK1|GALT|ADA|PDHA1|NDUFA3|VCP|NDUFB6|ACSF3|KYNU|NUDT1|ATP5B|HK3|ADCY8|PDE4D|SDHD|NPR2|ELOVL1|CYCS|SLC26A2|NDUFB9|PARK7|COA6|NUDT16|APOBEC3G|PDE2A|SMPDL3A|HAAO|ENO1|BST1|NDUFB10|SDHA|ADCY4|TYMP|MT-CO3|APOBEC3C|NDUFS7|RAN|ATP5O|NDUFB1|NDUFB7|NDUFA6|CTPS1|PGAM1|HPRT1|TPST2|GNPNAT1|CDA|MOCS2|PRPS1|MBIP|EPHA2|NPR1|RFK|GAPDH|NDUFS6|COQ7|HMGCS1|NUDT18|UMPS|GMPPB|FMO2|NDUFB4|HACD2|NUDT4|MACROD2|NDUFA12|SDHAF2|GMPS|NME2|LDHA|CMPK2|TK1|GFPT2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|ACOT2|STOML2|ENPP4|PDHX|ABCD1|NDUFA4|HINT1|ATP5H|TAF9|NMNAT3|NDUFV1|PNP|NANS|ERH|CSGALNACT1|UQCRQ|SULT1A4|PGK1|NDUFS3|GPHN|RRM1|SAMHD1|TALDO1|UQCRC2|FASN|AK6|QPRT|COX6A1|NME1|UCK1|NNMT|UQCC3|NDUFA8|ADCY9|ALDOA|NDUFS8|RENBP|ALDOC|AK1|ATP5G1|MTHFD1|BAD|PTGIS|NDUFV3
POSITIVE REGULATION OF P38MAPK CASCADE%GOBP%GO:1900745,0.598476890756303,0.84557799939374,-0.22283639969144398,-0.894015367479855,4557,20,GADD45B|SASH1|GADD45G|BMP2
GLUCOSAMINE METABOLIC PROCESS%GOBP%GO:0006041,0.404864283794679,0.7419998354794191,0.536995918005728,1.0562076010297499,3012,3,GNPDA2|PGM3
SULFATE TRANSMEMBRANE TRANSPORT%GOBP%GO:1902358,0.28454849498327806,0.657331235237559,-0.854874283193648,-1.1388978126345,2126,1,SLC26A2
PROTEIN DENEDDYLATION%GOBP%GO:0000338,0.923247907949791,0.9776156396135859,-0.19376985046340398,-0.607055646699331,7060,10,TOR1A|COPS6|GPS1
CIRCADIAN TEMPERATURE HOMEOSTASIS%GOBP%GO:0060086,0.11746031746031697,0.468392769062825,-0.6982289498041729,-1.3634641735677,887,3,TNFRSF11A|NR1D1
AMYLOID-BETA METABOLIC PROCESS%GOBP%GO:0050435,0.984052287581699,0.994044512176225,-0.148522125794623,-0.497117461398985,7527,12,BACE2
POSITIVE REGULATION OF FC-GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS%GOBP%GO:1905451,0.0376757760679225,0.276572928839036,-0.875504220780963,-1.45697902703081,283,2,PTPRJ
NEGATIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION%GOBP%GO:0051562,0.19989374418913503,0.577843341057244,0.901742390824879,1.20235180348846,1504,1,MICU2
MEMORY T CELL PROLIFERATION%GOBP%GO:0061485,0.9332441471571908,0.9800972968717879,-0.532807675341862,-0.709827758222855,6975,1,DOCK8
REPLICATIVE CELL AGING%GOBP%GO:0001302,0.8195377586670249,0.9392252610104441,0.36758667790090294,0.7229996173491708,6098,3,WRN|CHEK2
GLYCOSIDE METABOLIC PROCESS%GOBP%GO:0016137,0.9293392763502879,0.9793746057014829,-0.17108839514398902,-0.6052857231280451,7088,14,GLA|ABHD10|FUCA1
REGULATION OF ENDOPEPTIDASE ACTIVITY%GOBP%GO:0052548,0.000128139415684264,0.00518555396908895,-0.31747097457207,-2.3318369167005697,0,201,FIS1|PYCARD|APOPT1|GNB2L1|FNIP1|RPS6KA1|TRIAP1|IGBP1|REST|AGT|SERPINA3|PPM1F|SERPINB8|SPOCK2|KLF4|TNFRSF10A|TNFRSF10B|NRD1|PDCD6|SERPINB1|HGF|CASP10|NGF|PDCD5|GAS6|GPX1|CASP1|GRIN1|VCP|TRAF2|VTN|PRELID1|DDX3X|SIAH2|EFNA1|TNFSF10|CAAP1|CYCS|CASP4|STAT3|SERPINA1|PSME2|PARK7|F3|PERP|IFI27L1|ANP32B|TIMP3|DPEP1|CARD16|IFI6|RECK|IFI16|NAIP|CAST|C10orf54|CYFIP2|GPER1|CIDEB|GSN|F2R|USP47|DLC1|GAPDH|PLAUR|NLRP3|EFNA3|SERPINE2|ASPH|LGALS9|THBS1|SERPINH1|XIAP|FADD|EPHA4|MMP9|BCAP31|SERPINE1|MYC|PPARG|BCL2L12|ARL6IP1|S100A8|PSMA3|S100A9|ARL6IP5|TIMP1|LGMN|SERPING1|NGFRAP1|DHCR24|NGFR|SERPINF1|SERPINF2|BAD
CENP-A CONTAINING CHROMATIN ORGANIZATION%GOBP%GO:0061641,0.000387697079348669,0.0111294649577428,-0.45647287693768396,-2.21752063105977,2,37,MIS18BP1|RBBP4|HIST1H4J|CENPQ|HIST4H4|NASP|CASC5|HIST1H4H|HJURP|ITGB3BP|CENPL|CENPU|CENPW|OIP5|RUVBL1|CENPM|NPM1|CENPI|HIST1H4I|STRA13|RBBP7|CENPH|HIST2H4A|POLE3|HIST2H4B|CENPK|MIS18A|CENPP
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION%GOBP%GO:0001938,0.38078062604663104,0.729499056535481,-0.18219949959468104,-1.0463458016873,2955,67,STAT5A|KIAA1462|CCL11|NR4A1|MYDGF|HMGB2|KDR|EMC10|PDCD6|CCL24|EGFL7|VEGFC|FLT4|TNFSF12|PRKD1|F3|HMOX1|APLNR|VEGFB|NRP2|ECM1|BMP2|TEK|SEMA5A|ANG|PDGFB
I-KAPPAB PHOSPHORYLATION%GOBP%GO:0007252,0.134069400630915,0.495641459539577,-0.49983206386302004,-1.36626865687686,1019,7,DAB2IP|TLR2|TLR4|PRDX4
SESQUITERPENOID METABOLIC PROCESS%GOBP%GO:0006714,0.77991765174658,0.924704689181848,0.609726510807234,0.8129880300217339,5871,1,AKR1C3
OXALATE TRANSPORT%GOBP%GO:0019532,0.252143622722401,0.632257972333528,0.707306313757927,1.1883659311281298,1881,2,SLC26A6|SLC26A1
DNA REPLICATION-INDEPENDENT NUCLEOSOME ORGANIZATION%GOBP%GO:0034724,0.0006461617989144481,0.0163625161342847,-0.3975643891835561,-2.08416172577612,4,48,MIS18BP1|RBBP4|HIST1H4J|CENPQ|ATRX|HIST4H4|NASP|CASC5|HIST1H4H|HJURP|ITGB3BP|CENPL|CENPU|CENPW|OIP5|RUVBL1|CENPM|NPM1|ASF1B|CENPI|IPO4|SUPT16H|HIST1H4I|STRA13|RBBP7|CENPH|HIST2H4A|POLE3|HIST2H4B|CENPK|H3F3B|MIS18A|CENPP
ER TO GOLGI CERAMIDE TRANSPORT%GOBP%GO:0035621,0.5904326793872621,0.841700481190927,0.453385943843451,0.891756648478643,4393,3,PLEKHA3|PLEKHA8|COL4A3BP
AMINO-ACID BETAINE TRANSPORT%GOBP%GO:0015838,0.848841774636828,0.9492491301138911,-0.316450538648533,-0.692776379149264,6485,4,SLC22A5|PDZK1|SLC22A4
ASCENDING AORTA DEVELOPMENT%GOBP%GO:0035905,0.783405313440649,0.92691610564026,-0.33987757127888396,-0.744063050706779,5985,4,HEY2|SOX4|TGFB2|HES1
REGULATION OF NEUROLOGICAL SYSTEM PROCESS%GOBP%GO:0031644,0.318046763983981,0.6867397844771489,-0.21297387036887802,-1.10327166038627,2461,46,GRIN1|FMR1|CBLN1|ZFHX2|TYMP|STX1B|F2R|NOV|TNFRSF21|TMEM108|MGLL|NPTX2|NPTXR
PEPTIDE CROSS-LINKING%GOBP%GO:0018149,0.0010479434110558,0.0240545523142212,-0.624599581806484,-2.02217475080555,7,11,FN1|THBS1|F13A1|COL3A1|ANXA1|RNF113A
MATURE NATURAL KILLER CELL CHEMOTAXIS%GOBP%GO:0035782,0.0848718289281445,0.40376145987147494,0.958314953683282,1.2777836825626498,638,1,XCL1
SUGAR MEDIATED SIGNALING PATHWAY%GOBP%GO:0010182,0.7673122844255771,0.9202818175694271,-0.48025666060759,-0.799223882065292,5783,2,ADCY8
DNA REPLICATION-DEPENDENT NUCLEOSOME ASSEMBLY%GOBP%GO:0006335,0.0128138075313808,0.149991146428462,-0.457515304981085,-1.7753295378270701,97,18,RBBP4|HIST1H4J|HIST4H4|NASP|HIST1H3D|HIST1H4H|ASF1B|CHAF1A|IPO4|HIST1H4I|CHAF1B|HIST2H4A|HIST1H3H|HIST2H4B
VENTRICULAR CARDIAC MYOFIBRIL ASSEMBLY%GOBP%GO:0055005,0.628483386923901,0.8598358835891559,0.536035290874001,0.9006084989862421,4690,2,PROX1|MEF2A
DETERMINATION OF AFFECT%GOBP%GO:0050894,0.853101341479612,0.949296218452153,0.572562858403176,0.763435314138695,6422,1,SHANK1
REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT%GOBP%GO:2000074,0.70710752408227,0.894949003158309,-0.276432633209621,-0.7958108613774041,5431,8,BAD
NEGATIVE REGULATION OF IMMUNE RESPONSE%GOBP%GO:0050777,0.0005154639175257731,0.0139121625154964,-0.34852948110212295,-1.9873843250126397,3,65,TGFB2|FOXP3|TNF|JAK3|SERPINB9|PARP14|MICA|TGFB1|MUL1|LILRB1|HLA-E|LYN|NDFIP1|SAMSN1|IRAK3|SLAMF8|CD84|FCGR2B|TGFB3|INS|TNFAIP3|RC3H2|NR1H3|TRAFD1|IFI16|CEACAM1|CD300A|HFE|LGALS3|A2M|BST2|LGALS9|COL3A1|PPARG|HAVCR2|DHX58|ANXA1|CD55|FAM3A|SERPING1|SAMHD1
PERIPHERAL NERVOUS SYSTEM MYELIN FORMATION%GOBP%GO:0032290,0.8013377926421399,0.9325377000668108,-0.603826643140715,-0.8044420759907359,5989,1,DICER1
REGULATION OF CELL GROWTH%GOBP%GO:0001558,0.0014037774374681,0.0301860198914787,-0.209115702947474,-1.6068760210252402,10,260,INS|BCAR1|GOLGA4|TAOK2|DDX3X|RERG|CPNE6|CHPT1|SGK1|INHBA|LGI1|DCUN1D3|NCBP1|CISH|DSCAM|TRIM32|MMP14|ENO1|CPNE5|RBBP7|ABL1|NTN1|IGF1|SEMA3B|SEMA3D|MAP3K13|EIF4G2|RPTOR|SEMA7A|N6AMT1|CDA|CEACAM1|CXCL16|TAF9B|NPR1|PSMD10|APOE|USP47|PPP2CA|HYAL1|NOV|BST2|FXN|WFDC1|SEMA5A|TMEM97|DACT3|SEMA3E|SLIT2|APBB1|FAM107A|SEMA3A|SEMA6B|PLAA|BCL6|S100A8|CDKN2C|S100A9|TAF9|OSGIN1|H3F3B|PHB|NDUFS3|TFRC|ACVRL1|EXOSC2|SPHK1|AK6|NET1|FAM122A|PTPRJ|EIF4G1
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION%GOBP%GO:0045668,0.49632352941176505,0.794012168719884,-0.24067282090857897,-0.9655747477742859,3779,20,TMEM64|GREM1|CDK6|SMAD6|NOTCH1|CHRD|C14orf169|MEN1|LRP5|CCRN4L
NEGATIVE REGULATION OF T-CIRCLE FORMATION%GOBP%GO:1904430,0.675180002717022,0.882488012133495,0.37692967893568896,0.8281305571667671,4969,4,RTEL1|XRCC5|RTEL1-TNFRSF6B
PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS%GOBP%GO:0009176,0.344282238442822,0.702174649119653,0.45341616615021296,1.09046327947125,2546,5,DCTD|CDADC1|DUT|HDDC2
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS%GOBP%GO:0021952,0.139376473670422,0.504314492208813,-0.41724403575295793,-1.35085001431405,1063,11,SPTBN4|C12orf57|EPHA4|SLIT2|SCN1B
BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0060837,0.5648160716709649,0.8295590091625621,0.34613237298078,0.8956378591083249,4160,6,DLL1|NRP1|HEY2|HEY1|RBPJ
CDP-DIACYLGLYCEROL BIOSYNTHETIC PROCESS%GOBP%GO:0016024,0.29472705538584104,0.667556940989968,0.8548191442434939,1.13978598565988,2218,1,CDS1
"POSITIVE REGULATION OF CD4-POSITIVE, CD25-POSITIVE, ALPHA-BETA REGULATORY T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0032834",0.14648829431438098,0.513872620660976,-0.92550727834142,-1.23299792215364,1094,1,LGALS9
EMBRYONIC LIVER DEVELOPMENT%GOBP%GO:1990402,0.5966555183946489,0.844613508628182,-0.705668284075871,-0.940119595336448,4459,1,TGFB1
GLYCEROPHOSPHATE SHUTTLE%GOBP%GO:0006127,0.214769557710187,0.5979177134734279,0.894078076753419,1.19213247484196,1616,1,GPD2
REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS%GOBP%GO:1905165,0.8386378519973811,0.946300451776032,-0.271952568510067,-0.6995352664512751,6402,6,MGAT3|GBA|LRP1|LDLR
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN DEFINITIVE ENDODERMAL CELL FATE SPECIFICATION%GOBP%GO:0060807,0.453244147157191,0.769943206592495,-0.7742059991177771,-1.03142828864815,3387,1,SOX17
CELLULAR PROTEIN CATABOLIC PROCESS%GOBP%GO:0044257,0.37900580368407794,0.7288595569929351,-0.12262014890504598,-1.02936698039035,3003,463,UBE2D2|FBXL14|PSMB4|GZMA|RNF13|ENC1|UBD|PCYOX1L|PML|CUL4B|FBXO45|DCAF11|FBXW11|LONP1|KLHL20|MARCH6|GET4|PSMD1|PSMC2|TTC3|BNIP3L|ARRDC1|PCNP|CDC20|ANAPC10|TRIM3|UBE2Z|HSP90B1|RNF216|DTX3L|UBE2B|TSG101|CPVL|AP2A2|FBXO6|ANAPC2|RLIM|TRIM9|HSPA13|DAB2IP|TCIRG1|ANAPC5|KCTD2|UBQLN2|CTSF|CTSV|RNF121|RAB7A|HM13|USP9X|PSMD3|CTSS|TOR1A|KLHL15|PSMB2|UBAP1|CDC23|PSMF1|CLTA|PTTG1|ARMC8|VCP|RNF144B|UBE2G2|MAD2L1|TNFAIP3|CTSB|RNF7|MAGEC2|SIAH2|PSMD4|RBBP6|SEL1L|SMURF2|UBE2S|UBQLN1|CLTC|RNF168|UBXN1|ARRB1|PSMB5|UHRF1|TRIM32|UBE2R2|RCN3|FAF2|HUWE1|MVB12B|HERPUD1|CDC27|RAD23B|RNF20|SEC13|DTL|SKP1|FAP|NPLOC4|RCHY1|CTSZ|CTSH|NEDD8|VPS25|PSMC6|USP44|FBXO4|CCNB1|PLK1|NSFL1C|PSMB3|CTSC|SYVN1|SNF8|NR1D1|RNF40|KIAA0368|PSMD2|SEC61B|UBC|SGTB|PSMD6|ERCC8|FBXW5|LAMP2|DDB1|SPOP|PLAA|DERL3|MYLIP|PSMD12|PSMA3|KAT5|CTSL|HSPA5|LGMN|ANAPC11|UBE2L6|TOLLIP|PSMA6|PSMD13|PSMB7|PSMA1|PSMC5|AP2M1|SQSTM1|RMND5B|RNF130|PRPF19|SPSB1
INNATE IMMUNE RESPONSE IN MUCOSA%GOBP%GO:0002227,0.00442593074720125,0.0739635107007063,-0.6628787769476739,-1.90833522202678,33,8,RPL39|HIST1H2BE|HIST1H2BC|HIST1H2BG|HIST2H2BE|HIST1H2BK|HIST1H2BJ
BILE ACID BIOSYNTHETIC PROCESS%GOBP%GO:0006699,0.6178085774058579,0.854944793214197,-0.22622135412229397,-0.8778229879700971,4724,18,CYP46A1|CYP7B1|OSBP|OSBPL3
EMBRYONIC NEUROCRANIUM MORPHOGENESIS%GOBP%GO:0048702,0.278306878306878,0.653204101106396,-0.600050525718805,-1.17174659454827,2103,3,NDST1|MTHFD1
VITAMIN K METABOLIC PROCESS%GOBP%GO:0042373,0.261876717707106,0.6375978126944121,-0.547912662869413,-1.1994953533458401,2000,4,CBR1|VKORC1
VERY LONG-CHAIN FATTY ACID CATABOLIC PROCESS%GOBP%GO:0042760,0.15953409239628302,0.5293397224673839,-0.6020261400083239,-1.317961066552,1218,4,SLC27A4|ABCD1
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT%GOBP%GO:0046824,0.147513309959745,0.514965886850433,-0.24870809438304897,-1.2784453095794999,1135,45,TGFB1|PSEN1|HYAL2|DHX9|CAMK1|JUP|ECT2|NCBP2|TRIM28|HCLS1|GAS6|BAG3|ANP32B|RAPGEF3|FLNA|IGF1|RBM22|TMEM173|RBM27|EMD
POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION%GOBP%GO:1902462,0.424214046822743,0.754268592539614,-0.7886524040582271,-1.05067436881522,3170,1,LTBP3
CADMIUM ION HOMEOSTASIS%GOBP%GO:0055073,0.256588628762542,0.634929462604421,-0.868052492280547,-1.1564543514128502,1917,1,SLC11A1
PROTEIN LOCALIZATION TO LYSOSOME%GOBP%GO:0061462,0.18390648362104103,0.556389345131177,0.269194778111337,1.24629011228201,1352,30,NAGPA|CACNG7|GCC2|SCARB2|SNX16|SH3BP4|NEDD4|CACNG4|AP4M1|ZFYVE16
CRANIAL SUTURE MORPHOGENESIS%GOBP%GO:0060363,0.17598618674458802,0.548366806412612,0.9138729598588441,1.21852628048293,1324,1,TWIST1
PROTEIN ACTIVATION CASCADE%GOBP%GO:0072376,0.00012891581797086499,0.00518555396908895,-0.5710582903811711,-3.20239503024063,0,61,IGHV2-26|COLEC11|IGHV1OR15-1|IGKV3-11|IGHV5-51|RGCC|C4B|FCN3|F12|IGHV1-24|F10|IGHV3-49|COL20A1|IGHG4|IGLL5|C4A|PRCP|GP1BA|GP1BB|C2|IGKV2-28|C3|IGHV4-4|VWF|IGHV4-61|C1QB|IGHV1-3|F3|F8|IGHV3-43|FCN1|IGHV3-73|C1QA|CFB|C1QC|C7|IGKV2D-28|A2M|F13A1|IGHV3-15|CFP|C1S|IGHV1-18|CFD|TFPI|IGHG2|SERPING1|IGHA1|C1R|CFH|FBLN1
PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006221,0.519026909486273,0.8049078833377921,0.25068404863274896,0.9439085838779521,3818,16,CAD|DCTD|CDADC1|CDS1|AK5|DHODH|DUT|DTYMK
CHAPERONE MEDIATED PROTEIN FOLDING INDEPENDENT OF COFACTOR%GOBP%GO:0051086,0.8529765886287629,0.949296218452153,-0.5766982796647551,-0.7683005819365459,6375,1,CCT2
REGULATION OF OLIGODENDROCYTE APOPTOTIC PROCESS%GOBP%GO:1900141,0.36428093645485,0.718457761443038,-0.8158359064843409,-1.08688932119066,2722,1,GAS6
NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION%GOBP%GO:0048715,0.20154430048423,0.579746099203836,-0.579813660588351,-1.26933330585924,1539,4,HES1|NOTCH1|DAAM2
AEROBIC RESPIRATION%GOBP%GO:0009060,0.20383072343729802,0.583012195310033,-0.219662952834691,-1.20284161946369,1574,56,COX5A|BLOC1S1|ACO2|COX20|COX4I1|MT-CO2|ME3|COX7C|SDHC|UQCRC1|SURF1|UQCR10|OXA1L|FH|SDHB|PDHA1|SDHD|CYCS|SDHA|ACO1|MT-CO3|NDUFS7|SDHAF2|COX4I2|UQCRC2|COX6A1|NDUFS8
NEGATIVE REGULATION OF HEMOSTASIS%GOBP%GO:1900047,0.00013089005235602098,0.00518555396908895,-0.5614128384574689,-2.50733252687983,0,28,CD34|GP1BA|PLAU|VTN|CEACAM1|THBD|APOE|PLAUR|NOS3|SERPINE2|SERPINE1|PLAT|PDGFA|ANXA2|PDGFRA|TFPI|PDGFB|SERPINF2|C1QTNF1
POSITIVE REGULATION OF HELICASE ACTIVITY%GOBP%GO:0051096,0.668575891694871,0.881270721295667,-0.28684828457448197,-0.825796063877686,5135,8,GTF2H2
MITOTIC DNA REPLICATION INITIATION%GOBP%GO:1902975,0.0698327759197324,0.37596389138254704,-0.9637185707984119,-1.28390453877875,521,1,POLA1
QUORUM SENSING%GOBP%GO:0009372,0.8490969899665551,0.9492491301138911,-0.578683281870313,-0.770945081501486,6346,1,SLC22A5
POSITIVE REGULATION OF MAP KINASE ACTIVITY%GOBP%GO:0043406,0.159248777977875,0.5293397224673839,-0.17173282823326902,-1.20030920102296,1237,156,ARHGEF5|ADAM8|MADD|CCL19|EZH2|DAB2IP|PIK3R6|DUSP5|RAPGEF1|NGF|TNFRSF11A|PDGFD|PKN1|MDFIC|TRAF2|FPR1|TAOK2|CXCR4|MST1R|PDGFC|MAPKAPK2|MLKL|PIK3CB|FGF10|MAPK3|GHRL|SOD1|IRAK1|HRAS|IGF1|MAP3K13|GADD45B|MAP2K3|F2R|SASH1|MUC20|GADD45G|BMP2|THBS1|MAP3K11|PEA15|UBC|PDGFRB|TLR4|PDGFA|GNG3|DBNL|CD81|PDGFB|C5AR1|ERN1
DNA DEMETHYLATION OF MALE PRONUCLEUS%GOBP%GO:0044727,0.36193385575773707,0.7162129985904979,0.820191883546537,1.09361520587568,2724,1,TET3
HISTONE H3-K4 ACETYLATION%GOBP%GO:0043973,0.6546686146898659,0.874775007199212,0.670765328628143,0.894375057443877,4928,1,LDB1
CUT METABOLIC PROCESS%GOBP%GO:0071043,0.27875932469571996,0.653204101106396,-0.5390357216023121,-1.1800618732980401,2129,4,EXOSC3|EXOSC2
POSITIVE REGULATION OF TRANSCRIPTION INVOLVED IN EXIT FROM MITOSIS%GOBP%GO:0007072,0.983397529552397,0.993657503777746,0.50766431407146,0.6769018622183129,7403,1,SIRT7
PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS%GOBP%GO:0009078,0.758666489573649,0.9172140592138721,0.6206991618879579,0.827618579666726,5711,1,GPT2
MATERNAL PLACENTA DEVELOPMENT%GOBP%GO:0001893,0.254122735874561,0.633328402505013,0.493564953166319,1.18702088201132,1879,5,CYP27B1|PPARD|STOX2
IRE1-MEDIATED UNFOLDED PROTEIN RESPONSE%GOBP%GO:0036498,0.0479134466769706,0.313386489106363,-0.27477863914350503,-1.48313648246671,371,53,ATP6V0D1|TPP1|WIPI1|LMNA|PDIA5|SRPRB|SYVN1|SSR1|KDELR3|HSPA5|GOSR2|DNAJB11|SERP1|YIF1A|ERN1
INNER EAR RECEPTOR CELL DIFFERENTIATION%GOBP%GO:0060113,0.269150599270453,0.643111105831479,-0.389804507928714,-1.17262737325149,2065,9,DFNB31|PDZD7|SOD1|JAG2|ADGRV1
ERYTHROCYTE HOMEOSTASIS%GOBP%GO:0034101,0.340491591203105,0.701955655133333,-0.22491478817865698,-1.08302764736753,2631,36,ACIN1|LYN|CEBPG|NCKAP1L|DYRK3|HCLS1|MED1|ATPIF1|INHBA|RPS14|HSPA9|TAL1|HMOX1|TGFBR3
POSITIVE REGULATION OF STEROID METABOLIC PROCESS%GOBP%GO:0045940,0.9278972207655999,0.979345221662042,-0.171868692800241,-0.60804630213004,7077,14,IL1B|TNF|AGT|APOC1|ABCG1|APOE|NR1D1
"POSITIVE REGULATION OF SYNAPTIC TRANSMISSION, DOPAMINERGIC%GOBP%GO:0032226",0.00502649096590137,0.0799644467319547,0.8258975348811559,1.81453205715989,36,4,DRD2|RAB3B|DRD4|FLOT1
OVULATION CYCLE%GOBP%GO:0042698,0.30980751604033,0.680816461591689,-0.326131070102145,-1.12260638725001,2365,13,TGFB3|INHBA|SLIT2|PDGFRA|ANXA1
MODULATION BY HOST OF VIRAL MOLECULAR FUNCTION%GOBP%GO:0044868,0.562350756168745,0.828541380171721,-0.574364058225496,-0.955833640605842,4238,2,NUCKS1
PHOSPHOLIPID DEPHOSPHORYLATION%GOBP%GO:0046839,0.42181966766548606,0.7527812076478722,0.241579291957,1.0256115482743,3096,23,MTMR6|INPP5K|INPP5J|PPAPDC1B|MTMR2|INPP5F|PPAPDC1A
LYMPHANGIOGENESIS%GOBP%GO:0001946,0.0678738926524231,0.3717128095954961,-0.504473265494188,-1.5175790637604298,520,9,SOX18|FOXC2|FLT4|PDPN|CCBE1|ACVRL1
PYRIMIDINE-CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT%GOBP%GO:0072531,0.285695589582515,0.658457633141178,-0.535516319157322,-1.17235716565866,2182,4,SLC25A19
HISTONE H2A-S1 PHOSPHORYLATION%GOBP%GO:0043990,0.635986622073579,0.8636797415465791,-0.686369651521835,-0.914409182899524,4753,1,RPS6KA5
POSITIVE REGULATION OF NUCLEAR DIVISION%GOBP%GO:0051785,0.0129315918789603,0.15039332381142,-0.34617364113348603,-1.7233306317258101,99,40,NIPBL|PHB2|BECN1|IL1B|AURKA|RGCC|NUSAP1|DLGAP5|PLCB1|CDT1|ANAPC5|ESPL1|ANKRD32|HNRNPU|INS|IGF1|LRP5|NSFL1C|PDGFRB|H2AFY|ANAPC11|CDCA5|PDGFB
REGULATION OF METANEPHRIC COMMA-SHAPED BODY MORPHOGENESIS%GOBP%GO:2000006,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
"REGULATION OF TRANSPOSITION, RNA-MEDIATED%GOBP%GO:0010525",0.17619888602092101,0.548366806412612,0.589385687402513,1.2949054557681499,1296,4,ERCC3|MOV10|ZCCHC11|ZCCHC6
CELLULAR RESPONSE TO LIPOPOLYSACCHARIDE%GOBP%GO:0071222,0.00025618035096708103,0.00819882332206558,-0.347157004681918,-2.08669486454794,1,80,CXCL1|CD274|TGFB1|CXCL2|LILRB1|SBNO2|LYN|ADAM9|MTDH|PYCARD|IL18|HMGB2|DAB2IP|PDCD1LG2|TICAM2|IL1RN|PDE4B|CASP1|TNFAIP3|LILRB2|MEF2C|CTR9|CARD16|IRAK1|NR1H3|CCL2|CD86|NLRP3|AXL|HCK|NR1D1|PABPN1|TICAM1|SERPINE1|PLAA|NFKB1|TLR4|VIM|GSTP1|CD14|TNFRSF1B|SIRPA
POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS%GOBP%GO:0036493,0.23109578137437,0.614511437916015,-0.7178384339674659,-1.1945979451181798,1741,2,DNAJC3|NCK1
NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS%GOBP%GO:0031944,0.61005291005291,0.850714570847612,-0.45228383087048707,-0.8831956908243579,4611,3,REST|BMP2
NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH%GOBP%GO:0040015,0.890620800859984,0.965159112268525,0.33506121098489,0.659025862182996,6627,3,BBS2|PTCH1
GASTRO-INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION%GOBP%GO:0014831,0.8331093791991401,0.944555653379678,0.361367161527536,0.7107665625939781,6199,3,SULF2|PTGER3
VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS%GOBP%GO:0060979,0.0708994708994709,0.3767214120425879,-0.7385402136469079,-1.44218185500474,535,3,NOTCH1|TGFBR3
OXIDATIVE STRESS-INDUCED PREMATURE SENESCENCE%GOBP%GO:0090403,0.41600529100529104,0.7493091022753771,-0.538873991451387,-1.05228432825287,3144,3,ARNTL|PLA2R1
PROTEIN K33-LINKED UBIQUITINATION%GOBP%GO:1990390,0.562675585284281,0.828541380171721,-0.7223753859726509,-0.9623774666746999,4205,1,KLHL20
CELLULAR RESPONSE TO INTERLEUKIN-17%GOBP%GO:0097398,0.898704358068316,0.967428248648255,-0.296503576448664,-0.649108309229496,6866,4,IL17RE|IL17RA
NEGATIVE REGULATION OF HEPATOCYTE GROWTH FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0048178,0.573913043478261,0.835204333784353,-0.717247463608293,-0.955545842798603,4289,1,INHBB
REGULATION OF CELL DIVISION%GOBP%GO:0051302,0.22688606888857898,0.609201573718782,0.18810251420045998,1.1580799270242899,1626,84,EFHC1|AURKC|DRD2|FGFR2|DLL1|KIF13A|BBS4|KLHL13|FSD1|GIT1|ZFYVE19|MAP9|PKP4|CSPP1|PRKCE|RAB11FIP3|NCOA3|SH3GLB1|RAB11A|PLK3|ANKRD53|FGF1|PRPF40A|SPAST
GLUCAN METABOLIC PROCESS%GOBP%GO:0044042,0.37140992167101794,0.7231271705612199,-0.253394243233924,-1.0638963840795699,2844,23,GYG1|PER2|GAA|PHKG2|PPP1R3C|PGM5|NR1D1|PYGL|PYGM|GYG2
RENAL FILTRATION CELL DIFFERENTIATION%GOBP%GO:0061318,0.273058884835852,0.647246599153167,-0.38817710075281797,-1.16773173412197,2095,9,NUP93|IQGAP1|JAG1|BASP1|KLF15|MYO1E
RETINA HOMEOSTASIS%GOBP%GO:0001895,0.7883211678832119,0.927903725560957,-0.164771790213273,-0.766453414600732,6047,32,JCHAIN|HSPB1|SOD1|LCN1|ACTB|ADGRV1|IGHA1
TAURINE METABOLIC PROCESS%GOBP%GO:0019530,0.9442481350608559,0.982694945797028,-0.27034843936904,-0.591849246756231,7214,4,STAT5B|STAT5A|CDO1
REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN DORSAL/VENTRAL AXIS SPECIFICATION%GOBP%GO:2000053,0.0298844468056847,0.244735657013286,0.9855535950595501,1.31410273545021,224,1,SFRP1
PHYTOSTEROID BIOSYNTHETIC PROCESS%GOBP%GO:0016129,0.00517378615017246,0.0809542541983624,-0.950758202371106,-1.5822136864132499,38,2,DHCR7|C14orf1
POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION%GOBP%GO:1903980,0.542214623882167,0.815809610803359,-0.384487743240917,-0.921543753534146,4122,5,APP|ITGB2|ITGAM
SNORNA CATABOLIC PROCESS%GOBP%GO:0016077,0.272240802675585,0.646576786621306,-0.860498456109396,-1.14639056140183,2034,1,NUDT16
REGULATION OF AMNIOTIC STEM CELL DIFFERENTIATION%GOBP%GO:2000797,0.506488294314381,0.798168488166378,-0.7508270842523159,-1.00028196043885,3785,1,REST
PEPTIDYL-GLYCINE MODIFICATION%GOBP%GO:0018201,0.23622562491820398,0.62149045081524,-0.5611835810176551,-1.22854816729265,1804,4,NMT1|RNF113A|NTMT1
CMP-N-ACETYLNEURAMINATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0015782,0.35117545490769,0.7096786709855101,0.825319805910896,1.10045259842334,2643,1,SLC35A1
PROSTATE GLAND GROWTH%GOBP%GO:0060736,0.32301714898177897,0.6913268291919421,0.6728890260992559,1.13054044406567,2410,2,FGFR2|PSAP
VERY-LOW-DENSITY LIPOPROTEIN PARTICLE ASSEMBLY%GOBP%GO:0034379,0.136901630720673,0.5013772459896221,-0.5674792473175639,-1.36013947081293,1040,5,DGAT1|APOC1|P4HB
REGULATION OF GAMMA-AMINOBUTYRIC ACID SECRETION%GOBP%GO:0014052,0.0888564218355691,0.41228493992510207,0.956495368328187,1.27535751101348,668,1,TRH
CALCIUM ION IMPORT INTO CYTOSOL%GOBP%GO:1902656,0.127460295914212,0.48455507597591796,0.534537873543359,1.38314816539647,938,6,FAM155A|TRPV1|ATP2B4|CACNA2D1|FAM155B
ACYLGLYCEROL CATABOLIC PROCESS%GOBP%GO:0046464,0.00315043318456288,0.0571886039479394,-0.5464636544113229,-1.9841209480776498,23,15,PNPLA2|FABP3|DAGLB|APOE|FABP4|DAGLA|MGLL|PNPLA4
N-TERMINAL PEPTIDYL-METHIONINE ACETYLATION%GOBP%GO:0017196,0.910139812678159,0.9720943283119721,0.243560752302686,0.6302277619299821,6704,6,NAA60|NAA16|NAA15|NAA25|NAA20|NAA30
XENOBIOTIC CATABOLIC PROCESS%GOBP%GO:0042178,0.038544766026508,0.279776552671739,0.588959459474143,1.6258067792823798,284,7,GSTM2|GSTM4|GSTM1|GSTM3|GSTO1|ACAA1|CRYZ
CELL-CELL JUNCTION ORGANIZATION%GOBP%GO:0045216,0.7530012771392081,0.915448362583738,-0.136927255326917,-0.826327512195505,5895,81,GJA5|TGFB1|APC|CDH6|TBCD|GJA1|JUP|CTNND1|ECT2|CXADR|CLDN5|MICALL2|TLN1|CTNND2|TGFB3|PKP2|PERP|CDH8|SNAI2|CDH11|CDH5|F2R|CDH7|VCL|ARL2|GJA4|CSF1R|OCLN
REGULATION OF PANCREATIC JUICE SECRETION%GOBP%GO:0090186,0.220066889632107,0.60254214895295,-0.886689457432731,-1.1812832639948,1644,1,NR1H3
NEGATIVE REGULATION OF PROLACTIN SECRETION%GOBP%GO:1902721,0.472174259529818,0.7831522581932591,0.764887516541685,1.01987429485092,3554,1,ANXA5
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE%GOBP%GO:0002700,0.0790152101056973,0.39433306471489704,-0.24326335445264,-1.38142443043068,612,64,IL1B|TGFB2|FOXP3|TNF|JAK3|TGFB1|LILRB1|HLA-E|NDFIP1|CD74|TNFRSF14|B2M|IL18|IRAK3|STX4|PAXIP1|GPI|FCGR2B|TGFB3|TRAF2|MZB1|RSAD2|TNFRSF4|TNFSF13|SEMA7A|GPRC5B|HFE|NLRP3|BST2|TICAM1|IL1R1|TFRC|TNFRSF1B
EARLY VIRAL TRANSCRIPTION%GOBP%GO:0019085,0.0728831725616292,0.380043520400863,0.833526330300524,1.4004318558456998,543,2,MON1B|CCNT2
SEROTONIN METABOLIC PROCESS%GOBP%GO:0042428,0.282640456899987,0.655069746883962,0.861215262461403,1.14831434625696,2127,1,ATP7A
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL%GOBP%GO:1903320,0.0943661971830986,0.42444285484771793,-0.178730127208822,-1.2726508413881201,736,171,PRICKLE1|PEF1|NDFIP1|DCUN1D1|CDC20|PARP10|ZER1|TRIM21|PER2|DTX3L|WDR70|KDM1A|PDCD6|TRIM44|PAXIP1|NDNL2|OGT|BAG5|FEM1A|VCP|MAD2L1|TNFAIP3|MAGEC2|SENP2|UBE2S|DCUN1D3|UBQLN1|PARK7|UBXN1|BRCA1|STRA13|ARRB1|CTR9|ISG15|ARRDC3|ABL1|RNF20|TNIP1|RCHY1|USP44|FBXO4|PSMD10|PLK1|PRMT3|SASH1|RNF40|HDAC8|XIAP|FKBP1A|FANCM|CAV1|DNAJA1|FAM107A|PLAA|NXN|HSP90AA1|OTUB1|SPHK1|ADGRB1
TRANSLATIONAL INITIATION%GOBP%GO:0006413,0.19518134051006,0.569886844179673,-0.176302613782137,-1.1741141104718602,1522,123,RPL3|RPL7A|RPS2|EIF2B5|RPL15|RPL37|RPL27A|YAE1D1|RPL18|EIF3J|RPL39|DENR|RPL27|EIF2S3|EIF3C|LARP1|EIF2B1|EIF3M|RPLP2|DDX3X|RPS14|RPS4X|RPL35A|RPS29|RPL10|RPL36A|RPL24|EIF1AX|EIF3B|RPL35|RPL38|RPS15A|EIF5|MCTS1|RPS13|EIF2S1|EIF2B2|EIF4A2|ORAOV1|RBM4|EIF2B3|EIF2D|EIF4G1
POSITIVE REGULATION OF PRO-B CELL DIFFERENTIATION%GOBP%GO:2000975,0.987692307692308,0.996030692679047,-0.506120423467137,-0.674273930738651,7382,1,NUDT21
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE%GOBP%GO:0042770,0.8902050694179091,0.965159112268525,-0.11766188459644301,-0.7399923795880309,6988,95,PCBP4|GTSE1|CNOT4|ATRX|BTG2|CNOT10|CNOT6L|MAPK14|SFN|STK33|CDKN1B|CNOT6|AURKA|PIDD1|PRMT1|UIMC1|PML|RGCC|SP100|TRIAP1|TFDP2|BATF|NBN|PAXIP1|PLK2|BRCC3|PCNA|CDC25C|GRB2|FOXM1|BRCA1|ABL1|DTL|E2F1|BCL3|CCNB1|PLK1|PLAGL1|TNKS1BP1|KAT5|CEP63|ZNF385A|PRPF19
MESONEPHRIC DUCT MORPHOGENESIS%GOBP%GO:0072180,0.601540709257538,0.847046653006894,0.6970114689016321,0.929370744031899,4528,1,GPC3
OLFACTORY BULB DEVELOPMENT%GOBP%GO:0021772,0.232732732732733,0.616523546447917,0.398119507886575,1.20984846590822,1704,9,SLIT1|ROBO2|SLIT3|SKI|AGTPBP1
CAMERA-TYPE EYE DEVELOPMENT%GOBP%GO:0043010,0.00538748445917945,0.0831520318065897,0.288751765271364,1.71390110651173,38,72,PDE6B|NPHP1|WNT6|STRA6|LRP5L|DLL1|WNT5B|AHI1|HDAC1|SDHAF4|WNT2B|IFT140|TWIST1|PTPRM|NES|RAB3GAP1|ALDH1A3|CACNA1C|ZNF513|MEGF11|TFAP2B|NF1|PHACTR4|SKI|TENM3|CHD7|POU4F2|LRP6|NRP1
INTERLEUKIN-1 ALPHA PRODUCTION%GOBP%GO:0032610,0.296989966555184,0.6689039624806751,-0.848257609175121,-1.13008281408469,2219,1,S100A13
POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION%GOBP%GO:1902905,0.243150248502612,0.626082056933819,-0.16570690245222,-1.12967367941393,1907,137,CCL24|ARPC1A|WAS|FES|IQGAP2|PLEK|TGFB3|GPX1|CDK5RAP2|LMOD1|PDXP|CD47|S100A10|CTGF|PXN|MECP2|ABL1|RAPGEF3|ARHGEF15|GSN|BAIAP2L1|APOE|HCK|CDC42EP4|CFL2|SEMA5A|ARPC5L|ARL2|NAV3|CX3CL1|EVL|NF2|CDC42EP1|CDC42EP5|SYNPO|NCK1|ARF6|CDC42EP2|SERPINF2
INCLUSION BODY ASSEMBLY%GOBP%GO:0070841,0.9006379801818921,0.968348087372091,0.248011629294329,0.641744667747314,6634,6,PARK2|HDAC6
ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0045446,0.0663245670301475,0.3690551432905871,-0.267675001137487,-1.4293145642821499,516,51,JAG1|SOX18|COL23A1|SOX17|RAPGEF1|RAP2B|MESP1|PDE4D|NOTCH1|ICAM1|PDE2A|MSN|RAPGEF3|TJP2|PDPN|RAP1A|RAB1B|NR2F2|ANXA2|ENG|ACVRL1|EDF1
REGULATION OF CYTOTOXIC T CELL DEGRANULATION%GOBP%GO:0043317,0.0876890421862563,0.40905715364188894,-0.813895781637717,-1.35445273236629,660,2,FCGR2B|CEACAM1
PLATELET ACTIVATING FACTOR BIOSYNTHETIC PROCESS%GOBP%GO:0006663,0.5339947089947089,0.812403303192621,-0.48824805576978897,-0.953424706957365,4036,3,CHPT1|PLA2G4A
NEGATIVE REGULATION BY HOST OF VIRAL PROCESS%GOBP%GO:0044793,0.8494638251662819,0.9492491301138911,0.266120445367311,0.688602293686548,6257,6,PARK2|PTX3|VAPA|EIF2AK4|ZC3H12A
URETER UROTHELIUM DEVELOPMENT%GOBP%GO:0072190,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002752,0.22127090301003302,0.603701387932317,-0.8859726510807242,-1.18032830581857,1653,1,FCN1
POSITIVE REGULATION OF LIPID TRANSPORTER ACTIVITY%GOBP%GO:0110113,0.779784831982999,0.924704689181848,0.6098919276576971,0.813208591071659,5870,1,PRKCD
TOLERANCE INDUCTION TO SELF ANTIGEN%GOBP%GO:0002513,0.575919732441472,0.8359897176758009,-0.7165857962064399,-0.954664342943622,4304,1,LYN
"REGULATION OF WNT SIGNALING PATHWAY, PLANAR CELL POLARITY PATHWAY%GOBP%GO:2000095",0.42717524093932396,0.755533439554473,0.39094522432458506,1.01159374584745,3146,6,DKK1|NPHP3-ACAD11|NPHP3
TRIVALENT INORGANIC CATION TRANSPORT%GOBP%GO:0072512,0.00130344108446298,0.0284733155294161,-0.43567211815582396,-2.02657495057043,9,32,ATP6V1D|ATP6V0A1|TCIRG1|ATP6V0B|ATP6V0A2|ATP6V1G2|ATP6V1F|ATP6V0D1|CLTC|ARHGAP1|HFE|STEAP4|ATP6V0E1|ATP6AP1|ATP6V0E2|TFRC|ATP6V1A|ATP6V1G1
NEGATIVE REGULATION OF PATHWAY-RESTRICTED SMAD PROTEIN PHOSPHORYLATION%GOBP%GO:0060394,0.77968877968878,0.924704689181848,0.245406088815445,0.7457664701084972,5711,9,DKK1|PBLD|PMEPA1
PROTEIN PEPTIDYL-PROLYL ISOMERIZATION%GOBP%GO:0000413,0.362465501379945,0.716751184280987,-0.271789756013489,-1.07381597026097,2757,19,PPIF|PPIA|PPIB|PPIC|FKBP1A|FKBP4|CWC27|FKBP5
MITOCHONDRIAL TRNA PSEUDOURIDINE SYNTHESIS%GOBP%GO:0070902,0.547084606189401,0.818317601346006,0.7249117776797529,0.9665720411191658,4118,1,PUS1
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION%GOBP%GO:0023019,0.6469650684021779,0.8697778704754799,0.6744596382884871,0.8993009208921909,4870,1,EPCAM
DETOXIFICATION OF MERCURY ION%GOBP%GO:0050787,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION%GOBP%GO:0050974,0.402402402402402,0.740287621109606,0.341101164114144,1.0365749779852,2947,9,PIEZO2|KIT|COL11A1|MKKS
POSITIVE REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT%GOBP%GO:1904398,0.1722655200215,0.546112036193732,0.6563852574696889,1.29103234288638,1281,3,DCTN1|AGRN
TRICUSPID VALVE MORPHOGENESIS%GOBP%GO:0003186,0.533252230332522,0.812079525085925,0.382977672294214,0.921059105677896,3944,5,ZFPM1|BMPR1A|BMPR2|HEY2
NEUTROPHIL AGGREGATION%GOBP%GO:0070488,0.004510480233483679,0.0743264309917645,-0.9585332230493521,-1.59515256414114,33,2,S100A8|S100A9
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION%GOBP%GO:0045669,0.17686897629591,0.548551967663807,-0.271996966625541,-1.2535179104936398,1357,31,HGF|DDR2|IL6ST|MEF2C|PRKD1|IGF1|LRP5|BMP2|ATP6AP1|IFITM1|TMEM119|ZHX3
NEGATIVE REGULATION OF MITOCHONDRIAL FUSION%GOBP%GO:0010637,0.6527439848607729,0.8735476294907571,0.347212172107289,0.8350432828259959,4828,5,PARK2|OMA1|BNIP3|VAT1|MUL1
DNA DAMAGE CHECKPOINT%GOBP%GO:0000077,0.922139558748076,0.9776156396135859,-0.10991096667624001,-0.7255702993140991,7188,118,PCBP4|GTSE1|CNOT4|BTG2|CNOT10|CNOT6L|CLOCK|FOXN3|BLM|SFN|ATRIP|STK33|CDKN1B|CNOT6|AURKA|EME2|PIDD1|PRMT1|UIMC1|RAD9A|PML|RGCC|CLSPN|RPA2|BRIP1|TRIAP1|TFDP2|INTS7|DONSON|FBXO6|H2AFX|NBN|PLK2|RAD1|RAD17|BRCC3|PCNA|TAOK2|CDC25C|RHNO1|BRCA1|EME1|DTL|E2F1|CCNB1|PLK1|PLAGL1|TNKS1BP1|CEP63|ZNF385A|CCND1|MUS81|PRPF19
PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS%GOBP%GO:0009146,0.0147886402303363,0.16327644723639997,-0.7637011327803442,-1.6719014218755202,112,4,NUDT1|NUDT16|SAMHD1
"REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION, CENTROMERIC%GOBP%GO:2000718",0.44709030100334396,0.768229288546963,-0.7780657256285842,-1.03657037113554,3341,1,NAA10
FATTY-ACYL-COA CATABOLIC PROCESS%GOBP%GO:0036115,0.590076943486336,0.8414799095069009,-0.562920901767139,-0.9367903983608341,4447,2,ABCD1
REGULATION OF ALKALINE PHOSPHATASE ACTIVITY%GOBP%GO:0010692,0.600444967936134,0.8464076674715391,-0.40269839946286207,-0.8815909755139839,4587,4,SEMA4D|TGFB2|MEF2C
POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS%GOBP%GO:0042986,0.88670474166556,0.965013712426871,0.556241729157477,0.741673290546143,6675,1,SOAT1
AMINE BIOSYNTHETIC PROCESS%GOBP%GO:0009309,0.532549019607843,0.812079525085925,-0.278027118395337,-0.930582797393334,4073,12,AMD1|SRM|SAT1|MOXD1|ODC1|SMOX|SMS
MYELOID DENDRITIC CELL CHEMOTAXIS%GOBP%GO:0002408,0.9714778455823829,0.9915747942934481,-0.331348221670802,-0.5514164274247328,7322,2,CCR7|CCL19
POSITIVE REGULATION OF HISTONE H3-K9 TRIMETHYLATION%GOBP%GO:1900114,0.817372825076371,0.9378212107586109,0.590924128804588,0.7879175906803149,6153,1,ZNF304
INTRACELLULAR SEQUESTERING OF IRON ION%GOBP%GO:0006880,0.21772486772486802,0.6000568371428749,-0.632018053700565,-1.23417107455999,1645,3,FTL|FTH1
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS%GOBP%GO:1902992,0.755424836601307,0.916183794263895,-0.22880574644117702,-0.765834256786914,5778,12,GGA3|APOE|PRNP
RESPONSE TO G1 DNA DAMAGE CHECKPOINT SIGNALING%GOBP%GO:0072432,0.441492894142648,0.7653693162885199,0.7806572562858399,1.04090111494372,3323,1,APAF1
REGULATION OF MEMORY T CELL DIFFERENTIATION%GOBP%GO:0043380,0.37473204715970004,0.7254164153140609,0.649003844741035,1.09041025544327,2796,2,CD46|IL12RB1
POSITIVE REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS%GOBP%GO:0000962,0.379421221864952,0.728914030571579,0.6461538461538461,1.0856218898385699,2831,2,PNPT1|SUPV3L1
IODIDE TRANSPORT%GOBP%GO:0015705,0.7336454849498331,0.907913422943088,-0.6374062637847379,-0.849178193630985,5483,1,ANO1
LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT%GOBP%GO:0060716,0.434291857027681,0.762034923704788,0.5213962721958749,1.02552493860109,3231,3,HEY2|HEY1|RBPJ
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION%GOBP%GO:2000726,0.18569110089261603,0.559093571852282,0.46556770321477203,1.2851871481567299,1372,7,DKK1|SOX6
NEGATIVE REGULATION OF CHAPERONE-MEDIATED AUTOPHAGY%GOBP%GO:1904715,0.10816984681537199,0.452488212455009,0.7034300209551121,1.38356384101486,804,3,SNRNP70|CTSA|SNCA
APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS%GOBP%GO:0003278,0.857123745819398,0.949296218452153,-0.574437582708425,-0.7652887907653629,6406,1,BMP4
CELLULAR RESPIRATION%GOBP%GO:0045333,0.00128155837498398,0.0282608365487479,-0.267738592152276,-1.7830459357358999,9,123,NDUFB5|SURF1|UQCR10|OXA1L|NDUFA9|NDUFA7|FH|SLC25A18|SDHB|PDHA1|NDUFA3|NDUFB6|SDHD|CYCS|NDUFB9|COA6|NDUFB10|SDHA|ACO1|SLC25A22|MT-CO3|NDUFS7|NDUFB1|NDUFB7|NDUFA6|NDUFS6|COQ7|LYRM5|NDUFB4|NDUFA12|SDHAF2|NDUFA2|NDUFAB1|COX4I2|NDUFA1|NDUFA4|NDUFV1|UQCRQ|NDUFAF2|NDUFS3|UQCRC2|COX6A1|UQCC3|NDUFA8|NDUFS8|NDUFV3
REGULATION OF HISTONE H2A K63-LINKED UBIQUITINATION%GOBP%GO:1901314,0.735582010582011,0.908157084784786,-0.403461004886932,-0.787857085772851,5560,3,OTUB1
POSITIVE REGULATION OF ACETYLCHOLINE METABOLIC PROCESS%GOBP%GO:0060409,0.904635409748971,0.9698755111576809,0.547529775033083,0.730057075250119,6810,1,PEBP1
HETEROCHROMATIN ORGANIZATION%GOBP%GO:0070828,0.197647058823529,0.5747254604125179,-0.37544239459619394,-1.2566408479858502,1511,12,SNAI1|POLE3|LOXL2
"REGULATION OF VESICLE TARGETING, TO, FROM OR WITHIN GOLGI%GOBP%GO:0048209",0.507662082514735,0.7987565605553191,-0.36927844644214397,-0.949883642731825,3875,6,SEC23B|PREB|SEC23A|SAR1B
NEGATIVE REGULATION OF CELL ACTIVATION%GOBP%GO:0050866,0.000128139415684264,0.00518555396908895,-0.38072202028741703,-2.3707621553174,0,92,CD274|DUSP3|MNDA|MICA|LILRB1|SLA2|LYN|NDFIP1|TNFAIP8L2|TNFRSF14|SAMSN1|RUNX1|TWSG1|CD84|RUNX3|PDCD1LG2|SPN|FCGR2B|PLA2G2D|TNFAIP3|RC3H2|LILRB2|GPNMB|INHBA|PRKAR1A|SOCS1|SDC4|CEBPB|NR1H3|C10orf54|CEACAM1|THBD|GPER1|CD300A|HFE|APOE|LST1|CD86|NOS3|LGALS3|SERPINE2|TNFRSF21|CD200|LGALS9|CD300LF|CX3CL1|LDLR|HAVCR2|MILR1|PDGFA|PDGFRA|ANXA1|PDGFB|C1QTNF1|PRNP
LONG-CHAIN FATTY ACID BIOSYNTHETIC PROCESS%GOBP%GO:0042759,0.139219934994583,0.504314492208813,0.36305312612299395,1.3391533260806798,1027,15,GSTM4|CYP2E1|CYP2C8|ASAH2B|ACOT7|CYP2D6|ELOVL6|LTA4H
PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION%GOBP%GO:0086068,0.18788861854555303,0.561259634150956,0.5335810260841379,1.2832593079060701,1389,5,TRPM4|SCN5A
PLASMA MEMBRANE RAFT ORGANIZATION%GOBP%GO:0044857,0.22514466070489197,0.60796033359428,-0.514878992389804,-1.23406669680357,1711,5,CAV2|CAV1|EMP2
REGULATION OF RIBONUCLEOPROTEIN COMPLEX LOCALIZATION%GOBP%GO:2000197,0.9770083851771709,0.9927322181739301,0.19240528357262698,0.531129620842535,7223,7,IWS1|SUPT6H|TPR|SETD2|AKAP8L|RIOK2
INTERLEUKIN-17 PRODUCTION%GOBP%GO:0032620,0.127679528403001,0.484643747394476,0.7868210642404191,1.32196097850372,952,2,RFTN1|ZBTB7B
NEGATIVE REGULATION OF ORGAN GROWTH%GOBP%GO:0046621,0.537442552041092,0.8137306732814521,0.38198787865910605,0.9186786576614431,3975,5,WWC2|WWC1|GSK3A
NEGATIVE REGULATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY%GOBP%GO:1905598,0.43194481294773207,0.760487817191567,-0.626137303556658,-1.0419926000013,3255,2,APP|PSEN1
NEGATIVE REGULATION OF FATTY ACID TRANSPORT%GOBP%GO:2000192,0.79431877958969,0.929656485793048,-0.30780733511135905,-0.737755447216238,6039,5,PLA2R1|THBS1
POST-EMBRYONIC ANIMAL ORGAN MORPHOGENESIS%GOBP%GO:0048563,0.433201058201058,0.7614924524950341,-0.5315953888411971,-1.03807106210942,3274,3,FBN1|EFEMP1
REACTIVE OXYGEN SPECIES METABOLIC PROCESS%GOBP%GO:0072593,0.124919427613768,0.479403240873216,-0.23195805463742397,-1.30078020739241,968,61,CYP1B1|SOD2|GPX1|PLA2R1|PARK7|SOD3|CYBB|IFI6|SOD1|NCF4|CCS|NOXA1|CAT|NCF2|NOS3|GPX3|PRDX4|PRDX5|NDUFS3|PDGFB
PEROXISOMAL MEMBRANE TRANSPORT%GOBP%GO:0015919,0.579777113346018,0.8386526275338391,0.23906951939208101,0.9001760292628441,4265,16,PEX7|PEX2|PEX5|PEX13|PEX1|PEX10|PEX19|PEX5L|PEX12|RAB8B|PEX26|PEX3
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT%GOBP%GO:0060742,0.32301714898177897,0.6913268291919421,0.6728890260992559,1.13054044406567,2410,2,FGFR2|PSAP
POSITIVE REGULATION OF RIBOSOME BIOGENESIS%GOBP%GO:0090070,0.569437206878583,0.832269842301315,-0.300404577309032,-0.903690499308019,4370,9,RIOK1|TRMT112|DIMT1
MODULATION BY SYMBIONT OF HOST I-KAPPAB KINASE/NF-KAPPAB CASCADE%GOBP%GO:0085032,0.211772575250836,0.5937395205509979,-0.892258491398324,-1.1887025544408798,1582,1,TNIP1
RESPONSE TO MYCOPHENOLIC ACID%GOBP%GO:0071505,0.0562483417352083,0.34424567164700104,-0.845359028176015,-1.40681260595743,423,2,PDGFB
DIGESTIVE TRACT MORPHOGENESIS%GOBP%GO:0048546,0.139171758316361,0.504314492208813,0.38342837114656103,1.3428460956405401,1024,13,RBPMS2|STRA6|FGFR2|AHI1
NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION INVOLVED IN AXON REGENERATION%GOBP%GO:1905045,0.456103068136539,0.7711961414599979,0.7731583590648431,1.03090234734715,3433,1,CERS2
POSITIVE REGULATION OF ACTIVATED T CELL AUTONOMOUS CELL DEATH%GOBP%GO:0070241,0.14648829431438098,0.513872620660976,-0.92550727834142,-1.23299792215364,1094,1,LGALS9
NUCLEAR MIGRATION%GOBP%GO:0007097,0.623919308357349,0.857688646775448,-0.267021109424057,-0.864495208030266,4762,11,DCTN4|SLC9A3R1|SUN2|SYNE3
REGULATION OF NEUROTROPHIN PRODUCTION%GOBP%GO:0032899,0.756162915326903,0.9166093439295571,0.4698809906411289,0.7894607330675691,5643,2,HAP1|FURIN
G-QUADRUPLEX DNA UNWINDING%GOBP%GO:0044806,0.47292323869610897,0.7831522581932591,-0.359132433844287,-0.9816724926310849,3597,7,BLM|DNA2|DHX9|DHX36|HNRNPA2B1
"VESICLE TARGETING, ROUGH ER TO CIS-GOLGI%GOBP%GO:0048207",0.00012951690195570501,0.00518555396908895,-0.392691078686275,-2.1699906414076797,0,58,TFG|PDCD6|TRAPPC5|NAPA|SCFD1|SEC23A|SERPINA1|F8|SEC13|SEC24A|PPP6R3|CNIH2|CNIH1|TMED2|CTSZ|CTSC|RAB1B|NSF|CD59|STX5|CNIH3|TMED10|TRAPPC2|GOSR2|PPP6C|SAR1B|GRIA1
REGULATION OF NUCLEAR DIVISION%GOBP%GO:0051783,0.0389677419354839,0.28119598004076196,-0.20249149923694604,-1.40648250086294,301,151,TRIP13|DUSP1|AURKAIP1|KLHL22|KIF11|NEK2|ANLN|CCND2|APC|RGCC|NUSAP1|MKI67|DLGAP5|CDC20|PLCB1|CCSAP|CDT1|LCMT1|ANAPC5|ESPL1|CDC6|ANKRD32|NAA10|CDC23|HNRNPU|STAG2|CAV2|RAD1|PTTG1|INS|PKMYT1|CDK5RAP2|MAD2L1|CDC25C|KNTC1|PDXP|NDC80|RCC1|CDC27|IGF1|LRP5|CCNI2|CCNI|USP44|CCNB1|PLK1|NSFL1C|PDGFRB|CCND3|IK|SMC1A|CCDC8|NEK6|H2AFY|ANAPC11|PRMT5|CCND1|CDCA5|PDGFB|XRCC3
REGULATION OF SKELETAL MUSCLE TISSUE GROWTH%GOBP%GO:0048631,0.0613627307743392,0.35631208031004796,0.9693427437141601,1.2924877525576102,461,1,DLL1
ANTRAL OVARIAN FOLLICLE GROWTH%GOBP%GO:0001547,0.5849382388099351,0.839854222268064,0.7058337009263341,0.941134000027873,4403,1,BMPR1B
NEGATIVE REGULATION OF PHOSPHATIDYLCHOLINE CATABOLIC PROCESS%GOBP%GO:0010900,0.4319732441471571,0.760487817191567,-0.7856749007498901,-1.04670761946781,3228,1,APOC1
"SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE, SIGNAL SEQUENCE RECOGNITION%GOBP%GO:0006617",0.487264526399575,0.788226301622024,-0.604466501240695,-1.0059289195257,3672,2,SRP54|SRP19
GALACTOSYLCERAMIDE BIOSYNTHETIC PROCESS%GOBP%GO:0006682,0.0287037037037037,0.238792268557792,-0.7999561498643699,-1.5621116126323997,216,3,B3GALT2|B3GALT1
REGULATION OF TOOTH MINERALIZATION%GOBP%GO:0070170,0.40365493147003495,0.7412049911665691,0.5375598477924449,1.05731678437213,3003,3,WNT6
REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS%GOBP%GO:0099072,0.24869246861924696,0.629273639847723,-0.30570462382609803,-1.1862476350408,1901,18,RAB8A|SYNJ1|CTNND1|DNM1|ARHGAP44|STX1B|STX3|GPHN|DNM3
NEGATIVE REGULATION OF CHEMOKINE-MEDIATED SIGNALING PATHWAY%GOBP%GO:0070100,0.26279282816385297,0.638514088500817,-0.547200947515874,-1.1979372596617,2007,4,SLIT2|RNF113A
ACETYL-COA BIOSYNTHETIC PROCESS%GOBP%GO:0006085,0.8976828950794059,0.9674268340009909,-0.22193810657847401,-0.638928746284281,6895,8,PDHA1|PDHX
REGULATION OF ERK5 CASCADE%GOBP%GO:0070376,0.938060200668896,0.9806508984207809,-0.5308226731363039,-0.7071832586579141,7011,1,FAM150B
PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0009177,0.344282238442822,0.702174649119653,0.45341616615021296,1.09046327947125,2546,5,DCTD|CDADC1|DUT|HDDC2
GLYCOPROTEIN METABOLIC PROCESS%GOBP%GO:0009100,0.305849369185676,0.677423587903087,-0.139244337306484,-1.0731124335300999,2399,264,VCP|ST6GALNAC4|ARSB|UBE2G2|B3GLCT|KRTCAP2|GALNT10|HS3ST5|DCN|CHST7|MGAT1|DAD1|NDST1|SEL1L|GALNT18|GCNT2|FUT9|PARK7|NEU4|GALNT16|BGN|MUC4|ERP44|VCAN|GALNT1|SULF1|IGF1|TNIP1|B4GALT7|PCSK6|B3GALT2|HS3ST4|HYAL1|MUC20|SYVN1|EXT2|MUC15|B3GAT3|GFPT2|CANT1|B4GALT1|B3GNT5|SRD5A3|B3GALT6|DERL3|GANAB|DOLK|B4GAT1|HEXB|ALG6|MAGT1|CSGALNACT1|DOLPP1|B3GALT1|XYLT2|ST3GAL5|SERP1|ENGASE|RPN1
CYTOTOXIC T CELL DIFFERENTIATION%GOBP%GO:0045065,0.518528357019525,0.8047799431921201,0.7403506837229821,0.98715773911212,3903,1,CD8A
CELLULAR RESPONSE TO UV-A%GOBP%GO:0071492,0.305466237942122,0.677423587903087,0.6811298183971639,1.14438603913792,2279,2,CERS1|PPID
DETECTION OF VISIBLE LIGHT%GOBP%GO:0009584,0.174037674037674,0.54811765844537,0.42505455365088,1.2917015857668899,1274,9,PDE6B|GNGT1|EYS|REEP6|GNA11|GNB1
POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY%GOBP%GO:0032077,0.523803261441347,0.8077007274422849,-0.390194131921465,-0.935220878322235,3982,5,PRKCD|DDX11|RPS3|AKT1|PCNA
AMP BIOSYNTHETIC PROCESS%GOBP%GO:0006167,0.548974324140742,0.81957665032857,0.41680913252081797,0.915747415065066,4040,4,ADSL|ADSS|APRT
LATE VIRAL TRANSCRIPTION%GOBP%GO:0019086,0.6830593669338411,0.885415243771438,0.374254595779597,0.822253285547358,5027,4,MON1B|CCNT2
GRANULOCYTE DIFFERENTIATION%GOBP%GO:0030851,0.40340537000654897,0.7411577915108121,-0.403786410413627,-1.0386474220325101,3079,6,CBFA2T3|CEBPA|TAL1
MYD88-INDEPENDENT TOLL-LIKE RECEPTOR SIGNALING PATHWAY%GOBP%GO:0002756,0.0381201044386423,0.278599757108718,-0.38012436006451705,-1.59598310921319,291,23,FADD|UBC|CD300LF|TICAM1|TRAF3|TLR4|CD14|LY96
REGULATION OF HEXOKINASE ACTIVITY%GOBP%GO:1903299,0.582193582325092,0.8387093286508721,-0.37193216682610797,-0.8914504326923491,4426,5,BAD
POSITIVE REGULATION OF LOCOMOTION%GOBP%GO:0040017,0.00012758356723653998,0.00518555396908895,-0.26395980044476997,-2.1483720394090198,0,373,FLT1|MAPRE2|PYCARD|NCKAP1L|CD74|GNB2L1|TNFRSF14|F10|ADAM8|CCL19|PIK3C2A|TSG101|AGT|DAB2IP|LAMC2|PPM1F|SPOCK2|KDR|STX4|NUMB|P2RX4|FGR|EMC10|SEMA6A|TRIP6|PDCD6|CCL24|HGF|MOSPD2|GPI|SOD2|SPN|GATA3|TNFRSF18|PDGFD|AZU1|CAV2|PLAU|SRPX2|VEGFC|GAS6|INS|THY1|DDR2|BCAR1|RREB1|FOXC2|VTN|CREB3|DOCK5|ATP5B|MYLK|SMOC2|PDGFC|ZNF268|FLT4|PHPT1|NOTCH1|GPNMB|SMURF2|STAT3|GCNT2|PRKD1|MADCAM1|ICAM1|DSCAM|F3|BCAS3|TRIM32|SNAI2|MMP14|PLA2G7|FGF10|RHOD|ABL1|CALR|HMOX1|HSPB1|NTN1|SPARC|HRAS|PIK3R3|IGF1|SEMA3B|SEMA3D|NSMF|SEMA7A|RHOJ|HBEGF|C10orf54|DOCK1|CSF1|CTSH|CXCL16|PDPN|GPER1|MAP2K3|PLVAP|F2R|CCR1|FN1|INSL3|SASH1|NOS3|HYAL1|VEGFB|NRP2|LGALS3|CD151|BMP2|FGF9|LGALS9|THBS1|ZP3|TEK|ATOH8|SUN2|FGF7|STX3|COL1A1|SEMA5A|FADD|AIF1|PDGFRB|SEMA3E|RARRES2|NEDD9|SYDE1|SLIT2|FAM89B|FOXP1|MMP9|IGFBP5|SNAI1|SERPINE1|CAV1|FAM107A|SEMA3A|DDB1|SEMA6B|PLAA|PTRF|FERMT3|DAB2|PDGFA|CSF1R|TIAM1|PDGFRA|HSPA5|CMKLR1|ANXA1|LGMN|TMSB4X|GLIPR2|ARF6|SPHK1|PDGFB
NEUROPEPTIDE SIGNALING PATHWAY%GOBP%GO:0007218,0.7579734873342959,0.917143966125732,-0.19210697634240198,-0.7826452048542991,5774,21,LTB4R|PYY|CYSLTR2|NXPH4|SSTR2
OXIDATION-DEPENDENT PROTEIN CATABOLIC PROCESS%GOBP%GO:0070407,0.565351170568562,0.8298130582102241,-0.7208314953683279,-0.960320633679746,4225,1,LONP1
REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL%GOBP%GO:0003057,0.0703678929765886,0.3767214120425879,-0.9633877370974859,-1.28346378885126,525,1,ADRBK1
RESPONSE TO TEMPERATURE STIMULUS%GOBP%GO:0009266,0.10199100834939,0.441073279931729,-0.220437288170202,-1.32047145254035,793,79,SLU7|ERO1L|PDCD6|HSBP1L1|C8orf4|EIF2B1|VCP|DHX36|BAG3|HSPA6|HSPA9|RBBP7|HMOX1|SOD1|IGF1|NFKBIA|NOS3|THBS1|EIF2B2|YBX3|PRKACA|HSP90AA1|HSPA5|METRNL|EIF2B3
MANNOSYLATION%GOBP%GO:0097502,0.7839924160346701,0.927080511528825,0.203152624965728,0.7493462908034859,5788,15,LARGE|DPY19L3|DPY19L1|DPY19L2|DPM1|DPY19L4|PIGB
URETERIC BUD MORPHOGENESIS%GOBP%GO:0060675,0.36292073832790395,0.7173944076687071,0.32513731103599997,1.06990140066356,2673,11,CITED1|PAX8|FGF2|PKD2|FGF1
PEPTIDYL-ARGININE DEGLYCATION%GOBP%GO:0036527,0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS%GOBP%GO:0034249,0.806497357225732,0.9337214381011629,-0.12357315199801899,-0.8130725557466542,6255,116,FMR1|DHX36|DDX3X|ZNF540|GGA3|STAT3|FXR1|ORMDL3|MALSU1|CALR|TNRC6C|DHFR|APOE|GAPDH|UNK|CPEB1|PAIP2|EIF4A3|IGFBP5|EIF2S1|RBM4|CAPRIN1|PRNP
POSITIVE REGULATION OF EXTRACELLULAR EXOSOME ASSEMBLY%GOBP%GO:1903553,0.48648281483494105,0.787704526445195,0.43821923513864897,0.96278632232216,3580,4,SDC1|PDCD6IP|SDCBP
MICROTUBULE NUCLEATION BY SPINDLE POLE BODY%GOBP%GO:0051417,0.419179173861071,0.750814005874236,0.7915747684164091,1.05545814423874,3155,1,MZT1
POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS%GOBP%GO:0010893,0.9632814632814631,0.990916952887267,0.183996614971333,0.5591487428915289,7056,9,STARD4|WNT4|FGF1|PRKAA1
CMP-N-ACETYLNEURAMINATE METABOLIC PROCESS%GOBP%GO:0046381,0.0612709030100335,0.35631208031004796,-0.967798853109837,-1.28934045455113,457,1,NANS
DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS%GOBP%GO:0046121,0.10664523043944302,0.449288135667161,0.8040253653156879,1.3508664256474001,795,2,DERA|DPYD
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION%GOBP%GO:0050680,0.000388550705867116,0.0111294649577428,-0.36896118152631996,-2.03886045395616,2,58,TGFB2|VASH1|PDCD10|ROBO1|MTSS1|TGFB1|RGCC|CDK6|FLT1|RUNX3|DAB2IP|TINF2|CDKN1C|MED1|SYNJ2BP|SFRP2|GATA3|ATPIF1|CAV2|CASK|MEF2C|SNAI2|CDKN2B|GHRL|SPARC|SULF1|CCL2|CEACAM1|APOE|TGFBR3|THBS1|ATOH8|NR2F2|CAV1|PPARG|MAGED1|MCC|NGFR
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS%GOBP%GO:1905461,0.752104155707522,0.915314007578303,-0.320124577023344,-0.767277525733175,5718,5,SOD2|PPARG
POSITIVE REGULATION OF BMP SIGNALING PATHWAY%GOBP%GO:0030513,0.102694924123496,0.441229839424518,-0.376497166529707,-1.39920925328863,784,16,SMAD4|BMP4|CYR61|SOX11|RNF165|UBE2O|NOTCH1|SULF1|ENG|ACVRL1
PHOSPHATE ION TRANSPORT%GOBP%GO:0006817,0.36905085667663895,0.72201432219986,0.336566289727199,1.06626475608639,2713,10,SLC25A30|XPR1|SLC37A3|SLC20A1|SLC20A2|SLC37A1|SLC25A14
REGULATION OF CARTILAGE DEVELOPMENT%GOBP%GO:0061035,0.32343363292953003,0.6920393275123959,-0.25608075815492,-1.10400003060827,2482,25,BMP2|ANXA2|EFEMP1|ACVRL1|LOXL2
MESENCHYMAL CELL PROLIFERATION%GOBP%GO:0010463,0.39071541294055795,0.7364714265545841,-0.438724187846258,-1.05153816198694,2970,5,BMP2|FGF7
FOREGUT MORPHOGENESIS%GOBP%GO:0007440,0.453244147157191,0.769943206592495,-0.7742059991177771,-1.03142828864815,3387,1,SOX17
VIRAL TRANSLATION%GOBP%GO:0019081,0.6443629697525209,0.8688307429995409,-0.24847955546398398,-0.855314815535807,4920,13,EIF3B|MCTS1|EIF2D
NEGATIVE REGULATION OF INTERLEUKIN-5 SECRETION%GOBP%GO:2000663,0.14862876254180601,0.5154128781388279,-0.923522276135862,-1.2303534225886998,1110,1,TNFRSF21
REGULATION OF WHITE FAT CELL PROLIFERATION%GOBP%GO:0070350,0.965466861468987,0.990916952887267,0.516541685046317,0.6887386385642621,7268,1,VSTM2A
LACTATE TRANSPORT%GOBP%GO:0015727,0.5564461350360009,0.8257149029717741,0.41461481488909296,0.9109264057773591,4095,4,SLC16A8|EMB|SLC16A7|SLC16A1
G0 TO G1 TRANSITION%GOBP%GO:0045023,0.280010718113612,0.653204101106396,0.693575958092087,1.1652971608115401,2089,2,CDK3|MDM4
POSITIVE CHEMOTAXIS%GOBP%GO:0050918,0.14433665443104401,0.510760541459938,-0.3763420210617971,-1.33144303662529,1100,14,GPNMB|FGF10|LGALS3|FGF7|SEMA5A|PTPRJ
MITOCHONDRIAL RNA SURVEILLANCE%GOBP%GO:2000827,0.7069996015407092,0.894949003158309,0.6461182179091309,0.861511461005126,5322,1,SUPV3L1
SULFUR AMINO ACID BIOSYNTHETIC PROCESS%GOBP%GO:0000097,0.38107114728275104,0.729499056535481,-0.291390179733665,-1.05799050862127,2902,15,CDO1|GGT1|ADI1|GGT5|APIP|MTHFD1
"GUANINE DEGLYCATION, METHYLGLYOXAL REMOVAL%GOBP%GO:0106045",0.280133779264214,0.653204101106396,-0.856859285399206,-1.14154231219944,2093,1,PARK7
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY%GOBP%GO:0010716,0.0335034681324434,0.261345744270986,-0.718330884880996,-1.57257646513805,255,4,DPP4|FAP|CST3
EMBRYONIC NAIL PLATE MORPHOGENESIS%GOBP%GO:0035880,0.7582680302829058,0.917143966125732,0.62097485663873,0.827986181416601,5708,1,MSX1
IN UTERO EMBRYONIC DEVELOPMENT%GOBP%GO:0001701,0.625494205862304,0.858842084733938,0.17129665493371396,0.8890076759344999,4587,44,PTPRR|FGFR2|INPP5K|BMP7|PKD1|ZNF568|CASP8|PKD2|EGFL8|CHD7|HINFP|IGF2|ARNT2|ADAM10|FLCN|LIG4|NPM2|HEY2|HAND1|LEF1
NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS%GOBP%GO:2000110,0.7102679755903419,0.8964108318214721,-0.5119722830282349,-0.852003749482595,5353,2,IRF7
POSITIVE REGULATION OF BILE ACID METABOLIC PROCESS%GOBP%GO:1904253,0.6616500940607359,0.8792094365513811,0.42688625038961603,0.839634878624521,4923,3,STARD4|STAR
NEGATIVE REGULATION OF NEGATIVE CHEMOTAXIS%GOBP%GO:0050925,0.634780278670954,0.8634223229282929,0.5323433103630519,0.8944054950369491,4737,2,ROBO2|ROBO1
DETECTION OF HEXOSE STIMULUS%GOBP%GO:0009732,0.163719185423366,0.5351003413847161,0.7607940446650121,1.27823222513252,1221,2,GCK|NKX6-1
CHONDROCYTE PROLIFERATION%GOBP%GO:0035988,0.40925975059697495,0.7448505271608159,-0.6365039977943199,-1.05924443697182,3084,2,STC1|DDR2
ENDOPLASMIC RETICULUM MEMBRANE FUSION%GOBP%GO:0016320,0.931414168214381,0.9793746057014829,-0.37447795609374,-0.623191202467594,7020,2,BNIP1
SEROTONIN PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE%GOBP%GO:0002351,0.667023411371237,0.880719592999549,-0.6703242170269079,-0.8930328114162521,4985,1,SYK
CALCIUM-MEDIATED SIGNALING USING EXTRACELLULAR CALCIUM SOURCE%GOBP%GO:0035585,0.404864283794679,0.7419998354794191,0.5370592224934679,1.05633211348672,3012,3,CACNA1C|P2RX7|DMTN
REGULATION OF WNT SIGNALING PATHWAY%GOBP%GO:0030111,0.0140953357252691,0.158905959799987,-0.199421628385695,-1.47907046337645,109,213,GNB2L1|TMEM88|KANK1|SMARCA4|RUNX1|UBE2B|TERT|JUP|CTNND1|DAB2IP|PRDM15|SOX17|TLR2|TAX1BP3|LRP1|SFRP4|WLS|RUVBL1|SFRP2|MLLT3|CBY3|FRAT1|WWOX|CTNND2|MDFIC|APCDD1|VCP|MESP1|ILK|TNFAIP3|SLC9A3R1|DDX3X|SIAH2|SENP2|SMURF2|ATP6AP2|DAAM2|SNAI2|SULF1|NKD2|NFATC1|GPRC5B|GNAQ|HIC1|STK3|MDFI|APOE|USP47|PPP2CA|BMP2|WWTR1|COL1A1|SEMA5A|XIAP|SDHAF2|DACT3|LATS2|IGFBP6|CAV1|ADGRA2|CHD8|DACT1|NFKB1|NXN|DAB2|TIAM1|MCC|CSNK1A1|IGFBP4|EMD|PPP1CA|DEPDC1B|AMER2|GRB10|WNK2
RIBOSOME BIOGENESIS%GOBP%GO:0042254,0.99930526608309,0.999667442561284,0.0756516475720585,0.576695602020633,7191,228,FDXACB1|WDR12|WDR75|NUP88|IMP4|EBNA1BP2|DDX27|MPHOSPH6|DIS3L2|PIH1D1|TFB1M|RPS27L|BTRC|RPL26|MDN1|EXOSC10|MRPS9|DCAF13|HEATR1|AAMP|TSR1|FASTKD2|PDCD11|WDR18|MTERF4|ISG20L2|C1QBP|RPF1|ERAL1|EFTUD1|UTP20|XRN2|C1D|XPO1|UTP3|PELP1|BMS1|RNMTL1|NOP58|EXOSC8|WDR46|RPL23A|NSUN4|GAR1|RPF2|CIRH1A|ZNHIT6|NSUN3|NOL10|RPS24|UTP6|WBSCR22|URB2|NIP7|MPHOSPH10|GLTSCR2|PIH1D2|MRTO4|POP5|RPS21|DIEXF|DIS3|RPL14|TFB2M|RPS19
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION%GOBP%GO:0044328,0.603745819397993,0.848175106515994,-0.7015328628142921,-0.934610221242822,4512,1,PPAP2B
POSITIVE REGULATION OF HYDROGEN PEROXIDE CATABOLIC PROCESS%GOBP%GO:1903285,0.5890556514809399,0.8414799095069009,0.7033524481693871,0.937825584279005,4434,1,SNCA
NUCLEOTIDE CATABOLIC PROCESS%GOBP%GO:0009166,0.026091449237922996,0.227301678500391,-0.266395083095047,-1.5468503705064198,201,70,DNPH1|DCTPP1|GPI|PFKFB2|NUDT17|GPX1|HK1|VCP|NUDT1|HK3|PDE4D|NUDT16|PDE2A|ENO1|PGAM1|HPRT1|GAPDH|NUDT18|NUDT4|LDHA|ABCD1|HINT1|PNP|PGK1|SAMHD1|ALDOA|ALDOC
POSITIVE REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT%GOBP%GO:0045844,0.786211604095563,0.9274485629622209,0.176214088377515,0.767750016010708,5758,25,FGFR2|DLL1|FGF2|RBM24|EFNB2|FLOT1|BMPR1A|GPC1|MKL2
NEGATIVE REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION%GOBP%GO:1900158,0.533055630206934,0.812079525085925,0.475112135295179,0.934489503204922,3966,3,FAM101B|FAM101A|GREM1
RIBONUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS%GOBP%GO:0034030,0.715988598082405,0.899551221015245,-0.165215330645612,-0.8325397304666311,5525,42,ACSL5|DCAKD|COASY|ACSL4|ELOVL2|PDHA1|ACSF3|ELOVL1|SLC26A2|HACD2|PDHX|FASN
REGULATION OF SIGNALING RECEPTOR ACTIVITY%GOBP%GO:0010469,0.47695104531879,0.7850984235874658,-0.17005726077303102,-0.982669370509285,3672,69,MED1|SHISA7|PLAU|FCGR2B|PDE4D|CRHBP|MEF2C|PARK7|CAPN1|CNIH2|SNX6|VPS25|HFE|ADRA2C|CHMP6|ERRFI1|SERPINE1|CNIH3|NPTX2|NPTXR
NCRNA CATABOLIC PROCESS%GOBP%GO:0034661,0.6529811715481171,0.873648503959312,-0.201934703266328,-0.858216795942345,4993,24,EXOSC7|EXOSC4|POP1|LIN28B|SLFN13|NUDT16|PELO|EXOSC3|EXOSC2
NEGATIVE REGULATION OF NEUROFIBRILLARY TANGLE ASSEMBLY%GOBP%GO:1902997,0.982733430734493,0.993436724391485,0.507940008822232,0.677269463968187,7398,1,SORL1
WATER-SOLUBLE VITAMIN BIOSYNTHETIC PROCESS%GOBP%GO:0042364,0.0888538380651945,0.41228493992510207,-0.533943547142947,-1.45951087524265,675,7,RFK|PNPO|PDXK
REGULATION OF PLANT EPIDERMAL CELL DIFFERENTIATION%GOBP%GO:1903888,0.256342143710984,0.634929462604421,0.873786943096603,1.16507698605122,1929,1,GAL
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III ASSEMBLY%GOBP%GO:0034551,0.88015288015288,0.9616184093028008,0.21705833720404996,0.659620267474375,6447,9,TTC19|BCS1L|UQCC1
ADIPONECTIN-ACTIVATED SIGNALING PATHWAY%GOBP%GO:0033211,0.44954848841774603,0.7682357359081929,-0.457855818641499,-1.0023420960682001,3434,4,ADIPOR1|ADIPOR2
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION%GOBP%GO:0003006,0.00276854928017719,0.0515747408650331,0.23418559227358798,1.65093387500827,19,154,NPHP1|LRRC6|SPAG6|STRA6|DDX25|CYP27B1|FGFR2|BBS4|SRD5A1|CITED1|PPARD|CDKL2|TBX3|CFAP44|CFAP43|PSME4|RAB13|WNT2B|TSSK6|ITGB8|KIT|ROBO2|C14orf39|DZIP1|C9orf117|IQCG|PTPRN|BMP7|BRCA2|NME5|PKD1|CHD5|PDE3A|SLIT3|ZNF568|EIF2B4|CASP8|ADCYAP1|PCSK4|CEP57|STOX2|WNT4|MKKS|CUL7|PKD2|DNAH1|CITED2|MAST2|CATSPER2|BBS2|CHD7|RQCD1|DPY19L2|LRP6
NEURON-NEURON SYNAPTIC TRANSMISSION%GOBP%GO:0007270,0.48675451704931394,0.78790014907289,0.438145317151249,0.9626239213558481,3582,4,DRD2|KIF1B
POLYADENYLATION-DEPENDENT MRNA CATABOLIC PROCESS%GOBP%GO:0071047,0.6193451976633609,0.854944793214197,0.39443212358558094,0.866584173450374,4558,4,PNPT1|EXOSC8
CARBOXYLIC ACID CATABOLIC PROCESS%GOBP%GO:0046395,0.25821269487750603,0.636098664976652,0.15269158460284302,1.10886559844222,1854,179,AASS|ALDH3A2|LPIN1|BDH2|PPARD|AADAT|HADHB|GNPDA2|GCSH|SLC25A17|DDAH1|GLS|ADHFE1|ACBD5|FGF2|SORD|BCKDHB|BLMH|HADHA|NUDT7|PEX2|AMT|GLUD1|HIBCH|PEX13|PCBD1|QDPR|ACADVL|HMGCLL1|HOGA1|ACADSB|ACADM|ACAT1|SHMT1|GCDH|ECHDC1|PIPOX|MCAT|CSAD|PM20D2|PCYOX1|ACAD8|ACOT7|ACOX2|ACAA2|HRSP12|ACAD11|ECI1|GLS2|ACADS|IDUA|CHP1|CTH|ECHS1|HMGCL|MECR|ACOX3|AKR1A1|ALDH7A1|EHHADH|ACOT8|ABCD3|TXN2|MPST|PHYH|AMDHD2|IVD|GSTZ1
"NEGATIVE REGULATION OF MAINTENANCE OF MITOTIC SISTER CHROMATID COHESION, CENTROMERIC%GOBP%GO:2000719",0.44709030100334396,0.768229288546963,-0.7780657256285842,-1.03657037113554,3341,1,NAA10
LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY%GOBP%GO:0032511,0.700338453527727,0.8931369333627571,-0.278226847131925,-0.800976152140747,5379,8,VPS25|SNF8
ASPARTYL-TRNA AMINOACYLATION%GOBP%GO:0006422,0.154735024571656,0.522998966467616,0.925176444640494,1.23359795222777,1164,1,DARS
GLOMERULAR CAPILLARY FORMATION%GOBP%GO:0072104,0.0408730158730159,0.289643994810875,-0.777165282157383,-1.51760682432233,308,3,PDGFRB|PDGFRA
PHOSPHOLIPID METABOLIC PROCESS%GOBP%GO:0006644,0.355164049534023,0.7132037834765931,-0.136261884768053,-1.0474338155099399,2781,261,PLA1A|ABHD3|GPX4|PGS1|INPP5B|ACP6|PLCB1|GPAA1|PGP|DPM2|PIK3C2A|ACHE|PTDSS2|IDI1|SOCS3|RAB14|GPD1|PYURF|AGPAT1|GPAM|FDPS|TMEM55B|GDE1|PLA2G2A|FAR1|PLEK|PPAP2C|PLA2G2D|PCYT1A|MTMR12|PLSCR1|CPNE6|CHPT1|PIGP|TMEM86B|PLA2G4D|ETNK2|PLA2G4A|SOCS1|CDIPT|CISH|DGKE|SMPDL3A|CETP|PLA2G7|PIK3CB|ABHD5|PIK3R3|MTMR1|ARF1|TTC7B|PLD1|PLA2G4C|SERINC5|SLC44A1|PLA2G16|SYNJ2|HMGCS1|FAM126A|PPAP2A|INPP4B|FITM2|PIGH|PDGFRB|PLEKHA4|NDUFAB1|SRD5A3|LPIN3|PLAA|DOLK|PCTP|CSF1R|SMPD1|PLBD1|DOLPP1|AGPAT2|FADS1|LPIN2|PTPMT1|AGPAT3|OSBPL5|PLA2G12A
NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION%GOBP%GO:0045835,0.9442481350608559,0.982694945797028,-0.27042718001585697,-0.592021626491866,7214,4,TRIP13|RAD1
L-ASPARTATE TRANSMEMBRANE TRANSPORT%GOBP%GO:0070778,0.47744759883258203,0.7850984235874658,-0.6076708961626159,-1.0112615450970501,3598,2,SLC1A3
REGULATION OF ACTIN FILAMENT BINDING%GOBP%GO:1904529,0.899708145396657,0.9678510292896422,-0.40116175957510797,-0.667597318521592,6781,2,ABL1
DETERMINATION OF ADULT LIFESPAN%GOBP%GO:0008340,0.7092457420924569,0.8960839116793909,0.331260675802502,0.796680025687014,5246,5,WRN|MSH6|IDE
DETERMINATION OF PANCREATIC LEFT/RIGHT ASYMMETRY%GOBP%GO:0035469,0.276049449803016,0.651140142171734,0.531413714627326,1.1675385626916202,2031,4,NPHP3-ACAD11|NPHP3|CCDC40
PHOTOTRANSDUCTION%GOBP%GO:0007602,0.0423014145810664,0.294833299013666,0.46605208635594203,1.58402039348718,310,12,PDE6B|PLEKHB1|GNGT1|OPN3|CDS1|UNC119
LOW-DENSITY LIPOPROTEIN PARTICLE MEDIATED SIGNALING%GOBP%GO:0055096,0.487540192926045,0.788226301622024,0.597242900468707,1.00344518593972,3638,2,LPL|CDH13
MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN LUNG DEVELOPMENT%GOBP%GO:0060915,0.0572453181033338,0.34436604181231795,0.97160344067049,1.29550208690658,430,1,FGFR2
PHOTORECEPTOR CELL DEVELOPMENT%GOBP%GO:0042461,0.0233251966368321,0.212363156406034,0.469287126804266,1.6867920570842099,171,14,BBS4|CDHR1|AHI1|GNGT1|ARL3|CEP290
POSITIVE REGULATION OF MEMBRANE PERMEABILITY%GOBP%GO:1905710,0.679445244014131,0.884536278926676,-0.21961966246925801,-0.834608347672842,5192,17,STPG1|BAD
NEGATIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS%GOBP%GO:1900543,0.089173640167364,0.41228493992510207,-0.46796991056958004,-1.46608864081411,681,10,PID1|PPIF|PARP1|CBFA2T3|PDE12|PPARA
CALCIUM-INDEPENDENT CELL-MATRIX ADHESION%GOBP%GO:0007161,0.7406216505894959,0.909493931144346,0.47779882346129904,0.802763714518231,5527,2,PKD1|ITGB1
MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL%GOBP%GO:0086046,0.0786577910609972,0.393097409792852,0.665383136942909,1.46187508896034,578,4,SCN5A|ANK2
OSTEOCLAST DEVELOPMENT%GOBP%GO:0036035,0.10925925925925901,0.45349438410841897,-0.702822005058361,-1.3724332463740598,825,3,FOXP1|ANXA2
PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS%GOBP%GO:0006656,0.806499864019581,0.9337214381011629,0.173042836505808,0.745403355696318,5930,24,LPIN1|SLC44A5|LCAT|SLC27A1
INTERLEUKIN-21 SECRETION%GOBP%GO:0072619,0.12013377926421401,0.47223724623656504,-0.938134097926775,-1.24981987771951,897,1,FOXP1
CELLULAR CREATININE HOMEOSTASIS%GOBP%GO:0097276,0.311329525833444,0.68160868787154,0.845059550066167,1.12677288371433,2343,1,TFAP2B
HEME A BIOSYNTHETIC PROCESS%GOBP%GO:0006784,0.09244372990353698,0.420939346122012,0.8164323132065071,1.3717117000298602,689,2,COX10|COX15
CHOLESTEROL CATABOLIC PROCESS%GOBP%GO:0006707,0.11237721021611,0.45952567367629604,-0.548780100031595,-1.4116102510153299,857,6,CYP46A1|SCARF1|APOE
REGULATION OF ISOPRENOID METABOLIC PROCESS%GOBP%GO:0019747,0.221676837357389,0.604285118926805,-0.7229596323490359,-1.20312043816631,1670,2,NPC2
ENDOTHELIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE%GOBP%GO:0002264,0.40735785953177295,0.7445496113654559,-0.796923246581385,-1.06169311700248,3044,1,C8orf4
CORTICOSPINAL NEURON AXON GUIDANCE THROUGH SPINAL CORD%GOBP%GO:0021972,0.121070234113712,0.472999327000989,-0.937858403176003,-1.2494525861132701,904,1,SLIT2
PEYER'S PATCH DEVELOPMENT%GOBP%GO:0048541,0.004648691725328729,0.0752560935123842,0.998014997794442,1.3307183345445301,34,1,RET
REGULATION OF CENTROSOME CYCLE%GOBP%GO:0046605,0.184472290401757,0.557533473973628,-0.237524541476508,-1.2304518615517799,1427,46,PLK2|NPM1|CDK5RAP2|BRCA1|SPICE1|CEP131|NSFL1C|RBM14|KAT2B|FBXW5|CETN2|ATF5|XRCC3
MITOCHONDRIAL DNA REPAIR%GOBP%GO:0043504,0.7129956811935609,0.897735989983013,-0.36392213092152403,-0.7967016179805351,5447,4,MGME1|LIG3|DNA2|PARP1
REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION%GOBP%GO:0043416,0.902228707880074,0.968486494114721,-0.39862145023435297,-0.66336983755257,6800,2,CAPN3|SOX15
ENSHEATHMENT OF NEURONS%GOBP%GO:0007272,0.8432174505794141,0.9481593344082329,0.142157840824957,0.7377809668061879,6184,44,PPARD|NFASC|PARD3|TENM4|MARVELD1|EIF2B4|NF1|EPB41L3|SCN2A|ZSCAN26|ARHGEF10|SKI
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS%GOBP%GO:1903587,0.33743777835996897,0.699636319850872,-0.338326764299327,-1.09535110207584,2575,11,HMOX1|APLNR|THBS1|NGFR
"NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME, TELOMERIC REGION%GOBP%GO:1904815",0.37397187582913205,0.724682900261831,-0.650597199825897,-1.08269777882482,2818,2,H2AFY
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION%GOBP%GO:0051148,0.397808790922134,0.73849471880523,-0.23609598290602,-1.04129862876626,3049,27,NOTCH1|DNMT1|NFATC1|HDAC5|NOV|BMP2|FGF9|PDGFB
XENOBIOTIC METABOLIC PROCESS%GOBP%GO:0006805,0.866847125547822,0.9555750264459809,-0.129381897063072,-0.7347235421486009,6724,64,AKR7L|STAT5A|POR|CES1|CDO1|FMO3|BCHE|RORA|CYP1B1|AHR|GGT1|NAT1|GRIN1|PTGS1|DPEP1|N6AMT1|CYP46A1|AIP|FMO2|GSTP1|AOC3
AGE-DEPENDENT GENERAL METABOLIC DECLINE%GOBP%GO:0007571,0.40414715719063593,0.7412049911665691,-0.7982465813850899,-1.06345611671244,3020,1,SOD2
KININ CASCADE%GOBP%GO:0002254,0.9991961414791,0.999656642395059,0.26269644334160497,0.4413639429246429,7457,2,KLKB1|F12
NEUROENDOCRINE CELL DIFFERENTIATION%GOBP%GO:0061101,0.779377801929086,0.924704689181848,0.34322152415312396,0.7540723055587479,5736,4,INSM1
FATTY ACID DERIVATIVE CATABOLIC PROCESS%GOBP%GO:1901569,0.588434912447401,0.8414799095069009,0.33997865634463303,0.8797147556259929,4334,6,ACAT1|ACOT7|BDH1|OXCT1
REGULATION OF TAU-PROTEIN KINASE ACTIVITY%GOBP%GO:1902947,0.48593454152015203,0.7872939093021379,0.348764866509595,0.962756052603498,3592,7,DKK1|NAB2
POSITIVE REGULATION OF TRANSLATIONAL INITIATION%GOBP%GO:0045948,0.140700879380496,0.505564604777695,-0.32473899359213504,-1.3229889981251899,1071,21,POLR2G|RPS6KB1|NCK1|RPS6KB2
ADAPTATION OF SIGNALING PATHWAY%GOBP%GO:0023058,0.12612966601178802,0.48175523567590006,-0.538588816153816,-1.38539552349141,962,6,ADRB2|ADM|ARRB1|ADRBK1|GTF2H2
REGULATION OF INTRACELLULAR PH%GOBP%GO:0051453,0.25991189427312805,0.636098664976652,-0.228410063427752,-1.15098551628906,2005,42,PPT1|CLN6|SLC9A5|ATP6V0A1|SLAMF8|GPR89B|TCIRG1|ATP6V0A2|RAB7A|ATP5B|DMXL1|ATP6V0D1|CA2|SLC9A1|SLC9A7|SLC11A1|SLC9A9|ATP6V0E1|ATP6V0E2|RAB20
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION%GOBP%GO:0110057,0.36140257670341297,0.716154857259883,0.820632995147772,1.09420336867548,2720,1,FOXJ2
